Citrus Sinensis ID: 007869

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580------
Protein Sequence
MPFKNKNSNSSTANGTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGLFNDTNLGNETNHVFAVELDTIKSHGFLDINDNHVGIDINSLKSESSAPAGYYVEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSVLNDAMYVGFSSSTGSVLASHYILGWSFKINGQAEELNLSQLPKLPRVGPKKRSKFLTIGLPVICVSVIFAAVSGVVYVIRMKRKFAEELEDWELDHGPHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERDVALPAISALRLSTSGITYLEGFDDFAVSNPPSMGFTRPSSVAESLLSGGR
Secondary Structure (PSIPRED)
cccccccccccccccEEEEEEEEEEEEEEcccccccccEEEEEEccccccccccccccEEcccccccccccccEEEEEEEccccccccccccccEEEEcccccccccEEEEEEEEEEccccEEEEEEEEcccccccccccccccccccccccccEEEEEEccccccEEEEEEEEEEccccccccccccccccccccccccccccEEEEEEEHHHHHHHHHHHHHHHHHHEEcccHHHHHccccccccccEEcHHHHHHHHcccccccccccccccEEEEEEccccccEEEEEEccccccccHHHHHHHHHHHHccccccccccccEEEcccEEEEEEEccccccccccccccccccccHHHHHHHHHHHHHHHHHHHcccccEEEEccccccccccccccccccccccccccccccccccccEEccccccccccccccccccccccEEEHHHHHHHccccccccccccccccccHHHHHHHHHccccccccccccccccccHHHHHHHHHHHHccccccccccccHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
ccccccccccccccccEEEEEEEEEEEEEcccccccccEEEEEEEcccccccccHHHHcEEEEcccccccccEEEEEEEEccccccccccccccEEEEEcccccccccccEEEEEcccccEEEEEEEccccccccccccEEEEEEccHHHccccEEEEEEcccccEccEEEEEEEEEccccccccccHHHcccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccHHHHHHHHcccccccccccccccEEEEcEccccccEEEEEEEccccHccHHHHHHHHHHHHHcccHHHHHHHHHHcccccEEEEEEccccccHHHHHcccccccccHHHHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEcccccEEEccccccEEcccccEEcccccccccccccHHHHHHcEEcHHHHHHHHHHHHHHHHccccccccccccccEEEHHHHHHHHHcccHHHHccHHHcccccHHHHHHHHHHccccccccccccccHHHHHHHHccccccccccccccccHHHHHcccccccEcccccccccccccccEcccccccc
Coil and Loop (DISEMBL)
mpfknknsnsstangtvfSFSTTFVFSILSEYQSQSGHGIAFVIAStrglpgarpsqylglfndtnlgnetnhVFAVELDtikshgfldindnhvgidinslksessapagyyveydglekrtnvtlapiniprprslntmsLSRDLSSVLNDAMYvgfssstgsvlaSHYILGWSfkingqaeelnlsqlpklprvgpkkrskfltiglPVICVSVIFAAVSGVVYVIRMKRKFAEELEDweldhgphrfrykdLYIATKgfrekellgtggfgrvyrgtlpksQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLvydympngsldkylydqpkvtLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKasnvlldgelngrlgdfglarlydhgtdpqtthvvgtlgylapehtrtgkattsadvFSFGAFLLEVacgrrpiqrqgpsenliLVDWVFDFwnrgelleardpnlgteYVAEELELVLKLGLlcshsdptarpsMRQVVQILERDVALPAISALRLstsgitylegfddfavsnppsmgftrpsSVAESLLSGGR
Flexible Loop (DISEMBL)
mpfknknsnsstangTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGLFNDTNLGNETNHVFAVELDTIKSHGFLDINDNHVGIDINSLKSESSAPAGYYVEYdglekrtnvtlapiniprprslntMSLSRDLSSVLNDAMYVGFSSSTGSVLASHYILGWSFKINGQAEELNLSQLPKLPRVGPKKRSKFLTIGLPVICVSVIFAAVSGVVYVIRMKRKFAEELedweldhgphrfrYKDLYIATKGfrekellgtggfgrvyrgtlpkSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRpiqrqgpsenlILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERDVALPAISALRLSTSGITYLEGFDDFAVSnppsmgftrpssvaesllsggr
Low Complexity Region (SEG)
MPFKNKNSNSSTANGtvfsfsttfvfsILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGLFNDTNLGNETNHVFAVELDTIKSHGFLDINDNHVGIDINSLKSESSAPAGYYVEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSVLNDAMYVGFSSSTGSVLASHYILGWSFKINGQAEELNLSQLPKLPRVGPKKRSKFLTIGLPVICVSVIFAAVSGVVYVIRMKRKFAEELEDWELDHGPHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAeelelvlklgllCSHSDPTARPSMRQVVQILERDVALPAISALRLSTSGITYLEGFDDFAVSNPPSMGFTRPSSVAESLLSGGR
Disordered region (IsUnstruct)
***************TVFSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGLFNDTNLGNETNHVFAVELDTIKSHGFLDINDNHVGIDINSLK****APAGYYVEYDGLEKRTNVTLAPINIP************DLSSVLNDAMYVGFSSSTGSVLASHYILGWSFKINGQAEELNLS************RSKFLTIGLPVICVSVIFAAVSGVVYVIRMKRKFAEELEDWELDHGPHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHS*******MRQVVQILERDVALPAISALRLSTSGITYLEGFDDFAV***********************
Disordered Region (DISOPRED)
MPFKNK*SNS****GTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGLFNDTNLGNETNHVFAVELDTIKSHGFLDINDNHVGIDINSLKSESSAPAGYYVEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSVLNDAMYVGFSSSTGSVLASHYILGWSFKINGQAEELN*****************FLTIGLPVICVSVIFAAVSGVVYVIRMKRKF*****D***DHGPHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE****MKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERDVALPAISAL**********************************SLLSGG*
Disordered Region (DISEMBL)
************ANGTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGLFNDTNLGNETNHVFAVELDTIKSHGFLDINDNHVGIDINSLKSESSAPAGYYVEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSVLNDAMYVGFSSSTGSVLASHYILGWSFKINGQAEELNLSQLPKLPRVGPKKRSKFLTIGLPVICVSVIFAAVSGVVYVIRMKRKFAEELEDWELDHGPHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERDVALPAISALRLSTSGITYLEGFDDFAVSNPPSMGF***************
Disordered Region (DISPRO)
*PFKNKNSNSSTANGTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGLFNDTNLGNETNHVFAVELDTIKSHGFLDINDNHVGIDINSLKSESSAPAGYYVEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSVLNDAMYVGFSSSTGSVLASHYILGWSFKINGQAEELNLSQLPKLPRVGPKKRSKFLTIGLPVICVSVIFAAVSGVVYVIRMKRKFAEELEDWELDHGPHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERDVALPAISALRLSTSGITYLEGFDDFAVSN*********************
Transmembrane Helix (TMHMM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
iiiiiiiiiiHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MPFKNKNSNSSTANGTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGLFNDTNLGNETNHVFAVELDTIKSHGFLDINDNHVGIDINSLKSESSAPAGYYVEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSVLNDAMYVGFSSSTGSVLASHYILGWSFKINGQAEELNLSQLPKLPRVGPKKRSKFLTIGLPVICVSVIFAAVSGVVYVIRMKRKFAEELEDWELDHGPHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERDVALPAISALRLSTSGITYLEGFDDFAVSNPPSMGFTRPSSVAESLLSGGR
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	586	2.2.26 [Sep-21-2011]
O80939	675	L-type lectin-domain cont	yes	no	0.988	0.857	0.649	0.0
Q9M345	677	L-type lectin-domain cont	no	no	0.979	0.847	0.612	0.0
O81291	669	L-type lectin-domain cont	no	no	0.977	0.856	0.586	0.0
O81292	674	L-type lectin-domain cont	no	no	0.981	0.853	0.573	0.0
Q9SZD5	669	L-type lectin-domain cont	no	no	0.972	0.852	0.519	1e-177
O04534	666	Putative L-type lectin-do	no	no	0.977	0.860	0.502	1e-169
Q9M2S4	684	L-type lectin-domain cont	no	no	0.889	0.761	0.539	1e-168
Q96285	661	L-type lectin-domain cont	no	no	0.909	0.806	0.514	1e-160
O04533	656	Putative L-type lectin-do	no	no	0.962	0.859	0.483	1e-157
O22833	658	L-type lectin-domain cont	no	no	0.902	0.803	0.511	1e-155

>sp|O80939|LRK41_ARATH L-type lectin-domain containing receptor kinase IV.1 OS=Arabidopsis thaliana GN=LECRK41 PE=1 SV=1

 Score =  761 bits (1965), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 397/611 (64%), Positives = 471/611 (77%), Gaps = 32/611 (5%)

Query: 2   PFKNKNSNSSTANGTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGL 61
           P + K+S     NGTV SFST+FVF+I S+    SGHGIAFV+A    LP   PSQY+GL
Sbjct: 71  PIRFKDS----PNGTVSSFSTSFVFAIHSQIAILSGHGIAFVVAPNASLPYGNPSQYIGL 126

Query: 62  FNDTNLGNETNHVFAVELDTIKSHGFLDINDNHVGIDINSLKSESSAPAGYY-------- 113
           FN  N GNETNHVFAVELDTI S  F D NDNHVGIDINSLKS  S+PAGY+        
Sbjct: 127 FNLANNGNETNHVFAVELDTILSTEFNDTNDNHVGIDINSLKSVQSSPAGYWDEKGQFKN 186

Query: 114 ------------VEYDGLEKRTNVTLAPINIPRP-RSLNTMSLSRDLSSVLNDAMYVGFS 160
                       V+YDG   + +VT+AP N  +P R L T    RDLSSVL   MYVGFS
Sbjct: 187 LTLISRKPMQVWVDYDGRTNKIDVTMAPFNEDKPTRPLVTAV--RDLSSVLLQDMYVGFS 244

Query: 161 SSTGSVLASHYILGWSFKINGQAEELNLSQLPKLPRVGPKKRSKFLTIGLPVICVSVIFA 220
           S+TGSVL+ HYILGWSF +N +A  L LS+LPKLPR  PK+ S+F  IG+P+I + +IF+
Sbjct: 245 SATGSVLSEHYILGWSFGLNEKAPPLALSRLPKLPRFEPKRISEFYKIGMPLISLFLIFS 304

Query: 221 AVSGVVYVIRMKRKFAEELEDWELDHGPHRFRYKDLYIATKGFREKELLGTGGFGRVYRG 280
            +  V Y++R +RKFAEELE+WE + G +RFR+KDLY ATKGF+EK LLGTGGFG VY+G
Sbjct: 305 FIFLVCYIVRRRRKFAEELEEWEKEFGKNRFRFKDLYYATKGFKEKGLLGTGGFGSVYKG 364

Query: 281 TLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYM 340
            +P +++EIAVK++SHESRQGMKEFVAEIVSIGR+ HRNLV LLGYCRR+GELLLVYDYM
Sbjct: 365 VMPGTKLEIAVKRVSHESRQGMKEFVAEIVSIGRMSHRNLVPLLGYCRRRGELLLVYDYM 424

Query: 341 PNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGEL 400
           PNGSLDKYLY+ P+VTLNW QR +VI GVA GLFYLH+EWEQVVIHRDVKASNVLLDGEL
Sbjct: 425 PNGSLDKYLYNTPEVTLNWKQRIKVILGVASGLFYLHEEWEQVVIHRDVKASNVLLDGEL 484

Query: 401 NGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACG 460
           NGRLGDFGLARLYDHG+DPQTTHVVGTLGYLAPEHTRTG+AT + DVF+FGAFLLEVACG
Sbjct: 485 NGRLGDFGLARLYDHGSDPQTTHVVGTLGYLAPEHTRTGRATMATDVFAFGAFLLEVACG 544

Query: 461 RRPIQ-RQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSD 519
           RRPI+ +Q   E  +LVDWVF  WN+G++L A+DPN+G+E   +E+E+VLKLGLLCSHSD
Sbjct: 545 RRPIEFQQETDETFLLVDWVFGLWNKGDILAAKDPNMGSECDEKEVEMVLKLGLLCSHSD 604

Query: 520 PTARPSMRQVVQILERDVALPAISALRLSTSGITY--LEGFDDFAVSNPPSM--GFTRPS 575
           P ARPSMRQV+  L  D  LP +S L LS SG+ +   +GF +  +S   S+  GFT  S
Sbjct: 605 PRARPSMRQVLHYLRGDAKLPELSPLDLSGSGMMFGVHDGFSELGMSYSSSVFKGFTGGS 664

Query: 576 SVAESLLSGGR 586
           S+A+S LSGGR
Sbjct: 665 SIADSQLSGGR 675

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9M345|LRK42_ARATH L-type lectin-domain containing receptor kinase IV.2 OS=Arabidopsis thaliana GN=LECRK42 PE=2 SV=1

 Score =  752 bits (1941), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 369/602 (61%), Positives = 470/602 (78%), Gaps = 28/602 (4%)

Query: 12  TANGTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGLFNDTNLGNET 71
           + NG V SFSTTFVF+I S+  + SGHGIAFV+A T GLP A PSQY+GLFN +N GN+T
Sbjct: 77  SQNGNVSSFSTTFVFAIHSQIPTLSGHGIAFVVAPTLGLPFALPSQYIGLFNISNNGNDT 136

Query: 72  NHVFAVELDTIKSHGFLDINDNHVGIDINSLKSESSAPAGY------------------- 112
           NH+FAVE DTI+S  F D NDNHVGID+N L+S + + AGY                   
Sbjct: 137 NHIFAVEFDTIQSSEFGDPNDNHVGIDLNGLRSANYSTAGYRDDHDKFQNLSLISRKRIQ 196

Query: 113 -YVEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSVLNDAMYVGFSSSTGSVLASHY 171
            +++YD    R +VT+AP +  +PR    +S  RDLSS+L + MYVGFSS+TGSVL+ H+
Sbjct: 197 VWIDYDNRSHRIDVTVAPFDSDKPRK-PLVSYVRDLSSILLEDMYVGFSSATGSVLSEHF 255

Query: 172 ILGWSFKINGQAEELNLSQLPKLPRVGPKKRSKFLTIGLPVICVSVIFAAVSGVVYVIRM 231
           ++GWSF++NG+A  L+LS+LPKLPR  P++ S+F  IG+P+I +S+IF+ +    Y++R 
Sbjct: 256 LVGWSFRLNGEAPMLSLSKLPKLPRFEPRRISEFYKIGMPLISLSLIFSIIFLAFYIVRR 315

Query: 232 KRKFAEELEDWELDHGPHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAV 291
           K+K+ EEL+DWE + G +RFR+K+LY ATKGF+EK+LLG+GGFGRVYRG LP +++E+AV
Sbjct: 316 KKKYEEELDDWETEFGKNRFRFKELYHATKGFKEKDLLGSGGFGRVYRGILPTTKLEVAV 375

Query: 292 KKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYD 351
           K++SH+S+QGMKEFVAEIVSIGR+ HRNLV LLGYCRR+GELLLVYDYMPNGSLDKYLY+
Sbjct: 376 KRVSHDSKQGMKEFVAEIVSIGRMSHRNLVPLLGYCRRRGELLLVYDYMPNGSLDKYLYN 435

Query: 352 QPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR 411
            P+ TL+W QR  +IKGVA GLFYLH+EWEQVVIHRDVKASNVLLD + NGRLGDFGLAR
Sbjct: 436 NPETTLDWKQRSTIIKGVASGLFYLHEEWEQVVIHRDVKASNVLLDADFNGRLGDFGLAR 495

Query: 412 LYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSE 471
           LYDHG+DPQTTHVVGTLGYLAPEH+RTG+ATT+ DV++FGAFLLEV  GRRPI+    S+
Sbjct: 496 LYDHGSDPQTTHVVGTLGYLAPEHSRTGRATTTTDVYAFGAFLLEVVSGRRPIEFHSASD 555

Query: 472 N-LILVDWVFDFWNRGELLEARDPNLGTE-YVAEELELVLKLGLLCSHSDPTARPSMRQV 529
           +  +LV+WVF  W RG ++EA+DP LG+  Y  EE+E+VLKLGLLCSHSDP ARPSMRQV
Sbjct: 556 DTFLLVEWVFSLWLRGNIMEAKDPKLGSSGYDLEEVEMVLKLGLLCSHSDPRARPSMRQV 615

Query: 530 VQILERDVALPAISALRLSTSGITYL---EGFDDFAVSNPPSM--GFTRPSSVAESLLSG 584
           +Q L  D+ALP ++ L LS   +  L   +GF   A+++  ++  GFT  SS+A+SLLSG
Sbjct: 616 LQYLRGDMALPELTPLDLSAGSVMNLGGRDGFSGIAMTDFSTVFKGFTGGSSIADSLLSG 675

Query: 585 GR 586
           GR
Sbjct: 676 GR 677

Required during pollen development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O81291|LRK44_ARATH L-type lectin-domain containing receptor kinase IV.4 OS=Arabidopsis thaliana GN=LECRK44 PE=3 SV=1

 Score =  676 bits (1745), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 358/610 (58%), Positives = 443/610 (72%), Gaps = 37/610 (6%)

Query: 2   PFKNKNSNSSTANGTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGL 61
           P + K+S     NGTV SFSTTFVF+I S  Q    HG+AFVIA    LP   P QYLGL
Sbjct: 72  PIRFKDS----PNGTVSSFSTTFVFAIHS--QIPIAHGMAFVIAPNPRLPFGSPLQYLGL 125

Query: 62  FNDTNLGNETNHVFAVELDTIKSHGFLDINDNHVGIDINSLKSESSAPAGYY-------- 113
           FN TN GN  NHVFAVELDTI +  F D N+NHVGIDINSL S  S+PAGY+        
Sbjct: 126 FNVTNNGNVRNHVFAVELDTIMNIEFNDTNNNHVGIDINSLNSVKSSPAGYWDENDQFHN 185

Query: 114 ------------VEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSVLNDAMYVGFSS 161
                       V++DG     +VT+AP    +PR    +S+ RDLSSVL   M+VGFSS
Sbjct: 186 LTLISSKRMQVWVDFDGPTHLIDVTMAPFGEVKPRK-PLVSIVRDLSSVLLQDMFVGFSS 244

Query: 162 STGSVLASHYILGWSFKINGQAEELNLSQLPKLP--RVGPKKRSKFLTIGLPVICVSVIF 219
           +TG++++  ++LGWSF +NG+A+ L LS+LP+LP   + P +  +F    +P+I + +I 
Sbjct: 245 ATGNIVSEIFVLGWSFGVNGEAQPLALSKLPRLPVWDLKPTRVYRFYKNWVPLISLLLIP 304

Query: 220 AAVSG--VVYVIRMKRKFAEELEDWELDHGPHRFRYKDLYIATKGFREKELLGTGGFGRV 277
             +    V ++++ +RKFAEE+EDWE + G +R R+KDLY ATKGF++K +LG+GGFG V
Sbjct: 305 FLLIIFLVRFIMKRRRKFAEEVEDWETEFGKNRLRFKDLYYATKGFKDKNILGSGGFGSV 364

Query: 278 YRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY 337
           Y+G +PK++ EIAVK++S+ESRQG+KEFVAEIVSIG++ HRNLV L+GYCRR+ ELLLVY
Sbjct: 365 YKGIMPKTKKEIAVKRVSNESRQGLKEFVAEIVSIGQMSHRNLVPLVGYCRRRDELLLVY 424

Query: 338 DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLD 397
           DYMPNGSLDKYLY+ P+VTL+W QRF+VI GVA  LFYLH+EWEQVVIHRDVKASNVLLD
Sbjct: 425 DYMPNGSLDKYLYNSPEVTLDWKQRFKVINGVASALFYLHEEWEQVVIHRDVKASNVLLD 484

Query: 398 GELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEV 457
            ELNGRLGDFGLA+L DHG+DPQTT VVGT GYLAP+H RTG+ATT+ DVF+FG  LLEV
Sbjct: 485 AELNGRLGDFGLAQLCDHGSDPQTTRVVGTWGYLAPDHIRTGRATTTTDVFAFGVLLLEV 544

Query: 458 ACGRRPIQRQGPS-ENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCS 516
           ACGRRPI+    S E ++LVDWVF FW    +L+A+DPNLG+EY  +E+E+VLKLGLLCS
Sbjct: 545 ACGRRPIEINNQSGERVVLVDWVFRFWMEANILDAKDPNLGSEYDQKEVEMVLKLGLLCS 604

Query: 517 HSDPTARPSMRQVVQILERDVALPAISALRLSTSGITYLEGFDDFAVSNPPSMGFTRPSS 576
           HSDP ARP+MRQV+Q L  D  LP +S L L  SGI           SN   M FT  SS
Sbjct: 605 HSDPLARPTMRQVLQYLRGDAMLPDLSPLDLRGSGIM----LGTHNGSNESGM-FTSGSS 659

Query: 577 VAESLLSGGR 586
           VA SLLS GR
Sbjct: 660 VAYSLLSSGR 669

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O81292|LRK43_ARATH L-type lectin-domain containing receptor kinase IV.3 OS=Arabidopsis thaliana GN=LECRK43 PE=2 SV=1

 Score =  669 bits (1725), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 351/612 (57%), Positives = 431/612 (70%), Gaps = 37/612 (6%)

Query: 2   PFKNKNSNSSTANGTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGL 61
           P + K+S     N TV SFSTTFV  I S   + SGHG+AF IA    L  A  SQYLGL
Sbjct: 73  PIRFKDS----PNDTVSSFSTTFVIGIYSGIPTISGHGMAFFIAPNPVLSSAMASQYLGL 128

Query: 62  FNDTNLGNETNHVFAVELDTIKSHGFLDINDNHVGIDINSLKSESSAPAGYY-------- 113
           F+ TN GN+TNH+ AVE DTI +  F D NDNHVGI+INSL S  S+  GY+        
Sbjct: 129 FSSTNNGNDTNHILAVEFDTIMNPEFDDTNDNHVGININSLTSVKSSLVGYWDEINQFNN 188

Query: 114 ------------VEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSVLNDAMYVGFSS 161
                       V+YD    + +VT+AP    +PR    +S+ RDLSSV    MY+GFS+
Sbjct: 189 LTLISRKRMQVWVDYDDRTNQIDVTMAPFGEVKPRKA-LVSVVRDLSSVFLQDMYLGFSA 247

Query: 162 STGSVLASHYILGWSFKINGQ-AEELNLSQLPKLPRVGPKKRSKFLTIGLPV-----ICV 215
           +TG VL+ H++ GWSF + G+ A  L LS++PK PRVGP    +F    +P+     I V
Sbjct: 248 ATGYVLSEHFVFGWSFMVKGKTAPPLTLSKVPKFPRVGPTSLQRFYKNRMPLFSLLLIPV 307

Query: 216 SVIFAAVSGVVYVIRMKRKFAEELEDWELDHGPHRFRYKDLYIATKGFREKELLGTGGFG 275
             + + +  V +++R +RKFAEE EDWE + G +R R+KDLY ATKGF++K+LLG+GGFG
Sbjct: 308 LFVVSLIFLVRFIVRRRRKFAEEFEDWETEFGKNRLRFKDLYYATKGFKDKDLLGSGGFG 367

Query: 276 RVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLL 335
           RVYRG +P ++ EIAVK++S+ESRQG+KEFVAEIVSIGR+ HRNLV LLGYCRR+ ELLL
Sbjct: 368 RVYRGVMPTTKKEIAVKRVSNESRQGLKEFVAEIVSIGRMSHRNLVPLLGYCRRRDELLL 427

Query: 336 VYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVL 395
           VYDYMPNGSLDKYLYD P+VTL+W QRF VI GVA GLFYLH+EWEQVVIHRD+KASNVL
Sbjct: 428 VYDYMPNGSLDKYLYDCPEVTLDWKQRFNVIIGVASGLFYLHEEWEQVVIHRDIKASNVL 487

Query: 396 LDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLL 455
           LD E NGRLGDFGLARL DHG+DPQTT VVGT GYLAP+H RTG+ATT+ DVF+FG  LL
Sbjct: 488 LDAEYNGRLGDFGLARLCDHGSDPQTTRVVGTWGYLAPDHVRTGRATTATDVFAFGVLLL 547

Query: 456 EVACGRRPIQRQGPS-ENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLL 514
           EVACGRRPI+ +  S E+++LVD VF FW  G +L+A DPNLG+ Y   E+E VLKLGLL
Sbjct: 548 EVACGRRPIEIEIESDESVLLVDSVFGFWIEGNILDATDPNLGSVYDQREVETVLKLGLL 607

Query: 515 CSHSDPTARPSMRQVVQILERDVALPAISALRLSTSGITYLEGFDDFAVSNPPSMGFTRP 574
           CSHSDP  RP+MRQV+Q L  D  LP +S L    SG   L     F+     S  F+  
Sbjct: 608 CSHSDPQVRPTMRQVLQYLRGDATLPDLSPLDFRGSG-KMLGMNHRFS----ESCTFSSG 662

Query: 575 SSVAESLLSGGR 586
           SS+A S++SGGR
Sbjct: 663 SSIAYSIVSGGR 674

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SZD5|LRK59_ARATH L-type lectin-domain containing receptor kinase V.9 OS=Arabidopsis thaliana GN=LECRK59 PE=2 SV=1

 Score =  622 bits (1605), Expect = e-177,   Method: Compositional matrix adjust.
 Identities = 321/618 (51%), Positives = 428/618 (69%), Gaps = 48/618 (7%)

Query: 2   PFKNKNSNSSTANGTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGL 61
           P + KNS     NGTV SFSTTFVF+I+S   +  GHG+AFVI+ T+GLP +  SQYLGL
Sbjct: 67  PVRFKNS----PNGTVSSFSTTFVFAIVSNVNALDGHGLAFVISPTKGLPYSSSSQYLGL 122

Query: 62  FNDTNLGNETNHVFAVELDTIKSHGFLDINDNHVGIDINSLKSESSAPAGYY-------- 113
           FN TN G+ +NH+ AVE DT ++  F D+++NHVGIDINSL SE ++ AGYY        
Sbjct: 123 FNLTNNGDPSNHIVAVEFDTFQNQEFDDMDNNHVGIDINSLSSEKASTAGYYEDDDGTFK 182

Query: 114 -------------VEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSVLNDAMYVGFS 160
                        +EYD   ++ NVT+ PI++P+P+ +  +SL++DLS  L D+MYVGF+
Sbjct: 183 NIRLINQKPIQAWIEYDSSRRQLNVTIHPIHLPKPK-IPLLSLTKDLSPYLFDSMYVGFT 241

Query: 161 SSTGSVLASHYILGWSFKINGQAEELNLSQLPKLPRVGPKKR-SKFLTIGLPVICVSV-I 218
           S+TG + +SHYILGW+FK+NG A  +++S+LPKLPR        K L I L +  +++ +
Sbjct: 242 SATGRLRSSHYILGWTFKLNGTASNIDISRLPKLPRDSRSTSVKKILAISLSLTSLAILV 301

Query: 219 FAAVSGVVYVIRMKRKFAEELEDWELDHGPHRFRYKDLYIATKGFREKELLGTGGFGRVY 278
           F  +S ++++ R  +K  E LEDWE+  GPHRF YKDLYIATKGFR  ELLG GGFG+VY
Sbjct: 302 FLTISYMLFLKR--KKLMEVLEDWEVQFGPHRFAYKDLYIATKGFRNSELLGKGGFGKVY 359

Query: 279 RGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYD 338
           +GTL  S ++IAVKK+SH+SRQGM+EFVAEI +IGRLRH NLV+LLGYCRRKGEL LVYD
Sbjct: 360 KGTLSTSNMDIAVKKVSHDSRQGMREFVAEIATIGRLRHPNLVRLLGYCRRKGELYLVYD 419

Query: 339 YMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDG 398
            MP GSLDK+LY QP+ +L+W QRF++IK VA GL YLH +W QV+IHRD+K +NVLLD 
Sbjct: 420 CMPKGSLDKFLYHQPEQSLDWSQRFKIIKDVASGLCYLHHQWVQVIIHRDIKPANVLLDD 479

Query: 399 ELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVA 458
            +NG+LGDFGLA+L +HG DPQT++V GT GY++PE +RTGKA+TS+DVF+FG  +LE+ 
Sbjct: 480 SMNGKLGDFGLAKLCEHGFDPQTSNVAGTFGYISPELSRTGKASTSSDVFAFGILMLEIT 539

Query: 459 CGRRPI--QRQGPSENLILVDWVFDFWNRGELLEARDPNLGTE--YVAEELELVLKLGLL 514
           CGRRP+  +   PSE ++L DWV D W   ++L+  D  +  +  Y+ E++ LVLKLGL 
Sbjct: 540 CGRRPVLPRASSPSE-MVLTDWVLDCW-EDDILQVVDERVKQDDKYLEEQVALVLKLGLF 597

Query: 515 CSHSDPTARPSMRQVVQILERDVALP-AISALRLSTSGITYLEGFDDFAVSNPPSMGFTR 573
           CSH     RPSM  V+Q L+    LP  +  +  +   +  +EGF + A S         
Sbjct: 598 CSHPVAAVRPSMSSVIQFLDGVAQLPNNLFDIVKARENVGAIEGFGEAAES------LAE 651

Query: 574 PSSVA-----ESLLSGGR 586
           P SVA     E  +S GR
Sbjct: 652 PCSVATLTFTEPFVSHGR 669

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O04534|LRK51_ARATH Putative L-type lectin-domain containing receptor kinase V.1 OS=Arabidopsis thaliana GN=LECRK51 PE=3 SV=1

 Score =  596 bits (1536), Expect = e-169,   Method: Compositional matrix adjust.
 Identities = 301/599 (50%), Positives = 400/599 (66%), Gaps = 26/599 (4%)

Query: 11  STANGTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGLFNDTNLGNE 70
           ++ NGTV SFSTTFVFSI        G+GIAFVI  TR L    P+ YLGLFN +N+G+ 
Sbjct: 71  NSVNGTVSSFSTTFVFSIEFHNGIYGGYGIAFVICPTRDLSPTFPTTYLGLFNRSNMGDP 130

Query: 71  TNHVFAVELDTIKSHGFLDINDNHVGIDINSLKSESSAPAGYY----------------- 113
            NH+ AVELDT     F D + NHVGIDIN+L S++ A AGYY                 
Sbjct: 131 KNHIVAVELDTKVDQQFEDKDANHVGIDINTLVSDTVALAGYYMDNGTFRSLLLNSGQPM 190

Query: 114 ---VEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSVLNDAMYVGFSSSTGSVLASH 170
              +EYD  +K+ NVTL P+ +P+P+ +  +SL +DLS  L + MYVGF+S+TG + ASH
Sbjct: 191 QIWIEYDSKQKQINVTLHPLYVPKPK-IPLLSLEKDLSPYLLELMYVGFTSTTGDLTASH 249

Query: 171 YILGWSFKINGQAEELNLSQLPKLPRVGP---KKRSKFLTIGLPVICVSVIFAAVSGVVY 227
           YILGW+FK+NG   +++ S+LPK+PR      +  +  LTI L V  V ++       ++
Sbjct: 250 YILGWTFKMNGTTPDIDPSRLPKIPRYNQPWIQSPNGILTISLTVSGVIILIILSL-SLW 308

Query: 228 VIRMKRKFAEELEDWELDHGPHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQI 287
           +   ++K  E LEDWE+  GPHRF +KDL+IATKGF++ E+LG GGFG+VY+GTLP S +
Sbjct: 309 LFLKRKKLLEVLEDWEVQFGPHRFAFKDLHIATKGFKDTEVLGKGGFGKVYKGTLPVSNV 368

Query: 288 EIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDK 347
           EIAVK +SH+SRQGM+EF+AEI +IGRLRH NLV+L GYCR KGEL LVYD M  GSLDK
Sbjct: 369 EIAVKMVSHDSRQGMREFIAEIATIGRLRHPNLVRLQGYCRHKGELYLVYDCMAKGSLDK 428

Query: 348 YLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDF 407
           +LY Q    L+W QRF++IK VA GL+YLHQ+W QV+IHRD+K +N+LLD  +N +LGDF
Sbjct: 429 FLYHQQTGNLDWSQRFKIIKDVASGLYYLHQQWVQVIIHRDIKPANILLDANMNAKLGDF 488

Query: 408 GLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQ 467
           GLA+L DHGTDPQT+HV GTLGY++PE +RTGKA+T +DVF+FG  +LE+ACGR+PI  +
Sbjct: 489 GLAKLCDHGTDPQTSHVAGTLGYISPELSRTGKASTRSDVFAFGIVMLEIACGRKPILPR 548

Query: 468 GPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMR 527
                ++L DWV + W   ++++  D  +G EYV E+  LVLKLGL CSH     RP+M 
Sbjct: 549 ASQREMVLTDWVLECWENEDIMQVLDHKIGQEYVEEQAALVLKLGLFCSHPVAAIRPNMS 608

Query: 528 QVVQILERDVALPAISALRLSTSGITYLEGFDDFAVSNPPSMGFTRPSSVAESLLSGGR 586
            V+Q+L+    LP      + T  +         A  +P S     P +  ES +S GR
Sbjct: 609 SVIQLLDSVAQLPHNLLDIVQTREVHRGTEISGEAADSPESCSIA-PLTFTESFVSHGR 666

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9M2S4|LRKS4_ARATH L-type lectin-domain containing receptor kinase S.4 OS=Arabidopsis thaliana GN=LECRKS4 PE=1 SV=1

 Score =  592 bits (1527), Expect = e-168,   Method: Compositional matrix adjust.
 Identities = 296/549 (53%), Positives = 397/549 (72%), Gaps = 28/549 (5%)

Query: 18  FSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGLFNDTNLGNETNHVFAV 77
            SFST+F  +++ E+ +  GHG+AF I  T  L G+ PSQYLGL N + + N ++H FAV
Sbjct: 82  LSFSTSFAIAMVPEFVTLGGHGLAFAITPTPDLRGSLPSQYLGLLNSSRV-NFSSHFFAV 140

Query: 78  ELDTIKSHGFLDINDNHVGIDINSLKSESSAPAGYY--------------------VEYD 117
           E DT++   F DINDNHVGIDINS++S  S PAGY+                    ++YD
Sbjct: 141 EFDTVRDLEFEDINDNHVGIDINSMESSISTPAGYFLANSTKKELFLDGGRVIQAWIDYD 200

Query: 118 GLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSVLNDAMYVGFSSSTGSVLASHYILGWSF 177
             +KR +V L+P +  +P+ L+ +S   DLSSVL D MYVGFS+STG + +SHYILGW+F
Sbjct: 201 SNKKRLDVKLSPFS-EKPK-LSLLSYDVDLSSVLGDEMYVGFSASTGLLASSHYILGWNF 258

Query: 178 KINGQAEELNLSQLPKLPR--VGPKKRSKFLTIGLPVICVSVIFAA-VSGVVYVIRMKRK 234
            ++G+A  L+L  LP++P      KK+ + L +G+ ++C  +IFA  V+  ++V+R K K
Sbjct: 259 NMSGEAFSLSLPSLPRIPSSIKKRKKKRQSLILGVSLLCSLLIFAVLVAASLFVVR-KVK 317

Query: 235 FAEELEDWELDHGPHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKI 294
             + +E+WELD GPHRF Y++L  AT GF +KELLG+GGFG+VY+G LP S   +AVK+I
Sbjct: 318 DEDRVEEWELDFGPHRFSYRELKKATNGFGDKELLGSGGFGKVYKGKLPGSDEFVAVKRI 377

Query: 295 SHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQ-P 353
           SHESRQG++EF++E+ SIG LRHRNLVQLLG+CRR+ +LLLVYD+MPNGSLD YL+D+ P
Sbjct: 378 SHESRQGVREFMSEVSSIGHLRHRNLVQLLGWCRRRDDLLLVYDFMPNGSLDMYLFDENP 437

Query: 354 KVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLY 413
           +V L W QRF++IKGVA GL YLH+ WEQ VIHRD+KA+NVLLD E+NGR+GDFGLA+LY
Sbjct: 438 EVILTWKQRFKIIKGVASGLLYLHEGWEQTVIHRDIKAANVLLDSEMNGRVGDFGLAKLY 497

Query: 414 DHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENL 473
           +HG+DP  T VVGT GYLAPE T++GK TTS DV++FGA LLEVACGRRPI+     E L
Sbjct: 498 EHGSDPGATRVVGTFGYLAPELTKSGKLTTSTDVYAFGAVLLEVACGRRPIETSALPEEL 557

Query: 474 ILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQIL 533
           ++VDWV+  W  G++ +  D  L  E+  EE+ +V+KLGLLCS++ P  RP+MRQVV  L
Sbjct: 558 VMVDWVWSRWQSGDIRDVVDRRLNGEFDEEEVVMVIKLGLLCSNNSPEVRPTMRQVVMYL 617

Query: 534 ERDVALPAI 542
           E+    P +
Sbjct: 618 EKQFPSPEV 626

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q96285|LRK55_ARATH L-type lectin-domain containing receptor kinase V.5 OS=Arabidopsis thaliana GN=LECRK55 PE=1 SV=1

 Score =  564 bits (1454), Expect = e-160,   Method: Compositional matrix adjust.
 Identities = 292/567 (51%), Positives = 379/567 (66%), Gaps = 34/567 (5%)

Query: 3   FKNKN---SNSSTANGTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYL 59
           F+N++    NSST  G + SFS  F F+I+ E+  Q  HG+ FVI+ TRGLPGA   QYL
Sbjct: 55  FENEHVEIKNSST--GVISSFSVNFFFAIVPEHNQQGSHGMTFVISPTRGLPGASSDQYL 112

Query: 60  GLFNDTNLGNETNHVFAVELDTIKSHGFLDINDNHVGIDINSLKSESSAPAGYYVEYDGL 119
           G+FN TN G  +N+V A+ELD  K   F DI+DNHVGI+IN L+S +SA AGYY + DG 
Sbjct: 113 GIFNKTNNGKASNNVIAIELDIHKDEEFGDIDDNHVGININGLRSVASASAGYYDDKDGS 172

Query: 120 ---------------------EKRTNVTLAPINIPRPRSLNTMSLSRDLSSVLNDAMYVG 158
                                +++ NVTL P  IP P     +SL+RDLS  L + MY+G
Sbjct: 173 FKKLSLISREVMRLSIVYSQPDQQLNVTLFPAEIPVPPLKPLLSLNRDLSPYLLEKMYLG 232

Query: 159 FSSSTGSVLASHYILGWSFKINGQAE----ELNLSQLPKLPRVGPKKRSKFLTIGLPVIC 214
           F++STGSV A HY++GW   +NG  E    EL++  LP  P+    +    L + L V  
Sbjct: 233 FTASTGSVGAIHYLMGW--LVNGVIEYPRLELSIPVLPPYPKKTSNRTKTVLAVCLTVSV 290

Query: 215 VSVIFAAVSGVVYVIRMKRKFAEELEDWELDHGPHRFRYKDLYIATKGFREKELLGTGGF 274
            +   A+  G V+ +R K K  E LE+WE+ +GPHRF YK+L+ ATKGF+EK+LLG GGF
Sbjct: 291 FAAFVASWIGFVFYLRHK-KVKEVLEEWEIQYGPHRFAYKELFNATKGFKEKQLLGKGGF 349

Query: 275 GRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELL 334
           G+VY+GTLP S  EIAVK+ SH+SRQGM EF+AEI +IGRLRH NLV+LLGYCR K  L 
Sbjct: 350 GQVYKGTLPGSDAEIAVKRTSHDSRQGMSEFLAEISTIGRLRHPNLVRLLGYCRHKENLY 409

Query: 335 LVYDYMPNGSLDKYL-YDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASN 393
           LVYDYMPNGSLDKYL   + +  L W QRFR+IK VA  L +LHQEW QV+IHRD+K +N
Sbjct: 410 LVYDYMPNGSLDKYLNRSENQERLTWEQRFRIIKDVATALLHLHQEWVQVIIHRDIKPAN 469

Query: 394 VLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAF 453
           VL+D E+N RLGDFGLA+LYD G DP+T+ V GT GY+APE  RTG+ATTS DV++FG  
Sbjct: 470 VLIDNEMNARLGDFGLAKLYDQGFDPETSKVAGTFGYIAPEFLRTGRATTSTDVYAFGLV 529

Query: 454 LLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGL 513
           +LEV CGRR I+R+       LVDW+ + W  G++ +A + ++  E    ++ELVLKLG+
Sbjct: 530 MLEVVCGRRIIERRAAENEEYLVDWILELWENGKIFDAAEESIRQEQNRGQVELVLKLGV 589

Query: 514 LCSHSDPTARPSMRQVVQILERDVALP 540
           LCSH   + RP+M  V++IL     LP
Sbjct: 590 LCSHQAASIRPAMSVVMRILNGVSQLP 616

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O04533|LRK52_ARATH Putative L-type lectin-domain containing receptor kinase V.2 OS=Arabidopsis thaliana GN=LECRK52 PE=3 SV=1

 Score =  556 bits (1432), Expect = e-157,   Method: Compositional matrix adjust.
 Identities = 294/608 (48%), Positives = 399/608 (65%), Gaps = 44/608 (7%)

Query: 2   PFKNKNSNSSTANGTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGL 61
           P + KNS     NGTV SFSTTFVF+I++  ++ +G G++F I+ T+GL           
Sbjct: 70  PLQFKNS----PNGTVSSFSTTFVFAIVAVRKTIAGCGLSFNISPTKGL----------- 114

Query: 62  FNDTNLGNETNHVFAVELDTIKSHGFLDINDNHVGIDINSLKSESSAPAGYY-------- 113
            N     + +NH  +V   T KS      + N VGI+I+S K + +  AGYY        
Sbjct: 115 -NSVPNIDHSNHSVSVGFHTAKSDKPDGEDVNLVGINIDSSKMDRNCSAGYYKDDGRLVN 173

Query: 114 ------------VEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSVLNDAMYVGFSS 161
                       +EY+   K+ +VT+  I I +P+ +  +S+ +DLS  L++ MY+GF+S
Sbjct: 174 LDIASGKPIQVWIEYNNSTKQLDVTMHSIKISKPK-IPLLSMRKDLSPYLHEYMYIGFTS 232

Query: 162 STGSVLASHYILGWSFKINGQAEELNLSQLPKLPRVGPKKR--SKFLTIGLPVICVSVIF 219
             GS  +SHYILGWSF   G   ++NLS+LPK+P    ++   SK L I L +  V+++ 
Sbjct: 233 -VGSPTSSHYILGWSFNNKGAVSDINLSRLPKVPDEDQERSLSSKILAISLSISGVTLVI 291

Query: 220 AAVSGVVYVIRMKRKFAEELEDWELDHGPHRFRYKDLYIATKGFREKELLGTGGFGRVYR 279
             + GV+  ++ ++KF E +EDWE+  GPH+F YKDL+IATKGF+  E+LG GGFG+V++
Sbjct: 292 VLILGVMLFLK-RKKFLEVIEDWEVQFGPHKFTYKDLFIATKGFKNSEVLGKGGFGKVFK 350

Query: 280 GTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY 339
           G LP S I IAVKKISH+SRQGM+EF+AEI +IGRLRH +LV+LLGYCRRKGEL LVYD+
Sbjct: 351 GILPLSSIPIAVKKISHDSRQGMREFLAEIATIGRLRHPDLVRLLGYCRRKGELYLVYDF 410

Query: 340 MPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGE 399
           MP GSLDK+LY+QP   L+W QRF +IK VA GL YLHQ+W QV+IHRD+K +N+LLD  
Sbjct: 411 MPKGSLDKFLYNQPNQILDWSQRFNIIKDVASGLCYLHQQWVQVIIHRDIKPANILLDEN 470

Query: 400 LNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC 459
           +N +LGDFGLA+L DHG D QT++V GT GY++PE +RTGK++TS+DVF+FG F+LE+ C
Sbjct: 471 MNAKLGDFGLAKLCDHGIDSQTSNVAGTFGYISPELSRTGKSSTSSDVFAFGVFMLEITC 530

Query: 460 GRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSD 519
           GRRPI  +G    ++L DWV D W+ G++L+  D  LG  Y+AE++ LVLKLGLLCSH  
Sbjct: 531 GRRPIGPRGSPSEMVLTDWVLDCWDSGDILQVVDEKLGHRYLAEQVTLVLKLGLLCSHPV 590

Query: 520 PTARPSMRQVVQILERDVALPAISALRLSTSGITYLEGFDDFAVSNPPSMGFTRPSSV-A 578
              RPSM  V+Q L+    LP  + L L  S I   EGFD   V+       +  S V  
Sbjct: 591 AATRPSMSSVIQFLDGVATLPH-NLLDLVNSRIIN-EGFDTLGVTTESMEASSNVSLVMT 648

Query: 579 ESLLSGGR 586
           ES LS GR
Sbjct: 649 ESFLSSGR 656

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O22833|LRK54_ARATH L-type lectin-domain containing receptor kinase V.4 OS=Arabidopsis thaliana GN=LECRK54 PE=2 SV=1

 Score =  548 bits (1413), Expect = e-155,   Method: Compositional matrix adjust.
 Identities = 289/565 (51%), Positives = 376/565 (66%), Gaps = 36/565 (6%)

Query: 1   MPFKNKNSNSSTANGTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLG 60
           +PFKN      +AN TV SFS TF F+I  E + +  HG+AFVI+ TRG+ GA   QYLG
Sbjct: 59  VPFKN------SANDTVTSFSVTFFFAIAPEDKHKGAHGMAFVISPTRGITGASADQYLG 112

Query: 61  LFNDTNLGNETNHVFAVELDTIKSHGFLDINDNHVGIDINSLKSESSAPAGYY------- 113
           +FN  N G+ +NHV AVELD  K   F DINDNHVGI+IN ++S   APAGYY       
Sbjct: 113 IFNKANNGDSSNHVIAVELDINKDEEFGDINDNHVGININGMRSIKFAPAGYYDQEGQFK 172

Query: 114 -------------VEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSVLNDAMYVGFS 160
                        + Y  +EK+ NVTL+        +   +SL++DLS  + + MYVGFS
Sbjct: 173 DLSLISGSLLRVTILYSQMEKQLNVTLSSPEEAYYPNKPLLSLNQDLSPYILENMYVGFS 232

Query: 161 SSTGSVLASHYILGWSFKINGQAEELNLS-QLPKLPRVGPKKRSKFLTIGLPVICVSVIF 219
           +STGSV A HY+L W   ++G  +  NL   +P  P   PK++S    I L      V+F
Sbjct: 233 ASTGSVRAMHYMLSWF--VHGGVDVPNLDLGIPTFPPY-PKEKSLVYRIVLVTSLALVLF 289

Query: 220 AAVSGV---VYVIRMKRKFAEELEDWELDHGPHRFRYKDLYIATKGFREKELLGTGGFGR 276
            A+      ++  R  +K  E LE+WE+  GPHRF YK+L+ ATKGF  K+LLG GGFG+
Sbjct: 290 VALVASALSIFFYRRHKKVKEVLEEWEIQCGPHRFAYKELFKATKGF--KQLLGKGGFGQ 347

Query: 277 VYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLV 336
           V++GTLP S  EIAVK+ISH+S+QGM+EF+AEI +IGRLRH+NLV+L GYCR K EL LV
Sbjct: 348 VFKGTLPGSDAEIAVKRISHDSKQGMQEFLAEISTIGRLRHQNLVRLQGYCRYKEELYLV 407

Query: 337 YDYMPNGSLDKYLYDQP-KVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVL 395
           YD+MPNGSLDKYLY +  +  L W QRF++IK +A  L YLH EW QVVIHRD+K +NVL
Sbjct: 408 YDFMPNGSLDKYLYHRANQEQLTWNQRFKIIKDIASALCYLHHEWVQVVIHRDIKPANVL 467

Query: 396 LDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLL 455
           +D ++N RLGDFGLA+LYD G DPQT+ V GT  Y+APE  R+G+ATT  DV++FG F+L
Sbjct: 468 IDHQMNARLGDFGLAKLYDQGYDPQTSRVAGTFWYIAPELIRSGRATTGTDVYAFGLFML 527

Query: 456 EVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLC 515
           EV+CGRR I+R+  S+ ++L +W    W  G++LEA +  +  E   E+LELVLKLG+LC
Sbjct: 528 EVSCGRRLIERRTASDEVVLAEWTLKCWENGDILEAVNDGIRHEDNREQLELVLKLGVLC 587

Query: 516 SHSDPTARPSMRQVVQILERDVALP 540
           SH     RP M +VVQIL  D+ LP
Sbjct: 588 SHQAVAIRPDMSKVVQILGGDLQLP 612

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	586
359481749	1258	PREDICTED: L-type lectin-domain containi	0.984	0.458	0.716	0.0
255588220	669	kinase, putative [Ricinus communis] gi|2	0.976	0.855	0.719	0.0
147808029	616	hypothetical protein VITISV_019444 [Viti	0.885	0.842	0.731	0.0
38112427	669	lectin-like receptor kinase 7;2 [Medicag	0.981	0.859	0.687	0.0
356520929	667	PREDICTED: L-type lectin-domain containi	0.977	0.859	0.675	0.0
356567974	667	PREDICTED: L-type lectin-domain containi	0.979	0.860	0.667	0.0
224110964	623	predicted protein [Populus trichocarpa]	0.899	0.845	0.665	0.0
31324528	641	receptor kinase Lecrk [Gossypium hirsutu	0.899	0.822	0.679	0.0
15224347	675	receptor lectin kinase [Arabidopsis thal	0.988	0.857	0.649	0.0
297827329	670	hypothetical protein ARALYDRAFT_482773 [	0.989	0.865	0.647	0.0

>gi|359481749|ref|XP_003632669.1| PREDICTED: L-type lectin-domain containing receptor kinase IV.2-like [Vitis vinifera]

 Score =  884 bits (2283), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 437/610 (71%), Positives = 501/610 (82%), Gaps = 33/610 (5%)

Query: 2    PFKNKNSNSSTANGTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGL 61
            P + KNS    +N   FSFSTTFVF+I  +Y + SGHGIAFVIA TRGLPGA PSQ+LGL
Sbjct: 657  PMRFKNS----SNAPAFSFSTTFVFAIHPQYPTLSGHGIAFVIAPTRGLPGALPSQHLGL 712

Query: 62   FNDTNLGNETNHVFAVELDTIKSHGFLDINDNHVGIDINSLKSESSAPAGYY-------- 113
            F+D N GN TNH+ AVELDTI++    DINDNHVGIDIN LKS+ +APAGY+        
Sbjct: 713  FSDANNGNSTNHIVAVELDTIQNEELGDINDNHVGIDINGLKSDKAAPAGYFASKNGDFK 772

Query: 114  -------------VEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSVLNDAMYVGFS 160
                         V+Y+ LEK+ +V LAP+++ +P  +  +SL RDLS +LN+ MYVGFS
Sbjct: 773  NLSLISGRPMQVWVDYNALEKQIDVRLAPVSVDKP-DIPLLSLPRDLSLILNNTMYVGFS 831

Query: 161  SSTGSVLASHYILGWSFKINGQAEELNLSQLPKLPRVGPKKRSKFLTIGLPVICVSVIFA 220
            SSTGSVL SHY+LGWSFK+NGQA+ L +SQLPKLPR+G +K+S FLT GLPVICV  I A
Sbjct: 832  SSTGSVLTSHYLLGWSFKMNGQAQPLAISQLPKLPRIGGQKKSAFLTSGLPVICVVSILA 891

Query: 221  AVSGVVYVIRMKRKFAEELEDWELDHGPHRFRYKDLYIATKGFREKELLGTGGFGRVYRG 280
             +SG VY+IR K+KFAEELEDWELD+GPHRF+YKDLY ATKGF++KELLG+GGFGRVYRG
Sbjct: 892  VMSGAVYLIRRKKKFAEELEDWELDYGPHRFKYKDLYFATKGFKDKELLGSGGFGRVYRG 951

Query: 281  TLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYM 340
             LP S++EIAVKKISHESRQGMKEFVAEIVSIGRLRHRN+V LLGYCRRKGELLLVYDYM
Sbjct: 952  VLPTSKLEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNIVSLLGYCRRKGELLLVYDYM 1011

Query: 341  PNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGEL 400
            PNGSLDKYLYDQPKVTLNW QRFRV+KGVA GL YLH EWEQVV+HRDVKASNVLLDGEL
Sbjct: 1012 PNGSLDKYLYDQPKVTLNWNQRFRVLKGVASGLSYLHGEWEQVVVHRDVKASNVLLDGEL 1071

Query: 401  NGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACG 460
            NGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATT  DV++FGAFLLEVACG
Sbjct: 1072 NGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTRTDVYAFGAFLLEVACG 1131

Query: 461  RRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDP 520
            RRPI    P E+LILVDWVF FWNRGE+L+A DP LG +Y AEE+ELVLKLGL+CSHS+P
Sbjct: 1132 RRPI---APMEDLILVDWVFFFWNRGEILQASDPKLGVDYNAEEMELVLKLGLMCSHSEP 1188

Query: 521  TARPSMRQVVQILERDVALPAISALRLSTSGITYL--EGFDDFAVSNPPSMG--FTRPSS 576
             ARPSM QVVQ LER V LP  ++L LS +G+++   EGFDDFA+S P S+   F+  S+
Sbjct: 1189 NARPSMPQVVQYLERTVPLPEFTSLGLSANGLSFAHREGFDDFALSYPFSLDKTFSHAST 1248

Query: 577  VAESLLSGGR 586
            V ESLLSGGR
Sbjct: 1249 VPESLLSGGR 1258

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255588220|ref|XP_002534539.1| kinase, putative [Ricinus communis] gi|223525084|gb|EEF27843.1| kinase, putative [Ricinus communis]

 Score =  851 bits (2199), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 430/598 (71%), Positives = 496/598 (82%), Gaps = 26/598 (4%)

Query: 14  NGTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGLFNDTNLGNETNH 73
           NG+  +FSTTFVF+I+SE    SGHGIAFVI+  RGLP + PSQYLGLFN+ N GN+ NH
Sbjct: 73  NGSAVTFSTTFVFAIVSEIPDLSGHGIAFVISPKRGLPESLPSQYLGLFNENNNGNDINH 132

Query: 74  VFAVELDTIKSHGFLDINDNHVGIDINSLKSESSAPAGY--------------------- 112
           V AVELDTI S  F DINDNHV IDIN L+S  SA AGY                     
Sbjct: 133 VVAVELDTIYSSEFGDINDNHVAIDINGLRSVQSAAAGYHANPGNRTTNLSLISGKPMQL 192

Query: 113 YVEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSVLNDAMYVGFSSSTGSVLASHYI 172
           +VEYDG +K+ NVTLAPI I +P S+  +SL+RDLS +L + MYVGFSSSTGSVL SHY+
Sbjct: 193 WVEYDGAKKQLNVTLAPIKIGKP-SVPLLSLTRDLSPILQNTMYVGFSSSTGSVLTSHYV 251

Query: 173 LGWSFKINGQAEELNLSQLPKLPRVGPKKRSKFLTIGLPVICVSVIFAAVSGVVYVIRMK 232
           LGWS+K+NGQA+ L+LS LPKLPR+GPKKRSKF+TIG+P I +S I  A+SG VY IR K
Sbjct: 252 LGWSYKMNGQAQPLDLSALPKLPRIGPKKRSKFVTIGVPAISISSILIAISGSVYFIRRK 311

Query: 233 RKFAEELEDWELDHGPHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVK 292
           RKFAEELEDWELD+ PHRF+YKDLYIATKGF++KELLG+GGFGRVY+G LP  ++EIAVK
Sbjct: 312 RKFAEELEDWELDYWPHRFKYKDLYIATKGFKDKELLGSGGFGRVYKGVLPIPKLEIAVK 371

Query: 293 KISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQ 352
           ++SHE+RQGMK F+AEIVSIGRLRHRNLV LLGYCRRKGELLLVYDYMPNGSLDKYLYDQ
Sbjct: 372 RVSHETRQGMKVFIAEIVSIGRLRHRNLVTLLGYCRRKGELLLVYDYMPNGSLDKYLYDQ 431

Query: 353 PKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARL 412
           P+VTLNW QRF+VIKGVA GLFYLH+EWEQVVIHRDVKASNVLLDGE+N RLGDFGLARL
Sbjct: 432 PEVTLNWSQRFKVIKGVASGLFYLHEEWEQVVIHRDVKASNVLLDGEMNARLGDFGLARL 491

Query: 413 YDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSEN 472
           YDHGTDPQTTHVVGT GYLAPEHTRTGKATT  DVFSFGAFLLEVA GRRPI+R    E+
Sbjct: 492 YDHGTDPQTTHVVGTFGYLAPEHTRTGKATTKTDVFSFGAFLLEVASGRRPIERSTTPED 551

Query: 473 LILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQI 532
           +I VDWVF  W RGE++EA+DPNLGT+++AEE+ELVLKLGLLCSH++P ARPSMRQV+QI
Sbjct: 552 IISVDWVFSCWIRGEIVEAKDPNLGTDFIAEEVELVLKLGLLCSHAEPEARPSMRQVMQI 611

Query: 533 LERDVALPAISALRLSTSGITYL--EGFDDFAVSNPPSM--GFTRPSSVAESLLSGGR 586
           LERD+ LP +S+L LS SG+ +   EGFDDFA+S P SM   F+  S++AESLLSGGR
Sbjct: 612 LERDIPLPELSSLGLSASGLVFARHEGFDDFAMSCPSSMDKAFSHTSTIAESLLSGGR 669

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147808029|emb|CAN77672.1| hypothetical protein VITISV_019444 [Vitis vinifera]

 Score =  825 bits (2132), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 401/548 (73%), Positives = 456/548 (83%), Gaps = 29/548 (5%)

Query: 2   PFKNKNSNSSTANGTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGL 61
           P + KNS    +N   FSFSTTFVF+I  +Y + SGHGIAFVIA TRGLPGA PSQ+LGL
Sbjct: 66  PXRFKNS----SNAPAFSFSTTFVFAIHPQYPTLSGHGIAFVIAPTRGLPGALPSQHLGL 121

Query: 62  FNDTNLGNETNHVFAVELDTIKSHGFLDINDNHVGIDINSLKSESSAPAGYY-------- 113
           F+D N GN TNH+ AVELDTI++    DINDNHVGIDIN LKS+ +APAGY+        
Sbjct: 122 FSDANNGNSTNHIVAVELDTIQNEELGDINDNHVGIDINGLKSDKAAPAGYFASKNGDFK 181

Query: 114 -------------VEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSVLNDAMYVGFS 160
                        V+Y+ LEK+ +V LAP+++ +P  +  +SL RDLS +LN+ MYVGFS
Sbjct: 182 NLSLISGRPMQVWVDYNALEKQIDVRLAPVSVDKP-DIPLLSLPRDLSLILNNTMYVGFS 240

Query: 161 SSTGSVLASHYILGWSFKINGQAEELNLSQLPKLPRVGPKKRSKFLTIGLPVICVSVIFA 220
           SSTGSVL SHY+LGWSFK+NGQA+ L +SQLPKLPR+G +K+S FLT GLPVICV  + A
Sbjct: 241 SSTGSVLTSHYLLGWSFKMNGQAQPLAISQLPKLPRIGGQKKSAFLTSGLPVICVVSVLA 300

Query: 221 AVSGVVYVIRMKRKFAEELEDWELDHGPHRFRYKDLYIATKGFREKELLGTGGFGRVYRG 280
            +SG VY+IR K+KFAEELEDWELD+GPHRF+YKDLY ATKGF++KELLG+GGFGRVYRG
Sbjct: 301 VMSGAVYLIRRKKKFAEELEDWELDYGPHRFKYKDLYFATKGFKDKELLGSGGFGRVYRG 360

Query: 281 TLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYM 340
            LP S++EIAVKKISHESRQGMKEFVAEIVSIGRLRHRN+V LLGYCRRKGELLLVYDYM
Sbjct: 361 VLPTSKLEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNIVSLLGYCRRKGELLLVYDYM 420

Query: 341 PNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGEL 400
           PNGSLDKYLYDQPKV LNW QRFRV+KGVA GL YLH EWEQVV+HRDVKASNVLLDGEL
Sbjct: 421 PNGSLDKYLYDQPKVXLNWXQRFRVLKGVASGLSYLHGEWEQVVVHRDVKASNVLLDGEL 480

Query: 401 NGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACG 460
           NGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATT  DV++FGAFLLEVACG
Sbjct: 481 NGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTRTDVYAFGAFLLEVACG 540

Query: 461 RRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDP 520
           RRPI    P E+LILVDWVF FWNRGE+L+A DP LG +Y AEE+ELVLKLGL+CSHS+P
Sbjct: 541 RRPI---APMEDLILVDWVFFFWNRGEILQASDPKLGVDYNAEEMELVLKLGLMCSHSEP 597

Query: 521 TARPSMRQ 528
            ARPSM Q
Sbjct: 598 NARPSMPQ 605

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|38112427|gb|AAR11299.1| lectin-like receptor kinase 7;2 [Medicago truncatula]

 Score =  822 bits (2122), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 413/601 (68%), Positives = 490/601 (81%), Gaps = 26/601 (4%)

Query: 11  STANGTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGLFNDTNLGNE 70
           +T+NG+V SFSTTFVF+I  +Y + SGHGI FV++ T+GLP +  SQYLGLFN +N GN 
Sbjct: 70  NTSNGSVSSFSTTFVFAIRPQYPTLSGHGIVFVVSPTKGLPNSLQSQYLGLFNKSNNGNS 129

Query: 71  TNHVFAVELDTIKSHGFLDINDNHVGIDINSLKSESSAPAGYY----------------- 113
           +NHVF VELDTI S  F DINDNHVGIDIN LKS  S PAGYY                 
Sbjct: 130 SNHVFGVELDTIISSEFNDINDNHVGIDINDLKSAKSTPAGYYDVNGQLKNLTLFSGNPM 189

Query: 114 ---VEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSVLNDAMYVGFSSSTGSVLASH 170
              +EYDG +K+ +VTLAPIN+ +P+    +SL+RDLS +LN++MYVGFSS+TGSV  SH
Sbjct: 190 QVWIEYDGEKKKIDVTLAPINVVKPKQ-PLLSLTRDLSPILNNSMYVGFSSATGSVFTSH 248

Query: 171 YILGWSFKINGQAEELNLSQLPKLPRVGPKKRSKFLTIGLPVICVSVIFAAVSGVVYVIR 230
           YILGWSFK+NGQAE L +S+LPKLPR G KK S FLT+GLP++ +S++F    GV+Y I+
Sbjct: 249 YILGWSFKVNGQAENLVISELPKLPRFGEKKESMFLTVGLPLVLLSLVFMITLGVIYYIK 308

Query: 231 MKRKFAEELEDWELDHGPHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIA 290
            ++KFAE LEDWE ++GPHRF++KDLY ATKGF+EK LLG GGFGRVY+G +P S++E+A
Sbjct: 309 RRKKFAELLEDWEHEYGPHRFKFKDLYFATKGFKEKGLLGVGGFGRVYKGVMPGSKLEVA 368

Query: 291 VKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLY 350
           VK++SHESRQGM+EFV+EIVSIGRLRHRNLV LLGYCRRKGELLLVYDYMPNGSLD YLY
Sbjct: 369 VKRVSHESRQGMREFVSEIVSIGRLRHRNLVPLLGYCRRKGELLLVYDYMPNGSLDNYLY 428

Query: 351 DQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLA 410
           +QP+VTLNW QRFR+IKGVALGLFYLH+EWEQVVIHRD+KASNVLLDGELNGRLGDFGLA
Sbjct: 429 NQPRVTLNWSQRFRIIKGVALGLFYLHEEWEQVVIHRDIKASNVLLDGELNGRLGDFGLA 488

Query: 411 RLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPS 470
           RLYDHG DP TTH+VGT+GYLAPEHTRTGKAT  +DVFSFGAFLLEVACGRRPI+    +
Sbjct: 489 RLYDHGADPHTTHLVGTVGYLAPEHTRTGKATKFSDVFSFGAFLLEVACGRRPIENVAEN 548

Query: 471 ENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVV 530
           E +ILVD VF+ W RG +LEA+D NLGT YV+EE+ELVLKLGLLCSHS+P ARP MRQVV
Sbjct: 549 ECVILVDCVFECWKRGNILEAKDVNLGTNYVSEEVELVLKLGLLCSHSEPLARPGMRQVV 608

Query: 531 QILERDVALPAISALRLSTSGIT--YLEGFDDFAVSNPPSMGFTRPS---SVAESLLSGG 585
           Q LERD+ LP +S L LS+SG+T  Y E F+DF +S P SMG T      S+A+SLLSGG
Sbjct: 609 QYLERDIPLPDLSLLSLSSSGLTFGYQEFFEDFPLSYPSSMGNTMSHTSVSIADSLLSGG 668

Query: 586 R 586
           R
Sbjct: 669 R 669

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356520929|ref|XP_003529112.1| PREDICTED: L-type lectin-domain containing receptor kinase IV.1-like [Glycine max]

 Score =  808 bits (2087), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 405/600 (67%), Positives = 489/600 (81%), Gaps = 27/600 (4%)

Query: 11  STANGTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGLFNDTNLGNE 70
           +T NG+VFSFSTTFVF+I SE+ + SGHGIAFV++ T+ +P + PSQYLGLF+DTN GN 
Sbjct: 71  NTTNGSVFSFSTTFVFAIRSEFPNLSGHGIAFVVSPTKEVPHSLPSQYLGLFDDTNNGNN 130

Query: 71  TNHVFAVELDTIKSHGFLDINDNHVGIDINSLKSESSAPAGYY----------------- 113
           +NHVF VELDTI +  F DINDNHVGID+N LKS  SA AGYY                 
Sbjct: 131 SNHVFGVELDTILNTEFGDINDNHVGIDVNELKSVKSASAGYYSDGGFKNLSLISGYPMQ 190

Query: 114 --VEYDGLEKRTNVTLAPINIPRP-RSLNTMSLSRDLSSVLNDAMYVGFSSSTGSVLASH 170
             VEYDGL+K+ +VTLAPIN+ +P R L  +SL++DLS +LN +MYVGF+SSTGS+L+SH
Sbjct: 191 VWVEYDGLKKQIDVTLAPINVGKPERPL--LSLNKDLSRILNSSMYVGFTSSTGSILSSH 248

Query: 171 YILGWSFKINGQAEELNLSQLPKLPRVGPKKRSKFLTIGLPVICVSVIFAAVSGVVYVIR 230
           Y+LGWSFK+NG+A++L +S+LP LPR+  K+ SK L +GLP+I + +I      VV+ I+
Sbjct: 249 YVLGWSFKVNGKAQQLAISELPMLPRLVGKQESKVLIVGLPLILLILILMVALAVVHAIK 308

Query: 231 MKRKFAEELEDWELDHGPHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIA 290
            ++KF E LEDWE D+GPHRF+YKDL +ATKGFREKELLG+GGFGRVY+G +P S+IE+A
Sbjct: 309 -RKKFVELLEDWEQDYGPHRFKYKDLSLATKGFREKELLGSGGFGRVYKGVMPISKIEVA 367

Query: 291 VKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLY 350
           VKK+SHESRQGM+EFVAEI SIGRLRHRNLV LLGYCRRKGELLLVYDYMPNGSLDKYLY
Sbjct: 368 VKKVSHESRQGMREFVAEIASIGRLRHRNLVPLLGYCRRKGELLLVYDYMPNGSLDKYLY 427

Query: 351 DQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLA 410
           ++P+VTLNW QRFR+ KGVA GLFYLH+EWEQVV+HRD+KASNVLLD ELNGRLGDFGL+
Sbjct: 428 NKPRVTLNWSQRFRITKGVASGLFYLHEEWEQVVLHRDIKASNVLLDAELNGRLGDFGLS 487

Query: 411 RLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPS 470
           RLY+HGTDP TTHVVGTLGYLAPEHTRTGKATTS+DVF+FGAF+LEV CGRRPI++   S
Sbjct: 488 RLYEHGTDPHTTHVVGTLGYLAPEHTRTGKATTSSDVFAFGAFMLEVVCGRRPIEQGRES 547

Query: 471 ENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVV 530
            + ILVDWV++ W +GE+LEARDPNLG  Y  +E+ELVLKL LLCSHS+P ARPSMRQVV
Sbjct: 548 GSEILVDWVYNCWKKGEILEARDPNLGANYRPDEVELVLKLALLCSHSEPLARPSMRQVV 607

Query: 531 QILERDVALPAISALRLSTSGITY--LEGFDDFAVSNPPSMG--FTRPSSVAESLLSGGR 586
           Q LE+DV LP +S L LS+ G+T+   E F D  +S P SM    +  SS+AESLLSGGR
Sbjct: 608 QYLEKDVPLPDLSMLSLSSIGLTFGLHEDFQDCPMSYPSSMDRPISHTSSIAESLLSGGR 667

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356567974|ref|XP_003552189.1| PREDICTED: L-type lectin-domain containing receptor kinase IV.1-like [Glycine max]

 Score =  795 bits (2054), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 400/599 (66%), Positives = 488/599 (81%), Gaps = 25/599 (4%)

Query: 11  STANGTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGLFNDTNLGNE 70
           +T +G+VFSFSTTFVF+I SE+ + SGHGI FV++ T+G+P + PSQYLGLF+DTN GN 
Sbjct: 71  NTTSGSVFSFSTTFVFAIRSEFPNLSGHGIVFVVSPTKGVPHSLPSQYLGLFDDTNNGNN 130

Query: 71  TNHVFAVELDTIKSHGFLDINDNHVGIDINSLKSESSAPAGYY----------------- 113
           +NH+F VELDTI +  F DINDNHVG+D+N LKS  SA AGYY                 
Sbjct: 131 SNHIFGVELDTILNTEFGDINDNHVGVDVNELKSVKSAAAGYYSDEGFKNLSLISGYPMQ 190

Query: 114 --VEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSVLNDAMYVGFSSSTGSVLASHY 171
             VEYDGL+K+ +VTLAPIN+ +P     +SLS+DLS +LN +MYVGFSSSTGS+L+SHY
Sbjct: 191 VWVEYDGLKKQIDVTLAPINVGKPEG-PLLSLSKDLSPILNSSMYVGFSSSTGSILSSHY 249

Query: 172 ILGWSFKINGQAEELNLSQLPKLPRVGPKKRSKFLTIGLPVICVSVIFAAVSGVVYVIRM 231
           +LGWSFK+NG+A++L +S+LP LPR+G K+ SK L +GLP+I +S+I      VV+VI+ 
Sbjct: 250 VLGWSFKVNGKAQQLAISELPMLPRLGGKEESKVLIVGLPLILLSLILMVALAVVHVIK- 308

Query: 232 KRKFAEELEDWELDHGPHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAV 291
           ++KF E LEDWE D+GPHRF+YKDL +ATKGFREKELLG+GGFGRVY+G +P S+IE+AV
Sbjct: 309 RKKFTELLEDWEQDYGPHRFKYKDLSLATKGFREKELLGSGGFGRVYKGVMPISKIEVAV 368

Query: 292 KKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYD 351
           KK+S ESRQGM+EFVAEIVSIG LRHRNLV LLGYCRRKGELLLVYDYMPNGSLDKYLY+
Sbjct: 369 KKVSRESRQGMREFVAEIVSIGCLRHRNLVPLLGYCRRKGELLLVYDYMPNGSLDKYLYN 428

Query: 352 QPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR 411
           +P+VTLNW QRF++ KGVA GLFYLH+EWEQVV+HRD+KASNVLLD ELNGRLGDFGL+R
Sbjct: 429 KPRVTLNWSQRFKITKGVASGLFYLHEEWEQVVVHRDIKASNVLLDAELNGRLGDFGLSR 488

Query: 412 LYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSE 471
           LY+HGTDP TTHVVGTLGYLAPEHTRTGKATTS+DVF+FGAF+LEV CGRRPI++ G S 
Sbjct: 489 LYEHGTDPHTTHVVGTLGYLAPEHTRTGKATTSSDVFAFGAFMLEVVCGRRPIEKGGESG 548

Query: 472 NLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ 531
           + ILVDWV++ W +GE+LE+ DPNLG  Y  +E+ELVLKL LLCSHS+P ARPSMRQVVQ
Sbjct: 549 SEILVDWVYNCWKKGEILESMDPNLGANYRPDEVELVLKLALLCSHSEPLARPSMRQVVQ 608

Query: 532 ILERDVALPAISALRLSTSGITY--LEGFDDFAVSNPPSMG--FTRPSSVAESLLSGGR 586
            LE+DV LP +  L LS++G+T+   E F D  +S P SM    +  SS+ ESLLSGGR
Sbjct: 609 YLEKDVPLPDLCMLSLSSNGLTFGLHEDFQDCPMSYPSSMNRPISHTSSIVESLLSGGR 667

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224110964|ref|XP_002333003.1| predicted protein [Populus trichocarpa] gi|222834498|gb|EEE72975.1| predicted protein [Populus trichocarpa]

 Score =  773 bits (1997), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 409/615 (66%), Positives = 456/615 (74%), Gaps = 88/615 (14%)

Query: 2   PFKNKNSNSSTANGTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGL 61
           P   KNS +STA    F+FST FVF+I+ EY S  GHGIAFVIA TRGLPGA PSQ+LGL
Sbjct: 67  PVTFKNSINSTA----FTFSTAFVFAIIPEYASFGGHGIAFVIAPTRGLPGALPSQHLGL 122

Query: 62  FNDTNLGNETNHVFAVELDTIKSHGFLDINDNHVGIDINSLKSESSAPAGYY-------- 113
           FN+TN GN+TNHV AVELDTI +  F DINDNHVGIDIN L SE SA AGYY        
Sbjct: 123 FNETNNGNQTNHVVAVELDTIYNSDFNDINDNHVGIDINGLVSERSASAGYYSQLNGKLT 182

Query: 114 -------------VEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSVLNDAMYVGFS 160
                        +EYDG+EK+ NVT+API++ +P S   ++LS DLS +LN        
Sbjct: 183 NLTLSSGHPMQVWMEYDGMEKQFNVTIAPIDVDKP-SRPLLTLSCDLSPILNST------ 235

Query: 161 SSTGSVLASHYILGWSFKINGQAEELNLSQLPKLPRVGPKKRSKFLTIGLPVICVSVIFA 220
                   S Y+LGWSFK+NG A+ LN+S+LPKLPRVGPKK SKFLTIGLPV+C+S++  
Sbjct: 236 --------SQYVLGWSFKMNGLAKGLNISRLPKLPRVGPKKTSKFLTIGLPVLCLSLVLV 287

Query: 221 AVSGVVYVIRMKRKFAEELEDWELDHGPHRFRYKDLYIATKGFREKELLGTGGFGRVYRG 280
           AVS + Y IR  RKFAE LEDWELD+GPHRF+ KDLY ATKGFR++E LG+GGFGRVY+G
Sbjct: 288 AVSSISYAIRRARKFAEVLEDWELDYGPHRFKLKDLYTATKGFRDEEQLGSGGFGRVYKG 347

Query: 281 TLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYM 340
            LP S+I+IAVK++SHESRQGM+EFVAEIVSIGRLRHRNLV LLGYCRRKGELLLVYDYM
Sbjct: 348 VLPTSKIQIAVKRVSHESRQGMREFVAEIVSIGRLRHRNLVPLLGYCRRKGELLLVYDYM 407

Query: 341 PNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGEL 400
           PNGSLDKYLYDQP V LNW QRFRVIKGVA GL YLH+EWEQVVIHRDVKASNVLLDGEL
Sbjct: 408 PNGSLDKYLYDQPTVALNWSQRFRVIKGVASGLLYLHEEWEQVVIHRDVKASNVLLDGEL 467

Query: 401 NGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACG 460
           NGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEH RTGKATTS DVF+FGAFLLEVA G
Sbjct: 468 NGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHARTGKATTSTDVFAFGAFLLEVASG 527

Query: 461 RRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDP 520
           RRPIQ   P+E++ILVDWVF  W            LG                       
Sbjct: 528 RRPIQ---PTEDIILVDWVFSRW------------LG----------------------- 549

Query: 521 TARPSMRQVVQILERDVALPAISALRLSTSGITY--LEGFDDFAV-----SNPPSM--GF 571
            ARPSMRQVVQ LE DV LP IS LRLS SG+T+   EGFDDFA+     S P SM   F
Sbjct: 550 -ARPSMRQVVQFLEGDVPLPDISPLRLSASGLTFSHREGFDDFAIDDFANSYPSSMDKAF 608

Query: 572 TRPSSVAESLLSGGR 586
              SSVAESLLSGGR
Sbjct: 609 AHSSSVAESLLSGGR 623

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|31324528|gb|AAP47579.1| receptor kinase Lecrk [Gossypium hirsutum]

 Score =  764 bits (1974), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 379/558 (67%), Positives = 443/558 (79%), Gaps = 31/558 (5%)

Query: 2   PFKNKNSNSSTANGTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGL 61
           P   KNS     NG+VFSFS+TFVF+IL EY + SGHGIAFVIA T+GLPG+ PSQYLGL
Sbjct: 66  PVDFKNS----TNGSVFSFSSTFVFAILPEYPTLSGHGIAFVIAPTKGLPGSLPSQYLGL 121

Query: 62  FNDTNLGNETNHVFAVELDTIKSHGFLDINDNHVGIDINSLKSESSAPAGYY-------- 113
           FN +N GN+TNHV AVELDTI+S  F DINDNHVGIDIN LKS +S+PAGYY        
Sbjct: 122 FNGSNNGNDTNHVVAVELDTIRSTEFDDINDNHVGIDINGLKSPTSSPAGYYEDDSHDFK 181

Query: 114 -------------VEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSVLNDAMYVGFS 160
                        VEY GLEKR +VTLAP  +P+P +          S V  + +   F 
Sbjct: 182 NLTLISGKQMQVWVEYHGLEKRMDVTLAPFKVPKPDTPLLSLSRDLSSIVNRENVCWFFI 241

Query: 161 SSTGSVLASHYILGWSFKING---QAEELNLSQLPKLPRVGPKKRSKFLTIGLPVICVSV 217
            +       H  L +  +++    QAEEL LSQLPKLPR+GPKK+ K LTIGLP+I VS+
Sbjct: 242 VNW---FGPHISLCFGLELSRLMVQAEELTLSQLPKLPRLGPKKKPKVLTIGLPLILVSL 298

Query: 218 IFAAVSGVVYVIRMKRKFAEELEDWELDHGPHRFRYKDLYIATKGFREKELLGTGGFGRV 277
             A VSG  Y++R KRKFA+ +EDWEL++GPHRF++KDLYIATKGF++KELLG GGFGRV
Sbjct: 299 ALAGVSGAAYLVRRKRKFADVVEDWELEYGPHRFKFKDLYIATKGFKDKELLGAGGFGRV 358

Query: 278 YRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY 337
           YRG LP +++E+AVK++SHESRQGM+EFVAEIVSIGRLRHRNLVQLLGYCRRK ELLLVY
Sbjct: 359 YRGVLPSNKLEVAVKRVSHESRQGMREFVAEIVSIGRLRHRNLVQLLGYCRRKDELLLVY 418

Query: 338 DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLD 397
           DYMPNGSLDKYL+DQPKVTLNW QRFRVIKGVA GLFYLH EW+QVV+HR+VKASNVLLD
Sbjct: 419 DYMPNGSLDKYLHDQPKVTLNWRQRFRVIKGVASGLFYLHGEWDQVVVHRNVKASNVLLD 478

Query: 398 GELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEV 457
           GELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKAT S DVF+FGAFLLEV
Sbjct: 479 GELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATPSTDVFAFGAFLLEV 538

Query: 458 ACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSH 517
           ACGRRPI+ + P+E++ILVDWV+  W+ G+++EA+DPNLG+ Y AEE+ELVLKLGLLCSH
Sbjct: 539 ACGRRPIEAKSPTEDVILVDWVYSCWSNGDIMEAKDPNLGSGYEAEEVELVLKLGLLCSH 598

Query: 518 SDPTARPSMRQVVQILER 535
           S+P ARP+MRQ   +  R
Sbjct: 599 SEPEARPTMRQSPSVFRR 616

Source: Gossypium hirsutum

Species: Gossypium hirsutum

Genus: Gossypium

Family: Malvaceae

Order: Malvales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|15224347|ref|NP_181307.1| receptor lectin kinase [Arabidopsis thaliana] gi|75318718|sp|O80939.1|LRK41_ARATH RecName: Full=L-type lectin-domain containing receptor kinase IV.1; Short=Arabidopsis thaliana lectin-receptor kinase e; Short=AthlecRK-e; Short=LecRK-IV.1; AltName: Full=Lectin Receptor Kinase 1; Flags: Precursor gi|3236253|gb|AAC23641.1| putative receptor-like protein kinase [Arabidopsis thaliana] gi|20259541|gb|AAM13890.1| putative receptor protein kinase [Arabidopsis thaliana] gi|330254344|gb|AEC09438.1| receptor lectin kinase [Arabidopsis thaliana]

 Score =  761 bits (1965), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 397/611 (64%), Positives = 471/611 (77%), Gaps = 32/611 (5%)

Query: 2   PFKNKNSNSSTANGTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGL 61
           P + K+S     NGTV SFST+FVF+I S+    SGHGIAFV+A    LP   PSQY+GL
Sbjct: 71  PIRFKDS----PNGTVSSFSTSFVFAIHSQIAILSGHGIAFVVAPNASLPYGNPSQYIGL 126

Query: 62  FNDTNLGNETNHVFAVELDTIKSHGFLDINDNHVGIDINSLKSESSAPAGYY-------- 113
           FN  N GNETNHVFAVELDTI S  F D NDNHVGIDINSLKS  S+PAGY+        
Sbjct: 127 FNLANNGNETNHVFAVELDTILSTEFNDTNDNHVGIDINSLKSVQSSPAGYWDEKGQFKN 186

Query: 114 ------------VEYDGLEKRTNVTLAPINIPRP-RSLNTMSLSRDLSSVLNDAMYVGFS 160
                       V+YDG   + +VT+AP N  +P R L T    RDLSSVL   MYVGFS
Sbjct: 187 LTLISRKPMQVWVDYDGRTNKIDVTMAPFNEDKPTRPLVTAV--RDLSSVLLQDMYVGFS 244

Query: 161 SSTGSVLASHYILGWSFKINGQAEELNLSQLPKLPRVGPKKRSKFLTIGLPVICVSVIFA 220
           S+TGSVL+ HYILGWSF +N +A  L LS+LPKLPR  PK+ S+F  IG+P+I + +IF+
Sbjct: 245 SATGSVLSEHYILGWSFGLNEKAPPLALSRLPKLPRFEPKRISEFYKIGMPLISLFLIFS 304

Query: 221 AVSGVVYVIRMKRKFAEELEDWELDHGPHRFRYKDLYIATKGFREKELLGTGGFGRVYRG 280
            +  V Y++R +RKFAEELE+WE + G +RFR+KDLY ATKGF+EK LLGTGGFG VY+G
Sbjct: 305 FIFLVCYIVRRRRKFAEELEEWEKEFGKNRFRFKDLYYATKGFKEKGLLGTGGFGSVYKG 364

Query: 281 TLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYM 340
            +P +++EIAVK++SHESRQGMKEFVAEIVSIGR+ HRNLV LLGYCRR+GELLLVYDYM
Sbjct: 365 VMPGTKLEIAVKRVSHESRQGMKEFVAEIVSIGRMSHRNLVPLLGYCRRRGELLLVYDYM 424

Query: 341 PNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGEL 400
           PNGSLDKYLY+ P+VTLNW QR +VI GVA GLFYLH+EWEQVVIHRDVKASNVLLDGEL
Sbjct: 425 PNGSLDKYLYNTPEVTLNWKQRIKVILGVASGLFYLHEEWEQVVIHRDVKASNVLLDGEL 484

Query: 401 NGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACG 460
           NGRLGDFGLARLYDHG+DPQTTHVVGTLGYLAPEHTRTG+AT + DVF+FGAFLLEVACG
Sbjct: 485 NGRLGDFGLARLYDHGSDPQTTHVVGTLGYLAPEHTRTGRATMATDVFAFGAFLLEVACG 544

Query: 461 RRPIQ-RQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSD 519
           RRPI+ +Q   E  +LVDWVF  WN+G++L A+DPN+G+E   +E+E+VLKLGLLCSHSD
Sbjct: 545 RRPIEFQQETDETFLLVDWVFGLWNKGDILAAKDPNMGSECDEKEVEMVLKLGLLCSHSD 604

Query: 520 PTARPSMRQVVQILERDVALPAISALRLSTSGITY--LEGFDDFAVSNPPSM--GFTRPS 575
           P ARPSMRQV+  L  D  LP +S L LS SG+ +   +GF +  +S   S+  GFT  S
Sbjct: 605 PRARPSMRQVLHYLRGDAKLPELSPLDLSGSGMMFGVHDGFSELGMSYSSSVFKGFTGGS 664

Query: 576 SVAESLLSGGR 586
           S+A+S LSGGR
Sbjct: 665 SIADSQLSGGR 675

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297827329|ref|XP_002881547.1| hypothetical protein ARALYDRAFT_482773 [Arabidopsis lyrata subsp. lyrata] gi|297327386|gb|EFH57806.1| hypothetical protein ARALYDRAFT_482773 [Arabidopsis lyrata subsp. lyrata]

 Score =  761 bits (1964), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 395/610 (64%), Positives = 470/610 (77%), Gaps = 30/610 (4%)

Query: 2   PFKNKNSNSSTANGTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGL 61
           P + K+S     NGTV SFSTTFVF+I S+    SGHGIAFV+A    LP A PSQYLGL
Sbjct: 66  PIRFKDS----PNGTVSSFSTTFVFAIHSQIAILSGHGIAFVVAPNSSLPYATPSQYLGL 121

Query: 62  FNDTNLGNETNHVFAVELDTIKSHGFLDINDNHVGIDINSLKSESSAPAGYY-------- 113
           FN +N GN+TNHVFAVELDTI S  F D NDNHVGIDINSLKS  S  AGY+        
Sbjct: 122 FNISNNGNDTNHVFAVELDTILSTEFNDTNDNHVGIDINSLKSVQSFRAGYWDEKNQFKN 181

Query: 114 ------------VEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSVLNDAMYVGFSS 161
                       V+YD    + +VT+AP N  +P+    +S  RDLSSV    MYVGFSS
Sbjct: 182 LTLISRKPMQVWVDYDAPTTKIDVTMAPFNEDKPKR-PLVSAVRDLSSVFLQDMYVGFSS 240

Query: 162 STGSVLASHYILGWSFKINGQAEELNLSQLPKLPRVGPKKRSKFLTIGLPVICVSVIFAA 221
           +TGSVL+ HY+LGWSF +N +A  L LS+LPKLPR  PK+ S+F  IG+P+I + +IF+ 
Sbjct: 241 ATGSVLSEHYVLGWSFGLNEKAPPLALSRLPKLPRFEPKRISEFYKIGMPLISLFLIFSF 300

Query: 222 VSGVVYVIRMKRKFAEELEDWELDHGPHRFRYKDLYIATKGFREKELLGTGGFGRVYRGT 281
           +  V Y++R +RKFAEELEDWE + G +RFR+KDLY ATKGF+EK LLGTGGFG VY+G 
Sbjct: 301 IFLVCYIVRRRRKFAEELEDWEKEFGKNRFRFKDLYYATKGFKEKGLLGTGGFGSVYKGV 360

Query: 282 LPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMP 341
           +P +++EIAVK++SHESRQGMKEFVAEIVSIGR+ HRNLV LLGYCRR+GELLLVYDYMP
Sbjct: 361 MPGTKLEIAVKRVSHESRQGMKEFVAEIVSIGRMSHRNLVPLLGYCRRRGELLLVYDYMP 420

Query: 342 NGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELN 401
           NGSLDKYLY+ P+VTLNW QR +VI GVA GLFYLH+EWEQVVIHRDVKASNVLLDGELN
Sbjct: 421 NGSLDKYLYNTPEVTLNWKQRIKVILGVASGLFYLHEEWEQVVIHRDVKASNVLLDGELN 480

Query: 402 GRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGR 461
           GRLGDFGLARLYDHG+DPQTTHVVGTLGYLAPEHTRTG+ATT+ DVF+FGAFLLEV+CGR
Sbjct: 481 GRLGDFGLARLYDHGSDPQTTHVVGTLGYLAPEHTRTGRATTATDVFAFGAFLLEVSCGR 540

Query: 462 RPIQRQGPS-ENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDP 520
           RPI+ Q  + E  +LVDWVF  WN+G +L A+DPN+G+E   +E+E+VLKLGLLCSHSDP
Sbjct: 541 RPIEIQHETDETFLLVDWVFGLWNKGNILAAKDPNMGSECDEKEVEMVLKLGLLCSHSDP 600

Query: 521 TARPSMRQVVQILERDVALPAISALRLSTSGITY--LEGFDDFAVSNPPSM--GFTRPSS 576
            ARPSMRQV+  L  D  LP +S L LS SG+ +   +GF +  +S   S+  GFT  SS
Sbjct: 601 RARPSMRQVLHYLRGDAKLPELSPLDLSGSGMMFGVHDGFSELGMSYSSSVFKGFTGGSS 660

Query: 577 VAESLLSGGR 586
           +A+SLLSGGR
Sbjct: 661 IADSLLSGGR 670

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	586
TAIR|locus:2040681	675	RLK "receptor lectin kinase" [	0.875	0.76	0.615	1.1e-167
TAIR|locus:2084375	677	AT3G53810 [Arabidopsis thalian	0.882	0.763	0.574	8.4e-161
TAIR|locus:2119936	669	AT4G29050 [Arabidopsis thalian	0.843	0.738	0.485	2.4e-155
TAIR|locus:2099941	684	AT3G55550 [Arabidopsis thalian	0.802	0.687	0.513	7.4e-150
TAIR|locus:2020608	666	AT1G70110 [Arabidopsis thalian	0.875	0.770	0.476	1.1e-148
TAIR|locus:2133239	669	AT4G02420 [Arabidopsis thalian	0.868	0.760	0.560	3.9e-147
TAIR|locus:2133229	674	LPK1 "lectin-like protein kina	0.868	0.755	0.548	5.9e-144
TAIR|locus:2043909	658	AT2G43700 [Arabidopsis thalian	0.810	0.721	0.470	7.6e-133
TAIR|locus:2020593	656	AT1G70130 [Arabidopsis thalian	0.972	0.868	0.456	3.1e-131
TAIR|locus:2097613	693	AT3G08870 [Arabidopsis thalian	0.733	0.620	0.482	4.4e-126

TAIR|locus:2040681 RLK "receptor lectin kinase" [Arabidopsis thaliana (taxid:3702)]

 Score = 1631 (579.2 bits), Expect = 1.1e-167, P = 1.1e-167
 Identities = 330/536 (61%), Positives = 402/536 (75%)

Query:    62 FNDTNLGNETNHVFAVELDTIKS-----HGFLDINDNHVGIDINSLKSESSAPAGYYVEY 116
             FNDTN     NHV  ++++++KS      G+ D       + + S K     P   +V+Y
Sbjct:   152 FNDTN----DNHV-GIDINSLKSVQSSPAGYWDEKGQFKNLTLISRK-----PMQVWVDY 201

Query:   117 DGLEKRTNVTLAPINIPRP-RSLNTMSLSRDLSSVLNDAMYVGFSSSTGSVLASHYILGW 175
             DG   + +VT+AP N  +P R L T    RDLSSVL   MYVGFSS+TGSVL+ HYILGW
Sbjct:   202 DGRTNKIDVTMAPFNEDKPTRPLVTAV--RDLSSVLLQDMYVGFSSATGSVLSEHYILGW 259

Query:   176 SFKINGQAEELNLSQLPKLPRVGPKKRSKFLTIGLPVICVSVIFAAVSGVVYVIRMKRKF 235
             SF +N +A  L LS+LPKLPR  PK+ S+F  IG+P+I + +IF+ +  V Y++R +RKF
Sbjct:   260 SFGLNEKAPPLALSRLPKLPRFEPKRISEFYKIGMPLISLFLIFSFIFLVCYIVRRRRKF 319

Query:   236 AEELEDWELDHGPHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKIS 295
             AEELE+WE + G +RFR+KDLY ATKGF+EK LLGTGGFG VY+G +P +++EIAVK++S
Sbjct:   320 AEELEEWEKEFGKNRFRFKDLYYATKGFKEKGLLGTGGFGSVYKGVMPGTKLEIAVKRVS 379

Query:   296 HESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKV 355
             HESRQGMKEFVAEIVSIGR+ HRNLV LLGYCRR+GELLLVYDYMPNGSLDKYLY+ P+V
Sbjct:   380 HESRQGMKEFVAEIVSIGRMSHRNLVPLLGYCRRRGELLLVYDYMPNGSLDKYLYNTPEV 439

Query:   356 TLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH 415
             TLNW QR +VI GVA GLFYLH+EWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH
Sbjct:   440 TLNWKQRIKVILGVASGLFYLHEEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH 499

Query:   416 GTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQ-RQGPSENLI 474
             G+DPQTTHVVGTLGYLAPEHTRTG+AT + DVF+FGAFLLEVACGRRPI+ +Q   E  +
Sbjct:   500 GSDPQTTHVVGTLGYLAPEHTRTGRATMATDVFAFGAFLLEVACGRRPIEFQQETDETFL 559

Query:   475 LVDWVFDFWNRGELLEARDPNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQILE 534
             LVDWVF  WN+G++L A+DPN+G+E               CSHSDP ARPSMRQV+  L 
Sbjct:   560 LVDWVFGLWNKGDILAAKDPNMGSECDEKEVEMVLKLGLLCSHSDPRARPSMRQVLHYLR 619

Query:   535 RDVALPAISALRLSTSGITY--LEGFDDFAVSNPPSM--GFTRPSSVAESLLSGGR 586
              D  LP +S L LS SG+ +   +GF +  +S   S+  GFT  SS+A+S LSGGR
Sbjct:   620 GDAKLPELSPLDLSGSGMMFGVHDGFSELGMSYSSSVFKGFTGGSSIADSQLSGGR 675

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009751 "response to salicylic acid stimulus" evidence=IEP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006995 "cellular response to nitrogen starvation" evidence=RCA

GO:0009617 "response to bacterium" evidence=RCA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035304 "regulation of protein dephosphorylation" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0045088 "regulation of innate immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2084375 AT3G53810 [Arabidopsis thaliana (taxid:3702)]

 Score = 1566 (556.3 bits), Expect = 8.4e-161, P = 8.4e-161
 Identities = 307/534 (57%), Positives = 399/534 (74%)

Query:    62 FNDTNLGNETNHVFAVELDTIKSHGF--LDINDNHVGIDINSLKSESSAPAGYYVEYDGL 119
             F D N     NHV  ++L+ ++S  +      D+H      SL S        +++YD  
Sbjct:   152 FGDPN----DNHV-GIDLNGLRSANYSTAGYRDDHDKFQNLSLISRKRIQV--WIDYDNR 204

Query:   120 EKRTNVTLAPINIPRPRSLNTMSLSRDLSSVLNDAMYVGFSSSTGSVLASHYILGWSFKI 179
               R +VT+AP +  +PR    +S  RDLSS+L + MYVGFSS+TGSVL+ H+++GWSF++
Sbjct:   205 SHRIDVTVAPFDSDKPRK-PLVSYVRDLSSILLEDMYVGFSSATGSVLSEHFLVGWSFRL 263

Query:   180 NGQAEELNLSQLPKLPRVGPKKRSKFLTIGLPVICVSVIFAAVSGVVYVIRMKRKFAEEL 239
             NG+A  L+LS+LPKLPR  P++ S+F  IG+P+I +S+IF+ +    Y++R K+K+ EEL
Sbjct:   264 NGEAPMLSLSKLPKLPRFEPRRISEFYKIGMPLISLSLIFSIIFLAFYIVRRKKKYEEEL 323

Query:   240 EDWELDHGPHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR 299
             +DWE + G +RFR+K+LY ATKGF+EK+LLG+GGFGRVYRG LP +++E+AVK++SH+S+
Sbjct:   324 DDWETEFGKNRFRFKELYHATKGFKEKDLLGSGGFGRVYRGILPTTKLEVAVKRVSHDSK 383

Query:   300 QGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNW 359
             QGMKEFVAEIVSIGR+ HRNLV LLGYCRR+GELLLVYDYMPNGSLDKYLY+ P+ TL+W
Sbjct:   384 QGMKEFVAEIVSIGRMSHRNLVPLLGYCRRRGELLLVYDYMPNGSLDKYLYNNPETTLDW 443

Query:   360 IQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP 419
              QR  +IKGVA GLFYLH+EWEQVVIHRDVKASNVLLD + NGRLGDFGLARLYDHG+DP
Sbjct:   444 KQRSTIIKGVASGLFYLHEEWEQVVIHRDVKASNVLLDADFNGRLGDFGLARLYDHGSDP 503

Query:   420 QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSEN-LILVDW 478
             QTTHVVGTLGYLAPEH+RTG+ATT+ DV++FGAFLLEV  GRRPI+    S++  +LV+W
Sbjct:   504 QTTHVVGTLGYLAPEHSRTGRATTTTDVYAFGAFLLEVVSGRRPIEFHSASDDTFLLVEW 563

Query:   479 VFDFWNRGELLEARDPNLGTE-YVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQILERDV 537
             VF  W RG ++EA+DP LG+  Y              CSHSDP ARPSMRQV+Q L  D+
Sbjct:   564 VFSLWLRGNIMEAKDPKLGSSGYDLEEVEMVLKLGLLCSHSDPRARPSMRQVLQYLRGDM 623

Query:   538 ALPAISALRLSTSGITYL---EGFDDFAVSNPPSM--GFTRPSSVAESLLSGGR 586
             ALP ++ L LS   +  L   +GF   A+++  ++  GFT  SS+A+SLLSGGR
Sbjct:   624 ALPELTPLDLSAGSVMNLGGRDGFSGIAMTDFSTVFKGFTGGSSIADSLLSGGR 677

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009555 "pollen development" evidence=IMP

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

TAIR|locus:2119936 AT4G29050 [Arabidopsis thaliana (taxid:3702)]

 Score = 1257 (447.5 bits), Expect = 2.4e-155, Sum P(2) = 2.4e-155
 Identities = 254/523 (48%), Positives = 354/523 (67%)

Query:    70 ETNHVFAVELDTIKSH-----GFLDINDNHVGIDINSLKSESSAPAGYYVEYDGLEKRTN 124
             + NHV  ++++++ S      G+ + +D        +++  +  P   ++EYD   ++ N
Sbjct:   152 DNNHV-GIDINSLSSEKASTAGYYEDDDG----TFKNIRLINQKPIQAWIEYDSSRRQLN 206

Query:   125 VTLAPINIPRPRSLNTMSLSRDLSSVLNDAMYVGFSSSTGSVLASHYILGWSFKINGQAE 184
             VT+ PI++P+P+ +  +SL++DLS  L D+MYVGF+S+TG + +SHYILGW+FK+NG A 
Sbjct:   207 VTIHPIHLPKPK-IPLLSLTKDLSPYLFDSMYVGFTSATGRLRSSHYILGWTFKLNGTAS 265

Query:   185 ELNLSQLPKLPRVGPKKR-SKFLTIGLPVICVSV-IFAAVSGVVYVIRMKRK-FAEELED 241
              +++S+LPKLPR        K L I L +  +++ +F  +S   Y++ +KRK   E LED
Sbjct:   266 NIDISRLPKLPRDSRSTSVKKILAISLSLTSLAILVFLTIS---YMLFLKRKKLMEVLED 322

Query:   242 WELDHGPHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQG 301
             WE+  GPHRF YKDLYIATKGFR  ELLG GGFG+VY+GTL  S ++IAVKK+SH+SRQG
Sbjct:   323 WEVQFGPHRFAYKDLYIATKGFRNSELLGKGGFGKVYKGTLSTSNMDIAVKKVSHDSRQG 382

Query:   302 MKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQ 361
             M+EFVAEI +IGRLRH NLV+LLGYCRRKGEL LVYD MP GSLDK+LY QP+ +L+W Q
Sbjct:   383 MREFVAEIATIGRLRHPNLVRLLGYCRRKGELYLVYDCMPKGSLDKFLYHQPEQSLDWSQ 442

Query:   362 RFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQT 421
             RF++IK VA GL YLH +W QV+IHRD+K +NVLLD  +NG+LGDFGLA+L +HG DPQT
Sbjct:   443 RFKIIKDVASGLCYLHHQWVQVIIHRDIKPANVLLDDSMNGKLGDFGLAKLCEHGFDPQT 502

Query:   422 THVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPI--QRQGPSENLILVDWV 479
             ++V GT GY++PE +RTGKA+TS+DVF+FG  +LE+ CGRRP+  +   PSE ++L DWV
Sbjct:   503 SNVAGTFGYISPELSRTGKASTSSDVFAFGILMLEITCGRRPVLPRASSPSE-MVLTDWV 561

Query:   480 FDFWNRGELLEARDPNLGTE--YVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQILERDV 537
              D W   ++L+  D  +  +  Y+             CSH     RPSM  V+Q L+   
Sbjct:   562 LDCWE-DDILQVVDERVKQDDKYLEEQVALVLKLGLFCSHPVAAVRPSMSSVIQFLDGVA 620

Query:   538 ALPA-ISALRLSTSGITYLEGFDDFAVS--NPPSMG---FTRP 574
              LP  +  +  +   +  +EGF + A S   P S+    FT P
Sbjct:   621 QLPNNLFDIVKARENVGAIEGFGEAAESLAEPCSVATLTFTEP 663

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=ISS

TAIR|locus:2099941 AT3G55550 [Arabidopsis thaliana (taxid:3702)]

 Score = 1246 (443.7 bits), Expect = 7.4e-150, Sum P(2) = 7.4e-150
 Identities = 251/489 (51%), Positives = 338/489 (69%)

Query:    70 ETNHVFAVELDTIK-SHGFLDINDNHVGIDI-------NSLKSESSAPAGY----YVEYD 117
             E + V  +E + I  +H  +DIN     I         NS K E     G     +++YD
Sbjct:   141 EFDTVRDLEFEDINDNHVGIDINSMESSISTPAGYFLANSTKKELFLDGGRVIQAWIDYD 200

Query:   118 GLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSVLNDAMYVGFSSSTGSVLASHYILGWSF 177
               +KR +V L+P +  +P+ L+ +S   DLSSVL D MYVGFS+STG + +SHYILGW+F
Sbjct:   201 SNKKRLDVKLSPFS-EKPK-LSLLSYDVDLSSVLGDEMYVGFSASTGLLASSHYILGWNF 258

Query:   178 KINGQAEELNLSQLPKLPRVGPKKRSK--FLTIGLPVICVSVIFAA-VSGVVYVIRMKRK 234
              ++G+A  L+L  LP++P    K++ K   L +G+ ++C  +IFA  V+  ++V+R K K
Sbjct:   259 NMSGEAFSLSLPSLPRIPSSIKKRKKKRQSLILGVSLLCSLLIFAVLVAASLFVVR-KVK 317

Query:   235 FAEELEDWELDHGPHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKI 294
               + +E+WELD GPHRF Y++L  AT GF +KELLG+GGFG+VY+G LP S   +AVK+I
Sbjct:   318 DEDRVEEWELDFGPHRFSYRELKKATNGFGDKELLGSGGFGKVYKGKLPGSDEFVAVKRI 377

Query:   295 SHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQ-P 353
             SHESRQG++EF++E+ SIG LRHRNLVQLLG+CRR+ +LLLVYD+MPNGSLD YL+D+ P
Sbjct:   378 SHESRQGVREFMSEVSSIGHLRHRNLVQLLGWCRRRDDLLLVYDFMPNGSLDMYLFDENP 437

Query:   354 KVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLY 413
             +V L W QRF++IKGVA GL YLH+ WEQ VIHRD+KA+NVLLD E+NGR+GDFGLA+LY
Sbjct:   438 EVILTWKQRFKIIKGVASGLLYLHEGWEQTVIHRDIKAANVLLDSEMNGRVGDFGLAKLY 497

Query:   414 DHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENL 473
             +HG+DP  T VVGT GYLAPE T++GK TTS DV++FGA LLEVACGRRPI+     E L
Sbjct:   498 EHGSDPGATRVVGTFGYLAPELTKSGKLTTSTDVYAFGAVLLEVACGRRPIETSALPEEL 557

Query:   474 ILVDWVFDFWNRGELLEARDPNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQIL 533
             ++VDWV+  W  G++ +  D  L  E+              CS++ P  RP+MRQVV  L
Sbjct:   558 VMVDWVWSRWQSGDIRDVVDRRLNGEFDEEEVVMVIKLGLLCSNNSPEVRPTMRQVVMYL 617

Query:   534 ERDVALPAI 542
             E+    P +
Sbjct:   618 EKQFPSPEV 626

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2020608 AT1G70110 [Arabidopsis thaliana (taxid:3702)]

 Score = 1256 (447.2 bits), Expect = 1.1e-148, Sum P(2) = 1.1e-148
 Identities = 248/520 (47%), Positives = 340/520 (65%)

Query:    70 ETNHVFAVELDTIKSHGFLDINDNHVGIDINSLKSESSAPAGYYVEYDGLEKRTNVTLAP 129
             + NHV  ++++T+ S                SL   S  P   ++EYD  +K+ NVTL P
Sbjct:   151 DANHV-GIDINTLVSDTVALAGYYMDNGTFRSLLLNSGQPMQIWIEYDSKQKQINVTLHP 209

Query:   130 INIPRPRSLNTMSLSRDLSSVLNDAMYVGFSSSTGSVLASHYILGWSFKINGQAEELNLS 189
             + +P+P+ +  +SL +DLS  L + MYVGF+S+TG + ASHYILGW+FK+NG   +++ S
Sbjct:   210 LYVPKPK-IPLLSLEKDLSPYLLELMYVGFTSTTGDLTASHYILGWTFKMNGTTPDIDPS 268

Query:   190 QLPKLPRVG-PKKRSK--FLTIGLPVICVSVIFAAVSGVVYVIRMKRKFAEELEDWELDH 246
             +LPK+PR   P  +S    LTI L V  V +I   +S  +++   ++K  E LEDWE+  
Sbjct:   269 RLPKIPRYNQPWIQSPNGILTISLTVSGV-IILIILSLSLWLFLKRKKLLEVLEDWEVQF 327

Query:   247 GPHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFV 306
             GPHRF +KDL+IATKGF++ E+LG GGFG+VY+GTLP S +EIAVK +SH+SRQGM+EF+
Sbjct:   328 GPHRFAFKDLHIATKGFKDTEVLGKGGFGKVYKGTLPVSNVEIAVKMVSHDSRQGMREFI 387

Query:   307 AEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVI 366
             AEI +IGRLRH NLV+L GYCR KGEL LVYD M  GSLDK+LY Q    L+W QRF++I
Sbjct:   388 AEIATIGRLRHPNLVRLQGYCRHKGELYLVYDCMAKGSLDKFLYHQQTGNLDWSQRFKII 447

Query:   367 KGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVG 426
             K VA GL+YLHQ+W QV+IHRD+K +N+LLD  +N +LGDFGLA+L DHGTDPQT+HV G
Sbjct:   448 KDVASGLYYLHQQWVQVIIHRDIKPANILLDANMNAKLGDFGLAKLCDHGTDPQTSHVAG 507

Query:   427 TLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRG 486
             TLGY++PE +RTGKA+T +DVF+FG  +LE+ACGR+PI  +     ++L DWV + W   
Sbjct:   508 TLGYISPELSRTGKASTRSDVFAFGIVMLEIACGRKPILPRASQREMVLTDWVLECWENE 567

Query:   487 ELLEARDPNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQILERDVALPAISALR 546
             ++++  D  +G EYV             CSH     RP+M  V+Q+L+    LP      
Sbjct:   568 DIMQVLDHKIGQEYVEEQAALVLKLGLFCSHPVAAIRPNMSSVIQLLDSVAQLPHNLLDI 627

Query:   547 LSTSGITYLEGFDDFAVSNPPSMGFTRPSSVAESLLSGGR 586
             + T  +         A  +P S     P +  ES +S GR
Sbjct:   628 VQTREVHRGTEISGEAADSPESCSIA-PLTFTESFVSHGR 666

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=ISS

TAIR|locus:2133239 AT4G02420 [Arabidopsis thaliana (taxid:3702)]

 Score = 1437 (510.9 bits), Expect = 3.9e-147, P = 3.9e-147
 Identities = 300/535 (56%), Positives = 386/535 (72%)

Query:    62 FNDTNLGNETNHVFAVE---LDTIKSH--GFLDINDNHVGIDINSLKSESSAPAGYYVEY 116
             FNDTN     NHV  ++   L+++KS   G+ D ND       ++L   SS     +V++
Sbjct:   151 FNDTN----NNHV-GIDINSLNSVKSSPAGYWDENDQ-----FHNLTLISSKRMQVWVDF 200

Query:   117 DGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSVLNDAMYVGFSSSTGSVLASHYILGWS 176
             DG     +VT+AP    +PR    +S+ RDLSSVL   M+VGFSS+TG++++  ++LGWS
Sbjct:   201 DGPTHLIDVTMAPFGEVKPRK-PLVSIVRDLSSVLLQDMFVGFSSATGNIVSEIFVLGWS 259

Query:   177 FKINGQAEELNLSQLPKLP--RVGPKKRSKFLTIGLPVICVSVI-FAAVSGVV-YVIRMK 232
             F +NG+A+ L LS+LP+LP   + P +  +F    +P+I + +I F  +  +V ++++ +
Sbjct:   260 FGVNGEAQPLALSKLPRLPVWDLKPTRVYRFYKNWVPLISLLLIPFLLIIFLVRFIMKRR 319

Query:   233 RKFAEELEDWELDHGPHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVK 292
             RKFAEE+EDWE + G +R R+KDLY ATKGF++K +LG+GGFG VY+G +PK++ EIAVK
Sbjct:   320 RKFAEEVEDWETEFGKNRLRFKDLYYATKGFKDKNILGSGGFGSVYKGIMPKTKKEIAVK 379

Query:   293 KISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQ 352
             ++S+ESRQG+KEFVAEIVSIG++ HRNLV L+GYCRR+ ELLLVYDYMPNGSLDKYLY+ 
Sbjct:   380 RVSNESRQGLKEFVAEIVSIGQMSHRNLVPLVGYCRRRDELLLVYDYMPNGSLDKYLYNS 439

Query:   353 PKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARL 412
             P+VTL+W QRF+VI GVA  LFYLH+EWEQVVIHRDVKASNVLLD ELNGRLGDFGLA+L
Sbjct:   440 PEVTLDWKQRFKVINGVASALFYLHEEWEQVVIHRDVKASNVLLDAELNGRLGDFGLAQL 499

Query:   413 YDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPS-E 471
              DHG+DPQTT VVGT GYLAP+H RTG+ATT+ DVF+FG  LLEVACGRRPI+    S E
Sbjct:   500 CDHGSDPQTTRVVGTWGYLAPDHIRTGRATTTTDVFAFGVLLLEVACGRRPIEINNQSGE 559

Query:   472 NLILVDWVFDFWNRGELLEARDPNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQ 531
              ++LVDWVF FW    +L+A+DPNLG+EY              CSHSDP ARP+MRQV+Q
Sbjct:   560 RVVLVDWVFRFWMEANILDAKDPNLGSEYDQKEVEMVLKLGLLCSHSDPLARPTMRQVLQ 619

Query:   532 ILERDVALPAISALRLSTSGITYLEGFDDFAVSNPPSMGFTRPSSVAESLLSGGR 586
              L  D  LP +S L L  SGI  + G  +   SN   M FT  SSVA SLLS GR
Sbjct:   620 YLRGDAMLPDLSPLDLRGSGI--MLGTHNG--SNESGM-FTSGSSVAYSLLSSGR 669

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2133229 LPK1 "lectin-like protein kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1407 (500.3 bits), Expect = 5.9e-144, P = 5.9e-144
 Identities = 292/532 (54%), Positives = 371/532 (69%)

Query:    63 NDTNLGNETNHVFAVELDTIKSHGFLD-INDNHVGIDINSLKSESSAPAGYYVEYDGLEK 121
             ND ++G   N + +V+   +   G+ D IN        N+L   S      +V+YD    
Sbjct:   158 NDNHVGININSLTSVKSSLV---GYWDEINQ------FNNLTLISRKRMQVWVDYDDRTN 208

Query:   122 RTNVTLAPINIPRPRSLNTMSLSRDLSSVLNDAMYVGFSSSTGSVLASHYILGWSFKING 181
             + +VT+AP    +PR    +S+ RDLSSV    MY+GFS++TG VL+ H++ GWSF + G
Sbjct:   209 QIDVTMAPFGEVKPRKA-LVSVVRDLSSVFLQDMYLGFSAATGYVLSEHFVFGWSFMVKG 267

Query:   182 Q-AEELNLSQLPKLPRVGPKKRSKFLTIGLPV---ICVSVIFAA--VSGVVYVIRMKRKF 235
             + A  L LS++PK PRVGP    +F    +P+   + + V+F    +  V +++R +RKF
Sbjct:   268 KTAPPLTLSKVPKFPRVGPTSLQRFYKNRMPLFSLLLIPVLFVVSLIFLVRFIVRRRRKF 327

Query:   236 AEELEDWELDHGPHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKIS 295
             AEE EDWE + G +R R+KDLY ATKGF++K+LLG+GGFGRVYRG +P ++ EIAVK++S
Sbjct:   328 AEEFEDWETEFGKNRLRFKDLYYATKGFKDKDLLGSGGFGRVYRGVMPTTKKEIAVKRVS 387

Query:   296 HESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKV 355
             +ESRQG+KEFVAEIVSIGR+ HRNLV LLGYCRR+ ELLLVYDYMPNGSLDKYLYD P+V
Sbjct:   388 NESRQGLKEFVAEIVSIGRMSHRNLVPLLGYCRRRDELLLVYDYMPNGSLDKYLYDCPEV 447

Query:   356 TLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH 415
             TL+W QRF VI GVA GLFYLH+EWEQVVIHRD+KASNVLLD E NGRLGDFGLARL DH
Sbjct:   448 TLDWKQRFNVIIGVASGLFYLHEEWEQVVIHRDIKASNVLLDAEYNGRLGDFGLARLCDH 507

Query:   416 GTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPS-ENLI 474
             G+DPQTT VVGT GYLAP+H RTG+ATT+ DVF+FG  LLEVACGRRPI+ +  S E+++
Sbjct:   508 GSDPQTTRVVGTWGYLAPDHVRTGRATTATDVFAFGVLLLEVACGRRPIEIEIESDESVL 567

Query:   475 LVDWVFDFWNRGELLEARDPNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQILE 534
             LVD VF FW  G +L+A DPNLG+ Y              CSHSDP  RP+MRQV+Q L 
Sbjct:   568 LVDSVFGFWIEGNILDATDPNLGSVYDQREVETVLKLGLLCSHSDPQVRPTMRQVLQYLR 627

Query:   535 RDVALPAISALRLSTSGITYLEGFDDFAVSNPPSMGFTRPSSVAESLLSGGR 586
              D  LP +S L    SG   + G +    S   S  F+  SS+A S++SGGR
Sbjct:   628 GDATLPDLSPLDFRGSG--KMLGMNH-RFSE--SCTFSSGSSIAYSIVSGGR 674

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009625 "response to insect" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

TAIR|locus:2043909 AT2G43700 [Arabidopsis thaliana (taxid:3702)]

 Score = 1063 (379.3 bits), Expect = 7.6e-133, Sum P(2) = 7.6e-133
 Identities = 230/489 (47%), Positives = 309/489 (63%)

Query:    59 LGLFNDTNLGN-ETNHVFAVELDTIKSHGFLDINDNHVGIDINSLKSESSAPAGYYVEYD 117
             L +  D   G+   NHV  + ++ ++S  F              L   S +     + Y 
Sbjct:   131 LDINKDEEFGDINDNHV-GININGMRSIKFAPAGYYDQEGQFKDLSLISGSLLRVTILYS 189

Query:   118 GLEKRTNVTLA-PINIPRPRSLNTMSLSRDLSSVLNDAMYVGFSSSTGSVLASHYILGWS 176
              +EK+ NVTL+ P     P     +SL++DLS  + + MYVGFS+STGSV A HY+L W 
Sbjct:   190 QMEKQLNVTLSSPEEAYYPNK-PLLSLNQDLSPYILENMYVGFSASTGSVRAMHYMLSW- 247

Query:   177 FKINGQAEELNLSQ-LPKLPRVGPKKRSKFLTIGLPVICVSVIFAAV--SGV-VYVIRMK 232
             F ++G  +  NL   +P  P   PK++S    I L      V+F A+  S + ++  R  
Sbjct:   248 F-VHGGVDVPNLDLGIPTFPPY-PKEKSLVYRIVLVTSLALVLFVALVASALSIFFYRRH 305

Query:   233 RKFAEELEDWELDHGPHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVK 292
             +K  E LE+WE+  GPHRF YK+L+ ATKGF  K+LLG GGFG+V++GTLP S  EIAVK
Sbjct:   306 KKVKEVLEEWEIQCGPHRFAYKELFKATKGF--KQLLGKGGFGQVFKGTLPGSDAEIAVK 363

Query:   293 KISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQ 352
             +ISH+S+QGM+EF+AEI +IGRLRH+NLV+L GYCR K EL LVYD+MPNGSLDKYLY +
Sbjct:   364 RISHDSKQGMQEFLAEISTIGRLRHQNLVRLQGYCRYKEELYLVYDFMPNGSLDKYLYHR 423

Query:   353 P-KVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR 411
               +  L W QRF++IK +A  L YLH EW QVVIHRD+K +NVL+D ++N RLGDFGLA+
Sbjct:   424 ANQEQLTWNQRFKIIKDIASALCYLHHEWVQVVIHRDIKPANVLIDHQMNARLGDFGLAK 483

Query:   412 LYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSE 471
             LYD G DPQT+ V GT  Y+APE  R+G+ATT  DV++FG F+LEV+CGRR I+R+  S+
Sbjct:   484 LYDQGYDPQTSRVAGTFWYIAPELIRSGRATTGTDVYAFGLFMLEVSCGRRLIERRTASD 543

Query:   472 NLILVDWVFDFWNRGELLEARDPNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQ 531
              ++L +W    W  G++LEA +  +  E               CSH     RP M +VVQ
Sbjct:   544 EVVLAEWTLKCWENGDILEAVNDGIRHEDNREQLELVLKLGVLCSHQAVAIRPDMSKVVQ 603

Query:   532 ILERDVALP 540
             IL  D+ LP
Sbjct:   604 ILGGDLQLP 612

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2020593 AT1G70130 [Arabidopsis thaliana (taxid:3702)]

 Score = 1287 (458.1 bits), Expect = 3.1e-131, P = 3.1e-131
 Identities = 275/602 (45%), Positives = 378/602 (62%)

Query:     2 PFKNKNSNSSTANGXXXXXXXXXXXXILSEYQSQSGHGIAFVIASTRGL---PGARPSQY 58
             P + KNS     NG            I++  ++ +G G++F I+ T+GL   P    S +
Sbjct:    70 PLQFKNS----PNGTVSSFSTTFVFAIVAVRKTIAGCGLSFNISPTKGLNSVPNIDHSNH 125

Query:    59 ---LGLF---NDTNLGNETNHVFAVELDTIK-----SHGFLDINDNHVGIDINSLKSESS 107
                +G     +D   G + N V  + +D+ K     S G+   +   V +DI S K    
Sbjct:   126 SVSVGFHTAKSDKPDGEDVNLV-GINIDSSKMDRNCSAGYYKDDGRLVNLDIASGK---- 180

Query:   108 APAGYYVEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSVLNDAMYVGFSSSTGSVL 167
              P   ++EY+   K+ +VT+  I I +P+ +  +S+ +DLS  L++ MY+GF+S  GS  
Sbjct:   181 -PIQVWIEYNNSTKQLDVTMHSIKISKPK-IPLLSMRKDLSPYLHEYMYIGFTS-VGSPT 237

Query:   168 ASHYILGWSFKINGQAEELNLSQLPKLPRVGPKKR--SKFLTIGLPVICVSVIFAAVSGV 225
             +SHYILGWSF   G   ++NLS+LPK+P    ++   SK L I L +  V+++   + GV
Sbjct:   238 SSHYILGWSFNNKGAVSDINLSRLPKVPDEDQERSLSSKILAISLSISGVTLVIVLILGV 297

Query:   226 VYVIRMKRKFAEELEDWELDHGPHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKS 285
             +  ++ K KF E +EDWE+  GPH+F YKDL+IATKGF+  E+LG GGFG+V++G LP S
Sbjct:   298 MLFLKRK-KFLEVIEDWEVQFGPHKFTYKDLFIATKGFKNSEVLGKGGFGKVFKGILPLS 356

Query:   286 QIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSL 345
              I IAVKKISH+SRQGM+EF+AEI +IGRLRH +LV+LLGYCRRKGEL LVYD+MP GSL
Sbjct:   357 SIPIAVKKISHDSRQGMREFLAEIATIGRLRHPDLVRLLGYCRRKGELYLVYDFMPKGSL 416

Query:   346 DKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLG 405
             DK+LY+QP   L+W QRF +IK VA GL YLHQ+W QV+IHRD+K +N+LLD  +N +LG
Sbjct:   417 DKFLYNQPNQILDWSQRFNIIKDVASGLCYLHQQWVQVIIHRDIKPANILLDENMNAKLG 476

Query:   406 DFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQ 465
             DFGLA+L DHG D QT++V GT GY++PE +RTGK++TS+DVF+FG F+LE+ CGRRPI 
Sbjct:   477 DFGLAKLCDHGIDSQTSNVAGTFGYISPELSRTGKSSTSSDVFAFGVFMLEITCGRRPIG 536

Query:   466 RQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAXXXXXXXXXXXXCSHSDPTARPS 525
              +G    ++L DWV D W+ G++L+  D  LG  Y+A            CSH     RPS
Sbjct:   537 PRGSPSEMVLTDWVLDCWDSGDILQVVDEKLGHRYLAEQVTLVLKLGLLCSHPVAATRPS 596

Query:   526 MRQVVQILERDVALPAISALRLSTSGITYLEGFDDFAVSNPPSMGFTRPSSV-AESLLSG 584
             M  V+Q L+    LP  + L L  S I   EGFD   V+       +  S V  ES LS 
Sbjct:   597 MSSVIQFLDGVATLPH-NLLDLVNSRIIN-EGFDTLGVTTESMEASSNVSLVMTESFLSS 654

Query:   585 GR 586
             GR
Sbjct:   655 GR 656

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2097613 AT3G08870 [Arabidopsis thaliana (taxid:3702)]

 Score = 1069 (381.4 bits), Expect = 4.4e-126, Sum P(2) = 4.4e-126
 Identities = 217/450 (48%), Positives = 297/450 (66%)

Query:   105 ESSAPAGYYVEYDGLEKRTNVTLAPINIP-RPRS-LNTMSLSRDLSSVLNDAMYVGFSSS 162
             ES  P    ++YDG  +  NVT+ P  +  +P+  L +  +S +LS ++ D MYVGF+++
Sbjct:   204 ESGEPIRVLIDYDGSSETLNVTIYPTRLEFKPKKPLISRRVS-ELSEIVKDEMYVGFTAA 262

Query:   163 TGSVLAS-HYILGWSFKINGQ---AEELNLSQLPKLPRVGPKKRSKFLTIGLPVICVSVI 218
             TG   +S HY++GWSF   G+   A+ L +S+LP  PR+  KK      I L ++ +S++
Sbjct:   263 TGKDQSSAHYVMGWSFSSCGENPMADWLEISRLPPPPRLSNKKGYNSQVIVL-IVALSIV 321

Query:   219 FAAVSGVVYVIRM-KRKFAEE--LEDWELDHGPHRFRYKDLYIATKGFREKELLGTGGFG 275
                +  ++++  M KR+  EE  LEDWE+D+ PHRFRY+DLY+ATK F+E E++GTGGFG
Sbjct:   322 TLVLLVLLFIFVMYKRRIQEEDTLEDWEIDY-PHRFRYRDLYLATKKFKESEIIGTGGFG 380

Query:   276 RVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLL 335
              VYRG L  S   IAVKKI+  S QG++EF+AEI S+GRL H+NLV L G+C+ K ELLL
Sbjct:   381 IVYRGNLSSSG-PIAVKKITSNSLQGVREFMAEIESLGRLGHKNLVNLQGWCKHKNELLL 439

Query:   336 VYDYMPNGSLDKYLYDQPK---VTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKAS 392
             +YDY+PNGSLD  LY  P+   + L W  RF +IKG+A GL YLH+EWEQ+V+HRDVK S
Sbjct:   440 IYDYIPNGSLDSLLYQTPRRNGIVLPWDVRFEIIKGIASGLLYLHEEWEQIVVHRDVKPS 499

Query:   393 NVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGA 452
             NVL+D ++N +LGDFGLARLY+ GT  QTT +VGTLGY+APE TR GK +T++DVF+FG 
Sbjct:   500 NVLIDEDMNAKLGDFGLARLYERGTLTQTTKIVGTLGYMAPELTRNGKGSTASDVFAFGV 559

Query:   453 FLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAXXXXXXXXXX 512
              LLE+ CG +P      +EN  L DWV +F   G +L   D NLG+ +            
Sbjct:   560 LLLEIVCGNKPTN----AENFFLADWVMEFHTNGGILCVVDQNLGSSFNGREAKLALVVG 615

Query:   513 XXCSHSDPTARPSMRQVVQILERDVALPAI 542
               C H  P  RPSMR V++ L  +  +P I
Sbjct:   616 LLCCHQKPKFRPSMRMVLRYLNGEENVPQI 645

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
O80939	LRK41_ARATH	2, ., 7, ., 1, 1, ., 1	0.6497	0.9880	0.8577	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.946
3rd Layer	2.7.11	0.963

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	586
cd06899	236	cd06899, lectin_legume_LecRK_Arcelin_ConA, legume	6e-74
pfam00139	231	pfam00139, Lectin_legB, Legume lectin domain	8e-65
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	4e-51
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-47
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	7e-47
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-46
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	2e-46
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	2e-46
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	3e-44
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-38
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-35
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	4e-33
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-31
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-29
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	6e-29
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	7e-29
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	5e-28
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	1e-27
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	3e-27
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	9e-27
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	1e-26
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-26
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	3e-26
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	3e-26
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	3e-26
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	6e-26
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	7e-26
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-25
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	3e-25
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	7e-25
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	7e-25
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	8e-25
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-24
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	5e-24
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	8e-24
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-23
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	1e-23
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-23
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	3e-23
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	4e-23
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	5e-23
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	7e-23
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	8e-23
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	8e-23
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-22
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-22
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	4e-22
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	6e-22
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	7e-22
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	1e-21
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-21
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-21
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	3e-21
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	4e-21
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	5e-21
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	6e-21
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	7e-21
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	7e-21
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	1e-20
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	1e-20
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-20
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-20
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	4e-20
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	4e-20
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	5e-20
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	5e-20
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	1e-19
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-19
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-19
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-19
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	3e-19
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	3e-19
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	4e-19
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	4e-19
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	5e-19
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	5e-19
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	5e-19
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	5e-19
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	6e-19
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	8e-19
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	1e-18
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-18
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-18
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-18
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-18
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-18
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-18
cd01951	223	cd01951, lectin_L-type, legume lectins	2e-18
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-18
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-18
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-18
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	3e-18
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	6e-18
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	6e-18
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	7e-18
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	7e-18
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-17
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-17
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-17
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	2e-17
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-17
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-17
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	3e-17
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	3e-17
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	3e-17
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	3e-17
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	4e-17
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	5e-17
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	5e-17
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	7e-17
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	8e-17
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	9e-17
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	1e-16
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-16
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	1e-16
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-16
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-16
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	2e-16
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-16
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-16
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	2e-16
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-16
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-16
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-16
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	3e-16
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	3e-16
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	4e-16
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	4e-16
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	4e-16
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	5e-16
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	5e-16
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	7e-16
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	9e-16
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	9e-16
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	1e-15
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-15
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	1e-15
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-15
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-15
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-15
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	3e-15
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	3e-15
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	3e-15
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	4e-15
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	5e-15
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	5e-15
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	6e-15
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	7e-15
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	7e-15
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	9e-15
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	9e-15
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	1e-14
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	1e-14
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-14
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-14
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	1e-14
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-14
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-14
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-14
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	2e-14
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	3e-14
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	3e-14
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	3e-14
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	3e-14
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	4e-14
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	4e-14
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	4e-14
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	4e-14
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	5e-14
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	6e-14
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	6e-14
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	7e-14
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	7e-14
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-13
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	1e-13
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-13
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	1e-13
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	1e-13
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	1e-13
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	1e-13
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-13
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	3e-13
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	3e-13
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	4e-13
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	4e-13
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	5e-13
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	6e-13
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	6e-13
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	7e-13
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	8e-13
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	9e-13
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	9e-13
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-12
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	1e-12
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	1e-12
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	1e-12
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-12
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-12
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	2e-12
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-12
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-12
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	3e-12
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	3e-12
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	4e-12
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	5e-12
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	6e-12
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	6e-12
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	8e-12
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	9e-12
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	9e-12
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	1e-11
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	1e-11
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	1e-11
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-11
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	1e-11
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-11
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	2e-11
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-11
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-11
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	3e-11
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	4e-11
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	5e-11
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	6e-11
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	8e-11
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	1e-10
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-10
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-10
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-10
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-10
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-10
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	3e-10
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	3e-10
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	3e-10
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	3e-10
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	4e-10
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	5e-10
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	5e-10
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	5e-10
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	6e-10
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	6e-10
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	6e-10
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	1e-09
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	1e-09
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	1e-09
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	1e-09
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-09
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-09
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	2e-09
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	3e-09
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	4e-09
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	4e-09
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	4e-09
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	6e-09
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	7e-09
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	7e-09
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	8e-09
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	1e-08
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	1e-08
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	1e-08
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-08
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-08
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-08
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	2e-08
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	4e-08
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	4e-08
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	5e-08
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	5e-08
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	5e-08
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	7e-08
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	7e-08
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	1e-07
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-07
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	2e-07
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	3e-07
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	3e-07
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	4e-07
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	4e-07
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	4e-07
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	5e-07
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	5e-07
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	6e-07
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	6e-07
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	7e-07
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	1e-06
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	1e-06
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	2e-06
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	3e-06
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	6e-06
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	7e-06
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	8e-06
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-05
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-05
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	1e-05
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	2e-05
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	2e-05
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	3e-05
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	4e-05
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	4e-05
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	4e-05
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	5e-05
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	6e-05
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	1e-04
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	2e-04
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	6e-04
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	9e-04
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	0.002

>gnl|CDD|173887 cd06899, lectin_legume_LecRK_Arcelin_ConA, legume lectins, lectin-like receptor kinases, arcelin, concanavalinA, and alpha-amylase inhibitor

 Score =  235 bits (602), Expect = 6e-74
 Identities = 84/187 (44%), Positives = 107/187 (57%), Gaps = 20/187 (10%)

Query: 11  STANGTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGLFNDTNLGNE 70
            +  G V SFST+F FSI     S  G G+AF +A T  LP A    YLGLFN +N GN 
Sbjct: 54  DSTTGKVASFSTSFSFSITPPNPSLGGDGLAFFLAPTDSLPPASSGGYLGLFNSSNNGNS 113

Query: 71  TNHVFAVELDTIKSHGFLDINDNHVGIDINSLKSESSAPAGYY----------------V 114
           +NH+ AVE DT ++  F D +DNHVGID+NSL    S  AGY+                +
Sbjct: 114 SNHIVAVEFDTFQNPEFGDPDDNHVGIDVNSLV---SVKAGYWDDDGGKLKSGKPMQAWI 170

Query: 115 EYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSVLNDAMYVGFSSSTGSVLASHYILG 174
           +YD   KR +VTLA   + +P+    +S   DLS VL + +YVGFS+STG +   HYIL 
Sbjct: 171 DYDSSSKRLSVTLAYSGVAKPKK-PLLSYPVDLSKVLPEEVYVGFSASTGLLTELHYILS 229

Query: 175 WSFKING 181
           WSF  NG
Sbjct: 230 WSFSSNG 236

This alignment model includes the legume lectins (also known as agglutinins), the arcelin (also known as phytohemagglutinin-L) family of lectin-like defense proteins, the LecRK family of lectin-like receptor kinases, concanavalinA (ConA), and an alpha-amylase inhibitor. Arcelin is a major seed glycoprotein discovered in kidney beans (Phaseolus vulgaris) that has insecticidal properties and protects the seeds from predation by larvae of various bruchids. Arcelin is devoid of monosaccharide binding properties and lacks a key metal-binding loop that is present in other members of this family. Phytohaemagglutinin (PHA) is a lectin found in plants, especially beans, that affects cell metabolism by inducing mitosis and by altering the permeability of the cell membrane to various proteins. PHA agglutinates most mammalian red blood cell types by binding glycans on the cell surface. Medically, PHA is used as a mitogen to trigger cell division in T-lymphocytes and to activate latent HIV-1 from human peripheral lymphocytes. Plant L-type lectins are primarily found in the seeds of leguminous plants where they constitute about 10% of the total soluble protein of the seed extracts. They are synthesized during seed development several weeks after flowering and transported to the vacuole where they become condensed into specialized vesicles called protein bodies. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat six-stranded beta-sheet referred to as the "back face". This domain homodimerizes so that adjacent back sheets form a contiguous 12-stranded sheet and homotetramers occur by a back-to-back association of these homodimers. Though L-type lectins exhibit both sequence and structural similarity to one another, their carbohydrate binding specificities differ widely. Length = 236

>gnl|CDD|215744 pfam00139, Lectin_legB, Legume lectin domain

 Score =  211 bits (540), Expect = 8e-65
 Identities = 83/182 (45%), Positives = 113/182 (62%), Gaps = 17/182 (9%)

Query: 11  STANGTVFSFSTTFVFSILSEYQSQS-GHGIAFVIASTRGLPGARPSQYLGLFNDTNLGN 69
            ++ G V SFST+FVF+I +  +S + G G+AF +A +   PGA    YLGLFN +N GN
Sbjct: 53  DSSTGKVASFSTSFVFAIKNIPKSTNGGDGLAFFLAPSGTQPGASSGGYLGLFNSSNNGN 112

Query: 70  ETNHVFAVELDTIKSHGFLDINDNHVGIDINSLKSESSAPAGY-------------YVEY 116
            +NH+ AVE DT  +  F DI+DNHVGID+NS+ S +S  A +             +++Y
Sbjct: 113 SSNHIVAVEFDTFLNPEFNDIDDNHVGIDVNSIISVASESASFVPLDLNSGKPIQVWIDY 172

Query: 117 DGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSVLNDAMYVGFSSSTGSVLASHYILGWS 176
           DG  KR +VTLA  N P+      +S S DLS+VL + +YVGFS+STG    SHY+L WS
Sbjct: 173 DGSSKRLSVTLAYPNKPK---RPLLSASVDLSTVLPEWVYVGFSASTGGATESHYVLSWS 229

Query: 177 FK 178
           F 
Sbjct: 230 FS 231

Length = 231

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  176 bits (448), Expect = 4e-51
 Identities = 78/272 (28%), Positives = 119/272 (43%), Gaps = 19/272 (6%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKE--FVAEIVSIGRLRHRNL 320
           +     LG+G FG VY+     +   +AVK +   S +  K+     EI  + RL H N+
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60

Query: 321 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEW 380
           V+L+     K  L LV +Y   G L  YL       L+  +  ++   +  GL YLH   
Sbjct: 61  VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSR--GGPLSEDEAKKIALQILRGLEYLHSNG 118

Query: 381 EQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGK 440
              +IHRD+K  N+LLD     ++ DFGLA+     +    T  VGT  Y+APE    G 
Sbjct: 119 ---IIHRDLKPENILLDENGVVKIADFGLAKKL-LKSSSSLTTFVGTPWYMAPEVLLGGN 174

Query: 441 -ATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTE 499
                 DV+S G  L E+  G+ P   +   + L L+        R              
Sbjct: 175 GYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIR-------RILGPPLEFDEPKWS 227

Query: 500 YVAEELELVLKLGLLCSHSDPTARPSMRQVVQ 531
             +EE + ++K   L    DP+ RP+  +++Q
Sbjct: 228 SGSEEAKDLIK-KCLN--KDPSKRPTAEEILQ 256

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  166 bits (422), Expect = 2e-47
 Identities = 63/202 (31%), Positives = 105/202 (51%), Gaps = 8/202 (3%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKE-FVAEIVSIGRLRHRNLV 321
           +   E LG G FG+VY     K+   +A+K I  +  +  +E  + EI  + +L+H N+V
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 322 QLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
           +L      + +L LV +Y   G L   L  + +++ +  + +  ++ +   L YLH +  
Sbjct: 61  RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFY--LRQILSALEYLHSKG- 117

Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKA 441
             ++HRD+K  N+LLD + + +L DFGLAR  D G   + T  VGT  Y+APE       
Sbjct: 118 --IVHRDLKPENILLDEDGHVKLADFGLARQLDPGE--KLTTFVGTPEYMAPEVLLGKGY 173

Query: 442 TTSADVFSFGAFLLEVACGRRP 463
             + D++S G  L E+  G+ P
Sbjct: 174 GKAVDIWSLGVILYELLTGKPP 195

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  164 bits (418), Expect = 7e-47
 Identities = 87/276 (31%), Positives = 130/276 (47%), Gaps = 29/276 (10%)

Query: 266 KELLGTGGFGRVYRGTL----PKSQIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNL 320
            + LG G FG VY+GTL       ++E+AVK +  + S Q ++EF+ E   + +L H N+
Sbjct: 4   GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63

Query: 321 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEW 380
           V+LLG C  +  L++V +YMP G L  YL       L+          +A G+ YL    
Sbjct: 64  VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE--- 120

Query: 381 EQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGY--LAPEHTRT 438
            +  IHRD+ A N L+   L  ++ DFGL+R  D   D       G L    +APE  + 
Sbjct: 121 SKNFIHRDLAARNCLVGENLVVKISDFGLSR--DLYDDDYYKVKGGKLPIRWMAPESLKE 178

Query: 439 GKATTSADVFSFGAFLLEVA-CGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLG 497
           GK T+ +DV+SFG  L E+   G  P      +E       V ++  +G  L        
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAE-------VLEYLKKGYRLPKP----- 226

Query: 498 TEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQIL 533
                 EL  ++     C   DP  RP+  ++V+IL
Sbjct: 227 -PNCPPELYKLML---QCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  162 bits (411), Expect = 2e-46
 Identities = 67/192 (34%), Positives = 97/192 (50%), Gaps = 10/192 (5%)

Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKE-FVAEIVSIGRLRHRNLVQLLGYC 327
           LG GGFG VY     K+  ++A+K I  E    + E  + EI  + +L H N+V+L G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 328 RRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHR 387
             +  L LV +Y   GSL   L +     L+  +  R++  +  GL YLH      +IHR
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEG-KLSEDEILRILLQILEGLEYLH---SNGIIHR 116

Query: 388 DVKASNVLLDGELNGR--LGDFGLARLYDHGTDPQTTHVVGTLGYLAPE-HTRTGKATTS 444
           D+K  N+LLD   NG+  L DFGL++L           +VGT  Y+APE     G  +  
Sbjct: 117 DLKPENILLD-SDNGKVKLADFGLSKLLTSDKS-LLKTIVGTPAYMAPEVLLGKGYYSEK 174

Query: 445 ADVFSFGAFLLE 456
           +D++S G  L E
Sbjct: 175 SDIWSLGVILYE 186

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  163 bits (415), Expect = 2e-46
 Identities = 81/274 (29%), Positives = 131/274 (47%), Gaps = 27/274 (9%)

Query: 267 ELLGTGGFGRVYRGTL----PKSQIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLV 321
           + LG G FG VY+GTL      ++ ++AVK +    S +  +EF+ E   + +L H N+V
Sbjct: 5   KKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIV 64

Query: 322 QLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
           +LLG C +   L +V +YMP G L  +L    +  L      ++   +A G+ YL     
Sbjct: 65  RLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGE-KLTLKDLLQMALQIAKGMEYLE---S 120

Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVGTLGYLAPEHTRTGK 440
           +  +HRD+ A N L+   L  ++ DFGL+R +Y+     +       + ++APE  + GK
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGK 180

Query: 441 ATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTE 499
            T+ +DV+SFG  L E+   G +P       E       V +    G  L    P    E
Sbjct: 181 FTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE-------VLELLEDGYRLPR--P----E 227

Query: 500 YVAEELELVLKLGLLCSHSDPTARPSMRQVVQIL 533
              +EL  ++     C   DP  RP+  ++V+ L
Sbjct: 228 NCPDELYELML---QCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  163 bits (415), Expect = 2e-46
 Identities = 87/278 (31%), Positives = 129/278 (46%), Gaps = 30/278 (10%)

Query: 264 REKELLGTGGFGRVYRGTL----PKSQIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHR 318
              + LG G FG VY+G L     K ++E+AVK +  + S Q ++EF+ E   + +L H 
Sbjct: 2   TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61

Query: 319 NLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQ 378
           N+V+LLG C  +  L +V +YM  G L  YL    +  L+          +A G+ YL  
Sbjct: 62  NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRK-NRPKLSLSDLLSFALQIARGMEYLE- 119

Query: 379 EWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGY--LAPEHT 436
              +  IHRD+ A N L+   L  ++ DFGL+R  D   D       G L    +APE  
Sbjct: 120 --SKNFIHRDLAARNCLVGENLVVKISDFGLSR--DLYDDDYYRKRGGKLPIRWMAPESL 175

Query: 437 RTGKATTSADVFSFGAFLLEVA-CGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPN 495
           + GK T+ +DV+SFG  L E+   G +P       E       V ++   G  L    P 
Sbjct: 176 KEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE-------VLEYLKNGYRLPQ--P- 225

Query: 496 LGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQIL 533
                   EL  ++     C   DP  RP+  ++V+IL
Sbjct: 226 ---PNCPPELYDLML---QCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  157 bits (400), Expect = 3e-44
 Identities = 89/286 (31%), Positives = 131/286 (45%), Gaps = 42/286 (14%)

Query: 267 ELLGTGGFGRVYRGTL---PKSQIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQ 322
           + LG G FG VY+G L        E+AVK +  + S +  K+F+ E   + +L H N+V+
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 323 LLGYCRRKGELLLVYDYMPNGSLDKYL-------YDQPKVTLNWIQRFRVIKGVALGLFY 375
           LLG C  +  L LV +YM  G L  YL           K TL+          +A G+ Y
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 376 LHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLG-----Y 430
           L     +  +HRD+ A N L+  +L  ++ DFGL+R        +      T G     +
Sbjct: 121 LA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKK----TGGKLPIRW 173

Query: 431 LAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELL 489
           +APE  + G  T+ +DV+SFG  L E+   G  P       E       V ++  +G  L
Sbjct: 174 MAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE-------VLEYLRKGYRL 226

Query: 490 EARDPNLGTEYVAEEL-ELVLKLGLLCSHSDPTARPSMRQVVQILE 534
               P    EY  +EL EL+L     C   DP  RP+  ++V+ LE
Sbjct: 227 PK--P----EYCPDELYELMLS----CWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  141 bits (359), Expect = 2e-38
 Identities = 67/202 (33%), Positives = 106/202 (52%), Gaps = 10/202 (4%)

Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKI--SHESRQGMKEFVAEIVSIGRLRHRNLVQLL 324
           ELLG G FG VY      +   +AVK +  S +S + ++    EI  +  L+H N+V+  
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 325 GYCR--RKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQ 382
           G  R   K  L +  +Y+  GSL   L    K+    I+++   + +  GL YLH     
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKY--TRQILEGLAYLH---SN 120

Query: 383 VVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVGTLGYLAPEHTRTGKA 441
            ++HRD+K +N+L+D +   +L DFG A+ L D  T   T  V GT  ++APE  R  + 
Sbjct: 121 GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEY 180

Query: 442 TTSADVFSFGAFLLEVACGRRP 463
             +AD++S G  ++E+A G+ P
Sbjct: 181 GRAADIWSLGCTVIEMATGKPP 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  133 bits (337), Expect = 2e-35
 Identities = 73/218 (33%), Positives = 110/218 (50%), Gaps = 14/218 (6%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQ 322
           F   E +G GGFG VY+    ++  E+A+K I  ES++  ++ + EI  + + +H N+V+
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61

Query: 323 LLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLN--WIQRFRVIKGVALGLFYLHQEW 380
             G   +K EL +V ++   GSL   L      TL    I    V K +  GL YLH   
Sbjct: 62  YYGSYLKKDELWIVMEFCSGGSLKD-LLKSTNQTLTESQIA--YVCKELLKGLEYLH--- 115

Query: 381 EQVVIHRDVKASNVLL--DGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRT 438
              +IHRD+KA+N+LL  DGE+  +L DFGL+          T   VGT  ++APE    
Sbjct: 116 SNGIIHRDIKAANILLTSDGEV--KLIDFGLSAQLSDTKARNTM--VGTPYWMAPEVING 171

Query: 439 GKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILV 476
                 AD++S G   +E+A G+ P     P + L  +
Sbjct: 172 KPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKI 209

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  127 bits (320), Expect = 4e-33
 Identities = 85/275 (30%), Positives = 126/275 (45%), Gaps = 35/275 (12%)

Query: 266 KELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLG 325
              +G G FG V  G     ++  AVK +  +S    + F+AE   +  LRH NLVQLLG
Sbjct: 11  GATIGKGEFGDVMLGDYRGQKV--AVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLG 67

Query: 326 YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVI 385
              +   L +V +YM  GSL  YL  + +  +   Q+      V  G+ YL    E+  +
Sbjct: 68  VVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE---EKNFV 124

Query: 386 HRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTL--GYLAPEHTRTGKATT 443
           HRD+ A NVL+  +L  ++ DFGLA+      +       G L   + APE  R  K +T
Sbjct: 125 HRDLAARNVLVSEDLVAKVSDFGLAK------EASQGQDSGKLPVKWTAPEALREKKFST 178

Query: 444 SADVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARD--PNLGTEY 500
            +DV+SFG  L E+ + GR P  R    +   +V  V     +G  +EA +  P      
Sbjct: 179 KSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPHV----EKGYRMEAPEGCP------ 225

Query: 501 VAEELELVLKLGLLCSHSDPTARPSMRQVVQILER 535
                  V K+   C   DP  RP+ +Q+ + L  
Sbjct: 226 -----PEVYKVMKDCWELDPAKRPTFKQLREQLAL 255

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  123 bits (310), Expect = 1e-31
 Identities = 66/209 (31%), Positives = 105/209 (50%), Gaps = 26/209 (12%)

Query: 266 KELLGTGGFGRVYRGTLPKSQIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQL 323
            +L+G G FG VY+G   ++   +A+K+IS E    + +K  + EI  +  L+H N+V+ 
Sbjct: 5   GDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKY 64

Query: 324 LGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRF---------RVIKGVALGLF 374
           +G       L ++ +Y  NGSL              I++F           +  V  GL 
Sbjct: 65  IGSIETSDSLYIILEYAENGSL-----------RQIIKKFGPFPESLVAVYVYQVLQGLA 113

Query: 375 YLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE 434
           YLH   EQ VIHRD+KA+N+L   +   +L DFG+A    +        VVGT  ++APE
Sbjct: 114 YLH---EQGVIHRDIKAANILTTKDGVVKLADFGVA-TKLNDVSKDDASVVGTPYWMAPE 169

Query: 435 HTRTGKATTSADVFSFGAFLLEVACGRRP 463
                 A+T++D++S G  ++E+  G  P
Sbjct: 170 VIEMSGASTASDIWSLGCTVIELLTGNPP 198

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  117 bits (296), Expect = 1e-29
 Identities = 76/270 (28%), Positives = 128/270 (47%), Gaps = 30/270 (11%)

Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKI-SHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYC 327
           LG G  G VY+     +    A+KKI      +  K+ + E+ ++       +V+  G  
Sbjct: 9   LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAF 68

Query: 328 RRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHR 387
            ++GE+ +V +YM  GSL   L    K+    +    + + +  GL YLH +     IHR
Sbjct: 69  YKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAY--IARQILKGLDYLHTKRHI--IHR 124

Query: 388 DVKASNVLL--DGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSA 445
           D+K SN+L+   GE+  ++ DFG++++ ++  D   T V GT+ Y++PE  +    + +A
Sbjct: 125 DIKPSNLLINSKGEV--KIADFGISKVLENTLDQCNTFV-GTVTYMSPERIQGESYSYAA 181

Query: 446 DVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEA----RDPNLGTEYV 501
           D++S G  LLE A G+ P    G             F+   EL++A      P+L  E  
Sbjct: 182 DIWSLGLTLLECALGKFPFLPPG----------QPSFF---ELMQAICDGPPPSLPAEEF 228

Query: 502 AEELELVLKLGLLCSHSDPTARPSMRQVVQ 531
           + E    +     C   DP  RPS  +++Q
Sbjct: 229 SPEFRDFIS---ACLQKDPKKRPSAAELLQ 255

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  115 bits (290), Expect = 6e-29
 Identities = 81/284 (28%), Positives = 134/284 (47%), Gaps = 44/284 (15%)

Query: 267 ELLGTGGFGRVYRGTL---PKSQIEIAVKKISHESRQGMK-EFVAEIVSIGRLRHRNLVQ 322
           +++G G FG V RG L    K +I++A+K +   S    + +F+ E   +G+  H N+++
Sbjct: 10  KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69

Query: 323 LLGYCRRKGELLLVYDYMPNGSLDKYL--YDQPKVTLNWIQRFRVIKGVALGLFYLHQEW 380
           L G   +   ++++ +YM NGSLDK+L   D         Q   +++G+A G+ YL    
Sbjct: 70  LEGVVTKSRPVMIITEYMENGSLDKFLRENDG---KFTVGQLVGMLRGIASGMKYLS--- 123

Query: 381 EQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVG--TLGYLAPEHTRT 438
           E   +HRD+ A N+L++  L  ++ DFGL+R     ++   T   G   + + APE    
Sbjct: 124 EMNYVHRDLAARNILVNSNLVCKVSDFGLSRR-LEDSEATYTTKGGKIPIRWTAPEAIAY 182

Query: 439 GKATTSADVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDW----VFDFWNRGELLEA-R 492
            K T+++DV+SFG  + EV + G RP             D     V      G  L    
Sbjct: 183 RKFTSASDVWSFGIVMWEVMSYGERPYW-----------DMSNQDVIKAVEDGYRLPPPM 231

Query: 493 D-PNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER 535
           D P+            + +L L C   D   RP+  Q+V  L++
Sbjct: 232 DCPS-----------ALYQLMLDCWQKDRNERPTFSQIVSTLDK 264

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  118 bits (295), Expect = 7e-29
 Identities = 73/284 (25%), Positives = 120/284 (42%), Gaps = 24/284 (8%)

Query: 262 GFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRH- 317
            +R    LG G FG VY     + +  +A+K ++ +     + ++ F+ EI  +  L H 
Sbjct: 1   SYRILRKLGEGSFGEVYLA---RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57

Query: 318 RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYL-YDQPKVTLNWIQRFRVIKGVALGLFYL 376
            N+V+L  + + +G L LV +Y+  GSL+  L     K  L+  +   ++  +   L YL
Sbjct: 58  PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117

Query: 377 HQEWEQVVIHRDVKASNVLLDGELN-GRLGDFGLARLYDHGTDPQ-----TTHVVGTLGY 430
           H    + +IHRD+K  N+LLD +    +L DFGLA+L              +  VGT GY
Sbjct: 118 H---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174

Query: 431 LAPE---HTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGE 487
           +APE         A++S+D++S G  L E+  G  P   +G   +      +        
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPP--FEGEKNSSATSQTLKIILELP- 231

Query: 488 LLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ 531
              +    L         +    L       DP  R S    + 
Sbjct: 232 -TPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274

Length = 384

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  112 bits (283), Expect = 5e-28
 Identities = 77/285 (27%), Positives = 129/285 (45%), Gaps = 46/285 (16%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKI--SHESRQGMKEFVAEIVSIGRLRHRNL 320
           +   + +G G FG+VY            +K+I  S+ S +  ++ + E+  + +L H N+
Sbjct: 2   YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI 61

Query: 321 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVT--------LNW-IQRFRVIKGVAL 371
           ++       KG+L +V +Y   G L + +  Q K          L+W +Q       + L
Sbjct: 62  IKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQ-------LCL 114

Query: 372 GLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYL 431
            L YLH    + ++HRD+K  N+ L      +LGDFG++++     D   T VVGT  YL
Sbjct: 115 ALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT-VVGTPYYL 170

Query: 432 APEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGEL--- 488
           +PE  +       +D++S G  L E+   + P                F+  N  EL   
Sbjct: 171 SPELCQNKPYNYKSDIWSLGCVLYELCTLKHP----------------FEGENLLELALK 214

Query: 489 -LEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQI 532
            L+ + P + ++Y +E   LV  L L     DP  RPS+ Q++Q 
Sbjct: 215 ILKGQYPPIPSQYSSELRNLVSSL-L---QKDPEERPSIAQILQS 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  112 bits (281), Expect = 1e-27
 Identities = 77/287 (26%), Positives = 138/287 (48%), Gaps = 42/287 (14%)

Query: 263 FREKELLGTGGFGRVYRGT----LPKSQIEIAVKKISHES-RQGMKEFVAEIVSIGRLRH 317
             + ++LG+G FG VY+G       K +I +A+K +  E+  +  KE + E   +  + H
Sbjct: 9   LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDH 68

Query: 318 RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQ-----PKVTLNWIQRFRVIKGVALG 372
            ++V+LLG C    ++ L+   MP G L  Y+ +       +  LNW  +      +A G
Sbjct: 69  PHVVRLLGICLSS-QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKG 121

Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVG---TLG 429
           + YL    E+ ++HRD+ A NVL+    + ++ DFGLA+L D   D +  H  G    + 
Sbjct: 122 MSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD--VDEKEYHAEGGKVPIK 176

Query: 430 YLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGEL 488
           ++A E       T  +DV+S+G  + E+   G +P       E +  V+ + D   +GE 
Sbjct: 177 WMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPY------EGIPAVE-IPDLLEKGER 229

Query: 489 LEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER 535
           L    P + T     ++ +VL   + C   D  +RP+ ++++    +
Sbjct: 230 LP--QPPICT----IDVYMVL---VKCWMIDAESRPTFKELINEFSK 267

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  110 bits (277), Expect = 3e-27
 Identities = 77/272 (28%), Positives = 129/272 (47%), Gaps = 25/272 (9%)

Query: 266 KELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLG 325
           K  LG G +G VY G   K  + +AVK +  ++ + ++EF+ E   +  ++H NLVQLLG
Sbjct: 11  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 69

Query: 326 YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVI 385
            C R+    ++ ++M  G+L  YL +  +  +N +    +   ++  + YL +   +  I
Sbjct: 70  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFI 126

Query: 386 HRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT--LGYLAPEHTRTGKATT 443
           HRD+ A N L+      ++ DFGL+RL     D  T H      + + APE     K + 
Sbjct: 127 HRDLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAHAGAKFPIKWTAPESLAYNKFSI 184

Query: 444 SADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVA 502
            +DV++FG  L E+A  G  P     P  +L     V++   +G  +E R      +   
Sbjct: 185 KSDVWAFGVLLWEIATYGMSPY----PGIDL---SQVYELLEKGYRME-RPEGCPPK--- 233

Query: 503 EELELVLKLGLLCSHSDPTARPSMRQVVQILE 534
                V +L   C   +P+ RPS  ++ Q  E
Sbjct: 234 -----VYELMRACWQWNPSDRPSFAEIHQAFE 260

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  108 bits (273), Expect = 9e-27
 Identities = 85/280 (30%), Positives = 131/280 (46%), Gaps = 39/280 (13%)

Query: 269 LGTGGFGRVYRGT-LPKS--QIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLL 324
           LG G FG V +G  L KS  ++E+AVK +  E    G KEF+ E   + +L H  +V+L+
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 325 GYCRRKGE-LLLVYDYMPNGSLDKYLYDQPKVT----LNWIQRFRVIKGVALGLFYLHQE 379
           G C  KGE L+LV +  P G L KYL  + ++          +      VA+G+ YL   
Sbjct: 63  GVC--KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQ------VAMGMAYLE-- 112

Query: 380 WEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD--PQTTHVVGTLGYLAPEHTR 437
             +  +HRD+ A NVLL      ++ DFG++R    G+D    TT     L + APE   
Sbjct: 113 -SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECIN 171

Query: 438 TGKATTSADVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNL 496
            GK ++ +DV+S+G  L E  + G +P      +E + +++        GE L    P  
Sbjct: 172 YGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLE-------SGERLPR--PEE 222

Query: 497 GTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERD 536
             + +         + L C    P  RP+  ++     RD
Sbjct: 223 CPQEIYS-------IMLSCWKYRPEDRPTFSELESTFRRD 255

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score =  109 bits (273), Expect = 1e-26
 Identities = 77/283 (27%), Positives = 144/283 (50%), Gaps = 37/283 (13%)

Query: 265 EKELLGTGGFGRVYRGTLP---KSQIEIAVK--KISHESRQGMKEFVAEIVSIGRLRHRN 319
           +++++G G FG V+RG L    + ++ +A+K  K  +  +Q  ++F++E   +G+  H N
Sbjct: 9   KQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQ-RQDFLSEASIMGQFSHHN 67

Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQE 379
           +++L G   +    +++ +YM NG+LDKYL D      +  Q   +++G+A G+ YL   
Sbjct: 68  IIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDG-EFSSYQLVGMLRGIAAGMKYLS-- 124

Query: 380 WEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVG----TLGYLAPEH 435
            +   +HRD+ A N+L++  L  ++ DFGL+R+ +   DP+ T+        + + APE 
Sbjct: 125 -DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLE--DDPEGTYTTSGGKIPIRWTAPEA 181

Query: 436 TRTGKATTSADVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFWNRG--ELLEAR 492
               K T+++DV+SFG  + EV + G RP                  +W+    E+++A 
Sbjct: 182 IAYRKFTSASDVWSFGIVMWEVMSFGERP------------------YWDMSNHEVMKAI 223

Query: 493 DPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER 535
           +         +    V +L L C   D   RP    +V +L++
Sbjct: 224 NDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDK 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  108 bits (273), Expect = 2e-26
 Identities = 64/207 (30%), Positives = 110/207 (53%), Gaps = 19/207 (9%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE-SRQGM-KEFVAEIVSIGRLRHRNL 320
           + + E LG G +G VY+    K+   +A+KKI  +   +G+    + EI  +  L+H N+
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNI 60

Query: 321 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQP-KVTLNWIQR--FRVIKGVALGLFYLH 377
           V+LL     + +L LV++Y     L KYL  +P  ++ N I+   +++++G+A    Y H
Sbjct: 61  VKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLA----YCH 115

Query: 378 QEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE--- 434
                 ++HRD+K  N+L++ +   +L DFGLAR +        TH V TL Y APE   
Sbjct: 116 SHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGI-PLRTYTHEVVTLWYRAPEILL 171

Query: 435 HTRTGKATTSADVFSFGAFLLEVACGR 461
            ++    +T+ D++S G    E+  G+
Sbjct: 172 GSK--HYSTAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score =  108 bits (270), Expect = 3e-26
 Identities = 69/208 (33%), Positives = 118/208 (56%), Gaps = 15/208 (7%)

Query: 266 KELLGTGGFGRVYRGTLP---KSQIEIAVK--KISHESRQGMKEFVAEIVSIGRLRHRNL 320
           +E++G G FG V RG L    K +I +A+K  K  +  +Q  ++F++E   +G+  H N+
Sbjct: 9   EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQ-RRDFLSEASIMGQFDHPNI 67

Query: 321 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEW 380
           + L G   +   ++++ ++M NG+LD +L  Q       IQ   +++G+A G+ YL    
Sbjct: 68  IHLEGVVTKSRPVMIITEFMENGALDSFL-RQNDGQFTVIQLVGMLRGIAAGMKYLS--- 123

Query: 381 EQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVG---TLGYLAPEHT 436
           E   +HRD+ A N+L++  L  ++ DFGL+R L D  +DP  T  +G    + + APE  
Sbjct: 124 EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAI 183

Query: 437 RTGKATTSADVFSFGAFLLEV-ACGRRP 463
              K T+++DV+S+G  + EV + G RP
Sbjct: 184 AYRKFTSASDVWSYGIVMWEVMSYGERP 211

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  107 bits (270), Expect = 3e-26
 Identities = 79/269 (29%), Positives = 124/269 (46%), Gaps = 29/269 (10%)

Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCR 328
           LG+G FG V+ G   + +I++A+K I  E      +F+ E   + +L H NLVQL G C 
Sbjct: 12  LGSGQFGVVHLGKW-RGKIDVAIKMI-REGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCT 69

Query: 329 RKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRD 388
           ++  + +V +YM NG L  YL ++    L       +   V   + YL        IHRD
Sbjct: 70  KQRPIFIVTEYMANGCLLNYLRERKGK-LGTEWLLDMCSDVCEAMEYLE---SNGFIHRD 125

Query: 389 VKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT---LGYLAPEHTRTGKATTSA 445
           + A N L+  +   ++ DFGLAR      D Q T   GT   + +  PE     + ++ +
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYV---LDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKS 182

Query: 446 DVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAEE 504
           DV+SFG  + EV + G+ P +R   SE       V +  + G  L    P L    V   
Sbjct: 183 DVWSFGVLMWEVFSEGKMPYERFSNSE-------VVESVSAGYRLY--RPKLAPTEVYT- 232

Query: 505 LELVLKLGLLCSHSDPTARPSMRQVVQIL 533
              ++     C H  P  RP+ ++++  L
Sbjct: 233 ---IMY---SCWHEKPEDRPAFKKLLSQL 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  107 bits (269), Expect = 3e-26
 Identities = 61/195 (31%), Positives = 99/195 (50%), Gaps = 5/195 (2%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQ 322
           F  +  LG+G FG V+ G L K+++ +A+K +  +     ++F  E+ ++ RLRH++L+ 
Sbjct: 8   FTLERKLGSGYFGEVWEG-LWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLIS 66

Query: 323 LLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQ 382
           L   C     + ++ + M  GSL  +L       L       +   VA G+ YL    EQ
Sbjct: 67  LFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLE---EQ 123

Query: 383 VVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKAT 442
             IHRD+ A N+L+  +L  ++ DFGLARL        +   +    + APE    G  +
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI-PYKWTAPEAASHGTFS 182

Query: 443 TSADVFSFGAFLLEV 457
           T +DV+SFG  L E+
Sbjct: 183 TKSDVWSFGILLYEM 197

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  107 bits (270), Expect = 6e-26
 Identities = 67/203 (33%), Positives = 100/203 (49%), Gaps = 10/203 (4%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQ 322
           ++  E +G G  G VY+ T   +  E+A+KK+     Q  +  + EI+ +   +H N+V 
Sbjct: 21  YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRK-QNKELIINEILIMKDCKHPNIVD 79

Query: 323 LLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQ 382
                    EL +V +YM  GSL   +  Q  V +N  Q   V + V  GL YLH    Q
Sbjct: 80  YYDSYLVGDELWVVMEYMDGGSL-TDIITQNFVRMNEPQIAYVCREVLQGLEYLHS---Q 135

Query: 383 VVIHRDVKASNVLL--DGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGK 440
            VIHRD+K+ N+LL  DG +  +L DFG A         + + VVGT  ++APE  +   
Sbjct: 136 NVIHRDIKSDNILLSKDGSV--KLADFGFAAQLTKEKSKRNS-VVGTPYWMAPEVIKRKD 192

Query: 441 ATTSADVFSFGAFLLEVACGRRP 463
                D++S G   +E+A G  P
Sbjct: 193 YGPKVDIWSLGIMCIEMAEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  107 bits (269), Expect = 7e-26
 Identities = 85/285 (29%), Positives = 130/285 (45%), Gaps = 32/285 (11%)

Query: 269 LGTGGFGRVYRGTLP----KSQIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQL 323
           LG G FG+V           +  ++AVK ++H    Q   +F  EI  +  L H N+V+ 
Sbjct: 12  LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71

Query: 324 LGYCRRKGE--LLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
            G C + G   L L+ +Y+P+GSL  YL    +  +N  +       +  G+ YL     
Sbjct: 72  KGVCEKPGGRSLRLIMEYLPSGSLRDYLQRH-RDQINLKRLLLFSSQICKGMDYLG---S 127

Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLG--YLAPEHTRTG 439
           Q  IHRD+ A N+L++ E   ++ DFGLA++     D       G     + APE  RT 
Sbjct: 128 QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTS 187

Query: 440 KATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDW------VFDFWNR---GELLE 490
           K ++++DV+SFG  L E+     P Q   P+E L ++        V         GE L 
Sbjct: 188 KFSSASDVWSFGVTLYELFTYGDPSQ-SPPAEFLRMIGIAQGQMIVTRLLELLKEGERL- 245

Query: 491 ARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER 535
            R P+   E        V  L  LC  ++P  RPS   ++ I++R
Sbjct: 246 PRPPSCPDE--------VYDLMKLCWEAEPQDRPSFADLILIVDR 282

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  105 bits (264), Expect = 2e-25
 Identities = 78/288 (27%), Positives = 132/288 (45%), Gaps = 43/288 (14%)

Query: 260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISH------ESRQGMKEFVAEIVSIG 313
            KG    + LGTG F   Y+    K+   +AVK++++      E  + ++    EI  + 
Sbjct: 3   LKG----QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMA 58

Query: 314 RLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYD----QPKVTLNWIQRFRVIKGV 369
           RL H +++++LG         L  ++M  GS+   L      +  V +N+ ++      +
Sbjct: 59  RLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQ------L 112

Query: 370 ALGLFYLHQEWEQVVIHRDVKASNVLLDGELNG---RLGDFGLA-RLYDH--GTDPQTTH 423
             GL YLH   E  +IHRDVK +N+L+D    G   R+ DFG A RL     G       
Sbjct: 113 LRGLSYLH---ENQIIHRDVKGANLLIDS--TGQRLRIADFGAAARLAAKGTGAGEFQGQ 167

Query: 424 VVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFW 483
           ++GT+ ++APE  R  +   S DV+S G  ++E+A  + P   +  S +L L+       
Sbjct: 168 LLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALI------- 220

Query: 484 NRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ 531
              ++  A       E+++  L  V    L C    P  RP  R++++
Sbjct: 221 --FKIASATTAPSIPEHLSPGLRDVT---LRCLELQPEDRPPSRELLK 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  104 bits (262), Expect = 3e-25
 Identities = 79/275 (28%), Positives = 128/275 (46%), Gaps = 30/275 (10%)

Query: 264 REKELLGTGGFGRVYRGTLPKSQIEIAVKKIS-----HESRQGMKEFVAEIVSIGRLRHR 318
           R+ ELLG+G FG VY G         AVK++S        ++ +K+   EI  + +L+H 
Sbjct: 3   RKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHP 62

Query: 319 NLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQ 378
           N+VQ LG  R +  L +  + +P GSL K L          I+ +   + + LGL YLH 
Sbjct: 63  NIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLY--TRQILLGLEYLH- 119

Query: 379 EWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE-HTR 437
             ++  +HRD+K +N+L+D     +L DFG+A+              G+  ++APE   +
Sbjct: 120 --DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVV--EFSFAKSFKGSPYWMAPEVIAQ 175

Query: 438 TGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLG 497
            G    +AD++S G  +LE+A G+ P  +         V  VF      EL         
Sbjct: 176 QGGYGLAADIWSLGCTVLEMATGKPPWSQLEG------VAAVFKIGRSKELPP------- 222

Query: 498 TEYVAEELELVLKLG-LLCSHSDPTARPSMRQVVQ 531
              + + L    K   L C   DP+ RP+  ++++
Sbjct: 223 ---IPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score =  104 bits (260), Expect = 7e-25
 Identities = 80/280 (28%), Positives = 124/280 (44%), Gaps = 40/280 (14%)

Query: 265 EKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLL 324
           E+ +LG G +G VY      +Q+ IA+K+I     + ++    EI     L+HRN+VQ L
Sbjct: 12  ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYL 71

Query: 325 GYCRRKGELLLVYDYMPNGSLDKYL------YDQPKVTLNWIQRFRVIKGVALGLFYLHQ 378
           G     G   +  + +P GSL   L          + T+ +       K +  GL YLH 
Sbjct: 72  GSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYT-----KQILEGLKYLH- 125

Query: 379 EWEQVVIHRDVKASNVLLD---GELNGRLGDFGLA-RLYDHGTDPQTTHVVGTLGYLAPE 434
             +  ++HRD+K  NVL++   G +  ++ DFG + RL   G +P T    GTL Y+APE
Sbjct: 126 --DNQIVHRDIKGDNVLVNTYSGVV--KISDFGTSKRL--AGINPCTETFTGTLQYMAPE 179

Query: 435 HTRTGKA--TTSADVFSFGAFLLEVACGRRP-IQRQGPSENLILVDWVFDFWNRGELLEA 491
               G       AD++S G  ++E+A G+ P I+   P   +  V               
Sbjct: 180 VIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKI---------- 229

Query: 492 RDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ 531
             P +     AE    +L+    C   DP  R S   ++Q
Sbjct: 230 -HPEIPESLSAEAKNFILR----CFEPDPDKRASAHDLLQ 264

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  103 bits (260), Expect = 7e-25
 Identities = 70/208 (33%), Positives = 102/208 (49%), Gaps = 18/208 (8%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQG-MK--EFVAEIVSIGRLRHRN 319
            + +  LG G FG V+ GT   +  ++AVK +    + G M    F+ E   + +LRH  
Sbjct: 8   LKLERKLGAGQFGEVWMGTWNGT-TKVAVKTL----KPGTMSPEAFLQEAQIMKKLRHDK 62

Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQE 379
           LVQL   C  +  + +V +YM  GSL  +L       L   Q   +   +A G+ YL   
Sbjct: 63  LVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE-- 120

Query: 380 WEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT---LGYLAPEHT 436
             +  IHRD+ A N+L+   L  ++ DFGLARL +   D + T   G    + + APE  
Sbjct: 121 -SRNYIHRDLAARNILVGENLVCKIADFGLARLIE---DDEYTAREGAKFPIKWTAPEAA 176

Query: 437 RTGKATTSADVFSFGAFLLE-VACGRRP 463
             G+ T  +DV+SFG  L E V  GR P
Sbjct: 177 NYGRFTIKSDVWSFGILLTEIVTYGRVP 204

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  103 bits (259), Expect = 8e-25
 Identities = 65/196 (33%), Positives = 93/196 (47%), Gaps = 6/196 (3%)

Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCR 328
           LG G FG V+ G L  +   +AVK +   +    K+F+AE   + +LRH  L+QL   C 
Sbjct: 14  LGAGQFGEVWEG-LWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAVCT 71

Query: 329 RKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRD 388
            +  + +V + M  GSL +YL       L   Q   +   VA G+ YL     Q  IHRD
Sbjct: 72  LEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEA---QNYIHRD 128

Query: 389 VKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVF 448
           + A NVL+      ++ DFGLAR+               + + APE     + +  +DV+
Sbjct: 129 LAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVW 188

Query: 449 SFGAFLLE-VACGRRP 463
           SFG  L E V  GR P
Sbjct: 189 SFGILLTEIVTYGRMP 204

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  102 bits (257), Expect = 1e-24
 Identities = 58/200 (29%), Positives = 92/200 (46%), Gaps = 13/200 (6%)

Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKIS--HESRQGMKEFV-AE--IVSIGRLRHRNLVQL 323
           LG G FG+V       +    A+K +      ++   E    E  I+S  R+ H  +V+L
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILS--RINHPFIVKL 58

Query: 324 LGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQV 383
               + + +L LV +Y P G L  +L  + + +    + +     + L L YLH      
Sbjct: 59  HYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFY--AAEIVLALEYLH---SLG 113

Query: 384 VIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATT 443
           +I+RD+K  N+LLD + + +L DFGLA+        +T    GT  YLAPE         
Sbjct: 114 IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS-RTNTFCGTPEYLAPEVLLGKGYGK 172

Query: 444 SADVFSFGAFLLEVACGRRP 463
           + D +S G  L E+  G+ P
Sbjct: 173 AVDWWSLGVLLYEMLTGKPP 192

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score =  101 bits (252), Expect = 5e-24
 Identities = 79/271 (29%), Positives = 130/271 (47%), Gaps = 29/271 (10%)

Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
           E++G G FG V +G     ++  AVK I  +     + F+ E   + +L H+NLV+LLG 
Sbjct: 12  EIIGEGEFGAVLQGEYTGQKV--AVKNIKCDVTA--QAFLEETAVMTKLHHKNLVRLLGV 67

Query: 327 CRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIH 386
               G L +V + M  G+L  +L  + +  ++ IQ  +    VA G+ YL     + ++H
Sbjct: 68  ILHNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES---KKLVH 123

Query: 387 RDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSAD 446
           RD+ A N+L+  +   ++ DFGLAR+   G D     V  T    APE  +  K ++ +D
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWT----APEALKHKKFSSKSD 179

Query: 447 VFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAEEL 505
           V+S+G  L EV + GR P  +    E       V +   +G  +E  +      YV    
Sbjct: 180 VWSYGVLLWEVFSYGRAPYPKMSLKE-------VKECVEKGYRMEPPEGCPADVYV---- 228

Query: 506 ELVLKLGLLCSHSDPTARPSMRQVVQILERD 536
                L   C  ++P  RPS  ++ + LE++
Sbjct: 229 -----LMTSCWETEPKKRPSFHKLREKLEKE 254

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score =  101 bits (254), Expect = 8e-24
 Identities = 83/296 (28%), Positives = 129/296 (43%), Gaps = 50/296 (16%)

Query: 267 ELLGTGGFGRVYRGTL-----PKSQIEIAVKKI-SHESRQGMKEFVAEIV---SIGRLRH 317
           + LG G FG+V +        P     +AVK +    + + + + V+E+     IG+  H
Sbjct: 18  KPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK--H 75

Query: 318 RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYD-QPKVTLNWIQRFRVIKG-------- 368
           +N++ LLG C ++G L +V +Y  +G+L  +L   +P          R  +         
Sbjct: 76  KNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLV 135

Query: 369 -----VALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYD-HGTDPQTT 422
                VA G+ +L     +  IHRD+ A NVL+  +   ++ DFGLAR  D H  D    
Sbjct: 136 SFAYQVARGMEFLAS---KKCIHRDLAARNVLVTEDHVMKIADFGLAR--DIHHIDYYRK 190

Query: 423 HVVGTLGY--LAPEHTRTGKATTSADVFSFGAFLLE-VACGRRPIQRQGPSENLILVDWV 479
              G L    +APE       T  +DV+SFG  L E    G  P     P    I V+ +
Sbjct: 191 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY----PG---IPVEEL 243

Query: 480 FDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER 535
           F     G  +E +  N   E        +  L   C H  P+ RP+ +Q+V+ L+R
Sbjct: 244 FKLLKEGYRME-KPQNCTQE--------LYHLMRDCWHEVPSQRPTFKQLVEDLDR 290

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score =  100 bits (250), Expect = 1e-23
 Identities = 87/282 (30%), Positives = 127/282 (45%), Gaps = 41/282 (14%)

Query: 261 KGFREKELLGTGGFGRV----YRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLR 316
           K  +  + +G G FG V    YRG       ++AVK I +++    + F+AE   + +LR
Sbjct: 6   KELKLLQTIGKGEFGDVMLGDYRGN------KVAVKCIKNDATA--QAFLAEASVMTQLR 57

Query: 317 HRNLVQLLGY-CRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFY 375
           H NLVQLLG     KG L +V +YM  GSL  YL  + +  L      +    V   + Y
Sbjct: 58  HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 117

Query: 376 LHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEH 435
           L        +HRD+ A NVL+  +   ++ DFGL +      D     V  T    APE 
Sbjct: 118 LEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEA 170

Query: 436 TRTGKATTSADVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARD- 493
            R  K +T +DV+SFG  L E+ + GR P  R    + +  V+       +G  ++A D 
Sbjct: 171 LREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-------KGYKMDAPDG 223

Query: 494 -PNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILE 534
            P            +V  +   C H D   RPS  Q+ + LE
Sbjct: 224 CP-----------PVVYDVMKQCWHLDAATRPSFLQLREQLE 254

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  100 bits (250), Expect = 1e-23
 Identities = 76/272 (27%), Positives = 119/272 (43%), Gaps = 39/272 (14%)

Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKI-----SHESRQGMKEFVAEIVSIGRLRHRNLVQL 323
           LG G  G V +     +   +AVK I         +Q ++E   +I+   +     +V  
Sbjct: 9   LGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILREL--DILH--KCNSPYIVGF 64

Query: 324 LGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRF---RVIKGVALGLFYLHQEW 380
            G     G++ +  +YM  GSLDK L    K     I      ++   V  GL YLH++ 
Sbjct: 65  YGAFYNNGDISICMEYMDGGSLDKIL----KEVQGRIPERILGKIAVAVLKGLTYLHEKH 120

Query: 381 EQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGK 440
           +  +IHRDVK SN+L++     +L DFG++       +      VGT  Y+APE  +   
Sbjct: 121 K--IIHRDVKPSNILVNSRGQIKLCDFGVSGQL---VNSLAKTFVGTSSYMAPERIQGND 175

Query: 441 ATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEA----RDPNL 496
            +  +D++S G  L+E+A GR P     P EN         F    ELL+       P L
Sbjct: 176 YSVKSDIWSLGLSLIELATGRFPY----PPEN---DPPDGIF----ELLQYIVNEPPPRL 224

Query: 497 GTEYVAEELELVLKLGLLCSHSDPTARPSMRQ 528
            +   + + +  +    LC   DP  RPS ++
Sbjct: 225 PSGKFSPDFQDFVN---LCLIKDPRERPSYKE 253

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 99.6 bits (249), Expect = 2e-23
 Identities = 58/201 (28%), Positives = 97/201 (48%), Gaps = 7/201 (3%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQ 322
           F   E LG G +G VY+    ++   +A+K +  E    ++E + EI  + +     +V+
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE--DLQEIIKEISILKQCDSPYIVK 62

Query: 323 LLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQ 382
             G   +  +L +V +Y   GS+   +    K TL   +   ++     GL YLH     
Sbjct: 63  YYGSYFKNTDLWIVMEYCGAGSVSDIMKITNK-TLTEEEIAAILYQTLKGLEYLHS---N 118

Query: 383 VVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKAT 442
             IHRD+KA N+LL+ E   +L DFG++         + T V+GT  ++APE  +     
Sbjct: 119 KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT-VIGTPFWMAPEVIQEIGYN 177

Query: 443 TSADVFSFGAFLLEVACGRRP 463
             AD++S G   +E+A G+ P
Sbjct: 178 NKADIWSLGITAIEMAEGKPP 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 99.1 bits (247), Expect = 3e-23
 Identities = 77/275 (28%), Positives = 122/275 (44%), Gaps = 32/275 (11%)

Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKE-FVAEIVSIGRLRHRNLVQLLG 325
           E +G G FG VY+G L K   E+AVK         +K  F+ E   + +  H N+V+L+G
Sbjct: 1   EKIGKGNFGDVYKGVL-KGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIG 59

Query: 326 YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVI 385
            C +K  + +V + +P GSL  +L  + K  L   +  ++    A G+ YL     +  I
Sbjct: 60  VCVQKQPIYIVMELVPGGSLLTFL-RKKKNRLTVKKLLQMSLDAAAGMEYLES---KNCI 115

Query: 386 HRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLG-----YLAPEHTRTGK 440
           HRD+ A N L+      ++ DFG++R  + G       V   L      + APE    G+
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSREEEGG----IYTVSDGLKQIPIKWTAPEALNYGR 171

Query: 441 ATTSADVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTE 499
            T+ +DV+S+G  L E  + G  P       +    ++        G  + A  P L  E
Sbjct: 172 YTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIE-------SGYRMPA--PQLCPE 222

Query: 500 YVAEELELVLKLGLLCSHSDPTARPSMRQVVQILE 534
            +        +L L C   DP  RPS  ++   L+
Sbjct: 223 EIY-------RLMLQCWAYDPENRPSFSEIYNELQ 250

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 99.4 bits (248), Expect = 4e-23
 Identities = 65/224 (29%), Positives = 103/224 (45%), Gaps = 35/224 (15%)

Query: 266 KELLGTGGFGRVYRGTLPK-----SQIEIAVKKISH-ESRQGMKEFVAEIVSIGRLRHRN 319
           K  LG G FG+V+ G          +  +AVK +    S    K+F  E   +   +H N
Sbjct: 10  KRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHEN 69

Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYL------------YDQPKVTLNWIQRFRVIK 367
           +V+  G C      ++V++YM +G L+K+L             D P   L   Q  ++  
Sbjct: 70  IVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAV 129

Query: 368 GVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTT----- 422
            +A G+ YL     Q  +HRD+   N L+  +L  ++GDFG++R      D  TT     
Sbjct: 130 QIASGMVYLAS---QHFVHRDLATRNCLVGYDLVVKIGDFGMSR------DVYTTDYYRV 180

Query: 423 --HVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEV-ACGRRP 463
             H +  + ++ PE     K TT +DV+SFG  L E+   G++P
Sbjct: 181 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 98.8 bits (247), Expect = 5e-23
 Identities = 57/236 (24%), Positives = 106/236 (44%), Gaps = 30/236 (12%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKIS--HESRQG-MKEFVAEIVSIGRL-RHR 318
           F+  +++G G F  V      ++  E A+K +      ++  +K    E   + RL  H 
Sbjct: 3   FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62

Query: 319 NLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQ 378
            +++L    + +  L  V +Y PNG L +Y+     +     + +     + L L YLH 
Sbjct: 63  GIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFY--AAEILLALEYLHS 120

Query: 379 EWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ------------------ 420
              + +IHRD+K  N+LLD +++ ++ DFG A++ D  + P+                  
Sbjct: 121 ---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRR 177

Query: 421 -TTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLIL 475
                VGT  Y++PE      A  S+D+++ G  + ++  G+ P   +G +E L  
Sbjct: 178 RFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPF--RGSNEYLTF 231

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 98.4 bits (246), Expect = 7e-23
 Identities = 72/220 (32%), Positives = 109/220 (49%), Gaps = 24/220 (10%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKIS-HESRQGMKEFVA-EIVSIGRLRHRNL 320
           + +   +G G +G+VY+    K+   +A+KKI     ++G       EI  + +LRH N+
Sbjct: 1   YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNI 60

Query: 321 VQLLGYC--RRKGELLLVYDYMP---NGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFY 375
           V+L      + KG + +V++YM     G     L D P+V     Q    +K +  GL Y
Sbjct: 61  VRLKEIVTSKGKGSIYMVFEYMDHDLTG-----LLDSPEVKFTESQIKCYMKQLLEGLQY 115

Query: 376 LHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE- 434
           LH      ++HRD+K SN+L++ +   +L DFGLAR Y        T+ V TL Y  PE 
Sbjct: 116 LHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPEL 172

Query: 435 ---HTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSE 471
               TR G      D++S G  L E+  G +PI  QG +E
Sbjct: 173 LLGATRYG---PEVDMWSVGCILAELFLG-KPI-FQGSTE 207

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 97.6 bits (243), Expect = 8e-23
 Identities = 75/275 (27%), Positives = 122/275 (44%), Gaps = 30/275 (10%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKI--SHESRQGMKEFVAEIVSIGRLRHRNL 320
           F     +G G FG V++      +   A+K+I  S  +R+  +E + E   + +L    +
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61

Query: 321 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEW 380
           ++       KG+L +V +Y  NG L K L  Q    L   Q +R    + LGL +LH   
Sbjct: 62  IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS-- 119

Query: 381 EQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGK 440
            + ++HRD+K+ N+ LD   N ++GD G+A+L    T+   T +VGT  YL+PE      
Sbjct: 120 -KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT-IVGTPYYLSPELCEDKP 177

Query: 441 ATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGEL----LEARDPNL 496
               +DV++ G  L E   G+ P                FD  N+G L    +    P +
Sbjct: 178 YNEKSDVWALGVVLYECCTGKHP----------------FDANNQGALILKIIRGVFPPV 221

Query: 497 GTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ 531
              Y  +  +L+      C   D   RP   Q+++
Sbjct: 222 SQMYSQQLAQLI----DQCLTKDYRQRPDTFQLLR 252

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 98.4 bits (245), Expect = 8e-23
 Identities = 86/291 (29%), Positives = 125/291 (42%), Gaps = 48/291 (16%)

Query: 269 LGTGGFGRV----YRGTLPKSQIEIAVKKISHESRQGMKE-FVAEIVSIGRLRHRNLVQL 323
           LG G FG+V    Y      +   +AVK +  E  Q     +  EI  +  L H N+V+ 
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71

Query: 324 LGYCRRKGE--LLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
            G C  +G   L L+ +Y+P GSL  YL   PK  LN  Q     + +  G+ YLH    
Sbjct: 72  KGCCSEQGGKGLQLIMEYVPLGSLRDYL---PKHKLNLAQLLLFAQQICEGMAYLHS--- 125

Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLA----------RLYDHGTDPQTTHVVGTLGYL 431
           Q  IHRD+ A NVLLD +   ++GDFGLA          R+ + G  P        + + 
Sbjct: 126 QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP--------VFWY 177

Query: 432 APEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQ--------GPSENLILVDWVFDFW 483
           A E  +  K + ++DV+SFG  L E+       Q          GP +  + V  + +  
Sbjct: 178 AVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELL 237

Query: 484 NRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILE 534
            RG  L     N   E        V  L   C  ++   RP+ R ++ IL+
Sbjct: 238 ERGMRLPCPK-NCPQE--------VYILMKNCWETEAKFRPTFRSLIPILK 279

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  102 bits (256), Expect = 1e-22
 Identities = 127/511 (24%), Positives = 213/511 (41%), Gaps = 77/511 (15%)

Query: 68  GNETNHVFAVELDTIKSHGFLDINDNHVGIDINSLKSESSAPAGYYVEYDGLEKRTNVTL 127
            N+ +     EL + K    LD++ N +   I +  SE    +   +  + L        
Sbjct: 508 ENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEI---- 563

Query: 128 APINIPRPRSLNTMSLSRDLSSVLNDAMYVGFSSSTGSVLASHYILGWSFKINGQAEELN 187
            P N+    SL  +++S +           G   STG+ LA          IN  A   N
Sbjct: 564 -PKNLGNVESLVQVNISHNH--------LHGSLPSTGAFLA----------INASAVAGN 604

Query: 188 L--------SQLPKLPRVGPKKRSKFLTIGLPVICVSVIFA--AVSGVVYVIRMKRKFAE 237
           +        S LP   RV       F      + C    F   A+    +V    R   E
Sbjct: 605 IDLCGGDTTSGLPPCKRVRKTPSWWFY-----ITCTLGAFLVLALVAFGFVFIRGRNNLE 659

Query: 238 ----ELED--WELDHGPHRFRYKDLYIAT--KGFREKELLGTGGFGRVYRGTLPKSQIEI 289
               E ED  WEL     +   K + I       +E+ ++  G  G  Y+G   K+ ++ 
Sbjct: 660 LKRVENEDGTWELQFFDSKVS-KSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQF 718

Query: 290 AVKKIS-HESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKY 348
            VK+I+   S         EI  +G+L+H N+V+L+G CR +    L+++Y+   +L + 
Sbjct: 719 VVKEINDVNSIPSS-----EIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEV 773

Query: 349 LYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFG 408
           L +     L+W +R ++  G+A  L +LH      V+  ++    +++DG+    L    
Sbjct: 774 LRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL---- 824

Query: 409 LARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQ- 467
             RL   G     T    +  Y+APE   T   T  +D++ FG  L+E+  G+ P   + 
Sbjct: 825 --RLSLPGLLCTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEF 882

Query: 468 GPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELV--LKLGLLCSHSDPTARPS 525
           G   +  +V+W    ++   L    DP++  +    + E+V  + L L C+ +DPTARP 
Sbjct: 883 GVHGS--IVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPC 940

Query: 526 MRQVVQILERDVALPAISALRLSTSGITYLE 556
              V++ LE        SA R S+S +T L+
Sbjct: 941 ANDVLKTLE--------SASRSSSSCVTGLK 963

Length = 968

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 96.9 bits (241), Expect = 2e-22
 Identities = 64/206 (31%), Positives = 113/206 (54%), Gaps = 13/206 (6%)

Query: 266 KELLGTGGFGRVYRGTLP---KSQIEIAVK--KISHESRQGMKEFVAEIVSIGRLRHRNL 320
           ++++G G FG V  G L    K +I +A+K  K  +  +Q  ++F++E   +G+  H N+
Sbjct: 9   EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQ-RRDFLSEASIMGQFDHPNI 67

Query: 321 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEW 380
           + L G   +   +++V +YM NGSLD +L          IQ   +++G+A G+ YL    
Sbjct: 68  IHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDG-QFTVIQLVGMLRGIASGMKYLS--- 123

Query: 381 EQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLG--YLAPEHTRT 438
           +   +HRD+ A N+L++  L  ++ DFGL+R+ +   +   T   G +   + APE    
Sbjct: 124 DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY 183

Query: 439 GKATTSADVFSFGAFLLEV-ACGRRP 463
            K T+++DV+S+G  + EV + G RP
Sbjct: 184 RKFTSASDVWSYGIVMWEVMSYGERP 209

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 95.8 bits (239), Expect = 4e-22
 Identities = 74/289 (25%), Positives = 126/289 (43%), Gaps = 46/289 (15%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKE-----FVAEIVSIGR-LR 316
           +   E +G G FG V +         +  K+I + +   M E      V+E V+I R L+
Sbjct: 2   YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGN---MTEKEKQQLVSE-VNILRELK 57

Query: 317 HRNLVQLLGYCRR-----KGELLLVYDYMPNGSL----DKYLYDQPKVTLNWIQRFRVIK 367
           H N+V+   Y  R        L +V +Y   G L     K   ++  +   +I  +R++ 
Sbjct: 58  HPNIVR---YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFI--WRILT 112

Query: 368 GVALGLFYLH--QEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVV 425
            + L L+  H   +    V+HRD+K +N+ LD   N +LGDFGLA++  H +    T+ V
Sbjct: 113 QLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTY-V 171

Query: 426 GTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNR 485
           GT  Y++PE          +D++S G  + E+     P   +   + L            
Sbjct: 172 GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ-LA----------- 219

Query: 486 GELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILE 534
            ++ E +   +   Y + EL  V+K      + DP  RPS     ++L+
Sbjct: 220 SKIKEGKFRRIPYRY-SSELNEVIK---SMLNVDPDKRPS---TEELLQ 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 94.9 bits (236), Expect = 6e-22
 Identities = 84/270 (31%), Positives = 130/270 (48%), Gaps = 29/270 (10%)

Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCR 328
           LGTG FG V  G   + Q ++A+K I  E      EF+ E   + +L H  LVQL G C 
Sbjct: 12  LGTGQFGVVKYGKW-RGQYDVAIKMIK-EGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69

Query: 329 RKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRD 388
           ++  + +V +YM NG L  YL +  K      Q   + K V  G+ YL  E +Q  IHRD
Sbjct: 70  KQRPIYIVTEYMSNGCLLNYLREHGK-RFQPSQLLEMCKDVCEGMAYL--ESKQ-FIHRD 125

Query: 389 VKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT---LGYLAPEHTRTGKATTSA 445
           + A N L+D +   ++ DFGL+R   +  D + T  VG+   + +  PE     K ++ +
Sbjct: 126 LAARNCLVDDQGCVKVSDFGLSR---YVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKS 182

Query: 446 DVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAEE 504
           DV++FG  + EV + G+ P +R   SE +  V          + L    P+L +E     
Sbjct: 183 DVWAFGVLMWEVYSLGKMPYERFNNSETVEKV---------SQGLRLYRPHLASEK---- 229

Query: 505 LELVLKLGLLCSHSDPTARPSMRQVVQILE 534
              V  +   C H     RP+ +Q++  +E
Sbjct: 230 ---VYAIMYSCWHEKAEERPTFQQLLSSIE 256

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 95.1 bits (237), Expect = 7e-22
 Identities = 81/272 (29%), Positives = 124/272 (45%), Gaps = 34/272 (12%)

Query: 267 ELLGTGGFGRVYRG-TLPKSQIEIAVKKISHESRQ-GMKEFVAEIVSIGRLRHRNLVQLL 324
           E++G G    VY    LP ++ ++A+K+I  E  Q  + E   E+ ++ +  H N+V+  
Sbjct: 7   EVIGVGATAVVYAAICLPNNE-KVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYY 65

Query: 325 GYCRRKGELLLVYDYMPNGS-LDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQV 383
                  EL LV  Y+  GS LD      P+  L+      V+K V  GL YLH      
Sbjct: 66  TSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS---NG 122

Query: 384 VIHRDVKASNVLLDGELNGRLGDFGL-ARLYDHGTDPQTTH--VVGTLGYLAPE--HTRT 438
            IHRD+KA N+LL  + + ++ DFG+ A L D G   +      VGT  ++APE      
Sbjct: 123 QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVH 182

Query: 439 GKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGT 498
           G     AD++SFG   +E+A G  P  +  P + L+L             L+   P+L T
Sbjct: 183 G-YDFKADIWSFGITAIELATGAAPYSKYPPMKVLML------------TLQNDPPSLET 229

Query: 499 E-----YVAEELELVLKLGLLCSHSDPTARPS 525
                 Y     +++      C   DP+ RP+
Sbjct: 230 GADYKKYSKSFRKMISL----CLQKDPSKRPT 257

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 94.0 bits (234), Expect = 1e-21
 Identities = 78/276 (28%), Positives = 119/276 (43%), Gaps = 30/276 (10%)

Query: 267 ELLGTGGFGRVYRGTLPKSQ---IEIAVKKISHESRQG-MKEFVAEIVSIGRLRHRNLVQ 322
           + LG G FG V RG    S    I +AVK +  +     M +F+ E   +  L H NL++
Sbjct: 1   KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60

Query: 323 LLGYCRRKGELLLVYDYMPNGSLDKYLYDQ--PKVTLNWIQRFRVIKGVALGLFYLHQEW 380
           L G       L++V +  P GSL   L         ++ +  + V   +A G+ YL    
Sbjct: 61  LYGVVLTH-PLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAV--QIANGMRYLES-- 115

Query: 381 EQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTT--HVVGTLGYLAPEHTRT 438
            +  IHRD+ A N+LL  +   ++GDFGL R      D      H+     + APE  RT
Sbjct: 116 -KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRT 174

Query: 439 GKATTSADVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLG 497
              + ++DV+ FG  L E+   G  P      S+ L  +D        GE LE       
Sbjct: 175 RTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKID------KEGERLER------ 222

Query: 498 TEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQIL 533
            E   +++  V+   L C   +P  RP+   + + L
Sbjct: 223 PEACPQDIYNVM---LQCWAHNPADRPTFAALREFL 255

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 94.1 bits (234), Expect = 2e-21
 Identities = 68/212 (32%), Positives = 114/212 (53%), Gaps = 22/212 (10%)

Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKIS--------HESRQ-GM-KEFVAEIVSIGRLR 316
           EL+G G +GRVY      +   +AVK++         H+SRQ  M K   +EI ++  L 
Sbjct: 7   ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD 66

Query: 317 HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRF--RVIKGVALGLF 374
           H N+VQ LG+   +  L +  +Y+P GS+   L    +     ++ F  +V++G+A    
Sbjct: 67  HLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLA---- 122

Query: 375 YLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP-QTTHVVGTLGYLAP 433
           YLH    + ++HRD+KA N+L+D +   ++ DFG+++  D   D  Q   + G++ ++AP
Sbjct: 123 YLHS---KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAP 179

Query: 434 EHTRTGKATTSA--DVFSFGAFLLEVACGRRP 463
           E   +     SA  D++S G  +LE+  GRRP
Sbjct: 180 EVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 93.6 bits (233), Expect = 2e-21
 Identities = 64/207 (30%), Positives = 109/207 (52%), Gaps = 21/207 (10%)

Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKIS-HESRQGM-KEFVAEIVSIGRLRHRNLVQLLGY 326
           +G G FG+VY      +   +AVK+I   ++     KE   E+  +  L+H NLV+  G 
Sbjct: 8   IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67

Query: 327 CRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRF--RVIKGVALGLFYLHQEWEQVV 384
              + ++ +  +Y   G+L++ L     +  + I+ +  ++++G+A    YLH      +
Sbjct: 68  EVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLA----YLH---SHGI 120

Query: 385 IHRDVKASNVLLDGELNG--RLGDFGLA-RLYDHGTDPQTT--HVVGTLGYLAPEHTRTG 439
           +HRD+K +N+ LD   NG  +LGDFG A +L ++ T        + GT  Y+APE    G
Sbjct: 121 VHRDIKPANIFLDH--NGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGG 178

Query: 440 KAT---TSADVFSFGAFLLEVACGRRP 463
           K      +AD++S G  +LE+A G+RP
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGKRP 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 93.9 bits (234), Expect = 3e-21
 Identities = 62/200 (31%), Positives = 105/200 (52%), Gaps = 17/200 (8%)

Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKIS--HESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
           +G G +G VY+     +   +A+KKI    ES    K  + EI  +  L H N+++LL  
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66

Query: 327 CRRKGELLLVYDYMPNGSLDKYLYDQPK-VTLNWIQRF--RVIKGVALGLFYLHQEWEQV 383
            R KG+L LV+++M +  L K + D+ + +  + I+ +  ++++G+A    + H      
Sbjct: 67  FRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLA----FCHSHG--- 118

Query: 384 VIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQT-THVVGTLGYLAPE-HTRTGKA 441
           ++HRD+K  N+L++ E   +L DFGLAR +  G+  +  TH V T  Y APE        
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSF--GSPVRPYTHYVVTRWYRAPELLLGDKGY 176

Query: 442 TTSADVFSFGAFLLEVACGR 461
           +T  D++S G    E+   R
Sbjct: 177 STPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 93.5 bits (232), Expect = 4e-21
 Identities = 78/289 (26%), Positives = 134/289 (46%), Gaps = 40/289 (13%)

Query: 266 KELLGTGGFGRV-----YRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNL 320
           K  LG G FG+V     Y  +  K ++ +AVK +   +    K+F  E   +  L+H ++
Sbjct: 10  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 69

Query: 321 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYD--------------QPKVTLNWIQRFRVI 366
           V+  G C     L++V++YM +G L+K+L                Q K  L   Q   + 
Sbjct: 70  VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129

Query: 367 KGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVV 425
             +A G+ YL     Q  +HRD+   N L+   L  ++GDFG++R +Y         H +
Sbjct: 130 SQIASGMVYLAS---QHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 186

Query: 426 GTLGYLAPEHTRTGKATTSADVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFWN 484
             + ++ PE     K TT +DV+SFG  L E+   G++P  +   +E       V +   
Sbjct: 187 LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE-------VIECIT 239

Query: 485 RGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQIL 533
           +G +LE   P +  + V +     + LG  C   +P  R +++++ +IL
Sbjct: 240 QGRVLER--PRVCPKEVYD-----IMLG--CWQREPQQRLNIKEIYKIL 279

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 93.2 bits (232), Expect = 5e-21
 Identities = 74/285 (25%), Positives = 128/285 (44%), Gaps = 39/285 (13%)

Query: 269 LGTGGFGRVYRGTL-----PKSQIEIAVKKIS-HESRQGMKEFVAEIVSIGRLRHRNLVQ 322
           LG G FG VY G        + +  +A+K ++ + S +   EF+ E   +      ++V+
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 323 LLGYCRRKGELLLVYDYMPNGSLDKYLYDQ-------PKVTLNWIQRFRVIKG-VALGLF 374
           LLG        L+V + M  G L  YL  +       P +    +Q+F  +   +A G+ 
Sbjct: 74  LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133

Query: 375 YLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVGTLGYLAP 433
           YL     +  +HRD+ A N ++  +L  ++GDFG+ R +Y+     +    +  + ++AP
Sbjct: 134 YLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190

Query: 434 EHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEAR 492
           E  + G  TT +DV+SFG  L E+A    +P Q     E       V  F   G  L+  
Sbjct: 191 ESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE-------VLKFVIDGGHLDLP 243

Query: 493 D--PNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER 535
           +  P+            +L+L  +C   +P  RP+  ++V  L+ 
Sbjct: 244 ENCPD-----------KLLELMRMCWQYNPKMRPTFLEIVSSLKD 277

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 92.3 bits (229), Expect = 6e-21
 Identities = 63/207 (30%), Positives = 102/207 (49%), Gaps = 13/207 (6%)

Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCR 328
           +G+G FG V+ G     + ++A+K I  E     ++F+ E   + +L H  LVQL G C 
Sbjct: 12  IGSGQFGLVWLGYW-LEKRKVAIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69

Query: 329 RKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRD 388
            +  + LV+++M +G L  YL  Q +   +      +   V  G+ YL       VIHRD
Sbjct: 70  ERSPICLVFEFMEHGCLSDYLRAQ-RGKFSQETLLGMCLDVCEGMAYLES---SNVIHRD 125

Query: 389 VKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT---LGYLAPEHTRTGKATTSA 445
           + A N L+      ++ DFG+ R      D Q T   GT   + + +PE     K ++ +
Sbjct: 126 LAARNCLVGENQVVKVSDFGMTRFV---LDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKS 182

Query: 446 DVFSFGAFLLEV-ACGRRPIQRQGPSE 471
           DV+SFG  + EV + G+ P + +  SE
Sbjct: 183 DVWSFGVLMWEVFSEGKTPYENRSNSE 209

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 92.4 bits (230), Expect = 7e-21
 Identities = 58/206 (28%), Positives = 99/206 (48%), Gaps = 12/206 (5%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQ 322
           +   + +G+G +G VY+     +   +A+K I  E     +    EI  +   RH N+V 
Sbjct: 5   YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVA 64

Query: 323 LLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQ 382
             G   R+ +L +V +Y   GSL   +Y   +  L+ +Q   V +    GL YLH+    
Sbjct: 65  YFGSYLRRDKLWIVMEYCGGGSLQD-IYQVTRGPLSELQIAYVCRETLKGLAYLHE---T 120

Query: 383 VVIHRDVKASNVLL--DGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE---HTR 437
             IHRD+K +N+LL  DG++  +L DFG++         + +  +GT  ++APE     R
Sbjct: 121 GKIHRDIKGANILLTEDGDV--KLADFGVSAQLTATIAKRKS-FIGTPYWMAPEVAAVER 177

Query: 438 TGKATTSADVFSFGAFLLEVACGRRP 463
            G      D+++ G   +E+A  + P
Sbjct: 178 KGGYDGKCDIWALGITAIELAELQPP 203

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 92.2 bits (229), Expect = 7e-21
 Identities = 77/269 (28%), Positives = 130/269 (48%), Gaps = 29/269 (10%)

Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCR 328
           LG+G FG V+ G   ++QI++A+K I +E     ++F+ E   + +L H  LVQL G C 
Sbjct: 12  LGSGQFGVVHLGKW-RAQIKVAIKAI-NEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69

Query: 329 RKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRD 388
           ++  L +V ++M NG L  YL  Q +  L+      + + V  G+ YL +      IHRD
Sbjct: 70  QQKPLYIVTEFMENGCLLNYL-RQRQGKLSKDMLLSMCQDVCEGMEYLER---NSFIHRD 125

Query: 389 VKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT---LGYLAPEHTRTGKATTSA 445
           + A N L+      ++ DFG+ R   +  D + T   G    + +  PE     K ++ +
Sbjct: 126 LAARNCLVSSTGVVKVSDFGMTR---YVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKS 182

Query: 446 DVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAEE 504
           DV+SFG  + EV   G+ P ++     N  +V+ +    +RG  L    P L +  V E 
Sbjct: 183 DVWSFGVLMWEVFTEGKMPFEK---KSNYEVVEMI----SRGFRL--YRPKLASMTVYEV 233

Query: 505 LELVLKLGLLCSHSDPTARPSMRQVVQIL 533
           +         C H  P  RP+  ++++ +
Sbjct: 234 M-------YSCWHEKPEGRPTFAELLRAI 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 92.1 bits (229), Expect = 1e-20
 Identities = 61/213 (28%), Positives = 102/213 (47%), Gaps = 26/213 (12%)

Query: 267 ELLGTGGFGRVYRGTL-----PKSQIEIAVK--KISHESRQGMKEFVAEIVSIGRLRHRN 319
           E LG G FG+VY+G L       S   +A+K  K + E +   +EF  E   +  L+H N
Sbjct: 11  EELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKV-QQEFRQEAELMSDLQHPN 69

Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYL--------------YDQPKVTLNWIQRFRV 365
           +V LLG C ++    ++++Y+ +G L ++L               +  K +L+      +
Sbjct: 70  IVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHI 129

Query: 366 IKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARL-YDHGTDPQTTHV 424
              +A G+ YL        +HRD+ A N L+   L  ++ DFGL+R  Y        +  
Sbjct: 130 AIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKS 186

Query: 425 VGTLGYLAPEHTRTGKATTSADVFSFGAFLLEV 457
           +  + ++ PE    GK TT +D++SFG  L E+
Sbjct: 187 LLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 91.2 bits (226), Expect = 1e-20
 Identities = 62/192 (32%), Positives = 102/192 (53%), Gaps = 8/192 (4%)

Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMK-EFVAEIVSIGRLRHRNLVQLLG 325
           ELLG G FG V++GTL K +  +AVK    +  Q +K +F++E   + +  H N+V+L+G
Sbjct: 1   ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIG 59

Query: 326 YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVI 385
            C ++  + +V + +P G    +L  + K  L   Q  +     A G+ YL     +  I
Sbjct: 60  VCTQRQPIYIVMELVPGGDFLSFLRKK-KDELKTKQLVKFALDAAAGMAYLES---KNCI 115

Query: 386 HRDVKASNVLLDGELNG-RLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTS 444
           HRD+ A N L+ GE N  ++ DFG++R  D G    +      + + APE    G+ ++ 
Sbjct: 116 HRDLAARNCLV-GENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSE 174

Query: 445 ADVFSFGAFLLE 456
           +DV+S+G  L E
Sbjct: 175 SDVWSYGILLWE 186

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 92.0 bits (229), Expect = 2e-20
 Identities = 77/239 (32%), Positives = 113/239 (47%), Gaps = 46/239 (19%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKIS-HESRQGMK-EFVAEIVSIGRLRHRNL 320
           +     LG G FG VY+    K+   +A+KKI  H  + G     + EI  + +L+H N+
Sbjct: 10  YEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNV 69

Query: 321 VQLL--------GYCRRKGELLLVYDYMP---NGSLDKYLYDQPKVTLNWIQRFRVIKGV 369
           V L+           R++G + +V  YM    +G     L + P V L   Q    IK  
Sbjct: 70  VPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSG-----LLENPSVKLTESQ----IKCY 120

Query: 370 AL----GLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYD-------HGTD 418
            L    G+ YLH   E  ++HRD+KA+N+L+D +   ++ DFGLAR YD        G  
Sbjct: 121 MLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGG 177

Query: 419 PQT---THVVGTLGYLAPE---HTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSE 471
             T   T++V T  Y  PE     R  + TT+ D++  G    E+   RRPI  QG S+
Sbjct: 178 GGTRKYTNLVVTRWYRPPELLLGER--RYTTAVDIWGIGCVFAEMF-TRRPI-LQGKSD 232

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 91.2 bits (226), Expect = 2e-20
 Identities = 73/244 (29%), Positives = 117/244 (47%), Gaps = 34/244 (13%)

Query: 263 FREKEL-----LGTGGFGRVYRGT-LPKS---QIEIAVKKISHES-RQGMKEFVAEIVSI 312
            +E EL     LG+G FG V++G  +P+    +I +A+K I   S RQ  +E    ++++
Sbjct: 4   LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAM 63

Query: 313 GRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQ-----PKVTLNWIQRFRVIK 367
           G L H  +V+LLG C     L LV    P GSL  ++        P+  LNW  +     
Sbjct: 64  GSLDHAYIVRLLGICP-GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQ----- 117

Query: 368 GVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVG 426
            +A G++YL    E  ++HR++ A N+LL  +   ++ DFG+A  LY        +    
Sbjct: 118 -IAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKT 173

Query: 427 TLGYLAPEHTRTGKATTSADVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFWNR 485
            + ++A E    G+ T  +DV+S+G  + E+ + G  P     P E       V D   +
Sbjct: 174 PIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE-------VPDLLEK 226

Query: 486 GELL 489
           GE L
Sbjct: 227 GERL 230

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 90.3 bits (224), Expect = 4e-20
 Identities = 74/288 (25%), Positives = 135/288 (46%), Gaps = 40/288 (13%)

Query: 267 ELLGTGGFGRVYRGTLPK---SQIEIAVK--KISHESRQGMKEFVAEIVSIGRLRHRNLV 321
           ++LG G FG V  G L +   SQ+++AVK  K+   +   ++EF++E   +    H N++
Sbjct: 5   KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVM 64

Query: 322 QLLGYCRRKGEL------LLVYDYMPNGSLDKYLY-----DQP-KVTLNWIQRFRVIKGV 369
           +L+G C     L      +++  +M +G L  +L        P K+ L  + +F V   +
Sbjct: 65  KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV--DI 122

Query: 370 ALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT-L 428
           ALG+ YL     +  IHRD+ A N +L  ++   + DFGL++    G   +   +    +
Sbjct: 123 ALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV 179

Query: 429 GYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGE 487
            ++A E       T+ +DV++FG  + E+A  G+ P       E       ++D+   G 
Sbjct: 180 KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE-------IYDYLRHGN 232

Query: 488 LLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER 535
            L  + P        + L+ +  L   C  +DP  RP+  ++ ++LE 
Sbjct: 233 RL--KQP-------EDCLDELYDLMYSCWRADPKDRPTFTKLREVLEN 271

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 90.5 bits (224), Expect = 4e-20
 Identities = 61/216 (28%), Positives = 101/216 (46%), Gaps = 21/216 (9%)

Query: 266 KELLGTGGFGRVYRGTL-----PKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNL 320
           K  LG G FG+V+          + +I +AVK +   S    K+F  E   +  L+H ++
Sbjct: 10  KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHI 69

Query: 321 VQLLGYCRRKGELLLVYDYMPNGSLDKYLY-----------DQPKVTLNWIQRFRVIKGV 369
           V+  G C     L++V++YM +G L+K+L                  L   Q   + + +
Sbjct: 70  VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQI 129

Query: 370 ALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVGTL 428
           A G+ YL     Q  +HRD+   N L+   L  ++GDFG++R +Y         H +  +
Sbjct: 130 AAGMVYLAS---QHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 186

Query: 429 GYLAPEHTRTGKATTSADVFSFGAFLLEV-ACGRRP 463
            ++ PE     K TT +DV+S G  L E+   G++P
Sbjct: 187 RWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 89.7 bits (223), Expect = 5e-20
 Identities = 56/205 (27%), Positives = 93/205 (45%), Gaps = 10/205 (4%)

Query: 262 GFREKELLGTGGFGRVYRGTLPKSQIEIAVKKIS---HESRQGMKEFVAEIVSIGRLRHR 318
            F    ++G G FG+V       ++   A+K ++      +  ++  + E   +  L H 
Sbjct: 1   HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60

Query: 319 NLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQ 378
            LV L    + +  + LV D +  G L  +L  + K +   ++ +  I  + L L YLH 
Sbjct: 61  FLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFW--ICEIVLALEYLH- 117

Query: 379 EWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRT 438
              + +IHRD+K  N+LLD + +  + DF +A       D  TT   GT GY+APE    
Sbjct: 118 --SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVT--PDTLTTSTSGTPGYMAPEVLCR 173

Query: 439 GKATTSADVFSFGAFLLEVACGRRP 463
              + + D +S G    E   G+RP
Sbjct: 174 QGYSVAVDWWSLGVTAYECLRGKRP 198

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 89.9 bits (223), Expect = 5e-20
 Identities = 64/210 (30%), Positives = 105/210 (50%), Gaps = 16/210 (7%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKI-----SHESRQGMKEFVAEIVSIGRLRH 317
           +R  +LLG G FGRVY      +  E+AVK++     S E+++ +     EI  +  L+H
Sbjct: 4   WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQH 63

Query: 318 RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLH 377
             +VQ  G  R    L +  +YMP GS+   L     +T    +++   + +  G+ YLH
Sbjct: 64  ERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKY--TRQILEGVEYLH 121

Query: 378 QEWEQVVIHRDVKASNVLLDGELNGRLGDFG----LARLYDHGTDPQTTHVVGTLGYLAP 433
                +++HRD+K +N+L D   N +LGDFG    L  +   GT  ++  V GT  +++P
Sbjct: 122 ---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS--VTGTPYWMSP 176

Query: 434 EHTRTGKATTSADVFSFGAFLLEVACGRRP 463
           E          ADV+S G  ++E+   + P
Sbjct: 177 EVISGEGYGRKADVWSVGCTVVEMLTEKPP 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 88.6 bits (219), Expect = 1e-19
 Identities = 74/271 (27%), Positives = 128/271 (47%), Gaps = 26/271 (9%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKIS-HESRQGMKEFVAEIVSIGRLRHRNLV 321
           F + E +G G FG V++G   ++Q  +A+K I   E+   +++   EI  + +     + 
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 322 QLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
           +  G   +  +L ++ +Y+  GS    L   P   L+  Q   +++ +  GL YLH E +
Sbjct: 66  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP---LDETQIATILREILKGLDYLHSEKK 122

Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLA-RLYDHGTDPQTTHVVGTLGYLAPEHTRTGK 440
              IHRD+KA+NVLL      +L DFG+A +L D  T  +    VGT  ++APE  +   
Sbjct: 123 ---IHRDIKAANVLLSEHGEVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPEVIKQSA 177

Query: 441 ATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEY 500
             + AD++S G   +E+A G  P     P + L L+             +   P L   Y
Sbjct: 178 YDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIP------------KNNPPTLEGNY 225

Query: 501 VAEELELVLKLGLLCSHSDPTARPSMRQVVQ 531
                E V      C + +P+ RP+ +++++
Sbjct: 226 SKPLKEFVEA----CLNKEPSFRPTAKELLK 252

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 88.8 bits (221), Expect = 2e-19
 Identities = 67/214 (31%), Positives = 96/214 (44%), Gaps = 33/214 (15%)

Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKE---FVA--EIVSIGRLRHRNLV 321
           + LG G +  VY+    ++   +A+KKI    R+  K+   F A  EI  +  L+H N++
Sbjct: 6   KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65

Query: 322 QLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRV--IKGVAL----GLFY 375
            LL     K  + LV+++M          D  KV  +         IK   L    GL Y
Sbjct: 66  GLLDVFGHKSNINLVFEFME--------TDLEKVIKDKSIVLTPADIKSYMLMTLRGLEY 117

Query: 376 LHQEWEQVVIHRDVKASNVLL--DGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAP 433
           LH  W   ++HRD+K +N+L+  DG L  +L DFGLAR +       T  VV T  Y AP
Sbjct: 118 LHSNW---ILHRDLKPNNLLIASDGVL--KLADFGLARSFGSPNRKMTHQVV-TRWYRAP 171

Query: 434 E---HTRTGKATTSADVFSFGAFLLEVACGRRPI 464
           E     R        D++S G    E+   R P 
Sbjct: 172 ELLFGAR--HYGVGVDMWSVGCIFAEL-LLRVPF 202

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 88.9 bits (221), Expect = 2e-19
 Identities = 79/298 (26%), Positives = 124/298 (41%), Gaps = 53/298 (17%)

Query: 267 ELLGTGGFGRVYRG-TLPKSQIEIAVK--KISHESRQGMKEFVAEIVSIGRLRHRNLVQL 323
            ++G G +G V +       +I +A+K  K S +     K  + E+  + +LRH N+V L
Sbjct: 7   GVVGEGAYGVVLKCRNKATGEI-VAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNL 65

Query: 324 LGYCRRKGELLLVYDYMPNGSLDKYLYDQPK-VTLNWIQR--FRVIKGVALGLFYLHQEW 380
               RRKG L LV++Y+    L+  L   P  +  + ++   +++++ +A    Y H   
Sbjct: 66  KEAFRRKGRLYLVFEYVERTLLE-LLEASPGGLPPDAVRSYIWQLLQAIA----YCHS-- 118

Query: 381 EQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE----HT 436
              +IHRD+K  N+L+      +L DFG AR          T  V T  Y APE     T
Sbjct: 119 -HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDT 177

Query: 437 RTGKATTSADVFSFGAFLLEVACGRRP-------------IQRQ-GP---------SENL 473
             GK     DV++ G  + E+  G  P             IQ+  GP         S N 
Sbjct: 178 NYGKP---VDVWAIGCIMAELLDG-EPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNP 233

Query: 474 ILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ 531
                 F   ++ E LE R P       A  L+ +      C   DP  R +  +++Q
Sbjct: 234 RFAGVAFPEPSQPESLERRYPGK-VSSPA--LDFLKA----CLRMDPKERLTCDELLQ 284

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 88.3 bits (219), Expect = 2e-19
 Identities = 59/200 (29%), Positives = 100/200 (50%), Gaps = 10/200 (5%)

Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCR 328
           LG G FG+VY+    ++ +  A K I  ES + +++F+ EI  +   +H N+V L     
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 329 RKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRD 388
            + +L ++ ++   G+LD  +  + +  L   Q   V + +   L +LH      VIHRD
Sbjct: 73  YENKLWILIEFCDGGALDS-IMLELERGLTEPQIRYVCRQMLEALNFLH---SHKVIHRD 128

Query: 389 VKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE--HTRTGKAT---T 443
           +KA N+LL  + + +L DFG++      T  +    +GT  ++APE     T K      
Sbjct: 129 LKAGNILLTLDGDVKLADFGVSAKNKS-TLQKRDTFIGTPYWMAPEVVACETFKDNPYDY 187

Query: 444 SADVFSFGAFLLEVACGRRP 463
            AD++S G  L+E+A    P
Sbjct: 188 KADIWSLGITLIELAQMEPP 207

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 88.6 bits (220), Expect = 3e-19
 Identities = 66/206 (32%), Positives = 96/206 (46%), Gaps = 37/206 (17%)

Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHE-SRQGMK-EFVAEIVSIGRLRHRNLVQLL-- 324
           +G G +G VYR     S   +A+KK+  +  R G+    + EI  +  LRH N+V+L   
Sbjct: 15  IGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEV 74

Query: 325 -------------GYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVAL 371
                         YC +  +L  + D MP        + + +V    +Q  R       
Sbjct: 75  VVGKHLDSIFLVMEYCEQ--DLASLLDNMPTP------FSESQVKCLMLQLLR------- 119

Query: 372 GLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYL 431
           GL YLH+ +   +IHRD+K SN+LL  +   ++ DFGLAR Y     P T  VV TL Y 
Sbjct: 120 GLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLWYR 175

Query: 432 APEHT-RTGKATTSADVFSFGAFLLE 456
           APE        TT+ D+++ G  L E
Sbjct: 176 APELLLGCTTYTTAIDMWAVGCILAE 201

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 87.4 bits (216), Expect = 3e-19
 Identities = 66/199 (33%), Positives = 98/199 (49%), Gaps = 13/199 (6%)

Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCR 328
           LG G FG V+ GT      ++AVK +        + F+ E   + +LRH  LVQL     
Sbjct: 14  LGNGQFGEVWMGTW-NGNTKVAVKTLK-PGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS 71

Query: 329 RKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRD 388
            +  + +V +YM  GSL  +L D     L       +   VA G+ Y+ +      IHRD
Sbjct: 72  EE-PIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRD 127

Query: 389 VKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT---LGYLAPEHTRTGKATTSA 445
           ++++N+L+   L  ++ DFGLARL +   D + T   G    + + APE    G+ T  +
Sbjct: 128 LRSANILVGDGLVCKIADFGLARLIE---DNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184

Query: 446 DVFSFGAFLLE-VACGRRP 463
           DV+SFG  L E V  GR P
Sbjct: 185 DVWSFGILLTELVTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 87.3 bits (217), Expect = 4e-19
 Identities = 60/207 (28%), Positives = 101/207 (48%), Gaps = 18/207 (8%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKIS-HESRQGMKEFVAEIVSIGRLRHRNLV 321
           F   E +G G FG VY+    ++   +A+K I   E+   +++   EI  + + R   + 
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62

Query: 322 QLLGYCRRKGELLLVYDYMPNGS----LDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLH 377
           +  G   +  +L ++ +Y   GS    L     D+  +         +++ V LGL YLH
Sbjct: 63  KYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAF-------ILREVLLGLEYLH 115

Query: 378 QEWEQVVIHRDVKASNVLLDGELNGRLGDFGLA-RLYDHGTDPQTTHVVGTLGYLAPEHT 436
              E+  IHRD+KA+N+LL  E + +L DFG++ +L    +   T   VGT  ++APE  
Sbjct: 116 ---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTF--VGTPFWMAPEVI 170

Query: 437 RTGKATTSADVFSFGAFLLEVACGRRP 463
           +       AD++S G   +E+A G  P
Sbjct: 171 KQSGYDEKADIWSLGITAIELAKGEPP 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 87.9 bits (218), Expect = 4e-19
 Identities = 79/279 (28%), Positives = 130/279 (46%), Gaps = 35/279 (12%)

Query: 269 LGTGGFGRVYRGT---LPKSQ--IEIAVKKISHESRQGMKE-FVAEIVSIGRL-RHRNLV 321
           LG G FG+V   T   L KS   +++AVK +   +    +E  ++E+  +  L  H N+V
Sbjct: 43  LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102

Query: 322 QLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
            LLG C   G +L++ +Y   G L  +L  + +  L           VA G+ +L     
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLAS--- 159

Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVG-----TLGYLAPEHT 436
           +  IHRD+ A NVLL      ++ DFGLAR   + ++    +VV       + ++APE  
Sbjct: 160 KNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSN----YVVKGNARLPVKWMAPESI 215

Query: 437 RTGKATTSADVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPN 495
                T  +DV+S+G  L E+ + G  P     P    + VD  F      +L++     
Sbjct: 216 FNCVYTFESDVWSYGILLWEIFSLGSNPY----PG---MPVDSKF-----YKLIKEGYRM 263

Query: 496 LGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILE 534
              E+   E+  ++K    C  +DP  RP+ +Q+VQ++ 
Sbjct: 264 AQPEHAPAEIYDIMK---TCWDADPLKRPTFKQIVQLIG 299

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 87.0 bits (215), Expect = 5e-19
 Identities = 65/210 (30%), Positives = 102/210 (48%), Gaps = 13/210 (6%)

Query: 258 IATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRH 317
           I  +  R +  LG G FG V+ GT       +A+K +        + F+ E   + +LRH
Sbjct: 3   IPRESLRLEVKLGQGCFGEVWMGTW-NGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRH 60

Query: 318 RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLH 377
             LVQL      +  + +V +YM  GSL  +L  +    L   Q   +   +A G+ Y+ 
Sbjct: 61  EKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE 119

Query: 378 QEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT---LGYLAPE 434
           +      +HRD++A+N+L+   L  ++ DFGLARL +   D + T   G    + + APE
Sbjct: 120 R---MNYVHRDLRAANILVGENLVCKVADFGLARLIE---DNEYTARQGAKFPIKWTAPE 173

Query: 435 HTRTGKATTSADVFSFGAFLLEVAC-GRRP 463
               G+ T  +DV+SFG  L E+   GR P
Sbjct: 174 AALYGRFTIKSDVWSFGILLTELTTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 87.0 bits (215), Expect = 5e-19
 Identities = 66/213 (30%), Positives = 106/213 (49%), Gaps = 20/213 (9%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKI-----SHESRQGMKEFVAEIVSIGRLRH 317
           +R  +LLG G FG VY      +  E+AVK++     S E+ + +     EI  +  LRH
Sbjct: 4   WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRH 63

Query: 318 RNLVQLLGYCRRKGE---LLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLF 374
             +VQ  G C R  E   L +  +YMP GS+   L     +T N  +R+   + +  G+ 
Sbjct: 64  DRIVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRY--TRQILQGVS 120

Query: 375 YLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR----LYDHGTDPQTTHVVGTLGY 430
           YLH     +++HRD+K +N+L D   N +LGDFG ++    +   GT  ++  V GT  +
Sbjct: 121 YLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKS--VTGTPYW 175

Query: 431 LAPEHTRTGKATTSADVFSFGAFLLEVACGRRP 463
           ++PE          ADV+S    ++E+   + P
Sbjct: 176 MSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 87.0 bits (215), Expect = 5e-19
 Identities = 74/271 (27%), Positives = 129/271 (47%), Gaps = 26/271 (9%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKIS-HESRQGMKEFVAEIVSIGRLRHRNLV 321
           F + E +G G FG V++G   ++Q  +A+K I   E+   +++   EI  + +     + 
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 322 QLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
           +  G   +  +L ++ +Y+  GS    L   P    +  Q   ++K +  GL YLH E +
Sbjct: 66  KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGP---FDEFQIATMLKEILKGLDYLHSEKK 122

Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLA-RLYDHGTDPQTTHVVGTLGYLAPEHTRTGK 440
              IHRD+KA+NVLL  + + +L DFG+A +L D  T  +    VGT  ++APE  +   
Sbjct: 123 ---IHRDIKAANVLLSEQGDVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPEVIQQSA 177

Query: 441 ATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEY 500
             + AD++S G   +E+A G  P     P   L L+             +   P L  E+
Sbjct: 178 YDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIP------------KNNPPTLTGEF 225

Query: 501 VAEELELVLKLGLLCSHSDPTARPSMRQVVQ 531
                E +      C + DP+ RP+ +++++
Sbjct: 226 SKPFKEFIDA----CLNKDPSFRPTAKELLK 252

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 86.9 bits (215), Expect = 5e-19
 Identities = 72/288 (25%), Positives = 134/288 (46%), Gaps = 47/288 (16%)

Query: 266 KELLGTGGFGRVYRGTLP---KSQIEIAVKKI----SHESRQGMKEFVAEIVSIGRLRHR 318
           + +LGTG FG + RG L    K ++ +A+  +    S + R+G   F+AE +++G+  H 
Sbjct: 10  ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRG---FLAEALTLGQFDHS 66

Query: 319 NLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQ 378
           N+V+L G   R   +++V +YM NG+LD +L    +  L   Q   ++ G+A G+ YL  
Sbjct: 67  NIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKH-EGQLVAGQLMGMLPGLASGMKYLS- 124

Query: 379 EWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLG------YLA 432
             E   +H+ + A  VL++ +L  ++  F          + ++  +  T+       + A
Sbjct: 125 --EMGYVHKGLAAHKVLVNSDLVCKISGFR------RLQEDKSEAIYTTMSGKSPVLWAA 176

Query: 433 PEHTRTGKATTSADVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFWNRG--ELL 489
           PE  +    ++++DV+SFG  + EV + G RP                  +W+    +++
Sbjct: 177 PEAIQYHHFSSASDVWSFGIVMWEVMSYGERP------------------YWDMSGQDVI 218

Query: 490 EARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERDV 537
           +A +             L+ +L L C   +   RP   Q+  IL + V
Sbjct: 219 KAVEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKMV 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 87.2 bits (216), Expect = 6e-19
 Identities = 75/297 (25%), Positives = 129/297 (43%), Gaps = 51/297 (17%)

Query: 269 LGTGGFGRVYRGTLP-----KSQIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQ 322
           +G G FGRV++   P     +    +AVK +  E S     +F  E   +    H N+V+
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 323 LLGYCRRKGELLLVYDYMPNGSLDKYL--------------------YDQPKVTLNWIQR 362
           LLG C     + L+++YM  G L+++L                         + L+  ++
Sbjct: 73  LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132

Query: 363 FRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR---LYDHGTDP 419
             + K VA G+ YL    E+  +HRD+   N L+   +  ++ DFGL+R     D+    
Sbjct: 133 LCIAKQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189

Query: 420 QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDW 478
           +   +   + ++ PE     + TT +DV+++G  L E+ + G +P       E   ++ +
Sbjct: 190 ENDAI--PIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE---VIYY 244

Query: 479 VFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER 535
           V D    G +L   D N   E        +  L  LC    P+ RPS   + +IL+R
Sbjct: 245 VRD----GNVLSCPD-NCPLE--------LYNLMRLCWSKLPSDRPSFASINRILQR 288

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 86.5 bits (215), Expect = 8e-19
 Identities = 68/219 (31%), Positives = 108/219 (49%), Gaps = 18/219 (8%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKIS-HESRQGMKEF-VAEIVSIGRLR---H 317
           + E   +G G +G VY+     +   +A+KK+    S +G+    + EI  + +L    H
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60

Query: 318 RNLVQLLGYC---RRKGE--LLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALG 372
            N+V+LL  C   R   E  L LV++++ +  L  YL   PK  L       +++ +  G
Sbjct: 61  PNIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYLSKCPKPGLPPETIKDLMRQLLRG 119

Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLA 432
           + +LH      ++HRD+K  N+L+  +   ++ DFGLAR+Y    +   T VV TL Y A
Sbjct: 120 VDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLARIYSF--EMALTSVVVTLWYRA 174

Query: 433 PEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSE 471
           PE        T  D++S G    E+   RRP+ R G SE
Sbjct: 175 PEVLLQSSYATPVDMWSVGCIFAELF-RRRPLFR-GTSE 211

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 86.2 bits (213), Expect = 1e-18
 Identities = 61/215 (28%), Positives = 107/215 (49%), Gaps = 33/215 (15%)

Query: 266 KELLGTGGFGRVYRGTLPKS--QIEIAVKKIS-HESRQGMKEFVAEIVSIGRL-RHRNLV 321
           ++++G G FG+V +  + K   +++ A+K++  + S+   ++F  E+  + +L  H N++
Sbjct: 12  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71

Query: 322 QLLGYCRRKGELLLVYDYMPNGSLDKYLY--------------DQPKVTLNWIQRFRVIK 367
            LLG C  +G L L  +Y P+G+L  +L               +    TL+  Q      
Sbjct: 72  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131

Query: 368 GVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT 427
            VA G+ YL Q   +  IHRD+ A N+L+      ++ DFGL+R        Q  +V  T
Sbjct: 132 DVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR-------GQEVYVKKT 181

Query: 428 LG-----YLAPEHTRTGKATTSADVFSFGAFLLEV 457
           +G     ++A E       TT++DV+S+G  L E+
Sbjct: 182 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI 216

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 85.5 bits (211), Expect = 1e-18
 Identities = 66/212 (31%), Positives = 107/212 (50%), Gaps = 18/212 (8%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVA---EIVSIGRLRH 317
           +R  +LLG G FGRVY      +  E+A K++    ES +  KE  A   EI  +  L+H
Sbjct: 4   WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQH 63

Query: 318 RNLVQLLGYCRRKGE--LLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFY 375
             +VQ  G  R + E  L +  +YMP GS+   L     +T +  +++   + +  G+ Y
Sbjct: 64  ERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKY--TRQILEGMSY 121

Query: 376 LHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYD----HGTDPQTTHVVGTLGYL 431
           LH     +++HRD+K +N+L D   N +LGDFG ++        GT  ++  V GT  ++
Sbjct: 122 LHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRS--VTGTPYWM 176

Query: 432 APEHTRTGKATTSADVFSFGAFLLEVACGRRP 463
           +PE          ADV+S G  ++E+   + P
Sbjct: 177 SPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 85.6 bits (212), Expect = 2e-18
 Identities = 64/222 (28%), Positives = 113/222 (50%), Gaps = 18/222 (8%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQG-MKEFVAEIVSIGRLRH---R 318
           ++  EL+G G +G VYRG    +   +A+K I+ ++    + +   E+  + +LR     
Sbjct: 3   YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62

Query: 319 NLVQLLGYCRRKG-ELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFR--VIKGVALGLFY 375
           N+ +  G    KG  L ++ +Y   GS+   +   P       +++   +I+ V + L Y
Sbjct: 63  NITKYYG-SYLKGPRLWIIMEYAEGGSVRTLMKAGPIA-----EKYISVIIREVLVALKY 116

Query: 376 LHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEH 435
           +H+     VIHRD+KA+N+L+    N +L DFG+A L +  +  ++T  VGT  ++APE 
Sbjct: 117 IHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST-FVGTPYWMAPEV 172

Query: 436 TRTGKA-TTSADVFSFGAFLLEVACGRRPIQRQGPSENLILV 476
              GK   T AD++S G  + E+A G  P         ++L+
Sbjct: 173 ITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLI 214

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 85.3 bits (211), Expect = 2e-18
 Identities = 61/201 (30%), Positives = 103/201 (51%), Gaps = 13/201 (6%)

Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
           + LG G FG V+ G       ++A+K +  +     + F+AE   + +L+H  LV+L   
Sbjct: 12  KKLGAGQFGEVWMG-YYNGHTKVAIKSLK-QGSMSPEAFLAEANLMKQLQHPRLVRLYAV 69

Query: 327 CRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIH 386
             ++  + ++ +YM NGSL  +L     + L   +   +   +A G+ ++ +   +  IH
Sbjct: 70  VTQE-PIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER---KNYIH 125

Query: 387 RDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT---LGYLAPEHTRTGKATT 443
           RD++A+N+L+   L  ++ DFGLARL +   D + T   G    + + APE    G  T 
Sbjct: 126 RDLRAANILVSETLCCKIADFGLARLIE---DNEYTAREGAKFPIKWTAPEAINYGTFTI 182

Query: 444 SADVFSFGAFLLE-VACGRRP 463
            +DV+SFG  L E V  GR P
Sbjct: 183 KSDVWSFGILLTEIVTYGRIP 203

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 85.2 bits (211), Expect = 2e-18
 Identities = 85/284 (29%), Positives = 128/284 (45%), Gaps = 43/284 (15%)

Query: 267 ELLGTGGFGRVYRGTL---PKSQIEIAVKKISH-ESRQGMKEFVAEIVSIGRLRHRNLVQ 322
            ++G G FG VY GTL      +I  AVK ++     + +++F+ E + +    H N++ 
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 323 LLGYC-RRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKG-------VALGLF 374
           LLG C   +G  L+V  YM +G L  ++  +             +K        VA G+ 
Sbjct: 61  LLGICLPSEGSPLVVLPYMKHGDLRNFIRSE--------THNPTVKDLIGFGLQVAKGME 112

Query: 375 YLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVGTL--GYL 431
           YL     +  +HRD+ A N +LD     ++ DFGLAR +YD        H    L   ++
Sbjct: 113 YLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWM 169

Query: 432 APEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEA 491
           A E  +T K TT +DV+SFG  L E+     P            VD  FD      LL+ 
Sbjct: 170 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD--------VD-SFDITVY--LLQG 218

Query: 492 RDPNLGTEYVAEEL-ELVLKLGLLCSHSDPTARPSMRQVVQILE 534
           R   L  EY  + L E++L     C H  P  RP+  ++V  +E
Sbjct: 219 RRL-LQPEYCPDPLYEVMLS----CWHPKPEMRPTFSELVSRIE 257

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 85.6 bits (212), Expect = 2e-18
 Identities = 68/210 (32%), Positives = 115/210 (54%), Gaps = 24/210 (11%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEF-VAEIVSIGRLRHRNLV 321
           F++ E LG G +  VY+G    +   +A+K+I  ++ +G     + EI  +  L+H N+V
Sbjct: 2   FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIV 61

Query: 322 QLLGYCRRKGELLLVYDYMPNGSLDKYL---YDQPKVTLNWIQRF--RVIKGVALGLFYL 376
           +L      + +L+LV++YM +  L KY+     +  +  N ++ F  +++KG+A    + 
Sbjct: 62  RLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIA----FC 116

Query: 377 HQEWEQVVIHRDVKASNVLL--DGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE 434
           H   E  V+HRD+K  N+L+   GEL  +L DFGLAR +    +  +  VV TL Y AP+
Sbjct: 117 H---ENRVLHRDLKPQNLLINKRGEL--KLADFGLARAFGIPVNTFSNEVV-TLWYRAPD 170

Query: 435 ---HTRTGKATTSADVFSFGAFLLEVACGR 461
               +RT   +TS D++S G  + E+  GR
Sbjct: 171 VLLGSRT--YSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 85.6 bits (212), Expect = 2e-18
 Identities = 63/206 (30%), Positives = 93/206 (45%), Gaps = 14/206 (6%)

Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLG 325
           LG GGFG V    +  +    A KK+  +    R+G +  + E   + ++  R +V L  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 326 YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVI---KGVALGLFYLHQEWEQ 382
               K +L LV   M  G L  ++Y+   V        R I     +  GL +LHQ    
Sbjct: 61  AFETKDDLCLVMTLMNGGDLKYHIYN---VGEPGFPEARAIFYAAQIICGLEHLHQRR-- 115

Query: 383 VVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKAT 442
            +++RD+K  NVLLD   N R+ D GLA     G   +     GT GY+APE  +     
Sbjct: 116 -IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKGRAGTPGYMAPEVLQGEVYD 172

Query: 443 TSADVFSFGAFLLEVACGRRPIQRQG 468
            S D F+ G  L E+  GR P +++ 
Sbjct: 173 FSVDWFALGCTLYEMIAGRSPFRQRK 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173886 cd01951, lectin_L-type, legume lectins

 Score = 84.0 bits (208), Expect = 2e-18
 Identities = 47/176 (26%), Positives = 67/176 (38%), Gaps = 26/176 (14%)

Query: 19  SFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGLFNDTNLGNETNHVFAVE 78
            F+TTF F  L    +    GIAFV+ +     GA      G       G    +  AVE
Sbjct: 55  DFTTTFKFY-LGTKGTNGADGIAFVLQNDP--AGALGGGGGGG-GLGYGGI--GNSVAVE 108

Query: 79  LDTIKSHGFLDINDNHVGIDIN--SLKSESSAPAGYY---------------VEYDGLEK 121
            DT K+    D N NH+ ID+N     +  +   G                 + YD    
Sbjct: 109 FDTYKNDDNNDPNGNHISIDVNGNGNNTALATSLGSASLPNGTGLGNEHTVRITYDPTTN 168

Query: 122 RTNVTLAPINIPRPRSLNTMSLSRDLSSVLNDAMYVGFSSSTGSVLASHYILGWSF 177
              V L   +     +   +++  DL  +     Y GF++STG +   H IL WSF
Sbjct: 169 TLTVYLDNGSTL---TSLDITIPVDLIQLGPTKAYFGFTASTGGLTNLHDILNWSF 221

The L-type (legume-type) lectins are a highly diverse family of carbohydrate binding proteins that generally display no enzymatic activity toward the sugars they bind. This family includes arcelin, concanavalinA, the lectin-like receptor kinases, the ERGIC-53/VIP36/EMP46 type1 transmembrane proteins, and an alpha-amylase inhibitor. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat six-stranded beta-sheet referred to as the "back face". This domain homodimerizes so that adjacent back sheets form a contiguous 12-stranded sheet and homotetramers occur by a back-to-back association of these homodimers. Though L-type lectins exhibit both sequence and structural similarity to one another, their carbohydrate binding specificities differ widely. Length = 223

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 85.6 bits (212), Expect = 2e-18
 Identities = 72/277 (25%), Positives = 122/277 (44%), Gaps = 18/277 (6%)

Query: 261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQG-MKEFVAEIVSIGRLRHRN 319
           +   E   LG G  G V +  L  + +  A+K I+ +      K+ + E+      +   
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60

Query: 320 LVQLLGYC--RRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRF---RVIKGVALGLF 374
           +V+  G         + +  +Y   GSLD  +Y + K     I      ++ + V  GL 
Sbjct: 61  IVKYYGAFLDESSSSIGIAMEYCEGGSLDS-IYKKVKKRGGRIGEKVLGKIAESVLKGLS 119

Query: 375 YLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE 434
           YLH    + +IHRD+K SN+LL  +   +L DFG++       +       GT  Y+APE
Sbjct: 120 YLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVS---GELVNSLAGTFTGTSFYMAPE 173

Query: 435 HTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDP 494
             +    + ++DV+S G  LLEVA  R P   +G    L  ++ +    N        +P
Sbjct: 174 RIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGE-PPLGPIELLSYIVNMPNPELKDEP 232

Query: 495 NLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ 531
             G ++ +EE +  +K    C   DPT RP+   +++
Sbjct: 233 GNGIKW-SEEFKDFIK---QCLEKDPTRRPTPWDMLE 265

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 85.5 bits (211), Expect = 2e-18
 Identities = 74/271 (27%), Positives = 126/271 (46%), Gaps = 26/271 (9%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKIS-HESRQGMKEFVAEIVSIGRLRHRNLV 321
           F + E +G G FG VY+G   +++  +A+K I   E+   +++   EI  + +     + 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65

Query: 322 QLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
           +  G   +  +L ++ +Y+  GS    L   P   L       +++ +  GL YLH E +
Sbjct: 66  RYYGSYLKGTKLWIIMEYLGGGSALDLLKPGP---LEETYIATILREILKGLDYLHSERK 122

Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLA-RLYDHGTDPQTTHVVGTLGYLAPEHTRTGK 440
              IHRD+KA+NVLL  + + +L DFG+A +L D  T  +    VGT  ++APE  +   
Sbjct: 123 ---IHRDIKAANVLLSEQGDVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPEVIKQSA 177

Query: 441 ATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEY 500
               AD++S G   +E+A G  P     P   L L+             +   P L  +Y
Sbjct: 178 YDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIP------------KNSPPTLEGQY 225

Query: 501 VAEELELVLKLGLLCSHSDPTARPSMRQVVQ 531
                E V      C + DP  RP+ +++++
Sbjct: 226 SKPFKEFVEA----CLNKDPRFRPTAKELLK 252

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 84.9 bits (210), Expect = 2e-18
 Identities = 81/286 (28%), Positives = 120/286 (41%), Gaps = 38/286 (13%)

Query: 268 LLGTGGFGRVYRGTLP------KSQIEIAVKKISHESR-QGMKEFVAEIVSIGRLRHRNL 320
            LG+G FG VY GT           I +AVK +   +  Q  KEF+ E   +    H N+
Sbjct: 2   FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNI 61

Query: 321 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVT-----LNWIQRFRVIKGVALGLFY 375
           V+LLG C       ++ + M  G L  YL D          L   +   +   VA G  Y
Sbjct: 62  VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVY 121

Query: 376 LHQEWEQVVIHRDVKASNVLLDGELNGR-----LGDFGLAR-LYDHGTDPQTTHVVGTLG 429
           L Q      IHRD+ A N L+  +         +GDFGLAR +Y      +    +  + 
Sbjct: 122 LEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR 178

Query: 430 YLAPEHTRTGKATTSADVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFWNRGEL 488
           ++APE    GK TT +DV+SFG  + E+   G++P       E       V      G  
Sbjct: 179 WMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE-------VLQHVTAGGR 231

Query: 489 LEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILE 534
           L+   P    + + +       L   C   DP+ RP+  ++ +IL+
Sbjct: 232 LQK--PENCPDKIYQ-------LMTNCWAQDPSERPTFDRIQEILQ 268

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 85.8 bits (212), Expect = 3e-18
 Identities = 80/305 (26%), Positives = 146/305 (47%), Gaps = 42/305 (13%)

Query: 269 LGTGGFGRVYRG-------TLPKSQIEIAVKKISHE-SRQGMKEFVAEIVSIGRL-RHRN 319
           LG G FG+V R        + P   + +AVK +    + + + + ++E+  +  + +H+N
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYL-----------YDQPKVT---LNWIQRFRV 365
           ++ LLG C ++G L ++ +Y   G+L ++L           +D  KV    L++      
Sbjct: 80  IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139

Query: 366 IKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHV 424
              VA G+ YL     +  IHRD+ A NVL+  +   ++ DFGLAR ++D     +T++ 
Sbjct: 140 AYQVARGMEYLES---RRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196

Query: 425 VGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWN 484
              + ++APE       T  +DV+SFG  + E+          G     I V+ +F    
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEI------FTLGGSPYPGIPVEELFKLLR 250

Query: 485 RGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERDVALPAISA 544
            G  ++ +  N        EL ++++    C H+ PT RP+ +Q+V+ L++ +A  +   
Sbjct: 251 EGHRMD-KPSN-----CTHELYMLMR---ECWHAVPTQRPTFKQLVEALDKVLAAVSEEY 301

Query: 545 LRLST 549
           L LS 
Sbjct: 302 LDLSM 306

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 83.9 bits (207), Expect = 6e-18
 Identities = 66/212 (31%), Positives = 106/212 (50%), Gaps = 18/212 (8%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVA---EIVSIGRLRH 317
           +R  +LLG G FGRVY      +  E+AVK++    ES +  KE  A   EI  +  L H
Sbjct: 4   WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLH 63

Query: 318 RNLVQLLGYCRRKGE--LLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFY 375
             +VQ  G  R   E  L +  ++MP GS+   L     +T N  +++   + +  G+ Y
Sbjct: 64  ERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYT--RQILEGVSY 121

Query: 376 LHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYD----HGTDPQTTHVVGTLGYL 431
           LH     +++HRD+K +N+L D   N +LGDFG ++        GT  ++  V GT  ++
Sbjct: 122 LHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS--VTGTPYWM 176

Query: 432 APEHTRTGKATTSADVFSFGAFLLEVACGRRP 463
           +PE          AD++S G  ++E+   + P
Sbjct: 177 SPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 84.7 bits (209), Expect = 6e-18
 Identities = 82/297 (27%), Positives = 140/297 (47%), Gaps = 46/297 (15%)

Query: 269 LGTGGFGRVYRGTL-------PKSQIEIAVKKISHE-SRQGMKEFVAEIVSIGRL-RHRN 319
           LG G FG+V            PK  + +AVK +  + + + + + V+E+  +  + +H+N
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYL-----------YDQPKVT---LNWIQRFRV 365
           ++ LLG C + G L ++ +Y   G+L +YL           YD  +V    + +      
Sbjct: 83  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142

Query: 366 IKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD--PQTTH 423
              VA G+ YL     Q  IHRD+ A NVL+      ++ DFGLAR   +  D   +TT+
Sbjct: 143 TYQVARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDV-NNIDYYKKTTN 198

Query: 424 VVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDF 482
               + ++APE       T  +DV+SFG  + E+   G  P     P    I V+ +F  
Sbjct: 199 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY----PG---IPVEELFKL 251

Query: 483 WNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERDVAL 539
              G  ++ +  N        EL ++++    C H+ P+ RP+ +Q+V+ L+R + L
Sbjct: 252 LKEGHRMD-KPAN-----CTNELYMMMR---DCWHAIPSHRPTFKQLVEDLDRILTL 299

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 83.1 bits (205), Expect = 7e-18
 Identities = 57/205 (27%), Positives = 99/205 (48%), Gaps = 13/205 (6%)

Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVA---EIVSIGRLRHRNLVQL 323
           + +G G FG++Y            +K+I    +  +KE  A   E++ + +++H N+V  
Sbjct: 6   KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLT-KMPVKEKEASKKEVILLAKMKHPNIVTF 64

Query: 324 LGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQV 383
               +  G L +V +Y   G L K +  Q  V  +  Q       ++LGL ++H   ++ 
Sbjct: 65  FASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIH---DRK 121

Query: 384 VIHRDVKASNVLLDGELNG---RLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGK 440
           ++HRD+K+ N+ L    NG   +LGDFG+AR  +   +   T  VGT  YL+PE  +   
Sbjct: 122 ILHRDIKSQNIFLSK--NGMVAKLGDFGIARQLNDSMELAYT-CVGTPYYLSPEICQNRP 178

Query: 441 ATTSADVFSFGAFLLEVACGRRPIQ 465
                D++S G  L E+   + P +
Sbjct: 179 YNNKTDIWSLGCVLYELCTLKHPFE 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 83.6 bits (206), Expect = 7e-18
 Identities = 60/211 (28%), Positives = 104/211 (49%), Gaps = 27/211 (12%)

Query: 267 ELLGTGGFGRVYRGTLPKSQIEI--AVKKI-SHESRQGMKEFVAEIVSIGRL-RHRNLVQ 322
           +++G G FG+V +  + K  + +  A+K++  + S+   ++F  E+  + +L  H N++ 
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60

Query: 323 LLGYCRRKGELLLVYDYMPNGSL------DKYLYDQPKV--------TLNWIQRFRVIKG 368
           LLG C  +G L L  +Y P+G+L       + L   P          TL+  Q       
Sbjct: 61  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120

Query: 369 VALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTL 428
           VA G+ YL    ++  IHRD+ A N+L+      ++ DFGL+R    G +      +G L
Sbjct: 121 VARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVKKTMGRL 173

Query: 429 G--YLAPEHTRTGKATTSADVFSFGAFLLEV 457
              ++A E       TT++DV+S+G  L E+
Sbjct: 174 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEI 204

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 82.9 bits (205), Expect = 1e-17
 Identities = 72/295 (24%), Positives = 127/295 (43%), Gaps = 50/295 (16%)

Query: 260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKI------SHESRQGMKEFVAEIVSIG 313
              F+ ++ +G G F  VY+         +A+KK+        ++RQ   + + EI  + 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQ---DCLKEIDLLK 57

Query: 314 RLRHRNLVQLLGYCRRKGELLLVYDYMPNGSL---------DKYLYDQPKVTLNWIQRFR 364
           +L H N+++ L       EL +V +    G L          K L  +  +   ++Q   
Sbjct: 58  QLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQ--- 114

Query: 365 VIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTT-- 422
               +   L ++H    + ++HRD+K +NV +      +LGD GL R +      +TT  
Sbjct: 115 ----LCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS----KTTAA 163

Query: 423 -HVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFD 481
             +VGT  Y++PE          +D++S G  L E+A  + P    G   NL      + 
Sbjct: 164 HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF--YGDKMNL------YS 215

Query: 482 FWNRGELLEARDPNLGTEYVAEEL-ELVLKLGLLCSHSDPTARPSMRQVVQILER 535
              + E  +   P L  ++ +EEL +LV      C + DP  RP +  V+Q+ + 
Sbjct: 216 LCKKIEKCDY--PPLPADHYSEELRDLV----SRCINPDPEKRPDISYVLQVAKE 264

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 83.3 bits (206), Expect = 1e-17
 Identities = 62/205 (30%), Positives = 98/205 (47%), Gaps = 24/205 (11%)

Query: 267 ELLGTGGFGRV----YRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQ 322
           + LG G FG V    Y      +   +AVKK+ H + + +++F  EI  +  L+H N+V+
Sbjct: 10  QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69

Query: 323 LLGYCRRKG--ELLLVYDYMPNGSLDKYL------YDQPKVTLNWIQRFRVIKGVALGLF 374
             G C   G   L LV +Y+P GSL  YL       D  K+ L   Q       +  G+ 
Sbjct: 70  YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQ-------ICKGME 122

Query: 375 YLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT--LGYLA 432
           YL     +  +HRD+   N+L++ E   ++GDFGL ++     +       G   + + A
Sbjct: 123 YLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYA 179

Query: 433 PEHTRTGKATTSADVFSFGAFLLEV 457
           PE     K + ++DV+SFG  L E+
Sbjct: 180 PESLTESKFSVASDVWSFGVVLYEL 204

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 83.1 bits (205), Expect = 2e-17
 Identities = 64/212 (30%), Positives = 101/212 (47%), Gaps = 27/212 (12%)

Query: 266 KELLGTGGFGRVYRGTLPKS--QIEIAVKKI-SHESRQGMKEFVAEIVSIGRL-RHRNLV 321
           ++++G G FG+V R  + K   ++  A+K +    S    ++F  E+  + +L  H N++
Sbjct: 7   EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66

Query: 322 QLLGYCRRKGELLLVYDYMPNGSL------DKYLYDQPKV--------TLNWIQRFRVIK 367
            LLG C  +G L +  +Y P G+L       + L   P          TL   Q  +   
Sbjct: 67  NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126

Query: 368 GVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT 427
            VA G+ YL    E+  IHRD+ A NVL+   L  ++ DFGL+R    G +      +G 
Sbjct: 127 DVATGMQYLS---EKQFIHRDLAARNVLVGENLASKIADFGLSR----GEEVYVKKTMGR 179

Query: 428 LG--YLAPEHTRTGKATTSADVFSFGAFLLEV 457
           L   ++A E       TT +DV+SFG  L E+
Sbjct: 180 LPVRWMAIESLNYSVYTTKSDVWSFGVLLWEI 211

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 82.5 bits (204), Expect = 2e-17
 Identities = 64/203 (31%), Positives = 107/203 (52%), Gaps = 18/203 (8%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKI--SHESRQGMKEFVAEIVSIGRLRHRNL 320
           F++ E +G G +G VY+     +   +A+KKI    E+       + EI  +  L H N+
Sbjct: 2   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61

Query: 321 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPK--VTLNWIQR--FRVIKGVALGLFYL 376
           V+LL     + +L LV++++ +  L K++   P   + L  I+   F++++G+A    + 
Sbjct: 62  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLA----FC 116

Query: 377 HQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQT-THVVGTLGYLAPEH 435
           H      V+HRD+K  N+L++ E   +L DFGLAR +  G   +T TH V TL Y APE 
Sbjct: 117 HS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEI 171

Query: 436 TRTGK-ATTSADVFSFGAFLLEV 457
               K  +T+ D++S G    E+
Sbjct: 172 LLGCKYYSTAVDIWSLGCIFAEM 194

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 82.8 bits (205), Expect = 2e-17
 Identities = 66/220 (30%), Positives = 100/220 (45%), Gaps = 39/220 (17%)

Query: 265 EKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQ-GMKEFVAEIVSIGRLRH-RNLVQ 322
           +   +G G FG V +     S   +AVK+I     +   K  + ++  + R      +V+
Sbjct: 8   DLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVK 67

Query: 323 LLGYCRRKGELLLVYDYMPNGSLD---KYLYDQPKVTLNWIQRFRVIKGVAL----GLFY 375
             G   R+G+  +  + M + SLD   KY+Y+  K  +       ++  +A+     L Y
Sbjct: 68  FYGALFREGDCWICMELM-DISLDKFYKYVYEVLKSVIPE----EILGKIAVATVKALNY 122

Query: 376 LHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGL--------ARLYDHGTDPQTTHVVGT 427
           L +E +  +IHRDVK SN+LLD   N +L DFG+        A+  D G  P        
Sbjct: 123 LKEELK--IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRP-------- 172

Query: 428 LGYLAPE----HTRTGKATTSADVFSFGAFLLEVACGRRP 463
             Y+APE      R G    S DV+S G  L EVA G+ P
Sbjct: 173 --YMAPERIDPSARDGYDVRS-DVWSLGITLYEVATGKFP 209

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 82.4 bits (203), Expect = 2e-17
 Identities = 64/209 (30%), Positives = 99/209 (47%), Gaps = 10/209 (4%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRN 319
           FR+  +LG GGFG V    +  +    A KK+  +    R+G    + E   + ++  R 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61

Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQE 379
           +V L      K  L LV   M  G L  ++Y   +      +       +  GL  LHQE
Sbjct: 62  VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE 121

Query: 380 WEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTH-VVGTLGYLAPEHTRT 438
               +++RD+K  N+LLD   + R+ D GLA    H  + QT    VGT+GY+APE  + 
Sbjct: 122 ---RIVYRDLKPENILLDDHGHIRISDLGLAV---HVPEGQTIKGRVGTVGYMAPEVVKN 175

Query: 439 GKATTSADVFSFGAFLLEVACGRRPIQRQ 467
            + T S D ++ G  L E+  G+ P Q++
Sbjct: 176 ERYTFSPDWWALGCLLYEMIAGQSPFQQR 204

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 82.8 bits (204), Expect = 3e-17
 Identities = 81/296 (27%), Positives = 141/296 (47%), Gaps = 44/296 (14%)

Query: 269 LGTGGFGRVYRGTL-------PKSQIEIAVKKI-SHESRQGMKEFVAEIVSIGRL-RHRN 319
           LG G FG+V            P    ++AVK + S  + + + + ++E+  +  + +H+N
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQ--------------PKVTLNWIQRFRV 365
           ++ LLG C + G L ++ +Y   G+L +YL  +              P+  L++      
Sbjct: 86  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145

Query: 366 IKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH-GTDPQTTHV 424
              VA G+ YL     +  IHRD+ A NVL+  +   ++ DFGLAR   H     +TT+ 
Sbjct: 146 AYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202

Query: 425 VGTLGYLAPEHTRTGKATTSADVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFW 483
              + ++APE       T  +DV+SFG  L E+   G  P     P    + V+ +F   
Sbjct: 203 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY----PG---VPVEELFKLL 255

Query: 484 NRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERDVAL 539
             G  ++   P+  T     EL ++++    C H+ P+ RP+ +Q+V+ L+R +AL
Sbjct: 256 KEGHRMDK--PSNCT----NELYMMMR---DCWHAVPSQRPTFKQLVEDLDRILAL 302

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 81.9 bits (203), Expect = 3e-17
 Identities = 51/173 (29%), Positives = 90/173 (52%), Gaps = 17/173 (9%)

Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQG--MKEFVAEIVSIGRLRHRNLVQLLGY 326
           +G G  G V++    ++   +A+KK++    +G    + + EI ++   +H  +V+LL  
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67

Query: 327 CRRKGELLLVYDYMPNGSLDKYLYDQPK-VTLNWIQRF--RVIKGVALGLFYLHQEWEQV 383
                  +LV +YMP   L + L D+ + +    ++ +   ++KGVA    Y+H      
Sbjct: 68  FPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEAQVKSYMRMLLKGVA----YMHAN---G 119

Query: 384 VIHRDVKASNVLL--DGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE 434
           ++HRD+K +N+L+  DG L  ++ DFGLARL+        +H V T  Y APE
Sbjct: 120 IMHRDLKPANLLISADGVL--KIADFGLARLFSEEEPRLYSHQVATRWYRAPE 170

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 81.7 bits (202), Expect = 3e-17
 Identities = 84/297 (28%), Positives = 131/297 (44%), Gaps = 43/297 (14%)

Query: 256 LYIATKGFREKELLGTGGFGRVYRGTL----PKSQIEIAVKKIS-HESRQGMKEFVAEIV 310
           + I+       +LL  G FGR++ G L    P  + E+ VK +  H S   +   + E  
Sbjct: 1   IAISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESC 60

Query: 311 SIGRLRHRNLVQLLGYCRRKGELLLV-YDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGV 369
            +  L H+N++ +L  C   GE   V Y YM  G+L  +L        N  Q     + V
Sbjct: 61  LLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLV 120

Query: 370 ------ALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTT 422
                 A G+ YLH+   + VIH+D+ A N ++D EL  ++ D  L+R L+     P   
Sbjct: 121 HMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDNALSRDLF-----PMDY 172

Query: 423 HVVGT-----LGYLAPEHTRTGKATTSADVFSFGAFLLE-VACGRRPIQRQGPSENLILV 476
           H +G      + ++A E     + ++++DV+SFG  L E +  G+ P     P E     
Sbjct: 173 HCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE----- 227

Query: 477 DWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQIL 533
             +  +   G  L A+  N       +EL  V+     C   DP  RPS  Q+VQ L
Sbjct: 228 --MAAYLKDGYRL-AQPIN-----CPDELFAVM---ACCWALDPEERPSFSQLVQCL 273

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 82.8 bits (204), Expect = 3e-17
 Identities = 81/293 (27%), Positives = 136/293 (46%), Gaps = 46/293 (15%)

Query: 269 LGTGGFGRVYRGTL-------PKSQIEIAVKKISHE-SRQGMKEFVAEIVSIGRL-RHRN 319
           LG G FG+V            P   + +AVK +  + + + + + V+E+  +  + +H+N
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYL-----------YDQ---PKVTLNWIQRFRV 365
           ++ LLG C + G L ++ +Y   G+L +YL           +D    P+  L +      
Sbjct: 80  IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139

Query: 366 IKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD--PQTTH 423
              VA G+ YL     Q  IHRD+ A NVL+  +   ++ DFGLAR   H  D   +TT+
Sbjct: 140 AYQVARGMEYLAS---QKCIHRDLAARNVLVTEDNVMKIADFGLARDV-HNIDYYKKTTN 195

Query: 424 VVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDF 482
               + ++APE       T  +DV+SFG  L E+   G  P     P    I V+ +F  
Sbjct: 196 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY----PG---IPVEELFKL 248

Query: 483 WNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER 535
              G  ++             EL ++++    C H+ P+ RP+ +Q+V+ L+R
Sbjct: 249 LKEGHRMDK------PANCTHELYMIMR---ECWHAVPSQRPTFKQLVEDLDR 292

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 81.0 bits (200), Expect = 4e-17
 Identities = 61/210 (29%), Positives = 107/210 (50%), Gaps = 19/210 (9%)

Query: 268 LLGTGGFGRVYRGTLPKSQIEIAVKKI--------SHESRQGMKEFVA-EIVSIGRLRHR 318
           L+G+G FG VY G    S   +AVK++        S + ++ M + +A EI  +  L+H 
Sbjct: 7   LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66

Query: 319 NLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQ 378
           N+VQ LG       L +  +Y+P GS+   L +        ++ F  ++ +  GL YLH 
Sbjct: 67  NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNF--VRQILKGLNYLHN 124

Query: 379 EWEQVVIHRDVKASNVLLDGELNGRLGDFGL-----ARLYDHGTDPQTTHVVGTLGYLAP 433
              + +IHRD+K +N+L+D +   ++ DFG+     A      T+     + G++ ++AP
Sbjct: 125 ---RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181

Query: 434 EHTRTGKATTSADVFSFGAFLLEVACGRRP 463
           E  +    T  AD++S G  ++E+  G+ P
Sbjct: 182 EVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 81.2 bits (201), Expect = 5e-17
 Identities = 69/209 (33%), Positives = 108/209 (51%), Gaps = 25/209 (11%)

Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVA-----EIVSIGRLRHRNLV 321
           E +G G +G VY+     +   +A+KKI  E+     E V      EI  +  L H N+V
Sbjct: 5   EKIGEGTYGVVYKARDKLTGEIVALKKIRLETE---DEGVPSTAIREISLLKELNHPNIV 61

Query: 322 QLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLN--WIQRF--RVIKGVALGLFYLH 377
           +LL     + +L LV++++ +  L KY+   P   L+   I+ +  ++++G+A    Y H
Sbjct: 62  RLLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIA----YCH 116

Query: 378 QEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQT-THVVGTLGYLAPEHT 436
                 V+HRD+K  N+L+D E   +L DFGLAR +  G   +T TH V TL Y APE  
Sbjct: 117 S---HRVLHRDLKPQNLLIDREGALKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEIL 171

Query: 437 RTGKA-TTSADVFSFGAFLLEVACGRRPI 464
              +  +T  D++S G    E+   RRP+
Sbjct: 172 LGSRQYSTPVDIWSIGCIFAEM-VNRRPL 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 81.4 bits (201), Expect = 5e-17
 Identities = 63/212 (29%), Positives = 98/212 (46%), Gaps = 23/212 (10%)

Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLG 325
           LG GGFG V    +  +    A KK++ +    R+G +  + E   + ++  R +V L  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 326 YCRRKGELLLVYDYMPNGSLDKYLY---------DQPKVTLNWIQRFRVIKGVALGLFYL 376
             + K +L LV   M  G L  ++Y          +P+      Q       +  GL +L
Sbjct: 61  AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQ-------IISGLEHL 113

Query: 377 HQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHT 436
           HQ   + +I+RD+K  NVLLD + N R+ D GLA     G   +T    GT G++APE  
Sbjct: 114 HQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKGYAGTPGFMAPELL 169

Query: 437 RTGKATTSADVFSFGAFLLEVACGRRPIQRQG 468
           +  +   S D F+ G  L E+   R P + +G
Sbjct: 170 QGEEYDFSVDYFALGVTLYEMIAARGPFRARG 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 81.3 bits (201), Expect = 7e-17
 Identities = 58/182 (31%), Positives = 93/182 (51%), Gaps = 24/182 (13%)

Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVA--EIVSIGRLRHRNLVQLLGY 326
           +G G FG V++    K++  +A+KK+  E+ +      A  EI  +  L+H N+V L+  
Sbjct: 20  IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 79

Query: 327 CRR--------KGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQ 378
           CR         KG   LV+++  +  L   L     V     +  +V+K +  GL+Y+H+
Sbjct: 80  CRTKATPYNRYKGSFYLVFEFCEH-DLAGLL-SNKNVKFTLSEIKKVMKMLLNGLYYIHR 137

Query: 379 EWEQVVIHRDVKASNVLL--DGELNGRLGDFGLARLYDHGTDPQ----TTHVVGTLGYLA 432
                ++HRD+KA+N+L+  DG L  +L DFGLAR +    + +    T  VV TL Y  
Sbjct: 138 ---NKILHRDMKAANILITKDGIL--KLADFGLARAFSLSKNSKPNRYTNRVV-TLWYRP 191

Query: 433 PE 434
           PE
Sbjct: 192 PE 193

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 80.5 bits (199), Expect = 8e-17
 Identities = 56/208 (26%), Positives = 102/208 (49%), Gaps = 16/208 (7%)

Query: 266 KELLGTGGFGRVYRGT--LPKS-QIEIAVKKISHESRQGMKE-FVAEIVSIGRLRHRNLV 321
              +G G FG VY+G    P++ +I +AVK   + +   ++E F+ E   + +  H ++V
Sbjct: 11  GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70

Query: 322 QLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIK---GVALGLFYLHQ 378
           +L+G       + +V +  P G L  YL    +V    +    +I     ++  L YL  
Sbjct: 71  KLIGVITEN-PVWIVMELAPLGELRSYL----QVNKYSLDLASLILYSYQLSTALAYLES 125

Query: 379 EWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRT 438
              +  +HRD+ A NVL+      +LGDFGL+R  +  +  + +     + ++APE    
Sbjct: 126 ---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINF 182

Query: 439 GKATTSADVFSFGAFLLEV-ACGRRPIQ 465
            + T+++DV+ FG  + E+   G +P Q
Sbjct: 183 RRFTSASDVWMFGVCMWEILMLGVKPFQ 210

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 80.8 bits (199), Expect = 9e-17
 Identities = 79/305 (25%), Positives = 132/305 (43%), Gaps = 52/305 (17%)

Query: 263 FREKELLGTGGFGRV----------YRGTLPKSQ----IEIAVKKI-SHESRQGMKEFVA 307
            R KE LG G FG V          + G          + +AVK + +  ++    +F+ 
Sbjct: 7   LRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLK 66

Query: 308 EIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQ------------PKV 355
           EI  + RL++ N+++LLG C     L ++ +YM NG L+++L  +            P V
Sbjct: 67  EIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSV 126

Query: 356 TLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYD 414
           ++  +    V   +A G+ YL        +HRD+   N L+      ++ DFG++R LY 
Sbjct: 127 SIANLLYMAV--QIASGMKYLAS---LNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYS 181

Query: 415 HGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEV--ACGRRPIQRQGPSEN 472
                     V  + ++A E    GK TT++DV++FG  L E+   C  +P        +
Sbjct: 182 GDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPY-------S 234

Query: 473 LILVDWVFDFWNRGELLEARDPNLGTEYVAEELEL----VLKLGLLCSHSDPTARPSMRQ 528
           L+  + V +  N GE       N G +    +  L    V KL + C   D   RP+  +
Sbjct: 235 LLSDEQVIE--NTGEFFR----NQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNK 288

Query: 529 VVQIL 533
           +   L
Sbjct: 289 IHHFL 293

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 80.9 bits (199), Expect = 1e-16
 Identities = 62/207 (29%), Positives = 111/207 (53%), Gaps = 23/207 (11%)

Query: 263 FREKELLGTGGFGRVYRGT-LPKSQ---IEIAVKKISHES-RQGMKEFVAEIVSIGRLRH 317
            +  ++LG+G FG VY+G  +P+ +   I +A+K ++  +  +   EF+ E + +  + H
Sbjct: 9   LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDH 68

Query: 318 RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQ-----PKVTLNWIQRFRVIKGVALG 372
            +LV+LLG C     + LV   MP+G L  Y+++       ++ LNW  +      +A G
Sbjct: 69  PHLVRLLGVCLSP-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ------IAKG 121

Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTL--GY 430
           + YL    E+ ++HRD+ A NVL+    + ++ DFGLARL + G + +     G +   +
Sbjct: 122 MMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLE-GDEKEYNADGGKMPIKW 177

Query: 431 LAPEHTRTGKATTSADVFSFGAFLLEV 457
           +A E     K T  +DV+S+G  + E+
Sbjct: 178 MALECIHYRKFTHQSDVWSYGVTIWEL 204

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 81.0 bits (201), Expect = 1e-16
 Identities = 62/212 (29%), Positives = 103/212 (48%), Gaps = 23/212 (10%)

Query: 266 KELLGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGRLRHRNLVQL 323
            + +G+G +G V      ++  ++A+KKIS+  +     K  + EI  +  LRH N++ L
Sbjct: 5   LKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGL 64

Query: 324 L-----GYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRF--RVIKGVALGLFYL 376
           L            ++ +V + M    L K +     +T + IQ F  ++++G    L YL
Sbjct: 65  LDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRG----LKYL 119

Query: 377 HQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH---GTDPQTTHVVGTLGYLAP 433
           H      VIHRD+K SN+L++   + ++ DFGLAR  D         T +VV T  Y AP
Sbjct: 120 H---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVV-TRWYRAP 175

Query: 434 EHTRTGKA-TTSADVFSFGAFLLEVACGRRPI 464
           E   +    T + D++S G    E+   R+P+
Sbjct: 176 ELLLSSSRYTKAIDIWSVGCIFAELL-TRKPL 206

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 80.0 bits (197), Expect = 1e-16
 Identities = 60/218 (27%), Positives = 103/218 (47%), Gaps = 29/218 (13%)

Query: 269 LGTGGFGRVY----RGTLPKS-QIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQL 323
           LG G FG+V+       LP+  ++ +AVK +   S    ++F  E   +  L+H+++V+ 
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 324 LGYCRRKGELLLVYDYMPNGSLDKYLY-------------DQPKVTLNWIQRFRVIKGVA 370
            G C     LL+V++YM +G L+++L              D     L   Q   +   +A
Sbjct: 73  YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132

Query: 371 LGLFY---LHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVG 426
            G+ Y   LH       +HRD+   N L+   L  ++GDFG++R +Y           + 
Sbjct: 133 SGMVYLASLH------FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 186

Query: 427 TLGYLAPEHTRTGKATTSADVFSFGAFLLEV-ACGRRP 463
            + ++ PE     K TT +D++SFG  L E+   G++P
Sbjct: 187 PIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 79.8 bits (197), Expect = 2e-16
 Identities = 68/216 (31%), Positives = 113/216 (52%), Gaps = 17/216 (7%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR-QGMKEF-VAEIVSIGRLRHRNL 320
           + + E +G G +G VY+G   K+   +A+KKI  ES  +G+    + EI  +  L+H N+
Sbjct: 2   YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNI 61

Query: 321 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRV---IKGVALGLFYLH 377
           V L     ++  L L+++++ +  L KYL   PK    ++    V   +  +  G+ + H
Sbjct: 62  VCLQDVLMQESRLYLIFEFL-SMDLKKYLDSLPKG--QYMDAELVKSYLYQILQGILFCH 118

Query: 378 QEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQT-THVVGTLGYLAPEHT 436
               + V+HRD+K  N+L+D +   +L DFGLAR +  G   +  TH V TL Y APE  
Sbjct: 119 S---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAF--GIPVRVYTHEVVTLWYRAPEVL 173

Query: 437 RTG-KATTSADVFSFGAFLLEVACGRRPIQRQGPSE 471
               + +T  D++S G    E+A  ++P+   G SE
Sbjct: 174 LGSPRYSTPVDIWSIGTIFAEMAT-KKPL-FHGDSE 207

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 79.3 bits (195), Expect = 2e-16
 Identities = 57/192 (29%), Positives = 96/192 (50%), Gaps = 11/192 (5%)

Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCR 328
           LG G FG V+ G    S  ++AVK +   +   ++ F+ E   +  L+H  LV+L     
Sbjct: 14  LGAGQFGEVWMGYYNNST-KVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVT 71

Query: 329 RKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRD 388
           ++  + ++ +YM  GSL  +L       +   +       +A G+ Y+ +   +  IHRD
Sbjct: 72  KEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRD 128

Query: 389 VKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT---LGYLAPEHTRTGKATTSA 445
           ++A+NVL+   L  ++ DFGLAR+ +   D + T   G    + + APE    G  T  +
Sbjct: 129 LRAANVLVSESLMCKIADFGLARVIE---DNEYTAREGAKFPIKWTAPEAINFGSFTIKS 185

Query: 446 DVFSFGAFLLEV 457
           DV+SFG  L E+
Sbjct: 186 DVWSFGILLYEI 197

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 80.2 bits (198), Expect = 2e-16
 Identities = 68/215 (31%), Positives = 107/215 (49%), Gaps = 31/215 (14%)

Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHES-RQGMK-EFVAEIVSIGRLRHRNLVQL--- 323
           +G G +G+VY+     +   +A+KK+  ++ ++G     + EI  + +L HRN+V L   
Sbjct: 15  IGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEI 74

Query: 324 -------LGYCRRKGELLLVYDYMPN---GSLDKYLYDQPKVTLNWIQRFRVIKGVALGL 373
                  L + + KG   LV++YM +   G L+  L     V  +       +K +  GL
Sbjct: 75  VTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGL-----VHFSEDHIKSFMKQLLEGL 129

Query: 374 FYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAP 433
            Y H+   +  +HRD+K SN+LL+ +   +L DFGLARLY+       T+ V TL Y  P
Sbjct: 130 NYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPP 186

Query: 434 E----HTRTGKATTSADVFSFGAFLLEVACGRRPI 464
           E      R G A    DV+S G  L E+   ++PI
Sbjct: 187 ELLLGEERYGPAI---DVWSCGCILGELFT-KKPI 217

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 79.8 bits (197), Expect = 2e-16
 Identities = 66/270 (24%), Positives = 122/270 (45%), Gaps = 26/270 (9%)

Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGM-KEFVAEIVSIGRLRHRNLVQLLGYC 327
           LG G  G V +     +   +A K +   ++  + K+ + E+  +   R   +V   G  
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72

Query: 328 RRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHR 387
             +  + +  ++M  GSLD+       + +  + +  +   V  GL YL+      ++HR
Sbjct: 73  LNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGK--IAVAVVEGLTYLYNVHR--IMHR 128

Query: 388 DVKASNVLLDGELNGRLGDFGLA-RLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSAD 446
           D+K SN+L++     +L DFG++  L +   D      VGT  Y++PE  + GK T  +D
Sbjct: 129 DIKPSNILVNSRGQIKLCDFGVSGELINSIADT----FVGTSTYMSPERIQGGKYTVKSD 184

Query: 447 VFSFGAFLLEVACGRRPIQRQGPSENLILVDW------VFDFWNRGELLEARDPNLGTEY 500
           V+S G  ++E+A G+ P      + + I  D       + D   +  +++   P L +  
Sbjct: 185 VWSLGISIIELALGKFPF-----AFSNIDDDGQDDPMGILDLLQQ--IVQEPPPRLPSSD 237

Query: 501 VAEELELVLKLGLLCSHSDPTARPSMRQVV 530
             E+L   +     C   DPT RP+ +Q+ 
Sbjct: 238 FPEDLRDFVD---ACLLKDPTERPTPQQLC 264

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 79.2 bits (195), Expect = 2e-16
 Identities = 64/219 (29%), Positives = 98/219 (44%), Gaps = 26/219 (11%)

Query: 268 LLGTGGFGRVYRGTLPKSQIEIAVKKI-----SHESRQGMKEFVAEIVSIGRLRHRNLVQ 322
           ++G G FGR        S  + A+K+I     S       KE V     + +++H N+V 
Sbjct: 7   VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVL----LAKMKHPNIVA 62

Query: 323 LLGYCRRKGELLLVYDYMPNGSLDKYLYDQ-----PKVT-LNWIQRFRVIKGVALGLFYL 376
                   G L +V +Y   G L + +  Q     P+ T L W  +      + LG+ ++
Sbjct: 63  FKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQ------MCLGVQHI 116

Query: 377 HQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHT 436
           H   E+ V+HRD+K+ N+ L      +LGDFG ARL         T+ VGT  Y+ PE  
Sbjct: 117 H---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTY-VGTPYYVPPEIW 172

Query: 437 RTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLIL 475
                   +D++S G  L E+   + P Q     +NLIL
Sbjct: 173 ENMPYNNKSDIWSLGCILYELCTLKHPFQ-ANSWKNLIL 210

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 79.7 bits (196), Expect = 2e-16
 Identities = 78/284 (27%), Positives = 133/284 (46%), Gaps = 37/284 (13%)

Query: 269 LGTGGFGRVYRGTLPK--SQIEIAVK--KISHESRQGMKEFVAEIVSIGRLRHRNLVQLL 324
           LG G FG V  G L +  S +++AVK  KI+  +R  M++F++E V +    H N+++L+
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 325 GYCRRKGEL------LLVYDYMPNGSLDKYLY-----DQPKVTLNWIQRFRVIKGVALGL 373
           G C +  E       +++  +M +G L  +L      D P   L      + +  +A G+
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCP-QYLPTQMLVKFMTDIASGM 125

Query: 374 FYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLA-RLYDHGTDPQTTHVVGTLGYLA 432
            YL     +  IHRD+ A N +L+  +N  + DFGL+ ++Y+     Q       + ++A
Sbjct: 126 EYLSS---KSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIA 182

Query: 433 PEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEA 491
            E       TT +DV+SFG  + E+A  G+ P      SE       ++D+  +G  L  
Sbjct: 183 IESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE-------IYDYLRQGNRL-- 233

Query: 492 RDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER 535
           + P        + L+ +  L   C   +P  RPS   +   LE+
Sbjct: 234 KQP-------PDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK 270

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 79.2 bits (195), Expect = 2e-16
 Identities = 67/219 (30%), Positives = 104/219 (47%), Gaps = 27/219 (12%)

Query: 260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKIS-HESRQGMKE-----FVAEIVSIG 313
           TKG    E+LG G +G VY G   + Q+ IAVK++    S     E        E+  + 
Sbjct: 3   TKG----EVLGKGAYGTVYCGLTNQGQL-IAVKQVELDTSNVLAAEKEYEKLQEEVDLLK 57

Query: 314 RLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLY---DQPKVTLNWIQRFRVIKGVA 370
            L+H N+VQ LG C     + +  +++P GS+   L      P+       + +++ GVA
Sbjct: 58  SLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTK-QILDGVA 116

Query: 371 LGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR----LYDHGTDPQTTHVV- 425
               YLH      V+HRD+K +NV+L      +L DFG AR    +  HGT       + 
Sbjct: 117 ----YLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMH 169

Query: 426 GTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPI 464
           GT  ++APE          +D++S G  + E+A G+ P+
Sbjct: 170 GTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPL 208

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 79.8 bits (197), Expect = 2e-16
 Identities = 58/204 (28%), Positives = 102/204 (50%), Gaps = 23/204 (11%)

Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKI--SHESRQGMKEFVAEIVSIGRLRHRNLVQLL 324
            L+G G +G V +    ++   +A+KK   S + +   K  + EI  + +LRH NLV L+
Sbjct: 7   GLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLI 66

Query: 325 GYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQR--FRVIKGVALGLFYLHQEWEQ 382
              RRK  L LV++++ +  LD        +  + +++  F++++G+     + H     
Sbjct: 67  EVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIE----FCHS---H 119

Query: 383 VVIHRDVKASNVLLDGELNG--RLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE----HT 436
            +IHRD+K  N+L+    +G  +L DFG AR      +  T + V T  Y APE     T
Sbjct: 120 NIIHRDIKPENILV--SQSGVVKLCDFGFARTLAAPGEVYTDY-VATRWYRAPELLVGDT 176

Query: 437 RTGKATTSADVFSFGAFLLEVACG 460
           + G+A    D+++ G  + E+  G
Sbjct: 177 KYGRAV---DIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 79.9 bits (197), Expect = 2e-16
 Identities = 66/225 (29%), Positives = 104/225 (46%), Gaps = 28/225 (12%)

Query: 245 DHGPHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKE 304
              P +  + DL       RE   +G G FG VY     ++   +A+KK+S+  +Q  ++
Sbjct: 10  KDDPEK-LFTDL-------RE---IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEK 58

Query: 305 F---VAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQ 361
           +   + E+  + +LRH N ++  G   R+    LV +Y    + D  + +  K  L  ++
Sbjct: 59  WQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASD--ILEVHKKPLQEVE 116

Query: 362 RFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQT 421
              +  G   GL YLH       IHRD+KA N+LL      +L DFG A L      P  
Sbjct: 117 IAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASL----VSPAN 169

Query: 422 THVVGTLGYLAPE---HTRTGKATTSADVFSFGAFLLEVACGRRP 463
           +  VGT  ++APE       G+     DV+S G   +E+A  R+P
Sbjct: 170 S-FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA-ERKP 212

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 80.3 bits (198), Expect = 3e-16
 Identities = 68/228 (29%), Positives = 113/228 (49%), Gaps = 33/228 (14%)

Query: 258 IATKGFREKE---LLGTGGFGRVYRGTLPKSQIEIAVKKI--SHES---RQGMKEFVAEI 309
            A K   E E    +G+G  G VY+     +    A+K I  +HE    RQ  +E     
Sbjct: 68  SAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICRE----- 122

Query: 310 VSIGR-LRHRNLVQLLGYCRRKGELLLVYDYMPNGSLD-KYLYDQPKVTLNWIQRFRVIK 367
           + I R + H N+V+        GE+ ++ ++M  GSL+  ++ D+  +         V +
Sbjct: 123 IEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLA-------DVAR 175

Query: 368 GVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT 427
            +  G+ YLH+   + ++HRD+K SN+L++   N ++ DFG++R+     DP  +  VGT
Sbjct: 176 QILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS-VGT 231

Query: 428 LGYLAPEHTRT----GKATTSA-DVFSFGAFLLEVACGRRP--IQRQG 468
           + Y++PE   T    G     A D++S G  +LE   GR P  + RQG
Sbjct: 232 IAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG 279

Length = 353

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 78.4 bits (194), Expect = 3e-16
 Identities = 65/203 (32%), Positives = 89/203 (43%), Gaps = 20/203 (9%)

Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKIS--HESRQGMKEFV---AEIVSIGRLRHRNLVQL 323
           LG GGFGRV    +       A+K +   H    G +E +    EI+      H  +V+L
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEE--CNHPFIVKL 58

Query: 324 LGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQV 383
               + K  + ++ +Y   G L   L D+      +  RF  I  V L   YLH    + 
Sbjct: 59  YRTFKDKKYIYMLMEYCLGGELWTILRDRGLFD-EYTARF-YIACVVLAFEYLH---NRG 113

Query: 384 VIHRDVKASNVLLDGELNGR--LGDFGLARLYDHGTDPQTTH-VVGTLGYLAPEHTRTGK 440
           +I+RD+K  N+LLD   NG   L DFG A+    G   Q T    GT  Y+APE      
Sbjct: 114 IIYRDLKPENLLLD--SNGYVKLVDFGFAKKLKSG---QKTWTFCGTPEYVAPEIILNKG 168

Query: 441 ATTSADVFSFGAFLLEVACGRRP 463
              S D +S G  L E+  GR P
Sbjct: 169 YDFSVDYWSLGILLYELLTGRPP 191

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 78.9 bits (194), Expect = 4e-16
 Identities = 60/203 (29%), Positives = 106/203 (52%), Gaps = 26/203 (12%)

Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCR 328
           LG G FG+VY+    ++    A K I  +S + +++++ EI  +    H  +V+LLG   
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79

Query: 329 RKGELLLVYDYMPNGSLDKYLYD------QPKVTLNWIQRFRVIKGVALGLFYLHQEWEQ 382
             G+L ++ ++ P G++D  + +      +P++ +       + + +   L YLH     
Sbjct: 80  WDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV-------ICRQMLEALQYLHS---M 129

Query: 383 VVIHRDVKASNVLL--DGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE--HTRT 438
            +IHRD+KA NVLL  DG++  +L DFG++   +  T  +    +GT  ++APE     T
Sbjct: 130 KIIHRDLKAGNVLLTLDGDI--KLADFGVSA-KNVKTLQRRDSFIGTPYWMAPEVVMCET 186

Query: 439 GKATT---SADVFSFGAFLLEVA 458
            K T     AD++S G  L+E+A
Sbjct: 187 MKDTPYDYKADIWSLGITLIEMA 209

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 78.6 bits (194), Expect = 4e-16
 Identities = 72/283 (25%), Positives = 119/283 (42%), Gaps = 37/283 (13%)

Query: 269 LGTGGFGRVYRGTL-----PKSQIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQ 322
           LG G FG VY G          ++++AVK +    S Q   +F+ E + + +  H+N+V+
Sbjct: 14  LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73

Query: 323 LLGYCRRKGELLLVYDYMPNGSLDKYLY------DQPKVTLNWIQRFRVIKGVALGLFYL 376
           L+G    +    ++ + M  G L  +L       ++P   L         + VA G  YL
Sbjct: 74  LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSS-LTMKDLLFCARDVAKGCKYL 132

Query: 377 HQEWEQVVIHRDVKASNVLLDGELNGR---LGDFGLAR-LYDHGTDPQTTHVVGTLGYLA 432
               E   IHRD+ A N LL  +  GR   + DFG+AR +Y      +    +  + ++ 
Sbjct: 133 E---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMP 189

Query: 433 PEHTRTGKATTSADVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFWNRGELLEA 491
           PE    G  T+  DV+SFG  L E+ + G  P   +   E       V +F   G  L+ 
Sbjct: 190 PEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE-------VMEFVTGGGRLDP 242

Query: 492 RDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILE 534
                G  Y         ++   C    P  RP+   +++ ++
Sbjct: 243 PKGCPGPVY---------RIMTDCWQHTPEDRPNFATILERIQ 276

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 79.0 bits (195), Expect = 4e-16
 Identities = 61/206 (29%), Positives = 103/206 (50%), Gaps = 14/206 (6%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMK-EFVAEIVSIGRLRHRNLV 321
           F +   LG G  G V +     S + +A K I  E +  ++ + + E+  +       +V
Sbjct: 3   FEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIV 62

Query: 322 QLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
              G     GE+ +  ++M  GSLD+ L    ++  N + +  +   V  GL YL ++ +
Sbjct: 63  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGK--ISIAVLRGLTYLREKHK 120

Query: 382 QVVIHRDVKASNVLL--DGELNGRLGDFGLA-RLYDHGTDPQTTHVVGTLGYLAPEHTRT 438
             ++HRDVK SN+L+   GE+  +L DFG++ +L D          VGT  Y++PE  + 
Sbjct: 121 --IMHRDVKPSNILVNSRGEI--KLCDFGVSGQLID----SMANSFVGTRSYMSPERLQG 172

Query: 439 GKATTSADVFSFGAFLLEVACGRRPI 464
              T  +D++S G  L+E+A GR PI
Sbjct: 173 THYTVQSDIWSLGLSLVEMAIGRYPI 198

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 77.9 bits (192), Expect = 5e-16
 Identities = 79/285 (27%), Positives = 124/285 (43%), Gaps = 49/285 (17%)

Query: 269 LGTGGFGRVYRGTL-PKSQIEIA--------VKKISHESRQGMKEFVAEIVSIGRLRHRN 319
           LG G F  +Y+G L  +S ++I         V K+     +    F      + +L H++
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPK-VTLNWIQRFRVIKGVALGLFYLHQ 378
           LV+L G C R  E ++V +Y+  G LD +L+ +   V+L+W  +  V K +A  L YL  
Sbjct: 63  LVKLYGVCVRD-ENIMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLE- 118

Query: 379 EWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGY-------L 431
             ++ ++H +V   N+L+      R G       +   +DP     V +          +
Sbjct: 119 --DKKLVHGNVCGKNILV-----ARYGLNEGYVPFIKLSDPGIPITVLSREERVERIPWI 171

Query: 432 APEHTRTGKA--TTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGEL 488
           APE  R G+A  T +AD +SFG  LLE+   G  P+     SE          F+     
Sbjct: 172 APECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKE-------RFYQDQHR 224

Query: 489 LEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQIL 533
           L   D        AE   L+ +    C   DPT RPS R +++ L
Sbjct: 225 LPMPD-------CAELANLINQ----CWTYDPTKRPSFRAILRDL 258

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 77.8 bits (191), Expect = 5e-16
 Identities = 81/281 (28%), Positives = 125/281 (44%), Gaps = 29/281 (10%)

Query: 258 IATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRH 317
           I  +  R    LG G FG V+ GT      ++A+K +   +    + F+ E   + +LRH
Sbjct: 3   IPRESLRLDVKLGQGCFGEVWMGTW-NGTTKVAIKTLKPGTMMP-EAFLQEAQIMKKLRH 60

Query: 318 RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLH 377
             LV L      +  + +V ++M  GSL  +L +     L   Q   +   +A G+ Y+ 
Sbjct: 61  DKLVPLYAVVSEE-PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE 119

Query: 378 QEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT---LGYLAPE 434
           +      IHRD++A+N+L+   L  ++ DFGLARL +   D + T   G    + + APE
Sbjct: 120 R---MNYIHRDLRAANILVGDNLVCKIADFGLARLIE---DNEYTARQGAKFPIKWTAPE 173

Query: 435 HTRTGKATTSADVFSFGAFLLE-VACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARD 493
               G+ T  +DV+SFG  L E V  GR P       E L  V+       RG  +    
Sbjct: 174 AALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVE-------RGYRMPC-- 224

Query: 494 PNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILE 534
           P    E + E ++       LC   DP  RP+   +   LE
Sbjct: 225 PQGCPESLHELMK-------LCWKKDPDERPTFEYIQSFLE 258

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 78.0 bits (193), Expect = 7e-16
 Identities = 66/216 (30%), Positives = 99/216 (45%), Gaps = 36/216 (16%)

Query: 263 FREKELLGTGGFGRV----YRGT--------LPKSQIEIAVKKISHESRQGMKEFVAEIV 310
           F   + LGTG FGRV    ++G+        L K++I + +K++ H         + E  
Sbjct: 3   FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKI-VKLKQVEH--------VLNEKR 53

Query: 311 SIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVA 370
            +  +RH  LV L G  +    L LV +Y+P G L  +L    +       RF   + V 
Sbjct: 54  ILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVA-RFYAAQ-VV 111

Query: 371 LGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGY 430
           L L YLH      +++RD+K  N+LLD +   ++ DFG A+     T   T  + GT  Y
Sbjct: 112 LALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRT--YT--LCGTPEY 164

Query: 431 LAPE---HTRTGKATTSADVFSFGAFLLEVACGRRP 463
           LAPE       GKA    D ++ G  + E+  G  P
Sbjct: 165 LAPEIILSKGYGKA---VDWWALGILIYEMLAGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 77.2 bits (190), Expect = 9e-16
 Identities = 68/280 (24%), Positives = 122/280 (43%), Gaps = 36/280 (12%)

Query: 267 ELLGTGGFGRVYRGTLPK-------SQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRN 319
           E LG G F ++++G   +        + E+ +K +    R   + F      + +L H++
Sbjct: 1   ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKH 60

Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYL-YDQPKVTLNWIQRFRVIKGVALGLFYLHQ 378
           LV   G C    E ++V +Y+  GSLD YL  ++  + ++W  +  V K +A  L +L  
Sbjct: 61  LVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLE- 117

Query: 379 EWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTH---VVGTLGYLAPEH 435
             ++ + H +V A NVLL  E + + G+    +L D G          ++  + ++ PE 
Sbjct: 118 --DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPEC 175

Query: 436 TRTGKA-TTSADVFSFGAFLLEVACG-RRPIQRQGPSENLILVDWVFDFWNRGELLEARD 493
               +  + +AD +SFG  L E+  G  +P+      + L        F+     L A  
Sbjct: 176 IENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKL-------QFYEDRHQLPA-- 226

Query: 494 PNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQIL 533
           P         EL  ++     C   +P  RPS R +++ L
Sbjct: 227 PKW------TELANLIN---QCMDYEPDFRPSFRAIIRDL 257

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 77.4 bits (190), Expect = 9e-16
 Identities = 77/283 (27%), Positives = 130/283 (45%), Gaps = 45/283 (15%)

Query: 269 LGTGGFGRVYRGTL-------PKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLV 321
           LG G FG VY G         P++++ I     +   R+ + EF+ E   +      ++V
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERI-EFLNEASVMKEFNCHHVV 72

Query: 322 QLLGYCRRKGELLLVYDYMPNGSLDKYLYD-QPKVTLNWIQRFRVIKG-------VALGL 373
           +LLG   +    L++ + M  G L  YL   +P++  N +Q    +K        +A G+
Sbjct: 73  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132

Query: 374 FYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVGTLG--Y 430
            YL+       +HRD+ A N ++  +   ++GDFG+ R +Y+  TD       G L   +
Sbjct: 133 AYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE--TDYYRKGGKGLLPVRW 187

Query: 431 LAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELL 489
           ++PE  + G  TT +DV+SFG  L E+A    +P   QG S   +L      F   G LL
Sbjct: 188 MSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY--QGMSNEQVL-----RFVMEGGLL 240

Query: 490 EARD--PNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVV 530
           +  D  P           +++ +L  +C   +P  RPS  +++
Sbjct: 241 DKPDNCP-----------DMLFELMRMCWQYNPKMRPSFLEII 272

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 77.3 bits (191), Expect = 1e-15
 Identities = 66/233 (28%), Positives = 104/233 (44%), Gaps = 29/233 (12%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLR----HR 318
           F   E++G G +G+VY+    K+   +A+K +  +  +  +E + E  +I  LR    H 
Sbjct: 8   FELVEVIGEGTYGKVYKARHKKTGQLVAIKIM--DIIEDEEEEIKEEYNI--LRKYSNHP 63

Query: 319 NLVQLLGYCRRKG------ELLLVYDYMPNGS---LDKYLYDQPK-VTLNWIQRFRVIKG 368
           N+    G   +K       +L LV +    GS   L K L  + K +   WI     ++ 
Sbjct: 64  NIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYI--LRE 121

Query: 369 VALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTL 428
              GL YLH   E  VIHRD+K  N+LL      +L DFG++   D  T  +    +GT 
Sbjct: 122 TLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDS-TLGRRNTFIGTP 177

Query: 429 GYLAPE-----HTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILV 476
            ++APE               +DV+S G   +E+A G+ P+    P   L  +
Sbjct: 178 YWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKI 230

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 77.0 bits (189), Expect = 1e-15
 Identities = 74/269 (27%), Positives = 121/269 (44%), Gaps = 27/269 (10%)

Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCR 328
           LG G FG V+  T  K   ++AVK +   S   ++ F+AE   +  L+H  LV+L     
Sbjct: 14  LGAGQFGEVWMATYNK-HTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT 71

Query: 329 RKGELLLVYDYMPNGSLDKYLYDQP--KVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIH 386
           ++  + ++ ++M  GSL  +L      K  L  +  F     +A G+ ++ Q   +  IH
Sbjct: 72  KE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSA--QIAEGMAFIEQ---RNYIH 125

Query: 387 RDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSAD 446
           RD++A+N+L+   L  ++ DFGLAR+ +             + + APE    G  T  +D
Sbjct: 126 RDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSD 185

Query: 447 VFSFGAFLLE-VACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAEEL 505
           V+SFG  L+E V  GR P       E       V     RG  +         E   EEL
Sbjct: 186 VWSFGILLMEIVTYGRIPYPGMSNPE-------VIRALERGYRMPR------PENCPEEL 232

Query: 506 ELVLKLGLLCSHSDPTARPSMRQVVQILE 534
             ++   + C  + P  RP+   +  +L+
Sbjct: 233 YNIM---MRCWKNRPEERPTFEYIQSVLD 258

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 76.9 bits (189), Expect = 1e-15
 Identities = 72/268 (26%), Positives = 123/268 (45%), Gaps = 29/268 (10%)

Query: 269 LGTGGFGRVYRGTLP--KSQIEIAVKKISHESR-QGMK-EFVAEIVSIGRLRHRNLVQLL 324
           LG+G FG V +G     KS+  +AVK + +++    +K E + E   + +L +  +V+++
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62

Query: 325 GYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVV 384
           G C  +   +LV +    G L+K+L     VT   I    ++  V++G+ YL    E   
Sbjct: 63  GICEAES-WMLVMELAELGPLNKFLQKNKHVTEKNITE--LVHQVSMGMKYLE---ETNF 116

Query: 385 IHRDVKASNVLLDGELNGRLGDFGLARLY--DHGTDPQTTHVVGTLGYLAPEHTRTGKAT 442
           +HRD+ A NVLL  +   ++ DFGL++    D       TH    + + APE     K +
Sbjct: 117 VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFS 176

Query: 443 TSADVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYV 501
           + +DV+SFG  + E  + G++P +    +E       V      GE +E        +  
Sbjct: 177 SKSDVWSFGVLMWEAFSYGQKPYKGMKGNE-------VTQMIESGERMEC------PQRC 223

Query: 502 AEELELVLKLGLLCSHSDPTARPSMRQV 529
             E+  ++K   LC       RP    V
Sbjct: 224 PPEMYDLMK---LCWTYGVDERPGFAVV 248

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 76.9 bits (189), Expect = 1e-15
 Identities = 62/229 (27%), Positives = 118/229 (51%), Gaps = 20/229 (8%)

Query: 269 LGTGGFGRVYRGT--LPKSQIEIAVKKISHESRQGMK-EFVAEIVSIGRLRHRNLVQLLG 325
           LG+G FG V +G   + K QI++A+K + +E+ + ++ E + E   + +L +  +V+++G
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIG 62

Query: 326 YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVI 385
            C  +  L+LV +    G L+K+L  + K  +       ++  V++G+ YL     +  +
Sbjct: 63  VCEAEA-LMLVMEMASGGPLNKFLSGK-KDEITVSNVVELMHQVSMGMKYLE---GKNFV 117

Query: 386 HRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT--LGYLAPEHTRTGKATT 443
           HRD+ A NVLL  +   ++ DFGL++              G   L + APE     K ++
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSS 177

Query: 444 SADVFSFGAFLLEV-ACGRRPIQR-QGPSENLILVDWVFDFWNRGELLE 490
            +DV+S+G  + E  + G++P ++ +GP         V  F  +G+ L+
Sbjct: 178 RSDVWSYGITMWEAFSYGQKPYKKMKGPE--------VMSFIEQGKRLD 218

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 77.0 bits (189), Expect = 1e-15
 Identities = 71/282 (25%), Positives = 129/282 (45%), Gaps = 30/282 (10%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKIS------HESRQGMKEFVAEIVSIGRLR 316
           FR ++ +G G F  VYR T     + +A+KK+        ++R    + + EI  + +L 
Sbjct: 4   FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARA---DCIKEIDLLKQLN 60

Query: 317 HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYL--YDQPKVTLNWIQRFRVIKGVALGLF 374
           H N+++         EL +V +    G L + +  + + K  +     ++    +   L 
Sbjct: 61  HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE 120

Query: 375 YLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE 434
           ++H    + V+HRD+K +NV +      +LGD GL R +   T    + +VGT  Y++PE
Sbjct: 121 HMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-LVGTPYYMSPE 176

Query: 435 HTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARD- 493
                     +D++S G  L E+A  + P    G   NL         ++  + +E  D 
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPF--YGDKMNL---------YSLCKKIEQCDY 225

Query: 494 PNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER 535
           P L +++ +EEL    +L  +C + DP  RP +  V  + +R
Sbjct: 226 PPLPSDHYSEELR---QLVNMCINPDPEKRPDITYVYDVAKR 264

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 76.6 bits (188), Expect = 2e-15
 Identities = 80/283 (28%), Positives = 129/283 (45%), Gaps = 38/283 (13%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKIS------HESRQGMKEFVAEIVSIGRLR 316
           F+ ++ +G G F  VYR T    +  +A+KK+        ++RQ   + V EI  + +L 
Sbjct: 4   FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQ---DCVKEIDLLKQLN 60

Query: 317 HRNLVQLLGYCRRKGELLLVYDYMPNGSLD---KYLYDQ----PKVTLNWIQRFRVIKGV 369
           H N+++ L       EL +V +    G L    KY   Q    P+ T+ W    ++   V
Sbjct: 61  HPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTV-WKYFVQLCSAV 119

Query: 370 ALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLG 429
                ++H    + V+HRD+K +NV +      +LGD GL R +   T    + +VGT  
Sbjct: 120 E----HMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-LVGTPY 171

Query: 430 YLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELL 489
           Y++PE          +D++S G  L E+A  + P    G   NL      F    + E  
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF--YGDKMNL------FSLCQKIEQC 223

Query: 490 EARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQI 532
           +   P L TE+ +E+L    +L  +C + DP  RP +  V QI
Sbjct: 224 DY--PPLPTEHYSEKLR---ELVSMCIYPDPDQRPDIGYVHQI 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 76.3 bits (187), Expect = 3e-15
 Identities = 58/216 (26%), Positives = 100/216 (46%), Gaps = 7/216 (3%)

Query: 261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNL 320
           K +   E +G G  G V+      +  E+A+K+I+ + +   +  + EI+ +  L++ N+
Sbjct: 19  KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNI 78

Query: 321 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEW 380
           V  L       EL +V +Y+  GSL   + +     ++  Q   V +     L +LH   
Sbjct: 79  VNFLDSFLVGDELFVVMEYLAGGSLTDVVTE---TCMDEAQIAAVCRECLQALEFLHA-- 133

Query: 381 EQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGK 440
              VIHRD+K+ NVLL  + + +L DFG           ++T +VGT  ++APE      
Sbjct: 134 -NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRKA 191

Query: 441 ATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILV 476
                D++S G   +E+  G  P   + P   L L+
Sbjct: 192 YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI 227

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 76.6 bits (188), Expect = 3e-15
 Identities = 66/210 (31%), Positives = 100/210 (47%), Gaps = 16/210 (7%)

Query: 261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQG---MKEFVAEIVSIGRLRH 317
           K F +   +G G FG VY     ++   +A+KK+S+  +Q     ++ + E+  + +LRH
Sbjct: 15  KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74

Query: 318 RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLH 377
            N +Q  G   R+    LV +Y    + D  L +  K  L  ++   V  G   GL YLH
Sbjct: 75  PNTIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAAVTHGALQGLAYLH 132

Query: 378 QEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE--- 434
                 +IHRDVKA N+LL      +LGDFG A +      P     VGT  ++APE   
Sbjct: 133 S---HNMIHRDVKAGNILLSEPGLVKLGDFGSASI----MAPANX-FVGTPYWMAPEVIL 184

Query: 435 HTRTGKATTSADVFSFGAFLLEVACGRRPI 464
               G+     DV+S G   +E+A  + P+
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERKPPL 214

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 75.8 bits (186), Expect = 3e-15
 Identities = 58/215 (26%), Positives = 104/215 (48%), Gaps = 24/215 (11%)

Query: 264 REKELLGTGGFGRVYRG----TLPKSQIE-IAVKKISHESRQGMKE-FVAEIVSIGRLRH 317
           R  E LG   FG+VY+G    T P  Q + +A+K +  ++   ++E F  E +   RL+H
Sbjct: 8   RFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQH 67

Query: 318 RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQP--------------KVTLNWIQRF 363
            N+V LLG   ++  L +++ Y  +  L ++L  +               K TL      
Sbjct: 68  PNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFV 127

Query: 364 RVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTT 422
            ++  +A G+ +L       V+H+D+   NVL+  +LN ++ D GL R +Y         
Sbjct: 128 HIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMG 184

Query: 423 HVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEV 457
           + +  + +++PE    GK +  +D++S+G  L EV
Sbjct: 185 NSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEV 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 75.8 bits (186), Expect = 4e-15
 Identities = 64/213 (30%), Positives = 106/213 (49%), Gaps = 14/213 (6%)

Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCR 328
           LG G FG+VY+    ++ +  A K I  +S + +++++ EI  +    H N+V+LL    
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 72

Query: 329 RKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRD 388
            +  L ++ ++   G++D  + +  +  L   Q   V K     L YLH   E  +IHRD
Sbjct: 73  YENNLWILIEFCAGGAVDAVMLELER-PLTEPQIRVVCKQTLEALNYLH---ENKIIHRD 128

Query: 389 VKASNVL--LDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE--HTRTGKATT- 443
           +KA N+L  LDG++  +L DFG++   +  T  +    +GT  ++APE     T K    
Sbjct: 129 LKAGNILFTLDGDI--KLADFGVSA-KNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPY 185

Query: 444 --SADVFSFGAFLLEVACGRRPIQRQGPSENLI 474
              ADV+S G  L+E+A    P     P   L+
Sbjct: 186 DYKADVWSLGITLIEMAQIEPPHHELNPMRVLL 218

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 76.2 bits (188), Expect = 5e-15
 Identities = 62/212 (29%), Positives = 103/212 (48%), Gaps = 19/212 (8%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGM-KEFVAEIVSIGRLRHRNLV 321
           ++    +G G +G V   T   + +++A+KKIS    Q   +  + EI  + R +H N++
Sbjct: 7   YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENII 66

Query: 322 QLL------GYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFY 375
            +L       +     ++ +V + M    L K +  Q  ++ + IQ F  +  +  GL Y
Sbjct: 67  GILDIIRPPSFESFN-DVYIVQELMET-DLYKLIKTQH-LSNDHIQYF--LYQILRGLKY 121

Query: 376 LHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP--QTTHVVGTLGYLAP 433
           +H      V+HRD+K SN+LL+   + ++ DFGLAR+ D   D     T  V T  Y AP
Sbjct: 122 IHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAP 178

Query: 434 EHTRTGKA-TTSADVFSFGAFLLEVACGRRPI 464
           E     K  T + D++S G  L E+    RP+
Sbjct: 179 EIMLNSKGYTKAIDIWSVGCILAEMLSN-RPL 209

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 75.1 bits (184), Expect = 5e-15
 Identities = 70/271 (25%), Positives = 120/271 (44%), Gaps = 25/271 (9%)

Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMK-EFVAEIVSIGRLRHRNLVQLLG 325
           E +G G FG V+ G L      +AVK         +K +F+ E   + +  H N+V+L+G
Sbjct: 1   ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60

Query: 326 YCRRKGELLLVYDYMPNGSLDKYLYDQ-PKVTLNWIQRFRVIKGVALGLFYLHQEWEQVV 384
            C +K  + +V + +  G    +L  + P++ +   +  ++++  A G+ YL     +  
Sbjct: 61  VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVK--ELIQMVENAAAGMEYLES---KHC 115

Query: 385 IHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT-LGYLAPEHTRTGKATT 443
           IHRD+ A N L+  +   ++ DFG++R  + G    T  +    + + APE    G+ ++
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSS 175

Query: 444 SADVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVA 502
            +DV+SFG  L E  + G  P       +         +   +G  L    P L  +   
Sbjct: 176 ESDVWSFGILLWEAFSLGAVPYANLSNQQTR-------EAIEQGVRLPC--PELCPDA-- 224

Query: 503 EELELVLKLGLLCSHSDPTARPSMRQVVQIL 533
                V +L   C   DP  RPS   V Q L
Sbjct: 225 -----VYRLMERCWEYDPGQRPSFSTVHQEL 250

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 75.1 bits (185), Expect = 6e-15
 Identities = 58/201 (28%), Positives = 93/201 (46%), Gaps = 21/201 (10%)

Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKI--SHESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
           +G G +G V++    ++   +A+KK   S +     K  + EI  + +L+H NLV L+  
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68

Query: 327 CRRKGELLLVYDYMPN---GSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQV 383
            RRK +L LV++Y  +     L+K     P+  +      ++I      + + H+     
Sbjct: 69  FRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIK-----KIIWQTLQAVNFCHK---HN 120

Query: 384 VIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE----HTRTG 439
            IHRDVK  N+L+  +   +L DFG AR+   G     T  V T  Y APE     T+ G
Sbjct: 121 CIHRDVKPENILITKQGQIKLCDFGFARILT-GPGDDYTDYVATRWYRAPELLVGDTQYG 179

Query: 440 KATTSADVFSFGAFLLEVACG 460
                 DV++ G    E+  G
Sbjct: 180 ---PPVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 74.9 bits (185), Expect = 7e-15
 Identities = 59/210 (28%), Positives = 98/210 (46%), Gaps = 25/210 (11%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMK-------EFVA--EIVSIG 313
           ++  + LG G FG VY     ++   +A+KK        MK       E +   E+ S+ 
Sbjct: 1   YKVIKQLGDGTFGSVYLARNKETGELVAIKK--------MKKKFYSWEECMNLREVKSLR 52

Query: 314 RL-RHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALG 372
           +L  H N+V+L    R   EL  V++YM  G+L + + D+     +      +I  +  G
Sbjct: 53  KLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQG 111

Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLA 432
           L ++H+       HRD+K  N+L+ G    ++ DFGLAR       P T + V T  Y A
Sbjct: 112 LAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAR-EIRSRPPYTDY-VSTRWYRA 166

Query: 433 PE-HTRTGKATTSADVFSFGAFLLEVACGR 461
           PE   R+   ++  D+++ G  + E+   R
Sbjct: 167 PEILLRSTSYSSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 75.9 bits (186), Expect = 7e-15
 Identities = 55/197 (27%), Positives = 97/197 (49%), Gaps = 8/197 (4%)

Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMK-EFVAEIVSIGRLRHRNLVQLLGYC 327
           LG G  G V +     S + +A K I  E +  ++ + + E+  +       +V   G  
Sbjct: 13  LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72

Query: 328 RRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHR 387
              GE+ +  ++M  GSLD+ L +  ++    + +  +   V  GL YL ++ +  ++HR
Sbjct: 73  YSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSI--AVLRGLAYLREKHQ--IMHR 128

Query: 388 DVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADV 447
           DVK SN+L++     +L DFG++       D      VGT  Y++PE  +    +  +D+
Sbjct: 129 DVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDI 185

Query: 448 FSFGAFLLEVACGRRPI 464
           +S G  L+E+A GR PI
Sbjct: 186 WSMGLSLVELAIGRYPI 202

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 75.0 bits (184), Expect = 9e-15
 Identities = 61/238 (25%), Positives = 106/238 (44%), Gaps = 42/238 (17%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQ----------------IEIAVKKISHE-SRQGMKEF 305
           F+EK  LG G FG V+   +   Q                + +AVK +  + ++    +F
Sbjct: 9   FKEK--LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDF 66

Query: 306 VAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYL---------------- 349
           + E+  + RL+  N+++LLG C  +  L ++ +YM NG L+++L                
Sbjct: 67  LKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAV 126

Query: 350 -YDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFG 408
                   +++     V   +A G+ YL        +HRD+   N L+   L  ++ DFG
Sbjct: 127 PPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVHRDLATRNCLVGENLTIKIADFG 183

Query: 409 LAR-LYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEV--ACGRRP 463
           ++R LY           V  + ++A E    GK TT++DV++FG  L E+   C  +P
Sbjct: 184 MSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 74.9 bits (184), Expect = 9e-15
 Identities = 65/211 (30%), Positives = 105/211 (49%), Gaps = 20/211 (9%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR-QGMKEF-VAEIVSIGRLRHRNL 320
           + + E +G G +G VY+     +   IA+KKI  E   +G+    + EI  +  ++H N+
Sbjct: 4   YEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNI 63

Query: 321 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKG----VALGLFYL 376
           V+L      +  L LV++Y     LD  L      + ++ +  R+IK     +  G+ Y 
Sbjct: 64  VRLQDVVHSEKRLYLVFEY-----LDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYC 118

Query: 377 HQEWEQVVIHRDVKASNVLLDGELNG-RLGDFGLARLYDHGTDPQT-THVVGTLGYLAPE 434
           H      V+HRD+K  N+L+D   N  +L DFGLAR +  G   +T TH V TL Y APE
Sbjct: 119 HS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAF--GIPVRTFTHEVVTLWYRAPE 173

Query: 435 HTRTGKA-TTSADVFSFGAFLLEVACGRRPI 464
                +  +T  D++S G    E+   ++P+
Sbjct: 174 ILLGSRHYSTPVDIWSVGCIFAEMV-NQKPL 203

Length = 294

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 74.7 bits (184), Expect = 1e-14
 Identities = 77/310 (24%), Positives = 124/310 (40%), Gaps = 47/310 (15%)

Query: 258 IATKGFREKELLGTGGFGRVY-------RGTLPKSQIE---------IAVKKI-SHESRQ 300
              +     E LG G FG V+       +    K+  E         +AVK +    S  
Sbjct: 2   FPRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDN 61

Query: 301 GMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYL--YDQPKVTLN 358
             ++F+ E+  + RL   N+ +LLG C     L ++ +YM NG L+++L  +      L 
Sbjct: 62  AREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLA 121

Query: 359 WIQRF-------RVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR 411
              +         +   +A G+ YL        +HRD+   N L+      ++ DFG++R
Sbjct: 122 CNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIADFGMSR 178

Query: 412 -LYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVA--CGRRPIQR-- 466
            LY              + ++A E    GK TT +DV++FG  L E+   C  +P +   
Sbjct: 179 NLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT 238

Query: 467 -QGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPS 525
            Q   EN       F    R   L  R PN   +        + +L L C   D   RP+
Sbjct: 239 DQQVIENAGH---FFRDDGRQIYL-PRPPNCPKD--------IYELMLECWRRDEEDRPT 286

Query: 526 MRQVVQILER 535
            R++   L+R
Sbjct: 287 FREIHLFLQR 296

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 74.0 bits (182), Expect = 1e-14
 Identities = 65/271 (23%), Positives = 117/271 (43%), Gaps = 36/271 (13%)

Query: 269 LGTGGFGR--VYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
           LG G FG   +YR T   S +      ++  S +  ++ + EIV +  L+H N++    +
Sbjct: 8   LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67

Query: 327 CRRKGELLLVYDYMPNGSL-------DKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQE 379
                 LL+  +Y   G+L          L+++  V   W   F+++  V+    Y+H+ 
Sbjct: 68  FMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVL--WYL-FQIVSAVS----YIHKA 120

Query: 380 WEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTG 439
               ++HRD+K  N+ L      +LGDFG++++         T VVGT  Y++PE  +  
Sbjct: 121 ---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET-VVGTPYYMSPELCQGV 176

Query: 440 KATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTE 499
           K    +D+++ G  L E+   +R      P    ++V  V   +              + 
Sbjct: 177 KYNFKSDIWALGCVLYELLTLKRTFDATNPLN--LVVKIVQGNYTPVV----------SV 224

Query: 500 YVAEELELVLKLGLLCSHSDPTARPSMRQVV 530
           Y +E + LV          DP  RP+  +V+
Sbjct: 225 YSSELISLVHS----LLQQDPEKRPTADEVL 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 75.1 bits (185), Expect = 1e-14
 Identities = 59/208 (28%), Positives = 97/208 (46%), Gaps = 17/208 (8%)

Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR--QGMKEFVAEIVSIGRLRHRNLVQLL 324
           E +G+G +G V      +S  ++A+KKI H        K  + E+  +   +H N++ + 
Sbjct: 11  ENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIR 70

Query: 325 GYCRRKGELL----LVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEW 380
              R  G       +V D M +  L   ++    +T   I+ F  +  +  GL Y+H   
Sbjct: 71  DILRPPGADFKDVYVVMDLMES-DLHHIIHSDQPLTEEHIRYF--LYQLLRGLKYIHS-- 125

Query: 381 EQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHV---VGTLGYLAPEHTR 437
              VIHRD+K SN+L++ +   R+GDFG+AR            +   V T  Y APE   
Sbjct: 126 -ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLL 184

Query: 438 T-GKATTSADVFSFGAFLLEVACGRRPI 464
           +  + TT+ D++S G    E+  GRR +
Sbjct: 185 SLPEYTTAIDMWSVGCIFAEM-LGRRQL 211

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 74.6 bits (183), Expect = 1e-14
 Identities = 60/217 (27%), Positives = 100/217 (46%), Gaps = 9/217 (4%)

Query: 261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVA-EIVSIGRLRHRN 319
           K +   E +G G  G VY      +  E+A+K+++   +Q  KE +  EI+ +   +H N
Sbjct: 19  KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNL-QQQPKKELIINEILVMRENKHPN 77

Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQE 379
           +V  L       EL +V +Y+  GSL   + +     ++  Q   V +     L +LH  
Sbjct: 78  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHS- 133

Query: 380 WEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTG 439
               VIHRD+K+ N+LL  + + +L DFG           ++T +VGT  ++APE     
Sbjct: 134 --NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRK 190

Query: 440 KATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILV 476
                 D++S G   +E+  G  P   + P   L L+
Sbjct: 191 AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI 227

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 74.7 bits (183), Expect = 1e-14
 Identities = 61/210 (29%), Positives = 100/210 (47%), Gaps = 16/210 (7%)

Query: 261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGM---KEFVAEIVSIGRLRH 317
           K F +   +G G FG VY     ++   +A+KK+S+  +Q     ++ + E+  + R++H
Sbjct: 25  KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKH 84

Query: 318 RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLH 377
            N ++  G   R+    LV +Y    + D  L +  K  L  ++   +  G   GL YLH
Sbjct: 85  PNSIEYKGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAAITHGALQGLAYLH 142

Query: 378 QEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE--- 434
                 +IHRD+KA N+LL      +L DFG A +      P  +  VGT  ++APE   
Sbjct: 143 S---HNMIHRDIKAGNILLTEPGQVKLADFGSASI----ASPANS-FVGTPYWMAPEVIL 194

Query: 435 HTRTGKATTSADVFSFGAFLLEVACGRRPI 464
               G+     DV+S G   +E+A  + P+
Sbjct: 195 AMDEGQYDGKVDVWSLGITCIELAERKPPL 224

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 73.4 bits (180), Expect = 2e-14
 Identities = 62/267 (23%), Positives = 121/267 (45%), Gaps = 26/267 (9%)

Query: 268 LLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVA--EIVSIGRLRHRNLVQLLG 325
           ++G G FG V+       Q  + +K+I  E     +   A  E   +  L H N+++   
Sbjct: 7   VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66

Query: 326 YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVI 385
                  L++V +Y P G+L +Y+  +    L+          + L L ++H    ++++
Sbjct: 67  NFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT---KLIL 123

Query: 386 HRDVKASNVLLDGELN-GRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTS 444
           HRD+K  N+LLD      ++GDFG++++    +  +   VVGT  Y++PE          
Sbjct: 124 HRDLKTQNILLDKHKMVVKIGDFGISKIL--SSKSKAYTVVGTPCYISPELCEGKPYNQK 181

Query: 445 ADVFSFGAFLLEVACGRRPIQRQGPSENL-ILVDWVFDFWNRGELLEARDPNLGTEYVAE 503
           +D+++ G  L E+A  +R  +    + NL  LV          +++      +   Y  +
Sbjct: 182 SDIWALGCVLYELASLKRAFE----AANLPALV---------LKIMSGTFAPISDRYSPD 228

Query: 504 ELELVLKLGLLCSHSDPTARPSMRQVV 530
             +L+L +     + DP+ RP + Q++
Sbjct: 229 LRQLILSM----LNLDPSKRPQLSQIM 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 73.4 bits (180), Expect = 2e-14
 Identities = 58/200 (29%), Positives = 88/200 (44%), Gaps = 8/200 (4%)

Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLG 325
           LG GGFG V    +  +    A KK+  +    + G K  + E   + ++    +V L  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60

Query: 326 YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVI 385
               K  L LV   M  G L  ++Y+  +  L   +       +  G+ +LH      ++
Sbjct: 61  AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH---SMDIV 117

Query: 386 HRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSA 445
           +RD+K  NVLLD + N RL D GLA     G     T   GT GY+APE  +    +   
Sbjct: 118 YRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQRAGTNGYMAPEILKEEPYSYPV 175

Query: 446 DVFSFGAFLLEVACGRRPIQ 465
           D F+ G  + E+  GR P +
Sbjct: 176 DWFAMGCSIYEMVAGRTPFK 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 73.4 bits (180), Expect = 2e-14
 Identities = 61/211 (28%), Positives = 91/211 (43%), Gaps = 33/211 (15%)

Query: 269 LGTGGFGRVYRGTLPK--SQIEIAVKKISHESR-QGMKEFVAEIVSIGRLRHRNLVQLLG 325
           +G G FG+V  G   +  S+  + VK++   +       F+ E+     L H N++Q LG
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 326 YCRRKGELLLVYDYMPNGSLDKYLYD---------QPKVTLNWIQRFRVIKGVALGLFYL 376
            C      LLV ++ P G L  YL           Q  V        R+   VA GL +L
Sbjct: 63  QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQ------RMACEVASGLLWL 116

Query: 377 HQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTT---HVVGTLGYLAP 433
           HQ      IH D+   N  L  +L+ ++GD+GLA L  +  D   T   H V  L +LAP
Sbjct: 117 HQ---ADFIHSDLALRNCQLTADLSVKIGDYGLA-LEQYPEDYYITKDCHAV-PLRWLAP 171

Query: 434 E-----HTR--TGKATTSADVFSFGAFLLEV 457
           E              T  ++++S G  + E+
Sbjct: 172 ELVEIRGQDLLPKDQTKKSNIWSLGVTMWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 74.3 bits (182), Expect = 2e-14
 Identities = 56/203 (27%), Positives = 100/203 (49%), Gaps = 8/203 (3%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMK-EFVAEIVSIGRLRHRNLV 321
           F +   LG G  G V++ +   S + +A K I  E +  ++ + + E+  +       +V
Sbjct: 7   FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66

Query: 322 QLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
              G     GE+ +  ++M  GSLD+ L    ++    + +  +   V  GL YL ++ +
Sbjct: 67  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSI--AVIKGLTYLREKHK 124

Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKA 441
             ++HRDVK SN+L++     +L DFG++       D      VGT  Y++PE  +    
Sbjct: 125 --IMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSFVGTRSYMSPERLQGTHY 179

Query: 442 TTSADVFSFGAFLLEVACGRRPI 464
           +  +D++S G  L+E+A GR PI
Sbjct: 180 SVQSDIWSMGLSLVEMAIGRYPI 202

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 73.0 bits (179), Expect = 3e-14
 Identities = 57/201 (28%), Positives = 97/201 (48%), Gaps = 13/201 (6%)

Query: 264 REKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQ 322
           + +E+LG G  G VY+     ++  +AVK I  + + +  K+ ++E+  + +     ++ 
Sbjct: 4   QYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIG 63

Query: 323 LLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQ 382
             G    +  + +  ++M  GSLD Y    P+  L      R+   V  GL YL   W  
Sbjct: 64  FYGAFFVENRISICTEFMDGGSLDVY-RKIPEHVLG-----RIAVAVVKGLTYL---WSL 114

Query: 383 VVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKAT 442
            ++HRDVK SN+L++     +L DFG++       +      VGT  Y+APE     +  
Sbjct: 115 KILHRDVKPSNMLVNTRGQVKLCDFGVST---QLVNSIAKTYVGTNAYMAPERISGEQYG 171

Query: 443 TSADVFSFGAFLLEVACGRRP 463
             +DV+S G   +E+A GR P
Sbjct: 172 IHSDVWSLGISFMELALGRFP 192

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 73.3 bits (180), Expect = 3e-14
 Identities = 74/272 (27%), Positives = 123/272 (45%), Gaps = 28/272 (10%)

Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQG-MKEFVAEIVSIGRLRHRNLVQLLGYC 327
           LG G +G VY+     + + +A+K+I  E  +    + + E+  + +     +V   G  
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68

Query: 328 RRKGELLLVYDYMPNGSLDKYLYDQPKVT--LNWIQRFRVIKGVALGLFYLHQEWEQVVI 385
             +G + +  +YM  GSLDK LY     T  +      R+   V  GL +L +E    +I
Sbjct: 69  FIEGAVYMCMEYMDAGSLDK-LYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--II 125

Query: 386 HRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKA---- 441
           HRDVK +NVL++G    +L DFG++              +G   Y+APE  ++G      
Sbjct: 126 HRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN---IGCQSYMAPERIKSGGPNQNP 182

Query: 442 --TTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTE 499
             T  +DV+S G  +LE+A GR P     P E    +     F     +++   P L + 
Sbjct: 183 TYTVQSDVWSLGLSILEMALGRYPY----PPETYANI-----FAQLSAIVDGDPPTLPSG 233

Query: 500 YVAEELELVLKLGLLCSHSDPTARPSMRQVVQ 531
           Y  +  + V K    C +  P  RP+  Q+++
Sbjct: 234 YSDDAQDFVAK----CLNKIPNRRPTYAQLLE 261

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 73.5 bits (180), Expect = 3e-14
 Identities = 75/282 (26%), Positives = 134/282 (47%), Gaps = 42/282 (14%)

Query: 263 FREKELLGTGGFGRVYRGT-LPKSQ---IEIAVKKISHE-SRQGMKEFVAEIVSIGRLRH 317
           F++ ++LG+G FG VY+G  +P+ +   I +A+K++    S +  KE + E   +  + +
Sbjct: 9   FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68

Query: 318 RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQP-----KVTLNWIQRFRVIKGVALG 372
            ++ +LLG C     + L+   MP G L  Y+ +       +  LNW  +      +A G
Sbjct: 69  PHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 121

Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVG---TLG 429
           + YL    E+ ++HRD+ A NVL+    + ++ DFGLA+L   G D +  H  G    + 
Sbjct: 122 MNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GADEKEYHAEGGKVPIK 176

Query: 430 YLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGEL 488
           ++A E       T  +DV+S+G  + E+   G +P      SE       +     +GE 
Sbjct: 177 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-------ISSILEKGER 229

Query: 489 LEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVV 530
           L    P + T    +   +++K    C   D  +RP  R+++
Sbjct: 230 LP--QPPICT---IDVYMIMVK----CWMIDADSRPKFRELI 262

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 73.4 bits (180), Expect = 3e-14
 Identities = 77/301 (25%), Positives = 129/301 (42%), Gaps = 46/301 (15%)

Query: 266 KELLGTGGFGRVY----RGTL------------PKSQIEIAVKKISHESRQGMK-EFVAE 308
           KE LG G FG V+     G                  + +AVK +  ++ +  + +F+ E
Sbjct: 10  KEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKE 69

Query: 309 IVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYL---------YDQPKVTLNW 359
           I  + RL+  N+++LL  C     L ++ +YM NG L+++L              VT+++
Sbjct: 70  IKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISY 129

Query: 360 IQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTD 418
                +   +A G+ YL        +HRD+   N L+      ++ DFG++R LY     
Sbjct: 130 STLIFMATQIASGMKYLSS---LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYY 186

Query: 419 PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVA--CGRRPIQRQGPSENLILV 476
                 V  + +++ E    GK TT++DV++FG  L E+   C  +P   Q   E +I  
Sbjct: 187 RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYS-QLSDEQVI-- 243

Query: 477 DWVFDFWNRGELLEARDPNLGTEYVAEEL--ELVLKLGLLCSHSDPTARPSMRQV-VQIL 533
                  N GE    RD           L  + + KL L C   +   RPS +++   +L
Sbjct: 244 ------ENTGEFF--RDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL 295

Query: 534 E 534
           E
Sbjct: 296 E 296

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 73.1 bits (180), Expect = 4e-14
 Identities = 59/197 (29%), Positives = 86/197 (43%), Gaps = 52/197 (26%)

Query: 270 GTGGFGRVYRGTL--PKSQIEIAVKKISHESRQGM---KEFVAEIVSIGRLRHRNLVQLL 324
           G G +GRVY+      K   E A+KK   +  Q     +    EI  +  L+H N+V L+
Sbjct: 9   GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLV 68

Query: 325 GYC--RRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRF-RVIKGVAL---------- 371
                     + L++DY          +D     L  I +F R  K V++          
Sbjct: 69  EVFLEHADKSVYLLFDYAE--------HD-----LWQIIKFHRQAKRVSIPPSMVKSLLW 115

Query: 372 ----GLFYLHQEWEQVVIHRDVKASNVLL--DGELNGR--LGDFGLARLYD------HGT 417
               G+ YLH  W   V+HRD+K +N+L+  +G   G   +GD GLARL++         
Sbjct: 116 QILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADL 172

Query: 418 DPQTTHVVGTLGYLAPE 434
           DP    VV T+ Y APE
Sbjct: 173 DP----VVVTIWYRAPE 185

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 72.2 bits (177), Expect = 4e-14
 Identities = 70/271 (25%), Positives = 122/271 (45%), Gaps = 34/271 (12%)

Query: 269 LGTGGFGRVYRGTLPKSQI--------EIAVKKISHESRQGMKEFVAEIVSIGRLRHRNL 320
           +G G FG+     L KS+         EI + K+S + R+   E   E+  +  ++H N+
Sbjct: 8   IGEGSFGKAI---LVKSKEDGKQYVIKEINISKMSPKERE---ESRKEVAVLSNMKHPNI 61

Query: 321 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEW 380
           VQ        G L +V DY   G L K +  Q  V     Q       + L L ++H   
Sbjct: 62  VQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVH--- 118

Query: 381 EQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGK 440
           ++ ++HRD+K+ N+ L  +   +LGDFG+AR+ +   +   T  +GT  YL+PE      
Sbjct: 119 DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART-CIGTPYYLSPEICENRP 177

Query: 441 ATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEY 500
               +D+++ G  L E+ C  +     G  +NL+L           +++    P + + Y
Sbjct: 178 YNNKSDIWALGCVLYEM-CTLKHAFEAGNMKNLVL-----------KIIRGSYPPVSSHY 225

Query: 501 VAEELELVLKLGLLCSHSDPTARPSMRQVVQ 531
             +   LV +L       +P  RPS+  +++
Sbjct: 226 SYDLRNLVSQL----FKRNPRDRPSVNSILE 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 72.9 bits (179), Expect = 4e-14
 Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 25/209 (11%)

Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR-QGMKEF-VAEIVSIGRLRHRNLVQLL 324
           E +G G +G V++    ++   +A+K++  +   +G+    + EI  +  L+H+N+V+L 
Sbjct: 6   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLY 65

Query: 325 GYCRRKGELLLVYDYMPNGSLDKYL------YDQPKVTLNWIQRFRVIKGVALGLFYLHQ 378
                  +L LV++Y  +  L KY        D   V     Q  +       GL + H 
Sbjct: 66  DVLHSDKKLTLVFEYC-DQDLKKYFDSCNGDIDPEIVKSFMFQLLK-------GLAFCHS 117

Query: 379 EWEQVVIHRDVKASNVLL--DGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHT 436
                V+HRD+K  N+L+  +GEL  +L DFGLAR +       +  VV TL Y  P+  
Sbjct: 118 ---HNVLHRDLKPQNLLINKNGEL--KLADFGLARAFGIPVRCYSAEVV-TLWYRPPDVL 171

Query: 437 RTGKA-TTSADVFSFGAFLLEVACGRRPI 464
              K  +TS D++S G    E+A   RP+
Sbjct: 172 FGAKLYSTSIDMWSAGCIFAELANAGRPL 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 72.7 bits (178), Expect = 4e-14
 Identities = 62/200 (31%), Positives = 100/200 (50%), Gaps = 17/200 (8%)

Query: 269 LGTGGFGRV----YRGTLPKSQIEIAVKKISHESRQG-MKEFVAEIVSIGRLRHRNLVQL 323
           LG G FG+V    Y      +  ++AVK +  ES    + +   EI  +  L H N+V+ 
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71

Query: 324 LGYCRRKGE--LLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
            G C   G   + L+ +++P+GSL +YL  + K  +N  Q+ +    +  G+ YL     
Sbjct: 72  KGICTEDGGNGIKLIMEFLPSGSLKEYL-PRNKNKINLKQQLKYAVQICKGMDYLGS--- 127

Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLG----YLAPEHTR 437
           +  +HRD+ A NVL++ E   ++GDFGL +  +  TD +   V   L     + APE   
Sbjct: 128 RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE--TDKEYYTVKDDLDSPVFWYAPECLI 185

Query: 438 TGKATTSADVFSFGAFLLEV 457
             K   ++DV+SFG  L E+
Sbjct: 186 QSKFYIASDVWSFGVTLYEL 205

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 72.7 bits (178), Expect = 5e-14
 Identities = 75/297 (25%), Positives = 128/297 (43%), Gaps = 49/297 (16%)

Query: 269 LGTGGFGRVYRGTLPKSQ-----IEIAVKKISHESRQG-MKEFVAEIVSIGRLRHRNLVQ 322
           LG G FG+V + T  + +       +AVK +   +    +++ ++E   + ++ H ++++
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67

Query: 323 LLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVAL----------- 371
           L G C + G LLL+ +Y   GSL  +L +  KV  +++          L           
Sbjct: 68  LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127

Query: 372 -----------GLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDP 419
                      G+ YL    E  ++HRD+ A NVL+      ++ DFGL+R +Y+  +  
Sbjct: 128 DLISFAWQISRGMQYLA---EMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184

Query: 420 QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLE-VACGRRPIQRQGPSENLILVDW 478
           + +     + ++A E       TT +DV+SFG  L E V  G  P     P E L     
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP-ERL----- 238

Query: 479 VFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER 535
            F+    G  +E R  N   E        +  L L C   +P  RP+   + + LE+
Sbjct: 239 -FNLLKTGYRME-RPENCSEE--------MYNLMLTCWKQEPDKRPTFADISKELEK 285

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 72.3 bits (177), Expect = 6e-14
 Identities = 77/291 (26%), Positives = 134/291 (46%), Gaps = 47/291 (16%)

Query: 269 LGTGGFGRVYRGTLP-----KSQIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQ 322
           LG G FG VY G        +++  +AVK ++   S +   EF+ E   +      ++V+
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73

Query: 323 LLGYCRRKGELLLVYDYMPNGSLDKYLYD----------QPKVTLNWIQRFRVIKGVALG 372
           LLG   +    L+V + M +G L  YL            +P  TL   +  ++   +A G
Sbjct: 74  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQ--EMIQMAAEIADG 131

Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVGTL--G 429
           + YL+    +  +HRD+ A N ++  +   ++GDFG+ R +Y+  TD       G L   
Sbjct: 132 MAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYE--TDYYRKGGKGLLPVR 186

Query: 430 YLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFD--FWNRG 486
           ++APE  + G  TTS+D++SFG  L E+     +P   QG S   +L  +V D  + ++ 
Sbjct: 187 WMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPY--QGLSNEQVL-KFVMDGGYLDQP 243

Query: 487 ELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERDV 537
           +    R  +L                 +C   +P  RP+  ++V +L+ D+
Sbjct: 244 DNCPERVTDLMR---------------MCWQFNPKMRPTFLEIVNLLKDDL 279

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 72.1 bits (177), Expect = 6e-14
 Identities = 72/283 (25%), Positives = 122/283 (43%), Gaps = 47/283 (16%)

Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKI-SHESRQGMKEFVAEI-VSIGRLRHRNLVQLL 324
           E LG G +G V +     +   +AVK+I +  + Q  K  + ++ +S+  +     V   
Sbjct: 7   EELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFY 66

Query: 325 GYCRRKGELLLVYDYMPNGSLDKY---LYDQPK-VTLNWIQRFRVIKGVALGLFYLHQEW 380
           G   R+G++ +  + M + SLDK+   +YD+   +  + + +  V   +   L YLH + 
Sbjct: 67  GALFREGDVWICMEVM-DTSLDKFYKKVYDKGLTIPEDILGKIAV--SIVKALEYLHSKL 123

Query: 381 EQVVIHRDVKASNVLLDGELNGRLGDFG--------LARLYDHGTDPQTTHVVGTLGYLA 432
              VIHRDVK SNVL++     +L DFG        +A+  D G  P          Y+A
Sbjct: 124 S--VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKP----------YMA 171

Query: 433 PEH----TRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGEL 488
           PE              +DV+S G  ++E+A GR P              W   F    ++
Sbjct: 172 PERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS-----------WKTPFQQLKQV 220

Query: 489 LEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ 531
           +E   P L  E  + E +  +     C   +   RP+  +++Q
Sbjct: 221 VEEPSPQLPAEKFSPEFQDFVN---KCLKKNYKERPNYPELLQ 260

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 71.7 bits (176), Expect = 7e-14
 Identities = 54/210 (25%), Positives = 97/210 (46%), Gaps = 18/210 (8%)

Query: 262 GFREKELLGTGGFGRVYRGTLPKSQIE-----IAVKKISHESRQGMK-EFVAEIVSIGRL 315
             +E   LG G FG V+       + E     + VK +     + ++ EF  E+    +L
Sbjct: 6   NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65

Query: 316 RHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLY-DQPKVT------LNWIQRFRVIKG 368
            H+N+V+LLG CR      ++ +Y   G L ++L   + K        L+  Q+  +   
Sbjct: 66  SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125

Query: 369 VALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVGT 427
           +ALG+ +L        +HRD+ A N L+  +   ++    L++ +Y+         ++  
Sbjct: 126 IALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI-P 181

Query: 428 LGYLAPEHTRTGKATTSADVFSFGAFLLEV 457
           L +LAPE  +    +T +DV+SFG  + EV
Sbjct: 182 LRWLAPEAVQEDDFSTKSDVWSFGVLMWEV 211

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 72.0 bits (176), Expect = 7e-14
 Identities = 77/287 (26%), Positives = 127/287 (44%), Gaps = 42/287 (14%)

Query: 263 FREKELLGTGGFGRVYRGT-LPKSQ---IEIAVKKI-SHESRQGMKEFVAEIVSIGRLRH 317
            ++ ++LG+G FG VY+G  +P  +   I +A+K +  + S +  KE + E   +  +  
Sbjct: 9   LKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGS 68

Query: 318 RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQ-----PKVTLNWIQRFRVIKGVALG 372
             + +LLG C     + LV   MP G L  Y+ +       +  LNW  +      +A G
Sbjct: 69  PYVCRLLGICL-TSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQ------IAKG 121

Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVG---TLG 429
           + YL    E  ++HRD+ A NVL+    + ++ DFGLARL D   D    H  G    + 
Sbjct: 122 MSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD--IDETEYHADGGKVPIK 176

Query: 430 YLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGEL 488
           ++A E     + T  +DV+S+G  + E+   G +P       E       + D   +GE 
Sbjct: 177 WMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE-------IPDLLEKGER 229

Query: 489 LEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER 535
           L  + P    +        V  + + C   D   RP  R++V    R
Sbjct: 230 L-PQPPICTID--------VYMIMVKCWMIDSECRPRFRELVDEFSR 267

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 72.0 bits (177), Expect = 1e-13
 Identities = 60/220 (27%), Positives = 99/220 (45%), Gaps = 14/220 (6%)

Query: 268 LLGTGGFGRVYRGTLPKSQIEIAVKKISHE---SRQGMKEFVAE--IVSIGRLRHRNLVQ 322
           +LG G FG+V    L  +    AVK +  +       ++  + E  ++++   +H  L Q
Sbjct: 2   VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG-KHPFLTQ 60

Query: 323 LLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQ 382
           L    + K  L  V +Y+  G L  ++    +       RF   + + LGL +LH   E+
Sbjct: 61  LHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEP-RARFYAAE-IVLGLQFLH---ER 115

Query: 383 VVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKAT 442
            +I+RD+K  NVLLD E + ++ DFG+ +         T+   GT  Y+APE        
Sbjct: 116 GIIYRDLKLDNVLLDSEGHIKIADFGMCK-EGILGGVTTSTFCGTPDYIAPEILSYQPYG 174

Query: 443 TSADVFSFGAFLLEVACGRRPIQRQGPSE--NLILVDWVF 480
            + D ++ G  L E+  G+ P +     E    IL D V 
Sbjct: 175 PAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVR 214

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 71.6 bits (175), Expect = 1e-13
 Identities = 55/207 (26%), Positives = 100/207 (48%), Gaps = 29/207 (14%)

Query: 268 LLGTGGFGRVYRGTLPKSQIEIAVKKI--SHESRQGMKEFVAEIVSIGRLRHRNLVQLLG 325
           ++G G +G V +    +++  +A+KK   S E+ +  +  + E+  +  L+  N+V+L  
Sbjct: 8   VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67

Query: 326 YCRRKGELLLVYDY-----------MPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLF 374
             RR+G+L LV++Y           MPNG         P+   ++I  +++IK +     
Sbjct: 68  AFRRRGKLYLVFEYVEKNMLELLEEMPNGVP-------PEKVRSYI--YQLIKAI----- 113

Query: 375 YLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE 434
             H   +  ++HRD+K  N+L+      +L DFG AR    G++   T  V T  Y +PE
Sbjct: 114 --HWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPE 171

Query: 435 HTRTGKATTSADVFSFGAFLLEVACGR 461
                    + D++S G  L E++ G+
Sbjct: 172 LLLGAPYGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 71.5 bits (176), Expect = 1e-13
 Identities = 67/208 (32%), Positives = 101/208 (48%), Gaps = 45/208 (21%)

Query: 272 GGFGRVYRGTLPKSQIEI-AVKKIS-HESRQGMKEF----VAEIVSIGRLRHRNLVQL-- 323
           G +G VYR    K   EI A+KK+   + ++G   F    + EI  + +L+H N+V +  
Sbjct: 16  GTYGVVYRA-RDKKTGEIVALKKLKMEKEKEG---FPITSLREINILLKLQHPNIVTVKE 71

Query: 324 --LGYCRRKGELLLVYDYMPNGSLD-KYLYDQPKVTLNWIQRFRV--IKGVALGLF---- 374
             +G    K  + +V +Y+ +   D K L +  K      Q F    +K + L L     
Sbjct: 72  VVVGSNLDK--IYMVMEYVEH---DLKSLMETMK------QPFLQSEVKCLMLQLLSGVA 120

Query: 375 YLHQEWEQVVIHRDVKASNVLLD--GELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLA 432
           +LH  W   ++HRD+K SN+LL+  G L  ++ DFGLAR Y     P T  VV TL Y A
Sbjct: 121 HLHDNW---ILHRDLKTSNLLLNNRGIL--KICDFGLAREYGSPLKPYTQLVV-TLWYRA 174

Query: 433 PE-HTRTGKATTSADVFS----FGAFLL 455
           PE      + +T+ D++S    F   L 
Sbjct: 175 PELLLGAKEYSTAIDMWSVGCIFAELLT 202

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 71.2 bits (174), Expect = 1e-13
 Identities = 57/206 (27%), Positives = 92/206 (44%), Gaps = 8/206 (3%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRN 319
           FR+  +LG GGFG V    +  +    A K++  +    R+G    + E   + ++  + 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61

Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQE 379
           +V L      K  L LV   M  G L  ++Y+         +       +  GL  LH+E
Sbjct: 62  VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE 121

Query: 380 WEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTG 439
                ++RD+K  N+LLD   + R+ D GLA     G   +    VGT+GY+APE     
Sbjct: 122 ---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR--VGTVGYMAPEVLNNQ 176

Query: 440 KATTSADVFSFGAFLLEVACGRRPIQ 465
           + T S D +  G  + E+  G+ P +
Sbjct: 177 RYTLSPDYWGLGCLIYEMIEGQSPFR 202

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 71.2 bits (174), Expect = 1e-13
 Identities = 53/215 (24%), Positives = 102/215 (47%), Gaps = 24/215 (11%)

Query: 264 REKELLGTGGFGRVYRGTLPKSQIE----IAVKKIS-HESRQGMKEFVAEIVSIGRLRHR 318
           R  E LG   FG++Y+G L    ++    +A+K +    + Q   EF  E   +  L H 
Sbjct: 8   RFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHP 67

Query: 319 NLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQP---------------KVTLNWIQRF 363
           N+V LLG   ++  + ++++Y+  G L ++L  +                K +L+     
Sbjct: 68  NIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFL 127

Query: 364 RVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTT 422
            +   +A G+ YL   +    +H+D+ A N+L+  +L+ ++ D GL+R +Y         
Sbjct: 128 HIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQP 184

Query: 423 HVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEV 457
             +  + ++ PE    GK ++ +D++SFG  L E+
Sbjct: 185 KSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 71.6 bits (175), Expect = 1e-13
 Identities = 61/201 (30%), Positives = 97/201 (48%), Gaps = 17/201 (8%)

Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQ---GMKEFVAEIVSIGRLRHRNLVQLLG 325
           +G G FG VY  T   +   +AVKK+S+  +Q     ++ + E+  + +L+H N ++  G
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88

Query: 326 YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVI 385
              ++    LV +Y    + D  L +  K  L  ++   +  G   GL YLH      +I
Sbjct: 89  CYLKEHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAAITHGALQGLAYLHS---HNMI 143

Query: 386 HRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE---HTRTGKAT 442
           HRD+KA N+LL      +L DFG A      + P  +  VGT  ++APE       G+  
Sbjct: 144 HRDIKAGNILLTEPGQVKLADFGSASK----SSPANS-FVGTPYWMAPEVILAMDEGQYD 198

Query: 443 TSADVFSFGAFLLEVACGRRP 463
              DV+S G   +E+A  R+P
Sbjct: 199 GKVDVWSLGITCIELA-ERKP 218

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 72.2 bits (177), Expect = 1e-13
 Identities = 60/211 (28%), Positives = 88/211 (41%), Gaps = 17/211 (8%)

Query: 269 LGTGGFGRVYRGTL--PKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
           L  G  G V+  T    + + ++ VK ++     G K    EI  +  + HR ++ L+  
Sbjct: 100 LTPGSEGEVFVCTKHGDEQRKKVIVKAVT-----GGKTPGREIDILKTISHRAIINLIHA 154

Query: 327 CRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIH 386
            R K  + +V   MP    D + Y      L   Q   + + +   L YLH    + +IH
Sbjct: 155 YRWKSTVCMV---MPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLH---GRGIIH 208

Query: 387 RDVKASNVLLDGELNGRLGDFGLA-RLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSA 445
           RDVK  N+ LD   N  LGDFG A +L  H   PQ     GTL   +PE           
Sbjct: 209 RDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKT 268

Query: 446 DVFSFGAFLLEVACGRRP---IQRQGPSENL 473
           D++S G  L E++         Q +  S  L
Sbjct: 269 DIWSAGLVLFEMSVKNVTLFGKQVKSSSSQL 299

Length = 392

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 70.2 bits (172), Expect = 2e-13
 Identities = 57/216 (26%), Positives = 102/216 (47%), Gaps = 26/216 (12%)

Query: 262 GFREKELLGTGGFGRVYRGTLPKSQIEIAVKK--ISHESRQGMKEFVAEIVSIGRLRHRN 319
            F+  + LG G +G VY+          A+K+  +   S++  ++ V EI  +  + H N
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 320 LVQ-----LLGYCRRKGELLLVYDYMPNGSLDKYLYDQPK----VTLNWIQRFRVIKGVA 370
           ++      L G  +    L +V +Y P G L K +  + K    +    I R  +   + 
Sbjct: 61  IISYKEAFLDG-NK----LCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFI--QLL 113

Query: 371 LGLFYLHQEWEQVVIHRDVKASNVLL-DGELNGRLGDFGLARLYDHGTDPQTTHVVGTLG 429
            GL  LH   EQ ++HRD+K++N+LL   +L  ++GD G++++            +GT  
Sbjct: 114 RGLQALH---EQKILHRDLKSANILLVANDL-VKIGDLGISKVL---KKNMAKTQIGTPH 166

Query: 430 YLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQ 465
           Y+APE  +    +  +D++S G  L E+A    P +
Sbjct: 167 YMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFE 202

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 70.4 bits (172), Expect = 3e-13
 Identities = 58/203 (28%), Positives = 94/203 (46%), Gaps = 11/203 (5%)

Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCR 328
           +G G  G V       S  ++AVK +    +Q  +    E+V +   +H+N+V++     
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYL 88

Query: 329 RKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRD 388
              EL ++ +++  G+L   +    +  LN  Q   V + V   L YLH    Q VIHRD
Sbjct: 89  VGEELWVLMEFLQGGALTDIV---SQTRLNEEQIATVCESVLQALCYLHS---QGVIHRD 142

Query: 389 VKASNVLLDGELNGR--LGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSAD 446
           +K+ ++LL   L+GR  L DFG          P+   +VGT  ++APE        T  D
Sbjct: 143 IKSDSILL--TLDGRVKLSDFGFCAQISKDV-PKRKSLVGTPYWMAPEVISRTPYGTEVD 199

Query: 447 VFSFGAFLLEVACGRRPIQRQGP 469
           ++S G  ++E+  G  P     P
Sbjct: 200 IWSLGIMVIEMVDGEPPYFSDSP 222

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 70.8 bits (173), Expect = 3e-13
 Identities = 62/236 (26%), Positives = 102/236 (43%), Gaps = 20/236 (8%)

Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRL----RHRNLVQ 322
           ++LG G FG+V+   L  +    A+K +  +      +    +V    L     H  L  
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60

Query: 323 LLGYCRRKGELLLVYDYMPNGSLDKYL-----YDQPKVTLNWIQRFRVIKGVALGLFYLH 377
           L    + K  L  V +Y+  G L  ++     +D P+ T    +       +  GL +LH
Sbjct: 61  LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAE-------IICGLQFLH 113

Query: 378 QEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTR 437
            +    +++RD+K  N+LLD + + ++ DFG+ +    G D +T    GT  Y+APE   
Sbjct: 114 SKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLG-DAKTCTFCGTPDYIAPEILL 169

Query: 438 TGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARD 493
             K  TS D +SFG  L E+  G+ P       E    +      + R    EA+D
Sbjct: 170 GQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKD 225

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 69.4 bits (169), Expect = 4e-13
 Identities = 65/228 (28%), Positives = 104/228 (45%), Gaps = 21/228 (9%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRL-RHRNLV 321
           F   EL+G G +G+VY+G   K+  ++A  K+   +    +E   EI  + +   HRN+ 
Sbjct: 8   FELVELVGNGTYGQVYKGRHVKTG-QLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIA 66

Query: 322 QLLGYCRRKG------ELLLVYDYMPNGSLDKYLYDQPKVTLN--WIQRFRVIKGVALGL 373
              G   +K       +L LV ++   GS+   + +    TL   WI    + + +  GL
Sbjct: 67  TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGL 124

Query: 374 FYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAP 433
            +LHQ     VIHRD+K  NVLL      +L DFG++   D     + T  +GT  ++AP
Sbjct: 125 SHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-FIGTPYWMAP 180

Query: 434 E-----HTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILV 476
           E               +D++S G   +E+A G  P+    P   L L+
Sbjct: 181 EVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI 228

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 69.8 bits (171), Expect = 4e-13
 Identities = 59/213 (27%), Positives = 97/213 (45%), Gaps = 21/213 (9%)

Query: 269 LGTGGFGRVY---------RGTLPKSQIEIAVKKISHESRQGMKEFV-AEIVSIGRLRHR 318
           LGTG +G+V+          G L   ++   +KK +   +    E    E   +  +R  
Sbjct: 8   LGTGAYGKVFLVRKVGGHDAGKLYAMKV---LKKATIVQKAKTAEHTRTERQVLEAVRRC 64

Query: 319 NLVQLLGYC-RRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLH 377
             +  L Y  +   +L L+ DY+  G L  +LY +   T + ++ +  I  + L L +LH
Sbjct: 65  PFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVY--IAEIVLALDHLH 122

Query: 378 QEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTR 437
           Q     +I+RD+K  N+LLD E +  L DFGL++ +    + +     GT+ Y+APE  R
Sbjct: 123 Q---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIR 179

Query: 438 TGKA--TTSADVFSFGAFLLEVACGRRPIQRQG 468
            G      + D +S G    E+  G  P    G
Sbjct: 180 GGSGGHDKAVDWWSLGVLTFELLTGASPFTVDG 212

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 69.6 bits (170), Expect = 5e-13
 Identities = 59/208 (28%), Positives = 94/208 (45%), Gaps = 8/208 (3%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRN 319
           FR   +LG GGFG V    +  +    A KK+  +    R+G    + E   + ++  R 
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61

Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQE 379
           +V L      K  L LV   M  G L  ++Y+      +  +       +  GL  L +E
Sbjct: 62  VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE 121

Query: 380 WEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTG 439
               +++RD+K  N+LLD   + R+ D GLA     G   +    VGT+GY+APE     
Sbjct: 122 ---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGR--VGTVGYMAPEVINNE 176

Query: 440 KATTSADVFSFGAFLLEVACGRRPIQRQ 467
           K T S D +  G  + E+  G+ P +++
Sbjct: 177 KYTFSPDWWGLGCLIYEMIQGQSPFRKR 204

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 68.7 bits (168), Expect = 6e-13
 Identities = 64/220 (29%), Positives = 93/220 (42%), Gaps = 46/220 (20%)

Query: 272 GGFGRVY----RGT--------LPKSQIEIAVKKISH---ESR----QGMKEFVAEIVSI 312
           G FG VY    R T        L KS + IA  ++++   E      QG   +VA     
Sbjct: 7   GAFGSVYLAKKRSTGDYFAIKVLKKSDM-IAKNQVTNVKAERAIMMIQGESPYVA----- 60

Query: 313 GRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALG 372
                    +L    + K  L LV +Y+  G     +     +  +W +++  I  V LG
Sbjct: 61  ---------KLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQY--IAEVVLG 109

Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLA 432
           +  LHQ     +IHRD+K  N+L+D   + +L DFGL+R    G + +    VGT  YLA
Sbjct: 110 VEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRN---GLENK--KFVGTPDYLA 161

Query: 433 PEHTRTGKATTSA-DVFSFGAFLLEVACGRRPIQRQGPSE 471
           PE T  G       D +S G  + E   G  P   + P  
Sbjct: 162 PE-TILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA 200

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 69.9 bits (171), Expect = 6e-13
 Identities = 55/202 (27%), Positives = 88/202 (43%), Gaps = 17/202 (8%)

Query: 258 IATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMK-EFVAEIVSIGRLR 316
           +A+ G+   + L  G  GRV+  T    Q +  V KI      G K   + E + +  + 
Sbjct: 63  VASLGYTVIKTLTPGSEGRVFVAT-KPGQPDPVVLKI------GQKGTTLIEAMLLQNVN 115

Query: 317 HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVT-LNWIQRFRVIKGVALGLFY 375
           H +++++           +V   +P+ S D Y Y   +   L   Q   + K +  GL Y
Sbjct: 116 HPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRY 172

Query: 376 LHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEH 435
           LH    Q +IHRDVK  N+ ++      +GD G A+       P    + GT+   APE 
Sbjct: 173 LHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQF--PVVAPAFLGLAGTVETNAPEV 227

Query: 436 TRTGKATTSADVFSFGAFLLEV 457
               K  + AD++S G  L E+
Sbjct: 228 LARDKYNSKADIWSAGIVLFEM 249

Length = 357

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 69.4 bits (170), Expect = 7e-13
 Identities = 57/217 (26%), Positives = 96/217 (44%), Gaps = 28/217 (12%)

Query: 268 LLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAE------------IVSIGRL 315
           +LG G FG+V    L  +    A+K +        K+ V E            ++++   
Sbjct: 2   VLGKGSFGKVMLAELKGTNEFFAIKALK-------KDVVLEDDDVECTMVERRVLALA-W 53

Query: 316 RHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKG-VALGLF 374
            H  L  L    + K  L  V +Y+  G L  ++    +       R R     +  GL 
Sbjct: 54  EHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDE---ARARFYAAEIICGLQ 110

Query: 375 YLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE 434
           +LH++    +I+RD+K  NVLLD + + ++ DFG+ +   +G + + +   GT  Y+APE
Sbjct: 111 FLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNG-EGKASTFCGTPDYIAPE 166

Query: 435 HTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSE 471
             +  K   S D +SFG  L E+  G+ P   +   E
Sbjct: 167 ILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE 203

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 69.3 bits (169), Expect = 8e-13
 Identities = 63/203 (31%), Positives = 97/203 (47%), Gaps = 24/203 (11%)

Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMK-EFVAEIVSIGRLRHRNLVQLLGYC 327
           LG G +  VY+G    +   +A+K+I  E  +G     + E+  +  L+H N+V L    
Sbjct: 14  LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 73

Query: 328 RRKGELLLVYDYMPNGSLDKYLYD------QPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
             +  L LV++Y+ +  L +YL D         V L   Q  R       GL Y H+   
Sbjct: 74  HTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQLLR-------GLNYCHR--- 122

Query: 382 QVVIHRDVKASNVLLD--GELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE-HTRT 438
           + V+HRD+K  N+L++  GEL  +L DFGLAR     T   +  VV TL Y  P+    +
Sbjct: 123 RKVLHRDLKPQNLLINERGEL--KLADFGLARAKSIPTKTYSNEVV-TLWYRPPDILLGS 179

Query: 439 GKATTSADVFSFGAFLLEVACGR 461
              +T  D++  G    E++ GR
Sbjct: 180 TDYSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 68.4 bits (167), Expect = 9e-13
 Identities = 76/286 (26%), Positives = 130/286 (45%), Gaps = 40/286 (13%)

Query: 268 LLGTGGFGRVYRGTLPK---SQIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQ 322
           +LG G FG V    L     S  ++AVK +  +  S   ++EF+ E   +    H N+++
Sbjct: 6   MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65

Query: 323 LLG---YCRRKGEL---LLVYDYMPNGSLDKYLY-----DQP-KVTLNWIQRFRVIKGVA 370
           L+G     R KG L   +++  +M +G L  +L      ++P  + L  + RF +   +A
Sbjct: 66  LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMI--DIA 123

Query: 371 LGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVGTLG 429
            G+ YL     +  IHRD+ A N +L+  +   + DFGL++ +Y      Q       + 
Sbjct: 124 SGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVK 180

Query: 430 YLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGEL 488
           +LA E       TT +DV++FG  + E+   G+ P      SE       ++++  +G  
Sbjct: 181 WLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE-------IYNYLIKGNR 233

Query: 489 LEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILE 534
           L  + P        + LE V +L   C   +P  RPS + +   LE
Sbjct: 234 L--KQP-------PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLE 270

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 68.3 bits (167), Expect = 9e-13
 Identities = 71/277 (25%), Positives = 125/277 (45%), Gaps = 33/277 (11%)

Query: 267 ELLGTGGFGRVYR-GTLPKSQIEIAVKKIS----------HESRQGMKEFVAEIVSIG-R 314
           E LG+G FG VY+       Q  +A+K+I+           E  + + + V+E+  I  +
Sbjct: 6   EHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQ 65

Query: 315 LRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYL--YDQPKVTLNWIQRFRVIKGVALG 372
           LRH N+V+          L +V D +    L ++     + K      + + +   + L 
Sbjct: 66  LRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA 125

Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLA 432
           L YLH+E  + ++HRD+  +N++L  +    + DFGLA+      + + T VVGT+ Y  
Sbjct: 126 LRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAK--QKQPESKLTSVVGTILYSC 181

Query: 433 PEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEAR 492
           PE  +       ADV++FG  L ++   + P      S N++ +          +++EA 
Sbjct: 182 PEIVKNEPYGEKADVWAFGCILYQMCTLQPPFY----STNMLSL--------ATKIVEAV 229

Query: 493 DPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQV 529
              L     +E++  V+     C   D  ARP + QV
Sbjct: 230 YEPLPEGMYSEDVTDVIT---SCLTPDAEARPDIIQV 263

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 68.5 bits (167), Expect = 1e-12
 Identities = 61/206 (29%), Positives = 100/206 (48%), Gaps = 17/206 (8%)

Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQ-GMK-EFVAEIVSIGRLR---HRNLVQL 323
           +G G +G VY+   P S   +A+K +  ++ + G+    V E+  + RL    H N+V+L
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 324 LGYCR-----RKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQ 378
           +  C      R+ ++ LV++++ +  L  YL   P   L       +++    GL +LH 
Sbjct: 68  MDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA 126

Query: 379 EWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRT 438
                ++HRD+K  N+L+      +L DFGLAR+Y        T VV TL Y APE    
Sbjct: 127 ---NCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQM--ALTPVVVTLWYRAPEVLLQ 181

Query: 439 GKATTSADVFSFGAFLLEVACGRRPI 464
               T  D++S G    E+   R+P+
Sbjct: 182 STYATPVDMWSVGCIFAEMF-RRKPL 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 71.0 bits (174), Expect = 1e-12
 Identities = 55/195 (28%), Positives = 92/195 (47%), Gaps = 20/195 (10%)

Query: 285 SQIEIAVKKISHESRQGMKE---FVAEIVSIGRLRHRNLVQLL--GYCRRKGELLLVYDY 339
           +  E+A+K +  ++ +   +   F  E     RL H N+V LL  G     G L  V++Y
Sbjct: 2   TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAP-PGLLFAVFEY 60

Query: 340 MPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLL--- 396
           +P  +L + L       L   +  R++  V   L   H    Q ++HRD+K  N+++   
Sbjct: 61  VPGRTLREVL--AADGALPAGETGRLMLQVLDALACAH---NQGIVHRDLKPQNIMVSQT 115

Query: 397 DGELNGRLGDFGLARL------YDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSF 450
               + ++ DFG+  L       D  T  +TT V+GT  Y APE  R    T ++D++++
Sbjct: 116 GVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAW 175

Query: 451 GAFLLEVACGRRPIQ 465
           G   LE   G+R +Q
Sbjct: 176 GLIFLECLTGQRVVQ 190

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 68.3 bits (167), Expect = 1e-12
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 10/209 (4%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRN 319
           FR   +LG GGFG V    +  +    A KK+  +    R+G    + E   + ++  R 
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61

Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQE 379
           +V L      K  L LV   M  G L  ++Y+      +  +       +  GL  LH+E
Sbjct: 62  VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE 121

Query: 380 WEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTH-VVGTLGYLAPEHTRT 438
               +++RD+K  N+LLD   + R+ D GLA       + +T    VGT+GY+APE  + 
Sbjct: 122 ---RIVYRDLKPENILLDDYGHIRISDLGLAV---EIPEGETIRGRVGTVGYMAPEVVKN 175

Query: 439 GKATTSADVFSFGAFLLEVACGRRPIQRQ 467
            + T S D +  G  + E+  G+ P +++
Sbjct: 176 ERYTFSPDWWGLGCLIYEMIEGKSPFRQR 204

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 68.5 bits (167), Expect = 1e-12
 Identities = 60/202 (29%), Positives = 107/202 (52%), Gaps = 18/202 (8%)

Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMK-EFVAEIVSIGRLRHRNLVQLLG 325
           E LG G +  V++G    ++  +A+K+I  E  +G     + E+  +  L+H N+V L  
Sbjct: 12  EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71

Query: 326 YCRRKGELLLVYDYMPNGSLDKYLYDQPKV-TLNWIQRF--RVIKGVALGLFYLHQEWEQ 382
                  L LV++Y+ +  L +Y+ D   + +++ ++ F  ++++G+A    Y H+   +
Sbjct: 72  IVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFLYQILRGLA----YCHR---R 123

Query: 383 VVIHRDVKASNVLLD--GELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE-HTRTG 439
            V+HRD+K  N+L++  GEL  +L DFGLAR     T   +  VV TL Y  P+    + 
Sbjct: 124 KVLHRDLKPQNLLINERGEL--KLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGSS 180

Query: 440 KATTSADVFSFGAFLLEVACGR 461
           + +T  D++  G    E+A GR
Sbjct: 181 EYSTQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 68.8 bits (169), Expect = 1e-12
 Identities = 66/223 (29%), Positives = 101/223 (45%), Gaps = 57/223 (25%)

Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVA------------EIVSIGRLR 316
           LG G +G V++    +++  +A+KKI          F A            EI+ +  L 
Sbjct: 15  LGKGAYGIVWKAIDRRTKEVVALKKI----------FDAFRNATDAQRTFREIMFLQELG 64

Query: 317 -HRNLVQLLGYCRRKG--ELLLVYDYMPNGSLD-------KYLYDQPKVTLNWIQRFRVI 366
            H N+V+LL   + +   ++ LV++YM     D         L D  K  + + Q  + +
Sbjct: 65  DHPNIVKLLNVIKAENDKDIYLVFEYMET---DLHAVIRANILEDVHKRYIMY-QLLKAL 120

Query: 367 KGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR----LYDHGTDPQTT 422
           K       Y+H      VIHRD+K SN+LL+ +   +L DFGLAR    L ++  +P  T
Sbjct: 121 K-------YIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLT 170

Query: 423 HVVGTLGYLAPE----HTRTGKATTSADVFSFGAFLLEVACGR 461
             V T  Y APE     TR    T   D++S G  L E+  G+
Sbjct: 171 DYVATRWYRAPEILLGSTRY---TKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 68.1 bits (166), Expect = 1e-12
 Identities = 56/201 (27%), Positives = 90/201 (44%), Gaps = 7/201 (3%)

Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCR 328
           +G G  G V   T   +  ++AVKK+    +Q  +    E+V +    H N+V +     
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89

Query: 329 RKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRD 388
              EL +V +++  G+L   +       +N  Q   V   V   L YLH    Q VIHRD
Sbjct: 90  VGDELWVVMEFLEGGALTDIV---THTRMNEEQIATVCLSVLRALSYLHN---QGVIHRD 143

Query: 389 VKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVF 448
           +K+ ++LL  +   +L DFG          P+   +VGT  ++APE        T  D++
Sbjct: 144 IKSDSILLTSDGRIKLSDFGFCAQVSKEV-PKRKSLVGTPYWMAPEVISRLPYGTEVDIW 202

Query: 449 SFGAFLLEVACGRRPIQRQGP 469
           S G  ++E+  G  P   + P
Sbjct: 203 SLGIMVIEMIDGEPPYFNEPP 223

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 67.4 bits (164), Expect = 2e-12
 Identities = 58/212 (27%), Positives = 99/212 (46%), Gaps = 11/212 (5%)

Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCR 328
           +G+G +G VY+     +    A+K I  E  +       EI+ +   +H N+V   G   
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL 76

Query: 329 RKGELLLVYDYMPNGSL-DKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHR 387
           R+ +L +  ++   GSL D Y    P   L+  Q   V +    GL+YLH + +   +HR
Sbjct: 77  RRDKLWICMEFCGGGSLQDIYHVTGP---LSESQIAYVSRETLQGLYYLHSKGK---MHR 130

Query: 388 DVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHT---RTGKATTS 444
           D+K +N+LL    + +L DFG++      T  +    +GT  ++APE     R G     
Sbjct: 131 DIKGANILLTDNGHVKLADFGVSAQIT-ATIAKRKSFIGTPYWMAPEVAAVERKGGYNQL 189

Query: 445 ADVFSFGAFLLEVACGRRPIQRQGPSENLILV 476
            D+++ G   +E+A  + P+    P   L L+
Sbjct: 190 CDIWAVGITAIELAELQPPMFDLHPMRALFLM 221

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 67.8 bits (166), Expect = 2e-12
 Identities = 67/216 (31%), Positives = 98/216 (45%), Gaps = 38/216 (17%)

Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEI---VSIGRLRHR--NLV 321
             +G+G  G+VY+    K+   +AVK++    R G KE    I   + +    H    +V
Sbjct: 21  GEIGSGTCGQVYKMRFKKTGHVMAVKQMR---RTGNKEENKRILMDLDVVLKSHDCPYIV 77

Query: 322 QLLGYCRRKGELLLVYDYMPNGSLDKYL--YDQP-------KVTLNWIQRFRVIKGVALG 372
           +  GY     ++ +  + M    LDK L     P       K+T+       ++K     
Sbjct: 78  KCYGYFITDSDVFICMELMST-CLDKLLKRIQGPIPEDILGKMTVA------IVKA---- 126

Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLA-RLYDHGTDPQTTHVVGTLGYL 431
           L YL ++    VIHRDVK SN+LLD   N +L DFG++ RL D       T   G   Y+
Sbjct: 127 LHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVD---SKAKTRSAGCAAYM 181

Query: 432 APEH----TRTGKATTSADVFSFGAFLLEVACGRRP 463
           APE         K    ADV+S G  L+E+A G+ P
Sbjct: 182 APERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 67.4 bits (165), Expect = 2e-12
 Identities = 69/210 (32%), Positives = 101/210 (48%), Gaps = 34/210 (16%)

Query: 267 ELLGTGGFGRVYRGTLPKSQIE---IAVKKISHESRQGMKEFVA--EIVSIGRLRHRNLV 321
           + LG G +  VY+G   +S++    +A+K+I  E  +G   F A  E   +  L+H N+V
Sbjct: 11  DKLGEGSYATVYKG---RSKLTGQLVALKEIRLEHEEGAP-FTAIREASLLKDLKHANIV 66

Query: 322 QLLGYCRRKGELLLVYDYMPNGSLDKYLYDQP------KVTLNWIQRFRVIKGVALGLFY 375
            L      K  L LV++Y+ +  L +Y+ D         V L   Q  R       GL Y
Sbjct: 67  TLHDIIHTKKTLTLVFEYL-DTDLKQYMDDCGGGLSMHNVRLFLFQLLR-------GLAY 118

Query: 376 LHQEWEQVVIHRDVKASNVLLD--GELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAP 433
            HQ   + V+HRD+K  N+L+   GEL  +L DFGLAR     +   +  VV TL Y  P
Sbjct: 119 CHQ---RRVLHRDLKPQNLLISERGEL--KLADFGLARAKSVPSKTYSNEVV-TLWYRPP 172

Query: 434 EHTRTGKA--TTSADVFSFGAFLLEVACGR 461
           +    G    +TS D++  G    E+A GR
Sbjct: 173 D-VLLGSTEYSTSLDMWGVGCIFYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 67.4 bits (164), Expect = 3e-12
 Identities = 56/216 (25%), Positives = 99/216 (45%), Gaps = 7/216 (3%)

Query: 261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNL 320
           K +   E +G G  G VY      +  E+A+K+++ + +   +  + EI+ +   ++ N+
Sbjct: 19  KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNI 78

Query: 321 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEW 380
           V  L       EL +V +Y+  GSL   + +     ++  Q   V +     L +LH   
Sbjct: 79  VNYLDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHS-- 133

Query: 381 EQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGK 440
              VIHRD+K+ N+LL  + + +L DFG           ++T +VGT  ++APE      
Sbjct: 134 -NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRKA 191

Query: 441 ATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILV 476
                D++S G   +E+  G  P   + P   L L+
Sbjct: 192 YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI 227

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 67.0 bits (163), Expect = 3e-12
 Identities = 61/213 (28%), Positives = 97/213 (45%), Gaps = 26/213 (12%)

Query: 269 LGTGGFGRVYRG-TLPKSQIEIAVKKIS-HESRQGMKEFVAEIVSIGR----LRHRNLVQ 322
           +G G +G+V++   L      +A+K++      +GM       V++ R      H N+V+
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 323 LLGYCR-----RKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLF--- 374
           L   C      R+ +L LV++++ +  L  YL   P+  +        IK +   L    
Sbjct: 69  LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVP----TETIKDMMFQLLRGL 123

Query: 375 -YLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAP 433
            +LH      V+HRD+K  N+L+      +L DFGLAR+Y        T VV TL Y AP
Sbjct: 124 DFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF--QMALTSVVVTLWYRAP 178

Query: 434 EHTRTGKATTSADVFSFGAFLLEVACGRRPIQR 466
           E        T  D++S G    E+   R+P+ R
Sbjct: 179 EVLLQSSYATPVDLWSVGCIFAEMF-RRKPLFR 210

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 66.5 bits (162), Expect = 4e-12
 Identities = 61/205 (29%), Positives = 95/205 (46%), Gaps = 21/205 (10%)

Query: 269 LGTGGFGRVYRGTLPK--SQIEIAVKKI-SHESRQGMKEFVAEIVSIGRLRHRNLVQLLG 325
           +G G FG+V  G +    +  ++ VK++    S Q   +F+ E      L+H NL+Q LG
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLG 62

Query: 326 YCRRKGELLLVYDYMPNGSLDKYLYDQPK---VTLNWIQRFRVIKGVALGLFYLHQEWEQ 382
            C      LLV ++ P G L  YL    K   +T +     R+   +ALGL +LH+    
Sbjct: 63  QCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK---N 119

Query: 383 VVIHRDVKASNVLLDGELNGRLGDFGLARLY---DHGTDPQTTHVVGTLGYLAPE----- 434
             IH D+   N LL  +L  ++GD+GL+      D+   P    V   L ++APE     
Sbjct: 120 NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWV--PLRWIAPELVDEV 177

Query: 435 HTR--TGKATTSADVFSFGAFLLEV 457
           H        T  ++V+S G  + E+
Sbjct: 178 HGNLLVVDQTKESNVWSLGVTIWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 67.0 bits (163), Expect = 5e-12
 Identities = 50/158 (31%), Positives = 77/158 (48%), Gaps = 10/158 (6%)

Query: 317 HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYL 376
           H  LV L    + +  L  V +Y+  G L  ++  Q K+     + +     ++L L YL
Sbjct: 55  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA--EISLALNYL 112

Query: 377 HQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP--QTTHVVGTLGYLAPE 434
           H   E+ +I+RD+K  NVLLD E + +L D+G+ +    G  P   T+   GT  Y+APE
Sbjct: 113 H---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK---EGLRPGDTTSTFCGTPNYIAPE 166

Query: 435 HTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSEN 472
             R      S D ++ G  + E+  GR P    G S+N
Sbjct: 167 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN 204

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 66.2 bits (161), Expect = 6e-12
 Identities = 62/228 (27%), Positives = 105/228 (46%), Gaps = 21/228 (9%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRL-RHRNLV 321
           F   E++G G +G+VY+G   K+  ++A  K+   +    +E   EI  + +   HRN+ 
Sbjct: 18  FELVEVVGNGTYGQVYKGRHVKTG-QLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIA 76

Query: 322 QLLGYCRRKG------ELLLVYDYMPNGSLDKYLYDQPKVTL--NWIQRFRVIKGVALGL 373
              G   +K       +L LV ++   GS+   + +     L  +WI    + + +  GL
Sbjct: 77  TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY--ICREILRGL 134

Query: 374 FYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAP 433
            +LH      VIHRD+K  NVLL      +L DFG++   D     + T  +GT  ++AP
Sbjct: 135 AHLHA---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-FIGTPYWMAP 190

Query: 434 EHTRTGKATTS-----ADVFSFGAFLLEVACGRRPIQRQGPSENLILV 476
           E     +   +     +D++S G   +E+A G  P+    P   L L+
Sbjct: 191 EVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLI 238

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 66.2 bits (161), Expect = 6e-12
 Identities = 65/213 (30%), Positives = 100/213 (46%), Gaps = 27/213 (12%)

Query: 268 LLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLL--G 325
           ++G GGFG VY G       ++   K   + R  MK+   E ++   L  R ++ L+  G
Sbjct: 1   IIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQ--GETLA---LNERIMLSLVSTG 54

Query: 326 YC----------RRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFY 375
            C              +L  + D M  G L  +L  Q  V      RF   + + LGL +
Sbjct: 55  DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHL-SQHGVFSEKEMRFYATE-IILGLEH 112

Query: 376 LHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEH 435
           +H  +   V++RD+K +N+LLD   + R+ D GLA  +     P  +  VGT GY+APE 
Sbjct: 113 MHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHAS--VGTHGYMAPEV 166

Query: 436 TRTGKA-TTSADVFSFGAFLLEVACGRRPIQRQ 467
            + G A  +SAD FS G  L ++  G  P ++ 
Sbjct: 167 LQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQH 199

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 65.3 bits (159), Expect = 8e-12
 Identities = 73/278 (26%), Positives = 129/278 (46%), Gaps = 36/278 (12%)

Query: 266 KELLGTGGFGRVY--------RGTLPKSQIEIAVKKIS-HESRQGMKEFVAEIVSIGRLR 316
           ++ LG G FG VY             K   EI V +++ +E+ Q  +E  A+++S  +L 
Sbjct: 5   QQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQE--AQLLS--KLD 60

Query: 317 HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYL--YDQPKVTLNWIQRFRVIKGVALGLF 374
           H  +V+       +    ++ +Y     LD  L        TL+  Q       + LG+ 
Sbjct: 61  HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH 120

Query: 375 YLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE 434
           Y+HQ   + ++HRD+KA N+ L   L  ++GDFG++RL     D  TT   GT  Y++PE
Sbjct: 121 YMHQ---RRILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGSCDLATT-FTGTPYYMSPE 175

Query: 435 HTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDP 494
             +     + +D++S G  L E+ C    +      +N + V  V        ++E   P
Sbjct: 176 ALKHQGYDSKSDIWSLGCILYEMCC----LAHAFEGQNFLSV--VL------RIVEGPTP 223

Query: 495 NLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQI 532
           +L   Y + +L  +++  L   + DP+ RPS  ++++ 
Sbjct: 224 SLPETY-SRQLNSIMQSML---NKDPSLRPSAAEILRN 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 65.5 bits (160), Expect = 9e-12
 Identities = 55/196 (28%), Positives = 93/196 (47%), Gaps = 9/196 (4%)

Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCR 328
           +G G  G V   T   +  ++AVKK+    +Q  +    E+V +   +H N+V++     
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYL 86

Query: 329 RKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRD 388
              EL +V +++  G+L   +       +N  Q   V   V   L +LH    Q VIHRD
Sbjct: 87  VGDELWVVMEFLEGGALTDIV---THTRMNEEQIATVCLAVLKALSFLHA---QGVIHRD 140

Query: 389 VKASNVLLDGELNGRLGDFGL-ARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADV 447
           +K+ ++LL  +   +L DFG  A++      P+   +VGT  ++APE        T  D+
Sbjct: 141 IKSDSILLTSDGRVKLSDFGFCAQVSKE--VPRRKSLVGTPYWMAPEVISRLPYGTEVDI 198

Query: 448 FSFGAFLLEVACGRRP 463
           +S G  ++E+  G  P
Sbjct: 199 WSLGIMVIEMVDGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 66.0 bits (161), Expect = 9e-12
 Identities = 66/223 (29%), Positives = 110/223 (49%), Gaps = 27/223 (12%)

Query: 267 ELLGTGGFGRVY---------RGTLPKSQI-EIAVKKISHESRQGM-KEFVAEIVSIGRL 315
           ++LG G FG+V+          G L   ++ + A  K+    R  M ++ +AE+      
Sbjct: 2   KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEV------ 55

Query: 316 RHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFY 375
            H  +V+L    + +G+L L+ D++  G L   L  +   T   ++ +  +  +AL L +
Sbjct: 56  NHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFY--LAELALALDH 113

Query: 376 LHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVGTLGYLAPE 434
           LH      +I+RD+K  N+LLD E + +L DFGL++   DH  + +     GT+ Y+APE
Sbjct: 114 LHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH--EKKAYSFCGTVEYMAPE 168

Query: 435 HTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSE--NLIL 475
                  T SAD +SFG  + E+  G  P Q +   E   +IL
Sbjct: 169 VVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMIL 211

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 65.0 bits (158), Expect = 1e-11
 Identities = 66/266 (24%), Positives = 117/266 (43%), Gaps = 23/266 (8%)

Query: 269 LGTGGFGRV--YRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLL-G 325
           +G G +G V   R      Q  I    + + SR+  K    E   + +L+H N+V     
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67

Query: 326 YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVI 385
           +    G L +V  +   G L   L +Q    L   Q       +A+ L YLH   E+ ++
Sbjct: 68  WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH---EKHIL 124

Query: 386 HRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSA 445
           HRD+K  NV L      ++GD G+AR+ ++  D  +T ++GT  Y++PE          +
Sbjct: 125 HRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST-LIGTPYYMSPELFSNKPYNYKS 183

Query: 446 DVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAEEL 505
           DV++ G  + E+A  +     +    +L+             ++E + P +  +Y  E  
Sbjct: 184 DVWALGCCVYEMATLKHAFNAKD-MNSLVY-----------RIIEGKLPPMPKDYSPELG 231

Query: 506 ELVLKLGLLCSHSDPTARPSMRQVVQ 531
           EL+    +L     P  RPS++ +++
Sbjct: 232 ELIAT--MLSKR--PEKRPSVKSILR 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 65.9 bits (160), Expect = 1e-11
 Identities = 55/217 (25%), Positives = 102/217 (47%), Gaps = 9/217 (4%)

Query: 261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNL 320
           K +   E +G G  G VY      +  E+A+++++ + +   +  + EI+ +   ++ N+
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 79

Query: 321 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEW 380
           V  L       EL +V +Y+  GSL   + +     ++  Q   V +     L +LH   
Sbjct: 80  VNYLDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHS-- 134

Query: 381 EQVVIHRDVKASNVLLDGELNGRLGDFGL-ARLYDHGTDPQTTHVVGTLGYLAPEHTRTG 439
              VIHRD+K+ N+LL  + + +L DFG  A++    +  + + +VGT  ++APE     
Sbjct: 135 -NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRK 191

Query: 440 KATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILV 476
                 D++S G   +E+  G  P   + P   L L+
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI 228

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 65.5 bits (160), Expect = 1e-11
 Identities = 58/213 (27%), Positives = 98/213 (46%), Gaps = 14/213 (6%)

Query: 263 FREKELLGTGGFGRVY--RGTLPKSQIEIAVKKISHESRQGMKEFV-AEIVSIGRLRHRN 319
               + +GTG FGRV+  R  + +    + V  I    R   ++ V  E   +  + H  
Sbjct: 3   LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPF 62

Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQE 379
           +++L      +  L ++ +Y+P G L  YL +  + + N    F   + V   L YLH  
Sbjct: 63  IIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFS-NSTGLFYASEIVC-ALEYLHS- 119

Query: 380 WEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVGTLGYLAPEHTRT 438
             + +++RD+K  N+LLD E + +L DFG A+ L D     +T  + GT  YLAPE  ++
Sbjct: 120 --KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD-----RTWTLCGTPEYLAPEVIQS 172

Query: 439 GKATTSADVFSFGAFLLEVACGRRPIQRQGPSE 471
                + D ++ G  + E+  G  P     P  
Sbjct: 173 KGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG 205

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 65.7 bits (160), Expect = 1e-11
 Identities = 57/201 (28%), Positives = 95/201 (47%), Gaps = 10/201 (4%)

Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVS--IGRLRHRN--LVQ 322
           ++LG G FG+V    L       AVK +  +      +    +V   +  L   N  L  
Sbjct: 1   KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60

Query: 323 LLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQ 382
           L    + K  L  V +++  G L  ++ D+ +  L +   F   + +  GL +LH +   
Sbjct: 61  LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDL-YRATFYAAE-IVCGLQFLHSKG-- 116

Query: 383 VVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKAT 442
            +I+RD+K  NV+LD + + ++ DFG+ +    G +  +T   GT  Y+APE  +  K T
Sbjct: 117 -IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST-FCGTPDYIAPEILQGLKYT 174

Query: 443 TSADVFSFGAFLLEVACGRRP 463
            S D +SFG  L E+  G+ P
Sbjct: 175 FSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 65.9 bits (161), Expect = 1e-11
 Identities = 60/204 (29%), Positives = 102/204 (50%), Gaps = 16/204 (7%)

Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
           +G G +G V      ++  ++A+KKI++  ++R   K  + EI  +  L H N++ +   
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72

Query: 327 ----CRRKGE-LLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
                R     + +VY+ M +  L + +     ++ +  Q F  +  +  GL Y+H    
Sbjct: 73  MPPPHREAFNDVYIVYELM-DTDLHQIIRSSQTLSDDHCQYF--LYQLLRGLKYIHS--- 126

Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHT-RTGK 440
             V+HRD+K SN+LL+   + ++ DFGLAR      D  T +VV T  Y APE      +
Sbjct: 127 ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRWYRAPELLLNCSE 185

Query: 441 ATTSADVFSFGAFLLEVACGRRPI 464
            TT+ DV+S G    E+  GR+P+
Sbjct: 186 YTTAIDVWSVGCIFAELL-GRKPL 208

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 65.7 bits (160), Expect = 2e-11
 Identities = 61/209 (29%), Positives = 95/209 (45%), Gaps = 27/209 (12%)

Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQ--LLGY 326
           +G G FG+VY+     ++   A+K +S       KE VA+      +  RN++   LL  
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSK------KEIVAKKEVAHTIGERNILVRTLLDE 54

Query: 327 C----------RRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRV-IKGVALGLFY 375
                      +   +L LV DYM  G L  +L  + + +     R +  I  + L L +
Sbjct: 55  SPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSE---DRAKFYIAELVLALEH 111

Query: 376 LHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEH 435
           LH   +  +++RD+K  N+LLD   +  L DFGL++  +   +  T    GT  YLAPE 
Sbjct: 112 LH---KYDIVYRDLKPENILLDATGHIALCDFGLSKA-NLTDNKTTNTFCGTTEYLAPEV 167

Query: 436 TRTGKA-TTSADVFSFGAFLLEVACGRRP 463
               K  T   D +S G  + E+ CG  P
Sbjct: 168 LLDEKGYTKHVDFWSLGVLVFEMCCGWSP 196

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 65.2 bits (159), Expect = 2e-11
 Identities = 63/212 (29%), Positives = 98/212 (46%), Gaps = 20/212 (9%)

Query: 269 LGTGGFGRVYRGTLPKSQIE---IAVKKISHES---RQGMKEFVAE-IVSIGRLRHRNLV 321
           +G G FG+V    L K + +    AVK +  ++   ++  K  +AE  V +  ++H  LV
Sbjct: 3   IGKGSFGKVL---LAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLV 59

Query: 322 QLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
            L    +   +L  V DY+  G L  +L  + +       RF   + +A  L YLH    
Sbjct: 60  GLHYSFQTADKLYFVLDYVNGGELFFHL-QRERSFPEPRARFYAAE-IASALGYLH---S 114

Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ--TTHVVGTLGYLAPEHTRTG 439
             +I+RD+K  N+LLD + +  L DFGL +    G +    T+   GT  YLAPE  R  
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCK---EGIEHSKTTSTFCGTPEYLAPEVLRKQ 171

Query: 440 KATTSADVFSFGAFLLEVACGRRPIQRQGPSE 471
               + D +  GA L E+  G  P   +  +E
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE 203

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 64.7 bits (157), Expect = 2e-11
 Identities = 55/208 (26%), Positives = 94/208 (45%), Gaps = 7/208 (3%)

Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCR 328
           +G G  G V   T+  S   +AVKK+    +Q  +    E+V +   +H N+V++     
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87

Query: 329 RKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRD 388
              EL +V +++  G+L   +       +N  Q   V   V   L  LH    Q VIHRD
Sbjct: 88  VGDELWVVMEFLEGGALTDIV---THTRMNEEQIAAVCLAVLKALSVLHA---QGVIHRD 141

Query: 389 VKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVF 448
           +K+ ++LL  +   +L DFG          P+   +VGT  ++APE           D++
Sbjct: 142 IKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKSLVGTPYWMAPELISRLPYGPEVDIW 200

Query: 449 SFGAFLLEVACGRRPIQRQGPSENLILV 476
           S G  ++E+  G  P   + P + + ++
Sbjct: 201 SLGIMVIEMVDGEPPYFNEPPLKAMKMI 228

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 64.2 bits (156), Expect = 2e-11
 Identities = 65/212 (30%), Positives = 100/212 (47%), Gaps = 27/212 (12%)

Query: 268 LLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLL--G 325
           ++G GGFG VY G       ++   K   + R  MK+   E ++   L  R ++ L+  G
Sbjct: 1   IIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQ--GETLA---LNERIMLSLVSTG 54

Query: 326 YC----------RRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFY 375
            C              +L  + D M  G L  +L  Q  V      RF   + + LGL +
Sbjct: 55  DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL-SQHGVFSEAEMRFYAAE-IILGLEH 112

Query: 376 LHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEH 435
           +H  +   V++RD+K +N+LLD   + R+ D GLA  +     P  +  VGT GY+APE 
Sbjct: 113 MHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHAS--VGTHGYMAPEV 166

Query: 436 TRTGKA-TTSADVFSFGAFLLEVACGRRPIQR 466
            + G A  +SAD FS G  L ++  G  P ++
Sbjct: 167 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 64.6 bits (158), Expect = 3e-11
 Identities = 57/222 (25%), Positives = 97/222 (43%), Gaps = 48/222 (21%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGRLRHRNL 320
           ++    +G+G +G+V      K+  ++A+KK+S   +S    K    E+  +  + H N+
Sbjct: 17  YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENV 76

Query: 321 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVT------LNWIQRFRV--------- 365
           + LL              + P  SL+ +  D   VT      LN I + +          
Sbjct: 77  IGLLDV------------FTPASSLEDF-QDVYLVTHLMGADLNNIVKCQKLSDDHIQFL 123

Query: 366 IKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVV 425
           +  +  GL Y+H      +IHRD+K SN+ ++ +   ++ DFGLAR     TD + T  V
Sbjct: 124 VYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARH----TDDEMTGYV 176

Query: 426 GTLGYLAPE------HTRTGKATTSADVFSFGAFLLEVACGR 461
            T  Y APE      H        + D++S G  + E+  G+
Sbjct: 177 ATRWYRAPEIMLNWMHY-----NQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 63.9 bits (155), Expect = 4e-11
 Identities = 61/203 (30%), Positives = 99/203 (48%), Gaps = 24/203 (11%)

Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMK-EFVAEIVSIGRLRHRNLVQLLGYC 327
           LG G +  V++G    ++  +A+K+I  E  +G     + E+  +  L+H N+V L    
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII 72

Query: 328 RRKGELLLVYDYMPNGSLDKYL------YDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
             +  L LV++Y+ +  L +YL           V +   Q  R       GL Y H   +
Sbjct: 73  HTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLR-------GLSYCH---K 121

Query: 382 QVVIHRDVKASNVLLD--GELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE-HTRT 438
           + ++HRD+K  N+L++  GEL  +L DFGLAR     T   +  VV TL Y  P+    +
Sbjct: 122 RKILHRDLKPQNLLINEKGEL--KLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGS 178

Query: 439 GKATTSADVFSFGAFLLEVACGR 461
            + +T  D++  G  L E+A GR
Sbjct: 179 TEYSTPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 63.4 bits (154), Expect = 5e-11
 Identities = 65/206 (31%), Positives = 99/206 (48%), Gaps = 26/206 (12%)

Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVA--EIVSIGRLRHRNLVQLL 324
           E LG G +  VY+G    +   +A+K IS ++ +G+  F A  E   +  L+H N+V L 
Sbjct: 11  EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVP-FTAIREASLLKGLKHANIVLLH 69

Query: 325 GYCRRKGELLLVYDYMPNGSLDKYLYDQP------KVTLNWIQRFRVIKGVALGLFYLHQ 378
                K  L  V++YM +  L +Y+   P       V L   Q  R       GL Y+H 
Sbjct: 70  DIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQLLR-------GLAYIHG 121

Query: 379 EWEQVVIHRDVKASNVLLD--GELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHT 436
              Q ++HRD+K  N+L+   GEL  +L DFGLAR     +   ++ VV TL Y  P+  
Sbjct: 122 ---QHILHRDLKPQNLLISYLGEL--KLADFGLARAKSIPSQTYSSEVV-TLWYRPPDVL 175

Query: 437 RTGKATTSA-DVFSFGAFLLEVACGR 461
                 +SA D++  G   +E+  G+
Sbjct: 176 LGATDYSSALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 63.5 bits (155), Expect = 6e-11
 Identities = 64/216 (29%), Positives = 92/216 (42%), Gaps = 31/216 (14%)

Query: 263 FREKELLGTGGFGRV----YRGT--------LPKSQIEIA---VKKISHESRQGMKEFVA 307
           FR   +LG G FG+V    Y+ T        L K  I IA   V+ +  E R      + 
Sbjct: 1   FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDI-IARDEVESLMCEKR------IF 53

Query: 308 EIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIK 367
           E  +    RH  LV L    + +  +  V +Y   G L   ++    V       F    
Sbjct: 54  ETAN--SERHPFLVNLFACFQTEDHVCFVMEYAAGGDL--MMHIHTDVFSEPRAVFYAAC 109

Query: 368 GVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT 427
            V LGL YLH   E  +++RD+K  N+LLD E   ++ DFGL +    G   +T+   GT
Sbjct: 110 -VVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCK-EGMGFGDRTSTFCGT 164

Query: 428 LGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRP 463
             +LAPE       T + D +  G  + E+  G  P
Sbjct: 165 PEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP 200

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 63.6 bits (155), Expect = 8e-11
 Identities = 58/219 (26%), Positives = 99/219 (45%), Gaps = 20/219 (9%)

Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGRLRHRNLVQLL-- 324
           +G G FG V+  T P+    +A+KK+ +  ++    K    E+  +   +H N++  L  
Sbjct: 8   IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDI 67

Query: 325 ------GYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQ 378
                        E+ +V + M    L K +     ++ + ++ F  +  +  GL YLH 
Sbjct: 68  LQPPHIDPFE---EIYVVTELM-QSDLHKIIVSPQPLSSDHVKVF--LYQILRGLKYLHS 121

Query: 379 EWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRT 438
                ++HRD+K  N+L++     ++ DFGLAR+ +       T  V T  Y APE    
Sbjct: 122 AG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMG 178

Query: 439 GKATTSA-DVFSFGAFLLEVACGRRPIQRQGPSENLILV 476
            +  TSA D++S G    E+   R   Q Q P + L L+
Sbjct: 179 SRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLI 217

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 61.9 bits (151), Expect = 1e-10
 Identities = 58/213 (27%), Positives = 98/213 (46%), Gaps = 21/213 (9%)

Query: 272 GGFGRVY--RGTLPKSQIEIAVKKISHESRQGMKEFV-AEIVSIGRLRHRNLVQLLGYCR 328
           G +GRV+  +         I V K +   R+   + V  E   + + +   +V+L  Y  
Sbjct: 4   GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL--YYS 61

Query: 329 RKGE--LLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIH 386
            +G+  L LV +Y+P G L   L +   +  +  + +  I  + L L YLH      +IH
Sbjct: 62  FQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIY--IAEIVLALEYLHS---NGIIH 116

Query: 387 RDVKASNVLLDGELNGRLGDFGLAR-------LYDHGTDPQTTHVVGTLGYLAPEHTRTG 439
           RD+K  N+L+D   + +L DFGL++       +  +  + +   +VGT  Y+APE    G
Sbjct: 117 RDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPE-VILG 175

Query: 440 KATT-SADVFSFGAFLLEVACGRRPIQRQGPSE 471
           +  + + D +S G  L E   G  P   + P E
Sbjct: 176 QGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE 208

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 62.5 bits (152), Expect = 1e-10
 Identities = 60/204 (29%), Positives = 93/204 (45%), Gaps = 29/204 (14%)

Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVA---------EIVSIGRLRHRN 319
           +G G FG V       +   +A+KKI       MK F           E+  +  LRH N
Sbjct: 18  VGMGAFGLVCSARDQLTGQNVAIKKI-------MKPFSTPVLAKRTYRELKLLKHLRHEN 70

Query: 320 LVQLLG-YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQ 378
           ++ L   +     ++  V + +    L + L  +P +   +IQ F  +  +  GL Y+H 
Sbjct: 71  IISLSDIFISPLEDIYFVTELLGT-DLHRLLTSRP-LEKQFIQYF--LYQILRGLKYVHS 126

Query: 379 EWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRT 438
                V+HRD+K SN+L++   + ++ DFGLAR+     DPQ T  V T  Y APE   T
Sbjct: 127 AG---VVHRDLKPSNILINENCDLKICDFGLARI----QDPQMTGYVSTRYYRAPEIMLT 179

Query: 439 -GKATTSADVFSFGAFLLEVACGR 461
             K     D++S G    E+  G+
Sbjct: 180 WQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 62.5 bits (152), Expect = 2e-10
 Identities = 34/96 (35%), Positives = 55/96 (57%), Gaps = 6/96 (6%)

Query: 369 VALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHV-VGT 427
           +A+GLF+LH    + +I+RD+K  NV+LD E + ++ DFG+ +  ++    +TT    GT
Sbjct: 110 IAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCK--ENIFGGKTTRTFCGT 164

Query: 428 LGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRP 463
             Y+APE         S D ++FG  L E+  G+ P
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPP 200

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 61.6 bits (149), Expect = 2e-10
 Identities = 59/212 (27%), Positives = 96/212 (45%), Gaps = 11/212 (5%)

Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCR 328
           +G+G +G VY+     +    AVK I  E          EI  +   +H N+V   G   
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76

Query: 329 RKGELLLVYDYMPNGSL-DKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHR 387
            + +L +  +Y   GSL D Y    P   L+ +Q   V +    GL YLH + +   +HR
Sbjct: 77  SREKLWICMEYCGGGSLQDIYHVTGP---LSELQIAYVCRETLQGLAYLHSKGK---MHR 130

Query: 388 DVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHT---RTGKATTS 444
           D+K +N+LL    + +L DFG+A      T  +    +GT  ++APE     + G     
Sbjct: 131 DIKGANILLTDNGDVKLADFGVAAKIT-ATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQL 189

Query: 445 ADVFSFGAFLLEVACGRRPIQRQGPSENLILV 476
            D+++ G   +E+A  + P+    P   L L+
Sbjct: 190 CDIWAVGITAIELAELQPPMFDLHPMRALFLM 221

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 62.1 bits (151), Expect = 2e-10
 Identities = 65/238 (27%), Positives = 93/238 (39%), Gaps = 55/238 (23%)

Query: 252 RYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVS 311
           RY DL            LG G  G V+          +AVKKI     Q +K  + EI  
Sbjct: 6   RYMDLRP----------LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKI 55

Query: 312 IGRLRHRNLVQLLGYCRRKGE--------------LLLVYDYMPNGSLDKYLYDQP---- 353
           I RL H N+V++       G               + +V +YM    L   L   P    
Sbjct: 56  IRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYM-ETDLANVLEQGPLSEE 114

Query: 354 KVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGE-LNGRLGDFGLARL 412
              L   Q  R       GL Y+H      V+HRD+K +NV ++ E L  ++GDFGLAR+
Sbjct: 115 HARLFMYQLLR-------GLKYIHS---ANVLHRDLKPANVFINTEDLVLKIGDFGLARI 164

Query: 413 YDHGTDPQTTH------VVGTLGYLAPE---HTRTGKATTSADVFSFGAFLLEVACGR 461
                DP  +H       + T  Y +P           T + D+++ G    E+  G+
Sbjct: 165 ----VDPHYSHKGYLSEGLVTKWYRSPRLLLSPN--NYTKAIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 62.1 bits (151), Expect = 2e-10
 Identities = 55/210 (26%), Positives = 93/210 (44%), Gaps = 12/210 (5%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKE---FVAEIVSIGRLRHRN 319
           F   E LGTG FGRV       +    A+K +       MK+      E   +  L H  
Sbjct: 20  FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPF 79

Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQE 379
           +V ++   + +  +  + +++  G L  +L    +   N + +F   + + L   YLH  
Sbjct: 80  IVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFP-NDVAKFYHAE-LVLAFEYLH-- 135

Query: 380 WEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTG 439
             + +I+RD+K  N+LLD + + ++ DFG A+      D +T  + GT  YLAPE  ++ 
Sbjct: 136 -SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKV---PD-RTFTLCGTPEYLAPEVIQSK 190

Query: 440 KATTSADVFSFGAFLLEVACGRRPIQRQGP 469
               + D ++ G  L E   G  P     P
Sbjct: 191 GHGKAVDWWTMGVLLYEFIAGYPPFFDDTP 220

Length = 329

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 61.6 bits (149), Expect = 3e-10
 Identities = 58/206 (28%), Positives = 95/206 (46%), Gaps = 20/206 (9%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMK-EFVAEIVSIGRLRHRNLV 321
           + + E LG G +  VY+G    +   +A+K I  +  +G     + E   +  L+H N+V
Sbjct: 7   YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIV 66

Query: 322 QLLGYCRRKGELLLVYDYMPNGSLDKYLYDQP------KVTLNWIQRFRVIKGVALGLFY 375
            L      K  L LV++Y+ +  L +Y+   P       V L   Q  R       GL Y
Sbjct: 67  LLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFLFQLLR-------GLSY 118

Query: 376 LHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE- 434
           +HQ +   ++HRD+K  N+L+      +L DFGLAR     +   +  VV TL Y  P+ 
Sbjct: 119 IHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV-TLWYRPPDV 174

Query: 435 HTRTGKATTSADVFSFGAFLLEVACG 460
              + + +T  D++  G   +E+  G
Sbjct: 175 LLGSTEYSTCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 61.9 bits (150), Expect = 3e-10
 Identities = 59/219 (26%), Positives = 101/219 (46%), Gaps = 22/219 (10%)

Query: 263 FREKELLGTGGFGRVY--RGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGR-----L 315
           F   ++LGTG +G+V+  R        ++   K+  ++    K    E     R     +
Sbjct: 2   FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61

Query: 316 RHRNLVQLLGYC-RRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKG-VALGL 373
           R    +  L Y  + + +L L+ DY+  G +  +LY +   + + +   R   G + L L
Sbjct: 62  RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEV---RFYSGEIILAL 118

Query: 374 FYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAP 433
            +LH+     +++RD+K  N+LLD E +  L DFGL++ +      +T    GT+ Y+AP
Sbjct: 119 EHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAP 175

Query: 434 EHTRT----GKATTSADVFSFGAFLLEVACGRRPIQRQG 468
           E  R     GKA    D +S G  + E+  G  P   +G
Sbjct: 176 EIIRGKGGHGKAV---DWWSLGILIFELLTGASPFTLEG 211

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 61.2 bits (148), Expect = 3e-10
 Identities = 60/227 (26%), Positives = 100/227 (44%), Gaps = 37/227 (16%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKIS-HESRQ--GMKEFV-AEIVSIGRLRH- 317
           F   ++LGTG +G+V+            V+K+S H+S +   MK    A IV   +    
Sbjct: 2   FELLKVLGTGAYGKVF-----------LVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEH 50

Query: 318 -RNLVQLLGYCRR-------------KGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRF 363
            R   Q+L + R+               +L L+ DY+  G L  +L  + +     +Q +
Sbjct: 51  TRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIY 110

Query: 364 RVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTH 423
                + L L +LH+     +I+RD+K  N+LLD   +  L DFGL++ +      +   
Sbjct: 111 --SGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYS 165

Query: 424 VVGTLGYLAPEHTRTGKA--TTSADVFSFGAFLLEVACGRRPIQRQG 468
             GT+ Y+AP+  R G      + D +S G  + E+  G  P    G
Sbjct: 166 FCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDG 212

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 61.5 bits (149), Expect = 3e-10
 Identities = 63/216 (29%), Positives = 99/216 (45%), Gaps = 24/216 (11%)

Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHES---RQGMKEFVAE-IVSIGRLRHRNLVQ 322
           +++G G FG+V            AVK +  ++   ++     +AE  V +  L+H  LV 
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60

Query: 323 LLGYCRRKGELLLVYDYMPNGSLDKYL-----YDQPKVTLNWIQRFRVIKGVALGLFYLH 377
           L    +   +L  V DY+  G L  +L     + +P+       RF   + VA  + YLH
Sbjct: 61  LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRA------RFYAAE-VASAIGYLH 113

Query: 378 QEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ--TTHVVGTLGYLAPEH 435
                 +I+RD+K  N+LLD + +  L DFGL +    G +P+  T+   GT  YLAPE 
Sbjct: 114 S---LNIIYRDLKPENILLDSQGHVVLTDFGLCK---EGVEPEETTSTFCGTPEYLAPEV 167

Query: 436 TRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSE 471
            R      + D +  GA L E+  G  P   +  S+
Sbjct: 168 LRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ 203

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 61.0 bits (148), Expect = 4e-10
 Identities = 46/142 (32%), Positives = 72/142 (50%), Gaps = 10/142 (7%)

Query: 333 LLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKAS 392
           L  V +++  G L  ++  Q K+      RF   + ++L L +LH   E+ +I+RD+K  
Sbjct: 71  LFFVIEFVSGGDLMFHMQRQRKLPEEH-ARFYSAE-ISLALNFLH---ERGIIYRDLKLD 125

Query: 393 NVLLDGELNGRLGDFGLARLYDHGTDP--QTTHVVGTLGYLAPEHTRTGKATTSADVFSF 450
           NVLLD E + +L D+G+ +    G  P   T+   GT  Y+APE  R      S D ++ 
Sbjct: 126 NVLLDAEGHIKLTDYGMCK---EGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWAL 182

Query: 451 GAFLLEVACGRRPIQRQGPSEN 472
           G  + E+  GR P    G S+N
Sbjct: 183 GVLMFEMMAGRSPFDIVGMSDN 204

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 61.0 bits (148), Expect = 5e-10
 Identities = 59/213 (27%), Positives = 95/213 (44%), Gaps = 30/213 (14%)

Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHES-------RQGMKEFVAEIVSIGRLRHRN 319
           ++LG G FG+V    L  +    A+K +  +           M E    I+++   +H  
Sbjct: 1   KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTE--KRILALAA-KHPF 57

Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSL-----DKYLYDQPKVTLNWIQRFRVIKGVALGLF 374
           L  L    + K  L  V +Y+  G L         +D+P+       RF   + V L L 
Sbjct: 58  LTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPR------SRFYAAE-VTLALM 110

Query: 375 YLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP--QTTHVVGTLGYLA 432
           +LH+     VI+RD+K  N+LLD E + +L DFG+ +    G      TT   GT  Y+A
Sbjct: 111 FLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCK---EGILNGVTTTTFCGTPDYIA 164

Query: 433 PEHTRTGKATTSADVFSFGAFLLEVACGRRPIQ 465
           PE  +  +   S D ++ G  + E+  G+ P +
Sbjct: 165 PEILQELEYGPSVDWWALGVLMYEMMAGQPPFE 197

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 60.7 bits (147), Expect = 5e-10
 Identities = 73/278 (26%), Positives = 122/278 (43%), Gaps = 57/278 (20%)

Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHES-------RQGMKEFVAEIVSIGRLRHRN 319
            +LG G FG+V    L +S    AVK +  +           M E    I+S+ R  H  
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTE--KRILSLAR-NHPF 57

Query: 320 LVQLLGYCRRKGE-LLLVYDYMPNGSLDKYL-----YDQPKVTLNWIQRFRVIKGVALGL 373
           L QL   C +  + L  V +++  G L  ++     +D+ +       RF   + +   L
Sbjct: 58  LTQLY-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARA------RFYAAE-ITSAL 109

Query: 374 FYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR--LYDHGTDPQTTHVVGTLGYL 431
            +LH   ++ +I+RD+K  NVLLD E + +L DFG+ +  +++  T   T+   GT  Y+
Sbjct: 110 MFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT---TSTFCGTPDYI 163

Query: 432 APEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEA 491
           APE  +      S D ++ G  L E+ CG  P                F+  N  +L EA
Sbjct: 164 APEILQEMLYGPSVDWWAMGVLLYEMLCGHAP----------------FEAENEDDLFEA 207

Query: 492 --RDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMR 527
              D  +   +++++   +LK   +      T  P+MR
Sbjct: 208 ILNDEVVYPTWLSQDAVDILK-AFM------TKNPTMR 238

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 60.8 bits (148), Expect = 5e-10
 Identities = 58/241 (24%), Positives = 90/241 (37%), Gaps = 48/241 (19%)

Query: 268 LLGTGGFGRVYRGTLPKSQIEIAVKKIS----HESRQGM-----KEFVAEIVSIGRLRHR 318
           ++G G FG V+      +    A+K +      +  Q       ++ +A+  S       
Sbjct: 8   VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS------P 61

Query: 319 NLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQ 378
            +V+L    + +  L LV +YMP G L   L  +        + +  I  + L L  +H+
Sbjct: 62  WIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFY--IAELVLALDSVHK 119

Query: 379 EWEQVVIHRDVKASNVLLDGELNGRLGDFGLA--------RLYD---------------H 415
                 IHRD+K  N+L+D + + +L DFGL         R Y                 
Sbjct: 120 ---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVR 176

Query: 416 GTDPQTTHV-----VGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPS 470
             D +   V     VGT  Y+APE  R        D +S G  L E+  G  P       
Sbjct: 177 RRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ 236

Query: 471 E 471
           E
Sbjct: 237 E 237

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 60.5 bits (147), Expect = 6e-10
 Identities = 64/220 (29%), Positives = 100/220 (45%), Gaps = 42/220 (19%)

Query: 269 LGTGGFGRV--YRGTLPKSQIEIAVKKISHESRQGM--KEFVAEIVSIGRLR-HRNLVQL 323
           LG G +G V   R      +  +A+KKI++   + +  K  + E+  +   R H+N+  L
Sbjct: 8   LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCL 67

Query: 324 LGYCRRKGELLLVYDYMPNGSLDKYLYDQP-KVTLNWI------------QRFRVIKGVA 370
                   ++ +V+    N     YLY++  +  L+ I            Q F  I  + 
Sbjct: 68  Y-------DMDIVFPGNFNEL---YLYEELMEADLHQIIRSGQPLTDAHFQSF--IYQIL 115

Query: 371 LGLFYLHQEWEQVVIHRDVKASNVL--LDGELNGRLGDFGLARLYDHG---TDPQTTHVV 425
            GL Y+H      V+HRD+K  N+L   D EL  ++ DFGLAR +           T  V
Sbjct: 116 CGLKYIHS---ANVLHRDLKPGNLLVNADCEL--KICDFGLARGFSENPGENAGFMTEYV 170

Query: 426 GTLGYLAPEHTRTGKATTSA-DVFSFGAFLLEVACGRRPI 464
            T  Y APE   + ++ T A DV+S G  L E+  GR+P+
Sbjct: 171 ATRWYRAPEIMLSFQSYTKAIDVWSVGCILAEL-LGRKPV 209

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 60.8 bits (147), Expect = 6e-10
 Identities = 64/228 (28%), Positives = 93/228 (40%), Gaps = 24/228 (10%)

Query: 252 RYKDLYIATKGFREK-------ELLGTGGFGRVYRGTLPKSQIEIAVK---KISHESRQG 301
           RY+ +    +  + K       +++G G FG V       SQ   A+K   K     R  
Sbjct: 27  RYEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSD 86

Query: 302 MKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYL--YDQPKVTLNW 359
              F  E   +       +VQL    +    L +V +YMP G L   +  YD P+    W
Sbjct: 87  SAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPE---KW 143

Query: 360 IQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP 419
            + +     V L L  +H      +IHRDVK  N+LLD   + +L DFG     D     
Sbjct: 144 AKFYTA--EVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMV 198

Query: 420 QTTHVVGTLGYLAPEHTRT----GKATTSADVFSFGAFLLEVACGRRP 463
           +    VGT  Y++PE  ++    G      D +S G FL E+  G  P
Sbjct: 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 60.4 bits (146), Expect = 6e-10
 Identities = 36/105 (34%), Positives = 58/105 (55%), Gaps = 8/105 (7%)

Query: 369 VALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR--LYDHGTDPQTTHVVG 426
           +A+GLF+LH +    +I+RD+K  NV+LD E + ++ DFG+ +  ++D  T   T    G
Sbjct: 110 IAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT---TKTFCG 163

Query: 427 TLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSE 471
           T  Y+APE         S D ++FG  L E+  G+ P + +   E
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE 208

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 59.8 bits (145), Expect = 1e-09
 Identities = 59/215 (27%), Positives = 104/215 (48%), Gaps = 33/215 (15%)

Query: 266 KELLGTGGFGRVYR---------------GTLPKSQIEIAVKKISHESRQGMKEFVAEIV 310
            ++LG GG+G+V++                 L K+ I    K  +H          AE  
Sbjct: 1   LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTK--------AERN 52

Query: 311 SIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVA 370
            +  ++H  +V L+   +  G+L L+ +Y+  G L  +L ++  + +     F  +  ++
Sbjct: 53  ILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHL-EREGIFMEDTACF-YLSEIS 110

Query: 371 LGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHV-VGTLG 429
           L L +LHQ   Q +I+RD+K  N+LLD + + +L DFGL +  +   +   TH   GT+ 
Sbjct: 111 LALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCK--ESIHEGTVTHTFCGTIE 165

Query: 430 YLAPE-HTRTGKATTSADVFSFGAFLLEVACGRRP 463
           Y+APE   R+G    + D +S GA + ++  G  P
Sbjct: 166 YMAPEILMRSGHG-KAVDWWSLGALMYDMLTGAPP 199

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 59.6 bits (144), Expect = 1e-09
 Identities = 57/214 (26%), Positives = 97/214 (45%), Gaps = 22/214 (10%)

Query: 268 LLGTGGFGRVY----RGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQL 323
           +LG G FG+V     +GT     I+I  K +  +        V + V   + +   L QL
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQL 66

Query: 324 LGYCRRKGELLLVYDYMPNGSLDKYL-----YDQPKVTLNWIQRFRVIKGVALGLFYLHQ 378
               +    L  V +Y+  G L  ++     + +P+      +       +++GLF+LH 
Sbjct: 67  HSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAE-------ISVGLFFLH- 118

Query: 379 EWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHV-VGTLGYLAPEHTR 437
              + +I+RD+K  NV+LD E + ++ DFG+ +  +H  D  TT    GT  Y+APE   
Sbjct: 119 --RRGIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGTPDYIAPEIIA 174

Query: 438 TGKATTSADVFSFGAFLLEVACGRRPIQRQGPSE 471
                 S D +++G  L E+  G+ P   +   E
Sbjct: 175 YQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE 208

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 59.8 bits (145), Expect = 1e-09
 Identities = 56/224 (25%), Positives = 95/224 (42%), Gaps = 40/224 (17%)

Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKI--------SHESRQGMKE----FVA--EIVSIGR 314
           LG G +G+V +     +   +A+KK+          + RQ +      F    E+  +  
Sbjct: 17  LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76

Query: 315 LRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLF 374
           ++H N++ L+        + LV D M    L K +    K+ L   Q   ++  +  GL 
Sbjct: 77  IKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDR--KIRLTESQVKCILLQILNGLN 133

Query: 375 YLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP--------------- 419
            LH+ +    +HRD+  +N+ ++ +   ++ DFGLAR Y  G  P               
Sbjct: 134 VLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRY--GYPPYSDTLSKDETMQRRE 188

Query: 420 -QTTHVVGTLGYLAPEHTRTGKATTSA-DVFSFGAFLLEVACGR 461
             T+ VV TL Y APE     +    A D++S G    E+  G+
Sbjct: 189 EMTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 59.8 bits (145), Expect = 1e-09
 Identities = 64/221 (28%), Positives = 94/221 (42%), Gaps = 21/221 (9%)

Query: 254 KDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES--RQGMKEFVAEIVS 311
             L +  + F   +++G G FG V       S+   A+K +S     ++    F  E   
Sbjct: 36  TKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERD 95

Query: 312 IGRLRHRN---LVQLLGYCRRKGELLLVYDYMPNGSLDKYL--YDQPKVTLNWIQRFRVI 366
           I  + H N   +VQL    +    L +V +YMP G L   +  YD P+    W + +   
Sbjct: 96  I--MAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPE---KWARFY--T 148

Query: 367 KGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVG 426
             V L L  +H       IHRDVK  N+LLD   + +L DFG     D     +    VG
Sbjct: 149 AEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVG 205

Query: 427 TLGYLAPEHTRT----GKATTSADVFSFGAFLLEVACGRRP 463
           T  Y++PE  ++    G      D +S G FL E+  G  P
Sbjct: 206 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 58.9 bits (142), Expect = 2e-09
 Identities = 68/225 (30%), Positives = 101/225 (44%), Gaps = 28/225 (12%)

Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRL-RHRNLVQLLG 325
           E +G G +G+VY+ T  K     AVK I        +E  AE   +  L  H N+V+  G
Sbjct: 28  ETIGKGTYGKVYKVTNKKDGSLAAVK-ILDPISDVDEEIEAEYNILQSLPNHPNVVKFYG 86

Query: 326 YCRRK-----GELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFR------VIKGVALGLF 374
              +      G+L LV +    GS+ + +    K  L   QR        ++ G  LGL 
Sbjct: 87  MFYKADKLVGGQLWLVLELCNGGSVTELV----KGLLICGQRLDEAMISYILYGALLGLQ 142

Query: 375 YLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGL-ARLYDHGTDPQTTHVVGTLGYLAP 433
           +LH      +IHRDVK +N+LL  E   +L DFG+ A+L        T+  VGT  ++AP
Sbjct: 143 HLHN---NRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--VGTPFWMAP 197

Query: 434 EHTRTGKATTSA-----DVFSFGAFLLEVACGRRPIQRQGPSENL 473
           E     +    +     DV+S G   +E+  G  P+    P + L
Sbjct: 198 EVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTL 242

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 59.3 bits (143), Expect = 2e-09
 Identities = 46/146 (31%), Positives = 73/146 (50%), Gaps = 10/146 (6%)

Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQE 379
           LV L    +    L LV +Y+  G L  ++  Q K+      RF   + + + L +LH  
Sbjct: 58  LVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEH-ARFYAAE-ICIALNFLH-- 113

Query: 380 WEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP--QTTHVVGTLGYLAPEHTR 437
            E+ +I+RD+K  NVLLD + + +L D+G+ +    G  P   T+   GT  Y+APE  R
Sbjct: 114 -ERGIIYRDLKLDNVLLDADGHIKLTDYGMCK---EGLGPGDTTSTFCGTPNYIAPEILR 169

Query: 438 TGKATTSADVFSFGAFLLEVACGRRP 463
             +   S D ++ G  + E+  GR P
Sbjct: 170 GEEYGFSVDWWALGVLMFEMMAGRSP 195

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 59.7 bits (144), Expect = 2e-09
 Identities = 48/183 (26%), Positives = 88/183 (48%), Gaps = 19/183 (10%)

Query: 283 PKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLV------ 336
           PK +  IA K++   SR  + +   EI+++GRL H N++++    R +    ++      
Sbjct: 190 PKCERLIA-KRVKAGSRAAI-QLENEILALGRLNHENILKIEEILRSEANTYMITQKYDF 247

Query: 337 --YDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNV 394
             Y +M + + D    D+P   L    R  ++K +   + Y+H   ++ +IHRD+K  N+
Sbjct: 248 DLYSFMYDEAFD--WKDRP---LLKQTR-AIMKQLLCAVEYIH---DKKLIHRDIKLENI 298

Query: 395 LLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFL 454
            L+ +    LGDFG A  ++   +      VGT+   +PE           D++S G  L
Sbjct: 299 FLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLIL 358

Query: 455 LEV 457
           L++
Sbjct: 359 LDM 361

Length = 501

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 59.1 bits (143), Expect = 3e-09
 Identities = 53/159 (33%), Positives = 72/159 (45%), Gaps = 27/159 (16%)

Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHG-TDPQTTHVVGTLGYL 431
           L  +H    + +IHRD+K++N+LL      +LGDFG +++Y    +D       GT  Y+
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212

Query: 432 APEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGEL--- 488
           APE  R    +  AD+FS G  L E+   +RP                FD  N  E+   
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLKRP----------------FDGENMEEVMHK 256

Query: 489 -LEAR-DPNLGTEYVAEELELVLKLGLLCSHSDPTARPS 525
            L  R DP L      E  E+V    LL   SDP  RPS
Sbjct: 257 TLAGRYDP-LPPSISPEMQEIV--TALLS--SDPKRRPS 290

Length = 496

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 58.5 bits (141), Expect = 4e-09
 Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 18/201 (8%)

Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
           +G+G +G V      K+ + +AVKK+S   +S    K    E+  +  ++H N++ LL  
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 84

Query: 327 ---CRRKGELLLVY--DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
               R   E   VY   ++    L+  +  Q K+T + +Q   +I  +  GL Y+H    
Sbjct: 85  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQF--LIYQILRGLKYIHS--- 138

Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE-HTRTGK 440
             +IHRD+K SN+ ++ +   ++ DFGLAR     TD + T  V T  Y APE       
Sbjct: 139 ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMH 194

Query: 441 ATTSADVFSFGAFLLEVACGR 461
              + D++S G  + E+  GR
Sbjct: 195 YNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 58.2 bits (140), Expect = 4e-09
 Identities = 60/213 (28%), Positives = 94/213 (44%), Gaps = 27/213 (12%)

Query: 267 ELLGTGGFGRV-----------YRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRL 315
           +LLG G FG+V           Y   + K ++ IA  +++H         + E   +   
Sbjct: 1   KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHT--------LTESRVLKNT 52

Query: 316 RHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFY 375
           RH  L  L    + K  L  V +Y+  G L  +L  + +V      RF   + V+  L Y
Sbjct: 53  RHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHL-SRERVFSEDRTRFYGAEIVS-ALDY 110

Query: 376 LHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHV-VGTLGYLAPE 434
           LH      +++RD+K  N++LD + + ++ DFGL +  +  TD  T     GT  YLAPE
Sbjct: 111 LHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCK--EGITDAATMKTFCGTPEYLAPE 165

Query: 435 HTRTGKATTSADVFSFGAFLLEVACGRRPIQRQ 467
                    + D +  G  + E+ CGR P   Q
Sbjct: 166 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 198

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 58.1 bits (141), Expect = 4e-09
 Identities = 65/235 (27%), Positives = 96/235 (40%), Gaps = 40/235 (17%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRN 319
           F++ +LLG G  GRV+   L  +    A+K +  +    R  +K  + E   +  L H  
Sbjct: 3   FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPF 62

Query: 320 LVQLLGYCRRKGE--LLLVYDYMPNGSLDKYLYDQP-KVTLNWIQRFRVIKGVALGLFYL 376
           L  L  Y   + E  L LV DY P G L + L  QP K     + RF   + V L L YL
Sbjct: 63  LPTL--YASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAE-VLLALEYL 119

Query: 377 HQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP----------------- 419
           H      +++RD+K  N+LL    +  L DF L++  D    P                 
Sbjct: 120 HL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSI 176

Query: 420 -----------QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRP 463
                      ++   VGT  Y+APE        ++ D ++ G  L E+  G  P
Sbjct: 177 PSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 58.5 bits (141), Expect = 6e-09
 Identities = 56/203 (27%), Positives = 98/203 (48%), Gaps = 16/203 (7%)

Query: 279 RGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYD 338
           RG+ PK ++      ++ E +       +E+  +    H  +V+     +   +LLL+ +
Sbjct: 88  RGSDPKEKVVAKFVMLNDERQAAYAR--SELHCLAACDHFGIVKHFDDFKSDDKLLLIME 145

Query: 339 YMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFY-----LHQEWEQVVIHRDVKASN 393
           Y   G L+K +  + K  L + Q + V  G+   LFY     L +   + ++HRD+K++N
Sbjct: 146 YGSGGDLNKQIKQRLKEHLPF-QEYEV--GL---LFYQIVLALDEVHSRKMMHRDLKSAN 199

Query: 394 VLLDGELNGRLGDFGLARLY-DHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGA 452
           + L      +LGDFG ++ Y D  +    +   GT  YLAPE     + +  AD++S G 
Sbjct: 200 IFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGV 259

Query: 453 FLLEVACGRRPIQRQGPSENLIL 475
            L E+    RP   +GPS+  I+
Sbjct: 260 ILYELLTLHRPF--KGPSQREIM 280

Length = 478

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 56.9 bits (137), Expect = 7e-09
 Identities = 66/226 (29%), Positives = 109/226 (48%), Gaps = 30/226 (13%)

Query: 267 ELLGTGGFGRVYRGTL-PKS-------QIEIAVK---KISHESRQGMKEFVAEIVSIGR- 314
           E LG G   ++Y G L  K          E  +K   K+   S + +     E  S+ R 
Sbjct: 1   EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQ 60

Query: 315 LRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKV-TLNWIQRFRVIKGVALGL 373
           + H+++V L G C R  E ++V +++  G LD +++ +  V T  W  +F+V K +A  L
Sbjct: 61  VSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPW--KFKVAKQLASAL 118

Query: 374 FYLHQEWEQVVIHRDVKASNVLLDGE-LNGRLGDFGLARLYDHGTDPQTT----HVVGTL 428
            YL    ++ ++H +V   N+LL  E ++G  G F   +L D G  P T       V  +
Sbjct: 119 SYLE---DKDLVHGNVCTKNILLAREGIDGECGPF--IKLSDPGI-PITVLSRQECVERI 172

Query: 429 GYLAPEHTRTGKA-TTSADVFSFGAFLLEVAC--GRRPIQRQGPSE 471
            ++APE     K  + +AD +SFG  L E+ C  G  P++ +  +E
Sbjct: 173 PWIAPECVEDSKNLSIAADKWSFGTTLWEI-CYNGEIPLKDKTLAE 217

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 57.1 bits (138), Expect = 7e-09
 Identities = 80/311 (25%), Positives = 130/311 (41%), Gaps = 73/311 (23%)

Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
           E +G G +G+VY+     +   +A+KK    +R  M E   E +    LR  +L+Q+L  
Sbjct: 7   EKIGEGTYGKVYKARDKNTGKLVALKK----TRLEMDE---EGIPPTALREISLLQMLSE 59

Query: 327 C---------------RRKGELLLVYDYMPNGSLDKYL---YDQP--KVTLNWIQRF--R 364
                             K  L LV++Y+ +  L K++      P   +    I+ F  +
Sbjct: 60  SIYIVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQ 118

Query: 365 VIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNG-RLGDFGLARLYDHGTDP--QT 421
           ++KGVA    + H+     V+HRD+K  N+L+D +    ++ D GL R +   + P    
Sbjct: 119 LLKGVA----HCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAF---SIPVKSY 168

Query: 422 THVVGTLGYLAPEHTRTGKA-TTSADVFSFGAFLLEVA------CGRRPIQR-------- 466
           TH + TL Y APE        +T  D++S G    E++       G   +Q+        
Sbjct: 169 THEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLL 228

Query: 467 QGPSEN-----LILVDW-VFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDP 520
             P+E        L DW  F  W   +L  A  P+L      E L+L+ K+       DP
Sbjct: 229 GTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAV-PDLS----PEGLDLLQKMLRY----DP 279

Query: 521 TARPSMRQVVQ 531
             R S +  + 
Sbjct: 280 AKRISAKAALT 290

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 57.1 bits (138), Expect = 8e-09
 Identities = 64/220 (29%), Positives = 90/220 (40%), Gaps = 29/220 (13%)

Query: 261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKE---FVAEIVSIGRLRH 317
           K F  K L+G G FG V +    K+  +I   K+  +S    +E   F  E   I  + +
Sbjct: 1   KDFDVKSLVGRGHFGEV-QVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISN 59

Query: 318 RN-LVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYL 376
              + QL    + K  L LV +Y P G L           L+ + R+       +  FYL
Sbjct: 60  SPWIPQLQYAFQDKDNLYLVMEYQPGGDL-----------LSLLNRYEDQFDEDMAQFYL 108

Query: 377 -------HQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLG 429
                  H   +   +HRD+K  NVL+D   + +L DFG A          +   VGT  
Sbjct: 109 AELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPD 168

Query: 430 YLAPEHTRT----GKAT--TSADVFSFGAFLLEVACGRRP 463
           Y+APE   T    GK T     D +S G    E+  GR P
Sbjct: 169 YIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 56.6 bits (136), Expect = 1e-08
 Identities = 59/213 (27%), Positives = 93/213 (43%), Gaps = 27/213 (12%)

Query: 267 ELLGTGGFGRV-----------YRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRL 315
           +LLG G FG+V           Y   + + ++ IA  +++H         V E   +   
Sbjct: 1   KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHT--------VTESRVLQNT 52

Query: 316 RHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFY 375
           RH  L  L    +    L  V +Y   G L  +L  + +V      RF   + V+  L Y
Sbjct: 53  RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARFYGAEIVS-ALEY 110

Query: 376 LHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHV-VGTLGYLAPE 434
           LH    + V++RD+K  N++LD + + ++ DFGL +  +  +D  T     GT  YLAPE
Sbjct: 111 LHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPE 165

Query: 435 HTRTGKATTSADVFSFGAFLLEVACGRRPIQRQ 467
                    + D +  G  + E+ CGR P   Q
Sbjct: 166 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 198

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 56.5 bits (136), Expect = 1e-08
 Identities = 58/198 (29%), Positives = 91/198 (45%), Gaps = 9/198 (4%)

Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLG 325
           +G G FG+V +     +Q   A+K I      SR  +   +AE   + ++    +V L  
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 326 YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVI 385
             +   +L LV  ++  G L  +L  + +  L+   RF   + +   L  LH   +  VI
Sbjct: 61  SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSR-ARFYTAE-LLCALENLH---KFNVI 115

Query: 386 HRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSA 445
           +RD+K  N+LLD + +  L DFGL +L     D +T    GT  YLAPE       T + 
Sbjct: 116 YRDLKPENILLDYQGHIALCDFGLCKLNMKDDD-KTNTFCGTPEYLAPELLLGHGYTKAV 174

Query: 446 DVFSFGAFLLEVACGRRP 463
           D ++ G  L E+  G  P
Sbjct: 175 DWWTLGVLLYEMLTGLPP 192

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 56.6 bits (136), Expect = 1e-08
 Identities = 60/211 (28%), Positives = 99/211 (46%), Gaps = 14/211 (6%)

Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHES---RQGMKEFVAEI-VSIGRLRHRNLVQ 322
           +++G G FG+V        +   AVK +  ++   ++  K  ++E  V +  ++H  LV 
Sbjct: 1   KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60

Query: 323 LLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQ 382
           L    +   +L  V DY+  G L  +L  + +  L    RF   + +A  L YLH     
Sbjct: 61  LHFSFQTADKLYFVLDYINGGELFYHL-QRERCFLEPRARFYAAE-IASALGYLHS---L 115

Query: 383 VVIHRDVKASNVLLDGELNGRLGDFGLAR--LYDHGTDPQTTHVVGTLGYLAPEHTRTGK 440
            +++RD+K  N+LLD + +  L DFGL +  +  +GT   T+   GT  YLAPE      
Sbjct: 116 NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGT---TSTFCGTPEYLAPEVLHKQP 172

Query: 441 ATTSADVFSFGAFLLEVACGRRPIQRQGPSE 471
              + D +  GA L E+  G  P   +  +E
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE 203

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 56.2 bits (135), Expect = 2e-08
 Identities = 61/206 (29%), Positives = 95/206 (46%), Gaps = 20/206 (9%)

Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHE---SRQGMKEFVAEI-VSIGRLRHRNLVQ 322
           +++G G FG+V            AVK +  +   +R+  K  +AE  V +  ++H  LV 
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 323 LLGYCRRKGELLLVYDYMPNGSLDKYL-----YDQPKVTLNWIQRFRVIKGVALGLFYLH 377
           L    +   +L  V D++  G L  +L     + +P+       RF   + +A  L YLH
Sbjct: 61  LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRA------RFYAAE-IASALGYLH 113

Query: 378 QEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTR 437
                 +++RD+K  N+LLD + +  L DFGL +     +D  TT   GT  YLAPE  R
Sbjct: 114 S---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTT-FCGTPEYLAPEVIR 169

Query: 438 TGKATTSADVFSFGAFLLEVACGRRP 463
                 + D +  GA L E+  G  P
Sbjct: 170 KQPYDNTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 56.4 bits (136), Expect = 2e-08
 Identities = 87/349 (24%), Positives = 138/349 (39%), Gaps = 105/349 (30%)

Query: 269 LGTGGFGRVYRGT---LPK--SQIEIAVKKISHESRQGMKE-FVAEIVSIGRL-RHRNLV 321
           LG G FG+V   T   L K  + + +AVK +   +    +E  ++E+  +  L +H+N+V
Sbjct: 46  LGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIV 105

Query: 322 QLLG-------------YC---------RRKGELLLVY----DYMPNGS----------- 344
            LLG             YC         R+K E  L +      +   S           
Sbjct: 106 NLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKK 165

Query: 345 ------------LDKYLYDQPKVT-------------------LNWIQRFRVIKGVALGL 373
                        D Y+  +P  +                   L+     R    VA G+
Sbjct: 166 YIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGM 225

Query: 374 FYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVG-----TL 428
            +L     +  IHRDV A NVLL      ++ DFGLAR  D   D  + +VV       +
Sbjct: 226 DFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLAR--DIMND--SNYVVKGNARLPV 278

Query: 429 GYLAPEHTRTGKATTSADVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVF-DFWNRG 486
            ++APE       T  +DV+S+G  L E+ + G+ P     P    ILV+  F     RG
Sbjct: 279 KWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPY----PG---ILVNSKFYKMVKRG 331

Query: 487 ELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER 535
             +   D      +   E+  ++K   +C + +PT RP+  Q+ Q+++R
Sbjct: 332 YQMSRPD------FAPPEIYSIMK---MCWNLEPTERPTFSQISQLIQR 371

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 56.1 bits (135), Expect = 2e-08
 Identities = 60/233 (25%), Positives = 101/233 (43%), Gaps = 36/233 (15%)

Query: 249 HRFRYKDL-YIATKGFREKELLGTGGFGRVYRGTLPKSQIE-IAVKKISHES--RQGMKE 304
           ++ +Y+D  +I T        LGTG FGRV   T        +A+K+       +Q   +
Sbjct: 25  NKMKYEDFNFIRT--------LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVD 76

Query: 305 FV-AEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRF 363
            V +E   +  + H   V L G  + +  L LV +++  G    +L    +   +     
Sbjct: 77  HVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPND----- 131

Query: 364 RVIKGVALGLFYLHQ-----EWEQV--VIHRDVKASNVLLDGELNGRLGDFGLARLYDHG 416
                  +G FY  Q     E+ Q   +++RD+K  N+LLD +   ++ DFG A++    
Sbjct: 132 -------VGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV---- 180

Query: 417 TDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGP 469
            D +T  + GT  Y+APE         +AD ++ G F+ E+  G  P     P
Sbjct: 181 VDTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP 233

Length = 340

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 55.3 bits (133), Expect = 2e-08
 Identities = 64/225 (28%), Positives = 103/225 (45%), Gaps = 34/225 (15%)

Query: 317 HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLY-DQPKVTLNWIQRFRVIKGVALGLFY 375
           H +L  + G C R  E ++V +++ +G LD  L  ++ +V + W  +  V + +A  L Y
Sbjct: 75  HIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KITVAQQLASALSY 132

Query: 376 LHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHG---TDPQTTHVVGTLGYLA 432
           L    ++ ++H +V A N+LL   L    G     +L D G   T       V  + ++A
Sbjct: 133 LE---DKNLVHGNVCAKNILL-ARLGLAEGTSPFIKLSDPGVSFTALSREERVERIPWIA 188

Query: 433 PEHTRTGKA-TTSADVFSFGAFLLEVAC--GRRPIQRQGPSENLILVDWVFDFWNRGELL 489
           PE    G + +T+AD +SFG  LLE+ C  G  P++ + PSE          F+ +   L
Sbjct: 189 PECVPGGNSLSTAADKWSFGTTLLEI-CFDGEVPLKERTPSEKE-------RFYEKKHRL 240

Query: 490 -EARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQIL 533
            E     L T            L   C   +PT RPS R +++ L
Sbjct: 241 PEPSCKELAT------------LISQCLTYEPTQRPSFRTILRDL 273

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 55.0 bits (132), Expect = 4e-08
 Identities = 59/214 (27%), Positives = 92/214 (42%), Gaps = 28/214 (13%)

Query: 267 ELLGTGGFGRV-----------YRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRL 315
           +LLG G FG+V           Y   + K ++ +A  +++H         + E   +   
Sbjct: 1   KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT--------LTENRVLQNS 52

Query: 316 RHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFY 375
           RH  L  L    +    L  V +Y   G L  +L  + +V      RF   + V+  L Y
Sbjct: 53  RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHL-SRERVFSEDRARFYGAEIVS-ALDY 110

Query: 376 LHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR--LYDHGTDPQTTHVVGTLGYLAP 433
           LH E    V++RD+K  N++LD + + ++ DFGL +  + D  T        GT  YLAP
Sbjct: 111 LHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT---MKTFCGTPEYLAP 165

Query: 434 EHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQ 467
           E         + D +  G  + E+ CGR P   Q
Sbjct: 166 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 199

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 55.0 bits (132), Expect = 4e-08
 Identities = 62/221 (28%), Positives = 96/221 (43%), Gaps = 17/221 (7%)

Query: 252 RYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES--RQGMKEFVAEI 309
           + +DL +  + +   +++G G FG V       ++   A+K +S     ++    F  E 
Sbjct: 34  KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEE 93

Query: 310 VSIGRLRHRN-LVQLLGYCRRKGELLLVYDYMPNGSLDKYL--YDQPKVTLNWIQRFRVI 366
             I    +   +VQL    +    L +V +YMP G L   +  YD P+    W  RF   
Sbjct: 94  RDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE---KW-ARFYTA 149

Query: 367 KGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVG 426
           + V L L  +H       IHRDVK  N+LLD   + +L DFG     +     +    VG
Sbjct: 150 E-VVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVG 205

Query: 427 TLGYLAPEHTRT----GKATTSADVFSFGAFLLEVACGRRP 463
           T  Y++PE  ++    G      D +S G FL E+  G  P
Sbjct: 206 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 55.0 bits (132), Expect = 5e-08
 Identities = 49/155 (31%), Positives = 68/155 (43%), Gaps = 25/155 (16%)

Query: 385 IHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT---LGYLAPEHTRTGKA 441
           IHRD+ A N+LL      ++ DFGLAR  D   DP           L ++APE       
Sbjct: 196 IHRDLAARNILLSENNVVKICDFGLAR--DIYKDPDYVRKGSARLPLKWMAPESIFDKVY 253

Query: 442 TTSADVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEY 500
           TT +DV+SFG  L E+ + G  P      +E         +F  R      +D   GT  
Sbjct: 254 TTQSDVWSFGVLLWEIFSLGASPYPGVQINE---------EFCQR-----LKD---GTRM 296

Query: 501 VAEELEL--VLKLGLLCSHSDPTARPSMRQVVQIL 533
            A E     + ++ L C   DP  RP+   +V+IL
Sbjct: 297 RAPENATPEIYRIMLACWQGDPKERPTFSALVEIL 331

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 54.6 bits (131), Expect = 5e-08
 Identities = 56/218 (25%), Positives = 100/218 (45%), Gaps = 40/218 (18%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGRLRHRNL 320
           +R+ + +G+G +G V      ++  ++A+KK+    +S    K    E+  +  ++H N+
Sbjct: 17  YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENV 76

Query: 321 VQLLGYCRRKGELLLVYDYMPNGSLDKY----------------LYDQPKVTLNWIQRFR 364
           + LL              + P+ SLD++                L    K++ + IQ F 
Sbjct: 77  IGLLDV------------FTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQ-FL 123

Query: 365 VIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHV 424
           V + +  GL Y+H      +IHRD+K  N+ ++ +   ++ DFGLAR     TD + T  
Sbjct: 124 VYQ-MLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR----QTDSEMTGY 175

Query: 425 VGTLGYLAPEHTRTG-KATTSADVFSFGAFLLEVACGR 461
           V T  Y APE        T + D++S G  + E+  G+
Sbjct: 176 VVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 54.7 bits (131), Expect = 5e-08
 Identities = 56/202 (27%), Positives = 95/202 (47%), Gaps = 20/202 (9%)

Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
           +G+G +G V      + + ++AVKK+S   +S    +    E+  +  ++H N++ LL  
Sbjct: 23  VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82

Query: 327 ------CRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEW 380
                      E+ LV + M    L+  +  Q K++   +Q   +I  +  GL Y+H   
Sbjct: 83  FTPATSIENFNEVYLVTNLM-GADLNNIVKCQ-KLSDEHVQF--LIYQLLRGLKYIHSAG 138

Query: 381 EQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE-HTRTG 439
              +IHRD+K SNV ++ +   R+ DFGLAR      D + T  V T  Y APE      
Sbjct: 139 ---IIHRDLKPSNVAVNEDCELRILDFGLAR----QADDEMTGYVATRWYRAPEIMLNWM 191

Query: 440 KATTSADVFSFGAFLLEVACGR 461
               + D++S G  + E+  G+
Sbjct: 192 HYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 54.3 bits (130), Expect = 7e-08
 Identities = 61/207 (29%), Positives = 91/207 (43%), Gaps = 24/207 (11%)

Query: 269 LGTGGFGRVYRGTLP--KSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQL--- 323
           +G G +G VY+      K + E A+K+I  E          EI  +  L+H N++ L   
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQI--EGTGISMSACREIALLRELKHPNVIALQKV 66

Query: 324 -LGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVAL-----GLFYLH 377
            L +  RK  LL  Y       + K+ +   K     +Q  R +    L     G+ YLH
Sbjct: 67  FLSHSDRKVWLLFDYAEHDLWHIIKF-HRASKANKKPMQLPRSMVKSLLYQILDGIHYLH 125

Query: 378 QEWEQVVIHRDVKASNVLLDGELNGR----LGDFGLARLYDHGTDP--QTTHVVGTLGYL 431
             W   V+HRD+K +N+L+ GE   R    + D G ARL++    P      VV T  Y 
Sbjct: 126 ANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182

Query: 432 APEHTRTGKATTSA-DVFSFGAFLLEV 457
           APE     +  T A D+++ G    E+
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAEL 209

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 53.8 bits (130), Expect = 7e-08
 Identities = 50/204 (24%), Positives = 93/204 (45%), Gaps = 33/204 (16%)

Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKI--SHESRQGMKEFVAEIVSIGRLR-HRNLVQLLG 325
           +G G F  V +    K+    A+K +    +S + +     EI ++ RL  H N+++L+ 
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNL-REIQALRRLSPHPNILRLIE 65

Query: 326 --YCRRKGELLLV--------YDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFY 375
             + R+ G L LV        Y+ +      K    + +V  +++  ++++K     L +
Sbjct: 66  VLFDRKTGRLALVFELMDMNLYELIKG---RKRPLPEKRV-KSYM--YQLLKS----LDH 115

Query: 376 LHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVGTLGYLAPE 434
           +H+     + HRD+K  N+L+  ++  +L DFG  R +Y     P  T  + T  Y APE
Sbjct: 116 MHRNG---IFHRDIKPENILIKDDI-LKLADFGSCRGIYSK---PPYTEYISTRWYRAPE 168

Query: 435 HTRT-GKATTSADVFSFGAFLLEV 457
              T G      D+++ G    E+
Sbjct: 169 CLLTDGYYGPKMDIWAVGCVFFEI 192

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 53.5 bits (128), Expect = 1e-07
 Identities = 59/207 (28%), Positives = 91/207 (43%), Gaps = 24/207 (11%)

Query: 269 LGTGGFGRVYRGTLP--KSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQL--- 323
           +G G +G VY+      K   + A+K+I  E          EI  +  L+H N++ L   
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQI--EGTGISMSACREIALLRELKHPNVISLQKV 66

Query: 324 -LGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFR-----VIKGVALGLFYLH 377
            L +  RK  LL  Y       + K+ +   K     +Q  R     ++  +  G+ YLH
Sbjct: 67  FLSHADRKVWLLFDYAEHDLWHIIKF-HRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 125

Query: 378 QEWEQVVIHRDVKASNVLLDGELNGR----LGDFGLARLYDHGTDP--QTTHVVGTLGYL 431
             W   V+HRD+K +N+L+ GE   R    + D G ARL++    P      VV T  Y 
Sbjct: 126 ANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182

Query: 432 APEHTRTGKATTSA-DVFSFGAFLLEV 457
           APE     +  T A D+++ G    E+
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAEL 209

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 53.3 bits (128), Expect = 2e-07
 Identities = 60/216 (27%), Positives = 92/216 (42%), Gaps = 33/216 (15%)

Query: 267 ELLGTGGFGRV-----------YRGTLPKSQIEIAVKKISH---ESRQGMKEFVAEIVSI 312
           +LLG G FG+V           Y   + K ++ IA  +++H   ESR            +
Sbjct: 1   KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESR-----------VL 49

Query: 313 GRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALG 372
              RH  L  L    +    L  V +Y   G L  +L  + +V      RF   + +   
Sbjct: 50  QNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHL-SRERVFSEDRARFYGAE-IVSA 107

Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHV-VGTLGYL 431
           L YLH      V++RD+K  N++LD + + ++ DFGL +  +  +D  T     GT  YL
Sbjct: 108 LGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYL 162

Query: 432 APEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQ 467
           APE         + D +  G  + E+ CGR P   Q
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 198

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 53.1 bits (127), Expect = 2e-07
 Identities = 52/208 (25%), Positives = 96/208 (46%), Gaps = 8/208 (3%)

Query: 257 YIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGR 314
           +   K ++  + +G+G  G V        +  +A+KK+S   +++   K    E+V +  
Sbjct: 20  FTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKC 79

Query: 315 LRHRNLVQLLGYCRRKGELLLVYD-YMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGL 373
           + H+N++ LL     +  L    D Y+    +D  L    ++ L+  +   ++  +  G+
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 139

Query: 374 FYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAP 433
            +LH      +IHRD+K SN+++  +   ++ DFGLAR    GT    T  V T  Y AP
Sbjct: 140 KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAP 194

Query: 434 EHTRTGKATTSADVFSFGAFLLEVACGR 461
           E         + D++S G  + E+  G 
Sbjct: 195 EVILGMGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 52.3 bits (125), Expect = 3e-07
 Identities = 53/207 (25%), Positives = 96/207 (46%), Gaps = 8/207 (3%)

Query: 257 YIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGR 314
           +   K +++ + +G+G  G V         I +AVKK+S   +++   K    E+V +  
Sbjct: 17  FTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKC 76

Query: 315 LRHRNLVQLLGYCRRKGELLLVYD-YMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGL 373
           + H+N++ LL     +  L    D Y+    +D  L     + L+  +   ++  +  G+
Sbjct: 77  VNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGI 136

Query: 374 FYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAP 433
            +LH      +IHRD+K SN+++  +   ++ DFGLAR     T+   T  V T  Y AP
Sbjct: 137 KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TACTNFMMTPYVVTRYYRAP 191

Query: 434 EHTRTGKATTSADVFSFGAFLLEVACG 460
           E         + D++S G  + E+  G
Sbjct: 192 EVILGMGYKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 51.8 bits (124), Expect = 3e-07
 Identities = 53/210 (25%), Positives = 93/210 (44%), Gaps = 19/210 (9%)

Query: 269 LGTGGFGRVYRGTL--PKSQIEIAVKKI-SHESRQGMKEFVAEIVSIGRLRHRNLVQLLG 325
           +G G FG+V    +        + VK++ ++ S +   EF+ +      L+H N++Q LG
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLG 62

Query: 326 YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLN--WIQRFRVIKGVALGLFYLHQEWEQV 383
            C      LLV++Y   G L  YL  +     N   +   R+   +A G+ ++H+     
Sbjct: 63  QCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK---HN 119

Query: 384 VIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTH--VVGTLGYLAPE-----HT 436
            +H D+   N  L  +L  ++GD+G+     +  D   T       L +LAPE     H 
Sbjct: 120 FLHSDLALRNCFLTSDLTVKVGDYGIG-PSRYKEDYIETEDDKCVPLRWLAPELVGEFHG 178

Query: 437 R--TGKATTSADVFSFGAFLLEV-ACGRRP 463
              T + T  ++V++ G  L E+     +P
Sbjct: 179 GLITAEQTKPSNVWALGVTLWELFENAAQP 208

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 51.8 bits (124), Expect = 4e-07
 Identities = 50/154 (32%), Positives = 69/154 (44%), Gaps = 23/154 (14%)

Query: 385 IHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT---LGYLAPEHTRTGKA 441
           IHRD+ A N+LL      ++ DFGLAR  D   DP           L ++APE       
Sbjct: 195 IHRDLAARNILLSENNVVKICDFGLAR--DIYKDPDYVRKGDARLPLKWMAPESIFDKVY 252

Query: 442 TTSADVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFWNR-GELLEARDPNLGTE 499
           TT +DV+SFG  L E+ + G  P       E         +F  R  E    R P    E
Sbjct: 253 TTQSDVWSFGVLLWEIFSLGASPYPGVQIDE---------EFCRRLKEGTRMRAP----E 299

Query: 500 YVAEELELVLKLGLLCSHSDPTARPSMRQVVQIL 533
           Y   E   +  + L C H++P  RP+  ++V+IL
Sbjct: 300 YATPE---IYSIMLDCWHNNPEDRPTFSELVEIL 330

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 52.0 bits (125), Expect = 4e-07
 Identities = 62/234 (26%), Positives = 98/234 (41%), Gaps = 30/234 (12%)

Query: 254 KDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVS-- 311
           KD  I T+       +G GG+G+V+      +   +A+K++       + E V  +++  
Sbjct: 1   KDFQILTQ-------VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNE-VRHVLTER 52

Query: 312 --IGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQ----RFRV 365
             +   +   LV+LL   +    L L  +Y+P G     L       L  +     RF +
Sbjct: 53  DILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLL-----NNLGVLSEDHARFYM 107

Query: 366 IKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVV 425
            +     +  LH+      IHRD+K  N L+D   + +L DFGL++    G       VV
Sbjct: 108 AEMFE-AVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSK----GIVTYANSVV 159

Query: 426 GTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLI-LVDW 478
           G+  Y+APE  R      + D +S G  L E  CG  P     P+E    L  W
Sbjct: 160 GSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYW 213

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 51.9 bits (124), Expect = 4e-07
 Identities = 45/137 (32%), Positives = 63/137 (45%), Gaps = 11/137 (8%)

Query: 333 LLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKAS 392
           L LV DY   G L   L          + RF + + V L +  +HQ      +HRD+K  
Sbjct: 76  LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMV-LAIHSIHQ---LHYVHRDIKPD 131

Query: 393 NVLLDGELNGRLGDFG-LARLYDHGTDPQTTHVVGTLGYLAPEHTRT-----GKATTSAD 446
           NVLLD   + RL DFG   ++   GT  Q++  VGT  Y++PE  +      GK     D
Sbjct: 132 NVLLDMNGHIRLADFGSCLKMNQDGT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECD 190

Query: 447 VFSFGAFLLEVACGRRP 463
            +S G  + E+  G  P
Sbjct: 191 WWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 51.6 bits (124), Expect = 5e-07
 Identities = 49/214 (22%), Positives = 83/214 (38%), Gaps = 35/214 (16%)

Query: 272 GGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFV---AEIVSIGRLRHRNLVQLLGYCR 328
                + +     +   +AVKKI+ +S    ++      EI++  +L+H N++  +    
Sbjct: 13  LMIVHLAKHK--PTNTLVAVKKINLDS-CSKEDLKLLQQEIITSRQLQHPNILPYVTSFI 69

Query: 329 RKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRD 388
              EL +V   M  GS +  L       L  +    ++K V   L Y+H +     IHR 
Sbjct: 70  VDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG---FIHRS 126

Query: 389 VKASNVLLDGELNGRL-----------GDFGLARLYDHGTDPQTTHVVGTLGYLAPE--- 434
           VKAS++LL G+    L                  ++D          V  L +L+PE   
Sbjct: 127 VKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDF-----PKSSVKNLPWLSPEVLQ 181

Query: 435 ---HTRTGKATTSADVFSFGAFLLEVACGRRPIQ 465
                   K    +D++S G    E+A G  P +
Sbjct: 182 QNLQGYNEK----SDIYSVGITACELANGHVPFK 211

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 51.8 bits (124), Expect = 5e-07
 Identities = 46/159 (28%), Positives = 76/159 (47%), Gaps = 25/159 (15%)

Query: 385 IHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVG-----TLGYLAPEHTRTG 439
           IHRD+ A N+LL      ++ DFGLAR  D   D  + +VV       + ++APE     
Sbjct: 236 IHRDLAARNILLTHGRITKICDFGLAR--DIRND--SNYVVKGNARLPVKWMAPESIFNC 291

Query: 440 KATTSADVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGT 498
             T  +DV+S+G  L E+ + G  P          + VD  F      ++++     L  
Sbjct: 292 VYTFESDVWSYGILLWEIFSLGSSPYPG-------MPVDSKF-----YKMIKEGYRMLSP 339

Query: 499 EYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERDV 537
           E    E+  ++K    C  +DP  RP+ +Q+VQ++E+ +
Sbjct: 340 ECAPSEMYDIMK---SCWDADPLKRPTFKQIVQLIEQQL 375

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 51.3 bits (123), Expect = 6e-07
 Identities = 32/85 (37%), Positives = 43/85 (50%), Gaps = 7/85 (8%)

Query: 385 IHRDVKASNVLLDGELNGRLGDFG-LARLYDHGTDPQTTHVVGTLGYLAPEHTR-----T 438
           +HRD+K  NVLLD   + RL DFG   RL   GT  Q+   VGT  Y++PE  +      
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT-VQSNVAVGTPDYISPEILQAMEDGK 182

Query: 439 GKATTSADVFSFGAFLLEVACGRRP 463
           G+     D +S G  + E+  G  P
Sbjct: 183 GRYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 51.3 bits (123), Expect = 6e-07
 Identities = 57/210 (27%), Positives = 99/210 (47%), Gaps = 17/210 (8%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGRLRHRNL 320
           ++ +E++G G +G V       +  ++A+KKI+   E        + EI  +  LRH ++
Sbjct: 2   YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 61

Query: 321 VQ----LLGYCRRK-GELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFY 375
           V+    +L   RR+  ++ +V++ M    L + +     +T    Q F  +  +   L Y
Sbjct: 62  VEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHHQFF--LYQLLRALKY 118

Query: 376 LHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQT--THVVGTLGYLAP 433
           +H      V HRD+K  N+L + +   ++ DFGLAR+  + T      T  V T  Y AP
Sbjct: 119 IHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 175

Query: 434 EHTRT--GKATTSADVFSFGAFLLEVACGR 461
           E   +   K T + D++S G    EV  G+
Sbjct: 176 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 51.2 bits (122), Expect = 7e-07
 Identities = 53/207 (25%), Positives = 98/207 (47%), Gaps = 14/207 (6%)

Query: 257 YIATKGFREKELLGTGGFGRV---YRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVS 311
           +   K ++  + +G+G  G V   Y   L ++   +A+KK+S   +++   K    E+V 
Sbjct: 13  FTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVL 69

Query: 312 IGRLRHRNLVQLLGYCRRKGELLLVYD-YMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVA 370
           +  + H+N++ LL     +  L    D Y+    +D  L    ++ L+  +   ++  + 
Sbjct: 70  MKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQML 129

Query: 371 LGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGY 430
            G+ +LH      +IHRD+K SN+++  +   ++ DFGLAR    GT    T  V T  Y
Sbjct: 130 CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYY 184

Query: 431 LAPEHTRTGKATTSADVFSFGAFLLEV 457
            APE         + D++S G  + E+
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEM 211

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 51.7 bits (123), Expect = 1e-06
 Identities = 77/311 (24%), Positives = 136/311 (43%), Gaps = 58/311 (18%)

Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKE-----FVAEIVSIGRLRHRNLVQL 323
           +G G FG V+     ++Q     K IS+   +G+KE      V E+  +  L+H+N+V+ 
Sbjct: 21  IGNGRFGEVFLVKHKRTQEFFCWKAISY---RGLKEREKSQLVIEVNVMRELKHKNIVRY 77

Query: 324 LGYCRRKG--ELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVI---KGVALGLFYLHQ 378
           +     K   +L ++ ++   G L + +    K+    I+   ++   + +   L Y H 
Sbjct: 78  IDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKM-FGKIEEHAIVDITRQLLHALAYCHN 136

Query: 379 EWE----QVVIHRDVKASNVLLD-------------GELNGR----LGDFGLARLYDHGT 417
             +    + V+HRD+K  N+ L                LNGR    +GDFGL++  + G 
Sbjct: 137 LKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSK--NIGI 194

Query: 418 DPQTTHVVGTLGYLAPEHT--RTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLIL 475
           +      VGT  Y +PE     T      +D+++ G  + E+  G+ P  +      LI 
Sbjct: 195 ESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLI- 253

Query: 476 VDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVV--QIL 533
                      EL   R P+L  +  ++EL +++K  L  S  +   RPS  Q +  QI+
Sbjct: 254 ----------SEL--KRGPDLPIKGKSKELNILIKNLLNLSAKE---RPSALQCLGYQII 298

Query: 534 ERDVALPAISA 544
            ++V  P  +A
Sbjct: 299 -KNVGPPVGAA 308

Length = 1021

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 50.4 bits (120), Expect = 1e-06
 Identities = 55/230 (23%), Positives = 103/230 (44%), Gaps = 22/230 (9%)

Query: 259 ATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHR 318
             K ++   ++G G FG VY      +  ++A+KK+  + +   +    E++ +  L H 
Sbjct: 64  PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNR----ELLIMKNLNHI 119

Query: 319 NLVQLLGY----CRRKGE----LLLVYDYMPNGSLDKYL--YDQPKVTLNWIQRFRVIKG 368
           N++ L  Y    C +K E    L +V +++P  ++ KY+  Y +    L           
Sbjct: 120 NIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQ 178

Query: 369 VALGLFYLHQEWEQVVIHRDVKASNVLLDGELNG-RLGDFGLARLYDHGTDPQTTHVVGT 427
           +   L Y+H ++   + HRD+K  N+L+D   +  +L DFG A+    G   ++   + +
Sbjct: 179 LCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQ--RSVSYICS 233

Query: 428 LGYLAPE-HTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILV 476
             Y APE        TT  D++S G  + E+  G      Q   + L+ +
Sbjct: 234 RFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRI 283

Length = 440

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 49.5 bits (118), Expect = 2e-06
 Identities = 50/205 (24%), Positives = 90/205 (43%), Gaps = 25/205 (12%)

Query: 268 LLGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGRLRHRNLVQLLG 325
            +G+G +G V      ++  ++A+KK+S   +S    K    E+  +  ++H N++ LL 
Sbjct: 22  QVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLD 81

Query: 326 YCRRKGELLLVYDY---MPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQ 382
                       D+   MP    D        ++ + +Q   ++  +  GL Y+H     
Sbjct: 82  VFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQY--LVYQMLCGLKYIHSAG-- 137

Query: 383 VVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE------HT 436
            +IHRD+K  N+ ++ +   ++ DFGLAR      D + T  V T  Y APE      H 
Sbjct: 138 -IIHRDLKPGNLAVNEDCELKILDFGLAR----HADAEMTGYVVTRWYRAPEVILNWMHY 192

Query: 437 RTGKATTSADVFSFGAFLLEVACGR 461
                  + D++S G  + E+  G+
Sbjct: 193 -----NQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 49.3 bits (117), Expect = 3e-06
 Identities = 47/154 (30%), Positives = 67/154 (43%), Gaps = 23/154 (14%)

Query: 385 IHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT---LGYLAPEHTRTGKA 441
           IHRD+ A N+LL      ++ DFGLAR  D   DP           L ++APE       
Sbjct: 201 IHRDLAARNILLSENNVVKICDFGLAR--DIYKDPDYVRKGDARLPLKWMAPETIFDRVY 258

Query: 442 TTSADVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFWNR-GELLEARDPNLGTE 499
           T  +DV+SFG  L E+ + G  P       E         +F  R  E    R P    +
Sbjct: 259 TIQSDVWSFGVLLWEIFSLGASPYPGVKIDE---------EFCRRLKEGTRMRAP----D 305

Query: 500 YVAEELELVLKLGLLCSHSDPTARPSMRQVVQIL 533
           Y   E+   +   L C H +P+ RP+  ++V+ L
Sbjct: 306 YTTPEMYQTM---LDCWHGEPSQRPTFSELVEHL 336

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 48.7 bits (116), Expect = 6e-06
 Identities = 50/193 (25%), Positives = 77/193 (39%), Gaps = 50/193 (25%)

Query: 330 KGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDV 389
           K  L  V DY+P G +   L  +  +    + RF  I  +   +  +H+      IHRD+
Sbjct: 73  KDNLYFVMDYIPGGDMMSLLI-RLGIFEEDLARF-YIAELTCAIESVHK---MGFIHRDI 127

Query: 390 KASNVLLDGELNGRLGDFGL---------ARLYDHGTDPQ-------------------- 420
           K  N+L+D + + +L DFGL         ++ Y  G   +                    
Sbjct: 128 KPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKP 187

Query: 421 ------------TTH-VVGTLGYLAPE-HTRTGKATTSADVFSFGAFLLEVACGRRPIQR 466
                         H +VGT  Y+APE   RTG  T   D +S G  L E+  G+ P   
Sbjct: 188 LERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGY-TQLCDWWSVGVILYEMLVGQPPFLA 246

Query: 467 QGPSE-NLILVDW 478
             P+E  L +++W
Sbjct: 247 DTPAETQLKVINW 259

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 48.4 bits (115), Expect = 7e-06
 Identities = 60/209 (28%), Positives = 87/209 (41%), Gaps = 26/209 (12%)

Query: 258 IATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVK-----KISHESRQGMKEFVAEIVSI 312
           +A  GF     L  G  G V+  + P     + VK        HE+R            +
Sbjct: 166 VAGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWYASSVHEARL-----------L 214

Query: 313 GRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVT-LNWIQRFRVIKGVAL 371
            RL H  ++ LL      G   LV   +P    D Y Y   ++  L   Q   V + +  
Sbjct: 215 RRLSHPAVLALLDVRVVGGLTCLV---LPKYRSDLYTYLGARLRPLGLAQVTAVARQLLS 271

Query: 372 GLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTH--VVGTLG 429
            + Y+H E    +IHRD+K  NVL++G  +  LGDFG A  +  G+     H  + GT+ 
Sbjct: 272 AIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFG-AACFARGSWSTPFHYGIAGTVD 327

Query: 430 YLAPEHTRTGKATTSADVFSFGAFLLEVA 458
             APE       T S D++S G  + E A
Sbjct: 328 TNAPEVLAGDPYTPSVDIWSAGLVIFEAA 356

Length = 461

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 48.1 bits (114), Expect = 8e-06
 Identities = 42/163 (25%), Positives = 65/163 (39%), Gaps = 9/163 (5%)

Query: 299 RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLN 358
           R G      E   +  + H +++QL G         L+   +P    D Y Y   K  + 
Sbjct: 127 RGGT---ATEAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNIA 180

Query: 359 WIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD 418
                 + + V   + YLH   E  +IHRD+KA N+ ++   +  LGDFG A        
Sbjct: 181 ICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA 237

Query: 419 PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGR 461
            +     GT+   APE         + D++S G  L E+A   
Sbjct: 238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 47.8 bits (114), Expect = 1e-05
 Identities = 61/243 (25%), Positives = 89/243 (36%), Gaps = 60/243 (24%)

Query: 268 LLGTGGFGRVYRGTLPKSQIEIAVKKISH---ESRQGMKEFVAEIVSIGRLRHRNLVQLL 324
           L+G GG G VY    P     +A+KKI     E+    K F+ E      L H  +V + 
Sbjct: 9   LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68

Query: 325 GYCRRKGELLLVYDYMP----------------NGSLDKYLYDQPKVTLNWIQRFRVIKG 368
             C        VY  MP                  SL K L ++  V         +   
Sbjct: 69  SICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVG----AFLSIFHK 121

Query: 369 VALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLG-----DFGLAR------------ 411
           +   + Y+H    + V+HRD+K  N+LL     G  G     D+G A             
Sbjct: 122 ICATIEYVHS---KGVLHRDLKPDNILL-----GLFGEVVILDWGAAIFKKLEEEDLLDI 173

Query: 412 -------LYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPI 464
                   Y   T P    +VGT  Y+APE      A+ S D+++ G  L ++     P 
Sbjct: 174 DVDERNICYSSMTIP--GKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY 231

Query: 465 QRQ 467
           +R+
Sbjct: 232 RRK 234

Length = 932

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 46.9 bits (111), Expect = 1e-05
 Identities = 65/225 (28%), Positives = 96/225 (42%), Gaps = 28/225 (12%)

Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLR-HRNLVQLLG 325
           E +G G +G+V++  L K     A  KI        +E  AE   +  L  H N+V+  G
Sbjct: 24  ETIGKGTYGKVFK-VLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYG 82

Query: 326 YCRRKG-----ELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFR------VIKGVALGLF 374
              +K      +L LV +    GS+     D  K  L   +R        ++    +GL 
Sbjct: 83  MYYKKDVKNGDQLWLVLELCNGGSVT----DLVKGFLKRGERMEEPIIAYILHEALMGLQ 138

Query: 375 YLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGL-ARLYDHGTDPQTTHVVGTLGYLAP 433
           +LH       IHRDVK +N+LL  E   +L DFG+ A+L        T+  VGT  ++AP
Sbjct: 139 HLH---VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--VGTPFWMAP 193

Query: 434 EHTRTGKATTSA-----DVFSFGAFLLEVACGRRPIQRQGPSENL 473
           E     +   S      DV+S G   +E+  G  P+    P   L
Sbjct: 194 EVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL 238

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 47.3 bits (112), Expect = 1e-05
 Identities = 31/89 (34%), Positives = 49/89 (55%), Gaps = 7/89 (7%)

Query: 269 LGTGGFGRVYRGT---LPKSQ--IEIAVKKISHESRQGMKE-FVAEIVSIGRL-RHRNLV 321
           LG+G FGRV   T   L  SQ  +++AVK +   +R   K+  ++E+  +  L  H N+V
Sbjct: 45  LGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIV 104

Query: 322 QLLGYCRRKGELLLVYDYMPNGSLDKYLY 350
            LLG C + G + ++ +Y   G L  YL+
Sbjct: 105 NLLGACTKGGPIYIITEYCRYGDLVDYLH 133

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 47.3 bits (112), Expect = 2e-05
 Identities = 31/90 (34%), Positives = 52/90 (57%), Gaps = 7/90 (7%)

Query: 268 LLGTGGFGRVYRGT---LPKSQ--IEIAVKKISHESRQGMKE-FVAEIVSIGRL-RHRNL 320
           +LG+G FG+V  GT   L +SQ  +++AVK +   +R   K+  ++E+  +  L  H N+
Sbjct: 44  ILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNI 103

Query: 321 VQLLGYCRRKGELLLVYDYMPNGSLDKYLY 350
           V LLG C + G + ++ +Y   G L  YL+
Sbjct: 104 VNLLGACTKSGPIYIITEYCFYGDLVNYLH 133

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 46.6 bits (110), Expect = 2e-05
 Identities = 59/252 (23%), Positives = 92/252 (36%), Gaps = 54/252 (21%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNL-- 320
           F   +++G G FG V R    K    I   KI  ++    KE VA I +      R++  
Sbjct: 3   FESLKVIGRGAFGEV-RLVQKKDTGHIYAMKILRKADMLEKEQVAHIRA-----ERDILV 56

Query: 321 -------VQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGL 373
                  V++    + K  L L+ +++P G +   L  +  ++    Q +  I    L +
Sbjct: 57  EADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFY--IAETVLAI 114

Query: 374 FYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGL------------------------ 409
             +HQ      IHRD+K  N+LLD + + +L DFGL                        
Sbjct: 115 DAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDF 171

Query: 410 ----------ARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC 459
                     A  +           VGT  Y+APE           D +S G  + E+  
Sbjct: 172 SFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI 231

Query: 460 GRRPIQRQGPSE 471
           G  P   + P E
Sbjct: 232 GYPPFCSETPQE 243

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 46.1 bits (109), Expect = 3e-05
 Identities = 50/197 (25%), Positives = 85/197 (43%), Gaps = 15/197 (7%)

Query: 279 RGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYD 338
           R T   + + + +  + + + + +K    E+V     RH N++           L ++  
Sbjct: 20  RHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISP 79

Query: 339 YMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDG 398
           +M  GS +  L       ++      ++ G   GL YLHQ      IHR++KAS++L+ G
Sbjct: 80  FMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISG 136

Query: 399 ELNGRLGDFGLARLYDHGTDPQTTHVV--------GTLGYLAPEHTRTGKA--TTSADVF 448
           +  G +   GL+ LY    + Q   VV          L +L+PE  R         +D++
Sbjct: 137 D--GLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIY 194

Query: 449 SFGAFLLEVACGRRPIQ 465
           S G    E+A GR P Q
Sbjct: 195 SVGITACELATGRVPFQ 211

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 45.8 bits (108), Expect = 4e-05
 Identities = 62/266 (23%), Positives = 105/266 (39%), Gaps = 55/266 (20%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRN 319
           F + + LG G FG V       +    A+K +  +   +R  +    AE   +    +  
Sbjct: 3   FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62

Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQE 379
           +V+L    + K  L  V DY+P G +   L  + +V    + RF + + + L +  +H+ 
Sbjct: 63  VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLI-RMEVFPEVLARFYIAE-LTLAIESVHK- 119

Query: 380 WEQVVIHRDVKASNVLLDGELNGRLGDFGL---------ARLYDHGT-------DPQ--- 420
                IHRD+K  N+L+D + + +L DFGL         ++ Y  G+       +P    
Sbjct: 120 --MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLW 177

Query: 421 ---------------------------TTHVVGTLGYLAPEHTRTGKATTSADVFSFGAF 453
                                         +VGT  Y+APE       T   D +S G  
Sbjct: 178 DDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237

Query: 454 LLEVACGRRPIQRQGPSE-NLILVDW 478
           L E+  G+ P     P+E  L +++W
Sbjct: 238 LFEMLVGQPPFLAPTPTETQLKVINW 263

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 45.8 bits (108), Expect = 4e-05
 Identities = 43/137 (31%), Positives = 64/137 (46%), Gaps = 11/137 (8%)

Query: 333 LLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKAS 392
           L LV DY   G L   L          + RF + + V + +  +HQ      +HRD+K  
Sbjct: 76  LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMV-IAIDSVHQLH---YVHRDIKPD 131

Query: 393 NVLLDGELNGRLGDFG-LARLYDHGTDPQTTHVVGTLGYLAPEHTRT-----GKATTSAD 446
           N+L+D   + RL DFG   +L + GT  Q++  VGT  Y++PE  +      GK     D
Sbjct: 132 NILMDMNGHIRLADFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECD 190

Query: 447 VFSFGAFLLEVACGRRP 463
            +S G  + E+  G  P
Sbjct: 191 WWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 45.8 bits (108), Expect = 4e-05
 Identities = 59/247 (23%), Positives = 92/247 (37%), Gaps = 44/247 (17%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVS----IGRLRHR 318
           F   +++G G FG V R    K    +   KI  ++    KE V  I +    +      
Sbjct: 3   FESLKVIGRGAFGEV-RLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61

Query: 319 NLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQ 378
            +V++    + K  L L+ +++P G +   L  +  +T    Q +  I    L +  +HQ
Sbjct: 62  WVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFY--IAETVLAIDSIHQ 119

Query: 379 EWEQVVIHRDVKASNVLLDGELNGRLGDFGLA------------RLYDHGTDPQTT---- 422
                 IHRD+K  N+LLD + + +L DFGL             R  +H      T    
Sbjct: 120 ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNM 176

Query: 423 ------------------HVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPI 464
                               VGT  Y+APE           D +S G  + E+  G  P 
Sbjct: 177 NSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236

Query: 465 QRQGPSE 471
             + P E
Sbjct: 237 CSETPQE 243

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 45.8 bits (108), Expect = 5e-05
 Identities = 53/201 (26%), Positives = 88/201 (43%), Gaps = 22/201 (10%)

Query: 337 YDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLL 396
           Y    +  +   L D     L  +        VA G+ +L     +  +HRD+ A NVLL
Sbjct: 214 YKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLL 270

Query: 397 DGELNGRLGDFGLARLYDHGTDPQTT-HVVGTLGYLAPEHTRTGKATTSADVFSFGAFLL 455
                 ++ DFGLAR   H ++  +       + ++APE       TT +DV+S+G  L 
Sbjct: 271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLW 330

Query: 456 EV-ACGRRPIQRQGPSENLILVDWVFDFWNR-GELLEARDPNLGTEYVAEELELVLKLGL 513
           E+ + G  P     P    ++VD    F+N+         P+  T+   E  ++++K   
Sbjct: 331 EIFSLGGTPY----PG---MIVD--STFYNKIKSGYRMAKPDHATQ---EVYDIMVK--- 375

Query: 514 LCSHSDPTARPSMRQVVQILE 534
            C +S+P  RPS   +  I+E
Sbjct: 376 -CWNSEPEKRPSFLHLSDIVE 395

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 45.6 bits (108), Expect = 6e-05
 Identities = 43/149 (28%), Positives = 69/149 (46%), Gaps = 18/149 (12%)

Query: 272 GGFGRVYRGTLPKSQIEIAVK--KISHESRQGMKEFV-AEIVSIGRLRHRNLVQLLGYCR 328
           G FG+VY G    +    AVK  K +    + M   V AE  ++   +   +V L    +
Sbjct: 15  GAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQ 74

Query: 329 RKGELLLVYDYMPNGSLDKYL-----YDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQV 383
               + LV +Y+  G +   L     +D+           + I  VAL L YLH+     
Sbjct: 75  SANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAV-------KYISEVALALDYLHR---HG 124

Query: 384 VIHRDVKASNVLLDGELNGRLGDFGLARL 412
           +IHRD+K  N+L+  E + +L DFGL+++
Sbjct: 125 IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 44.2 bits (104), Expect = 1e-04
 Identities = 66/274 (24%), Positives = 104/274 (37%), Gaps = 71/274 (25%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRN 319
           F + + LG G FG V       ++   A+K +  +    R  +    AE   +    +  
Sbjct: 3   FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62

Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQ- 378
           +V+L    + K  L  V DY+P G +           ++ + R  +     L  FY+ + 
Sbjct: 63  VVRLYYSFQDKDNLYFVMDYIPGGDM-----------MSLLIRMGIFPE-DLARFYIAEL 110

Query: 379 --EWEQV----VIHRDVKASNVLLDGELNGRLGDFGL---------ARLYDHGT------ 417
               E V     IHRD+K  N+L+D + + +L DFGL         ++ Y  G       
Sbjct: 111 TCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDS 170

Query: 418 --------DPQTTH-----------------------VVGTLGYLAPE-HTRTGKATTSA 445
                   DP                           +VGT  Y+APE   RTG  T   
Sbjct: 171 MDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTG-YTQLC 229

Query: 446 DVFSFGAFLLEVACGRRPIQRQGPSE-NLILVDW 478
           D +S G  L E+  G+ P   Q P E  + +++W
Sbjct: 230 DWWSVGVILYEMLVGQPPFLAQTPLETQMKVINW 263

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 43.3 bits (102), Expect = 2e-04
 Identities = 36/143 (25%), Positives = 62/143 (43%), Gaps = 9/143 (6%)

Query: 319 NLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQ 378
           N+V L  Y   +  + LV  +   G L  ++     +    ++R+     VAL    LH+
Sbjct: 46  NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDA--LHR 103

Query: 379 EWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRT 438
           E    ++ RD+  +N+LLD   + +L  F      +   D +    +    Y APE    
Sbjct: 104 EG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM----YCAPEVGGI 156

Query: 439 GKATTSADVFSFGAFLLEVACGR 461
            + T + D +S GA L E+  G+
Sbjct: 157 SEETEACDWWSLGAILFELLTGK 179

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 42.0 bits (99), Expect = 6e-04
 Identities = 30/90 (33%), Positives = 45/90 (50%), Gaps = 5/90 (5%)

Query: 372 GLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYL 431
           G+ +LH      +IHRD+K SN+++  +   ++ DFGLAR    GT    T  V T  Y 
Sbjct: 130 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYR 184

Query: 432 APEHTRTGKATTSADVFSFGAFLLEVACGR 461
           APE         + D++S G  + E+  G 
Sbjct: 185 APEVILGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 41.5 bits (97), Expect = 9e-04
 Identities = 29/76 (38%), Positives = 45/76 (59%), Gaps = 5/76 (6%)

Query: 385 IHRDVKASNVLL-DGELNGRLGDFGLAR--LYDHGTDPQTTHVVGTLGYLAPEHTRTGKA 441
           +HRD+ A NVL+ +G+L  ++ DFGLAR  + D     + +  +  L ++APE       
Sbjct: 261 VHRDLAARNVLICEGKLV-KICDFGLARDIMRDSNYISKGSTFL-PLKWMAPESIFNNLY 318

Query: 442 TTSADVFSFGAFLLEV 457
           TT +DV+SFG  L E+
Sbjct: 319 TTLSDVWSFGILLWEI 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 40.2 bits (94), Expect = 0.002
 Identities = 55/226 (24%), Positives = 95/226 (42%), Gaps = 22/226 (9%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRN 319
           F   +L+  G +G VY     +++   A+KKI+ ++   R  +++   E   +    +  
Sbjct: 3   FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPF 62

Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQE 379
           +V +      K  L +V +Y+  G     L +   + ++ + R    + V L L YLH  
Sbjct: 63  VVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVD-MARMYFAETV-LALEYLHNY 120

Query: 380 WEQVVIHRDVKASNVLLDGELNGRLGDFGLAR---------LYDHGTDPQT-----THVV 425
               ++HRD+K  N+L+    + +L DFGL++         LY+   +  T       V 
Sbjct: 121 G---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVC 177

Query: 426 GTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSE 471
           GT  Y+APE           D ++ G  L E   G  P     P E
Sbjct: 178 GTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE 223

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	586
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd06899	236	lectin_legume_LecRK_Arcelin_ConA legume lectins, l	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
PF00139	236	Lectin_legB: Legume lectin domain; InterPro: IPR00	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.98
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.98
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.98
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.97
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.97
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.97
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.97
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.97
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.97
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.97
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.97
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.97
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.96
cd01951	223	lectin_L-type legume lectins. The L-type (legume-t	99.96
KOG1152	772	consensus Signal transduction serine/threonine kin	99.96
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.96
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.95
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.95
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.95
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.95
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.95
PLN00181	793	protein SPA1-RELATED; Provisional	99.94
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.93
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.92
PRK09188	365	serine/threonine protein kinase; Provisional	99.92
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.89
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.89
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.89
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.86
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.84
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.84
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.83
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.83
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.82
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.82
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.81
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.8
PRK10345	210	hypothetical protein; Provisional	99.8
PRK12274	218	serine/threonine protein kinase; Provisional	99.8
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.77
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.75
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.75
smart00090	237	RIO RIO-like kinase.	99.74
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.74
PRK14879	211	serine/threonine protein kinase; Provisional	99.73
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.72
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.72
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.7
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.65
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.65
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.61
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.57
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.57
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.46
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.45
cd07308	218	lectin_leg-like legume-like lectins: ERGIC-53, ERG	99.35
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.35
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.35
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.31
KOG1243	690	consensus Protein kinase [General function predict	99.24
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.16
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.15
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.13
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.0
KOG3087	229	consensus Serine/threonine protein kinase [General	98.97
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.95
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.87
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.87
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.76
cd06902	225	lectin_ERGIC-53_ERGL ERGIC-53 and ERGL type 1 tran	98.76
cd06901	248	lectin_VIP36_VIPL VIP36 and VIPL type 1 transmembr	98.72
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.64
COG4248	637	Uncharacterized protein with protein kinase and he	98.63
PRK09902	216	hypothetical protein; Provisional	98.62
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.49
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.44
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.4
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.33
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.32
PF01636	239	APH: Phosphotransferase enzyme family This family	98.23
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.22
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.11
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.09
PLN02876	822	acyl-CoA dehydrogenase	97.99
PF03388	229	Lectin_leg-like: Legume-like lectin family; InterP	97.98
cd06903	215	lectin_EMP46_EMP47 EMP46 and EMP47 type 1 transmem	97.98
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.94
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	97.82
KOG3839	351	consensus Lectin VIP36, involved in the transport	97.77
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.75
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.73
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.71
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.69
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.66
PRK10593	297	hypothetical protein; Provisional	97.66
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.62
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.56
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.37
KOG3838	497	consensus Mannose lectin ERGIC-53, involved in gly	97.27
PRK05231	319	homoserine kinase; Provisional	97.21
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.15
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.08
PLN02236	344	choline kinase	96.99
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	96.91
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.85
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.8
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	96.58
cd06900	255	lectin_VcfQ VcfQ bacterial pilus biogenesis protei	96.56
KOG1093	725	consensus Predicted protein kinase (contains TBC a	96.39
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.38
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.36
KOG2268	465	consensus Serine/threonine protein kinase [Signal	96.2
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.18
PLN02756	418	S-methyl-5-thioribose kinase	95.69
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	95.56
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	95.55

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-59  Score=487.01  Aligned_cols=289  Identities=45%  Similarity=0.793  Sum_probs=257.9

Q ss_pred             CCcccchhhhhhhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeee
Q 007869          247 GPHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGY  326 (586)
Q Consensus       247 ~~~~~~~~el~~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~  326 (586)
                      ....|+|+|+..||++|+..++||+|+||.||+|.+.++ ..||||++.....+..++|.+|++++.+++|||+|+|+||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~-~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGy  139 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDG-TVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGY  139 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCC-CEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEE
Confidence            467899999999999999999999999999999999765 7899998876654314669999999999999999999999


Q ss_pred             eeccC-eEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEc
Q 007869          327 CRRKG-ELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLG  405 (586)
Q Consensus       327 ~~~~~-~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~  405 (586)
                      |.+.+ +.+||||||++|+|.++|+.....+++|.+|++|+.++|+||+|||+.+..+||||||||+|||||+++++||+
T Consensus       140 C~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls  219 (361)
T KOG1187|consen  140 CLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS  219 (361)
T ss_pred             EecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence            99998 59999999999999999988654389999999999999999999999988899999999999999999999999


Q ss_pred             cccceeeccCCCCCceeee-ccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhc
Q 007869          406 DFGLARLYDHGTDPQTTHV-VGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWN  484 (586)
Q Consensus       406 DFGla~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~  484 (586)
                      |||+|+..... ....... .||.+|+|||++..+..+.|+|||||||+|+||+||+++.+...+.....+++|++..+.
T Consensus       220 DFGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~  298 (361)
T KOG1187|consen  220 DFGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLE  298 (361)
T ss_pred             CccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHH
Confidence            99999765431 1111122 899999999999999999999999999999999999999987665555669999999999


Q ss_pred             cCccccccCCCCC-ccccH-HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 007869          485 RGELLEARDPNLG-TEYVA-EELELVLKLGLLCSHSDPTARPSMRQVVQILERDV  537 (586)
Q Consensus       485 ~~~~~~~~d~~l~-~~~~~-~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  537 (586)
                      ++.+.+.+||++. ..+.. +++..+.+++++|++.+|.+||+|.||++.|+...
T Consensus       299 ~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~  353 (361)
T KOG1187|consen  299 EGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL  353 (361)
T ss_pred             CcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence            9999999999987 66665 78999999999999999999999999999996543

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-48  Score=400.08  Aligned_cols=255  Identities=35%  Similarity=0.514  Sum_probs=209.5

Q ss_pred             CcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccch--hHHHHHHHHHHhcccCCCceeeeeeeeeccC-eEEEEEe
Q 007869          262 GFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQ--GMKEFVAEIVSIGRLRHRNLVQLLGYCRRKG-ELLLVYD  338 (586)
Q Consensus       262 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~-~~~lV~E  338 (586)
                      ++...+.||+|+||+||+|.+.+. ..||||++......  ..++|.+|+.+|.+++|||||+++|.|.+.. .+++|||
T Consensus        42 ~l~~~~~iG~G~~g~V~~~~~~g~-~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtE  120 (362)
T KOG0192|consen   42 ELPIEEVLGSGSFGTVYKGKWRGT-DVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTE  120 (362)
T ss_pred             HhhhhhhcccCCceeEEEEEeCCc-eeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEE
Confidence            344455699999999999999653 23999999765322  2568999999999999999999999999987 7999999


Q ss_pred             cCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCc-EEeCCCCCCCeeecCCC-CeEEccccceeeccCC
Q 007869          339 YMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQV-VIHRDVKASNVLLDGEL-NGRLGDFGLARLYDHG  416 (586)
Q Consensus       339 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~-ivHrDIkp~NIll~~~~-~~kL~DFGla~~~~~~  416 (586)
                      ||++|+|.++++...+..+++..+++|+.|||+||.|||+   .+ ||||||||+|||++.++ ++||+|||+++.....
T Consensus       121 y~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~---~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~  197 (362)
T KOG0192|consen  121 YMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHS---EGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS  197 (362)
T ss_pred             eCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhc---CCCeeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence            9999999999988545689999999999999999999998   66 99999999999999997 9999999999976543


Q ss_pred             CCCceeeeccCCCccCccccc--CCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCC
Q 007869          417 TDPQTTHVVGTLGYLAPEHTR--TGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDP  494 (586)
Q Consensus       417 ~~~~~~~~~gt~~y~aPE~~~--~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~  494 (586)
                      . ...+...||..|||||++.  ...++.|+||||||++||||+||+.||.......   ....+.   .     ....|
T Consensus       198 ~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~---~~~~v~---~-----~~~Rp  265 (362)
T KOG0192|consen  198 K-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQ---VASAVV---V-----GGLRP  265 (362)
T ss_pred             c-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHH---HHHHHH---h-----cCCCC
Confidence            2 2334478999999999999  5689999999999999999999999998765421   111111   1     11112


Q ss_pred             CCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 007869          495 NLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERD  536 (586)
Q Consensus       495 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  536 (586)
                      .+    .......+..++.+||+.||.+||++.+++..|+..
T Consensus       266 ~~----p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~  303 (362)
T KOG0192|consen  266 PI----PKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESI  303 (362)
T ss_pred             CC----CccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHH
Confidence            21    222456677888889999999999999999999753

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1e-46  Score=372.93  Aligned_cols=251  Identities=27%  Similarity=0.412  Sum_probs=211.4

Q ss_pred             CcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc-cchhHHHHHHHHHHhcccCCCceeeeeeeeeccC-eEEEEEec
Q 007869          262 GFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKG-ELLLVYDY  339 (586)
Q Consensus       262 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~-~~~lV~E~  339 (586)
                      +++..+.||+|..|+|||++++.+++.+|+|.+... .....+++.+|++++++.+|||||.++|.|...+ +..|+|||
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY  159 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY  159 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence            445577899999999999999999999999999654 3445678999999999999999999999999998 59999999


Q ss_pred             CCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCC
Q 007869          340 MPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP  419 (586)
Q Consensus       340 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~  419 (586)
                      |++|||++++...  ..+++...-+|+.++++||.|||+  +++||||||||+|||++..|++||||||.++.+...   
T Consensus       160 MDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---  232 (364)
T KOG0581|consen  160 MDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---  232 (364)
T ss_pred             cCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh---
Confidence            9999999999765  358888999999999999999996  389999999999999999999999999999976554   


Q ss_pred             ceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCC--CccchhhHHHHhhhccCccccccCCCCC
Q 007869          420 QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGP--SENLILVDWVFDFWNRGELLEARDPNLG  497 (586)
Q Consensus       420 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~--~~~~~l~~~v~~~~~~~~~~~~~d~~l~  497 (586)
                      .....+||..|||||-+.+..|+.++||||||+.++|+++|+.|+....+  .....+.+++         ....-|++.
T Consensus       233 ~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~I---------v~~ppP~lP  303 (364)
T KOG0581|consen  233 IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAI---------VDEPPPRLP  303 (364)
T ss_pred             hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHH---------hcCCCCCCC
Confidence            34567999999999999999999999999999999999999999976422  1112222221         122334443


Q ss_pred             ccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          498 TEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       498 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      ..   ....++..++..||++||.+||+++|+++
T Consensus       304 ~~---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  304 EG---EFSPEFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             cc---cCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            33   24456778888999999999999999985

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-47  Score=393.41  Aligned_cols=259  Identities=33%  Similarity=0.515  Sum_probs=218.1

Q ss_pred             hhhhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEE
Q 007869          256 LYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLL  335 (586)
Q Consensus       256 l~~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~l  335 (586)
                      ..+..+.+...+.||+|.||.||.|.+.++ ..||+|.+..... ..+.|.+|+++|++|+|+|||+++|+|..++.++|
T Consensus       201 wei~r~~l~l~~~LG~G~FG~V~~g~~~~~-~~vavk~ik~~~m-~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyI  278 (468)
T KOG0197|consen  201 WEIPREELKLIRELGSGQFGEVWLGKWNGS-TKVAVKTIKEGSM-SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYI  278 (468)
T ss_pred             eeecHHHHHHHHHhcCCccceEEEEEEcCC-CcccceEEecccc-ChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEE
Confidence            334444556678899999999999999653 4699999976532 34789999999999999999999999999889999


Q ss_pred             EEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccC
Q 007869          336 VYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH  415 (586)
Q Consensus       336 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~  415 (586)
                      |||||+.|+|.++|....+..+...+.+.++.|||+||+||++   +++|||||.++||||+++..+||+|||||+....
T Consensus       279 VtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes---~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d  355 (468)
T KOG0197|consen  279 VTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLES---KNYIHRDLAARNILVDEDLVVKISDFGLARLIGD  355 (468)
T ss_pred             EEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHh---CCccchhhhhhheeeccCceEEEcccccccccCC
Confidence            9999999999999998666789999999999999999999998   9999999999999999999999999999996655


Q ss_pred             CCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccCccccccCC
Q 007869          416 GTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEARDP  494 (586)
Q Consensus       416 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~  494 (586)
                      +.........-+..|.|||.+..++++.|||||||||+||||+| |+.|+......+       +.+..++|..+.    
T Consensus       356 ~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e-------v~~~le~GyRlp----  424 (468)
T KOG0197|consen  356 DEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE-------VLELLERGYRLP----  424 (468)
T ss_pred             CceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH-------HHHHHhccCcCC----
Confidence            44433444455789999999999999999999999999999999 999988765543       222333443332    


Q ss_pred             CCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 007869          495 NLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER  535 (586)
Q Consensus       495 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  535 (586)
                           .+..++..+.+++..||+.+|++|||++.+...|+.
T Consensus       425 -----~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~  460 (468)
T KOG0197|consen  425 -----RPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLED  460 (468)
T ss_pred             -----CCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHH
Confidence                 233456778899999999999999999999888864

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.8e-46  Score=387.86  Aligned_cols=248  Identities=26%  Similarity=0.436  Sum_probs=211.5

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc---cchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEE
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY  337 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  337 (586)
                      ..|...+.||+|||+.||+++...++..||+|++.+.   .....+...+||++.++|+|||||+++++|++.+..|||.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            5788999999999999999999899999999999764   3344577899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCC
Q 007869          338 DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT  417 (586)
Q Consensus       338 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~  417 (586)
                      |+|++++|.+++++.  .++++.++..+++||+.||.|||+   ++|+|||||..|+||+++.++||+|||||..+....
T Consensus        98 ELC~~~sL~el~Krr--k~ltEpEary~l~QIv~GlkYLH~---~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~  172 (592)
T KOG0575|consen   98 ELCHRGSLMELLKRR--KPLTEPEARYFLRQIVEGLKYLHS---LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG  172 (592)
T ss_pred             EecCCccHHHHHHhc--CCCCcHHHHHHHHHHHHHHHHHHh---cCceecccchhheeecCcCcEEecccceeeeecCcc
Confidence            999999999999743  579999999999999999999998   999999999999999999999999999999887543


Q ss_pred             CCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCC
Q 007869          418 DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLG  497 (586)
Q Consensus       418 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~  497 (586)
                      . ...+.+|||.|+|||++.....+..+||||+||+||-|++|++||+...-.+...-+          +..+-.-|.  
T Consensus       173 E-rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~I----------k~~~Y~~P~--  239 (592)
T KOG0575|consen  173 E-RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKI----------KLNEYSMPS--  239 (592)
T ss_pred             c-ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHH----------HhcCccccc--
Confidence            3 455689999999999999888999999999999999999999999875433222111          111111121  


Q ss_pred             ccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          498 TEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       498 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                           .......+|+.++|++||.+|||+.+|+.
T Consensus       240 -----~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  240 -----HLSAEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             -----ccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                 22234556777789999999999999995

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-46  Score=369.83  Aligned_cols=205  Identities=29%  Similarity=0.514  Sum_probs=186.2

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc--cchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEE
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY  337 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  337 (586)
                      -.+|...+.||+|.|++||+|+++.++..||||.+.+.  .+...+.+..|+.+|++++|||||+|++++..++.++|||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            35688888899999999999999999999999999877  5666777899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCC------CCeEEcccccee
Q 007869          338 DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGE------LNGRLGDFGLAR  411 (586)
Q Consensus       338 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~------~~~kL~DFGla~  411 (586)
                      |||.+|+|.++|+..+  .+++.....++.|||.||++||+   ++||||||||+||||+..      -.+||+|||+||
T Consensus        89 EyC~gGDLs~yi~~~~--~l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR  163 (429)
T KOG0595|consen   89 EYCNGGDLSDYIRRRG--RLPEATARHFMQQLASALQFLHE---NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR  163 (429)
T ss_pred             EeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence            9999999999998764  68899999999999999999998   999999999999999764      458999999999


Q ss_pred             eccCCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCc
Q 007869          412 LYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSE  471 (586)
Q Consensus       412 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~  471 (586)
                      .+....  ...+.+|++-|||||++...+|+.|.|+||.|++|||+++|+.||+..+..+
T Consensus       164 ~L~~~~--~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~e  221 (429)
T KOG0595|consen  164 FLQPGS--MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKE  221 (429)
T ss_pred             hCCchh--HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHH
Confidence            887443  3456799999999999999999999999999999999999999998765543

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.6e-47  Score=361.22  Aligned_cols=260  Identities=25%  Similarity=0.393  Sum_probs=213.7

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc--cchhHHHHHHHHHHhcccCCCceeeeeee-eeccCe-EEEE
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGY-CRRKGE-LLLV  336 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~~~-~~~~~~-~~lV  336 (586)
                      .+|++.++||+|.||.|||+.+..++..+|.|.+..+  +.+..+....|+.+|++|+|||||+++++ +.++++ ++||
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            4578889999999999999999999999999998754  45566789999999999999999999994 455555 8999


Q ss_pred             EecCCCCChhhhhhc--CCCccchhHHHHHHHHHHHHHHHHhhcccCC-cEEeCCCCCCCeeecCCCCeEEccccceeec
Q 007869          337 YDYMPNGSLDKYLYD--QPKVTLNWIQRFRVIKGVALGLFYLHQEWEQ-VVIHRDVKASNVLLDGELNGRLGDFGLARLY  413 (586)
Q Consensus       337 ~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~-~ivHrDIkp~NIll~~~~~~kL~DFGla~~~  413 (586)
                      ||||..|+|..+++.  .++..+++...|+++.|++.||.++|+.+.+ -|+||||||.||+|+++|.+||+||||++.+
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l  178 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL  178 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence            999999999999965  3456799999999999999999999985533 3999999999999999999999999999998


Q ss_pred             cCCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccC
Q 007869          414 DHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARD  493 (586)
Q Consensus       414 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d  493 (586)
                      ..... .....+|||.||+||.+....|+.||||||+||++|||+.-++||.+.+-   ..    +.+...+++.     
T Consensus       179 ~s~~t-fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~---~~----L~~KI~qgd~-----  245 (375)
T KOG0591|consen  179 SSKTT-FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNL---LS----LCKKIEQGDY-----  245 (375)
T ss_pred             cchhH-HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccH---HH----HHHHHHcCCC-----
Confidence            76443 34457999999999999999999999999999999999999999998621   11    2233334422     


Q ss_pred             CCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 007869          494 PNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERD  536 (586)
Q Consensus       494 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  536 (586)
                      |++..   .-....+.+|+..|+.+||+.||+....++.+..+
T Consensus       246 ~~~p~---~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~~  285 (375)
T KOG0591|consen  246 PPLPD---EHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQSE  285 (375)
T ss_pred             CCCcH---HHhhhHHHHHHHHHccCCcccCCCcchHHHHHHHH
Confidence            22222   22345667777889999999999976666665543

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.8e-45  Score=363.95  Aligned_cols=254  Identities=25%  Similarity=0.344  Sum_probs=205.8

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccc-------hhHHHHHHHHHHhcccCCCceeeeeeeeeccCe
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR-------QGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGE  332 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~  332 (586)
                      .+.|...+.||+|+||.|-+|..+.+++.||||++++...       .......+|+++|++|+|||||++++++...+.
T Consensus       171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds  250 (475)
T KOG0615|consen  171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS  250 (475)
T ss_pred             cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence            3557778999999999999999999999999999976421       122345799999999999999999999999999


Q ss_pred             EEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCC---CCeEEccccc
Q 007869          333 LLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGE---LNGRLGDFGL  409 (586)
Q Consensus       333 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~---~~~kL~DFGl  409 (586)
                      .|+|||||+||.|.+.+-.+.  .+.+..-..+++|++.|+.|||+   ++|+||||||+|||+..+   ..+||+|||+
T Consensus       251 ~YmVlE~v~GGeLfd~vv~nk--~l~ed~~K~~f~Qll~avkYLH~---~GI~HRDiKPeNILl~~~~e~~llKItDFGl  325 (475)
T KOG0615|consen  251 SYMVLEYVEGGELFDKVVANK--YLREDLGKLLFKQLLTAVKYLHS---QGIIHRDIKPENILLSNDAEDCLLKITDFGL  325 (475)
T ss_pred             eEEEEEEecCccHHHHHHhcc--ccccchhHHHHHHHHHHHHHHHH---cCcccccCCcceEEeccCCcceEEEecccch
Confidence            999999999999999997764  45555667789999999999998   999999999999999765   7799999999


Q ss_pred             eeeccCCCCCceeeeccCCCccCcccccCCCC--C-CcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccC
Q 007869          410 ARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKA--T-TSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRG  486 (586)
Q Consensus       410 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--s-~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~  486 (586)
                      |+.....  ....+.+||+.|.|||++.++..  + .+.|+||+||+||-++||.+||.......  .+.+    ...+|
T Consensus       326 AK~~g~~--sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--sl~e----QI~~G  397 (475)
T KOG0615|consen  326 AKVSGEG--SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--SLKE----QILKG  397 (475)
T ss_pred             hhccccc--eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--cHHH----HHhcC
Confidence            9987643  24556899999999999987653  3 37899999999999999999998654322  1111    11222


Q ss_pred             ccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          487 ELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       487 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                      +..  ..|    ..-.+..++.++++.+||..||++|||+.|+++.
T Consensus       398 ~y~--f~p----~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h  437 (475)
T KOG0615|consen  398 RYA--FGP----LQWDRISEEALDLINWMLVVDPENRPSADEALNH  437 (475)
T ss_pred             ccc--ccC----hhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence            221  111    1233456778899999999999999999999863

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-45  Score=391.11  Aligned_cols=272  Identities=28%  Similarity=0.514  Sum_probs=231.2

Q ss_pred             ccchhhhhhhcCCc---------ccceeEeecCceEEEEEEeCCCC---eEEEEEEeccc-cchhHHHHHHHHHHhcccC
Q 007869          250 RFRYKDLYIATKGF---------REKELLGTGGFGRVYRGTLPKSQ---IEIAVKKISHE-SRQGMKEFVAEIVSIGRLR  316 (586)
Q Consensus       250 ~~~~~el~~a~~~f---------~~~~~LG~G~~g~Vy~~~~~~~~---~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~  316 (586)
                      .++|+|...|-..|         .++++||.|-||.||+|+++..+   ..||||.++.. ......+|+.|..+|.++.
T Consensus       609 P~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFd  688 (996)
T KOG0196|consen  609 PHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFD  688 (996)
T ss_pred             CccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCC
Confidence            46777766555555         46799999999999999997544   56999999876 4455678999999999999


Q ss_pred             CCceeeeeeeeeccCeEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeee
Q 007869          317 HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLL  396 (586)
Q Consensus       317 H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll  396 (586)
                      ||||++|.|+.......+||.|||+||+|+.+|+.+. ..+.+.|..-++++||.||+||-+   .++|||||.++|||+
T Consensus       689 HPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~D-GqftviQLVgMLrGIAsGMkYLsd---m~YVHRDLAARNILV  764 (996)
T KOG0196|consen  689 HPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQND-GQFTVIQLVGMLRGIASGMKYLSD---MNYVHRDLAARNILV  764 (996)
T ss_pred             CCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcC-CceEeehHHHHHHHHHHHhHHHhh---cCchhhhhhhhheee
Confidence            9999999999999999999999999999999998886 469999999999999999999998   999999999999999


Q ss_pred             cCCCCeEEccccceeeccCCCCCceeeecc--CCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccc
Q 007869          397 DGELNGRLGDFGLARLYDHGTDPQTTHVVG--TLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENL  473 (586)
Q Consensus       397 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~  473 (586)
                      +.+..+|++||||+|.++.+.....+..-|  ..+|.|||.+...+++.+||||||||||||+++ |.+||-...+.+  
T Consensus       765 NsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQd--  842 (996)
T KOG0196|consen  765 NSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD--  842 (996)
T ss_pred             ccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHH--
Confidence            999999999999999887665433333333  578999999999999999999999999999877 999998765433  


Q ss_pred             hhhHHHHhhhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhccCCCc
Q 007869          474 ILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERDVALPA  541 (586)
Q Consensus       474 ~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~p~  541 (586)
                                    +.+.++...+..-+.+++..|.+|++.||++|-.+||.+.+++..|++.+.-|.
T Consensus       843 --------------VIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~  896 (996)
T KOG0196|consen  843 --------------VIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPN  896 (996)
T ss_pred             --------------HHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCch
Confidence                          222333333334456778889999999999999999999999999999876664

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=9.3e-45  Score=347.96  Aligned_cols=265  Identities=23%  Similarity=0.315  Sum_probs=214.2

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc--cchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEe
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYD  338 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E  338 (586)
                      +.|+...++|+|+||.||||+++++|+.||||++...  ++.-.+-.++|+++|++++|+|+|.|+..|..+..++||+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            4577788999999999999999999999999999653  23344567899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCC
Q 007869          339 YMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD  418 (586)
Q Consensus       339 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~  418 (586)
                      ||+.. +.+.|.+.+ ..++.....+++.|+++|+.|+|+   +++|||||||+|||++.++.+||||||.|+.+... .
T Consensus        82 ~~dhT-vL~eLe~~p-~G~~~~~vk~~l~Q~l~ai~~cHk---~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p-g  155 (396)
T KOG0593|consen   82 YCDHT-VLHELERYP-NGVPSELVKKYLYQLLKAIHFCHK---NNCIHRDIKPENILITQNGVVKLCDFGFARTLSAP-G  155 (396)
T ss_pred             ecchH-HHHHHHhcc-CCCCHHHHHHHHHHHHHHhhhhhh---cCeecccCChhheEEecCCcEEeccchhhHhhcCC-c
Confidence            99764 444455544 357888899999999999999998   89999999999999999999999999999988742 2


Q ss_pred             CceeeeccCCCccCcccccC-CCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHH--------HhhhccCcc-
Q 007869          419 PQTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWV--------FDFWNRGEL-  488 (586)
Q Consensus       419 ~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v--------~~~~~~~~~-  488 (586)
                      ...+..+.|.+|+|||.+.+ .+|....||||.||++.||++|.+-|.+.+.-+++.++...        .+.+..+.. 
T Consensus       156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F  235 (396)
T KOG0593|consen  156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFF  235 (396)
T ss_pred             chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCce
Confidence            35577889999999999987 68999999999999999999999999988777766555332        222222211 


Q ss_pred             -----ccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          489 -----LEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       489 -----~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                           .+..++.....-.+....-+++++..|++.||.+|++-+|++.
T Consensus       236 ~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  236 HGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             eeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence                 1112222212222334457889999999999999999999873

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=2.1e-44  Score=388.98  Aligned_cols=265  Identities=29%  Similarity=0.471  Sum_probs=223.0

Q ss_pred             hhhhhhcCCcccceeEeecCceEEEEEEeCC-----CCeEEEEEEeccccch-hHHHHHHHHHHhcccCCCceeeeeeee
Q 007869          254 KDLYIATKGFREKELLGTGGFGRVYRGTLPK-----SQIEIAVKKISHESRQ-GMKEFVAEIVSIGRLRHRNLVQLLGYC  327 (586)
Q Consensus       254 ~el~~a~~~f~~~~~LG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~~~~  327 (586)
                      +-......+....+.||+|+||+||+|...+     ....||||.++..... ...+|++|++++..++|||||+|+|.|
T Consensus       479 ~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC  558 (774)
T KOG1026|consen  479 KVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVC  558 (774)
T ss_pred             ceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEE
Confidence            3344556666778889999999999998643     3467999999887554 788999999999999999999999999


Q ss_pred             eccCeEEEEEecCCCCChhhhhhcCC------------CccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCee
Q 007869          328 RRKGELLLVYDYMPNGSLDKYLYDQP------------KVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVL  395 (586)
Q Consensus       328 ~~~~~~~lV~E~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIl  395 (586)
                      .+++.+++|+|||..|+|.++|....            +.+|+..+.+.|+.|||.||.||-+   +.+|||||..+|+|
T Consensus       559 ~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~---~~FVHRDLATRNCL  635 (774)
T KOG1026|consen  559 REGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSS---HHFVHRDLATRNCL  635 (774)
T ss_pred             ccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---Ccccccchhhhhce
Confidence            99999999999999999999997531            2238899999999999999999998   99999999999999


Q ss_pred             ecCCCCeEEccccceeeccCCC-CCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccc
Q 007869          396 LDGELNGRLGDFGLARLYDHGT-DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENL  473 (586)
Q Consensus       396 l~~~~~~kL~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~  473 (586)
                      |.++..|||+||||+|..-... ........-..+||+||.+..+++|++||||||||+|||+++ |+.|+.+....+  
T Consensus       636 Vge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E--  713 (774)
T KOG1026|consen  636 VGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE--  713 (774)
T ss_pred             eccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH--
Confidence            9999999999999999543222 222223344789999999999999999999999999999998 999999876644  


Q ss_pred             hhhHHHHhhhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 007869          474 ILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERDV  537 (586)
Q Consensus       474 ~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  537 (586)
                           |.+..++|.++..         +..++..+..|++.||+.+|.+||+++||-..|+...
T Consensus       714 -----VIe~i~~g~lL~~---------Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~  763 (774)
T KOG1026|consen  714 -----VIECIRAGQLLSC---------PENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWA  763 (774)
T ss_pred             -----HHHHHHcCCcccC---------CCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHH
Confidence                 4455567766543         3345678999999999999999999999999998654

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.1e-43  Score=358.32  Aligned_cols=266  Identities=29%  Similarity=0.374  Sum_probs=213.5

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc--chhHHHHHHHHHHhcccCCCceeeeeeeeecc--CeEEEE
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES--RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRK--GELLLV  336 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~--~~~~lV  336 (586)
                      +.|+..++||+|.||.|||+++..++..||+|+++.+.  .....-..+||.+|++|+||||++|.+...+.  +.+|||
T Consensus       117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV  196 (560)
T KOG0600|consen  117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV  196 (560)
T ss_pred             HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence            35667788999999999999999999999999998765  33445668999999999999999999988776  789999


Q ss_pred             EecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCC
Q 007869          337 YDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHG  416 (586)
Q Consensus       337 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~  416 (586)
                      +|||+. +|.-++... ...++..++..+++|+++||.|+|+   ++|+|||||.+|||||.+|.+||+|||||+++...
T Consensus       197 FeYMdh-DL~GLl~~p-~vkft~~qIKc~mkQLl~Gl~~cH~---~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~  271 (560)
T KOG0600|consen  197 FEYMDH-DLSGLLSSP-GVKFTEPQIKCYMKQLLEGLEYCHS---RGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS  271 (560)
T ss_pred             Eecccc-hhhhhhcCC-CcccChHHHHHHHHHHHHHHHHHhh---cCeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence            999965 888877553 4679999999999999999999998   99999999999999999999999999999998877


Q ss_pred             CCCceeeeccCCCccCcccccCC-CCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHH-----HhhhccCcccc
Q 007869          417 TDPQTTHVVGTLGYLAPEHTRTG-KATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWV-----FDFWNRGELLE  490 (586)
Q Consensus       417 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v-----~~~~~~~~~~~  490 (586)
                      .....+..+-|.+|+|||++.+. .|+.+.|+||.||||.||+.|++.|.+..+-+++..+-.+     ...|...++..
T Consensus       272 ~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~  351 (560)
T KOG0600|consen  272 GSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPH  351 (560)
T ss_pred             CCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCc
Confidence            66667778889999999999875 6999999999999999999999999987766554333111     11122112211


Q ss_pred             ccCCCCCcccc-------HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          491 ARDPNLGTEYV-------AEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       491 ~~d~~l~~~~~-------~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      ..-.+....+.       .......++|+..+|..||.+|.|+.++++
T Consensus       352 ~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  352 ATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             ccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence            11111111111       112245667888889999999999999985

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-43  Score=367.29  Aligned_cols=274  Identities=27%  Similarity=0.448  Sum_probs=221.6

Q ss_pred             ccchhhhhhhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc--cchhHHHHHHHHHHhcccCCCceeeeeeee
Q 007869          250 RFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYC  327 (586)
Q Consensus       250 ~~~~~el~~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~  327 (586)
                      +.+.+++.+..+.+...+.||+|.||+||+|.+-+   .||||++.-+  +.+..+.|++|+..+++-||.||+-+.|||
T Consensus       381 s~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~  457 (678)
T KOG0193|consen  381 SDSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGAC  457 (678)
T ss_pred             CccccccccCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhh
Confidence            34447777888888889999999999999999965   4999999765  445678999999999999999999999999


Q ss_pred             eccCeEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccc
Q 007869          328 RRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDF  407 (586)
Q Consensus       328 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DF  407 (586)
                      ...+. .||..+|+|.+|+.+|+..+ ..++..+.++|+.|||+|+.|||.   ++|||||||..||||.++++|||+||
T Consensus       458 ~~p~~-AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kVkIgDF  532 (678)
T KOG0193|consen  458 MNPPL-AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKVKIGDF  532 (678)
T ss_pred             cCCce-eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcEEEecc
Confidence            99877 99999999999999998764 578999999999999999999998   99999999999999999999999999


Q ss_pred             cceeeccCC-CCCceeeeccCCCccCcccccCC---CCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhh
Q 007869          408 GLARLYDHG-TDPQTTHVVGTLGYLAPEHTRTG---KATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFW  483 (586)
Q Consensus       408 Gla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~---~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~  483 (586)
                      ||+.....- .........|...|||||+++..   +|+..|||||||||+|||+||..||. ....+++.   |   ..
T Consensus       533 GLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~dqIi---f---mV  605 (678)
T KOG0193|consen  533 GLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRDQII---F---MV  605 (678)
T ss_pred             cceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChhheE---E---Ee
Confidence            999753221 11223334688899999999754   58999999999999999999999998 34333321   1   11


Q ss_pred             ccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhccC-CCccc
Q 007869          484 NRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERDVA-LPAIS  543 (586)
Q Consensus       484 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~-~p~~~  543 (586)
                      .+|.+.  .|..   .....+.+.+.+|+..||..++++||.+.+++..|+...+ +|.+.
T Consensus       606 GrG~l~--pd~s---~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~pki~  661 (678)
T KOG0193|consen  606 GRGYLM--PDLS---KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSLPKIN  661 (678)
T ss_pred             cccccC--ccch---hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcccccc
Confidence            223222  1221   1233456677888889999999999999999998876554 55544

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-43  Score=349.13  Aligned_cols=245  Identities=26%  Similarity=0.353  Sum_probs=202.9

Q ss_pred             hhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc---cchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEE
Q 007869          258 IATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELL  334 (586)
Q Consensus       258 ~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~  334 (586)
                      ...+.|+..++||+|+||+||+++.+++++.+|+|++++.   .....+...+|..+|.+++||.||+++-.|.+.+.+|
T Consensus        22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLy  101 (357)
T KOG0598|consen   22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLY  101 (357)
T ss_pred             CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEE
Confidence            4467899999999999999999999999999999999765   2345677899999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeecc
Q 007869          335 LVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYD  414 (586)
Q Consensus       335 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~  414 (586)
                      ||+||+.||.|..+|.++.  .+++....-++.+|+.||.|||+   ++||||||||+|||||.+|.++|+|||||+...
T Consensus       102 lVld~~~GGeLf~hL~~eg--~F~E~~arfYlaEi~lAL~~LH~---~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~  176 (357)
T KOG0598|consen  102 LVLDYLNGGELFYHLQREG--RFSEDRARFYLAEIVLALGYLHS---KGIIYRDLKPENILLDEQGHIKLTDFGLCKEDL  176 (357)
T ss_pred             EEEeccCCccHHHHHHhcC--CcchhHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence            9999999999999998764  57777778889999999999998   999999999999999999999999999999644


Q ss_pred             CCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCC
Q 007869          415 HGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDP  494 (586)
Q Consensus       415 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~  494 (586)
                      ... ..+.+.+||+.|||||++....|+..+|.||+|+++|||++|.+||...+..+      +. +...++++     +
T Consensus       177 ~~~-~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~------~~-~~I~~~k~-----~  243 (357)
T KOG0598|consen  177 KDG-DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKK------MY-DKILKGKL-----P  243 (357)
T ss_pred             cCC-CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHH------HH-HHHhcCcC-----C
Confidence            332 23455799999999999999999999999999999999999999998765432      11 11112221     1


Q ss_pred             CCCccccHHHHHHHHHHHHHhcccCCCCCC
Q 007869          495 NLGTEYVAEELELVLKLGLLCSHSDPTARP  524 (586)
Q Consensus       495 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP  524 (586)
                      .. ..+   ......+++...++.||++|.
T Consensus       244 ~~-p~~---ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  244 LP-PGY---LSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             CC-Ccc---CCHHHHHHHHHHhccCHHHhc
Confidence            11 111   123344556667889999996

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-43  Score=351.86  Aligned_cols=257  Identities=28%  Similarity=0.416  Sum_probs=208.4

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccC--eEEEEE
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKG--ELLLVY  337 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~--~~~lV~  337 (586)
                      ..++...+.||+|.||.||++...+++...|||.+...+....+.+.+|+.+|.+++|||||+++|......  .+++.|
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m   95 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM   95 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence            345677889999999999999999888999999997764444677899999999999999999999855444  699999


Q ss_pred             ecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecC-CCCeEEccccceeeccC-
Q 007869          338 DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDG-ELNGRLGDFGLARLYDH-  415 (586)
Q Consensus       338 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~-~~~~kL~DFGla~~~~~-  415 (586)
                      ||+++|+|.+++.+.+. .|++..+..+..||++||.|||+   ++||||||||+|||++. ++.+||+|||+++.... 
T Consensus        96 Ey~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs---~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~  171 (313)
T KOG0198|consen   96 EYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHS---KGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESK  171 (313)
T ss_pred             eccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHh---CCEeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence            99999999999988765 79999999999999999999998   99999999999999999 79999999999997663 


Q ss_pred             -CCCCceeeeccCCCccCcccccCCC-CCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccC
Q 007869          416 -GTDPQTTHVVGTLGYLAPEHTRTGK-ATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARD  493 (586)
Q Consensus       416 -~~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d  493 (586)
                       ..........||+.|||||++..+. ...++|||||||++.||+||++||...     ....+++......+     .-
T Consensus       172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~~-----~~  241 (313)
T KOG0198|consen  172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGRED-----SL  241 (313)
T ss_pred             cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhccC-----CC
Confidence             2222344578999999999998643 345999999999999999999999763     11122222222222     11


Q ss_pred             CCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 007869          494 PNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILE  534 (586)
Q Consensus       494 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  534 (586)
                      |.    ++........+++.+|++.+|++|||+.++++..-
T Consensus       242 P~----ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf  278 (313)
T KOG0198|consen  242 PE----IPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPF  278 (313)
T ss_pred             CC----CCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence            22    22234456677888899999999999999997643

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=6e-42  Score=352.53  Aligned_cols=265  Identities=28%  Similarity=0.459  Sum_probs=215.0

Q ss_pred             hcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccc-hhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEE
Q 007869          259 ATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR-QGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY  337 (586)
Q Consensus       259 a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  337 (586)
                      +.+...+.++||+|.||.|..|.... +..||||.++.+.. ...++|..|+++|.+++||||++|+|.|..++.+++++
T Consensus       536 PRs~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~  614 (807)
T KOG1094|consen  536 PRSRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMIT  614 (807)
T ss_pred             chhheehhhhhcCcccceeEEEEecC-ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHH
Confidence            33445667899999999999999854 68899999988754 44589999999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCC
Q 007869          338 DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT  417 (586)
Q Consensus       338 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~  417 (586)
                      |||++|+|.++|..+....+.-....+|+.|||.||+||.+   .++|||||.+.|+|+|+++++||+|||++|-+-.+.
T Consensus       615 EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes---~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~  691 (807)
T KOG1094|consen  615 EYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLES---LNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGD  691 (807)
T ss_pred             HHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHh---hchhhccccccceeecCcccEEecCcccccccccCC
Confidence            99999999999988754445666778899999999999998   999999999999999999999999999999543332


Q ss_pred             -CCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHH--HhCCCCCCCCCCCccchhhHHHHhhhccCccccccCC
Q 007869          418 -DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEV--ACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDP  494 (586)
Q Consensus       418 -~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~El--ltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~  494 (586)
                       .......+-..+|||+|.+..++++.+||||+||+++||+  +|...||......+   .++-...+...+.....   
T Consensus       692 yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~---vven~~~~~~~~~~~~~---  765 (807)
T KOG1094|consen  692 YYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ---VVENAGEFFRDQGRQVV---  765 (807)
T ss_pred             ceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH---HHHhhhhhcCCCCccee---
Confidence             2333455668999999999999999999999999999997  56889997654322   22323333322211111   


Q ss_pred             CCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 007869          495 NLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERD  536 (586)
Q Consensus       495 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  536 (586)
                         ...+.-+...+.++++.||..+-++||+++++...|+..
T Consensus       766 ---l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  766 ---LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             ---ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence               112334556788999999999999999999999998764

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-42  Score=345.14  Aligned_cols=264  Identities=26%  Similarity=0.368  Sum_probs=215.0

Q ss_pred             hhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc-cchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEE
Q 007869          258 IATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLV  336 (586)
Q Consensus       258 ~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV  336 (586)
                      ...+.|...+.||.|..++||+|+....+..||||++..+ .....+.+..|++.|+.++||||++++..|..+.++|+|
T Consensus        23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvV  102 (516)
T KOG0582|consen   23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVV  102 (516)
T ss_pred             CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEe
Confidence            4557899999999999999999999989999999999875 334468899999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCC
Q 007869          337 YDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHG  416 (586)
Q Consensus       337 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~  416 (586)
                      |.||.+||+.+.++..-...+++..+..|++++++||.|||+   ++.||||||+.||||+++|.+||+|||....+...
T Consensus       103 mpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~---~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~  179 (516)
T KOG0582|consen  103 MPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQ---NGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDS  179 (516)
T ss_pred             ehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHh---cCceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence            999999999999988766779999999999999999999998   99999999999999999999999999988755443


Q ss_pred             CCCce---eeeccCCCccCcccccC--CCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccc
Q 007869          417 TDPQT---THVVGTLGYLAPEHTRT--GKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEA  491 (586)
Q Consensus       417 ~~~~~---~~~~gt~~y~aPE~~~~--~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~  491 (586)
                      .....   ...+||++|||||++..  ..|+.|+||||||++.+||.+|..||....+.+.+.+     .+  ++.....
T Consensus       180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~-----tL--qn~pp~~  252 (516)
T KOG0582|consen  180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLL-----TL--QNDPPTL  252 (516)
T ss_pred             CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHH-----Hh--cCCCCCc
Confidence            33221   44689999999999533  3589999999999999999999999987765432211     01  1111000


Q ss_pred             cCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          492 RDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       492 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      .-..+..+........+.+++-.|++.||.+|||++++++
T Consensus       253 ~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  253 LTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             ccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            0001111222233346788888999999999999999985

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-42  Score=358.73  Aligned_cols=250  Identities=25%  Similarity=0.397  Sum_probs=215.5

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEecC
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYM  340 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  340 (586)
                      ..|....+||+|+.|.||.+....+++.||||++........+-+.+|+.+|+..+|+|||++++.|..+++++.|||||
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym  352 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM  352 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence            45667788999999999999999999999999998877777778999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCCc
Q 007869          341 PNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ  420 (586)
Q Consensus       341 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~  420 (586)
                      ++|+|.+.+...   .+++.++..|++++++||+|||.   ++|+|||||.+|||++.++++||+|||+|..+..... .
T Consensus       353 ~ggsLTDvVt~~---~~~E~qIA~Icre~l~aL~fLH~---~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-K  425 (550)
T KOG0578|consen  353 EGGSLTDVVTKT---RMTEGQIAAICREILQGLKFLHA---RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-K  425 (550)
T ss_pred             CCCchhhhhhcc---cccHHHHHHHHHHHHHHHHHHHh---cceeeeccccceeEeccCCcEEEeeeeeeeccccccC-c
Confidence            999999998655   58999999999999999999998   9999999999999999999999999999998766543 3


Q ss_pred             eeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCccc
Q 007869          421 TTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEY  500 (586)
Q Consensus       421 ~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~  500 (586)
                      ....+||+.|||||++....|.+|.||||||++++||+-|++||-..++...+.++      ..+|.      |.+.  .
T Consensus       426 R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLI------a~ng~------P~lk--~  491 (550)
T KOG0578|consen  426 RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI------ATNGT------PKLK--N  491 (550)
T ss_pred             cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHH------hhcCC------CCcC--C
Confidence            45578999999999999999999999999999999999999999875543322222      12222      2221  2


Q ss_pred             cHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          501 VAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       501 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      .......+.++..+||+.|+++||++.|+|+
T Consensus       492 ~~klS~~~kdFL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  492 PEKLSPELKDFLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             ccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence            2334456778888999999999999999996

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=3.3e-42  Score=359.12  Aligned_cols=262  Identities=27%  Similarity=0.414  Sum_probs=206.0

Q ss_pred             hhcCCcccceeEeecCceEEEEEEeC-----CCCeEEEEEEecccc-chhHHHHHHHHHHhccc-CCCceeeeeeeeecc
Q 007869          258 IATKGFREKELLGTGGFGRVYRGTLP-----KSQIEIAVKKISHES-RQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRK  330 (586)
Q Consensus       258 ~a~~~f~~~~~LG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~  330 (586)
                      ...++|+..+.||+|+||.||+|.+.     .++..||||++.... ....+.+.+|+.++.++ +||||++++++|...
T Consensus         4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~   83 (338)
T cd05102           4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP   83 (338)
T ss_pred             cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence            44578999999999999999999752     334679999987543 23456789999999999 899999999988765


Q ss_pred             -CeEEEEEecCCCCChhhhhhcCC--------------------------------------------------------
Q 007869          331 -GELLLVYDYMPNGSLDKYLYDQP--------------------------------------------------------  353 (586)
Q Consensus       331 -~~~~lV~E~~~~gsL~~~l~~~~--------------------------------------------------------  353 (586)
                       +.+++||||+++|+|.+++....                                                        
T Consensus        84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (338)
T cd05102          84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET  163 (338)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence             45899999999999999987531                                                        


Q ss_pred             ----CccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCC-ceeeeccCC
Q 007869          354 ----KVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP-QTTHVVGTL  428 (586)
Q Consensus       354 ----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~  428 (586)
                          ...+++..+..++.||++||.|||+   ++|+||||||+|||++.++.+||+|||+++........ ......++.
T Consensus       164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~  240 (338)
T cd05102         164 DDLWKSPLTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL  240 (338)
T ss_pred             cccccCCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence                1247788899999999999999998   89999999999999999999999999999865432211 122345678


Q ss_pred             CccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCccccHHHHHH
Q 007869          429 GYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELEL  507 (586)
Q Consensus       429 ~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~  507 (586)
                      .|+|||++.+..++.++|||||||++|||++ |+.||......+.      ......++..     +..    .......
T Consensus       241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~------~~~~~~~~~~-----~~~----~~~~~~~  305 (338)
T cd05102         241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE------FCQRLKDGTR-----MRA----PENATPE  305 (338)
T ss_pred             cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH------HHHHHhcCCC-----CCC----CCCCCHH
Confidence            8999999999999999999999999999997 9999976443221      1111112211     111    1122346


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 007869          508 VLKLGLLCSHSDPTARPSMRQVVQILERDV  537 (586)
Q Consensus       508 l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  537 (586)
                      +.+++.+||+.||.+|||+.|+++.|+...
T Consensus       306 l~~li~~cl~~dp~~RPs~~el~~~l~~~~  335 (338)
T cd05102         306 IYRIMLACWQGDPKERPTFSALVEILGDLL  335 (338)
T ss_pred             HHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            788999999999999999999999998643

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-43  Score=355.93  Aligned_cols=265  Identities=25%  Similarity=0.376  Sum_probs=214.5

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHH--HHHHHHHhcccC-CCceeeeeeeeeccC-eEEE
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKE--FVAEIVSIGRLR-HRNLVQLLGYCRRKG-ELLL  335 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~--~~~Ei~~l~~l~-H~niv~l~~~~~~~~-~~~l  335 (586)
                      .++|...++||.|.||.||+|+...++..||||+++..-.. +++  =++|++.|++|+ ||||++|.+.+.+.+ .+++
T Consensus         9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f   87 (538)
T KOG0661|consen    9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF   87 (538)
T ss_pred             HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence            45678889999999999999999999999999999765433 233  368999999998 999999999999887 9999


Q ss_pred             EEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccC
Q 007869          336 VYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH  415 (586)
Q Consensus       336 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~  415 (586)
                      ||||| ..+|+++++++ ...+++..+..|+.||++||+|+|.   +|+.|||+||+|||+..+..+||+||||||....
T Consensus        88 VfE~M-d~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk---~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~S  162 (538)
T KOG0661|consen   88 VFEFM-DCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHK---HGFFHRDLKPENILISGNDVIKIADFGLAREVRS  162 (538)
T ss_pred             eHHhh-hhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHh---cCcccccCChhheEecccceeEeccccccccccc
Confidence            99999 46999999888 6689999999999999999999998   9999999999999999999999999999997654


Q ss_pred             CCCCceeeeccCCCccCcccc-cCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHH-----hhhccCc-c
Q 007869          416 GTDPQTTHVVGTLGYLAPEHT-RTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVF-----DFWNRGE-L  488 (586)
Q Consensus       416 ~~~~~~~~~~gt~~y~aPE~~-~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~-----~~~~~~~-~  488 (586)
                      .  +..+..+.|.+|+|||++ +.+-|+.+.|+||+||+++|+.+-++-|.+.++.+++.-+--|.     +-|.+|. +
T Consensus       163 k--pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~L  240 (538)
T KOG0661|consen  163 K--PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNL  240 (538)
T ss_pred             C--CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHH
Confidence            3  456778999999999987 46678999999999999999999999998877665543221111     1111110 0


Q ss_pred             ---ccccCCCCC----ccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          489 ---LEARDPNLG----TEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       489 ---~~~~d~~l~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                         +...-|...    ...........++++.+|+..||.+|||+.|+++.
T Consensus       241 a~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  241 ASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             HHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence               111111111    11222355778899999999999999999999974

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=5.5e-41  Score=396.56  Aligned_cols=262  Identities=27%  Similarity=0.493  Sum_probs=217.4

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEecC
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYM  340 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  340 (586)
                      ..|...++||+|+||.||+|++..++..||||++......    ...|++.+++++||||++++++|.+.+..++||||+
T Consensus       690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~  765 (968)
T PLN00113        690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYI  765 (968)
T ss_pred             hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCC
Confidence            4577889999999999999999888899999998654322    234688899999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCCc
Q 007869          341 PNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ  420 (586)
Q Consensus       341 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~  420 (586)
                      ++|+|.++++     .++|.++.+|+.|+|+||+|||+.+.++|+||||||+||+++.++.+++. ||.......     
T Consensus       766 ~~g~L~~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~-----  834 (968)
T PLN00113        766 EGKNLSEVLR-----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT-----  834 (968)
T ss_pred             CCCcHHHHHh-----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc-----
Confidence            9999999995     37899999999999999999997666899999999999999999888875 665543321     


Q ss_pred             eeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCc--
Q 007869          421 TTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGT--  498 (586)
Q Consensus       421 ~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~--  498 (586)
                      .....||..|+|||++.+..++.++|||||||++|||++|+.||+.... ....+.+|+...+.........||.+..  
T Consensus       835 ~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  913 (968)
T PLN00113        835 DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDCHLDMWIDPSIRGDV  913 (968)
T ss_pred             CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCccchhheeCccccCCC
Confidence            1223688999999999999999999999999999999999999964322 2334667777666555555556666533  


Q ss_pred             cccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhccC
Q 007869          499 EYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERDVA  538 (586)
Q Consensus       499 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~  538 (586)
                      ....+++..+.+++.+||+.||++||+|+||++.|++...
T Consensus       914 ~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  953 (968)
T PLN00113        914 SVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR  953 (968)
T ss_pred             CccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence            3455677789999999999999999999999999987543

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=2.2e-41  Score=344.48  Aligned_cols=252  Identities=26%  Similarity=0.340  Sum_probs=205.0

Q ss_pred             CcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc---chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEe
Q 007869          262 GFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYD  338 (586)
Q Consensus       262 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E  338 (586)
                      .|+..+.||+|+||.||+|.+..++..||+|.+....   ......+.+|+.++.+++|+|++++++++...+..++|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            4778899999999999999998889999999986542   2334567899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCC
Q 007869          339 YMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD  418 (586)
Q Consensus       339 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~  418 (586)
                      |+++|+|.+++.......+++.++..++.|++.||.|||+   .+|+||||||+|||+++++.+||+|||++....... 
T Consensus        81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-  156 (285)
T cd05631          81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-  156 (285)
T ss_pred             ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-
Confidence            9999999988876544578999999999999999999998   899999999999999999999999999998754322 


Q ss_pred             CceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCc
Q 007869          419 PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGT  498 (586)
Q Consensus       419 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~  498 (586)
                       ......||..|+|||++.+..++.++|||||||++|||++|+.||..........   -+........          .
T Consensus       157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~---~~~~~~~~~~----------~  222 (285)
T cd05631         157 -TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKRE---EVDRRVKEDQ----------E  222 (285)
T ss_pred             -eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHH---HHHHHhhccc----------c
Confidence             2234578999999999999999999999999999999999999998654322111   1111111100          1


Q ss_pred             cccHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 007869          499 EYVAEELELVLKLGLLCSHSDPTARPS-----MRQVVQ  531 (586)
Q Consensus       499 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~  531 (586)
                      .+.......+.+++.+||+.||.+||+     ++++++
T Consensus       223 ~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         223 EYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             cCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence            112223356778889999999999997     777775

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-41  Score=344.42  Aligned_cols=274  Identities=27%  Similarity=0.389  Sum_probs=208.9

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcc--cCCCceeeeeeeeeccC----eE
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGR--LRHRNLVQLLGYCRRKG----EL  333 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~--l~H~niv~l~~~~~~~~----~~  333 (586)
                      -......++||+|+||.||||++.  ++.||||++....   .+.|++|-++.+.  ++|+||+++++.-+...    ++
T Consensus       209 l~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~~~---kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ey  283 (534)
T KOG3653|consen  209 LDPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPEQE---KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEY  283 (534)
T ss_pred             CCchhhHHHhhcCccceeehhhcc--CceeEEEecCHHH---HHHHHhHHHHHhccCccchhHHHhhchhccCCccccce
Confidence            455667888999999999999995  4789999996544   3556776666554  58999999999877665    89


Q ss_pred             EEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhccc------CCcEEeCCCCCCCeeecCCCCeEEccc
Q 007869          334 LLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEW------EQVVIHRDVKASNVLLDGELNGRLGDF  407 (586)
Q Consensus       334 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~------~~~ivHrDIkp~NIll~~~~~~kL~DF  407 (586)
                      +||+||.++|+|.++|..+   .++|....+|+..+++||+|||++.      .++|+|||||++||||.+|+++.|+||
T Consensus       284 wLVt~fh~kGsL~dyL~~n---tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF  360 (534)
T KOG3653|consen  284 WLVTEFHPKGSLCDYLKAN---TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF  360 (534)
T ss_pred             eEEeeeccCCcHHHHHHhc---cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence            9999999999999999876   7999999999999999999999864      457999999999999999999999999


Q ss_pred             cceeeccCCCCCc-eeeeccCCCccCcccccCCC-C-----CCcceEEehhHHHHHHHhCCCCCCC-CCCCccchhhHHH
Q 007869          408 GLARLYDHGTDPQ-TTHVVGTLGYLAPEHTRTGK-A-----TTSADVFSFGAFLLEVACGRRPIQR-QGPSENLILVDWV  479 (586)
Q Consensus       408 Gla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~-~-----s~ksDVyS~Gvvl~ElltG~~p~~~-~~~~~~~~l~~~v  479 (586)
                      |||..+..+.... ....+||.+|||||++.+.- +     -.+.||||+|.|||||++...-++. ..+..+.-...-+
T Consensus       361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ev  440 (534)
T KOG3653|consen  361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEV  440 (534)
T ss_pred             ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHh
Confidence            9999887654432 33479999999999997642 2     2478999999999999998766542 1111111110000


Q ss_pred             -----HhhhccCccccccCCCCCcccc-HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhccCCCc
Q 007869          480 -----FDFWNRGELLEARDPNLGTEYV-AEELELVLKLGLLCSHSDPTARPSMRQVVQILERDVALPA  541 (586)
Q Consensus       480 -----~~~~~~~~~~~~~d~~l~~~~~-~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~p~  541 (586)
                           .+-+++-.+.+...|.+..... ...+..+.+.+..||..||+.|.|+.=|-+++.....+++
T Consensus       441 G~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~  508 (534)
T KOG3653|consen  441 GNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE  508 (534)
T ss_pred             cCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence                 0011111223334455443322 2457889999999999999999999999988877655444

>cd06899 lectin_legume_LecRK_Arcelin_ConA legume lectins, lectin-like receptor kinases, arcelin, concanavalinA, and alpha-amylase inhibitor

Probab=100.00  E-value=3.4e-41  Score=331.22  Aligned_cols=174  Identities=47%  Similarity=0.729  Sum_probs=157.4

Q ss_pred             CcccCCCCCCCCCCeeeeeEEEEEEEEEeCCCCCCCCcEEEEEecCCCCCCCCCCCcccccccCCCCCCCccEEEEEeec
Q 007869            2 PFKNKNSNSSTANGTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGLFNDTNLGNETNHVFAVELDT   81 (586)
Q Consensus         2 p~~~~~~~~~~~~~~~asF~t~F~f~i~~~~~~~~g~GlaF~l~p~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEfDt   81 (586)
                      ||++|+..+    ++++||+|+|+|.|.+.....+||||||+|+|....+.++.|++||+++.++.+...+++|||||||
T Consensus        49 pi~l~~~~~----~~~~sFst~F~F~i~~~~~~~~gdGlAF~i~~~~~~~~~~~G~~lG~~~~~~~~~~~~~~vAVEFDT  124 (236)
T cd06899          49 PVRLWDSTT----GKVASFSTSFSFSITPPNPSLGGDGLAFFLAPTDSLPPASSGGYLGLFNSSNNGNSSNHIVAVEFDT  124 (236)
T ss_pred             CEEeecCCC----CCceeEEEEEEEEEEcCCCCCCCCeEEEEEecCCCCCCCCCcceeeeecCCCCCCcccceEEEEeec
Confidence            899999987    9999999999999998766789999999999977655578899999999887777889999999999


Q ss_pred             cccCCCCCCCCCeeEEeCCCCcccccccC-------------ceEEEEcCeeeEEEEEEeecCCCCCCccceeeeeecch
Q 007869           82 IKSHGFLDINDNHVGIDINSLKSESSAPA-------------GYYVEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLS  148 (586)
Q Consensus        82 ~~~~~~~d~~~~hvgidvns~~s~~~~~~-------------~~~i~y~~~~~~l~v~~~~~~~~~~~~~~~ls~~~dL~  148 (586)
                      ++|.+++||++||||||+|++.|..+..+             ..||+||+.+++|+|++......+|.. |+++..+||+
T Consensus       125 ~~n~~~~D~~~nHigIdvn~~~S~~~~~~~~~~~~l~~g~~~~v~I~Y~~~~~~L~V~l~~~~~~~~~~-~~ls~~vdL~  203 (236)
T cd06899         125 FQNPEFGDPDDNHVGIDVNSLVSVKAGYWDDDGGKLKSGKPMQAWIDYDSSSKRLSVTLAYSGVAKPKK-PLLSYPVDLS  203 (236)
T ss_pred             ccCcccCCCCCCeEEEEcCCcccceeeccccccccccCCCeEEEEEEEcCCCCEEEEEEEeCCCCCCcC-CEEEEeccHH
Confidence            99999899999999999999987764331             368999999999999999877667877 9999999999


Q ss_pred             hccccceeeeeecCCCccceeeeeeecccccc
Q 007869          149 SVLNDAMYVGFSSSTGSVLASHYILGWSFKIN  180 (586)
Q Consensus       149 ~~l~~~~~vGFsastg~~~~~~~i~~Wsf~~~  180 (586)
                      .+|+++||||||||||...|.|+|++|+|+++
T Consensus       204 ~~l~~~~~vGFSasTG~~~~~h~i~sWsF~s~  235 (236)
T cd06899         204 KVLPEEVYVGFSASTGLLTELHYILSWSFSSN  235 (236)
T ss_pred             HhCCCceEEEEEeEcCCCcceEEEEEEEEEcC
Confidence            99999999999999999999999999999874

This alignment model includes the legume lectins (also known as agglutinins), the arcelin (also known as phytohemagglutinin-L) family of lectin-like defense proteins, the LecRK family of lectin-like receptor kinases, concanavalinA (ConA), and an alpha-amylase inhibitor. Arcelin is a major seed glycoprotein discovered in kidney beans (Phaseolus vulgaris) that has insecticidal properties and protects the seeds from predation by larvae of various bruchids. Arcelin is devoid of monosaccharide binding properties and lacks a key metal-binding loop that is present in other members of this family. Phytohaemagglutinin (PHA) is a lectin found in plants, especially beans, that affects cell metabolism by inducing mitosis and by altering the permeability of the cell membrane to various proteins. PHA agglutinates most mammalian red blood cell types by bindin

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1.6e-41  Score=320.88  Aligned_cols=276  Identities=24%  Similarity=0.344  Sum_probs=216.5

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccch-h-HHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEe
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQ-G-MKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYD  338 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~-~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E  338 (586)
                      ++|...+.||+|.||.||+|++..+++.||||+++..... + .....+|++.|++++|+||+.|++.|-..+.+.||+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            4677889999999999999999999999999999865322 2 3457899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCC
Q 007869          339 YMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD  418 (586)
Q Consensus       339 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~  418 (586)
                      ||+ .+|+..++++. ..+...++..++.++++||+|||+   +.|+||||||.|+|+++++.+||+|||+|+.+.....
T Consensus        82 fm~-tdLe~vIkd~~-i~l~pa~iK~y~~m~LkGl~y~H~---~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~  156 (318)
T KOG0659|consen   82 FMP-TDLEVVIKDKN-IILSPADIKSYMLMTLKGLAYCHS---KWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR  156 (318)
T ss_pred             ecc-ccHHHHhcccc-cccCHHHHHHHHHHHHHHHHHHHh---hhhhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence            995 58999998764 578888999999999999999998   8999999999999999999999999999998876543


Q ss_pred             CceeeeccCCCccCcccccCC-CCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHH--------Hhhhc---c-
Q 007869          419 PQTTHVVGTLGYLAPEHTRTG-KATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWV--------FDFWN---R-  485 (586)
Q Consensus       419 ~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v--------~~~~~---~-  485 (586)
                       ..+..+-|.+|+|||.+.+. .|+...|+||.||++.||+.|.+-|.+.+.-+++..+=.+        |..+.   + 
T Consensus       157 -~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY  235 (318)
T KOG0659|consen  157 -IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDY  235 (318)
T ss_pred             -ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccH
Confidence             33445789999999998765 6899999999999999999999888877665544322111        11100   0 


Q ss_pred             CccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH-hhccCCCccc
Q 007869          486 GELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQIL-ERDVALPAIS  543 (586)
Q Consensus       486 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L-~~~~~~p~~~  543 (586)
                      .++.....+.+.. .-.......++++..++..||.+|+++.|+++.= -...|.|..+
T Consensus       236 ~~~~~~P~~~~~~-lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~pt~~  293 (318)
T KOG0659|consen  236 VKIQQFPKPPLNN-LFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLPTPP  293 (318)
T ss_pred             HHHhcCCCCcccc-ccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCCCCh
Confidence            0111111122222 2233445668999999999999999999998642 1224444433

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=7.2e-41  Score=340.53  Aligned_cols=245  Identities=17%  Similarity=0.307  Sum_probs=198.8

Q ss_pred             ceeEeecCceEEEEEEeCCCCeEEEEEEeccccchh---HHHHHHHHHHhcccCCCceeeeeeeeec----cCeEEEEEe
Q 007869          266 KELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQG---MKEFVAEIVSIGRLRHRNLVQLLGYCRR----KGELLLVYD  338 (586)
Q Consensus       266 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~---~~~~~~Ei~~l~~l~H~niv~l~~~~~~----~~~~~lV~E  338 (586)
                      ...||+|++|.||+|.+  ++..||||++.......   .+.|.+|+.+|.+++||||+++++++.+    ....++|||
T Consensus        25 ~~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~E  102 (283)
T PHA02988         25 SVLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILE  102 (283)
T ss_pred             CeEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEE
Confidence            46799999999999998  56789999997653322   5678899999999999999999999876    357899999


Q ss_pred             cCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCC
Q 007869          339 YMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD  418 (586)
Q Consensus       339 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~  418 (586)
                      |+++|+|.+++...  ..++|...++++.|++.||.|||+  ..+++||||||+|||+++++.+||+|||+++.+...  
T Consensus       103 y~~~g~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~--~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~--  176 (283)
T PHA02988        103 YCTRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYK--YTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP--  176 (283)
T ss_pred             eCCCCcHHHHHhhC--CCCChhHHHHHHHHHHHHHHHHHh--cCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc--
Confidence            99999999999765  368899999999999999999997  247889999999999999999999999999865432  


Q ss_pred             CceeeeccCCCccCcccccC--CCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCC
Q 007869          419 PQTTHVVGTLGYLAPEHTRT--GKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNL  496 (586)
Q Consensus       419 ~~~~~~~gt~~y~aPE~~~~--~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l  496 (586)
                        .....|+..|+|||++.+  ..++.++|||||||++|||++|+.||......+   +...+.   ..+     ..+.+
T Consensus       177 --~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~---~~~~i~---~~~-----~~~~~  243 (283)
T PHA02988        177 --PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE---IYDLII---NKN-----NSLKL  243 (283)
T ss_pred             --cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH---HHHHHH---hcC-----CCCCC
Confidence              123468899999999976  689999999999999999999999998654321   111111   111     01111


Q ss_pred             CccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 007869          497 GTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER  535 (586)
Q Consensus       497 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  535 (586)
                          +......+.+++.+||+.||++|||+.|+++.|+.
T Consensus       244 ----~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~  278 (283)
T PHA02988        244 ----PLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSL  278 (283)
T ss_pred             ----CCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence                11234567888999999999999999999999875

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-42  Score=350.99  Aligned_cols=243  Identities=27%  Similarity=0.450  Sum_probs=202.1

Q ss_pred             CcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEecCC
Q 007869          262 GFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMP  341 (586)
Q Consensus       262 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~  341 (586)
                      ...+.+-||.|+.|.||+|++.  +..||||+++.-.       ..+|+-|++|+||||+.+.|+|.....+|||||||+
T Consensus       125 ~IsELeWlGSGaQGAVF~Grl~--netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa  195 (904)
T KOG4721|consen  125 EISELEWLGSGAQGAVFLGRLH--NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCA  195 (904)
T ss_pred             HhhhhhhhccCcccceeeeecc--CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccc
Confidence            3455677999999999999995  4579999985322       357889999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCCce
Q 007869          342 NGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQT  421 (586)
Q Consensus       342 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~  421 (586)
                      .|.|...|+...  ++.-.....|.++||.||.|||.   +.|||||||.-||||..+..+||+|||.++.....  ...
T Consensus       196 ~GqL~~VLka~~--~itp~llv~Wsk~IA~GM~YLH~---hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STk  268 (904)
T KOG4721|consen  196 QGQLYEVLKAGR--PITPSLLVDWSKGIAGGMNYLHL---HKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STK  268 (904)
T ss_pred             cccHHHHHhccC--ccCHHHHHHHHHHhhhhhHHHHH---hhHhhhccCCCceEeeccceEEeccccchHhhhhh--hhh
Confidence            999999998763  56777888999999999999998   89999999999999999999999999999876543  233


Q ss_pred             eeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCcccc
Q 007869          422 THVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYV  501 (586)
Q Consensus       422 ~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~  501 (586)
                      ...+||..|||||++++.+.++|.||||||||||||+||..||.+.+...    +  +|   .-|      ...+....+
T Consensus       269 MSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA----I--Iw---GVG------sNsL~LpvP  333 (904)
T KOG4721|consen  269 MSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA----I--IW---GVG------SNSLHLPVP  333 (904)
T ss_pred             hhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe----e--EE---ecc------CCcccccCc
Confidence            45789999999999999999999999999999999999999997644321    1  11   111      111222334


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 007869          502 AEELELVLKLGLLCSHSDPTARPSMRQVVQILER  535 (586)
Q Consensus       502 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  535 (586)
                      ..+++-+.-|+..||+..|.+||++++++..|+=
T Consensus       334 stcP~GfklL~Kqcw~sKpRNRPSFrqil~HldI  367 (904)
T KOG4721|consen  334 STCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI  367 (904)
T ss_pred             ccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence            4556677778888999999999999999998863

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=4.2e-41  Score=338.75  Aligned_cols=258  Identities=26%  Similarity=0.431  Sum_probs=206.9

Q ss_pred             hcCCcccceeEeecCceEEEEEEeC---CCCeEEEEEEecccc-chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEE
Q 007869          259 ATKGFREKELLGTGGFGRVYRGTLP---KSQIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELL  334 (586)
Q Consensus       259 a~~~f~~~~~LG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~  334 (586)
                      ..++|+..+.||+|+||.||+|.+.   ..+..||+|.+.... ....+.|.+|+..+.+++||||+++++++...+..+
T Consensus         3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   82 (266)
T cd05064           3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM   82 (266)
T ss_pred             chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence            3457888999999999999999874   346789999987653 334567999999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeecc
Q 007869          335 LVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYD  414 (586)
Q Consensus       335 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~  414 (586)
                      +||||+++|+|.+++.... ..+++.+++.++.|++.||+|||+   ++++||||||+|||++.++.+|++|||.+....
T Consensus        83 lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~---~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~  158 (266)
T cd05064          83 IVTEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDK  158 (266)
T ss_pred             EEEEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCEeeccccHhhEEEcCCCcEEECCCccccccc
Confidence            9999999999999997653 468899999999999999999998   899999999999999999999999999876532


Q ss_pred             CCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccCccccccC
Q 007869          415 HGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEARD  493 (586)
Q Consensus       415 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d  493 (586)
                      ...........++..|+|||.+.+..++.++|||||||++||+++ |+.||......+   ..+.    ..++...    
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~---~~~~----~~~~~~~----  227 (266)
T cd05064         159 SEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD---VIKA----VEDGFRL----  227 (266)
T ss_pred             ccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHHH----HHCCCCC----
Confidence            221111122345678999999999999999999999999999775 999997654321   1111    1122111    


Q ss_pred             CCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 007869          494 PNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERD  536 (586)
Q Consensus       494 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  536 (586)
                       ..    .......+.+++..||+.+|.+||++.++++.|.+.
T Consensus       228 -~~----~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         228 -PA----PRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             -CC----CCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence             11    122345678889999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.3e-40  Score=338.55  Aligned_cols=266  Identities=22%  Similarity=0.317  Sum_probs=207.0

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc--chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEe
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES--RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYD  338 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E  338 (586)
                      ++|+..+.||+|+||.||+|++..++..||+|++....  ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            46888999999999999999999899999999987542  3345678899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCC
Q 007869          339 YMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD  418 (586)
Q Consensus       339 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~  418 (586)
                      |++++.+..+...  ...+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||+++.......
T Consensus        81 ~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  155 (287)
T cd07848          81 YVEKNMLELLEEM--PNGVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN  155 (287)
T ss_pred             cCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence            9998777655432  2368888999999999999999998   8999999999999999999999999999987654333


Q ss_pred             CceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHH---------HHhhhccCccc
Q 007869          419 PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDW---------VFDFWNRGELL  489 (586)
Q Consensus       419 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~---------v~~~~~~~~~~  489 (586)
                      .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+..         ......+....
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd07848         156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFH  235 (287)
T ss_pred             ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhc
Confidence            333446789999999999988899999999999999999999999986543222111111         01111111111


Q ss_pred             cccCCCCCc------cccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          490 EARDPNLGT------EYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       490 ~~~d~~l~~------~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      ....+....      .+.......+.+++.+||+.||++|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            111111110      011123356889999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-41  Score=348.47  Aligned_cols=252  Identities=26%  Similarity=0.423  Sum_probs=208.3

Q ss_pred             hhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc----cc-hhHHHHHHHHHHhcccC-CCceeeeeeeeeccC
Q 007869          258 IATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE----SR-QGMKEFVAEIVSIGRLR-HRNLVQLLGYCRRKG  331 (586)
Q Consensus       258 ~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~-~~~~~~~~Ei~~l~~l~-H~niv~l~~~~~~~~  331 (586)
                      ...++|...+.||+|.||+|+.|.+..++..||+|.+...    .. ...+.+.+|+.++++++ ||||++++.++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            3456899999999999999999999999999999977653    11 23455678999999998 999999999999999


Q ss_pred             eEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCC-CCeEEccccce
Q 007869          332 ELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGE-LNGRLGDFGLA  410 (586)
Q Consensus       332 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~-~~~kL~DFGla  410 (586)
                      ..++||||+.+|+|.+++.+.  ..+.+.....++.|++.|++|+|+   ++|+||||||+|||+|.+ +++||+|||++
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~~--g~l~E~~ar~~F~Qlisav~y~H~---~gi~HRDLK~ENilld~~~~~~Kl~DFG~s  168 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVNK--GRLKEDEARKYFRQLISAVAYCHS---RGIVHRDLKPENILLDGNEGNLKLSDFGLS  168 (370)
T ss_pred             eEEEEEEecCCccHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence            999999999999999999883  467888999999999999999998   999999999999999999 99999999999


Q ss_pred             eeccCCCCCceeeeccCCCccCcccccCCC-CC-CcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCcc
Q 007869          411 RLYDHGTDPQTTHVVGTLGYLAPEHTRTGK-AT-TSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGEL  488 (586)
Q Consensus       411 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s-~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~  488 (586)
                      .... .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+......   +.    ....++..
T Consensus       169 ~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~---l~----~ki~~~~~  240 (370)
T KOG0583|consen  169 AISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPN---LY----RKIRKGEF  240 (370)
T ss_pred             cccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHH---HH----HHHhcCCc
Confidence            9874 2233456679999999999999877 75 78999999999999999999998743221   11    11112211


Q ss_pred             ccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          489 LEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       489 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                         .-|..   ..   ...+..|+.+|+..||.+|+++.++++
T Consensus       241 ---~~p~~---~~---S~~~~~Li~~mL~~~P~~R~t~~~i~~  274 (370)
T KOG0583|consen  241 ---KIPSY---LL---SPEARSLIEKMLVPDPSTRITLLEILE  274 (370)
T ss_pred             ---cCCCC---cC---CHHHHHHHHHHcCCCcccCCCHHHHhh
Confidence               11111   10   456778888999999999999999984

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-41  Score=347.96  Aligned_cols=253  Identities=23%  Similarity=0.346  Sum_probs=208.6

Q ss_pred             hhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc---cchhHHHHHHHHHHhccc-CCCceeeeeeeeeccCeE
Q 007869          258 IATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE---SRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKGEL  333 (586)
Q Consensus       258 ~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~~~~  333 (586)
                      ...++|...+.||.|.|++|++|+.+.++.++|||++.+.   .....+-...|-++|.+| .||.|++|+-.|.+...+
T Consensus        70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL  149 (604)
T KOG0592|consen   70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL  149 (604)
T ss_pred             CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence            3456788899999999999999999999999999999764   222334567788889999 899999999999999999


Q ss_pred             EEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeec
Q 007869          334 LLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLY  413 (586)
Q Consensus       334 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~  413 (586)
                      |+|+||+++|+|.++|++.+  .+++.....++.+|+.||+|||+   .+||||||||+|||||+|+++||.|||.|+.+
T Consensus       150 YFvLe~A~nGdll~~i~K~G--sfde~caR~YAAeIldAleylH~---~GIIHRDlKPENILLd~dmhikITDFGsAK~l  224 (604)
T KOG0592|consen  150 YFVLEYAPNGDLLDLIKKYG--SFDETCARFYAAEILDALEYLHS---NGIIHRDLKPENILLDKDGHIKITDFGSAKIL  224 (604)
T ss_pred             EEEEEecCCCcHHHHHHHhC--cchHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeEcCCCcEEEeeccccccC
Confidence            99999999999999998774  67888888899999999999998   99999999999999999999999999999987


Q ss_pred             cCCCC----------Cc--eeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHh
Q 007869          414 DHGTD----------PQ--TTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFD  481 (586)
Q Consensus       414 ~~~~~----------~~--~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~  481 (586)
                      .....          ..  ....+||..|.+||++..+..++.+|+|+|||+||+|+.|++||...++.-   +-+.+  
T Consensus       225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyl---iFqkI--  299 (604)
T KOG0592|consen  225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYL---IFQKI--  299 (604)
T ss_pred             ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHH---HHHHH--
Confidence            54311          11  144899999999999999999999999999999999999999998765421   11111  


Q ss_pred             hhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          482 FWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       482 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                              ..++-.+...++    +.+.+|+.+.|..||.+|++..++.+.
T Consensus       300 --------~~l~y~fp~~fp----~~a~dLv~KLLv~dp~~Rlt~~qIk~H  338 (604)
T KOG0592|consen  300 --------QALDYEFPEGFP----EDARDLIKKLLVRDPSDRLTSQQIKAH  338 (604)
T ss_pred             --------HHhcccCCCCCC----HHHHHHHHHHHccCccccccHHHHhhC
Confidence                    112222222333    556677777788999999999998764

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.7e-41  Score=348.07  Aligned_cols=247  Identities=26%  Similarity=0.391  Sum_probs=210.5

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc--chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEe
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES--RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYD  338 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E  338 (586)
                      ++|...+.||+|.||.||||+.+.+.+.||+|.+.+..  ....+.+.+|++++++++||||+.+++||+...++++|.|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            56888899999999999999999999999999997653  3456779999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCC
Q 007869          339 YMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD  418 (586)
Q Consensus       339 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~  418 (586)
                      |+.+ +|..+|...  ..+++.+...|+.++..||.|||+   .+|+|||+||.|||++..+.+|+||||+|+.+..+. 
T Consensus        82 ~a~g-~L~~il~~d--~~lpEe~v~~~a~~LVsaL~yLhs---~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t-  154 (808)
T KOG0597|consen   82 YAVG-DLFTILEQD--GKLPEEQVRAIAYDLVSALYYLHS---NRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT-  154 (808)
T ss_pred             hhhh-hHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHh---cCcccccCCcceeeecCCCceeechhhhhhhcccCc-
Confidence            9966 999999776  468999999999999999999998   999999999999999999999999999999877643 


Q ss_pred             CceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCc
Q 007869          419 PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGT  498 (586)
Q Consensus       419 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~  498 (586)
                      ...+...||+-|||||+..++.|+..+|+||+||++||++.|++||.....      .+.+.....        ||..  
T Consensus       155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si------~~Lv~~I~~--------d~v~--  218 (808)
T KOG0597|consen  155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSI------TQLVKSILK--------DPVK--  218 (808)
T ss_pred             eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHH------HHHHHHHhc--------CCCC--
Confidence            456678899999999999999999999999999999999999999975422      122221111        1111  


Q ss_pred             cccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          499 EYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       499 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                       ++......+..++...+.+||.+|.+..+++.
T Consensus       219 -~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  219 -PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             -CcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence             12244455666777788999999999999885

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-40  Score=346.82  Aligned_cols=254  Identities=24%  Similarity=0.328  Sum_probs=206.5

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc---chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEE
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY  337 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  337 (586)
                      ++|+..+.||+|+||.||+|++..++..||||++....   ....+.+..|++++.+++||||+++++++...+..++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            46889999999999999999999889999999997542   234567889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCC
Q 007869          338 DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT  417 (586)
Q Consensus       338 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~  417 (586)
                      ||+++|+|.+++...  ..+++.+...++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++....  
T Consensus        81 e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--  153 (333)
T cd05600          81 EYVPGGDFRTLLNNL--GVLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--  153 (333)
T ss_pred             eCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence            999999999999765  357888999999999999999998   8999999999999999999999999999986543  


Q ss_pred             CCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCC
Q 007869          418 DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLG  497 (586)
Q Consensus       418 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~  497 (586)
                        ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+   . .+.  ....  .|...
T Consensus       154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i---~-~~~--~~~~--~~~~~  223 (333)
T cd05600         154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENL---K-YWK--ETLQ--RPVYD  223 (333)
T ss_pred             --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHH---H-hcc--cccc--CCCCC
Confidence              233457999999999999999999999999999999999999999765432211110   0 000  0000  11110


Q ss_pred             ccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          498 TEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       498 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                       .........+.+++.+|++.+|.+||++.++++.
T Consensus       224 -~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         224 -DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             -ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence             0001223556788889999999999999999864

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=6.3e-41  Score=354.56  Aligned_cols=262  Identities=26%  Similarity=0.404  Sum_probs=207.0

Q ss_pred             hhhcCCcccceeEeecCceEEEEEEe-----CCCCeEEEEEEecccc-chhHHHHHHHHHHhccc-CCCceeeeeeeeec
Q 007869          257 YIATKGFREKELLGTGGFGRVYRGTL-----PKSQIEIAVKKISHES-RQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRR  329 (586)
Q Consensus       257 ~~a~~~f~~~~~LG~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~  329 (586)
                      ....++|+..+.||+|+||.||+|++     .+++..||||+++... ....+.+.+|+.++..+ +||||++++++|..
T Consensus        31 ~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~  110 (375)
T cd05104          31 EFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTV  110 (375)
T ss_pred             ccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc
Confidence            33455789999999999999999974     3456689999986542 33456788999999999 89999999999999


Q ss_pred             cCeEEEEEecCCCCChhhhhhcCC--------------------------------------------------------
Q 007869          330 KGELLLVYDYMPNGSLDKYLYDQP--------------------------------------------------------  353 (586)
Q Consensus       330 ~~~~~lV~E~~~~gsL~~~l~~~~--------------------------------------------------------  353 (586)
                      .+..++||||+++|+|.+++....                                                        
T Consensus       111 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  190 (375)
T cd05104         111 GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVR  190 (375)
T ss_pred             CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccc
Confidence            999999999999999999986431                                                        


Q ss_pred             -----------------CccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCC
Q 007869          354 -----------------KVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHG  416 (586)
Q Consensus       354 -----------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~  416 (586)
                                       ...++|..+++++.||++||.|||+   ++|+||||||+|||++.++.+||+|||+++.....
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~  267 (375)
T cd05104         191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRND  267 (375)
T ss_pred             cceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCccceeccCc
Confidence                             1247888999999999999999998   89999999999999999999999999999866433


Q ss_pred             CCCc-eeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccCccccccCC
Q 007869          417 TDPQ-TTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEARDP  494 (586)
Q Consensus       417 ~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~  494 (586)
                      .... .....++..|+|||++.+..++.++|||||||++|||++ |..||.......  ...+++    .++..  ...|
T Consensus       268 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~~~~----~~~~~--~~~~  339 (375)
T cd05104         268 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFYKMI----KEGYR--MLSP  339 (375)
T ss_pred             ccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHHHHH----HhCcc--CCCC
Confidence            2211 122345678999999999999999999999999999998 888987543221  111111    11111  0111


Q ss_pred             CCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 007869          495 NLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERD  536 (586)
Q Consensus       495 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  536 (586)
                      .       .....+.+++.+||+.||++||++.|+++.|++.
T Consensus       340 ~-------~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         340 E-------CAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             C-------CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence            1       1124577889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=8.2e-41  Score=335.80  Aligned_cols=256  Identities=28%  Similarity=0.465  Sum_probs=209.9

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEec
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY  339 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  339 (586)
                      ..+|+..+.||+|+||.||+|...+.+..||+|.+..+ ....+++.+|++.+++++|+||++++++|...+..+++|||
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (263)
T cd05052           5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF   83 (263)
T ss_pred             hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence            34678889999999999999999888899999998654 33457899999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCC
Q 007869          340 MPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP  419 (586)
Q Consensus       340 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~  419 (586)
                      +++++|.+++.......+++..++.++.|+++||.|||+   .+++||||||+||++++++.+||+|||+++........
T Consensus        84 ~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~  160 (263)
T cd05052          84 MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT  160 (263)
T ss_pred             CCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence            999999999977655678999999999999999999998   89999999999999999999999999999876543222


Q ss_pred             ceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCc
Q 007869          420 QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGT  498 (586)
Q Consensus       420 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~  498 (586)
                      ......++..|+|||.+.+..++.++|||||||++|||++ |..||......+   +    ++....+.     .+.   
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~---~----~~~~~~~~-----~~~---  225 (263)
T cd05052         161 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---V----YELLEKGY-----RME---  225 (263)
T ss_pred             ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---H----HHHHHCCC-----CCC---
Confidence            2222334678999999998899999999999999999998 999987543211   1    11111110     111   


Q ss_pred             cccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 007869          499 EYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER  535 (586)
Q Consensus       499 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  535 (586)
                       ........+.+++.+||+.+|++||++.++++.|+.
T Consensus       226 -~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~  261 (263)
T cd05052         226 -RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFET  261 (263)
T ss_pred             -CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHh
Confidence             111223567889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=5.4e-40  Score=337.27  Aligned_cols=262  Identities=25%  Similarity=0.399  Sum_probs=204.8

Q ss_pred             cCCcccceeEeecCceEEEEEEeCC----------------CCeEEEEEEecccc-chhHHHHHHHHHHhcccCCCceee
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPK----------------SQIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQ  322 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~----------------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~  322 (586)
                      .++|+..+.||+|+||.||+|.+..                ++..||+|.+.... .....+|.+|++++.+++||||++
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            3568889999999999999998632                34579999987643 334567999999999999999999


Q ss_pred             eeeeeeccCeEEEEEecCCCCChhhhhhcCC-----------------CccchhHHHHHHHHHHHHHHHHhhcccCCcEE
Q 007869          323 LLGYCRRKGELLLVYDYMPNGSLDKYLYDQP-----------------KVTLNWIQRFRVIKGVALGLFYLHQEWEQVVI  385 (586)
Q Consensus       323 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~-----------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iv  385 (586)
                      +++++...+..++||||+++|+|.+++....                 ...++|...++++.||+.||.|||+   .+|+
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~iv  160 (304)
T cd05096          84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFV  160 (304)
T ss_pred             EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---CCcc
Confidence            9999999999999999999999999986432                 1247888999999999999999998   8999


Q ss_pred             eCCCCCCCeeecCCCCeEEccccceeeccCCCCC-ceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh--CCC
Q 007869          386 HRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP-QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC--GRR  462 (586)
Q Consensus       386 HrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt--G~~  462 (586)
                      ||||||+|||++.++.+||+|||+++.+...... ......++..|+|||++..+.++.++|||||||++|||++  +..
T Consensus       161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~  240 (304)
T cd05096         161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ  240 (304)
T ss_pred             ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence            9999999999999999999999999865432211 1223455789999999998899999999999999999986  556


Q ss_pred             CCCCCCCCccchhhHHHHhhhccCccc-cccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 007869          463 PIQRQGPSENLILVDWVFDFWNRGELL-EARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILE  534 (586)
Q Consensus       463 p~~~~~~~~~~~l~~~v~~~~~~~~~~-~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  534 (586)
                      ||......+   ....+.......... ....       .......+.+++.+||+.||++|||+.++.+.|+
T Consensus       241 p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         241 PYGELTDEQ---VIENAGEFFRDQGRQVYLFR-------PPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             CCCcCCHHH---HHHHHHHHhhhccccccccC-------CCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            776543221   222222222211110 0111       1122356788999999999999999999999886

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-41  Score=375.23  Aligned_cols=259  Identities=31%  Similarity=0.496  Sum_probs=212.9

Q ss_pred             hcCCcccceeEeecCceEEEEEEeCCC-----CeEEEEEEeccc-cchhHHHHHHHHHHhcccCCCceeeeeeeeeccCe
Q 007869          259 ATKGFREKELLGTGGFGRVYRGTLPKS-----QIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGE  332 (586)
Q Consensus       259 a~~~f~~~~~LG~G~~g~Vy~~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~  332 (586)
                      ..++....+.||+|+||.||+|...+.     ...||||.+... +.+...+|.+|..+|++++|||||+++|.|.+...
T Consensus       690 ~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~  769 (1025)
T KOG1095|consen  690 PRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGP  769 (1025)
T ss_pred             ChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCC
Confidence            355666788999999999999997543     234999999765 56677899999999999999999999999999999


Q ss_pred             EEEEEecCCCCChhhhhhcCC-----CccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccc
Q 007869          333 LLLVYDYMPNGSLDKYLYDQP-----KVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDF  407 (586)
Q Consensus       333 ~~lV~E~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DF  407 (586)
                      .++++|||++|+|..+|++..     ...|.....+.++.|||+|+.||++   +++|||||..+|+||+....+||+||
T Consensus       770 ~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~---~~fvHRDLAaRNCLL~~~r~VKIaDF  846 (1025)
T KOG1095|consen  770 PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLES---KHFVHRDLAARNCLLDERRVVKIADF  846 (1025)
T ss_pred             cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHh---CCCcCcchhhhheeecccCcEEEccc
Confidence            999999999999999998761     2468888999999999999999998   99999999999999999999999999


Q ss_pred             cceeec-cCCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhcc
Q 007869          408 GLARLY-DHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNR  485 (586)
Q Consensus       408 Gla~~~-~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~  485 (586)
                      |||+.+ +...........-...|||||.+..+.++.|||||||||+|||++| |..||....+.+.+  ..+    .+.
T Consensus       847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~--~~~----~~g  920 (1025)
T KOG1095|consen  847 GLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVL--LDV----LEG  920 (1025)
T ss_pred             chhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHH--HHH----HhC
Confidence            999943 3222222222234578999999999999999999999999999999 89999876654321  111    122


Q ss_pred             CccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 007869          486 GELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERD  536 (586)
Q Consensus       486 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  536 (586)
                      |+          .+.+..+.+.+.+++..||+.+|++||++..+++.+...
T Consensus       921 gR----------L~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i  961 (1025)
T KOG1095|consen  921 GR----------LDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAI  961 (1025)
T ss_pred             Cc----------cCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhh
Confidence            21          122334567788999999999999999999999987653

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-41  Score=342.22  Aligned_cols=250  Identities=27%  Similarity=0.451  Sum_probs=215.3

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc-cchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEe
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYD  338 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E  338 (586)
                      ...|+..+.||+|.||.||||.+..+++.||+|++..+ .....++.++|+.+|.+++++||.++++.+..+..++++||
T Consensus        12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMe   91 (467)
T KOG0201|consen   12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIME   91 (467)
T ss_pred             ccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHH
Confidence            34577778999999999999999999999999999876 44557889999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCC
Q 007869          339 YMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD  418 (586)
Q Consensus       339 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~  418 (586)
                      ||.+|++.+.|....  .+.+..+..|++++..||.|||+   .+.+|||||+.|||+..++.+||+|||.+..+.....
T Consensus        92 y~~gGsv~~lL~~~~--~~~E~~i~~ilre~l~~l~ylH~---~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~  166 (467)
T KOG0201|consen   92 YCGGGSVLDLLKSGN--ILDEFEIAVILREVLKGLDYLHS---EKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK  166 (467)
T ss_pred             HhcCcchhhhhccCC--CCccceeeeehHHHHHHhhhhhh---cceecccccccceeEeccCcEEEEecceeeeeechhh
Confidence            999999999997653  34777777889999999999998   8999999999999999999999999999998776544


Q ss_pred             CceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCc
Q 007869          419 PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGT  498 (586)
Q Consensus       419 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~  498 (586)
                      .. .+.+||+.|||||++....|+.|+||||||++.+||++|.+|+....+...+.+            +.+..-|.+..
T Consensus       167 rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlfl------------Ipk~~PP~L~~  233 (467)
T KOG0201|consen  167 RR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFL------------IPKSAPPRLDG  233 (467)
T ss_pred             cc-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEe------------ccCCCCCcccc
Confidence            33 668999999999999988999999999999999999999999987766433222            22334455555


Q ss_pred             cccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          499 EYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       499 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      .+.    ..+.+++..|++.||+.||++.++++
T Consensus       234 ~~S----~~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  234 DFS----PPFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             ccC----HHHHHHHHHHhhcCcccCcCHHHHhh
Confidence            443    45777888899999999999999985

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=3.7e-40  Score=341.73  Aligned_cols=242  Identities=23%  Similarity=0.279  Sum_probs=198.7

Q ss_pred             eeEeecCceEEEEEEeCCCCeEEEEEEecccc---chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEecCCCC
Q 007869          267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNG  343 (586)
Q Consensus       267 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~g  343 (586)
                      +.||+|+||.||+++...++..||||++....   ......+..|+.++++++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999999899999999997542   334456889999999999999999999999999999999999999


Q ss_pred             ChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCCceee
Q 007869          344 SLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTH  423 (586)
Q Consensus       344 sL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~  423 (586)
                      +|.+++...  ..+++.+...++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++...... .....
T Consensus        81 ~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~~~  154 (323)
T cd05571          81 ELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKT  154 (323)
T ss_pred             cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-Ccccc
Confidence            999998765  368889999999999999999998   899999999999999999999999999997532211 22334


Q ss_pred             eccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCccccHH
Q 007869          424 VVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAE  503 (586)
Q Consensus       424 ~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~  503 (586)
                      ..||+.|+|||++.+..++.++|||||||++|||++|+.||.......   +...+    ..+      +..+..    .
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~---~~~~~----~~~------~~~~p~----~  217 (323)
T cd05571         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---LFELI----LME------EIRFPR----T  217 (323)
T ss_pred             eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH---HHHHH----HcC------CCCCCC----C
Confidence            679999999999999999999999999999999999999997543211   11111    111      111111    2


Q ss_pred             HHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 007869          504 ELELVLKLGLLCSHSDPTARP-----SMRQVVQ  531 (586)
Q Consensus       504 ~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~  531 (586)
                      ....+.+++.+||+.||++||     ++.++++
T Consensus       218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         218 LSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             CCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence            234567888899999999999     7888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=3e-40  Score=336.44  Aligned_cols=262  Identities=25%  Similarity=0.374  Sum_probs=198.5

Q ss_pred             CCcccceeEeecCceEEEEEEeC-CCCeEEEEEEecccc--chhHHHHHHHHHHhccc---CCCceeeeeeeee-----c
Q 007869          261 KGFREKELLGTGGFGRVYRGTLP-KSQIEIAVKKISHES--RQGMKEFVAEIVSIGRL---RHRNLVQLLGYCR-----R  329 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l---~H~niv~l~~~~~-----~  329 (586)
                      ++|+..+.||+|+||.||+|+.. .++..||+|++....  ......+.+|+.+++++   +||||++++++|.     .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            36888999999999999999985 456789999986542  22234556677666655   7999999999885     2


Q ss_pred             cCeEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccc
Q 007869          330 KGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGL  409 (586)
Q Consensus       330 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGl  409 (586)
                      ...+++||||++ ++|.+++.......+++..+..++.|+++||.|||+   ++|+||||||+|||++.++.+||+|||+
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~~~kl~Dfg~  156 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGL  156 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCCCEEEccccc
Confidence            456899999996 699999977655678999999999999999999998   8999999999999999999999999999


Q ss_pred             eeeccCCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhc---cC
Q 007869          410 ARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWN---RG  486 (586)
Q Consensus       410 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~---~~  486 (586)
                      ++.....  .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+..   ..+.....   ..
T Consensus       157 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~---~~i~~~~~~~~~~  231 (290)
T cd07862         157 ARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL---GKILDVIGLPGEE  231 (290)
T ss_pred             eEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHH---HHHHHHhCCCChh
Confidence            9876533  2334457899999999998889999999999999999999999999875443211   11111000   00


Q ss_pred             cc------c-cccCCCCC---ccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          487 EL------L-EARDPNLG---TEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       487 ~~------~-~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      ..      . ....+...   ..........+.+++.+|++.||++|||+.|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         232 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             hchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            00      0 00000000   0111123356678999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=2.3e-40  Score=344.19  Aligned_cols=245  Identities=23%  Similarity=0.286  Sum_probs=202.9

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc---chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEE
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY  337 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  337 (586)
                      ++|+..+.||+|+||.||+|++..++..||+|++....   ....+.+.+|+.++++++||||+++++++...+..++||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            57888999999999999999999899999999986542   234567899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCC
Q 007869          338 DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT  417 (586)
Q Consensus       338 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~  417 (586)
                      ||+++|+|.+++....  .+++.....++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++..... 
T Consensus        98 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-  171 (329)
T PTZ00263         98 EFVVGGELFTHLRKAG--RFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR-  171 (329)
T ss_pred             cCCCCChHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC-
Confidence            9999999999997653  57788888899999999999998   89999999999999999999999999999875432 


Q ss_pred             CCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCC
Q 007869          418 DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLG  497 (586)
Q Consensus       418 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~  497 (586)
                         .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+   ..    +...++..      .+.
T Consensus       172 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~---~~----~~i~~~~~------~~p  235 (329)
T PTZ00263        172 ---TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR---IY----EKILAGRL------KFP  235 (329)
T ss_pred             ---cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH---HH----HHHhcCCc------CCC
Confidence               234579999999999999999999999999999999999999997543211   11    11112211      111


Q ss_pred             ccccHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 007869          498 TEYVAEELELVLKLGLLCSHSDPTARPS-----MRQVVQ  531 (586)
Q Consensus       498 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~  531 (586)
                      ..    ....+.+++.+||+.||.+||+     ++++++
T Consensus       236 ~~----~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  270 (329)
T PTZ00263        236 NW----FDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN  270 (329)
T ss_pred             CC----CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence            11    1245678889999999999997     677764

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=2.7e-40  Score=335.41  Aligned_cols=256  Identities=27%  Similarity=0.481  Sum_probs=208.1

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCC-----eEEEEEEecccc-chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEE
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQ-----IEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELL  334 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~-----~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~  334 (586)
                      ++|+..+.||+|+||.||+|.....+     ..||+|.+.... ......|.+|++.+.+++||||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            46788899999999999999876544     679999986543 334567899999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhhcCCC--------------ccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCC
Q 007869          335 LVYDYMPNGSLDKYLYDQPK--------------VTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGEL  400 (586)
Q Consensus       335 lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~  400 (586)
                      ++|||+++++|.+++.....              ..+++..++.++.|++.||.|||+   .+++||||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccccceEEEcCCC
Confidence            99999999999999975421              457888999999999999999998   8999999999999999999


Q ss_pred             CeEEccccceeeccCCCC-CceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHH
Q 007869          401 NGRLGDFGLARLYDHGTD-PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDW  478 (586)
Q Consensus       401 ~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~  478 (586)
                      .+||+|||+++....... .......+++.|+|||++.+..++.++|||||||++|||++ |..||......+   +..+
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~---~~~~  238 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE---VIEM  238 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH
Confidence            999999999986533221 12334466889999999998899999999999999999998 999997654322   1111


Q ss_pred             HHhhhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 007869          479 VFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER  535 (586)
Q Consensus       479 v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  535 (586)
                      +    ..+...         .........+.+++.+||+.||.+||++.|+++.|+.
T Consensus       239 i----~~~~~~---------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         239 I----RSRQLL---------PCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             H----HcCCcC---------CCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence            1    111111         1122334678889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=3e-40  Score=331.02  Aligned_cols=256  Identities=25%  Similarity=0.430  Sum_probs=208.7

Q ss_pred             hcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEe
Q 007869          259 ATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYD  338 (586)
Q Consensus       259 a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E  338 (586)
                      ..++|+..++||+|+||.||+|.... +..||+|.+.... ...+.+.+|+.++++++|+||+++++.+...+..+++||
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~-~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (261)
T cd05072           4 PRESIKLVKKLGAGQFGEVWMGYYNN-STKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITE   81 (261)
T ss_pred             chHHeEEeeecCCcCCceEEEEEecC-CceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEe
Confidence            34678889999999999999999754 5579999986543 235789999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCC
Q 007869          339 YMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD  418 (586)
Q Consensus       339 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~  418 (586)
                      |+++++|.+++.......+++.+++.++.|+++||+|||+   .+++||||||+||++++++.+||+|||+++.......
T Consensus        82 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05072          82 YMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY  158 (261)
T ss_pred             cCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence            9999999999987655678899999999999999999998   8999999999999999999999999999987654332


Q ss_pred             CceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCC
Q 007869          419 PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLG  497 (586)
Q Consensus       419 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~  497 (586)
                      .......++..|+|||++....++.++|||||||++|||++ |+.||......+   ...++.    ++..    .+.. 
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~~~~----~~~~----~~~~-  226 (261)
T cd05072         159 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD---VMSALQ----RGYR----MPRM-  226 (261)
T ss_pred             eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH---HHHHHH----cCCC----CCCC-
Confidence            22233446778999999988889999999999999999998 999997543221   111111    1110    0111 


Q ss_pred             ccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 007869          498 TEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER  535 (586)
Q Consensus       498 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  535 (586)
                      .    .....+.+++.+|++.+|++||++.++.+.|+.
T Consensus       227 ~----~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         227 E----NCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             C----CCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            1    123457789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-41  Score=352.24  Aligned_cols=257  Identities=30%  Similarity=0.434  Sum_probs=207.1

Q ss_pred             CcccceeEeecCceEEEEEEeCCCC---eE-EEEEEecc---ccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEE
Q 007869          262 GFREKELLGTGGFGRVYRGTLPKSQ---IE-IAVKKISH---ESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELL  334 (586)
Q Consensus       262 ~f~~~~~LG~G~~g~Vy~~~~~~~~---~~-vavK~~~~---~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~  334 (586)
                      +....++||+|+||.||+|++...+   .. ||||....   ..+....+|.+|.++|++++|||||+++|++..+..++
T Consensus       158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~  237 (474)
T KOG0194|consen  158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLM  237 (474)
T ss_pred             CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccE
Confidence            4444588999999999999986432   23 89999875   34677889999999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeecc
Q 007869          335 LVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYD  414 (586)
Q Consensus       335 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~  414 (586)
                      +|||+|+||+|.++|...+. .++..+++.++.+.|.||+|||+   +++|||||-.+|+|++.++.+||+||||++.-.
T Consensus       238 ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~---k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~  313 (474)
T KOG0194|consen  238 LVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHS---KNCIHRDIAARNCLYSKKGVVKISDFGLSRAGS  313 (474)
T ss_pred             EEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHH---CCCcchhHhHHHheecCCCeEEeCccccccCCc
Confidence            99999999999999988754 68999999999999999999998   999999999999999999999999999988543


Q ss_pred             CCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccCccccccC
Q 007869          415 HGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEARD  493 (586)
Q Consensus       415 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d  493 (586)
                      .. ........-...|+|||.+..+.++.++|||||||++||+++ |..||.+....+   ...++.   .++...    
T Consensus       314 ~~-~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~---v~~kI~---~~~~r~----  382 (474)
T KOG0194|consen  314 QY-VMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYE---VKAKIV---KNGYRM----  382 (474)
T ss_pred             ce-eeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHH---HHHHHH---hcCccC----
Confidence            11 111111234679999999999999999999999999999998 888998754431   222221   111111    


Q ss_pred             CCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhccC
Q 007869          494 PNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERDVA  538 (586)
Q Consensus       494 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~  538 (586)
                           ..+......+..++..||..+|++||+|.++.+.|+....
T Consensus       383 -----~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~  422 (474)
T KOG0194|consen  383 -----PIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEK  422 (474)
T ss_pred             -----CCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHh
Confidence                 1112334556667779999999999999999999976543

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-40  Score=339.68  Aligned_cols=246  Identities=24%  Similarity=0.290  Sum_probs=202.9

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc---chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEE
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY  337 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  337 (586)
                      ++|+..+.||+|+||.||+|....++..||+|++....   ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            46888999999999999999999889999999986532   234466889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCC
Q 007869          338 DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT  417 (586)
Q Consensus       338 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~  417 (586)
                      ||+++|+|.+++...  ..+++.....++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++..... 
T Consensus        81 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~-  154 (291)
T cd05612          81 EYVPGGELFSYLRNS--GRFSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-  154 (291)
T ss_pred             eCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEEecCcchhccCC-
Confidence            999999999999765  357888999999999999999998   99999999999999999999999999999865432 


Q ss_pred             CCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCC
Q 007869          418 DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLG  497 (586)
Q Consensus       418 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~  497 (586)
                         .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+   +.+.    ...+..      .+.
T Consensus       155 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~---~~~~----i~~~~~------~~~  218 (291)
T cd05612         155 ---TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG---IYEK----ILAGKL------EFP  218 (291)
T ss_pred             ---cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHH----HHhCCc------CCC
Confidence               223578999999999998889999999999999999999999997643321   1111    111111      111


Q ss_pred             ccccHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHHH
Q 007869          498 TEYVAEELELVLKLGLLCSHSDPTARPS-----MRQVVQI  532 (586)
Q Consensus       498 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~~  532 (586)
                      .    .....+.+++.+||+.||.+||+     +.++++.
T Consensus       219 ~----~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         219 R----HLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             c----cCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence            1    11345678889999999999995     7777643

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.8e-40  Score=350.87  Aligned_cols=262  Identities=27%  Similarity=0.450  Sum_probs=205.9

Q ss_pred             hhhcCCcccceeEeecCceEEEEEEeCC-----CCeEEEEEEecccc-chhHHHHHHHHHHhccc-CCCceeeeeeeeec
Q 007869          257 YIATKGFREKELLGTGGFGRVYRGTLPK-----SQIEIAVKKISHES-RQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRR  329 (586)
Q Consensus       257 ~~a~~~f~~~~~LG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~  329 (586)
                      ....++|+..+.||+|+||.||+|+...     +...||||++.... ......+.+|+++++.+ +|+||++++++|..
T Consensus        34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~  113 (374)
T cd05106          34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTH  113 (374)
T ss_pred             cccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence            3445578899999999999999998633     33579999997543 33346688999999999 89999999999999


Q ss_pred             cCeEEEEEecCCCCChhhhhhcCC--------------------------------------------------------
Q 007869          330 KGELLLVYDYMPNGSLDKYLYDQP--------------------------------------------------------  353 (586)
Q Consensus       330 ~~~~~lV~E~~~~gsL~~~l~~~~--------------------------------------------------------  353 (586)
                      .+..++||||+++|+|.++++...                                                        
T Consensus       114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (374)
T cd05106         114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ  193 (374)
T ss_pred             CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence            999999999999999999986421                                                        


Q ss_pred             ------------CccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCC-c
Q 007869          354 ------------KVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP-Q  420 (586)
Q Consensus       354 ------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~-~  420 (586)
                                  ...+++.+.++++.||++||.|||+   ++|+||||||+|||+++++.+||+|||+++........ .
T Consensus       194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~  270 (374)
T cd05106         194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV  270 (374)
T ss_pred             cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceee
Confidence                        1247888899999999999999998   89999999999999999999999999999865433211 1


Q ss_pred             eeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCcc
Q 007869          421 TTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTE  499 (586)
Q Consensus       421 ~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~  499 (586)
                      .....++..|+|||++....++.++|||||||++|||++ |+.||........  .    ......+.  ....+.    
T Consensus       271 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~--~----~~~~~~~~--~~~~~~----  338 (374)
T cd05106         271 KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK--F----YKMVKRGY--QMSRPD----  338 (374)
T ss_pred             ccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH--H----HHHHHccc--CccCCC----
Confidence            122335678999999998899999999999999999997 9999976433221  1    11111110  111111    


Q ss_pred             ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 007869          500 YVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERD  536 (586)
Q Consensus       500 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  536 (586)
                         .....+.+++.+||+.||.+||++.++++.|++.
T Consensus       339 ---~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~  372 (374)
T cd05106         339 ---FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ  372 (374)
T ss_pred             ---CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence               1134577888899999999999999999999863

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=5.1e-41  Score=337.03  Aligned_cols=250  Identities=34%  Similarity=0.553  Sum_probs=196.6

Q ss_pred             cceeEeecCceEEEEEEeC----CCCeEEEEEEeccc-cchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEec
Q 007869          265 EKELLGTGGFGRVYRGTLP----KSQIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY  339 (586)
Q Consensus       265 ~~~~LG~G~~g~Vy~~~~~----~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  339 (586)
                      ..+.||.|.||.||+|.+.    ..+..|+||.+... ..+..++|.+|++.+++++||||++++|+|...+..++||||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            4678999999999999987    45678999999654 334478899999999999999999999999988889999999


Q ss_pred             CCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCC
Q 007869          340 MPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP  419 (586)
Q Consensus       340 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~  419 (586)
                      +++|+|.++|.......+++.+++.|+.||++||.|||+   .+++|+||+++||++++++.+||+|||+++........
T Consensus        83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~  159 (259)
T PF07714_consen   83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY  159 (259)
T ss_dssp             -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred             ccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccc
Confidence            999999999998756679999999999999999999998   89999999999999999999999999999876322111


Q ss_pred             -ceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCC
Q 007869          420 -QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLG  497 (586)
Q Consensus       420 -~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~  497 (586)
                       ..........|+|||.+....++.++||||||+++|||++ |+.|+......      ++.... .++.....      
T Consensus       160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~------~~~~~~-~~~~~~~~------  226 (259)
T PF07714_consen  160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNE------EIIEKL-KQGQRLPI------  226 (259)
T ss_dssp             EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHH------HHHHHH-HTTEETTS------
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccc------cccccc-ccccccee------
Confidence             1223456788999999999999999999999999999999 77888654221      111111 22222111      


Q ss_pred             ccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 007869          498 TEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQIL  533 (586)
Q Consensus       498 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L  533 (586)
                         .......+.+++..||+.||++||++.++++.|
T Consensus       227 ---~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  227 ---PDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             ---BTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             ---ccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence               111235577889999999999999999999886

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.6e-40  Score=329.24  Aligned_cols=256  Identities=29%  Similarity=0.414  Sum_probs=208.0

Q ss_pred             hcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEe
Q 007869          259 ATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYD  338 (586)
Q Consensus       259 a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E  338 (586)
                      ..++|+..+.||+|++|.||+|.+.. +..||+|.+.... ...+++.+|++++++++||||+++++++...+..++|||
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (261)
T cd05068           4 DRTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE   81 (261)
T ss_pred             chhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence            45678899999999999999999754 4679999986543 235678999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCC
Q 007869          339 YMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD  418 (586)
Q Consensus       339 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~  418 (586)
                      |+++++|.+++.......+++..+..++.|++.||.|||+   .+++||||||+||++++++.+||+|||+++.......
T Consensus        82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05068          82 LMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY  158 (261)
T ss_pred             cccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence            9999999999977654568999999999999999999998   8999999999999999999999999999987653322


Q ss_pred             CceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCC
Q 007869          419 PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLG  497 (586)
Q Consensus       419 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~  497 (586)
                      ........+..|+|||++.+..++.++||||||+++|||++ |+.||.......   +..    ....+..     .   
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~----~~~~~~~-----~---  223 (261)
T cd05068         159 EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE---VLQ----QVDQGYR-----M---  223 (261)
T ss_pred             cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHH----HHHcCCC-----C---
Confidence            21222233468999999998899999999999999999999 999997543221   111    1111100     0   


Q ss_pred             ccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 007869          498 TEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER  535 (586)
Q Consensus       498 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  535 (586)
                       .........+.+++.+|++.+|.+||++.++++.|+.
T Consensus       224 -~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         224 -PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             -CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence             0111234568889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.1e-39  Score=339.49  Aligned_cols=201  Identities=28%  Similarity=0.384  Sum_probs=178.7

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc-chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEe
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYD  338 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E  338 (586)
                      .++|+..+.||+|+||.||++++..++..+|+|.+.... ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            468999999999999999999999999999999987653 3345679999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCC
Q 007869          339 YMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD  418 (586)
Q Consensus       339 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~  418 (586)
                      |+++++|.+++....  .+++..+..++.|++.||.|||+  ..+|+||||||+|||++.++.+||+|||+++.....  
T Consensus        84 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--  157 (331)
T cd06649          84 HMDGGSLDQVLKEAK--RIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  157 (331)
T ss_pred             cCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhh--cCCEEcCCCChhhEEEcCCCcEEEccCccccccccc--
Confidence            999999999997653  57888899999999999999997  246999999999999999999999999999865332  


Q ss_pred             CceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCC
Q 007869          419 PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQ  467 (586)
Q Consensus       419 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~  467 (586)
                       ......||..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       158 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~  205 (331)
T cd06649         158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPP  205 (331)
T ss_pred             -ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence             223457899999999999989999999999999999999999999653

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.9e-40  Score=332.20  Aligned_cols=256  Identities=28%  Similarity=0.462  Sum_probs=212.6

Q ss_pred             hcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEe
Q 007869          259 ATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYD  338 (586)
Q Consensus       259 a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E  338 (586)
                      +..+|+..+.||.|+||.||+|.... +..+|+|.+.........++..|+.++++++|+||+++++++...+..++|||
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   82 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE   82 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence            44578889999999999999999977 77899999987766566789999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCC
Q 007869          339 YMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD  418 (586)
Q Consensus       339 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~  418 (586)
                      |+++++|.+++.......+++.+++.++.|++.||.|||+   ++|+||||||+||++++++.+||+|||++........
T Consensus        83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~  159 (261)
T cd05148          83 LMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY  159 (261)
T ss_pred             ecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence            9999999999987666678999999999999999999998   8999999999999999999999999999986643221


Q ss_pred             CceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCC
Q 007869          419 PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLG  497 (586)
Q Consensus       419 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~  497 (586)
                       ......++..|+|||.+....++.++||||||+++|||++ |+.||......+   ..+...    .+.     .+   
T Consensus       160 -~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~---~~~~~~----~~~-----~~---  223 (261)
T cd05148         160 -LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE---VYDQIT----AGY-----RM---  223 (261)
T ss_pred             -cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH---HHHHHH----hCC-----cC---
Confidence             1223346778999999988899999999999999999998 899997644221   111111    110     01   


Q ss_pred             ccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 007869          498 TEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER  535 (586)
Q Consensus       498 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  535 (586)
                       .........+.+++.+||+.||.+|||+.++++.|+.
T Consensus       224 -~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         224 -PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             -CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence             1112233567889999999999999999999999974

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-40  Score=339.22  Aligned_cols=242  Identities=25%  Similarity=0.268  Sum_probs=195.9

Q ss_pred             EeecCceEEEEEEeCCCCeEEEEEEeccc---cchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEecCCCCCh
Q 007869          269 LGTGGFGRVYRGTLPKSQIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSL  345 (586)
Q Consensus       269 LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL  345 (586)
                      ||+|+||.||+|....++..||+|++...   .......+..|+.++.+++||||+++++++...+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            69999999999999988999999998653   234456788999999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCCceeeec
Q 007869          346 DKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVV  425 (586)
Q Consensus       346 ~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~  425 (586)
                      .+++...  ..+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++...... .......
T Consensus        81 ~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~  154 (312)
T cd05585          81 FHHLQRE--GRFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTFC  154 (312)
T ss_pred             HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Ccccccc
Confidence            9999765  358888999999999999999998   999999999999999999999999999998643222 2234467


Q ss_pred             cCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCccccHHHH
Q 007869          426 GTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAEEL  505 (586)
Q Consensus       426 gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~  505 (586)
                      ||+.|+|||++.+..++.++|||||||++|||++|+.||......+      ...... .+.      ..+    .....
T Consensus       155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~------~~~~~~-~~~------~~~----~~~~~  217 (312)
T cd05585         155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE------MYRKIL-QEP------LRF----PDGFD  217 (312)
T ss_pred             CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHH------HHHHHH-cCC------CCC----CCcCC
Confidence            9999999999999999999999999999999999999997643211      111111 111      111    11223


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 007869          506 ELVLKLGLLCSHSDPTARPSMRQVVQIL  533 (586)
Q Consensus       506 ~~l~~l~~~Cl~~dP~~RPs~~evl~~L  533 (586)
                      ..+.+++.+||+.||.+||+...+.+.|
T Consensus       218 ~~~~~li~~~L~~dp~~R~~~~~~~e~l  245 (312)
T cd05585         218 RDAKDLLIGLLSRDPTRRLGYNGAQEIK  245 (312)
T ss_pred             HHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence            4567888899999999998644333333

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=6.6e-40  Score=334.12  Aligned_cols=265  Identities=23%  Similarity=0.316  Sum_probs=202.9

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc-chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEec
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY  339 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  339 (586)
                      ++|+..+.||+|+||.||+|....++..||+|++.... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            56888999999999999999999889999999987543 23345678999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCC
Q 007869          340 MPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP  419 (586)
Q Consensus       340 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~  419 (586)
                      ++ ++|.+++.... ..+++.....++.||++||.|||+   ++|+||||||+|||++.++.+||+|||+++...... .
T Consensus        85 ~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~-~  158 (288)
T cd07871          85 LD-SDLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT-K  158 (288)
T ss_pred             CC-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC-c
Confidence            97 59999886543 357888999999999999999998   999999999999999999999999999998654322 1


Q ss_pred             ceeeeccCCCccCcccccC-CCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHH-----hhhcc----Cccc
Q 007869          420 QTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVF-----DFWNR----GELL  489 (586)
Q Consensus       420 ~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~-----~~~~~----~~~~  489 (586)
                      ......+++.|+|||++.+ ..++.++|||||||++|||++|+.||......+.........     ..+..    ....
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (288)
T cd07871         159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFR  238 (288)
T ss_pred             cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhh
Confidence            2234568999999998865 568999999999999999999999997654433221110000     00000    0000


Q ss_pred             cccCCCCCcc----ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          490 EARDPNLGTE----YVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       490 ~~~d~~l~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      ....+.....    ..........+++.+|++.||.+|||++|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             ccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            1111111000    00112245678899999999999999999975

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.7e-41  Score=311.96  Aligned_cols=251  Identities=27%  Similarity=0.380  Sum_probs=214.3

Q ss_pred             hcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc---chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEE
Q 007869          259 ATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLL  335 (586)
Q Consensus       259 a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~l  335 (586)
                      +-++|++.+.||+|.||.||.|+.+.+.-.||+|++.+..   .+..+++.+|+++.+.|+||||+++++||.+....||
T Consensus        20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL   99 (281)
T KOG0580|consen   20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL   99 (281)
T ss_pred             chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence            4467899999999999999999999999999999996642   2345678999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccC
Q 007869          336 VYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH  415 (586)
Q Consensus       336 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~  415 (586)
                      ++||.++|.|...|.......+++.....++.|+|.||.|+|.   +++|||||||+|+|++.++..||+|||.+..-..
T Consensus       100 ilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~  176 (281)
T KOG0580|consen  100 ILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS  176 (281)
T ss_pred             EEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCeeccCCCceeecCC
Confidence            9999999999999997766778888999999999999999998   9999999999999999999999999999986442


Q ss_pred             CCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCC
Q 007869          416 GTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPN  495 (586)
Q Consensus       416 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~  495 (586)
                         ....+.+||..|.+||+..+...+...|+|++|++.||++.|.+||+.....+...-+          ...+..+| 
T Consensus       177 ---~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI----------~k~~~~~p-  242 (281)
T KOG0580|consen  177 ---NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRI----------RKVDLKFP-  242 (281)
T ss_pred             ---CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHH----------HHccccCC-
Confidence               2345679999999999999999999999999999999999999999876533321111          11222223 


Q ss_pred             CCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          496 LGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       496 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                            ........+++..|+..+|.+|.+..|+++.
T Consensus       243 ------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h  273 (281)
T KOG0580|consen  243 ------STISGGAADLISRLLVKNPIERLALTEVMDH  273 (281)
T ss_pred             ------cccChhHHHHHHHHhccCccccccHHHHhhh
Confidence                  2233556788889999999999999999864

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=9.1e-40  Score=345.10  Aligned_cols=258  Identities=24%  Similarity=0.263  Sum_probs=204.9

Q ss_pred             hhhhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc---cchhHHHHHHHHHHhcccCCCceeeeeeeeeccCe
Q 007869          256 LYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGE  332 (586)
Q Consensus       256 l~~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~  332 (586)
                      +....++|+..+.||+|+||.||+++...++..||+|++...   .....+.+..|+.+++.++||||+++++++...+.
T Consensus        38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~  117 (370)
T cd05596          38 LRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKY  117 (370)
T ss_pred             CCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence            344567899999999999999999999999999999999653   22334557889999999999999999999999999


Q ss_pred             EEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceee
Q 007869          333 LLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARL  412 (586)
Q Consensus       333 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~  412 (586)
                      .++||||+++|+|.+++...   .++......++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++.
T Consensus       118 ~~lv~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~  191 (370)
T cd05596         118 LYMVMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMK  191 (370)
T ss_pred             EEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEcCCCCEEEEeccceee
Confidence            99999999999999998654   46677788889999999999998   8999999999999999999999999999987


Q ss_pred             ccCCCCCceeeeccCCCccCcccccCC----CCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCcc
Q 007869          413 YDHGTDPQTTHVVGTLGYLAPEHTRTG----KATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGEL  488 (586)
Q Consensus       413 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~  488 (586)
                      .............||+.|+|||++.+.    .++.++|||||||++|||++|+.||........   .   .........
T Consensus       192 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~---~---~~i~~~~~~  265 (370)
T cd05596         192 MDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT---Y---SKIMDHKNS  265 (370)
T ss_pred             ccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHH---H---HHHHcCCCc
Confidence            654332233446799999999998653    478999999999999999999999986543211   1   111111000


Q ss_pred             ccccCCCCCccccHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 007869          489 LEARDPNLGTEYVAEELELVLKLGLLCSHSDPTA--RPSMRQVVQI  532 (586)
Q Consensus       489 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~  532 (586)
                      .  ..|.     .......+.+++..|++.+|.+  ||++.|+++.
T Consensus       266 ~--~~~~-----~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         266 L--TFPD-----DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             C--CCCC-----cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence            0  0011     0112355677888899999988  9999999753

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.3e-39  Score=337.65  Aligned_cols=242  Identities=24%  Similarity=0.285  Sum_probs=197.8

Q ss_pred             eeEeecCceEEEEEEeCCCCeEEEEEEeccc---cchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEecCCCC
Q 007869          267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNG  343 (586)
Q Consensus       267 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~g  343 (586)
                      +.||+|+||.||++....++..||+|++...   .......+..|++++++++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            4699999999999999888999999999754   2334556788999999999999999999999999999999999999


Q ss_pred             ChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCCceee
Q 007869          344 SLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTH  423 (586)
Q Consensus       344 sL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~  423 (586)
                      +|..++...  ..+++.....++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++...... .....
T Consensus        81 ~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~  154 (323)
T cd05595          81 ELFFHLSRE--RVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKT  154 (323)
T ss_pred             cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Ccccc
Confidence            999988665  368899999999999999999998   899999999999999999999999999987532211 12234


Q ss_pred             eccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCccccHH
Q 007869          424 VVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAE  503 (586)
Q Consensus       424 ~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~  503 (586)
                      ..||+.|+|||++.+..++.++|||||||++|||++|+.||......+.   ....   . ..      +..+...    
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~---~~~~---~-~~------~~~~p~~----  217 (323)
T cd05595         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL---FELI---L-ME------EIRFPRT----  217 (323)
T ss_pred             ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHH---HHHH---h-cC------CCCCCCC----
Confidence            5799999999999999999999999999999999999999976433211   1100   0 01      1111112    


Q ss_pred             HHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 007869          504 ELELVLKLGLLCSHSDPTARP-----SMRQVVQ  531 (586)
Q Consensus       504 ~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~  531 (586)
                      ....+.+++.+||+.||.+||     ++.++++
T Consensus       218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         218 LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             CCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence            234567888899999999998     8888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=7.3e-40  Score=327.44  Aligned_cols=251  Identities=28%  Similarity=0.459  Sum_probs=203.0

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEecC
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYM  340 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  340 (586)
                      ++|+..+.||+|+||.||++.+.. +..+|+|.+.... ...+++.+|++++++++||||+++++++...+..++||||+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~   81 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM   81 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence            457788999999999999999865 4579999886432 23467899999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCCc
Q 007869          341 PNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ  420 (586)
Q Consensus       341 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~  420 (586)
                      ++|+|.+++.... ..+++..+..++.|++.||.|||+   ++|+||||||+||++++++.+||+|||+++.........
T Consensus        82 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~  157 (256)
T cd05114          82 ENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS  157 (256)
T ss_pred             CCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence            9999999987543 358899999999999999999998   899999999999999999999999999998654322222


Q ss_pred             eeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCcc
Q 007869          421 TTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTE  499 (586)
Q Consensus       421 ~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~  499 (586)
                      .....++..|+|||++.+..++.++||||||+++|||++ |+.||......+   ....+.    ++..  ...|..   
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~---~~~~i~----~~~~--~~~~~~---  225 (256)
T cd05114         158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE---VVEMIS----RGFR--LYRPKL---  225 (256)
T ss_pred             cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHH----CCCC--CCCCCC---
Confidence            223345678999999988889999999999999999999 899997543221   222211    1111  111111   


Q ss_pred             ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 007869          500 YVAEELELVLKLGLLCSHSDPTARPSMRQVVQIL  533 (586)
Q Consensus       500 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L  533 (586)
                          ....+.+++.+||+.+|.+||++.++++.|
T Consensus       226 ----~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         226 ----ASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             ----CCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence                124678999999999999999999999887

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1e-39  Score=339.24  Aligned_cols=243  Identities=24%  Similarity=0.287  Sum_probs=198.9

Q ss_pred             eeEeecCceEEEEEEeCCCCeEEEEEEeccc---cchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEecCCCC
Q 007869          267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNG  343 (586)
Q Consensus       267 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~g  343 (586)
                      +.||+|+||.||++....++..||+|++...   .......+.+|+.++++++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999999989999999999754   2344567889999999999999999999999999999999999999


Q ss_pred             ChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCCceee
Q 007869          344 SLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTH  423 (586)
Q Consensus       344 sL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~  423 (586)
                      +|.+++...  ..+++.+...++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++...... .....
T Consensus        81 ~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~  154 (328)
T cd05593          81 ELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATMKT  154 (328)
T ss_pred             CHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-ccccc
Confidence            999988665  368899999999999999999998   899999999999999999999999999987533221 12234


Q ss_pred             eccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCccccHH
Q 007869          424 VVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAE  503 (586)
Q Consensus       424 ~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~  503 (586)
                      ..||+.|+|||++.+..++.++|||||||++|||++|+.||......+   +..    ....+      +..+...    
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~---~~~----~~~~~------~~~~p~~----  217 (328)
T cd05593         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---LFE----LILME------DIKFPRT----  217 (328)
T ss_pred             ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH---HHH----HhccC------CccCCCC----
Confidence            579999999999998899999999999999999999999997643321   111    00011      1111112    


Q ss_pred             HHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 007869          504 ELELVLKLGLLCSHSDPTARP-----SMRQVVQI  532 (586)
Q Consensus       504 ~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~  532 (586)
                      ....+.+++.+||+.||++||     ++.|+++.
T Consensus       218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         218 LSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence            234567888899999999997     88998753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.3e-40  Score=342.95  Aligned_cols=252  Identities=25%  Similarity=0.324  Sum_probs=205.7

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc---chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEE
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY  337 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  337 (586)
                      ++|...+.||+|+||.||+|+...++..||||++....   ......+..|++++..++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            46889999999999999999999889999999997542   234567899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCC
Q 007869          338 DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT  417 (586)
Q Consensus       338 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~  417 (586)
                      ||+++++|.+++...  ..+++.....++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++......
T Consensus        81 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~  155 (350)
T cd05573          81 EYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK  155 (350)
T ss_pred             cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence            999999999999766  468888999999999999999998   999999999999999999999999999998654432


Q ss_pred             ----------------------------CCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCC
Q 007869          418 ----------------------------DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGP  469 (586)
Q Consensus       418 ----------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~  469 (586)
                                                  ........||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~  235 (350)
T cd05573         156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL  235 (350)
T ss_pred             cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence                                        1122345799999999999999999999999999999999999999986543


Q ss_pred             CccchhhHHHHhhhc-cCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCC-HHHHHHH
Q 007869          470 SENLILVDWVFDFWN-RGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPS-MRQVVQI  532 (586)
Q Consensus       470 ~~~~~l~~~v~~~~~-~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-~~evl~~  532 (586)
                      .+..      ..... ....   ..|.. ..    ....+.+++..|++ ||.+||+ +.++++.
T Consensus       236 ~~~~------~~i~~~~~~~---~~p~~-~~----~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         236 QETY------NKIINWKESL---RFPPD-PP----VSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             HHHH------HHHhccCCcc---cCCCC-CC----CCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            2111      11111 0000   01111 11    23456677888997 9999999 9999874

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-39  Score=327.90  Aligned_cols=257  Identities=29%  Similarity=0.504  Sum_probs=207.7

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCC---CeEEEEEEecccc-chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEE
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKS---QIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLL  335 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~l  335 (586)
                      .++|+..+.||+|+||.||+|.+...   ...||||.+.... .....+|.+|+.++++++||||+++++++...+..++
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   82 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI   82 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence            45788899999999999999998643   4579999987543 3345678999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccC
Q 007869          336 VYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH  415 (586)
Q Consensus       336 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~  415 (586)
                      ||||+++++|.+++.... ..+++.+++.++.|++.||.|||+   .+|+||||||+|||+++++.+||+|||+++....
T Consensus        83 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  158 (266)
T cd05033          83 ITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLED  158 (266)
T ss_pred             EEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence            999999999999997653 368999999999999999999998   8999999999999999999999999999997652


Q ss_pred             CCCC-ceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccCccccccC
Q 007869          416 GTDP-QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEARD  493 (586)
Q Consensus       416 ~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d  493 (586)
                      .... ......++..|+|||.+.+..++.++||||||+++|||++ |..||......+   +.+..    .++...    
T Consensus       159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~---~~~~~----~~~~~~----  227 (266)
T cd05033         159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD---VIKAV----EDGYRL----  227 (266)
T ss_pred             cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH---HHHHH----HcCCCC----
Confidence            2211 1122345678999999998899999999999999999998 999986543221   11111    111100    


Q ss_pred             CCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 007869          494 PNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERD  536 (586)
Q Consensus       494 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  536 (586)
                      +.     .......+.+++.+|++.+|++||++.|+++.|++.
T Consensus       228 ~~-----~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         228 PP-----PMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             CC-----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            11     112235678999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-39  Score=330.60  Aligned_cols=252  Identities=26%  Similarity=0.349  Sum_probs=204.8

Q ss_pred             CcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc---chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEe
Q 007869          262 GFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYD  338 (586)
Q Consensus       262 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E  338 (586)
                      +|+..++||+|+||.||++....++..||+|++....   ......+.+|+.++++++||||+++++++..++.+++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            4778899999999999999998888999999986532   2233457889999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCC
Q 007869          339 YMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD  418 (586)
Q Consensus       339 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~  418 (586)
                      |+++|+|.+++.......+++..+..++.|++.||.|||+   .+|+||||||+||++++++.++|+|||+++...... 
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-  156 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE-  156 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-
Confidence            9999999999876555578999999999999999999998   899999999999999999999999999998754322 


Q ss_pred             CceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCc
Q 007869          419 PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGT  498 (586)
Q Consensus       419 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~  498 (586)
                       ......|+..|+|||++.+..++.++|||||||++|||++|+.||.........   +.+.......      .    .
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~---~~~~~~~~~~------~----~  222 (285)
T cd05605         157 -TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKR---EEVERRVKED------Q----E  222 (285)
T ss_pred             -ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHH---HHHHHHhhhc------c----c
Confidence             223347899999999999889999999999999999999999999864332111   1111111110      0    1


Q ss_pred             cccHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 007869          499 EYVAEELELVLKLGLLCSHSDPTARP-----SMRQVVQ  531 (586)
Q Consensus       499 ~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~  531 (586)
                      .+.......+.+++..|++.||++||     ++.++++
T Consensus       223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05605         223 EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA  260 (285)
T ss_pred             ccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence            11222345677889999999999999     7778764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=9.3e-40  Score=356.15  Aligned_cols=251  Identities=21%  Similarity=0.314  Sum_probs=205.4

Q ss_pred             CcccceeEeecCceEEEEEEeCCC-CeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEecC
Q 007869          262 GFREKELLGTGGFGRVYRGTLPKS-QIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYM  340 (586)
Q Consensus       262 ~f~~~~~LG~G~~g~Vy~~~~~~~-~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  340 (586)
                      .|...+.||+|++|.||++....+ +..||+|.+..........+..|+.++++++||||++++++|...+..+|||||+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            488899999999999999998766 6789999876665555567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcC--CCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCC
Q 007869          341 PNGSLDKYLYDQ--PKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD  418 (586)
Q Consensus       341 ~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~  418 (586)
                      ++|+|.++|...  ...++++.....++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++.+.....
T Consensus       148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~  224 (478)
T PTZ00267        148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS  224 (478)
T ss_pred             CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence            999999988643  23468888999999999999999998   8999999999999999999999999999997654322


Q ss_pred             C-ceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCC
Q 007869          419 P-QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLG  497 (586)
Q Consensus       419 ~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~  497 (586)
                      . ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+   +   ..... .+..    ++ . 
T Consensus       225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~---~---~~~~~-~~~~----~~-~-  291 (478)
T PTZ00267        225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQRE---I---MQQVL-YGKY----DP-F-  291 (478)
T ss_pred             cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH---H---HHHHH-hCCC----CC-C-
Confidence            1 2344579999999999999999999999999999999999999997543211   1   11111 1111    11 1 


Q ss_pred             ccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          498 TEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       498 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                         .......+.+++.+||+.||++||++.++++
T Consensus       292 ---~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        292 ---PCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             ---CccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence               1112345778889999999999999999864

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=8.6e-40  Score=339.89  Aligned_cols=253  Identities=24%  Similarity=0.265  Sum_probs=203.8

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc---chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEE
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY  337 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  337 (586)
                      ++|...+.||+|+||.||++....++..||+|++....   .+..+.+..|+.+++.++|+||+++++++...+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            46889999999999999999999899999999997642   234566889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCC
Q 007869          338 DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT  417 (586)
Q Consensus       338 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~  417 (586)
                      ||+++|+|.+++.... ..+++..+..++.|+++||.|||+   .+|+||||||+|||++.++.+||+|||+++.+....
T Consensus        81 e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~  156 (330)
T cd05601          81 EYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK  156 (330)
T ss_pred             CCCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence            9999999999997652 368888999999999999999998   899999999999999999999999999998765443


Q ss_pred             CCceeeeccCCCccCccccc------CCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccc
Q 007869          418 DPQTTHVVGTLGYLAPEHTR------TGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEA  491 (586)
Q Consensus       418 ~~~~~~~~gt~~y~aPE~~~------~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~  491 (586)
                      ........||+.|+|||++.      ...++.++|||||||++|||++|+.||......+.      .............
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~------~~~i~~~~~~~~~  230 (330)
T cd05601         157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT------YNNIMNFQRFLKF  230 (330)
T ss_pred             ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH------HHHHHcCCCccCC
Confidence            33334457999999999986      45678999999999999999999999976543211      1111111111110


Q ss_pred             cCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          492 RDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       492 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                        |.     .......+.+++..|++ +|.+||++.++++
T Consensus       231 --~~-----~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         231 --PE-----DPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             --CC-----CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence              10     01122446677778897 9999999999885

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.1e-40  Score=341.53  Aligned_cols=252  Identities=23%  Similarity=0.348  Sum_probs=214.4

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc--chhHHHHHHHHHHhcccCCCceeeeeeeeeccCe-EEEEE
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES--RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGE-LLLVY  337 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~-~~lV~  337 (586)
                      ++|...+++|+|+||.++..+++.....+++|++....  ....+...+|+.++++++|||||.+.+.+.+++. ++|||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            57888999999999999999999999999999997652  3334567899999999999999999999998888 99999


Q ss_pred             ecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCC
Q 007869          338 DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT  417 (586)
Q Consensus       338 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~  417 (586)
                      +|++||+|.+.|.+.....+++.++.+++.|++.|+.|||+   ..|+|||||++|||++.+..+||+|||+|+.+....
T Consensus        84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~---~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~  160 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHE---NRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED  160 (426)
T ss_pred             eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHh---hhhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence            99999999999988876789999999999999999999997   899999999999999999999999999999887654


Q ss_pred             CCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCC
Q 007869          418 DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLG  497 (586)
Q Consensus       418 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~  497 (586)
                      . ....++||+.||.||++.+.+|..|+|||||||++|||++-+++|...+...   |+..+         ....-.   
T Consensus       161 ~-~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~---Li~ki---------~~~~~~---  224 (426)
T KOG0589|consen  161 S-LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE---LILKI---------NRGLYS---  224 (426)
T ss_pred             h-hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH---HHHHH---------hhccCC---
Confidence            2 3456899999999999999999999999999999999999999998765432   22111         111111   


Q ss_pred             ccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          498 TEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       498 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                       ..+......+..++..|++.+|..||++.+++..
T Consensus       225 -Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  225 -PLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             -CCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence             1222334567777888999999999999999864

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=2.1e-39  Score=342.15  Aligned_cols=260  Identities=24%  Similarity=0.268  Sum_probs=203.6

Q ss_pred             hhhhhhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc---cchhHHHHHHHHHHhcccCCCceeeeeeeeecc
Q 007869          254 KDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRK  330 (586)
Q Consensus       254 ~el~~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~  330 (586)
                      +++....++|+..+.||+|+||.||++++..++..+|+|.+...   .....+.+.+|+.+++.++||||+++++++...
T Consensus        36 ~~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~  115 (370)
T cd05621          36 RKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDD  115 (370)
T ss_pred             HhcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence            34455667899999999999999999999999999999998643   222345688999999999999999999999999


Q ss_pred             CeEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccce
Q 007869          331 GELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLA  410 (586)
Q Consensus       331 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla  410 (586)
                      +..++||||+++|+|.+++...   .+++.....++.||+.||.|||+   ++|+||||||+|||+++++.+||+|||++
T Consensus       116 ~~~~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~~~~kL~DFG~a  189 (370)
T cd05621         116 KYLYMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTC  189 (370)
T ss_pred             CEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEEecccc
Confidence            9999999999999999999654   47788888999999999999998   89999999999999999999999999999


Q ss_pred             eeccCCCCCceeeeccCCCccCcccccCC----CCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccC
Q 007869          411 RLYDHGTDPQTTHVVGTLGYLAPEHTRTG----KATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRG  486 (586)
Q Consensus       411 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~  486 (586)
                      +..............||+.|+|||++...    .++.++|||||||++|||++|+.||......+.      ........
T Consensus       190 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~------~~~i~~~~  263 (370)
T cd05621         190 MKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGT------YSKIMDHK  263 (370)
T ss_pred             eecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHH------HHHHHhCC
Confidence            87654332233456799999999998654    378899999999999999999999976543211      11111110


Q ss_pred             ccccccCCCCCccccHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 007869          487 ELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTA--RPSMRQVVQI  532 (586)
Q Consensus       487 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~  532 (586)
                      ....     ...  .......+.+++..|++.++.+  ||++.|+++.
T Consensus       264 ~~~~-----~p~--~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         264 NSLN-----FPE--DVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             cccC-----CCC--cccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence            0000     000  1112344556677788755543  8899999875

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.3e-39  Score=340.01  Aligned_cols=248  Identities=23%  Similarity=0.306  Sum_probs=202.5

Q ss_pred             hcCCcccceeEeecCceEEEEEEeCCCC-eEEEEEEecccc---chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEE
Q 007869          259 ATKGFREKELLGTGGFGRVYRGTLPKSQ-IEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELL  334 (586)
Q Consensus       259 a~~~f~~~~~LG~G~~g~Vy~~~~~~~~-~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~  334 (586)
                      .-++|...+.||+|+||.||+|.+..++ ..||+|++....   ....+.+.+|+.+++.++||||+++++++...+..+
T Consensus        28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~  107 (340)
T PTZ00426         28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY  107 (340)
T ss_pred             ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence            3457889999999999999999876544 689999986532   234567889999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeecc
Q 007869          335 LVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYD  414 (586)
Q Consensus       335 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~  414 (586)
                      +||||+++|+|.+++....  .+++..+..++.|++.||.|||+   .+|+||||||+|||++.++++||+|||+++...
T Consensus       108 lv~Ey~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~  182 (340)
T PTZ00426        108 LVLEFVIGGEFFTFLRRNK--RFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD  182 (340)
T ss_pred             EEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence            9999999999999997653  57888999999999999999998   899999999999999999999999999998754


Q ss_pred             CCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCC
Q 007869          415 HGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDP  494 (586)
Q Consensus       415 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~  494 (586)
                      ..    .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......   .    .....++..      
T Consensus       183 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~---~----~~~i~~~~~------  245 (340)
T PTZ00426        183 TR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL---I----YQKILEGII------  245 (340)
T ss_pred             CC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH---H----HHHHhcCCC------
Confidence            32    234679999999999998889999999999999999999999997643311   1    111111111      


Q ss_pred             CCCccccHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 007869          495 NLGTEYVAEELELVLKLGLLCSHSDPTARP-----SMRQVVQI  532 (586)
Q Consensus       495 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~  532 (586)
                      ......    ...+.+++.+|++.||++|+     +++++++.
T Consensus       246 ~~p~~~----~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        246 YFPKFL----DNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             CCCCCC----CHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence            011111    23466788899999999995     88888753

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=2.6e-39  Score=322.69  Aligned_cols=251  Identities=28%  Similarity=0.414  Sum_probs=208.9

Q ss_pred             CcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc--cchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEec
Q 007869          262 GFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY  339 (586)
Q Consensus       262 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  339 (586)
                      +|...+.||+|++|.||+|+...++..|++|.+...  .....+.+.+|++++++++|||++++++++...+..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            477789999999999999999988999999998643  344567899999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCC
Q 007869          340 MPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP  419 (586)
Q Consensus       340 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~  419 (586)
                      +++++|.+++.......+++.+++.++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||+++....... 
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~-  156 (256)
T cd08529          81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN-  156 (256)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEcccccceeccCccc-
Confidence            999999999987655678999999999999999999998   8999999999999999999999999999987654322 


Q ss_pred             ceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCcc
Q 007869          420 QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTE  499 (586)
Q Consensus       420 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~  499 (586)
                      ......|+..|+|||+..+..++.++|+|||||+++||++|+.||......+   .....    .++.     .+.+   
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~----~~~~-----~~~~---  221 (256)
T cd08529         157 FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA---LILKI----IRGV-----FPPV---  221 (256)
T ss_pred             hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH---HHHHH----HcCC-----CCCC---
Confidence            2233568899999999999999999999999999999999999997654211   11111    1111     1111   


Q ss_pred             ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          500 YVAEELELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       500 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                       .......+.+++.+||+.+|++||++.++++.
T Consensus       222 -~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         222 -SQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             -ccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence             11234567889999999999999999999863

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-40  Score=343.55  Aligned_cols=262  Identities=26%  Similarity=0.432  Sum_probs=223.5

Q ss_pred             hhhhhhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeE
Q 007869          254 KDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGEL  333 (586)
Q Consensus       254 ~el~~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~  333 (586)
                      ++++....+....++||.|.||.||.|+|++-...||||.++.+.. ..++|+.|..+|+.++|||+|+|+|+|..+..+
T Consensus       260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM-eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF  338 (1157)
T KOG4278|consen  260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF  338 (1157)
T ss_pred             chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch-hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence            3444444566678899999999999999999888999999976543 468999999999999999999999999999999


Q ss_pred             EEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeec
Q 007869          334 LLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLY  413 (586)
Q Consensus       334 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~  413 (586)
                      |||.|||..|+|.++|++..+..++-...+.++.||+.||.||..   +++|||||...|+|+.++..+|++||||++++
T Consensus       339 YIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEk---knFIHRDLAARNCLVgEnhiVKvADFGLsRlM  415 (1157)
T KOG4278|consen  339 YIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHIVKVADFGLSRLM  415 (1157)
T ss_pred             EEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhccccccceEEeeccchhhhh
Confidence            999999999999999998877788888899999999999999998   99999999999999999999999999999998


Q ss_pred             cCCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccCcccccc
Q 007869          414 DHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEAR  492 (586)
Q Consensus       414 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~  492 (586)
                      ..+...........+.|.|||-+....++.|+|||+|||+|||+.| |-.||.+.+..       .|..+.++|-.++  
T Consensus       416 tgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlS-------qVY~LLEkgyRM~--  486 (1157)
T KOG4278|consen  416 TGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-------QVYGLLEKGYRMD--  486 (1157)
T ss_pred             cCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHH-------HHHHHHhcccccc--
Confidence            7665433333445788999999999999999999999999999988 88888764332       2444444443332  


Q ss_pred             CCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 007869          493 DPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER  535 (586)
Q Consensus       493 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  535 (586)
                             .+..+...+.+|++.||+.+|.+||++.|+-+.++.
T Consensus       487 -------~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEt  522 (1157)
T KOG4278|consen  487 -------GPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFET  522 (1157)
T ss_pred             -------CCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHH
Confidence                   344566789999999999999999999999887764

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.3e-39  Score=336.41  Aligned_cols=256  Identities=25%  Similarity=0.411  Sum_probs=203.8

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCe----EEEEEEecccc-chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEE
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQI----EIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLL  335 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~l  335 (586)
                      .+|+..+.||+|+||.||+|++..++.    .||+|.+.... ....+++.+|+.+++.++||||++++++|... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            568999999999999999999765444    48999987543 34457899999999999999999999999865 5689


Q ss_pred             EEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccC
Q 007869          336 VYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH  415 (586)
Q Consensus       336 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~  415 (586)
                      ++||+++|+|.+++.... ..+++...+.++.||+.||+|||+   ++|+||||||+|||+++++.+||+|||+++.+..
T Consensus        86 v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~---~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~  161 (316)
T cd05108          86 ITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  161 (316)
T ss_pred             eeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEecCCCcEEEccccccccccC
Confidence            999999999999997653 357888999999999999999998   8999999999999999999999999999997654


Q ss_pred             CCCCc-eeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccCccccccC
Q 007869          416 GTDPQ-TTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEARD  493 (586)
Q Consensus       416 ~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d  493 (586)
                      ..... .....++..|+|||++.+..++.++|||||||++|||++ |+.||......+   +..    ....+...  ..
T Consensus       162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~---~~~----~~~~~~~~--~~  232 (316)
T cd05108         162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISS----ILEKGERL--PQ  232 (316)
T ss_pred             CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH---HHH----HHhCCCCC--CC
Confidence            32211 112234678999999999999999999999999999997 999997543221   111    11111111  11


Q ss_pred             CCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 007869          494 PNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERDV  537 (586)
Q Consensus       494 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  537 (586)
                      +.       .....+.+++.+||+.+|.+||++.++++.|....
T Consensus       233 ~~-------~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~  269 (316)
T cd05108         233 PP-------ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA  269 (316)
T ss_pred             CC-------CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            11       12245778899999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-39  Score=341.71  Aligned_cols=252  Identities=23%  Similarity=0.327  Sum_probs=200.1

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc---chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEE
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY  337 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  337 (586)
                      ++|+..+.||+|+||.||+|+...++..||||++....   ......+.+|+.++.+++||||+++++++...+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            47889999999999999999999889999999997542   234456889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCC
Q 007869          338 DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT  417 (586)
Q Consensus       338 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~  417 (586)
                      ||+++|+|.+++....  .+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++.+....
T Consensus        81 E~~~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  155 (364)
T cd05599          81 EYLPGGDMMTLLMKKD--TFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH  155 (364)
T ss_pred             CCCCCcHHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence            9999999999997653  58889999999999999999998   899999999999999999999999999997643211


Q ss_pred             CC-------------------------------------ceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhC
Q 007869          418 DP-------------------------------------QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACG  460 (586)
Q Consensus       418 ~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG  460 (586)
                      ..                                     .....+||+.|+|||++....++.++|||||||++|||++|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G  235 (364)
T cd05599         156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG  235 (364)
T ss_pred             cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence            00                                     01124699999999999998999999999999999999999


Q ss_pred             CCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCC---HHHHHH
Q 007869          461 RRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPS---MRQVVQ  531 (586)
Q Consensus       461 ~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs---~~evl~  531 (586)
                      +.||......+.   ...+.. + ....   ..|.. ...    ...+.+++.+|+. +|.+|++   +.|+++
T Consensus       236 ~~Pf~~~~~~~~---~~~i~~-~-~~~~---~~~~~-~~~----s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         236 YPPFCSDNPQET---YRKIIN-W-KETL---QFPDE-VPL----SPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             CCCCCCCCHHHH---HHHHHc-C-CCcc---CCCCC-CCC----CHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            999976543221   111110 0 0000   00110 011    2345566667786 9999998   888876

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.2e-39  Score=339.42  Aligned_cols=265  Identities=23%  Similarity=0.320  Sum_probs=198.8

Q ss_pred             CcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc--cchhHHHHHHHHHHhcccCCCceeeeeeeeecc-----CeEE
Q 007869          262 GFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRK-----GELL  334 (586)
Q Consensus       262 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~-----~~~~  334 (586)
                      +|+..+.||+|+||.||+|+...++..||||++...  .......+.+|++++++++||||+++++++...     ...+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            478889999999999999999988999999998643  223445788999999999999999999987543     3589


Q ss_pred             EEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeecc
Q 007869          335 LVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYD  414 (586)
Q Consensus       335 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~  414 (586)
                      +||||+. ++|.+++....  .+++..+..++.||++||.|||+   ++|+||||||+|||++.++.+||+|||+++...
T Consensus        81 lv~e~~~-~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~  154 (338)
T cd07859          81 VVFELME-SDLHQVIKAND--DLTPEHHQFFLYQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAF  154 (338)
T ss_pred             EEEecCC-CCHHHHHHhcc--cCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEccCccccccc
Confidence            9999995 68999886553  58899999999999999999998   899999999999999999999999999998643


Q ss_pred             CCCC--CceeeeccCCCccCcccccC--CCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhH-H-------HHhh
Q 007869          415 HGTD--PQTTHVVGTLGYLAPEHTRT--GKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVD-W-------VFDF  482 (586)
Q Consensus       415 ~~~~--~~~~~~~gt~~y~aPE~~~~--~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~-~-------v~~~  482 (586)
                      ....  .......||+.|+|||++.+  ..++.++|||||||++|||++|+.||............. .       ....
T Consensus       155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (338)
T cd07859         155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR  234 (338)
T ss_pred             cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence            2221  11234579999999999865  678999999999999999999999997644321111000 0       0000


Q ss_pred             hccCc---cccccCCCCCccc---cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          483 WNRGE---LLEARDPNLGTEY---VAEELELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       483 ~~~~~---~~~~~d~~l~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                      .....   ......+.....+   .......+.+++.+||+.||++||++.|+++.
T Consensus       235 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         235 VRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             hhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence            00000   0000000000000   01122456789999999999999999999853

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=9.2e-40  Score=313.14  Aligned_cols=200  Identities=29%  Similarity=0.420  Sum_probs=184.2

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccc---hhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEE
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR---QGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY  337 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  337 (586)
                      ++|+..+.||.|.||+|.+++.+.++..+|+|++++..-   ...+...+|..+|+.+.||.+++|++.|.+.+.++|||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            478889999999999999999999999999999987532   33456788999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCC
Q 007869          338 DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT  417 (586)
Q Consensus       338 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~  417 (586)
                      ||.+||-|..+|++.+  .+++....-++.||+.||+|||+   ..|++|||||+|||||.+|.+||.|||.|+....  
T Consensus       124 eyv~GGElFS~Lrk~~--rF~e~~arFYAAeivlAleylH~---~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~--  196 (355)
T KOG0616|consen  124 EYVPGGELFSYLRKSG--RFSEPHARFYAAEIVLALEYLHS---LDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG--  196 (355)
T ss_pred             eccCCccHHHHHHhcC--CCCchhHHHHHHHHHHHHHHHHh---cCeeeccCChHHeeeccCCcEEEEeccceEEecC--
Confidence            9999999999998764  57888888999999999999998   9999999999999999999999999999998653  


Q ss_pred             CCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCC
Q 007869          418 DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGP  469 (586)
Q Consensus       418 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~  469 (586)
                        .+.+.+||+.|+|||++..+.+..++|-|||||++|||++|.+||...++
T Consensus       197 --rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~  246 (355)
T KOG0616|consen  197 --RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP  246 (355)
T ss_pred             --cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh
Confidence              46778999999999999999999999999999999999999999998766

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.4e-39  Score=329.39  Aligned_cols=257  Identities=27%  Similarity=0.471  Sum_probs=208.3

Q ss_pred             cCCcccceeEeecCceEEEEEEeCC-----CCeEEEEEEeccccch-hHHHHHHHHHHhcccCCCceeeeeeeeeccCeE
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPK-----SQIEIAVKKISHESRQ-GMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGEL  333 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~  333 (586)
                      .++|...+.||+|+||.||+|.+.+     ++..||||.+...... ..+.+.+|++++++++|+||+++++++...+..
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   83 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP   83 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence            3568888999999999999998743     3567999999765443 457899999999999999999999999999999


Q ss_pred             EEEEecCCCCChhhhhhcCC------------CccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCC
Q 007869          334 LLVYDYMPNGSLDKYLYDQP------------KVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELN  401 (586)
Q Consensus       334 ~lV~E~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~  401 (586)
                      ++||||+++++|.+++....            ...+++.++..++.|++.||.|||+   ++++||||||+||+++.++.
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~  160 (280)
T cd05049          84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS---QHFVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeeccccccceEEEcCCCe
Confidence            99999999999999997542            2458899999999999999999998   89999999999999999999


Q ss_pred             eEEccccceeeccCCCC-CceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHH
Q 007869          402 GRLGDFGLARLYDHGTD-PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWV  479 (586)
Q Consensus       402 ~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v  479 (586)
                      +||+|||+++....... .......+++.|+|||++.+..++.++|||||||++|||++ |+.||......+   ..+..
T Consensus       161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~---~~~~~  237 (280)
T cd05049         161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE---VIECI  237 (280)
T ss_pred             EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHH
Confidence            99999999986533221 11233456788999999999999999999999999999998 999987644322   12211


Q ss_pred             HhhhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 007869          480 FDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER  535 (586)
Q Consensus       480 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  535 (586)
                          ..+.....         .......+.+++.+||+.||++||++.|+++.|++
T Consensus       238 ----~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         238 ----TQGRLLQR---------PRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             ----HcCCcCCC---------CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence                12221110         11223567889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=4.1e-39  Score=341.60  Aligned_cols=252  Identities=25%  Similarity=0.375  Sum_probs=197.7

Q ss_pred             CcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc---chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEe
Q 007869          262 GFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYD  338 (586)
Q Consensus       262 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E  338 (586)
                      .|...+.||+|+||+||+|++..++..||||++....   ....+.+.+|++++++++||||+++++++.+.+.+++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            5788999999999999999999999999999997542   3345678999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCC
Q 007869          339 YMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD  418 (586)
Q Consensus       339 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~  418 (586)
                      |+++|+|.+++....  .+++.....++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.+.....
T Consensus        82 ~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~  156 (381)
T cd05626          82 YIPGGDMMSLLIRME--VFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN  156 (381)
T ss_pred             cCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence            999999999997653  57888888899999999999998   8999999999999999999999999999864311000


Q ss_pred             ----------------------------------------------CceeeeccCCCccCcccccCCCCCCcceEEehhH
Q 007869          419 ----------------------------------------------PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGA  452 (586)
Q Consensus       419 ----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gv  452 (586)
                                                                    ......+||+.|+|||++.+..++.++|||||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~  236 (381)
T cd05626         157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV  236 (381)
T ss_pred             cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence                                                          0012347999999999999888999999999999


Q ss_pred             HHHHHHhCCCCCCCCCCCccch-hhHHHHhhhccCccccccCCCCCccccHHHHHHHHHHHHH--hcccCCCCCCCHHHH
Q 007869          453 FLLEVACGRRPIQRQGPSENLI-LVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLL--CSHSDPTARPSMRQV  529 (586)
Q Consensus       453 vl~ElltG~~p~~~~~~~~~~~-l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~--Cl~~dP~~RPs~~ev  529 (586)
                      ++|||++|+.||......+... ...|      .... .  .|. ...++.+    +.+++.+  |+..+|..||++.++
T Consensus       237 il~elltG~~Pf~~~~~~~~~~~i~~~------~~~~-~--~~~-~~~~s~~----~~dli~~ll~~~~~~~~R~~~~~~  302 (381)
T cd05626         237 ILFEMLVGQPPFLAPTPTETQLKVINW------ENTL-H--IPP-QVKLSPE----AVDLITKLCCSAEERLGRNGADDI  302 (381)
T ss_pred             HHHHHHhCCCCCcCCCHHHHHHHHHcc------cccc-C--CCC-CCCCCHH----HHHHHHHHccCcccccCCCCHHHH
Confidence            9999999999998654322110 1100      0000 0  011 1112333    3334433  667777789999999


Q ss_pred             HHH
Q 007869          530 VQI  532 (586)
Q Consensus       530 l~~  532 (586)
                      ++.
T Consensus       303 l~h  305 (381)
T cd05626         303 KAH  305 (381)
T ss_pred             hcC
Confidence            863

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.5e-39  Score=341.27  Aligned_cols=248  Identities=25%  Similarity=0.370  Sum_probs=195.3

Q ss_pred             CcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc-chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEecC
Q 007869          262 GFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYM  340 (586)
Q Consensus       262 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  340 (586)
                      +|+..+.||+|+||.||+|++..+++.||||++.... ....+.+.+|++++++++|+||+++++++...+.+++||||+
T Consensus        75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  154 (353)
T PLN00034         75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM  154 (353)
T ss_pred             HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence            4556788999999999999998889999999986543 234567899999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCCc
Q 007869          341 PNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ  420 (586)
Q Consensus       341 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~  420 (586)
                      ++++|.+..      ...+..+..++.||+.||.|||+   ++|+||||||+|||+++++.+||+|||+++.+..... .
T Consensus       155 ~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~  224 (353)
T PLN00034        155 DGGSLEGTH------IADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-P  224 (353)
T ss_pred             CCCcccccc------cCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEcccccceecccccc-c
Confidence            999987542      34566778899999999999998   8999999999999999999999999999987654322 2


Q ss_pred             eeeeccCCCccCcccccCC-----CCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCC
Q 007869          421 TTHVVGTLGYLAPEHTRTG-----KATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPN  495 (586)
Q Consensus       421 ~~~~~gt~~y~aPE~~~~~-----~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~  495 (586)
                      .....||..|+|||++...     ..+.++|||||||++|||++|+.||......+...+...   .. ..     ..+.
T Consensus       225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~---~~-~~-----~~~~  295 (353)
T PLN00034        225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCA---IC-MS-----QPPE  295 (353)
T ss_pred             ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHH---Hh-cc-----CCCC
Confidence            2345799999999987432     245689999999999999999999974332221111100   00 00     0111


Q ss_pred             CCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          496 LGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       496 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                      .    .......+.+++.+||+.||++||++.|+++.
T Consensus       296 ~----~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        296 A----PATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             C----CCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            1    11223567888899999999999999999864

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=1.9e-39  Score=331.14  Aligned_cols=258  Identities=28%  Similarity=0.478  Sum_probs=209.7

Q ss_pred             CCcccceeEeecCceEEEEEEeC-----CCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEE
Q 007869          261 KGFREKELLGTGGFGRVYRGTLP-----KSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLL  335 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~l  335 (586)
                      ++|...+.||+|+||.||+|...     .+...+++|.+........+.+.+|++++++++|+||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            45777899999999999999853     2455699999977666666789999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhhcCC--------------CccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCC
Q 007869          336 VYDYMPNGSLDKYLYDQP--------------KVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELN  401 (586)
Q Consensus       336 V~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~  401 (586)
                      ||||+++++|.+++....              ...+++.+++.++.||+.||.|||+   ++|+||||||+|||++.++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCc
Confidence            999999999999997542              2348899999999999999999998   89999999999999999999


Q ss_pred             eEEccccceeeccCCCC-CceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHH
Q 007869          402 GRLGDFGLARLYDHGTD-PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWV  479 (586)
Q Consensus       402 ~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v  479 (586)
                      +||+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |+.||......+   ..   
T Consensus       162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~---  235 (291)
T cd05094         162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE---VI---  235 (291)
T ss_pred             EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HH---
Confidence            99999999986543221 11233456789999999998999999999999999999998 999987644322   11   


Q ss_pred             HhhhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 007869          480 FDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERDV  537 (586)
Q Consensus       480 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  537 (586)
                       +....+.....         .......+.+++.+||+.+|++||++.++++.|+...
T Consensus       236 -~~~~~~~~~~~---------~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~  283 (291)
T cd05094         236 -ECITQGRVLER---------PRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALG  283 (291)
T ss_pred             -HHHhCCCCCCC---------CccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence             11122221111         1122356789999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=2.5e-39  Score=330.15  Aligned_cols=262  Identities=29%  Similarity=0.460  Sum_probs=209.2

Q ss_pred             hhhhcCCcccceeEeecCceEEEEEEeCC-----CCeEEEEEEeccc-cchhHHHHHHHHHHhccc-CCCceeeeeeeee
Q 007869          256 LYIATKGFREKELLGTGGFGRVYRGTLPK-----SQIEIAVKKISHE-SRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCR  328 (586)
Q Consensus       256 l~~a~~~f~~~~~LG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~  328 (586)
                      +....++|+..+.||+|+||.||++....     ....+|+|.+... ..+...++.+|++++.++ +|+||+++++++.
T Consensus         7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   86 (293)
T cd05053           7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT   86 (293)
T ss_pred             cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence            44556678889999999999999998753     3367999998754 234456789999999999 8999999999999


Q ss_pred             ccCeEEEEEecCCCCChhhhhhcC--------------CCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCe
Q 007869          329 RKGELLLVYDYMPNGSLDKYLYDQ--------------PKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNV  394 (586)
Q Consensus       329 ~~~~~~lV~E~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NI  394 (586)
                      ..+..+++|||+++|+|.+++...              ....+++..++.++.|++.||.|||+   .+|+||||||+||
T Consensus        87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~Ni  163 (293)
T cd05053          87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLAS---KKCIHRDLAARNV  163 (293)
T ss_pred             CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCccccccceeeE
Confidence            999999999999999999999642              23468899999999999999999998   8999999999999


Q ss_pred             eecCCCCeEEccccceeeccCCCCC-ceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCcc
Q 007869          395 LLDGELNGRLGDFGLARLYDHGTDP-QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSEN  472 (586)
Q Consensus       395 ll~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~  472 (586)
                      |+++++.+||+|||+++.+...... ......++..|+|||.+.+..++.++|||||||++|||++ |..||......+ 
T Consensus       164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-  242 (293)
T cd05053         164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE-  242 (293)
T ss_pred             EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH-
Confidence            9999999999999999876443211 1222345678999999988899999999999999999998 999987543221 


Q ss_pred             chhhHHHHhhhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 007869          473 LILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERD  536 (586)
Q Consensus       473 ~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  536 (586)
                        +    .+....+...         .........+.+++.+|++.||++|||+.|+++.|+..
T Consensus       243 --~----~~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~  291 (293)
T cd05053         243 --L----FKLLKEGYRM---------EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM  291 (293)
T ss_pred             --H----HHHHHcCCcC---------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence              1    1111111111         11112345678899999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=2.6e-39  Score=324.24  Aligned_cols=254  Identities=30%  Similarity=0.464  Sum_probs=204.7

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEec
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY  339 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  339 (586)
                      .++|+..+.||+|+||.||+|.... +..+|+|.+..... ..+.+.+|+.++++++|+|++++++++. .+..+++|||
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~-~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~   81 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWNG-NTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEY   81 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEecC-CceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEe
Confidence            3568888999999999999998764 45699999876433 3467999999999999999999999885 4568999999


Q ss_pred             CCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCC
Q 007869          340 MPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP  419 (586)
Q Consensus       340 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~  419 (586)
                      +++++|.+++.......+++.+++.++.|++.||.|||+   .+|+||||||+||++++++.+||+|||++..+......
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05070          82 MSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence            999999999987655568999999999999999999998   89999999999999999999999999999876543222


Q ss_pred             ceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCc
Q 007869          420 QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGT  498 (586)
Q Consensus       420 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~  498 (586)
                      ......++..|+|||++.+..++.++||||||+++|||++ |+.||......+   ..+..    ..+.     .+    
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~~~----~~~~-----~~----  222 (260)
T cd05070         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE---VLEQV----ERGY-----RM----  222 (260)
T ss_pred             cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHH----HcCC-----CC----
Confidence            2222345678999999988899999999999999999999 889997543221   11111    1110     01    


Q ss_pred             cccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 007869          499 EYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER  535 (586)
Q Consensus       499 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  535 (586)
                      .........+.+++.+|++.+|.+|||+.++.+.|+.
T Consensus       223 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         223 PCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            1112233568889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.7e-39  Score=345.52  Aligned_cols=262  Identities=27%  Similarity=0.422  Sum_probs=207.5

Q ss_pred             hhcCCcccceeEeecCceEEEEEEeCC-----CCeEEEEEEeccccc-hhHHHHHHHHHHhcccC-CCceeeeeeeeecc
Q 007869          258 IATKGFREKELLGTGGFGRVYRGTLPK-----SQIEIAVKKISHESR-QGMKEFVAEIVSIGRLR-HRNLVQLLGYCRRK  330 (586)
Q Consensus       258 ~a~~~f~~~~~LG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~-H~niv~l~~~~~~~  330 (586)
                      ...++|.+.++||+|+||.||+|++..     ....||||++..... ...+.+.+|+++++++. ||||++++++|...
T Consensus        34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~  113 (400)
T cd05105          34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS  113 (400)
T ss_pred             ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence            345678899999999999999998643     234699999975433 33467999999999996 99999999999999


Q ss_pred             CeEEEEEecCCCCChhhhhhcCC---------------------------------------------------------
Q 007869          331 GELLLVYDYMPNGSLDKYLYDQP---------------------------------------------------------  353 (586)
Q Consensus       331 ~~~~lV~E~~~~gsL~~~l~~~~---------------------------------------------------------  353 (586)
                      +..+|||||+++|+|.++|....                                                         
T Consensus       114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (400)
T cd05105         114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE  193 (400)
T ss_pred             CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence            99999999999999999886531                                                         


Q ss_pred             -------------------------------------CccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeee
Q 007869          354 -------------------------------------KVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLL  396 (586)
Q Consensus       354 -------------------------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll  396 (586)
                                                           ...+++..++.++.|+++||.|||+   .+|+||||||+|||+
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dikp~Nill  270 (400)
T cd05105         194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLL  270 (400)
T ss_pred             hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHhEEE
Confidence                                                 1247788889999999999999998   899999999999999


Q ss_pred             cCCCCeEEccccceeeccCCCCC-ceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccch
Q 007869          397 DGELNGRLGDFGLARLYDHGTDP-QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLI  474 (586)
Q Consensus       397 ~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~  474 (586)
                      ++++.+||+|||+++........ ......++..|+|||++.+..++.++|||||||++|||++ |..||........  
T Consensus       271 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~--  348 (400)
T cd05105         271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST--  348 (400)
T ss_pred             eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH--
Confidence            99999999999999865432221 2223456788999999998899999999999999999997 9999875432211  


Q ss_pred             hhHHHHhhhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 007869          475 LVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERDV  537 (586)
Q Consensus       475 l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  537 (586)
                          .......+.     .+.    ........+.+++.+||+.||++||++.++.+.|++..
T Consensus       349 ----~~~~~~~~~-----~~~----~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~  398 (400)
T cd05105         349 ----FYNKIKSGY-----RMA----KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL  398 (400)
T ss_pred             ----HHHHHhcCC-----CCC----CCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence                111111111     011    11223456788999999999999999999999998643

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=3.2e-39  Score=336.18  Aligned_cols=202  Identities=28%  Similarity=0.393  Sum_probs=178.2

Q ss_pred             hcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc-chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEE
Q 007869          259 ATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY  337 (586)
Q Consensus       259 a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  337 (586)
                      ..++|+..+.||+|+||.||++.+..++..+|+|.+.... ......+.+|++++++++||||++++++|...+..++||
T Consensus         3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   82 (333)
T cd06650           3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   82 (333)
T ss_pred             chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence            3478999999999999999999999889999999987653 334567899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCC
Q 007869          338 DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT  417 (586)
Q Consensus       338 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~  417 (586)
                      ||+++++|.+++....  .+++.....++.|++.||.|||+  ..+|+||||||+|||++.++.+||+|||++...... 
T Consensus        83 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-  157 (333)
T cd06650          83 EHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  157 (333)
T ss_pred             ecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-
Confidence            9999999999997643  57888889999999999999997  247999999999999999999999999999765332 


Q ss_pred             CCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCC
Q 007869          418 DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQ  467 (586)
Q Consensus       418 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~  467 (586)
                        ......||..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       158 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~  205 (333)
T cd06650         158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP  205 (333)
T ss_pred             --ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence              223356899999999999888999999999999999999999999754

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=2.6e-39  Score=324.90  Aligned_cols=255  Identities=29%  Similarity=0.447  Sum_probs=205.9

Q ss_pred             hcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEe
Q 007869          259 ATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYD  338 (586)
Q Consensus       259 a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E  338 (586)
                      ..++|+..+.||+|+||.||+|++.++. .||+|++..... ..+.|.+|++++++++||||+++++.+.. +..++|||
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e   80 (262)
T cd05071           4 PRESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE   80 (262)
T ss_pred             ChHHeeEeeecCCCCCCcEEEEEecCCc-eEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEE
Confidence            3456889999999999999999986654 599999975332 34678999999999999999999998754 56799999


Q ss_pred             cCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCC
Q 007869          339 YMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD  418 (586)
Q Consensus       339 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~  418 (586)
                      |+++|+|.+++.......+++..+..++.|+++||.|||+   .+++||||||+||++++++.+||+|||+++.+.....
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~  157 (262)
T cd05071          81 YMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  157 (262)
T ss_pred             cCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence            9999999999986544568899999999999999999998   8999999999999999999999999999987654332


Q ss_pred             CceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCC
Q 007869          419 PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLG  497 (586)
Q Consensus       419 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~  497 (586)
                      .......++..|+|||+..+..++.++|||||||++|||++ |+.||......+   ..    .....+.     ..   
T Consensus       158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~---~~----~~~~~~~-----~~---  222 (262)
T cd05071         158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---VL----DQVERGY-----RM---  222 (262)
T ss_pred             ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH---HH----HHHhcCC-----CC---
Confidence            22223456778999999988899999999999999999999 888887543321   11    1111110     00   


Q ss_pred             ccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 007869          498 TEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER  535 (586)
Q Consensus       498 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  535 (586)
                       ....+....+.+++.+|++.+|++||++.++++.|+.
T Consensus       223 -~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~  259 (262)
T cd05071         223 -PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED  259 (262)
T ss_pred             -CCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence             1122344667899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=6.1e-39  Score=332.71  Aligned_cols=245  Identities=24%  Similarity=0.318  Sum_probs=195.7

Q ss_pred             cccceeEeecCceEEEEEEeCCCCeEEEEEEecccc---chhHHHHHHHHHH---hcccCCCceeeeeeeeeccCeEEEE
Q 007869          263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES---RQGMKEFVAEIVS---IGRLRHRNLVQLLGYCRRKGELLLV  336 (586)
Q Consensus       263 f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~---l~~l~H~niv~l~~~~~~~~~~~lV  336 (586)
                      |+..+.||+|+||.||+|.+..++..||||++....   ....+.+..|+.+   +++++||||+++++++...+..++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            567889999999999999999889999999997542   2234456666554   4677899999999999999999999


Q ss_pred             EecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCC
Q 007869          337 YDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHG  416 (586)
Q Consensus       337 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~  416 (586)
                      |||+++++|..++...   .+++.+...++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.....
T Consensus        81 ~E~~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~  154 (324)
T cd05589          81 MEYAAGGDLMMHIHTD---VFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF  154 (324)
T ss_pred             EcCCCCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence            9999999999888543   68999999999999999999998   89999999999999999999999999998753322


Q ss_pred             CCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCC
Q 007869          417 TDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNL  496 (586)
Q Consensus       417 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l  496 (586)
                      . .......|++.|+|||++.+..++.++|||||||++|||++|+.||......+   ..   .. ...+.      +..
T Consensus       155 ~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~---~~---~~-i~~~~------~~~  220 (324)
T cd05589         155 G-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE---VF---DS-IVNDE------VRY  220 (324)
T ss_pred             C-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH---HH---HH-HHhCC------CCC
Confidence            1 22334679999999999999999999999999999999999999997643321   11   11 11111      111


Q ss_pred             CccccHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 007869          497 GTEYVAEELELVLKLGLLCSHSDPTARP-----SMRQVVQ  531 (586)
Q Consensus       497 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~  531 (586)
                      ..    .....+.+++.+||+.||.+||     ++.++++
T Consensus       221 p~----~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         221 PR----FLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             CC----CCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence            11    1234567888999999999999     4666655

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=5.5e-39  Score=329.67  Aligned_cols=264  Identities=23%  Similarity=0.290  Sum_probs=200.6

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccc-hhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEe
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR-QGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYD  338 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E  338 (586)
                      .++|+..+.||+|+||.||+|+...++..||||++..... .....+.+|+.++++++||||+++++++......++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            4689999999999999999999988889999999875432 233467889999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCC
Q 007869          339 YMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD  418 (586)
Q Consensus       339 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~  418 (586)
                      |++ ++|.+++.... ..+++..+..++.|++.||.|||+   .+|+||||||+|||+++++.+||+|||+++...... 
T Consensus        84 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-  157 (303)
T cd07869          84 YVH-TDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-  157 (303)
T ss_pred             CCC-cCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC-
Confidence            995 68888876542 457888899999999999999998   899999999999999999999999999998643222 


Q ss_pred             CceeeeccCCCccCcccccC-CCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCc--------cc
Q 007869          419 PQTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGE--------LL  489 (586)
Q Consensus       419 ~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~--------~~  489 (586)
                      .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......  ...+.+........        ..
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  235 (303)
T cd07869         158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ--DQLERIFLVLGTPNEDTWPGVHSL  235 (303)
T ss_pred             ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHH--HHHHHHHHHhCCCChhhccchhhc
Confidence            12234568999999999865 457889999999999999999999998643211  11111111000000        00


Q ss_pred             cccCCCCC---cccc-H------HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          490 EARDPNLG---TEYV-A------EELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       490 ~~~d~~l~---~~~~-~------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      ...++...   .... .      .....+.+++.+|++.||++|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         236 PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             cccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence            00000000   0000 0      01245678889999999999999999985

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.6e-39  Score=342.57  Aligned_cols=260  Identities=20%  Similarity=0.209  Sum_probs=200.3

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEec
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY  339 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  339 (586)
                      ..+|+..+.||+|+||.||++.+..+++.||+|....      ..+.+|++++++++||||+++++++......++|+|+
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~  164 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR  164 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence            3579999999999999999999999999999997532      3467899999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCC
Q 007869          340 MPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP  419 (586)
Q Consensus       340 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~  419 (586)
                      +. ++|.+++...  ..+++..++.++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++........
T Consensus       165 ~~-~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH~---~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~  238 (391)
T PHA03212        165 YK-TDLYCYLAAK--RNIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN  238 (391)
T ss_pred             CC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHhEEEcCCCCEEEEeCCccccccccccc
Confidence            94 7898888654  357888999999999999999998   89999999999999999999999999999754332222


Q ss_pred             ceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCcc----chhhHHHHhhhcc----------
Q 007869          420 QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSEN----LILVDWVFDFWNR----------  485 (586)
Q Consensus       420 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~----~~l~~~v~~~~~~----------  485 (586)
                      ......||+.|+|||++....++.++|||||||++|||++|+.|+......+.    ......+......          
T Consensus       239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~  318 (391)
T PHA03212        239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ  318 (391)
T ss_pred             ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence            33446799999999999988999999999999999999999988754321110    0000001000000          


Q ss_pred             Ccc---------ccccCCCCCcc--ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          486 GEL---------LEARDPNLGTE--YVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       486 ~~~---------~~~~d~~l~~~--~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      ..+         .....+.....  ........+.+++.+||+.||++|||++|+++
T Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence            000         00000110000  01123456788999999999999999999985

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-39  Score=351.28  Aligned_cols=260  Identities=22%  Similarity=0.308  Sum_probs=211.8

Q ss_pred             hhhhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccC-CCceeeeeee-eec----
Q 007869          256 LYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLR-HRNLVQLLGY-CRR----  329 (586)
Q Consensus       256 l~~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~~~-~~~----  329 (586)
                      +.+...+.++++.|.+|||+.||.+++...+..+|+|++-..+++..+...+||++|++|+ |||||.+++. ...    
T Consensus        32 ~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~  111 (738)
T KOG1989|consen   32 FTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSN  111 (738)
T ss_pred             EEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCC
Confidence            3455667788999999999999999998877899999998888888999999999999996 9999999993 221    


Q ss_pred             --cCeEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccc
Q 007869          330 --KGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDF  407 (586)
Q Consensus       330 --~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DF  407 (586)
                        .-+.+|.||||++|+|-+++.......|++.++++|+.|+++|+.+||. +..+|||||||-+||||+.+++.|||||
T Consensus       112 ~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCDF  190 (738)
T KOG1989|consen  112 NGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCDF  190 (738)
T ss_pred             CceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCcc
Confidence              2378999999999999999987655669999999999999999999997 4578999999999999999999999999


Q ss_pred             cceeeccCCCC-C-------ceeeeccCCCccCcccc---cCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhh
Q 007869          408 GLARLYDHGTD-P-------QTTHVVGTLGYLAPEHT---RTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILV  476 (586)
Q Consensus       408 Gla~~~~~~~~-~-------~~~~~~gt~~y~aPE~~---~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~  476 (586)
                      |.|...-.... .       ......-|+.|+|||++   .+...++|+|||+|||+||-|+....||+......     
T Consensus       191 GSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la-----  265 (738)
T KOG1989|consen  191 GSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA-----  265 (738)
T ss_pred             cccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee-----
Confidence            99974322221 0       01112459999999987   46678999999999999999999999998754321     


Q ss_pred             HHHHhhhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 007869          477 DWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER  535 (586)
Q Consensus       477 ~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  535 (586)
                                    .++-+..-.-.+.....+..|+..||++||.+||++-+|++.+-.
T Consensus       266 --------------Ilng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~  310 (738)
T KOG1989|consen  266 --------------ILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFE  310 (738)
T ss_pred             --------------EEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHH
Confidence                          111111111123556788889999999999999999999987754

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.6e-39  Score=329.07  Aligned_cols=258  Identities=24%  Similarity=0.450  Sum_probs=205.1

Q ss_pred             hhcCCcccceeEeecCceEEEEEEeCC-----CCeEEEEEEecccc-chhHHHHHHHHHHhcccCCCceeeeeeeeeccC
Q 007869          258 IATKGFREKELLGTGGFGRVYRGTLPK-----SQIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKG  331 (586)
Q Consensus       258 ~a~~~f~~~~~LG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~  331 (586)
                      .++++|+..+.||+|+||.||+|.+.+     .+..||||++.... .....++.+|+.++++++||||+++++++...+
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~   82 (277)
T cd05062           3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ   82 (277)
T ss_pred             ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            456789999999999999999998642     35679999986432 234567899999999999999999999999999


Q ss_pred             eEEEEEecCCCCChhhhhhcCC--------CccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeE
Q 007869          332 ELLLVYDYMPNGSLDKYLYDQP--------KVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGR  403 (586)
Q Consensus       332 ~~~lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~k  403 (586)
                      ..++||||+++++|.+++....        ...+++.+++.++.|+++||.|||+   .+++||||||+||++++++.+|
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~vH~dlkp~Nil~~~~~~~~  159 (277)
T cd05062          83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVK  159 (277)
T ss_pred             CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCcchheEEEcCCCCEE
Confidence            9999999999999999986532        1246788899999999999999998   8999999999999999999999


Q ss_pred             EccccceeeccCCCCC-ceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHh
Q 007869          404 LGDFGLARLYDHGTDP-QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFD  481 (586)
Q Consensus       404 L~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~  481 (586)
                      |+|||+++........ ......++..|+|||++.++.++.++|||||||++|||++ |..||......+   ..+.+  
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~---~~~~~--  234 (277)
T cd05062         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ---VLRFV--  234 (277)
T ss_pred             ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHH--
Confidence            9999999865432211 1122345788999999998899999999999999999999 788887543321   11111  


Q ss_pred             hhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 007869          482 FWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILE  534 (586)
Q Consensus       482 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  534 (586)
                        .++...     ..    .......+.+++.+|++.||++||++.|+++.|+
T Consensus       235 --~~~~~~-----~~----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         235 --MEGGLL-----DK----PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             --HcCCcC-----CC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence              111111     11    1122356788999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=5.1e-39  Score=338.67  Aligned_cols=204  Identities=25%  Similarity=0.345  Sum_probs=178.7

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc---chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEE
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY  337 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  337 (586)
                      ++|+..+.||+|+||+||++....++..||||++....   ......+..|+.++.+++|+||+++++.+.+.+.+++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            47888999999999999999999889999999997542   233456888999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCC
Q 007869          338 DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT  417 (586)
Q Consensus       338 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~  417 (586)
                      ||+++|+|.+++...  ..+++.+...++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++.+....
T Consensus        81 E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~  155 (363)
T cd05628          81 EFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH  155 (363)
T ss_pred             cCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence            999999999999765  368889999999999999999998   999999999999999999999999999997543211


Q ss_pred             C----------------------------------CceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCC
Q 007869          418 D----------------------------------PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRP  463 (586)
Q Consensus       418 ~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p  463 (586)
                      .                                  ......+||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P  235 (363)
T cd05628         156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP  235 (363)
T ss_pred             cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence            0                                  001235799999999999999999999999999999999999999


Q ss_pred             CCCCCC
Q 007869          464 IQRQGP  469 (586)
Q Consensus       464 ~~~~~~  469 (586)
                      |.....
T Consensus       236 f~~~~~  241 (363)
T cd05628         236 FCSETP  241 (363)
T ss_pred             CCCCCH
Confidence            986543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.4e-39  Score=339.44  Aligned_cols=261  Identities=28%  Similarity=0.417  Sum_probs=205.6

Q ss_pred             hcCCcccceeEeecCceEEEEEEeCC-----CCeEEEEEEecccc-chhHHHHHHHHHHhccc-CCCceeeeeeeeecc-
Q 007869          259 ATKGFREKELLGTGGFGRVYRGTLPK-----SQIEIAVKKISHES-RQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRK-  330 (586)
Q Consensus       259 a~~~f~~~~~LG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~-  330 (586)
                      ..++|++.+.||+|+||.||+|...+     ++..||+|++.... ....+.+..|++++.++ +|+||++++++|... 
T Consensus         5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~   84 (337)
T cd05054           5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG   84 (337)
T ss_pred             CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence            44578999999999999999997543     34689999987543 33446788899999999 899999999988654 


Q ss_pred             CeEEEEEecCCCCChhhhhhcCCC--------------------------------------------------------
Q 007869          331 GELLLVYDYMPNGSLDKYLYDQPK--------------------------------------------------------  354 (586)
Q Consensus       331 ~~~~lV~E~~~~gsL~~~l~~~~~--------------------------------------------------------  354 (586)
                      ..++++|||+++++|.+++.....                                                        
T Consensus        85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (337)
T cd05054          85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE  164 (337)
T ss_pred             CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence            568899999999999999864321                                                        


Q ss_pred             ---ccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCC-ceeeeccCCCc
Q 007869          355 ---VTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP-QTTHVVGTLGY  430 (586)
Q Consensus       355 ---~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y  430 (586)
                         ..++|..+..++.||+.||.|||+   .+|+||||||+|||+++++.+||+|||+++.+...... ......++..|
T Consensus       165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y  241 (337)
T cd05054         165 LYKEPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW  241 (337)
T ss_pred             HhhcCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence               268899999999999999999998   89999999999999999999999999999875432211 22234567889


Q ss_pred             cCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCccccHHHHHHHH
Q 007869          431 LAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVL  509 (586)
Q Consensus       431 ~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~  509 (586)
                      +|||++.+..++.++|||||||++|||++ |+.||......+.  +    ......+....  .       .......+.
T Consensus       242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~--~----~~~~~~~~~~~--~-------~~~~~~~~~  306 (337)
T cd05054         242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE--F----CRRLKEGTRMR--A-------PEYATPEIY  306 (337)
T ss_pred             cCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH--H----HHHHhccCCCC--C-------CccCCHHHH
Confidence            99999999999999999999999999998 9999976433221  1    11111111110  0       112235678


Q ss_pred             HHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 007869          510 KLGLLCSHSDPTARPSMRQVVQILERDV  537 (586)
Q Consensus       510 ~l~~~Cl~~dP~~RPs~~evl~~L~~~~  537 (586)
                      +++.+||+.+|++||++.|+++.|+...
T Consensus       307 ~l~~~cl~~~p~~RPs~~ell~~l~~~~  334 (337)
T cd05054         307 SIMLDCWHNNPEDRPTFSELVEILGDLL  334 (337)
T ss_pred             HHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            8999999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=2.1e-39  Score=324.43  Aligned_cols=252  Identities=32%  Similarity=0.477  Sum_probs=203.2

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEecC
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYM  340 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  340 (586)
                      ++|...+.||+|+||.||+|.+.+ +..+|+|.+..... ..++|.+|+.++++++||||+++++++...+..++||||+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM   81 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence            457788999999999999998854 44699999875432 3467999999999999999999999999988999999999


Q ss_pred             CCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCCc
Q 007869          341 PNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ  420 (586)
Q Consensus       341 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~  420 (586)
                      ++|+|.+++..... .+++.+++.++.|++.||.|||+   .+++|+||||+||++++++.+||+|||+++.........
T Consensus        82 ~~~~l~~~i~~~~~-~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~  157 (256)
T cd05113          82 SNGCLLNYLREHGK-RFQPSQLLEMCKDVCEGMAYLES---KQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS  157 (256)
T ss_pred             CCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence            99999999976533 68999999999999999999998   899999999999999999999999999998654332212


Q ss_pred             eeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCcc
Q 007869          421 TTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTE  499 (586)
Q Consensus       421 ~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~  499 (586)
                      .....++..|+|||++.+..++.++|||||||++|||++ |+.||......+   ..+.+    .++...  ..+.    
T Consensus       158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~~~----~~~~~~--~~~~----  224 (256)
T cd05113         158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE---TVEKV----SQGLRL--YRPH----  224 (256)
T ss_pred             cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHHHH----hcCCCC--CCCC----
Confidence            222345678999999988889999999999999999998 999987543321   11111    111110  0011    


Q ss_pred             ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 007869          500 YVAEELELVLKLGLLCSHSDPTARPSMRQVVQILE  534 (586)
Q Consensus       500 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  534 (586)
                         .....+.+++.+||+.+|.+||++.++++.|+
T Consensus       225 ---~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         225 ---LASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             ---CCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence               12356788999999999999999999998774

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=2.3e-39  Score=330.01  Aligned_cols=259  Identities=27%  Similarity=0.469  Sum_probs=209.1

Q ss_pred             cCCcccceeEeecCceEEEEEEeC-----CCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEE
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLP-----KSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELL  334 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~  334 (586)
                      .++|.+.+.||+|+||.||++...     .++..+|+|.+........+.+.+|++++++++||||+++++++...+..+
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   83 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence            457888999999999999999852     345679999997766666778999999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhhcCC-----------CccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeE
Q 007869          335 LVYDYMPNGSLDKYLYDQP-----------KVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGR  403 (586)
Q Consensus       335 lV~E~~~~gsL~~~l~~~~-----------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~k  403 (586)
                      +||||+++++|.+++....           ...+++.+++.++.|++.||.|||+   .+++||||||+|||+++++.+|
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~---~~i~H~dlkp~Nili~~~~~~k  160 (288)
T cd05093          84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVK  160 (288)
T ss_pred             EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccCcceEEEccCCcEE
Confidence            9999999999999997532           1358999999999999999999998   8999999999999999999999


Q ss_pred             EccccceeeccCCCC-CceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHh
Q 007869          404 LGDFGLARLYDHGTD-PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFD  481 (586)
Q Consensus       404 L~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~  481 (586)
                      |+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |+.||......+   ..+    
T Consensus       161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~---~~~----  233 (288)
T cd05093         161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---VIE----  233 (288)
T ss_pred             eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH----
Confidence            999999986533221 11223345788999999998899999999999999999998 899987544321   111    


Q ss_pred             hhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 007869          482 FWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERDV  537 (586)
Q Consensus       482 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  537 (586)
                      ...++...     .....    ....+.+++.+||+.||.+|||+.++++.|+...
T Consensus       234 ~i~~~~~~-----~~~~~----~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~  280 (288)
T cd05093         234 CITQGRVL-----QRPRT----CPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA  280 (288)
T ss_pred             HHHcCCcC-----CCCCC----CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence            11122211     11111    2245788999999999999999999999997643

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=7.4e-40  Score=323.54  Aligned_cols=261  Identities=25%  Similarity=0.357  Sum_probs=203.4

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccC-----eEEE
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKG-----ELLL  335 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~-----~~~l  335 (586)
                      -.|...+++|.|.||.||+|++..++..||||+.-.+.+-    -..|+++|++++|||||+|+-+|....     .+.|
T Consensus        24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl   99 (364)
T KOG0658|consen   24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL   99 (364)
T ss_pred             EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence            3567789999999999999999999999999999765432    246899999999999999999886432     4578


Q ss_pred             EEecCCCCChhhhhhcC--CCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCC-CCeEEccccceee
Q 007869          336 VYDYMPNGSLDKYLYDQ--PKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGE-LNGRLGDFGLARL  412 (586)
Q Consensus       336 V~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~-~~~kL~DFGla~~  412 (586)
                      ||||||. +|.+.++..  .+..++...+.-+..||.+||.|||+   .+|+||||||+|+|+|.+ +.+||||||.|+.
T Consensus       100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~---~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~  175 (364)
T KOG0658|consen  100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS---HGICHRDIKPQNLLVDPDTGVLKICDFGSAKV  175 (364)
T ss_pred             HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh---cCcccCCCChheEEEcCCCCeEEeccCCccee
Confidence            9999975 899988742  23456666777789999999999998   999999999999999976 8999999999998


Q ss_pred             ccCCCCCceeeeccCCCccCcccccCC-CCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccC-----
Q 007869          413 YDHGTDPQTTHVVGTLGYLAPEHTRTG-KATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRG-----  486 (586)
Q Consensus       413 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~-----  486 (586)
                      +..+..  .....-|..|+|||.+.+. .|+.+.||||.|||+.||+-|++-|.+.+..+++.++--+...-.+.     
T Consensus       176 L~~~ep--niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~m  253 (364)
T KOG0658|consen  176 LVKGEP--NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSM  253 (364)
T ss_pred             eccCCC--ceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhc
Confidence            876543  2445668999999998775 69999999999999999999999999877666554433222111111     


Q ss_pred             --ccccccCCCCCcc-----ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          487 --ELLEARDPNLGTE-----YVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       487 --~~~~~~d~~l~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                        ...+...|.+...     +........++++.++++.+|.+|.++.|++.
T Consensus       254 n~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  254 NPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             CcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence              1112222332211     23344567788999999999999999999985

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=4e-39  Score=335.13  Aligned_cols=252  Identities=23%  Similarity=0.290  Sum_probs=200.3

Q ss_pred             CcccceeEeecCceEEEEEEeC---CCCeEEEEEEecccc----chhHHHHHHHHHHhccc-CCCceeeeeeeeeccCeE
Q 007869          262 GFREKELLGTGGFGRVYRGTLP---KSQIEIAVKKISHES----RQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKGEL  333 (586)
Q Consensus       262 ~f~~~~~LG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~~~~  333 (586)
                      +|+..+.||+|+||.||+++..   .++..||+|++....    ....+.+..|++++.++ +||||+++++++...+..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            4788999999999999998863   467889999986532    22345678899999999 599999999999999999


Q ss_pred             EEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeec
Q 007869          334 LLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLY  413 (586)
Q Consensus       334 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~  413 (586)
                      ++||||+++|+|.+++...  ..+++.++..++.||++||.|||+   ++|+||||||+|||++.++.+||+|||+++..
T Consensus        81 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~  155 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEF  155 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence            9999999999999999765  358888999999999999999998   89999999999999999999999999999865


Q ss_pred             cCCCCCceeeeccCCCccCcccccCC-CCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCcccccc
Q 007869          414 DHGTDPQTTHVVGTLGYLAPEHTRTG-KATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEAR  492 (586)
Q Consensus       414 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~  492 (586)
                      ............||+.|+|||++.+. .++.++|||||||++|||++|+.||..........   .+.....      ..
T Consensus       156 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~---~~~~~~~------~~  226 (332)
T cd05614         156 LSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQS---EVSRRIL------KC  226 (332)
T ss_pred             cccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHH---HHHHHHh------cC
Confidence            44333334456799999999999765 47889999999999999999999997543322111   1111111      11


Q ss_pred             CCCCCccccHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 007869          493 DPNLGTEYVAEELELVLKLGLLCSHSDPTARP-----SMRQVVQ  531 (586)
Q Consensus       493 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~  531 (586)
                      ++.+...    ....+.+++.+||+.||++||     +++++++
T Consensus       227 ~~~~~~~----~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         227 DPPFPSF----IGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             CCCCCCC----CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence            2222222    234567788899999999999     6777765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=2e-39  Score=336.48  Aligned_cols=244  Identities=24%  Similarity=0.291  Sum_probs=198.0

Q ss_pred             eeEeecCceEEEEEEeCCCCeEEEEEEeccc---cchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEecCCCC
Q 007869          267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNG  343 (586)
Q Consensus       267 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~g  343 (586)
                      +.||+|+||.||++....++..||+|.+...   .......+..|++++.+++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999999889999999999754   2334566788999999999999999999999999999999999999


Q ss_pred             ChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCCceee
Q 007869          344 SLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTH  423 (586)
Q Consensus       344 sL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~  423 (586)
                      +|.+++...  ..+++.++..++.||+.||.|||+  ..+|+||||||+|||++.++.+||+|||+++...... .....
T Consensus        81 ~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~--~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~  155 (325)
T cd05594          81 ELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-ATMKT  155 (325)
T ss_pred             cHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC-ccccc
Confidence            999988655  368899999999999999999996  3689999999999999999999999999987533221 12234


Q ss_pred             eccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCccccHH
Q 007869          424 VVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAE  503 (586)
Q Consensus       424 ~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~  503 (586)
                      ..||+.|+|||++.+..++.++|||||||++|||++|+.||......+   +...+    ...      ...+...+   
T Consensus       156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~---~~~~i----~~~------~~~~p~~~---  219 (325)
T cd05594         156 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---LFELI----LME------EIRFPRTL---  219 (325)
T ss_pred             ccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHH---HHHHH----hcC------CCCCCCCC---
Confidence            579999999999999999999999999999999999999997643321   11111    011      11111112   


Q ss_pred             HHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 007869          504 ELELVLKLGLLCSHSDPTARP-----SMRQVVQI  532 (586)
Q Consensus       504 ~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~  532 (586)
                       ...+.+++.+||+.||++|+     ++.++++.
T Consensus       220 -~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         220 -SPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             -CHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence             24567888899999999996     89998753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=2.8e-39  Score=328.25  Aligned_cols=256  Identities=25%  Similarity=0.449  Sum_probs=203.7

Q ss_pred             CCcccceeEeecCceEEEEEEe----CCCCeEEEEEEeccc-cchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEE
Q 007869          261 KGFREKELLGTGGFGRVYRGTL----PKSQIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLL  335 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~----~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~l  335 (586)
                      ++|+..+.||+|+||.||+|..    ...+..||+|.+... ..+....+.+|++++++++||||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            4677889999999999999985    235578999999753 33445678999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhhcCC---------------CccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCC
Q 007869          336 VYDYMPNGSLDKYLYDQP---------------KVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGEL  400 (586)
Q Consensus       336 V~E~~~~gsL~~~l~~~~---------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~  400 (586)
                      ||||+++++|.+++....               ...+++.+.+.++.|++.||.|||+   ++++||||||+|||+++++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSS---HFFVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---cCeehhccccceEEEcCCC
Confidence            999999999999985331               2357889999999999999999998   8999999999999999999


Q ss_pred             CeEEccccceeeccCCCC-CceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHH
Q 007869          401 NGRLGDFGLARLYDHGTD-PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDW  478 (586)
Q Consensus       401 ~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~  478 (586)
                      .+||+|||+++....... .......++..|+|||++.+..++.++|||||||++|||++ |..||......+   +.+.
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~---~~~~  238 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE---VIEM  238 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH
Confidence            999999999986533221 11223345778999999988889999999999999999998 999987643211   1111


Q ss_pred             HHhhhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 007869          479 VFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER  535 (586)
Q Consensus       479 v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  535 (586)
                      +    ..+...     ..    .......+.+++.+|++.||++||++.++++.|..
T Consensus       239 ~----~~~~~~-----~~----~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         239 V----RKRQLL-----PC----SEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             H----HcCCcC-----CC----CCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            1    111111     11    11223457788899999999999999999998853

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=2.1e-39  Score=328.25  Aligned_cols=258  Identities=24%  Similarity=0.429  Sum_probs=206.0

Q ss_pred             hhcCCcccceeEeecCceEEEEEEeCC-----CCeEEEEEEecccc-chhHHHHHHHHHHhcccCCCceeeeeeeeeccC
Q 007869          258 IATKGFREKELLGTGGFGRVYRGTLPK-----SQIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKG  331 (586)
Q Consensus       258 ~a~~~f~~~~~LG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~  331 (586)
                      .++++|...+.||+|++|.||+|.+..     .+..||+|.+.... ......|..|+.++++++|+||+++++++.+.+
T Consensus         3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   82 (277)
T cd05036           3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL   82 (277)
T ss_pred             CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence            345789999999999999999999976     67889999886543 334567999999999999999999999999999


Q ss_pred             eEEEEEecCCCCChhhhhhcCCC-----ccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCC---CeE
Q 007869          332 ELLLVYDYMPNGSLDKYLYDQPK-----VTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGEL---NGR  403 (586)
Q Consensus       332 ~~~lV~E~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~---~~k  403 (586)
                      ..++||||+++++|.+++.....     ..++|.+++.++.||+.||.|||+   ++++||||||+||+++.++   .+|
T Consensus        83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~~~~~~k  159 (277)
T cd05036          83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAK  159 (277)
T ss_pred             CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccCCCcceE
Confidence            99999999999999999976431     358999999999999999999998   8999999999999998654   599


Q ss_pred             EccccceeeccCCCCC-ceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHh
Q 007869          404 LGDFGLARLYDHGTDP-QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFD  481 (586)
Q Consensus       404 L~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~  481 (586)
                      |+|||+++........ .......+..|+|||++.+..++.++|||||||++|||++ |+.||......+   +.+.+  
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~---~~~~~--  234 (277)
T cd05036         160 IADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE---VMEFV--  234 (277)
T ss_pred             eccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHH--
Confidence            9999999875322111 1112234568999999998999999999999999999997 999997644322   11111  


Q ss_pred             hhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 007869          482 FWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILE  534 (586)
Q Consensus       482 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  534 (586)
                       .....      +    .........+.+++.+|++.+|++||++.+|++.|+
T Consensus       235 -~~~~~------~----~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         235 -TGGGR------L----DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             -HcCCc------C----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence             11111      0    111122356788999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=4.5e-39  Score=339.89  Aligned_cols=263  Identities=23%  Similarity=0.259  Sum_probs=206.5

Q ss_pred             chhhhhhhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc---cchhHHHHHHHHHHhcccCCCceeeeeeeee
Q 007869          252 RYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCR  328 (586)
Q Consensus       252 ~~~el~~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~  328 (586)
                      .++++....++|+..+.||+|+||.||++.+..++..+|+|++...   .....+.+.+|+.+++.++||||+++++++.
T Consensus        34 ~~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~  113 (371)
T cd05622          34 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ  113 (371)
T ss_pred             HHhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence            4566777889999999999999999999999999999999998643   2233456788999999999999999999999


Q ss_pred             ccCeEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEcccc
Q 007869          329 RKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFG  408 (586)
Q Consensus       329 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFG  408 (586)
                      ..+..++||||+++|+|.+++...   .++...+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||
T Consensus       114 ~~~~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NIll~~~~~ikL~DfG  187 (371)
T cd05622         114 DDRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFG  187 (371)
T ss_pred             cCCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHEEECCCCCEEEEeCC
Confidence            999999999999999999998654   46777888899999999999998   999999999999999999999999999


Q ss_pred             ceeeccCCCCCceeeeccCCCccCcccccCC----CCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhc
Q 007869          409 LARLYDHGTDPQTTHVVGTLGYLAPEHTRTG----KATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWN  484 (586)
Q Consensus       409 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~  484 (586)
                      +++..............||+.|+|||++...    .++.++|||||||++|||++|+.||.......      .......
T Consensus       188 ~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~------~~~~i~~  261 (371)
T cd05622         188 TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG------TYSKIMN  261 (371)
T ss_pred             ceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHH------HHHHHHc
Confidence            9987654333233456799999999998654    37899999999999999999999998643311      1111111


Q ss_pred             cCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHHH
Q 007869          485 RGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTA--RPSMRQVVQIL  533 (586)
Q Consensus       485 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~L  533 (586)
                      ........+       .......+.+++..|+..++.+  ||++.++++..
T Consensus       262 ~~~~~~~~~-------~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~  305 (371)
T cd05622         262 HKNSLTFPD-------DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  305 (371)
T ss_pred             CCCcccCCC-------cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence            111111111       1122344667777888744433  78999988753

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=7.3e-39  Score=332.91  Aligned_cols=249  Identities=24%  Similarity=0.326  Sum_probs=197.7

Q ss_pred             eeEeecCceEEEEEEeCCCCeEEEEEEeccc---cchhHHHHHHHHHHhccc-CCCceeeeeeeeeccCeEEEEEecCCC
Q 007869          267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHE---SRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKGELLLVYDYMPN  342 (586)
Q Consensus       267 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~lV~E~~~~  342 (586)
                      +.||+|+||.||++++..++..||+|++...   .....+.+..|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            4699999999999999999999999999754   233445678899888877 899999999999999999999999999


Q ss_pred             CChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCCcee
Q 007869          343 GSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTT  422 (586)
Q Consensus       343 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~  422 (586)
                      |+|..++...  ..+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++...... ....
T Consensus        81 ~~L~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-~~~~  154 (329)
T cd05618          81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DTTS  154 (329)
T ss_pred             CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-Cccc
Confidence            9999988655  368888999999999999999998   899999999999999999999999999997532211 1233


Q ss_pred             eeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCc--cchhhHHHHhhhccCccccccCCCCCccc
Q 007869          423 HVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSE--NLILVDWVFDFWNRGELLEARDPNLGTEY  500 (586)
Q Consensus       423 ~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~--~~~l~~~v~~~~~~~~~~~~~d~~l~~~~  500 (586)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||.......  .....+++.+.......      .+    
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~------~~----  224 (329)
T cd05618         155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI------RI----  224 (329)
T ss_pred             cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC------CC----
Confidence            4679999999999999999999999999999999999999996422211  11122333332222111      11    


Q ss_pred             cHHHHHHHHHHHHHhcccCCCCCCC------HHHHHH
Q 007869          501 VAEELELVLKLGLLCSHSDPTARPS------MRQVVQ  531 (586)
Q Consensus       501 ~~~~~~~l~~l~~~Cl~~dP~~RPs------~~evl~  531 (586)
                      +......+.+++.+||+.||++||+      +.++++
T Consensus       225 p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05618         225 PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG  261 (329)
T ss_pred             CCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhc
Confidence            1122345678888999999999998      466653

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=7.5e-39  Score=332.82  Aligned_cols=249  Identities=24%  Similarity=0.321  Sum_probs=199.0

Q ss_pred             eeEeecCceEEEEEEeCCCCeEEEEEEeccc---cchhHHHHHHHHHHhccc-CCCceeeeeeeeeccCeEEEEEecCCC
Q 007869          267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHE---SRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKGELLLVYDYMPN  342 (586)
Q Consensus       267 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~lV~E~~~~  342 (586)
                      ++||+|+||.||++.+..++..||+|++...   .....+.+..|..++.++ +||||+++++++...+.+++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            4699999999999999999999999999754   223445688899999988 799999999999999999999999999


Q ss_pred             CChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCCcee
Q 007869          343 GSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTT  422 (586)
Q Consensus       343 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~  422 (586)
                      |+|.+++...  ..+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++...... ....
T Consensus        81 g~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~~~  154 (329)
T cd05588          81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DTTS  154 (329)
T ss_pred             CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEECcCccccccccCC-Cccc
Confidence            9999988654  368999999999999999999998   899999999999999999999999999987532211 2233


Q ss_pred             eeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCc--cchhhHHHHhhhccCccccccCCCCCccc
Q 007869          423 HVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSE--NLILVDWVFDFWNRGELLEARDPNLGTEY  500 (586)
Q Consensus       423 ~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~--~~~l~~~v~~~~~~~~~~~~~d~~l~~~~  500 (586)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||......+  .....++..+.......      .+... 
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~------~~p~~-  227 (329)
T cd05588         155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI------RIPRS-  227 (329)
T ss_pred             cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC------CCCCC-
Confidence            4679999999999999999999999999999999999999997432221  11122333332222211      11111 


Q ss_pred             cHHHHHHHHHHHHHhcccCCCCCCC------HHHHHH
Q 007869          501 VAEELELVLKLGLLCSHSDPTARPS------MRQVVQ  531 (586)
Q Consensus       501 ~~~~~~~l~~l~~~Cl~~dP~~RPs------~~evl~  531 (586)
                         ....+.+++.+|++.||.+||+      +.++++
T Consensus       228 ---~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05588         228 ---LSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS  261 (329)
T ss_pred             ---CCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence               2245678888999999999997      667764

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.2e-39  Score=316.58  Aligned_cols=266  Identities=23%  Similarity=0.270  Sum_probs=208.1

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccch-h-HHHHHHHHHHhcccCCCceeeeeeeeec--cCeEEEE
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQ-G-MKEFVAEIVSIGRLRHRNLVQLLGYCRR--KGELLLV  336 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~-~~~~~~Ei~~l~~l~H~niv~l~~~~~~--~~~~~lV  336 (586)
                      ++|+..+.|++|.||.||+|+++.++..||+|+++.+... + --.-++||.+|.+++|||||.+..+...  -+..|+|
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V  155 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV  155 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence            4688889999999999999999999999999999765321 1 1245899999999999999999987764  3679999


Q ss_pred             EecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCC
Q 007869          337 YDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHG  416 (586)
Q Consensus       337 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~  416 (586)
                      ||||+. +|..++..-+ .++...+...+..|+++|++|||.   .-|+|||||++|+|++..|.+||+||||||.+...
T Consensus       156 Me~~Eh-DLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~---~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp  230 (419)
T KOG0663|consen  156 MEYVEH-DLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHD---NWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP  230 (419)
T ss_pred             HHHHHh-hHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhh---ceeEecccchhheeeccCCcEEecccchhhhhcCC
Confidence            999965 8999887664 567888889999999999999998   88999999999999999999999999999988765


Q ss_pred             CCCceeeeccCCCccCcccccCC-CCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHH--------HHhhhccCc
Q 007869          417 TDPQTTHVVGTLGYLAPEHTRTG-KATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDW--------VFDFWNRGE  487 (586)
Q Consensus       417 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~--------v~~~~~~~~  487 (586)
                      .. ..+..+-|.+|+|||.+.+. .|++..|+||+||++.||+++++-|.+....+++..+-.        .|..+..-.
T Consensus       231 ~k-~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp  309 (419)
T KOG0663|consen  231 LK-PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELP  309 (419)
T ss_pred             cc-cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccc
Confidence            33 35667789999999998765 589999999999999999999999998776655433211        121111111


Q ss_pred             cc------cccCCCCCccccHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          488 LL------EARDPNLGTEYVAE-ELELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       488 ~~------~~~d~~l~~~~~~~-~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                      ..      +.....+...|... ..+.-.+|+...+..||.+|.|+.|.++.
T Consensus       310 ~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h  361 (419)
T KOG0663|consen  310 AVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH  361 (419)
T ss_pred             hhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence            11      11111122222221 22455677777889999999999999863

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.4e-39  Score=323.78  Aligned_cols=251  Identities=28%  Similarity=0.434  Sum_probs=201.9

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEecC
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYM  340 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  340 (586)
                      .+|+..+.||+|+||.||+|.+.. +..+|+|.+..... ...+|.+|++++++++||||+++++++...+..++||||+
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~-~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRG-KIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYM   81 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecC-CccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecC
Confidence            457788999999999999999864 55799999864332 3457889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCCc
Q 007869          341 PNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ  420 (586)
Q Consensus       341 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~  420 (586)
                      ++++|.+++..... .+++..++.++.|++.||.|||+   .+++||||||+||++++++.+||+|||+++.........
T Consensus        82 ~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~  157 (256)
T cd05059          82 ANGCLLNYLRERKG-KLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS  157 (256)
T ss_pred             CCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence            99999999976543 68999999999999999999998   899999999999999999999999999998654322111


Q ss_pred             eeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCcc
Q 007869          421 TTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTE  499 (586)
Q Consensus       421 ~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~  499 (586)
                      .....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+   ....+    ..+     ..+..   
T Consensus       158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~----~~~-----~~~~~---  222 (256)
T cd05059         158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE---VVESV----SAG-----YRLYR---  222 (256)
T ss_pred             cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH---HHHHH----HcC-----CcCCC---
Confidence            122234568999999998899999999999999999999 899987543322   11111    111     01111   


Q ss_pred             ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 007869          500 YVAEELELVLKLGLLCSHSDPTARPSMRQVVQIL  533 (586)
Q Consensus       500 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L  533 (586)
                       .......+.+++.+||+.+|++|||+.|+++.|
T Consensus       223 -~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         223 -PKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             -CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence             112345688999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=2.6e-39  Score=322.43  Aligned_cols=248  Identities=27%  Similarity=0.419  Sum_probs=198.9

Q ss_pred             eeEeecCceEEEEEEeCCCCeEEEEEEecccc-chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEecCCCCCh
Q 007869          267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSL  345 (586)
Q Consensus       267 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL  345 (586)
                      +.||+|+||.||+|++..++..+|+|.+.... ......+.+|++++++++||||++++++|...+..++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            36999999999999998888999999886543 34456799999999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCCce-eee
Q 007869          346 DKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQT-THV  424 (586)
Q Consensus       346 ~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~-~~~  424 (586)
                      .+++.... ..+++..++.++.|+++||.|||+   .+++||||||+|||++.++.+||+|||+++.......... ...
T Consensus        81 ~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  156 (252)
T cd05084          81 LTFLRTEG-PRLKVKELIQMVENAAAGMEYLES---KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK  156 (252)
T ss_pred             HHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence            99996542 358899999999999999999998   8999999999999999999999999999886443211111 111


Q ss_pred             ccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCccccHH
Q 007869          425 VGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAE  503 (586)
Q Consensus       425 ~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~  503 (586)
                      ..+..|+|||.+.++.++.++|||||||++|||++ |..||......+   ..    .....+.     .+    .....
T Consensus       157 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~---~~----~~~~~~~-----~~----~~~~~  220 (252)
T cd05084         157 QIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ---TR----EAIEQGV-----RL----PCPEL  220 (252)
T ss_pred             CCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH---HH----HHHHcCC-----CC----CCccc
Confidence            23457999999998899999999999999999998 888886543211   11    1111110     00    11112


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 007869          504 ELELVLKLGLLCSHSDPTARPSMRQVVQILE  534 (586)
Q Consensus       504 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  534 (586)
                      ....+.+++.+|++.+|++||++.++++.|+
T Consensus       221 ~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         221 CPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             CCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            2456788999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.5e-39  Score=321.32  Aligned_cols=252  Identities=25%  Similarity=0.384  Sum_probs=204.7

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc-----chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEE
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES-----RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLL  335 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~l  335 (586)
                      ++|...+.||+|++|.||++....++..+|+|.+....     ....+.+.+|++++++++||||+++++++...+..++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            57899999999999999999998889999999986432     2234578899999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccC
Q 007869          336 VYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH  415 (586)
Q Consensus       336 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~  415 (586)
                      |+||+++++|.+++....  .+++.....++.|++.||.|||+   .+|+||||||+||++++++++||+|||+++....
T Consensus        82 v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~  156 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYG--ALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT  156 (263)
T ss_pred             EEEECCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence            999999999999987653  57888889999999999999998   8999999999999999999999999999986543


Q ss_pred             CCCCce--eeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccC
Q 007869          416 GTDPQT--THVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARD  493 (586)
Q Consensus       416 ~~~~~~--~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d  493 (586)
                      ......  ....|+..|+|||++.+..++.++||||||+++|||++|+.||......+   .....   ....     ..
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~~~~---~~~~-----~~  225 (263)
T cd06625         157 ICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA---AIFKI---ATQP-----TN  225 (263)
T ss_pred             cccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHH---HHHHH---hccC-----CC
Confidence            221111  23467889999999999889999999999999999999999997543221   11110   0000     11


Q ss_pred             CCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          494 PNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       494 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                      +.    ........+.+++..||+.+|.+||++.++++.
T Consensus       226 ~~----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         226 PQ----LPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             CC----CCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence            11    122233557788899999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2e-39  Score=339.22  Aligned_cols=246  Identities=26%  Similarity=0.341  Sum_probs=207.0

Q ss_pred             cccceeEeecCceEEEEEEeCCCCeEEEEEEecccc---chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEec
Q 007869          263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY  339 (586)
Q Consensus       263 f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  339 (586)
                      |+..+.||+|+.|.|-.|++..+|+.+|||.+.+..   ......+.+|+-+|+-++|||+++|++.++++.++|||.||
T Consensus        14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy   93 (786)
T KOG0588|consen   14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY   93 (786)
T ss_pred             eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence            556788999999999999999999999999997652   22335578999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCC
Q 007869          340 MPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP  419 (586)
Q Consensus       340 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~  419 (586)
                      +++|-|.+++..+  +++++.+..++++||+.|+.|+|.   .+|+||||||+|+|||.++++||+|||+|.+-..+.  
T Consensus        94 v~gGELFdylv~k--G~l~e~eaa~ff~QIi~gv~yCH~---~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk--  166 (786)
T KOG0588|consen   94 VPGGELFDYLVRK--GPLPEREAAHFFRQILDGVSYCHA---FNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK--  166 (786)
T ss_pred             cCCchhHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHhh---hcceeccCCchhhhhhcccCEeeeccceeecccCCc--
Confidence            9999999999776  468888999999999999999998   899999999999999999999999999998754332  


Q ss_pred             ceeeeccCCCccCcccccCCCCC-CcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCc
Q 007869          420 QTTHVVGTLGYLAPEHTRTGKAT-TSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGT  498 (586)
Q Consensus       420 ~~~~~~gt~~y~aPE~~~~~~~s-~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~  498 (586)
                      ...+.+|.+.|.+||++.+.+|. .++||||+||+||.|++|+.||++++..   .|    ....++|....        
T Consensus       167 lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir---~L----LlKV~~G~f~M--------  231 (786)
T KOG0588|consen  167 LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIR---VL----LLKVQRGVFEM--------  231 (786)
T ss_pred             cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHH---HH----HHHHHcCcccC--------
Confidence            44567999999999999999984 6899999999999999999999854321   12    22233443321        


Q ss_pred             cccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          499 EYVAEELELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       499 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                        +.....+..+|+.+|+..||++|-|++||++.
T Consensus       232 --Ps~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH  263 (786)
T KOG0588|consen  232 --PSNISSEAQDLLRRMLDVDPSTRITTEEILKH  263 (786)
T ss_pred             --CCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence              11223456677788999999999999999974

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.1e-38  Score=320.59  Aligned_cols=259  Identities=25%  Similarity=0.381  Sum_probs=209.8

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc---cchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEE
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY  337 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  337 (586)
                      ++|+..+.||+|+||.||+|+...++..||||.+...   .......+.+|++++++++||||+++++++...+..++|+
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            5788999999999999999999888999999987542   2334467899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcC--CCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccC
Q 007869          338 DYMPNGSLDKYLYDQ--PKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH  415 (586)
Q Consensus       338 E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~  415 (586)
                      ||+++++|.+++...  ....+++...+.++.|+++||.|||+   .+++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            999999999988542  22457888999999999999999998   8999999999999999999999999999987643


Q ss_pred             CCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCC
Q 007869          416 GTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPN  495 (586)
Q Consensus       416 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~  495 (586)
                      ... ......|++.|+|||.+.+..++.++|+||||+++|||++|+.||......    ..++... ...     ...+.
T Consensus       159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~----~~~~~~~-~~~-----~~~~~  227 (267)
T cd08228         159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LFSLCQK-IEQ-----CDYPP  227 (267)
T ss_pred             hhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc----HHHHHHH-Hhc-----CCCCC
Confidence            321 122346889999999998888999999999999999999999998654321    1111111 111     11111


Q ss_pred             CCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 007869          496 LGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERD  536 (586)
Q Consensus       496 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  536 (586)
                      ..   .......+.+++.+||+.+|++||++.+|++.|++.
T Consensus       228 ~~---~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         228 LP---TEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             CC---hhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence            11   122345678889999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=4.6e-39  Score=323.72  Aligned_cols=258  Identities=29%  Similarity=0.518  Sum_probs=207.0

Q ss_pred             hcCCcccceeEeecCceEEEEEEeCCCC---eEEEEEEeccc-cchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEE
Q 007869          259 ATKGFREKELLGTGGFGRVYRGTLPKSQ---IEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELL  334 (586)
Q Consensus       259 a~~~f~~~~~LG~G~~g~Vy~~~~~~~~---~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~  334 (586)
                      .+++|+..+.||+|+||.||+|++..++   ..+|+|.+... .....+.+.+|++++++++|+|++++++++...+..+
T Consensus         3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (268)
T cd05063           3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAM   82 (268)
T ss_pred             ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcE
Confidence            3457888999999999999999986544   36999998755 2344567999999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeecc
Q 007869          335 LVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYD  414 (586)
Q Consensus       335 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~  414 (586)
                      +||||+++++|.+++.... ..+++.++..++.|++.||.|||+   .+++||||||+||++++++.+||+|||++....
T Consensus        83 lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~  158 (268)
T cd05063          83 IITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLE  158 (268)
T ss_pred             EEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEEcCCCcEEECCCccceecc
Confidence            9999999999999997643 468999999999999999999998   899999999999999999999999999998765


Q ss_pred             CCCCCcee--eeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccCccccc
Q 007869          415 HGTDPQTT--HVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEA  491 (586)
Q Consensus       415 ~~~~~~~~--~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~  491 (586)
                      ........  ....+..|+|||++....++.++|||||||++|||++ |+.||......+      +... ...+.    
T Consensus       159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~------~~~~-i~~~~----  227 (268)
T cd05063         159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE------VMKA-INDGF----  227 (268)
T ss_pred             cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH------HHHH-HhcCC----
Confidence            43222111  1223457999999988889999999999999999997 999996543221      1111 11110    


Q ss_pred             cCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 007869          492 RDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERD  536 (586)
Q Consensus       492 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  536 (586)
                      ..|.     .......+.+++.+|++.+|++||++.++++.|++.
T Consensus       228 ~~~~-----~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         228 RLPA-----PMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             CCCC-----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            1111     112335678999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1e-38  Score=330.87  Aligned_cols=238  Identities=26%  Similarity=0.285  Sum_probs=190.5

Q ss_pred             eeEeecCceEEEEEEeCCCCeEEEEEEecccc---chhHHHHHHHHH-HhcccCCCceeeeeeeeeccCeEEEEEecCCC
Q 007869          267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHES---RQGMKEFVAEIV-SIGRLRHRNLVQLLGYCRRKGELLLVYDYMPN  342 (586)
Q Consensus       267 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~-~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~  342 (586)
                      +.||+|+||+||+|++..++..||+|++....   ....+++..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46999999999999999899999999997542   222344555554 46778999999999999999999999999999


Q ss_pred             CChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCCcee
Q 007869          343 GSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTT  422 (586)
Q Consensus       343 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~  422 (586)
                      |+|.+++...  ..+++.....++.||++||.|||+   ++|+||||||+|||++.++.+||+|||+++..... .....
T Consensus        81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~~  154 (323)
T cd05575          81 GELFFHLQRE--RSFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH-SKTTS  154 (323)
T ss_pred             CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccC-CCccc
Confidence            9999998765  357888899999999999999998   89999999999999999999999999998753221 12234


Q ss_pred             eeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCccccH
Q 007869          423 HVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVA  502 (586)
Q Consensus       423 ~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~  502 (586)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||......+      ...... .+.      ..+...   
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~------~~~~i~-~~~------~~~~~~---  218 (323)
T cd05575         155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE------MYDNIL-NKP------LRLKPN---  218 (323)
T ss_pred             cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH------HHHHHH-cCC------CCCCCC---
Confidence            4579999999999999999999999999999999999999997643221      111111 111      111111   


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCHH
Q 007869          503 EELELVLKLGLLCSHSDPTARPSMR  527 (586)
Q Consensus       503 ~~~~~l~~l~~~Cl~~dP~~RPs~~  527 (586)
                       ....+.+++.+|++.||.+||+++
T Consensus       219 -~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         219 -ISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             -CCHHHHHHHHHHhhcCHHhCCCCC
Confidence             234567888899999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=3.3e-39  Score=331.83  Aligned_cols=255  Identities=24%  Similarity=0.327  Sum_probs=207.0

Q ss_pred             hhhhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc---chhHHHHHHHHHHhcccCCCceeeeeeeeeccCe
Q 007869          256 LYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGE  332 (586)
Q Consensus       256 l~~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~  332 (586)
                      .+...++|+....||+|+||.||+|+-+.+|..+|+|++++..   ....+..+.|-.+|...++|+||+|+..|.+...
T Consensus       136 ~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~  215 (550)
T KOG0605|consen  136 TRLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEY  215 (550)
T ss_pred             ccCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCe
Confidence            3557788999999999999999999999999999999998753   4456778899999999999999999999999999


Q ss_pred             EEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceee
Q 007869          333 LLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARL  412 (586)
Q Consensus       333 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~  412 (586)
                      +||||||++||++..+|.+..  .|++.....++.+++.|+.-||+   .++|||||||+|+|||..|++||+||||+.-
T Consensus       216 LYLiMEylPGGD~mTLL~~~~--~L~e~~arfYiaE~vlAI~~iH~---~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~g  290 (550)
T KOG0605|consen  216 LYLIMEYLPGGDMMTLLMRKD--TLTEDWARFYIAETVLAIESIHQ---LGYIHRDIKPDNLLIDAKGHIKLSDFGLSTG  290 (550)
T ss_pred             eEEEEEecCCccHHHHHHhcC--cCchHHHHHHHHHHHHHHHHHHH---cCcccccCChhheeecCCCCEeeccccccch
Confidence            999999999999999998764  56777777789999999999998   9999999999999999999999999999953


Q ss_pred             ccC---------------C-------CCC-----ce-------------------eeeccCCCccCcccccCCCCCCcce
Q 007869          413 YDH---------------G-------TDP-----QT-------------------THVVGTLGYLAPEHTRTGKATTSAD  446 (586)
Q Consensus       413 ~~~---------------~-------~~~-----~~-------------------~~~~gt~~y~aPE~~~~~~~s~ksD  446 (586)
                      +..               .       ...     ..                   ...+|||.|||||++.+..|+..+|
T Consensus       291 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cD  370 (550)
T KOG0605|consen  291 LDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECD  370 (550)
T ss_pred             hhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcccc
Confidence            211               0       000     00                   1247999999999999999999999


Q ss_pred             EEehhHHHHHHHhCCCCCCCCCCCccc-hhhHHHHhhhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCC
Q 007869          447 VFSFGAFLLEVACGRRPIQRQGPSENL-ILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPS  525 (586)
Q Consensus       447 VyS~Gvvl~ElltG~~p~~~~~~~~~~-~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs  525 (586)
                      .|||||++||||.|-+||...++.+.. .+..|...      +....+..        ...+..+|+.+|+. ||++|.-
T Consensus       371 wWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~------l~fP~~~~--------~s~eA~DLI~rll~-d~~~RLG  435 (550)
T KOG0605|consen  371 WWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRET------LKFPEEVD--------LSDEAKDLITRLLC-DPENRLG  435 (550)
T ss_pred             HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhh------ccCCCcCc--------ccHHHHHHHHHHhc-CHHHhcC
Confidence            999999999999999999988775433 23333211      11111111        11556677778888 9999976


Q ss_pred             ---HHHHH
Q 007869          526 ---MRQVV  530 (586)
Q Consensus       526 ---~~evl  530 (586)
                         +.||.
T Consensus       436 ~~G~~EIK  443 (550)
T KOG0605|consen  436 SKGAEEIK  443 (550)
T ss_pred             cccHHHHh
Confidence               55554

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=6.7e-39  Score=340.06  Aligned_cols=203  Identities=27%  Similarity=0.351  Sum_probs=176.1

Q ss_pred             CcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc---chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEe
Q 007869          262 GFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYD  338 (586)
Q Consensus       262 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E  338 (586)
                      .|+..+.||+|+||.||+|+...++..||+|++....   ....+.+.+|++++++++||||+++++.+...+.+++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            5888999999999999999999999999999987542   2345678899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCC-
Q 007869          339 YMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT-  417 (586)
Q Consensus       339 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~-  417 (586)
                      |+++|+|.+++.+.  ..+++.....++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.+.... 
T Consensus        82 ~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~  156 (382)
T cd05625          82 YIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD  156 (382)
T ss_pred             CCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence            99999999999765  357788888899999999999998   899999999999999999999999999985321100 


Q ss_pred             ---------------------------------------------CCceeeeccCCCccCcccccCCCCCCcceEEehhH
Q 007869          418 ---------------------------------------------DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGA  452 (586)
Q Consensus       418 ---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gv  452 (586)
                                                                   .......+||+.|+|||++.+..++.++|||||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv  236 (382)
T cd05625         157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV  236 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence                                                         00012347999999999999999999999999999


Q ss_pred             HHHHHHhCCCCCCCCCC
Q 007869          453 FLLEVACGRRPIQRQGP  469 (586)
Q Consensus       453 vl~ElltG~~p~~~~~~  469 (586)
                      ++|||++|+.||....+
T Consensus       237 il~elltG~~Pf~~~~~  253 (382)
T cd05625         237 ILYEMLVGQPPFLAQTP  253 (382)
T ss_pred             HHHHHHhCCCCCCCCCH
Confidence            99999999999986543

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=5.5e-39  Score=331.92  Aligned_cols=241  Identities=24%  Similarity=0.354  Sum_probs=192.7

Q ss_pred             eeEeecCceEEEEEEeCCCCeEEEEEEecccc---chhHHHHHHHHHHhccc-CCCceeeeeeeeeccCeEEEEEecCCC
Q 007869          267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHES---RQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKGELLLVYDYMPN  342 (586)
Q Consensus       267 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~lV~E~~~~  342 (586)
                      +.||+|+||.||+|++..++..||||++....   ....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999999889999999997542   23344556677777654 899999999999999999999999999


Q ss_pred             CChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCCcee
Q 007869          343 GSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTT  422 (586)
Q Consensus       343 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~  422 (586)
                      |+|.+++....  .+++.+...++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++...... ....
T Consensus        81 g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~  154 (316)
T cd05592          81 GDLMFHIQSSG--RFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKAS  154 (316)
T ss_pred             CcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cccc
Confidence            99999987653  57888889999999999999998   899999999999999999999999999998643322 2334


Q ss_pred             eeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCccccH
Q 007869          423 HVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVA  502 (586)
Q Consensus       423 ~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~  502 (586)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||......+   +.   .... .      ..+.+..    
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~---~~---~~i~-~------~~~~~~~----  217 (316)
T cd05592         155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE---LF---DSIL-N------DRPHFPR----  217 (316)
T ss_pred             cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH---HH---HHHH-c------CCCCCCC----
Confidence            4679999999999998899999999999999999999999997654321   11   1111 1      0111111    


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 007869          503 EELELVLKLGLLCSHSDPTARPSMR-QVV  530 (586)
Q Consensus       503 ~~~~~l~~l~~~Cl~~dP~~RPs~~-evl  530 (586)
                      .....+.+++.+||+.||.+||++. +++
T Consensus       218 ~~~~~~~~ll~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05592         218 WISKEAKDCLSKLFERDPTKRLGVDGDIR  246 (316)
T ss_pred             CCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            1224466788899999999999976 454

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=2.8e-39  Score=353.01  Aligned_cols=259  Identities=25%  Similarity=0.333  Sum_probs=207.8

Q ss_pred             hhhhhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc--cchhHHHHHHHHHHhcccCCCceeeeeeeeeccC-
Q 007869          255 DLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKG-  331 (586)
Q Consensus       255 el~~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~-  331 (586)
                      +.....++|...+.||+|+||.||+++...++..||||++...  .......+.+|+..+..++|+|+++++..+...+ 
T Consensus        26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~  105 (496)
T PTZ00283         26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP  105 (496)
T ss_pred             cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence            3445667999999999999999999999888999999998654  3344567889999999999999999988765332 


Q ss_pred             -------eEEEEEecCCCCChhhhhhcCC--CccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCe
Q 007869          332 -------ELLLVYDYMPNGSLDKYLYDQP--KVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNG  402 (586)
Q Consensus       332 -------~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~  402 (586)
                             .+++||||+++|+|.+++....  ...+++.....++.|++.||.|||+   ++|+||||||+|||++.++.+
T Consensus       106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~---~~IiHrDLKP~NILl~~~~~v  182 (496)
T PTZ00283        106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSANILLCSNGLV  182 (496)
T ss_pred             cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEeCCCCE
Confidence                   3689999999999999997532  2468888999999999999999998   899999999999999999999


Q ss_pred             EEccccceeeccCCCC-CceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHh
Q 007869          403 RLGDFGLARLYDHGTD-PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFD  481 (586)
Q Consensus       403 kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~  481 (586)
                      ||+|||+++.+..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......      +.+..
T Consensus       183 kL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~------~~~~~  256 (496)
T PTZ00283        183 KLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME------EVMHK  256 (496)
T ss_pred             EEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH------HHHHH
Confidence            9999999987643321 1233467999999999999999999999999999999999999999754321      11111


Q ss_pred             hhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          482 FWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       482 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                      . ..+..    ++ +    .......+.+++.+||+.||.+||++.++++.
T Consensus       257 ~-~~~~~----~~-~----~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        257 T-LAGRY----DP-L----PPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             H-hcCCC----CC-C----CCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            1 11111    11 1    11223557788999999999999999999763

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=5e-39  Score=326.05  Aligned_cols=256  Identities=28%  Similarity=0.448  Sum_probs=203.2

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCe----EEEEEEecccc-chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEE
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQI----EIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLL  335 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~l  335 (586)
                      ++|+..+.||+|+||.||+|++..++.    .+++|.+.... .....++..|+..+++++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence            467788999999999999999866554    47888875442 3345678889999999999999999998864 45789


Q ss_pred             EEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccC
Q 007869          336 VYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH  415 (586)
Q Consensus       336 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~  415 (586)
                      ++||+++|+|.+++.... ..+++...+.++.||+.||.|||+   ++++||||||+|||+++++.+||+|||+++....
T Consensus        86 i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~  161 (279)
T cd05111          86 VTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEE---HRMVHRNLAARNILLKSDSIVQIADFGVADLLYP  161 (279)
T ss_pred             EEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence            999999999999997653 468999999999999999999998   8999999999999999999999999999987543


Q ss_pred             CCCC-ceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccCccccccC
Q 007869          416 GTDP-QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEARD  493 (586)
Q Consensus       416 ~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d  493 (586)
                      .... ......++..|+|||++.++.++.++|||||||++|||++ |+.||.......   +.++    ...+...  ..
T Consensus       162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~---~~~~----~~~~~~~--~~  232 (279)
T cd05111         162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE---VPDL----LEKGERL--AQ  232 (279)
T ss_pred             CCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH----HHCCCcC--CC
Confidence            3221 2233457789999999998999999999999999999998 999997643321   1111    1222211  11


Q ss_pred             CCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 007869          494 PNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERDV  537 (586)
Q Consensus       494 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  537 (586)
                      +..       ....+.+++.+||..+|++|||+.|+++.|....
T Consensus       233 ~~~-------~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~  269 (279)
T cd05111         233 PQI-------CTIDVYMVMVKCWMIDENVRPTFKELANEFTRMA  269 (279)
T ss_pred             CCC-------CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence            111       1234677888999999999999999999987744

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=6.1e-39  Score=332.70  Aligned_cols=242  Identities=23%  Similarity=0.318  Sum_probs=196.3

Q ss_pred             CcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc---chhHHHHHHHHHHhcccCC-CceeeeeeeeeccCeEEEEE
Q 007869          262 GFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES---RQGMKEFVAEIVSIGRLRH-RNLVQLLGYCRRKGELLLVY  337 (586)
Q Consensus       262 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H-~niv~l~~~~~~~~~~~lV~  337 (586)
                      +|+..+.||+|+||.||+|+...++..||||++....   ....+.+..|.+++..++| ++|+++++++...+.+++||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4788899999999999999999888999999997542   3345678889999999976 56888999999999999999


Q ss_pred             ecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCC
Q 007869          338 DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT  417 (586)
Q Consensus       338 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~  417 (586)
                      ||+++|+|.+++....  .+++.++..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++......
T Consensus        81 E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  155 (324)
T cd05587          81 EYVNGGDLMYHIQQVG--KFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG  155 (324)
T ss_pred             cCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence            9999999999987653  57888999999999999999998   899999999999999999999999999987532211


Q ss_pred             CCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCC
Q 007869          418 DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLG  497 (586)
Q Consensus       418 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~  497 (586)
                       .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+   +...+    .+..      +.+.
T Consensus       156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~---~~~~i----~~~~------~~~~  221 (324)
T cd05587         156 -KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE---LFQSI----MEHN------VSYP  221 (324)
T ss_pred             -CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---HHHHH----HcCC------CCCC
Confidence             22344679999999999999999999999999999999999999997643321   11111    1111      1111


Q ss_pred             ccccHHHHHHHHHHHHHhcccCCCCCCCH
Q 007869          498 TEYVAEELELVLKLGLLCSHSDPTARPSM  526 (586)
Q Consensus       498 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~  526 (586)
                      ..    ....+.+++.+|++.||.+|++.
T Consensus       222 ~~----~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         222 KS----LSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             CC----CCHHHHHHHHHHhhcCHHHcCCC
Confidence            11    23456788889999999999986

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=5.1e-39  Score=325.70  Aligned_cols=248  Identities=26%  Similarity=0.330  Sum_probs=198.6

Q ss_pred             EeecCceEEEEEEeCCCCeEEEEEEecccc---chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEecCCCCCh
Q 007869          269 LGTGGFGRVYRGTLPKSQIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSL  345 (586)
Q Consensus       269 LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL  345 (586)
                      ||+|+||.||++....++..+|+|++....   ....+.+..|++++++++||||+++++++..+...++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            699999999999999889999999986432   12234566799999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCCceeeec
Q 007869          346 DKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVV  425 (586)
Q Consensus       346 ~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~  425 (586)
                      .+++.......+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||++.......  ......
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~~  155 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQRA  155 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeeccC
Confidence            999877655678999999999999999999998   999999999999999999999999999998764322  223457


Q ss_pred             cCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCccccHHHH
Q 007869          426 GTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAEEL  505 (586)
Q Consensus       426 gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~  505 (586)
                      |+..|+|||++.+..++.++|||||||++|||++|+.||........  ..+...... ...    ..  ...   ....
T Consensus       156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~--~~~~~~~~~-~~~----~~--~~~---~~~~  223 (277)
T cd05607         156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA--KEELKRRTL-EDE----VK--FEH---QNFT  223 (277)
T ss_pred             CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh--HHHHHHHhh-ccc----cc--ccc---ccCC
Confidence            89999999999988899999999999999999999999975432111  111111111 111    00  000   1123


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 007869          506 ELVLKLGLLCSHSDPTARPSMRQVVQIL  533 (586)
Q Consensus       506 ~~l~~l~~~Cl~~dP~~RPs~~evl~~L  533 (586)
                      ..+.+++.+||+.||++||+++|+++.+
T Consensus       224 ~~~~~li~~~L~~~P~~R~~~~~~~~~~  251 (277)
T cd05607         224 EESKDICRLFLAKKPEDRLGSREKNDDP  251 (277)
T ss_pred             HHHHHHHHHHhccCHhhCCCCccchhhh
Confidence            4567888999999999999998776443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=5.2e-39  Score=326.15  Aligned_cols=246  Identities=26%  Similarity=0.343  Sum_probs=197.2

Q ss_pred             EeecCceEEEEEEeCCCCeEEEEEEecccc---chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEecCCCCCh
Q 007869          269 LGTGGFGRVYRGTLPKSQIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSL  345 (586)
Q Consensus       269 LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL  345 (586)
                      ||+|+||+||++.+..+++.+|+|++....   ....+.+..|++++++++|+||+++.+++...+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            699999999999999889999999986542   22345678899999999999999999999999999999999999999


Q ss_pred             hhhhhcC--CCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCCceee
Q 007869          346 DKYLYDQ--PKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTH  423 (586)
Q Consensus       346 ~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~  423 (586)
                      ..++...  ....+++..+..++.||+.||.|||+   .+|+||||||+||++++++.+||+|||+++....... ....
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~  156 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG  156 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence            9888542  23468999999999999999999998   8999999999999999999999999999986644322 2334


Q ss_pred             eccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCccccHH
Q 007869          424 VVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAE  503 (586)
Q Consensus       424 ~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~  503 (586)
                      ..||+.|+|||++.+..++.++|||||||++|||++|+.||.........  ........ .+       +   ..+...
T Consensus       157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~-~~-------~---~~~~~~  223 (280)
T cd05608         157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN--KELKQRIL-ND-------S---VTYPDK  223 (280)
T ss_pred             cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH--HHHHHhhc-cc-------C---CCCccc
Confidence            57899999999999999999999999999999999999999764332110  00000000 00       0   011222


Q ss_pred             HHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 007869          504 ELELVLKLGLLCSHSDPTARP-----SMRQVVQ  531 (586)
Q Consensus       504 ~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~  531 (586)
                      ....+.+++.+||+.||++||     +++++++
T Consensus       224 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         224 FSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence            345677888999999999999     6677764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=5.4e-39  Score=329.81  Aligned_cols=261  Identities=25%  Similarity=0.405  Sum_probs=208.5

Q ss_pred             hhcCCcccceeEeecCceEEEEEEe-----CCCCeEEEEEEecccc-chhHHHHHHHHHHhccc-CCCceeeeeeeeecc
Q 007869          258 IATKGFREKELLGTGGFGRVYRGTL-----PKSQIEIAVKKISHES-RQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRK  330 (586)
Q Consensus       258 ~a~~~f~~~~~LG~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~  330 (586)
                      ...++|...+.||+|+||.||++..     ...+..||||+++... ....+.+.+|+.+++++ +||||+++++++...
T Consensus        32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~  111 (302)
T cd05055          32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG  111 (302)
T ss_pred             ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC
Confidence            3345788899999999999999975     2345679999987543 33456789999999999 899999999999999


Q ss_pred             CeEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccce
Q 007869          331 GELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLA  410 (586)
Q Consensus       331 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla  410 (586)
                      +..++||||+++|+|.+++.......+++.++..++.|++.||.|||+   ++|+|+||||+|||++.++.+||+|||++
T Consensus       112 ~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~dfg~~  188 (302)
T cd05055         112 GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNVLLTHGKIVKICDFGLA  188 (302)
T ss_pred             CceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeehhhhccceEEEcCCCeEEECCCccc
Confidence            999999999999999999976544458999999999999999999998   89999999999999999999999999999


Q ss_pred             eeccCCCCC-ceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccCcc
Q 007869          411 RLYDHGTDP-QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGEL  488 (586)
Q Consensus       411 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~  488 (586)
                      +........ ......++..|+|||.+....++.++|||||||++|||++ |+.||......+.  .....    ..+..
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~--~~~~~----~~~~~  262 (302)
T cd05055         189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK--FYKLI----KEGYR  262 (302)
T ss_pred             ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH--HHHHH----HcCCc
Confidence            865433221 1122345788999999998899999999999999999998 9999876443221  11111    11110


Q ss_pred             ccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 007869          489 LEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERD  536 (586)
Q Consensus       489 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  536 (586)
                           +..    .......+.+++.+|++.+|++||++.|+++.|++.
T Consensus       263 -----~~~----~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         263 -----MAQ----PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             -----CCC----CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence                 000    111235678899999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=5.2e-39  Score=326.31  Aligned_cols=263  Identities=24%  Similarity=0.395  Sum_probs=203.4

Q ss_pred             cCCcccceeEeecCceEEEEEEe----CCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeec--cCeE
Q 007869          260 TKGFREKELLGTGGFGRVYRGTL----PKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRR--KGEL  333 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~----~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~--~~~~  333 (586)
                      .+.|+..+.||+|+||.||++..    ..++..||+|++........+.+.+|++++++++||||+++++++..  ....
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   82 (284)
T cd05081           3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   82 (284)
T ss_pred             cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence            35688889999999999999984    34677899999987766667889999999999999999999998754  3468


Q ss_pred             EEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeec
Q 007869          334 LLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLY  413 (586)
Q Consensus       334 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~  413 (586)
                      ++||||+++++|.+++.... ..+++..++.++.|++.||.|||+   .+|+||||||+||++++++.+||+|||+++..
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~  158 (284)
T cd05081          83 RLVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKVL  158 (284)
T ss_pred             EEEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEEECCCcccccc
Confidence            99999999999999997542 368999999999999999999998   89999999999999999999999999999876


Q ss_pred             cCCCCCc--eeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCc--------c-chhhHHHHhh
Q 007869          414 DHGTDPQ--TTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSE--------N-LILVDWVFDF  482 (586)
Q Consensus       414 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~--------~-~~l~~~v~~~  482 (586)
                      .......  .....++..|+|||++.+..++.++|||||||++|||++|..++.......        . ........+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05081         159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIEL  238 (284)
T ss_pred             cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHH
Confidence            4432211  111223456999999998899999999999999999999887754321100        0 0000000111


Q ss_pred             hccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 007869          483 WNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER  535 (586)
Q Consensus       483 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  535 (586)
                      ...+..     .    .........+.+++.+||+.+|++|||+.|+++.|+.
T Consensus       239 ~~~~~~-----~----~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~  282 (284)
T cd05081         239 LKNNGR-----L----PAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEA  282 (284)
T ss_pred             HhcCCc-----C----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHh
Confidence            111100     0    0111223568889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=9.5e-39  Score=321.24  Aligned_cols=256  Identities=24%  Similarity=0.365  Sum_probs=205.5

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEec
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY  339 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  339 (586)
                      .++|+..+.||+|+||.||+|+...++..||+|++..........+.+|+.++++++||||+++++++..++..++||||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~   87 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY   87 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence            35788899999999999999999888999999999766555556788999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCC
Q 007869          340 MPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP  419 (586)
Q Consensus       340 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~  419 (586)
                      +++++|.+++...  ..+++.++..++.|+++||.|||+   .+|+||||||+||++++++.+||+|||+++....... 
T Consensus        88 ~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-  161 (267)
T cd06646          88 CGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA-  161 (267)
T ss_pred             CCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEECcCccceeeccccc-
Confidence            9999999998654  357888999999999999999998   8999999999999999999999999999987643221 


Q ss_pred             ceeeeccCCCccCccccc---CCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCC
Q 007869          420 QTTHVVGTLGYLAPEHTR---TGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNL  496 (586)
Q Consensus       420 ~~~~~~gt~~y~aPE~~~---~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l  496 (586)
                      ......|+..|+|||.+.   ...++.++|||||||++|||++|+.|+....+.+....       ......   ..+..
T Consensus       162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~-------~~~~~~---~~~~~  231 (267)
T cd06646         162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL-------MSKSNF---QPPKL  231 (267)
T ss_pred             ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhee-------eecCCC---CCCCC
Confidence            223356889999999874   34578899999999999999999999865433221100       000000   01111


Q ss_pred             CccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 007869          497 GTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQIL  533 (586)
Q Consensus       497 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L  533 (586)
                      ..  .......+.+++.+||+.+|++||+++++++.|
T Consensus       232 ~~--~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         232 KD--KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             cc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            10  112235677889999999999999999998753

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.1e-39  Score=339.28  Aligned_cols=253  Identities=22%  Similarity=0.256  Sum_probs=197.6

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc---cchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEE
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY  337 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  337 (586)
                      ++|+..+.||+|+||.||++....++..||||++...   .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            4688899999999999999999999999999998653   2334567889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCC
Q 007869          338 DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT  417 (586)
Q Consensus       338 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~  417 (586)
                      ||+++|+|.+++...  ..+++.....++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++.+....
T Consensus        81 E~~~gg~L~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~---~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~  155 (377)
T cd05629          81 EFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH  155 (377)
T ss_pred             eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence            999999999999765  357788888899999999999998   899999999999999999999999999996432100


Q ss_pred             C------------C----------------------------------ceeeeccCCCccCcccccCCCCCCcceEEehh
Q 007869          418 D------------P----------------------------------QTTHVVGTLGYLAPEHTRTGKATTSADVFSFG  451 (586)
Q Consensus       418 ~------------~----------------------------------~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~G  451 (586)
                      .            .                                  .....+||+.|+|||++.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG  235 (377)
T cd05629         156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG  235 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence            0            0                                  00124699999999999988999999999999


Q ss_pred             HHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCC---CCHHH
Q 007869          452 AFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTAR---PSMRQ  528 (586)
Q Consensus       452 vvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R---Ps~~e  528 (586)
                      |++|||++|+.||......+...      ..........  .|.. ..    ....+.+++.+|++ +|.+|   +++.|
T Consensus       236 vil~elltG~~Pf~~~~~~~~~~------~i~~~~~~~~--~p~~-~~----~s~~~~dli~~lL~-~~~~r~~r~~~~~  301 (377)
T cd05629         236 AIMFECLIGWPPFCSENSHETYR------KIINWRETLY--FPDD-IH----LSVEAEDLIRRLIT-NAENRLGRGGAHE  301 (377)
T ss_pred             hhhhhhhcCCCCCCCCCHHHHHH------HHHccCCccC--CCCC-CC----CCHHHHHHHHHHhc-CHhhcCCCCCHHH
Confidence            99999999999997654322111      0000000000  0110 01    12345667777887 66665   69999


Q ss_pred             HHHH
Q 007869          529 VVQI  532 (586)
Q Consensus       529 vl~~  532 (586)
                      +++.
T Consensus       302 ~l~h  305 (377)
T cd05629         302 IKSH  305 (377)
T ss_pred             HhcC
Confidence            8864

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=3.8e-39  Score=341.17  Aligned_cols=253  Identities=23%  Similarity=0.302  Sum_probs=196.8

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc---chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEE
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY  337 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  337 (586)
                      .+|+..+.||+|+||.||+++...++..||||++....   ......+.+|++++++++|+||+++++.+..++.+++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            36889999999999999999999999999999986532   233466889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCC
Q 007869          338 DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT  417 (586)
Q Consensus       338 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~  417 (586)
                      ||+++|+|.+++....  .+++.....++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+|..+....
T Consensus        81 E~~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~  155 (376)
T cd05598          81 DYIPGGDMMSLLIRLG--IFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (376)
T ss_pred             eCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence            9999999999997653  57788888899999999999998   899999999999999999999999999985331000


Q ss_pred             ------------------------------------------CCceeeeccCCCccCcccccCCCCCCcceEEehhHHHH
Q 007869          418 ------------------------------------------DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLL  455 (586)
Q Consensus       418 ------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~  455 (586)
                                                                ........||+.|+|||++.+..++.++|||||||++|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily  235 (376)
T cd05598         156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY  235 (376)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence                                                      00012357999999999999999999999999999999


Q ss_pred             HHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCC---CHHHHHHH
Q 007869          456 EVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARP---SMRQVVQI  532 (586)
Q Consensus       456 ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP---s~~evl~~  532 (586)
                      ||++|+.||......+....   +. .+.. .   ...+. ......    .+.+++.+|+ .+|.+|+   ++.|+++.
T Consensus       236 ell~G~~Pf~~~~~~~~~~~---i~-~~~~-~---~~~~~-~~~~s~----~~~~li~~l~-~~p~~R~~~~t~~ell~h  301 (376)
T cd05598         236 EMLVGQPPFLADTPAETQLK---VI-NWET-T---LHIPS-QAKLSR----EASDLILRLC-CGAEDRLGKNGADEIKAH  301 (376)
T ss_pred             ehhhCCCCCCCCCHHHHHHH---Hh-ccCc-c---ccCCC-CCCCCH----HHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence            99999999986543221110   00 0000 0   00111 112222    3344444554 4999999   88888753

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=8.7e-39  Score=325.19  Aligned_cols=264  Identities=28%  Similarity=0.373  Sum_probs=198.3

Q ss_pred             CcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccc--hhHHHHHHHHHHhccc---CCCceeeeeeeeec-----cC
Q 007869          262 GFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR--QGMKEFVAEIVSIGRL---RHRNLVQLLGYCRR-----KG  331 (586)
Q Consensus       262 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l---~H~niv~l~~~~~~-----~~  331 (586)
                      +|+..+.||+|+||.||+|.+..++..||+|.+.....  .....+.+|+.+++++   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            47888999999999999999999999999999875321  2223456677766655   79999999998764     34


Q ss_pred             eEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEcccccee
Q 007869          332 ELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR  411 (586)
Q Consensus       332 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~  411 (586)
                      ..++||||++ ++|.+++.......+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++
T Consensus        81 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~kl~dfg~~~  156 (288)
T cd07863          81 KVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGLAR  156 (288)
T ss_pred             eEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccCccc
Confidence            5899999997 589998877655568999999999999999999998   899999999999999999999999999998


Q ss_pred             eccCCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccch-hhHHHH----hhhcc-
Q 007869          412 LYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLI-LVDWVF----DFWNR-  485 (586)
Q Consensus       412 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~-l~~~v~----~~~~~-  485 (586)
                      ......  ......||..|+|||++.+..++.++|||||||++|||++|++||......+... +..+..    ..+.. 
T Consensus       157 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T cd07863         157 IYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD  234 (288)
T ss_pred             cccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccc
Confidence            764322  2234578999999999998899999999999999999999999997654322111 011000    00000 


Q ss_pred             Cccc-cccC---CCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          486 GELL-EARD---PNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       486 ~~~~-~~~d---~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      .... ....   +...........+.+.+++.+|++.||++|||+.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             ccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            0000 0000   00001111223456788999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-39  Score=304.98  Aligned_cols=267  Identities=25%  Similarity=0.302  Sum_probs=213.9

Q ss_pred             hhhhhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeecc----
Q 007869          255 DLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRK----  330 (586)
Q Consensus       255 el~~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~----  330 (586)
                      .+.+..++|++.+.||+|||+.||.++...++..+|+|++...+.+..+..++|++..++++|||++++++++..+    
T Consensus        15 tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~   94 (302)
T KOG2345|consen   15 TVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDG   94 (302)
T ss_pred             cEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccC
Confidence            4556778999999999999999999998888999999999988888889999999999999999999999987643    


Q ss_pred             -CeEEEEEecCCCCChhhhhhcCC--CccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccc
Q 007869          331 -GELLLVYDYMPNGSLDKYLYDQP--KVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDF  407 (586)
Q Consensus       331 -~~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DF  407 (586)
                       .+.||+++|...|+|.+.+....  ...+++.+.++|+.+|++||++||+. ..++.||||||.|||+.+.+.++|.||
T Consensus        95 ~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~  173 (302)
T KOG2345|consen   95 KHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDL  173 (302)
T ss_pred             ceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEec
Confidence             35999999999999999997642  34689999999999999999999983 245999999999999999999999999


Q ss_pred             cceeeccCCCCC--------ceeeeccCCCccCcccccC---CCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhh
Q 007869          408 GLARLYDHGTDP--------QTTHVVGTLGYLAPEHTRT---GKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILV  476 (586)
Q Consensus       408 Gla~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~---~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~  476 (586)
                      |.+....-....        ......-|..|+|||.+.-   ...++++|||||||+||+|+.|..||+..-...     
T Consensus       174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~G-----  248 (302)
T KOG2345|consen  174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQG-----  248 (302)
T ss_pred             cCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcC-----
Confidence            999865422111        1112346899999999854   356899999999999999999999997532211     


Q ss_pred             HHHHhhhccCccc-cccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 007869          477 DWVFDFWNRGELL-EARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERD  536 (586)
Q Consensus       477 ~~v~~~~~~~~~~-~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  536 (586)
                               |.+. ....+.+.-.-.....+.+.+++.+|++.||.+||++.+++..++..
T Consensus       249 ---------gSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L  300 (302)
T KOG2345|consen  249 ---------GSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL  300 (302)
T ss_pred             ---------CeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence                     1110 11111111111122457788999999999999999999999988753

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=5.1e-39  Score=339.80  Aligned_cols=261  Identities=25%  Similarity=0.318  Sum_probs=202.4

Q ss_pred             CcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc--cchhHHHHHHHHHHhcccCCCceeeeeeeeeccC-----eEE
Q 007869          262 GFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKG-----ELL  334 (586)
Q Consensus       262 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~-----~~~  334 (586)
                      +|+..+.||+|+||.||++....++..||||++...  .....+.+.+|+++++.++||||+++++++...+     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            478889999999999999999888999999998653  2334567889999999999999999999998776     789


Q ss_pred             EEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeecc
Q 007869          335 LVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYD  414 (586)
Q Consensus       335 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~  414 (586)
                      +|+||+. ++|.+.+...  ..+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++...
T Consensus        81 lv~e~~~-~~l~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~  154 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSP--QPLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEE  154 (372)
T ss_pred             EEeeccc-cCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHHEEECCCCCEEeccccceeecc
Confidence            9999996 6888887554  368889999999999999999998   899999999999999999999999999998765


Q ss_pred             CCCCCceeeeccCCCccCcccccCC-CCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHH---------------
Q 007869          415 HGTDPQTTHVVGTLGYLAPEHTRTG-KATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDW---------------  478 (586)
Q Consensus       415 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~---------------  478 (586)
                      ...........+|..|+|||++.+. .++.++|||||||++|||++|+.||......+....+..               
T Consensus       155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~  234 (372)
T cd07853         155 PDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE  234 (372)
T ss_pred             cCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH
Confidence            4333333445689999999998764 478999999999999999999999986554322111100               


Q ss_pred             -HHhhhccCccccccCCC-CC--ccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          479 -VFDFWNRGELLEARDPN-LG--TEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       479 -v~~~~~~~~~~~~~d~~-l~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                       ........    ...+. ..  ..........+.+++.+|++.||++|||+.|+++.
T Consensus       235 ~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         235 GARAHILRG----PHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             HHHHHHHhC----CCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence             00000000    00000 00  00111224567789999999999999999999863

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=8.3e-39  Score=320.52  Aligned_cols=255  Identities=27%  Similarity=0.456  Sum_probs=206.3

Q ss_pred             hcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEe
Q 007869          259 ATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYD  338 (586)
Q Consensus       259 a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E  338 (586)
                      ..++|+..++||+|+||.||+|.... +..||+|.+..... ...++.+|+.++++++|+|++++++++. .+..+++||
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~-~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e   80 (260)
T cd05067           4 PRETLKLVKKLGAGQFGEVWMGYYNG-HTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITE   80 (260)
T ss_pred             chHHceeeeeeccCccceEEeeecCC-CceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEE
Confidence            34678889999999999999999754 56799999875443 3467899999999999999999999874 457899999


Q ss_pred             cCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCC
Q 007869          339 YMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD  418 (586)
Q Consensus       339 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~  418 (586)
                      |+++++|.+++.......+++.+++.++.|++.||+|||+   .+++||||||+||++++++.++|+|||++........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05067          81 YMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY  157 (260)
T ss_pred             cCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence            9999999999977655678999999999999999999998   8999999999999999999999999999987653322


Q ss_pred             CceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCC
Q 007869          419 PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLG  497 (586)
Q Consensus       419 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~  497 (586)
                      .......++..|+|||++....++.++||||||+++|||++ |+.||......+   +...    ..++...     .. 
T Consensus       158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~----~~~~~~~-----~~-  224 (260)
T cd05067         158 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE---VIQN----LERGYRM-----PR-  224 (260)
T ss_pred             ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH---HHHH----HHcCCCC-----CC-
Confidence            22223446778999999998889999999999999999999 999997644321   1111    1111100     11 


Q ss_pred             ccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 007869          498 TEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER  535 (586)
Q Consensus       498 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  535 (586)
                         .......+.+++.+|++.+|++||+++++++.|+.
T Consensus       225 ---~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         225 ---PDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             ---CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence               11123468889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=6.3e-39  Score=332.18  Aligned_cols=242  Identities=24%  Similarity=0.335  Sum_probs=196.3

Q ss_pred             eeEeecCceEEEEEEeCCCCeEEEEEEecccc---chhHHHHHHHHHHhccc-CCCceeeeeeeeeccCeEEEEEecCCC
Q 007869          267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHES---RQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKGELLLVYDYMPN  342 (586)
Q Consensus       267 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~lV~E~~~~  342 (586)
                      ++||+|+||.||+|++..++..||||++....   ....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999999889999999997542   23445677888888866 899999999999999999999999999


Q ss_pred             CChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCCcee
Q 007869          343 GSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTT  422 (586)
Q Consensus       343 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~  422 (586)
                      |+|..++...  ..+++..+..++.|+++||.|||+   ++|+||||||+|||++.++.+||+|||+++...... ....
T Consensus        81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~~  154 (321)
T cd05591          81 GDLMFQIQRS--RKFDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VTTT  154 (321)
T ss_pred             CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeecccceecccCC-cccc
Confidence            9999988765  357888999999999999999998   899999999999999999999999999998543222 2233


Q ss_pred             eeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCccccH
Q 007869          423 HVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVA  502 (586)
Q Consensus       423 ~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~  502 (586)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||......+   +.+.+   . .+..   ..|.       
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~---~~~~i---~-~~~~---~~p~-------  217 (321)
T cd05591         155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD---LFESI---L-HDDV---LYPV-------  217 (321)
T ss_pred             ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH---HHHHH---H-cCCC---CCCC-------
Confidence            4579999999999998899999999999999999999999998654321   11111   1 1111   1111       


Q ss_pred             HHHHHHHHHHHHhcccCCCCCC-------CHHHHHH
Q 007869          503 EELELVLKLGLLCSHSDPTARP-------SMRQVVQ  531 (586)
Q Consensus       503 ~~~~~l~~l~~~Cl~~dP~~RP-------s~~evl~  531 (586)
                      .....+.+++..|++.||++||       ++.++++
T Consensus       218 ~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~  253 (321)
T cd05591         218 WLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ  253 (321)
T ss_pred             CCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence            1124567888899999999999       7788774

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=8.9e-39  Score=331.36  Aligned_cols=242  Identities=25%  Similarity=0.347  Sum_probs=194.9

Q ss_pred             eeEeecCceEEEEEEeC---CCCeEEEEEEecccc----chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEec
Q 007869          267 ELLGTGGFGRVYRGTLP---KSQIEIAVKKISHES----RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY  339 (586)
Q Consensus       267 ~~LG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  339 (586)
                      +.||+|+||.||+++..   .++..||||++....    ......+.+|++++++++||||+++++++..++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            57999999999999863   467889999987532    23345678899999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCC
Q 007869          340 MPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP  419 (586)
Q Consensus       340 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~  419 (586)
                      +++++|.+++....  .+.+.....++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++...... .
T Consensus        82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~  155 (323)
T cd05584          82 LSGGELFMHLEREG--IFMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG-T  155 (323)
T ss_pred             CCCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC-C
Confidence            99999999997653  56778888899999999999998   899999999999999999999999999997543222 1


Q ss_pred             ceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCcc
Q 007869          420 QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTE  499 (586)
Q Consensus       420 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~  499 (586)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......      .... ...+..      .+.. 
T Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~------~~~~-~~~~~~------~~~~-  221 (323)
T cd05584         156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK------TIDK-ILKGKL------NLPP-  221 (323)
T ss_pred             cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH------HHHH-HHcCCC------CCCC-
Confidence            2334579999999999998889999999999999999999999997643321      1111 111111      1111 


Q ss_pred             ccHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 007869          500 YVAEELELVLKLGLLCSHSDPTARP-----SMRQVVQ  531 (586)
Q Consensus       500 ~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~  531 (586)
                         .....+.+++.+|++.||++||     ++.++++
T Consensus       222 ---~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         222 ---YLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             ---CCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence               1234567888999999999999     7888765

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.1e-38  Score=330.35  Aligned_cols=238  Identities=26%  Similarity=0.303  Sum_probs=189.4

Q ss_pred             eeEeecCceEEEEEEeCCCCeEEEEEEecccc---chhHHHHHHHHH-HhcccCCCceeeeeeeeeccCeEEEEEecCCC
Q 007869          267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHES---RQGMKEFVAEIV-SIGRLRHRNLVQLLGYCRRKGELLLVYDYMPN  342 (586)
Q Consensus       267 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~-~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~  342 (586)
                      ++||+|+||.||+|++..++..||+|++....   ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999999889999999986542   222344555554 57889999999999999999999999999999


Q ss_pred             CChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCCcee
Q 007869          343 GSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTT  422 (586)
Q Consensus       343 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~  422 (586)
                      ++|..++...  ..+++.+...++.||++||.|||+   .+|+||||||+|||++.++.+||+|||+++..... .....
T Consensus        81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~~  154 (321)
T cd05603          81 GELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP-EETTS  154 (321)
T ss_pred             CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCC-CCccc
Confidence            9999888654  357778888899999999999998   89999999999999999999999999998753221 12233


Q ss_pred             eeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCccccH
Q 007869          423 HVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVA  502 (586)
Q Consensus       423 ~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~  502 (586)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||...+...   +.+.+   . .+.      ..    ...
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i---~-~~~------~~----~~~  217 (321)
T cd05603         155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQ---MYDNI---L-HKP------LQ----LPG  217 (321)
T ss_pred             cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHH---HHHHH---h-cCC------CC----CCC
Confidence            4578999999999998899999999999999999999999997643211   11111   1 111      01    111


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCHH
Q 007869          503 EELELVLKLGLLCSHSDPTARPSMR  527 (586)
Q Consensus       503 ~~~~~l~~l~~~Cl~~dP~~RPs~~  527 (586)
                      .....+.+++.+|++.||.+||+..
T Consensus       218 ~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         218 GKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CCCHHHHHHHHHHccCCHhhcCCCC
Confidence            2234577889999999999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.1e-38  Score=320.73  Aligned_cols=259  Identities=25%  Similarity=0.391  Sum_probs=209.8

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc---cchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEE
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY  337 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  337 (586)
                      ++|+..+.||+|++|.||+++...++..+|||.+...   ......++.+|+.++++++|+||+++++++...+..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            4678889999999999999999888899999988643   2334467899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcC--CCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccC
Q 007869          338 DYMPNGSLDKYLYDQ--PKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH  415 (586)
Q Consensus       338 E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~  415 (586)
                      ||+++++|.+++...  ....+++.+.+.++.|+++||.|||+   .+++|+||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            999999999998642  23468999999999999999999998   8999999999999999999999999999886643


Q ss_pred             CCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCC
Q 007869          416 GTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPN  495 (586)
Q Consensus       416 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~  495 (586)
                      ... ......|+..|+|||++.+..++.++|+||||+++|||++|..||....... ......         +.....+.
T Consensus       159 ~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~---------~~~~~~~~  227 (267)
T cd08229         159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-YSLCKK---------IEQCDYPP  227 (267)
T ss_pred             CCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchH-HHHhhh---------hhcCCCCC
Confidence            322 2233568999999999988889999999999999999999999997543211 111110         11111121


Q ss_pred             CCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 007869          496 LGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERD  536 (586)
Q Consensus       496 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  536 (586)
                      ...   ......+.+++.+||+.||++||||.+|++.+.+.
T Consensus       228 ~~~---~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~  265 (267)
T cd08229         228 LPS---DHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM  265 (267)
T ss_pred             CCc---ccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence            111   12345677888899999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1e-38  Score=320.00  Aligned_cols=253  Identities=29%  Similarity=0.445  Sum_probs=203.6

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEecC
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYM  340 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  340 (586)
                      ++|+..+.||+|++|.||++.+..+. .+|+|.+.... ...+.+.+|++++++++|+|++++++++. .+..++||||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~-~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~   82 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTT-KVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFM   82 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCc-eEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcC
Confidence            46888899999999999999986654 59999886543 23467899999999999999999999875 45689999999


Q ss_pred             CCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCCc
Q 007869          341 PNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ  420 (586)
Q Consensus       341 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~  420 (586)
                      ++++|.+++.......+++..+..++.|++.||.|||+   .+++||||||+||++++++.+||+|||+++.........
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~  159 (260)
T cd05069          83 GKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA  159 (260)
T ss_pred             CCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCeEEECCCccceEccCCcccc
Confidence            99999999987655568999999999999999999998   899999999999999999999999999998764432222


Q ss_pred             eeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCcc
Q 007869          421 TTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTE  499 (586)
Q Consensus       421 ~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~  499 (586)
                      .....++..|+|||...+..++.++||||||+++|||++ |+.||......+   ..++..    .+.     .+.    
T Consensus       160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~~----~~~-----~~~----  223 (260)
T cd05069         160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE---VLEQVE----RGY-----RMP----  223 (260)
T ss_pred             cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHH----cCC-----CCC----
Confidence            223346778999999988899999999999999999999 899987643321   111111    110     011    


Q ss_pred             ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 007869          500 YVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER  535 (586)
Q Consensus       500 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  535 (586)
                      ........+.+++.+||+.||++||+++++++.|+.
T Consensus       224 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         224 CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             CCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            111234567888899999999999999999999874

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-39  Score=339.41  Aligned_cols=247  Identities=25%  Similarity=0.333  Sum_probs=205.1

Q ss_pred             hhhhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc---chhHHHHHHHHHHhccc-CCCceeeeeeeeeccC
Q 007869          256 LYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES---RQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKG  331 (586)
Q Consensus       256 l~~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~~  331 (586)
                      -...-++|...++||+|.||+|+++..+.+++.+|||.++++.   +...+..+.|-.++... +||.|++|+.+|..++
T Consensus       363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~  442 (694)
T KOG0694|consen  363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE  442 (694)
T ss_pred             CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence            3456678999999999999999999999999999999998763   45566778888887777 5999999999999999


Q ss_pred             eEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEcccccee
Q 007869          332 ELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR  411 (586)
Q Consensus       332 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~  411 (586)
                      ++++||||+.||++..+.+   ...+++..+.-++..|+.||+|||+   ++|||||||.+|||||.+|.+||+|||||+
T Consensus       443 ~l~fvmey~~Ggdm~~~~~---~~~F~e~rarfyaAev~l~L~fLH~---~~IIYRDlKLdNiLLD~eGh~kiADFGlcK  516 (694)
T KOG0694|consen  443 HLFFVMEYVAGGDLMHHIH---TDVFSEPRARFYAAEVVLGLQFLHE---NGIIYRDLKLDNLLLDTEGHVKIADFGLCK  516 (694)
T ss_pred             eEEEEEEecCCCcEEEEEe---cccccHHHHHHHHHHHHHHHHHHHh---cCceeeecchhheEEcccCcEEeccccccc
Confidence            9999999999999554443   2468888999999999999999998   999999999999999999999999999998


Q ss_pred             eccCCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccc
Q 007869          412 LYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEA  491 (586)
Q Consensus       412 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~  491 (586)
                      .--. ....+.+.+||+.|||||++.+..|+...|-|||||+||||+.|..||.++++.+...-+       .      .
T Consensus       517 e~m~-~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI-------~------~  582 (694)
T KOG0694|consen  517 EGMG-QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSI-------V------N  582 (694)
T ss_pred             ccCC-CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH-------h------c
Confidence            5332 223567799999999999999999999999999999999999999999987765422211       0      1


Q ss_pred             cCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCH
Q 007869          492 RDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSM  526 (586)
Q Consensus       492 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~  526 (586)
                      .|+.    |+.....+.+.++.+.+..+|++|.-+
T Consensus       583 d~~~----yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  583 DEVR----YPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             CCCC----CCCcccHHHHHHHHHHhccCcccccCC
Confidence            1222    122233455667777889999999876

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=8.3e-39  Score=322.39  Aligned_cols=255  Identities=26%  Similarity=0.364  Sum_probs=204.3

Q ss_pred             hhhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhccc-CCCceeeeeeeeecc-----
Q 007869          257 YIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRK-----  330 (586)
Q Consensus       257 ~~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~-----  330 (586)
                      ..+++.|+..+.||+|+||.||+|....++..||+|++.... .....+.+|+.++.++ +|+|++++++++...     
T Consensus         2 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   80 (272)
T cd06637           2 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM   80 (272)
T ss_pred             CChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence            346678899999999999999999999889999999986543 3346788999999998 799999999998753     


Q ss_pred             -CeEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccc
Q 007869          331 -GELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGL  409 (586)
Q Consensus       331 -~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGl  409 (586)
                       ...++||||+++++|.+++.......+++..+..++.|++.||.|||+   ++|+||||||+||++++++.+||+|||+
T Consensus        81 ~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~~~~l~Dfg~  157 (272)
T cd06637          81 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGV  157 (272)
T ss_pred             CcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCCCEEEccCCC
Confidence             468999999999999999987555678999999999999999999998   8999999999999999999999999999


Q ss_pred             eeeccCCCCCceeeeccCCCccCccccc-----CCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhc
Q 007869          410 ARLYDHGTDPQTTHVVGTLGYLAPEHTR-----TGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWN  484 (586)
Q Consensus       410 a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~  484 (586)
                      ++...... .......|+..|+|||++.     ...++.++|||||||++|||++|+.||..........      ....
T Consensus       158 ~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~------~~~~  230 (272)
T cd06637         158 SAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF------LIPR  230 (272)
T ss_pred             ceeccccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHH------HHhc
Confidence            98754322 1233467899999999986     3357889999999999999999999996543221110      0000


Q ss_pred             cCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          485 RGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       485 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      .      ..+...   .......+.+++.+||+.+|.+|||+.++++
T Consensus       231 ~------~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         231 N------PAPRLK---SKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             C------CCCCCC---CCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence            0      011111   1112345778899999999999999999975

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-38  Score=320.34  Aligned_cols=254  Identities=26%  Similarity=0.473  Sum_probs=202.0

Q ss_pred             cccceeEeecCceEEEEEEeCCC---CeEEEEEEecccc--chhHHHHHHHHHHhcccCCCceeeeeeeeeccCe-----
Q 007869          263 FREKELLGTGGFGRVYRGTLPKS---QIEIAVKKISHES--RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGE-----  332 (586)
Q Consensus       263 f~~~~~LG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~-----  332 (586)
                      |...+.||+|+||.||+|.+..+   +..||+|++....  ......+.+|++.+++++|||++++++++.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            46678899999999999997643   3679999987542  3345679999999999999999999998876544     


Q ss_pred             -EEEEEecCCCCChhhhhhcC----CCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccc
Q 007869          333 -LLLVYDYMPNGSLDKYLYDQ----PKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDF  407 (586)
Q Consensus       333 -~~lV~E~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DF  407 (586)
                       .++++||+++|+|..++...    ....+++.....++.|++.||.|||+   .+++||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchheEEECCCCeEEECCc
Confidence             79999999999999998543    22468899999999999999999998   89999999999999999999999999


Q ss_pred             cceeeccCCCCC-ceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhcc
Q 007869          408 GLARLYDHGTDP-QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNR  485 (586)
Q Consensus       408 Gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~  485 (586)
                      |+++.+...... ......++..|+|||.+.+..++.++|||||||++|||++ |..||......+   +.+++.    .
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~---~~~~~~----~  230 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE---IYDYLR----H  230 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHH----c
Confidence            999876443221 1222345678999999988889999999999999999999 888886543321   222221    1


Q ss_pred             CccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 007869          486 GELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER  535 (586)
Q Consensus       486 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  535 (586)
                      +..     +..    .......+.+++.+||+.||++||++.|+++.|+.
T Consensus       231 ~~~-----~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~  271 (273)
T cd05035         231 GNR-----LKQ----PEDCLDELYDLMYSCWRADPKDRPTFTKLREVLEN  271 (273)
T ss_pred             CCC-----CCC----CcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence            111     111    11234567888899999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=2e-38  Score=319.21  Aligned_cols=258  Identities=28%  Similarity=0.431  Sum_probs=207.6

Q ss_pred             hhhhhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEE
Q 007869          255 DLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELL  334 (586)
Q Consensus       255 el~~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~  334 (586)
                      |++.+++++.....||+|+||.||+|.+..++..||+|.+........+.+.+|++++++++|+||+++++++...+..+
T Consensus         2 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   81 (268)
T cd06624           2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK   81 (268)
T ss_pred             CcccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence            45667788888899999999999999998888999999998766666778999999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhhcCCCccc--hhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecC-CCCeEEcccccee
Q 007869          335 LVYDYMPNGSLDKYLYDQPKVTL--NWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDG-ELNGRLGDFGLAR  411 (586)
Q Consensus       335 lV~E~~~~gsL~~~l~~~~~~~l--~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~-~~~~kL~DFGla~  411 (586)
                      +|+||+++++|.+++.... ..+  ++..+..++.|++.||.|||+   .+|+||||||+||+++. ++.+||+|||++.
T Consensus        82 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~  157 (268)
T cd06624          82 IFMEQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSK  157 (268)
T ss_pred             EEEecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecchhhe
Confidence            9999999999999997642 234  788888999999999999998   89999999999999976 6789999999998


Q ss_pred             eccCCCCCceeeeccCCCccCcccccCCC--CCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccc
Q 007869          412 LYDHGTDPQTTHVVGTLGYLAPEHTRTGK--ATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELL  489 (586)
Q Consensus       412 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~  489 (586)
                      ...... .......|+..|+|||++....  ++.++||||||+++|||++|+.||........   ..+.....      
T Consensus       158 ~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~---~~~~~~~~------  227 (268)
T cd06624         158 RLAGIN-PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA---AMFKVGMF------  227 (268)
T ss_pred             ecccCC-CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh---hHhhhhhh------
Confidence            654322 2223346899999999986644  78899999999999999999999965332111   11100000      


Q ss_pred             cccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          490 EARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       490 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                       ...+.+    .......+.+++.+||+.+|.+||++.|+++
T Consensus       228 -~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         228 -KIHPEI----PESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             -ccCCCC----CcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence             011111    2223356778899999999999999999975

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.2e-38  Score=330.38  Aligned_cols=242  Identities=23%  Similarity=0.314  Sum_probs=196.2

Q ss_pred             CcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc---chhHHHHHHHHHHhccc-CCCceeeeeeeeeccCeEEEEE
Q 007869          262 GFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES---RQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKGELLLVY  337 (586)
Q Consensus       262 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~lV~  337 (586)
                      +|+..+.||+|+||.||+|+...++..||||++....   ....+.+..|..++..+ +|++|+++++++...+.+++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4788899999999999999999889999999997542   22344567788888777 5899999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCC
Q 007869          338 DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT  417 (586)
Q Consensus       338 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~  417 (586)
                      ||+++|+|.+++....  .+++.++..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++......
T Consensus        81 E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~  155 (323)
T cd05616          81 EYVNGGDLMYQIQQVG--RFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG  155 (323)
T ss_pred             cCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence            9999999999987653  57888999999999999999998   899999999999999999999999999998543221


Q ss_pred             CCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCC
Q 007869          418 DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLG  497 (586)
Q Consensus       418 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~  497 (586)
                       .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+   +...+.    +..      ... 
T Consensus       156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~---~~~~i~----~~~------~~~-  220 (323)
T cd05616         156 -VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---LFQSIM----EHN------VAY-  220 (323)
T ss_pred             -CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH---HHHHHH----hCC------CCC-
Confidence             12334679999999999999999999999999999999999999997644321   111111    111      111 


Q ss_pred             ccccHHHHHHHHHHHHHhcccCCCCCCCH
Q 007869          498 TEYVAEELELVLKLGLLCSHSDPTARPSM  526 (586)
Q Consensus       498 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~  526 (586)
                         +......+.+++.+|++.||.+|++.
T Consensus       221 ---p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         221 ---PKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             ---CCcCCHHHHHHHHHHcccCHHhcCCC
Confidence               11223456788899999999999984

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.4e-38  Score=325.05  Aligned_cols=263  Identities=24%  Similarity=0.378  Sum_probs=208.0

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCC----------------eEEEEEEecccc-chhHHHHHHHHHHhcccCCCceee
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQ----------------IEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQ  322 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~----------------~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~  322 (586)
                      .++|+..+.||+|+||.||++.+...+                ..||+|++.... ....+.+.+|++++++++|||+++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            457888999999999999999875433                568999987653 345678999999999999999999


Q ss_pred             eeeeeeccCeEEEEEecCCCCChhhhhhcCC---------CccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCC
Q 007869          323 LLGYCRRKGELLLVYDYMPNGSLDKYLYDQP---------KVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASN  393 (586)
Q Consensus       323 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~N  393 (586)
                      ++++|..++..++++||+++++|.+++....         ...+++..++.++.|+++||.|||+   .+|+||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~---~~i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHH---cCccccccchhc
Confidence            9999999999999999999999999997653         1268999999999999999999998   899999999999


Q ss_pred             eeecCCCCeEEccccceeeccCCCC-CceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh--CCCCCCCCCCC
Q 007869          394 VLLDGELNGRLGDFGLARLYDHGTD-PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC--GRRPIQRQGPS  470 (586)
Q Consensus       394 Ill~~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt--G~~p~~~~~~~  470 (586)
                      |+++.++.+||+|||+++....... .......++..|+|||++....++.++|||||||++|||++  |..||......
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ  240 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence            9999999999999999986543221 12233456789999999988899999999999999999998  67777654321


Q ss_pred             ccchhhHHHHhhhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 007869          471 ENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILE  534 (586)
Q Consensus       471 ~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  534 (586)
                         ...+.+...+..........      ........+.+++.+|++.||++||++.|+++.|+
T Consensus       241 ---~~~~~~~~~~~~~~~~~~~~------~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         241 ---QVIENAGHFFRDDGRQIYLP------RPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             ---HHHHHHHhccccccccccCC------CccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence               12222222222211111110      11122356889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=6.2e-39  Score=328.33  Aligned_cols=256  Identities=29%  Similarity=0.454  Sum_probs=202.9

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCe--EEEEEEeccc-cchhHHHHHHHHHHhccc-CCCceeeeeeeeeccCeEEEE
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQI--EIAVKKISHE-SRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKGELLLV  336 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~--~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~lV  336 (586)
                      ++|+..+.||+|+||.||+|....++.  .+++|.++.. .....+.+.+|++++.++ +||||+++++++...+..++|
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            578889999999999999999876553  4788888643 334456789999999999 799999999999999999999


Q ss_pred             EecCCCCChhhhhhcCC--------------CccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCe
Q 007869          337 YDYMPNGSLDKYLYDQP--------------KVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNG  402 (586)
Q Consensus       337 ~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~  402 (586)
                      +||+++++|.+++....              ...+++..++.++.|++.||+|||+   .+|+||||||+|||+++++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCcCCcceEEECCCCeE
Confidence            99999999999997542              1258889999999999999999998   899999999999999999999


Q ss_pred             EEccccceeeccCCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHh
Q 007869          403 RLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFD  481 (586)
Q Consensus       403 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~  481 (586)
                      ||+|||++.......  .......+..|+|||++....++.++|||||||++|||++ |+.||......+   +.+    
T Consensus       159 kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~---~~~----  229 (297)
T cd05089         159 KIADFGLSRGEEVYV--KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE---LYE----  229 (297)
T ss_pred             EECCcCCCcccccee--ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHH----
Confidence            999999987432211  1111223567999999988889999999999999999997 999997643321   111    


Q ss_pred             hhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 007869          482 FWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERDV  537 (586)
Q Consensus       482 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  537 (586)
                      ....+.     .+..    .......+.+++.+||+.+|.+||++.++++.|+...
T Consensus       230 ~~~~~~-----~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~  276 (297)
T cd05089         230 KLPQGY-----RMEK----PRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRML  276 (297)
T ss_pred             HHhcCC-----CCCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            111111     1111    1122355778999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.2e-38  Score=323.63  Aligned_cols=267  Identities=28%  Similarity=0.382  Sum_probs=202.2

Q ss_pred             cccceeEeecCceEEEEEEe----CCCCeEEEEEEecccc-chhHHHHHHHHHHhcccCCCceeeeeeeeecc--CeEEE
Q 007869          263 FREKELLGTGGFGRVYRGTL----PKSQIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRK--GELLL  335 (586)
Q Consensus       263 f~~~~~LG~G~~g~Vy~~~~----~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~--~~~~l  335 (586)
                      |...+.||+|+||+||++..    ..++..||+|.+.... ......|.+|++++++++||||+++++++...  ...++
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL   85 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence            47889999999999988653    3467789999987653 23456789999999999999999999988754  45899


Q ss_pred             EEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccC
Q 007869          336 VYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH  415 (586)
Q Consensus       336 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~  415 (586)
                      ||||+++++|.+++...   .+++.+++.++.|++.||.|||+   ++|+||||||+|||+++++.+||+|||+++....
T Consensus        86 v~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  159 (283)
T cd05080          86 IMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE  159 (283)
T ss_pred             EecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHH---CCeeccccChheEEEcCCCcEEEeecccccccCC
Confidence            99999999999999654   58999999999999999999998   8999999999999999999999999999987653


Q ss_pred             CCCC--ceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccC
Q 007869          416 GTDP--QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARD  493 (586)
Q Consensus       416 ~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d  493 (586)
                      ....  ......++..|+|||++....++.++||||||+++|||++|+.|+........ ....+.........+.+..+
T Consensus       160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  238 (283)
T cd05080         160 GHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQGQMTVVRLIELLE  238 (283)
T ss_pred             cchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-hhhcccccccchhhhhhhhh
Confidence            3211  11223456779999999888999999999999999999999999865332100 00000000000001111111


Q ss_pred             CCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 007869          494 PNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERD  536 (586)
Q Consensus       494 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  536 (586)
                      ..............+.+++..||+.+|++||+++++++.|+..
T Consensus       239 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~  281 (283)
T cd05080         239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM  281 (283)
T ss_pred             cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence            1111111222346788899999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=7.8e-39  Score=324.71  Aligned_cols=255  Identities=25%  Similarity=0.440  Sum_probs=205.5

Q ss_pred             CCcccceeEeecCceEEEEEEeC-----CCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEE
Q 007869          261 KGFREKELLGTGGFGRVYRGTLP-----KSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLL  335 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~l  335 (586)
                      ++|+..++||+|+||.||++...     .++..+|+|.+........+.+.+|++++++++|+||+++++++...+..++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            56778899999999999999742     3456799999877666667789999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhhcCCC-------------ccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCe
Q 007869          336 VYDYMPNGSLDKYLYDQPK-------------VTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNG  402 (586)
Q Consensus       336 V~E~~~~gsL~~~l~~~~~-------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~  402 (586)
                      +|||+++++|.+++.....             ..+++..++.++.|++.||.|||+   .+++||||||+|||+++++.+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS---LHFVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHH---CCeecccccHhhEEEcCCCCE
Confidence            9999999999999976421             358899999999999999999998   899999999999999999999


Q ss_pred             EEccccceeeccCCCCC-ceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHH
Q 007869          403 RLGDFGLARLYDHGTDP-QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVF  480 (586)
Q Consensus       403 kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~  480 (586)
                      ||+|||+++........ ......+++.|+|||++.+..++.++|||||||++|||++ |+.||......+.   .+.  
T Consensus       162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~~~--  236 (280)
T cd05092         162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA---IEC--  236 (280)
T ss_pred             EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH---HHH--
Confidence            99999999865432211 1122345788999999999999999999999999999998 8999865433221   111  


Q ss_pred             hhhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 007869          481 DFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILE  534 (586)
Q Consensus       481 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  534 (586)
                        ...+...  ..+       ......+.+++.+||+.||.+||++.++++.|+
T Consensus       237 --~~~~~~~--~~~-------~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         237 --ITQGREL--ERP-------RTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             --HHcCccC--CCC-------CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence              1111110  011       112345778899999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=2.3e-38  Score=328.92  Aligned_cols=244  Identities=23%  Similarity=0.286  Sum_probs=196.4

Q ss_pred             eeEeecCceEEEEEEeCCCCeEEEEEEecccc---chhHHHHHHHHHHhccc-CCCceeeeeeeeeccCeEEEEEecCCC
Q 007869          267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHES---RQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKGELLLVYDYMPN  342 (586)
Q Consensus       267 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~lV~E~~~~  342 (586)
                      +.||+|+||+||+|....++..||+|++....   ....+.+..|+.++.++ +||||+++++++...+.+++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999999999999999997642   23456688999999888 699999999999999999999999999


Q ss_pred             CChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCCcee
Q 007869          343 GSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTT  422 (586)
Q Consensus       343 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~  422 (586)
                      |+|..++...  ..+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++...... ....
T Consensus        81 ~~L~~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~  154 (327)
T cd05617          81 GDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DTTS  154 (327)
T ss_pred             CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Ccee
Confidence            9999988654  358899999999999999999998   899999999999999999999999999997532211 2234


Q ss_pred             eeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCccccH
Q 007869          423 HVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVA  502 (586)
Q Consensus       423 ~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~  502 (586)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||............++..+.......      .+...   
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~------~~p~~---  225 (327)
T cd05617         155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI------RIPRF---  225 (327)
T ss_pred             cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCC------CCCCC---
Confidence            467999999999999999999999999999999999999999754332222222333332222111      11111   


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCH
Q 007869          503 EELELVLKLGLLCSHSDPTARPSM  526 (586)
Q Consensus       503 ~~~~~l~~l~~~Cl~~dP~~RPs~  526 (586)
                       ....+.+++.+||+.||.+||++
T Consensus       226 -~~~~~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         226 -LSVKASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             -CCHHHHHHHHHHhccCHHHcCCC
Confidence             22446678889999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.8e-39  Score=323.89  Aligned_cols=257  Identities=26%  Similarity=0.438  Sum_probs=206.9

Q ss_pred             hcCCcccceeEeecCceEEEEEEeCCC-----CeEEEEEEecccc-chhHHHHHHHHHHhcccCCCceeeeeeeeeccCe
Q 007869          259 ATKGFREKELLGTGGFGRVYRGTLPKS-----QIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGE  332 (586)
Q Consensus       259 a~~~f~~~~~LG~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~  332 (586)
                      ..++|...+.||+|+||.||+|.....     +..||+|.+.... ......+.+|+.++.+++||||+++++++...+.
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   83 (277)
T cd05032           4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP   83 (277)
T ss_pred             chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence            345788899999999999999988643     3789999986543 2345678999999999999999999999999999


Q ss_pred             EEEEEecCCCCChhhhhhcCC--------CccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEE
Q 007869          333 LLLVYDYMPNGSLDKYLYDQP--------KVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRL  404 (586)
Q Consensus       333 ~~lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL  404 (586)
                      .++||||+++|+|.+++....        ...++|..++.++.|++.||.|||+   .+++||||||+|||++.++.+||
T Consensus        84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~di~p~nill~~~~~~kl  160 (277)
T cd05032          84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKI  160 (277)
T ss_pred             cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccChheEEEcCCCCEEE
Confidence            999999999999999996532        2347889999999999999999998   89999999999999999999999


Q ss_pred             ccccceeeccCCCC-CceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhh
Q 007869          405 GDFGLARLYDHGTD-PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDF  482 (586)
Q Consensus       405 ~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~  482 (586)
                      +|||+++....... .......++..|+|||.+.++.++.++|||||||++|||++ |+.||......+   ..++.   
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~---~~~~~---  234 (277)
T cd05032         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE---VLKFV---  234 (277)
T ss_pred             CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH---HHHHH---
Confidence            99999986543321 12233456889999999988889999999999999999998 999987543322   11111   


Q ss_pred             hccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 007869          483 WNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILE  534 (586)
Q Consensus       483 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  534 (586)
                       ..+...     .....    ....+.+++.+||+.+|++|||+.++++.|+
T Consensus       235 -~~~~~~-----~~~~~----~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         235 -IDGGHL-----DLPEN----CPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             -hcCCCC-----CCCCC----CCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence             111111     11111    2456788999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.8e-38  Score=324.83  Aligned_cols=250  Identities=24%  Similarity=0.372  Sum_probs=206.9

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEecC
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYM  340 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  340 (586)
                      .+|+..+.||+|++|.||+|+...++..||+|.+........+.+.+|+.++++++|+|++++++.+......++||||+
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~   99 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence            57888999999999999999998888999999998766555678899999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCCc
Q 007869          341 PNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ  420 (586)
Q Consensus       341 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~  420 (586)
                      ++++|.+++...   .+++.++..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||++........ .
T Consensus       100 ~~~~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH~---~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~  172 (296)
T cd06654         100 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K  172 (296)
T ss_pred             CCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEECccccchhcccccc-c
Confidence            999999998653   47888999999999999999998   8999999999999999999999999999886543221 2


Q ss_pred             eeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCccc
Q 007869          421 TTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEY  500 (586)
Q Consensus       421 ~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~  500 (586)
                      .....|++.|+|||.+.+..++.++|||||||++|||++|+.||....+.+..  .    .....+      .+.+  ..
T Consensus       173 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~--~----~~~~~~------~~~~--~~  238 (296)
T cd06654         173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL--Y----LIATNG------TPEL--QN  238 (296)
T ss_pred             cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhH--H----HHhcCC------CCCC--CC
Confidence            23346899999999999888999999999999999999999999765432111  0    011111      0111  11


Q ss_pred             cHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          501 VAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       501 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      .......+.+++.+||..+|++||++.++++
T Consensus       239 ~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         239 PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             ccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence            1223356778899999999999999999996

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.1e-38  Score=324.59  Aligned_cols=252  Identities=27%  Similarity=0.355  Sum_probs=203.5

Q ss_pred             CcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc---chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEe
Q 007869          262 GFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYD  338 (586)
Q Consensus       262 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E  338 (586)
                      .|+..+.||+|+||.||++....+++.||||.+....   ....+.+.+|+.++++++|+|++++++.+...+..++|||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            3677889999999999999999999999999986542   2233567889999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCC
Q 007869          339 YMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD  418 (586)
Q Consensus       339 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~  418 (586)
                      |+++++|.+++.......+++.++..++.|++.||.|||+   .+|+||||||+||++++++.++|+|||++....... 
T Consensus        81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-  156 (285)
T cd05630          81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-  156 (285)
T ss_pred             ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc-
Confidence            9999999999976555578999999999999999999998   999999999999999999999999999998654322 


Q ss_pred             CceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCc
Q 007869          419 PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGT  498 (586)
Q Consensus       419 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~  498 (586)
                       ......|+..|+|||++.+..++.++|||||||++|||++|+.||............   ......      .....  
T Consensus       157 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~---~~~~~~------~~~~~--  224 (285)
T cd05630         157 -TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV---ERLVKE------VQEEY--  224 (285)
T ss_pred             -cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHH---Hhhhhh------hhhhc--
Confidence             122347899999999999999999999999999999999999999764332111100   000000      00011  


Q ss_pred             cccHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 007869          499 EYVAEELELVLKLGLLCSHSDPTARPS-----MRQVVQ  531 (586)
Q Consensus       499 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~  531 (586)
                        .......+.+++..||+.||++|||     +.|+++
T Consensus       225 --~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         225 --SEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             --CccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence              1112345678888999999999999     788875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=3.6e-38  Score=316.47  Aligned_cols=259  Identities=24%  Similarity=0.370  Sum_probs=211.3

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc---cchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEE
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY  337 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  337 (586)
                      ++|+..+.||+|+||.||+|....++..||+|.++..   .....+.+.+|++++++++|+|++++++++...+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            5789999999999999999999888899999988642   2334567899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcC--CCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccC
Q 007869          338 DYMPNGSLDKYLYDQ--PKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH  415 (586)
Q Consensus       338 E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~  415 (586)
                      ||+++++|.+++...  ....+++.+++.++.|+++||.|||+   .+|+||||||+||+++.++.++|+|||+++....
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            999999999998653  23468899999999999999999998   8999999999999999999999999999986544


Q ss_pred             CCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCC
Q 007869          416 GTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPN  495 (586)
Q Consensus       416 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~  495 (586)
                      ... ......++..|+|||.+.+..++.++|||||||++|||++|+.||......    +.+... ....+..     +.
T Consensus       159 ~~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~-~~~~~~~-----~~  227 (267)
T cd08224         159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLCK-KIEKCDY-----PP  227 (267)
T ss_pred             CCc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc----HHHHHh-hhhcCCC-----CC
Confidence            322 223456889999999998888999999999999999999999998654321    111111 1111111     11


Q ss_pred             CCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 007869          496 LGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERD  536 (586)
Q Consensus       496 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  536 (586)
                      ..   .......+.+++.+||+.+|++||++.++++.|++.
T Consensus       228 ~~---~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~  265 (267)
T cd08224         228 LP---ADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM  265 (267)
T ss_pred             CC---hhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence            11   113345678899999999999999999999999764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=7.8e-39  Score=331.39  Aligned_cols=237  Identities=25%  Similarity=0.340  Sum_probs=193.3

Q ss_pred             eeEeecCceEEEEEEeCCCCeEEEEEEeccc---cchhHHHHHHHHHHhccc-CCCceeeeeeeeeccCeEEEEEecCCC
Q 007869          267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHE---SRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKGELLLVYDYMPN  342 (586)
Q Consensus       267 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~lV~E~~~~  342 (586)
                      +.||+|+||.||+|+++.++..||||++...   .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            4699999999999999988999999998754   233456678888888876 799999999999999999999999999


Q ss_pred             CChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCCcee
Q 007869          343 GSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTT  422 (586)
Q Consensus       343 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~  422 (586)
                      |+|.+++....  .+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++...... ....
T Consensus        81 g~L~~~i~~~~--~l~~~~~~~~~~ql~~~L~~lH~---~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~~~  154 (320)
T cd05590          81 GDLMFHIQKSR--RFDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KTTS  154 (320)
T ss_pred             chHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Cccc
Confidence            99999987653  58888999999999999999998   899999999999999999999999999988543221 1233


Q ss_pred             eeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCccccH
Q 007869          423 HVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVA  502 (586)
Q Consensus       423 ~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~  502 (586)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||......+   +...    ...+..   ..|   .    
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~---~~~~----i~~~~~---~~~---~----  217 (320)
T cd05590         155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD---LFEA----ILNDEV---VYP---T----  217 (320)
T ss_pred             ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH---HHHH----HhcCCC---CCC---C----
Confidence            4579999999999998899999999999999999999999997654321   1111    111111   111   1    


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCH
Q 007869          503 EELELVLKLGLLCSHSDPTARPSM  526 (586)
Q Consensus       503 ~~~~~l~~l~~~Cl~~dP~~RPs~  526 (586)
                      .....+.+++.+|++.||.+||++
T Consensus       218 ~~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         218 WLSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             CCCHHHHHHHHHHcccCHHHCCCC
Confidence            123456788889999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=8.3e-39  Score=326.07  Aligned_cols=257  Identities=26%  Similarity=0.434  Sum_probs=204.3

Q ss_pred             CcccceeEeecCceEEEEEEeCC-----CCeEEEEEEecccc-chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEE
Q 007869          262 GFREKELLGTGGFGRVYRGTLPK-----SQIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLL  335 (586)
Q Consensus       262 ~f~~~~~LG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~l  335 (586)
                      +|+..+.||+|+||.||+|+...     ....+++|.+.... ....+++.+|+.++++++||||+++++.|...+..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            46778999999999999998742     23568999887543 2345679999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhhcCC----------------------CccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCC
Q 007869          336 VYDYMPNGSLDKYLYDQP----------------------KVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASN  393 (586)
Q Consensus       336 V~E~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~N  393 (586)
                      ++||+++++|.+++....                      ...+++..++.++.|++.||.|||+   .+|+||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHH---CCeehhhhhhhe
Confidence            999999999999986421                      1358899999999999999999998   899999999999


Q ss_pred             eeecCCCCeEEccccceeeccCCCCC-ceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCc
Q 007869          394 VLLDGELNGRLGDFGLARLYDHGTDP-QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSE  471 (586)
Q Consensus       394 Ill~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~  471 (586)
                      ||+++++.+||+|||+++........ ......++..|+|||++.+..++.++||||||+++|||++ |+.||....+.+
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~  237 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER  237 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence            99999999999999999865332211 1222345778999999988889999999999999999998 999996543221


Q ss_pred             cchhhHHHHhhhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 007869          472 NLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERDV  537 (586)
Q Consensus       472 ~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  537 (586)
                         +    +.....+.     .+..    .......+.+++..|++.+|++||++.|+++.|++..
T Consensus       238 ---~----~~~~~~~~-----~~~~----~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~  287 (290)
T cd05045         238 ---L----FNLLKTGY-----RMER----PENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMM  287 (290)
T ss_pred             ---H----HHHHhCCC-----CCCC----CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHH
Confidence               1    11111111     0111    1122356778999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=3.9e-38  Score=327.74  Aligned_cols=256  Identities=24%  Similarity=0.251  Sum_probs=199.0

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc---cchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEE
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY  337 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  337 (586)
                      ++|+..+.||+|+||.||++++..++..||+|.+...   .......+.+|+.++..++|+||+++++++...+..++||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            4788999999999999999999988999999998653   2233456888999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCC
Q 007869          338 DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT  417 (586)
Q Consensus       338 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~  417 (586)
                      ||+++|+|.+++.... ..+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++......
T Consensus        81 Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH~---~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  156 (331)
T cd05624          81 DYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIHQ---LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG  156 (331)
T ss_pred             eCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence            9999999999997642 367888889999999999999998   999999999999999999999999999998765433


Q ss_pred             CCceeeeccCCCccCcccccC-----CCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCcccccc
Q 007869          418 DPQTTHVVGTLGYLAPEHTRT-----GKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEAR  492 (586)
Q Consensus       418 ~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~  492 (586)
                      ........||+.|+|||++.+     +.++.++|||||||++|||++|+.||......+.      ............ .
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~------~~~i~~~~~~~~-~  229 (331)
T cd05624         157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET------YGKIMNHEERFQ-F  229 (331)
T ss_pred             ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHH------HHHHHcCCCccc-C
Confidence            323334579999999999875     4678999999999999999999999976433211      111111110000 0


Q ss_pred             CCCCCccccHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 007869          493 DPNLGTEYVAEELELVLKLGLLCSHSDPTA--RPSMRQVVQI  532 (586)
Q Consensus       493 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~  532 (586)
                       |...    ....+.+.+++.+|++.++.+  |++++++++.
T Consensus       230 -p~~~----~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         230 -PSHI----TDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             -CCcc----ccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence             1111    112345666777777755543  5688888753

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=4.7e-39  Score=326.45  Aligned_cols=255  Identities=26%  Similarity=0.420  Sum_probs=203.2

Q ss_pred             CcccceeEeecCceEEEEEEeCC-----CCeEEEEEEeccccch-hHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEE
Q 007869          262 GFREKELLGTGGFGRVYRGTLPK-----SQIEIAVKKISHESRQ-GMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLL  335 (586)
Q Consensus       262 ~f~~~~~LG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~l  335 (586)
                      .|+..+.||+|+||.||+|.+..     .+..||+|++...... ..+.+..|+.++.+++||||+++++++...+..++
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~   85 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM   85 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence            46778889999999999998754     3577999999765433 34668899999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhhcCC--------------CccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCC
Q 007869          336 VYDYMPNGSLDKYLYDQP--------------KVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELN  401 (586)
Q Consensus       336 V~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~  401 (586)
                      ++||+++++|.+++....              +..+++..++.++.|++.||.|||+   ++|+||||||+|||+++++.
T Consensus        86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~  162 (283)
T cd05091          86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKLN  162 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---cCccccccchhheEecCCCc
Confidence            999999999999985321              2357888899999999999999998   89999999999999999999


Q ss_pred             eEEccccceeeccCCCCC-ceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHH
Q 007869          402 GRLGDFGLARLYDHGTDP-QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWV  479 (586)
Q Consensus       402 ~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v  479 (586)
                      +||+|||+++........ ......+++.|+|||++.++.++.++|||||||++|||++ |..||......+   ..+. 
T Consensus       163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~~~~-  238 (283)
T cd05091         163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD---VIEM-  238 (283)
T ss_pred             eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH-
Confidence            999999998865432211 1223456789999999988889999999999999999998 888887543221   1111 


Q ss_pred             HhhhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 007869          480 FDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER  535 (586)
Q Consensus       480 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  535 (586)
                         ..++...         .........+.+++..||+.+|.+||++.++++.|+.
T Consensus       239 ---i~~~~~~---------~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         239 ---IRNRQVL---------PCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             ---HHcCCcC---------CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence               1111111         1112234557889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-39  Score=320.15  Aligned_cols=270  Identities=26%  Similarity=0.340  Sum_probs=210.7

Q ss_pred             hhhhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEec--cccchhHHHHHHHHHHhcccCCCceeeeeeeeec----
Q 007869          256 LYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKIS--HESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRR----  329 (586)
Q Consensus       256 l~~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~--~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~----  329 (586)
                      .......|...+.||+|+||.|+.+..+.++..||||++.  ....-..+.-.+|+++|+.++|+||+.+++.+..    
T Consensus        17 ~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~   96 (359)
T KOG0660|consen   17 LFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRD   96 (359)
T ss_pred             EEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccc
Confidence            3445566777889999999999999999999999999997  3455566788999999999999999999998765    


Q ss_pred             -cCeEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEcccc
Q 007869          330 -KGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFG  408 (586)
Q Consensus       330 -~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFG  408 (586)
                       -+..|+|+|+| ..+|...|+.+.  .|......-++.|+++||+|+|+   .+|+||||||+|+|++.+..+||+|||
T Consensus        97 ~f~DvYiV~elM-etDL~~iik~~~--~L~d~H~q~f~YQiLrgLKyiHS---AnViHRDLKPsNll~n~~c~lKI~DFG  170 (359)
T KOG0660|consen   97 KFNDVYLVFELM-ETDLHQIIKSQQ--DLTDDHAQYFLYQILRGLKYIHS---ANVIHRDLKPSNLLLNADCDLKICDFG  170 (359)
T ss_pred             ccceeEEehhHH-hhHHHHHHHcCc--cccHHHHHHHHHHHHHhcchhhc---ccccccccchhheeeccCCCEEecccc
Confidence             35799999999 679999997763  47888888899999999999999   999999999999999999999999999


Q ss_pred             ceeeccCCC-CCceeeeccCCCccCcccccC-CCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHH-------
Q 007869          409 LARLYDHGT-DPQTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWV-------  479 (586)
Q Consensus       409 la~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v-------  479 (586)
                      +||...... ....+..+-|.+|.|||++.+ ..|+.+.||||.||++.||++|++-|.+.+.-+++.++--+       
T Consensus       171 LAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e  250 (359)
T KOG0660|consen  171 LARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEE  250 (359)
T ss_pred             ceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHH
Confidence            999876431 223467788999999998854 57999999999999999999999999887655544433111       


Q ss_pred             -HhhhccCcc---ccccCCCCCccc---cHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          480 -FDFWNRGEL---LEARDPNLGTEY---VAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       480 -~~~~~~~~~---~~~~d~~l~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                       .......+.   ....-......+   -+..-...++|..+||..||.+|+|++|.++
T Consensus       251 ~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~  309 (359)
T KOG0660|consen  251 DLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA  309 (359)
T ss_pred             HHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence             111111000   000001111111   1122345678888999999999999999986

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.1e-38  Score=327.48  Aligned_cols=256  Identities=29%  Similarity=0.459  Sum_probs=202.6

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCe--EEEEEEeccc-cchhHHHHHHHHHHhccc-CCCceeeeeeeeeccCeEEE
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQI--EIAVKKISHE-SRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKGELLL  335 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~--~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~l  335 (586)
                      .++|+..+.||+|+||.||+|.+..++.  .+|+|++... .....+.+.+|++++.++ +|+||+++++++...+..++
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l   85 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   85 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence            3578889999999999999999876554  4688877643 334556789999999999 89999999999999999999


Q ss_pred             EEecCCCCChhhhhhcCC--------------CccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCC
Q 007869          336 VYDYMPNGSLDKYLYDQP--------------KVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELN  401 (586)
Q Consensus       336 V~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~  401 (586)
                      ||||+++++|.+++....              ...+++.+++.++.|+++||.|||+   .+++||||||+|||+++++.
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dlkp~Nili~~~~~  162 (303)
T cd05088          86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYV  162 (303)
T ss_pred             EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEecCCCc
Confidence            999999999999997542              1357899999999999999999998   89999999999999999999


Q ss_pred             eEEccccceeeccCCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHH
Q 007869          402 GRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVF  480 (586)
Q Consensus       402 ~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~  480 (586)
                      +||+|||+++.....  .......++..|+|||++.+..++.++|||||||++|||++ |..||......+   ..+.+ 
T Consensus       163 ~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~~~-  236 (303)
T cd05088         163 AKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LYEKL-  236 (303)
T ss_pred             EEeCccccCcccchh--hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH---HHHHH-
Confidence            999999998643211  11122234678999999988889999999999999999998 999997543321   11111 


Q ss_pred             hhhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 007869          481 DFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERD  536 (586)
Q Consensus       481 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  536 (586)
                         ..+     ..+..    .......+.+++.+|++.+|++||++.++++.|+..
T Consensus       237 ---~~~-----~~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~  280 (303)
T cd05088         237 ---PQG-----YRLEK----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  280 (303)
T ss_pred             ---hcC-----CcCCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence               111     00001    111234578899999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=5.4e-38  Score=318.37  Aligned_cols=251  Identities=24%  Similarity=0.355  Sum_probs=200.7

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc-cchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEec
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY  339 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  339 (586)
                      ++|+..++||+|+||.||+|++..++..||+|.+... .....+++.+|++++++++||||+++++++...+..++||||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            3677889999999999999999888999999998654 334456799999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCC
Q 007869          340 MPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP  419 (586)
Q Consensus       340 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~  419 (586)
                      +++++|..+.      .+++.....++.|++.||.|||+   .+|+|+||||+|||++.++.+||+|||++......   
T Consensus        81 ~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~---  148 (279)
T cd06619          81 MDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---  148 (279)
T ss_pred             CCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc---
Confidence            9999997652      46777888999999999999998   99999999999999999999999999999865432   


Q ss_pred             ceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccch-hhHHHHhhhccCccccccCCCCCc
Q 007869          420 QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLI-LVDWVFDFWNRGELLEARDPNLGT  498 (586)
Q Consensus       420 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~-l~~~v~~~~~~~~~~~~~d~~l~~  498 (586)
                      ......||..|+|||++.+..++.++|||||||++|||++|+.||......+... ...+.. ....     ...+.+..
T Consensus       149 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~-----~~~~~~~~  222 (279)
T cd06619         149 IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQ-CIVD-----EDPPVLPV  222 (279)
T ss_pred             cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHH-HHhc-----cCCCCCCC
Confidence            2233578999999999998899999999999999999999999997533221110 111111 1000     01111111


Q ss_pred             cccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          499 EYVAEELELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       499 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                         ......+.+++.+|++.+|++||+++|+++.
T Consensus       223 ---~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         223 ---GQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             ---CcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence               1122456788899999999999999999864

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=2e-38  Score=316.60  Aligned_cols=251  Identities=24%  Similarity=0.342  Sum_probs=206.2

Q ss_pred             CcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc-cchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEecC
Q 007869          262 GFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYM  340 (586)
Q Consensus       262 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  340 (586)
                      +|+..+.||+|+||.||++.+..++..+|+|.+... .....+.+..|+.++++++|+|++++++.+..++.+++||||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            477889999999999999999988999999998643 3344567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCCc
Q 007869          341 PNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ  420 (586)
Q Consensus       341 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~  420 (586)
                      ++++|.+++.......+++...+.++.|++.||.|||+   ++|+|+||||+||++++++.++|+|||+++....... .
T Consensus        81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~  156 (255)
T cd08219          81 DGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-Y  156 (255)
T ss_pred             CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEECCCCcEEEcccCcceeeccccc-c
Confidence            99999999876545568889999999999999999998   8999999999999999999999999999987644322 2


Q ss_pred             eeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCccc
Q 007869          421 TTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEY  500 (586)
Q Consensus       421 ~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~  500 (586)
                      .....|+..|+|||++.+..++.++|+||||+++|+|++|+.||.......      ..... ..+...     .+..  
T Consensus       157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~------~~~~~-~~~~~~-----~~~~--  222 (255)
T cd08219         157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKN------LILKV-CQGSYK-----PLPS--  222 (255)
T ss_pred             cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHH------HHHHH-hcCCCC-----CCCc--
Confidence            234578999999999998889999999999999999999999997543211      11111 111111     1111  


Q ss_pred             cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          501 VAEELELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       501 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                        .....+.+++.+||+.||++||++.+++..
T Consensus       223 --~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         223 --HYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             --ccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence              122456788899999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=1.4e-38  Score=328.79  Aligned_cols=241  Identities=24%  Similarity=0.366  Sum_probs=194.2

Q ss_pred             eeEeecCceEEEEEEeCCCCeEEEEEEecccc---chhHHHHHHHHHHhccc-CCCceeeeeeeeeccCeEEEEEecCCC
Q 007869          267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHES---RQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKGELLLVYDYMPN  342 (586)
Q Consensus       267 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~lV~E~~~~  342 (586)
                      +.||+|+||.||+|++..++..||||++....   ....+.+..|..++..+ +||||+++++++...+.+++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999999889999999997642   23345567788888764 999999999999999999999999999


Q ss_pred             CChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCCcee
Q 007869          343 GSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTT  422 (586)
Q Consensus       343 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~  422 (586)
                      |+|.+++...  ..+++.+...++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++..... .....
T Consensus        81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~  154 (316)
T cd05619          81 GDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLG-DAKTC  154 (316)
T ss_pred             CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCC-CCcee
Confidence            9999999764  357888899999999999999998   89999999999999999999999999999753222 12334


Q ss_pred             eeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCccccH
Q 007869          423 HVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVA  502 (586)
Q Consensus       423 ~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~  502 (586)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||......+   +.+.+    ..+      .+....    
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~---~~~~i----~~~------~~~~~~----  217 (316)
T cd05619         155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE---LFQSI----RMD------NPCYPR----  217 (316)
T ss_pred             eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH---HHHHH----HhC------CCCCCc----
Confidence            5679999999999998899999999999999999999999997643321   11111    111      111111    


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 007869          503 EELELVLKLGLLCSHSDPTARPSMR-QVV  530 (586)
Q Consensus       503 ~~~~~l~~l~~~Cl~~dP~~RPs~~-evl  530 (586)
                      .....+.+++.+||+.||++||++. +++
T Consensus       218 ~~~~~~~~li~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05619         218 WLTREAKDILVKLFVREPERRLGVKGDIR  246 (316)
T ss_pred             cCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence            1224567888899999999999997 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.6e-38  Score=328.68  Aligned_cols=239  Identities=26%  Similarity=0.333  Sum_probs=193.2

Q ss_pred             eeEeecCceEEEEEEe---CCCCeEEEEEEeccccc--hhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEecCC
Q 007869          267 ELLGTGGFGRVYRGTL---PKSQIEIAVKKISHESR--QGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMP  341 (586)
Q Consensus       267 ~~LG~G~~g~Vy~~~~---~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~  341 (586)
                      +.||+|+||.||++..   ..++..+|+|++.....  .....+..|++++++++||||+++++++...+..++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            5799999999999876   35678899999975432  234567889999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCCce
Q 007869          342 NGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQT  421 (586)
Q Consensus       342 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~  421 (586)
                      +|+|.+++...  ..+++..+..++.||++||.|||+   .+|+||||||+|||+++++.+||+|||+++...... ...
T Consensus        82 ~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~~  155 (318)
T cd05582          82 GGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-KKA  155 (318)
T ss_pred             CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-Cce
Confidence            99999999654  358899999999999999999998   899999999999999999999999999998654321 223


Q ss_pred             eeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCcccc
Q 007869          422 THVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYV  501 (586)
Q Consensus       422 ~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~  501 (586)
                      ....||+.|+|||++....++.++|||||||++|||++|+.||......+   ....   .. +...      .+    +
T Consensus       156 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~---~~~~---i~-~~~~------~~----p  218 (318)
T cd05582         156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE---TMTM---IL-KAKL------GM----P  218 (318)
T ss_pred             ecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHH---HHHH---HH-cCCC------CC----C
Confidence            44679999999999998889999999999999999999999997643221   1111   11 1110      11    1


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHH
Q 007869          502 AEELELVLKLGLLCSHSDPTARPSMRQ  528 (586)
Q Consensus       502 ~~~~~~l~~l~~~Cl~~dP~~RPs~~e  528 (586)
                      ......+.+++.+||+.||++||++.+
T Consensus       219 ~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         219 QFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            112345678888999999999999544

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-38  Score=318.88  Aligned_cols=257  Identities=31%  Similarity=0.478  Sum_probs=208.7

Q ss_pred             hhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEE
Q 007869          258 IATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY  337 (586)
Q Consensus       258 ~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  337 (586)
                      ...++|.+.+.||+|+||.||++.+.+ +..+|||.+..... ..+++.+|+.++++++|+||+++++++......++||
T Consensus         3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~-~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (261)
T cd05034           3 IPRESLKLERKLGAGQFGEVWMGTWNG-TTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVT   80 (261)
T ss_pred             cchhheeeeeeeccCcceEEEEEEEcC-CceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEE
Confidence            345688999999999999999999864 46799999875433 3467999999999999999999999999989999999


Q ss_pred             ecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCC
Q 007869          338 DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT  417 (586)
Q Consensus       338 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~  417 (586)
                      ||+++++|.+++.......+++..+..++.|++.||.|||+   .+++|+||||+||++++++.+||+|||+++......
T Consensus        81 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~  157 (261)
T cd05034          81 EYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE  157 (261)
T ss_pred             eccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence            99999999999987655678999999999999999999998   899999999999999999999999999998765432


Q ss_pred             CCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccCccccccCCCC
Q 007869          418 DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNL  496 (586)
Q Consensus       418 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l  496 (586)
                      ........++..|+|||.+.+..++.++||||||++++||++ |+.||.......   ..+...    .+.     ....
T Consensus       158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~~~~~----~~~-----~~~~  225 (261)
T cd05034         158 YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE---VLEQVE----RGY-----RMPR  225 (261)
T ss_pred             hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHH----cCC-----CCCC
Confidence            222222335678999999998889999999999999999998 999996543211   111111    110     0000


Q ss_pred             CccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 007869          497 GTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER  535 (586)
Q Consensus       497 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  535 (586)
                          .......+.+++.+|++.+|.+||+++++++.|+.
T Consensus       226 ----~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         226 ----PPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             ----CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence                11123567889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.3e-38  Score=320.96  Aligned_cols=254  Identities=28%  Similarity=0.461  Sum_probs=199.9

Q ss_pred             cccceeEeecCceEEEEEEeCCCCe--EEEEEEeccc--cchhHHHHHHHHHHhcccCCCceeeeeeeeecc------Ce
Q 007869          263 FREKELLGTGGFGRVYRGTLPKSQI--EIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRK------GE  332 (586)
Q Consensus       263 f~~~~~LG~G~~g~Vy~~~~~~~~~--~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~------~~  332 (586)
                      |...+.||+|+||.||+|++..++.  .+|+|.+...  .....+.+..|++++++++|+||++++++|...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            3456889999999999999876654  6899988653  344567889999999999999999999987532      25


Q ss_pred             EEEEEecCCCCChhhhhhcC----CCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEcccc
Q 007869          333 LLLVYDYMPNGSLDKYLYDQ----PKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFG  408 (586)
Q Consensus       333 ~~lV~E~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFG  408 (586)
                      .+++|||+++|+|.+++...    ....+++.....++.|++.||.|||+   ++|+||||||+|||+++++.+||+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCEEECCCC
Confidence            78999999999999987432    22458899999999999999999998   899999999999999999999999999


Q ss_pred             ceeeccCCCCC-ceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccC
Q 007869          409 LARLYDHGTDP-QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRG  486 (586)
Q Consensus       409 la~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~  486 (586)
                      +++.+...... ......+++.|++||+.....++.++|||||||++|||++ |+.||......+   +    .....++
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~----~~~~~~~  230 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE---I----YDYLRQG  230 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---H----HHHHHcC
Confidence            99876433211 1122345778999999998899999999999999999999 788986543211   1    1112222


Q ss_pred             ccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 007869          487 ELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER  535 (586)
Q Consensus       487 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  535 (586)
                      ....     .    .......+.+++.+||+.||++|||+.++++.|+.
T Consensus       231 ~~~~-----~----~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~  270 (272)
T cd05075         231 NRLK-----Q----PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK  270 (272)
T ss_pred             CCCC-----C----CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence            2111     0    11223557899999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=2.3e-38  Score=322.22  Aligned_cols=251  Identities=25%  Similarity=0.339  Sum_probs=202.1

Q ss_pred             cccceeEeecCceEEEEEEeCCCCeEEEEEEecccc---chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEec
Q 007869          263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY  339 (586)
Q Consensus       263 f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  339 (586)
                      |+..+.||+|+||+||++.+..+++.+|+|.+....   ......+.+|++++++++|+|++++.+.+..++..++||||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            667789999999999999999889999999986542   22335578899999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCC
Q 007869          340 MPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP  419 (586)
Q Consensus       340 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~  419 (586)
                      +++++|.+++.......+++..+..++.|++.||.|||+   .+|+||||||+||++++++.+||+|||++.......  
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~---~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~--  156 (285)
T cd05632          82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE--  156 (285)
T ss_pred             ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC--
Confidence            999999999876555579999999999999999999998   899999999999999999999999999997654322  


Q ss_pred             ceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCcc
Q 007869          420 QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTE  499 (586)
Q Consensus       420 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~  499 (586)
                      ......|+..|+|||++.+..++.++|+|||||++|||++|+.||.........  .. +......+      .+.    
T Consensus       157 ~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~--~~-~~~~~~~~------~~~----  223 (285)
T cd05632         157 SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKR--EE-VDRRVLET------EEV----  223 (285)
T ss_pred             cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHH--HH-HHHhhhcc------ccc----
Confidence            223457899999999999889999999999999999999999999764332111  11 11111111      011    


Q ss_pred             ccHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 007869          500 YVAEELELVLKLGLLCSHSDPTARPS-----MRQVVQ  531 (586)
Q Consensus       500 ~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~  531 (586)
                      +.......+.+++..|++.||++||+     +.++++
T Consensus       224 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         224 YSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             cCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence            11122345678888999999999999     555554

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-39  Score=324.05  Aligned_cols=256  Identities=26%  Similarity=0.349  Sum_probs=204.2

Q ss_pred             hhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccc--------------hhHHHHHHHHHHhcccCCCceeee
Q 007869          258 IATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR--------------QGMKEFVAEIVSIGRLRHRNLVQL  323 (586)
Q Consensus       258 ~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------------~~~~~~~~Ei~~l~~l~H~niv~l  323 (586)
                      ..-++|...+.||+|.||+|-+|+...+++.||||++.+...              ...+...+||.+|++++|||||+|
T Consensus        94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L  173 (576)
T KOG0585|consen   94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL  173 (576)
T ss_pred             eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence            445789999999999999999999999999999999965321              123578999999999999999999


Q ss_pred             eeeeecc--CeEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCC
Q 007869          324 LGYCRRK--GELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELN  401 (586)
Q Consensus       324 ~~~~~~~--~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~  401 (586)
                      +.+..+.  +.+|||+|||..|.+...=-..  ..+.+.+.++++.++..||.|||.   ++||||||||+|+||+++++
T Consensus       174 iEvLDDP~s~~~YlVley~s~G~v~w~p~d~--~els~~~Ar~ylrDvv~GLEYLH~---QgiiHRDIKPsNLLl~~~g~  248 (576)
T KOG0585|consen  174 IEVLDDPESDKLYLVLEYCSKGEVKWCPPDK--PELSEQQARKYLRDVVLGLEYLHY---QGIIHRDIKPSNLLLSSDGT  248 (576)
T ss_pred             EEeecCcccCceEEEEEeccCCccccCCCCc--ccccHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEEcCCCc
Confidence            9998764  6799999999988876543222  228999999999999999999998   99999999999999999999


Q ss_pred             eEEccccceeeccCCCC----CceeeeccCCCccCcccccCCC----CCCcceEEehhHHHHHHHhCCCCCCCCCCCccc
Q 007869          402 GRLGDFGLARLYDHGTD----PQTTHVVGTLGYLAPEHTRTGK----ATTSADVFSFGAFLLEVACGRRPIQRQGPSENL  473 (586)
Q Consensus       402 ~kL~DFGla~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~----~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~  473 (586)
                      +||+|||.+.....+..    ......+||+.|+|||.+.++.    .+.+.||||+||+||.|+.|+.||.+....+  
T Consensus       249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~--  326 (576)
T KOG0585|consen  249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELE--  326 (576)
T ss_pred             EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHH--
Confidence            99999999987643322    1233468999999999998743    3567899999999999999999998754322  


Q ss_pred             hhhHHHHhhhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 007869          474 ILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQIL  533 (586)
Q Consensus       474 ~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L  533 (586)
                       +-    ...        +...+.-.-.+++-+.+.+|++++|++||++|.+..+|....
T Consensus       327 -l~----~KI--------vn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp  373 (576)
T KOG0585|consen  327 -LF----DKI--------VNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP  373 (576)
T ss_pred             -HH----HHH--------hcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence             11    111        111111112234567788899999999999999999998765

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-38  Score=317.23  Aligned_cols=250  Identities=32%  Similarity=0.484  Sum_probs=206.8

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEec
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY  339 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  339 (586)
                      .++|+..+.||+|+||.||+|...  +..||+|.+..... ..+++.+|+.++++++|+||+++++++...+..++||||
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   81 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY   81 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence            457888999999999999999874  56799999976644 567899999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCC
Q 007869          340 MPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP  419 (586)
Q Consensus       340 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~  419 (586)
                      +++++|.+++.......+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||+++......  
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~--  156 (256)
T cd05039          82 MAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ--  156 (256)
T ss_pred             cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCccchhcccceEEEeCCCCEEEccccccccccccc--
Confidence            999999999987655578999999999999999999998   999999999999999999999999999998763322  


Q ss_pred             ceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCc
Q 007869          420 QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGT  498 (586)
Q Consensus       420 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~  498 (586)
                        ....++..|+|||++.++.++.++||||||+++||+++ |+.||......+   +...+    ..+..     +.   
T Consensus       157 --~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~----~~~~~-----~~---  219 (256)
T cd05039         157 --DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPHV----EKGYR-----ME---  219 (256)
T ss_pred             --ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHH----hcCCC-----CC---
Confidence              12345678999999998899999999999999999997 999986543211   11111    11100     00   


Q ss_pred             cccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 007869          499 EYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER  535 (586)
Q Consensus       499 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  535 (586)
                       ........+.+++.+|+..+|++||++.++++.|+.
T Consensus       220 -~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         220 -APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             -CccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence             111223567888999999999999999999999864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=8.7e-39  Score=340.02  Aligned_cols=263  Identities=27%  Similarity=0.422  Sum_probs=207.4

Q ss_pred             hhhhcCCcccceeEeecCceEEEEEEeC-----CCCeEEEEEEeccccc-hhHHHHHHHHHHhcccC-CCceeeeeeeee
Q 007869          256 LYIATKGFREKELLGTGGFGRVYRGTLP-----KSQIEIAVKKISHESR-QGMKEFVAEIVSIGRLR-HRNLVQLLGYCR  328 (586)
Q Consensus       256 l~~a~~~f~~~~~LG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~-H~niv~l~~~~~  328 (586)
                      .....++|...+.||+|+||.||+|++.     ..+..||||++..... ...+.+..|+++|.++. ||||++++++|.
T Consensus        32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~  111 (401)
T cd05107          32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT  111 (401)
T ss_pred             ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence            4455567888899999999999999964     3456899999976532 33457899999999997 999999999999


Q ss_pred             ccCeEEEEEecCCCCChhhhhhcCCC------------------------------------------------------
Q 007869          329 RKGELLLVYDYMPNGSLDKYLYDQPK------------------------------------------------------  354 (586)
Q Consensus       329 ~~~~~~lV~E~~~~gsL~~~l~~~~~------------------------------------------------------  354 (586)
                      ..+..++||||+++|+|.++++....                                                      
T Consensus       112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (401)
T cd05107         112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP  191 (401)
T ss_pred             cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence            99999999999999999999965321                                                      


Q ss_pred             ------------------------------------------ccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCC
Q 007869          355 ------------------------------------------VTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKAS  392 (586)
Q Consensus       355 ------------------------------------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~  392 (586)
                                                                ..+++...+.++.|++.||.|||+   .+++||||||+
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrdlkp~  268 (401)
T cd05107         192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAAR  268 (401)
T ss_pred             hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhc---CCcCcccCCcc
Confidence                                                      236777889999999999999998   89999999999


Q ss_pred             CeeecCCCCeEEccccceeeccCCCC-CceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCC
Q 007869          393 NVLLDGELNGRLGDFGLARLYDHGTD-PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPS  470 (586)
Q Consensus       393 NIll~~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~  470 (586)
                      |||+++++.+||+|||+++....... .......++..|+|||.+....++.++|||||||++|||++ |+.||......
T Consensus       269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~  348 (401)
T cd05107         269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN  348 (401)
T ss_pred             eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence            99999999999999999986543221 11223457889999999998889999999999999999998 88998654322


Q ss_pred             ccchhhHHHHhhhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 007869          471 ENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERD  536 (586)
Q Consensus       471 ~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  536 (586)
                      +.      .......+..  ...|       ......+.+++.+||+.+|.+||+++++++.|++.
T Consensus       349 ~~------~~~~~~~~~~--~~~p-------~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~  399 (401)
T cd05107         349 EQ------FYNAIKRGYR--MAKP-------AHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL  399 (401)
T ss_pred             HH------HHHHHHcCCC--CCCC-------CCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            21      1111111110  0111       11235678888899999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.4e-38  Score=329.17  Aligned_cols=242  Identities=24%  Similarity=0.315  Sum_probs=197.0

Q ss_pred             eeEeecCceEEEEEEeCCCCeEEEEEEecccc---chhHHHHHHHHHHhccc-CCCceeeeeeeeeccCeEEEEEecCCC
Q 007869          267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHES---RQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKGELLLVYDYMPN  342 (586)
Q Consensus       267 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~lV~E~~~~  342 (586)
                      +.||+|+||.||++.+..++..||||++....   ......+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999999889999999997542   23455677888888887 799999999999999999999999999


Q ss_pred             CChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCCcee
Q 007869          343 GSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTT  422 (586)
Q Consensus       343 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~  422 (586)
                      |+|..++...  ..+++.++..++.|++.||.|||+   .+|+||||||+|||+++++.+||+|||+++...... ....
T Consensus        81 ~~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~  154 (318)
T cd05570          81 GDLMFHIQRS--GRFDEPRARFYAAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-VTTS  154 (318)
T ss_pred             CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeEccCCCHHHeEECCCCcEEecccCCCeecCcCC-Cccc
Confidence            9999988765  368899999999999999999998   899999999999999999999999999987532211 1233


Q ss_pred             eeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCccccH
Q 007869          423 HVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVA  502 (586)
Q Consensus       423 ~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~  502 (586)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||......+   +..    ......      +..    ..
T Consensus       155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~---~~~----~i~~~~------~~~----~~  217 (318)
T cd05570         155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE---LFQ----SILEDE------VRY----PR  217 (318)
T ss_pred             ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH---HHH----HHHcCC------CCC----CC
Confidence            4578999999999999999999999999999999999999997543211   111    111111      111    11


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 007869          503 EELELVLKLGLLCSHSDPTARPSM-----RQVVQ  531 (586)
Q Consensus       503 ~~~~~l~~l~~~Cl~~dP~~RPs~-----~evl~  531 (586)
                      .....+.+++.+||+.||.+||++     .++++
T Consensus       218 ~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         218 WLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             cCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence            123457788899999999999999     77764

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=2e-38  Score=315.61  Aligned_cols=247  Identities=26%  Similarity=0.429  Sum_probs=199.0

Q ss_pred             eeEeecCceEEEEEEeCCCCeEEEEEEeccccc-hhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEecCCCCCh
Q 007869          267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR-QGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSL  345 (586)
Q Consensus       267 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL  345 (586)
                      ++||+|+||.||+|... ++..+|+|.+..... .....+.+|++++++++||||++++++|...+..++||||+++++|
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   79 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF   79 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence            36999999999999975 567899999876543 3345689999999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCCceeeec
Q 007869          346 DKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVV  425 (586)
Q Consensus       346 ~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~  425 (586)
                      .+++.... ..+++..++.++.|++.+|.|||+   ++++||||||+||+++.++.+||+|||+++..............
T Consensus        80 ~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  155 (250)
T cd05085          80 LSFLRKKK-DELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQ  155 (250)
T ss_pred             HHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCC
Confidence            99986553 457899999999999999999998   89999999999999999999999999999865433222222234


Q ss_pred             cCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCccccHHH
Q 007869          426 GTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAEE  504 (586)
Q Consensus       426 gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~  504 (586)
                      ++..|+|||++.+..++.++||||||+++||+++ |..||.......   ..    .....+..     ..    .....
T Consensus       156 ~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~---~~----~~~~~~~~-----~~----~~~~~  219 (250)
T cd05085         156 IPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ---AR----EQVEKGYR-----MS----CPQKC  219 (250)
T ss_pred             CcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH---HH----HHHHcCCC-----CC----CCCCC
Confidence            4678999999998899999999999999999998 999997543221   11    11111111     01    11123


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 007869          505 LELVLKLGLLCSHSDPTARPSMRQVVQILE  534 (586)
Q Consensus       505 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  534 (586)
                      ...+.+++.+|++.+|++||++.|+++.|.
T Consensus       220 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         220 PDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            456888999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=3.4e-38  Score=316.20  Aligned_cols=256  Identities=27%  Similarity=0.468  Sum_probs=206.7

Q ss_pred             hhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEE
Q 007869          258 IATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY  337 (586)
Q Consensus       258 ~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  337 (586)
                      +..++|+..+.||+|+||.||++.+.. +..+|+|.+.... ...+.+.+|++++++++|+|++++++.+.. ...+++|
T Consensus         3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~-~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~   79 (260)
T cd05073           3 IPRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIIT   79 (260)
T ss_pred             ccccceeEEeEecCccceEEEEEEecC-CccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEE
Confidence            345678999999999999999998754 4569999886543 335678999999999999999999999887 7789999


Q ss_pred             ecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCC
Q 007869          338 DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT  417 (586)
Q Consensus       338 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~  417 (586)
                      ||+++++|.+++.......+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++.......
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  156 (260)
T cd05073          80 EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE  156 (260)
T ss_pred             EeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence            99999999999987655678899999999999999999998   899999999999999999999999999998765433


Q ss_pred             CCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccCccccccCCCC
Q 007869          418 DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNL  496 (586)
Q Consensus       418 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l  496 (586)
                      ........++..|+|||++....++.++|+|||||++||+++ |+.||......+   +..+.    ..+...    +  
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~~~----~~~~~~----~--  223 (260)
T cd05073         157 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---VIRAL----ERGYRM----P--  223 (260)
T ss_pred             cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH---HHHHH----hCCCCC----C--
Confidence            222233346678999999998889999999999999999998 899997543221   11111    111111    0  


Q ss_pred             CccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 007869          497 GTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER  535 (586)
Q Consensus       497 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  535 (586)
                         ........+.+++.+|++.+|++||++.++++.|+.
T Consensus       224 ---~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         224 ---RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             ---CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence               111223567888999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1.8e-38  Score=319.53  Aligned_cols=256  Identities=28%  Similarity=0.509  Sum_probs=205.5

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCC---CeEEEEEEecccc-chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEE
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKS---QIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLL  335 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~l  335 (586)
                      ..+|+..+.||+|+||.||+|.+..+   +..+|+|.+.... ....+.+..|+.++.+++||||+++++++...+..++
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI   82 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            35678889999999999999987533   3479999986542 3345678999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccC
Q 007869          336 VYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH  415 (586)
Q Consensus       336 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~  415 (586)
                      ||||+++++|.+++.... ..+++.+++.++.|++.||.|||+   ++++||||||+|||++.++.+||+|||+++.+..
T Consensus        83 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd05066          83 VTEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  158 (267)
T ss_pred             EEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCEeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence            999999999999997653 368899999999999999999998   8999999999999999999999999999987654


Q ss_pred             CCCCcee--eeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccCcccccc
Q 007869          416 GTDPQTT--HVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEAR  492 (586)
Q Consensus       416 ~~~~~~~--~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~  492 (586)
                      ......+  ...++..|+|||++.+..++.++|||||||++||+++ |+.||......+   ....+.    ++.  .  
T Consensus       159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---~~~~~~----~~~--~--  227 (267)
T cd05066         159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD---VIKAIE----EGY--R--  227 (267)
T ss_pred             ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH---HHHHHh----CCC--c--
Confidence            3221111  1223568999999998899999999999999999886 999997654322   111111    110  0  


Q ss_pred             CCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 007869          493 DPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER  535 (586)
Q Consensus       493 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  535 (586)
                      .+.     .......+.+++.+|++.+|.+||+|.++++.|++
T Consensus       228 ~~~-----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  265 (267)
T cd05066         228 LPA-----PMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDK  265 (267)
T ss_pred             CCC-----CCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence            011     11223567789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.8e-38  Score=321.62  Aligned_cols=260  Identities=25%  Similarity=0.390  Sum_probs=205.6

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCe----EEEEEEecccc-chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEE
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQI----EIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELL  334 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~  334 (586)
                      .++|+..+.||+|+||.||+|++..++.    .||+|.+.... ....+++.+|+.++.+++||||++++++|... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~   84 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQ   84 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcE
Confidence            4578888999999999999999765554    48999987543 33456789999999999999999999999754 578


Q ss_pred             EEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeecc
Q 007869          335 LVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYD  414 (586)
Q Consensus       335 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~  414 (586)
                      +++||+++|+|.+++.... ..+++..++.++.|++.||.|||+   ++|+||||||+|||+++++.+||+|||+++...
T Consensus        85 l~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~  160 (279)
T cd05109          85 LVTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLD  160 (279)
T ss_pred             EEEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCCCceeecc
Confidence            9999999999999997653 368899999999999999999998   899999999999999999999999999998765


Q ss_pred             CCCCC-ceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccCcccccc
Q 007869          415 HGTDP-QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEAR  492 (586)
Q Consensus       415 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~  492 (586)
                      ..... ......++..|+|||.+.+..++.++|||||||++|||++ |..||......   .+..++.    .+...   
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~~~----~~~~~---  230 (279)
T cd05109         161 IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR---EIPDLLE----KGERL---  230 (279)
T ss_pred             cccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHH----CCCcC---
Confidence            33221 1112235678999999998899999999999999999998 89998654321   1222211    11111   


Q ss_pred             CCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhccCCC
Q 007869          493 DPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERDVALP  540 (586)
Q Consensus       493 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~p  540 (586)
                        ..    .......+.+++.+||+.||++||++.++++.|+....-|
T Consensus       231 --~~----~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~  272 (279)
T cd05109         231 --PQ----PPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP  272 (279)
T ss_pred             --CC----CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence              00    1112345778899999999999999999999998765444

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.8e-38  Score=328.12  Aligned_cols=241  Identities=24%  Similarity=0.341  Sum_probs=193.8

Q ss_pred             eeEeecCceEEEEEEeCCCCeEEEEEEecccc---chhHHHHHHHHHHhccc-CCCceeeeeeeeeccCeEEEEEecCCC
Q 007869          267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHES---RQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKGELLLVYDYMPN  342 (586)
Q Consensus       267 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~lV~E~~~~  342 (586)
                      +.||+|+||.||+|++..++..||+|++....   ....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999999999999999997542   23345667788887764 899999999999999999999999999


Q ss_pred             CChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCCcee
Q 007869          343 GSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTT  422 (586)
Q Consensus       343 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~  422 (586)
                      |+|.+++...  ..+++.+...++.|+++||.|||+   ++|+||||||+|||++.++.+||+|||+++...... ....
T Consensus        81 g~L~~~i~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~  154 (316)
T cd05620          81 GDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NRAS  154 (316)
T ss_pred             CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Ccee
Confidence            9999998765  357888899999999999999998   899999999999999999999999999987532221 2334


Q ss_pred             eeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCccccH
Q 007869          423 HVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVA  502 (586)
Q Consensus       423 ~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~  502 (586)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||......+   +.    +....+      .+.+...   
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~---~~----~~~~~~------~~~~~~~---  218 (316)
T cd05620         155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE---LF----ESIRVD------TPHYPRW---  218 (316)
T ss_pred             ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---HH----HHHHhC------CCCCCCC---
Confidence            5679999999999999999999999999999999999999997643211   11    111111      1111111   


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 007869          503 EELELVLKLGLLCSHSDPTARPSMR-QVV  530 (586)
Q Consensus       503 ~~~~~l~~l~~~Cl~~dP~~RPs~~-evl  530 (586)
                       ....+.+++.+||+.||++||++. +++
T Consensus       219 -~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         219 -ITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             -CCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence             224566788899999999999985 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=4.5e-38  Score=322.15  Aligned_cols=259  Identities=25%  Similarity=0.366  Sum_probs=210.9

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEecC
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYM  340 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  340 (586)
                      ++|+..+.||+|+||.||+++...++..||+|.+........+.+.+|+.++++++|+|++++++++...+..++||||+
T Consensus        19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~   98 (297)
T cd06656          19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   98 (297)
T ss_pred             hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence            67888999999999999999998889999999997665555677899999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCCc
Q 007869          341 PNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ  420 (586)
Q Consensus       341 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~  420 (586)
                      ++++|.+++.+.   .+++.++..++.|++.||.|||+   .+++||||||+|||++.++.+||+|||++........ .
T Consensus        99 ~~~~L~~~~~~~---~~~~~~~~~~~~~l~~~L~~LH~---~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~-~  171 (297)
T cd06656          99 AGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K  171 (297)
T ss_pred             CCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc-C
Confidence            999999998653   57888999999999999999998   8999999999999999999999999999986543322 2


Q ss_pred             eeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCccc
Q 007869          421 TTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEY  500 (586)
Q Consensus       421 ~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~  500 (586)
                      .....+++.|+|||.+.+..++.++|+|||||++|+|++|+.||...........      ....      ..+.+  ..
T Consensus       172 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~------~~~~------~~~~~--~~  237 (297)
T cd06656         172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------IATN------GTPEL--QN  237 (297)
T ss_pred             cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee------eccC------CCCCC--CC
Confidence            2345688999999999988899999999999999999999999976443221100      0000      01111  11


Q ss_pred             cHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHhhccCCC
Q 007869          501 VAEELELVLKLGLLCSHSDPTARPSMRQVVQ--ILERDVALP  540 (586)
Q Consensus       501 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~~~~~p  540 (586)
                      .......+.+++.+||+.+|++||++.++++  .++...+.+
T Consensus       238 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~  279 (297)
T cd06656         238 PERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPLS  279 (297)
T ss_pred             ccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhccccccc
Confidence            1223355678889999999999999999997  444444433

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=2.3e-38  Score=318.93  Aligned_cols=255  Identities=27%  Similarity=0.483  Sum_probs=204.3

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCe---EEEEEEeccc-cchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEE
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQI---EIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLV  336 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~---~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV  336 (586)
                      ..|+..+.||+|+||.||+|.+..++.   .||||.+... ......+|..|+.++++++||||+++++++...+..++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            347788999999999999999876553   6999998764 344567899999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCC
Q 007869          337 YDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHG  416 (586)
Q Consensus       337 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~  416 (586)
                      |||+++++|.+++.... ..+++.+++.++.|++.||.|||+   ++++||||||+||+++.++.+||+|||+++.....
T Consensus        84 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  159 (269)
T cd05065          84 TEFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD  159 (269)
T ss_pred             EecCCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEEECCCccccccccC
Confidence            99999999999997653 468899999999999999999998   89999999999999999999999999999865433


Q ss_pred             CCCc-eee-ec--cCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccCccccc
Q 007869          417 TDPQ-TTH-VV--GTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEA  491 (586)
Q Consensus       417 ~~~~-~~~-~~--gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~  491 (586)
                      .... ... ..  .+..|+|||++....++.++|||||||++||+++ |+.||......   ...+++...+        
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---~~~~~i~~~~--------  228 (269)
T cd05065         160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVINAIEQDY--------  228 (269)
T ss_pred             ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---HHHHHHHcCC--------
Confidence            2211 111 11  2457999999998999999999999999999886 99999754322   1222221110        


Q ss_pred             cCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 007869          492 RDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER  535 (586)
Q Consensus       492 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  535 (586)
                       ....    ..+....+.+++..||+.+|.+||++.++++.|++
T Consensus       229 -~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  267 (269)
T cd05065         229 -RLPP----PMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDK  267 (269)
T ss_pred             -cCCC----cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence             0000    11223457789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=2e-38  Score=329.06  Aligned_cols=241  Identities=25%  Similarity=0.282  Sum_probs=191.9

Q ss_pred             eeEeecCceEEEEEEeCCCCeEEEEEEeccc---cchhHHHHHHHHH-HhcccCCCceeeeeeeeeccCeEEEEEecCCC
Q 007869          267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHE---SRQGMKEFVAEIV-SIGRLRHRNLVQLLGYCRRKGELLLVYDYMPN  342 (586)
Q Consensus       267 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~-~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~  342 (586)
                      +.||+|+||+||+++...++..+|+|++...   .......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            4699999999999999989999999999654   2233345566655 46778999999999999999999999999999


Q ss_pred             CChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCCcee
Q 007869          343 GSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTT  422 (586)
Q Consensus       343 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~  422 (586)
                      |+|..++...  ..+++.+...++.||+.||.|||+   .+|+||||||+|||+++++.+||+|||+++...... ....
T Consensus        81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~  154 (325)
T cd05604          81 GELFFHLQRE--RSFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-DTTT  154 (325)
T ss_pred             CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-CCcc
Confidence            9999988654  368888999999999999999998   899999999999999999999999999987532211 2234


Q ss_pred             eeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCccccH
Q 007869          423 HVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVA  502 (586)
Q Consensus       423 ~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~  502 (586)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||......+   +.   .. ...+..  ...+        
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~---~~---~~-~~~~~~--~~~~--------  217 (325)
T cd05604         155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE---MY---DN-ILHKPL--VLRP--------  217 (325)
T ss_pred             cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH---HH---HH-HHcCCc--cCCC--------
Confidence            4679999999999999999999999999999999999999997643321   11   11 111111  0111        


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 007869          503 EELELVLKLGLLCSHSDPTARPSMRQVV  530 (586)
Q Consensus       503 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl  530 (586)
                      .....+.+++.+|++.+|.+||++++.+
T Consensus       218 ~~~~~~~~ll~~ll~~~p~~R~~~~~~~  245 (325)
T cd05604         218 GASLTAWSILEELLEKDRQRRLGAKEDF  245 (325)
T ss_pred             CCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence            1224566788889999999999886433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.1e-38  Score=343.92  Aligned_cols=263  Identities=21%  Similarity=0.317  Sum_probs=195.8

Q ss_pred             hcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeecc--------
Q 007869          259 ATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRK--------  330 (586)
Q Consensus       259 a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~--------  330 (586)
                      ..++|+..+.||+|+||.||+|++..++..||||++....    ....+|+.++++++||||+++++++...        
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~  139 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN  139 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence            4567999999999999999999998889999999985432    2345799999999999999999876432        


Q ss_pred             CeEEEEEecCCCCChhhhhhc--CCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCC-CeEEccc
Q 007869          331 GELLLVYDYMPNGSLDKYLYD--QPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGEL-NGRLGDF  407 (586)
Q Consensus       331 ~~~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~-~~kL~DF  407 (586)
                      ..+++||||++ ++|.+++..  .....+++.....++.||+.||.|||+   ++|+||||||+|||++.++ .+||+||
T Consensus       140 ~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~---~~IiHrDLKp~NILl~~~~~~vkL~DF  215 (440)
T PTZ00036        140 IFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDF  215 (440)
T ss_pred             eEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCcCHHHEEEcCCCCceeeecc
Confidence            24679999997 477777653  223568888999999999999999998   8999999999999998664 7999999


Q ss_pred             cceeeccCCCCCceeeeccCCCccCcccccCC-CCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhc--
Q 007869          408 GLARLYDHGTDPQTTHVVGTLGYLAPEHTRTG-KATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWN--  484 (586)
Q Consensus       408 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~--  484 (586)
                      |+|+.+....  ......||+.|+|||++.+. .++.++|||||||++|||++|++||.+....+....+..+.....  
T Consensus       216 Gla~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~  293 (440)
T PTZ00036        216 GSAKNLLAGQ--RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTED  293 (440)
T ss_pred             ccchhccCCC--CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence            9998764332  22345789999999998654 689999999999999999999999987554332211110000000  


Q ss_pred             -----cCccccccCCCCC-----ccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          485 -----RGELLEARDPNLG-----TEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       485 -----~~~~~~~~d~~l~-----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                           ........-|...     ..+.......+.+++.+||+.||.+|||+.|+++
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~  350 (440)
T PTZ00036        294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA  350 (440)
T ss_pred             HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence                 0000000001110     1111122356789999999999999999999984

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.8e-38  Score=325.06  Aligned_cols=204  Identities=26%  Similarity=0.312  Sum_probs=177.5

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc---cchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEE
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY  337 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  337 (586)
                      ++|+..+.||+|+||.||+++...++..||+|++...   .....+.+.+|+.++..++|+||+++++++...+..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            4688899999999999999999988999999999652   2233456889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCC
Q 007869          338 DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT  417 (586)
Q Consensus       338 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~  417 (586)
                      ||+++|+|.+++.+. ...+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||++..+....
T Consensus        81 e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  156 (331)
T cd05597          81 DYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG  156 (331)
T ss_pred             ecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence            999999999999653 2357888899999999999999998   999999999999999999999999999998765433


Q ss_pred             CCceeeeccCCCccCcccccC-----CCCCCcceEEehhHHHHHHHhCCCCCCCCC
Q 007869          418 DPQTTHVVGTLGYLAPEHTRT-----GKATTSADVFSFGAFLLEVACGRRPIQRQG  468 (586)
Q Consensus       418 ~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~  468 (586)
                      ........||+.|+|||++..     ..++.++|||||||++|||++|+.||....
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~  212 (331)
T cd05597         157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAES  212 (331)
T ss_pred             CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCC
Confidence            333334579999999999863     457889999999999999999999997643

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.3e-38  Score=318.14  Aligned_cols=253  Identities=31%  Similarity=0.488  Sum_probs=203.1

Q ss_pred             cccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhH--HHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEecC
Q 007869          263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGM--KEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYM  340 (586)
Q Consensus       263 f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~--~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  340 (586)
                      |+..+.||+|+||+||+++...++..+|+|++........  .....|+..+++++||||+++++++...+..++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            5678999999999999999999999999999987644332  23456999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCCc
Q 007869          341 PNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ  420 (586)
Q Consensus       341 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~  420 (586)
                      ++++|.+++...  ..+++..++.++.|+++||.|||+   .+|+||||||+||++++++.++|+|||.+..... ....
T Consensus        81 ~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~Lh~---~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~-~~~~  154 (260)
T PF00069_consen   81 PGGSLQDYLQKN--KPLSEEEILKIAYQILEALAYLHS---KGIVHRDIKPENILLDENGEVKLIDFGSSVKLSE-NNEN  154 (260)
T ss_dssp             TTEBHHHHHHHH--SSBBHHHHHHHHHHHHHHHHHHHH---TTEEESSBSGGGEEESTTSEEEESSGTTTEESTS-TTSE
T ss_pred             cccccccccccc--cccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc-cccc
Confidence            999999999832  468999999999999999999998   8999999999999999999999999999986521 2234


Q ss_pred             eeeeccCCCccCccccc-CCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCcc
Q 007869          421 TTHVVGTLGYLAPEHTR-TGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTE  499 (586)
Q Consensus       421 ~~~~~gt~~y~aPE~~~-~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~  499 (586)
                      .....++..|+|||++. +..++.++||||+|+++++|++|+.||......+........   ... ......   .   
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~---~~~-~~~~~~---~---  224 (260)
T PF00069_consen  155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKI---LKR-PLPSSS---Q---  224 (260)
T ss_dssp             BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHH---HHT-HHHHHT---T---
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhc---ccc-cccccc---c---
Confidence            44567899999999998 788999999999999999999999999865211111111100   000 000000   0   


Q ss_pred             ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          500 YVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       500 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      ........+.+++..||+.||++||++.++++
T Consensus       225 ~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  225 QSREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             ccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00011267889999999999999999999985

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=4.5e-38  Score=314.11  Aligned_cols=251  Identities=24%  Similarity=0.363  Sum_probs=205.6

Q ss_pred             CcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc--chhHHHHHHHHHHhcccCCCceeeeeeeeec-cCeEEEEEe
Q 007869          262 GFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES--RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRR-KGELLLVYD  338 (586)
Q Consensus       262 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~-~~~~~lV~E  338 (586)
                      +|+..+.||+|++|.||++....++..+|+|++....  ....+.+.+|++++++++|+|++++++.+.. .+.++++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4788999999999999999998888999999986542  3445678999999999999999999998764 456899999


Q ss_pred             cCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCC
Q 007869          339 YMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD  418 (586)
Q Consensus       339 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~  418 (586)
                      |+++++|.+++.......+++.+++.++.|++.||.|||+   .+++||||||+||+++.++.++|+|||++........
T Consensus        81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~---~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~  157 (257)
T cd08223          81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD  157 (257)
T ss_pred             ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCchhEEEecCCcEEEecccceEEecccCC
Confidence            9999999999987555568999999999999999999998   8999999999999999999999999999987644322


Q ss_pred             CceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCc
Q 007869          419 PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGT  498 (586)
Q Consensus       419 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~  498 (586)
                       ......+++.|+|||++.+..++.++|||||||+++||++|+.||......      +..... ..+..     +.+  
T Consensus       158 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~------~~~~~~-~~~~~-----~~~--  222 (257)
T cd08223         158 -MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN------SLVYRI-IEGKL-----PPM--  222 (257)
T ss_pred             -ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH------HHHHHH-HhcCC-----CCC--
Confidence             233456899999999999999999999999999999999999998754321      111111 11111     111  


Q ss_pred             cccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          499 EYVAEELELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       499 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                        .......+.+++.+|++.+|++||++.++++.
T Consensus       223 --~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         223 --PKDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             --ccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence              12233567889999999999999999999853

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=1.8e-38  Score=323.44  Aligned_cols=261  Identities=25%  Similarity=0.444  Sum_probs=205.6

Q ss_pred             hhcCCcccceeEeecCceEEEEEEeCC-----CCeEEEEEEecccc-chhHHHHHHHHHHhcccCCCceeeeeeeeeccC
Q 007869          258 IATKGFREKELLGTGGFGRVYRGTLPK-----SQIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKG  331 (586)
Q Consensus       258 ~a~~~f~~~~~LG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~  331 (586)
                      ...++|++.+.||+|+||.||+|..++     .+..||+|.+.... ......+.+|+..+++++||||+++++++...+
T Consensus         3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   82 (288)
T cd05061           3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ   82 (288)
T ss_pred             ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            456789999999999999999997642     34579999886543 233456889999999999999999999999999


Q ss_pred             eEEEEEecCCCCChhhhhhcCC--------CccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeE
Q 007869          332 ELLLVYDYMPNGSLDKYLYDQP--------KVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGR  403 (586)
Q Consensus       332 ~~~lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~k  403 (586)
                      ..++||||+++|+|.+++....        ...+.+..+..++.|++.||.|||+   ++|+||||||+|||+++++.+|
T Consensus        83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dikp~nili~~~~~~~  159 (288)
T cd05061          83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNA---KKFVHRDLAARNCMVAHDFTVK  159 (288)
T ss_pred             CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCCChheEEEcCCCcEE
Confidence            9999999999999999997532        1345677888999999999999998   8999999999999999999999


Q ss_pred             EccccceeeccCCCC-CceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHh
Q 007869          404 LGDFGLARLYDHGTD-PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFD  481 (586)
Q Consensus       404 L~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~  481 (586)
                      |+|||+++....... .......++..|+|||.+.++.++.++|||||||++|||++ |+.||......+   ..+.+  
T Consensus       160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~---~~~~~--  234 (288)
T cd05061         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ---VLKFV--  234 (288)
T ss_pred             ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH--
Confidence            999999986533221 11222345778999999998899999999999999999998 788886543221   11111  


Q ss_pred             hhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 007869          482 FWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERDV  537 (586)
Q Consensus       482 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  537 (586)
                        ..+..     +..    .......+.+++.+|++.||++||++.++++.|+...
T Consensus       235 --~~~~~-----~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         235 --MDGGY-----LDQ----PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             --HcCCC-----CCC----CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence              11111     111    1122357889999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.1e-38  Score=315.82  Aligned_cols=247  Identities=31%  Similarity=0.500  Sum_probs=198.7

Q ss_pred             eeEeecCceEEEEEEeCCCC---eEEEEEEeccccc-hhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEecCCC
Q 007869          267 ELLGTGGFGRVYRGTLPKSQ---IEIAVKKISHESR-QGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPN  342 (586)
Q Consensus       267 ~~LG~G~~g~Vy~~~~~~~~---~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~  342 (586)
                      +.||+|+||.||+|+....+   ..+|+|.+..... ...+++.+|+++++++.|+|++++++++. .+..++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            46999999999999875444   7899999976543 34567999999999999999999999876 4568999999999


Q ss_pred             CChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCCce-
Q 007869          343 GSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQT-  421 (586)
Q Consensus       343 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~-  421 (586)
                      ++|.+++....  .+++..++.++.|++.||.|||+   .+++||||||+|||++.++.+||+|||+++.......... 
T Consensus        80 ~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~  154 (257)
T cd05060          80 GPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA  154 (257)
T ss_pred             CcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEeccccccceeecCCccccc
Confidence            99999998764  68899999999999999999998   8999999999999999999999999999987654332211 


Q ss_pred             -eeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCcc
Q 007869          422 -THVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTE  499 (586)
Q Consensus       422 -~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~  499 (586)
                       ....++..|+|||.+.+..++.++|||||||++|||++ |+.||......   .+..++.    .+...  ..      
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~---~~~~~~~----~~~~~--~~------  219 (257)
T cd05060         155 TTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA---EVIAMLE----SGERL--PR------  219 (257)
T ss_pred             ccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH---HHHHHHH----cCCcC--CC------
Confidence             12234568999999998899999999999999999998 99999764332   1222221    11100  01      


Q ss_pred             ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 007869          500 YVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER  535 (586)
Q Consensus       500 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  535 (586)
                       .......+.+++.+||+.+|++||++.++++.|++
T Consensus       220 -~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~  254 (257)
T cd05060         220 -PEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRR  254 (257)
T ss_pred             -CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence             11223567889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=6.8e-38  Score=322.49  Aligned_cols=259  Identities=25%  Similarity=0.338  Sum_probs=204.3

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc-chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEec
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY  339 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  339 (586)
                      ++|+..+.||+|+||.||++.+..++..+|+|.+.... .....++.+|++++.+++||||++++++|...+..++||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            46889999999999999999999889999999987553 33446688999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCC
Q 007869          340 MPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP  419 (586)
Q Consensus       340 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~  419 (586)
                      +++++|.+++...  ..+++.....++.|+++||.|||+  ..+++||||||+|||++.++.+||+|||++......   
T Consensus        81 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---  153 (308)
T cd06615          81 MDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---  153 (308)
T ss_pred             cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCccccccc---
Confidence            9999999999765  357888899999999999999996  258999999999999999999999999998765322   


Q ss_pred             ceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCcc-----------
Q 007869          420 QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGEL-----------  488 (586)
Q Consensus       420 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~-----------  488 (586)
                      ......|+..|+|||++.+..++.++|||||||++|||++|+.||.......   ...+..........           
T Consensus       154 ~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~  230 (308)
T cd06615         154 MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE---LEAMFGRPVSEGEAKESHRPVSGHP  230 (308)
T ss_pred             ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh---HHHhhcCccccccccCCcccccCCC
Confidence            2234578999999999988889999999999999999999999986543211   11111000000000           


Q ss_pred             ----------------ccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          489 ----------------LEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       489 ----------------~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                                      .....|.+..   ......+.+++.+||+.+|++||++.++++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         231 PDSPRPMAIFELLDYIVNEPPPKLPS---GAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             CCccchhhHHHHHHHHhcCCCccCcC---cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                            0000011100   0123457899999999999999999999865

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.7e-38  Score=320.27  Aligned_cols=262  Identities=25%  Similarity=0.417  Sum_probs=203.7

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCC--------------CeEEEEEEeccc-cchhHHHHHHHHHHhcccCCCceeeee
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKS--------------QIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLL  324 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~--------------~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~  324 (586)
                      .++|+..+.||+|+||.||++...+.              ...||+|.++.. .......|.+|++++++++|+|+++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            35788899999999999999987532              235899998765 333456799999999999999999999


Q ss_pred             eeeeccCeEEEEEecCCCCChhhhhhcCC----------CccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCe
Q 007869          325 GYCRRKGELLLVYDYMPNGSLDKYLYDQP----------KVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNV  394 (586)
Q Consensus       325 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~----------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NI  394 (586)
                      +++...+..++||||+++++|.+++....          ...+++..++.++.|++.||.|||+   .+++||||||+||
T Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~i~H~dlkp~Ni  160 (295)
T cd05097          84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLAS---LNFVHRDLATRNC  160 (295)
T ss_pred             EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHh---cCeeccccChhhE
Confidence            99999999999999999999999986532          1247888999999999999999998   8999999999999


Q ss_pred             eecCCCCeEEccccceeeccCCCC-CceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh--CCCCCCCCCCCc
Q 007869          395 LLDGELNGRLGDFGLARLYDHGTD-PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC--GRRPIQRQGPSE  471 (586)
Q Consensus       395 ll~~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt--G~~p~~~~~~~~  471 (586)
                      ++++++.+||+|||+++....... .......++..|+|||++.++.++.++|||||||++|||++  |..||......+
T Consensus       161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~  240 (295)
T cd05097         161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ  240 (295)
T ss_pred             EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence            999999999999999986533221 11222345778999999998899999999999999999988  566776543322


Q ss_pred             cchhhHHHHhhhccC-ccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 007869          472 NLILVDWVFDFWNRG-ELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILE  534 (586)
Q Consensus       472 ~~~l~~~v~~~~~~~-~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  534 (586)
                         ......+.+... .......+.       .....+.+++.+|++.||++||++.+|++.|+
T Consensus       241 ---~~~~~~~~~~~~~~~~~~~~~~-------~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         241 ---VIENTGEFFRNQGRQIYLSQTP-------LCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             ---HHHHHHHhhhhccccccCCCCC-------CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence               111111111111 111111111       12357889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=2.1e-37  Score=322.34  Aligned_cols=204  Identities=25%  Similarity=0.311  Sum_probs=177.1

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc---cchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEE
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY  337 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  337 (586)
                      ++|+..+.||+|+||.||++++..++..+|+|++...   .......+..|+.++..++|+||+++++++...+.+++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            4688899999999999999999988999999998643   2233445888999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCC
Q 007869          338 DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT  417 (586)
Q Consensus       338 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~  417 (586)
                      ||+++|+|.+++.+.. ..+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||++.......
T Consensus        81 ey~~~g~L~~~l~~~~-~~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~  156 (332)
T cd05623          81 DYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG  156 (332)
T ss_pred             eccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence            9999999999997642 358888899999999999999998   999999999999999999999999999998654333


Q ss_pred             CCceeeeccCCCccCccccc-----CCCCCCcceEEehhHHHHHHHhCCCCCCCCC
Q 007869          418 DPQTTHVVGTLGYLAPEHTR-----TGKATTSADVFSFGAFLLEVACGRRPIQRQG  468 (586)
Q Consensus       418 ~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~  468 (586)
                      ........||+.|+|||++.     ...++.++|||||||++|||++|+.||....
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~  212 (332)
T cd05623         157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES  212 (332)
T ss_pred             cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC
Confidence            32333457999999999986     3468899999999999999999999997643

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=3.6e-38  Score=315.81  Aligned_cols=246  Identities=27%  Similarity=0.450  Sum_probs=196.0

Q ss_pred             EeecCceEEEEEEeC--CCCeEEEEEEecccc-chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEecCCCCCh
Q 007869          269 LGTGGFGRVYRGTLP--KSQIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSL  345 (586)
Q Consensus       269 LG~G~~g~Vy~~~~~--~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL  345 (586)
                      ||+|+||.||+|.+.  +.+..||+|++.... ....+.+.+|+.++++++||||++++++|.. +..++||||+++++|
T Consensus         3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~L   81 (257)
T cd05115           3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGPL   81 (257)
T ss_pred             cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCCH
Confidence            899999999999874  445679999987653 3334679999999999999999999998864 578999999999999


Q ss_pred             hhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCCc--eee
Q 007869          346 DKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ--TTH  423 (586)
Q Consensus       346 ~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~--~~~  423 (586)
                      .+++... ...+++..+++++.|++.||.|||+   ++++||||||+|||++.++.+||+|||+++.........  ...
T Consensus        82 ~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  157 (257)
T cd05115          82 NKFLSGK-KDEITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA  157 (257)
T ss_pred             HHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence            9998754 3468999999999999999999998   899999999999999999999999999998654332211  112


Q ss_pred             eccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCccccH
Q 007869          424 VVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVA  502 (586)
Q Consensus       424 ~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~  502 (586)
                      ..++..|+|||++.+..++.++|||||||++||+++ |+.||......+   ..    .....+...         ..+.
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~----~~~~~~~~~---------~~~~  221 (257)
T cd05115         158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE---VM----SFIEQGKRL---------DCPA  221 (257)
T ss_pred             CCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH---HH----HHHHCCCCC---------CCCC
Confidence            233578999999988889999999999999999996 999997653321   11    111122111         1112


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 007869          503 EELELVLKLGLLCSHSDPTARPSMRQVVQILER  535 (586)
Q Consensus       503 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  535 (586)
                      .....+.+++..||+.+|++||++.+|.+.|+.
T Consensus       222 ~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~  254 (257)
T cd05115         222 ECPPEMYALMKDCWIYKWEDRPNFAKVEERMRT  254 (257)
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhh
Confidence            234567789999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=2.4e-38  Score=316.73  Aligned_cols=246  Identities=26%  Similarity=0.403  Sum_probs=196.5

Q ss_pred             eEeecCceEEEEEEe--CCCCeEEEEEEecccc--chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEecCCCC
Q 007869          268 LLGTGGFGRVYRGTL--PKSQIEIAVKKISHES--RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNG  343 (586)
Q Consensus       268 ~LG~G~~g~Vy~~~~--~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~g  343 (586)
                      .||+|+||.||+|.+  ..++..+|+|++....  ....+++..|+.++++++||||+++++++.. +..++||||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence            589999999999975  4567889999986543  3345679999999999999999999998864 5678999999999


Q ss_pred             ChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCCc--e
Q 007869          344 SLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ--T  421 (586)
Q Consensus       344 sL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~--~  421 (586)
                      +|.+++...  ..+++.....++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++.+.......  .
T Consensus        81 ~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  155 (257)
T cd05116          81 PLNKFLQKN--KHVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK  155 (257)
T ss_pred             cHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence            999999654  358889999999999999999998   899999999999999999999999999998765433211  1


Q ss_pred             eeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCccc
Q 007869          422 THVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEY  500 (586)
Q Consensus       422 ~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~  500 (586)
                      ....++..|+|||.+....++.++|||||||++|||++ |+.||......+   +.+.    ..++..     +....  
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~----i~~~~~-----~~~~~--  221 (257)
T cd05116         156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE---VTQM----IESGER-----MECPQ--  221 (257)
T ss_pred             CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH----HHCCCC-----CCCCC--
Confidence            22234678999999988889999999999999999998 999997643321   1111    112211     11111  


Q ss_pred             cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 007869          501 VAEELELVLKLGLLCSHSDPTARPSMRQVVQILER  535 (586)
Q Consensus       501 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  535 (586)
                        .....+.+++.+||+.||++||++.+|.+.|++
T Consensus       222 --~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~  254 (257)
T cd05116         222 --RCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN  254 (257)
T ss_pred             --CCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence              223557789999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>PF00139 Lectin_legB: Legume lectin domain; InterPro: IPR001220 Legume lectins are one of the largest lectin families with more than 70 lectins reported

Probab=100.00  E-value=1.1e-38  Score=314.44  Aligned_cols=171  Identities=44%  Similarity=0.722  Sum_probs=151.4

Q ss_pred             CcccCCCCCCCCCCeeeeeEEEEEEEEEeC--CCCCCCCcEEEEEecCCCCCCCCCCCcccccccCCCCCCCccEEEEEe
Q 007869            2 PFKNKNSNSSTANGTVFSFSTTFVFSILSE--YQSQSGHGIAFVIASTRGLPGARPSQYLGLFNDTNLGNETNHVFAVEL   79 (586)
Q Consensus         2 p~~~~~~~~~~~~~~~asF~t~F~f~i~~~--~~~~~g~GlaF~l~p~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEf   79 (586)
                      ||+|||..+    ++++||+|+|+|.|...  ....+||||||+|+|....+.++.|++||+++.++.+...++.|||||
T Consensus        48 pi~l~d~~~----~~~~sF~t~F~f~i~~~~~~~~~~~dGlAFvi~~~~~~~~~~~g~~lG~~~~~~~~~~~~~~vAVEF  123 (236)
T PF00139_consen   48 PIQLWDSTT----GNVASFSTSFSFSITNGPGSSNNGGDGLAFVIQPDPNLPGGSSGGYLGLFNSSTDGNGINNSVAVEF  123 (236)
T ss_dssp             EEESBETTT----TEBEEEEEEEEEEEEESSSSSSS-BEEEEEEEEETTSSTTTSSGGGTTTSSSSSTTGGGGCEEEEEE
T ss_pred             cEEEeCCCC----cceeeeeeEEEEEEeccCCCCccCCCceEEEEecCcccccCCCCCccCccccccCCCccCcEEEEEE
Confidence            899999988    99999999999999643  567799999999999887777789999999998877777899999999


Q ss_pred             eccccCCCCCCCCCeeEEeCCCCcccccccC----------------ceEEEEcCeeeEEEEEEeecCCCCCCccceeee
Q 007869           80 DTIKSHGFLDINDNHVGIDINSLKSESSAPA----------------GYYVEYDGLEKRTNVTLAPINIPRPRSLNTMSL  143 (586)
Q Consensus        80 Dt~~~~~~~d~~~~hvgidvns~~s~~~~~~----------------~~~i~y~~~~~~l~v~~~~~~~~~~~~~~~ls~  143 (586)
                      ||++|++++||++||||||+|++.|..+.++                ..||+||+.+++|.|++.... .+|.. |+++.
T Consensus       124 DT~~N~~~~d~~~nHIgI~~n~~~s~~~~~~~~~~~~~~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~-~~~~~-~~l~~  201 (236)
T PF00139_consen  124 DTYKNPEYNDPDDNHIGIDVNSVVSNKTASAGYYSSPSFSLSDGKWHTVWIDYDASTKRLSVYLDDNS-SKPSS-PVLSV  201 (236)
T ss_dssp             ETSTCGGGTTTSSSEEEEEESSSSESEEEE----EEEEHHHGTTSEEEEEEEEETTTTEEEEEEEETT-TTSEE-EEEEE
T ss_pred             eeeecccccccCCCEEEEECCCCcccccccccccccccccccCCcEEEEEEEEcCCccEEEEEEeccc-CCCcc-eeEEE
Confidence            9999999999999999999999998876332                258999999999999999874 57777 99999


Q ss_pred             eecchhccccceeeeeecCCCccceeeeeeecccc
Q 007869          144 SRDLSSVLNDAMYVGFSSSTGSVLASHYILGWSFK  178 (586)
Q Consensus       144 ~~dL~~~l~~~~~vGFsastg~~~~~~~i~~Wsf~  178 (586)
                      .+||+.+|+++||||||||||...|.|.|++|+|+
T Consensus       202 ~vdL~~~l~~~v~vGFsasTG~~~~~h~I~sW~F~  236 (236)
T PF00139_consen  202 NVDLSAVLPEQVYVGFSASTGGSYQTHDILSWSFS  236 (236)
T ss_dssp             E--HHHHSCSEEEEEEEEEESSSSEEEEEEEEEEE
T ss_pred             EEchHHhcCCCcEEEEEeecCCCcceEEEEEEEeC
Confidence            99999999999999999999999999999999995

Leguminous plant lectins resemble each other in their physicochemical properties although they differ in their carbohydrate specificities. They consist of two or four subunits with relative molecular mass of 30 kDa and each subunit has one carbohydrate-binding site. The interaction with sugars requires tightly bound calcium and manganese ions. The structural similarities of these lectins are reported by the primary structural analyses and X-ray crystallographic studies. X-ray studies have shown that the folding of the polypeptide chains in the region of the carbohydrate-binding sites is also similar, despite differences in the primary sequences. The carbohydrate-binding sites of these lectins consist of two conserved amino acids on beta pleated sheets. One of these loops contains transition metals, calcium and manganese, which keep the amino acid residues of the sugar-binding site at the required positions. Amino acid sequences of this loop play an important role in the carbohydrate-binding specificities of these lectins. These lectins bind either glucose/mannose or galactose. The exact function of legume lectins is not known but they may be involved in the attachment of nitrogen-fixing bacteria to legumes and in the protection against pathogens. Some legume lectins are proteolytically processed to produce two chains, beta (which corresponds to the N-terminal) and alpha (C-terminal) (IPR000985 from INTERPRO). The lectin concanavalin A (conA) from jack bean is exceptional in that the two chains are transposed and ligated (by formation of a new peptide bond). The N terminus of mature conA thus corresponds to that of the alpha chain and the C terminus to the beta chain.; GO: 0005488 binding; PDB: 1VLN_B 2GDF_C 2JE9_C 2JEC_C 1DGL_B 2P37_B 2CWM_A 2P34_D 2OW4_A 3IPV_B ....

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=6e-38  Score=313.24  Aligned_cols=251  Identities=22%  Similarity=0.342  Sum_probs=208.6

Q ss_pred             CcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc--cchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEec
Q 007869          262 GFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY  339 (586)
Q Consensus       262 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  339 (586)
                      +|+..+.||+|+||.||.++...++..+++|.+...  +....+++.+|++++++++|+||+++++++.+.+.++++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            478889999999999999999888999999998654  344567789999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCC
Q 007869          340 MPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP  419 (586)
Q Consensus       340 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~  419 (586)
                      +++++|.+++.......+++.++..++.|++++|.|||+   .+++||||||+||++++++.+||+|||++........ 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-  156 (256)
T cd08221          81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-  156 (256)
T ss_pred             cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence            999999999987655578999999999999999999998   8999999999999999999999999999987654332 


Q ss_pred             ceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCcc
Q 007869          420 QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTE  499 (586)
Q Consensus       420 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~  499 (586)
                      ......|++.|+|||++.+..++.++||||||+++|||++|+.||......+      ..... ..+....         
T Consensus       157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~------~~~~~-~~~~~~~---------  220 (256)
T cd08221         157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN------LVVKI-VQGNYTP---------  220 (256)
T ss_pred             cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH------HHHHH-HcCCCCC---------
Confidence            2234568999999999988889999999999999999999999997643321      11111 1111111         


Q ss_pred             ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          500 YVAEELELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       500 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                      ........+.+++.+||+.+|.+||++.++++.
T Consensus       221 ~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~  253 (256)
T cd08221         221 VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ  253 (256)
T ss_pred             CccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence            011223557788889999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=2.4e-38  Score=325.80  Aligned_cols=265  Identities=23%  Similarity=0.319  Sum_probs=202.2

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc-chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEec
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY  339 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  339 (586)
                      ++|...+.||+|+||.||+|+...++..||+|++.... ......+.+|++++++++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            56888999999999999999998888999999987543 22335678899999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCC
Q 007869          340 MPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP  419 (586)
Q Consensus       340 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~  419 (586)
                      +++ +|.+++.... ..+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++....... 
T Consensus        86 ~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-  159 (309)
T cd07872          86 LDK-DLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK-  159 (309)
T ss_pred             CCC-CHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECccccceecCCCcc-
Confidence            974 8888876543 357888899999999999999998   8999999999999999999999999999986433221 


Q ss_pred             ceeeeccCCCccCcccccC-CCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHH--------HhhhccC-ccc
Q 007869          420 QTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWV--------FDFWNRG-ELL  489 (586)
Q Consensus       420 ~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v--------~~~~~~~-~~~  489 (586)
                      ......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||......+........        |...... ...
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (309)
T cd07872         160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK  239 (309)
T ss_pred             ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhh
Confidence            2233467999999998865 46889999999999999999999999765543322111111        0000000 000


Q ss_pred             cccCCCCCc----cccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          490 EARDPNLGT----EYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       490 ~~~d~~l~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      ....+....    .........+.+++.+|++.||.+|||+.|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         240 NYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             hhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence            000011000    001112345678999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=2.9e-38  Score=318.66  Aligned_cols=249  Identities=29%  Similarity=0.469  Sum_probs=197.3

Q ss_pred             eeEeecCceEEEEEEeCCCCe--EEEEEEeccc-cchhHHHHHHHHHHhccc-CCCceeeeeeeeeccCeEEEEEecCCC
Q 007869          267 ELLGTGGFGRVYRGTLPKSQI--EIAVKKISHE-SRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKGELLLVYDYMPN  342 (586)
Q Consensus       267 ~~LG~G~~g~Vy~~~~~~~~~--~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~lV~E~~~~  342 (586)
                      +.||+|+||.||+|++.+++.  .+++|.+... .....+.+.+|++++.++ +||||++++++|...+..++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            368999999999999877654  4688888753 334556789999999999 899999999999999999999999999


Q ss_pred             CChhhhhhcCC--------------CccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEcccc
Q 007869          343 GSLDKYLYDQP--------------KVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFG  408 (586)
Q Consensus       343 gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFG  408 (586)
                      |+|.+++....              ...+++.++..++.|++.||+|||+   .+++||||||+|||+++++.+||+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEEECCCC
Confidence            99999997542              1247899999999999999999998   899999999999999999999999999


Q ss_pred             ceeeccCCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccCc
Q 007869          409 LARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGE  487 (586)
Q Consensus       409 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~  487 (586)
                      +++......  .......+..|+|||++....++.++|||||||++|||++ |+.||......+   ...    ....+.
T Consensus       158 l~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~---~~~----~~~~~~  228 (270)
T cd05047         158 LSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LYE----KLPQGY  228 (270)
T ss_pred             Cccccchhh--hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH---HHH----HHhCCC
Confidence            986422111  1112234667999999988889999999999999999997 999996543221   111    111110


Q ss_pred             cccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 007869          488 LLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERD  536 (586)
Q Consensus       488 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  536 (586)
                      .     ...    .......+.+++.+|++.+|.+||++.++++.|++.
T Consensus       229 ~-----~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~  268 (270)
T cd05047         229 R-----LEK----PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  268 (270)
T ss_pred             C-----CCC----CCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence            0     001    112234578999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=3.8e-38  Score=314.99  Aligned_cols=248  Identities=32%  Similarity=0.453  Sum_probs=200.7

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeee-ccCeEEEEEec
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCR-RKGELLLVYDY  339 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~-~~~~~~lV~E~  339 (586)
                      ++|...+.||+|+||.||++...  +..+|+|.+....  ..+.+.+|+.++++++|+|++++++++. ..+..++||||
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~   81 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   81 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence            47888899999999999999875  5679999986543  3467899999999999999999999765 45678999999


Q ss_pred             CCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCC
Q 007869          340 MPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP  419 (586)
Q Consensus       340 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~  419 (586)
                      +++++|.+++.......+++..++.++.|++.||.|||+   ++++||||||+||++++++.+||+|||+++......  
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--  156 (256)
T cd05082          82 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--  156 (256)
T ss_pred             CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence            999999999987655568999999999999999999998   899999999999999999999999999988643322  


Q ss_pred             ceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCc
Q 007869          420 QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGT  498 (586)
Q Consensus       420 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~  498 (586)
                        ....++..|+|||++....++.++|||||||++|||++ |+.||......+   +..++.    .+.     .+..  
T Consensus       157 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~---~~~~~~----~~~-----~~~~--  220 (256)
T cd05082         157 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPRVE----KGY-----KMDA--  220 (256)
T ss_pred             --CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHh----cCC-----CCCC--
Confidence              22344678999999998889999999999999999997 999986532211   111111    110     0111  


Q ss_pred             cccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 007869          499 EYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER  535 (586)
Q Consensus       499 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  535 (586)
                        .......+.+++.+|++.+|++|||+.++++.|+.
T Consensus       221 --~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  255 (256)
T cd05082         221 --PDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH  255 (256)
T ss_pred             --CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence              11234567788999999999999999999999874

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=2e-38  Score=322.75  Aligned_cols=258  Identities=26%  Similarity=0.460  Sum_probs=206.3

Q ss_pred             hcCCcccceeEeecCceEEEEEEeCC-----CCeEEEEEEecccc-chhHHHHHHHHHHhcccCCCceeeeeeeeeccCe
Q 007869          259 ATKGFREKELLGTGGFGRVYRGTLPK-----SQIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGE  332 (586)
Q Consensus       259 a~~~f~~~~~LG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~  332 (586)
                      ..++|+..+.||+|+||.||++.+..     ++..||+|++.... ....+++.+|+.++++++||||++++++|...+.
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~   82 (288)
T cd05050           3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP   82 (288)
T ss_pred             ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence            34678889999999999999998743     56789999987543 3445679999999999999999999999999999


Q ss_pred             EEEEEecCCCCChhhhhhcCC--------------------CccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCC
Q 007869          333 LLLVYDYMPNGSLDKYLYDQP--------------------KVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKAS  392 (586)
Q Consensus       333 ~~lV~E~~~~gsL~~~l~~~~--------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~  392 (586)
                      .++||||+++|+|.+++....                    ...+++.+++.++.|++.||.|||+   .+++||||||+
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~dl~p~  159 (288)
T cd05050          83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATR  159 (288)
T ss_pred             cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeecccccHh
Confidence            999999999999999997431                    1357888999999999999999998   89999999999


Q ss_pred             CeeecCCCCeEEccccceeeccCCCC-CceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCC
Q 007869          393 NVLLDGELNGRLGDFGLARLYDHGTD-PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPS  470 (586)
Q Consensus       393 NIll~~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~  470 (586)
                      |||+++++.+||+|||+++....... ........+..|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus       160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~  239 (288)
T cd05050         160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE  239 (288)
T ss_pred             heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999999986543221 11222345678999999998899999999999999999997 88888654322


Q ss_pred             ccchhhHHHHhhhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 007869          471 ENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER  535 (586)
Q Consensus       471 ~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  535 (586)
                      +      +. .....+....     .    .......+.+++.+|++.+|.+||++.|+++.|++
T Consensus       240 ~------~~-~~~~~~~~~~-----~----~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         240 E------VI-YYVRDGNVLS-----C----PDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             H------HH-HHHhcCCCCC-----C----CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence            1      11 1112222111     0    11223567889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=2.5e-38  Score=332.99  Aligned_cols=204  Identities=25%  Similarity=0.348  Sum_probs=178.4

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc---chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEE
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY  337 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  337 (586)
                      ++|+..+.||+|+||.||+++...++..||+|++....   ......+..|+.++.+++||||+++++.+...+.+++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46888999999999999999999999999999997532   334567888999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCC
Q 007869          338 DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT  417 (586)
Q Consensus       338 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~  417 (586)
                      ||+++|+|.+++...  ..+++.....++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++......
T Consensus        81 E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~~L~~lH~---~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~  155 (360)
T cd05627          81 EFLPGGDMMTLLMKK--DTLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH  155 (360)
T ss_pred             eCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence            999999999999765  357888999999999999999998   999999999999999999999999999987543211


Q ss_pred             C----------------------------------CceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCC
Q 007869          418 D----------------------------------PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRP  463 (586)
Q Consensus       418 ~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p  463 (586)
                      .                                  ......+||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P  235 (360)
T cd05627         156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP  235 (360)
T ss_pred             ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence            0                                  001235799999999999999999999999999999999999999


Q ss_pred             CCCCCC
Q 007869          464 IQRQGP  469 (586)
Q Consensus       464 ~~~~~~  469 (586)
                      |.....
T Consensus       236 f~~~~~  241 (360)
T cd05627         236 FCSETP  241 (360)
T ss_pred             CCCCCH
Confidence            986544

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=2.7e-38  Score=324.65  Aligned_cols=261  Identities=27%  Similarity=0.436  Sum_probs=207.1

Q ss_pred             hhcCCcccceeEeecCceEEEEEEeC-------CCCeEEEEEEecccc-chhHHHHHHHHHHhccc-CCCceeeeeeeee
Q 007869          258 IATKGFREKELLGTGGFGRVYRGTLP-------KSQIEIAVKKISHES-RQGMKEFVAEIVSIGRL-RHRNLVQLLGYCR  328 (586)
Q Consensus       258 ~a~~~f~~~~~LG~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~  328 (586)
                      ....+|...+.||+|+||.||+++..       ..+..||+|.+.... ....+.+.+|+.+++.+ +||||+++++++.
T Consensus        12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   91 (304)
T cd05101          12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT   91 (304)
T ss_pred             ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence            44567888899999999999999752       234579999987542 34457799999999999 8999999999999


Q ss_pred             ccCeEEEEEecCCCCChhhhhhcCC--------------CccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCe
Q 007869          329 RKGELLLVYDYMPNGSLDKYLYDQP--------------KVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNV  394 (586)
Q Consensus       329 ~~~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NI  394 (586)
                      ..+..++||||+++|+|.+++....              ...+++.++..++.||++||.|||+   ++++||||||+||
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Ni  168 (304)
T cd05101          92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLAS---QKCIHRDLAARNV  168 (304)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHH---CCeeecccccceE
Confidence            9999999999999999999997642              2357888999999999999999998   8999999999999


Q ss_pred             eecCCCCeEEccccceeeccCCCCC-ceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCcc
Q 007869          395 LLDGELNGRLGDFGLARLYDHGTDP-QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSEN  472 (586)
Q Consensus       395 ll~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~  472 (586)
                      ++++++.+||+|||+++........ ......++..|+|||++.+..++.++||||||+++|||++ |..||......  
T Consensus       169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--  246 (304)
T cd05101         169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE--  246 (304)
T ss_pred             EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH--
Confidence            9999999999999999876543221 1223345678999999988889999999999999999998 78888654321  


Q ss_pred             chhhHHHHhhhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 007869          473 LILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERDV  537 (586)
Q Consensus       473 ~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  537 (586)
                          ++.. ....+....         ........+.+++.+||+.+|.+||++.|+++.|++-.
T Consensus       247 ----~~~~-~~~~~~~~~---------~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~  297 (304)
T cd05101         247 ----ELFK-LLKEGHRMD---------KPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRIL  297 (304)
T ss_pred             ----HHHH-HHHcCCcCC---------CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHH
Confidence                1111 111111100         01123456778899999999999999999999997643

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.2e-37  Score=318.62  Aligned_cols=263  Identities=26%  Similarity=0.416  Sum_probs=204.2

Q ss_pred             cCCcccceeEeecCceEEEEEEeC----------------CCCeEEEEEEeccc-cchhHHHHHHHHHHhcccCCCceee
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLP----------------KSQIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQ  322 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~----------------~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~  322 (586)
                      .++|+..+.||+|+||.||++...                ++...+|+|++... .......|.+|++++++++|+||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence            356889999999999999998543                23457999999754 3344568999999999999999999


Q ss_pred             eeeeeeccCeEEEEEecCCCCChhhhhhcCCC---------ccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCC
Q 007869          323 LLGYCRRKGELLLVYDYMPNGSLDKYLYDQPK---------VTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASN  393 (586)
Q Consensus       323 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~---------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~N  393 (586)
                      +++++...+..++||||+++++|.+++.....         ..+++.+++.++.|++.||.|||+   .+++||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dlkp~N  160 (296)
T cd05095          84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhe
Confidence            99999999999999999999999999976421         247788999999999999999998   899999999999


Q ss_pred             eeecCCCCeEEccccceeeccCCCCC-ceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh--CCCCCCCCCCC
Q 007869          394 VLLDGELNGRLGDFGLARLYDHGTDP-QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC--GRRPIQRQGPS  470 (586)
Q Consensus       394 Ill~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt--G~~p~~~~~~~  470 (586)
                      ||++.++.+||+|||+++.+...... ......++..|++||....+.++.++|||||||++|||++  |..||......
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~  240 (296)
T cd05095         161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE  240 (296)
T ss_pred             EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence            99999999999999999865432211 1222345678999999888899999999999999999998  77888654332


Q ss_pred             ccchhhHHHHhhhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 007869          471 ENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILE  534 (586)
Q Consensus       471 ~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  534 (586)
                      +.   .......+...... ...+.     .......+.+++.+||+.||.+||++.++++.|+
T Consensus       241 ~~---~~~~~~~~~~~~~~-~~~~~-----~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         241 QV---IENTGEFFRDQGRQ-VYLPK-----PALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             HH---HHHHHHHHhhcccc-ccCCC-----CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            21   11111111111100 01111     1112356788999999999999999999999886

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=7.5e-38  Score=317.60  Aligned_cols=251  Identities=26%  Similarity=0.363  Sum_probs=202.5

Q ss_pred             cccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEecCCC
Q 007869          263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPN  342 (586)
Q Consensus       263 f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~  342 (586)
                      |+..+.||+|+||.||+|.+..++..+++|.+........+.+.+|+++++.++|||++++++++...+..++||||+++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~   86 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   86 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence            56678899999999999999988999999999776666677899999999999999999999999999999999999999


Q ss_pred             CChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCCcee
Q 007869          343 GSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTT  422 (586)
Q Consensus       343 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~  422 (586)
                      ++|..++... ...+++..+..++.|+++||.|||+   .+++||||||+|||++.++.+||+|||++....... ....
T Consensus        87 ~~l~~~~~~~-~~~l~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~~~  161 (282)
T cd06643          87 GAVDAVMLEL-ERPLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QRRD  161 (282)
T ss_pred             CcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEccCCCEEEccccccccccccc-cccc
Confidence            9999988653 2468999999999999999999998   899999999999999999999999999997643322 1223


Q ss_pred             eeccCCCccCccccc-----CCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCC
Q 007869          423 HVVGTLGYLAPEHTR-----TGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLG  497 (586)
Q Consensus       423 ~~~gt~~y~aPE~~~-----~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~  497 (586)
                      ...++..|+|||++.     +..++.++|||||||++|||++|+.||......+.  ....    . ...     .+...
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~--~~~~----~-~~~-----~~~~~  229 (282)
T cd06643         162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRV--LLKI----A-KSE-----PPTLA  229 (282)
T ss_pred             cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHH--HHHH----h-hcC-----CCCCC
Confidence            356899999999974     34578899999999999999999999976433211  1111    0 000     01110


Q ss_pred             ccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          498 TEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       498 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                        ........+.+++.+||+.||.+||++.++++.
T Consensus       230 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  262 (282)
T cd06643         230 --QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH  262 (282)
T ss_pred             --CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              011123457788899999999999999998753

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-38  Score=332.81  Aligned_cols=247  Identities=31%  Similarity=0.500  Sum_probs=208.6

Q ss_pred             ceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEecCCCCCh
Q 007869          266 KELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSL  345 (586)
Q Consensus       266 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL  345 (586)
                      .-+||+|.||+||-|++..++..+|||.+...+.+..+-+..|+.+-++|+|+|||+++|.|.+++.+-+.||.+|||+|
T Consensus       580 rvVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSL  659 (1226)
T KOG4279|consen  580 RVVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSL  659 (1226)
T ss_pred             eEEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcH
Confidence            34799999999999999999999999999877666677789999999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCccc--hhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecC-CCCeEEccccceeeccCCCCCcee
Q 007869          346 DKYLYDQPKVTL--NWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDG-ELNGRLGDFGLARLYDHGTDPQTT  422 (586)
Q Consensus       346 ~~~l~~~~~~~l--~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~-~~~~kL~DFGla~~~~~~~~~~~~  422 (586)
                      .++|+.. -.++  ++..+--+.+||++||.|||+   +.|||||||-.|||++. .|.+||+|||.++.+.. ..+.+.
T Consensus       660 SsLLrsk-WGPlKDNEstm~fYtkQILeGLkYLHe---n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg-inP~TE  734 (1226)
T KOG4279|consen  660 SSLLRSK-WGPLKDNESTMNFYTKQILEGLKYLHE---NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG-INPCTE  734 (1226)
T ss_pred             HHHHHhc-cCCCccchhHHHHHHHHHHHHhhhhhh---cceeeccccCCcEEEeeccceEEecccccchhhcc-CCcccc
Confidence            9999765 2344  667777789999999999998   99999999999999975 68899999999987653 456777


Q ss_pred             eeccCCCccCcccccCCC--CCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCccc
Q 007869          423 HVVGTLGYLAPEHTRTGK--ATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEY  500 (586)
Q Consensus       423 ~~~gt~~y~aPE~~~~~~--~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~  500 (586)
                      +..||..|||||++..+.  |..++|||||||++.||.||++||.........        .++-|.  -...|.+    
T Consensus       735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA--------MFkVGm--yKvHP~i----  800 (1226)
T KOG4279|consen  735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA--------MFKVGM--YKVHPPI----  800 (1226)
T ss_pred             ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh--------hhhhcc--eecCCCC----
Confidence            889999999999997764  888999999999999999999999865543211        111121  1233433    


Q ss_pred             cHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          501 VAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       501 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      +.+.......++++|+.+||.+||+++++++
T Consensus       801 Peelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  801 PEELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             cHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            4555677788999999999999999999985

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.2e-38  Score=315.69  Aligned_cols=248  Identities=25%  Similarity=0.397  Sum_probs=211.5

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc---cchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEE
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY  337 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  337 (586)
                      .+|++.+.||+|.||+|-+++....++.||||.++++   +.+..-.+.+|+++|+.|+||||++++.+|+.++...|||
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM  132 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM  132 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence            4577788999999999999999888999999999875   3455556889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCC
Q 007869          338 DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT  417 (586)
Q Consensus       338 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~  417 (586)
                      ||..+|.|++++.+.  ..|++.....+++||..|+.|+|.   ++++|||||.+|||||.|+++||+||||+.++....
T Consensus       133 EYaS~GeLYDYiSer--~~LsErEaRhfFRQIvSAVhYCHk---nrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~k  207 (668)
T KOG0611|consen  133 EYASGGELYDYISER--GSLSEREARHFFRQIVSAVHYCHK---NRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKK  207 (668)
T ss_pred             EecCCccHHHHHHHh--ccccHHHHHHHHHHHHHHHHHHhh---ccceecccchhheeecCCCCeeeeccchhhhhcccc
Confidence            999999999999776  468999999999999999999998   999999999999999999999999999999876543


Q ss_pred             CCceeeeccCCCccCcccccCCCC-CCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCC
Q 007869          418 DPQTTHVVGTLGYLAPEHTRTGKA-TTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNL  496 (586)
Q Consensus       418 ~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l  496 (586)
                        ..++.+|++-|.+||++.+.+| .+..|-|||||+||-|+.|..||++.+...   ++    +...+|...+...   
T Consensus       208 --fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~---lv----rQIs~GaYrEP~~---  275 (668)
T KOG0611|consen  208 --FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKR---LV----RQISRGAYREPET---  275 (668)
T ss_pred             --HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHH---HH----HHhhcccccCCCC---
Confidence              4466899999999999999888 578999999999999999999998764321   21    2223444333222   


Q ss_pred             CccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 007869          497 GTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQIL  533 (586)
Q Consensus       497 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L  533 (586)
                              +....-|+.|||-.+|++|.|+.+|....
T Consensus       276 --------PSdA~gLIRwmLmVNP~RRATieDiAsHW  304 (668)
T KOG0611|consen  276 --------PSDASGLIRWMLMVNPERRATIEDIASHW  304 (668)
T ss_pred             --------CchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence                    23345677889999999999999998765

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=2.4e-38  Score=328.44  Aligned_cols=243  Identities=25%  Similarity=0.296  Sum_probs=191.4

Q ss_pred             eeEeecCceEEEEEEeCCCCeEEEEEEecccc---chhHHHHHHHHH-HhcccCCCceeeeeeeeeccCeEEEEEecCCC
Q 007869          267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHES---RQGMKEFVAEIV-SIGRLRHRNLVQLLGYCRRKGELLLVYDYMPN  342 (586)
Q Consensus       267 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~-~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~  342 (586)
                      +.||+|+||.||+|++..++..||+|++....   ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            46999999999999999888999999987532   122334444444 56778999999999999999999999999999


Q ss_pred             CChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCCcee
Q 007869          343 GSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTT  422 (586)
Q Consensus       343 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~  422 (586)
                      |+|.+++....  .+.+.....++.||++||.|||+   .+|+||||||+|||++.++.+||+|||+++...... ....
T Consensus        81 ~~L~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~~~  154 (325)
T cd05602          81 GELFYHLQRER--CFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GTTS  154 (325)
T ss_pred             CcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCCCcccccCC-CCcc
Confidence            99999997653  46777888899999999999998   899999999999999999999999999997533221 2234


Q ss_pred             eeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCccccH
Q 007869          423 HVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVA  502 (586)
Q Consensus       423 ~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~  502 (586)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||......+   ..+.+.    ....  ...+        
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~----~~~~--~~~~--------  217 (325)
T cd05602         155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE---MYDNIL----NKPL--QLKP--------  217 (325)
T ss_pred             cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH---HHHHHH----hCCc--CCCC--------
Confidence            4679999999999999999999999999999999999999997643321   111111    1100  0111        


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          503 EELELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       503 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                      .....+.+++.+|++.||.+||++.+.++.
T Consensus       218 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~~  247 (325)
T cd05602         218 NITNSARHLLEGLLQKDRTKRLGAKDDFME  247 (325)
T ss_pred             CCCHHHHHHHHHHcccCHHHCCCCCCCHHH
Confidence            123456788889999999999998754433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=3.3e-38  Score=312.39  Aligned_cols=264  Identities=27%  Similarity=0.352  Sum_probs=207.2

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccch--hHHHHHHHHHHhcccCCCc-eeeeeeeeeccC------
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQ--GMKEFVAEIVSIGRLRHRN-LVQLLGYCRRKG------  331 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~~~~Ei~~l~~l~H~n-iv~l~~~~~~~~------  331 (586)
                      ..|...++||+|.||+||+|+.+.+++.||+|+++.+..+  .-....+|+.+|++++|+| |++|++++...+      
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            4566678899999999999999999999999999876442  2345689999999999999 999999998877      


Q ss_pred             eEEEEEecCCCCChhhhhhcCCC--ccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccc
Q 007869          332 ELLLVYDYMPNGSLDKYLYDQPK--VTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGL  409 (586)
Q Consensus       332 ~~~lV~E~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGl  409 (586)
                      .+++|+||+ ..+|..++...+.  ..++...+..++.||+.||+|||+   ++|+||||||+|||+++++.+||+|||+
T Consensus        91 ~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~---~~IlHRDLKPQNlLi~~~G~lKlaDFGl  166 (323)
T KOG0594|consen   91 KLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS---HGILHRDLKPQNLLISSSGVLKLADFGL  166 (323)
T ss_pred             eEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCcceEEECCCCcEeeeccch
Confidence            899999999 5699999977653  356667889999999999999998   9999999999999999999999999999


Q ss_pred             eeeccCCCCCceeeeccCCCccCcccccCC-CCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccC--
Q 007869          410 ARLYDHGTDPQTTHVVGTLGYLAPEHTRTG-KATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRG--  486 (586)
Q Consensus       410 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~--  486 (586)
                      |+.+..... ..+..++|..|+|||++.+. .|+...||||+||++.||++++.-|.+....+++..   +.+.....  
T Consensus       167 Ara~~ip~~-~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~---If~~lGtP~e  242 (323)
T KOG0594|consen  167 ARAFSIPMR-TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFR---IFRLLGTPNE  242 (323)
T ss_pred             HHHhcCCcc-cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHH---HHHHcCCCCc
Confidence            997653332 34567889999999999877 689999999999999999999999988765443221   11111110  


Q ss_pred             ------ccccccC---CCCC--ccccHHH---HHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          487 ------ELLEARD---PNLG--TEYVAEE---LELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       487 ------~~~~~~d---~~l~--~~~~~~~---~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                            ......+   +...  .......   .....+++.+|++.+|.+|.|++.+++.
T Consensus       243 ~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  243 KDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             cCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence                  0000001   1111  0111111   1367889999999999999999999874

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=3.6e-38  Score=315.00  Aligned_cols=249  Identities=29%  Similarity=0.431  Sum_probs=202.0

Q ss_pred             eeEeecCceEEEEEEeCC-CC--eEEEEEEeccccc-hhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEecCCC
Q 007869          267 ELLGTGGFGRVYRGTLPK-SQ--IEIAVKKISHESR-QGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPN  342 (586)
Q Consensus       267 ~~LG~G~~g~Vy~~~~~~-~~--~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~  342 (586)
                      +.||+|++|.||+|.+.. ++  ..||||.+..... ...+.+..|+..+++++||||+++++.+.. ...++||||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999999854 22  3699999987765 567789999999999999999999999988 889999999999


Q ss_pred             CChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCC--c
Q 007869          343 GSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP--Q  420 (586)
Q Consensus       343 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~--~  420 (586)
                      ++|.+++.......++|...+.++.|+++||.|||+   ++++||||||+||+++.++.+||+|||+++........  .
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  156 (257)
T cd05040          80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM  156 (257)
T ss_pred             CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence            999999987643568999999999999999999998   89999999999999999999999999999876543211  1


Q ss_pred             eeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCcc
Q 007869          421 TTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTE  499 (586)
Q Consensus       421 ~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~  499 (586)
                      .....++..|+|||++.+..++.++|||||||++|||++ |+.||......+   ......   ..+...         .
T Consensus       157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~~---~~~~~~---------~  221 (257)
T cd05040         157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ---ILKKID---KEGERL---------E  221 (257)
T ss_pred             ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHH---hcCCcC---------C
Confidence            123457789999999998899999999999999999998 999997543322   111111   111000         0


Q ss_pred             ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 007869          500 YVAEELELVLKLGLLCSHSDPTARPSMRQVVQILE  534 (586)
Q Consensus       500 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  534 (586)
                      ........+.+++.+|++.+|++||++.++++.|.
T Consensus       222 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         222 RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            11122356788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=2.4e-38  Score=325.55  Aligned_cols=258  Identities=27%  Similarity=0.437  Sum_probs=204.4

Q ss_pred             cCCcccceeEeecCceEEEEEEeCC-------CCeEEEEEEecccc-chhHHHHHHHHHHhccc-CCCceeeeeeeeecc
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPK-------SQIEIAVKKISHES-RQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRK  330 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~  330 (586)
                      .++|...+.||+|+||.||++...+       ....+|+|.+.... .....++..|++++.++ +||||++++++|...
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            4678899999999999999998643       23469999997642 34456788999999999 799999999999999


Q ss_pred             CeEEEEEecCCCCChhhhhhcCC--------------CccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeee
Q 007869          331 GELLLVYDYMPNGSLDKYLYDQP--------------KVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLL  396 (586)
Q Consensus       331 ~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll  396 (586)
                      +..++||||+++|+|.+++....              ...++|.++++++.|++.||+|||+   .+++||||||+|||+
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nill  173 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLV  173 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHHheEE
Confidence            99999999999999999997642              1358899999999999999999998   899999999999999


Q ss_pred             cCCCCeEEccccceeeccCCCCC-ceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccch
Q 007869          397 DGELNGRLGDFGLARLYDHGTDP-QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLI  474 (586)
Q Consensus       397 ~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~  474 (586)
                      +.++.+||+|||+++........ ......++..|+|||++.+..++.++|||||||++|||++ |+.||......+   
T Consensus       174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~---  250 (307)
T cd05098         174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---  250 (307)
T ss_pred             cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH---
Confidence            99999999999999865432111 1122234578999999998889999999999999999998 888886533211   


Q ss_pred             hhHHHHhhhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 007869          475 LVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERD  536 (586)
Q Consensus       475 l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  536 (586)
                         .. .....+...         +........+.+++.+|++.+|.+||++.++++.|+..
T Consensus       251 ---~~-~~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~  299 (307)
T cd05098         251 ---LF-KLLKEGHRM---------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  299 (307)
T ss_pred             ---HH-HHHHcCCCC---------CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence               11 111111110         11112235677889999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=4.4e-38  Score=326.17  Aligned_cols=242  Identities=22%  Similarity=0.306  Sum_probs=195.5

Q ss_pred             CcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc---chhHHHHHHHHHHhcccC-CCceeeeeeeeeccCeEEEEE
Q 007869          262 GFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES---RQGMKEFVAEIVSIGRLR-HRNLVQLLGYCRRKGELLLVY  337 (586)
Q Consensus       262 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~-H~niv~l~~~~~~~~~~~lV~  337 (586)
                      +|+..+.||+|+||.||++....++..||+|++....   ....+.+..|..++..+. |++|+++++++...+.+++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            4777899999999999999999899999999987542   233456788898888885 577888999999999999999


Q ss_pred             ecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCC
Q 007869          338 DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT  417 (586)
Q Consensus       338 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~  417 (586)
                      ||+++|+|.+++...  ..+++.++..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++......
T Consensus        81 Ey~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~  155 (323)
T cd05615          81 EYVNGGDLMYHIQQV--GKFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG  155 (323)
T ss_pred             cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence            999999999998765  358899999999999999999998   899999999999999999999999999998543221


Q ss_pred             CCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCC
Q 007869          418 DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLG  497 (586)
Q Consensus       418 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~  497 (586)
                       .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......   +...+.    +..      ... 
T Consensus       156 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~---~~~~i~----~~~------~~~-  220 (323)
T cd05615         156 -VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE---LFQSIM----EHN------VSY-  220 (323)
T ss_pred             -ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH---HHHHHH----hCC------CCC-
Confidence             12234568999999999998899999999999999999999999997653311   111111    111      111 


Q ss_pred             ccccHHHHHHHHHHHHHhcccCCCCCCCH
Q 007869          498 TEYVAEELELVLKLGLLCSHSDPTARPSM  526 (586)
Q Consensus       498 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~  526 (586)
                         .......+.+++.+|++.+|.+|++.
T Consensus       221 ---p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         221 ---PKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             ---CccCCHHHHHHHHHHcccCHhhCCCC
Confidence               11123456788899999999999984

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=7e-38  Score=312.38  Aligned_cols=251  Identities=27%  Similarity=0.398  Sum_probs=207.0

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEec
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY  339 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  339 (586)
                      .++|+..+.||+|+||.||+|....++..+++|.+.....  .+++.+|++++++++|+|++++++++......++++||
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~   79 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY   79 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence            3678889999999999999999988888999999876533  67899999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCC
Q 007869          340 MPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP  419 (586)
Q Consensus       340 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~  419 (586)
                      +++++|.+++.... ..+++..+..++.|++.||.|||+   .+++||||+|+||++++++.+||+|||++........ 
T Consensus        80 ~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-  154 (256)
T cd06612          80 CGAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-  154 (256)
T ss_pred             CCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence            99999999986543 468999999999999999999998   8999999999999999999999999999987654321 


Q ss_pred             ceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCcc
Q 007869          420 QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTE  499 (586)
Q Consensus       420 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~  499 (586)
                      ......++..|+|||++.+..++.++||||||+++|||++|+.||............            .....+.+  .
T Consensus       155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~------------~~~~~~~~--~  220 (256)
T cd06612         155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI------------PNKPPPTL--S  220 (256)
T ss_pred             ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhh------------ccCCCCCC--C
Confidence            223456889999999998889999999999999999999999999764332211000            00000111  1


Q ss_pred             ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          500 YVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       500 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      ........+.+++.+|++.||++||++.|+++
T Consensus       221 ~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         221 DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             chhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            11223356788889999999999999999985

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=6.8e-38  Score=329.56  Aligned_cols=264  Identities=23%  Similarity=0.252  Sum_probs=199.5

Q ss_pred             hcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc--cchhHHHHHHHHHHhcccCCCceeeeeeeeeccC-----
Q 007869          259 ATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKG-----  331 (586)
Q Consensus       259 a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~-----  331 (586)
                      ..++|+..+.||+|+||.||++.+..++..||||++...  .......+.+|+.++++++||||+++++++...+     
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            347899999999999999999999888999999999653  2334567889999999999999999999886443     


Q ss_pred             -eEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccce
Q 007869          332 -ELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLA  410 (586)
Q Consensus       332 -~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla  410 (586)
                       ..++||||+++ +|.+.+..    .+++..+..++.|+++||.|||+   ++|+||||||+|||++.++.+||+|||++
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a  170 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVIHM----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA  170 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEecCCCc
Confidence             57999999965 66666632    47788888999999999999998   89999999999999999999999999999


Q ss_pred             eeccCCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccch------------hhH-
Q 007869          411 RLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLI------------LVD-  477 (586)
Q Consensus       411 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~------------l~~-  477 (586)
                      +.....  .......||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+...            ..+ 
T Consensus       171 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (359)
T cd07876         171 RTACTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNR  248 (359)
T ss_pred             cccccC--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHH
Confidence            864322  12334578999999999999999999999999999999999999998654321100            000 


Q ss_pred             ---HHHhhhccCccc-----cccCCCCC----ccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          478 ---WVFDFWNRGELL-----EARDPNLG----TEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       478 ---~v~~~~~~~~~~-----~~~d~~l~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                         .+..........     ....+...    ..........+.+++.+||+.||++|||+.|+++.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  315 (359)
T cd07876         249 LQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH  315 (359)
T ss_pred             HHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence               000000000000     00000000    00111123557889999999999999999999863

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=4.6e-38  Score=324.57  Aligned_cols=260  Identities=27%  Similarity=0.446  Sum_probs=204.9

Q ss_pred             hcCCcccceeEeecCceEEEEEEeC-------CCCeEEEEEEeccc-cchhHHHHHHHHHHhccc-CCCceeeeeeeeec
Q 007869          259 ATKGFREKELLGTGGFGRVYRGTLP-------KSQIEIAVKKISHE-SRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRR  329 (586)
Q Consensus       259 a~~~f~~~~~LG~G~~g~Vy~~~~~-------~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~  329 (586)
                      ..++|...+.||+|+||.||+++..       .....+|+|.+... ......++..|+++++++ +||||++++++|..
T Consensus        10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~   89 (314)
T cd05099          10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ   89 (314)
T ss_pred             cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc
Confidence            3457888999999999999999753       23456999998754 234456789999999999 69999999999999


Q ss_pred             cCeEEEEEecCCCCChhhhhhcCC--------------CccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCee
Q 007869          330 KGELLLVYDYMPNGSLDKYLYDQP--------------KVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVL  395 (586)
Q Consensus       330 ~~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIl  395 (586)
                      .+..++||||+++|+|.+++....              ...++|.+..+++.|++.||.|||+   .+++||||||+|||
T Consensus        90 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~---~gi~H~dlkp~Nil  166 (314)
T cd05099          90 EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNVL  166 (314)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeeccccceeEE
Confidence            999999999999999999996532              1358899999999999999999998   89999999999999


Q ss_pred             ecCCCCeEEccccceeeccCCCCC-ceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccc
Q 007869          396 LDGELNGRLGDFGLARLYDHGTDP-QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENL  473 (586)
Q Consensus       396 l~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~  473 (586)
                      +++++.+||+|||+++........ ......++..|+|||++.++.++.++|||||||++|||++ |+.||......+  
T Consensus       167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~--  244 (314)
T cd05099         167 VTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE--  244 (314)
T ss_pred             EcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH--
Confidence            999999999999999865432211 1122234567999999988899999999999999999999 889986543221  


Q ss_pred             hhhHHHHhhhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 007869          474 ILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERDV  537 (586)
Q Consensus       474 ~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  537 (586)
                       +.    .....+....         ........+.+++.+|++.+|++||++.++++.|++..
T Consensus       245 -~~----~~~~~~~~~~---------~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~  294 (314)
T cd05099         245 -LF----KLLREGHRMD---------KPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVL  294 (314)
T ss_pred             -HH----HHHHcCCCCC---------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence             11    1111111111         11122345778899999999999999999999997643

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.5e-38  Score=317.10  Aligned_cols=249  Identities=27%  Similarity=0.444  Sum_probs=206.5

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc-chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEec
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY  339 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  339 (586)
                      ++|+..+.||.|++|.||+|++..++..||+|.+.... ......+.+|++++++++|+|++++++++......++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            36788889999999999999999889999999987653 44456789999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCC
Q 007869          340 MPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP  419 (586)
Q Consensus       340 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~  419 (586)
                      +++++|.+++...   .+++.....++.|++.||.|||+   ++++||||+|+||++++++.++|+|||+++...... .
T Consensus        81 ~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~  153 (274)
T cd06609          81 CGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-S  153 (274)
T ss_pred             eCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEcccccceeecccc-c
Confidence            9999999999754   68899999999999999999998   899999999999999999999999999998775432 2


Q ss_pred             ceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCcc
Q 007869          420 QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTE  499 (586)
Q Consensus       420 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~  499 (586)
                      ......++..|+|||++.+..++.++|||||||++|||++|+.||....+.+.      .. ....+     ..+.+...
T Consensus       154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~------~~-~~~~~-----~~~~~~~~  221 (274)
T cd06609         154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV------LF-LIPKN-----NPPSLEGN  221 (274)
T ss_pred             ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHH------HH-Hhhhc-----CCCCCccc
Confidence            23345788999999999988899999999999999999999999976443211      00 00111     11111111


Q ss_pred             ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          500 YVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       500 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                         .....+.+++.+||+.+|++||+++++++
T Consensus       222 ---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         222 ---KFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             ---ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence               02345778889999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=2.8e-38  Score=333.28  Aligned_cols=261  Identities=23%  Similarity=0.328  Sum_probs=210.1

Q ss_pred             CcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccC-C-----CceeeeeeeeeccCeEEE
Q 007869          262 GFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLR-H-----RNLVQLLGYCRRKGELLL  335 (586)
Q Consensus       262 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H-----~niv~l~~~~~~~~~~~l  335 (586)
                      +|.+.+.||+|.||+|-||.+..+++.||||+++.. ..-..+-..|+.+|..|+ |     -|+|+++++|..++++||
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci  265 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI  265 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence            788999999999999999999999999999999754 334466688999999996 4     489999999999999999


Q ss_pred             EEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCC--CCeEEccccceeec
Q 007869          336 VYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGE--LNGRLGDFGLARLY  413 (586)
Q Consensus       336 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~--~~~kL~DFGla~~~  413 (586)
                      |+|.+ ..+|.++|+.+....++......|+.||+.||.+||+   .+|||+||||+||||.+-  ..+||+|||.++..
T Consensus       266 VfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~---l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~  341 (586)
T KOG0667|consen  266 VFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHE---LGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFE  341 (586)
T ss_pred             eehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCChhheeeccCCcCceeEEeccccccc
Confidence            99998 5699999999888889999999999999999999998   999999999999999653  36999999999975


Q ss_pred             cCCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhH--------HHHhh---
Q 007869          414 DHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVD--------WVFDF---  482 (586)
Q Consensus       414 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~--------~v~~~---  482 (586)
                      ....    ...+.+..|+|||++.+.+|+.+.||||||||+.||++|.+-|.+.++.+++..+.        |+.+.   
T Consensus       342 ~q~v----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~  417 (586)
T KOG0667|consen  342 SQRV----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKK  417 (586)
T ss_pred             CCcc----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccc
Confidence            4422    25678999999999999999999999999999999999988888776655443221        11110   


Q ss_pred             ----hcc----------Cc-----------------cccccCCC----CCccccHHHHHHHHHHHHHhcccCCCCCCCHH
Q 007869          483 ----WNR----------GE-----------------LLEARDPN----LGTEYVAEELELVLKLGLLCSHSDPTARPSMR  527 (586)
Q Consensus       483 ----~~~----------~~-----------------~~~~~d~~----l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~  527 (586)
                          +..          ..                 ..+..-|.    +........-+.+++++.+|++.||.+|+|..
T Consensus       418 ~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~  497 (586)
T KOG0667|consen  418 AHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPA  497 (586)
T ss_pred             cceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHH
Confidence                001          00                 01111110    00111223446788999999999999999999


Q ss_pred             HHHH
Q 007869          528 QVVQ  531 (586)
Q Consensus       528 evl~  531 (586)
                      |+++
T Consensus       498 qal~  501 (586)
T KOG0667|consen  498 QALN  501 (586)
T ss_pred             HHhc
Confidence            9986

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=3.4e-38  Score=319.63  Aligned_cols=259  Identities=26%  Similarity=0.376  Sum_probs=206.7

Q ss_pred             hhcCCcccceeEeecCceEEEEEEeCC----CCeEEEEEEeccc-cchhHHHHHHHHHHhcccCCCceeeeeeeeec-cC
Q 007869          258 IATKGFREKELLGTGGFGRVYRGTLPK----SQIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRR-KG  331 (586)
Q Consensus       258 ~a~~~f~~~~~LG~G~~g~Vy~~~~~~----~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~-~~  331 (586)
                      ...++|...+.||+|+||.||+|.+..    ++..|++|++... .....+.+.+|+.++++++|+||+++++++.. ..
T Consensus         3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~   82 (280)
T cd05043           3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE   82 (280)
T ss_pred             cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence            345788899999999999999999865    3578999988754 23445678999999999999999999998876 46


Q ss_pred             eEEEEEecCCCCChhhhhhcCCC------ccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEc
Q 007869          332 ELLLVYDYMPNGSLDKYLYDQPK------VTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLG  405 (586)
Q Consensus       332 ~~~lV~E~~~~gsL~~~l~~~~~------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~  405 (586)
                      ..++++||+++++|.+++.....      ..+++.+++.++.|++.||.|||+   .+++||||||+||++++++.+||+
T Consensus        83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kl~  159 (280)
T cd05043          83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKIT  159 (280)
T ss_pred             CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCHhhEEEcCCCcEEEC
Confidence            78999999999999999865422      458899999999999999999998   899999999999999999999999


Q ss_pred             cccceeeccCCCCC-ceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhh
Q 007869          406 DFGLARLYDHGTDP-QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFW  483 (586)
Q Consensus       406 DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~  483 (586)
                      |||+++.+...... ......++..|+|||++.+..++.++|||||||++||+++ |+.||......   .+..++.   
T Consensus       160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~~~---  233 (280)
T cd05043         160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF---EMAAYLK---  233 (280)
T ss_pred             CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH---HHHHHHH---
Confidence            99999865432211 1122345778999999988889999999999999999998 99999764332   1222211   


Q ss_pred             ccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 007869          484 NRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER  535 (586)
Q Consensus       484 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  535 (586)
                       .+.     .+..    .......+.+++.+||+.||++|||+.++++.|+.
T Consensus       234 -~~~-----~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~  275 (280)
T cd05043         234 -DGY-----RLAQ----PINCPDELFAVMACCWALDPEERPSFSQLVQCLTD  275 (280)
T ss_pred             -cCC-----CCCC----CCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence             111     0111    11123467889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=6.3e-38  Score=312.87  Aligned_cols=249  Identities=32%  Similarity=0.519  Sum_probs=204.9

Q ss_pred             eeEeecCceEEEEEEeCCC---CeEEEEEEeccccch-hHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEecCCC
Q 007869          267 ELLGTGGFGRVYRGTLPKS---QIEIAVKKISHESRQ-GMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPN  342 (586)
Q Consensus       267 ~~LG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~  342 (586)
                      +.||+|+||.||+|.....   +..|++|.+...... ..+.+.+|++.+.+++|+|++++++++......++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            4699999999999999765   788999999765443 367899999999999999999999999999999999999999


Q ss_pred             CChhhhhhcCC-------CccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccC
Q 007869          343 GSLDKYLYDQP-------KVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH  415 (586)
Q Consensus       343 gsL~~~l~~~~-------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~  415 (586)
                      ++|.+++....       ...+++.+++.++.|+++||.|||+   ++++||||||+||++++++.+||+|||.++....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEccccccccccc
Confidence            99999997752       2578999999999999999999998   9999999999999999999999999999987654


Q ss_pred             CCC-CceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccCccccccC
Q 007869          416 GTD-PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEARD  493 (586)
Q Consensus       416 ~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d  493 (586)
                      ... .......++..|+|||.+....++.++|||||||++|||++ |+.||......+   +.+    ...++..     
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~----~~~~~~~-----  225 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE---VLE----YLRKGYR-----  225 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH---HHH----HHHcCCC-----
Confidence            321 12334567889999999988889999999999999999999 699997653221   111    1111111     


Q ss_pred             CCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 007869          494 PNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILE  534 (586)
Q Consensus       494 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  534 (586)
                      ..    ........+.+++.+|++.+|.+||++.|+++.|+
T Consensus       226 ~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         226 LP----KPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             CC----CCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            11    11122456788999999999999999999998874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=7.2e-38  Score=320.52  Aligned_cols=250  Identities=26%  Similarity=0.397  Sum_probs=206.5

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEecC
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYM  340 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  340 (586)
                      ++|+..+.||.|++|.||+|+...++..|++|.+........+.+.+|+.++++++|||++++++++...+..++|+||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            46888999999999999999998889999999997665555678899999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCCc
Q 007869          341 PNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ  420 (586)
Q Consensus       341 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~  420 (586)
                      ++++|.+++...   .+++.++..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++........ .
T Consensus        99 ~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~---~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~  171 (296)
T cd06655          99 AGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-K  171 (296)
T ss_pred             CCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccchhcccccc-c
Confidence            999999998654   58899999999999999999998   8999999999999999999999999999886543322 2


Q ss_pred             eeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCccc
Q 007869          421 TTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEY  500 (586)
Q Consensus       421 ~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~  500 (586)
                      .....++..|+|||.+.+..++.++|||||||++|||++|+.||......+...   ..   ...+      .+.+.  .
T Consensus       172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~---~~---~~~~------~~~~~--~  237 (296)
T cd06655         172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY---LI---ATNG------TPELQ--N  237 (296)
T ss_pred             CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HH---HhcC------CcccC--C
Confidence            233568899999999998889999999999999999999999997654322111   01   0000      00110  1


Q ss_pred             cHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          501 VAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       501 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      .......+.+++.+||+.||.+||++.++++
T Consensus       238 ~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         238 PEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             cccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence            1122345677889999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=5.3e-38  Score=313.62  Aligned_cols=253  Identities=28%  Similarity=0.458  Sum_probs=203.5

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEec
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY  339 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  339 (586)
                      ..+|+..+.||+|+||.||++.+.. +..+|+|.+..... ...+|.+|++++++++|||++++++++......++||||
T Consensus         3 ~~~~~~~~~ig~g~~g~v~~~~~~~-~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd05112           3 PSELTLVQEIGSGQFGLVWLGYWLE-KRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEF   80 (256)
T ss_pred             hhHeEEEeeecCcccceEEEEEEeC-CCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEc
Confidence            3467888999999999999998854 55799998865432 346789999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCC
Q 007869          340 MPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP  419 (586)
Q Consensus       340 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~  419 (586)
                      +++++|.+++.... ..+++..++.++.|++.+|.|||+   .+++||||||+||+++.++.+||+|||+++........
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~  156 (256)
T cd05112          81 MEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLES---SNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT  156 (256)
T ss_pred             CCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHH---CCccccccccceEEEcCCCeEEECCCcceeecccCccc
Confidence            99999999987653 357899999999999999999998   89999999999999999999999999999865432221


Q ss_pred             ceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCc
Q 007869          420 QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGT  498 (586)
Q Consensus       420 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~  498 (586)
                      ......++.+|+|||++.++.++.++||||||+++|||++ |+.||......+      ..... .++  .....+..  
T Consensus       157 ~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~------~~~~~-~~~--~~~~~~~~--  225 (256)
T cd05112         157 SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE------VVETI-NAG--FRLYKPRL--  225 (256)
T ss_pred             ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH------HHHHH-hCC--CCCCCCCC--
Confidence            1222345678999999998899999999999999999998 999987543211      11111 111  01112222  


Q ss_pred             cccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 007869          499 EYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILE  534 (586)
Q Consensus       499 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  534 (586)
                           ....+.+++.+||+.+|++||++.++++.|.
T Consensus       226 -----~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         226 -----ASQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             -----CCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence                 2356888999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-37  Score=311.02  Aligned_cols=255  Identities=25%  Similarity=0.394  Sum_probs=209.1

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEec
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY  339 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  339 (586)
                      .++|+..+.||+|+||.||+|....++..+++|.+........+.+.+|++++++++||||+++++++...+.++++|||
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~   81 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY   81 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence            36788999999999999999999888889999999876666678899999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCC
Q 007869          340 MPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP  419 (586)
Q Consensus       340 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~  419 (586)
                      +++++|.+++... ...+++.++..++.|++.||.|||+   .+|+|+||||+||++++++.+||+|||++........ 
T Consensus        82 ~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-  156 (262)
T cd06613          82 CGGGSLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-  156 (262)
T ss_pred             CCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHh---CCceecCCChhhEEECCCCCEEECccccchhhhhhhh-
Confidence            9999999988764 2468889999999999999999998   8999999999999999999999999999986543221 


Q ss_pred             ceeeeccCCCccCcccccCC---CCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCC
Q 007869          420 QTTHVVGTLGYLAPEHTRTG---KATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNL  496 (586)
Q Consensus       420 ~~~~~~gt~~y~aPE~~~~~---~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l  496 (586)
                      ......++..|+|||.+.+.   .++.++|||||||++|||++|+.||......+....       ......   ..+.+
T Consensus       157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~-------~~~~~~---~~~~~  226 (262)
T cd06613         157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFL-------ISKSNF---PPPKL  226 (262)
T ss_pred             ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH-------HHhccC---CCccc
Confidence            22345688999999999776   789999999999999999999999976443221110       000000   01111


Q ss_pred             CccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          497 GTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       497 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                        .........+.+++.+||+.+|.+||++.++++
T Consensus       227 --~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         227 --KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             --cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence              112233456889999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=1.7e-37  Score=316.77  Aligned_cols=253  Identities=26%  Similarity=0.381  Sum_probs=205.4

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEec
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY  339 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  339 (586)
                      .+.|++.+.||+|+||.||+|.+..++..+++|.+........+.+.+|++++++++|||++++++.+..++..++||||
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   90 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEF   90 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEec
Confidence            35788899999999999999999988999999999877766778899999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCC
Q 007869          340 MPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP  419 (586)
Q Consensus       340 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~  419 (586)
                      +++++|..++.... ..+++..+..++.|++.+|.|||+   .+++||||||+||+++.++++||+|||++....... .
T Consensus        91 ~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-~  165 (292)
T cd06644          91 CPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-Q  165 (292)
T ss_pred             CCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhc---CCeeecCCCcceEEEcCCCCEEEccCccceeccccc-c
Confidence            99999998876543 468999999999999999999998   899999999999999999999999999987643321 1


Q ss_pred             ceeeeccCCCccCccccc-----CCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCC
Q 007869          420 QTTHVVGTLGYLAPEHTR-----TGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDP  494 (586)
Q Consensus       420 ~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~  494 (586)
                      ......++..|+|||++.     ...++.++|||||||++|||++|+.||.......      ..... ....     .+
T Consensus       166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~------~~~~~-~~~~-----~~  233 (292)
T cd06644         166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR------VLLKI-AKSE-----PP  233 (292)
T ss_pred             ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH------HHHHH-hcCC-----Cc
Confidence            223456889999999984     3456889999999999999999999987543211      11111 1110     11


Q ss_pred             CCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          495 NLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       495 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      ...  ........+.+++.+||+.+|++||++.++++
T Consensus       234 ~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         234 TLS--QPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             cCC--CCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            110  11122345778889999999999999999975

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.3e-37  Score=335.30  Aligned_cols=263  Identities=25%  Similarity=0.259  Sum_probs=199.6

Q ss_pred             hcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEe
Q 007869          259 ATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYD  338 (586)
Q Consensus       259 a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E  338 (586)
                      ...+|.+.+.||+|+||.||++.+...+..||||....      ..+.+|+++|++++|+||+++++++...+..++|||
T Consensus       167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e  240 (461)
T PHA03211        167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP  240 (461)
T ss_pred             ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence            34579999999999999999999999899999996432      345789999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCC
Q 007869          339 YMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD  418 (586)
Q Consensus       339 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~  418 (586)
                      ++ .++|.+++.... ..++|.+++.|+.|+++||.|||+   ++|+||||||+|||++.++.+||+|||+++.......
T Consensus       241 ~~-~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~  315 (461)
T PHA03211        241 KY-RSDLYTYLGARL-RPLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS  315 (461)
T ss_pred             cc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence            99 478988886543 368999999999999999999998   8999999999999999999999999999987643322


Q ss_pred             C-ceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCC-c----cchhhHHHHhhhc-cCcccc-
Q 007869          419 P-QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPS-E----NLILVDWVFDFWN-RGELLE-  490 (586)
Q Consensus       419 ~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~-~----~~~l~~~v~~~~~-~~~~~~-  490 (586)
                      . ......||..|+|||++.+..++.++|||||||+||||++|..|+...... .    ...+.+.+..... ...... 
T Consensus       316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~  395 (461)
T PHA03211        316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH  395 (461)
T ss_pred             cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence            1 223457999999999999999999999999999999999988766432211 1    0011111111000 000000 


Q ss_pred             ---------------ccCCCCCc-ccc--HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          491 ---------------ARDPNLGT-EYV--AEELELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       491 ---------------~~d~~l~~-~~~--~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                                     ...+.... .+.  ......+.+|+.+||+.||.+|||+.|+++.
T Consensus       396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence                           00000000 000  0112357788999999999999999999864

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=6.3e-38  Score=318.61  Aligned_cols=261  Identities=25%  Similarity=0.402  Sum_probs=203.9

Q ss_pred             CCcccceeEeecCceEEEEEEe----CCCCeEEEEEEecccc-chhHHHHHHHHHHhcccCCCceeeeeeeeecc--CeE
Q 007869          261 KGFREKELLGTGGFGRVYRGTL----PKSQIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRK--GEL  333 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~----~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~--~~~  333 (586)
                      +.|+..+.||+|+||.||++..    ..++..||+|.+.... ......+.+|++++++++|||++++++++...  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            4578889999999999999984    3567789999987553 34456799999999999999999999998875  568


Q ss_pred             EEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeec
Q 007869          334 LLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLY  413 (586)
Q Consensus       334 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~  413 (586)
                      ++||||+++++|.+++.... ..+++..++.++.|++.||+|||+   ++++||||||+||+++.++.+||+|||+++..
T Consensus        84 ~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~  159 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAI  159 (284)
T ss_pred             EEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECCCcccccc
Confidence            99999999999999996653 368999999999999999999998   99999999999999999999999999999876


Q ss_pred             cCCCCC--ceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCC---------CccchhhHHHHhh
Q 007869          414 DHGTDP--QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGP---------SENLILVDWVFDF  482 (586)
Q Consensus       414 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~---------~~~~~l~~~v~~~  482 (586)
                      ......  ......++..|+|||++.+..++.++|||||||++|||++++.|......         ....... .....
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  238 (284)
T cd05079         160 ETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVT-RLVRV  238 (284)
T ss_pred             ccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHH-HHHHH
Confidence            443221  11234567789999999888899999999999999999998876532111         0000111 11111


Q ss_pred             hccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 007869          483 WNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER  535 (586)
Q Consensus       483 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  535 (586)
                      ..++...    +     ........+.+++.+|++.+|++||++.++++.|+.
T Consensus       239 ~~~~~~~----~-----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  282 (284)
T cd05079         239 LEEGKRL----P-----RPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEA  282 (284)
T ss_pred             HHcCccC----C-----CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHh
Confidence            1111110    0     011234578899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=7.4e-38  Score=340.72  Aligned_cols=268  Identities=24%  Similarity=0.302  Sum_probs=198.8

Q ss_pred             hhhhhhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCC------Cceeeeeeee
Q 007869          254 KDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRH------RNLVQLLGYC  327 (586)
Q Consensus       254 ~el~~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H------~niv~l~~~~  327 (586)
                      +++...+++|++.++||+|+||+||+|.+..++..||||+++... ...+++..|++++.+++|      .+++++++++
T Consensus       122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~  200 (467)
T PTZ00284        122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF  200 (467)
T ss_pred             CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence            445566789999999999999999999998889999999996432 223445667777666654      4588999988


Q ss_pred             ecc-CeEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCC------
Q 007869          328 RRK-GELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGEL------  400 (586)
Q Consensus       328 ~~~-~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~------  400 (586)
                      ... +..++|||++ +++|.+++...  ..+++..+..|+.||+.||.|||+  +.+||||||||+|||++.++      
T Consensus       201 ~~~~~~~~iv~~~~-g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~--~~gIiHrDlKP~NILl~~~~~~~~~~  275 (467)
T PTZ00284        201 QNETGHMCIVMPKY-GPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHT--ELHLMHTDLKPENILMETSDTVVDPV  275 (467)
T ss_pred             EcCCceEEEEEecc-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh--cCCeecCCCCHHHEEEecCCcccccc
Confidence            754 5789999988 77899888765  368899999999999999999996  25899999999999998765      


Q ss_pred             ----------CeEEccccceeeccCCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCC
Q 007869          401 ----------NGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPS  470 (586)
Q Consensus       401 ----------~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~  470 (586)
                                .+||+|||++.....    ..+..+||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus       276 ~~~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~  351 (467)
T PTZ00284        276 TNRALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNL  351 (467)
T ss_pred             cccccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence                      499999998864322    234568999999999999999999999999999999999999999875543


Q ss_pred             ccchhhHHH---------Hh--------hhcc-CccccccCCCCC-----cc--ccHHHHHHHHHHHHHhcccCCCCCCC
Q 007869          471 ENLILVDWV---------FD--------FWNR-GELLEARDPNLG-----TE--YVAEELELVLKLGLLCSHSDPTARPS  525 (586)
Q Consensus       471 ~~~~l~~~v---------~~--------~~~~-~~~~~~~d~~l~-----~~--~~~~~~~~l~~l~~~Cl~~dP~~RPs  525 (586)
                      +...++...         ..        ++.. +.+....++...     ..  ........+++|+.+||+.||++|||
T Consensus       352 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t  431 (467)
T PTZ00284        352 EHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLN  431 (467)
T ss_pred             HHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCC
Confidence            322221111         00        0000 000000000000     00  00011345779999999999999999


Q ss_pred             HHHHHH
Q 007869          526 MRQVVQ  531 (586)
Q Consensus       526 ~~evl~  531 (586)
                      ++|+++
T Consensus       432 a~e~L~  437 (467)
T PTZ00284        432 ARQMTT  437 (467)
T ss_pred             HHHHhc
Confidence            999986

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=7.2e-38  Score=315.53  Aligned_cols=255  Identities=25%  Similarity=0.415  Sum_probs=204.0

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCC---CeEEEEEEecccc-chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEE
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKS---QIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLL  335 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~l  335 (586)
                      .++|...+.||+|+||.||+|.+...   ...||||...... .+..+.+.+|+.++++++||||+++++++.. +..++
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l   83 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI   83 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence            35678889999999999999987543   3468999887654 4456789999999999999999999998875 45789


Q ss_pred             EEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccC
Q 007869          336 VYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH  415 (586)
Q Consensus       336 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~  415 (586)
                      ||||+++++|.+++.... ..+++.+++.++.|++.||.|||+   .+++||||||+|||++.++.+||+|||+++....
T Consensus        84 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  159 (270)
T cd05056          84 VMELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED  159 (270)
T ss_pred             EEEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccChheEEEecCCCeEEccCceeeeccc
Confidence            999999999999997653 358999999999999999999998   8999999999999999999999999999987654


Q ss_pred             CCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccCccccccCC
Q 007869          416 GTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEARDP  494 (586)
Q Consensus       416 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~  494 (586)
                      ..........++..|+|||.+....++.++|||||||++|||++ |+.||......+.   ..+.    .++...     
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~---~~~~----~~~~~~-----  227 (270)
T cd05056         160 ESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV---IGRI----ENGERL-----  227 (270)
T ss_pred             ccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH---HHHH----HcCCcC-----
Confidence            32222222344578999999988889999999999999999986 9999976543221   1111    111111     


Q ss_pred             CCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 007869          495 NLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER  535 (586)
Q Consensus       495 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  535 (586)
                      ..    .......+.+++.+|+..+|.+|||+.++++.|+.
T Consensus       228 ~~----~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~  264 (270)
T cd05056         228 PM----PPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSD  264 (270)
T ss_pred             CC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            11    11223567788899999999999999999999875

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=8.7e-38  Score=314.25  Aligned_cols=254  Identities=24%  Similarity=0.384  Sum_probs=204.4

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEec
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY  339 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  339 (586)
                      .++|...+.||+|+||.||+|+...++..||+|.++.........+.+|+.+++.++||||+++++.+...+..++|+||
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~   87 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF   87 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence            34778888999999999999999888999999999776555566788999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCC
Q 007869          340 MPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP  419 (586)
Q Consensus       340 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~  419 (586)
                      +++++|.+++....  .+++.+.+.++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||++....... .
T Consensus        88 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-~  161 (267)
T cd06645          88 CGGGSLQDIYHVTG--PLSESQIAYVSRETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI-A  161 (267)
T ss_pred             cCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc-c
Confidence            99999999986553  58889999999999999999998   899999999999999999999999999998654322 1


Q ss_pred             ceeeeccCCCccCccccc---CCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCC
Q 007869          420 QTTHVVGTLGYLAPEHTR---TGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNL  496 (586)
Q Consensus       420 ~~~~~~gt~~y~aPE~~~---~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l  496 (586)
                      ......|+..|+|||++.   ...++.++|||||||++|||++|+.||....+......      . ......   .+..
T Consensus       162 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~------~-~~~~~~---~~~~  231 (267)
T cd06645         162 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL------M-TKSNFQ---PPKL  231 (267)
T ss_pred             ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHh------h-hccCCC---CCcc
Confidence            223457899999999874   45688999999999999999999999865443221110      0 011110   0111


Q ss_pred             CccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          497 GTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       497 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      ..  .......+.+++.+|++.+|++||++.++++
T Consensus       232 ~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         232 KD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             cc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence            00  0012245678899999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1.5e-37  Score=315.82  Aligned_cols=263  Identities=24%  Similarity=0.299  Sum_probs=207.5

Q ss_pred             cchhhhhhhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhccc-CCCceeeeeeeee-
Q 007869          251 FRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCR-  328 (586)
Q Consensus       251 ~~~~el~~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~-  328 (586)
                      +.++.+..+.++|+..+.||+|+||.||++....++..+|+|++.... ....++.+|+.++.++ +||||+++++++. 
T Consensus         8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   86 (286)
T cd06638           8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK   86 (286)
T ss_pred             EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence            445677788999999999999999999999998889999999886532 2235688899999999 7999999999874 


Q ss_pred             ----ccCeEEEEEecCCCCChhhhhhcC--CCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCe
Q 007869          329 ----RKGELLLVYDYMPNGSLDKYLYDQ--PKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNG  402 (586)
Q Consensus       329 ----~~~~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~  402 (586)
                          ..+..++||||+++++|.+++...  ....+++..+..++.|+++||.|||+   .+++||||||+||+++.++.+
T Consensus        87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~  163 (286)
T cd06638          87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTEGGV  163 (286)
T ss_pred             cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCHHhEEECCCCCE
Confidence                345689999999999999987642  23468889999999999999999998   899999999999999999999


Q ss_pred             EEccccceeeccCCCCCceeeeccCCCccCcccccC-----CCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhH
Q 007869          403 RLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRT-----GKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVD  477 (586)
Q Consensus       403 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~  477 (586)
                      ||+|||+++...... .......|+..|+|||++..     ..++.++|||||||++|||++|+.|+.........  . 
T Consensus       164 kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~--~-  239 (286)
T cd06638         164 KLVDFGVSAQLTSTR-LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL--F-  239 (286)
T ss_pred             EEccCCceeecccCC-CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHH--h-
Confidence            999999998764322 12234578999999998753     44788999999999999999999999764332211  0 


Q ss_pred             HHHhhhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          478 WVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       478 ~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                         . ...+......++.       .....+.+++.+||+.||++||++.|+++.
T Consensus       240 ---~-~~~~~~~~~~~~~-------~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         240 ---K-IPRNPPPTLHQPE-------LWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             ---h-ccccCCCcccCCC-------CcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence               0 0011000111111       112457788999999999999999999874

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=2.3e-37  Score=311.84  Aligned_cols=253  Identities=27%  Similarity=0.423  Sum_probs=193.2

Q ss_pred             eeEeecCceEEEEEEeCC--CCeEEEEEEecccc-chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEecCCCC
Q 007869          267 ELLGTGGFGRVYRGTLPK--SQIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNG  343 (586)
Q Consensus       267 ~~LG~G~~g~Vy~~~~~~--~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~g  343 (586)
                      +.||+|+||.||+|....  ++..+|+|.++... ......+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            358999999999998643  45679999987653 334457899999999999999999999999999999999999999


Q ss_pred             ChhhhhhcCC---CccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCC-C
Q 007869          344 SLDKYLYDQP---KVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD-P  419 (586)
Q Consensus       344 sL~~~l~~~~---~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~-~  419 (586)
                      +|.+++....   ....++..+..++.|++.||.|||+   .+++||||||+||+++.++++||+|||+++....... .
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK---NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            9999997532   2356777888899999999999998   8999999999999999999999999999975432221 1


Q ss_pred             ceeeeccCCCccCcccccCC-------CCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccCccccc
Q 007869          420 QTTHVVGTLGYLAPEHTRTG-------KATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEA  491 (586)
Q Consensus       420 ~~~~~~gt~~y~aPE~~~~~-------~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~  491 (586)
                      ......++..|+|||++...       .++.++|+||||+++|||++ |+.||......+.   ....    ..+.....
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~---~~~~----~~~~~~~~  230 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV---LTYT----VREQQLKL  230 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH---HHHH----hhcccCCC
Confidence            12234578899999998542       35789999999999999996 9999975443221   1111    11111222


Q ss_pred             cCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 007869          492 RDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILE  534 (586)
Q Consensus       492 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  534 (586)
                      .+|.+....    .+.+.+++..|+ .+|++|||+.||++.|+
T Consensus       231 ~~~~~~~~~----~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         231 PKPRLKLPL----SDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCCccCCCC----ChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            233332222    234566777898 58999999999998875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=6.2e-38  Score=317.67  Aligned_cols=262  Identities=29%  Similarity=0.447  Sum_probs=205.7

Q ss_pred             CCcccceeEeecCceEEEEEEeCC----CCeEEEEEEeccccch-hHHHHHHHHHHhcccCCCceeeeeeeeec--cCeE
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPK----SQIEIAVKKISHESRQ-GMKEFVAEIVSIGRLRHRNLVQLLGYCRR--KGEL  333 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~----~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~~~~~~--~~~~  333 (586)
                      +.|+..+.||+|+||.||++.+..    ++..+|||.+...... ..+.|.+|++++++++|+||+++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            456778899999999999999743    4778999999765443 56789999999999999999999999887  5678


Q ss_pred             EEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeec
Q 007869          334 LLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLY  413 (586)
Q Consensus       334 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~  413 (586)
                      ++||||+++++|.+++.... ..+++..++.++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++...
T Consensus        84 ~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  159 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVL  159 (284)
T ss_pred             EEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEccccccccc
Confidence            99999999999999997653 358999999999999999999998   89999999999999999999999999999876


Q ss_pred             cCCCCC--ceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccc--------hhhHHHHhhh
Q 007869          414 DHGTDP--QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENL--------ILVDWVFDFW  483 (586)
Q Consensus       414 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~--------~l~~~v~~~~  483 (586)
                      ......  ......++..|++||.+.+..++.++||||||++++||++|+.|+.........        ..........
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T cd05038         160 PEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELL  239 (284)
T ss_pred             ccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHH
Confidence            532221  111234566799999998889999999999999999999999998653221100        0001111111


Q ss_pred             ccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 007869          484 NRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER  535 (586)
Q Consensus       484 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  535 (586)
                      ..+..         ..........+.+++.+||+.+|++||++.|++++|+.
T Consensus       240 ~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~  282 (284)
T cd05038         240 KEGER---------LPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDR  282 (284)
T ss_pred             HcCCc---------CCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhh
Confidence            11110         00111223568899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1e-37  Score=313.52  Aligned_cols=241  Identities=27%  Similarity=0.433  Sum_probs=191.1

Q ss_pred             eeEeecCceEEEEEEeCC------------CCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEE
Q 007869          267 ELLGTGGFGRVYRGTLPK------------SQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELL  334 (586)
Q Consensus       267 ~~LG~G~~g~Vy~~~~~~------------~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~  334 (586)
                      +.||+|+||.||+|+...            ....|++|.+..........|..|+.++++++||||+++++++..+...+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            368999999999998632            23358999887665555668899999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCC-------eEEccc
Q 007869          335 LVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELN-------GRLGDF  407 (586)
Q Consensus       335 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~-------~kL~DF  407 (586)
                      +||||+++++|+.++.... ..+++..++.++.||++||.|||+   ++|+||||||+|||++.++.       +|++||
T Consensus        81 lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~  156 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLED---KDLVHGNVCTKNILLAREGIDGECGPFIKLSDP  156 (262)
T ss_pred             EEEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhh---CCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence            9999999999999886542 358888999999999999999998   89999999999999987654       899999


Q ss_pred             cceeeccCCCCCceeeeccCCCccCccccc-CCCCCCcceEEehhHHHHHHH-hCCCCCCCCCCCccchhhHHHHhhhcc
Q 007869          408 GLARLYDHGTDPQTTHVVGTLGYLAPEHTR-TGKATTSADVFSFGAFLLEVA-CGRRPIQRQGPSENLILVDWVFDFWNR  485 (586)
Q Consensus       408 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~ksDVyS~Gvvl~Ell-tG~~p~~~~~~~~~~~l~~~v~~~~~~  485 (586)
                      |++......     ....++..|+|||++. +..++.++|||||||++|||+ .|+.|+......+.    .   .... 
T Consensus       157 g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~----~---~~~~-  223 (262)
T cd05077         157 GIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK----E---RFYE-  223 (262)
T ss_pred             CCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH----H---HHHh-
Confidence            998754321     2345788999999986 466899999999999999997 58888765432211    0   0111 


Q ss_pred             CccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 007869          486 GELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILE  534 (586)
Q Consensus       486 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  534 (586)
                      +..      ....    .....+.+++.+||+.||.+||++.++++.|+
T Consensus       224 ~~~------~~~~----~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         224 GQC------MLVT----PSCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             cCc------cCCC----CChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence            110      0101    11245778899999999999999999998764

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=8.7e-38  Score=351.60  Aligned_cols=258  Identities=23%  Similarity=0.321  Sum_probs=203.7

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc---chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEE
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY  337 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  337 (586)
                      ++|+..++||+|+||.||+|++..++..||||++....   ....+.|.+|++++++++||||+++++++.+.+..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            47889999999999999999999889999999997542   233467999999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCC---------CccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEcccc
Q 007869          338 DYMPNGSLDKYLYDQP---------KVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFG  408 (586)
Q Consensus       338 E~~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFG  408 (586)
                      ||+++|+|.+++....         ...+++..+++++.||++||.|||+   ++|+||||||+|||++.++.+||+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---CCccccCCchheEEEcCCCCEEEEecC
Confidence            9999999999986421         1345677889999999999999998   899999999999999999999999999


Q ss_pred             ceeeccCCCC-----------------CceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCc
Q 007869          409 LARLYDHGTD-----------------PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSE  471 (586)
Q Consensus       409 la~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~  471 (586)
                      +++.......                 ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......+
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k  238 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK  238 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence            9987621110                 01123469999999999999999999999999999999999999997633221


Q ss_pred             cchhhHHHHhhhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHhh
Q 007869          472 NLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARP-SMRQVVQILER  535 (586)
Q Consensus       472 ~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~evl~~L~~  535 (586)
                      ..      .    ...+.   +|..... ..+....+.+++.+|++.||++|| +++++++.|+.
T Consensus       239 i~------~----~~~i~---~P~~~~p-~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~  289 (932)
T PRK13184        239 IS------Y----RDVIL---SPIEVAP-YREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEP  289 (932)
T ss_pred             hh------h----hhhcc---Chhhccc-cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            10      0    00011   1100000 112234577888999999999996 56667666654

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=5.1e-38  Score=328.47  Aligned_cols=259  Identities=27%  Similarity=0.412  Sum_probs=201.7

Q ss_pred             cCCcccceeEeecCceEEEEEEeC-----CCCeEEEEEEecccc-chhHHHHHHHHHHhccc-CCCceeeeeeeeecc-C
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLP-----KSQIEIAVKKISHES-RQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRK-G  331 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~-~  331 (586)
                      .++|+..+.||+|+||.||+|++.     .+++.||||++.... ......+.+|+.++.++ +||||++++++|... .
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            457889999999999999999842     356789999997543 33456788999999999 789999999988654 5


Q ss_pred             eEEEEEecCCCCChhhhhhcCC----------------------------------------------------------
Q 007869          332 ELLLVYDYMPNGSLDKYLYDQP----------------------------------------------------------  353 (586)
Q Consensus       332 ~~~lV~E~~~~gsL~~~l~~~~----------------------------------------------------------  353 (586)
                      ..++||||+++|+|.+++....                                                          
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            6899999999999999986431                                                          


Q ss_pred             -------CccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCC-Cceeeec
Q 007869          354 -------KVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD-PQTTHVV  425 (586)
Q Consensus       354 -------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~-~~~~~~~  425 (586)
                             ...+++.++..++.|+++||.|||+   ++|+||||||+|||++.++++||+|||+++....... .......
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  242 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR  242 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence                   1236788889999999999999998   8999999999999999999999999999986533221 1122234


Q ss_pred             cCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCccccHHH
Q 007869          426 GTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAEE  504 (586)
Q Consensus       426 gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~  504 (586)
                      ++..|+|||.+.+..++.++||||||+++|||++ |..||......+.  +    .....++....  .|.   .    .
T Consensus       243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~----~~~~~~~~~~~--~~~---~----~  307 (343)
T cd05103         243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--F----CRRLKEGTRMR--APD---Y----T  307 (343)
T ss_pred             CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH--H----HHHHhccCCCC--CCC---C----C
Confidence            5678999999988899999999999999999997 8999865432211  1    11111221111  111   1    1


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 007869          505 LELVLKLGLLCSHSDPTARPSMRQVVQILERD  536 (586)
Q Consensus       505 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  536 (586)
                      ...+.+++..||+.||++||++.|+++.|+..
T Consensus       308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~  339 (343)
T cd05103         308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  339 (343)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            23578889999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=2e-37  Score=311.72  Aligned_cols=250  Identities=26%  Similarity=0.427  Sum_probs=197.4

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc-----chhHHHHHHHHHHhcccCCCceeeeeeeeec--cCeE
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES-----RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRR--KGEL  333 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~--~~~~  333 (586)
                      .+|+..+.||+|+||.||++....++..||+|++....     .+..+.+.+|+.++++++||||+++++++..  .+..
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            47888999999999999999998889999999886432     2334568899999999999999999998875  3678


Q ss_pred             EEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeec
Q 007869          334 LLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLY  413 (586)
Q Consensus       334 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~  413 (586)
                      ++++||+++++|.+++....  .+++...+.++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||+++..
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~LH~---~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~  156 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYG--ALTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRL  156 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCCCcccc
Confidence            99999999999999997653  47888899999999999999998   89999999999999999999999999999865


Q ss_pred             cCCCC--CceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccc
Q 007869          414 DHGTD--PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEA  491 (586)
Q Consensus       414 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~  491 (586)
                      .....  .......++..|+|||++.+..++.++|||||||++|||++|+.||......+.      ......     ..
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~------~~~~~~-----~~  225 (266)
T cd06651         157 QTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA------IFKIAT-----QP  225 (266)
T ss_pred             ccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHH------HHHHhc-----CC
Confidence            43211  112234688999999999988899999999999999999999999975432211      111100     11


Q ss_pred             cCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          492 RDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       492 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      ..+.+.    ......+..++ .||..+|++||+++|+++
T Consensus       226 ~~~~~~----~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         226 TNPQLP----SHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             CCCCCc----hhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence            112221    11223333443 688899999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=9.4e-38  Score=311.99  Aligned_cols=239  Identities=29%  Similarity=0.482  Sum_probs=192.9

Q ss_pred             eeEeecCceEEEEEEeCCCC----------eEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEE
Q 007869          267 ELLGTGGFGRVYRGTLPKSQ----------IEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLV  336 (586)
Q Consensus       267 ~~LG~G~~g~Vy~~~~~~~~----------~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV  336 (586)
                      +.||+|+||.||+|.+..++          ..+++|.+...... ...|.+|+.++++++||||+++++++.. +..++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            46999999999999997665          45888887655433 6789999999999999999999999988 788999


Q ss_pred             EecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCC-------CeEEccccc
Q 007869          337 YDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGEL-------NGRLGDFGL  409 (586)
Q Consensus       337 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~-------~~kL~DFGl  409 (586)
                      |||+++|+|.+++..... .+++..++.++.||+.||.|||+   ++|+||||||+|||++.++       .+||+|||+
T Consensus        79 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~  154 (259)
T cd05037          79 EEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLED---KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI  154 (259)
T ss_pred             EEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhh---CCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence            999999999999977543 68888999999999999999998   8999999999999999887       799999999


Q ss_pred             eeeccCCCCCceeeeccCCCccCcccccCC--CCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccC
Q 007869          410 ARLYDHGTDPQTTHVVGTLGYLAPEHTRTG--KATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRG  486 (586)
Q Consensus       410 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~  486 (586)
                      +.....     .....++..|+|||++...  .++.++|||||||++|||++ |..|+......+.   ..    .+...
T Consensus       155 a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~---~~----~~~~~  222 (259)
T cd05037         155 PITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK---ER----FYQDQ  222 (259)
T ss_pred             cccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhH---HH----HHhcC
Confidence            986543     2234567789999999876  78999999999999999999 5777765432211   11    11111


Q ss_pred             ccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 007869          487 ELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILE  534 (586)
Q Consensus       487 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  534 (586)
                      ..    .+..       ....+.+++.+||+.+|.+||++.++++.|+
T Consensus       223 ~~----~~~~-------~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         223 HR----LPMP-------DCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             CC----CCCC-------CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            00    0100       0166788999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.2e-37  Score=327.31  Aligned_cols=195  Identities=26%  Similarity=0.331  Sum_probs=169.3

Q ss_pred             hhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEE
Q 007869          258 IATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY  337 (586)
Q Consensus       258 ~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  337 (586)
                      ....+|+..+.||+|+||.||+|+...++..||+|.....      ....|+.++++++||||+++++++...+..++|+
T Consensus        63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  136 (357)
T PHA03209         63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL  136 (357)
T ss_pred             hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence            3456799999999999999999999988889999985432      2356899999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCC
Q 007869          338 DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT  417 (586)
Q Consensus       338 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~  417 (586)
                      ||+ .++|.+++.... ..+++..+..|+.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++..... 
T Consensus       137 e~~-~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-  210 (357)
T PHA03209        137 PHY-SSDLYTYLTKRS-RPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA-  210 (357)
T ss_pred             Ecc-CCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEecCccccccccC-
Confidence            999 468888886543 468999999999999999999998   89999999999999999999999999999753321 


Q ss_pred             CCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCC
Q 007869          418 DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQ  465 (586)
Q Consensus       418 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~  465 (586)
                       .......||..|+|||++.+..++.++|||||||++|||+++..|+.
T Consensus       211 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f  257 (357)
T PHA03209        211 -PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIF  257 (357)
T ss_pred             -cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccc
Confidence             22334579999999999999999999999999999999998666553

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=5.7e-38  Score=317.63  Aligned_cols=248  Identities=26%  Similarity=0.400  Sum_probs=203.6

Q ss_pred             CcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc-chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEecC
Q 007869          262 GFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYM  340 (586)
Q Consensus       262 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  340 (586)
                      .|+..+.||+|+||.||+|.+..++..||+|.+.... ....+.+.+|++++++++||||+++++++...+..++||||+
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence            3566778999999999999998888999999987543 344567899999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCCc
Q 007869          341 PNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ  420 (586)
Q Consensus       341 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~  420 (586)
                      ++++|.+++...   .+++..+..++.|+++||.|||+   ++++|+||+|+||++++++.+||+|||++....... ..
T Consensus        85 ~~~~L~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~~  157 (277)
T cd06642          85 GGGSALDLLKPG---PLEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-IK  157 (277)
T ss_pred             CCCcHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEccccccccccCcc-hh
Confidence            999999988643   58889999999999999999998   899999999999999999999999999998654322 12


Q ss_pred             eeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCccc
Q 007869          421 TTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEY  500 (586)
Q Consensus       421 ~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~  500 (586)
                      .....|+..|+|||++.+..++.++|||||||++|||++|+.|+........   ..+    .     .....+.+    
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~---~~~----~-----~~~~~~~~----  221 (277)
T cd06642         158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV---LFL----I-----PKNSPPTL----  221 (277)
T ss_pred             hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH---Hhh----h-----hcCCCCCC----
Confidence            2234688999999999988899999999999999999999999875433211   100    0     01111222    


Q ss_pred             cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          501 VAEELELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       501 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                      .......+.+++.+|++.+|++||++.++++.
T Consensus       222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         222 EGQYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             CcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            12234567889999999999999999999973

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1.5e-37  Score=315.35  Aligned_cols=265  Identities=28%  Similarity=0.381  Sum_probs=200.1

Q ss_pred             CcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc--chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEec
Q 007869          262 GFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES--RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY  339 (586)
Q Consensus       262 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  339 (586)
                      +|+..+.||+|++|.||+|+...++..||||++....  ....+.+.+|+.++++++|||++++++++..++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4778899999999999999998889999999986542  23346788999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCCC-ccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCC
Q 007869          340 MPNGSLDKYLYDQPK-VTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD  418 (586)
Q Consensus       340 ~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~  418 (586)
                      ++ ++|.+++..... ..+++.++..++.|+++||.|||+   .+|+||||||+||+++.++.+||+|||++........
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  156 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR  156 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence            97 689888865432 568999999999999999999998   8999999999999999999999999999986543221


Q ss_pred             CceeeeccCCCccCcccccCC-CCCCcceEEehhHHHHHHHhCCCCCCCCCCCccch-hhHHH----HhhhccCccc---
Q 007869          419 PQTTHVVGTLGYLAPEHTRTG-KATTSADVFSFGAFLLEVACGRRPIQRQGPSENLI-LVDWV----FDFWNRGELL---  489 (586)
Q Consensus       419 ~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~-l~~~v----~~~~~~~~~~---  489 (586)
                       ......+++.|+|||++.+. .++.++|||||||+++||++|+.||......+... .....    ...+......   
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (285)
T cd07861         157 -VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDY  235 (285)
T ss_pred             -cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHH
Confidence             22334678999999988654 47899999999999999999999997643321110 00000    0000000000   


Q ss_pred             cccCCCCCc----cccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          490 EARDPNLGT----EYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       490 ~~~d~~l~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      ...-+....    .........+.+++.+||+.||.+|||+.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         236 KNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             HhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            000000000    000112345678999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.2e-37  Score=310.95  Aligned_cols=250  Identities=24%  Similarity=0.386  Sum_probs=206.3

Q ss_pred             CcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc--cchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEec
Q 007869          262 GFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY  339 (586)
Q Consensus       262 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  339 (586)
                      +|+..+.||+|+||.+|++....++..||+|++...  .....+++.+|+.++++++||||+++++++...+..++||||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            478889999999999999999888999999998653  233456889999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCC
Q 007869          340 MPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP  419 (586)
Q Consensus       340 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~  419 (586)
                      +++++|.+++.......+++.+.+.++.|++.||.|||+   .+++|+||+|+|||++.++.++|+|||++........ 
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~-  156 (256)
T cd08218          81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE-  156 (256)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh-
Confidence            999999999976544568899999999999999999998   8999999999999999999999999999987644321 


Q ss_pred             ceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCcc
Q 007869          420 QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTE  499 (586)
Q Consensus       420 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~  499 (586)
                      ......|++.|+|||++.+...+.++|+|||||+++||++|+.||......+      .+.... .+..     +..   
T Consensus       157 ~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~------~~~~~~-~~~~-----~~~---  221 (256)
T cd08218         157 LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN------LVLKII-RGSY-----PPV---  221 (256)
T ss_pred             hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHH------HHHHHh-cCCC-----CCC---
Confidence            1223468899999999998899999999999999999999999987543211      111111 1111     111   


Q ss_pred             ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          500 YVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       500 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                       .......+.+++.+||+.+|.+||++.+|++
T Consensus       222 -~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         222 -SSHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             -cccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence             1122355788889999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1.1e-37  Score=316.27  Aligned_cols=261  Identities=25%  Similarity=0.365  Sum_probs=208.5

Q ss_pred             cchhhhhhhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhccc-CCCceeeeeeeeec
Q 007869          251 FRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRR  329 (586)
Q Consensus       251 ~~~~el~~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~  329 (586)
                      .+..++..+.+.|+..+.||+|+||.||+|.+..++..+|+|.+.... ....++..|+.++.++ +|+|++++++++..
T Consensus         6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   84 (282)
T cd06636           6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIK   84 (282)
T ss_pred             hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence            356677778889999999999999999999998889999999986543 3346788999999998 79999999998853


Q ss_pred             ------cCeEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeE
Q 007869          330 ------KGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGR  403 (586)
Q Consensus       330 ------~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~k  403 (586)
                            .+..+++|||+++|+|.+++.......+++..+..++.|+++||.|||+   .+|+||||||+||++++++.++
T Consensus        85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dl~~~nili~~~~~~~  161 (282)
T cd06636          85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAEVK  161 (282)
T ss_pred             ccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEE
Confidence                  4578999999999999999977655568888899999999999999998   8999999999999999999999


Q ss_pred             EccccceeeccCCCCCceeeeccCCCccCccccc-----CCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHH
Q 007869          404 LGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTR-----TGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDW  478 (586)
Q Consensus       404 L~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~  478 (586)
                      |+|||++........ ......|+..|+|||.+.     ...++.++|||||||++|||++|+.||....+.+....   
T Consensus       162 l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~---  237 (282)
T cd06636         162 LVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL---  237 (282)
T ss_pred             EeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhh---
Confidence            999999886543221 223456899999999886     34578899999999999999999999975433221110   


Q ss_pred             HHhhhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          479 VFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       479 v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                               ......+...   .......+.+++.+||+.||.+||++.|+++
T Consensus       238 ---------~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         238 ---------IPRNPPPKLK---SKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             ---------HhhCCCCCCc---ccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence                     0011111111   1122356788899999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.1e-37  Score=310.97  Aligned_cols=252  Identities=32%  Similarity=0.538  Sum_probs=204.4

Q ss_pred             cccceeEeecCceEEEEEEeCCCC----eEEEEEEeccccch-hHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEE
Q 007869          263 FREKELLGTGGFGRVYRGTLPKSQ----IEIAVKKISHESRQ-GMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY  337 (586)
Q Consensus       263 f~~~~~LG~G~~g~Vy~~~~~~~~----~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  337 (586)
                      |+..+.||+|+||.||+++....+    ..||+|.+...... ..+.+..|+..+.+++|+||+++++++...+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            356788999999999999997755    88999999765433 5678999999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCC
Q 007869          338 DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT  417 (586)
Q Consensus       338 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~  417 (586)
                      ||+++++|.+++.......+++.+++.++.|++.||.|||+   .+++||||||+||++++++.++|+|||+++......
T Consensus        81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~---~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  157 (258)
T smart00219       81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD  157 (258)
T ss_pred             eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhc---CCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence            99999999999977544338999999999999999999998   899999999999999999999999999998765442


Q ss_pred             CCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccCccccccCCCC
Q 007869          418 DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNL  496 (586)
Q Consensus       418 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l  496 (586)
                      ........++..|+|||.+.+..++.++||||||++++||++ |+.||......+   +.+.+    ..+...     ..
T Consensus       158 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~---~~~~~----~~~~~~-----~~  225 (258)
T smart00219      158 YYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE---VLEYL----KKGYRL-----PK  225 (258)
T ss_pred             ccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH----hcCCCC-----CC
Confidence            222212347789999999988889999999999999999998 788887532211   11111    111111     01


Q ss_pred             CccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 007869          497 GTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQIL  533 (586)
Q Consensus       497 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L  533 (586)
                          .......+.+++.+|++.||++|||+.|+++.|
T Consensus       226 ----~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      226 ----PENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             ----CCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence                111345677889999999999999999999864

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=2.9e-37  Score=309.65  Aligned_cols=256  Identities=28%  Similarity=0.408  Sum_probs=208.3

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc-chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEec
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY  339 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  339 (586)
                      ++|+..+.||.|+||.||+|....++..+++|++.... ....+.+.+|++.++.++|+|++++++.+...+..++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            46888999999999999999998888899999986542 33567899999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCCC-ccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCC
Q 007869          340 MPNGSLDKYLYDQPK-VTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD  418 (586)
Q Consensus       340 ~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~  418 (586)
                      +++++|.+++..... ..+++.....++.|++.||.|||+   .+++||||||+||++++++.+||+|||++..+.....
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~---~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~  157 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD  157 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence            999999999976432 568999999999999999999998   9999999999999999999999999999986654332


Q ss_pred             C---ceeeeccCCCccCcccccCC-CCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCC
Q 007869          419 P---QTTHVVGTLGYLAPEHTRTG-KATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDP  494 (586)
Q Consensus       419 ~---~~~~~~gt~~y~aPE~~~~~-~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~  494 (586)
                      .   ......|+..|+|||++... .++.++|+|||||++|||++|+.||......+.  ..+..    ..      ..+
T Consensus       158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~--~~~~~----~~------~~~  225 (267)
T cd06610         158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV--LMLTL----QN------DPP  225 (267)
T ss_pred             ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh--HHHHh----cC------CCC
Confidence            2   22345689999999998777 789999999999999999999999976543221  11111    11      111


Q ss_pred             CCCccc-cHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          495 NLGTEY-VAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       495 ~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      .+.... .......+.+++.+|++.||++||++.++++
T Consensus       226 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         226 SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            111111 1133466788999999999999999999986

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=2.5e-37  Score=313.03  Aligned_cols=248  Identities=27%  Similarity=0.427  Sum_probs=206.0

Q ss_pred             CcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc-chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEecC
Q 007869          262 GFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYM  340 (586)
Q Consensus       262 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  340 (586)
                      .|+..+.||+|+||.||+|.+..++..||+|.+.... ......+.+|+.++++++||||+++++++...+..++||||+
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence            4667788999999999999998888999999987543 445677999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCCc
Q 007869          341 PNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ  420 (586)
Q Consensus       341 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~  420 (586)
                      ++++|.+++...   .+++.+...++.|++.||.|||+   .+++|+||+|+||+++.++.++|+|||++....... ..
T Consensus        85 ~~~~L~~~i~~~---~l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-~~  157 (277)
T cd06640          85 GGGSALDLLRAG---PFDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-IK  157 (277)
T ss_pred             CCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEcccccceeccCCc-cc
Confidence            999999998653   57888999999999999999998   899999999999999999999999999998764432 12


Q ss_pred             eeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCccc
Q 007869          421 TTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEY  500 (586)
Q Consensus       421 ~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~  500 (586)
                      .....++..|+|||++.+..++.++|+|||||++|||++|+.||....+......       ...+     ..+    ..
T Consensus       158 ~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~-------~~~~-----~~~----~~  221 (277)
T cd06640         158 RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFL-------IPKN-----NPP----TL  221 (277)
T ss_pred             cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhh-------hhcC-----CCC----CC
Confidence            3345688999999999888899999999999999999999999976443211100       0000     011    22


Q ss_pred             cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          501 VAEELELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       501 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                      .......+.+++.+||+.+|++||++.++++.
T Consensus       222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         222 TGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             chhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            33455678899999999999999999999864

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=6.5e-38  Score=315.37  Aligned_cols=249  Identities=31%  Similarity=0.497  Sum_probs=198.4

Q ss_pred             eeEeecCceEEEEEEeCCCC------eEEEEEEecccc-chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEec
Q 007869          267 ELLGTGGFGRVYRGTLPKSQ------IEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY  339 (586)
Q Consensus       267 ~~LG~G~~g~Vy~~~~~~~~------~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  339 (586)
                      +.||+|+||.||+|+..+..      ..+|+|.+.... .....++.+|++++++++||||++++++|...+..++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            35999999999999986433      679999886543 34467899999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCC-----CccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCC-----CeEEccccc
Q 007869          340 MPNGSLDKYLYDQP-----KVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGEL-----NGRLGDFGL  409 (586)
Q Consensus       340 ~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~-----~~kL~DFGl  409 (586)
                      +++++|.+++....     ...+++.+++.++.|++.||.|||+   .+++|+||||+||+++.+.     .+||+|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence            99999999997532     2347889999999999999999998   8999999999999999877     899999999


Q ss_pred             eeeccCCCC-CceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccCc
Q 007869          410 ARLYDHGTD-PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGE  487 (586)
Q Consensus       410 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~  487 (586)
                      ++....... .......++..|+|||++.++.++.++|||||||++|||++ |+.||......+   ....+    ..+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~---~~~~~----~~~~  230 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE---VLQHV----TAGG  230 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH---HHHHH----hcCC
Confidence            986533221 11223345788999999999999999999999999999998 999986543211   11111    1111


Q ss_pred             cccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 007869          488 LLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILE  534 (586)
Q Consensus       488 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  534 (586)
                      .     +    .........+.+++.+||+.+|.+||++.++++.|+
T Consensus       231 ~-----~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         231 R-----L----QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             c-----c----CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            0     0    111223456788999999999999999999999886

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=9.8e-38  Score=327.81  Aligned_cols=264  Identities=22%  Similarity=0.246  Sum_probs=200.4

Q ss_pred             hcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc--cchhHHHHHHHHHHhcccCCCceeeeeeeeecc------
Q 007869          259 ATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRK------  330 (586)
Q Consensus       259 a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~------  330 (586)
                      ..++|+..+.||+|+||.||++....++..||||++...  .....+.+.+|+.+++.++||||+++++++...      
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            457899999999999999999999888999999999754  233456788999999999999999999987643      


Q ss_pred             CeEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccce
Q 007869          331 GELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLA  410 (586)
Q Consensus       331 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla  410 (586)
                      ...++||||+++ +|.+.+..    .+++..+..++.|+++||.|||+   ++|+||||||+|||++.++.+||+|||++
T Consensus        95 ~~~~lv~e~~~~-~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~---~givHrDikp~Nill~~~~~~kl~Dfg~~  166 (355)
T cd07874          95 QDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA  166 (355)
T ss_pred             ceeEEEhhhhcc-cHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEECCCCCEEEeeCccc
Confidence            357999999964 67766643    47888899999999999999998   89999999999999999999999999999


Q ss_pred             eeccCCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhh--------------
Q 007869          411 RLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILV--------------  476 (586)
Q Consensus       411 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~--------------  476 (586)
                      +......  ......||..|+|||++.+..++.++|||||||++|||++|+.||......+.....              
T Consensus       167 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (355)
T cd07874         167 RTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK  244 (355)
T ss_pred             ccCCCcc--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            8654322  223457899999999999889999999999999999999999999764322111000              


Q ss_pred             --HHHHhhhccC-ccccccCCCC--------CccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          477 --DWVFDFWNRG-ELLEARDPNL--------GTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       477 --~~v~~~~~~~-~~~~~~d~~l--------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                        ..+.....+. .......+..        ...........+.+++.+|++.||++|||+.|+++.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             hcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence              0000000000 0000000000        001111223567889999999999999999999974

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.7e-37  Score=309.53  Aligned_cols=249  Identities=24%  Similarity=0.408  Sum_probs=204.9

Q ss_pred             CcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc--cchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEec
Q 007869          262 GFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY  339 (586)
Q Consensus       262 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  339 (586)
                      +|+..+.||+|+||.||++....++..+|+|++...  .....+.+.+|++++++++|||++++++.+...+..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            478889999999999999999888999999998654  234467899999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCC-CCeEEccccceeeccCCCC
Q 007869          340 MPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGE-LNGRLGDFGLARLYDHGTD  418 (586)
Q Consensus       340 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~-~~~kL~DFGla~~~~~~~~  418 (586)
                      +++++|.+++.......+++..+..++.|++++|.|||+   ++++|+||||+||+++++ ..+||+|||++....... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-  156 (256)
T cd08220          81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS-  156 (256)
T ss_pred             CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-
Confidence            999999999987655568999999999999999999998   899999999999999855 458999999998765432 


Q ss_pred             CceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCc
Q 007869          419 PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGT  498 (586)
Q Consensus       419 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~  498 (586)
                       ......|+..|+|||.+....++.++||||||+++|||++|+.||.......   .....   . .+..     +.+  
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~---~~~~~---~-~~~~-----~~~--  221 (256)
T cd08220         157 -KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA---LVLKI---M-SGTF-----API--  221 (256)
T ss_pred             -cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH---HHHHH---H-hcCC-----CCC--
Confidence             2233568899999999998889999999999999999999999997654321   11111   1 1110     111  


Q ss_pred             cccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          499 EYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       499 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                        .......+.+++..||+.+|.+|||+.|+++
T Consensus       222 --~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         222 --SDRYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             --CCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence              1112345778899999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-37  Score=323.87  Aligned_cols=252  Identities=25%  Similarity=0.324  Sum_probs=212.7

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccch---hHHHHHHHHHHhcccC-CCceeeeeeeeeccCeEEE
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQ---GMKEFVAEIVSIGRLR-HRNLVQLLGYCRRKGELLL  335 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~Ei~~l~~l~-H~niv~l~~~~~~~~~~~l  335 (586)
                      ...|...+.||+|.||.||+++.+.++..+|+|.+.+....   ..+.+.+|+.+|+++. ||||+.+.+.++.....++
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l  113 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL  113 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence            45678889999999999999999999999999999775432   3468999999999998 9999999999999999999


Q ss_pred             EEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCC----CCeEEcccccee
Q 007869          336 VYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGE----LNGRLGDFGLAR  411 (586)
Q Consensus       336 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~----~~~kL~DFGla~  411 (586)
                      |||++.+|.|.+.+...   .+++.....++.|+++++.|||+   .+|+||||||+|+|+...    +.+|++|||++.
T Consensus       114 vmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~  187 (382)
T KOG0032|consen  114 VMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK  187 (382)
T ss_pred             EEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence            99999999999999776   28899999999999999999998   999999999999999543    479999999999


Q ss_pred             eccCCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccc
Q 007869          412 LYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEA  491 (586)
Q Consensus       412 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~  491 (586)
                      ....  .......+||+.|+|||++....|+..+||||+||++|.|++|..||......+...       ...+++.   
T Consensus       188 ~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-------~i~~~~~---  255 (382)
T KOG0032|consen  188 FIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-------AILRGDF---  255 (382)
T ss_pred             EccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-------HHHcCCC---
Confidence            8766  345677899999999999999999999999999999999999999999866543221       1112222   


Q ss_pred             cCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          492 RDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       492 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                         ....+.-....+.+.+++..|+..||.+|+|+.++++.
T Consensus       256 ---~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  256 ---DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             ---CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence               11122222334566778888999999999999999983

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-37  Score=309.53  Aligned_cols=247  Identities=28%  Similarity=0.442  Sum_probs=199.8

Q ss_pred             eeEeecCceEEEEEEeCCCCeEEEEEEeccccch-hHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEecCCCCCh
Q 007869          267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQ-GMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSL  345 (586)
Q Consensus       267 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL  345 (586)
                      ++||+|+||.||++.+.. +..||+|.+...... ..+.+.+|++++++++|+||+++++++...+..++||||+++++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l   79 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL   79 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence            469999999999999977 888999998765433 557899999999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCCce-eee
Q 007869          346 DKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQT-THV  424 (586)
Q Consensus       346 ~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~-~~~  424 (586)
                      .+++.... ..+++.....++.+++.+|.|||+   ++++||||||+|||++.++.+||+|||+++.......... ...
T Consensus        80 ~~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  155 (251)
T cd05041          80 LTFLRKKK-NRLTVKKLLQMSLDAAAGMEYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK  155 (251)
T ss_pred             HHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence            99997653 367888999999999999999998   8999999999999999999999999999986543221111 122


Q ss_pred             ccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCccccHH
Q 007869          425 VGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAE  503 (586)
Q Consensus       425 ~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~  503 (586)
                      .++..|+|||.+.++.++.++|+|||||++|||++ |..||.......   ..+.+    ..+.  .   .    .....
T Consensus       156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~---~~~~~----~~~~--~---~----~~~~~  219 (251)
T cd05041         156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ---TRERI----ESGY--R---M----PAPQL  219 (251)
T ss_pred             cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH---HHHHH----hcCC--C---C----CCCcc
Confidence            34667999999988899999999999999999999 888886654321   11111    1110  0   0    01112


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 007869          504 ELELVLKLGLLCSHSDPTARPSMRQVVQILE  534 (586)
Q Consensus       504 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  534 (586)
                      ....+.+++.+|++.+|.+||++.|+++.|+
T Consensus       220 ~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         220 CPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             CCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            3456888999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.3e-37  Score=314.31  Aligned_cols=256  Identities=25%  Similarity=0.395  Sum_probs=204.9

Q ss_pred             CCcccceeEeecCceEEEEEEeCC-----CCeEEEEEEeccccch-hHHHHHHHHHHhcccCCCceeeeeeeeeccCeEE
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPK-----SQIEIAVKKISHESRQ-GMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELL  334 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~  334 (586)
                      ++|+..+.||+|+||.||+|+.+.     ....|++|.+...... ..+++.+|++++++++|+||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            578889999999999999999753     3457999988654433 4578999999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhhcCCC-------ccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccc
Q 007869          335 LVYDYMPNGSLDKYLYDQPK-------VTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDF  407 (586)
Q Consensus       335 lV~E~~~~gsL~~~l~~~~~-------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DF  407 (586)
                      +||||+++|+|.+++.....       ..+++.++..++.|++.||.|||+   .+|+||||||+||+++.++.+||+||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSN---ARFVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhh---cCcccCcCccceEEEeCCCcEEEccc
Confidence            99999999999999976541       258999999999999999999998   89999999999999999999999999


Q ss_pred             cceeeccCCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccC
Q 007869          408 GLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRG  486 (586)
Q Consensus       408 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~  486 (586)
                      |+++..............++..|+|||.+.+..++.++||||||+++|||++ |..||.......   ...    ....+
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~---~~~----~~~~~  234 (275)
T cd05046         162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE---VLN----RLQAG  234 (275)
T ss_pred             ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH---HHH----HHHcC
Confidence            9987543322222233456788999999988889999999999999999999 788886533211   111    11111


Q ss_pred             ccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 007869          487 ELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILE  534 (586)
Q Consensus       487 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  534 (586)
                      .....        ........+.+++.+||+.+|.+||++.|+++.|.
T Consensus       235 ~~~~~--------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         235 KLELP--------VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             CcCCC--------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            11110        01122356888999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.4e-37  Score=322.89  Aligned_cols=262  Identities=19%  Similarity=0.238  Sum_probs=197.5

Q ss_pred             cceeEeec--CceEEEEEEeCCCCeEEEEEEecccc--chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEecC
Q 007869          265 EKELLGTG--GFGRVYRGTLPKSQIEIAVKKISHES--RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYM  340 (586)
Q Consensus       265 ~~~~LG~G--~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  340 (586)
                      ..++||+|  +|++||+++.+.++..||+|++....  ....+.+.+|+++++.++||||++++++|..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            35679999  78999999999999999999997542  233456778999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCC-
Q 007869          341 PNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP-  419 (586)
Q Consensus       341 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~-  419 (586)
                      ++|+|.+++.......+++..++.++.|++.||.|||+   .+|+||||||+|||++.++.++++||+.+......... 
T Consensus        82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~  158 (327)
T cd08227          82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL  158 (327)
T ss_pred             CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence            99999999976544568999999999999999999998   89999999999999999999999999876543211110 


Q ss_pred             -----ceeeeccCCCccCcccccC--CCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhh----c----
Q 007869          420 -----QTTHVVGTLGYLAPEHTRT--GKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFW----N----  484 (586)
Q Consensus       420 -----~~~~~~gt~~y~aPE~~~~--~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~----~----  484 (586)
                           ......++..|+|||++.+  ..++.++|||||||++|||++|+.||........  .........    .    
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~  236 (327)
T cd08227         159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLEKLNGTVPCLLDTTTI  236 (327)
T ss_pred             cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH--HHHHhcCCccccccccch
Confidence                 1122356788999999876  4588999999999999999999999975332110  000000000    0    


Q ss_pred             -------------------cCccccccCC----CCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          485 -------------------RGELLEARDP----NLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       485 -------------------~~~~~~~~d~----~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                                         .+.......+    .....+.......+.+++.+||+.||++|||+.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~  306 (327)
T cd08227         237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN  306 (327)
T ss_pred             hhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence                               0000000000    0001112223456788999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-37  Score=316.07  Aligned_cols=254  Identities=26%  Similarity=0.376  Sum_probs=206.3

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEec
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY  339 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  339 (586)
                      .++|++.+.||+|+||.||++.+..++..+|+|.+........+.|..|++++++++|||++++++.+...+..++||||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            45788899999999999999999888899999999876666677899999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCC
Q 007869          340 MPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP  419 (586)
Q Consensus       340 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~  419 (586)
                      +++++|.+++.... ..+++.....++.|++.||.|||+   .+|+|+||||+||+++.++.+||+|||++....... .
T Consensus        84 ~~~~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~  158 (280)
T cd06611          84 CDGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL-Q  158 (280)
T ss_pred             cCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEECCCCCEEEccCccchhhcccc-c
Confidence            99999999987643 368899999999999999999998   899999999999999999999999999987643322 2


Q ss_pred             ceeeeccCCCccCccccc-----CCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCC
Q 007869          420 QTTHVVGTLGYLAPEHTR-----TGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDP  494 (586)
Q Consensus       420 ~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~  494 (586)
                      ......++..|+|||++.     ...++.++|||||||++|||++|+.||......+.  +..     ...+.     .+
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~--~~~-----~~~~~-----~~  226 (280)
T cd06611         159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRV--LLK-----ILKSE-----PP  226 (280)
T ss_pred             ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHH--HHH-----HhcCC-----CC
Confidence            233457899999999975     34467899999999999999999999976433211  111     11111     11


Q ss_pred             CCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          495 NLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       495 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                      .+.  ........+.+++..||+.+|.+||++.++++.
T Consensus       227 ~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         227 TLD--QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             CcC--CcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence            110  011123456788889999999999999999863

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1.2e-37  Score=328.39  Aligned_cols=264  Identities=22%  Similarity=0.259  Sum_probs=200.5

Q ss_pred             hcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc--cchhHHHHHHHHHHhcccCCCceeeeeeeeecc------
Q 007869          259 ATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRK------  330 (586)
Q Consensus       259 a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~------  330 (586)
                      ..++|+..+.||+|+||.||++....++..||||++...  .....+.+.+|+.+++.++||||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            457899999999999999999999888999999999753  233456788999999999999999999987543      


Q ss_pred             CeEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccce
Q 007869          331 GELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLA  410 (586)
Q Consensus       331 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla  410 (586)
                      ...++||||++ ++|.+.+..    .+++..+..++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||++
T Consensus       102 ~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a  173 (364)
T cd07875         102 QDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA  173 (364)
T ss_pred             CeEEEEEeCCC-CCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEECCCCcEEEEeCCCc
Confidence            35799999996 477777643    47788899999999999999998   89999999999999999999999999999


Q ss_pred             eeccCCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhh---------HH---
Q 007869          411 RLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILV---------DW---  478 (586)
Q Consensus       411 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~---------~~---  478 (586)
                      +......  ......||..|+|||++.+..++.++|||||||++|||++|+.||...+..+....+         ++   
T Consensus       174 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (364)
T cd07875         174 RTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKK  251 (364)
T ss_pred             cccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHh
Confidence            8654322  223457899999999999999999999999999999999999999765432211000         00   


Q ss_pred             ----HHhhhccC-cc----ccccCCCC----CccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          479 ----VFDFWNRG-EL----LEARDPNL----GTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       479 ----v~~~~~~~-~~----~~~~d~~l----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                          +.....+. ..    .+...+..    ...........+.+++.+|++.||.+|||+.|+++.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         252 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             hhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence                00000000 00    00000000    001111123467889999999999999999999863

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.1e-37  Score=315.60  Aligned_cols=240  Identities=26%  Similarity=0.396  Sum_probs=189.5

Q ss_pred             eEeecCceEEEEEEeCC------------------------CCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeee
Q 007869          268 LLGTGGFGRVYRGTLPK------------------------SQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQL  323 (586)
Q Consensus       268 ~LG~G~~g~Vy~~~~~~------------------------~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l  323 (586)
                      +||+|+||.||+|.+..                        ....|++|.+.........+|.+|+.++++++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            59999999999998532                        124589999876655556778999999999999999999


Q ss_pred             eeeeeccCeEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCC---
Q 007869          324 LGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGEL---  400 (586)
Q Consensus       324 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~---  400 (586)
                      +++|...+..++||||+++|+|..++... ...+++..+..++.|+++||.|||+   ++|+||||||+|||++..+   
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~iiH~dlkp~Nill~~~~~~~  157 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALSYLED---KNLVHGNVCAKNILLARLGLAE  157 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHc---CCccCCCCCcccEEEeccCccc
Confidence            99999999999999999999999998654 2367888899999999999999998   8999999999999997643   


Q ss_pred             ----CeEEccccceeeccCCCCCceeeeccCCCccCcccccC-CCCCCcceEEehhHHHHHHH-hCCCCCCCCCCCccch
Q 007869          401 ----NGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVA-CGRRPIQRQGPSENLI  474 (586)
Q Consensus       401 ----~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~Ell-tG~~p~~~~~~~~~~~  474 (586)
                          .+|++|||++......     ....++..|+|||.+.+ ..++.++|||||||++|||+ +|+.||......+.  
T Consensus       158 ~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~--  230 (274)
T cd05076         158 GTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK--  230 (274)
T ss_pred             CccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH--
Confidence                3799999998643221     22357888999998865 56899999999999999994 69999876543221  


Q ss_pred             hhHHHHhhhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 007869          475 LVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILE  534 (586)
Q Consensus       475 l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  534 (586)
                       ..+    ....       .......    ...+.+++.+||+.+|++||++.++++.|.
T Consensus       231 -~~~----~~~~-------~~~~~~~----~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         231 -ERF----YEKK-------HRLPEPS----CKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             -HHH----HHhc-------cCCCCCC----ChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence             111    1100       0011111    135778899999999999999999998873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.4e-37  Score=310.87  Aligned_cols=249  Identities=25%  Similarity=0.435  Sum_probs=201.8

Q ss_pred             CcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccc---------hhHHHHHHHHHHhcccCCCceeeeeeeeeccCe
Q 007869          262 GFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR---------QGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGE  332 (586)
Q Consensus       262 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~  332 (586)
                      +|.....||+|++|.||+|....++..+|+|.+.....         +..+.+..|++++++++||||+++++++...+.
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            36677899999999999999988888999998865422         123568899999999999999999999999999


Q ss_pred             EEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceee
Q 007869          333 LLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARL  412 (586)
Q Consensus       333 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~  412 (586)
                      .++||||+++++|.+++...  ..+++..+..++.|++.||.|||+   .+++||||||+||++++++.+||+|||+++.
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~nil~~~~~~~~l~dfg~~~~  155 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKK  155 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHHEEEcCCCCEEecccCCCcc
Confidence            99999999999999999765  357888999999999999999998   8999999999999999999999999999987


Q ss_pred             ccCCCCC-----ceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCc
Q 007869          413 YDHGTDP-----QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGE  487 (586)
Q Consensus       413 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~  487 (586)
                      .......     ......|+..|+|||.+.+..++.++|||||||++|||++|+.||........      +...     
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~------~~~~-----  224 (267)
T cd06628         156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA------IFKI-----  224 (267)
T ss_pred             cccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH------HHHH-----
Confidence            6532111     11234588999999999988899999999999999999999999976432111      0100     


Q ss_pred             cccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          488 LLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       488 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                       .....+.+.    ......+.+++.+||+.||.+||++.|+++
T Consensus       225 -~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         225 -GENASPEIP----SNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             -hccCCCcCC----cccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence             011112221    223456778888999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=3e-37  Score=314.68  Aligned_cols=262  Identities=28%  Similarity=0.346  Sum_probs=207.4

Q ss_pred             cchhhhhhhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhccc-CCCceeeeeeeeec
Q 007869          251 FRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRR  329 (586)
Q Consensus       251 ~~~~el~~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~  329 (586)
                      +...++..++++|...+.||+|+||.||++....++..+|+|++.... .....+.+|+.++.++ +|||++++++++..
T Consensus        12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   90 (291)
T cd06639          12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK   90 (291)
T ss_pred             hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence            455677778899999999999999999999998889999999986532 2345678899999998 89999999999875


Q ss_pred             c-----CeEEEEEecCCCCChhhhhhcC--CCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCe
Q 007869          330 K-----GELLLVYDYMPNGSLDKYLYDQ--PKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNG  402 (586)
Q Consensus       330 ~-----~~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~  402 (586)
                      .     +..++||||+++++|.+++...  ....+++..++.++.|++.||.|||+   .+++||||||+||+++.++.+
T Consensus        91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~~~~~~  167 (291)
T cd06639          91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGV  167 (291)
T ss_pred             ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCE
Confidence            3     3589999999999999988642  23468899999999999999999998   899999999999999999999


Q ss_pred             EEccccceeeccCCCCCceeeeccCCCccCcccccCCC-----CCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhH
Q 007869          403 RLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGK-----ATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVD  477 (586)
Q Consensus       403 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~  477 (586)
                      ||+|||+++....... ......|+..|+|||++....     ++.++|||||||++|||++|+.||......+.  +.+
T Consensus       168 kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~--~~~  244 (291)
T cd06639         168 KLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT--LFK  244 (291)
T ss_pred             EEeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH--HHH
Confidence            9999999986543221 223356889999999986443     68899999999999999999999976433211  111


Q ss_pred             HHHhhhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          478 WVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       478 ~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      +     .++..     +.+.  ........+.+++.+|++.+|++||++.|+++
T Consensus       245 ~-----~~~~~-----~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         245 I-----PRNPP-----PTLL--HPEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             H-----hcCCC-----CCCC--cccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            1     01111     1110  01122346888999999999999999999986

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=3e-38  Score=316.37  Aligned_cols=241  Identities=27%  Similarity=0.427  Sum_probs=191.9

Q ss_pred             eeEeecCceEEEEEEeCCCCe-------EEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEec
Q 007869          267 ELLGTGGFGRVYRGTLPKSQI-------EIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY  339 (586)
Q Consensus       267 ~~LG~G~~g~Vy~~~~~~~~~-------~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  339 (586)
                      +.||+|+||.||+|.....+.       .+++|.+........+.+.+|+.++++++|||++++++++...+..++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            369999999999998865433       4888988766555667889999999999999999999999998999999999


Q ss_pred             CCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCC--------eEEcccccee
Q 007869          340 MPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELN--------GRLGDFGLAR  411 (586)
Q Consensus       340 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~--------~kL~DFGla~  411 (586)
                      +++|+|.+++.... ..+++..++.++.||+.||.|||+   ++|+||||||+|||++.++.        +|++|||++.
T Consensus        81 ~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~  156 (258)
T cd05078          81 VKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLED---KGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI  156 (258)
T ss_pred             CCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence            99999999997653 368899999999999999999998   99999999999999987765        5999999887


Q ss_pred             eccCCCCCceeeeccCCCccCcccccCC-CCCCcceEEehhHHHHHHHhCC-CCCCCCCCCccchhhHHHHhhhccCccc
Q 007869          412 LYDHGTDPQTTHVVGTLGYLAPEHTRTG-KATTSADVFSFGAFLLEVACGR-RPIQRQGPSENLILVDWVFDFWNRGELL  489 (586)
Q Consensus       412 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVyS~Gvvl~ElltG~-~p~~~~~~~~~~~l~~~v~~~~~~~~~~  489 (586)
                      ....     .....++..|+|||++.+. .++.++|||||||++|||++|. .|+........   ..    .....   
T Consensus       157 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~---~~----~~~~~---  221 (258)
T cd05078         157 TVLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK---LQ----FYEDR---  221 (258)
T ss_pred             ccCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH---HH----HHHcc---
Confidence            5432     2234678899999999764 5799999999999999999985 55543322110   00    11110   


Q ss_pred             cccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 007869          490 EARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILE  534 (586)
Q Consensus       490 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  534 (586)
                          ..+    .......+.+++.+||+.||++|||++++++.|+
T Consensus       222 ----~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         222 ----HQL----PAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             ----ccC----CCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                011    1112245788999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.4e-37  Score=311.59  Aligned_cols=250  Identities=28%  Similarity=0.440  Sum_probs=193.7

Q ss_pred             eeEeecCceEEEEEEeCC---CCeEEEEEEeccc-cchhHHHHHHHHHHhcccCCCceeeeeeeee-ccCeEEEEEecCC
Q 007869          267 ELLGTGGFGRVYRGTLPK---SQIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCR-RKGELLLVYDYMP  341 (586)
Q Consensus       267 ~~LG~G~~g~Vy~~~~~~---~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~-~~~~~~lV~E~~~  341 (586)
                      +.||+|+||.||+|.+..   ....+|+|++... .....+.+.+|+.+++.++|||+++++++|. .++..++|+||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            468999999999998643   3467999998543 3345678899999999999999999999876 4556899999999


Q ss_pred             CCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCC---
Q 007869          342 NGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD---  418 (586)
Q Consensus       342 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~---  418 (586)
                      +|+|.+++.... ..+.+..+..++.|+++||.|||+   .+++||||||+|||+++++.+||+|||+++.......   
T Consensus        81 ~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~  156 (262)
T cd05058          81 HGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV  156 (262)
T ss_pred             CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence            999999997653 346777888999999999999998   8999999999999999999999999999986533211   


Q ss_pred             CceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhC-CCCCCCCCCCccchhhHHHHhhhccCccccccCCCCC
Q 007869          419 PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACG-RRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLG  497 (586)
Q Consensus       419 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG-~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~  497 (586)
                      .......++..|+|||.+.+..++.++|||||||++|||++| ..||.....   ..+...+.    .+.     .+...
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~---~~~~~~~~----~~~-----~~~~~  224 (262)
T cd05058         157 HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS---FDITVYLL----QGR-----RLLQP  224 (262)
T ss_pred             cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH---HHHHHHHh----cCC-----CCCCC
Confidence            111233467789999999888999999999999999999995 555654322   11222211    111     11111


Q ss_pred             ccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 007869          498 TEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERD  536 (586)
Q Consensus       498 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  536 (586)
                      .    .....+.+++..||+.+|++||++.++++.|+..
T Consensus       225 ~----~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~  259 (262)
T cd05058         225 E----YCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI  259 (262)
T ss_pred             C----cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence            1    1234678899999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=1.1e-37  Score=324.57  Aligned_cols=259  Identities=28%  Similarity=0.428  Sum_probs=204.9

Q ss_pred             cCCcccceeEeecCceEEEEEEeCC-------CCeEEEEEEecccc-chhHHHHHHHHHHhccc-CCCceeeeeeeeecc
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPK-------SQIEIAVKKISHES-RQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRK  330 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~  330 (586)
                      ..+|.+.+.||+|+||.||+++...       ....||+|.+.... ....+++.+|++++.++ +||||++++++|...
T Consensus        11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (334)
T cd05100          11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   90 (334)
T ss_pred             HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence            3468889999999999999998632       23468999887542 33457899999999999 899999999999999


Q ss_pred             CeEEEEEecCCCCChhhhhhcCC--------------CccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeee
Q 007869          331 GELLLVYDYMPNGSLDKYLYDQP--------------KVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLL  396 (586)
Q Consensus       331 ~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll  396 (586)
                      +..+++|||+++|+|.+++....              ...++|.+++.++.|+++||.|||+   ++|+||||||+|||+
T Consensus        91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~givH~dlkp~Nill  167 (334)
T cd05100          91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLAS---QKCIHRDLAARNVLV  167 (334)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEE
Confidence            99999999999999999997532              2358889999999999999999998   899999999999999


Q ss_pred             cCCCCeEEccccceeeccCCCCC-ceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccch
Q 007869          397 DGELNGRLGDFGLARLYDHGTDP-QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLI  474 (586)
Q Consensus       397 ~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~  474 (586)
                      +.++.+||+|||+++........ ......++..|+|||++.+..++.++|||||||++|||++ |..||......+   
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---  244 (334)
T cd05100         168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE---  244 (334)
T ss_pred             cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH---
Confidence            99999999999999865432211 1222334568999999999899999999999999999998 888886543221   


Q ss_pred             hhHHHHhhhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 007869          475 LVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERDV  537 (586)
Q Consensus       475 l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  537 (586)
                         +... ...+...     .    ........+.+++.+|++.+|++||++.|+++.|++..
T Consensus       245 ---~~~~-~~~~~~~-----~----~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~  294 (334)
T cd05100         245 ---LFKL-LKEGHRM-----D----KPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL  294 (334)
T ss_pred             ---HHHH-HHcCCCC-----C----CCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence               1111 1111111     0    11122346778899999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-37  Score=315.82  Aligned_cols=266  Identities=24%  Similarity=0.332  Sum_probs=206.1

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc--cchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEe
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYD  338 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E  338 (586)
                      ++|+..+.||+|+||.||+|.+..++..||+|++...  .....+.+.+|++++++++|+||+++++++...+..++|||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            3688899999999999999999988999999998653  23345778999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCC
Q 007869          339 YMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD  418 (586)
Q Consensus       339 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~  418 (586)
                      |++++.+..++...  ..+++.+++.++.|++.||.|||+   .+++||||||+||++++++.+||+|||++........
T Consensus        81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~  155 (288)
T cd07833          81 YVERTLLELLEASP--GGLPPDAVRSYIWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA  155 (288)
T ss_pred             cCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence            99987776665443  358899999999999999999998   8999999999999999999999999999987665443


Q ss_pred             CceeeeccCCCccCcccccCC-CCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHh--------hhc-cCcc
Q 007869          419 PQTTHVVGTLGYLAPEHTRTG-KATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFD--------FWN-RGEL  488 (586)
Q Consensus       419 ~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~--------~~~-~~~~  488 (586)
                      .......++..|+|||++.+. .++.++||||||+++|||++|+.||......+........+.        .+. +...
T Consensus       156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07833         156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRF  235 (288)
T ss_pred             ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccc
Confidence            233446788999999999888 789999999999999999999999976433221111111000        000 0000


Q ss_pred             c--cccCCCCC----ccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          489 L--EARDPNLG----TEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       489 ~--~~~d~~l~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      .  ...++...    ..+.......+.+++.+||+.+|++||+++++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         236 AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             cccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence            0  00000000    0111122567889999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=2.5e-37  Score=313.73  Aligned_cols=265  Identities=24%  Similarity=0.331  Sum_probs=204.0

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc--chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEe
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES--RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYD  338 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E  338 (586)
                      ++|+..+.||+|++|.||+|++..++..||+|++....  ....+.+.+|++++++++|+|++++++++......++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            46888899999999999999998889999999986542  2234568899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCC
Q 007869          339 YMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD  418 (586)
Q Consensus       339 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~  418 (586)
                      |+++++|..++...  ..+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++........
T Consensus        81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  155 (286)
T cd07847          81 YCDHTVLNELEKNP--RGVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD  155 (286)
T ss_pred             ccCccHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence            99999888876543  358999999999999999999998   9999999999999999999999999999987654321


Q ss_pred             CceeeeccCCCccCcccccC-CCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhH-HH-------HhhhccCccc
Q 007869          419 PQTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVD-WV-------FDFWNRGELL  489 (586)
Q Consensus       419 ~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~-~v-------~~~~~~~~~~  489 (586)
                       ......++..|+|||++.+ ..++.++||||||+++|||++|+.||......+...... ..       ...+......
T Consensus       156 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (286)
T cd07847         156 -DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFF  234 (286)
T ss_pred             -cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccc
Confidence             2233467889999999875 457899999999999999999999998654432211110 00       0001111100


Q ss_pred             -cccCCCCCccc-----cHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          490 -EARDPNLGTEY-----VAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       490 -~~~d~~l~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                       ....+......     .......+.+++.+||+.+|++||++.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         235 KGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             ccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence             00011110000     0112356789999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1.3e-37  Score=319.20  Aligned_cols=265  Identities=23%  Similarity=0.302  Sum_probs=201.6

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc-chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEec
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY  339 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  339 (586)
                      ++|...+.||+|+||.||+|+...++..||+|.+.... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            46888999999999999999998888999999987543 22345678899999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCC
Q 007869          340 MPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP  419 (586)
Q Consensus       340 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~  419 (586)
                      ++ ++|.+++.... ..+++.....++.|+++||.|||+   .+|+||||||+|||+++++.+||+|||++........ 
T Consensus        86 ~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-  159 (301)
T cd07873          86 LD-KDLKQYLDDCG-NSINMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-  159 (301)
T ss_pred             cc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC-
Confidence            97 68998886643 357888999999999999999998   8999999999999999999999999999976433221 


Q ss_pred             ceeeeccCCCccCcccccCC-CCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhH--------HHHhhh-ccCccc
Q 007869          420 QTTHVVGTLGYLAPEHTRTG-KATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVD--------WVFDFW-NRGELL  489 (586)
Q Consensus       420 ~~~~~~gt~~y~aPE~~~~~-~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~--------~v~~~~-~~~~~~  489 (586)
                      ......+++.|+|||++.+. .++.++|||||||++|||++|+.||...+..+......        ..|..+ ......
T Consensus       160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (301)
T cd07873         160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK  239 (301)
T ss_pred             cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccc
Confidence            22234578999999988654 57889999999999999999999997654322111000        000000 000000


Q ss_pred             cccCCCCCccc----cHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          490 EARDPNLGTEY----VAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       490 ~~~d~~l~~~~----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      ....+....+.    .......+.+++.+|++.||.+|||+.|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         240 SYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             ccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            00111111110    1112345678999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-37  Score=320.50  Aligned_cols=253  Identities=26%  Similarity=0.349  Sum_probs=205.5

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccc---hhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEE
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR---QGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY  337 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  337 (586)
                      ++|+..+.||+|++|.||+|....++..+|+|.+.....   ...+.+..|++++++++|+||+++++.+...+..++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            468889999999999999999988889999999976532   24567899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCC
Q 007869          338 DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT  417 (586)
Q Consensus       338 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~  417 (586)
                      ||+++++|.+++.......+++..+..++.|+++||.|||+   .+++||||||+||+++.++.++|+|||++.......
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~  157 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP  157 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence            99999999999986655678999999999999999999998   899999999999999999999999999987653221


Q ss_pred             CC----------------------------ceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCC
Q 007869          418 DP----------------------------QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGP  469 (586)
Q Consensus       418 ~~----------------------------~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~  469 (586)
                      ..                            ......||..|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~  237 (316)
T cd05574         158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR  237 (316)
T ss_pred             cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence            10                            11134688999999999988899999999999999999999999976543


Q ss_pred             CccchhhHHHHhhhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCC----HHHHHH
Q 007869          470 SENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPS----MRQVVQ  531 (586)
Q Consensus       470 ~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs----~~evl~  531 (586)
                      .+..  .    .....       ++....  .......+.+++.+|++.||++||+    +.|+++
T Consensus       238 ~~~~--~----~~~~~-------~~~~~~--~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         238 DETF--S----NILKK-------EVTFPG--SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             HHHH--H----HHhcC-------CccCCC--ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            2211  0    00100       011100  1114467888999999999999999    666654

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.2e-37  Score=311.11  Aligned_cols=247  Identities=30%  Similarity=0.500  Sum_probs=200.1

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEecC
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYM  340 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  340 (586)
                      ++|...+.||+|+||.||++..  ++..||+|.+....  ..+.+.+|+.++++++|||++++++++... ..++||||+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~   80 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELM   80 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECC
Confidence            4578889999999999999975  46679999986543  236789999999999999999999998764 479999999


Q ss_pred             CCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCCc
Q 007869          341 PNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ  420 (586)
Q Consensus       341 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~  420 (586)
                      ++++|.+++.......+++..++.++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++.......   
T Consensus        81 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~---  154 (254)
T cd05083          81 SKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV---  154 (254)
T ss_pred             CCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccccCcceEEEcCCCcEEECCCccceeccccC---
Confidence            99999999987655578999999999999999999998   899999999999999999999999999998643221   


Q ss_pred             eeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCcc
Q 007869          421 TTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTE  499 (586)
Q Consensus       421 ~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~  499 (586)
                       .....+..|+|||++.++.++.++|+|||||++|||++ |+.||......+   ...    ...++...   ++     
T Consensus       155 -~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~~~----~~~~~~~~---~~-----  218 (254)
T cd05083         155 -DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE---VKE----CVEKGYRM---EP-----  218 (254)
T ss_pred             -CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH---HHH----HHhCCCCC---CC-----
Confidence             12234578999999988899999999999999999997 999987643321   111    11111111   11     


Q ss_pred             ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 007869          500 YVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER  535 (586)
Q Consensus       500 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  535 (586)
                       .......+.+++.+||+.+|++||++.++++.|++
T Consensus       219 -~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         219 -PEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             -CCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence             11223567789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2e-37  Score=313.91  Aligned_cols=256  Identities=25%  Similarity=0.422  Sum_probs=204.7

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCe----EEEEEEecccc-chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEE
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQI----EIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLL  335 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~l  335 (586)
                      .+|+..+.||+|+||.||+|.++.++.    .+|+|.+.... .....++.+|+.++++++||||++++++|.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            567888999999999999999865543    58999887653 3445778999999999999999999999987 78899


Q ss_pred             EEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccC
Q 007869          336 VYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH  415 (586)
Q Consensus       336 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~  415 (586)
                      ||||+++|+|.+++.... ..+++..++.++.|++.||+|||+   .+++||||||+||++++++.+||+|||+++....
T Consensus        86 v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~  161 (279)
T cd05057          86 ITQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV  161 (279)
T ss_pred             EEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHh---CCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence            999999999999997653 358999999999999999999998   8999999999999999999999999999987653


Q ss_pred             CCCCce-eeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccCccccccC
Q 007869          416 GTDPQT-THVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEARD  493 (586)
Q Consensus       416 ~~~~~~-~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d  493 (586)
                      ...... ....++..|+|||.+....++.++|+|||||++||+++ |+.||......+   +.+.+    ..+...  ..
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~----~~~~~~--~~  232 (279)
T cd05057         162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE---IPDLL----EKGERL--PQ  232 (279)
T ss_pred             cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH---HHHHH----hCCCCC--CC
Confidence            322111 11223568999999988889999999999999999998 999997653321   11111    111110  11


Q ss_pred             CCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 007869          494 PNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERDV  537 (586)
Q Consensus       494 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  537 (586)
                      +.       .....+.+++.+||..+|.+||++.++++.|+...
T Consensus       233 ~~-------~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~  269 (279)
T cd05057         233 PP-------ICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMA  269 (279)
T ss_pred             CC-------CCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence            11       11235678889999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=2.4e-37  Score=319.41  Aligned_cols=196  Identities=25%  Similarity=0.372  Sum_probs=161.9

Q ss_pred             ceeEeecCceEEEEEEeC--CCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeec--cCeEEEEEecCC
Q 007869          266 KELLGTGGFGRVYRGTLP--KSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRR--KGELLLVYDYMP  341 (586)
Q Consensus       266 ~~~LG~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~--~~~~~lV~E~~~  341 (586)
                      .++||+|+||.||+|+..  .++..+|+|.+....  ....+.+|++++++++||||+++++++..  ....+++|||+.
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            467999999999999975  356789999986543  23457889999999999999999998854  456899999995


Q ss_pred             CCChhhhhhcC-------CCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeee----cCCCCeEEccccce
Q 007869          342 NGSLDKYLYDQ-------PKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLL----DGELNGRLGDFGLA  410 (586)
Q Consensus       342 ~gsL~~~l~~~-------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll----~~~~~~kL~DFGla  410 (586)
                       ++|.+++...       ....+++..+..++.||+.||.|||+   .+|+||||||+|||+    +.++.+||+|||++
T Consensus        84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence             5888877532       12358888999999999999999998   899999999999999    45678999999999


Q ss_pred             eeccCCCCC--ceeeeccCCCccCcccccCC-CCCCcceEEehhHHHHHHHhCCCCCCCC
Q 007869          411 RLYDHGTDP--QTTHVVGTLGYLAPEHTRTG-KATTSADVFSFGAFLLEVACGRRPIQRQ  467 (586)
Q Consensus       411 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~s~ksDVyS~Gvvl~ElltG~~p~~~~  467 (586)
                      +........  ......||+.|+|||++.+. .++.++||||+||++|||++|+.||...
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~  219 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence            876543221  22346789999999998764 5899999999999999999999999754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=2.9e-37  Score=313.34  Aligned_cols=263  Identities=23%  Similarity=0.309  Sum_probs=205.8

Q ss_pred             CcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc--chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEec
Q 007869          262 GFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES--RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY  339 (586)
Q Consensus       262 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  339 (586)
                      +|+..+.||+|++|.||+|++..++..||+|++....  ....+.+.+|+.++++++||||+++++++...+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            4778899999999999999998889999999987653  33456799999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCC
Q 007869          340 MPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP  419 (586)
Q Consensus       340 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~  419 (586)
                      + +++|.+++.... ..+++.+++.++.|+++||.|||+   .+++|+||||+||+++.++.++|+|||++.........
T Consensus        81 ~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~  155 (286)
T cd07832          81 M-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPR  155 (286)
T ss_pred             c-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCC
Confidence            9 999999987653 468999999999999999999998   89999999999999999999999999999876544322


Q ss_pred             ceeeeccCCCccCcccccCC-CCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCc-----------
Q 007869          420 QTTHVVGTLGYLAPEHTRTG-KATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGE-----------  487 (586)
Q Consensus       420 ~~~~~~gt~~y~aPE~~~~~-~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~-----------  487 (586)
                      ......|+..|+|||++.+. .++.++||||+||+++||++|++||......+   ...++........           
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd07832         156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIE---QLAIVFRTLGTPNEETWPGLTSLP  232 (286)
T ss_pred             ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHH---HHHHHHHHcCCCChHHHhhccCcc
Confidence            23445789999999998654 46899999999999999999988886543322   1111111111000           


Q ss_pred             -cccccCCCCC----ccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          488 -LLEARDPNLG----TEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       488 -~~~~~d~~l~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                       ......+...    .....+....+.+++.+|++.+|++||+++++++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence             0000000000    01111223678899999999999999999999863

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=9.2e-38  Score=317.14  Aligned_cols=265  Identities=26%  Similarity=0.377  Sum_probs=203.4

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccc--hhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEe
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR--QGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYD  338 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E  338 (586)
                      ++|+..+.||+|+||.||+|.+..++..||+|++.....  ...+.+.+|++++++++||||+++++++...+..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            468888999999999999999988889999998865322  234678899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCC
Q 007869          339 YMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD  418 (586)
Q Consensus       339 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~  418 (586)
                      |+++++|.++....  ..+++.+++.++.|+++||.|||+   .+++|+||+|+||++++++.+||+|||++....... 
T Consensus        81 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-  154 (286)
T cd07846          81 FVDHTVLDDLEKYP--NGLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-  154 (286)
T ss_pred             cCCccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-
Confidence            99999998877544  348999999999999999999998   899999999999999999999999999998764433 


Q ss_pred             CceeeeccCCCccCcccccC-CCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccch-hhHHHH-------hhhccCccc
Q 007869          419 PQTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLI-LVDWVF-------DFWNRGELL  489 (586)
Q Consensus       419 ~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~-l~~~v~-------~~~~~~~~~  489 (586)
                      .......++..|+|||++.+ ..++.++||||||+++|||++|+.||......+... +..+..       ..+......
T Consensus       155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (286)
T cd07846         155 EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLF  234 (286)
T ss_pred             cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHh
Confidence            22334568899999999865 457889999999999999999999997544322111 010000       000000000


Q ss_pred             -cccCCCCCcc-----ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          490 -EARDPNLGTE-----YVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       490 -~~~d~~l~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                       ....+.....     ..+.....+.+++.+||+.+|++||++.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         235 AGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             hccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence             0001111000     01123466889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=3.2e-37  Score=311.02  Aligned_cols=255  Identities=27%  Similarity=0.438  Sum_probs=201.6

Q ss_pred             CcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccc----------hhHHHHHHHHHHhcccCCCceeeeeeeeeccC
Q 007869          262 GFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR----------QGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKG  331 (586)
Q Consensus       262 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----------~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~  331 (586)
                      +|...+.||+|+||.||+|....++..+|+|.+.....          ...+.+..|++++++++|||++++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            46678899999999999999988889999998854211          12346888999999999999999999999999


Q ss_pred             eEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEcccccee
Q 007869          332 ELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR  411 (586)
Q Consensus       332 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~  411 (586)
                      ..++||||+++++|.+++...  ..+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||+++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~~~~~~l~d~~~~~  156 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGISK  156 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcCCCeEEEeeccccc
Confidence            999999999999999999765  368888999999999999999998   899999999999999999999999999998


Q ss_pred             eccCCCCC-ceeeeccCCCccCcccccCCC--CCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCcc
Q 007869          412 LYDHGTDP-QTTHVVGTLGYLAPEHTRTGK--ATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGEL  488 (586)
Q Consensus       412 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~  488 (586)
                      ........ ......|+..|+|||.+....  ++.++|+||||+++||+++|+.||......+      ......... .
T Consensus       157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~------~~~~~~~~~-~  229 (272)
T cd06629         157 KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA------AMFKLGNKR-S  229 (272)
T ss_pred             cccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH------HHHHhhccc-c
Confidence            65432211 223456889999999987654  7899999999999999999999996432211      111111111 1


Q ss_pred             ccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          489 LEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       489 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                          .+.............+.+++.+|++.+|.+||++.++++.
T Consensus       230 ----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         230 ----APPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             ----CCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence                1111111122234667788899999999999999999863

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.8e-37  Score=313.84  Aligned_cols=256  Identities=24%  Similarity=0.346  Sum_probs=207.1

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc-chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEec
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY  339 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  339 (586)
                      ++|+..+.||+|+||+||++....++..||+|++.... ....+.+.+|+++++.++||||+++++++...+.+++||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            56788899999999999999998888999999886543 34457899999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCC
Q 007869          340 MPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP  419 (586)
Q Consensus       340 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~  419 (586)
                      +++++|.+++...  ..+++.....++.+++.+|.|||+  ..+++||||||+||++++++.++|+|||++.......  
T Consensus        85 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~--  158 (284)
T cd06620          85 MDCGSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI--  158 (284)
T ss_pred             CCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc--
Confidence            9999999998664  358888999999999999999996  2579999999999999999999999999987543221  


Q ss_pred             ceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCc-----cchhhHHHHhhhccCccccccCC
Q 007869          420 QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSE-----NLILVDWVFDFWNRGELLEARDP  494 (586)
Q Consensus       420 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~-----~~~l~~~v~~~~~~~~~~~~~d~  494 (586)
                       .....|+..|+|||++.+..++.++|||||||++|||++|+.||......+     ...+.++.......      ..+
T Consensus       159 -~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~  231 (284)
T cd06620         159 -ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQE------PPP  231 (284)
T ss_pred             -cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhc------cCC
Confidence             223578999999999988899999999999999999999999998644321     11112222221111      111


Q ss_pred             CCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          495 NLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       495 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                      .+..   ......+.+++.+|++.||.+||++.|+++.
T Consensus       232 ~~~~---~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~  266 (284)
T cd06620         232 RLPS---SDFPEDLRDFVDACLLKDPTERPTPQQLCAM  266 (284)
T ss_pred             CCCc---hhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            1111   1233567788899999999999999999975

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.6e-37  Score=308.46  Aligned_cols=248  Identities=30%  Similarity=0.461  Sum_probs=202.7

Q ss_pred             CcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc-----chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEE
Q 007869          262 GFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES-----RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLV  336 (586)
Q Consensus       262 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV  336 (586)
                      +|+..+.||+|++|.||+|....++..|++|.+....     .+..+.+.+|+.++++++|+|++++++++...+..+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            3677789999999999999998788899999986543     23557799999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCC
Q 007869          337 YDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHG  416 (586)
Q Consensus       337 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~  416 (586)
                      |||+++++|.+++.+.  ..+++.++..++.|+++||.|||+   .+++|+||||+||+++.++.+||+|||++......
T Consensus        81 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~  155 (258)
T cd06632          81 LELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF  155 (258)
T ss_pred             EEecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence            9999999999999765  357899999999999999999998   89999999999999999999999999999875433


Q ss_pred             CCCceeeeccCCCccCcccccCCC-CCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCC
Q 007869          417 TDPQTTHVVGTLGYLAPEHTRTGK-ATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPN  495 (586)
Q Consensus       417 ~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~  495 (586)
                      .  ......|+..|++||.+.... ++.++|+|||||++|||++|+.||......+      ...........     +.
T Consensus       156 ~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~------~~~~~~~~~~~-----~~  222 (258)
T cd06632         156 S--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA------AVFKIGRSKEL-----PP  222 (258)
T ss_pred             c--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH------HHHHHHhcccC-----CC
Confidence            2  233456889999999987776 8999999999999999999999997643211      11111110111     11


Q ss_pred             CCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          496 LGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       496 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      .    .......+.+++.+||+.+|.+||++.++++
T Consensus       223 ~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         223 I----PDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             c----CCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence            1    1122355677888999999999999999985

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=2.1e-37  Score=312.04  Aligned_cols=252  Identities=25%  Similarity=0.383  Sum_probs=189.7

Q ss_pred             eEeecCceEEEEEEeCC--CCeEEEEEEecccc-chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEecCCCCC
Q 007869          268 LLGTGGFGRVYRGTLPK--SQIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGS  344 (586)
Q Consensus       268 ~LG~G~~g~Vy~~~~~~--~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gs  344 (586)
                      .||+|+||.||+|....  ....+++|.+.... ......|.+|++.++.++|+||++++++|...+..++||||+++|+
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD   81 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence            59999999999997533  34568999876543 3345678999999999999999999999999999999999999999


Q ss_pred             hhhhhhcCCC---ccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCC-Cc
Q 007869          345 LDKYLYDQPK---VTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD-PQ  420 (586)
Q Consensus       345 L~~~l~~~~~---~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~-~~  420 (586)
                      |.+++.....   ...++.....++.||+.||+|||+   ++|+||||||+|||+++++++||+|||+++....... ..
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~  158 (269)
T cd05042          82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ---ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT  158 (269)
T ss_pred             HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh---cCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence            9999976532   235677888999999999999998   8999999999999999999999999999875432211 11


Q ss_pred             eeeeccCCCccCcccccC-------CCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccCcccccc
Q 007869          421 TTHVVGTLGYLAPEHTRT-------GKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEAR  492 (586)
Q Consensus       421 ~~~~~gt~~y~aPE~~~~-------~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~  492 (586)
                      .....++..|+|||++..       ..++.++|||||||++|||++ |+.||......+   ..   ......+ .....
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~---~~---~~~~~~~-~~~~~  231 (269)
T cd05042         159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ---VL---KQVVREQ-DIKLP  231 (269)
T ss_pred             cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH---HH---HHHhhcc-CccCC
Confidence            223346778999998743       356889999999999999999 788886543221   11   1111111 11222


Q ss_pred             CCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 007869          493 DPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILE  534 (586)
Q Consensus       493 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  534 (586)
                      ++.+...    ....+.+++..|+ .||++||++++|++.|.
T Consensus       232 ~~~~~~~----~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         232 KPQLDLK----YSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             CCccccc----CCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            2322222    2344556667788 59999999999999873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=2.9e-37  Score=310.77  Aligned_cols=254  Identities=26%  Similarity=0.388  Sum_probs=202.6

Q ss_pred             CcccceeEeecCceEEEEEEeCC-CCeEEEEEEeccc----------cchhHHHHHHHHHHhcc-cCCCceeeeeeeeec
Q 007869          262 GFREKELLGTGGFGRVYRGTLPK-SQIEIAVKKISHE----------SRQGMKEFVAEIVSIGR-LRHRNLVQLLGYCRR  329 (586)
Q Consensus       262 ~f~~~~~LG~G~~g~Vy~~~~~~-~~~~vavK~~~~~----------~~~~~~~~~~Ei~~l~~-l~H~niv~l~~~~~~  329 (586)
                      +|+..+.||+|+||.||+|.+.. ++..+|+|.+...          ......++.+|+.++.+ ++||||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47788899999999999999977 6788999988532          22234567889988875 799999999999999


Q ss_pred             cCeEEEEEecCCCCChhhhhhcC--CCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccc
Q 007869          330 KGELLLVYDYMPNGSLDKYLYDQ--PKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDF  407 (586)
Q Consensus       330 ~~~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DF  407 (586)
                      .+..+++|||+++++|.+++...  ....+++..++.++.|++.||.|||+  ..+++|+||||+||+++.++.+||+||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~df  158 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDF  158 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEecc
Confidence            99999999999999999988542  23468889999999999999999995  368999999999999999999999999


Q ss_pred             cceeeccCCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCc
Q 007869          408 GLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGE  487 (586)
Q Consensus       408 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~  487 (586)
                      |++.......  ......|+..|+|||.+.+..++.++||||||+++|||++|+.||.......   ..   .. ..++.
T Consensus       159 g~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~---~~---~~-~~~~~  229 (269)
T cd08528         159 GLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS---LA---TK-IVEAV  229 (269)
T ss_pred             cceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH---HH---HH-Hhhcc
Confidence            9998755432  3344578999999999998889999999999999999999999986542211   11   11 11111


Q ss_pred             cccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 007869          488 LLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILE  534 (586)
Q Consensus       488 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  534 (586)
                      ..    +....    .....+.+++.+||+.||++||++.|+..++.
T Consensus       230 ~~----~~~~~----~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         230 YE----PLPEG----MYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             CC----cCCcc----cCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            11    11101    12355778888999999999999999998874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.3e-37  Score=313.37  Aligned_cols=253  Identities=26%  Similarity=0.403  Sum_probs=202.6

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc-cchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEec
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY  339 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  339 (586)
                      ++|+..+.||+|+||.||++.+..++..||+|.+... .......+.+|++++++++|+||+++++.+...+..++||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            3678889999999999999999888999999988754 333456789999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCC-CccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCC
Q 007869          340 MPNGSLDKYLYDQP-KVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD  418 (586)
Q Consensus       340 ~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~  418 (586)
                      +++++|..++.... ...+++..+..++.|++.||.|||+  +.+|+||||||+||+++.++.+||+|||++..+...  
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--  156 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS--  156 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC--
Confidence            99999999886542 2368999999999999999999996  258999999999999999999999999999765332  


Q ss_pred             CceeeeccCCCccCcccccCCC------CCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCcccccc
Q 007869          419 PQTTHVVGTLGYLAPEHTRTGK------ATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEAR  492 (586)
Q Consensus       419 ~~~~~~~gt~~y~aPE~~~~~~------~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~  492 (586)
                       ......++..|+|||++.+..      ++.++|+|||||++|||++|+.||...........   . .....+     .
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~---~-~~~~~~-----~  226 (286)
T cd06622         157 -LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQ---L-SAIVDG-----D  226 (286)
T ss_pred             -ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHH---H-HHHhhc-----C
Confidence             223346888999999986543      47899999999999999999999975432211100   0 000011     1


Q ss_pred             CCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          493 DPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       493 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      .+.+    .......+.+++.+|++.+|.+||++.++++
T Consensus       227 ~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         227 PPTL----PSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             CCCC----CcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence            1111    2224456778889999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=7.8e-37  Score=312.36  Aligned_cols=263  Identities=25%  Similarity=0.383  Sum_probs=211.9

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEecC
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYM  340 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  340 (586)
                      ++|...+.||+|+||.||++....++..||+|.+........+.+.+|+.++++++|||++++++.+...+..++|+||+
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~   98 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL   98 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence            67888999999999999999988888899999987655555677899999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCCc
Q 007869          341 PNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ  420 (586)
Q Consensus       341 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~  420 (586)
                      ++++|.+++.+.   .+++.++..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++........ .
T Consensus        99 ~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~---~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-~  171 (293)
T cd06647          99 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K  171 (293)
T ss_pred             CCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHh---CCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc-c
Confidence            999999998654   47888999999999999999998   8999999999999999999999999999886543322 2


Q ss_pred             eeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCccc
Q 007869          421 TTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEY  500 (586)
Q Consensus       421 ~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~  500 (586)
                      .....|++.|+|||.+....++.++|||||||++||+++|+.||......+....      ....+      .+..  ..
T Consensus       172 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~------~~~~~------~~~~--~~  237 (293)
T cd06647         172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL------IATNG------TPEL--QN  237 (293)
T ss_pred             cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee------hhcCC------CCCC--CC
Confidence            2334688999999999888899999999999999999999999976543221110      00000      0111  11


Q ss_pred             cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HhhccCCCcccc
Q 007869          501 VAEELELVLKLGLLCSHSDPTARPSMRQVVQI--LERDVALPAISA  544 (586)
Q Consensus       501 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~~~~~p~~~~  544 (586)
                      .......+.+++.+||+.+|++||++.++++.  +....++..+++
T Consensus       238 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~~~~~~~~  283 (293)
T cd06647         238 PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKPLSSLTP  283 (293)
T ss_pred             ccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCcccccccc
Confidence            11233567788999999999999999999964  454444444443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=6e-37  Score=307.92  Aligned_cols=250  Identities=25%  Similarity=0.373  Sum_probs=198.2

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc-----chhHHHHHHHHHHhcccCCCceeeeeeeeecc--CeE
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES-----RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRK--GEL  333 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~--~~~  333 (586)
                      ++|+..+.||+|+||.||+|.+..++..||||++....     ....+.+.+|++++++++||||+++++++.+.  ..+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            57889999999999999999999889999999886431     23356788999999999999999999988763  468


Q ss_pred             EEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeec
Q 007869          334 LLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLY  413 (586)
Q Consensus       334 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~  413 (586)
                      ++||||+++++|.+++....  .+++....+++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||+++..
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~  156 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYG--ALTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKRL  156 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEecCCCCEEECcCcccccc
Confidence            89999999999999987653  46788888999999999999998   89999999999999999999999999999865


Q ss_pred             cCCCC--CceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccc
Q 007869          414 DHGTD--PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEA  491 (586)
Q Consensus       414 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~  491 (586)
                      .....  .......|+..|+|||++.+..++.++|||||||++|||++|+.||........  .    .....     ..
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--~----~~~~~-----~~  225 (265)
T cd06652         157 QTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA--I----FKIAT-----QP  225 (265)
T ss_pred             ccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH--H----HHHhc-----CC
Confidence            43211  122334689999999999888899999999999999999999999975422111  0    01000     00


Q ss_pred             cCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          492 RDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       492 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      ..+.    ........+..++.+|+. +|++||++.|+++
T Consensus       226 ~~~~----~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         226 TNPV----LPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             CCCC----CchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence            1111    122334556667777885 9999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.4e-37  Score=328.05  Aligned_cols=261  Identities=24%  Similarity=0.246  Sum_probs=198.9

Q ss_pred             CCcccceeEeecCceEEEEEEeCC--CCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEe
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPK--SQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYD  338 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E  338 (586)
                      .+|...+.||+|+||.||++...+  .+..||+|.+...     +.+.+|++++++++||||+++++++...+..++|||
T Consensus        92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e  166 (392)
T PHA03207         92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMP  166 (392)
T ss_pred             CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEeh
Confidence            468889999999999999997643  4578999988643     235689999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCC
Q 007869          339 YMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD  418 (586)
Q Consensus       339 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~  418 (586)
                      ++. ++|.+++...  ..+++..++.++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++.......
T Consensus       167 ~~~-~~l~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~---~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~  240 (392)
T PHA03207        167 KYK-CDLFTYVDRS--GPLPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD  240 (392)
T ss_pred             hcC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEccCccccccCcccc
Confidence            995 6888888433  468999999999999999999998   8999999999999999999999999999986554322


Q ss_pred             -CceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCcc---------
Q 007869          419 -PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGEL---------  488 (586)
Q Consensus       419 -~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~---------  488 (586)
                       .......||+.|+|||++....++.++|||||||++|||++|+.||.............-+.+.......         
T Consensus       241 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~  320 (392)
T PHA03207        241 TPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTN  320 (392)
T ss_pred             cccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchh
Confidence             2233567999999999999999999999999999999999999999765433211111111111100000         


Q ss_pred             --------ccccCCCCC-cc-c-cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          489 --------LEARDPNLG-TE-Y-VAEELELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       489 --------~~~~d~~l~-~~-~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                              .....+... .. . .......+.+++.+|++.||++||++.|++..
T Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        321 LCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             HHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence                    000000000 00 0 00112356678889999999999999999864

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=6.6e-37  Score=307.66  Aligned_cols=253  Identities=26%  Similarity=0.416  Sum_probs=204.0

Q ss_pred             CcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc------chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEE
Q 007869          262 GFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES------RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLL  335 (586)
Q Consensus       262 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~l  335 (586)
                      +|+..+.||+|++|.||++....++..+|+|++....      ....+.+.+|++.+++++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            4778899999999999999998889999999986532      1235678999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCC-CeEEccccceeecc
Q 007869          336 VYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGEL-NGRLGDFGLARLYD  414 (586)
Q Consensus       336 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~-~~kL~DFGla~~~~  414 (586)
                      ||||+++++|.+++.+.  ..+++.....++.|++.||.|||+   ++++|+||||+||+++.++ .+||+|||++..+.
T Consensus        81 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~ql~~al~~LH~---~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~  155 (268)
T cd06630          81 FVEWMAGGSVSHLLSKY--GAFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLA  155 (268)
T ss_pred             EEeccCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence            99999999999999764  367888999999999999999998   8999999999999998775 59999999998765


Q ss_pred             CCCC---CceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccc
Q 007869          415 HGTD---PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEA  491 (586)
Q Consensus       415 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~  491 (586)
                      ....   .......|+..|+|||.+.+..++.++||||+|++++||++|+.||...........   ..+....     .
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~---~~~~~~~-----~  227 (268)
T cd06630         156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLAL---IFKIASA-----T  227 (268)
T ss_pred             cccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHH---HHHHhcc-----C
Confidence            4321   112235688999999999888899999999999999999999999975433221111   1111000     0


Q ss_pred             cCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          492 RDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       492 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      ..    ..........+.+++.+|++.+|.+||++.++++
T Consensus       228 ~~----~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         228 TA----PSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             CC----CCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence            01    1122234466778999999999999999999974

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-38  Score=323.78  Aligned_cols=256  Identities=25%  Similarity=0.438  Sum_probs=213.1

Q ss_pred             hhcCCcccceeEeecCceEEEEEEeC----CCCeEEEEEEeccc-cchhHHHHHHHHHHhcccCCCceeeeeeeeeccCe
Q 007869          258 IATKGFREKELLGTGGFGRVYRGTLP----KSQIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGE  332 (586)
Q Consensus       258 ~a~~~f~~~~~LG~G~~g~Vy~~~~~----~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~  332 (586)
                      ...+.....++||.|.||.||+|+..    +....||||..+.+ .....+.|++|..+|++++||||++|+|.|.+. .
T Consensus       386 l~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P  464 (974)
T KOG4257|consen  386 LRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-P  464 (974)
T ss_pred             eehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-c
Confidence            33334445678999999999999873    33456999998774 455678899999999999999999999999875 5


Q ss_pred             EEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceee
Q 007869          333 LLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARL  412 (586)
Q Consensus       333 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~  412 (586)
                      .+||||.++-|.|..+|..+ +..|+......++.||+.+|.|||+   ...|||||..+|||+...--+||+||||+|.
T Consensus       465 ~WivmEL~~~GELr~yLq~n-k~sL~l~tL~ly~~Qi~talaYLeS---krfVHRDIAaRNiLVsSp~CVKLaDFGLSR~  540 (974)
T KOG4257|consen  465 MWIVMELAPLGELREYLQQN-KDSLPLRTLTLYCYQICTALAYLES---KRFVHRDIAARNILVSSPQCVKLADFGLSRY  540 (974)
T ss_pred             eeEEEecccchhHHHHHHhc-cccchHHHHHHHHHHHHHHHHHHHh---hchhhhhhhhhheeecCcceeeecccchhhh
Confidence            79999999999999999877 3578888889999999999999999   9999999999999999999999999999999


Q ss_pred             ccCCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccCccccc
Q 007869          413 YDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEA  491 (586)
Q Consensus       413 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~  491 (586)
                      ++.......+...-...|||||.+.-.+++.+||||.|||.+||++. |.+||.+-.+.+.+.       ..++|..   
T Consensus       541 ~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~-------~iEnGeR---  610 (974)
T KOG4257|consen  541 LEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIG-------HIENGER---  610 (974)
T ss_pred             ccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEE-------EecCCCC---
Confidence            87765555454555789999999999999999999999999999876 999999876654321       1223332   


Q ss_pred             cCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 007869          492 RDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILE  534 (586)
Q Consensus       492 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  534 (586)
                            ...++.++..+..|+.+||..+|.+||.+.|+...|.
T Consensus       611 ------lP~P~nCPp~LYslmskcWayeP~kRPrftei~~~ls  647 (974)
T KOG4257|consen  611 ------LPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILS  647 (974)
T ss_pred             ------CCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHH
Confidence                  2234456677889999999999999999999887664

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-37  Score=309.00  Aligned_cols=255  Identities=25%  Similarity=0.361  Sum_probs=204.3

Q ss_pred             hhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhccc-CCCceeeeeeeeeccC-----
Q 007869          258 IATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKG-----  331 (586)
Q Consensus       258 ~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~~-----  331 (586)
                      .++++|+..+.||+|++|.||+|....++..+++|.+..... ..+.+.+|+.+++++ +|+||+++++++....     
T Consensus         3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            467899999999999999999999988888999999876543 346789999999999 7999999999997644     


Q ss_pred             -eEEEEEecCCCCChhhhhhcCC--CccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEcccc
Q 007869          332 -ELLLVYDYMPNGSLDKYLYDQP--KVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFG  408 (586)
Q Consensus       332 -~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFG  408 (586)
                       ..++||||+++++|.+++....  ...+++..+..++.|+++||.|||+   .+++|+||+|+||++++++.+||+|||
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~~l~p~ni~~~~~~~~~l~d~~  158 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFG  158 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEEccCCeEEECCCc
Confidence             4899999999999999986543  3578899999999999999999998   899999999999999999999999999


Q ss_pred             ceeeccCCCCCceeeeccCCCccCcccccC-----CCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhh
Q 007869          409 LARLYDHGTDPQTTHVVGTLGYLAPEHTRT-----GKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFW  483 (586)
Q Consensus       409 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~  483 (586)
                      ++....... .......|+..|+|||++..     ..++.++|||||||+++||++|+.||........  +.    +. 
T Consensus       159 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~----~~-  230 (275)
T cd06608         159 VSAQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA--LF----KI-  230 (275)
T ss_pred             cceecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH--HH----Hh-
Confidence            998654322 22234568999999998753     3467899999999999999999999975332111  11    00 


Q ss_pred             ccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          484 NRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       484 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      ..     ...+.+  .......+.+.+++.+||..||++|||+.++++
T Consensus       231 ~~-----~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         231 PR-----NPPPTL--KSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             hc-----cCCCCC--CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            01     111111  111223456788999999999999999999985

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.7e-37  Score=308.48  Aligned_cols=254  Identities=27%  Similarity=0.317  Sum_probs=211.4

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc---chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEE
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLV  336 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV  336 (586)
                      -+.|+..+.||+|.-|+||++.+.+++..+|+|++.+..   ++.....+.|-++|+.++||.++.|++.++.+...|||
T Consensus        76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~  155 (459)
T KOG0610|consen   76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV  155 (459)
T ss_pred             HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence            346777889999999999999999999999999998763   44556678899999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccC-
Q 007869          337 YDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH-  415 (586)
Q Consensus       337 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~-  415 (586)
                      ||||+||+|..++++++...++...+.-++.+++-||+|||.   .+||+|||||+||||.++|++-|+||.|+..... 
T Consensus       156 meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHm---lGivYRDLKPENILvredGHIMLsDFDLS~~~~~~  232 (459)
T KOG0610|consen  156 MEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHM---LGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS  232 (459)
T ss_pred             EecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHh---hceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence            999999999999999988899999999999999999999998   9999999999999999999999999998753210 


Q ss_pred             --------------------------------C-CC---------------------CceeeeccCCCccCcccccCCCC
Q 007869          416 --------------------------------G-TD---------------------PQTTHVVGTLGYLAPEHTRTGKA  441 (586)
Q Consensus       416 --------------------------------~-~~---------------------~~~~~~~gt~~y~aPE~~~~~~~  441 (586)
                                                      . ..                     ..+...+||..|+|||++++...
T Consensus       233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH  312 (459)
T KOG0610|consen  233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH  312 (459)
T ss_pred             CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence                                            0 00                     01123579999999999999999


Q ss_pred             CCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCC
Q 007869          442 TTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPT  521 (586)
Q Consensus       442 s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~  521 (586)
                      +.+.|.|+|||++|||+.|+.||.+.+..+.+.-+  +         .  .++...  ........+.+|+.+.|.+||.
T Consensus       313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NI--v---------~--~~l~Fp--~~~~vs~~akDLIr~LLvKdP~  377 (459)
T KOG0610|consen  313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNI--V---------G--QPLKFP--EEPEVSSAAKDLIRKLLVKDPS  377 (459)
T ss_pred             CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHH--h---------c--CCCcCC--CCCcchhHHHHHHHHHhccChh
Confidence            99999999999999999999999988765533211  1         0  111111  1124456677888888999999


Q ss_pred             CCCC----HHHHHH
Q 007869          522 ARPS----MRQVVQ  531 (586)
Q Consensus       522 ~RPs----~~evl~  531 (586)
                      +|..    +.||-+
T Consensus       378 kRlg~~rGA~eIK~  391 (459)
T KOG0610|consen  378 KRLGSKRGAAEIKR  391 (459)
T ss_pred             hhhccccchHHhhc
Confidence            9998    777765

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.6e-37  Score=321.96  Aligned_cols=263  Identities=24%  Similarity=0.283  Sum_probs=197.8

Q ss_pred             hcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc--chhHHHHHHHHHHhcccCCCceeeeeeeeecc------
Q 007869          259 ATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES--RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRK------  330 (586)
Q Consensus       259 a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~------  330 (586)
                      ..++|+..+.||+|+||.||+|....++..||||++....  ....+.+.+|++++++++||||+++++++...      
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07878          13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF   92 (343)
T ss_pred             hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence            4578999999999999999999998889999999986542  23345678899999999999999999987533      


Q ss_pred             CeEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccce
Q 007869          331 GELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLA  410 (586)
Q Consensus       331 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla  410 (586)
                      ...++++|++ +++|.+++...   .+++..+..++.||++||.|||+   ++|+||||||+|||+++++.+||+|||++
T Consensus        93 ~~~~~~~~~~-~~~l~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~  165 (343)
T cd07878          93 NEVYLVTNLM-GADLNNIVKCQ---KLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLA  165 (343)
T ss_pred             CcEEEEeecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhhEEECCCCCEEEcCCccc
Confidence            4579999998 78998887543   58889999999999999999998   89999999999999999999999999999


Q ss_pred             eeccCCCCCceeeeccCCCccCcccccC-CCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhh-HHH-------Hh
Q 007869          411 RLYDHGTDPQTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILV-DWV-------FD  481 (586)
Q Consensus       411 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~-~~v-------~~  481 (586)
                      +.....    .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+..... ...       ..
T Consensus       166 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  241 (343)
T cd07878         166 RQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLK  241 (343)
T ss_pred             eecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            865432    234578999999999876 56899999999999999999999999754322111000 000       00


Q ss_pred             hhccCcccccc--CCCCCcc----ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          482 FWNRGELLEAR--DPNLGTE----YVAEELELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       482 ~~~~~~~~~~~--d~~l~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                      ...........  .+.....    ........+.+++.+|++.||.+|||+.|+++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         242 KISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             hcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            00000000000  0000000    000112346789999999999999999999853

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=2e-37  Score=318.16  Aligned_cols=256  Identities=27%  Similarity=0.448  Sum_probs=202.3

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCe----EEEEEEeccccc-hhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEE
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQI----EIAVKKISHESR-QGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELL  334 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~  334 (586)
                      .++|+..+.||+|+||.||+|++..++.    .||+|.+..... ....++.+|+.++++++||||++++++|... ..+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~   84 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ   84 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence            4567788999999999999999866554    478898865432 3345789999999999999999999998764 467


Q ss_pred             EEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeecc
Q 007869          335 LVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYD  414 (586)
Q Consensus       335 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~  414 (586)
                      +++||+++|+|.+++.... ..+++..++.++.|++.||.|||+   ++|+||||||+||++++++.+||+|||+++...
T Consensus        85 ~v~e~~~~g~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~  160 (303)
T cd05110          85 LVTQLMPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLE  160 (303)
T ss_pred             eeehhcCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHhh---cCeeccccccceeeecCCCceEEcccccccccc
Confidence            9999999999999987653 357888999999999999999998   899999999999999999999999999998764


Q ss_pred             CCCCC-ceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccCcccccc
Q 007869          415 HGTDP-QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEAR  492 (586)
Q Consensus       415 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~  492 (586)
                      ..... ......++..|+|||++.+..++.++|||||||++|||++ |+.||......+   ..+++    ..+...  .
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~---~~~~~----~~~~~~--~  231 (303)
T cd05110         161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE---IPDLL----EKGERL--P  231 (303)
T ss_pred             CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH----HCCCCC--C
Confidence            33221 1222345778999999998899999999999999999997 999987543211   12221    111111  0


Q ss_pred             CCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 007869          493 DPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERD  536 (586)
Q Consensus       493 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  536 (586)
                      .+   .    .....+.+++..||..+|++||++.++++.|+..
T Consensus       232 ~~---~----~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~  268 (303)
T cd05110         232 QP---P----ICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM  268 (303)
T ss_pred             CC---C----CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            11   1    1224577889999999999999999999998864

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=5.8e-37  Score=312.37  Aligned_cols=263  Identities=25%  Similarity=0.346  Sum_probs=199.0

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccc-hhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEec
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR-QGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY  339 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  339 (586)
                      ++|+..+.||+|++|.||+|+.+.++..||||.+..... .....+.+|++++++++|+||+++++++...+..++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            678889999999999999999988889999999875432 2234577899999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCC
Q 007869          340 MPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP  419 (586)
Q Consensus       340 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~  419 (586)
                      ++ ++|.+++..... .+++.....++.|+++||.|||+   .+|+||||||+||+++.++++||+|||+++....... 
T Consensus        85 ~~-~~L~~~~~~~~~-~~~~~~~~~~~~ql~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-  158 (291)
T cd07844          85 LD-TDLKQYMDDCGG-GLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK-  158 (291)
T ss_pred             CC-CCHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCHHHEEEcCCCCEEECccccccccCCCCc-
Confidence            97 499998876543 68889999999999999999998   8999999999999999999999999999875432211 


Q ss_pred             ceeeeccCCCccCcccccC-CCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccC---c--------
Q 007869          420 QTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRG---E--------  487 (586)
Q Consensus       420 ~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~---~--------  487 (586)
                      ......++..|+|||++.+ ..++.++|||||||++|||++|+.||........  .....+......   .        
T Consensus       159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  236 (291)
T cd07844         159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVED--QLHKIFRVLGTPTEETWPGVSSNP  236 (291)
T ss_pred             cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH--HHHHHHHhcCCCChhhhhhhhhcc
Confidence            1122356889999999865 4578999999999999999999999975432111  011111110000   0        


Q ss_pred             -cccc----cCCC-CCccc-cHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          488 -LLEA----RDPN-LGTEY-VAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       488 -~~~~----~d~~-l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                       ....    ..+. +.... .......+.+++.+|++.+|++||++.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         237 EFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             ccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence             0000    0000 00000 0001256678999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=5e-37  Score=307.17  Aligned_cols=254  Identities=23%  Similarity=0.375  Sum_probs=205.4

Q ss_pred             CcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc--cchhHHHHHHHHHHhcccCCCceeeeeeeeec--cCeEEEEE
Q 007869          262 GFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRR--KGELLLVY  337 (586)
Q Consensus       262 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~--~~~~~lV~  337 (586)
                      +|+..+.||.|+||.||++....++..+|+|++...  .....+.+..|++++++++|+|++++++++..  ....+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            477889999999999999999888899999998653  33445678899999999999999999998754  45689999


Q ss_pred             ecCCCCChhhhhhcC--CCccchhHHHHHHHHHHHHHHHHhhccc--CCcEEeCCCCCCCeeecCCCCeEEccccceeec
Q 007869          338 DYMPNGSLDKYLYDQ--PKVTLNWIQRFRVIKGVALGLFYLHQEW--EQVVIHRDVKASNVLLDGELNGRLGDFGLARLY  413 (586)
Q Consensus       338 E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~  413 (586)
                      ||+++++|.+++...  ....+++...+.++.|++.||.|||..+  ..+++|+||||+||++++++.+||+|||++...
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            999999999998653  2357899999999999999999999322  389999999999999999999999999999876


Q ss_pred             cCCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccC
Q 007869          414 DHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARD  493 (586)
Q Consensus       414 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d  493 (586)
                      ..... ......++..|+|||.+.+..++.++|+||||+++++|++|+.||......   .+.+.    ...+.     .
T Consensus       161 ~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~~~----~~~~~-----~  227 (265)
T cd08217         161 GHDSS-FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL---QLASK----IKEGK-----F  227 (265)
T ss_pred             cCCcc-cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH---HHHHH----HhcCC-----C
Confidence            54332 123457899999999999888999999999999999999999999764421   11111    11111     1


Q ss_pred             CCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          494 PNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       494 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                      +.    ........+.+++.+|++.+|++||++.+|++.
T Consensus       228 ~~----~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         228 RR----IPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             CC----CccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence            11    122334667889999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=5.9e-37  Score=316.26  Aligned_cols=196  Identities=24%  Similarity=0.375  Sum_probs=161.5

Q ss_pred             ceeEeecCceEEEEEEeCC--CCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeec--cCeEEEEEecCC
Q 007869          266 KELLGTGGFGRVYRGTLPK--SQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRR--KGELLLVYDYMP  341 (586)
Q Consensus       266 ~~~LG~G~~g~Vy~~~~~~--~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~--~~~~~lV~E~~~  341 (586)
                      ..+||+|+||.||+|+...  ++..||+|.+.....  ...+.+|++++++++||||+++++++..  ....++||||++
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            4679999999999999754  457899999865432  3467889999999999999999998853  567899999986


Q ss_pred             CCChhhhhhcC-------CCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeee----cCCCCeEEccccce
Q 007869          342 NGSLDKYLYDQ-------PKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLL----DGELNGRLGDFGLA  410 (586)
Q Consensus       342 ~gsL~~~l~~~-------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll----~~~~~~kL~DFGla  410 (586)
                       ++|.+++...       ....+++..+..++.|++.||.|||+   .+|+||||||+|||+    +.++.+||+|||++
T Consensus        84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence             4777776422       12358888999999999999999998   899999999999999    56678999999999


Q ss_pred             eeccCCCCC--ceeeeccCCCccCcccccCC-CCCCcceEEehhHHHHHHHhCCCCCCCC
Q 007869          411 RLYDHGTDP--QTTHVVGTLGYLAPEHTRTG-KATTSADVFSFGAFLLEVACGRRPIQRQ  467 (586)
Q Consensus       411 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~s~ksDVyS~Gvvl~ElltG~~p~~~~  467 (586)
                      +........  ......||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~  219 (317)
T cd07867         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence            876543221  22345789999999998764 5799999999999999999999999754

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=3.1e-38  Score=298.80  Aligned_cols=251  Identities=27%  Similarity=0.434  Sum_probs=207.0

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc--------chhHHHHHHHHHHhccc-CCCceeeeeeeeeccC
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES--------RQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKG  331 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~~  331 (586)
                      .+|...+.||+|..+.|-++.++.++.+.|+|++....        ....+.-.+|+.+|+++ -||+|+++.++++...
T Consensus        17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s   96 (411)
T KOG0599|consen   17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA   96 (411)
T ss_pred             hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence            46788899999999999999999999999999986431        12234457899999998 7999999999999999


Q ss_pred             eEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEcccccee
Q 007869          332 ELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR  411 (586)
Q Consensus       332 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~  411 (586)
                      .+++|+|.|+.|.|.++|...  ..+++....+|++|+.+|+.|||.   ++||||||||+|||+|++.++||+|||.++
T Consensus        97 F~FlVFdl~prGELFDyLts~--VtlSEK~tR~iMrqlfegVeylHa---~~IVHRDLKpENILlddn~~i~isDFGFa~  171 (411)
T KOG0599|consen   97 FVFLVFDLMPRGELFDYLTSK--VTLSEKETRRIMRQLFEGVEYLHA---RNIVHRDLKPENILLDDNMNIKISDFGFAC  171 (411)
T ss_pred             hhhhhhhhcccchHHHHhhhh--eeecHHHHHHHHHHHHHHHHHHHH---hhhhhcccChhheeeccccceEEeccceee
Confidence            999999999999999999654  679999999999999999999998   999999999999999999999999999999


Q ss_pred             eccCCCCCceeeeccCCCccCcccccCC------CCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhcc
Q 007869          412 LYDHGTDPQTTHVVGTLGYLAPEHTRTG------KATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNR  485 (586)
Q Consensus       412 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~  485 (586)
                      .+..+.  .....+||++|+|||.+...      .|+...|+||+||+||-|+.|.+||....   ++..    .+...+
T Consensus       172 ~l~~Ge--kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk---QmlM----LR~Ime  242 (411)
T KOG0599|consen  172 QLEPGE--KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK---QMLM----LRMIME  242 (411)
T ss_pred             ccCCch--hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH---HHHH----HHHHHh
Confidence            887654  45668999999999988643      47889999999999999999999997532   1111    122233


Q ss_pred             CccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          486 GELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       486 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      |+.. ...|..     .+......+|+.+|++.||.+|-|.+|+++
T Consensus       243 Gkyq-F~speW-----adis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  243 GKYQ-FRSPEW-----ADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             cccc-cCCcch-----hhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence            3321 111111     233456778899999999999999999985

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.2e-36  Score=304.94  Aligned_cols=252  Identities=28%  Similarity=0.434  Sum_probs=203.6

Q ss_pred             CcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccc--hhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEec
Q 007869          262 GFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR--QGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY  339 (586)
Q Consensus       262 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  339 (586)
                      +|+..+.||+|+||.||+|....++..|++|.+.....  ...+.+.+|++++++++|+||+++++++...+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            47788999999999999999988889999999876543  3667899999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCC
Q 007869          340 MPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP  419 (586)
Q Consensus       340 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~  419 (586)
                      +++++|.+++...  ..+++..+..++.|++.||.|||+   .+|+|+||||+||++++++.+||+|||++.........
T Consensus        81 ~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~  155 (264)
T cd06626          81 CSGGTLEELLEHG--RILDEHVIRVYTLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT  155 (264)
T ss_pred             CCCCcHHHHHhhc--CCCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence            9999999999765  347888999999999999999998   89999999999999999999999999999876543322


Q ss_pred             ce---eeeccCCCccCcccccCCC---CCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccC
Q 007869          420 QT---THVVGTLGYLAPEHTRTGK---ATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARD  493 (586)
Q Consensus       420 ~~---~~~~gt~~y~aPE~~~~~~---~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d  493 (586)
                      ..   ....++..|+|||++....   .+.++||||||++++|+++|+.||........  ..   .... .     ...
T Consensus       156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~--~~---~~~~-~-----~~~  224 (264)
T cd06626         156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ--IM---FHVG-A-----GHK  224 (264)
T ss_pred             ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH--HH---HHHh-c-----CCC
Confidence            21   1356789999999998766   88999999999999999999999975432111  11   0000 0     111


Q ss_pred             CCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          494 PNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       494 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      +.+..  .......+.+++.+||+.+|.+||++.++++
T Consensus       225 ~~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         225 PPIPD--SLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             CCCCc--ccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            11111  1112355678889999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.6e-36  Score=307.32  Aligned_cols=258  Identities=26%  Similarity=0.347  Sum_probs=204.0

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc-chhHHHHHHHHHHhcccCCCceeeeeeeeecc--CeEEEEE
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRK--GELLLVY  337 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~--~~~~lV~  337 (586)
                      ++|+..+.||.|++|.||++.+..++..+|+|.+.... ......+.+|++++++++||||++++++|...  +.+++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            46888999999999999999998889999999987543 24457799999999999999999999988653  4689999


Q ss_pred             ecCCCCChhhhhhcC--CCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccC
Q 007869          338 DYMPNGSLDKYLYDQ--PKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH  415 (586)
Q Consensus       338 E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~  415 (586)
                      ||+++++|.+++...  ....+++.....++.|++.||.|||+   .+++|+||+|+||++++++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            999999999887542  23467888999999999999999998   8999999999999999999999999999875433


Q ss_pred             CCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCC--ccchhhHHHHhhhccCccccccC
Q 007869          416 GTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPS--ENLILVDWVFDFWNRGELLEARD  493 (586)
Q Consensus       416 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~--~~~~l~~~v~~~~~~~~~~~~~d  493 (586)
                      ..   .....++..|+|||.+.+..++.++|||||||++|||++|+.||......  ....+..+...    .......+
T Consensus       158 ~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~~  230 (287)
T cd06621         158 SL---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN----MPNPELKD  230 (287)
T ss_pred             cc---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc----CCchhhcc
Confidence            22   12345788999999999889999999999999999999999999865321  11122222211    01001000


Q ss_pred             CCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          494 PNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       494 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                       ...  ........+.+++.+||+.+|.+|||+.|+++
T Consensus       231 -~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         231 -EPG--NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             -CCC--CCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence             000  01123456789999999999999999999986

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-39  Score=299.15  Aligned_cols=252  Identities=23%  Similarity=0.316  Sum_probs=205.3

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc--cchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEE
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY  337 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  337 (586)
                      +++|+..+.||+|.|+.||++.+..+|+.+|+|.+...  +....+++.+|+.+-+.|+||||++|.+.+.+.+..+||+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            46788889999999999999999999999999988543  3446788999999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCC---CCeEEccccceeecc
Q 007869          338 DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGE---LNGRLGDFGLARLYD  414 (586)
Q Consensus       338 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~---~~~kL~DFGla~~~~  414 (586)
                      |+|.|++|..-|-..  ...++...-..+.||+++|.|.|.   ++|||||+||.|++|-..   --+||+|||+|..+.
T Consensus        90 e~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~  164 (355)
T KOG0033|consen   90 DLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN  164 (355)
T ss_pred             ecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence            999999998766544  457778888999999999999998   999999999999999533   348999999999877


Q ss_pred             CCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCC
Q 007869          415 HGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDP  494 (586)
Q Consensus       415 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~  494 (586)
                      .  .......+|||+|||||+++..+|+..+|||+.||+||-|+.|+.||.+.+...   +    .+....|...  .++
T Consensus       165 ~--g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r---l----ye~I~~g~yd--~~~  233 (355)
T KOG0033|consen  165 D--GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR---L----YEQIKAGAYD--YPS  233 (355)
T ss_pred             C--ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH---H----HHHHhccccC--CCC
Confidence            2  234456789999999999999999999999999999999999999998754322   1    1112222211  112


Q ss_pred             CCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          495 NLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       495 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      +..    ....+....|+.+||..||.+|.|+.|.+.
T Consensus       234 ~~w----~~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  234 PEW----DTVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             ccc----CcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence            111    122344567778899999999999998874

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-37  Score=323.28  Aligned_cols=241  Identities=24%  Similarity=0.309  Sum_probs=188.4

Q ss_pred             EeecCceEEEEEEeCCCCeEEEEEEecccc---chhHHHHHHHHHHhccc---CCCceeeeeeeeeccCeEEEEEecCCC
Q 007869          269 LGTGGFGRVYRGTLPKSQIEIAVKKISHES---RQGMKEFVAEIVSIGRL---RHRNLVQLLGYCRRKGELLLVYDYMPN  342 (586)
Q Consensus       269 LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l---~H~niv~l~~~~~~~~~~~lV~E~~~~  342 (586)
                      ||+|+||+||+|+...++..||||++....   ......+..|..++.+.   +||||+++++++...+..++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            699999999999999889999999986532   22234455677776665   699999999999999999999999999


Q ss_pred             CChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCCcee
Q 007869          343 GSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTT  422 (586)
Q Consensus       343 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~  422 (586)
                      |+|.+++...  ..+++..+..++.||++||.|||+   ++|+||||||+|||++.++.+||+|||+++...... ....
T Consensus        81 g~L~~~l~~~--~~~~~~~~~~~~~qil~al~~LH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~~~  154 (330)
T cd05586          81 GELFWHLQKE--GRFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KTTN  154 (330)
T ss_pred             ChHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CCcc
Confidence            9999998764  358888999999999999999998   899999999999999999999999999987533221 1233


Q ss_pred             eeccCCCccCcccccCC-CCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCcccc
Q 007869          423 HVVGTLGYLAPEHTRTG-KATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYV  501 (586)
Q Consensus       423 ~~~gt~~y~aPE~~~~~-~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~  501 (586)
                      ...||..|+|||++.+. .++.++|||||||++|||++|+.||......+       .......+..      .+...  
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~-------~~~~i~~~~~------~~~~~--  219 (330)
T cd05586         155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ-------MYRNIAFGKV------RFPKN--  219 (330)
T ss_pred             CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH-------HHHHHHcCCC------CCCCc--
Confidence            45799999999998765 47999999999999999999999997643211       1111111111      11111  


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCC----HHHHHH
Q 007869          502 AEELELVLKLGLLCSHSDPTARPS----MRQVVQ  531 (586)
Q Consensus       502 ~~~~~~l~~l~~~Cl~~dP~~RPs----~~evl~  531 (586)
                       .....+.+++.+||+.||.+||+    +.++++
T Consensus       220 -~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         220 -VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             -cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence             12245667888999999999984    566554

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.4e-36  Score=312.08  Aligned_cols=258  Identities=21%  Similarity=0.267  Sum_probs=206.4

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc---chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEE
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY  337 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  337 (586)
                      ++|+..+.||+|+||.||++.+..++..|++|.+....   ....+.+.+|++++++++||||+++++.+..++..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            46888999999999999999999999999999987543   234567889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCC
Q 007869          338 DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT  417 (586)
Q Consensus       338 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~  417 (586)
                      ||+++++|.+++...  ..+++.....++.|++.||.|||+   .+++||||||+||+++.++.+||+|||+++......
T Consensus        81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~  155 (305)
T cd05609          81 EYVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL  155 (305)
T ss_pred             ecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence            999999999999765  358888999999999999999998   899999999999999999999999999987421100


Q ss_pred             C--------------CceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhh
Q 007869          418 D--------------PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFW  483 (586)
Q Consensus       418 ~--------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~  483 (586)
                      .              .......++..|+|||.+.+..++.++|+|||||++|||++|+.||......+      +.... 
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~------~~~~~-  228 (305)
T cd05609         156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE------LFGQV-  228 (305)
T ss_pred             cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HHHHH-
Confidence            0              01122457889999999988889999999999999999999999997543321      11111 


Q ss_pred             ccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 007869          484 NRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERDV  537 (586)
Q Consensus       484 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  537 (586)
                      ..+.   ...+....    .....+.+++.+||+.||++||++.++.+.|+...
T Consensus       229 ~~~~---~~~~~~~~----~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~  275 (305)
T cd05609         229 ISDD---IEWPEGDE----ALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRF  275 (305)
T ss_pred             Hhcc---cCCCCccc----cCCHHHHHHHHHHhccChhhccCccCHHHHHhCcc
Confidence            1111   01111111    12345678899999999999999888888777643

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=8.5e-37  Score=312.23  Aligned_cols=262  Identities=24%  Similarity=0.319  Sum_probs=202.6

Q ss_pred             CcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccch-----hHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEE
Q 007869          262 GFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQ-----GMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLV  336 (586)
Q Consensus       262 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV  336 (586)
                      +|+..+.||+|++|.||+|....++..||||++......     ....+..|++++++++|+||+++++++...+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            477788999999999999999888899999999765322     334577899999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCC
Q 007869          337 YDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHG  416 (586)
Q Consensus       337 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~  416 (586)
                      |||+ +++|.+++.... ..+++..+..++.||++||.|||+   .+|+|+||||+|||++.++.+||+|||+++.....
T Consensus        81 ~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~  155 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSP  155 (298)
T ss_pred             Eccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence            9999 999999997654 368999999999999999999998   89999999999999999999999999999876543


Q ss_pred             CCCceeeeccCCCccCcccccC-CCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhcc---------C
Q 007869          417 TDPQTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNR---------G  486 (586)
Q Consensus       417 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~---------~  486 (586)
                      .. ......++..|+|||.+.+ ..++.++|||||||+++||++|..||......+..   .........         .
T Consensus       156 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~  231 (298)
T cd07841         156 NR-KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQL---GKIFEALGTPTEENWPGVT  231 (298)
T ss_pred             Cc-cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHH---HHHHHHcCCCchhhhhhcc
Confidence            22 2233456888999998854 45789999999999999999998887654432211   111000000         0


Q ss_pred             ccccccCCCCC-----ccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          487 ELLEARDPNLG-----TEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       487 ~~~~~~d~~l~-----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                      ...........     ..........+.+++.+||+.+|++|||+.|+++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             cccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            00000000000     00112234678899999999999999999999974

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=2.9e-37  Score=316.18  Aligned_cols=247  Identities=24%  Similarity=0.354  Sum_probs=200.8

Q ss_pred             cceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEecCCCCC
Q 007869          265 EKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGS  344 (586)
Q Consensus       265 ~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gs  344 (586)
                      ....||+|+||.||++....++..||+|++........+.+.+|+.++..++|||++++++++...+..++|+||+++++
T Consensus        25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~  104 (297)
T cd06659          25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA  104 (297)
T ss_pred             hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence            34569999999999999988888999999976555556778999999999999999999999999999999999999999


Q ss_pred             hhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCCceeee
Q 007869          345 LDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHV  424 (586)
Q Consensus       345 L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~  424 (586)
                      |.+++...   .+++.+++.++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++....... ......
T Consensus       105 L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~~~  177 (297)
T cd06659         105 LTDIVSQT---RLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKRKSL  177 (297)
T ss_pred             HHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHeEEccCCcEEEeechhHhhccccc-ccccce
Confidence            99987543   57899999999999999999998   899999999999999999999999999987554322 122345


Q ss_pred             ccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCccccHHH
Q 007869          425 VGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAEE  504 (586)
Q Consensus       425 ~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~  504 (586)
                      .|+..|+|||++.+..++.++|||||||++|||++|+.||......+.   ...+.    ...     .+...  .....
T Consensus       178 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~---~~~~~----~~~-----~~~~~--~~~~~  243 (297)
T cd06659         178 VGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA---MKRLR----DSP-----PPKLK--NAHKI  243 (297)
T ss_pred             ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHh----ccC-----CCCcc--ccCCC
Confidence            789999999999988899999999999999999999999975433221   11110    100     00000  01112


Q ss_pred             HHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          505 LELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       505 ~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                      ...+.+++..|++.+|++||++.++++.
T Consensus       244 ~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         244 SPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             CHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            3456788889999999999999999973

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=3e-37  Score=315.30  Aligned_cols=248  Identities=24%  Similarity=0.336  Sum_probs=201.4

Q ss_pred             ccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEecCCCC
Q 007869          264 REKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNG  343 (586)
Q Consensus       264 ~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~g  343 (586)
                      .....||+|+||.||++....++..||||++........+.+.+|+..+++++|+||+++++.+...+..++||||++++
T Consensus        25 ~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~  104 (292)
T cd06658          25 DSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGG  104 (292)
T ss_pred             hhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCC
Confidence            33466999999999999998888899999987665556677999999999999999999999999999999999999999


Q ss_pred             ChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCCceee
Q 007869          344 SLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTH  423 (586)
Q Consensus       344 sL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~  423 (586)
                      +|.+++...   .+++.....++.||+.||.|||+   ++|+||||||+||++++++.+||+|||++........ ....
T Consensus       105 ~L~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-~~~~  177 (292)
T cd06658         105 ALTDIVTHT---RMNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-KRKS  177 (292)
T ss_pred             cHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-cCce
Confidence            999988543   57888999999999999999998   8999999999999999999999999999976543222 2234


Q ss_pred             eccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCccccHH
Q 007869          424 VVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAE  503 (586)
Q Consensus       424 ~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~  503 (586)
                      ..|+..|+|||.+.+..++.++||||||+++|||++|+.||......+...       ...     ....+.+..  ...
T Consensus       178 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~-------~~~-----~~~~~~~~~--~~~  243 (292)
T cd06658         178 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMR-------RIR-----DNLPPRVKD--SHK  243 (292)
T ss_pred             eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-------HHH-----hcCCCcccc--ccc
Confidence            578999999999988889999999999999999999999997543321110       000     011111111  111


Q ss_pred             HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          504 ELELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       504 ~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                      ....+..++.+|++.||.+|||++++++.
T Consensus       244 ~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         244 VSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             cCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            23356677888999999999999999964

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-38  Score=328.13  Aligned_cols=253  Identities=26%  Similarity=0.382  Sum_probs=210.8

Q ss_pred             CCcccceeEeecCceEEEEEEeCC---CCeEEEEEEeccccch-hHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEE
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPK---SQIEIAVKKISHESRQ-GMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLV  336 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV  336 (586)
                      +.....++||+|.||.|++|.|..   +-..||||.+..+... ...+|++|+.+|.+|+|||+++|+|...+ ....+|
T Consensus       110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV  188 (1039)
T KOG0199|consen  110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV  188 (1039)
T ss_pred             HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence            344556889999999999999864   2356999999877544 67899999999999999999999999988 678999


Q ss_pred             EecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCC
Q 007869          337 YDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHG  416 (586)
Q Consensus       337 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~  416 (586)
                      +|+++.|+|.+.|++..+..|.......++.|||.||.||.+   +++|||||...|+||-....+||+||||.|.+..+
T Consensus       189 ~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLes---krlvHRDLAARNlllasprtVKI~DFGLmRaLg~n  265 (1039)
T KOG0199|consen  189 FELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLES---KRLVHRDLAARNLLLASPRTVKICDFGLMRALGEN  265 (1039)
T ss_pred             hhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhhhheecccceeeeecccceeccCCC
Confidence            999999999999998666778888899999999999999998   99999999999999999999999999999988765


Q ss_pred             CCCce--eeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccCccccccC
Q 007869          417 TDPQT--THVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEARD  493 (586)
Q Consensus       417 ~~~~~--~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d  493 (586)
                      .+.-.  ....-...|.|||.++..+++.+||||+|||+||||++ |..||-+.....                +++.+|
T Consensus       266 ed~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~q----------------IL~~iD  329 (1039)
T KOG0199|consen  266 EDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQ----------------ILKNID  329 (1039)
T ss_pred             CcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHH----------------HHHhcc
Confidence            43221  11223567999999999999999999999999999998 889998765432                122233


Q ss_pred             CCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 007869          494 PNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQIL  533 (586)
Q Consensus       494 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L  533 (586)
                      ..-+....+.+.+.+.+++..||..+|.+|||+..+.+.+
T Consensus       330 ~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~  369 (1039)
T KOG0199|consen  330 AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL  369 (1039)
T ss_pred             ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence            2222333556778999999999999999999999998544

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=1.6e-36  Score=305.68  Aligned_cols=252  Identities=23%  Similarity=0.375  Sum_probs=190.2

Q ss_pred             eEeecCceEEEEEEeCCC--CeEEEEEEecccc-chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEecCCCCC
Q 007869          268 LLGTGGFGRVYRGTLPKS--QIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGS  344 (586)
Q Consensus       268 ~LG~G~~g~Vy~~~~~~~--~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gs  344 (586)
                      .||+|+||.||+|....+  ...+++|.+.... ....+.|.+|+..++.++||||+++++.|......++||||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            599999999999975432  3356777776543 3445789999999999999999999999999999999999999999


Q ss_pred             hhhhhhcCC--CccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCC-Cce
Q 007869          345 LDKYLYDQP--KVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD-PQT  421 (586)
Q Consensus       345 L~~~l~~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~-~~~  421 (586)
                      |.+++....  ...+++.....++.||++||.|||+   .+++||||||+|||++.++.+||+|||++........ ...
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  158 (268)
T cd05086          82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE  158 (268)
T ss_pred             HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH---CCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence            999997642  2346667788899999999999998   8999999999999999999999999999864322111 122


Q ss_pred             eeeccCCCccCcccccC-------CCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccCccccccC
Q 007869          422 THVVGTLGYLAPEHTRT-------GKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEARD  493 (586)
Q Consensus       422 ~~~~gt~~y~aPE~~~~-------~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d  493 (586)
                      ....++..|+|||++..       ..++.++|||||||++|||++ |..||......+      ...... .+......+
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~------~~~~~~-~~~~~~~~~  231 (268)
T cd05086         159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE------VLNHVI-KDQQVKLFK  231 (268)
T ss_pred             cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH------HHHHHH-hhcccccCC
Confidence            34567899999998753       245789999999999999997 567776433211      111111 122223344


Q ss_pred             CCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 007869          494 PNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILE  534 (586)
Q Consensus       494 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  534 (586)
                      |.+...+.    ..+.+++..|| .+|++||+++++++.|.
T Consensus       232 ~~~~~~~~----~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         232 PQLELPYS----ERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             CccCCCCc----HHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            44433333    34556777798 57999999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=5.4e-37  Score=346.49  Aligned_cols=260  Identities=21%  Similarity=0.318  Sum_probs=203.2

Q ss_pred             hhhhhhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc--cchhHHHHHHHHHHhcccCCCceeeeeeeeec--
Q 007869          254 KDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRR--  329 (586)
Q Consensus       254 ~el~~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~--  329 (586)
                      .+.....++|.+.+.||+|+||.||++.+..++..+|+|.+...  .......|..|+.++.+++||||+++++++..  
T Consensus         6 ~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~   85 (1021)
T PTZ00266          6 DDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKA   85 (1021)
T ss_pred             cCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecC
Confidence            33444557899999999999999999999999999999998754  23345678999999999999999999998854  


Q ss_pred             cCeEEEEEecCCCCChhhhhhcCC--CccchhHHHHHHHHHHHHHHHHhhccc----CCcEEeCCCCCCCeeecC-----
Q 007869          330 KGELLLVYDYMPNGSLDKYLYDQP--KVTLNWIQRFRVIKGVALGLFYLHQEW----EQVVIHRDVKASNVLLDG-----  398 (586)
Q Consensus       330 ~~~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~----~~~ivHrDIkp~NIll~~-----  398 (586)
                      ...++|||||+++|+|.++|....  ...+++..++.|+.||+.||.|||+..    .++||||||||+||||+.     
T Consensus        86 ~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~l  165 (1021)
T PTZ00266         86 NQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHI  165 (1021)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccc
Confidence            356899999999999999997532  246899999999999999999999732    145999999999999964     


Q ss_pred             ------------CCCeEEccccceeeccCCCCCceeeeccCCCccCcccccC--CCCCCcceEEehhHHHHHHHhCCCCC
Q 007869          399 ------------ELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRT--GKATTSADVFSFGAFLLEVACGRRPI  464 (586)
Q Consensus       399 ------------~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDVyS~Gvvl~ElltG~~p~  464 (586)
                                  ...+||+|||+++.+....  ......||+.|+|||++..  ..++.++|||||||+||||++|+.||
T Consensus       166 g~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF  243 (1021)
T PTZ00266        166 GKITAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF  243 (1021)
T ss_pred             ccccccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCC
Confidence                        2348999999998654322  2234579999999999854  45889999999999999999999999


Q ss_pred             CCCCCCccchhhHHHHhhhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          465 QRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       465 ~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      .......     ..+ .....+       +.+..   ......+.+|+..||+.+|.+||++.|+++
T Consensus       244 ~~~~~~~-----qli-~~lk~~-------p~lpi---~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        244 HKANNFS-----QLI-SELKRG-------PDLPI---KGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             CcCCcHH-----HHH-HHHhcC-------CCCCc---CCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            7543221     111 111111       11110   011345778889999999999999999984

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.6e-36  Score=304.73  Aligned_cols=250  Identities=26%  Similarity=0.401  Sum_probs=199.7

Q ss_pred             CcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc------chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEE
Q 007869          262 GFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES------RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLL  335 (586)
Q Consensus       262 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~l  335 (586)
                      +|...+.||+|+||.||+|... ++..+|+|.+....      ....+.+.+|++++++++|+||++++++|...+..++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   79 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI   79 (265)
T ss_pred             CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence            4677889999999999999874 56789999886432      2234568899999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccC
Q 007869          336 VYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH  415 (586)
Q Consensus       336 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~  415 (586)
                      ||||+++++|.+++.+.  ..+++..+..++.|++.||.|||+   .+|+|+||||+||++++++.+||+|||++.....
T Consensus        80 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  154 (265)
T cd06631          80 FMEFVPGGSISSILNRF--GPLPEPVFCKYTKQILDGVAYLHN---NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW  154 (265)
T ss_pred             EEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence            99999999999999765  357888999999999999999998   8999999999999999999999999999986432


Q ss_pred             CC-----CCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCcccc
Q 007869          416 GT-----DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLE  490 (586)
Q Consensus       416 ~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~  490 (586)
                      ..     ........|+..|+|||++.+..++.++|||||||++|||++|+.||............       ..   ..
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~-------~~---~~  224 (265)
T cd06631         155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYI-------GA---HR  224 (265)
T ss_pred             ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHh-------hh---cc
Confidence            11     11223356899999999999888999999999999999999999999754322111000       00   00


Q ss_pred             ccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          491 ARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       491 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      ...+.+...    ....+.+++.+||+.+|.+||++.++++
T Consensus       225 ~~~~~~~~~----~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         225 GLMPRLPDS----FSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             CCCCCCCCC----CCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            111222222    2355678889999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=4.3e-37  Score=312.03  Aligned_cols=265  Identities=26%  Similarity=0.342  Sum_probs=201.5

Q ss_pred             CcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc--chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEec
Q 007869          262 GFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES--RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY  339 (586)
Q Consensus       262 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  339 (586)
                      +|+..+.||+|++|.||+|+...++..||||++....  ......+.+|++++++++||||+++++++...+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            5788999999999999999998889999999987543  22345788999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCC
Q 007869          340 MPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP  419 (586)
Q Consensus       340 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~  419 (586)
                      +. ++|.+++.......+++.+...++.|+++||+|||+   .+++||||||+||++++++.+||+|||+++....... 
T Consensus        81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~-  155 (284)
T cd07860          81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-  155 (284)
T ss_pred             cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-
Confidence            95 689999877666678999999999999999999998   8999999999999999999999999999986543221 


Q ss_pred             ceeeeccCCCccCcccccCCC-CCCcceEEehhHHHHHHHhCCCCCCCCCCCccch-hhHH-------HHhhhccCcccc
Q 007869          420 QTTHVVGTLGYLAPEHTRTGK-ATTSADVFSFGAFLLEVACGRRPIQRQGPSENLI-LVDW-------VFDFWNRGELLE  490 (586)
Q Consensus       420 ~~~~~~gt~~y~aPE~~~~~~-~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~-l~~~-------v~~~~~~~~~~~  490 (586)
                      ......++..|+|||++.+.. ++.++|||||||++|||+||+.||......+... ..++       .+.....-....
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd07860         156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYK  235 (284)
T ss_pred             ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHH
Confidence            223345788999999887654 5889999999999999999999997643321110 0000       000000000000


Q ss_pred             ccCCCCCc----cccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          491 ARDPNLGT----EYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       491 ~~d~~l~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      ...+....    .........+.+++.+|++.||.+||+++++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         236 PSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             hhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence            00000000    000112245678899999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1.3e-36  Score=308.10  Aligned_cols=251  Identities=25%  Similarity=0.332  Sum_probs=195.8

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc-chhHHHHHHHHHH-hcccCCCceeeeeeeeeccCeEEEEEe
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES-RQGMKEFVAEIVS-IGRLRHRNLVQLLGYCRRKGELLLVYD  338 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~-l~~l~H~niv~l~~~~~~~~~~~lV~E  338 (586)
                      ++|+..+.||+|+||.||++++..++..||+|++.... .+...++..|+.. ++.++|||++++++++...+..+++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            46888999999999999999999899999999987642 2333456666665 556689999999999999999999999


Q ss_pred             cCCCCChhhhhhcC--CCccchhHHHHHHHHHHHHHHHHhhcccCC-cEEeCCCCCCCeeecCCCCeEEccccceeeccC
Q 007869          339 YMPNGSLDKYLYDQ--PKVTLNWIQRFRVIKGVALGLFYLHQEWEQ-VVIHRDVKASNVLLDGELNGRLGDFGLARLYDH  415 (586)
Q Consensus       339 ~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~-~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~  415 (586)
                      |++ |+|.+++...  ....+++..++.++.|++.||.|||+   + +++||||||+|||++.++++||+|||+++....
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS---KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD  156 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            996 7888887542  23568999999999999999999997   5 899999999999999999999999999986543


Q ss_pred             CCCCceeeeccCCCccCcccccC----CCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccc
Q 007869          416 GTDPQTTHVVGTLGYLAPEHTRT----GKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEA  491 (586)
Q Consensus       416 ~~~~~~~~~~gt~~y~aPE~~~~----~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~  491 (586)
                      ..  ..+...|+..|+|||++.+    ..++.++|+|||||++|||++|+.||.......  ...   ....      ..
T Consensus       157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~~---~~~~------~~  223 (283)
T cd06617         157 SV--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF--QQL---KQVV------EE  223 (283)
T ss_pred             cc--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH--HHH---HHHH------hc
Confidence            21  2233568899999998864    456889999999999999999999996432211  000   1100      11


Q ss_pred             cCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          492 RDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       492 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      ..+.+...   .....+.+++.+||+.+|.+||++.++++
T Consensus       224 ~~~~~~~~---~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         224 PSPQLPAE---KFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             CCCCCCcc---ccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            11111111   12355778899999999999999999986

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1.7e-36  Score=306.95  Aligned_cols=247  Identities=26%  Similarity=0.439  Sum_probs=202.7

Q ss_pred             cccceeEeecCceEEEEEEeCCCCeEEEEEEecccc-chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEecCC
Q 007869          263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMP  341 (586)
Q Consensus       263 f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~  341 (586)
                      |+..+.||+|+||.||+|....++..+|+|.+.... ....+.+.+|+..+++++||||+++++++..++..++||||++
T Consensus         6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06641           6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG   85 (277)
T ss_pred             hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence            667888999999999999998888899999986442 3445678999999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCCce
Q 007869          342 NGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQT  421 (586)
Q Consensus       342 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~  421 (586)
                      +++|.+++...   .+++.....++.|++.+|.|||+   .+++|+||||+||+++.++.++|+|||++....... ...
T Consensus        86 ~~~l~~~i~~~---~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-~~~  158 (277)
T cd06641          86 GGSALDLLEPG---PLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IKR  158 (277)
T ss_pred             CCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEEEeecccceecccch-hhh
Confidence            99999998643   58899999999999999999998   999999999999999999999999999998654322 122


Q ss_pred             eeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCcccc
Q 007869          422 THVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYV  501 (586)
Q Consensus       422 ~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~  501 (586)
                      ....++..|+|||.+.+...+.++|+|||||++|||++|+.|+.......      +.... ..+     ..+.+    .
T Consensus       159 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~------~~~~~-~~~-----~~~~~----~  222 (277)
T cd06641         159 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK------VLFLI-PKN-----NPPTL----E  222 (277)
T ss_pred             ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH------HHHHH-hcC-----CCCCC----C
Confidence            33568899999999988889999999999999999999999997543211      11111 011     01111    1


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          502 AEELELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       502 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                      ......+.+++.+|++.+|.+||++.++++.
T Consensus       223 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         223 GNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             cccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            2233557788899999999999999999983

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-36  Score=306.97  Aligned_cols=248  Identities=26%  Similarity=0.455  Sum_probs=202.4

Q ss_pred             CcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc-cchhHHHHHHHHHHhcccC---CCceeeeeeeeeccCeEEEEE
Q 007869          262 GFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE-SRQGMKEFVAEIVSIGRLR---HRNLVQLLGYCRRKGELLLVY  337 (586)
Q Consensus       262 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~---H~niv~l~~~~~~~~~~~lV~  337 (586)
                      .|+..+.||+|+||.||+|.+..++..+|+|.+... ......++.+|+.++++++   |||++++++++......++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            477788999999999999999888899999998754 3344567889999999986   999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCC
Q 007869          338 DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT  417 (586)
Q Consensus       338 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~  417 (586)
                      ||+++++|.+++...   .+++...+.++.|+++||.|||+   .+|+|+||+|+||++++++.++|+|||++.......
T Consensus        82 e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06917          82 EYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS  155 (277)
T ss_pred             ecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence            999999999998654   68899999999999999999998   899999999999999999999999999998765433


Q ss_pred             CCceeeeccCCCccCcccccCC-CCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCC
Q 007869          418 DPQTTHVVGTLGYLAPEHTRTG-KATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNL  496 (586)
Q Consensus       418 ~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l  496 (586)
                      . ......|+..|+|||.+.++ .++.++|||||||++|||++|+.||..........   +         +.....+.+
T Consensus       156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~---~---------~~~~~~~~~  222 (277)
T cd06917         156 S-KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMM---L---------IPKSKPPRL  222 (277)
T ss_pred             c-ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhh---c---------cccCCCCCC
Confidence            2 23345789999999998654 46899999999999999999999997643321110   0         001111222


Q ss_pred             CccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          497 GTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       497 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      ...   .....+.+++.+||+.||++||++.++++
T Consensus       223 ~~~---~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         223 EDN---GYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             Ccc---cCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence            111   13356778889999999999999999986

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.4e-36  Score=309.07  Aligned_cols=249  Identities=24%  Similarity=0.320  Sum_probs=204.0

Q ss_pred             CcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEecCC
Q 007869          262 GFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMP  341 (586)
Q Consensus       262 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~  341 (586)
                      .|...+.||+|++|.||++....++..+++|++........+.+.+|+.++++++|||++++++++...+..++++||++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~   99 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE   99 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence            35556799999999999999988889999999876655556778999999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCCce
Q 007869          342 NGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQT  421 (586)
Q Consensus       342 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~  421 (586)
                      +++|.+++...   .+++..+..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++........ ..
T Consensus       100 ~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~~  172 (285)
T cd06648         100 GGALTDIVTHT---RMNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-RR  172 (285)
T ss_pred             CCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-cc
Confidence            99999998762   58888999999999999999998   8999999999999999999999999999876543321 22


Q ss_pred             eeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCcccc
Q 007869          422 THVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYV  501 (586)
Q Consensus       422 ~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~  501 (586)
                      ....|+..|+|||.+.+..++.++|||||||++|||++|+.||......+      ...... .+     ..+....  .
T Consensus       173 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~------~~~~~~-~~-----~~~~~~~--~  238 (285)
T cd06648         173 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQ------AMKRIR-DN-----LPPKLKN--L  238 (285)
T ss_pred             ccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHH------HHHHHH-hc-----CCCCCcc--c
Confidence            33568999999999988889999999999999999999999997543321      111111 11     1111111  1


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          502 AEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       502 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      ......+.+++.+||+.+|++||++.++++
T Consensus       239 ~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         239 HKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             ccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence            112356888999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=8.2e-37  Score=309.74  Aligned_cols=261  Identities=30%  Similarity=0.392  Sum_probs=202.6

Q ss_pred             cccceeEeecCceEEEEEEeCCCCeEEEEEEecccc--chhHHHHHHHHHHhcccCCCceeeeeeeeecc--CeEEEEEe
Q 007869          263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES--RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRK--GELLLVYD  338 (586)
Q Consensus       263 f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~--~~~~lV~E  338 (586)
                      |+..+.||+|++|.||+|+...++..+|+|++....  ....+.+.+|++++++++|+|++++++++...  +..++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            567789999999999999998888999999997653  33446788999999999999999999999887  89999999


Q ss_pred             cCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCC
Q 007869          339 YMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD  418 (586)
Q Consensus       339 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~  418 (586)
                      |++ ++|.+++.... ..+++.+++.++.|+++||.|||+   .+++|+||||+||++++++.+||+|||++........
T Consensus        81 ~~~-~~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~---~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~  155 (287)
T cd07840          81 YMD-HDLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS  155 (287)
T ss_pred             ccc-ccHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence            997 48988886653 468999999999999999999998   8999999999999999999999999999987655433


Q ss_pred             CceeeeccCCCccCcccccC-CCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccC---c---c---
Q 007869          419 PQTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRG---E---L---  488 (586)
Q Consensus       419 ~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~---~---~---  488 (586)
                      ...+...++..|+|||.+.+ ..++.++||||||+++|||++|+.||.........   ..+.+.....   .   .   
T Consensus       156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07840         156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQL---EKIFELCGSPTDENWPGVSKL  232 (287)
T ss_pred             ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHhCCCchhhccccccc
Confidence            23344567889999998764 45789999999999999999999999765432211   1111110000   0   0   


Q ss_pred             --ccccCCC------CCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          489 --LEARDPN------LGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       489 --~~~~d~~------l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                        .....+.      +...+...+...+.+++.+|++.+|.+||+++++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             hhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence              0000000      000011112467889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=6.6e-37  Score=310.72  Aligned_cols=262  Identities=24%  Similarity=0.332  Sum_probs=198.9

Q ss_pred             CcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc--chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEec
Q 007869          262 GFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES--RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY  339 (586)
Q Consensus       262 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  339 (586)
                      +|+..+.||+|+||.||+|++..++..+|+|++....  ......+.+|++++++++|||++++++++...+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4777899999999999999999889999999986542  22335678899999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCC
Q 007869          340 MPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP  419 (586)
Q Consensus       340 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~  419 (586)
                      ++ ++|.+++.... ..+++.....++.||++||.|||+   .+|+||||||+||+++.++++||+|||+++....... 
T Consensus        81 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~-  154 (284)
T cd07839          81 CD-QDLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR-  154 (284)
T ss_pred             CC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC-
Confidence            96 58888876542 468999999999999999999998   8999999999999999999999999999986543221 


Q ss_pred             ceeeeccCCCccCcccccCCC-CCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccC------cccccc
Q 007869          420 QTTHVVGTLGYLAPEHTRTGK-ATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRG------ELLEAR  492 (586)
Q Consensus       420 ~~~~~~gt~~y~aPE~~~~~~-~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~------~~~~~~  492 (586)
                      ......++..|+|||++.+.. ++.++|||||||++|||++|+.|+......+.  ..+...+.....      .+....
T Consensus       155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  232 (284)
T cd07839         155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPTEESWPGVSKLP  232 (284)
T ss_pred             CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHH--HHHHHHHHhCCCChHHhHHhhhcc
Confidence            223346789999999987654 68999999999999999999998754332211  111111000000      000000


Q ss_pred             C----CCCCc-----cccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          493 D----PNLGT-----EYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       493 d----~~l~~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      +    +....     +........+.+++.+||+.||.+|||+.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             cccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence            0    00000     011123456778999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=3.4e-36  Score=301.40  Aligned_cols=255  Identities=27%  Similarity=0.432  Sum_probs=210.2

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccc-hhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEec
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR-QGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY  339 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  339 (586)
                      ++|+..+.||+|++|.||++++..++..|+||++..... ...+.+.+|+..+.+++|+|++++++++...+..++||||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            368888999999999999999998899999999876644 4567899999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCC
Q 007869          340 MPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP  419 (586)
Q Consensus       340 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~  419 (586)
                      +++++|.+++...  ..+++..++.++.|+++||.|||+  ..+++||||+|+||+++.++.++|+|||++.........
T Consensus        81 ~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~--~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~  156 (264)
T cd06623          81 MDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHT--KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ  156 (264)
T ss_pred             cCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhc--cCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence            9999999999765  468899999999999999999995  278999999999999999999999999999876543322


Q ss_pred             ceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCcc
Q 007869          420 QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTE  499 (586)
Q Consensus       420 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~  499 (586)
                       .....++..|+|||.+.+..++.++|+||||+++|||++|+.||..........+..++.         ....+.....
T Consensus       157 -~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~---------~~~~~~~~~~  226 (264)
T cd06623         157 -CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC---------DGPPPSLPAE  226 (264)
T ss_pred             -ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh---------cCCCCCCCcc
Confidence             234568899999999999999999999999999999999999997654322112222211         1111111111


Q ss_pred             ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          500 YVAEELELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       500 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                         .....+.+++.+|++.+|++||++.++++.
T Consensus       227 ---~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         227 ---EFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             ---cCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence               034667888899999999999999999863

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=5.7e-37  Score=305.96  Aligned_cols=250  Identities=24%  Similarity=0.422  Sum_probs=204.6

Q ss_pred             CcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc--chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEec
Q 007869          262 GFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES--RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY  339 (586)
Q Consensus       262 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  339 (586)
                      +|+..+.||+|+||.||+|....++..+|+|.+....  ....+.+.+|++++++++|+|++++++.+...+..++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4778899999999999999999888999999986542  23446788999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCC-CeEEccccceeeccCCCC
Q 007869          340 MPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGEL-NGRLGDFGLARLYDHGTD  418 (586)
Q Consensus       340 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~-~~kL~DFGla~~~~~~~~  418 (586)
                      +++++|.+++.......+++..+..++.|+++||.|||+   .+++|+||||+||++++++ .+||+|||.+........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (257)
T cd08225          81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME  157 (257)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence            999999999977655568999999999999999999998   8999999999999998875 469999999987654322


Q ss_pred             CceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCc
Q 007869          419 PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGT  498 (586)
Q Consensus       419 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~  498 (586)
                       ......|++.|+|||+..+..++.++|+||||++++||++|+.||......      +++..... +..    .+ .  
T Consensus       158 -~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~~~~~-~~~----~~-~--  222 (257)
T cd08225         158 -LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH------QLVLKICQ-GYF----AP-I--  222 (257)
T ss_pred             -cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH------HHHHHHhc-ccC----CC-C--
Confidence             223346899999999998888999999999999999999999998754321      22222111 111    11 1  


Q ss_pred             cccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          499 EYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       499 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                        .......+.+++.+|++.+|++|||+.++++
T Consensus       223 --~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         223 --SPNFSRDLRSLISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             --CCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence              1122345778889999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.5e-36  Score=309.44  Aligned_cols=265  Identities=22%  Similarity=0.267  Sum_probs=199.5

Q ss_pred             hcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccc-hhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEE
Q 007869          259 ATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR-QGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY  337 (586)
Q Consensus       259 a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  337 (586)
                      ++++|...+.||+|+||.||+|....++..||+|++..... .....+.+|+.++++++|+||+++++++...+..++||
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            56789999999999999999999988888999999875532 23346788999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCC
Q 007869          338 DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT  417 (586)
Q Consensus       338 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~  417 (586)
                      ||+. ++|.+++.... ..+++.++..++.|++.||.|||+   .+|+||||||+|||++.++++||+|||+++......
T Consensus        83 e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~  157 (291)
T cd07870          83 EYMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS  157 (291)
T ss_pred             eccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEEcCCCcEEEeccccccccCCCC
Confidence            9995 67877775543 357788888999999999999998   899999999999999999999999999998643322


Q ss_pred             CCceeeeccCCCccCcccccCC-CCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhcc-----------
Q 007869          418 DPQTTHVVGTLGYLAPEHTRTG-KATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNR-----------  485 (586)
Q Consensus       418 ~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~-----------  485 (586)
                      . ......++..|+|||++.+. .++.++|||||||++|||++|+.||............  .+.....           
T Consensus       158 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~  234 (291)
T cd07870         158 Q-TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEK--IWTVLGVPTEDTWPGVSK  234 (291)
T ss_pred             C-CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHH--HHHHcCCCChhhhhhhhh
Confidence            1 12234578999999998754 5788999999999999999999999754432111100  0100000           


Q ss_pred             -CccccccC----CCCCccc--cHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          486 -GELLEARD----PNLGTEY--VAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       486 -~~~~~~~d----~~l~~~~--~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                       ........    +......  .......+.+++.+|++.||++|||+.|++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         235 LPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             cccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence             00000000    0000000  0011345678889999999999999999874

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=9.5e-37  Score=307.56  Aligned_cols=254  Identities=28%  Similarity=0.439  Sum_probs=199.2

Q ss_pred             cccceeEeecCceEEEEEEeCC---CCeEEEEEEeccc--cchhHHHHHHHHHHhcccCCCceeeeeeeeeccC------
Q 007869          263 FREKELLGTGGFGRVYRGTLPK---SQIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKG------  331 (586)
Q Consensus       263 f~~~~~LG~G~~g~Vy~~~~~~---~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~------  331 (586)
                      |...+.||+|+||.||+|.+..   ++..||||++..+  .....+++.+|++++++++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            5567889999999999998643   4678999998754  3344677899999999999999999999886432      


Q ss_pred             eEEEEEecCCCCChhhhhhcCC----CccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccc
Q 007869          332 ELLLVYDYMPNGSLDKYLYDQP----KVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDF  407 (586)
Q Consensus       332 ~~~lV~E~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DF  407 (586)
                      ..++++||+++|+|.+++....    ...+++...+.++.|++.||+|||+   .+|+||||||+||++++++.+||+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCCCCEEECcc
Confidence            3478999999999998875321    2357888999999999999999998   89999999999999999999999999


Q ss_pred             cceeeccCCCC-CceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhcc
Q 007869          408 GLARLYDHGTD-PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNR  485 (586)
Q Consensus       408 Gla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~  485 (586)
                      |+++....... .......++..|++||.+....++.++|||||||++|||++ |+.||......   .+..+..    .
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~---~~~~~~~----~  230 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS---EIYNYLI----K  230 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH---HHHHHHH----c
Confidence            99986543221 11223345678999999988889999999999999999999 88888754321   1111111    1


Q ss_pred             CccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 007869          486 GELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER  535 (586)
Q Consensus       486 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  535 (586)
                      +..     ...    .......+.+++.+|++.+|++||++.++++.|++
T Consensus       231 ~~~-----~~~----~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~  271 (273)
T cd05074         231 GNR-----LKQ----PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLEL  271 (273)
T ss_pred             CCc-----CCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence            110     000    11233578899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1e-36  Score=305.71  Aligned_cols=255  Identities=27%  Similarity=0.378  Sum_probs=205.7

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc-chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEec
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY  339 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  339 (586)
                      ++|+..+.||+|++|.||++.+..++..+|+|++.... ....+++.+|++++++++||||+++++.+...+..++++||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            35777889999999999999999889999999987653 34556789999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCC
Q 007869          340 MPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP  419 (586)
Q Consensus       340 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~  419 (586)
                      +++++|.+++.... ..+++.....++.|+++||.|||+  ..+++|+||||+||++++++.+||+|||.+........ 
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~--~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-  156 (265)
T cd06605          81 MDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA-  156 (265)
T ss_pred             cCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcC--CCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh-
Confidence            99999999997653 468888899999999999999996  37899999999999999999999999999876543221 


Q ss_pred             ceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCcc
Q 007869          420 QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTE  499 (586)
Q Consensus       420 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~  499 (586)
                        ....++..|+|||++.+..++.++||||||+++|||++|+.||........ ...+.+......      ..+.+...
T Consensus       157 --~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~------~~~~~~~~  227 (265)
T cd06605         157 --KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD-GIFELLQYIVNE------PPPRLPSG  227 (265)
T ss_pred             --hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc-cHHHHHHHHhcC------CCCCCChh
Confidence              126788999999999888999999999999999999999999975432111 111111111111      11111111


Q ss_pred             ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          500 YVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       500 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                         .....+.+++..||+.+|++||++.++++
T Consensus       228 ---~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         228 ---KFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             ---hcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence               13455778889999999999999999975

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1.8e-36  Score=308.97  Aligned_cols=245  Identities=26%  Similarity=0.316  Sum_probs=202.3

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc---chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEE
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY  337 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  337 (586)
                      ++|+..+.||+|+||.||++.+..+++.+|+|++....   ....+.+.+|++++++++||||+++++++...+..++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            46888999999999999999998889999999986532   234567899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCC
Q 007869          338 DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT  417 (586)
Q Consensus       338 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~  417 (586)
                      ||+++++|.+++...  ..+++..+..++.|+++||.|||+   .+++||||||+|||++.++.+||+|||+++..... 
T Consensus        81 e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-  154 (290)
T cd05580          81 EYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-  154 (290)
T ss_pred             ecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence            999999999999765  368888999999999999999998   99999999999999999999999999999876443 


Q ss_pred             CCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCC
Q 007869          418 DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLG  497 (586)
Q Consensus       418 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~  497 (586)
                         .....|++.|+|||.+.+...+.++||||||+++|||++|+.||......+   .    .+....+.      +.+ 
T Consensus       155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~----~~~~~~~~------~~~-  217 (290)
T cd05580         155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ---I----YEKILEGK------VRF-  217 (290)
T ss_pred             ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH---H----HHHHhcCC------ccC-
Confidence               234568999999999988889999999999999999999999997544211   1    11111111      111 


Q ss_pred             ccccHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 007869          498 TEYVAEELELVLKLGLLCSHSDPTARP-----SMRQVVQ  531 (586)
Q Consensus       498 ~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~  531 (586)
                         .......+.+++.+||+.||.+||     +++|+++
T Consensus       218 ---~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~  253 (290)
T cd05580         218 ---PSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN  253 (290)
T ss_pred             ---CccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence               111235677888999999999999     6666653

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-37  Score=306.49  Aligned_cols=267  Identities=28%  Similarity=0.402  Sum_probs=205.7

Q ss_pred             hhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhc--ccCCCceeeeeeeeecc----C
Q 007869          258 IATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIG--RLRHRNLVQLLGYCRRK----G  331 (586)
Q Consensus       258 ~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~--~l~H~niv~l~~~~~~~----~  331 (586)
                      ...++....+.||+|.||.||+|.+.  |..||||++...++   +.+.+|.++.+  .|||+||+.+++.-..+    .
T Consensus       208 TiarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T  282 (513)
T KOG2052|consen  208 TIARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT  282 (513)
T ss_pred             hhhheeEEEEEecCccccceeecccc--CCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence            44567778899999999999999996  45799999976544   34455555554  46999999999976543    3


Q ss_pred             eEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcc-----cCCcEEeCCCCCCCeeecCCCCeEEcc
Q 007869          332 ELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQE-----WEQVVIHRDVKASNVLLDGELNGRLGD  406 (586)
Q Consensus       332 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-----~~~~ivHrDIkp~NIll~~~~~~kL~D  406 (586)
                      +++||.+|.++|||.|+|.++   +++-...++++..+|.||++||.+     ..+.|.|||||++|||+..++.+.|+|
T Consensus       283 QLwLvTdYHe~GSL~DyL~r~---tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IAD  359 (513)
T KOG2052|consen  283 QLWLVTDYHEHGSLYDYLNRN---TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD  359 (513)
T ss_pred             EEEEeeecccCCcHHHHHhhc---cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEee
Confidence            799999999999999999774   788889999999999999999963     346799999999999999999999999


Q ss_pred             ccceeeccCCCC---CceeeeccCCCccCcccccCCC------CCCcceEEehhHHHHHHHhC----------CCCCCCC
Q 007869          407 FGLARLYDHGTD---PQTTHVVGTLGYLAPEHTRTGK------ATTSADVFSFGAFLLEVACG----------RRPIQRQ  467 (586)
Q Consensus       407 FGla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~------~s~ksDVyS~Gvvl~ElltG----------~~p~~~~  467 (586)
                      +|||.......+   ......+||.+|||||++...-      .-..+||||||.|+||++..          +.||.+.
T Consensus       360 LGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~  439 (513)
T KOG2052|consen  360 LGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDV  439 (513)
T ss_pred             ceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccC
Confidence            999998766532   2345579999999999986432      13468999999999999653          2366543


Q ss_pred             CCCccchhhHHHHhhhccCccccccCCCCCcc-ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhccC
Q 007869          468 GPSENLILVDWVFDFWNRGELLEARDPNLGTE-YVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERDVA  538 (586)
Q Consensus       468 ~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~  538 (586)
                      .+.+..      .+-+++-...+...|.+... .+.+.+..+.+++..||..+|..|-|+-.+-+.|.+...
T Consensus       440 Vp~DPs------~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~  505 (513)
T KOG2052|consen  440 VPSDPS------FEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN  505 (513)
T ss_pred             CCCCCC------HHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence            333221      11112222233444554433 355788999999999999999999999999998876543

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=8.6e-37  Score=310.63  Aligned_cols=255  Identities=27%  Similarity=0.372  Sum_probs=198.1

Q ss_pred             CcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc-chhHHHHHHHHHHhcccC-CCceeeeeeeeeccCeEEEEEec
Q 007869          262 GFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES-RQGMKEFVAEIVSIGRLR-HRNLVQLLGYCRRKGELLLVYDY  339 (586)
Q Consensus       262 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~-H~niv~l~~~~~~~~~~~lV~E~  339 (586)
                      +|...+.||+|+||.||++.+..++..+|+|++.... ......+.+|+.++.++. |+||+++++++...+..+++|||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            4556788999999999999999889999999987543 334567899999999996 99999999999999999999999


Q ss_pred             CCCCChhhh---hhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCC
Q 007869          340 MPNGSLDKY---LYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHG  416 (586)
Q Consensus       340 ~~~gsL~~~---l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~  416 (586)
                      +. ++|.++   +.......+++.....++.|++.||+|||+  +.+++||||||+||+++.++.+||+|||+++.....
T Consensus        85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  161 (288)
T cd06616          85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS  161 (288)
T ss_pred             cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence            86 455443   333333568999999999999999999997  358999999999999999999999999999765432


Q ss_pred             CCCceeeeccCCCccCcccccCC---CCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccC
Q 007869          417 TDPQTTHVVGTLGYLAPEHTRTG---KATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARD  493 (586)
Q Consensus       417 ~~~~~~~~~gt~~y~aPE~~~~~---~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d  493 (586)
                      .  ......|+..|+|||++.+.   .++.++|||||||++|||++|+.||.....     ..+.+.+..      ....
T Consensus       162 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~~~~~~------~~~~  228 (288)
T cd06616         162 I--AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQLTQVV------KGDP  228 (288)
T ss_pred             C--ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHHHhhhc------CCCC
Confidence            2  22334688999999998776   689999999999999999999999975431     111111111      1111


Q ss_pred             CCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          494 PNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       494 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                      +.+...........+.+++.+|++.+|++||++.++++.
T Consensus       229 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         229 PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             CcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            222222212344568889999999999999999999863

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1.8e-36  Score=309.25  Aligned_cols=265  Identities=22%  Similarity=0.271  Sum_probs=202.1

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccc--hhHHHHHHHHHHhcccCCCceeeeeeeeecc--CeEEEE
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR--QGMKEFVAEIVSIGRLRHRNLVQLLGYCRRK--GELLLV  336 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~--~~~~lV  336 (586)
                      ++|+..+.||+|+||.||+|....++..+|+|.+.....  .....+.+|+.++++++||||+++++++...  +..++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            478888999999999999999988889999999975432  2234577899999999999999999998877  889999


Q ss_pred             EecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCC
Q 007869          337 YDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHG  416 (586)
Q Consensus       337 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~  416 (586)
                      |||++ ++|.+++.... ..+++.....++.|++.||.|||+   .+++|+||||+|||++.++.+||+|||+++.....
T Consensus        85 ~e~~~-~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~  159 (293)
T cd07843          85 MEYVE-HDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP  159 (293)
T ss_pred             ehhcC-cCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCcEEEeecCceeeccCC
Confidence            99997 59999887653 368999999999999999999998   89999999999999999999999999999876543


Q ss_pred             CCCceeeeccCCCccCcccccCC-CCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhh-HH-------HHhhhc---
Q 007869          417 TDPQTTHVVGTLGYLAPEHTRTG-KATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILV-DW-------VFDFWN---  484 (586)
Q Consensus       417 ~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~-~~-------v~~~~~---  484 (586)
                      .. ......++..|+|||.+.+. .++.++|+||||+++|||++|+.||......+....+ ..       .|..+.   
T Consensus       160 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (293)
T cd07843         160 LK-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP  238 (293)
T ss_pred             cc-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccc
Confidence            21 22334678999999998654 4689999999999999999999999765432211100 00       010000   


Q ss_pred             ---cCccccccCCCCCccccHH-HHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          485 ---RGELLEARDPNLGTEYVAE-ELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       485 ---~~~~~~~~d~~l~~~~~~~-~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                         ...........+...+... ....+.+++..||+.+|++|||+.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence               0000011111111112111 2456778899999999999999999985

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=3e-36  Score=309.98  Aligned_cols=248  Identities=27%  Similarity=0.410  Sum_probs=200.0

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc---chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEE
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLV  336 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV  336 (586)
                      .+.|+..+.||+|+||.||+|+...++..||+|++....   .+..+++.+|++++++++|||+++++++|...+..++|
T Consensus        14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv   93 (307)
T cd06607          14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV   93 (307)
T ss_pred             chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence            356888899999999999999998888999999986432   23346788999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCC
Q 007869          337 YDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHG  416 (586)
Q Consensus       337 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~  416 (586)
                      |||++ |+|.+++.... ..+++..+..++.|++.||.|||+   .+|+||||+|+||++++++.+||+|||++......
T Consensus        94 ~e~~~-g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~---~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~  168 (307)
T cd06607          94 MEYCL-GSASDILEVHK-KPLQEVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA  168 (307)
T ss_pred             HHhhC-CCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence            99996 67777775432 368999999999999999999998   89999999999999999999999999998765322


Q ss_pred             CCCceeeeccCCCccCccccc---CCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccC
Q 007869          417 TDPQTTHVVGTLGYLAPEHTR---TGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARD  493 (586)
Q Consensus       417 ~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d  493 (586)
                           ....++..|+|||++.   ...++.++||||||+++|||++|+.||........      .......      ..
T Consensus       169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~------~~~~~~~------~~  231 (307)
T cd06607         169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIAQN------DS  231 (307)
T ss_pred             -----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH------HHHHhcC------CC
Confidence                 2346788999999874   45688999999999999999999999875432111      1110000      01


Q ss_pred             CCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          494 PNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       494 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                      +.+.   .......+.+++.+||+.+|++||++.++++.
T Consensus       232 ~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         232 PTLS---SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             CCCC---chhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            1111   11234568889999999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=3.3e-36  Score=298.36  Aligned_cols=250  Identities=30%  Similarity=0.458  Sum_probs=206.9

Q ss_pred             CcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEecCC
Q 007869          262 GFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMP  341 (586)
Q Consensus       262 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~  341 (586)
                      .|+..+.||+|++|.||++....++..+++|++........+.+.+|++.+++++|+|++++++++...+..++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            36778899999999999999988888999999977655566789999999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCCce
Q 007869          342 NGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQT  421 (586)
Q Consensus       342 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~  421 (586)
                      +++|.+++.... ..+++..+..++.|++++|.|||+   .+++||||+|+||++++++.+||+|||.+........  .
T Consensus        81 ~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~  154 (253)
T cd05122          81 GGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--R  154 (253)
T ss_pred             CCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeecccccccccccc--c
Confidence            999999987653 468999999999999999999998   8999999999999999999999999999987654332  3


Q ss_pred             eeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCcccc
Q 007869          422 THVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYV  501 (586)
Q Consensus       422 ~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~  501 (586)
                      ....++..|++||++....++.++||||||++++||++|+.||......+...      ... ...     .+.+..  .
T Consensus       155 ~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~------~~~-~~~-----~~~~~~--~  220 (253)
T cd05122         155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALF------KIA-TNG-----PPGLRN--P  220 (253)
T ss_pred             cceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHH------HHH-hcC-----CCCcCc--c
Confidence            44578999999999988889999999999999999999999997643221111      000 000     011100  1


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          502 AEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       502 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      ......+.+++..|++.||++|||+.++++
T Consensus       221 ~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         221 EKWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             cccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            111356788889999999999999999985

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=3.6e-36  Score=305.90  Aligned_cols=254  Identities=30%  Similarity=0.415  Sum_probs=208.3

Q ss_pred             hhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEE
Q 007869          258 IATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY  337 (586)
Q Consensus       258 ~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  337 (586)
                      ..+++|+..+.||+|++|.||+|.+..++..+++|++..... ..+.+.+|++.+++++|+|++++++.+...+..++|+
T Consensus        16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   94 (286)
T cd06614          16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM   94 (286)
T ss_pred             CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence            456778889999999999999999987888999999976544 5577899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCC
Q 007869          338 DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT  417 (586)
Q Consensus       338 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~  417 (586)
                      ||+++++|.+++.... ..+++..++.++.|++.||.|||+   .+++|+||||+||+++.++.+||+|||++.......
T Consensus        95 e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  170 (286)
T cd06614          95 EYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK  170 (286)
T ss_pred             eccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence            9999999999998754 478999999999999999999998   999999999999999999999999999987554322


Q ss_pred             CCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCC
Q 007869          418 DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLG  497 (586)
Q Consensus       418 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~  497 (586)
                      . ......++..|++||++.+..++.++|||||||++|||++|+.||.........  .    ... ....     +...
T Consensus       171 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~--~----~~~-~~~~-----~~~~  237 (286)
T cd06614         171 S-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRAL--F----LIT-TKGI-----PPLK  237 (286)
T ss_pred             h-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHH--H----HHH-hcCC-----CCCc
Confidence            1 223345788999999998888999999999999999999999998754332110  0    000 0000     1110


Q ss_pred             ccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          498 TEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       498 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                        ........+.+++.+|++.+|.+||++.++++
T Consensus       238 --~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         238 --NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             --chhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence              01113356778899999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-36  Score=308.60  Aligned_cols=261  Identities=28%  Similarity=0.358  Sum_probs=200.9

Q ss_pred             cccceeEeecCceEEEEEEeCCCCeEEEEEEecccc--chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEecC
Q 007869          263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES--RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYM  340 (586)
Q Consensus       263 f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  340 (586)
                      |+..+.||.|++|.||+|.+..++..||+|++....  ......+.+|++.+++++|||++++++++...+..+++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            567789999999999999998889999999987543  223457889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCCc
Q 007869          341 PNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ  420 (586)
Q Consensus       341 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~  420 (586)
                      + ++|.+++.......+++..++.++.|+++||.|||+   ++++||||+|+||+++.++.+||+|||+++....... .
T Consensus        81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~-~  155 (283)
T cd07835          81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR-T  155 (283)
T ss_pred             C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-c
Confidence            5 699999877654578999999999999999999998   8999999999999999999999999999986543221 1


Q ss_pred             eeeeccCCCccCcccccCC-CCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccC-----------c-
Q 007869          421 TTHVVGTLGYLAPEHTRTG-KATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRG-----------E-  487 (586)
Q Consensus       421 ~~~~~gt~~y~aPE~~~~~-~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~-----------~-  487 (586)
                      .....++..|+|||++.+. .++.++||||||+++|||++|+.||......+.  +.+.........           . 
T Consensus       156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd07835         156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ--LFRIFRTLGTPDEDVWPGVTSLPDY  233 (283)
T ss_pred             cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCChHHhhhhhhchhh
Confidence            2234568899999987654 578999999999999999999999976433211  111110000000           0 


Q ss_pred             ---cccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          488 ---LLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       488 ---~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                         ......+.. ..........+.+++.+|++.||.+||+++|+++
T Consensus       234 ~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         234 KPTFPKWARQDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             hhhcccccccch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence               000000000 0111122356778999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-37  Score=328.71  Aligned_cols=255  Identities=28%  Similarity=0.437  Sum_probs=210.5

Q ss_pred             cccceeEeecCceEEEEEEeCCCC----eEEEEEEeccc-cchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEE
Q 007869          263 FREKELLGTGGFGRVYRGTLPKSQ----IEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY  337 (586)
Q Consensus       263 f~~~~~LG~G~~g~Vy~~~~~~~~----~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  337 (586)
                      .+..++||+|+||+||||.+...+    .+||+|++... ..+..++++.|+.+|.+++|||+++|+|+|.... +.||+
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt  776 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT  776 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence            456789999999999999985433    46899988654 4566789999999999999999999999998776 88999


Q ss_pred             ecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCC
Q 007869          338 DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT  417 (586)
Q Consensus       338 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~  417 (586)
                      +||+.|+|.++++.+ +..+.-...+.|..|||+||.|||+   ++++||||-.+|||+..-..+||.|||+++.+....
T Consensus       777 q~mP~G~LlDyvr~h-r~~igsq~lLnw~~QIAkgM~YLe~---qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~  852 (1177)
T KOG1025|consen  777 QLMPLGCLLDYVREH-RDNIGSQDLLNWCYQIAKGMKYLEE---QRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE  852 (1177)
T ss_pred             HhcccchHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHh---cchhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence            999999999999876 4578888899999999999999997   999999999999999999999999999999887654


Q ss_pred             CCcee-eeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccCccccccCCC
Q 007869          418 DPQTT-HVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPN  495 (586)
Q Consensus       418 ~~~~~-~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~  495 (586)
                      ..-.. ...-.+.|||-|.+....++.+||||||||++||++| |..|+++....+.       .++.+.|..+      
T Consensus       853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI-------~dlle~geRL------  919 (1177)
T KOG1025|consen  853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEI-------PDLLEKGERL------  919 (1177)
T ss_pred             ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHh-------hHHHhccccC------
Confidence            32221 1223678999999999999999999999999999998 9999988665432       2233333321      


Q ss_pred             CCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhccC
Q 007869          496 LGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERDVA  538 (586)
Q Consensus       496 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~  538 (586)
                         ..++.....+..++++||..|+..||+++++...+.+...
T Consensus       920 ---sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar  959 (1177)
T KOG1025|consen  920 ---SQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR  959 (1177)
T ss_pred             ---CCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence               2233445678889999999999999999999988866543

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.2e-36  Score=304.42  Aligned_cols=248  Identities=26%  Similarity=0.311  Sum_probs=204.7

Q ss_pred             CcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc---chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEe
Q 007869          262 GFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYD  338 (586)
Q Consensus       262 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E  338 (586)
                      +|+..+.||+|+||.||+|.+..++..||+|.+....   ....+.+.+|++++++++||||+++++.+...+..++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            5788999999999999999998889999999997542   2456789999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCC
Q 007869          339 YMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD  418 (586)
Q Consensus       339 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~  418 (586)
                      |+++++|.+++...  .++++.+...++.|+++||.|||+   .+++|+||||+||++++++.++|+|||++....... 
T Consensus        81 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-  154 (258)
T cd05578          81 LLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-  154 (258)
T ss_pred             CCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-
Confidence            99999999999765  468889999999999999999998   899999999999999999999999999998654332 


Q ss_pred             CceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCc
Q 007869          419 PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGT  498 (586)
Q Consensus       419 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~  498 (586)
                       ......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||.......    .++.......      ..+    
T Consensus       155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~~~~~------~~~----  219 (258)
T cd05578         155 -LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI----RDQIRAKQET------ADV----  219 (258)
T ss_pred             -cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH----HHHHHHHhcc------ccc----
Confidence             2234568899999999988889999999999999999999999998654321    1122111111      001    


Q ss_pred             cccHHHHHHHHHHHHHhcccCCCCCCCH--HHHH
Q 007869          499 EYVAEELELVLKLGLLCSHSDPTARPSM--RQVV  530 (586)
Q Consensus       499 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~--~evl  530 (586)
                      .........+.+++.+||+.||.+||++  +|++
T Consensus       220 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         220 LYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             cCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence            1112223667788899999999999999  6554

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-37  Score=319.82  Aligned_cols=245  Identities=28%  Similarity=0.412  Sum_probs=205.4

Q ss_pred             CcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc---chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEe
Q 007869          262 GFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYD  338 (586)
Q Consensus       262 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E  338 (586)
                      -|...+.||-|.||.||-+++..+...||||+++...   .+.+.+++.|+..|.+++|||++.+.|||......+||||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME  106 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME  106 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence            3566778999999999999999999999999998654   3456789999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCC
Q 007869          339 YMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD  418 (586)
Q Consensus       339 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~  418 (586)
                      || -|+-.+++.-. +.++.+..+..|+.+.+.||.|||+   .+.||||||..||||++.+.|||+|||.|.++.+   
T Consensus       107 YC-lGSAsDlleVh-kKplqEvEIAAi~~gaL~gLaYLHS---~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P---  178 (948)
T KOG0577|consen  107 YC-LGSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHS---HNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP---  178 (948)
T ss_pred             HH-hccHHHHHHHH-hccchHHHHHHHHHHHHHHHHHHHH---hhHHhhhccccceEecCCCeeeeccccchhhcCc---
Confidence            99 56777777554 3578999999999999999999999   9999999999999999999999999999987653   


Q ss_pred             CceeeeccCCCccCccccc---CCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCC
Q 007869          419 PQTTHVVGTLGYLAPEHTR---TGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPN  495 (586)
Q Consensus       419 ~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~  495 (586)
                        ....+|||.|||||++.   .+.|+-|.||||||++..||.-.++|+...+....+.            .+...-.|.
T Consensus       179 --AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALY------------HIAQNesPt  244 (948)
T KOG0577|consen  179 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY------------HIAQNESPT  244 (948)
T ss_pred             --hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHH------------HHHhcCCCC
Confidence              23478999999999974   5789999999999999999999999987654322111            111222333


Q ss_pred             CCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          496 LGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       496 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      +.   ..+-.+.+..++..||++-|.+|||.+++++
T Consensus       245 Lq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  245 LQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             CC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence            33   3345567888888999999999999998875

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=7e-36  Score=297.22  Aligned_cols=251  Identities=27%  Similarity=0.409  Sum_probs=208.0

Q ss_pred             CcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccc--hhHHHHHHHHHHhcccCCCceeeeeeeeecc--CeEEEEE
Q 007869          262 GFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR--QGMKEFVAEIVSIGRLRHRNLVQLLGYCRRK--GELLLVY  337 (586)
Q Consensus       262 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~--~~~~lV~  337 (586)
                      +|+..+.||+|++|.||+|....++..|++|++.....  ...+.+.+|++.+++++|+||+++++.+...  +..++|+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            47778999999999999999988899999999876542  4567899999999999999999999999988  8899999


Q ss_pred             ecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCC
Q 007869          338 DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT  417 (586)
Q Consensus       338 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~  417 (586)
                      ||+++++|.+++....  .+++.+++.++.|++.+|.|||+   .+++|+||+|+||+++.++.+||+|||.+.......
T Consensus        81 e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  155 (260)
T cd06606          81 EYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIE  155 (260)
T ss_pred             EecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcccccEEeccccc
Confidence            9999999999997664  78999999999999999999998   899999999999999999999999999998765543


Q ss_pred             CC-ceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCC
Q 007869          418 DP-QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNL  496 (586)
Q Consensus       418 ~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l  496 (586)
                      .. ......++..|+|||.+.....+.++||||||++++||++|+.||......     ....+....         ...
T Consensus       156 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~~~~~---------~~~  221 (260)
T cd06606         156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP-----MAALYKIGS---------SGE  221 (260)
T ss_pred             ccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch-----HHHHHhccc---------cCC
Confidence            21 123456889999999998888999999999999999999999999765411     111111110         001


Q ss_pred             CccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          497 GTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       497 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      ...........+.+++.+|++.+|.+||++.++++
T Consensus       222 ~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         222 PPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             CcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence            11112223567888899999999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-36  Score=310.12  Aligned_cols=265  Identities=22%  Similarity=0.307  Sum_probs=199.0

Q ss_pred             CcccceeEeecCceEEEEEEeCC--CCeEEEEEEecccc---chhHHHHHHHHHHhcccCCCceeeeeeeeecc--CeEE
Q 007869          262 GFREKELLGTGGFGRVYRGTLPK--SQIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRK--GELL  334 (586)
Q Consensus       262 ~f~~~~~LG~G~~g~Vy~~~~~~--~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~--~~~~  334 (586)
                      +|+..+.||+|+||.||+|+...  .+..||+|.+....   ....+.+.+|+.++.+++||||+++++++...  +..+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            47788999999999999999987  78899999997633   33446778899999999999999999999988  8899


Q ss_pred             EEEecCCCCChhhhhhcCC---CccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecC----CCCeEEccc
Q 007869          335 LVYDYMPNGSLDKYLYDQP---KVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDG----ELNGRLGDF  407 (586)
Q Consensus       335 lV~E~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~----~~~~kL~DF  407 (586)
                      +||||+++ +|.+++....   ...+++...+.++.|++.||.|||+   .+|+||||||+|||++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999964 6777664321   2368888999999999999999998   89999999999999999    899999999


Q ss_pred             cceeeccCCCC--CceeeeccCCCccCcccccCC-CCCCcceEEehhHHHHHHHhCCCCCCCCCCCcc-------chhhH
Q 007869          408 GLARLYDHGTD--PQTTHVVGTLGYLAPEHTRTG-KATTSADVFSFGAFLLEVACGRRPIQRQGPSEN-------LILVD  477 (586)
Q Consensus       408 Gla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~-------~~l~~  477 (586)
                      |+++.......  .......++..|+|||++.+. .++.++|||||||+++||++|+.||........       ..+..
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence            99987644322  122335678999999988664 578999999999999999999999976543220       00111


Q ss_pred             HHHhhhcc------------Ccccc---c-cCCCCCcc-----ccH--HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          478 WVFDFWNR------------GELLE---A-RDPNLGTE-----YVA--EELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       478 ~v~~~~~~------------~~~~~---~-~d~~l~~~-----~~~--~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      .+ ..+..            .....   . ........     ...  .....+.+++.+|++.||++|||+.|+++
T Consensus       237 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         237 IF-EVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             HH-HHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            11 10000            00000   0 00000000     000  22346788999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=4e-36  Score=307.75  Aligned_cols=265  Identities=26%  Similarity=0.337  Sum_probs=201.6

Q ss_pred             hhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc--chhHHHHHHHHHHhcccCCCceeeeeeeeeccC----
Q 007869          258 IATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES--RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKG----  331 (586)
Q Consensus       258 ~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~----  331 (586)
                      ...++|+..+.||+|+||.||+|.+..++..||+|++....  ......+.+|++++++++|||++++++++....    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            45578999999999999999999998888999999997543  223356788999999999999999999987654    


Q ss_pred             ------eEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEc
Q 007869          332 ------ELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLG  405 (586)
Q Consensus       332 ------~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~  405 (586)
                            ..++|+||+++ +|...+... ...+++.++..++.|++.||.|||+   .+|+||||||+||++++++.+||+
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~kl~  158 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLA  158 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCcEEeC
Confidence                  78999999975 777777654 3468999999999999999999998   899999999999999999999999


Q ss_pred             cccceeeccCCCCCceeeeccCCCccCcccccC-CCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhc
Q 007869          406 DFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWN  484 (586)
Q Consensus       406 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~  484 (586)
                      |||++...............++..|+|||.+.+ ..++.++|||||||++|||++|+.||......+..   ..+.+...
T Consensus       159 dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~---~~~~~~~~  235 (302)
T cd07864         159 DFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQL---ELISRLCG  235 (302)
T ss_pred             cccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHhC
Confidence            999998765433222233456888999998864 35789999999999999999999999754332211   11111110


Q ss_pred             cCc-----------cccccCC------CCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          485 RGE-----------LLEARDP------NLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       485 ~~~-----------~~~~~d~------~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      ...           .....++      .....+ ......+.+++..||+.||.+||++.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         236 SPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEF-SFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             CCChhhcccccccccccccccccccccchhhhc-CCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            000           0000000      000000 012456788999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-36  Score=315.75  Aligned_cols=264  Identities=24%  Similarity=0.343  Sum_probs=199.9

Q ss_pred             hcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc-chhHHHHHHHHHHhcccCCCceeeeeeeeecc-----Ce
Q 007869          259 ATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRK-----GE  332 (586)
Q Consensus       259 a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~-----~~  332 (586)
                      .+++|+..+.||+|+||.||+|++..++..||+|++.... ......+..|+.++++++|+||+++++++...     ..
T Consensus         3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   82 (336)
T cd07849           3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND   82 (336)
T ss_pred             cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence            3578999999999999999999998889999999986532 33456788999999999999999999987644     35


Q ss_pred             EEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceee
Q 007869          333 LLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARL  412 (586)
Q Consensus       333 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~  412 (586)
                      .++|+||+. ++|.+++...   .+++..+..++.|+++||.|||+   .+|+||||||+|||++.++.+||+|||+++.
T Consensus        83 ~~lv~e~~~-~~l~~~~~~~---~l~~~~~~~i~~ql~~aL~~LH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~  155 (336)
T cd07849          83 VYIVQELME-TDLYKLIKTQ---HLSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARI  155 (336)
T ss_pred             EEEEehhcc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEECcccceee
Confidence            899999996 5888877543   58889999999999999999998   8999999999999999999999999999987


Q ss_pred             ccCCCCC--ceeeeccCCCccCcccccC-CCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCc--
Q 007869          413 YDHGTDP--QTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGE--  487 (586)
Q Consensus       413 ~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~--  487 (586)
                      .......  ......||..|+|||.+.+ ..++.++|||||||++|||++|+.||........   ...+........  
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~---~~~~~~~~~~~~~~  232 (336)
T cd07849         156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQ---LNLILGVLGTPSQE  232 (336)
T ss_pred             ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCCHH
Confidence            5432221  1233568999999998754 4688999999999999999999999965432111   111111111000  


Q ss_pred             -c-----------cccc--CCCCC-ccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          488 -L-----------LEAR--DPNLG-TEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       488 -~-----------~~~~--d~~l~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                       .           ....  .+... ..........+.+++.+||+.+|++||++.|+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             HHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence             0           0000  00000 00011224567899999999999999999999875

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=5e-36  Score=304.07  Aligned_cols=265  Identities=25%  Similarity=0.359  Sum_probs=202.8

Q ss_pred             CcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccc-hhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEecC
Q 007869          262 GFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR-QGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYM  340 (586)
Q Consensus       262 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  340 (586)
                      +|+..+.||+|++|.||+|++..++..||||++..... ...+.+.+|++++++++|+||+++++++...+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            57889999999999999999998899999999976533 23466788999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCC-CccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCC
Q 007869          341 PNGSLDKYLYDQP-KVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP  419 (586)
Q Consensus       341 ~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~  419 (586)
                      ++ +|.+++.... ...+++.++..++.|+++||.|||+   .+++||||||+||++++++.+||+|||+++....... 
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-  155 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-  155 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence            84 8888886543 3468999999999999999999998   8999999999999999999999999999986543221 


Q ss_pred             ceeeeccCCCccCcccccCC-CCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhh-HH-------HHhhhccCcccc
Q 007869          420 QTTHVVGTLGYLAPEHTRTG-KATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILV-DW-------VFDFWNRGELLE  490 (586)
Q Consensus       420 ~~~~~~gt~~y~aPE~~~~~-~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~-~~-------v~~~~~~~~~~~  490 (586)
                      ......++..|++||++.+. .++.++|||||||++|||++|+.||......+..... +.       .++.+.......
T Consensus       156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd07836         156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYK  235 (284)
T ss_pred             ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhc
Confidence            22334678899999988654 5688999999999999999999999765433211100 00       000010000000


Q ss_pred             ccCCCCC----ccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          491 ARDPNLG----TEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       491 ~~d~~l~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      ...+...    ....+.....+.+++.+|++.||.+||++.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         236 PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             ccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            0001100    0011122456778999999999999999999985

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=4.3e-36  Score=306.53  Aligned_cols=263  Identities=25%  Similarity=0.341  Sum_probs=200.1

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc--chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEe
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES--RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYD  338 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E  338 (586)
                      ++|+..+.||+|++|.||+|....+++.||+|++....  ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            46888999999999999999998889999999986542  2334678899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecC-CCCeEEccccceeeccCCC
Q 007869          339 YMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDG-ELNGRLGDFGLARLYDHGT  417 (586)
Q Consensus       339 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~-~~~~kL~DFGla~~~~~~~  417 (586)
                      |++ ++|.+++.......+++.....++.||+.||.|||+   ++++||||||+||+++. ++.+||+|||++.......
T Consensus        82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~  157 (294)
T PLN00009         82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV  157 (294)
T ss_pred             ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence            995 588888866555557788888999999999999998   89999999999999985 5679999999998654322


Q ss_pred             CCceeeeccCCCccCcccccCC-CCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCc--c------
Q 007869          418 DPQTTHVVGTLGYLAPEHTRTG-KATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGE--L------  488 (586)
Q Consensus       418 ~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~--~------  488 (586)
                       .......+++.|+|||++.+. .++.++|||||||++|||++|+.||......+....   .........  .      
T Consensus       158 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~  233 (294)
T PLN00009        158 -RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFK---IFRILGTPNEETWPGVTS  233 (294)
T ss_pred             -cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHHHhCCCChhhcccccc
Confidence             122334678999999988664 578999999999999999999999976433221110   000000000  0      


Q ss_pred             -c--cccCCCCCc----cccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          489 -L--EARDPNLGT----EYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       489 -~--~~~d~~l~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                       .  ....+....    .........+.+++.+|++.+|++||++.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        234 LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             chhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence             0  000000000    011122355778999999999999999999986

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=4.7e-36  Score=303.68  Aligned_cols=242  Identities=28%  Similarity=0.345  Sum_probs=194.2

Q ss_pred             EeecCceEEEEEEeCCCCeEEEEEEecccc---chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEecCCCCCh
Q 007869          269 LGTGGFGRVYRGTLPKSQIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSL  345 (586)
Q Consensus       269 LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL  345 (586)
                      ||+|+||+||++....++..+|+|.+....   ......+..|++++++++|||++++++.+...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            689999999999998889999999986532   22345678899999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCCceeeec
Q 007869          346 DKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVV  425 (586)
Q Consensus       346 ~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~  425 (586)
                      .+++.......+++.++..++.|++.||.|||+   .+++||||||+||++++++.+||+|||++.......  ......
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~  155 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKGRA  155 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC--cccccc
Confidence            999987655578999999999999999999998   899999999999999999999999999998654322  223346


Q ss_pred             cCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCccccHHHH
Q 007869          426 GTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAEEL  505 (586)
Q Consensus       426 gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~  505 (586)
                      ++..|+|||++.+..++.++|||||||+++||++|+.||..........   .+.    .....  ....    ......
T Consensus       156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---~~~----~~~~~--~~~~----~~~~~~  222 (277)
T cd05577         156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE---ELK----RRTLE--MAVE----YPDKFS  222 (277)
T ss_pred             CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH---HHH----hcccc--cccc----CCccCC
Confidence            7889999999988889999999999999999999999997644311100   000    00000  0111    111224


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHH
Q 007869          506 ELVLKLGLLCSHSDPTARPSMRQ  528 (586)
Q Consensus       506 ~~l~~l~~~Cl~~dP~~RPs~~e  528 (586)
                      ..+.+++.+||+.+|.+||+.++
T Consensus       223 ~~~~~li~~~l~~~p~~R~~~~~  245 (277)
T cd05577         223 PEAKDLCEALLQKDPEKRLGCRG  245 (277)
T ss_pred             HHHHHHHHHHccCChhHccCCCc
Confidence            56778889999999999995444

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1e-35  Score=307.64  Aligned_cols=249  Identities=27%  Similarity=0.409  Sum_probs=199.7

Q ss_pred             CcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc---chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEe
Q 007869          262 GFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYD  338 (586)
Q Consensus       262 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E  338 (586)
                      .|...+.||+|+||.||+++...++..+|+|++....   ......+..|++++++++|||++++++++...+..++|||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  105 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME  105 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence            3667888999999999999998888999999987542   2334578899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCC
Q 007869          339 YMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD  418 (586)
Q Consensus       339 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~  418 (586)
                      |++ |+|.+.+... ...++|.++..++.|++.||.|||+   .+|+||||+|+||+++.++.+||+|||++.....   
T Consensus       106 ~~~-g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~---  177 (317)
T cd06635         106 YCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASP---  177 (317)
T ss_pred             CCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcccEEECCCCCEEEecCCCccccCC---
Confidence            996 5887777544 3468999999999999999999998   8999999999999999999999999999875432   


Q ss_pred             CceeeeccCCCccCccccc---CCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCC
Q 007869          419 PQTTHVVGTLGYLAPEHTR---TGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPN  495 (586)
Q Consensus       419 ~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~  495 (586)
                        .....|+..|+|||++.   .+.++.++|||||||++|||++|+.||........  +..+.     .+.     .+.
T Consensus       178 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~--~~~~~-----~~~-----~~~  243 (317)
T cd06635         178 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--LYHIA-----QNE-----SPT  243 (317)
T ss_pred             --cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH--HHHHH-----hcc-----CCC
Confidence              22346889999999973   45689999999999999999999999875432211  11111     110     011


Q ss_pred             CCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 007869          496 LGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER  535 (586)
Q Consensus       496 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  535 (586)
                      ..   .......+.+++.+|++.+|.+||++.++++.+..
T Consensus       244 ~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~  280 (317)
T cd06635         244 LQ---SNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV  280 (317)
T ss_pred             CC---CccccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence            11   11233457888999999999999999999986543

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=5.4e-36  Score=305.68  Aligned_cols=263  Identities=23%  Similarity=0.295  Sum_probs=198.1

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc--chhHHHHHHHHHHhcccC-CCceeeeeeeeeccCe-----
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES--RQGMKEFVAEIVSIGRLR-HRNLVQLLGYCRRKGE-----  332 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~-H~niv~l~~~~~~~~~-----  332 (586)
                      ++|+..+.||+|+||.||+|.+..++..||+|++....  ......+.+|+.++++++ ||||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            46888999999999999999999889999999986543  223467888999999995 6999999999877655     


Q ss_pred             EEEEEecCCCCChhhhhhcCC---CccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecC-CCCeEEcccc
Q 007869          333 LLLVYDYMPNGSLDKYLYDQP---KVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDG-ELNGRLGDFG  408 (586)
Q Consensus       333 ~~lV~E~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~-~~~~kL~DFG  408 (586)
                      .++||||+++ +|.+++....   ...+++..++.++.||++||.|||+   ++|+||||||+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEecCCCeEEEeecc
Confidence            8999999985 8988886542   2468999999999999999999998   89999999999999998 8899999999


Q ss_pred             ceeeccCCCCCceeeeccCCCccCcccccC-CCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCc
Q 007869          409 LARLYDHGTDPQTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGE  487 (586)
Q Consensus       409 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~  487 (586)
                      +++....... ......+++.|+|||++.+ ..++.++||||||+++|||++|+.||......+..  ... ........
T Consensus       157 ~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~--~~~-~~~~~~~~  232 (295)
T cd07837         157 LGRAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQL--LHI-FKLLGTPT  232 (295)
T ss_pred             cceecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHH--HHH-HHHhCCCC
Confidence            9986543221 1223457889999998865 45789999999999999999999999764432211  000 00000000


Q ss_pred             c------cccc----CCCCC----ccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          488 L------LEAR----DPNLG----TEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       488 ~------~~~~----d~~l~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      .      ....    .+...    ....+.....+.+++.+||+.||.+||++.|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         233 EQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             hhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            0      0000    00000    0001123456788999999999999999999875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=6.4e-36  Score=302.79  Aligned_cols=258  Identities=21%  Similarity=0.248  Sum_probs=197.1

Q ss_pred             cccceeEeecCceEEEEEEeCCCCeEEEEEEecccc-chhHHHHHHHHHHhcccC-CCceeeeeeeeecc--CeEEEEEe
Q 007869          263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES-RQGMKEFVAEIVSIGRLR-HRNLVQLLGYCRRK--GELLLVYD  338 (586)
Q Consensus       263 f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~-H~niv~l~~~~~~~--~~~~lV~E  338 (586)
                      |+..+.||+|+||.||+|....++..||+|++.... .........|+..+.++. |+|++++++++...  +.+++|+|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            566788999999999999998889999999987542 222234567888999885 99999999999887  88999999


Q ss_pred             cCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCC
Q 007869          339 YMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD  418 (586)
Q Consensus       339 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~  418 (586)
                      |++ ++|.+.+.... ..++|.+++.++.|++.||.|||+   .+++||||||+||+++. +.+||+|||+++...... 
T Consensus        81 ~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~-  153 (282)
T cd07831          81 LMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHR---NGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP-  153 (282)
T ss_pred             cCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEcC-CCeEEEecccccccccCC-
Confidence            996 58888886543 468999999999999999999998   89999999999999999 999999999998764332 


Q ss_pred             CceeeeccCCCccCcccccC-CCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHh-----------hhccC
Q 007869          419 PQTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFD-----------FWNRG  486 (586)
Q Consensus       419 ~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~-----------~~~~~  486 (586)
                       ......++..|+|||++.. +.++.++|||||||++|||++|+.||...+..+   ...+...           .....
T Consensus       154 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  229 (282)
T cd07831         154 -PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD---QIAKIHDVLGTPDAEVLKKFRKS  229 (282)
T ss_pred             -CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH---HHHHHHHHcCCCCHHHHHhhccc
Confidence             2233467899999997654 557889999999999999999999997654322   1111111           11111


Q ss_pred             ccccccCCCCCc----cccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          487 ELLEARDPNLGT----EYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       487 ~~~~~~d~~l~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      .......+....    .........+.+++.+||+.+|++||++.++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         230 RHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             ccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            111111111100    011233577889999999999999999999986

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-35  Score=301.48  Aligned_cols=261  Identities=26%  Similarity=0.327  Sum_probs=198.9

Q ss_pred             cccceeEeecCceEEEEEEeCCCCeEEEEEEeccccc--hhHHHHHHHHHHhccc---CCCceeeeeeeeeccCe-----
Q 007869          263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR--QGMKEFVAEIVSIGRL---RHRNLVQLLGYCRRKGE-----  332 (586)
Q Consensus       263 f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l---~H~niv~l~~~~~~~~~-----  332 (586)
                      |++.+.||+|+||.||+|++..++..+|+|++.....  .....+.+|+.++.++   +|+|++++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            5678899999999999999988889999999974322  2234566777776655   69999999999988776     


Q ss_pred             EEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceee
Q 007869          333 LLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARL  412 (586)
Q Consensus       333 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~  412 (586)
                      .+++|||++ ++|.+++.......+++.+++.++.|+++||.|||+   .+++|+||||+||+++.++++||+|||++..
T Consensus        81 ~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~---~~i~h~~l~~~nili~~~~~~~l~dfg~~~~  156 (287)
T cd07838          81 LTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLARI  156 (287)
T ss_pred             eEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhEEEccCCCEEEeccCccee
Confidence            999999996 589998877554568999999999999999999998   8999999999999999999999999999987


Q ss_pred             ccCCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccc---
Q 007869          413 YDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELL---  489 (586)
Q Consensus       413 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~---  489 (586)
                      .....  ......++..|+|||++.+..++.++|+|||||++|||++|+.||......+..  ..+.......+...   
T Consensus       157 ~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~  232 (287)
T cd07838         157 YSFEM--ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQL--DKIFDVIGLPSEEEWPR  232 (287)
T ss_pred             ccCCc--ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHH--HHHHHHcCCCChHhcCC
Confidence            65432  222345788999999999889999999999999999999999998765432211  11111000000000   


Q ss_pred             ------cccCCCCC---ccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          490 ------EARDPNLG---TEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       490 ------~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                            ........   ..........+.+++.+||+.||.+||++.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence                  00000000   1112233466788999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=6.5e-36  Score=307.01  Aligned_cols=266  Identities=25%  Similarity=0.351  Sum_probs=197.6

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc--chhHHHHHHHHHHhcccCCCceeeeeeeeeccC-------
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES--RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKG-------  331 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~-------  331 (586)
                      ++|+..+.||+|+||.||+|....++..||||++....  ......+.+|++++++++||||++++++|...+       
T Consensus        12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   91 (310)
T cd07865          12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK   91 (310)
T ss_pred             hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence            47889999999999999999999889999999986542  222345678999999999999999999987643       


Q ss_pred             -eEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccce
Q 007869          332 -ELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLA  410 (586)
Q Consensus       332 -~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla  410 (586)
                       ..++||||+. ++|.+.+.... ..+++.+.+.++.|+++||.|||+   .+++|+||||+||+++.++.+||+|||++
T Consensus        92 ~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~  166 (310)
T cd07865          92 GSFYLVFEFCE-HDLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADFGLA  166 (310)
T ss_pred             ceEEEEEcCCC-cCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEECCCCcEEECcCCCc
Confidence             4599999996 58888876542 468999999999999999999998   89999999999999999999999999999


Q ss_pred             eeccCCCCC---ceeeeccCCCccCcccccCC-CCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhc--
Q 007869          411 RLYDHGTDP---QTTHVVGTLGYLAPEHTRTG-KATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWN--  484 (586)
Q Consensus       411 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~--  484 (586)
                      ..+......   ......++..|+|||++.+. .++.++||||||+++|||++|+.||...........+..+.....  
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (310)
T cd07865         167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE  246 (310)
T ss_pred             ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence            866432211   12234678899999988654 478899999999999999999999976543222222211111000  


Q ss_pred             ---cCcccc----ccCCCCCccccH------HHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          485 ---RGELLE----ARDPNLGTEYVA------EELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       485 ---~~~~~~----~~d~~l~~~~~~------~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                         ......    ...+........      .....+.+++.+||+.||.+|||+.|+++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         247 VWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             hcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence               000000    000000000000      01245678999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=5.1e-36  Score=298.73  Aligned_cols=249  Identities=23%  Similarity=0.368  Sum_probs=206.1

Q ss_pred             CcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc--cchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEec
Q 007869          262 GFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY  339 (586)
Q Consensus       262 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  339 (586)
                      +|+..+.||+|+||.||+++...++..+++|.+...  ......++..|++++++++|+||+++++++......++||||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            477889999999999999999888899999998754  233456788999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCC--CccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCC
Q 007869          340 MPNGSLDKYLYDQP--KVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT  417 (586)
Q Consensus       340 ~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~  417 (586)
                      +++++|.+++.+..  ...+++..++.++.|++.||.|||+   .+++|+||+|+||++++++.+||+|||+++..... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~---~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence            99999999986632  2468899999999999999999998   89999999999999999999999999999876543 


Q ss_pred             CCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCC
Q 007869          418 DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLG  497 (586)
Q Consensus       418 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~  497 (586)
                        ......++..|++||.+.+..++.++|+||||+++|||++|+.||......+   +...    ...+..     +.  
T Consensus       157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~---~~~~----~~~~~~-----~~--  220 (256)
T cd08530         157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD---LRYK----VQRGKY-----PP--  220 (256)
T ss_pred             --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHH----HhcCCC-----CC--
Confidence              2223468899999999998889999999999999999999999997654321   1111    111111     11  


Q ss_pred             ccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          498 TEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       498 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                        ........+.+++.+|++.+|++||++.++++.
T Consensus       221 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         221 --IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             --CchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence              122344668899999999999999999999863

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-38  Score=300.95  Aligned_cols=249  Identities=25%  Similarity=0.380  Sum_probs=210.8

Q ss_pred             CcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEecCC
Q 007869          262 GFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMP  341 (586)
Q Consensus       262 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~  341 (586)
                      -|.+.++||+|.||.||++.++.+|..+|||++.-++  ..+++..|+.++.+++.|++|+++|.+.....+++|||||-
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s--DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG  111 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT--DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG  111 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc--hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence            4777889999999999999999999999999986553  45789999999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCCce
Q 007869          342 NGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQT  421 (586)
Q Consensus       342 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~  421 (586)
                      .|++.+.++.+ +.+|.+..+..+++..++||+|||.   ..-||||||..||||+.+|.+||+|||.|-.+..... ..
T Consensus       112 AGSiSDI~R~R-~K~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA-KR  186 (502)
T KOG0574|consen  112 AGSISDIMRAR-RKPLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA-KR  186 (502)
T ss_pred             CCcHHHHHHHh-cCCccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccchhhhhhccccchhhhhHH-hh
Confidence            99999999766 4589999999999999999999998   7789999999999999999999999999986654322 33


Q ss_pred             eeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCcccc
Q 007869          422 THVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYV  501 (586)
Q Consensus       422 ~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~  501 (586)
                      .++.||+.|||||++..-.|+.++||||||++..||..|++||.+..+.....              +-.-.|...-..+
T Consensus       187 NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIF--------------MIPT~PPPTF~KP  252 (502)
T KOG0574|consen  187 NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIF--------------MIPTKPPPTFKKP  252 (502)
T ss_pred             CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeE--------------eccCCCCCCCCCh
Confidence            45789999999999999899999999999999999999999998654432111              1111122211223


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          502 AEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       502 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      ..-...+-+++..||-..|++|-|+.++++
T Consensus       253 E~WS~~F~DFi~~CLiK~PE~R~TA~~L~~  282 (502)
T KOG0574|consen  253 EEWSSEFNDFIRSCLIKKPEERKTALRLCE  282 (502)
T ss_pred             HhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence            444577889999999999999999998876

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=7e-36  Score=307.44  Aligned_cols=267  Identities=27%  Similarity=0.327  Sum_probs=199.9

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccc--hhHHHHHHHHHHhcccCCCceeeeeeeeecc--CeEEE
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR--QGMKEFVAEIVSIGRLRHRNLVQLLGYCRRK--GELLL  335 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~--~~~~l  335 (586)
                      .++|+..+.||+|+||.||+|.+..++..||+|++.....  .....+.+|+.++++++|+|++++++++...  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            4679999999999999999999998899999999875432  2233567899999999999999999998754  56899


Q ss_pred             EEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccC
Q 007869          336 VYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH  415 (586)
Q Consensus       336 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~  415 (586)
                      ||||+. ++|.+++.... ..+++.++..++.|+++||.|||+   .+++||||||+||++++++.+||+|||+++....
T Consensus        86 v~e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~  160 (309)
T cd07845          86 VMEYCE-QDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL  160 (309)
T ss_pred             EEecCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence            999996 58888886542 468999999999999999999998   8999999999999999999999999999987654


Q ss_pred             CCCCceeeeccCCCccCcccccC-CCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhh-H-------HHHhhhccC
Q 007869          416 GTDPQTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILV-D-------WVFDFWNRG  486 (586)
Q Consensus       416 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~-~-------~v~~~~~~~  486 (586)
                      ... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...+..+....+ +       ..|......
T Consensus       161 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (309)
T cd07845         161 PAK-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDL  239 (309)
T ss_pred             ccC-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcc
Confidence            321 2223346888999999865 45789999999999999999999999765433221111 0       000000000


Q ss_pred             cccccc--CCCCCccc---cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          487 ELLEAR--DPNLGTEY---VAEELELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       487 ~~~~~~--d~~l~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                      ......  ........   .......+.+++.+|++.||++|||+.++++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h  290 (309)
T cd07845         240 PLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES  290 (309)
T ss_pred             cccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            000000  00000000   00123456789999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=9.3e-36  Score=312.61  Aligned_cols=264  Identities=22%  Similarity=0.245  Sum_probs=201.0

Q ss_pred             hcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc--cchhHHHHHHHHHHhcccCCCceeeeeeeeecc------
Q 007869          259 ATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRK------  330 (586)
Q Consensus       259 a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~------  330 (586)
                      ..++|+..+.||+|+||.||+|....++..||+|++...  .....+.+.+|+.++++++||||+++++++...      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            457899999999999999999999988999999998643  233446678899999999999999999988643      


Q ss_pred             CeEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccce
Q 007869          331 GELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLA  410 (586)
Q Consensus       331 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla  410 (586)
                      ...++||||+. ++|.+.+...    +++.++..++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||++
T Consensus        94 ~~~~lv~e~~~-~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~  165 (353)
T cd07850          94 QDVYLVMELMD-ANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA  165 (353)
T ss_pred             CcEEEEEeccC-CCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCccc
Confidence            35799999995 5888877543    7888899999999999999998   89999999999999999999999999999


Q ss_pred             eeccCCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhh---------HH---
Q 007869          411 RLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILV---------DW---  478 (586)
Q Consensus       411 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~---------~~---  478 (586)
                      +......  ......++..|+|||++.+..++.++|||||||++|||++|+.||...+..+....+         ++   
T Consensus       166 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (353)
T cd07850         166 RTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSR  243 (353)
T ss_pred             eeCCCCC--CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence            8754322  223346889999999999999999999999999999999999999754321110000         00   


Q ss_pred             ----HHhhhccCc------ccccc----CCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          479 ----VFDFWNRGE------LLEAR----DPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       479 ----v~~~~~~~~------~~~~~----d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                          +.....+..      ..+..    .+.............+.+++.+|++.||++|||+.|+++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         244 LQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             hhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                000000000      00000    0000011111234567899999999999999999999853

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=8.7e-36  Score=296.71  Aligned_cols=250  Identities=25%  Similarity=0.414  Sum_probs=207.3

Q ss_pred             CcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccc--hhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEec
Q 007869          262 GFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR--QGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY  339 (586)
Q Consensus       262 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  339 (586)
                      +|+..+.||+|+||.||++.+..++..+++|++.....  ...+.+.+|++.+++++|+|++++++.+...+..++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            47788999999999999999988889999999976533  4567789999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCC--CccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCC
Q 007869          340 MPNGSLDKYLYDQP--KVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT  417 (586)
Q Consensus       340 ~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~  417 (586)
                      +++++|.+++....  ...+++..+..++.++++||.|||+   .+++|+||+|+||+++++++++|+|||.+.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            99999999997653  3578999999999999999999998   899999999999999999999999999998765443


Q ss_pred             CCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCC
Q 007869          418 DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLG  497 (586)
Q Consensus       418 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~  497 (586)
                       .......|++.|+|||......++.++||||+|+++++|++|+.||......+      ...... ...     .+.+.
T Consensus       158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~------~~~~~~-~~~-----~~~~~  224 (258)
T cd08215         158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLE------LALKIL-KGQ-----YPPIP  224 (258)
T ss_pred             -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHH------HHHHHh-cCC-----CCCCC
Confidence             22334578899999999988889999999999999999999999997543221      111111 111     11111


Q ss_pred             ccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          498 TEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       498 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      .    .....+.+++.+||..+|++||++.++++
T Consensus       225 ~----~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         225 S----QYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             C----CCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            1    22356778889999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.1e-35  Score=298.22  Aligned_cols=243  Identities=26%  Similarity=0.346  Sum_probs=197.5

Q ss_pred             EeecCceEEEEEEeCCCCeEEEEEEecccc---chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEecCCCCCh
Q 007869          269 LGTGGFGRVYRGTLPKSQIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSL  345 (586)
Q Consensus       269 LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL  345 (586)
                      ||+|++|.||+++...++..+|+|++....   ....+.+.+|++++++++||||+++++.+..++..++|+||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            689999999999998888999999986532   23456799999999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCCceeeec
Q 007869          346 DKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVV  425 (586)
Q Consensus       346 ~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~  425 (586)
                      .+++.+..  .+++..+..++.|+++||.|||+   .+++|+||||+||+++.++.+||+|||+++......  ......
T Consensus        81 ~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~  153 (262)
T cd05572          81 WTILRDRG--LFDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFC  153 (262)
T ss_pred             HHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccccc
Confidence            99997653  47888999999999999999998   999999999999999999999999999998765432  223356


Q ss_pred             cCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCccccHHHH
Q 007869          426 GTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAEEL  505 (586)
Q Consensus       426 gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~  505 (586)
                      ++..|++||.+....++.++|+||||+++|||++|+.||....... .   +...... .+.    ..+    .+.....
T Consensus       154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~---~~~~~~~-~~~----~~~----~~~~~~~  220 (262)
T cd05572         154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP-M---EIYNDIL-KGN----GKL----EFPNYID  220 (262)
T ss_pred             CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH-H---HHHHHHh-ccC----CCC----CCCcccC
Confidence            8899999999988889999999999999999999999997654211 1   1111111 000    001    1111224


Q ss_pred             HHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 007869          506 ELVLKLGLLCSHSDPTARPS-----MRQVVQ  531 (586)
Q Consensus       506 ~~l~~l~~~Cl~~dP~~RPs-----~~evl~  531 (586)
                      ..+.+++.+||+.+|++||+     ++|+++
T Consensus       221 ~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         221 KAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             HHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            56888999999999999999     666654

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=8e-37  Score=319.48  Aligned_cols=251  Identities=22%  Similarity=0.393  Sum_probs=200.5

Q ss_pred             cccceeEeecCceEEEEEEeCCCCeEEEEEEeccc----cchhHHHHHHHHHHhcccCCCceeeeeeeeeccC--eEEEE
Q 007869          263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE----SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKG--ELLLV  336 (586)
Q Consensus       263 f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~--~~~lV  336 (586)
                      .+...+||+|+|-+||||.+..+|.+||--.++..    +....+.|..|+.+|+.|+||||++++.++.+..  ...+|
T Consensus        42 ~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~i  121 (632)
T KOG0584|consen   42 LKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFI  121 (632)
T ss_pred             eehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeee
Confidence            34456799999999999999999988886655432    3444578999999999999999999999887654  48899


Q ss_pred             EecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCC-CCeEEccccceeeccC
Q 007869          337 YDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGE-LNGRLGDFGLARLYDH  415 (586)
Q Consensus       337 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~-~~~kL~DFGla~~~~~  415 (586)
                      +|.|..|+|..|+++..  .++......|++||++||.|||+. .++|||||||-.||||+.+ |.|||+|+|||..+..
T Consensus       122 TEL~TSGtLr~Y~kk~~--~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~  198 (632)
T KOG0584|consen  122 TELFTSGTLREYRKKHR--RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK  198 (632)
T ss_pred             eecccCCcHHHHHHHhc--cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence            99999999999998875  456668889999999999999984 5899999999999999875 8999999999998765


Q ss_pred             CCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCC
Q 007869          416 GTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPN  495 (586)
Q Consensus       416 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~  495 (586)
                      ..   ...++|||.|||||+.. ..|++..||||||++|+||+|+..||.......+++      +....|..-..+   
T Consensus       199 s~---aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIY------KKV~SGiKP~sl---  265 (632)
T KOG0584|consen  199 SH---AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIY------KKVTSGIKPAAL---  265 (632)
T ss_pred             cc---cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHH------HHHHcCCCHHHh---
Confidence            32   33489999999999987 789999999999999999999999998655433221      112222211111   


Q ss_pred             CCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHhh
Q 007869          496 LGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ--ILER  535 (586)
Q Consensus       496 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~  535 (586)
                           ..-....+.+++.+|+.. ..+|||+.|+|+  +|..
T Consensus       266 -----~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~  301 (632)
T KOG0584|consen  266 -----SKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDE  301 (632)
T ss_pred             -----hccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhcc
Confidence                 111123567888999999 999999999995  4544

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-35  Score=298.20  Aligned_cols=250  Identities=25%  Similarity=0.379  Sum_probs=199.5

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc-----cchhHHHHHHHHHHhcccCCCceeeeeeeeecc--CeE
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE-----SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRK--GEL  333 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~--~~~  333 (586)
                      .+|+..+.||+|+||.||+|.+..++..||+|.+...     ..+....+.+|++++++++|+||+++++++...  +.+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            4788999999999999999999888999999987532     233456789999999999999999999998754  568


Q ss_pred             EEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeec
Q 007869          334 LLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLY  413 (586)
Q Consensus       334 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~  413 (586)
                      ++|+||+++++|.+++....  .+++.....++.|++.||.|||+   .+++|+||||+||+++.++.++|+|||+++..
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~  156 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYG--ALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRI  156 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcccccccc
Confidence            89999999999999987643  47888889999999999999998   89999999999999999999999999999865


Q ss_pred             cCCCC--CceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccc
Q 007869          414 DHGTD--PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEA  491 (586)
Q Consensus       414 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~  491 (586)
                      .....  .......++..|+|||++.+..++.++|+|||||+++||++|+.||......+..      .+....     .
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~~~~~~-----~  225 (264)
T cd06653         157 QTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAI------FKIATQ-----P  225 (264)
T ss_pred             ccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHH------HHHHcC-----C
Confidence            43211  1223456899999999998888999999999999999999999999754322111      111100     0


Q ss_pred             cCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          492 RDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       492 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      ..+.    .+....+.+.+++..|++ +|.+||+..++++
T Consensus       226 ~~~~----~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         226 TKPM----LPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             CCCC----CCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence            1111    122333567778888999 5799999998875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1e-35  Score=301.60  Aligned_cols=263  Identities=25%  Similarity=0.330  Sum_probs=200.8

Q ss_pred             cccceeEeecCceEEEEEEeCCCCeEEEEEEeccccc-hhHHHHHHHHHHhcccC-CCceeeeeeeeeccCeEEEEEecC
Q 007869          263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR-QGMKEFVAEIVSIGRLR-HRNLVQLLGYCRRKGELLLVYDYM  340 (586)
Q Consensus       263 f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~-H~niv~l~~~~~~~~~~~lV~E~~  340 (586)
                      |+..+.||+|++|.||+|+...++..|+||++..... .......+|+..+++++ |+|++++++++..++..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            5677889999999999999988888999999865432 22234567999999998 999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCCc
Q 007869          341 PNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ  420 (586)
Q Consensus       341 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~  420 (586)
                       +|+|.+++.......+++.++..++.|++.+|.|||+   .+++|+||||+||++++++.++|+|||++.......  .
T Consensus        81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~--~  154 (283)
T cd07830          81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP--P  154 (283)
T ss_pred             -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCCEEEeecccceeccCCC--C
Confidence             8899999877654578999999999999999999998   899999999999999999999999999998654322  2


Q ss_pred             eeeeccCCCccCccccc-CCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhh----------HHHHhhhccCccc
Q 007869          421 TTHVVGTLGYLAPEHTR-TGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILV----------DWVFDFWNRGELL  489 (586)
Q Consensus       421 ~~~~~gt~~y~aPE~~~-~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~----------~~v~~~~~~~~~~  489 (586)
                      .....++..|+|||++. ...++.++|+||||++++||++|+.||......+.....          .|...........
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd07830         155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG  234 (283)
T ss_pred             cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence            23356889999999875 455799999999999999999999999765432211100          0111000000000


Q ss_pred             cccCCCCC---ccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          490 EARDPNLG---TEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       490 ~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      ........   ..........+.+++.+||+.+|++||+++|++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence            00000000   0111112366889999999999999999999975

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=3.7e-36  Score=313.47  Aligned_cols=266  Identities=25%  Similarity=0.344  Sum_probs=200.7

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc--cchhHHHHHHHHHHhccc-CCCceeeeeeeeecc--CeEE
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE--SRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRK--GELL  334 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~--~~~~  334 (586)
                      .++|+..+.||+|+||.||+|.+..++..+|+|++...  .......+..|+.+++++ +||||++++++|...  ...+
T Consensus         6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~   85 (337)
T cd07852           6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY   85 (337)
T ss_pred             hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence            46788889999999999999999888899999988542  233445678899999999 999999999988653  4689


Q ss_pred             EEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeecc
Q 007869          335 LVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYD  414 (586)
Q Consensus       335 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~  414 (586)
                      +||||++ ++|.+++...   .++|..+..++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||+++...
T Consensus        86 lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~  158 (337)
T cd07852          86 LVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSLS  158 (337)
T ss_pred             EEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccchhccc
Confidence            9999996 5999888654   67899999999999999999998   899999999999999999999999999998654


Q ss_pred             CCCC----CceeeeccCCCccCcccccC-CCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHh--------
Q 007869          415 HGTD----PQTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFD--------  481 (586)
Q Consensus       415 ~~~~----~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~--------  481 (586)
                      ....    .......|+..|+|||++.+ ..++.++||||||+++|||++|+.||......+..........        
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  238 (337)
T cd07852         159 ELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIE  238 (337)
T ss_pred             cccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence            3322    22334578999999998754 4578999999999999999999999975443221110000000        


Q ss_pred             hhc---cCccccccC-CC--CCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          482 FWN---RGELLEARD-PN--LGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       482 ~~~---~~~~~~~~d-~~--l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                      .+.   ...+..... ..  ............+.+++.+||+.||.+|||+.++++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         239 SIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence            000   000000000 00  0001111134567889999999999999999999864

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-35  Score=295.29  Aligned_cols=248  Identities=29%  Similarity=0.474  Sum_probs=205.6

Q ss_pred             CcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccc--hhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEec
Q 007869          262 GFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR--QGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY  339 (586)
Q Consensus       262 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  339 (586)
                      +|+..+.||+|++|.||+++...++..+++|.+.....  ...+.+.+|++++++++|+|++++++++...+..+++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            47778999999999999999988888999999977643  4567899999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCC
Q 007869          340 MPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP  419 (586)
Q Consensus       340 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~  419 (586)
                      +++++|.+++...  ..+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||++........ 
T Consensus        81 ~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-  154 (254)
T cd06627          81 AENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK-  154 (254)
T ss_pred             CCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc-
Confidence            9999999998765  468999999999999999999998   8999999999999999999999999999987654332 


Q ss_pred             ceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCcc
Q 007869          420 QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTE  499 (586)
Q Consensus       420 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~  499 (586)
                      ......++..|+|||...+..++.++||||+|++++||++|+.||.......    .  .+... .     ...+.+   
T Consensus       155 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~----~--~~~~~-~-----~~~~~~---  219 (254)
T cd06627         155 DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMA----A--LFRIV-Q-----DDHPPL---  219 (254)
T ss_pred             cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHH----H--HHHHh-c-----cCCCCC---
Confidence            1234568899999999988888999999999999999999999997543211    0  11111 0     011111   


Q ss_pred             ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          500 YVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       500 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                       .......+.+++.+|++.+|++||++.+++.
T Consensus       220 -~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         220 -PEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             -CCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence             1122356778889999999999999999974

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.1e-35  Score=301.76  Aligned_cols=243  Identities=24%  Similarity=0.302  Sum_probs=189.2

Q ss_pred             eEeecCceEEEEEEeCCCCeEEEEEEecccc---chhHHHHHHHHHHh---cccCCCceeeeeeeeeccCeEEEEEecCC
Q 007869          268 LLGTGGFGRVYRGTLPKSQIEIAVKKISHES---RQGMKEFVAEIVSI---GRLRHRNLVQLLGYCRRKGELLLVYDYMP  341 (586)
Q Consensus       268 ~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l---~~l~H~niv~l~~~~~~~~~~~lV~E~~~  341 (586)
                      .||+|+||.||++....++..+|+|.+....   ......+.+|..++   ...+|||++.+++++...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999998889999999886542   12223344444333   33479999999999999999999999999


Q ss_pred             CCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCCce
Q 007869          342 NGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQT  421 (586)
Q Consensus       342 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~  421 (586)
                      +++|.+++...  ..+++.+...++.|++.||.|||+   .+|+||||||+|||+++++.+||+|||++.......   .
T Consensus        81 ~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---~  152 (279)
T cd05633          81 GGDLHYHLSQH--GVFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---P  152 (279)
T ss_pred             CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC---c
Confidence            99999998765  358999999999999999999998   899999999999999999999999999997654322   2


Q ss_pred             eeeccCCCccCcccccC-CCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCccc
Q 007869          422 THVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEY  500 (586)
Q Consensus       422 ~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~  500 (586)
                      ....|+..|+|||.+.+ ..++.++|||||||++|||++|+.||..........+.    ...      ....+.+    
T Consensus       153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~----~~~------~~~~~~~----  218 (279)
T cd05633         153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID----RMT------LTVNVEL----  218 (279)
T ss_pred             cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHH----HHh------hcCCcCC----
Confidence            23468999999999864 45789999999999999999999999764432211111    100      0011111    


Q ss_pred             cHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHH
Q 007869          501 VAEELELVLKLGLLCSHSDPTARP-----SMRQVVQI  532 (586)
Q Consensus       501 ~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~  532 (586)
                      .......+.+++.+|++.||.+||     +++|+++.
T Consensus       219 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         219 PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             ccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence            122335677888899999999999     59888764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7e-37  Score=307.50  Aligned_cols=252  Identities=28%  Similarity=0.357  Sum_probs=206.7

Q ss_pred             hhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc---cchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEE
Q 007869          258 IATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELL  334 (586)
Q Consensus       258 ~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~  334 (586)
                      ...+.|+.-++||+||||.||-++.+.+|+.+|.|++.+.   .+++....++|-++|.+++.+.||.+--.|+.++.++
T Consensus       182 vt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LC  261 (591)
T KOG0986|consen  182 VTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALC  261 (591)
T ss_pred             ccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceE
Confidence            3446688999999999999999999999999999998654   3455667889999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeecc
Q 007869          335 LVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYD  414 (586)
Q Consensus       335 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~  414 (586)
                      ||+..|.||+|.-||.+.....+++....-++.+|+.||.+||.   .+||+||+||+|||||+.|+++|+|+|||..+.
T Consensus       262 lVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~---~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~  338 (591)
T KOG0986|consen  262 LVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHR---RRIVYRDLKPENILLDDHGHVRISDLGLAVEIP  338 (591)
T ss_pred             EEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHh---cceeeccCChhheeeccCCCeEeeccceEEecC
Confidence            99999999999999998877789999999999999999999998   899999999999999999999999999999876


Q ss_pred             CCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCC
Q 007869          415 HGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDP  494 (586)
Q Consensus       415 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~  494 (586)
                      .+..  ....+||.+|||||++.++.|+...|.|||||+||||+.|+.||..........   -+.+..     .  -|+
T Consensus       339 ~g~~--~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~e---Evdrr~-----~--~~~  406 (591)
T KOG0986|consen  339 EGKP--IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKRE---EVDRRT-----L--EDP  406 (591)
T ss_pred             CCCc--cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHH---HHHHHH-----h--cch
Confidence            6542  334489999999999999999999999999999999999999997644322110   011110     0  011


Q ss_pred             CCCccccHHHHHHHHHHHHHhcccCCCCCCCHH
Q 007869          495 NLGTEYVAEELELVLKLGLLCSHSDPTARPSMR  527 (586)
Q Consensus       495 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~  527 (586)
                         .+++....+....+....|+.||++|.-.+
T Consensus       407 ---~ey~~kFS~eakslc~~LL~Kdp~~RLGcr  436 (591)
T KOG0986|consen  407 ---EEYSDKFSEEAKSLCEGLLTKDPEKRLGCR  436 (591)
T ss_pred             ---hhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence               123333334444555556789999997533

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=5.1e-36  Score=299.84  Aligned_cols=247  Identities=25%  Similarity=0.370  Sum_probs=200.3

Q ss_pred             EeecCceEEEEEEeCCCCeEEEEEEeccccc---hhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEecCCCCCh
Q 007869          269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESR---QGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSL  345 (586)
Q Consensus       269 LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL  345 (586)
                      ||+|+||.||++++..++..+++|.+.....   ...+.+.+|++++++++||||+++++.+...+..+++|||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            6899999999999988899999999865433   4556789999999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCC-------
Q 007869          346 DKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD-------  418 (586)
Q Consensus       346 ~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~-------  418 (586)
                      .+++.+..  .+++..+..++.|+++||.|||+   .+++|+||+|+||++++++.+||+|||++........       
T Consensus        81 ~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  155 (265)
T cd05579          81 ASLLENVG--SLDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE  155 (265)
T ss_pred             HHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence            99997653  68899999999999999999998   8999999999999999999999999999886433211       


Q ss_pred             CceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCc
Q 007869          419 PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGT  498 (586)
Q Consensus       419 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~  498 (586)
                      .......++..|++||.......+.++||||||++++||++|+.||......+      ...... .+..    .+.  .
T Consensus       156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~------~~~~~~-~~~~----~~~--~  222 (265)
T cd05579         156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE------IFQNIL-NGKI----EWP--E  222 (265)
T ss_pred             ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHh-cCCc----CCC--c
Confidence            12234568889999999988889999999999999999999999997544221      111111 1111    000  0


Q ss_pred             cccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 007869          499 EYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER  535 (586)
Q Consensus       499 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  535 (586)
                        .......+.+++.+|++.+|.+||++.++.+.|+.
T Consensus       223 --~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~  257 (265)
T cd05579         223 --DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNH  257 (265)
T ss_pred             --cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcC
Confidence              00124667888999999999999999777776654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=9.2e-36  Score=301.62  Aligned_cols=262  Identities=26%  Similarity=0.346  Sum_probs=203.2

Q ss_pred             cccceeEeecCceEEEEEEeCCCCeEEEEEEeccccc--hhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEecC
Q 007869          263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR--QGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYM  340 (586)
Q Consensus       263 f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  340 (586)
                      |+..+.||+|++|.||+|....++..+++|++.....  .....+..|++++++++|+||+++++++...+..++|+||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            5567889999999999999988899999999876533  24567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCCc
Q 007869          341 PNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ  420 (586)
Q Consensus       341 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~  420 (586)
                      ++ +|.+++.... ..+++..++.++.|+++||.|||+   .+|+|+||||+||+++.++.+||+|||.+....... ..
T Consensus        81 ~~-~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~  154 (283)
T cd05118          81 DT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RP  154 (283)
T ss_pred             CC-CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-cc
Confidence            75 8888886643 478999999999999999999998   899999999999999999999999999998765433 12


Q ss_pred             eeeeccCCCccCcccccCC-CCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhh-H-------HHHhhhcc----Cc
Q 007869          421 TTHVVGTLGYLAPEHTRTG-KATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILV-D-------WVFDFWNR----GE  487 (586)
Q Consensus       421 ~~~~~gt~~y~aPE~~~~~-~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~-~-------~v~~~~~~----~~  487 (586)
                      .....++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+..+..... +       ..+....+    ..
T Consensus       155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd05118         155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYK  234 (283)
T ss_pred             ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhh
Confidence            2335678899999998776 7899999999999999999999999765432211110 0       00000000    00


Q ss_pred             c--ccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          488 L--LEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       488 ~--~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      .  ....+... ..........+.+++..||++||.+||++.+++.
T Consensus       235 ~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         235 FSFPKKAGMPL-PKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hhhccccccCH-HHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence            0  00000000 1112234567889999999999999999999985

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=1.5e-35  Score=307.85  Aligned_cols=260  Identities=23%  Similarity=0.267  Sum_probs=196.5

Q ss_pred             eeEeec--CceEEEEEEeCCCCeEEEEEEecccc--chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEecCCC
Q 007869          267 ELLGTG--GFGRVYRGTLPKSQIEIAVKKISHES--RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPN  342 (586)
Q Consensus       267 ~~LG~G--~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~  342 (586)
                      ..||+|  +||+||++.+..++..||+|.+....  ....+.+.+|+.+++.++||||++++++|...+..++|+||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            346666  99999999998889999999987542  33456789999999999999999999999999999999999999


Q ss_pred             CChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCCc--
Q 007869          343 GSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ--  420 (586)
Q Consensus       343 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~--  420 (586)
                      ++|.+++.......+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+|++||+.+..........  
T Consensus        84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (328)
T cd08226          84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV  160 (328)
T ss_pred             CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence            999999987655568899999999999999999998   899999999999999999999999998664332211110  


Q ss_pred             ----eeeeccCCCccCcccccCC--CCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHh-------------
Q 007869          421 ----TTHVVGTLGYLAPEHTRTG--KATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFD-------------  481 (586)
Q Consensus       421 ----~~~~~gt~~y~aPE~~~~~--~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~-------------  481 (586)
                          .....++..|+|||++.+.  .++.++|||||||++|||++|+.||........  +......             
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~  238 (328)
T cd08226         161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM--LLQKLKGPPYSPLDITTFPC  238 (328)
T ss_pred             cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH--HHHHhcCCCCCCccccccch
Confidence                1112346679999999764  478999999999999999999999976432211  1100000             


Q ss_pred             ---h-------h---------ccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          482 ---F-------W---------NRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       482 ---~-------~---------~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                         .       +         ..+......+..+...........+.+++.+||+.||++|||+.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~  307 (328)
T cd08226         239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS  307 (328)
T ss_pred             hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence               0       0         000000111111112222345567889999999999999999999985

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=6.3e-36  Score=311.83  Aligned_cols=265  Identities=23%  Similarity=0.313  Sum_probs=201.3

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc--cchhHHHHHHHHHHhcccCCCceeeeeeeeecc-----Ce
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRK-----GE  332 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~-----~~  332 (586)
                      .++|...+.||+|+||.||+++...++..||||++...  .......+..|+.++++++|+||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            45789999999999999999999988999999998653  233445678899999999999999999988644     35


Q ss_pred             EEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceee
Q 007869          333 LLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARL  412 (586)
Q Consensus       333 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~  412 (586)
                      .++||||+. ++|.+++...  ..+++.....++.|++.||.|||+   ++++||||||+|||++.++.+||+|||+++.
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~  157 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLART  157 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcCccccc
Confidence            899999995 7898888654  358889999999999999999998   8999999999999999999999999999987


Q ss_pred             ccCCCCCceeeeccCCCccCcccccC-CCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHH--------Hhhh
Q 007869          413 YDHGTDPQTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWV--------FDFW  483 (586)
Q Consensus       413 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v--------~~~~  483 (586)
                      ..... .......++..|+|||.+.. ..++.++|||||||++|||++|+.||......+......-+        +...
T Consensus       158 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (337)
T cd07858         158 TSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFI  236 (337)
T ss_pred             cCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhc
Confidence            64332 12233567899999998865 46889999999999999999999999754321111110000        0000


Q ss_pred             ccCccc-------cccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          484 NRGELL-------EARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       484 ~~~~~~-------~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                      ......       ...++... .........+.+++.+||+.+|++|||++++++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h  291 (337)
T cd07858         237 RNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH  291 (337)
T ss_pred             CchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence            000000       00011100 0111234567899999999999999999999865

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=5.6e-36  Score=311.80  Aligned_cols=267  Identities=24%  Similarity=0.311  Sum_probs=202.6

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc--chhHHHHHHHHHHhcccCCCceeeeeeeeec----cCeE
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES--RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRR----KGEL  333 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~----~~~~  333 (586)
                      .++|+..+.||+|++|.||+|....++..||+|++....  ....+.+.+|+.++++++||||+++++++..    ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            478899999999999999999999889999999987542  2345677889999999999999999998763    3568


Q ss_pred             EEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeec
Q 007869          334 LLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLY  413 (586)
Q Consensus       334 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~  413 (586)
                      ++||||+. ++|.+++...  ..+++.....++.|++.||.|||+   .+|+||||||+||++++++.+||+|||+++..
T Consensus        84 ~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~  157 (334)
T cd07855          84 YVVMDLME-SDLHHIIHSD--QPLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGL  157 (334)
T ss_pred             EEEEehhh-hhHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEecccccceee
Confidence            99999995 6899988654  348899999999999999999998   89999999999999999999999999999865


Q ss_pred             cCCCCC---ceeeeccCCCccCcccccC-CCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHH--------Hh
Q 007869          414 DHGTDP---QTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWV--------FD  481 (586)
Q Consensus       414 ~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v--------~~  481 (586)
                      ......   ......|+..|+|||.+.. ..++.++|||||||++|||++|+.||...............        .+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~  237 (334)
T cd07855         158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN  237 (334)
T ss_pred             cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhh
Confidence            433221   1234578999999998865 46889999999999999999999999765432211110000        00


Q ss_pred             hhccCccc---cccCCCCC---ccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          482 FWNRGELL---EARDPNLG---TEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       482 ~~~~~~~~---~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                      ......+.   +.......   ..........+.+++..|++.+|.+||++.++++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  294 (334)
T cd07855         238 RIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH  294 (334)
T ss_pred             hhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            00000000   00000000   01112235678899999999999999999999863

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-36  Score=304.20  Aligned_cols=247  Identities=25%  Similarity=0.344  Sum_probs=211.6

Q ss_pred             CcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccc--hhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEec
Q 007869          262 GFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR--QGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY  339 (586)
Q Consensus       262 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  339 (586)
                      =|..++.||+|.|..|-++++--+|..||||++.+..-  -....+.+|+..|+-++|||||+|+.+......+|||.|+
T Consensus        19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL   98 (864)
T KOG4717|consen   19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL   98 (864)
T ss_pred             eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence            47788999999999999999999999999999977532  3345688999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeee-cCCCCeEEccccceeeccCCCC
Q 007869          340 MPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLL-DGELNGRLGDFGLARLYDHGTD  418 (586)
Q Consensus       340 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll-~~~~~~kL~DFGla~~~~~~~~  418 (586)
                      -.+|+|.++|.+++. .+.+....+++.||..|+.|+|+   ..+|||||||+||.+ ..-|-+||.|||.+..+..+. 
T Consensus        99 GD~GDl~DyImKHe~-Gl~E~La~kYF~QI~~AI~YCHq---LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~-  173 (864)
T KOG4717|consen   99 GDGGDLFDYIMKHEE-GLNEDLAKKYFAQIVHAISYCHQ---LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK-  173 (864)
T ss_pred             cCCchHHHHHHhhhc-cccHHHHHHHHHHHHHHHHHHhh---hhhhcccCCcceeEEeeecCceEeeeccccccCCCcc-
Confidence            999999999988754 68888999999999999999998   899999999999766 566889999999998877654 


Q ss_pred             CceeeeccCCCccCcccccCCCCC-CcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCC
Q 007869          419 PQTTHVVGTLGYLAPEHTRTGKAT-TSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLG  497 (586)
Q Consensus       419 ~~~~~~~gt~~y~aPE~~~~~~~s-~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~  497 (586)
                       ..++.+|+..|-|||++.+..|+ ++.|||||||+||-|+||+.||+..+..+.+.               ..+|... 
T Consensus       174 -kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLT---------------mImDCKY-  236 (864)
T KOG4717|consen  174 -KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLT---------------MIMDCKY-  236 (864)
T ss_pred             -hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhh---------------hhhcccc-
Confidence             44567999999999999999885 68899999999999999999999877665332               2233322 


Q ss_pred             ccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          498 TEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       498 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                       ..+.....++.+|+..||..||.+|.+.+|++.
T Consensus       237 -tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  237 -TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             -cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence             223445667788889999999999999999975

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=1.2e-35  Score=303.46  Aligned_cols=245  Identities=25%  Similarity=0.340  Sum_probs=199.9

Q ss_pred             ceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEecCCCCCh
Q 007869          266 KELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSL  345 (586)
Q Consensus       266 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL  345 (586)
                      ...||+|+||.||++....++..||||++........+.+.+|+.++++++|+|++++++++...+..++||||+++++|
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  104 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL  104 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcH
Confidence            45799999999999999888999999998765555667799999999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCCceeeec
Q 007869          346 DKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVV  425 (586)
Q Consensus       346 ~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~  425 (586)
                      .+++...   .+++.....++.|++.+|.|||+   .+++||||||+||+++.++.++|+|||++....... .......
T Consensus       105 ~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-~~~~~~~  177 (292)
T cd06657         105 TDIVTHT---RMNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKSLV  177 (292)
T ss_pred             HHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEcccccceeccccc-ccccccc
Confidence            9987543   57888999999999999999998   899999999999999999999999999987654322 1223456


Q ss_pred             cCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCccccHHHH
Q 007869          426 GTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAEEL  505 (586)
Q Consensus       426 gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~  505 (586)
                      |+..|+|||++.+..++.++|+||||+++|||++|+.||......+.   ......         ...+.+..  .....
T Consensus       178 ~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~---~~~~~~---------~~~~~~~~--~~~~~  243 (292)
T cd06657         178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA---MKMIRD---------NLPPKLKN--LHKVS  243 (292)
T ss_pred             cCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHh---------hCCcccCC--cccCC
Confidence            89999999999888899999999999999999999999975432211   111110         01111100  11123


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          506 ELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       506 ~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      ..+.+++.+||+.+|.+||++.++++
T Consensus       244 ~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         244 PSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             HHHHHHHHHHHhCCcccCcCHHHHhc
Confidence            45677888999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.9e-36  Score=328.30  Aligned_cols=267  Identities=21%  Similarity=0.286  Sum_probs=188.3

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCe-EEEEE------------------EeccccchhHHHHHHHHHHhcccCCCce
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQI-EIAVK------------------KISHESRQGMKEFVAEIVSIGRLRHRNL  320 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~-~vavK------------------~~~~~~~~~~~~~~~Ei~~l~~l~H~ni  320 (586)
                      .++|++.+.||+|+||+||+|.++.... ..++|                  .+. ........+.+|+++|++++||||
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCCc
Confidence            3679999999999999999987643221 11212                  111 112234568899999999999999


Q ss_pred             eeeeeeeeccCeEEEEEecCCCCChhhhhhcCC---CccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeec
Q 007869          321 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQP---KVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLD  397 (586)
Q Consensus       321 v~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~  397 (586)
                      +++++++...+..++|+|++ .++|.+++....   .......+...|+.||+.||.|||+   ++|+||||||+|||++
T Consensus       226 v~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~---~gIiHrDLKP~NILl~  301 (501)
T PHA03210        226 LKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD---KKLIHRDIKLENIFLN  301 (501)
T ss_pred             CcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEC
Confidence            99999999999999999998 467777775432   1123345667899999999999998   8999999999999999


Q ss_pred             CCCCeEEccccceeeccCCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCC-CCCCCCCccchhh
Q 007869          398 GELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRP-IQRQGPSENLILV  476 (586)
Q Consensus       398 ~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p-~~~~~~~~~~~l~  476 (586)
                      .++.+||+|||+++.+............||..|+|||++.+..++.++|||||||++|||++|..+ +..........+.
T Consensus       302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~  381 (501)
T PHA03210        302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL  381 (501)
T ss_pred             CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence            999999999999987755433334456799999999999999999999999999999999998854 4332221111111


Q ss_pred             HHHH-----------------hhhccCccccccCCCCCccc-cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          477 DWVF-----------------DFWNRGELLEARDPNLGTEY-VAEELELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       477 ~~v~-----------------~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                      +...                 ........... ...+...+ .......+.+++.+|++.||.+|||+.|+++.
T Consensus       382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h  454 (501)
T PHA03210        382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHA-GHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL  454 (501)
T ss_pred             HHHHhcccChhhcCCcHHHHHHHhhhhhcccC-ccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            1110                 00000000000 00000000 00012345677889999999999999999863

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.6e-36  Score=311.64  Aligned_cols=256  Identities=25%  Similarity=0.392  Sum_probs=203.2

Q ss_pred             hhhhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc--cchhHHHHHHHHHHhccc-CCCceeeeeeeeeccCe
Q 007869          256 LYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE--SRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKGE  332 (586)
Q Consensus       256 l~~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~~~  332 (586)
                      +.+..+.|++.++||+||.++||++...+.+ .+|+|++...  +.+...-|.+|+..|.+| .|.+||+|++|-..++.
T Consensus       356 i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~-iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~  434 (677)
T KOG0596|consen  356 IKVKGREYEILKQIGSGGSSKVFKVLNSDKQ-IYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGY  434 (677)
T ss_pred             EEECcchhhHHHhhcCCCcceeeeeecCCCc-chhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCce
Confidence            4456678999999999999999999986554 5777766543  566778899999999999 59999999999999999


Q ss_pred             EEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceee
Q 007869          333 LLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARL  412 (586)
Q Consensus       333 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~  412 (586)
                      +|+||||- .-+|..+|.........| .+..+..|++.++.++|.   .+|||.||||.|+|+- .|.+||+|||+|..
T Consensus       435 lYmvmE~G-d~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~---~gIVHSDLKPANFLlV-kG~LKLIDFGIA~a  508 (677)
T KOG0596|consen  435 LYMVMECG-DIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQ---HGIVHSDLKPANFLLV-KGRLKLIDFGIANA  508 (677)
T ss_pred             EEEEeecc-cccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHH---hceeecCCCcccEEEE-eeeEEeeeechhcc
Confidence            99999986 569999998876655556 566789999999999998   9999999999999885 46899999999998


Q ss_pred             ccCCCCC-ceeeeccCCCccCcccccCC-----------CCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHH
Q 007869          413 YDHGTDP-QTTHVVGTLGYLAPEHTRTG-----------KATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVF  480 (586)
Q Consensus       413 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~-----------~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~  480 (586)
                      +..+... ....++||+.||+||.+...           +.+++||||||||+||+|+.|+.||.....       .|  
T Consensus       509 I~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n-------~~--  579 (677)
T KOG0596|consen  509 IQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN-------QI--  579 (677)
T ss_pred             cCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH-------HH--
Confidence            7665432 34567999999999987432           256799999999999999999999975321       11  


Q ss_pred             hhhccCccccccCCCCCccccHH-HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          481 DFWNRGELLEARDPNLGTEYVAE-ELELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       481 ~~~~~~~~~~~~d~~l~~~~~~~-~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                           .++....||...-+|+.- .-..+++++..||+.||++||++.|+|+.
T Consensus       580 -----aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh  627 (677)
T KOG0596|consen  580 -----AKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH  627 (677)
T ss_pred             -----HHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence                 123334455433333211 11228899999999999999999999864

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=5.1e-35  Score=299.12  Aligned_cols=258  Identities=20%  Similarity=0.275  Sum_probs=189.0

Q ss_pred             hcCCcccceeEeecCceEEEEEEeCCC---CeEEEEEEeccccchhH-----------HHHHHHHHHhcccCCCceeeee
Q 007869          259 ATKGFREKELLGTGGFGRVYRGTLPKS---QIEIAVKKISHESRQGM-----------KEFVAEIVSIGRLRHRNLVQLL  324 (586)
Q Consensus       259 a~~~f~~~~~LG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~-----------~~~~~Ei~~l~~l~H~niv~l~  324 (586)
                      ..++|.+.++||+|+||.||+|.+..+   +..+|+|..........           .....+...+..++|+|+++++
T Consensus        10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~   89 (294)
T PHA02882         10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY   89 (294)
T ss_pred             CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence            446899999999999999999998776   55677776543322111           1123344556677999999999


Q ss_pred             eeeeccC----eEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCC
Q 007869          325 GYCRRKG----ELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGEL  400 (586)
Q Consensus       325 ~~~~~~~----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~  400 (586)
                      +++....    ..++++|++. .++.+.+...  ...++..+..|+.|+++||.|||+   .+|+||||||+|||++.++
T Consensus        90 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~---~~iiHrDiKp~Nill~~~~  163 (294)
T PHA02882         90 GCGSFKRCRMYYRFILLEKLV-ENTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIHE---HGISHGDIKPENIMVDGNN  163 (294)
T ss_pred             EeeeEecCCceEEEEEEehhc-cCHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCC
Confidence            9766543    3467788763 4666665443  235677888999999999999998   8999999999999999999


Q ss_pred             CeEEccccceeeccCCCC------CceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccch
Q 007869          401 NGRLGDFGLARLYDHGTD------PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLI  474 (586)
Q Consensus       401 ~~kL~DFGla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~  474 (586)
                      .+||+|||+|+.+.....      .......||+.|+|||+..+..++.++|||||||++|||++|+.||..........
T Consensus       164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~  243 (294)
T PHA02882        164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI  243 (294)
T ss_pred             cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence            999999999987643221      11223469999999999999999999999999999999999999998764322211


Q ss_pred             h---hHHHHhhhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 007869          475 L---VDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILE  534 (586)
Q Consensus       475 l---~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  534 (586)
                      .   .++.. ...++...        .   ......+.+++..|++.+|++||++.++++.|+
T Consensus       244 ~~~~~~~~~-~~~~~~~~--------~---~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        244 HAAKCDFIK-RLHEGKIK--------I---KNANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             HHhHHHHHH-Hhhhhhhc--------c---CCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence            1   11111 11111110        0   112355778888899999999999999998763

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-35  Score=296.15  Aligned_cols=246  Identities=25%  Similarity=0.281  Sum_probs=192.9

Q ss_pred             eeEeecCceEEEEEEeCCCCeEEEEEEecccc---chhHHHHHHHHHH-hcccCCCceeeeeeeeeccCeEEEEEecCCC
Q 007869          267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHES---RQGMKEFVAEIVS-IGRLRHRNLVQLLGYCRRKGELLLVYDYMPN  342 (586)
Q Consensus       267 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~-l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~  342 (586)
                      +.||+|+||.||+|....++..||+|.+....   ......+..|..+ ....+|+|++++++++...+..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            46999999999999998888999999986542   2223344555544 4455899999999999999999999999999


Q ss_pred             CChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCCcee
Q 007869          343 GSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTT  422 (586)
Q Consensus       343 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~  422 (586)
                      ++|.+++....  .+++..+..++.|+++||.|||+   .+++||||+|+||++++++.+||+|||+++....     ..
T Consensus        82 ~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~  151 (260)
T cd05611          82 GDCASLIKTLG--GLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NK  151 (260)
T ss_pred             CCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEeecccceeccc-----cc
Confidence            99999997653  57888889999999999999998   8999999999999999999999999999886432     22


Q ss_pred             eeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCccccH
Q 007869          423 HVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVA  502 (586)
Q Consensus       423 ~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~  502 (586)
                      ...++..|+|||.+.+..++.++||||||+++|||++|..||......+       ++.....+...      .......
T Consensus       152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-------~~~~~~~~~~~------~~~~~~~  218 (260)
T cd05611         152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA-------VFDNILSRRIN------WPEEVKE  218 (260)
T ss_pred             cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH-------HHHHHHhcccC------CCCcccc
Confidence            3468899999999988888999999999999999999999997543321       11111111110      0001111


Q ss_pred             HHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 007869          503 EELELVLKLGLLCSHSDPTARPSMRQVVQILER  535 (586)
Q Consensus       503 ~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  535 (586)
                      .....+.+++.+||+.+|++||++.++.+.|..
T Consensus       219 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~  251 (260)
T cd05611         219 FCSPEAVDLINRLLCMDPAKRLGANGYQEIKSH  251 (260)
T ss_pred             cCCHHHHHHHHHHccCCHHHccCCCcHHHHHcC
Confidence            234567889999999999999988777666543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.1e-35  Score=308.68  Aligned_cols=262  Identities=24%  Similarity=0.298  Sum_probs=204.5

Q ss_pred             CcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc--chhHHHHHHHHHHhcccCCCceeeeeeeeeccC-----eEE
Q 007869          262 GFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES--RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKG-----ELL  334 (586)
Q Consensus       262 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~-----~~~  334 (586)
                      +|+..+.||+|++|.||+|+...++..||||++....  ....+.+..|+.++++++|+||+++++++...+     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            4778899999999999999998888999999987643  344567899999999999999999999988765     789


Q ss_pred             EEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeecc
Q 007869          335 LVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYD  414 (586)
Q Consensus       335 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~  414 (586)
                      ++|||++ ++|.+++....  .+++..++.++.|+++||.|||+   .+|+||||||+|||++.++.++|+|||++....
T Consensus        81 lv~e~~~-~~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~---~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~  154 (330)
T cd07834          81 IVTELME-TDLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVD  154 (330)
T ss_pred             EEecchh-hhHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccCceEeec
Confidence            9999997 58998886653  78999999999999999999998   899999999999999999999999999999765


Q ss_pred             CCCC--CceeeeccCCCccCcccccCC-CCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhc-------
Q 007869          415 HGTD--PQTTHVVGTLGYLAPEHTRTG-KATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWN-------  484 (586)
Q Consensus       415 ~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~-------  484 (586)
                      ....  .......++..|+|||++.+. .++.++|+||||+++|+|++|+.||......+...   .+.....       
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~---~i~~~~~~~~~~~~  231 (330)
T cd07834         155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLN---LIVEVLGTPSEEDL  231 (330)
T ss_pred             ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHH---HHHHhcCCCChhHh
Confidence            4321  123345688999999999887 78999999999999999999999997654322111   0100000       


Q ss_pred             ----cCccccc---cCCCCC---ccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          485 ----RGELLEA---RDPNLG---TEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       485 ----~~~~~~~---~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                          .......   ......   ..........+.+++.+||+.+|.+||++.++++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  289 (330)
T cd07834         232 KFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH  289 (330)
T ss_pred             hhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                0000000   000000   00111234567889999999999999999999973

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=6.5e-35  Score=294.10  Aligned_cols=245  Identities=21%  Similarity=0.266  Sum_probs=191.2

Q ss_pred             hcCCcccceeE--eecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhccc-CCCceeeeeeeeeccCeEEE
Q 007869          259 ATKGFREKELL--GTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKGELLL  335 (586)
Q Consensus       259 a~~~f~~~~~L--G~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~l  335 (586)
                      ..++|...+.+  |+|+||.||+++.+.++..+|+|.+........     |+.....+ +|||++++++++...+..++
T Consensus        12 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~i   86 (267)
T PHA03390         12 FLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGHVL   86 (267)
T ss_pred             HHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCeeEE
Confidence            34556665655  999999999999998999999999865422211     22222212 79999999999999999999


Q ss_pred             EEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCC-CeEEccccceeecc
Q 007869          336 VYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGEL-NGRLGDFGLARLYD  414 (586)
Q Consensus       336 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~-~~kL~DFGla~~~~  414 (586)
                      ||||+++++|.+++....  .+++.++..++.|+++||.|||+   .+++||||||+||+++.++ .++|+|||+++...
T Consensus        87 v~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~  161 (267)
T PHA03390         87 IMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG  161 (267)
T ss_pred             EEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEeCCCCeEEEecCccceecC
Confidence            999999999999997653  78999999999999999999998   8999999999999999988 99999999998654


Q ss_pred             CCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCC
Q 007869          415 HGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDP  494 (586)
Q Consensus       415 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~  494 (586)
                      ..     ....++..|+|||++.+..++.++|||||||++|||++|+.||..... +.....++....  .    .  ..
T Consensus       162 ~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~--~----~--~~  227 (267)
T PHA03390        162 TP-----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDED-EELDLESLLKRQ--Q----K--KL  227 (267)
T ss_pred             CC-----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCc-chhhHHHHHHhh--c----c--cC
Confidence            32     224688999999999988999999999999999999999999985432 222222222111  0    0  00


Q ss_pred             CCCccccHHHHHHHHHHHHHhcccCCCCCCC-HHHHHH
Q 007869          495 NLGTEYVAEELELVLKLGLLCSHSDPTARPS-MRQVVQ  531 (586)
Q Consensus       495 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-~~evl~  531 (586)
                      .    ........+.+++.+||+.+|.+||+ ++++++
T Consensus       228 ~----~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        228 P----FIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             C----cccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence            0    11123356778888999999999996 688874

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-37  Score=316.55  Aligned_cols=251  Identities=25%  Similarity=0.376  Sum_probs=207.7

Q ss_pred             CcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEecCC
Q 007869          262 GFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMP  341 (586)
Q Consensus       262 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~  341 (586)
                      -+.+...||.|+||+||+++.+.++...|-|++...+.+..++|+-||++|..+.||+||+|++.|...+.+++..|||.
T Consensus        33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~  112 (1187)
T KOG0579|consen   33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG  112 (1187)
T ss_pred             HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence            35667779999999999999998888888999988888889999999999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCCce
Q 007869          342 NGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQT  421 (586)
Q Consensus       342 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~  421 (586)
                      ||-.+..+-.-+ ..|.+.++.-+++|++.||.|||+   +.|||||||..|||++-+|.++|+|||.+...... ....
T Consensus       113 GGAVDaimlEL~-r~LtE~QIqvvc~q~ldALn~LHs---~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t-~qkR  187 (1187)
T KOG0579|consen  113 GGAVDAIMLELG-RVLTEDQIQVVCYQVLDALNWLHS---QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST-RQKR  187 (1187)
T ss_pred             CchHhHHHHHhc-cccchHHHHHHHHHHHHHHHHHhh---cchhhhhccccceEEEecCcEeeecccccccchhH-Hhhh
Confidence            999998887654 479999999999999999999998   99999999999999999999999999987653322 1233


Q ss_pred             eeeccCCCccCccccc-----CCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCC
Q 007869          422 THVVGTLGYLAPEHTR-----TGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNL  496 (586)
Q Consensus       422 ~~~~gt~~y~aPE~~~-----~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l  496 (586)
                      ....||++|||||+..     ..+|+.++||||||++|.||..+.+|-...++..  .++.          +.+.-.|.+
T Consensus       188 DsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMR--VllK----------iaKSePPTL  255 (1187)
T KOG0579|consen  188 DSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMR--VLLK----------IAKSEPPTL  255 (1187)
T ss_pred             ccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHH--HHHH----------HhhcCCCcc
Confidence            4578999999999864     4579999999999999999999999976654422  1111          111112222


Q ss_pred             CccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          497 GTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       497 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      ..  +..-...+.++...||..||..||++.++++
T Consensus       256 lq--PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  256 LQ--PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             cC--cchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence            21  2233456778888899999999999999886

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=2e-35  Score=303.50  Aligned_cols=266  Identities=26%  Similarity=0.338  Sum_probs=197.6

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccc--hhHHHHHHHHHHhcccCCCceeeeeeeeecc-------
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR--QGMKEFVAEIVSIGRLRHRNLVQLLGYCRRK-------  330 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~-------  330 (586)
                      .++|+..+.||+|+||.||+|+...++..+|||++.....  .....+.+|++++++++||||+++++++...       
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            4789999999999999999999988889999999865432  2234678899999999999999999987543       


Q ss_pred             -CeEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccc
Q 007869          331 -GELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGL  409 (586)
Q Consensus       331 -~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGl  409 (586)
                       ..+++|+||+.+ +|...+... ...+++.++..++.|+++||.|||+   .+|+||||||+||++++++.+||+|||+
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~  161 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFGL  161 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECcCcc
Confidence             347999999964 677776543 3468999999999999999999998   8999999999999999999999999999


Q ss_pred             eeeccCCCCC----------ceeeeccCCCccCcccccCC-CCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHH
Q 007869          410 ARLYDHGTDP----------QTTHVVGTLGYLAPEHTRTG-KATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDW  478 (586)
Q Consensus       410 a~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~-~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~  478 (586)
                      ++........          ..+...+++.|+|||.+.+. .++.++|||||||++|||++|+.||..............
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~  241 (311)
T cd07866         162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK  241 (311)
T ss_pred             chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            9865432211          12334678899999987654 578999999999999999999999976443221111100


Q ss_pred             H--------HhhhccCc------cccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          479 V--------FDFWNRGE------LLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       479 v--------~~~~~~~~------~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      .        +..+....      ......+.+... .......+.+++.+|++.||.+|||+.|+++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEER-FGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             HhCCCChhhchhhhhcccccccccCCCCCccHHHH-cccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            0        00000000      000000111000 0112256788999999999999999999875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=1.7e-35  Score=298.93  Aligned_cols=249  Identities=23%  Similarity=0.371  Sum_probs=204.1

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc---cchhHHHHHHHHHHhcccC-CCceeeeeeeeeccCeEEEE
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE---SRQGMKEFVAEIVSIGRLR-HRNLVQLLGYCRRKGELLLV  336 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~-H~niv~l~~~~~~~~~~~lV  336 (586)
                      ++|...+.||+|+||.||+++...++..||+|++...   .....+.+..|++++++++ ||||+++++++...+..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            4688899999999999999999888999999998653   2234467889999999998 99999999999999999999


Q ss_pred             EecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCC
Q 007869          337 YDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHG  416 (586)
Q Consensus       337 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~  416 (586)
                      |||+++++|.+++....  .+++..++.++.|++.||.|||+   .+++|+||||+||+++.+++++|+|||++......
T Consensus        81 ~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh~---~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~  155 (280)
T cd05581          81 LEYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN  155 (280)
T ss_pred             EcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence            99999999999997653  68999999999999999999998   89999999999999999999999999999865443


Q ss_pred             CC-------------------CceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhH
Q 007869          417 TD-------------------PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVD  477 (586)
Q Consensus       417 ~~-------------------~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~  477 (586)
                      ..                   .......++..|+|||......++.++||||||++++|+++|+.||.......   ...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~  232 (280)
T cd05581         156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL---TFQ  232 (280)
T ss_pred             cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH---HHH
Confidence            21                   12223467899999999988889999999999999999999999998654211   111


Q ss_pred             HHHhhhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCH----HHHHH
Q 007869          478 WVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSM----RQVVQ  531 (586)
Q Consensus       478 ~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~----~evl~  531 (586)
                      ...    .      ...    .+.......+.+++.+||+.+|.+||++    +++++
T Consensus       233 ~~~----~------~~~----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         233 KIL----K------LEY----SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             HHH----h------cCC----CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence            111    0      011    1111224567889999999999999999    66654

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=3.6e-35  Score=300.27  Aligned_cols=255  Identities=25%  Similarity=0.359  Sum_probs=197.3

Q ss_pred             hcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc-chhHHHHHHHHHHhcccC-CCceeeeeeeeeccCeEEEE
Q 007869          259 ATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES-RQGMKEFVAEIVSIGRLR-HRNLVQLLGYCRRKGELLLV  336 (586)
Q Consensus       259 a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~-H~niv~l~~~~~~~~~~~lV  336 (586)
                      .-++|+..+.||+|+||.||+|.+..++..||||++.... .....++..|+..+.+.. ||||++++++|......+++
T Consensus        13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v   92 (296)
T cd06618          13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC   92 (296)
T ss_pred             CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence            4467888999999999999999998888999999997543 234456777887777764 99999999999999999999


Q ss_pred             EecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCC
Q 007869          337 YDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHG  416 (586)
Q Consensus       337 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~  416 (586)
                      |||++ ++|.+++.... ..+++..+..++.|++.||.|||+  ..+|+||||+|+||++++++.+||+|||++..+...
T Consensus        93 ~e~~~-~~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~  168 (296)
T cd06618          93 MELMS-TCLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS  168 (296)
T ss_pred             eeccC-cCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence            99985 57777765533 378999999999999999999996  258999999999999999999999999999865432


Q ss_pred             CCCceeeeccCCCccCcccccCCC----CCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCcccccc
Q 007869          417 TDPQTTHVVGTLGYLAPEHTRTGK----ATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEAR  492 (586)
Q Consensus       417 ~~~~~~~~~gt~~y~aPE~~~~~~----~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~  492 (586)
                      .  ......++..|+|||++.+..    ++.++||||||+++|||++|+.||....... ..+.    ......      
T Consensus       169 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~----~~~~~~------  235 (296)
T cd06618         169 K--AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF-EVLT----KILQEE------  235 (296)
T ss_pred             C--cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH-HHHH----HHhcCC------
Confidence            2  122345788999999987554    7889999999999999999999996532211 0111    111110      


Q ss_pred             CCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          493 DPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       493 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                      .+....  .......+.+++.+||+.||.+||++.++++.
T Consensus       236 ~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         236 PPSLPP--NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             CCCCCC--CCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            011100  01123567888999999999999999999864

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=6.6e-35  Score=300.67  Aligned_cols=257  Identities=25%  Similarity=0.312  Sum_probs=191.6

Q ss_pred             eEeecCceEEEEEEeCCCCeEEEEEEeccc--cchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEecCCCCCh
Q 007869          268 LLGTGGFGRVYRGTLPKSQIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSL  345 (586)
Q Consensus       268 ~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL  345 (586)
                      .+|.|++  ||.++...++..||||++...  .....+.+..|++++++++|+||+++++++...+..+++|||+++++|
T Consensus         9 ~~~~~~~--v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l   86 (314)
T cd08216           9 CFEDLMI--VHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC   86 (314)
T ss_pred             hhcCCce--EEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCH
Confidence            3444444  455555557889999999765  344567899999999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCC------C
Q 007869          346 DKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD------P  419 (586)
Q Consensus       346 ~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~------~  419 (586)
                      .+++.......+++.....++.|+++||.|||+   .+|+||||||+||+++.++.+||+|||.+........      .
T Consensus        87 ~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~---~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~  163 (314)
T cd08216          87 EDLLKTHFPEGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHD  163 (314)
T ss_pred             HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCcceEEEecCCceEEecCccceeecccccccccccc
Confidence            999987544568888999999999999999998   8999999999999999999999999999875532211      1


Q ss_pred             ceeeeccCCCccCcccccCC--CCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhh----hcc-------C
Q 007869          420 QTTHVVGTLGYLAPEHTRTG--KATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDF----WNR-------G  486 (586)
Q Consensus       420 ~~~~~~gt~~y~aPE~~~~~--~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~----~~~-------~  486 (586)
                      ......++..|+|||++...  .++.++|||||||++|||++|+.||.......  .+.+.....    ...       .
T Consensus       164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  241 (314)
T cd08216         164 FPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVPCLLDKSTYPLYED  241 (314)
T ss_pred             ccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCccccccCchhhhcC
Confidence            12334578899999998653  57899999999999999999999997643221  111100000    000       0


Q ss_pred             cccc----ccCCCCC----ccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          487 ELLE----ARDPNLG----TEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       487 ~~~~----~~d~~l~----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      ....    ..++...    ..........+.+++.+||+.||++|||+.++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  294 (314)
T cd08216         242 SMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN  294 (314)
T ss_pred             CcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence            0000    0011100    1112233456788999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=5.4e-35  Score=300.93  Aligned_cols=248  Identities=29%  Similarity=0.418  Sum_probs=198.1

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc---cchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEE
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY  337 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  337 (586)
                      +.|...+.||+|+||.||+|+...++..+|+|.+...   .....+++.+|++++++++|+|++++++++...+..++||
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            3466778899999999999999888889999998643   2334567889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCC
Q 007869          338 DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT  417 (586)
Q Consensus       338 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~  417 (586)
                      ||+. |+|.+.+.... ..+++.++..++.|++.||.|||+   .+++||||||+||+++.++.+||+|||++...... 
T Consensus        95 e~~~-~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-  168 (308)
T cd06634          95 EYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-  168 (308)
T ss_pred             EccC-CCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHhEEECCCCcEEECCcccceeecCc-
Confidence            9996 68887775442 357889999999999999999998   89999999999999999999999999998865432 


Q ss_pred             CCceeeeccCCCccCccccc---CCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCC
Q 007869          418 DPQTTHVVGTLGYLAPEHTR---TGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDP  494 (586)
Q Consensus       418 ~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~  494 (586)
                          ....++..|+|||++.   ...++.++|||||||++|||++|+.||......+.      ... ...+.     .+
T Consensus       169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~------~~~-~~~~~-----~~  232 (308)
T cd06634         169 ----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYH-IAQNE-----SP  232 (308)
T ss_pred             ----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHH------HHH-HhhcC-----CC
Confidence                2346889999999974   35678899999999999999999999865432211      110 11111     11


Q ss_pred             CCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 007869          495 NLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQIL  533 (586)
Q Consensus       495 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L  533 (586)
                      ...   .......+.+++.+||+.+|++||++.++++..
T Consensus       233 ~~~---~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~  268 (308)
T cd06634         233 ALQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR  268 (308)
T ss_pred             CcC---cccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence            111   112335577889999999999999999998753

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2e-35  Score=308.80  Aligned_cols=266  Identities=21%  Similarity=0.281  Sum_probs=197.0

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc--cchhHHHHHHHHHHhcccCCCceeeeeeeeecc------C
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRK------G  331 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~------~  331 (586)
                      .++|...+.||+|+||.||+|+...++..||||++...  .......+.+|+.++++++||||+++++++...      .
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            36899999999999999999999888899999998653  222345688999999999999999999988754      3


Q ss_pred             eEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEcccccee
Q 007869          332 ELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR  411 (586)
Q Consensus       332 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~  411 (586)
                      ..++|+||+. .+|..++.    ..+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||+++
T Consensus        94 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dlkp~NIll~~~~~~kL~dfg~~~  165 (342)
T cd07879          94 DFYLVMPYMQ-TDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLAR  165 (342)
T ss_pred             eEEEEecccc-cCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCCCCc
Confidence            4699999996 47776652    257888999999999999999998   899999999999999999999999999988


Q ss_pred             eccCCCCCceeeeccCCCccCcccccC-CCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHH--------Hhh
Q 007869          412 LYDHGTDPQTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWV--------FDF  482 (586)
Q Consensus       412 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v--------~~~  482 (586)
                      ....    ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...............        .+.
T Consensus       166 ~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (342)
T cd07879         166 HADA----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQK  241 (342)
T ss_pred             CCCC----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence            6432    1223467889999999876 46889999999999999999999999864322111100000        000


Q ss_pred             hccCc---cccccCCCCCccc---cHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHhhcc
Q 007869          483 WNRGE---LLEARDPNLGTEY---VAEELELVLKLGLLCSHSDPTARPSMRQVVQ--ILERDV  537 (586)
Q Consensus       483 ~~~~~---~~~~~d~~l~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~~~  537 (586)
                      ..+..   .............   .+.....+.+++..||+.||++||++.++++  .++...
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~  304 (342)
T cd07879         242 LEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR  304 (342)
T ss_pred             hcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence            00000   0000000000000   0112345778999999999999999999984  355443

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=7.4e-35  Score=302.70  Aligned_cols=266  Identities=23%  Similarity=0.280  Sum_probs=201.9

Q ss_pred             hhhhhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc--cchhHHHHHHHHHHhcccCCCceeeeeeeeec-cC
Q 007869          255 DLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRR-KG  331 (586)
Q Consensus       255 el~~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~-~~  331 (586)
                      ++...+++|+..+.||+|+||.||++....++..||+|++...  .....+.+..|++++++++||||+++++++.. .+
T Consensus         4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   83 (328)
T cd07856           4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE   83 (328)
T ss_pred             ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence            4456788999999999999999999999989999999988643  22344678899999999999999999998865 56


Q ss_pred             eEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEcccccee
Q 007869          332 ELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR  411 (586)
Q Consensus       332 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~  411 (586)
                      ..++++||+ +++|.+++...   .+++.....++.|+++||.|||+   .+|+||||||+|||+++++.+||+|||++.
T Consensus        84 ~~~lv~e~~-~~~L~~~~~~~---~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~Nili~~~~~~~l~dfg~~~  156 (328)
T cd07856          84 DIYFVTELL-GTDLHRLLTSR---PLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLAR  156 (328)
T ss_pred             cEEEEeehh-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEeECCCCCEEeCcccccc
Confidence            789999999 56898888643   47778888899999999999998   899999999999999999999999999998


Q ss_pred             eccCCCCCceeeeccCCCccCcccccC-CCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccch-hh--------HHHHh
Q 007869          412 LYDHGTDPQTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLI-LV--------DWVFD  481 (586)
Q Consensus       412 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~-l~--------~~v~~  481 (586)
                      .....    .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||.......... +.        +|...
T Consensus       157 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (328)
T cd07856         157 IQDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT  232 (328)
T ss_pred             ccCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            54322    223467889999998766 568999999999999999999999997543211110 00        11110


Q ss_pred             hhccCcccccc-CCCCCcccc-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          482 FWNRGELLEAR-DPNLGTEYV-----AEELELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       482 ~~~~~~~~~~~-d~~l~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                      .... ...+.. .-.......     ......+.+++.+|++.+|++||++.+++..
T Consensus       233 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         233 ICSE-NTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             ccch-hhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            0000 000000 000000001     1123678889999999999999999999754

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=6.2e-35  Score=303.93  Aligned_cols=263  Identities=21%  Similarity=0.286  Sum_probs=198.3

Q ss_pred             CCcc-cceeEeecCceEEEEEEeCCCCeEEEEEEeccccchh--------------HHHHHHHHHHhcccCCCceeeeee
Q 007869          261 KGFR-EKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQG--------------MKEFVAEIVSIGRLRHRNLVQLLG  325 (586)
Q Consensus       261 ~~f~-~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~--------------~~~~~~Ei~~l~~l~H~niv~l~~  325 (586)
                      ++|. ..+.||+|+||.||+|.+..+++.||||++.......              ...+.+|++++++++|+||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            3454 4577999999999999998889999999986542211              125788999999999999999999


Q ss_pred             eeeccCeEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEc
Q 007869          326 YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLG  405 (586)
Q Consensus       326 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~  405 (586)
                      ++...+..++||||++ |+|.+++...  ..+++.....++.|++.||.|||+   .+++||||||+||+++.++.+||+
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~---~~i~H~dl~~~nill~~~~~~kl~  161 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDRK--IRLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGICKIA  161 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHeEECCCCCEEEC
Confidence            9999999999999996 6999988654  357888999999999999999998   899999999999999999999999


Q ss_pred             cccceeeccCCC-------------CCceeeeccCCCccCcccccCC-CCCCcceEEehhHHHHHHHhCCCCCCCCCCCc
Q 007869          406 DFGLARLYDHGT-------------DPQTTHVVGTLGYLAPEHTRTG-KATTSADVFSFGAFLLEVACGRRPIQRQGPSE  471 (586)
Q Consensus       406 DFGla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~  471 (586)
                      |||+++......             ........++..|+|||++.+. .++.++|||||||++|||++|+.||......+
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~  241 (335)
T PTZ00024        162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEID  241 (335)
T ss_pred             CccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            999998764111             1111223568899999998764 46899999999999999999999997654322


Q ss_pred             cchhhHHHHhhhccCcc-----------ccccCCCCC---ccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          472 NLILVDWVFDFWNRGEL-----------LEARDPNLG---TEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       472 ~~~l~~~v~~~~~~~~~-----------~~~~d~~l~---~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                      .   ...+........-           .....+...   ..........+.+++..|++.+|++||++.|++..
T Consensus       242 ~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~  313 (335)
T PTZ00024        242 Q---LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH  313 (335)
T ss_pred             H---HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence            1   1111111111000           000000000   00011224567889999999999999999999863

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=1.4e-34  Score=293.25  Aligned_cols=242  Identities=24%  Similarity=0.302  Sum_probs=189.0

Q ss_pred             eEeecCceEEEEEEeCCCCeEEEEEEeccccc---hhHHHHHHHHH---HhcccCCCceeeeeeeeeccCeEEEEEecCC
Q 007869          268 LLGTGGFGRVYRGTLPKSQIEIAVKKISHESR---QGMKEFVAEIV---SIGRLRHRNLVQLLGYCRRKGELLLVYDYMP  341 (586)
Q Consensus       268 ~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~Ei~---~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~  341 (586)
                      +||+|+||.||++....+++.||+|.+.....   .....+..|..   .++...||||+++++++...+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            48999999999999988889999999875421   22223444433   4444589999999999999999999999999


Q ss_pred             CCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCCce
Q 007869          342 NGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQT  421 (586)
Q Consensus       342 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~  421 (586)
                      +++|.+++...  ..+++..+..++.|+++||.|||+   .+|+||||||+||+++.++.+||+|||+++......   .
T Consensus        81 g~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---~  152 (278)
T cd05606          81 GGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---P  152 (278)
T ss_pred             CCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC---C
Confidence            99999988654  368999999999999999999998   899999999999999999999999999997654322   2


Q ss_pred             eeeccCCCccCcccccCC-CCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCccc
Q 007869          422 THVVGTLGYLAPEHTRTG-KATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEY  500 (586)
Q Consensus       422 ~~~~gt~~y~aPE~~~~~-~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~  500 (586)
                      ....|+..|+|||++.++ .++.++|||||||++|||++|+.||..........    .....      ....+.+..  
T Consensus       153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~----~~~~~------~~~~~~~~~--  220 (278)
T cd05606         153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE----IDRMT------LTMAVELPD--  220 (278)
T ss_pred             cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH----HHHHh------hccCCCCCC--
Confidence            234689999999998754 58999999999999999999999997653322111    00000      011111211  


Q ss_pred             cHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 007869          501 VAEELELVLKLGLLCSHSDPTARP-----SMRQVVQ  531 (586)
Q Consensus       501 ~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~  531 (586)
                        .....+.+++.+|++.+|.+||     ++.++++
T Consensus       221 --~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         221 --SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             --cCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence              1235677888899999999999     8999875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=1.3e-34  Score=298.77  Aligned_cols=245  Identities=27%  Similarity=0.413  Sum_probs=195.5

Q ss_pred             cccceeEeecCceEEEEEEeCCCCeEEEEEEecccc---chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEec
Q 007869          263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY  339 (586)
Q Consensus       263 f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  339 (586)
                      |...+.||+|+||.||+|+...++..|++|++....   ....+.+.+|++++++++|||++++++++.+....++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            455677999999999999998889999999986532   23345788999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCC
Q 007869          340 MPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP  419 (586)
Q Consensus       340 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~  419 (586)
                      +. |+|.+++... ...+++.++..++.|++.+|.|||+   .+++||||||+||+++.++.+||+|||++....     
T Consensus       103 ~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~-----  172 (313)
T cd06633         103 CL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSS-----  172 (313)
T ss_pred             CC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChhhEEECCCCCEEEeecCCCcccC-----
Confidence            95 6787777554 2468999999999999999999998   899999999999999999999999999986432     


Q ss_pred             ceeeeccCCCccCccccc---CCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCC
Q 007869          420 QTTHVVGTLGYLAPEHTR---TGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNL  496 (586)
Q Consensus       420 ~~~~~~gt~~y~aPE~~~---~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l  496 (586)
                      ......|+..|+|||++.   ...++.++|||||||++|||++|+.||........   .   ...... .     .+..
T Consensus       173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~---~---~~~~~~-~-----~~~~  240 (313)
T cd06633         173 PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA---L---YHIAQN-D-----SPTL  240 (313)
T ss_pred             CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH---H---HHHHhc-C-----CCCC
Confidence            122356889999999984   45688999999999999999999999876533211   1   111100 1     1111


Q ss_pred             CccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          497 GTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       497 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                      .   .......+.+++.+||+.+|.+||++.++++.
T Consensus       241 ~---~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         241 Q---SNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             C---ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            1   11122457788899999999999999999854

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-35  Score=281.85  Aligned_cols=252  Identities=25%  Similarity=0.358  Sum_probs=201.0

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc-cchhHHHHHHHHHHhcccC-CCceeeeeeeeeccCeEEEEEe
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE-SRQGMKEFVAEIVSIGRLR-HRNLVQLLGYCRRKGELLLVYD  338 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~-H~niv~l~~~~~~~~~~~lV~E  338 (586)
                      ++.+....||.|..|.|++++.+.++..+|||.+... +.+..+.++..+.++.+-+ +|+||+.+|||..+...++-||
T Consensus        92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe  171 (391)
T KOG0983|consen   92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME  171 (391)
T ss_pred             HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence            3444566799999999999999999999999999775 4555677888888777664 8999999999999999999999


Q ss_pred             cCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCC
Q 007869          339 YMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD  418 (586)
Q Consensus       339 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~  418 (586)
                      .| ...++.++.+- +.++++...-++...+.+||.||.+  .++|+|||+||+|||+|+.|++||||||++-.+-... 
T Consensus       172 lM-s~C~ekLlkri-k~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk-  246 (391)
T KOG0983|consen  172 LM-STCAEKLLKRI-KGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK-  246 (391)
T ss_pred             HH-HHHHHHHHHHh-cCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeeccc-
Confidence            99 44666666554 4578888888999999999999998  6899999999999999999999999999997654332 


Q ss_pred             CceeeeccCCCccCcccccC---CCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCC
Q 007869          419 PQTTHVVGTLGYLAPEHTRT---GKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPN  495 (586)
Q Consensus       419 ~~~~~~~gt~~y~aPE~~~~---~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~  495 (586)
                       ..+...|-+.|||||-+.-   .+|+-++||||||+.|+||.||+.||......- ..+.          ++....-|.
T Consensus       247 -AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdF-e~lt----------kvln~ePP~  314 (391)
T KOG0983|consen  247 -AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDF-EVLT----------KVLNEEPPL  314 (391)
T ss_pred             -ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccH-HHHH----------HHHhcCCCC
Confidence             3456789999999998853   468899999999999999999999998754321 1111          111222244


Q ss_pred             CCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          496 LGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       496 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      +...  ......+++++..||++|+.+||...++++
T Consensus       315 L~~~--~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  315 LPGH--MGFSPDFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             CCcc--cCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence            4322  124456778888899999999999999886

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-35  Score=312.70  Aligned_cols=203  Identities=33%  Similarity=0.477  Sum_probs=176.4

Q ss_pred             cccceeEeecCceEEEEEEeCCCCeEEEEEEecccc-chhHHHHHHHHHHhcccCCCceeeeeeeeeccC------eEEE
Q 007869          263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKG------ELLL  335 (586)
Q Consensus       263 f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~------~~~l  335 (586)
                      +...+.||+||||.||+|+++.+|..||||.+.... ....+....|+++|++++|+|||++++.-+...      ...+
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl   94 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL   94 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence            345677999999999999999999999999997753 344566788999999999999999999866543      6799


Q ss_pred             EEecCCCCChhhhhhcCCC-ccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeec----CCCCeEEccccce
Q 007869          336 VYDYMPNGSLDKYLYDQPK-VTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLD----GELNGRLGDFGLA  410 (586)
Q Consensus       336 V~E~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~----~~~~~kL~DFGla  410 (586)
                      |||||.+|||...|.+.+. ..|++.+.+.++.+++.||.|||+   ++|+||||||.||++-    ..-.-||+|||.|
T Consensus        95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrE---n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A  171 (732)
T KOG4250|consen   95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRE---NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA  171 (732)
T ss_pred             EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHH---cCceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence            9999999999999976543 679999999999999999999997   9999999999999993    3334799999999


Q ss_pred             eeccCCCCCceeeeccCCCccCccccc-CCCCCCcceEEehhHHHHHHHhCCCCCCCCCCC
Q 007869          411 RLYDHGTDPQTTHVVGTLGYLAPEHTR-TGKATTSADVFSFGAFLLEVACGRRPIQRQGPS  470 (586)
Q Consensus       411 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~  470 (586)
                      +-++.+.  ..+..+||..|.+||+.. .+.|+...|.|||||++||.+||..||......
T Consensus       172 rel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p  230 (732)
T KOG4250|consen  172 RELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP  230 (732)
T ss_pred             ccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence            9877654  667789999999999998 488999999999999999999999999765443

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.8e-35  Score=304.28  Aligned_cols=270  Identities=23%  Similarity=0.292  Sum_probs=202.4

Q ss_pred             chhhhhhhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc--chhHHHHHHHHHHhcccCCCceeeeeeeeec
Q 007869          252 RYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES--RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRR  329 (586)
Q Consensus       252 ~~~el~~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~  329 (586)
                      ...++...+++|...+.||+|+||.||+|....++..||+|++....  ....+.+.+|+.++++++||||+++++++..
T Consensus         8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~   87 (345)
T cd07877           8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP   87 (345)
T ss_pred             HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence            34566778899999999999999999999998889999999987532  2334668889999999999999999998754


Q ss_pred             c------CeEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeE
Q 007869          330 K------GELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGR  403 (586)
Q Consensus       330 ~------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~k  403 (586)
                      .      ...++++|++ +++|.+++...   .+++..+..++.|+++||.|||+   .+|+||||||+||++++++.+|
T Consensus        88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~k  160 (345)
T cd07877          88 ARSLEEFNDVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELK  160 (345)
T ss_pred             cccccccccEEEEehhc-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEcCCCCEE
Confidence            3      3478888887 78998887543   58899999999999999999998   8999999999999999999999


Q ss_pred             EccccceeeccCCCCCceeeeccCCCccCcccccC-CCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhh-H----
Q 007869          404 LGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILV-D----  477 (586)
Q Consensus       404 L~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~-~----  477 (586)
                      |+|||+++....    ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||............ +    
T Consensus       161 l~dfg~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  236 (345)
T cd07877         161 ILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT  236 (345)
T ss_pred             Eecccccccccc----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            999999886432    2233567899999999866 46889999999999999999999999654332211100 0    


Q ss_pred             ---HHHhhhccCc---cccccCCCCCccc---cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          478 ---WVFDFWNRGE---LLEARDPNLGTEY---VAEELELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       478 ---~v~~~~~~~~---~~~~~d~~l~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                         ..........   ............+   .......+.+++..|++.||.+||++.++++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         237 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             CCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence               0000000000   0000000000000   00123457789999999999999999999853

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=7.8e-35  Score=296.36  Aligned_cols=256  Identities=24%  Similarity=0.313  Sum_probs=201.5

Q ss_pred             CcccceeEeecCceEEEEEEeC---CCCeEEEEEEecccc----chhHHHHHHHHHHhccc-CCCceeeeeeeeeccCeE
Q 007869          262 GFREKELLGTGGFGRVYRGTLP---KSQIEIAVKKISHES----RQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKGEL  333 (586)
Q Consensus       262 ~f~~~~~LG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~~~~  333 (586)
                      +|+..+.||+|++|.||+++..   .++..||||.+....    ....+.+..|++++.++ +||||+++++.+......
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            4778899999999999999863   356789999986532    22345688999999999 599999999999999999


Q ss_pred             EEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeec
Q 007869          334 LLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLY  413 (586)
Q Consensus       334 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~  413 (586)
                      ++||||+++++|.+++...  ..+++.....++.|++++|.|||+   .+++||||||+||+++.++.++|+|||+++..
T Consensus        81 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~  155 (288)
T cd05583          81 HLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEF  155 (288)
T ss_pred             EEEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence            9999999999999998754  357888999999999999999998   89999999999999999999999999999875


Q ss_pred             cCCCCCceeeeccCCCccCcccccCCC--CCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccc
Q 007869          414 DHGTDPQTTHVVGTLGYLAPEHTRTGK--ATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEA  491 (586)
Q Consensus       414 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~  491 (586)
                      ............|+..|+|||.+.+..  .+.++||||||+++|||++|+.||.......  ...+.......       
T Consensus       156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~-------  226 (288)
T cd05583         156 LAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQN--SQSEISRRILK-------  226 (288)
T ss_pred             ccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccc--hHHHHHHHHHc-------
Confidence            543332333456899999999987665  7889999999999999999999996432211  11111111111       


Q ss_pred             cCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 007869          492 RDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER  535 (586)
Q Consensus       492 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  535 (586)
                      ..+.....    ....+.+++.+||+.||++|||+.++.+.|+.
T Consensus       227 ~~~~~~~~----~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         227 SKPPFPKT----MSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             cCCCCCcc----cCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence            11111111    22456778889999999999999999888765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=1.4e-34  Score=294.84  Aligned_cols=252  Identities=23%  Similarity=0.319  Sum_probs=197.3

Q ss_pred             CcccceeEeecCceEEEEEEeC---CCCeEEEEEEecccc----chhHHHHHHHHHHhccc-CCCceeeeeeeeeccCeE
Q 007869          262 GFREKELLGTGGFGRVYRGTLP---KSQIEIAVKKISHES----RQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKGEL  333 (586)
Q Consensus       262 ~f~~~~~LG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~~~~  333 (586)
                      +|+..+.||+|+||.||++...   .++..||+|++....    ....+.+..|++++.++ +|+||+++++++..++..
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            4778899999999999999874   367889999986532    22346688899999999 599999999999999999


Q ss_pred             EEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeec
Q 007869          334 LLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLY  413 (586)
Q Consensus       334 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~  413 (586)
                      ++||||+++++|.+++...  ..+++.....++.|+++||.|||+   .+++||||||+|||++.++.+||+|||+++..
T Consensus        81 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  155 (290)
T cd05613          81 HLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEF  155 (290)
T ss_pred             EEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence            9999999999999999765  357888889999999999999998   89999999999999999999999999999876


Q ss_pred             cCCCCCceeeeccCCCccCcccccCC--CCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccc
Q 007869          414 DHGTDPQTTHVVGTLGYLAPEHTRTG--KATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEA  491 (586)
Q Consensus       414 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~  491 (586)
                      ............|+..|+|||.+...  .++.++||||||+++|||++|+.||........  ..++.......      
T Consensus       156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~--~~~~~~~~~~~------  227 (290)
T cd05613         156 HEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS--QAEISRRILKS------  227 (290)
T ss_pred             ccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc--HHHHHHHhhcc------
Confidence            44332233345689999999998753  467899999999999999999999975332211  11111111111      


Q ss_pred             cCCCCCccccHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 007869          492 RDPNLGTEYVAEELELVLKLGLLCSHSDPTARP-----SMRQVVQ  531 (586)
Q Consensus       492 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~  531 (586)
                       .+..    .......+.+++.+|++.||++||     ++.++++
T Consensus       228 -~~~~----~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         228 -EPPY----PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             -CCCC----CccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence             1111    112335667888999999999997     5666653

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=9.6e-35  Score=294.00  Aligned_cols=263  Identities=26%  Similarity=0.352  Sum_probs=202.1

Q ss_pred             cccceeEeecCceEEEEEEeCCCCeEEEEEEecccc--chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEecC
Q 007869          263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES--RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYM  340 (586)
Q Consensus       263 f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  340 (586)
                      |+..+.||+|++|.||+|+...++..+|+|.+....  ....+.+..|+.++++++|+|++++++++...+..++||||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            456788999999999999999889999999997653  333467889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCCc
Q 007869          341 PNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ  420 (586)
Q Consensus       341 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~  420 (586)
                      + ++|.+++.... ..+++..++.++.|++.||.|||+   .+|+||||+|+||++++++.+||+|||+++....... .
T Consensus        81 ~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~  154 (282)
T cd07829          81 D-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-T  154 (282)
T ss_pred             C-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-c
Confidence            7 59999997653 368899999999999999999998   8999999999999999999999999999987654322 2


Q ss_pred             eeeeccCCCccCcccccCC-CCCCcceEEehhHHHHHHHhCCCCCCCCCCCccch-hh-------HHHHhhhccCccccc
Q 007869          421 TTHVVGTLGYLAPEHTRTG-KATTSADVFSFGAFLLEVACGRRPIQRQGPSENLI-LV-------DWVFDFWNRGELLEA  491 (586)
Q Consensus       421 ~~~~~gt~~y~aPE~~~~~-~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~-l~-------~~v~~~~~~~~~~~~  491 (586)
                      .....++..|+|||.+.+. .++.++|||||||+++||++|+.||......+... +.       ...|..+.+-.....
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (282)
T cd07829         155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKP  234 (282)
T ss_pred             cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccc
Confidence            2234567889999998776 78999999999999999999999997654321110 00       000100000000000


Q ss_pred             cCCCCCc----cccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          492 RDPNLGT----EYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       492 ~d~~l~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      .-+....    ...+.....+.+++..||+.||++||++.+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         235 TFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             cccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence            0011000    011112456889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=8.5e-35  Score=304.00  Aligned_cols=265  Identities=23%  Similarity=0.296  Sum_probs=197.7

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeecc---------
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRK---------  330 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~---------  330 (586)
                      ..+|...+.||.|+||.||+|+...++..||+|++........+.+.+|++++++++||||+++++++...         
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            36789999999999999999999999999999999776666667889999999999999999999876543         


Q ss_pred             -----CeEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecC-CCCeEE
Q 007869          331 -----GELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDG-ELNGRL  404 (586)
Q Consensus       331 -----~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~-~~~~kL  404 (586)
                           ...++||||++ ++|.+++...   .+++.....++.||++||.|||+   .+|+||||||+||+++. +..+||
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~---~givH~dikp~Nili~~~~~~~kl  156 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLEQG---PLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTEDLVLKI  156 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCceEEE
Confidence                 35799999997 5898887543   57889999999999999999998   89999999999999974 567899


Q ss_pred             ccccceeeccCCCCC--ceeeeccCCCccCcccccC-CCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHH--
Q 007869          405 GDFGLARLYDHGTDP--QTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWV--  479 (586)
Q Consensus       405 ~DFGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v--  479 (586)
                      +|||+++........  ......++..|+|||++.. ..++.++|||||||++|||++|+.||......+........  
T Consensus       157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~  236 (342)
T cd07854         157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVP  236 (342)
T ss_pred             CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence            999999865432211  1123467889999998754 45788999999999999999999999765432211100000  


Q ss_pred             -------Hhhhcc--Cccc-cccCCCC-CccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          480 -------FDFWNR--GELL-EARDPNL-GTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       480 -------~~~~~~--~~~~-~~~d~~l-~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                             ......  .... ....+.. ...........+.+++.+|++.||.+||++.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         237 VVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             CCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence                   000000  0000 0000000 00011122356778999999999999999999984

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-36  Score=335.07  Aligned_cols=256  Identities=26%  Similarity=0.395  Sum_probs=205.1

Q ss_pred             hhhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc--cchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEE
Q 007869          257 YIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELL  334 (586)
Q Consensus       257 ~~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~  334 (586)
                      ..-+-+++....||.|.||.||-|...++|...|+|.+...  .....+...+|+.++..++|||+|+++|+-.+++..+
T Consensus      1231 snV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~ 1310 (1509)
T KOG4645|consen 1231 SNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVY 1310 (1509)
T ss_pred             ccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHH
Confidence            34455667778999999999999999999999999988653  3444567889999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeecc
Q 007869          335 LVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYD  414 (586)
Q Consensus       335 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~  414 (586)
                      |.||||++|+|.+.+....  -+++.....+..|++.|+.|||+   ++||||||||.||+|+.+|.+|++|||.|+.+.
T Consensus      1311 IFMEyC~~GsLa~ll~~gr--i~dE~vt~vyt~qll~gla~LH~---~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~ 1385 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLEHGR--IEDEMVTRVYTKQLLEGLAYLHE---HGIVHRDIKPANILLDFNGLIKYGDFGSAVKIK 1385 (1509)
T ss_pred             HHHHHhccCcHHHHHHhcc--hhhhhHHHHHHHHHHHHHHHHHh---cCceecCCCccceeeecCCcEEeecccceeEec
Confidence            9999999999999997653  35566666678999999999998   999999999999999999999999999999876


Q ss_pred             CCCC---CceeeeccCCCccCcccccCCC---CCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCcc
Q 007869          415 HGTD---PQTTHVVGTLGYLAPEHTRTGK---ATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGEL  488 (586)
Q Consensus       415 ~~~~---~~~~~~~gt~~y~aPE~~~~~~---~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~  488 (586)
                      ....   .......||+.|||||++.+.+   ...+.||||+|||++||+||++||...+..       |..-+.    +
T Consensus      1386 ~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne-------~aIMy~----V 1454 (1509)
T KOG4645|consen 1386 NNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE-------WAIMYH----V 1454 (1509)
T ss_pred             CchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch-------hHHHhH----H
Confidence            6532   1233568999999999996543   456899999999999999999999865442       322111    1


Q ss_pred             ccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          489 LEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       489 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                      ...-.|.+    +......=.+++..|++.||++|.++.|+++.
T Consensus      1455 ~~gh~Pq~----P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1455 AAGHKPQI----PERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             hccCCCCC----chhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence            11112332    22234445677888999999999988887764

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=2.2e-35  Score=326.66  Aligned_cols=255  Identities=28%  Similarity=0.409  Sum_probs=194.5

Q ss_pred             hhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc-cchhHHHHHHHHHHhcccCCCceeeeeeeeec-------
Q 007869          258 IATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRR-------  329 (586)
Q Consensus       258 ~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~-------  329 (586)
                      ....+|++.++||+||||.|||++.+-+|+.+|||++... +........+|+..|++|+|||||+++..+.+       
T Consensus       476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~  555 (1351)
T KOG1035|consen  476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV  555 (1351)
T ss_pred             hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence            3456789999999999999999999999999999999766 34445678899999999999999998653100       


Q ss_pred             ------------------------------------------------c-------------------------------
Q 007869          330 ------------------------------------------------K-------------------------------  330 (586)
Q Consensus       330 ------------------------------------------------~-------------------------------  330 (586)
                                                                      .                               
T Consensus       556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~  635 (1351)
T KOG1035|consen  556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD  635 (1351)
T ss_pred             ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence                                                            0                               


Q ss_pred             ---------------------------------CeEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhh
Q 007869          331 ---------------------------------GELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLH  377 (586)
Q Consensus       331 ---------------------------------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH  377 (586)
                                                       ..+||=||||+.-.|.+++.++.... .-...|+++++|++||.|+|
T Consensus       636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIlEGLaYIH  714 (1351)
T KOG1035|consen  636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREILEGLAYIH  714 (1351)
T ss_pred             cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHHHHHHHHH
Confidence                                             12577789999888888887663221 35577899999999999999


Q ss_pred             cccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccC----------------C-CCCceeeeccCCCccCcccccCC-
Q 007869          378 QEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH----------------G-TDPQTTHVVGTLGYLAPEHTRTG-  439 (586)
Q Consensus       378 ~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~----------------~-~~~~~~~~~gt~~y~aPE~~~~~-  439 (586)
                      +   ++||||||||.||+||++..|||+|||+|.....                + .....+..+||.-|+|||++.+. 
T Consensus       715 ~---~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~  791 (1351)
T KOG1035|consen  715 D---QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS  791 (1351)
T ss_pred             h---CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence            8   8999999999999999999999999999987220                0 11234667999999999999765 


Q ss_pred             --CCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCccccHHHHHHHHHHHHHhcc
Q 007869          440 --KATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSH  517 (586)
Q Consensus       440 --~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~  517 (586)
                        +|+.|+|+||+|||++||+   .||.....  ..    -+....+++.+...      ..+...+...-.+++.++++
T Consensus       792 ~~~Yn~KiDmYSLGIVlFEM~---yPF~TsME--Ra----~iL~~LR~g~iP~~------~~f~~~~~~~e~slI~~Ll~  856 (1351)
T KOG1035|consen  792 SNKYNSKIDMYSLGIVLFEML---YPFGTSME--RA----SILTNLRKGSIPEP------ADFFDPEHPEEASLIRWLLS  856 (1351)
T ss_pred             cccccchhhhHHHHHHHHHHh---ccCCchHH--HH----HHHHhcccCCCCCC------cccccccchHHHHHHHHHhc
Confidence              4999999999999999998   45653221  11    11222234433322      12233344445678889999


Q ss_pred             cCCCCCCCHHHHHH
Q 007869          518 SDPTARPSMRQVVQ  531 (586)
Q Consensus       518 ~dP~~RPs~~evl~  531 (586)
                      .||.+|||+.|+|.
T Consensus       857 hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  857 HDPSKRPTATELLN  870 (1351)
T ss_pred             CCCccCCCHHHHhh
Confidence            99999999999874

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1e-34  Score=323.20  Aligned_cols=264  Identities=28%  Similarity=0.475  Sum_probs=212.9

Q ss_pred             hhhhhcCCcccceeEeecCceEEEEEEeCC-------CCeEEEEEEecccc-chhHHHHHHHHHHhccc-CCCceeeeee
Q 007869          255 DLYIATKGFREKELLGTGGFGRVYRGTLPK-------SQIEIAVKKISHES-RQGMKEFVAEIVSIGRL-RHRNLVQLLG  325 (586)
Q Consensus       255 el~~a~~~f~~~~~LG~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~~  325 (586)
                      .++...++....+.||+|.||.|++|....       ....||||.++... ....+.+..|+++|+.+ +|+|++.++|
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG  369 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG  369 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence            345556666667799999999999998531       25679999997653 34567899999999999 7999999999


Q ss_pred             eeeccCeEEEEEecCCCCChhhhhhcCC------------C--ccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCC
Q 007869          326 YCRRKGELLLVYDYMPNGSLDKYLYDQP------------K--VTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKA  391 (586)
Q Consensus       326 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~------------~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp  391 (586)
                      +|..++.+++|.||++.|+|.++|+...            .  ..+...+.+.++.|||.|++||++   .++|||||-.
T Consensus       370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~---~~~vHRDLAa  446 (609)
T KOG0200|consen  370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLAS---VPCVHRDLAA  446 (609)
T ss_pred             eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhh---CCccchhhhh
Confidence            9999999999999999999999998764            0  138888999999999999999998   8999999999


Q ss_pred             CCeeecCCCCeEEccccceeeccCCCCCceeeecc--CCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCC
Q 007869          392 SNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVG--TLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQG  468 (586)
Q Consensus       392 ~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~  468 (586)
                      +|||+.++..+||+|||+|+...+..........|  ...|||||.+....++.|||||||||+||||++ |..|+.+..
T Consensus       447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~  526 (609)
T KOG0200|consen  447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP  526 (609)
T ss_pred             hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence            99999999999999999999654433322222222  456999999999999999999999999999998 889987633


Q ss_pred             CCccchhhHHHHhhhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 007869          469 PSENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERD  536 (586)
Q Consensus       469 ~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  536 (586)
                      ..+     + +.++.++|..++.         +..+...+..++..||+.+|++||++.++++.++..
T Consensus       527 ~~~-----~-l~~~l~~G~r~~~---------P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~  579 (609)
T KOG0200|consen  527 PTE-----E-LLEFLKEGNRMEQ---------PEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH  579 (609)
T ss_pred             cHH-----H-HHHHHhcCCCCCC---------CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence            221     1 1334445544332         222346677999999999999999999999999874

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=1.2e-34  Score=290.25  Aligned_cols=249  Identities=25%  Similarity=0.371  Sum_probs=196.5

Q ss_pred             CcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc-----cchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEE
Q 007869          262 GFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE-----SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLV  336 (586)
Q Consensus       262 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV  336 (586)
                      +|...+.||+|+||.||++.+...+..+++|.+...     ......++..|+.++++++|||++++++++.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            477789999999999999998776666666665432     122334577899999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhcC--CCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeecc
Q 007869          337 YDYMPNGSLDKYLYDQ--PKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYD  414 (586)
Q Consensus       337 ~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~  414 (586)
                      |||+++++|.+++...  ....+++.+++.++.|+++||.|||+   .+++|+||||+||++++ +.+||+|||+++...
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH---cCccccCCChhheEeec-CCEeecccCceeecC
Confidence            9999999999988642  23578999999999999999999998   89999999999999975 469999999998754


Q ss_pred             CCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCC
Q 007869          415 HGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDP  494 (586)
Q Consensus       415 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~  494 (586)
                      .... ......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||......      ....... .+     ..+
T Consensus       157 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~------~~~~~~~-~~-----~~~  223 (260)
T cd08222         157 GSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL------SVVLRIV-EG-----PTP  223 (260)
T ss_pred             CCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH------HHHHHHH-cC-----CCC
Confidence            3221 223346788999999998888899999999999999999999998643211      1111111 11     112


Q ss_pred             CCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          495 NLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       495 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      ..    .......+.+++.+||+.+|++||++.|+++
T Consensus       224 ~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         224 SL----PETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             CC----cchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence            11    2233456788999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.5e-34  Score=302.08  Aligned_cols=249  Identities=23%  Similarity=0.335  Sum_probs=204.9

Q ss_pred             hcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc--chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEE
Q 007869          259 ATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES--RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLV  336 (586)
Q Consensus       259 a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV  336 (586)
                      -...|.+...||+|.|++|..+++..++..||||.+.+..  ......+.+|+++|..++|||||+++.+......+|+|
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV  133 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV  133 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence            3467899999999999999999999999999999997753  23345589999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCC
Q 007869          337 YDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHG  416 (586)
Q Consensus       337 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~  416 (586)
                      |||+.+|.+.++|.++.+  +.......++.|+.++++|||+   +.|||||||++||||+.+.++||+|||++..+...
T Consensus       134 ~eya~~ge~~~yl~~~gr--~~e~~ar~~F~q~vsaveYcH~---k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~  208 (596)
T KOG0586|consen  134 MEYASGGELFDYLVKHGR--MKEKEARAKFRQIVSAVEYCHS---KNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG  208 (596)
T ss_pred             EEeccCchhHHHHHhccc--chhhhhhhhhHHHHHHHHHHhh---cceeccccchhhcccccccceeeeccccceeeccc
Confidence            999999999999988754  4447778889999999999998   99999999999999999999999999999988743


Q ss_pred             CCCceeeeccCCCccCcccccCCCC-CCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCC
Q 007869          417 TDPQTTHVVGTLGYLAPEHTRTGKA-TTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPN  495 (586)
Q Consensus       417 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~  495 (586)
                      .  .....+|++.|.|||++.+.+| .+++|+||+|++||-|++|..||++..-.+-.           ...+.    ..
T Consensus       209 ~--~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr-----------~rvl~----gk  271 (596)
T KOG0586|consen  209 L--MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELR-----------PRVLR----GK  271 (596)
T ss_pred             c--cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccccc-----------chhee----ee
Confidence            3  4556799999999999998876 58999999999999999999999875433210           00000    00


Q ss_pred             CCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          496 LGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       496 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      ++-.+  -....+-+++.+++-.+|.+|+++.++.+
T Consensus       272 ~rIp~--~ms~dce~lLrk~lvl~Pskr~~~dqim~  305 (596)
T KOG0586|consen  272 YRIPF--YMSCDCEDLLRKFLVLNPSKRGPCDQIMK  305 (596)
T ss_pred             ecccc--eeechhHHHHHHhhccCccccCCHHHhhh
Confidence            01111  11233445666678889999999999975

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.6e-34  Score=302.04  Aligned_cols=263  Identities=22%  Similarity=0.305  Sum_probs=200.1

Q ss_pred             hhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc--cchhHHHHHHHHHHhcccCCCceeeeeeeeeccCe---
Q 007869          258 IATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGE---  332 (586)
Q Consensus       258 ~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~---  332 (586)
                      ...++|+..+.||+|++|.||+|++..++..||||++...  .....+.+.+|+.++++++|||++++++++...+.   
T Consensus        12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07851          12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED   91 (343)
T ss_pred             cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence            3467899999999999999999999988999999998653  22344667889999999999999999998766554   


Q ss_pred             ---EEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccc
Q 007869          333 ---LLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGL  409 (586)
Q Consensus       333 ---~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGl  409 (586)
                         .++|+||+ +++|.+++...   .+++..+..++.|+++||.|||+   .+|+||||||+||++++++.+||+|||+
T Consensus        92 ~~~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nill~~~~~~kL~dfg~  164 (343)
T cd07851          92 FQDVYLVTHLM-GADLNNIVKCQ---KLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGL  164 (343)
T ss_pred             cccEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEccccc
Confidence               89999999 67999988653   58999999999999999999998   8999999999999999999999999999


Q ss_pred             eeeccCCCCCceeeeccCCCccCcccccC-CCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccch-hhHH-------HH
Q 007869          410 ARLYDHGTDPQTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLI-LVDW-------VF  480 (586)
Q Consensus       410 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~-l~~~-------v~  480 (586)
                      +......    .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||......+... +.+.       .+
T Consensus       165 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~  240 (343)
T cd07851         165 ARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELL  240 (343)
T ss_pred             ccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHH
Confidence            9865432    233467889999999865 367899999999999999999999997543321110 0000       00


Q ss_pred             hhhccCc---cccccCCCCCccc---cHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          481 DFWNRGE---LLEARDPNLGTEY---VAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       481 ~~~~~~~---~~~~~d~~l~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      ..+....   ............+   .......+.+++.+|++.||++|||+.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         241 QKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             hhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence            0000000   0000000000000   0112457889999999999999999999975

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=2.6e-34  Score=299.05  Aligned_cols=264  Identities=23%  Similarity=0.290  Sum_probs=194.2

Q ss_pred             CcccceeEeecCceEEEEEEeCCC--CeEEEEEEeccc--cchhHHHHHHHHHHhccc-CCCceeeeeeeeecc----Ce
Q 007869          262 GFREKELLGTGGFGRVYRGTLPKS--QIEIAVKKISHE--SRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRK----GE  332 (586)
Q Consensus       262 ~f~~~~~LG~G~~g~Vy~~~~~~~--~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~----~~  332 (586)
                      +|+..+.||+|+||.||+++....  +..||+|++...  .....+.+.+|+.+++++ +||||+++++.+...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            477889999999999999999877  888999998653  222346788899999999 599999999975432    45


Q ss_pred             EEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceee
Q 007869          333 LLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARL  412 (586)
Q Consensus       333 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~  412 (586)
                      .++++||+. ++|.+++...  ..+++..+..++.||+.||.|||+   .+|+||||||+|||+++++.+||+|||+++.
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~givH~dlkp~Nili~~~~~~kl~Dfg~a~~  154 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSG--QPLTDAHFQSFIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARG  154 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHeEEcCCCCEEeCcCCCcee
Confidence            788899985 6899988654  368899999999999999999998   8999999999999999999999999999986


Q ss_pred             ccCCCCC---ceeeeccCCCccCcccccC-CCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchh-h--------HHH
Q 007869          413 YDHGTDP---QTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLIL-V--------DWV  479 (586)
Q Consensus       413 ~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l-~--------~~v  479 (586)
                      .......   ......||..|+|||++.+ ..++.++|+|||||++|||++|+.||......+.... .        ++.
T Consensus       155 ~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  234 (332)
T cd07857         155 FSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETL  234 (332)
T ss_pred             cccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            5433211   1233578999999998765 4689999999999999999999999976432111000 0        000


Q ss_pred             HhhhccC--cccccc--CCCCC-ccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          480 FDFWNRG--ELLEAR--DPNLG-TEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       480 ~~~~~~~--~~~~~~--d~~l~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      .......  ......  .+... ..........+.+++.+|++.||++|||+.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         235 SRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             HhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            0000000  000000  00000 0001112356788999999999999999999874

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.7e-34  Score=300.31  Aligned_cols=261  Identities=22%  Similarity=0.323  Sum_probs=198.0

Q ss_pred             hcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc--cchhHHHHHHHHHHhcccCCCceeeeeeeeeccC-----
Q 007869          259 ATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKG-----  331 (586)
Q Consensus       259 a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~-----  331 (586)
                      ..++|+..+.||+|+||.||++....++..||||++...  .....+.+.+|+.++++++||||+++++++....     
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF   92 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence            457799999999999999999999888999999998543  2333456889999999999999999999887543     


Q ss_pred             -eEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccce
Q 007869          332 -ELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLA  410 (586)
Q Consensus       332 -~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla  410 (586)
                       ..++||||+ +++|.+++...   .+++..+..++.|+++||.|||+   .+|+||||||+||++++++.+||+|||++
T Consensus        93 ~~~~lv~e~~-~~~l~~~~~~~---~l~~~~~~~i~~qi~~al~~LH~---~gi~H~dlkp~Nill~~~~~~kl~dfg~~  165 (343)
T cd07880          93 HDFYLVMPFM-GTDLGKLMKHE---KLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLA  165 (343)
T ss_pred             ceEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccc
Confidence             468999999 77998888643   58899999999999999999998   89999999999999999999999999999


Q ss_pred             eeccCCCCCceeeeccCCCccCcccccC-CCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccch-h--------hHHHH
Q 007869          411 RLYDHGTDPQTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLI-L--------VDWVF  480 (586)
Q Consensus       411 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~-l--------~~~v~  480 (586)
                      ......    .....+++.|+|||.+.+ ..++.++|+|||||++|+|++|+.||.......... .        .++..
T Consensus       166 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  241 (343)
T cd07880         166 RQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQ  241 (343)
T ss_pred             cccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            865432    223467899999999876 458899999999999999999999997543211100 0        00000


Q ss_pred             hhhccCccccc--cCCCCCc----cccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          481 DFWNRGELLEA--RDPNLGT----EYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       481 ~~~~~~~~~~~--~d~~l~~----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      .. ........  .-+....    .........+.+++.+|++.||++|||+.++++
T Consensus       242 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         242 KL-QSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             hh-cchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            00 00000000  0000000    001122345778999999999999999999984

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-34  Score=279.14  Aligned_cols=207  Identities=25%  Similarity=0.326  Sum_probs=180.9

Q ss_pred             hhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc---chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEE
Q 007869          258 IATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELL  334 (586)
Q Consensus       258 ~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~  334 (586)
                      ...++|...++||+|.||+|-+++-+.+++.+|+|+++++.   +.....-+.|-.+|...+||.+..|.-.|...+.+|
T Consensus       165 vTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlC  244 (516)
T KOG0690|consen  165 VTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLC  244 (516)
T ss_pred             eccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEE
Confidence            34567888999999999999999999999999999998763   333444577889999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeecc
Q 007869          335 LVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYD  414 (586)
Q Consensus       335 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~  414 (586)
                      +||||..||.|.-+|.+.  ..+++....-+-..|..||.|||+   ++||.||||.+|.|||.+|.+||.|||||+.--
T Consensus       245 FVMeyanGGeLf~HLsre--r~FsE~RtRFYGaEIvsAL~YLHs---~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I  319 (516)
T KOG0690|consen  245 FVMEYANGGELFFHLSRE--RVFSEDRTRFYGAEIVSALGYLHS---RNIVYRDLKLENLLLDKDGHIKITDFGLCKEEI  319 (516)
T ss_pred             EEEEEccCceEeeehhhh--hcccchhhhhhhHHHHHHhhhhhh---CCeeeeechhhhheeccCCceEeeecccchhcc
Confidence            999999999999999765  356776777778899999999998   999999999999999999999999999998422


Q ss_pred             CCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCC
Q 007869          415 HGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPS  470 (586)
Q Consensus       415 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~  470 (586)
                      . ....+...+||+.|+|||++....|..+.|.|.+|||+|||+||+.||...+..
T Consensus       320 ~-~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~  374 (516)
T KOG0690|consen  320 K-YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE  374 (516)
T ss_pred             c-ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh
Confidence            1 122455689999999999999999999999999999999999999999876543

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.5e-34  Score=283.19  Aligned_cols=237  Identities=25%  Similarity=0.313  Sum_probs=195.2

Q ss_pred             EeecCceEEEEEEeCCCCeEEEEEEeccccc---hhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEecCCCCCh
Q 007869          269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESR---QGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSL  345 (586)
Q Consensus       269 LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL  345 (586)
                      ||+|+||.||++....++..+|+|.+.....   .....+..|++++++++|+||+++++.+..++..++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            6899999999999988888999999875432   2456789999999999999999999999999999999999999999


Q ss_pred             hhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCCceeeec
Q 007869          346 DKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVV  425 (586)
Q Consensus       346 ~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~  425 (586)
                      .+++....  .+++.....++.|+++||.|||+   .+++|+||||+||+++.++.++|+|||++....... .......
T Consensus        81 ~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~  154 (250)
T cd05123          81 FSHLSKEG--RFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFC  154 (250)
T ss_pred             HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCc
Confidence            99997653  58899999999999999999998   999999999999999999999999999998764432 1234456


Q ss_pred             cCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCccccHHHH
Q 007869          426 GTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAEEL  505 (586)
Q Consensus       426 gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~  505 (586)
                      ++..|++||...+...+.++|+||||+++|||++|+.||......   .....+.    ++.      ...    +....
T Consensus       155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~---~~~~~~~----~~~------~~~----~~~~~  217 (250)
T cd05123         155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK---EIYEKIL----KDP------LRF----PEFLS  217 (250)
T ss_pred             CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHh----cCC------CCC----CCCCC
Confidence            889999999998888999999999999999999999999654321   1111111    110      111    11124


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHH
Q 007869          506 ELVLKLGLLCSHSDPTARPSMRQ  528 (586)
Q Consensus       506 ~~l~~l~~~Cl~~dP~~RPs~~e  528 (586)
                      ..+.+++.+|+..||++||++.+
T Consensus       218 ~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         218 PEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             HHHHHHHHHHhcCCHhhCCCccc
Confidence            56778899999999999999954

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-34  Score=304.95  Aligned_cols=262  Identities=24%  Similarity=0.348  Sum_probs=219.9

Q ss_pred             cchhhhhhhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhccc-CCCceeeeeeeeec
Q 007869          251 FRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRR  329 (586)
Q Consensus       251 ~~~~el~~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~  329 (586)
                      ..++.+...++.|.+.++||+|.+|+||+++..++++..|+|+...... ..++...|.++|+.+ .|||++.++|++..
T Consensus         9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k   87 (953)
T KOG0587|consen    9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIK   87 (953)
T ss_pred             cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence            3455566678889999999999999999999999999999999865533 346778888998887 79999999998863


Q ss_pred             -----cCeEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEE
Q 007869          330 -----KGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRL  404 (586)
Q Consensus       330 -----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL  404 (586)
                           +++++||||||.+||..|+++......+.|..+..|++.++.||.+||.   ..++|||||-.||||+.++.+||
T Consensus        88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~---nkviHRDikG~NiLLT~e~~VKL  164 (953)
T KOG0587|consen   88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHN---NKVIHRDIKGQNVLLTENAEVKL  164 (953)
T ss_pred             ecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhh---cceeeecccCceEEEeccCcEEE
Confidence                 4689999999999999999988767789999999999999999999998   89999999999999999999999


Q ss_pred             ccccceeeccCCCCCceeeeccCCCccCcccccCC-----CCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHH
Q 007869          405 GDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTG-----KATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWV  479 (586)
Q Consensus       405 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v  479 (586)
                      +|||.+..++.... ...+.+||+.|||||++...     .|+..+|+||||++..||.-|.+|+.+..+...+.     
T Consensus       165 vDFGvSaQldsT~g-rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF-----  238 (953)
T KOG0587|consen  165 VDFGVSAQLDSTVG-RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALF-----  238 (953)
T ss_pred             eeeeeeeeeecccc-cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhc-----
Confidence            99999988765432 34457899999999998654     46779999999999999999999998765532211     


Q ss_pred             HhhhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          480 FDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       480 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                               .-...|.........-.+.+.+++..|+.+|-++||++.++++
T Consensus       239 ---------~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  239 ---------LIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             ---------cCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence                     1123344444445667788999999999999999999999875

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-34  Score=279.82  Aligned_cols=260  Identities=24%  Similarity=0.357  Sum_probs=203.8

Q ss_pred             chhhhhhhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhccc-CCCceeeeeeeeecc
Q 007869          252 RYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRK  330 (586)
Q Consensus       252 ~~~el~~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~  330 (586)
                      +++|++.-|     .++||+|+|+.|--++...++.++|||++.+..........+|++++.+. .|+||++|+.||+++
T Consensus        74 ~F~d~YkLt-----~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd  148 (463)
T KOG0607|consen   74 KFEDMYKLT-----SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD  148 (463)
T ss_pred             hHHHHHHhH-----HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence            356777666     46799999999999999999999999999887666778899999999998 599999999999999


Q ss_pred             CeEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCC---CeEEccc
Q 007869          331 GELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGEL---NGRLGDF  407 (586)
Q Consensus       331 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~---~~kL~DF  407 (586)
                      ..+|||||-|.||+|..+|.+.  ..+++....++.++|+.||.|||.   ++|.||||||+|||-.+-.   -+|||||
T Consensus       149 ~~FYLVfEKm~GGplLshI~~~--~~F~E~EAs~vvkdia~aLdFlH~---kgIAHRDlKPENiLC~~pn~vsPvKiCDf  223 (463)
T KOG0607|consen  149 TRFYLVFEKMRGGPLLSHIQKR--KHFNEREASRVVKDIASALDFLHT---KGIAHRDLKPENILCESPNKVSPVKICDF  223 (463)
T ss_pred             ceEEEEEecccCchHHHHHHHh--hhccHHHHHHHHHHHHHHHHHHhh---cCcccccCCccceeecCCCCcCceeeecc
Confidence            9999999999999999999876  368888999999999999999998   9999999999999996543   3899999


Q ss_pred             cceeeccCC------CCCceeeeccCCCccCccccc-----CCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCc-----
Q 007869          408 GLARLYDHG------TDPQTTHVVGTLGYLAPEHTR-----TGKATTSADVFSFGAFLLEVACGRRPIQRQGPSE-----  471 (586)
Q Consensus       408 Gla~~~~~~------~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~-----  471 (586)
                      .|..-+...      ..+...+.+|+..|||||+..     ...|+.++|.|||||+||-|++|-+||.+.-..+     
T Consensus       224 DLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdr  303 (463)
T KOG0607|consen  224 DLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDR  303 (463)
T ss_pred             ccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccC
Confidence            988643222      123344578999999999763     2357899999999999999999999997643322     


Q ss_pred             --cc-hhhHHHHhhhccCccccccCCCCCccccHHH----HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          472 --NL-ILVDWVFDFWNRGELLEARDPNLGTEYVAEE----LELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       472 --~~-~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~----~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                        .. .-.+.+++-.++|+.          +|+.++    .....+++...+..|+.+|.++.+++.
T Consensus       304 Ge~Cr~CQ~~LFesIQEGkY----------eFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  304 GEVCRVCQNKLFESIQEGKY----------EFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             CCccHHHHHHHHHHHhccCC----------cCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence              11 111122233333332          222222    233445555667799999999999886

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=2.4e-33  Score=316.59  Aligned_cols=146  Identities=27%  Similarity=0.398  Sum_probs=132.6

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc---chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEE
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY  337 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  337 (586)
                      ++|.+.+.||+|+||.||+|.+..++..||||++....   ......+..|+.++..++||||+++++++...+..+|||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            57889999999999999999999889999999986532   233467889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEcccccee
Q 007869          338 DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR  411 (586)
Q Consensus       338 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~  411 (586)
                      ||+++++|.+++....  .+++...+.|+.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++
T Consensus        84 Ey~~g~~L~~li~~~~--~l~~~~~~~i~~qil~aL~yLH~---~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          84 EYLIGGDVKSLLHIYG--YFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             eCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            9999999999997643  57788899999999999999998   899999999999999999999999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-34  Score=284.47  Aligned_cols=265  Identities=22%  Similarity=0.282  Sum_probs=211.5

Q ss_pred             hcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCC--Cc----eeeeeeeeeccCe
Q 007869          259 ATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRH--RN----LVQLLGYCRRKGE  332 (586)
Q Consensus       259 a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H--~n----iv~l~~~~~~~~~  332 (586)
                      -+++|.+..++|+|.||+|-++.+..++..||||+++.-.+ -.+.-+-|+++|.++.+  |+    ++++.+|+.-.++
T Consensus        87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k-YreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh  165 (415)
T KOG0671|consen   87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK-YREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH  165 (415)
T ss_pred             cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH-HhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence            37889999999999999999999988889999999975433 23456779999999942  33    8889999999999


Q ss_pred             EEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeec---------------
Q 007869          333 LLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLD---------------  397 (586)
Q Consensus       333 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~---------------  397 (586)
                      .+||+|.+ |-|+.++|..+.-.+++..++..|+.|++++++|||+   .+++|.||||+|||+.               
T Consensus       166 iCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~---~kl~HTDLKPENILfvss~~~~~~~~k~~~~  241 (415)
T KOG0671|consen  166 ICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHD---LKLTHTDLKPENILFVSSEYFKTYNPKKKVC  241 (415)
T ss_pred             eEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHh---cceeecCCChheEEEeccceEEEeccCCccc
Confidence            99999998 6799999999888889999999999999999999998   9999999999999993               


Q ss_pred             -----CCCCeEEccccceeeccCCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCcc
Q 007869          398 -----GELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSEN  472 (586)
Q Consensus       398 -----~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~  472 (586)
                           .+..+||+|||.|+.-..    .....+.|..|+|||++.+-.++..+||||+||+|.|+++|...|+.....|.
T Consensus       242 ~~r~~ks~~I~vIDFGsAtf~~e----~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EH  317 (415)
T KOG0671|consen  242 FIRPLKSTAIKVIDFGSATFDHE----HHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEH  317 (415)
T ss_pred             eeccCCCcceEEEecCCcceecc----CcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHH
Confidence                 134589999999987433    23567889999999999999999999999999999999999999988765554


Q ss_pred             chhhHHH--------------HhhhccCccc-----------cccCCCCC----ccccHHHHHHHHHHHHHhcccCCCCC
Q 007869          473 LILVDWV--------------FDFWNRGELL-----------EARDPNLG----TEYVAEELELVLKLGLLCSHSDPTAR  523 (586)
Q Consensus       473 ~~l~~~v--------------~~~~~~~~~~-----------~~~d~~l~----~~~~~~~~~~l~~l~~~Cl~~dP~~R  523 (586)
                      +.+.+.+              .++...+.+.           ...++...    ......+...|.+|+..|+..||.+|
T Consensus       318 LaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~R  397 (415)
T KOG0671|consen  318 LAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARR  397 (415)
T ss_pred             HHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcccc
Confidence            3222221              1122222111           11111110    11244566789999999999999999


Q ss_pred             CCHHHHHHH
Q 007869          524 PSMRQVVQI  532 (586)
Q Consensus       524 Ps~~evl~~  532 (586)
                      +|+.|+++.
T Consensus       398 iTl~EAL~H  406 (415)
T KOG0671|consen  398 ITLREALSH  406 (415)
T ss_pred             ccHHHHhcC
Confidence            999999853

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=2.1e-33  Score=277.96  Aligned_cols=221  Identities=21%  Similarity=0.170  Sum_probs=178.6

Q ss_pred             cCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEecCCCCChhhhhhc
Q 007869          272 GGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYD  351 (586)
Q Consensus       272 G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  351 (586)
                      |.+|.||++++..+++.+|+|++....     .+..|...+....|||++++++++...+..++||||+++|+|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            899999999999999999999997643     233455555566799999999999999999999999999999999876


Q ss_pred             CCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCCceeeeccCCCcc
Q 007869          352 QPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYL  431 (586)
Q Consensus       352 ~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~  431 (586)
                      ..  .+++.....++.|+++||.|||+   ++|+||||||+||+++.++.++|+|||++......    .....++..|+
T Consensus        79 ~~--~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y~  149 (237)
T cd05576          79 FL--NIPEECVKRWAAEMVVALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMYC  149 (237)
T ss_pred             hc--CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCcccc
Confidence            53  58899999999999999999998   89999999999999999999999999988765432    12234577899


Q ss_pred             CcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCccccHHHHHHHHHH
Q 007869          432 APEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKL  511 (586)
Q Consensus       432 aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l  511 (586)
                      |||.+....++.++||||+|+++|||++|+.|+.......                 .......+    .......+.++
T Consensus       150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-----------------~~~~~~~~----~~~~~~~~~~l  208 (237)
T cd05576         150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI-----------------NTHTTLNI----PEWVSEEARSL  208 (237)
T ss_pred             CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-----------------ccccccCC----cccCCHHHHHH
Confidence            9999988889999999999999999999998875422110                 00000011    11123457788


Q ss_pred             HHHhcccCCCCCCCHH
Q 007869          512 GLLCSHSDPTARPSMR  527 (586)
Q Consensus       512 ~~~Cl~~dP~~RPs~~  527 (586)
                      +.+|++.||++||++.
T Consensus       209 i~~~l~~dp~~R~~~~  224 (237)
T cd05576         209 LQQLLQFNPTERLGAG  224 (237)
T ss_pred             HHHHccCCHHHhcCCC
Confidence            8999999999999973

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-34  Score=317.02  Aligned_cols=216  Identities=28%  Similarity=0.335  Sum_probs=191.7

Q ss_pred             CcccchhhhhhhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc---cchhHHHHHHHHHHhcccCCCceeeee
Q 007869          248 PHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLL  324 (586)
Q Consensus       248 ~~~~~~~el~~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~  324 (586)
                      |..-..++++...++|.+.++||+|+||.|..++++.+++.+|+|++++.   .+....-|..|-.+|..-+.+-|++|+
T Consensus        62 p~v~~v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~Lh  141 (1317)
T KOG0612|consen   62 PIVKKVKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLH  141 (1317)
T ss_pred             HHHHHHHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHH
Confidence            44445678888899999999999999999999999999999999999873   234456688999999988999999999


Q ss_pred             eeeeccCeEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEE
Q 007869          325 GYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRL  404 (586)
Q Consensus       325 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL  404 (586)
                      -.|.+..++|+|||||+||+|-.++.+..  .+++....-++..|..||.-||+   .|+|||||||+|||||..|++||
T Consensus       142 yAFQD~~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~---mgyVHRDiKPDNvLld~~GHikL  216 (1317)
T KOG0612|consen  142 YAFQDERYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHS---MGYVHRDIKPDNVLLDKSGHIKL  216 (1317)
T ss_pred             HHhcCccceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHh---ccceeccCCcceeEecccCcEee
Confidence            99999999999999999999999998775  45555566678999999999998   99999999999999999999999


Q ss_pred             ccccceeeccCCCCCceeeeccCCCccCcccccC-----CCCCCcceEEehhHHHHHHHhCCCCCCCCC
Q 007869          405 GDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRT-----GKATTSADVFSFGAFLLEVACGRRPIQRQG  468 (586)
Q Consensus       405 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~  468 (586)
                      +|||.|..+..+..-.+...+|||.|++||++..     +.|.+.+|.||+||++|||++|..||..+.
T Consensus       217 ADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads  285 (1317)
T KOG0612|consen  217 ADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS  285 (1317)
T ss_pred             ccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH
Confidence            9999999888776666777899999999999852     578999999999999999999999998653

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=8e-34  Score=272.34  Aligned_cols=265  Identities=23%  Similarity=0.307  Sum_probs=202.7

Q ss_pred             hcCCcccc-eeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhccc-CCCceeeeeeeeec----cCe
Q 007869          259 ATKGFREK-ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRR----KGE  332 (586)
Q Consensus       259 a~~~f~~~-~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~----~~~  332 (586)
                      .+++|++. ++||-|-.|+|-.+.++.+++.+|+|++...     ....+|++.--+. .|||||+++++++.    ...
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc  133 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC  133 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence            34555543 6799999999999999999999999999654     2345677765554 69999999998764    467


Q ss_pred             EEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecC---CCCeEEccccc
Q 007869          333 LLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDG---ELNGRLGDFGL  409 (586)
Q Consensus       333 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~---~~~~kL~DFGl  409 (586)
                      +++|||.|+||.|...+.++....+++.+.-.|++||+.|+.|||+   .+|.||||||+|+|...   |-.+||+|||.
T Consensus       134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~---~nIAHRDlKpENLLyt~t~~na~lKLtDfGF  210 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHS---MNIAHRDLKPENLLYTTTSPNAPLKLTDFGF  210 (400)
T ss_pred             eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHh---cchhhccCChhheeeecCCCCcceEeccccc
Confidence            8999999999999999999888889999999999999999999998   99999999999999964   45689999999


Q ss_pred             eeeccCCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccc
Q 007869          410 ARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELL  489 (586)
Q Consensus       410 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~  489 (586)
                      |+......  ...+.+-|+.|.|||++...+|+..+|+||+||++|-|+||-+||.......   +..=+......|.. 
T Consensus       211 AK~t~~~~--~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a---ispgMk~rI~~gqy-  284 (400)
T KOG0604|consen  211 AKETQEPG--DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA---ISPGMKRRIRTGQY-  284 (400)
T ss_pred             ccccCCCc--cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc---CChhHHhHhhccCc-
Confidence            98654322  3345678999999999999999999999999999999999999997643210   10001111111110 


Q ss_pred             cccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH--HhhccCCCcc
Q 007869          490 EARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQI--LERDVALPAI  542 (586)
Q Consensus       490 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~--L~~~~~~p~~  542 (586)
                      +..+|    ++ ....+...+++...|..+|.+|.|+.+++..  +.+...+|..
T Consensus       285 ~FP~p----EW-s~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp~t  334 (400)
T KOG0604|consen  285 EFPEP----EW-SCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVPQT  334 (400)
T ss_pred             cCCCh----hH-hHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCCCC
Confidence            11111    11 1223455677778899999999999999853  4444445543

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=2e-35  Score=279.09  Aligned_cols=254  Identities=26%  Similarity=0.334  Sum_probs=198.1

Q ss_pred             CcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccc-hhHHHHHHHHHHhccc-CCCceeeeeeeeeccCeEEEEEec
Q 007869          262 GFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR-QGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKGELLLVYDY  339 (586)
Q Consensus       262 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~lV~E~  339 (586)
                      +.+....||.|+||+|+|-.++.+++..|||+++.... ...++++.|.+...+- ++||||+++|.+..++..++-||+
T Consensus        65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMEL  144 (361)
T KOG1006|consen   65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMEL  144 (361)
T ss_pred             hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHH
Confidence            34556779999999999999999999999999987644 5567888998876665 799999999999999999999999


Q ss_pred             CCCCChhhh---hhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCC
Q 007869          340 MPNGSLDKY---LYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHG  416 (586)
Q Consensus       340 ~~~gsL~~~---l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~  416 (586)
                      |. -||+.+   ++...+..+++...-+|......||.||.+  +..|||||+||+|||||..|.+||||||++-.+...
T Consensus       145 Md-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S  221 (361)
T KOG1006|consen  145 MD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS  221 (361)
T ss_pred             Hh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHHH
Confidence            94 466554   334445678888888889999999999998  588999999999999999999999999999765432


Q ss_pred             CCCceeeeccCCCccCcccccCC--CCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCC
Q 007869          417 TDPQTTHVVGTLGYLAPEHTRTG--KATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDP  494 (586)
Q Consensus       417 ~~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~  494 (586)
                      .  ..+.-+|-..|||||-+...  .|+-+|||||||++|+|+.||+.|+...+.     ..+-+.+.       ..-||
T Consensus       222 i--AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfeql~~V-------v~gdp  287 (361)
T KOG1006|consen  222 I--AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFEQLCQV-------VIGDP  287 (361)
T ss_pred             H--HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHHHHHHH-------HcCCC
Confidence            2  34556788999999988543  488999999999999999999999986543     11111111       11122


Q ss_pred             C-CCccc-cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          495 N-LGTEY-VAEELELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       495 ~-l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                      . +.... ..+....+.+++-.|+.+|-..||+..+++++
T Consensus       288 p~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  288 PILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             CeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence            2 21111 12234567777888999999999999998753

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=9.4e-34  Score=272.97  Aligned_cols=203  Identities=26%  Similarity=0.385  Sum_probs=170.1

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCe----EEEEEEeccccch--hHHHHHHHHHHhcccCCCceeeeeeeeec-cCeE
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQI----EIAVKKISHESRQ--GMKEFVAEIVSIGRLRHRNLVQLLGYCRR-KGEL  333 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~~--~~~~~~~Ei~~l~~l~H~niv~l~~~~~~-~~~~  333 (586)
                      ..|+....||+|.||.||+++.++++.    .+|+|+++.+...  --...-+|+.+++.++|||++.|..++.. +...
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v  103 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV  103 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence            467788899999999999997655433    6899999765221  12446789999999999999999998877 7889


Q ss_pred             EEEEecCCCCChhhhhhcCC---CccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCC----CCeEEcc
Q 007869          334 LLVYDYMPNGSLDKYLYDQP---KVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGE----LNGRLGD  406 (586)
Q Consensus       334 ~lV~E~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~----~~~kL~D  406 (586)
                      +|++||.+. +|...|+-..   ...++-.....|+.||+.|+.|||+   .=|+||||||.|||+..+    |.|||+|
T Consensus       104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~---NWvlHRDLKPaNIlvmgdgperG~VKIaD  179 (438)
T KOG0666|consen  104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS---NWVLHRDLKPANILVMGDGPERGRVKIAD  179 (438)
T ss_pred             EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh---hheeeccCCcceEEEeccCCccCeeEeec
Confidence            999999965 8888886432   2468888999999999999999999   669999999999999877    8999999


Q ss_pred             ccceeeccCCCCC--ceeeeccCCCccCcccccCC-CCCCcceEEehhHHHHHHHhCCCCCCCC
Q 007869          407 FGLARLYDHGTDP--QTTHVVGTLGYLAPEHTRTG-KATTSADVFSFGAFLLEVACGRRPIQRQ  467 (586)
Q Consensus       407 FGla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~s~ksDVyS~Gvvl~ElltG~~p~~~~  467 (586)
                      ||++|++...-.+  ....++-|..|+|||.+.+. .||++.||||.||++.||++-++-|.+.
T Consensus       180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~  243 (438)
T KOG0666|consen  180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR  243 (438)
T ss_pred             ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence            9999998765443  23456789999999999876 5899999999999999999999888754

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-33  Score=286.93  Aligned_cols=244  Identities=25%  Similarity=0.351  Sum_probs=198.1

Q ss_pred             ceeEeecCceEEEEEEeCCCCeEEEEEEeccc--cchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEecCCCC
Q 007869          266 KELLGTGGFGRVYRGTLPKSQIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNG  343 (586)
Q Consensus       266 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~g  343 (586)
                      .++||+|.||+||-|+++.+|+.||||++.+.  ......++.+|+.+|.+++||.||.|...|+..+..+.|||-+ +|
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G  647 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG  647 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence            57899999999999999999999999999764  2334478899999999999999999999999999999999999 67


Q ss_pred             ChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecC---CCCeEEccccceeeccCCCCCc
Q 007869          344 SLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDG---ELNGRLGDFGLARLYDHGTDPQ  420 (586)
Q Consensus       344 sL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~---~~~~kL~DFGla~~~~~~~~~~  420 (586)
                      +..++|-..++..|++..-.-++.||+.||.|||.   ++|+|+||||+||||.+   --++||||||.||++.+..  -
T Consensus       648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~---knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks--F  722 (888)
T KOG4236|consen  648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHF---KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS--F  722 (888)
T ss_pred             hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhh---cceeeccCCchheeeccCCCCCceeeccccceeecchhh--h
Confidence            88888877777889988888899999999999998   99999999999999954   3579999999999987643  3


Q ss_pred             eeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCccc
Q 007869          421 TTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEY  500 (586)
Q Consensus       421 ~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~  500 (586)
                      ...++||+.|+|||+++++.|+..-|+||.||++|--++|..||..+....+.         .++...+.  .|..-.+.
T Consensus       723 RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQ---------IQNAaFMy--Pp~PW~ei  791 (888)
T KOG4236|consen  723 RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQ---------IQNAAFMY--PPNPWSEI  791 (888)
T ss_pred             hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHH---------hhcccccc--CCCchhhc
Confidence            34579999999999999999999999999999999999999999865332111         11111221  12222222


Q ss_pred             cHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 007869          501 VAEELELVLKLGLLCSHSDPTARPSMRQVV  530 (586)
Q Consensus       501 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl  530 (586)
                      .    ...++++...|+..-.+|-|..+.+
T Consensus       792 s----~~AidlIn~LLqVkm~kRysvdk~l  817 (888)
T KOG4236|consen  792 S----PEAIDLINNLLQVKMRKRYSVDKSL  817 (888)
T ss_pred             C----HHHHHHHHHHHHHHHHHhcchHhhc
Confidence            2    3445566666777778888877654

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=1.2e-32  Score=270.75  Aligned_cols=239  Identities=28%  Similarity=0.361  Sum_probs=196.2

Q ss_pred             CceEEEEEEeCCCCeEEEEEEeccccchh-HHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEecCCCCChhhhhhc
Q 007869          273 GFGRVYRGTLPKSQIEIAVKKISHESRQG-MKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYD  351 (586)
Q Consensus       273 ~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~  351 (586)
                      +||.||+|+..+++..+++|++....... .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999998888999999997765444 68899999999999999999999999999999999999999999999876


Q ss_pred             CCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCCceeeeccCCCcc
Q 007869          352 QPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYL  431 (586)
Q Consensus       352 ~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~  431 (586)
                      ...  +++..++.++.+++.++.|||+   .+++|+||+|+||++++++.++|+|||.+.......  ......++..|+
T Consensus        81 ~~~--~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~  153 (244)
T smart00220       81 RGR--LSEDEARFYARQILSALEYLHS---NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYM  153 (244)
T ss_pred             ccC--CCHHHHHHHHHHHHHHHHHHHH---cCeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCC
Confidence            532  8889999999999999999998   899999999999999999999999999998765432  233456889999


Q ss_pred             CcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCccccHHHHHHHHHH
Q 007869          432 APEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKL  511 (586)
Q Consensus       432 aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l  511 (586)
                      +||......++.++||||||++++||++|+.||......+  ...++.    ..+....       ..........+.++
T Consensus       154 ~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~--~~~~~~----~~~~~~~-------~~~~~~~~~~~~~~  220 (244)
T smart00220      154 APEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL--ELFKKI----GKPKPPF-------PPPEWKISPEAKDL  220 (244)
T ss_pred             CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH--HHHHHH----hccCCCC-------ccccccCCHHHHHH
Confidence            9999988889999999999999999999999997632211  111111    1111110       00000033567889


Q ss_pred             HHHhcccCCCCCCCHHHHHH
Q 007869          512 GLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       512 ~~~Cl~~dP~~RPs~~evl~  531 (586)
                      +.+|+..+|++||++.++++
T Consensus       221 i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      221 IRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHHccCCchhccCHHHHhh
Confidence            99999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=1.3e-32  Score=303.46  Aligned_cols=262  Identities=18%  Similarity=0.216  Sum_probs=173.8

Q ss_pred             hhcCCcccceeEeecCceEEEEEEeCCC----CeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeee------e
Q 007869          258 IATKGFREKELLGTGGFGRVYRGTLPKS----QIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGY------C  327 (586)
Q Consensus       258 ~a~~~f~~~~~LG~G~~g~Vy~~~~~~~----~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~------~  327 (586)
                      ...++|+..+.||+|+||.||+|++..+    +..||||++......  +....|  .+.+..+.++..++..      +
T Consensus       129 ~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~  204 (566)
T PLN03225        129 FKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSS  204 (566)
T ss_pred             CccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhccccc
Confidence            3667899999999999999999999888    889999998643221  111111  1222222333222221      2


Q ss_pred             eccCeEEEEEecCCCCChhhhhhcCCCc------------------cchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCC
Q 007869          328 RRKGELLLVYDYMPNGSLDKYLYDQPKV------------------TLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDV  389 (586)
Q Consensus       328 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~------------------~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDI  389 (586)
                      ....+.++||||+++++|.+++......                  ......+..++.|++.||.|||+   ++|+||||
T Consensus       205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~---~gIiHRDL  281 (566)
T PLN03225        205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHRDV  281 (566)
T ss_pred             ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH---CCEEeCcC
Confidence            4567899999999999999998754210                  11223456789999999999998   89999999


Q ss_pred             CCCCeeecC-CCCeEEccccceeeccCCCCCceeeeccCCCccCcccccCC----------------------CCCCcce
Q 007869          390 KASNVLLDG-ELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTG----------------------KATTSAD  446 (586)
Q Consensus       390 kp~NIll~~-~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~s~ksD  446 (586)
                      ||+|||+++ ++.+||+|||+|+.+............+|+.|+|||.+...                      .++.++|
T Consensus       282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D  361 (566)
T PLN03225        282 KPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD  361 (566)
T ss_pred             CHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence            999999986 57899999999987655444444557889999999965322                      2345679


Q ss_pred             EEehhHHHHHHHhCCCCCCCCCCC-------ccchhhHHHHhhhccCccccccCCCCCccc--cHHHHHHHHHHHHHhcc
Q 007869          447 VFSFGAFLLEVACGRRPIQRQGPS-------ENLILVDWVFDFWNRGELLEARDPNLGTEY--VAEELELVLKLGLLCSH  517 (586)
Q Consensus       447 VyS~Gvvl~ElltG~~p~~~~~~~-------~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~--~~~~~~~l~~l~~~Cl~  517 (586)
                      ||||||+||||+++..++......       ....+..|.....      ....+.+...+  .........+|+.+|++
T Consensus       362 VwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~  435 (566)
T PLN03225        362 IYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVE------PRASPDLRRGFEVLDLDGGAGWELLKSMMR  435 (566)
T ss_pred             cHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhc------cccchhhhhhhhhccccchHHHHHHHHHcc
Confidence            999999999999977654321000       0000111111000      00000000000  00011234578999999


Q ss_pred             cCCCCCCCHHHHHHH
Q 007869          518 SDPTARPSMRQVVQI  532 (586)
Q Consensus       518 ~dP~~RPs~~evl~~  532 (586)
                      .||++|||+.|+++.
T Consensus       436 ~dP~kR~ta~e~L~H  450 (566)
T PLN03225        436 FKGRQRISAKAALAH  450 (566)
T ss_pred             CCcccCCCHHHHhCC
Confidence            999999999999863

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-33  Score=248.53  Aligned_cols=265  Identities=23%  Similarity=0.294  Sum_probs=198.4

Q ss_pred             CcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccc--hhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEec
Q 007869          262 GFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR--QGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY  339 (586)
Q Consensus       262 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  339 (586)
                      +|...++||+|.||+||+|+..++.+.||+|+++.++.  ..-...++|+-+|+.++|+|||++++....++.+-+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            46667889999999999999999999999999976532  2235678999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCC
Q 007869          340 MPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP  419 (586)
Q Consensus       340 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~  419 (586)
                      | ..+|..+...- ...++......++.|+++||.+.|+   +++.|||+||.|.|++.+|+.||+|||+++.++-... 
T Consensus        83 c-dqdlkkyfdsl-ng~~d~~~~rsfmlqllrgl~fchs---hnvlhrdlkpqnllin~ngelkladfglarafgipvr-  156 (292)
T KOG0662|consen   83 C-DQDLKKYFDSL-NGDLDPEIVRSFMLQLLRGLGFCHS---HNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR-  156 (292)
T ss_pred             h-hHHHHHHHHhc-CCcCCHHHHHHHHHHHHhhhhhhhh---hhhhhccCCcceEEeccCCcEEecccchhhhcCCceE-
Confidence            9 45787776544 3467888888999999999999998   9999999999999999999999999999998765432 


Q ss_pred             ceeeeccCCCccCcccccCCC-CCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccC---ccccccCC
Q 007869          420 QTTHVVGTLGYLAPEHTRTGK-ATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRG---ELLEARDP  494 (586)
Q Consensus       420 ~~~~~~gt~~y~aPE~~~~~~-~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~---~~~~~~d~  494 (586)
                      .....+-|..|.+|.++.+.+ |++..|+||-||++.|+.. |++.|.+.+-.++...+-|+.....+.   .+.+..|.
T Consensus       157 cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdy  236 (292)
T KOG0662|consen  157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDY  236 (292)
T ss_pred             eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCC
Confidence            233456799999999998765 7889999999999999987 666666655544443333332222111   11222222


Q ss_pred             CCCcccc---------HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          495 NLGTEYV---------AEELELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       495 ~l~~~~~---------~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                      .....|.         +..-..=.++..+.+.-+|.+|.++++.++.
T Consensus       237 k~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh  283 (292)
T KOG0662|consen  237 KPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH  283 (292)
T ss_pred             cccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence            2211111         1111111234444455599999999888753

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.98  E-value=6.6e-32  Score=291.22  Aligned_cols=261  Identities=20%  Similarity=0.305  Sum_probs=182.0

Q ss_pred             hhcCCcccceeEeecCceEEEEEEeC----------------CCCeEEEEEEeccccchhHHHH--------------HH
Q 007869          258 IATKGFREKELLGTGGFGRVYRGTLP----------------KSQIEIAVKKISHESRQGMKEF--------------VA  307 (586)
Q Consensus       258 ~a~~~f~~~~~LG~G~~g~Vy~~~~~----------------~~~~~vavK~~~~~~~~~~~~~--------------~~  307 (586)
                      ...++|++.++||+|+||.||+|.+.                ..++.||||++........++|              ..
T Consensus       142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v  221 (507)
T PLN03224        142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV  221 (507)
T ss_pred             ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence            35778999999999999999999752                2345799999876543333333              34


Q ss_pred             HHHHhcccCCCce-----eeeeeeeec--------cCeEEEEEecCCCCChhhhhhcCC---------------------
Q 007869          308 EIVSIGRLRHRNL-----VQLLGYCRR--------KGELLLVYDYMPNGSLDKYLYDQP---------------------  353 (586)
Q Consensus       308 Ei~~l~~l~H~ni-----v~l~~~~~~--------~~~~~lV~E~~~~gsL~~~l~~~~---------------------  353 (586)
                      |+..+.+++|.++     ++++++|..        ++..+|||||+++++|.++++...                     
T Consensus       222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~  301 (507)
T PLN03224        222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM  301 (507)
T ss_pred             HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence            6777777776654     677887753        356899999999999999987431                     


Q ss_pred             -CccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCCceeeeccCCCccC
Q 007869          354 -KVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLA  432 (586)
Q Consensus       354 -~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~a  432 (586)
                       ...++|..+..++.|++++|.|||+   .+|+||||||+|||++.++.+||+|||+++.+............+|+.|+|
T Consensus       302 ~~~~~~~~~~~~i~~ql~~aL~~lH~---~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~a  378 (507)
T PLN03224        302 PQDKRDINVIKGVMRQVLTGLRKLHR---IGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSP  378 (507)
T ss_pred             ccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeC
Confidence             1234677888999999999999998   899999999999999999999999999998654433222223345889999


Q ss_pred             cccccCCCC----------------------CCcceEEehhHHHHHHHhCCC-CCCCCCCCc------cchhhHHHHhhh
Q 007869          433 PEHTRTGKA----------------------TTSADVFSFGAFLLEVACGRR-PIQRQGPSE------NLILVDWVFDFW  483 (586)
Q Consensus       433 PE~~~~~~~----------------------s~ksDVyS~Gvvl~ElltG~~-p~~~~~~~~------~~~l~~~v~~~~  483 (586)
                      ||.+.....                      ..+.||||+||+++||++|.. |+.......      ...+..|  +.+
T Consensus       379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~--r~~  456 (507)
T PLN03224        379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRW--RMY  456 (507)
T ss_pred             hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHH--Hhh
Confidence            998754321                      134799999999999999875 665321111      0011111  111


Q ss_pred             ccCccccccCCCCCccccHHHHHHHHHHHHHhcccCC---CCCCCHHHHHH
Q 007869          484 NRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDP---TARPSMRQVVQ  531 (586)
Q Consensus       484 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP---~~RPs~~evl~  531 (586)
                      .....    +...    .........+++.+|+..+|   .+|+|+.|+++
T Consensus       457 ~~~~~----~~~~----~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        457 KGQKY----DFSL----LDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             cccCC----Cccc----ccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence            11111    1111    11123445566677777655   78999999985

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.98  E-value=8.4e-33  Score=273.44  Aligned_cols=264  Identities=25%  Similarity=0.347  Sum_probs=211.7

Q ss_pred             hhhhhhhcCCcccceeEeecCceEEEEEEeCCC-----CeEEEEEEeccc-cchhHHHHHHHHHHhcccCCCceeeeeee
Q 007869          253 YKDLYIATKGFREKELLGTGGFGRVYRGTLPKS-----QIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGY  326 (586)
Q Consensus       253 ~~el~~a~~~f~~~~~LG~G~~g~Vy~~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~~~  326 (586)
                      .+|+.....+++...++-+|.||.||+|.+++.     .+.|-||.++.. ++-....++.|...+..+.|||+.++.+.
T Consensus       276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V  355 (563)
T KOG1024|consen  276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV  355 (563)
T ss_pred             HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence            356677777888889999999999999977543     334667766543 34445678999999999999999999998


Q ss_pred             eecc-CeEEEEEecCCCCChhhhhhc------CCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCC
Q 007869          327 CRRK-GELLLVYDYMPNGSLDKYLYD------QPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGE  399 (586)
Q Consensus       327 ~~~~-~~~~lV~E~~~~gsL~~~l~~------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~  399 (586)
                      +.+. ...+..|.++.-|+|..+|..      +....+.-.+...++.|++.|+.|||+   +++||.||..+|.+||+.
T Consensus       356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~---~~ViHkDiAaRNCvIdd~  432 (563)
T KOG1024|consen  356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHN---HGVIHKDIAARNCVIDDQ  432 (563)
T ss_pred             EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHh---cCcccchhhhhcceehhh
Confidence            8765 567889999999999999972      123567888999999999999999998   999999999999999999


Q ss_pred             CCeEEccccceeeccCCCCCce-eeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhH
Q 007869          400 LNGRLGDFGLARLYDHGTDPQT-THVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVD  477 (586)
Q Consensus       400 ~~~kL~DFGla~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~  477 (586)
                      .++||+|-.++|.+-....... .....+..||+||.+.+..|+.++|||||||+||||+| |+.|+...++.|..    
T Consensus       433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~----  508 (563)
T KOG1024|consen  433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEME----  508 (563)
T ss_pred             eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHH----
Confidence            9999999999996544332222 22334778999999999999999999999999999998 99999877665422    


Q ss_pred             HHHhhhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 007869          478 WVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER  535 (586)
Q Consensus       478 ~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  535 (586)
                         .+..+|....         .+-.+++++..++.-||..+|++||+++|++..|..
T Consensus       509 ---~ylkdGyRla---------QP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse  554 (563)
T KOG1024|consen  509 ---HYLKDGYRLA---------QPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE  554 (563)
T ss_pred             ---HHHhccceec---------CCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence               2223333221         123456788999999999999999999999988853

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.98  E-value=1.1e-32  Score=289.74  Aligned_cols=241  Identities=24%  Similarity=0.270  Sum_probs=195.4

Q ss_pred             hcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhccc-CCCceeeeeeeeeccCeEEEEE
Q 007869          259 ATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKGELLLVY  337 (586)
Q Consensus       259 a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~lV~  337 (586)
                      .++.|.....+|.|+|+.|-++.+..+++..+||++.....    +-.+|+.++.+. +||||+++.+.+.+..+.++||
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~  395 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM  395 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence            36677788889999999999999999999999999976622    234566555555 7999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeee-cCCCCeEEccccceeeccCC
Q 007869          338 DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLL-DGELNGRLGDFGLARLYDHG  416 (586)
Q Consensus       338 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll-~~~~~~kL~DFGla~~~~~~  416 (586)
                      |++.++-|.+.+...+.   ...++..|+.+|+.++.|||+   +++|||||||+|||+ ++.++++|+|||.++.....
T Consensus       396 e~l~g~ell~ri~~~~~---~~~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~  469 (612)
T KOG0603|consen  396 ELLDGGELLRRIRSKPE---FCSEASQWAAELVSAVDYLHE---QGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS  469 (612)
T ss_pred             hhccccHHHHHHHhcch---hHHHHHHHHHHHHHHHHHHHh---cCeeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence            99999988887766532   226777899999999999998   999999999999999 58899999999999876543


Q ss_pred             CCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCC
Q 007869          417 TDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNL  496 (586)
Q Consensus       417 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l  496 (586)
                          ....+-|..|.|||++....|++++|+||||++||||++|+.||.......+  +.    .....+          
T Consensus       470 ----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~e--i~----~~i~~~----------  529 (612)
T KOG0603|consen  470 ----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIE--IH----TRIQMP----------  529 (612)
T ss_pred             ----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHH--HH----HhhcCC----------
Confidence                2234568899999999989999999999999999999999999987544311  11    111111          


Q ss_pred             CccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          497 GTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       497 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                        ++.....+...+|+.+||+.||.+||+|.++..
T Consensus       530 --~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  530 --KFSECVSDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             --ccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence              122333455667888899999999999999975

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=7.5e-34  Score=266.38  Aligned_cols=267  Identities=27%  Similarity=0.414  Sum_probs=203.9

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccc--hhHHHHHHHHHHhcccCCCceeeeeeeeecc--------
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR--QGMKEFVAEIVSIGRLRHRNLVQLLGYCRRK--------  330 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~--------  330 (586)
                      ..|....+||+|.||.||+++.+++++.||+|++-.+++  .--...++|+++|..++|+|++.++..|...        
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            346667889999999999999999999999997754322  1224568999999999999999999988643        


Q ss_pred             CeEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccce
Q 007869          331 GELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLA  410 (586)
Q Consensus       331 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla  410 (586)
                      ..+++||++|+. +|..+|.+. ...++...+.+++.++..||.|+|.   ..|+|||+|+.|+||+.++.+||+|||++
T Consensus        97 ~t~ylVf~~ceh-DLaGlLsn~-~vr~sls~Ikk~Mk~Lm~GL~~iHr---~kilHRDmKaaNvLIt~dgilklADFGla  171 (376)
T KOG0669|consen   97 ATFYLVFDFCEH-DLAGLLSNR-KVRFSLSEIKKVMKGLMNGLYYIHR---NKILHRDMKAANVLITKDGILKLADFGLA  171 (376)
T ss_pred             ceeeeeHHHhhh-hHHHHhcCc-cccccHHHHHHHHHHHHHHHHHHHH---hhHHhhcccHhhEEEcCCceEEeeccccc
Confidence            358999999964 888888654 3567778888999999999999998   89999999999999999999999999999


Q ss_pred             eeccCCC---CCceeeeccCCCccCcccccCC-CCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHH-------
Q 007869          411 RLYDHGT---DPQTTHVVGTLGYLAPEHTRTG-KATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWV-------  479 (586)
Q Consensus       411 ~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v-------  479 (586)
                      +.+....   .+..+..+-|..|++||.+.+. .|+++.|||+-||++.||.+|.+-+++.....++.++..+       
T Consensus       172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tke  251 (376)
T KOG0669|consen  172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKE  251 (376)
T ss_pred             cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcc
Confidence            8765432   2334556779999999998765 6899999999999999999999999887665555444332       


Q ss_pred             -HhhhccCcccccc--CCCCCccc--cHHHH------HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          480 -FDFWNRGELLEAR--DPNLGTEY--VAEEL------ELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       480 -~~~~~~~~~~~~~--d~~l~~~~--~~~~~------~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                       |....+-.+.+.+  .|-....+  ..+.+      ...++|+..++..||.+|+.+.+++..
T Consensus       252 vWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh  315 (376)
T KOG0669|consen  252 VWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH  315 (376)
T ss_pred             cCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence             2222222222222  11111111  11122      255677788899999999999999853

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.3e-32  Score=273.45  Aligned_cols=246  Identities=23%  Similarity=0.308  Sum_probs=193.4

Q ss_pred             hhhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccc---hhHHHHHHHHHHhccc-CCCceeeeeeeeeccCe
Q 007869          257 YIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR---QGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKGE  332 (586)
Q Consensus       257 ~~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~~~  332 (586)
                      ++-..+|....+||+|.||+|.++..+++...+|||+++++..   ...+--+.|-++|.-. +-|.+++|+.++..-+.
T Consensus       345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR  424 (683)
T KOG0696|consen  345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR  424 (683)
T ss_pred             ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence            3445578889999999999999999999999999999987532   1222334566666655 67899999999999999


Q ss_pred             EEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceee
Q 007869          333 LLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARL  412 (586)
Q Consensus       333 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~  412 (586)
                      +|+||||+.+|+|--++..-+  .+.+..+.-++..||-||-+||+   ++||+||||..|||||.+|.+||+|||+++.
T Consensus       425 LyFVMEyvnGGDLMyhiQQ~G--kFKEp~AvFYAaEiaigLFFLh~---kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKE  499 (683)
T KOG0696|consen  425 LYFVMEYVNGGDLMYHIQQVG--KFKEPVAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE  499 (683)
T ss_pred             eeeEEEEecCchhhhHHHHhc--ccCCchhhhhhHHHHHHhhhhhc---CCeeeeeccccceEeccCCceEeeecccccc
Confidence            999999999999999987664  46677788889999999999998   9999999999999999999999999999984


Q ss_pred             ccCCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCcccccc
Q 007869          413 YDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEAR  492 (586)
Q Consensus       413 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~  492 (586)
                      --- ....+.+.+||+.|+|||++...+|....|.|||||+||||+.|++||++.+..+..       +...+..+    
T Consensus       500 ni~-~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF-------~aI~ehnv----  567 (683)
T KOG0696|consen  500 NIF-DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELF-------QAIMEHNV----  567 (683)
T ss_pred             ccc-CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHH-------HHHHHccC----
Confidence            211 122345689999999999999999999999999999999999999999987654321       11111111    


Q ss_pred             CCCCCccccHHHHHHHHHHHHHhcccCCCCCCC
Q 007869          493 DPNLGTEYVAEELELVLKLGLLCSHSDPTARPS  525 (586)
Q Consensus       493 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs  525 (586)
                            .|+.....+...+....+...|.+|..
T Consensus       568 ------syPKslSkEAv~ickg~ltK~P~kRLG  594 (683)
T KOG0696|consen  568 ------SYPKSLSKEAVAICKGLLTKHPGKRLG  594 (683)
T ss_pred             ------cCcccccHHHHHHHHHHhhcCCccccC
Confidence                  122223334445555567788888853

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=1.8e-31  Score=277.07  Aligned_cols=240  Identities=25%  Similarity=0.360  Sum_probs=195.6

Q ss_pred             hhhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc---chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeE
Q 007869          257 YIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGEL  333 (586)
Q Consensus       257 ~~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~  333 (586)
                      +....-|...+.||-|+||.|.++.-.++...+|+|.+++.+   +......++|-.+|..-..+-||+|+-.|.+++.+
T Consensus       625 KMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnL  704 (1034)
T KOG0608|consen  625 KMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNL  704 (1034)
T ss_pred             hccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCce
Confidence            334455888999999999999999988888889999997753   34455678899999999999999999999999999


Q ss_pred             EEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeec
Q 007869          334 LLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLY  413 (586)
Q Consensus       334 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~  413 (586)
                      |+||||++||++-.+|-+.+  -+++....-++.++..|+++.|.   .++|||||||+|||||.+|.+||.|||||.-+
T Consensus       705 YFVMdYIPGGDmMSLLIrmg--IFeE~LARFYIAEltcAiesVHk---mGFIHRDiKPDNILIDrdGHIKLTDFGLCTGf  779 (1034)
T KOG0608|consen  705 YFVMDYIPGGDMMSLLIRMG--IFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGF  779 (1034)
T ss_pred             EEEEeccCCccHHHHHHHhc--cCHHHHHHHHHHHHHHHHHHHHh---ccceecccCccceEEccCCceeeeeccccccc
Confidence            99999999999999987653  56777777788999999999998   99999999999999999999999999999632


Q ss_pred             c---------CCCC----------------C----------------ceeeeccCCCccCcccccCCCCCCcceEEehhH
Q 007869          414 D---------HGTD----------------P----------------QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGA  452 (586)
Q Consensus       414 ~---------~~~~----------------~----------------~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gv  452 (586)
                      .         .+..                .                .....+||+.|+|||++....++..+|.||.||
T Consensus       780 RWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gv  859 (1034)
T KOG0608|consen  780 RWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGV  859 (1034)
T ss_pred             eeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhH
Confidence            1         1100                0                001257999999999999999999999999999


Q ss_pred             HHHHHHhCCCCCCCCCCCccc-hhhHHHHhhhccCccccccCCCCCccccHHHHHHHHHH
Q 007869          453 FLLEVACGRRPIQRQGPSENL-ILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKL  511 (586)
Q Consensus       453 vl~ElltG~~p~~~~~~~~~~-~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l  511 (586)
                      +||||+.|+.||....+.+.. ..+.|-          ..++-........++...+.+|
T Consensus       860 il~em~~g~~pf~~~tp~~tq~kv~nw~----------~~l~~~~~~~ls~e~~~li~kL  909 (1034)
T KOG0608|consen  860 ILYEMLVGQPPFLADTPGETQYKVINWR----------NFLHIPYQGNLSKEALDLIQKL  909 (1034)
T ss_pred             HHHHHhhCCCCccCCCCCcceeeeeehh----------hccccccccccCHHHHHHHHHH
Confidence            999999999999988776543 333342          2233344455667777777666

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.97  E-value=8.5e-32  Score=246.05  Aligned_cols=209  Identities=27%  Similarity=0.365  Sum_probs=174.1

Q ss_pred             hhhhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc-cchhHHHHHHHHHHhccc-CCCceeeeeeeeeccCeE
Q 007869          256 LYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE-SRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKGEL  333 (586)
Q Consensus       256 l~~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~~~~  333 (586)
                      +....+.......||+|++|.|-+-++..+|...|+|++... ..+..+..+.|+.+..+. .+|.+|.++|...+.+..
T Consensus        41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdv  120 (282)
T KOG0984|consen   41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDV  120 (282)
T ss_pred             cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccE
Confidence            334445555567799999999999999999999999999765 445567788999887765 799999999999999999


Q ss_pred             EEEEecCCCCChhhhhhc--CCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEcccccee
Q 007869          334 LLVYDYMPNGSLDKYLYD--QPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR  411 (586)
Q Consensus       334 ~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~  411 (586)
                      ++.||.| .-||+.+-.+  .....+++...-+|+..+.+||.|||+  ...+||||+||+|||++.+|++|+||||.+-
T Consensus       121 wIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG  197 (282)
T KOG0984|consen  121 WICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISG  197 (282)
T ss_pred             EEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccce
Confidence            9999999 4577765433  123578888899999999999999999  5789999999999999999999999999998


Q ss_pred             eccCCCCCceeeeccCCCccCcccccC----CCCCCcceEEehhHHHHHHHhCCCCCCCCCC
Q 007869          412 LYDHGTDPQTTHVVGTLGYLAPEHTRT----GKATTSADVFSFGAFLLEVACGRRPIQRQGP  469 (586)
Q Consensus       412 ~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~  469 (586)
                      .+....  ..+...|-..|||||.+..    ..|+-||||||||+.+.||.+++.|++....
T Consensus       198 ~L~dSi--Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t  257 (282)
T KOG0984|consen  198 YLVDSI--AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT  257 (282)
T ss_pred             eehhhh--HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence            765432  3344568889999998743    3688999999999999999999999986543

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=4e-31  Score=264.68  Aligned_cols=259  Identities=24%  Similarity=0.337  Sum_probs=198.4

Q ss_pred             hhhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc--ch-----hHHHHHHHHHHhcccCCCceeeeeeeeec
Q 007869          257 YIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES--RQ-----GMKEFVAEIVSIGRLRHRNLVQLLGYCRR  329 (586)
Q Consensus       257 ~~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~-----~~~~~~~Ei~~l~~l~H~niv~l~~~~~~  329 (586)
                      ..-.++|-..++||+|||+.||++.+...++.||||+-....  ++     -.+...+|..+-+.|.||.||++++++.-
T Consensus       459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl  538 (775)
T KOG1151|consen  459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL  538 (775)
T ss_pred             cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee
Confidence            344456777899999999999999998889999999864331  11     12345679999999999999999999874


Q ss_pred             -cCeEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeec---CCCCeEEc
Q 007869          330 -KGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLD---GELNGRLG  405 (586)
Q Consensus       330 -~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~---~~~~~kL~  405 (586)
                       .+.+|-|+|||+|.+|+-+|+.+  ..+++.....|+.||..||.||.+ ...+|||-||||.||||-   ..|.+||.
T Consensus       539 DtdsFCTVLEYceGNDLDFYLKQh--klmSEKEARSIiMQiVnAL~YLNE-ikpPIIHYDLKPgNILLv~GtacGeIKIT  615 (775)
T KOG1151|consen  539 DTDSFCTVLEYCEGNDLDFYLKQH--KLMSEKEARSIIMQIVNALKYLNE-IKPPIIHYDLKPGNILLVNGTACGEIKIT  615 (775)
T ss_pred             ccccceeeeeecCCCchhHHHHhh--hhhhHHHHHHHHHHHHHHHHHHhc-cCCCeeeeccCCccEEEecCcccceeEee
Confidence             46789999999999999999776  368889999999999999999996 458999999999999994   46889999


Q ss_pred             cccceeeccCCCCC------ceeeeccCCCccCcccccCC----CCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchh
Q 007869          406 DFGLARLYDHGTDP------QTTHVVGTLGYLAPEHTRTG----KATTSADVFSFGAFLLEVACGRRPIQRQGPSENLIL  475 (586)
Q Consensus       406 DFGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~----~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l  475 (586)
                      ||||+++++.....      .+....||.+|++||++.-+    +.+.|.||||.||++|..+.|++||........   
T Consensus       616 DFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQd---  692 (775)
T KOG1151|consen  616 DFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQD---  692 (775)
T ss_pred             ecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHH---
Confidence            99999998765332      23446899999999988544    468899999999999999999999976433211   


Q ss_pred             hHHHHhhhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 007869          476 VDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQV  529 (586)
Q Consensus       476 ~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev  529 (586)
                            ....+.++++..-.+...  +........++.+||+..-++|-...++
T Consensus       693 ------ILqeNTIlkAtEVqFP~K--PvVsseAkaFIRRCLaYRKeDR~DV~qL  738 (775)
T KOG1151|consen  693 ------ILQENTILKATEVQFPPK--PVVSSEAKAFIRRCLAYRKEDRIDVQQL  738 (775)
T ss_pred             ------HHhhhchhcceeccCCCC--CccCHHHHHHHHHHHHhhhhhhhhHHHH
Confidence                  122333333322222111  1112334567778999999998865554

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.7e-32  Score=277.41  Aligned_cols=250  Identities=23%  Similarity=0.322  Sum_probs=203.7

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc---cchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEE
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLV  336 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV  336 (586)
                      -.++.....||-||||.|=++........+|+|.+++.   +....+....|-.+|.+.+.|.||+|+-.|.+....|+.
T Consensus       419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL  498 (732)
T KOG0614|consen  419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML  498 (732)
T ss_pred             hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence            34556667799999999999988765556888888654   334456678899999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCC
Q 007869          337 YDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHG  416 (586)
Q Consensus       337 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~  416 (586)
                      ||-|-||.|...|++.+  .++.....-++..+.+|+.|||+   ++||+|||||+|.|||.+|-+||.|||.|+.+..+
T Consensus       499 mEaClGGElWTiLrdRg--~Fdd~tarF~~acv~EAfeYLH~---k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g  573 (732)
T KOG0614|consen  499 MEACLGGELWTILRDRG--SFDDYTARFYVACVLEAFEYLHR---KGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG  573 (732)
T ss_pred             HHhhcCchhhhhhhhcC--CcccchhhhhHHHHHHHHHHHHh---cCceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence            99999999999998764  56777777789999999999998   99999999999999999999999999999988764


Q ss_pred             CCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCC
Q 007869          417 TDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNL  496 (586)
Q Consensus       417 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l  496 (586)
                      .  .+.+.+||+.|.|||++.++..+.+.|.||||+++|||++|++||.+.++.....++            ++.+|.  
T Consensus       574 ~--KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~I------------LkGid~--  637 (732)
T KOG0614|consen  574 R--KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLI------------LKGIDK--  637 (732)
T ss_pred             C--ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHH------------Hhhhhh--
Confidence            3  567789999999999999999999999999999999999999999987664433222            111111  


Q ss_pred             CccccHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 007869          497 GTEYVAEELELVLKLGLLCSHSDPTARPS-----MRQVVQ  531 (586)
Q Consensus       497 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~  531 (586)
                       .+++........+|+.+.+..+|.+|.-     +.++-+
T Consensus       638 -i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkk  676 (732)
T KOG0614|consen  638 -IEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKK  676 (732)
T ss_pred             -hhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHh
Confidence             1122233344556666777889999986     666654

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.97  E-value=2.2e-31  Score=285.65  Aligned_cols=244  Identities=27%  Similarity=0.385  Sum_probs=187.3

Q ss_pred             cccceeEeecCce-EEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhccc-CCCceeeeeeeeeccCeEEEEEecC
Q 007869          263 FREKELLGTGGFG-RVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKGELLLVYDYM  340 (586)
Q Consensus       263 f~~~~~LG~G~~g-~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~lV~E~~  340 (586)
                      |...+++|.|+.| .||+|..  .++.||||++-.+..   .-..+|+..|+.- +|||||++++.-.++..+||..|.|
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e~~---~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC  585 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLLEEFF---DFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC  585 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee--CCceehHHHHhhHhH---HHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence            5566789999988 5799998  467899999865432   3457899999887 7999999999988999999999999


Q ss_pred             CCCChhhhhhcC-CC-ccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecC-----CCCeEEccccceeec
Q 007869          341 PNGSLDKYLYDQ-PK-VTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDG-----ELNGRLGDFGLARLY  413 (586)
Q Consensus       341 ~~gsL~~~l~~~-~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~-----~~~~kL~DFGla~~~  413 (586)
                       .-+|.+++... .. ....-...+.++.|+++||++||+   .+||||||||.||||+.     ..+++|+|||+++.+
T Consensus       586 -~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs---l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl  661 (903)
T KOG1027|consen  586 -ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS---LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL  661 (903)
T ss_pred             -hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh---cccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence             56999999774 11 111113456789999999999998   89999999999999965     357999999999988


Q ss_pred             cCCCCC--ceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhC-CCCCCCCCCCccchhhHHHHhhhccCcccc
Q 007869          414 DHGTDP--QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACG-RRPIQRQGPSENLILVDWVFDFWNRGELLE  490 (586)
Q Consensus       414 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG-~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~  490 (586)
                      ..+...  ......||-+|+|||++....-+.+.||||+|||+|..++| .+||...-..+              .++..
T Consensus       662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~--------------~NIl~  727 (903)
T KOG1027|consen  662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--------------ANILT  727 (903)
T ss_pred             CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh--------------hhhhc
Confidence            765443  23456899999999999999889999999999999999995 89997642211              11111


Q ss_pred             ccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          491 ARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       491 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      ....-...+...++  ...+|+..|++++|..||++.+|+.
T Consensus       728 ~~~~L~~L~~~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  728 GNYTLVHLEPLPDC--EAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             CccceeeeccCchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence            00000000111111  6678889999999999999999973

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=6.5e-32  Score=255.83  Aligned_cols=267  Identities=27%  Similarity=0.370  Sum_probs=202.4

Q ss_pred             CcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc--cchhHHHHHHHHHHhcccCCCceeeeeeeeecc-----CeEE
Q 007869          262 GFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRK-----GELL  334 (586)
Q Consensus       262 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~-----~~~~  334 (586)
                      +.+..+.||-|+||.||..+++.+++.||+|++...  +-...+.+.+|+++|.-++|.|++..++...-.     .++|
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY  133 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY  133 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence            345567899999999999999999999999998653  233457789999999999999999998876543     3578


Q ss_pred             EEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeecc
Q 007869          335 LVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYD  414 (586)
Q Consensus       335 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~  414 (586)
                      .+.|.| ..+|.+.|-..  ..|+-....-++.||++||+|||+   .+|.||||||.|.|++.|-.+||||||+|+..+
T Consensus       134 V~TELm-QSDLHKIIVSP--Q~Ls~DHvKVFlYQILRGLKYLHs---A~ILHRDIKPGNLLVNSNCvLKICDFGLARvee  207 (449)
T KOG0664|consen  134 VLTELM-QSDLHKIIVSP--QALTPDHVKVFVYQILRGLKYLHT---ANILHRDIKPGNLLVNSNCILKICDFGLARTWD  207 (449)
T ss_pred             HHHHHH-HhhhhheeccC--CCCCcchhhhhHHHHHhhhHHHhh---cchhhccCCCccEEeccCceEEecccccccccc
Confidence            889988 56888877554  356666777789999999999998   999999999999999999999999999999877


Q ss_pred             CCCCCceeeeccCCCccCcccccCC-CCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHH--------Hhhhcc
Q 007869          415 HGTDPQTTHVVGTLGYLAPEHTRTG-KATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWV--------FDFWNR  485 (586)
Q Consensus       415 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v--------~~~~~~  485 (586)
                      .+.....+..+-|..|+|||++.+. .|+.+.||||.||++.||+..+..|+..++-+++.++.-+        .+..-+
T Consensus       208 ~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACE  287 (449)
T KOG0664|consen  208 QRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACE  287 (449)
T ss_pred             hhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhh
Confidence            6666666777889999999998765 5899999999999999999999999887776655443211        011111


Q ss_pred             Cccccc-----cCCCCCccc---c-HHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 007869          486 GELLEA-----RDPNLGTEY---V-AEELELVLKLGLLCSHSDPTARPSMRQVVQILE  534 (586)
Q Consensus       486 ~~~~~~-----~d~~l~~~~---~-~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  534 (586)
                      |.....     ..|.+..-|   + ...-...+.+...++.+||.+|.+..+.+..+.
T Consensus       288 GAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~  345 (449)
T KOG0664|consen  288 GAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY  345 (449)
T ss_pred             hhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence            111111     111111111   1 111223345556689999999999999887653

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.7e-30  Score=252.38  Aligned_cols=203  Identities=26%  Similarity=0.357  Sum_probs=176.7

Q ss_pred             hhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc---cchhHHHHHHHHHHhccc-CCCceeeeeeeeeccCeE
Q 007869          258 IATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE---SRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKGEL  333 (586)
Q Consensus       258 ~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~~~~  333 (586)
                      ..-++|+..++||+|.|.+|..++++.+.+.+|+|+++++   ..+.++-.+.|-.+..+. +||.+|-|..+|..+..+
T Consensus       247 l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrl  326 (593)
T KOG0695|consen  247 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRL  326 (593)
T ss_pred             cccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceE
Confidence            3456899999999999999999999999999999999765   233344455666666655 899999999999999999


Q ss_pred             EEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeec
Q 007869          334 LLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLY  413 (586)
Q Consensus       334 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~  413 (586)
                      ++|.||+++|+|--++.+.  ..|+++...-+...|+.||.|||+   ++||.||||..|||+|.++.+||.|+|+++.-
T Consensus       327 ffvieyv~ggdlmfhmqrq--rklpeeharfys~ei~lal~flh~---rgiiyrdlkldnvlldaeghikltdygmcke~  401 (593)
T KOG0695|consen  327 FFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEICLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG  401 (593)
T ss_pred             EEEEEEecCcceeeehhhh--hcCcHHHhhhhhHHHHHHHHHHhh---cCeeeeeccccceEEccCCceeecccchhhcC
Confidence            9999999999998888665  468888888889999999999998   99999999999999999999999999999852


Q ss_pred             cCCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCC
Q 007869          414 DHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQR  466 (586)
Q Consensus       414 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~  466 (586)
                      -.. ...+.+.+||+.|+|||++++..|....|.|++||+++||+.|+.||+-
T Consensus       402 l~~-gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdi  453 (593)
T KOG0695|consen  402 LGP-GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI  453 (593)
T ss_pred             CCC-CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcce
Confidence            221 2245668999999999999999999999999999999999999999974

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=2.9e-29  Score=240.21  Aligned_cols=211  Identities=33%  Similarity=0.530  Sum_probs=185.8

Q ss_pred             EeecCceEEEEEEeCCCCeEEEEEEeccccch-hHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEecCCCCChhh
Q 007869          269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQ-GMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDK  347 (586)
Q Consensus       269 LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~  347 (586)
                      ||+|.+|.||++....++..+++|++...... ..+.+.+|++.+++++|++++++++++......++++||+++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            68999999999999877889999999766443 35679999999999999999999999999999999999999999999


Q ss_pred             hhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecC-CCCeEEccccceeeccCCCCCceeeecc
Q 007869          348 YLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDG-ELNGRLGDFGLARLYDHGTDPQTTHVVG  426 (586)
Q Consensus       348 ~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~-~~~~kL~DFGla~~~~~~~~~~~~~~~g  426 (586)
                      ++.... ..+++..++.++.+++++|.+||+   .+++|+||+|.||+++. ++.++|+|||.+........ ......+
T Consensus        81 ~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~---~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~  155 (215)
T cd00180          81 LLKENE-GKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVG  155 (215)
T ss_pred             HHHhcc-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccC
Confidence            987653 368889999999999999999998   89999999999999999 89999999999987654321 2333567


Q ss_pred             CCCccCcccccCC-CCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCccccHHHH
Q 007869          427 TLGYLAPEHTRTG-KATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAEEL  505 (586)
Q Consensus       427 t~~y~aPE~~~~~-~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~  505 (586)
                      ...|++||..... ..+.++|+|++|+++++|                                                
T Consensus       156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------  187 (215)
T cd00180         156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------  187 (215)
T ss_pred             CCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------------
Confidence            8899999999877 788999999999999999                                                


Q ss_pred             HHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          506 ELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       506 ~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                      ..+.+++..|++.+|.+||++.++++.
T Consensus       188 ~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence            457788889999999999999999864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.96  E-value=1.4e-28  Score=239.65  Aligned_cols=200  Identities=32%  Similarity=0.460  Sum_probs=176.0

Q ss_pred             cccceeEeecCceEEEEEEeCCCCeEEEEEEeccccch-hHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEecCC
Q 007869          263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQ-GMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMP  341 (586)
Q Consensus       263 f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~  341 (586)
                      |+..+.||+|++|.||++...+++..+++|.+...... ..+.+.+|++.+.+++|+|++++++++......++++||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            45678899999999999999887889999999876544 56789999999999999999999999999999999999999


Q ss_pred             CCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCCce
Q 007869          342 NGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQT  421 (586)
Q Consensus       342 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~  421 (586)
                      +++|.+++..... .+++.....++.+++.+|.+||+   .+++|+||+|+||+++.++.++|+|||++...........
T Consensus        81 ~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~  156 (225)
T smart00221       81 GGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHS---LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALL  156 (225)
T ss_pred             CCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccc
Confidence            9999999976532 27889999999999999999998   8999999999999999999999999999987654431122


Q ss_pred             eeeccCCCccCcccc-cCCCCCCcceEEehhHHHHHHHhCCCCCCC
Q 007869          422 THVVGTLGYLAPEHT-RTGKATTSADVFSFGAFLLEVACGRRPIQR  466 (586)
Q Consensus       422 ~~~~gt~~y~aPE~~-~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~  466 (586)
                      ....++..|++||.. ....++.++|||+||++++||++|+.||..
T Consensus       157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            345678899999998 666788899999999999999999999965

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>cd01951 lectin_L-type legume lectins

Probab=99.96  E-value=1.5e-28  Score=240.82  Aligned_cols=150  Identities=31%  Similarity=0.399  Sum_probs=126.0

Q ss_pred             eeeEEEEEEEEEeCCCCCCCCcEEEEEecCCCCCCCCCC--CcccccccCCCCCCCccEEEEEeeccccCCCCCCCCCee
Q 007869           18 FSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPS--QYLGLFNDTNLGNETNHVFAVELDTIKSHGFLDINDNHV   95 (586)
Q Consensus        18 asF~t~F~f~i~~~~~~~~g~GlaF~l~p~~~~~~~~~g--~~lGl~~~~~~~~~~~~~vaVEfDt~~~~~~~d~~~~hv   95 (586)
                      ++|+|+|+|.|.... ..+||||||+|+|....+.+.+|  ++||+       ...++.+||||||++|.+++||+.|||
T Consensus        54 ~~F~~~F~f~i~~~~-~~~gdG~aF~l~~~~~~~~~~~g~~~~lG~-------~~~~~~~aVefDT~~N~~~~dp~~~hi  125 (223)
T cd01951          54 KDFTTTFKFYLGTKG-TNGADGIAFVLQNDPAGALGGGGGGGGLGY-------GGIGNSVAVEFDTYKNDDNNDPNGNHI  125 (223)
T ss_pred             CCEEEEEEEEEeCCC-CCCCCcEEEEEecCCCCccccCCCCCccCc-------cccCCeEEEEEeccccCCCCCCCCCEE
Confidence            689999999998754 56899999999997655555555  78886       456778999999999998889999999


Q ss_pred             EEeCCCCccc-------cccc----------CceEEEEcCeeeEEEEEEeecCCCCCCccceeeeeecchhccccceeee
Q 007869           96 GIDINSLKSE-------SSAP----------AGYYVEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSVLNDAMYVG  158 (586)
Q Consensus        96 gidvns~~s~-------~~~~----------~~~~i~y~~~~~~l~v~~~~~~~~~~~~~~~ls~~~dL~~~l~~~~~vG  158 (586)
                      ||++|+..+.       ....          ..+||+|++.++.|+|++.....  |.. +.++.++||+..++++||||
T Consensus       126 gi~~n~~~~~~~~~~~~~~~~~~~~~~~g~~~~v~I~Y~~~~~~L~v~l~~~~~--~~~-~~l~~~~~l~~~~~~~~yvG  202 (223)
T cd01951         126 SIDVNGNGNNTALATSLGSASLPNGTGLGNEHTVRITYDPTTNTLTVYLDNGST--LTS-LDITIPVDLIQLGPTKAYFG  202 (223)
T ss_pred             EEEcCCCCCCcccccccceeeCCCccCCCCEEEEEEEEeCCCCEEEEEECCCCc--ccc-ccEEEeeeecccCCCcEEEE
Confidence            9999998642       1111          12579999999999999986433  444 88999999999999999999


Q ss_pred             eecCCCccceeeeeeecccc
Q 007869          159 FSSSTGSVLASHYILGWSFK  178 (586)
Q Consensus       159 Fsastg~~~~~~~i~~Wsf~  178 (586)
                      ||||||...+.|.|++|+|.
T Consensus       203 FTAsTG~~~~~h~V~~wsf~  222 (223)
T cd01951         203 FTASTGGLTNLHDILNWSFT  222 (223)
T ss_pred             EEcccCCCcceeEEEEEEec
Confidence            99999999999999999996

The L-type (legume-type) lectins are a highly diverse family of carbohydrate binding proteins that generally display no enzymatic activity toward the sugars they bind. This family includes arcelin, concanavalinA, the lectin-like receptor kinases, the ERGIC-53/VIP36/EMP46 type1 transmembrane proteins, and an alpha-amylase inhibitor. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat six-stranded beta-sheet referred to as the "back face". This domain homodimerizes so that adjacent back sheets form a contiguous 12-stranded sheet and homotetramers occur by a back-to-back association of these homodimers. Though L-type lectins exhibit both sequence and structural similarity to one another, their carbohydrate binding specificities differ widely.

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.96  E-value=2.4e-29  Score=259.65  Aligned_cols=197  Identities=25%  Similarity=0.388  Sum_probs=171.5

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccc--------hhHHHHHHHHHHhcccC---CCceeeeeeeeec
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR--------QGMKEFVAEIVSIGRLR---HRNLVQLLGYCRR  329 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~Ei~~l~~l~---H~niv~l~~~~~~  329 (586)
                      ..|...+.+|.|+||+|+.|.++.+...|+||.+.++..        ...-..-.|+++|..++   |+||++++++|++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            357888999999999999999999999999999876421        11123567999999997   9999999999999


Q ss_pred             cCeEEEEEecC-CCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEcccc
Q 007869          330 KGELLLVYDYM-PNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFG  408 (586)
Q Consensus       330 ~~~~~lV~E~~-~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFG  408 (586)
                      ++.+||+||-. ++-+|.++|..++  .+++....-|++|++.|+++||+   ++|||||||-+||.++.+|-+||+|||
T Consensus       641 dd~yyl~te~hg~gIDLFd~IE~kp--~m~E~eAk~IFkQV~agi~hlh~---~~ivhrdikdenvivd~~g~~klidfg  715 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFIEFKP--RMDEPEAKLIFKQVVAGIKHLHD---QGIVHRDIKDENVIVDSNGFVKLIDFG  715 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhhhccC--ccchHHHHHHHHHHHhccccccc---cCceecccccccEEEecCCeEEEeecc
Confidence            99999999965 5668999997764  57888889999999999999998   999999999999999999999999999


Q ss_pred             ceeeccCCCCCceeeeccCCCccCcccccCCCC-CCcceEEehhHHHHHHHhCCCCCC
Q 007869          409 LARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKA-TTSADVFSFGAFLLEVACGRRPIQ  465 (586)
Q Consensus       409 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVyS~Gvvl~ElltG~~p~~  465 (586)
                      .|.....+   .....+||..|.|||++.+.+| ...-|||++|++||-++....||.
T Consensus       716 saa~~ksg---pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  716 SAAYTKSG---PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             chhhhcCC---CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            99876543   3456789999999999999887 456799999999999999888875

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.96  E-value=4.6e-29  Score=231.31  Aligned_cols=258  Identities=22%  Similarity=0.310  Sum_probs=193.3

Q ss_pred             hcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccC-CCceeeeeeeeecc--CeEEE
Q 007869          259 ATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLR-HRNLVQLLGYCRRK--GELLL  335 (586)
Q Consensus       259 a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~~~~~~~--~~~~l  335 (586)
                      ..++|++.+++|+|.|+.||.|....+++.++||.++...   .+.+.+|+.+|..|+ ||||+.|++...+.  ....|
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL  112 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL  112 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence            3467899999999999999999988888899999997643   366889999999997 99999999998765  45789


Q ss_pred             EEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCC-CCeEEccccceeecc
Q 007869          336 VYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGE-LNGRLGDFGLARLYD  414 (586)
Q Consensus       336 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~-~~~kL~DFGla~~~~  414 (586)
                      ++||+.+.+...+-     .+|.-..+...+.++++||.|+|+   .+|.|||+||.|+|+|.. -.++|+|+|||..+-
T Consensus       113 iFE~v~n~Dfk~ly-----~tl~d~dIryY~~elLkALdyCHS---~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH  184 (338)
T KOG0668|consen  113 IFEYVNNTDFKQLY-----PTLTDYDIRYYIYELLKALDYCHS---MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  184 (338)
T ss_pred             HhhhhccccHHHHh-----hhhchhhHHHHHHHHHHHHhHHHh---cCcccccCCcceeeechhhceeeeeecchHhhcC
Confidence            99999887766543     246667788889999999999999   999999999999999964 569999999999876


Q ss_pred             CCCCCceeeeccCCCccCcccccCC-CCCCcceEEehhHHHHHHHhCCCCCCC-CCCCccchhhHHH------HhhhccC
Q 007869          415 HGTDPQTTHVVGTLGYLAPEHTRTG-KATTSADVFSFGAFLLEVACGRRPIQR-QGPSENLILVDWV------FDFWNRG  486 (586)
Q Consensus       415 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVyS~Gvvl~ElltG~~p~~~-~~~~~~~~l~~~v------~~~~~~~  486 (586)
                      .+..  -...+.+..|.-||.+-.- .|+..-|+|||||++.+|+..+.||.. .++.+++..+..+      .....+-
T Consensus       185 p~~e--YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY  262 (338)
T KOG0668|consen  185 PGKE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKY  262 (338)
T ss_pred             CCce--eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHH
Confidence            5432  2334567888999998654 578899999999999999999999864 3333433222111      1111111


Q ss_pred             ccccccCCCCCc---c--------c----cHHH-HHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          487 ELLEARDPNLGT---E--------Y----VAEE-LELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       487 ~~~~~~d~~l~~---~--------~----~~~~-~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      .  -.+||+...   .        |    .... ..+.++++.+.+..|-.+|||++|.+.
T Consensus       263 ~--i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  263 Q--IDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             c--cCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence            1  112222211   0        0    0000 134566667778899999999999874

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=7.3e-28  Score=244.80  Aligned_cols=134  Identities=25%  Similarity=0.317  Sum_probs=116.8

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccC-----C---Cceeeeeeeeecc-
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLR-----H---RNLVQLLGYCRRK-  330 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-----H---~niv~l~~~~~~~-  330 (586)
                      ..+|...++||.|.|++||++.+..+.+.||+|+.+.. ..-.+.-+.||++|++++     |   ..||+|++.|... 
T Consensus        77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG  155 (590)
T KOG1290|consen   77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG  155 (590)
T ss_pred             CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence            46788999999999999999999999999999998643 233456788999999983     3   4699999999854 


Q ss_pred             ---CeEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeec
Q 007869          331 ---GELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLD  397 (586)
Q Consensus       331 ---~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~  397 (586)
                         .+.++|+|++ |-+|..+|....-..++.....+|++||+.||.|||++  .+|||.||||+|||+.
T Consensus       156 pNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~e--cgIIHTDlKPENvLl~  222 (590)
T KOG1290|consen  156 PNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRE--CGIIHTDLKPENVLLC  222 (590)
T ss_pred             CCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHh--cCccccCCCcceeeee
Confidence               5799999999 78999999888777899999999999999999999994  6899999999999994

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1.4e-28  Score=233.34  Aligned_cols=254  Identities=20%  Similarity=0.319  Sum_probs=193.5

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhccc-CCCceeeeeee-eeccCeEEEEE
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRL-RHRNLVQLLGY-CRRKGELLLVY  337 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~-~~~~~~~~lV~  337 (586)
                      .+.|.+.+.||+|.||.+-++.++.++..+++|-+.... ...++|.+|...--.| .|.||+.-++. |...+.+++++
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q  101 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ  101 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence            356888999999999999999999999999999986542 3457899998776666 68999988774 66778899999


Q ss_pred             ecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeee-c-CCCCeEEccccceeeccC
Q 007869          338 DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLL-D-GELNGRLGDFGLARLYDH  415 (586)
Q Consensus       338 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll-~-~~~~~kL~DFGla~~~~~  415 (586)
                      ||+|.|+|.+-+...   .+.+....+++.|+++|+.|+|+   +++||||||.+|||+ + +..++||||||+.+..+.
T Consensus       102 E~aP~gdL~snv~~~---GigE~~~K~v~~ql~SAi~fMHs---knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~  175 (378)
T KOG1345|consen  102 EFAPRGDLRSNVEAA---GIGEANTKKVFAQLLSAIEFMHS---KNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT  175 (378)
T ss_pred             ccCccchhhhhcCcc---cccHHHHHHHHHHHHHHHHHhhc---cchhhcccccceEEEecCCccEEEeeecccccccCc
Confidence            999999999888654   57777888999999999999998   999999999999999 3 345899999999886543


Q ss_pred             CCCCceeeeccCCCccCcccccCC-----CCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCcccc
Q 007869          416 GTDPQTTHVVGTLGYLAPEHTRTG-----KATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLE  490 (586)
Q Consensus       416 ~~~~~~~~~~gt~~y~aPE~~~~~-----~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~  490 (586)
                      ...    ..--+..|.+||.....     ...+.+|+|.||++++..+||+.|++.....+. .  -|-|..|..+... 
T Consensus       176 tV~----~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~-~--Y~~~~~w~~rk~~-  247 (378)
T KOG1345|consen  176 TVK----YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDK-P--YWEWEQWLKRKNP-  247 (378)
T ss_pred             eeh----hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCc-h--HHHHHHHhcccCc-
Confidence            221    12336679999976433     357889999999999999999999995433322 2  2344455555444 


Q ss_pred             ccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHH
Q 007869          491 ARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQIL  533 (586)
Q Consensus       491 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L  533 (586)
                       .-|+....+.+..+    ++-.+-+.++|++|-.+.++.++.
T Consensus       248 -~~P~~F~~fs~~a~----r~Fkk~lt~~~~drcki~~~kk~r  285 (378)
T KOG1345|consen  248 -ALPKKFNPFSEKAL----RLFKKSLTPRFKDRCKIWTAKKMR  285 (378)
T ss_pred             -cCchhhcccCHHHH----HHHHHhcCCcccccchhHHHHHHH
Confidence             23444444554444    444556889999997766665543

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.95  E-value=7.9e-29  Score=240.50  Aligned_cols=262  Identities=23%  Similarity=0.247  Sum_probs=198.8

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc--cchhHHHHHHHHHHhcccCCCceeeeeeeeecc------C
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRK------G  331 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~------~  331 (586)
                      ..+|...+.+|.|.- .|..+.+.-.+++||+|+....  .....+...+|...+..++|+|+++++.++.-.      .
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~   94 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ   94 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence            345666778888887 7777777777889999988654  334456778999999999999999999988643      4


Q ss_pred             eEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEcccccee
Q 007869          332 ELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR  411 (586)
Q Consensus       332 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~  411 (586)
                      +.|+||||| ..+|...+.    ..++-.....|+.|++.|++|||+   .+|+||||||+||++..+..+||.|||+|+
T Consensus        95 e~y~v~e~m-~~nl~~vi~----~elDH~tis~i~yq~~~~ik~lhs---~~IihRdLkPsnivv~~~~~lKi~dfg~ar  166 (369)
T KOG0665|consen   95 EVYLVMELM-DANLCQVIL----MELDHETISYILYQMLCGIKHLHS---AGIIHRDLKPSNIVVNSDCTLKILDFGLAR  166 (369)
T ss_pred             hHHHHHHhh-hhHHHHHHH----HhcchHHHHHHHHHHHHHHHHHHh---cceeecccCcccceecchhheeeccchhhc
Confidence            689999999 568988886    247777888999999999999998   999999999999999999999999999999


Q ss_pred             eccCCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhh---------------
Q 007869          412 LYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILV---------------  476 (586)
Q Consensus       412 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~---------------  476 (586)
                      .-...  ...+..+.|..|.|||++.+..+.+..||||.||++.||++|+.-|.+.+.-++...+               
T Consensus       167 ~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL  244 (369)
T KOG0665|consen  167 TEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQL  244 (369)
T ss_pred             ccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHh
Confidence            64433  3566788999999999999888999999999999999999999998765432222111               


Q ss_pred             -HHHHhhhccC------cccc-ccCCCC--CccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          477 -DWVFDFWNRG------ELLE-ARDPNL--GTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       477 -~~v~~~~~~~------~~~~-~~d~~l--~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                       .-+..+.+..      ...+ ..|...  ..+.+........+++.+||-.||++|-+++++|+.
T Consensus       245 ~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H  310 (369)
T KOG0665|consen  245 QPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH  310 (369)
T ss_pred             hHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence             0111111100      0000 011111  111222344567788899999999999999999963

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.95  E-value=3.7e-29  Score=262.15  Aligned_cols=255  Identities=26%  Similarity=0.383  Sum_probs=206.0

Q ss_pred             hcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEe
Q 007869          259 ATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYD  338 (586)
Q Consensus       259 a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E  338 (586)
                      ..++|.....+|.|.||.|||++++.++...|+|.++.+......-.++|+-+++..+||||+.++|.+...+.+++.||
T Consensus        13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME   92 (829)
T KOG0576|consen   13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME   92 (829)
T ss_pred             CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence            34678889999999999999999999999999999998876677778899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCC
Q 007869          339 YMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD  418 (586)
Q Consensus       339 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~  418 (586)
                      ||.+|+|.+.-+-.  .++++.++...++...+||+|||+   ++-+|||||-.|||+++.+.+|++|||.+-.+.....
T Consensus        93 ycgggslQdiy~~T--gplselqiayvcRetl~gl~ylhs---~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~  167 (829)
T KOG0576|consen   93 YCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLKYLHS---QGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIA  167 (829)
T ss_pred             ecCCCcccceeeec--ccchhHHHHHHHhhhhccchhhhc---CCcccccccccceeecccCceeecccCchhhhhhhhh
Confidence            99999999876544  579999999999999999999998   8889999999999999999999999999876654322


Q ss_pred             CceeeeccCCCccCcccc---cCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCC
Q 007869          419 PQTTHVVGTLGYLAPEHT---RTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPN  495 (586)
Q Consensus       419 ~~~~~~~gt~~y~aPE~~---~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~  495 (586)
                       ......||+.|||||+.   +.+.|..++|||+.|+...|+---++|.....+.....+       +.+..   ..-|.
T Consensus       168 -KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~L-------mTkS~---~qpp~  236 (829)
T KOG0576|consen  168 -KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFL-------MTKSG---FQPPT  236 (829)
T ss_pred             -hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHH-------hhccC---CCCCc
Confidence             23457899999999987   456789999999999999999887777655433221111       11110   01122


Q ss_pred             CCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          496 LGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       496 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      +..  ...-.+.+-+++..|+..+|++||+++.+++
T Consensus       237 lkD--k~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  237 LKD--KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             ccC--CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence            221  1122345667778899999999999887653

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.95  E-value=2.4e-28  Score=249.35  Aligned_cols=283  Identities=22%  Similarity=0.258  Sum_probs=214.2

Q ss_pred             hhhhcccCCCcccchhhhhhhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccC--
Q 007869          239 LEDWELDHGPHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLR--  316 (586)
Q Consensus       239 ~~~~~~~~~~~~~~~~el~~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~--  316 (586)
                      .++|.-..|-.++.+-|+  -...|.+....|+|-|++|.+|.+..-+..||||++.... -..+.=+.|+++|++|+  
T Consensus       412 ~DNWdDaEGYYrv~igE~--LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~A  488 (752)
T KOG0670|consen  412 QDNWDDAEGYYRVRIGEL--LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDA  488 (752)
T ss_pred             ccCcccccceEEEehhhh--hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhcc
Confidence            455665555445555444  4678999999999999999999998888899999997542 23345578999999995  


Q ss_pred             ----CCceeeeeeeeeccCeEEEEEecCCCCChhhhhhcCC-CccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCC
Q 007869          317 ----HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQP-KVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKA  391 (586)
Q Consensus       317 ----H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp  391 (586)
                          --|+++|+-.|...+++|||+|-+ ..+|.+.|+.-+ ...|.......++.|+..||..|..   .+|+|.||||
T Consensus       489 D~Edk~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~---c~vlHaDIKP  564 (752)
T KOG0670|consen  489 DPEDKFHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKK---CGVLHADIKP  564 (752)
T ss_pred             CchhhhHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHh---cCeeecccCc
Confidence                357899999999999999999977 579999998754 3578888899999999999999997   8999999999


Q ss_pred             CCeeecCC-CCeEEccccceeeccCCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCC
Q 007869          392 SNVLLDGE-LNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPS  470 (586)
Q Consensus       392 ~NIll~~~-~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~  470 (586)
                      .|||+++. ..+||||||.|.....+   ..+...-+..|.|||++.+-.|+...|+||.||+||||.||+..|.+....
T Consensus       565 DNiLVNE~k~iLKLCDfGSA~~~~en---eitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN  641 (752)
T KOG0670|consen  565 DNILVNESKNILKLCDFGSASFASEN---EITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNN  641 (752)
T ss_pred             cceEeccCcceeeeccCccccccccc---cccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcH
Confidence            99999865 56899999999876543   223344567899999999999999999999999999999999999876554


Q ss_pred             ccchhhHHH-----HhhhccCc---------------------------cccccCCC--CC---------ccccHHHHHH
Q 007869          471 ENLILVDWV-----FDFWNRGE---------------------------LLEARDPN--LG---------TEYVAEELEL  507 (586)
Q Consensus       471 ~~~~l~~~v-----~~~~~~~~---------------------------~~~~~d~~--l~---------~~~~~~~~~~  507 (586)
                      ..+.+.--+     ..+.+.|.                           ++..+.|.  +.         ..-....+..
T Consensus       642 ~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~  721 (752)
T KOG0670|consen  642 QMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQ  721 (752)
T ss_pred             HHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHH
Confidence            322211100     00011111                           11111220  00         1112344677


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHHH
Q 007869          508 VLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       508 l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      +..|+..|+..||++|.|..+.|+
T Consensus       722 ~rdLLdkml~LdP~KRit~nqAL~  745 (752)
T KOG0670|consen  722 LRDLLDKMLILDPEKRITVNQALK  745 (752)
T ss_pred             HHHHHHHHhccChhhcCCHHHHhc
Confidence            888999999999999999999875

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.94  E-value=1.5e-27  Score=275.58  Aligned_cols=195  Identities=17%  Similarity=0.294  Sum_probs=141.2

Q ss_pred             ccCC-Cceeeeeeee-------eccCeEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEE
Q 007869          314 RLRH-RNLVQLLGYC-------RRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVI  385 (586)
Q Consensus       314 ~l~H-~niv~l~~~~-------~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iv  385 (586)
                      +++| +||.+++++|       .+...+++++||+ +++|.++|... ...+++.+++.++.||++||.|||+   ++|+
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~---~gIv  102 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHS---QGIV  102 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHh---CCee
Confidence            4566 6888899987       2334578889988 66999999754 3468999999999999999999998   9999


Q ss_pred             eCCCCCCCeeecC-------------------CCCeEEccccceeeccCCCC---------------CceeeeccCCCcc
Q 007869          386 HRDVKASNVLLDG-------------------ELNGRLGDFGLARLYDHGTD---------------PQTTHVVGTLGYL  431 (586)
Q Consensus       386 HrDIkp~NIll~~-------------------~~~~kL~DFGla~~~~~~~~---------------~~~~~~~gt~~y~  431 (586)
                      ||||||+||||+.                   ++.+||+|||+++.......               .......||+.||
T Consensus       103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~  182 (793)
T PLN00181        103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT  182 (793)
T ss_pred             eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence            9999999999954                   44566777777764221000               0011246899999


Q ss_pred             CcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCccccHHHHHHHHHH
Q 007869          432 APEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKL  511 (586)
Q Consensus       432 aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l  511 (586)
                      |||++.+..++.++|||||||+||||++|..|+.....    ....+..     .    ...+..     .........+
T Consensus       183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~----~~~~~~~-----~----~~~~~~-----~~~~~~~~~~  244 (793)
T PLN00181        183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR----TMSSLRH-----R----VLPPQI-----LLNWPKEASF  244 (793)
T ss_pred             ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH----HHHHHHH-----h----hcChhh-----hhcCHHHHHH
Confidence            99999999999999999999999999999888653211    0111100     0    011111     1112334577


Q ss_pred             HHHhcccCCCCCCCHHHHHH
Q 007869          512 GLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       512 ~~~Cl~~dP~~RPs~~evl~  531 (586)
                      +.+||+++|.+||+|.|+++
T Consensus       245 ~~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        245 CLWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             HHHhCCCChhhCcChHHHhh
Confidence            88899999999999999985

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.93  E-value=2.1e-26  Score=231.56  Aligned_cols=201  Identities=27%  Similarity=0.427  Sum_probs=167.2

Q ss_pred             hhhcCCcccceeEeecCceEEEEEEeCC---CCeEEEEEEeccccchhHHHHHHHHHHhccc-CCCceeeeeeeeeccCe
Q 007869          257 YIATKGFREKELLGTGGFGRVYRGTLPK---SQIEIAVKKISHESRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKGE  332 (586)
Q Consensus       257 ~~a~~~f~~~~~LG~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~~~  332 (586)
                      ....+.|...++||.|.|++||++++..   .+..||+|.+...+..  ....+|++.|..+ -+.||+++.+++...+.
T Consensus        32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p--~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~  109 (418)
T KOG1167|consen   32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP--SRILNELEMLYRLGGSDNIIKLNGCFRNNDQ  109 (418)
T ss_pred             hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc--hHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence            3445678889999999999999999876   7788999999765433  5688999999999 59999999999999999


Q ss_pred             EEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCC-CCeEEcccccee
Q 007869          333 LLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGE-LNGRLGDFGLAR  411 (586)
Q Consensus       333 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~-~~~kL~DFGla~  411 (586)
                      ..+|+||++.-.-.++...     ++..++..+++.+..||.++|+   ++||||||||+|+|.+.. +.-.|.|||||.
T Consensus       110 v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~---~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~  181 (418)
T KOG1167|consen  110 VAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHK---NGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQ  181 (418)
T ss_pred             eEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhc---cCccccCCCccccccccccCCceEEechhHH
Confidence            9999999999888888743     4566778889999999999998   999999999999999754 568999999997


Q ss_pred             eccCCC--------------C-----------------------------CceeeeccCCCccCccccc-CCCCCCcceE
Q 007869          412 LYDHGT--------------D-----------------------------PQTTHVVGTLGYLAPEHTR-TGKATTSADV  447 (586)
Q Consensus       412 ~~~~~~--------------~-----------------------------~~~~~~~gt~~y~aPE~~~-~~~~s~ksDV  447 (586)
                      ..+...              .                             .......||+||.|||++. ...-+++.||
T Consensus       182 ~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDi  261 (418)
T KOG1167|consen  182 RYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDI  261 (418)
T ss_pred             HHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccce
Confidence            221000              0                             0011247999999999985 4567899999


Q ss_pred             EehhHHHHHHHhCCCCCCCC
Q 007869          448 FSFGAFLLEVACGRRPIQRQ  467 (586)
Q Consensus       448 yS~Gvvl~ElltG~~p~~~~  467 (586)
                      ||-||+++.+++++.||...
T Consensus       262 ws~GVI~Lslls~~~PFf~a  281 (418)
T KOG1167|consen  262 WSAGVILLSLLSRRYPFFKA  281 (418)
T ss_pred             eeccceeehhhccccccccC
Confidence            99999999999999999754

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.92  E-value=3.7e-25  Score=208.26  Aligned_cols=166  Identities=20%  Similarity=0.133  Sum_probs=125.7

Q ss_pred             CChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCCcee
Q 007869          343 GSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTT  422 (586)
Q Consensus       343 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~  422 (586)
                      |+|.+++... ...++|.+++.|+.|+++||.|||+   .+      ||+|||++.++.+|+  ||+++......     
T Consensus         1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~---~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~-----   63 (176)
T smart00750        1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHR---QA------KSGNILLTWDGLLKL--DGSVAFKTPEQ-----   63 (176)
T ss_pred             CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHh---cC------CcccEeEcCccceee--ccceEeecccc-----
Confidence            6899999764 3469999999999999999999998   44      999999999999999  99998764422     


Q ss_pred             eeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCccccH
Q 007869          423 HVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVA  502 (586)
Q Consensus       423 ~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~  502 (586)
                       ..||+.|||||++.+..++.++|||||||++|||++|+.||........ .+..+.. ....      .++.. .....
T Consensus        64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~-~~~~~~~-~~~~------~~~~~-~~~~~  133 (176)
T smart00750       64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSA-ILEILLN-GMPA------DDPRD-RSNLE  133 (176)
T ss_pred             -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcH-HHHHHHH-Hhcc------CCccc-cccHH
Confidence             2689999999999999999999999999999999999999965432111 1111111 1100      11110 01111


Q ss_pred             HHHH--HHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 007869          503 EELE--LVLKLGLLCSHSDPTARPSMRQVVQILER  535 (586)
Q Consensus       503 ~~~~--~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  535 (586)
                      ....  .+.+++.+||+.+|.+||++.|+++.+..
T Consensus       134 ~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~  168 (176)
T smart00750      134 SVSAARSFADFMRVCASRLPQRREAANHYLAHCRA  168 (176)
T ss_pred             HHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHH
Confidence            2222  58899999999999999999999988753

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.92  E-value=1e-24  Score=226.21  Aligned_cols=169  Identities=21%  Similarity=0.207  Sum_probs=133.5

Q ss_pred             hhhhhcCCcccceeEeecCceEEEEEEeCC-CCeEEEEEEeccc-----cchhHHHHHHHHHHhcccCCCceee-eeeee
Q 007869          255 DLYIATKGFREKELLGTGGFGRVYRGTLPK-SQIEIAVKKISHE-----SRQGMKEFVAEIVSIGRLRHRNLVQ-LLGYC  327 (586)
Q Consensus       255 el~~a~~~f~~~~~LG~G~~g~Vy~~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~Ei~~l~~l~H~niv~-l~~~~  327 (586)
                      ......++|...+.||+|+||+||+|++.. ++..||||++...     .....+.|.+|+++|++++|+|+++ ++++ 
T Consensus        12 ~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~-   90 (365)
T PRK09188         12 QIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT-   90 (365)
T ss_pred             ccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc-
Confidence            345567789999999999999999999865 6777899987533     1223466999999999999999985 4432 


Q ss_pred             eccCeEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCC-CCCCeeecCCCCeEEcc
Q 007869          328 RRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDV-KASNVLLDGELNGRLGD  406 (586)
Q Consensus       328 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDI-kp~NIll~~~~~~kL~D  406 (586)
                         +..+|||||+++++|... ...  .      ...++.|++++|.|||+   ++|+|||| ||+|||++.++++||+|
T Consensus        91 ---~~~~LVmE~~~G~~L~~~-~~~--~------~~~~~~~i~~aL~~lH~---~gIiHrDL~KP~NILv~~~~~ikLiD  155 (365)
T PRK09188         91 ---GKDGLVRGWTEGVPLHLA-RPH--G------DPAWFRSAHRALRDLHR---AGITHNDLAKPQNWLMGPDGEAAVID  155 (365)
T ss_pred             ---CCcEEEEEccCCCCHHHh-Ccc--c------hHHHHHHHHHHHHHHHH---CCCeeCCCCCcceEEEcCCCCEEEEE
Confidence               457999999999999632 111  1      14578899999999998   99999999 99999999999999999


Q ss_pred             ccceeeccCCCCC-------ceeeeccCCCccCcccccCC
Q 007869          407 FGLARLYDHGTDP-------QTTHVVGTLGYLAPEHTRTG  439 (586)
Q Consensus       407 FGla~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~  439 (586)
                      ||+|+.+......       .-+...+++.|+|||.+...
T Consensus       156 FGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        156 FQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             CccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            9999976543211       11356789999999998654

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.89  E-value=1.6e-24  Score=205.70  Aligned_cols=248  Identities=24%  Similarity=0.393  Sum_probs=192.0

Q ss_pred             ceeEeecCceEEEEEEeCCCCeEEEEEEecc--ccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEecCCCC
Q 007869          266 KELLGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNG  343 (586)
Q Consensus       266 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~--~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~g  343 (586)
                      ..+|.+...|..|+|++.++  .+++|++.-  .+....++|..|.-.|+-+.||||+.++|.|.....+.++..||+.|
T Consensus       195 ~tkl~e~hsgelwrgrwqgn--divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~g  272 (448)
T KOG0195|consen  195 ITKLAESHSGELWRGRWQGN--DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFG  272 (448)
T ss_pred             hhhhccCCCcccccccccCc--chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccch
Confidence            44688999999999999654  466676643  23334478999999999999999999999999999999999999999


Q ss_pred             ChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCCceee
Q 007869          344 SLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTH  423 (586)
Q Consensus       344 sL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~  423 (586)
                      +|+..|+.......+..|..+++.++|+|++|||+. +.-|----|.+..|++|++.+++|+- +-+++     ..+...
T Consensus       273 slynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarism-ad~kf-----sfqe~g  345 (448)
T KOG0195|consen  273 SLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISM-ADTKF-----SFQEVG  345 (448)
T ss_pred             HHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheec-cccee-----eeeccc
Confidence            999999998778889999999999999999999984 34455556899999999999988842 11111     011112


Q ss_pred             eccCCCccCcccccCCCC---CCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCccc
Q 007869          424 VVGTLGYLAPEHTRTGKA---TTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEY  500 (586)
Q Consensus       424 ~~gt~~y~aPE~~~~~~~---s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~  500 (586)
                      ..-.+.||+||.+..++.   -.++|+|||.+++|||.|...||....+.+....+           .++.    ++...
T Consensus       346 r~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmki-----------aleg----lrv~i  410 (448)
T KOG0195|consen  346 RAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI-----------ALEG----LRVHI  410 (448)
T ss_pred             cccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh-----------hhcc----ccccC
Confidence            234688999999976654   35789999999999999999999887665533211           1112    22223


Q ss_pred             cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 007869          501 VAEELELVLKLGLLCSHSDPTARPSMRQVVQILERDV  537 (586)
Q Consensus       501 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  537 (586)
                      ++.....+.+|+.-|+..||.+||.+..++-.|+++.
T Consensus       411 ppgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  411 PPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             CCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence            4444566778888899999999999999999998754

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.89  E-value=1.7e-22  Score=209.19  Aligned_cols=259  Identities=22%  Similarity=0.213  Sum_probs=193.5

Q ss_pred             CcccceeEeecCceEEEEEEeCCCC-eEEEEEEeccccchhHHHHHHHHHHhcccCC----Cceeeeeeee-eccCeEEE
Q 007869          262 GFREKELLGTGGFGRVYRGTLPKSQ-IEIAVKKISHESRQGMKEFVAEIVSIGRLRH----RNLVQLLGYC-RRKGELLL  335 (586)
Q Consensus       262 ~f~~~~~LG~G~~g~Vy~~~~~~~~-~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H----~niv~l~~~~-~~~~~~~l  335 (586)
                      +|.+.+.||+|+||.||++.....+ ..+|+|............+..|+.++..+..    +++..+++.. ......++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            7999999999999999999987654 5788888766533333367788888888863    6888899888 47778899


Q ss_pred             EEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCC-----CCeEEccccce
Q 007869          336 VYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGE-----LNGRLGDFGLA  410 (586)
Q Consensus       336 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~-----~~~kL~DFGla  410 (586)
                      ||+.+ +.+|.++....+...++....++|+.|++.+|.+||+   .+++||||||+|+++...     ..+.|.|||++
T Consensus        99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~---~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla  174 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHS---KGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA  174 (322)
T ss_pred             EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHh---cCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence            99988 8899998876665678999999999999999999998   999999999999999754     46999999999


Q ss_pred             eecc--CCC-----CCc--eeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHh
Q 007869          411 RLYD--HGT-----DPQ--TTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFD  481 (586)
Q Consensus       411 ~~~~--~~~-----~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~  481 (586)
                      +.+.  ...     ...  .....||..|.+++...+...+.+.|+||++.++.|++.|..|+............   .+
T Consensus       175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~---~~  251 (322)
T KOG1164|consen  175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKF---EK  251 (322)
T ss_pred             ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHH---HH
Confidence            9322  111     111  23356999999999999999999999999999999999999999765433221111   00


Q ss_pred             hhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 007869          482 FWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERD  536 (586)
Q Consensus       482 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  536 (586)
                      ...+    .....  .....+.+   +.++...+-..+...+|....+...|...
T Consensus       252 ~~~~----~~~~~--~~~~~~~~---~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~  297 (322)
T KOG1164|consen  252 DPRK----LLTDR--FGDLKPEE---FAKILEYIDSLDYEDKPDYEKLAELLKDV  297 (322)
T ss_pred             Hhhh----hcccc--ccCCChHH---HHHHHHHhhccCCcCCCCHHHHHHHHHHH
Confidence            0000    00000  11112233   33344444557999999999998887654

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.89  E-value=7.8e-22  Score=200.85  Aligned_cols=259  Identities=28%  Similarity=0.404  Sum_probs=197.5

Q ss_pred             cccceeEeecCceEEEEEEeCCCCeEEEEEEeccccch---hHHHHHHHHHHhcccCCC-ceeeeeeeeeccCeEEEEEe
Q 007869          263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQ---GMKEFVAEIVSIGRLRHR-NLVQLLGYCRRKGELLLVYD  338 (586)
Q Consensus       263 f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~~Ei~~l~~l~H~-niv~l~~~~~~~~~~~lV~E  338 (586)
                      |...+.||.|+||.||++...   ..+++|.+......   ....+.+|+..+..+.|+ +++++.+.+......++++|
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~   78 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME   78 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence            667788999999999999986   57899998765332   467899999999999988 79999999977777899999


Q ss_pred             cCCCCChhhhhhcCCC-ccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCC-CeEEccccceeeccCC
Q 007869          339 YMPNGSLDKYLYDQPK-VTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGEL-NGRLGDFGLARLYDHG  416 (586)
Q Consensus       339 ~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~-~~kL~DFGla~~~~~~  416 (586)
                      ++.+++|.+++..... ..+.......++.|++.++.|+|+   .+++|||+||+||+++... .++++|||+++.....
T Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~---~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~  155 (384)
T COG0515          79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP  155 (384)
T ss_pred             cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence            9999999977655432 267888899999999999999998   8899999999999999988 7999999999865543


Q ss_pred             CCC-----ceeeeccCCCccCcccccC---CCCCCcceEEehhHHHHHHHhCCCCCCCCCCC-ccchhhHHHHhhhccCc
Q 007869          417 TDP-----QTTHVVGTLGYLAPEHTRT---GKATTSADVFSFGAFLLEVACGRRPIQRQGPS-ENLILVDWVFDFWNRGE  487 (586)
Q Consensus       417 ~~~-----~~~~~~gt~~y~aPE~~~~---~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~-~~~~l~~~v~~~~~~~~  487 (586)
                      ...     ......||..|++||.+..   .......|+||+|++++++++|..|+...... ......+.+...... .
T Consensus       156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-~  234 (384)
T COG0515         156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP-S  234 (384)
T ss_pred             CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc-c
Confidence            322     2356789999999999987   57889999999999999999999997654431 001111111111100 0


Q ss_pred             cccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          488 LLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       488 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                      ..    ..............+.+++..|+..+|..|.++.+....
T Consensus       235 ~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         235 LA----SPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             cc----cccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            00    011110012223566778888999999999999887753

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.86  E-value=1.5e-22  Score=223.27  Aligned_cols=254  Identities=22%  Similarity=0.261  Sum_probs=191.2

Q ss_pred             ccceeEeecCceEEEEEEeCCCCeEEEEEEec-----ccc-chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEE
Q 007869          264 REKELLGTGGFGRVYRGTLPKSQIEIAVKKIS-----HES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY  337 (586)
Q Consensus       264 ~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~-----~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  337 (586)
                      ...+++|.|++|.|+...........+.|...     .+. .+....+..|+.+-..++|+|++..+..+.+.....-+|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            45788999999988888765555445555432     111 112223667888888899999998888887776666669


Q ss_pred             ecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCC
Q 007869          338 DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT  417 (586)
Q Consensus       338 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~  417 (586)
                      ||+++ +|..++...  ..+....+..+++|+..|++|||+   .+|.|||+|++|+++..++.+||+|||.+..+....
T Consensus       401 E~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~---~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~  474 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHS---MGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW  474 (601)
T ss_pred             hcccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHh---cCceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence            99999 999999765  357777888999999999999998   999999999999999999999999999998765543


Q ss_pred             C---CceeeeccCCCccCcccccCCCCCC-cceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccC
Q 007869          418 D---PQTTHVVGTLGYLAPEHTRTGKATT-SADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARD  493 (586)
Q Consensus       418 ~---~~~~~~~gt~~y~aPE~~~~~~~s~-ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d  493 (586)
                      .   ......+|+..|+|||.+....|.+ ..||||.|+++..|++|+.||......++.. .      ..++.. ...+
T Consensus       475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-~------~~~~~~-~~~~  546 (601)
T KOG0590|consen  475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-K------TNNYSD-QRNI  546 (601)
T ss_pred             chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-h------hhcccc-cccc
Confidence            3   3455678999999999999999976 5799999999999999999997654443321 0      000000 0000


Q ss_pred             CCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          494 PNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       494 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      ..-..............++.++++.||.+|-||.++++
T Consensus       547 ~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  547 FEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             ccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            00011223344566778888999999999999999985

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.84  E-value=7.5e-21  Score=181.35  Aligned_cols=140  Identities=16%  Similarity=0.082  Sum_probs=107.6

Q ss_pred             ceeEeecCceEEEEEEeCCCCeEEEEEEeccccch--h-------HHH-----------------HHHHHHHhcccCCCc
Q 007869          266 KELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQ--G-------MKE-----------------FVAEIVSIGRLRHRN  319 (586)
Q Consensus       266 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~-------~~~-----------------~~~Ei~~l~~l~H~n  319 (586)
                      .+.||+|+||.||+|.+. ++..||||+++.....  .       ...                 ...|++.+.++.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            467999999999999997 7889999999754211  1       111                 234999999998877


Q ss_pred             eeeeeeeeeccCeEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHh-hcccCCcEEeCCCCCCCeeecC
Q 007869          320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYL-HQEWEQVVIHRDVKASNVLLDG  398 (586)
Q Consensus       320 iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yL-H~~~~~~ivHrDIkp~NIll~~  398 (586)
                      +.....+..  ...+|||||++++++...+...  ..+++.+...++.|++.+|.|| |+   .+|+||||||+|||++ 
T Consensus        81 v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~--~~~~~~~~~~i~~qi~~~L~~l~H~---~giiHrDlkP~NIli~-  152 (190)
T cd05147          81 IPCPEPILL--KSHVLVMEFIGDDGWAAPRLKD--APLSESKARELYLQVIQIMRILYQD---CRLVHADLSEYNLLYH-  152 (190)
T ss_pred             CCCCcEEEe--cCCEEEEEEeCCCCCcchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEE-
Confidence            643322221  2238999999988776553322  3678889999999999999999 56   7999999999999998 


Q ss_pred             CCCeEEccccceeecc
Q 007869          399 ELNGRLGDFGLARLYD  414 (586)
Q Consensus       399 ~~~~kL~DFGla~~~~  414 (586)
                      ++.++|+|||+|...+
T Consensus       153 ~~~v~LiDFG~a~~~~  168 (190)
T cd05147         153 DGKLYIIDVSQSVEHD  168 (190)
T ss_pred             CCcEEEEEccccccCC
Confidence            4789999999997543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.84  E-value=5.7e-21  Score=184.88  Aligned_cols=171  Identities=13%  Similarity=0.121  Sum_probs=132.4

Q ss_pred             hcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHH---------HHHHHHHHhcccCCCceeeeeeeeec
Q 007869          259 ATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMK---------EFVAEIVSIGRLRHRNLVQLLGYCRR  329 (586)
Q Consensus       259 a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~---------~~~~Ei~~l~~l~H~niv~l~~~~~~  329 (586)
                      -.++|+..++||.|+||.||....  ++..+|||.+.........         .+.+|+..+.+++|++|..+..++..
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~  106 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL  106 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence            467899999999999999999655  3557999999765332222         26899999999999999999887553


Q ss_pred             c--------CeEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCC
Q 007869          330 K--------GELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELN  401 (586)
Q Consensus       330 ~--------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~  401 (586)
                      .        +..+|||||++|.+|.++..      ++.    ....+++.+|..+|+   .+++|||+||+||+++.++ 
T Consensus       107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~---~gi~H~Dikp~Nili~~~g-  172 (232)
T PRK10359        107 AERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQ---HGMVSGDPHKGNFIVSKNG-  172 (232)
T ss_pred             cccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHH---cCCccCCCChHHEEEeCCC-
Confidence            2        35899999999999988731      221    246699999999998   9999999999999999888 


Q ss_pred             eEEccccceeeccCCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHH
Q 007869          402 GRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVA  458 (586)
Q Consensus       402 ~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ell  458 (586)
                      ++|+|||..+........             ..+.....+..++|+|+||+.+.-+.
T Consensus       173 i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        173 LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence            999999988754322110             01333445667999999999987654

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.83  E-value=9.2e-21  Score=177.65  Aligned_cols=205  Identities=22%  Similarity=0.278  Sum_probs=171.5

Q ss_pred             hcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCC-CceeeeeeeeeccCeEEEEE
Q 007869          259 ATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRH-RNLVQLLGYCRRKGELLLVY  337 (586)
Q Consensus       259 a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H-~niv~l~~~~~~~~~~~lV~  337 (586)
                      ...+|...+.||.|.||.+|.|....+|..||||.-+...+.  .++..|..+.+.|++ ..|..+..+..++..-.+||
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM   90 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM   90 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence            446799999999999999999999999999999998665443  467788888888875 67888888888999999999


Q ss_pred             ecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeec---CCCCeEEccccceeecc
Q 007869          338 DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLD---GELNGRLGDFGLARLYD  414 (586)
Q Consensus       338 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~---~~~~~kL~DFGla~~~~  414 (586)
                      |.. +.+|.+++.-.. ..++....+-++-|++.-++|+|.   +++|||||||+|.|..   ....+.|+|||||+.+.
T Consensus        91 dLL-GPsLEdLfnfC~-R~ftmkTvLMLaDQml~RiEyvH~---r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~  165 (341)
T KOG1163|consen   91 DLL-GPSLEDLFNFCS-RRFTMKTVLMLADQMLSRIEYVHL---RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR  165 (341)
T ss_pred             ecc-CccHHHHHHHHh-hhhhHHhHHHHHHHHHHHHHHHHh---hccccccCCccceeeccccccceEEEEeccchhhhc
Confidence            998 889999875442 357777888899999999999998   9999999999999984   34568999999999764


Q ss_pred             CCCC------CceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCC
Q 007869          415 HGTD------PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPS  470 (586)
Q Consensus       415 ~~~~------~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~  470 (586)
                      ....      .......||.+|.+-....+..-+.+-|+=|+|.+|..+--|..||++....
T Consensus       166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~  227 (341)
T KOG1163|consen  166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAA  227 (341)
T ss_pred             cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchh
Confidence            3321      2334568999999888777777888999999999999999999999986554

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.83  E-value=3e-20  Score=196.26  Aligned_cols=215  Identities=26%  Similarity=0.386  Sum_probs=163.7

Q ss_pred             hcccCCCceeeeeeeeeccCeEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCC
Q 007869          312 IGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKA  391 (586)
Q Consensus       312 l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp  391 (586)
                      |+.+.|.|+.+++|.+.+....+.|.+||..|+|.+.+... ...++|.-...++++|++||.|||.  ..--.|+.+++
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~-~~~~d~~F~~s~~rdi~~Gl~ylh~--s~i~~hg~l~s   77 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE-DIKLDYFFILSFIRDISKGLAYLHN--SPIGYHGALKS   77 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc-ccCccHHHHHHHHHHHHHHHHHHhc--Ccceeeeeecc
Confidence            46789999999999999999999999999999999999874 4689999999999999999999998  23339999999


Q ss_pred             CCeeecCCCCeEEccccceeeccCCCC-CceeeeccCCCccCcccccCCC-------CCCcceEEehhHHHHHHHhCCCC
Q 007869          392 SNVLLDGELNGRLGDFGLARLYDHGTD-PQTTHVVGTLGYLAPEHTRTGK-------ATTSADVFSFGAFLLEVACGRRP  463 (586)
Q Consensus       392 ~NIll~~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~-------~s~ksDVyS~Gvvl~ElltG~~p  463 (586)
                      .|.++|....+||.|||+......... .......-..-|.|||.++...       .+.+.||||||++++|+++.+.|
T Consensus        78 ~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~  157 (484)
T KOG1023|consen   78 SNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP  157 (484)
T ss_pred             ccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence            999999999999999999987643111 1111122345699999987642       46789999999999999999999


Q ss_pred             CCCCCCCccc-hhhHHHHhhhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 007869          464 IQRQGPSENL-ILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERD  536 (586)
Q Consensus       464 ~~~~~~~~~~-~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  536 (586)
                      |......+.. .++.++..     .......|.+....  +....++.++..||..+|.+||+++++-..++..
T Consensus       158 ~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~  224 (484)
T KOG1023|consen  158 FDLRNLVEDPDEIILRVKK-----GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTI  224 (484)
T ss_pred             cccccccCChHHHHHHHHh-----cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhh
Confidence            9864433221 12222221     11122333332111  3444788999999999999999999998777543

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.82  E-value=7.4e-20  Score=182.32  Aligned_cols=234  Identities=23%  Similarity=0.319  Sum_probs=156.5

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc---cchhHHHHHHHHHHhcccCC-----------Ccee-----
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRH-----------RNLV-----  321 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H-----------~niv-----  321 (586)
                      ..+...+.||.|+++.||.+++.++++++|||++...   .....+++++|...+..+.+           +-++     
T Consensus        12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~   91 (288)
T PF14531_consen   12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL   91 (288)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred             eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence            3455678899999999999999999999999988644   33456778888877666433           1111     


Q ss_pred             eeee---eeeccC--------eEEEEEecCCCCChhhhhh---cCC--CccchhHHHHHHHHHHHHHHHHhhcccCCcEE
Q 007869          322 QLLG---YCRRKG--------ELLLVYDYMPNGSLDKYLY---DQP--KVTLNWIQRFRVIKGVALGLFYLHQEWEQVVI  385 (586)
Q Consensus       322 ~l~~---~~~~~~--------~~~lV~E~~~~gsL~~~l~---~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iv  385 (586)
                      ++-+   +.....        ..+++|+-+ .++|.+++.   ...  ...+....++.+..|+++.+++||+   .+++
T Consensus        92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~---~GlV  167 (288)
T PF14531_consen   92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHS---YGLV  167 (288)
T ss_dssp             EETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEE
T ss_pred             EEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhh---cceE
Confidence            1111   111111        246788877 678888754   221  2356677788888999999999999   9999


Q ss_pred             eCCCCCCCeeecCCCCeEEccccceeeccCCCCCceeeeccCCCccCcccccCC--------CCCCcceEEehhHHHHHH
Q 007869          386 HRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTG--------KATTSADVFSFGAFLLEV  457 (586)
Q Consensus       386 HrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~s~ksDVyS~Gvvl~El  457 (586)
                      |+||||+|++++.+|.++|+||+.....+....    ....+..|.+||.....        .++.+.|.|++|+++|.|
T Consensus       168 Hgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~----~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l  243 (288)
T PF14531_consen  168 HGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYR----CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL  243 (288)
T ss_dssp             EST-SGGGEEE-TTS-EEE--GGGEEETTEEEE----GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred             ecccceeeEEEcCCCCEEEcChHHHeecCceee----ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence            999999999999999999999998876443211    13456789999976442        478899999999999999


Q ss_pred             HhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCC
Q 007869          458 ACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTAR  523 (586)
Q Consensus       458 ltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R  523 (586)
                      .||+.||........   .+|              +  + ..+. +..+.+..|+..+|+.||.+|
T Consensus       244 WC~~lPf~~~~~~~~---~~~--------------~--f-~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  244 WCGRLPFGLSSPEAD---PEW--------------D--F-SRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHSS-STCCCGGGST---SGG--------------G--G-TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             HHccCCCCCCCcccc---ccc--------------c--c-hhcC-CcCHHHHHHHHHHccCCcccC
Confidence            999999986533211   011              0  0 1223 556778888888999999988

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.82  E-value=9.3e-20  Score=174.13  Aligned_cols=141  Identities=21%  Similarity=0.174  Sum_probs=110.3

Q ss_pred             ceeEeecCceEEEEEEeCCCCeEEEEEEeccccch---------------------h-----HHHHHHHHHHhcccCCCc
Q 007869          266 KELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQ---------------------G-----MKEFVAEIVSIGRLRHRN  319 (586)
Q Consensus       266 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~---------------------~-----~~~~~~Ei~~l~~l~H~n  319 (586)
                      .+.||+|++|.||+|.+. ++..||||+++.....                     .     ...+..|.+.+.++.|++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05145           2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG   80 (190)
T ss_pred             CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            467999999999999987 7889999998764211                     0     112457899999999998


Q ss_pred             eeeeeeeeeccCeEEEEEecCCCCChhhh-hhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecC
Q 007869          320 LVQLLGYCRRKGELLLVYDYMPNGSLDKY-LYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDG  398 (586)
Q Consensus       320 iv~l~~~~~~~~~~~lV~E~~~~gsL~~~-l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~  398 (586)
                      +.....+...  ..+|||||++++++... +..   ..++......++.|++.+|.+||+  +.+|+||||||+|||++ 
T Consensus        81 i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH~--~~givHrDlkP~NIll~-  152 (190)
T cd05145          81 VPVPEPILLK--KNVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLYQ--EAGLVHGDLSEYNILYH-  152 (190)
T ss_pred             CCCceEEEec--CCEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHHH--hCCEecCCCChhhEEEE-
Confidence            7544333322  24899999998865443 322   356777889999999999999997  47999999999999999 


Q ss_pred             CCCeEEccccceeeccC
Q 007869          399 ELNGRLGDFGLARLYDH  415 (586)
Q Consensus       399 ~~~~kL~DFGla~~~~~  415 (586)
                      +++++|+|||+++....
T Consensus       153 ~~~~~liDFG~a~~~~~  169 (190)
T cd05145         153 DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             CCCEEEEEcccceecCC
Confidence            78999999999987653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.81  E-value=7.9e-20  Score=178.66  Aligned_cols=204  Identities=19%  Similarity=0.250  Sum_probs=170.8

Q ss_pred             hcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhccc-CCCceeeeeeeeeccCeEEEEE
Q 007869          259 ATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKGELLLVY  337 (586)
Q Consensus       259 a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~lV~  337 (586)
                      ..-+|++.++||+|.||..+.|+..-++++||||.-...++  ..++..|....+.| ..++|.+.+-+-.+..+-.||+
T Consensus        26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi  103 (449)
T KOG1165|consen   26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI  103 (449)
T ss_pred             ecccceeccccccCcceeeecccccccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence            34579999999999999999999988899999998655443  24567777777777 5799999998888888889999


Q ss_pred             ecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecC-----CCCeEEccccceee
Q 007869          338 DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDG-----ELNGRLGDFGLARL  412 (586)
Q Consensus       338 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~-----~~~~kL~DFGla~~  412 (586)
                      |++ |.||+|++.-.. ..++......+++|++.-++|+|+   +.+|.|||||+|+||..     ...+.|+|||+|+.
T Consensus       104 dLL-GPSLEDLFD~Cg-R~FSvKTV~miA~Qmi~rie~vH~---k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~  178 (449)
T KOG1165|consen  104 DLL-GPSLEDLFDLCG-RRFSVKTVAMIAKQMITRIEYVHE---KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE  178 (449)
T ss_pred             hhh-CcCHHHHHHHhc-CcccHHhHHHHHHHHHHHHHHHHh---cceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence            998 889998875443 367888899999999999999998   99999999999999953     34589999999997


Q ss_pred             ccCCCC------CceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCC
Q 007869          413 YDHGTD------PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGP  469 (586)
Q Consensus       413 ~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~  469 (586)
                      +.....      .......||.+||+-.-..+..-+.+-|+=|||-++..++-|..||++...
T Consensus       179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA  241 (449)
T KOG1165|consen  179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA  241 (449)
T ss_pred             hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccC
Confidence            654322      123446799999999999999999999999999999999999999987543

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.80  E-value=2.1e-20  Score=206.24  Aligned_cols=248  Identities=23%  Similarity=0.256  Sum_probs=178.8

Q ss_pred             CcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc-chhHHHHHHHHHHhc--ccCCCceeeeeeeeeccCeEEEEEe
Q 007869          262 GFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES-RQGMKEFVAEIVSIG--RLRHRNLVQLLGYCRRKGELLLVYD  338 (586)
Q Consensus       262 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~--~l~H~niv~l~~~~~~~~~~~lV~E  338 (586)
                      ++...+.||++.|=+|.+|++.+ |. |+||++-+.. .-..+.|.++++-++  .++|||.+++..+-......|||-+
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRq  101 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQ  101 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHH
Confidence            56778889999999999999965 43 8999886543 334555655554443  4589999999998877788889999


Q ss_pred             cCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceee--ccCC
Q 007869          339 YMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARL--YDHG  416 (586)
Q Consensus       339 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~--~~~~  416 (586)
                      |.. -+|+|.|..++  -|...+...|+.|++.||...|.   .+|+|+|||.+|||++.-.-+.|+||-.-+.  +.++
T Consensus       102 yvk-hnLyDRlSTRP--FL~~iEKkWiaFQLL~al~qcH~---~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD  175 (1431)
T KOG1240|consen  102 YVK-HNLYDRLSTRP--FLVLIEKKWIAFQLLKALSQCHK---LGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPED  175 (1431)
T ss_pred             HHh-hhhhhhhccch--HHHHHHHHHHHHHHHHHHHHHHH---cCccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence            985 48999886654  46667777899999999999998   9999999999999999988899999976652  2222


Q ss_pred             CCCceeee----ccCCCccCcccccCC-----------CCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHH
Q 007869          417 TDPQTTHV----VGTLGYLAPEHTRTG-----------KATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVF  480 (586)
Q Consensus       417 ~~~~~~~~----~gt~~y~aPE~~~~~-----------~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~  480 (586)
                      .....+-.    ..-.+|+|||-+...           ..+++.||||+||++.||++ |+++|.-..      |.    
T Consensus       176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ------L~----  245 (1431)
T KOG1240|consen  176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ------LL----  245 (1431)
T ss_pred             CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH------HH----
Confidence            22111211    234579999976431           15789999999999999988 788885311      11    


Q ss_pred             hhhccCccccccCCCCCccccHH--HHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 007869          481 DFWNRGELLEARDPNLGTEYVAE--ELELVLKLGLLCSHSDPTARPSMRQVVQILER  535 (586)
Q Consensus       481 ~~~~~~~~~~~~d~~l~~~~~~~--~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  535 (586)
                       .|+.|.   ..++    +...+  +...+..+++.|++.||.+|.++++.|+.-.+
T Consensus       246 -aYr~~~---~~~~----e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG  294 (1431)
T KOG1240|consen  246 -AYRSGN---ADDP----EQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQKYRG  294 (1431)
T ss_pred             -hHhccC---ccCH----HHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHhhhc
Confidence             122221   0010    00001  11246788899999999999999999986433

>PRK10345 hypothetical protein; Provisional

Probab=99.80  E-value=4.9e-19  Score=170.71  Aligned_cols=137  Identities=19%  Similarity=0.248  Sum_probs=109.3

Q ss_pred             cccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhccc-----CCCceeeeeeeeeccC---e-E
Q 007869          263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRL-----RHRNLVQLLGYCRRKG---E-L  333 (586)
Q Consensus       263 f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-----~H~niv~l~~~~~~~~---~-~  333 (586)
                      +...++||+|+||.||.  ++.+... +||++........+.+.+|+.+++++     .||||++++|++.++.   . .
T Consensus         4 L~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~   80 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY   80 (210)
T ss_pred             cCCcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence            34567899999999996  6666655 69998765555567899999999999     5799999999998763   4 3


Q ss_pred             EEEEec--CCCCChhhhhhcCCCccchhHHHHHHHHHHHHHH-HHhhcccCCcEEeCCCCCCCeeecC----CCCeEEcc
Q 007869          334 LLVYDY--MPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGL-FYLHQEWEQVVIHRDVKASNVLLDG----ELNGRLGD  406 (586)
Q Consensus       334 ~lV~E~--~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L-~yLH~~~~~~ivHrDIkp~NIll~~----~~~~kL~D  406 (586)
                      .+|+||  +++|+|.+++.+.   .+++.  ..++.|++.++ +|||+   ++|+||||||+|||++.    +.+++|+|
T Consensus        81 ~~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~---~~IvhrDlKp~NILl~~~~~~~~~~~LiD  152 (210)
T PRK10345         81 DVIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLD---NRIVTMELKPQNILCQRISESEVIPVVCD  152 (210)
T ss_pred             EEEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEeccCCCCCcEEEEE
Confidence            478999  5689999999653   24444  35678888888 99998   99999999999999973    34799999


Q ss_pred             ccce
Q 007869          407 FGLA  410 (586)
Q Consensus       407 FGla  410 (586)
                      |+-+
T Consensus       153 g~G~  156 (210)
T PRK10345        153 NIGE  156 (210)
T ss_pred             CCCC
Confidence            5443

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.80  E-value=2.7e-19  Score=169.70  Aligned_cols=189  Identities=16%  Similarity=0.101  Sum_probs=141.4

Q ss_pred             cccceeEeecCceEEEEEEeCCCCeEEEEEEeccccch----hHHHHHHHHHHhcccC-CCceeeeeeeeeccCeEEEEE
Q 007869          263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQ----GMKEFVAEIVSIGRLR-HRNLVQLLGYCRRKGELLLVY  337 (586)
Q Consensus       263 f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~Ei~~l~~l~-H~niv~l~~~~~~~~~~~lV~  337 (586)
                      +.....|++|+||+||.+..  .+.+++.+.+......    ....|.+|+++|++|. |+++++++++    +..+++|
T Consensus         4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm   77 (218)
T PRK12274          4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR   77 (218)
T ss_pred             cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence            34567899999999997765  4567777777554321    1225889999999995 5889999887    3469999


Q ss_pred             ecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCC-CCCCeeecCCCCeEEccccceeeccCC
Q 007869          338 DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDV-KASNVLLDGELNGRLGDFGLARLYDHG  416 (586)
Q Consensus       338 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDI-kp~NIll~~~~~~kL~DFGla~~~~~~  416 (586)
                      ||+.+.+|.+.+..         ....++.|++++|.++|+   .+|+|||| ||+|||++.++.++|+|||+|......
T Consensus        78 eyI~G~~L~~~~~~---------~~~~~~~qi~~~L~~lH~---~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~  145 (218)
T PRK12274         78 SYLAGAAMYQRPPR---------GDLAYFRAARRLLQQLHR---CGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPR  145 (218)
T ss_pred             eeecCccHHhhhhh---------hhHHHHHHHHHHHHHHHH---CcCccCCCCCcceEEEcCCCCEEEEECCCceecCCc
Confidence            99999998754321         113467899999999998   99999999 799999999999999999999865443


Q ss_pred             CCC----c--------eeeeccCCCccCcccccCC-CCC-CcceEEehhHHHHHHHhCCCCCCCCCC
Q 007869          417 TDP----Q--------TTHVVGTLGYLAPEHTRTG-KAT-TSADVFSFGAFLLEVACGRRPIQRQGP  469 (586)
Q Consensus       417 ~~~----~--------~~~~~gt~~y~aPE~~~~~-~~s-~ksDVyS~Gvvl~ElltG~~p~~~~~~  469 (586)
                      ...    .        ..-...++.|++|+...-- ..+ ...+.++-|+-+|.++|++.+...+.+
T Consensus       146 ~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~  212 (218)
T PRK12274        146 ARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE  212 (218)
T ss_pred             chHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence            210    0        0112357888888754322 222 567899999999999999998766543

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.77  E-value=1.8e-18  Score=194.82  Aligned_cols=252  Identities=19%  Similarity=0.171  Sum_probs=184.9

Q ss_pred             hhhhhhhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccC---CCceeeeeeeeec
Q 007869          253 YKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLR---HRNLVQLLGYCRR  329 (586)
Q Consensus       253 ~~el~~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~---H~niv~l~~~~~~  329 (586)
                      ..+.....+.|.+.+.||+|+||+||+|...+ ++.||+|+-+..+...   |.--.+++.||+   -+-|..+...+.-
T Consensus       690 ~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~  765 (974)
T KOG1166|consen  690 NTEFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVF  765 (974)
T ss_pred             cceeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHcc
Confidence            45667778889999999999999999999977 8899999987765432   222233444554   2233444444455


Q ss_pred             cCeEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeec-------CCCCe
Q 007869          330 KGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLD-------GELNG  402 (586)
Q Consensus       330 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~-------~~~~~  402 (586)
                      .+..+||+||.+.|+|.+++..  ...++|.....++.|++.-+.+||.   .+|||+||||+|.||.       ++..+
T Consensus       766 ~~~S~lv~ey~~~Gtlld~~N~--~~~m~e~lv~~~~~qml~ive~lH~---~~IIHgDiKPDNfll~~~~~~~~~~~~l  840 (974)
T KOG1166|consen  766 QNASVLVSEYSPYGTLLDLINT--NKVMDEYLVMFFSCQMLRIVEHLHA---MGIIHGDIKPDNFLLRREICADSDSKGL  840 (974)
T ss_pred             CCcceeeeeccccccHHHhhcc--CCCCCchhhhHHHHHHHHHHHHHHh---cceecccCCcceeEeecccCCCCcccce
Confidence            6778999999999999999973  4579999999999999999999998   9999999999999993       34568


Q ss_pred             EEccccceeeccCCCCC-ceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHh
Q 007869          403 RLGDFGLARLYDHGTDP-QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFD  481 (586)
Q Consensus       403 kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~  481 (586)
                      +|+|||.+..+.--.+. .....++|-.+-.+|+..++.++++.|.|.+..+++-|+.|+..-.                
T Consensus       841 ~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q~----------------  904 (974)
T KOG1166|consen  841 YLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYMEV----------------  904 (974)
T ss_pred             EEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHHh----------------
Confidence            99999999865432222 3456788999999999999999999999999999999999974320                


Q ss_pred             hhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 007869          482 FWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER  535 (586)
Q Consensus       482 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  535 (586)
                        .+|... .++..+..-+..+....+..+++.   +|...=|...++...|++
T Consensus       905 --~~g~~~-~~~~~~~Ry~~~~~W~~~F~~lLN---~~~~~~p~l~~lr~~~~~  952 (974)
T KOG1166|consen  905 --KNGSSW-MVKTNFPRYWKRDMWNKFFDLLLN---PDCDTLPNLQELRTELEE  952 (974)
T ss_pred             --cCCcce-eccccchhhhhHHHHHHHHHHHhC---cCcccchhHHHHHHHHHH
Confidence              111111 122222222344556666666554   555555666666666654

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.75  E-value=1.5e-18  Score=173.16  Aligned_cols=195  Identities=23%  Similarity=0.296  Sum_probs=135.1

Q ss_pred             CCCceeeeeeeeec---------------------------cCeEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHH
Q 007869          316 RHRNLVQLLGYCRR---------------------------KGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKG  368 (586)
Q Consensus       316 ~H~niv~l~~~~~~---------------------------~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~  368 (586)
                      +|||||++++.|.+                           ...+|+||...+ .+|.+++..+.   .+.....-|+.|
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~---~s~r~~~~~laQ  349 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH---RSYRTGRVILAQ  349 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC---CchHHHHHHHHH
Confidence            69999999987642                           235789998774 58999987652   344455668999


Q ss_pred             HHHHHHHhhcccCCcEEeCCCCCCCeee--cCC--CCeEEccccceeeccCCC-----CCceeeeccCCCccCcccccCC
Q 007869          369 VALGLFYLHQEWEQVVIHRDVKASNVLL--DGE--LNGRLGDFGLARLYDHGT-----DPQTTHVVGTLGYLAPEHTRTG  439 (586)
Q Consensus       369 ia~~L~yLH~~~~~~ivHrDIkp~NIll--~~~--~~~kL~DFGla~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~  439 (586)
                      +++|+.|||.   ++|.|||+|++|||+  |++  -...|+|||+|-.-+...     ....-..-|...-||||+....
T Consensus       350 lLEav~hL~~---hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~  426 (598)
T KOG4158|consen  350 LLEAVTHLHK---HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV  426 (598)
T ss_pred             HHHHHHHHHH---ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence            9999999998   999999999999999  333  357899999986433211     1112234578889999998643


Q ss_pred             C------CCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCccccHHHHHHHHHHHH
Q 007869          440 K------ATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGL  513 (586)
Q Consensus       440 ~------~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~  513 (586)
                      +      -..|.|.|+.|.+.||++....||....... +...          ...+..-|.+...    ....+.+++.
T Consensus       427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~-L~~r----------~Yqe~qLPalp~~----vpp~~rqlV~  491 (598)
T KOG4158|consen  427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML-LDTR----------TYQESQLPALPSR----VPPVARQLVF  491 (598)
T ss_pred             CCCceeeccchhhhhhhhhhHHHHhccCCcccccchhe-echh----------hhhhhhCCCCccc----CChHHHHHHH
Confidence            2      2468999999999999999999998733211 1111          1122222333322    2344566777


Q ss_pred             HhcccCCCCCCCHHHHHHH
Q 007869          514 LCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       514 ~Cl~~dP~~RPs~~evl~~  532 (586)
                      ..+++||++||+..-....
T Consensus       492 ~lL~r~pskRvsp~iAANv  510 (598)
T KOG4158|consen  492 DLLKRDPSKRVSPNIAANV  510 (598)
T ss_pred             HHhcCCccccCCccHHHhH
Confidence            7899999999995544433

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.75  E-value=4.4e-19  Score=187.48  Aligned_cols=187  Identities=27%  Similarity=0.328  Sum_probs=153.8

Q ss_pred             eEeecCceEEEEEEe---CCCCeEEEEEEeccccchh--HHHHHHHHHHhcccC-CCceeeeeeeeeccCeEEEEEecCC
Q 007869          268 LLGTGGFGRVYRGTL---PKSQIEIAVKKISHESRQG--MKEFVAEIVSIGRLR-HRNLVQLLGYCRRKGELLLVYDYMP  341 (586)
Q Consensus       268 ~LG~G~~g~Vy~~~~---~~~~~~vavK~~~~~~~~~--~~~~~~Ei~~l~~l~-H~niv~l~~~~~~~~~~~lV~E~~~  341 (586)
                      .+|+|.||.|+.+.-   .+.+..+|+|.+.+.....  ......|-.++...+ ||.++++.-.+..+..++++.+|..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            378999999987643   3456678888876542211  114456777888886 9999999999999999999999999


Q ss_pred             CCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCCce
Q 007869          342 NGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQT  421 (586)
Q Consensus       342 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~  421 (586)
                      +|.|...+....  .+...........++-++.++|+   .+|+|||+|++||+++.+|.+|+.|||+.+..-....   
T Consensus        81 gg~lft~l~~~~--~f~~~~~~~~~aelaLald~lh~---l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~---  152 (612)
T KOG0603|consen   81 GGDLFTRLSKEV--MFDELDVAFYLAELALALDHLHK---LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI---  152 (612)
T ss_pred             cchhhhccccCC--chHHHHHHHHHHHHHHHHhhcch---hHHHHhcccccceeecccCccccCCchhhhHhHhhhh---
Confidence            999998886653  45556666678889999999998   9999999999999999999999999999986433221   


Q ss_pred             eeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCC
Q 007869          422 THVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQR  466 (586)
Q Consensus       422 ~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~  466 (586)
                        .+||.-|||||++.  ......|-||||++++||++|..||..
T Consensus       153 --~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~  193 (612)
T KOG0603|consen  153 --ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG  193 (612)
T ss_pred             --cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence              18999999999997  567889999999999999999999986

>smart00090 RIO RIO-like kinase

Probab=99.74  E-value=7.6e-18  Score=166.15  Aligned_cols=144  Identities=17%  Similarity=0.125  Sum_probs=111.8

Q ss_pred             CCcccceeEeecCceEEEEEE-eCCCCeEEEEEEeccccch------------------------hHHHHHHHHHHhccc
Q 007869          261 KGFREKELLGTGGFGRVYRGT-LPKSQIEIAVKKISHESRQ------------------------GMKEFVAEIVSIGRL  315 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~-~~~~~~~vavK~~~~~~~~------------------------~~~~~~~Ei~~l~~l  315 (586)
                      ..|++.+.||+|++|.||+|. ...++..||||++......                        ....+..|+..+.++
T Consensus        28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L  107 (237)
T smart00090       28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL  107 (237)
T ss_pred             chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence            347788899999999999999 6667889999998753210                        012356899999999


Q ss_pred             CCC--ceeeeeeeeeccCeEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCc-EEeCCCCCC
Q 007869          316 RHR--NLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQV-VIHRDVKAS  392 (586)
Q Consensus       316 ~H~--niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~-ivHrDIkp~  392 (586)
                      .+.  .+.+++++    ...++||||+++.+|.......  ..+...+...++.|++.+|.+||+   .+ |+||||||+
T Consensus       108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~---~g~iiH~Dikp~  178 (237)
T smart00090      108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD--VEPEEEEEFELYDDILEEMRKLYK---EGELVHGDLSEY  178 (237)
T ss_pred             HhcCCCCCeeeEe----cCceEEEEEecCCccccccccc--CCcchHHHHHHHHHHHHHHHHHHh---cCCEEeCCCChh
Confidence            753  34444543    2348999999998887665332  234555677899999999999998   88 999999999


Q ss_pred             CeeecCCCCeEEccccceeecc
Q 007869          393 NVLLDGELNGRLGDFGLARLYD  414 (586)
Q Consensus       393 NIll~~~~~~kL~DFGla~~~~  414 (586)
                      ||+++ +++++|+|||.+....
T Consensus       179 NIli~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      179 NILVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             hEEEE-CCCEEEEEChhhhccC
Confidence            99999 8899999999987543

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.74  E-value=1.1e-17  Score=184.79  Aligned_cols=144  Identities=19%  Similarity=0.208  Sum_probs=115.3

Q ss_pred             hhhhhhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc--c------chhHHHHHHHHHHhcccCCCceeeeee
Q 007869          254 KDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE--S------RQGMKEFVAEIVSIGRLRHRNLVQLLG  325 (586)
Q Consensus       254 ~el~~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~------~~~~~~~~~Ei~~l~~l~H~niv~l~~  325 (586)
                      .........|...+.||+|+||.||+|.+....  +++|+....  .      ....+.+.+|++++.+++|++++....
T Consensus       326 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~--~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~  403 (535)
T PRK09605        326 IKEEEVKRRKIPDHLIGKGAEADIKKGEYLGRD--AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVI  403 (535)
T ss_pred             ccccccccccCccceeccCCcEEEEEEeecCcc--ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEE
Confidence            333444555677899999999999999886543  444432111  1      112356889999999999999998888


Q ss_pred             eeeccCeEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEc
Q 007869          326 YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLG  405 (586)
Q Consensus       326 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~  405 (586)
                      ++......++||||+++++|.+++.          ....++.+++++|.|||+   .+++||||||+|||+ +++.++|+
T Consensus       404 ~~~~~~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~---~giiHrDlkp~NILl-~~~~~~li  469 (535)
T PRK09605        404 YDVDPEEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHK---AGIVHGDLTTSNFIV-RDDRLYLI  469 (535)
T ss_pred             EEEeCCCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHh---CCCccCCCChHHEEE-ECCcEEEE
Confidence            8877778899999999999998874          346789999999999998   899999999999999 57799999


Q ss_pred             cccceeec
Q 007869          406 DFGLARLY  413 (586)
Q Consensus       406 DFGla~~~  413 (586)
                      |||+++..
T Consensus       470 DFGla~~~  477 (535)
T PRK09605        470 DFGLGKYS  477 (535)
T ss_pred             eCcccccC
Confidence            99999763

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.73  E-value=1.5e-17  Score=161.41  Aligned_cols=134  Identities=20%  Similarity=0.269  Sum_probs=112.7

Q ss_pred             eeEeecCceEEEEEEeCCCCeEEEEEEeccccc--------hhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEe
Q 007869          267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR--------QGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYD  338 (586)
Q Consensus       267 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E  338 (586)
                      +.||+|++|.||+|..  .+..+++|+......        .....+.+|+.++.+++|+++.....++...+..++|||
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e   79 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME   79 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence            5699999999999988  455789997654321        112457889999999999998887777777778899999


Q ss_pred             cCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceee
Q 007869          339 YMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARL  412 (586)
Q Consensus       339 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~  412 (586)
                      |+++++|.+++....     + .+..++.+++.+|.+||+   .+++|+|++|.|||++ ++.++|+|||+++.
T Consensus        80 ~~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~---~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         80 YIEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHS---AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             EeCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHh---CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            999999999985432     2 788899999999999998   8999999999999999 78899999998875

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.72  E-value=1.2e-18  Score=180.84  Aligned_cols=123  Identities=26%  Similarity=0.438  Sum_probs=108.7

Q ss_pred             CeEEEEEecCCCCChhhhhhcCC-CccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccc
Q 007869          331 GELLLVYDYMPNGSLDKYLYDQP-KVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGL  409 (586)
Q Consensus       331 ~~~~lV~E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGl  409 (586)
                      ..+++.|++|...+|.++|.+.. ....+|...+.++.|++.|+.|      ++.+|||+||.||+...+..+||+|||+
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl  402 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGL  402 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhh
Confidence            35899999999999999997543 3567888899999999999999      6799999999999999999999999999


Q ss_pred             eeeccCCC-----CCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh
Q 007869          410 ARLYDHGT-----DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC  459 (586)
Q Consensus       410 a~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt  459 (586)
                      ...+....     ....+..+||..||+||.+.+..|+.|+||||||++|+||+.
T Consensus       403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~  457 (516)
T KOG1033|consen  403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI  457 (516)
T ss_pred             eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence            98776544     224566789999999999999999999999999999999986

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.72  E-value=2.6e-17  Score=158.28  Aligned_cols=145  Identities=16%  Similarity=0.120  Sum_probs=112.3

Q ss_pred             hhhhhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccc----------------------hhHHHHHHHHHHh
Q 007869          255 DLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR----------------------QGMKEFVAEIVSI  312 (586)
Q Consensus       255 el~~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~Ei~~l  312 (586)
                      ++......|...+.||+|+||.||++... ++..||||++.....                      .....+..|+..+
T Consensus         9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l   87 (198)
T cd05144           9 TLVKRGVVESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL   87 (198)
T ss_pred             HHHHcCchhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence            44444445778899999999999999985 688899998754321                      0112367788889


Q ss_pred             cccCCCc--eeeeeeeeeccCeEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCC
Q 007869          313 GRLRHRN--LVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVK  390 (586)
Q Consensus       313 ~~l~H~n--iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIk  390 (586)
                      .++.|++  ++..++.    +..++||||+++++|.+....        .....++.++++++.++|+   .+|+|||||
T Consensus        88 ~~l~~~~i~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~---~gi~H~Dl~  152 (198)
T cd05144          88 KALYEEGFPVPKPIDW----NRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYK---HGIIHGDLS  152 (198)
T ss_pred             HHHHHcCCCCCceeec----CCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHH---CCCCcCCCC
Confidence            9888774  4444443    345899999999999776421        2345688999999999998   899999999


Q ss_pred             CCCeeecCCCCeEEccccceeeccC
Q 007869          391 ASNVLLDGELNGRLGDFGLARLYDH  415 (586)
Q Consensus       391 p~NIll~~~~~~kL~DFGla~~~~~  415 (586)
                      |+||++++++.++|+|||++.....
T Consensus       153 p~Nill~~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         153 EFNILVDDDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             cccEEEcCCCcEEEEECCccccCCC
Confidence            9999999999999999999976543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.70  E-value=4.2e-17  Score=156.77  Aligned_cols=130  Identities=18%  Similarity=0.281  Sum_probs=105.9

Q ss_pred             eEeecCceEEEEEEeCCCCeEEEEEEeccccc--------hhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEec
Q 007869          268 LLGTGGFGRVYRGTLPKSQIEIAVKKISHESR--------QGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY  339 (586)
Q Consensus       268 ~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  339 (586)
                      .||+|+||.||+|.+  .+..+++|+......        .....+.+|++++..++|+++.....++...+..++||||
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   78 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY   78 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence            489999999999996  356789998643221        1235678899999999988766555555566677999999


Q ss_pred             CCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceee
Q 007869          340 MPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARL  412 (586)
Q Consensus       340 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~  412 (586)
                      +++++|.+.+.....         .++.+++.+|.+||+   .+++|+|+||+||+++ ++.++++|||+++.
T Consensus        79 ~~g~~l~~~~~~~~~---------~~~~~i~~~l~~lH~---~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        79 IEGKPLKDVIEEGND---------ELLREIGRLVGKLHK---AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             ECCccHHHHHhhcHH---------HHHHHHHHHHHHHHH---CCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            999999998754311         789999999999998   9999999999999999 78999999999875

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.65  E-value=6.7e-17  Score=178.84  Aligned_cols=170  Identities=26%  Similarity=0.378  Sum_probs=126.7

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEec
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY  339 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  339 (586)
                      ..+|..+++|..|+||.||..+++.+.+.+|+| +.+.+.     +.+-  ++.....|.+|                  
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l-----ilRn--ilt~a~npfvv------------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL-----ILRN--ILTFAGNPFVV------------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhc-ccccch-----hhhc--cccccCCccee------------------
Confidence            457888999999999999999999888899994 332211     0000  22222333322                  


Q ss_pred             CCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCC--
Q 007869          340 MPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT--  417 (586)
Q Consensus       340 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~--  417 (586)
                         |+-...++.-+.  ++-        +++.+++|||+   .+|+|||+||+|.+|+.-|.+|+.|||+.+......  
T Consensus       136 ---gDc~tllk~~g~--lPv--------dmvla~Eylh~---ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at  199 (1205)
T KOG0606|consen  136 ---GDCATLLKNIGP--LPV--------DMVLAVEYLHS---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT  199 (1205)
T ss_pred             ---chhhhhcccCCC--Ccc--------hhhHHhHhhcc---CCeecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence               444444443322  221        23789999998   999999999999999999999999999987532110  


Q ss_pred             ------------CCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCc
Q 007869          418 ------------DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSE  471 (586)
Q Consensus       418 ------------~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~  471 (586)
                                  ......++||+.|+|||++....|....|.|++|+++||.+-|+.||.++.+++
T Consensus       200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee  265 (1205)
T KOG0606|consen  200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE  265 (1205)
T ss_pred             hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH
Confidence                        012234689999999999999999999999999999999999999999987765

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.65  E-value=1e-15  Score=138.94  Aligned_cols=135  Identities=20%  Similarity=0.168  Sum_probs=114.9

Q ss_pred             cceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCC--CceeeeeeeeeccCeEEEEEecCCC
Q 007869          265 EKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRH--RNLVQLLGYCRRKGELLLVYDYMPN  342 (586)
Q Consensus       265 ~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H--~niv~l~~~~~~~~~~~lV~E~~~~  342 (586)
                      +.+.||+|.++.||++...+  ..+++|.......  ...+..|+..+..++|  .+++++++++...+..+++|||+++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g   77 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG   77 (155)
T ss_pred             cceecccccccceEEEEecC--CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence            35779999999999999854  5799999865543  4678999999999976  5899999998888899999999998


Q ss_pred             CChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceee
Q 007869          343 GSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARL  412 (586)
Q Consensus       343 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~  412 (586)
                      +.+..+         +......++.+++++|.+||.....+++|+|++|+||++++.+.++++|||+++.
T Consensus        78 ~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          78 ETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             eecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            877654         4456677899999999999985446899999999999999989999999999875

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.61  E-value=2.3e-15  Score=143.09  Aligned_cols=137  Identities=20%  Similarity=0.166  Sum_probs=96.8

Q ss_pred             ceeEeecCceEEEEEEeCCCCeEEEEEEeccccch--hHHH----------------------HHHHHHHhcccCCCc--
Q 007869          266 KELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQ--GMKE----------------------FVAEIVSIGRLRHRN--  319 (586)
Q Consensus       266 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~Ei~~l~~l~H~n--  319 (586)
                      .+.||+|+||+||+|.+. ++..||||++......  ....                      ...|...+.++.+..  
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            467999999999999986 6788999998654211  1111                      134555555554332  


Q ss_pred             eeeeeeeeeccCeEEEEEecCCCCChhh-hhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecC
Q 007869          320 LVQLLGYCRRKGELLLVYDYMPNGSLDK-YLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDG  398 (586)
Q Consensus       320 iv~l~~~~~~~~~~~lV~E~~~~gsL~~-~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~  398 (586)
                      +.+.+++    ...++||||++++.+.. .+...   ... .+...++.+++.++.++|.  +.+|+||||||+||+++ 
T Consensus        81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~---~~~-~~~~~~~~~~~~~l~~lh~--~~~ivH~Dl~p~Nili~-  149 (187)
T cd05119          81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV---RLL-EDPEELYDQILELMRKLYR--EAGLVHGDLSEYNILVD-  149 (187)
T ss_pred             CCceEec----CCCEEEEEEeCCCCccChhhhhh---hhc-ccHHHHHHHHHHHHHHHhh--ccCcCcCCCChhhEEEE-
Confidence            3334432    24589999999854432 12111   011 5677889999999999996  47899999999999999 


Q ss_pred             CCCeEEccccceeecc
Q 007869          399 ELNGRLGDFGLARLYD  414 (586)
Q Consensus       399 ~~~~kL~DFGla~~~~  414 (586)
                      ++.++|+|||.+....
T Consensus       150 ~~~~~liDfg~a~~~~  165 (187)
T cd05119         150 DGKVYIIDVPQAVEID  165 (187)
T ss_pred             CCcEEEEECccccccc
Confidence            8899999999997544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.57  E-value=1.3e-14  Score=143.33  Aligned_cols=135  Identities=18%  Similarity=0.194  Sum_probs=105.2

Q ss_pred             ceeEe-ecCceEEEEEEeCCCCeEEEEEEecccc-------------chhHHHHHHHHHHhcccCCCce--eeeeeeeec
Q 007869          266 KELLG-TGGFGRVYRGTLPKSQIEIAVKKISHES-------------RQGMKEFVAEIVSIGRLRHRNL--VQLLGYCRR  329 (586)
Q Consensus       266 ~~~LG-~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~Ei~~l~~l~H~ni--v~l~~~~~~  329 (586)
                      ...|| .||.|+||++...  +..++||++....             ......+.+|++++.+++|+++  ++.++++..
T Consensus        36 ~~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~  113 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV  113 (239)
T ss_pred             CceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence            45688 8999999999884  4578999885321             1223457889999999998885  677776543


Q ss_pred             cC----eEEEEEecCCC-CChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEE
Q 007869          330 KG----ELLLVYDYMPN-GSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRL  404 (586)
Q Consensus       330 ~~----~~~lV~E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL  404 (586)
                      ..    ..++|+||+++ .+|.+++...   .++..    .+.+++.+|.+||+   .+|+||||||.|||++.++.++|
T Consensus       114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~----~~~~i~~~l~~lH~---~GI~HrDlkp~NILv~~~~~v~L  183 (239)
T PRK01723        114 RHGLFYRADILIERIEGARDLVALLQEA---PLSEE----QWQAIGQLIARFHD---AGVYHADLNAHNILLDPDGKFWL  183 (239)
T ss_pred             ecCcceeeeEEEEecCCCCCHHHHHhcC---CCCHH----HHHHHHHHHHHHHH---CCCCCCCCCchhEEEcCCCCEEE
Confidence            32    23599999997 6899888543   23332    36789999999998   99999999999999999889999


Q ss_pred             ccccceee
Q 007869          405 GDFGLARL  412 (586)
Q Consensus       405 ~DFGla~~  412 (586)
                      +|||.++.
T Consensus       184 IDfg~~~~  191 (239)
T PRK01723        184 IDFDRGEL  191 (239)
T ss_pred             EECCCccc
Confidence            99998875

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.57  E-value=6.6e-16  Score=170.74  Aligned_cols=257  Identities=23%  Similarity=0.286  Sum_probs=188.2

Q ss_pred             cCCcccceeEeecCceEEEEEEeC-CCCeEEEEEEecccc--chhHHHHHHHHHHhcccC-CCceeeeeeeeeccCeEEE
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLP-KSQIEIAVKKISHES--RQGMKEFVAEIVSIGRLR-HRNLVQLLGYCRRKGELLL  335 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~-H~niv~l~~~~~~~~~~~l  335 (586)
                      ...|...+.||+|.|+.|-..... .....+|+|.+....  ....+....|..+-..+. |+|++.+++.....+..++
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~   98 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL   98 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence            445777788999999999888764 334557777776543  222334445777777776 9999999999999999999


Q ss_pred             EEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhh-cccCCcEEeCCCCCCCeeecCCC-CeEEccccceeec
Q 007869          336 VYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLH-QEWEQVVIHRDVKASNVLLDGEL-NGRLGDFGLARLY  413 (586)
Q Consensus       336 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH-~~~~~~ivHrDIkp~NIll~~~~-~~kL~DFGla~~~  413 (586)
                      ..||..++++.+-+........+....-.++.|+..++.|+| +   .++.||||||+|.+++..+ ..|++|||+|..+
T Consensus        99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~---~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~  175 (601)
T KOG0590|consen   99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPE---NGVTHRDIKPSNSLLDESGSALKIADFGLATAY  175 (601)
T ss_pred             ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcc---cccccCCCCCccchhccCCCcccCCCchhhccc
Confidence            999999999999884222223445556677999999999999 6   8999999999999999999 9999999999977


Q ss_pred             cC--CCCCceeeecc-CCCccCcccccCC-CCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccc
Q 007869          414 DH--GTDPQTTHVVG-TLGYLAPEHTRTG-KATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELL  489 (586)
Q Consensus       414 ~~--~~~~~~~~~~g-t~~y~aPE~~~~~-~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~  489 (586)
                      ..  +.........| ++.|+|||...+. ...+..|+||.|+++.-+++|..|++........ ...|..     ..  
T Consensus       176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-~~~~~~-----~~--  247 (601)
T KOG0590|consen  176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-YSSWKS-----NK--  247 (601)
T ss_pred             cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc-ceeecc-----cc--
Confidence            65  33333445678 9999999999874 4567899999999999999999999765443311 111111     10  


Q ss_pred             cccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          490 EARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       490 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      .........    .......++..+++..+|..|.+.+++..
T Consensus       248 ~~~~~~~~~----~~~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  248 GRFTQLPWN----SISDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             cccccCccc----cCChhhhhcccccccCCchhccccccccc
Confidence            000011111    12234556666788899999999888753

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.46  E-value=8.8e-14  Score=136.51  Aligned_cols=201  Identities=21%  Similarity=0.312  Sum_probs=140.1

Q ss_pred             HHhcccCCCceeeeeeeeecc-----CeEEEEEecCCCCChhhhhhcCCC--ccchhHHHHHHHHHHHHHHHHhhcccCC
Q 007869          310 VSIGRLRHRNLVQLLGYCRRK-----GELLLVYDYMPNGSLDKYLYDQPK--VTLNWIQRFRVIKGVALGLFYLHQEWEQ  382 (586)
Q Consensus       310 ~~l~~l~H~niv~l~~~~~~~-----~~~~lV~E~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~  382 (586)
                      ..|-++-|-||++++.|+.+.     .+..++.|||..|+|..+|++..+  ..+......+++-||..||.|||+ |..
T Consensus       119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~P  197 (458)
T KOG1266|consen  119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDP  197 (458)
T ss_pred             HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCC
Confidence            445566799999999987644     457899999999999999986532  457777888899999999999997 678


Q ss_pred             cEEeCCCCCCCeeecCCCCeEEccccceee---ccCCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh
Q 007869          383 VVIHRDVKASNVLLDGELNGRLGDFGLARL---YDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC  459 (586)
Q Consensus       383 ~ivHrDIkp~NIll~~~~~~kL~DFGla~~---~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt  459 (586)
                      +|+|+++..+-|++..++-+|++----...   .............+-++|.+||+-...+.+..+|||+||+..+||.-
T Consensus       198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai  277 (458)
T KOG1266|consen  198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI  277 (458)
T ss_pred             ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence            999999999999999998888842111000   00011112333457889999999888888899999999999999988


Q ss_pred             CCCC-CCCCCCCccchhhHHHHhhhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          460 GRRP-IQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       460 G~~p-~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      +..- -+.....+...-+..+        +. .....+           -..++.+|++..|..||+|++++.
T Consensus       278 lEiq~tnseS~~~~ee~ia~~--------i~-~len~l-----------qr~~i~kcl~~eP~~rp~ar~llf  330 (458)
T KOG1266|consen  278 LEIQSTNSESKVEVEENIANV--------II-GLENGL-----------QRGSITKCLEGEPNGRPDARLLLF  330 (458)
T ss_pred             heeccCCCcceeehhhhhhhh--------ee-eccCcc-----------ccCcCcccccCCCCCCcchhhhhc
Confidence            7643 2222111110000000        00 001111           123456799999999999999874

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.45  E-value=3.5e-13  Score=144.67  Aligned_cols=142  Identities=18%  Similarity=0.172  Sum_probs=99.9

Q ss_pred             ceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhH----------------------------------------HHH
Q 007869          266 KELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGM----------------------------------------KEF  305 (586)
Q Consensus       266 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~----------------------------------------~~~  305 (586)
                      .+.||.|++|+||+|+++ +|+.||||+.+.......                                        -+|
T Consensus       122 ~~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf  200 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL  200 (437)
T ss_pred             CcceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence            467999999999999986 567899999865421110                                        024


Q ss_pred             HHHHHHhcccC----CCceeeeeeeee-ccCeEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHH-HHHHhhcc
Q 007869          306 VAEIVSIGRLR----HRNLVQLLGYCR-RKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVAL-GLFYLHQE  379 (586)
Q Consensus       306 ~~Ei~~l~~l~----H~niv~l~~~~~-~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~-~L~yLH~~  379 (586)
                      ..|...+.+++    |.+-+.+-..+. ..+..+|||||++|++|.+....... ..   .+..++..++. .+..+|. 
T Consensus       201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~---~~~~ia~~~~~~~l~ql~~-  275 (437)
T TIGR01982       201 RREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GL---DRKALAENLARSFLNQVLR-  275 (437)
T ss_pred             HHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CC---CHHHHHHHHHHHHHHHHHh-
Confidence            55666555552    322233323222 23457999999999999987653211 11   23456666666 4677887 


Q ss_pred             cCCcEEeCCCCCCCeeecCCCCeEEccccceeeccC
Q 007869          380 WEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH  415 (586)
Q Consensus       380 ~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~  415 (586)
                        .+++|+|+||.||+++.+++++++|||++..+..
T Consensus       276 --~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       276 --DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             --CCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence              8999999999999999999999999999987653

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>cd07308 lectin_leg-like legume-like lectins: ERGIC-53, ERGL, VIP36, VIPL, EMP46, and EMP47

Probab=99.35  E-value=1.4e-11  Score=120.08  Aligned_cols=141  Identities=21%  Similarity=0.242  Sum_probs=89.7

Q ss_pred             eeeeeEEEEEEEEEeCCCCCCCCcEEEEEecCCCCCCCCCCCcccccccCCCCCCCccEEEEEeeccccCCCCCCCCCee
Q 007869           16 TVFSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGLFNDTNLGNETNHVFAVELDTIKSHGFLDINDNHV   95 (586)
Q Consensus        16 ~~asF~t~F~f~i~~~~~~~~g~GlaF~l~p~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEfDt~~~~~~~d~~~~hv   95 (586)
                      ..++|+|+|+|+|... ...+||||||+++|...    ..|..+|.       ....+-+||||||+.|.   +-...+|
T Consensus        55 ~~~~F~~~f~F~i~~~-~~~~gdG~af~~~~~~~----~~g~~~G~-------~~~~~Glai~fdt~~n~---~~~~p~i  119 (218)
T cd07308          55 PAKDFEIEVEFSIHGG-SGLGGDGFAFWYTEEPG----SDGPLFGG-------PDKFKGLAIFFDTYDND---GKGFPSI  119 (218)
T ss_pred             cCCCEEEEEEEEEeCC-CCCCCCEEEEEEECCCC----CCCccccc-------CCCCCEEEEEEEcCCCC---CCCCCeE
Confidence            3479999999999875 35689999999998542    24444444       11234599999999885   2223344


Q ss_pred             EEeCCCCc-c-----------cc---------cccCceEEEEcCeeeEEEEEEeecCCCCCCccceeeeeecchhccccc
Q 007869           96 GIDINSLK-S-----------ES---------SAPAGYYVEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSVLNDA  154 (586)
Q Consensus        96 gidvns~~-s-----------~~---------~~~~~~~i~y~~~~~~l~v~~~~~~~~~~~~~~~ls~~~dL~~~l~~~  154 (586)
                      .+-+|--. +           ..         ..+...+|.|+  .+.|.|.+..... ..   ..+-..++.- .+|+.
T Consensus       120 ~~~~Ndg~~~~~~~~d~~~~~~~~c~~~~~~~~~~~~~~I~y~--~~~l~v~i~~~~~-~~---~~~c~~~~~~-~l~~~  192 (218)
T cd07308         120 SVFLNDGTKSYDYETDGEKLELASCSLKFRNSNAPTTLRISYL--NNTLKVDITYSEG-NN---WKECFTVEDV-ILPSQ  192 (218)
T ss_pred             EEEEeCCCceecccCCCccccccceeEecccCCCCeEEEEEEE--CCEEEEEEeCCCC-CC---ccEEEEcCCc-ccCCC
Confidence            33222111 1           00         01233569998  5788888864211 11   1122222211 46789


Q ss_pred             eeeeeecCCCccceeeeeeecccc
Q 007869          155 MYVGFSSSTGSVLASHYILGWSFK  178 (586)
Q Consensus       155 ~~vGFsastg~~~~~~~i~~Wsf~  178 (586)
                      .|+||||+||...+.|.|++|.+.
T Consensus       193 ~y~G~sA~tg~~~d~~dIls~~~~  216 (218)
T cd07308         193 GYFGFSAQTGDLSDNHDILSVHTY  216 (218)
T ss_pred             CEEEEEeccCCCcCcEEEEEEEee
Confidence            999999999999999999999764

The legume-like (leg-like) lectins are eukaryotic intracellular sugar transport proteins with a carbohydrate recognition domain similar to that of the legume lectins. This domain binds high-mannose-type oligosaccharides for transport from the endoplasmic reticulum to the Golgi complex. These leg-like lectins include ERGIC-53, ERGL, VIP36, VIPL, EMP46, EMP47, and the UIP5 (ULP1-interacting protein 5) precursor protein. Leg-like lectins have different intracellular distributions and dynamics in the endoplasmic reticulum-Golgi system of the secretory pathway and interact with N-glycans of glycoproteins in a calcium-dependent manner, suggesting a role in glycoprotein sorting and trafficking. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat six-stranded beta-sheet referred to as the "ba

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.35  E-value=1.4e-12  Score=138.47  Aligned_cols=248  Identities=23%  Similarity=0.274  Sum_probs=180.7

Q ss_pred             CcccceeEee--cCceEEEEEEe--CCCCeEEEEEEeccccc--hhHHHHHHHHHHhccc-CCCceeeeeeeeeccCeEE
Q 007869          262 GFREKELLGT--GGFGRVYRGTL--PKSQIEIAVKKISHESR--QGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKGELL  334 (586)
Q Consensus       262 ~f~~~~~LG~--G~~g~Vy~~~~--~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~  334 (586)
                      .|...+.+|.  |.+|.||.+..  ..++..+|+|+-+....  +....=.+|+....++ .|+|.++....+...+.++
T Consensus       115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf  194 (524)
T KOG0601|consen  115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF  194 (524)
T ss_pred             hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence            4556777999  99999999998  88888999998544322  2223335666666666 5999999888888999999


Q ss_pred             EEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHH----HHHHhhcccCCcEEeCCCCCCCeeecCC-CCeEEccccc
Q 007869          335 LVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVAL----GLFYLHQEWEQVVIHRDVKASNVLLDGE-LNGRLGDFGL  409 (586)
Q Consensus       335 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~----~L~yLH~~~~~~ivHrDIkp~NIll~~~-~~~kL~DFGl  409 (586)
                      +-.|++ +.+|..+.+... ..++....+.++.+..+    ||.++|+   ..++|-|+||.||++..+ ...+++|||+
T Consensus       195 iqtE~~-~~sl~~~~~~~~-~~~p~~~l~~~~~~~~~~~~~al~~~hs---~~~~~~~~kp~~i~~~~~~~s~~~~df~~  269 (524)
T KOG0601|consen  195 IQTELC-GESLQSYCHTPC-NFLPDNLLWNSLRDWLSRDVTALSHLHS---NNIVHDDLKPANIFTTSDWTSCKLTDFGL  269 (524)
T ss_pred             eeeccc-cchhHHhhhccc-ccCCchhhhhHHhhhhhcccccccccCC---CcccccccchhheecccccceeecCCcce
Confidence            999988 578888776542 23566677777777878    9999998   999999999999999998 8999999999


Q ss_pred             eeeccCCCCC----ceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhcc
Q 007869          410 ARLYDHGTDP----QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNR  485 (586)
Q Consensus       410 a~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~  485 (586)
                      ...+......    ......|...|++||... +.++..+|+|++|.+.+|..++-.........      .|  ...+.
T Consensus       270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~------~W--~~~r~  340 (524)
T KOG0601|consen  270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNS------SW--SQLRQ  340 (524)
T ss_pred             eEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCC------Cc--ccccc
Confidence            9987654321    122336788899999874 56888999999999999999987665432111      11  11111


Q ss_pred             CccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          486 GELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       486 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      +.        +..++.......+......+++.+|..|++.+.+..
T Consensus       341 ~~--------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  341 GY--------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             cc--------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence            11        112222222334444777789999999999887763

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.35  E-value=1.1e-12  Score=142.64  Aligned_cols=144  Identities=15%  Similarity=0.150  Sum_probs=94.3

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchh----------------------------------HH---
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQG----------------------------------MK---  303 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----------------------------------~~---  303 (586)
                      ..|+. +.||+|++|+||+|+++++|+.||||+.++...+.                                  .+   
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~  198 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH  198 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence            45665 78999999999999998878999999997542110                                  01   


Q ss_pred             ---HHHHHHHHhcccC----CCceeeeeeeeec-cCeEEEEEecCCCCChhhhh--hcCCC--ccchhHHHHHHHHHHHH
Q 007869          304 ---EFVAEIVSIGRLR----HRNLVQLLGYCRR-KGELLLVYDYMPNGSLDKYL--YDQPK--VTLNWIQRFRVIKGVAL  371 (586)
Q Consensus       304 ---~~~~Ei~~l~~l~----H~niv~l~~~~~~-~~~~~lV~E~~~~gsL~~~l--~~~~~--~~l~~~~~~~i~~~ia~  371 (586)
                         +|..|+..+.+++    +.+.+.+-..+.+ ....+|||||++|+.|.+.-  ...+.  ..+.......++.|+  
T Consensus       199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi--  276 (537)
T PRK04750        199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV--  276 (537)
T ss_pred             HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH--
Confidence               1344444444442    3333333222222 34568999999999998742  22211  123322233333333  


Q ss_pred             HHHHhhcccCCcEEeCCCCCCCeeecCCC----CeEEccccceeeccC
Q 007869          372 GLFYLHQEWEQVVIHRDVKASNVLLDGEL----NGRLGDFGLARLYDH  415 (586)
Q Consensus       372 ~L~yLH~~~~~~ivHrDIkp~NIll~~~~----~~kL~DFGla~~~~~  415 (586)
                           +.   .+++|+|+||.||+++.++    +++++|||++..++.
T Consensus       277 -----f~---~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        277 -----FR---DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             -----Hh---CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence                 23   7899999999999999887    999999999987654

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.31  E-value=5.4e-12  Score=117.72  Aligned_cols=131  Identities=18%  Similarity=0.115  Sum_probs=96.4

Q ss_pred             ceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCcee-eeeeeeeccCeEEEEEecCCCCC
Q 007869          266 KELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLV-QLLGYCRRKGELLLVYDYMPNGS  344 (586)
Q Consensus       266 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv-~l~~~~~~~~~~~lV~E~~~~gs  344 (586)
                      .+.|+.|.++.||++...  +..+++|....... ....+..|+..+..+.+.+++ +++.+..  ...++||||+++.+
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~   77 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSE   77 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCc
Confidence            456899999999999874  56799999865432 223567899999988665544 4554433  23579999999988


Q ss_pred             hhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhccc--CCcEEeCCCCCCCeeecCCCCeEEccccceee
Q 007869          345 LDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEW--EQVVIHRDVKASNVLLDGELNGRLGDFGLARL  412 (586)
Q Consensus       345 L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~  412 (586)
                      +.+.-       .   ....++.+++++|..||+..  ...++|+|++|+||+++ ++.++++|||.+..
T Consensus        78 l~~~~-------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          78 LLTED-------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             ccccc-------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            76530       0   11235678999999999822  22369999999999999 66899999998764

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.24  E-value=3.5e-11  Score=129.13  Aligned_cols=170  Identities=17%  Similarity=0.199  Sum_probs=129.5

Q ss_pred             EEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEecCCCCChhhhhhcCCCccch
Q 007869          279 RGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLN  358 (586)
Q Consensus       279 ~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~  358 (586)
                      .|..+.++.+|.|...+..+........+-++.|+.+|||||++++...+.++.+|||+|-+.  -|..++.+..     
T Consensus        30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~-----  102 (690)
T KOG1243|consen   30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG-----  102 (690)
T ss_pred             ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH-----
Confidence            456666778899988876655445567788899999999999999999999999999999873  5666665432     


Q ss_pred             hHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCCceeeeccCCCccCcccccC
Q 007869          359 WIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRT  438 (586)
Q Consensus       359 ~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~  438 (586)
                      .....-.+.||+.||.|||.  +.+++|++|....|+++..|+.||++|.++........ ......--..|..|+.+..
T Consensus       103 ~~~v~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~  179 (690)
T KOG1243|consen  103 KEEVCLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDP  179 (690)
T ss_pred             HHHHHHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCc
Confidence            33444568899999999997  47899999999999999999999999999875433221 1111222334667765532


Q ss_pred             CCCCCcceEEehhHHHHHHHhC
Q 007869          439 GKATTSADVFSFGAFLLEVACG  460 (586)
Q Consensus       439 ~~~s~ksDVyS~Gvvl~ElltG  460 (586)
                      ..  -..|.|.|||+++|++.|
T Consensus       180 s~--~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  180 SE--WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             cc--cchhhhhHHHHHHHHhCc
Confidence            22  346999999999999999

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.16  E-value=3.1e-10  Score=107.77  Aligned_cols=138  Identities=17%  Similarity=0.101  Sum_probs=98.2

Q ss_pred             eeEeecCceEEEEEEeCC------CCeEEEEEEecccc----------------------chhHHHHH----HHHHHhcc
Q 007869          267 ELLGTGGFGRVYRGTLPK------SQIEIAVKKISHES----------------------RQGMKEFV----AEIVSIGR  314 (586)
Q Consensus       267 ~~LG~G~~g~Vy~~~~~~------~~~~vavK~~~~~~----------------------~~~~~~~~----~Ei~~l~~  314 (586)
                      ..||.|.-+.||.|...+      .+..+|||..+...                      ....+.+.    +|+..|.+
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            468999999999998653      24689999764210                      01122333    79999998


Q ss_pred             cCC--CceeeeeeeeeccCeEEEEEecCCCCChhh-hhhcCCCccchhHHHHHHHHHHHHHHHHh-hcccCCcEEeCCCC
Q 007869          315 LRH--RNLVQLLGYCRRKGELLLVYDYMPNGSLDK-YLYDQPKVTLNWIQRFRVIKGVALGLFYL-HQEWEQVVIHRDVK  390 (586)
Q Consensus       315 l~H--~niv~l~~~~~~~~~~~lV~E~~~~gsL~~-~l~~~~~~~l~~~~~~~i~~~ia~~L~yL-H~~~~~~ivHrDIk  390 (586)
                      +..  -++.+.+++    ..-+|||||+.+..+.. .+.+   ..++..+...+..+++.+|..| |.   .+|||+||+
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~---~glVHGDLs  152 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKE---CNLVHADLS  152 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHh---CCeecCCCC
Confidence            853  455566654    45689999997654422 2222   1233445667789999999999 76   899999999


Q ss_pred             CCCeeecCCCCeEEccccceeeccC
Q 007869          391 ASNVLLDGELNGRLGDFGLARLYDH  415 (586)
Q Consensus       391 p~NIll~~~~~~kL~DFGla~~~~~  415 (586)
                      +.|||+++ +.+.|+|||.+....+
T Consensus       153 ~~NIL~~~-~~v~iIDF~qav~~~h  176 (197)
T cd05146         153 EYNMLWHD-GKVWFIDVSQSVEPTH  176 (197)
T ss_pred             HHHEEEEC-CcEEEEECCCceeCCC
Confidence            99999974 6799999999886554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.15  E-value=2.2e-10  Score=111.56  Aligned_cols=143  Identities=19%  Similarity=0.180  Sum_probs=110.2

Q ss_pred             ceeEeecCceEEEEEEeCCCCeEEEEEEeccccc-hhHHHHHHHHHHhcccCC--Cceeeeeeeeecc---CeEEEEEec
Q 007869          266 KELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR-QGMKEFVAEIVSIGRLRH--RNLVQLLGYCRRK---GELLLVYDY  339 (586)
Q Consensus       266 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H--~niv~l~~~~~~~---~~~~lV~E~  339 (586)
                      .+.|+.|..+.||++...+ +..+++|....... .....+..|++++..+++  .++.+++.++...   +..++||||
T Consensus         3 ~~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~   81 (223)
T cd05154           3 VRQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMER   81 (223)
T ss_pred             ceecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEE
Confidence            3568999999999998854 56799999765432 234678899999999976  3467788877664   356899999


Q ss_pred             CCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcc----------------------------------------
Q 007869          340 MPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQE----------------------------------------  379 (586)
Q Consensus       340 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~----------------------------------------  379 (586)
                      +++.++.+.+..   ..++..++..++.++++.|.+||+.                                        
T Consensus        82 i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (223)
T cd05154          82 VDGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME  158 (223)
T ss_pred             eCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence            999988876532   2466667778888888888888852                                        


Q ss_pred             -------------cCCcEEeCCCCCCCeeecC--CCCeEEccccceee
Q 007869          380 -------------WEQVVIHRDVKASNVLLDG--ELNGRLGDFGLARL  412 (586)
Q Consensus       380 -------------~~~~ivHrDIkp~NIll~~--~~~~kL~DFGla~~  412 (586)
                                   ....++|+|+++.||+++.  +..+.|+||+.+..
T Consensus       159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                         1256899999999999998  56689999998764

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.13  E-value=6.1e-11  Score=126.15  Aligned_cols=255  Identities=19%  Similarity=0.176  Sum_probs=173.6

Q ss_pred             cchhh-hhhhcCCcccceeEeecCceEEEEEEeC-CCCeEEEEEEeccccchhHHH--HHHHHHHhccc-CCCceeeeee
Q 007869          251 FRYKD-LYIATKGFREKELLGTGGFGRVYRGTLP-KSQIEIAVKKISHESRQGMKE--FVAEIVSIGRL-RHRNLVQLLG  325 (586)
Q Consensus       251 ~~~~e-l~~a~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~~~~~~--~~~Ei~~l~~l-~H~niv~l~~  325 (586)
                      |.-++ ...-..+|.....||.|.|+.|++.... .++..+++|.+.........+  -..|+.+...+ .|.+++....
T Consensus       254 ~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~  333 (524)
T KOG0601|consen  254 FTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNS  333 (524)
T ss_pred             ecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCC
Confidence            33344 4455667899999999999999998765 677789999876543322222  23455555555 5778887766


Q ss_pred             eeeccCeEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCC-CCeEE
Q 007869          326 YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGE-LNGRL  404 (586)
Q Consensus       326 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~-~~~kL  404 (586)
                      .+......++--||++++++...+.-  ...++...++++..|++.++.++|+   +.++|+|+||+||++..+ +..++
T Consensus       334 ~W~~~r~~~ip~e~~~~~s~~l~~~~--~~~~d~~~~~~~~~q~~~~l~~i~s---~~~~~~d~~psni~i~~~~~~~~~  408 (524)
T KOG0601|consen  334 SWSQLRQGYIPLEFCEGGSSSLRSVT--SQMLDEDPRLRLTAQILTALNVIHS---KLFVHLDVKPSNILISNDGFFSKL  408 (524)
T ss_pred             CccccccccCchhhhcCcchhhhhHH--HHhcCcchhhhhHHHHHhccccccc---hhhhcccccccceeeccchhhhhc
Confidence            55555666788999999988766522  2356777888999999999999998   999999999999999876 88999


Q ss_pred             ccccceeeccCCCCCceeeeccCCCcc--CcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhh
Q 007869          405 GDFGLARLYDHGTDPQTTHVVGTLGYL--APEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDF  482 (586)
Q Consensus       405 ~DFGla~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~  482 (586)
                      +|||++..+.-.    .....+.-+++  +++......+-.+.|+||||.-+.|.+++..--.....        |.   
T Consensus       409 ~~~~~~t~~~~~----~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~--------~~---  473 (524)
T KOG0601|consen  409 GDFGCWTRLAFS----SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ--------SL---  473 (524)
T ss_pred             ccccccccccee----cccccccccccccchhhccccccccccccccccccccccccCcccCccccc--------ce---
Confidence            999998642211    11112233344  56666667788999999999999999988653322111        10   


Q ss_pred             hccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 007869          483 WNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILE  534 (586)
Q Consensus       483 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  534 (586)
                          .+....-+.+...     .+.+..+...+..+++..||.+.+.....+
T Consensus       474 ----~i~~~~~p~~~~~-----~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~  516 (524)
T KOG0601|consen  474 ----TIRSGDTPNLPGL-----KLQLQVLLKVMINPDRKRRPSAVELSLHSE  516 (524)
T ss_pred             ----eeecccccCCCch-----HHhhhhhhhhhcCCccccchhhhhhcccch
Confidence                1111122222221     134445555578899999999888765443

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.00  E-value=5.3e-09  Score=109.22  Aligned_cols=170  Identities=18%  Similarity=0.305  Sum_probs=131.8

Q ss_pred             CceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeee----ccCeEEEEEecCCC-CChhh
Q 007869          273 GFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCR----RKGELLLVYDYMPN-GSLDK  347 (586)
Q Consensus       273 ~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~----~~~~~~lV~E~~~~-gsL~~  347 (586)
                      --.+.||+....+|..+++|+++-+..+.......-+++.+++.|.|+|++...+.    .+..++|||+|.|+ ++|.+
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence            34578999998899999999994433333333456678899999999999999876    34578999999986 67887


Q ss_pred             hhhcCC-------------CccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeecc
Q 007869          348 YLYDQP-------------KVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYD  414 (586)
Q Consensus       348 ~l~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~  414 (586)
                      +-+...             ....++...|.++.|+..||.++|+   .|+.-+-|.+.+||++.+.+++|+..|....+.
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHs---sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~  444 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHS---SGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ  444 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHh---cCceeecccHhHeEeeCcceEEEecccceeeec
Confidence            665432             2357788999999999999999998   899999999999999999999999888777654


Q ss_pred             CCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCC
Q 007869          415 HGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRP  463 (586)
Q Consensus       415 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p  463 (586)
                      .+..             +|  +   .--.+-|.=.||.+++.|.||+.-
T Consensus       445 ~d~~-------------~~--l---e~~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  445 EDPT-------------EP--L---ESQQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             CCCC-------------cc--h---hHHhhhhHHHHHHHHHHHhhcccc
Confidence            4320             00  1   112356777899999999999654

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.97  E-value=4.6e-09  Score=96.25  Aligned_cols=143  Identities=18%  Similarity=0.191  Sum_probs=101.5

Q ss_pred             cceeEeecCceEEEEEEeCCCCeEEEEEE-ecccc-------chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEE
Q 007869          265 EKELLGTGGFGRVYRGTLPKSQIEIAVKK-ISHES-------RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLV  336 (586)
Q Consensus       265 ~~~~LG~G~~g~Vy~~~~~~~~~~vavK~-~~~~~-------~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV  336 (586)
                      ...+|-||+-+.|+++.+.  |+...||. +.+.-       +-..+...+|++.|.+++--.|.--.-++.+...-.|+
T Consensus        11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~   88 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY   88 (229)
T ss_pred             cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence            5678999999999999985  44555653 32221       12234578899999988644443333344455555789


Q ss_pred             EecCCC-CChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCC---CeEEccccceee
Q 007869          337 YDYMPN-GSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGEL---NGRLGDFGLARL  412 (586)
Q Consensus       337 ~E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~---~~kL~DFGla~~  412 (586)
                      |||+++ .++.+++...-.....-.....++..|-+.+.-||.   .+|||+||..+||+|..++   .+.++|||++..
T Consensus        89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~---ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHD---NDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhh---CCeecccccccceEEecCCCcCceEEEeecchhc
Confidence            999976 478888765433223333336788999999999998   8999999999999996554   358999999864

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.95  E-value=4.9e-09  Score=96.55  Aligned_cols=131  Identities=21%  Similarity=0.270  Sum_probs=98.3

Q ss_pred             eeEeecCceEEEEEEeCCCCeEEEEEEeccc-c-------chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEe
Q 007869          267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHE-S-------RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYD  338 (586)
Q Consensus       267 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-~-------~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E  338 (586)
                      ..+++|+-+.+|.+.+.+  .++.+|.-.+. -       +-....-.+|+.+|.+++--.|..-.=+..+.+...|+||
T Consensus         2 ~~i~~GAEa~i~~~~~~g--~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me   79 (204)
T COG3642           2 DLIKQGAEAIIYLTDFLG--LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME   79 (204)
T ss_pred             chhhCCcceeEEeeeccC--cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence            357899999999997743  34566643221 1       1112346789999998865555444445566777889999


Q ss_pred             cCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceee
Q 007869          339 YMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARL  412 (586)
Q Consensus       339 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~  412 (586)
                      |+++..|.+.+...         +..++..+-.-+.-||.   .+|+|+||.++||++.+.. +.++||||+..
T Consensus        80 ~I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~---~givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          80 YIEGELLKDALEEA---------RPDLLREVGRLVGKLHK---AGIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             EeCChhHHHHHHhc---------chHHHHHHHHHHHHHHh---cCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            99999999888654         25677888888999998   9999999999999998764 99999999975

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.87  E-value=2.2e-08  Score=100.36  Aligned_cols=141  Identities=19%  Similarity=0.115  Sum_probs=99.4

Q ss_pred             eeEeecCceEEEEEEeCCCCeEEEEEEeccccch-hH----------HHHHHHHHHhcccCCCce--eeeeeeeec----
Q 007869          267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQ-GM----------KEFVAEIVSIGRLRHRNL--VQLLGYCRR----  329 (586)
Q Consensus       267 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~----------~~~~~Ei~~l~~l~H~ni--v~l~~~~~~----  329 (586)
                      +.+-.-....|++..+  +|+.+.||+....... ..          ..+.+|...+.++...+|  ++.+++...    
T Consensus        28 e~v~~~~~rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~  105 (268)
T PRK15123         28 EVFRELEGRRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP  105 (268)
T ss_pred             cEEecCCCceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence            3444444445677766  4567999977433211 11          137789998888854433  344555543    


Q ss_pred             -cCeEEEEEecCCCC-ChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecC-------CC
Q 007869          330 -KGELLLVYDYMPNG-SLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDG-------EL  400 (586)
Q Consensus       330 -~~~~~lV~E~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~-------~~  400 (586)
                       ...-+||+|++++- +|.+++........+...+..++.+++..+.-||.   .+|+|+|++++|||++.       +.
T Consensus       106 ~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~---~Gi~HgDL~~~NiLl~~~~~~~~~~~  182 (268)
T PRK15123        106 ATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHA---AGINHRDCYICHFLLHLPFPGREEDL  182 (268)
T ss_pred             ccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHH---CcCccCCCChhhEEEeccccCCCCCc
Confidence             23578999999876 89988854222334555677899999999999998   99999999999999975       46


Q ss_pred             CeEEccccceee
Q 007869          401 NGRLGDFGLARL  412 (586)
Q Consensus       401 ~~kL~DFGla~~  412 (586)
                      .+.|+||+.++.
T Consensus       183 ~~~LIDl~r~~~  194 (268)
T PRK15123        183 KLSVIDLHRAQI  194 (268)
T ss_pred             eEEEEECCcccc
Confidence            899999998864

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.87  E-value=1.1e-09  Score=122.51  Aligned_cols=209  Identities=22%  Similarity=0.224  Sum_probs=149.6

Q ss_pred             hhhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc---chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeE
Q 007869          257 YIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGEL  333 (586)
Q Consensus       257 ~~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~  333 (586)
                      ....+.|.+.+-+-+|.++.++-..-...+...+.|......   ....+....+-.++-..+||-++...--+......
T Consensus       800 rsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~  879 (1205)
T KOG0606|consen  800 RSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPL  879 (1205)
T ss_pred             cCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCc
Confidence            355667777788889999999988766666555555443221   11112222222222223456666555455566788


Q ss_pred             EEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeec
Q 007869          334 LLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLY  413 (586)
Q Consensus       334 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~  413 (586)
                      .||++|..+++|...|+..+  ..+.......+..+.++++|||.   ..+.|||++|.|++...++..++.|||+....
T Consensus       880 ~L~~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s---~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v  954 (1205)
T KOG0606|consen  880 PLVGHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHS---SLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKV  954 (1205)
T ss_pred             chhhHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhcccc---chhhcccccccchhhcccCCcccCcccccccc
Confidence            99999999999999998764  34444444556678889999997   66999999999999999999999999854322


Q ss_pred             cCC---------------------CC---------CceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCC
Q 007869          414 DHG---------------------TD---------PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRP  463 (586)
Q Consensus       414 ~~~---------------------~~---------~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p  463 (586)
                      .-.                     ..         .......||+.|.+||...+.......|.|+.|++++|.++|..|
T Consensus       955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen  955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred             ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence            100                     00         012335789999999999999999999999999999999999999


Q ss_pred             CCCCCCC
Q 007869          464 IQRQGPS  470 (586)
Q Consensus       464 ~~~~~~~  470 (586)
                      |+...+.
T Consensus      1035 ~na~tpq 1041 (1205)
T KOG0606|consen 1035 FNAETPQ 1041 (1205)
T ss_pred             CCCcchh
Confidence            9876553

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.76  E-value=1e-07  Score=90.27  Aligned_cols=126  Identities=22%  Similarity=0.264  Sum_probs=81.5

Q ss_pred             EEEEEEeCCCCeEEEEEEecccc--------------c------------hhHHHHHHHHHHhcccCCC--ceeeeeeee
Q 007869          276 RVYRGTLPKSQIEIAVKKISHES--------------R------------QGMKEFVAEIVSIGRLRHR--NLVQLLGYC  327 (586)
Q Consensus       276 ~Vy~~~~~~~~~~vavK~~~~~~--------------~------------~~~~~~~~Ei~~l~~l~H~--niv~l~~~~  327 (586)
                      .||.|... ++..+|||..+...              +            .......+|.+.|.++..-  ++.+.+.+.
T Consensus         1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            38999885 45689999774320              0            0112467899999999765  456666543


Q ss_pred             eccCeEEEEEecCC--CCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHh-hcccCCcEEeCCCCCCCeeecCCCCeEE
Q 007869          328 RRKGELLLVYDYMP--NGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYL-HQEWEQVVIHRDVKASNVLLDGELNGRL  404 (586)
Q Consensus       328 ~~~~~~~lV~E~~~--~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yL-H~~~~~~ivHrDIkp~NIll~~~~~~kL  404 (586)
                          .-+|||||++  +..+.. |...   .+.......++.+++..+..+ |.   .+|+|+||.+.|||++++ .+.|
T Consensus        80 ----~~~ivME~I~~~G~~~~~-l~~~---~~~~~~~~~~~~~il~~~~~~~~~---~givHGDLs~~NIlv~~~-~~~i  147 (188)
T PF01163_consen   80 ----RNVIVMEYIGEDGVPLPR-LKDV---DLSPEEPKELLEEILEEIIKMLHK---AGIVHGDLSEYNILVDDG-KVYI  147 (188)
T ss_dssp             ----TTEEEEE--EETTEEGGC-HHHC---GGGGSTHHHHHHHHHHHHHHHHHC---TTEEESS-STTSEEEETT-CEEE
T ss_pred             ----CCEEEEEecCCCccchhh-HHhc---cccchhHHHHHHHHHHHHHHHHHh---cCceecCCChhhEEeecc-eEEE
Confidence                2379999998  544443 3222   122345566788888866664 66   899999999999999988 9999


Q ss_pred             ccccceeecc
Q 007869          405 GDFGLARLYD  414 (586)
Q Consensus       405 ~DFGla~~~~  414 (586)
                      +|||.+....
T Consensus       148 IDf~qav~~~  157 (188)
T PF01163_consen  148 IDFGQAVDSS  157 (188)
T ss_dssp             --GTTEEETT
T ss_pred             EecCcceecC
Confidence            9999988654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>cd06902 lectin_ERGIC-53_ERGL ERGIC-53 and ERGL type 1 transmembrane proteins, N-terminal lectin domain

Probab=98.76  E-value=2.5e-07  Score=90.09  Aligned_cols=144  Identities=18%  Similarity=0.246  Sum_probs=85.0

Q ss_pred             eeeeEEEEEEEEEeCCCCCCCCcEEEEEecCCCCCCCCCCCcccccccCCCCCCCccEEEEEeeccccCCCCCCCCCeeE
Q 007869           17 VFSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGLFNDTNLGNETNHVFAVELDTIKSHGFLDINDNHVG   96 (586)
Q Consensus        17 ~asF~t~F~f~i~~~~~~~~g~GlaF~l~p~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEfDt~~~~~~~d~~~~hvg   96 (586)
                      .-+|+.+|+|+|... ...+||||||.++...    +..|..+|.-+      .-+. +||.|||+.|.+  ..+...|-
T Consensus        58 ~~~w~ie~~Fri~g~-~~~~gdG~a~W~t~~~----~~~G~~~G~~~------~f~G-l~I~~Dt~~n~~--~~~~p~i~  123 (225)
T cd06902          58 FENWEVEVTFRVTGR-GRIGADGLAIWYTKER----GEEGPVFGSSD------KWNG-VGIFFDSFDNDG--KKNNPAIL  123 (225)
T ss_pred             CCCEEEEEEEEEecC-CCCCCCEEEEEEECCC----CCCCCccCCCC------cccE-EEEEEECCCCCC--CCCCcEEE
Confidence            447999999999864 3357899999999543    12444444421      1222 799999998753  22334553


Q ss_pred             EeCC-CCccccc--------------------ccCceEEEEcCeeeEEEEEEeecCCCCCCccceeeeeecchh-ccccc
Q 007869           97 IDIN-SLKSESS--------------------APAGYYVEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSS-VLNDA  154 (586)
Q Consensus        97 idvn-s~~s~~~--------------------~~~~~~i~y~~~~~~l~v~~~~~~~~~~~~~~~ls~~~dL~~-~l~~~  154 (586)
                      +-+| +......                    .+....|.|..  ..|.|.+.....  +.. .-...-.++.. .||..
T Consensus       124 ~~~NDGt~~yd~~~D~~~~~~~~C~~~~rn~~~p~~~rI~Y~~--~~l~V~~d~~~~--~~~-~~~~~Cf~~~~v~LP~~  198 (225)
T cd06902         124 VVGNDGTKSYDHQNDGLTQALGSCLRDFRNKPYPVRAKITYYQ--NVLTVSINNGFT--PNK-DDYELCTRVENMVLPPN  198 (225)
T ss_pred             EEECCCCeeccccCCCcccccceEEEeccCCCCCeEEEEEEEC--CeEEEEEeCCcC--CCC-CcccEEEecCCeeCCCC
Confidence            3222 1111110                    11122488885  457777763211  111 00111122222 36678


Q ss_pred             eeeeeecCCCccceeeeeeeccccc
Q 007869          155 MYVGFSSSTGSVLASHYILGWSFKI  179 (586)
Q Consensus       155 ~~vGFsastg~~~~~~~i~~Wsf~~  179 (586)
                      .|+||||+||...+.|.|++|++.+
T Consensus       199 ~yfGiSA~Tg~l~d~hDIls~~~~s  223 (225)
T cd06902         199 GYFGVSAATGGLADDHDVLSFLTFS  223 (225)
T ss_pred             CEEEEEecCCCCCCcEeEEEEEEec
Confidence            9999999999999999999998863

ERGIC-53 and ERGL, N-terminal carbohydrate recognition domain. ERGIC-53 and ERGL are eukaryotic mannose-binding type 1 transmembrane proteins of the early secretory pathway that transport newly synthesized glycoproteins from the endoplasmic reticulum (ER) to the ER-Golgi intermediate compartment (ERGIC). ERGIC-53 and ERGL have an N-terminal lectin-like carbohydrate recognition domain (represented by this alignment model) as well as a C-terminal transmembrane domain. ERGIC-53 functions as a 'cargo receptor' to facilitate the export of glycoproteins with different characteristics from the ER, while the ERGIC-53-like protein (ERGL) which may act as a regulator of ERGIC-53. In mammals, ERGIC-53 forms a complex with MCFD2 (multi-coagulation factor deficiency 2) which then recruits blood coagulation factors V and VIII. Mutations in either MCFD2 or ERGIC-53 cause a mild form of inherite

>cd06901 lectin_VIP36_VIPL VIP36 and VIPL type 1 transmembrane proteins, lectin domain

Probab=98.72  E-value=2.6e-07  Score=91.13  Aligned_cols=146  Identities=16%  Similarity=0.135  Sum_probs=83.4

Q ss_pred             eeeeeEEEEEEEEEeCCCCCCCCcEEEEEecCCCCCCCCCCCcccccccCCCCCCCccEEEEEeeccccCCC-CCCCCCe
Q 007869           16 TVFSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGLFNDTNLGNETNHVFAVELDTIKSHGF-LDINDNH   94 (586)
Q Consensus        16 ~~asF~t~F~f~i~~~~~~~~g~GlaF~l~p~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEfDt~~~~~~-~d~~~~h   94 (586)
                      ...+|+|+|+|+|.......+||||||.++...    +..|..+|-   .   +.-+. +||-|||+.|..- .....+-
T Consensus        55 ~~~~F~~~f~F~I~~~~~~~~GdGlAfw~t~~~----~~~G~~fG~---~---~~f~G-l~I~~Dt~~n~~~~~~~~~P~  123 (248)
T cd06901          55 YLRDWEMHVHFKVHGSGKNLFGDGFAIWYTKER----MQPGPVFGS---K---DNFHG-LAIFFDTYSNQNGEHEHVHPY  123 (248)
T ss_pred             cCCCEEEEEEEEEeCCCCCCCCCEEEEEEEcCC----CccCccccc---C---CCCce-EEEEEECCCCCCCcccCCCce
Confidence            457899999999998655678999999999653    223433333   1   11122 7999999988521 0011111


Q ss_pred             e-EEeCCCCccccc-------c-------------cCceEEEEcCeeeEEEEEEeecCCCCCCccceeeeeecchhcccc
Q 007869           95 V-GIDINSLKSESS-------A-------------PAGYYVEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSVLND  153 (586)
Q Consensus        95 v-gidvns~~s~~~-------~-------------~~~~~i~y~~~~~~l~v~~~~~~~~~~~~~~~ls~~~dL~~~l~~  153 (586)
                      | ++--++...-..       +             +....|.|..  ..+.|.+...+...=.. |.-...+    .||.
T Consensus       124 i~~~~NDGt~~yd~~~Dg~~~~~~~C~~~~rn~~~~t~~rI~Y~~--~~l~v~vd~~~~~~w~~-Cf~~~~v----~LP~  196 (248)
T cd06901         124 ISAMVNNGSLSYDHDRDGTHTELAGCSAPFRNKDHDTFVAIRYSK--GRLTVMTDIDGKNEWKE-CFDVTGV----RLPT  196 (248)
T ss_pred             EEEEEcCCCeeecccCCCchhhcCceeeeccCCCCCeEEEEEEEC--CeEEEEEecCCCCceee-eEEeCCe----ecCC
Confidence            2 211122111000       0             0113488884  34666665422111012 3222222    3567


Q ss_pred             ceeeeeecCCCccceeeeeeeccccc
Q 007869          154 AMYVGFSSSTGSVLASHYILGWSFKI  179 (586)
Q Consensus       154 ~~~vGFsastg~~~~~~~i~~Wsf~~  179 (586)
                      ..|+||||+||...+.|.|++-.+..
T Consensus       197 ~~yfGiSA~Tg~~sd~hdIlsv~~~~  222 (248)
T cd06901         197 GYYFGASAATGDLSDNHDIISMKLYE  222 (248)
T ss_pred             CCEEEEEecCCCCCCcEEEEEEEEec
Confidence            79999999999988889998876553

The vesicular integral protein of 36 kDa (VIP36) is a type 1 transmembrane protein of the mammalian early secretory pathway that acts as a cargo receptor transporting high mannose type glycoproteins between the Golgi and the endoplasmic reticulum (ER). Lectins of the early secretory pathway are involved in the selective transport of newly synthesized glycoproteins from the ER to the ER-Golgi intermediate compartment (ERGIC). The most prominent cycling lectin is the mannose-binding type1 membrane protein ERGIC-53, which functions as a cargo receptor to facilitate export of glycoproteins from the ER. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat six-stranded beta-sheet referred to as the "back face". This domain homodimerizes so that adjacent back sheets form a contiguous 12-stranded she

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.64  E-value=1.2e-08  Score=110.33  Aligned_cols=152  Identities=22%  Similarity=0.314  Sum_probs=102.7

Q ss_pred             HHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCC--------ceeeeccCCCccCccccc
Q 007869          366 IKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP--------QTTHVVGTLGYLAPEHTR  437 (586)
Q Consensus       366 ~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~--------~~~~~~gt~~y~aPE~~~  437 (586)
                      +.+++.||.|+|.  ...+||++|.|++|.+++++..||+.|+.+.........        ...-..-...|.|||++.
T Consensus       105 l~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~  182 (700)
T KOG2137|consen  105 LGNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL  182 (700)
T ss_pred             hhcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence            4456699999998  689999999999999999999999999998765442211        011123466799999999


Q ss_pred             CCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCccccHHHHHHHHHHHHHhc
Q 007869          438 TGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCS  516 (586)
Q Consensus       438 ~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl  516 (586)
                      ....+.++|+||+||++|-+.. |+.-+............         +...+..    ...+......++.+-+.+.+
T Consensus       183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~---------~~~~~~~----~~~~s~~~p~el~~~l~k~l  249 (700)
T KOG2137|consen  183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFS---------RNLLNAG----AFGYSNNLPSELRESLKKLL  249 (700)
T ss_pred             cccccccccceeeeeEEEEEecCCcchhhccCCcchhhhh---------hcccccc----cccccccCcHHHHHHHHHHh
Confidence            9888999999999999999985 44444433222111100         0011110    01122233445555556678


Q ss_pred             ccCCCCCCCHHHHHHH
Q 007869          517 HSDPTARPSMRQVVQI  532 (586)
Q Consensus       517 ~~dP~~RPs~~evl~~  532 (586)
                      ..++..||++.++...
T Consensus       250 ~~~~~~rp~~~~l~~~  265 (700)
T KOG2137|consen  250 NGDSAVRPTLDLLLSI  265 (700)
T ss_pred             cCCcccCcchhhhhcc
Confidence            8999999988877653

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.63  E-value=1.3e-06  Score=89.57  Aligned_cols=193  Identities=17%  Similarity=0.204  Sum_probs=128.7

Q ss_pred             ccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhccc-CCCceeeeeeee------eccC-eEEE
Q 007869          264 REKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRL-RHRNLVQLLGYC------RRKG-ELLL  335 (586)
Q Consensus       264 ~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~------~~~~-~~~l  335 (586)
                      ...+.||+|+-+.+|-.---.+   .+-|+..........+...   .|... .||-+-.=+.|=      -+.+ ..-+
T Consensus        14 ~~gr~LgqGgea~ly~l~e~~d---~VAKIYh~Pppa~~aqk~a---~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf   87 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGEVRD---QVAKIYHAPPPAAQAQKVA---ELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF   87 (637)
T ss_pred             CCCccccCCccceeeecchhhc---hhheeecCCCchHHHHHHH---HhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence            3457799999999996533222   2346665544333222222   23333 565443322221      1222 2667


Q ss_pred             EEecCCCCC-hhhhhhc---C-CCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccce
Q 007869          336 VYDYMPNGS-LDKYLYD---Q-PKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLA  410 (586)
Q Consensus       336 V~E~~~~gs-L~~~l~~---~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla  410 (586)
                      .|..+++.. +..+...   . .-....|.-.++.++.+|.+.+-||.   .+.+-+|++++|+|+.++..+.|.|-..-
T Consensus        88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~---~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf  164 (637)
T COG4248          88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHE---HGHVVGDVNQNSFLVSDDSKVVLVDSDSF  164 (637)
T ss_pred             ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHh---cCCcccccCccceeeecCceEEEEcccce
Confidence            788776642 2222211   1 11357899999999999999999998   89999999999999999999999885544


Q ss_pred             eeccCCCCCceeeeccCCCccCccccc-----CCCCCCcceEEehhHHHHHHHhC-CCCCCCC
Q 007869          411 RLYDHGTDPQTTHVVGTLGYLAPEHTR-----TGKATTSADVFSFGAFLLEVACG-RRPIQRQ  467 (586)
Q Consensus       411 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVyS~Gvvl~ElltG-~~p~~~~  467 (586)
                      ....++  ......+|...|.+||...     +...+..+|.|.||++++||+.| ++||.+.
T Consensus       165 qi~~ng--~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI  225 (637)
T COG4248         165 QINANG--TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI  225 (637)
T ss_pred             eeccCC--ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence            432222  2334467899999999765     33457789999999999999886 9999753

>PRK09902 hypothetical protein; Provisional

Probab=98.62  E-value=4e-07  Score=86.91  Aligned_cols=138  Identities=20%  Similarity=0.196  Sum_probs=104.7

Q ss_pred             EeecCceEEEEEEeCCCCeEEEEEEeccc---c---chhHHHHHHHHHHhcccCCCc--eeeeeeeee-cc----CeEEE
Q 007869          269 LGTGGFGRVYRGTLPKSQIEIAVKKISHE---S---RQGMKEFVAEIVSIGRLRHRN--LVQLLGYCR-RK----GELLL  335 (586)
Q Consensus       269 LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~---~~~~~~~~~Ei~~l~~l~H~n--iv~l~~~~~-~~----~~~~l  335 (586)
                      -|+||-+.|++-.+.+  ..+-+|+....   +   +.+...|.+|+..|.++...+  +.+.. ++. .+    -.-+|
T Consensus        26 ~~rgG~SgV~r~~~~g--~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L  102 (216)
T PRK09902         26 YRRNGMSGVQCVERNG--KKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL  102 (216)
T ss_pred             cCCCCcceEEEEEeCC--cEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence            5778999999987743  36889987521   1   335678999999999995432  44444 332 21    24689


Q ss_pred             EEecCCC-CChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCC--eEEccccceee
Q 007869          336 VYDYMPN-GSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELN--GRLGDFGLARL  412 (586)
Q Consensus       336 V~E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~--~kL~DFGla~~  412 (586)
                      |+|-+++ -+|.+++.+....+.+..++..++.+++..+.-||.   .++.|+|+.+.||+++.++.  ++++||.-++.
T Consensus       103 VTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~---~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        103 VTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHS---VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            9997754 589998866544456777788999999999999998   99999999999999986666  99999987663

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.49  E-value=7.6e-07  Score=86.07  Aligned_cols=106  Identities=24%  Similarity=0.290  Sum_probs=82.9

Q ss_pred             HHHHHHHHHhcccCCC--ceeeeeeeeeccC----eEEEEEecCCCC-ChhhhhhcCCCccchhHHHHHHHHHHHHHHHH
Q 007869          303 KEFVAEIVSIGRLRHR--NLVQLLGYCRRKG----ELLLVYDYMPNG-SLDKYLYDQPKVTLNWIQRFRVIKGVALGLFY  375 (586)
Q Consensus       303 ~~~~~Ei~~l~~l~H~--niv~l~~~~~~~~----~~~lV~E~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~y  375 (586)
                      ....+|...+.++...  ..++.+++.....    ..+||+|++++- +|.+++.....  ++......++.++++.+.-
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~~  133 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIAK  133 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHHH
Confidence            4577888888777543  3445666655432    458999999874 89999876432  4555677899999999999


Q ss_pred             hhcccCCcEEeCCCCCCCeeecCCC---CeEEccccceeec
Q 007869          376 LHQEWEQVVIHRDVKASNVLLDGEL---NGRLGDFGLARLY  413 (586)
Q Consensus       376 LH~~~~~~ivHrDIkp~NIll~~~~---~~kL~DFGla~~~  413 (586)
                      ||.   .+|+|+|+++.|||++.+.   .+.++||+-++..
T Consensus       134 lH~---~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  134 LHD---AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHH---CcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            998   9999999999999998876   8999999988753

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.44  E-value=5.8e-07  Score=97.52  Aligned_cols=142  Identities=18%  Similarity=0.216  Sum_probs=90.8

Q ss_pred             eeEeecCceEEEEEEeCCCCeEEEEEEeccccchhH------------------------------H----------HHH
Q 007869          267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGM------------------------------K----------EFV  306 (586)
Q Consensus       267 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~------------------------------~----------~~~  306 (586)
                      +.|+.++-|+||+|+++. |+.||||+.++.-.+..                              +          ++.
T Consensus       131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            679999999999999975 78999999865422111                              1          134


Q ss_pred             HHHHHhcccC----CCceeeeeeeee-ccCeEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccC
Q 007869          307 AEIVSIGRLR----HRNLVQLLGYCR-RKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE  381 (586)
Q Consensus       307 ~Ei~~l~~l~----H~niv~l~~~~~-~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~  381 (586)
                      .|...+.+++    ...-+++=..|. -.+...|+|||++|-.+.+...-.. ...+   +..++..++++.  +-+...
T Consensus       210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d---~k~ia~~~~~~f--~~q~~~  283 (517)
T COG0661         210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGID---RKELAELLVRAF--LRQLLR  283 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCC---HHHHHHHHHHHH--HHHHHh
Confidence            4555554442    111122222222 2356799999999999988743222 2233   222233333221  111112


Q ss_pred             CcEEeCCCCCCCeeecCCCCeEEccccceeeccC
Q 007869          382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH  415 (586)
Q Consensus       382 ~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~  415 (586)
                      .++.|.|.+|.||+++.++++.+.|||+...++.
T Consensus       284 dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         284 DGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             cCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            6899999999999999999999999999987654

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.40  E-value=1.5e-06  Score=85.07  Aligned_cols=135  Identities=15%  Similarity=0.117  Sum_probs=91.9

Q ss_pred             cccceeEeecCceEEEEEEeCCCCeEEEEEEeccccc----------------------hhHHHHHHHHHHhcccCCC--
Q 007869          263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR----------------------QGMKEFVAEIVSIGRLRHR--  318 (586)
Q Consensus       263 f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~----------------------~~~~~~~~Ei~~l~~l~H~--  318 (586)
                      ..+...||-|.-+.||.|..+ .+.++|||.-+....                      -.....++|.+.|.+|.-.  
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            344678999999999999997 466899995432100                      0122457899999998654  


Q ss_pred             ceeeeeeeeeccCeEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecC
Q 007869          319 NLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDG  398 (586)
Q Consensus       319 niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~  398 (586)
                      .+.+-++|-    .-.+||||+++--|...--       +-...-.|+..|++-+.-+-.   .+|||+|+.+-||++++
T Consensus       172 ~VP~P~~~n----RHaVvMe~ieG~eL~~~r~-------~~en~~~il~~il~~~~~~~~---~GiVHGDlSefNIlV~~  237 (304)
T COG0478         172 KVPKPIAWN----RHAVVMEYIEGVELYRLRL-------DVENPDEILDKILEEVRKAYR---RGIVHGDLSEFNILVTE  237 (304)
T ss_pred             CCCCccccc----cceeeeehcccceeecccC-------cccCHHHHHHHHHHHHHHHHH---cCccccCCchheEEEec
Confidence            666666653    4489999998866654321       111222233333333333333   79999999999999999


Q ss_pred             CCCeEEccccceee
Q 007869          399 ELNGRLGDFGLARL  412 (586)
Q Consensus       399 ~~~~kL~DFGla~~  412 (586)
                      ++.+.++||--+..
T Consensus       238 dg~~~vIDwPQ~v~  251 (304)
T COG0478         238 DGDIVVIDWPQAVP  251 (304)
T ss_pred             CCCEEEEeCccccc
Confidence            99999999976554

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.33  E-value=4.7e-06  Score=81.74  Aligned_cols=139  Identities=14%  Similarity=0.145  Sum_probs=84.6

Q ss_pred             eeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCc--eeeeeeeeeccCeEEEEEecCCCCC
Q 007869          267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRN--LVQLLGYCRRKGELLLVYDYMPNGS  344 (586)
Q Consensus       267 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~n--iv~l~~~~~~~~~~~lV~E~~~~gs  344 (586)
                      ..||+|..+.||+..    +..+++|......  ......+|.+.++.+..-.  +.+.++++...+...+|||+++|..
T Consensus         7 ~~i~~G~t~~~y~~~----~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~   80 (226)
T TIGR02172         7 TQTGEGGNGESYTHK----TGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR   80 (226)
T ss_pred             eeecCCCCcceeEec----CCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence            568999999999842    3357788876533  2345688999998886443  4667888877777889999998863


Q ss_pred             -hhhhh---------------------hcCCCccchhHHHH-HHHH----------HHHH-HHHHhhc-ccCCcEEeCCC
Q 007869          345 -LDKYL---------------------YDQPKVTLNWIQRF-RVIK----------GVAL-GLFYLHQ-EWEQVVIHRDV  389 (586)
Q Consensus       345 -L~~~l---------------------~~~~~~~l~~~~~~-~i~~----------~ia~-~L~yLH~-~~~~~ivHrDI  389 (586)
                       +.+.+                     +.-+.......... .+..          .+.+ ...+|.. .....++|+|+
T Consensus        81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~  160 (226)
T TIGR02172        81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF  160 (226)
T ss_pred             chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence             22211                     11000000100000 0000          0001 1111211 11345799999


Q ss_pred             CCCCeeecCCCCeEEccccceee
Q 007869          390 KASNVLLDGELNGRLGDFGLARL  412 (586)
Q Consensus       390 kp~NIll~~~~~~kL~DFGla~~  412 (586)
                      .|.||++++++ +.|+||+.+..
T Consensus       161 ~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       161 QIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             CCCcEEEcCCC-cEEEechhcCc
Confidence            99999999887 99999998753

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.32  E-value=1.4e-07  Score=101.16  Aligned_cols=190  Identities=18%  Similarity=0.151  Sum_probs=141.6

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCc-eeeeeeeeeccCeEEEEEe
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRN-LVQLLGYCRRKGELLLVYD  338 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~n-iv~l~~~~~~~~~~~lV~E  338 (586)
                      ++-+...+-+++++++++||.+...+.. ..++.+...     ....-++++|.+++||| .+..++-+..+...+++++
T Consensus       241 ~kws~~fh~fvK~altknpKkRptaekl-L~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~  314 (829)
T KOG0576|consen  241 TKWSEFFHNFVKGALTKNPKKRPTAEKL-LQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMR  314 (829)
T ss_pred             ccchHHHHHHHHHHhcCCCccCCChhhh-eeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhh
Confidence            3444455668999999999988755443 336665433     34456889999999999 7777777777888999999


Q ss_pred             cCCCC-ChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCC
Q 007869          339 YMPNG-SLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT  417 (586)
Q Consensus       339 ~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~  417 (586)
                      ++..+ +-...... ....+...+...+.+.-+++|+|||+   ..-+|||    ||+..+ ...|..||+....+....
T Consensus       315 i~s~~rs~~~~~~~-se~~~~~~~~~~~~r~et~~l~~l~~---~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~  385 (829)
T KOG0576|consen  315 ICSTGRSSALEMTV-SEIALEQYQFAYPLRKETRPLAELHS---SYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM  385 (829)
T ss_pred             hhcCCccccccCCh-hhHhhhhhhhhhhhhhhccccccccc---ccccCcc----cccccc-cccccccccCCcccCccc
Confidence            99877 32222211 12345566677778888999999998   4458888    887765 578999999988766543


Q ss_pred             CCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCC
Q 007869          418 DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQR  466 (586)
Q Consensus       418 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~  466 (586)
                        ......+|+.++|||+.....+..+-|+|++|+-..++.-|-+|-..
T Consensus       386 --~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~  432 (829)
T KOG0576|consen  386 --KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS  432 (829)
T ss_pred             --ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence              33456799999999999999999999999999987788777776543

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.23  E-value=1.2e-05  Score=78.41  Aligned_cols=143  Identities=22%  Similarity=0.226  Sum_probs=85.5

Q ss_pred             ceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCC--ceeeeeeeeec---cCeEEEEEecC
Q 007869          266 KELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHR--NLVQLLGYCRR---KGELLLVYDYM  340 (586)
Q Consensus       266 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~--niv~l~~~~~~---~~~~~lV~E~~  340 (586)
                      .+.|+.|..+.||+....+ + .+++|.....  .....+..|..+++.+...  .+.+++.++..   ....+++|+++
T Consensus         2 i~~l~~G~~n~~~~v~~~~-~-~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i   77 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD-G-RYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYI   77 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT-S-EEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC-c-EEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEe
Confidence            4679999999999999865 4 7999997655  4456777888888888533  35566664432   34578999999


Q ss_pred             CCCChhh----------------hh---hcC--CCccchhHH---------HHHH------------HHHHHH-HHHHhh
Q 007869          341 PNGSLDK----------------YL---YDQ--PKVTLNWIQ---------RFRV------------IKGVAL-GLFYLH  377 (586)
Q Consensus       341 ~~gsL~~----------------~l---~~~--~~~~l~~~~---------~~~i------------~~~ia~-~L~yLH  377 (586)
                      ++..+..                .+   +..  ......+..         ....            ...+.+ .+..++
T Consensus        78 ~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (239)
T PF01636_consen   78 PGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELE  157 (239)
T ss_dssp             SSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHH
Confidence            9988877                11   111  111111100         0000            111222 233333


Q ss_pred             c----ccCCcEEeCCCCCCCeeec-CCCCeEEccccceee
Q 007869          378 Q----EWEQVVIHRDVKASNVLLD-GELNGRLGDFGLARL  412 (586)
Q Consensus       378 ~----~~~~~ivHrDIkp~NIll~-~~~~~kL~DFGla~~  412 (586)
                      +    .....++|+|+.|.|||++ +++.+-|+||+.+..
T Consensus       158 ~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  158 ALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             HHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             hhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence            2    1347799999999999999 566667999988764

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.22  E-value=1.2e-05  Score=77.22  Aligned_cols=139  Identities=15%  Similarity=0.180  Sum_probs=93.8

Q ss_pred             hhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHH---------HHHHHHhcccCC---Cceeeeee
Q 007869          258 IATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEF---------VAEIVSIGRLRH---RNLVQLLG  325 (586)
Q Consensus       258 ~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~---------~~Ei~~l~~l~H---~niv~l~~  325 (586)
                      ....+|...+++-......|.+-..  ++..+++|..+.......+.|         .+++..+.+++.   .....++.
T Consensus        28 i~~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl  105 (229)
T PF06176_consen   28 ILDNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL  105 (229)
T ss_pred             HHhCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence            3456788888888888777777766  456799999877654433332         334444444432   22222222


Q ss_pred             ee-----eccCeEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCC
Q 007869          326 YC-----RRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGEL  400 (586)
Q Consensus       326 ~~-----~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~  400 (586)
                      ..     .-....+|+|||++|..|.+...      ++.    .+...+.+++.-||+   .++.|+|.+|+|++++++ 
T Consensus       106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~---~G~~HGD~hpgNFlv~~~-  171 (229)
T PF06176_consen  106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHK---HGFYHGDPHPGNFLVSNN-  171 (229)
T ss_pred             eeeeeeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHH---cCCccCCCCcCcEEEECC-
Confidence            22     22345679999999988876532      221    245667888999998   999999999999999865 


Q ss_pred             CeEEccccceee
Q 007869          401 NGRLGDFGLARL  412 (586)
Q Consensus       401 ~~kL~DFGla~~  412 (586)
                      .++++||+..+.
T Consensus       172 ~i~iID~~~k~~  183 (229)
T PF06176_consen  172 GIRIIDTQGKRM  183 (229)
T ss_pred             cEEEEECccccc
Confidence            499999987654

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.11  E-value=2.1e-05  Score=77.99  Aligned_cols=139  Identities=17%  Similarity=0.161  Sum_probs=84.1

Q ss_pred             EeecCc-eEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccC-CCceeeeeeeeeccCeEEEEEecCCCCChh
Q 007869          269 LGTGGF-GRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLR-HRNLVQLLGYCRRKGELLLVYDYMPNGSLD  346 (586)
Q Consensus       269 LG~G~~-g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~~~~~~~~~~~lV~E~~~~gsL~  346 (586)
                      |-.|.. ..||+....+  ..+.||+.....   ......|+++++.+. +--+.+++++....+..++|||+++|.+|.
T Consensus         6 ~~~g~~~~~v~~~~~~~--~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~   80 (244)
T cd05150           6 VTEGQSGATVYRLDGKN--PGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA   80 (244)
T ss_pred             cCCCCCcCeEEEEcCCC--CcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence            444555 7889997643  468888875443   345677888888873 444667788777666789999999998876


Q ss_pred             hhhh-------------------cCCC--ccch--hHHHHHHHHH--------------------HHHHHHHhhc----c
Q 007869          347 KYLY-------------------DQPK--VTLN--WIQRFRVIKG--------------------VALGLFYLHQ----E  379 (586)
Q Consensus       347 ~~l~-------------------~~~~--~~l~--~~~~~~i~~~--------------------ia~~L~yLH~----~  379 (586)
                      ....                   ..+.  .+..  ..........                    +...+..|-.    .
T Consensus        81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  160 (244)
T cd05150          81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE  160 (244)
T ss_pred             HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence            4421                   1100  0110  0000000000                    1111111111    1


Q ss_pred             cCCcEEeCCCCCCCeeecCCCCeEEccccceee
Q 007869          380 WEQVVIHRDVKASNVLLDGELNGRLGDFGLARL  412 (586)
Q Consensus       380 ~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~  412 (586)
                      ....++|+|+.|.|||++++..+.|+||+.+..
T Consensus       161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~  193 (244)
T cd05150         161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV  193 (244)
T ss_pred             CceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence            135699999999999999877788999987753

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.09  E-value=1.1e-05  Score=87.46  Aligned_cols=141  Identities=18%  Similarity=0.231  Sum_probs=90.7

Q ss_pred             ceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhH-------------------------------------HHHHHH
Q 007869          266 KELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGM-------------------------------------KEFVAE  308 (586)
Q Consensus       266 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~-------------------------------------~~~~~E  308 (586)
                      .+.||.-..|+||+|++++ |+.||||+-++.-+...                                     -+|..|
T Consensus       166 ~~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E  244 (538)
T KOG1235|consen  166 EEPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE  244 (538)
T ss_pred             cchhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence            3679999999999999987 88899998765422110                                     025556


Q ss_pred             HHHhccc----CCCc------eeeeeeeeeccCeEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhc
Q 007869          309 IVSIGRL----RHRN------LVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQ  378 (586)
Q Consensus       309 i~~l~~l----~H~n------iv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~  378 (586)
                      .+-..+.    +|-+      |.+++-.  -.....|+||||+|..+.+.-.-.. ..++-.   .++..+.++  |++.
T Consensus       245 A~Nae~~~~~f~~~~~~~~V~VP~Vy~~--~st~RVLtME~~~G~~i~Dl~~i~~-~gi~~~---~i~~~l~~~--~~~q  316 (538)
T KOG1235|consen  245 AKNAERFRENFKDFSLLTYVLVPKVYWD--LSTKRVLTMEYVDGIKINDLDAIDK-RGISPH---DILNKLVEA--YLEQ  316 (538)
T ss_pred             HHhHHHHHHHHHhcccccceeCCeehhh--cCcceEEEEEecCCccCCCHHHHHH-cCCCHH---HHHHHHHHH--HHHH
Confidence            6554444    3444      2233222  2345799999999988776543221 123333   233333332  2222


Q ss_pred             ccCCcEEeCCCCCCCeeec----CCCCeEEccccceeeccC
Q 007869          379 EWEQVVIHRDVKASNVLLD----GELNGRLGDFGLARLYDH  415 (586)
Q Consensus       379 ~~~~~ivHrDIkp~NIll~----~~~~~kL~DFGla~~~~~  415 (586)
                      -...+++|.|=+|.||+++    .++++.+-|||+.....+
T Consensus       317 If~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  317 IFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             HHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            2236799999999999998    367899999999886554

>PLN02876 acyl-CoA dehydrogenase

Probab=97.99  E-value=5.7e-05  Score=88.10  Aligned_cols=80  Identities=13%  Similarity=0.226  Sum_probs=58.5

Q ss_pred             ceeEeecCceEEEEEEeCCCC--eEEEEEEecccc-chhHHHHHHHHHHhcccC-CCce--eeeeeeeecc---CeEEEE
Q 007869          266 KELLGTGGFGRVYRGTLPKSQ--IEIAVKKISHES-RQGMKEFVAEIVSIGRLR-HRNL--VQLLGYCRRK---GELLLV  336 (586)
Q Consensus       266 ~~~LG~G~~g~Vy~~~~~~~~--~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~-H~ni--v~l~~~~~~~---~~~~lV  336 (586)
                      .+.|+.|.+..+|+.....++  ..+++|+..... ......+.+|+++|+.+. |.++  .+++.+|.+.   +..++|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            567899999999998875432  357778764432 123356889999999995 6665  7888888764   467899


Q ss_pred             EecCCCCCh
Q 007869          337 YDYMPNGSL  345 (586)
Q Consensus       337 ~E~~~~gsL  345 (586)
                      |||+++..+
T Consensus       123 ME~v~G~~~  131 (822)
T PLN02876        123 MEYLEGRIF  131 (822)
T ss_pred             EEecCCccc
Confidence            999987654

>PF03388 Lectin_leg-like: Legume-like lectin family; InterPro: IPR005052 Lectins are structurally diverse proteins that bind to specific carbohydrates

Probab=97.98  E-value=6.3e-05  Score=73.78  Aligned_cols=145  Identities=18%  Similarity=0.199  Sum_probs=79.6

Q ss_pred             CeeeeeEEEEEEEEEeCCCCCCCCcEEEEEecCCCCCCCCCCCcccccccCCCCCCCccEEEEEeeccccCCCC-CCCCC
Q 007869           15 GTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGLFNDTNLGNETNHVFAVELDTIKSHGFL-DINDN   93 (586)
Q Consensus        15 ~~~asF~t~F~f~i~~~~~~~~g~GlaF~l~p~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEfDt~~~~~~~-d~~~~   93 (586)
                      -..-+|+.+|+|+|........||||||.+.....    ..|..+|.-+      .-+. ++|=||||.|.+-. .....
T Consensus        56 ~~~~~w~i~~~Fri~g~~~~~~g~G~a~W~t~~~~----~~G~~fG~~~------~f~G-l~i~idt~~N~~~~~~~~~p  124 (229)
T PF03388_consen   56 IPFDNWEIEFTFRISGQEKGLGGDGMAFWYTKDPG----SDGPVFGGPD------KFDG-LGIFIDTYDNDEGGHKRGFP  124 (229)
T ss_dssp             BEESEEEEEEEEEEESS-SSS-S-EEEEEEESSSS----SSCSBTTB-S------S-EE-EEEEEEES-TTCTTCTSTSS
T ss_pred             CCccCEEEEEEEEEeccccCcCCCeEEEEEEcCcc----ccccccCCCc------ccce-EEEEEEcccCCCcccccccc
Confidence            34578999999999977556789999999996432    2444455311      1122 68889999885311 11223


Q ss_pred             eeEEeCCCCc-cccc------ccC--------------ceEEEEcCeeeEEEEEEeec--CCCCCCccceeeeeecchhc
Q 007869           94 HVGIDINSLK-SESS------APA--------------GYYVEYDGLEKRTNVTLAPI--NIPRPRSLNTMSLSRDLSSV  150 (586)
Q Consensus        94 hvgidvns~~-s~~~------~~~--------------~~~i~y~~~~~~l~v~~~~~--~~~~~~~~~~ls~~~dL~~~  150 (586)
                      .|.+-+|--. +...      ...              ...|.|..  ..+.|.+...  .....-..|.-...++    
T Consensus       125 ~i~~~~NDGt~~~~~~~dg~~~~~~~C~~~~rn~~~p~~~ri~Y~~--~~l~v~id~~~~~~~~~~~~Cf~~~~v~----  198 (229)
T PF03388_consen  125 YISAMLNDGTKSYDHDNDGKDQSLGSCSADYRNSDVPTRIRISYSK--NTLTVSIDSNYLKNQDDWELCFTTDGVD----  198 (229)
T ss_dssp             EEEEEEEESSS---GGGTTTTT-SEEEE---BTESSEEEEEEEEET--TEEEEEEETSCCSECCTTEEEEEESTEE----
T ss_pred             eEEEEecCCCccccccccCcccccccceeccCcCCCCEEEEEEEEC--CeEEEEEecccccCCcCCcEEEEcCCee----
Confidence            4443333211 1000      001              12377774  3566666521  1111122133223343    


Q ss_pred             cccceeeeeecCCCccceeeeeeecc
Q 007869          151 LNDAMYVGFSSSTGSVLASHYILGWS  176 (586)
Q Consensus       151 l~~~~~vGFsastg~~~~~~~i~~Ws  176 (586)
                      ||+..|+||||+||...+.|.|++-.
T Consensus       199 LP~~~yfGvSA~Tg~~~d~hdi~s~~  224 (229)
T PF03388_consen  199 LPEGYYFGVSAATGELSDNHDILSVK  224 (229)
T ss_dssp             GGSSBEEEEEEEESSSGGEEEEEEEE
T ss_pred             cCCCCEEEEEecCCCCCCcEEEEEEE
Confidence            57788999999999999999998753

This family includes the VIP36 and ERGIC-53 lectins. These two proteins were the first members of the family of animal lectins similar to the leguminous plant lectins []. The alignment for this family is towards the N terminus, where the similarity of VIP36 and ERGIC-53 is greatest. Although they have been identified as a family of animal lectins, this alignment also includes yeast sequences[]. ERGIC-53 is a 53kDa protein, localised to the intermediate region between the endoplasmic reticulum and the Golgi apparatus (ER-Golgi-Intermediate Compartment, ERGIC). It was identified as a calcium-dependent, mannose-specific lectin []. Its dysfunction has been associated with combined factors V and VIII deficiency, suggesting an important and substrate-specific role for ERGIC-53 in the glycoprotein-secreting pathway [,]. The L-type lectin-like domain has an overall globular shape composed of a beta-sandwich of two major twisted antiparallel beta-sheets. The beta-sandwich comprises a major concave beta-sheet and a minor convex beta-sheet, in a variation of the jelly roll fold [, , , ]. ; GO: 0016020 membrane; PDB: 3A4U_A 3LCP_B 2A6Z_A 2A71_C 2A70_B 2A6Y_A 2A6X_A 2A6W_B 2A6V_B 2E6V_B ....

>cd06903 lectin_EMP46_EMP47 EMP46 and EMP47 type 1 transmembrane proteins, N-terminal lectin domain

Probab=97.98  E-value=0.0002  Score=69.21  Aligned_cols=134  Identities=14%  Similarity=0.152  Sum_probs=74.8

Q ss_pred             eeEEEEEEEEEeCCCCCCCCcEEEEEecCCCCCCCCCC-CcccccccCCCCCCCccEEEEEeeccccCCCCCCCCCeeEE
Q 007869           19 SFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPS-QYLGLFNDTNLGNETNHVFAVELDTIKSHGFLDINDNHVGI   97 (586)
Q Consensus        19 sF~t~F~f~i~~~~~~~~g~GlaF~l~p~~~~~~~~~g-~~lGl~~~~~~~~~~~~~vaVEfDt~~~~~~~d~~~~hvgi   97 (586)
                      +|+.+|+|+|.... ..+||||||-++......   .| ...|-   .   +.-+. +||.|||+.|.   .|  ...++
T Consensus        59 ~w~ie~~Fri~G~~-~~~gdGla~W~t~~~~~~---~g~~~fG~---~---~~f~G-l~I~~Dt~~n~---~p--~i~~~  122 (215)
T cd06903          59 EWTIEWTFRSTGPE-GRSGGGLNFWLVKDGNAD---VGTSSIYG---P---SKFDG-LQLLIDNNGGS---GG--SLRGF  122 (215)
T ss_pred             CEEEEEEEEecccC-CcCCCEEEEEEECCCccc---CCccccCC---C---CCCcE-EEEEEECCCCC---Cc--eEEEE
Confidence            79999999997643 368999999999543211   11 12221   1   11112 68899998762   11  11122


Q ss_pred             eCCCCcccccc-------------------cCceEEEEcCeeeEEEEEEeecCCCCCCccceeeeeecchhccccceeee
Q 007869           98 DINSLKSESSA-------------------PAGYYVEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSVLNDAMYVG  158 (586)
Q Consensus        98 dvns~~s~~~~-------------------~~~~~i~y~~~~~~l~v~~~~~~~~~~~~~~~ls~~~dL~~~l~~~~~vG  158 (586)
                      .-++.......                   +....|.|......|.|.+..       +.|.-...+.|..   .-.|+|
T Consensus       123 ~NDGt~~yd~~~d~~~~~g~C~~~~rn~~~p~~iri~Y~~~~~~l~v~vd~-------~~Cf~~~~v~lP~---~~y~fG  192 (215)
T cd06903         123 LNDGSKDYKNEDVDSLAFGSCLFAYQDSGVPSTIRLSYDALNSLFKVQVDN-------RLCFQTDKVQLPQ---GGYRFG  192 (215)
T ss_pred             ECCCCeeccccCCcccccceeeEeccCCCCCEEEEEEEECCCCEEEEEECC-------CEEEecCCeecCC---CCCEEE
Confidence            22221111110                   111237776544566666631       1143333344332   456799


Q ss_pred             eecCCCccceeeeeeecccc
Q 007869          159 FSSSTGSVLASHYILGWSFK  178 (586)
Q Consensus       159 Fsastg~~~~~~~i~~Wsf~  178 (586)
                      |||+||...+.|.|++-.+.
T Consensus       193 iSAaTg~~~d~hdIl~~~~~  212 (215)
T cd06903         193 ITAANADNPESFEILKLKVW  212 (215)
T ss_pred             EEEcCCCCCCcEEEEEEEEe
Confidence            99999998899999886543

EMP46 and EMP47, N-terminal carbohydrate recognition domain. EMP46 and EMP47 are fungal type-I transmembrane proteins that cycle between the endoplasmic reticulum and the golgi apparatus and are thought to function as cargo receptors that transport newly synthesized glycoproteins. EMP47 is a receptor for EMP46 responsible for the selective transport of EMP46 by forming hetero-oligomerization between the two proteins. EMP46 and EMP47 have an N-terminal lectin-like carbohydrate recognition domain (represented by this alignment model) as well as a C-terminal transmembrane domain. EMP46 and EMP47 are 45% sequence-identical to one another and have sequence homology to a class of intracellular lectins defined by ERGIC-53 and VIP36. L-type lectins have a dome-shaped beta-barrel carbohydrate recognition domain with a curved seven-stranded beta-sheet referred to as the "front face" and a flat s

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.94  E-value=2.4e-05  Score=74.29  Aligned_cols=105  Identities=22%  Similarity=0.192  Sum_probs=83.7

Q ss_pred             HHHHHHhcccCC-CceeeeeeeeeccCeEEEEEecCCCCChhhhhhc-CCCccchhHHHHHHHHHHHHHHHHhhcccCCc
Q 007869          306 VAEIVSIGRLRH-RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYD-QPKVTLNWIQRFRVIKGVALGLFYLHQEWEQV  383 (586)
Q Consensus       306 ~~Ei~~l~~l~H-~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~  383 (586)
                      ..|.-++..+++ +++++++|+|-+    ++|.||.+.+++...-.. ..-..-+|..|.+|+.++++.+.+|++.....
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            357778888866 699999999944    789999987766432100 01135689999999999999999999866666


Q ss_pred             EEeCCCCCCCeeecCCCCeEEccccceeecc
Q 007869          384 VIHRDVKASNVLLDGELNGRLGDFGLARLYD  414 (586)
Q Consensus       384 ivHrDIkp~NIll~~~~~~kL~DFGla~~~~  414 (586)
                      +.-.|++++|+-+++++++|++|...+...+
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~~  113 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVED  113 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcchhH
Confidence            9999999999999999999999998776543

Proteins in this uncharacterised family are described as transmembrane proteins.

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=97.82  E-value=0.00022  Score=69.31  Aligned_cols=154  Identities=18%  Similarity=0.133  Sum_probs=94.1

Q ss_pred             cchhhhhhhcCCccccee---EeecCceEEEEEEeCCCCeEEEEEEeccccchhH-------------------H-----
Q 007869          251 FRYKDLYIATKGFREKEL---LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGM-------------------K-----  303 (586)
Q Consensus       251 ~~~~el~~a~~~f~~~~~---LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~-------------------~-----  303 (586)
                      .+.+.+....+...+...   |..|....||+|.. .++..+|||+.........                   +     
T Consensus        35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~  113 (268)
T COG1718          35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFA  113 (268)
T ss_pred             HHHHHHHHHhcCCceeeeEeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHH
Confidence            344555555555555444   55777889999987 3467899998864321110                   0     


Q ss_pred             HHHHHHHHhcccCC--CceeeeeeeeeccCeEEEEEecCCCC-ChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhccc
Q 007869          304 EFVAEIVSIGRLRH--RNLVQLLGYCRRKGELLLVYDYMPNG-SLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEW  380 (586)
Q Consensus       304 ~~~~Ei~~l~~l~H--~niv~l~~~~~~~~~~~lV~E~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~  380 (586)
                      -...|+.-|.++..  =.+.+-+++.    .-.|||||+... .-.-.|.+-   ++.......+..++++.+.-|-.  
T Consensus       114 W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~LkDv---~~e~~e~~~~~~~~v~~~~~l~~--  184 (268)
T COG1718         114 WARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLKDV---PLELEEAEGLYEDVVEYMRRLYK--  184 (268)
T ss_pred             HHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcccC---CcCchhHHHHHHHHHHHHHHHHH--
Confidence            02346666665532  2222233322    237999999543 111122221   22222455566777777776654  


Q ss_pred             CCcEEeCCCCCCCeeecCCCCeEEccccceeeccC
Q 007869          381 EQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH  415 (586)
Q Consensus       381 ~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~  415 (586)
                      ..++||+||..-|||+. ++.+.|+|||-|....+
T Consensus       185 ~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~h  218 (268)
T COG1718         185 EAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTIDH  218 (268)
T ss_pred             hcCcccccchhhheEEE-CCeEEEEECccccccCC
Confidence            37899999999999999 78999999998876553

>KOG3839 consensus Lectin VIP36, involved in the transport of glycoproteins carrying high mannose-type glycans [Intracellular trafficking, secretion, and vesicular transport]

Probab=97.77  E-value=0.00021  Score=71.06  Aligned_cols=140  Identities=23%  Similarity=0.299  Sum_probs=87.6

Q ss_pred             eeeEEEEEEEEEeCCCCCCCCcEEEEEecCCCCCCCCCCCcccccccCCCCCCCccEEEEEeeccccCCCCCCC--CCee
Q 007869           18 FSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGLFNDTNLGNETNHVFAVELDTIKSHGFLDIN--DNHV   95 (586)
Q Consensus        18 asF~t~F~f~i~~~~~~~~g~GlaF~l~p~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEfDt~~~~~~~d~~--~~hv   95 (586)
                      -.|...+.|.+..+....-|||||+..+-....    +|.-+|-++.       -+-.||=.||+.|.+ +-+.  ..-|
T Consensus       109 ~~wev~v~fkv~~~s~~lfgdG~Aiw~t~Er~q----~GPvFG~~dk-------F~GL~vfidtY~n~~-g~~~~v~P~i  176 (351)
T KOG3839|consen  109 RDWEVLVHFKVHGQSKNLFGDGMAIWYTKERAQ----PGPVFGSKDK-------FTGLAVFIDTYGNHN-GPHEHVFPYI  176 (351)
T ss_pred             cceeEEEEEEEecCCCcccccceEEEeeccccc----CCCCCCCccc-------ceeEEEEEeccCCcC-CCcccceeeE
Confidence            468999999999888888999999999954322    4555665332       234789999997742 1111  1112


Q ss_pred             EEeCC--CCc---cc---ccccCc-------------eEEEEcCeeeEEEEEEeecCCCCCCccceeeeeecchhc-ccc
Q 007869           96 GIDIN--SLK---SE---SSAPAG-------------YYVEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSV-LND  153 (586)
Q Consensus        96 gidvn--s~~---s~---~~~~~~-------------~~i~y~~~~~~l~v~~~~~~~~~~~~~~~ls~~~dL~~~-l~~  153 (586)
                      .+.+|  +..   +.   .|.-.+             ..|.|+.  +.|++..+..   .|.   ...--.+|..+ ||.
T Consensus       177 svmv~~gs~sYD~~~Dg~~tel~gc~a~~rn~~~dt~~~iry~~--~~l~~~~dl~---~~~---~~~~c~~~n~v~lp~  248 (351)
T KOG3839|consen  177 SVMVNIGSLSYDHSKDGTHTELAGCTANFRNLPHDTLVVIRYEK--KTLSISIDLE---GPN---EWIDCFSLNNVELPL  248 (351)
T ss_pred             EEEeccCCcccccCCCCCccccccceeeeccCCCcceeEEEecC--CceEEEEecC---CCc---eeeeeeeecceeccc
Confidence            22222  221   00   010011             1388886  6677766643   222   24444566554 677


Q ss_pred             ceeeeeecCCCccceeeeeeeccc
Q 007869          154 AMYVGFSSSTGSVLASHYILGWSF  177 (586)
Q Consensus       154 ~~~vGFsastg~~~~~~~i~~Wsf  177 (586)
                      --|+|+||+||...+.|.|.+-.+
T Consensus       249 g~~fg~SasTGdlSd~HdivS~kl  272 (351)
T KOG3839|consen  249 GYFFGVSASTGDLSDSHDIVSLKL  272 (351)
T ss_pred             ceEEeeeeccCccchhhHHHHhhh
Confidence            889999999999999999998753

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.75  E-value=0.00015  Score=71.57  Aligned_cols=74  Identities=18%  Similarity=0.145  Sum_probs=46.2

Q ss_pred             eeEeecCce-EEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCC---ceeeeeeeeecc---CeEEEEEec
Q 007869          267 ELLGTGGFG-RVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHR---NLVQLLGYCRRK---GELLLVYDY  339 (586)
Q Consensus       267 ~~LG~G~~g-~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~---niv~l~~~~~~~---~~~~lV~E~  339 (586)
                      +.|+.||.. .||+..     ..+++|.....  .....+..|.+.+..+...   -+.+.++.....   +..+++||+
T Consensus         3 ~~~~~gG~~n~vy~~~-----~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~   75 (235)
T cd05155           3 EPVDSGGTDNATFRLG-----DDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW   75 (235)
T ss_pred             eeccCCCcccceEEcC-----CceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence            457777776 488752     24677775432  2345788899988877532   244445444332   235889999


Q ss_pred             CCCCChhh
Q 007869          340 MPNGSLDK  347 (586)
Q Consensus       340 ~~~gsL~~  347 (586)
                      ++|.++.+
T Consensus        76 i~G~~l~~   83 (235)
T cd05155          76 LEGETATA   83 (235)
T ss_pred             ecCCCCCc
Confidence            99877753

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.73  E-value=0.00035  Score=66.40  Aligned_cols=125  Identities=28%  Similarity=0.393  Sum_probs=90.7

Q ss_pred             CCcccceeEeecCc-eEEEEEEeCCCCeEEEEEEecc---ccc------------------hhHHHHHHHHHHhcccC--
Q 007869          261 KGFREKELLGTGGF-GRVYRGTLPKSQIEIAVKKISH---ESR------------------QGMKEFVAEIVSIGRLR--  316 (586)
Q Consensus       261 ~~f~~~~~LG~G~~-g~Vy~~~~~~~~~~vavK~~~~---~~~------------------~~~~~~~~Ei~~l~~l~--  316 (586)
                      .+++..+.||.|.- |.||++...  +..+|+|.+..   ...                  .....|..|.+...+|+  
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            78888999999999 999999994  56899999422   000                  11235889999988884  


Q ss_pred             -CCce--eeeeeeeecc------------------CeEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHH
Q 007869          317 -HRNL--VQLLGYCRRK------------------GELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFY  375 (586)
Q Consensus       317 -H~ni--v~l~~~~~~~------------------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~y  375 (586)
                       +.++  ++.+||..-.                  ....||.||.+...           .+    ..+-+.+|.+-|..
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~----~~~~~~~~~~dl~~  179 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PL----QIRDIPQMLRDLKI  179 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------cc----chhHHHHHHHHHHH
Confidence             4456  8999987422                  12467888775433           11    12235677788888


Q ss_pred             hhcccCCcEEeCCCCCCCeeecCCCCeEEccccce
Q 007869          376 LHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLA  410 (586)
Q Consensus       376 LH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla  410 (586)
                      +|.   .+|+-+|+|+.|..     .-||+|||.+
T Consensus       180 ~~k---~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  180 LHK---LGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHH---CCeeeccCcccccc-----CCEEEecccC
Confidence            998   99999999999986     3599999864

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.71  E-value=0.00036  Score=66.68  Aligned_cols=130  Identities=18%  Similarity=0.321  Sum_probs=89.1

Q ss_pred             ccceeEeecCceEEEEEEeCCCCeEEEEEEecccc----------------chhHHHHHHHHHHhcccC------CCcee
Q 007869          264 REKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES----------------RQGMKEFVAEIVSIGRLR------HRNLV  321 (586)
Q Consensus       264 ~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~Ei~~l~~l~------H~niv  321 (586)
                      +....||+|+.=.||.-  +.+. ...||+.....                ....++..+|+....++.      +.+|.
T Consensus         4 ~~~~~i~~G~~R~cy~H--P~dp-~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~   80 (199)
T PF10707_consen    4 SESDLIAQGGERDCYQH--PDDP-NLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIP   80 (199)
T ss_pred             CCCcccccCCCceEEEC--CCCC-CeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccc
Confidence            34567999999999964  3332 36788887655                123456677776666665      78899


Q ss_pred             eeeeeeeccCeEEEEEecCCC------CChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCee
Q 007869          322 QLLGYCRRKGELLLVYDYMPN------GSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVL  395 (586)
Q Consensus       322 ~l~~~~~~~~~~~lV~E~~~~------gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIl  395 (586)
                      +++|+.+.+--+-+|+|.+.+      .+|.+++.+.   .++. ...+.+.++   ..||-+   ..|+.+|++|.||+
T Consensus        81 r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~---~~~~-~~~~~L~~f---~~~l~~---~~Iv~~dl~~~NIv  150 (199)
T PF10707_consen   81 RFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG---GLTE-ELRQALDEF---KRYLLD---HHIVIRDLNPHNIV  150 (199)
T ss_pred             cEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC---CccH-HHHHHHHHH---HHHHHH---cCCeecCCCcccEE
Confidence            999999999889999998642      3577777544   2443 333333333   345554   77999999999999


Q ss_pred             ecCC--C--CeEEcc
Q 007869          396 LDGE--L--NGRLGD  406 (586)
Q Consensus       396 l~~~--~--~~kL~D  406 (586)
                      +...  +  .+.|+|
T Consensus       151 ~~~~~~~~~~lvlID  165 (199)
T PF10707_consen  151 VQRRDSGEFRLVLID  165 (199)
T ss_pred             EEecCCCceEEEEEe
Confidence            9532  2  466776

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.69  E-value=0.00032  Score=69.04  Aligned_cols=76  Identities=13%  Similarity=0.198  Sum_probs=48.1

Q ss_pred             ceeEeecCceEEEEEEeCC-CCeEEEEEEeccccchhHHHHHHHHHHhcccCCCc-eeeeeeeeeccCeEEEEEecCCCC
Q 007869          266 KELLGTGGFGRVYRGTLPK-SQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRN-LVQLLGYCRRKGELLLVYDYMPNG  343 (586)
Q Consensus       266 ~~~LG~G~~g~Vy~~~~~~-~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~n-iv~l~~~~~~~~~~~lV~E~~~~g  343 (586)
                      .+.|..|-...+|+....+ .+..+++|........ ..+-.+|+.++..+...+ .+++++.+. .   .++|||+++.
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~-~---~~l~e~i~G~   77 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ-N---GLIYEFIPGR   77 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC-C---cEEEEeeCCC
Confidence            3567788888999998653 2456888876543221 123346888888874333 344444332 2   4799999987


Q ss_pred             Chh
Q 007869          344 SLD  346 (586)
Q Consensus       344 sL~  346 (586)
                      ++.
T Consensus        78 ~l~   80 (235)
T cd05157          78 TLE   80 (235)
T ss_pred             cCC
Confidence            763

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.66  E-value=0.00018  Score=66.26  Aligned_cols=131  Identities=18%  Similarity=0.207  Sum_probs=88.4

Q ss_pred             cccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCcee-eeeeeeeccCeEEEEEecCC
Q 007869          263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLV-QLLGYCRRKGELLLVYDYMP  341 (586)
Q Consensus       263 f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv-~l~~~~~~~~~~~lV~E~~~  341 (586)
                      .+..+.|++|.+|.||+|.+.+  .++|+|+-..+++.  ..+..|+++|..++--++- +++.|-.+    ++.|||+.
T Consensus        24 ~~v~~~L~KG~~s~Vyl~~~~~--~~~a~Kvrr~ds~r--~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~   95 (201)
T COG2112          24 LRVEKELAKGTTSVVYLGEWRG--GEVALKVRRRDSPR--RNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYID   95 (201)
T ss_pred             hhhhhhhhcccccEEEEeeccC--ceEEEEEecCCcch--hhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhc
Confidence            3456779999999999999954  47999998776543  6788999999888765544 34444332    45599998


Q ss_pred             CCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCC-CCCeeecCCCCeEEccccceeec
Q 007869          342 NGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVK-ASNVLLDGELNGRLGDFGLARLY  413 (586)
Q Consensus       342 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIk-p~NIll~~~~~~kL~DFGla~~~  413 (586)
                      |..|.+.-...     +    .+-+..+++.---|-.   .+|-|..|. |...+|-++..+.|+||..|...
T Consensus        96 G~~L~~~~~~~-----~----rk~l~~vlE~a~~LD~---~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k  156 (201)
T COG2112          96 GRPLGKLEIGG-----D----RKHLLRVLEKAYKLDR---LGIEHGELSRPWKNVLVNDRDVYIIDFDSATFK  156 (201)
T ss_pred             Ccchhhhhhcc-----c----HHHHHHHHHHHHHHHH---hccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence            88887765321     1    1123445555333443   777787776 44444444448999999998843

>PRK10593 hypothetical protein; Provisional

Probab=97.66  E-value=0.00061  Score=69.72  Aligned_cols=78  Identities=9%  Similarity=0.019  Sum_probs=56.7

Q ss_pred             ccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCC---Cceeeeeeeeec---cCeEEEEE
Q 007869          264 REKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRH---RNLVQLLGYCRR---KGELLLVY  337 (586)
Q Consensus       264 ~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H---~niv~l~~~~~~---~~~~~lV~  337 (586)
                      ...+.||.|..+.||+....+ + .+.+|..+..  .....|..|.+.|+.+.-   -.+.+++++|..   .+..+|||
T Consensus        17 ~~~~~i~~G~~~~vy~~~~~~-~-~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm   92 (297)
T PRK10593         17 SRVECISEQPYAALWALYDSQ-G-NPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL   92 (297)
T ss_pred             heeeecCCccceeEEEEEcCC-C-CEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence            345679999999999987643 3 4666774321  123578899999988843   367888888754   36689999


Q ss_pred             ecCCCCCh
Q 007869          338 DYMPNGSL  345 (586)
Q Consensus       338 E~~~~gsL  345 (586)
                      |+++++++
T Consensus        93 E~i~G~~~  100 (297)
T PRK10593         93 ERLRGVSV  100 (297)
T ss_pred             eccCCEec
Confidence            99998765

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.62  E-value=0.00023  Score=71.18  Aligned_cols=137  Identities=17%  Similarity=0.077  Sum_probs=77.6

Q ss_pred             EeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCce-eeeeeeeeccCeEEEEEecCCCCChhh
Q 007869          269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNL-VQLLGYCRRKGELLLVYDYMPNGSLDK  347 (586)
Q Consensus       269 LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~~~~~~~~~~~lV~E~~~~gsL~~  347 (586)
                      +..|-...+|+...  ++..+++|..........-...+|..+++.+....+ .+++..+.    -.+||||++|..+..
T Consensus         4 ~~~G~tn~~y~~~~--~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~   77 (256)
T TIGR02721         4 LSGGLTNRSWRIEH--PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL   77 (256)
T ss_pred             CCCcCcCCeEEEEe--CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence            55677889998874  355688887654332211235678888888854333 34444432    368999999876643


Q ss_pred             h-----------------hhcCC--CccchhHHH-HHHHHHH---------HHHHHHhhc-----ccCCcEEeCCCCCCC
Q 007869          348 Y-----------------LYDQP--KVTLNWIQR-FRVIKGV---------ALGLFYLHQ-----EWEQVVIHRDVKASN  393 (586)
Q Consensus       348 ~-----------------l~~~~--~~~l~~~~~-~~i~~~i---------a~~L~yLH~-----~~~~~ivHrDIkp~N  393 (586)
                      .                 |+..+  ..+++...+ .....++         ..-+..+-.     .....++|+|+.|.|
T Consensus        78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N  157 (256)
T TIGR02721        78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN  157 (256)
T ss_pred             ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence            1                 11111  111111111 1111111         111111111     113469999999999


Q ss_pred             eeecCCCCeEEccccceee
Q 007869          394 VLLDGELNGRLGDFGLARL  412 (586)
Q Consensus       394 Ill~~~~~~kL~DFGla~~  412 (586)
                      |++++++ +.|+||+.|..
T Consensus       158 il~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       158 LVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             EEEeCCC-CEEEeccccCc
Confidence            9999876 78999988764

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.56  E-value=0.0012  Score=69.89  Aligned_cols=77  Identities=12%  Similarity=0.098  Sum_probs=54.2

Q ss_pred             ceeEeecCceEEEEEEeCCCCeEEEEEEecccc-------chhHHHHHHHHHHhcccC---CCceeeeeeeeeccCeEEE
Q 007869          266 KELLGTGGFGRVYRGTLPKSQIEIAVKKISHES-------RQGMKEFVAEIVSIGRLR---HRNLVQLLGYCRRKGELLL  335 (586)
Q Consensus       266 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~Ei~~l~~l~---H~niv~l~~~~~~~~~~~l  335 (586)
                      .+.||.|.+..||++...++++.++||.-....       +-..+.+..|.+.|..+.   -.++++++.+..  +..++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~--~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDE--ELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECC--CCCEE
Confidence            356999999999999997654579999854221       123456677888877762   245677777643  45789


Q ss_pred             EEecCCCCC
Q 007869          336 VYDYMPNGS  344 (586)
Q Consensus       336 V~E~~~~gs  344 (586)
                      ||||+++..
T Consensus       109 VME~L~~~~  117 (401)
T PRK09550        109 VMEDLSDHK  117 (401)
T ss_pred             EEecCCCcc
Confidence            999998643

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.37  E-value=0.00088  Score=68.66  Aligned_cols=141  Identities=21%  Similarity=0.224  Sum_probs=83.1

Q ss_pred             eeEeecCceEEEEEEeCCC------CeEEEEEEeccccchhHHHHHHHHHHhcccCCCc-eeeeeeeeeccCeEEEEEec
Q 007869          267 ELLGTGGFGRVYRGTLPKS------QIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRN-LVQLLGYCRRKGELLLVYDY  339 (586)
Q Consensus       267 ~~LG~G~~g~Vy~~~~~~~------~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~n-iv~l~~~~~~~~~~~lV~E~  339 (586)
                      +.|..|-...+|+......      +..+++|....... ...+..+|.+++..+.... ..++++++. +   .+|+||
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v~e~   78 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE-LLIDRERELVVFARLSERNLGPKLYGIFP-N---GRIEEF   78 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc-ceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cchhhe
Confidence            4566777779999886542      46788998765432 2234567887777774333 334555553 2   358999


Q ss_pred             CCCCChhhhh-----------------hcCCCc---------cchhHHHHH--------------------------HHH
Q 007869          340 MPNGSLDKYL-----------------YDQPKV---------TLNWIQRFR--------------------------VIK  367 (586)
Q Consensus       340 ~~~gsL~~~l-----------------~~~~~~---------~l~~~~~~~--------------------------i~~  367 (586)
                      ++|..+....                 +.....         ..-|.....                          +..
T Consensus        79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (302)
T cd05156          79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE  158 (302)
T ss_pred             eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence            9887764321                 111100         111111111                          011


Q ss_pred             HHHHHHHHhhc------ccCCcEEeCCCCCCCeeecCC----CCeEEccccceee
Q 007869          368 GVALGLFYLHQ------EWEQVVIHRDVKASNVLLDGE----LNGRLGDFGLARL  412 (586)
Q Consensus       368 ~ia~~L~yLH~------~~~~~ivHrDIkp~NIll~~~----~~~kL~DFGla~~  412 (586)
                      .+..-+.+|-.      .....++|+|+.+.|||++++    +.++++||..|..
T Consensus       159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~  213 (302)
T cd05156         159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY  213 (302)
T ss_pred             HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence            22222333331      235689999999999999874    7899999988754

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>KOG3838 consensus Mannose lectin ERGIC-53, involved in glycoprotein traffic [Intracellular trafficking, secretion, and vesicular transport]

Probab=97.27  E-value=0.0063  Score=61.74  Aligned_cols=142  Identities=16%  Similarity=0.267  Sum_probs=86.4

Q ss_pred             eeeEEEEEEEEEeCCCCCCCCcEEEEEecCCCCCCCCCCCcccccccCCCCCCCccEEEEEeeccccCCCCCCCCCeeEE
Q 007869           18 FSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGLFNDTNLGNETNHVFAVELDTIKSHGFLDINDNHVGI   97 (586)
Q Consensus        18 asF~t~F~f~i~~~~~~~~g~GlaF~l~p~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEfDt~~~~~~~d~~~~hvgi   97 (586)
                      -.|...-+|.|+.. +..++|||||--+....    .-|.-+|   ..   ..=|. +++=||.|.|.  +.-|+.-|.+
T Consensus        91 e~weVev~~rVtGr-GRiGAdGlaiWYt~~~G----~~GpVfG---g~---d~WnG-igiffDSfdnD--~qknnP~Is~  156 (497)
T KOG3838|consen   91 ENWEVEVQFRVTGR-GRIGADGLAIWYTRGRG----HVGPVFG---GL---DSWNG-IGIFFDSFDND--GQKNNPAISV  156 (497)
T ss_pred             ccceEEEEEEeccc-ccccCCceEEEEecCCC----ccccccc---cc---ccccc-eEEEeeccccc--CCcCCccEEE
Confidence            35788899999864 67799999999884321    1122222   11   11122 67889999875  2345556666


Q ss_pred             eCCCCc--ccc-------------------cccCceEEEEcCeeeEEEEEEeecCCCCCCccceeeeeecchh-ccccce
Q 007869           98 DINSLK--SES-------------------SAPAGYYVEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSS-VLNDAM  155 (586)
Q Consensus        98 dvns~~--s~~-------------------~~~~~~~i~y~~~~~~l~v~~~~~~~~~~~~~~~ls~~~dL~~-~l~~~~  155 (586)
                      -.|.-.  ...                   ..+....|+|-  ..+|+|.+...-.+.+.  .  ..-++... .||..-
T Consensus       157 ~lndGt~~ydh~~DGasQ~LssCqrDFRNkPyPvRarItY~--~nvLtv~innGmtp~d~--y--E~C~rve~~~lp~nG  230 (497)
T KOG3838|consen  157 LLNDGTIPYDHPGDGASQGLSSCQRDFRNKPYPVRARITYY--GNVLTVMINNGMTPSDD--Y--EFCVRVENLLLPPNG  230 (497)
T ss_pred             EecCCcccccCCCccHHHHHHHhhHHhccCCCCceEEEEEe--ccEEEEEEcCCCCCCCC--c--ceeEeccceeccCCC
Confidence            555422  111                   11122349987  48899988743222221  1  11223333 467889


Q ss_pred             eeeeecCCCccceeeeeeecc-ccc
Q 007869          156 YVGFSSSTGSVLASHYILGWS-FKI  179 (586)
Q Consensus       156 ~vGFsastg~~~~~~~i~~Ws-f~~  179 (586)
                      |.|.||+||....-|.|++.. |+.
T Consensus       231 yFGvSAATGgLADDHDVl~FltfsL  255 (497)
T KOG3838|consen  231 YFGVSAATGGLADDHDVLSFLTFSL  255 (497)
T ss_pred             eeeeeecccccccccceeeeEEeee
Confidence            999999999998999999985 443

>PRK05231 homoserine kinase; Provisional

Probab=97.21  E-value=0.0027  Score=65.64  Aligned_cols=142  Identities=16%  Similarity=0.133  Sum_probs=76.5

Q ss_pred             ceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCc--eeeeee------eeeccCeEEEEE
Q 007869          266 KELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRN--LVQLLG------YCRRKGELLLVY  337 (586)
Q Consensus       266 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~n--iv~l~~------~~~~~~~~~lV~  337 (586)
                      .+.|+.|....+|+....+ + .+++|+.....   .+....|+..+..|...+  +.+.+.      +....+..++++
T Consensus        27 ~~~l~~G~~n~~y~v~t~~-g-~~vLK~~~~~~---~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~  101 (319)
T PRK05231         27 LKGIAEGIENSNFFLTTTQ-G-EYVLTLFERLT---AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIV  101 (319)
T ss_pred             cchhccccccceEEEEeCC-C-cEEEEEeccCC---hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEE
Confidence            3457778778999987643 3 58889875222   233334445554442211  223332      122345679999


Q ss_pred             ecCCCCChhh-----------hh---hcCC---------Cccchh-HHHHHH------------HHH-HHHHHHHhhc--
Q 007869          338 DYMPNGSLDK-----------YL---YDQP---------KVTLNW-IQRFRV------------IKG-VALGLFYLHQ--  378 (586)
Q Consensus       338 E~~~~gsL~~-----------~l---~~~~---------~~~l~~-~~~~~i------------~~~-ia~~L~yLH~--  378 (586)
                      ||++|..+..           .|   +...         ...+.| .....-            +.+ +...+..+.+  
T Consensus       102 ~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  181 (319)
T PRK05231        102 TFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAA  181 (319)
T ss_pred             EecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccc
Confidence            9998875421           11   1100         011222 111111            111 1112222221  


Q ss_pred             --ccCCcEEeCCCCCCCeeecCCCCeEEccccceee
Q 007869          379 --EWEQVVIHRDVKASNVLLDGELNGRLGDFGLARL  412 (586)
Q Consensus       379 --~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~  412 (586)
                        ....++||+|+++.|||++++...-|+||+.+..
T Consensus       182 ~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        182 WPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             cccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence              1346899999999999999765568999998753

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.15  E-value=0.0024  Score=65.15  Aligned_cols=142  Identities=18%  Similarity=0.149  Sum_probs=84.9

Q ss_pred             ceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCc--eeeeeee------eeccCeEEEEE
Q 007869          266 KELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRN--LVQLLGY------CRRKGELLLVY  337 (586)
Q Consensus       266 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~n--iv~l~~~------~~~~~~~~lV~  337 (586)
                      .+.|..|....+|+....+  ..+++|+....   .......|++++..+.+.+  +.+++..      ....+..++|+
T Consensus        19 i~~i~~G~~n~~y~v~~~~--~~~vLr~~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~   93 (296)
T cd05153          19 FEGISAGIENTNYFVTTDS--GRYVLTLFEKV---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV   93 (296)
T ss_pred             eecccCccccceEEEEeCC--CcEEEEEcCCC---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence            4567788888999987643  35888987642   2345666777777774332  3444432      12235568999


Q ss_pred             ecCCCCChhh----hh----------hcCC---------CccchhHHHHH----------HHHHHHHHHHHhhc----cc
Q 007869          338 DYMPNGSLDK----YL----------YDQP---------KVTLNWIQRFR----------VIKGVALGLFYLHQ----EW  380 (586)
Q Consensus       338 E~~~~gsL~~----~l----------~~~~---------~~~l~~~~~~~----------i~~~ia~~L~yLH~----~~  380 (586)
                      ||++|..+..    ..          +...         .....|.....          ....+...+.++.+    ..
T Consensus        94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~  173 (296)
T cd05153          94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL  173 (296)
T ss_pred             EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence            9999877532    11          1000         01122322210          11123334444442    22


Q ss_pred             CCcEEeCCCCCCCeeecCCCCeEEccccceee
Q 007869          381 EQVVIHRDVKASNVLLDGELNGRLGDFGLARL  412 (586)
Q Consensus       381 ~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~  412 (586)
                      ...++|+|+.|.|||++++..+.|+||+.+..
T Consensus       174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         174 PRGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             CCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            35799999999999999887778999987753

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.08  E-value=0.00087  Score=77.31  Aligned_cols=198  Identities=18%  Similarity=0.151  Sum_probs=129.9

Q ss_pred             HHHHHHHHHhcccCCCceeeeeeeeeccCeE----EEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhc
Q 007869          303 KEFVAEIVSIGRLRHRNLVQLLGYCRRKGEL----LLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQ  378 (586)
Q Consensus       303 ~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~----~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~  378 (586)
                      .....|++.+.++.|+|++.++.|-.++...    .+..|++..-++...+....  .++....+.+..++.+||.|+|+
T Consensus       227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~--~i~~~~~r~~~~~~~~GL~~~h~  304 (1351)
T KOG1035|consen  227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG--SIPLETLRILHQKLLEGLAYLHS  304 (1351)
T ss_pred             HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc--ccCHHHHHHHHHHHhhhHHHHHH
Confidence            3345677888889999999999987665332    33457888888888776653  45666777788999999999998


Q ss_pred             ccCCcEEeCCCCCC---CeeecCCCCeEEc--cccceeeccCCCCCceeeeccCCCccCcccccCCCCCC--cceEEehh
Q 007869          379 EWEQVVIHRDVKAS---NVLLDGELNGRLG--DFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATT--SADVFSFG  451 (586)
Q Consensus       379 ~~~~~ivHrDIkp~---NIll~~~~~~kL~--DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~--ksDVyS~G  451 (586)
                         ....|.-+..+   +--.+.++.+.++  ||+..+.......  .....-+..+.+||......+..  ..|+|.+|
T Consensus       305 ---~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~--~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lg  379 (1351)
T KOG1035|consen  305 ---LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK--SFSDLLAEIRNADEDLKENTAKKSRLTDLWCLG  379 (1351)
T ss_pred             ---hccceeEEecccccccccCccceeecchhhhcccccCCCccc--chhhcCccccccccccccccchhhhhhHHHHHH
Confidence               44444433333   3334556666776  8887775543321  12223456678888876655544  47999999


Q ss_pred             HHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          452 AFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       452 vvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      .++..+..|..+-.......                  ...+    ..+.    ..+.....+|+..++++|++..+++.
T Consensus       380 ll~~~~~~~~~i~~~~~~~~------------------~~l~----~~~~----~~~~d~~~~~~~~~~~~Rl~~~~ll~  433 (1351)
T KOG1035|consen  380 LLLLQLSQGEDISEKSAVPV------------------SLLD----VLST----SELLDALPKCLDEDSEERLSALELLT  433 (1351)
T ss_pred             HHHhhhhhcCcccccccchh------------------hhhc----cccc----hhhhhhhhhhcchhhhhccchhhhhh
Confidence            99999988865532211100                  0000    0011    14556667899999999999999986


Q ss_pred             HH
Q 007869          532 IL  533 (586)
Q Consensus       532 ~L  533 (586)
                      ..
T Consensus       434 ~~  435 (1351)
T KOG1035|consen  434 HP  435 (1351)
T ss_pred             ch
Confidence            53

>PLN02236 choline kinase

Probab=96.99  E-value=0.0051  Score=64.34  Aligned_cols=141  Identities=17%  Similarity=0.152  Sum_probs=82.2

Q ss_pred             eeEeecCceEEEEEEeCC----CCeEEEEEEeccccchhHHHHHHHHHHhcccCCCcee-eeeeeeeccCeEEEEEecCC
Q 007869          267 ELLGTGGFGRVYRGTLPK----SQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLV-QLLGYCRRKGELLLVYDYMP  341 (586)
Q Consensus       267 ~~LG~G~~g~Vy~~~~~~----~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv-~l~~~~~~~~~~~lV~E~~~  341 (586)
                      ..|-.|-.-.+|+.....    .+..+.+|........... -.+|..++..+...++. ++++.+.. +   .|+||++
T Consensus        42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~efi~  116 (344)
T PLN02236         42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPN-G---RVEEFIH  116 (344)
T ss_pred             EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECC-c---eEEEeeC
Confidence            345557778899987532    2357889988665433222 36788888888544433 45555533 2   5899998


Q ss_pred             CCChhhh-----------------hhcCC----CccchhHHHHHHHHHH-----------------HHHHHHh----hc-
Q 007869          342 NGSLDKY-----------------LYDQP----KVTLNWIQRFRVIKGV-----------------ALGLFYL----HQ-  378 (586)
Q Consensus       342 ~gsL~~~-----------------l~~~~----~~~l~~~~~~~i~~~i-----------------a~~L~yL----H~-  378 (586)
                      +.+|...                 +|..+    .....|.+..++..++                 ...+..|    .. 
T Consensus       117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~  196 (344)
T PLN02236        117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD  196 (344)
T ss_pred             CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence            7776421                 11111    1122233332332211                 1112122    11 


Q ss_pred             ccCCcEEeCCCCCCCeeecC-CCCeEEccccceee
Q 007869          379 EWEQVVIHRDVKASNVLLDG-ELNGRLGDFGLARL  412 (586)
Q Consensus       379 ~~~~~ivHrDIkp~NIll~~-~~~~kL~DFGla~~  412 (586)
                      .....++|+|+++.|||+++ +..++|+||..|..
T Consensus       197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            22357999999999999986 46799999988764

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=96.91  E-value=0.0092  Score=61.35  Aligned_cols=142  Identities=17%  Similarity=0.120  Sum_probs=81.9

Q ss_pred             ceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCc--eeeeeeee------eccCeEEEEE
Q 007869          266 KELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRN--LVQLLGYC------RRKGELLLVY  337 (586)
Q Consensus       266 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~n--iv~l~~~~------~~~~~~~lV~  337 (586)
                      .+.++.|-...+|+.... ++ .+++|+.....  ..++...|++++..|....  +.+++...      ...+..++++
T Consensus        27 i~~~~~G~~n~~y~v~t~-~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~  102 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTD-VG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLV  102 (307)
T ss_pred             ccccCCccccceEEEEeC-CC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEE
Confidence            456777777899998753 33 47788765422  1234456666666664322  33444321      2245678999


Q ss_pred             ecCCCCChhhh--------------hhcCCC----------ccchhHHHHH------------HHHHHHHHHHHhhc---
Q 007869          338 DYMPNGSLDKY--------------LYDQPK----------VTLNWIQRFR------------VIKGVALGLFYLHQ---  378 (586)
Q Consensus       338 E~~~~gsL~~~--------------l~~~~~----------~~l~~~~~~~------------i~~~ia~~L~yLH~---  378 (586)
                      ||++|..+...              ++....          ..-.|.....            ....+.+.+.++..   
T Consensus       103 e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~  182 (307)
T TIGR00938       103 EFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWP  182 (307)
T ss_pred             EeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhh
Confidence            99988654211              111000          0112221111            01123334555532   


Q ss_pred             -ccCCcEEeCCCCCCCeeecCCCCeEEcccccee
Q 007869          379 -EWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR  411 (586)
Q Consensus       379 -~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~  411 (586)
                       ....+++|+|+++.||+++++....|+||+.+.
T Consensus       183 ~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       183 RDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             hcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence             235789999999999999988767899998775

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.85  E-value=0.014  Score=59.28  Aligned_cols=75  Identities=17%  Similarity=0.257  Sum_probs=48.5

Q ss_pred             ccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccC---CCceeeeeeeeeccCeEEEEEecC
Q 007869          264 REKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLR---HRNLVQLLGYCRRKGELLLVYDYM  340 (586)
Q Consensus       264 ~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~---H~niv~l~~~~~~~~~~~lV~E~~  340 (586)
                      ...+.++.|....+|+..  .++..+.||.-..   .....|..|.+-|+.|.   --.+.+.+++....+..+||+||+
T Consensus        20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l   94 (288)
T PF03881_consen   20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL   94 (288)
T ss_dssp             -EEEEE--SSSSEEEEEE--TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred             eeeEecCCCChhheEEEE--CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence            445679999999999987  4566799998763   23356788888887773   455778899888777789999999


Q ss_pred             CCC
Q 007869          341 PNG  343 (586)
Q Consensus       341 ~~g  343 (586)
                      +.+
T Consensus        95 ~~~   97 (288)
T PF03881_consen   95 EMG   97 (288)
T ss_dssp             ---
T ss_pred             cCC
Confidence            876

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.80  E-value=0.011  Score=59.86  Aligned_cols=31  Identities=26%  Similarity=0.502  Sum_probs=25.9

Q ss_pred             CcEEeCCCCCCCeeecCCCC-eEEccccceee
Q 007869          382 QVVIHRDVKASNVLLDGELN-GRLGDFGLARL  412 (586)
Q Consensus       382 ~~ivHrDIkp~NIll~~~~~-~kL~DFGla~~  412 (586)
                      ..++|+|+++.|||++++++ .-|+||+.+..
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            45899999999999997555 46999998764

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=96.58  E-value=0.00022  Score=83.72  Aligned_cols=189  Identities=13%  Similarity=-0.001  Sum_probs=125.8

Q ss_pred             eEEEEEEeCCCCe-EEEEEEeccccchh-----HHHHHHHHHHhcccCCCceeeeeeeee--ccCeEEEEEecCCCCChh
Q 007869          275 GRVYRGTLPKSQI-EIAVKKISHESRQG-----MKEFVAEIVSIGRLRHRNLVQLLGYCR--RKGELLLVYDYMPNGSLD  346 (586)
Q Consensus       275 g~Vy~~~~~~~~~-~vavK~~~~~~~~~-----~~~~~~Ei~~l~~l~H~niv~l~~~~~--~~~~~~lV~E~~~~gsL~  346 (586)
                      +.-+|+.+.+... -+.+|+.+..+-+.     .+....|...+++..|+++.....-..  +..+.+.+++|+..|.+.
T Consensus      1240 ~~~~R~k~Lr~kid~Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f 1319 (2724)
T KOG1826|consen 1240 HFHFRNKWLRSKIDWFKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLF 1319 (2724)
T ss_pred             ceeeccchHhhhhceeEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHH
Confidence            4445555432211 13455554433222     334455656666678988777655433  334678899999999999


Q ss_pred             hhhhcCCC--ccchhHHHHHHHHHHHHHHHHhhccc--CCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCCcee
Q 007869          347 KYLYDQPK--VTLNWIQRFRVIKGVALGLFYLHQEW--EQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTT  422 (586)
Q Consensus       347 ~~l~~~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~  422 (586)
                      +.|-+.-+  ..++..-....-.+...+..-.|+..  ..-.+|+++|+-|.+|..+.++|++++|+.+...+.. ....
T Consensus      1320 ~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~-sf~G 1398 (2724)
T KOG1826|consen 1320 SIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVL-SFFG 1398 (2724)
T ss_pred             HHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCchH-hhhh
Confidence            98876422  23333333333333355555555422  2457999999999999999999999999999533322 2233


Q ss_pred             eeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCC
Q 007869          423 HVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPI  464 (586)
Q Consensus       423 ~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~  464 (586)
                      ...+++.|+.|++...-+++.++|+|..|+.+|+..-|..+|
T Consensus      1399 l~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1399 LELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred             hhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHH
Confidence            456788999999998888999999999999999998887766

>cd06900 lectin_VcfQ VcfQ bacterial pilus biogenesis protein, lectin domain

Probab=96.56  E-value=0.098  Score=50.50  Aligned_cols=64  Identities=14%  Similarity=0.229  Sum_probs=40.6

Q ss_pred             EEEEEEEEEeCCCCCCCCcEEEEEecCCCCC-CCCCCCcccccccC-CCCCCCccEEEEEeeccccC
Q 007869           21 STTFVFSILSEYQSQSGHGIAFVIASTRGLP-GARPSQYLGLFNDT-NLGNETNHVFAVELDTIKSH   85 (586)
Q Consensus        21 ~t~F~f~i~~~~~~~~g~GlaF~l~p~~~~~-~~~~g~~lGl~~~~-~~~~~~~~~vaVEfDt~~~~   85 (586)
                      ..+|.+-.-.. ...++||+||||+-....| .+..||-||+-..+ ....-..-.+.|-||-|-|.
T Consensus        61 ~veFd~yayg~-~g~GADGia~vLsDasv~p~~G~fGGsLGYa~~~~~~~GfaGGwLGiGlDEyGNF  126 (255)
T cd06900          61 EVEFDYYAYGS-GGNGADGVALVLSDASVTPQAGAFGGSLGYAQRNDGVPGFAGGWLGIGLDEYGNF  126 (255)
T ss_pred             EEEEEEEEecC-CCCCCceEEEEEeCCCcCCcCCCcCcccccccccCCCCccccceEEEEEeccccc
Confidence            34444443322 4668999999999432222 34668889987654 22234566888999987774

This family includes bacterial proteins homologous to the VcfQ (also known as MshQ) bacterial pilus biogenesis protein. VcfQ is encoded by the vcfQ gene of the type IV pilus gene cluster of Vibrio cholerae and is essential for type IV pilus assembly. VcfQ has a Laminin G-like domain as well as an L-type lectin domain.

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=96.39  E-value=0.0019  Score=68.72  Aligned_cols=159  Identities=23%  Similarity=0.268  Sum_probs=89.8

Q ss_pred             HHHHHHHHHhcccCCCceeeeeeeeecc-CeEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccC
Q 007869          303 KEFVAEIVSIGRLRHRNLVQLLGYCRRK-GELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE  381 (586)
Q Consensus       303 ~~~~~Ei~~l~~l~H~niv~l~~~~~~~-~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~  381 (586)
                      .+.+...++++.+.|+|+.+.+.+.+.. ....+|+|++ +.||++.+..+..   .-      ....      -     
T Consensus        27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~l---~~------~s~~------~-----   85 (725)
T KOG1093|consen   27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGNL---KD------ESLL------A-----   85 (725)
T ss_pred             HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhccc---ch------hhhc------c-----
Confidence            4566778888999999999999887755 3478899998 7799998866531   10      0001      1     


Q ss_pred             CcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCC
Q 007869          382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGR  461 (586)
Q Consensus       382 ~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~  461 (586)
                      +++.|     .||+       +++| -   .....                |-.     ..+|+||||+|.++.|+.-|.
T Consensus        86 ~~~~~-----~~~~-------~~td-~---~~t~~----------------~~~-----~~pKsdVwsl~~i~~el~L~~  128 (725)
T KOG1093|consen   86 HGVLH-----LNII-------YITD-H---FLTKY----------------PSP-----IGPKSDVWSLGFIILELYLGI  128 (725)
T ss_pred             cccce-----ehhh-------hccc-c---ccccC----------------CCC-----CCcchhhhhHHHHHHHHHHhh
Confidence            12222     2222       2223 0   00000                100     114999999999999999987


Q ss_pred             CCCCCCCCCccchhhHHHHhhhcc-CccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCC
Q 007869          462 RPIQRQGPSENLILVDWVFDFWNR-GELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPS  525 (586)
Q Consensus       462 ~p~~~~~~~~~~~l~~~v~~~~~~-~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs  525 (586)
                      .-+......+...   .+..++.. +........   ..+..+..+.++++...|+-..|..||.
T Consensus       129 ~l~~~~~~s~~l~---~i~k~~~~d~~~~~~a~e---~~~~~~~d~~~~~~~~~c~~~~~~ir~l  187 (725)
T KOG1093|consen  129 SLEAELTESEYLE---ILLKYYTDDQELLSTAME---HLIQLLADKKRLPLLKKCLWLEPIIRPL  187 (725)
T ss_pred             HHHHHHHHHHHHH---HHHHhccCchhHHHHHHH---HHHHHhhhHhHHHHhccCCccccccccc
Confidence            7665433222111   11111111 111000000   0223344567788889999999988885

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.38  E-value=0.029  Score=57.47  Aligned_cols=135  Identities=18%  Similarity=0.186  Sum_probs=80.5

Q ss_pred             EeecCceEEEEEEeCCCCeEEEEEEec-cccchhHHHHHHHHHHhcccCC--CceeeeeeeeeccC--eEEEEEecCCCC
Q 007869          269 LGTGGFGRVYRGTLPKSQIEIAVKKIS-HESRQGMKEFVAEIVSIGRLRH--RNLVQLLGYCRRKG--ELLLVYDYMPNG  343 (586)
Q Consensus       269 LG~G~~g~Vy~~~~~~~~~~vavK~~~-~~~~~~~~~~~~Ei~~l~~l~H--~niv~l~~~~~~~~--~~~lV~E~~~~g  343 (586)
                      +..|-.-.+|+....  ++++++++-. ...........+|..+|+.+.-  --....+++|.++.  ..+.||+|+++.
T Consensus        33 ~~~G~sn~t~~~~~~--~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe  110 (321)
T COG3173          33 ISGGWSNDTFRLGDT--GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGE  110 (321)
T ss_pred             ccCCcccceEEEecC--CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecce
Confidence            333333344554443  5567777321 1223334556677777777632  23445677777665  679999999885


Q ss_pred             ChhhhhhcCCCccchhHHHHHHH-HHHHHHHHHhh---------------------------------------------
Q 007869          344 SLDKYLYDQPKVTLNWIQRFRVI-KGVALGLFYLH---------------------------------------------  377 (586)
Q Consensus       344 sL~~~l~~~~~~~l~~~~~~~i~-~~ia~~L~yLH---------------------------------------------  377 (586)
                      .+.+.+....   ..    .+++ ..+++.|.-||                                             
T Consensus       111 ~~~~~~~~~~---~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~  183 (321)
T COG3173         111 VVWSALPPES---LG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRL  183 (321)
T ss_pred             eccCcCCccc---ch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHH
Confidence            4444332211   11    0111 24444444444                                             


Q ss_pred             -----cc-----cCCcEEeCCCCCCCeeecCCCCeEEccccceee
Q 007869          378 -----QE-----WEQVVIHRDVKASNVLLDGELNGRLGDFGLARL  412 (586)
Q Consensus       378 -----~~-----~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~  412 (586)
                           ..     ....++|+|+++.|++++.+.-+=+.||+++..
T Consensus       184 ~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l  228 (321)
T COG3173         184 IKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL  228 (321)
T ss_pred             HHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence                 21     124699999999999999888899999999875

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.36  E-value=0.023  Score=59.14  Aligned_cols=141  Identities=17%  Similarity=0.243  Sum_probs=80.5

Q ss_pred             eeEeecCceEEEEEEeCCC---CeEEEEEEeccccchhHHHHHHHHHHhcccCCCce-eeeeeeeeccCeEEEEEecCCC
Q 007869          267 ELLGTGGFGRVYRGTLPKS---QIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNL-VQLLGYCRRKGELLLVYDYMPN  342 (586)
Q Consensus       267 ~~LG~G~~g~Vy~~~~~~~---~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~~~~~~~~~~~lV~E~~~~  342 (586)
                      +.|..|=...+|+....+.   +..|.+|......... -+-.+|..+++.+..-++ .++++++. .+   +|.+|+++
T Consensus        20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~-IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g   94 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYV-IDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINA   94 (330)
T ss_pred             EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeE-echHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcC
Confidence            4455577778898876432   2368889876543322 223578888888855444 35565553 22   58999977


Q ss_pred             CChhhh-----------------hhcCC----CccchhHHHHHHHHHH----------------------HHHHHHhhc-
Q 007869          343 GSLDKY-----------------LYDQP----KVTLNWIQRFRVIKGV----------------------ALGLFYLHQ-  378 (586)
Q Consensus       343 gsL~~~-----------------l~~~~----~~~l~~~~~~~i~~~i----------------------a~~L~yLH~-  378 (586)
                      ..|...                 +|..+    ..+-.|....++..++                      .+-+..+.. 
T Consensus        95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~  174 (330)
T PLN02421         95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI  174 (330)
T ss_pred             CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence            665321                 11111    0111233332222221                      111111111 


Q ss_pred             ----ccCCcEEeCCCCCCCeeecC-CCCeEEccccceee
Q 007869          379 ----EWEQVVIHRDVKASNVLLDG-ELNGRLGDFGLARL  412 (586)
Q Consensus       379 ----~~~~~ivHrDIkp~NIll~~-~~~~kL~DFGla~~  412 (586)
                          ..+..++|+|+.+.|||+++ ++.++++||..|..
T Consensus       175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence                11245899999999999974 57899999998764

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=96.20  E-value=0.0045  Score=62.48  Aligned_cols=137  Identities=12%  Similarity=0.027  Sum_probs=86.9

Q ss_pred             CcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc--c-------c-------h------hHHHHHHHHHHhcccCC-C
Q 007869          262 GFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE--S-------R-------Q------GMKEFVAEIVSIGRLRH-R  318 (586)
Q Consensus       262 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~-------~-------~------~~~~~~~Ei~~l~~l~H-~  318 (586)
                      -+...+.||-|.-+-+|.+.... |.+.++|.-+..  +       +       +      ..-....|...|+.|.. -
T Consensus        93 v~svGnqIGVGKESDIY~v~d~~-G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g  171 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVADEE-GNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG  171 (465)
T ss_pred             hhhhccccccccccceEEEecCC-CCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence            35678899999999999999854 567888843221  0       0       0      01123557777777632 1


Q ss_pred             -ceeeeeeeeeccCeEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeec
Q 007869          319 -NLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLD  397 (586)
Q Consensus       319 -niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~  397 (586)
                       -+.+.++++    .-++|||++.+-.|...-+-.     +..+++.-+.   .-+.-|..   +++||+|..-=||+++
T Consensus       172 fpVPkpiD~~----RH~Vvmelv~g~Pl~~v~~v~-----d~~~ly~~lm---~~Iv~la~---~GlIHgDFNEFNimv~  236 (465)
T KOG2268|consen  172 FPVPKPIDHN----RHCVVMELVDGYPLRQVRHVE-----DPPTLYDDLM---GLIVRLAN---HGLIHGDFNEFNIMVK  236 (465)
T ss_pred             CCCCCccccc----ceeeHHHhhcccceeeeeecC-----ChHHHHHHHH---HHHHHHHH---cCceecccchheeEEe
Confidence             233444443    458999999887776543221     1222222222   22223333   8999999999999999


Q ss_pred             CCCCeEEccccceeecc
Q 007869          398 GELNGRLGDFGLARLYD  414 (586)
Q Consensus       398 ~~~~~kL~DFGla~~~~  414 (586)
                      ++..++++||--+....
T Consensus       237 dd~~i~vIDFPQmvS~s  253 (465)
T KOG2268|consen  237 DDDKIVVIDFPQMVSTS  253 (465)
T ss_pred             cCCCEEEeechHhhccC
Confidence            99999999997665443

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.18  E-value=0.015  Score=56.19  Aligned_cols=31  Identities=29%  Similarity=0.434  Sum_probs=22.5

Q ss_pred             CcEEeCCCCCCCeee-cCCCCeEEccccceee
Q 007869          382 QVVIHRDVKASNVLL-DGELNGRLGDFGLARL  412 (586)
Q Consensus       382 ~~ivHrDIkp~NIll-~~~~~~kL~DFGla~~  412 (586)
                      ..++|+|+.+.|||+ +.++.++|+||..|..
T Consensus       143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             ceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            579999999999999 8889999999998865

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PLN02756 S-methyl-5-thioribose kinase

Probab=95.69  E-value=0.14  Score=54.37  Aligned_cols=80  Identities=16%  Similarity=0.124  Sum_probs=52.1

Q ss_pred             ceeEeecCceEEEEEEeCCCCeEEEEEEeccccc-------hhHHHHHHHHHHhcccC---CCceeeeeeeeeccCeEEE
Q 007869          266 KELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR-------QGMKEFVAEIVSIGRLR---HRNLVQLLGYCRRKGELLL  335 (586)
Q Consensus       266 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~Ei~~l~~l~---H~niv~l~~~~~~~~~~~l  335 (586)
                      .+.||.|....||+....  +..++||+-....+       .....-..|.+.|..+.   ..++.+++.+|.+  ..++
T Consensus        37 ~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~vl  112 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MALI  112 (418)
T ss_pred             EEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCEE
Confidence            567899999999998873  34588998652211       12233344566665543   3578889988874  4578


Q ss_pred             EEecCCC--CChhhhh
Q 007869          336 VYDYMPN--GSLDKYL  349 (586)
Q Consensus       336 V~E~~~~--gsL~~~l  349 (586)
                      +|||+++  ..+.+.+
T Consensus       113 vME~L~~~~~ilr~~L  128 (418)
T PLN02756        113 GMRYLEPPHIILRKGL  128 (418)
T ss_pred             EEeecCCcceehhhhh
Confidence            8999976  3454444

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=95.56  E-value=0.093  Score=53.79  Aligned_cols=30  Identities=23%  Similarity=0.230  Sum_probs=26.0

Q ss_pred             CCcEEeCCCCCCCeeecCCCCeEEcccccee
Q 007869          381 EQVVIHRDVKASNVLLDGELNGRLGDFGLAR  411 (586)
Q Consensus       381 ~~~ivHrDIkp~NIll~~~~~~kL~DFGla~  411 (586)
                      ..+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus       186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             cCceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            367999999999999987 578999998765

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=95.55  E-value=0.11  Score=54.03  Aligned_cols=80  Identities=13%  Similarity=0.083  Sum_probs=48.8

Q ss_pred             eEeecCceEEEEEEeCCCCeEEEEEEecccc-------chhHHHHHHHHHHhcccC--CCc-eeeeeeeeeccCeEEEEE
Q 007869          268 LLGTGGFGRVYRGTLPKSQIEIAVKKISHES-------RQGMKEFVAEIVSIGRLR--HRN-LVQLLGYCRRKGELLLVY  337 (586)
Q Consensus       268 ~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~Ei~~l~~l~--H~n-iv~l~~~~~~~~~~~lV~  337 (586)
                      .||.|....||++...+++..|+||.-....       +-..+...-|.+.|....  .|. +++++.+  +.....+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence            4799999999999986544679999754321       222334456666665542  343 4444433  444557999


Q ss_pred             ecCCCC-Chhhhh
Q 007869          338 DYMPNG-SLDKYL  349 (586)
Q Consensus       338 E~~~~g-sL~~~l  349 (586)
                      |+++.. .|.+.|
T Consensus        80 EdL~~~~ilR~~L   92 (370)
T TIGR01767        80 EDLSHHKIARKGL   92 (370)
T ss_pred             hhCccchHHHHHH
Confidence            998653 344444

This enzyme is involved in the methionine salvage pathway in certain bacteria.

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	586
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		1e-52
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		6e-52
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		1e-47
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-47
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		6e-33
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		1e-32
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-32
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-30
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		1e-22
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-22
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-22
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		3e-22
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		3e-22
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		3e-22
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		4e-22
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		4e-22
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		4e-22
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-22
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		5e-22
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		6e-22
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		6e-22
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-22
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		6e-22
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		7e-22
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		9e-22
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-21
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-21
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-21
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		4e-21
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		6e-21
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-21
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		9e-21
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		9e-21
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-20
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-20
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-20
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-20
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		1e-20
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-20
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-20
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-20
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-20
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-20
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-20
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-20
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		5e-20
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		6e-20
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		6e-20
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		7e-20
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		7e-20
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		7e-20
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		8e-20
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		1e-19
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-19
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		2e-19
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		2e-19
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-19
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-19
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		3e-19
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		3e-19
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		5e-19
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		5e-19
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		5e-19
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		6e-19
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-18
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-18
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		4e-18
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		6e-18
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		7e-18
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		7e-18
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		7e-18
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		7e-18
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		7e-18
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		7e-18
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		8e-18
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		8e-18
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		8e-18
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		8e-18
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		8e-18
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		9e-18
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		9e-18
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		9e-18
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		9e-18
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		1e-17
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		1e-17
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		1e-17
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		1e-17
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		1e-17
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		1e-17
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		1e-17
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		1e-17
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		1e-17
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-17
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		1e-17
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		1e-17
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		1e-17
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		1e-17
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		1e-17
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		1e-17
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-17
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-17
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-17
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-17
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-17
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		2e-17
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-17
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		3e-17
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		3e-17
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		3e-17
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		3e-17
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		3e-17
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		3e-17
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-17
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		4e-17
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-17
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-17
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		4e-17
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		4e-17
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		4e-17
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		5e-17
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		5e-17
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		5e-17
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		6e-17
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		6e-17
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		6e-17
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		6e-17
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		6e-17
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		7e-17
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		7e-17
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		7e-17
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		7e-17
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-17
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		7e-17
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		7e-17
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		8e-17
4h58_A	275	Braf In Complex With Compound 3 Length = 275		8e-17
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		8e-17
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		8e-17
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-17
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		8e-17
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		9e-17
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-16
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		1e-16
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		1e-16
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-16
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-16
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		1e-16
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-16
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-16
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		1e-16
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-16
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		1e-16
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		1e-16
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		1e-16
1fvr_A	327	Tie2 Kinase Domain Length = 327		1e-16
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-16
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-16
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-16
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-16
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-16
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-16
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-16
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-16
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-16
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-16
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-16
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		3e-16
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		3e-16
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		3e-16
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		3e-16
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		3e-16
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		3e-16
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		3e-16
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		4e-16
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		4e-16
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		4e-16
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		4e-16
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		4e-16
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		4e-16
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		4e-16
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		4e-16
3a7f_A	303	Human Mst3 Kinase Length = 303		4e-16
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		4e-16
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		4e-16
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		5e-16
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		5e-16
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		5e-16
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		5e-16
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		6e-16
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		6e-16
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		6e-16
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		6e-16
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		6e-16
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		6e-16
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		7e-16
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		7e-16
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		7e-16
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		8e-16
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		8e-16
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		8e-16
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		8e-16
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		8e-16
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		8e-16
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		9e-16
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		9e-16
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		9e-16
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		1e-15
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-15
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		1e-15
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-15
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		1e-15
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		1e-15
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		1e-15
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		1e-15
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		2e-15
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-15
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		2e-15
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-15
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-15
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-15
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-15
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-15
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		2e-15
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-15
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-15
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		3e-15
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-15
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		3e-15
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		3e-15
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		3e-15
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-15
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-15
3a4o_X	286	Lyn Kinase Domain Length = 286		4e-15
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		4e-15
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		4e-15
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		4e-15
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		4e-15
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		4e-15
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		4e-15
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		5e-15
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		5e-15
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-15
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		5e-15
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		5e-15
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		6e-15
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		6e-15
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		6e-15
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		7e-15
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		7e-15
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		8e-15
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		8e-15
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		8e-15
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		9e-15
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		9e-15
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		9e-15
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		1e-14
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-14
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		1e-14
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		1e-14
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		1e-14
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		1e-14
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-14
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-14
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		1e-14
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-14
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		1e-14
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-14
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-14
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		2e-14
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-14
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-14
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-14
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-14
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		2e-14
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-14
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		2e-14
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		2e-14
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-14
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		2e-14
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		2e-14
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-14
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		3e-14
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		3e-14
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		3e-14
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		3e-14
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		3e-14
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		3e-14
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		3e-14
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		3e-14
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		3e-14
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-14
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		3e-14
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-14
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		3e-14
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		3e-14
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		4e-14
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		4e-14
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		4e-14
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-14
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		4e-14
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		4e-14
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		4e-14
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		4e-14
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		4e-14
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-14
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		4e-14
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-14
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		4e-14
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		5e-14
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		5e-14
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		5e-14
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		5e-14
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		5e-14
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		5e-14
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		5e-14
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		5e-14
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		5e-14
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		5e-14
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		6e-14
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		6e-14
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		6e-14
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		7e-14
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		7e-14
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		7e-14
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		8e-14
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		8e-14
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		8e-14
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		8e-14
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		9e-14
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		9e-14
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		9e-14
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		9e-14
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		9e-14
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-13
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		1e-13
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		1e-13
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		1e-13
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		1e-13
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		1e-13
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		1e-13
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		1e-13
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		1e-13
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		1e-13
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		1e-13
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		1e-13
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		1e-13
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		1e-13
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		1e-13
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		1e-13
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		1e-13
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		1e-13
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-13
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		1e-13
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-13
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-13
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-13
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-13
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-13
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-13
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-13
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-13
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		2e-13
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-13
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-13
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-13
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-13
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-13
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-13
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		2e-13
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-13
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		2e-13
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-13
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-13
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		2e-13
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-13
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-13
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-13
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-13
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		3e-13
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-13
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-13
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-13
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		4e-13
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		4e-13
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-13
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		4e-13
4fl3_A	635	Structural And Biophysical Characterization Of The		4e-13
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		4e-13
4fl2_A	636	Structural And Biophysical Characterization Of The		4e-13
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		4e-13
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		4e-13
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		4e-13
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		4e-13
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		5e-13
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		5e-13
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		5e-13
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		5e-13
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		5e-13
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		5e-13
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		5e-13
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-13
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		5e-13
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		5e-13
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		5e-13
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		5e-13
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		5e-13
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-13
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		5e-13
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		5e-13
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		5e-13
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		5e-13
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		5e-13
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		5e-13
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-13
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		5e-13
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		6e-13
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-13
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		6e-13
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		6e-13
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		6e-13
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		6e-13
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		6e-13
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		6e-13
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		6e-13
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		6e-13
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		6e-13
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		6e-13
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		6e-13
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		6e-13
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-13
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		7e-13
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		7e-13
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		7e-13
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		7e-13
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		8e-13
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		8e-13
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		8e-13
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		9e-13
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		9e-13
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		9e-13
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		1e-12
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		1e-12
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-12
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-12
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-12
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		1e-12
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		1e-12
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		1e-12
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-12
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		1e-12
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-12
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-12
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-12
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-12
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-12
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		2e-12
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-12
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		2e-12
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		2e-12
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-12
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-12
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-12
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-12
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		2e-12
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		2e-12
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-12
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-12
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		3e-12
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		3e-12
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		3e-12
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		3e-12
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-12
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		3e-12
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		3e-12
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		3e-12
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		3e-12
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		3e-12
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		3e-12
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		3e-12
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		3e-12
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		3e-12
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		3e-12
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		3e-12
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		4e-12
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		4e-12
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		4e-12
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		4e-12
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		4e-12
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		4e-12
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		4e-12
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		4e-12
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		4e-12
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		4e-12
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		4e-12
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		4e-12
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		4e-12
3usu_B	242	Crystal Structure Of Butea Monosperma Seed Lectin L		4e-12
3usu_A	256	Crystal Structure Of Butea Monosperma Seed Lectin L		5e-12
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		5e-12
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		5e-12
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		5e-12
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		5e-12
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		5e-12
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		5e-12
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		5e-12
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		5e-12
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		5e-12
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		6e-12
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		6e-12
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		6e-12
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		6e-12
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		6e-12
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-12
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		7e-12
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		7e-12
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		7e-12
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		7e-12
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		7e-12
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		7e-12
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		7e-12
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		7e-12
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		7e-12
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		7e-12
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		7e-12
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		7e-12
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		7e-12
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		8e-12
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		8e-12
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		8e-12
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		8e-12
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		9e-12
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		9e-12
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		9e-12
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		9e-12
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		9e-12
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-11
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		1e-11
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		1e-11
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		1e-11
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-11
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-11
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		1e-11
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		1e-11
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-11
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		1e-11
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-11
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		1e-11
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-11
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		1e-11
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		1e-11
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-11
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-11
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-11
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-11
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-11
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-11
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-11
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-11
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-11
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		2e-11
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		2e-11
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		2e-11
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-11
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-11
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-11
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-11
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-11
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-11
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-11
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		2e-11
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-11
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-11
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-11
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-11
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-11
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-11
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-11
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-11
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-11
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		2e-11
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-11
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		3e-11
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		3e-11
4fie_A	423	Full-Length Human Pak4 Length = 423		3e-11
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		3e-11
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-11
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-11
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-11
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		3e-11
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-11
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		3e-11
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-11
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		3e-11
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		3e-11
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		3e-11
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		3e-11
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		3e-11
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		3e-11
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		3e-11
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-11
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		4e-11
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-11
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		4e-11
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		5e-11
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-11
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		5e-11
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		5e-11
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		5e-11
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		5e-11
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		5e-11
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		5e-11
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		5e-11
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		6e-11
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		6e-11
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		6e-11
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		6e-11
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		7e-11
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		7e-11
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		7e-11
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		7e-11
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		7e-11
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		7e-11
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		7e-11
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		7e-11
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		8e-11
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		8e-11
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		9e-11
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		9e-11
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		9e-11
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		9e-11
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		9e-11
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		9e-11
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		9e-11
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		9e-11
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		9e-11
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		9e-11
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		1e-10
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		1e-10
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		1e-10
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		1e-10
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-10
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-10
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		1e-10
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-10
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-10
2fmd_A	240	Structural Basis Of Carbohydrate Recognition By Bow		1e-10
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		1e-10
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-10
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		1e-10
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		1e-10
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		1e-10
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		1e-10
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-10
3zvx_A	261	Structure Of The Lectin From Platypodium Elegans In		2e-10
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		2e-10
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		3e-10
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-10
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-10
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-10
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-10
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-10
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		3e-10
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		3e-10
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		3e-10
3ujo_A	281	Galactose-Specific Seed Lectin From Dolichos Lablab		3e-10
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		3e-10
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		3e-10
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		4e-10
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-10
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		4e-10
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		4e-10
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		4e-10
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		4e-10
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		4e-10
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		4e-10
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		4e-10
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		4e-10
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		4e-10
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		4e-10
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		4e-10
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		4e-10
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		4e-10
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		4e-10
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		4e-10
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		4e-10
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		4e-10
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		5e-10
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		5e-10
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		5e-10
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		5e-10
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		5e-10
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		5e-10
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		5e-10
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		5e-10
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		5e-10
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		5e-10
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		5e-10
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		5e-10
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		5e-10
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		5e-10
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		5e-10
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		5e-10
3hec_A	348	P38 In Complex With Imatinib Length = 348		5e-10
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		5e-10
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		5e-10
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		5e-10
2sba_A	253	Soybean Agglutinin Complexed With 2,6-Pentasacchari		6e-10
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		6e-10
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		6e-10
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		6e-10
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		6e-10
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		6e-10
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		7e-10
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		8e-10
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		8e-10
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		8e-10
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		8e-10
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		8e-10
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		8e-10
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		8e-10
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		8e-10
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		8e-10
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		9e-10
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		9e-10
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		9e-10
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		9e-10
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		1e-09
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		1e-09
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-09
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		1e-09
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-09
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		1e-09
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		2e-09
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		2e-09
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		2e-09
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-09
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-09
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-09
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-09
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-09
2oza_B	366	Structure Of P38alpha Complex Length = 366		2e-09
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		2e-09
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		2e-09
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-09
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-09
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		2e-09
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-09
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-09
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		2e-09
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-09
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-09
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		2e-09
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		2e-09
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		2e-09
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		3e-09
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		3e-09
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-09
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		3e-09
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		3e-09
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		3e-09
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		3e-09
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		3e-09
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		4e-09
3ipv_B	239	Crystal Structure Of Spatholobus Parviflorus Seed L		4e-09
1bjq_A	253	The Dolichos Biflorus Seed Lectin In Complex With A		4e-09
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		4e-09
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		4e-09
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		4e-09
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		4e-09
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-09
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		5e-09
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		5e-09
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		5e-09
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		5e-09
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		5e-09
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-09
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		5e-09
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		5e-09
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-09
3kk8_A	284	Camkii Substrate Complex A Length = 284		5e-09
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		5e-09
3kk9_A	282	Camkii Substrate Complex B Length = 282		5e-09
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		5e-09
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		5e-09
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		6e-09
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		6e-09
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		6e-09
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		6e-09
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		6e-09
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		6e-09
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		6e-09
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		6e-09
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		6e-09
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		6e-09
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		6e-09
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		6e-09
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		6e-09
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		6e-09
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		7e-09
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		7e-09
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		7e-09
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		7e-09
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		7e-09
1dbn_A	239	Maackia Amurensis Leukoagglutinin (Lectin) With Sia		7e-09
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		7e-09
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		7e-09
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		7e-09
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		7e-09
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		8e-09
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		8e-09
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		8e-09
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		8e-09
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		8e-09
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		8e-09
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		9e-09
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		9e-09
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		9e-09
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		9e-09
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		9e-09
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		9e-09
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		9e-09
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		1e-08
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		1e-08
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		1e-08
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-08
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		1e-08
1fat_A	252	Phytohemagglutinin-L Length = 252		1e-08
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		1e-08
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		1e-08
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		1e-08
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		1e-08
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		1e-08
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		1e-08
1gz9_A	239	High-Resolution Crystal Structure Of Erythrina Cris		1e-08
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		1e-08
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		1e-08
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		1e-08
4ae6_A	343	Structure And Function Of The Human Sperm-specific		1e-08
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		1e-08
2bqp_A	234	The Structure Of The Pea Lectin-D-Glucopyranose Com		1e-08
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		1e-08
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		2e-08
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		2e-08
4ae9_A	343	Structure And Function Of The Human Sperm-specific		2e-08
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-08
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		2e-08
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-08
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		2e-08
1n47_A	233	Isolectin B4 From Vicia Villosa In Complex With The		2e-08
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-08
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		2e-08
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-08
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		3e-08
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		3e-08
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		3e-08
4exu_A	371	Mapk13, Inactive Form Length = 371		3e-08
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		3e-08
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		3e-08
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		3e-08
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		3e-08
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		3e-08
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		3e-08
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		3e-08
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		3e-08
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		3e-08
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-08
1lul_A	253	Db58, A Legume Lectin From Dolichos Biflorus Length		3e-08
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		3e-08
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		4e-08
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		4e-08
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		4e-08
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		4e-08
3soa_A	444	Full-Length Human Camkii Length = 444		4e-08
3ipv_A	251	Crystal Structure Of Spatholobus Parviflorus Seed L		4e-08
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		4e-08
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		4e-08
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		4e-08
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		5e-08
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		5e-08
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		5e-08
1g8w_A	233	Improved Structure Of Phytohemagglutinin-L From The		5e-08
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		6e-08
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		6e-08
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		6e-08
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		6e-08
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		7e-08
1uzy_A	242	Erythrina Crystagalli Lectin Length = 242		7e-08
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		8e-08
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		9e-08
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		9e-08
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		9e-08
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		9e-08
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		9e-08
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		9e-08
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		9e-08
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		1e-07
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		1e-07
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		1e-07
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		1e-07
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		1e-07
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		1e-07
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-07
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		1e-07
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		1e-07
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		1e-07
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		1e-07
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		1e-07
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		1e-07
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		1e-07
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-07
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		1e-07
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		1e-07
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-07
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		1e-07
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		1e-07
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		1e-07
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-07
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		1e-07
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		1e-07
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		1e-07
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		1e-07
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		1e-07
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		1e-07
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		1e-07
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-07
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-07
1qnw_A	242	Lectin Ii From Ulex Europaeus Length = 242		2e-07
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-07
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		2e-07
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		2e-07
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-07
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		2e-07
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		2e-07
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-07
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-07
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		2e-07
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		2e-07
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		2e-07
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		2e-07
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-07
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		2e-07
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-07
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		2e-07
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-07
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		2e-07
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		2e-07
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-07
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-07
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-07
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		2e-07
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		2e-07
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		2e-07
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		2e-07
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		2e-07
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		2e-07
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-07
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		2e-07
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		2e-07
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		2e-07
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-07
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		2e-07
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-07
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		2e-07
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-07
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-07
1gnz_A	257	Lectin I-B4 From Griffonia Simplicifolia (Gs I-B4)m		2e-07
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-07
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		2e-07
1hql_A	257	The Xenograft Antigen In Complex With The B4 Isolec		2e-07
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		2e-07
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		2e-07
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		2e-07
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		2e-07
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		2e-07
2gdf_A	237	Crystal Structure Of Dioclea Violacea Seed Lectin L		2e-07
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-07
3n35_A	242	Erythrina Corallodendron Lectin Mutant (Y106g) With		3e-07
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		3e-07
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		3e-07
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		3e-07
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		3e-07
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		3e-07
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		3e-07
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		3e-07
1sfy_A	239	Crystal Structure Of Recombinant Erythrina Corallod		3e-07
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		3e-07
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		4e-07
1ax0_A	239	Erythrina Corallodendron Lectin In Complex With N-A		4e-07
2je9_A	239	Crystal Structure Of Recombinant Dioclea Grandiflor		4e-07
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		4e-07
3sh3_A	237	Crystal Structure Of A Pro-Inflammatory Lectin From		4e-07
1lte_A	239	Structure Of A Legume Lectin With An Ordered N-Link		4e-07
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		4e-07
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		5e-07
1fyu_A	255	Crystal Structure Of Erythrina Corallodendron Lecti		6e-07
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		6e-07
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		6e-07
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		7e-07
1fx5_A	242	Crystal Structure Analysis Of Ulex Europaeus Lectin		7e-07
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		7e-07

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  204 bits (518), Expect = 1e-52,   Method: Compositional matrix adjust.
 Identities = 114/292 (39%), Positives = 166/292 (56%), Gaps = 6/292 (2%)
Query: 250 RFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMK-EFVAE 308
           RF  ++L +A+  F  K +LG GGFG+VY+G L    + +AVK++  E  QG + +F  E
Sbjct: 27  RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTL-VAVKRLKEERXQGGELQFQTE 85
Query: 309 IVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVT--LNWIQRFRVI 366
           +  I    HRNL++L G+C    E LLVY YM NGS+   L ++P+    L+W +R R+ 
Sbjct: 86  VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 145
Query: 367 KGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVG 426
            G A GL YLH   +  +IHRDVKA+N+LLD E    +GDFGLA+L D+        V G
Sbjct: 146 LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRG 205
Query: 427 TLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRP--IQRQGPSENLILVDWVFDFWN 484
           T+G++APE+  TGK++   DVF +G  LLE+  G+R   + R    ++++L+DWV     
Sbjct: 206 TIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 265
Query: 485 RGELLEARDPNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQILERD 536
             +L    D +L   Y              C+ S P  RP M +VV++LE D
Sbjct: 266 EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 317

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  202 bits (513), Expect = 6e-52,   Method: Compositional matrix adjust.
 Identities = 113/292 (38%), Positives = 165/292 (56%), Gaps = 6/292 (2%)
Query: 250 RFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMK-EFVAE 308
           RF  ++L +A+  F  K +LG GGFG+VY+G L    + +AVK++  E  QG + +F  E
Sbjct: 19  RFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXL-VAVKRLKEERTQGGELQFQTE 77
Query: 309 IVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVT--LNWIQRFRVI 366
           +  I    HRNL++L G+C    E LLVY YM NGS+   L ++P+    L+W +R R+ 
Sbjct: 78  VEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA 137
Query: 367 KGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVG 426
            G A GL YLH   +  +IHRDVKA+N+LLD E    +GDFGLA+L D+        V G
Sbjct: 138 LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRG 197
Query: 427 TLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRP--IQRQGPSENLILVDWVFDFWN 484
            +G++APE+  TGK++   DVF +G  LLE+  G+R   + R    ++++L+DWV     
Sbjct: 198 XIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 257
Query: 485 RGELLEARDPNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQILERD 536
             +L    D +L   Y              C+ S P  RP M +VV++LE D
Sbjct: 258 EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  187 bits (475), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 118/310 (38%), Positives = 170/310 (54%), Gaps = 21/310 (6%)
Query: 249 HRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAE 308
           +R    DL  AT  F  K L+G G FG+VY+G L +   ++A+K+ + ES QG++EF  E
Sbjct: 27  YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQGIEEFETE 85
Query: 309 IVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLY--DQPKVTLNWIQRFRVI 366
           I ++   RH +LV L+G+C  + E++L+Y YM NG+L ++LY  D P ++++W QR  + 
Sbjct: 86  IETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEIC 145
Query: 367 KGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTH--- 423
            G A GL YLH    + +IHRDVK+ N+LLD     ++ DFG+++    GT+   TH   
Sbjct: 146 IGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISK---KGTELDQTHLXX 199
Query: 424 -VVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDF 482
            V GTLGY+ PE+   G+ T  +DV+SFG  L EV C R  I +  P E + L +W  + 
Sbjct: 200 VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVES 259
Query: 483 WNRGELLEARDPNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQILERDVALPAI 542
            N G+L +  DPNL  +               C       RPSM  V+  LE        
Sbjct: 260 HNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE-------- 311
Query: 543 SALRLSTSGI 552
            ALRL  S I
Sbjct: 312 YALRLQESVI 321

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  186 bits (473), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 118/310 (38%), Positives = 170/310 (54%), Gaps = 21/310 (6%)
Query: 249 HRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAE 308
           +R    DL  AT  F  K L+G G FG+VY+G L +   ++A+K+ + ES QG++EF  E
Sbjct: 27  YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQGIEEFETE 85
Query: 309 IVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLY--DQPKVTLNWIQRFRVI 366
           I ++   RH +LV L+G+C  + E++L+Y YM NG+L ++LY  D P ++++W QR  + 
Sbjct: 86  IETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEIC 145
Query: 367 KGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTH--- 423
            G A GL YLH    + +IHRDVK+ N+LLD     ++ DFG+++    GT+   TH   
Sbjct: 146 IGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISK---KGTELGQTHLXX 199
Query: 424 -VVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDF 482
            V GTLGY+ PE+   G+ T  +DV+SFG  L EV C R  I +  P E + L +W  + 
Sbjct: 200 VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVES 259
Query: 483 WNRGELLEARDPNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQILERDVALPAI 542
            N G+L +  DPNL  +               C       RPSM  V+  LE        
Sbjct: 260 HNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE-------- 311
Query: 543 SALRLSTSGI 552
            ALRL  S I
Sbjct: 312 YALRLQESVI 321

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  139 bits (349), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 93/302 (30%), Positives = 149/302 (49%), Gaps = 20/302 (6%)
Query: 249 HRFRYKDLYIATKGFREKEL------LGTGGFGRVYRGTLPKSQIEIAVKKISH----ES 298
           H F + +L   T  F E+ +      +G GGFG VY+G +  + +  AVKK++      +
Sbjct: 13  HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTV--AVKKLAAMVDITT 70
Query: 299 RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGS-LDKYLYDQPKVTL 357
            +  ++F  EI  + + +H NLV+LLG+     +L LVY YMPNGS LD+         L
Sbjct: 71  EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPL 130
Query: 358 NWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH-G 416
           +W  R ++ +G A G+ +LH+      IHRD+K++N+LLD     ++ DFGLAR  +   
Sbjct: 131 SWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFA 187
Query: 417 TDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILV 476
                + +VGT  Y+APE  R G+ T  +D++SFG  LLE+  G  P   +     L+L 
Sbjct: 188 QTVMXSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITG-LPAVDEHREPQLLLD 245
Query: 477 DWVFDFWNRGELLEARDPNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQILERD 536
                      + +  D  +  +  +            C H     RP +++V Q+L+  
Sbjct: 246 IKEEIEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304
Query: 537 VA 538
            A
Sbjct: 305 TA 306

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  138 bits (347), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 93/302 (30%), Positives = 148/302 (49%), Gaps = 20/302 (6%)
Query: 249 HRFRYKDLYIATKGFREKEL------LGTGGFGRVYRGTLPKSQIEIAVKKISH----ES 298
           H F + +L   T  F E+ +      +G GGFG VY+G +  + +  AVKK++      +
Sbjct: 13  HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTV--AVKKLAAMVDITT 70
Query: 299 RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGS-LDKYLYDQPKVTL 357
            +  ++F  EI  + + +H NLV+LLG+     +L LVY YMPNGS LD+         L
Sbjct: 71  EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPL 130
Query: 358 NWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH-G 416
           +W  R ++ +G A G+ +LH+      IHRD+K++N+LLD     ++ DFGLAR  +   
Sbjct: 131 SWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFA 187
Query: 417 TDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILV 476
                  +VGT  Y+APE  R G+ T  +D++SFG  LLE+  G  P   +     L+L 
Sbjct: 188 QTVMXXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITG-LPAVDEHREPQLLLD 245
Query: 477 DWVFDFWNRGELLEARDPNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQILERD 536
                      + +  D  +  +  +            C H     RP +++V Q+L+  
Sbjct: 246 IKEEIEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304
Query: 537 VA 538
            A
Sbjct: 305 TA 306

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  137 bits (346), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 93/302 (30%), Positives = 148/302 (49%), Gaps = 20/302 (6%)
Query: 249 HRFRYKDLYIATKGFREKEL------LGTGGFGRVYRGTLPKSQIEIAVKKISH----ES 298
           H F + +L   T  F E+ +      +G GGFG VY+G +  +   +AVKK++      +
Sbjct: 7   HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITT 64
Query: 299 RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGS-LDKYLYDQPKVTL 357
            +  ++F  EI  + + +H NLV+LLG+     +L LVY YMPNGS LD+         L
Sbjct: 65  EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPL 124
Query: 358 NWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH-G 416
           +W  R ++ +G A G+ +LH+      IHRD+K++N+LLD     ++ DFGLAR  +   
Sbjct: 125 SWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFA 181
Query: 417 TDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILV 476
                  +VGT  Y+APE  R G+ T  +D++SFG  LLE+  G  P   +     L+L 
Sbjct: 182 QXVMXXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITG-LPAVDEHREPQLLLD 239
Query: 477 DWVFDFWNRGELLEARDPNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQILERD 536
                      + +  D  +  +  +            C H     RP +++V Q+L+  
Sbjct: 240 IKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 298
Query: 537 VA 538
            A
Sbjct: 299 TA 300

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  130 bits (327), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 93/302 (30%), Positives = 145/302 (48%), Gaps = 20/302 (6%)
Query: 249 HRFRYKDLYIATKGFREKEL------LGTGGFGRVYRGTLPKSQIEIAVKKISH----ES 298
           H F + +L   T  F E+ +       G GGFG VY+G +  +   +AVKK++      +
Sbjct: 4   HSFSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITT 61
Query: 299 RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGS-LDKYLYDQPKVTL 357
            +  ++F  EI    + +H NLV+LLG+     +L LVY Y PNGS LD+         L
Sbjct: 62  EELKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPL 121
Query: 358 NWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH-G 416
           +W  R ++ +G A G+ +LH+      IHRD+K++N+LLD     ++ DFGLAR  +   
Sbjct: 122 SWHXRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFA 178
Query: 417 TDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILV 476
                + +VGT  Y APE  R G+ T  +D++SFG  LLE+  G  P   +     L+L 
Sbjct: 179 QXVXXSRIVGTTAYXAPEALR-GEITPKSDIYSFGVVLLEIITG-LPAVDEHREPQLLLD 236
Query: 477 DWVFDFWNRGELLEARDPNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQILERD 536
                      + +  D     +  +            C H     RP +++V Q+L+  
Sbjct: 237 IKEEIEDEEKTIEDYIDKKX-NDADSTSVEAXYSVASQCLHEKKNKRPDIKKVQQLLQEX 295
Query: 537 VA 538
            A
Sbjct: 296 TA 297

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score =  105 bits (261), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 119/209 (56%), Gaps = 18/209 (8%)
Query: 266 KELLGTGGFGRVYRGTLP----KSQIEIAVK--KISHESRQGMKEFVAEIVSIGRLRHRN 319
           ++++G G FG VY+G L     K ++ +A+K  K  +  +Q + +F+ E   +G+  H N
Sbjct: 49  QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRV-DFLGEAGIMGQFSHHN 107
Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQE 379
           +++L G   +   ++++ +YM NG+LDK+L ++     + +Q   +++G+A G+ YL   
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGALDKFLREKDG-EFSVLQLVGMLRGIAAGMKYLAN- 165
Query: 380 WEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVG----TLGYLAPEH 435
                +HRD+ A N+L++  L  ++ DFGL+R+ +   DP+ T+        + + APE 
Sbjct: 166 --MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED--DPEATYTTSGGKIPIRWTAPEA 221
Query: 436 TRTGKATTSADVFSFGAFLLEVAC-GRRP 463
               K T+++DV+SFG  + EV   G RP
Sbjct: 222 ISYRKFTSASDVWSFGIVMWEVMTYGERP 250

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 75/280 (26%), Positives = 131/280 (46%), Gaps = 18/280 (6%)
Query: 255 DLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGR 314
           D+ I       KE +G G FG V+R     S + + +        + + EF+ E+  + R
Sbjct: 31  DMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKR 90
Query: 315 LRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQ-PKVTLNWIQRFRVIKGVALGL 373
           LRH N+V  +G   +   L +V +Y+  GSL + L+    +  L+  +R  +   VA G+
Sbjct: 91  LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGM 150
Query: 374 FYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAP 433
            YLH      ++HR++K+ N+L+D +   ++ DFGL+RL    T   +    GT  ++AP
Sbjct: 151 NYLHNR-NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL-KASTFLSSKSAAGTPEWMAP 208
Query: 434 EHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARD 493
           E  R   +   +DV+SFG  L E+A  ++P     P++ +  V +      R E+    +
Sbjct: 209 EVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKC---KRLEIPRNLN 265
Query: 494 PNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQIL 533
           P +                  C  ++P  RPS   ++ +L
Sbjct: 266 PQVAA------------IIEGCWTNEPWKRPSFATIMDLL 293

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 80/297 (26%), Positives = 142/297 (47%), Gaps = 39/297 (13%)
Query: 267 ELLGTGGFGRVYRGTLP---KSQIEIAVK--KISHESRQGMKEFVAEIVSIGRLRHRNLV 321
           +++G G FG V  G L    K +I +A+K  K+ +  +Q  ++F+ E   +G+  H N++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASIMGQFDHPNII 109
Query: 322 QLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
           +L G   +   +++V +YM NGSLD +L          IQ   +++G+A G+ YL    +
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLS---D 165
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVG----TLGYLAPEHTR 437
              +HRD+ A N+L++  L  ++ DFGLAR+ +   DP+  +        + + +PE   
Sbjct: 166 MGYVHRDLAARNILINSNLVCKVSDFGLARVLED--DPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 438 TGKATTSADVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFW--NRGELLEARDP 494
             K T+++DV+S+G  L EV + G RP                  +W  +  ++++A D 
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMSYGERP------------------YWEMSNQDVIKAVDE 265
Query: 495 NLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQILERDVALPAISALRLSTSG 551
                               C   D   RP   Q+V IL++ +  P   +L++ TS 
Sbjct: 266 GYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPG--SLKIITSA 320

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 75/280 (26%), Positives = 130/280 (46%), Gaps = 18/280 (6%)
Query: 255 DLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGR 314
           D+ I       KE +G G FG V+R     S + + +        + + EF+ E+  + R
Sbjct: 31  DMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKR 90
Query: 315 LRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQ-PKVTLNWIQRFRVIKGVALGL 373
           LRH N+V  +G   +   L +V +Y+  GSL + L+    +  L+  +R  +   VA G+
Sbjct: 91  LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGM 150
Query: 374 FYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAP 433
            YLH      ++HRD+K+ N+L+D +   ++ DFGL+RL        +    GT  ++AP
Sbjct: 151 NYLHNR-NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL-KASXFLXSKXAAGTPEWMAP 208
Query: 434 EHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARD 493
           E  R   +   +DV+SFG  L E+A  ++P     P++ +  V +      R E+    +
Sbjct: 209 EVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKC---KRLEIPRNLN 265
Query: 494 PNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQIL 533
           P +                  C  ++P  RPS   ++ +L
Sbjct: 266 PQVAA------------IIEGCWTNEPWKRPSFATIMDLL 293

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 118/207 (57%), Gaps = 13/207 (6%)
Query: 266 KELLGTGGFGRVYRGTLP---KSQIEIAVKKI-SHESRQGMKEFVAEIVSIGRLRHRNLV 321
           ++++G G FG V  G L    K +I +A+K + S  + +  ++F++E   +G+  H N++
Sbjct: 38  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 97
Query: 322 QLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
            L G   +   ++++ ++M NGSLD +L  Q       IQ   +++G+A G+ YL    +
Sbjct: 98  HLEGVVTKSTPVMIITEFMENGSLDSFLR-QNDGQFTVIQLVGMLRGIAAGMKYLA---D 153
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVG---TLGYLAPEHTR 437
              +HRD+ A N+L++  L  ++ DFGL+R L D  +DP  T  +G    + + APE  +
Sbjct: 154 MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQ 213
Query: 438 TGKATTSADVFSFGAFLLEV-ACGRRP 463
             K T+++DV+S+G  + EV + G RP
Sbjct: 214 YRKFTSASDVWSYGIVMWEVMSYGERP 240

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 111/215 (51%), Gaps = 26/215 (12%)
Query: 266 KELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRL----RHRNLV 321
           +E++G GGFG+VYR        E+AVK   H+  + + + +  +    +L    +H N++
Sbjct: 12  EEIIGIGGFGKVYRAFWIGD--EVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69
Query: 322 QLLGYCRRKGELLLVYDYMPNGSLDKYLYDQ---PKVTLNWIQRFRVIKGVALGLFYLHQ 378
            L G C ++  L LV ++   G L++ L  +   P + +NW  +      +A G+ YLH 
Sbjct: 70  ALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQ------IARGMNYLHD 123
Query: 379 EWEQVVIHRDVKASNVLL-----DGELNG---RLGDFGLARLYDHGTDPQTTHVVGTLGY 430
           E    +IHRD+K+SN+L+     +G+L+    ++ DFGLAR +   T        G   +
Sbjct: 124 EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT---KMSAAGAYAW 180
Query: 431 LAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQ 465
           +APE  R    +  +DV+S+G  L E+  G  P +
Sbjct: 181 MAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFR 215

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score =  103 bits (256), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 81/287 (28%), Positives = 144/287 (50%), Gaps = 33/287 (11%)
Query: 266 KELLGTGGFGRVYRGTLP---KSQIEIAVKKIS--HESRQGMKEFVAEIVSIGRLRHRNL 320
           +E++G G FG V RG L    K +  +A+K +   +  RQ  +EF++E   +G+  H N+
Sbjct: 21  EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQ-RREFLSEASIMGQFEHPNI 79
Query: 321 VQLLGYCRRKGELLLVYDYMPNGSLDKYL-YDQPKVTLNWIQRFRVIKGVALGLFYLHQE 379
           ++L G       ++++ ++M NG+LD +L  +  + T+  IQ   +++G+A G+ YL   
Sbjct: 80  IRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTV--IQLVGMLRGIASGMRYLA-- 135
Query: 380 WEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVG---TLGYLAPEH 435
            E   +HRD+ A N+L++  L  ++ DFGL+R L ++ +DP  T  +G    + + APE 
Sbjct: 136 -EMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEA 194
Query: 436 TRTGKATTSADVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDP 494
               K T+++D +S+G  + EV + G RP                +D  N+ +++ A + 
Sbjct: 195 IAFRKFTSASDAWSYGIVMWEVMSFGERP---------------YWDMSNQ-DVINAIEQ 238
Query: 495 NLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQILERDVALPA 541
           +                   C   D  ARP   QVV  L++ +  PA
Sbjct: 239 DYRLPPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVSALDKMIRNPA 285

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score =  102 bits (255), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 81/287 (28%), Positives = 144/287 (50%), Gaps = 33/287 (11%)
Query: 266 KELLGTGGFGRVYRGTLP---KSQIEIAVKKIS--HESRQGMKEFVAEIVSIGRLRHRNL 320
           +E++G G FG V RG L    K +  +A+K +   +  RQ  +EF++E   +G+  H N+
Sbjct: 19  EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQ-RREFLSEASIMGQFEHPNI 77
Query: 321 VQLLGYCRRKGELLLVYDYMPNGSLDKYL-YDQPKVTLNWIQRFRVIKGVALGLFYLHQE 379
           ++L G       ++++ ++M NG+LD +L  +  + T+  IQ   +++G+A G+ YL   
Sbjct: 78  IRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTV--IQLVGMLRGIASGMRYLA-- 133
Query: 380 WEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVG---TLGYLAPEH 435
            E   +HRD+ A N+L++  L  ++ DFGL+R L ++ +DP  T  +G    + + APE 
Sbjct: 134 -EMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEA 192
Query: 436 TRTGKATTSADVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDP 494
               K T+++D +S+G  + EV + G RP                +D  N+ +++ A + 
Sbjct: 193 IAFRKFTSASDAWSYGIVMWEVMSFGERP---------------YWDMSNQ-DVINAIEQ 236
Query: 495 NLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQILERDVALPA 541
           +                   C   D  ARP   QVV  L++ +  PA
Sbjct: 237 DYRLPPPPDCPTSLHQLMLDCWQKDRNARPRFPQVVSALDKMIRNPA 283

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score =  102 bits (255), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 79/297 (26%), Positives = 142/297 (47%), Gaps = 39/297 (13%)
Query: 267 ELLGTGGFGRVYRGTLP---KSQIEIAVK--KISHESRQGMKEFVAEIVSIGRLRHRNLV 321
           +++G G FG V  G L    K +I +A+K  K+ +  +Q  ++F+ E   +G+  H N++
Sbjct: 22  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASIMGQFDHPNII 80
Query: 322 QLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
           +L G   +   +++V +YM NGSLD +L          IQ   +++G+A G+ YL    +
Sbjct: 81  RLEGVVTKSKPVMIVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLS---D 136
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVG----TLGYLAPEHTR 437
              +HRD+ A N+L++  L  ++ DFGL+R+ +   DP+  +        + + +PE   
Sbjct: 137 MGYVHRDLAARNILINSNLVCKVSDFGLSRVLED--DPEAAYTTRGGKIPIRWTSPEAIA 194
Query: 438 TGKATTSADVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFW--NRGELLEARDP 494
             K T+++DV+S+G  L EV + G RP                  +W  +  ++++A D 
Sbjct: 195 YRKFTSASDVWSYGIVLWEVMSYGERP------------------YWEMSNQDVIKAVDE 236
Query: 495 NLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQILERDVALPAISALRLSTSG 551
                               C   D   RP   Q+V IL++ +  P   +L++ TS 
Sbjct: 237 GYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPG--SLKIITSA 291

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score =  102 bits (255), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 79/297 (26%), Positives = 142/297 (47%), Gaps = 39/297 (13%)
Query: 267 ELLGTGGFGRVYRGTLP---KSQIEIAVK--KISHESRQGMKEFVAEIVSIGRLRHRNLV 321
           +++G G FG V  G L    K +I +A+K  K+ +  +Q  ++F+ E   +G+  H N++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASIMGQFDHPNII 109
Query: 322 QLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
           +L G   +   +++V +YM NGSLD +L          IQ   +++G+A G+ YL    +
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLS---D 165
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVG----TLGYLAPEHTR 437
              +HRD+ A N+L++  L  ++ DFGL+R+ +   DP+  +        + + +PE   
Sbjct: 166 MGFVHRDLAARNILINSNLVCKVSDFGLSRVLED--DPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 438 TGKATTSADVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFW--NRGELLEARDP 494
             K T+++DV+S+G  L EV + G RP                  +W  +  ++++A D 
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMSYGERP------------------YWEMSNQDVIKAVDE 265
Query: 495 NLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQILERDVALPAISALRLSTSG 551
                               C   D   RP   Q+V IL++ +  P   +L++ TS 
Sbjct: 266 GYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPG--SLKIITSA 320

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score =  102 bits (254), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 79/297 (26%), Positives = 142/297 (47%), Gaps = 39/297 (13%)
Query: 267 ELLGTGGFGRVYRGTLP---KSQIEIAVK--KISHESRQGMKEFVAEIVSIGRLRHRNLV 321
           +++G G FG V  G L    K +I +A+K  K+ +  +Q  ++F+ E   +G+  H N++
Sbjct: 39  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASIMGQFDHPNII 97
Query: 322 QLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
           +L G   +   +++V +YM NGSLD +L          IQ   +++G+A G+ YL    +
Sbjct: 98  RLEGVVTKSKPVMIVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLS---D 153
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVG----TLGYLAPEHTR 437
              +HRD+ A N+L++  L  ++ DFGL+R+ +   DP+  +        + + +PE   
Sbjct: 154 MGYVHRDLAARNILINSNLVCKVSDFGLSRVLED--DPEAAYTTRGGKIPIRWTSPEAIA 211
Query: 438 TGKATTSADVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFW--NRGELLEARDP 494
             K T+++DV+S+G  L EV + G RP                  +W  +  ++++A D 
Sbjct: 212 YRKFTSASDVWSYGIVLWEVMSYGERP------------------YWEMSNQDVIKAVDE 253
Query: 495 NLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQILERDVALPAISALRLSTSG 551
                               C   D   RP   Q+V IL++ +  P   +L++ TS 
Sbjct: 254 GYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPG--SLKIITSA 308

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score =  102 bits (254), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 79/297 (26%), Positives = 142/297 (47%), Gaps = 39/297 (13%)
Query: 267 ELLGTGGFGRVYRGTLP---KSQIEIAVK--KISHESRQGMKEFVAEIVSIGRLRHRNLV 321
           +++G G FG V  G L    K +I +A+K  K+ +  +Q  ++F+ E   +G+  H N++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASIMGQFDHPNII 109
Query: 322 QLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
           +L G   +   +++V +YM NGSLD +L          IQ   +++G+A G+ YL    +
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLS---D 165
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVG----TLGYLAPEHTR 437
              +HRD+ A N+L++  L  ++ DFGL+R+ +   DP+  +        + + +PE   
Sbjct: 166 MGYVHRDLAARNILINSNLVCKVSDFGLSRVLED--DPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 438 TGKATTSADVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFW--NRGELLEARDP 494
             K T+++DV+S+G  L EV + G RP                  +W  +  ++++A D 
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMSYGERP------------------YWEMSNQDVIKAVDE 265
Query: 495 NLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQILERDVALPAISALRLSTSG 551
                               C   D   RP   Q+V IL++ +  P   +L++ TS 
Sbjct: 266 GYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPG--SLKIITSA 320

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score =  102 bits (254), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 79/297 (26%), Positives = 142/297 (47%), Gaps = 39/297 (13%)
Query: 267 ELLGTGGFGRVYRGTLP---KSQIEIAVK--KISHESRQGMKEFVAEIVSIGRLRHRNLV 321
           +++G G FG V  G L    K +I +A+K  K+ +  +Q  ++F+ E   +G+  H N++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASIMGQFDHPNII 109
Query: 322 QLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
           +L G   +   +++V +YM NGSLD +L          IQ   +++G+A G+ YL    +
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLS---D 165
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVG----TLGYLAPEHTR 437
              +HRD+ A N+L++  L  ++ DFGL+R+ +   DP+  +        + + +PE   
Sbjct: 166 MGYVHRDLAARNILINSNLVCKVSDFGLSRVLED--DPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 438 TGKATTSADVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFW--NRGELLEARDP 494
             K T+++DV+S+G  L EV + G RP                  +W  +  ++++A D 
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMSYGERP------------------YWEMSNQDVIKAVDE 265
Query: 495 NLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQILERDVALPAISALRLSTSG 551
                               C   D   RP   Q+V IL++ +  P   +L++ TS 
Sbjct: 266 GYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPG--SLKIITSA 320

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score =  102 bits (254), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 79/297 (26%), Positives = 142/297 (47%), Gaps = 39/297 (13%)
Query: 267 ELLGTGGFGRVYRGTLP---KSQIEIAVK--KISHESRQGMKEFVAEIVSIGRLRHRNLV 321
           +++G G FG V  G L    K +I +A+K  K+ +  +Q  ++F+ E   +G+  H N++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASIMGQFDHPNII 109
Query: 322 QLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
           +L G   +   +++V +YM NGSLD +L          IQ   +++G+A G+ YL    +
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLS---D 165
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVG----TLGYLAPEHTR 437
              +HRD+ A N+L++  L  ++ DFGL+R+ +   DP+  +        + + +PE   
Sbjct: 166 MGYVHRDLAARNILINSNLVCKVSDFGLSRVLED--DPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 438 TGKATTSADVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFW--NRGELLEARDP 494
             K T+++DV+S+G  L EV + G RP                  +W  +  ++++A D 
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMSYGERP------------------YWEMSNQDVIKAVDE 265
Query: 495 NLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQILERDVALPAISALRLSTSG 551
                               C   D   RP   Q+V IL++ +  P   +L++ TS 
Sbjct: 266 GYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPG--SLKIITSA 320

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score =  102 bits (254), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 79/297 (26%), Positives = 142/297 (47%), Gaps = 39/297 (13%)
Query: 267 ELLGTGGFGRVYRGTLP---KSQIEIAVK--KISHESRQGMKEFVAEIVSIGRLRHRNLV 321
           +++G G FG V  G L    K +I +A+K  K+ +  +Q  ++F+ E   +G+  H N++
Sbjct: 49  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASIMGQFDHPNII 107
Query: 322 QLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
           +L G   +   +++V +YM NGSLD +L          IQ   +++G+A G+ YL    +
Sbjct: 108 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLS---D 163
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVG----TLGYLAPEHTR 437
              +HRD+ A N+L++  L  ++ DFGL+R+ +   DP+  +        + + +PE   
Sbjct: 164 MGYVHRDLAARNILINSNLVCKVSDFGLSRVLED--DPEAAYTTRGGKIPIRWTSPEAIA 221
Query: 438 TGKATTSADVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFW--NRGELLEARDP 494
             K T+++DV+S+G  L EV + G RP                  +W  +  ++++A D 
Sbjct: 222 YRKFTSASDVWSYGIVLWEVMSYGERP------------------YWEMSNQDVIKAVDE 263
Query: 495 NLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQILERDVALPAISALRLSTSG 551
                               C   D   RP   Q+V IL++ +  P   +L++ TS 
Sbjct: 264 GYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPG--SLKIITSA 318

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score =  102 bits (254), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 79/297 (26%), Positives = 142/297 (47%), Gaps = 39/297 (13%)
Query: 267 ELLGTGGFGRVYRGTLP---KSQIEIAVK--KISHESRQGMKEFVAEIVSIGRLRHRNLV 321
           +++G G FG V  G L    K +I +A+K  K+ +  +Q  ++F+ E   +G+  H N++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASIMGQFDHPNII 109
Query: 322 QLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
           +L G   +   +++V +YM NGSLD +L          IQ   +++G+A G+ YL    +
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLS---D 165
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVG----TLGYLAPEHTR 437
              +HRD+ A N+L++  L  ++ DFGL+R+ +   DP+  +        + + +PE   
Sbjct: 166 MGYVHRDLAARNILINSNLVCKVSDFGLSRVLED--DPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 438 TGKATTSADVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFW--NRGELLEARDP 494
             K T+++DV+S+G  L EV + G RP                  +W  +  ++++A D 
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMSYGERP------------------YWEMSNQDVIKAVDE 265
Query: 495 NLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQILERDVALPAISALRLSTSG 551
                               C   D   RP   Q+V IL++ +  P   +L++ TS 
Sbjct: 266 GYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPG--SLKIITSA 320

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score =  102 bits (253), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 79/297 (26%), Positives = 141/297 (47%), Gaps = 39/297 (13%)
Query: 267 ELLGTGGFGRVYRGTLP---KSQIEIAVK--KISHESRQGMKEFVAEIVSIGRLRHRNLV 321
           +++G G FG V  G L    K +I +A+K  K+ +  +Q  ++F+ E   +G+  H N++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASIMGQFDHPNII 109
Query: 322 QLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
           +L G   +   +++V +YM NGSLD +L          IQ   +++G+A G+ YL    +
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLS---D 165
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVG----TLGYLAPEHTR 437
              +HRD+ A N+L++  L  ++ DFGL R+ +   DP+  +        + + +PE   
Sbjct: 166 MGYVHRDLAARNILINSNLVCKVSDFGLGRVLED--DPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 438 TGKATTSADVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFW--NRGELLEARDP 494
             K T+++DV+S+G  L EV + G RP                  +W  +  ++++A D 
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMSYGERP------------------YWEMSNQDVIKAVDE 265
Query: 495 NLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQILERDVALPAISALRLSTSG 551
                               C   D   RP   Q+V IL++ +  P   +L++ TS 
Sbjct: 266 GYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPG--SLKIITSA 320

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 117/207 (56%), Gaps = 13/207 (6%)
Query: 266 KELLGTGGFGRVYRGTLP---KSQIEIAVKKI-SHESRQGMKEFVAEIVSIGRLRHRNLV 321
           ++++G G FG V  G L    K +I +A+K + S  + +  ++F++E   +G+  H N++
Sbjct: 12  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 71
Query: 322 QLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
            L G   +   ++++ ++M NGSLD +L  Q       IQ   +++G+A G+ YL    +
Sbjct: 72  HLEGVVTKSTPVMIITEFMENGSLDSFLR-QNDGQFTVIQLVGMLRGIAAGMKYLA---D 127
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVG---TLGYLAPEHTR 437
              +HR + A N+L++  L  ++ DFGL+R L D  +DP  T  +G    + + APE  +
Sbjct: 128 MNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQ 187
Query: 438 TGKATTSADVFSFGAFLLEV-ACGRRP 463
             K T+++DV+S+G  + EV + G RP
Sbjct: 188 YRKFTSASDVWSYGIVMWEVMSYGERP 214

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score =  100 bits (248), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 76/279 (27%), Positives = 127/279 (45%), Gaps = 21/279 (7%)
Query: 266 KELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLG 325
           K  LG G FG VY G   K  + +AVK +  ++ + ++EF+ E   +  ++H NLVQLLG
Sbjct: 16  KHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 74
Query: 326 YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVI 385
            C R+    ++ ++M  G+L  YL +  +  ++ +    +   ++  + YL +   +  I
Sbjct: 75  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFI 131
Query: 386 HRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSA 445
           HRD+ A N L+      ++ DFGL+RL    T          + + APE     K +  +
Sbjct: 132 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKS 191
Query: 446 DVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAXX 504
           DV++FG  L E+A  G  P     PS+       V++   +   +E   P    E V   
Sbjct: 192 DVWAFGVLLWEIATYGMSPYPGIDPSQ-------VYELLEKDYRMER--PEGCPEKV--- 239
Query: 505 XXXXXXXXXXCSHSDPTARPSMRQVVQILERDVALPAIS 543
                     C   +P+ RPS  ++ Q  E      +IS
Sbjct: 240 ----YELMRACWQWNPSDRPSFAEIHQAFETMFQESSIS 274

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 78/297 (26%), Positives = 141/297 (47%), Gaps = 39/297 (13%)
Query: 267 ELLGTGGFGRVYRGTLP---KSQIEIAVK--KISHESRQGMKEFVAEIVSIGRLRHRNLV 321
           +++G G FG V  G L    K +I +A+K  K+ +  +Q  ++F+ E   +G+  H N++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASIMGQFDHPNII 109
Query: 322 QLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
           +L G   +   +++V + M NGSLD +L          IQ   +++G+A G+ YL    +
Sbjct: 110 RLEGVVTKSKPVMIVTEXMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLS---D 165
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVG----TLGYLAPEHTR 437
              +HRD+ A N+L++  L  ++ DFGL+R+ +   DP+  +        + + +PE   
Sbjct: 166 MGAVHRDLAARNILINSNLVCKVSDFGLSRVLED--DPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 438 TGKATTSADVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFW--NRGELLEARDP 494
             K T+++DV+S+G  L EV + G RP                  +W  +  ++++A D 
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMSYGERP------------------YWEMSNQDVIKAVDE 265
Query: 495 NLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQILERDVALPAISALRLSTSG 551
                               C   D   RP   Q+V IL++ +  P   +L++ TS 
Sbjct: 266 GYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPG--SLKIITSA 320

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 99.8 bits (247), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 78/297 (26%), Positives = 141/297 (47%), Gaps = 39/297 (13%)
Query: 267 ELLGTGGFGRVYRGTLP---KSQIEIAVK--KISHESRQGMKEFVAEIVSIGRLRHRNLV 321
           +++G G FG V  G L    K +I +A+K  K+ +  +Q  ++F+ E   +G+  H N++
Sbjct: 22  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASIMGQFDHPNII 80
Query: 322 QLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
           +L G   +   +++V + M NGSLD +L          IQ   +++G+A G+ YL    +
Sbjct: 81  RLEGVVTKSKPVMIVTEXMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLS---D 136
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVG----TLGYLAPEHTR 437
              +HRD+ A N+L++  L  ++ DFGL+R+ +   DP+  +        + + +PE   
Sbjct: 137 MGYVHRDLAARNILINSNLVCKVSDFGLSRVLED--DPEAAYTTRGGKIPIRWTSPEAIA 194
Query: 438 TGKATTSADVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFW--NRGELLEARDP 494
             K T+++DV+S+G  L EV + G RP                  +W  +  ++++A D 
Sbjct: 195 YRKFTSASDVWSYGIVLWEVMSYGERP------------------YWEMSNQDVIKAVDE 236
Query: 495 NLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQILERDVALPAISALRLSTSG 551
                               C   D   RP   Q+V IL++ +  P   +L++ TS 
Sbjct: 237 GYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPG--SLKIITSA 291

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 99.0 bits (245), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 78/297 (26%), Positives = 141/297 (47%), Gaps = 39/297 (13%)
Query: 267 ELLGTGGFGRVYRGTLP---KSQIEIAVK--KISHESRQGMKEFVAEIVSIGRLRHRNLV 321
           +++G G FG V  G L    K +I +A+K  K+ +  +Q  ++F+ E   +G+  H N++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGEASIMGQFDHPNII 109
Query: 322 QLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
           +L G   +   +++V + M NGSLD +L          IQ   +++G+A G+ YL    +
Sbjct: 110 RLEGVVTKSKPVMIVTEXMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLS---D 165
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVG----TLGYLAPEHTR 437
              +HRD+ A N+L++  L  ++ DFGL+R+ +   DP+  +        + + +PE   
Sbjct: 166 MGYVHRDLAARNILINSNLVCKVSDFGLSRVLED--DPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 438 TGKATTSADVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFW--NRGELLEARDP 494
             K T+++DV+S+G  L EV + G RP                  +W  +  ++++A D 
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMSYGERP------------------YWEMSNQDVIKAVDE 265
Query: 495 NLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQILERDVALPAISALRLSTSG 551
                               C   D   RP   Q+V IL++ +  P   +L++ TS 
Sbjct: 266 GYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNPG--SLKIITSA 320

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 99.0 bits (245), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 127/279 (45%), Gaps = 21/279 (7%)
Query: 266 KELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLG 325
           K  LG G +G VY G   K  + +AVK +  ++ + ++EF+ E   +  ++H NLVQLLG
Sbjct: 16  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 74
Query: 326 YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVI 385
            C R+    ++ ++M  G+L  YL +  +  ++ +    +   ++  + YL +   +  I
Sbjct: 75  VCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFI 131
Query: 386 HRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSA 445
           HRD+ A N L+      ++ DFGL+RL    T          + + APE     K +  +
Sbjct: 132 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKS 191
Query: 446 DVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAXX 504
           DV++FG  L E+A  G  P     PS+       V++   +   +E   P    E V   
Sbjct: 192 DVWAFGVLLWEIATYGMSPYPGIDPSQ-------VYELLEKDYRMER--PEGCPEKV--- 239
Query: 505 XXXXXXXXXXCSHSDPTARPSMRQVVQILERDVALPAIS 543
                     C   +P+ RPS  ++ Q  E      +IS
Sbjct: 240 ----YELMRACWQWNPSDRPSFAEIHQAFETMFQESSIS 274

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 98.6 bits (244), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 58/193 (30%), Positives = 99/193 (51%), Gaps = 4/193 (2%)
Query: 266 KELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLG 325
           K  LG G +G VY G   K  + +AVK +  ++ + ++EF+ E   +  ++H NLVQLLG
Sbjct: 23  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 81
Query: 326 YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVI 385
            C R+    ++ ++M  G+L  YL +  +  +N +    +   ++  + YL +   +  I
Sbjct: 82  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFI 138
Query: 386 HRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSA 445
           HRD+ A N L+      ++ DFGL+RL    T          + + APE     K +  +
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKS 198
Query: 446 DVFSFGAFLLEVA 458
           DV++FG  L E+A
Sbjct: 199 DVWAFGVLLWEIA 211

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 98.6 bits (244), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 58/193 (30%), Positives = 99/193 (51%), Gaps = 4/193 (2%)
Query: 266 KELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLG 325
           K  LG G +G VY G   K  + +AVK +  ++ + ++EF+ E   +  ++H NLVQLLG
Sbjct: 19  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 77
Query: 326 YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVI 385
            C R+    ++ ++M  G+L  YL +  +  +N +    +   ++  + YL +   +  I
Sbjct: 78  VCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFI 134
Query: 386 HRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSA 445
           HRD+ A N L+      ++ DFGL+RL    T          + + APE     K +  +
Sbjct: 135 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKS 194
Query: 446 DVFSFGAFLLEVA 458
           DV++FG  L E+A
Sbjct: 195 DVWAFGVLLWEIA 207

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 58/193 (30%), Positives = 99/193 (51%), Gaps = 4/193 (2%)
Query: 266 KELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLG 325
           K  LG G +G VY G   K  + +AVK +  ++ + ++EF+ E   +  ++H NLVQLLG
Sbjct: 19  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 77
Query: 326 YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVI 385
            C R+    ++ ++M  G+L  YL +  +  +N +    +   ++  + YL +   +  I
Sbjct: 78  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFI 134
Query: 386 HRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSA 445
           HRD+ A N L+      ++ DFGL+RL    T          + + APE     K +  +
Sbjct: 135 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIKS 194
Query: 446 DVFSFGAFLLEVA 458
           DV++FG  L E+A
Sbjct: 195 DVWAFGVLLWEIA 207

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 58/193 (30%), Positives = 99/193 (51%), Gaps = 4/193 (2%)
Query: 266 KELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLG 325
           K  LG G +G VY G   K  + +AVK +  ++ + ++EF+ E   +  ++H NLVQLLG
Sbjct: 20  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 78
Query: 326 YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVI 385
            C R+    ++ ++M  G+L  YL +  +  +N +    +   ++  + YL +   +  I
Sbjct: 79  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFI 135
Query: 386 HRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSA 445
           HRD+ A N L+      ++ DFGL+RL    T          + + APE     K +  +
Sbjct: 136 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIKS 195
Query: 446 DVFSFGAFLLEVA 458
           DV++FG  L E+A
Sbjct: 196 DVWAFGVLLWEIA 208

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 58/193 (30%), Positives = 99/193 (51%), Gaps = 4/193 (2%)
Query: 266 KELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLG 325
           K  LG G +G VY G   K  + +AVK +  ++ + ++EF+ E   +  ++H NLVQLLG
Sbjct: 23  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 81
Query: 326 YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVI 385
            C R+    ++ ++M  G+L  YL +  +  +N +    +   ++  + YL +   +  I
Sbjct: 82  VCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFI 138
Query: 386 HRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSA 445
           HRD+ A N L+      ++ DFGL+RL    T          + + APE     K +  +
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 198
Query: 446 DVFSFGAFLLEVA 458
           DV++FG  L E+A
Sbjct: 199 DVWAFGVLLWEIA 211

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 58/193 (30%), Positives = 99/193 (51%), Gaps = 4/193 (2%)
Query: 266 KELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLG 325
           K  LG G +G VY G   K  + +AVK +  ++ + ++EF+ E   +  ++H NLVQLLG
Sbjct: 23  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 81
Query: 326 YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVI 385
            C R+    ++ ++M  G+L  YL +  +  +N +    +   ++  + YL +   +  I
Sbjct: 82  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFI 138
Query: 386 HRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSA 445
           HRD+ A N L+      ++ DFGL+RL    T          + + APE     K +  +
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 198
Query: 446 DVFSFGAFLLEVA 458
           DV++FG  L E+A
Sbjct: 199 DVWAFGVLLWEIA 211

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 58/193 (30%), Positives = 99/193 (51%), Gaps = 4/193 (2%)
Query: 266 KELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLG 325
           K  LG G +G VY G   K  + +AVK +  ++ + ++EF+ E   +  ++H NLVQLLG
Sbjct: 22  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 80
Query: 326 YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVI 385
            C R+    ++ ++M  G+L  YL +  +  +N +    +   ++  + YL +   +  I
Sbjct: 81  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFI 137
Query: 386 HRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSA 445
           HRD+ A N L+      ++ DFGL+RL    T          + + APE     K +  +
Sbjct: 138 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 197
Query: 446 DVFSFGAFLLEVA 458
           DV++FG  L E+A
Sbjct: 198 DVWAFGVLLWEIA 210

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 127/279 (45%), Gaps = 21/279 (7%)
Query: 266 KELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLG 325
           K  LG G +G VY G   K  + +AVK +  ++ + ++EF+ E   +  ++H NLVQLLG
Sbjct: 16  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 74
Query: 326 YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVI 385
            C R+    ++ ++M  G+L  YL +  +  ++ +    +   ++  + YL +   +  I
Sbjct: 75  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFI 131
Query: 386 HRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSA 445
           HRD+ A N L+      ++ DFGL+RL    T          + + APE     K +  +
Sbjct: 132 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTAPESLAYNKFSIKS 191
Query: 446 DVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAXX 504
           DV++FG  L E+A  G  P     PS+       V++   +   +E   P    E V   
Sbjct: 192 DVWAFGVLLWEIATYGMSPYPGIDPSQ-------VYELLEKDYRMER--PEGCPEKV--- 239
Query: 505 XXXXXXXXXXCSHSDPTARPSMRQVVQILERDVALPAIS 543
                     C   +P+ RPS  ++ Q  E      +IS
Sbjct: 240 ----YELMRACWQWNPSDRPSFAEIHQAFETMFQESSIS 274

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 58/193 (30%), Positives = 99/193 (51%), Gaps = 4/193 (2%)
Query: 266 KELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLG 325
           K  LG G +G VY G   K  + +AVK +  ++ + ++EF+ E   +  ++H NLVQLLG
Sbjct: 23  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 81
Query: 326 YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVI 385
            C R+    ++ ++M  G+L  YL +  +  +N +    +   ++  + YL +   +  I
Sbjct: 82  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFI 138
Query: 386 HRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSA 445
           HRD+ A N L+      ++ DFGL+RL    T          + + APE     K +  +
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 198
Query: 446 DVFSFGAFLLEVA 458
           DV++FG  L E+A
Sbjct: 199 DVWAFGVLLWEIA 211

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 58/193 (30%), Positives = 99/193 (51%), Gaps = 4/193 (2%)
Query: 266 KELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLG 325
           K  LG G +G VY G   K  + +AVK +  ++ + ++EF+ E   +  ++H NLVQLLG
Sbjct: 20  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 78
Query: 326 YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVI 385
            C R+    ++ ++M  G+L  YL +  +  +N +    +   ++  + YL +   +  I
Sbjct: 79  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFI 135
Query: 386 HRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSA 445
           HRD+ A N L+      ++ DFGL+RL    T          + + APE     K +  +
Sbjct: 136 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 195
Query: 446 DVFSFGAFLLEVA 458
           DV++FG  L E+A
Sbjct: 196 DVWAFGVLLWEIA 208

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 58/193 (30%), Positives = 99/193 (51%), Gaps = 4/193 (2%)
Query: 266 KELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLG 325
           K  LG G +G VY G   K  + +AVK +  ++ + ++EF+ E   +  ++H NLVQLLG
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 326 YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVI 385
            C R+    ++ ++M  G+L  YL +  +  +N +    +   ++  + YL +   +  I
Sbjct: 77  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFI 133
Query: 386 HRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSA 445
           HRD+ A N L+      ++ DFGL+RL    T          + + APE     K +  +
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 193
Query: 446 DVFSFGAFLLEVA 458
           DV++FG  L E+A
Sbjct: 194 DVWAFGVLLWEIA 206

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 58/193 (30%), Positives = 99/193 (51%), Gaps = 4/193 (2%)
Query: 266 KELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLG 325
           K  LG G +G VY G   K  + +AVK +  ++ + ++EF+ E   +  ++H NLVQLLG
Sbjct: 20  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 78
Query: 326 YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVI 385
            C R+    ++ ++M  G+L  YL +  +  +N +    +   ++  + YL +   +  I
Sbjct: 79  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFI 135
Query: 386 HRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSA 445
           HRD+ A N L+      ++ DFGL+RL    T          + + APE     K +  +
Sbjct: 136 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 195
Query: 446 DVFSFGAFLLEVA 458
           DV++FG  L E+A
Sbjct: 196 DVWAFGVLLWEIA 208

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 58/193 (30%), Positives = 99/193 (51%), Gaps = 4/193 (2%)
Query: 266 KELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLG 325
           K  LG G +G VY G   K  + +AVK +  ++ + ++EF+ E   +  ++H NLVQLLG
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 326 YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVI 385
            C R+    ++ ++M  G+L  YL +  +  +N +    +   ++  + YL +   +  I
Sbjct: 77  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFI 133
Query: 386 HRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSA 445
           HRD+ A N L+      ++ DFGL+RL    T          + + APE     K +  +
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 193
Query: 446 DVFSFGAFLLEVA 458
           DV++FG  L E+A
Sbjct: 194 DVWAFGVLLWEIA 206

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 58/193 (30%), Positives = 99/193 (51%), Gaps = 4/193 (2%)
Query: 266 KELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLG 325
           K  LG G +G VY G   K  + +AVK +  ++ + ++EF+ E   +  ++H NLVQLLG
Sbjct: 31  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 89
Query: 326 YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVI 385
            C R+    ++ ++M  G+L  YL +  +  +N +    +   ++  + YL +   +  I
Sbjct: 90  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFI 146
Query: 386 HRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSA 445
           HRD+ A N L+      ++ DFGL+RL    T          + + APE     K +  +
Sbjct: 147 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 206
Query: 446 DVFSFGAFLLEVA 458
           DV++FG  L E+A
Sbjct: 207 DVWAFGVLLWEIA 219

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 99/193 (51%), Gaps = 4/193 (2%)
Query: 266 KELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLG 325
           K  LG G +G VY G   K  + +AVK +  ++ + ++EF+ E   +  ++H NLVQLLG
Sbjct: 264 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 322
Query: 326 YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVI 385
            C R+    ++ ++M  G+L  YL +  +  +N +    +   ++  + YL +   +  I
Sbjct: 323 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK---KNFI 379
Query: 386 HRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSA 445
           HR++ A N L+      ++ DFGL+RL    T          + + APE     K +  +
Sbjct: 380 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 439
Query: 446 DVFSFGAFLLEVA 458
           DV++FG  L E+A
Sbjct: 440 DVWAFGVLLWEIA 452

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 99/193 (51%), Gaps = 4/193 (2%)
Query: 266 KELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLG 325
           K  LG G +G VY G   K  + +AVK +  ++ + ++EF+ E   +  ++H NLVQLLG
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 326 YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVI 385
            C R+    ++ ++M  G+L  YL +  +  ++ +    +   ++  + YL +   +  I
Sbjct: 77  VCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFI 133
Query: 386 HRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSA 445
           HRD+ A N L+      ++ DFGL+RL    T          + + APE     K +  +
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 193
Query: 446 DVFSFGAFLLEVA 458
           DV++FG  L E+A
Sbjct: 194 DVWAFGVLLWEIA 206

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 99/193 (51%), Gaps = 4/193 (2%)
Query: 266 KELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLG 325
           K  LG G +G VY G   K  + +AVK +  ++ + ++EF+ E   +  ++H NLVQLLG
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 326 YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVI 385
            C R+    ++ ++M  G+L  YL +  +  ++ +    +   ++  + YL +   +  I
Sbjct: 77  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFI 133
Query: 386 HRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSA 445
           HRD+ A N L+      ++ DFGL+RL    T          + + APE     K +  +
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 193
Query: 446 DVFSFGAFLLEVA 458
           DV++FG  L E+A
Sbjct: 194 DVWAFGVLLWEIA 206

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 99/193 (51%), Gaps = 4/193 (2%)
Query: 266 KELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLG 325
           K  LG G +G VY G   K  + +AVK +  ++ + ++EF+ E   +  ++H NLVQLLG
Sbjct: 23  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 81
Query: 326 YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVI 385
            C R+    ++ ++M  G+L  YL +  +  ++ +    +   ++  + YL +   +  I
Sbjct: 82  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFI 138
Query: 386 HRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSA 445
           HRD+ A N L+      ++ DFGL+RL    T          + + APE     K +  +
Sbjct: 139 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 198
Query: 446 DVFSFGAFLLEVA 458
           DV++FG  L E+A
Sbjct: 199 DVWAFGVLLWEIA 211

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 99/193 (51%), Gaps = 4/193 (2%)
Query: 266 KELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLG 325
           K  LG G +G VY G   K  + +AVK +  ++ + ++EF+ E   +  ++H NLVQLLG
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 326 YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVI 385
            C R+    ++ ++M  G+L  YL +  +  ++ +    +   ++  + YL +   +  I
Sbjct: 77  VCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFI 133
Query: 386 HRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSA 445
           HRD+ A N L+      ++ DFGL+RL    T          + + APE     K +  +
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 193
Query: 446 DVFSFGAFLLEVA 458
           DV++FG  L E+A
Sbjct: 194 DVWAFGVLLWEIA 206

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 95.5 bits (236), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 99/193 (51%), Gaps = 4/193 (2%)
Query: 266 KELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLG 325
           K  LG G +G VY G   K  + +AVK +  ++ + ++EF+ E   +  ++H NLVQLLG
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 326 YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVI 385
            C R+    ++ ++M  G+L  YL +  +  ++ +    +   ++  + YL +   +  I
Sbjct: 77  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFI 133
Query: 386 HRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSA 445
           HRD+ A N L+      ++ DFGL+RL    T          + + APE     K +  +
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 193
Query: 446 DVFSFGAFLLEVA 458
           DV++FG  L E+A
Sbjct: 194 DVWAFGVLLWEIA 206

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 113/208 (54%), Gaps = 17/208 (8%)
Query: 266 KELLGTGGFGRVYRGTLP---KSQIEIAVK--KISHESRQGMKEFVAEIVSIGRLRHRNL 320
           + ++G G FG V  G L    K ++ +A+K  K+ +  +Q  ++F+ E   +G+  H N+
Sbjct: 27  ERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQ-RRDFLGEASIMGQFDHPNI 85
Query: 321 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEW 380
           + L G   +   +++V +YM NGSLD +L  +       IQ   +++G++ G+ YL    
Sbjct: 86  IHLEGVVTKSKPVMIVTEYMENGSLDTFL-KKNDGQFTVIQLVGMLRGISAGMKYLS--- 141
Query: 381 EQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVG----TLGYLAPEHT 436
           +   +HRD+ A N+L++  L  ++ DFGL+R+ +   DP+  +        + + APE  
Sbjct: 142 DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED--DPEAAYTTRGGKIPIRWTAPEAI 199
Query: 437 RTGKATTSADVFSFGAFLLEVAC-GRRP 463
              K T+++DV+S+G  + EV   G RP
Sbjct: 200 AFRKFTSASDVWSYGIVMWEVVSYGERP 227

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 112/206 (54%), Gaps = 13/206 (6%)
Query: 266 KELLGTGGFGRVYRGTLP---KSQIEIAVK--KISHESRQGMKEFVAEIVSIGRLRHRNL 320
           + ++G G FG V  G L    K  + +A+K  K+ +  +Q  ++F+ E   +G+  H N+
Sbjct: 48  ERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQ-RRDFLCEASIMGQFDHPNV 106
Query: 321 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEW 380
           V L G   R   +++V ++M NG+LD +L          IQ   +++G+A G+ YL    
Sbjct: 107 VHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDG-QFTVIQLVGMLRGIAAGMRYLA--- 162
Query: 381 EQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLG--YLAPEHTRT 438
           +   +HRD+ A N+L++  L  ++ DFGL+R+ +   +   T   G +   + APE  + 
Sbjct: 163 DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAIQY 222
Query: 439 GKATTSADVFSFGAFLLEV-ACGRRP 463
            K T+++DV+S+G  + EV + G RP
Sbjct: 223 RKFTSASDVWSYGIVMWEVMSYGERP 248

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 58/193 (30%), Positives = 97/193 (50%), Gaps = 4/193 (2%)
Query: 266 KELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLG 325
           K  LG G +G VY G   K  + +AVK +  ++ + ++EF+ E   +  ++H NLVQLLG
Sbjct: 37  KHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 95
Query: 326 YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVI 385
            C  +    +V +YMP G+L  YL +  +  +  +    +   ++  + YL +   +  I
Sbjct: 96  VCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLEK---KNFI 152
Query: 386 HRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSA 445
           HRD+ A N L+      ++ DFGL+RL    T          + + APE       +  +
Sbjct: 153 HRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKS 212
Query: 446 DVFSFGAFLLEVA 458
           DV++FG  L E+A
Sbjct: 213 DVWAFGVLLWEIA 225

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 83/289 (28%), Positives = 128/289 (44%), Gaps = 37/289 (12%)
Query: 249 HRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAE 308
           H   YK++ +       +E++G G FG V +        ++A+K+I  ES +  K F+ E
Sbjct: 4   HMIDYKEIEV-------EEVVGRGAFGVVCKAKWRAK--DVAIKQIESESER--KAFIVE 52
Query: 309 IVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYD-QPKVTLNWIQRFRVIK 367
           +  + R+ H N+V+L G C     + LV +Y   GSL   L+  +P              
Sbjct: 53  LRQLSRVNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCL 110
Query: 368 GVALGLFYLHQEWEQVVIHRDVKASNVLL-DGELNGRLGDFGLARLYDHGTDPQT--THV 424
             + G+ YLH    + +IHRD+K  N+LL  G    ++ DFG A       D QT  T+ 
Sbjct: 111 QCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA------CDIQTHMTNN 164
Query: 425 VGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWN 484
            G+  ++APE       +   DVFS+G  L EV   R+P    G     I+  W      
Sbjct: 165 KGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM--WAVHNGT 222
Query: 485 RGELLEARDPNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQIL 533
           R  L++    NL                  C   DP+ RPSM ++V+I+
Sbjct: 223 RPPLIK----NLPKP--------IESLMTRCWSKDPSQRPSMEEIVKIM 259

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 99/193 (51%), Gaps = 4/193 (2%)
Query: 266 KELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLG 325
           K  LG G +G VY G   K  + +AVK +  ++ + ++EF+ E   +  ++H NLVQLLG
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 283
Query: 326 YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVI 385
            C R+    ++ ++M  G+L  YL +  +  ++ +    +   ++  + YL +   +  I
Sbjct: 284 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFI 340
Query: 386 HRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSA 445
           HR++ A N L+      ++ DFGL+RL    T          + + APE     K +  +
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 400
Query: 446 DVFSFGAFLLEVA 458
           DV++FG  L E+A
Sbjct: 401 DVWAFGVLLWEIA 413

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 83/289 (28%), Positives = 128/289 (44%), Gaps = 37/289 (12%)
Query: 249 HRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAE 308
           H   YK++ +       +E++G G FG V +        ++A+K+I  ES +  K F+ E
Sbjct: 3   HMIDYKEIEV-------EEVVGRGAFGVVCKAKWRAK--DVAIKQIESESER--KAFIVE 51
Query: 309 IVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYD-QPKVTLNWIQRFRVIK 367
           +  + R+ H N+V+L G C     + LV +Y   GSL   L+  +P              
Sbjct: 52  LRQLSRVNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCL 109
Query: 368 GVALGLFYLHQEWEQVVIHRDVKASNVLL-DGELNGRLGDFGLARLYDHGTDPQT--THV 424
             + G+ YLH    + +IHRD+K  N+LL  G    ++ DFG A       D QT  T+ 
Sbjct: 110 QCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA------CDIQTHMTNN 163
Query: 425 VGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWN 484
            G+  ++APE       +   DVFS+G  L EV   R+P    G     I+  W      
Sbjct: 164 KGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM--WAVHNGT 221
Query: 485 RGELLEARDPNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQIL 533
           R  L++    NL                  C   DP+ RPSM ++V+I+
Sbjct: 222 RPPLIK----NLPKP--------IESLMTRCWSKDPSQRPSMEEIVKIM 258

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 82/272 (30%), Positives = 128/272 (47%), Gaps = 33/272 (12%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCR 328
           LG+G FG V  G   K Q ++AVK I  E      EF  E  ++ +L H  LV+  G C 
Sbjct: 16  LGSGQFGVVKLGKW-KGQYDVAVKMIK-EGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCS 73
Query: 329 RKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYL--HQEWEQVVIH 386
           ++  + +V +Y+ NG L  YL    K  L   Q   +   V  G+ +L  HQ      IH
Sbjct: 74  KEYPIYIVTEYISNGCLLNYLRSHGK-GLEPSQLLEMCYDVCEGMAFLESHQ-----FIH 127
Query: 387 RDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT---LGYLAPEHTRTGKATT 443
           RD+ A N L+D +L  ++ DFG+ R   +  D Q    VGT   + + APE     K ++
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTR---YVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSS 184
Query: 444 SADVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVA 502
            +DV++FG  + EV + G+ P      SE ++ V       ++G  L    P+L ++ + 
Sbjct: 185 KSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKV-------SQGHRL--YRPHLASDTI- 234
Query: 503 XXXXXXXXXXXXCSHSDPTARPSMRQVVQILE 534
                       C H  P  RP+ +Q++  +E
Sbjct: 235 ------YQIMYSCWHELPEKRPTFQQLLSSIE 260

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 119/217 (54%), Gaps = 19/217 (8%)
Query: 258 IATKGFREKELLGTGGFGRVYRGTLP---KSQIEIAVK--KISHESRQGMKEFVAEIVSI 312
           I     + ++++G G FG V  G L    K +I +A+K  K  +  +Q  ++F++E   +
Sbjct: 26  IDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQ-RRDFLSEASIM 84
Query: 313 GRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYL-YDQPKVTLNWIQRFRVIKGVAL 371
           G+  H N++ L G   +   ++++ +YM NGSLD +L  +  + T+  IQ   +++G+  
Sbjct: 85  GQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTV--IQLVGMLRGIGS 142
Query: 372 GLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVG----T 427
           G+ YL    +   +HRD+ A N+L++  L  ++ DFG++R+ +   DP+  +        
Sbjct: 143 GMKYLS---DMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLED--DPEAAYTTRGGKIP 197
Query: 428 LGYLAPEHTRTGKATTSADVFSFGAFLLEV-ACGRRP 463
           + + APE     K T+++DV+S+G  + EV + G RP
Sbjct: 198 IRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 234

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 119/217 (54%), Gaps = 19/217 (8%)
Query: 258 IATKGFREKELLGTGGFGRVYRGTLP---KSQIEIAVK--KISHESRQGMKEFVAEIVSI 312
           I     + ++++G G FG V  G L    K +I +A+K  K  +  +Q  ++F++E   +
Sbjct: 5   IDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQ-RRDFLSEASIM 63
Query: 313 GRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYL-YDQPKVTLNWIQRFRVIKGVAL 371
           G+  H N++ L G   +   ++++ +YM NGSLD +L  +  + T+  IQ   +++G+  
Sbjct: 64  GQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTV--IQLVGMLRGIGS 121
Query: 372 GLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVG----T 427
           G+ YL    +   +HRD+ A N+L++  L  ++ DFG++R+ +   DP+  +        
Sbjct: 122 GMKYLS---DMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLED--DPEAAYTTRGGKIP 176
Query: 428 LGYLAPEHTRTGKATTSADVFSFGAFLLEV-ACGRRP 463
           + + APE     K T+++DV+S+G  + EV + G RP
Sbjct: 177 IRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 213

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 119/217 (54%), Gaps = 19/217 (8%)
Query: 258 IATKGFREKELLGTGGFGRVYRGTLP---KSQIEIAVK--KISHESRQGMKEFVAEIVSI 312
           I     + ++++G G FG V  G L    K +I +A+K  K  +  +Q  ++F++E   +
Sbjct: 11  IDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQ-RRDFLSEASIM 69
Query: 313 GRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYL-YDQPKVTLNWIQRFRVIKGVAL 371
           G+  H N++ L G   +   ++++ +YM NGSLD +L  +  + T+  IQ   +++G+  
Sbjct: 70  GQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTV--IQLVGMLRGIGS 127
Query: 372 GLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVG----T 427
           G+ YL    +   +HRD+ A N+L++  L  ++ DFG++R+ +   DP+  +        
Sbjct: 128 GMKYLS---DMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLED--DPEAAYTTRGGKIP 182
Query: 428 LGYLAPEHTRTGKATTSADVFSFGAFLLEV-ACGRRP 463
           + + APE     K T+++DV+S+G  + EV + G RP
Sbjct: 183 IRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 219

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 131/285 (45%), Gaps = 33/285 (11%)
Query: 266 KELLGTGGFGRVYRGTLP---KSQIEIAVK--KISHESRQGMKEFVAEIVSIGRLRHRNL 320
           ++++G+G  G V  G L    +  + +A+K  K  +  RQ  ++F++E   +G+  H N+
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQ-RRDFLSEASIMGQFDHPNI 112
Query: 321 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEW 380
           ++L G   R    ++V +YM NGSLD +L          +Q   +++GV  G+ YL    
Sbjct: 113 IRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDG-QFTIMQLVGMLRGVGAGMRYLS--- 168
Query: 381 EQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLG--YLAPEHTRT 438
           +   +HRD+ A NVL+D  L  ++ DFGL+R+ +   D   T   G +   + APE    
Sbjct: 169 DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPEAIAF 228
Query: 439 GKATTSADVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFWNRG--ELLEARDPN 495
              ++++DV+SFG  + EV A G RP                  +WN    +++ + +  
Sbjct: 229 RTFSSASDVWSFGVVMWEVLAYGERP------------------YWNMTNRDVISSVEEG 270
Query: 496 LGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQILERDVALP 540
                              C H D   RP   Q+V +L+  +  P
Sbjct: 271 YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP 315

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 131/285 (45%), Gaps = 33/285 (11%)
Query: 266 KELLGTGGFGRVYRGTLP---KSQIEIAVK--KISHESRQGMKEFVAEIVSIGRLRHRNL 320
           ++++G+G  G V  G L    +  + +A+K  K  +  RQ  ++F++E   +G+  H N+
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQ-RRDFLSEASIMGQFDHPNI 112
Query: 321 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEW 380
           ++L G   R    ++V +YM NGSLD +L          +Q   +++GV  G+ YL    
Sbjct: 113 IRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDG-QFTIMQLVGMLRGVGAGMRYLS--- 168
Query: 381 EQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLG--YLAPEHTRT 438
           +   +HRD+ A NVL+D  L  ++ DFGL+R+ +   D   T   G +   + APE    
Sbjct: 169 DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAF 228
Query: 439 GKATTSADVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFWNRG--ELLEARDPN 495
              ++++DV+SFG  + EV A G RP                  +WN    +++ + +  
Sbjct: 229 RTFSSASDVWSFGVVMWEVLAYGERP------------------YWNMTNRDVISSVEEG 270
Query: 496 LGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQILERDVALP 540
                              C H D   RP   Q+V +L+  +  P
Sbjct: 271 YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP 315

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 100/209 (47%), Gaps = 8/209 (3%)
Query: 258 IATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKI---SHESRQGMKEFVAEIVSIGR 314
           I  + ++  + LG GG   VY        I++A+K I     E  + +K F  E+ +  +
Sbjct: 8   IINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQ 67
Query: 315 LRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLF 374
           L H+N+V ++          LV +Y+   +L +Y+     ++++    F     +  G+ 
Sbjct: 68  LSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFT--NQILDGIK 125
Query: 375 YLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE 434
           + H   +  ++HRD+K  N+L+D     ++ DFG+A+     +  QT HV+GT+ Y +PE
Sbjct: 126 HAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPE 182
Query: 435 HTRTGKATTSADVFSFGAFLLEVACGRRP 463
             +        D++S G  L E+  G  P
Sbjct: 183 QAKGEATDECTDIYSIGIVLYEMLVGEPP 211

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 119/226 (52%), Gaps = 15/226 (6%)
Query: 259 ATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGM-KEFVAEIVSIGRLRH 317
           ++  F++ E LG G +  VY+G    + + +A+K++  +S +G     + EI  +  L+H
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH 62
Query: 318 RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLY-----DQPK-VTLNWIQRFRVIKGVAL 371
            N+V+L      + +L LV+++M N  L KY+      + P+ + LN ++ F+    +  
Sbjct: 63  ENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQW--QLLQ 119
Query: 372 GLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYL 431
           GL + H   E  ++HRD+K  N+L++     +LGDFGLAR +    +  ++ VV TL Y 
Sbjct: 120 GLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-TLWYR 175
Query: 432 APEHTRTGKA-TTSADVFSFGAFLLEVACGRRPIQRQGPSENLILV 476
           AP+     +  +TS D++S G  L E+  G+         E L L+
Sbjct: 176 APDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLI 221

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 102/216 (47%), Gaps = 21/216 (9%)
Query: 266 KELLGTGGFGRVYRGTL-----PKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNL 320
           K  LG G FG+V+          + +I +AVK +   S    K+F  E   +  L+H ++
Sbjct: 18  KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHI 77
Query: 321 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQ-----------PKVTLNWIQRFRVIKGV 369
           V+  G C     L++V++YM +G L+K+L              P   L   Q   + + +
Sbjct: 78  VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQI 137
Query: 370 ALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVGTL 428
           A G+ YL     Q  +HRD+   N L+   L  ++GDFG++R +Y         H +  +
Sbjct: 138 AAGMVYLA---SQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 194
Query: 429 GYLAPEHTRTGKATTSADVFSFGAFLLEV-ACGRRP 463
            ++ PE     K TT +DV+S G  L E+   G++P
Sbjct: 195 RWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 230

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 103/207 (49%), Gaps = 12/207 (5%)
Query: 268 LLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYC 327
           +LG G +G VY G    +Q+ IA+K+I     +  +    EI     L+H+N+VQ LG  
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 328 RRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRV-IKGVALGLFYLHQEWEQVVIH 386
              G + +  + +P GSL   L  +     +  Q      K +  GL YLH   +  ++H
Sbjct: 89  SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQIVH 145
Query: 387 RDVKASNVLLD---GELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKA-- 441
           RD+K  NVL++   G L  ++ DFG ++    G +P T    GTL Y+APE    G    
Sbjct: 146 RDIKGDNVLINTYSGVL--KISDFGTSKRL-AGINPCTETFTGTLQYMAPEIIDKGPRGY 202
Query: 442 TTSADVFSFGAFLLEVACGRRPIQRQG 468
             +AD++S G  ++E+A G+ P    G
Sbjct: 203 GKAADIWSLGCTIIEMATGKPPFYELG 229

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 72/263 (27%), Positives = 119/263 (45%), Gaps = 29/263 (11%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCR 328
           LGTG FG V  G   + Q ++A+K I  E      EF+ E   +  L H  LVQL G C 
Sbjct: 16  LGTGQFGVVKYGKW-RGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 73
Query: 329 RKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRD 388
           ++  + ++ +YM NG L  YL +  +      Q   + K V   + YL     +  +HRD
Sbjct: 74  KQRPIFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRD 129
Query: 389 VKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT---LGYLAPEHTRTGKATTSA 445
           + A N L++ +   ++ DFGL+R   +  D + T  VG+   + +  PE     K ++ +
Sbjct: 130 LAARNCLVNDQGVVKVSDFGLSR---YVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 186
Query: 446 DVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAXX 504
           D+++FG  + E+ + G+ P +R   SE    +          + L    P+L +E V   
Sbjct: 187 DIWAFGVLMWEIYSLGKMPYERFTNSETAEHI---------AQGLRLYRPHLASEKV--- 234
Query: 505 XXXXXXXXXXCSHSDPTARPSMR 527
                     C H     RP+ +
Sbjct: 235 ----YTIMYSCWHEKADERPTFK 253

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 109/218 (50%), Gaps = 8/218 (3%)
Query: 248 PHRFRYKDLY-IATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFV 306
           P +  ++D + +  +  +  E LG G FG V+ G       ++AVK +   S      F+
Sbjct: 8   PQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGS-MSPDAFL 65
Query: 307 AEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVI 366
           AE   + +L+H+ LV+L     ++  + ++ +YM NGSL  +L     + L   +   + 
Sbjct: 66  AEANLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMA 124
Query: 367 KGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVG 426
             +A G+ ++    E+  IHRD++A+N+L+   L+ ++ DFGLARL +            
Sbjct: 125 AQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKF 181
Query: 427 TLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRP 463
            + + APE    G  T  +DV+SFG  L E+   GR P
Sbjct: 182 PIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 219

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 105/210 (50%), Gaps = 12/210 (5%)
Query: 265 EKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLL 324
           ++ +LG G +G VY G    +Q+ IA+K+I     +  +    EI     L+H+N+VQ L
Sbjct: 12  DRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYL 71
Query: 325 GYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRV-IKGVALGLFYLHQEWEQV 383
           G     G + +  + +P GSL   L  +     +  Q      K +  GL YLH   +  
Sbjct: 72  GSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH---DNQ 128
Query: 384 VIHRDVKASNVLLD---GELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGK 440
           ++HRD+K  NVL++   G L  ++ DFG ++    G +P T    GTL Y+APE    G 
Sbjct: 129 IVHRDIKGDNVLINTYSGVL--KISDFGTSKRL-AGINPCTETFTGTLQYMAPEIIDKGP 185
Query: 441 A--TTSADVFSFGAFLLEVACGRRPIQRQG 468
                +AD++S G  ++E+A G+ P    G
Sbjct: 186 RGYGKAADIWSLGCTIIEMATGKPPFYELG 215

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 72/263 (27%), Positives = 119/263 (45%), Gaps = 29/263 (11%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCR 328
           LGTG FG V  G   + Q ++A+K I  E      EF+ E   +  L H  LVQL G C 
Sbjct: 32  LGTGQFGVVKYGKW-RGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 329 RKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRD 388
           ++  + ++ +YM NG L  YL +  +      Q   + K V   + YL     +  +HRD
Sbjct: 90  KQRPIFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRD 145
Query: 389 VKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT---LGYLAPEHTRTGKATTSA 445
           + A N L++ +   ++ DFGL+R   +  D + T  VG+   + +  PE     K ++ +
Sbjct: 146 LAARNCLVNDQGVVKVSDFGLSR---YVLDDEETSSVGSKFPVRWSPPEVLMYSKFSSKS 202
Query: 446 DVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAXX 504
           D+++FG  + E+ + G+ P +R   SE    +          + L    P+L +E V   
Sbjct: 203 DIWAFGVLMWEIYSLGKMPYERFTNSETAEHI---------AQGLRLYRPHLASEKV--- 250
Query: 505 XXXXXXXXXXCSHSDPTARPSMR 527
                     C H     RP+ +
Sbjct: 251 ----YTIMYSCWHEKADERPTFK 269

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 130/289 (44%), Gaps = 40/289 (13%)
Query: 266 KELLGTGGFGRV-----YRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNL 320
           K  LG G FG+V     Y  +  K ++ +AVK +   +    K+F  E   +  L+H ++
Sbjct: 20  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79
Query: 321 VQLLGYCRRKGELLLVYDYMPNGSLDKYLY--------------DQPKVTLNWIQRFRVI 366
           V+  G C     L++V++YM +G L+K+L                Q K  L   Q   + 
Sbjct: 80  VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 367 KGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVV 425
             +A G+ YL     Q  +HRD+   N L+   L  ++GDFG++R +Y         H +
Sbjct: 140 SQIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 196
Query: 426 GTLGYLAPEHTRTGKATTSADVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFWN 484
             + ++ PE     K TT +DV+SFG  L E+   G++P  +   +E       V +   
Sbjct: 197 LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE-------VIECIT 249
Query: 485 RGELLEARDPNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQIL 533
           +G +LE   P +  + V             C   +P  R +++++ +IL
Sbjct: 250 QGRVLER--PRVCPKEV-------YDVMLGCWQREPQQRLNIKEIYKIL 289

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 109/220 (49%), Gaps = 8/220 (3%)
Query: 246 HGPHRFRYKDLY-IATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKE 304
             P +  ++D + +  +  +  E LG G FG V+ G       ++AVK +   S      
Sbjct: 3   QKPQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGS-MSPDA 60
Query: 305 FVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFR 364
           F+AE   + +L+H+ LV+L     ++  + ++ +YM NGSL  +L     + L   +   
Sbjct: 61  FLAEANLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLD 119
Query: 365 VIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHV 424
           +   +A G+ ++    E+  IHRD++A+N+L+   L+ ++ DFGLARL +          
Sbjct: 120 MAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGA 176
Query: 425 VGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRP 463
              + + APE    G  T  +DV+SFG  L E+   GR P
Sbjct: 177 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 216

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 109/220 (49%), Gaps = 8/220 (3%)
Query: 246 HGPHRFRYKDLY-IATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKE 304
             P +  ++D + +  +  +  E LG G FG V+ G       ++AVK +   S      
Sbjct: 5   QKPQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGS-MSPDA 62
Query: 305 FVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFR 364
           F+AE   + +L+H+ LV+L     ++  + ++ +YM NGSL  +L     + L   +   
Sbjct: 63  FLAEANLMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLD 121
Query: 365 VIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHV 424
           +   +A G+ ++    E+  IHRD++A+N+L+   L+ ++ DFGLARL +          
Sbjct: 122 MAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGA 178
Query: 425 VGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRP 463
              + + APE    G  T  +DV+SFG  L E+   GR P
Sbjct: 179 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 218

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 109/218 (50%), Gaps = 8/218 (3%)
Query: 248 PHRFRYKDLY-IATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFV 306
           P +  ++D + +  +  +  E LG G FG V+ G       ++AVK +   S      F+
Sbjct: 1   PQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGS-MSPDAFL 58
Query: 307 AEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVI 366
           AE   + +L+H+ LV+L     ++  + ++ +YM NGSL  +L     + L   +   + 
Sbjct: 59  AEANLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMA 117
Query: 367 KGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVG 426
             +A G+ ++    E+  IHRD++A+N+L+   L+ ++ DFGLARL +            
Sbjct: 118 AQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKF 174
Query: 427 TLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRP 463
            + + APE    G  T  +DV+SFG  L E+   GR P
Sbjct: 175 PIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 212

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 72/263 (27%), Positives = 119/263 (45%), Gaps = 29/263 (11%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCR 328
           LGTG FG V  G   + Q ++A+K I  E      EF+ E   +  L H  LVQL G C 
Sbjct: 17  LGTGQFGVVKYGKW-RGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 74
Query: 329 RKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRD 388
           ++  + ++ +YM NG L  YL +  +      Q   + K V   + YL     +  +HRD
Sbjct: 75  KQRPIFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRD 130
Query: 389 VKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT---LGYLAPEHTRTGKATTSA 445
           + A N L++ +   ++ DFGL+R   +  D + T  VG+   + +  PE     K ++ +
Sbjct: 131 LAARNCLVNDQGVVKVSDFGLSR---YVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 187
Query: 446 DVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAXX 504
           D+++FG  + E+ + G+ P +R   SE    +          + L    P+L +E V   
Sbjct: 188 DIWAFGVLMWEIYSLGKMPYERFTNSETAEHI---------AQGLRLYRPHLASEKV--- 235
Query: 505 XXXXXXXXXXCSHSDPTARPSMR 527
                     C H     RP+ +
Sbjct: 236 ----YTIMYSCWHEKADERPTFK 254

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 72/263 (27%), Positives = 119/263 (45%), Gaps = 29/263 (11%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCR 328
           LGTG FG V  G   + Q ++A+K I  E      EF+ E   +  L H  LVQL G C 
Sbjct: 12  LGTGQFGVVKYGKW-RGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 69
Query: 329 RKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRD 388
           ++  + ++ +YM NG L  YL +  +      Q   + K V   + YL     +  +HRD
Sbjct: 70  KQRPIFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRD 125
Query: 389 VKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT---LGYLAPEHTRTGKATTSA 445
           + A N L++ +   ++ DFGL+R   +  D + T  VG+   + +  PE     K ++ +
Sbjct: 126 LAARNCLVNDQGVVKVSDFGLSR---YVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 182
Query: 446 DVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAXX 504
           D+++FG  + E+ + G+ P +R   SE    +          + L    P+L +E V   
Sbjct: 183 DIWAFGVLMWEIYSLGKMPYERFTNSETAEHI---------AQGLRLYRPHLASEKV--- 230
Query: 505 XXXXXXXXXXCSHSDPTARPSMR 527
                     C H     RP+ +
Sbjct: 231 ----YTIMYSCWHEKADERPTFK 249

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 72/263 (27%), Positives = 119/263 (45%), Gaps = 29/263 (11%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCR 328
           LGTG FG V  G   + Q ++A+K I  E      EF+ E   +  L H  LVQL G C 
Sbjct: 32  LGTGQFGVVKYGKW-RGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 329 RKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRD 388
           ++  + ++ +YM NG L  YL +  +      Q   + K V   + YL     +  +HRD
Sbjct: 90  KQRPIFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRD 145
Query: 389 VKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT---LGYLAPEHTRTGKATTSA 445
           + A N L++ +   ++ DFGL+R   +  D + T  VG+   + +  PE     K ++ +
Sbjct: 146 LAARNCLVNDQGVVKVSDFGLSR---YVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 202
Query: 446 DVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAXX 504
           D+++FG  + E+ + G+ P +R   SE    +          + L    P+L +E V   
Sbjct: 203 DIWAFGVLMWEIYSLGKMPYERFTNSETAEHI---------AQGLRLYRPHLASEKV--- 250
Query: 505 XXXXXXXXXXCSHSDPTARPSMR 527
                     C H     RP+ +
Sbjct: 251 ----YTIMYSCWHEKADERPTFK 269

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 100/198 (50%), Gaps = 7/198 (3%)
Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
           E LG G FG V+ G       ++AVK +   S      F+AE   + +L+H+ LV+L   
Sbjct: 19  ERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 327 CRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIH 386
             ++  + ++ +YM NGSL  +L     + L   +   +   +A G+ ++    E+  IH
Sbjct: 77  VTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIH 132
Query: 387 RDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSAD 446
           RD++A+N+L+   L+ ++ DFGLARL +             + + APE    G  T  +D
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSD 192
Query: 447 VFSFGAFLLEVAC-GRRP 463
           V+SFG  L E+   GR P
Sbjct: 193 VWSFGILLTEIVTHGRIP 210

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 100/198 (50%), Gaps = 7/198 (3%)
Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
           E LG G FG V+ G       ++AVK +   S      F+AE   + +L+H+ LV+L   
Sbjct: 19  ERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 327 CRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIH 386
             ++  + ++ +YM NGSL  +L     + L   +   +   +A G+ ++    E+  IH
Sbjct: 77  VTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIH 132
Query: 387 RDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSAD 446
           RD++A+N+L+   L+ ++ DFGLARL +             + + APE    G  T  +D
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSD 192
Query: 447 VFSFGAFLLEVAC-GRRP 463
           V+SFG  L E+   GR P
Sbjct: 193 VWSFGILLTEIVTHGRIP 210

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 72/263 (27%), Positives = 119/263 (45%), Gaps = 29/263 (11%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCR 328
           LGTG FG V  G   + Q ++A+K I  E      EF+ E   +  L H  LVQL G C 
Sbjct: 23  LGTGQFGVVKYGKW-RGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 80
Query: 329 RKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRD 388
           ++  + ++ +YM NG L  YL +  +      Q   + K V   + YL     +  +HRD
Sbjct: 81  KQRPIFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRD 136
Query: 389 VKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT---LGYLAPEHTRTGKATTSA 445
           + A N L++ +   ++ DFGL+R   +  D + T  VG+   + +  PE     K ++ +
Sbjct: 137 LAARNCLVNDQGVVKVSDFGLSR---YVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 193
Query: 446 DVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAXX 504
           D+++FG  + E+ + G+ P +R   SE    +          + L    P+L +E V   
Sbjct: 194 DIWAFGVLMWEIYSLGKMPYERFTNSETAEHI---------AQGLRLYRPHLASEKV--- 241
Query: 505 XXXXXXXXXXCSHSDPTARPSMR 527
                     C H     RP+ +
Sbjct: 242 ----YTIMYSCWHEKADERPTFK 260

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 100/198 (50%), Gaps = 7/198 (3%)
Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
           E LG G FG V+ G       ++AVK +   S      F+AE   + +L+H+ LV+L   
Sbjct: 20  ERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAV 77
Query: 327 CRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIH 386
             ++  + ++ +YM NGSL  +L     + L   +   +   +A G+ ++    E+  IH
Sbjct: 78  VTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIH 133
Query: 387 RDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSAD 446
           RD++A+N+L+   L+ ++ DFGLARL +             + + APE    G  T  +D
Sbjct: 134 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSD 193
Query: 447 VFSFGAFLLEVAC-GRRP 463
           V+SFG  L E+   GR P
Sbjct: 194 VWSFGILLTEIVTHGRIP 211

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 103/208 (49%), Gaps = 17/208 (8%)
Query: 263 FREKEL-----LGTGGFGRV----YRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIG 313
           F E+ L     LG G FG V    Y      +   +AVKK+ H + + +++F  EI  + 
Sbjct: 14  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 73
Query: 314 RLRHRNLVQLLGYCRRKGE--LLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVAL 371
            L+H N+V+  G C   G   L L+ +Y+P GSL  YL  + K  ++ I+  +    +  
Sbjct: 74  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICK 132
Query: 372 GLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT--LG 429
           G+ YL     +  IHRD+   N+L++ E   ++GDFGL ++     +       G   + 
Sbjct: 133 GMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 189
Query: 430 YLAPEHTRTGKATTSADVFSFGAFLLEV 457
           + APE     K + ++DV+SFG  L E+
Sbjct: 190 WYAPESLTESKFSVASDVWSFGVVLYEL 217

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 103/208 (49%), Gaps = 17/208 (8%)
Query: 263 FREKEL-----LGTGGFGRV----YRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIG 313
           F E+ L     LG G FG V    Y      +   +AVKK+ H + + +++F  EI  + 
Sbjct: 12  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 71
Query: 314 RLRHRNLVQLLGYCRRKGE--LLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVAL 371
            L+H N+V+  G C   G   L L+ +Y+P GSL  YL  + K  ++ I+  +    +  
Sbjct: 72  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICK 130
Query: 372 GLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT--LG 429
           G+ YL     +  IHRD+   N+L++ E   ++GDFGL ++     +       G   + 
Sbjct: 131 GMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 187
Query: 430 YLAPEHTRTGKATTSADVFSFGAFLLEV 457
           + APE     K + ++DV+SFG  L E+
Sbjct: 188 WYAPESLTESKFSVASDVWSFGVVLYEL 215

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 103/208 (49%), Gaps = 17/208 (8%)
Query: 263 FREKEL-----LGTGGFGRV----YRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIG 313
           F E+ L     LG G FG V    Y      +   +AVKK+ H + + +++F  EI  + 
Sbjct: 11  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 70
Query: 314 RLRHRNLVQLLGYCRRKGE--LLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVAL 371
            L+H N+V+  G C   G   L L+ +Y+P GSL  YL  + K  ++ I+  +    +  
Sbjct: 71  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICK 129
Query: 372 GLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT--LG 429
           G+ YL     +  IHRD+   N+L++ E   ++GDFGL ++     +       G   + 
Sbjct: 130 GMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 186
Query: 430 YLAPEHTRTGKATTSADVFSFGAFLLEV 457
           + APE     K + ++DV+SFG  L E+
Sbjct: 187 WYAPESLTESKFSVASDVWSFGVVLYEL 214

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 88.6 bits (218), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 103/208 (49%), Gaps = 17/208 (8%)
Query: 263 FREKEL-----LGTGGFGRV----YRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIG 313
           F E+ L     LG G FG V    Y      +   +AVKK+ H + + +++F  EI  + 
Sbjct: 38  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 97
Query: 314 RLRHRNLVQLLGYCRRKGE--LLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVAL 371
            L+H N+V+  G C   G   L L+ +Y+P GSL  YL  + K  ++ I+  +    +  
Sbjct: 98  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICK 156
Query: 372 GLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT--LG 429
           G+ YL     +  IHRD+   N+L++ E   ++GDFGL ++     +       G   + 
Sbjct: 157 GMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 213
Query: 430 YLAPEHTRTGKATTSADVFSFGAFLLEV 457
           + APE     K + ++DV+SFG  L E+
Sbjct: 214 WYAPESLTESKFSVASDVWSFGVVLYEL 241

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 103/208 (49%), Gaps = 17/208 (8%)
Query: 263 FREKEL-----LGTGGFGRV----YRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIG 313
           F E+ L     LG G FG V    Y      +   +AVKK+ H + + +++F  EI  + 
Sbjct: 10  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 69
Query: 314 RLRHRNLVQLLGYCRRKGE--LLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVAL 371
            L+H N+V+  G C   G   L L+ +Y+P GSL  YL  + K  ++ I+  +    +  
Sbjct: 70  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICK 128
Query: 372 GLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT--LG 429
           G+ YL     +  IHRD+   N+L++ E   ++GDFGL ++     +       G   + 
Sbjct: 129 GMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 185
Query: 430 YLAPEHTRTGKATTSADVFSFGAFLLEV 457
           + APE     K + ++DV+SFG  L E+
Sbjct: 186 WYAPESLTESKFSVASDVWSFGVVLYEL 213

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 103/208 (49%), Gaps = 17/208 (8%)
Query: 263 FREKEL-----LGTGGFGRV----YRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIG 313
           F E+ L     LG G FG V    Y      +   +AVKK+ H + + +++F  EI  + 
Sbjct: 7   FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 66
Query: 314 RLRHRNLVQLLGYCRRKGE--LLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVAL 371
            L+H N+V+  G C   G   L L+ +Y+P GSL  YL  + K  ++ I+  +    +  
Sbjct: 67  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICK 125
Query: 372 GLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT--LG 429
           G+ YL     +  IHRD+   N+L++ E   ++GDFGL ++     +       G   + 
Sbjct: 126 GMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 182
Query: 430 YLAPEHTRTGKATTSADVFSFGAFLLEV 457
           + APE     K + ++DV+SFG  L E+
Sbjct: 183 WYAPESLTESKFSVASDVWSFGVVLYEL 210

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 103/208 (49%), Gaps = 17/208 (8%)
Query: 263 FREKEL-----LGTGGFGRV----YRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIG 313
           F E+ L     LG G FG V    Y      +   +AVKK+ H + + +++F  EI  + 
Sbjct: 13  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 72
Query: 314 RLRHRNLVQLLGYCRRKGE--LLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVAL 371
            L+H N+V+  G C   G   L L+ +Y+P GSL  YL  + K  ++ I+  +    +  
Sbjct: 73  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICK 131
Query: 372 GLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT--LG 429
           G+ YL     +  IHRD+   N+L++ E   ++GDFGL ++     +       G   + 
Sbjct: 132 GMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 188
Query: 430 YLAPEHTRTGKATTSADVFSFGAFLLEV 457
           + APE     K + ++DV+SFG  L E+
Sbjct: 189 WYAPESLTESKFSVASDVWSFGVVLYEL 216

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 103/208 (49%), Gaps = 17/208 (8%)
Query: 263 FREKEL-----LGTGGFGRV----YRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIG 313
           F E+ L     LG G FG V    Y      +   +AVKK+ H + + +++F  EI  + 
Sbjct: 6   FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 65
Query: 314 RLRHRNLVQLLGYCRRKGE--LLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVAL 371
            L+H N+V+  G C   G   L L+ +Y+P GSL  YL  + K  ++ I+  +    +  
Sbjct: 66  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICK 124
Query: 372 GLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT--LG 429
           G+ YL     +  IHRD+   N+L++ E   ++GDFGL ++     +       G   + 
Sbjct: 125 GMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 181
Query: 430 YLAPEHTRTGKATTSADVFSFGAFLLEV 457
           + APE     K + ++DV+SFG  L E+
Sbjct: 182 WYAPESLTESKFSVASDVWSFGVVLYEL 209

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 103/208 (49%), Gaps = 17/208 (8%)
Query: 263 FREKEL-----LGTGGFGRV----YRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIG 313
           F E+ L     LG G FG V    Y      +   +AVKK+ H + + +++F  EI  + 
Sbjct: 7   FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 66
Query: 314 RLRHRNLVQLLGYCRRKGE--LLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVAL 371
            L+H N+V+  G C   G   L L+ +Y+P GSL  YL  + K  ++ I+  +    +  
Sbjct: 67  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICK 125
Query: 372 GLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT--LG 429
           G+ YL     +  IHRD+   N+L++ E   ++GDFGL ++     +       G   + 
Sbjct: 126 GMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 182
Query: 430 YLAPEHTRTGKATTSADVFSFGAFLLEV 457
           + APE     K + ++DV+SFG  L E+
Sbjct: 183 WYAPESLTESKFSVASDVWSFGVVLYEL 210

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 107/223 (47%), Gaps = 13/223 (5%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES--RQGMKEFVAEIVSI-GRLRHRN 319
           F+   LLG G F  VYR     + +E+A+K I  ++  + GM + V   V I  +L+H +
Sbjct: 13  FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPS 72
Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPK-VTLNWIQRFRVIKGVALGLFYLHQ 378
           +++L  Y      + LV +   NG +++YL ++ K  + N  + F  +  +  G+ YLH 
Sbjct: 73  ILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHF--MHQIITGMLYLHS 130
Query: 379 EWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRT 438
                ++HRD+  SN+LL   +N ++ DFGLA       +   T + GT  Y++PE    
Sbjct: 131 HG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPEIATR 186
Query: 439 GKATTSADVFSFGAFLLEVACGRRPIQRQGPSENL---ILVDW 478
                 +DV+S G     +  GR P         L   +L D+
Sbjct: 187 SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADY 229

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 103/208 (49%), Gaps = 17/208 (8%)
Query: 263 FREKEL-----LGTGGFGRV----YRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIG 313
           F E+ L     LG G FG V    Y      +   +AVKK+ H + + +++F  EI  + 
Sbjct: 5   FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 64
Query: 314 RLRHRNLVQLLGYCRRKGE--LLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVAL 371
            L+H N+V+  G C   G   L L+ +Y+P GSL  YL  + K  ++ I+  +    +  
Sbjct: 65  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICK 123
Query: 372 GLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT--LG 429
           G+ YL     +  IHRD+   N+L++ E   ++GDFGL ++     +       G   + 
Sbjct: 124 GMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 180
Query: 430 YLAPEHTRTGKATTSADVFSFGAFLLEV 457
           + APE     K + ++DV+SFG  L E+
Sbjct: 181 WYAPESLTESKFSVASDVWSFGVVLYEL 208

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 85/276 (30%), Positives = 125/276 (45%), Gaps = 41/276 (14%)
Query: 267 ELLGTGGFGRV----YRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQ 322
           + +G G FG V    YRG       ++AVK I +++    + F+AE   + +LRH NLVQ
Sbjct: 27  QTIGKGEFGDVMLGDYRGN------KVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQ 78
Query: 323 LLGY-CRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
           LLG     KG L +V +YM  GSL  YL  + +  L      +    V   + YL     
Sbjct: 79  LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG--- 135
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTL--GYLAPEHTRTG 439
              +HRD+ A NVL+  +   ++ DFGL +      +  +T   G L   + APE  R  
Sbjct: 136 NNFVHRDLAARNVLVSEDNVAKVSDFGLTK------EASSTQDTGKLPVKWTAPEALREK 189
Query: 440 KATTSADVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGT 498
           K +T +DV+SFG  L E+ + GR P  R    + +  V+       +G  ++A D     
Sbjct: 190 KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-------KGYKMDAPDGCPPA 242
Query: 499 EYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQILE 534
            Y              C H D   RPS  Q+ + LE
Sbjct: 243 VY---------EVMKNCWHLDAAMRPSFLQLREQLE 269

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 85/276 (30%), Positives = 125/276 (45%), Gaps = 41/276 (14%)
Query: 267 ELLGTGGFGRV----YRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQ 322
           + +G G FG V    YRG       ++AVK I +++    + F+AE   + +LRH NLVQ
Sbjct: 12  QTIGKGEFGDVMLGDYRGN------KVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQ 63
Query: 323 LLGY-CRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
           LLG     KG L +V +YM  GSL  YL  + +  L      +    V   + YL     
Sbjct: 64  LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG--- 120
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTL--GYLAPEHTRTG 439
              +HRD+ A NVL+  +   ++ DFGL +      +  +T   G L   + APE  R  
Sbjct: 121 NNFVHRDLAARNVLVSEDNVAKVSDFGLTK------EASSTQDTGKLPVKWTAPEALREK 174
Query: 440 KATTSADVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGT 498
           K +T +DV+SFG  L E+ + GR P  R    + +  V+       +G  ++A D     
Sbjct: 175 KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-------KGYKMDAPDGCPPA 227
Query: 499 EYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQILE 534
            Y              C H D   RPS  Q+ + LE
Sbjct: 228 VY---------EVMKNCWHLDAAMRPSFLQLREQLE 254

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 103/208 (49%), Gaps = 17/208 (8%)
Query: 263 FREKEL-----LGTGGFGRV----YRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIG 313
           F E+ L     LG G FG V    Y      +   +AVKK+ H + + +++F  EI  + 
Sbjct: 25  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 84
Query: 314 RLRHRNLVQLLGYCRRKGE--LLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVAL 371
            L+H N+V+  G C   G   L L+ +Y+P GSL  YL  + K  ++ I+  +    +  
Sbjct: 85  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICK 143
Query: 372 GLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT--LG 429
           G+ YL     +  IHRD+   N+L++ E   ++GDFGL ++     +       G   + 
Sbjct: 144 GMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 200
Query: 430 YLAPEHTRTGKATTSADVFSFGAFLLEV 457
           + APE     K + ++DV+SFG  L E+
Sbjct: 201 WYAPESLTESKFSVASDVWSFGVVLYEL 228

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 109/220 (49%), Gaps = 8/220 (3%)
Query: 246 HGPHRFRYKDLY-IATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKE 304
             P +  ++D + +  +  +  E LG G FG V+ G       ++AVK +   S      
Sbjct: 2   QKPQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGS-MSPDA 59
Query: 305 FVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFR 364
           F+AE   + +L+H+ LV+L     ++  + ++ +YM NGSL  +L     + L   +   
Sbjct: 60  FLAEANLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLD 118
Query: 365 VIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHV 424
           +   +A G+ ++    E+  IHRD++A+N+L+   L+ ++ DFGLARL +          
Sbjct: 119 MAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGA 175
Query: 425 VGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRP 463
              + + APE    G  T  +DV+SFG  L E+   GR P
Sbjct: 176 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 215

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 103/208 (49%), Gaps = 17/208 (8%)
Query: 263 FREKEL-----LGTGGFGRV----YRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIG 313
           F E+ L     LG G FG V    Y      +   +AVKK+ H + + +++F  EI  + 
Sbjct: 25  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 84
Query: 314 RLRHRNLVQLLGYCRRKGE--LLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVAL 371
            L+H N+V+  G C   G   L L+ +Y+P GSL  YL  + K  ++ I+  +    +  
Sbjct: 85  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICK 143
Query: 372 GLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT--LG 429
           G+ YL     +  IHRD+   N+L++ E   ++GDFGL ++     +       G   + 
Sbjct: 144 GMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 200
Query: 430 YLAPEHTRTGKATTSADVFSFGAFLLEV 457
           + APE     K + ++DV+SFG  L E+
Sbjct: 201 WYAPESLTESKFSVASDVWSFGVVLYEL 228

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 109/220 (49%), Gaps = 8/220 (3%)
Query: 246 HGPHRFRYKDLY-IATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKE 304
             P +  ++D + +  +  +  E LG G FG V+ G       ++AVK +   S      
Sbjct: 3   QKPQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGS-MSPDA 60
Query: 305 FVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFR 364
           F+AE   + +L+H+ LV+L     ++  + ++ +YM NGSL  +L     + L   +   
Sbjct: 61  FLAEANLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLD 119
Query: 365 VIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHV 424
           +   +A G+ ++    E+  IHRD++A+N+L+   L+ ++ DFGLARL +          
Sbjct: 120 MAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGA 176
Query: 425 VGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRP 463
              + + APE    G  T  +DV+SFG  L E+   GR P
Sbjct: 177 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 216

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 109/218 (50%), Gaps = 8/218 (3%)
Query: 248 PHRFRYKDLY-IATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFV 306
           P +  ++D + +  +  +  E LG G FG V+ G       ++AVK +   S      F+
Sbjct: 9   PQKPWWEDEWEVPRETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGS-MSPDAFL 66
Query: 307 AEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVI 366
           AE   + +L+H+ LV+L     ++  + ++ +YM NGSL  +L     + L   +   + 
Sbjct: 67  AEANLMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMA 125
Query: 367 KGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVG 426
             +A G+ ++    E+  IHRD++A+N+L+   L+ ++ DFGLARL +            
Sbjct: 126 AQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF 182
Query: 427 TLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRP 463
            + + APE    G  T  +DV+SFG  L E+   GR P
Sbjct: 183 PIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 220

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 100/198 (50%), Gaps = 7/198 (3%)
Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
           E LG G FG V+ G       ++AVK +   S      F+AE   + +L+H+ LV+L   
Sbjct: 19  ERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 327 CRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIH 386
             ++  + ++ +YM NGSL  +L     + L   +   +   +A G+ ++    E+  IH
Sbjct: 77  VTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIH 132
Query: 387 RDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSAD 446
           RD++A+N+L+   L+ ++ DFGLARL +             + + APE    G  T  +D
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSD 192
Query: 447 VFSFGAFLLEVAC-GRRP 463
           V+SFG  L E+   GR P
Sbjct: 193 VWSFGILLTEIVTHGRIP 210

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 100/198 (50%), Gaps = 7/198 (3%)
Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
           E LG G FG V+ G       ++AVK +   S      F+AE   + +L+H+ LV+L   
Sbjct: 14  ERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAV 71
Query: 327 CRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIH 386
             ++  + ++ +YM NGSL  +L     + L   +   +   +A G+ ++    E+  IH
Sbjct: 72  VTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIH 127
Query: 387 RDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSAD 446
           RD++A+N+L+   L+ ++ DFGLARL +             + + APE    G  T  +D
Sbjct: 128 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSD 187
Query: 447 VFSFGAFLLEVAC-GRRP 463
           V+SFG  L E+   GR P
Sbjct: 188 VWSFGILLTEIVTHGRIP 205

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 104/208 (50%), Gaps = 17/208 (8%)
Query: 263 FREKEL-----LGTGGFGRV----YRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIG 313
           F E+ L     LG G FG V    Y      +   +AVKK+ H + + +++F  EI  + 
Sbjct: 10  FEERHLKFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 69
Query: 314 RLRHRNLVQLLGYCRRKGE--LLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVAL 371
            L+H N+V+  G C   G   L L+ +++P GSL +YL  + K  ++ I+  +    +  
Sbjct: 70  SLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYL-QKHKERIDHIKLLQYTSQICK 128
Query: 372 GLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT--LG 429
           G+ YL     +  IHRD+   N+L++ E   ++GDFGL ++     +       G   + 
Sbjct: 129 GMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 185
Query: 430 YLAPEHTRTGKATTSADVFSFGAFLLEV 457
           + APE     K + ++DV+SFG  L E+
Sbjct: 186 WYAPESLTESKFSVASDVWSFGVVLYEL 213

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 84/276 (30%), Positives = 125/276 (45%), Gaps = 41/276 (14%)
Query: 267 ELLGTGGFGRV----YRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQ 322
           + +G G FG V    YRG       ++AVK I +++    + F+AE   + +LRH NLVQ
Sbjct: 199 QTIGKGEFGDVMLGDYRGN------KVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQ 250
Query: 323 LLGY-CRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
           LLG     KG L +V +YM  GSL  YL  + +  L      +    V   + YL     
Sbjct: 251 LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG--- 307
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTL--GYLAPEHTRTG 439
              +HRD+ A NVL+  +   ++ DFGL +      +  +T   G L   + APE  R  
Sbjct: 308 NNFVHRDLAARNVLVSEDNVAKVSDFGLTK------EASSTQDTGKLPVKWTAPEALREK 361
Query: 440 KATTSADVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGT 498
           K +T +DV+SFG  L E+ + GR P  R    + +  V+       +G  ++A D     
Sbjct: 362 KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-------KGYKMDAPDGCPPA 414
Query: 499 EYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQILE 534
            Y              C H D   RP+  Q+ + LE
Sbjct: 415 VY---------DVMKNCWHLDAATRPTFLQLREQLE 441

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/201 (33%), Positives = 107/201 (53%), Gaps = 16/201 (7%)
Query: 267 ELLGTGGFGRVYRGTLPKS---QIEIAVKKISHESRQG-MKEFVAEIVSIGRLRHRNLVQ 322
           E++G G FG VY GTL  +   +I  AVK ++  +  G + +F+ E + +    H N++ 
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 323 LLGYC-RRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKG--VALGLFYLHQE 379
           LLG C R +G  L+V  YM +G L  ++ ++   T N   +  +  G  VA G+ +L   
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLAS- 210
Query: 380 WEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVGTL--GYLAPEHT 436
             +  +HRD+ A N +LD +   ++ DFGLAR +YD   D         L   ++A E  
Sbjct: 211 --KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 268
Query: 437 RTGKATTSADVFSFGAFLLEV 457
           +T K TT +DV+SFG  L E+
Sbjct: 269 QTQKFTTKSDVWSFGVLLWEL 289

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 107/214 (50%), Gaps = 14/214 (6%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVK--KISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
           +G+G FG VY+G   K   ++AVK  K+   + +  + F  E+  + + RH N++  +GY
Sbjct: 44  IGSGSFGTVYKG---KWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGY 100
Query: 327 CRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIH 386
              K  L +V  +    SL K+L+ Q +      Q   + +  A G+ YLH    + +IH
Sbjct: 101 MT-KDNLAIVTQWCEGSSLYKHLHVQ-ETKFQMFQLIDIARQTAQGMDYLH---AKNIIH 155
Query: 387 RDVKASNVLLDGELNGRLGDFGLARLYDHGT-DPQTTHVVGTLGYLAPEHTR---TGKAT 442
           RD+K++N+ L   L  ++GDFGLA +    +   Q     G++ ++APE  R       +
Sbjct: 156 RDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFS 215
Query: 443 TSADVFSFGAFLLEVACGRRPIQRQGPSENLILV 476
             +DV+S+G  L E+  G  P       + +I +
Sbjct: 216 FQSDVYSYGIVLYELMTGELPYSHINNRDQIIFM 249

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 79/296 (26%), Positives = 135/296 (45%), Gaps = 44/296 (14%)
Query: 269 LGTGGFGRVYRGTL-------PKSQIEIAVKKISHE-SRQGMKEFVAEIVSIGRL-RHRN 319
           LG G FG+V            PK  + +AVK +  + + + + + V+E+  +  + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYL-----------YD---QPKVTLNWIQRFRV 365
           ++ LLG C + G L ++ +Y   G+L +YL           YD    P+  + +      
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSC 162
Query: 366 IKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHV 424
              +A G+ YL     Q  IHRD+ A NVL+      ++ DFGLAR + +     +TT+ 
Sbjct: 163 TYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 425 VGTLGYLAPEHTRTGKATTSADVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFW 483
              + ++APE       T  +DV+SFG  + E+   G  P     P    I V+ +F   
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY----PG---IPVEELFKLL 272
Query: 484 NRGELLEARDPNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQILERDVAL 539
             G  ++ +  N   E               C H+ P+ RP+ +Q+V+ L+R + L
Sbjct: 273 KEGHRMD-KPANCTNELY--------MMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 79/296 (26%), Positives = 135/296 (45%), Gaps = 44/296 (14%)
Query: 269 LGTGGFGRVYRGTL-------PKSQIEIAVKKISHE-SRQGMKEFVAEIVSIGRL-RHRN 319
           LG G FG+V            PK  + +AVK +  + + + + + V+E+  +  + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYL-----------YD---QPKVTLNWIQRFRV 365
           ++ LLG C + G L ++ +Y   G+L +YL           YD    P+  + +      
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 366 IKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHV 424
              +A G+ YL     Q  IHRD+ A NVL+      ++ DFGLAR + +     +TT+ 
Sbjct: 163 TYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 425 VGTLGYLAPEHTRTGKATTSADVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFW 483
              + ++APE       T  +DV+SFG  + E+   G  P     P    I V+ +F   
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY----PG---IPVEELFKLL 272
Query: 484 NRGELLEARDPNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQILERDVAL 539
             G  ++ +  N   E               C H+ P+ RP+ +Q+V+ L+R + L
Sbjct: 273 KEGHRMD-KPANCTNELY--------MMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 85/282 (30%), Positives = 126/282 (44%), Gaps = 41/282 (14%)
Query: 261 KGFREKELLGTGGFGRV----YRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLR 316
           K  +  + +G G FG V    YRG       ++AVK I +++    + F+AE   + +LR
Sbjct: 12  KELKLLQTIGKGEFGDVMLGDYRGN------KVAVKCIKNDATA--QAFLAEASVMTQLR 63
Query: 317 HRNLVQLLGY-CRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFY 375
           H NLVQLLG     KG L +V +YM  GSL  YL  + +  L      +    V   + Y
Sbjct: 64  HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEY 123
Query: 376 LHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTL--GYLAP 433
           L        +HRD+ A NVL+  +   ++ DFGL +      +  +T   G L   + AP
Sbjct: 124 LEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTK------EASSTQDTGKLPVKWTAP 174
Query: 434 EHTRTGKATTSADVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFWNRGELLEAR 492
           E  R    +T +DV+SFG  L E+ + GR P  R    + +  V+       +G  ++A 
Sbjct: 175 EALREAAFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-------KGYKMDAP 227
Query: 493 DPNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQILE 534
           D      Y              C H D   RPS  Q+ + LE
Sbjct: 228 DGCPPAVY---------EVMKNCWHLDAAMRPSFLQLREQLE 260

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 102/208 (49%), Gaps = 17/208 (8%)
Query: 263 FREKEL-----LGTGGFGRV----YRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIG 313
           F E+ L     LG G FG V    Y      +   +AVKK+ H + + +++F  EI  + 
Sbjct: 10  FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 69
Query: 314 RLRHRNLVQLLGYCRRKGE--LLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVAL 371
            L+H N+V+  G C   G   L L+ +Y+P GSL  YL    +  ++ I+  +    +  
Sbjct: 70  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAE-RIDHIKLLQYTSQICK 128
Query: 372 GLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT--LG 429
           G+ YL     +  IHRD+   N+L++ E   ++GDFGL ++     +       G   + 
Sbjct: 129 GMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIF 185
Query: 430 YLAPEHTRTGKATTSADVFSFGAFLLEV 457
           + APE     K + ++DV+SFG  L E+
Sbjct: 186 WYAPESLTESKFSVASDVWSFGVVLYEL 213

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 68/201 (33%), Positives = 107/201 (53%), Gaps = 16/201 (7%)
Query: 267 ELLGTGGFGRVYRGTLPKS---QIEIAVKKISHESRQG-MKEFVAEIVSIGRLRHRNLVQ 322
           E++G G FG VY GTL  +   +I  AVK ++  +  G + +F+ E + +    H N++ 
Sbjct: 41  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 100
Query: 323 LLGYC-RRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKG--VALGLFYLHQE 379
           LLG C R +G  L+V  YM +G L  ++ ++   T N   +  +  G  VA G+ +L   
Sbjct: 101 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLAS- 156
Query: 380 WEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVGTL--GYLAPEHT 436
             +  +HRD+ A N +LD +   ++ DFGLAR +YD   D         L   ++A E  
Sbjct: 157 --KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 214
Query: 437 RTGKATTSADVFSFGAFLLEV 457
           +T K TT +DV+SFG  L E+
Sbjct: 215 QTQKFTTKSDVWSFGVLLWEL 235

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 80/296 (27%), Positives = 135/296 (45%), Gaps = 44/296 (14%)
Query: 269 LGTGGFGRVYRGTL-------PKSQIEIAVKKISHE-SRQGMKEFVAEIVSIGRL-RHRN 319
           LG G FG+V            PK  + +AVK +  + + + + + V+E+  +  + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYL-----------YD---QPKVTLNWIQRFRV 365
           ++ LLG C + G L ++ +Y   G+L +YL           YD    P+  + +      
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 366 IKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHV 424
              +A G+ YL     Q  IHRD+ A NVL+      R+ DFGLAR + +     +TT+ 
Sbjct: 163 TYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNG 219
Query: 425 VGTLGYLAPEHTRTGKATTSADVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFW 483
              + ++APE       T  +DV+SFG  + E+   G  P     P    I V+ +F   
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY----PG---IPVEELFKLL 272
Query: 484 NRGELLEARDPNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQILERDVAL 539
             G  ++ +  N   E               C H+ P+ RP+ +Q+V+ L+R + L
Sbjct: 273 KEGHRMD-KPANCTNELY--------MMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 86.7 bits (213), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 68/201 (33%), Positives = 107/201 (53%), Gaps = 16/201 (7%)
Query: 267 ELLGTGGFGRVYRGTLPKS---QIEIAVKKISHESRQG-MKEFVAEIVSIGRLRHRNLVQ 322
           E++G G FG VY GTL  +   +I  AVK ++  +  G + +F+ E + +    H N++ 
Sbjct: 37  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 96
Query: 323 LLGYC-RRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKG--VALGLFYLHQE 379
           LLG C R +G  L+V  YM +G L  ++ ++   T N   +  +  G  VA G+ +L   
Sbjct: 97  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLAS- 152
Query: 380 WEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVGTL--GYLAPEHT 436
             +  +HRD+ A N +LD +   ++ DFGLAR +YD   D         L   ++A E  
Sbjct: 153 --KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 210
Query: 437 RTGKATTSADVFSFGAFLLEV 457
           +T K TT +DV+SFG  L E+
Sbjct: 211 QTQKFTTKSDVWSFGVLLWEL 231

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 68/201 (33%), Positives = 107/201 (53%), Gaps = 16/201 (7%)
Query: 267 ELLGTGGFGRVYRGTLPKS---QIEIAVKKISHESRQG-MKEFVAEIVSIGRLRHRNLVQ 322
           E++G G FG VY GTL  +   +I  AVK ++  +  G + +F+ E + +    H N++ 
Sbjct: 34  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 93
Query: 323 LLGYC-RRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKG--VALGLFYLHQE 379
           LLG C R +G  L+V  YM +G L  ++ ++   T N   +  +  G  VA G+ +L   
Sbjct: 94  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLAS- 149
Query: 380 WEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVGTL--GYLAPEHT 436
             +  +HRD+ A N +LD +   ++ DFGLAR +YD   D         L   ++A E  
Sbjct: 150 --KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 207
Query: 437 RTGKATTSADVFSFGAFLLEV 457
           +T K TT +DV+SFG  L E+
Sbjct: 208 QTQKFTTKSDVWSFGVLLWEL 228

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 68/201 (33%), Positives = 107/201 (53%), Gaps = 16/201 (7%)
Query: 267 ELLGTGGFGRVYRGTLPKS---QIEIAVKKISHESRQG-MKEFVAEIVSIGRLRHRNLVQ 322
           E++G G FG VY GTL  +   +I  AVK ++  +  G + +F+ E + +    H N++ 
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 95
Query: 323 LLGYC-RRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKG--VALGLFYLHQE 379
           LLG C R +G  L+V  YM +G L  ++ ++   T N   +  +  G  VA G+ +L   
Sbjct: 96  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLAS- 151
Query: 380 WEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVGTL--GYLAPEHT 436
             +  +HRD+ A N +LD +   ++ DFGLAR +YD   D         L   ++A E  
Sbjct: 152 --KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 209
Query: 437 RTGKATTSADVFSFGAFLLEV 457
           +T K TT +DV+SFG  L E+
Sbjct: 210 QTQKFTTKSDVWSFGVLLWEL 230

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 81/301 (26%), Positives = 122/301 (40%), Gaps = 39/301 (12%)
Query: 248 PHR-FRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFV 306
           PHR FR  DL          E+LG G FG+  + T  ++   + +K++     +  + F+
Sbjct: 3   PHRIFRPSDLI-------HGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFL 55
Query: 307 AEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVI 366
            E+  +  L H N+++ +G   +   L  + +Y+  G+L + +         W QR    
Sbjct: 56  KEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTL-RGIIKSMDSQYPWSQRVSFA 114
Query: 367 KGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLY-DHGTDPQTTH-- 423
           K +A G+ YLH      +IHRD+ + N L+    N  + DFGLARL  D  T P+     
Sbjct: 115 KDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSL 171
Query: 424 ----------VVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENL 473
                     VVG   ++APE           DVFSFG  L E+      I R     + 
Sbjct: 172 KKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEI------IGRVNADPDY 225
Query: 474 ILVDWVFDFWNRGELLEARDPNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQIL 533
           +     F    RG L     PN    +              C   DP  RPS  ++   L
Sbjct: 226 LPRTMDFGLNVRGFLDRYCPPNCPPSFFP--------ITVRCCDLDPEKRPSFVKLEHWL 277
Query: 534 E 534
           E
Sbjct: 278 E 278

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 68/201 (33%), Positives = 107/201 (53%), Gaps = 16/201 (7%)
Query: 267 ELLGTGGFGRVYRGTLPKS---QIEIAVKKISHESRQG-MKEFVAEIVSIGRLRHRNLVQ 322
           E++G G FG VY GTL  +   +I  AVK ++  +  G + +F+ E + +    H N++ 
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 95
Query: 323 LLGYC-RRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKG--VALGLFYLHQE 379
           LLG C R +G  L+V  YM +G L  ++ ++   T N   +  +  G  VA G+ +L   
Sbjct: 96  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLAS- 151
Query: 380 WEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVGTL--GYLAPEHT 436
             +  +HRD+ A N +LD +   ++ DFGLAR +YD   D         L   ++A E  
Sbjct: 152 --KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 209
Query: 437 RTGKATTSADVFSFGAFLLEV 457
           +T K TT +DV+SFG  L E+
Sbjct: 210 QTQKFTTKSDVWSFGVLLWEL 230

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 63/208 (30%), Positives = 103/208 (49%), Gaps = 17/208 (8%)
Query: 263 FREKEL-----LGTGGFGRV----YRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIG 313
           F E+ L     LG G FG V    Y      +   +AVKK+ H + + +++F  EI  + 
Sbjct: 7   FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 66
Query: 314 RLRHRNLVQLLGYCRRKGE--LLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVAL 371
            L+H N+V+  G C   G   L L+ +Y+P GSL  YL  + K  ++ I+  +    +  
Sbjct: 67  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICK 125
Query: 372 GLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT--LG 429
           G+ YL     +  IHRD+   N+L++ E   ++GDFGL ++     +       G   + 
Sbjct: 126 GMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIF 182
Query: 430 YLAPEHTRTGKATTSADVFSFGAFLLEV 457
           + APE     K + ++DV+SFG  L E+
Sbjct: 183 WYAPESLTESKFSVASDVWSFGVVLYEL 210

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 68/201 (33%), Positives = 109/201 (54%), Gaps = 16/201 (7%)
Query: 267 ELLGTGGFGRVYRGTLPKS---QIEIAVKKISHESRQG-MKEFVAEIVSIGRLRHRNLVQ 322
           E++G G FG VY GTL  +   +I  AVK ++  +  G + +F+ E + +    H N++ 
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 95
Query: 323 LLGYC-RRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKG--VALGLFYLHQE 379
           LLG C R +G  L+V  YM +G L  ++ ++   T N   +  +  G  VA G+ YL   
Sbjct: 96  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKYLAS- 151
Query: 380 WEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYD--HGTDPQTTHVVGTLGYLAPEHT 436
             +  +HRD+ A N +LD +   ++ DFGLAR +YD  + +    T     + ++A E  
Sbjct: 152 --KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 209
Query: 437 RTGKATTSADVFSFGAFLLEV 457
           +T K TT +DV+SFG  L E+
Sbjct: 210 QTQKFTTKSDVWSFGVLLWEL 230

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 68/201 (33%), Positives = 109/201 (54%), Gaps = 16/201 (7%)
Query: 267 ELLGTGGFGRVYRGTLPKS---QIEIAVKKISHESRQG-MKEFVAEIVSIGRLRHRNLVQ 322
           E++G G FG VY GTL  +   +I  AVK ++  +  G + +F+ E + +    H N++ 
Sbjct: 54  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 113
Query: 323 LLGYC-RRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKG--VALGLFYLHQE 379
           LLG C R +G  L+V  YM +G L  ++ ++   T N   +  +  G  VA G+ YL   
Sbjct: 114 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKYLAS- 169
Query: 380 WEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYD--HGTDPQTTHVVGTLGYLAPEHT 436
             +  +HRD+ A N +LD +   ++ DFGLAR +YD  + +    T     + ++A E  
Sbjct: 170 --KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 227
Query: 437 RTGKATTSADVFSFGAFLLEV 457
           +T K TT +DV+SFG  L E+
Sbjct: 228 QTQKFTTKSDVWSFGVLLWEL 248

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 78/296 (26%), Positives = 132/296 (44%), Gaps = 44/296 (14%)
Query: 269 LGTGGFGRVYRGTL-------PKSQIEIAVKKI-SHESRQGMKEFVAEIVSIGRL-RHRN 319
           LG G FG+V            P    ++AVK + S  + + + + ++E+  +  + +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQ--------------PKVTLNWIQRFRV 365
           ++ LLG C + G L ++ +Y   G+L +YL  +              P+  L+       
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSC 155
Query: 366 IKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH-GTDPQTTHV 424
              VA G+ YL     +  IHRD+ A NVL+  +   ++ DFGLAR   H     +TT+ 
Sbjct: 156 AYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNG 212
Query: 425 VGTLGYLAPEHTRTGKATTSADVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFW 483
              + ++APE       T  +DV+SFG  L E+   G  P          + V+ +F   
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG-------VPVEELFKLL 265
Query: 484 NRGELLEARDPNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQILERDVAL 539
             G  ++         Y+             C H+ P+ RP+ +Q+V+ L+R VAL
Sbjct: 266 KEGHRMDKPSNCTNELYM---------MMRDCWHAVPSQRPTFKQLVEDLDRIVAL 312

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 71/263 (26%), Positives = 118/263 (44%), Gaps = 29/263 (11%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCR 328
           LGTG FG V  G   + Q ++A+K I  E      EF+ E   +  L H  LVQL G C 
Sbjct: 17  LGTGQFGVVKYGKW-RGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 74
Query: 329 RKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRD 388
           ++  + ++ +YM NG L  YL +  +      Q   + K V   + YL     +  +HRD
Sbjct: 75  KQRPIFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRD 130
Query: 389 VKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT---LGYLAPEHTRTGKATTSA 445
           + A N L++ +   ++ DFGL+R   +  D + T   G+   + +  PE     K ++ +
Sbjct: 131 LAARNCLVNDQGVVKVSDFGLSR---YVLDDEYTSSRGSKFPVRWSPPEVLMYSKFSSKS 187
Query: 446 DVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAXX 504
           D+++FG  + E+ + G+ P +R   SE    +          + L    P+L +E V   
Sbjct: 188 DIWAFGVLMWEIYSLGKMPYERFTNSETAEHI---------AQGLRLYRPHLASEKV--- 235
Query: 505 XXXXXXXXXXCSHSDPTARPSMR 527
                     C H     RP+ +
Sbjct: 236 ----YTIMYSCWHEKADERPTFK 254

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 68/201 (33%), Positives = 109/201 (54%), Gaps = 16/201 (7%)
Query: 267 ELLGTGGFGRVYRGTLPKS---QIEIAVKKISHESRQG-MKEFVAEIVSIGRLRHRNLVQ 322
           E++G G FG VY GTL  +   +I  AVK ++  +  G + +F+ E + +    H N++ 
Sbjct: 28  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 87
Query: 323 LLGYC-RRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKG--VALGLFYLHQE 379
           LLG C R +G  L+V  YM +G L  ++ ++   T N   +  +  G  VA G+ YL   
Sbjct: 88  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKYLAS- 143
Query: 380 WEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYD--HGTDPQTTHVVGTLGYLAPEHT 436
             +  +HRD+ A N +LD +   ++ DFGLAR +YD  + +    T     + ++A E  
Sbjct: 144 --KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 201
Query: 437 RTGKATTSADVFSFGAFLLEV 457
           +T K TT +DV+SFG  L E+
Sbjct: 202 QTQKFTTKSDVWSFGVLLWEL 222

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 68/201 (33%), Positives = 109/201 (54%), Gaps = 16/201 (7%)
Query: 267 ELLGTGGFGRVYRGTLPKS---QIEIAVKKISHESRQG-MKEFVAEIVSIGRLRHRNLVQ 322
           E++G G FG VY GTL  +   +I  AVK ++  +  G + +F+ E + +    H N++ 
Sbjct: 55  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 114
Query: 323 LLGYC-RRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKG--VALGLFYLHQE 379
           LLG C R +G  L+V  YM +G L  ++ ++   T N   +  +  G  VA G+ YL   
Sbjct: 115 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKYLAS- 170
Query: 380 WEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYD--HGTDPQTTHVVGTLGYLAPEHT 436
             +  +HRD+ A N +LD +   ++ DFGLAR +YD  + +    T     + ++A E  
Sbjct: 171 --KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 228
Query: 437 RTGKATTSADVFSFGAFLLEV 457
           +T K TT +DV+SFG  L E+
Sbjct: 229 QTQKFTTKSDVWSFGVLLWEL 249

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 67/243 (27%), Positives = 120/243 (49%), Gaps = 28/243 (11%)
Query: 240 EDWELDHGPHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVK--KISHE 297
           +DWE+  G            T G R    +G+G FG VY+G   K   ++AVK   ++  
Sbjct: 6   DDWEIPDGQ----------ITVGQR----IGSGSFGTVYKG---KWHGDVAVKMLNVTAP 48
Query: 298 SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTL 357
           + Q ++ F  E+  + + RH N++  +GY   K +L +V  +    SL  +L+   +   
Sbjct: 49  TPQQLQAFKNEVGVLRKTRHVNILLFMGYST-KPQLAIVTQWCEGSSLYHHLHI-IETKF 106
Query: 358 NWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT 417
             I+   + +  A G+ YLH    + +IHRD+K++N+ L  +L  ++GDFGLA +    +
Sbjct: 107 EMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 163
Query: 418 -DPQTTHVVGTLGYLAPEHTRTGKA---TTSADVFSFGAFLLEVACGRRPIQRQGPSENL 473
              Q   + G++ ++APE  R       +  +DV++FG  L E+  G+ P       + +
Sbjct: 164 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI 223
Query: 474 ILV 476
           I +
Sbjct: 224 IFM 226

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 68/201 (33%), Positives = 106/201 (52%), Gaps = 16/201 (7%)
Query: 267 ELLGTGGFGRVYRGTLPKS---QIEIAVKKISHESRQG-MKEFVAEIVSIGRLRHRNLVQ 322
           E++G G FG VY GTL  +   +I  AVK ++  +  G + +F+ E + +    H N++ 
Sbjct: 35  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 94
Query: 323 LLGYC-RRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKG--VALGLFYLHQE 379
           LLG C R +G  L+V  YM +G L  ++ ++   T N   +  +  G  VA G+ YL   
Sbjct: 95  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKYLAS- 150
Query: 380 WEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVGTL--GYLAPEHT 436
             +  +HRD+ A N +LD +   ++ DFGLAR +YD             L   ++A E  
Sbjct: 151 --KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESL 208
Query: 437 RTGKATTSADVFSFGAFLLEV 457
           +T K TT +DV+SFG  L E+
Sbjct: 209 QTQKFTTKSDVWSFGVLLWEL 229

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 85.9 bits (211), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 67/243 (27%), Positives = 120/243 (49%), Gaps = 28/243 (11%)
Query: 240 EDWELDHGPHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVK--KISHE 297
           +DWE+  G            T G R    +G+G FG VY+G   K   ++AVK   ++  
Sbjct: 3   DDWEIPDGQ----------ITVGQR----IGSGSFGTVYKG---KWHGDVAVKMLNVTAP 45
Query: 298 SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTL 357
           + Q ++ F  E+  + + RH N++  +GY   K +L +V  +    SL  +L+   +   
Sbjct: 46  TPQQLQAFKNEVGVLRKTRHVNILLFMGYST-KPQLAIVTQWCEGSSLYHHLHI-IETKF 103
Query: 358 NWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT 417
             I+   + +  A G+ YLH    + +IHRD+K++N+ L  +L  ++GDFGLA +    +
Sbjct: 104 EMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 160
Query: 418 -DPQTTHVVGTLGYLAPEHTRTGKA---TTSADVFSFGAFLLEVACGRRPIQRQGPSENL 473
              Q   + G++ ++APE  R       +  +DV++FG  L E+  G+ P       + +
Sbjct: 161 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI 220
Query: 474 ILV 476
           I +
Sbjct: 221 IFM 223

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 68/201 (33%), Positives = 109/201 (54%), Gaps = 16/201 (7%)
Query: 267 ELLGTGGFGRVYRGTLPKS---QIEIAVKKISHESRQG-MKEFVAEIVSIGRLRHRNLVQ 322
           E++G G FG VY GTL  +   +I  AVK ++  +  G + +F+ E + +    H N++ 
Sbjct: 36  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 95
Query: 323 LLGYC-RRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKG--VALGLFYLHQE 379
           LLG C R +G  L+V  YM +G L  ++ ++   T N   +  +  G  VA G+ YL   
Sbjct: 96  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKYLAS- 151
Query: 380 WEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYD--HGTDPQTTHVVGTLGYLAPEHT 436
             +  +HRD+ A N +LD +   ++ DFGLAR +YD  + +    T     + ++A E  
Sbjct: 152 --KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 209
Query: 437 RTGKATTSADVFSFGAFLLEV 457
           +T K TT +DV+SFG  L E+
Sbjct: 210 QTQKFTTKSDVWSFGVLLWEL 230

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 68/201 (33%), Positives = 109/201 (54%), Gaps = 16/201 (7%)
Query: 267 ELLGTGGFGRVYRGTLPKS---QIEIAVKKISHESRQG-MKEFVAEIVSIGRLRHRNLVQ 322
           E++G G FG VY GTL  +   +I  AVK ++  +  G + +F+ E + +    H N++ 
Sbjct: 35  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 94
Query: 323 LLGYC-RRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKG--VALGLFYLHQE 379
           LLG C R +G  L+V  YM +G L  ++ ++   T N   +  +  G  VA G+ YL   
Sbjct: 95  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKYLAS- 150
Query: 380 WEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYD--HGTDPQTTHVVGTLGYLAPEHT 436
             +  +HRD+ A N +LD +   ++ DFGLAR +YD  + +    T     + ++A E  
Sbjct: 151 --KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 208
Query: 437 RTGKATTSADVFSFGAFLLEV 457
           +T K TT +DV+SFG  L E+
Sbjct: 209 QTQKFTTKSDVWSFGVLLWEL 229

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 68/201 (33%), Positives = 109/201 (54%), Gaps = 16/201 (7%)
Query: 267 ELLGTGGFGRVYRGTLPKS---QIEIAVKKISHESRQG-MKEFVAEIVSIGRLRHRNLVQ 322
           E++G G FG VY GTL  +   +I  AVK ++  +  G + +F+ E + +    H N++ 
Sbjct: 34  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 93
Query: 323 LLGYC-RRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKG--VALGLFYLHQE 379
           LLG C R +G  L+V  YM +G L  ++ ++   T N   +  +  G  VA G+ YL   
Sbjct: 94  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKYLAS- 149
Query: 380 WEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYD--HGTDPQTTHVVGTLGYLAPEHT 436
             +  +HRD+ A N +LD +   ++ DFGLAR +YD  + +    T     + ++A E  
Sbjct: 150 --KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 207
Query: 437 RTGKATTSADVFSFGAFLLEV 457
           +T K TT +DV+SFG  L E+
Sbjct: 208 QTQKFTTKSDVWSFGVLLWEL 228

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 79/296 (26%), Positives = 135/296 (45%), Gaps = 44/296 (14%)
Query: 269 LGTGGFGRVYRGTL-------PKSQIEIAVKKISHE-SRQGMKEFVAEIVSIGRL-RHRN 319
           LG G FG+V            PK  + +AVK +  + + + + + V+E+  +  + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYL-----------YD---QPKVTLNWIQRFRV 365
           ++ LLG C + G L ++ +Y   G+L +YL           YD    P+  + +      
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 366 IKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHV 424
              +A G+ YL     Q  IHRD+ A NVL+      ++ DFGLAR + +     +TT+ 
Sbjct: 163 TYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 425 VGTLGYLAPEHTRTGKATTSADVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFW 483
              + ++APE       T  +DV+SFG  + E+   G  P     P    I V+ +F   
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY----PG---IPVEELFKLL 272
Query: 484 NRGELLEARDPNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQILERDVAL 539
             G  ++ +  N   E               C H+ P+ RP+ +Q+V+ L+R + L
Sbjct: 273 KEGHRMD-KPANCTNELY--------MMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 100/198 (50%), Gaps = 7/198 (3%)
Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
           E LG G FG V+ G       ++AVK +   S      F+AE   + +L+H+ LV+L   
Sbjct: 15  ERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAV 72
Query: 327 CRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIH 386
             ++  + ++ +YM NGSL  +L     + L   +   +   +A G+ ++    E+  IH
Sbjct: 73  VTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIH 128
Query: 387 RDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSAD 446
           R+++A+N+L+   L+ ++ DFGLARL +             + + APE    G  T  +D
Sbjct: 129 RNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSD 188
Query: 447 VFSFGAFLLEVAC-GRRP 463
           V+SFG  L E+   GR P
Sbjct: 189 VWSFGILLTEIVTHGRIP 206

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 67/243 (27%), Positives = 120/243 (49%), Gaps = 28/243 (11%)
Query: 240 EDWELDHGPHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVK--KISHE 297
           +DWE+  G            T G R    +G+G FG VY+G   K   ++AVK   ++  
Sbjct: 6   DDWEIPDGQ----------ITVGQR----IGSGSFGTVYKG---KWHGDVAVKMLNVTAP 48
Query: 298 SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTL 357
           + Q ++ F  E+  + + RH N++  +GY   K +L +V  +    SL  +L+   +   
Sbjct: 49  TPQQLQAFKNEVGVLRKTRHVNILLFMGYST-KPQLAIVTQWCEGSSLYHHLHI-IETKF 106
Query: 358 NWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT 417
             I+   + +  A G+ YLH    + +IHRD+K++N+ L  +L  ++GDFGLA +    +
Sbjct: 107 EMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 163
Query: 418 -DPQTTHVVGTLGYLAPEHTRTGKA---TTSADVFSFGAFLLEVACGRRPIQRQGPSENL 473
              Q   + G++ ++APE  R       +  +DV++FG  L E+  G+ P       + +
Sbjct: 164 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI 223
Query: 474 ILV 476
           I +
Sbjct: 224 IFM 226

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 68/201 (33%), Positives = 109/201 (54%), Gaps = 16/201 (7%)
Query: 267 ELLGTGGFGRVYRGTLPKS---QIEIAVKKISHESRQG-MKEFVAEIVSIGRLRHRNLVQ 322
           E++G G FG VY GTL  +   +I  AVK ++  +  G + +F+ E + +    H N++ 
Sbjct: 33  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 92
Query: 323 LLGYC-RRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKG--VALGLFYLHQE 379
           LLG C R +G  L+V  YM +G L  ++ ++   T N   +  +  G  VA G+ YL   
Sbjct: 93  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKYLAS- 148
Query: 380 WEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYD--HGTDPQTTHVVGTLGYLAPEHT 436
             +  +HRD+ A N +LD +   ++ DFGLAR +YD  + +    T     + ++A E  
Sbjct: 149 --KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 206
Query: 437 RTGKATTSADVFSFGAFLLEV 457
           +T K TT +DV+SFG  L E+
Sbjct: 207 QTQKFTTKSDVWSFGVLLWEL 227

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 67/243 (27%), Positives = 120/243 (49%), Gaps = 28/243 (11%)
Query: 240 EDWELDHGPHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVK--KISHE 297
           +DWE+  G            T G R    +G+G FG VY+G   K   ++AVK   ++  
Sbjct: 1   DDWEIPDGQ----------ITVGQR----IGSGSFGTVYKG---KWHGDVAVKMLNVTAP 43
Query: 298 SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTL 357
           + Q ++ F  E+  + + RH N++  +GY   K +L +V  +    SL  +L+   +   
Sbjct: 44  TPQQLQAFKNEVGVLRKTRHVNILLFMGYST-KPQLAIVTQWCEGSSLYHHLHI-IETKF 101
Query: 358 NWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT 417
             I+   + +  A G+ YLH    + +IHRD+K++N+ L  +L  ++GDFGLA +    +
Sbjct: 102 EMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158
Query: 418 -DPQTTHVVGTLGYLAPEHTRTGKA---TTSADVFSFGAFLLEVACGRRPIQRQGPSENL 473
              Q   + G++ ++APE  R       +  +DV++FG  L E+  G+ P       + +
Sbjct: 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI 218
Query: 474 ILV 476
           I +
Sbjct: 219 IFM 221

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 99/198 (50%), Gaps = 7/198 (3%)
Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
           E LG G  G V+ G       ++AVK +   S      F+AE   + +L+H+ LV+L   
Sbjct: 19  ERLGAGQAGEVWMGYY-NGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 327 CRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIH 386
             ++  + ++ +YM NGSL  +L     + L   +   +   +A G+ ++    E+  IH
Sbjct: 77  VTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIH 132
Query: 387 RDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSAD 446
           RD++A+N+L+   L+ ++ DFGLARL +             + + APE    G  T  +D
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEAINYGTFTIKSD 192
Query: 447 VFSFGAFLLEVAC-GRRP 463
           V+SFG  L E+   GR P
Sbjct: 193 VWSFGILLTEIVTHGRIP 210

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 103/208 (49%), Gaps = 17/208 (8%)
Query: 263 FREKEL-----LGTGGFGRV----YRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIG 313
           F E+ L     LG G FG V    Y      +   +AVKK+ H + + +++F  EI  + 
Sbjct: 8   FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 67
Query: 314 RLRHRNLVQLLGYCRRKGE--LLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVAL 371
            L+H N+V+  G C   G   L L+ +Y+P GSL  YL  + K  ++ I+  +    +  
Sbjct: 68  SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICK 126
Query: 372 GLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT--LG 429
           G+ YL     +  IHR++   N+L++ E   ++GDFGL ++     +       G   + 
Sbjct: 127 GMEYLGT---KRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIF 183
Query: 430 YLAPEHTRTGKATTSADVFSFGAFLLEV 457
           + APE     K + ++DV+SFG  L E+
Sbjct: 184 WYAPESLTESKFSVASDVWSFGVVLYEL 211

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 79/296 (26%), Positives = 135/296 (45%), Gaps = 44/296 (14%)
Query: 269 LGTGGFGRVYRGTL-------PKSQIEIAVKKISHE-SRQGMKEFVAEIVSIGRL-RHRN 319
           LG G FG+V            PK  + +AVK +  + + + + + V+E+  +  + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYL-----------YD---QPKVTLNWIQRFRV 365
           ++ LLG C + G L ++ +Y   G+L +YL           YD    P+  + +      
Sbjct: 103 IIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 366 IKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHV 424
              +A G+ YL     Q  IHRD+ A NVL+      ++ DFGLAR + +     +TT+ 
Sbjct: 163 TYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 425 VGTLGYLAPEHTRTGKATTSADVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFW 483
              + ++APE       T  +DV+SFG  + E+   G  P     P    I V+ +F   
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY----PG---IPVEELFKLL 272
Query: 484 NRGELLEARDPNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQILERDVAL 539
             G  ++ +  N   E               C H+ P+ RP+ +Q+V+ L+R + L
Sbjct: 273 KEGHRMD-KPANCTNELY--------MMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 85.5 bits (210), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 68/201 (33%), Positives = 109/201 (54%), Gaps = 16/201 (7%)
Query: 267 ELLGTGGFGRVYRGTLPKS---QIEIAVKKISHESRQG-MKEFVAEIVSIGRLRHRNLVQ 322
           E++G G FG VY GTL  +   +I  AVK ++  +  G + +F+ E + +    H N++ 
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 323 LLGYC-RRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKG--VALGLFYLHQE 379
           LLG C R +G  L+V  YM +G L  ++ ++   T N   +  +  G  VA G+ YL   
Sbjct: 91  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKYLAS- 146
Query: 380 WEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYD--HGTDPQTTHVVGTLGYLAPEHT 436
             +  +HRD+ A N +LD +   ++ DFGLAR +YD  + +    T     + ++A E  
Sbjct: 147 --KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 204
Query: 437 RTGKATTSADVFSFGAFLLEV 457
           +T K TT +DV+SFG  L E+
Sbjct: 205 QTQKFTTKSDVWSFGVLLWEL 225

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 67/243 (27%), Positives = 120/243 (49%), Gaps = 28/243 (11%)
Query: 240 EDWELDHGPHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVK--KISHE 297
           +DWE+  G            T G R    +G+G FG VY+G   K   ++AVK   ++  
Sbjct: 28  DDWEIPDGQ----------ITVGQR----IGSGSFGTVYKG---KWHGDVAVKMLNVTAP 70
Query: 298 SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTL 357
           + Q ++ F  E+  + + RH N++  +GY   K +L +V  +    SL  +L+   +   
Sbjct: 71  TPQQLQAFKNEVGVLRKTRHVNILLFMGYST-KPQLAIVTQWCEGSSLYHHLH-IIETKF 128
Query: 358 NWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT 417
             I+   + +  A G+ YLH    + +IHRD+K++N+ L  +L  ++GDFGLA +    +
Sbjct: 129 EMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 185
Query: 418 -DPQTTHVVGTLGYLAPEHTRTGKA---TTSADVFSFGAFLLEVACGRRPIQRQGPSENL 473
              Q   + G++ ++APE  R       +  +DV++FG  L E+  G+ P       + +
Sbjct: 186 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI 245
Query: 474 ILV 476
           I +
Sbjct: 246 IFM 248

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 79/296 (26%), Positives = 135/296 (45%), Gaps = 44/296 (14%)
Query: 269 LGTGGFGRVYRGTL-------PKSQIEIAVKKISHE-SRQGMKEFVAEIVSIGRL-RHRN 319
           LG G FG+V            PK  + +AVK +  + + + + + V+E+  +  + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYL-----------YD---QPKVTLNWIQRFRV 365
           ++ LLG C + G L ++ +Y   G+L +YL           YD    P+  + +      
Sbjct: 103 IITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 366 IKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHV 424
              +A G+ YL     Q  IHRD+ A NVL+      ++ DFGLAR + +     +TT+ 
Sbjct: 163 TYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 425 VGTLGYLAPEHTRTGKATTSADVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFW 483
              + ++APE       T  +DV+SFG  + E+   G  P     P    I V+ +F   
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY----PG---IPVEELFKLL 272
Query: 484 NRGELLEARDPNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQILERDVAL 539
             G  ++ +  N   E               C H+ P+ RP+ +Q+V+ L+R + L
Sbjct: 273 KEGHRMD-KPANCTNELY--------MMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/243 (27%), Positives = 120/243 (49%), Gaps = 28/243 (11%)
Query: 240 EDWELDHGPHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVK--KISHE 297
           +DWE+  G            T G R    +G+G FG VY+G   K   ++AVK   ++  
Sbjct: 29  DDWEIPDGQ----------ITVGQR----IGSGSFGTVYKG---KWHGDVAVKMLNVTAP 71
Query: 298 SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTL 357
           + Q ++ F  E+  + + RH N++  +GY   K +L +V  +    SL  +L+   +   
Sbjct: 72  TPQQLQAFKNEVGVLRKTRHVNILLFMGYST-KPQLAIVTQWCEGSSLYHHLH-IIETKF 129
Query: 358 NWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT 417
             I+   + +  A G+ YLH    + +IHRD+K++N+ L  +L  ++GDFGLA +    +
Sbjct: 130 EMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 186
Query: 418 -DPQTTHVVGTLGYLAPEHTRTGKA---TTSADVFSFGAFLLEVACGRRPIQRQGPSENL 473
              Q   + G++ ++APE  R       +  +DV++FG  L E+  G+ P       + +
Sbjct: 187 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI 246
Query: 474 ILV 476
           I +
Sbjct: 247 IFM 249

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 78/296 (26%), Positives = 132/296 (44%), Gaps = 44/296 (14%)
Query: 269 LGTGGFGRVYRGTL-------PKSQIEIAVKKI-SHESRQGMKEFVAEIVSIGRL-RHRN 319
           LG G FG+V            P    ++AVK + S  + + + + ++E+  +  + +H+N
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQ--------------PKVTLNWIQRFRV 365
           ++ LLG C + G L ++ +Y   G+L +YL  +              P+  L+       
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 366 IKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH-GTDPQTTHV 424
              VA G+ YL     +  IHRD+ A NVL+  +   ++ DFGLAR   H     +TT+ 
Sbjct: 197 AYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253
Query: 425 VGTLGYLAPEHTRTGKATTSADVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFW 483
              + ++APE       T  +DV+SFG  L E+   G  P          + V+ +F   
Sbjct: 254 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG-------VPVEELFKLL 306
Query: 484 NRGELLEARDPNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQILERDVAL 539
             G  ++         Y+             C H+ P+ RP+ +Q+V+ L+R VAL
Sbjct: 307 KEGHRMDKPSNCTNELYM---------MMRDCWHAVPSQRPTFKQLVEDLDRIVAL 353

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 79/296 (26%), Positives = 134/296 (45%), Gaps = 44/296 (14%)
Query: 269 LGTGGFGRVYRGTL-------PKSQIEIAVKKISHE-SRQGMKEFVAEIVSIGRL-RHRN 319
           LG G FG+V            PK  + +AVK +  + + + + + V+E+  +  + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYL-----------YD---QPKVTLNWIQRFRV 365
           ++ LLG C + G L ++ +Y   G+L +YL           YD    P+  + +      
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 366 IKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHV 424
              +A G+ YL     Q  IHRD+ A NVL+      ++ DFGLAR + +      TT+ 
Sbjct: 163 TYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNG 219
Query: 425 VGTLGYLAPEHTRTGKATTSADVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFW 483
              + ++APE       T  +DV+SFG  + E+   G  P     P    I V+ +F   
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY----PG---IPVEELFKLL 272
Query: 484 NRGELLEARDPNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQILERDVAL 539
             G  ++ +  N   E               C H+ P+ RP+ +Q+V+ L+R + L
Sbjct: 273 KEGHRMD-KPANCTNELY--------MMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 78/296 (26%), Positives = 134/296 (45%), Gaps = 44/296 (14%)
Query: 269 LGTGGFGRVYRGTL-------PKSQIEIAVKKISHE-SRQGMKEFVAEIVSIGRL-RHRN 319
           LG G FG+V            PK  + +AVK +  + + + + + V+E+  +  + +H+N
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYL-----------YD---QPKVTLNWIQRFRV 365
           ++ LLG C + G L ++ +Y   G+L +YL           YD    P+  + +      
Sbjct: 92  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 151
Query: 366 IKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHV 424
              +A G+ YL     Q  IHRD+ A NVL+      ++ DFGLAR + +     +TT+ 
Sbjct: 152 TYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 208
Query: 425 VGTLGYLAPEHTRTGKATTSADVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFW 483
              + ++APE       T  +DV+SFG  + E+   G  P          I V+ +F   
Sbjct: 209 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG-------IPVEELFKLL 261
Query: 484 NRGELLEARDPNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQILERDVAL 539
             G  ++ +  N   E               C H+ P+ RP+ +Q+V+ L+R + L
Sbjct: 262 KEGHRMD-KPANCTNELY--------MMMRDCWHAVPSQRPTFKQLVEDLDRILTL 308

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 110/219 (50%), Gaps = 22/219 (10%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCR 328
           LG G FG+VY+    ++    A K I  +S + +++++ EI  +    H  +V+LLG   
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 329 RKGELLLVYDYMPNGSLDKYLYD------QPKVTLNWIQRFRVIKGVALGLFYLHQEWEQ 382
             G+L ++ ++ P G++D  + +      +P++ +       V + +   L +LH    +
Sbjct: 79  HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV-------VCRQMLEALNFLHS---K 128
Query: 383 VVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE--HTRTGK 440
            +IHRD+KA NVL+  E + RL DFG++   +  T  +    +GT  ++APE     T K
Sbjct: 129 RIIHRDLKAGNVLMTLEGDIRLADFGVSA-KNLKTLQKRDSFIGTPYWMAPEVVMCETMK 187
Query: 441 ATT---SADVFSFGAFLLEVACGRRPIQRQGPSENLILV 476
            T     AD++S G  L+E+A    P     P   L+ +
Sbjct: 188 DTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKI 226

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 79/296 (26%), Positives = 135/296 (45%), Gaps = 44/296 (14%)
Query: 269 LGTGGFGRVYRGTL-------PKSQIEIAVKKISHE-SRQGMKEFVAEIVSIGRL-RHRN 319
           LG G FG+V            PK  + +AVK +  + + + + + V+E+  +  + +H+N
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYL-----------YD---QPKVTLNWIQRFRV 365
           ++ LLG C + G L ++ +Y   G+L +YL           YD    P+  + +      
Sbjct: 95  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 154
Query: 366 IKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHV 424
              +A G+ YL     Q  IHRD+ A NVL+      ++ DFGLAR + +     +TT+ 
Sbjct: 155 TYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 211
Query: 425 VGTLGYLAPEHTRTGKATTSADVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFW 483
              + ++APE       T  +DV+SFG  + E+   G  P     P    I V+ +F   
Sbjct: 212 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY----PG---IPVEELFKLL 264
Query: 484 NRGELLEARDPNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQILERDVAL 539
             G  ++ +  N   E               C H+ P+ RP+ +Q+V+ L+R + L
Sbjct: 265 KEGHRMD-KPANCTNELY--------MMMRDCWHAVPSQRPTFKQLVEDLDRILTL 311

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 110/219 (50%), Gaps = 22/219 (10%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCR 328
           LG G FG+VY+    ++    A K I  +S + +++++ EI  +    H  +V+LLG   
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 329 RKGELLLVYDYMPNGSLDKYLYD------QPKVTLNWIQRFRVIKGVALGLFYLHQEWEQ 382
             G+L ++ ++ P G++D  + +      +P++ +       V + +   L +LH    +
Sbjct: 87  HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV-------VCRQMLEALNFLHS---K 136
Query: 383 VVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE--HTRTGK 440
            +IHRD+KA NVL+  E + RL DFG++   +  T  +    +GT  ++APE     T K
Sbjct: 137 RIIHRDLKAGNVLMTLEGDIRLADFGVSA-KNLKTLQKRDSFIGTPYWMAPEVVMCETMK 195
Query: 441 ATT---SADVFSFGAFLLEVACGRRPIQRQGPSENLILV 476
            T     AD++S G  L+E+A    P     P   L+ +
Sbjct: 196 DTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKI 234

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 78/296 (26%), Positives = 132/296 (44%), Gaps = 44/296 (14%)
Query: 269 LGTGGFGRVYRGTL-------PKSQIEIAVKKI-SHESRQGMKEFVAEIVSIGRL-RHRN 319
           LG G FG+V            P    ++AVK + S  + + + + ++E+  +  + +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQ--------------PKVTLNWIQRFRV 365
           ++ LLG C + G L ++ +Y   G+L +YL  +              P+  L+       
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 366 IKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH-GTDPQTTHV 424
              VA G+ YL     +  IHRD+ A NVL+  +   ++ DFGLAR   H     +TT+ 
Sbjct: 156 AYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 425 VGTLGYLAPEHTRTGKATTSADVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFW 483
              + ++APE       T  +DV+SFG  L E+   G  P          + V+ +F   
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG-------VPVEELFKLL 265
Query: 484 NRGELLEARDPNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQILERDVAL 539
             G  ++         Y+             C H+ P+ RP+ +Q+V+ L+R VAL
Sbjct: 266 KEGHRMDKPSNCTNELYM---------MMRDCWHAVPSQRPTFKQLVEDLDRIVAL 312

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 79/296 (26%), Positives = 135/296 (45%), Gaps = 44/296 (14%)
Query: 269 LGTGGFGRVYRGTL-------PKSQIEIAVKKISHE-SRQGMKEFVAEIVSIGRL-RHRN 319
           LG G FG+V            PK  + +AVK +  + + + + + V+E+  +  + +H+N
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYL-----------YD---QPKVTLNWIQRFRV 365
           ++ LLG C + G L ++ +Y   G+L +YL           YD    P+  + +      
Sbjct: 90  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 149
Query: 366 IKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHV 424
              +A G+ YL     Q  IHRD+ A NVL+      ++ DFGLAR + +     +TT+ 
Sbjct: 150 TYQLARGMEYLAS---QKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 206
Query: 425 VGTLGYLAPEHTRTGKATTSADVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFW 483
              + ++APE       T  +DV+SFG  + E+   G  P     P    I V+ +F   
Sbjct: 207 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY----PG---IPVEELFKLL 259
Query: 484 NRGELLEARDPNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQILERDVAL 539
             G  ++ +  N   E               C H+ P+ RP+ +Q+V+ L+R + L
Sbjct: 260 KEGHRMD-KPANCTNELY--------MMMRDCWHAVPSQRPTFKQLVEDLDRILTL 306

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 78/296 (26%), Positives = 132/296 (44%), Gaps = 44/296 (14%)
Query: 269 LGTGGFGRVYRGTL-------PKSQIEIAVKKI-SHESRQGMKEFVAEIVSIGRL-RHRN 319
           LG G FG+V            P    ++AVK + S  + + + + ++E+  +  + +H+N
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQ--------------PKVTLNWIQRFRV 365
           ++ LLG C + G L ++ +Y   G+L +YL  +              P+  L+       
Sbjct: 85  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 144
Query: 366 IKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH-GTDPQTTHV 424
              VA G+ YL     +  IHRD+ A NVL+  +   ++ DFGLAR   H     +TT+ 
Sbjct: 145 AYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 201
Query: 425 VGTLGYLAPEHTRTGKATTSADVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFW 483
              + ++APE       T  +DV+SFG  L E+   G  P          + V+ +F   
Sbjct: 202 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG-------VPVEELFKLL 254
Query: 484 NRGELLEARDPNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQILERDVAL 539
             G  ++         Y+             C H+ P+ RP+ +Q+V+ L+R VAL
Sbjct: 255 KEGHRMDKPSNCTNELYM---------MMRDCWHAVPSQRPTFKQLVEDLDRIVAL 301

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 107/215 (49%), Gaps = 33/215 (15%)
Query: 266 KELLGTGGFGRVYRGTLPKS--QIEIAVKKI-SHESRQGMKEFVAEIVSIGRL-RHRNLV 321
           ++++G G FG+V +  + K   +++ A+K++  + S+   ++F  E+  + +L  H N++
Sbjct: 20  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 79
Query: 322 QLLGYCRRKGELLLVYDYMPNGSLDKYL--------------YDQPKVTLNWIQRFRVIK 367
            LLG C  +G L L  +Y P+G+L  +L               +    TL+  Q      
Sbjct: 80  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 139
Query: 368 GVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT 427
            VA G+ YL Q   +  IHRD+ A N+L+      ++ DFGL+R        Q  +V  T
Sbjct: 140 DVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR-------GQEVYVKKT 189
Query: 428 LG-----YLAPEHTRTGKATTSADVFSFGAFLLEV 457
           +G     ++A E       TT++DV+S+G  L E+
Sbjct: 190 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI 224

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 78/296 (26%), Positives = 132/296 (44%), Gaps = 44/296 (14%)
Query: 269 LGTGGFGRVYRGTL-------PKSQIEIAVKKI-SHESRQGMKEFVAEIVSIGRL-RHRN 319
           LG G FG+V            P    ++AVK + S  + + + + ++E+  +  + +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQ--------------PKVTLNWIQRFRV 365
           ++ LLG C + G L ++ +Y   G+L +YL  +              P+  L+       
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 366 IKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH-GTDPQTTHV 424
              VA G+ YL     +  IHRD+ A NVL+  +   ++ DFGLAR   H     +TT+ 
Sbjct: 156 AYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 425 VGTLGYLAPEHTRTGKATTSADVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFW 483
              + ++APE       T  +DV+SFG  L E+   G  P          + V+ +F   
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG-------VPVEELFKLL 265
Query: 484 NRGELLEARDPNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQILERDVAL 539
             G  ++         Y+             C H+ P+ RP+ +Q+V+ L+R VAL
Sbjct: 266 KEGHRMDKPSNCTNELYM---------MMRDCWHAVPSQRPTFKQLVEDLDRIVAL 312

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 107/215 (49%), Gaps = 33/215 (15%)
Query: 266 KELLGTGGFGRVYRGTLPKS--QIEIAVKKI-SHESRQGMKEFVAEIVSIGRL-RHRNLV 321
           ++++G G FG+V +  + K   +++ A+K++  + S+   ++F  E+  + +L  H N++
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 322 QLLGYCRRKGELLLVYDYMPNGSLDKYL--------------YDQPKVTLNWIQRFRVIK 367
            LLG C  +G L L  +Y P+G+L  +L               +    TL+  Q      
Sbjct: 90  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 368 GVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT 427
            VA G+ YL Q   +  IHRD+ A N+L+      ++ DFGL+R        Q  +V  T
Sbjct: 150 DVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR-------GQEVYVKKT 199
Query: 428 LG-----YLAPEHTRTGKATTSADVFSFGAFLLEV 457
           +G     ++A E       TT++DV+S+G  L E+
Sbjct: 200 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI 234

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 79/296 (26%), Positives = 135/296 (45%), Gaps = 44/296 (14%)
Query: 269 LGTGGFGRVYRGTL-------PKSQIEIAVKKISHE-SRQGMKEFVAEIVSIGRL-RHRN 319
           LG G FG+V            PK  + +AVK +  + + + + + V+E+  +  + +H+N
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYL-----------YD---QPKVTLNWIQRFRV 365
           ++ LLG C + G L ++ +Y   G+L +YL           YD    P+  + +      
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 366 IKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHV 424
              +A G+ YL     Q  IHRD+ A NVL+      ++ DFGLAR + +     +TT+ 
Sbjct: 209 TYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 265
Query: 425 VGTLGYLAPEHTRTGKATTSADVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFW 483
              + ++APE       T  +DV+SFG  + E+   G  P     P    I V+ +F   
Sbjct: 266 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY----PG---IPVEELFKLL 318
Query: 484 NRGELLEARDPNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQILERDVAL 539
             G  ++ +  N   E               C H+ P+ RP+ +Q+V+ L+R + L
Sbjct: 319 KEGHRMD-KPANCTNEL--------YMMMRDCWHAVPSQRPTFKQLVEDLDRILTL 365

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 78/296 (26%), Positives = 132/296 (44%), Gaps = 44/296 (14%)
Query: 269 LGTGGFGRVYRGTL-------PKSQIEIAVKKI-SHESRQGMKEFVAEIVSIGRL-RHRN 319
           LG G FG+V            P    ++AVK + S  + + + + ++E+  +  + +H+N
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQ--------------PKVTLNWIQRFRV 365
           ++ LLG C + G L ++ +Y   G+L +YL  +              P+  L+       
Sbjct: 88  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 147
Query: 366 IKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH-GTDPQTTHV 424
              VA G+ YL     +  IHRD+ A NVL+  +   ++ DFGLAR   H     +TT+ 
Sbjct: 148 AYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 204
Query: 425 VGTLGYLAPEHTRTGKATTSADVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFW 483
              + ++APE       T  +DV+SFG  L E+   G  P          + V+ +F   
Sbjct: 205 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG-------VPVEELFKLL 257
Query: 484 NRGELLEARDPNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQILERDVAL 539
             G  ++         Y+             C H+ P+ RP+ +Q+V+ L+R VAL
Sbjct: 258 KEGHRMDKPSNCTNELYM---------MMRDCWHAVPSQRPTFKQLVEDLDRIVAL 304

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 78/296 (26%), Positives = 132/296 (44%), Gaps = 44/296 (14%)
Query: 269 LGTGGFGRVYRGTL-------PKSQIEIAVKKI-SHESRQGMKEFVAEIVSIGRL-RHRN 319
           LG G FG+V            P    ++AVK + S  + + + + ++E+  +  + +H+N
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQ--------------PKVTLNWIQRFRV 365
           ++ LLG C + G L ++ +Y   G+L +YL  +              P+  L+       
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 155
Query: 366 IKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH-GTDPQTTHV 424
              VA G+ YL     +  IHRD+ A NVL+  +   ++ DFGLAR   H     +TT+ 
Sbjct: 156 AYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 425 VGTLGYLAPEHTRTGKATTSADVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFW 483
              + ++APE       T  +DV+SFG  L E+   G  P          + V+ +F   
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG-------VPVEELFKLL 265
Query: 484 NRGELLEARDPNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQILERDVAL 539
             G  ++         Y+             C H+ P+ RP+ +Q+V+ L+R VAL
Sbjct: 266 KEGHRMDKPSNCTNELYM---------MMRDCWHAVPSQRPTFKQLVEDLDRIVAL 312

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 78/296 (26%), Positives = 132/296 (44%), Gaps = 44/296 (14%)
Query: 269 LGTGGFGRVYRGTL-------PKSQIEIAVKKI-SHESRQGMKEFVAEIVSIGRL-RHRN 319
           LG G FG+V            P    ++AVK + S  + + + + ++E+  +  + +H+N
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQ--------------PKVTLNWIQRFRV 365
           ++ LLG C + G L ++ +Y   G+L +YL  +              P+  L+       
Sbjct: 89  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 148
Query: 366 IKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH-GTDPQTTHV 424
              VA G+ YL     +  IHRD+ A NVL+  +   ++ DFGLAR   H     +TT+ 
Sbjct: 149 AYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 205
Query: 425 VGTLGYLAPEHTRTGKATTSADVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFW 483
              + ++APE       T  +DV+SFG  L E+   G  P          + V+ +F   
Sbjct: 206 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG-------VPVEELFKLL 258
Query: 484 NRGELLEARDPNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQILERDVAL 539
             G  ++         Y+             C H+ P+ RP+ +Q+V+ L+R VAL
Sbjct: 259 KEGHRMDKPSNCTNELYM---------MMRDCWHAVPSQRPTFKQLVEDLDRIVAL 305

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 113/218 (51%), Gaps = 30/218 (13%)
Query: 258 IATKGFREKEL-----LGTGGFGRVYRGT-LPKSQ---IEIAVKKISHES-RQGMKEFVA 307
           +  + F+E EL     LG+G FG V++G  +P+ +   I + +K I  +S RQ  +    
Sbjct: 23  VLARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTD 82
Query: 308 EIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQ-----PKVTLNW-IQ 361
            +++IG L H ++V+LLG C     L LV  Y+P GSL  ++        P++ LNW +Q
Sbjct: 83  HMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQ 141
Query: 362 RFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQT 421
                  +A G++YL    E  ++HR++ A NVLL      ++ DFG+A L     D Q 
Sbjct: 142 -------IAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLP-PDDKQL 190
Query: 422 --THVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEV 457
             +     + ++A E    GK T  +DV+S+G  + E+
Sbjct: 191 LYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWEL 228

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 78/296 (26%), Positives = 132/296 (44%), Gaps = 44/296 (14%)
Query: 269 LGTGGFGRVYRGTL-------PKSQIEIAVKKI-SHESRQGMKEFVAEIVSIGRL-RHRN 319
           LG G FG+V            P    ++AVK + S  + + + + ++E+  +  + +H+N
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQ--------------PKVTLNWIQRFRV 365
           ++ LLG C + G L ++ +Y   G+L +YL  +              P+  L+       
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 140
Query: 366 IKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH-GTDPQTTHV 424
              VA G+ YL     +  IHRD+ A NVL+  +   ++ DFGLAR   H     +TT+ 
Sbjct: 141 AYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 197
Query: 425 VGTLGYLAPEHTRTGKATTSADVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFW 483
              + ++APE       T  +DV+SFG  L E+   G  P          + V+ +F   
Sbjct: 198 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG-------VPVEELFKLL 250
Query: 484 NRGELLEARDPNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQILERDVAL 539
             G  ++         Y+             C H+ P+ RP+ +Q+V+ L+R VAL
Sbjct: 251 KEGHRMDKPSNCTNELYM---------MMRDCWHAVPSQRPTFKQLVEDLDRIVAL 297

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/243 (27%), Positives = 119/243 (48%), Gaps = 28/243 (11%)
Query: 240 EDWELDHGPHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVK--KISHE 297
           +DWE+  G            T G R    +G+G FG VY+G   K   ++AVK   ++  
Sbjct: 1   DDWEIPDGQ----------ITVGQR----IGSGSFGTVYKG---KWHGDVAVKMLNVTAP 43
Query: 298 SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTL 357
           + Q ++ F  E+  + + RH N++  +GY   K +L +V  +    SL  +L+   +   
Sbjct: 44  TPQQLQAFKNEVGVLRKTRHVNILLFMGYST-KPQLAIVTQWCEGSSLYHHLHI-IETKF 101
Query: 358 NWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT 417
             I+   + +  A G+ YLH    + +IHRD+K++N+ L  +L  ++GDFGLA      +
Sbjct: 102 EMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWS 158
Query: 418 -DPQTTHVVGTLGYLAPEHTRTGKA---TTSADVFSFGAFLLEVACGRRPIQRQGPSENL 473
              Q   + G++ ++APE  R       +  +DV++FG  L E+  G+ P       + +
Sbjct: 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI 218
Query: 474 ILV 476
           I +
Sbjct: 219 IFM 221

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 126/271 (46%), Gaps = 26/271 (9%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKIS-HESRQGMKEFVAEIVSIGRLRHRNLV 321
           F + E +G G FG V++G   ++Q  +A+K I   E+   +++   EI  + +     + 
Sbjct: 25  FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVT 84
Query: 322 QLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
           +  G   +  +L ++ +Y+  GS    L   P    +  Q   ++K +  GL YLH E +
Sbjct: 85  KYYGSYLKGSKLWIIMEYLGGGSALDLLRAGP---FDEFQIATMLKEILKGLDYLHSEKK 141
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLA-RLYDHGTDPQTTHVVGTLGYLAPEHTRTGK 440
              IHRD+KA+NVLL  + + +L DFG+A +L D  T  +    VGT  ++APE  +   
Sbjct: 142 ---IHRDIKAANVLLSEQGDVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPEVIQQSA 196
Query: 441 ATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEY 500
             + AD++S G   +E+A G  P     P   L L+             +   P L    
Sbjct: 197 YDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIP------------KNNPPTL---- 240
Query: 501 VAXXXXXXXXXXXXCSHSDPTARPSMRQVVQ 531
           V             C + DP+ RP+ +++++
Sbjct: 241 VGDFTKSFKEFIDACLNKDPSFRPTAKELLK 271

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/296 (26%), Positives = 134/296 (45%), Gaps = 44/296 (14%)
Query: 269 LGTGGFGRVYRGTL-------PKSQIEIAVKKISHE-SRQGMKEFVAEIVSIGRL-RHRN 319
           LG G FG+V            PK  + +AVK +  + + + + + V+E+  +  + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYL-----------YD---QPKVTLNWIQRFRV 365
           ++ LLG C + G L ++  Y   G+L +YL           YD    P+  + +      
Sbjct: 103 IINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 366 IKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHV 424
              +A G+ YL     Q  IHRD+ A NVL+      ++ DFGLAR + +     +TT+ 
Sbjct: 163 TYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 425 VGTLGYLAPEHTRTGKATTSADVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFW 483
              + ++APE       T  +DV+SFG  + E+   G  P     P    I V+ +F   
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY----PG---IPVEELFKLL 272
Query: 484 NRGELLEARDPNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQILERDVAL 539
             G  ++ +  N   E               C H+ P+ RP+ +Q+V+ L+R + L
Sbjct: 273 KEGHRMD-KPANCTNELY--------MMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/220 (31%), Positives = 114/220 (51%), Gaps = 30/220 (13%)
Query: 256 LYIATKGFREKEL-----LGTGGFGRVYRGT-LPKSQ---IEIAVKKISHES-RQGMKEF 305
           + +  + F+E EL     LG+G FG V++G  +P+ +   I + +K I  +S RQ  +  
Sbjct: 3   MKVLARIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAV 62
Query: 306 VAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQ-----PKVTLNW- 359
              +++IG L H ++V+LLG C     L LV  Y+P GSL  ++        P++ LNW 
Sbjct: 63  TDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWG 121
Query: 360 IQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP 419
           +Q       +A G++YL    E  ++HR++ A NVLL      ++ DFG+A L     D 
Sbjct: 122 VQ-------IAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLP-PDDK 170
Query: 420 QT--THVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEV 457
           Q   +     + ++A E    GK T  +DV+S+G  + E+
Sbjct: 171 QLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWEL 210

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/296 (26%), Positives = 134/296 (45%), Gaps = 44/296 (14%)
Query: 269 LGTGGFGRVYRGTL-------PKSQIEIAVKKISHE-SRQGMKEFVAEIVSIGRL-RHRN 319
           LG G FG+V            PK  + +AVK +  + + + + + V+E+  +  + +H+N
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYL-----------YD---QPKVTLNWIQRFRV 365
           ++ LLG C + G L ++  Y   G+L +YL           YD    P+  + +      
Sbjct: 103 IINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 366 IKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHV 424
              +A G+ YL     Q  IHRD+ A NVL+      ++ DFGLAR + +     +TT+ 
Sbjct: 163 TYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219
Query: 425 VGTLGYLAPEHTRTGKATTSADVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFW 483
              + ++APE       T  +DV+SFG  + E+   G  P     P    I V+ +F   
Sbjct: 220 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY----PG---IPVEELFKLL 272
Query: 484 NRGELLEARDPNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQILERDVAL 539
             G  ++ +  N   E               C H+ P+ RP+ +Q+V+ L+R + L
Sbjct: 273 KEGHRMD-KPANCTNELY--------MMMRDCWHAVPSQRPTFKQLVEDLDRILTL 319

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 99/207 (47%), Gaps = 7/207 (3%)
Query: 258 IATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRH 317
           I  +  R +  LG G FG V+ GT       +A+K +   +    + F+ E   + +LRH
Sbjct: 5   IPRESLRLEVKLGQGCFGEVWMGTW-NGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRH 62
Query: 318 RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLH 377
             LVQL      +  + +V +YM  GSL  +L  +    L   Q   +   +A G+ Y+ 
Sbjct: 63  EKLVQLYAVVSEE-PIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE 121
Query: 378 QEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTR 437
           +      +HRD++A+N+L+   L  ++ DFGLARL +             + + APE   
Sbjct: 122 R---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAAL 178
Query: 438 TGKATTSADVFSFGAFLLEVAC-GRRP 463
            G+ T  +DV+SFG  L E+   GR P
Sbjct: 179 YGRFTIKSDVWSFGILLTELTTKGRVP 205

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/243 (27%), Positives = 119/243 (48%), Gaps = 28/243 (11%)
Query: 240 EDWELDHGPHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVK--KISHE 297
           +DWE+  G            T G R    +G+G FG VY+G   K   ++AVK   ++  
Sbjct: 21  DDWEIPDGQ----------ITVGQR----IGSGSFGTVYKG---KWHGDVAVKMLNVTAP 63
Query: 298 SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTL 357
           + Q ++ F  E+  + + RH N++  +GY   K +L +V  +    SL  +L+   +   
Sbjct: 64  TPQQLQAFKNEVGVLRKTRHVNILLFMGYST-KPQLAIVTQWCEGSSLYHHLHI-IETKF 121
Query: 358 NWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT 417
             I+   + +  A G+ YLH    + +IHRD+K++N+ L  +L  ++GDFGLA      +
Sbjct: 122 EMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWS 178
Query: 418 -DPQTTHVVGTLGYLAPEHTRTGKA---TTSADVFSFGAFLLEVACGRRPIQRQGPSENL 473
              Q   + G++ ++APE  R       +  +DV++FG  L E+  G+ P       + +
Sbjct: 179 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI 238
Query: 474 ILV 476
           I +
Sbjct: 239 IFM 241

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/243 (27%), Positives = 119/243 (48%), Gaps = 28/243 (11%)
Query: 240 EDWELDHGPHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVK--KISHE 297
           +DWE+  G            T G R    +G+G FG VY+G   K   ++AVK   ++  
Sbjct: 29  DDWEIPDGQ----------ITVGQR----IGSGSFGTVYKG---KWHGDVAVKMLNVTAP 71
Query: 298 SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTL 357
           + Q ++ F  E+  + + RH N++  +GY   K +L +V  +    SL  +L+   +   
Sbjct: 72  TPQQLQAFKNEVGVLRKTRHVNILLFMGYST-KPQLAIVTQWCEGSSLYHHLH-IIETKF 129
Query: 358 NWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT 417
             I+   + +  A G+ YLH    + +IHRD+K++N+ L  +L  ++GDFGLA      +
Sbjct: 130 EMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWS 186
Query: 418 -DPQTTHVVGTLGYLAPEHTRTGKA---TTSADVFSFGAFLLEVACGRRPIQRQGPSENL 473
              Q   + G++ ++APE  R       +  +DV++FG  L E+  G+ P       + +
Sbjct: 187 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI 246
Query: 474 ILV 476
           I +
Sbjct: 247 IFM 249

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 106/201 (52%), Gaps = 16/201 (7%)
Query: 267 ELLGTGGFGRVYRGTLPKS---QIEIAVKKISHESRQG-MKEFVAEIVSIGRLRHRNLVQ 322
           E++G G FG VY GTL  +   +I  AVK ++  +  G + +F+ E + +    H N++ 
Sbjct: 37  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 96
Query: 323 LLGYC-RRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKG--VALGLFYLHQE 379
           LLG C R +G  L+V  YM +G L  ++ ++   T N   +  +  G  VA G+ +L   
Sbjct: 97  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLAS- 152
Query: 380 WEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVGTL--GYLAPEHT 436
             +  +HRD+ A N +LD +   ++ DFGLAR + D   D         L   ++A E  
Sbjct: 153 --KKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESL 210
Query: 437 RTGKATTSADVFSFGAFLLEV 457
           +T K TT +DV+SFG  L E+
Sbjct: 211 QTQKFTTKSDVWSFGVLLWEL 231

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/243 (27%), Positives = 119/243 (48%), Gaps = 28/243 (11%)
Query: 240 EDWELDHGPHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVK--KISHE 297
           +DWE+  G            T G R    +G+G FG VY+G   K   ++AVK   ++  
Sbjct: 1   DDWEIPDGQ----------ITVGQR----IGSGSFGTVYKG---KWHGDVAVKMLNVTAP 43
Query: 298 SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTL 357
           + Q ++ F  E+  + + RH N++  +GY     +L +V  +    SL  +L+   +   
Sbjct: 44  TPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHI-IETKF 101
Query: 358 NWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT 417
             I+   + +  A G+ YLH    + +IHRD+K++N+ L  +L  ++GDFGLA +    +
Sbjct: 102 EMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158
Query: 418 -DPQTTHVVGTLGYLAPEHTRTGKA---TTSADVFSFGAFLLEVACGRRPIQRQGPSENL 473
              Q   + G++ ++APE  R       +  +DV++FG  L E+  G+ P       + +
Sbjct: 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI 218
Query: 474 ILV 476
           I +
Sbjct: 219 IFM 221

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 103/211 (48%), Gaps = 21/211 (9%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCR 328
           +G+G FG V+ G       ++A+K I  E     ++F+ E   + +L H  LVQL G C 
Sbjct: 18  IGSGQFGLVHLGYWLNKD-KVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 75
Query: 329 RKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVAL----GLFYLHQEWEQVV 384
            +  + LV+++M +G L  YL  Q  +          + G+ L    G+ YL    E  V
Sbjct: 76  EQAPICLVFEFMEHGCLSDYLRTQRGLFAA-----ETLLGMCLDVCEGMAYLE---EACV 127
Query: 385 IHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT---LGYLAPEHTRTGKA 441
           IHRD+ A N L+      ++ DFG+ R      D Q T   GT   + + +PE     + 
Sbjct: 128 IHRDLAARNCLVGENQVIKVSDFGMTRFV---LDDQYTSSTGTKFPVKWASPEVFSFSRY 184
Query: 442 TTSADVFSFGAFLLEV-ACGRRPIQRQGPSE 471
           ++ +DV+SFG  + EV + G+ P + +  SE
Sbjct: 185 SSKSDVWSFGVLMWEVFSEGKIPYENRSNSE 215

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 102/212 (48%), Gaps = 8/212 (3%)
Query: 254 KDLY-IATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSI 312
           KD + I  +  R +  LG G FG V+ GT       +A+K +   +    + F+ E   +
Sbjct: 259 KDAWEIPRESLRLEVKLGQGCFGEVWMGTW-NGTTRVAIKTLKPGT-MSPEAFLQEAQVM 316
Query: 313 GRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALG 372
            +LRH  LVQL      +  + +V +YM  GSL  +L  +    L   Q   +   +A G
Sbjct: 317 KKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 375
Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLA 432
           + Y+ +      +HRD++A+N+L+   L  ++ DFGLARL +             + + A
Sbjct: 376 MAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA 432
Query: 433 PEHTRTGKATTSADVFSFGAFLLEVAC-GRRP 463
           PE    G+ T  +DV+SFG  L E+   GR P
Sbjct: 433 PEAALYGRFTIKSDVWSFGILLTELTTKGRVP 464

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 74/271 (27%), Positives = 128/271 (47%), Gaps = 26/271 (9%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKIS-HESRQGMKEFVAEIVSIGRLRHRNLV 321
           F + E +G G FG V++G   ++Q  +A+K I   E+   +++   EI  + +     + 
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 88
Query: 322 QLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
           +  G   +  +L ++ +Y+  GS    L   P   L+  Q   +++ +  GL YLH E +
Sbjct: 89  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP---LDETQIATILREILKGLDYLHSEKK 145
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLA-RLYDHGTDPQTTHVVGTLGYLAPEHTRTGK 440
              IHRD+KA+NVLL      +L DFG+A +L D  T  +    VGT  ++APE  +   
Sbjct: 146 ---IHRDIKAANVLLSEHGEVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPEVIKQSA 200
Query: 441 ATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEY 500
             + AD++S G   +E+A G  P     P + L L+       N    LE        E+
Sbjct: 201 YDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIP-----KNNPPTLEGNYSKPLKEF 255
Query: 501 VAXXXXXXXXXXXXCSHSDPTARPSMRQVVQ 531
           V             C + +P+ RP+ +++++
Sbjct: 256 VE-----------ACLNKEPSFRPTAKELLK 275

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 103/211 (48%), Gaps = 21/211 (9%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCR 328
           +G+G FG V+ G       ++A+K I  E     ++F+ E   + +L H  LVQL G C 
Sbjct: 15  IGSGQFGLVHLGYWLNKD-KVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 72
Query: 329 RKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVAL----GLFYLHQEWEQVV 384
            +  + LV+++M +G L  YL  Q  +          + G+ L    G+ YL    E  V
Sbjct: 73  EQAPICLVFEFMEHGCLSDYLRTQRGLFAA-----ETLLGMCLDVCEGMAYLE---EACV 124
Query: 385 IHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT---LGYLAPEHTRTGKA 441
           IHRD+ A N L+      ++ DFG+ R      D Q T   GT   + + +PE     + 
Sbjct: 125 IHRDLAARNCLVGENQVIKVSDFGMTRFV---LDDQYTSSTGTKFPVKWASPEVFSFSRY 181
Query: 442 TTSADVFSFGAFLLEV-ACGRRPIQRQGPSE 471
           ++ +DV+SFG  + EV + G+ P + +  SE
Sbjct: 182 SSKSDVWSFGVLMWEVFSEGKIPYENRSNSE 212

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 71/217 (32%), Positives = 96/217 (44%), Gaps = 32/217 (14%)
Query: 266 KELLGTGGFGRVYRGTLPKSQIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQL- 323
           KE LGTGGFG V R     +  ++A+K+   E S +  + +  EI  + +L H N+V   
Sbjct: 20  KERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAR 79
Query: 324 -----LGYCRRKGELLLVYDYMPNGSLDKYL---------YDQPKVTLNWIQRFRVIKGV 369
                L         LL  +Y   G L KYL          + P  TL        +  +
Sbjct: 80  EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTL--------LSDI 131
Query: 370 ALGLFYLHQEWEQVVIHRDVKASNVLLD---GELNGRLGDFGLARLYDHGTDPQTTHVVG 426
           +  L YLH   E  +IHRD+K  N++L      L  ++ D G A+  D G     T  VG
Sbjct: 132 SSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE--LCTEFVG 186
Query: 427 TLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRP 463
           TL YLAPE     K T + D +SFG    E   G RP
Sbjct: 187 TLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 223

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 71/217 (32%), Positives = 96/217 (44%), Gaps = 32/217 (14%)
Query: 266 KELLGTGGFGRVYRGTLPKSQIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQL- 323
           KE LGTGGFG V R     +  ++A+K+   E S +  + +  EI  + +L H N+V   
Sbjct: 19  KERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAR 78
Query: 324 -----LGYCRRKGELLLVYDYMPNGSLDKYL---------YDQPKVTLNWIQRFRVIKGV 369
                L         LL  +Y   G L KYL          + P  TL        +  +
Sbjct: 79  EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTL--------LSDI 130
Query: 370 ALGLFYLHQEWEQVVIHRDVKASNVLLD---GELNGRLGDFGLARLYDHGTDPQTTHVVG 426
           +  L YLH   E  +IHRD+K  N++L      L  ++ D G A+  D G     T  VG
Sbjct: 131 SSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE--LCTEFVG 185
Query: 427 TLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRP 463
           TL YLAPE     K T + D +SFG    E   G RP
Sbjct: 186 TLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRP 222

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 102/212 (48%), Gaps = 8/212 (3%)
Query: 254 KDLY-IATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSI 312
           KD + I  +  R +  LG G FG V+ GT       +A+K +   +    + F+ E   +
Sbjct: 10  KDAWEIPRESLRLEVKLGQGCFGEVWMGTW-NGTTRVAIKTLKPGT-MSPEAFLQEAQVM 67
Query: 313 GRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALG 372
            +LRH  LVQL      +  + +V +YM  GSL  +L  +    L   Q   +   +A G
Sbjct: 68  KKLRHEKLVQLYAVVSEE-PIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASG 126
Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLA 432
           + Y+ +      +HRD++A+N+L+   L  ++ DFGLARL +             + + A
Sbjct: 127 MAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTA 183
Query: 433 PEHTRTGKATTSADVFSFGAFLLEVAC-GRRP 463
           PE    G+ T  +DV+SFG  L E+   GR P
Sbjct: 184 PEAALYGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 102/218 (46%), Gaps = 35/218 (16%)
Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAE--IVSIGRLRHRNLVQLL 324
           EL+G G +G VY+G+L +  +  AVK  S  +RQ    F+ E  I  +  + H N+ + +
Sbjct: 19  ELIGRGRYGAVYKGSLDERPV--AVKVFSFANRQN---FINEKNIYRVPLMEHDNIARFI 73
Query: 325 GYCRR-----KGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQE 379
               R     + E LLV +Y PNGSL KYL      T +W+   R+   V  GL YLH E
Sbjct: 74  VGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH---TSDWVSSCRLAHSVTRGLAYLHTE 130
Query: 380 ------WEQVVIHRDVKASNVLLDGELNGRLGDFGLA------RLYDHG-TDPQTTHVVG 426
                 ++  + HRD+ + NVL+  +    + DFGL+      RL   G  D      VG
Sbjct: 131 LPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVG 190
Query: 427 TLGYLAPEHTRTG-------KATTSADVFSFGAFLLEV 457
           T+ Y+APE             A    D+++ G    E+
Sbjct: 191 TIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEI 228

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 106/203 (52%), Gaps = 14/203 (6%)
Query: 266 KELLGTGGFGRVYRGTLPKSQIEIAVKKISHE--SRQGMKEFVA-EIVSIGRLRHRNLVQ 322
           +E LG G FG+V   T  K+Q ++A+K IS +   +  M   V  EI  +  LRH ++++
Sbjct: 14  RETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIK 73
Query: 323 LLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQ 382
           L        ++++V +Y   G L  Y+ ++ ++T +  +RF   + +   + Y H+    
Sbjct: 74  LYDVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRF--FQQIICAIEYCHR---H 127
Query: 383 VVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGK-- 440
            ++HRD+K  N+LLD  LN ++ DFGL+ +   G   +T+   G+  Y APE    GK  
Sbjct: 128 KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPE-VINGKLY 184
Query: 441 ATTSADVFSFGAFLLEVACGRRP 463
           A    DV+S G  L  +  GR P
Sbjct: 185 AGPEVDVWSCGIVLYVMLVGRLP 207

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 102/212 (48%), Gaps = 8/212 (3%)
Query: 254 KDLY-IATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSI 312
           KD + I  +  R +  LG G FG V+ GT       +A+K +   +    + F+ E   +
Sbjct: 3   KDAWEIPRESLRLEVKLGQGCFGEVWMGTW-NGTTRVAIKTLKPGT-MSPEAFLQEAQVM 60
Query: 313 GRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALG 372
            +LRH  LVQL      +  + +V +YM  GSL  +L  +    L   Q   +   +A G
Sbjct: 61  KKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 119
Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLA 432
           + Y+ +      +HRD++A+N+L+   L  ++ DFGLARL +             + + A
Sbjct: 120 MAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA 176
Query: 433 PEHTRTGKATTSADVFSFGAFLLEVAC-GRRP 463
           PE    G+ T  +DV+SFG  L E+   GR P
Sbjct: 177 PEAALYGRFTIKSDVWSFGILLTELTTKGRVP 208

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 74/271 (27%), Positives = 128/271 (47%), Gaps = 26/271 (9%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKIS-HESRQGMKEFVAEIVSIGRLRHRNLV 321
           F + E +G G FG V++G   ++Q  +A+K I   E+   +++   EI  + +     + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 322 QLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
           +  G   +  +L ++ +Y+  GS    L   P   L+  Q   +++ +  GL YLH E +
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP---LDETQIATILREILKGLDYLHSEKK 140
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLA-RLYDHGTDPQTTHVVGTLGYLAPEHTRTGK 440
              IHRD+KA+NVLL      +L DFG+A +L D  T  +    VGT  ++APE  +   
Sbjct: 141 ---IHRDIKAANVLLSEHGEVKLADFGVAGQLTD--TQIKRNXFVGTPFWMAPEVIKQSA 195
Query: 441 ATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEY 500
             + AD++S G   +E+A G  P     P + L L+       N    LE        E+
Sbjct: 196 YDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIP-----KNNPPTLEGNYSKPLKEF 250
Query: 501 VAXXXXXXXXXXXXCSHSDPTARPSMRQVVQ 531
           V             C + +P+ RP+ +++++
Sbjct: 251 VE-----------ACLNKEPSFRPTAKELLK 270

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 103/211 (48%), Gaps = 21/211 (9%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCR 328
           +G+G FG V+ G       ++A+K I  E     ++F+ E   + +L H  LVQL G C 
Sbjct: 13  IGSGQFGLVHLGYWLNKD-KVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 70
Query: 329 RKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVAL----GLFYLHQEWEQVV 384
            +  + LV+++M +G L  YL  Q  +          + G+ L    G+ YL    E  V
Sbjct: 71  EQAPICLVFEFMEHGCLSDYLRTQRGLFAA-----ETLLGMCLDVCEGMAYLE---EACV 122
Query: 385 IHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT---LGYLAPEHTRTGKA 441
           IHRD+ A N L+      ++ DFG+ R      D Q T   GT   + + +PE     + 
Sbjct: 123 IHRDLAARNCLVGENQVIKVSDFGMTRFV---LDDQYTSSTGTKFPVKWASPEVFSFSRY 179
Query: 442 TTSADVFSFGAFLLEV-ACGRRPIQRQGPSE 471
           ++ +DV+SFG  + EV + G+ P + +  SE
Sbjct: 180 SSKSDVWSFGVLMWEVFSEGKIPYENRSNSE 210

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 95/196 (48%), Gaps = 7/196 (3%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCR 328
           LG G FG V+ GT      ++A+K +   +    + F+ E   + +L+H  LVQL     
Sbjct: 17  LGNGQFGEVWMGTW-NGNTKVAIKTLKPGT-MSPESFLEEAQIMKKLKHDKLVQLYAVVS 74
Query: 329 RKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRD 388
            +  + +V +YM  GSL  +L D     L       +   VA G+ Y+ +      IHRD
Sbjct: 75  EE-PIYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRD 130
Query: 389 VKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVF 448
           ++++N+L+   L  ++ DFGLARL +             + + APE    G+ T  +DV+
Sbjct: 131 LRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVW 190
Query: 449 SFGAFLLE-VACGRRP 463
           SFG  L E V  GR P
Sbjct: 191 SFGILLTELVTKGRVP 206

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 102/212 (48%), Gaps = 8/212 (3%)
Query: 254 KDLY-IATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSI 312
           KD + I  +  R +  LG G FG V+ GT       +A+K +   +    + F+ E   +
Sbjct: 176 KDAWEIPRESLRLEVKLGQGCFGEVWMGTW-NGTTRVAIKTLKPGT-MSPEAFLQEAQVM 233
Query: 313 GRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALG 372
            +LRH  LVQL      +  + +V +YM  GSL  +L  +    L   Q   +   +A G
Sbjct: 234 KKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 292
Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLA 432
           + Y+ +      +HRD++A+N+L+   L  ++ DFGLARL +             + + A
Sbjct: 293 MAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA 349
Query: 433 PEHTRTGKATTSADVFSFGAFLLEVAC-GRRP 463
           PE    G+ T  +DV+SFG  L E+   GR P
Sbjct: 350 PEAALYGRFTIKSDVWSFGILLTELTTKGRVP 381

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 107/215 (49%), Gaps = 33/215 (15%)
Query: 266 KELLGTGGFGRVYRGTLPKS--QIEIAVKKIS-HESRQGMKEFVAEIVSIGRL-RHRNLV 321
           ++++G G FG+V +  + K   +++ A+K++  + S+   ++F  E+  + +L  H N++
Sbjct: 27  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 86
Query: 322 QLLGYCRRKGELLLVYDYMPNGSLDKYL--------------YDQPKVTLNWIQRFRVIK 367
            LLG C  +G L L  +Y P+G+L  +L               +    TL+  Q      
Sbjct: 87  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 146
Query: 368 GVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT 427
            VA G+ YL Q   +  IHR++ A N+L+      ++ DFGL+R        Q  +V  T
Sbjct: 147 DVARGMDYLSQ---KQFIHRNLAARNILVGENYVAKIADFGLSR-------GQEVYVKKT 196
Query: 428 LG-----YLAPEHTRTGKATTSADVFSFGAFLLEV 457
           +G     ++A E       TT++DV+S+G  L E+
Sbjct: 197 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI 231

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 102/212 (48%), Gaps = 8/212 (3%)
Query: 254 KDLY-IATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSI 312
           KD + I  +  R +  LG G FG V+ GT       +A+K +   +    + F+ E   +
Sbjct: 176 KDAWEIPRESLRLEVKLGQGCFGEVWMGTW-NGTTRVAIKTLKPGT-MSPEAFLQEAQVM 233
Query: 313 GRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALG 372
            +LRH  LVQL      +  + +V +YM  GSL  +L  +    L   Q   +   +A G
Sbjct: 234 KKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 292
Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLA 432
           + Y+ +      +HRD++A+N+L+   L  ++ DFGLARL +             + + A
Sbjct: 293 MAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA 349
Query: 433 PEHTRTGKATTSADVFSFGAFLLEVAC-GRRP 463
           PE    G+ T  +DV+SFG  L E+   GR P
Sbjct: 350 PEAALYGRFTIKSDVWSFGILLTELTTKGRVP 381

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 70/255 (27%), Positives = 123/255 (48%), Gaps = 34/255 (13%)
Query: 240 EDWELDHGPHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVK--KISHE 297
           +DWE+  G            T G R    +G+G FG VY+G   K   ++AVK   ++  
Sbjct: 5   DDWEIPDGQ----------ITVGQR----IGSGSFGTVYKG---KWHGDVAVKMLNVTAP 47
Query: 298 SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTL 357
           + Q ++ F  E+  + + RH N++  +GY   K +L +V  +    SL  +L+   +   
Sbjct: 48  TPQQLQAFKNEVGVLRKTRHVNILLFMGYST-KPQLAIVTQWCEGSSLYHHLH-ASETKF 105
Query: 358 NWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT 417
              +   + +  A G+ YLH    + +IHRD+K++N+ L  +   ++GDFGLA +    +
Sbjct: 106 EMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWS 162
Query: 418 -DPQTTHVVGTLGYLAPEHTRTGKA---TTSADVFSFGAFLLEVACGRRPIQRQGPSENL 473
              Q   + G++ ++APE  R   +   +  +DV++FG  L E+  G      Q P  N+
Sbjct: 163 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTG------QLPYSNI 216
Query: 474 ILVDWVFDFWNRGEL 488
              D + +   RG L
Sbjct: 217 NNRDQIIEMVGRGSL 231

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 82.8 bits (203), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 74/271 (27%), Positives = 128/271 (47%), Gaps = 26/271 (9%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKIS-HESRQGMKEFVAEIVSIGRLRHRNLV 321
           F + E +G G FG V++G   ++Q  +A+K I   E+   +++   EI  + +     + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 322 QLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
           +  G   +  +L ++ +Y+  GS    L   P   L+  Q   +++ +  GL YLH E +
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP---LDETQIATILREILKGLDYLHSEKK 125
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLA-RLYDHGTDPQTTHVVGTLGYLAPEHTRTGK 440
              IHRD+KA+NVLL      +L DFG+A +L D  T  +    VGT  ++APE  +   
Sbjct: 126 ---IHRDIKAANVLLSEHGEVKLADFGVAGQLTD--TQIKRNXFVGTPFWMAPEVIKQSA 180
Query: 441 ATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEY 500
             + AD++S G   +E+A G  P     P + L L+       N    LE        E+
Sbjct: 181 YDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIP-----KNNPPTLEGNYSKPLKEF 235
Query: 501 VAXXXXXXXXXXXXCSHSDPTARPSMRQVVQ 531
           V             C + +P+ RP+ +++++
Sbjct: 236 VE-----------ACLNKEPSFRPTAKELLK 255

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 102/212 (48%), Gaps = 8/212 (3%)
Query: 254 KDLY-IATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSI 312
           KD + I  +  R +  LG G FG V+ GT       +A+K +   +    + F+ E   +
Sbjct: 10  KDAWEIPRESLRLEVKLGQGCFGEVWMGTW-NGTTRVAIKTLKPGT-MSPEAFLQEAQVM 67
Query: 313 GRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALG 372
            +LRH  LVQL      +  + +V +YM  GSL  +L  +    L   Q   +   +A G
Sbjct: 68  KKLRHEKLVQLYAVVSEE-PIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASG 126
Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLA 432
           + Y+ +      +HRD++A+N+L+   L  ++ DFGLARL +             + + A
Sbjct: 127 MAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA 183
Query: 433 PEHTRTGKATTSADVFSFGAFLLEVAC-GRRP 463
           PE    G+ T  +DV+SFG  L E+   GR P
Sbjct: 184 PEAALYGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 103/211 (48%), Gaps = 21/211 (9%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCR 328
           +G+G FG V+ G       ++A+K I  E     ++F+ E   + +L H  LVQL G C 
Sbjct: 15  IGSGQFGLVHLGYWLNKD-KVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 72
Query: 329 RKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVAL----GLFYLHQEWEQVV 384
            +  + LV+++M +G L  YL  Q  +          + G+ L    G+ YL    E  V
Sbjct: 73  EQAPICLVFEFMEHGCLSDYLRTQRGLFAA-----ETLLGMCLDVCEGMAYLE---EASV 124
Query: 385 IHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT---LGYLAPEHTRTGKA 441
           IHRD+ A N L+      ++ DFG+ R      D Q T   GT   + + +PE     + 
Sbjct: 125 IHRDLAARNCLVGENQVIKVSDFGMTRFV---LDDQYTSSTGTKFPVKWASPEVFSFSRY 181
Query: 442 TTSADVFSFGAFLLEV-ACGRRPIQRQGPSE 471
           ++ +DV+SFG  + EV + G+ P + +  SE
Sbjct: 182 SSKSDVWSFGVLMWEVFSEGKIPYENRSNSE 212

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 74/271 (27%), Positives = 128/271 (47%), Gaps = 26/271 (9%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKIS-HESRQGMKEFVAEIVSIGRLRHRNLV 321
           F + E +G G FG V++G   ++Q  +A+K I   E+   +++   EI  + +     + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 322 QLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
           +  G   +  +L ++ +Y+  GS    L   P   L+  Q   +++ +  GL YLH E +
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP---LDETQIATILREILKGLDYLHSEKK 125
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLA-RLYDHGTDPQTTHVVGTLGYLAPEHTRTGK 440
              IHRD+KA+NVLL      +L DFG+A +L D  T  +    VGT  ++APE  +   
Sbjct: 126 ---IHRDIKAANVLLSEHGEVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPEVIKQSA 180
Query: 441 ATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEY 500
             + AD++S G   +E+A G  P     P + L L+       N    LE        E+
Sbjct: 181 YDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIP-----KNNPPTLEGNYSKPLKEF 235
Query: 501 VAXXXXXXXXXXXXCSHSDPTARPSMRQVVQ 531
           V             C + +P+ RP+ +++++
Sbjct: 236 VE-----------ACLNKEPSFRPTAKELLK 255

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 76/278 (27%), Positives = 123/278 (44%), Gaps = 41/278 (14%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCR 328
           +G+G FG V+ G       ++A+K I  E      +F+ E   + +L H  LVQL G C 
Sbjct: 35  IGSGQFGLVHLGYWLNKD-KVAIKTIK-EGSMSEDDFIEEAEVMMKLSHPKLVQLYGVCL 92
Query: 329 RKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVAL----GLFYLHQEWEQVV 384
            +  + LV+++M +G L  YL  Q  +          + G+ L    G+ YL    E  V
Sbjct: 93  EQAPICLVFEFMEHGCLSDYLRTQRGLFAA-----ETLLGMCLDVCEGMAYLE---EACV 144
Query: 385 IHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT---LGYLAPEHTRTGKA 441
           IHRD+ A N L+      ++ DFG+ R      D Q T   GT   + + +PE     + 
Sbjct: 145 IHRDLAARNCLVGENQVIKVSDFGMTRFV---LDDQYTSSTGTKFPVKWASPEVFSFSRY 201
Query: 442 TTSADVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEY 500
           ++ +DV+SFG  + EV + G+ P + +  SE +  +   F  +          P L + +
Sbjct: 202 SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK---------PRLASTH 252
Query: 501 VAXXXXXXXXXXXXCSHSDPTARPS----MRQVVQILE 534
           V             C    P  RP+    +RQ+ +I E
Sbjct: 253 V-------YQIMNHCWKERPEDRPAFSRLLRQLAEIAE 283

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 102/212 (48%), Gaps = 8/212 (3%)
Query: 254 KDLY-IATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSI 312
           KD + I  +  R +  LG G FG V+ GT       +A+K +   +    + F+ E   +
Sbjct: 1   KDAWEIPRESLRLEVKLGQGCFGEVWMGTW-NGTTRVAIKTLKPGT-MSPEAFLQEAQVM 58
Query: 313 GRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALG 372
            +LRH  LVQL      +  + +V +YM  GSL  +L  +    L   Q   +   +A G
Sbjct: 59  KKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASG 117
Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLA 432
           + Y+ +      +HRD++A+N+L+   L  ++ DFGLARL +             + + A
Sbjct: 118 MAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA 174
Query: 433 PEHTRTGKATTSADVFSFGAFLLEVAC-GRRP 463
           PE    G+ T  +DV+SFG  L E+   GR P
Sbjct: 175 PEAALYGRFTIKSDVWSFGILLTELTTKGRVP 206

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 102/212 (48%), Gaps = 8/212 (3%)
Query: 254 KDLY-IATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSI 312
           KD + I  +  R +  LG G FG V+ GT       +A+K +   +    + F+ E   +
Sbjct: 10  KDAWEIPRESLRLEVKLGQGCFGEVWMGTW-NGTTRVAIKTLKPGT-MSPEAFLQEAQVM 67
Query: 313 GRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALG 372
            +LRH  LVQL      +  + +V +YM  GSL  +L  +    L   Q   +   +A G
Sbjct: 68  KKLRHEKLVQLYAVVSEE-PIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASG 126
Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLA 432
           + Y+ +      +HRD++A+N+L+   L  ++ DFGLARL +             + + A
Sbjct: 127 MAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA 183
Query: 433 PEHTRTGKATTSADVFSFGAFLLEVAC-GRRP 463
           PE    G+ T  +DV+SFG  L E+   GR P
Sbjct: 184 PEAALYGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 102/212 (48%), Gaps = 8/212 (3%)
Query: 254 KDLY-IATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSI 312
           KD + I  +  R +  LG G FG V+ GT       +A+K +   +    + F+ E   +
Sbjct: 10  KDAWEIPRESLRLEVKLGQGCFGEVWMGTW-NGTTRVAIKTLKPGT-MSPEAFLQEAQVM 67
Query: 313 GRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALG 372
            +LRH  LVQL      +  + +V +YM  GSL  +L  +    L   Q   +   +A G
Sbjct: 68  KKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASG 126
Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLA 432
           + Y+ +      +HRD++A+N+L+   L  ++ DFGLARL +             + + A
Sbjct: 127 MAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA 183
Query: 433 PEHTRTGKATTSADVFSFGAFLLEVAC-GRRP 463
           PE    G+ T  +DV+SFG  L E+   GR P
Sbjct: 184 PEAALYGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 99/207 (47%), Gaps = 7/207 (3%)
Query: 258 IATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRH 317
           I  +  R +  LG G FG V+ GT       +A+K +   +    + F+ E   + +LRH
Sbjct: 4   IPRESLRLEVKLGQGCFGEVWMGTW-NGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRH 61
Query: 318 RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLH 377
             LVQL      +  + +V +YM  GSL  +L  +    L   Q   +   +A G+ Y+ 
Sbjct: 62  EKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE 120
Query: 378 QEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTR 437
           +      +HRD++A+N+L+   L  ++ DFGLARL +             + + APE   
Sbjct: 121 R---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 177
Query: 438 TGKATTSADVFSFGAFLLEVAC-GRRP 463
            G+ T  +DV+SFG  L E+   GR P
Sbjct: 178 YGRFTIKSDVWSFGILLTELTTKGRVP 204

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 97/205 (47%), Gaps = 20/205 (9%)
Query: 269 LGTGGFGRVYRGTLP-----KSQIEIAVKKISH-ESRQGMKEFVAEIVSIGRLRHRNLVQ 322
           LG G FG VY G +       S +++AVK +    S Q   +F+ E + I +  H+N+V+
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 323 LLGYCRRKGELLLVYDYMPNGSLDKYLYD------QPKVTLNWIQRFRVIKGVALGLFYL 376
            +G   +     ++ + M  G L  +L +      QP  +L  +    V + +A G  YL
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPS-SLAMLDLLHVARDIACGCQYL 197
Query: 377 HQEWEQVVIHRDVKASNVLLDGELNGR---LGDFGLAR-LYDHGTDPQTTHVVGTLGYLA 432
               E   IHRD+ A N LL     GR   +GDFG+AR +Y  G   +    +  + ++ 
Sbjct: 198 E---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMP 254
Query: 433 PEHTRTGKATTSADVFSFGAFLLEV 457
           PE    G  T+  D +SFG  L E+
Sbjct: 255 PEAFMEGIFTSKTDTWSFGVLLWEI 279

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 7/209 (3%)
Query: 269 LGTGGFGR--VYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
           +G G FG+  + + T    Q  I    IS  S +  +E   E+  +  ++H N+VQ    
Sbjct: 32  IGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRES 91
Query: 327 CRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIH 386
               G L +V DY   G L K +  Q  V     Q       + L L ++H   ++ ++H
Sbjct: 92  FEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH---DRKILH 148
Query: 387 RDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSAD 446
           RD+K+ N+ L  +   +LGDFG+AR+ +  T       +GT  YL+PE          +D
Sbjct: 149 RDIKSQNIFLTKDGTVQLGDFGIARVLN-STVELARACIGTPYYLSPEICENKPYNNKSD 207
Query: 447 VFSFGAFLLEVACGRRPIQRQGPSENLIL 475
           +++ G  L E+ C  +     G  +NL+L
Sbjct: 208 IWALGCVLYEL-CTLKHAFEAGSMKNLVL 235

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 97/205 (47%), Gaps = 20/205 (9%)
Query: 269 LGTGGFGRVYRGTLP-----KSQIEIAVKKISH-ESRQGMKEFVAEIVSIGRLRHRNLVQ 322
           LG G FG VY G +       S +++AVK +    S Q   +F+ E + I +  H+N+V+
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 115
Query: 323 LLGYCRRKGELLLVYDYMPNGSLDKYLYD------QPKVTLNWIQRFRVIKGVALGLFYL 376
            +G   +     ++ + M  G L  +L +      QP  +L  +    V + +A G  YL
Sbjct: 116 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPS-SLAMLDLLHVARDIACGCQYL 174
Query: 377 HQEWEQVVIHRDVKASNVLLDGELNGR---LGDFGLAR-LYDHGTDPQTTHVVGTLGYLA 432
               E   IHRD+ A N LL     GR   +GDFG+AR +Y  G   +    +  + ++ 
Sbjct: 175 E---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMP 231
Query: 433 PEHTRTGKATTSADVFSFGAFLLEV 457
           PE    G  T+  D +SFG  L E+
Sbjct: 232 PEAFMEGIFTSKTDTWSFGVLLWEI 256

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 100/209 (47%), Gaps = 22/209 (10%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKI-------SHESRQGMKEFVAEIVSIGRLRHRNLV 321
           +G GGFG V++G L K +  +A+K +         E  +  +EF  E+  +  L H N+V
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 322 QLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
           +L G         +V +++P G L   L D+    + W  + R++  +ALG+ Y+ Q   
Sbjct: 87  KLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAH-PIKWSVKLRLMLDIALGIEYM-QNQN 142
Query: 382 QVVIHRDVKASNVLL-----DGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEH- 435
             ++HRD+++ N+ L     +  +  ++ DFGL++   H      + ++G   ++APE  
Sbjct: 143 PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS----VSGLLGNFQWMAPETI 198
Query: 436 -TRTGKATTSADVFSFGAFLLEVACGRRP 463
                  T  AD +SF   L  +  G  P
Sbjct: 199 GAEEESYTEKADTYSFAMILYTILTGEGP 227

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 102/212 (48%), Gaps = 8/212 (3%)
Query: 254 KDLY-IATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSI 312
           KD + I  +  R +  LG G FG V+ GT       +A+K +   +    + F+ E   +
Sbjct: 7   KDAWEIPRESLRLEVKLGQGCFGEVWMGTW-NGTTRVAIKTLKPGT-MSPEAFLQEAQVM 64
Query: 313 GRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALG 372
            +LRH  LVQL      +  + +V +YM  GSL  +L  +    L   Q   +   +A G
Sbjct: 65  KKLRHEKLVQLYAVVSEE-PIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASG 123
Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLA 432
           + Y+ +      +HRD++A+N+L+   L  ++ DFGLARL +             + + A
Sbjct: 124 MAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTA 180
Query: 433 PEHTRTGKATTSADVFSFGAFLLEVAC-GRRP 463
           PE    G+ T  +DV+SFG  L E+   GR P
Sbjct: 181 PEAALYGRFTIKSDVWSFGILLTELTTKGRVP 212

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 77/286 (26%), Positives = 128/286 (44%), Gaps = 32/286 (11%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQ-GMKEFVAEIVSIGRLRHRNLV 321
           +  +E++G+G    V        + ++A+K+I+ E  Q  M E + EI ++ +  H N+V
Sbjct: 12  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 71
Query: 322 QLLGYCRRKGELLLVYDYMPNGS-LD--KYLY---DQPKVTLNWIQRFRVIKGVALGLFY 375
                   K EL LV   +  GS LD  K++    +     L+      +++ V  GL Y
Sbjct: 72  SYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEY 131
Query: 376 LHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHV----VGTLGYL 431
           LH+  +   IHRDVKA N+LL  + + ++ DFG++     G D     V    VGT  ++
Sbjct: 132 LHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWM 188
Query: 432 APEHTRTGKATT-SADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLE 490
           APE     +     AD++SFG   +E+A G  P  +  P + L+L             L+
Sbjct: 189 APEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLT------------LQ 236
Query: 491 ARDPNLGT-----EYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQ 531
              P+L T     E +             C   DP  RP+  ++++
Sbjct: 237 NDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 282

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 102/212 (48%), Gaps = 8/212 (3%)
Query: 254 KDLY-IATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSI 312
           KD + I  +  R +  LG G FG V+ GT       +A+K +   +    + F+ E   +
Sbjct: 176 KDAWEIPRESLRLEVKLGQGCFGEVWMGTW-NGTTRVAIKTLKPGT-MSPEAFLQEAQVM 233
Query: 313 GRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALG 372
            +LRH  LVQL      +  + +V +YM  GSL  +L  +    L   Q   +   +A G
Sbjct: 234 KKLRHEKLVQLYAVVSEE-PIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 292
Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLA 432
           + Y+ +      +HRD++A+N+L+   L  ++ DFGLARL +             + + A
Sbjct: 293 MAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA 349
Query: 433 PEHTRTGKATTSADVFSFGAFLLEVAC-GRRP 463
           PE    G+ T  +DV+SFG  L E+   GR P
Sbjct: 350 PEAALYGRFTIKSDVWSFGILLTELTTKGRVP 381

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 112/207 (54%), Gaps = 23/207 (11%)
Query: 263 FREKELLGTGGFGRVYRGT-LPKSQ---IEIAVKKISHES-RQGMKEFVAEIVSIGRLRH 317
            +  ++LG+G FG VY+G  +P+ +   I +A+K ++  +  +   EF+ E + +  + H
Sbjct: 17  LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDH 76
Query: 318 RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQP-----KVTLNWIQRFRVIKGVALG 372
            +LV+LLG C     + LV   MP+G L +Y+++       ++ LNW  +      +A G
Sbjct: 77  PHLVRLLGVCLSPT-IQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQ------IAKG 129
Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTL--GY 430
           + YL    E+ ++HRD+ A NVL+    + ++ DFGLARL + G + +     G +   +
Sbjct: 130 MMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLE-GDEKEYNADGGKMPIKW 185
Query: 431 LAPEHTRTGKATTSADVFSFGAFLLEV 457
           +A E     K T  +DV+S+G  + E+
Sbjct: 186 MALECIHYRKFTHQSDVWSYGVTIWEL 212

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 82.0 bits (201), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 77/283 (27%), Positives = 127/283 (44%), Gaps = 32/283 (11%)
Query: 266 KELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQ-GMKEFVAEIVSIGRLRHRNLVQLL 324
           +E++G+G    V        + ++A+K+I+ E  Q  M E + EI ++ +  H N+V   
Sbjct: 20  QEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYY 79
Query: 325 GYCRRKGELLLVYDYMPNGS-LD--KYLY---DQPKVTLNWIQRFRVIKGVALGLFYLHQ 378
                K EL LV   +  GS LD  K++    +     L+      +++ V  GL YLH+
Sbjct: 80  TSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK 139
Query: 379 EWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHV----VGTLGYLAPE 434
             +   IHRDVKA N+LL  + + ++ DFG++     G D     V    VGT  ++APE
Sbjct: 140 NGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPE 196
Query: 435 HTRTGKATT-SADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARD 493
                +     AD++SFG   +E+A G  P  +  P + L+L             L+   
Sbjct: 197 VMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLT------------LQNDP 244
Query: 494 PNLGT-----EYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQ 531
           P+L T     E +             C   DP  RP+  ++++
Sbjct: 245 PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR 287

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 102/212 (48%), Gaps = 8/212 (3%)
Query: 254 KDLY-IATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSI 312
           KD + I  +  R +  LG G FG V+ GT       +A+K +   +    + F+ E   +
Sbjct: 7   KDAWEIPRESLRLEVKLGQGCFGEVWMGTW-NGTTRVAIKTLKPGT-MSPEAFLQEAQVM 64
Query: 313 GRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALG 372
            +LRH  LVQL      +  + +V +YM  GSL  +L  +    L   Q   +   +A G
Sbjct: 65  KKLRHEKLVQLYAVVSEE-PIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASG 123
Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLA 432
           + Y+ +      +HRD++A+N+L+   L  ++ DFGLARL +             + + A
Sbjct: 124 MAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA 180
Query: 433 PEHTRTGKATTSADVFSFGAFLLEVAC-GRRP 463
           PE    G+ T  +DV+SFG  L E+   GR P
Sbjct: 181 PEAALYGRFTIKSDVWSFGILLTELTTKGRVP 212

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 112/207 (54%), Gaps = 23/207 (11%)
Query: 263 FREKELLGTGGFGRVYRGT-LPKSQ---IEIAVKKISHES-RQGMKEFVAEIVSIGRLRH 317
            +  ++LG+G FG VY+G  +P+ +   I +A+K ++  +  +   EF+ E + +  + H
Sbjct: 40  LKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDH 99
Query: 318 RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQP-----KVTLNWIQRFRVIKGVALG 372
            +LV+LLG C     + LV   MP+G L +Y+++       ++ LNW  +      +A G
Sbjct: 100 PHLVRLLGVCLSP-TIQLVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQ------IAKG 152
Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTL--GY 430
           + YL    E+ ++HRD+ A NVL+    + ++ DFGLARL + G + +     G +   +
Sbjct: 153 MMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLE-GDEKEYNADGGKMPIKW 208
Query: 431 LAPEHTRTGKATTSADVFSFGAFLLEV 457
           +A E     K T  +DV+S+G  + E+
Sbjct: 209 MALECIHYRKFTHQSDVWSYGVTIWEL 235

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 99/209 (47%), Gaps = 22/209 (10%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKI-------SHESRQGMKEFVAEIVSIGRLRHRNLV 321
           +G GGFG V++G L K +  +A+K +         E  +  +EF  E+  +  L H N+V
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 322 QLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
           +L G         +V +++P G L   L D+    + W  + R++  +ALG+ Y+ Q   
Sbjct: 87  KLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAH-PIKWSVKLRLMLDIALGIEYM-QNQN 142
Query: 382 QVVIHRDVKASNVLLDG-ELNGRLGDFGLARLYDHGTDPQTTHVV----GTLGYLAPEH- 435
             ++HRD+++ N+ L   + N  +     A++ D GT  Q+ H V    G   ++APE  
Sbjct: 143 PPIVHRDLRSPNIFLQSLDENAPV----CAKVADFGTSQQSVHSVSGLLGNFQWMAPETI 198
Query: 436 -TRTGKATTSADVFSFGAFLLEVACGRRP 463
                  T  AD +SF   L  +  G  P
Sbjct: 199 GAEEESYTEKADTYSFAMILYTILTGEGP 227

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 102/212 (48%), Gaps = 8/212 (3%)
Query: 254 KDLY-IATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSI 312
           KD + I  +  R +  LG G FG V+ GT       +A+K +   +    + F+ E   +
Sbjct: 10  KDAWEIPRESLRLEVKLGQGCFGEVWMGTW-NGTTRVAIKTLKPGT-MSPEAFLQEAQVM 67
Query: 313 GRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALG 372
            ++RH  LVQL      +  + +V +YM  GSL  +L  +    L   Q   +   +A G
Sbjct: 68  KKIRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASG 126
Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLA 432
           + Y+ +      +HRD++A+N+L+   L  ++ DFGLARL +             + + A
Sbjct: 127 MAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA 183
Query: 433 PEHTRTGKATTSADVFSFGAFLLEVAC-GRRP 463
           PE    G+ T  +DV+SFG  L E+   GR P
Sbjct: 184 PEAALYGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 102/211 (48%), Gaps = 21/211 (9%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCR 328
           +G+G FG V+ G       ++A+K I  E     ++F+ E   + +L H  LVQL G C 
Sbjct: 16  IGSGQFGLVHLGYWLNKD-KVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 73
Query: 329 RKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVAL----GLFYLHQEWEQVV 384
            +  + LV ++M +G L  YL  Q  +          + G+ L    G+ YL    E  V
Sbjct: 74  EQAPICLVTEFMEHGCLSDYLRTQRGLFAA-----ETLLGMCLDVCEGMAYLE---EACV 125
Query: 385 IHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT---LGYLAPEHTRTGKA 441
           IHRD+ A N L+      ++ DFG+ R      D Q T   GT   + + +PE     + 
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRFV---LDDQYTSSTGTKFPVKWASPEVFSFSRY 182
Query: 442 TTSADVFSFGAFLLEV-ACGRRPIQRQGPSE 471
           ++ +DV+SFG  + EV + G+ P + +  SE
Sbjct: 183 SSKSDVWSFGVLMWEVFSEGKIPYENRSNSE 213

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 101/212 (47%), Gaps = 8/212 (3%)
Query: 254 KDLY-IATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSI 312
           KD + I  +  R +  LG G FG V+ GT       +A+K +   +    + F+ E   +
Sbjct: 10  KDAWEIPRESLRLEVKLGQGCFGEVWMGTW-NGTTRVAIKTLKPGT-MSPEAFLQEAQVM 67
Query: 313 GRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALG 372
            +LRH  LVQL      +  + +V +YM  GSL  +L  +    L   Q   +   +A G
Sbjct: 68  KKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASG 126
Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLA 432
           + Y+ +      +HRD+ A+N+L+   L  ++ DFGLARL +             + + A
Sbjct: 127 MAYVER---MNYVHRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA 183
Query: 433 PEHTRTGKATTSADVFSFGAFLLEVAC-GRRP 463
           PE    G+ T  +DV+SFG  L E+   GR P
Sbjct: 184 PEAALYGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 98/205 (47%), Gaps = 20/205 (9%)
Query: 269 LGTGGFGRVYRGT---LPK--SQIEIAVKKISH-ESRQGMKEFVAEIVSIGRLRHRNLVQ 322
           LG G FG VY G    +P   S +++AVK +    S Q   +F+ E + I +L H+N+V+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 323 LLGYCRRKGELLLVYDYMPNGSLDKYLYD------QPKVTLNWIQRFRVIKGVALGLFYL 376
            +G   +     ++ + M  G L  +L +      QP  +L  +    V + +A G  YL
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPS-SLAMLDLLHVARDIACGCQYL 157
Query: 377 HQEWEQVVIHRDVKASNVLLDGELNGR---LGDFGLAR-LYDHGTDPQTTHVVGTLGYLA 432
               E   IHRD+ A N LL     GR   +GDFG+AR +Y      +    +  + ++ 
Sbjct: 158 E---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 214
Query: 433 PEHTRTGKATTSADVFSFGAFLLEV 457
           PE    G  T+  D +SFG  L E+
Sbjct: 215 PEAFMEGIFTSKTDTWSFGVLLWEI 239

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 97/205 (47%), Gaps = 20/205 (9%)
Query: 269 LGTGGFGRVYRGTLP-----KSQIEIAVKKISH-ESRQGMKEFVAEIVSIGRLRHRNLVQ 322
           LG G FG VY G +       S +++AVK +    S Q   +F+ E + I +L H+N+V+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 323 LLGYCRRKGELLLVYDYMPNGSLDKYLYD------QPKVTLNWIQRFRVIKGVALGLFYL 376
            +G   +     ++ + M  G L  +L +      QP  +L  +    V + +A G  YL
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPS-SLAMLDLLHVARDIACGCQYL 171
Query: 377 HQEWEQVVIHRDVKASNVLLDGELNGR---LGDFGLAR-LYDHGTDPQTTHVVGTLGYLA 432
               E   IHRD+ A N LL     GR   +GDFG+AR +Y      +    +  + ++ 
Sbjct: 172 E---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 228
Query: 433 PEHTRTGKATTSADVFSFGAFLLEV 457
           PE    G  T+  D +SFG  L E+
Sbjct: 229 PEAFMEGIFTSKTDTWSFGVLLWEI 253

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 109/211 (51%), Gaps = 9/211 (4%)
Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
           E LG G +G VY+    ++   +A+K++  ES   ++E + EI  + +    ++V+  G 
Sbjct: 35  EKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGS 92
Query: 327 CRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIH 386
             +  +L +V +Y   GS+   +  + K TL   +   +++    GL YLH   +   IH
Sbjct: 93  YFKNTDLWIVMEYCGAGSVSDIIRLRNK-TLTEDEIATILQSTLKGLEYLHFMRK---IH 148
Query: 387 RDVKASNVLLDGELNGRLGDFGLA-RLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSA 445
           RD+KA N+LL+ E + +L DFG+A +L D     +   V+GT  ++APE  +       A
Sbjct: 149 RDIKAGNILLNTEGHAKLADFGVAGQLTDXMA--KRNXVIGTPFWMAPEVIQEIGYNCVA 206
Query: 446 DVFSFGAFLLEVACGRRPIQRQGPSENLILV 476
           D++S G   +E+A G+ P     P   + ++
Sbjct: 207 DIWSLGITAIEMAEGKPPYADIHPMRAIFMI 237

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 101/212 (47%), Gaps = 8/212 (3%)
Query: 254 KDLY-IATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSI 312
           KD + I  +  R +  LG G FG V+ GT       +A+K +   +    + F+ E   +
Sbjct: 10  KDAWEIPRESLRLEVKLGQGCFGEVWMGTW-NGTTRVAIKTLKPGT-MSPEAFLQEAQVM 67
Query: 313 GRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALG 372
            +LRH  LVQL      +  + +V +YM  G L  +L  +    L   Q   +   +A G
Sbjct: 68  KKLRHEKLVQLYAVVSEE-PIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASG 126
Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLA 432
           + Y+ +      +HRD++A+N+L+   L  ++ DFGLARL +             + + A
Sbjct: 127 MAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA 183
Query: 433 PEHTRTGKATTSADVFSFGAFLLEVAC-GRRP 463
           PE    G+ T  +DV+SFG  L E+   GR P
Sbjct: 184 PEAALYGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 100/212 (47%), Gaps = 8/212 (3%)
Query: 254 KDLY-IATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSI 312
           KD + I  +  R +  LG G FG V+ GT       +A+K +        + F+ E   +
Sbjct: 177 KDAWEIPRESLRLEVKLGQGCFGEVWMGTW-NGTTRVAIKTLK-PGNMSPEAFLQEAQVM 234
Query: 313 GRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALG 372
            +LRH  LVQL      +  + +V +YM  GSL  +L  +    L   Q   +   +A G
Sbjct: 235 KKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASG 293
Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLA 432
           + Y+ +      +HRD++A+N+L+   L  ++ DFGL RL +             + + A
Sbjct: 294 MAYVER---MNYVHRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWTA 350
Query: 433 PEHTRTGKATTSADVFSFGAFLLEVAC-GRRP 463
           PE    G+ T  +DV+SFG  L E+   GR P
Sbjct: 351 PEAALYGRFTIKSDVWSFGILLTELTTKGRVP 382

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 101/201 (50%), Gaps = 21/201 (10%)
Query: 269 LGTGGFGRV----YRGTLPKSQIEIAVKKISHES----RQGMKEFVAEIVSIGRLRHRNL 320
           LG G FG+V    Y  T   +   +AVK +  +     R G K+   EI  +  L H ++
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQ---EIDILRTLYHEHI 78
Query: 321 VQLLGYCRRKGE--LLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQ 378
           ++  G C  +GE  L LV +Y+P GSL  YL   P+ ++   Q     + +  G+ YLH 
Sbjct: 79  IKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL---PRHSIGLAQLLLFAQQICEGMAYLHS 135
Query: 379 EWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT--LGYLAPEHT 436
              Q  IHR++ A NVLLD +   ++GDFGLA+    G +       G   + + APE  
Sbjct: 136 ---QHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL 192
Query: 437 RTGKATTSADVFSFGAFLLEV 457
           +  K   ++DV+SFG  L E+
Sbjct: 193 KEYKFYYASDVWSFGVTLYEL 213

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 101/212 (47%), Gaps = 8/212 (3%)
Query: 254 KDLY-IATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSI 312
           KD + I  +  R +  LG G FG V+ GT       +A+K +   +    + F+ E   +
Sbjct: 10  KDAWEIPRESLRLEVKLGQGCFGEVWMGTW-NGTTRVAIKTLKPGT-MSPEAFLQEAQVM 67
Query: 313 GRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALG 372
            +LRH  LVQL      +  + +V +YM  G L  +L  +    L   Q   +   +A G
Sbjct: 68  KKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASG 126
Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLA 432
           + Y+ +      +HRD++A+N+L+   L  ++ DFGLARL +             + + A
Sbjct: 127 MAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA 183
Query: 433 PEHTRTGKATTSADVFSFGAFLLEVAC-GRRP 463
           PE    G+ T  +DV+SFG  L E+   GR P
Sbjct: 184 PEAALYGRFTIKSDVWSFGILLTELTTKGRVP 215

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 110/216 (50%), Gaps = 16/216 (7%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCR 328
           LG G FG+VY+    ++ +  A K I  +S + +++++ EI  +    H N+V+LL    
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 329 RKGELLLVYDYMPNGSLDKYLYDQPK-VTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHR 387
            +  L ++ ++   G++D  + +  + +T + IQ   V K     L YLH   +  +IHR
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERPLTESQIQ--VVCKQTLDALNYLH---DNKIIHR 159
Query: 388 DVKASNVL--LDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE--HTRTGKA-- 441
           D+KA N+L  LDG++  +L DFG++   +  T  +    +GT  ++APE     T K   
Sbjct: 160 DLKAGNILFTLDGDI--KLADFGVSA-KNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRP 216
Query: 442 -TTSADVFSFGAFLLEVACGRRPIQRQGPSENLILV 476
               ADV+S G  L+E+A    P     P   L+ +
Sbjct: 217 YDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI 252

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/255 (27%), Positives = 122/255 (47%), Gaps = 34/255 (13%)
Query: 240 EDWELDHGPHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVK--KISHE 297
           +DWE+  G            T G R    +G+G FG VY+G   K   ++AVK   ++  
Sbjct: 17  DDWEIPDGQ----------ITVGQR----IGSGSFGTVYKG---KWHGDVAVKMLNVTAP 59
Query: 298 SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTL 357
           + Q ++ F  E+  + + RH N++  +GY   K +L +V  +    SL  +L+   +   
Sbjct: 60  TPQQLQAFKNEVGVLRKTRHVNILLFMGYST-KPQLAIVTQWCEGSSLYHHLH-ASETKF 117
Query: 358 NWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT 417
              +   + +  A G+ YLH    + +IHRD+K++N+ L  +   ++GDFGLA      +
Sbjct: 118 EMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS 174
Query: 418 -DPQTTHVVGTLGYLAPEHTRTGKA---TTSADVFSFGAFLLEVACGRRPIQRQGPSENL 473
              Q   + G++ ++APE  R   +   +  +DV++FG  L E+  G      Q P  N+
Sbjct: 175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTG------QLPYSNI 228
Query: 474 ILVDWVFDFWNRGEL 488
              D + +   RG L
Sbjct: 229 NNRDQIIEMVGRGSL 243

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 101/201 (50%), Gaps = 21/201 (10%)
Query: 269 LGTGGFGRV----YRGTLPKSQIEIAVKKISHES----RQGMKEFVAEIVSIGRLRHRNL 320
           LG G FG+V    Y  T   +   +AVK +  +     R G K+   EI  +  L H ++
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQ---EIDILRTLYHEHI 78
Query: 321 VQLLGYCRRKGE--LLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQ 378
           ++  G C  +GE  L LV +Y+P GSL  YL   P+ ++   Q     + +  G+ YLH 
Sbjct: 79  IKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL---PRHSIGLAQLLLFAQQICEGMAYLHA 135
Query: 379 EWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT--LGYLAPEHT 436
              Q  IHR++ A NVLLD +   ++GDFGLA+    G +       G   + + APE  
Sbjct: 136 ---QHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL 192
Query: 437 RTGKATTSADVFSFGAFLLEV 457
           +  K   ++DV+SFG  L E+
Sbjct: 193 KEYKFYYASDVWSFGVTLYEL 213

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 106/222 (47%), Gaps = 8/222 (3%)
Query: 244 LDHGPHRFRYKDLY-IATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGM 302
           +   P +   KD + I  +  + ++ LG G FG V+  T  K   ++AVK +   S   +
Sbjct: 170 MSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGS-MSV 227
Query: 303 KEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQR 362
           + F+AE   +  L+H  LV+L      K  + ++ ++M  GSL  +L           + 
Sbjct: 228 EAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKL 286
Query: 363 FRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTT 422
                 +A G+ ++ Q   +  IHRD++A+N+L+   L  ++ DFGLAR+ +        
Sbjct: 287 IDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTARE 343
Query: 423 HVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRP 463
                + + APE    G  T  +DV+SFG  L+E+   GR P
Sbjct: 344 GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIP 385

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/201 (33%), Positives = 100/201 (49%), Gaps = 21/201 (10%)
Query: 269 LGTGGFGRV----YRGTLPKSQIEIAVKKISHES----RQGMKEFVAEIVSIGRLRHRNL 320
           LG G FG+V    Y  T   +   +AVK +  ++    R G K+   EI  +  L H ++
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQ---EIDILRTLYHEHI 95
Query: 321 VQLLGYCRRKG--ELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQ 378
           ++  G C   G   L LV +Y+P GSL  YL   P+ ++   Q     + +  G+ YLH 
Sbjct: 96  IKYKGCCEDAGAASLQLVMEYVPLGSLRDYL---PRHSIGLAQLLLFAQQICEGMAYLHA 152
Query: 379 EWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT--LGYLAPEHT 436
              Q  IHRD+ A NVLLD +   ++GDFGLA+    G +       G   + + APE  
Sbjct: 153 ---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECL 209
Query: 437 RTGKATTSADVFSFGAFLLEV 457
           +  K   ++DV+SFG  L E+
Sbjct: 210 KEYKFYYASDVWSFGVTLYEL 230

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 102/206 (49%), Gaps = 16/206 (7%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAV-KKISH----ESRQGMKEFVAEIVSIGRLRHRNLVQL 323
           +GTG +GR  +    KS  +I V K++ +    E+ + M   V+E+  +  L+H N+V+ 
Sbjct: 14  IGTGSYGRCQK-IRRKSDGKILVWKELDYGSMTEAEKQM--LVSEVNLLRELKHPNIVRY 70
Query: 324 LGYC--RRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRF--RVIKGVALGLFYLHQE 379
                 R    L +V +Y   G L   +    K      + F  RV+  + L L   H+ 
Sbjct: 71  YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR 130
Query: 380 WE--QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTR 437
            +    V+HRD+K +NV LDG+ N +LGDFGLAR+ +H T    T  VGT  Y++PE   
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT-FVGTPYYMSPEQMN 189
Query: 438 TGKATTSADVFSFGAFLLEVACGRRP 463
                  +D++S G  L E+ C   P
Sbjct: 190 RMSYNEKSDIWSLGCLLYEL-CALMP 214

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 80.5 bits (197), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 103/212 (48%), Gaps = 8/212 (3%)
Query: 254 KDLY-IATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSI 312
           KD + I  +  + ++ LG G FG V+  T  K   ++AVK +   S   ++ F+AE   +
Sbjct: 7   KDAWEIPRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGS-MSVEAFLAEANVM 64
Query: 313 GRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALG 372
             L+H  LV+L      K  + ++ ++M  GSL  +L           +       +A G
Sbjct: 65  KTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEG 123
Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLA 432
           + ++ Q   +  IHRD++A+N+L+   L  ++ DFGLAR+ +             + + A
Sbjct: 124 MAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTA 180
Query: 433 PEHTRTGKATTSADVFSFGAFLLEVAC-GRRP 463
           PE    G  T  +DV+SFG  L+E+   GR P
Sbjct: 181 PEAINFGSFTIKSDVWSFGILLMEIVTYGRIP 212

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 96/205 (46%), Gaps = 20/205 (9%)
Query: 269 LGTGGFGRVYRGTLP-----KSQIEIAVKKISH-ESRQGMKEFVAEIVSIGRLRHRNLVQ 322
           LG G FG VY G +       S +++AVK +    S Q   +F+ E + I +  H+N+V+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 323 LLGYCRRKGELLLVYDYMPNGSLDKYLYD------QPKVTLNWIQRFRVIKGVALGLFYL 376
            +G   +     ++ + M  G L  +L +      QP  +L  +    V + +A G  YL
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPS-SLAMLDLLHVARDIACGCQYL 156
Query: 377 HQEWEQVVIHRDVKASNVLLDGELNGR---LGDFGLAR-LYDHGTDPQTTHVVGTLGYLA 432
               E   IHRD+ A N LL     GR   +GDFG+AR +Y      +    +  + ++ 
Sbjct: 157 E---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 213
Query: 433 PEHTRTGKATTSADVFSFGAFLLEV 457
           PE    G  T+  D +SFG  L E+
Sbjct: 214 PEAFMEGIFTSKTDTWSFGVLLWEI 238

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 96/205 (46%), Gaps = 20/205 (9%)
Query: 269 LGTGGFGRVYRGTLP-----KSQIEIAVKKISH-ESRQGMKEFVAEIVSIGRLRHRNLVQ 322
           LG G FG VY G +       S +++AVK +    S Q   +F+ E + I +  H+N+V+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 323 LLGYCRRKGELLLVYDYMPNGSLDKYLYD------QPKVTLNWIQRFRVIKGVALGLFYL 376
            +G   +     ++ + M  G L  +L +      QP  +L  +    V + +A G  YL
Sbjct: 98  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPS-SLAMLDLLHVARDIACGCQYL 156
Query: 377 HQEWEQVVIHRDVKASNVLLDGELNGR---LGDFGLAR-LYDHGTDPQTTHVVGTLGYLA 432
               E   IHRD+ A N LL     GR   +GDFG+AR +Y      +    +  + ++ 
Sbjct: 157 E---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 213
Query: 433 PEHTRTGKATTSADVFSFGAFLLEV 457
           PE    G  T+  D +SFG  L E+
Sbjct: 214 PEAFMEGIFTSKTDTWSFGVLLWEI 238

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 96/205 (46%), Gaps = 20/205 (9%)
Query: 269 LGTGGFGRVYRGTLP-----KSQIEIAVKKISH-ESRQGMKEFVAEIVSIGRLRHRNLVQ 322
           LG G FG VY G +       S +++AVK +    S Q   +F+ E + I +  H+N+V+
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 323 LLGYCRRKGELLLVYDYMPNGSLDKYLYD------QPKVTLNWIQRFRVIKGVALGLFYL 376
            +G   +     ++ + M  G L  +L +      QP  +L  +    V + +A G  YL
Sbjct: 90  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPS-SLAMLDLLHVARDIACGCQYL 148
Query: 377 HQEWEQVVIHRDVKASNVLLDGELNGR---LGDFGLAR-LYDHGTDPQTTHVVGTLGYLA 432
               E   IHRD+ A N LL     GR   +GDFG+AR +Y      +    +  + ++ 
Sbjct: 149 E---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 205
Query: 433 PEHTRTGKATTSADVFSFGAFLLEV 457
           PE    G  T+  D +SFG  L E+
Sbjct: 206 PEAFMEGIFTSKTDTWSFGVLLWEI 230

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 99/209 (47%), Gaps = 22/209 (10%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKI-------SHESRQGMKEFVAEIVSIGRLRHRNLV 321
           +G GGFG V++G L K +  +A+K +         E  +  +EF  E+  +  L H N+V
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 322 QLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
           +L G         +V +++P G L   L D+    + W  + R++  +ALG+ Y+ Q   
Sbjct: 87  KLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAH-PIKWSVKLRLMLDIALGIEYM-QNQN 142
Query: 382 QVVIHRDVKASNVLL-----DGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEH- 435
             ++HRD+++ N+ L     +  +  ++ DF L++   H      + ++G   ++APE  
Sbjct: 143 PPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQSVHS----VSGLLGNFQWMAPETI 198
Query: 436 -TRTGKATTSADVFSFGAFLLEVACGRRP 463
                  T  AD +SF   L  +  G  P
Sbjct: 199 GAEEESYTEKADTYSFAMILYTILTGEGP 227

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 96/205 (46%), Gaps = 20/205 (9%)
Query: 269 LGTGGFGRVYRGTLP-----KSQIEIAVKKISH-ESRQGMKEFVAEIVSIGRLRHRNLVQ 322
           LG G FG VY G +       S +++AVK +    S Q   +F+ E + I +  H+N+V+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 323 LLGYCRRKGELLLVYDYMPNGSLDKYLYD------QPKVTLNWIQRFRVIKGVALGLFYL 376
            +G   +     ++ + M  G L  +L +      QP  +L  +    V + +A G  YL
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPS-SLAMLDLLHVARDIACGCQYL 157
Query: 377 HQEWEQVVIHRDVKASNVLLDGELNGR---LGDFGLAR-LYDHGTDPQTTHVVGTLGYLA 432
               E   IHRD+ A N LL     GR   +GDFG+AR +Y      +    +  + ++ 
Sbjct: 158 E---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 214
Query: 433 PEHTRTGKATTSADVFSFGAFLLEV 457
           PE    G  T+  D +SFG  L E+
Sbjct: 215 PEAFMEGIFTSKTDTWSFGVLLWEI 239

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 96/205 (46%), Gaps = 20/205 (9%)
Query: 269 LGTGGFGRVYRGTLP-----KSQIEIAVKKISH-ESRQGMKEFVAEIVSIGRLRHRNLVQ 322
           LG G FG VY G +       S +++AVK +    S Q   +F+ E + I +  H+N+V+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 323 LLGYCRRKGELLLVYDYMPNGSLDKYLYD------QPKVTLNWIQRFRVIKGVALGLFYL 376
            +G   +     ++ + M  G L  +L +      QP  +L  +    V + +A G  YL
Sbjct: 113 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPS-SLAMLDLLHVARDIACGCQYL 171
Query: 377 HQEWEQVVIHRDVKASNVLLDGELNGR---LGDFGLAR-LYDHGTDPQTTHVVGTLGYLA 432
               E   IHRD+ A N LL     GR   +GDFG+AR +Y      +    +  + ++ 
Sbjct: 172 E---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 228
Query: 433 PEHTRTGKATTSADVFSFGAFLLEV 457
           PE    G  T+  D +SFG  L E+
Sbjct: 229 PEAFMEGIFTSKTDTWSFGVLLWEI 253

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 98/198 (49%), Gaps = 10/198 (5%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCR 328
           LG G FG V+ G    S  ++AVK +   +   ++ F+ E   +  L+H  LV+L     
Sbjct: 21  LGAGQFGEVWMGYYNNS-TKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVT 78
Query: 329 RKGELLLVYDYMPNGSLDKYLYDQP--KVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIH 386
           R+  + ++ +YM  GSL  +L      KV L  +  F     +A G+ Y+ +   +  IH
Sbjct: 79  REEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSA--QIAEGMAYIER---KNYIH 133
Query: 387 RDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSAD 446
           RD++A+NVL+   L  ++ DFGLAR+ +             + + APE    G  T  +D
Sbjct: 134 RDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSD 193
Query: 447 VFSFGAFLLEVAC-GRRP 463
           V+SFG  L E+   G+ P
Sbjct: 194 VWSFGILLYEIVTYGKIP 211

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 96/205 (46%), Gaps = 20/205 (9%)
Query: 269 LGTGGFGRVYRGTLP-----KSQIEIAVKKISH-ESRQGMKEFVAEIVSIGRLRHRNLVQ 322
           LG G FG VY G +       S +++AVK +    S Q   +F+ E + I +  H+N+V+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 323 LLGYCRRKGELLLVYDYMPNGSLDKYLYD------QPKVTLNWIQRFRVIKGVALGLFYL 376
            +G   +     ++ + M  G L  +L +      QP  +L  +    V + +A G  YL
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPS-SLAMLDLLHVARDIACGCQYL 171
Query: 377 HQEWEQVVIHRDVKASNVLLDGELNGR---LGDFGLAR-LYDHGTDPQTTHVVGTLGYLA 432
               E   IHRD+ A N LL     GR   +GDFG+AR +Y      +    +  + ++ 
Sbjct: 172 E---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 228
Query: 433 PEHTRTGKATTSADVFSFGAFLLEV 457
           PE    G  T+  D +SFG  L E+
Sbjct: 229 PEAFMEGIFTSKTDTWSFGVLLWEI 253

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 99/210 (47%), Gaps = 16/210 (7%)
Query: 261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQG---MKEFVAEIVSIGRLRH 317
           K F +   +G G FG VY     ++   +A+KK+S+  +Q     ++ + E+  + +LRH
Sbjct: 54  KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 113
Query: 318 RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLH 377
            N +Q  G   R+    LV +Y    + D  L +  K  L  ++   V  G   GL YLH
Sbjct: 114 PNTIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAAVTHGALQGLAYLH 171
Query: 378 QEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE--- 434
                 +IHRDVKA N+LL      +LGDFG A +            VGT  ++APE   
Sbjct: 172 S---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM-----APANXFVGTPYWMAPEVIL 223
Query: 435 HTRTGKATTSADVFSFGAFLLEVACGRRPI 464
               G+     DV+S G   +E+A  + P+
Sbjct: 224 AMDEGQYDGKVDVWSLGITCIELAERKPPL 253

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 96/205 (46%), Gaps = 20/205 (9%)
Query: 269 LGTGGFGRVYRGTLP-----KSQIEIAVKKISH-ESRQGMKEFVAEIVSIGRLRHRNLVQ 322
           LG G FG VY G +       S +++AVK +    S Q   +F+ E + I +  H+N+V+
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 323 LLGYCRRKGELLLVYDYMPNGSLDKYLYD------QPKVTLNWIQRFRVIKGVALGLFYL 376
            +G   +     ++ + M  G L  +L +      QP  +L  +    V + +A G  YL
Sbjct: 115 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPS-SLAMLDLLHVARDIACGCQYL 173
Query: 377 HQEWEQVVIHRDVKASNVLLDGELNGR---LGDFGLAR-LYDHGTDPQTTHVVGTLGYLA 432
               E   IHRD+ A N LL     GR   +GDFG+AR +Y      +    +  + ++ 
Sbjct: 174 E---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 230
Query: 433 PEHTRTGKATTSADVFSFGAFLLEV 457
           PE    G  T+  D +SFG  L E+
Sbjct: 231 PEAFMEGIFTSKTDTWSFGVLLWEI 255

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 96/205 (46%), Gaps = 20/205 (9%)
Query: 269 LGTGGFGRVYRGTLP-----KSQIEIAVKKISH-ESRQGMKEFVAEIVSIGRLRHRNLVQ 322
           LG G FG VY G +       S +++AVK +    S Q   +F+ E + I +  H+N+V+
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 323 LLGYCRRKGELLLVYDYMPNGSLDKYLYD------QPKVTLNWIQRFRVIKGVALGLFYL 376
            +G   +     ++ + M  G L  +L +      QP  +L  +    V + +A G  YL
Sbjct: 105 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPS-SLAMLDLLHVARDIACGCQYL 163
Query: 377 HQEWEQVVIHRDVKASNVLLDGELNGR---LGDFGLAR-LYDHGTDPQTTHVVGTLGYLA 432
               E   IHRD+ A N LL     GR   +GDFG+AR +Y      +    +  + ++ 
Sbjct: 164 E---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 220
Query: 433 PEHTRTGKATTSADVFSFGAFLLEV 457
           PE    G  T+  D +SFG  L E+
Sbjct: 221 PEAFMEGIFTSKTDTWSFGVLLWEI 245

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 109/216 (50%), Gaps = 16/216 (7%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCR 328
           LG G FG+VY+    ++ +  A K I  +S + +++++ EI  +    H N+V+LL    
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 329 RKGELLLVYDYMPNGSLDKYLYDQPK-VTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHR 387
            +  L ++ ++   G++D  + +  + +T + IQ   V K     L YLH   +  +IHR
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERPLTESQIQ--VVCKQTLDALNYLH---DNKIIHR 159
Query: 388 DVKASNVL--LDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE--HTRTGKA-- 441
           D+KA N+L  LDG++  +L DFG++         + +  +GT  ++APE     T K   
Sbjct: 160 DLKAGNILFTLDGDI--KLADFGVSAKNTRXIQRRDS-FIGTPYWMAPEVVMCETSKDRP 216
Query: 442 -TTSADVFSFGAFLLEVACGRRPIQRQGPSENLILV 476
               ADV+S G  L+E+A    P     P   L+ +
Sbjct: 217 YDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI 252

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 79.7 bits (195), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 105/204 (51%), Gaps = 22/204 (10%)
Query: 269 LGTGGFGRV----YRGTLPKSQIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQL 323
           LG G FG+V    +  T  K  ++I  KK+  +S  QG  E   EI  +  LRH ++++L
Sbjct: 22  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLRHPHIIKL 79
Query: 324 LGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRF--RVIKGVALGLFYLHQEWE 381
               + K E+++V +Y  N   D Y+  + K++    +RF  ++I  V     Y H+   
Sbjct: 80  YDVIKSKDEIIMVIEYAGNELFD-YIVQRDKMSEQEARRFFQQIISAVE----YCHR--- 131
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGK- 440
             ++HRD+K  N+LLD  LN ++ DFGL+ +   G   +T+   G+  Y APE   +GK 
Sbjct: 132 HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPE-VISGKL 188
Query: 441 -ATTSADVFSFGAFLLEVACGRRP 463
            A    DV+S G  L  + C R P
Sbjct: 189 YAGPEVDVWSCGVILYVMLCRRLP 212

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 79.7 bits (195), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 105/204 (51%), Gaps = 22/204 (10%)
Query: 269 LGTGGFGRV----YRGTLPKSQIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQL 323
           LG G FG+V    +  T  K  ++I  KK+  +S  QG  E   EI  +  LRH ++++L
Sbjct: 21  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLRHPHIIKL 78
Query: 324 LGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRF--RVIKGVALGLFYLHQEWE 381
               + K E+++V +Y  N   D Y+  + K++    +RF  ++I  V     Y H+   
Sbjct: 79  YDVIKSKDEIIMVIEYAGNELFD-YIVQRDKMSEQEARRFFQQIISAVE----YCHR--- 130
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGK- 440
             ++HRD+K  N+LLD  LN ++ DFGL+ +   G   +T+   G+  Y APE   +GK 
Sbjct: 131 HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPE-VISGKL 187
Query: 441 -ATTSADVFSFGAFLLEVACGRRP 463
            A    DV+S G  L  + C R P
Sbjct: 188 YAGPEVDVWSCGVILYVMLCRRLP 211

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 99/210 (47%), Gaps = 16/210 (7%)
Query: 261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQG---MKEFVAEIVSIGRLRH 317
           K F +   +G G FG VY     ++   +A+KK+S+  +Q     ++ + E+  + +LRH
Sbjct: 15  KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 318 RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLH 377
            N +Q  G   R+    LV +Y    + D  L +  K  L  ++   V  G   GL YLH
Sbjct: 75  PNTIQYRGCYLREHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIAAVTHGALQGLAYLH 132
Query: 378 QEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE--- 434
                 +IHRDVKA N+LL      +LGDFG A +            VGT  ++APE   
Sbjct: 133 S---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM-----APANXFVGTPYWMAPEVIL 184
Query: 435 HTRTGKATTSADVFSFGAFLLEVACGRRPI 464
               G+     DV+S G   +E+A  + P+
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERKPPL 214

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 97/205 (47%), Gaps = 20/205 (9%)
Query: 269 LGTGGFGRVYRGT---LPK--SQIEIAVKKISH-ESRQGMKEFVAEIVSIGRLRHRNLVQ 322
           LG G FG VY G    +P   S +++AVK +    S Q   +F+ E + I +  H+N+V+
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 323 LLGYCRRKGELLLVYDYMPNGSLDKYLYD------QPKVTLNWIQRFRVIKGVALGLFYL 376
            +G   +     ++ + M  G L  +L +      QP  +L  +    V + +A G  YL
Sbjct: 125 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPS-SLAMLDLLHVARDIACGCQYL 183
Query: 377 HQEWEQVVIHRDVKASNVLLDGELNGR---LGDFGLAR-LYDHGTDPQTTHVVGTLGYLA 432
               E   IHRD+ A N LL     GR   +GDFG+AR +Y      +    +  + ++ 
Sbjct: 184 E---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 240
Query: 433 PEHTRTGKATTSADVFSFGAFLLEV 457
           PE    G  T+  D +SFG  L E+
Sbjct: 241 PEAFMEGIFTSKTDTWSFGVLLWEI 265

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 104/202 (51%), Gaps = 18/202 (8%)
Query: 269 LGTGGFGRV----YRGTLPKSQIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQL 323
           LG G FG+V    +  T  K  ++I  KK+  +S  QG  E   EI  +  LRH ++++L
Sbjct: 12  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLRHPHIIKL 69
Query: 324 LGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQV 383
               + K E+++V +Y  N   D Y+  + K++    +RF   + +   + Y H+     
Sbjct: 70  YDVIKSKDEIIMVIEYAGNELFD-YIVQRDKMSEQEARRF--FQQIISAVEYCHR---HK 123
Query: 384 VIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGK--A 441
           ++HRD+K  N+LLD  LN ++ DFGL+ +   G   +T+   G+  Y APE   +GK  A
Sbjct: 124 IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPE-VISGKLYA 180
Query: 442 TTSADVFSFGAFLLEVACGRRP 463
               DV+S G  L  + C R P
Sbjct: 181 GPEVDVWSCGVILYVMLCRRLP 202

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 101/206 (49%), Gaps = 16/206 (7%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAV-KKISH----ESRQGMKEFVAEIVSIGRLRHRNLVQL 323
           +GTG +GR  +    KS  +I V K++ +    E+ + M   V+E+  +  L+H N+V+ 
Sbjct: 14  IGTGSYGRCQK-IRRKSDGKILVWKELDYGSMTEAEKQM--LVSEVNLLRELKHPNIVRY 70
Query: 324 LGYC--RRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRF--RVIKGVALGLFYLHQE 379
                 R    L +V +Y   G L   +    K      + F  RV+  + L L   H+ 
Sbjct: 71  YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR 130
Query: 380 WE--QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTR 437
            +    V+HRD+K +NV LDG+ N +LGDFGLAR+ +H  D      VGT  Y++PE   
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDED-FAKEFVGTPYYMSPEQMN 189
Query: 438 TGKATTSADVFSFGAFLLEVACGRRP 463
                  +D++S G  L E+ C   P
Sbjct: 190 RMSYNEKSDIWSLGCLLYEL-CALMP 214

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 64/239 (26%), Positives = 111/239 (46%), Gaps = 25/239 (10%)
Query: 254 KDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIG 313
           ++LY  +   +  E+   G FG V++  L    + + +  I  + +    E+  E+ S+ 
Sbjct: 17  ENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPI-QDKQSWQNEY--EVYSLP 73
Query: 314 RLRHRNLVQLLGYCRRKG----ELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGV 369
            ++H N++Q +G  +R      +L L+  +   GSL  +L       ++W +   + + +
Sbjct: 74  GMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN---VVSWNELCHIAETM 130
Query: 370 ALGLFYLHQE-------WEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTT 422
           A GL YLH++        +  + HRD+K+ NVLL   L   + DFGLA  ++ G     T
Sbjct: 131 ARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDT 190
Query: 423 H-VVGTLGYLAPEHTRTG-----KATTSADVFSFGAFLLEVACGRRPIQRQGPSENLIL 475
           H  VGT  Y+APE           A    D+++ G  L E+A   R     GP +  +L
Sbjct: 191 HGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELA--SRCTAADGPVDEYML 247

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 108/216 (50%), Gaps = 16/216 (7%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCR 328
           LG G FG+VY+    ++ +  A K I  +S + +++++ EI  +    H N+V+LL    
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 329 RKGELLLVYDYMPNGSLDKYLYDQPK-VTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHR 387
            +  L ++ ++   G++D  + +  + +T + IQ   V K     L YLH   +  +IHR
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERPLTESQIQ--VVCKQTLDALNYLH---DNKIIHR 159
Query: 388 DVKASNVL--LDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE--HTRTGKA-- 441
           D+KA N+L  LDG++  +L DFG++         +    +GT  ++APE     T K   
Sbjct: 160 DLKAGNILFTLDGDI--KLADFGVSAKNTRXIQ-RRDXFIGTPYWMAPEVVMCETSKDRP 216
Query: 442 -TTSADVFSFGAFLLEVACGRRPIQRQGPSENLILV 476
               ADV+S G  L+E+A    P     P   L+ +
Sbjct: 217 YDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI 252

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 105/204 (51%), Gaps = 22/204 (10%)
Query: 269 LGTGGFGRV----YRGTLPKSQIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQL 323
           LG G FG+V    +  T  K  ++I  KK+  +S  QG  E   EI  +  LRH ++++L
Sbjct: 16  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLRHPHIIKL 73
Query: 324 LGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRF--RVIKGVALGLFYLHQEWE 381
               + K E+++V +Y  N   D Y+  + K++    +RF  ++I  V     Y H+   
Sbjct: 74  YDVIKSKDEIIMVIEYAGNELFD-YIVQRDKMSEQEARRFFQQIISAVE----YCHR--- 125
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGK- 440
             ++HRD+K  N+LLD  LN ++ DFGL+ +   G   +T+   G+  Y APE   +GK 
Sbjct: 126 HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPE-VISGKL 182
Query: 441 -ATTSADVFSFGAFLLEVACGRRP 463
            A    DV+S G  L  + C R P
Sbjct: 183 YAGPEVDVWSCGVILYVMLCRRLP 206

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 78/297 (26%), Positives = 138/297 (46%), Gaps = 45/297 (15%)
Query: 269 LGTGGFGRVYRGTLP-----KSQIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQ 322
           LG G FG VY G        +++  +AVK ++   S +   EF+ E   +      ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 323 LLGYCRRKGELLLVYDYMPNGSLDKYLYD----------QPKVTLNWIQRFRVIKGVALG 372
           LLG   +    L+V + M +G L  YL            +P  TL   +  ++   +A G
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQ--EMIQMAAEIADG 142
Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVGTLGYL 431
           + YL+    +  +HRD+ A N ++  +   ++GDFG+ R +Y+     +    +  + ++
Sbjct: 143 MAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRWM 199
Query: 432 APEHTRTGKATTSADVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFWNRGELLE 490
           APE  + G  TTS+D++SFG  L E+ +   +P   QG S   +L  +V D    G  L+
Sbjct: 200 APESLKDGVFTTSSDMWSFGVVLWEITSLAEQPY--QGLSNEQVL-KFVMD----GGYLD 252
Query: 491 ARD--PNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQILERDV--ALPAIS 543
             D  P   T+ +             C   +P  RP+  ++V +L+ D+  + P +S
Sbjct: 253 QPDNCPERVTDLM-----------RMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVS 298

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 69/255 (27%), Positives = 121/255 (47%), Gaps = 34/255 (13%)
Query: 240 EDWELDHGPHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVK--KISHE 297
           +DWE+  G            T G R    +G+G FG VY+G   K   ++AVK   ++  
Sbjct: 17  DDWEIPDGQ----------ITVGQR----IGSGSFGTVYKG---KWHGDVAVKMLNVTAP 59
Query: 298 SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTL 357
           + Q ++ F  E+  + + RH N++  +GY     +L +V  +    SL  +L+   +   
Sbjct: 60  TPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLH-ASETKF 117
Query: 358 NWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT 417
              +   + +  A G+ YLH    + +IHRD+K++N+ L  +   ++GDFGLA      +
Sbjct: 118 EMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS 174
Query: 418 -DPQTTHVVGTLGYLAPEHTRTGKA---TTSADVFSFGAFLLEVACGRRPIQRQGPSENL 473
              Q   + G++ ++APE  R   +   +  +DV++FG  L E+  G      Q P  N+
Sbjct: 175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTG------QLPYSNI 228
Query: 474 ILVDWVFDFWNRGEL 488
              D + +   RG L
Sbjct: 229 NNRDQIIEMVGRGSL 243

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 102/202 (50%), Gaps = 13/202 (6%)
Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMK---EFVAEIVSIGRLRHRNLVQL 323
           + LG G FG+V  G    +  ++AVK ++ +  + +    +   EI ++   RH ++++L
Sbjct: 22  DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81
Query: 324 LGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQV 383
                   ++ +V +Y+  G L  Y+    +  L+  +  R+ + +  G+ Y H+    +
Sbjct: 82  YQVISTPSDIFMVMEYVSGGELFDYICKNGR--LDEKESRRLFQQILSGVDYCHR---HM 136
Query: 384 VIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGK--A 441
           V+HRD+K  NVLLD  +N ++ DFGL+ +   G   + +   G+  Y APE   +G+  A
Sbjct: 137 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXS--CGSPNYAAPE-VISGRLYA 193
Query: 442 TTSADVFSFGAFLLEVACGRRP 463
               D++S G  L  + CG  P
Sbjct: 194 GPEVDIWSSGVILYALLCGTLP 215

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 67/242 (27%), Positives = 111/242 (45%), Gaps = 36/242 (14%)
Query: 245 DHGPHRFRYKDLYIATKGFREKELLGTGGFGRVY----RGTLP-KSQIEIAVKKISHESR 299
           D   H  + +D+ +       K  LG G FG+V+       LP + ++ +AVK +   S 
Sbjct: 32  DACVHHIKRRDIVL-------KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE 84
Query: 300 QGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLY--------- 350
              ++F  E   +  L+H+++V+  G C     LL+V++YM +G L+++L          
Sbjct: 85  SARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLL 144
Query: 351 ----DQPKVTLNWIQRFRVIKGVALGLFY---LHQEWEQVVIHRDVKASNVLLDGELNGR 403
               D     L   Q   V   VA G+ Y   LH       +HRD+   N L+   L  +
Sbjct: 145 AGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH------FVHRDLATRNCLVGQGLVVK 198
Query: 404 LGDFGLAR-LYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEV-ACGR 461
           +GDFG++R +Y           +  + ++ PE     K TT +DV+SFG  L E+   G+
Sbjct: 199 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGK 258
Query: 462 RP 463
           +P
Sbjct: 259 QP 260

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 125/271 (46%), Gaps = 26/271 (9%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKIS-HESRQGMKEFVAEIVSIGRLRHRNLV 321
           F + + +G G FG VY+G    ++  +A+K I   E+   +++   EI  + +     + 
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 80
Query: 322 QLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
           +  G   +  +L ++ +Y+  GS    L   P   L       +++ +  GL YLH E +
Sbjct: 81  RYFGSYLKSTKLWIIMEYLGGGSALDLLKPGP---LEETYIATILREILKGLDYLHSERK 137
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLA-RLYDHGTDPQTTHVVGTLGYLAPEHTRTGK 440
              IHRD+KA+NVLL  + + +L DFG+A +L D  T  +    VGT  ++APE  +   
Sbjct: 138 ---IHRDIKAANVLLSEQGDVKLADFGVAGQLTD--TQIKRNXFVGTPFWMAPEVIKQSA 192
Query: 441 ATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEY 500
               AD++S G   +E+A G  P     P   L L+       N    LE +      E+
Sbjct: 193 YDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIP-----KNSPPTLEGQHSKPFKEF 247
Query: 501 VAXXXXXXXXXXXXCSHSDPTARPSMRQVVQ 531
           V             C + DP  RP+ +++++
Sbjct: 248 VE-----------ACLNKDPRFRPTAKELLK 267

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 67/242 (27%), Positives = 111/242 (45%), Gaps = 36/242 (14%)
Query: 245 DHGPHRFRYKDLYIATKGFREKELLGTGGFGRVY----RGTLP-KSQIEIAVKKISHESR 299
           D   H  + +D+ +       K  LG G FG+V+       LP + ++ +AVK +   S 
Sbjct: 9   DACVHHIKRRDIVL-------KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE 61
Query: 300 QGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLY--------- 350
              ++F  E   +  L+H+++V+  G C     LL+V++YM +G L+++L          
Sbjct: 62  SARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLL 121
Query: 351 ----DQPKVTLNWIQRFRVIKGVALGLFY---LHQEWEQVVIHRDVKASNVLLDGELNGR 403
               D     L   Q   V   VA G+ Y   LH       +HRD+   N L+   L  +
Sbjct: 122 AGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH------FVHRDLATRNCLVGQGLVVK 175
Query: 404 LGDFGLAR-LYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEV-ACGR 461
           +GDFG++R +Y           +  + ++ PE     K TT +DV+SFG  L E+   G+
Sbjct: 176 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGK 235
Query: 462 RP 463
           +P
Sbjct: 236 QP 237

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 101/206 (49%), Gaps = 16/206 (7%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAV-KKISH----ESRQGMKEFVAEIVSIGRLRHRNLVQL 323
           +GTG +GR  +    KS  +I V K++ +    E+ + M   V+E+  +  L+H N+V+ 
Sbjct: 14  IGTGSYGRCQK-IRRKSDGKILVWKELDYGSMTEAEKQM--LVSEVNLLRELKHPNIVRY 70
Query: 324 LGYC--RRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRF--RVIKGVALGLFYLHQE 379
                 R    L +V +Y   G L   +    K      + F  RV+  + L L   H+ 
Sbjct: 71  YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR 130
Query: 380 WE--QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTR 437
            +    V+HRD+K +NV LDG+ N +LGDFGLAR+ +H T       VGT  Y++PE   
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA-FVGTPYYMSPEQMN 189
Query: 438 TGKATTSADVFSFGAFLLEVACGRRP 463
                  +D++S G  L E+ C   P
Sbjct: 190 RMSYNEKSDIWSLGCLLYEL-CALMP 214

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/242 (27%), Positives = 111/242 (45%), Gaps = 36/242 (14%)
Query: 245 DHGPHRFRYKDLYIATKGFREKELLGTGGFGRVY----RGTLP-KSQIEIAVKKISHESR 299
           D   H  + +D+ +       K  LG G FG+V+       LP + ++ +AVK +   S 
Sbjct: 3   DACVHHIKRRDIVL-------KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE 55
Query: 300 QGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLY--------- 350
              ++F  E   +  L+H+++V+  G C     LL+V++YM +G L+++L          
Sbjct: 56  SARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLL 115
Query: 351 ----DQPKVTLNWIQRFRVIKGVALGLFY---LHQEWEQVVIHRDVKASNVLLDGELNGR 403
               D     L   Q   V   VA G+ Y   LH       +HRD+   N L+   L  +
Sbjct: 116 AGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH------FVHRDLATRNCLVGQGLVVK 169
Query: 404 LGDFGLAR-LYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEV-ACGR 461
           +GDFG++R +Y           +  + ++ PE     K TT +DV+SFG  L E+   G+
Sbjct: 170 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGK 229
Query: 462 RP 463
           +P
Sbjct: 230 QP 231

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 78/297 (26%), Positives = 138/297 (46%), Gaps = 45/297 (15%)
Query: 269 LGTGGFGRVYRGTLP-----KSQIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQ 322
           LG G FG VY G        +++  +AVK ++   S +   EF+ E   +      ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 323 LLGYCRRKGELLLVYDYMPNGSLDKYLYD----------QPKVTLNWIQRFRVIKGVALG 372
           LLG   +    L+V + M +G L  YL            +P  TL   +  ++   +A G
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQ--EMIQMAAEIADG 142
Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVGTLGYL 431
           + YL+    +  +HRD+ A N ++  +   ++GDFG+ R +Y+     +    +  + ++
Sbjct: 143 MAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 199
Query: 432 APEHTRTGKATTSADVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFWNRGELLE 490
           APE  + G  TTS+D++SFG  L E+ +   +P   QG S   +L  +V D    G  L+
Sbjct: 200 APESLKDGVFTTSSDMWSFGVVLWEITSLAEQPY--QGLSNEQVL-KFVMD----GGYLD 252
Query: 491 ARD--PNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQILERDV--ALPAIS 543
             D  P   T+ +             C   +P  RP+  ++V +L+ D+  + P +S
Sbjct: 253 QPDNCPERVTDLM-----------RMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVS 298

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 96/205 (46%), Gaps = 20/205 (9%)
Query: 269 LGTGGFGRVYRGTLP-----KSQIEIAVKKISH-ESRQGMKEFVAEIVSIGRLRHRNLVQ 322
           LG G FG VY G +       S +++AVK +    S Q   +F+ E + I +  H+N+V+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 323 LLGYCRRKGELLLVYDYMPNGSLDKYLYD------QPKVTLNWIQRFRVIKGVALGLFYL 376
            +G   +     ++ + M  G L  +L +      QP  +L  +    V + +A G  YL
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPS-SLAMLDLLHVARDIACGCQYL 157
Query: 377 HQEWEQVVIHRDVKASNVLLDGELNGR---LGDFGLAR-LYDHGTDPQTTHVVGTLGYLA 432
               E   IHRD+ A N LL     GR   +GDFG+A+ +Y      +    +  + ++ 
Sbjct: 158 E---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKWMP 214
Query: 433 PEHTRTGKATTSADVFSFGAFLLEV 457
           PE    G  T+  D +SFG  L E+
Sbjct: 215 PEAFMEGIFTSKTDTWSFGVLLWEI 239

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 100/203 (49%), Gaps = 8/203 (3%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMK-EFVAEIVSIGRLRHRNLV 321
           F +   LG G  G V++ +   S + +A K I  E +  ++ + + E+  +       +V
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 322 QLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
              G     GE+ +  ++M  GSLD+ L    ++    + +  +   V  GL YL ++ +
Sbjct: 68  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSI--AVIKGLTYLREKHK 125
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKA 441
             ++HRDVK SN+L++     +L DFG++       D      VGT  Y++PE  +    
Sbjct: 126 --IMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSFVGTRSYMSPERLQGTHY 180
Query: 442 TTSADVFSFGAFLLEVACGRRPI 464
           +  +D++S G  L+E+A GR PI
Sbjct: 181 SVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 104/227 (45%), Gaps = 26/227 (11%)
Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
           E+   G FG V++  L    +  AVK    + +Q  +    EI S   ++H NL+Q +  
Sbjct: 21  EIKARGRFGCVWKAQLMNDFV--AVKIFPLQDKQSWQS-EREIFSTPGMKHENLLQFIAA 77
Query: 327 CRR----KGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQE--W 380
            +R    + EL L+  +   GSL  YL       + W +   V + ++ GL YLH++  W
Sbjct: 78  EKRGSNLEVELWLITAFHDKGSLTDYLKGN---IITWNELCHVAETMSRGLSYLHEDVPW 134
Query: 381 ------EQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTH-VVGTLGYLAP 433
                 +  + HRD K+ NVLL  +L   L DFGLA  ++ G  P  TH  VGT  Y+AP
Sbjct: 135 CRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAP 194
Query: 434 EHTRTG-----KATTSADVFSFGAFLLEVACGRRPIQRQGPSENLIL 475
           E           A    D+++ G  L E+    R     GP +  +L
Sbjct: 195 EVLEGAINFQRDAFLRIDMYAMGLVLWELV--SRCKAADGPVDEYML 239

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 100/203 (49%), Gaps = 8/203 (3%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMK-EFVAEIVSIGRLRHRNLV 321
           F +   LG G  G V++ +   S + +A K I  E +  ++ + + E+  +       +V
Sbjct: 70  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 129
Query: 322 QLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
              G     GE+ +  ++M  GSLD+ L    ++    + +  +   V  GL YL ++ +
Sbjct: 130 GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSI--AVIKGLTYLREKHK 187
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKA 441
             ++HRDVK SN+L++     +L DFG++       D      VGT  Y++PE  +    
Sbjct: 188 --IMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSFVGTRSYMSPERLQGTHY 242
Query: 442 TTSADVFSFGAFLLEVACGRRPI 464
           +  +D++S G  L+E+A GR PI
Sbjct: 243 SVQSDIWSMGLSLVEMAVGRYPI 265

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 100/203 (49%), Gaps = 8/203 (3%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMK-EFVAEIVSIGRLRHRNLV 321
           F +   LG G  G V++ +   S + +A K I  E +  ++ + + E+  +       +V
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 322 QLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
              G     GE+ +  ++M  GSLD+ L    ++    + +  +   V  GL YL ++ +
Sbjct: 68  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSI--AVIKGLTYLREKHK 125
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKA 441
             ++HRDVK SN+L++     +L DFG++       D      VGT  Y++PE  +    
Sbjct: 126 --IMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSFVGTRSYMSPERLQGTHY 180
Query: 442 TTSADVFSFGAFLLEVACGRRPI 464
           +  +D++S G  L+E+A GR PI
Sbjct: 181 SVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 100/203 (49%), Gaps = 8/203 (3%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMK-EFVAEIVSIGRLRHRNLV 321
           F +   LG G  G V++ +   S + +A K I  E +  ++ + + E+  +       +V
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 322 QLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
              G     GE+ +  ++M  GSLD+ L    ++    + +  +   V  GL YL ++ +
Sbjct: 68  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSI--AVIKGLTYLREKHK 125
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKA 441
             ++HRDVK SN+L++     +L DFG++       D      VGT  Y++PE  +    
Sbjct: 126 --IMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSFVGTRSYMSPERLQGTHY 180
Query: 442 TTSADVFSFGAFLLEVACGRRPI 464
           +  +D++S G  L+E+A GR PI
Sbjct: 181 SVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 81/298 (27%), Positives = 136/298 (45%), Gaps = 47/298 (15%)
Query: 269 LGTGGFGRVYRGTLP-----KSQIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQ 322
           LG G FG VY G        +++  +AVK ++   S +   EF+ E   +      ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 323 LLGYCRRKGELLLVYDYMPNGSLDKYLYD----------QPKVTLNWIQRFRVIKGVALG 372
           LLG   +    L+V + M +G L  YL            +P  TL   +  ++   +A G
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQ--EMIQMAAEIADG 142
Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLG--Y 430
           + YL+    +  +HRD+ A N ++  +   ++GDFG+ R     TD       G L   +
Sbjct: 143 MAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXE-TDXXRKGGKGLLPVRW 198
Query: 431 LAPEHTRTGKATTSADVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFWNRGELL 489
           +APE  + G  TTS+D++SFG  L E+ +   +P   QG S   +L  +V D    G  L
Sbjct: 199 MAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPY--QGLSNEQVL-KFVMD----GGYL 251
Query: 490 EARD--PNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQILERDV--ALPAIS 543
           +  D  P   T+ +             C   +P  RP+  ++V +L+ D+  + P +S
Sbjct: 252 DQPDNCPERVTDLM-----------RMCWQFNPNMRPTFLEIVNLLKDDLHPSFPEVS 298

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 110/230 (47%), Gaps = 20/230 (8%)
Query: 266 KELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMK-EFVAEIVSIGRLRHRNLVQLL 324
           +++LGTG F  V      ++Q  +A+K I+ E+ +G +     EI  + +++H N+V L 
Sbjct: 23  RDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALD 82
Query: 325 GYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQR--FRVIKGVALGLFYLHQEWEQ 382
                 G L L+   +  G L   + ++   T     R  F+V+  V     YLH   + 
Sbjct: 83  DIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVK----YLH---DL 135
Query: 383 VVIHRDVKASNVL---LDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTG 439
            ++HRD+K  N+L   LD +    + DFGL+++ D G+   T    GT GY+APE     
Sbjct: 136 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA--CGTPGYVAPEVLAQK 193
Query: 440 KATTSADVFSFGAFLLEVACGRRPIQRQGPS---ENLILVDWVFD--FWN 484
             + + D +S G     + CG  P   +  +   E ++  ++ FD  +W+
Sbjct: 194 PYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWD 243

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 110/230 (47%), Gaps = 20/230 (8%)
Query: 266 KELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMK-EFVAEIVSIGRLRHRNLVQLL 324
           +++LGTG F  V      ++Q  +A+K I+ E+ +G +     EI  + +++H N+V L 
Sbjct: 23  RDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALD 82
Query: 325 GYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQR--FRVIKGVALGLFYLHQEWEQ 382
                 G L L+   +  G L   + ++   T     R  F+V+  V     YLH   + 
Sbjct: 83  DIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVK----YLH---DL 135
Query: 383 VVIHRDVKASNVL---LDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTG 439
            ++HRD+K  N+L   LD +    + DFGL+++ D G+   T    GT GY+APE     
Sbjct: 136 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA--CGTPGYVAPEVLAQK 193
Query: 440 KATTSADVFSFGAFLLEVACGRRPIQRQGPS---ENLILVDWVFD--FWN 484
             + + D +S G     + CG  P   +  +   E ++  ++ FD  +W+
Sbjct: 194 PYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWD 243

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 100/203 (49%), Gaps = 8/203 (3%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMK-EFVAEIVSIGRLRHRNLV 321
           F +   LG G  G V++ +   S + +A K I  E +  ++ + + E+  +       +V
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 322 QLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
              G     GE+ +  ++M  GSLD+ L    ++    + +  +   V  GL YL ++ +
Sbjct: 68  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSI--AVIKGLTYLREKHK 125
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKA 441
             ++HRDVK SN+L++     +L DFG++       D      VGT  Y++PE  +    
Sbjct: 126 --IMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSFVGTRSYMSPERLQGTHY 180
Query: 442 TTSADVFSFGAFLLEVACGRRPI 464
           +  +D++S G  L+E+A GR PI
Sbjct: 181 SVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 100/203 (49%), Gaps = 8/203 (3%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMK-EFVAEIVSIGRLRHRNLV 321
           F +   LG G  G V++ +   S + +A K I  E +  ++ + + E+  +       +V
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 322 QLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
              G     GE+ +  ++M  GSLD+ L    ++    + +  +   V  GL YL ++ +
Sbjct: 68  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSI--AVIKGLTYLREKHK 125
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKA 441
             ++HRDVK SN+L++     +L DFG++       D      VGT  Y++PE  +    
Sbjct: 126 --IMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSFVGTRSYMSPERLQGTHY 180
Query: 442 TTSADVFSFGAFLLEVACGRRPI 464
           +  +D++S G  L+E+A GR PI
Sbjct: 181 SVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 78/297 (26%), Positives = 138/297 (46%), Gaps = 45/297 (15%)
Query: 269 LGTGGFGRVYRGTLP-----KSQIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQ 322
           LG G FG VY G        +++  +AVK ++   S +   EF+ E   +      ++V+
Sbjct: 24  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 83
Query: 323 LLGYCRRKGELLLVYDYMPNGSLDKYLYD----------QPKVTLNWIQRFRVIKGVALG 372
           LLG   +    L+V + M +G L  YL            +P  TL   +  ++   +A G
Sbjct: 84  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQ--EMIQMAAEIADG 141
Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVGTLGYL 431
           + YL+    +  +HRD+ A N ++  +   ++GDFG+ R +Y+     +    +  + ++
Sbjct: 142 MAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 198
Query: 432 APEHTRTGKATTSADVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFWNRGELLE 490
           APE  + G  TTS+D++SFG  L E+ +   +P   QG S   +L  +V D    G  L+
Sbjct: 199 APESLKDGVFTTSSDMWSFGVVLWEITSLAEQPY--QGLSNEQVL-KFVMD----GGYLD 251
Query: 491 ARD--PNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQILERDV--ALPAIS 543
             D  P   T+ +             C   +P  RP+  ++V +L+ D+  + P +S
Sbjct: 252 QPDNCPERVTDLM-----------RMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVS 297

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 101/202 (50%), Gaps = 13/202 (6%)
Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMK---EFVAEIVSIGRLRHRNLVQL 323
           + LG G FG+V  G    +  ++AVK ++ +  + +    +   EI ++   RH ++++L
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 324 LGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQV 383
                   +  +V +Y+  G L  Y+    +V    ++  R+ + +   + Y H+    +
Sbjct: 77  YQVISTPTDFFMVMEYVSGGELFDYICKHGRV--EEMEARRLFQQILSAVDYCHR---HM 131
Query: 384 VIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGK--A 441
           V+HRD+K  NVLLD  +N ++ DFGL+ +   G   +T+   G+  Y APE   +G+  A
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAAPE-VISGRLYA 188
Query: 442 TTSADVFSFGAFLLEVACGRRP 463
               D++S G  L  + CG  P
Sbjct: 189 GPEVDIWSCGVILYALLCGTLP 210

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 73/270 (27%), Positives = 114/270 (42%), Gaps = 36/270 (13%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKI--SHESRQGMKEFVAEIVSI-GRLRHRNLVQLLG 325
           LG G FG VY     +S+  +A+K +  +   + G++  +   V I   LRH N+++L G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 326 YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVI 385
           Y      + L+ +Y P G + K L    K        +  I  +A  L Y H    + VI
Sbjct: 81  YFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATY--ITELANALSYCHS---KRVI 135
Query: 386 HRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSA 445
           HRD+K  N+LL      ++ DFG +    H    + T + GTL YL PE           
Sbjct: 136 HRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKV 192
Query: 446 DVFSFGAFLLEVACGRRPIQR---QGPSENLILVDWVF-DFWNRGELLEARDPNLGTEYV 501
           D++S G    E   G+ P +    Q   + +  V++ F DF   G    ARD        
Sbjct: 193 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEG----ARD-------- 240
Query: 502 AXXXXXXXXXXXXCSHSDPTARPSMRQVVQ 531
                            +P+ RP +R+V++
Sbjct: 241 ---------LISRLLKHNPSQRPMLREVLE 261

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 81/298 (27%), Positives = 136/298 (45%), Gaps = 47/298 (15%)
Query: 269 LGTGGFGRVYRGTLP-----KSQIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQ 322
           LG G FG VY G        +++  +AVK ++   S +   EF+ E   +      ++V+
Sbjct: 22  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 81
Query: 323 LLGYCRRKGELLLVYDYMPNGSLDKYLYD----------QPKVTLNWIQRFRVIKGVALG 372
           LLG   +    L+V + M +G L  YL            +P  TL   +  ++   +A G
Sbjct: 82  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQ--EMIQMAAEIADG 139
Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLG--Y 430
           + YL+    +  +HRD+ A N ++  +   ++GDFG+ R     TD       G L   +
Sbjct: 140 MAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXE-TDXXRKGGKGLLPVRW 195
Query: 431 LAPEHTRTGKATTSADVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFWNRGELL 489
           +APE  + G  TTS+D++SFG  L E+ +   +P   QG S   +L  +V D    G  L
Sbjct: 196 MAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPY--QGLSNEQVL-KFVMD----GGYL 248
Query: 490 EARD--PNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQILERDV--ALPAIS 543
           +  D  P   T+ +             C   +P  RP+  ++V +L+ D+  + P +S
Sbjct: 249 DQPDNCPERVTDLM-----------RMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVS 295

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 77/257 (29%), Positives = 112/257 (43%), Gaps = 51/257 (19%)
Query: 259 ATKGFRE----KELLGTGGFGRVYRGTLPKSQIEIAVKKI--------SHESRQGMKEFV 306
           +T GF E    KE+LG G    V R     +  E AVK I        S E  Q ++E  
Sbjct: 11  STHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREAT 70
Query: 307 AEIVSIGRLR--HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFR 364
            + V I R    H N++QL           LV+D M  G L  YL +  KVTL+  +  +
Sbjct: 71  LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE--KVTLSEKETRK 128
Query: 365 VIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHV 424
           +++ +   +  LH+     ++HRD+K  N+LLD ++N +L DFG +   D G   +   V
Sbjct: 129 IMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE--KLREV 183
Query: 425 VGTLGYLAPE---------HTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLIL 475
            GT  YLAPE         H   GK     D++S G  +  +  G  P            
Sbjct: 184 CGTPSYLAPEIIECSMNDNHPGYGK---EVDMWSTGVIMYTLLAGSPP------------ 228
Query: 476 VDWVFDFWNRGELLEAR 492
                 FW+R ++L  R
Sbjct: 229 ------FWHRKQMLMLR 239

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 77/257 (29%), Positives = 113/257 (43%), Gaps = 51/257 (19%)
Query: 259 ATKGFRE----KELLGTGGFGRVYRGTLPKSQIEIAVKKI--------SHESRQGMKEFV 306
           +T GF E    KE+LG G    V R     +  E AVK I        S E  Q ++E  
Sbjct: 11  STHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREAT 70
Query: 307 AEIVSIGRLR--HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFR 364
            + V I R    H N++QL           LV+D M  G L  YL +  KVTL+  +  +
Sbjct: 71  LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE--KVTLSEKETRK 128
Query: 365 VIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHV 424
           +++ +   +  LH+     ++HRD+K  N+LLD ++N +L DFG +   D G   ++  V
Sbjct: 129 IMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRS--V 183
Query: 425 VGTLGYLAPE---------HTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLIL 475
            GT  YLAPE         H   GK     D++S G  +  +  G  P            
Sbjct: 184 CGTPSYLAPEIIECSMNDNHPGYGK---EVDMWSTGVIMYTLLAGSPP------------ 228
Query: 476 VDWVFDFWNRGELLEAR 492
                 FW+R ++L  R
Sbjct: 229 ------FWHRKQMLMLR 239

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 81/298 (27%), Positives = 136/298 (45%), Gaps = 47/298 (15%)
Query: 269 LGTGGFGRVYRGTLP-----KSQIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQ 322
           LG G FG VY G        +++  +AVK ++   S +   EF+ E   +      ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 323 LLGYCRRKGELLLVYDYMPNGSLDKYLYD----------QPKVTLNWIQRFRVIKGVALG 372
           LLG   +    L+V + M +G L  YL            +P  TL   +  ++   +A G
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQ--EMIQMAAEIADG 142
Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLG--Y 430
           + YL+    +  +HRD+ A N ++  +   ++GDFG+ R     TD       G L   +
Sbjct: 143 MAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXE-TDXXRKGGKGLLPVRW 198
Query: 431 LAPEHTRTGKATTSADVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFWNRGELL 489
           +APE  + G  TTS+D++SFG  L E+ +   +P   QG S   +L  +V D    G  L
Sbjct: 199 MAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPY--QGLSNEQVL-KFVMD----GGYL 251
Query: 490 EARD--PNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQILERDV--ALPAIS 543
           +  D  P   T+ +             C   +P  RP+  ++V +L+ D+  + P +S
Sbjct: 252 DQPDNCPERVTDLM-----------RMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVS 298

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/230 (27%), Positives = 110/230 (47%), Gaps = 20/230 (8%)
Query: 266 KELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMK-EFVAEIVSIGRLRHRNLVQLL 324
           +++LGTG F  V      ++Q  +A+K I+ E+ +G +     EI  + +++H N+V L 
Sbjct: 23  RDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALD 82
Query: 325 GYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQR--FRVIKGVALGLFYLHQEWEQ 382
                 G L L+   +  G L   + ++   T     R  F+V+  V     YLH   + 
Sbjct: 83  DIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVK----YLH---DL 135
Query: 383 VVIHRDVKASNVL---LDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTG 439
            ++HRD+K  N+L   LD +    + DFGL+++ D G+   T    GT GY+APE     
Sbjct: 136 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA--CGTPGYVAPEVLAQK 193
Query: 440 KATTSADVFSFGAFLLEVACGRRPIQRQGPS---ENLILVDWVFD--FWN 484
             + + D +S G     + CG  P   +  +   E ++  ++ FD  +W+
Sbjct: 194 PYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWD 243

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 77/314 (24%), Positives = 141/314 (44%), Gaps = 45/314 (14%)
Query: 248 PHRFRYKDLYIATKG--FREK----ELLGTGGFGRVYRGTLP-----KSQIEIAVKKISH 296
           P  F   D+Y+  +    REK      LG G FG VY G        + +  +A+K ++ 
Sbjct: 6   PEYFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNE 65
Query: 297 ESRQGMK-EFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYD-QPK 354
            +    + EF+ E   +      ++V+LLG   +    L++ + M  G L  YL   +P+
Sbjct: 66  AASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPE 125
Query: 355 VTLNWI-------QRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDF 407
           +  N +       +  ++   +A G+ YL+       +HRD+ A N ++  +   ++GDF
Sbjct: 126 MENNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDF 182
Query: 408 GLAR-LYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQ 465
           G+ R +Y+     +    +  + +++PE  + G  TT +DV+SFG  L E+A    +P  
Sbjct: 183 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY- 241
Query: 466 RQGPSENLILVDWVFDFWNRGELLEARD--PNLGTEYVAXXXXXXXXXXXXCSHSDPTAR 523
            QG S   +L      F   G LL+  D  P++  E +             C   +P  R
Sbjct: 242 -QGLSNEQVL-----RFVMEGGLLDKPDNCPDMLFELM-----------RMCWQYNPKMR 284
Query: 524 PSMRQVVQILERDV 537
           PS  +++  ++ ++
Sbjct: 285 PSFLEIISSIKEEM 298

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 77/314 (24%), Positives = 140/314 (44%), Gaps = 45/314 (14%)
Query: 248 PHRFRYKDLYIATKG--FREK----ELLGTGGFGRVYRGTLP-----KSQIEIAVKKISH 296
           P  F   D+Y+  +    REK      LG G FG VY G        + +  +A+K ++ 
Sbjct: 6   PEYFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNE 65
Query: 297 ESRQGMK-EFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYD-QPK 354
            +    + EF+ E   +      ++V+LLG   +    L++ + M  G L  YL   +P 
Sbjct: 66  AASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPA 125
Query: 355 VTLNWI-------QRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDF 407
           +  N +       +  ++   +A G+ YL+       +HRD+ A N ++  +   ++GDF
Sbjct: 126 MANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDF 182
Query: 408 GLAR-LYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQ 465
           G+ R +Y+     +    +  + +++PE  + G  TT +DV+SFG  L E+A    +P  
Sbjct: 183 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY- 241
Query: 466 RQGPSENLILVDWVFDFWNRGELLEARD--PNLGTEYVAXXXXXXXXXXXXCSHSDPTAR 523
            QG S   +L      F   G LL+  D  P++  E +             C   +P  R
Sbjct: 242 -QGLSNEQVL-----RFVMEGGLLDKPDNCPDMLFELM-----------RMCWQYNPKMR 284
Query: 524 PSMRQVVQILERDV 537
           PS  +++  ++ ++
Sbjct: 285 PSFLEIISSIKEEM 298

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 100/203 (49%), Gaps = 8/203 (3%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMK-EFVAEIVSIGRLRHRNLV 321
           F +   LG G  G V++ +   S + +A K I  E +  ++ + + E+  +       +V
Sbjct: 27  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 86
Query: 322 QLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
              G     GE+ +  ++M  GSLD+ L    ++    + +  +   V  GL YL ++ +
Sbjct: 87  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSI--AVIKGLTYLREKHK 144
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKA 441
             ++HRDVK SN+L++     +L DFG++       D      VGT  Y++PE  +    
Sbjct: 145 --IMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSFVGTRSYMSPERLQGTHY 199
Query: 442 TTSADVFSFGAFLLEVACGRRPI 464
           +  +D++S G  L+E+A GR PI
Sbjct: 200 SVQSDIWSMGLSLVEMAVGRYPI 222

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 100/203 (49%), Gaps = 8/203 (3%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMK-EFVAEIVSIGRLRHRNLV 321
           F +   LG G  G V++ +   S + +A K I  E +  ++ + + E+  +       +V
Sbjct: 35  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94
Query: 322 QLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
              G     GE+ +  ++M  GSLD+ L    ++    + +  +   V  GL YL ++ +
Sbjct: 95  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSI--AVIKGLTYLREKHK 152
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKA 441
             ++HRDVK SN+L++     +L DFG++       D      VGT  Y++PE  +    
Sbjct: 153 --IMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSFVGTRSYMSPERLQGTHY 207
Query: 442 TTSADVFSFGAFLLEVACGRRPI 464
           +  +D++S G  L+E+A GR PI
Sbjct: 208 SVQSDIWSMGLSLVEMAVGRYPI 230

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 76/292 (26%), Positives = 122/292 (41%), Gaps = 43/292 (14%)
Query: 247 GPHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKI--SHESRQGMKE 304
           GP ++  +D  I          LG G FG VY     +S+  +A+K +  +   + G++ 
Sbjct: 1   GPRQWALEDFEIGRP-------LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH 53
Query: 305 FVAEIVSI-GRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRF 363
            +   V I   LRH N+++L GY      + L+ +Y P G++ + L    K        +
Sbjct: 54  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY 113
Query: 364 RVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTH 423
             I  +A  L Y H    + VIHRD+K  N+LL      ++ DFG +    H    + T 
Sbjct: 114 --ITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTE 165
Query: 424 VVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQR---QGPSENLILVDWVF 480
           + GTL YL PE           D++S G    E   G+ P +    Q   + +  V++ F
Sbjct: 166 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF 225
Query: 481 -DFWNRGELLEARDPNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQ 531
            DF   G    ARD                         +P+ RP +R+V++
Sbjct: 226 PDFVTEG----ARD-----------------LISRLLKHNPSQRPMLREVLE 256

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 77/297 (25%), Positives = 138/297 (46%), Gaps = 45/297 (15%)
Query: 269 LGTGGFGRVYRGTLP-----KSQIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQ 322
           LG G FG VY G        +++  +AVK ++   S +   EF+ E   +      ++V+
Sbjct: 25  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 84
Query: 323 LLGYCRRKGELLLVYDYMPNGSLDKYLYD----------QPKVTLNWIQRFRVIKGVALG 372
           LLG   +    L+V + M +G L  YL            +P  TL   +  ++   +A G
Sbjct: 85  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQ--EMIQMAAEIADG 142
Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVGTLGYL 431
           + YL+    +  +HR++ A N ++  +   ++GDFG+ R +Y+     +    +  + ++
Sbjct: 143 MAYLNA---KKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 199
Query: 432 APEHTRTGKATTSADVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFWNRGELLE 490
           APE  + G  TTS+D++SFG  L E+ +   +P   QG S   +L  +V D    G  L+
Sbjct: 200 APESLKDGVFTTSSDMWSFGVVLWEITSLAEQPY--QGLSNEQVL-KFVMD----GGYLD 252
Query: 491 ARD--PNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQILERDV--ALPAIS 543
             D  P   T+ +             C   +P  RP+  ++V +L+ D+  + P +S
Sbjct: 253 QPDNCPERVTDLM-----------RMCWQFNPNMRPTFLEIVNLLKDDLHPSFPEVS 298

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 77/297 (25%), Positives = 138/297 (46%), Gaps = 45/297 (15%)
Query: 269 LGTGGFGRVYRGTLP-----KSQIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQ 322
           LG G FG VY G        +++  +AVK ++   S +   EF+ E   +      ++V+
Sbjct: 26  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 85
Query: 323 LLGYCRRKGELLLVYDYMPNGSLDKYLYD----------QPKVTLNWIQRFRVIKGVALG 372
           LLG   +    L+V + M +G L  YL            +P  TL   +  ++   +A G
Sbjct: 86  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQ--EMIQMAAEIADG 143
Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVGTLGYL 431
           + YL+    +  +HR++ A N ++  +   ++GDFG+ R +Y+     +    +  + ++
Sbjct: 144 MAYLNA---KKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 200
Query: 432 APEHTRTGKATTSADVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFWNRGELLE 490
           APE  + G  TTS+D++SFG  L E+ +   +P   QG S   +L  +V D    G  L+
Sbjct: 201 APESLKDGVFTTSSDMWSFGVVLWEITSLAEQPY--QGLSNEQVL-KFVMD----GGYLD 253
Query: 491 ARD--PNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQILERDV--ALPAIS 543
             D  P   T+ +             C   +P  RP+  ++V +L+ D+  + P +S
Sbjct: 254 QPDNCPERVTDLM-----------RMCWQFNPNMRPTFLEIVNLLKDDLHPSFPEVS 299

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 77/314 (24%), Positives = 141/314 (44%), Gaps = 45/314 (14%)
Query: 248 PHRFRYKDLYIATKG--FREK----ELLGTGGFGRVYRGTLP-----KSQIEIAVKKISH 296
           P  F   D+Y+  +    REK      LG G FG VY G        + +  +A+K ++ 
Sbjct: 28  PEYFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNE 87
Query: 297 ESRQGMK-EFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYD-QPK 354
            +    + EF+ E   +      ++V+LLG   +    L++ + M  G L  YL   +P+
Sbjct: 88  AASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPE 147
Query: 355 VTLNWI-------QRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDF 407
           +  N +       +  ++   +A G+ YL+       +HRD+ A N ++  +   ++GDF
Sbjct: 148 MENNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDF 204
Query: 408 GLAR-LYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQ 465
           G+ R +Y+     +    +  + +++PE  + G  TT +DV+SFG  L E+A    +P  
Sbjct: 205 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY- 263
Query: 466 RQGPSENLILVDWVFDFWNRGELLEARD--PNLGTEYVAXXXXXXXXXXXXCSHSDPTAR 523
            QG S   +L      F   G LL+  D  P++  E +             C   +P  R
Sbjct: 264 -QGLSNEQVL-----RFVMEGGLLDKPDNCPDMLFELM-----------RMCWQYNPKMR 306
Query: 524 PSMRQVVQILERDV 537
           PS  +++  ++ ++
Sbjct: 307 PSFLEIISSIKEEM 320

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 107/220 (48%), Gaps = 11/220 (5%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMK-EFVAEIVSIGRLRHRNLV 321
           F +   LG G  G V++ +   S + +A K I  E +  ++ + + E+  +       +V
Sbjct: 11  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 70
Query: 322 QLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
              G     GE+ +  ++M  GSLD+ L    ++    + +  +   V  GL YL ++ +
Sbjct: 71  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSI--AVIKGLTYLREKHK 128
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKA 441
             ++HRDVK SN+L++     +L DFG++       D      VGT  Y++PE  +    
Sbjct: 129 --IMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDEMANEFVGTRSYMSPERLQGTHY 183
Query: 442 TTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFD 481
           +  +D++S G  L+E+A GR P   + P     L+D++ +
Sbjct: 184 SVQSDIWSMGLSLVEMAVGRYP---RPPMAIFELLDYIVN 220

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 102/212 (48%), Gaps = 26/212 (12%)
Query: 266 KELLGTGGFGRVYRGTLPKSQIEIAVKKIS-HESRQGMKEFVAEIVSIGRLRHRNLVQLL 324
           +E +G G FG V+RG       E+AVK  S  E R   +E  AEI     LRH N++  +
Sbjct: 47  QESIGKGRFGEVWRGKWRGE--EVAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFI 102
Query: 325 GYCRRKG----ELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEW 380
               +      +L LV DY  +GSL  YL ++  VT+  +   ++    A GL +LH E 
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGM--IKLALSTASGLAHLHMEI 159
Query: 381 -----EQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP---QTTHVVGTLGYLA 432
                +  + HRD+K+ N+L+       + D GLA  +D  TD       H VGT  Y+A
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 219
Query: 433 PE------HTRTGKATTSADVFSFGAFLLEVA 458
           PE      + +  ++   AD+++ G    E+A
Sbjct: 220 PEVLDDSINMKHFESFKRADIYAMGLVFWEIA 251

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 102/212 (48%), Gaps = 26/212 (12%)
Query: 266 KELLGTGGFGRVYRGTLPKSQIEIAVKKIS-HESRQGMKEFVAEIVSIGRLRHRNLVQLL 324
           +E +G G FG V+RG       E+AVK  S  E R   +E  AEI     LRH N++  +
Sbjct: 9   QESIGKGRFGEVWRGKWRGE--EVAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFI 64
Query: 325 GYCRRKG----ELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEW 380
               +      +L LV DY  +GSL  YL ++  VT+  +   ++    A GL +LH E 
Sbjct: 65  AADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGM--IKLALSTASGLAHLHMEI 121
Query: 381 -----EQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP---QTTHVVGTLGYLA 432
                +  + HRD+K+ N+L+       + D GLA  +D  TD       H VGT  Y+A
Sbjct: 122 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 181
Query: 433 PE------HTRTGKATTSADVFSFGAFLLEVA 458
           PE      + +  ++   AD+++ G    E+A
Sbjct: 182 PEVLDDSINMKHFESFKRADIYAMGLVFWEIA 213

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 102/212 (48%), Gaps = 26/212 (12%)
Query: 266 KELLGTGGFGRVYRGTLPKSQIEIAVKKIS-HESRQGMKEFVAEIVSIGRLRHRNLVQLL 324
           +E +G G FG V+RG       E+AVK  S  E R   +E  AEI     LRH N++  +
Sbjct: 14  QESIGKGRFGEVWRGKWRGE--EVAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFI 69
Query: 325 GYCRRKG----ELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEW 380
               +      +L LV DY  +GSL  YL ++  VT+  +   ++    A GL +LH E 
Sbjct: 70  AADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGM--IKLALSTASGLAHLHMEI 126
Query: 381 -----EQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP---QTTHVVGTLGYLA 432
                +  + HRD+K+ N+L+       + D GLA  +D  TD       H VGT  Y+A
Sbjct: 127 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 186
Query: 433 PE------HTRTGKATTSADVFSFGAFLLEVA 458
           PE      + +  ++   AD+++ G    E+A
Sbjct: 187 PEVLDDSINMKHFESFKRADIYAMGLVFWEIA 218

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 104/232 (44%), Gaps = 19/232 (8%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKI--SHESRQGMKEFVAEIVSI-GRLRHRNLVQLLG 325
           LG G FG VY     +S+  +A+K +  +   + G++  +   V I   LRH N+++L G
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 101
Query: 326 YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVI 385
           Y      + L+ +Y P G++ + L    K        +  I  +A  L Y H    + VI
Sbjct: 102 YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSYCHS---KRVI 156
Query: 386 HRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSA 445
           HRD+K  N+LL      ++ DFG +    H    + T + GTL YL PE           
Sbjct: 157 HRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLCGTLDYLPPEMIEGRMHDEKV 213
Query: 446 DVFSFGAFLLEVACGRRPIQR---QGPSENLILVDWVF-DFWNRGELLEARD 493
           D++S G    E   G+ P +    Q   + +  V++ F DF   G    ARD
Sbjct: 214 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEG----ARD 261

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 97/197 (49%), Gaps = 8/197 (4%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMK-EFVAEIVSIGRLRHRNLVQLLGYC 327
           LG G  G V +     S + +A K I  E +  ++ + + E+  +       +V   G  
Sbjct: 24  LGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 83
Query: 328 RRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHR 387
              GE+ +  ++M  GSLD+ L +  ++    + +  +   V  GL YL ++ +  ++HR
Sbjct: 84  YSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSI--AVLRGLAYLREKHQ--IMHR 139
Query: 388 DVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADV 447
           DVK SN+L++     +L DFG++       D      VGT  Y+APE  +    +  +D+
Sbjct: 140 DVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSFVGTRSYMAPERLQGTHYSVQSDI 196
Query: 448 FSFGAFLLEVACGRRPI 464
           +S G  L+E+A GR PI
Sbjct: 197 WSMGLSLVELAVGRYPI 213

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 102/212 (48%), Gaps = 26/212 (12%)
Query: 266 KELLGTGGFGRVYRGTLPKSQIEIAVKKIS-HESRQGMKEFVAEIVSIGRLRHRNLVQLL 324
           +E +G G FG V+RG       E+AVK  S  E R   +E  AEI     LRH N++  +
Sbjct: 8   QESIGKGRFGEVWRGKWRGE--EVAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFI 63
Query: 325 GYCRRKG----ELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEW 380
               +      +L LV DY  +GSL  YL ++  VT+  +   ++    A GL +LH E 
Sbjct: 64  AADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGM--IKLALSTASGLAHLHMEI 120
Query: 381 -----EQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP---QTTHVVGTLGYLA 432
                +  + HRD+K+ N+L+       + D GLA  +D  TD       H VGT  Y+A
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 180
Query: 433 PE------HTRTGKATTSADVFSFGAFLLEVA 458
           PE      + +  ++   AD+++ G    E+A
Sbjct: 181 PEVLDDSINMKHFESFKRADIYAMGLVFWEIA 212

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 99/222 (44%), Gaps = 32/222 (14%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRH----- 317
           F E  +LG G FG+V +          A+KKI H + + +   ++E++ +  L H     
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVR 66
Query: 318 --------RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGV 369
                   RN V+ +   ++K  L +  +Y  NG+L   ++ +  +     + +R+ + +
Sbjct: 67  YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSE-NLNQQRDEYWRLFRQI 125
Query: 370 ALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH-------------G 416
              L Y+H    Q +IHRD+K  N+ +D   N ++GDFGLA+                 G
Sbjct: 126 LEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 417 TDPQTTHVVGTLGYLAPEHTR-TGKATTSADVFSFGAFLLEV 457
           +    T  +GT  Y+A E    TG      D++S G    E+
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM 224

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 115/270 (42%), Gaps = 36/270 (13%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKI--SHESRQGMKEFVAEIVSI-GRLRHRNLVQLLG 325
           LG G FG VY     +S+  +A+K +  +   + G++  +   V I   LRH N+++L G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 326 YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVI 385
           Y      + L+ +Y P G++ + L    K        +  I  +A  L Y H    + VI
Sbjct: 81  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSYCHS---KRVI 135
Query: 386 HRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSA 445
           HRD+K  N+LL      ++ DFG +    H    + T + GTL YL PE           
Sbjct: 136 HRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEXIEGRXHDEKV 192
Query: 446 DVFSFGAFLLEVACGRRPIQR---QGPSENLILVDWVF-DFWNRGELLEARDPNLGTEYV 501
           D++S G    E   G+ P +    Q   + +  V++ F DF   G    ARD        
Sbjct: 193 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEG----ARD-------- 240
Query: 502 AXXXXXXXXXXXXCSHSDPTARPSMRQVVQ 531
                            +P+ RP +R+V++
Sbjct: 241 ---------LISRLLKHNPSQRPXLREVLE 261

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 97/218 (44%), Gaps = 10/218 (4%)
Query: 258 IATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRL-- 315
           +  + F   ++LG G FG+V+     K+    A+K +  +      +    +V    L  
Sbjct: 15  LKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSL 74
Query: 316 --RHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGL 373
              H  L  +    + K  L  V +Y+  G L  ++    K  L+    +     + LGL
Sbjct: 75  AWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAA--EIILGL 132
Query: 374 FYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAP 433
            +LH    + +++RD+K  N+LLD + + ++ DFG+ +    G D +T    GT  Y+AP
Sbjct: 133 QFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG-DAKTNEFCGTPDYIAP 188
Query: 434 EHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSE 471
           E     K   S D +SFG  L E+  G+ P   Q   E
Sbjct: 189 EILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE 226

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 102/212 (48%), Gaps = 26/212 (12%)
Query: 266 KELLGTGGFGRVYRGTLPKSQIEIAVKKIS-HESRQGMKEFVAEIVSIGRLRHRNLVQLL 324
           +E +G G FG V+RG       E+AVK  S  E R   +E  AEI     LRH N++  +
Sbjct: 11  QESIGKGRFGEVWRGKWRGE--EVAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFI 66
Query: 325 GYCRRKG----ELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEW 380
               +      +L LV DY  +GSL  YL ++  VT+  +   ++    A GL +LH E 
Sbjct: 67  AADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGM--IKLALSTASGLAHLHMEI 123
Query: 381 -----EQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP---QTTHVVGTLGYLA 432
                +  + HRD+K+ N+L+       + D GLA  +D  TD       H VGT  Y+A
Sbjct: 124 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 183
Query: 433 PE------HTRTGKATTSADVFSFGAFLLEVA 458
           PE      + +  ++   AD+++ G    E+A
Sbjct: 184 PEVLDDSINMKHFESFKRADIYAMGLVFWEIA 215

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 67/212 (31%), Positives = 102/212 (48%), Gaps = 26/212 (12%)
Query: 266 KELLGTGGFGRVYRGTLPKSQIEIAVKKIS-HESRQGMKEFVAEIVSIGRLRHRNLVQLL 324
           +E +G G FG V+RG       E+AVK  S  E R   +E  AEI     LRH N++  +
Sbjct: 34  QESIGKGRFGEVWRGKWRGE--EVAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFI 89
Query: 325 GYCRRKG----ELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEW 380
               +      +L LV DY  +GSL  YL ++  VT+  +   ++    A GL +LH E 
Sbjct: 90  AADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGM--IKLALSTASGLAHLHMEI 146
Query: 381 -----EQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP---QTTHVVGTLGYLA 432
                +  + HRD+K+ N+L+       + D GLA  +D  TD       H VGT  Y+A
Sbjct: 147 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 206
Query: 433 PE------HTRTGKATTSADVFSFGAFLLEVA 458
           PE      + +  ++   AD+++ G    E+A
Sbjct: 207 PEVLDDSINMKHFESFKRADIYAMGLVFWEIA 238

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 106/225 (47%), Gaps = 24/225 (10%)
Query: 244 LDHGPHRFRYKDLY-IATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGM 302
           +   P +   KD + I  +  + ++ LG G FG V+  T  K   ++AVK +   S   +
Sbjct: 164 MSSKPQKPWEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGS-MSV 221
Query: 303 KEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQR 362
           + F+AE   +  L+H  LV+L      K  + ++ ++M  GSL  +L           + 
Sbjct: 222 EAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKL 280
Query: 363 FRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTT 422
                 +A G+ ++ Q   +  IHRD++A+N+L+   L  ++ DFGLAR           
Sbjct: 281 IDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLAR----------- 326
Query: 423 HVVGT---LGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRP 463
             VG    + + APE    G  T  +DV+SFG  L+E+   GR P
Sbjct: 327 --VGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIP 369

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/198 (32%), Positives = 97/198 (48%), Gaps = 15/198 (7%)
Query: 269 LGTGGFGRV----YRGTLPKSQIEIAVKKISHESRQGMKE-FVAEIVSIGRLRHRNLVQL 323
           LG G FG+V    Y  T   +   +AVK +       ++  +  EI  +  L H ++V+ 
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 76
Query: 324 LGYCRRKGE--LLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
            G C  +GE  + LV +Y+P GSL  YL   P+  +   Q     + +  G+ YLH    
Sbjct: 77  KGCCEDQGEKSVQLVMEYVPLGSLRDYL---PRHCVGLAQLLLFAQQICEGMAYLHA--- 130
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT--LGYLAPEHTRTG 439
           Q  IHR + A NVLLD +   ++GDFGLA+    G +       G   + + APE  +  
Sbjct: 131 QHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEC 190
Query: 440 KATTSADVFSFGAFLLEV 457
           K   ++DV+SFG  L E+
Sbjct: 191 KFYYASDVWSFGVTLYEL 208

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 105/221 (47%), Gaps = 24/221 (10%)
Query: 258 IATKGFREKELLGTGGFGRVYRGTL----PKSQIE-IAVKKISHESRQGMKE-FVAEIVS 311
           I+    R  E LG   FG+VY+G L    P  Q + +A+K +  ++   ++E F  E + 
Sbjct: 23  ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAML 82
Query: 312 IGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYL-YDQPKVTLNWIQRFRVIKG-- 368
             RL+H N+V LLG   +   L +++ Y  +G L ++L    P   +      R +K   
Sbjct: 83  RARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSAL 142
Query: 369 -----------VALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHG 416
                      +A G+ YL       V+H+D+   NVL+  +LN ++ D GL R +Y   
Sbjct: 143 EPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAAD 199
Query: 417 TDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEV 457
                 + +  + ++APE    GK +  +D++S+G  L EV
Sbjct: 200 YYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEV 240

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 73/270 (27%), Positives = 116/270 (42%), Gaps = 36/270 (13%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKI--SHESRQGMKEFVAEIVSI-GRLRHRNLVQLLG 325
           LG G FG VY     +S+  +A+K +  +   + G++  +   V I   LRH N+++L G
Sbjct: 33  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 92
Query: 326 YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVI 385
           Y      + L+ +Y P G++ + L    K        +  I  +A  L Y H    + VI
Sbjct: 93  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSYCHS---KRVI 147
Query: 386 HRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSA 445
           HRD+K  N+LL      ++ DFG +    H    + T + GTL YL PE           
Sbjct: 148 HRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLCGTLDYLPPEMIEGRMHDEKV 204
Query: 446 DVFSFGAFLLEVACGRRPIQR---QGPSENLILVDWVF-DFWNRGELLEARDPNLGTEYV 501
           D++S G    E   G+ P +    Q   + +  V++ F DF   G    ARD        
Sbjct: 205 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEG----ARD-------- 252
Query: 502 AXXXXXXXXXXXXCSHSDPTARPSMRQVVQ 531
                          H +P+ RP +R+V++
Sbjct: 253 --------LISRLLKH-NPSQRPMLREVLE 273

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/198 (32%), Positives = 97/198 (48%), Gaps = 15/198 (7%)
Query: 269 LGTGGFGRV----YRGTLPKSQIEIAVKKISHESRQGMKE-FVAEIVSIGRLRHRNLVQL 323
           LG G FG+V    Y  T   +   +AVK +       ++  +  EI  +  L H ++V+ 
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 75
Query: 324 LGYCRRKGE--LLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
            G C  +GE  + LV +Y+P GSL  YL   P+  +   Q     + +  G+ YLH    
Sbjct: 76  KGCCEDQGEKSVQLVMEYVPLGSLRDYL---PRHCVGLAQLLLFAQQICEGMAYLHA--- 129
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT--LGYLAPEHTRTG 439
           Q  IHR + A NVLLD +   ++GDFGLA+    G +       G   + + APE  +  
Sbjct: 130 QHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEC 189
Query: 440 KATTSADVFSFGAFLLEV 457
           K   ++DV+SFG  L E+
Sbjct: 190 KFYYASDVWSFGVTLYEL 207

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 76/292 (26%), Positives = 122/292 (41%), Gaps = 43/292 (14%)
Query: 247 GPHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKI--SHESRQGMKE 304
           GP ++  +D  I          LG G FG VY     +S+  +A+K +  +   + G++ 
Sbjct: 1   GPRQWALEDFEIGRP-------LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEH 53
Query: 305 FVAEIVSI-GRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRF 363
            +   V I   LRH N+++L GY      + L+ +Y P G++ + L    K        +
Sbjct: 54  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY 113
Query: 364 RVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTH 423
             I  +A  L Y H    + VIHRD+K  N+LL      ++ DFG +    H    + T 
Sbjct: 114 --ITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTT 165
Query: 424 VVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQR---QGPSENLILVDWVF 480
           + GTL YL PE           D++S G    E   G+ P +    Q   + +  V++ F
Sbjct: 166 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF 225
Query: 481 -DFWNRGELLEARDPNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQ 531
            DF   G    ARD                         +P+ RP +R+V++
Sbjct: 226 PDFVTEG----ARD-----------------LISRLLKHNPSQRPMLREVLE 256

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 115/270 (42%), Gaps = 36/270 (13%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKI--SHESRQGMKEFVAEIVSI-GRLRHRNLVQLLG 325
           LG G FG VY     +S+  +A+K +  +   + G++  +   V I   LRH N+++L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 326 YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVI 385
           Y      + L+ +Y P G++ + L    K        +  I  +A  L Y H    + VI
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSYCHS---KRVI 130
Query: 386 HRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSA 445
           HRD+K  N+LL      ++ DFG +    H    + T + GTL YL PE           
Sbjct: 131 HRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTDLCGTLDYLPPEMIEGRMHDEKV 187
Query: 446 DVFSFGAFLLEVACGRRPIQR---QGPSENLILVDWVF-DFWNRGELLEARDPNLGTEYV 501
           D++S G    E   G+ P +    Q   + +  V++ F DF   G    ARD        
Sbjct: 188 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEG----ARD-------- 235
Query: 502 AXXXXXXXXXXXXCSHSDPTARPSMRQVVQ 531
                            +P+ RP +R+V++
Sbjct: 236 ---------LISRLLKHNPSQRPMLREVLE 256

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 115/270 (42%), Gaps = 36/270 (13%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKI--SHESRQGMKEFVAEIVSI-GRLRHRNLVQLLG 325
           LG G FG VY     +S+  +A+K +  +   + G++  +   V I   LRH N+++L G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 326 YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVI 385
           Y      + L+ +Y P G++ + L    K        +  I  +A  L Y H    + VI
Sbjct: 81  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSYCHS---KRVI 135
Query: 386 HRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSA 445
           HRD+K  N+LL      ++ DFG +    H    + T + GTL YL PE           
Sbjct: 136 HRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTDLCGTLDYLPPEMIEGRMHDEKV 192
Query: 446 DVFSFGAFLLEVACGRRPIQR---QGPSENLILVDWVF-DFWNRGELLEARDPNLGTEYV 501
           D++S G    E   G+ P +    Q   + +  V++ F DF   G    ARD        
Sbjct: 193 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEG----ARD-------- 240
Query: 502 AXXXXXXXXXXXXCSHSDPTARPSMRQVVQ 531
                            +P+ RP +R+V++
Sbjct: 241 ---------LISRLLKHNPSQRPMLREVLE 261

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 115/270 (42%), Gaps = 36/270 (13%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKI--SHESRQGMKEFVAEIVSI-GRLRHRNLVQLLG 325
           LG G FG VY     +S+  +A+K +  +   + G++  +   V I   LRH N+++L G
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 326 YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVI 385
           Y      + L+ +Y P G++ + L    K        +  I  +A  L Y H    + VI
Sbjct: 77  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSYCHS---KRVI 131
Query: 386 HRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSA 445
           HRD+K  N+LL      ++ DFG +    H    + T + GTL YL PE           
Sbjct: 132 HRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKV 188
Query: 446 DVFSFGAFLLEVACGRRPIQR---QGPSENLILVDWVF-DFWNRGELLEARDPNLGTEYV 501
           D++S G    E   G+ P +    Q   + +  V++ F DF   G    ARD        
Sbjct: 189 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEG----ARD-------- 236
Query: 502 AXXXXXXXXXXXXCSHSDPTARPSMRQVVQ 531
                            +P+ RP +R+V++
Sbjct: 237 ---------LISRLLKHNPSQRPMLREVLE 257

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 115/270 (42%), Gaps = 36/270 (13%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKI--SHESRQGMKEFVAEIVSI-GRLRHRNLVQLLG 325
           LG G FG VY     +S+  +A+K +  +   + G++  +   V I   LRH N+++L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 326 YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVI 385
           Y      + L+ +Y P G++ + L    K        +  I  +A  L Y H    + VI
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSYCHS---KRVI 130
Query: 386 HRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSA 445
           HRD+K  N+LL      ++ DFG +    H    + T + GTL YL PE           
Sbjct: 131 HRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTDLCGTLDYLPPEMIEGRMHDEKV 187
Query: 446 DVFSFGAFLLEVACGRRPIQR---QGPSENLILVDWVF-DFWNRGELLEARDPNLGTEYV 501
           D++S G    E   G+ P +    Q   + +  V++ F DF   G    ARD        
Sbjct: 188 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEG----ARD-------- 235
Query: 502 AXXXXXXXXXXXXCSHSDPTARPSMRQVVQ 531
                            +P+ RP +R+V++
Sbjct: 236 ---------LISRLLKHNPSQRPMLREVLE 256

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 115/270 (42%), Gaps = 36/270 (13%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKI--SHESRQGMKEFVAEIVSI-GRLRHRNLVQLLG 325
           LG G FG VY     +S+  +A+K +  +   + G++  +   V I   LRH N+++L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 326 YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVI 385
           Y      + L+ +Y P G++ + L    K        +  I  +A  L Y H    + VI
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSYCHS---KRVI 130
Query: 386 HRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSA 445
           HRD+K  N+LL      ++ DFG +    H    + T + GTL YL PE           
Sbjct: 131 HRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTXLCGTLDYLPPEMIEGRMHDEKV 187
Query: 446 DVFSFGAFLLEVACGRRPIQR---QGPSENLILVDWVF-DFWNRGELLEARDPNLGTEYV 501
           D++S G    E   G+ P +    Q   + +  V++ F DF   G    ARD        
Sbjct: 188 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEG----ARD-------- 235
Query: 502 AXXXXXXXXXXXXCSHSDPTARPSMRQVVQ 531
                            +P+ RP +R+V++
Sbjct: 236 ---------LISRLLKHNPSQRPMLREVLE 256

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 115/270 (42%), Gaps = 36/270 (13%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKI--SHESRQGMKEFVAEIVSI-GRLRHRNLVQLLG 325
           LG G FG VY     +S+  +A+K +  +   + G++  +   V I   LRH N+++L G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 326 YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVI 385
           Y      + L+ +Y P G++ + L    K        +  I  +A  L Y H    + VI
Sbjct: 81  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSYCHS---KRVI 135
Query: 386 HRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSA 445
           HRD+K  N+LL      ++ DFG +    H    + T + GTL YL PE           
Sbjct: 136 HRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKV 192
Query: 446 DVFSFGAFLLEVACGRRPIQR---QGPSENLILVDWVF-DFWNRGELLEARDPNLGTEYV 501
           D++S G    E   G+ P +    Q   + +  V++ F DF   G    ARD        
Sbjct: 193 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEG----ARD-------- 240
Query: 502 AXXXXXXXXXXXXCSHSDPTARPSMRQVVQ 531
                            +P+ RP +R+V++
Sbjct: 241 ---------LISRLLKHNPSQRPMLREVLE 261

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 115/270 (42%), Gaps = 36/270 (13%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKI--SHESRQGMKEFVAEIVSI-GRLRHRNLVQLLG 325
           LG G FG VY     +S+  +A+K +  +   + G++  +   V I   LRH N+++L G
Sbjct: 20  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 326 YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVI 385
           Y      + L+ +Y P G++ + L    K        +  I  +A  L Y H    + VI
Sbjct: 80  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSYCHS---KRVI 134
Query: 386 HRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSA 445
           HRD+K  N+LL      ++ DFG +    H    + T + GTL YL PE           
Sbjct: 135 HRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKV 191
Query: 446 DVFSFGAFLLEVACGRRPIQR---QGPSENLILVDWVF-DFWNRGELLEARDPNLGTEYV 501
           D++S G    E   G+ P +    Q   + +  V++ F DF   G    ARD        
Sbjct: 192 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEG----ARD-------- 239
Query: 502 AXXXXXXXXXXXXCSHSDPTARPSMRQVVQ 531
                            +P+ RP +R+V++
Sbjct: 240 ---------LISRLLKHNPSQRPMLREVLE 260

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 115/270 (42%), Gaps = 36/270 (13%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKI--SHESRQGMKEFVAEIVSI-GRLRHRNLVQLLG 325
           LG G FG VY     +S+  +A+K +  +   + G++  +   V I   LRH N+++L G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 326 YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVI 385
           Y      + L+ +Y P G++ + L    K        +  I  +A  L Y H    + VI
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSYCHS---KRVI 133
Query: 386 HRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSA 445
           HRD+K  N+LL      ++ DFG +    H    + T + GTL YL PE           
Sbjct: 134 HRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKV 190
Query: 446 DVFSFGAFLLEVACGRRPIQR---QGPSENLILVDWVF-DFWNRGELLEARDPNLGTEYV 501
           D++S G    E   G+ P +    Q   + +  V++ F DF   G    ARD        
Sbjct: 191 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEG----ARD-------- 238
Query: 502 AXXXXXXXXXXXXCSHSDPTARPSMRQVVQ 531
                            +P+ RP +R+V++
Sbjct: 239 ---------LISRLLKHNPSQRPMLREVLE 259

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 100/218 (45%), Gaps = 32/218 (14%)
Query: 269 LGTGGFGRVYR----GTLPKSQIE-IAVKKISHESRQGMK-EFVAEIVSIGRLRHRNLVQ 322
           +G G FGRV++    G LP      +AVK +  E+   M+ +F  E   +    + N+V+
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 323 LLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVT----------------------LNWI 360
           LLG C     + L+++YM  G L+++L      T                      L+  
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 361 QRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDP 419
           ++  + + VA G+ YL    E+  +HRD+   N L+   +  ++ DFGL+R +Y      
Sbjct: 175 EQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 231
Query: 420 QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEV 457
              +    + ++ PE     + TT +DV+++G  L E+
Sbjct: 232 ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 269

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 110/221 (49%), Gaps = 23/221 (10%)
Query: 267 ELLGTGGFGRVY---RGTLPKSQIEIAVK-------KISHESRQGMKEFVAEIVSIGRLR 316
           ++LG G FG+V+   + T P S    A+K       K+    R  M+  +     +  + 
Sbjct: 34  KVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDI-----LADVN 88
Query: 317 HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYL 376
           H  +V+L    + +G+L L+ D++  G L   L  +   T   ++ +  +  +ALGL +L
Sbjct: 89  HPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFY--LAELALGLDHL 146
Query: 377 HQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVGTLGYLAPEH 435
           H      +I+RD+K  N+LLD E + +L DFGL++   DH  + +     GT+ Y+APE 
Sbjct: 147 HS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDH--EKKAYSFCGTVEYMAPEV 201
Query: 436 TRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILV 476
                 + SAD +S+G  + E+  G  P Q +   E + L+
Sbjct: 202 VNRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLI 242

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 73/251 (29%), Positives = 109/251 (43%), Gaps = 47/251 (18%)
Query: 261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKI--------SHESRQGMKEFVAEIVSI 312
           + +  KE+LG G    V R     +  E AVK I        S E  Q ++E   + V I
Sbjct: 4   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 63
Query: 313 GRLR--HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVA 370
            R    H N++QL           LV+D M  G L  YL +  KVTL+  +  ++++ + 
Sbjct: 64  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALL 121
Query: 371 LGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGY 430
             +  LH+     ++HRD+K  N+LLD ++N +L DFG +   D G   +   V GT  Y
Sbjct: 122 EVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE--KLREVCGTPSY 176
Query: 431 LAPE---------HTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFD 481
           LAPE         H   GK     D++S G  +  +  G  P                  
Sbjct: 177 LAPEIIECSMNDNHPGYGK---EVDMWSTGVIMYTLLAGSPP------------------ 215
Query: 482 FWNRGELLEAR 492
           FW+R ++L  R
Sbjct: 216 FWHRKQMLMLR 226

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 105/221 (47%), Gaps = 24/221 (10%)
Query: 258 IATKGFREKELLGTGGFGRVYRGTL----PKSQIE-IAVKKISHESRQGMKE-FVAEIVS 311
           I+    R  E LG   FG+VY+G L    P  Q + +A+K +  ++   ++E F  E + 
Sbjct: 6   ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAML 65
Query: 312 IGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYL-YDQPKVTLNWIQRFRVIKG-- 368
             RL+H N+V LLG   +   L +++ Y  +G L ++L    P   +      R +K   
Sbjct: 66  RARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSAL 125
Query: 369 -----------VALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHG 416
                      +A G+ YL       V+H+D+   NVL+  +LN ++ D GL R +Y   
Sbjct: 126 EPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAAD 182
Query: 417 TDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEV 457
                 + +  + ++APE    GK +  +D++S+G  L EV
Sbjct: 183 YYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEV 223

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 110/230 (47%), Gaps = 20/230 (8%)
Query: 266 KELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMK-EFVAEIVSIGRLRHRNLVQLL 324
           +++LGTG F  V      ++Q  +A+K I+ ++ +G +     EI  + +++H N+V L 
Sbjct: 23  RDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALD 82
Query: 325 GYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQR--FRVIKGVALGLFYLHQEWEQ 382
                 G L L+   +  G L   + ++   T     R  F+V+  V     YLH   + 
Sbjct: 83  DIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVK----YLH---DL 135
Query: 383 VVIHRDVKASNVL---LDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTG 439
            ++HRD+K  N+L   LD +    + DFGL+++ D G+   T    GT GY+APE     
Sbjct: 136 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTA--CGTPGYVAPEVLAQK 193
Query: 440 KATTSADVFSFGAFLLEVACGRRPIQRQGPS---ENLILVDWVFD--FWN 484
             + + D +S G     + CG  P   +  +   E ++  ++ FD  +W+
Sbjct: 194 PYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWD 243

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 115/270 (42%), Gaps = 36/270 (13%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKI--SHESRQGMKEFVAEIVSI-GRLRHRNLVQLLG 325
           LG G FG VY     +S+  +A+K +  +   + G++  +   V I   LRH N+++L G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 326 YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVI 385
           Y      + L+ +Y P G++ + L    K        +  I  +A  L Y H    + VI
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSYCHS---KRVI 133
Query: 386 HRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSA 445
           HRD+K  N+LL      ++ DFG +    H    + T + GTL YL PE           
Sbjct: 134 HRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKV 190
Query: 446 DVFSFGAFLLEVACGRRPIQR---QGPSENLILVDWVF-DFWNRGELLEARDPNLGTEYV 501
           D++S G    E   G+ P +    Q   + +  V++ F DF   G    ARD        
Sbjct: 191 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEG----ARD-------- 238
Query: 502 AXXXXXXXXXXXXCSHSDPTARPSMRQVVQ 531
                            +P+ RP +R+V++
Sbjct: 239 ---------LISRLLKHNPSQRPMLREVLE 259

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 115/270 (42%), Gaps = 36/270 (13%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKI--SHESRQGMKEFVAEIVSI-GRLRHRNLVQLLG 325
           LG G FG VY     +S+  +A+K +  +   + G++  +   V I   LRH N+++L G
Sbjct: 15  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 74
Query: 326 YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVI 385
           Y      + L+ +Y P G++ + L    K        +  I  +A  L Y H    + VI
Sbjct: 75  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSYCHS---KRVI 129
Query: 386 HRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSA 445
           HRD+K  N+LL      ++ DFG +    H    + T + GTL YL PE           
Sbjct: 130 HRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKV 186
Query: 446 DVFSFGAFLLEVACGRRPIQR---QGPSENLILVDWVF-DFWNRGELLEARDPNLGTEYV 501
           D++S G    E   G+ P +    Q   + +  V++ F DF   G    ARD        
Sbjct: 187 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEG----ARD-------- 234
Query: 502 AXXXXXXXXXXXXCSHSDPTARPSMRQVVQ 531
                            +P+ RP +R+V++
Sbjct: 235 ---------LISRLLKHNPSQRPMLREVLE 255

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 66/238 (27%), Positives = 107/238 (44%), Gaps = 26/238 (10%)
Query: 261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVA-EIVSIGRLRHRN 319
           K F  KE LGTG F  V       +    AVK I  ++ +G +  +  EI  + +++H N
Sbjct: 22  KIFEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIKHEN 81
Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSL-----DKYLYDQPKVTLNWIQRFRVIKGVALGLF 374
           +V L         L LV   +  G L     +K  Y +   +        +I+ V   ++
Sbjct: 82  IVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDAST-------LIRQVLDAVY 134
Query: 375 YLHQEWEQVVIHRDVKASNVLL---DGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYL 431
           YLH+     ++HRD+K  N+L    D E    + DFGL+++   G D  +T   GT GY+
Sbjct: 135 YLHR---MGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKG-DVMST-ACGTPGYV 189
Query: 432 APEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPS---ENLILVDWVFD--FWN 484
           APE       + + D +S G     + CG  P   +  S   E ++  ++ FD  +W+
Sbjct: 190 APEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDSKLFEQILKAEYEFDSPYWD 247

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 113/270 (41%), Gaps = 36/270 (13%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKI--SHESRQGMKEFVAEIVSI-GRLRHRNLVQLLG 325
           LG G FG VY     +S+  +A+K +  +   + G++  +   V I   LRH N+++L G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 326 YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVI 385
           Y      + L+ +Y P G + K L    K        +  I  +A  L Y H    + VI
Sbjct: 81  YFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATY--ITELANALSYCHS---KRVI 135
Query: 386 HRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSA 445
           HRD+K  N+LL      ++ DFG +    H    +   + GTL YL PE           
Sbjct: 136 HRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRXXLXGTLDYLPPEMIEGRMHDEKV 192
Query: 446 DVFSFGAFLLEVACGRRPIQR---QGPSENLILVDWVF-DFWNRGELLEARDPNLGTEYV 501
           D++S G    E   G+ P +    Q   + +  V++ F DF   G    ARD        
Sbjct: 193 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEG----ARD-------- 240
Query: 502 AXXXXXXXXXXXXCSHSDPTARPSMRQVVQ 531
                            +P+ RP +R+V++
Sbjct: 241 ---------LISRLLKHNPSQRPMLREVLE 261

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 60/182 (32%), Positives = 95/182 (52%), Gaps = 24/182 (13%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVA--EIVSIGRLRHRNLVQLLGY 326
           +G G FG V++    K+  ++A+KK+  E+ +      A  EI  +  L+H N+V L+  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 327 CRRK--------GELLLVYDYMPN---GSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFY 375
           CR K        G + LV+D+  +   G L   L    K TL+ I+R  V++ +  GL+Y
Sbjct: 86  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV---KFTLSEIKR--VMQMLLNGLYY 140
Query: 376 LHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHV---VGTLGYLA 432
           +H+     ++HRD+KA+NVL+  +   +L DFGLAR +    + Q       V TL Y  
Sbjct: 141 IHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRP 197
Query: 433 PE 434
           PE
Sbjct: 198 PE 199

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 115/270 (42%), Gaps = 36/270 (13%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKI--SHESRQGMKEFVAEIVSI-GRLRHRNLVQLLG 325
           LG G FG VY     +S+  +A+K +  +   + G++  +   V I   LRH N+++L G
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 326 YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVI 385
           Y      + L+ +Y P G++ + L    K        +  I  +A  L Y H    + VI
Sbjct: 77  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSYCHS---KRVI 131
Query: 386 HRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSA 445
           HRD+K  N+LL      ++ DFG +    H    + T + GTL YL PE           
Sbjct: 132 HRDIKPENLLLGSAGELKIADFGWS---CHAPSSRRTTLSGTLDYLPPEMIEGRMHDEKV 188
Query: 446 DVFSFGAFLLEVACGRRPIQR---QGPSENLILVDWVF-DFWNRGELLEARDPNLGTEYV 501
           D++S G    E   G+ P +    Q   + +  V++ F DF   G    ARD        
Sbjct: 189 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEG----ARD-------- 236
Query: 502 AXXXXXXXXXXXXCSHSDPTARPSMRQVVQ 531
                            +P+ RP +R+V++
Sbjct: 237 ---------LISRLLKHNPSQRPMLREVLE 257

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 100/200 (50%), Gaps = 17/200 (8%)
Query: 269 LGTGGFGRV----YRGTLPKSQIEIAVKKISHESR-QGMKEFVAEIVSIGRLRHRNLVQL 323
           LG G FG+V    Y      +  ++AVK +  ES    + +   EI  +  L H N+V+ 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 324 LGYCRRKGE--LLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
            G C   G   + L+ +++P+GSL +YL  + K  +N  Q+ +    +  G+ YL     
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYL-PKNKNKINLKQQLKYAVQICKGMDYLGS--- 144
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVV----GTLGYLAPEHTR 437
           +  +HRD+ A NVL++ E   ++GDFGL +  +  TD +   V       + + APE   
Sbjct: 145 RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE--TDKEXXTVKDDRDSPVFWYAPECLM 202
Query: 438 TGKATTSADVFSFGAFLLEV 457
             K   ++DV+SFG  L E+
Sbjct: 203 QSKFYIASDVWSFGVTLHEL 222

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 100/202 (49%), Gaps = 13/202 (6%)
Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMK---EFVAEIVSIGRLRHRNLVQL 323
           + LG G FG+V  G    +  ++AVK ++ +  + +    +   EI ++   RH ++++L
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 324 LGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQV 383
                   +  +V +Y+  G L  Y+    +V    ++  R+ + +   + Y H+    +
Sbjct: 77  YQVISTPTDFFMVMEYVSGGELFDYICKHGRV--EEMEARRLFQQILSAVDYCHR---HM 131
Query: 384 VIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGK--A 441
           V+HRD+K  NVLLD  +N ++ DFGL+ +   G   + +   G+  Y APE   +G+  A
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDS--CGSPNYAAPE-VISGRLYA 188
Query: 442 TTSADVFSFGAFLLEVACGRRP 463
               D++S G  L  + CG  P
Sbjct: 189 GPEVDIWSCGVILYALLCGTLP 210

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 70/287 (24%), Positives = 131/287 (45%), Gaps = 39/287 (13%)
Query: 269 LGTGGFGRVYRGTLP-----KSQIEIAVKKISHESRQGMK-EFVAEIVSIGRLRHRNLVQ 322
           LG G FG VY G        + +  +A+K ++  +    + EF+ E   +      ++V+
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 85
Query: 323 LLGYCRRKGELLLVYDYMPNGSLDKYLYD-QPKVTLNWI-------QRFRVIKGVALGLF 374
           LLG   +    L++ + M  G L  YL   +P++  N +       +  ++   +A G+ 
Sbjct: 86  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 145
Query: 375 YLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVGTLGYLAP 433
           YL+       +HRD+ A N ++  +   ++GDFG+ R +Y+     +    +  + +++P
Sbjct: 146 YLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 202
Query: 434 EHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEAR 492
           E  + G  TT +DV+SFG  L E+A    +P   QG S   +L      F   G LL+  
Sbjct: 203 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY--QGLSNEQVL-----RFVMEGGLLDKP 255
Query: 493 D--PNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQILERDV 537
           D  P++  E +             C   +P  RPS  +++  ++ ++
Sbjct: 256 DNCPDMLFELM-----------RMCWQYNPKMRPSFLEIISSIKEEM 291

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 70/287 (24%), Positives = 131/287 (45%), Gaps = 39/287 (13%)
Query: 269 LGTGGFGRVYRGTLP-----KSQIEIAVKKISHESRQGMK-EFVAEIVSIGRLRHRNLVQ 322
           LG G FG VY G        + +  +A+K ++  +    + EF+ E   +      ++V+
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 85
Query: 323 LLGYCRRKGELLLVYDYMPNGSLDKYLYD-QPKVTLNWI-------QRFRVIKGVALGLF 374
           LLG   +    L++ + M  G L  YL   +P++  N +       +  ++   +A G+ 
Sbjct: 86  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 145
Query: 375 YLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVGTLGYLAP 433
           YL+       +HRD+ A N ++  +   ++GDFG+ R +Y+     +    +  + +++P
Sbjct: 146 YLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 202
Query: 434 EHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEAR 492
           E  + G  TT +DV+SFG  L E+A    +P   QG S   +L      F   G LL+  
Sbjct: 203 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY--QGLSNEQVL-----RFVMEGGLLDKP 255
Query: 493 D--PNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQILERDV 537
           D  P++  E +             C   +P  RPS  +++  ++ ++
Sbjct: 256 DNCPDMLFELM-----------RMCWQYNPKMRPSFLEIISSIKEEM 291

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 100/200 (50%), Gaps = 17/200 (8%)
Query: 269 LGTGGFGRV----YRGTLPKSQIEIAVKKISHESR-QGMKEFVAEIVSIGRLRHRNLVQL 323
           LG G FG+V    Y      +  ++AVK +  ES    + +   EI  +  L H N+V+ 
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 324 LGYCRRKGE--LLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
            G C   G   + L+ +++P+GSL +YL  + K  +N  Q+ +    +  G+ YL     
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYL-PKNKNKINLKQQLKYAVQICKGMDYLGS--- 132
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVV----GTLGYLAPEHTR 437
           +  +HRD+ A NVL++ E   ++GDFGL +  +  TD +   V       + + APE   
Sbjct: 133 RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE--TDKEXXTVKDDRDSPVFWYAPECLM 190
Query: 438 TGKATTSADVFSFGAFLLEV 457
             K   ++DV+SFG  L E+
Sbjct: 191 QSKFYIASDVWSFGVTLHEL 210

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 60/182 (32%), Positives = 95/182 (52%), Gaps = 24/182 (13%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVA--EIVSIGRLRHRNLVQLLGY 326
           +G G FG V++    K+  ++A+KK+  E+ +      A  EI  +  L+H N+V L+  
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84
Query: 327 CRRK--------GELLLVYDYMPN---GSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFY 375
           CR K        G + LV+D+  +   G L   L    K TL+ I+R  V++ +  GL+Y
Sbjct: 85  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV---KFTLSEIKR--VMQMLLNGLYY 139
Query: 376 LHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHV---VGTLGYLA 432
           +H+     ++HRD+KA+NVL+  +   +L DFGLAR +    + Q       V TL Y  
Sbjct: 140 IHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRP 196
Query: 433 PE 434
           PE
Sbjct: 197 PE 198

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 70/287 (24%), Positives = 131/287 (45%), Gaps = 39/287 (13%)
Query: 269 LGTGGFGRVYRGTLP-----KSQIEIAVKKISHESRQGMK-EFVAEIVSIGRLRHRNLVQ 322
           LG G FG VY G        + +  +A+K ++  +    + EF+ E   +      ++V+
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 79
Query: 323 LLGYCRRKGELLLVYDYMPNGSLDKYLYD-QPKVTLNWI-------QRFRVIKGVALGLF 374
           LLG   +    L++ + M  G L  YL   +P++  N +       +  ++   +A G+ 
Sbjct: 80  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 139
Query: 375 YLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVGTLGYLAP 433
           YL+       +HRD+ A N ++  +   ++GDFG+ R +Y+     +    +  + +++P
Sbjct: 140 YLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 196
Query: 434 EHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEAR 492
           E  + G  TT +DV+SFG  L E+A    +P   QG S   +L      F   G LL+  
Sbjct: 197 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY--QGLSNEQVL-----RFVMEGGLLDKP 249
Query: 493 D--PNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQILERDV 537
           D  P++  E +             C   +P  RPS  +++  ++ ++
Sbjct: 250 DNCPDMLFELM-----------RMCWQYNPKMRPSFLEIISSIKEEM 285

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 98/198 (49%), Gaps = 10/198 (5%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCR 328
           LG G FG V+ G    S  ++AVK +   +   ++ F+ E   +  L+H  LV+L     
Sbjct: 20  LGAGQFGEVWMGYYNNS-TKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVT 77
Query: 329 RKGELLLVYDYMPNGSLDKYLYDQP--KVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIH 386
           ++  + ++ ++M  GSL  +L      KV L  +  F     +A G+ Y+ +   +  IH
Sbjct: 78  KEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSA--QIAEGMAYIER---KNYIH 132
Query: 387 RDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSAD 446
           RD++A+NVL+   L  ++ DFGLAR+ +             + + APE    G  T  ++
Sbjct: 133 RDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSN 192
Query: 447 VFSFGAFLLEVAC-GRRP 463
           V+SFG  L E+   G+ P
Sbjct: 193 VWSFGILLYEIVTYGKIP 210

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 70/287 (24%), Positives = 131/287 (45%), Gaps = 39/287 (13%)
Query: 269 LGTGGFGRVYRGTLP-----KSQIEIAVKKISHESRQGMK-EFVAEIVSIGRLRHRNLVQ 322
           LG G FG VY G        + +  +A+K ++  +    + EF+ E   +      ++V+
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 86
Query: 323 LLGYCRRKGELLLVYDYMPNGSLDKYLYD-QPKVTLNWI-------QRFRVIKGVALGLF 374
           LLG   +    L++ + M  G L  YL   +P++  N +       +  ++   +A G+ 
Sbjct: 87  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 146
Query: 375 YLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVGTLGYLAP 433
           YL+       +HRD+ A N ++  +   ++GDFG+ R +Y+     +    +  + +++P
Sbjct: 147 YLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 203
Query: 434 EHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEAR 492
           E  + G  TT +DV+SFG  L E+A    +P   QG S   +L      F   G LL+  
Sbjct: 204 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY--QGLSNEQVL-----RFVMEGGLLDKP 256
Query: 493 D--PNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQILERDV 537
           D  P++  E +             C   +P  RPS  +++  ++ ++
Sbjct: 257 DNCPDMLFELM-----------RMCWQYNPKMRPSFLEIISSIKEEM 292

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 70/287 (24%), Positives = 131/287 (45%), Gaps = 39/287 (13%)
Query: 269 LGTGGFGRVYRGTLP-----KSQIEIAVKKISHESRQGMK-EFVAEIVSIGRLRHRNLVQ 322
           LG G FG VY G        + +  +A+K ++  +    + EF+ E   +      ++V+
Sbjct: 24  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 83
Query: 323 LLGYCRRKGELLLVYDYMPNGSLDKYLYD-QPKVTLNWI-------QRFRVIKGVALGLF 374
           LLG   +    L++ + M  G L  YL   +P++  N +       +  ++   +A G+ 
Sbjct: 84  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 143
Query: 375 YLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVGTLGYLAP 433
           YL+       +HRD+ A N ++  +   ++GDFG+ R +Y+     +    +  + +++P
Sbjct: 144 YLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 200
Query: 434 EHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEAR 492
           E  + G  TT +DV+SFG  L E+A    +P   QG S   +L      F   G LL+  
Sbjct: 201 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY--QGLSNEQVL-----RFVMEGGLLDKP 253
Query: 493 D--PNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQILERDV 537
           D  P++  E +             C   +P  RPS  +++  ++ ++
Sbjct: 254 DNCPDMLFELM-----------RMCWQYNPKMRPSFLEIISSIKEEM 289

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 97/218 (44%), Gaps = 10/218 (4%)
Query: 258 IATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRL-- 315
           +  + F   ++LG G FG+V+     K+    A+K +  +      +    +V    L  
Sbjct: 14  LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSL 73
Query: 316 --RHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGL 373
              H  L  +    + K  L  V +Y+  G L  ++    K  L+    +     + LGL
Sbjct: 74  AWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAA--EIILGL 131
Query: 374 FYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAP 433
            +LH    + +++RD+K  N+LLD + + ++ DFG+ +    G D +T    GT  Y+AP
Sbjct: 132 QFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG-DAKTNXFCGTPDYIAP 187
Query: 434 EHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSE 471
           E     K   S D +SFG  L E+  G+ P   Q   E
Sbjct: 188 EILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE 225

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 104/218 (47%), Gaps = 30/218 (13%)
Query: 259 ATKGFREKELLGTGGFGRV-----------YRGTLPKSQIEIAVKKISHESRQGMKEFVA 307
           + + F+    LGTG FGRV           Y   + K +I + +K++ H + + +     
Sbjct: 4   SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERL----- 58
Query: 308 EIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIK 367
            ++SI  + H  ++++ G  +   ++ ++ DY+  G L   L    +   N + +F   +
Sbjct: 59  -MLSI--VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFP-NPVAKFYAAE 114
Query: 368 GVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTH-VVG 426
            V L L YLH    + +I+RD+K  N+LLD   + ++ DFG A+       P  T+ + G
Sbjct: 115 -VCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYV-----PDVTYXLCG 165
Query: 427 TLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPI 464
           T  Y+APE   T     S D +SFG  + E+  G  P 
Sbjct: 166 TPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPF 203

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 70/287 (24%), Positives = 130/287 (45%), Gaps = 39/287 (13%)
Query: 269 LGTGGFGRVYRGTLP-----KSQIEIAVKKISHESRQGMK-EFVAEIVSIGRLRHRNLVQ 322
           LG G FG VY G        + +  +A+K ++  +    + EF+ E   +      ++V+
Sbjct: 23  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 82
Query: 323 LLGYCRRKGELLLVYDYMPNGSLDKYLYD-QPKVTLNWI-------QRFRVIKGVALGLF 374
           LLG   +    L++ + M  G L  YL   +P +  N +       +  ++   +A G+ 
Sbjct: 83  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMA 142
Query: 375 YLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVGTLGYLAP 433
           YL+       +HRD+ A N ++  +   ++GDFG+ R +Y+     +    +  + +++P
Sbjct: 143 YLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 199
Query: 434 EHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEAR 492
           E  + G  TT +DV+SFG  L E+A    +P   QG S   +L      F   G LL+  
Sbjct: 200 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY--QGLSNEQVL-----RFVMEGGLLDKP 252
Query: 493 D--PNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQILERDV 537
           D  P++  E +             C   +P  RPS  +++  ++ ++
Sbjct: 253 DNCPDMLFELM-----------RMCWQYNPKMRPSFLEIISSIKEEM 288

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 100/213 (46%), Gaps = 12/213 (5%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKI--SHESRQGMKEFVAEIVSIGRLRHRNL 320
           +R ++ +G G F +V       +  E+AVK I  +  +   +++   E+  +  L H N+
Sbjct: 17  YRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNI 76
Query: 321 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQ-RFRVIKGVALGLFYLHQE 379
           V+L      +  L LV +Y   G +  YL    ++     + +FR I      + Y HQ+
Sbjct: 77  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQI---VSAVQYCHQK 133
Query: 380 WEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTG 439
           +   ++HRD+KA N+LLDG++N ++ DFG +  +  G    T    G+  Y APE  +  
Sbjct: 134 Y---IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDT--FCGSPPYAAPELFQGK 188
Query: 440 KAT-TSADVFSFGAFLLEVACGRRPIQRQGPSE 471
           K      DV+S G  L  +  G  P   Q   E
Sbjct: 189 KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE 221

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/182 (32%), Positives = 95/182 (52%), Gaps = 24/182 (13%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVA--EIVSIGRLRHRNLVQLLGY 326
           +G G FG V++    K+  ++A+KK+  E+ +      A  EI  +  L+H N+V L+  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 327 CRRK--------GELLLVYDYMPN---GSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFY 375
           CR K        G + LV+D+  +   G L   L    K TL+ I+R  V++ +  GL+Y
Sbjct: 86  CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV---KFTLSEIKR--VMQMLLNGLYY 140
Query: 376 LHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHV---VGTLGYLA 432
           +H+     ++HRD+KA+NVL+  +   +L DFGLAR +    + Q       V TL Y  
Sbjct: 141 IHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRP 197
Query: 433 PE 434
           PE
Sbjct: 198 PE 199

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/226 (28%), Positives = 103/226 (45%), Gaps = 24/226 (10%)
Query: 255 DLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKI--SHESRQGMKEFVAEIVSI 312
           DL+I    +R  + +G G F +V       +  E+AVK I  +  +   +++   E+  +
Sbjct: 3   DLHIGN--YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIM 60
Query: 313 GRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQ------RFRVI 366
             L H N+V+L      +  L LV +Y   G +  YL     V   W++      +FR I
Sbjct: 61  KVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYL-----VAHGWMKEKEARAKFRQI 115
Query: 367 KGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVG 426
                 + Y HQ++   ++HRD+KA N+LLD ++N ++ DFG +  +  G    T    G
Sbjct: 116 VS---AVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT--FCG 167
Query: 427 TLGYLAPEHTRTGKAT-TSADVFSFGAFLLEVACGRRPIQRQGPSE 471
           +  Y APE  +  K      DV+S G  L  +  G  P   Q   E
Sbjct: 168 SPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE 213

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 113/216 (52%), Gaps = 13/216 (6%)
Query: 269 LGTGGFGRVYRGT--LPKSQIEIAVKKISHESRQG-MKEFVAEIVSIGRLRHRNLVQLLG 325
           LG G FG V +G   + K QI++A+K +   + +   +E + E   + +L +  +V+L+G
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 326 YCRRKGELLLVYDYMPNGSLDKYLY-DQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVV 384
            C+ +  L+LV +    G L K+L   + ++ ++ +    ++  V++G+ YL    E+  
Sbjct: 78  VCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAE--LLHQVSMGMKYLE---EKNF 131
Query: 385 IHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT--LGYLAPEHTRTGKAT 442
           +HRD+ A NVLL      ++ DFGL++         T    G   L + APE     K +
Sbjct: 132 VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 191
Query: 443 TSADVFSFGAFLLE-VACGRRPIQRQGPSENLILVD 477
           + +DV+S+G  + E ++ G++P ++    E +  ++
Sbjct: 192 SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE 227

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 99/218 (45%), Gaps = 14/218 (6%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKI--SHESRQGMK-EFVAEIVSIGRLRHRNLVQLLG 325
           LG G FG VY     KS   +A+K +  S   ++G++ +   EI     L H N+++L  
Sbjct: 31  LGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPNILRLYN 90
Query: 326 YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVI 385
           Y   +  + L+ +Y P G L K L  Q   T +  +   +++ +A  L Y H    + VI
Sbjct: 91  YFYDRRRIYLILEYAPRGELYKEL--QKSCTFDEQRTATIMEELADALMYCHG---KKVI 145
Query: 386 HRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSA 445
           HRD+K  N+LL  +   ++ DFG +    H    +   + GTL YL PE           
Sbjct: 146 HRDIKPENLLLGLKGELKIADFGWSV---HAPSLRRKTMCGTLDYLPPEMIEGRMHNEKV 202
Query: 446 DVFSFGAFLLEVACGRRPIQRQGPSEN---LILVDWVF 480
           D++  G    E+  G  P +    +E    ++ VD  F
Sbjct: 203 DLWCIGVLCYELLVGNPPFESASHNETYRRIVKVDLKF 240

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 114/212 (53%), Gaps = 20/212 (9%)
Query: 259 ATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR-QGMKEF-VAEIVSIGRLR 316
           + + F++ E +G G +G VY+     +   +A+KKI  ++  +G+    + EI  +  L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 317 HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVT---LNWIQR--FRVIKGVAL 371
           H N+V+LL     + +L LV++++ +  L K++ D   +T   L  I+   F++++G+A 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLA- 118
Query: 372 GLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQT-THVVGTLGY 430
              + H      V+HRD+K  N+L++ E   +L DFGLAR +  G   +T TH V TL Y
Sbjct: 119 ---FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWY 170
Query: 431 LAPEHTRTGK-ATTSADVFSFGAFLLEVACGR 461
            APE     K  +T+ D++S G    E+   R
Sbjct: 171 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 114/213 (53%), Gaps = 20/213 (9%)
Query: 258 IATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR-QGMKEF-VAEIVSIGRL 315
           +  + F++ E +G G +G VY+     +   +A+KKI  ++  +G+    + EI  +  L
Sbjct: 4   VDMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL 63
Query: 316 RHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVT---LNWIQR--FRVIKGVA 370
            H N+V+LL     + +L LV++++ +  L K++ D   +T   L  I+   F++++G+A
Sbjct: 64  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLA 121
Query: 371 LGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQT-THVVGTLG 429
               + H      V+HRD+K  N+L++ E   +L DFGLAR +  G   +T TH V TL 
Sbjct: 122 ----FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLW 172
Query: 430 YLAPEHTRTGK-ATTSADVFSFGAFLLEVACGR 461
           Y APE     K  +T+ D++S G    E+   R
Sbjct: 173 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 96/209 (45%), Gaps = 15/209 (7%)
Query: 258 IATKGFREKELLGTGGFGRVYRGTLPK---SQIEIAVKKISHE---SRQGMKEFVAEIVS 311
           I  K  R  E LG G FG V RG         + +AVK +  +     + M +F+ E+ +
Sbjct: 9   IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 68
Query: 312 IGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSL-DKYLYDQPKVTLNWIQRFRVIKGVA 370
           +  L HRNL++L G       + +V +  P GSL D+    Q    L  + R+ V   VA
Sbjct: 69  MHSLDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVA 125
Query: 371 LGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP--QTTHVVGTL 428
            G+ YL     +  IHRD+ A N+LL      ++GDFGL R      D      H     
Sbjct: 126 EGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF 182
Query: 429 GYLAPEHTRTGKATTSADVFSFGAFLLEV 457
            + APE  +T   + ++D + FG  L E+
Sbjct: 183 AWCAPESLKTRTFSHASDTWMFGVTLWEM 211

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 98/209 (46%), Gaps = 15/209 (7%)
Query: 258 IATKGFREKELLGTGGFGRVYRGTL--PKSQ-IEIAVKKISHE---SRQGMKEFVAEIVS 311
           I  K  R  E LG G FG V RG    P  + + +AVK +  +     + M +F+ E+ +
Sbjct: 15  IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 74
Query: 312 IGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSL-DKYLYDQPKVTLNWIQRFRVIKGVA 370
           +  L HRNL++L G       + +V +  P GSL D+    Q    L  + R+ V   VA
Sbjct: 75  MHSLDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVA 131
Query: 371 LGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTT--HVVGTL 428
            G+ YL     +  IHRD+ A N+LL      ++GDFGL R      D      H     
Sbjct: 132 EGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPF 188
Query: 429 GYLAPEHTRTGKATTSADVFSFGAFLLEV 457
            + APE  +T   + ++D + FG  L E+
Sbjct: 189 AWCAPESLKTRTFSHASDTWMFGVTLWEM 217

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 129/288 (44%), Gaps = 41/288 (14%)
Query: 269 LGTGGFGRVYRGTLP-----KSQIEIAVKKISHESRQGMK-EFVAEIVSIGRLRHRNLVQ 322
           LG G FG VY G        + +  +A+K ++  +    + EF+ E   +      ++V+
Sbjct: 18  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 77
Query: 323 LLGYCRRKGELLLVYDYMPNGSLDKYLYD-QPKVTLNWI-------QRFRVIKGVALGLF 374
           LLG   +    L++ + M  G L  YL   +P++  N +       +  ++   +A G+ 
Sbjct: 78  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 137
Query: 375 YLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLG--YLA 432
           YL+       +HRD+ A N ++  +   ++GDFG+ R     TD       G L   +++
Sbjct: 138 YLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXE-TDXXRKGGKGLLPVRWMS 193
Query: 433 PEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEA 491
           PE  + G  TT +DV+SFG  L E+A    +P   QG S   +L      F   G LL+ 
Sbjct: 194 PESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY--QGLSNEQVL-----RFVMEGGLLDK 246
Query: 492 RD--PNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQILERDV 537
            D  P++  E +             C   +P  RPS  +++  ++ ++
Sbjct: 247 PDNCPDMLLELM-----------RMCWQYNPKMRPSFLEIISSIKEEM 283

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 113/210 (53%), Gaps = 20/210 (9%)
Query: 261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR-QGMKEF-VAEIVSIGRLRHR 318
           + F++ E +G G +G VY+     +   +A+KKI  ++  +G+    + EI  +  L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 319 NLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVT---LNWIQR--FRVIKGVALGL 373
           N+V+LL     + +L LV++++ +  L K++ D   +T   L  I+   F++++G+A   
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLA--- 116
Query: 374 FYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQT-THVVGTLGYLA 432
            + H      V+HRD+K  N+L++ E   +L DFGLAR +  G   +T TH V TL Y A
Sbjct: 117 -FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRA 170
Query: 433 PEHTRTGK-ATTSADVFSFGAFLLEVACGR 461
           PE     K  +T+ D++S G    E+   R
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/232 (28%), Positives = 103/232 (44%), Gaps = 19/232 (8%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKI--SHESRQGMKEFVAEIVSI-GRLRHRNLVQLLG 325
           LG G FG VY     +S+  +A+K +  +   + G++  +   V I   LRH N+++L G
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 101
Query: 326 YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVI 385
           Y      + L+ +Y P G++ + L    K        +  I  +A  L Y H    + VI
Sbjct: 102 YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSYCHS---KRVI 156
Query: 386 HRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSA 445
           HRD+K  N+LL      ++ DFG +    H    +   + GTL YL PE           
Sbjct: 157 HRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRDDLCGTLDYLPPEMIEGRMHDEKV 213
Query: 446 DVFSFGAFLLEVACGRRPIQR---QGPSENLILVDWVF-DFWNRGELLEARD 493
           D++S G    E   G+ P +    Q   + +  V++ F DF   G    ARD
Sbjct: 214 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEG----ARD 261

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 73/288 (25%), Positives = 129/288 (44%), Gaps = 41/288 (14%)
Query: 269 LGTGGFGRVYRGTLP-----KSQIEIAVKKISHESRQGMK-EFVAEIVSIGRLRHRNLVQ 322
           LG G FG VY G        + +  +A+K ++  +    + EF+ E   +      ++V+
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 86
Query: 323 LLGYCRRKGELLLVYDYMPNGSLDKYLYD-QPKVTLNWI-------QRFRVIKGVALGLF 374
           LLG   +    L++ + M  G L  YL   +P++  N +       +  ++   +A G+ 
Sbjct: 87  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 146
Query: 375 YLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLG--YLA 432
           YL+       +HRD+ A N ++  +   ++GDFG+ R     TD       G L   +++
Sbjct: 147 YLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXE-TDXXRKGGKGLLPVRWMS 202
Query: 433 PEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEA 491
           PE  + G  TT +DV+SFG  L E+A    +P   QG S   +L      F   G LL+ 
Sbjct: 203 PESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY--QGLSNEQVL-----RFVMEGGLLDK 255
Query: 492 RD--PNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQILERDV 537
            D  P++  E +             C   +P  RPS  +++  ++ ++
Sbjct: 256 PDNCPDMLFELM-----------RMCWQYNPKMRPSFLEIISSIKEEM 292

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 98/209 (46%), Gaps = 15/209 (7%)
Query: 258 IATKGFREKELLGTGGFGRVYRGTL--PKSQ-IEIAVKKISHE---SRQGMKEFVAEIVS 311
           I  K  R  E LG G FG V RG    P  + + +AVK +  +     + M +F+ E+ +
Sbjct: 5   IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64
Query: 312 IGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSL-DKYLYDQPKVTLNWIQRFRVIKGVA 370
           +  L HRNL++L G       + +V +  P GSL D+    Q    L  + R+ V   VA
Sbjct: 65  MHSLDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVA 121
Query: 371 LGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTT--HVVGTL 428
            G+ YL     +  IHRD+ A N+LL      ++GDFGL R      D      H     
Sbjct: 122 EGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPF 178
Query: 429 GYLAPEHTRTGKATTSADVFSFGAFLLEV 457
            + APE  +T   + ++D + FG  L E+
Sbjct: 179 AWCAPESLKTRTFSHASDTWMFGVTLWEM 207

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 97/205 (47%), Gaps = 19/205 (9%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKI--SHESRQGMKEFVAEIVSIGRLRHRNL 320
           +R    LG G +G VY+     +   +A+K+I   HE        + E+  +  L+HRN+
Sbjct: 36  YRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNI 95
Query: 321 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRF--RVIKGVALGLFYLHQ 378
           ++L         L L+++Y  N  L KY+   P V++  I+ F  ++I GV     + H 
Sbjct: 96  IELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVN----FCHS 150
Query: 379 EWEQVVIHRDVKASNVLLDGELNG-----RLGDFGLARLYDHGTDPQTTHVVGTLGYLAP 433
              +  +HRD+K  N+LL           ++GDFGLAR +      Q TH + TL Y  P
Sbjct: 151 ---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIR-QFTHEIITLWYRPP 206
Query: 434 EHTRTGKA-TTSADVFSFGAFLLEV 457
           E     +  +TS D++S      E+
Sbjct: 207 EILLGSRHYSTSVDIWSIACIWAEM 231

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 113/210 (53%), Gaps = 20/210 (9%)
Query: 261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR-QGMKEF-VAEIVSIGRLRHR 318
           + F++ E +G G +G VY+     +   +A+KKI  ++  +G+    + EI  +  L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 319 NLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVT---LNWIQR--FRVIKGVALGL 373
           N+V+LL     + +L LV++++ +  L K++ D   +T   L  I+   F++++G+A   
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLA--- 117
Query: 374 FYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQT-THVVGTLGYLA 432
            + H      V+HRD+K  N+L++ E   +L DFGLAR +  G   +T TH V TL Y A
Sbjct: 118 -FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRA 171
Query: 433 PEHTRTGK-ATTSADVFSFGAFLLEVACGR 461
           PE     K  +T+ D++S G    E+   R
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 113/210 (53%), Gaps = 20/210 (9%)
Query: 261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR-QGMKEF-VAEIVSIGRLRHR 318
           + F++ E +G G +G VY+     +   +A+KKI  ++  +G+    + EI  +  L H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 319 NLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVT---LNWIQR--FRVIKGVALGL 373
           N+V+LL     + +L LV++++ +  L K++ D   +T   L  I+   F++++G+A   
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLA--- 124
Query: 374 FYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQT-THVVGTLGYLA 432
            + H      V+HRD+K  N+L++ E   +L DFGLAR +  G   +T TH V TL Y A
Sbjct: 125 -FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRA 178
Query: 433 PEHTRTGK-ATTSADVFSFGAFLLEVACGR 461
           PE     K  +T+ D++S G    E+   R
Sbjct: 179 PEILLGXKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 113/210 (53%), Gaps = 20/210 (9%)
Query: 261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR-QGMKEF-VAEIVSIGRLRHR 318
           + F++ E +G G +G VY+     +   +A+KKI  ++  +G+    + EI  +  L H 
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 69
Query: 319 NLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVT---LNWIQR--FRVIKGVALGL 373
           N+V+LL     + +L LV++++ +  L K++ D   +T   L  I+   F++++G+A   
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLA--- 124
Query: 374 FYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQT-THVVGTLGYLA 432
            + H      V+HRD+K  N+L++ E   +L DFGLAR +  G   +T TH V TL Y A
Sbjct: 125 -FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRA 178
Query: 433 PEHTRTGK-ATTSADVFSFGAFLLEVACGR 461
           PE     K  +T+ D++S G    E+   R
Sbjct: 179 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 113/210 (53%), Gaps = 20/210 (9%)
Query: 261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR-QGMKEF-VAEIVSIGRLRHR 318
           + F++ E +G G +G VY+     +   +A+KKI  ++  +G+    + EI  +  L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 319 NLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVT---LNWIQR--FRVIKGVALGL 373
           N+V+LL     + +L LV++++ +  L K++ D   +T   L  I+   F++++G+A   
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLA--- 117
Query: 374 FYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQT-THVVGTLGYLA 432
            + H      V+HRD+K  N+L++ E   +L DFGLAR +  G   +T TH V TL Y A
Sbjct: 118 -FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRA 171
Query: 433 PEHTRTGK-ATTSADVFSFGAFLLEVACGR 461
           PE     K  +T+ D++S G    E+   R
Sbjct: 172 PEILLGXKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 100/212 (47%), Gaps = 14/212 (6%)
Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
           E+LG G FG+V++     + +++A K I     +  +E   EI  + +L H NL+QL   
Sbjct: 95  EILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDA 154
Query: 327 CRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIH 386
              K +++LV +Y+  G L   + D+    L  +     +K +  G+ ++HQ +   ++H
Sbjct: 155 FESKNDIVLVMEYVDGGELFDRIIDES-YNLTELDTILFMKQICEGIRHMHQMY---ILH 210
Query: 387 RDVKASNVLL---DGELNGRLGDFGLARLYDHGTDPQTTHVV--GTLGYLAPEHTRTGKA 441
            D+K  N+L    D +   ++ DFGLAR Y     P+    V  GT  +LAPE       
Sbjct: 211 LDLKPENILCVNRDAK-QIKIIDFGLARRY----KPREKLKVNFGTPEFLAPEVVNYDFV 265
Query: 442 TTSADVFSFGAFLLEVACGRRPIQRQGPSENL 473
           +   D++S G     +  G  P      +E L
Sbjct: 266 SFPTDMWSVGVIAYMLLSGLSPFLGDNDAETL 297

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 74.7 bits (182), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/270 (26%), Positives = 115/270 (42%), Gaps = 36/270 (13%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKI--SHESRQGMKEFVAEIVSI-GRLRHRNLVQLLG 325
           LG G FG VY     +S+  +A+K +  +   + G++  +   V I   LRH N+++L G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 326 YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVI 385
           Y      + L+ +Y P G++ + L    K        +  I  +A  L Y H    + VI
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSYCHS---KRVI 133
Query: 386 HRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSA 445
           HRD+K  N+LL      ++ +FG +    H    + T + GTL YL PE           
Sbjct: 134 HRDIKPENLLLGSAGELKIANFGWS---VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKV 190
Query: 446 DVFSFGAFLLEVACGRRPIQR---QGPSENLILVDWVF-DFWNRGELLEARDPNLGTEYV 501
           D++S G    E   G+ P +    Q   + +  V++ F DF   G    ARD        
Sbjct: 191 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEG----ARD-------- 238
Query: 502 AXXXXXXXXXXXXCSHSDPTARPSMRQVVQ 531
                            +P+ RP +R+V++
Sbjct: 239 ---------LISRLLKHNPSQRPMLREVLE 259

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 113/210 (53%), Gaps = 20/210 (9%)
Query: 261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR-QGMKEF-VAEIVSIGRLRHR 318
           + F++ E +G G +G VY+     +   +A+KKI  ++  +G+    + EI  +  L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 319 NLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVT---LNWIQR--FRVIKGVALGL 373
           N+V+LL     + +L LV++++ +  L K++ D   +T   L  I+   F++++G+A   
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLA--- 117
Query: 374 FYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQT-THVVGTLGYLA 432
            + H      V+HRD+K  N+L++ E   +L DFGLAR +  G   +T TH V TL Y A
Sbjct: 118 -FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRA 171
Query: 433 PEHTRTGK-ATTSADVFSFGAFLLEVACGR 461
           PE     K  +T+ D++S G    E+   R
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 113/210 (53%), Gaps = 20/210 (9%)
Query: 261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR-QGMKEF-VAEIVSIGRLRHR 318
           + F++ E +G G +G VY+     +   +A+KKI  ++  +G+    + EI  +  L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 319 NLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVT---LNWIQR--FRVIKGVALGL 373
           N+V+LL     + +L LV++++ +  L K++ D   +T   L  I+   F++++G+A   
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLA--- 116
Query: 374 FYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQT-THVVGTLGYLA 432
            + H      V+HRD+K  N+L++ E   +L DFGLAR +  G   +T TH V TL Y A
Sbjct: 117 -FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRA 170
Query: 433 PEHTRTGK-ATTSADVFSFGAFLLEVACGR 461
           PE     K  +T+ D++S G    E+   R
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 98/209 (46%), Gaps = 15/209 (7%)
Query: 258 IATKGFREKELLGTGGFGRVYRGTL--PKSQ-IEIAVKKISHE---SRQGMKEFVAEIVS 311
           I  K  R  E LG G FG V RG    P  + + +AVK +  +     + M +F+ E+ +
Sbjct: 15  IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 74
Query: 312 IGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSL-DKYLYDQPKVTLNWIQRFRVIKGVA 370
           +  L HRNL++L G       + +V +  P GSL D+    Q    L  + R+ V   VA
Sbjct: 75  MHSLDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVA 131
Query: 371 LGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP--QTTHVVGTL 428
            G+ YL     +  IHRD+ A N+LL      ++GDFGL R      D      H     
Sbjct: 132 EGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF 188
Query: 429 GYLAPEHTRTGKATTSADVFSFGAFLLEV 457
            + APE  +T   + ++D + FG  L E+
Sbjct: 189 AWCAPESLKTRTFSHASDTWMFGVTLWEM 217

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/270 (26%), Positives = 115/270 (42%), Gaps = 36/270 (13%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKI--SHESRQGMKEFVAEIVSI-GRLRHRNLVQLLG 325
           LG G FG VY     +S+  +A+K +  +   + G++  +   V I   LRH N+++L G
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 77
Query: 326 YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVI 385
           Y      + L+ +Y P G++ + L    K        +  I  +A  L Y H    + VI
Sbjct: 78  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSYCHS---KRVI 132
Query: 386 HRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSA 445
           HRD+K  N+LL      ++ +FG +    H    + T + GTL YL PE           
Sbjct: 133 HRDIKPENLLLGSAGELKIANFGWS---VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKV 189
Query: 446 DVFSFGAFLLEVACGRRPIQR---QGPSENLILVDWVF-DFWNRGELLEARDPNLGTEYV 501
           D++S G    E   G+ P +    Q   + +  V++ F DF   G    ARD        
Sbjct: 190 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEG----ARD-------- 237
Query: 502 AXXXXXXXXXXXXCSHSDPTARPSMRQVVQ 531
                            +P+ RP +R+V++
Sbjct: 238 ---------LISRLLKHNPSQRPMLREVLE 258

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/270 (26%), Positives = 113/270 (41%), Gaps = 36/270 (13%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKI--SHESRQGMKEFVAEIVSI-GRLRHRNLVQLLG 325
           LG G FG VY      S+  +A+K +  +   + G++  +   V I   LRH N+++L G
Sbjct: 16  LGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 326 YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVI 385
           Y      + L+ +Y P G++ + L    K        +  I  +A  L Y H    + VI
Sbjct: 76  YFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSYCHS---KKVI 130
Query: 386 HRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSA 445
           HRD+K  N+LL      ++ DFG +    H    +   + GTL YL PE           
Sbjct: 131 HRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRAALCGTLDYLPPEMIEGRMHDEKV 187
Query: 446 DVFSFGAFLLEVACGRRPIQR---QGPSENLILVDWVF-DFWNRGELLEARDPNLGTEYV 501
           D++S G    E   G+ P +    Q   + +  V++ F DF   G    ARD        
Sbjct: 188 DLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRVEFTFPDFVTEG----ARD-------- 235
Query: 502 AXXXXXXXXXXXXCSHSDPTARPSMRQVVQ 531
                            +P+ RP +R+V++
Sbjct: 236 ---------LISRLLKHNPSQRPMLREVLE 256

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/270 (26%), Positives = 114/270 (42%), Gaps = 36/270 (13%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKI--SHESRQGMKEFVAEIVSI-GRLRHRNLVQLLG 325
           LG G FG VY     +S+  +A+K +  +   + G++  +   V I   LRH N+++L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 326 YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVI 385
           Y      + L+ +Y P G++ + L    K        +  I  +A  L Y H    + VI
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSYCHS---KRVI 130
Query: 386 HRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSA 445
           HRD+K  N+LL      ++ DFG +    H    +   + GTL YL PE           
Sbjct: 131 HRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRAALCGTLDYLPPEMIEGRMHDEKV 187
Query: 446 DVFSFGAFLLEVACGRRPIQR---QGPSENLILVDWVF-DFWNRGELLEARDPNLGTEYV 501
           D++S G    E   G+ P +    Q   + +  V++ F DF   G    ARD        
Sbjct: 188 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEG----ARD-------- 235
Query: 502 AXXXXXXXXXXXXCSHSDPTARPSMRQVVQ 531
                            +P+ RP +R+V++
Sbjct: 236 ---------LISRLLKHNPSQRPMLREVLE 256

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/270 (26%), Positives = 114/270 (42%), Gaps = 36/270 (13%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKI--SHESRQGMKEFVAEIVSI-GRLRHRNLVQLLG 325
           LG G FG VY     +S+  +A+K +  +   + G++  +   V I   LRH N+++L G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 326 YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVI 385
           Y      + L+ +Y P G++ + L    K        +  I  +A  L Y H    + VI
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSYCHS---KRVI 133
Query: 386 HRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSA 445
           HRD+K  N+LL      ++ DFG +    H    +   + GTL YL PE           
Sbjct: 134 HRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRAALCGTLDYLPPEMIEGRMHDEKV 190
Query: 446 DVFSFGAFLLEVACGRRPIQR---QGPSENLILVDWVF-DFWNRGELLEARDPNLGTEYV 501
           D++S G    E   G+ P +    Q   + +  V++ F DF   G    ARD        
Sbjct: 191 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEG----ARD-------- 238
Query: 502 AXXXXXXXXXXXXCSHSDPTARPSMRQVVQ 531
                            +P+ RP +R+V++
Sbjct: 239 ---------LISRLLKHNPSQRPMLREVLE 259

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/270 (26%), Positives = 114/270 (42%), Gaps = 36/270 (13%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKI--SHESRQGMKEFVAEIVSI-GRLRHRNLVQLLG 325
           LG G FG VY     +S+  +A+K +  +   + G++  +   V I   LRH N+++L G
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 77
Query: 326 YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVI 385
           Y      + L+ +Y P G++ + L    K        +  I  +A  L Y H    + VI
Sbjct: 78  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSYCHS---KRVI 132
Query: 386 HRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSA 445
           HRD+K  N+LL      ++ DFG +    H    +   + GTL YL PE           
Sbjct: 133 HRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRXXLCGTLDYLPPEMIEGRMHDEKV 189
Query: 446 DVFSFGAFLLEVACGRRPIQR---QGPSENLILVDWVF-DFWNRGELLEARDPNLGTEYV 501
           D++S G    E   G+ P +    Q   + +  V++ F DF   G    ARD        
Sbjct: 190 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEG----ARD-------- 237
Query: 502 AXXXXXXXXXXXXCSHSDPTARPSMRQVVQ 531
                            +P+ RP +R+V++
Sbjct: 238 ---------LISRLLKHNPSQRPMLREVLE 258

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/270 (26%), Positives = 114/270 (42%), Gaps = 36/270 (13%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKI--SHESRQGMKEFVAEIVSI-GRLRHRNLVQLLG 325
           LG G FG VY     +S+  +A+K +  +   + G++  +   V I   LRH N+++L G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 326 YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVI 385
           Y      + L+ +Y P G++ + L    K        +  I  +A  L Y H    + VI
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSYCHS---KRVI 133
Query: 386 HRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSA 445
           HRD+K  N+LL      ++ DFG +    H    +   + GTL YL PE           
Sbjct: 134 HRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRXXLCGTLDYLPPEMIEGRMHDEKV 190
Query: 446 DVFSFGAFLLEVACGRRPIQR---QGPSENLILVDWVF-DFWNRGELLEARDPNLGTEYV 501
           D++S G    E   G+ P +    Q   + +  V++ F DF   G    ARD        
Sbjct: 191 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEG----ARD-------- 238
Query: 502 AXXXXXXXXXXXXCSHSDPTARPSMRQVVQ 531
                            +P+ RP +R+V++
Sbjct: 239 ---------LISRLLKHNPSQRPMLREVLE 259

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 96/209 (45%), Gaps = 15/209 (7%)
Query: 258 IATKGFREKELLGTGGFGRVYRGTLPK---SQIEIAVKKISHE---SRQGMKEFVAEIVS 311
           I  K  R  E LG G FG V RG         + +AVK +  +     + M +F+ E+ +
Sbjct: 9   IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 68
Query: 312 IGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSL-DKYLYDQPKVTLNWIQRFRVIKGVA 370
           +  L HRNL++L G       + +V +  P GSL D+    Q    L  + R+ V   VA
Sbjct: 69  MHSLDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVA 125
Query: 371 LGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP--QTTHVVGTL 428
            G+ YL     +  IHRD+ A N+LL      ++GDFGL R      D      H     
Sbjct: 126 EGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF 182
Query: 429 GYLAPEHTRTGKATTSADVFSFGAFLLEV 457
            + APE  +T   + ++D + FG  L E+
Sbjct: 183 AWCAPESLKTRTFSHASDTWMFGVTLWEM 211

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 100/213 (46%), Gaps = 31/213 (14%)
Query: 269 LGTGGFGRVYRGTL-----PKSQIEIAVKKISHESRQGMKE-FVAEIVSIGRL-RHRNLV 321
           LG G FG+V   T        + +++AVK +   +    KE  ++E+  +  L +H N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 322 QLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKV------------TLNWIQRFRVIKGV 369
            LLG C   G +L++ +Y   G L  +L  + +V            TL+          V
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQV 173
Query: 370 ALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVG--- 426
           A G+ +L     +  IHRDV A NVLL      ++GDFGLAR  D   D  + ++V    
Sbjct: 174 AQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLAR--DIMND--SNYIVKGNA 226
Query: 427 --TLGYLAPEHTRTGKATTSADVFSFGAFLLEV 457
              + ++APE       T  +DV+S+G  L E+
Sbjct: 227 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 259

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/270 (26%), Positives = 114/270 (42%), Gaps = 36/270 (13%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKI--SHESRQGMKEFVAEIVSI-GRLRHRNLVQLLG 325
           LG G FG VY     +S+  +A+K +  +   + G++  +   V I   LRH N+++L G
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 326 YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVI 385
           Y      + L+ +Y P G++ + L    K        +  I  +A  L Y H    + VI
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSYCHS---KRVI 130
Query: 386 HRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSA 445
           HRD+K  N+LL      ++ DFG +    H    +   + GTL YL PE           
Sbjct: 131 HRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRXXLCGTLDYLPPEMIEGRMHDEKV 187
Query: 446 DVFSFGAFLLEVACGRRPIQR---QGPSENLILVDWVF-DFWNRGELLEARDPNLGTEYV 501
           D++S G    E   G+ P +    Q   + +  V++ F DF   G    ARD        
Sbjct: 188 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEG----ARD-------- 235
Query: 502 AXXXXXXXXXXXXCSHSDPTARPSMRQVVQ 531
                            +P+ RP +R+V++
Sbjct: 236 ---------LISRLLKHNPSQRPMLREVLE 256

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/270 (26%), Positives = 114/270 (42%), Gaps = 36/270 (13%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKI--SHESRQGMKEFVAEIVSI-GRLRHRNLVQLLG 325
           LG G FG VY     + +  +A+K +  +   + G++  +   V I   LRH N+++L G
Sbjct: 13  LGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 72
Query: 326 YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVI 385
           Y      + L+ +Y P G++ + L    K        +  I  +A  L Y H    + VI
Sbjct: 73  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSYCHS---KRVI 127
Query: 386 HRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSA 445
           HRD+K  N+LL      ++ DFG +    H    + T + GTL YL PE           
Sbjct: 128 HRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKV 184
Query: 446 DVFSFGAFLLEVACGRRPIQR---QGPSENLILVDWVF-DFWNRGELLEARDPNLGTEYV 501
           D++S G    E   G+ P +    Q   + +  V++ F DF   G    ARD        
Sbjct: 185 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEG----ARD-------- 232
Query: 502 AXXXXXXXXXXXXCSHSDPTARPSMRQVVQ 531
                            +P+ RP +R+V++
Sbjct: 233 ---------LISRLLKHNPSQRPMLREVLE 253

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 98/209 (46%), Gaps = 15/209 (7%)
Query: 258 IATKGFREKELLGTGGFGRVYRGTL--PKSQ-IEIAVKKISHE---SRQGMKEFVAEIVS 311
           I  K  R  E LG G FG V RG    P  + + +AVK +  +     + M +F+ E+ +
Sbjct: 5   IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64
Query: 312 IGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSL-DKYLYDQPKVTLNWIQRFRVIKGVA 370
           +  L HRNL++L G       + +V +  P GSL D+    Q    L  + R+ V   VA
Sbjct: 65  MHSLDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVA 121
Query: 371 LGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP--QTTHVVGTL 428
            G+ YL     +  IHRD+ A N+LL      ++GDFGL R      D      H     
Sbjct: 122 EGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF 178
Query: 429 GYLAPEHTRTGKATTSADVFSFGAFLLEV 457
            + APE  +T   + ++D + FG  L E+
Sbjct: 179 AWCAPESLKTRTFSHASDTWMFGVTLWEM 207

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/270 (26%), Positives = 114/270 (42%), Gaps = 36/270 (13%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKI--SHESRQGMKEFVAEIVSI-GRLRHRNLVQLLG 325
           LG G FG VY     +S+  +A+K +  +   + G++  +   V I   LRH N+++L G
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 326 YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVI 385
           Y      + L+ +Y P G++ + L    K        +  I  +A  L Y H    + VI
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSYCHS---KRVI 133
Query: 386 HRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSA 445
           HRD+K  N+LL      ++ DFG +    H    +   + GTL YL PE           
Sbjct: 134 HRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRDDLCGTLDYLPPEMIEGRMHDEKV 190
Query: 446 DVFSFGAFLLEVACGRRPIQR---QGPSENLILVDWVF-DFWNRGELLEARDPNLGTEYV 501
           D++S G    E   G+ P +    Q   + +  V++ F DF   G    ARD        
Sbjct: 191 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEG----ARD-------- 238
Query: 502 AXXXXXXXXXXXXCSHSDPTARPSMRQVVQ 531
                            +P+ RP +R+V++
Sbjct: 239 ---------LISRLLKHNPSQRPMLREVLE 259

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/209 (31%), Positives = 98/209 (46%), Gaps = 15/209 (7%)
Query: 258 IATKGFREKELLGTGGFGRVYRGTL--PKSQ-IEIAVKKISHE---SRQGMKEFVAEIVS 311
           I  K  R  E LG G FG V RG    P  + + +AVK +  +     + M +F+ E+ +
Sbjct: 5   IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64
Query: 312 IGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSL-DKYLYDQPKVTLNWIQRFRVIKGVA 370
           +  L HRNL++L G       + +V +  P GSL D+    Q    L  + R+ V   VA
Sbjct: 65  MHSLDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVA 121
Query: 371 LGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP--QTTHVVGTL 428
            G+ YL     +  IHRD+ A N+LL      ++GDFGL R      D      H     
Sbjct: 122 EGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF 178
Query: 429 GYLAPEHTRTGKATTSADVFSFGAFLLEV 457
            + APE  +T   + ++D + FG  L E+
Sbjct: 179 AWCAPESLKTRTFSHASDTWMFGVTLWEM 207

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 107/222 (48%), Gaps = 25/222 (11%)
Query: 267 ELLGTGGFGRVY----------RGTLPKSQIEIAVKKISHESRQGM-KEFVAEIVSIGRL 315
           ++LG G FG+V+          R       ++ A  K+    R  M ++ + E+      
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV------ 83
Query: 316 RHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFY 375
            H  +V+L    + +G+L L+ D++  G L   L  +   T   ++ +  +  +AL L +
Sbjct: 84  NHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFY--LAELALALDH 141
Query: 376 LHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARL-YDHGTDPQTTHVVGTLGYLAPE 434
           LH      +I+RD+K  N+LLD E + +L DFGL++   DH  + +     GT+ Y+APE
Sbjct: 142 LHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH--EKKAYSFCGTVEYMAPE 196
Query: 435 HTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILV 476
                  T SAD +SFG  + E+  G  P Q +   E + ++
Sbjct: 197 VVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMI 238

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 70/287 (24%), Positives = 130/287 (45%), Gaps = 39/287 (13%)
Query: 269 LGTGGFGRVYRGTLP-----KSQIEIAVKKISHESRQGMK-EFVAEIVSIGRLRHRNLVQ 322
           LG G FG VY G        + +  +A+K ++  +    + EF+ E   +      ++V+
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 79
Query: 323 LLGYCRRKGELLLVYDYMPNGSLDKYLYD-QPKVTLNWI-------QRFRVIKGVALGLF 374
           LLG   +    L++ + M  G L  YL   +P++  N +       +  ++   +A G+ 
Sbjct: 80  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMA 139
Query: 375 YLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVGTLGYLAP 433
           YL+       +HRD+ A N  +  +   ++GDFG+ R +Y+     +    +  + +++P
Sbjct: 140 YLNA---NKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 196
Query: 434 EHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEAR 492
           E  + G  TT +DV+SFG  L E+A    +P   QG S   +L      F   G LL+  
Sbjct: 197 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY--QGLSNEQVL-----RFVMEGGLLDKP 249
Query: 493 D--PNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQILERDV 537
           D  P++  E +             C   +P  RPS  +++  ++ ++
Sbjct: 250 DNCPDMLLELM-----------RMCWQYNPKMRPSFLEIISSIKEEM 285

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 112/207 (54%), Gaps = 20/207 (9%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR-QGMKEF-VAEIVSIGRLRHRNL 320
           +++ E +G G +G VY+    + +I +A+K+I  ++  +G+    + EI  +  L H N+
Sbjct: 23  YQKLEKVGEGTYGVVYKAKDSQGRI-VALKRIRLDAEDEGIPSTAIREISLLKELHHPNI 81
Query: 321 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLN----WIQRFRVIKGVALGLFYL 376
           V L+     +  L LV+++M    L K L D+ K  L      I  +++++GVA    + 
Sbjct: 82  VSLIDVIHSERCLTLVFEFM-EKDLKKVL-DENKTGLQDSQIKIYLYQLLRGVA----HC 135
Query: 377 HQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQT-THVVGTLGYLAPEH 435
           HQ     ++HRD+K  N+L++ +   +L DFGLAR +  G   ++ TH V TL Y AP+ 
Sbjct: 136 HQ---HRILHRDLKPQNLLINSDGALKLADFGLARAF--GIPVRSYTHEVVTLWYRAPDV 190
Query: 436 TR-TGKATTSADVFSFGAFLLEVACGR 461
              + K +TS D++S G    E+  G+
Sbjct: 191 LMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 107/222 (48%), Gaps = 25/222 (11%)
Query: 267 ELLGTGGFGRVY----------RGTLPKSQIEIAVKKISHESRQGM-KEFVAEIVSIGRL 315
           ++LG G FG+V+          R       ++ A  K+    R  M ++ + E+      
Sbjct: 31  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV------ 84
Query: 316 RHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFY 375
            H  +V+L    + +G+L L+ D++  G L   L  +   T   ++ +  +  +AL L +
Sbjct: 85  NHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFY--LAELALALDH 142
Query: 376 LHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARL-YDHGTDPQTTHVVGTLGYLAPE 434
           LH      +I+RD+K  N+LLD E + +L DFGL++   DH  + +     GT+ Y+APE
Sbjct: 143 LHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH--EKKAYSFCGTVEYMAPE 197
Query: 435 HTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILV 476
                  T SAD +SFG  + E+  G  P Q +   E + ++
Sbjct: 198 VVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMI 239

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 107/222 (48%), Gaps = 25/222 (11%)
Query: 267 ELLGTGGFGRVY----------RGTLPKSQIEIAVKKISHESRQGM-KEFVAEIVSIGRL 315
           ++LG G FG+V+          R       ++ A  K+    R  M ++ + E+      
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV------ 83
Query: 316 RHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFY 375
            H  +V+L    + +G+L L+ D++  G L   L  +   T   ++ +  +  +AL L +
Sbjct: 84  NHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFY--LAELALALDH 141
Query: 376 LHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVGTLGYLAPE 434
           LH      +I+RD+K  N+LLD E + +L DFGL++   DH  + +     GT+ Y+APE
Sbjct: 142 LHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH--EKKAYSFCGTVEYMAPE 196
Query: 435 HTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILV 476
                  T SAD +SFG  + E+  G  P Q +   E + ++
Sbjct: 197 VVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMI 238

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/207 (30%), Positives = 112/207 (54%), Gaps = 20/207 (9%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR-QGMKEF-VAEIVSIGRLRHRNL 320
           +++ E +G G +G VY+    + +I +A+K+I  ++  +G+    + EI  +  L H N+
Sbjct: 23  YQKLEKVGEGTYGVVYKAKDSQGRI-VALKRIRLDAEDEGIPSTAIREISLLKELHHPNI 81
Query: 321 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLN----WIQRFRVIKGVALGLFYL 376
           V L+     +  L LV+++M    L K L D+ K  L      I  +++++GVA    + 
Sbjct: 82  VSLIDVIHSERCLTLVFEFM-EKDLKKVL-DENKTGLQDSQIKIYLYQLLRGVA----HC 135
Query: 377 HQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQT-THVVGTLGYLAPEH 435
           HQ     ++HRD+K  N+L++ +   +L DFGLAR +  G   ++ TH V TL Y AP+ 
Sbjct: 136 HQ---HRILHRDLKPQNLLINSDGALKLADFGLARAF--GIPVRSYTHEVVTLWYRAPDV 190
Query: 436 TR-TGKATTSADVFSFGAFLLEVACGR 461
              + K +TS D++S G    E+  G+
Sbjct: 191 LMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 71/270 (26%), Positives = 114/270 (42%), Gaps = 36/270 (13%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKI--SHESRQGMKEFVAEIVSI-GRLRHRNLVQLLG 325
           LG G FG VY     +S+  +A+K +  +   + G++  +   V I   LRH N+++L G
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 326 YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVI 385
           Y      + L+ +Y P G++ + L    K        +  I  +A  L Y H    + VI
Sbjct: 77  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSYCHS---KRVI 131
Query: 386 HRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSA 445
           HRD+K  N+LL      ++ DFG +    H    +   + GTL YL PE           
Sbjct: 132 HRDIKPENLLLGSAGELKIADFGWS---VHAPSSRRDTLCGTLDYLPPEMIEGRMHDEKV 188
Query: 446 DVFSFGAFLLEVACGRRPIQR---QGPSENLILVDWVF-DFWNRGELLEARDPNLGTEYV 501
           D++S G    E   G+ P +    Q   + +  V++ F DF   G    ARD        
Sbjct: 189 DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEG----ARD-------- 236
Query: 502 AXXXXXXXXXXXXCSHSDPTARPSMRQVVQ 531
                            +P+ RP +R+V++
Sbjct: 237 ---------LISRLLKHNPSQRPMLREVLE 257

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 73.9 bits (180), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 98/222 (44%), Gaps = 32/222 (14%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRH----- 317
           F E  +LG G FG+V +          A+KKI H + + +   ++E++ +  L H     
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVR 66
Query: 318 --------RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGV 369
                   RN V+ +   ++K  L +  +Y  N +L   ++ +  +     + +R+ + +
Sbjct: 67  YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSE-NLNQQRDEYWRLFRQI 125
Query: 370 ALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH-------------G 416
              L Y+H    Q +IHRD+K  N+ +D   N ++GDFGLA+                 G
Sbjct: 126 LEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 417 TDPQTTHVVGTLGYLAPEHTR-TGKATTSADVFSFGAFLLEV 457
           +    T  +GT  Y+A E    TG      D++S G    E+
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM 224

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 113/210 (53%), Gaps = 20/210 (9%)
Query: 261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR-QGMKEF-VAEIVSIGRLRHR 318
           + F++ E +G G +G VY+     +   +A+KKI  ++  +G+    + EI  +  L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 319 NLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVT---LNWIQR--FRVIKGVALGL 373
           N+V+LL     + +L LV++++ +  L K++ D   +T   L  I+   F++++G  L  
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQG--LSF 118
Query: 374 FYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQT-THVVGTLGYLA 432
            + H+     V+HRD+K  N+L++ E   +L DFGLAR +  G   +T TH V TL Y A
Sbjct: 119 CHSHR-----VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRA 171
Query: 433 PEHTRTGK-ATTSADVFSFGAFLLEVACGR 461
           PE     K  +T+ D++S G    E+   R
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 100/212 (47%), Gaps = 20/212 (9%)
Query: 258 IATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKIS-HESRQGMK-EFVAEIVSIGRL 315
           +AT  +     +G G +G VY+   P S   +A+K +      +G+    V E+  + RL
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRL 60
Query: 316 R---HRNLVQLLGYCR-----RKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIK 367
               H N+V+L+  C      R+ ++ LV++++ +  L  YL   P   L       +++
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMR 119
Query: 368 GVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH--GTDPQTTHVV 425
               GL +LH      ++HRD+K  N+L+      +L DFGLAR+Y +    DP    VV
Sbjct: 120 QFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDP----VV 172
Query: 426 GTLGYLAPEHTRTGKATTSADVFSFGAFLLEV 457
            TL Y APE        T  D++S G    E+
Sbjct: 173 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 204

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/252 (25%), Positives = 124/252 (49%), Gaps = 21/252 (8%)
Query: 248 PHRFRYKDLYIATKGFREKEL-LGTGGFGRVYRGT--LPKSQIEIAVKKISHESRQG-MK 303
           P   + K L++        ++ LG G FG V +G   + K QI++A+K +   + +   +
Sbjct: 322 PEELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTE 381
Query: 304 EFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRF 363
           E + E   + +L +  +V+L+G C+ +  L+LV +    G L K+L  + +  +      
Sbjct: 382 EMMREAQIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGK-REEIPVSNVA 439
Query: 364 RVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTH 423
            ++  V++G+ YL    E+  +HR++ A NVLL      ++ DFGL++         T  
Sbjct: 440 ELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR 496
Query: 424 VVGT--LGYLAPEHTRTGKATTSADVFSFGAFLLE-VACGRRPIQR-QGPSENLILVDWV 479
             G   L + APE     K ++ +DV+S+G  + E ++ G++P ++ +GP         V
Sbjct: 497 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--------V 548
Query: 480 FDFWNRGELLEA 491
             F  +G+ +E 
Sbjct: 549 MAFIEQGKRMEC 560

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/182 (32%), Positives = 94/182 (51%), Gaps = 24/182 (13%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVA--EIVSIGRLRHRNLVQLLGY 326
           +G G FG V++    K+  ++A+KK+  E+ +      A  EI  +  L+H N+V L+  
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 327 CRRKGE--------LLLVYDYMPN---GSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFY 375
           CR K          + LV+D+  +   G L   L    K TL+ I+R  V++ +  GL+Y
Sbjct: 86  CRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLV---KFTLSEIKR--VMQMLLNGLYY 140
Query: 376 LHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHV---VGTLGYLA 432
           +H+     ++HRD+KA+NVL+  +   +L DFGLAR +    + Q       V TL Y  
Sbjct: 141 IHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRP 197
Query: 433 PE 434
           PE
Sbjct: 198 PE 199

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 110/215 (51%), Gaps = 26/215 (12%)
Query: 263 FREKELLGTGGFGRVYRGT-LP---KSQIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRH 317
           F++ ++LG+G FG VY+G  +P   K +I +A+K++    S +  KE + E   +  + +
Sbjct: 18  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 318 RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQP-----KVTLNWIQRFRVIKGVALG 372
            ++ +LLG C     + L+   MP G L  Y+ +       +  LNW  +      +A G
Sbjct: 78  PHVCRLLGICL-TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 130
Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVG---TLG 429
           + YL    ++ ++HRD+ A NVL+    + ++ DFGLA+L   G + +  H  G    + 
Sbjct: 131 MNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVPIK 185
Query: 430 YLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRP 463
           ++A E       T  +DV+S+G  + E+   G +P
Sbjct: 186 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 220

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 110/215 (51%), Gaps = 26/215 (12%)
Query: 263 FREKELLGTGGFGRVYRGT-LP---KSQIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRH 317
           F++ ++LG+G FG VY+G  +P   K +I +A+K++    S +  KE + E   +  + +
Sbjct: 21  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 80
Query: 318 RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQP-----KVTLNWIQRFRVIKGVALG 372
            ++ +LLG C     + L+   MP G L  Y+ +       +  LNW  +      +A G
Sbjct: 81  PHVCRLLGICL-TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 133
Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVG---TLG 429
           + YL    ++ ++HRD+ A NVL+    + ++ DFGLA+L   G + +  H  G    + 
Sbjct: 134 MNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVPIK 188
Query: 430 YLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRP 463
           ++A E       T  +DV+S+G  + E+   G +P
Sbjct: 189 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 223

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 74/270 (27%), Positives = 124/270 (45%), Gaps = 33/270 (12%)
Query: 235 FAEELEDWELDHGPHR-------------------FRYKDLYIATKGFR-EKELLGTGGF 274
           +  EL  W  D GP R                    R K++Y+  K    E + LG+G F
Sbjct: 323 YEPELAPWAADKGPQREALPMDTEVFESPFADPEEIRPKEVYLDRKLLTLEDKELGSGNF 382
Query: 275 GRVYRG--TLPKSQIEIAVKKISHESRQGM--KEFVAEIVSIGRLRHRNLVQLLGYCRRK 330
           G V +G   + K    +AVK + +E+       E +AE   + +L +  +V+++G C  +
Sbjct: 383 GTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE 442
Query: 331 GELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVK 390
              +LV +    G L+KYL     V    I    ++  V++G+ YL    E   +HRD+ 
Sbjct: 443 S-WMLVMEMAELGPLNKYLQQNRHVKDKNI--IELVHQVSMGMKYLE---ESNFVHRDLA 496
Query: 391 ASNVLLDGELNGRLGDFGLARLY--DHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVF 448
           A NVLL  +   ++ DFGL++    D       TH    + + APE     K ++ +DV+
Sbjct: 497 ARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVW 556
Query: 449 SFGAFLLEV-ACGRRPIQRQGPSENLILVD 477
           SFG  + E  + G++P +    SE   +++
Sbjct: 557 SFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 586

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 103/210 (49%), Gaps = 14/210 (6%)
Query: 255 DLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKIS----HESRQGM-KEFVAEI 309
           D+    K + + + LG G F  VY+     +   +A+KKI      E++ G+ +  + EI
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 310 VSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKV-TLNWIQRFRVIKG 368
             +  L H N++ LL     K  + LV+D+M    L+  + D   V T + I+ + ++  
Sbjct: 64  KLLQELSHPNIIGLLDAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIKAYMLM-- 120
Query: 369 VALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTL 428
              GL YLHQ W   ++HRD+K +N+LLD     +L DFGLA+ +    +    H V T 
Sbjct: 121 TLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFG-SPNRAYXHQVVTR 176
Query: 429 GYLAPEHTRTGKAT-TSADVFSFGAFLLEV 457
            Y APE     +      D+++ G  L E+
Sbjct: 177 WYRAPELLFGARMYGVGVDMWAVGCILAEL 206

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 74/270 (27%), Positives = 124/270 (45%), Gaps = 33/270 (12%)
Query: 235 FAEELEDWELDHGPHR-------------------FRYKDLYIATKGFR-EKELLGTGGF 274
           +  EL  W  D GP R                    R K++Y+  K    E + LG+G F
Sbjct: 324 YEPELAPWAADKGPQREALPMDTEVYESPYADPEEIRPKEVYLDRKLLTLEDKELGSGNF 383
Query: 275 GRVYRG--TLPKSQIEIAVKKISHESRQGM--KEFVAEIVSIGRLRHRNLVQLLGYCRRK 330
           G V +G   + K    +AVK + +E+       E +AE   + +L +  +V+++G C  +
Sbjct: 384 GTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE 443
Query: 331 GELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVK 390
              +LV +    G L+KYL     V    I    ++  V++G+ YL    E   +HRD+ 
Sbjct: 444 S-WMLVMEMAELGPLNKYLQQNRHVKDKNI--IELVHQVSMGMKYLE---ESNFVHRDLA 497
Query: 391 ASNVLLDGELNGRLGDFGLARLY--DHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVF 448
           A NVLL  +   ++ DFGL++    D       TH    + + APE     K ++ +DV+
Sbjct: 498 ARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVW 557
Query: 449 SFGAFLLEV-ACGRRPIQRQGPSENLILVD 477
           SFG  + E  + G++P +    SE   +++
Sbjct: 558 SFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 587

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 113/212 (53%), Gaps = 20/212 (9%)
Query: 259 ATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR-QGMKEF-VAEIVSIGRLR 316
           + + F++ E +G G +G VY+     +   +A+KKI  ++  +G+    + EI  +  L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 317 HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVT---LNWIQR--FRVIKGVAL 371
           H N+V+LL     + +L LV++++ +  L K++ D   +T   L  I+   F++++G+A 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLA- 117
Query: 372 GLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQT-THVVGTLGY 430
              + H      V+HRD+K  N+L++ E   +L DFGLAR +  G   +T  H V TL Y
Sbjct: 118 ---FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWY 169
Query: 431 LAPEHTRTGK-ATTSADVFSFGAFLLEVACGR 461
            APE     K  +T+ D++S G    E+   R
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 110/215 (51%), Gaps = 26/215 (12%)
Query: 263 FREKELLGTGGFGRVYRGT-LP---KSQIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRH 317
           F++ ++LG+G FG VY+G  +P   K +I +A+K++    S +  KE + E   +  + +
Sbjct: 27  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 86
Query: 318 RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQP-----KVTLNWIQRFRVIKGVALG 372
            ++ +LLG C     + L+   MP G L  Y+ +       +  LNW  +      +A G
Sbjct: 87  PHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 139
Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVG---TLG 429
           + YL    ++ ++HRD+ A NVL+    + ++ DFGLA+L   G + +  H  G    + 
Sbjct: 140 MNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVPIK 194
Query: 430 YLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRP 463
           ++A E       T  +DV+S+G  + E+   G +P
Sbjct: 195 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 229

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 110/215 (51%), Gaps = 26/215 (12%)
Query: 263 FREKELLGTGGFGRVYRGT-LP---KSQIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRH 317
           F++ ++LG+G FG VY+G  +P   K +I +A+K++    S +  KE + E   +  + +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 318 RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQP-----KVTLNWIQRFRVIKGVALG 372
            ++ +LLG C     + L+   MP G L  Y+ +       +  LNW  +      +A G
Sbjct: 79  PHVCRLLGICL-TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 131
Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVG---TLG 429
           + YL    ++ ++HRD+ A NVL+    + ++ DFGLA+L   G + +  H  G    + 
Sbjct: 132 MNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVPIK 186
Query: 430 YLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRP 463
           ++A E       T  +DV+S+G  + E+   G +P
Sbjct: 187 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 221

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 110/215 (51%), Gaps = 26/215 (12%)
Query: 263 FREKELLGTGGFGRVYRGT-LP---KSQIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRH 317
           F++ ++LG+G FG VY+G  +P   K +I +A+K++    S +  KE + E   +  + +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 318 RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQP-----KVTLNWIQRFRVIKGVALG 372
            ++ +LLG C     + L+   MP G L  Y+ +       +  LNW  +      +A G
Sbjct: 80  PHVCRLLGICL-TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 132
Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVG---TLG 429
           + YL    ++ ++HRD+ A NVL+    + ++ DFGLA+L   G + +  H  G    + 
Sbjct: 133 MNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVPIK 187
Query: 430 YLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRP 463
           ++A E       T  +DV+S+G  + E+   G +P
Sbjct: 188 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 222

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 108/210 (51%), Gaps = 20/210 (9%)
Query: 261 KGFREKELLGTGGFGRVY--RGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHR 318
           + F++ E +G G +G VY  R  L    + +   ++  E+       + EI  +  L H 
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 62
Query: 319 NLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVT---LNWIQR--FRVIKGVALGL 373
           N+V+LL     + +L LV++++ +  L K++ D   +T   L  I+   F++++G+A   
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLA--- 117
Query: 374 FYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQT-THVVGTLGYLA 432
            + H      V+HRD+K  N+L++ E   +L DFGLAR +  G   +T TH V TL Y A
Sbjct: 118 -FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRA 171
Query: 433 PEHTRTGK-ATTSADVFSFGAFLLEVACGR 461
           PE     K  +T+ D++S G    E+   R
Sbjct: 172 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 113/212 (53%), Gaps = 20/212 (9%)
Query: 259 ATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR-QGMKEF-VAEIVSIGRLR 316
           + + F++ E +G G +G VY+     +   +A+KKI  ++  +G+    + EI  +  L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 317 HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVT---LNWIQR--FRVIKGVAL 371
           H N+V+LL     + +L LV++++ +  L K++ D   +T   L  I+   F++++G+A 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLA- 117
Query: 372 GLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQT-THVVGTLGY 430
              + H      V+HRD+K  N+L++ E   +L DFGLAR +  G   +T  H V TL Y
Sbjct: 118 ---FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWY 169
Query: 431 LAPEHTRTGK-ATTSADVFSFGAFLLEVACGR 461
            APE     K  +T+ D++S G    E+   R
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 108/210 (51%), Gaps = 20/210 (9%)
Query: 261 KGFREKELLGTGGFGRVY--RGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHR 318
           + F++ E +G G +G VY  R  L    + +   ++  E+       + EI  +  L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 319 NLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVT---LNWIQR--FRVIKGVALGL 373
           N+V+LL     + +L LV++++ +  L K++ D   +T   L  I+   F++++G+A   
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLA--- 116
Query: 374 FYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQT-THVVGTLGYLA 432
            + H      V+HRD+K  N+L++ E   +L DFGLAR +  G   +T TH V TL Y A
Sbjct: 117 -FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRA 170
Query: 433 PEHTRTGK-ATTSADVFSFGAFLLEVACGR 461
           PE     K  +T+ D++S G    E+   R
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 113/212 (53%), Gaps = 20/212 (9%)
Query: 259 ATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR-QGMKEF-VAEIVSIGRLR 316
           + + F++ E +G G +G VY+     +   +A+KKI  ++  +G+    + EI  +  L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 317 HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVT---LNWIQR--FRVIKGVAL 371
           H N+V+LL     + +L LV++++ +  L K++ D   +T   L  I+   F++++G+A 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLA- 120
Query: 372 GLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQT-THVVGTLGY 430
              + H      V+HRD+K  N+L++ E   +L DFGLAR +  G   +T  H V TL Y
Sbjct: 121 ---FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWY 172
Query: 431 LAPEHTRTGK-ATTSADVFSFGAFLLEVACGR 461
            APE     K  +T+ D++S G    E+   R
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 113/212 (53%), Gaps = 20/212 (9%)
Query: 259 ATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR-QGMKEF-VAEIVSIGRLR 316
           + + F++ E +G G +G VY+     +   +A+KKI  ++  +G+    + EI  +  L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 317 HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVT---LNWIQR--FRVIKGVAL 371
           H N+V+LL     + +L LV++++ +  L K++ D   +T   L  I+   F++++G+A 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLA- 119
Query: 372 GLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQT-THVVGTLGY 430
              + H      V+HRD+K  N+L++ E   +L DFGLAR +  G   +T  H V TL Y
Sbjct: 120 ---FCHS---HRVLHRDLKPENLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWY 171
Query: 431 LAPEHTRTGK-ATTSADVFSFGAFLLEVACGR 461
            APE     K  +T+ D++S G    E+   R
Sbjct: 172 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 113/212 (53%), Gaps = 20/212 (9%)
Query: 259 ATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR-QGMKEF-VAEIVSIGRLR 316
           + + F++ E +G G +G VY+     +   +A+KKI  ++  +G+    + EI  +  L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 317 HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVT---LNWIQR--FRVIKGVAL 371
           H N+V+LL     + +L LV++++ +  L K++ D   +T   L  I+   F++++G+A 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLA- 119
Query: 372 GLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQT-THVVGTLGY 430
              + H      V+HRD+K  N+L++ E   +L DFGLAR +  G   +T  H V TL Y
Sbjct: 120 ---FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWY 171
Query: 431 LAPEHTRTGK-ATTSADVFSFGAFLLEVACGR 461
            APE     K  +T+ D++S G    E+   R
Sbjct: 172 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 113/212 (53%), Gaps = 20/212 (9%)
Query: 259 ATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR-QGMKEF-VAEIVSIGRLR 316
           + + F++ E +G G +G VY+     +   +A+KKI  ++  +G+    + EI  +  L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 317 HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVT---LNWIQR--FRVIKGVAL 371
           H N+V+LL     + +L LV++++ +  L K++ D   +T   L  I+   F++++G+A 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLA- 118
Query: 372 GLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQT-THVVGTLGY 430
              + H      V+HRD+K  N+L++ E   +L DFGLAR +  G   +T  H V TL Y
Sbjct: 119 ---FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWY 170
Query: 431 LAPEHTRTGK-ATTSADVFSFGAFLLEVACGR 461
            APE     K  +T+ D++S G    E+   R
Sbjct: 171 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 110/215 (51%), Gaps = 26/215 (12%)
Query: 263 FREKELLGTGGFGRVYRGT-LP---KSQIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRH 317
           F++ ++LG+G FG VY+G  +P   K +I +A+K++    S +  KE + E   +  + +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 318 RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQP-----KVTLNWIQRFRVIKGVALG 372
            ++ +LLG C     + L+   MP G L  Y+ +       +  LNW  +      +A G
Sbjct: 77  PHVCRLLGICL-TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 129
Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVG---TLG 429
           + YL    ++ ++HRD+ A NVL+    + ++ DFGLA+L   G + +  H  G    + 
Sbjct: 130 MNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVPIK 184
Query: 430 YLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRP 463
           ++A E       T  +DV+S+G  + E+   G +P
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 113/212 (53%), Gaps = 20/212 (9%)
Query: 259 ATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR-QGMKEF-VAEIVSIGRLR 316
           + + F++ E +G G +G VY+     +   +A+KKI  ++  +G+    + EI  +  L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 317 HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVT---LNWIQR--FRVIKGVAL 371
           H N+V+LL     + +L LV++++ +  L K++ D   +T   L  I+   F++++G+A 
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLA- 118
Query: 372 GLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQT-THVVGTLGY 430
              + H      V+HRD+K  N+L++ E   +L DFGLAR +  G   +T  H V TL Y
Sbjct: 119 ---FCHS---HRVLHRDLKPENLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWY 170
Query: 431 LAPEHTRTGK-ATTSADVFSFGAFLLEVACGR 461
            APE     K  +T+ D++S G    E+   R
Sbjct: 171 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 110/215 (51%), Gaps = 26/215 (12%)
Query: 263 FREKELLGTGGFGRVYRGT-LP---KSQIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRH 317
           F++ ++LG+G FG VY+G  +P   K +I +A+K++    S +  KE + E   +  + +
Sbjct: 23  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 82
Query: 318 RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQP-----KVTLNWIQRFRVIKGVALG 372
            ++ +LLG C     + L+   MP G L  Y+ +       +  LNW  +      +A G
Sbjct: 83  PHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 135
Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVG---TLG 429
           + YL    ++ ++HRD+ A NVL+    + ++ DFGLA+L   G + +  H  G    + 
Sbjct: 136 MNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVPIK 190
Query: 430 YLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRP 463
           ++A E       T  +DV+S+G  + E+   G +P
Sbjct: 191 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 225

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 113/212 (53%), Gaps = 20/212 (9%)
Query: 259 ATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR-QGMKEF-VAEIVSIGRLR 316
           + + F++ E +G G +G VY+     +   +A+KKI  ++  +G+    + EI  +  L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 317 HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVT---LNWIQR--FRVIKGVAL 371
           H N+V+LL     + +L LV++++ +  L K++ D   +T   L  I+   F++++G+A 
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLA- 119
Query: 372 GLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQT-THVVGTLGY 430
              + H      V+HRD+K  N+L++ E   +L DFGLAR +  G   +T  H V TL Y
Sbjct: 120 ---FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWY 171
Query: 431 LAPEHTRTGK-ATTSADVFSFGAFLLEVACGR 461
            APE     K  +T+ D++S G    E+   R
Sbjct: 172 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 113/212 (53%), Gaps = 20/212 (9%)
Query: 259 ATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR-QGMKEF-VAEIVSIGRLR 316
           + + F++ E +G G +G VY+     +   +A+KKI  ++  +G+    + EI  +  L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 317 HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVT---LNWIQR--FRVIKGVAL 371
           H N+V+LL     + +L LV++++ +  L K++ D   +T   L  I+   F++++G+A 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLA- 120
Query: 372 GLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQT-THVVGTLGY 430
              + H      V+HRD+K  N+L++ E   +L DFGLAR +  G   +T  H V TL Y
Sbjct: 121 ---FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWY 172
Query: 431 LAPEHTRTGK-ATTSADVFSFGAFLLEVACGR 461
            APE     K  +T+ D++S G    E+   R
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 110/215 (51%), Gaps = 26/215 (12%)
Query: 263 FREKELLGTGGFGRVYRGT-LP---KSQIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRH 317
           F++ ++LG+G FG VY+G  +P   K +I +A+K++    S +  KE + E   +  + +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 318 RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQP-----KVTLNWIQRFRVIKGVALG 372
            ++ +LLG C     + L+   MP G L  Y+ +       +  LNW  +      +A G
Sbjct: 71  PHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 123
Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVG---TLG 429
           + YL    ++ ++HRD+ A NVL+    + ++ DFGLA+L   G + +  H  G    + 
Sbjct: 124 MNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVPIK 178
Query: 430 YLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRP 463
           ++A E       T  +DV+S+G  + E+   G +P
Sbjct: 179 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 213

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 112/213 (52%), Gaps = 22/213 (10%)
Query: 259 ATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR-QGMKEF-VAEIVSIGRLR 316
           + + F++ E +G G +G VY+     +   +A+KKI  ++  +G+    + EI  +  L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 317 HRNLVQLLGYCRRKGELLLVYDYMPNGSLD-KYLYDQPKVT---LNWIQR--FRVIKGVA 370
           H N+V+LL     + +L LV++++   S+D K   D   +T   L  I+   F++++G+A
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 371 LGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQT-THVVGTLG 429
               + H      V+HRD+K  N+L++ E   +L DFGLAR +  G   +T  H V TL 
Sbjct: 121 ----FCHS---HRVLHRDLKPENLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLW 171
Query: 430 YLAPEHTRTGK-ATTSADVFSFGAFLLEVACGR 461
           Y APE     K  +T+ D++S G    E+   R
Sbjct: 172 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 112/210 (53%), Gaps = 20/210 (9%)
Query: 261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR-QGMKEF-VAEIVSIGRLRHR 318
           + F++ E +G G +G VY+     +   +A+KKI  ++  +G+    + EI  +  L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 319 NLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVT---LNWIQR--FRVIKGVALGL 373
           N+V+LL     + +L LV++++ +  L K++ D   +T   L  I+   F++++G+A   
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLA--- 116
Query: 374 FYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQT-THVVGTLGYLA 432
            + H      V+HRD+K  N+L++ E   +L DFGLAR +  G   +T  H V TL Y A
Sbjct: 117 -FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRA 170
Query: 433 PEHTRTGK-ATTSADVFSFGAFLLEVACGR 461
           PE     K  +T+ D++S G    E+   R
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 113/212 (53%), Gaps = 20/212 (9%)
Query: 259 ATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR-QGMKEF-VAEIVSIGRLR 316
           + + F++ E +G G +G VY+     +   +A+KKI  ++  +G+    + EI  +  L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 317 HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVT---LNWIQR--FRVIKGVAL 371
           H N+V+LL     + +L LV++++ +  L K++ D   +T   L  I+   F++++G+A 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLA- 117
Query: 372 GLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQT-THVVGTLGY 430
              + H      V+HRD+K  N+L++ E   +L DFGLAR +  G   +T  H V TL Y
Sbjct: 118 ---FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWY 169
Query: 431 LAPEHTRTGK-ATTSADVFSFGAFLLEVACGR 461
            APE     K  +T+ D++S G    E+   R
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 70/234 (29%), Positives = 107/234 (45%), Gaps = 23/234 (9%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKI--SHESRQGMKEFVAEIVSI-GRLRHRNLVQLLG 325
           LG G FG VY     +S+  +A+K +  +   + G++  +   V I   LRH N+++L G
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 326 YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVI 385
           Y      + L+ +Y P G++ + L  Q     +  +    I  +A  L Y H    + VI
Sbjct: 80  YFHDATRVYLILEYAPLGTVYREL--QKLSRFDEQRTATYITELANALSYCHS---KRVI 134
Query: 386 HRDVKASNVLL--DGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATT 443
           HRD+K  N+LL  +GEL  ++ DFG +    H    + T + GTL YL PE         
Sbjct: 135 HRDIKPENLLLGSNGEL--KIADFGWS---VHAPSSRRTTLCGTLDYLPPEMIEGRMHDE 189
Query: 444 SADVFSFGAFLLEVACGRRPIQRQGPSEN---LILVDWVF-DFWNRGELLEARD 493
             D++S G    E   G  P +     E    +  V++ F DF   G    ARD
Sbjct: 190 KVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPDFVTEG----ARD 239

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 113/212 (53%), Gaps = 20/212 (9%)
Query: 259 ATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR-QGMKEF-VAEIVSIGRLR 316
           + + F++ E +G G +G VY+     +   +A+KKI  ++  +G+    + EI  +  L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 317 HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVT---LNWIQR--FRVIKGVAL 371
           H N+V+LL     + +L LV++++ +  L K++ D   +T   L  I+   F++++G+A 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLA- 117
Query: 372 GLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQT-THVVGTLGY 430
              + H      V+HRD+K  N+L++ E   +L DFGLAR +  G   +T  H V TL Y
Sbjct: 118 ---FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWY 169
Query: 431 LAPEHTRTGK-ATTSADVFSFGAFLLEVACGR 461
            APE     K  +T+ D++S G    E+   R
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 110/215 (51%), Gaps = 26/215 (12%)
Query: 263 FREKELLGTGGFGRVYRGT-LP---KSQIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRH 317
           F++ ++LG+G FG VY+G  +P   K +I +A+K++    S +  KE + E   +  + +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 318 RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQP-----KVTLNWIQRFRVIKGVALG 372
            ++ +LLG C     + L+   MP G L  Y+ +       +  LNW  +      +A G
Sbjct: 80  PHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 132
Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVG---TLG 429
           + YL    ++ ++HRD+ A NVL+    + ++ DFGLA+L   G + +  H  G    + 
Sbjct: 133 MNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVPIK 187
Query: 430 YLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRP 463
           ++A E       T  +DV+S+G  + E+   G +P
Sbjct: 188 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 222

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 98/213 (46%), Gaps = 12/213 (5%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKI--SHESRQGMKEFVAEIVSIGRLRHRNL 320
           +R  + +G G F +V       +  E+AVK I  +  +   +++   E+  +  L H N+
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 321 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQ-RFRVIKGVALGLFYLHQE 379
           V+L      +  L LV +Y   G +  YL    ++     + +FR I      + Y HQ+
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQI---VSAVQYCHQK 132
Query: 380 WEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTG 439
           +   ++HRD+KA N+LLD ++N ++ DFG +  +  G    T    G+  Y APE  +  
Sbjct: 133 F---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT--FCGSPPYAAPELFQGK 187
Query: 440 KAT-TSADVFSFGAFLLEVACGRRPIQRQGPSE 471
           K      DV+S G  L  +  G  P   Q   E
Sbjct: 188 KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE 220

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 112/213 (52%), Gaps = 22/213 (10%)
Query: 259 ATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR-QGMKEF-VAEIVSIGRLR 316
           + + F++ E +G G +G VY+     +   +A+KKI  ++  +G+    + EI  +  L 
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 61
Query: 317 HRNLVQLLGYCRRKGELLLVYDYMPNGSLD-KYLYDQPKVT---LNWIQR--FRVIKGVA 370
           H N+V+LL     + +L LV++++   S+D K   D   +T   L  I+   F++++G+A
Sbjct: 62  HPNIVKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 118
Query: 371 LGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQT-THVVGTLG 429
               + H      V+HRD+K  N+L++ E   +L DFGLAR +  G   +T  H V TL 
Sbjct: 119 ----FCHS---HRVLHRDLKPENLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLW 169
Query: 430 YLAPEHTRTGK-ATTSADVFSFGAFLLEVACGR 461
           Y APE     K  +T+ D++S G    E+   R
Sbjct: 170 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 110/215 (51%), Gaps = 26/215 (12%)
Query: 263 FREKELLGTGGFGRVYRGT-LP---KSQIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRH 317
           F++ ++LG+G FG VY+G  +P   K +I +A+K++    S +  KE + E   +  + +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 318 RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQP-----KVTLNWIQRFRVIKGVALG 372
            ++ +LLG C     + L+   MP G L  Y+ +       +  LNW  +      +A G
Sbjct: 80  PHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 132
Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVG---TLG 429
           + YL    ++ ++HRD+ A NVL+    + ++ DFGLA+L   G + +  H  G    + 
Sbjct: 133 MNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVPIK 187
Query: 430 YLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRP 463
           ++A E       T  +DV+S+G  + E+   G +P
Sbjct: 188 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 222

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 110/215 (51%), Gaps = 26/215 (12%)
Query: 263 FREKELLGTGGFGRVYRGT-LP---KSQIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRH 317
           F++ ++LG+G FG VY+G  +P   K +I +A+K++    S +  KE + E   +  + +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 318 RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQP-----KVTLNWIQRFRVIKGVALG 372
            ++ +LLG C     + L+   MP G L  Y+ +       +  LNW  +      +A G
Sbjct: 79  PHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 131
Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVG---TLG 429
           + YL    ++ ++HRD+ A NVL+    + ++ DFGLA+L   G + +  H  G    + 
Sbjct: 132 MNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVPIK 186
Query: 430 YLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRP 463
           ++A E       T  +DV+S+G  + E+   G +P
Sbjct: 187 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 221

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 110/215 (51%), Gaps = 26/215 (12%)
Query: 263 FREKELLGTGGFGRVYRGT-LP---KSQIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRH 317
           F++ ++LG+G FG VY+G  +P   K +I +A+K++    S +  KE + E   +  + +
Sbjct: 18  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 318 RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQP-----KVTLNWIQRFRVIKGVALG 372
            ++ +LLG C     + L+   MP G L  Y+ +       +  LNW  +      +A G
Sbjct: 78  PHVCRLLGICL-TSTVQLIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQ------IAKG 130
Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVG---TLG 429
           + YL    ++ ++HRD+ A NVL+    + ++ DFGLA+L   G + +  H  G    + 
Sbjct: 131 MNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVPIK 185
Query: 430 YLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRP 463
           ++A E       T  +DV+S+G  + E+   G +P
Sbjct: 186 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 220

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 113/212 (53%), Gaps = 20/212 (9%)
Query: 259 ATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR-QGMKEF-VAEIVSIGRLR 316
           + + F++ E +G G +G VY+     +   +A+KKI  ++  +G+    + EI  +  L 
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 64
Query: 317 HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVT---LNWIQR--FRVIKGVAL 371
           H N+V+LL     + +L LV++++ +  L K++ D   +T   L  I+   F++++G+A 
Sbjct: 65  HPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLA- 121
Query: 372 GLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQT-THVVGTLGY 430
              + H      V+HRD+K  N+L++ E   +L DFGLAR +  G   +T  H V TL Y
Sbjct: 122 ---FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWY 173
Query: 431 LAPEHTRTGK-ATTSADVFSFGAFLLEVACGR 461
            APE     K  +T+ D++S G    E+   R
Sbjct: 174 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 110/215 (51%), Gaps = 26/215 (12%)
Query: 263 FREKELLGTGGFGRVYRGT-LP---KSQIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRH 317
           F++ ++LG+G FG VY+G  +P   K +I +A+K++    S +  KE + E   +  + +
Sbjct: 24  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 318 RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQP-----KVTLNWIQRFRVIKGVALG 372
            ++ +LLG C     + L+   MP G L  Y+ +       +  LNW  +      +A G
Sbjct: 84  PHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 136
Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVG---TLG 429
           + YL    ++ ++HRD+ A NVL+    + ++ DFGLA+L   G + +  H  G    + 
Sbjct: 137 MNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVPIK 191
Query: 430 YLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRP 463
           ++A E       T  +DV+S+G  + E+   G +P
Sbjct: 192 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 226

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 72.8 bits (177), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 110/215 (51%), Gaps = 26/215 (12%)
Query: 263 FREKELLGTGGFGRVYRGT-LP---KSQIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRH 317
           F++ ++LG+G FG VY+G  +P   K +I +A+K++    S +  KE + E   +  + +
Sbjct: 42  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 101
Query: 318 RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQP-----KVTLNWIQRFRVIKGVALG 372
            ++ +LLG C     + L+   MP G L  Y+ +       +  LNW  +      +A G
Sbjct: 102 PHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 154
Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVG---TLG 429
           + YL    ++ ++HRD+ A NVL+    + ++ DFGLA+L   G + +  H  G    + 
Sbjct: 155 MNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVPIK 209
Query: 430 YLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRP 463
           ++A E       T  +DV+S+G  + E+   G +P
Sbjct: 210 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 244

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 110/215 (51%), Gaps = 26/215 (12%)
Query: 263 FREKELLGTGGFGRVYRGT-LP---KSQIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRH 317
           F++ ++LG+G FG VY+G  +P   K +I +A+K++    S +  KE + E   +  + +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 318 RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQP-----KVTLNWIQRFRVIKGVALG 372
            ++ +LLG C     + L+   MP G L  Y+ +       +  LNW  +      +A G
Sbjct: 77  PHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 129
Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVG---TLG 429
           + YL    ++ ++HRD+ A NVL+    + ++ DFGLA+L   G + +  H  G    + 
Sbjct: 130 MNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVPIK 184
Query: 430 YLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRP 463
           ++A E       T  +DV+S+G  + E+   G +P
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 110/215 (51%), Gaps = 26/215 (12%)
Query: 263 FREKELLGTGGFGRVYRGT-LP---KSQIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRH 317
           F++ ++LG+G FG VY+G  +P   K +I +A+K++    S +  KE + E   +  + +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 318 RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQP-----KVTLNWIQRFRVIKGVALG 372
            ++ +LLG C     + L+   MP G L  Y+ +       +  LNW  +      +A G
Sbjct: 77  PHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 129
Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVG---TLG 429
           + YL    ++ ++HRD+ A NVL+    + ++ DFGLA+L   G + +  H  G    + 
Sbjct: 130 MNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVPIK 184
Query: 430 YLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRP 463
           ++A E       T  +DV+S+G  + E+   G +P
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 110/215 (51%), Gaps = 26/215 (12%)
Query: 263 FREKELLGTGGFGRVYRGT-LP---KSQIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRH 317
           F++ ++LG+G FG VY+G  +P   K +I +A+K++    S +  KE + E   +  + +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 318 RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQP-----KVTLNWIQRFRVIKGVALG 372
            ++ +LLG C     + L+   MP G L  Y+ +       +  LNW  +      +A G
Sbjct: 80  PHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 132
Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVG---TLG 429
           + YL    ++ ++HRD+ A NVL+    + ++ DFGLA+L   G + +  H  G    + 
Sbjct: 133 MNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVPIK 187
Query: 430 YLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRP 463
           ++A E       T  +DV+S+G  + E+   G +P
Sbjct: 188 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 222

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 74/287 (25%), Positives = 132/287 (45%), Gaps = 39/287 (13%)
Query: 267 ELLGTGGFGRVYRGTLPK---SQIEIAVK--KISHESRQGMKEFVAEIVSIGRLRHRNLV 321
           ++LG G FG V  G L +   + +++AVK  K+ + S++ ++EF++E   +    H N++
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 322 QLLGYCRRKG-----ELLLVYDYMPNGSLDKY-LYDQ----PK-VTLNWIQRFRVIKGVA 370
           +LLG C         + +++  +M  G L  Y LY +    PK + L  + +F V   +A
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMV--DIA 157
Query: 371 LGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLA-RLYDHGTDPQTTHVVGTLG 429
           LG+ YL     +  +HRD+ A N +L  ++   + DFGL+ ++Y      Q       + 
Sbjct: 158 LGMEYLSN---RNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK 214
Query: 430 YLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGEL 488
           ++A E       T+ +DV++FG  + E+A  G  P       E       ++D+   G  
Sbjct: 215 WIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE-------MYDYLLHGHR 267
Query: 489 LEARDPNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQILER 535
           L+  +  L   Y              C  +DP  RP+   +   LE+
Sbjct: 268 LKQPEDCLDELY---------EIMYSCWRTDPLDRPTFSVLRLQLEK 305

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 112/210 (53%), Gaps = 20/210 (9%)
Query: 261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR-QGMKEF-VAEIVSIGRLRHR 318
           + F++ E +G G +G VY+     +   +A+KKI  ++  +G+    + EI  +  L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 319 NLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVT---LNWIQR--FRVIKGVALGL 373
           N+V+LL     + +L LV++++ +  L K++ D   +T   L  I+   F++++G+A   
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLA--- 116
Query: 374 FYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQT-THVVGTLGYLA 432
            + H      V+HRD+K  N+L++ E   +L DFGLAR +  G   +T  H V TL Y A
Sbjct: 117 -FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRA 170
Query: 433 PEHTRTGK-ATTSADVFSFGAFLLEVACGR 461
           PE     K  +T+ D++S G    E+   R
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 69/232 (29%), Positives = 116/232 (50%), Gaps = 14/232 (6%)
Query: 248 PHRFRYKDLYIATKGFR-EKELLGTGGFGRVYRG--TLPKSQIEIAVKKISHESRQ-GMK 303
           P   R K++Y+  K    E + LG+G FG V +G   + K    +AVK + +E+    +K
Sbjct: 13  PEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALK 72
Query: 304 -EFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQR 362
            E +AE   + +L +  +V+++G C  +   +LV +    G L+KYL     V    I  
Sbjct: 73  DELLAEANVMQQLDNPYIVRMIGICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKNI-- 129
Query: 363 FRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLY--DHGTDPQ 420
             ++  V++G+ YL    E   +HRD+ A NVLL  +   ++ DFGL++    D      
Sbjct: 130 IELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 186
Query: 421 TTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEV-ACGRRPIQRQGPSE 471
            TH    + + APE     K ++ +DV+SFG  + E  + G++P +    SE
Sbjct: 187 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 238

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 69/232 (29%), Positives = 116/232 (50%), Gaps = 14/232 (6%)
Query: 248 PHRFRYKDLYIATKGFR-EKELLGTGGFGRVYRG--TLPKSQIEIAVKKISHESRQ-GMK 303
           P   R K++Y+  K    E + LG+G FG V +G   + K    +AVK + +E+    +K
Sbjct: 13  PEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALK 72
Query: 304 -EFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQR 362
            E +AE   + +L +  +V+++G C  +   +LV +    G L+KYL     V    I  
Sbjct: 73  DELLAEANVMQQLDNPYIVRMIGICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKNI-- 129
Query: 363 FRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLY--DHGTDPQ 420
             ++  V++G+ YL    E   +HRD+ A NVLL  +   ++ DFGL++    D      
Sbjct: 130 IELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 186
Query: 421 TTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEV-ACGRRPIQRQGPSE 471
            TH    + + APE     K ++ +DV+SFG  + E  + G++P +    SE
Sbjct: 187 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 238

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 110/215 (51%), Gaps = 26/215 (12%)
Query: 263 FREKELLGTGGFGRVYRGT-LP---KSQIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRH 317
           F++ ++LG+G FG VY+G  +P   K +I +A+K++    S +  KE + E   +  + +
Sbjct: 14  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 73
Query: 318 RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQP-----KVTLNWIQRFRVIKGVALG 372
            ++ +LLG C     + L+   MP G L  Y+ +       +  LNW  +      +A G
Sbjct: 74  PHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAEG 126
Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVG---TLG 429
           + YL    ++ ++HRD+ A NVL+    + ++ DFGLA+L   G + +  H  G    + 
Sbjct: 127 MNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVPIK 181
Query: 430 YLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRP 463
           ++A E       T  +DV+S+G  + E+   G +P
Sbjct: 182 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 216

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 112/210 (53%), Gaps = 20/210 (9%)
Query: 261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR-QGMKEF-VAEIVSIGRLRHR 318
           + F++ E +G G +G VY+     +   +A+KKI  ++  +G+    + EI  +  L H 
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 63
Query: 319 NLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVT---LNWIQR--FRVIKGVALGL 373
           N+V+LL     + +L LV++++ +  L K++ D   +T   L  I+   F++++G+A   
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLA--- 118
Query: 374 FYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQT-THVVGTLGYLA 432
            + H      V+HRD+K  N+L++ E   +L DFGLAR +  G   +T  H V TL Y A
Sbjct: 119 -FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRA 172
Query: 433 PEHTRTGK-ATTSADVFSFGAFLLEVACGR 461
           PE     K  +T+ D++S G    E+   R
Sbjct: 173 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 98/213 (46%), Gaps = 12/213 (5%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKI--SHESRQGMKEFVAEIVSIGRLRHRNL 320
           +R  + +G G F +V       +  E+AVK I  +  +   +++   E+  +  L H N+
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 321 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQ-RFRVIKGVALGLFYLHQE 379
           V+L      +  L LV +Y   G +  YL    ++     + +FR I      + Y HQ+
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQI---VSAVQYCHQK 132
Query: 380 WEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTG 439
           +   ++HRD+KA N+LLD ++N ++ DFG +  +  G    T    G+  Y APE  +  
Sbjct: 133 F---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT--FCGSPPYAAPELFQGK 187
Query: 440 KAT-TSADVFSFGAFLLEVACGRRPIQRQGPSE 471
           K      DV+S G  L  +  G  P   Q   E
Sbjct: 188 KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE 220

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 70/293 (23%), Positives = 124/293 (42%), Gaps = 24/293 (8%)
Query: 257 YIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMK---EFVAEIVSIG 313
           Y     FR ++ +G G F  VYR       + +A+KK+        K   + + EI  + 
Sbjct: 28  YNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLK 87
Query: 314 RLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYL--YDQPKVTLNWIQRFRVIKGVAL 371
           +L H N+++         EL +V +    G L + +  + + K  +     ++    +  
Sbjct: 88  QLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCS 147
Query: 372 GLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYL 431
            L ++H    + V+HRD+K +NV +      +LGD GL R +   T    + +VGT  Y+
Sbjct: 148 ALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-LVGTPYYM 203
Query: 432 APEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEA 491
           +PE          +D++S G  L E+A  + P    G   NL         ++  + +E 
Sbjct: 204 SPERIHENGYNFKSDIWSLGCLLYEMAALQSPF--YGDKMNL---------YSLCKKIEQ 252
Query: 492 RD-PNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQILERDVALPAIS 543
            D P L +++ +            C + DP  RP +  V  + +R  A  A S
Sbjct: 253 CDYPPLPSDHYS---EELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASS 302

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 110/215 (51%), Gaps = 26/215 (12%)
Query: 263 FREKELLGTGGFGRVYRGT-LP---KSQIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRH 317
           F++ ++LG+G FG VY+G  +P   K +I +A+K++    S +  KE + E   +  + +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 318 RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQP-----KVTLNWIQRFRVIKGVALG 372
            ++ +LLG C     + L+   MP G L  Y+ +       +  LNW  +      +A G
Sbjct: 77  PHVCRLLGICL-TSTVQLITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQ------IAKG 129
Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVG---TLG 429
           + YL    ++ ++HRD+ A NVL+    + ++ DFGLA+L   G + +  H  G    + 
Sbjct: 130 MNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVPIK 184
Query: 430 YLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRP 463
           ++A E       T  +DV+S+G  + E+   G +P
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 112/213 (52%), Gaps = 22/213 (10%)
Query: 259 ATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR-QGMKEF-VAEIVSIGRLR 316
           + + F++ E +G G +G VY+     +   +A+KKI  ++  +G+    + EI  +  L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 317 HRNLVQLLGYCRRKGELLLVYDYMPNGSLD-KYLYDQPKVT---LNWIQR--FRVIKGVA 370
           H N+V+LL     + +L LV++++   S+D K   D   +T   L  I+   F++++G+A
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLA 120
Query: 371 LGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQT-THVVGTLG 429
               + H      V+HRD+K  N+L++ E   +L DFGLAR +  G   +T  H V TL 
Sbjct: 121 ----FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLW 171
Query: 430 YLAPEHTRTGK-ATTSADVFSFGAFLLEVACGR 461
           Y APE     K  +T+ D++S G    E+   R
Sbjct: 172 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 98/209 (46%), Gaps = 27/209 (12%)
Query: 269 LGTGGFGRVYRGTL-----PKSQIEIAVKKISHESRQGMKE-FVAEIVSIGRL-RHRNLV 321
           LG G FG+V   T        + +++AVK +   +    KE  ++E+  +  L +H N+V
Sbjct: 46  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 105
Query: 322 QLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLN--------WIQRFRVIKGVALGL 373
            LLG C   G +L++ +Y   G L  +L  + +  L+                  VA G+
Sbjct: 106 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGM 165
Query: 374 FYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVG-----TL 428
            +L     +  IHRDV A NVLL      ++GDFGLAR  D   D  + ++V       +
Sbjct: 166 AFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLAR--DIMND--SNYIVKGNARLPV 218
Query: 429 GYLAPEHTRTGKATTSADVFSFGAFLLEV 457
            ++APE       T  +DV+S+G  L E+
Sbjct: 219 KWMAPESIFDCVYTVQSDVWSYGILLWEI 247

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 112/213 (52%), Gaps = 22/213 (10%)
Query: 259 ATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR-QGMKEF-VAEIVSIGRLR 316
           + + F++ E +G G +G VY+     +   +A+KKI  ++  +G+    + EI  +  L 
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 62
Query: 317 HRNLVQLLGYCRRKGELLLVYDYMPNGSLD-KYLYDQPKVT---LNWIQR--FRVIKGVA 370
           H N+V+LL     + +L LV++++   S+D K   D   +T   L  I+   F++++G+A
Sbjct: 63  HPNIVKLLDVIHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLA 119
Query: 371 LGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQT-THVVGTLG 429
               + H      V+HRD+K  N+L++ E   +L DFGLAR +  G   +T  H V TL 
Sbjct: 120 ----FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLW 170
Query: 430 YLAPEHTRTGK-ATTSADVFSFGAFLLEVACGR 461
           Y APE     K  +T+ D++S G    E+   R
Sbjct: 171 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 69/232 (29%), Positives = 116/232 (50%), Gaps = 14/232 (6%)
Query: 248 PHRFRYKDLYIATKGFR-EKELLGTGGFGRVYRG--TLPKSQIEIAVKKISHESRQ-GMK 303
           P   R K++Y+  K    E + LG+G FG V +G   + K    +AVK + +E+    +K
Sbjct: 11  PEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALK 70
Query: 304 -EFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQR 362
            E +AE   + +L +  +V+++G C  +   +LV +    G L+KYL     V    I  
Sbjct: 71  DELLAEANVMQQLDNPYIVRMIGICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKNI-- 127
Query: 363 FRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLY--DHGTDPQ 420
             ++  V++G+ YL    E   +HRD+ A NVLL  +   ++ DFGL++    D      
Sbjct: 128 IELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA 184
Query: 421 TTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEV-ACGRRPIQRQGPSE 471
            TH    + + APE     K ++ +DV+SFG  + E  + G++P +    SE
Sbjct: 185 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 236

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 31/213 (14%)
Query: 269 LGTGGFGRVYRGTL-----PKSQIEIAVKKISHESRQGMKE-FVAEIVSIGRL-RHRNLV 321
           LG G FG+V   T        + +++AVK +   +    KE  ++E+  +  L +H N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 322 QLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKV------------TLNWIQRFRVIKGV 369
            LLG C   G +L++ +Y   G L  +L  + +V            T +          V
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQV 173
Query: 370 ALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVG--- 426
           A G+ +L     +  IHRDV A NVLL      ++GDFGLAR  D   D  + ++V    
Sbjct: 174 AQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLAR--DIMND--SNYIVKGNA 226
Query: 427 --TLGYLAPEHTRTGKATTSADVFSFGAFLLEV 457
              + ++APE       T  +DV+S+G  L E+
Sbjct: 227 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 259

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 98/210 (46%), Gaps = 16/210 (7%)
Query: 258 IATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKIS-HESRQGMK-EFVAEIVSIGRL 315
           +AT  +     +G G +G VY+   P S   +A+K +      +G+    V E+  + RL
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRL 60
Query: 316 R---HRNLVQLLGYCR-----RKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIK 367
               H N+V+L+  C      R+ ++ LV++++ +  L  YL   P   L       +++
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMR 119
Query: 368 GVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT 427
               GL +LH      ++HRD+K  N+L+      +L DFGLAR+Y +        VV T
Sbjct: 120 QFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM--ALAPVVVT 174
Query: 428 LGYLAPEHTRTGKATTSADVFSFGAFLLEV 457
           L Y APE        T  D++S G    E+
Sbjct: 175 LWYRAPEVLLQSTYATPVDMWSVGCIFAEM 204

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 98/209 (46%), Gaps = 27/209 (12%)
Query: 269 LGTGGFGRVYRGTL-----PKSQIEIAVKKISHESRQGMKE-FVAEIVSIGRL-RHRNLV 321
           LG G FG+V   T        + +++AVK +   +    KE  ++E+  +  L +H N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 322 QLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLN--------WIQRFRVIKGVALGL 373
            LLG C   G +L++ +Y   G L  +L  + +  L+                  VA G+
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGM 173
Query: 374 FYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVG-----TL 428
            +L     +  IHRDV A NVLL      ++GDFGLAR  D   D  + ++V       +
Sbjct: 174 AFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLAR--DIMND--SNYIVKGNARLPV 226
Query: 429 GYLAPEHTRTGKATTSADVFSFGAFLLEV 457
            ++APE       T  +DV+S+G  L E+
Sbjct: 227 KWMAPESIFDCVYTVQSDVWSYGILLWEI 255

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 98/213 (46%), Gaps = 19/213 (8%)
Query: 258 IATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEF-----VAEIVSI 312
           +AT  +     +G G +G VY+   P S   +A+K +   +  G         V E+  +
Sbjct: 6   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65
Query: 313 GRLR---HRNLVQLLGYCR-----RKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFR 364
            RL    H N+V+L+  C      R+ ++ LV++++ +  L  YL   P   L       
Sbjct: 66  RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKD 124
Query: 365 VIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHV 424
           +++    GL +LH      ++HRD+K  N+L+      +L DFGLAR+Y +      T V
Sbjct: 125 LMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM--ALTPV 179
Query: 425 VGTLGYLAPEHTRTGKATTSADVFSFGAFLLEV 457
           V TL Y APE        T  D++S G    E+
Sbjct: 180 VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 212

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/294 (23%), Positives = 127/294 (43%), Gaps = 33/294 (11%)
Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
           E +G G +G V+RG+     + + +   S + +   +E   E+ +   LRH N++  +  
Sbjct: 43  ECVGKGRYGEVWRGSWQGENVAVKIFS-SRDEKSWFRE--TELYNTVMLRHENILGFIAS 99
Query: 327 C----RRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEW-- 380
                    +L L+  Y   GSL  YL      TL+ +   R++  +A GL +LH E   
Sbjct: 100 DMTSRHSSTQLWLITHYHEMGSLYDYL---QLTTLDTVSCLRIVLSIASGLAHLHIEIFG 156
Query: 381 ---EQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT---DPQTTHVVGTLGYLAPE 434
              +  + HRD+K+ N+L+       + D GLA ++   T   D      VGT  Y+APE
Sbjct: 157 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE 216
Query: 435 ------HTRTGKATTSADVFSFGAFLLEVACGRRPIQR------QGPSENLILVDWVFDF 482
                       +    D+++FG  L EVA  RR +        + P  +++  D  F+ 
Sbjct: 217 VLDETIQVDCFDSYKRVDIWAFGLVLWEVA--RRMVSNGIVEDYKPPFYDVVPNDPSFED 274
Query: 483 WNRGELLEARDPNLGTEYVAX-XXXXXXXXXXXCSHSDPTARPSMRQVVQILER 535
             +   ++ + PN+   + +             C + +P+AR +  ++ + L +
Sbjct: 275 MRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 328

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/212 (30%), Positives = 113/212 (53%), Gaps = 20/212 (9%)
Query: 259 ATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR-QGMKEF-VAEIVSIGRLR 316
           + + F++ E +G G +G VY+     +   +A+KKI  ++  +G+    + EI  +  L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 317 HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVT---LNWIQR--FRVIKGVAL 371
           H N+V+LL     + +L LV++++ +  L K++ D   +T   L  I+   F++++G+A 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEHV-DQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLA- 120
Query: 372 GLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQT-THVVGTLGY 430
              + H      V+HRD+K  N+L++ E   +L DFGLAR +  G   +T  H V TL Y
Sbjct: 121 ---FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWY 172
Query: 431 LAPEHTRTGK-ATTSADVFSFGAFLLEVACGR 461
            APE     K  +T+ D++S G    E+   R
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/192 (27%), Positives = 91/192 (47%), Gaps = 6/192 (3%)
Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMK-EFVAEIVSIGRLRHRNLVQLLG 325
           E +G G FG V+ G L      +AVK         +K +F+ E   + +  H N+V+L+G
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 326 YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVI 385
            C +K  + +V + +  G    +L  +    L      +++   A G+ YL     +  I
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLE---SKCCI 235
Query: 386 HRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT-LGYLAPEHTRTGKATTS 444
           HRD+ A N L+  +   ++ DFG++R    G    +  +    + + APE    G+ ++ 
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYGRYSSE 295
Query: 445 ADVFSFGAFLLE 456
           +DV+SFG  L E
Sbjct: 296 SDVWSFGILLWE 307

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 97/213 (45%), Gaps = 12/213 (5%)
Query: 263 FREKELLGTGGFGRVY--RGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNL 320
           +R  + +G G F +V   R  L   ++ + +   +  +   +++   E+  +  L H N+
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 321 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQ-RFRVIKGVALGLFYLHQE 379
           V+L      +  L LV +Y   G +  YL    ++     + +FR I      + Y HQ+
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQI---VSAVQYCHQK 132
Query: 380 WEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTG 439
           +   ++HRD+KA N+LLD ++N ++ DFG +  +  G    T    G+  Y APE  +  
Sbjct: 133 F---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT--FCGSPPYAAPELFQGK 187
Query: 440 KAT-TSADVFSFGAFLLEVACGRRPIQRQGPSE 471
           K      DV+S G  L  +  G  P   Q   E
Sbjct: 188 KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE 220

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 109/210 (51%), Gaps = 20/210 (9%)
Query: 261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR-QGMKEF-VAEIVSIGRLRHR 318
           + F++ E +G G +G VY+     +   +A+KKI  ++  +G+    + EI  +  L H 
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 319 NLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVT---LNWIQR--FRVIKGVALGL 373
           N+V+LL     + +L LV++++      K   D   +T   L  I+   F++++G+A   
Sbjct: 62  NIVKLLDVIHTENKLYLVFEHVHQDL--KTFMDASALTGIPLPLIKSYLFQLLQGLA--- 116
Query: 374 FYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQT-THVVGTLGYLA 432
            + H      V+HRD+K  N+L++ E   +L DFGLAR +  G   +T TH V TL Y A
Sbjct: 117 -FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRA 170
Query: 433 PEHTRTGK-ATTSADVFSFGAFLLEVACGR 461
           PE     K  +T+ D++S G    E+   R
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/294 (23%), Positives = 127/294 (43%), Gaps = 33/294 (11%)
Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
           E +G G +G V+RG+     + + +   S + +   +E   E+ +   LRH N++  +  
Sbjct: 14  ECVGKGRYGEVWRGSWQGENVAVKIFS-SRDEKSWFRE--TELYNTVMLRHENILGFIAS 70
Query: 327 C----RRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEW-- 380
                    +L L+  Y   GSL  YL      TL+ +   R++  +A GL +LH E   
Sbjct: 71  DMTSRHSSTQLWLITHYHEMGSLYDYL---QLTTLDTVSCLRIVLSIASGLAHLHIEIFG 127
Query: 381 ---EQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT---DPQTTHVVGTLGYLAPE 434
              +  + HRD+K+ N+L+       + D GLA ++   T   D      VGT  Y+APE
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE 187
Query: 435 ------HTRTGKATTSADVFSFGAFLLEVACGRRPIQR------QGPSENLILVDWVFDF 482
                       +    D+++FG  L EVA  RR +        + P  +++  D  F+ 
Sbjct: 188 VLDETIQVDCFDSYKRVDIWAFGLVLWEVA--RRMVSNGIVEDYKPPFYDVVPNDPSFED 245
Query: 483 WNRGELLEARDPNLGTEYVAX-XXXXXXXXXXXCSHSDPTARPSMRQVVQILER 535
             +   ++ + PN+   + +             C + +P+AR +  ++ + L +
Sbjct: 246 MRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 99/215 (46%), Gaps = 33/215 (15%)
Query: 269 LGTGGFGRVYRGTL-----PKSQIEIAVKKISHESRQGMKE-FVAEIVSIGRL-RHRNLV 321
           LG G FG+V   T        + +++AVK +   +    KE  ++E+  +  L +H N+V
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 322 QLLGYCRRKGELLLVYDYMPNGSLDKYLYDQ--------------PKVTLNWIQRFRVIK 367
            LLG C   G +L++ +Y   G L  +L  +              P+  L+         
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSS 173
Query: 368 GVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVG- 426
            VA G+ +L     +  IHRDV A NVLL      ++GDFGLAR  D   D  + ++V  
Sbjct: 174 QVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLAR--DIMND--SNYIVKG 226
Query: 427 ----TLGYLAPEHTRTGKATTSADVFSFGAFLLEV 457
                + ++APE       T  +DV+S+G  L E+
Sbjct: 227 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 261

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 10/214 (4%)
Query: 258 IATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQ---GMKEFVAEIVSIGR 314
           +    FR+  +LG GGFG V    +  +    A KK+  +  +   G    + E   + +
Sbjct: 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEK 240
Query: 315 LRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLF 374
           +  R +V L      K  L LV   M  G L  ++Y   +      +       +  GL 
Sbjct: 241 VNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLE 300
Query: 375 YLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTH-VVGTLGYLAP 433
            LH+E    +++RD+K  N+LLD   + R+ D GLA    H  + QT    VGT+GY+AP
Sbjct: 301 DLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAV---HVPEGQTIKGRVGTVGYMAP 354
Query: 434 EHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQ 467
           E  +  + T S D ++ G  L E+  G+ P Q++
Sbjct: 355 EVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR 388

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 106/233 (45%), Gaps = 27/233 (11%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISH---------ESRQGMKEFVAEIVS----IGRL 315
           LG+G +G V          E A+K I           +  + +++F  EI +    +  L
Sbjct: 44  LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 316 RHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFY 375
            H N+++L      K    LV ++   G L + + ++ K   +      ++K +  G+ Y
Sbjct: 104 DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHK--FDECDAANIMKQILSGICY 161
Query: 376 LHQEWEQVVIHRDVKASNVLLDGE---LNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLA 432
           LH+     ++HRD+K  N+LL+ +   LN ++ DFGL+  +    D +    +GT  Y+A
Sbjct: 162 LHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFF--SKDYKLRDRLGTAYYIA 216
Query: 433 PEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVD---WVFDF 482
           PE  +  K     DV+S G  +  + CG  P   Q   + +  V+   + FDF
Sbjct: 217 PEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDF 268

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/294 (23%), Positives = 127/294 (43%), Gaps = 33/294 (11%)
Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
           E +G G +G V+RG+     + + +   S + +   +E   E+ +   LRH N++  +  
Sbjct: 14  ECVGKGRYGEVWRGSWQGENVAVKIFS-SRDEKSWFRE--TELYNTVMLRHENILGFIAS 70
Query: 327 C----RRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEW-- 380
                    +L L+  Y   GSL  YL      TL+ +   R++  +A GL +LH E   
Sbjct: 71  DMTSRHSSTQLWLITHYHEMGSLYDYL---QLTTLDTVSCLRIVLSIASGLAHLHIEIFG 127
Query: 381 ---EQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT---DPQTTHVVGTLGYLAPE 434
              +  + HRD+K+ N+L+       + D GLA ++   T   D      VGT  Y+APE
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPE 187
Query: 435 ------HTRTGKATTSADVFSFGAFLLEVACGRRPIQR------QGPSENLILVDWVFDF 482
                       +    D+++FG  L EVA  RR +        + P  +++  D  F+ 
Sbjct: 188 VLDETIQVDCFDSYKRVDIWAFGLVLWEVA--RRMVSNGIVEDYKPPFYDVVPNDPSFED 245
Query: 483 WNRGELLEARDPNLGTEYVAX-XXXXXXXXXXXCSHSDPTARPSMRQVVQILER 535
             +   ++ + PN+   + +             C + +P+AR +  ++ + L +
Sbjct: 246 MRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 98/210 (46%), Gaps = 16/210 (7%)
Query: 258 IATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKIS-HESRQGMK-EFVAEIVSIGRL 315
           +AT  +     +G G +G VY+   P S   +A+K +      +G+    V E+  + RL
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRL 60
Query: 316 R---HRNLVQLLGYCR-----RKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIK 367
               H N+V+L+  C      R+ ++ LV++++ +  L  YL   P   L       +++
Sbjct: 61  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMR 119
Query: 368 GVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT 427
               GL +LH      ++HRD+K  N+L+      +L DFGLAR+Y +        VV T
Sbjct: 120 QFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM--ALFPVVVT 174
Query: 428 LGYLAPEHTRTGKATTSADVFSFGAFLLEV 457
           L Y APE        T  D++S G    E+
Sbjct: 175 LWYRAPEVLLQSTYATPVDMWSVGCIFAEM 204

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 77/280 (27%), Positives = 130/280 (46%), Gaps = 29/280 (10%)
Query: 268 LLGTGGFGRVYRGTL---PKSQIEIAVKKISHESR-QGMKEFVAEIVSIGRLRHRNLVQL 323
           ++G G FG VY G      +++I+ A+K +S  +  Q ++ F+ E + +  L H N++ L
Sbjct: 28  VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLAL 87
Query: 324 LG-YCRRKGELLLVYDYMPNGSLDKYLYD-QPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
           +G     +G   ++  YM +G L +++   Q   T+  +  F +   VA G+ YL    E
Sbjct: 88  IGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGL--QVARGMEYLA---E 142
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLY---DHGTDPQTTHVVGTLGYLAPEHTRT 438
           Q  +HRD+ A N +LD     ++ DFGLAR     ++ +  Q  H    + + A E  +T
Sbjct: 143 QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQT 202
Query: 439 GKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGT 498
            + TT +DV+SFG  L E+     P  R     +L        F  +G  L   +    +
Sbjct: 203 YRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLT------HFLAQGRRLPQPEYCPDS 256
Query: 499 EYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQILERDVA 538
            Y              C  +DP  RP+ R +V  +E+ V+
Sbjct: 257 LY---------QVMQQCWEADPAVRPTFRVLVGEVEQIVS 287

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 109/212 (51%), Gaps = 20/212 (9%)
Query: 259 ATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR-QGMKEF-VAEIVSIGRLR 316
           + + F++ E +G G +G VY+     +   +A+KKI  ++  +G+    + EI  +  L 
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 60
Query: 317 HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVT---LNWIQR--FRVIKGVAL 371
           H N+V+LL     + +L LV++++     D    D   +T   L  I+   F++++G+A 
Sbjct: 61  HPNIVKLLDVIHTENKLYLVFEFLHQDLKD--FMDASALTGIPLPLIKSYLFQLLQGLA- 117
Query: 372 GLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQT-THVVGTLGY 430
              + H      V+HRD+K  N+L++ E   +L DFGLAR +  G   +T  H V TL Y
Sbjct: 118 ---FCHS---HRVLHRDLKPENLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWY 169
Query: 431 LAPEHTRTGK-ATTSADVFSFGAFLLEVACGR 461
            APE     K  +T+ D++S G    E+   R
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 10/214 (4%)
Query: 258 IATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQ---GMKEFVAEIVSIGR 314
           +    FR+  +LG GGFG V    +  +    A KK+  +  +   G    + E   + +
Sbjct: 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEK 240
Query: 315 LRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLF 374
           +  R +V L      K  L LV   M  G L  ++Y   +      +       +  GL 
Sbjct: 241 VNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLE 300
Query: 375 YLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTH-VVGTLGYLAP 433
            LH+E    +++RD+K  N+LLD   + R+ D GLA    H  + QT    VGT+GY+AP
Sbjct: 301 DLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAV---HVPEGQTIKGRVGTVGYMAP 354
Query: 434 EHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQ 467
           E  +  + T S D ++ G  L E+  G+ P Q++
Sbjct: 355 EVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR 388

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 97/213 (45%), Gaps = 12/213 (5%)
Query: 263 FREKELLGTGGFGRVY--RGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNL 320
           +R  + +G G F +V   R  L   ++ + +   +  +   +++   E+  +  L H N+
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 321 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQ-RFRVIKGVALGLFYLHQE 379
           V+L      +  L LV +Y   G +  YL    ++     + +FR I      + Y HQ+
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQI---VSAVQYCHQK 132
Query: 380 WEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTG 439
           +   ++HRD+KA N+LLD ++N ++ DFG +  +  G   +     G+  Y APE  +  
Sbjct: 133 F---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGN--KLDEFCGSPPYAAPELFQGK 187
Query: 440 KAT-TSADVFSFGAFLLEVACGRRPIQRQGPSE 471
           K      DV+S G  L  +  G  P   Q   E
Sbjct: 188 KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE 220

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 109/215 (50%), Gaps = 26/215 (12%)
Query: 263 FREKELLGTGGFGRVYRGT-LP---KSQIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRH 317
           F++ ++L +G FG VY+G  +P   K +I +A+K++    S +  KE + E   +  + +
Sbjct: 24  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 318 RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQP-----KVTLNWIQRFRVIKGVALG 372
            ++ +LLG C     + L+   MP G L  Y+ +       +  LNW  +      +A G
Sbjct: 84  PHVCRLLGICL-TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 136
Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVG---TLG 429
           + YL    ++ ++HRD+ A NVL+    + ++ DFGLA+L   G + +  H  G    + 
Sbjct: 137 MNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVPIK 191
Query: 430 YLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRP 463
           ++A E       T  +DV+S+G  + E+   G +P
Sbjct: 192 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 226

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 102/212 (48%), Gaps = 12/212 (5%)
Query: 258 IATKGFREKELLGTGGFGRVYRGTLPK---SQIEIAVKKISHESRQGMKE-FVAEIVSIG 313
           IA +      +LG G FG VY G        +I +AVK    +     KE F++E V + 
Sbjct: 21  IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMK 80
Query: 314 RLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGL 373
            L H ++V+L+G    +   +++  Y P G L  YL ++ K +L  +        +   +
Sbjct: 81  NLDHPHIVKLIGIIEEEPTWIIMELY-PYGELGHYL-ERNKNSLKVLTLVLYSLQICKAM 138
Query: 374 FYLHQEWEQV-VIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLA 432
            YL    E +  +HRD+   N+L+      +LGDFGL+R  +     + +     + +++
Sbjct: 139 AYL----ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMS 194
Query: 433 PEHTRTGKATTSADVFSFGAFLLEV-ACGRRP 463
           PE     + TT++DV+ F   + E+ + G++P
Sbjct: 195 PESINFRRFTTASDVWMFAVCMWEILSFGKQP 226

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/192 (27%), Positives = 91/192 (47%), Gaps = 6/192 (3%)
Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMK-EFVAEIVSIGRLRHRNLVQLLG 325
           E +G G FG V+ G L      +AVK         +K +F+ E   + +  H N+V+L+G
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 326 YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVI 385
            C +K  + +V + +  G    +L  +    L      +++   A G+ YL     +  I
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLE---SKCCI 235
Query: 386 HRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT-LGYLAPEHTRTGKATTS 444
           HRD+ A N L+  +   ++ DFG++R    G    +  +    + + APE    G+ ++ 
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSE 295
Query: 445 ADVFSFGAFLLE 456
           +DV+SFG  L E
Sbjct: 296 SDVWSFGILLWE 307

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 102/212 (48%), Gaps = 12/212 (5%)
Query: 258 IATKGFREKELLGTGGFGRVYRGTLPK---SQIEIAVKKISHESRQGMKE-FVAEIVSIG 313
           IA +      +LG G FG VY G        +I +AVK    +     KE F++E V + 
Sbjct: 5   IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMK 64
Query: 314 RLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGL 373
            L H ++V+L+G    +   +++  Y P G L  YL ++ K +L  +        +   +
Sbjct: 65  NLDHPHIVKLIGIIEEEPTWIIMELY-PYGELGHYL-ERNKNSLKVLTLVLYSLQICKAM 122
Query: 374 FYLHQEWEQV-VIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLA 432
            YL    E +  +HRD+   N+L+      +LGDFGL+R  +     + +     + +++
Sbjct: 123 AYL----ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMS 178
Query: 433 PEHTRTGKATTSADVFSFGAFLLEV-ACGRRP 463
           PE     + TT++DV+ F   + E+ + G++P
Sbjct: 179 PESINFRRFTTASDVWMFAVCMWEILSFGKQP 210

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 94/205 (45%), Gaps = 7/205 (3%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCR 328
           +G G  G V       S  ++AVK +    +Q  +    E+V +   +H N+V++     
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112
Query: 329 RKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRD 388
              EL ++ +++  G+L   +    +V LN  Q   V + V   L YLH    Q VIHRD
Sbjct: 113 VGEELWVLMEFLQGGALTDIV---SQVRLNEEQIATVCEAVLQALAYLH---AQGVIHRD 166
Query: 389 VKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVF 448
           +K+ ++LL  +   +L DFG          P+   +VGT  ++APE        T  D++
Sbjct: 167 IKSDSILLTLDGRVKLSDFGFCAQISKDV-PKRKXLVGTPYWMAPEVISRSLYATEVDIW 225
Query: 449 SFGAFLLEVACGRRPIQRQGPSENL 473
           S G  ++E+  G  P     P + +
Sbjct: 226 SLGIMVIEMVDGEPPYFSDSPVQAM 250

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 106/228 (46%), Gaps = 21/228 (9%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRL-RHRNLV 321
           F   EL+G G +G+VY+G   K+  ++A  K+   +    +E   EI  + +   HRN+ 
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTG-QLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIA 84
Query: 322 QLLGYCRRKG------ELLLVYDYMPNGSLDKYLYDQPKVTLN--WIQRFRVIKGVALGL 373
              G   +K       +L LV ++   GS+   + +    TL   WI    + + +  GL
Sbjct: 85  TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGL 142
Query: 374 FYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAP 433
            +LHQ     VIHRD+K  NVLL      +L DFG++   D     + T  +GT  ++AP
Sbjct: 143 SHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-FIGTPYWMAP 198
Query: 434 EHTRTGKATTS-----ADVFSFGAFLLEVACGRRPIQRQGPSENLILV 476
           E     +   +     +D++S G   +E+A G  P+    P   L L+
Sbjct: 199 EVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI 246

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 109/212 (51%), Gaps = 20/212 (9%)
Query: 259 ATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR-QGMKEF-VAEIVSIGRLR 316
           + + F++ E +G G +G VY+     +   +A+KKI  ++  +G+    + EI  +  L 
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN 63
Query: 317 HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVT---LNWIQR--FRVIKGVAL 371
           H N+V+LL     + +L LV++++      K   D   +T   L  I+   F++++G+A 
Sbjct: 64  HPNIVKLLDVIHTENKLYLVFEFLHQDL--KTFMDASALTGIPLPLIKSYLFQLLQGLA- 120
Query: 372 GLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQT-THVVGTLGY 430
              + H      V+HRD+K  N+L++ E   +L DFGLAR +  G   +T  H V TL Y
Sbjct: 121 ---FCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWY 172
Query: 431 LAPEHTRTGK-ATTSADVFSFGAFLLEVACGR 461
            APE     K  +T+ D++S G    E+   R
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 97/213 (45%), Gaps = 12/213 (5%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKI--SHESRQGMKEFVAEIVSIGRLRHRNL 320
           +R  + +G G F +V       +  E+AVK I  +  +   +++   E+  +  L H N+
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 321 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQ-RFRVIKGVALGLFYLHQE 379
           V+L      +  L LV +Y   G +  YL    ++     + +FR I      + Y HQ+
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQI---VSAVQYCHQK 132
Query: 380 WEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTG 439
           +   ++HRD+KA N+LLD ++N ++ DFG +  +  G   +     G   Y APE  +  
Sbjct: 133 F---IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGN--KLDAFCGAPPYAAPELFQGK 187
Query: 440 KAT-TSADVFSFGAFLLEVACGRRPIQRQGPSE 471
           K      DV+S G  L  +  G  P   Q   E
Sbjct: 188 KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE 220

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 109/215 (50%), Gaps = 26/215 (12%)
Query: 263 FREKELLGTGGFGRVYRGT-LP---KSQIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRH 317
           F++ ++L +G FG VY+G  +P   K +I +A+K++    S +  KE + E   +  + +
Sbjct: 24  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 318 RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQP-----KVTLNWIQRFRVIKGVALG 372
            ++ +LLG C     + L+   MP G L  Y+ +       +  LNW  +      +A G
Sbjct: 84  PHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 136
Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVG---TLG 429
           + YL    ++ ++HRD+ A NVL+    + ++ DFGLA+L   G + +  H  G    + 
Sbjct: 137 MNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVPIK 191
Query: 430 YLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRP 463
           ++A E       T  +DV+S+G  + E+   G +P
Sbjct: 192 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 226

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 109/215 (50%), Gaps = 26/215 (12%)
Query: 263 FREKELLGTGGFGRVYRGT-LP---KSQIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRH 317
           F++ ++LG+G FG VY+G  +P   K +I +A+K++    S +  KE + E   +  + +
Sbjct: 21  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 80
Query: 318 RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQP-----KVTLNWIQRFRVIKGVALG 372
            ++ +LLG C     + L+   MP G L  Y+ +       +  LNW  +      +A G
Sbjct: 81  PHVCRLLGICL-TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 133
Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVG---TLG 429
           + YL    ++ ++HRD+ A NVL+    + ++ DFG A+L   G + +  H  G    + 
Sbjct: 134 MNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLL--GAEEKEYHAEGGKVPIK 188
Query: 430 YLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRP 463
           ++A E       T  +DV+S+G  + E+   G +P
Sbjct: 189 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 223

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 94/202 (46%), Gaps = 15/202 (7%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKI--SHESRQGMKEFVAEIVSI-GRLRHRNLVQLLG 325
           LG G FG VY     +S+  +A+K +  +   + G++  +   V I   LRH N+++L G
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 326 YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVI 385
           Y      + L+ +Y P G++ + L  Q     +  +    I  +A  L Y H    + VI
Sbjct: 80  YFHDATRVYLILEYAPLGTVYREL--QKLSRFDEQRTATYITELANALSYCHS---KRVI 134
Query: 386 HRDVKASNVLL--DGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATT 443
           HRD+K  N+LL  +GEL  ++ DFG +    H    +   + GTL YL PE         
Sbjct: 135 HRDIKPENLLLGSNGEL--KIADFGWS---VHAPSSRRDTLCGTLDYLPPEMIEGRMHDE 189
Query: 444 SADVFSFGAFLLEVACGRRPIQ 465
             D++S G    E   G  P +
Sbjct: 190 KVDLWSLGVLCYEFLVGMPPFE 211

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 102/212 (48%), Gaps = 12/212 (5%)
Query: 258 IATKGFREKELLGTGGFGRVYRGTLPK---SQIEIAVKKISHESRQGMKE-FVAEIVSIG 313
           IA +      +LG G FG VY G        +I +AVK    +     KE F++E V + 
Sbjct: 9   IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMK 68
Query: 314 RLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGL 373
            L H ++V+L+G    +   +++  Y P G L  YL ++ K +L  +        +   +
Sbjct: 69  NLDHPHIVKLIGIIEEEPTWIIMELY-PYGELGHYL-ERNKNSLKVLTLVLYSLQICKAM 126
Query: 374 FYLHQEWEQV-VIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLA 432
            YL    E +  +HRD+   N+L+      +LGDFGL+R  +     + +     + +++
Sbjct: 127 AYL----ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMS 182
Query: 433 PEHTRTGKATTSADVFSFGAFLLEV-ACGRRP 463
           PE     + TT++DV+ F   + E+ + G++P
Sbjct: 183 PESINFRRFTTASDVWMFAVCMWEILSFGKQP 214

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 109/215 (50%), Gaps = 26/215 (12%)
Query: 263 FREKELLGTGGFGRVYRGT-LP---KSQIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRH 317
           F++ ++LG+G FG VY+G  +P   K +I +A+K++    S +  KE + E   +  + +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 318 RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQP-----KVTLNWIQRFRVIKGVALG 372
            ++ +LLG C     + L+   MP G L  Y+ +       +  LNW  +      +A G
Sbjct: 79  PHVCRLLGICL-TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 131
Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVG---TLG 429
           + YL    ++ ++HRD+ A NVL+    + ++ DFG A+L   G + +  H  G    + 
Sbjct: 132 MNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLL--GAEEKEYHAEGGKVPIK 186
Query: 430 YLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRP 463
           ++A E       T  +DV+S+G  + E+   G +P
Sbjct: 187 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 221

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 109/215 (50%), Gaps = 26/215 (12%)
Query: 263 FREKELLGTGGFGRVYRGT-LP---KSQIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRH 317
           F++ ++LG+G FG VY+G  +P   K +I +A+K++    S +  KE + E   +  + +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 318 RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQP-----KVTLNWIQRFRVIKGVALG 372
            ++ +LLG C     + L+   MP G L  Y+ +       +  LNW  +      +A G
Sbjct: 79  PHVCRLLGICL-TSTVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 131
Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVG---TLG 429
           + YL    ++ ++HRD+ A NVL+    + ++ DFG A+L   G + +  H  G    + 
Sbjct: 132 MNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLL--GAEEKEYHAEGGKVPIK 186
Query: 430 YLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRP 463
           ++A E       T  +DV+S+G  + E+   G +P
Sbjct: 187 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 221

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 100/205 (48%), Gaps = 17/205 (8%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKIS-HESRQGMKEFVAEIVSIGRLRHRNLVQLLGYC 327
           +G G +G V       +++ +A+KKIS  E +   +  + EI  + R RH N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 328 R-----RKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQ 382
           R     +  ++ +V D M    L K L  Q  ++ + I  F  +  +  GL Y+H     
Sbjct: 91  RAPTIEQMKDVYIVQDLM-ETDLYKLLKTQ-HLSNDHICYF--LYQILRGLKYIHS---A 143
Query: 383 VVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ--TTHVVGTLGYLAPEHTRTGK 440
            V+HRD+K SN+LL+   + ++ DFGLAR+ D   D     T  V T  Y APE     K
Sbjct: 144 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 203
Query: 441 A-TTSADVFSFGAFLLEVACGRRPI 464
             T S D++S G  L E+    RPI
Sbjct: 204 GYTKSIDIWSVGCILAEML-SNRPI 227

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 109/215 (50%), Gaps = 26/215 (12%)
Query: 263 FREKELLGTGGFGRVYRGT-LP---KSQIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRH 317
           F++ ++L +G FG VY+G  +P   K +I +A+K++    S +  KE + E   +  + +
Sbjct: 17  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 318 RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQP-----KVTLNWIQRFRVIKGVALG 372
            ++ +LLG C     + L+   MP G L  Y+ +       +  LNW  +      +A G
Sbjct: 77  PHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 129
Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVG---TLG 429
           + YL    ++ ++HRD+ A NVL+    + ++ DFGLA+L   G + +  H  G    + 
Sbjct: 130 MNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVPIK 184
Query: 430 YLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRP 463
           ++A E       T  +DV+S+G  + E+   G +P
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 100/205 (48%), Gaps = 17/205 (8%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKIS-HESRQGMKEFVAEIVSIGRLRHRNLVQLLGYC 327
           +G G +G V       +++ +A+KKIS  E +   +  + EI  + R RH N++ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 92
Query: 328 R-----RKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQ 382
           R     +  ++ +V D M    L K L  Q  ++ + I  F  +  +  GL Y+H     
Sbjct: 93  RAPTIEQMKDVYIVQDLM-ETDLYKLLKTQ-HLSNDHICYF--LYQILRGLKYIHS---A 145
Query: 383 VVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ--TTHVVGTLGYLAPEHTRTGK 440
            V+HRD+K SN+LL+   + ++ DFGLAR+ D   D     T  V T  Y APE     K
Sbjct: 146 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 205
Query: 441 A-TTSADVFSFGAFLLEVACGRRPI 464
             T S D++S G  L E+    RPI
Sbjct: 206 GYTKSIDIWSVGCILAEML-SNRPI 229

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 97/218 (44%), Gaps = 14/218 (6%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKI--SHESRQGMK-EFVAEIVSIGRLRHRNLVQLLG 325
           LG G FG VY     +++  +A+K +  S   ++G++ +   EI     LRH N++++  
Sbjct: 23  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 82
Query: 326 YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVI 385
           Y   +  + L+ ++ P G L K L    +        F  ++ +A  L Y H   E+ VI
Sbjct: 83  YFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATF--MEELADALHYCH---ERKVI 137
Query: 386 HRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSA 445
           HRD+K  N+L+  +   ++ DFG +    H    +   + GTL YL PE           
Sbjct: 138 HRDIKPENLLMGYKGELKIADFGWSV---HAPSLRRRXMCGTLDYLPPEMIEGKTHDEKV 194
Query: 446 DVFSFGAFLLEVACGRRPIQRQGPSEN---LILVDWVF 480
           D++  G    E   G  P      +E    ++ VD  F
Sbjct: 195 DLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKF 232

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 99/199 (49%), Gaps = 16/199 (8%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMK-EFVAEIVSIGRLRHRNLVQLLGYC 327
           LG G +  VY+G    +   +A+K+I  E  +G     + E+  +  L+H N+V L    
Sbjct: 10  LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDII 69
Query: 328 RRKGELLLVYDYMPNGSLDKYLYDQPKVTLNW----IQRFRVIKGVALGLFYLHQEWEQV 383
             +  L LV++Y+ +  L +YL D   + +N     +  F++++G+A    Y H+   Q 
Sbjct: 70  HTEKSLTLVFEYL-DKDLKQYLDDCGNI-INMHNVKLFLFQLLRGLA----YCHR---QK 120
Query: 384 VIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTR-TGKAT 442
           V+HRD+K  N+L++     +L DFGLAR     T      VV TL Y  P+    +   +
Sbjct: 121 VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRPPDILLGSTDYS 179
Query: 443 TSADVFSFGAFLLEVACGR 461
           T  D++  G    E+A GR
Sbjct: 180 TQIDMWGVGCIFYEMATGR 198

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 109/215 (50%), Gaps = 26/215 (12%)
Query: 263 FREKELLGTGGFGRVYRGT-LP---KSQIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRH 317
           F++ ++LG+G FG VY+G  +P   K +I +A+K++    S +  KE + E   +  + +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 318 RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQP-----KVTLNWIQRFRVIKGVALG 372
            ++ +LLG C     + L+   MP G L  Y+ +       +  LNW  +      +A G
Sbjct: 77  PHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 129
Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVG---TLG 429
           + YL    ++ ++HRD+ A NVL+    + ++ DFG A+L   G + +  H  G    + 
Sbjct: 130 MNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLL--GAEEKEYHAEGGKVPIK 184
Query: 430 YLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRP 463
           ++A E       T  +DV+S+G  + E+   G +P
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 97/218 (44%), Gaps = 14/218 (6%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKI--SHESRQGMK-EFVAEIVSIGRLRHRNLVQLLG 325
           LG G FG VY     +++  +A+K +  S   ++G++ +   EI     LRH N++++  
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 326 YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVI 385
           Y   +  + L+ ++ P G L K L    +        F  ++ +A  L Y H   E+ VI
Sbjct: 82  YFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATF--MEELADALHYCH---ERKVI 136
Query: 386 HRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSA 445
           HRD+K  N+L+  +   ++ DFG +    H    +   + GTL YL PE           
Sbjct: 137 HRDIKPENLLMGYKGELKIADFGWSV---HAPSLRRRXMCGTLDYLPPEMIEGKTHDEKV 193
Query: 446 DVFSFGAFLLEVACGRRPIQRQGPSEN---LILVDWVF 480
           D++  G    E   G  P      +E    ++ VD  F
Sbjct: 194 DLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKF 231

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 99/216 (45%), Gaps = 7/216 (3%)
Query: 261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNL 320
           K +   E +G G  G VY      +  E+A+++++ + +   +  + EI+ +   ++ N+
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 79
Query: 321 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEW 380
           V  L       EL +V +Y+  GSL   + +     ++  Q   V +     L +LH   
Sbjct: 80  VNYLDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 381 EQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGK 440
              VIHRD+K+ N+LL  + + +L DFG           ++T +VGT  ++APE      
Sbjct: 137 ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRKA 192
Query: 441 ATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILV 476
                D++S G   +E+  G  P   + P   L L+
Sbjct: 193 YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI 228

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 109/215 (50%), Gaps = 26/215 (12%)
Query: 263 FREKELLGTGGFGRVYRGT-LP---KSQIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRH 317
           F++ ++LG+G FG VY+G  +P   K +I +A+ ++    S +  KE + E   +  + +
Sbjct: 51  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDN 110
Query: 318 RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQP-----KVTLNWIQRFRVIKGVALG 372
            ++ +LLG C     + L+   MP G L  Y+ +       +  LNW  +      +A G
Sbjct: 111 PHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 163
Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVG---TLG 429
           + YL    ++ ++HRD+ A NVL+    + ++ DFGLA+L   G + +  H  G    + 
Sbjct: 164 MNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL--GAEEKEYHAEGGKVPIK 218
Query: 430 YLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRP 463
           ++A E       T  +DV+S+G  + E+   G +P
Sbjct: 219 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 253

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 70/284 (24%), Positives = 123/284 (43%), Gaps = 38/284 (13%)
Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
           EL+G G FG+VY G     ++ I +  I  ++   +K F  E+++  + RH N+V  +G 
Sbjct: 39  ELIGKGRFGQVYHGRW-HGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGA 97
Query: 327 CRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIH 386
           C     L ++       +L   + D  K+ L+  +  ++ + +  G+ YLH    + ++H
Sbjct: 98  CMSPPHLAIITSLCKGRTLYSVVRD-AKIVLDVNKTRQIAQEIVKGMGYLHA---KGILH 153
Query: 387 RDVKASNVLLDGELNGR--LGDFGL---ARLYDHGTDPQTTHVV-GTLGYLAPEHTRTGK 440
           +D+K+ NV  D   NG+  + DFGL   + +   G       +  G L +LAPE  R   
Sbjct: 154 KDLKSKNVFYD---NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210
Query: 441 ATTS---------ADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEA 491
             T          +DVF+ G    E+     P + Q P+E +I        W  G  ++ 
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ-PAEAII--------WQMGTGMK- 260
Query: 492 RDPNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQILER 535
             PNL                  C   +   RP+  +++ +LE+
Sbjct: 261 --PNLSQ---IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEK 299

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 109/215 (50%), Gaps = 26/215 (12%)
Query: 263 FREKELLGTGGFGRVYRGT-LP---KSQIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRH 317
           F++ ++LG+G FG VY+G  +P   K +I +A+K++    S +  KE + E   +  + +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 318 RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQP-----KVTLNWIQRFRVIKGVALG 372
            ++ +LLG C     + L+   MP G L  Y+ +       +  LNW  +      +A G
Sbjct: 79  PHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 131
Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVG---TLG 429
           + YL    ++ ++HRD+ A NVL+    + ++ DFG A+L   G + +  H  G    + 
Sbjct: 132 MNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLL--GAEEKEYHAEGGKVPIK 186
Query: 430 YLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRP 463
           ++A E       T  +DV+S+G  + E+   G +P
Sbjct: 187 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 221

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 100/205 (48%), Gaps = 17/205 (8%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKIS-HESRQGMKEFVAEIVSIGRLRHRNLVQLLGYC 327
           +G G +G V       +++ +A+KKIS  E +   +  + EI  + R RH N++ +    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 328 R-----RKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQ 382
           R     +  ++ +V D M    L K L  Q  ++ + I  F  +  +  GL Y+H     
Sbjct: 89  RAPTIEQMKDVYIVQDLM-ETDLYKLLKTQ-HLSNDHICYF--LYQILRGLKYIHS---A 141
Query: 383 VVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ--TTHVVGTLGYLAPEHTRTGK 440
            V+HRD+K SN+LL+   + ++ DFGLAR+ D   D     T  V T  Y APE     K
Sbjct: 142 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 201
Query: 441 A-TTSADVFSFGAFLLEVACGRRPI 464
             T S D++S G  L E+    RPI
Sbjct: 202 GYTKSIDIWSVGCILAEML-SNRPI 225

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 109/215 (50%), Gaps = 26/215 (12%)
Query: 263 FREKELLGTGGFGRVYRGT-LP---KSQIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRH 317
           F++ ++LG+G FG VY+G  +P   K +I +A+K++    S +  KE + E   +  + +
Sbjct: 24  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 318 RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQP-----KVTLNWIQRFRVIKGVALG 372
            ++ +LLG C     + L+   MP G L  Y+ +       +  LNW  +      +A G
Sbjct: 84  PHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 136
Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVG---TLG 429
           + YL    ++ ++HRD+ A NVL+    + ++ DFG A+L   G + +  H  G    + 
Sbjct: 137 MNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLL--GAEEKEYHAEGGKVPIK 191
Query: 430 YLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRP 463
           ++A E       T  +DV+S+G  + E+   G +P
Sbjct: 192 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 226

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 49/211 (23%), Positives = 100/211 (47%), Gaps = 25/211 (11%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQ 322
           F+E EL+G+GGFG+V++           +K++ + + +  +    E+ ++ +L H N+V 
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAER----EVKALAKLDHVNIVH 68
Query: 323 LLGY---------------CRRKGELLLV-YDYMPNGSLDKYLYDQPKVTLNWIQRFRVI 366
             G                 R K + L +  ++   G+L++++  +    L+ +    + 
Sbjct: 69  YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELF 128
Query: 367 KGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVG 426
           + +  G+ Y+H    + +I+RD+K SN+ L      ++GDFGL     +  D +     G
Sbjct: 129 EQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKN--DGKRXRSKG 183
Query: 427 TLGYLAPEHTRTGKATTSADVFSFGAFLLEV 457
           TL Y++PE   +       D+++ G  L E+
Sbjct: 184 TLRYMSPEQISSQDYGKEVDLYALGLILAEL 214

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 111/239 (46%), Gaps = 22/239 (9%)
Query: 246 HGPHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQI---EIAVKKISH---ESR 299
            GP  F      I +  ++ + +LG G FG V    L K +I   E AVK IS    + +
Sbjct: 17  QGPGMFVQHSTAIFSDRYKGQRVLGKGSFGEV---ILCKDKITGQECAVKVISKRQVKQK 73
Query: 300 QGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNW 359
              +  + E+  + +L H N+++L  +   KG   LV +    G L   +  + +   + 
Sbjct: 74  TDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR--FSE 131
Query: 360 IQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDG---ELNGRLGDFGLARLYDHG 416
           +   R+I+ V  G+ Y+H+     ++HRD+K  N+LL+    + N R+ DFGL+  ++  
Sbjct: 132 VDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE-- 186
Query: 417 TDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLIL 475
              +    +GT  Y+APE    G      DV+S G  L  +  G  P    G +E  IL
Sbjct: 187 ASKKMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPPF--NGANEYDIL 242

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 100/205 (48%), Gaps = 17/205 (8%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKIS-HESRQGMKEFVAEIVSIGRLRHRNLVQLLGYC 327
           +G G +G V       +++ +A+KKIS  E +   +  + EI  + R RH N++ +    
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 98
Query: 328 R-----RKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQ 382
           R     +  ++ +V D M    L K L  Q  ++ + I  F  +  +  GL Y+H     
Sbjct: 99  RAPTIEQMKDVYIVQDLM-ETDLYKLLKTQ-HLSNDHICYF--LYQILRGLKYIHS---A 151
Query: 383 VVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ--TTHVVGTLGYLAPEHTRTGK 440
            V+HRD+K SN+LL+   + ++ DFGLAR+ D   D     T  V T  Y APE     K
Sbjct: 152 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 211
Query: 441 A-TTSADVFSFGAFLLEVACGRRPI 464
             T S D++S G  L E+    RPI
Sbjct: 212 GYTKSIDIWSVGCILAEML-SNRPI 235

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 100/205 (48%), Gaps = 17/205 (8%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKIS-HESRQGMKEFVAEIVSIGRLRHRNLVQLLGYC 327
           +G G +G V       +++ +A+KKIS  E +   +  + EI  + R RH N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 328 R-----RKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQ 382
           R     +  ++ +V D M    L K L  Q  ++ + I  F  +  +  GL Y+H     
Sbjct: 91  RAPTIEQMKDVYIVQDLM-ETDLYKLLKTQ-HLSNDHICYF--LYQILRGLKYIHS---A 143
Query: 383 VVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ--TTHVVGTLGYLAPEHTRTGK 440
            V+HRD+K SN+LL+   + ++ DFGLAR+ D   D     T  V T  Y APE     K
Sbjct: 144 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 203
Query: 441 A-TTSADVFSFGAFLLEVACGRRPI 464
             T S D++S G  L E+    RPI
Sbjct: 204 GYTKSIDIWSVGCILAEML-SNRPI 227

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 100/205 (48%), Gaps = 17/205 (8%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKIS-HESRQGMKEFVAEIVSIGRLRHRNLVQLLGYC 327
           +G G +G V       +++ +A+KKIS  E +   +  + EI  + R RH N++ +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 328 R-----RKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQ 382
           R     +  ++ +V D M    L K L  Q  ++ + I  F  +  +  GL Y+H     
Sbjct: 96  RAPTIEQMKDVYIVQDLM-ETDLYKLLKTQ-HLSNDHICYF--LYQILRGLKYIHS---A 148
Query: 383 VVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ--TTHVVGTLGYLAPEHTRTGK 440
            V+HRD+K SN+LL+   + ++ DFGLAR+ D   D     T  V T  Y APE     K
Sbjct: 149 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 208
Query: 441 A-TTSADVFSFGAFLLEVACGRRPI 464
             T S D++S G  L E+    RPI
Sbjct: 209 GYTKSIDIWSVGCILAEML-SNRPI 232

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 100/205 (48%), Gaps = 17/205 (8%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKIS-HESRQGMKEFVAEIVSIGRLRHRNLVQLLGYC 327
           +G G +G V       +++ +A+KKIS  E +   +  + EI  + R RH N++ +    
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 96
Query: 328 R-----RKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQ 382
           R     +  ++ +V D M    L K L  Q  ++ + I  F  +  +  GL Y+H     
Sbjct: 97  RAPTIEQMKDVYIVQDLM-ETDLYKLLKTQ-HLSNDHICYF--LYQILRGLKYIHS---A 149
Query: 383 VVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ--TTHVVGTLGYLAPEHTRTGK 440
            V+HRD+K SN+LL+   + ++ DFGLAR+ D   D     T  V T  Y APE     K
Sbjct: 150 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 209
Query: 441 A-TTSADVFSFGAFLLEVACGRRPI 464
             T S D++S G  L E+    RPI
Sbjct: 210 GYTKSIDIWSVGCILAEML-SNRPI 233

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 100/205 (48%), Gaps = 17/205 (8%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKIS-HESRQGMKEFVAEIVSIGRLRHRNLVQLLGYC 327
           +G G +G V       +++ +A+KKIS  E +   +  + EI  + R RH N++ +    
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 87
Query: 328 R-----RKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQ 382
           R     +  ++ +V D M    L K L  Q  ++ + I  F  +  +  GL Y+H     
Sbjct: 88  RAPTIEQMKDVYIVQDLM-ETDLYKLLKTQ-HLSNDHICYF--LYQILRGLKYIHS---A 140
Query: 383 VVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ--TTHVVGTLGYLAPEHTRTGK 440
            V+HRD+K SN+LL+   + ++ DFGLAR+ D   D     T  V T  Y APE     K
Sbjct: 141 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 200
Query: 441 A-TTSADVFSFGAFLLEVACGRRPI 464
             T S D++S G  L E+    RPI
Sbjct: 201 GYTKSIDIWSVGCILAEML-SNRPI 224

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 100/205 (48%), Gaps = 17/205 (8%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKIS-HESRQGMKEFVAEIVSIGRLRHRNLVQLLGYC 327
           +G G +G V       +++ +A+KKIS  E +   +  + EI  + R RH N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 328 R-----RKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQ 382
           R     +  ++ +V D M    L K L  Q  ++ + I  F  +  +  GL Y+H     
Sbjct: 95  RAPTIEQMKDVYIVQDLM-ETDLYKLLKTQ-HLSNDHICYF--LYQILRGLKYIHS---A 147
Query: 383 VVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ--TTHVVGTLGYLAPEHTRTGK 440
            V+HRD+K SN+LL+   + ++ DFGLAR+ D   D     T  V T  Y APE     K
Sbjct: 148 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 207
Query: 441 A-TTSADVFSFGAFLLEVACGRRPI 464
             T S D++S G  L E+    RPI
Sbjct: 208 GYTKSIDIWSVGCILAEML-SNRPI 231

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 100/205 (48%), Gaps = 17/205 (8%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKIS-HESRQGMKEFVAEIVSIGRLRHRNLVQLLGYC 327
           +G G +G V       +++ +A+KKIS  E +   +  + EI  + R RH N++ +    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 328 R-----RKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQ 382
           R     +  ++ +V D M    L K L  Q  ++ + I  F  +  +  GL Y+H     
Sbjct: 89  RAPTIEQMKDVYIVQDLM-ETDLYKLLKTQ-HLSNDHICYF--LYQILRGLKYIHS---A 141
Query: 383 VVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ--TTHVVGTLGYLAPEHTRTGK 440
            V+HRD+K SN+LL+   + ++ DFGLAR+ D   D     T  V T  Y APE     K
Sbjct: 142 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 201
Query: 441 A-TTSADVFSFGAFLLEVACGRRPI 464
             T S D++S G  L E+    RPI
Sbjct: 202 GYTKSIDIWSVGCILAEML-SNRPI 225

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 100/205 (48%), Gaps = 17/205 (8%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKIS-HESRQGMKEFVAEIVSIGRLRHRNLVQLLGYC 327
           +G G +G V       +++ +A+KKIS  E +   +  + EI  + R RH N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 328 R-----RKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQ 382
           R     +  ++ +V D M    L K L  Q  ++ + I  F  +  +  GL Y+H     
Sbjct: 91  RAPTIEQMKDVYIVQDLM-ETDLYKLLKTQ-HLSNDHICYF--LYQILRGLKYIHS---A 143
Query: 383 VVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ--TTHVVGTLGYLAPEHTRTGK 440
            V+HRD+K SN+LL+   + ++ DFGLAR+ D   D     T  V T  Y APE     K
Sbjct: 144 NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 203
Query: 441 A-TTSADVFSFGAFLLEVACGRRPI 464
             T S D++S G  L E+    RPI
Sbjct: 204 GYTKSIDIWSVGCILAEML-SNRPI 227

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 100/205 (48%), Gaps = 17/205 (8%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKIS-HESRQGMKEFVAEIVSIGRLRHRNLVQLLGYC 327
           +G G +G V       +++ +A+KKIS  E +   +  + EI  + R RH N++ +    
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 328 R-----RKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQ 382
           R     +  ++ +V D M    L K L  Q  ++ + I  F  +  +  GL Y+H     
Sbjct: 111 RAPTIEQMKDVYIVQDLM-ETDLYKLLKTQ-HLSNDHICYF--LYQILRGLKYIHS---A 163
Query: 383 VVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ--TTHVVGTLGYLAPEHTRTGK 440
            V+HRD+K SN+LL+   + ++ DFGLAR+ D   D     T  V T  Y APE     K
Sbjct: 164 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 223
Query: 441 A-TTSADVFSFGAFLLEVACGRRPI 464
             T S D++S G  L E+    RPI
Sbjct: 224 GYTKSIDIWSVGCILAEML-SNRPI 247

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 100/205 (48%), Gaps = 17/205 (8%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKIS-HESRQGMKEFVAEIVSIGRLRHRNLVQLLGYC 327
           +G G +G V       +++ +A+KKIS  E +   +  + EI  + R RH N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 328 R-----RKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQ 382
           R     +  ++ +V D M    L K L  Q  ++ + I  F  +  +  GL Y+H     
Sbjct: 91  RAPTIEQMKDVYIVQDLM-ETDLYKLLKTQ-HLSNDHICYF--LYQILRGLKYIHS---A 143
Query: 383 VVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ--TTHVVGTLGYLAPEHTRTGK 440
            V+HRD+K SN+LL+   + ++ DFGLAR+ D   D     T  V T  Y APE     K
Sbjct: 144 NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 203
Query: 441 A-TTSADVFSFGAFLLEVACGRRPI 464
             T S D++S G  L E+    RPI
Sbjct: 204 GYTKSIDIWSVGCILAEM-LSNRPI 227

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 93/201 (46%), Gaps = 10/201 (4%)
Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGR-LRHRNLVQLLG 325
           + LG G +G V       ++  +AVK +  +      E + + + I + L H N+V+  G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 326 YCRRKGEL-LLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVV 384
           + RR+G +  L  +Y   G L   +  +P + +      R    +  G+ YLH      +
Sbjct: 73  H-RREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLHG---IGI 126
Query: 385 IHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ-TTHVVGTLGYLAPE-HTRTGKAT 442
            HRD+K  N+LLD   N ++ DFGLA ++ +    +    + GTL Y+APE   R     
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 443 TSADVFSFGAFLLEVACGRRP 463
              DV+S G  L  +  G  P
Sbjct: 187 EPVDVWSCGIVLTAMLAGELP 207

>pdb|3USU|B Chain B, Crystal Structure Of Butea Monosperma Seed Lectin Length = 242

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 50/152 (32%), Positives = 79/152 (51%), Gaps = 16/152 (10%)
Query: 37  GHGIAFVIASTRGLPGARPSQYLGLFNDTNLGNETNHVFAVELDTIKSHGFLDINDNHVG 96
             G+AF +A     P A  + +LGLF D+ + N +    AVE DT ++  FLD  D H+G
Sbjct: 88  ADGLAFFLAPVSSPPKAG-AGFLGLF-DSAVFNSSYQTVAVEFDTYENTVFLDPPDTHIG 145
Query: 97  IDINSLKSESSA--------PAGYYVEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLS 148
           ID+NS+KS  +          A   + YD   K   + +A +  P  ++   +S   DL 
Sbjct: 146 IDVNSIKSIKTVKWDLANGEAAKVLITYDSSAK---LLVAALVYPSSKTSFILSDVVDLK 202
Query: 149 SVLNDAMYVGFSSSTGS---VLASHYILGWSF 177
           SVL + + +GFS++TG+    + +H +  WSF
Sbjct: 203 SVLPEWVSIGFSAATGASSGYIETHDVFSWSF 234

>pdb|3USU|A Chain A, Crystal Structure Of Butea Monosperma Seed Lectin Length = 256

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 50/152 (32%), Positives = 79/152 (51%), Gaps = 16/152 (10%)
Query: 37  GHGIAFVIASTRGLPGARPSQYLGLFNDTNLGNETNHVFAVELDTIKSHGFLDINDNHVG 96
             G+AF +A     P A  + +LGLF D+ + N +    AVE DT ++  FLD  D H+G
Sbjct: 88  ADGLAFFLAPVSSPPKAG-AGFLGLF-DSAVFNSSYQTVAVEFDTYENTVFLDPPDTHIG 145
Query: 97  IDINSLKSESSA--------PAGYYVEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLS 148
           ID+NS+KS  +          A   + YD   K   + +A +  P  ++   +S   DL 
Sbjct: 146 IDVNSIKSIKTVKWDLANGEAAKVLITYDSSAK---LLVAALVYPSSKTSFILSDVVDLK 202
Query: 149 SVLNDAMYVGFSSSTGS---VLASHYILGWSF 177
           SVL + + +GFS++TG+    + +H +  WSF
Sbjct: 203 SVLPEWVSIGFSAATGASSGYIETHDVFSWSF 234

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 100/205 (48%), Gaps = 17/205 (8%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKIS-HESRQGMKEFVAEIVSIGRLRHRNLVQLLGYC 327
           +G G +G V       +++ +A+KKIS  E +   +  + EI  + R RH N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 328 R-----RKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQ 382
           R     +  ++ +V D M    L K L  Q  ++ + I  F  +  +  GL Y+H     
Sbjct: 91  RAPTIEQMKDVYIVQDLM-ETDLYKLLKTQ-HLSNDHICYF--LYQILRGLKYIHS---A 143
Query: 383 VVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ--TTHVVGTLGYLAPEHTRTGK 440
            V+HRD+K SN+LL+   + ++ DFGLAR+ D   D     T  V T  Y APE     K
Sbjct: 144 NVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 203
Query: 441 A-TTSADVFSFGAFLLEVACGRRPI 464
             T S D++S G  L E+    RPI
Sbjct: 204 GYTKSIDIWSVGCILAEM-LSNRPI 227

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 94/212 (44%), Gaps = 14/212 (6%)
Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMK---EFVAEIVSIGRLRHRNLVQL 323
           E+LG GG   V+     +   ++AVK +  +  +       F  E  +   L H  +V +
Sbjct: 18  EILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 324 LGYCRRK---GEL-LLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQE 379
                 +   G L  +V +Y+   +L   ++ +  +T    +   VI      L + HQ 
Sbjct: 78  YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPK--RAIEVIADACQALNFSHQN 135
Query: 380 WEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTD-PQTTHVVGTLGYLAPEHTR 437
               +IHRDVK +N+L+      ++ DFG+AR + D G    QT  V+GT  YL+PE  R
Sbjct: 136 G---IIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQAR 192
Query: 438 TGKATTSADVFSFGAFLLEVACGRRPIQRQGP 469
                  +DV+S G  L EV  G  P     P
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 100/205 (48%), Gaps = 17/205 (8%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKIS-HESRQGMKEFVAEIVSIGRLRHRNLVQLLGYC 327
           +G G +G V       +++ +A+KKIS  E +   +  + EI  + R RH N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 328 R-----RKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQ 382
           R     +  ++ +V D M    L K L  Q  ++ + I  F  +  +  GL Y+H     
Sbjct: 95  RAPTIEQMKDVYIVQDLM-ETDLYKLLKTQ-HLSNDHICYF--LYQILRGLKYIHS---A 147
Query: 383 VVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ--TTHVVGTLGYLAPEHTRTGK 440
            V+HRD+K SN+LL+   + ++ DFGLAR+ D   D     T  V T  Y APE     K
Sbjct: 148 NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 207
Query: 441 A-TTSADVFSFGAFLLEVACGRRPI 464
             T S D++S G  L E+    RPI
Sbjct: 208 GYTKSIDIWSVGCILAEML-SNRPI 231

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 93/201 (46%), Gaps = 10/201 (4%)
Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGR-LRHRNLVQLLG 325
           + LG G +G V       ++  +AVK +  +      E + + + I + L H N+V+  G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 326 YCRRKGEL-LLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVV 384
           + RR+G +  L  +Y   G L   +  +P + +      R    +  G+ YLH      +
Sbjct: 72  H-RREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLHG---IGI 125
Query: 385 IHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ-TTHVVGTLGYLAPE-HTRTGKAT 442
            HRD+K  N+LLD   N ++ DFGLA ++ +    +    + GTL Y+APE   R     
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 443 TSADVFSFGAFLLEVACGRRP 463
              DV+S G  L  +  G  P
Sbjct: 186 EPVDVWSCGIVLTAMLAGELP 206

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 72/298 (24%), Positives = 123/298 (41%), Gaps = 43/298 (14%)
Query: 249 HRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPK-------SQIEIAVKKISHESRQG 301
           H+ R +DL          E LG G F ++++G   +        + E+ +K +    R  
Sbjct: 3   HKIRNEDLIF-------NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNY 55
Query: 302 MKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQ 361
            + F      + +L H++LV   G C    E +LV +++  GSLD YL  + K  +N + 
Sbjct: 56  SESFFEAASMMSKLSHKHLVLNYGVCFCGDENILVQEFVKFGSLDTYL-KKNKNCINILW 114
Query: 362 RFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD--- 418
           +  V K +A  + +L    E  +IH +V A N+LL  E + + G+    +L D G     
Sbjct: 115 KLEVAKQLAWAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV 171
Query: 419 -PQTTHVVGTLGYLAPEHTRTGKATTSA-DVFSFGAFLLEVAC-GRRPIQRQGPSENLIL 475
            P+   +   + ++ PE     K    A D +SFG  L E+   G +P+        L  
Sbjct: 172 LPKDI-LQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQF 230
Query: 476 VDWVFDFWNRGELLEARDPNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQIL 533
            +      +R +L   +   L                  C   +P  RPS R +++ L
Sbjct: 231 YE------DRHQLPAPKAAELAN------------LINNCMDYEPDHRPSFRAIIRDL 270

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 100/205 (48%), Gaps = 17/205 (8%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKIS-HESRQGMKEFVAEIVSIGRLRHRNLVQLLGYC 327
           +G G +G V       +++ +A+KKIS  E +   +  + EI  + R RH N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 328 R-----RKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQ 382
           R     +  ++ +V D M    L K L  Q  ++ + I  F  +  +  GL Y+H     
Sbjct: 95  RAPTIEQMKDVYIVQDLM-ETDLYKLLKCQ-HLSNDHICYF--LYQILRGLKYIHS---A 147
Query: 383 VVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ--TTHVVGTLGYLAPEHTRTGK 440
            V+HRD+K SN+LL+   + ++ DFGLAR+ D   D     T  V T  Y APE     K
Sbjct: 148 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 207
Query: 441 A-TTSADVFSFGAFLLEVACGRRPI 464
             T S D++S G  L E+    RPI
Sbjct: 208 GYTKSIDIWSVGCILAEML-SNRPI 231

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 96/208 (46%), Gaps = 17/208 (8%)
Query: 263 FREKEL-----LGTGGFGRV----YRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIG 313
           F E+ L     LG G FG V    Y      +   +AVK++ H      ++F  EI  + 
Sbjct: 4   FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILK 63
Query: 314 RLRHRNLVQLLG--YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVAL 371
            L    +V+  G  Y   + EL LV +Y+P+G L  +L  + +  L+  +       +  
Sbjct: 64  ALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFL-QRHRARLDASRLLLYSSQICK 122
Query: 372 GLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT--LG 429
           G+ YL     +  +HRD+ A N+L++ E + ++ DFGLA+L     D       G   + 
Sbjct: 123 GMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIF 179
Query: 430 YLAPEHTRTGKATTSADVFSFGAFLLEV 457
           + APE       +  +DV+SFG  L E+
Sbjct: 180 WYAPESLSDNIFSRQSDVWSFGVVLYEL 207

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 100/205 (48%), Gaps = 17/205 (8%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKIS-HESRQGMKEFVAEIVSIGRLRHRNLVQLLGYC 327
           +G G +G V       +++ +A+KKIS  E +   +  + EI  + R RH N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGINDII 94
Query: 328 R-----RKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQ 382
           R     +  ++ +V D M    L K L  Q  ++ + I  F  +  +  GL Y+H     
Sbjct: 95  RAPTIEQMKDVYIVQDLM-ETDLYKLLKTQ-HLSNDHICYF--LYQILRGLKYIHS---A 147
Query: 383 VVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ--TTHVVGTLGYLAPEHTRTGK 440
            V+HRD+K SN+LL+   + ++ DFGLAR+ D   D     T  V T  Y APE     K
Sbjct: 148 NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 207
Query: 441 A-TTSADVFSFGAFLLEVACGRRPI 464
             T S D++S G  L E+    RPI
Sbjct: 208 GYTKSIDIWSVGCILAEM-LSNRPI 231

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 79/299 (26%), Positives = 129/299 (43%), Gaps = 43/299 (14%)
Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQG-MKEFVAEIVSIGRLRHRNLVQLLG 325
           E +G G +G V+RG        +AVK  S    Q   +E   EI +   LRH N++  + 
Sbjct: 14  ECVGKGRYGEVWRGLWHGE--SVAVKIFSSRDEQSWFRE--TEIYNTVLLRHDNILGFIA 69
Query: 326 --YCRRKG--ELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEW- 380
                R    +L L+  Y  +GSL  +L  Q   TL      R+    A GL +LH E  
Sbjct: 70  SDMTSRNSSTQLWLITHYHEHGSLYDFLQRQ---TLEPHLALRLAVSAACGLAHLHVEIF 126
Query: 381 ----EQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD-------PQTTHVVGTLG 429
               +  + HRD K+ NVL+   L   + D GLA ++  G+D       P+    VGT  
Sbjct: 127 GTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPR----VGTKR 182
Query: 430 YLAPE------HTRTGKATTSADVFSFGAFLLEVACGRRPI------QRQGPSENLILVD 477
           Y+APE       T   ++    D+++FG  L E+A  RR I        + P  +++  D
Sbjct: 183 YMAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEIA--RRTIVNGIVEDYRPPFYDVVPND 240
Query: 478 WVFDFWNRGELLEARDPNLGTEYVAXXXXX-XXXXXXXCSHSDPTARPSMRQVVQILER 535
             F+   +   ++ + P +     A             C + +P+AR +  ++ + L++
Sbjct: 241 PSFEDMKKVVCVDQQTPTIPNRLAADPVLSGLAQMMRECWYPNPSARLTALRIKKTLQK 299

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 72/298 (24%), Positives = 122/298 (40%), Gaps = 43/298 (14%)
Query: 249 HRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPK-------SQIEIAVKKISHESRQG 301
           H+ R +DL          E LG G F ++++G   +        + E+ +K +    R  
Sbjct: 3   HKIRNEDLIF-------NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNY 55
Query: 302 MKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQ 361
            + F      + +L H++LV   G C    E +LV +++  GSLD YL  + K  +N + 
Sbjct: 56  SESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYL-KKNKNCINILW 114
Query: 362 RFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD--- 418
           +  V K +A  + +L    E  +IH +V A N+LL  E + + G+    +L D G     
Sbjct: 115 KLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV 171
Query: 419 -PQTTHVVGTLGYLAPEHTRTGKATTSA-DVFSFGAFLLEVAC-GRRPIQRQGPSENLIL 475
            P+   +   + ++ PE     K    A D +SFG  L E+   G +P+           
Sbjct: 172 LPKDI-LQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLS---------- 220
Query: 476 VDWVFDFWNRGELLEARDPNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQIL 533
                D   + +  E R      +  A            C   +P  RPS R +++ L
Sbjct: 221 ---ALDSQRKLQFYEDRH-----QLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDL 270

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 92/205 (44%), Gaps = 7/205 (3%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCR 328
           +G G  G V   T   +  ++AVKK+    +Q  +    E+V +    H N+V +     
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYL 112
Query: 329 RKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRD 388
              EL +V +++  G+L   +       +N  Q   V   V   L YLH    Q VIHRD
Sbjct: 113 VGDELWVVMEFLEGGALTDIV---THTRMNEEQIATVCLSVLRALSYLHN---QGVIHRD 166
Query: 389 VKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVF 448
           +K+ ++LL  +   +L DFG          P+   +VGT  ++APE        T  D++
Sbjct: 167 IKSDSILLTSDGRIKLSDFGFCAQVSKEV-PKRKXLVGTPYWMAPEVISRLPYGTEVDIW 225
Query: 449 SFGAFLLEVACGRRPIQRQGPSENL 473
           S G  ++E+  G  P   + P + +
Sbjct: 226 SLGIMVIEMIDGEPPYFNEPPLQAM 250

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 94/212 (44%), Gaps = 14/212 (6%)
Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMK---EFVAEIVSIGRLRHRNLVQL 323
           E+LG GG   V+     +   ++AVK +  +  +       F  E  +   L H  +V +
Sbjct: 18  EILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 324 LGYCRRK---GEL-LLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQE 379
                 +   G L  +V +Y+   +L   ++ +  +T    +   VI      L + HQ 
Sbjct: 78  YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPK--RAIEVIADACQALNFSHQN 135
Query: 380 WEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTD-PQTTHVVGTLGYLAPEHTR 437
               +IHRDVK +N+++      ++ DFG+AR + D G    QT  V+GT  YL+PE  R
Sbjct: 136 G---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192
Query: 438 TGKATTSADVFSFGAFLLEVACGRRPIQRQGP 469
                  +DV+S G  L EV  G  P     P
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 96/208 (46%), Gaps = 33/208 (15%)
Query: 268 LLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVA--EIVSIGRLRHRNLVQLLG 325
           L+G G +G V +     +   +A+KK        M + +A  EI  + +LRH NLV LL 
Sbjct: 32  LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLE 91
Query: 326 YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQR--FRVIKGVALGLFYLHQEWEQV 383
            C++K    LV++++ +  LD        +    +Q+  F++I G+  G  + H      
Sbjct: 92  VCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGI--GFCHSHN----- 144
Query: 384 VIHRDVKASNVLLDGELNGRLGDFGLAR-------LYDHGTDPQTTHVVGTLGYLAPE-- 434
           +IHRD+K  N+L+      +L DFG AR       +YD          V T  Y APE  
Sbjct: 145 IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDE--------VATRWYRAPELL 196
Query: 435 --HTRTGKATTSADVFSFGAFLLEVACG 460
               + GKA    DV++ G  + E+  G
Sbjct: 197 VGDVKYGKAV---DVWAIGCLVTEMFMG 221

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 51/225 (22%), Positives = 102/225 (45%), Gaps = 40/225 (17%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQ 322
           F+E EL+G+GGFG+V++           ++++ + + +  +    E+ ++ +L H N+V 
Sbjct: 14  FKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAER----EVKALAKLDHVNIVH 69
Query: 323 LLGYC-----------------------------RRKGELLLV-YDYMPNGSLDKYLYDQ 352
             G C                             R K + L +  ++   G+L++++  +
Sbjct: 70  YNG-CWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR 128
Query: 353 PKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARL 412
               L+ +    + + +  G+ Y+H    + +IHRD+K SN+ L      ++GDFGL   
Sbjct: 129 RGEKLDKVLALELFEQITKGVDYIHS---KKLIHRDLKPSNIFLVDTKQVKIGDFGLVTS 185
Query: 413 YDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEV 457
             +  D + T   GTL Y++PE   +       D+++ G  L E+
Sbjct: 186 LKN--DGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAEL 228

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 94/221 (42%), Gaps = 32/221 (14%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRH----- 317
           F E  +LG G FG+V +          A+KKI H + + +   ++E+  +  L H     
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVXLLASLNHQYVVR 66
Query: 318 --------RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGV 369
                   RN V+     ++K  L +  +Y  N +L   ++ +  +     + +R+ + +
Sbjct: 67  YYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSE-NLNQQRDEYWRLFRQI 125
Query: 370 ALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH-------------G 416
              L Y+H    Q +IHR++K  N+ +D   N ++GDFGLA+                 G
Sbjct: 126 LEALSYIHS---QGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 417 TDPQTTHVVGTLGYLAPEHTR-TGKATTSADVFSFGAFLLE 456
           +    T  +GT  Y+A E    TG      D +S G    E
Sbjct: 183 SSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFE 223

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 94/201 (46%), Gaps = 10/201 (4%)
Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGR-LRHRNLVQLLG 325
           + LG G +G V       ++  +AVK +  +      E + + + I + L H N+V+  G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 326 YCRRKGEL-LLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVV 384
           + RR+G +  L  +Y   G L   +  +P + +      R    +  G+ YLH      +
Sbjct: 72  H-RREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLHG---IGI 125
Query: 385 IHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTH-VVGTLGYLAPE-HTRTGKAT 442
            HRD+K  N+LLD   N ++ DFGLA ++ +    +  + + GTL Y+APE   R     
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 443 TSADVFSFGAFLLEVACGRRP 463
              DV+S G  L  +  G  P
Sbjct: 186 EPVDVWSCGIVLTAMLAGELP 206

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 94/201 (46%), Gaps = 10/201 (4%)
Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGR-LRHRNLVQLLG 325
           + LG G +G V       ++  +AVK +  +      E + + + I + L H N+V+  G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 326 YCRRKGEL-LLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVV 384
           + RR+G +  L  +Y   G L   +  +P + +      R    +  G+ YLH      +
Sbjct: 73  H-RREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLHG---IGI 126
Query: 385 IHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTH-VVGTLGYLAPE-HTRTGKAT 442
            HRD+K  N+LLD   N ++ DFGLA ++ +    +  + + GTL Y+APE   R     
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 443 TSADVFSFGAFLLEVACGRRP 463
              DV+S G  L  +  G  P
Sbjct: 187 EPVDVWSCGIVLTAMLAGELP 207

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 102/217 (47%), Gaps = 9/217 (4%)
Query: 261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNL 320
           K +   E +G G  G VY      +  E+A+++++ + +   +  + EI+ +   ++ N+
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 79
Query: 321 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEW 380
           V  L       EL +V +Y+  GSL   + +     ++  Q   V +     L +LH   
Sbjct: 80  VNYLDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 381 EQVVIHRDVKASNVLLDGELNGRLGDFGL-ARLYDHGTDPQTTHVVGTLGYLAPEHTRTG 439
              VIHRD+K+ N+LL  + + +L DFG  A++    +  + + +VGT  ++APE     
Sbjct: 137 ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSEMVGTPYWMAPEVVTRK 191
Query: 440 KATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILV 476
                 D++S G   +E+  G  P   + P   L L+
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI 228

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 115/231 (49%), Gaps = 14/231 (6%)
Query: 249 HRFRYKDLYIATKGFR-EKELLGTGGFGRVYRG--TLPKSQIEIAVKKISHESRQ-GMK- 303
              R K++Y+  K    E + LG+G FG V +G   + K    +AVK + +E+    +K 
Sbjct: 4   EEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD 63
Query: 304 EFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRF 363
           E +AE   + +L +  +V+++G C  +   +LV +    G L+KYL     V    I   
Sbjct: 64  ELLAEANVMQQLDNPYIVRMIGICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKNI--I 120
Query: 364 RVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLY--DHGTDPQT 421
            ++  V++G+ YL    E   +HRD+ A NVLL  +   ++ DFGL++    D       
Sbjct: 121 ELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 177
Query: 422 THVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEV-ACGRRPIQRQGPSE 471
           TH    + + APE     K ++ +DV+SFG  + E  + G++P +    SE
Sbjct: 178 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 228

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 94/212 (44%), Gaps = 14/212 (6%)
Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMK---EFVAEIVSIGRLRHRNLVQL 323
           E+LG GG   V+     +   ++AVK +  +  +       F  E  +   L H  +V +
Sbjct: 18  EILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 324 LGYCRRK---GEL-LLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQE 379
                 +   G L  +V +Y+   +L   ++ +  +T    +   VI      L + HQ 
Sbjct: 78  YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPK--RAIEVIADACQALNFSHQN 135
Query: 380 WEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTD-PQTTHVVGTLGYLAPEHTR 437
               +IHRDVK +N+++      ++ DFG+AR + D G    QT  V+GT  YL+PE  R
Sbjct: 136 G---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192
Query: 438 TGKATTSADVFSFGAFLLEVACGRRPIQRQGP 469
                  +DV+S G  L EV  G  P     P
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 93/201 (46%), Gaps = 10/201 (4%)
Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGR-LRHRNLVQLLG 325
           + LG G +G V       ++  +AVK +  +      E + + + I + L H N+V+  G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 326 YCRRKGEL-LLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVV 384
           + RR+G +  L  +Y   G L   +  +P + +      R    +  G+ YLH      +
Sbjct: 73  H-RREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLHG---IGI 126
Query: 385 IHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ-TTHVVGTLGYLAPE-HTRTGKAT 442
            HRD+K  N+LLD   N ++ DFGLA ++ +    +    + GTL Y+APE   R     
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 443 TSADVFSFGAFLLEVACGRRP 463
              DV+S G  L  +  G  P
Sbjct: 187 EPVDVWSCGIVLTAMLAGELP 207

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 93/201 (46%), Gaps = 10/201 (4%)
Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGR-LRHRNLVQLLG 325
           + LG G +G V       ++  +AVK +  +      E + + + I + L H N+V+  G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 326 YCRRKGEL-LLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVV 384
           + RR+G +  L  +Y   G L   +  +P + +      R    +  G+ YLH      +
Sbjct: 73  H-RREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLHG---IGI 126
Query: 385 IHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ-TTHVVGTLGYLAPE-HTRTGKAT 442
            HRD+K  N+LLD   N ++ DFGLA ++ +    +    + GTL Y+APE   R     
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 443 TSADVFSFGAFLLEVACGRRP 463
              DV+S G  L  +  G  P
Sbjct: 187 EPVDVWSCGIVLTAMLAGELP 207

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 93/201 (46%), Gaps = 10/201 (4%)
Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGR-LRHRNLVQLLG 325
           + LG G +G V       ++  +AVK +  +      E + + + I + L H N+V+  G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 326 YCRRKGEL-LLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVV 384
           + RR+G +  L  +Y   G L   +  +P + +      R    +  G+ YLH      +
Sbjct: 73  H-RREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLHG---IGI 126
Query: 385 IHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ-TTHVVGTLGYLAPE-HTRTGKAT 442
            HRD+K  N+LLD   N ++ DFGLA ++ +    +    + GTL Y+APE   R     
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 443 TSADVFSFGAFLLEVACGRRP 463
              DV+S G  L  +  G  P
Sbjct: 187 EPVDVWSCGIVLTAMLAGELP 207

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 93/201 (46%), Gaps = 10/201 (4%)
Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGR-LRHRNLVQLLG 325
           + LG G +G V       ++  +AVK +  +      E + + + I + L H N+V+  G
Sbjct: 11  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70
Query: 326 YCRRKGEL-LLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVV 384
           + RR+G +  L  +Y   G L   +  +P + +      R    +  G+ YLH      +
Sbjct: 71  H-RREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLHG---IGI 124
Query: 385 IHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ-TTHVVGTLGYLAPE-HTRTGKAT 442
            HRD+K  N+LLD   N ++ DFGLA ++ +    +    + GTL Y+APE   R     
Sbjct: 125 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 184
Query: 443 TSADVFSFGAFLLEVACGRRP 463
              DV+S G  L  +  G  P
Sbjct: 185 EPVDVWSCGIVLTAMLAGELP 205

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 94/214 (43%), Gaps = 18/214 (8%)
Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMK---EFVAEIVSIGRLRHRNLVQL 323
           E+LG GG   V+     +   ++AVK +  +  +       F  E  +   L H  +V +
Sbjct: 18  EILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 324 LGYCRRKGEL------LLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLH 377
             Y   + E        +V +Y+   +L   ++ +  +T    +   VI      L + H
Sbjct: 78  --YATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPK--RAIEVIADACQALNFSH 133
Query: 378 QEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTD-PQTTHVVGTLGYLAPEH 435
           Q     +IHRDVK +N+++      ++ DFG+AR + D G    QT  V+GT  YL+PE 
Sbjct: 134 QNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190
Query: 436 TRTGKATTSADVFSFGAFLLEVACGRRPIQRQGP 469
            R       +DV+S G  L EV  G  P     P
Sbjct: 191 ARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 93/201 (46%), Gaps = 10/201 (4%)
Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGR-LRHRNLVQLLG 325
           + LG G +G V       ++  +AVK +  +      E + + + I + L H N+V+  G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 326 YCRRKGEL-LLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVV 384
           + RR+G +  L  +Y   G L   +  +P + +      R    +  G+ YLH      +
Sbjct: 72  H-RREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLHG---IGI 125
Query: 385 IHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ-TTHVVGTLGYLAPE-HTRTGKAT 442
            HRD+K  N+LLD   N ++ DFGLA ++ +    +    + GTL Y+APE   R     
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 443 TSADVFSFGAFLLEVACGRRP 463
              DV+S G  L  +  G  P
Sbjct: 186 EPVDVWSCGIVLTAMLAGELP 206

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 93/201 (46%), Gaps = 10/201 (4%)
Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGR-LRHRNLVQLLG 325
           + LG G +G V       ++  +AVK +  +      E + + + I + L H N+V+  G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 326 YCRRKGEL-LLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVV 384
           + RR+G +  L  +Y   G L   +  +P + +      R    +  G+ YLH      +
Sbjct: 73  H-RREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLHG---IGI 126
Query: 385 IHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ-TTHVVGTLGYLAPE-HTRTGKAT 442
            HRD+K  N+LLD   N ++ DFGLA ++ +    +    + GTL Y+APE   R     
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 443 TSADVFSFGAFLLEVACGRRP 463
              DV+S G  L  +  G  P
Sbjct: 187 EPVDVWSCGIVLTAMLAGELP 207

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 94/201 (46%), Gaps = 10/201 (4%)
Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGR-LRHRNLVQLLG 325
           + LG G +G V       ++  +AVK +  +      E + + + I + L H N+V+  G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 326 YCRRKGEL-LLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVV 384
           + RR+G +  L  +Y   G L   +  +P + +      R    +  G+ YLH      +
Sbjct: 72  H-RREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLHG---IGI 125
Query: 385 IHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTH-VVGTLGYLAPE-HTRTGKAT 442
            HRD+K  N+LLD   N ++ DFGLA ++ +    +  + + GTL Y+APE   R     
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 443 TSADVFSFGAFLLEVACGRRP 463
              DV+S G  L  +  G  P
Sbjct: 186 EPVDVWSCGIVLTAMLAGELP 206

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 100/205 (48%), Gaps = 17/205 (8%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKIS-HESRQGMKEFVAEIVSIGRLRHRNLVQLLGYC 327
           +G G +G V       +++ +A++KIS  E +   +  + EI  + R RH N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 328 R-----RKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQ 382
           R     +  ++ +V D M    L K L  Q  ++ + I  F  +  +  GL Y+H     
Sbjct: 95  RAPTIEQMKDVYIVQDLM-ETDLYKLLKTQ-HLSNDHICYF--LYQILRGLKYIHS---A 147
Query: 383 VVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ--TTHVVGTLGYLAPEHTRTGK 440
            V+HRD+K SN+LL+   + ++ DFGLAR+ D   D     T  V T  Y APE     K
Sbjct: 148 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 207
Query: 441 A-TTSADVFSFGAFLLEVACGRRPI 464
             T S D++S G  L E+    RPI
Sbjct: 208 GYTKSIDIWSVGCILAEML-SNRPI 231

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 93/201 (46%), Gaps = 10/201 (4%)
Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGR-LRHRNLVQLLG 325
           + LG G +G V       ++  +AVK +  +      E + + + I + L H N+V+  G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 326 YCRRKGEL-LLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVV 384
           + RR+G +  L  +Y   G L   +  +P + +      R    +  G+ YLH      +
Sbjct: 72  H-RREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLHG---IGI 125
Query: 385 IHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ-TTHVVGTLGYLAPE-HTRTGKAT 442
            HRD+K  N+LLD   N ++ DFGLA ++ +    +    + GTL Y+APE   R     
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 443 TSADVFSFGAFLLEVACGRRP 463
              DV+S G  L  +  G  P
Sbjct: 186 EPVDVWSCGIVLTAMLAGELP 206

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 93/201 (46%), Gaps = 10/201 (4%)
Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGR-LRHRNLVQLLG 325
           + LG G +G V       ++  +AVK +  +      E + + + I + L H N+V+  G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 326 YCRRKGEL-LLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVV 384
           + RR+G +  L  +Y   G L   +  +P + +      R    +  G+ YLH      +
Sbjct: 72  H-RREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLHG---IGI 125
Query: 385 IHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ-TTHVVGTLGYLAPE-HTRTGKAT 442
            HRD+K  N+LLD   N ++ DFGLA ++ +    +    + GTL Y+APE   R     
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 443 TSADVFSFGAFLLEVACGRRP 463
              DV+S G  L  +  G  P
Sbjct: 186 EPVDVWSCGIVLTAMLAGELP 206

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 114/226 (50%), Gaps = 14/226 (6%)
Query: 254 KDLYIATKGFR-EKELLGTGGFGRVYRG--TLPKSQIEIAVKKISHESRQ-GMK-EFVAE 308
           K++Y+  K    E + LG+G FG V +G   + K    +AVK + +E+    +K E +AE
Sbjct: 3   KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAE 62
Query: 309 IVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKG 368
              + +L +  +V+++G C  +   +LV +    G L+KYL     V    I    ++  
Sbjct: 63  ANVMQQLDNPYIVRMIGICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKNI--IELVHQ 119
Query: 369 VALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLY--DHGTDPQTTHVVG 426
           V++G+ YL    E   +HRD+ A NVLL  +   ++ DFGL++    D       TH   
Sbjct: 120 VSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKW 176
Query: 427 TLGYLAPEHTRTGKATTSADVFSFGAFLLEV-ACGRRPIQRQGPSE 471
            + + APE     K ++ +DV+SFG  + E  + G++P +    SE
Sbjct: 177 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 222

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 99/197 (50%), Gaps = 10/197 (5%)
Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR-QGM-KEFVAEIVSIGRLRHRNLVQLL 324
           E +G G +G VY+      +   A+KKI  E   +G+    + EI  +  L+H N+V+L 
Sbjct: 8   EKIGEGTYGVVYKAQNNYGET-FALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLY 66
Query: 325 GYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVV 384
                K  L+LV++++      K L D  +  L  +     +  +  G+ Y H   ++ V
Sbjct: 67  DVIHTKKRLVLVFEHLDQDL--KKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRV 121
Query: 385 IHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTR-TGKATT 443
           +HRD+K  N+L++ E   ++ DFGLAR +      + TH V TL Y AP+    + K +T
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVR-KYTHEVVTLWYRAPDVLMGSKKYST 180
Query: 444 SADVFSFGAFLLEVACG 460
           + D++S G    E+  G
Sbjct: 181 TIDIWSVGCIFAEMVNG 197

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 99/197 (50%), Gaps = 10/197 (5%)
Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR-QGM-KEFVAEIVSIGRLRHRNLVQLL 324
           E +G G +G VY+      +   A+KKI  E   +G+    + EI  +  L+H N+V+L 
Sbjct: 8   EKIGEGTYGVVYKAQNNYGET-FALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLY 66
Query: 325 GYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVV 384
                K  L+LV++++      K L D  +  L  +     +  +  G+ Y H   ++ V
Sbjct: 67  DVIHTKKRLVLVFEHLDQDL--KKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRV 121
Query: 385 IHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTR-TGKATT 443
           +HRD+K  N+L++ E   ++ DFGLAR +      + TH V TL Y AP+    + K +T
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVR-KYTHEVVTLWYRAPDVLMGSKKYST 180
Query: 444 SADVFSFGAFLLEVACG 460
           + D++S G    E+  G
Sbjct: 181 TIDIWSVGCIFAEMVNG 197

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 105/217 (48%), Gaps = 10/217 (4%)
Query: 254 KDLYIATKGFREKELLGTGGFGRVYRGTLPKSQ---IEIAVKKISHESRQGMKE-FVAEI 309
           +D  I  +       +G G FG V++G     +   + +A+K   + +   ++E F+ E 
Sbjct: 3   RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEA 62
Query: 310 VSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGV 369
           +++ +  H ++V+L+G    +  + ++ +    G L  +L  + K +L+          +
Sbjct: 63  LTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQL 120
Query: 370 ALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLG 429
           +  L YL     +  +HRD+ A NVL+      +LGDFGL+R  +  T  + +     + 
Sbjct: 121 STALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIK 177
Query: 430 YLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQ 465
           ++APE     + T+++DV+ FG  + E+   G +P Q
Sbjct: 178 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ 214

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 105/222 (47%), Gaps = 18/222 (8%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKI--SHESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
           LG+G +G V       + +E A+K I  +  S     + + E+  +  L H N+++L  +
Sbjct: 45  LGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF 104
Query: 327 CRRKGELLLVYDYMPNGSL-DKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVI 385
              K    LV +    G L D+ ++   ++  N +    +IK V  G+ YLH+     ++
Sbjct: 105 FEDKRNYYLVMECYKGGELFDEIIH---RMKFNEVDAAVIIKQVLSGVTYLHK---HNIV 158
Query: 386 HRDVKASNVLLDGELNG---RLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKAT 442
           HRD+K  N+LL+ +      ++ DFGL+ ++++    +    +GT  Y+APE  R  K  
Sbjct: 159 HRDLKPENLLLESKEKDALIKIVDFGLSAVFEN--QKKMKERLGTAYYIAPEVLRK-KYD 215
Query: 443 TSADVFSFGAFLLEVACGRRPIQRQGPSENLILVD---WVFD 481
              DV+S G  L  +  G  P   Q   E L  V+   + FD
Sbjct: 216 EKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFD 257

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 102/217 (47%), Gaps = 9/217 (4%)
Query: 261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNL 320
           K +   E +G G  G VY      +  E+A+++++ + +   +  + EI+ +   ++ N+
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 79
Query: 321 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEW 380
           V  L       EL +V +Y+  GSL   + +     ++  Q   V +     L +LH   
Sbjct: 80  VNYLDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 381 EQVVIHRDVKASNVLLDGELNGRLGDFGL-ARLYDHGTDPQTTHVVGTLGYLAPEHTRTG 439
              VIHRD+K+ N+LL  + + +L DFG  A++    +  + + +VGT  ++APE     
Sbjct: 137 ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSXMVGTPYWMAPEVVTRK 191
Query: 440 KATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILV 476
                 D++S G   +E+  G  P   + P   L L+
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI 228

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/226 (29%), Positives = 114/226 (50%), Gaps = 14/226 (6%)
Query: 254 KDLYIATKGFR-EKELLGTGGFGRVYRG--TLPKSQIEIAVKKISHESRQ-GMK-EFVAE 308
           K++Y+  K    E + LG+G FG V +G   + K    +AVK + +E+    +K E +AE
Sbjct: 3   KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAE 62
Query: 309 IVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKG 368
              + +L +  +V+++G C  +   +LV +    G L+KYL     V    I    ++  
Sbjct: 63  ANVMQQLDNPYIVRMIGICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKNI--IELVHQ 119
Query: 369 VALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLY--DHGTDPQTTHVVG 426
           V++G+ YL    E   +HRD+ A NVLL  +   ++ DFGL++    D       TH   
Sbjct: 120 VSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKW 176
Query: 427 TLGYLAPEHTRTGKATTSADVFSFGAFLLEV-ACGRRPIQRQGPSE 471
            + + APE     K ++ +DV+SFG  + E  + G++P +    SE
Sbjct: 177 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 222

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 100/209 (47%), Gaps = 25/209 (11%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKIS-HESRQGMKEFVAEIVSIGRLRHRNLVQLLGYC 327
           +G G +G V       +++ +A+KKIS  E +   +  + EI  + R RH N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 328 R-----RKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQ 382
           R     +  ++ +V D M    L K L  Q  ++ + I  F  +  +  GL Y+H     
Sbjct: 95  RAPTIEQMKDVYIVQDLM-ETDLYKLLKTQ-HLSNDHICYF--LYQILRGLKYIHS---A 147
Query: 383 VVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHV------VGTLGYLAPEHT 436
            V+HRD+K SN+LL+   + ++ DFGLAR+     DP   H       V T  Y APE  
Sbjct: 148 NVLHRDLKPSNLLLNTTCDLKICDFGLARV----ADPDHDHTGFLXEXVATRWYRAPEIM 203
Query: 437 RTGKA-TTSADVFSFGAFLLEVACGRRPI 464
              K  T S D++S G  L E+    RPI
Sbjct: 204 LNSKGYTKSIDIWSVGCILAEML-SNRPI 231

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 100/209 (47%), Gaps = 25/209 (11%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKIS-HESRQGMKEFVAEIVSIGRLRHRNLVQLLGYC 327
           +G G +G V       +++ +A+KKIS  E +   +  + EI  + R RH N++ +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 328 R-----RKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQ 382
           R     +  ++ +V D M    L K L  Q  ++ + I  F  +  +  GL Y+H     
Sbjct: 96  RAPTIEQMKDVYIVQDLM-ETDLYKLLKTQ-HLSNDHICYF--LYQILRGLKYIHS---A 148
Query: 383 VVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHV------VGTLGYLAPEHT 436
            V+HRD+K SN+LL+   + ++ DFGLAR+     DP   H       V T  Y APE  
Sbjct: 149 NVLHRDLKPSNLLLNTTCDLKICDFGLARV----ADPDHDHTGFLXEXVATRWYRAPEIM 204
Query: 437 RTGKA-TTSADVFSFGAFLLEVACGRRPI 464
              K  T S D++S G  L E+    RPI
Sbjct: 205 LNSKGYTKSIDIWSVGCILAEML-SNRPI 232

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 102/217 (47%), Gaps = 9/217 (4%)
Query: 261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNL 320
           K +   E +G G  G VY      +  E+A+++++ + +   +  + EI+ +   ++ N+
Sbjct: 21  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 80
Query: 321 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEW 380
           V  L       EL +V +Y+  GSL   + +     ++  Q   V +     L +LH   
Sbjct: 81  VNYLDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQ 137
Query: 381 EQVVIHRDVKASNVLLDGELNGRLGDFGL-ARLYDHGTDPQTTHVVGTLGYLAPEHTRTG 439
              VIHRD+K+ N+LL  + + +L DFG  A++    +  + + +VGT  ++APE     
Sbjct: 138 ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSXMVGTPYWMAPEVVTRK 192
Query: 440 KATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILV 476
                 D++S G   +E+  G  P   + P   L L+
Sbjct: 193 AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI 229

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 68/244 (27%), Positives = 113/244 (46%), Gaps = 25/244 (10%)
Query: 244 LDH---GPHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQI---EIAVKKISH- 296
           +DH    P  F      I +  ++ + +LG G FG V    L K +I   E AVK IS  
Sbjct: 6   MDHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEV---ILCKDKITGQECAVKVISKR 62
Query: 297 --ESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPK 354
             + +   +  + E+  + +L H N+++L  +   KG   LV +    G L   +  + +
Sbjct: 63  QVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR 122
Query: 355 VTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDG---ELNGRLGDFGLAR 411
              + +   R+I+ V  G+ Y+H+     ++HRD+K  N+LL+    + N R+ DFGL+ 
Sbjct: 123 --FSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLST 177
Query: 412 LYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSE 471
            ++     +    +GT  Y+APE    G      DV+S G  L  +  G  P    G +E
Sbjct: 178 HFE--ASKKMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPPF--NGANE 232
Query: 472 NLIL 475
             IL
Sbjct: 233 YDIL 236

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 93/201 (46%), Gaps = 10/201 (4%)
Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGR-LRHRNLVQLLG 325
           + LG G +G V       ++  +AVK +  +      E + + + I + L H N+V+  G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYG 71
Query: 326 YCRRKGEL-LLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVV 384
           + RR+G +  L  +Y   G L   +  +P + +      R    +  G+ YLH      +
Sbjct: 72  H-RREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLHG---IGI 125
Query: 385 IHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ-TTHVVGTLGYLAPE-HTRTGKAT 442
            HRD+K  N+LLD   N ++ DFGLA ++ +    +    + GTL Y+APE   R     
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 443 TSADVFSFGAFLLEVACGRRP 463
              DV+S G  L  +  G  P
Sbjct: 186 EPVDVWSCGIVLTAMLAGELP 206

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 94/201 (46%), Gaps = 13/201 (6%)
Query: 268 LLGTGGFGRVYRGTLPKSQIEIAVKKISHES--RQGMKEFVAEIVSIGRLRHRNLVQLLG 325
           +LG G FG V +     +Q E AVK I+  S   +     + E+  + +L H N+++L  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 326 YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVI 385
                    +V +    G L   +  + + + +     R+IK V  G+ Y+H+     ++
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEIIKRKRFSEH--DAARIIKQVFSGITYMHK---HNIV 143
Query: 386 HRDVKASNVLLDG---ELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKAT 442
           HRD+K  N+LL+    + + ++ DFGL+  +   T  +    +GT  Y+APE  R G   
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT--KMKDRIGTAYYIAPEVLR-GTYD 200
Query: 443 TSADVFSFGAFLLEVACGRRP 463
              DV+S G  L  +  G  P
Sbjct: 201 EKCDVWSAGVILYILLSGTPP 221

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 93/201 (46%), Gaps = 10/201 (4%)
Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGR-LRHRNLVQLLG 325
           + LG G +G V       ++  +AVK +  +      E + + + I + L H N+V+  G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 326 YCRRKGEL-LLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVV 384
           + RR+G +  L  +Y   G L   +  +P + +      R    +  G+ YLH      +
Sbjct: 72  H-RREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLHG---IGI 125
Query: 385 IHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ-TTHVVGTLGYLAPE-HTRTGKAT 442
            HRD+K  N+LLD   N ++ DFGLA ++ +    +    + GTL Y+APE   R     
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHA 185
Query: 443 TSADVFSFGAFLLEVACGRRP 463
              DV+S G  L  +  G  P
Sbjct: 186 EPVDVWSCGIVLTAMLAGELP 206

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 93/201 (46%), Gaps = 10/201 (4%)
Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGR-LRHRNLVQLLG 325
           + LG G +G V       ++  +AVK +  +      E + + + I + L H N+V+  G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 326 YCRRKGEL-LLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVV 384
           + RR+G +  L  +Y   G L   +  +P + +      R    +  G+ YLH      +
Sbjct: 72  H-RREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLHG---IGI 125
Query: 385 IHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ-TTHVVGTLGYLAPE-HTRTGKAT 442
            HRD+K  N+LLD   N ++ DFGLA ++ +    +    + GTL Y+APE   R     
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHA 185
Query: 443 TSADVFSFGAFLLEVACGRRP 463
              DV+S G  L  +  G  P
Sbjct: 186 EPVDVWSCGIVLTAMLAGELP 206

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 99/197 (50%), Gaps = 10/197 (5%)
Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR-QGM-KEFVAEIVSIGRLRHRNLVQLL 324
           E +G G +G VY+      +   A+KKI  E   +G+    + EI  +  L+H N+V+L 
Sbjct: 8   EKIGEGTYGVVYKAQNNYGET-FALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLY 66
Query: 325 GYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVV 384
                K  L+LV++++      K L D  +  L  +     +  +  G+ Y H   ++ V
Sbjct: 67  DVIHTKKRLVLVFEHLDQDL--KKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRV 121
Query: 385 IHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTR-TGKATT 443
           +HRD+K  N+L++ E   ++ DFGLAR +      + TH + TL Y AP+    + K +T
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIPVR-KYTHEIVTLWYRAPDVLMGSKKYST 180
Query: 444 SADVFSFGAFLLEVACG 460
           + D++S G    E+  G
Sbjct: 181 TIDIWSVGCIFAEMVNG 197

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 93/201 (46%), Gaps = 10/201 (4%)
Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGR-LRHRNLVQLLG 325
           + LG G +G V       ++  +AVK +  +      E + + + I + L H N+V+  G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 326 YCRRKGEL-LLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVV 384
           + RR+G +  L  +Y   G L   +  +P + +      R    +  G+ YLH      +
Sbjct: 72  H-RREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLHG---IGI 125
Query: 385 IHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ-TTHVVGTLGYLAPE-HTRTGKAT 442
            HRD+K  N+LLD   N ++ DFGLA ++ +    +    + GTL Y+APE   R     
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHA 185
Query: 443 TSADVFSFGAFLLEVACGRRP 463
              DV+S G  L  +  G  P
Sbjct: 186 EPVDVWSCGIVLTAMLAGELP 206

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 99/216 (45%), Gaps = 7/216 (3%)
Query: 261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNL 320
           K +   E +G G  G VY      +  E+A+++++ + +   +  + EI+ +   ++ N+
Sbjct: 21  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNI 80
Query: 321 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEW 380
           V  L       EL +V +Y+  GSL   + +     ++  Q   V +     L +LH   
Sbjct: 81  VNYLDSYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQ 137
Query: 381 EQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGK 440
              VIHR++K+ N+LL  + + +L DFG           ++T +VGT  ++APE      
Sbjct: 138 ---VIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRKA 193
Query: 441 ATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILV 476
                D++S G   +E+  G  P   + P   L L+
Sbjct: 194 YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI 229

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 110/237 (46%), Gaps = 22/237 (9%)
Query: 248 PHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQI---EIAVKKISH---ESRQG 301
           P  F      I +  ++ + +LG G FG V    L K +I   E AVK IS    + +  
Sbjct: 36  PGMFVQHSTAIFSDRYKGQRVLGKGSFGEV---ILCKDKITGQECAVKVISKRQVKQKTD 92
Query: 302 MKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQ 361
            +  + E+  + +L H N+++L  +   KG   LV +    G L   +  + +   + + 
Sbjct: 93  KESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR--FSEVD 150
Query: 362 RFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDG---ELNGRLGDFGLARLYDHGTD 418
             R+I+ V  G+ Y+H+     ++HRD+K  N+LL+    + N R+ DFGL+  ++    
Sbjct: 151 AARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE--AS 205
Query: 419 PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLIL 475
            +    +GT  Y+APE    G      DV+S G  L  +  G  P    G +E  IL
Sbjct: 206 KKMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPPF--NGANEYDIL 259

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 108/214 (50%), Gaps = 13/214 (6%)
Query: 265 EKELLGTGGFGRVYRG--TLPKSQIEIAVKKISHESRQ-GMK-EFVAEIVSIGRLRHRNL 320
           E + LG+G FG V +G   + K    +AVK + +E+    +K E +AE   + +L +  +
Sbjct: 11  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 321 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEW 380
           V+++G C  +   +LV +    G L+KYL     V    I    ++  V++G+ YL    
Sbjct: 71  VRMIGICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKNI--IELVHQVSMGMKYLE--- 124
Query: 381 EQVVIHRDVKASNVLLDGELNGRLGDFGLARLY--DHGTDPQTTHVVGTLGYLAPEHTRT 438
           E   +HRD+ A NVLL  +   ++ DFGL++    D       TH    + + APE    
Sbjct: 125 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184
Query: 439 GKATTSADVFSFGAFLLEV-ACGRRPIQRQGPSE 471
            K ++ +DV+SFG  + E  + G++P +    SE
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 218

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 108/214 (50%), Gaps = 13/214 (6%)
Query: 265 EKELLGTGGFGRVYRG--TLPKSQIEIAVKKISHESRQ-GMK-EFVAEIVSIGRLRHRNL 320
           E + LG+G FG V +G   + K    +AVK + +E+    +K E +AE   + +L +  +
Sbjct: 9   EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 68
Query: 321 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEW 380
           V+++G C  +   +LV +    G L+KYL     V    I    ++  V++G+ YL    
Sbjct: 69  VRMIGICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKNI--IELVHQVSMGMKYLE--- 122
Query: 381 EQVVIHRDVKASNVLLDGELNGRLGDFGLARLY--DHGTDPQTTHVVGTLGYLAPEHTRT 438
           E   +HRD+ A NVLL  +   ++ DFGL++    D       TH    + + APE    
Sbjct: 123 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 182
Query: 439 GKATTSADVFSFGAFLLEV-ACGRRPIQRQGPSE 471
            K ++ +DV+SFG  + E  + G++P +    SE
Sbjct: 183 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 216

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 94/212 (44%), Gaps = 14/212 (6%)
Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMK---EFVAEIVSIGRLRHRNLVQL 323
           E+LG GG   V+     +   ++AVK +  +  +       F  E  +   L H  +V +
Sbjct: 18  EILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77
Query: 324 LGYCRRK---GEL-LLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQE 379
                 +   G L  +V +Y+   +L   ++ +  +T    +   VI      L + HQ 
Sbjct: 78  YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPK--RAIEVIADACQALNFSHQN 135
Query: 380 WEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTD-PQTTHVVGTLGYLAPEHTR 437
               +IHRDVK +N+++      ++ DFG+AR + D G    QT  V+GT  YL+PE  R
Sbjct: 136 G---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192
Query: 438 TGKATTSADVFSFGAFLLEVACGRRPIQRQGP 469
                  +DV+S G  L EV  G  P     P
Sbjct: 193 GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 94/201 (46%), Gaps = 13/201 (6%)
Query: 268 LLGTGGFGRVYRGTLPKSQIEIAVKKISHES--RQGMKEFVAEIVSIGRLRHRNLVQLLG 325
           +LG G FG V +     +Q E AVK I+  S   +     + E+  + +L H N+++L  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 326 YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVI 385
                    +V +    G L   +  + + + +     R+IK V  G+ Y+H+     ++
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEIIKRKRFSEH--DAARIIKQVFSGITYMHK---HNIV 143
Query: 386 HRDVKASNVLLDG---ELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKAT 442
           HRD+K  N+LL+    + + ++ DFGL+  +   T  +    +GT  Y+APE  R G   
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT--KMKDRIGTAYYIAPEVLR-GTYD 200
Query: 443 TSADVFSFGAFLLEVACGRRP 463
              DV+S G  L  +  G  P
Sbjct: 201 EKCDVWSAGVILYILLSGTPP 221

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 110/237 (46%), Gaps = 22/237 (9%)
Query: 248 PHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQI---EIAVKKISH---ESRQG 301
           P  F      I +  ++ + +LG G FG V    L K +I   E AVK IS    + +  
Sbjct: 37  PGMFVQHSTAIFSDRYKGQRVLGKGSFGEV---ILCKDKITGQECAVKVISKRQVKQKTD 93
Query: 302 MKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQ 361
            +  + E+  + +L H N+++L  +   KG   LV +    G L   +  + +   + + 
Sbjct: 94  KESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR--FSEVD 151
Query: 362 RFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDG---ELNGRLGDFGLARLYDHGTD 418
             R+I+ V  G+ Y+H+     ++HRD+K  N+LL+    + N R+ DFGL+  ++    
Sbjct: 152 AARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE--AS 206
Query: 419 PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLIL 475
            +    +GT  Y+APE    G      DV+S G  L  +  G  P    G +E  IL
Sbjct: 207 KKMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPPF--NGANEYDIL 260

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 93/201 (46%), Gaps = 10/201 (4%)
Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGR-LRHRNLVQLLG 325
           + LG G +G V       ++  +AVK +  +      E + + + I + L H N+V+  G
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYG 71
Query: 326 YCRRKGEL-LLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVV 384
           + RR+G +  L  +Y   G L   +  +P + +      R    +  G+ YLH      +
Sbjct: 72  H-RREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLHG---IGI 125
Query: 385 IHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ-TTHVVGTLGYLAPE-HTRTGKAT 442
            HRD+K  N+LLD   N ++ DFGLA ++ +    +    + GTL Y+APE   R     
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHA 185
Query: 443 TSADVFSFGAFLLEVACGRRP 463
              DV+S G  L  +  G  P
Sbjct: 186 EPVDVWSCGIVLTAMLAGELP 206

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 94/201 (46%), Gaps = 13/201 (6%)
Query: 268 LLGTGGFGRVYRGTLPKSQIEIAVKKISHES--RQGMKEFVAEIVSIGRLRHRNLVQLLG 325
           +LG G FG V +     +Q E AVK I+  S   +     + E+  + +L H N+++L  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 326 YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVI 385
                    +V +    G L   +  + + + +     R+IK V  G+ Y+H+     ++
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEIIKRKRFSEH--DAARIIKQVFSGITYMHK---HNIV 143
Query: 386 HRDVKASNVLLDG---ELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKAT 442
           HRD+K  N+LL+    + + ++ DFGL+  +   T  +    +GT  Y+APE  R G   
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT--KMKDRIGTAYYIAPEVLR-GTYD 200
Query: 443 TSADVFSFGAFLLEVACGRRP 463
              DV+S G  L  +  G  P
Sbjct: 201 EKCDVWSAGVILYILLSGTPP 221

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 93/201 (46%), Gaps = 10/201 (4%)
Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGR-LRHRNLVQLLG 325
           + LG G +G V       ++  +AVK +  +      E + + + I + L H N+V+  G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYG 72
Query: 326 YCRRKGEL-LLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVV 384
           + RR+G +  L  +Y   G L   +  +P + +      R    +  G+ YLH      +
Sbjct: 73  H-RREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLHG---IGI 126
Query: 385 IHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ-TTHVVGTLGYLAPE-HTRTGKAT 442
            HRD+K  N+LLD   N ++ DFGLA ++ +    +    + GTL Y+APE   R     
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHA 186
Query: 443 TSADVFSFGAFLLEVACGRRP 463
              DV+S G  L  +  G  P
Sbjct: 187 EPVDVWSCGIVLTAMLAGELP 207

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 92/201 (45%), Gaps = 10/201 (4%)
Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSI-GRLRHRNLVQLLG 325
           + LG G +G V       ++  +AVK +  +      E + + + I   L H N+V+  G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYG 72
Query: 326 YCRRKGEL-LLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVV 384
           + RR+G +  L  +Y   G L   +  +P + +      R    +  G+ YLH      +
Sbjct: 73  H-RREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLHG---IGI 126
Query: 385 IHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ-TTHVVGTLGYLAPE-HTRTGKAT 442
            HRD+K  N+LLD   N ++ DFGLA ++ +    +    + GTL Y+APE   R     
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 443 TSADVFSFGAFLLEVACGRRP 463
              DV+S G  L  +  G  P
Sbjct: 187 EPVDVWSCGIVLTAMLAGELP 207

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 28/218 (12%)
Query: 268 LLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLR----------- 316
           ++G G + +V    L K+    A+K +        KE V +   I  ++           
Sbjct: 27  VIGRGSYAKVLLVRLKKTDRIYAMKVVK-------KELVNDDEDIDWVQTEKHVFEQASN 79
Query: 317 HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYL 376
           H  LV L    + +  L  V +Y+  G L  ++  Q K+     + +     ++L L YL
Sbjct: 80  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA--EISLALNYL 137
Query: 377 HQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP--QTTHVVGTLGYLAPE 434
           H   E+ +I+RD+K  NVLLD E + +L D+G+ +    G  P   T+   GT  Y+APE
Sbjct: 138 H---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK---EGLRPGDTTSXFCGTPNYIAPE 191
Query: 435 HTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSEN 472
             R      S D ++ G  + E+  GR P    G S+N
Sbjct: 192 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN 229

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 108/228 (47%), Gaps = 48/228 (21%)
Query: 267 ELLGTGGFGRVYRGT---LPKS--QIEIAVKKISHESRQGMKE-FVAEIVSIGRL-RHRN 319
           ++LG+G FG+V   T   + K+   I++AVK +  ++    +E  ++E+  + +L  H N
Sbjct: 51  KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110
Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYL------YDQPKVTLNWIQR----------- 362
           +V LLG C   G + L+++Y   G L  YL      + + ++     +R           
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170
Query: 363 --------FRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYD 414
                   ++V KG+    F       +  +HRD+ A NVL+      ++ DFGLAR  D
Sbjct: 171 FEDLLCFAYQVAKGMEFLEF-------KSCVHRDLAARNVLVTHGKVVKICDFGLAR--D 221
Query: 415 HGTDPQTTHVVG-----TLGYLAPEHTRTGKATTSADVFSFGAFLLEV 457
             +D  + +VV       + ++APE    G  T  +DV+S+G  L E+
Sbjct: 222 IMSD--SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEI 267

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 101/211 (47%), Gaps = 17/211 (8%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKIS-HESRQGMKEFVAEIVSIGRLRHRNLV 321
           + + + +G G +G V        +  +A+KKIS  E +   +  + EI  + R RH N++
Sbjct: 45  YTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVI 104
Query: 322 QLLGYCRRKG-----ELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYL 376
            +    R        ++ +V D M    L K L  Q +++ + I  F  +  +  GL Y+
Sbjct: 105 GIRDILRASTLEAMRDVYIVQDLM-ETDLYKLLKSQ-QLSNDHICYF--LYQILRGLKYI 160
Query: 377 HQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYD--HGTDPQTTHVVGTLGYLAPE 434
           H      V+HRD+K SN+L++   + ++ DFGLAR+ D  H      T  V T  Y APE
Sbjct: 161 HS---ANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPE 217
Query: 435 HTRTGKA-TTSADVFSFGAFLLEVACGRRPI 464
                K  T S D++S G  L E+    RPI
Sbjct: 218 IMLNSKGYTKSIDIWSVGCILAEM-LSNRPI 247

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 99/205 (48%), Gaps = 17/205 (8%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKIS-HESRQGMKEFVAEIVSIGRLRHRNLVQLLGYC 327
           +G G +G V       +++ +A+KKIS  E +   +  + EI  + R RH N++ +    
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 328 R-----RKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQ 382
           R     +  ++ LV   M    L K L  Q  ++ + I  F  +  +  GL Y+H     
Sbjct: 111 RAPTIEQMKDVYLVTHLM-GADLYKLLKTQ-HLSNDHICYF--LYQILRGLKYIHS---A 163
Query: 383 VVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ--TTHVVGTLGYLAPEHTRTGK 440
            V+HRD+K SN+LL+   + ++ DFGLAR+ D   D     T  V T  Y APE     K
Sbjct: 164 NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 223
Query: 441 A-TTSADVFSFGAFLLEVACGRRPI 464
             T S D++S G  L E+    RPI
Sbjct: 224 GYTKSIDIWSVGCILAEM-LSNRPI 247

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 28/218 (12%)
Query: 268 LLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLR----------- 316
           ++G G + +V    L K+    A+K +        KE V +   I  ++           
Sbjct: 12  VIGRGSYAKVLLVRLKKTDRIYAMKVVK-------KELVNDDEDIDWVQTEKHVFEQASN 64
Query: 317 HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYL 376
           H  LV L    + +  L  V +Y+  G L  ++  Q K+     + +     ++L L YL
Sbjct: 65  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA--EISLALNYL 122
Query: 377 HQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP--QTTHVVGTLGYLAPE 434
           H   E+ +I+RD+K  NVLLD E + +L D+G+ +    G  P   T+   GT  Y+APE
Sbjct: 123 H---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK---EGLRPGDTTSXFCGTPNYIAPE 176
Query: 435 HTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSEN 472
             R      S D ++ G  + E+  GR P    G S+N
Sbjct: 177 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN 214

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 98/211 (46%), Gaps = 9/211 (4%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQ---GMKEFVAEIVSIGRLRHRN 319
           F +  +LG GGFG V+   +  +    A KK++ +  +   G +  + E   + ++  R 
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYLY--DQPKVTLNWIQRFRVIKGVALGLFYLH 377
           +V L      K +L LV   M  G +  ++Y  D+        +       +  GL +LH
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH 306
Query: 378 QEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTR 437
           Q   + +I+RD+K  NVLLD + N R+ D GLA     G   +T    GT G++APE   
Sbjct: 307 Q---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ-TKTKGYAGTPGFMAPELLL 362
Query: 438 TGKATTSADVFSFGAFLLEVACGRRPIQRQG 468
             +   S D F+ G  L E+   R P + +G
Sbjct: 363 GEEYDFSVDYFALGVTLYEMIAARGPFRARG 393

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 98/211 (46%), Gaps = 9/211 (4%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQ---GMKEFVAEIVSIGRLRHRN 319
           F +  +LG GGFG V+   +  +    A KK++ +  +   G +  + E   + ++  R 
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYLY--DQPKVTLNWIQRFRVIKGVALGLFYLH 377
           +V L      K +L LV   M  G +  ++Y  D+        +       +  GL +LH
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH 306
Query: 378 QEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTR 437
           Q   + +I+RD+K  NVLLD + N R+ D GLA     G   +T    GT G++APE   
Sbjct: 307 Q---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ-TKTKGYAGTPGFMAPELLL 362
Query: 438 TGKATTSADVFSFGAFLLEVACGRRPIQRQG 468
             +   S D F+ G  L E+   R P + +G
Sbjct: 363 GEEYDFSVDYFALGVTLYEMIAARGPFRARG 393

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 98/211 (46%), Gaps = 9/211 (4%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQ---GMKEFVAEIVSIGRLRHRN 319
           F +  +LG GGFG V+   +  +    A KK++ +  +   G +  + E   + ++  R 
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYLY--DQPKVTLNWIQRFRVIKGVALGLFYLH 377
           +V L      K +L LV   M  G +  ++Y  D+        +       +  GL +LH
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH 306
Query: 378 QEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTR 437
           Q   + +I+RD+K  NVLLD + N R+ D GLA     G   +T    GT G++APE   
Sbjct: 307 Q---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ-TKTKGYAGTPGFMAPELLL 362
Query: 438 TGKATTSADVFSFGAFLLEVACGRRPIQRQG 468
             +   S D F+ G  L E+   R P + +G
Sbjct: 363 GEEYDFSVDYFALGVTLYEMIAARGPFRARG 393

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 99/205 (48%), Gaps = 17/205 (8%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKIS-HESRQGMKEFVAEIVSIGRLRHRNLVQLLGYC 327
           +G G +G V       +++ +A+KKIS  E +   +  + EI  +   RH N++ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 328 R-----RKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQ 382
           R     +  ++ +V D M    L K L  Q  ++ + I  F  +  +  GL Y+H     
Sbjct: 93  RAPTIEQMKDVYIVQDLM-ETDLYKLLKTQ-HLSNDHICYF--LYQILRGLKYIHS---A 145
Query: 383 VVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ--TTHVVGTLGYLAPEHTRTGK 440
            V+HRD+K SN+LL+   + ++ DFGLAR+ D   D     T  V T  Y APE     K
Sbjct: 146 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 205
Query: 441 A-TTSADVFSFGAFLLEVACGRRPI 464
             T S D++S G  L E+    RPI
Sbjct: 206 GYTKSIDIWSVGCILAEML-SNRPI 229

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 96/213 (45%), Gaps = 12/213 (5%)
Query: 263 FREKELLGTGGFGRVY--RGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNL 320
           +R  + +G G F +V   R  L   ++ I +   +  +   +++   E+  +  L H N+
Sbjct: 14  YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNI 73
Query: 321 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQ-RFRVIKGVALGLFYLHQE 379
           V+L      +  L L+ +Y   G +  YL    ++     + +FR I      + Y HQ 
Sbjct: 74  VKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQI---VSAVQYCHQ- 129
Query: 380 WEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTG 439
             + ++HRD+KA N+LLD ++N ++ DFG +  +  G    T    G+  Y APE  +  
Sbjct: 130 --KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDT--FCGSPPYAAPELFQGK 185
Query: 440 KAT-TSADVFSFGAFLLEVACGRRPIQRQGPSE 471
           K      DV+S G  L  +  G  P   Q   E
Sbjct: 186 KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE 218

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/158 (31%), Positives = 77/158 (48%), Gaps = 10/158 (6%)
Query: 317 HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYL 376
           H  LV L    + +  L  V +Y+  G L  ++  Q K+     + +     ++L L YL
Sbjct: 112 HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA--EISLALNYL 169
Query: 377 HQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP--QTTHVVGTLGYLAPE 434
           H   E+ +I+RD+K  NVLLD E + +L D+G+ +    G  P   T+   GT  Y+APE
Sbjct: 170 H---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK---EGLRPGDTTSTFCGTPNYIAPE 223
Query: 435 HTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSEN 472
             R      S D ++ G  + E+  GR P    G S+N
Sbjct: 224 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN 261

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 98/211 (46%), Gaps = 9/211 (4%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQ---GMKEFVAEIVSIGRLRHRN 319
           F +  +LG GGFG V+   +  +    A KK++ +  +   G +  + E   + ++  R 
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246
Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYLY--DQPKVTLNWIQRFRVIKGVALGLFYLH 377
           +V L      K +L LV   M  G +  ++Y  D+        +       +  GL +LH
Sbjct: 247 IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLH 306
Query: 378 QEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTR 437
           Q   + +I+RD+K  NVLLD + N R+ D GLA     G   +T    GT G++APE   
Sbjct: 307 Q---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ-TKTKGYAGTPGFMAPELLL 362
Query: 438 TGKATTSADVFSFGAFLLEVACGRRPIQRQG 468
             +   S D F+ G  L E+   R P + +G
Sbjct: 363 GEEYDFSVDYFALGVTLYEMIAARGPFRARG 393

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 96/209 (45%), Gaps = 28/209 (13%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAV-----KKISHESRQGMKEFVAEIVSIGRLRHRNLVQL 323
           +G G F  VY+G   ++ +E+A      +K++   RQ  KE   E   +  L+H N+V+ 
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKE---EAEXLKGLQHPNIVRF 90
Query: 324 L----GYCRRKGELLLVYDYMPNGSLDKYL----YDQPKVTLNWIQRFRVIKGVALGLFY 375
                   + K  ++LV +   +G+L  YL      + KV  +W ++      +  GL +
Sbjct: 91  YDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQ------ILKGLQF 144
Query: 376 LHQEWEQVVIHRDVKASNVLLDGELNG-RLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE 434
           LH      +IHRD+K  N+ + G     ++GD GLA L           V+GT  + APE
Sbjct: 145 LHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF---AKAVIGTPEFXAPE 200
Query: 435 HTRTGKATTSADVFSFGAFLLEVACGRRP 463
                K   S DV++FG   LE A    P
Sbjct: 201 XYEE-KYDESVDVYAFGXCXLEXATSEYP 228

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 108/212 (50%), Gaps = 19/212 (8%)
Query: 261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKIS-HESRQGM-KEFVAEIVSIGRLRHR 318
           + + + E +G G +G V++    ++   +A+K++   +  +G+    + EI  +  L+H+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 319 NLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYD-----QPKVTLNWIQRFRVIKGVALGL 373
           N+V+L        +L LV+++  +  L KY         P++  +++  F+++KG+    
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFC-DQDLKKYFDSCNGDLDPEIVKSFL--FQLLKGLG--- 115
Query: 374 FYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAP 433
            + H    + V+HRD+K  N+L++     +L DFGLAR +       +  VV TL Y  P
Sbjct: 116 -FCHS---RNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPP 170
Query: 434 EHTRTGKA-TTSADVFSFGAFLLEVACGRRPI 464
           +     K  +TS D++S G    E+A   RP+
Sbjct: 171 DVLFGAKLYSTSIDMWSAGCIFAELANAARPL 202

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 28/218 (12%)
Query: 268 LLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLR----------- 316
           ++G G + +V    L K+    A+K +        KE V +   I  ++           
Sbjct: 16  VIGRGSYAKVLLVRLKKTDRIYAMKVVK-------KELVNDDEDIDWVQTEKHVFEQASN 68
Query: 317 HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYL 376
           H  LV L    + +  L  V +Y+  G L  ++  Q K+     + +     ++L L YL
Sbjct: 69  HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA--EISLALNYL 126
Query: 377 HQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP--QTTHVVGTLGYLAPE 434
           H   E+ +I+RD+K  NVLLD E + +L D+G+ +    G  P   T+   GT  Y+APE
Sbjct: 127 H---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK---EGLRPGDTTSXFCGTPNYIAPE 180
Query: 435 HTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSEN 472
             R      S D ++ G  + E+  GR P    G S+N
Sbjct: 181 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN 218

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 94/208 (45%), Gaps = 7/208 (3%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCR 328
           +G G  G V   T+  S   +AVKK+    +Q  +    E+V +   +H N+V++     
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 98
Query: 329 RKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRD 388
              EL +V +++  G+L   +       +N  Q   V   V   L  LH    Q VIHRD
Sbjct: 99  VGDELWVVMEFLEGGALTDIVT---HTRMNEEQIAAVCLAVLQALSVLHA---QGVIHRD 152
Query: 389 VKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVF 448
           +K+ ++LL  +   +L DFG          P+   +VGT  ++APE           D++
Sbjct: 153 IKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKXLVGTPYWMAPELISRLPYGPEVDIW 211
Query: 449 SFGAFLLEVACGRRPIQRQGPSENLILV 476
           S G  ++E+  G  P   + P + + ++
Sbjct: 212 SLGIMVIEMVDGEPPYFNEPPLKAMKMI 239

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 94/213 (44%), Gaps = 12/213 (5%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKI--SHESRQGMKEFVAEIVSIGRLRHRNL 320
           +R  + +G G F +V       +  E+AVK I  +  +   +++   E+     L H N+
Sbjct: 16  YRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNI 75
Query: 321 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQ-RFRVIKGVALGLFYLHQE 379
           V+L      +  L LV +Y   G +  YL    +      + +FR I      + Y HQ+
Sbjct: 76  VKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQI---VSAVQYCHQK 132
Query: 380 WEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTG 439
           +   ++HRD+KA N+LLD + N ++ DFG +  +  G   +     G   Y APE  +  
Sbjct: 133 F---IVHRDLKAENLLLDADXNIKIADFGFSNEFTFGN--KLDAFCGAPPYAAPELFQGK 187
Query: 440 KAT-TSADVFSFGAFLLEVACGRRPIQRQGPSE 471
           K      DV+S G  L  +  G  P   Q   E
Sbjct: 188 KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE 220

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 104/213 (48%), Gaps = 26/213 (12%)
Query: 269 LGTGGFGRVYRG-TLPKSQIEIAVKKISHES-RQGMKEFVAEIVSIGR----LRHRNLVQ 322
           +G G +G+V++   L      +A+K++  ++  +GM       V++ R      H N+V+
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 323 LLGYCR-----RKGELLLVYDYMPNGSLDKYL--YDQPKVTLNWIQ--RFRVIKGVALGL 373
           L   C      R+ +L LV++++ +  L  YL    +P V    I+   F++++G    L
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRG----L 133
Query: 374 FYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAP 433
            +LH      V+HRD+K  N+L+      +L DFGLAR+Y        T VV TL Y AP
Sbjct: 134 DFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM--ALTSVVVTLWYRAP 188
Query: 434 EHTRTGKATTSADVFSFGAFLLEVACGRRPIQR 466
           E        T  D++S G    E+   R+P+ R
Sbjct: 189 EVLLQSSYATPVDLWSVGCIFAEMF-RRKPLFR 220

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 94/208 (45%), Gaps = 7/208 (3%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCR 328
           +G G  G V   T+  S   +AVKK+    +Q  +    E+V +   +H N+V++     
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 96
Query: 329 RKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRD 388
              EL +V +++  G+L   +       +N  Q   V   V   L  LH    Q VIHRD
Sbjct: 97  VGDELWVVMEFLEGGALTDIVT---HTRMNEEQIAAVCLAVLQALSVLH---AQGVIHRD 150
Query: 389 VKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVF 448
           +K+ ++LL  +   +L DFG          P+   +VGT  ++APE           D++
Sbjct: 151 IKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKXLVGTPYWMAPELISRLPYGPEVDIW 209
Query: 449 SFGAFLLEVACGRRPIQRQGPSENLILV 476
           S G  ++E+  G  P   + P + + ++
Sbjct: 210 SLGIMVIEMVDGEPPYFNEPPLKAMKMI 237

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 101/202 (50%), Gaps = 11/202 (5%)
Query: 268 LLGTGGFGRVYRGTLPKSQIEIAVKKISHES---RQGMKEFVAEIVSIGR-LRHRNLVQL 323
            LG GGF + +  +   ++ E+   KI  +S   +   +E ++  +SI R L H+++V  
Sbjct: 28  FLGKGGFAKCFEISDADTK-EVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 86
Query: 324 LGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQV 383
            G+      + +V +     SL + L+ + K       R+  ++ + LG  YLH+     
Sbjct: 87  HGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARY-YLRQIVLGCQYLHRNR--- 141
Query: 384 VIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATT 443
           VIHRD+K  N+ L+ +L  ++GDFGLA   ++  + + T + GT  Y+APE       + 
Sbjct: 142 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT-LCGTPNYIAPEVLSKKGHSF 200
Query: 444 SADVFSFGAFLLEVACGRRPIQ 465
             DV+S G  +  +  G+ P +
Sbjct: 201 EVDVWSIGCIMYTLLVGKPPFE 222

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 94/212 (44%), Gaps = 14/212 (6%)
Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMK---EFVAEIVSIGRLRHRNLVQL 323
           E+LG GG   V+     +   ++AVK +  +  +       F  E  +   L H  +V +
Sbjct: 35  EILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 94
Query: 324 LGYCRRK---GEL-LLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQE 379
                 +   G L  +V +Y+   +L   ++ +  +T    +   VI      L + HQ 
Sbjct: 95  YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPK--RAIEVIADACQALNFSHQN 152
Query: 380 WEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTD-PQTTHVVGTLGYLAPEHTR 437
               +IHRDVK +N+++      ++ DFG+AR + D G    QT  V+GT  YL+PE  R
Sbjct: 153 G---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 209
Query: 438 TGKATTSADVFSFGAFLLEVACGRRPIQRQGP 469
                  +DV+S G  L EV  G  P     P
Sbjct: 210 GDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 241

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 94/208 (45%), Gaps = 7/208 (3%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCR 328
           +G G  G V   T+  S   +AVKK+    +Q  +    E+V +   +H N+V++     
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 91
Query: 329 RKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRD 388
              EL +V +++  G+L   +       +N  Q   V   V   L  LH    Q VIHRD
Sbjct: 92  VGDELWVVMEFLEGGALTDIVT---HTRMNEEQIAAVCLAVLQALSVLHA---QGVIHRD 145
Query: 389 VKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVF 448
           +K+ ++LL  +   +L DFG          P+   +VGT  ++APE           D++
Sbjct: 146 IKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKXLVGTPYWMAPELISRLPYGPEVDIW 204
Query: 449 SFGAFLLEVACGRRPIQRQGPSENLILV 476
           S G  ++E+  G  P   + P + + ++
Sbjct: 205 SLGIMVIEMVDGEPPYFNEPPLKAMKMI 232

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 94/208 (45%), Gaps = 7/208 (3%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCR 328
           +G G  G V   T+  S   +AVKK+    +Q  +    E+V +   +H N+V++     
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 329 RKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRD 388
              EL +V +++  G+L   +       +N  Q   V   V   L  LH    Q VIHRD
Sbjct: 88  VGDELWVVMEFLEGGALTDIVT---HTRMNEEQIAAVCLAVLQALSVLHA---QGVIHRD 141
Query: 389 VKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVF 448
           +K+ ++LL  +   +L DFG          P+   +VGT  ++APE           D++
Sbjct: 142 IKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKXLVGTPYWMAPELISRLPYGPEVDIW 200
Query: 449 SFGAFLLEVACGRRPIQRQGPSENLILV 476
           S G  ++E+  G  P   + P + + ++
Sbjct: 201 SLGIMVIEMVDGEPPYFNEPPLKAMKMI 228

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 105/217 (48%), Gaps = 10/217 (4%)
Query: 254 KDLYIATKGFREKELLGTGGFGRVYRGTLPKSQ---IEIAVKKISHESRQGMKE-FVAEI 309
           +D  I  +       +G G FG V++G     +   + +A+K   + +   ++E F+ E 
Sbjct: 31  RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEA 90
Query: 310 VSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGV 369
           +++ +  H ++V+L+G    +  + ++ +    G L  +L  + K +L+          +
Sbjct: 91  LTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQL 148
Query: 370 ALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLG 429
           +  L YL     +  +HRD+ A NVL+      +LGDFGL+R  +  T  + +     + 
Sbjct: 149 STALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 205
Query: 430 YLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQ 465
           ++APE     + T+++DV+ FG  + E+   G +P Q
Sbjct: 206 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ 242

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 94/214 (43%), Gaps = 33/214 (15%)
Query: 287 IEIAVKKISHESRQGMKEFVAEIVSIGR--LRHRNLVQLLGYCRRKGELLLVYDYMPNGS 344
           +E+  +++S E  + ++E       I R    H +++ L+        + LV+D M  G 
Sbjct: 127 MEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGE 186
Query: 345 LDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRL 404
           L  YL +  KV L+  +   +++ +   + +LH      ++HRD+K  N+LLD  +  RL
Sbjct: 187 LFDYLTE--KVALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRL 241
Query: 405 GDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATT------SADVFSFGAFLLEVA 458
            DFG +   + G   +   + GT GYLAPE  +     T        D+++ G  L  + 
Sbjct: 242 SDFGFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLL 299
Query: 459 CGRRPIQRQGPSENLILVDWVFDFWNRGELLEAR 492
            G  P                  FW+R ++L  R
Sbjct: 300 AGSPP------------------FWHRRQILMLR 315

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 103/219 (47%), Gaps = 33/219 (15%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKI--SHESRQGMKEFVAEIVSIGRLR-HRNLVQLLG 325
           LG G +G V++    ++   +AVKKI  + ++    +    EI+ +  L  H N+V LL 
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLN 76
Query: 326 YCRRKGE--LLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQV 383
             R   +  + LV+DYM     D +   +  + L  + +  V+  +   + YLH      
Sbjct: 77  VLRADNDRDVYLVFDYM---ETDLHAVIRANI-LEPVHKQYVVYQLIKVIKYLHSGG--- 129
Query: 384 VIHRDVKASNVLLDGELNGRLGDFGLARLY--------------DHGTD------PQTTH 423
           ++HRD+K SN+LL+ E + ++ DFGL+R +              +  T+      P  T 
Sbjct: 130 LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTD 189
Query: 424 VVGTLGYLAPEHTR-TGKATTSADVFSFGAFLLEVACGR 461
            V T  Y APE    + K T   D++S G  L E+ CG+
Sbjct: 190 YVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 94/208 (45%), Gaps = 7/208 (3%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCR 328
           +G G  G V   T+  S   +AVKK+    +Q  +    E+V +   +H N+V++     
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 218
Query: 329 RKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRD 388
              EL +V +++  G+L   +       +N  Q   V   V   L  LH    Q VIHRD
Sbjct: 219 VGDELWVVMEFLEGGALTDIVT---HTRMNEEQIAAVCLAVLQALSVLHA---QGVIHRD 272
Query: 389 VKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVF 448
           +K+ ++LL  +   +L DFG          P+   +VGT  ++APE           D++
Sbjct: 273 IKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKXLVGTPYWMAPELISRLPYGPEVDIW 331
Query: 449 SFGAFLLEVACGRRPIQRQGPSENLILV 476
           S G  ++E+  G  P   + P + + ++
Sbjct: 332 SLGIMVIEMVDGEPPYFNEPPLKAMKMI 359

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 105/217 (48%), Gaps = 10/217 (4%)
Query: 254 KDLYIATKGFREKELLGTGGFGRVYRGTLPKSQ---IEIAVKKISHESRQGMKE-FVAEI 309
           +D  I  +       +G G FG V++G     +   + +A+K   + +   ++E F+ E 
Sbjct: 3   RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEA 62
Query: 310 VSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGV 369
           +++ +  H ++V+L+G    +  + ++ +    G L  +L  + K +L+          +
Sbjct: 63  LTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQL 120
Query: 370 ALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLG 429
           +  L YL     +  +HRD+ A NVL+      +LGDFGL+R  +  T  + +     + 
Sbjct: 121 STALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 177
Query: 430 YLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQ 465
           ++APE     + T+++DV+ FG  + E+   G +P Q
Sbjct: 178 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ 214

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 101/202 (50%), Gaps = 10/202 (4%)
Query: 269 LGTGGFGRVYRGTLPKSQ---IEIAVKKISHESRQGMKE-FVAEIVSIGRLRHRNLVQLL 324
           +G G FG V++G     +   + +A+K   + +   ++E F+ E +++ +  H ++V+L+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 325 GYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVV 384
           G    +  + ++ +    G L  +L  + K +L+          ++  L YL     +  
Sbjct: 78  GVIT-ENPVWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLES---KRF 132
Query: 385 IHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTS 444
           +HRD+ A NVL+      +LGDFGL+R  +  T  + +     + ++APE     + T++
Sbjct: 133 VHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 192
Query: 445 ADVFSFGAFLLEVAC-GRRPIQ 465
           +DV+ FG  + E+   G +P Q
Sbjct: 193 SDVWMFGVCMWEILMHGVKPFQ 214

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 105/217 (48%), Gaps = 10/217 (4%)
Query: 254 KDLYIATKGFREKELLGTGGFGRVYRGTLPKSQ---IEIAVKKISHESRQGMKE-FVAEI 309
           +D  I  +       +G G FG V++G     +   + +A+K   + +   ++E F+ E 
Sbjct: 3   RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEA 62
Query: 310 VSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGV 369
           +++ +  H ++V+L+G    +  + ++ +    G L  +L  + K +L+          +
Sbjct: 63  LTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQL 120
Query: 370 ALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLG 429
           +  L YL     +  +HRD+ A NVL+      +LGDFGL+R  +  T  + +     + 
Sbjct: 121 STALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 177
Query: 430 YLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQ 465
           ++APE     + T+++DV+ FG  + E+   G +P Q
Sbjct: 178 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ 214

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 105/217 (48%), Gaps = 10/217 (4%)
Query: 254 KDLYIATKGFREKELLGTGGFGRVYRGTLPKSQ---IEIAVKKISHESRQGMKE-FVAEI 309
           +D  I  +       +G G FG V++G     +   + +A+K   + +   ++E F+ E 
Sbjct: 6   RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEA 65
Query: 310 VSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGV 369
           +++ +  H ++V+L+G    +  + ++ +    G L  +L  + K +L+          +
Sbjct: 66  LTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQL 123
Query: 370 ALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLG 429
           +  L YL     +  +HRD+ A NVL+      +LGDFGL+R  +  T  + +     + 
Sbjct: 124 STALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 180
Query: 430 YLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQ 465
           ++APE     + T+++DV+ FG  + E+   G +P Q
Sbjct: 181 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ 217

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 102/208 (49%), Gaps = 25/208 (12%)
Query: 263 FREKELLGTGGFGRVYRGT-LPKSQ---IEIAVKKI-SHESRQGMKEFVAEIVSIGRLRH 317
            R+ ++LG+G FG VY+G  +P  +   I +A+K +  + S +  KE + E   +  +  
Sbjct: 19  LRKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGS 78
Query: 318 RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQ-----PKVTLNWIQRFRVIKGVALG 372
             + +LLG C     + LV   MP G L  ++ +       +  LNW  +      +A G
Sbjct: 79  PYVSRLLGICL-TSTVQLVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQ------IAKG 131
Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVG---TLG 429
           + YL    +  ++HRD+ A NVL+    + ++ DFGLARL D   D    H  G    + 
Sbjct: 132 MSYLE---DVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD--IDETEYHADGGKVPIK 186
Query: 430 YLAPEHTRTGKATTSADVFSFGAFLLEV 457
           ++A E     + T  +DV+S+G  + E+
Sbjct: 187 WMALESILRRRFTHQSDVWSYGVTVWEL 214

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 101/202 (50%), Gaps = 11/202 (5%)
Query: 268 LLGTGGFGRVYRGTLPKSQIEIAVKKISHES---RQGMKEFVAEIVSIGR-LRHRNLVQL 323
            LG GGF + +  +   ++ E+   KI  +S   +   +E ++  +SI R L H+++V  
Sbjct: 24  FLGKGGFAKCFEISDADTK-EVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 82
Query: 324 LGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQV 383
            G+      + +V +     SL + L+ + K       R+  ++ + LG  YLH+     
Sbjct: 83  HGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARY-YLRQIVLGCQYLHRNR--- 137
Query: 384 VIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATT 443
           VIHRD+K  N+ L+ +L  ++GDFGLA   ++  + + T + GT  Y+APE       + 
Sbjct: 138 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT-LCGTPNYIAPEVLSKKGHSF 196
Query: 444 SADVFSFGAFLLEVACGRRPIQ 465
             DV+S G  +  +  G+ P +
Sbjct: 197 EVDVWSIGCIMYTLLVGKPPFE 218

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 105/217 (48%), Gaps = 10/217 (4%)
Query: 254 KDLYIATKGFREKELLGTGGFGRVYRGTLPKSQ---IEIAVKKISHESRQGMKE-FVAEI 309
           +D  I  +       +G G FG V++G     +   + +A+K   + +   ++E F+ E 
Sbjct: 8   RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEA 67
Query: 310 VSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGV 369
           +++ +  H ++V+L+G    +  + ++ +    G L  +L  + K +L+          +
Sbjct: 68  LTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQL 125
Query: 370 ALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLG 429
           +  L YL     +  +HRD+ A NVL+      +LGDFGL+R  +  T  + +     + 
Sbjct: 126 STALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 182
Query: 430 YLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQ 465
           ++APE     + T+++DV+ FG  + E+   G +P Q
Sbjct: 183 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ 219

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 101/202 (50%), Gaps = 11/202 (5%)
Query: 268 LLGTGGFGRVYRGTLPKSQIEIAVKKISHES---RQGMKEFVAEIVSIGR-LRHRNLVQL 323
            LG GGF + +  +   ++ E+   KI  +S   +   +E ++  +SI R L H+++V  
Sbjct: 24  FLGKGGFAKCFEISDADTK-EVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 82
Query: 324 LGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQV 383
            G+      + +V +     SL + L+ + K       R+  ++ + LG  YLH+     
Sbjct: 83  HGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARY-YLRQIVLGCQYLHRNR--- 137
Query: 384 VIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATT 443
           VIHRD+K  N+ L+ +L  ++GDFGLA   ++  + + T + GT  Y+APE       + 
Sbjct: 138 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT-LCGTPNYIAPEVLSKKGHSF 196
Query: 444 SADVFSFGAFLLEVACGRRPIQ 465
             DV+S G  +  +  G+ P +
Sbjct: 197 EVDVWSIGCIMYTLLVGKPPFE 218

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 97/222 (43%), Gaps = 40/222 (18%)
Query: 269 LGTGGFGRVYRGTL-----PKSQIEIAVKKISHESRQGMKE-FVAEIVSIGRL-RHRNLV 321
           LG G FG+V   T        + +++AVK +   +    KE  ++E+  +  L +H N+V
Sbjct: 39  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 98
Query: 322 QLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTL---------------------NWI 360
            LLG C   G +L++ +Y   G L  +L  + +  L                        
Sbjct: 99  NLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELR 158
Query: 361 QRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ 420
                   VA G+ +L     +  IHRDV A NVLL      ++GDFGLAR  D   D  
Sbjct: 159 DLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLAR--DIMND-- 211
Query: 421 TTHVVG-----TLGYLAPEHTRTGKATTSADVFSFGAFLLEV 457
           + ++V       + ++APE       T  +DV+S+G  L E+
Sbjct: 212 SNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 253

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 92/201 (45%), Gaps = 10/201 (4%)
Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGR-LRHRNLVQLLG 325
           + LG G  G V       ++  +AVK +  +      E + + + I + L H N+V+  G
Sbjct: 12  QTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 326 YCRRKGEL-LLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVV 384
           + RR+G +  L  +Y   G L   +  +P + +      R    +  G+ YLH      +
Sbjct: 72  H-RREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLHG---IGI 125
Query: 385 IHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ-TTHVVGTLGYLAPE-HTRTGKAT 442
            HRD+K  N+LLD   N ++ DFGLA ++ +    +    + GTL Y+APE   R     
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 443 TSADVFSFGAFLLEVACGRRP 463
              DV+S G  L  +  G  P
Sbjct: 186 EPVDVWSCGIVLTAMLAGELP 206

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 101/202 (50%), Gaps = 10/202 (4%)
Query: 269 LGTGGFGRVYRGTLPKSQ---IEIAVKKISHESRQGMKE-FVAEIVSIGRLRHRNLVQLL 324
           +G G FG V++G     +   + +A+K   + +   ++E F+ E +++ +  H ++V+L+
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 325 GYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVV 384
           G    +  + ++ +    G L  +L  + K +L+          ++  L YL     +  
Sbjct: 75  GVIT-ENPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLES---KRF 129
Query: 385 IHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTS 444
           +HRD+ A NVL+      +LGDFGL+R  +  T  + +     + ++APE     + T++
Sbjct: 130 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 189
Query: 445 ADVFSFGAFLLEVAC-GRRPIQ 465
           +DV+ FG  + E+   G +P Q
Sbjct: 190 SDVWMFGVCMWEILMHGVKPFQ 211

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 105/217 (48%), Gaps = 10/217 (4%)
Query: 254 KDLYIATKGFREKELLGTGGFGRVYRGTLPKSQ---IEIAVKKISHESRQGMKE-FVAEI 309
           +D  I  +       +G G FG V++G     +   + +A+K   + +   ++E F+ E 
Sbjct: 5   RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEA 64
Query: 310 VSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGV 369
           +++ +  H ++V+L+G    +  + ++ +    G L  +L  + K +L+          +
Sbjct: 65  LTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQL 122
Query: 370 ALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLG 429
           +  L YL     +  +HRD+ A NVL+      +LGDFGL+R  +  T  + +     + 
Sbjct: 123 STALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 179
Query: 430 YLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQ 465
           ++APE     + T+++DV+ FG  + E+   G +P Q
Sbjct: 180 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQ 216

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 104/213 (48%), Gaps = 26/213 (12%)
Query: 269 LGTGGFGRVYRG-TLPKSQIEIAVKKISHES-RQGMKEFVAEIVSIGR----LRHRNLVQ 322
           +G G +G+V++   L      +A+K++  ++  +GM       V++ R      H N+V+
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 323 LLGYCR-----RKGELLLVYDYMPNGSLDKYL--YDQPKVTLNWIQ--RFRVIKGVALGL 373
           L   C      R+ +L LV++++ +  L  YL    +P V    I+   F++++G    L
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRG----L 133
Query: 374 FYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAP 433
            +LH      V+HRD+K  N+L+      +L DFGLAR+Y        T VV TL Y AP
Sbjct: 134 DFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM--ALTSVVVTLWYRAP 188
Query: 434 EHTRTGKATTSADVFSFGAFLLEVACGRRPIQR 466
           E        T  D++S G    E+   R+P+ R
Sbjct: 189 EVLLQSSYATPVDLWSVGCIFAEMF-RRKPLFR 220

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 94/208 (45%), Gaps = 7/208 (3%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCR 328
           +G G  G V   T+  S   +AVKK+    +Q  +    E+V +   +H N+V++     
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 141
Query: 329 RKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRD 388
              EL +V +++  G+L   +       +N  Q   V   V   L  LH    Q VIHRD
Sbjct: 142 VGDELWVVMEFLEGGALTDIVT---HTRMNEEQIAAVCLAVLQALSVLH---AQGVIHRD 195
Query: 389 VKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVF 448
           +K+ ++LL  +   +L DFG          P+   +VGT  ++APE           D++
Sbjct: 196 IKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKXLVGTPYWMAPELISRLPYGPEVDIW 254
Query: 449 SFGAFLLEVACGRRPIQRQGPSENLILV 476
           S G  ++E+  G  P   + P + + ++
Sbjct: 255 SLGIMVIEMVDGEPPYFNEPPLKAMKMI 282

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 104/213 (48%), Gaps = 26/213 (12%)
Query: 269 LGTGGFGRVYRG-TLPKSQIEIAVKKISHES-RQGMKEFVAEIVSIGR----LRHRNLVQ 322
           +G G +G+V++   L      +A+K++  ++  +GM       V++ R      H N+V+
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 323 LLGYCR-----RKGELLLVYDYMPNGSLDKYL--YDQPKVTLNWIQ--RFRVIKGVALGL 373
           L   C      R+ +L LV++++ +  L  YL    +P V    I+   F++++G    L
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRG----L 133
Query: 374 FYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAP 433
            +LH      V+HRD+K  N+L+      +L DFGLAR+Y        T VV TL Y AP
Sbjct: 134 DFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM--ALTSVVVTLWYRAP 188
Query: 434 EHTRTGKATTSADVFSFGAFLLEVACGRRPIQR 466
           E        T  D++S G    E+   R+P+ R
Sbjct: 189 EVLLQSSYATPVDLWSVGCIFAEMF-RRKPLFR 220

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 101/202 (50%), Gaps = 10/202 (4%)
Query: 269 LGTGGFGRVYRGTLPKSQ---IEIAVKKISHESRQGMKE-FVAEIVSIGRLRHRNLVQLL 324
           +G G FG V++G     +   + +A+K   + +   ++E F+ E +++ +  H ++V+L+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 325 GYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVV 384
           G    +  + ++ +    G L  +L  + K +L+          ++  L YL     +  
Sbjct: 458 GVIT-ENPVWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLES---KRF 512
Query: 385 IHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTS 444
           +HRD+ A NVL+      +LGDFGL+R  +  T  + +     + ++APE     + T++
Sbjct: 513 VHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 572
Query: 445 ADVFSFGAFLLEVAC-GRRPIQ 465
           +DV+ FG  + E+   G +P Q
Sbjct: 573 SDVWMFGVCMWEILMHGVKPFQ 594

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 78/302 (25%), Positives = 128/302 (42%), Gaps = 57/302 (18%)
Query: 269 LGTGGFGRVYRGT---LPKSQ--IEIAVKKISHESRQGMKE-FVAEIVSIGRL-RHRNLV 321
           LG G FG+V   T   L KS   + +AVK +   +    +E  ++E+  +  L  H N+V
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 322 QLLGYCRRKGELLLVYDYMPNGSLDKYLYDQ----------PKVTLNWIQ---------- 361
            LLG C   G  L++ +Y   G L  +L  +          P +  +             
Sbjct: 114 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 173
Query: 362 RFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQT 421
            ++V KG+A           +  IHRD+ A N+LL      ++ DFGLAR   H  +   
Sbjct: 174 SYQVAKGMAFLA-------SKNCIHRDLAARNILLTHGRITKICDFGLAR---HIKNDSN 223
Query: 422 THVVGT----LGYLAPEHTRTGKATTSADVFSFGAFLLEV-ACGRRPIQRQGPSENLILV 476
             V G     + ++APE       T  +DV+S+G FL E+ + G  P          + V
Sbjct: 224 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG-------MPV 276
Query: 477 DWVFDFWNRGELLEARDPNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQILERD 536
           D  F      ++++     L  E+              C  +DP  RP+ +Q+VQ++E+ 
Sbjct: 277 DSKF-----YKMIKEGFRMLSPEHAP---AEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 328
Query: 537 VA 538
           ++
Sbjct: 329 IS 330

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/202 (24%), Positives = 101/202 (50%), Gaps = 10/202 (4%)
Query: 269 LGTGGFGRVYRGTLPKSQ---IEIAVKKISHESRQGMKE-FVAEIVSIGRLRHRNLVQLL 324
           +G G FG V++G     +   + +A+K   + +   ++E F+ E +++ +  H ++V+L+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 325 GYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVV 384
           G    +  + ++ +    G L  +L  + K +L+          ++  L YL     +  
Sbjct: 458 GVIT-ENPVWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLES---KRF 512
Query: 385 IHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTS 444
           +HRD+ A NVL+      +LGDFGL+R  +  T  + +     + ++APE     + T++
Sbjct: 513 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 572
Query: 445 ADVFSFGAFLLEVAC-GRRPIQ 465
           +DV+ FG  + E+   G +P Q
Sbjct: 573 SDVWMFGVCMWEILMHGVKPFQ 594

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 71/297 (23%), Positives = 122/297 (41%), Gaps = 49/297 (16%)
Query: 269 LGTGGFGRVYRGTL-----PKSQIEIAVKKIS-HESRQGMKEFVAEIVSIGRLRHRNLVQ 322
           LG G FG+V + T            +AVK +  + S   +++ ++E   + ++ H ++++
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 323 LLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVAL----------- 371
           L G C + G LLL+ +Y   GSL  +L +  KV   ++         +L           
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 372 -----------GLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDP 419
                      G+ YL    E  ++HRD+ A N+L+      ++ DFGL+R +Y+  +  
Sbjct: 151 DLISFAWQISQGMQYLA---EMSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXV 207
Query: 420 QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLE-VACGRRPIQRQGPSENLILVDW 478
           + +     + ++A E       TT +DV+SFG  L E V  G  P     P         
Sbjct: 208 KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPER------- 260
Query: 479 VFDFWNRGELLEARDPNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQILER 535
           +F+    G  +E  D N   E               C   +P  RP    + + LE+
Sbjct: 261 LFNLLKTGHRMERPD-NCSEE--------MYRLMLQCWKQEPDKRPVFADISKDLEK 308

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 17/208 (8%)
Query: 263 FREKEL-----LGTGGFGRV----YRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIG 313
           F E+ L     LG G FG V    Y      +   +AVK++ H      ++F  EI  + 
Sbjct: 7   FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILK 66
Query: 314 RLRHRNLVQLLG--YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVAL 371
            L    +V+  G  Y   +  L LV +Y+P+G L  +L  + +  L+  +       +  
Sbjct: 67  ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL-QRHRARLDASRLLLYSSQICK 125
Query: 372 GLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT--LG 429
           G+ YL     +  +HRD+ A N+L++ E + ++ DFGLA+L     D       G   + 
Sbjct: 126 GMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF 182
Query: 430 YLAPEHTRTGKATTSADVFSFGAFLLEV 457
           + APE       +  +DV+SFG  L E+
Sbjct: 183 WYAPESLSDNIFSRQSDVWSFGVVLYEL 210

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 64/205 (31%), Positives = 99/205 (48%), Gaps = 17/205 (8%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKIS-HESRQGMKEFVAEIVSIGRLRHRNLVQLLGYC 327
           +G G +G V       +++ +A+KKIS  E +   +  + EI  +   RH N++ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 328 R-----RKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQ 382
           R     +  ++ +V D M    L K L  Q  ++ + I  F  +  +  GL Y+H     
Sbjct: 93  RAPTIEQMKDVYIVQDLM-ETDLYKLLKTQ-HLSNDHICYF--LYQILRGLKYIHS---A 145
Query: 383 VVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ--TTHVVGTLGYLAPEHTRTGK 440
            V+HRD+K SN+LL+   + ++ DFGLAR+ D   D     T  V T  Y APE     K
Sbjct: 146 NVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 205
Query: 441 A-TTSADVFSFGAFLLEVACGRRPI 464
             T S D++S G  L E+    RPI
Sbjct: 206 GYTKSIDIWSVGCILAEM-LSNRPI 229

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 92/220 (41%), Gaps = 11/220 (5%)
Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
           E LGTG FG V+R T   +    A K +        +    EI ++  LRH  LV L   
Sbjct: 163 EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA 222
Query: 327 CRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIH 386
                E++++Y++M  G L + + D+    ++  +    ++ V  GL ++H   E   +H
Sbjct: 223 FEDDNEMVMIYEFMSGGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMH---ENNYVH 278
Query: 387 RDVKASNVLLDGELNGRLG--DFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTS 444
            D+K  N++   + +  L   DFGL    D     + T   GT  + APE          
Sbjct: 279 LDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--TGTAEFAAPEVAEGKPVGYY 336
Query: 445 ADVFSFGAFLLEVACGRRPIQRQGPSE---NLILVDWVFD 481
            D++S G     +  G  P   +   E   N+   DW  D
Sbjct: 337 TDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMD 376

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 17/208 (8%)
Query: 263 FREKEL-----LGTGGFGRV----YRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIG 313
           F E+ L     LG G FG V    Y      +   +AVK++ H      ++F  EI  + 
Sbjct: 20  FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILK 79
Query: 314 RLRHRNLVQLLG--YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVAL 371
            L    +V+  G  Y   +  L LV +Y+P+G L  +L  + +  L+  +       +  
Sbjct: 80  ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL-QRHRARLDASRLLLYSSQICK 138
Query: 372 GLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT--LG 429
           G+ YL     +  +HRD+ A N+L++ E + ++ DFGLA+L     D       G   + 
Sbjct: 139 GMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF 195
Query: 430 YLAPEHTRTGKATTSADVFSFGAFLLEV 457
           + APE       +  +DV+SFG  L E+
Sbjct: 196 WYAPESLSDNIFSRQSDVWSFGVVLYEL 223

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 17/208 (8%)
Query: 263 FREKEL-----LGTGGFGRV----YRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIG 313
           F E+ L     LG G FG V    Y      +   +AVK++ H      ++F  EI  + 
Sbjct: 8   FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILK 67
Query: 314 RLRHRNLVQLLG--YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVAL 371
            L    +V+  G  Y   +  L LV +Y+P+G L  +L  + +  L+  +       +  
Sbjct: 68  ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL-QRHRARLDASRLLLYSSQICK 126
Query: 372 GLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT--LG 429
           G+ YL     +  +HRD+ A N+L++ E + ++ DFGLA+L     D       G   + 
Sbjct: 127 GMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIF 183
Query: 430 YLAPEHTRTGKATTSADVFSFGAFLLEV 457
           + APE       +  +DV+SFG  L E+
Sbjct: 184 WYAPESLSDNIFSRQSDVWSFGVVLYEL 211

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 92/220 (41%), Gaps = 11/220 (5%)
Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
           E LGTG FG V+R T   +    A K +        +    EI ++  LRH  LV L   
Sbjct: 57  EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA 116
Query: 327 CRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIH 386
                E++++Y++M  G L + + D+    ++  +    ++ V  GL ++H   E   +H
Sbjct: 117 FEDDNEMVMIYEFMSGGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMH---ENNYVH 172
Query: 387 RDVKASNVLLDGELNGRLG--DFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTS 444
            D+K  N++   + +  L   DFGL    D     + T   GT  + APE          
Sbjct: 173 LDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--TGTAEFAAPEVAEGKPVGYY 230
Query: 445 ADVFSFGAFLLEVACGRRPIQRQGPSE---NLILVDWVFD 481
            D++S G     +  G  P   +   E   N+   DW  D
Sbjct: 231 TDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMD 270

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 109/234 (46%), Gaps = 28/234 (11%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVS-----IGRLRH 317
           F+  ++LG G F  V       +  E A+K +  E R  +KE     V+     + RL H
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 318 RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYL-----YDQPKVTLNWIQRFRVIKGVALG 372
              V+L    +   +L     Y  NG L KY+     +D+         RF   + V+  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDET------CTRFYTAEIVS-A 144
Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVGTLGYL 431
           L YLH +    +IHRD+K  N+LL+ +++ ++ DFG A+ L       +    VGT  Y+
Sbjct: 145 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 201
Query: 432 APEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLI---LVDWVFDF 482
           +PE      A+ S+D+++ G  + ++  G  P  R G +E LI   ++   +DF
Sbjct: 202 SPELLTEKSASKSSDLWALGCIIYQLVAGLPPF-RAG-NEYLIFQKIIKLEYDF 253

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 109/239 (45%), Gaps = 26/239 (10%)
Query: 248 PHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQI---EIAVKKISH---ESRQG 301
           P  F      I +  ++ + +LG G FG V    L K +I   E AVK IS    + +  
Sbjct: 13  PGXFVQHSTAIFSDRYKGQRVLGKGSFGEV---ILCKDKITGQECAVKVISKRQVKQKTD 69
Query: 302 MKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQ--PKVTLNW 359
            +  + E+  + +L H N+ +L  +   KG   LV +    G L    +D+   +   + 
Sbjct: 70  KESLLREVQLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRFSE 125
Query: 360 IQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDG---ELNGRLGDFGLARLYDHG 416
           +   R+I+ V  G+ Y H+     ++HRD+K  N+LL+    + N R+ DFGL+  ++  
Sbjct: 126 VDAARIIRQVLSGITYXHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE-- 180
Query: 417 TDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLIL 475
              +    +GT  Y+APE    G      DV+S G  L  +  G  P    G +E  IL
Sbjct: 181 ASKKXKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPPF--NGANEYDIL 236

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 71/297 (23%), Positives = 122/297 (41%), Gaps = 49/297 (16%)
Query: 269 LGTGGFGRVYRGTL-----PKSQIEIAVKKIS-HESRQGMKEFVAEIVSIGRLRHRNLVQ 322
           LG G FG+V + T            +AVK +  + S   +++ ++E   + ++ H ++++
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 323 LLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVAL----------- 371
           L G C + G LLL+ +Y   GSL  +L +  KV   ++         +L           
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 372 -----------GLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDP 419
                      G+ YL    E  ++HRD+ A N+L+      ++ DFGL+R +Y+  +  
Sbjct: 151 DLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXV 207
Query: 420 QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLE-VACGRRPIQRQGPSENLILVDW 478
           + +     + ++A E       TT +DV+SFG  L E V  G  P     P         
Sbjct: 208 KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPER------- 260
Query: 479 VFDFWNRGELLEARDPNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQILER 535
           +F+    G  +E  D N   E               C   +P  RP    + + LE+
Sbjct: 261 LFNLLKTGHRMERPD-NCSEE--------MYRLMLQCWKQEPDKRPVFADISKDLEK 308

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 79/303 (26%), Positives = 130/303 (42%), Gaps = 59/303 (19%)
Query: 269 LGTGGFGRVYRGT---LPKSQ--IEIAVKKISHESRQGMKE-FVAEIVSIGRL-RHRNLV 321
           LG G FG+V   T   L KS   + +AVK +   +    +E  ++E+  +  L  H N+V
Sbjct: 49  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 108
Query: 322 QLLGYCRRKGELLLVYDYMPNGSLDKYLYDQ----------PKVTLNWIQ---------- 361
            LLG C   G  L++ +Y   G L  +L  +          P +  +             
Sbjct: 109 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 168
Query: 362 RFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQT 421
            ++V KG+A           +  IHRD+ A N+LL      ++ DFGLAR  D   D  +
Sbjct: 169 SYQVAKGMAFLA-------SKNCIHRDLAARNILLTHGRITKICDFGLAR--DIKND--S 217
Query: 422 THVVG-----TLGYLAPEHTRTGKATTSADVFSFGAFLLEV-ACGRRPIQRQGPSENLIL 475
            +VV       + ++APE       T  +DV+S+G FL E+ + G  P          + 
Sbjct: 218 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG-------MP 270
Query: 476 VDWVFDFWNRGELLEARDPNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQILER 535
           VD  F      ++++     L  E+              C  +DP  RP+ +Q+VQ++E+
Sbjct: 271 VDSKF-----YKMIKEGFRMLSPEHAP---AEMYDIMKTCWDADPLKRPTFKQIVQLIEK 322
Query: 536 DVA 538
            ++
Sbjct: 323 QIS 325

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 79/303 (26%), Positives = 130/303 (42%), Gaps = 59/303 (19%)
Query: 269 LGTGGFGRVYRGT---LPKSQ--IEIAVKKISHESRQGMKE-FVAEIVSIGRL-RHRNLV 321
           LG G FG+V   T   L KS   + +AVK +   +    +E  ++E+  +  L  H N+V
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 113
Query: 322 QLLGYCRRKGELLLVYDYMPNGSLDKYLYDQ----------PKVTLNWIQ---------- 361
            LLG C   G  L++ +Y   G L  +L  +          P +  +             
Sbjct: 114 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 173
Query: 362 RFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQT 421
            ++V KG+A           +  IHRD+ A N+LL      ++ DFGLAR  D   D  +
Sbjct: 174 SYQVAKGMAFLA-------SKNCIHRDLAARNILLTHGRITKICDFGLAR--DIKND--S 222
Query: 422 THVVG-----TLGYLAPEHTRTGKATTSADVFSFGAFLLEV-ACGRRPIQRQGPSENLIL 475
            +VV       + ++APE       T  +DV+S+G FL E+ + G  P          + 
Sbjct: 223 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG-------MP 275
Query: 476 VDWVFDFWNRGELLEARDPNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQILER 535
           VD  F      ++++     L  E+              C  +DP  RP+ +Q+VQ++E+
Sbjct: 276 VDSKF-----YKMIKEGFRMLSPEHAP---AEMYDIMKTCWDADPLKRPTFKQIVQLIEK 327
Query: 536 DVA 538
            ++
Sbjct: 328 QIS 330

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 107/234 (45%), Gaps = 28/234 (11%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVS-----IGRLRH 317
           F+  ++LG G F  V       +  E A+K +  E R  +KE     V+     + RL H
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 318 RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYL-----YDQPKVTLNWIQRFRVIKGVALG 372
              V+L    +   +L     Y  NG L KY+     +D+         RF   + V+  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET------CTRFYTAEIVS-A 144
Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVGTLGYL 431
           L YLH +    +IHRD+K  N+LL+ +++ ++ DFG A+ L       +    VGT  Y+
Sbjct: 145 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 201
Query: 432 APEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWV---FDF 482
           +PE      A  S+D+++ G  + ++  G  P  R G +E LI    +   +DF
Sbjct: 202 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPF-RAG-NEGLIFAKIIKLEYDF 253

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 95/213 (44%), Gaps = 12/213 (5%)
Query: 263 FREKELLGTGGFGRVY--RGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNL 320
           +R  + +G G F +V   R  L   ++ I +   +  +   +++   E+  +  L H N+
Sbjct: 17  YRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNI 76
Query: 321 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQ-RFRVIKGVALGLFYLHQE 379
           V+L      +  L L+ +Y   G +  YL    ++     + +FR I      + Y HQ 
Sbjct: 77  VKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQI---VSAVQYCHQ- 132
Query: 380 WEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTG 439
             + ++HRD+KA N+LLD ++N ++ DFG +  +  G   +     G   Y APE  +  
Sbjct: 133 --KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG--KLDAFCGAPPYAAPELFQGK 188
Query: 440 KAT-TSADVFSFGAFLLEVACGRRPIQRQGPSE 471
           K      DV+S G  L  +  G  P   Q   E
Sbjct: 189 KYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE 221

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 102/224 (45%), Gaps = 23/224 (10%)
Query: 255 DLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKE---------F 305
           ++++    F    ++G GGFG VY G       ++   K   + R  MK+          
Sbjct: 182 NIHLTMNDFSVHRIIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERI 240
Query: 306 VAEIVSIGRLRHRNLVQLLGYC-RRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFR 364
           +  +VS G       +  + Y      +L  + D M  G L  +L  Q  V      RF 
Sbjct: 241 MLSLVSTGDC---PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL-SQHGVFSEADMRFY 296
Query: 365 VIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHV 424
             + + LGL ++H  +   V++RD+K +N+LLD   + R+ D GLA  +     P  +  
Sbjct: 297 AAE-IILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHAS-- 349
Query: 425 VGTLGYLAPEHTRTGKA-TTSADVFSFGAFLLEVACGRRPIQRQ 467
           VGT GY+APE  + G A  +SAD FS G  L ++  G  P ++ 
Sbjct: 350 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 393

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 79/303 (26%), Positives = 130/303 (42%), Gaps = 59/303 (19%)
Query: 269 LGTGGFGRVYRGT---LPKSQ--IEIAVKKISHESRQGMKE-FVAEIVSIGRL-RHRNLV 321
           LG G FG+V   T   L KS   + +AVK +   +    +E  ++E+  +  L  H N+V
Sbjct: 47  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 106
Query: 322 QLLGYCRRKGELLLVYDYMPNGSLDKYLYDQ----------PKVTLNWIQ---------- 361
            LLG C   G  L++ +Y   G L  +L  +          P +  +             
Sbjct: 107 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 166
Query: 362 RFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQT 421
            ++V KG+A           +  IHRD+ A N+LL      ++ DFGLAR  D   D  +
Sbjct: 167 SYQVAKGMAFLA-------SKNCIHRDLAARNILLTHGRITKICDFGLAR--DIKND--S 215
Query: 422 THVVG-----TLGYLAPEHTRTGKATTSADVFSFGAFLLEV-ACGRRPIQRQGPSENLIL 475
            +VV       + ++APE       T  +DV+S+G FL E+ + G  P          + 
Sbjct: 216 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG-------MP 268
Query: 476 VDWVFDFWNRGELLEARDPNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQILER 535
           VD  F      ++++     L  E+              C  +DP  RP+ +Q+VQ++E+
Sbjct: 269 VDSKF-----YKMIKEGFRMLSPEHAP---AEMYDIMKTCWDADPLKRPTFKQIVQLIEK 320
Query: 536 DVA 538
            ++
Sbjct: 321 QIS 323

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 102/224 (45%), Gaps = 23/224 (10%)
Query: 255 DLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKE---------F 305
           ++++    F    ++G GGFG VY G       ++   K   + R  MK+          
Sbjct: 183 NIHLTMNDFSVHRIIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERI 241
Query: 306 VAEIVSIGRLRHRNLVQLLGYC-RRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFR 364
           +  +VS G       +  + Y      +L  + D M  G L  +L  Q  V      RF 
Sbjct: 242 MLSLVSTGDC---PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL-SQHGVFSEADMRFY 297
Query: 365 VIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHV 424
             + + LGL ++H  +   V++RD+K +N+LLD   + R+ D GLA  +     P  +  
Sbjct: 298 AAE-IILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHAS-- 350
Query: 425 VGTLGYLAPEHTRTGKA-TTSADVFSFGAFLLEVACGRRPIQRQ 467
           VGT GY+APE  + G A  +SAD FS G  L ++  G  P ++ 
Sbjct: 351 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 394

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 79/303 (26%), Positives = 130/303 (42%), Gaps = 59/303 (19%)
Query: 269 LGTGGFGRVYRGT---LPKSQ--IEIAVKKISHESRQGMKE-FVAEIVSIGRL-RHRNLV 321
           LG G FG+V   T   L KS   + +AVK +   +    +E  ++E+  +  L  H N+V
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 322 QLLGYCRRKGELLLVYDYMPNGSLDKYLYDQ----------PKVTLNWIQ---------- 361
            LLG C   G  L++ +Y   G L  +L  +          P +  +             
Sbjct: 91  NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 362 RFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQT 421
            ++V KG+A           +  IHRD+ A N+LL      ++ DFGLAR  D   D  +
Sbjct: 151 SYQVAKGMAFLA-------SKNCIHRDLAARNILLTHGRITKICDFGLAR--DIKND--S 199
Query: 422 THVVG-----TLGYLAPEHTRTGKATTSADVFSFGAFLLEV-ACGRRPIQRQGPSENLIL 475
            +VV       + ++APE       T  +DV+S+G FL E+ + G  P          + 
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG-------MP 252
Query: 476 VDWVFDFWNRGELLEARDPNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQILER 535
           VD  F      ++++     L  E+              C  +DP  RP+ +Q+VQ++E+
Sbjct: 253 VDSKF-----YKMIKEGFRMLSPEHAP---AEMYDIMKTCWDADPLKRPTFKQIVQLIEK 304
Query: 536 DVA 538
            ++
Sbjct: 305 QIS 307

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 102/224 (45%), Gaps = 23/224 (10%)
Query: 255 DLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKE---------F 305
           ++++    F    ++G GGFG VY G       ++   K   + R  MK+          
Sbjct: 183 NIHLTMNDFSVHRIIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERI 241
Query: 306 VAEIVSIGRLRHRNLVQLLGYC-RRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFR 364
           +  +VS G       +  + Y      +L  + D M  G L  +L  Q  V      RF 
Sbjct: 242 MLSLVSTGDC---PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL-SQHGVFSEADMRFY 297
Query: 365 VIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHV 424
             + + LGL ++H  +   V++RD+K +N+LLD   + R+ D GLA  +     P  +  
Sbjct: 298 AAE-IILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHAS-- 350
Query: 425 VGTLGYLAPEHTRTGKA-TTSADVFSFGAFLLEVACGRRPIQRQ 467
           VGT GY+APE  + G A  +SAD FS G  L ++  G  P ++ 
Sbjct: 351 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 394

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 102/224 (45%), Gaps = 23/224 (10%)
Query: 255 DLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKE---------F 305
           ++++    F    ++G GGFG VY G       ++   K   + R  MK+          
Sbjct: 183 NIHLTMNDFSVHRIIGRGGFGEVY-GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERI 241
Query: 306 VAEIVSIGRLRHRNLVQLLGYC-RRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFR 364
           +  +VS G       +  + Y      +L  + D M  G L  +L  Q  V      RF 
Sbjct: 242 MLSLVSTGDC---PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL-SQHGVFSEADMRFY 297
Query: 365 VIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHV 424
             + + LGL ++H  +   V++RD+K +N+LLD   + R+ D GLA  +     P  +  
Sbjct: 298 AAE-IILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSK-KKPHAS-- 350
Query: 425 VGTLGYLAPEHTRTGKA-TTSADVFSFGAFLLEVACGRRPIQRQ 467
           VGT GY+APE  + G A  +SAD FS G  L ++  G  P ++ 
Sbjct: 351 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 394

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 106/224 (47%), Gaps = 23/224 (10%)
Query: 252 RYKDLYIATKGFREKELLGTGGFGRVYRGTLPK---SQIEIAVKKISHE--SRQGMKEFV 306
           + +D+ I  + F    +LG G FG V    L +   S +++AVK +  +  +   ++EF+
Sbjct: 14  KLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFL 73
Query: 307 AEIVSIGRLRHRNLVQLLGYC---RRKGEL---LLVYDYMPNGSLDKYLY-----DQP-K 354
            E   +    H ++ +L+G     R KG L   +++  +M +G L  +L      + P  
Sbjct: 74  REAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFN 133
Query: 355 VTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LY 413
           + L  + RF V   +A G+ YL     +  IHRD+ A N +L  ++   + DFGL+R +Y
Sbjct: 134 LPLQTLVRFMV--DIACGMEYLSS---RNFIHRDLAARNCMLAEDMTVCVADFGLSRKIY 188
Query: 414 DHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEV 457
                 Q       + +LA E       T  +DV++FG  + E+
Sbjct: 189 SGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEI 232

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 107/234 (45%), Gaps = 28/234 (11%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVS-----IGRLRH 317
           F+  ++LG G F  V       +  E A+K +  E R  +KE     V+     + RL H
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 318 RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYL-----YDQPKVTLNWIQRFRVIKGVALG 372
              V+L    +   +L     Y  NG L KY+     +D+         RF   + V+  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET------CTRFYTAEIVS-A 144
Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVGTLGYL 431
           L YLH +    +IHRD+K  N+LL+ +++ ++ DFG A+ L       +    VGT  Y+
Sbjct: 145 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 201
Query: 432 APEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWV---FDF 482
           +PE      A  S+D+++ G  + ++  G  P  R G +E LI    +   +DF
Sbjct: 202 SPELLTEKSAXKSSDLWALGCIIYQLVAGLPPF-RAG-NEGLIFAKIIKLEYDF 253

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 71/297 (23%), Positives = 122/297 (41%), Gaps = 49/297 (16%)
Query: 269 LGTGGFGRVYRGTL-----PKSQIEIAVKKIS-HESRQGMKEFVAEIVSIGRLRHRNLVQ 322
           LG G FG+V + T            +AVK +  + S   +++ ++E   + ++ H ++++
Sbjct: 31  LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIK 90
Query: 323 LLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVAL----------- 371
           L G C + G LLL+ +Y   GSL  +L +  KV   ++         +L           
Sbjct: 91  LYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMG 150
Query: 372 -----------GLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDP 419
                      G+ YL    E  ++HRD+ A N+L+      ++ DFGL+R +Y+  +  
Sbjct: 151 DLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYV 207
Query: 420 QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLE-VACGRRPIQRQGPSENLILVDW 478
           + +     + ++A E       TT +DV+SFG  L E V  G  P     P         
Sbjct: 208 KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPER------- 260
Query: 479 VFDFWNRGELLEARDPNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQILER 535
           +F+    G  +E  D N   E               C   +P  RP    + + LE+
Sbjct: 261 LFNLLKTGHRMERPD-NCSEE--------MYRLMLQCWKQEPDKRPVFADISKDLEK 308

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 108/234 (46%), Gaps = 28/234 (11%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVS-----IGRLRH 317
           F+  ++LG G F  V       +  E A+K +  E R  +KE     V+     + RL H
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 318 RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYL-----YDQPKVTLNWIQRFRVIKGVALG 372
              V+L    +   +L     Y  NG L KY+     +D+         RF   + V+  
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET------CTRFYTAEIVS-A 145
Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVGTLGYL 431
           L YLH +    +IHRD+K  N+LL+ +++ ++ DFG A+ L       +    VGT  Y+
Sbjct: 146 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 202
Query: 432 APEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLI---LVDWVFDF 482
           +PE      A  S+D+++ G  + ++  G  P  R G +E LI   ++   +DF
Sbjct: 203 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPF-RAG-NEYLIFQKIIKLEYDF 254

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 108/234 (46%), Gaps = 28/234 (11%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVS-----IGRLRH 317
           F+  ++LG G F  V       +  E A+K +  E R  +KE     V+     + RL H
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 318 RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYL-----YDQPKVTLNWIQRFRVIKGVALG 372
              V+L    +   +L     Y  NG L KY+     +D+         RF   + V+  
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET------CTRFYTAEIVS-A 142
Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVGTLGYL 431
           L YLH +    +IHRD+K  N+LL+ +++ ++ DFG A+ L       +    VGT  Y+
Sbjct: 143 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 199
Query: 432 APEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLI---LVDWVFDF 482
           +PE      A  S+D+++ G  + ++  G  P  R G +E LI   ++   +DF
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPF-RAG-NEYLIFQKIIKLEYDF 251

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 68/235 (28%), Positives = 110/235 (46%), Gaps = 30/235 (12%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVS-----IGRLRH 317
           F+  ++LG G F  V       +  E A+K +  E R  +KE     V+     + RL H
Sbjct: 39  FKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDH 96
Query: 318 RNLVQLLGYCRRKGELLLV-YDYMPNGSLDKYL-----YDQPKVTLNWIQRFRVIKGVAL 371
              V+L  +C +  E L     Y  NG L KY+     +D+         RF   + V+ 
Sbjct: 97  PFFVKLY-FCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET------CTRFYTAEIVS- 148
Query: 372 GLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVGTLGY 430
            L YLH +    +IHRD+K  N+LL+ +++ ++ DFG A+ L       +    VGT  Y
Sbjct: 149 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 205
Query: 431 LAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLI---LVDWVFDF 482
           ++PE      A  S+D+++ G  + ++  G  P  R G +E LI   ++   +DF
Sbjct: 206 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF-RAG-NEYLIFQKIIKLEYDF 258

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 108/234 (46%), Gaps = 28/234 (11%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVS-----IGRLRH 317
           F+  ++LG G F  V       +  E A+K +  E R  +KE     V+     + RL H
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 318 RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYL-----YDQPKVTLNWIQRFRVIKGVALG 372
              V+L    +   +L     Y  NG L KY+     +D+         RF   + V+  
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET------CTRFYTAEIVS-A 142
Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVGTLGYL 431
           L YLH +    +IHRD+K  N+LL+ +++ ++ DFG A+ L       +    VGT  Y+
Sbjct: 143 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 199
Query: 432 APEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLI---LVDWVFDF 482
           +PE      A  S+D+++ G  + ++  G  P  R G +E LI   ++   +DF
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPF-RAG-NEYLIFQKIIKLEYDF 251

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 108/234 (46%), Gaps = 28/234 (11%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVS-----IGRLRH 317
           F+  ++LG G F  V       +  E A+K +  E R  +KE     V+     + RL H
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 318 RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYL-----YDQPKVTLNWIQRFRVIKGVALG 372
              V+L    +   +L     Y  NG L KY+     +D+         RF   + V+  
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET------CTRFYTAEIVS-A 141
Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVGTLGYL 431
           L YLH +    +IHRD+K  N+LL+ +++ ++ DFG A+ L       +    VGT  Y+
Sbjct: 142 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYV 198
Query: 432 APEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLI---LVDWVFDF 482
           +PE      A  S+D+++ G  + ++  G  P  R G +E LI   ++   +DF
Sbjct: 199 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPF-RAG-NEYLIFQKIIKLEYDF 250

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 100/202 (49%), Gaps = 11/202 (5%)
Query: 268 LLGTGGFGRVYRGTLPKSQIEIAVKKISHES---RQGMKEFVAEIVSIGR-LRHRNLVQL 323
            LG GGF + +  +   ++ E+   KI  +S   +   +E ++  +SI R L H+++V  
Sbjct: 48  FLGKGGFAKCFEISDADTK-EVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 106
Query: 324 LGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQV 383
            G+      + +V +     SL + L+ + K       R+  ++ + LG  YLH+     
Sbjct: 107 HGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARY-YLRQIVLGCQYLHRNR--- 161
Query: 384 VIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATT 443
           VIHRD+K  N+ L+ +L  ++GDFGLA   ++  + +   + GT  Y+APE       + 
Sbjct: 162 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGHSF 220
Query: 444 SADVFSFGAFLLEVACGRRPIQ 465
             DV+S G  +  +  G+ P +
Sbjct: 221 EVDVWSIGCIMYTLLVGKPPFE 242

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 108/234 (46%), Gaps = 28/234 (11%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVS-----IGRLRH 317
           F+  ++LG G F  V       +  E A+K +  E R  +KE     V+     + RL H
Sbjct: 37  FKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDH 94
Query: 318 RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYL-----YDQPKVTLNWIQRFRVIKGVALG 372
              V+L    +   +L     Y  NG L KY+     +D+         RF   + V+  
Sbjct: 95  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET------CTRFYTAEIVS-A 147
Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVGTLGYL 431
           L YLH +    +IHRD+K  N+LL+ +++ ++ DFG A+ L       +    VGT  Y+
Sbjct: 148 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 204
Query: 432 APEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLI---LVDWVFDF 482
           +PE      A  S+D+++ G  + ++  G  P  R G +E LI   ++   +DF
Sbjct: 205 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPF-RAG-NEYLIFQKIIKLEYDF 256

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 108/234 (46%), Gaps = 28/234 (11%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVS-----IGRLRH 317
           F+  ++LG G F  V       +  E A+K +  E R  +KE     V+     + RL H
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDH 88
Query: 318 RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYL-----YDQPKVTLNWIQRFRVIKGVALG 372
              V+L    +   +L     Y  NG L KY+     +D+         RF   + V+  
Sbjct: 89  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET------CTRFYTAEIVS-A 141
Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVGTLGYL 431
           L YLH +    +IHRD+K  N+LL+ +++ ++ DFG A+ L       +    VGT  Y+
Sbjct: 142 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 198
Query: 432 APEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLI---LVDWVFDF 482
           +PE      A  S+D+++ G  + ++  G  P  R G +E LI   ++   +DF
Sbjct: 199 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPF-RAG-NEYLIFQKIIKLEYDF 250

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 108/234 (46%), Gaps = 28/234 (11%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVS-----IGRLRH 317
           F+  ++LG G F  V       +  E A+K +  E R  +KE     V+     + RL H
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 318 RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYL-----YDQPKVTLNWIQRFRVIKGVALG 372
              V+L    +   +L     Y  NG L KY+     +D+         RF   + V+  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET------CTRFYTAEIVS-A 144
Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVGTLGYL 431
           L YLH +    +IHRD+K  N+LL+ +++ ++ DFG A+ L       +    VGT  Y+
Sbjct: 145 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 201
Query: 432 APEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLI---LVDWVFDF 482
           +PE      A  S+D+++ G  + ++  G  P  R G +E LI   ++   +DF
Sbjct: 202 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPF-RAG-NEYLIFQKIIKLEYDF 253

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 108/234 (46%), Gaps = 28/234 (11%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVS-----IGRLRH 317
           F+  ++LG G F  V       +  E A+K +  E R  +KE     V+     + RL H
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDH 92
Query: 318 RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYL-----YDQPKVTLNWIQRFRVIKGVALG 372
              V+L    +   +L     Y  NG L KY+     +D+         RF   + V+  
Sbjct: 93  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET------CTRFYTAEIVS-A 145
Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVGTLGYL 431
           L YLH +    +IHRD+K  N+LL+ +++ ++ DFG A+ L       +    VGT  Y+
Sbjct: 146 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 202
Query: 432 APEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLI---LVDWVFDF 482
           +PE      A  S+D+++ G  + ++  G  P  R G +E LI   ++   +DF
Sbjct: 203 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPF-RAG-NEYLIFQKIIKLEYDF 254

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 100/202 (49%), Gaps = 11/202 (5%)
Query: 268 LLGTGGFGRVYRGTLPKSQIEIAVKKISHES---RQGMKEFVAEIVSIGR-LRHRNLVQL 323
            LG GGF + +  +   ++ E+   KI  +S   +   +E ++  +SI R L H+++V  
Sbjct: 46  FLGKGGFAKCFEISDADTK-EVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 104
Query: 324 LGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQV 383
            G+      + +V +     SL + L+ + K       R+  ++ + LG  YLH+     
Sbjct: 105 HGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARY-YLRQIVLGCQYLHRNR--- 159
Query: 384 VIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATT 443
           VIHRD+K  N+ L+ +L  ++GDFGLA   ++  + +   + GT  Y+APE       + 
Sbjct: 160 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGHSF 218
Query: 444 SADVFSFGAFLLEVACGRRPIQ 465
             DV+S G  +  +  G+ P +
Sbjct: 219 EVDVWSIGCIMYTLLVGKPPFE 240

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 108/234 (46%), Gaps = 28/234 (11%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVS-----IGRLRH 317
           F+  ++LG G F  V       +  E A+K +  E R  +KE     V+     + RL H
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 318 RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYL-----YDQPKVTLNWIQRFRVIKGVALG 372
              V+L    +   +L     Y  NG L KY+     +D+         RF   + V+  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET------CTRFYTAEIVS-A 144
Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVGTLGYL 431
           L YLH +    +IHRD+K  N+LL+ +++ ++ DFG A+ L       +    VGT  Y+
Sbjct: 145 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 201
Query: 432 APEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLI---LVDWVFDF 482
           +PE      A  S+D+++ G  + ++  G  P  R G +E LI   ++   +DF
Sbjct: 202 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPF-RAG-NEYLIFQKIIKLEYDF 253

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 108/234 (46%), Gaps = 28/234 (11%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVS-----IGRLRH 317
           F+  ++LG G F  V       +  E A+K +  E R  +KE     V+     + RL H
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDH 91
Query: 318 RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYL-----YDQPKVTLNWIQRFRVIKGVALG 372
              V+L    +   +L     Y  NG L KY+     +D+         RF   + V+  
Sbjct: 92  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET------CTRFYTAEIVS-A 144
Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVGTLGYL 431
           L YLH +    +IHRD+K  N+LL+ +++ ++ DFG A+ L       +    VGT  Y+
Sbjct: 145 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 201
Query: 432 APEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLI---LVDWVFDF 482
           +PE      A  S+D+++ G  + ++  G  P  R G +E LI   ++   +DF
Sbjct: 202 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPF-RAG-NEYLIFQKIIKLEYDF 253

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 108/234 (46%), Gaps = 28/234 (11%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVS-----IGRLRH 317
           F+  ++LG G F  V       +  E A+K +  E R  +KE     V+     + RL H
Sbjct: 12  FKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDH 69
Query: 318 RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYL-----YDQPKVTLNWIQRFRVIKGVALG 372
              V+L    +   +L     Y  NG L KY+     +D+         RF   + V+  
Sbjct: 70  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET------CTRFYTAEIVS-A 122
Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVGTLGYL 431
           L YLH +    +IHRD+K  N+LL+ +++ ++ DFG A+ L       +    VGT  Y+
Sbjct: 123 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 179
Query: 432 APEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLI---LVDWVFDF 482
           +PE      A  S+D+++ G  + ++  G  P  R G +E LI   ++   +DF
Sbjct: 180 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPF-RAG-NEYLIFQKIIKLEYDF 231

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 108/234 (46%), Gaps = 28/234 (11%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVS-----IGRLRH 317
           F+  ++LG G F  V       +  E A+K +  E R  +KE     V+     + RL H
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 318 RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYL-----YDQPKVTLNWIQRFRVIKGVALG 372
              V+L    +   +L     Y  NG L KY+     +D+         RF   + V+  
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET------CTRFYTAEIVS-A 142
Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVGTLGYL 431
           L YLH +    +IHRD+K  N+LL+ +++ ++ DFG A+ L       +    VGT  Y+
Sbjct: 143 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYV 199
Query: 432 APEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLI---LVDWVFDF 482
           +PE      A  S+D+++ G  + ++  G  P  R G +E LI   ++   +DF
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPF-RAG-NEYLIFQKIIKLEYDF 251

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 108/234 (46%), Gaps = 28/234 (11%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVS-----IGRLRH 317
           F+  ++LG G F  V       +  E A+K +  E R  +KE     V+     + RL H
Sbjct: 9   FKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDH 66
Query: 318 RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYL-----YDQPKVTLNWIQRFRVIKGVALG 372
              V+L    +   +L     Y  NG L KY+     +D+         RF   + V+  
Sbjct: 67  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET------CTRFYTAEIVS-A 119
Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVGTLGYL 431
           L YLH +    +IHRD+K  N+LL+ +++ ++ DFG A+ L       +    VGT  Y+
Sbjct: 120 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 176
Query: 432 APEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLI---LVDWVFDF 482
           +PE      A  S+D+++ G  + ++  G  P  R G +E LI   ++   +DF
Sbjct: 177 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPF-RAG-NEYLIFQKIIKLEYDF 228

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 108/234 (46%), Gaps = 28/234 (11%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVS-----IGRLRH 317
           F+  ++LG G F  V       +  E A+K +  E R  +KE     V+     + RL H
Sbjct: 11  FKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDH 68
Query: 318 RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYL-----YDQPKVTLNWIQRFRVIKGVALG 372
              V+L    +   +L     Y  NG L KY+     +D+         RF   + V+  
Sbjct: 69  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET------CTRFYTAEIVS-A 121
Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVGTLGYL 431
           L YLH +    +IHRD+K  N+LL+ +++ ++ DFG A+ L       +    VGT  Y+
Sbjct: 122 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 178
Query: 432 APEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLI---LVDWVFDF 482
           +PE      A  S+D+++ G  + ++  G  P  R G +E LI   ++   +DF
Sbjct: 179 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPF-RAG-NEYLIFQKIIKLEYDF 230

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 108/234 (46%), Gaps = 28/234 (11%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVS-----IGRLRH 317
           F+  ++LG G F  V       +  E A+K +  E R  +KE     V+     + RL H
Sbjct: 16  FKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDH 73
Query: 318 RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYL-----YDQPKVTLNWIQRFRVIKGVALG 372
              V+L    +   +L     Y  NG L KY+     +D+         RF   + V+  
Sbjct: 74  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET------CTRFYTAEIVS-A 126
Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVGTLGYL 431
           L YLH +    +IHRD+K  N+LL+ +++ ++ DFG A+ L       +    VGT  Y+
Sbjct: 127 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 183
Query: 432 APEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLI---LVDWVFDF 482
           +PE      A  S+D+++ G  + ++  G  P  R G +E LI   ++   +DF
Sbjct: 184 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPF-RAG-NEYLIFQKIIKLEYDF 235

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 108/234 (46%), Gaps = 28/234 (11%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVS-----IGRLRH 317
           F+  ++LG G F  V       +  E A+K +  E R  +KE     V+     + RL H
Sbjct: 10  FKFGKILGEGSFSTVVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 318 RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYL-----YDQPKVTLNWIQRFRVIKGVALG 372
              V+L    +   +L     Y  NG L KY+     +D+         RF   + V+  
Sbjct: 68  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET------CTRFYTAEIVS-A 120
Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVGTLGYL 431
           L YLH +    +IHRD+K  N+LL+ +++ ++ DFG A+ L       +    VGT  Y+
Sbjct: 121 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 177
Query: 432 APEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLI---LVDWVFDF 482
           +PE      A  S+D+++ G  + ++  G  P  R G +E LI   ++   +DF
Sbjct: 178 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPF-RAG-NEYLIFQKIIKLEYDF 229

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 73/297 (24%), Positives = 128/297 (43%), Gaps = 31/297 (10%)
Query: 261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES---RQGMKEFVAEIVSIGR-LR 316
           K +     LG GGF + Y  T   ++ E+   K+  +S   +   KE ++  ++I + L 
Sbjct: 42  KRYMRGRFLGKGGFAKCYEITDMDTK-EVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLD 100
Query: 317 HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYL 376
           + ++V   G+      + +V +     SL +    +  VT    + F  ++    G+ YL
Sbjct: 101 NPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYF--MRQTIQGVQYL 158
Query: 377 HQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHT 436
           H      VIHRD+K  N+ L+ +++ ++GDFGLA   +   + + T + GT  Y+APE  
Sbjct: 159 HNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKT-LCGTPNYIAPEVL 214
Query: 437 RTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNL 496
                +   D++S G  L  +  G+ P +     E  I +        + E    R  N 
Sbjct: 215 CKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRI-------KKNEYSVPRHINP 267
Query: 497 GTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQILERDVALPAISALRLSTSGIT 553
               +               H+DPT RPS   V ++L  +      + +RL TS +T
Sbjct: 268 VASALIRRML----------HADPTLRPS---VAELLTDEFFTSGYAPMRLPTSCLT 311

>pdb|2FMD|A Chain A, Structural Basis Of Carbohydrate Recognition By Bowringia Milbraedii Seed Agglutinin Length = 240

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 79/159 (49%), Gaps = 13/159 (8%)
Query: 29  LSEYQSQSGHGIAFVIAS-TRGLPGARPSQYLGLFNDTNLGNETNHVFAVELDTIKSHGF 87
           +S+  S     + F IAS    +P     + LGLF  +N     N V +VE DT  +   
Sbjct: 77  ISQGSSTPADALTFFIASPDTKIPSGSGGRLLGLFGSSNNAGSDNGVVSVEFDTYPNTDI 136
Query: 88  LDINDNHVGIDINSLKSESSA--------PAGYYVEYDGLEKRTNVTLAPINIPRPRSLN 139
            D N  H+GID+NS++S++++         A  ++ Y+   KR +V  +  N     S  
Sbjct: 137 GDPNYRHIGIDVNSIRSKAASKWDWQNGKTATAHISYNSASKRLSVVSSYPN----SSPV 192
Query: 140 TMSLSRDLSSVLNDAMYVGFSSSTGSVLASHYILGWSFK 178
            +S   +L++V    + VGFS++TG    ++ IL WSF+
Sbjct: 193 VVSFDVELNNVXPXWVRVGFSATTGQYTQTNNILAWSFR 231

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 93/229 (40%), Gaps = 24/229 (10%)
Query: 252 RYKDLYIATKGFREK-------ELLGTGGFGRVYRGTLPKSQIEIAVK---KISHESRQG 301
           RY+ +    +G + K       +++G G FG V       SQ   A+K   K     R  
Sbjct: 59  RYEKIVKKIRGLQMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSD 118
Query: 302 MKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYL--YDQPKVTLNW 359
              F  E   +       +VQL    +    L +V +YMP G L   +  YD P+    W
Sbjct: 119 SAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPE---KW 175
Query: 360 IQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP 419
            + +     V L L  +H      +IHRDVK  N+LLD   + +L DFG     D     
Sbjct: 176 AKFYTA--EVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMV 230
Query: 420 QTTHVVGTLGYLAPEHTRT----GKATTSADVFSFGAFLLEVACGRRPI 464
                VGT  Y++PE  ++    G      D +S G FL E+  G  P 
Sbjct: 231 HCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 279

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 100/202 (49%), Gaps = 11/202 (5%)
Query: 268 LLGTGGFGRVYRGTLPKSQIEIAVKKISHES---RQGMKEFVAEIVSIGR-LRHRNLVQL 323
            LG GGF + +  +   ++ E+   KI  +S   +   +E ++  +SI R L H+++V  
Sbjct: 22  FLGKGGFAKCFEISDADTK-EVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 80
Query: 324 LGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQV 383
            G+      + +V +     SL + L+ + K       R+  ++ + LG  YLH+     
Sbjct: 81  HGFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARY-YLRQIVLGCQYLHRNR--- 135
Query: 384 VIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATT 443
           VIHRD+K  N+ L+ +L  ++GDFGLA   ++  + +   + GT  Y+APE       + 
Sbjct: 136 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGHSF 194
Query: 444 SADVFSFGAFLLEVACGRRPIQ 465
             DV+S G  +  +  G+ P +
Sbjct: 195 EVDVWSIGCIMYTLLVGKPPFE 216

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 104/227 (45%), Gaps = 28/227 (12%)
Query: 256 LYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMK-EFVAEIVSIGR 314
           +Y  +  F+ K LLG G +G V   T   +   +A+KKI    +       + EI  +  
Sbjct: 6   VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKH 65
Query: 315 LRHRNLVQLLGYCRRKG-----ELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRF--RVIK 367
            +H N++ +    R        E+ ++ + M    L + +  Q  ++ + IQ F  + ++
Sbjct: 66  FKHENIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVISTQ-MLSDDHIQYFIYQTLR 123
Query: 368 GVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH---------GTD 418
            V +    LH      VIHRD+K SN+L++   + ++ DFGLAR+ D          G  
Sbjct: 124 AVKV----LHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQ 176
Query: 419 PQTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPI 464
              T  V T  Y APE   T  K + + DV+S G  L E+   RRPI
Sbjct: 177 SGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPI 222

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 104/227 (45%), Gaps = 28/227 (12%)
Query: 256 LYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMK-EFVAEIVSIGR 314
           +Y  +  F+ K LLG G +G V   T   +   +A+KKI    +       + EI  +  
Sbjct: 6   VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKH 65
Query: 315 LRHRNLVQLLGYCRRKG-----ELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRF--RVIK 367
            +H N++ +    R        E+ ++ + M    L + +  Q  ++ + IQ F  + ++
Sbjct: 66  FKHENIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVISTQ-MLSDDHIQYFIYQTLR 123
Query: 368 GVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH---------GTD 418
            V +    LH      VIHRD+K SN+L++   + ++ DFGLAR+ D          G  
Sbjct: 124 AVKV----LHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQ 176
Query: 419 PQTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPI 464
              T  V T  Y APE   T  K + + DV+S G  L E+   RRPI
Sbjct: 177 SGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPI 222

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 93/201 (46%), Gaps = 13/201 (6%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLG 325
           +G G FG+V       ++   A+K ++ +    R  ++    E+  +  L H  LV L  
Sbjct: 23  IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWY 82
Query: 326 YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVI 385
             + + ++ +V D +  G L  +L          ++ F  I  + + L YL     Q +I
Sbjct: 83  SFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLF--ICELVMALDYLQN---QRII 137
Query: 386 HRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE--HTRTGKATT 443
           HRD+K  N+LLD   +  + DF +A +    T  Q T + GT  Y+APE   +R G   +
Sbjct: 138 HRDMKPDNILLDEHGHVHITDFNIAAMLPRET--QITTMAGTKPYMAPEMFSSRKGAGYS 195
Query: 444 SA-DVFSFGAFLLEVACGRRP 463
            A D +S G    E+  GRRP
Sbjct: 196 FAVDWWSLGVTAYELLRGRRP 216

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 108/212 (50%), Gaps = 19/212 (8%)
Query: 261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKIS-HESRQGM-KEFVAEIVSIGRLRHR 318
           + + + E +G G +G V++    ++   +A+K++   +  +G+    + EI  +  L+H+
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 319 NLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYD-----QPKVTLNWIQRFRVIKGVALGL 373
           N+V+L        +L LV+++  +  L KY         P++  +++  F+++KG+    
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFC-DQDLKKYFDSCNGDLDPEIVKSFL--FQLLKGLG--- 115
Query: 374 FYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAP 433
            + H    + V+HRD+K  N+L++     +L +FGLAR +       +  VV TL Y  P
Sbjct: 116 -FCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLWYRPP 170
Query: 434 EHTRTGKA-TTSADVFSFGAFLLEVACGRRPI 464
           +     K  +TS D++S G    E+A   RP+
Sbjct: 171 DVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 97/214 (45%), Gaps = 22/214 (10%)
Query: 268 LLGTGGFGRVY----RGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQL 323
           +LG G FG+V     +GT     I+I  K +  +        V + V     +   L QL
Sbjct: 26  VLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPFLTQL 85
Query: 324 LGYCRRKGELLLVYDYMPNGSLDKYL-----YDQPKVTLNWIQRFRVIKGVALGLFYLHQ 378
               +    L  V +Y+  G L  ++     + +P+      +       +++GLF+LH+
Sbjct: 86  HSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAE-------ISIGLFFLHK 138
Query: 379 EWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTT-HVVGTLGYLAPEHTR 437
              + +I+RD+K  NV+LD E + ++ DFG+ +  +H  D  TT    GT  Y+APE   
Sbjct: 139 ---RGIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMMDGVTTREFCGTPDYIAPEIIA 193
Query: 438 TGKATTSADVFSFGAFLLEVACGRRPIQRQGPSE 471
                 S D +++G  L E+  G+ P   +   E
Sbjct: 194 YQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE 227

>pdb|3ZVX|A Chain A, Structure Of The Lectin From Platypodium Elegans In Complex With A Trimannoside Length = 261

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/165 (32%), Positives = 79/165 (47%), Gaps = 22/165 (13%)
Query: 28  ILSEYQSQSGHGIAFVIAS-TRGLPGARPSQYLGLFND-TNLGNETNHVFAVELDTI--K 83
            LS   S    GIAF IA     +P       LGLFN  T L    N V AVE DT   +
Sbjct: 85  FLSSPLSNPADGIAFFIAPPDTTIPSGSAGGLLGLFNPRTALNESANQVLAVEFDTFFAQ 144
Query: 84  SHGFLDINDNHVGIDINSLKSESSAPAGYYVEYDGLEKRTNVTLAPINIPRPRSLNTMS- 142
           +    D N  H+GID+NS++S         V ++  E +T   L   N P  R+++ ++ 
Sbjct: 145 NSNTWDPNYQHIGIDVNSIRSSK------VVRWERREGKTLNVLVTYN-PSTRTIDVVAT 197
Query: 143 --------LSR--DLSSVLNDAMYVGFSSSTGSVLASHYILGWSF 177
                   LS   DL+++L + + VGFS+++G    +H +  WSF
Sbjct: 198 YPDGQRYQLSHVVDLTTILPEWVRVGFSAASGEQFQTHNLESWSF 242

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
           +G+G +G V      KS ++IAVKK+S   +S    K    E+  +  ++H N++ LL  
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 118
Query: 327 CRRKGEL-----LLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
                 L     + +  ++    L+  +  Q K+T + +Q   +I  +  GL Y+H    
Sbjct: 119 FTPATSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQF--LIYQILRGLKYIHS--- 172
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE-HTRTGK 440
             +IHRD+K SN+ ++ +   ++ DFGLAR     TD + T  V T  Y APE       
Sbjct: 173 ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMH 228
Query: 441 ATTSADVFSFGAFLLEVACGR 461
              + D++S G  + E+  GR
Sbjct: 229 YNMTVDIWSVGCIMAELLTGR 249

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 94/224 (41%), Gaps = 36/224 (16%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVA-EIVSIGRLRHRNLV 321
           F   + LG GGFG V+           A+K+I   +R+  +E V  E+ ++ +L H  +V
Sbjct: 7   FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66
Query: 322 QLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTL-----NWIQRFRVI----KGVALG 372
           +       K       + +   S   YLY Q ++       +W+     I    + V L 
Sbjct: 67  RYFNAWLEKN----TTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLH 122
Query: 373 LF--------YLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQT--- 421
           +F        +LH +    ++HRD+K SN+    +   ++GDFGL    D   + QT   
Sbjct: 123 IFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 179
Query: 422 --------THVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEV 457
                   T  VGT  Y++PE       +   D+FS G  L E+
Sbjct: 180 PMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFEL 223

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 107/234 (45%), Gaps = 28/234 (11%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVS-----IGRLRH 317
           F+  ++LG G F          +  E A+K +  E R  +KE     V+     + RL H
Sbjct: 32  FKFGKILGEGSFSTTVLARELATSREYAIKIL--EKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 318 RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYL-----YDQPKVTLNWIQRFRVIKGVALG 372
              V+L    +   +L     Y  NG L KY+     +D+         RF   + V+  
Sbjct: 90  PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDET------CTRFYTAEIVS-A 142
Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVGTLGYL 431
           L YLH +    +IHRD+K  N+LL+ +++ ++ DFG A+ L       +    VGT  Y+
Sbjct: 143 LEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYV 199
Query: 432 APEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLI---LVDWVFDF 482
           +PE      A  S+D+++ G  + ++  G  P  R G +E LI   ++   +DF
Sbjct: 200 SPELLTEKSACKSSDLWALGCIIYQLVAGLPPF-RAG-NEYLIFQKIIKLEYDF 251

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 94/219 (42%), Gaps = 21/219 (9%)
Query: 261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNL 320
           K F   E+LG+G F  V+      +    A+K I             EI  + +++H N+
Sbjct: 9   KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENI 68
Query: 321 VQLLGYCRRKGELLLVYDYMPNGSL-----DKYLYDQPKVTLNWIQRFRVIKGVALGLFY 375
           V L           LV   +  G L     ++ +Y +   +L       VI+ V   + Y
Sbjct: 69  VTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASL-------VIQQVLSAVKY 121
Query: 376 LHQEWEQVVIHRDVKASNVL-LDGELNGRL--GDFGLARLYDHGTDPQTTHVVGTLGYLA 432
           LH   E  ++HRD+K  N+L L  E N ++   DFGL+++  +G     +   GT GY+A
Sbjct: 122 LH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI---MSTACGTPGYVA 175
Query: 433 PEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSE 471
           PE       + + D +S G     + CG  P   +  S+
Sbjct: 176 PEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK 214

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 72/297 (24%), Positives = 127/297 (42%), Gaps = 31/297 (10%)
Query: 261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES---RQGMKEFVAEIVSIGR-LR 316
           K +     LG GGF + Y  T   ++ E+   K+  +S   +   KE ++  ++I + L 
Sbjct: 26  KRYMRGRFLGKGGFAKCYEITDMDTK-EVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLD 84
Query: 317 HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYL 376
           + ++V   G+      + +V +     SL +    +  VT    + F  ++    G+ YL
Sbjct: 85  NPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYF--MRQTIQGVQYL 142
Query: 377 HQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHT 436
           H      VIHRD+K  N+ L+ +++ ++GDFGLA   +   + +   + GT  Y+APE  
Sbjct: 143 HNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGE-RKKDLCGTPNYIAPEVL 198
Query: 437 RTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNL 496
                +   D++S G  L  +  G+ P +     E  I +        + E    R  N 
Sbjct: 199 CKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRI-------KKNEYSVPRHINP 251
Query: 497 GTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQILERDVALPAISALRLSTSGIT 553
               +               H+DPT RPS   V ++L  +      + +RL TS +T
Sbjct: 252 VASALIRRML----------HADPTLRPS---VAELLTDEFFTSGYAPMRLPTSCLT 295

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 72/297 (24%), Positives = 127/297 (42%), Gaps = 31/297 (10%)
Query: 261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES---RQGMKEFVAEIVSIGR-LR 316
           K +     LG GGF + Y  T   ++ E+   K+  +S   +   KE ++  ++I + L 
Sbjct: 42  KRYMRGRFLGKGGFAKCYEITDMDTK-EVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLD 100
Query: 317 HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYL 376
           + ++V   G+      + +V +     SL +    +  VT    + F  ++    G+ YL
Sbjct: 101 NPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYF--MRQTIQGVQYL 158
Query: 377 HQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHT 436
           H      VIHRD+K  N+ L+ +++ ++GDFGLA   +   + +   + GT  Y+APE  
Sbjct: 159 HNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGE-RKKDLCGTPNYIAPEVL 214
Query: 437 RTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNL 496
                +   D++S G  L  +  G+ P +     E  I +        + E    R  N 
Sbjct: 215 CKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRI-------KKNEYSVPRHINP 267
Query: 497 GTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQILERDVALPAISALRLSTSGIT 553
               +               H+DPT RPS   V ++L  +      + +RL TS +T
Sbjct: 268 VASALIRRML----------HADPTLRPS---VAELLTDEFFTSGYAPMRLPTSCLT 311

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
           +G+G +G V      K+ + +AVKK+S   +S    K    E+  +  ++H N++ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 327 ---CRRKGELLLVY--DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
               R   E   VY   ++    L+  +  Q K+T + +Q   +I  +  GL Y+H    
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKXQ-KLTDDHVQF--LIYQILRGLKYIHS--- 143
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE-HTRTGK 440
             +IHRD+K SN+ ++ +   ++ DFGLAR     TD + T  V T  Y APE       
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 441 ATTSADVFSFGAFLLEVACGR 461
              + D++S G  + E+  GR
Sbjct: 200 YNQTVDIWSVGCIMAELLTGR 220

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
           +G+G +G V      K+ + +AVKK+S   +S    K    E+  +  ++H N++ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 327 ---CRRKGELLLVY--DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
               R   E   VY   ++    L+  +  Q K+T + +Q   +I  +  GL Y+H    
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQF--LIYQILRGLKYIHS--- 143
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE-HTRTGK 440
             +IHRD+K SN+ ++ +   ++ DFGLAR     TD + T  V T  Y APE       
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNAMH 199
Query: 441 ATTSADVFSFGAFLLEVACGR 461
              + D++S G  + E+  GR
Sbjct: 200 YNQTVDIWSVGCIMAELLTGR 220

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 98/209 (46%), Gaps = 18/209 (8%)
Query: 262 GFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLV 321
            + + +++G G FG VY+  L  S   +A+KK+  + R   +    E+  + +L H N+V
Sbjct: 26  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIV 81
Query: 322 QLLGYCRRKGE------LLLVYDYMPNGSLD-KYLYDQPKVTLNWIQRFRVIKGVALGLF 374
           +L  +    GE      L LV DY+P         Y + K TL  I     +  +   L 
Sbjct: 82  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 141
Query: 375 YLHQEWEQVVIHRDVKASNVLLDGELNG-RLGDFGLARLYDHGTDPQTTHVVGTLGYLAP 433
           Y+H      + HRD+K  N+LLD +    +L DFG A+    G +P  +++     Y AP
Sbjct: 142 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRY-YRAP 196
Query: 434 EHTR-TGKATTSADVFSFGAFLLEVACGR 461
           E        T+S DV+S G  L E+  G+
Sbjct: 197 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 225

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 98/209 (46%), Gaps = 18/209 (8%)
Query: 262 GFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLV 321
            + + +++G G FG VY+  L  S   +A+KK+  + R   +    E+  + +L H N+V
Sbjct: 49  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIV 104
Query: 322 QLLGYCRRKGE------LLLVYDYMPNGSLD-KYLYDQPKVTLNWIQRFRVIKGVALGLF 374
           +L  +    GE      L LV DY+P         Y + K TL  I     +  +   L 
Sbjct: 105 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 164
Query: 375 YLHQEWEQVVIHRDVKASNVLLDGELNG-RLGDFGLARLYDHGTDPQTTHVVGTLGYLAP 433
           Y+H      + HRD+K  N+LLD +    +L DFG A+    G +P  +++     Y AP
Sbjct: 165 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRY-YRAP 219
Query: 434 EHTR-TGKATTSADVFSFGAFLLEVACGR 461
           E        T+S DV+S G  L E+  G+
Sbjct: 220 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 248

>pdb|3UJO|A Chain A, Galactose-Specific Seed Lectin From Dolichos Lablab In Complex With Adenine And Galactose Length = 281

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/168 (31%), Positives = 85/168 (50%), Gaps = 21/168 (12%)
Query: 37  GHGIAFVIASTRGLPGARPSQYLGLFNDTNLGNETNHVFAVELDTIKSHGFLDINDNHVG 96
             G+AF +      P  +   +LGLF+  N  + +N   AVE DT  + G+ D  + H+G
Sbjct: 107 ADGLAFALVPVGSQPKDK-GGFLGLFDSKNYAS-SNQTVAVEFDTFYNGGW-DPTERHIG 163
Query: 97  IDINSLKSESSAP--------AGYYVEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLS 148
           ID+NS+KS  +          A   + YD     TN+ +A +  P  ++   +S   DL+
Sbjct: 164 IDVNSIKSIKTTSWDFANGENAEVLITYDS---STNLLVASLVHPSQKTSFIVSERVDLT 220
Query: 149 SVLNDAMYVGFSSSTG---SVLASHYILGWSF----KINGQAEELNLS 189
           SVL + + VGFS++TG     + ++ +L WSF     IN + EE  L+
Sbjct: 221 SVLPEWVSVGFSATTGLSKGYVETNEVLSWSFASKLSINKEDEENKLA 268

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 98/209 (46%), Gaps = 18/209 (8%)
Query: 262 GFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLV 321
            + + +++G G FG VY+  L  S   +A+KK+  + R   +    E+  + +L H N+V
Sbjct: 34  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIV 89
Query: 322 QLLGYCRRKGE------LLLVYDYMPNGSLD-KYLYDQPKVTLNWIQRFRVIKGVALGLF 374
           +L  +    GE      L LV DY+P         Y + K TL  I     +  +   L 
Sbjct: 90  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 149
Query: 375 YLHQEWEQVVIHRDVKASNVLLDGELNG-RLGDFGLARLYDHGTDPQTTHVVGTLGYLAP 433
           Y+H      + HRD+K  N+LLD +    +L DFG A+    G +P  +++     Y AP
Sbjct: 150 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRY-YRAP 204
Query: 434 EHTR-TGKATTSADVFSFGAFLLEVACGR 461
           E        T+S DV+S G  L E+  G+
Sbjct: 205 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 233

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 72/297 (24%), Positives = 127/297 (42%), Gaps = 31/297 (10%)
Query: 261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES---RQGMKEFVAEIVSIGR-LR 316
           K +     LG GGF + Y  T   ++ E+   K+  +S   +   KE ++  ++I + L 
Sbjct: 42  KRYMRGRFLGKGGFAKCYEITDMDTK-EVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLD 100
Query: 317 HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYL 376
           + ++V   G+      + +V +     SL +    +  VT    + F  ++    G+ YL
Sbjct: 101 NPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYF--MRQTIQGVQYL 158
Query: 377 HQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHT 436
           H      VIHRD+K  N+ L+ +++ ++GDFGLA   +   + +   + GT  Y+APE  
Sbjct: 159 HNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGE-RKKXLCGTPNYIAPEVL 214
Query: 437 RTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNL 496
                +   D++S G  L  +  G+ P +     E  I +        + E    R  N 
Sbjct: 215 CKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRI-------KKNEYSVPRHINP 267
Query: 497 GTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQILERDVALPAISALRLSTSGIT 553
               +               H+DPT RPS   V ++L  +      + +RL TS +T
Sbjct: 268 VASALIRRML----------HADPTLRPS---VAELLTDEFFTSGYAPMRLPTSCLT 311

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 98/209 (46%), Gaps = 18/209 (8%)
Query: 262 GFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLV 321
            + + +++G G FG VY+  L  S   +A+KK+  + R   +    E+  + +L H N+V
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIV 110
Query: 322 QLLGYCRRKGE------LLLVYDYMPNGSLD-KYLYDQPKVTLNWIQRFRVIKGVALGLF 374
           +L  +    GE      L LV DY+P         Y + K TL  I     +  +   L 
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 170
Query: 375 YLHQEWEQVVIHRDVKASNVLLDGELNG-RLGDFGLARLYDHGTDPQTTHVVGTLGYLAP 433
           Y+H      + HRD+K  N+LLD +    +L DFG A+    G +P  +++     Y AP
Sbjct: 171 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRY-YRAP 225
Query: 434 EHTR-TGKATTSADVFSFGAFLLEVACGR 461
           E        T+S DV+S G  L E+  G+
Sbjct: 226 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
           +G+G +G V      K+ + +AVKK+S   +S    K    E+  +  ++H N++ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 327 ---CRRKGELLLVY--DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
               R   E   VY   ++    L+  +  Q K+T + +Q   +I  +  GL Y+H    
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKXQ-KLTDDHVQF--LIYQILRGLKYIHS--- 143
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE-HTRTGK 440
             +IHRD+K SN+ ++ +   ++ DFGLAR     TD + T  V T  Y APE       
Sbjct: 144 ADIIHRDLKPSNLAVNEDXELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 441 ATTSADVFSFGAFLLEVACGR 461
              + D++S G  + E+  GR
Sbjct: 200 YNQTVDIWSVGCIMAELLTGR 220

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 98/209 (46%), Gaps = 18/209 (8%)
Query: 262 GFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLV 321
            + + +++G G FG VY+  L  S   +A+KK+  + R   +    E+  + +L H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIV 76
Query: 322 QLLGYCRRKGE------LLLVYDYMPNGSLD-KYLYDQPKVTLNWIQRFRVIKGVALGLF 374
           +L  +    GE      L LV DY+P         Y + K TL  I     +  +   L 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 375 YLHQEWEQVVIHRDVKASNVLLDGELNG-RLGDFGLARLYDHGTDPQTTHVVGTLGYLAP 433
           Y+H      + HRD+K  N+LLD +    +L DFG A+    G +P  +++     Y AP
Sbjct: 137 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRY-YRAP 191
Query: 434 EHTR-TGKATTSADVFSFGAFLLEVACGR 461
           E        T+S DV+S G  L E+  G+
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 103/227 (45%), Gaps = 28/227 (12%)
Query: 256 LYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMK-EFVAEIVSIGR 314
           +Y  +  F+ K LLG G +G V   T   +   +A+KKI    +       + EI  +  
Sbjct: 6   VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKH 65
Query: 315 LRHRNLVQLLGYCRRKG-----ELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRF--RVIK 367
            +H N++ +    R        E+ ++ + M    L + +  Q  ++ + IQ F  + ++
Sbjct: 66  FKHENIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVISTQ-MLSDDHIQYFIYQTLR 123
Query: 368 GVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH---------GTD 418
            V +    LH      VIHRD+K SN+L++   + ++ DFGLAR+ D          G  
Sbjct: 124 AVKV----LHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQ 176
Query: 419 PQTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPI 464
                 V T  Y APE   T  K + + DV+S G  L E+   RRPI
Sbjct: 177 SGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPI 222

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 98/208 (47%), Gaps = 18/208 (8%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQ 322
           + + +++G G FG VY+  L  S   +A+KK+  + R   +    E+  + +L H N+V+
Sbjct: 60  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 115
Query: 323 LLGYCRRKGE------LLLVYDYMPNGSLD-KYLYDQPKVTLNWIQRFRVIKGVALGLFY 375
           L  +    GE      L LV DY+P         Y + K TL  I     +  +   L Y
Sbjct: 116 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 175
Query: 376 LHQEWEQVVIHRDVKASNVLLDGELNG-RLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE 434
           +H      + HRD+K  N+LLD +    +L DFG A+    G +P  +++     Y APE
Sbjct: 176 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRY-YRAPE 230
Query: 435 HT-RTGKATTSADVFSFGAFLLEVACGR 461
                   T+S DV+S G  L E+  G+
Sbjct: 231 LIFGATDYTSSIDVWSAGCVLAELLLGQ 258

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 76/295 (25%), Positives = 122/295 (41%), Gaps = 55/295 (18%)
Query: 269 LGTGGFGRVYRG---------TLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRN 319
           LG G FG+V            T     +++  +  +H   + +   +  ++ IG   H N
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH--HLN 93
Query: 320 LVQLLGYCRRKG-ELLLVYDYMPNGSLDKYL---------YDQPK------VTLNWIQRF 363
           +V LLG C + G  L+++ ++   G+L  YL         Y  P+      +TL  +  +
Sbjct: 94  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICY 153
Query: 364 RVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTH 423
                VA G+ +L     +  IHRD+ A N+LL  +   ++ DFGLAR  D   DP    
Sbjct: 154 SF--QVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLAR--DIXKDPDXVR 206
Query: 424 VVGT---LGYLAPEHTRTGKATTSADVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWV 479
                  L ++APE       T  +DV+SFG  L E+ + G  P       E        
Sbjct: 207 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-------- 258
Query: 480 FDFWNR-GELLEARDPNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQIL 533
            +F  R  E    R P+  T  +             C H +P+ RP+  ++V+ L
Sbjct: 259 -EFCRRLKEGTRMRAPDYTTPEM-------YQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 98/209 (46%), Gaps = 18/209 (8%)
Query: 262 GFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLV 321
            + + +++G G FG VY+  L  S   +A+KK+  + R   +    E+  + +L H N+V
Sbjct: 57  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIV 112
Query: 322 QLLGYCRRKGE------LLLVYDYMPNGSLD-KYLYDQPKVTLNWIQRFRVIKGVALGLF 374
           +L  +    GE      L LV DY+P         Y + K TL  I     +  +   L 
Sbjct: 113 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 172
Query: 375 YLHQEWEQVVIHRDVKASNVLLDGELNG-RLGDFGLARLYDHGTDPQTTHVVGTLGYLAP 433
           Y+H      + HRD+K  N+LLD +    +L DFG A+    G +P  +++     Y AP
Sbjct: 173 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRY-YRAP 227
Query: 434 EHT-RTGKATTSADVFSFGAFLLEVACGR 461
           E        T+S DV+S G  L E+  G+
Sbjct: 228 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 256

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
           +G+G +G V      K+ + +AVKK+S   +S    K    E+  +  ++H N++ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 327 ---CRRKGELLLVY--DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
               R   E   VY   ++    L+  +  Q K+T + +Q   +I  +  GL Y+H    
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQF--LIYQILRGLKYIHS--- 143
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE-HTRTGK 440
             +IHRD+K SN+ ++ +   ++ DFGLAR     TD + T  V T  Y APE       
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGXVATRWYRAPEIMLNWMH 199
Query: 441 ATTSADVFSFGAFLLEVACGR 461
              + D++S G  + E+  GR
Sbjct: 200 YNQTVDIWSVGCIMAELLTGR 220

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/237 (24%), Positives = 108/237 (45%), Gaps = 38/237 (16%)
Query: 244 LDHGPHRFRYKDLYIATKGFREKELLGTGGFGRVYR---------------GTLPKSQIE 288
           ++ GP + R        + F    +LG GG+G+V++                 L K+ I 
Sbjct: 7   VNRGPEKIR-------PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIV 59
Query: 289 IAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKY 348
              K  +H          AE   +  ++H  +V L+   +  G+L L+ +Y+  G L   
Sbjct: 60  RNAKDTAHTK--------AERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQ 111
Query: 349 LYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFG 408
           L ++  + +     F + + +++ L +LHQ+    +I+RD+K  N++L+ + + +L DFG
Sbjct: 112 L-EREGIFMEDTACFYLAE-ISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFG 166
Query: 409 LARLYDHGTDPQTTHV-VGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPI 464
           L +   H  D   TH   GT+ Y+APE         + D +S GA + ++  G  P 
Sbjct: 167 LCKESIH--DGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPF 221

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
           +G+G +G V      K+ + +AVKK+S   +S    K    E+  +  ++H N++ LL  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 327 ---CRRKGELLLVY--DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
               R   E   VY   ++    L+  +  Q K+T + +Q   +I  +  GL Y+H    
Sbjct: 95  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQF--LIYQILRGLKYIHS--- 148
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE-HTRTGK 440
             +IHRD+K SN+ ++ +   ++ DFGLAR     TD + T  V T  Y APE       
Sbjct: 149 ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMH 204
Query: 441 ATTSADVFSFGAFLLEVACGR 461
              + D++S G  + E+  GR
Sbjct: 205 YNQTVDIWSVGCIMAELLTGR 225

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
           +G+G +G V      K+ + +AVKK+S   +S    K    E+  +  ++H N++ LL  
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 88
Query: 327 ---CRRKGELLLVY--DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
               R   E   VY   ++    L+  +  Q K+T + +Q   +I  +  GL Y+H    
Sbjct: 89  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQF--LIYQILRGLKYIHS--- 142
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE-HTRTGK 440
             +IHRD+K SN+ ++ +   ++ DFGLAR     TD + T  V T  Y APE       
Sbjct: 143 ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMH 198
Query: 441 ATTSADVFSFGAFLLEVACGR 461
              + D++S G  + E+  GR
Sbjct: 199 YNQTVDIWSVGCIMAELLTGR 219

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
           +G+G +G V      K+ + +AVKK+S   +S    K    E+  +  ++H N++ LL  
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 327 ---CRRKGELLLVY--DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
               R   E   VY   ++    L+  +  Q K+T + +Q   +I  +  GL Y+H    
Sbjct: 95  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQF--LIYQILRGLKYIHS--- 148
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE-HTRTGK 440
             +IHRD+K SN+ ++ +   ++ DFGLAR     TD + T  V T  Y APE       
Sbjct: 149 ADIIHRDLKPSNLAVNEDXELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMH 204
Query: 441 ATTSADVFSFGAFLLEVACGR 461
              + D++S G  + E+  GR
Sbjct: 205 YNQTVDIWSVGCIMAELLTGR 225

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
           +G+G +G V      K+ + +AVKK+S   +S    K    E+  +  ++H N++ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 327 ---CRRKGELLLVY--DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
               R   E   VY   ++    L+  +  Q K+T + +Q   +I  +  GL Y+H    
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQF--LIYQILRGLKYIHS--- 143
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE-HTRTGK 440
             +IHRD+K SN+ ++ +   ++ DFGLAR     TD + T  V T  Y APE       
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 441 ATTSADVFSFGAFLLEVACGR 461
              + D++S G  + E+  GR
Sbjct: 200 YNQTVDIWSVGCIMAELLTGR 220

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
           +G+G +G V      K+ + +AVKK+S   +S    K    E+  +  ++H N++ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 327 ---CRRKGELLLVY--DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
               R   E   VY   ++    L+  +  Q K+T + +Q   +I  +  GL Y+H    
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQF--LIYQILRGLKYIHS--- 143
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE-HTRTGK 440
             +IHRD+K SN+ ++ +   ++ DFGLAR     TD + T  V T  Y APE       
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 441 ATTSADVFSFGAFLLEVACGR 461
              + D++S G  + E+  GR
Sbjct: 200 YNQTVDIWSVGCIMAELLTGR 220

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 100/214 (46%), Gaps = 12/214 (5%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES---RQGMKEFVAEI-VSIGRLRHR 318
           F   +++G G FG+V        ++  AVK +  ++   ++  K  ++E  V +  ++H 
Sbjct: 40  FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHP 99
Query: 319 NLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQ 378
            LV L    +   +L  V DY+  G L  +L  + +  L    RF   + +A  L YLH 
Sbjct: 100 FLVGLHFSFQTADKLYFVLDYINGGELFYHL-QRERCFLEPRARFYAAE-IASALGYLHS 157
Query: 379 EWEQVVIHRDVKASNVLLDGELNGRLGDFGLARL-YDHGTDPQTTHVVGTLGYLAPEHTR 437
                +++RD+K  N+LLD + +  L DFGL +   +H +   T+   GT  YLAPE   
Sbjct: 158 ---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS--TTSTFCGTPEYLAPEVLH 212
Query: 438 TGKATTSADVFSFGAFLLEVACGRRPIQRQGPSE 471
                 + D +  GA L E+  G  P   +  +E
Sbjct: 213 KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE 246

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
           +G+G +G V      K+ + +AVKK+S   +S    K    E+  +  ++H N++ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 327 ---CRRKGELLLVY--DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
               R   E   VY   ++    L+  +  Q K+T + +Q   +I  +  GL Y+H    
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQF--LIYQILRGLKYIHS--- 143
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE-HTRTGK 440
             +IHRD+K SN+ ++ +   ++ DFGLAR     TD + T  V T  Y APE       
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 441 ATTSADVFSFGAFLLEVACGR 461
              + D++S G  + E+  GR
Sbjct: 200 YNQTVDIWSVGCIMAELLTGR 220

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
           +G+G +G V      K+ + +AVKK+S   +S    K    E+  +  ++H N++ LL  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 327 ---CRRKGELLLVY--DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
               R   E   VY   ++    L+  +  Q K+T + +Q   +I  +  GL Y+H    
Sbjct: 102 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQF--LIYQILRGLKYIHS--- 155
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE-HTRTGK 440
             +IHRD+K SN+ ++ +   ++ DFGLAR     TD + T  V T  Y APE       
Sbjct: 156 ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMH 211
Query: 441 ATTSADVFSFGAFLLEVACGR 461
              + D++S G  + E+  GR
Sbjct: 212 YNQTVDIWSVGCIMAELLTGR 232

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 98/208 (47%), Gaps = 18/208 (8%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQ 322
           + + +++G G FG VY+  L  S   +A+KK+  + R   +    E+  + +L H N+V+
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIVR 156
Query: 323 LLGYCRRKGE------LLLVYDYMPNGSLD-KYLYDQPKVTLNWIQRFRVIKGVALGLFY 375
           L  +    GE      L LV DY+P         Y + K TL  I     +  +   L Y
Sbjct: 157 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 216
Query: 376 LHQEWEQVVIHRDVKASNVLLDGELNG-RLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE 434
           +H      + HRD+K  N+LLD +    +L DFG A+    G +P  +++     Y APE
Sbjct: 217 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRY-YRAPE 271
Query: 435 HT-RTGKATTSADVFSFGAFLLEVACGR 461
                   T+S DV+S G  L E+  G+
Sbjct: 272 LIFGATDYTSSIDVWSAGCVLAELLLGQ 299

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
           +G+G +G V      K+ + +AVKK+S   +S    K    E+  +  ++H N++ LL  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 327 ---CRRKGELLLVY--DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
               R   E   VY   ++    L+  +  Q K+T + +Q   +I  +  GL Y+H    
Sbjct: 102 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQF--LIYQILRGLKYIHS--- 155
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE-HTRTGK 440
             +IHRD+K SN+ ++ +   ++ DFGLAR     TD + T  V T  Y APE       
Sbjct: 156 ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMH 211
Query: 441 ATTSADVFSFGAFLLEVACGR 461
              + D++S G  + E+  GR
Sbjct: 212 YNQTVDIWSVGCIMAELLTGR 232

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 63.2 bits (152), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
           +G+G +G V      K+ + +AVKK+S   +S    K    E+  +  ++H N++ LL  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 86
Query: 327 ---CRRKGELLLVY--DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
               R   E   VY   ++    L+  +  Q K+T + +Q   +I  +  GL Y+H    
Sbjct: 87  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQF--LIYQILRGLKYIHS--- 140
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE-HTRTGK 440
             +IHRD+K SN+ ++ +   ++ DFGLAR     TD + T  V T  Y APE       
Sbjct: 141 ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMH 196
Query: 441 ATTSADVFSFGAFLLEVACGR 461
              + D++S G  + E+  GR
Sbjct: 197 YNQTVDIWSVGCIMAELLTGR 217

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
           +G+G +G V      K+ + +AVKK+S   +S    K    E+  +  ++H N++ LL  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 327 ---CRRKGELLLVY--DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
               R   E   VY   ++    L+  +  Q K+T + +Q   +I  +  GL Y+H    
Sbjct: 97  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQF--LIYQILRGLKYIHS--- 150
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE-HTRTGK 440
             +IHRD+K SN+ ++ +   ++ DFGLAR     TD + T  V T  Y APE       
Sbjct: 151 ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMH 206
Query: 441 ATTSADVFSFGAFLLEVACGR 461
              + D++S G  + E+  GR
Sbjct: 207 YNQTVDIWSVGCIMAELLTGR 227

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
           +G+G +G V      K+ + +AVKK+S   +S    K    E+  +  ++H N++ LL  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 327 ---CRRKGELLLVY--DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
               R   E   VY   ++    L+  +  Q K+T + +Q   +I  +  GL Y+H    
Sbjct: 92  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQF--LIYQILRGLKYIHS--- 145
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE-HTRTGK 440
             +IHRD+K SN+ ++ +   ++ DFGLAR     TD + T  V T  Y APE       
Sbjct: 146 ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMH 201
Query: 441 ATTSADVFSFGAFLLEVACGR 461
              + D++S G  + E+  GR
Sbjct: 202 YNQTVDIWSVGCIMAELLTGR 222

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
           +G+G +G V      K+ + +AVKK+S   +S    K    E+  +  ++H N++ LL  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 327 ---CRRKGELLLVY--DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
               R   E   VY   ++    L+  +  Q K+T + +Q   +I  +  GL Y+H    
Sbjct: 96  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQF--LIYQILRGLKYIHS--- 149
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE-HTRTGK 440
             +IHRD+K SN+ ++ +   ++ DFGLAR     TD + T  V T  Y APE       
Sbjct: 150 ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMH 205
Query: 441 ATTSADVFSFGAFLLEVACGR 461
              + D++S G  + E+  GR
Sbjct: 206 YNQTVDIWSVGCIMAELLTGR 226

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
           +G+G +G V      K+ + +AVKK+S   +S    K    E+  +  ++H N++ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 327 ---CRRKGELLLVY--DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
               R   E   VY   ++    L+  +  Q K+T + +Q   +I  +  GL Y+H    
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQF--LIYQILRGLKYIHS--- 143
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE-HTRTGK 440
             +IHRD+K SN+ ++ +   ++ DFGLAR     TD + T  V T  Y APE       
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 441 ATTSADVFSFGAFLLEVACGR 461
              + D++S G  + E+  GR
Sbjct: 200 YNQTVDIWSVGCIMAELLTGR 220

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
           +G+G +G V      K+ + +AVKK+S   +S    K    E+  +  ++H N++ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 327 ---CRRKGELLLVY--DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
               R   E   VY   ++    L+  +  Q K+T + +Q   +I  +  GL Y+H    
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQF--LIYQILRGLKYIHS--- 143
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE-HTRTGK 440
             +IHRD+K SN+ ++ +   ++ DFGLAR     TD + T  V T  Y APE       
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 441 ATTSADVFSFGAFLLEVACGR 461
              + D++S G  + E+  GR
Sbjct: 200 YNQTVDIWSVGCIMAELLTGR 220

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
           +G+G +G V      K+ + +AVKK+S   +S    K    E+  +  ++H N++ LL  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 327 ---CRRKGELLLVY--DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
               R   E   VY   ++    L+  +  Q K+T + +Q   +I  +  GL Y+H    
Sbjct: 92  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQF--LIYQILRGLKYIHS--- 145
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE-HTRTGK 440
             +IHRD+K SN+ ++ +   ++ DFGLAR     TD + T  V T  Y APE       
Sbjct: 146 ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMH 201
Query: 441 ATTSADVFSFGAFLLEVACGR 461
              + D++S G  + E+  GR
Sbjct: 202 YNQTVDIWSVGCIMAELLTGR 222

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
           +G+G +G V      K+ + +AVKK+S   +S    K    E+  +  ++H N++ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 327 ---CRRKGELLLVY--DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
               R   E   VY   ++    L+  +  Q K+T + +Q   +I  +  GL Y+H    
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQF--LIYQILRGLKYIHS--- 143
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE-HTRTGK 440
             +IHRD+K SN+ ++ +   ++ DFGLAR     TD + T  V T  Y APE       
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 441 ATTSADVFSFGAFLLEVACGR 461
              + D++S G  + E+  GR
Sbjct: 200 YNQTVDIWSVGCIMAELLTGR 220

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
           +G+G +G V      K+ + +AVKK+S   +S    K    E+  +  ++H N++ LL  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 327 ---CRRKGELLLVY--DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
               R   E   VY   ++    L+  +  Q K+T + +Q   +I  +  GL Y+H    
Sbjct: 96  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQF--LIYQILRGLKYIHS--- 149
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE-HTRTGK 440
             +IHRD+K SN+ ++ +   ++ DFGLAR     TD + T  V T  Y APE       
Sbjct: 150 ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMH 205
Query: 441 ATTSADVFSFGAFLLEVACGR 461
              + D++S G  + E+  GR
Sbjct: 206 YNQTVDIWSVGCIMAELLTGR 226

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
           +G+G +G V      K+ + +AVKK+S   +S    K    E+  +  ++H N++ LL  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 327 ---CRRKGELLLVY--DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
               R   E   VY   ++    L+  +  Q K+T + +Q   +I  +  GL Y+H    
Sbjct: 92  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQF--LIYQILRGLKYIHS--- 145
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE-HTRTGK 440
             +IHRD+K SN+ ++ +   ++ DFGLAR     TD + T  V T  Y APE       
Sbjct: 146 ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMH 201
Query: 441 ATTSADVFSFGAFLLEVACGR 461
              + D++S G  + E+  GR
Sbjct: 202 YNQTVDIWSVGCIMAELLTGR 222

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/237 (24%), Positives = 108/237 (45%), Gaps = 38/237 (16%)
Query: 244 LDHGPHRFRYKDLYIATKGFREKELLGTGGFGRVYR---------------GTLPKSQIE 288
           ++ GP + R        + F    +LG GG+G+V++                 L K+ I 
Sbjct: 7   VNRGPEKIR-------PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIV 59
Query: 289 IAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKY 348
              K  +H          AE   +  ++H  +V L+   +  G+L L+ +Y+  G L   
Sbjct: 60  RNAKDTAHTK--------AERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQ 111
Query: 349 LYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFG 408
           L ++  + +     F + + +++ L +LHQ+    +I+RD+K  N++L+ + + +L DFG
Sbjct: 112 L-EREGIFMEDTACFYLAE-ISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFG 166
Query: 409 LARLYDHGTDPQTTH-VVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPI 464
           L +   H  D   TH   GT+ Y+APE         + D +S GA + ++  G  P 
Sbjct: 167 LCKESIH--DGTVTHXFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPF 221

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
           +G+G +G V      K+ + +AVKK+S   +S    K    E+  +  ++H N++ LL  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 101
Query: 327 ---CRRKGELLLVY--DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
               R   E   VY   ++    L+  +  Q K+T + +Q   +I  +  GL Y+H    
Sbjct: 102 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQF--LIYQILRGLKYIHS--- 155
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE-HTRTGK 440
             +IHRD+K SN+ ++ +   ++ DFGLAR     TD + T  V T  Y APE       
Sbjct: 156 ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMH 211
Query: 441 ATTSADVFSFGAFLLEVACGR 461
              + D++S G  + E+  GR
Sbjct: 212 YNQTVDIWSVGCIMAELLTGR 232

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
           +G+G +G V      K+ + +AVKK+S   +S    K    E+  +  ++H N++ LL  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 100
Query: 327 ---CRRKGELLLVY--DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
               R   E   VY   ++    L+  +  Q K+T + +Q   +I  +  GL Y+H    
Sbjct: 101 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQF--LIYQILRGLKYIHS--- 154
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE-HTRTGK 440
             +IHRD+K SN+ ++ +   ++ DFGLAR     TD + T  V T  Y APE       
Sbjct: 155 ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMH 210
Query: 441 ATTSADVFSFGAFLLEVACGR 461
              + D++S G  + E+  GR
Sbjct: 211 YNQTVDIWSVGCIMAELLTGR 231

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
           +G+G +G V      K+ + +AVKK+S   +S    K    E+  +  ++H N++ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 327 ---CRRKGELLLVY--DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
               R   E   VY   ++    L+  +  Q K+T + +Q   +I  +  GL Y+H    
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQF--LIYQILRGLKYIHS--- 143
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE-HTRTGK 440
             +IHRD+K SN+ ++ +   ++ DFGLAR     TD + T  V T  Y APE       
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 441 ATTSADVFSFGAFLLEVACGR 461
              + D++S G  + E+  GR
Sbjct: 200 YNQTVDIWSVGCIMAELLTGR 220

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
           +G+G +G V      K+ + +AVKK+S   +S    K    E+  +  ++H N++ LL  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 327 ---CRRKGELLLVY--DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
               R   E   VY   ++    L+  +  Q K+T + +Q   +I  +  GL Y+H    
Sbjct: 95  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQF--LIYQILRGLKYIHS--- 148
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE-HTRTGK 440
             +IHRD+K SN+ ++ +   ++ DFGLAR     TD + T  V T  Y APE       
Sbjct: 149 ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMH 204
Query: 441 ATTSADVFSFGAFLLEVACGR 461
              + D++S G  + E+  GR
Sbjct: 205 YNQTVDIWSVGCIMAELLTGR 225

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
           +G+G +G V      K+ + +AVKK+S   +S    K    E+  +  ++H N++ LL  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 86
Query: 327 ---CRRKGELLLVY--DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
               R   E   VY   ++    L+  +  Q K+T + +Q   +I  +  GL Y+H    
Sbjct: 87  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQF--LIYQILRGLKYIHS--- 140
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE-HTRTGK 440
             +IHRD+K SN+ ++ +   ++ DFGLAR     TD + T  V T  Y APE       
Sbjct: 141 ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMH 196
Query: 441 ATTSADVFSFGAFLLEVACGR 461
              + D++S G  + E+  GR
Sbjct: 197 YNQTVDIWSVGCIMAELLTGR 217

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
           +G+G +G V      K+ + +AVKK+S   +S    K    E+  +  ++H N++ LL  
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 327 ---CRRKGELLLVY--DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
               R   E   VY   ++    L+  +  Q K+T + +Q   +I  +  GL Y+H    
Sbjct: 86  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQF--LIYQILRGLKYIHS--- 139
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE-HTRTGK 440
             +IHRD+K SN+ ++ +   ++ DFGLAR     TD + T  V T  Y APE       
Sbjct: 140 ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMH 195
Query: 441 ATTSADVFSFGAFLLEVACGR 461
              + D++S G  + E+  GR
Sbjct: 196 YNQTVDIWSVGCIMAELLTGR 216

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
           +G+G +G V      K+ + +AVKK+S   +S    K    E+  +  ++H N++ LL  
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 87
Query: 327 ---CRRKGELLLVY--DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
               R   E   VY   ++    L+  +  Q K+T + +Q   +I  +  GL Y+H    
Sbjct: 88  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQF--LIYQILRGLKYIHS--- 141
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE-HTRTGK 440
             +IHRD+K SN+ ++ +   ++ DFGLAR     TD + T  V T  Y APE       
Sbjct: 142 ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMH 197
Query: 441 ATTSADVFSFGAFLLEVACGR 461
              + D++S G  + E+  GR
Sbjct: 198 YNQTVDIWSVGCIMAELLTGR 218

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
           +G+G +G V      K+ + +AVKK+S   +S    K    E+  +  ++H N++ LL  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 94
Query: 327 ---CRRKGELLLVY--DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
               R   E   VY   ++    L+  +  Q K+T + +Q   +I  +  GL Y+H    
Sbjct: 95  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQF--LIYQILRGLKYIHS--- 148
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE-HTRTGK 440
             +IHRD+K SN+ ++ +   ++ DFGLAR     TD + T  V T  Y APE       
Sbjct: 149 ADIIHRDLKPSNLAVNEDXELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMH 204
Query: 441 ATTSADVFSFGAFLLEVACGR 461
              + D++S G  + E+  GR
Sbjct: 205 YNQTVDIWSVGCIMAELLTGR 225

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 77/292 (26%), Positives = 124/292 (42%), Gaps = 50/292 (17%)
Query: 269 LGTGGFGRVYRGT---LPKSQIE--IAVKKI----SHESRQGMKEFVAEIVSIGRLRHRN 319
           LG G FG+V       + K+     +AVK +    +H   + +   +  ++ IG   H N
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGH--HLN 94
Query: 320 LVQLLGYCRRKG-ELLLVYDYMPNGSLDKYLYDQ-----PKVTLNWIQRFRVIK------ 367
           +V LLG C + G  L+++ ++   G+L  YL  +     P    +  + F  ++      
Sbjct: 95  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYS 154
Query: 368 -GVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVG 426
             VA G+ +L     +  IHRD+ A N+LL  +   ++ DFGLAR  D   DP       
Sbjct: 155 FQVAKGMEFLAS---RKXIHRDLAARNILLSEKNVVKICDFGLAR--DIXKDPDXVRKGD 209
Query: 427 T---LGYLAPEHTRTGKATTSADVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDF 482
               L ++APE       T  +DV+SFG  L E+ + G  P       E         +F
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE---------EF 260
Query: 483 WNR-GELLEARDPNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQIL 533
             R  E    R P+  T  +             C H +P+ RP+  ++V+ L
Sbjct: 261 CRRLKEGTRMRAPDYTTPEM-------YQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|2SBA|A Chain A, Soybean Agglutinin Complexed With 2,6-Pentasaccharide Length = 253

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 83/163 (50%), Gaps = 19/163 (11%)
Query: 39  GIAFVIASTRGLPGARPSQYLGLFNDTNLGNETNHVFAVELDTIKSHGFLDINDNHVGID 98
           G+AF +A     P    + YLGLFN+   G++   V AVE DT ++    D  + H+GI+
Sbjct: 89  GLAFFLAPIDTKPQTH-AGYLGLFNENESGDQ---VVAVEFDTFRNS--WDPPNPHIGIN 142
Query: 99  INSLKS--------ESSAPAGYYVEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSV 150
           +NS++S         ++  A   + YD     T++ +A +  P  R+ N +S   DL + 
Sbjct: 143 VNSIRSIKTTSWDLANNKVAKVLITYDA---STSLLVASLVYPSQRTSNILSDVVDLKTS 199
Query: 151 LNDAMYVGFSSSTGSVLA--SHYILGWSFKINGQAEELNLSQL 191
           L + + +GFS++TG  +   SH +L WSF  N      N+  L
Sbjct: 200 LPEWVRIGFSAATGLDIPGESHDVLSWSFASNLPHASSNIDPL 242

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
           +G+G +G V      K+ + +AVKK+S   +S    K    E+  +  ++H N++ LL  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 112
Query: 327 ---CRRKGELLLVY--DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
               R   E   VY   ++    L+  +  Q K+T + +Q   +I  +  GL Y+H    
Sbjct: 113 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQF--LIYQILRGLKYIHS--- 166
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE-HTRTGK 440
             +IHRD+K SN+ ++ +   ++ DFGLAR     TD + T  V T  Y APE       
Sbjct: 167 ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMH 222
Query: 441 ATTSADVFSFGAFLLEVACGR 461
              + D++S G  + E+  GR
Sbjct: 223 YNQTVDIWSVGCIMAELLTGR 243

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
           +G+G +G V      K+ + +AVKK+S   +S    K    E+  +  ++H N++ LL  
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 108
Query: 327 ---CRRKGELLLVY--DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
               R   E   VY   ++    L+  +  Q K+T + +Q   +I  +  GL Y+H    
Sbjct: 109 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQF--LIYQILRGLKYIHS--- 162
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE-HTRTGK 440
             +IHRD+K SN+ ++ +   ++ DFGLAR     TD + T  V T  Y APE       
Sbjct: 163 ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMH 218
Query: 441 ATTSADVFSFGAFLLEVACGR 461
              + D++S G  + E+  GR
Sbjct: 219 YNQTVDIWSVGCIMAELLTGR 239

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
           +G+G +G V      K+ + +AVKK+S   +S    K    E+  +  ++H N++ LL  
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 327 ---CRRKGELLLVY--DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
               R   E   VY   ++    L+  +  Q K+T + +Q   +I  +  GL Y+H    
Sbjct: 110 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQF--LIYQILRGLKYIHS--- 163
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE-HTRTGK 440
             +IHRD+K SN+ ++ +   ++ DFGLAR     TD + T  V T  Y APE       
Sbjct: 164 ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMH 219
Query: 441 ATTSADVFSFGAFLLEVACGR 461
              + D++S G  + E+  GR
Sbjct: 220 YNQTVDIWSVGCIMAELLTGR 240

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
           +G+G +G V      K+ + +AVKK+S   +S    K    E+  +  ++H N++ LL  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 100
Query: 327 ---CRRKGELLLVY--DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
               R   E   VY   ++    L+  +  Q K+T + +Q   +I  +  GL Y+H    
Sbjct: 101 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQF--LIYQILRGLKYIHS--- 154
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE-HTRTGK 440
             +IHRD+K SN+ ++ +   ++ DFGLAR     TD + T  V T  Y APE       
Sbjct: 155 ADIIHRDLKPSNLAVNEDXELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMH 210
Query: 441 ATTSADVFSFGAFLLEVACGR 461
              + D++S G  + E+  GR
Sbjct: 211 YNQTVDIWSVGCIMAELLTGR 231

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/221 (23%), Positives = 101/221 (45%), Gaps = 15/221 (6%)
Query: 258 IATKGFREKELLGTGGFGRVY-------RGTLPKSQIEIAVKKISHESRQGMKEFVAEIV 310
           +  + F   ++LGTG +G+V+         T     +++  K    +  +  +    E  
Sbjct: 51  VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQ 110
Query: 311 SIGRLRHRNLVQLLGYC-RRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGV 369
            +  +R    +  L Y  + + +L L+ DY+  G L  +L  + + T + +Q +  +  +
Sbjct: 111 VLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIY--VGEI 168
Query: 370 ALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLG 429
            L L +LH+     +I+RD+K  N+LLD   +  L DFGL++ +      +     GT+ 
Sbjct: 169 VLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIE 225
Query: 430 YLAPEHTRTGKA--TTSADVFSFGAFLLEVACGRRPIQRQG 468
           Y+AP+  R G +    + D +S G  + E+  G  P    G
Sbjct: 226 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG 266

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 110/238 (46%), Gaps = 23/238 (9%)
Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHE----SRQGM--KEFVAEIVSIGRLRHRNL 320
           E LG+G F  V +     +  E A K I       SR+G+  +E   E+  +  +RH N+
Sbjct: 18  EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNI 77
Query: 321 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEW 380
           + L      K +++L+ + +  G L  +L ++  +T +   +F  +K +  G+ YLH   
Sbjct: 78  ITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQF--LKQILDGVHYLHS-- 133
Query: 381 EQVVIHRDVKASNV-LLDGELNG---RLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHT 436
            + + H D+K  N+ LLD  +     +L DFG+A   + G   +  ++ GT  ++APE  
Sbjct: 134 -KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN--EFKNIFGTPEFVAPEIV 190
Query: 437 RTGKATTSADVFSFGAFLLEVACGRRPI---QRQGPSENLILVDWVFD---FWNRGEL 488
                   AD++S G     +  G  P     +Q    N+  V++ FD   F N  EL
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSEL 248

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 97/209 (46%), Gaps = 18/209 (8%)
Query: 262 GFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLV 321
            + + +++G G FG VY+  L  S   +A+KK+  + R   +    E+  + +L H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIV 76
Query: 322 QLLGYCRRKGE------LLLVYDYMPNGSLD-KYLYDQPKVTLNWIQRFRVIKGVALGLF 374
           +L  +    GE      L LV DY+P         Y + K TL  I     +  +   L 
Sbjct: 77  RLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 375 YLHQEWEQVVIHRDVKASNVLLDGELNG-RLGDFGLARLYDHGTDPQTTHVVGTLGYLAP 433
           Y+H      + HRD+K  N+LLD +    +L DFG A+    G +P  + +     Y AP
Sbjct: 137 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSXICSRY-YRAP 191
Query: 434 EHTR-TGKATTSADVFSFGAFLLEVACGR 461
           E        T+S DV+S G  L E+  G+
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 97/209 (46%), Gaps = 18/209 (8%)
Query: 262 GFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLV 321
            + + +++G G FG VY+  L  S   +A+KK+  + R   +    E+  + +L H N+V
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIV 88
Query: 322 QLLGYCRRKGE------LLLVYDYMPNGSLD-KYLYDQPKVTLNWIQRFRVIKGVALGLF 374
           +L  +    GE      L LV DY+P         Y + K TL  I     +  +   L 
Sbjct: 89  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 148
Query: 375 YLHQEWEQVVIHRDVKASNVLLDGELNG-RLGDFGLARLYDHGTDPQTTHVVGTLGYLAP 433
           Y+H      + HRD+K  N+LLD +    +L DFG A+    G +P  + +     Y AP
Sbjct: 149 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSXICSRY-YRAP 203
Query: 434 EHTR-TGKATTSADVFSFGAFLLEVACGR 461
           E        T+S DV+S G  L E+  G+
Sbjct: 204 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 97/209 (46%), Gaps = 18/209 (8%)
Query: 262 GFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLV 321
            + + +++G G FG VY+  L  S   +A+KK+  + R   +    E+  + +L H N+V
Sbjct: 40  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIV 95
Query: 322 QLLGYCRRKGE------LLLVYDYMPNGSLD-KYLYDQPKVTLNWIQRFRVIKGVALGLF 374
           +L  +    GE      L LV DY+P         Y + K TL  I     +  +   L 
Sbjct: 96  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 155
Query: 375 YLHQEWEQVVIHRDVKASNVLLDGELNG-RLGDFGLARLYDHGTDPQTTHVVGTLGYLAP 433
           Y+H      + HRD+K  N+LLD +    +L DFG A+    G +P  + +     Y AP
Sbjct: 156 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSXICSRY-YRAP 210
Query: 434 EHTR-TGKATTSADVFSFGAFLLEVACGR 461
           E        T+S DV+S G  L E+  G+
Sbjct: 211 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 239

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 97/209 (46%), Gaps = 18/209 (8%)
Query: 262 GFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLV 321
            + + +++G G FG VY+  L  S   +A+KK+  + R   +    E+  + +L H N+V
Sbjct: 29  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIV 84
Query: 322 QLLGYCRRKGE------LLLVYDYMPNGSLD-KYLYDQPKVTLNWIQRFRVIKGVALGLF 374
           +L  +    GE      L LV DY+P         Y + K TL  I     +  +   L 
Sbjct: 85  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 144
Query: 375 YLHQEWEQVVIHRDVKASNVLLDGELNG-RLGDFGLARLYDHGTDPQTTHVVGTLGYLAP 433
           Y+H      + HRD+K  N+LLD +    +L DFG A+    G +P  + +     Y AP
Sbjct: 145 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSXICSRY-YRAP 199
Query: 434 EHTR-TGKATTSADVFSFGAFLLEVACGR 461
           E        T+S DV+S G  L E+  G+
Sbjct: 200 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 228

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 97/209 (46%), Gaps = 18/209 (8%)
Query: 262 GFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLV 321
            + + +++G G FG VY+  L  S   +A+KK+  + R   +    E+  + +L H N+V
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIV 88
Query: 322 QLLGYCRRKGE------LLLVYDYMPNGSLD-KYLYDQPKVTLNWIQRFRVIKGVALGLF 374
           +L  +    GE      L LV DY+P         Y + K TL  I     +  +   L 
Sbjct: 89  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 148
Query: 375 YLHQEWEQVVIHRDVKASNVLLDGELNG-RLGDFGLARLYDHGTDPQTTHVVGTLGYLAP 433
           Y+H      + HRD+K  N+LLD +    +L DFG A+    G +P  + +     Y AP
Sbjct: 149 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSXICSRY-YRAP 203
Query: 434 EHTR-TGKATTSADVFSFGAFLLEVACGR 461
           E        T+S DV+S G  L E+  G+
Sbjct: 204 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 97/209 (46%), Gaps = 18/209 (8%)
Query: 262 GFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLV 321
            + + +++G G FG VY+  L  S   +A+KK+  + R   +    E+  + +L H N+V
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIV 110
Query: 322 QLLGYCRRKGE------LLLVYDYMPNGSLD-KYLYDQPKVTLNWIQRFRVIKGVALGLF 374
           +L  +    GE      L LV DY+P         Y + K TL  I     +  +   L 
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 170
Query: 375 YLHQEWEQVVIHRDVKASNVLLDGELNG-RLGDFGLARLYDHGTDPQTTHVVGTLGYLAP 433
           Y+H      + HRD+K  N+LLD +    +L DFG A+    G +P  + +     Y AP
Sbjct: 171 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSXICSRY-YRAP 225
Query: 434 EHTR-TGKATTSADVFSFGAFLLEVACGR 461
           E        T+S DV+S G  L E+  G+
Sbjct: 226 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 97/209 (46%), Gaps = 18/209 (8%)
Query: 262 GFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLV 321
            + + +++G G FG VY+  L  S   +A+KK+  + R   +    E+  + +L H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIV 76
Query: 322 QLLGYCRRKGE------LLLVYDYMPNGSLD-KYLYDQPKVTLNWIQRFRVIKGVALGLF 374
           +L  +    GE      L LV DY+P         Y + K TL  I     +  +   L 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 375 YLHQEWEQVVIHRDVKASNVLLDGELNG-RLGDFGLARLYDHGTDPQTTHVVGTLGYLAP 433
           Y+H      + HRD+K  N+LLD +    +L DFG A+    G +P  + +     Y AP
Sbjct: 137 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSXICSRY-YRAP 191
Query: 434 EHTR-TGKATTSADVFSFGAFLLEVACGR 461
           E        T+S DV+S G  L E+  G+
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 97/209 (46%), Gaps = 18/209 (8%)
Query: 262 GFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLV 321
            + + +++G G FG VY+  L  S   +A+KK+  + R   +    E+  + +L H N+V
Sbjct: 22  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIV 77
Query: 322 QLLGYCRRKGE------LLLVYDYMPNGSLD-KYLYDQPKVTLNWIQRFRVIKGVALGLF 374
           +L  +    GE      L LV DY+P         Y + K TL  I     +  +   L 
Sbjct: 78  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 137
Query: 375 YLHQEWEQVVIHRDVKASNVLLDGELNG-RLGDFGLARLYDHGTDPQTTHVVGTLGYLAP 433
           Y+H      + HRD+K  N+LLD +    +L DFG A+    G +P  + +     Y AP
Sbjct: 138 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSXICSRY-YRAP 192
Query: 434 EHTR-TGKATTSADVFSFGAFLLEVACGR 461
           E        T+S DV+S G  L E+  G+
Sbjct: 193 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 221

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 111/238 (46%), Gaps = 23/238 (9%)
Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHE----SRQGM--KEFVAEIVSIGRLRHRNL 320
           E LG+G F  V +     +  E A K I       SR+G+  +E   E+  +  +RH N+
Sbjct: 32  EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIRHPNI 91
Query: 321 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEW 380
           + L      K +++L+ + +  G L  +L ++  +T +   +F  +K +  G+ YLH   
Sbjct: 92  ITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQF--LKQILDGVHYLHS-- 147
Query: 381 EQVVIHRDVKASNV-LLDGELNG---RLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHT 436
            + + H D+K  N+ LLD  +     +L DFG+A   + G + +  ++ GT  ++APE  
Sbjct: 148 -KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFK--NIFGTPEFVAPEIV 204
Query: 437 RTGKATTSADVFSFGAFLLEVACGRRPI---QRQGPSENLILVDWVFD---FWNRGEL 488
                   AD++S G     +  G  P     +Q    N+  V++ FD   F N  EL
Sbjct: 205 NYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSEL 262

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 97/209 (46%), Gaps = 18/209 (8%)
Query: 262 GFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLV 321
            + + +++G G FG VY+  L  S   +A+KK+  + R   +    E+  + +L H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIV 76
Query: 322 QLLGYCRRKGE------LLLVYDYMPNGSLD-KYLYDQPKVTLNWIQRFRVIKGVALGLF 374
           +L  +    GE      L LV DY+P         Y + K TL  I     +  +   L 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 375 YLHQEWEQVVIHRDVKASNVLLDGELNG-RLGDFGLARLYDHGTDPQTTHVVGTLGYLAP 433
           Y+H      + HRD+K  N+LLD +    +L DFG A+    G +P  + +     Y AP
Sbjct: 137 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSXICSRY-YRAP 191
Query: 434 EHTR-TGKATTSADVFSFGAFLLEVACGR 461
           E        T+S DV+S G  L E+  G+
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 111/238 (46%), Gaps = 23/238 (9%)
Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHE----SRQGM--KEFVAEIVSIGRLRHRNL 320
           E LG+G F  V +     +  E A K I       SR+G+  +E   E+  +  +RH N+
Sbjct: 11  EELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNI 70
Query: 321 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEW 380
           + L      K +++L+ + +  G L  +L ++  +T +   +F  +K +  G+ YLH   
Sbjct: 71  ITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQF--LKQILDGVHYLHS-- 126
Query: 381 EQVVIHRDVKASNV-LLDGELNG---RLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHT 436
            + + H D+K  N+ LLD  +     +L DFG+A   + G + +  ++ GT  ++APE  
Sbjct: 127 -KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFK--NIFGTPEFVAPEIV 183
Query: 437 RTGKATTSADVFSFGAFLLEVACGRRPI---QRQGPSENLILVDWVFD---FWNRGEL 488
                   AD++S G     +  G  P     +Q    N+  V++ FD   F N  EL
Sbjct: 184 NYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSEL 241

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
           +G+G +G V      K+ + +AVKK+S   +S    K    E+  +  ++H N++ LL  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 327 ---CRRKGELLLVY--DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
               R   E   VY   ++    L+  +  Q K+T + +Q   +I  +  GL Y+H    
Sbjct: 96  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQF--LIYQILRGLKYIHS--- 149
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE-HTRTGK 440
             +IHRD+K SN+ ++ +   ++ DFGLAR     TD + T  V T  Y APE       
Sbjct: 150 ADIIHRDLKPSNLAVNEDSELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMH 205
Query: 441 ATTSADVFSFGAFLLEVACGR 461
              + D++S G  + E+  GR
Sbjct: 206 YNQTVDIWSVGCIMAELLTGR 226

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
           +G+G +G V      K+ + +AVKK+S   +S    K    E+  +  ++H N++ LL  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 91
Query: 327 ---CRRKGELLLVY--DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
               R   E   VY   ++    L+  +  Q K+T + +Q   +I  +  GL Y+H    
Sbjct: 92  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQF--LIYQILRGLKYIHS--- 145
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE-HTRTGK 440
             +IHRD+K SN+ ++ +   ++ DFGLAR     TD + T  V T  Y APE       
Sbjct: 146 ADIIHRDLKPSNLAVNEDSELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMH 201
Query: 441 ATTSADVFSFGAFLLEVACGR 461
              + D++S G  + E+  GR
Sbjct: 202 YNQTVDIWSVGCIMAELLTGR 222

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 97/209 (46%), Gaps = 18/209 (8%)
Query: 262 GFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLV 321
            + + +++G G FG VY+  L  S   +A+KK+  + R   +    E+  + +L H N+V
Sbjct: 25  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR----ELQIMRKLDHCNIV 80
Query: 322 QLLGYCRRKGE------LLLVYDYMPNGSLD-KYLYDQPKVTLNWIQRFRVIKGVALGLF 374
           +L  +    GE      L LV DY+P         Y + K TL  I     +  +   L 
Sbjct: 81  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 140
Query: 375 YLHQEWEQVVIHRDVKASNVLLDGELNG-RLGDFGLARLYDHGTDPQTTHVVGTLGYLAP 433
           Y+H      + HRD+K  N+LLD +    +L DFG A+    G +P  + +     Y AP
Sbjct: 141 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSXICSRY-YRAP 195
Query: 434 EHTR-TGKATTSADVFSFGAFLLEVACGR 461
           E        T+S DV+S G  L E+  G+
Sbjct: 196 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 224

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 95/215 (44%), Gaps = 24/215 (11%)
Query: 268 LLGTGGFGRVY----RGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQL 323
           +LG G FG+V     +GT     ++I  K +  +        V + V     +   L QL
Sbjct: 27  VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 86
Query: 324 LGYCRRKGELLLVYDYMPNGSLDKYL-----YDQPKVTLNWIQRFRVIKGVALGLFYLHQ 378
               +    L  V +Y+  G L  ++     + +P       +       +A+GLF+L  
Sbjct: 87  HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAE-------IAIGLFFLQS 139
Query: 379 EWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR--LYDHGTDPQTTHVVGTLGYLAPEHT 436
              + +I+RD+K  NV+LD E + ++ DFG+ +  ++D  T   T    GT  Y+APE  
Sbjct: 140 ---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT---TKXFCGTPDYIAPEII 193
Query: 437 RTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSE 471
                  S D ++FG  L E+  G+ P + +   E
Sbjct: 194 AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE 228

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
           +G+G +G V      K+ + +AVKK+S   +S    K    E+  +  ++H N++ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 327 ---CRRKGELLLVY--DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
               R   E   VY   ++    L+  +  Q K+T + +Q   +I  +  GL Y+H    
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQF--LIYQILRGLKYIHS--- 143
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE-HTRTGK 440
             +IHRD+K SN+ ++ +   ++ D+GLAR     TD + T  V T  Y APE       
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDYGLAR----HTDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 441 ATTSADVFSFGAFLLEVACGR 461
              + D++S G  + E+  GR
Sbjct: 200 YNQTVDIWSVGCIMAELLTGR 220

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 96/216 (44%), Gaps = 26/216 (12%)
Query: 268 LLGTGGFGRVY----RGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQL 323
           +LG G FG+V     +GT     ++I  K +  +        V + V     +   L QL
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 407
Query: 324 LGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGV------ALGLFYLH 377
               +    L  V +Y+  G L   +Y      +  + RF+    V      A+GLF+L 
Sbjct: 408 HSCFQTMDRLYFVMEYVNGGDL---MYH-----IQQVGRFKEPHAVFYAAEIAIGLFFLQ 459
Query: 378 QEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR--LYDHGTDPQTTHVVGTLGYLAPEH 435
               + +I+RD+K  NV+LD E + ++ DFG+ +  ++D  T   T    GT  Y+APE 
Sbjct: 460 S---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT---TKXFCGTPDYIAPEI 513
Query: 436 TRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSE 471
                   S D ++FG  L E+  G+ P + +   E
Sbjct: 514 IAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE 549

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 96/201 (47%), Gaps = 18/201 (8%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
           +G+G +G V      K+ + +AVKK+S   +S    K    E+  +  ++H N++ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 327 ---CRRKGELLLVY--DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
               R   E   VY   ++    L+  +  Q K+T + +Q   +I  +  GL Y+H    
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKSQ-KLTDDHVQF--LIYQILRGLKYIHS--- 143
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE-HTRTGK 440
             +IHRD+K SN+ ++ +   ++ DFGL R     TD + T  V T  Y APE       
Sbjct: 144 ADIIHRDLKPSNLAVNEDSELKILDFGLCR----HTDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 441 ATTSADVFSFGAFLLEVACGR 461
              + D++S G  + E+  GR
Sbjct: 200 YNQTVDIWSVGCIMAELLTGR 220

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 97/209 (46%), Gaps = 18/209 (8%)
Query: 262 GFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLV 321
            + + +++G G FG VY+  L  S   +A+KK+     QG      E+  + +L H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQGKAFKNRELQIMRKLDHCNIV 76
Query: 322 QLLGYCRRKGE------LLLVYDYMPNGSLD-KYLYDQPKVTLNWIQRFRVIKGVALGLF 374
           +L  +    GE      L LV DY+P         Y + K TL  I     +  +   L 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 375 YLHQEWEQVVIHRDVKASNVLLDGELNG-RLGDFGLARLYDHGTDPQTTHVVGTLGYLAP 433
           Y+H      + HRD+K  N+LLD +    +L DFG A+    G +P  +++     Y AP
Sbjct: 137 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRY-YRAP 191
Query: 434 EHTR-TGKATTSADVFSFGAFLLEVACGR 461
           E        T+S DV+S G  L E+  G+
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 94/210 (44%), Gaps = 28/210 (13%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCR 328
           +G G +G V+ G     ++ + V   + E+    +E   EI     +RH N++  +    
Sbjct: 45  IGKGRYGEVWMGKWRGEKVAVKVFFTTEEA-SWFRE--TEIYQTVLMRHENILGFIA-AD 100
Query: 329 RKG-----ELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEW--- 380
            KG     +L L+ DY  NGSL  YL      TL+     ++      GL +LH E    
Sbjct: 101 IKGTGSWTQLYLITDYHENGSLYDYL---KSTTLDAKSMLKLAYSSVSGLCHLHTEIFST 157
Query: 381 --EQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD----PQTTHVVGTLGYLAPE 434
             +  + HRD+K+ N+L+       + D GLA  +   T+    P  T  VGT  Y+ PE
Sbjct: 158 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTR-VGTKRYMPPE 216
Query: 435 ------HTRTGKATTSADVFSFGAFLLEVA 458
                 +    ++   AD++SFG  L EVA
Sbjct: 217 VLDESLNRNHFQSYIMADMYSFGLILWEVA 246

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 97/209 (46%), Gaps = 18/209 (8%)
Query: 262 GFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLV 321
            + + +++G G FG VY+  L  S   +A+KK+     QG      E+  + +L H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQGKAFKNRELQIMRKLDHCNIV 76
Query: 322 QLLGYCRRKGE------LLLVYDYMPNGSLD-KYLYDQPKVTLNWIQRFRVIKGVALGLF 374
           +L  +    GE      L LV DY+P         Y + K TL  I     +  +   L 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 375 YLHQEWEQVVIHRDVKASNVLLDGELNG-RLGDFGLARLYDHGTDPQTTHVVGTLGYLAP 433
           Y+H      + HRD+K  N+LLD +    +L DFG A+    G +P  +++     Y AP
Sbjct: 137 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRY-YRAP 191
Query: 434 EHTR-TGKATTSADVFSFGAFLLEVACGR 461
           E        T+S DV+S G  L E+  G+
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 96/201 (47%), Gaps = 18/201 (8%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
           +G+G +G V      K+   +AVKK+S   +S    K    E+  +  ++H N++ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 327 ---CRRKGELLLVY--DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
               R   E   VY   ++    L+  +  Q K+T + +Q   +I  +  GL Y+H    
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQF--LIYQILRGLKYIHS--- 143
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE-HTRTGK 440
             +IHRD+K SN+ ++ +   ++ DFGLAR     TD + T  V T  Y APE       
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 441 ATTSADVFSFGAFLLEVACGR 461
              + D++S G  + E+  GR
Sbjct: 200 YNQTVDIWSVGCIMAELLTGR 220

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 101/217 (46%), Gaps = 18/217 (8%)
Query: 269 LGTGGFGRVY----RGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLL 324
           LG+G +G V     + T  +  I+I +KK S  +       + E+  + +L H N+++L 
Sbjct: 29  LGSGAYGEVLLCKDKLTGAERAIKI-IKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLY 87
Query: 325 GYCRRKGELLLVYDYMPNGSL-DKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQV 383
            +   K    LV +    G L D+ +  Q     + +    ++K V  G  YLH+     
Sbjct: 88  EFFEDKRNYYLVMEVYRGGELFDEIILRQ---KFSEVDAAVIMKQVLSGTTYLHK---HN 141
Query: 384 VIHRDVKASNVLLDGELNG---RLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGK 440
           ++HRD+K  N+LL+ +      ++ DFGL+  ++ G   +    +GT  Y+APE  R  K
Sbjct: 142 IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGG--KMKERLGTAYYIAPEVLRK-K 198
Query: 441 ATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVD 477
                DV+S G  L  + CG  P   Q   E L  V+
Sbjct: 199 YDEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVE 235

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 96/201 (47%), Gaps = 18/201 (8%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
           +G+G +G V      K+   +AVKK+S   +S    K    E+  +  ++H N++ LL  
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 99
Query: 327 ---CRRKGELLLVY--DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
               R   E   VY   ++    L+  +  Q K+T + +Q   +I  +  GL Y+H    
Sbjct: 100 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQF--LIYQILRGLKYIHS--- 153
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE-HTRTGK 440
             +IHRD+K SN+ ++ +   ++ DFGLAR     TD + T  V T  Y APE       
Sbjct: 154 ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMH 209
Query: 441 ATTSADVFSFGAFLLEVACGR 461
              + D++S G  + E+  GR
Sbjct: 210 YNQTVDIWSVGCIMAELLTGR 230

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 78/290 (26%), Positives = 120/290 (41%), Gaps = 48/290 (16%)
Query: 269 LGTGGFGRVYRGT---LPKSQIE--IAVKKI----SHESRQGMKEFVAEIVSIGRLRHRN 319
           LG G FG+V       + K+     +AVK +    +H   + +   +  ++ IG   H N
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGH--HLN 92
Query: 320 LVQLLGYCRRKG-ELLLVYDYMPNGSLDKYL----------YDQPKVTLNWIQRFRVIKG 368
           +V LLG C + G  L+++ ++   G+L  YL           D  K  L           
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQ 152
Query: 369 VALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT- 427
           VA G+ +L     +  IHRD+ A N+LL  +   ++ DFGLAR  D   DP         
Sbjct: 153 VAKGMEFLAS---RKXIHRDLAARNILLSEKNVVKIXDFGLAR--DIYKDPDYVRKGDAR 207
Query: 428 --LGYLAPEHTRTGKATTSADVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFWN 484
             L ++APE       T  +DV+SFG  L E+ + G  P       E         +F  
Sbjct: 208 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE---------EFXR 258
Query: 485 R-GELLEARDPNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQIL 533
           R  E    R P+  T  +             C H +P+ RP+  ++V+ L
Sbjct: 259 RLKEGTRMRAPDYTTPEM-------YQTMLDCWHGEPSQRPTFSELVEHL 301

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 96/201 (47%), Gaps = 18/201 (8%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
           +G+G +G V      K+ + +AVKK+S   +S    K    E+  +  ++H N++ LL  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 112
Query: 327 ---CRRKGELLLVY--DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
               R   E   VY   ++    L+  +  Q K+T + +Q   +I  +  GL Y+H    
Sbjct: 113 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQF--LIYQILRGLKYIHS--- 166
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE-HTRTGK 440
             +IHRD+K SN+ ++ +   ++ DFGLAR     TD +    V T  Y APE       
Sbjct: 167 ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMXGYVATRWYRAPEIMLNWMH 222
Query: 441 ATTSADVFSFGAFLLEVACGR 461
              + D++S G  + E+  GR
Sbjct: 223 YNQTVDIWSVGCIMAELLTGR 243

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 74/287 (25%), Positives = 123/287 (42%), Gaps = 42/287 (14%)
Query: 269 LGTGGFGRVYRGT---LPKSQIE--IAVKKI----SHESRQGMKEFVAEIVSIGRLRHRN 319
           LG G FG+V       + K+     +AVK +    +H   + +   +  ++ IG   H N
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGH--HLN 92
Query: 320 LVQLLGYCRRKG-ELLLVYDYMPNGSLDKYLYDQPKVTLNW---IQRFRVIKGVALGLFY 375
           +V LLG C + G  L+++ ++   G+L  YL  +    + +    + F  ++ +    F 
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQ 152
Query: 376 LHQEWE----QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT---L 428
           + +  E    +  IHRD+ A N+LL  +   ++ DFGLAR  D   DP           L
Sbjct: 153 VAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLAR--DIYKDPDYVRKGDARLPL 210
Query: 429 GYLAPEHTRTGKATTSADVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFWNR-G 486
            ++APE       T  +DV+SFG  L E+ + G  P       E         +F  R  
Sbjct: 211 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE---------EFCRRLK 261
Query: 487 ELLEARDPNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQIL 533
           E    R P+  T  +             C H +P+ RP+  ++V+ L
Sbjct: 262 EGTRMRAPDYTTPEM-------YQTMLDCWHGEPSQRPTFSELVEHL 301

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 96/201 (47%), Gaps = 18/201 (8%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
           +G+G +G V      K+   +AVKK+S   +S    K    E+  +  ++H N++ LL  
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 95
Query: 327 ---CRRKGELLLVY--DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
               R   E   VY   ++    L+  +  Q K+T + +Q   +I  +  GL Y+H    
Sbjct: 96  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQF--LIYQILRGLKYIHS--- 149
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE-HTRTGK 440
             +IHRD+K SN+ ++ +   ++ DFGLAR     TD + T  V T  Y APE       
Sbjct: 150 ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMH 205
Query: 441 ATTSADVFSFGAFLLEVACGR 461
              + D++S G  + E+  GR
Sbjct: 206 YNQTVDIWSVGCIMAELLTGR 226

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 96/201 (47%), Gaps = 18/201 (8%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
           +G+G +G V      K+   +AVKK+S   +S    K    E+  +  ++H N++ LL  
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 108
Query: 327 ---CRRKGELLLVY--DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
               R   E   VY   ++    L+  +  Q K+T + +Q   +I  +  GL Y+H    
Sbjct: 109 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQF--LIYQILRGLKYIHS--- 162
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE-HTRTGK 440
             +IHRD+K SN+ ++ +   ++ DFGLAR     TD + T  V T  Y APE       
Sbjct: 163 ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMH 218
Query: 441 ATTSADVFSFGAFLLEVACGR 461
              + D++S G  + E+  GR
Sbjct: 219 YNQTVDIWSVGCIMAELLTGR 239

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 96/201 (47%), Gaps = 18/201 (8%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
           +G+G +G V      K+   +AVKK+S   +S    K    E+  +  ++H N++ LL  
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 327 ---CRRKGELLLVY--DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
               R   E   VY   ++    L+  +  Q K+T + +Q   +I  +  GL Y+H    
Sbjct: 110 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQF--LIYQILRGLKYIHS--- 163
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE-HTRTGK 440
             +IHRD+K SN+ ++ +   ++ DFGLAR     TD + T  V T  Y APE       
Sbjct: 164 ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMH 219
Query: 441 ATTSADVFSFGAFLLEVACGR 461
              + D++S G  + E+  GR
Sbjct: 220 YNQTVDIWSVGCIMAELLTGR 240

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
           +G+G +G V      K+ + +AVKK+S   +S    K    E+  +  ++H N++ LL  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 327 ---CRRKGELLLVY--DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
               R   E   VY   ++    L+  +  Q K+T + +Q   +I  +  GL Y+H    
Sbjct: 97  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQF--LIYQILRGLKYIHS--- 150
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE-HTRTGK 440
             +IHRD+K SN+ ++ +   ++ DFGLAR   H  D  T + V T  Y APE       
Sbjct: 151 ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTADEMTGY-VATRWYRAPEIMLNWMH 206
Query: 441 ATTSADVFSFGAFLLEVACGR 461
              + D++S G  + E+  GR
Sbjct: 207 YNQTVDIWSVGCIMAELLTGR 227

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 71/291 (24%), Positives = 120/291 (41%), Gaps = 46/291 (15%)
Query: 269 LGTGGFGRVYRG---------TLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRN 319
           LG G FG+V            T     +++  +  +H   + +   +  ++ IG   H N
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH--HLN 92
Query: 320 LVQLLGYCRRKG-ELLLVYDYMPNGSLDKYLYDQPKVTLNW-------IQRFRVIKGVAL 371
           +V LLG C + G  L+++ ++   G+L  YL  +    + +        + F  ++ +  
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 372 GLFYLHQEWE----QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT 427
             F + +  E    +  IHRD+ A N+LL  +   ++ DFGLAR  D   DP        
Sbjct: 153 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR--DIXKDPDXVRKGDA 210
Query: 428 ---LGYLAPEHTRTGKATTSADVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFW 483
              L ++APE       T  +DV+SFG  L E+ + G  P       E         +F 
Sbjct: 211 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE---------EFC 261
Query: 484 NR-GELLEARDPNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQIL 533
            R  E    R P+  T  +             C H +P+ RP+  ++V+ L
Sbjct: 262 RRLKEGTRMRAPDYTTPEM-------YQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 98/226 (43%), Gaps = 26/226 (11%)
Query: 258 IATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES-------RQGMKEFVAEIV 310
           +    F    +LG G FG+V    + ++    AVK +  +           M E    I+
Sbjct: 20  LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTE--KRIL 77
Query: 311 SIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYL-----YDQPKVTLNWIQRFRV 365
           S+ R  H  L QL    +    L  V +++  G L  ++     +D+ +       RF  
Sbjct: 78  SLAR-NHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARA------RFYA 130
Query: 366 IKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVV 425
            + ++  L +LH   ++ +I+RD+K  NVLLD E + +L DFG+ +         T    
Sbjct: 131 AEIIS-ALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK-EGICNGVTTATFC 185
Query: 426 GTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSE 471
           GT  Y+APE  +      + D ++ G  L E+ CG  P + +   +
Sbjct: 186 GTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD 231

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 101/215 (46%), Gaps = 18/215 (8%)
Query: 255 DLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQ-GMKEFVAEIVSIG 313
           DL+I    F+ K  LG+G FG V+      S +E  +K I+ +  Q  M++  AEI  + 
Sbjct: 22  DLFI----FKRK--LGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLK 75
Query: 314 RLRHRNLVQLLGYCRRKGELLLVYDYMPNGS-LDKYLYDQPK-VTLNWIQRFRVIKGVAL 371
            L H N++++         + +V +    G  L++ +  Q +   L+      ++K +  
Sbjct: 76  SLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMN 135
Query: 372 GLFYLHQEWEQVVIHRDVKASNVLLDGELNG---RLGDFGLARLYDHGTDPQTTHVVGTL 428
            L Y H    Q V+H+D+K  N+L          ++ DFGLA L+   +D  +T+  GT 
Sbjct: 136 ALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK--SDEHSTNAAGTA 190
Query: 429 GYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRP 463
            Y+APE  +    T   D++S G  +  +  G  P
Sbjct: 191 LYMAPEVFKRD-VTFKCDIWSAGVVMYFLLTGCLP 224

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 71/291 (24%), Positives = 120/291 (41%), Gaps = 46/291 (15%)
Query: 269 LGTGGFGRVYRG---------TLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRN 319
           LG G FG+V            T     +++  +  +H   + +   +  ++ IG   H N
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH--HLN 83
Query: 320 LVQLLGYCRRKG-ELLLVYDYMPNGSLDKYLYDQPKVTLNW-------IQRFRVIKGVAL 371
           +V LLG C + G  L+++ ++   G+L  YL  +    + +        + F  ++ +  
Sbjct: 84  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 372 GLFYLHQEWE----QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT 427
             F + +  E    +  IHRD+ A N+LL  +   ++ DFGLAR  D   DP        
Sbjct: 144 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR--DIXKDPDXVRKGDA 201
Query: 428 ---LGYLAPEHTRTGKATTSADVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFW 483
              L ++APE       T  +DV+SFG  L E+ + G  P       E         +F 
Sbjct: 202 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE---------EFC 252
Query: 484 NR-GELLEARDPNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQIL 533
            R  E    R P+  T  +             C H +P+ RP+  ++V+ L
Sbjct: 253 RRLKEGTRMRAPDYTTPEM-------YQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 96/201 (47%), Gaps = 18/201 (8%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
           +G+G +G V      K+   +AVKK+S   +S    K    E+  +  ++H N++ LL  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 327 ---CRRKGELLLVY--DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
               R   E   VY   ++    L+  +  Q K+T + +Q   +I  +  GL Y+H    
Sbjct: 86  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQF--LIYQILRGLKYIHS--- 139
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE-HTRTGK 440
             +IHRD+K SN+ ++ +   ++ DFGLAR     TD + T  V T  Y APE       
Sbjct: 140 ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMH 195
Query: 441 ATTSADVFSFGAFLLEVACGR 461
              + D++S G  + E+  GR
Sbjct: 196 YNQTVDIWSVGCIMAELLTGR 216

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
           +G+G +G V      K+ + +AVKK+S   +S    K    E+  +  ++H N++ LL  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 327 ---CRRKGELLLVY--DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
               R   E   VY   ++    L+  +  Q K+T + +Q   +I  +  GL Y+H    
Sbjct: 97  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQF--LIYQILRGLKYIHS--- 150
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE-HTRTGK 440
             +IHRD+K SN+ ++ +   ++ DFGLAR   H  D  T + V T  Y APE       
Sbjct: 151 ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTADEMTGY-VATRWYRAPEIMLNWMH 206
Query: 441 ATTSADVFSFGAFLLEVACGR 461
              + D++S G  + E+  GR
Sbjct: 207 YNQTVDIWSVGCIMAELLTGR 227

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 97/201 (48%), Gaps = 18/201 (8%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
           +G+G +G V      K+ + +AVKK+S   +S    K    E+  +  ++H N++ LL  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 96
Query: 327 ---CRRKGELLLVY--DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
               R   E   VY   ++    L+  +  Q K+T + +Q   +I  +  GL Y+H    
Sbjct: 97  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQF--LIYQILRGLKYIHS--- 150
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE-HTRTGK 440
             +IHRD+K SN+ ++ +   ++ DFGLAR   H  D  T + V T  Y APE       
Sbjct: 151 ADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTADEMTGY-VATRWYRAPEIMLNWMH 206
Query: 441 ATTSADVFSFGAFLLEVACGR 461
              + D++S G  + E+  GR
Sbjct: 207 YNQTVDIWSVGCIMAELLTGR 227

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 93/222 (41%), Gaps = 17/222 (7%)
Query: 252 RYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVK---KISHESRQGMKEFVAE 308
           + +DL +  + +   +++G G FG V       ++   A+K   K     R     F  E
Sbjct: 60  KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEE 119
Query: 309 IVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYL--YDQPKVTLNWIQRFRVI 366
              +       +VQL    +    L +V +YMP G L   +  YD P+    W  RF   
Sbjct: 120 RDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE---KW-ARFYTA 175
Query: 367 KGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVG 426
           + V L L  +H       IHRDVK  N+LLD   + +L DFG     +     +    VG
Sbjct: 176 E-VVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVG 231
Query: 427 TLGYLAPEHTRT----GKATTSADVFSFGAFLLEVACGRRPI 464
           T  Y++PE  ++    G      D +S G FL E+  G  P 
Sbjct: 232 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 273

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 92/208 (44%), Gaps = 20/208 (9%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQ 322
           F  +  LG G    VYR     +Q   A+K +     +  K    EI  + RL H N+++
Sbjct: 55  FEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPNIIK 112
Query: 323 LLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQR--FRVIKGVALGLFYLHQEW 380
           L        E+ LV + +  G L    +D+      + +R     +K +   + YLH   
Sbjct: 113 LKEIFETPTEISLVLELVTGGEL----FDRIVEKGYYSERDAADAVKQILEAVAYLH--- 165
Query: 381 EQVVIHRDVKASNVLL-----DGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEH 435
           E  ++HRD+K  N+L      D  L  ++ DFGL+++ +H    +T  V GT GY APE 
Sbjct: 166 ENGIVHRDLKPENLLYATPAPDAPL--KIADFGLSKIVEHQVLMKT--VCGTPGYCAPEI 221
Query: 436 TRTGKATTSADVFSFGAFLLEVACGRRP 463
            R        D++S G     + CG  P
Sbjct: 222 LRGCAYGPEVDMWSVGIITYILLCGFEP 249

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 93/222 (41%), Gaps = 17/222 (7%)
Query: 252 RYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVK---KISHESRQGMKEFVAE 308
           + +DL +  + +   +++G G FG V       ++   A+K   K     R     F  E
Sbjct: 65  KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEE 124
Query: 309 IVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYL--YDQPKVTLNWIQRFRVI 366
              +       +VQL    +    L +V +YMP G L   +  YD P+    W  RF   
Sbjct: 125 RDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE---KW-ARFYTA 180
Query: 367 KGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVG 426
           + V L L  +H       IHRDVK  N+LLD   + +L DFG     +     +    VG
Sbjct: 181 E-VVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVG 236
Query: 427 TLGYLAPEHTRT----GKATTSADVFSFGAFLLEVACGRRPI 464
           T  Y++PE  ++    G      D +S G FL E+  G  P 
Sbjct: 237 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 278

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 71/274 (25%), Positives = 117/274 (42%), Gaps = 29/274 (10%)
Query: 269 LGTGGFGRVYRGT-LPKSQIEIAVKKI-SHESRQGMKEFVAEIVSIGRLRHRN-LVQLLG 325
           +G G +G V +    P  QI +AVK+I S    +  K+ + ++  + R      +VQ  G
Sbjct: 30  IGRGAYGSVNKMVHKPSGQI-MAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88
Query: 326 YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYL--HQEWEQV 383
              R+G+  +  + M + S DK+ Y      L+ +    ++  + L       H +    
Sbjct: 89  ALFREGDCWICMELM-STSFDKF-YKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK 146
Query: 384 VIHRDVKASNVLLDGELNGRLGDFGLA-RLYDHGTDPQTTHVVGTLGYLAPEH-----TR 437
           +IHRD+K SN+LLD   N +L DFG++ +L D       T   G   Y+APE      +R
Sbjct: 147 IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIA---KTRDAGCRPYMAPERIDPSASR 203
Query: 438 TGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLG 497
            G    S DV+S G  L E+A GR P  +           W   F    ++++   P L 
Sbjct: 204 QGYDVRS-DVWSLGITLYELATGRFPYPK-----------WNSVFDQLTQVVKGDPPQLS 251
Query: 498 TEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQ 531
                            C   D + RP  +++++
Sbjct: 252 NSEEREFSPSFINFVNLCLTKDESKRPKYKELLK 285

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 95/203 (46%), Gaps = 17/203 (8%)
Query: 269 LGTGGFG--RVYRGTLPKSQIEIAVKKISHESRQGMKEFVA-EIVSIGRLRHRNLVQLLG 325
           +G+G FG  R+ R  L K  +  AVK I  E    + E V  EI++   LRH N+V+   
Sbjct: 28  IGSGNFGVARLMRDKLTKELV--AVKYI--ERGAAIDENVQREIINHRSLRHPNIVRFKE 83
Query: 326 YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVI 385
                  L ++ +Y   G L + + +  + + +  + F   + +  G+ Y H      + 
Sbjct: 84  VILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFF--FQQLLSGVSYCHS---MQIC 138
Query: 386 HRDVKASNVLLDGELNGRL--GDFGLARLYDHGTDPQTTHVVGTLGYLAPE-HTRTGKAT 442
           HRD+K  N LLDG    RL   DFG ++     + P++T  VGT  Y+APE   R     
Sbjct: 139 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLRQEYDG 196
Query: 443 TSADVFSFGAFLLEVACGRRPIQ 465
             ADV+S G  L  +  G  P +
Sbjct: 197 KIADVWSCGVTLYVMLVGAYPFE 219

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 71/291 (24%), Positives = 120/291 (41%), Gaps = 46/291 (15%)
Query: 269 LGTGGFGRVYRG---------TLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRN 319
           LG G FG+V            T     +++  +  +H   + +   +  ++ IG   H N
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH--HLN 83
Query: 320 LVQLLGYCRRKG-ELLLVYDYMPNGSLDKYLYDQPKVTLNW-------IQRFRVIKGVAL 371
           +V LLG C + G  L+++ ++   G+L  YL  +    + +        + F  ++ +  
Sbjct: 84  VVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 372 GLFYLHQEWE----QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT 427
             F + +  E    +  IHRD+ A N+LL  +   ++ DFGLAR  D   DP        
Sbjct: 144 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR--DIXKDPDXVRKGDA 201
Query: 428 ---LGYLAPEHTRTGKATTSADVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFW 483
              L ++APE       T  +DV+SFG  L E+ + G  P       E         +F 
Sbjct: 202 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE---------EFC 252
Query: 484 NR-GELLEARDPNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQIL 533
            R  E    R P+  T  +             C H +P+ RP+  ++V+ L
Sbjct: 253 RRLKEGTRMRAPDYTTPEM-------YQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 71/291 (24%), Positives = 120/291 (41%), Gaps = 46/291 (15%)
Query: 269 LGTGGFGRVYRG---------TLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRN 319
           LG G FG+V            T     +++  +  +H   + +   +  ++ IG   H N
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH--HLN 94
Query: 320 LVQLLGYCRRKG-ELLLVYDYMPNGSLDKYLYDQ-------PKVTLNWIQRFRVIKGVAL 371
           +V LLG C + G  L+++ ++   G+L  YL  +        +   +  + F  ++ +  
Sbjct: 95  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLIC 154
Query: 372 GLFYLHQEWE----QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT 427
             F + +  E    +  IHRD+ A N+LL  +   ++ DFGLAR  D   DP        
Sbjct: 155 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR--DIYKDPDYVRKGDA 212
Query: 428 ---LGYLAPEHTRTGKATTSADVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFW 483
              L ++APE       T  +DV+SFG  L E+ + G  P       E         +F 
Sbjct: 213 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE---------EFC 263
Query: 484 NR-GELLEARDPNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQIL 533
            R  E    R P+  T  +             C H +P+ RP+  ++V+ L
Sbjct: 264 RRLKEGTRMRAPDYTTPEM-------YQTMLDCWHGEPSQRPTFSELVEHL 307

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 93/201 (46%), Gaps = 21/201 (10%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVA--EIVSIGRLRHRNLVQLLGY 326
           +G G +G V++     +   +A+KK        + + +A  EI  + +L+H NLV LL  
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 327 CRRKGELLLVYDYMPNG---SLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQV 383
            RRK  L LV++Y  +     LD+Y    P+  +  I  ++ ++ V     + H+     
Sbjct: 71  FRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSIT-WQTLQAVN----FCHK---HN 122
Query: 384 VIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE----HTRTG 439
            IHRDVK  N+L+      +L DFG ARL    +D      V T  Y +PE     T+ G
Sbjct: 123 CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDE-VATRWYRSPELLVGDTQYG 181
Query: 440 KATTSADVFSFGAFLLEVACG 460
                 DV++ G    E+  G
Sbjct: 182 ---PPVDVWAIGCVFAELLSG 199

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 97/216 (44%), Gaps = 16/216 (7%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKE---FVAEIVSIGRLRHRNLVQLLG 325
           LG+G +G V       +  E A+K I   S          + E+  + +L H N+++L  
Sbjct: 12  LGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYE 71
Query: 326 YCRRKGELLLVYDYMPNGSL-DKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVV 384
           +   K    LV +    G L D+ +  Q     + +    ++K V  G  YLH+     +
Sbjct: 72  FFEDKRNYYLVMEVYRGGELFDEIILRQK---FSEVDAAVIMKQVLSGTTYLHK---HNI 125
Query: 385 IHRDVKASNVLLDGELNG---RLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKA 441
           +HRD+K  N+LL+ +      ++ DFGL+  ++ G   +    +GT  Y+APE  R  K 
Sbjct: 126 VHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVG--GKMKERLGTAYYIAPEVLRK-KY 182
Query: 442 TTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVD 477
               DV+S G  L  + CG  P   Q   E L  V+
Sbjct: 183 DEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVE 218

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 93/222 (41%), Gaps = 17/222 (7%)
Query: 252 RYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVK---KISHESRQGMKEFVAE 308
           + +DL +  + +   +++G G FG V       ++   A+K   K     R     F  E
Sbjct: 65  KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEE 124
Query: 309 IVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYL--YDQPKVTLNWIQRFRVI 366
              +       +VQL    +    L +V +YMP G L   +  YD P+    W  RF   
Sbjct: 125 RDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE---KW-ARFYTA 180
Query: 367 KGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVG 426
           + V L L  +H       IHRDVK  N+LLD   + +L DFG     +     +    VG
Sbjct: 181 E-VVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVG 236
Query: 427 TLGYLAPEHTRT----GKATTSADVFSFGAFLLEVACGRRPI 464
           T  Y++PE  ++    G      D +S G FL E+  G  P 
Sbjct: 237 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 278

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 71/291 (24%), Positives = 120/291 (41%), Gaps = 46/291 (15%)
Query: 269 LGTGGFGRVYRG---------TLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRN 319
           LG G FG+V            T     +++  +  +H   + +   +  ++ IG   H N
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH--HLN 92
Query: 320 LVQLLGYCRRKG-ELLLVYDYMPNGSLDKYLYDQPKVTLNW-------IQRFRVIKGVAL 371
           +V LLG C + G  L+++ ++   G+L  YL  +    + +        + F  ++ +  
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 372 GLFYLHQEWE----QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT 427
             F + +  E    +  IHRD+ A N+LL  +   ++ DFGLAR  D   DP        
Sbjct: 153 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR--DIYKDPDXVRKGDA 210
Query: 428 ---LGYLAPEHTRTGKATTSADVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFW 483
              L ++APE       T  +DV+SFG  L E+ + G  P       E         +F 
Sbjct: 211 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE---------EFC 261
Query: 484 NR-GELLEARDPNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQIL 533
            R  E    R P+  T  +             C H +P+ RP+  ++V+ L
Sbjct: 262 RRLKEGTRMRAPDYTTPEM-------YQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 108/228 (47%), Gaps = 20/228 (8%)
Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKI----SHESRQGM-KEFVAEIVSI-GRLRHRNL 320
           E LG+G F  V +     + ++ A K I    +  SR+G+ +E +   VSI   ++H N+
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 321 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEW 380
           + L      K +++L+ + +  G L  +L ++  +T      F  +K +  G++YLH   
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEF--LKQILNGVYYLHS-- 132
Query: 381 EQVVIHRDVKASNV-LLDGELNG---RLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHT 436
              + H D+K  N+ LLD  +     ++ DFGLA   D G + +  ++ GT  ++APE  
Sbjct: 133 -LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK--NIFGTPAFVAPEIV 189
Query: 437 RTGKATTSADVFSFGAFLLEVACGRRPI---QRQGPSENLILVDWVFD 481
                   AD++S G     +  G  P     +Q    N+  V++ F+
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE 237

>pdb|3IPV|B Chain B, Crystal Structure Of Spatholobus Parviflorus Seed Lectin Length = 239

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 76/152 (50%), Gaps = 16/152 (10%)
Query: 37  GHGIAFVIASTRGLPGARPSQYLGLFNDTNLGNETNHVFAVELDTIKSHGFLDINDNHVG 96
             G+AF +A     P +    +LGLF D+ +G+ T    AVE DT ++  F D    H+G
Sbjct: 87  ADGLAFFLAPVASAPDSG-GGFLGLF-DSAVGDTTYQTVAVEFDTYENTVFTDPPYTHIG 144
Query: 97  IDINSLKSESSA--------PAGYYVEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLS 148
            D+NS+ S  +          A   + Y+   K   + +A +  P  ++   ++   DLS
Sbjct: 145 FDVNSISSIKTVKWSLANGEAAKVLITYNSAVK---LLVASLVYPSSKTSFILADIVDLS 201
Query: 149 SVLNDAMYVGFSSSTGS---VLASHYILGWSF 177
           SVL + + VGFS++TG+    + +H +  WSF
Sbjct: 202 SVLPEWVRVGFSAATGASKGYIETHDVFSWSF 233

>pdb|1BJQ|A Chain A, The Dolichos Biflorus Seed Lectin In Complex With Adenine Length = 253

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 87/169 (51%), Gaps = 21/169 (12%)
Query: 37  GHGIAFVIASTRGLPGARPSQYLGLFNDTNLGNETNHVFAVELDTIKSHGFLDINDNHVG 96
             GIAF +      P  R   YLG+F D+++ N +    AVE DT+ + G+ D +  H+G
Sbjct: 84  ADGIAFALVPVGSEP-RRNGGYLGVF-DSDVYNNSAQTVAVEFDTLSNSGW-DPSMKHIG 140
Query: 97  IDINSLKSESSAP--------AGYYVEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLS 148
           ID+NS+KS ++          A   + Y+     T++ +A +  P  R+   +S   D++
Sbjct: 141 IDVNSIKSIATVSWDLANGENAEILITYNA---ATSLLVASLVHPSRRTSYILSERVDIT 197
Query: 149 SVLNDAMYVGFSSSTG---SVLASHYILGWSFKI----NGQAEELNLSQ 190
           + L + + VGFS++TG     + +H +L WSF      +  AE L+L+ 
Sbjct: 198 NELPEYVSVGFSATTGLSEGYIETHDVLSWSFASKLPDDSTAEPLDLAS 246

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 96/209 (45%), Gaps = 18/209 (8%)
Query: 262 GFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLV 321
            + + +++G G FG VY+  L  S   +A+KK+     QG      E+  + +L H N+V
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQGKAFKNRELQIMRKLDHCNIV 76
Query: 322 QLLGYCRRKGE------LLLVYDYMPNGSLD-KYLYDQPKVTLNWIQRFRVIKGVALGLF 374
           +L  +    GE      L LV DY+P         Y + K TL  I     +  +   L 
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 375 YLHQEWEQVVIHRDVKASNVLLDGELNG-RLGDFGLARLYDHGTDPQTTHVVGTLGYLAP 433
           Y+H      + HRD+K  N+LLD +    +L DFG A+    G +P  + +     Y AP
Sbjct: 137 YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSXICSRY-YRAP 191
Query: 434 EHTR-TGKATTSADVFSFGAFLLEVACGR 461
           E        T+S DV+S G  L E+  G+
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 106/228 (46%), Gaps = 25/228 (10%)
Query: 252 RYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVS 311
           +++D+Y  T      ELLG G + +V      ++  E AVK I  ++         E+ +
Sbjct: 9   KFEDMYKLTS-----ELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVET 63
Query: 312 IGRLR-HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVA 370
           + + + ++N+++L+ +        LV++ +  GS+  ++  Q +   N  +  RV++ VA
Sbjct: 64  LYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGSILAHI--QKQKHFNEREASRVVRDVA 121
Query: 371 LGLFYLHQEWEQVVIHRDVKASNVLLDGELN---GRLGDFGLA---RLYDHG---TDPQT 421
             L +LH    + + HRD+K  N+L +        ++ DF L    +L +     T P+ 
Sbjct: 122 AALDFLHT---KGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPEL 178
Query: 422 THVVGTLGYLAPE--HTRTGKAT---TSADVFSFGAFLLEVACGRRPI 464
           T   G+  Y+APE     T +AT      D++S G  L  +  G  P 
Sbjct: 179 TTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPF 226

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 71/291 (24%), Positives = 120/291 (41%), Gaps = 46/291 (15%)
Query: 269 LGTGGFGRVYRG---------TLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRN 319
           LG G FG+V            T     +++  +  +H   + +   +  ++ IG   H N
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH--HLN 129
Query: 320 LVQLLGYCRRKG-ELLLVYDYMPNGSLDKYLYDQPKVTLNW-------IQRFRVIKGVAL 371
           +V LLG C + G  L+++ ++   G+L  YL  +    + +        + F  ++ +  
Sbjct: 130 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 189
Query: 372 GLFYLHQEWE----QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT 427
             F + +  E    +  IHRD+ A N+LL  +   ++ DFGLAR  D   DP        
Sbjct: 190 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR--DIYKDPDYVRKGDA 247
Query: 428 ---LGYLAPEHTRTGKATTSADVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFW 483
              L ++APE       T  +DV+SFG  L E+ + G  P       E         +F 
Sbjct: 248 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE---------EFC 298
Query: 484 NR-GELLEARDPNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQIL 533
            R  E    R P+  T  +             C H +P+ RP+  ++V+ L
Sbjct: 299 RRLKEGTRMRAPDYTTPEM-------YQTMLDCWHGEPSQRPTFSELVEHL 342

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 91/209 (43%), Gaps = 24/209 (11%)
Query: 266 KELLGTGGFGRVYRGTLPKSQIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQL 323
           KE LG G F  V R     + +E A K I+ +  S +  ++   E     +L+H N+V+L
Sbjct: 11  KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRL 70
Query: 324 LGYCRRKGELLLVYDYMPNGSL-----DKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQ 378
               + +    LV+D +  G L      +  Y +   +         I+ +   + Y H 
Sbjct: 71  HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS-------HCIQQILESIAYCHS 123
Query: 379 EWEQVVIHRDVKASNVLLDGELNG---RLGDFGLARLYDHGTDPQTTH-VVGTLGYLAPE 434
                ++HR++K  N+LL  +  G   +L DFGLA       D +  H   GT GYL+PE
Sbjct: 124 ---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAI---EVNDSEAWHGFAGTPGYLSPE 177
Query: 435 HTRTGKATTSADVFSFGAFLLEVACGRRP 463
             +    +   D+++ G  L  +  G  P
Sbjct: 178 VLKKDPYSKPVDIWACGVILYILLVGYPP 206

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 71/291 (24%), Positives = 120/291 (41%), Gaps = 46/291 (15%)
Query: 269 LGTGGFGRVYRG---------TLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRN 319
           LG G FG+V            T     +++  +  +H   + +   +  ++ IG   H N
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH--HLN 92
Query: 320 LVQLLGYCRRKG-ELLLVYDYMPNGSLDKYLYDQPKVTLNW-------IQRFRVIKGVAL 371
           +V LLG C + G  L+++ ++   G+L  YL  +    + +        + F  ++ +  
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152
Query: 372 GLFYLHQEWE----QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT 427
             F + +  E    +  IHRD+ A N+LL  +   ++ DFGLAR  D   DP        
Sbjct: 153 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR--DIYKDPDYVRKGDA 210
Query: 428 ---LGYLAPEHTRTGKATTSADVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFW 483
              L ++APE       T  +DV+SFG  L E+ + G  P       E         +F 
Sbjct: 211 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE---------EFC 261
Query: 484 NR-GELLEARDPNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQIL 533
            R  E    R P+  T  +             C H +P+ RP+  ++V+ L
Sbjct: 262 RRLKEGTRMRAPDYTTPEM-------YQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 95/226 (42%), Gaps = 29/226 (12%)
Query: 255 DLYIATKGFREKELLGTGGFGRV-----------YRGTLPKSQIEIAVKKISHESRQGMK 303
           D  +    F   +LLG G FG+V           Y   + + ++ IA  +++H       
Sbjct: 4   DPKVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHT------ 57
Query: 304 EFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRF 363
             V E   +   RH  L  L    +    L  V +Y   G L  +L  + +V      RF
Sbjct: 58  --VTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARF 114
Query: 364 RVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR--LYDHGTDPQT 421
              + V+  L YLH    + V++RD+K  N++LD + + ++ DFGL +  + D  T    
Sbjct: 115 YGAEIVS-ALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT---M 167
Query: 422 THVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQ 467
               GT  YLAPE         + D +  G  + E+ CGR P   Q
Sbjct: 168 KXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 213

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 96/201 (47%), Gaps = 18/201 (8%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
           +G+G +G V      K+ + +AVKK+S   +S    K    E+  +  ++H N++ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 327 ---CRRKGELLLVY--DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
               R   E   VY   ++    L+  +  Q K+T + +Q   +I  +  GL Y+H    
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQF--LIYQILRGLKYIHS--- 143
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE-HTRTGK 440
             +IHRD+K SN+ ++ +   ++ D GLAR     TD + T  V T  Y APE       
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDAGLAR----HTDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 441 ATTSADVFSFGAFLLEVACGR 461
              + D++S G  + E+  GR
Sbjct: 200 YNQTVDIWSVGCIMAELLTGR 220

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 94/215 (43%), Gaps = 22/215 (10%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRN--- 319
           F   + +GTG FGRV      ++    A+K +  +    +K+    +     L+  N   
Sbjct: 43  FERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYL-----YDQPKVTLNWIQRFRVIKGVALGLF 374
           LV+L    +    L +V +YMP G +  +L     + +P        RF   + + L   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHA------RFYAAQ-IVLTFE 155
Query: 375 YLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE 434
           YLH      +I+RD+K  N+L+D +   ++ DFG A+        +T  + GT  YLAPE
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAK----RVKGRTWXLCGTPEYLAPE 208
Query: 435 HTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGP 469
              +     + D ++ G  + E+A G  P     P
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 94/223 (42%), Gaps = 29/223 (13%)
Query: 258 IATKGFREKELLGTGGFGRV-----------YRGTLPKSQIEIAVKKISHESRQGMKEFV 306
           +    F   +LLG G FG+V           Y   + + ++ IA  +++H         V
Sbjct: 2   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHT--------V 53
Query: 307 AEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVI 366
            E   +   RH  L  L    +    L  V +Y   G L  +L  + +V      RF   
Sbjct: 54  TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARFYGA 112
Query: 367 KGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR--LYDHGTDPQTTHV 424
           + V+  L YLH    + V++RD+K  N++LD + + ++ DFGL +  + D  T       
Sbjct: 113 EIVS-ALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT---MKXF 165
Query: 425 VGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQ 467
            GT  YLAPE         + D +  G  + E+ CGR P   Q
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 208

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 95/201 (47%), Gaps = 18/201 (8%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
           +G+G +G V      K+   +AVKK+S   +S    K    E+  +  ++H N++ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 327 ---CRRKGELLLVY--DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
               R   E   VY   ++    L+  +  Q K+T + +Q   +I  +  GL Y+H    
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQF--LIYQILRGLKYIHS--- 143
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE-HTRTGK 440
             +IHRD+K SN+ ++ +   ++ DFGLAR     TD +    V T  Y APE       
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMAGFVATRWYRAPEIMLNWMH 199
Query: 441 ATTSADVFSFGAFLLEVACGR 461
              + D++S G  + E+  GR
Sbjct: 200 YNQTVDIWSVGCIMAELLTGR 220

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 71/291 (24%), Positives = 120/291 (41%), Gaps = 46/291 (15%)
Query: 269 LGTGGFGRVYRG---------TLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRN 319
           LG G FG+V            T     +++  +  +H   + +   +  ++ IG   H N
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH--HLN 83
Query: 320 LVQLLGYCRRKG-ELLLVYDYMPNGSLDKYLYDQPKVTLNW-------IQRFRVIKGVAL 371
           +V LLG C + G  L+++ ++   G+L  YL  +    + +        + F  ++ +  
Sbjct: 84  VVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 372 GLFYLHQEWE----QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT 427
             F + +  E    +  IHRD+ A N+LL  +   ++ DFGLAR  D   DP        
Sbjct: 144 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR--DIYKDPDYVRKGDA 201
Query: 428 ---LGYLAPEHTRTGKATTSADVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFW 483
              L ++APE       T  +DV+SFG  L E+ + G  P       E         +F 
Sbjct: 202 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE---------EFC 252
Query: 484 NR-GELLEARDPNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQIL 533
            R  E    R P+  T  +             C H +P+ RP+  ++V+ L
Sbjct: 253 RRLKEGTRMRAPDYTTPEM-------YQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 103/240 (42%), Gaps = 30/240 (12%)
Query: 255 DLYIATKGFREKELLGTGGFGRV-----------YRGTLPKSQIEIAVKKISHESRQGMK 303
           D  +    F   +LLG G FG+V           Y   + K ++ +A  +++H       
Sbjct: 4   DPRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT------ 57
Query: 304 EFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRF 363
             + E   +   RH  L  L    +    L  V +Y   G L  +L  + +V      RF
Sbjct: 58  --LTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHL-SRERVFSEDRARF 114
Query: 364 RVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR--LYDHGTDPQT 421
              + V+  L YLH E  + V++RD+K  N++LD + + ++ DFGL +  + D  T    
Sbjct: 115 YGAEIVS-ALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT---M 168
Query: 422 THVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSE--NLILVDWV 479
               GT  YLAPE         + D +  G  + E+ CGR P   Q   +   LIL++ +
Sbjct: 169 KXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI 228

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 95/201 (47%), Gaps = 18/201 (8%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
           +G+G +G V      K+   +AVKK+S   +S    K    E+  +  ++H N++ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 327 ---CRRKGELLLVY--DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
               R   E   VY   ++    L+  +  Q K+T + +Q   +I  +  GL Y+H    
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQF--LIYQILRGLKYIHS--- 143
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE-HTRTGK 440
             +IHRD+K SN+ ++ +   ++ DFGLAR     TD +    V T  Y APE       
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMAGFVATRWYRAPEIMLNWMH 199
Query: 441 ATTSADVFSFGAFLLEVACGR 461
              + D++S G  + E+  GR
Sbjct: 200 YNQTVDIWSVGCIMAELLTGR 220

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 71/291 (24%), Positives = 120/291 (41%), Gaps = 46/291 (15%)
Query: 269 LGTGGFGRVYRG---------TLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRN 319
           LG G FG+V            T     +++  +  +H   + +   +  ++ IG   H N
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGH--HLN 83
Query: 320 LVQLLGYCRRKG-ELLLVYDYMPNGSLDKYLYDQPKVTLNW-------IQRFRVIKGVAL 371
           +V LLG C + G  L+++ ++   G+L  YL  +    + +        + F  ++ +  
Sbjct: 84  VVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 143
Query: 372 GLFYLHQEWE----QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT 427
             F + +  E    +  IHRD+ A N+LL  +   ++ DFGLAR  D   DP        
Sbjct: 144 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR--DIYKDPDYVRKGDA 201
Query: 428 ---LGYLAPEHTRTGKATTSADVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFW 483
              L ++APE       T  +DV+SFG  L E+ + G  P       E         +F 
Sbjct: 202 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE---------EFC 252
Query: 484 NR-GELLEARDPNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQIL 533
            R  E    R P+  T  +             C H +P+ RP+  ++V+ L
Sbjct: 253 RRLKEGTRMRAPDYTTPEM-------YQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 91/209 (43%), Gaps = 24/209 (11%)
Query: 266 KELLGTGGFGRVYRGTLPKSQIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQL 323
           KE LG G F  V R     + +E A K I+ +  S +  ++   E     +L+H N+V+L
Sbjct: 11  KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRL 70
Query: 324 LGYCRRKGELLLVYDYMPNGSL-----DKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQ 378
               + +    LV+D +  G L      +  Y +   +         I+ +   + Y H 
Sbjct: 71  HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS-------HCIQQILESIAYCHS 123
Query: 379 EWEQVVIHRDVKASNVLLDGELNG---RLGDFGLARLYDHGTDPQTTH-VVGTLGYLAPE 434
                ++HR++K  N+LL  +  G   +L DFGLA       D +  H   GT GYL+PE
Sbjct: 124 ---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAI---EVNDSEAWHGFAGTPGYLSPE 177
Query: 435 HTRTGKATTSADVFSFGAFLLEVACGRRP 463
             +    +   D+++ G  L  +  G  P
Sbjct: 178 VLKKDPYSKPVDIWACGVILYILLVGYPP 206

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 94/215 (43%), Gaps = 22/215 (10%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRN--- 319
           F   + +GTG FGRV      ++    A+K +  +    +K+    +     L+  N   
Sbjct: 43  FERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYL-----YDQPKVTLNWIQRFRVIKGVALGLF 374
           LV+L    +    L +V +YMP G +  +L     + +P        RF   + + L   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHA------RFYAAQ-IVLTFE 155
Query: 375 YLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE 434
           YLH      +I+RD+K  N+L+D +   ++ DFG A+        +T  + GT  YLAPE
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAK----RVKGRTWXLCGTPEYLAPE 208
Query: 435 HTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGP 469
              +     + D ++ G  + E+A G  P     P
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 91/209 (43%), Gaps = 24/209 (11%)
Query: 266 KELLGTGGFGRVYRGTLPKSQIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQL 323
           KE LG G F  V R     + +E A K I+ +  S +  ++   E     +L+H N+V+L
Sbjct: 10  KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRL 69
Query: 324 LGYCRRKGELLLVYDYMPNGSL-----DKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQ 378
               + +    LV+D +  G L      +  Y +   +         I+ +   + Y H 
Sbjct: 70  HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS-------HCIQQILESIAYCHS 122
Query: 379 EWEQVVIHRDVKASNVLLDGELNG---RLGDFGLARLYDHGTDPQTTH-VVGTLGYLAPE 434
                ++HR++K  N+LL  +  G   +L DFGLA       D +  H   GT GYL+PE
Sbjct: 123 ---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAI---EVNDSEAWHGFAGTPGYLSPE 176
Query: 435 HTRTGKATTSADVFSFGAFLLEVACGRRP 463
             +    +   D+++ G  L  +  G  P
Sbjct: 177 VLKKDPYSKPVDIWACGVILYILLVGYPP 205

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 106/228 (46%), Gaps = 20/228 (8%)
Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKI----SHESRQGM--KEFVAEIVSIGRLRHRNL 320
           E LG+G F  V +     + ++ A K I    +  SR+G+  ++   E+  +  ++H N+
Sbjct: 17  EELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 321 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEW 380
           + L      K +++L+ + +  G L  +L ++  +T      F  +K +  G++YLH   
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEF--LKQILNGVYYLHS-- 132
Query: 381 EQVVIHRDVKASNV-LLDGELNG---RLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHT 436
              + H D+K  N+ LLD  +     ++ DFGLA   D G   +  ++ GT  ++APE  
Sbjct: 133 -LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN--EFKNIFGTPEFVAPEIV 189
Query: 437 RTGKATTSADVFSFGAFLLEVACGRRPI---QRQGPSENLILVDWVFD 481
                   AD++S G     +  G  P     +Q    N+  V++ F+
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE 237

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 96/201 (47%), Gaps = 18/201 (8%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
           +G+G +G V      K+ + +AVKK+S   +S    K    E+  +  ++H N++ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 327 ---CRRKGELLLVY--DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
               R   E   VY   ++    L+  +  Q K+T + +Q   +I  +  GL Y+H    
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQF--LIYQILRGLKYIHS--- 143
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE-HTRTGK 440
             +IHRD+K SN+ ++ +   ++  FGLAR     TD + T  V T  Y APE       
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILGFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 441 ATTSADVFSFGAFLLEVACGR 461
              + D++S G  + E+  GR
Sbjct: 200 YNQTVDIWSVGCIMAELLTGR 220

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 92/209 (44%), Gaps = 24/209 (11%)
Query: 266 KELLGTGGFGRVYRGTLPKSQIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQL 323
           KE LG G F  V R     + +E A K I+ +  S +  ++   E     +L+H N+V+L
Sbjct: 34  KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRL 93
Query: 324 LGYCRRKGELLLVYDYMPNGSL-----DKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQ 378
               + +    LV+D +  G L      +  Y +   +         I+ +   + Y H 
Sbjct: 94  HDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS-------HCIQQILESIAYCHS 146
Query: 379 EWEQVVIHRDVKASNVLLDGELNG---RLGDFGLARLYDHGTDPQTTH-VVGTLGYLAPE 434
                ++HR++K  N+LL  +  G   +L DFGLA   +   D +  H   GT GYL+PE
Sbjct: 147 ---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN---DSEAWHGFAGTPGYLSPE 200
Query: 435 HTRTGKATTSADVFSFGAFLLEVACGRRP 463
             +    +   D+++ G  L  +  G  P
Sbjct: 201 VLKKDPYSKPVDIWACGVILYILLVGYPP 229

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 94/223 (42%), Gaps = 29/223 (13%)
Query: 258 IATKGFREKELLGTGGFGRV-----------YRGTLPKSQIEIAVKKISHESRQGMKEFV 306
           +    F   +LLG G FG+V           Y   + + ++ IA  +++H         V
Sbjct: 2   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHT--------V 53
Query: 307 AEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVI 366
            E   +   RH  L  L    +    L  V +Y   G L  +L  + +V      RF   
Sbjct: 54  TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARFYGA 112
Query: 367 KGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR--LYDHGTDPQTTHV 424
           + V+  L YLH    + V++RD+K  N++LD + + ++ DFGL +  + D  T       
Sbjct: 113 EIVS-ALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT---MKXF 165
Query: 425 VGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQ 467
            GT  YLAPE         + D +  G  + E+ CGR P   Q
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 208

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 103/220 (46%), Gaps = 36/220 (16%)
Query: 253 YKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSI 312
           + + YI T     KEL G G F  V R  + KS  +    K   + R+G ++  AEI   
Sbjct: 26  FNNFYILTS----KEL-GRGKFA-VVRQCISKSTGQEYAAKFLKKRRRG-QDCRAEI--- 75
Query: 313 GRLRHRNLVQLLGYCRR----------KGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQR 362
             L    +++L   C R            E++L+ +Y   G +      +    ++    
Sbjct: 76  --LHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDV 133
Query: 363 FRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLD-----GELNGRLGDFGLARLYDHGT 417
            R+IK +  G++YLHQ     ++H D+K  N+LL      G++  ++ DFG++R   H  
Sbjct: 134 IRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDI--KIVDFGMSRKIGHAC 188
Query: 418 DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFG--AFLL 455
           + +   ++GT  YLAPE       TT+ D+++ G  A++L
Sbjct: 189 ELR--EIMGTPEYLAPEILNYDPITTATDMWNIGIIAYML 226

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 95/201 (47%), Gaps = 18/201 (8%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
           +G+G +G V      K+   +AVKK+S   +S    K    E+  +  ++H N++ LL  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 327 ---CRRKGELLLVY--DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
               R   E   VY   ++    L+  +    K+T + +Q   +I  +  GL Y+H    
Sbjct: 86  FTPARSLEEFNDVYLVTHLMGADLNN-IVKCAKLTDDHVQF--LIYQILRGLKYIHS--- 139
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE-HTRTGK 440
             +IHRD+K SN+ ++ +   ++ DFGLAR     TD + T  V T  Y APE       
Sbjct: 140 ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMH 195
Query: 441 ATTSADVFSFGAFLLEVACGR 461
              + D++S G  + E+  GR
Sbjct: 196 YNQTVDIWSVGCIMAELLTGR 216

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 106/228 (46%), Gaps = 20/228 (8%)
Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKI----SHESRQGM--KEFVAEIVSIGRLRHRNL 320
           E LG+G F  V +     + ++ A K I    +  SR+G+  ++   E+  +  ++H N+
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 321 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEW 380
           + L      K +++L+ + +  G L  +L ++  +T      F  +K +  G++YLH   
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEF--LKQILNGVYYLHS-- 132
Query: 381 EQVVIHRDVKASNV-LLDGELNG---RLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHT 436
              + H D+K  N+ LLD  +     ++ DFGLA   D G   +  ++ GT  ++APE  
Sbjct: 133 -LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN--EFKNIFGTPEFVAPEIV 189
Query: 437 RTGKATTSADVFSFGAFLLEVACGRRPI---QRQGPSENLILVDWVFD 481
                   AD++S G     +  G  P     +Q    N+  V++ F+
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE 237

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 106/228 (46%), Gaps = 20/228 (8%)
Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKI----SHESRQGM--KEFVAEIVSIGRLRHRNL 320
           E LG+G F  V +     + ++ A K I    +  SR+G+  ++   E+  +  ++H N+
Sbjct: 16  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 75
Query: 321 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEW 380
           + L      K +++L+ + +  G L  +L ++  +T      F  +K +  G++YLH   
Sbjct: 76  ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEF--LKQILNGVYYLHS-- 131
Query: 381 EQVVIHRDVKASNV-LLDGELNG---RLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHT 436
              + H D+K  N+ LLD  +     ++ DFGLA   D G   +  ++ GT  ++APE  
Sbjct: 132 -LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN--EFKNIFGTPEFVAPEIV 188
Query: 437 RTGKATTSADVFSFGAFLLEVACGRRPI---QRQGPSENLILVDWVFD 481
                   AD++S G     +  G  P     +Q    N+  V++ F+
Sbjct: 189 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE 236

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 102/237 (43%), Gaps = 30/237 (12%)
Query: 258 IATKGFREKELLGTGGFGRV-----------YRGTLPKSQIEIAVKKISHESRQGMKEFV 306
           +    F   +LLG G FG+V           Y   + K ++ +A  +++H         +
Sbjct: 5   VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT--------L 56
Query: 307 AEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVI 366
            E   +   RH  L  L    +    L  V +Y   G L  +L  + +V      RF   
Sbjct: 57  TENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHL-SRERVFSEDRARFYGA 115
Query: 367 KGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR--LYDHGTDPQTTHV 424
           + V+  L YLH E  + V++RD+K  N++LD + + ++ DFGL +  + D  T       
Sbjct: 116 EIVS-ALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT---MKXF 169
Query: 425 VGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSE--NLILVDWV 479
            GT  YLAPE         + D +  G  + E+ CGR P   Q   +   LIL++ +
Sbjct: 170 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI 226

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 106/228 (46%), Gaps = 20/228 (8%)
Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKI----SHESRQGM--KEFVAEIVSIGRLRHRNL 320
           E LG+G F  V +     + ++ A K I    +  SR+G+  ++   E+  +  ++H N+
Sbjct: 16  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 75
Query: 321 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEW 380
           + L      K +++L+ + +  G L  +L ++  +T      F  +K +  G++YLH   
Sbjct: 76  ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEF--LKQILNGVYYLHS-- 131
Query: 381 EQVVIHRDVKASNV-LLDGELNG---RLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHT 436
              + H D+K  N+ LLD  +     ++ DFGLA   D G   +  ++ GT  ++APE  
Sbjct: 132 -LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN--EFKNIFGTPEFVAPEIV 188
Query: 437 RTGKATTSADVFSFGAFLLEVACGRRPI---QRQGPSENLILVDWVFD 481
                   AD++S G     +  G  P     +Q    N+  V++ F+
Sbjct: 189 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE 236

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 102/237 (43%), Gaps = 30/237 (12%)
Query: 258 IATKGFREKELLGTGGFGRV-----------YRGTLPKSQIEIAVKKISHESRQGMKEFV 306
           +    F   +LLG G FG+V           Y   + K ++ +A  +++H         +
Sbjct: 6   VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT--------L 57
Query: 307 AEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVI 366
            E   +   RH  L  L    +    L  V +Y   G L  +L  + +V      RF   
Sbjct: 58  TENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHL-SRERVFSEDRARFYGA 116
Query: 367 KGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR--LYDHGTDPQTTHV 424
           + V+  L YLH E  + V++RD+K  N++LD + + ++ DFGL +  + D  T       
Sbjct: 117 EIVS-ALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT---MKXF 170
Query: 425 VGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSE--NLILVDWV 479
            GT  YLAPE         + D +  G  + E+ CGR P   Q   +   LIL++ +
Sbjct: 171 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEI 227

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 95/222 (42%), Gaps = 27/222 (12%)
Query: 258 IATKGFREKELLGTGGFGRV-----------YRGTLPKSQIEIAVKKISHESRQGMKEFV 306
           +    F   +LLG G FG+V           Y   + + ++ IA  +++H         V
Sbjct: 2   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHT--------V 53
Query: 307 AEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVI 366
            E   +   RH  L  L    +    L  V +Y   G L  +L  + +V      RF   
Sbjct: 54  TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARFYGA 112
Query: 367 KGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHV-V 425
           + V+  L YLH    + V++RD+K  N++LD + + ++ DFGL +  +  +D  T     
Sbjct: 113 EIVS-ALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFC 166
Query: 426 GTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQ 467
           GT  YLAPE         + D +  G  + E+ CGR P   Q
Sbjct: 167 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 208

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 96/208 (46%), Gaps = 18/208 (8%)
Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKI--SHESRQGMKEFVAEIVSIGRLRHRNLVQLL 324
           E +G G +G V       +  ++A+KKI  + +     K  + E+  +   +H N++ + 
Sbjct: 61  ETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIK 120
Query: 325 GYCRRK---GELLLVY---DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQ 378
              R     GE   VY   D M    L + ++    +TL  ++ F  +  +  GL Y+H 
Sbjct: 121 DILRPTVPYGEFKSVYVVLDLM-ESDLHQIIHSSQPLTLEHVRYF--LYQLLRGLKYMHS 177
Query: 379 EWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQ--TTHVVGTLGYLAPEH 435
                VIHRD+K SN+L++     ++GDFG+AR L     + Q   T  V T  Y APE 
Sbjct: 178 AQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPEL 234
Query: 436 TRTGKATTSA-DVFSFGAFLLEVACGRR 462
             +    T A D++S G    E+   R+
Sbjct: 235 MLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 60/223 (26%), Positives = 94/223 (42%), Gaps = 29/223 (13%)
Query: 258 IATKGFREKELLGTGGFGRV-----------YRGTLPKSQIEIAVKKISHESRQGMKEFV 306
           +    F   +LLG G FG+V           Y   + + ++ IA  +++H         V
Sbjct: 2   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHT--------V 53
Query: 307 AEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVI 366
            E   +   RH  L  L    +    L  V +Y   G L  +L  + +V      RF   
Sbjct: 54  TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARFYGA 112
Query: 367 KGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR--LYDHGTDPQTTHV 424
           + V+  L YLH    + V++RD+K  N++LD + + ++ DFGL +  + D  T       
Sbjct: 113 EIVS-ALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT---MKXF 165
Query: 425 VGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQ 467
            GT  YLAPE         + D +  G  + E+ CGR P   Q
Sbjct: 166 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 208

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 96/201 (47%), Gaps = 18/201 (8%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
           +G+G +G V      K+ + +AVKK+S   +S    K    E+  +  ++H N++ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 327 ---CRRKGELLLVY--DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
               R   E   VY   ++    L+  +  Q K+T + +Q   +I  +  GL Y+H    
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQF--LIYQILRGLKYIHS--- 143
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE-HTRTGK 440
             +IHRD+K SN+ ++ +   ++ D GLAR     TD + T  V T  Y APE       
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDRGLAR----HTDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 441 ATTSADVFSFGAFLLEVACGR 461
              + D++S G  + E+  GR
Sbjct: 200 YNQTVDIWSVGCIMAELLTGR 220

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 95/201 (47%), Gaps = 18/201 (8%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
           +G+G +G V      K+   +AVKK+S   +S    K    E+  +  ++H N++ LL  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 85
Query: 327 ---CRRKGELLLVY--DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
               R   E   VY   ++    L+  +  Q K+T + +Q   +I  +  GL Y+H    
Sbjct: 86  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQF--LIYQILRGLKYIHS--- 139
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE-HTRTGK 440
             +IHRD+K SN+ ++ +   ++ DFGLAR     TD +    V T  Y APE       
Sbjct: 140 ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMAGFVATRWYRAPEIMLNWMH 195
Query: 441 ATTSADVFSFGAFLLEVACGR 461
              + D++S G  + E+  GR
Sbjct: 196 YNQTVDIWSVGCIMAELLTGR 216

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 106/228 (46%), Gaps = 20/228 (8%)
Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKI----SHESRQGM--KEFVAEIVSIGRLRHRNL 320
           E LG+G F  V +     + ++ A K I    +  SR+G+  ++   E+  +  ++H N+
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 321 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEW 380
           + L      K +++L+ + +  G L  +L ++  +T      F  +K +  G++YLH   
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEF--LKQILNGVYYLHS-- 132
Query: 381 EQVVIHRDVKASNV-LLDGELNG---RLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHT 436
              + H D+K  N+ LLD  +     ++ DFGLA   D G   +  ++ GT  ++APE  
Sbjct: 133 -LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN--EFKNIFGTPEFVAPEIV 189
Query: 437 RTGKATTSADVFSFGAFLLEVACGRRPI---QRQGPSENLILVDWVFD 481
                   AD++S G     +  G  P     +Q    N+  V++ F+
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE 237

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 108/228 (47%), Gaps = 20/228 (8%)
Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKI----SHESRQGM-KEFVAEIVSI-GRLRHRNL 320
           E LG+G F  V +     + ++ A K I    +  SR+G+ +E +   VSI   ++H N+
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 321 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEW 380
           + L      K +++L+ + +  G L  +L ++  +T      F  +K +  G++YLH   
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEF--LKQILNGVYYLHS-- 132
Query: 381 EQVVIHRDVKASNV-LLDGELNG---RLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHT 436
              + H D+K  N+ LLD  +     ++ DFGLA   D G + +  ++ GT  ++APE  
Sbjct: 133 -LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK--NIFGTPEFVAPEIV 189
Query: 437 RTGKATTSADVFSFGAFLLEVACGRRPI---QRQGPSENLILVDWVFD 481
                   AD++S G     +  G  P     +Q    N+  V++ F+
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE 237

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 95/222 (42%), Gaps = 27/222 (12%)
Query: 258 IATKGFREKELLGTGGFGRV-----------YRGTLPKSQIEIAVKKISHESRQGMKEFV 306
           +    F   +LLG G FG+V           Y   + + ++ IA  +++H         V
Sbjct: 2   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHT--------V 53
Query: 307 AEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVI 366
            E   +   RH  L  L    +    L  V +Y   G L  +L  + +V      RF   
Sbjct: 54  TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARFYGA 112
Query: 367 KGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHV-V 425
           + V+  L YLH    + V++RD+K  N++LD + + ++ DFGL +  +  +D  T     
Sbjct: 113 EIVS-ALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFC 166
Query: 426 GTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQ 467
           GT  YLAPE         + D +  G  + E+ CGR P   Q
Sbjct: 167 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 208

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 108/228 (47%), Gaps = 20/228 (8%)
Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKI----SHESRQGM-KEFVAEIVSI-GRLRHRNL 320
           E LG+G F  V +     + ++ A K I    +  SR+G+ +E +   VSI   ++H N+
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 321 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEW 380
           + L      K +++L+ + +  G L  +L ++  +T      F  +K +  G++YLH   
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEF--LKQILNGVYYLHS-- 132
Query: 381 EQVVIHRDVKASNV-LLDGELNG---RLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHT 436
              + H D+K  N+ LLD  +     ++ DFGLA   D G + +  ++ GT  ++APE  
Sbjct: 133 -LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK--NIFGTPEFVAPEIV 189
Query: 437 RTGKATTSADVFSFGAFLLEVACGRRPI---QRQGPSENLILVDWVFD 481
                   AD++S G     +  G  P     +Q    N+  V++ F+
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE 237

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 98/214 (45%), Gaps = 23/214 (10%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVA-EIVSIGRLRHRNLVQLLGYC 327
           +G+G FG        +S   +AVK I  E  + + E V  EI++   LRH N+V+     
Sbjct: 26  IGSGNFGVARLMRDKQSNELVAVKYI--ERGEKIDENVKREIINHRSLRHPNIVRFKEVI 83
Query: 328 RRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRF--RVIKGVALGLFYLHQEWEQVVI 385
                L +V +Y   G L + + +  + + +  + F  ++I GV+    Y H      V 
Sbjct: 84  LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS----YCHA---MQVC 136
Query: 386 HRDVKASNVLLDGELNGRL--GDFGLARLYDHGTDPQTTHVVGTLGYLAPE----HTRTG 439
           HRD+K  N LLDG    RL   DFG ++     + P++T  VGT  Y+APE        G
Sbjct: 137 HRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKKEYDG 194
Query: 440 KATTSADVFSFGAFLLEVACGRRPIQRQGPSENL 473
           K    ADV+S G  L  +  G  P +     +N 
Sbjct: 195 KV---ADVWSCGVTLYVMLVGAYPFEDPEEPKNF 225

>pdb|1DBN|A Chain A, Maackia Amurensis Leukoagglutinin (Lectin) With Sialyllactose Length = 239

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 50/158 (31%), Positives = 84/158 (53%), Gaps = 23/158 (14%)
Query: 36  SGHGIAFVIASTRG-LPGARPSQYLGLFNDTNLGNETNHVFAVELDTIKSHGF--LDIND 92
           +  G+AF +A     +P    S+YLGLFN  +  + +N + AVE DT  +H +   D N 
Sbjct: 85  TSDGLAFYLAPPDSQIPSGSVSKYLGLFN-NSNSDSSNQIVAVEFDTYFAHSYDPWDPNY 143
Query: 93  NHVGIDINSLKSESSAPAGYYVEYD----GLEKRTNVTLAP-------INIPRPRSLNTM 141
            H+GID+N ++S  +      V++D    G+   T   LAP       +  P  ++  ++
Sbjct: 144 RHIGIDVNGIESIKT------VQWDWINGGVAFATITYLAPNKTLIASLVYPSNQTTFSV 197
Query: 142 SLSRDLSSVLNDAMYVGFSSSTG--SVLASHYILGWSF 177
           + S DL  +L + + VGFS++TG  + + +H +L WSF
Sbjct: 198 AASVDLKEILPEWVRVGFSAATGYPTEVETHDVLSWSF 235

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 107/228 (46%), Gaps = 20/228 (8%)
Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKI----SHESRQGM--KEFVAEIVSIGRLRHRNL 320
           E LG+G F  V +     + ++ A K I    +  SR+G+  ++   E+  +  ++H N+
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 321 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEW 380
           + L      K +++L+ + +  G L  +L ++  +T      F  +K +  G++YLH   
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEF--LKQILNGVYYLHS-- 132
Query: 381 EQVVIHRDVKASNV-LLDGELNG---RLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHT 436
              + H D+K  N+ LLD  +     ++ DFGLA   D G + +  ++ GT  ++APE  
Sbjct: 133 -LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK--NIFGTPEFVAPEIV 189
Query: 437 RTGKATTSADVFSFGAFLLEVACGRRPI---QRQGPSENLILVDWVFD 481
                   AD++S G     +  G  P     +Q    N+  V++ F+
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE 237

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 106/228 (46%), Gaps = 20/228 (8%)
Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKI----SHESRQGM--KEFVAEIVSIGRLRHRNL 320
           E LG+G F  V +     + ++ A K I    +  SR+G+  ++   E+  +  ++H N+
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 321 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEW 380
           + L      K +++L+ + +  G L  +L ++  +T      F  +K +  G++YLH   
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEF--LKQILNGVYYLHS-- 132
Query: 381 EQVVIHRDVKASNV-LLDGELNG---RLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHT 436
              + H D+K  N+ LLD  +     ++ DFGLA   D G   +  ++ GT  ++APE  
Sbjct: 133 -LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN--EFKNIFGTPEFVAPEIV 189
Query: 437 RTGKATTSADVFSFGAFLLEVACGRRPI---QRQGPSENLILVDWVFD 481
                   AD++S G     +  G  P     +Q    N+  V++ F+
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE 237

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 106/228 (46%), Gaps = 20/228 (8%)
Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKI----SHESRQGM--KEFVAEIVSIGRLRHRNL 320
           E LG+G F  V +     + ++ A K I    +  SR+G+  ++   E+  +  ++H N+
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 321 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEW 380
           + L      K +++L+ + +  G L  +L ++  +T      F  +K +  G++YLH   
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEF--LKQILNGVYYLHS-- 132
Query: 381 EQVVIHRDVKASNV-LLDGELNG---RLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHT 436
              + H D+K  N+ LLD  +     ++ DFGLA   D G   +  ++ GT  ++APE  
Sbjct: 133 -LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN--EFKNIFGTPEFVAPEIV 189
Query: 437 RTGKATTSADVFSFGAFLLEVACGRRPI---QRQGPSENLILVDWVFD 481
                   AD++S G     +  G  P     +Q    N+  V++ F+
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE 237

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 95/222 (42%), Gaps = 27/222 (12%)
Query: 258 IATKGFREKELLGTGGFGRV-----------YRGTLPKSQIEIAVKKISHESRQGMKEFV 306
           +    F   +LLG G FG+V           Y   + + ++ IA  +++H         V
Sbjct: 5   VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHT--------V 56
Query: 307 AEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVI 366
            E   +   RH  L  L    +    L  V +Y   G L  +L  + +V      RF   
Sbjct: 57  TESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL-SRERVFTEERARFYGA 115
Query: 367 KGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHV-V 425
           + V+  L YLH    + V++RD+K  N++LD + + ++ DFGL +  +  +D  T     
Sbjct: 116 EIVS-ALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFC 169
Query: 426 GTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQ 467
           GT  YLAPE         + D +  G  + E+ CGR P   Q
Sbjct: 170 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 211

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 95/201 (47%), Gaps = 18/201 (8%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
           +G+G +G V      K+   +AVKK+S   +S    K    E+  +  ++H N++ LL  
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 109
Query: 327 ---CRRKGELLLVY--DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
               R   E   VY   ++    L+  +  Q K+T + +Q   +I  +  GL Y+H    
Sbjct: 110 FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQF--LIYQILRGLKYIHS--- 163
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE-HTRTGK 440
             +IHRD+K SN+ ++ +   ++ DFGLAR     TD +    V T  Y APE       
Sbjct: 164 ADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMXGXVATRWYRAPEIMLNWMH 219
Query: 441 ATTSADVFSFGAFLLEVACGR 461
              + D++S G  + E+  GR
Sbjct: 220 YNQTVDIWSVGCIMAELLTGR 240

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 94/215 (43%), Gaps = 22/215 (10%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRN--- 319
           F   + LGTG FGRV      ++    A+K +  +    +KE    +     L+  N   
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPF 102
Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYL-----YDQPKVTLNWIQRFRVIKGVALGLF 374
           LV+L    +    L +V +Y P G +  +L     + +P        RF   + + L   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHA------RFYAAQ-IVLTFE 155
Query: 375 YLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE 434
           YLH      +I+RD+K  N+++D +   ++ DFGLA+        +T  + GT  YLAPE
Sbjct: 156 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGLAK----RVKGRTWXLCGTPEYLAPE 208
Query: 435 HTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGP 469
              +     + D ++ G  + E+A G  P     P
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 106/228 (46%), Gaps = 20/228 (8%)
Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKI----SHESRQGM--KEFVAEIVSIGRLRHRNL 320
           E LG+G F  V +     + ++ A K I    +  SR+G+  ++   E+  +  ++H N+
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 321 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEW 380
           + L      K +++L+ + +  G L  +L ++  +T      F  +K +  G++YLH   
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEF--LKQILNGVYYLHS-- 132
Query: 381 EQVVIHRDVKASNV-LLDGELNG---RLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHT 436
              + H D+K  N+ LLD  +     ++ DFGLA   D G   +  ++ GT  ++APE  
Sbjct: 133 -LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN--EFKNIFGTPEFVAPEIV 189
Query: 437 RTGKATTSADVFSFGAFLLEVACGRRPI---QRQGPSENLILVDWVFD 481
                   AD++S G     +  G  P     +Q    N+  V++ F+
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE 237

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 96/201 (47%), Gaps = 18/201 (8%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
           +G+G +G V      K+ + +AVKK+S   +S    K    E+  +  ++H N++ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 327 ---CRRKGELLLVY--DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
               R   E   VY   ++    L+  +  Q K+T + +Q   +I  +  GL Y+H    
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQF--LIYQILRGLKYIHS--- 143
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE-HTRTGK 440
             +IHRD+K SN+ ++ +   ++ D GLAR     TD + T  V T  Y APE       
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDGGLAR----HTDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 441 ATTSADVFSFGAFLLEVACGR 461
              + D++S G  + E+  GR
Sbjct: 200 YNQTVDIWSVGCIMAELLTGR 220

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 96/208 (46%), Gaps = 18/208 (8%)
Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKI--SHESRQGMKEFVAEIVSIGRLRHRNLVQLL 324
           E +G G +G V       +  ++A+KKI  + +     K  + E+  +   +H N++ + 
Sbjct: 60  ETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIK 119
Query: 325 GYCRRK---GELLLVY---DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQ 378
              R     GE   VY   D M    L + ++    +TL  ++ F  +  +  GL Y+H 
Sbjct: 120 DILRPTVPYGEFKSVYVVLDLM-ESDLHQIIHSSQPLTLEHVRYF--LYQLLRGLKYMHS 176
Query: 379 EWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQ--TTHVVGTLGYLAPEH 435
                VIHRD+K SN+L++     ++GDFG+AR L     + Q   T  V T  Y APE 
Sbjct: 177 AQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPEL 233
Query: 436 TRTGKATTSA-DVFSFGAFLLEVACGRR 462
             +    T A D++S G    E+   R+
Sbjct: 234 MLSLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 106/228 (46%), Gaps = 20/228 (8%)
Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKI----SHESRQGM--KEFVAEIVSIGRLRHRNL 320
           E LG+G F  V +     + +E A K I    S  SR+G+  +E   E+  + ++ H N+
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 321 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEW 380
           + L      + +++L+ + +  G L  +L  +  ++      F  IK +  G+ YLH   
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF--IKQILDGVNYLHT-- 133
Query: 381 EQVVIHRDVKASNV-LLDGEL---NGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHT 436
            + + H D+K  N+ LLD  +   + +L DFGLA   + G + +  ++ GT  ++APE  
Sbjct: 134 -KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK--NIFGTPEFVAPEIV 190
Query: 437 RTGKATTSADVFSFGAFLLEVACGRRPI---QRQGPSENLILVDWVFD 481
                   AD++S G     +  G  P     +Q    N+  V + FD
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFD 238

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 106/228 (46%), Gaps = 20/228 (8%)
Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKI----SHESRQGM--KEFVAEIVSIGRLRHRNL 320
           E LG+G F  V +     + ++ A K I    +  SR+G+  ++   E+  +  ++H N+
Sbjct: 17  EELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 321 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEW 380
           + L      K +++L+ + +  G L  +L ++  +T      F  +K +  G++YLH   
Sbjct: 77  ITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEF--LKQILNGVYYLHS-- 132
Query: 381 EQVVIHRDVKASNV-LLDGELNG---RLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHT 436
              + H D+K  N+ LLD  +     ++ DFGLA   D G   +  ++ GT  ++APE  
Sbjct: 133 -LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN--EFKNIFGTPEFVAPEIV 189
Query: 437 RTGKATTSADVFSFGAFLLEVACGRRPI---QRQGPSENLILVDWVFD 481
                   AD++S G     +  G  P     +Q    N+  V++ F+
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE 237

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 94/206 (45%), Gaps = 21/206 (10%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEI-----VSIGRLRHRNLVQL 323
           +G+G  G+V++    K+   IAVK++    R G KE    I     V +       +VQ 
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMR---RSGNKEENKRILMDLDVVLKSHDCPYIVQC 89
Query: 324 LGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQV 383
            G      ++ +  + M  G+  + L  + +  +      ++   +   L+YL ++    
Sbjct: 90  FGTFITNTDVFIAMELM--GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEK--HG 145
Query: 384 VIHRDVKASNVLLDGELNGRLGDFGLA-RLYDHGTDPQTTHVVGTLGYLAPEHTRTGKAT 442
           VIHRDVK SN+LLD     +L DFG++ RL D   D       G   Y+APE       T
Sbjct: 146 VIHRDVKPSNILLDERGQIKLCDFGISGRLVD---DKAKDRSAGCAAYMAPERIDPPDPT 202
Query: 443 TS-----ADVFSFGAFLLEVACGRRP 463
                  ADV+S G  L+E+A G+ P
Sbjct: 203 KPDYDIRADVWSLGISLVELATGQFP 228

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 106/228 (46%), Gaps = 20/228 (8%)
Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKI----SHESRQGM--KEFVAEIVSIGRLRHRNL 320
           E LG+G F  V +     + +E A K I    S  SR+G+  +E   E+  + ++ H N+
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 321 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEW 380
           + L      + +++L+ + +  G L  +L  +  ++      F  IK +  G+ YLH   
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF--IKQILDGVNYLHT-- 133
Query: 381 EQVVIHRDVKASNV-LLDGEL---NGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHT 436
            + + H D+K  N+ LLD  +   + +L DFGLA   + G + +  ++ GT  ++APE  
Sbjct: 134 -KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK--NIFGTPEFVAPEIV 190
Query: 437 RTGKATTSADVFSFGAFLLEVACGRRPI---QRQGPSENLILVDWVFD 481
                   AD++S G     +  G  P     +Q    N+  V + FD
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFD 238

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 48/170 (28%), Positives = 81/170 (47%), Gaps = 15/170 (8%)
Query: 293 KISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSL---DKYL 349
           KIS +S+    +F  E+  I  +++   +   G      E+ ++Y+YM N S+   D+Y 
Sbjct: 80  KISIKSKYD--DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYF 137
Query: 350 Y--DQPKVTLNWIQRFR-VIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGD 406
           +  D+       IQ  + +IK V     Y+H E  + + HRDVK SN+L+D     +L D
Sbjct: 138 FVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNE--KNICHRDVKPSNILMDKNGRVKLSD 195
Query: 407 FGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSA--DVFSFGAFL 454
           FG +   ++  D +     GT  ++ PE      +   A  D++S G  L
Sbjct: 196 FGES---EYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICL 242

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 93/213 (43%), Gaps = 21/213 (9%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCR 328
           +G+G FG V R    K   E+   K      +       EI++   LRH N+V+      
Sbjct: 27  IGSGNFG-VARLMRDKQSNELVAVKYIERGEKIAANVKREIINHRSLRHPNIVRFKEVIL 85
Query: 329 RKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRF--RVIKGVALGLFYLHQEWEQVVIH 386
               L +V +Y   G L + + +  + + +  + F  ++I GV+    Y H      V H
Sbjct: 86  TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS----YCHA---MQVCH 138
Query: 387 RDVKASNVLLDGELNGRL--GDFGLARLYDHGTDPQTTHVVGTLGYLAPE----HTRTGK 440
           RD+K  N LLDG    RL   DFG ++     + P++T  VGT  Y+APE        GK
Sbjct: 139 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKKEYDGK 196
Query: 441 ATTSADVFSFGAFLLEVACGRRPIQRQGPSENL 473
               ADV+S G  L  +  G  P +     +N 
Sbjct: 197 V---ADVWSCGVTLYVMLVGAYPFEDPEEPKNF 226

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 68/308 (22%), Positives = 134/308 (43%), Gaps = 48/308 (15%)
Query: 244 LDHGPHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES--RQG 301
           +D G     ++ + +  + +   + +G+GG  +V++    K QI  A+K ++ E    Q 
Sbjct: 11  VDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQI-YAIKYVNLEEADNQT 69
Query: 302 MKEFVAEIVSIGRLRHRN--LVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNW 359
           +  +  EI  + +L+  +  +++L  Y      + +V   M  G++D   + + K +++ 
Sbjct: 70  LDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV---MECGNIDLNSWLKKKKSIDP 126
Query: 360 IQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLL-DGELNGRLGDFGLARLYDHGTD 418
            +R    K +   +  +HQ     ++H D+K +N L+ DG L  +L DFG+A    +   
Sbjct: 127 WERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDGML--KLIDFGIA----NQMQ 177
Query: 419 PQTTHVV-----GTLGYLAPEHTRTGKAT-----------TSADVFSFGAFLLEVACGRR 462
           P TT VV     GT+ Y+ PE  +   ++             +DV+S G  L  +  G+ 
Sbjct: 178 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 237
Query: 463 PIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAXXXXXXXXXXXXCSHSDPTA 522
           P Q+        +++ +       +L    DPN   E+              C   DP  
Sbjct: 238 PFQQ--------IINQI------SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQ 283
Query: 523 RPSMRQVV 530
           R S+ +++
Sbjct: 284 RISIPELL 291

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 94/202 (46%), Gaps = 11/202 (5%)
Query: 261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIG---RLRH 317
           + F+    LG G +G V++    +     AVK+ S    +G K+   ++  +G   ++  
Sbjct: 57  QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKR-SMSPFRGPKDRARKLAEVGSHEKVGQ 115
Query: 318 RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLH 377
                 L     +G +L +   +   SL ++  +    +L   Q +  ++   L L +LH
Sbjct: 116 HPCCVRLEQAWEEGGILYLQTELCGPSLQQHC-EAWGASLPEAQVWGYLRDTLLALAHLH 174
Query: 378 QEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTR 437
               Q ++H DVK +N+ L      +LGDFGL  L + GT        G   Y+APE  +
Sbjct: 175 ---SQGLVHLDVKPANIFLGPRGRCKLGDFGL--LVELGTAGAGEVQEGDPRYMAPELLQ 229
Query: 438 TGKATTSADVFSFGAFLLEVAC 459
            G   T+ADVFS G  +LEVAC
Sbjct: 230 -GSYGTAADVFSLGLTILEVAC 250

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/172 (27%), Positives = 88/172 (51%), Gaps = 12/172 (6%)
Query: 297 ESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGE--LLLVYDYMPNGSLDKYLYDQPK 354
           + R  +++   EI  + +L H N+V+L+       E  L +V++ +  G + +    +P 
Sbjct: 75  QPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKP- 133
Query: 355 VTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYD 414
             L+  Q     + +  G+ YLH    Q +IHRD+K SN+L+  + + ++ DFG++  + 
Sbjct: 134 --LSEDQARFYFQDLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEF- 187
Query: 415 HGTDPQTTHVVGTLGYLAPE---HTRTGKATTSADVFSFGAFLLEVACGRRP 463
            G+D   ++ VGT  ++APE    TR   +  + DV++ G  L     G+ P
Sbjct: 188 KGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 106/228 (46%), Gaps = 20/228 (8%)
Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKI----SHESRQGM--KEFVAEIVSIGRLRHRNL 320
           E LG+G F  V +     + +E A K I    S  SR+G+  +E   E+  + ++ H N+
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 321 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEW 380
           + L      + +++L+ + +  G L  +L  +  ++      F  IK +  G+ YLH   
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF--IKQILDGVNYLHT-- 133
Query: 381 EQVVIHRDVKASNV-LLDGEL---NGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHT 436
            + + H D+K  N+ LLD  +   + +L DFGLA   + G + +  ++ GT  ++APE  
Sbjct: 134 -KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK--NIFGTPEFVAPEIV 190
Query: 437 RTGKATTSADVFSFGAFLLEVACGRRPI---QRQGPSENLILVDWVFD 481
                   AD++S G     +  G  P     +Q    N+  V + FD
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFD 238

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 94/215 (43%), Gaps = 22/215 (10%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRN--- 319
           F   + LGTG FGRV      ++    A+K +  +    +KE    +     L+  N   
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPF 102
Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYL-----YDQPKVTLNWIQRFRVIKGVALGLF 374
           LV+L    +    L +V +Y P G +  +L     + +P        RF   + + L   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHA------RFYAAQ-IVLTFE 155
Query: 375 YLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE 434
           YLH      +I+RD+K  N+++D +   ++ DFGLA+        +T  + GT  YLAPE
Sbjct: 156 YLHS---LDLIYRDLKPENLMIDQQGYIQVTDFGLAK----RVKGRTWXLCGTPEYLAPE 208
Query: 435 HTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGP 469
              +     + D ++ G  + E+A G  P     P
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 106/228 (46%), Gaps = 20/228 (8%)
Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKI----SHESRQGM--KEFVAEIVSIGRLRHRNL 320
           E LG+G F  V +     + +E A K I    S  SR+G+  +E   E+  + ++ H N+
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 321 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEW 380
           + L      + +++L+ + +  G L  +L  +  ++      F  IK +  G+ YLH   
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF--IKQILDGVNYLHT-- 133
Query: 381 EQVVIHRDVKASNV-LLDGEL---NGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHT 436
            + + H D+K  N+ LLD  +   + +L DFGLA   + G + +  ++ GT  ++APE  
Sbjct: 134 -KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK--NIFGTPEFVAPEIV 190
Query: 437 RTGKATTSADVFSFGAFLLEVACGRRPI---QRQGPSENLILVDWVFD 481
                   AD++S G     +  G  P     +Q    N+  V + FD
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFD 238

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 107/228 (46%), Gaps = 20/228 (8%)
Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKI----SHESRQGM-KEFVAEIVSIGR-LRHRNL 320
           E LG+G F  V +     + +E A K I    S  SR+G+ +E +   VSI R + H N+
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNI 77
Query: 321 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEW 380
           + L      + +++L+ + +  G L  +L  +  ++      F  IK +  G+ YLH   
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF--IKQILDGVNYLHT-- 133
Query: 381 EQVVIHRDVKASNV-LLDGEL---NGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHT 436
            + + H D+K  N+ LLD  +   + +L DFGLA   + G + +  ++ GT  ++APE  
Sbjct: 134 -KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK--NIFGTPEFVAPEIV 190
Query: 437 RTGKATTSADVFSFGAFLLEVACGRRPI---QRQGPSENLILVDWVFD 481
                   AD++S G     +  G  P     +Q    N+  V + FD
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFD 238

>pdb|1FAT|A Chain A, Phytohemagglutinin-L Length = 252

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/170 (30%), Positives = 88/170 (51%), Gaps = 23/170 (13%)
Query: 37  GHGIAFVIASTRGLPGARPSQYLGLFNDTNLGNETNHVFAVELDTIKSHGFLDINDNHVG 96
             G+AF +      P  +   +LGLF+ +N      H  AVE DT+ +  + D  + H+G
Sbjct: 85  ADGLAFALVPVGSQPKDK-GGFLGLFDGSN---SNFHTVAVEFDTLYNKDW-DPTERHIG 139
Query: 97  IDINSLKSESSA--------PAGYYVEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLS 148
           ID+NS++S  +          A   + YD     TN+ +A +  P  ++   +S + DL 
Sbjct: 140 IDVNSIRSIKTTRWDFVNGENAEVLITYD---SSTNLLVASLVYPSQKTSFIVSDTVDLK 196
Query: 149 SVLNDAMYVGFSSSTG---SVLASHYILGWSF--KINGQ--AEELNLSQL 191
           SVL + + VGFS++TG     + ++ +L WSF  K++ +  +E LNL+ L
Sbjct: 197 SVLPEWVSVGFSATTGINKGNVETNDVLSWSFASKLSDETTSEGLNLANL 246

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/228 (26%), Positives = 106/228 (46%), Gaps = 20/228 (8%)
Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKI----SHESRQGM--KEFVAEIVSIGRLRHRNL 320
           E LG+G F  V +     + +E A K I    S  SR+G+  +E   E+  + ++ H N+
Sbjct: 18  EELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNV 77
Query: 321 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEW 380
           + L      + +++L+ + +  G L  +L  +  ++      F  IK +  G+ YLH   
Sbjct: 78  ITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSF--IKQILDGVNYLHT-- 133
Query: 381 EQVVIHRDVKASNV-LLDGEL---NGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHT 436
            + + H D+K  N+ LLD  +   + +L DFGLA   + G + +  ++ GT  ++APE  
Sbjct: 134 -KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK--NIFGTPEFVAPEIV 190
Query: 437 RTGKATTSADVFSFGAFLLEVACGRRPI---QRQGPSENLILVDWVFD 481
                   AD++S G     +  G  P     +Q    N+  V + FD
Sbjct: 191 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFD 238

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 101/235 (42%), Gaps = 30/235 (12%)
Query: 258 IATKGFREKELLGTGGFGRV-----------YRGTLPKSQIEIAVKKISHESRQGMKEFV 306
           +    F   +LLG G FG+V           Y   + K ++ +A  +++H         +
Sbjct: 145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT--------L 196
Query: 307 AEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVI 366
            E   +   RH  L  L    +    L  V +Y   G L  +L  + +V      RF   
Sbjct: 197 TENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHL-SRERVFSEDRARFYGA 255
Query: 367 KGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR--LYDHGTDPQTTHV 424
           + V+  L YLH E  + V++RD+K  N++LD + + ++ DFGL +  + D  T       
Sbjct: 256 EIVS-ALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT---MKTF 309
Query: 425 VGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSE--NLILVD 477
            GT  YLAPE         + D +  G  + E+ CGR P   Q   +   LIL++
Sbjct: 310 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME 364

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 92/199 (46%), Gaps = 15/199 (7%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
           +G+G +G V      +S  ++A+KK+S   +S    K    E++ +  ++H N++ LL  
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 91
Query: 327 CRRKGELLLVYDY---MPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQV 383
                 L   YD+   MP    D       K +   IQ   ++  +  GL Y+H      
Sbjct: 92  FTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQY--LVYQMLKGLKYIHSAG--- 146
Query: 384 VIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTG-KAT 442
           V+HRD+K  N+ ++ +   ++ DFGLAR      D + T  V T  Y APE   +     
Sbjct: 147 VVHRDLKPGNLAVNEDCELKILDFGLAR----HADAEMTGYVVTRWYRAPEVILSWMHYN 202
Query: 443 TSADVFSFGAFLLEVACGR 461
            + D++S G  + E+  G+
Sbjct: 203 QTVDIWSVGCIMAEMLTGK 221

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 94/215 (43%), Gaps = 22/215 (10%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRN--- 319
           F   + LGTG FGRV      ++    A+K +  +    +K+    +     L+  N   
Sbjct: 43  FERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYL-----YDQPKVTLNWIQRFRVIKGVALGLF 374
           LV+L    +    L +V +Y+P G +  +L     + +P        RF   + + L   
Sbjct: 103 LVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA------RFYAAQ-IVLTFE 155
Query: 375 YLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE 434
           YLH      +I+RD+K  N+L+D +   ++ DFG A+        +T  + GT  YLAPE
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPE 208
Query: 435 HTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGP 469
              +     + D ++ G  + E+A G  P     P
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/228 (25%), Positives = 106/228 (46%), Gaps = 20/228 (8%)
Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKI----SHESRQGM--KEFVAEIVSIGRLRHRNL 320
           E LG+G F  V +     + ++ A K I    +  SR+G+  ++   E+  +  ++H N+
Sbjct: 17  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 76
Query: 321 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEW 380
           + L      K +++L+ + +  G L  +L ++  +T      F  +K +  G++YLH   
Sbjct: 77  ITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTEEEATEF--LKQILNGVYYLHS-- 132
Query: 381 EQVVIHRDVKASNV-LLDGELNG---RLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHT 436
              + H D+K  N+ LLD  +     ++ DFGLA   D G   +  ++ GT  ++APE  
Sbjct: 133 -LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN--EFKNIFGTPEFVAPEIV 189
Query: 437 RTGKATTSADVFSFGAFLLEVACGRRPI---QRQGPSENLILVDWVFD 481
                   AD++S G     +  G  P     +Q    N+  V++ F+
Sbjct: 190 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE 237

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 101/235 (42%), Gaps = 30/235 (12%)
Query: 258 IATKGFREKELLGTGGFGRV-----------YRGTLPKSQIEIAVKKISHESRQGMKEFV 306
           +    F   +LLG G FG+V           Y   + K ++ +A  +++H         +
Sbjct: 148 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHT--------L 199
Query: 307 AEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVI 366
            E   +   RH  L  L    +    L  V +Y   G L  +L  + +V      RF   
Sbjct: 200 TENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHL-SRERVFSEDRARFYGA 258
Query: 367 KGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR--LYDHGTDPQTTHV 424
           + V+  L YLH E  + V++RD+K  N++LD + + ++ DFGL +  + D  T       
Sbjct: 259 EIVS-ALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT---MKTF 312
Query: 425 VGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSE--NLILVD 477
            GT  YLAPE         + D +  G  + E+ CGR P   Q   +   LIL++
Sbjct: 313 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME 367

>pdb|1GZ9|A Chain A, High-Resolution Crystal Structure Of Erythrina Cristagalli Lectin In Complex With 2'-Alpha-L-Fucosyllactose Length = 239

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 75/151 (49%), Gaps = 17/151 (11%)
Query: 39  GIAFVIASTRGLPGARPSQYLGLFNDTNLGNETNHVFAVELDTIKSHGFLDINDNHVGID 98
           G+ F +  T+  P A+   YLG+FN++   N +    AVE DT  S+ +      H+GID
Sbjct: 90  GLVFFMGPTKSKP-AQGYGYLGVFNNSKQDN-SYQTLAVEFDTF-SNPWDPPQVPHIGID 146
Query: 99  INSLKSESSAP--------AGYYVEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSV 150
           +NS++S  + P        A   ++YD   K  +V L     P   ++ T++   D+  V
Sbjct: 147 VNSIRSIKTQPFQLDNGQVANVVIKYDAPSKILHVVLV---YPSSGAIYTIAEIVDVKQV 203
Query: 151 LNDAMYVGFSSSTGS---VLASHYILGWSFK 178
           L D + VG S +TG+      +H +  WSF+
Sbjct: 204 LPDWVDVGLSGATGAQRDAAETHDVYSWSFQ 234

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 94/215 (43%), Gaps = 22/215 (10%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRN--- 319
           F   + LGTG FGRV      ++    A+K +  +    +K+    +     L+  N   
Sbjct: 43  FERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYL-----YDQPKVTLNWIQRFRVIKGVALGLF 374
           LV+L    +    L +V +Y+P G +  +L     + +P        RF   + + L   
Sbjct: 103 LVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA------RFYAAQ-IVLTFE 155
Query: 375 YLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE 434
           YLH      +I+RD+K  N+L+D +   ++ DFG A+        +T  + GT  YLAPE
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPE 208
Query: 435 HTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGP 469
              +     + D ++ G  + E+A G  P     P
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 94/215 (43%), Gaps = 22/215 (10%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRN--- 319
           F   + LGTG FGRV      ++    A+K +  +    +K+    +     L+  N   
Sbjct: 43  FERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYL-----YDQPKVTLNWIQRFRVIKGVALGLF 374
           LV+L    +    L +V +Y+P G +  +L     + +P        RF   + + L   
Sbjct: 103 LVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA------RFYAAQ-IVLTFE 155
Query: 375 YLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE 434
           YLH      +I+RD+K  N+L+D +   ++ DFG A+        +T  + GT  YLAPE
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPE 208
Query: 435 HTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGP 469
              +     + D ++ G  + E+A G  P     P
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 97/208 (46%), Gaps = 8/208 (3%)
Query: 257 YIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGR 314
           +   K ++  + +G+G  G V        +  +A+KK+S   +++   K    E+V +  
Sbjct: 14  FTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKC 73
Query: 315 LRHRNLVQLLGYCRRKGELLLVYD-YMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGL 373
           + H+N++ LL     +  L    D Y+    +D  L    ++ L+  +   ++  +  G+
Sbjct: 74  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 133
Query: 374 FYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAP 433
            +LH      +IHRD+K SN+++  +   ++ DFGLAR    GT    T  V T  Y AP
Sbjct: 134 KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAP 188
Query: 434 EHTRTGKATTSADVFSFGAFLLEVACGR 461
           E         + D++S G  + E+ C +
Sbjct: 189 EVILGMGYKENVDLWSVGCIMGEMVCHK 216

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 94/215 (43%), Gaps = 22/215 (10%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRN--- 319
           F   + LGTG FGRV      ++    A+K +  +    +K+    +     L+  N   
Sbjct: 36  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 95
Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYL-----YDQPKVTLNWIQRFRVIKGVALGLF 374
           LV+L    +    L +V +Y+P G +  +L     + +P        RF   + + L   
Sbjct: 96  LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA------RFYAAQ-IVLTFE 148
Query: 375 YLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE 434
           YLH      +I+RD+K  N+L+D +   ++ DFG A+        +T  + GT  YLAPE
Sbjct: 149 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPE 201
Query: 435 HTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGP 469
              +     + D ++ G  + E+A G  P     P
Sbjct: 202 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 236

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 97/208 (46%), Gaps = 8/208 (3%)
Query: 257 YIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGR 314
           +   K ++  + +G+G  G V        +  +A+KK+S   +++   K    E+V +  
Sbjct: 25  FTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKC 84
Query: 315 LRHRNLVQLLGYCRRKGELLLVYD-YMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGL 373
           + H+N++ LL     +  L    D Y+    +D  L    ++ L+  +   ++  +  G+
Sbjct: 85  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 144
Query: 374 FYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAP 433
            +LH      +IHRD+K SN+++  +   ++ DFGLAR    GT    T  V T  Y AP
Sbjct: 145 KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAP 199
Query: 434 EHTRTGKATTSADVFSFGAFLLEVACGR 461
           E         + D++S G  + E+ C +
Sbjct: 200 EVILGMGYKENVDLWSVGCIMGEMVCHK 227

>pdb|2BQP|A Chain A, The Structure Of The Pea Lectin-D-Glucopyranose Complex Length = 234

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 71/150 (47%), Gaps = 13/150 (8%)
Query: 39  GIAFVIASTRGLPGARPSQYLGLFNDTNLGNETNHVFAVELDTIKSHGFLDIN-DNHVGI 97
           G  F IA     P      YLG+FN     ++T    AVE DT  +  +   N D H+GI
Sbjct: 82  GFTFFIAPVDTKPQTG-GGYLGVFNSAEY-DKTTQTVAVEFDTFYNAAWDPSNRDRHIGI 139
Query: 98  DINSLKS--------ESSAPAGYYVEYDGLEKRTNVTLAPINIPRPRSLNTMSLSR--DL 147
           D+NS+KS        ++   A   + ++       V+L   N      + + +LS    L
Sbjct: 140 DVNSIKSVNTKSWKLQNGEEANVVIAFNAATNVLTVSLTYPNNSLEEEVTSYTLSDVVSL 199
Query: 148 SSVLNDAMYVGFSSSTGSVLASHYILGWSF 177
             V+ + + +GFS++TG+  A+H +L WSF
Sbjct: 200 KDVVPEWVRIGFSATTGAEYAAHEVLSWSF 229

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 100/220 (45%), Gaps = 27/220 (12%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQ 322
           F+ + + G G FG V  G    + + +A+KK+  + R   +E    +  +  L H N+VQ
Sbjct: 25  FQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQI-MQDLAVLHHPNIVQ 83
Query: 323 LLGYCRRKGE-------LLLVYDYMPNG---SLDKYLYDQ--PKVTLNWIQRFRVIKGVA 370
           L  Y    GE       L +V +Y+P+        Y   Q  P   L  +  F++I+ + 
Sbjct: 84  LQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSI- 142
Query: 371 LGLFYLHQEWEQVVIHRDVKASNVLL---DGELNGRLGDFGLARLYDHGTDPQTTHVVGT 427
            G  +L       V HRD+K  NVL+   DG L  +L DFG A+     ++P   ++   
Sbjct: 143 -GCLHLPS---VNVCHRDIKPHNVLVNEADGTL--KLCDFGSAKKLS-PSEPNVAYICSR 195
Query: 428 LGYLAPEHTRTGKA-TTSADVFSFGAFLLEVACGRRPIQR 466
             Y APE     +  TT+ D++S G    E+  G  PI R
Sbjct: 196 Y-YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG-EPIFR 233

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 95/201 (47%), Gaps = 18/201 (8%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
           +G+G +G V      K+   +AVKK+S   +S    K    E+  +  ++H N++ LL  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 89
Query: 327 ---CRRKGELLLVY--DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
               R   E   VY   ++    L+  +  Q K+T + +Q   +I  +  GL Y+H    
Sbjct: 90  FTPARSLEEFNDVYLVTHLMGADLNNIVKCQ-KLTDDHVQF--LIYQILRGLKYIHS--- 143
Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE-HTRTGK 440
             +IHRD+K SN+ ++ +   ++ DF LAR     TD + T  V T  Y APE       
Sbjct: 144 ADIIHRDLKPSNLAVNEDCELKILDFYLAR----HTDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 441 ATTSADVFSFGAFLLEVACGR 461
              + D++S G  + E+  GR
Sbjct: 200 YNQTVDIWSVGCIMAELLTGR 220

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 94/215 (43%), Gaps = 22/215 (10%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRN--- 319
           F   + LGTG FGRV      ++    A+K +  +    +K+    +     L+  N   
Sbjct: 44  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYL-----YDQPKVTLNWIQRFRVIKGVALGLF 374
           LV+L    +    L +V +Y+P G +  +L     + +P        RF   + + L   
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA------RFYAAQ-IVLTFE 156
Query: 375 YLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE 434
           YLH      +I+RD+K  N+L+D +   ++ DFG A+        +T  + GT  YLAPE
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPE 209
Query: 435 HTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGP 469
              +     + D ++ G  + E+A G  P     P
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 94/215 (43%), Gaps = 22/215 (10%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRN--- 319
           F   + LGTG FGRV      ++    A+K +  +    +K+    +     L+  N   
Sbjct: 36  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 95
Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYL-----YDQPKVTLNWIQRFRVIKGVALGLF 374
           LV+L    +    L +V +Y+P G +  +L     + +P        RF   + + L   
Sbjct: 96  LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHA------RFYAAQ-IVLTFE 148
Query: 375 YLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE 434
           YLH      +I+RD+K  N+L+D +   ++ DFG A+        +T  + GT  YLAPE
Sbjct: 149 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPE 201
Query: 435 HTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGP 469
              +     + D ++ G  + E+A G  P     P
Sbjct: 202 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 236

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 94/215 (43%), Gaps = 22/215 (10%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRN--- 319
           F   + LGTG FGRV      ++    A+K +  +    +K+    +     L+  N   
Sbjct: 44  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYL-----YDQPKVTLNWIQRFRVIKGVALGLF 374
           LV+L    +    L +V +Y+P G +  +L     + +P        RF   + + L   
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA------RFYAAQ-IVLTFE 156
Query: 375 YLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE 434
           YLH      +I+RD+K  N+L+D +   ++ DFG A+        +T  + GT  YLAPE
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPE 209
Query: 435 HTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGP 469
              +     + D ++ G  + E+A G  P     P
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 99/222 (44%), Gaps = 37/222 (16%)
Query: 266 KELLGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGRLRHRNLVQL 323
           K L+G G +G VY      ++  +A+KK++   E     K  + EI  + RL+   +++L
Sbjct: 31  KHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRL 90
Query: 324 LGYC-----RRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQ 378
                     +  EL +V + + +  L K L+  P + L       ++  + LG  ++H 
Sbjct: 91  YDLIIPDDLLKFDELYIVLE-IADSDLKK-LFKTP-IFLTEEHIKTILYNLLLGENFIH- 146
Query: 379 EWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ------------------ 420
             E  +IHRD+K +N LL+ + + ++ DFGLAR  +   D                    
Sbjct: 147 --ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNL 204
Query: 421 ----TTHVVGTLGYLAPEHTRTGKA-TTSADVFSFGAFLLEV 457
               T+HVV T  Y APE     +  T S D++S G    E+
Sbjct: 205 KKQLTSHVV-TRWYRAPELILLQENYTKSIDIWSTGCIFAEL 245

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 94/215 (43%), Gaps = 22/215 (10%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRN--- 319
           F   + LGTG FGRV      ++    A+K +  +    +K+    +     L+  N   
Sbjct: 44  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYL-----YDQPKVTLNWIQRFRVIKGVALGLF 374
           LV+L    +    L +V +Y+P G +  +L     + +P        RF   + + L   
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA------RFYAAQ-IVLTFE 156
Query: 375 YLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE 434
           YLH      +I+RD+K  N+L+D +   ++ DFG A+        +T  + GT  YLAPE
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPE 209
Query: 435 HTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGP 469
              +     + D ++ G  + E+A G  P     P
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 89/210 (42%), Gaps = 27/210 (12%)
Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVK-----KISHESRQGMKEFVAEIVSIGRLRHRNLV 321
           E LG G F  V R     +  E A K     K+S    Q + E  A I  +  L+H N+V
Sbjct: 28  EELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKL-EREARICRL--LKHPNIV 84
Query: 322 QLLGYCRRKGELLLVYDYMPNGSL-----DKYLYDQPKVTLNWIQRFRVIKGVALGLFYL 376
           +L      +G   L++D +  G L      +  Y +   +         I+ +   + + 
Sbjct: 85  RLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADAS-------HCIQQILEAVLHC 137
Query: 377 HQEWEQVVIHRDVKASNVLLDGELNG---RLGDFGLARLYDHGTDPQTTHVVGTLGYLAP 433
           HQ     V+HRD+K  N+LL  +L G   +L DFGLA +   G         GT GYL+P
Sbjct: 138 HQ---MGVVHRDLKPENLLLASKLKGAAVKLADFGLA-IEVEGEQQAWFGFAGTPGYLSP 193
Query: 434 EHTRTGKATTSADVFSFGAFLLEVACGRRP 463
           E  R        D+++ G  L  +  G  P
Sbjct: 194 EVLRKDPYGKPVDLWACGVILYILLVGYPP 223

>pdb|1N47|A Chain A, Isolectin B4 From Vicia Villosa In Complex With The Tn Antigen Length = 233

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 74/153 (48%), Gaps = 18/153 (11%)
Query: 39  GIAFVIASTRGLPGARPSQYLGLFNDTNLGNETNHVFAVELDTIKSHGFLDINDNHVGID 98
           G+AF +A     P AR   +LGLF D    + +    AVE DT  +    D N  H+GID
Sbjct: 86  GLAFFLAPPDTQPQAR-GGFLGLFAD-RAHDASYQTVAVEFDTYSNA--WDPNYTHIGID 141
Query: 99  INSLKSESSAP--------AGYYVEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSV 150
            N ++S+ + P        A   + Y   +  T    A +  P  ++   +S   DL  +
Sbjct: 142 TNGIESKKTTPFDMVYGEKANIVITY---QASTKALAASLVFPVSQTSYAVSARVDLRDI 198
Query: 151 LNDAMYVGFSSSTG---SVLASHYILGWSFKIN 180
           L + + VGFS++TG    V+ +H I+ WSF ++
Sbjct: 199 LPEYVRVGFSATTGLNAGVVETHDIVSWSFAVS 231

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 94/215 (43%), Gaps = 22/215 (10%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRN--- 319
           F   + +GTG FGRV      ++    A+K +  +    +K+    +     L+  N   
Sbjct: 43  FERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYL-----YDQPKVTLNWIQRFRVIKGVALGLF 374
           LV+L    +    L +V +Y+P G +  +L     + +P        RF   + + L   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA------RFYAAQ-IVLTFE 155
Query: 375 YLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE 434
           YLH      +I+RD+K  N+L+D +   ++ DFG A+        +T  + GT  YLAPE
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAK----RVKGRTWXLCGTPEYLAPE 208
Query: 435 HTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGP 469
              +     + D ++ G  + E+A G  P     P
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 94/215 (43%), Gaps = 22/215 (10%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRN--- 319
           F   + LGTG FGRV      ++    A+K +  +    +K+    +     L+  N   
Sbjct: 64  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 123
Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYL-----YDQPKVTLNWIQRFRVIKGVALGLF 374
           LV+L    +    L +V +Y+P G +  +L     + +P        RF   + + L   
Sbjct: 124 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA------RFYAAQ-IVLTFE 176
Query: 375 YLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE 434
           YLH      +I+RD+K  N+L+D +   ++ DFG A+        +T  + GT  YLAPE
Sbjct: 177 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPE 229
Query: 435 HTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGP 469
              +     + D ++ G  + E+A G  P     P
Sbjct: 230 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 264

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 94/215 (43%), Gaps = 22/215 (10%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRN--- 319
           F   + LGTG FGRV      ++    A+K +  +    +K+    +     L+  N   
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYL-----YDQPKVTLNWIQRFRVIKGVALGLF 374
           LV+L    +    L +V +Y+P G +  +L     + +P        RF   + + L   
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA------RFYAAQ-IVLTFE 156
Query: 375 YLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE 434
           YLH      +I+RD+K  N+L+D +   ++ DFG A+        +T  + GT  YLAPE
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPE 209
Query: 435 HTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGP 469
              +     + D ++ G  + E+A G  P     P
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 94/215 (43%), Gaps = 22/215 (10%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRN--- 319
           F   + LGTG FGRV      ++    A+K +  +    +K+    +     L+  N   
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYL-----YDQPKVTLNWIQRFRVIKGVALGLF 374
           LV+L    +    L +V +Y+P G +  +L     + +P        RF   + + L   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA------RFYAAQ-IVLTFE 155
Query: 375 YLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE 434
           YLH      +I+RD+K  N+L+D +   ++ DFG A+        +T  + GT  YLAPE
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPE 208
Query: 435 HTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGP 469
              +     + D ++ G  + E+A G  P     P
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 94/215 (43%), Gaps = 22/215 (10%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRN--- 319
           F   + LGTG FGRV      ++    A+K +  +    +K+    +     L+  N   
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYL-----YDQPKVTLNWIQRFRVIKGVALGLF 374
           LV+L    +    L +V +Y+P G +  +L     + +P        RF   + + L   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA------RFYAAQ-IVLTFE 155
Query: 375 YLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE 434
           YLH      +I+RD+K  N+L+D +   ++ DFG A+        +T  + GT  YLAPE
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPE 208
Query: 435 HTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGP 469
              +     + D ++ G  + E+A G  P     P
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 98/216 (45%), Gaps = 33/216 (15%)
Query: 268 LLGTGGFGRVYRGTLPKSQIEIAVKKISHE-----------SRQGMKEFVAEIVSIGRLR 316
           LLG+GGFG VY G      + +A+K +  +           +R  M+  + + VS G   
Sbjct: 15  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG--- 71
Query: 317 HRNLVQLLGYCRRKGELLLVYDYM-PNGSLDKYLYDQPKVTLNWIQRF--RVIKGVALGL 373
              +++LL +  R    +L+ + M P   L  ++ ++  +     + F  +V++ V    
Sbjct: 72  FSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARSFFWQVLEAVR--- 128
Query: 374 FYLHQEWEQVVIHRDVKASNVLLD---GELNGRLGDFGLARLYDHGTDPQTTHVVGTLGY 430
            + H      V+HRD+K  N+L+D   GEL  +L DFG   L     D   T   GT  Y
Sbjct: 129 -HCHN---CGVLHRDIKDENILIDLNRGEL--KLIDFGSGALL---KDTVYTDFDGTRVY 179
Query: 431 LAPEHTRTGKAT-TSADVFSFGAFLLEVACGRRPIQ 465
             PE  R  +    SA V+S G  L ++ CG  P +
Sbjct: 180 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 215

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 93/204 (45%), Gaps = 25/204 (12%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
           +G+G +G V      +S  ++A+KK+S   +S    K    E++ +  ++H N++ LL  
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 109
Query: 327 CRRKGELLLVYDY---MP--NGSLDKYL---YDQPKVTLNWIQRFRVIKGVALGLFYLHQ 378
                 L   YD+   MP     L K +   + + K+     Q  +       GL Y+H 
Sbjct: 110 FTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLK-------GLKYIHS 162
Query: 379 EWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRT 438
                V+HRD+K  N+ ++ +   ++ DFGLAR      D + T  V T  Y APE   +
Sbjct: 163 AG---VVHRDLKPGNLAVNEDCELKILDFGLAR----HADAEMTGYVVTRWYRAPEVILS 215
Query: 439 G-KATTSADVFSFGAFLLEVACGR 461
                 + D++S G  + E+  G+
Sbjct: 216 WMHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 94/215 (43%), Gaps = 22/215 (10%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRN--- 319
           F   + LGTG FGRV      ++    A+K +  +    +K+    +     L+  N   
Sbjct: 29  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 88
Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYL-----YDQPKVTLNWIQRFRVIKGVALGLF 374
           LV+L    +    L +V +Y+P G +  +L     + +P        RF   + + L   
Sbjct: 89  LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA------RFYAAQ-IVLTFE 141
Query: 375 YLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE 434
           YLH      +I+RD+K  N+L+D +   ++ DFG A+        +T  + GT  YLAPE
Sbjct: 142 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWTLCGTPEYLAPE 194
Query: 435 HTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGP 469
              +     + D ++ G  + E+A G  P     P
Sbjct: 195 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 229

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 94/215 (43%), Gaps = 22/215 (10%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRN--- 319
           F   + LGTG FGRV      ++    A+K +  +    +K+    +     L+  N   
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYL-----YDQPKVTLNWIQRFRVIKGVALGLF 374
           LV+L    +    L +V +Y+P G +  +L     + +P        RF   + + L   
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA------RFYAAQ-IVLTFE 156
Query: 375 YLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE 434
           YLH      +I+RD+K  N+L+D +   ++ DFG A+        +T  + GT  YLAPE
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWTLCGTPEYLAPE 209
Query: 435 HTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGP 469
              +     + D ++ G  + E+A G  P     P
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 94/215 (43%), Gaps = 22/215 (10%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRN--- 319
           F   + LGTG FGRV      ++    A+K +  +    +K+    +     L+  N   
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYL-----YDQPKVTLNWIQRFRVIKGVALGLF 374
           LV+L    +    L +V +Y+P G +  +L     + +P        RF   + + L   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHA------RFYAAQ-IVLTFE 155
Query: 375 YLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE 434
           YLH      +I+RD+K  N+L+D +   ++ DFG A+        +T  + GT  YLAPE
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPE 208
Query: 435 HTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGP 469
              +     + D ++ G  + E+A G  P     P
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 66/283 (23%), Positives = 124/283 (43%), Gaps = 48/283 (16%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHES--RQGMKEFVAEIVSIGRLRHRN--LVQLL 324
           +G+GG  +V++    K QI  A+K ++ E    Q +  +  EI  + +L+  +  +++L 
Sbjct: 20  IGSGGSSKVFQVLNEKKQI-YAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 78
Query: 325 GYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVV 384
            Y      + +V   M  G++D   + + K +++  +R    K +   +  +HQ     +
Sbjct: 79  DYEITDQYIYMV---MECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---I 132
Query: 385 IHRDVKASNVLL-DGELNGRLGDFGLARLYDHGTDPQTTHVV-----GTLGYLAPEHTRT 438
           +H D+K +N L+ DG L  +L DFG+A    +   P TT VV     GT+ Y+ PE  + 
Sbjct: 133 VHSDLKPANFLIVDGML--KLIDFGIA----NQMQPDTTSVVKDSQVGTVNYMPPEAIKD 186
Query: 439 GKAT-----------TSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGE 487
             ++             +DV+S G  L  +  G+ P Q+        +++ +       +
Sbjct: 187 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ--------IINQI------SK 232
Query: 488 LLEARDPNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVV 530
           L    DPN   E+              C   DP  R S+ +++
Sbjct: 233 LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 275

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 66/283 (23%), Positives = 124/283 (43%), Gaps = 48/283 (16%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRN--LVQLL 324
           +G+GG  +V++    K QI  A+K ++ E    Q +  +  EI  + +L+  +  +++L 
Sbjct: 64  IGSGGSSKVFQVLNEKKQI-YAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 325 GYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVV 384
            Y      + +V   M  G++D   + + K +++  +R    K +   +  +HQ     +
Sbjct: 123 DYEITDQYIYMV---MECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---I 176
Query: 385 IHRDVKASNVLL-DGELNGRLGDFGLARLYDHGTDPQTTHVV-----GTLGYLAPEHTRT 438
           +H D+K +N L+ DG L  +L DFG+A    +   P TT VV     GT+ Y+ PE  + 
Sbjct: 177 VHSDLKPANFLIVDGML--KLIDFGIA----NQMQPDTTSVVKDSQVGTVNYMPPEAIKD 230
Query: 439 GKAT-----------TSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGE 487
             ++             +DV+S G  L  +  G+ P Q+        +++ +       +
Sbjct: 231 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ--------IINQI------SK 276
Query: 488 LLEARDPNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVV 530
           L    DPN   E+              C   DP  R S+ +++
Sbjct: 277 LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 319

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 73/301 (24%), Positives = 122/301 (40%), Gaps = 44/301 (14%)
Query: 185 ELNLSQLPKLPRVGPKKRSKFLTIGLPVICVSVIFAAVSGVVYVIRMKRKFAEELEDWEL 244
           ++ L +L +L   GP +    L++   +  +  ++   S   +    + K+  E  +W  
Sbjct: 20  KVRLKKLEQLLLDGPWRNESALSVETLLDVLVCLYTECS---HSALRRDKYVAEFLEWA- 75
Query: 245 DHGPHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKE 304
              P     K++ +  + F   +++G G FG            E+AV K+ +  R    +
Sbjct: 76  --KPFTQLVKEMQLHREDFEIIKVIGRGAFG------------EVAVVKMKNTERIYAMK 121
Query: 305 FVAEIVSIGR-----LRHRNLVQLLGYCR----------RKGELLLVYDYMPNGSLDKYL 349
            + +   + R      R    V + G C+           +  L LV DY   G L   L
Sbjct: 122 ILNKWEMLKRAETACFREERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLL 181
Query: 350 YDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFG- 408
                     + RF  I  + L +  +HQ      +HRD+K  NVLLD   + RL DFG 
Sbjct: 182 SKFEDKLPEDMARF-YIGEMVLAIDSIHQ---LHYVHRDIKPDNVLLDVNGHIRLADFGS 237
Query: 409 LARLYDHGTDPQTTHVVGTLGYLAPEHTRT-----GKATTSADVFSFGAFLLEVACGRRP 463
             ++ D GT  Q++  VGT  Y++PE  +      GK     D +S G  + E+  G  P
Sbjct: 238 CLKMNDDGT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 296
Query: 464 I 464
Sbjct: 297 F 297

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 66/283 (23%), Positives = 124/283 (43%), Gaps = 48/283 (16%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHES--RQGMKEFVAEIVSIGRLRHRN--LVQLL 324
           +G+GG  +V++    K QI  A+K ++ E    Q +  +  EI  + +L+  +  +++L 
Sbjct: 17  IGSGGSSKVFQVLNEKKQI-YAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 75
Query: 325 GYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVV 384
            Y      + +V   M  G++D   + + K +++  +R    K +   +  +HQ     +
Sbjct: 76  DYEITDQYIYMV---MECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---I 129
Query: 385 IHRDVKASNVLL-DGELNGRLGDFGLARLYDHGTDPQTTHVV-----GTLGYLAPEHTRT 438
           +H D+K +N L+ DG L  +L DFG+A    +   P TT VV     GT+ Y+ PE  + 
Sbjct: 130 VHSDLKPANFLIVDGML--KLIDFGIA----NQMQPDTTSVVKDSQVGTVNYMPPEAIKD 183
Query: 439 GKAT-----------TSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGE 487
             ++             +DV+S G  L  +  G+ P Q+        +++ +       +
Sbjct: 184 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ--------IINQI------SK 229
Query: 488 LLEARDPNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVV 530
           L    DPN   E+              C   DP  R S+ +++
Sbjct: 230 LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 272

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 94/215 (43%), Gaps = 22/215 (10%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRN--- 319
           F   + LGTG FGRV      ++    A+K +  +    +K+    +     L+  N   
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYL-----YDQPKVTLNWIQRFRVIKGVALGLF 374
           LV+L    +    L +V +Y+P G +  +L     + +P        RF   + + L   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHA------RFYAAQ-IVLTFE 155
Query: 375 YLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE 434
           YLH      +I+RD+K  N+L+D +   ++ DFG A+        +T  + GT  YLAPE
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPE 208
Query: 435 HTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGP 469
              +     + D ++ G  + E+A G  P     P
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 94/216 (43%), Gaps = 24/216 (11%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHR---- 318
           F     LGTG FGRV      ++    A+K +  +    +K+ +   ++  R++      
Sbjct: 44  FERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQ-IEHTLNEKRIQQAVNFP 102
Query: 319 NLVQLLGYCRRKGELLLVYDYMPNGSLDKYL-----YDQPKVTLNWIQRFRVIKGVALGL 373
            LV+L    +    L +V +Y P G +  +L     + +P        RF   + + L  
Sbjct: 103 FLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHA------RFYAAQ-IVLTF 155
Query: 374 FYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAP 433
            YLH      +I+RD+K  N+L+D +   ++ DFG A+        +T  + GT  YLAP
Sbjct: 156 EYLHS---LDLIYRDLKPENLLIDQQGYIKVADFGFAK----RVKGRTWXLCGTPEYLAP 208
Query: 434 EHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGP 469
           E   +     + D ++ G  + E+A G  P     P
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 94/215 (43%), Gaps = 22/215 (10%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRN--- 319
           F   + LGTG FGRV      ++    A+K +  +    +K+    +     L+  N   
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYL-----YDQPKVTLNWIQRFRVIKGVALGLF 374
           LV+L    +    L +V +Y+P G +  +L     + +P        RF   + + L   
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHA------RFYAAQ-IVLTFE 156
Query: 375 YLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE 434
           YLH      +I+RD+K  N+L+D +   ++ DFG A+        +T  + GT  YLAPE
Sbjct: 157 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPE 209
Query: 435 HTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGP 469
              +     + D ++ G  + E+A G  P     P
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|1LUL|A Chain A, Db58, A Legume Lectin From Dolichos Biflorus Length = 253

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 82/161 (50%), Gaps = 17/161 (10%)
Query: 28  ILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGLFNDTNLGNETNHVFAVELDTIKSHGF 87
           I +  +S S  GIAF +      P +  S +LG+F D+++ + +    AVE DT  +  +
Sbjct: 75  IFAPNKSSSADGIAFALVPVGSEPKSN-SGFLGVF-DSDVYDNSAQTVAVEFDTFSNTDW 132
Query: 88  LDINDNHVGIDINSLKSESSAPAGY--------YVEYDGLEKRTNVTLAPINIPRPRSLN 139
            D    H+GID+NS+KS  +A  G          + Y+     T++ +A +  P  R+  
Sbjct: 133 -DPTSRHIGIDVNSIKSIRTASWGLANGQNAEILITYNA---ATSLLVASLVHPSRRTSY 188
Query: 140 TMSLSRDLSSVLNDAMYVGFSSSTG---SVLASHYILGWSF 177
            +S   D+++ L + + +GFS++TG       +H +L WSF
Sbjct: 189 IVSERVDITNELPEYVSIGFSATTGLSEGYTETHDVLSWSF 229

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 93/215 (43%), Gaps = 22/215 (10%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRN--- 319
           F   + LGTG FGRV      ++    A+K +  +    +K+    +     L+  N   
Sbjct: 44  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYL-----YDQPKVTLNWIQRFRVIKGVALGLF 374
           LV+L    +    L +V +Y P G +  +L     + +P        RF   + + L   
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHA------RFYAAQ-IVLTFE 156
Query: 375 YLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE 434
           YLH      +I+RD+K  N+++D +   ++ DFG A+        +T  + GT  YLAPE
Sbjct: 157 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK----RVKGRTWXLCGTPEYLAPE 209
Query: 435 HTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGP 469
              +     + D ++ G  + E+A G  P     P
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 68/285 (23%), Positives = 125/285 (43%), Gaps = 52/285 (18%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHES--RQGMKEFVAEIVSIGRLRHRN--LVQLL 324
           +G+GG  +V++    K QI  A+K ++ E    Q +  +  EI  + +L+  +  +++L 
Sbjct: 64  IGSGGSSKVFQVLNEKKQI-YAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 325 GYCRRKGELLLVYDYM--PNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQ 382
            Y     E+   Y YM    G++D   + + K +++  +R    K +   +  +HQ    
Sbjct: 123 DY-----EITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG-- 175
Query: 383 VVIHRDVKASNVLL-DGELNGRLGDFGLARLYDHGTDPQTTHVV-----GTLGYLAPEHT 436
            ++H D+K +N L+ DG L  +L DFG+A    +   P TT VV     GT+ Y+ PE  
Sbjct: 176 -IVHSDLKPANFLIVDGML--KLIDFGIA----NQMQPDTTSVVKDSQVGTVNYMPPEAI 228
Query: 437 RTGKAT-----------TSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNR 485
           +   ++             +DV+S G  L  +  G+ P Q+        +++ +      
Sbjct: 229 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ--------IINQI------ 274
Query: 486 GELLEARDPNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVV 530
            +L    DPN   E+              C   DP  R S+ +++
Sbjct: 275 SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 319

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 94/215 (43%), Gaps = 22/215 (10%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRN--- 319
           F   + LGTG FGRV      ++    A+K +  +    +K+    +     L+  N   
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYL-----YDQPKVTLNWIQRFRVIKGVALGLF 374
           LV+L    +    L +V +Y+P G +  +L     + +P        RF   + + L   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHA------RFYAAQ-IVLTFE 155
Query: 375 YLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE 434
           YLH      +I+RD+K  N+L+D +   ++ DFG A+        +T  + GT  YLAPE
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPE 208
Query: 435 HTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGP 469
              +     + D ++ G  + E+A G  P     P
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 73/301 (24%), Positives = 122/301 (40%), Gaps = 44/301 (14%)
Query: 185 ELNLSQLPKLPRVGPKKRSKFLTIGLPVICVSVIFAAVSGVVYVIRMKRKFAEELEDWEL 244
           ++ L +L +L   GP +    L++   +  +  ++   S   +    + K+  E  +W  
Sbjct: 4   KVRLKKLEQLLLDGPWRNESALSVETLLDVLVCLYTECS---HSALRRDKYVAEFLEWA- 59
Query: 245 DHGPHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKE 304
              P     K++ +  + F   +++G G FG            E+AV K+ +  R    +
Sbjct: 60  --KPFTQLVKEMQLHREDFEIIKVIGRGAFG------------EVAVVKMKNTERIYAMK 105
Query: 305 FVAEIVSIGR-----LRHRNLVQLLGYCR----------RKGELLLVYDYMPNGSLDKYL 349
            + +   + R      R    V + G C+           +  L LV DY   G L   L
Sbjct: 106 ILNKWEMLKRAETACFREERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLL 165
Query: 350 YDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFG- 408
                     + RF  I  + L +  +HQ      +HRD+K  NVLLD   + RL DFG 
Sbjct: 166 SKFEDKLPEDMARF-YIGEMVLAIDSIHQ---LHYVHRDIKPDNVLLDVNGHIRLADFGS 221
Query: 409 LARLYDHGTDPQTTHVVGTLGYLAPEHTRT-----GKATTSADVFSFGAFLLEVACGRRP 463
             ++ D GT  Q++  VGT  Y++PE  +      GK     D +S G  + E+  G  P
Sbjct: 222 CLKMNDDGT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 280
Query: 464 I 464
Sbjct: 281 F 281

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 96/207 (46%), Gaps = 8/207 (3%)
Query: 257 YIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGR 314
           +   K +++ + +G+G  G V         I +AVKK+S   +++   K    E+V +  
Sbjct: 20  FTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKC 79
Query: 315 LRHRNLVQLLGYCRRKGELLLVYD-YMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGL 373
           + H+N++ LL     +  L    D Y+    +D  L     + L+  +   ++  +  G+
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGI 139
Query: 374 FYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAP 433
            +LH      +IHRD+K SN+++  +   ++ DFGLAR     T+   T  V T  Y AP
Sbjct: 140 KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TACTNFMMTPYVVTRYYRAP 194
Query: 434 EHTRTGKATTSADVFSFGAFLLEVACG 460
           E         + D++S G  + E+  G
Sbjct: 195 EVILGMGYAANVDIWSVGCIMGELVKG 221

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 93/217 (42%), Gaps = 27/217 (12%)
Query: 260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIA-----VKKISHESRQGMKEFVAEIVSIGR 314
           T+ ++  E LG G F  V R     +  E A      KK+S    Q + E  A I  +  
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKL-EREARICRL-- 66
Query: 315 LRHRNLVQLLGYCRRKGELLLVYDYMPNGSL-----DKYLYDQPKVTLNWIQRFRVIKGV 369
           L+H N+V+L      +G   L++D +  G L      +  Y +   +         I+ +
Sbjct: 67  LKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADAS-------HCIQQI 119
Query: 370 ALGLFYLHQEWEQVVIHRDVKASNVLLDGELNG---RLGDFGLARLYDHGTDPQTTHVVG 426
              + + HQ     V+HR++K  N+LL  +L G   +L DFGLA +   G         G
Sbjct: 120 LEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLA-IEVEGEQQAWFGFAG 175
Query: 427 TLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRP 463
           T GYL+PE  R        D+++ G  L  +  G  P
Sbjct: 176 TPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPP 212

>pdb|3IPV|A Chain A, Crystal Structure Of Spatholobus Parviflorus Seed Lectin Length = 251

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 74/150 (49%), Gaps = 16/150 (10%)
Query: 39  GIAFVIASTRGLPGARPSQYLGLFNDTNLGNETNHVFAVELDTIKSHGFLDINDNHVGID 98
           G+AF +A     P +    +LGLF D+ +   T    AVE DT ++  F D    H+G D
Sbjct: 89  GLAFFLAPVASAPDSG-GGFLGLF-DSAVSGSTYQTVAVEFDTYENTVFTDPPYTHIGFD 146
Query: 99  INSLKS--------ESSAPAGYYVEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSV 150
           +NS+ S         +   A   + Y+   K   + +A +  P  ++   ++   DLSSV
Sbjct: 147 VNSISSIKTVKWSLANGEAAKVLITYNSAVK---LLVASLVYPSSKTSFILADIVDLSSV 203
Query: 151 LNDAMYVGFSSSTGSV---LASHYILGWSF 177
           L + + VGFS++TG+    + +H +  WSF
Sbjct: 204 LPEWVRVGFSAATGASGGKIETHDVFSWSF 233

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 66/283 (23%), Positives = 124/283 (43%), Gaps = 48/283 (16%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHES--RQGMKEFVAEIVSIGRLRHRN--LVQLL 324
           +G+GG  +V++    K QI  A+K ++ E    Q +  +  EI  + +L+  +  +++L 
Sbjct: 16  IGSGGSSKVFQVLNEKKQI-YAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 74
Query: 325 GYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVV 384
            Y      + +V   M  G++D   + + K +++  +R    K +   +  +HQ     +
Sbjct: 75  DYEITDQYIYMV---MECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---I 128
Query: 385 IHRDVKASNVLL-DGELNGRLGDFGLARLYDHGTDPQTTHVV-----GTLGYLAPEHTRT 438
           +H D+K +N L+ DG L  +L DFG+A    +   P TT VV     GT+ Y+ PE  + 
Sbjct: 129 VHSDLKPANFLIVDGML--KLIDFGIA----NQMQPDTTSVVKDSQVGTVNYMPPEAIKD 182
Query: 439 GKAT-----------TSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGE 487
             ++             +DV+S G  L  +  G+ P Q+        +++ +       +
Sbjct: 183 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ--------IINQI------SK 228
Query: 488 LLEARDPNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVV 530
           L    DPN   E+              C   DP  R S+ +++
Sbjct: 229 LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 271

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 67/215 (31%), Positives = 98/215 (45%), Gaps = 25/215 (11%)
Query: 269 LGTGGFGRVYRGTLPKSQIE-IAVKKISHESRQGMKEFVA-EIVSIGRLRHRNLVQLLGY 326
           +G G FG V R    K   E +AVK I  E  + + E V  EI++   LRH N+V+    
Sbjct: 27  IGAGNFG-VARLMRDKQANELVAVKYI--ERGEKIDENVKREIINHRSLRHPNIVRFKEV 83
Query: 327 CRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRF--RVIKGVALGLFYLHQEWEQVV 384
                 L +V +Y   G L + + +  + + +  + F  ++I GV+    Y H      V
Sbjct: 84  ILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS----YAHA---MQV 136
Query: 385 IHRDVKASNVLLDGELNGRL--GDFGLARLYDHGTDPQTTHVVGTLGYLAPE----HTRT 438
            HRD+K  N LLDG    RL   DFG ++     + P++   VGT  Y+APE        
Sbjct: 137 AHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSA--VGTPAYIAPEVLLKKEYD 194
Query: 439 GKATTSADVFSFGAFLLEVACGRRPIQRQGPSENL 473
           GK    ADV+S G  L  +  G  P +     +N 
Sbjct: 195 GKV---ADVWSCGVTLYVMLVGAYPFEDPEEPKNF 226

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 96/207 (46%), Gaps = 8/207 (3%)
Query: 257 YIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGR 314
           +   K +++ + +G+G  G V         I +AVKK+S   +++   K    E+V +  
Sbjct: 18  FTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKC 77
Query: 315 LRHRNLVQLLGYCRRKGELLLVYD-YMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGL 373
           + H+N++ LL     +  L    D Y+    +D  L     + L+  +   ++  +  G+
Sbjct: 78  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGI 137
Query: 374 FYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAP 433
            +LH      +IHRD+K SN+++  +   ++ DFGLAR     T+   T  V T  Y AP
Sbjct: 138 KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TASTNFMMTPYVVTRYYRAP 192
Query: 434 EHTRTGKATTSADVFSFGAFLLEVACG 460
           E         + D++S G  + E+  G
Sbjct: 193 EVILGMGYKENVDIWSVGCIMGELVKG 219

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 93/215 (43%), Gaps = 22/215 (10%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRN--- 319
           F   + LGTG FGRV      ++    A+K +  +    +K+    +     L+  N   
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYL-----YDQPKVTLNWIQRFRVIKGVALGLF 374
           LV+L    +    L +V +Y P G +  +L     + +P        RF   + + L   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHA------RFYAAQ-IVLTFE 155
Query: 375 YLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE 434
           YLH      +I+RD+K  N+++D +   ++ DFG A+        +T  + GT  YLAPE
Sbjct: 156 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK----RVKGRTWXLCGTPEYLAPE 208
Query: 435 HTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGP 469
              +     + D ++ G  + E+A G  P     P
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 96/208 (46%), Gaps = 8/208 (3%)
Query: 257 YIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGR 314
           +   K ++  + +G+G  G V        +  +A+KK+S   +++   K    E+V +  
Sbjct: 20  FTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKC 79
Query: 315 LRHRNLVQLLGYCRRKGELLLVYD-YMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGL 373
           + H+N++ LL     +  L    D Y+    +D  L    ++ L+  +   ++  +  G+
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 139
Query: 374 FYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAP 433
            +LH      +IHRD+K SN+++  +   ++ DFGLAR    GT       V T  Y AP
Sbjct: 140 KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMEPEVVTRYYRAP 194
Query: 434 EHTRTGKATTSADVFSFGAFLLEVACGR 461
           E         + D++S G  + E+ C +
Sbjct: 195 EVILGMGYKENVDIWSVGCIMGEMVCHK 222

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 86/206 (41%), Gaps = 13/206 (6%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQG-MKEFVAEIVSIGRLRHRNLVQLLGYC 327
           LG G F    +    KS    AVK IS        KE  A  +  G   H N+V+L    
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEG---HPNIVKLHEVF 75
Query: 328 RRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHR 387
             +    LV + +  G L + +  + K   +  +   +++ +   + ++H   +  V+HR
Sbjct: 76  HDQLHTFLVMELLNGGELFERI--KKKKHFSETEASYIMRKLVSAVSHMH---DVGVVHR 130
Query: 388 DVKASNVLLDGE---LNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTS 444
           D+K  N+L   E   L  ++ DFG ARL      P  T    TL Y APE         S
Sbjct: 131 DLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCF-TLHYAAPELLNQNGYDES 189
Query: 445 ADVFSFGAFLLEVACGRRPIQRQGPS 470
            D++S G  L  +  G+ P Q    S
Sbjct: 190 CDLWSLGVILYTMLSGQVPFQSHDRS 215

>pdb|1G8W|A Chain A, Improved Structure Of Phytohemagglutinin-L From The Kidney Bean Length = 233

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 77/150 (51%), Gaps = 19/150 (12%)
Query: 39  GIAFVIASTRGLPGARPSQYLGLFNDTNLGNETNHVFAVELDTIKSHGFLDINDNHVGID 98
           G+AF +      P  +   +LGLF+ +N      H  AVE DT+ +  + D  + H+GID
Sbjct: 87  GLAFALVPVGSQPKDK-GGFLGLFDGSN---SNFHTVAVEFDTLYNKDW-DPTERHIGID 141
Query: 99  INSLKSESSA--------PAGYYVEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSV 150
           +NS++S  +          A   + YD     TN+ +A +  P  ++   +S + DL SV
Sbjct: 142 VNSIRSIKTTRWDFVNGENAEVLITYD---SSTNLLVASLVYPSQKTSFIVSDTVDLKSV 198
Query: 151 LNDAMYVGFSSSTG---SVLASHYILGWSF 177
           L + + VGFS++TG     + ++ +L WSF
Sbjct: 199 LPEWVSVGFSATTGINKGNVETNDVLSWSF 228

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 97/214 (45%), Gaps = 23/214 (10%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVA-EIVSIGRLRHRNLVQLLGYC 327
           +G+G FG        +S   +AVK I  E  + + E V  EI++   LRH N+V+     
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYI--ERGEKIDENVKREIINHRSLRHPNIVRFKEVI 84
Query: 328 RRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRF--RVIKGVALGLFYLHQEWEQVVI 385
                L +V +Y   G L + + +  + + +  + F  ++I GV+    Y H      V 
Sbjct: 85  LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS----YCHA---MQVC 137
Query: 386 HRDVKASNVLLDGELNGRL--GDFGLARLYDHGTDPQTTHVVGTLGYLAPE----HTRTG 439
           HRD+K  N LLDG    RL    FG ++     + P++T  VGT  Y+APE        G
Sbjct: 138 HRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKKEYDG 195
Query: 440 KATTSADVFSFGAFLLEVACGRRPIQRQGPSENL 473
           K    ADV+S G  L  +  G  P +     +N 
Sbjct: 196 KV---ADVWSCGVTLYVMLVGAYPFEDPEEPKNF 226

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 93/215 (43%), Gaps = 22/215 (10%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRN--- 319
           F   + LGTG FGRV      ++    A+K +  +    +K+    +     L+  N   
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYL-----YDQPKVTLNWIQRFRVIKGVALGLF 374
           LV+L    +    L +V +Y P G +  +L     + +P        RF   + + L   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHA------RFYAAQ-IVLTFE 155
Query: 375 YLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE 434
           YLH      +I+RD+K  N+++D +   ++ DFG A+        +T  + GT  YLAPE
Sbjct: 156 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK----RVKGRTWXLCGTPEYLAPE 208
Query: 435 HTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGP 469
              +     + D ++ G  + E+A G  P     P
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 98/208 (47%), Gaps = 14/208 (6%)
Query: 257 YIATKGFREKELLGTGGFGRV---YRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVS 311
           +   K ++  + +G+G  G V   Y   L ++   +A+KK+S   +++   K    E+V 
Sbjct: 58  FTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVL 114
Query: 312 IGRLRHRNLVQLLGYCRRKGELLLVYD-YMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVA 370
           +  + H+N++ LL     +  L    D Y+    +D  L    ++ L+  +   ++  + 
Sbjct: 115 MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQML 174
Query: 371 LGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGY 430
            G+ +LH      +IHRD+K SN+++  +   ++ DFGLAR    GT    T  V T  Y
Sbjct: 175 CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYY 229
Query: 431 LAPEHTRTGKATTSADVFSFGAFLLEVA 458
            APE         + D++S G  + E+ 
Sbjct: 230 RAPEVILGMGYKENVDIWSVGCIMGEMV 257

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 93/215 (43%), Gaps = 22/215 (10%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRN--- 319
           F   + LGTG FGRV      ++    A+K +  +    +K+    +     L+  N   
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYL-----YDQPKVTLNWIQRFRVIKGVALGLF 374
           LV+L    +    L +V +Y P G +  +L     + +P        RF   + + L   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHA------RFYAAQ-IVLTFE 155
Query: 375 YLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE 434
           YLH      +I+RD+K  N+++D +   ++ DFG A+        +T  + GT  YLAPE
Sbjct: 156 YLHS---LDLIYRDLKPENLMIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPE 208
Query: 435 HTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGP 469
              +     + D ++ G  + E+A G  P     P
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 90/218 (41%), Gaps = 27/218 (12%)
Query: 260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIA-----VKKISHESRQGMKEFVAEIVSIGR 314
           T  ++  E LG G F  V R        E A      KK+S    Q + E  A I  +  
Sbjct: 30  TDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKL-EREARICRL-- 86
Query: 315 LRHRNLVQLLGYCRRKGELLLVYDYMPNGSL-----DKYLYDQPKVTLNWIQRFRVIKGV 369
           L+H N+V+L      +G   LV+D +  G L      +  Y +   +         I  +
Sbjct: 87  LKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADAS-------HCIHQI 139
Query: 370 ALGLFYLHQEWEQVVIHRDVKASNVLLDGELNG---RLGDFGLARLYDHGTDPQTTHVVG 426
              + ++HQ     ++HRD+K  N+LL  +  G   +L DFGLA +   G         G
Sbjct: 140 LESVNHIHQ---HDIVHRDLKPENLLLASKCKGAAVKLADFGLA-IEVQGEQQAWFGFAG 195
Query: 427 TLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPI 464
           T GYL+PE  R        D+++ G  L  +  G  P 
Sbjct: 196 TPGYLSPEVLRKDPYGKPVDIWACGVILYILLVGYPPF 233

>pdb|1UZY|A Chain A, Erythrina Crystagalli Lectin Length = 242

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 45/150 (30%), Positives = 75/150 (50%), Gaps = 17/150 (11%)
Query: 39  GIAFVIASTRGLPGARPSQYLGLFNDTNLGNETNHVFAVELDTIKSHGFLDINDNHVGID 98
           G+ F +  T+  P A+   YLG+FN++   N +    AVE DT  S+ +      H+GID
Sbjct: 90  GLVFFMGPTKSKP-AQGYGYLGVFNNSKQDN-SYQTLAVEFDTF-SNPWDPPQVPHIGID 146
Query: 99  INSLKSESSAP--------AGYYVEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSV 150
           +NS++S  + P        A   ++YD   K   + LA +  P   ++ T++   D+  V
Sbjct: 147 VNSIRSIKTQPFQLDNGQVANVVIKYDASSK---ILLAVLVYPSSGAIYTIAEIVDVKQV 203
Query: 151 LNDAMYVGFSSSTGS---VLASHYILGWSF 177
           L + + VG S +TG+      +H +  WSF
Sbjct: 204 LPEWVDVGLSGATGAQRDAAETHDVYSWSF 233

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 99/229 (43%), Gaps = 40/229 (17%)
Query: 262 GFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGRLRHRN 319
            +  K L+G G +G VY      +   +A+KK++   E     K  + EI  + RL+   
Sbjct: 29  NYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDY 88
Query: 320 LVQLLGYC-----RRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLF 374
           +++L          +  EL +V + + +  L K L+  P + L       ++  + LG  
Sbjct: 89  IIRLHDLIIPEDLLKFDELYIVLE-IADSDLKK-LFKTP-IFLTEQHVKTILYNLLLGEK 145
Query: 375 YLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ-------------- 420
           ++H   E  +IHRD+K +N LL+ + + ++ DFGLAR  +   D                
Sbjct: 146 FIH---ESGIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEEKEENEEP 202
Query: 421 -----------TTHVVGTLGYLAPEHTRTGKA-TTSADVFSFGAFLLEV 457
                      T+HVV T  Y APE     +  T S D++S G    E+
Sbjct: 203 GPHNKNLKKQLTSHVV-TRWYRAPELILLQENYTNSIDIWSTGCIFAEL 250

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 101/224 (45%), Gaps = 24/224 (10%)
Query: 248 PHRFRYKD-LYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFV 306
           P  + Y++ ++ AT   R    LG G FG V+R    ++  + AVKK+  E  +      
Sbjct: 64  PVDYEYREEVHWATHQLR----LGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFR-----A 114
Query: 307 AEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVI 366
            E+++   L    +V L G  R    + +  + +  GSL + + +Q  +  +   R    
Sbjct: 115 EELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPED---RALYY 171
Query: 367 KGVAL-GLFYLHQEWEQVVIHRDVKASNVLL--DGELNGRLGDFGLARLYDH---GTDPQ 420
            G AL GL YLH    + ++H DVKA NVLL  DG  +  L DFG A        G D  
Sbjct: 172 LGQALEGLEYLHS---RRILHGDVKADNVLLSSDGS-HAALCDFGHAVCLQPDGLGKDLL 227
Query: 421 T-THVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRP 463
           T  ++ GT  ++APE           DV+S    +L +  G  P
Sbjct: 228 TGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHP 271

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 98/208 (47%), Gaps = 14/208 (6%)
Query: 257 YIATKGFREKELLGTGGFGRV---YRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVS 311
           +   K ++  + +G+G  G V   Y   L ++   +A+KK+S   +++   K    E+V 
Sbjct: 58  FTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVL 114
Query: 312 IGRLRHRNLVQLLGYCRRKGELLLVYD-YMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVA 370
           +  + H+N++ LL     +  L    D Y+    +D  L    ++ L+  +   ++  + 
Sbjct: 115 MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQML 174
Query: 371 LGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGY 430
            G+ +LH      +IHRD+K SN+++  +   ++ DFGLAR    GT    T  V T  Y
Sbjct: 175 CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYY 229
Query: 431 LAPEHTRTGKATTSADVFSFGAFLLEVA 458
            APE         + D++S G  + E+ 
Sbjct: 230 RAPEVILGMGYKENVDIWSVGCIMGEMV 257

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 98/208 (47%), Gaps = 14/208 (6%)
Query: 257 YIATKGFREKELLGTGGFGRV---YRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVS 311
           +   K ++  + +G+G  G V   Y   L ++   +A+KK+S   +++   K    E+V 
Sbjct: 20  FTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVL 76
Query: 312 IGRLRHRNLVQLLGYCRRKGELLLVYD-YMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVA 370
           +  + H+N++ LL     +  L    D Y+    +D  L    ++ L+  +   ++  + 
Sbjct: 77  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQML 136
Query: 371 LGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGY 430
            G+ +LH      +IHRD+K SN+++  +   ++ DFGLAR    GT    T  V T  Y
Sbjct: 137 CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYY 191
Query: 431 LAPEHTRTGKATTSADVFSFGAFLLEVA 458
            APE         + D++S G  + E+ 
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 100/206 (48%), Gaps = 23/206 (11%)
Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
           +++G G FG V++  L +S  E+A+KK+  + R   +E   +I+ I  ++H N+V L  +
Sbjct: 46  KVIGNGSFGVVFQAKLVESD-EVAIKKVLQDKRFKNREL--QIMRI--VKHPNVVDLKAF 100
Query: 327 CRRKGE------LLLVYDYMPNGSLDKYL-YDQPKVTLNWIQRFRVIKGVALGLFYLHQE 379
               G+      L LV +Y+P         Y + K T+  +     +  +   L Y+H  
Sbjct: 101 FYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI 160
Query: 380 WEQVVIHRDVKASNVLLD---GELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHT 436
               + HRD+K  N+LLD   G L  +L DFG A++   G +P  + +     Y APE  
Sbjct: 161 G---ICHRDIKPQNLLLDPPSGVL--KLIDFGSAKILIAG-EPNVSXICSRY-YRAPELI 213
Query: 437 R-TGKATTSADVFSFGAFLLEVACGR 461
                 TT+ D++S G  + E+  G+
Sbjct: 214 FGATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 98/208 (47%), Gaps = 14/208 (6%)
Query: 257 YIATKGFREKELLGTGGFGRV---YRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVS 311
           +   K ++  + +G+G  G V   Y   L ++   +A+KK+S   +++   K    E+V 
Sbjct: 20  FTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVL 76
Query: 312 IGRLRHRNLVQLLGYCRRKGELLLVYD-YMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVA 370
           +  + H+N++ LL     +  L    D Y+    +D  L    ++ L+  +   ++  + 
Sbjct: 77  MKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQML 136
Query: 371 LGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGY 430
            G+ +LH      +IHRD+K SN+++  +   ++ DFGLAR    GT    T  V T  Y
Sbjct: 137 CGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPYVVTRYY 191
Query: 431 LAPEHTRTGKATTSADVFSFGAFLLEVA 458
            APE         + D++S G  + E+ 
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 98/208 (47%), Gaps = 14/208 (6%)
Query: 257 YIATKGFREKELLGTGGFGRV---YRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVS 311
           +   K ++  + +G+G  G V   Y   L ++   +A+KK+S   +++   K    E+V 
Sbjct: 14  FTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVL 70
Query: 312 IGRLRHRNLVQLLGYCRRKGELLLVYD-YMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVA 370
           +  + H+N++ LL     +  L    D Y+    +D  L    ++ L+  +   ++  + 
Sbjct: 71  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQML 130
Query: 371 LGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGY 430
            G+ +LH      +IHRD+K SN+++  +   ++ DFGLAR    GT    T  V T  Y
Sbjct: 131 CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYY 185
Query: 431 LAPEHTRTGKATTSADVFSFGAFLLEVA 458
            APE         + D++S G  + E+ 
Sbjct: 186 RAPEVILGMGYKENVDIWSVGCIMGEMV 213

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 98/208 (47%), Gaps = 14/208 (6%)
Query: 257 YIATKGFREKELLGTGGFGRV---YRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVS 311
           +   K ++  + +G+G  G V   Y   L ++   +A+KK+S   +++   K    E+V 
Sbjct: 21  FTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVL 77
Query: 312 IGRLRHRNLVQLLGYCRRKGELLLVYD-YMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVA 370
           +  + H+N++ LL     +  L    D Y+    +D  L    ++ L+  +   ++  + 
Sbjct: 78  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQML 137
Query: 371 LGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGY 430
            G+ +LH      +IHRD+K SN+++  +   ++ DFGLAR    GT    T  V T  Y
Sbjct: 138 CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYY 192
Query: 431 LAPEHTRTGKATTSADVFSFGAFLLEVA 458
            APE         + D++S G  + E+ 
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMV 220

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 98/208 (47%), Gaps = 14/208 (6%)
Query: 257 YIATKGFREKELLGTGGFGRV---YRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVS 311
           +   K ++  + +G+G  G V   Y   L ++   +A+KK+S   +++   K    E+V 
Sbjct: 19  FTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVL 75
Query: 312 IGRLRHRNLVQLLGYCRRKGELLLVYD-YMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVA 370
           +  + H+N++ LL     +  L    D Y+    +D  L    ++ L+  +   ++  + 
Sbjct: 76  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQML 135
Query: 371 LGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGY 430
            G+ +LH      +IHRD+K SN+++  +   ++ DFGLAR    GT    T  V T  Y
Sbjct: 136 CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYY 190
Query: 431 LAPEHTRTGKATTSADVFSFGAFLLEVA 458
            APE         + D++S G  + E+ 
Sbjct: 191 RAPEVILGMGYKENVDIWSVGCIMGEMV 218

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 98/208 (47%), Gaps = 14/208 (6%)
Query: 257 YIATKGFREKELLGTGGFGRV---YRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVS 311
           +   K ++  + +G+G  G V   Y   L ++   +A+KK+S   +++   K    E+V 
Sbjct: 14  FTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVL 70
Query: 312 IGRLRHRNLVQLLGYCRRKGELLLVYD-YMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVA 370
           +  + H+N++ LL     +  L    D Y+    +D  L    ++ L+  +   ++  + 
Sbjct: 71  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQML 130
Query: 371 LGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGY 430
            G+ +LH      +IHRD+K SN+++  +   ++ DFGLAR    GT    T  V T  Y
Sbjct: 131 CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYY 185
Query: 431 LAPEHTRTGKATTSADVFSFGAFLLEVA 458
            APE         + D++S G  + E+ 
Sbjct: 186 RAPEVILGMGYKENVDIWSVGCIMGEMV 213

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 63/288 (21%), Positives = 118/288 (40%), Gaps = 34/288 (11%)
Query: 253 YKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSI 312
           +K L   TK       L     G +++G    + I + V K+   S +  ++F  E   +
Sbjct: 9   FKQLNFLTK-------LNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRL 61
Query: 313 GRLRHRNLVQLLGYCRRK--GELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVA 370
               H N++ +LG C+        L+  +MP GSL   L++     ++  Q  +    +A
Sbjct: 62  RIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMA 121
Query: 371 LGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGY 430
            G+ +LH   E ++    + + +V++D ++  R+       + D     Q+   +    +
Sbjct: 122 RGMAFLHTL-EPLIPRHALNSRSVMIDEDMTARIS------MADVKFSFQSPGRMYAPAW 174
Query: 431 LAPEHTRTGKATT---SADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGE 487
           +APE  +     T   SAD++SF   L E+      + R+ P  +L  ++        G 
Sbjct: 175 VAPEALQKKPEDTNRRSADMWSFAVLLWEL------VTREVPFADLSNMEIGMKVALEG- 227
Query: 488 LLEARDPNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVVQILER 535
            L    P   + +V+            C + DP  RP    +V ILE+
Sbjct: 228 -LRPTIPPGISPHVS-------KLMKICMNEDPAKRPKFDMIVPILEK 267

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 96/208 (46%), Gaps = 8/208 (3%)
Query: 257 YIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGR 314
           +   K ++  + +G+G  G V        +  +A+KK+S   +++   K    E+V +  
Sbjct: 20  FTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKC 79
Query: 315 LRHRNLVQLLGYCRRKGELLLVYD-YMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGL 373
           + H+N++ LL     +  L    D Y+    +D  L    ++ L+  +   ++  +  G+
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 139
Query: 374 FYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAP 433
            +LH      +IHRD+K SN+++  +   ++ DFGLAR    GT       V T  Y AP
Sbjct: 140 KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMEPEVVTRYYRAP 194
Query: 434 EHTRTGKATTSADVFSFGAFLLEVACGR 461
           E         + D++S G  + E+ C +
Sbjct: 195 EVILGMGYKENVDLWSVGCIMGEMVCHK 222

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 98/208 (47%), Gaps = 14/208 (6%)
Query: 257 YIATKGFREKELLGTGGFGRV---YRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVS 311
           +   K ++  + +G+G  G V   Y   L ++   +A+KK+S   +++   K    E+V 
Sbjct: 20  FTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVL 76
Query: 312 IGRLRHRNLVQLLGYCRRKGELLLVYD-YMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVA 370
           +  + H+N++ LL     +  L    D Y+    +D  L    ++ L+  +   ++  + 
Sbjct: 77  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQML 136
Query: 371 LGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGY 430
            G+ +LH      +IHRD+K SN+++  +   ++ DFGLAR    GT    T  V T  Y
Sbjct: 137 CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYY 191
Query: 431 LAPEHTRTGKATTSADVFSFGAFLLEVA 458
            APE         + D++S G  + E+ 
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 63/227 (27%), Positives = 99/227 (43%), Gaps = 42/227 (18%)
Query: 266 KELLGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGRLRHRNLVQL 323
           + L+GTG +G V        +  +A+KKI    E     K  + EI  + RL H ++V++
Sbjct: 58  RHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKV 117
Query: 324 LGYCRRKG-----ELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQ 378
           L     K      EL +V +     S  K L+  P V L  +    ++  + +G+ Y+H 
Sbjct: 118 LDIVIPKDVEKFDELYVVLEIA--DSDFKKLFRTP-VYLTELHIKTLLYNLLVGVKYVHS 174
Query: 379 EWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHG-------------------TDP 419
                ++HRD+K +N L++ + + ++ DFGLAR  D+                    T P
Sbjct: 175 AG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFP 231
Query: 420 QTT--------HVVGTLGYLAPEHTRTGKATTSA-DVFSFGAFLLEV 457
            T         HVV T  Y APE     +  T A DV+S G    E+
Sbjct: 232 HTKNLKRQLTGHVV-TRWYRAPELILLQENYTEAIDVWSIGCIFAEL 277

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 98/208 (47%), Gaps = 14/208 (6%)
Query: 257 YIATKGFREKELLGTGGFGRV---YRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVS 311
           +   K ++  + +G+G  G V   Y   L ++   +A+KK+S   +++   K    E+V 
Sbjct: 13  FTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVL 69
Query: 312 IGRLRHRNLVQLLGYCRRKGELLLVYD-YMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVA 370
           +  + H+N++ LL     +  L    D Y+    +D  L    ++ L+  +   ++  + 
Sbjct: 70  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQML 129
Query: 371 LGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGY 430
            G+ +LH      +IHRD+K SN+++  +   ++ DFGLAR    GT    T  V T  Y
Sbjct: 130 CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYY 184
Query: 431 LAPEHTRTGKATTSADVFSFGAFLLEVA 458
            APE         + D++S G  + E+ 
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMV 212

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 91/217 (41%), Gaps = 27/217 (12%)
Query: 260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVK-----KISHESRQGMKEFVAEIVSIGR 314
           T  ++  E +G G F  V R     +  E A K     K+S    Q + E  A I  +  
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKL-EREARICRL-- 59
Query: 315 LRHRNLVQLLGYCRRKGELLLVYDYMPNGSL-----DKYLYDQPKVTLNWIQRFRVIKGV 369
           L+H N+V+L      +G   LV+D +  G L      +  Y +   +         I+ +
Sbjct: 60  LKHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADAS-------HCIQQI 112
Query: 370 ALGLFYLHQEWEQVVIHRDVKASNVLLDGELNG---RLGDFGLARLYDHGTDPQTTHVVG 426
              + + HQ     V+HRD+K  N+LL  +  G   +L DFGLA +   G         G
Sbjct: 113 LEAVLHCHQ---MGVVHRDLKPENLLLASKCKGAAVKLADFGLA-IEVQGDQQAWFGFAG 168
Query: 427 TLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRP 463
           T GYL+PE  R        D+++ G  L  +  G  P
Sbjct: 169 TPGYLSPEVLRKEAYGKPVDIWACGVILYILLVGYPP 205

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 96/214 (44%), Gaps = 23/214 (10%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVA-EIVSIGRLRHRNLVQLLGYC 327
           +G+G FG        +S   +AVK I  E  + + E V  EI++   LRH N+V+     
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYI--ERGEKIDENVKREIINHRSLRHPNIVRFKEVI 84
Query: 328 RRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRF--RVIKGVALGLFYLHQEWEQVVI 385
                L +V +Y   G L + + +  + + +  + F  ++I GV+    Y H      V 
Sbjct: 85  LTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS----YCHA---MQVC 137
Query: 386 HRDVKASNVLLDGELNGRL--GDFGLARLYDHGTDPQTTHVVGTLGYLAPE----HTRTG 439
           HRD+K  N LLDG    RL    FG ++     + P+ T  VGT  Y+APE        G
Sbjct: 138 HRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDT--VGTPAYIAPEVLLKKEYDG 195
Query: 440 KATTSADVFSFGAFLLEVACGRRPIQRQGPSENL 473
           K    ADV+S G  L  +  G  P +     +N 
Sbjct: 196 KV---ADVWSCGVTLYVMLVGAYPFEDPEEPKNF 226

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 98/208 (47%), Gaps = 14/208 (6%)
Query: 257 YIATKGFREKELLGTGGFGRV---YRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVS 311
           +   K ++  + +G+G  G V   Y   L ++   +A+KK+S   +++   K    E+V 
Sbjct: 21  FTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVL 77
Query: 312 IGRLRHRNLVQLLGYCRRKGELLLVYD-YMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVA 370
           +  + H+N++ LL     +  L    D Y+    +D  L    ++ L+  +   ++  + 
Sbjct: 78  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQML 137
Query: 371 LGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGY 430
            G+ +LH      +IHRD+K SN+++  +   ++ DFGLAR    GT    T  V T  Y
Sbjct: 138 CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYY 192
Query: 431 LAPEHTRTGKATTSADVFSFGAFLLEVA 458
            APE         + D++S G  + E+ 
Sbjct: 193 RAPEVILGMGYKENVDIWSVGCIMGEMV 220

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 98/208 (47%), Gaps = 14/208 (6%)
Query: 257 YIATKGFREKELLGTGGFGRV---YRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVS 311
           +   K ++  + +G+G  G V   Y   L ++   +A+KK+S   +++   K    E+V 
Sbjct: 20  FTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVL 76
Query: 312 IGRLRHRNLVQLLGYCRRKGELLLVYD-YMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVA 370
           +  + H+N++ LL     +  L    D Y+    +D  L    ++ L+  +   ++  + 
Sbjct: 77  MKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQML 136
Query: 371 LGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGY 430
            G+ +LH      +IHRD+K SN+++  +   ++ DFGLAR    GT    T  V T  Y
Sbjct: 137 CGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPYVVTRYY 191
Query: 431 LAPEHTRTGKATTSADVFSFGAFLLEVA 458
            APE         + D++S G  + E+ 
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 96/207 (46%), Gaps = 8/207 (3%)
Query: 257 YIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGR 314
           +   K ++  + +G+G  G V        +  +A+KK+S   +++   K    E+V +  
Sbjct: 20  FTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKC 79
Query: 315 LRHRNLVQLLGYCRRKGELLLVYD-YMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGL 373
           + H+N++ LL     +  L    D Y+    +D  L    ++ L+  +   ++  +  G+
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 139
Query: 374 FYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAP 433
            +LH      +IHRD+K SN+++  +   ++ DFGLAR    GT    T  V T  Y AP
Sbjct: 140 KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAP 194
Query: 434 EHTRTGKATTSADVFSFGAFLLEVACG 460
           E         + D++S G  + E+  G
Sbjct: 195 EVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 98/208 (47%), Gaps = 14/208 (6%)
Query: 257 YIATKGFREKELLGTGGFGRV---YRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVS 311
           +   K ++  + +G+G  G V   Y   L ++   +A+KK+S   +++   K    E+V 
Sbjct: 20  FTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVL 76
Query: 312 IGRLRHRNLVQLLGYCRRKGELLLVYD-YMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVA 370
           +  + H+N++ LL     +  L    D Y+    +D  L    ++ L+  +   ++  + 
Sbjct: 77  MKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQML 136
Query: 371 LGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGY 430
            G+ +LH      +IHRD+K SN+++  +   ++ DFGLAR    GT    T  V T  Y
Sbjct: 137 XGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPYVVTRYY 191
Query: 431 LAPEHTRTGKATTSADVFSFGAFLLEVA 458
            APE         + D++S G  + E+ 
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 69/284 (24%), Positives = 109/284 (38%), Gaps = 50/284 (17%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEF---------VAEIVSIG 313
           +R   LLG GGFG V+ G     ++++A+K I      G             VA +  +G
Sbjct: 33  YRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVG 92
Query: 314 R-LRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALG 372
               H  +++LL +   +   +LV +  P  + D + Y   K  L           V   
Sbjct: 93  AGGGHPGVIRLLDWFETQEGFMLVLE-RPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAA 151
Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT-----DPQTTHVVGT 427
           + + H    + V+HRD+K  N+L+D          G A+L D G+     D   T   GT
Sbjct: 152 IQHCHS---RGVVHRDIKDENILIDLRR-------GCAKLIDFGSGALLHDEPYTDFDGT 201
Query: 428 LGYLAPEH-TRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRG 486
             Y  PE  +R       A V+S G  L ++ CG  P +R                    
Sbjct: 202 RVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD------------------Q 243
Query: 487 ELLEARDPNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVV 530
           E+LEA        + A            C    P++RPS+ +++
Sbjct: 244 EILEAE-----LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEIL 282

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 96/207 (46%), Gaps = 8/207 (3%)
Query: 257 YIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGR 314
           +   K ++  + +G+G  G V        +  +A+KK+S   +++   K    E+V +  
Sbjct: 20  FTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKC 79
Query: 315 LRHRNLVQLLGYCRRKGELLLVYD-YMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGL 373
           + H+N++ LL     +  L    D Y+    +D  L    ++ L+  +   ++  +  G+
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 139
Query: 374 FYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAP 433
            +LH      +IHRD+K SN+++  +   ++ DFGLAR    GT    T  V T  Y AP
Sbjct: 140 KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAP 194
Query: 434 EHTRTGKATTSADVFSFGAFLLEVACG 460
           E         + D++S G  + E+  G
Sbjct: 195 EVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 97/207 (46%), Gaps = 8/207 (3%)
Query: 257 YIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGR 314
           +   K ++  + +G+G  G V        +  +A+KK+S   +++   K    E+V +  
Sbjct: 20  FTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKV 79
Query: 315 LRHRNLVQLLGYCRRKGELLLVYD-YMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGL 373
           + H+N++ LL     +  L    D Y+    +D  L    ++ L+  +   ++  + +G+
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGI 139
Query: 374 FYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAP 433
            +LH      +IHRD+K SN+++  +   ++ DFGLAR    GT    T  V T  Y AP
Sbjct: 140 KHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMTPYVVTRYYRAP 194
Query: 434 EHTRTGKATTSADVFSFGAFLLEVACG 460
           E         + D++S G  + E+  G
Sbjct: 195 EVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 96/207 (46%), Gaps = 8/207 (3%)
Query: 257 YIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGR 314
           +   K ++  + +G+G  G V        +  +A+KK+S   +++   K    E+V +  
Sbjct: 21  FTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKC 80
Query: 315 LRHRNLVQLLGYCRRKGELLLVYD-YMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGL 373
           + H+N++ LL     +  L    D Y+    +D  L    ++ L+  +   ++  +  G+
Sbjct: 81  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 140
Query: 374 FYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAP 433
            +LH      +IHRD+K SN+++  +   ++ DFGLAR    GT    T  V T  Y AP
Sbjct: 141 KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAP 195
Query: 434 EHTRTGKATTSADVFSFGAFLLEVACG 460
           E         + D++S G  + E+  G
Sbjct: 196 EVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 90/210 (42%), Gaps = 36/210 (17%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
           +G+G +G V      + + ++AVKK+S   +S    +    E+  +  L+H N++ LL  
Sbjct: 28  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDV 87
Query: 327 CRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVAL--------------G 372
                       + P  S++ +       TL       ++K  AL              G
Sbjct: 88  ------------FTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRG 135
Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLA 432
           L Y+H      +IHRD+K SNV ++ +   R+ DFGLAR      D + T  V T  Y A
Sbjct: 136 LKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR----QADEEMTGYVATRWYRA 188
Query: 433 PE-HTRTGKATTSADVFSFGAFLLEVACGR 461
           PE          + D++S G  + E+  G+
Sbjct: 189 PEIMLNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 96/207 (46%), Gaps = 8/207 (3%)
Query: 257 YIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGR 314
           +   K ++  + +G+G  G V        +  +A+KK+S   +++   K    E+V +  
Sbjct: 20  FTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKC 79
Query: 315 LRHRNLVQLLGYCRRKGELLLVYD-YMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGL 373
           + H+N++ LL     +  L    D Y+    +D  L    ++ L+  +   ++  +  G+
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 139
Query: 374 FYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAP 433
            +LH      +IHRD+K SN+++  +   ++ DFGLAR    GT    T  V T  Y AP
Sbjct: 140 KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPEVVTRYYRAP 194
Query: 434 EHTRTGKATTSADVFSFGAFLLEVACG 460
           E         + D++S G  + E+  G
Sbjct: 195 EVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 91/209 (43%), Gaps = 22/209 (10%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRN---LVQLLG 325
           LGTG FGRV      +S    A+K +  +    +K+    +     L+  N   LV+L  
Sbjct: 36  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 95
Query: 326 YCRRKGELLLVYDYMPNGSLDKYL-----YDQPKVTLNWIQRFRVIKGVALGLFYLHQEW 380
             +    L +V +Y+  G +  +L     + +P        RF   + + L   YLH   
Sbjct: 96  SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA------RFYAAQ-IVLTFEYLHS-- 146
Query: 381 EQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGK 440
              +I+RD+K  N+L+D +   ++ DFG A+        +T  + GT  YLAPE   +  
Sbjct: 147 -LDLIYRDLKPENLLIDEQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKG 201
Query: 441 ATTSADVFSFGAFLLEVACGRRPIQRQGP 469
              + D ++ G  + E+A G  P     P
Sbjct: 202 YNKAVDWWALGVLIYEMAAGYPPFFADQP 230

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 67/285 (23%), Positives = 124/285 (43%), Gaps = 52/285 (18%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHES--RQGMKEFVAEIVSIGRLRHRN--LVQLL 324
           +G+GG  +V++    K QI  A+K ++ E    Q +  +  EI  + +L+  +  +++L 
Sbjct: 64  IGSGGSSKVFQVLNEKKQI-YAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 325 GYCRRKGELLLVYDYM--PNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQ 382
            Y     E+   Y YM    G++D   + + K +++  +R    K +   +  +HQ    
Sbjct: 123 DY-----EITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG-- 175
Query: 383 VVIHRDVKASNVLL-DGELNGRLGDFGLARLYDHGTDPQTTHVV-----GTLGYLAPEHT 436
            ++H D+K +N L+ DG L  +L DFG+A    +   P TT VV     G + Y+ PE  
Sbjct: 176 -IVHSDLKPANFLIVDGML--KLIDFGIA----NQMQPDTTSVVKDSQVGAVNYMPPEAI 228
Query: 437 RTGKAT-----------TSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNR 485
           +   ++             +DV+S G  L  +  G+ P Q+        +++ +      
Sbjct: 229 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ--------IINQI------ 274
Query: 486 GELLEARDPNLGTEYVAXXXXXXXXXXXXCSHSDPTARPSMRQVV 530
            +L    DPN   E+              C   DP  R S+ +++
Sbjct: 275 SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 319

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 96/207 (46%), Gaps = 8/207 (3%)
Query: 257 YIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGR 314
           +   K ++  + +G+G  G V        +  +A+KK+S   +++   K    E+V +  
Sbjct: 20  FTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKC 79
Query: 315 LRHRNLVQLLGYCRRKGELLLVYD-YMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGL 373
           + H+N++ LL     +  L    D Y+    +D  L    ++ L+  +   ++  +  G+
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGI 139
Query: 374 FYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAP 433
            +LH      +IHRD+K SN+++  +   ++ DFGLAR    GT    T  V T  Y AP
Sbjct: 140 KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAP 194
Query: 434 EHTRTGKATTSADVFSFGAFLLEVACG 460
           E         + D++S G  + E+  G
Sbjct: 195 EVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 97/207 (46%), Gaps = 8/207 (3%)
Query: 257 YIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGR 314
           +   K ++  + +G+G  G V        +  +A+KK+S   +++   K    E+V +  
Sbjct: 20  FTVLKRYQNLKPIGSGAQGIVVAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKV 79
Query: 315 LRHRNLVQLLGYCRRKGELLLVYD-YMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGL 373
           + H+N++ LL     +  L    D Y+    +D  L    ++ L+  +   ++  + +G+
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGI 139
Query: 374 FYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAP 433
            +LH      +IHRD+K SN+++  +   ++ DFGLAR    GT    T  V T  Y AP
Sbjct: 140 KHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMTPYVVTRYYRAP 194
Query: 434 EHTRTGKATTSADVFSFGAFLLEVACG 460
           E         + D++S G  + E+  G
Sbjct: 195 EVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 93/215 (43%), Gaps = 22/215 (10%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRN--- 319
           F   + LGTG FGRV      +S    A+K +  +    +K+    +     L+  N   
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYL-----YDQPKVTLNWIQRFRVIKGVALGLF 374
           LV+L    +    L +V +Y+  G +  +L     + +P        RF   + + L   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA------RFYAAQ-IVLTFE 155
Query: 375 YLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE 434
           YLH      +I+RD+K  N+L+D +   ++ DFG A+        +T  + GT  YLAPE
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPE 208
Query: 435 HTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGP 469
              +     + D ++ G  + E+A G  P     P
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 95/220 (43%), Gaps = 41/220 (18%)
Query: 268 LLGTGGFGRVYRGTLPKSQIEIAVKKISHE-----------SRQGMKEFVAEIVSIGRLR 316
           LLG+GGFG VY G      + +A+K +  +           +R  M+  + + VS G   
Sbjct: 15  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG--- 71
Query: 317 HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYL 376
              +++LL +  R    +L+ +  P    D + +   +  L         + +A   F+ 
Sbjct: 72  FSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQ--------EELARSFFW- 121
Query: 377 HQEWEQV-------VIHRDVKASNVLLD---GELNGRLGDFGLARLYDHGTDPQTTHVVG 426
            Q  E V       V+HRD+K  N+L+D   GEL  +L DFG   L     D   T   G
Sbjct: 122 -QVLEAVRHCHNCGVLHRDIKDENILIDLNRGEL--KLIDFGSGALL---KDTVYTDFDG 175
Query: 427 TLGYLAPEHTRTGKAT-TSADVFSFGAFLLEVACGRRPIQ 465
           T  Y  PE  R  +    SA V+S G  L ++ CG  P +
Sbjct: 176 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 215

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 91/209 (43%), Gaps = 22/209 (10%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRN---LVQLLG 325
           LGTG FGRV      +S    A+K +  +    +K+    +     L+  N   LV+L  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 326 YCRRKGELLLVYDYMPNGSLDKYL-----YDQPKVTLNWIQRFRVIKGVALGLFYLHQEW 380
             +    L +V +Y+  G +  +L     + +P        RF   + + L   YLH   
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA------RFYAAQ-IVLTFEYLHS-- 159
Query: 381 EQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGK 440
              +I+RD+K  N+L+D +   ++ DFG A+        +T  + GT  YLAPE   +  
Sbjct: 160 -LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKG 214
Query: 441 ATTSADVFSFGAFLLEVACGRRPIQRQGP 469
              + D ++ G  + E+A G  P     P
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 95/220 (43%), Gaps = 41/220 (18%)
Query: 268 LLGTGGFGRVYRGTLPKSQIEIAVKKISHE-----------SRQGMKEFVAEIVSIGRLR 316
           LLG+GGFG VY G      + +A+K +  +           +R  M+  + + VS G   
Sbjct: 16  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG--- 72
Query: 317 HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYL 376
              +++LL +  R    +L+ +  P    D + +   +  L         + +A   F+ 
Sbjct: 73  FSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQ--------EELARSFFW- 122
Query: 377 HQEWEQV-------VIHRDVKASNVLLD---GELNGRLGDFGLARLYDHGTDPQTTHVVG 426
            Q  E V       V+HRD+K  N+L+D   GEL  +L DFG   L     D   T   G
Sbjct: 123 -QVLEAVRHCHNCGVLHRDIKDENILIDLNRGEL--KLIDFGSGALL---KDTVYTDFDG 176
Query: 427 TLGYLAPEHTRTGKAT-TSADVFSFGAFLLEVACGRRPIQ 465
           T  Y  PE  R  +    SA V+S G  L ++ CG  P +
Sbjct: 177 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 216

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 95/220 (43%), Gaps = 41/220 (18%)
Query: 268 LLGTGGFGRVYRGTLPKSQIEIAVKKISHE-----------SRQGMKEFVAEIVSIGRLR 316
           LLG+GGFG VY G      + +A+K +  +           +R  M+  + + VS G   
Sbjct: 16  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG--- 72
Query: 317 HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYL 376
              +++LL +  R    +L+ +  P    D + +   +  L         + +A   F+ 
Sbjct: 73  FSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQ--------EELARSFFW- 122
Query: 377 HQEWEQV-------VIHRDVKASNVLLD---GELNGRLGDFGLARLYDHGTDPQTTHVVG 426
            Q  E V       V+HRD+K  N+L+D   GEL  +L DFG   L     D   T   G
Sbjct: 123 -QVLEAVRHCHNCGVLHRDIKDENILIDLNRGEL--KLIDFGSGALL---KDTVYTDFDG 176
Query: 427 TLGYLAPEHTRTGKAT-TSADVFSFGAFLLEVACGRRPIQ 465
           T  Y  PE  R  +    SA V+S G  L ++ CG  P +
Sbjct: 177 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 216

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 92/215 (42%), Gaps = 22/215 (10%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRN--- 319
           F   + LGTG FGRV      ++    A+K +  +    +K+    +     L+  N   
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYL-----YDQPKVTLNWIQRFRVIKGVALGLF 374
           L +L    +    L +V +Y P G +  +L     + +P        RF   + + L   
Sbjct: 104 LTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHA------RFYAAQ-IVLTFE 156
Query: 375 YLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE 434
           YLH      +I+RD+K  N+++D +   ++ DFG A+        +T  + GT  YLAPE
Sbjct: 157 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK----RVKGRTWXLCGTPEYLAPE 209
Query: 435 HTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGP 469
              +     + D ++ G  + E+A G  P     P
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 91/209 (43%), Gaps = 22/209 (10%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRN---LVQLLG 325
           LGTG FGRV      +S    A+K +  +    +K+    +     L+  N   LV+L  
Sbjct: 50  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 326 YCRRKGELLLVYDYMPNGSLDKYL-----YDQPKVTLNWIQRFRVIKGVALGLFYLHQEW 380
             +    L +V +Y+  G +  +L     + +P        RF   + + L   YLH   
Sbjct: 110 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA------RFYAAQ-IVLTFEYLHS-- 160
Query: 381 EQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGK 440
              +I+RD+K  N+L+D +   ++ DFG A+        +T  + GT  YLAPE   +  
Sbjct: 161 -LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKG 215
Query: 441 ATTSADVFSFGAFLLEVACGRRPIQRQGP 469
              + D ++ G  + E+A G  P     P
Sbjct: 216 YNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 95/220 (43%), Gaps = 41/220 (18%)
Query: 268 LLGTGGFGRVYRGTLPKSQIEIAVKKISHE-----------SRQGMKEFVAEIVSIGRLR 316
           LLG+GGFG VY G      + +A+K +  +           +R  M+  + + VS G   
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG--- 100
Query: 317 HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYL 376
              +++LL +  R    +L+ +  P    D + +   +  L         + +A   F+ 
Sbjct: 101 FSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQ--------EELARSFFW- 150
Query: 377 HQEWEQV-------VIHRDVKASNVLLD---GELNGRLGDFGLARLYDHGTDPQTTHVVG 426
            Q  E V       V+HRD+K  N+L+D   GEL  +L DFG   L     D   T   G
Sbjct: 151 -QVLEAVRHCHNCGVLHRDIKDENILIDLNRGEL--KLIDFGSGALL---KDTVYTDFDG 204
Query: 427 TLGYLAPEHTRTGK-ATTSADVFSFGAFLLEVACGRRPIQ 465
           T  Y  PE  R  +    SA V+S G  L ++ CG  P +
Sbjct: 205 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 244

>pdb|1QNW|A Chain A, Lectin Ii From Ulex Europaeus Length = 242

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 78/166 (46%), Gaps = 17/166 (10%)
Query: 33  QSQSGHGIAFVIA-STRGLPGARPSQYLGLFNDTNLGNETNHVFAVELDTI--KSHGFLD 89
           +S    G+AF +A +   +P    +   GLF+ ++    +N + AVE DT   K++   D
Sbjct: 81  KSDGVDGLAFFLAPANSQIPSGSSAGMFGLFS-SSDSKSSNQIIAVEFDTYFGKAYNPWD 139
Query: 90  INDNHVGIDINSLKSESSAP--------AGYYVEYDGLEKRTNVTLAPINIPRPRSLNTM 141
            +  H+GID+NS+KS  +          A   + Y    K   V L+    P   + N +
Sbjct: 140 PDFKHIGIDVNSIKSIKTVKWDWRNGEVADVVITYRAPTKSLTVCLS---YPSDGTSNII 196
Query: 142 SLSRDLSSVLNDAMYVGFSSSTGSV--LASHYILGWSFKINGQAEE 185
           + S DL ++L + + VGFS   G+     +H +L W F  N +A  
Sbjct: 197 TASVDLKAILPEWVSVGFSGGVGNAAEFETHDVLSWYFTSNLEANN 242

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 97/207 (46%), Gaps = 8/207 (3%)
Query: 257 YIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGR 314
           +   K ++  + +G+G  G V        +  +A+KK+S   +++   K    E+V +  
Sbjct: 20  FTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKV 79
Query: 315 LRHRNLVQLLGYCRRKGELLLVYD-YMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGL 373
           + H+N++ LL     +  L    D Y+    +D  L    ++ L+  +   ++  + +G+
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGI 139
Query: 374 FYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAP 433
            +LH      +IHRD+K SN+++  +   ++ DFGLAR    GT    T  V T  Y AP
Sbjct: 140 KHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMTPYVVTRYYRAP 194
Query: 434 EHTRTGKATTSADVFSFGAFLLEVACG 460
           E         + D++S G  + E+  G
Sbjct: 195 EVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 98/208 (47%), Gaps = 14/208 (6%)
Query: 257 YIATKGFREKELLGTGGFGRV---YRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVS 311
           +   K ++  + +G+G  G V   Y   L ++   +A+KK+S   +++   K    E+V 
Sbjct: 13  FTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVL 69
Query: 312 IGRLRHRNLVQLLGYCRRKGELLLVYD-YMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVA 370
           +  + H+N++ LL     +  L    D Y+    +D  L    ++ L+  +   ++  + 
Sbjct: 70  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQML 129
Query: 371 LGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGY 430
            G+ +LH      +IHRD+K SN+++  +   ++ DFGLAR    GT    T  V T  Y
Sbjct: 130 XGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPYVVTRYY 184
Query: 431 LAPEHTRTGKATTSADVFSFGAFLLEVA 458
            APE         + D++S G  + E+ 
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMV 212

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 95/220 (43%), Gaps = 41/220 (18%)
Query: 268 LLGTGGFGRVYRGTLPKSQIEIAVKKISHE-----------SRQGMKEFVAEIVSIGRLR 316
           LLG+GGFG VY G      + +A+K +  +           +R  M+  + + VS G   
Sbjct: 30  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG--- 86
Query: 317 HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYL 376
              +++LL +  R    +L+ +  P    D + +   +  L         + +A   F+ 
Sbjct: 87  FSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQ--------EELARSFFW- 136
Query: 377 HQEWEQV-------VIHRDVKASNVLLD---GELNGRLGDFGLARLYDHGTDPQTTHVVG 426
            Q  E V       V+HRD+K  N+L+D   GEL  +L DFG   L     D   T   G
Sbjct: 137 -QVLEAVRHCHNCGVLHRDIKDENILIDLNRGEL--KLIDFGSGALL---KDTVYTDFDG 190
Query: 427 TLGYLAPEHTRTGKAT-TSADVFSFGAFLLEVACGRRPIQ 465
           T  Y  PE  R  +    SA V+S G  L ++ CG  P +
Sbjct: 191 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 230

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 91/209 (43%), Gaps = 22/209 (10%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRN---LVQLLG 325
           LGTG FGRV      +S    A+K +  +    +K+    +     L+  N   LV+L  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 326 YCRRKGELLLVYDYMPNGSLDKYL-----YDQPKVTLNWIQRFRVIKGVALGLFYLHQEW 380
             +    L +V +Y+  G +  +L     + +P        RF   + + L   YLH   
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA------RFYAAQ-IVLTFEYLHS-- 159
Query: 381 EQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGK 440
              +I+RD+K  N+L+D +   ++ DFG A+        +T  + GT  YLAPE   +  
Sbjct: 160 -LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKG 214
Query: 441 ATTSADVFSFGAFLLEVACGRRPIQRQGP 469
              + D ++ G  + E+A G  P     P
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 100/230 (43%), Gaps = 36/230 (15%)
Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHES-----RQGMKEFVAEIVSIGRLRHRNLV 321
           ++LG G    V+RG   K+    A+K  ++ S        M+EF      + +L H+N+V
Sbjct: 15  DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEV----LKKLNHKNIV 70
Query: 322 QLLGY-----CRRKGELLLVYDYMPNGSLDKYLYDQPKVT-LNWIQRFRVIKGVALGLFY 375
           +L         R K   +L+ ++ P GSL   L +      L   +   V++ V  G+ +
Sbjct: 71  KLFAIEEETTTRHK---VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 376 LHQEWEQVVIHRDVKASNVLL----DGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYL 431
           L    E  ++HR++K  N++     DG+   +L DFG AR  +   D Q   + GT  YL
Sbjct: 128 LR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE--DDEQFVXLYGTEEYL 182
Query: 432 APE--------HTRTGKATTSADVFSFGAFLLEVACGRRPIQR-QGPSEN 472
            P+             K   + D++S G      A G  P +  +GP  N
Sbjct: 183 HPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN 232

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 95/220 (43%), Gaps = 41/220 (18%)
Query: 268 LLGTGGFGRVYRGTLPKSQIEIAVKKISHE-----------SRQGMKEFVAEIVSIGRLR 316
           LLG+GGFG VY G      + +A+K +  +           +R  M+  + + VS G   
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG--- 67
Query: 317 HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYL 376
              +++LL +  R    +L+ +  P    D + +   +  L         + +A   F+ 
Sbjct: 68  FSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQ--------EELARSFFW- 117
Query: 377 HQEWEQV-------VIHRDVKASNVLLD---GELNGRLGDFGLARLYDHGTDPQTTHVVG 426
            Q  E V       V+HRD+K  N+L+D   GEL  +L DFG   L     D   T   G
Sbjct: 118 -QVLEAVRHCHNCGVLHRDIKDENILIDLNRGEL--KLIDFGSGALL---KDTVYTDFDG 171
Query: 427 TLGYLAPEHTRTGKAT-TSADVFSFGAFLLEVACGRRPIQ 465
           T  Y  PE  R  +    SA V+S G  L ++ CG  P +
Sbjct: 172 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 211

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 92/215 (42%), Gaps = 22/215 (10%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRN--- 319
           F   + LGTG FGRV      ++    A+K +  +    +K+    +     L+  N   
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYL-----YDQPKVTLNWIQRFRVIKGVALGLF 374
           L +L    +    L +V +Y P G +  +L     + +P        RF   + + L   
Sbjct: 104 LTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHA------RFYAAQ-IVLTFE 156
Query: 375 YLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE 434
           YLH      +I+RD+K  N+++D +   ++ DFG A+        +T  + GT  YLAPE
Sbjct: 157 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK----RVKGRTWXLCGTPEYLAPE 209
Query: 435 HTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGP 469
              +     + D ++ G  + E+A G  P     P
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 91/209 (43%), Gaps = 22/209 (10%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRN---LVQLLG 325
           LGTG FGRV      +S    A+K +  +    +K+    +     L+  N   LV+L  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 326 YCRRKGELLLVYDYMPNGSLDKYL-----YDQPKVTLNWIQRFRVIKGVALGLFYLHQEW 380
             +    L +V +Y+  G +  +L     + +P        RF   + + L   YLH   
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA------RFYAAQ-IVLTFEYLHS-- 159
Query: 381 EQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGK 440
              +I+RD+K  N+L+D +   ++ DFG A+        +T  + GT  YLAPE   +  
Sbjct: 160 -LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKG 214
Query: 441 ATTSADVFSFGAFLLEVACGRRPIQRQGP 469
              + D ++ G  + E+A G  P     P
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 91/209 (43%), Gaps = 22/209 (10%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRN---LVQLLG 325
           LGTG FGRV      +S    A+K +  +    +K+    +     L+  N   LV+L  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 326 YCRRKGELLLVYDYMPNGSLDKYL-----YDQPKVTLNWIQRFRVIKGVALGLFYLHQEW 380
             +    L +V +Y+  G +  +L     + +P        RF   + + L   YLH   
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA------RFYAAQ-IVLTFEYLHS-- 159
Query: 381 EQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGK 440
              +I+RD+K  N+L+D +   ++ DFG A+        +T  + GT  YLAPE   +  
Sbjct: 160 -LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLAGTPEYLAPEIILSKG 214
Query: 441 ATTSADVFSFGAFLLEVACGRRPIQRQGP 469
              + D ++ G  + E+A G  P     P
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 95/220 (43%), Gaps = 41/220 (18%)
Query: 268 LLGTGGFGRVYRGTLPKSQIEIAVKKISHE-----------SRQGMKEFVAEIVSIGRLR 316
           LLG+GGFG VY G      + +A+K +  +           +R  M+  + + VS G   
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG--- 99
Query: 317 HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYL 376
              +++LL +  R    +L+ +  P    D + +   +  L         + +A   F+ 
Sbjct: 100 FSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQ--------EELARSFFW- 149
Query: 377 HQEWEQV-------VIHRDVKASNVLLD---GELNGRLGDFGLARLYDHGTDPQTTHVVG 426
            Q  E V       V+HRD+K  N+L+D   GEL  +L DFG   L     D   T   G
Sbjct: 150 -QVLEAVRHCHNCGVLHRDIKDENILIDLNRGEL--KLIDFGSGALL---KDTVYTDFDG 203
Query: 427 TLGYLAPEHTRTGKAT-TSADVFSFGAFLLEVACGRRPIQ 465
           T  Y  PE  R  +    SA V+S G  L ++ CG  P +
Sbjct: 204 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 243

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 95/220 (43%), Gaps = 41/220 (18%)
Query: 268 LLGTGGFGRVYRGTLPKSQIEIAVKKISHE-----------SRQGMKEFVAEIVSIGRLR 316
           LLG+GGFG VY G      + +A+K +  +           +R  M+  + + VS G   
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG--- 99
Query: 317 HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYL 376
              +++LL +  R    +L+ +  P    D + +   +  L         + +A   F+ 
Sbjct: 100 FSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQ--------EELARSFFW- 149
Query: 377 HQEWEQV-------VIHRDVKASNVLLD---GELNGRLGDFGLARLYDHGTDPQTTHVVG 426
            Q  E V       V+HRD+K  N+L+D   GEL  +L DFG   L     D   T   G
Sbjct: 150 -QVLEAVRHCHNCGVLHRDIKDENILIDLNRGEL--KLIDFGSGALL---KDTVYTDFDG 203
Query: 427 TLGYLAPEHTRTGKAT-TSADVFSFGAFLLEVACGRRPIQ 465
           T  Y  PE  R  +    SA V+S G  L ++ CG  P +
Sbjct: 204 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 243

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 95/220 (43%), Gaps = 41/220 (18%)
Query: 268 LLGTGGFGRVYRGTLPKSQIEIAVKKISHE-----------SRQGMKEFVAEIVSIGRLR 316
           LLG+GGFG VY G      + +A+K +  +           +R  M+  + + VS G   
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG--- 99
Query: 317 HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYL 376
              +++LL +  R    +L+ +  P    D + +   +  L         + +A   F+ 
Sbjct: 100 FSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQ--------EELARSFFW- 149
Query: 377 HQEWEQV-------VIHRDVKASNVLLD---GELNGRLGDFGLARLYDHGTDPQTTHVVG 426
            Q  E V       V+HRD+K  N+L+D   GEL  +L DFG   L     D   T   G
Sbjct: 150 -QVLEAVRHCHNCGVLHRDIKDENILIDLNRGEL--KLIDFGSGALL---KDTVYTDFDG 203
Query: 427 TLGYLAPEHTRTGKAT-TSADVFSFGAFLLEVACGRRPIQ 465
           T  Y  PE  R  +    SA V+S G  L ++ CG  P +
Sbjct: 204 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 243

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 95/220 (43%), Gaps = 41/220 (18%)
Query: 268 LLGTGGFGRVYRGTLPKSQIEIAVKKISHE-----------SRQGMKEFVAEIVSIGRLR 316
           LLG+GGFG VY G      + +A+K +  +           +R  M+  + + VS G   
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG--- 100
Query: 317 HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYL 376
              +++LL +  R    +L+ +  P    D + +   +  L         + +A   F+ 
Sbjct: 101 FSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQ--------EELARSFFW- 150
Query: 377 HQEWEQV-------VIHRDVKASNVLLD---GELNGRLGDFGLARLYDHGTDPQTTHVVG 426
            Q  E V       V+HRD+K  N+L+D   GEL  +L DFG   L     D   T   G
Sbjct: 151 -QVLEAVRHCHNCGVLHRDIKDENILIDLNRGEL--KLIDFGSGALL---KDTVYTDFDG 204
Query: 427 TLGYLAPEHTRTGKAT-TSADVFSFGAFLLEVACGRRPIQ 465
           T  Y  PE  R  +    SA V+S G  L ++ CG  P +
Sbjct: 205 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 244

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 95/220 (43%), Gaps = 41/220 (18%)
Query: 268 LLGTGGFGRVYRGTLPKSQIEIAVKKISHE-----------SRQGMKEFVAEIVSIGRLR 316
           LLG+GGFG VY G      + +A+K +  +           +R  M+  + + VS G   
Sbjct: 31  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG--- 87
Query: 317 HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYL 376
              +++LL +  R    +L+ +  P    D + +   +  L         + +A   F+ 
Sbjct: 88  FSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQ--------EELARSFFW- 137
Query: 377 HQEWEQV-------VIHRDVKASNVLLD---GELNGRLGDFGLARLYDHGTDPQTTHVVG 426
            Q  E V       V+HRD+K  N+L+D   GEL  +L DFG   L     D   T   G
Sbjct: 138 -QVLEAVRHCHNCGVLHRDIKDENILIDLNRGEL--KLIDFGSGALL---KDTVYTDFDG 191
Query: 427 TLGYLAPEHTRTGK-ATTSADVFSFGAFLLEVACGRRPIQ 465
           T  Y  PE  R  +    SA V+S G  L ++ CG  P +
Sbjct: 192 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 231

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 95/220 (43%), Gaps = 41/220 (18%)
Query: 268 LLGTGGFGRVYRGTLPKSQIEIAVKKISHE-----------SRQGMKEFVAEIVSIGRLR 316
           LLG+GGFG VY G      + +A+K +  +           +R  M+  + + VS G   
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG--- 100
Query: 317 HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYL 376
              +++LL +  R    +L+ +  P    D + +   +  L         + +A   F+ 
Sbjct: 101 FSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQ--------EELARSFFW- 150
Query: 377 HQEWEQV-------VIHRDVKASNVLLD---GELNGRLGDFGLARLYDHGTDPQTTHVVG 426
            Q  E V       V+HRD+K  N+L+D   GEL  +L DFG   L     D   T   G
Sbjct: 151 -QVLEAVRHCHNCGVLHRDIKDENILIDLNRGEL--KLIDFGSGALL---KDTVYTDFDG 204
Query: 427 TLGYLAPEHTRTGKAT-TSADVFSFGAFLLEVACGRRPIQ 465
           T  Y  PE  R  +    SA V+S G  L ++ CG  P +
Sbjct: 205 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 244

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 95/220 (43%), Gaps = 41/220 (18%)
Query: 268 LLGTGGFGRVYRGTLPKSQIEIAVKKISHE-----------SRQGMKEFVAEIVSIGRLR 316
           LLG+GGFG VY G      + +A+K +  +           +R  M+  + + VS G   
Sbjct: 43  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG--- 99
Query: 317 HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYL 376
              +++LL +  R    +L+ +  P    D + +   +  L         + +A   F+ 
Sbjct: 100 FSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQ--------EELARSFFW- 149
Query: 377 HQEWEQV-------VIHRDVKASNVLLD---GELNGRLGDFGLARLYDHGTDPQTTHVVG 426
            Q  E V       V+HRD+K  N+L+D   GEL  +L DFG   L     D   T   G
Sbjct: 150 -QVLEAVRHCHNCGVLHRDIKDENILIDLNRGEL--KLIDFGSGALL---KDTVYTDFDG 203
Query: 427 TLGYLAPEHTRTGKAT-TSADVFSFGAFLLEVACGRRPIQ 465
           T  Y  PE  R  +    SA V+S G  L ++ CG  P +
Sbjct: 204 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 243

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 91/209 (43%), Gaps = 22/209 (10%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRN---LVQLLG 325
           LGTG FGRV      +S    A+K +  +    +K+    +     L+  N   LV+L  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 326 YCRRKGELLLVYDYMPNGSLDKYL-----YDQPKVTLNWIQRFRVIKGVALGLFYLHQEW 380
             +    L +V +Y+  G +  +L     + +P        RF   + + L   YLH   
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA------RFYAAQ-IVLTFEYLHS-- 159
Query: 381 EQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGK 440
              +I+RD+K  N+L+D +   ++ DFG A+        +T  + GT  YLAPE   +  
Sbjct: 160 -LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKG 214
Query: 441 ATTSADVFSFGAFLLEVACGRRPIQRQGP 469
              + D ++ G  + E+A G  P     P
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADEP 243

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 95/220 (43%), Gaps = 41/220 (18%)
Query: 268 LLGTGGFGRVYRGTLPKSQIEIAVKKISHE-----------SRQGMKEFVAEIVSIGRLR 316
           LLG+GGFG VY G      + +A+K +  +           +R  M+  + + VS G   
Sbjct: 16  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG--- 72
Query: 317 HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYL 376
              +++LL +  R    +L+ +  P    D + +   +  L         + +A   F+ 
Sbjct: 73  FSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQ--------EELARSFFW- 122
Query: 377 HQEWEQV-------VIHRDVKASNVLLD---GELNGRLGDFGLARLYDHGTDPQTTHVVG 426
            Q  E V       V+HRD+K  N+L+D   GEL  +L DFG   L     D   T   G
Sbjct: 123 -QVLEAVRHCHNCGVLHRDIKDENILIDLNRGEL--KLIDFGSGALL---KDTVYTDFDG 176
Query: 427 TLGYLAPEHTRTGKAT-TSADVFSFGAFLLEVACGRRPIQ 465
           T  Y  PE  R  +    SA V+S G  L ++ CG  P +
Sbjct: 177 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 216

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 98/208 (47%), Gaps = 14/208 (6%)
Query: 257 YIATKGFREKELLGTGGFGRV---YRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVS 311
           +   K ++  + +G+G  G V   Y   L ++   +A+KK+S   +++   K    E+V 
Sbjct: 20  FTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVL 76
Query: 312 IGRLRHRNLVQLLGYCRRKGELLLVYD-YMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVA 370
           +  + H+N++ LL     +  L    D Y+    +D  L    ++ L+  +   ++  + 
Sbjct: 77  MKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQML 136
Query: 371 LGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGY 430
            G+ +LH      +IHRD+K SN+++  +   ++ DFGLAR    GT    T  V T  Y
Sbjct: 137 XGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLAR--TAGTSFMMTPYVVTRYY 191
Query: 431 LAPEHTRTGKATTSADVFSFGAFLLEVA 458
            APE         + D++S G  + E+ 
Sbjct: 192 RAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 96/206 (46%), Gaps = 16/206 (7%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGRLRHRNL 320
           +R+ + +G+G +G V      ++  ++A+KK+    +S    K    E+  +  +RH N+
Sbjct: 27  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 86
Query: 321 VQLLGYCRRKGELLLVYDY---MPNGSLD-KYLYDQPKVTLNWIQRFRVIKGVALGLFYL 376
           + LL        L    D+   MP    D   L    K+  + IQ F V + +  GL Y+
Sbjct: 87  IGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQ-FLVYQMLK-GLRYI 144
Query: 377 HQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHT 436
           H      +IHRD+K  N+ ++ +   ++ DFGLAR      D +    V T  Y APE  
Sbjct: 145 HAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR----QADSEMXGXVVTRWYRAPEVI 197
Query: 437 RTG-KATTSADVFSFGAFLLEVACGR 461
               + T + D++S G  + E+  G+
Sbjct: 198 LNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 95/220 (43%), Gaps = 41/220 (18%)
Query: 268 LLGTGGFGRVYRGTLPKSQIEIAVKKISHE-----------SRQGMKEFVAEIVSIGRLR 316
           LLG+GGFG VY G      + +A+K +  +           +R  M+  + + VS G   
Sbjct: 44  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG--- 100
Query: 317 HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYL 376
              +++LL +  R    +L+ +  P    D + +   +  L         + +A   F+ 
Sbjct: 101 FSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQ--------EELARSFFW- 150
Query: 377 HQEWEQV-------VIHRDVKASNVLLD---GELNGRLGDFGLARLYDHGTDPQTTHVVG 426
            Q  E V       V+HRD+K  N+L+D   GEL  +L DFG   L     D   T   G
Sbjct: 151 -QVLEAVRHCHNCGVLHRDIKDENILIDLNRGEL--KLIDFGSGALL---KDTVYTDFDG 204
Query: 427 TLGYLAPEHTRTGK-ATTSADVFSFGAFLLEVACGRRPIQ 465
           T  Y  PE  R  +    SA V+S G  L ++ CG  P +
Sbjct: 205 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 244

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 95/220 (43%), Gaps = 41/220 (18%)
Query: 268 LLGTGGFGRVYRGTLPKSQIEIAVKKISHE-----------SRQGMKEFVAEIVSIGRLR 316
           LLG+GGFG VY G      + +A+K +  +           +R  M+  + + VS G   
Sbjct: 58  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG--- 114
Query: 317 HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYL 376
              +++LL +  R    +L+ +  P    D + +   +  L         + +A   F+ 
Sbjct: 115 FSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQ--------EELARSFFW- 164
Query: 377 HQEWEQV-------VIHRDVKASNVLLD---GELNGRLGDFGLARLYDHGTDPQTTHVVG 426
            Q  E V       V+HRD+K  N+L+D   GEL  +L DFG   L     D   T   G
Sbjct: 165 -QVLEAVRHCHNCGVLHRDIKDENILIDLNRGEL--KLIDFGSGALL---KDTVYTDFDG 218
Query: 427 TLGYLAPEHTRTGK-ATTSADVFSFGAFLLEVACGRRPIQ 465
           T  Y  PE  R  +    SA V+S G  L ++ CG  P +
Sbjct: 219 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 258

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 102/231 (44%), Gaps = 38/231 (16%)
Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHES-----RQGMKEFVAEIVSIGRLRHRNLV 321
           ++LG G    V+RG   K+    A+K  ++ S        M+EF      + +L H+N+V
Sbjct: 15  DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEV----LKKLNHKNIV 70
Query: 322 QLLGY-----CRRKGELLLVYDYMPNGSLDKYLYDQPKVT--LNWIQRFRVIKGVALGLF 374
           +L         R K   +L+ ++ P GSL   L ++P     L   +   V++ V  G+ 
Sbjct: 71  KLFAIEEETTTRHK---VLIMEFCPCGSLYTVL-EEPSNAYGLPESEFLIVLRDVVGGMN 126
Query: 375 YLHQEWEQVVIHRDVKASNVLL----DGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGY 430
           +L    E  ++HR++K  N++     DG+   +L DFG AR  +   D Q   + GT  Y
Sbjct: 127 HLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE--DDEQFVSLYGTEEY 181
Query: 431 LAPE--------HTRTGKATTSADVFSFGAFLLEVACGRRPIQR-QGPSEN 472
           L P+             K   + D++S G      A G  P +  +GP  N
Sbjct: 182 LHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN 232

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 95/220 (43%), Gaps = 41/220 (18%)
Query: 268 LLGTGGFGRVYRGTLPKSQIEIAVKKISHE-----------SRQGMKEFVAEIVSIGRLR 316
           LLG+GGFG VY G      + +A+K +  +           +R  M+  + + VS G   
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG--- 67
Query: 317 HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYL 376
              +++LL +  R    +L+ +  P    D + +   +  L         + +A   F+ 
Sbjct: 68  FSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQ--------EELARSFFW- 117
Query: 377 HQEWEQV-------VIHRDVKASNVLLD---GELNGRLGDFGLARLYDHGTDPQTTHVVG 426
            Q  E V       V+HRD+K  N+L+D   GEL  +L DFG   L     D   T   G
Sbjct: 118 -QVLEAVRHCHNCGVLHRDIKDENILIDLNRGEL--KLIDFGSGALL---KDTVYTDFDG 171
Query: 427 TLGYLAPEHTRTGKAT-TSADVFSFGAFLLEVACGRRPIQ 465
           T  Y  PE  R  +    SA V+S G  L ++ CG  P +
Sbjct: 172 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 211

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 95/220 (43%), Gaps = 41/220 (18%)
Query: 268 LLGTGGFGRVYRGTLPKSQIEIAVKKISHE-----------SRQGMKEFVAEIVSIGRLR 316
           LLG+GGFG VY G      + +A+K +  +           +R  M+  + + VS G   
Sbjct: 30  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG--- 86
Query: 317 HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYL 376
              +++LL +  R    +L+ +  P    D + +   +  L         + +A   F+ 
Sbjct: 87  FSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQ--------EELARSFFW- 136
Query: 377 HQEWEQV-------VIHRDVKASNVLLD---GELNGRLGDFGLARLYDHGTDPQTTHVVG 426
            Q  E V       V+HRD+K  N+L+D   GEL  +L DFG   L     D   T   G
Sbjct: 137 -QVLEAVRHCHNCGVLHRDIKDENILIDLNRGEL--KLIDFGSGALL---KDTVYTDFDG 190
Query: 427 TLGYLAPEHTRTGKAT-TSADVFSFGAFLLEVACGRRPIQ 465
           T  Y  PE  R  +    SA V+S G  L ++ CG  P +
Sbjct: 191 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 230

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 95/220 (43%), Gaps = 41/220 (18%)
Query: 268 LLGTGGFGRVYRGTLPKSQIEIAVKKISHE-----------SRQGMKEFVAEIVSIGRLR 316
           LLG+GGFG VY G      + +A+K +  +           +R  M+  + + VS G   
Sbjct: 14  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG--- 70
Query: 317 HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYL 376
              +++LL +  R    +L+ +  P    D + +   +  L         + +A   F+ 
Sbjct: 71  FSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQ--------EELARSFFW- 120
Query: 377 HQEWEQV-------VIHRDVKASNVLLD---GELNGRLGDFGLARLYDHGTDPQTTHVVG 426
            Q  E V       V+HRD+K  N+L+D   GEL  +L DFG   L     D   T   G
Sbjct: 121 -QVLEAVRHCHNCGVLHRDIKDENILIDLNRGEL--KLIDFGSGALL---KDTVYTDFDG 174
Query: 427 TLGYLAPEHTRTGKAT-TSADVFSFGAFLLEVACGRRPIQ 465
           T  Y  PE  R  +    SA V+S G  L ++ CG  P +
Sbjct: 175 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 214

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 95/220 (43%), Gaps = 41/220 (18%)
Query: 268 LLGTGGFGRVYRGTLPKSQIEIAVKKISHE-----------SRQGMKEFVAEIVSIGRLR 316
           LLG+GGFG VY G      + +A+K +  +           +R  M+  + + VS G   
Sbjct: 31  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG--- 87
Query: 317 HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYL 376
              +++LL +  R    +L+ +  P    D + +   +  L         + +A   F+ 
Sbjct: 88  FSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQ--------EELARSFFW- 137
Query: 377 HQEWEQV-------VIHRDVKASNVLLD---GELNGRLGDFGLARLYDHGTDPQTTHVVG 426
            Q  E V       V+HRD+K  N+L+D   GEL  +L DFG   L     D   T   G
Sbjct: 138 -QVLEAVRHCHNCGVLHRDIKDENILIDLNRGEL--KLIDFGSGALL---KDTVYTDFDG 191
Query: 427 TLGYLAPEHTRTGK-ATTSADVFSFGAFLLEVACGRRPIQ 465
           T  Y  PE  R  +    SA V+S G  L ++ CG  P +
Sbjct: 192 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 231

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 95/220 (43%), Gaps = 41/220 (18%)
Query: 268 LLGTGGFGRVYRGTLPKSQIEIAVKKISHE-----------SRQGMKEFVAEIVSIGRLR 316
           LLG+GGFG VY G      + +A+K +  +           +R  M+  + + VS G   
Sbjct: 58  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG--- 114
Query: 317 HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYL 376
              +++LL +  R    +L+ +  P    D + +   +  L         + +A   F+ 
Sbjct: 115 FSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQ--------EELARSFFW- 164
Query: 377 HQEWEQV-------VIHRDVKASNVLLD---GELNGRLGDFGLARLYDHGTDPQTTHVVG 426
            Q  E V       V+HRD+K  N+L+D   GEL  +L DFG   L     D   T   G
Sbjct: 165 -QVLEAVRHCHNCGVLHRDIKDENILIDLNRGEL--KLIDFGSGALL---KDTVYTDFDG 218
Query: 427 TLGYLAPEHTRTGKAT-TSADVFSFGAFLLEVACGRRPIQ 465
           T  Y  PE  R  +    SA V+S G  L ++ CG  P +
Sbjct: 219 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 258

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 96/207 (46%), Gaps = 8/207 (3%)
Query: 257 YIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGR 314
           +   K ++  + +G+G  G V        +  +A+KK+S   +++   K    E+V +  
Sbjct: 20  FTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKV 79
Query: 315 LRHRNLVQLLGYCRRKGELLLVYD-YMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGL 373
           + H+N++ LL     +  L    D Y+    +D  L    ++ L+  +   ++  +  G+
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGI 139
Query: 374 FYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAP 433
            +LH      +IHRD+K SN+++  +   ++ DFGLAR    GT    T  V T  Y AP
Sbjct: 140 KHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMTPYVVTRYYRAP 194
Query: 434 EHTRTGKATTSADVFSFGAFLLEVACG 460
           E         + D++S G  + E+  G
Sbjct: 195 EVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/215 (25%), Positives = 92/215 (42%), Gaps = 22/215 (10%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRN--- 319
           F   + LGTG FGRV      ++    A+K +  +    +K+    +     L+  N   
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYL-----YDQPKVTLNWIQRFRVIKGVALGLF 374
           L +L    +    L +V +Y P G +  +L     + +P        RF   + + L   
Sbjct: 104 LTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHA------RFYAAQ-IVLTFE 156
Query: 375 YLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE 434
           YLH      +I+RD+K  N+++D +   ++ DFG A+        +T  + GT  YLAPE
Sbjct: 157 YLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGFAK----RVKGRTWXLCGTPEYLAPE 209
Query: 435 HTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGP 469
              +     + D ++ G  + E+A G  P     P
Sbjct: 210 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 244

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 95/220 (43%), Gaps = 41/220 (18%)
Query: 268 LLGTGGFGRVYRGTLPKSQIEIAVKKISHE-----------SRQGMKEFVAEIVSIGRLR 316
           LLG+GGFG VY G      + +A+K +  +           +R  M+  + + VS G   
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG--- 67
Query: 317 HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYL 376
              +++LL +  R    +L+ +  P    D + +   +  L         + +A   F+ 
Sbjct: 68  FSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQ--------EELARSFFW- 117
Query: 377 HQEWEQV-------VIHRDVKASNVLLD---GELNGRLGDFGLARLYDHGTDPQTTHVVG 426
            Q  E V       V+HRD+K  N+L+D   GEL  +L DFG   L     D   T   G
Sbjct: 118 -QVLEAVRHCHNXGVLHRDIKDENILIDLNRGEL--KLIDFGSGALL---KDTVYTDFDG 171
Query: 427 TLGYLAPEHTRTGKAT-TSADVFSFGAFLLEVACGRRPIQ 465
           T  Y  PE  R  +    SA V+S G  L ++ CG  P +
Sbjct: 172 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 211

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 95/220 (43%), Gaps = 41/220 (18%)
Query: 268 LLGTGGFGRVYRGTLPKSQIEIAVKKISHE-----------SRQGMKEFVAEIVSIGRLR 316
           LLG+GGFG VY G      + +A+K +  +           +R  M+  + + VS G   
Sbjct: 63  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG--- 119
Query: 317 HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYL 376
              +++LL +  R    +L+ +  P    D + +   +  L         + +A   F+ 
Sbjct: 120 FSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQ--------EELARSFFW- 169
Query: 377 HQEWEQV-------VIHRDVKASNVLLD---GELNGRLGDFGLARLYDHGTDPQTTHVVG 426
            Q  E V       V+HRD+K  N+L+D   GEL  +L DFG   L     D   T   G
Sbjct: 170 -QVLEAVRHCHNCGVLHRDIKDENILIDLNRGEL--KLIDFGSGALL---KDTVYTDFDG 223
Query: 427 TLGYLAPEHTRTGK-ATTSADVFSFGAFLLEVACGRRPIQ 465
           T  Y  PE  R  +    SA V+S G  L ++ CG  P +
Sbjct: 224 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 263

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 93/215 (43%), Gaps = 22/215 (10%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRN--- 319
           F   + LGTG FGRV      +S    A+K +  +    +K+    +     L+  N   
Sbjct: 64  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 123
Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYL-----YDQPKVTLNWIQRFRVIKGVALGLF 374
           LV+L    +    L +V +Y+  G +  +L     + +P        RF   + + L   
Sbjct: 124 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHA------RFYAAQ-IVLTFE 176
Query: 375 YLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE 434
           YLH      +I+RD+K  N+L+D +   ++ DFG A+        +T  + GT  YLAPE
Sbjct: 177 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPE 229
Query: 435 HTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGP 469
              +     + D ++ G  + E+A G  P     P
Sbjct: 230 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 264

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 93/219 (42%), Gaps = 41/219 (18%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQL----- 323
           LG GG G V+          +A+KKI     Q +K  + EI  I RL H N+V++     
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG 78
Query: 324 ---------LGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVT----LNWIQRFRVIKGVA 370
                    +G       + +V +YM    L   L   P +     L   Q  R      
Sbjct: 79  PSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLEQGPLLEEHARLFMYQLLR------ 131
Query: 371 LGLFYLHQEWEQVVIHRDVKASNVLLDGE-LNGRLGDFGLARLYDHGTDPQTTHV----- 424
            GL Y+H      V+HRD+K +N+ ++ E L  ++GDFGLAR+     DP  +H      
Sbjct: 132 -GLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARI----MDPHYSHKGHLSE 183
Query: 425 -VGTLGYLAPEHTRTGKATTSA-DVFSFGAFLLEVACGR 461
            + T  Y +P    +    T A D+++ G    E+  G+
Sbjct: 184 GLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 91/209 (43%), Gaps = 22/209 (10%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRN---LVQLLG 325
           LGTG FGRV      +S    A+K +  +    +K+    +     L+  N   LV+L  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 326 YCRRKGELLLVYDYMPNGSLDKYL-----YDQPKVTLNWIQRFRVIKGVALGLFYLHQEW 380
             +    L +V +Y+  G +  +L     + +P        RF   + + L   YLH   
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHA------RFYAAQ-IVLTFEYLHS-- 159
Query: 381 EQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGK 440
              +I+RD+K  N+L+D +   ++ DFG A+        +T  + GT  YLAPE   +  
Sbjct: 160 -LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKG 214
Query: 441 ATTSADVFSFGAFLLEVACGRRPIQRQGP 469
              + D ++ G  + E+A G  P     P
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 95/220 (43%), Gaps = 41/220 (18%)
Query: 268 LLGTGGFGRVYRGTLPKSQIEIAVKKISHE-----------SRQGMKEFVAEIVSIGRLR 316
           LLG+GGFG VY G      + +A+K +  +           +R  M+  + + VS G   
Sbjct: 31  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG--- 87
Query: 317 HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYL 376
              +++LL +  R    +L+ +  P    D + +   +  L         + +A   F+ 
Sbjct: 88  FSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQ--------EELARSFFW- 137
Query: 377 HQEWEQV-------VIHRDVKASNVLLD---GELNGRLGDFGLARLYDHGTDPQTTHVVG 426
            Q  E V       V+HRD+K  N+L+D   GEL  +L DFG   L     D   T   G
Sbjct: 138 -QVLEAVRHCHNCGVLHRDIKDENILIDLNRGEL--KLIDFGSGALL---KDTVYTDFDG 191
Query: 427 TLGYLAPEHTRTGK-ATTSADVFSFGAFLLEVACGRRPIQ 465
           T  Y  PE  R  +    SA V+S G  L ++ CG  P +
Sbjct: 192 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 231

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 66/308 (21%), Positives = 132/308 (42%), Gaps = 48/308 (15%)
Query: 244 LDHGPHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES--RQG 301
           +D G     ++ + +  + +   + +G+GG  +V++    K QI  A+K ++ E    Q 
Sbjct: 11  VDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQI-YAIKYVNLEEADNQT 69
Query: 302 MKEFVAEIVSIGRLRHRN--LVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNW 359
           +  +  EI  + +L+  +  +++L  Y      + +V   M  G++D   + + K +++ 
Sbjct: 70  LDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV---MECGNIDLNSWLKKKKSIDP 126
Query: 360 IQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLL-DGELNGRLGDFGLARLYDHGTD 418
            +R    K +   +  +HQ     ++H D+K +N L+ DG L  +L DFG+A    +   
Sbjct: 127 WERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVDGML--KLIDFGIA----NQMQ 177
Query: 419 PQTTHVV-----GTLGYLAPEHTRTGKAT-----------TSADVFSFGAFLLEVACGRR 462
           P    VV     GT+ Y+ PE  +   ++             +DV+S G  L  +  G+ 
Sbjct: 178 PDXXXVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT 237
Query: 463 PIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAXXXXXXXXXXXXCSHSDPTA 522
           P Q+        +++ +       +L    DPN   E+              C   DP  
Sbjct: 238 PFQQ--------IINQI------SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQ 283
Query: 523 RPSMRQVV 530
           R S+ +++
Sbjct: 284 RISIPELL 291

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 96/207 (46%), Gaps = 8/207 (3%)
Query: 257 YIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGR 314
           +   K ++  + +G+G  G V        +  +A+KK+S   +++   K    E+V +  
Sbjct: 20  FTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKC 79
Query: 315 LRHRNLVQLLGYCRRKGELLLVYD-YMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGL 373
           + H+N++ LL     +  L    D Y+    +D  L    ++ L+  +   ++  +  G+
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGI 139
Query: 374 FYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAP 433
            +LH      +IHRD+K SN+++  +   ++ DFGLAR    GT    T  V T  Y AP
Sbjct: 140 KHLHSAG---IIHRDLKPSNIVVKSDATLKILDFGLAR--TAGTSFMMTPYVVTRYYRAP 194
Query: 434 EHTRTGKATTSADVFSFGAFLLEVACG 460
           E         + D++S G  + E+  G
Sbjct: 195 EVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1GNZ|A Chain A, Lectin I-B4 From Griffonia Simplicifolia (Gs I-B4)metal Free Form Length = 257

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 74/154 (48%), Gaps = 17/154 (11%)
Query: 57  QYLGLFNDTNLGNET-NHVFAVELDTIKSHGFLDINDNHVGIDINSLKSE---------- 105
           +YLGLFN +     + N V AVE DT  +  F + +  H+GI++NS+ S           
Sbjct: 106 EYLGLFNKSTATQPSKNQVVAVEFDTWTNPNFPEPSYRHIGINVNSIVSVATKRWEDSDI 165
Query: 106 -SSAPAGYYVEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSVLNDAMYVGFSSSTG 164
            S   A   + YDG  +   V L+  +     S   +S S D+   L +++ VG S+STG
Sbjct: 166 FSGKIATARISYDGSAEILTVVLSYPD----GSDYILSHSVDMRQNLPESVRVGISASTG 221
Query: 165 -SVLASHYILGWSFKINGQAEELNLSQLPKLPRV 197
            +   + YIL W F  N Q+  +  +  P++ R 
Sbjct: 222 NNQFLTVYILSWRFSSNLQSTSVKAAMEPEITRT 255

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 90/210 (42%), Gaps = 36/210 (17%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
           +G+G +G V      + + ++AVKK+S   +S    +    E+  +  L+H N++ LL  
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDV 95
Query: 327 CRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVAL--------------G 372
                       + P  S++ +       TL       ++K  AL              G
Sbjct: 96  ------------FTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQLLRG 143
Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLA 432
           L Y+H      +IHRD+K SNV ++ +   R+ DFGLAR      D + T  V T  Y A
Sbjct: 144 LKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLAR----QADEEMTGYVATRWYRA 196
Query: 433 PE-HTRTGKATTSADVFSFGAFLLEVACGR 461
           PE          + D++S G  + E+  G+
Sbjct: 197 PEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 91/209 (43%), Gaps = 22/209 (10%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRN---LVQLLG 325
           LGTG FGRV      +S    A+K +  +    +K+    +     L+  N   LV+L  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 326 YCRRKGELLLVYDYMPNGSLDKYL-----YDQPKVTLNWIQRFRVIKGVALGLFYLHQEW 380
             +    L +V +Y+  G +  +L     + +P        RF   + + L   YLH   
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA------RFYAAQ-IVLTFEYLHS-- 159
Query: 381 EQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGK 440
              +I+RD+K  N+L+D +   ++ DFG A+        +T  + GT  YLAPE   +  
Sbjct: 160 -LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLXGTPEYLAPEIILSKG 214
Query: 441 ATTSADVFSFGAFLLEVACGRRPIQRQGP 469
              + D ++ G  + E+A G  P     P
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1HQL|A Chain A, The Xenograft Antigen In Complex With The B4 Isolectin Of Griffonia Simplicifolia Lectin-1 Length = 257

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 74/154 (48%), Gaps = 17/154 (11%)
Query: 57  QYLGLFNDTNLGNET-NHVFAVELDTIKSHGFLDINDNHVGIDINSLKSE---------- 105
           +YLGLFN +     + N V AVE DT  +  F + +  H+GI++NS+ S           
Sbjct: 106 EYLGLFNKSTATQPSKNQVVAVEFDTWTNPNFPEPSYRHIGINVNSIVSVATKRWEDSDI 165
Query: 106 -SSAPAGYYVEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSVLNDAMYVGFSSSTG 164
            S   A   + YDG  +   V L+  +     S   +S S D+   L +++ VG S+STG
Sbjct: 166 FSGKIATARISYDGSAEILTVVLSYPD----GSDYILSHSVDMRQNLPESVRVGISASTG 221
Query: 165 -SVLASHYILGWSFKINGQAEELNLSQLPKLPRV 197
            +   + YIL W F  N Q+  +  +  P++ R 
Sbjct: 222 NNQFLTVYILSWRFSSNLQSTSVKAAMEPEITRT 255

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 95/220 (43%), Gaps = 41/220 (18%)
Query: 268 LLGTGGFGRVYRGTLPKSQIEIAVKKISHE-----------SRQGMKEFVAEIVSIGRLR 316
           LLG+GGFG VY G      + +A+K +  +           +R  M+  + + VS G   
Sbjct: 50  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSG--- 106
Query: 317 HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYL 376
              +++LL +  R    +L+ +  P    D + +   +  L         + +A   F+ 
Sbjct: 107 FSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFITERGALQ--------EELARSFFW- 156
Query: 377 HQEWEQV-------VIHRDVKASNVLLD---GELNGRLGDFGLARLYDHGTDPQTTHVVG 426
            Q  E V       V+HRD+K  N+L+D   GEL  +L DFG   L     D   T   G
Sbjct: 157 -QVLEAVRHCHNCGVLHRDIKDENILIDLNRGEL--KLIDFGSGALL---KDTVYTDFDG 210
Query: 427 TLGYLAPEHTRTGK-ATTSADVFSFGAFLLEVACGRRPIQ 465
           T  Y  PE  R  +    SA V+S G  L ++ CG  P +
Sbjct: 211 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE 250

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 91/209 (43%), Gaps = 22/209 (10%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRN---LVQLLG 325
           LGTG FGRV      +S    A+K +  +    +K+    +     L+  N   LV+L  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 326 YCRRKGELLLVYDYMPNGSLDKYL-----YDQPKVTLNWIQRFRVIKGVALGLFYLHQEW 380
             +    L +V +Y+  G +  +L     + +P        RF   + + L   YLH   
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHA------RFYAAQ-IVLTFEYLHS-- 159
Query: 381 EQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGK 440
              +I+RD+K  N+L+D +   ++ DFG A+        +T  + GT  YLAPE   +  
Sbjct: 160 -LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKG 214
Query: 441 ATTSADVFSFGAFLLEVACGRRPIQRQGP 469
              + D ++ G  + E+A G  P     P
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 91/209 (43%), Gaps = 22/209 (10%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRN---LVQLLG 325
           LGTG FGRV      +S    A+K +  +    +K+    +     L+  N   LV+L  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 326 YCRRKGELLLVYDYMPNGSLDKYL-----YDQPKVTLNWIQRFRVIKGVALGLFYLHQEW 380
             +    L +V +Y+  G +  +L     + +P        RF   + + L   YLH   
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHA------RFYAAQ-IVLTFEYLHS-- 159
Query: 381 EQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGK 440
              +I+RD+K  N+L+D +   ++ DFG A+        +T  + GT  YLAPE   +  
Sbjct: 160 -LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKG 214
Query: 441 ATTSADVFSFGAFLLEVACGRRPIQRQGP 469
              + D ++ G  + E+A G  P     P
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 91/209 (43%), Gaps = 22/209 (10%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRN---LVQLLG 325
           LGTG FGRV      +S    A+K +  +    +K+    +     L+  N   LV+L  
Sbjct: 44  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 103
Query: 326 YCRRKGELLLVYDYMPNGSLDKYL-----YDQPKVTLNWIQRFRVIKGVALGLFYLHQEW 380
             +    L +V +Y+  G +  +L     + +P        RF   + + L   YLH   
Sbjct: 104 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHA------RFYAAQ-IVLTFEYLHS-- 154
Query: 381 EQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGK 440
              +I+RD+K  N+L+D +   ++ DFG A+        +T  + GT  YLAPE   +  
Sbjct: 155 -LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKG 209
Query: 441 ATTSADVFSFGAFLLEVACGRRPIQRQGP 469
              + D ++ G  + E+A G  P     P
Sbjct: 210 YNKAVDWWALGVLIYEMAAGYPPFFADQP 238

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 67/244 (27%), Positives = 103/244 (42%), Gaps = 44/244 (18%)
Query: 244 LDHGPHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE------ 297
           L  GPH    K+       ++   LLG+GGFG VY G      + +A+K +  +      
Sbjct: 17  LFQGPH---MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWG 73
Query: 298 -----SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQ 352
                +R  M+  + + VS G      +++LL +  R    +L+ +  P    D + +  
Sbjct: 74  ELPNGTRVPMEVVLLKKVSSG---FSGVIRLLDWFERPDSFVLILE-RPEPVQDLFDFIT 129
Query: 353 PKVTLNWIQRFRVIKGVALGLFYLHQEWEQV-------VIHRDVKASNVLLD---GELNG 402
            +  L         + +A   F+  Q  E V       V+HRD+K  N+L+D   GEL  
Sbjct: 130 ERGALQ--------EELARSFFW--QVLEAVRHCHNCGVLHRDIKDENILIDLNRGEL-- 177
Query: 403 RLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKAT-TSADVFSFGAFLLEVACGR 461
           +L DFG   L     D   T   GT  Y  PE  R  +    SA V+S G  L ++ CG 
Sbjct: 178 KLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 234
Query: 462 RPIQ 465
            P +
Sbjct: 235 IPFE 238

>pdb|2GDF|A Chain A, Crystal Structure Of Dioclea Violacea Seed Lectin Length = 237

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/139 (33%), Positives = 71/139 (51%), Gaps = 23/139 (16%)
Query: 74  VFAVELDTIKSHGFLDINDNHVGIDINSLKSESSA--------PAGYYVEYDGLEKRTNV 125
           + AVELD+  +    D N  H+GIDI S++S+S+A            ++ Y+ + KR   
Sbjct: 4   IVAVELDSYPNTDIGDPNYPHIGIDIKSIRSKSTARWNMQTGKVGTVHISYNSVAKR--- 60
Query: 126 TLAPINIPRPRSLNTMSLSRDLSSVLNDAMYVGFSSSTGSVLASHYILGWSF----KING 181
            L+ +      S  T+S   DL++VL + + VG S++TG    ++ IL WSF    K N 
Sbjct: 61  -LSAVVSYSGSSSTTVSYDVDLNNVLPEWVRVGLSATTGLYKETNTILSWSFTSKLKTNS 119
Query: 182 QAEELNL-------SQLPK 193
            A+E +L       SQ PK
Sbjct: 120 AADENSLHFSFHKFSQNPK 138

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 91/209 (43%), Gaps = 22/209 (10%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRN---LVQLLG 325
           LGTG FGRV      +S    A+K +  +    +K+    +     L+  N   LV+L  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 326 YCRRKGELLLVYDYMPNGSLDKYL-----YDQPKVTLNWIQRFRVIKGVALGLFYLHQEW 380
             +    L +V +Y+  G +  +L     + +P        RF   + + L   YLH   
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHA------RFYAAQ-IVLTFEYLHS-- 159
Query: 381 EQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGK 440
              +I+RD+K  N+L+D +   ++ DFG A+        +T  + GT  YLAPE   +  
Sbjct: 160 -LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKG 214
Query: 441 ATTSADVFSFGAFLLEVACGRRPIQRQGP 469
              + D ++ G  + E+A G  P     P
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|3N35|A Chain A, Erythrina Corallodendron Lectin Mutant (Y106g) With N- Acetylgalactosamine Length = 242

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 73/151 (48%), Gaps = 17/151 (11%)
Query: 39  GIAFVIASTRGLPGARPSQYLGLFNDTNLGNETNHVFAVELDTIKSHGFLDINDNHVGID 98
           G+ F +  T+  P A+   YLG+FN++   N +     VE DT  S+ +      H+GID
Sbjct: 90  GLVFFMGPTKSKP-AQGGGYLGIFNNSKQDN-SYQTLGVEFDTF-SNQWDPPQVPHIGID 146
Query: 99  INSLKSESSAP--------AGYYVEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSV 150
           +NS++S  + P        A   ++YD   K  +  L     P   ++ T++   D+  V
Sbjct: 147 VNSIRSIKTQPFQLDNGQVANVVIKYDASSKILHAVLV---YPSSGAIYTIAEIVDVKQV 203
Query: 151 LNDAMYVGFSSSTGS---VLASHYILGWSFK 178
           L + + VG S +TG+      +H +  WSF+
Sbjct: 204 LPEWVDVGLSGATGAQRDAAETHDVYSWSFQ 234

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 90/209 (43%), Gaps = 16/209 (7%)
Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVK-----KISHESRQGMKEFVAEIVSIGRLRHRNLV 321
           E++G G F  V R    ++  + AVK     K +       ++   E      L+H ++V
Sbjct: 30  EVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89
Query: 322 QLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRF--RVIKGVALGLFYLHQE 379
           +LL      G L +V+++M    L   +  +      + +      ++ +   L Y H  
Sbjct: 90  ELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCH-- 147
Query: 380 WEQVVIHRDVKASNVLLDGELNG---RLGDFGLA-RLYDHGTDPQTTHVVGTLGYLAPEH 435
            +  +IHRDVK  NVLL  + N    +LGDFG+A +L + G        VGT  ++APE 
Sbjct: 148 -DNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGL--VAGGRVGTPHFMAPEV 204
Query: 436 TRTGKATTSADVFSFGAFLLEVACGRRPI 464
            +        DV+  G  L  +  G  P 
Sbjct: 205 VKREPYGKPVDVWGCGVILFILLSGCLPF 233

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 90/210 (42%), Gaps = 36/210 (17%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
           +G+G +G V      + + ++AVKK+S   +S    +    E+  +  L+H N++ LL  
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDV 95
Query: 327 CRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVAL--------------G 372
                       + P  S++ +       TL       ++K  AL              G
Sbjct: 96  ------------FTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLLRG 143
Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLA 432
           L Y+H      +IHRD+K SNV ++ +   R+ DFGLAR      D + T  V T  Y A
Sbjct: 144 LKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLAR----QADEEMTGYVATRWYRA 196
Query: 433 PE-HTRTGKATTSADVFSFGAFLLEVACGR 461
           PE          + D++S G  + E+  G+
Sbjct: 197 PEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 91/209 (43%), Gaps = 15/209 (7%)
Query: 267 ELLGTGGFGRVYR----GTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQ 322
           +LLG G +G+V       TL +  ++I  KK       G      EI  + RLRH+N++Q
Sbjct: 11  DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70
Query: 323 LLG--YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEW 380
           L+   Y   K ++ +V +Y   G + + L   P+      Q       +  GL YLH   
Sbjct: 71  LVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHS-- 127
Query: 381 EQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVGTLGYLAPEHTRTG 439
            Q ++H+D+K  N+LL      ++   G+A  L+    D       G+  +  PE    G
Sbjct: 128 -QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPE-IANG 185
Query: 440 KATTSA---DVFSFGAFLLEVACGRRPIQ 465
             T S    D++S G  L  +  G  P +
Sbjct: 186 LDTFSGFKVDIWSAGVTLYNITTGLYPFE 214

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 98/234 (41%), Gaps = 17/234 (7%)
Query: 244 LDHGPHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMK 303
           +D G     ++ + + + G+  KE +G G +    R     + +E AVK I    R   +
Sbjct: 11  VDLGTENLYFQSM-VFSDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSE 69
Query: 304 EFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGS-LDKYLYDQPKVTLNWIQR 362
           E +  ++  G  +H N++ L         + LV + M  G  LDK L  +     +  + 
Sbjct: 70  E-IEILLRYG--QHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQK---FFSEREA 123
Query: 363 FRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNG----RLGDFGLARLYDHGTD 418
             V+  +   + YLH    Q V+HRD+K SN+L   E       R+ DFG A+       
Sbjct: 124 SFVLHTIGKTVEYLHS---QGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENG 180
Query: 419 PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSEN 472
              T    T  ++APE  +        D++S G  L  +  G  P    GPS+ 
Sbjct: 181 LLMTPCY-TANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFA-NGPSDT 232

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 93/215 (43%), Gaps = 22/215 (10%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRN--- 319
           F   + LGTG FGRV      ++    A+K +  +    +K+    +     L+  N   
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYL-----YDQPKVTLNWIQRFRVIKGVALGLF 374
           LV+L    +    L +V +Y+  G +  +L     + +P        RF   + + L   
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA------RFYAAQ-IVLTFE 155
Query: 375 YLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE 434
           YLH      +I+RD+K  N+L+D +   ++ DFG A+        +T  + GT  YLAPE
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPE 208
Query: 435 HTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGP 469
              +     + D ++ G  + E+A G  P     P
Sbjct: 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 92/215 (42%), Gaps = 22/215 (10%)
Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRN--- 319
           F   + LGTG FGRV      +S    A+K +  +    +K+    +     L+  N   
Sbjct: 64  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 123
Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYL-----YDQPKVTLNWIQRFRVIKGVALGLF 374
           LV+L    +    L +V +Y+  G +  +L     + +P        RF   + + L   
Sbjct: 124 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA------RFYAAQ-IVLTFE 176
Query: 375 YLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE 434
           YLH      +I+RD+K  N+L+D +   ++ DFG A+         T  + GT  YLAPE
Sbjct: 177 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGATWTLCGTPEYLAPE 229
Query: 435 HTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGP 469
              +     + D ++ G  + E+A G  P     P
Sbjct: 230 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 264

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 103/224 (45%), Gaps = 45/224 (20%)
Query: 269 LGTGGFGRVYRGT-LPKSQIEIAVKKI-SHESRQGMKEFVAEI-VSIGRLRHRNLVQLLG 325
           LG G +G V +   +P  QI +AVK+I +  + Q  K  + ++ +S+  +     V   G
Sbjct: 59  LGRGAYGVVEKMRHVPSGQI-MAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 117
Query: 326 YCRRKGELLLVYDYMPNGSLDKYLYDQ--------PKVTLNWIQRFRVIKGVALGLFYLH 377
              R+G++ +  + M + SLDK+ Y Q        P+  L      ++   +   L +LH
Sbjct: 118 ALFREGDVWICMELM-DTSLDKF-YKQVIDKGQTIPEDILG-----KIAVSIVKALEHLH 170
Query: 378 QEWEQVVIHRDVKASNVLLDGELNGRLGDFGL--------ARLYDHGTDPQTTHVVGTLG 429
            +    VIHRDVK SNVL++     ++ DFG+        A+  D G  P          
Sbjct: 171 SKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDSVAKTIDAGCKP---------- 218
Query: 430 YLAPEH-----TRTGKATTSADVFSFGAFLLEVACGRRPIQRQG 468
           Y+APE       + G +  S D++S G  ++E+A  R P    G
Sbjct: 219 YMAPERINPELNQKGYSVKS-DIWSLGITMIELAILRFPYDSWG 261

>pdb|1SFY|A Chain A, Crystal Structure Of Recombinant Erythrina Corallodandron Lectin Length = 239

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 73/151 (48%), Gaps = 17/151 (11%)
Query: 39  GIAFVIASTRGLPGARPSQYLGLFNDTNLGNETNHVFAVELDTIKSHGFLDINDNHVGID 98
           G+ F +  T+  P A+   YLG+FN++   N +     VE DT  S+ +      H+GID
Sbjct: 90  GLVFFMGPTKSKP-AQGYGYLGIFNNSKQDN-SYQTLGVEFDTF-SNQWDPPQVPHIGID 146
Query: 99  INSLKSESSAP--------AGYYVEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSV 150
           +NS++S  + P        A   ++YD   K  +  L     P   ++ T++   D+  V
Sbjct: 147 VNSIRSIKTQPFQLDNGQVANVVIKYDASSKLLHAVLV---YPSSGAIYTIAEIVDVKQV 203
Query: 151 LNDAMYVGFSSSTGS---VLASHYILGWSFK 178
           L + + VG S +TG+      +H +  WSF+
Sbjct: 204 LPEWVDVGLSGATGAQRDAAETHDVYSWSFQ 234

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 91/209 (43%), Gaps = 22/209 (10%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRN---LVQLLG 325
           LGTG FGRV      +S    A+K +  +    +K+    +     L+  N   LV+L  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 326 YCRRKGELLLVYDYMPNGSLDKYL-----YDQPKVTLNWIQRFRVIKGVALGLFYLHQEW 380
             +    L +V +Y+  G +  +L     + +P        RF   + + L   YLH   
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA------RFYAAQ-IVLTFEYLHS-- 159
Query: 381 EQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGK 440
              +I+RD+K  N+++D +   ++ DFG A+        +T  + GT  YLAPE   +  
Sbjct: 160 -LDLIYRDLKPENLIIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIIISKG 214
Query: 441 ATTSADVFSFGAFLLEVACGRRPIQRQGP 469
              + D ++ G  + E+A G  P     P
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFADQP 243

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/207 (24%), Positives = 95/207 (45%), Gaps = 8/207 (3%)
Query: 257 YIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMKEFVAEIVSIGR 314
           +   K ++  + +G+G  G V        +  +A+KK+S   +++   K    E+V +  
Sbjct: 22  FTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKC 81
Query: 315 LRHRNLVQLLGYCRRKGELLLVYD-YMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGL 373
           + H+N++ LL     +  L    D Y+    +D  L    ++ L+  +   ++  +  G+
Sbjct: 82  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 141
Query: 374 FYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAP 433
            +LH      +IHRD+K SN+++  +   ++ DFGLAR    GT       V T  Y AP
Sbjct: 142 KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMVPFVVTRYYRAP 196
Query: 434 EHTRTGKATTSADVFSFGAFLLEVACG 460
           E         + D++S G  + E+  G
Sbjct: 197 EVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|1AX0|A Chain A, Erythrina Corallodendron Lectin In Complex With N-Actylgalactosamine Length = 239

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 73/151 (48%), Gaps = 17/151 (11%)
Query: 39  GIAFVIASTRGLPGARPSQYLGLFNDTNLGNETNHVFAVELDTIKSHGFLDINDNHVGID 98
           G+ F +  T+  P A+   YLG+FN++   N +     VE DT  S+ +      H+GID
Sbjct: 90  GLVFFMGPTKSKP-AQGYGYLGIFNNSKQDN-SYQTLGVEFDTF-SNPWDPPQVPHIGID 146
Query: 99  INSLKSESSAP--------AGYYVEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSV 150
           +NS++S  + P        A   ++YD   K  +  L     P   ++ T++   D+  V
Sbjct: 147 VNSIRSIKTQPFQLDNGQVANVVIKYDASSKILHAVLV---YPSSGAIYTIAEIVDVKQV 203
Query: 151 LNDAMYVGFSSSTGS---VLASHYILGWSFK 178
           L + + VG S +TG+      +H +  WSF+
Sbjct: 204 LPEWVDVGLSGATGAQRDAAETHDVYSWSFQ 234

>pdb|2JE9|A Chain A, Crystal Structure Of Recombinant Dioclea Grandiflora Lectin Complexed With 5-Bromo-4-Chloro-3-Indolyl-A-D-Mannose Length = 239

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/139 (33%), Positives = 71/139 (51%), Gaps = 23/139 (16%)
Query: 74  VFAVELDTIKSHGFLDINDNHVGIDINSLKSESSA--------PAGYYVEYDGLEKRTNV 125
           + AVELD+  +    D N  H+GIDI S++S+S+A            ++ Y+ + KR   
Sbjct: 6   IVAVELDSYPNTDIGDPNYPHIGIDIKSIRSKSTARWNMQTGKVGTVHISYNSVAKR--- 62
Query: 126 TLAPINIPRPRSLNTMSLSRDLSSVLNDAMYVGFSSSTGSVLASHYILGWSF----KING 181
            L+ +      S  T+S   DL++VL + + VG S++TG    ++ IL WSF    K N 
Sbjct: 63  -LSAVVSYSGSSSTTVSYDVDLNNVLPEWVRVGLSATTGLYKETNTILSWSFTSKLKTNS 121
Query: 182 QAEELNL-------SQLPK 193
            A+E +L       SQ PK
Sbjct: 122 IADENSLHFSFHKFSQNPK 140

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 91/209 (43%), Gaps = 22/209 (10%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRN---LVQLLG 325
           LGTG FGRV      +S    A+K +  +    +K+    +     L+  N   LV+L  
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 326 YCRRKGELLLVYDYMPNGSLDKYL-----YDQPKVTLNWIQRFRVIKGVALGLFYLHQEW 380
             +    L +V +Y+  G +  +L     + +P        RF   + + L   YLH   
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA------RFYAAQ-IVLTFEYLHS-- 159
Query: 381 EQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGK 440
              +I+RD+K  N+L+D +   ++ DFG A+        +T  + GT  YLAPE   +  
Sbjct: 160 -LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKG 214
Query: 441 ATTSADVFSFGAFLLEVACGRRPIQRQGP 469
              + D ++ G  + ++A G  P     P
Sbjct: 215 YNKAVDWWALGVLIYQMAAGYPPFFADQP 243

>pdb|3SH3|A Chain A, Crystal Structure Of A Pro-Inflammatory Lectin From The Seeds Of Dioclea Wilsonii Standl Length = 237

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/139 (33%), Positives = 71/139 (51%), Gaps = 23/139 (16%)
Query: 74  VFAVELDTIKSHGFLDINDNHVGIDINSLKSESSA--------PAGYYVEYDGLEKRTNV 125
           + AVELD+  +    D N  H+GIDI S++S+S+A            ++ Y+ + KR   
Sbjct: 4   IVAVELDSYPNTDIGDPNYPHIGIDIKSIRSKSTARWNMQTGKVGTVHISYNSVAKR--- 60
Query: 126 TLAPINIPRPRSLNTMSLSRDLSSVLNDAMYVGFSSSTGSVLASHYILGWSF----KING 181
            L+ +      S  T+S   DL++VL + + VG S++TG    ++ IL WSF    K N 
Sbjct: 61  -LSAVVSYSGSSSTTVSYDVDLNNVLPEWVRVGLSATTGLYKETNTILSWSFTSKLKTNS 119
Query: 182 QAEELNL-------SQLPK 193
            A+E +L       SQ PK
Sbjct: 120 IADENSLHFSFHKFSQNPK 138

>pdb|1LTE|A Chain A, Structure Of A Legume Lectin With An Ordered N-Linked Carbohydrate In Complex With Lactose Length = 239

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 72/151 (47%), Gaps = 17/151 (11%)
Query: 39  GIAFVIASTRGLPGARPSQYLGLFNDTNLGNETNHVFAVELDTIKSHGFLDINDNHVGID 98
           G+ F +  T+  P A+   YLG+FN +   N +     VE DT  S+ +      H+GID
Sbjct: 90  GLVFFMGPTKSKP-AQGYGYLGIFNQSKQDN-SYQTLGVEFDTF-SNPWDPPQVPHIGID 146
Query: 99  INSLKSESSAP--------AGYYVEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSV 150
           +NS++S  + P        A   ++YD   K  +  L     P   ++ T++   D+  V
Sbjct: 147 VNSIRSIKTQPFQLDNGQVANVVIKYDASSKLLHAVLV---YPSSGAIYTIAEIVDVKQV 203
Query: 151 LNDAMYVGFSSSTGS---VLASHYILGWSFK 178
           L + + VG S +TG+      +H +  WSF+
Sbjct: 204 LPEWVDVGLSGATGAQRDAAETHDVYSWSFQ 234

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 100/224 (44%), Gaps = 24/224 (10%)
Query: 248 PHRFRYKD-LYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFV 306
           P  + Y++ ++ AT   R    LG G FG V+R    ++  + AVKK+  E  +      
Sbjct: 83  PVDYEYREEVHWATHQLR----LGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFR-----A 133
Query: 307 AEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVI 366
            E+++   L    +V L G  R    + +  + +  GSL + + +Q  +  +   R    
Sbjct: 134 EELMACAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPED---RALYY 190
Query: 367 KGVAL-GLFYLHQEWEQVVIHRDVKASNVLL--DGELNGRLGDFGLA-RLYDHGTDPQT- 421
            G AL GL YLH    + ++H DVKA NVLL  DG  +  L DFG A  L   G      
Sbjct: 191 LGQALEGLEYLHS---RRILHGDVKADNVLLSSDGS-HAALCDFGHAVCLQPDGLGKSLL 246
Query: 422 --THVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRP 463
              ++ GT  ++APE           DV+S    +L +  G  P
Sbjct: 247 TGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHP 290

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/220 (26%), Positives = 94/220 (42%), Gaps = 16/220 (7%)
Query: 258 IATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRH 317
           + + G+  KE +G G +    R     + +E AVK I  +S++   E +  ++  G  +H
Sbjct: 24  VFSDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVID-KSKRDPSEEIEILLRYG--QH 80
Query: 318 RNLVQLLGYCRRKGELLLVYDYMPNGS-LDKYLYDQPKVTLNWIQRFRVIKGVALGLFYL 376
            N++ L         + LV + M  G  LDK L  +     +  +   V+  +   + YL
Sbjct: 81  PNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQK---FFSEREASFVLHTIGKTVEYL 137
Query: 377 HQEWEQVVIHRDVKASNVLLDGELNG----RLGDFGLARLYDHGTDPQTTHVVGTLGYLA 432
           H    Q V+HRD+K SN+L   E       R+ DFG A+          T    T  ++A
Sbjct: 138 H---SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCY-TANFVA 193
Query: 433 PEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSEN 472
           PE  +        D++S G  L  +  G  P    GPS+ 
Sbjct: 194 PEVLKRQGYDEGCDIWSLGILLYTMLAGYTPFA-NGPSDT 232

>pdb|1FYU|A Chain A, Crystal Structure Of Erythrina Corallodendron Lectin In Hexagonal Crystal Form Length = 255

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 73/151 (48%), Gaps = 17/151 (11%)
Query: 39  GIAFVIASTRGLPGARPSQYLGLFNDTNLGNETNHVFAVELDTIKSHGFLDINDNHVGID 98
           G+ F +  T+  P A+   YLG+FN++   N +     VE DT  S+ +      H+GID
Sbjct: 90  GLVFFMGPTKSKP-AQGYGYLGIFNNSKQDN-SYQTLGVEFDTF-SNPWDPPQVPHIGID 146
Query: 99  INSLKSESSAP--------AGYYVEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSV 150
           +NS++S  + P        A   ++YD   K  +  L     P   ++ T++   D+  V
Sbjct: 147 VNSIRSIKTQPFQLDNGQVANVVIKYDASSKILHAVLV---YPSSGAIYTIAEIVDVKQV 203
Query: 151 LNDAMYVGFSSSTGS---VLASHYILGWSFK 178
           L + + VG S +TG+      +H +  WSF+
Sbjct: 204 LPEWVDVGLSGATGAQRDAAETHDVYSWSFQ 234

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 84/201 (41%), Gaps = 15/201 (7%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCR 328
           +G G +G V       ++I  A KKI     + +  F  EI  +  L H N+++L     
Sbjct: 34  IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 93
Query: 329 RKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRD 388
              ++ LV +    G L + +    K         R++K V   + Y H+     V HRD
Sbjct: 94  DNTDIYLVMELCTGGELFERVVH--KRVFRESDAARIMKDVLSAVAYCHK---LNVAHRD 148
Query: 389 VKASNVLL-----DGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATT 443
           +K  N L      D  L  +L DFGLA  +  G   +T   VGT  Y++P+    G    
Sbjct: 149 LKPENFLFLTDSPDSPL--KLIDFGLAARFKPGKMMRTK--VGTPYYVSPQ-VLEGLYGP 203
Query: 444 SADVFSFGAFLLEVACGRRPI 464
             D +S G  +  + CG  P 
Sbjct: 204 ECDEWSAGVMMYVLLCGYPPF 224

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 84/201 (41%), Gaps = 15/201 (7%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCR 328
           +G G +G V       ++I  A KKI     + +  F  EI  +  L H N+++L     
Sbjct: 17  IGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE 76
Query: 329 RKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRD 388
              ++ LV +    G L + +    K         R++K V   + Y H+     V HRD
Sbjct: 77  DNTDIYLVMELCTGGELFERVVH--KRVFRESDAARIMKDVLSAVAYCHK---LNVAHRD 131
Query: 389 VKASNVLL-----DGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATT 443
           +K  N L      D  L  +L DFGLA  +  G   +T   VGT  Y++P+    G    
Sbjct: 132 LKPENFLFLTDSPDSPL--KLIDFGLAARFKPGKMMRTK--VGTPYYVSPQ-VLEGLYGP 186
Query: 444 SADVFSFGAFLLEVACGRRPI 464
             D +S G  +  + CG  P 
Sbjct: 187 ECDEWSAGVMMYVLLCGYPPF 207

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 77/174 (44%), Gaps = 14/174 (8%)
Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHE--------SRQGMKEFVAEIVSIGRLRHRNL 320
           LG+G FG V+     +   E+ VK I  E            + +   EI  + R+ H N+
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 321 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEW 380
           +++L     +G   LV +   +G LD + +      L+      + + +   + YL    
Sbjct: 92  IKVLDIFENQGFFQLVMEKHGSG-LDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRL-- 148
Query: 381 EQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE 434
            + +IHRD+K  N+++  +   +L DFG A   + G    T    GT+ Y APE
Sbjct: 149 -KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYT--FCGTIEYCAPE 199

>pdb|1FX5|A Chain A, Crystal Structure Analysis Of Ulex Europaeus Lectin I Length = 242

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 50/151 (33%), Positives = 71/151 (47%), Gaps = 17/151 (11%)
Query: 39  GIAFVIASTRGLPGARPSQYLGLFNDTNLGNETNHVFAVELDTIKSH-GFLDINDNHVGI 97
           G+ F +A     P  R   Y GLFNDT   +    V AVE DTI S   F D    H+GI
Sbjct: 88  GLTFFLAPPDS-PLRRAGGYFGLFNDTKCDSSYQTV-AVEFDTIGSPVNFWDPGFPHIGI 145
Query: 98  DINSLKSESSAPAGYYVEYDGLEKRTNVTL----------APINIPRPRSLNTMSLSRDL 147
           D+N +KS +   A  + +  GL    NV +          A +  P  ++  +++   DL
Sbjct: 146 DVNCVKSIN---AERWNKRYGLNNVANVEIIYEASSKTLTASLTYPSDQTSISVTSIVDL 202
Query: 148 SSVLNDAMYVGFSSSTG-SVLASHYILGWSF 177
             +L + + VGFS ST     A+H +L W F
Sbjct: 203 KEILPEWVSVGFSGSTYIGRQATHEVLNWYF 233

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 103/224 (45%), Gaps = 45/224 (20%)
Query: 269 LGTGGFGRVYRGT-LPKSQIEIAVKKI-SHESRQGMKEFVAEI-VSIGRLRHRNLVQLLG 325
           LG G +G V +   +P  QI +AVK+I +  + Q  K  + ++ +S+  +     V   G
Sbjct: 15  LGRGAYGVVEKMRHVPSGQI-MAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 73
Query: 326 YCRRKGELLLVYDYMPNGSLDKYLYDQ--------PKVTLNWIQRFRVIKGVALGLFYLH 377
              R+G++ +  + M + SLDK+ Y Q        P+  L      ++   +   L +LH
Sbjct: 74  ALFREGDVWICMELM-DTSLDKF-YKQVIDKGQTIPEDILG-----KIAVSIVKALEHLH 126
Query: 378 QEWEQVVIHRDVKASNVLLDGELNGRLGDFGL--------ARLYDHGTDPQTTHVVGTLG 429
            +    VIHRDVK SNVL++     ++ DFG+        A+  D G  P          
Sbjct: 127 SKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKP---------- 174
Query: 430 YLAPEH-----TRTGKATTSADVFSFGAFLLEVACGRRPIQRQG 468
           Y+APE       + G +  S D++S G  ++E+A  R P    G
Sbjct: 175 YMAPERINPELNQKGYSVKS-DIWSLGITMIELAILRFPYDSWG 217
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	586
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-129
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-120
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-116
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-81
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-64
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	3e-62
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	2e-59
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-58
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-57
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	3e-57
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-56
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	3e-56
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	8e-56
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	6e-55
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	7e-55
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-54
3q4u_A	301	Activin receptor type-1; structural genomics conso	7e-54
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-53
1hql_A	257	Lectin; xenograft antigen, sugar BI protein; HET:	6e-45
2fmd_A	240	Lectin, agglutinin, BMA; legume lectin, beta sandw	1e-43
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	4e-43
1fny_A	237	BARK lectin, BARK agglutinin I,polypeptide A; legu	1e-41
1g7y_A	253	Stem/LEAF lectin DB58; jelly roll fold, sugar bind	3e-41
3ipv_A	251	Lectin alpha chain; galactose binding, SEED lectin	3e-41
3zyr_A	261	Lectin; sugar binding protein, N-glycan; HET: NAG	4e-41
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-40
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	4e-40
2bqp_A	234	Protein (PEA lectin); D-glucopyranose complex, sug	7e-40
1gsl_A	243	Griffonia simplicifolia lectin 4; glycoprotein, ma	2e-39
2eig_A	234	Lectin; L-fucosyl, N-acetyl-D-glucosamine, SUG bin	3e-39
1fx5_A	242	UEA-I, UE-I, anti-H(O) lectin I; legume lectin, HO	9e-39
1fat_A	252	Phytohemagglutinin-L; glycoprotein, plant defense	1e-38
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-38
1v6i_A	232	Agglutinin, PNA, galactose-binding lectin; open qu	1e-38
1sbf_A	253	Soybean agglutinin; lectin; HET: NAG GAL; 2.43A {G	2e-38
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-38
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	9e-38
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	1e-37
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-37
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	4e-37
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	4e-37
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	4e-37
1ioa_A	240	Arcelin-5A, ARC5A; lectin-like proteins, plant def	4e-37
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	4e-37
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	4e-37
1n47_A	233	Isolectin B4; cancer antigen, vicia villosa lectin	5e-37
1dbn_A	239	MAL, protein (leukoagglutinin); plant lectin, carb	5e-37
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	6e-37
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	7e-37
1qnw_A	242	Chitin binding lectin, UEA-II; carbohydrate bindin	8e-37
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-36
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	1e-36
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-36
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-36
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-36
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-36
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-36
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	3e-36
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	3e-36
3pls_A	298	Macrophage-stimulating protein receptor; protein k	3e-36
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	4e-36
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	4e-36
1avb_A	226	Arcelin-1; lectin-like glycoprotein, plant defense	5e-36
1wbf_A	242	Protein (agglutinin); lectin (agglutinin), legume	5e-36
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	7e-36
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	9e-36
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-35
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	2e-35
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	2e-35
1gzc_A	239	Erythrina crista-galli lectin; carbohydrate, sugar	3e-35
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	3e-35
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	4e-35
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	5e-35
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	5e-35
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-34
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-34
1f9k_A	238	Acidic lectin; legume lectin, glycosylated protein	1e-34
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-34
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-34
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-34
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-34
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-34
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	3e-34
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	3e-34
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	4e-34
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	4e-34
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	7e-34
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	3e-33
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	5e-33
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	6e-33
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	7e-33
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	7e-33
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	8e-33
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-32
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	5e-32
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	6e-32
1dhk_B	223	Bean lectin-like inhibitor, porcine pancreatic alp	1e-31
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	4e-31
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	9e-31
1qmo_E	133	Mannose binding lectin, FRIL; crosslink, hematopoi	1e-30
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-30
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	2e-30
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	4e-30
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	4e-30
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	5e-30
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	7e-30
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-29
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-29
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-29
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-29
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	3e-29
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	3e-29
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	3e-29
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	3e-29
3aln_A	327	Dual specificity mitogen-activated protein kinase;	4e-29
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	5e-29
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	7e-29
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-28
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-28
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-28
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	1e-28
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-28
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-28
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-28
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-28
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-28
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	3e-28
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	4e-28
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	4e-28
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	8e-28
3an0_A	340	Dual specificity mitogen-activated protein kinase;	8e-28
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	9e-28
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	2e-27
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	4e-27
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	9e-27
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-26
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-26
2ltn_A	181	PEA lectin, alpha chain; 1.70A {Pisum sativum} SCO	3e-26
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	6e-26
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	6e-26
1nls_A	237	Concanavalin A; lectin, agglutinin; 0.94A {Canaval	7e-26
1nls_A	237	Concanavalin A; lectin, agglutinin; 0.94A {Canaval	3e-12
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	3e-25
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	4e-25
3ork_A	311	Serine/threonine protein kinase; structural genomi	9e-25
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-24
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	2e-24
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	4e-24
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	6e-24
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	9e-24
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-23
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-23
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-23
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-23
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	4e-23
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	4e-23
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	8e-23
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-22
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-22
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-22
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-22
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-22
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-22
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-22
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-22
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-22
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	3e-22
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	4e-22
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	4e-22
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	5e-22
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	5e-22
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	5e-22
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	6e-22
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	7e-22
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	7e-22
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-21
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-21
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	1e-21
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-21
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-21
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-21
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	2e-21
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	3e-21
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	3e-21
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	3e-21
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	3e-21
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	3e-21
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	3e-21
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	6e-21
3bhy_A	283	Death-associated protein kinase 3; death associate	6e-21
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	8e-21
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-20
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-20
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-20
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-20
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-20
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	3e-20
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	3e-20
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	4e-20
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	4e-20
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	7e-20
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	8e-20
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-19
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	3e-19
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	5e-19
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	6e-19
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	9e-19
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	9e-19
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-18
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-18
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-18
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-18
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	3e-18
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	3e-18
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	4e-18
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	4e-18
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-17
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	5e-17
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	7e-17
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	9e-17
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-16
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-16
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	3e-16
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	5e-16
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	5e-16
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	5e-16
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-15
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-15
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	3e-15
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-14
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-14
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-14
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	3e-14
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	3e-14
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	4e-14
1qmo_A	113	Mannose binding lectin, FRIL; crosslink, hematopoi	8e-14
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-13
3rp9_A	458	Mitogen-activated protein kinase; structural genom	1e-13
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-13
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-13
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	3e-13
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	4e-13
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	6e-13
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	7e-13
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-12
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-12
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	5e-12
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-11
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	8e-09
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-05
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-11
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	4e-11
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-09
2ltn_B	52	PEA lectin, beta chain; 1.70A {Pisum sativum} SCOP	2e-08
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	4e-07
1gv9_A	260	P58/ergic-53; lectin, carbohydrate binding; 1.46A	5e-07
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	5e-07
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	1e-06
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	1e-06
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-06
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	9e-06
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	2e-05
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	6e-05
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	8e-05
2dur_A	253	VIP36;, vesicular integral-membrane protein VIP36;	2e-04
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	3e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  379 bits (976), Expect = e-129
 Identities = 124/303 (40%), Positives = 181/303 (59%), Gaps = 7/303 (2%)

Query: 240 EDWELDHG-PHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES 298
           ED E+  G   RF  ++L +A+  F  K +LG GGFG+VY+G L      +AVK++  E 
Sbjct: 8   EDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGT-LVAVKRLKEER 66

Query: 299 RQGMK-EFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQP--KV 355
            QG + +F  E+  I    HRNL++L G+C    E LLVY YM NGS+   L ++P  + 
Sbjct: 67  TQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQP 126

Query: 356 TLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH 415
            L+W +R R+  G A GL YLH   +  +IHRDVKA+N+LLD E    +GDFGLA+L D+
Sbjct: 127 PLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 186

Query: 416 GTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPS--ENL 473
                TT V GT+G++APE+  TGK++   DVF +G  LLE+  G+R       +  +++
Sbjct: 187 KDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDV 246

Query: 474 ILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQIL 533
           +L+DWV       +L    D +L   Y  EE+E ++++ LLC+ S P  RP M +VV++L
Sbjct: 247 MLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306

Query: 534 ERD 536
           E D
Sbjct: 307 EGD 309

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  358 bits (920), Expect = e-120
 Identities = 115/297 (38%), Positives = 168/297 (56%), Gaps = 13/297 (4%)

Query: 249 HRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAE 308
           +R    DL  AT  F  K L+G G FG+VY+G L     ++A+K+ + ES QG++EF  E
Sbjct: 27  YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGA-KVALKRRTPESSQGIEEFETE 85

Query: 309 IVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLY--DQPKVTLNWIQRFRVI 366
           I ++   RH +LV L+G+C  + E++L+Y YM NG+L ++LY  D P ++++W QR  + 
Sbjct: 86  IETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEIC 145

Query: 367 KGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTH--- 423
            G A GL YLH    + +IHRDVK+ N+LLD     ++ DFG+++    GT+   TH   
Sbjct: 146 IGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKK---GTELDQTHLST 199

Query: 424 -VVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDF 482
            V GTLGY+ PE+   G+ T  +DV+SFG  L EV C R  I +  P E + L +W  + 
Sbjct: 200 VVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVES 259

Query: 483 WNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERDVAL 539
            N G+L +  DPNL  +   E L       + C       RPSM  V+  LE  + L
Sbjct: 260 HNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL 316

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  346 bits (890), Expect = e-116
 Identities = 96/315 (30%), Positives = 154/315 (48%), Gaps = 22/315 (6%)

Query: 237 EELEDWELDHGPHRFRYKDLYIATKGFREKE------LLGTGGFGRVYRGTLPKSQIEIA 290
           E       D   H F + +L   T  F E+        +G GGFG VY+G +  +   +A
Sbjct: 1   ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNT--TVA 58

Query: 291 VKKISH----ESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLD 346
           VKK++      + +  ++F  EI  + + +H NLV+LLG+     +L LVY YMPNGSL 
Sbjct: 59  VKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLL 118

Query: 347 KYLYDQPKV-TLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLG 405
             L        L+W  R ++ +G A G+ +LH   E   IHRD+K++N+LLD     ++ 
Sbjct: 119 DRLSCLDGTPPLSWHMRCKIAQGAANGINFLH---ENHHIHRDIKSANILLDEAFTAKIS 175

Query: 406 DFGLARLYDHGTDP-QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPI 464
           DFGLAR  +       T+ +VGT  Y+APE    G+ T  +D++SFG  LLE+  G   +
Sbjct: 176 DFGLARASEKFAQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAV 234

Query: 465 QRQGPSENLILVDWVFDFW-NRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTAR 523
                 +   L+D   +       + +  D  +  +  +  +E +  +   C H     R
Sbjct: 235 DEHREPQL--LLDIKEEIEDEEKTIEDYIDKKMN-DADSTSVEAMYSVASQCLHEKKNKR 291

Query: 524 PSMRQVVQILERDVA 538
           P +++V Q+L+   A
Sbjct: 292 PDIKKVQQLLQEMTA 306

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  257 bits (659), Expect = 2e-81
 Identities = 71/307 (23%), Positives = 127/307 (41%), Gaps = 29/307 (9%)

Query: 251 FRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIV 310
              ++LY  +   +  E+   G FG V++  L      +AVK    + +Q   +   E+ 
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNE--YVAVKIFPIQDKQSW-QNEYEVY 70

Query: 311 SIGRLRHRNLVQLLGYCRR----KGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVI 366
           S+  ++H N++Q +G  +R      +L L+  +   GSL  +L       ++W +   + 
Sbjct: 71  SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN---VVSWNELCHIA 127

Query: 367 KGVALGLFYLHQE-------WEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP 419
           + +A GL YLH++        +  + HRD+K+ NVLL   L   + DFGLA  ++ G   
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187

Query: 420 -QTTHVVGTLGYLAPE-----HTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENL 473
             T   VGT  Y+APE           A    D+++ G  L E+A              L
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247

Query: 474 ILVDWVFDFWNRGELLEA-----RDPNLGTEYVAEE-LELVLKLGLLCSHSDPTARPSMR 527
              + +    +  ++ E      + P L   +     + ++ +    C   D  AR S  
Sbjct: 248 PFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAG 307

Query: 528 QVVQILE 534
            V + + 
Sbjct: 308 CVGERIT 314

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  213 bits (545), Expect = 1e-64
 Identities = 72/322 (22%), Positives = 118/322 (36%), Gaps = 46/322 (14%)

Query: 251 FRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIV 310
               +  +     +  EL+G G +G VY+G+L   +  +AVK  S  +RQ        I 
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEK-NIY 59

Query: 311 SIGRLRHRNLVQLLGYCRR-----KGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRV 365
            +  + H N+ + +    R     + E LLV +Y PNGSL KYL      T +W+   R+
Sbjct: 60  RVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH---TSDWVSSCRL 116

Query: 366 IKGVALGLFYLHQEWEQ------VVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT-- 417
              V  GL YLH E  +       + HRD+ + NVL+  +    + DFGL+         
Sbjct: 117 AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV 176

Query: 418 -----DPQTTHVVGTLGYLAPE-------HTRTGKATTSADVFSFGAFLLEVACGRRPIQ 465
                D      VGT+ Y+APE             A    D+++ G    E+      + 
Sbjct: 177 RPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLF 236

Query: 466 RQGPSE--NLILVDWVFDFWNRGELLEARD--------PNLGTEYVAEELEL--VLKLGL 513
                    +     V    N     + +         P     +    L +  + +   
Sbjct: 237 PGESVPEYQMAFQTEV---GNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIE 293

Query: 514 LCSHSDPTARPSMRQVVQILER 535
            C   D  AR + +   + +  
Sbjct: 294 DCWDQDAEARLTAQXAEERMAE 315

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  206 bits (527), Expect = 3e-62
 Identities = 80/303 (26%), Positives = 141/303 (46%), Gaps = 36/303 (11%)

Query: 236 AEELEDWELDHGPHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKI- 294
           A + +D ++        + DL I       KE +G G FG V+R        ++AVK + 
Sbjct: 26  AMDGDDMDIP-------WCDLNI-------KEKIGAGSFGTVHRAEW-HGS-DVAVKILM 69

Query: 295 -SHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQ- 352
                 + + EF+ E+  + RLRH N+V  +G   +   L +V +Y+  GSL + L+   
Sbjct: 70  EQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSG 129

Query: 353 PKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARL 412
            +  L+  +R  +   VA G+ YLH      ++HR++K+ N+L+D +   ++ DFGL+RL
Sbjct: 130 AREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL 188

Query: 413 YDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSEN 472
               T   +    GT  ++APE  R   +   +DV+SFG  L E+A  ++P        N
Sbjct: 189 KAS-TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQP------WGN 241

Query: 473 LILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQI 532
           L     V     + + LE          +  ++  +++    C  ++P  RPS   ++ +
Sbjct: 242 LNPAQVVAAVGFKCKRLEIP------RNLNPQVAAIIEG---CWTNEPWKRPSFATIMDL 292

Query: 533 LER 535
           L  
Sbjct: 293 LRP 295

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  199 bits (509), Expect = 2e-59
 Identities = 72/301 (23%), Positives = 115/301 (38%), Gaps = 39/301 (12%)

Query: 248 PHR-FRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFV 306
           PHR FR  DL          E+LG G FG+  + T  ++   + +K++     +  + F+
Sbjct: 3   PHRIFRPSDLIH-------GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFL 55

Query: 307 AEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVI 366
            E+  +  L H N+++ +G   +   L  + +Y+  G+L   +         W QR    
Sbjct: 56  KEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSM-DSQYPWSQRVSFA 114

Query: 367 KGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYD------------ 414
           K +A G+ YLH      +IHRD+ + N L+    N  + DFGLARL              
Sbjct: 115 KDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSL 171

Query: 415 -HGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENL 473
                 +   VVG   ++APE           DVFSFG  L E+           P    
Sbjct: 172 KKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMD 231

Query: 474 ILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQIL 533
             ++     +          P+               + + C   DP  RPS  ++   L
Sbjct: 232 FGLN--VRGFLDRYCPPNCPPSF------------FPITVRCCDLDPEKRPSFVKLEHWL 277

Query: 534 E 534
           E
Sbjct: 278 E 278

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  196 bits (500), Expect = 2e-58
 Identities = 69/310 (22%), Positives = 124/310 (40%), Gaps = 49/310 (15%)

Query: 240 EDWELDHGPHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR 299
               L          ++         ++ +G GGFG V++G L K +  +A+K +     
Sbjct: 12  RLPTLA-------DNEIEY-------EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDS 57

Query: 300 QG-------MKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQ 352
           +G        +EF  E+  +  L H N+V+L G         +V +++P G L   L D+
Sbjct: 58  EGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDK 115

Query: 353 PKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLD-----GELNGRLGDF 407
               + W  + R++  +ALG+ Y+       ++HRD+++ N+ L        +  ++ DF
Sbjct: 116 AH-PIKWSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173

Query: 408 GLARLYDHGTDPQTTHVVGTLGYLAPE--HTRTGKATTSADVFSFGAFLLEVACGRRPIQ 465
           GL++   H      + ++G   ++APE         T  AD +SF   L  +  G  P  
Sbjct: 174 GLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229

Query: 466 RQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPS 525
                +    + ++      G       P    E     L  V++L   C   DP  RP 
Sbjct: 230 EYSYGK----IKFINMIREEGLRPTI--P----EDCPPRLRNVIEL---CWSGDPKKRPH 276

Query: 526 MRQVVQILER 535
              +V+ L  
Sbjct: 277 FSYIVKELSE 286

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  193 bits (492), Expect = 1e-57
 Identities = 74/305 (24%), Positives = 125/305 (40%), Gaps = 49/305 (16%)

Query: 242 WELDHGPHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKI----SHE 297
            E+D       + +L +       +E++G GGFG+VYR        E+AVK        +
Sbjct: 2   LEID-------FAELTL-------EEIIGIGGFGKVYRAFW-IGD-EVAVKAARHDPDED 45

Query: 298 SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTL 357
             Q ++    E      L+H N++ L G C ++  L LV ++   G L++ L  +    +
Sbjct: 46  ISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR---I 102

Query: 358 NWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGR--------LGDFGL 409
                      +A G+ YLH E    +IHRD+K+SN+L+  ++           + DFGL
Sbjct: 103 PPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGL 162

Query: 410 ARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGP 469
           AR +   T        G   ++APE  R    +  +DV+S+G  L E+  G  P      
Sbjct: 163 AREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP------ 213

Query: 470 SENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQV 529
              +  +   +        L    P        E    +++    C + DP +RPS   +
Sbjct: 214 FRGIDGLAVAYGVAMNKLALPI--P----STCPEPFAKLMED---CWNPDPHSRPSFTNI 264

Query: 530 VQILE 534
           +  L 
Sbjct: 265 LDQLT 269

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  193 bits (493), Expect = 3e-57
 Identities = 72/275 (26%), Positives = 120/275 (43%), Gaps = 26/275 (9%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQ 322
              +E++G G FG V +    +++ ++A+K+I  ES    K F+ E+  + R+ H N+V+
Sbjct: 10  IEVEEVVGRGAFGVVCKAKW-RAK-DVAIKQIESESE--RKAFIVELRQLSRVNHPNIVK 65

Query: 323 LLGYCRRKGELLLVYDYMPNGSLDKYLYDQ-PKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
           L G C     + LV +Y   GSL   L+   P                + G+ YLH    
Sbjct: 66  LYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQP 123

Query: 382 QVVIHRDVKASNVLLDGELN-GRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGK 440
           + +IHRD+K  N+LL       ++ DFG A           T+  G+  ++APE      
Sbjct: 124 KALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT----HMTNNKGSAAWMAPEVFEGSN 179

Query: 441 ATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEY 500
            +   DVFS+G  L EV   R+P            + W     + G            + 
Sbjct: 180 YSEKCDVFSWGIILWEVITRRKPF--DEIGGPAFRIMWAV---HNGTRPPL--I----KN 228

Query: 501 VAEELELVLKLGLLCSHSDPTARPSMRQVVQILER 535
           + + +E ++     C   DP+ RPSM ++V+I+  
Sbjct: 229 LPKPIESLMT---RCWSKDPSQRPSMEEIVKIMTH 260

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  189 bits (483), Expect = 3e-56
 Identities = 59/303 (19%), Positives = 117/303 (38%), Gaps = 45/303 (14%)

Query: 240 EDWELDHGPHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKI--SHE 297
           +   +D       +K L   TK       L     G +++G   +   +I VK +     
Sbjct: 3   KHSGID-------FKQLNFLTK-------LNENHSGELWKGRW-QGN-DIVVKVLKVRDW 46

Query: 298 SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRR--KGELLLVYDYMPNGSLDKYLYDQPKV 355
           S +  ++F  E   +    H N++ +LG C+        L+  +MP GSL   L++    
Sbjct: 47  STRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNF 106

Query: 356 TLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH 415
            ++  Q  +    +A G+ +LH   E ++    + + +V++D ++  R+    +   +  
Sbjct: 107 VVDQSQAVKFALDMARGMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMADVKFSF-- 163

Query: 416 GTDPQTTHVVGTLGYLAPE---HTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSEN 472
               Q+   +    ++APE            SAD++SF   L E+     P        +
Sbjct: 164 ----QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVP------FAD 213

Query: 473 LILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQI 532
           L  ++        G              ++  +  ++K+   C + DP  RP    +V I
Sbjct: 214 LSNMEIGMKVALEGLRPTI------PPGISPHVSKLMKI---CMNEDPAKRPKFDMIVPI 264

Query: 533 LER 535
           LE+
Sbjct: 265 LEK 267

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  190 bits (484), Expect = 8e-56
 Identities = 70/323 (21%), Positives = 134/323 (41%), Gaps = 56/323 (17%)

Query: 230 RMKRKFAEELEDWELDHGPHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEI 289
           R   + +  L++W++        ++ L I        EL+G G FG+VY G       E+
Sbjct: 16  RKASQTSIFLQEWDIP-------FEQLEI-------GELIGKGRFGQVYHGRWHG---EV 58

Query: 290 AVKKI--SHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDK 347
           A++ I    ++   +K F  E+++  + RH N+V  +G C     L ++       +L  
Sbjct: 59  AIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYS 118

Query: 348 YLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRL--G 405
            + D  K+ L+  +  ++ + +  G+ YLH    + ++H+D+K+ NV  D   NG++   
Sbjct: 119 VVRD-AKIVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD---NGKVVIT 171

Query: 406 DFGLARL----YDHGTDPQTTHVVGTLGYLAPEHTRTGKA---------TTSADVFSFGA 452
           DFGL  +         + +     G L +LAPE  R             +  +DVF+ G 
Sbjct: 172 DFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGT 231

Query: 453 FLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLG 512
              E+     P + Q     +  +         G         +G E      +++L   
Sbjct: 232 IWYELHAREWPFKTQPAEAIIWQM-------GTGMKPNLSQIGMGKEIS----DILLF-- 278

Query: 513 LLCSHSDPTARPSMRQVVQILER 535
             C   +   RP+  +++ +LE+
Sbjct: 279 --CWAFEQEERPTFTKLMDMLEK 299

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  187 bits (476), Expect = 6e-55
 Identities = 65/305 (21%), Positives = 129/305 (42%), Gaps = 39/305 (12%)

Query: 237 EELEDWELDHGPHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKI-- 294
           +  +DWE+           + +        + +G+G FG VY+G       ++AVK +  
Sbjct: 14  DAADDWEIP-------DGQITV-------GQRIGSGSFGTVYKGKWHG---DVAVKMLNV 56

Query: 295 SHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPK 354
           +  + Q ++ F  E+  + + RH N++  +GY     +L +V  +    SL  +L+   +
Sbjct: 57  TAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHA-SE 114

Query: 355 VTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYD 414
                 +   + +  A G+ YLH    + +IHRD+K++N+ L  +   ++GDFGLA    
Sbjct: 115 TKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171

Query: 415 HGTDPQT-THVVGTLGYLAPE---HTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPS 470
             +       + G++ ++APE      +   +  +DV++FG  L E+  G+ P       
Sbjct: 172 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 231

Query: 471 ENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVV 530
           + +I    +    +    L     N           L+ +    C       RPS  +++
Sbjct: 232 DQII---EMVGRGSLSPDLSKVRSNCPKRMK----RLMAE----CLKKKRDERPSFPRIL 280

Query: 531 QILER 535
             +E 
Sbjct: 281 AEIEE 285

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  188 bits (479), Expect = 7e-55
 Identities = 70/292 (23%), Positives = 119/292 (40%), Gaps = 29/292 (9%)

Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
           + +G G +G V+ G       ++AVK               EI     +RH N++  +  
Sbjct: 43  KQIGKGRYGEVWMGKW--RGEKVAVKVFFTTEEA-SWFRETEIYQTVLMRHENILGFIAA 99

Query: 327 CRRKG----ELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQE--- 379
             +      +L L+ DY  NGSL  YL      TL+     ++      GL +LH E   
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFS 156

Query: 380 --WEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ---TTHVVGTLGYLAPE 434
              +  + HRD+K+ N+L+       + D GLA  +   T+         VGT  Y+ PE
Sbjct: 157 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPE 216

Query: 435 ------HTRTGKATTSADVFSFGAFLLEVACGRRPIQR----QGPSENLILVDWVFDFWN 484
                 +    ++   AD++SFG  L EVA            Q P  +L+  D  ++   
Sbjct: 217 VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMR 276

Query: 485 RGELLEARDPNLGTEYVAEE-LELVLKLGLLCSHSDPTARPSMRQVVQILER 535
               ++   P+    + ++E L  + KL   C   +P +R +  +V + L +
Sbjct: 277 EIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAK 328

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  184 bits (469), Expect = 7e-54
 Identities = 72/293 (24%), Positives = 129/293 (44%), Gaps = 31/293 (10%)

Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKI-SHESRQGMKEFVAEIVSIGRLRHRNLVQLLG 325
           E +G G +G V+RG+       +AVK   S + +   +E   E+ +   LRH N++  + 
Sbjct: 14  ECVGKGRYGEVWRGSW--QGENVAVKIFSSRDEKSWFRE--TELYNTVMLRHENILGFIA 69

Query: 326 YCRRKG----ELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
                     +L L+  Y   GSL  YL      TL+ +   R++  +A GL +LH E  
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYLQLT---TLDTVSCLRIVLSIASGLAHLHIEIF 126

Query: 382 Q-----VVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ---TTHVVGTLGYLAP 433
                  + HRD+K+ N+L+       + D GLA ++   T+         VGT  Y+AP
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186

Query: 434 E------HTRTGKATTSADVFSFGAFLLEVACGRRPIQR----QGPSENLILVDWVFDFW 483
           E            +    D+++FG  L EVA            + P  +++  D  F+  
Sbjct: 187 EVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDM 246

Query: 484 NRGELLEARDPNLGTEYVAEE-LELVLKLGLLCSHSDPTARPSMRQVVQILER 535
            +   ++ + PN+   + ++  L  + KL   C + +P+AR +  ++ + L +
Sbjct: 247 RKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK 299

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  184 bits (469), Expect = 2e-53
 Identities = 79/293 (26%), Positives = 126/293 (43%), Gaps = 31/293 (10%)

Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKI-SHESRQGMKEFVAEIVSIGRLRHRNLVQLLG 325
           E +G G FG V+RG       E+AVK   S E R   +E  AEI     LRH N++  + 
Sbjct: 48  ESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFRE--AEIYQTVMLRHENILGFIA 103

Query: 326 YCRRKG----ELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
              +      +L LV DY  +GSL  YL      T+      ++    A GL +LH E  
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIV 160

Query: 382 Q-----VVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQT---THVVGTLGYLAP 433
                  + HRD+K+ N+L+       + D GLA  +D  TD       H VGT  Y+AP
Sbjct: 161 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 220

Query: 434 E------HTRTGKATTSADVFSFGAFLLEVACGRRPIQR----QGPSENLILVDWVFDFW 483
           E      + +  ++   AD+++ G    E+A            Q P  +L+  D   +  
Sbjct: 221 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 280

Query: 484 NRGELLEARDPNL-GTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER 535
            +    +   PN+       E L ++ K+   C +++  AR +  ++ + L +
Sbjct: 281 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 333

>1hql_A Lectin; xenograft antigen, sugar BI protein; HET: GLA MBG NAG; 2.20A {Griffonia simplicifolia} SCOP: b.29.1.1 PDB: 1gnz_A* Length = 257

 Score =  159 bits (402), Expect = 6e-45
 Identities = 55/209 (26%), Positives = 93/209 (44%), Gaps = 23/209 (11%)

Query: 2   PFKNKNSNSSTANGTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGL 61
           P +  ++ + +    V SF T F F +     +    G+AF +A           +YLGL
Sbjct: 57  PVQLWDNKTES----VASFYTEFTFFLKI-TGNGPADGLAFFLAPP-DSDVKDAGEYLGL 110

Query: 62  FNDTNLGNET-NHVFAVELDTIKSHGFLDINDNHVGIDINSLKSESSAPAGY-------- 112
           FN +     + N V AVE DT  +  F + +  H+GI++NS+ S ++             
Sbjct: 111 FNKSTATQPSKNQVVAVEFDTWTNPNFPEPSYRHIGINVNSIVSVATKRWEDSDIFSGKI 170

Query: 113 ---YVEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSVLNDAMYVGFSSSTGSVLA- 168
               + YDG  +   V L+  +         +S S D+   L +++ VG S+STG+    
Sbjct: 171 ATARISYDGSAEILTVVLSYPDGSDY----ILSHSVDMRQNLPESVRVGISASTGNNQFL 226

Query: 169 SHYILGWSFKINGQAEELNLSQLPKLPRV 197
           + YIL W F  N Q+  +  +  P++ R 
Sbjct: 227 TVYILSWRFSSNLQSTSVKAAMEPEITRT 255

>2fmd_A Lectin, agglutinin, BMA; legume lectin, beta sandwich, protein-carbohydrate complex, sugar binding protein; HET: MAN; 1.90A {Bowringia mildbraedii} Length = 240

 Score =  154 bits (390), Expect = 1e-43
 Identities = 51/183 (27%), Positives = 88/183 (48%), Gaps = 12/183 (6%)

Query: 13  ANGTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGLFNDTNLGNETN 72
           ++  V SF TTF FSI     + +     F+ +    +P     + LGLF  +N     N
Sbjct: 62  SSSLVASFETTFTFSISQGSSTPADALTFFIASPDTKIPSGSGGRLLGLFGSSNNAGSDN 121

Query: 73  HVFAVELDTIKSHGFLDINDNHVGIDINSLKSESSAPAGYY--------VEYDGLEKRTN 124
            V +VE DT  +    D N  H+GID+NS++S++++   +         + Y+   KR +
Sbjct: 122 GVVSVEFDTYPNTDIGDPNYRHIGIDVNSIRSKAASKWDWQNGKTATAHISYNSASKRLS 181

Query: 125 VTLAPINIPRPRSLNTMSLSRDLSSVLNDAMYVGFSSSTGSVLASHYILGWSFKINGQAE 184
           V  +  N         +S   +L++V  B + VGFS++TG    ++ IL WSF+ +    
Sbjct: 182 VVSSYPNSSPV----VVSFDVELNNVBPBWVRVGFSATTGQYTQTNNILAWSFRSSLMGY 237

Query: 185 ELN 187
           + N
Sbjct: 238 QAN 240

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  157 bits (400), Expect = 4e-43
 Identities = 73/302 (24%), Positives = 118/302 (39%), Gaps = 43/302 (14%)

Query: 240 EDWELDHGPHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKI-SHES 298
           + W L+H       +DL +        E +G G FG V+ G L      +AVK       
Sbjct: 107 DKWVLNH-------EDLVL-------GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLP 152

Query: 299 RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLN 358
                +F+ E   + +  H N+V+L+G C +K  + +V + +  G    +L  +    L 
Sbjct: 153 PDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGA-RLR 211

Query: 359 WIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD 418
                +++   A G+ YL     +  IHRD+ A N L+  +   ++ DFG++R      D
Sbjct: 212 VKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEA---D 265

Query: 419 PQTTHVVGTLGY----LAPEHTRTGKATTSADVFSFGAFLLEVA-CGRRPIQRQGPSENL 473
                  G         APE    G+ ++ +DV+SFG  L E    G  P       +  
Sbjct: 266 GVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ-- 323

Query: 474 ILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQIL 533
                  +F  +G  L    P L  + V         L   C   +P  RPS   + Q L
Sbjct: 324 -----TREFVEKGGRLPC--PELCPDAVFR-------LMEQCWAYEPGQRPSFSTIYQEL 369

Query: 534 ER 535
           + 
Sbjct: 370 QS 371

>1fny_A BARK lectin, BARK agglutinin I,polypeptide A; legume lectin, jelly roll, sugar binding protein; 1.81A {Robinia pseudoacacia} SCOP: b.29.1.1 PDB: 1fnz_A* Length = 237

 Score =  149 bits (377), Expect = 1e-41
 Identities = 47/194 (24%), Positives = 82/194 (42%), Gaps = 23/194 (11%)

Query: 1   MPFKNKNSNSSTANGTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLG 60
               +         G V SF T+F F I +   + +  G+AF +A             LG
Sbjct: 56  FQIWDST------TGNVASFVTSFTFIIQAPNPATTADGLAFFLAPV-DTQPLDLGGMLG 108

Query: 61  LFNDTNLGNETNHVFAVELDTIKSHGFLDINDNHVGIDINSLKSESSAPAGYY------- 113
           +F D    N++N + AVE DT  +  + D    H+GI++NS++S  + P  +        
Sbjct: 109 IFKDGY-FNKSNQIVAVEFDTFSNGDW-DPKGRHLGINVNSIESIKTVPWNWTNGEVANV 166

Query: 114 -VEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSVLNDAMYVGFSSSTGSVLA---S 169
            + Y+   K    +L   ++     +       D+  VL + +  GFS++TG       +
Sbjct: 167 FISYEASTKSLTASLVYPSLETSFII---DAIVDVKIVLPEWVRFGFSATTGIDKGYVQT 223

Query: 170 HYILGWSFKINGQA 183
           + +L WSF+ N   
Sbjct: 224 NDVLSWSFESNLPG 237

>1g7y_A Stem/LEAF lectin DB58; jelly roll fold, sugar binding protein; HET: NAG FUC FUL; 2.50A {Vigna unguiculata subsp} SCOP: b.29.1.1 PDB: 1lul_A 1lu1_A* 1bjq_A* 1lu2_A* Length = 253

 Score =  148 bits (375), Expect = 3e-41
 Identities = 51/204 (25%), Positives = 91/204 (44%), Gaps = 27/204 (13%)

Query: 1   MPFKNKNSNSSTANGTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLG 60
           +   +K+       G V S++T+F  +I +  +S S  GIAF +      P +  S +LG
Sbjct: 54  IQIYDKS------TGAVASWATSFTANIFAPNKSSSADGIAFALVPVGSEPKS-NSGFLG 106

Query: 61  LFNDTNLGNETNHVFAVELDTIKSHGFLDINDNHVGIDINSLKSESSAPAGYY------- 113
           +F+     N +    AVE DT  +  + D    H+GID+NS+KS  +A  G         
Sbjct: 107 VFDSDVYDN-SAQTVAVEFDTFSNTDW-DPTSRHIGIDVNSIKSIRTASWGLANGQNAEI 164

Query: 114 -VEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSVLNDAMYVGFSSSTGS---VLAS 169
            + Y+        +L   +      ++      D+++ L + + +GFS++TG       +
Sbjct: 165 LITYNAATSLLVASLVHPSRRTSYIVSE---RVDITNELPEYVSIGFSATTGLSEGYTET 221

Query: 170 HYILGWSFKIN----GQAEELNLS 189
           H +L WSF          E L+++
Sbjct: 222 HDVLSWSFASKLPDDSTTEPLDIA 245

>3ipv_A Lectin alpha chain; galactose binding, SEED lectin, hemagglutinin, legume lectin fungal, sugar binding protein; 2.04A {Spatholobus parviflorus} PDB: 3ipv_B 3usu_B* 3usu_A* Length = 251

 Score =  148 bits (375), Expect = 3e-41
 Identities = 56/201 (27%), Positives = 86/201 (42%), Gaps = 20/201 (9%)

Query: 2   PFKNKNSNSSTANGTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGL 61
           P    +S      G V SF+T+F F+I +   +    G+AF +A     P +    +LGL
Sbjct: 56  PINIWDSA----TGLVASFATSFRFTIYAPNIATIADGLAFFLAPVASAPDS-GGGFLGL 110

Query: 62  FNDTNLGNETNHVFAVELDTIKSHGFLDINDNHVGIDINSLKSESSAP--------AGYY 113
           F+    G+ T    AVE DT ++  F D    H+G D+NS+ S  +          A   
Sbjct: 111 FDSAVSGS-TYQTVAVEFDTYENTVFTDPPYTHIGFDVNSISSIKTVKWSLANGEAAKVL 169

Query: 114 VEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSVLNDAMYVGFSSSTGSV---LASH 170
           + Y+   K    +L   +      L       DLSSVL + + VGFS++TG+    + +H
Sbjct: 170 ITYNSAVKLLVASLVYPSSKTSFILAD---IVDLSSVLPEWVRVGFSAATGASGGKIETH 226

Query: 171 YILGWSFKINGQAEELNLSQL 191
            +  WSF           S  
Sbjct: 227 DVFSWSFASKLAGXXTKDSSF 247

>3zyr_A Lectin; sugar binding protein, N-glycan; HET: NAG BMA MAN GOL; 1.65A {Platypodium elegans} PDB: 3zvx_A* 1ukg_A* 1q8o_A* 1q8q_A* 1q8s_A* 1q8v_A* 1q8p_A* 2auy_A* 2gme_A 2gmm_A* 2gmp_A* 2gn3_A* 2gn7_A* 2gnb_A* 2gnd_A* 2gnm_A* 2gnt_A 2phf_A* 2phr_A* 2pht_A* ... Length = 261

 Score =  148 bits (375), Expect = 4e-41
 Identities = 50/203 (24%), Positives = 82/203 (40%), Gaps = 23/203 (11%)

Query: 2   PFKNKNSNSSTANGTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGL 61
             +    ++      V +  T F F + S   + +     F+      +P       LGL
Sbjct: 64  QVRLWEKST----NRVANLQTQFSFFLSSPLSNPADGIAFFIAPPDTTIPSGSAGGLLGL 119

Query: 62  FNDTNLGNET-NHVFAVELDTIKSHG--FLDINDNHVGIDINSLKSESSAPAGYY----- 113
           FN     NE+ N V AVE DT  +      D N  H+GID+NS++S              
Sbjct: 120 FNPRTALNESANQVLAVEFDTFFAQNSNTWDPNYQHIGIDVNSIRSSKVVRWERREGKTL 179

Query: 114 ---VEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSVLNDAMYVGFSSSTGSVLASH 170
              V Y+   +  +V     +  R      +S   DL+++L + + VGFS+++G    +H
Sbjct: 180 NVLVTYNPSTRTIDVVATYPDGQRY----QLSHVVDLTTILPEWVRVGFSAASGEQFQTH 235

Query: 171 YILGWSFK----INGQAEELNLS 189
            +  WSF        Q E+  L+
Sbjct: 236 NLESWSFTSTLLYTAQKEDEYLA 258

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  147 bits (373), Expect = 2e-40
 Identities = 80/299 (26%), Positives = 131/299 (43%), Gaps = 39/299 (13%)

Query: 240 EDWELDHGPHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR 299
           + WE++         D+ +       K  LG G +G VY G   K  + +AVK +  E  
Sbjct: 6   DKWEMER-------TDITM-------KHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDT 50

Query: 300 QGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNW 359
             ++EF+ E   +  ++H NLVQLLG C R+    ++ ++M  G+L  YL +  +  ++ 
Sbjct: 51  MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSA 110

Query: 360 IQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP 419
           +    +   ++  + YL    ++  IHRD+ A N L+      ++ DFGL+RL     D 
Sbjct: 111 VVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT--GDT 165

Query: 420 QTTHVVGTLGY--LAPEHTRTGKATTSADVFSFGAFLLEVA-CGRRPIQRQGPSENLILV 476
            T H          APE     K +  +DV++FG  L E+A  G  P      S+     
Sbjct: 166 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----- 220

Query: 477 DWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER 535
             V++   +   +E   P    E V E       L   C   +P+ RPS  ++ Q  E 
Sbjct: 221 --VYELLEKDYRMER--PEGCPEKVYE-------LMRACWQWNPSDRPSFAEIHQAFET 268

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  151 bits (384), Expect = 4e-40
 Identities = 77/299 (25%), Positives = 129/299 (43%), Gaps = 39/299 (13%)

Query: 240 EDWELDHGPHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVK--KISHE 297
           + WE++         D+ +       K  LG G +G VY G   K  + +AVK  K    
Sbjct: 213 DKWEMER-------TDITM-------KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM 258

Query: 298 SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTL 357
             +   EF+ E   +  ++H NLVQLLG C R+    ++ ++M  G+L  YL +  +  +
Sbjct: 259 EVE---EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEV 315

Query: 358 NWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT 417
           + +    +   ++  + YL    ++  IHR++ A N L+      ++ DFGL+RL    T
Sbjct: 316 SAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT 372

Query: 418 DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVA-CGRRPIQRQGPSENLILV 476
                     + + APE     K +  +DV++FG  L E+A  G  P      S+     
Sbjct: 373 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----- 427

Query: 477 DWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER 535
             V++   +   +E   P    E V E       L   C   +P+ RPS  ++ Q  E 
Sbjct: 428 --VYELLEKDYRMER--PEGCPEKVYE-------LMRACWQWNPSDRPSFAEIHQAFET 475

>2bqp_A Protein (PEA lectin); D-glucopyranose complex, sugar binding protein; HET: GLC; 1.90A {Pisum sativum} SCOP: b.29.1.1 Length = 234

 Score =  144 bits (364), Expect = 7e-40
 Identities = 50/190 (26%), Positives = 81/190 (42%), Gaps = 17/190 (8%)

Query: 2   PFKNKNSNSSTANGTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGL 61
           P    +  +      V +F T+F F I +        G  F IA            YLG+
Sbjct: 49  PIHIWDRETGN----VANFVTSFTFVINAPNSYNVADGFTFFIAPV-DTKPQTGGGYLGV 103

Query: 62  FNDTNLGNETNHVFAVELDTIKSHGFLDIN-DNHVGIDINSLKSESSAPAGYY------- 113
           FN     ++T    AVE DT  +  +   N D H+GID+NS+KS ++             
Sbjct: 104 FNSAE-YDKTTQTVAVEFDTFYNAAWDPSNRDRHIGIDVNSIKSVNTKSWKLQNGEEANV 162

Query: 114 -VEYDGLEKRTNVTLAPINIPRPRSLNTMSLSR--DLSSVLNDAMYVGFSSSTGSVLASH 170
            + ++       V+L   N      + + +LS    L  V+ + + +GFS++TG+  A+H
Sbjct: 163 VIAFNAATNVLTVSLTYPNNSLEEEVTSYTLSDVVSLKDVVPEWVRIGFSATTGAEYAAH 222

Query: 171 YILGWSFKIN 180
            +L WSF   
Sbjct: 223 EVLSWSFHSE 232

>1gsl_A Griffonia simplicifolia lectin 4; glycoprotein, manganese; HET: FUC GAL MAG NAG BMA; 2.00A {Griffonia simplicifolia} SCOP: b.29.1.1 PDB: 1lec_A* 1led_A* Length = 243

 Score =  143 bits (362), Expect = 2e-39
 Identities = 49/178 (27%), Positives = 74/178 (41%), Gaps = 19/178 (10%)

Query: 13  ANGTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGLFNDTNLGNET- 71
           + G   SF T+F F +   Y + +  G+AF +A            +LGLF      + + 
Sbjct: 65  STGKAASFYTSFTFLL-KNYGAPTADGLAFFLAPV-DSSVKDYGGFLGLFRHETAADPSK 122

Query: 72  NHVFAVELDTIKSHGFLDINDNHVGIDINSLKSESSAPAGYY-----------VEYDGLE 120
           N V AVE DT  +  + D    H+GID+NS+ S ++                 + YD   
Sbjct: 123 NQVVAVEFDTWINKDWNDPPYPHIGIDVNSIVSVATTRWENDDAYGSSIATAHITYDARS 182

Query: 121 KRTNVTLAPINIPRPRSLNTMSLSRDLSSVLNDAMYVGFSSSTGSVLASHYILGWSFK 178
           K   V L+  +         +S   DL+ VL   + +GFS+  G      YIL W F 
Sbjct: 183 KILTVLLSYEHGRDY----ILSHVVDLAKVLPQKVRIGFSAGVGYD-EVTYILSWHFF 235

>2eig_A Lectin; L-fucosyl, N-acetyl-D-glucosamine, SUG binding protein; HET: NAG; 2.00A {Lotus tetragonolobus} Length = 234

 Score =  142 bits (359), Expect = 3e-39
 Identities = 51/195 (26%), Positives = 78/195 (40%), Gaps = 22/195 (11%)

Query: 2   PFKNKNSNSSTANGTVFSFSTTFVFSILSEYQSQSGHGIAFVIAST-RGLPGARPSQYLG 60
           P    +S      G V SF T+F F + +  +     G+ F +A     +P      YLG
Sbjct: 48  PVPIWDSA----TGNVASFITSFSFIVSNVQRYPPTDGVVFFLAPWGTEIPPNSQGGYLG 103

Query: 61  LFNDTNLGNETNHVFAVELDTIKSHG-FLDINDNHVGIDINSLKSESSAPAGYY------ 113
           + +     N  N   AVE D+  +      +  +H+GID+NS+ S  +            
Sbjct: 104 ITDS---SNSQNQFVAVEFDSHPNVWDPKSLRSSHIGIDVNSIMSLKAVNWNRVSGSLEK 160

Query: 114 --VEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSVLNDAMYVGFSSST-GSVLASH 170
             + YD   K   V +   N        T+S   DL +VL + + VGFS++T       H
Sbjct: 161 ATIIYDSDTKILTVVMTHQNGQIT----TISQEIDLKTVLPEKVSVGFSATTWNPERERH 216

Query: 171 YILGWSFKINGQAEE 185
            I  WSF    +  E
Sbjct: 217 DIYSWSFTSTLKEPE 231

>1fx5_A UEA-I, UE-I, anti-H(O) lectin I; legume lectin, HOMO-dimer, fucose specific lectin, SUG binding protein; HET: NAG FUC BMA MAN; 2.20A {Ulex europaeus} SCOP: b.29.1.1 PDB: 1jxn_A* Length = 242

 Score =  141 bits (357), Expect = 9e-39
 Identities = 56/190 (29%), Positives = 81/190 (42%), Gaps = 22/190 (11%)

Query: 2   PFKNKNSNSSTANGTVFSFSTTFVFSIL-SEYQSQSGHGIAFVIASTRGLPGARPSQYLG 60
           P    N N+    G + SF T+F F +  S     +  G+ F +A     P  R   Y G
Sbjct: 54  PIHIWNCNT----GELASFITSFSFFMETSANPKAATDGLTFFLAPP-DSPLRRAGGYFG 108

Query: 61  LFNDTNLGNETNHVFAVELDTIKSHG-FLDINDNHVGIDINSLKSESSAPAGYY------ 113
           LFNDT   + +    AVE DTI S   F D    H+GID+N +KS ++            
Sbjct: 109 LFNDTK-CDSSYQTVAVEFDTIGSPVNFWDPGFPHIGIDVNCVKSINAERWNKRYGLNNV 167

Query: 114 ----VEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSVLNDAMYVGFSSSTG-SVLA 168
               + Y+   K    +L   +     S+ +     DL  +L + + VGFS ST     A
Sbjct: 168 ANVEIIYEASSKTLTASLTYPSDQTSISVTS---IVDLKEILPEWVSVGFSGSTYIGRQA 224

Query: 169 SHYILGWSFK 178
           +H +L W F 
Sbjct: 225 THEVLNWYFT 234

>1fat_A Phytohemagglutinin-L; glycoprotein, plant defense protein, lectin; HET: NAG; 2.80A {Phaseolus vulgaris} SCOP: b.29.1.1 PDB: 1g8w_A* Length = 252

 Score =  141 bits (357), Expect = 1e-38
 Identities = 53/194 (27%), Positives = 87/194 (44%), Gaps = 23/194 (11%)

Query: 13  ANGTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGLFNDTNLGNETN 72
             GTV SF+T+F F+I     +    G+AF +       G++P    G     +  N   
Sbjct: 61  TTGTVASFATSFTFNIQVPNNAGPADGLAFALVPV----GSQPKDKGGFLGLFDGSNSNF 116

Query: 73  HVFAVELDTIKSHGFLDINDNHVGIDINSLKSESSAPAGYY--------VEYDGLEKRTN 124
           H  AVE DT+ +  + D  + H+GID+NS++S  +    +         + YD       
Sbjct: 117 HTVAVEFDTLYNKDW-DPTERHIGIDVNSIRSIKTTRWDFVNGENAEVLITYDSSTNLLV 175

Query: 125 VTLAPINIPRPRSLNTMSLSRDLSSVLNDAMYVGFSSSTGSVLAS---HYILGWSFKIN- 180
            +L   +      ++    + DL SVL + + VGFS++TG    +   + +L WSF    
Sbjct: 176 ASLVYPSQKTSFIVSD---TVDLKSVLPEWVSVGFSATTGINKGNVETNDVLSWSFASKL 232

Query: 181 ---GQAEELNLSQL 191
                +E LNL+ L
Sbjct: 233 SDETTSEGLNLANL 246

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  143 bits (362), Expect = 1e-38
 Identities = 56/209 (26%), Positives = 98/209 (46%), Gaps = 16/209 (7%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKIS--HESRQGMKEFVAEIVSIGRLRHRNL 320
            +    +G G F  VY+G   ++ +E+A  ++     ++   + F  E   +  L+H N+
Sbjct: 28  LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 87

Query: 321 VQLLGY----CRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYL 376
           V+         + K  ++LV + M +G+L  YL     + +  ++ +   + +  GL +L
Sbjct: 88  VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSW--CRQILKGLQFL 145

Query: 377 HQEWEQVVIHRDVKASNVLLDGELNGR--LGDFGLARLYDHGTDPQTTHVVGTLGYLAPE 434
           H      +IHRD+K  N+ + G   G   +GD GLA L           V+GT  ++APE
Sbjct: 146 HTR-TPPIIHRDLKCDNIFITGP-TGSVKIGDLGLATL---KRASFAKAVIGTPEFMAPE 200

Query: 435 HTRTGKATTSADVFSFGAFLLEVACGRRP 463
                K   S DV++FG  +LE+A    P
Sbjct: 201 -MYEEKYDESVDVYAFGMCMLEMATSEYP 228

>1v6i_A Agglutinin, PNA, galactose-binding lectin; open quaternary association, orthorhombic, carbohydrate specificity, protein crystallography; HET: GAL GLC; 2.15A {Arachis hypogaea} SCOP: b.29.1.1 PDB: 1bzw_A* 1v6j_A* 1v6k_A* 1v6l_A* 1v6m_A 1v6n_A 1v6o_A 2dva_A* 1cq9_A 1ciw_A* 1qf3_A* 1rir_A* 1rit_A* 2dh1_A 1cr7_A* 2dv9_A* 2dvb_A* 2dvd_A* 2dvf_A 2dvg_A* ... Length = 232

 Score =  140 bits (355), Expect = 1e-38
 Identities = 51/185 (27%), Positives = 72/185 (38%), Gaps = 19/185 (10%)

Query: 2   PFKNKNSNSSTANGTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGL 61
           P +  +S +    G V SF T+F F +          GI F IA       A  S   G 
Sbjct: 51  PVRIWSSAT----GNVASFLTSFSFEMKDIKDYDPADGIIFFIAPEDTQIPA-GSIGGGT 105

Query: 62  FNDTNLGNETNHVFAVELDTIKSHGFLDINDNHVGIDINSLKSESSAPAGY--------Y 113
              ++      H   VE DT  +  + D   +HVGID+NS+ S  + P            
Sbjct: 106 LGVSD-TKGAGHFVGVEFDTYSNSEYNDPPTDHVGIDVNSVDSVKTVPWNSVSGAVVKVT 164

Query: 114 VEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSVLNDAMYVGFSSSTGSVLAS-HYI 172
           V YD   K  +V +   N        T++   DL + L + +  GFS+S        H I
Sbjct: 165 VIYDSSTKTLSVAVTNDNGDIT----TIAQVVDLKAKLPERVKFGFSASGSLGGRQIHLI 220

Query: 173 LGWSF 177
             WSF
Sbjct: 221 RSWSF 225

>1sbf_A Soybean agglutinin; lectin; HET: NAG GAL; 2.43A {Glycine max} SCOP: b.29.1.1 PDB: 1sbd_A* 1sbe_A* 1g9f_A* 2sba_A* Length = 253

 Score =  141 bits (355), Expect = 2e-38
 Identities = 52/201 (25%), Positives = 87/201 (43%), Gaps = 23/201 (11%)

Query: 2   PFKNKNSNSSTANGTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGL 61
           P    +  +    G+V SF+ +F F+  +    +   G+AF +A          + YLGL
Sbjct: 56  PIHIWDKET----GSVASFAASFNFTFYAPDTKRLADGLAFFLAPI-DTKPQTHAGYLGL 110

Query: 62  FNDTNLGNETNHVFAVELDTIKSHGFLDINDNHVGIDINSLKSESSAP--------AGYY 113
           FN+       + V AVE DT ++    D  + H+GI++NS++S  +          A   
Sbjct: 111 FNENE---SGDQVVAVEFDTFRNSW--DPPNPHIGINVNSIRSIKTTSWDLANNKVAKVL 165

Query: 114 VEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSVLNDAMYVGFSSSTGSVLA--SHY 171
           + YD        +L   +      L+      DL + L + + +GFS++TG  +   SH 
Sbjct: 166 ITYDASTSLLVASLVYPSQRTSNILSD---VVDLKTSLPEWVRIGFSAATGLDIPGESHD 222

Query: 172 ILGWSFKINGQAEELNLSQLP 192
           +L WSF  N      N+  L 
Sbjct: 223 VLSWSFASNLPHASSNIDPLD 243

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  142 bits (359), Expect = 2e-38
 Identities = 80/308 (25%), Positives = 124/308 (40%), Gaps = 44/308 (14%)

Query: 237 EEL--EDWELDHGPHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTL--PKSQIEIAVK 292
           EE+  ++  LD        K L +  K       LG+G FG V +G     K    +AVK
Sbjct: 4   EEIRPKEVYLDR-------KLLTLEDK------ELGSGNFGTVKKGYYQMKKVVKTVAVK 50

Query: 293 --KISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLY 350
             K          E +AE   + +L +  +V+++G C  +   +LV +    G L+KYL 
Sbjct: 51  ILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAES-WMLVMEMAELGPLNKYLQ 109

Query: 351 DQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLA 410
               V    I     +  V++G+ YL  E E   +HRD+ A NVLL  +   ++ DFGL+
Sbjct: 110 QNRHVKDKNIIEL--VHQVSMGMKYL--E-ESNFVHRDLAARNVLLVTQHYAKISDFGLS 164

Query: 411 RLYDHGTDPQTTHVVGTL--GYLAPEHTRTGKATTSADVFSFGAFLLEVA-CGRRPIQRQ 467
           +      +       G     + APE     K ++ +DV+SFG  + E    G++P +  
Sbjct: 165 KALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM 224

Query: 468 GPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMR 527
             SE       V     +GE +    P      + +       L  LC   D   RP   
Sbjct: 225 KGSE-------VTAMLEKGERMGC--PAGCPREMYD-------LMNLCWTYDVENRPGFA 268

Query: 528 QVVQILER 535
            V   L  
Sbjct: 269 AVELRLRN 276

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  141 bits (357), Expect = 9e-38
 Identities = 69/290 (23%), Positives = 114/290 (39%), Gaps = 37/290 (12%)

Query: 266 KELLGTGGFGRVYRGTL----PKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLV 321
              LG G FG V           +   +AVK++ H      ++F  EI  +  L    +V
Sbjct: 28  ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 87

Query: 322 QLLGYCRRKGE--LLLVYDYMPNGSLDKYLYD-QPKVTLNWIQRFRVIKGVALGLFYLHQ 378
           +  G     G   L LV +Y+P+G L  +L   + ++  + +  +     +  G+ YL  
Sbjct: 88  KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLY--SSQICKGMEYLG- 144

Query: 379 EWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYL-----AP 433
              +  +HRD+ A N+L++ E + ++ DFGLA+L     D    +VV   G       AP
Sbjct: 145 --SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKD---YYVVREPGQSPIFWYAP 199

Query: 434 EHTRTGKATTSADVFSFGAFLLEVA-CGRRPIQRQGPSENLILVDW-------VFDFWNR 485
           E       +  +DV+SFG  L E+     +          ++  +        + +    
Sbjct: 200 ESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEE 259

Query: 486 GELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER 535
           G+ L A  P      V E       L  LC    P  RPS   +   L+ 
Sbjct: 260 GQRLPA--PPACPAEVHE-------LMKLCWAPSPQDRPSFSALGPQLDM 300

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  144 bits (364), Expect = 1e-37
 Identities = 74/270 (27%), Positives = 113/270 (41%), Gaps = 23/270 (8%)

Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
             LG G FG V+ GT       +A+K +        + F+ E   + +LRH  LVQL   
Sbjct: 190 VKLGQGCFGEVWMGTW-NGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247

Query: 327 CRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIH 386
              +  + +V +YM  GSL  +L  +    L   Q   +   +A G+ Y+        +H
Sbjct: 248 VSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 303

Query: 387 RDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSAD 446
           RD++A+N+L+   L  ++ DFGLARL +             + + APE    G+ T  +D
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 363

Query: 447 VFSFGAFLLEVA-CGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAEEL 505
           V+SFG  L E+   GR P       E       V D   RG  +    P    E + +  
Sbjct: 364 VWSFGILLTELTTKGRVPYPGMVNRE-------VLDQVERGYRMPC--PPECPESLHD-- 412

Query: 506 ELVLKLGLLCSHSDPTARPSMRQVVQILER 535
                L   C   +P  RP+   +   LE 
Sbjct: 413 -----LMCQCWRKEPEERPTFEYLQAFLED 437

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  140 bits (356), Expect = 1e-37
 Identities = 68/289 (23%), Positives = 119/289 (41%), Gaps = 44/289 (15%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKE---FVAEIVSIGRLRHRN 319
           FR ++ +G G F  VYR       + +A+KK+        K     + EI  + +L H N
Sbjct: 34  FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93

Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPK--------VTLNW-IQRFRVIKGVA 370
           +++         EL +V +    G L + +    K            + +Q       + 
Sbjct: 94  VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQ-------LC 146

Query: 371 LGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGY 430
             L ++H    + V+HRD+K +NV +      +LGD GL R +   T    + +VGT  Y
Sbjct: 147 SALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-LVGTPYY 202

Query: 431 LAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGEL-- 488
           ++PE          +D++S G  L E+A  + P              +  D  N   L  
Sbjct: 203 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSP--------------FYGDKMNLYSLCK 248

Query: 489 --LEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER 535
              +   P L +++ +EEL  ++    +C + DP  RP +  V  + +R
Sbjct: 249 KIEQCDYPPLPSDHYSEELRQLVN---MCINPDPEKRPDVTYVYDVAKR 294

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  140 bits (354), Expect = 4e-37
 Identities = 71/320 (22%), Positives = 126/320 (39%), Gaps = 34/320 (10%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNL 320
           +   + +G G FG+       +   +  +K+I+    S +  +E   E+  +  ++H N+
Sbjct: 26  YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNI 85

Query: 321 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEW 380
           VQ        G L +V DY   G L K +  Q  V     Q       + L L ++H   
Sbjct: 86  VQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH--- 142

Query: 381 EQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGK 440
           ++ ++HRD+K+ N+ L  +   +LGDFG+AR+ +   +      +GT  YL+PE      
Sbjct: 143 DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA-CIGTPYYLSPEICENKP 201

Query: 441 ATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELL----EARDPNL 496
               +D+++ G  L E+   +                  F+  +   L+        P +
Sbjct: 202 YNNKSDIWALGCVLYELCTLKHA----------------FEAGSMKNLVLKIISGSFPPV 245

Query: 497 GTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERDVALPAISALRLSTSGITYLE 556
              Y + +L  ++         +P  RPS   V  ILE+      I    LS   I    
Sbjct: 246 SLHY-SYDLRSLVS---QLFKRNPRDRPS---VNSILEKGFIAKRIEKF-LSPQLIAEEF 297

Query: 557 GFDDFAVSNPPSMGFTRPSS 576
               F+      +   RP+S
Sbjct: 298 CLKTFSKFGSQPIPAKRPAS 317

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  138 bits (349), Expect = 4e-37
 Identities = 75/298 (25%), Positives = 126/298 (42%), Gaps = 43/298 (14%)

Query: 242 WELDHGPHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQG 301
           W +D         +L          + +G+G FG V+ G    ++ ++A+K I  E    
Sbjct: 3   WVIDP-------SELTF-------VQEIGSGQFGLVHLGYW-LNKDKVAIKTI-REGAMS 46

Query: 302 MKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQ 361
            ++F+ E   + +L H  LVQL G C  +  + LV ++M +G L  YL  Q         
Sbjct: 47  EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRG-LFAAET 105

Query: 362 RFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQ 420
              +   V  G+ YL    E  VIHRD+ A N L+      ++ DFG+ R + D   D  
Sbjct: 106 LLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD---DQY 159

Query: 421 TTHVVGTLGY--LAPEHTRTGKATTSADVFSFGAFLLEVA-CGRRPIQRQGPSENLILVD 477
           T+           +PE     + ++ +DV+SFG  + EV   G+ P + +  SE      
Sbjct: 160 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE------ 213

Query: 478 WVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER 535
            V +  + G  L    P L + +V +       +   C    P  RP+  ++++ L  
Sbjct: 214 -VVEDISTGFRLYK--PRLASTHVYQ-------IMNHCWRERPEDRPAFSRLLRQLAE 261

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  138 bits (349), Expect = 4e-37
 Identities = 80/297 (26%), Positives = 129/297 (43%), Gaps = 43/297 (14%)

Query: 242 WELDHGPHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQG 301
            EL         +++ +        + LG+G FG V  G   K Q ++AVK I  E    
Sbjct: 3   MELKR-------EEITL-------LKELGSGQFGVVKLGKW-KGQYDVAVKMI-KEGSMS 46

Query: 302 MKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQ 361
             EF  E  ++ +L H  LV+  G C ++  + +V +Y+ NG L  YL    K  L   Q
Sbjct: 47  EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGK-GLEPSQ 105

Query: 362 RFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQ 420
              +   V  G+ +L        IHRD+ A N L+D +L  ++ DFG+ R + D   D  
Sbjct: 106 LLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD---DQY 159

Query: 421 TTHVVGTLGY--LAPEHTRTGKATTSADVFSFGAFLLEVA-CGRRPIQRQGPSENLILVD 477
            + V         APE     K ++ +DV++FG  + EV   G+ P      SE      
Sbjct: 160 VSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE------ 213

Query: 478 WVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILE 534
            V    ++G  L    P+L ++ + +       +   C H  P  RP+ +Q++  +E
Sbjct: 214 -VVLKVSQGHRLYR--PHLASDTIYQ-------IMYSCWHELPEKRPTFQQLLSSIE 260

>1ioa_A Arcelin-5A, ARC5A; lectin-like proteins, plant defense proteins, lectin; HET: NAG FUC; 2.70A {Phaseolus vulgaris} SCOP: b.29.1.1 Length = 240

 Score =  137 bits (345), Expect = 4e-37
 Identities = 43/182 (23%), Positives = 74/182 (40%), Gaps = 13/182 (7%)

Query: 13  ANGTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGLFNDTNLGNETN 72
            +  V SF+T F F I ++ QS S +G+AF +      P     ++LG+FN  N      
Sbjct: 60  DSNNVASFNTNFTFIIRAKNQSISAYGLAFALVPVNSPPQK-KQEFLGIFNTNN-PEPNA 117

Query: 73  HVFAVELDTIKSHGFLDINDNHVGIDIN---SLKSESSAPAGYYVEYDGLEKRTNVTLAP 129
              AV  +T K+    D + N +   +N        +       + YD       V L  
Sbjct: 118 RTVAVVFNTFKNRI--DFDKNFIKPYVNENCDFHKYNGEKTDVQITYDSSNNDLRVFLHF 175

Query: 130 INIPRPRSLNTMSLSRDLSSVLNDAMYVGFSSSTGSV---LASHYILGWSFKINGQAEEL 186
                  S++    +  L   +++ + VGFS ++G       +H +L WSF    + +  
Sbjct: 176 TVSQVKCSVSA---TVHLEKEVDEWVSVGFSPTSGLTEDTTETHDVLSWSFSSKFRNKLS 232

Query: 187 NL 188
           N+
Sbjct: 233 NI 234

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  143 bits (363), Expect = 4e-37
 Identities = 74/270 (27%), Positives = 113/270 (41%), Gaps = 23/270 (8%)

Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGY 326
             LG G FG V+ GT       +A+K +        + F+ E   + +LRH  LVQL   
Sbjct: 273 VKLGQGCFGEVWMGTW-NGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 330

Query: 327 CRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIH 386
              +  + +V +YM  GSL  +L  +    L   Q   +   +A G+ Y+        +H
Sbjct: 331 VSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 386

Query: 387 RDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSAD 446
           RD++A+N+L+   L  ++ DFGLARL +             + + APE    G+ T  +D
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 446

Query: 447 VFSFGAFLLEVA-CGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAEEL 505
           V+SFG  L E+   GR P       E       V D   RG  +    P    E + +  
Sbjct: 447 VWSFGILLTELTTKGRVPYPGMVNRE-------VLDQVERGYRMPC--PPECPESLHD-- 495

Query: 506 ELVLKLGLLCSHSDPTARPSMRQVVQILER 535
                L   C   +P  RP+   +   LE 
Sbjct: 496 -----LMCQCWRKEPEERPTFEYLQAFLED 520

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  138 bits (350), Expect = 4e-37
 Identities = 82/280 (29%), Positives = 125/280 (44%), Gaps = 33/280 (11%)

Query: 267 ELLGTGGFGRVYRGTL---PKSQIEIAVKKI-SHESRQGMKEFVAEIVSIGRLRHRNLVQ 322
           E++G G FG VY GTL      +I  AVK +        + +F+ E + +    H N++ 
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90

Query: 323 LLGYC-RRKGELLLVYDYMPNGSLDKYL-YDQPKVTLNWIQRFRVIKGVALGLFYLHQEW 380
           LLG C R +G  L+V  YM +G L  ++  +    T+           VA G+ YL    
Sbjct: 91  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYLA--- 145

Query: 381 EQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVGTL--GYLAPEHTR 437
            +  +HRD+ A N +LD +   ++ DFGLAR +YD             L   ++A E  +
Sbjct: 146 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQ 205

Query: 438 TGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNL 496
           T K TT +DV+SFG  L E+   G  P       +       +  +  +G  L    P  
Sbjct: 206 TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-------ITVYLLQGRRLLQ--P-- 254

Query: 497 GTEYVAEEL-ELVLKLGLLCSHSDPTARPSMRQVVQILER 535
             EY  + L E++LK    C H     RPS  ++V  +  
Sbjct: 255 --EYCPDPLYEVMLK----CWHPKAEMRPSFSELVSRISA 288

>1n47_A Isolectin B4; cancer antigen, vicia villosa lectin, glycoprotein TN-bindin protein, carbohydrate recognition, sugar binding protein; HET: NAG FUC TNR; 2.70A {Vicia villosa} SCOP: b.29.1.1 Length = 233

 Score =  136 bits (344), Expect = 5e-37
 Identities = 50/179 (27%), Positives = 81/179 (45%), Gaps = 18/179 (10%)

Query: 14  NGTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGLFNDTNLGNETNH 73
           N T+ SF+T+F F + +   +    G+AF +A     P A    +LGLF D    + +  
Sbjct: 61  NTTLASFTTSFSFVMAAPAAAAVADGLAFFLAPPDTQPQA-RGGFLGLFADRA-HDASYQ 118

Query: 74  VFAVELDTIKSHGFLDINDNHVGIDINSLKSESSAP--------AGYYVEYDGLEKRTNV 125
             AVE DT  +    D N  H+GID N ++S+ + P        A   + Y    K    
Sbjct: 119 TVAVEFDTYSNAW--DPNYTHIGIDTNGIESKKTTPFDMVYGEKANIVITYQASTKALAA 176

Query: 126 TLAPINIPRPRSLNTMSLSRDLSSVLNDAMYVGFSSSTGSVLA---SHYILGWSFKING 181
           +L         +++      DL  +L + + VGFS++TG       +H I+ WSF ++ 
Sbjct: 177 SLVFPVSQTSYAVSA---RVDLRDILPEYVRVGFSATTGLNAGVVETHDIVSWSFAVSL 232

>1dbn_A MAL, protein (leukoagglutinin); plant lectin, carbohydrate binding, sialyllactose, sugar BIN protein; HET: NAG SIA GAL BGC; 2.75A {Maackia amurensis} SCOP: b.29.1.1 Length = 239

 Score =  136 bits (344), Expect = 5e-37
 Identities = 56/190 (29%), Positives = 94/190 (49%), Gaps = 21/190 (11%)

Query: 2   PFKNKNSNSSTANGTVFSFSTTFVFSILSEYQSQSGHGIAFVIAST-RGLPGARPSQYLG 60
           P +   + +    G+V SFST+F F + +     +  G+AF +A     +P    S+YLG
Sbjct: 55  PVRIWGNTT----GSVASFSTSFTFVVKAPNPDITSDGLAFYLAPPDSQIPSGSVSKYLG 110

Query: 61  LFNDTNLGNETNHVFAVELDTIKSHGF--LDINDNHVGIDINSLKSESSAPAGYY----- 113
           LFN++N  + +N + AVE DT  +H +   D N  H+GID+N ++S  +    +      
Sbjct: 111 LFNNSN-SDSSNQIVAVEFDTYFAHSYDPWDPNYRHIGIDVNGIESIKTVQWDWINGGVA 169

Query: 114 ---VEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSVLNDAMYVGFSSSTG--SVLA 168
              + Y    K    +L   +     S+     S DL  +L + + VGFS++TG  + + 
Sbjct: 170 FATITYLAPNKTLIASLVYPSNQTTFSVAA---SVDLKEILPEWVRVGFSAATGYPTEVE 226

Query: 169 SHYILGWSFK 178
           +H +L WSF 
Sbjct: 227 THDVLSWSFT 236

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  138 bits (349), Expect = 6e-37
 Identities = 71/302 (23%), Positives = 123/302 (40%), Gaps = 40/302 (13%)

Query: 240 EDWELDHGPHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTL--PKSQIEIAVKKISHE 297
           +   L          +L I          LG G FG V +G     K QI++A+K +   
Sbjct: 2   KKLFLKR-------DNLLI------ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG 48

Query: 298 -SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVT 356
             +   +E + E   + +L +  +V+L+G C+ +  L+LV +    G L K+L  + +  
Sbjct: 49  TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGPLHKFLVGKRE-E 106

Query: 357 LNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHG 416
           +       ++  V++G+ YL    E+  +HRD+ A NVLL      ++ DFGL++     
Sbjct: 107 IPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 163

Query: 417 TDPQTTHVVGTL--GYLAPEHTRTGKATTSADVFSFGAFLLEVA-CGRRPIQRQGPSENL 473
               T    G     + APE     K ++ +DV+S+G  + E    G++P ++    E  
Sbjct: 164 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-- 221

Query: 474 ILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQIL 533
                V  F  +G+ +E   P      +         L   C       RP    V Q +
Sbjct: 222 -----VMAFIEQGKRMEC--PPECPPELYA-------LMSDCWIYKWEDRPDFLTVEQRM 267

Query: 534 ER 535
             
Sbjct: 268 RA 269

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  138 bits (349), Expect = 7e-37
 Identities = 65/209 (31%), Positives = 103/209 (49%), Gaps = 18/209 (8%)

Query: 264 REKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQL 323
            ++ +LG G +G VY G    +Q+ IA+K+I     +  +    EI     L+H+N+VQ 
Sbjct: 25  GDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQY 84

Query: 324 LGYCRRKGELLLVYDYMPNGSLDKYL---YDQPKVTLNWIQRFRVIKGVALGLFYLHQEW 380
           LG     G + +  + +P GSL   L   +   K     I  +   K +  GL YLH   
Sbjct: 85  LGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFY--TKQILEGLKYLH--- 139

Query: 381 EQVVIHRDVKASNVLLDGELNGR--LGDFGLA-RLYDHGTDPQTTHVVGTLGYLAPE--- 434
           +  ++HRD+K  NVL++   +G   + DFG + RL       +T    GTL Y+APE   
Sbjct: 140 DNQIVHRDIKGDNVLIN-TYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAPEIID 196

Query: 435 HTRTGKATTSADVFSFGAFLLEVACGRRP 463
               G    +AD++S G  ++E+A G+ P
Sbjct: 197 KGPRG-YGKAADIWSLGCTIIEMATGKPP 224

>1qnw_A Chitin binding lectin, UEA-II; carbohydrate binding; HET: NAG; 2.35A {Ulex europaeus} SCOP: b.29.1.1 PDB: 1dzq_A* 1qoo_A* 1qos_A* 1qot_A* Length = 242

 Score =  136 bits (343), Expect = 8e-37
 Identities = 51/195 (26%), Positives = 88/195 (45%), Gaps = 22/195 (11%)

Query: 2   PFKNKNSNSSTANGTVFSFSTTFVFSILSEYQSQSGHGIAFVIA-STRGLPGARPSQYLG 60
           P +  +S +      V SF+T+F F + ++  S    G+AF +A +   +P    +   G
Sbjct: 55  PIQIWDSITGK----VASFATSFSFVVKADK-SDGVDGLAFFLAPANSQIPSGSSAGMFG 109

Query: 61  LFNDTNLGNETNHVFAVELDTIKSHGF--LDINDNHVGIDINSLKSESSAPAGYY----- 113
           LF+ ++    +N + AVE DT     +   D +  H+GID+NS+KS  +    +      
Sbjct: 110 LFSSSD-SKSSNQIIAVEFDTYFGKAYNPWDPDFKHIGIDVNSIKSIKTVKWDWRNGEVA 168

Query: 114 ---VEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSVLNDAMYVGFSSSTGSV--LA 168
              + Y    K   V L+  +      +     S DL ++L + + VGFS   G+     
Sbjct: 169 DVVITYRAPTKSLTVCLSYPSDGTSNIITA---SVDLKAILPEWVSVGFSGGVGNAAEFE 225

Query: 169 SHYILGWSFKINGQA 183
           +H +L W F  N +A
Sbjct: 226 THDVLSWYFTSNLEA 240

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  137 bits (348), Expect = 1e-36
 Identities = 66/287 (22%), Positives = 119/287 (41%), Gaps = 30/287 (10%)

Query: 266 KELLGTGGFGRVYRGTL----PKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLV 321
            + LG G FG V           +   +AVKK+ H + + +++F  EI  +  L+H N+V
Sbjct: 15  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 74

Query: 322 QLLGYCRRKGE--LLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQE 379
           +  G C   G   L L+ +Y+P GSL  YL    K  ++ I+  +    +  G+ YL   
Sbjct: 75  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLG-- 131

Query: 380 WEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTL--GYLAPEHTR 437
             +  IHRD+   N+L++ E   ++GDFGL ++     +       G     + APE   
Sbjct: 132 -TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLT 190

Query: 438 TGKATTSADVFSFGAFLLEVA--CGRRPIQRQGPSENLILVDW-------VFDFWNRGEL 488
             K + ++DV+SFG  L E+     +           +            + +       
Sbjct: 191 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGR 250

Query: 489 LEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER 535
           L    P+   + +         +   C +++   RPS R +   +++
Sbjct: 251 LPR--PDGCPDEIYM-------IMTECWNNNVNQRPSFRDLALRVDQ 288

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  138 bits (349), Expect = 1e-36
 Identities = 70/278 (25%), Positives = 125/278 (44%), Gaps = 32/278 (11%)

Query: 267 ELLGTGGFGRVYRGTL----PKSQIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLV 321
           ++LG+G FG VY+G       K +I +A+K++    S +  KE + E   +  + + ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 322 QLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
           +LLG C     + L+   MP G L  Y+ +  K  +           +A G+ YL    +
Sbjct: 81  RLLGICLTS-TVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLE---D 135

Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT---LGYLAPEHTRT 438
           + ++HRD+ A NVL+    + ++ DFGLA+L     + +  H  G    + ++A E    
Sbjct: 136 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA--EEKEYHAEGGKVPIKWMALESILH 193

Query: 439 GKATTSADVFSFGAFLLEVA-CGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLG 497
              T  +DV+S+G  + E+   G +P      SE       +     +GE L    P + 
Sbjct: 194 RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-------ISSILEKGERLPQ--PPIC 244

Query: 498 TEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER 535
           T  V     ++ K    C   D  +RP  R+++    +
Sbjct: 245 TIDV---YMIMRK----CWMIDADSRPKFRELIIEFSK 275

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  136 bits (345), Expect = 2e-36
 Identities = 58/286 (20%), Positives = 120/286 (41%), Gaps = 48/286 (16%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQ 322
           F+E EL+G+GGFG+V++           +K++ + + +  +E   + ++  +L H N+V 
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAERE--VKALA--KLDHVNIVH 68

Query: 323 LLGY----------------CRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVI 366
             G                   +   L +  ++   G+L++++  +    L+ +    + 
Sbjct: 69  YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELF 128

Query: 367 KGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVG 426
           + +  G+ Y+H    + +I+RD+K SN+ L      ++GDFGL     +  D + T   G
Sbjct: 129 EQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKN--DGKRTRSKG 183

Query: 427 TLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRG 486
           TL Y++PE   +       D+++ G  L E+                         +   
Sbjct: 184 TLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT------------------AFETS 225

Query: 487 ELLE-ARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ 531
           +     RD  +   +  +E  L+ KL L      P  RP+  ++++
Sbjct: 226 KFFTDLRDGIISDIFDKKEKTLLQKL-L---SKKPEDRPNTSEILR 267

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  137 bits (348), Expect = 2e-36
 Identities = 76/277 (27%), Positives = 129/277 (46%), Gaps = 27/277 (9%)

Query: 266 KELLGTGGFGRVYRGTL---PKSQIEIAVKKI-SHESRQGMKEFVAEIVSIGRLRHRNLV 321
           ++++G+G  G V  G L    +  + +A+K + +  + +  ++F++E   +G+  H N++
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113

Query: 322 QLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
           +L G   R    ++V +YM NGSLD +L          +Q   +++GV  G+ YL    +
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDG-QFTIMQLVGMLRGVGAGMRYLS---D 169

Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYL--APEHTRTG 439
              +HRD+ A NVL+D  L  ++ DFGL+R+ +   D   T   G +     APE     
Sbjct: 170 LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFR 229

Query: 440 KATTSADVFSFGAFLLEVA-CGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGT 498
             ++++DV+SFG  + EV   G RP       +       V      G  L A  P    
Sbjct: 230 TFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD-------VISSVEEGYRLPA--PMGCP 280

Query: 499 EYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER 535
             + +       L L C H D   RP   Q+V +L+ 
Sbjct: 281 HALHQ-------LMLDCWHKDRAQRPRFSQIVSVLDA 310

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  136 bits (345), Expect = 2e-36
 Identities = 79/301 (26%), Positives = 130/301 (43%), Gaps = 45/301 (14%)

Query: 240 EDWELDHGPHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR 299
             WE+D        KDL          + LGTG FG V  G   + Q ++A+K I  E  
Sbjct: 17  GSWEIDP-------KDLTF-------LKELGTGQFGVVKYGKW-RGQYDVAIKMI-KEGS 60

Query: 300 QGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYD-QPKVTLN 358
               EF+ E   +  L H  LVQL G C ++  + ++ +YM NG L  YL + + +    
Sbjct: 61  MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQT- 119

Query: 359 WIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD 418
             Q   + K V   + YL     +  +HRD+ A N L++ +   ++ DFGL+R      D
Sbjct: 120 -QQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL---D 172

Query: 419 PQTTHVVGTL---GYLAPEHTRTGKATTSADVFSFGAFLLEVA-CGRRPIQRQGPSENLI 474
            + T  VG+     +  PE     K ++ +D+++FG  + E+   G+ P +R   SE   
Sbjct: 173 DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE--- 229

Query: 475 LVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILE 534
                 +   +G  L    P+L +E V         +   C H     RP+ + ++  + 
Sbjct: 230 ----TAEHIAQGLRLYR--PHLASEKVYT-------IMYSCWHEKADERPTFKILLSNIL 276

Query: 535 R 535
            
Sbjct: 277 D 277

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  136 bits (344), Expect = 2e-36
 Identities = 80/301 (26%), Positives = 129/301 (42%), Gaps = 45/301 (14%)

Query: 240 EDWELDHGPHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVK--KISHE 297
           ++WE+         + L +        E LG G FG V+ G       ++AVK  K    
Sbjct: 6   DEWEVPR-------ETLKL-------VERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSM 50

Query: 298 SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTL 357
           S      F+AE   + +L+H+ LV+L     ++  + ++ +YM NGSL  +L     + L
Sbjct: 51  SPD---AFLAEANLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKL 106

Query: 358 NWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT 417
              +   +   +A G+ ++    E+  IHRD++A+N+L+   L+ ++ DFGLARL +   
Sbjct: 107 TINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIED-- 161

Query: 418 DPQTTHVVGTLGY--LAPEHTRTGKATTSADVFSFGAFLLEVA-CGRRPIQRQGPSENLI 474
           +  T            APE    G  T  +DV+SFG  L E+   GR P       E   
Sbjct: 162 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE--- 218

Query: 475 LVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILE 534
               V     RG  +    P+   E + +       L  LC    P  RP+   +  +LE
Sbjct: 219 ----VIQNLERGYRMVR--PDNCPEELYQ-------LMRLCWKERPEDRPTFDYLRSVLE 265

Query: 535 R 535
            
Sbjct: 266 D 266

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  138 bits (350), Expect = 2e-36
 Identities = 80/324 (24%), Positives = 145/324 (44%), Gaps = 35/324 (10%)

Query: 266 KELLGTGGFGRVYRGTL---PKSQIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLV 321
            +++G G FG V  G L    K +I +A+K +    + +  ++F+ E   +G+  H N++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109

Query: 322 QLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
           +L G   +   +++V +YM NGSLD +L          IQ   +++G+A G+ YL    +
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDA-QFTVIQLVGMLRGIASGMKYLS---D 165

Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYL--APEHTRTG 439
              +HRD+ A N+L++  L  ++ DFGL R+ +   +   T   G +     +PE     
Sbjct: 166 MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR 225

Query: 440 KATTSADVFSFGAFLLEVA-CGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGT 498
           K T+++DV+S+G  L EV   G RP       +       V    + G  L    P    
Sbjct: 226 KFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD-------VIKAVDEGYRLPP--PMDCP 276

Query: 499 EYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERDVALPA-ISALRLSTSGITYLEG 557
             + +       L L C   D   RP   Q+V IL++ +  P  +  +  + +  + L  
Sbjct: 277 AALYQ-------LMLDCWQKDRNNRPKFEQIVSILDKLIRNPGSLKIITSAAARPSNL-- 327

Query: 558 FDDFAVSNPPSMGFTRPSSVAESL 581
                + +  ++  T   +  + L
Sbjct: 328 -----LLDQSNVDITTFRTTGDWL 346

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  135 bits (343), Expect = 3e-36
 Identities = 88/302 (29%), Positives = 128/302 (42%), Gaps = 51/302 (16%)

Query: 240 EDWELDHGPHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR 299
             W L+        K+L +        + +G G FG V  G    +  ++AVK I    +
Sbjct: 14  SGWALNM-------KELKL-------LQTIGKGEFGDVMLGDYRGN--KVAVKCI----K 53

Query: 300 QGM--KEFVAEIVSIGRLRHRNLVQLLGYC-RRKGELLLVYDYMPNGSLDKYLYDQPKVT 356
                + F+AE   + +LRH NLVQLLG     KG L +V +YM  GSL  YL  + +  
Sbjct: 54  NDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV 113

Query: 357 LNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHG 416
           L      +    V   + YL        +HRD+ A NVL+  +   ++ DFGL +     
Sbjct: 114 LGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK----- 165

Query: 417 TDPQTTHVVGTLGY--LAPEHTRTGKATTSADVFSFGAFLLEVA-CGRRPIQRQGPSENL 473
            +  +T   G L     APE  R  K +T +DV+SFG  L E+   GR P  R    +  
Sbjct: 166 -EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-- 222

Query: 474 ILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQIL 533
                V     +G  ++A  P+     V E       +   C H D   RPS  Q+ + L
Sbjct: 223 -----VVPRVEKGYKMDA--PDGCPPAVYE-------VMKNCWHLDAAMRPSFLQLREQL 268

Query: 534 ER 535
           E 
Sbjct: 269 EH 270

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  137 bits (346), Expect = 3e-36
 Identities = 65/291 (22%), Positives = 120/291 (41%), Gaps = 38/291 (13%)

Query: 266 KELLGTGGFGRVYRGTL----PKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLV 321
            + LG G FG V           +   +AVKK+ H + + +++F  EI  +  L+H N+V
Sbjct: 46  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 105

Query: 322 QLLGYCRRKGE--LLLVYDYMPNGSLDKYLYD-QPKVTLNWIQRFRVIKGVALGLFYLHQ 378
           +  G C   G   L L+ +Y+P GSL  YL   + ++    + ++     +  G+ YL  
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY--TSQICKGMEYLG- 162

Query: 379 EWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYL-----AP 433
              +  IHRD+   N+L++ E   ++GDFGL ++     +    + V   G       AP
Sbjct: 163 --TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE---YYKVKEPGESPIFWYAP 217

Query: 434 EHTRTGKATTSADVFSFGAFLLEVA--CGRRPIQRQGPSENLILVDW-------VFDFWN 484
           E     K + ++DV+SFG  L E+     +           +            + +   
Sbjct: 218 ESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK 277

Query: 485 RGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER 535
               L    P+   + +         +   C +++   RPS R +   +++
Sbjct: 278 NNGRLPR--PDGCPDEIYM-------IMTECWNNNVNQRPSFRDLALRVDQ 319

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  136 bits (344), Expect = 3e-36
 Identities = 82/310 (26%), Positives = 136/310 (43%), Gaps = 45/310 (14%)

Query: 237 EELEDWELDHGPHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTL---PKSQIEIAVK- 292
            E++D  + H   R                 ++G G FG VY G      +++I+ A+K 
Sbjct: 9   AEVKDVLIPH--ERVV----------THSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKS 56

Query: 293 -KISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYC-RRKGELLLVYDYMPNGSLDKYLY 350
                E +Q ++ F+ E + +  L H N++ L+G     +G   ++  YM +G L +++ 
Sbjct: 57  LSRITEMQQ-VEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIR 115

Query: 351 DQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLA 410
             P+              VA G+ YL    EQ  +HRD+ A N +LD     ++ DFGLA
Sbjct: 116 S-PQRNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLA 171

Query: 411 R-LYDHGTDPQTTHVVGTL--GYLAPEHTRTGKATTSADVFSFGAFLLEVA-CGRRPIQR 466
           R + D        H    L   + A E  +T + TT +DV+SFG  L E+   G  P + 
Sbjct: 172 RDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRH 231

Query: 467 QGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAEEL-ELVLKLGLLCSHSDPTARPS 525
             P +       +  F  +G  L    P    EY  + L +++ +    C  +DP  RP+
Sbjct: 232 IDPFD-------LTHFLAQGRRLPQ--P----EYCPDSLYQVMQQ----CWEADPAVRPT 274

Query: 526 MRQVVQILER 535
            R +V  +E+
Sbjct: 275 FRVLVGEVEQ 284

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  137 bits (348), Expect = 4e-36
 Identities = 82/280 (29%), Positives = 126/280 (45%), Gaps = 33/280 (11%)

Query: 267 ELLGTGGFGRVYRGTL---PKSQIEIAVKKI-SHESRQGMKEFVAEIVSIGRLRHRNLVQ 322
           E++G G FG VY GTL      +I  AVK +        + +F+ E + +    H N++ 
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154

Query: 323 LLGYC-RRKGELLLVYDYMPNGSLDKYL-YDQPKVTLNWIQRFRVIKGVALGLFYLHQEW 380
           LLG C R +G  L+V  YM +G L  ++  +    T+           VA G+ +L    
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKFLA--- 209

Query: 381 EQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVGTL--GYLAPEHTR 437
            +  +HRD+ A N +LD +   ++ DFGLAR +YD   D         L   ++A E  +
Sbjct: 210 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 269

Query: 438 TGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNL 496
           T K TT +DV+SFG  L E+   G  P       +       +  +  +G  L    P  
Sbjct: 270 TQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-------ITVYLLQGRRLLQ--P-- 318

Query: 497 GTEYVAEEL-ELVLKLGLLCSHSDPTARPSMRQVVQILER 535
             EY  + L E++LK    C H     RPS  ++V  +  
Sbjct: 319 --EYCPDPLYEVMLK----CWHPKAEMRPSFSELVSRISA 352

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  136 bits (344), Expect = 4e-36
 Identities = 77/328 (23%), Positives = 141/328 (42%), Gaps = 61/328 (18%)

Query: 230 RMKRKFAEELEDWELDHGPHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTL---PKSQ 286
           R   +   +LED  +D          L +        ++LG G FG V  G L     + 
Sbjct: 17  RGSEELQNKLEDVVIDR-------NLLIL-------GKILGEGEFGSVMEGNLKQEDGTS 62

Query: 287 IEIAVK--KISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYC-----RRKGELLLVYDY 339
           +++AVK  K+ + S++ ++EF++E   +    H N+++LLG C     +   + +++  +
Sbjct: 63  LKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPF 122

Query: 340 MPNGSLDKYL----YDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVL 395
           M  G L  YL     +     +      + +  +ALG+ YL     +  +HRD+ A N +
Sbjct: 123 MKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCM 179

Query: 396 LDGELNGRLGDFGLAR-LYDHGTDPQTTHVVGTLGYL-----APEHTRTGKATTSADVFS 449
           L  ++   + DFGL++ +Y         +  G +  +     A E       T+ +DV++
Sbjct: 180 LRDDMTVCVADFGLSKKIYS-----GDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWA 234

Query: 450 FGAFLLEVA-CGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAEEL-EL 507
           FG  + E+A  G  P       E       ++D+   G  L+   P    E   +EL E+
Sbjct: 235 FGVTMWEIATRGMTPYPGVQNHE-------MYDYLLHGHRLKQ--P----EDCLDELYEI 281

Query: 508 VLKLGLLCSHSDPTARPSMRQVVQILER 535
           +      C  +DP  RP+   +   LE+
Sbjct: 282 MYS----CWRTDPLDRPTFSVLRLQLEK 305

>1avb_A Arcelin-1; lectin-like glycoprotein, plant defense, insecticidal activi lectin; HET: NAG; 1.90A {Phaseolus vulgaris} SCOP: b.29.1.1 Length = 226

 Score =  133 bits (336), Expect = 5e-36
 Identities = 49/192 (25%), Positives = 80/192 (41%), Gaps = 31/192 (16%)

Query: 2   PFKNKNSNSSTANGTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGL 61
           P +  +         + SFST F F I ++    S +G+AF +      P     +YLGL
Sbjct: 51  PIQINDRT----IDNLASFSTNFTFRINAKNIENSAYGLAFALVPVGSRPKL-KGRYLGL 105

Query: 62  FNDTNLGNETNHVFAVELDTIKSHGFLDINDNHVGIDINSLKSESSAPAGYY-------- 113
           FN TN  +   H  AV  DT           N + ID+NS++  ++    +         
Sbjct: 106 FNTTN-YDRDAHTVAVVFDT---------VSNRIEIDVNSIRPIATESCNFGHNNGEKAE 155

Query: 114 --VEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSVLNDAMYVGFSSSTGS---VLA 168
             + YD  +    V+L   +      ++    +  L   + D + VGFS+++GS      
Sbjct: 156 VRITYDSPKNDLRVSLLYPSSEEKCHVSA---TVPLEKEVEDWVSVGFSATSGSKKETTE 212

Query: 169 SHYILGWSFKIN 180
           +H +L WSF  N
Sbjct: 213 THNVLSWSFSSN 224

>1wbf_A Protein (agglutinin); lectin (agglutinin), legume lectin, protein crystallography, group specificity, saccharide free form; HET: NAG; 2.30A {Psophocarpus tetragonolobus} SCOP: b.29.1.1 PDB: 2d3s_A* 2dtw_A* 1wbl_A* 2dty_A* 2du0_A* 2du1_A* 2e51_A* 2e53_A* 2zmk_A* 2zml_A* 2zmn_A* 2e7t_A* 2e7q_A* Length = 242

 Score =  134 bits (337), Expect = 5e-36
 Identities = 54/200 (27%), Positives = 83/200 (41%), Gaps = 30/200 (15%)

Query: 2   PFKNKNSNSSTANGTVFSFSTTFVFSILSEYQSQ-SGHGIAFVIASTRGLPGARPSQYLG 60
           P +  +S +    G V SF T F FSI   +       G+ F IA      G     Y G
Sbjct: 55  PVQVWDSTT----GNVASFETRFSFSIRQPFPRPHPADGLVFFIAPPNTQTGE-GGGYFG 109

Query: 61  LFNDTNLGNETNHVFAVELDTIKSHGFLDINDNHVGIDINSLKSESSAPAGYY------- 113
           ++N  +         AVE DT ++    D    H+GID+NS+ S  + P           
Sbjct: 110 IYNPLS----PYPFVAVEFDTFRNTW--DPQIPHIGIDVNSVISTKTVPFTLDNGGIANV 163

Query: 114 -VEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSVLNDAMYVGFSSSTGSVLA---- 168
            ++YD   K  +V L   ++    ++   +   DL  VL +++ VGFS++TG        
Sbjct: 164 VIKYDASTKILHVVLVFPSLGTIYTI---ADIVDLKQVLPESVNVGFSAATGDPSGKQRN 220

Query: 169 ---SHYILGWSFKINGQAEE 185
              +H IL WSF  +     
Sbjct: 221 ATETHDILSWSFSASLPGTN 240

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  135 bits (341), Expect = 7e-36
 Identities = 66/293 (22%), Positives = 108/293 (36%), Gaps = 56/293 (19%)

Query: 266 KELLGTGGFGRVYRGTL-------PKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHR 318
            E LG G F ++++G            + E+ +K +    R   + F      + +L H+
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72

Query: 319 NLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQ 378
           +LV   G C    E +LV +++  GSLD YL       +N + +  V K +A  + +L  
Sbjct: 73  HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKN-CINILWKLEVAKQLAAAMHFLE- 130

Query: 379 EWEQVVIHRDVKASNVLLDGELNGR--------LGDFGLARLYDHGTDPQTTHVVGTLGY 430
             E  +IH +V A N+LL  E + +        L D G++             V+     
Sbjct: 131 --ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT-----------VLPKDIL 177

Query: 431 ------LAPEHTRTGKA-TTSADVFSFGAFLLEVA-CGRRPIQRQGPSENLILVDWVFDF 482
                 + PE     K    + D +SFG  L E+   G +P+                 F
Sbjct: 178 QERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR-------KLQF 230

Query: 483 WNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER 535
           +     L A  P                L   C   +P  RPS R +++ L  
Sbjct: 231 YEDRHQLPA--PKAAELA---------NLINNCMDYEPDHRPSFRAIIRDLNS 272

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  135 bits (343), Expect = 9e-36
 Identities = 73/330 (22%), Positives = 130/330 (39%), Gaps = 62/330 (18%)

Query: 229 IRMKRKFAEELEDWELDHGPHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTL---PKS 285
           + +  +  E+LED  +         +   +         +LG G FG V    L     S
Sbjct: 5   LGISDELKEKLEDVLIPE-------QQFTL-------GRMLGKGEFGSVREAQLKQEDGS 50

Query: 286 QIEIAVK--KISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKG------ELLLVY 337
            +++AVK  K    +   ++EF+ E   +    H ++ +L+G   R          +++ 
Sbjct: 51  FVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVIL 110

Query: 338 DYMPNGSLDKYL----YDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASN 393
            +M +G L  +L      +    L      R +  +A G+ YL     +  IHRD+ A N
Sbjct: 111 PFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARN 167

Query: 394 VLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVGTLGYL-----APEHTRTGKATTSADV 447
            +L  ++   + DFGL+R +Y         +  G    L     A E       T  +DV
Sbjct: 168 CMLAEDMTVCVADFGLSRKIYSGD-----YYRQGCASKLPVKWLALESLADNLYTVHSDV 222

Query: 448 FSFGAFLLEVA-CGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAEEL- 505
           ++FG  + E+   G+ P      +E       ++++   G  L+   P        EE+ 
Sbjct: 223 WAFGVTMWEIMTRGQTPYAGIENAE-------IYNYLIGGNRLKQ--P----PECMEEVY 269

Query: 506 ELVLKLGLLCSHSDPTARPSMRQVVQILER 535
           +L+ +    C  +DP  RPS   +   LE 
Sbjct: 270 DLMYQ----CWSADPKQRPSFTCLRMELEN 295

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  135 bits (342), Expect = 1e-35
 Identities = 79/301 (26%), Positives = 126/301 (41%), Gaps = 47/301 (15%)

Query: 266 KELLGTGGFGRVYRGTLP-----KSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNL 320
           K  LG G FG+V+          + ++ +AVK +   S    ++F  E   +  L+H+++
Sbjct: 46  KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 105

Query: 321 VQLLGYCRRKGELLLVYDYMPNGSLDKYL-------------YDQPKVTLNWIQRFRVIK 367
           V+  G C     LL+V++YM +G L+++L              D     L   Q   V  
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165

Query: 368 GVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT 427
            VA G+ YL        +HRD+   N L+   L  ++GDFG++R   + TD    + VG 
Sbjct: 166 QVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVVKIGDFGMSR-DIYSTD---YYRVGG 218

Query: 428 LGYL-----APEHTRTGKATTSADVFSFGAFLLEVA-CGRRPIQRQGPSENLILVDWVFD 481
              L      PE     K TT +DV+SFG  L E+   G++P  +   +E         D
Sbjct: 219 RTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE-------AID 271

Query: 482 FWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERDVALPA 541
              +G  LE   P         E+     +   C   +P  R S++ V   L+     P 
Sbjct: 272 CITQGRELER--P----RACPPEVY---AIMRGCWQREPQQRHSIKDVHARLQALAQAPP 322

Query: 542 I 542
           +
Sbjct: 323 V 323

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  134 bits (340), Expect = 2e-35
 Identities = 78/290 (26%), Positives = 120/290 (41%), Gaps = 38/290 (13%)

Query: 266 KELLGTGGFGRVYRGTL----PKSQIEIAVKKI-SHESRQGMKEFVAEIVSIGRLRHRNL 320
              LG G FG+V           +   +AVK + +    Q    +  EI  +  L H ++
Sbjct: 36  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95

Query: 321 VQLLGYCRRKGE--LLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQ 378
           ++  G C   G   L LV +Y+P GSL  YL   P+ ++   Q     + +  G+ YLH 
Sbjct: 96  IKYKGCCEDAGAASLQLVMEYVPLGSLRDYL---PRHSIGLAQLLLFAQQICEGMAYLH- 151

Query: 379 EWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYL-----AP 433
              Q  IHRD+ A NVLLD +   ++GDFGLA+    G +    + V   G       AP
Sbjct: 152 --AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE---YYRVREDGDSPVFWYAP 206

Query: 434 EHTRTGKATTSADVFSFGAFLLEVA-CGRRPIQRQGPSENLILVDW-------VFDFWNR 485
           E  +  K   ++DV+SFG  L E+                LI +         + +   R
Sbjct: 207 ECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLER 266

Query: 486 GELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER 535
           GE L    P+     V         L   C  ++ + RP+   ++ IL+ 
Sbjct: 267 GERLPR--PDKCPAEVYH-------LMKNCWETEASFRPTFENLIPILKT 307

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  135 bits (341), Expect = 2e-35
 Identities = 74/278 (26%), Positives = 134/278 (48%), Gaps = 28/278 (10%)

Query: 266 KELLGTGGFGRVYRGTL----PKSQIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNL 320
           ++++G G FG VY+G L     K ++ +A+K +    + +   +F+ E   +G+  H N+
Sbjct: 49  QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108

Query: 321 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEW 380
           ++L G   +   ++++ +YM NG+LDK+L ++     + +Q   +++G+A G+ YL    
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFLREKDG-EFSVLQLVGMLRGIAAGMKYLA--- 164

Query: 381 EQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGY--LAPEHTRT 438
               +HRD+ A N+L++  L  ++ DFGL+R+ +   +   T   G +     APE    
Sbjct: 165 NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY 224

Query: 439 GKATTSADVFSFGAFLLEVA-CGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLG 497
            K T+++DV+SFG  + EV   G RP       E       V    N G  L    P   
Sbjct: 225 RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE-------VMKAINDGFRLPT--PMDC 275

Query: 498 TEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER 535
              + +       L + C   +   RP    +V IL++
Sbjct: 276 PSAIYQ-------LMMQCWQQERARRPKFADIVSILDK 306

>1gzc_A Erythrina crista-galli lectin; carbohydrate, sugar binding protein, saccharide, protein-carbohydrate interactions, lactose, glycoprotein; HET: LAT; 1.58A {Erythrina crista-galli} SCOP: b.29.1.1 PDB: 1gz9_A* 1fyu_A* 1ax0_A* 1ax1_A* 1ax2_A* 1axy_A* 1axz_A* 1lte_A* 1sfy_A* 1v00_A* 1uzz_A 1uzy_A* 3n35_A* 3n36_A* 3n3h_A* Length = 239

 Score =  132 bits (332), Expect = 3e-35
 Identities = 54/192 (28%), Positives = 86/192 (44%), Gaps = 22/192 (11%)

Query: 2   PFKNKNSNSSTANGTVFSFSTTFVFSILSEY-QSQSGHGIAFVIASTRGLPGARPSQYLG 60
           P    +S +    GTV SF T F FSI   Y +     G+ F +  T+  P      YLG
Sbjct: 56  PVHMWDSTT----GTVASFETRFSFSIEQPYTRPLPADGLVFFMGPTKSKPAQ-GYGYLG 110

Query: 61  LFNDTNLGNETNHVFAVELDTIKSHGFLDINDNHVGIDINSLKSESSAPAGY-------- 112
           +FN++   N +    AVE DT  +  +      H+GID+NS++S  + P           
Sbjct: 111 VFNNSKQDN-SYQTLAVEFDTFSNP-WDPPQVPHIGIDVNSIRSIKTQPFQLDNGQVANV 168

Query: 113 YVEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSVLNDAMYVGFSSSTGS---VLAS 169
            ++YD   K  +V L   +     ++   +   D+  VL D + VG S +TG+      +
Sbjct: 169 VIKYDAPSKILHVVLVYPSSGAIYTI---AEIVDVKQVLPDWVDVGLSGATGAQRDAAET 225

Query: 170 HYILGWSFKING 181
           H +  WSF+ + 
Sbjct: 226 HDVYSWSFQASL 237

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  133 bits (338), Expect = 3e-35
 Identities = 68/290 (23%), Positives = 117/290 (40%), Gaps = 30/290 (10%)

Query: 263 FREKELLGTGGFGRVYRGTL----PKSQIEIAVKKI-SHESRQGMKEFVAEIVSIGRLRH 317
            +    LG G FG+V           +  ++AVK +        + +   EI  +  L H
Sbjct: 23  LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYH 82

Query: 318 RNLVQLLGYCRRKGE--LLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFY 375
            N+V+  G C   G   + L+ +++P+GSL +YL    K  +N  Q+ +    +  G+ Y
Sbjct: 83  ENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPK-NKNKINLKQQLKYAVQICKGMDY 141

Query: 376 LHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTL--GYLAP 433
           L     +  +HRD+ A NVL++ E   ++GDFGL +  +   +  T          + AP
Sbjct: 142 LG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAP 198

Query: 434 EHTRTGKATTSADVFSFGAFLLEVA-CGRRPIQRQGPSENLIL-------VDWVFDFWNR 485
           E     K   ++DV+SFG  L E+                +I        V  + +    
Sbjct: 199 ECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKE 258

Query: 486 GELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER 535
           G+ L    P    + V +       L   C    P+ R S + +++  E 
Sbjct: 259 GKRLPC--PPNCPDEVYQ-------LMRKCWEFQPSNRTSFQNLIEGFEA 299

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  133 bits (338), Expect = 4e-35
 Identities = 72/325 (22%), Positives = 135/325 (41%), Gaps = 39/325 (12%)

Query: 267 ELLGTGGFGRVYRGTL----PKSQIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLV 321
           ++LG+G FG VY+G       K +I +A+K++   +  +  KE + E   +  + + ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 322 QLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
           +LLG C     + L+   MP G L  Y+ +  K  +           +A G+ YL    +
Sbjct: 81  RLLGICLTS-TVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLE---D 135

Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTL--GYLAPEHTRTG 439
           + ++HRD+ A NVL+    + ++ DFGLA+L     + +     G +   ++A E     
Sbjct: 136 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE-EKEYHAEGGKVPIKWMALESILHR 194

Query: 440 KATTSADVFSFGAFLLEVA-CGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGT 498
             T  +DV+S+G  + E+   G +P      SE       +     +GE L    P + T
Sbjct: 195 IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-------ISSILEKGERLPQ--PPICT 245

Query: 499 EYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERDVALPAISALRLSTSGITYLEGF 558
             V         + + C   D  +RP  R+++    +         +         ++G 
Sbjct: 246 IDVYM-------IMVKCWMIDADSRPKFRELIIEFSK---------MARDPQRYLVIQGD 289

Query: 559 DDFAVSNPPSMGFTRPSSVAESLLS 583
           +   + +P    F R     E +  
Sbjct: 290 ERMHLPSPTDSNFYRALMDEEDMDD 314

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  136 bits (345), Expect = 5e-35
 Identities = 71/314 (22%), Positives = 127/314 (40%), Gaps = 41/314 (13%)

Query: 225 VVYVIRMKRKFAEELEDWELDHGPHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPK 284
            V  +  K +   E + WE+                +  + ++ LG G FG V+  T   
Sbjct: 166 SVPCMSSKPQKPWEKDAWEIPR--------------ESLKLEKKLGAGQFGEVWMATY-N 210

Query: 285 SQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGS 344
              ++AVK +       ++ F+AE   +  L+H  LV+L     ++  + ++ ++M  GS
Sbjct: 211 KHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEP-IYIITEFMAKGS 268

Query: 345 LDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRL 404
           L  +L           +       +A G+ ++    ++  IHRD++A+N+L+   L  ++
Sbjct: 269 LLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKI 325

Query: 405 GDFGLARLYDHGTDPQTTHVVGTLGY--LAPEHTRTGKATTSADVFSFGAFLLEVA-CGR 461
            DFGLAR+ +   +  T            APE    G  T  +DV+SFG  L+E+   GR
Sbjct: 326 ADFGLARVIED--NEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGR 383

Query: 462 RPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPT 521
            P       E       V     RG  +    P    E +         + + C  + P 
Sbjct: 384 IPYPGMSNPE-------VIRALERGYRMPR--PENCPEELYN-------IMMRCWKNRPE 427

Query: 522 ARPSMRQVVQILER 535
            RP+   +  +L+ 
Sbjct: 428 ERPTFEYIQSVLDD 441

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  133 bits (337), Expect = 5e-35
 Identities = 75/279 (26%), Positives = 124/279 (44%), Gaps = 32/279 (11%)

Query: 266 KELLGTGGFGRVYRGTL----PKSQIEIAVKKI-SHESRQGMKEFVAEIVSIGRLRHRNL 320
            ++LG+G FG V++G         +I + +K I     RQ  +     +++IG L H ++
Sbjct: 18  LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77

Query: 321 VQLLGYCRRKGELLLVYDYMPNGSLDKYL-YDQPKVTLNWIQRFRVIKGVALGLFYLHQE 379
           V+LLG C     L LV  Y+P GSL  ++   +  +    +  + V   +A G++YL   
Sbjct: 78  VRLLGLCPGS-SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGV--QIAKGMYYLE-- 132

Query: 380 WEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTL--GYLAPEHTR 437
            E  ++HR++ A NVLL      ++ DFG+A L     D Q  +        ++A E   
Sbjct: 133 -EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD-DKQLLYSEAKTPIKWMALESIH 190

Query: 438 TGKATTSADVFSFGAFLLEVA-CGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNL 496
            GK T  +DV+S+G  + E+   G  P      +E       V D   +GE L    P +
Sbjct: 191 FGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE-------VPDLLEKGERLAQ--PQI 241

Query: 497 GTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER 535
            T  V         + + C   D   RP+ +++     R
Sbjct: 242 CTIDVYM-------VMVKCWMIDENIRPTFKELANEFTR 273

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  131 bits (333), Expect = 1e-34
 Identities = 72/279 (25%), Positives = 111/279 (39%), Gaps = 29/279 (10%)

Query: 266 KELLGTGGFGRVYRGTL---PKSQIEIAVKKI---SHESRQGMKEFVAEIVSIGRLRHRN 319
            E LG G FG V RG         + +AVK +        + M +F+ E+ ++  L HRN
Sbjct: 23  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82

Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQE 379
           L++L G       + +V +  P GSL   L  + +         R    VA G+ YL   
Sbjct: 83  LIRLYGVVLTPP-MKMVTELAPLGSLLDRLR-KHQGHFLLGTLSRYAVQVAEGMGYLE-- 138

Query: 380 WEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGY--LAPEHTR 437
             +  IHRD+ A N+LL      ++GDFGL R      D         + +   APE  +
Sbjct: 139 -SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 197

Query: 438 TGKATTSADVFSFGAFLLEVA-CGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNL 496
           T   + ++D + FG  L E+   G+ P      S+ L  +D        GE L    P  
Sbjct: 198 TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID------KEGERLPR--PED 249

Query: 497 GTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER 535
             + +         + + C    P  RP+   +   L  
Sbjct: 250 CPQDIYN-------VMVQCWAHKPEDRPTFVALRDFLLE 281

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  132 bits (335), Expect = 1e-34
 Identities = 73/291 (25%), Positives = 116/291 (39%), Gaps = 45/291 (15%)

Query: 266 KELLGTGGFGRVYRGTLP-----KSQIEIAVKKI-SHESRQGMKEFVAEIVSIGRLRHRN 319
              LG G FG VY G +       S +++AVK +    S Q   +F+ E + I +  H+N
Sbjct: 35  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94

Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYL-----YDQPKVTLNWIQRFRVIKGVALGLF 374
           +V+ +G   +     ++ + M  G L  +L           +L  +    V + +A G  
Sbjct: 95  IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154

Query: 375 YLHQEWEQVVIHRDVKASNVLLDGELNGRL---GDFGLAR-LYDHGTDPQTTHVVGTLGY 430
           YL    E   IHRD+ A N LL     GR+   GDFG+AR +Y         +  G    
Sbjct: 155 YLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS-----YYRKGGCAM 206

Query: 431 L-----APEHTRTGKATTSADVFSFGAFLLEVA-CGRRPIQRQGPSENLILVDWVFDFWN 484
           L      PE    G  T+  D +SFG  L E+   G  P   +   E       V +F  
Sbjct: 207 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE-------VLEFVT 259

Query: 485 RGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER 535
            G  ++   P    +     +    ++   C    P  RP+   +++ +E 
Sbjct: 260 SGGRMDP--P----KNCPGPVY---RIMTQCWQHQPEDRPNFAIILERIEY 301

>1f9k_A Acidic lectin; legume lectin, glycosylated protein, H-antigenic specificity agglutinin, sugar binding protein; HET: NAG MAN AMG; 3.00A {Psophocarpus tetragonolobus} SCOP: b.29.1.1 PDB: 1fay_A* Length = 238

 Score =  130 bits (327), Expect = 1e-34
 Identities = 54/197 (27%), Positives = 83/197 (42%), Gaps = 28/197 (14%)

Query: 2   PFKNKNSNSSTANGTVFSFSTTFVFSILSEY-QSQSGHGIAFVIASTRGLPGARPSQYLG 60
           P K  +S +    G V SF T F F+I   Y   +   G+ F +      P       LG
Sbjct: 55  PIKIWDSTT----GNVASFETRFSFNITQPYAYPEPADGLTFFMVPP-NSPQGEDGGNLG 109

Query: 61  LFNDTNLGNETNHVFAVELDTIKSHGFLDINDNHVGIDINSLKSESSAPAGYY------- 113
           +F         ++ FAVE DT ++    D    H+GID+NS+ S  +             
Sbjct: 110 VFKPPE----GDNAFAVEFDTFQNTW--DPQVPHIGIDVNSIVSSKTLHFQLENGGVANV 163

Query: 114 -VEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSVL--NDAMYVGFSSSTGS---VL 167
            ++YD   K  NV LA  ++    +L   S   DL      ++ + VG S++TG     +
Sbjct: 164 VIKYDSPTKILNVVLAFHSVGTVYTL---SNIVDLKQEFPNSEWVNVGLSATTGYQKNAV 220

Query: 168 ASHYILGWSFKINGQAE 184
            +H I+ WSF  + Q  
Sbjct: 221 ETHEIISWSFTSSLQET 237

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  132 bits (333), Expect = 1e-34
 Identities = 68/272 (25%), Positives = 107/272 (39%), Gaps = 29/272 (10%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKI--SHESRQGMKEFVAEIVSIGRL-RHRN 319
           F+    LG G +G V++    +     AVK+        +     +AE+ S  ++ +H  
Sbjct: 59  FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPC 118

Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQE 379
            V+L       G L L  +     SL ++       +L   Q +  ++   L L +LH  
Sbjct: 119 CVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGA-SLPEAQVWGYLRDTLLALAHLH-- 174

Query: 380 WEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTG 439
             Q ++H DVK +N+ L      +LGDFGL          +     G   Y+APE  + G
Sbjct: 175 -SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV--QEGDPRYMAPELLQ-G 230

Query: 440 KATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTE 499
              T+ADVFS G  +LEVAC         P                 +L +   P   T 
Sbjct: 231 SYGTAADVFSLGLTILEVACNMEL-----P----------HGGEGWQQLRQGYLPPEFTA 275

Query: 500 YVAEELELVLKLGLLCSHSDPTARPSMRQVVQ 531
            ++ EL  VL    +    DP  R +   ++ 
Sbjct: 276 GLSSELRSVLV---MMLEPDPKLRATAEALLA 304

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  131 bits (332), Expect = 1e-34
 Identities = 78/296 (26%), Positives = 130/296 (43%), Gaps = 50/296 (16%)

Query: 266 KELLGTGGFGRVYRGTLP-----KSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNL 320
           K  LG G FG+V+          K ++ +AVK +   +    K+F  E   +  L+H ++
Sbjct: 20  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79

Query: 321 VQLLGYCRRKGELLLVYDYMPNGSLDKYL--------------YDQPKVTLNWIQRFRVI 366
           V+  G C     L++V++YM +G L+K+L                Q K  L   Q   + 
Sbjct: 80  VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139

Query: 367 KGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVV 425
             +A G+ YL     Q  +HRD+   N L+   L  ++GDFG++R +Y         + V
Sbjct: 140 SQIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTD-----YYRV 191

Query: 426 GTLGYL-----APEHTRTGKATTSADVFSFGAFLLEVA-CGRRPIQRQGPSENLILVDWV 479
           G    L      PE     K TT +DV+SFG  L E+   G++P  +   +E       V
Sbjct: 192 GGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE-------V 244

Query: 480 FDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER 535
            +   +G +LE   P        +E+     + L C   +P  R +++++ +IL  
Sbjct: 245 IECITQGRVLER--P----RVCPKEVY---DVMLGCWQREPQQRLNIKEIYKILHA 291

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  136 bits (345), Expect = 2e-34
 Identities = 67/276 (24%), Positives = 116/276 (42%), Gaps = 27/276 (9%)

Query: 266 KELLGTGGFGRVYRGTL--PKSQIEIAVKKISHESRQGMK-EFVAEIVSIGRLRHRNLVQ 322
              LG G FG V +G     K QI++A+K +   + +    E + E   + +L +  +V+
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400

Query: 323 LLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQ 382
           L+G C+ +  L+LV +    G L K+L    +  +       ++  V++G+ YL    E+
Sbjct: 401 LIGVCQAE-ALMLVMEMAGGGPLHKFLV-GKREEIPVSNVAELLHQVSMGMKYLE---EK 455

Query: 383 VVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGY--LAPEHTRTGK 440
             +HR++ A NVLL      ++ DFGL++         T    G       APE     K
Sbjct: 456 NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRK 515

Query: 441 ATTSADVFSFGAFLLEVA-CGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTE 499
            ++ +DV+S+G  + E    G++P ++    E       V  F  +G+ +E   P     
Sbjct: 516 FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-------VMAFIEQGKRMEC--PPECPP 566

Query: 500 YVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER 535
            +         L   C       RP    V Q +  
Sbjct: 567 ELYA-------LMSDCWIYKWEDRPDFLTVEQRMRA 595

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  130 bits (330), Expect = 2e-34
 Identities = 63/312 (20%), Positives = 119/312 (38%), Gaps = 48/312 (15%)

Query: 238 ELEDWELDHGPHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTL---PKSQIEIAVK-- 292
              D+E+         + + +          +G G FG V++G         + +A+K  
Sbjct: 6   STRDYEIQR-------ERIEL-------GRCIGEGQFGDVHQGIYMSPENPALAVAIKTC 51

Query: 293 KISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQ 352
           K         ++F+ E +++ +  H ++V+L+G       + ++ +    G L  +L  +
Sbjct: 52  KNCTSDSV-REKFLQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVR 109

Query: 353 PKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARL 412
              +L+          ++  L YL     +  +HRD+ A NVL+      +LGDFGL+R 
Sbjct: 110 KY-SLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 165

Query: 413 YDHGTDPQTTHVVGTL---GYLAPEHTRTGKATTSADVFSFGAFLLEVA-CGRRPIQRQG 468
            +   D              ++APE     + T+++DV+ FG  + E+   G +P Q   
Sbjct: 166 ME---DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 222

Query: 469 PSENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQ 528
            ++       V      GE L    P      +         L   C   DP+ RP   +
Sbjct: 223 NND-------VIGRIENGERLPM--PPNCPPTLYS-------LMTKCWAYDPSRRPRFTE 266

Query: 529 VVQILERDVALP 540
           +   L   +   
Sbjct: 267 LKAQLSTILEEE 278

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  134 bits (340), Expect = 2e-34
 Identities = 86/300 (28%), Positives = 130/300 (43%), Gaps = 47/300 (15%)

Query: 240 EDWELDHGPHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR 299
             W L+        K+L +        + +G G FG V  G    +  ++AVK I +++ 
Sbjct: 186 SGWALNM-------KELKL-------LQTIGKGEFGDVMLGDYRGN--KVAVKCIKNDAT 229

Query: 300 QGMKEFVAEIVSIGRLRHRNLVQLLGYC-RRKGELLLVYDYMPNGSLDKYLYDQPKVTLN 358
              + F+AE   + +LRH NLVQLLG     KG L +V +YM  GSL  YL  + +  L 
Sbjct: 230 A--QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLG 287

Query: 359 WIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD 418
                +    V   + YL        +HRD+ A NVL+  +   ++ DFGL +      +
Sbjct: 288 GDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTK------E 338

Query: 419 PQTTHVVGTLGY--LAPEHTRTGKATTSADVFSFGAFLLEVA-CGRRPIQRQGPSENLIL 475
             +T   G L     APE  R  K +T +DV+SFG  L E+   GR P  R    +    
Sbjct: 339 ASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---- 394

Query: 476 VDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER 535
              V     +G  ++A  P+     V +       +   C H D   RP+  Q+ + LE 
Sbjct: 395 ---VVPRVEKGYKMDA--PDGCPPAVYD-------VMKNCWHLDAATRPTFLQLREQLEH 442

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  131 bits (331), Expect = 3e-34
 Identities = 63/309 (20%), Positives = 125/309 (40%), Gaps = 50/309 (16%)

Query: 245 DHGPHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR--QGM 302
           D G     ++ + +  + +   + +G+GG  +V++    K QI  A+K ++ E    Q +
Sbjct: 12  DLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQI-YAIKYVNLEEADNQTL 70

Query: 303 KEFVAEIVSIGRLRHRNL--VQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWI 360
             +  EI  + +L+  +   ++L  Y      + +V +   N  L+ +L  +  +     
Sbjct: 71  DSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWER 129

Query: 361 QRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGR--LGDFGLAR-LYDHGT 417
           + +   K +   +  +HQ     ++H D+K +N L+    +G   L DFG+A  +    T
Sbjct: 130 KSY--WKNMLEAVHTIHQ---HGIVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTT 181

Query: 418 DPQTTHVVGTLGYLAPE-----------HTRTGKATTSADVFSFGAFLLEVACGRRPIQR 466
                  VGT+ Y+ PE                K +  +DV+S G  L  +  G+ P Q+
Sbjct: 182 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 241

Query: 467 QGPS----ENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTA 522
                     +I  +   +F                +   ++L+ VLK   L    DP  
Sbjct: 242 IINQISKLHAIIDPNHEIEFP---------------DIPEKDLQDVLK-CCLK--RDPKQ 283

Query: 523 RPSMRQVVQ 531
           R S+ +++ 
Sbjct: 284 RISIPELLA 292

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  132 bits (334), Expect = 3e-34
 Identities = 74/291 (25%), Positives = 117/291 (40%), Gaps = 45/291 (15%)

Query: 266 KELLGTGGFGRVYRGTLP-----KSQIEIAVKKI-SHESRQGMKEFVAEIVSIGRLRHRN 319
              LG G FG VY G +       S +++AVK +    S Q   +F+ E + I +  H+N
Sbjct: 76  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 135

Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYL-----YDQPKVTLNWIQRFRVIKGVALGLF 374
           +V+ +G   +     ++ + M  G L  +L           +L  +    V + +A G  
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195

Query: 375 YLHQEWEQVVIHRDVKASNVLLDGELNGRL---GDFGLAR-LYDHGTDPQTTHVVGTLGY 430
           YL    E   IHRD+ A N LL     GR+   GDFG+AR +Y  G      +  G    
Sbjct: 196 YLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG-----YYRKGGCAM 247

Query: 431 L-----APEHTRTGKATTSADVFSFGAFLLEVA-CGRRPIQRQGPSENLILVDWVFDFWN 484
           L      PE    G  T+  D +SFG  L E+   G  P   +   E       V +F  
Sbjct: 248 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE-------VLEFVT 300

Query: 485 RGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER 535
            G  ++   P    +     +    ++   C    P  RP+   +++ +E 
Sbjct: 301 SGGRMDP--P----KNCPGPVY---RIMTQCWQHQPEDRPNFAIILERIEY 342

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  130 bits (328), Expect = 4e-34
 Identities = 65/278 (23%), Positives = 112/278 (40%), Gaps = 32/278 (11%)

Query: 266 KELLGTGGFGRVYRGTL---PKSQIEIAVKKI-SHESRQGMKEFVAEIVSIGRLRHRNLV 321
             +LG G FG VY G        +I +AVK      +    ++F++E V +  L H ++V
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76

Query: 322 QLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
           +L+G    +    ++ +  P G L  YL      +L  +        +   + YL     
Sbjct: 77  KLIGIIEEE-PTWIIMELYPYGELGHYLERNKN-SLKVLTLVLYSLQICKAMAYLE---S 131

Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTL---GYLAPEHTRT 438
              +HRD+   N+L+      +LGDFGL+R  +   D        T     +++PE    
Sbjct: 132 INCVHRDIAVRNILVASPECVKLGDFGLSRYIE---DEDYYKASVTRLPIKWMSPESINF 188

Query: 439 GKATTSADVFSFGAFLLEVA-CGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLG 497
            + TT++DV+ F   + E+   G++P       +       V     +G+ L    P+L 
Sbjct: 189 RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD-------VIGVLEKGDRLPK--PDLC 239

Query: 498 TEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER 535
              +         L   C   DP+ RP   ++V  L  
Sbjct: 240 PPVLYT-------LMTRCWDYDPSDRPRFTELVCSLSD 270

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  130 bits (330), Expect = 4e-34
 Identities = 71/293 (24%), Positives = 123/293 (41%), Gaps = 47/293 (16%)

Query: 266 KELLGTGGFGRVYRGTLP-----KSQIEIAVKKI-SHESRQGMKEFVAEIVSIGRLRHRN 319
              LG G FG VY G        + +  +A+K +    S +   EF+ E   +      +
Sbjct: 30  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 89

Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYL--------YDQPKVTLNWIQRFRVIKGVAL 371
           +V+LLG   +    L++ + M  G L  YL         +      +  +  ++   +A 
Sbjct: 90  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149

Query: 372 GLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVGTLGY 430
           G+ YL+       +HRD+ A N ++  +   ++GDFG+ R +Y+        +  G  G 
Sbjct: 150 GMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD-----YYRKGGKGL 201

Query: 431 L-----APEHTRTGKATTSADVFSFGAFLLEVA-CGRRPIQRQGPSENLILVDWVFDFWN 484
           L     +PE  + G  TT +DV+SFG  L E+A    +P Q     +       V  F  
Sbjct: 202 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ-------VLRFVM 254

Query: 485 RGELLEARDPNLGTEYVAEEL-ELVLKLGLLCSHSDPTARPSMRQVVQILERD 536
            G LL+   P    +   + L EL+      C   +P  RPS  +++  ++ +
Sbjct: 255 EGGLLDK--P----DNCPDMLFELMRM----CWQYNPKMRPSFLEIISSIKEE 297

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  129 bits (326), Expect = 7e-34
 Identities = 69/288 (23%), Positives = 120/288 (41%), Gaps = 47/288 (16%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNL 320
           +     +GTG +GR  +         +  K++ +   +    +  V+E+  +  L+H N+
Sbjct: 8   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 67

Query: 321 VQLLG--YCRRKGELLLVYDYMPNGSLDKYLYDQPK--------VTLNW-IQRFRVIKGV 369
           V+       R    L +V +Y   G L   +    K          L    Q       +
Sbjct: 68  VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQ-------L 120

Query: 370 ALGLFYLHQ--EWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT 427
            L L   H+  +    V+HRD+K +NV LDG+ N +LGDFGLAR+ +H T    T  VGT
Sbjct: 121 TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT-FVGT 179

Query: 428 LGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGE 487
             Y++PE          +D++S G  L E+     P                F  +++ E
Sbjct: 180 PYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPP----------------FTAFSQKE 223

Query: 488 L----LEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ 531
           L     E +   +   Y ++EL  ++   +L  +     RPS+ ++++
Sbjct: 224 LAGKIREGKFRRIPYRY-SDELNEIIT-RML--NLKDYHRPSVEEILE 267

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  128 bits (325), Expect = 3e-33
 Identities = 76/295 (25%), Positives = 134/295 (45%), Gaps = 52/295 (17%)

Query: 266 KELLGTGGFGRVYRGTL--PKSQIEIAVKKI-SHESRQGMKEFVAEIVSIGRL-RHRNLV 321
           ++++G G FG+V +  +     +++ A+K++  + S+   ++F  E+  + +L  H N++
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89

Query: 322 QLLGYCRRKGELLLVYDYMPNGSLDKYL--------------YDQPKVTLNWIQRFRVIK 367
            LLG C  +G L L  +Y P+G+L  +L               +    TL+  Q      
Sbjct: 90  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149

Query: 368 GVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT 427
            VA G+ YL    ++  IHRD+ A N+L+      ++ DFGL+R  +        +V  T
Sbjct: 150 DVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQE-------VYVKKT 199

Query: 428 LGYL-----APEHTRTGKATTSADVFSFGAFLLEVA-CGRRPIQRQGPSENLILVDWVFD 481
           +G L     A E       TT++DV+S+G  L E+   G  P      +E       +++
Sbjct: 200 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-------LYE 252

Query: 482 FWNRGELLEARDPNLGTEYVAEEL-ELVLKLGLLCSHSDPTARPSMRQVVQILER 535
              +G  LE   P        +E+ +L+ +    C    P  RPS  Q++  L R
Sbjct: 253 KLPQGYRLEK--P----LNCDDEVYDLMRQ----CWREKPYERPSFAQILVSLNR 297

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  128 bits (324), Expect = 5e-33
 Identities = 61/298 (20%), Positives = 121/298 (40%), Gaps = 50/298 (16%)

Query: 256 LYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR--QGMKEFVAEIVSIG 313
           + +  + +   + +G+GG  +V++    K QI  A+K ++ E    Q +  +  EI  + 
Sbjct: 4   ISVKGRIYSILKQIGSGGSSKVFQVLNEKKQI-YAIKYVNLEEADNQTLDSYRNEIAYLN 62

Query: 314 RLRHRNL--VQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVAL 371
           +L+  +   ++L  Y      + +V +   N  L+ +L  +  +     + +   K +  
Sbjct: 63  KLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSY--WKNMLE 119

Query: 372 GLFYLHQEWEQVVIHRDVKASNVLLDGELNGR--LGDFGLAR-LYDHGTDPQTTHVVGTL 428
            +  +HQ     ++H D+K +N L+    +G   L DFG+A  +    T       VGT+
Sbjct: 120 AVHTIHQ---HGIVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSVVKDSQVGTV 173

Query: 429 GYLAPE-----------HTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPS----ENL 473
            Y+ PE                K +  +DV+S G  L  +  G+ P Q+          +
Sbjct: 174 NYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI 233

Query: 474 ILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ 531
           I  +   +F                +   ++L+ VLK    C   DP  R S+ +++ 
Sbjct: 234 IDPNHEIEFP---------------DIPEKDLQDVLK---CCLKRDPKQRISIPELLA 273

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  133 bits (335), Expect = 6e-33
 Identities = 65/286 (22%), Positives = 116/286 (40%), Gaps = 40/286 (13%)

Query: 267 ELLGTGGFGRVYRGTL---PKSQIEIAVK--KISHESRQGMKEFVAEIVSIGRLRHRNLV 321
             +G G FG V++G         + +A+K  K         ++F+ E +++ +  H ++V
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSV-REKFLQEALTMRQFDHPHIV 454

Query: 322 QLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
           +L+G       + ++ +    G L  +L    K +L+          ++  L YL     
Sbjct: 455 KLIGVITEN-PVWIIMELCTLGELRSFLQ-VRKFSLDLASLILYAYQLSTALAYLE---S 509

Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVGTLGYL-----APEH 435
           +  +HRD+ A NVL+      +LGDFGL+R + D      +T+   + G L     APE 
Sbjct: 510 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED------STYYKASKGKLPIKWMAPES 563

Query: 436 TRTGKATTSADVFSFGAFLLEVA-CGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDP 494
               + T+++DV+ FG  + E+   G +P Q    ++       V      GE L    P
Sbjct: 564 INFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-------VIGRIENGERLPM--P 614

Query: 495 NLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERDVALP 540
                 +         L   C   DP+ RP   ++   L   +   
Sbjct: 615 PNCPPTLYS-------LMTKCWAYDPSRRPRFTELKAQLSTILEEE 653

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  127 bits (322), Expect = 7e-33
 Identities = 52/208 (25%), Positives = 86/208 (41%), Gaps = 19/208 (9%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQ 322
              +  +G G FG V+R    ++  + AVKK+  E  +     V E+V+   L    +V 
Sbjct: 60  MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVP 114

Query: 323 LLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQ 382
           L G  R    + +  + +  GSL + +     +  +    +  +     GL YLH    +
Sbjct: 115 LYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYY--LGQALEGLEYLH---TR 169

Query: 383 VVIHRDVKASNVLLDGELNGR---LGDFG----LARLYDHGTDPQTTHVVGTLGYLAPEH 435
            ++H DVKA NVLL    +G    L DFG    L       +     ++ GT  ++APE 
Sbjct: 170 RILHGDVKADNVLLS--SDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEV 227

Query: 436 TRTGKATTSADVFSFGAFLLEVACGRRP 463
                     D++S    +L +  G  P
Sbjct: 228 VMGKPCDAKVDIWSSCCMMLHMLNGCHP 255

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  129 bits (325), Expect = 7e-33
 Identities = 60/300 (20%), Positives = 120/300 (40%), Gaps = 50/300 (16%)

Query: 254 KDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR--QGMKEFVAEIVS 311
           + + +  + +   + +G+GG  +V++    K QI  A+K ++ E    Q +  +  EI  
Sbjct: 49  ECISVKGRIYSILKQIGSGGSSKVFQVLNEKKQI-YAIKYVNLEEADNQTLDSYRNEIAY 107

Query: 312 IGRLRHRNL--VQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGV 369
           + +L+  +   ++L  Y      + +V +   N  L+ +L  +  +     + +   K +
Sbjct: 108 LNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSY--WKNM 164

Query: 370 ALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGR--LGDFGLARLY-DHGTDPQTTHVVG 426
              +  +HQ     ++H D+K +N L+    +G   L DFG+A       T       VG
Sbjct: 165 LEAVHTIHQ---HGIVHSDLKPANFLIV---DGMLKLIDFGIANQMQPDTTSVVKDSQVG 218

Query: 427 TLGYLAPE-----------HTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPS----E 471
            + Y+ PE                K +  +DV+S G  L  +  G+ P Q+         
Sbjct: 219 AVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH 278

Query: 472 NLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ 531
            +I  +   +F                +   ++L+ VLK    C   DP  R S+ +++ 
Sbjct: 279 AIIDPNHEIEFP---------------DIPEKDLQDVLK---CCLKRDPKQRISIPELLA 320

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  126 bits (319), Expect = 8e-33
 Identities = 74/299 (24%), Positives = 119/299 (39%), Gaps = 57/299 (19%)

Query: 266 KELLGTGGFGRVYRGTLP-----KSQIEIAVK--KISHESRQGMKEFVAEIVSIGRLRHR 318
            E LG   FG+VY+G L      +    +A+K  K   E     +EF  E +   RL+H 
Sbjct: 14  MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPL-REEFRHEAMLRARLQHP 72

Query: 319 NLVQLLGYCRRKGELLLVYDYMPNGSLDKYL--------------YDQPKVTLNWIQRFR 364
           N+V LLG   +   L +++ Y  +G L ++L                  K  L       
Sbjct: 73  NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132

Query: 365 VIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTH 423
           ++  +A G+ YL       V+H+D+   NVL+  +LN ++ D GL R +Y    D    +
Sbjct: 133 LVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYA--AD---YY 184

Query: 424 VVGTLGYL-----APEHTRTGKATTSADVFSFGAFLLEVA-CGRRPIQRQGPSENLILVD 477
            +     L     APE    GK +  +D++S+G  L EV   G +P       +      
Sbjct: 185 KLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD------ 238

Query: 478 WVFDFWNRGELLEARD--PNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILE 534
            V +     ++L   D  P             V  L + C +  P+ RP  + +   L 
Sbjct: 239 -VVEMIRNRQVLPCPDDCP-----------AWVYALMIECWNEFPSRRPRFKDIHSRLR 285

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  126 bits (318), Expect = 1e-32
 Identities = 65/303 (21%), Positives = 117/303 (38%), Gaps = 61/303 (20%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQ 322
           F E  +LG G FG+V +          A+KKI H   + +   ++E++ +  L H+ +V+
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQYVVR 66

Query: 323 LLG-------------YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGV 369
                             ++K  L +  +Y  NG+L   ++ +  +     + +R+ + +
Sbjct: 67  YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSE-NLNQQRDEYWRLFRQI 125

Query: 370 ALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH-------------G 416
              L Y+H    Q +IHRD+K  N+ +D   N ++GDFGLA+                 G
Sbjct: 126 LEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182

Query: 417 TDPQTTHVVGTLGYLAPE-HTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLIL 475
           +    T  +GT  Y+A E    TG      D++S G    E+                  
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPF-------------- 228

Query: 476 VDWVFDFWNRGELLE-------ARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQ 528
                    R  +L+          P+     +  E +++    L+    DP  RP  R 
Sbjct: 229 ----STGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRL--LID--HDPNKRPGART 280

Query: 529 VVQ 531
           ++ 
Sbjct: 281 LLN 283

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  125 bits (315), Expect = 5e-32
 Identities = 67/302 (22%), Positives = 111/302 (36%), Gaps = 40/302 (13%)

Query: 254 KDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIG 313
             + I  K +   + LG GGF  V            A+K+I    +Q  +E   E     
Sbjct: 22  HMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHR 81

Query: 314 RLRHRNLVQLLGYCRR----KGELLLVYDYMPNGSLDKYL--YDQPKVTLNWIQRFRVIK 367
              H N+++L+ YC R    K E  L+  +   G+L   +         L   Q   ++ 
Sbjct: 82  LFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLL 141

Query: 368 GVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHV--- 424
           G+  GL  +H    +   HRD+K +N+LL  E    L D G         +     +   
Sbjct: 142 GICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQ 198

Query: 425 -----VGTLGYLAPE--HTRTGKA-TTSADVFSFGAFLLEVACGRRP---IQRQGPSENL 473
                  T+ Y APE    ++        DV+S G  L  +  G  P   + ++G S  L
Sbjct: 199 DWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL 258

Query: 474 ILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQIL 533
            +         + +L   + P       +  L  +L   ++    DP  RP +  ++  L
Sbjct: 259 AV---------QNQLSIPQSPR-----HSSALWQLLN-SMM--TVDPHQRPHIPLLLSQL 301

Query: 534 ER 535
           E 
Sbjct: 302 EA 303

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  130 bits (327), Expect = 6e-32
 Identities = 75/288 (26%), Positives = 110/288 (38%), Gaps = 29/288 (10%)

Query: 266 KELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVA-EIVSIGRLRHRNLVQLL 324
           KE LGTGGFG V R     +  ++A+K+   E     +E    EI  + +L H N+V   
Sbjct: 19  KERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAR 78

Query: 325 ------GYCRRKGELLLVYDYMPNGSLDKYLYD-QPKVTLNWIQRFRVIKGVALGLFYLH 377
                          LL  +Y   G L KYL   +    L       ++  ++  L YLH
Sbjct: 79  EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH 138

Query: 378 QEWEQVVIHRDVKASNVLLDGELNGR---LGDFGLARLYDHGTDPQTTHVVGTLGYLAPE 434
              E  +IHRD+K  N++L          + D G A+  D G        VGTL YLAPE
Sbjct: 139 ---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTE--FVGTLQYLAPE 193

Query: 435 HTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILV------DWVFDFWNRGEL 488
                K T + D +SFG    E   G RP                   + +  + +    
Sbjct: 194 LLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGA 253

Query: 489 LEAR----DPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQI 532
           ++       PN  +  +A +LE  L+  L         R +  Q   +
Sbjct: 254 VKFSSVLPTPNHLSGILAGKLERWLQCML---MWHQRQRGTDPQNPNV 298

>1dhk_B Bean lectin-like inhibitor, porcine pancreatic alpha-amylase; CO (hydrolase-inhibitor), complex (hydrolase-inhibitor) comple; HET: NAG; 1.85A {Phaseolus vulgaris} SCOP: b.29.1.1 PDB: 1viw_B* Length = 223

 Score =  120 bits (303), Expect = 1e-31
 Identities = 42/201 (20%), Positives = 77/201 (38%), Gaps = 35/201 (17%)

Query: 11  STANGTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGLFNDTNLGNE 70
            +  G V SF T F  +I +  Q+ S  G+ FV+   +                      
Sbjct: 53  DSTTGNVASFDTNFTMNIRTHRQANSAVGLDFVLVPVQPESK------------------ 94

Query: 71  TNHVFAVELDTIKSHGFLDINDNHVGIDINSLKSESSAPAGYYVEYDGLEKRTNVTLAPI 130
                 VE DT  S   +D+N+N +      +       A   + Y+   K  +V+L+  
Sbjct: 95  -GDTVTVEFDTFLSRISIDVNNNDIKSVPWDVHDYDGQNAEVRITYNSSTKVFSVSLSNP 153

Query: 131 NIPRPRSLNTMSLSRDLSSVLNDAMYVGFSSSTGSVLAS---HYILGWSFKINGQAEELN 187
           +  +  +++T   + +L   + D + VGFS+++G+   S   H +L WSF          
Sbjct: 154 STGKSNNVST---TVELEKEVYDWVSVGFSATSGAYQWSYETHDVLSWSFS--------- 201

Query: 188 LSQLPKLPRVGPKKRSKFLTI 208
            S+   L     ++ +  L  
Sbjct: 202 -SKFINLKDQKSERSNIVLNK 221

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  122 bits (307), Expect = 4e-31
 Identities = 60/294 (20%), Positives = 108/294 (36%), Gaps = 46/294 (15%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKE-FVAEIVSIGRLRHRNLV 321
           F   + LG GGFG V+           A+K+I   +R+  +E  + E+ ++ +L H  +V
Sbjct: 7   FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66

Query: 322 QLLGYC------------RRKGELLLVYDYMPNGSLDKYLYDQPKVT-LNWIQRFRVIKG 368
           +                   K  L +        +L  ++  +  +          +   
Sbjct: 67  RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQ 126

Query: 369 VALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHV---- 424
           +A  + +LH    + ++HRD+K SN+    +   ++GDFGL    D   + QT       
Sbjct: 127 IAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183

Query: 425 -------VGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVD 477
                  VGT  Y++PE       +   D+FS G  L E+     P   Q      +   
Sbjct: 184 YARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTL--- 237

Query: 478 WVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ 531
                    ++   + P L T+    E  +V  + L      P  RP    +++
Sbjct: 238 --------TDVRNLKFPPLFTQKYPCEYVMVQDM-L---SPSPMERPEAINIIE 279

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  122 bits (307), Expect = 9e-31
 Identities = 72/306 (23%), Positives = 120/306 (39%), Gaps = 61/306 (19%)

Query: 266 KELLGTGGFGRVYRGTLP-----KSQIEIAVKKI-SHESRQGMKEFVAEIVSIGRLRHRN 319
              +G G FGRV++   P     +    +AVK +    S     +F  E   +    + N
Sbjct: 52  VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPN 111

Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYL----------------------YDQPKVTL 357
           +V+LLG C     + L+++YM  G L+++L                             L
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171

Query: 358 NWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHG 416
           +  ++  + + VA G+ YL    E+  +HRD+   N L+   +  ++ DFGL+R +Y   
Sbjct: 172 SCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS-- 226

Query: 417 TDPQTTHVVGTLGYL-----APEHTRTGKATTSADVFSFGAFLLEVA-CGRRPIQRQGPS 470
            D    +       +      PE     + TT +DV+++G  L E+   G +P       
Sbjct: 227 AD---YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE 283

Query: 471 ENLILVDWVFDFWNRGELLEARDPNLGTEYVAEEL-ELVLKLGLLCSHSDPTARPSMRQV 529
           E       V  +   G +L    P    E    EL  L+      C    P  RPS   +
Sbjct: 284 E-------VIYYVRDGNILAC--P----ENCPLELYNLMRL----CWSKLPADRPSFCSI 326

Query: 530 VQILER 535
            +IL+R
Sbjct: 327 HRILQR 332

>1qmo_E Mannose binding lectin, FRIL; crosslink, hematopoietic progenitor, sugar complex; HET: MAN; 3.5A {Dolichos lab lab} SCOP: b.29.1.1 Length = 133

 Score =  115 bits (289), Expect = 1e-30
 Identities = 37/135 (27%), Positives = 61/135 (45%), Gaps = 12/135 (8%)

Query: 72  NHVFAVELDTIKSHGFLDINDNHVGIDINSLKSESSAPAGYY--------VEYDGLEKRT 123
           ++V AVE DT  +  + D N  H+GID+NS++S+ +A   +         + Y+ + KR 
Sbjct: 1   SNVVAVEFDTYLNPDYGDPNYIHIGIDVNSIRSKVTAKWDWQNGKIATAHISYNSVSKRL 60

Query: 124 NVTLAPINIPRPRSLNTMSLSRDLSSVLNDAMYVGFSSSTGSVLASHYILGWSFKINGQA 183
           +VT             T+S   +L +VL + + VG S+STG     + +  WSF  +   
Sbjct: 61  SVTSYYAGSKPA----TLSYDIELHTVLPEWVRVGLSASTGQDKERNTVHSWSFTSSLWT 116

Query: 184 EELNLSQLPKLPRVG 198
                    K    G
Sbjct: 117 NVAKKENENKYITRG 131

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  120 bits (303), Expect = 2e-30
 Identities = 52/232 (22%), Positives = 93/232 (40%), Gaps = 21/232 (9%)

Query: 258 IATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVA-EIVSIGRLR 316
            +   +   ++LG G    V+RG   K+    A+K  ++ S     +    E   + +L 
Sbjct: 6   TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65

Query: 317 HRNLVQLLGY--CRRKGELLLVYDYMPNGSLDKYLYD-QPKVTLNWIQRFRVIKGVALGL 373
           H+N+V+L            +L+ ++ P GSL   L +      L   +   V++ V  G+
Sbjct: 66  HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125

Query: 374 FYLHQEWEQVVIHRDVKASNVLL----DGELNGRLGDFGLARLYDHGTDPQTTHVVGTLG 429
            +L    E  ++HR++K  N++     DG+   +L DFG AR  +      +  + GT  
Sbjct: 126 NHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS--LYGTEE 180

Query: 430 YLAPE--------HTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENL 473
           YL P+             K   + D++S G      A G  P +        
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN 232

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  121 bits (305), Expect = 2e-30
 Identities = 66/295 (22%), Positives = 117/295 (39%), Gaps = 37/295 (12%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQG-MKEFVAEIVSIGRLRHRNLV 321
           F +   LG G  G V++ +   S + +A K I  E +     + + E+  +       +V
Sbjct: 35  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94

Query: 322 QLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
              G     GE+ +  ++M  GSLD+ L    ++    + +  V   V  GL YL ++ +
Sbjct: 95  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK--VSIAVIKGLTYLREKHK 152

Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLA-RLYDHGTDPQTTHVVGTLGYLAPEHTRTGK 440
             ++HRDVK SN+L++     +L DFG++ +L     D      VGT  Y++PE  +   
Sbjct: 153 --IMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMSPERLQGTH 206

Query: 441 ATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEY 500
            +  +D++S G  L+E+A GR PI      E  ++     +          R P      
Sbjct: 207 YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNK 266

Query: 501 VAEELELVLKLGLL---------------------------CSHSDPTARPSMRQ 528
              +    + +  L                           C   +P  R  ++Q
Sbjct: 267 FGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 321

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  121 bits (305), Expect = 4e-30
 Identities = 79/307 (25%), Positives = 131/307 (42%), Gaps = 56/307 (18%)

Query: 266 KELLGTGGFGRVYRGTL-------PKSQIEIAVKKI-SHESRQGMKEFVAEIVSIGRL-R 316
            + LG G FG+V            P    ++AVK + S  + + + + ++E+  +  + +
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133

Query: 317 HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKG-------- 368
           H+N++ LLG C + G L ++ +Y   G+L +YL  +    L +                 
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193

Query: 369 ------VALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQT 421
                 VA G+ YL     +  IHRD+ A NVL+  +   ++ DFGLAR ++        
Sbjct: 194 VSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID----- 245

Query: 422 THVVGTLGYL-----APEHTRTGKATTSADVFSFGAFLLEVA-CGRRPIQRQGPSENLIL 475
            +   T G L     APE       T  +DV+SFG  L E+   G  P       E    
Sbjct: 246 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---- 301

Query: 476 VDWVFDFWNRGELLEARDPNLGTEYVAEEL-ELVLKLGLLCSHSDPTARPSMRQVVQILE 534
              +F     G  ++   P         EL  ++      C H+ P+ RP+ +Q+V+ L+
Sbjct: 302 ---LFKLLKEGHRMDK--P----SNCTNELYMMMRD----CWHAVPSQRPTFKQLVEDLD 348

Query: 535 RDVALPA 541
           R VAL +
Sbjct: 349 RIVALTS 355

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  119 bits (300), Expect = 4e-30
 Identities = 73/305 (23%), Positives = 128/305 (41%), Gaps = 59/305 (19%)

Query: 266 KELLGTGGFGRVYRGTLP-----KSQIEIAVKKI-SHESRQGMKEFVAEIVSIGRLRHRN 319
            + LG G FG+V + T            +AVK +  + S   +++ ++E   + ++ H +
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87

Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYL---------YDQPKVTLNWIQRFRVIKG-- 368
           +++L G C + G LLL+ +Y   GSL  +L         Y     + N        +   
Sbjct: 88  VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147

Query: 369 -----------VALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHG 416
                      ++ G+ YL    E  ++HRD+ A N+L+      ++ DFGL+R +Y+  
Sbjct: 148 TMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204

Query: 417 TDPQTTHVVGTLGYL-----APEHTRTGKATTSADVFSFGAFLLEVA-CGRRPIQRQGPS 470
                ++V  + G +     A E       TT +DV+SFG  L E+   G  P     P 
Sbjct: 205 -----SYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE 259

Query: 471 ENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVV 530
                   +F+    G  +E   P    +  +EE+    +L L C   +P  RP    + 
Sbjct: 260 R-------LFNLLKTGHRMER--P----DNCSEEMY---RLMLQCWKQEPDKRPVFADIS 303

Query: 531 QILER 535
           + LE+
Sbjct: 304 KDLEK 308

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  119 bits (301), Expect = 5e-30
 Identities = 80/336 (23%), Positives = 135/336 (40%), Gaps = 69/336 (20%)

Query: 245 DHGPHRFRYKDLYIATKGF-----------REK----ELLGTGGFGRVYRGTL------- 282
            H  H      +      +           R+K    + LG G FG+V            
Sbjct: 4   SHHHHHHSQDPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDK 63

Query: 283 PKSQIEIAVKKI-SHESRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKGELLLVYDYM 340
           PK  + +AVK +    + + + + V+E+  +  + +H+N++ LLG C + G L ++ +Y 
Sbjct: 64  PKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYA 123

Query: 341 PNGSLDKYL--------------YDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIH 386
             G+L +YL                 P+  + +         +A G+ YL     Q  IH
Sbjct: 124 SKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIH 180

Query: 387 RDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVGTLGYL-----APEHTRTGK 440
           RD+ A NVL+      ++ DFGLAR + +        +   T G L     APE      
Sbjct: 181 RDLAARNVLVTENNVMKIADFGLARDINNID-----YYKKTTNGRLPVKWMAPEALFDRV 235

Query: 441 ATTSADVFSFGAFLLEVA-CGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTE 499
            T  +DV+SFG  + E+   G  P       E       +F     G  ++   P     
Sbjct: 236 YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE-------LFKLLKEGHRMDK--P----A 282

Query: 500 YVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER 535
               EL +++     C H+ P+ RP+ +Q+V+ L+R
Sbjct: 283 NCTNELYMMM---RDCWHAVPSQRPTFKQLVEDLDR 315

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  120 bits (303), Expect = 7e-30
 Identities = 52/224 (23%), Positives = 91/224 (40%), Gaps = 21/224 (9%)

Query: 266 KELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVA-EIVSIGRLRHRNLVQLL 324
            ++LG G    V+RG   K+    A+K  ++ S     +    E   + +L H+N+V+L 
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73

Query: 325 GY--CRRKGELLLVYDYMPNGSLDKYLYD-QPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
                      +L+ ++ P GSL   L +      L   +   V++ V  G+ +L    E
Sbjct: 74  AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---E 130

Query: 382 QVVIHRDVKASNVLL----DGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE--- 434
             ++HR++K  N++     DG+   +L DFG AR  +      +  + GT  YL P+   
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS--LYGTEEYLHPDMYE 188

Query: 435 -----HTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENL 473
                     K   + D++S G      A G  P +        
Sbjct: 189 RAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN 232

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  119 bits (301), Expect = 1e-29
 Identities = 75/301 (24%), Positives = 127/301 (42%), Gaps = 56/301 (18%)

Query: 266 KELLGTGGFGRVYRGTL-------PKSQIEIAVKKI-SHESRQGMKEFVAEIVSIGRL-R 316
            + LG G FG+V            PK  + +AVK +    + + + + V+E+  +  + +
Sbjct: 86  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145

Query: 317 HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKG-------- 368
           H+N++ LLG C + G L ++ +Y   G+L +YL  +    + +      +          
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205

Query: 369 ------VALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQT 421
                 +A G+ YL     Q  IHRD+ A NVL+      ++ DFGLAR + +       
Sbjct: 206 VSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID----- 257

Query: 422 THVVGTLGYL-----APEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLIL 475
            +   T G L     APE       T  +DV+SFG  + E+   G  P       E    
Sbjct: 258 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE---- 313

Query: 476 VDWVFDFWNRGELLEARDPNLGTEYVAEEL-ELVLKLGLLCSHSDPTARPSMRQVVQILE 534
              +F     G  ++   P         EL  ++      C H+ P+ RP+ +Q+V+ L+
Sbjct: 314 ---LFKLLKEGHRMDK--P----ANCTNELYMMMRD----CWHAVPSQRPTFKQLVEDLD 360

Query: 535 R 535
           R
Sbjct: 361 R 361

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  117 bits (294), Expect = 2e-29
 Identities = 57/294 (19%), Positives = 106/294 (36%), Gaps = 52/294 (17%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE--SRQGMKEFVAEIVSIGRL-RHRN 319
           F E E +G+G FG V++          A+K+           +  + E+ +   L +H +
Sbjct: 13  FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72

Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYL--YDQPKVTLNWIQRFRVIKGVALGLFYLH 377
           +V+          +L+  +Y   GSL   +    +        +   ++  V  GL Y+H
Sbjct: 73  VVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH 132

Query: 378 QEWEQVVIHRDVKASNVLLD-------------------GELNGRLGDFGLARLYDHGTD 418
                 ++H D+K SN+ +                     ++  ++GD G        + 
Sbjct: 133 ---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT---RISS 186

Query: 419 PQTTHVVGTLGYLAPEHTRTGKA-TTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVD 477
           PQ     G   +LA E  +        AD+F+    ++  A          P        
Sbjct: 187 PQV--EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL-----PRNG----- 234

Query: 478 WVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ 531
              D W+   + + R P +     ++E   +LK   +  H DP  RPS   +V+
Sbjct: 235 ---DQWHE--IRQGRLPRIPQVL-SQEFTELLK---VMIHPDPERRPSAMALVK 279

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  117 bits (295), Expect = 2e-29
 Identities = 72/304 (23%), Positives = 124/304 (40%), Gaps = 55/304 (18%)

Query: 266 KELLGTGGFGRVYRGTLP-----KSQIEIAVKKI-SHESRQGMKEFVAEIVSIGRL-RHR 318
            + LG G FG+V   T        + + +AVK +         +  ++E+  +  L  H 
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87

Query: 319 NLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKG---------- 368
           N+V LLG C   G  L++ +Y   G L  +L  +    +       +++           
Sbjct: 88  NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147

Query: 369 ------VALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQT 421
                 VA G+ +L     +  IHRD+ A N+LL      ++ DFGLAR + +       
Sbjct: 148 LSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS----- 199

Query: 422 THVVGTLGYL-----APEHTRTGKATTSADVFSFGAFLLEVA-CGRRPIQRQGPSENLIL 475
            +VV     L     APE       T  +DV+S+G FL E+   G  P            
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK--- 256

Query: 476 VDWVFDFWNRGELLEARDPNLGTEYVAEEL-ELVLKLGLLCSHSDPTARPSMRQVVQILE 534
               +     G  + +  P    E+   E+ +++      C  +DP  RP+ +Q+VQ++E
Sbjct: 257 ---FYKMIKEGFRMLS--P----EHAPAEMYDIMKT----CWDADPLKRPTFKQIVQLIE 303

Query: 535 RDVA 538
           + ++
Sbjct: 304 KQIS 307

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  117 bits (294), Expect = 2e-29
 Identities = 57/206 (27%), Positives = 101/206 (49%), Gaps = 10/206 (4%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQ 322
           +     LG G FG+VY+    ++    A K I  +S + +++++ EI  +    H  +V+
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80

Query: 323 LLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQ 382
           LLG     G+L ++ ++ P G++D  +  +    L   Q   V + +   L +LH    +
Sbjct: 81  LLGAYYHDGKLWIMIEFCPGGAVDA-IMLELDRGLTEPQIQVVCRQMLEALNFLHS---K 136

Query: 383 VVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE-----HTR 437
            +IHRD+KA NVL+  E + RL DFG++         + +  +GT  ++APE       +
Sbjct: 137 RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS-FIGTPYWMAPEVVMCETMK 195

Query: 438 TGKATTSADVFSFGAFLLEVACGRRP 463
                  AD++S G  L+E+A    P
Sbjct: 196 DTPYDYKADIWSLGITLIEMAQIEPP 221

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  118 bits (297), Expect = 3e-29
 Identities = 34/304 (11%), Positives = 71/304 (23%), Gaps = 50/304 (16%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKI---SHESRQGMKEFVAEIVSIGRLRHRN 319
            +  E L  G    V+     +   + A+K     +  SR  ++       +  RL   +
Sbjct: 64  LKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGES 123

Query: 320 LVQLLGYCR--------------------------RKGELLLVYDYMP--NGSLDKYLYD 351
             +     R                               LL+          L   L  
Sbjct: 124 PEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDF 183

Query: 352 QPKV--TLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGL 409
                     +    +   +      L  +    ++H      N+ +  +    LGD   
Sbjct: 184 VYVFRGDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSA 240

Query: 410 ARLYDHGTDPQTTHVVGTLGYLAPE--HTRTGKATTSADVFSFGAFLLEVACGRRPIQRQ 467
                     +       + Y   E  +  T   T + + +  G  +  V C   P    
Sbjct: 241 LWKVGT----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLV 296

Query: 468 GPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMR 527
            P                  L            + + ++ ++    L    D   R    
Sbjct: 297 TPGIKGSWKRPSLRVPGTDSLAFGSCTP-----LPDFVKTLIG-RFLN--FDRRRRLLPL 348

Query: 528 QVVQ 531
           + ++
Sbjct: 349 EAME 352

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  119 bits (299), Expect = 3e-29
 Identities = 41/344 (11%), Positives = 79/344 (22%), Gaps = 63/344 (18%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRH-R 318
                +LG          T  ++     V             +K+   E++ +  LR  +
Sbjct: 80  LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139

Query: 319 NLVQLLGYCRRKGE----------------------------LLLVYDYMPNGSLDKYLY 350
           N  Q   + R                                 L         +  + L 
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199

Query: 351 DQPKV--TLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFG 408
                  +L    R ++   V   L  LH      ++H  ++  +++LD      L  F 
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFE 256

Query: 409 LARLYDHGTDPQTTHVVGTLGYLAPEHTR-----TGKATTSADVFSFGAFLLEVACGRRP 463
                                  A              T + D ++ G  +  + C   P
Sbjct: 257 HLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316

Query: 464 IQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTAR 523
                        +W+F                    + + +  +L+ G L        R
Sbjct: 317 NTDDAALG---GSEWIFRSCKN---------------IPQPVRALLE-GFLR--YPKEDR 355

Query: 524 PSMRQVVQILERDVALPAISALRLSTSGITYLEGFDDFAVSNPP 567
               Q ++  E +     +SA                   S   
Sbjct: 356 LLPLQAMETPEYEQLRTELSAALPLYQTDGEPTREGGAPPSGTS 399

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  117 bits (296), Expect = 3e-29
 Identities = 50/200 (25%), Positives = 91/200 (45%), Gaps = 9/200 (4%)

Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHES--RQGMKE-FVAEIVSIGRLRHRNLVQL 323
             LG GGF + +  +   ++   A K +      +   +E    EI     L H+++V  
Sbjct: 47  RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 106

Query: 324 LGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQV 383
            G+      + +V +     SL +    +  +T    + +  ++ + LG  YLH+     
Sbjct: 107 HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYY--LRQIVLGCQYLHR---NR 161

Query: 384 VIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATT 443
           VIHRD+K  N+ L+ +L  ++GDFGLA   ++  + +   + GT  Y+APE       + 
Sbjct: 162 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGHSF 220

Query: 444 SADVFSFGAFLLEVACGRRP 463
             DV+S G  +  +  G+ P
Sbjct: 221 EVDVWSIGCIMYTLLVGKPP 240

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  116 bits (293), Expect = 3e-29
 Identities = 50/200 (25%), Positives = 91/200 (45%), Gaps = 9/200 (4%)

Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHES--RQGMKE-FVAEIVSIGRLRHRNLVQL 323
             LG GGF + +  +   ++   A K +      +   +E    EI     L H+++V  
Sbjct: 21  RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 80

Query: 324 LGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQV 383
            G+      + +V +     SL +    +  +T    + +  ++ + LG  YLH+     
Sbjct: 81  HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYY--LRQIVLGCQYLHR---NR 135

Query: 384 VIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATT 443
           VIHRD+K  N+ L+ +L  ++GDFGLA   ++  + +   + GT  Y+APE       + 
Sbjct: 136 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGHSF 194

Query: 444 SADVFSFGAFLLEVACGRRP 463
             DV+S G  +  +  G+ P
Sbjct: 195 EVDVWSIGCIMYTLLVGKPP 214

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  117 bits (294), Expect = 4e-29
 Identities = 57/211 (27%), Positives = 93/211 (44%), Gaps = 16/211 (7%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES-RQGMKEFVAEI-VSIGRLRHRNL 320
            ++   +G G +G V +     S   +AVK+I      +  K+ + ++ V +       +
Sbjct: 24  LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYI 83

Query: 321 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRF---RVIKGVALGLFYLH 377
           VQ  G   R+G+  +  + M + S DK+      V  + I      ++       L +L 
Sbjct: 84  VQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLK 142

Query: 378 QEWEQVVIHRDVKASNVLLDGELNGRLGDFGL-ARLYDHGTDPQTTHVVGTLGYLAPE-- 434
           +  +  +IHRD+K SN+LLD   N +L DFG+  +L D       T   G   Y+APE  
Sbjct: 143 ENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK---TRDAGCRPYMAPERI 197

Query: 435 --HTRTGKATTSADVFSFGAFLLEVACGRRP 463
                       +DV+S G  L E+A GR P
Sbjct: 198 DPSASRQGYDVRSDVWSLGITLYELATGRFP 228

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  116 bits (293), Expect = 5e-29
 Identities = 72/300 (24%), Positives = 122/300 (40%), Gaps = 54/300 (18%)

Query: 266 KELLGTGGFGRVYRGTLP-----KSQIEIAVKKI-SHESRQGMKEFVAEIVSIGRL-RHR 318
            + LG G FG+V            +   +AVK +    +    +  ++E+  +  +  H 
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91

Query: 319 NLVQLLGYCRRKGE-LLLVYDYMPNGSLDKYLYDQ-PKVTLNWIQRFRVIKG-------- 368
           N+V LLG C + G  L+++ ++   G+L  YL  +  +     +    + K         
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151

Query: 369 -----VALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTT 422
                VA G+ +L     +  IHRD+ A N+LL  +   ++ DFGLAR +Y         
Sbjct: 152 CYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP-----D 203

Query: 423 HVVGTLGYL-----APEHTRTGKATTSADVFSFGAFLLEVA-CGRRPIQRQGPSENLILV 476
           +V      L     APE       T  +DV+SFG  L E+   G  P    G   +    
Sbjct: 204 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY--PGVKID---- 257

Query: 477 DWVFDFWNRGELLEARDPNLGTEYVAEEL-ELVLKLGLLCSHSDPTARPSMRQVVQILER 535
           +        G  + A  P    +Y   E+ + +L     C H +P+ RP+  ++V+ L  
Sbjct: 258 EEFCRRLKEGTRMRA--P----DYTTPEMYQTMLD----CWHGEPSQRPTFSELVEHLGN 307

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  115 bits (291), Expect = 7e-29
 Identities = 57/202 (28%), Positives = 99/202 (49%), Gaps = 8/202 (3%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQG-MKEFVAEIVSIGRLRHRNLV 321
           F + E +G G FG V++G   ++Q  +A+K I  E  +  +++   EI  + +     + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83

Query: 322 QLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
           +  G   +  +L ++ +Y+  GS    L +   +    I    +++ +  GL YLH    
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIAT--ILREILKGLDYLH---S 137

Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKA 441
           +  IHRD+KA+NVLL      +L DFG+A         + T  VGT  ++APE  +    
Sbjct: 138 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT-FVGTPFWMAPEVIKQSAY 196

Query: 442 TTSADVFSFGAFLLEVACGRRP 463
            + AD++S G   +E+A G  P
Sbjct: 197 DSKADIWSLGITAIELARGEPP 218

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  115 bits (290), Expect = 1e-28
 Identities = 53/215 (24%), Positives = 91/215 (42%), Gaps = 15/215 (6%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES-RQGMKEFVAEI-VSIGRLRHRNL 320
                 +G+G  G+V++    K+   IAVK++     ++  K  + ++ V +       +
Sbjct: 27  LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYI 86

Query: 321 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEW 380
           VQ  G      ++ +  + M   +       Q  +    + +  +   +   L+YL ++ 
Sbjct: 87  VQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGK--MTVAIVKALYYLKEK- 143

Query: 381 EQVVIHRDVKASNVLLDGELNGRLGDFGL-ARLYDHGTDPQTTHVVGTLGYLAPE----- 434
              VIHRDVK SN+LLD     +L DFG+  RL D     +     G   Y+APE     
Sbjct: 144 -HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD--DKAKDR-SAGCAAYMAPERIDPP 199

Query: 435 HTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGP 469
                     ADV+S G  L+E+A G+ P +    
Sbjct: 200 DPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT 234

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  115 bits (289), Expect = 1e-28
 Identities = 51/202 (25%), Positives = 94/202 (46%), Gaps = 9/202 (4%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQ 322
           +   E +G G  G VY      +  E+A+++++ + +   +  + EI+ +   ++ N+V 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 323 LLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQ 382
            L       EL +V +Y+  GSL   +  +  +    I    V +     L +LH     
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIA--AVCRECLQALEFLHS---N 135

Query: 383 VVIHRDVKASNVLLDGELNGRLGDFGL-ARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKA 441
            VIHRD+K+ N+LL  + + +L DFG  A++       + + +VGT  ++APE       
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMVGTPYWMAPEVVTRKAY 193

Query: 442 TTSADVFSFGAFLLEVACGRRP 463
               D++S G   +E+  G  P
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPP 215

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  115 bits (291), Expect = 1e-28
 Identities = 71/299 (23%), Positives = 118/299 (39%), Gaps = 55/299 (18%)

Query: 266 KELLGTGGFGRVYRGTLP-----KSQIEIAVKKI-SHESRQGMKEFVAEI---VSIGRLR 316
            + LG G FG+V   T        + +++AVK + S       +  ++E+     +G+  
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQ-- 108

Query: 317 HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYL------------YDQPKVTLNWIQRFR 364
           H N+V LLG C   G +L++ +Y   G L  +L            +     T +      
Sbjct: 109 HENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLH 168

Query: 365 VIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTH 423
               VA G+ +L     +  IHRDV A NVLL      ++GDFGLAR + +        +
Sbjct: 169 FSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS-----NY 220

Query: 424 VVGTLGYL-----APEHTRTGKATTSADVFSFGAFLLEVA-CGRRPIQRQGPSENLILVD 477
           +V     L     APE       T  +DV+S+G  L E+   G  P      +       
Sbjct: 221 IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK----- 275

Query: 478 WVFDFWNRGELLEARDPNLGTEYVAEEL-ELVLKLGLLCSHSDPTARPSMRQVVQILER 535
             +     G  +    P     +  + +  ++      C   +PT RP+ +Q+   L+ 
Sbjct: 276 -FYKLVKDGYQMAQ--P----AFAPKNIYSIMQA----CWALEPTHRPTFQQICSFLQE 323

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  115 bits (290), Expect = 1e-28
 Identities = 54/202 (26%), Positives = 93/202 (46%), Gaps = 9/202 (4%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQ 322
                 +G G  G V       S  ++AVK +    +Q  +    E+V +   +H N+V+
Sbjct: 47  LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106

Query: 323 LLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQ 382
           +        EL ++ +++  G+L   +  Q ++    I    V + V   L YLH    Q
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALTD-IVSQVRLNEEQIA--TVCEAVLQALAYLHA---Q 160

Query: 383 VVIHRDVKASNVLLDGELNGRLGDFGL-ARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKA 441
            VIHRD+K+ ++LL  +   +L DFG  A++      P+   +VGT  ++APE       
Sbjct: 161 GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK--DVPKRKSLVGTPYWMAPEVISRSLY 218

Query: 442 TTSADVFSFGAFLLEVACGRRP 463
            T  D++S G  ++E+  G  P
Sbjct: 219 ATEVDIWSLGIMVIEMVDGEPP 240

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  117 bits (295), Expect = 1e-28
 Identities = 62/288 (21%), Positives = 117/288 (40%), Gaps = 49/288 (17%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEI---VSIGR--LRH 317
           F  K++LG G  G +    +  ++ ++AVK+I         E  +     V + R    H
Sbjct: 26  FCPKDVLGHGAEGTIVYRGMFDNR-DVAVKRIL-------PECFSFADREVQLLRESDEH 77

Query: 318 RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLH 377
            N+++     + +    +  +     +L +Y+ +Q       ++   +++    GL +LH
Sbjct: 78  PNVIRYFCTEKDRQFQYIAIELCA-ATLQEYV-EQKDFAHLGLEPITLLQQTTSGLAHLH 135

Query: 378 QEWEQVVIHRDVKASNVLL-----DGELNGRLGDFGLARLYDHG--TDPQTTHVVGTLGY 430
                 ++HRD+K  N+L+      G++   + DFGL +    G  +  + + V GT G+
Sbjct: 136 ---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGW 192

Query: 431 LAPE---HTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLIL---VDWVFDFW 483
           +APE          T + D+FS G     V   G  P  +    +  IL           
Sbjct: 193 IAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHP 252

Query: 484 NRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ 531
            + E + AR+             L+ K  ++    DP  RPS + V++
Sbjct: 253 EKHEDVIARE-------------LIEK--MIA--MDPQKRPSAKHVLK 283

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  115 bits (290), Expect = 1e-28
 Identities = 62/346 (17%), Positives = 123/346 (35%), Gaps = 47/346 (13%)

Query: 247 GPHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFV 306
               F  + + +     R + +L  GGF  VY      S  E A+K++     +  +  +
Sbjct: 14  DQSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAII 73

Query: 307 AEIVSIGRLR-HRNLVQLLGYC--------RRKGELLLVYDYMPNGSLDKYLYDQPKVTL 357
            E+  + +L  H N+VQ               + E LL+ +      ++     + +  L
Sbjct: 74  QEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPL 133

Query: 358 NWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT 417
           +     ++       + ++H++ +  +IHRD+K  N+LL  +   +L DFG A    H  
Sbjct: 134 SCDTVLKIFYQTCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYP 192

Query: 418 DPQTTH-----------VVGTLGYLAPE--HTRTGK-ATTSADVFSFGAFLLEVACGRRP 463
           D   +               T  Y  PE     +        D+++ G  L  +   + P
Sbjct: 193 DYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHP 252

Query: 464 IQRQGPSENLILVDWVFDFWNRGELLEA--RDPNLGTEYVAEELELVLKLGLLCSHSDPT 521
                           F+   +  ++      P   T+Y       +++  +L    +P 
Sbjct: 253 ----------------FEDGAKLRIVNGKYSIPPHDTQY--TVFHSLIR-AML--QVNPE 291

Query: 522 ARPSMRQVVQILERDVALPAISALRLSTSGITYLEGFDDFAVSNPP 567
            R S+ +VV  L+   A   ++     T  +    G+    +S  P
Sbjct: 292 ERLSIAEVVHQLQEIAAARNVNPKSPITELLEQNGGYGSATLSRGP 337

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  114 bits (287), Expect = 2e-28
 Identities = 65/280 (23%), Positives = 110/280 (39%), Gaps = 39/280 (13%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES-RQGMKEFVAEI-VSIGRLRHRNL 320
                 LG G +G V +     S   +AVK+I      Q  K  + ++ +S+  +     
Sbjct: 9   LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFT 68

Query: 321 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRF------RVIKGVALGLF 374
           V   G   R+G++ +  + M + SLDK+     K  ++  Q        ++   +   L 
Sbjct: 69  VTFYGALFREGDVWICMELM-DTSLDKFY----KQVIDKGQTIPEDILGKIAVSIVKALE 123

Query: 375 YLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGL-ARLYDHGTDPQTTHVVGTLGYLAP 433
           +LH +    VIHRDVK SNVL++     ++ DFG+   L D     +     G   Y+AP
Sbjct: 124 HLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVD--DVAKDI-DAGCKPYMAP 178

Query: 434 E----HTRTGKATTSADVFSFGAFLLEVACGRRPIQR-QGPSENLILVDWVFDFWNRGEL 488
           E           +  +D++S G  ++E+A  R P      P + L  V            
Sbjct: 179 ERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV------------ 226

Query: 489 LEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQ 528
           +E   P L  +  + E          C   +   RP+  +
Sbjct: 227 VEEPSPQLPADKFSAEFVDFTS---QCLKKNSKERPTYPE 263

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  114 bits (288), Expect = 2e-28
 Identities = 53/206 (25%), Positives = 85/206 (41%), Gaps = 10/206 (4%)

Query: 262 GFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVA----EIVSIGRLRH 317
            +R + L+G GG G VY       +  +A+K +  E+      F      E  + GRL+ 
Sbjct: 35  PYRLRRLVGRGGMGDVYEAEDTVRERIVALK-LMSETLSSDPVFRTRMQREARTAGRLQE 93

Query: 318 RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLH 377
            ++V +  +    G+L +    +    L   L  Q  +     +   +++ +   L   H
Sbjct: 94  PHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPP--RAVAIVRQIGSALDAAH 151

Query: 378 QEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTR 437
                   HRDVK  N+L+  +    L DFG+A         Q  + VGTL Y+APE   
Sbjct: 152 A---AGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFS 208

Query: 438 TGKATTSADVFSFGAFLLEVACGRRP 463
              AT  AD+++    L E   G  P
Sbjct: 209 ESHATYRADIYALTCVLYECLTGSPP 234

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  114 bits (288), Expect = 2e-28
 Identities = 60/202 (29%), Positives = 102/202 (50%), Gaps = 9/202 (4%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQ 322
           F   E LG G +G VY+    ++   +A+K++  ES   ++E + EI  + +    ++V+
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEIIKEISIMQQCDSPHVVK 88

Query: 323 LLGYCRRKGELLLVYDYMPNGSL-DKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
             G   +  +L +V +Y   GS+ D        +T + I    +++    GL YLH    
Sbjct: 89  YYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIAT--ILQSTLKGLEYLHF--- 143

Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKA 441
              IHRD+KA N+LL+ E + +L DFG+A         + T V+GT  ++APE  +    
Sbjct: 144 MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT-VIGTPFWMAPEVIQEIGY 202

Query: 442 TTSADVFSFGAFLLEVACGRRP 463
              AD++S G   +E+A G+ P
Sbjct: 203 NCVADIWSLGITAIEMAEGKPP 224

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  113 bits (285), Expect = 3e-28
 Identities = 58/199 (29%), Positives = 97/199 (48%), Gaps = 8/199 (4%)

Query: 268 LLGTGGFGRVYRGTLPKSQIEIAVKKISHES--RQGMKEFVA-EIVSIGRLRHRNLVQLL 324
           LLG G F  VYR     + +E+A+K I  ++  + GM + V  E+    +L+H ++++L 
Sbjct: 18  LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77

Query: 325 GYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVV 384
            Y      + LV +   NG +++YL ++ K       R   +  +  G+ YLH      +
Sbjct: 78  NYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEAR-HFMHQIITGMLYLHS---HGI 133

Query: 385 IHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTS 444
           +HRD+  SN+LL   +N ++ DFGLA       +   T + GT  Y++PE          
Sbjct: 134 LHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPEIATRSAHGLE 192

Query: 445 ADVFSFGAFLLEVACGRRP 463
           +DV+S G     +  GR P
Sbjct: 193 SDVWSLGCMFYTLLIGRPP 211

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  114 bits (288), Expect = 4e-28
 Identities = 47/218 (21%), Positives = 81/218 (37%), Gaps = 28/218 (12%)

Query: 269 LGTGGFGRVYRGT----------LPKSQIE----IAVKKISHESRQGMKEFVA-EIVSIG 313
           L  G F ++                KS +E             S +   +    E+  I 
Sbjct: 39  LNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIIT 98

Query: 314 RLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRF------RVIK 367
            +++   +   G      E+ ++Y+YM N S+ K+      +  N+           +IK
Sbjct: 99  DIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIK 158

Query: 368 GVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT 427
            V     Y+H E  + + HRDVK SN+L+D     +L DFG +    +  D +     GT
Sbjct: 159 SVLNSFSYIHNE--KNICHRDVKPSNILMDKNGRVKLSDFGESE---YMVDKKIKGSRGT 213

Query: 428 LGYLAPE--HTRTGKATTSADVFSFGAFLLEVACGRRP 463
             ++ PE     +       D++S G  L  +     P
Sbjct: 214 YEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  112 bits (283), Expect = 4e-28
 Identities = 57/207 (27%), Positives = 90/207 (43%), Gaps = 11/207 (5%)

Query: 268 LLGTGGFGRVYRGTLPKSQIEIAVKKISHE--SRQGMKEFV-AEIVSIGRLRHRNLVQLL 324
            LG G FG VY     +S+  +A+K +      + G++  +  E+     LRH N+++L 
Sbjct: 16  PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 75

Query: 325 GYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVV 384
           GY      + L+ +Y P G++ + L    K        +  I  +A  L Y H    + V
Sbjct: 76  GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATY--ITELANALSYCHS---KRV 130

Query: 385 IHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTS 444
           IHRD+K  N+LL      ++ DFG +         +T  + GTL YL PE          
Sbjct: 131 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSR--RTD-LCGTLDYLPPEMIEGRMHDEK 187

Query: 445 ADVFSFGAFLLEVACGRRPIQRQGPSE 471
            D++S G    E   G+ P +     E
Sbjct: 188 VDLWSLGVLCYEFLVGKPPFEANTYQE 214

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  112 bits (282), Expect = 8e-28
 Identities = 50/201 (24%), Positives = 90/201 (44%), Gaps = 10/201 (4%)

Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVA----EIVSIGRLRHRNLVQ 322
           + LG GG   VY        I++A+K       +  +E +     E+ +  +L H+N+V 
Sbjct: 17  DKLGGGGMSTVYLAEDTILNIKVAIK-AIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75

Query: 323 LLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQ 382
           ++          LV +Y+   +L +Y+       L+          +  G+ + H     
Sbjct: 76  MIDVDEEDDCYYLVMEYIEGPTLSEYIESHGP--LSVDTAINFTNQILDGIKHAHD---M 130

Query: 383 VVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKAT 442
            ++HRD+K  N+L+D     ++ DFG+A+     +  QT HV+GT+ Y +PE  +     
Sbjct: 131 RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATD 190

Query: 443 TSADVFSFGAFLLEVACGRRP 463
              D++S G  L E+  G  P
Sbjct: 191 ECTDIYSIGIVLYEMLVGEPP 211

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  113 bits (285), Expect = 9e-28
 Identities = 75/310 (24%), Positives = 120/310 (38%), Gaps = 62/310 (20%)

Query: 266 KELLGTGGFGRVYRGTL-----PKSQIEIAVKKI-SHESRQGMKEFVAEI---VSIGRLR 316
            ++LG+G FG+V   T          I++AVK +         +  ++E+     +G   
Sbjct: 50  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGS-- 107

Query: 317 HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQ-PKVTLNWIQRFRVIKG------- 368
           H N+V LLG C   G + L+++Y   G L  YL  +  K + + I+     +        
Sbjct: 108 HENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167

Query: 369 -------------VALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYD 414
                        VA G+ +L     +  +HRD+ A NVL+      ++ DFGLAR +  
Sbjct: 168 VLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMS 224

Query: 415 HGTDPQTTHVVGTLGYL-----APEHTRTGKATTSADVFSFGAFLLEVA-CGRRPIQRQG 468
                   +VV     L     APE    G  T  +DV+S+G  L E+   G  P     
Sbjct: 225 DS-----NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279

Query: 469 PSENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQ 528
              N       +     G  ++   P     Y  EE+ +++     C   D   RPS   
Sbjct: 280 VDAN------FYKLIQNGFKMDQ--P----FYATEEIYIIM---QSCWAFDSRKRPSFPN 324

Query: 529 VVQILERDVA 538
           +   L   +A
Sbjct: 325 LTSFLGCQLA 334

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  111 bits (280), Expect = 2e-27
 Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 15/213 (7%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQ-GMKEFVAEIVSIGRLRHRNLV 321
           +  +E++G+G    V        + ++A+K+I+ E  Q  M E + EI ++ +  H N+V
Sbjct: 17  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 76

Query: 322 QLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFR------VIKGVALGLFY 375
                   K EL LV   +  GS+   +        +            +++ V  GL Y
Sbjct: 77  SYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEY 136

Query: 376 LHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGL-ARLYDHGTDPQTTH---VVGTLGYL 431
           LH   +   IHRDVKA N+LL  + + ++ DFG+ A L   G   +       VGT  ++
Sbjct: 137 LH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWM 193

Query: 432 APEHTRTGKA-TTSADVFSFGAFLLEVACGRRP 463
           APE     +     AD++SFG   +E+A G  P
Sbjct: 194 APEVMEQVRGYDFKADIWSFGITAIELATGAAP 226

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  112 bits (282), Expect = 4e-27
 Identities = 45/213 (21%), Positives = 79/213 (37%), Gaps = 15/213 (7%)

Query: 263 FREKELLGTG--GFGRVYRGTLPKSQIEIAVKKIS--HESRQGMKEFVAEIVSIGRLRHR 318
           +    ++G G      V       +   + V++I+    S + +     E+       H 
Sbjct: 27  YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHP 86

Query: 319 NLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQ 378
           N+V          EL +V  +M  GS    +       +N +    +++GV   L Y+H 
Sbjct: 87  NIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH 146

Query: 379 EWEQVVIHRDVKASNVLLDGELNGRLGDFG-LARLYDHGTDPQTTHV-----VGTLGYLA 432
                 +HR VKAS++L+  +    L        +  HG   +  H      V  L +L+
Sbjct: 147 ---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLS 203

Query: 433 PE--HTRTGKATTSADVFSFGAFLLEVACGRRP 463
           PE            +D++S G    E+A G  P
Sbjct: 204 PEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  110 bits (277), Expect = 9e-27
 Identities = 62/207 (29%), Positives = 93/207 (44%), Gaps = 16/207 (7%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKIS---HESRQGMKEFVAEIVSIGRLRHRN 319
           F +   +G G FG VY     ++   +A+KK+S    +S +  ++ + E+  + +LRH N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115

Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQE 379
            +Q  G   R+    LV +Y    + D     +  +    I    V  G   GL YLH  
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA--VTHGALQGLAYLH-- 171

Query: 380 WEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE---HT 436
               +IHRDVKA N+LL      +LGDFG A              VGT  ++APE     
Sbjct: 172 -SHNMIHRDVKAGNILLSEPGLVKLGDFGSA-----SIMAPANSFVGTPYWMAPEVILAM 225

Query: 437 RTGKATTSADVFSFGAFLLEVACGRRP 463
             G+     DV+S G   +E+A  + P
Sbjct: 226 DEGQYDGKVDVWSLGITCIELAERKPP 252

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  110 bits (276), Expect = 1e-26
 Identities = 43/269 (15%), Positives = 79/269 (29%), Gaps = 31/269 (11%)

Query: 254 KDLYIATKGFREKELLGTGGFGRVYRGT-----LPKSQIEIAVKKISHESRQGMKEFVAE 308
            +  + +K      LLG G F +VY  T       K++ +  +K     +          
Sbjct: 58  TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQL 117

Query: 309 IVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKG 368
           +  +        ++       +   +LV +    G+L   +          + +  VI  
Sbjct: 118 MERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177

Query: 369 ---VALGLFYLHQEWEQVVIHRDVKASNVLL-----------DGELNGRLGDFGLAR-LY 413
              +   +  +H   +  +IH D+K  N +L           D      L D G +  + 
Sbjct: 178 AMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234

Query: 414 DHGTDPQTTHVVGTLGYLAPEHTRTGKA-TTSADVFSFGAFLLEVACGRRPIQRQGPSEN 472
                   T    T G+   E   + K      D F   A +  +  G     +    E 
Sbjct: 235 LFPKGTIFTAKCETSGFQCVE-MLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC 293

Query: 473 LILVD----WVFDFWNR--GELLEARDPN 495
                       D WN     +L   D +
Sbjct: 294 KPEGLFRRLPHLDMWNEFFHVMLNIPDCH 322

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  108 bits (271), Expect = 2e-26
 Identities = 53/199 (26%), Positives = 90/199 (45%), Gaps = 11/199 (5%)

Query: 268 LLGTGGFGRVYRGTLPKSQIEIAVKKI--SHESRQGMKEFVA-EIVSIGRLRHRNLVQLL 324
            LG G FG VY     +++  +A+K +  S   ++G++  +  EI     LRH N++++ 
Sbjct: 21  PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80

Query: 325 GYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVV 384
            Y   +  + L+ ++ P G L K L    +        F  ++ +A  L Y H+   + V
Sbjct: 81  NYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATF--MEELADALHYCHE---RKV 135

Query: 385 IHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTS 444
           IHRD+K  N+L+  +   ++ DFG +         + T + GTL YL PE          
Sbjct: 136 IHRDIKPENLLMGYKGELKIADFGWSVHAPS--LRRRT-MCGTLDYLPPEMIEGKTHDEK 192

Query: 445 ADVFSFGAFLLEVACGRRP 463
            D++  G    E   G  P
Sbjct: 193 VDLWCAGVLCYEFLVGMPP 211

>2ltn_A PEA lectin, alpha chain; 1.70A {Pisum sativum} SCOP: b.29.1.1 PDB: 1bqp_A* 1hkd_A 1ofs_A* 1rin_A* 1lof_C* 1len_A 1lem_A 1les_A* 2lal_A 1loe_A 1loa_A* 1loc_A* 1lod_A* 1lob_A 1lof_A* 1log_A* 1lgc_A* 1lgb_A* 2b7y_A* Length = 181

 Score =  104 bits (261), Expect = 3e-26
 Identities = 35/135 (25%), Positives = 54/135 (40%), Gaps = 15/135 (11%)

Query: 2   PFKNKNSNSSTANGTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGL 61
           P    +  +    G V +F T+F F I +        G  F IA            YLG+
Sbjct: 49  PIHIWDRET----GNVANFVTSFTFVINAPNSYNVADGFTFFIAPV-DTKPQTGGGYLGV 103

Query: 62  FNDTNLGNETNHVFAVELDTIKSHGFLDIN-DNHVGIDINSLKSESSAPAGYY------- 113
           FN     ++T    AVE DT  +  +   N D H+GID+NS+KS ++             
Sbjct: 104 FNSAE-YDKTTQTVAVEFDTFYNAAWDPSNRDRHIGIDVNSIKSVNTKSWKLQNGEEANV 162

Query: 114 -VEYDGLEKRTNVTL 127
            + ++       V+L
Sbjct: 163 VIAFNAATNVLTVSL 177

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  107 bits (270), Expect = 6e-26
 Identities = 60/215 (27%), Positives = 97/215 (45%), Gaps = 21/215 (9%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRL-RHRNLV 321
           F   EL+G G +G+VY+G   K+    A+K +        +E   EI  + +   HRN+ 
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIA 84

Query: 322 QLLG------YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLN--WIQRFRVIKGVALGL 373
              G            +L LV ++   GS+   + +    TL   WI    + + +  GL
Sbjct: 85  TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGL 142

Query: 374 FYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAP 433
            +LH   +  VIHRD+K  NVLL      +L DFG++   D     + T  +GT  ++AP
Sbjct: 143 SHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNT-FIGTPYWMAP 198

Query: 434 EHTRTGKATTS-----ADVFSFGAFLLEVACGRRP 463
           E     +   +     +D++S G   +E+A G  P
Sbjct: 199 EVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  108 bits (270), Expect = 6e-26
 Identities = 68/343 (19%), Positives = 114/343 (33%), Gaps = 99/343 (28%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVA-EIVSIGRLRHRNLV 321
           F   + +G GGFG V+           A+K+I   +R+  +E V  E+ ++ +L H  +V
Sbjct: 8   FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67

Query: 322 QLLGYCRRKGELLLVYD-----------------------------------------YM 340
           +               +                                          +
Sbjct: 68  RYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQL 127

Query: 341 PNGSLDKYLYDQ----PKVTL-NWIQR------------FRVIKGVALGLFYLHQEWEQV 383
              S   YLY Q     K  L +W+ R              +   +A  + +LH    + 
Sbjct: 128 QPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS---KG 184

Query: 384 VIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQT-----------THVVGTLGYLA 432
           ++HRD+K SN+    +   ++GDFGL    D   + QT           T  VGT  Y++
Sbjct: 185 LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244

Query: 433 PEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLE-A 491
           PE       +   D+FS G  L E+                           R  ++   
Sbjct: 245 PEQIHGNNYSHKVDIFSLGLILFELLYSFST------------------QMERVRIITDV 286

Query: 492 RD---PNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ 531
           R+   P L T+   +E  +V     + S   PT RP    +++
Sbjct: 287 RNLKFPLLFTQKYPQEHMMVQD---MLSP-SPTERPEATDIIE 325

>1nls_A Concanavalin A; lectin, agglutinin; 0.94A {Canavalia ensiformis} SCOP: b.29.1.1 PDB: 1bxh_A* 1apn_A 1ces_A 1cjp_A* 1c57_A 1cvn_A* 1con_A 1dq1_A 1dq2_A 1dq4_A 1dq5_A 1dq6_A 1enq_A 1enr_A 1ens_A 1gic_A* 1dq0_A 1hqw_A 1gkb_A* 1i3h_A ... Length = 237

 Score =  105 bits (262), Expect = 7e-26
 Identities = 36/117 (30%), Positives = 60/117 (51%), Gaps = 12/117 (10%)

Query: 72  NHVFAVELDTIKSHGFLDINDNHVGIDINSLKSESSA--------PAGYYVEYDGLEKRT 123
           + + AVELDT  +    D +  H+GIDI S++S+ +A            ++ Y+ ++KR 
Sbjct: 2   DTIVAVELDTYPNTDIGDPSYPHIGIDIKSVRSKKTAKWNMQNGKVGTAHIIYNSVDKRL 61

Query: 124 NVTLAPINIPRPRSLNTMSLSRDLSSVLNDAMYVGFSSSTGSVLASHYILGWSFKIN 180
           +  ++  N        T+S   DL +VL + + VG S+STG    ++ IL WSF   
Sbjct: 62  SAVVSYPNADSA----TVSYDVDLDNVLPEWVRVGLSASTGLYKETNTILSWSFTSK 114

>1nls_A Concanavalin A; lectin, agglutinin; 0.94A {Canavalia ensiformis} SCOP: b.29.1.1 PDB: 1bxh_A* 1apn_A 1ces_A 1cjp_A* 1c57_A 1cvn_A* 1con_A 1dq1_A 1dq2_A 1dq4_A 1dq5_A 1dq6_A 1enq_A 1enr_A 1ens_A 1gic_A* 1dq0_A 1hqw_A 1gkb_A* 1i3h_A ... Length = 237

 Score = 65.7 bits (159), Expect = 3e-12
 Identities = 21/55 (38%), Positives = 27/55 (49%), Gaps = 2/55 (3%)

Query: 13  ANGTVFSFSTTFVFSILSEYQSQSGHGIAFVIAS-TRGLPGARPSQYLGLFNDTN 66
           ++  V SF  TF F I S   S    GIAF I++    +P     + LGLF D N
Sbjct: 184 SSAVVASFEATFTFLIKSPD-SHPADGIAFFISNIDSSIPSGSTGRLLGLFPDAN 237

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  105 bits (265), Expect = 3e-25
 Identities = 70/291 (24%), Positives = 110/291 (37%), Gaps = 47/291 (16%)

Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVA--EIVSIGRLRHRNLVQLL 324
             +G G +G V++     +   +A+KK        + + +A  EI  + +L+H NLV LL
Sbjct: 9   GKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLL 68

Query: 325 GYCRRKGELLLVYDYMPNGSLDKYLYDQPK-VTLNWIQRFRVIKGVALGLFYLHQEWEQV 383
              RRK  L LV++Y  + ++   L    + V  + ++           + + H+     
Sbjct: 69  EVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSI--TWQTLQAVNFCHKHN--- 122

Query: 384 VIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE---HTRTGK 440
            IHRDVK  N+L+      +L DFG ARL    +D     V  T  Y +PE        +
Sbjct: 123 CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA-TRWYRSPELLVGDT--Q 179

Query: 441 ATTSADVFSFGAFLLEVACGRRP-------------IQR----------QGPSENLILVD 477
                DV++ G    E+     P             I++          Q  S N     
Sbjct: 180 YGPPVDVWAIGCVFAEL-LSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG 238

Query: 478 WVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQ 528
                    E LE + PN+        L L+    L     DPT R +  Q
Sbjct: 239 VKIPDPEDMEPLELKFPNIS----YPALGLLKGC-LHM---DPTERLTCEQ 281

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  106 bits (266), Expect = 4e-25
 Identities = 42/317 (13%), Positives = 85/317 (26%), Gaps = 74/317 (23%)

Query: 260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQG---MKEFVAEIVSIGRLR 316
            +      +LG          T  ++     V       R     +K+   E++ +  LR
Sbjct: 72  PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLR 131

Query: 317 -------------------------HRNLVQLLGYCRRKGELLLVYDYM----PNGSLDK 347
                                     + ++++    R    L   + Y        +  +
Sbjct: 132 GIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGE 191

Query: 348 YLYDQPKV--TLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLG 405
            L        +L    R ++   V   L  LH      ++H  ++  +++LD      L 
Sbjct: 192 VLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLT 248

Query: 406 DFGLARLYDHGTDPQTTHVVGTLGYLAPE-----------HTRTGKATTSADVFSFGAFL 454
            F                   + G+  PE             R    T S D ++ G  +
Sbjct: 249 GFEHLVRDGARVVS-----SVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVI 303

Query: 455 LEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLL 514
             + C   PI +          +W+F                    + + +  +L+ G L
Sbjct: 304 YWIWCADLPITKDAALG---GSEWIFRSCKN---------------IPQPVRALLE-GFL 344

Query: 515 CSHSDPTARPSMRQVVQ 531
                   R    Q ++
Sbjct: 345 R--YPKEDRLLPLQAME 359

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  103 bits (260), Expect = 9e-25
 Identities = 52/207 (25%), Positives = 86/207 (41%), Gaps = 16/207 (7%)

Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVA----EIVSIGRLRHRNLVQ 322
           E+LG GG   V+     +   ++AVK +          F      E  +   L H  +V 
Sbjct: 18  EILGFGGMSEVHLARDLRDHRDVAVK-VLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76

Query: 323 LLGYCRRKGELL----LVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQ 378
           +      +        +V +Y+   +L   ++ +    +   +   VI      L + H 
Sbjct: 77  VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNFSH- 133

Query: 379 EWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP--QTTHVVGTLGYLAPEHT 436
             +  +IHRDVK +N+++      ++ DFG+AR      +   QT  V+GT  YL+PE  
Sbjct: 134 --QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191

Query: 437 RTGKATTSADVFSFGAFLLEVACGRRP 463
           R       +DV+S G  L EV  G  P
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGEPP 218

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  103 bits (260), Expect = 1e-24
 Identities = 71/292 (24%), Positives = 115/292 (39%), Gaps = 49/292 (16%)

Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVA--EIVSIGRLRHRNLVQLL 324
            L+G G +G V +     +   +A+KK        M + +A  EI  + +LRH NLV LL
Sbjct: 31  GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLL 90

Query: 325 GYCRRKGELLLVYDYMPNGSLDKYLYDQPK-VTLNWIQRF--RVIKGVALGLFYLHQEWE 381
             C++K    LV++++ + ++   L   P  +    +Q++  ++I G+     + H    
Sbjct: 91  EVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIG----FCHSHN- 144

Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEH-TRTGK 440
             +IHRD+K  N+L+      +L DFG AR      +     V  T  Y APE      K
Sbjct: 145 --IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA-TRWYRAPELLVGDVK 201

Query: 441 ATTSADVFSFGAFLLEVACGRRPIQRQGPSE----NLI-----------------LVDWV 479
              + DV++ G  + E+     P+   G S+      I                    + 
Sbjct: 202 YGKAVDVWAIGCLVTEM-FMGEPL-FPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFA 259

Query: 480 ---FDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQ 528
                     E LE R P L        ++L  K  L     DP  RP   +
Sbjct: 260 GVRLPEIKEREPLERRYPKLS----EVVIDLAKKC-LHI---DPDKRPFCAE 303

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  106 bits (267), Expect = 2e-24
 Identities = 53/302 (17%), Positives = 100/302 (33%), Gaps = 54/302 (17%)

Query: 263 FREKELLGTGGFGRVYRGT---LPKSQIEIAVKKISHESRQGMKE-FVAEIVSIGRLRHR 318
           +  K  +  GG G +Y      +    +   +K + H      +   +AE   +  + H 
Sbjct: 82  YEVKGCIAHGGLGWIYLALDRNVNGRPV--VLKGLVHSGDAEAQAMAMAERQFLAEVVHP 139

Query: 319 NLVQLLGY-----CRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGL 373
           ++VQ+  +             +V +Y+   SL +    +    L   +    +  +   L
Sbjct: 140 SIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK----LPVAEAIAYLLEILPAL 195

Query: 374 FYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAP 433
            YLH      +++ D+K  N++L  E   +L D G     +        ++ GT G+ AP
Sbjct: 196 SYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN-----SFGYLYGTPGFQAP 246

Query: 434 EHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARD 493
           E  R    T + D+++ G  L  +         +                     L   D
Sbjct: 247 EIVR-TGPTVATDIYTVGRTLAALTLDLPTRNGRYVDG-----------------LPEDD 288

Query: 494 PNLGTEYVAEELE-LVLKLGLLCSHSDPTARPS----MRQVVQILERDVALPAISALRLS 548
           P L      +    L+ +        DP  R +    M   +  + R+V        R  
Sbjct: 289 PVLK---TYDSYGRLLRR----AIDPDPRQRFTTAEEMSAQLTGVLREVVAQDTGVPRPG 341

Query: 549 TS 550
            S
Sbjct: 342 LS 343

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  105 bits (264), Expect = 4e-24
 Identities = 58/260 (22%), Positives = 93/260 (35%), Gaps = 33/260 (12%)

Query: 240 EDWELDHGPHRFRYKDLYIATKGFREK----ELLGTGGFGRVYRGTLPKSQIEIAVKKIS 295
            D  +     ++  + + I      +     E LGTG FG V+R T   +    A K + 
Sbjct: 132 YDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVM 191

Query: 296 HESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSL------DKYL 349
                  +    EI ++  LRH  LV L        E++++Y++M  G L      +   
Sbjct: 192 TPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK 251

Query: 350 YDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRL--GDF 407
             + +           ++ V  GL ++H   E   +H D+K  N++   + +  L   DF
Sbjct: 252 MSEDEAV-------EYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDF 301

Query: 408 GLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGA---FLLEVACGRRPI 464
           GL    D           GT  + APE           D++S G     LL    G  P 
Sbjct: 302 GLTAHLDPKQ--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILL---SGLSPF 356

Query: 465 Q---RQGPSENLILVDWVFD 481
                     N+   DW  D
Sbjct: 357 GGENDDETLRNVKSCDWNMD 376

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  100 bits (252), Expect = 6e-24
 Identities = 67/312 (21%), Positives = 111/312 (35%), Gaps = 58/312 (18%)

Query: 244 LDHGPHRFRYKDLYIATKGFREK----ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR 299
           + H  H    ++         +       LG+G FG V+      S +E  +K I+ +  
Sbjct: 1   MHHHHHHSSGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS 60

Query: 300 QGMKEFVA-EIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLN 358
           Q   E +  EI  +  L H N++++         + +V +    G     L ++      
Sbjct: 61  QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGE----LLERIVSAQA 116

Query: 359 WIQRF------RVIKGVALGLFYLHQEWEQVVIHRDVKASNVLL---DGELNGRLGDFGL 409
             +         ++K +   L Y H    Q V+H+D+K  N+L          ++ DFGL
Sbjct: 117 RGKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGL 173

Query: 410 ARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGA---FLLEVACGRRPIQR 466
           A L+            GT  Y+APE  +    T   D++S G    FLL    G  P   
Sbjct: 174 AELFKSDEHSTN--AAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLL---TGCLPF-- 225

Query: 467 QGPSENLIL-----VDWVFD--FWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSD 519
            G S   +       +  +           +A D             L+ +  +L    D
Sbjct: 226 TGTSLEEVQQKATYKEPNYAVECRPLTP--QAVD-------------LLKQ--MLT--KD 266

Query: 520 PTARPSMRQVVQ 531
           P  RPS  QV+ 
Sbjct: 267 PERRPSAAQVLH 278

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  102 bits (256), Expect = 9e-24
 Identities = 52/260 (20%), Positives = 96/260 (36%), Gaps = 33/260 (12%)

Query: 240 EDWELDHGPHRFRYKDLYIATKGFREK----ELLGTGGFGRVYRGTLPKSQIEIAVKKIS 295
            D   +    ++  + + +      +     E LG+G FG V+R     +      K I+
Sbjct: 26  YDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFIN 85

Query: 296 HESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSL------DKYL 349
                       EI  + +L H  L+ L      K E++L+ +++  G L      + Y 
Sbjct: 86  TPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK 145

Query: 350 YDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRL--GDF 407
             + +V          ++    GL ++H+     ++H D+K  N++ + +    +   DF
Sbjct: 146 MSEAEVI-------NYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDF 195

Query: 408 GLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGA---FLLEVACGRRPI 464
           GLA   +     +      T  + APE           D+++ G     LL    G  P 
Sbjct: 196 GLATKLNPDEIVKV--TTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLL---SGLSPF 250

Query: 465 QRQGPSE---NLILVDWVFD 481
             +   E   N+   DW FD
Sbjct: 251 AGEDDLETLQNVKRCDWEFD 270

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  102 bits (257), Expect = 1e-23
 Identities = 61/300 (20%), Positives = 111/300 (37%), Gaps = 52/300 (17%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRL-RHRNLV 321
              +++LG G  G V      + +  +AVK++           + EI  +     H N++
Sbjct: 17  VVSEKILGYGSSGTVVFQGSFQGR-PVAVKRML---IDFCDIALMEIKLLTESDDHPNVI 72

Query: 322 QLLGYCRRKGELLLVYDYMPNGSLDKYL-----YDQPKVTLNWIQRFRVIKGVALGLFYL 376
           +          L +  +   N +L   +      D+            +++ +A G+ +L
Sbjct: 73  RYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHL 131

Query: 377 HQEWEQVVIHRDVKASNVLLDGELNGR-------------LGDFGLARLYDHGTDPQTTH 423
           H      +IHRD+K  N+L+                    + DFGL +  D G     T+
Sbjct: 132 H---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTN 188

Query: 424 ---VVGTLGYLAPE-------HTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSEN 472
                GT G+ APE            + T S D+FS G     +   G+ P   +   E+
Sbjct: 189 LNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRES 248

Query: 473 LILVDWVFDFWNRGEL-LEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ 531
            I+         RG   L+          +AE  +L+ +  ++    DP  RP+  +V++
Sbjct: 249 NII---------RGIFSLDEMKCLHDRSLIAEATDLISQ--MID--HDPLKRPTAMKVLR 295

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =   99 bits (250), Expect = 2e-23
 Identities = 73/296 (24%), Positives = 123/296 (41%), Gaps = 58/296 (19%)

Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVA-----EIVSIGRLRHRNLV 321
           E +G G +G V++    ++   +A+K++  +      E V      EI  +  L+H+N+V
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD---DEGVPSSALREICLLKELKHKNIV 64

Query: 322 QLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKV-TLNWIQRF--RVIKGVALGLFYLHQ 378
           +L        +L LV+++     L KY            ++ F  +++KG+     + H 
Sbjct: 65  RLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLG----FCHS 119

Query: 379 EWEQVVIHRDVKASNVLLD--GELNGRLGDFGLARLYDHGTDPQT-THVVGTLGYLAPEH 435
                V+HRD+K  N+L++  GEL  +L +FGLAR +  G   +  +  V TL Y  P+ 
Sbjct: 120 RN---VLHRDLKPQNLLINRNGEL--KLANFGLARAF--GIPVRCYSAEVVTLWYRPPDV 172

Query: 436 TRTGKA-TTSADVFSFGAFLLEVACGRRPIQRQGPSE----NLI---------------- 474
               K  +TS D++S G    E+A   RP+   G         I                
Sbjct: 173 LFGAKLYSTSIDMWSAGCIFAELANAGRPL-FPGNDVDDQLKRIFRLLGTPTEEQWPSMT 231

Query: 475 -LVDWV-FDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQ 528
            L D+  +  +     L    P L     A   +L+  L L C   +P  R S  +
Sbjct: 232 KLPDYKPYPMYPATTSLVNVVPKLN----ATGRDLLQNL-LKC---NPVQRISAEE 279

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  100 bits (251), Expect = 2e-23
 Identities = 63/217 (29%), Positives = 105/217 (48%), Gaps = 22/217 (10%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVA--EIVSIGRLRHRNL 320
           + + + LG G +  VY+G    +   +A+K+I  E  +G     A  E+  +  L+H N+
Sbjct: 4   YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGA-PCTAIREVSLLKDLKHANI 62

Query: 321 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKV-TLNWIQRFRVIKGVALGLFYLHQE 379
           V L      +  L LV++Y+    L +YL D   +  ++ ++ F  +  +  GL Y H++
Sbjct: 63  VTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLF--LFQLLRGLAYCHRQ 119

Query: 380 WEQVVIHRDVKASNVLLD--GELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE--- 434
               V+HRD+K  N+L++  GEL  +L DFGLAR     T      VV TL Y  P+   
Sbjct: 120 K---VLHRDLKPQNLLINERGEL--KLADFGLARAKSIPTKTYDNEVV-TLWYRPPDILL 173

Query: 435 HTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSE 471
            +     +T  D++  G    E+A   RP+   G + 
Sbjct: 174 GST--DYSTQIDMWGVGCIFYEMAT-GRPL-FPGSTV 206

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  101 bits (253), Expect = 2e-23
 Identities = 52/206 (25%), Positives = 89/206 (43%), Gaps = 24/206 (11%)

Query: 254 KDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIG 313
              Y       + E+LG G FG+V++     + +++A K I     +  +E   EI  + 
Sbjct: 86  NSFYT----VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMN 141

Query: 314 RLRHRNLVQLLGYCRRKGELLLVYDYMPNGSL------DKYLYDQPKVTLNWIQRFRVIK 367
           +L H NL+QL      K +++LV +Y+  G L      + Y   +             +K
Sbjct: 142 QLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTI-------LFMK 194

Query: 368 GVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRL--GDFGLARLYDHGTDPQTTHVV 425
            +  G+ ++HQ     ++H D+K  N+L       ++   DFGLAR Y      +     
Sbjct: 195 QICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV--NF 249

Query: 426 GTLGYLAPEHTRTGKATTSADVFSFG 451
           GT  +LAPE       +   D++S G
Sbjct: 250 GTPEFLAPEVVNYDFVSFPTDMWSVG 275

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  103 bits (257), Expect = 4e-23
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 17/209 (8%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE---SRQGMKEFVAE---IVSIGRLR 316
           F    ++G GGFG VY      +    A+K +  +    +QG    + E   +  +    
Sbjct: 191 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 250

Query: 317 HRNLVQLLGYC-RRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFY 375
              +V +  Y      +L  + D M  G L  +L      +   + RF     + LGL +
Sbjct: 251 CPFIVCM-SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADM-RF-YAAEIILGLEH 307

Query: 376 LHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEH 435
           +H    + V++RD+K +N+LLD   + R+ D GLA      +  +    VGT GY+APE 
Sbjct: 308 MHN---RFVVYRDLKPANILLDEHGHVRISDLGLAC---DFSKKKPHASVGTHGYMAPEV 361

Query: 436 TRTGKA-TTSADVFSFGAFLLEVACGRRP 463
            + G A  +SAD FS G  L ++  G  P
Sbjct: 362 LQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 99.2 bits (248), Expect = 4e-23
 Identities = 65/207 (31%), Positives = 107/207 (51%), Gaps = 23/207 (11%)

Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVA--EIVSIGRLRHRNLVQLL 324
           E LG G +  VY+G    + + +A+K++  +S +G     A  EI  +  L+H N+V+L 
Sbjct: 11  EKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGT-PSTAIREISLMKELKHENIVRLY 69

Query: 325 GYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVAL----GLFYLHQEW 380
                + +L LV+++M N  L KY+  +            ++K        GL + H+  
Sbjct: 70  DVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK 128

Query: 381 EQVVIHRDVKASNVLLD--GELNGRLGDFGLARLYDHGTDPQT-THVVGTLGYLAPE--- 434
              ++HRD+K  N+L++  G+L  +LGDFGLAR +  G    T +  V TL Y AP+   
Sbjct: 129 ---ILHRDLKPQNLLINKRGQL--KLGDFGLARAF--GIPVNTFSSEVVTLWYRAPDVLM 181

Query: 435 HTRTGKATTSADVFSFGAFLLEVACGR 461
            +RT   +TS D++S G  L E+  G+
Sbjct: 182 GSRT--YSTSIDIWSCGCILAEMITGK 206

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 99.2 bits (248), Expect = 8e-23
 Identities = 71/226 (31%), Positives = 108/226 (47%), Gaps = 39/226 (17%)

Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHES-RQGMKEFVA--EIVSIGRLRHRNLVQLLG 325
           +G G FG V++    K+  ++A+KK+  E+ ++G     A  EI  +  L+H N+V L+ 
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFP-ITALREIKILQLLKHENVVNLIE 83

Query: 326 --------YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVAL----GL 373
                   Y R KG + LV+D+  +  L   L     V     +    IK V      GL
Sbjct: 84  ICRTKASPYNRCKGSIYLVFDFCEH-DLAGLL-SNVLVKFTLSE----IKRVMQMLLNGL 137

Query: 374 FYLHQEWEQVVIHRDVKASNVLLD--GELNGRLGDFGLARLYDHGTDPQT---THVVGTL 428
           +Y+H+     ++HRD+KA+NVL+   G L  +L DFGLAR +    + Q    T+ V TL
Sbjct: 138 YYIHRNK---ILHRDMKAANVLITRDGVL--KLADFGLARAFSLAKNSQPNRYTNRVVTL 192

Query: 429 GYLAPE---HTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSE 471
            Y  PE     R        D++  G  + E+   R PI  QG +E
Sbjct: 193 WYRPPELLLGER--DYGPPIDLWGAGCIMAEM-WTRSPIM-QGNTE 234

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 97.6 bits (244), Expect = 1e-22
 Identities = 70/246 (28%), Positives = 103/246 (41%), Gaps = 43/246 (17%)

Query: 247 GPHRFRYKDLYIATKGFREK-ELLGTGGFGRVYRGTLPKSQIEIAVKKIS-HESRQGMKE 304
           GP        Y       E    +G G +G VY+   P S   +A+K +       G   
Sbjct: 1   GPLGSMATSRY-------EPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGG 53

Query: 305 F----VAEIVSIGRLR---HRNLVQLL-----GYCRRKGELLLVYDYMPNGSLDKYLYDQ 352
                V E+  + RL    H N+V+L+         R+ ++ LV++++    L  YL   
Sbjct: 54  LPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKA 112

Query: 353 PKVTLNWIQRFRVIKGVAL----GLFYLHQEWEQVVIHRDVKASNVLLD--GELNGRLGD 406
           P   L        IK +      GL +LH      ++HRD+K  N+L+   G +  +L D
Sbjct: 113 PPPGLPAET----IKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTV--KLAD 163

Query: 407 FGLARLYDHGTDPQT-THVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQ 465
           FGLAR+Y         T VV TL Y APE        T  D++S G    E+   R+P+ 
Sbjct: 164 FGLARIYS---YQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL- 218

Query: 466 RQGPSE 471
             G SE
Sbjct: 219 FCGNSE 224

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 96.9 bits (242), Expect = 1e-22
 Identities = 58/202 (28%), Positives = 89/202 (44%), Gaps = 12/202 (5%)

Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVA-EIVSIGRLRHRNLVQLLG 325
           + LG G +G V       ++  +AVK +  +      E +  EI     L H N+V+  G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72

Query: 326 YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRF--RVIKGVALGLFYLHQEWEQV 383
           + R      L  +Y   G L   +     +     QRF  +++ GV     YLH      
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHG---IG 125

Query: 384 VIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTH-VVGTLGYLAPE-HTRTGKA 441
           + HRD+K  N+LLD   N ++ DFGLA ++ +    +  + + GTL Y+APE   R    
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185

Query: 442 TTSADVFSFGAFLLEVACGRRP 463
               DV+S G  L  +  G  P
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELP 207

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 97.3 bits (243), Expect = 2e-22
 Identities = 67/242 (27%), Positives = 97/242 (40%), Gaps = 61/242 (25%)

Query: 259 ATKGFREK----ELLGTGGFGRVYRGTLPKSQIEIAVKKIS--------HESRQGMKEFV 306
           +T GF E     E+LG G    V R     +  E AVK I          E  Q ++E  
Sbjct: 11  STHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREAT 70

Query: 307 AEIVSIGRLR----HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWI-- 360
            + V I  LR    H N++QL           LV+D M  G L            +++  
Sbjct: 71  LKEVDI--LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL-----------FDYLTE 117

Query: 361 -QRF------RVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLY 413
                     ++++ +   +  LH   +  ++HRD+K  N+LLD ++N +L DFG +   
Sbjct: 118 KVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL 174

Query: 414 DHGTDPQTTHVVGTLGYLAPE---------HTRTGKATTSADVFSFGA---FLLEVACGR 461
           D G   +   V GT  YLAPE         H   GK     D++S G     LL    G 
Sbjct: 175 DPGEKLRE--VCGTPSYLAPEIIECSMNDNHPGYGKE---VDMWSTGVIMYTLL---AGS 226

Query: 462 RP 463
            P
Sbjct: 227 PP 228

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 99.8 bits (249), Expect = 2e-22
 Identities = 66/280 (23%), Positives = 111/280 (39%), Gaps = 47/280 (16%)

Query: 266 KELLGTGGFGRVYRGTLPKSQIEIAVKKIS---HESRQGMKEFVAEIVSIGRLRHRNLVQ 322
           + +LG G FG V       +  E AVK IS    + +   +  + E+  + +L H N+++
Sbjct: 31  QRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMK 90

Query: 323 LLGYCRRKGELLLVYDYMPNGSL-----DKYLYDQPKVTLNWIQRFRVIKGVALGLFYLH 377
           L  +   KG   LV +    G L      +  + +           R+I+ V  G+ Y+H
Sbjct: 91  LYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA-------RIIRQVLSGITYMH 143

Query: 378 QEWEQVVIHRDVKASNVLL---DGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE 434
           +     ++HRD+K  N+LL     + N R+ DFGL+  ++     +    +GT  Y+APE
Sbjct: 144 K---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD--KIGTAYYIAPE 198

Query: 435 HTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSE--NLIL---VDWVFDFWNRGELL 489
               G      DV+S G  L  +  G  P       +    +      +    W +    
Sbjct: 199 VLH-GTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVS-E 256

Query: 490 EARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQV 529
            A+D             L+ K  +L     P+ R S R  
Sbjct: 257 SAKD-------------LIRK--MLT--YVPSMRISARDA 279

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 97.7 bits (244), Expect = 2e-22
 Identities = 72/306 (23%), Positives = 107/306 (34%), Gaps = 78/306 (25%)

Query: 266 KELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGR--LRHRNLVQL 323
           KE +G G +    R     + +E AVK I    R   +E     + I     +H N++ L
Sbjct: 27  KEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE-----IEILLRYGQHPNIITL 81

Query: 324 LGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQR---F------RVIKGVALGLF 374
                    + +V + M  G L           L+ I R   F       V+  +   + 
Sbjct: 82  KDVYDDGKYVYVVTELMKGGEL-----------LDKILRQKFFSEREASAVLFTITKTVE 130

Query: 375 YLHQEWEQVVIHRDVKASNVLLDGELNG----RLGDFGLARLYDHGTDPQTTHVVGTLGY 430
           YLH    Q V+HRD+K SN+L   E       R+ DFG A+          T    T  +
Sbjct: 131 YLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT-PCYTANF 186

Query: 431 LAPE---HTRTGKATTSADVFSFGA---FLLEVACGRRPIQRQGP-SENLIL-------V 476
           +APE         A    D++S G     +L    G  P       +   IL        
Sbjct: 187 VAPEVLERQGYDAA---CDIWSLGVLLYTML---TGYTPFANGPDDTPEEILARIGSGKF 240

Query: 477 DWVFDFWNR-GELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ---I 532
                +WN   +   A+D             LV K+ L   H DP  R +   V++   I
Sbjct: 241 SLSGGYWNSVSD--TAKD-------------LVSKM-L---HVDPHQRLTAALVLRHPWI 281

Query: 533 LERDVA 538
           +  D  
Sbjct: 282 VHWDQL 287

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 97.2 bits (243), Expect = 2e-22
 Identities = 67/242 (27%), Positives = 120/242 (49%), Gaps = 36/242 (14%)

Query: 246 HGPHRFRYKDLYIATK--GFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMK 303
           H  H    ++LY       +++ E +G G +G VY+    + +I +A+K+I  ++     
Sbjct: 4   HHHHSSGRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRI-VALKRIRLDAE---D 59

Query: 304 EFVA-----EIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKV-TL 357
           E +      EI  +  L H N+V L+     +  L LV+++M    L K L +       
Sbjct: 60  EGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQD 118

Query: 358 NWIQRF--RVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLD--GELNGRLGDFGLARLY 413
           + I+ +  ++++GVA    + HQ     ++HRD+K  N+L++  G L  +L DFGLAR +
Sbjct: 119 SQIKIYLYQLLRGVA----HCHQHR---ILHRDLKPQNLLINSDGAL--KLADFGLARAF 169

Query: 414 DHGTDPQT-THVVGTLGYLAPE---HTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGP 469
             G   ++ TH V TL Y AP+    ++    +TS D++S G    E+    +P+   G 
Sbjct: 170 --GIPVRSYTHEVVTLWYRAPDVLMGSKK--YSTSVDIWSIGCIFAEMIT-GKPL-FPGV 223

Query: 470 SE 471
           ++
Sbjct: 224 TD 225

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 98.7 bits (246), Expect = 2e-22
 Identities = 57/222 (25%), Positives = 89/222 (40%), Gaps = 35/222 (15%)

Query: 230 RMKRKFAEELEDWELDHGPHRFRYKDLYIATKGFREKELLGTGGFGRVY--RGTLPKSQI 287
           +M   F  +L          R R +DL+       E   +G G +G VY  +    K   
Sbjct: 2   KMDYDFKVKLSSE-------RERVEDLFE-----YEGCKVGRGTYGHVYKAKRKDGKDDK 49

Query: 288 EIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGE--LLLVYDYMPNGSL 345
           + A+K+I             EI  +  L+H N++ L        +  + L++DY  +  L
Sbjct: 50  DYALKQIEGTGIS--MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DL 106

Query: 346 DKYLYDQPKVTLNWIQRF---RVIKGVAL----GLFYLHQEWEQVVIHRDVKASNVLLDG 398
              +        N         ++K +      G+ YLH  W   V+HRD+K +N+L+ G
Sbjct: 107 WHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMG 163

Query: 399 ELNGR----LGDFGLARLYDHGTDPQT--THVVGTLGYLAPE 434
           E   R    + D G ARL++    P      VV T  Y APE
Sbjct: 164 EGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 205

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 99.8 bits (249), Expect = 2e-22
 Identities = 64/279 (22%), Positives = 112/279 (40%), Gaps = 46/279 (16%)

Query: 266 KELLGTGGFGRVYRGTLPKSQIEIAVKKI--SHESRQGMKEFVAEIVSIGRLRHRNLVQL 323
            + LG+G +G V       + +E A+K I  +  S     + + E+  +  L H N+++L
Sbjct: 42  VKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKL 101

Query: 324 LGYCRRKGELLLVYDYMPNGSL-----DKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQ 378
             +   K    LV +    G L      +  +++            +IK V  G+ YLH+
Sbjct: 102 YDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAA-------VIIKQVLSGVTYLHK 154

Query: 379 EWEQVVIHRDVKASNVLL---DGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEH 435
                ++HRD+K  N+LL   + +   ++ DFGL+ ++++    +    +GT  Y+APE 
Sbjct: 155 ---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKE--RLGTAYYIAPEV 209

Query: 436 TRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSE--NLIL---VDWVFDFWNRGELLE 490
            R  K     DV+S G  L  +  G  P   Q   E    +      +    W       
Sbjct: 210 LR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVS-EG 267

Query: 491 ARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQV 529
           A+D             L+ +  +L    D   R S +Q 
Sbjct: 268 AKD-------------LIKQ--MLQ--FDSQRRISAQQA 289

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 98.6 bits (246), Expect = 3e-22
 Identities = 59/217 (27%), Positives = 105/217 (48%), Gaps = 31/217 (14%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQ 322
           + + +++G G FG VY+  L  S   +A+KK+     Q  +    E+  + +L H N+V+
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIVR 111

Query: 323 LLGYCRRKGE------LLLVYDYMPNGSLDKYLYDQPK----VTLNWIQRFR--VIKGVA 370
           L  +    GE      L LV DY+P  ++ +      +    + + +++ +   + + +A
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 170

Query: 371 LGLFYLHQEWEQVVIHRDVKASNVLLDGELNG-RLGDFGLARLYDHGTDPQTTHVVGTLG 429
               Y+H      + HRD+K  N+LLD +    +L DFG A+    G +P  +++  +  
Sbjct: 171 ----YIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYIC-SRY 221

Query: 430 YLAPE--HTRTGKATTSADVFSFGAFLLEVACGRRPI 464
           Y APE     T   T+S DV+S G  L E+    +PI
Sbjct: 222 YRAPELIFGAT-DYTSSIDVWSAGCVLAEL-LLGQPI 256

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 96.9 bits (242), Expect = 4e-22
 Identities = 60/180 (33%), Positives = 89/180 (49%), Gaps = 25/180 (13%)

Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVA-----EIVSIGRLRHRNLV 321
           + LG G F  VY+     +   +A+KKI    R   K+ +      EI  +  L H N++
Sbjct: 16  DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 75

Query: 322 QLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKV-TLNWIQRF--RVIKGVALGLFYLHQ 378
            LL     K  + LV+D+M    L+  + D   V T + I+ +    ++G+     YLHQ
Sbjct: 76  GLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLE----YLHQ 130

Query: 379 EWEQVVIHRDVKASNVLLD--GELNGRLGDFGLARLYDHGTDPQT--THVVGTLGYLAPE 434
            W   ++HRD+K +N+LLD  G L  +L DFGLA+ +     P    TH V T  Y APE
Sbjct: 131 HW---ILHRDLKPNNLLLDENGVL--KLADFGLAKSF---GSPNRAYTHQVVTRWYRAPE 182

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 96.5 bits (241), Expect = 4e-22
 Identities = 60/213 (28%), Positives = 97/213 (45%), Gaps = 27/213 (12%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVA-----EIVSIGRLRH 317
           +R    LG G +G VY+     +   +A+K+I  E     +E V      E+  +  L+H
Sbjct: 36  YRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE---EEGVPGTAIREVSLLKELQH 92

Query: 318 RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLH 377
           RN+++L         L L+++Y  N  L KY+   P V++  I+ F  +  +  G+ + H
Sbjct: 93  RNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSF--LYQLINGVNFCH 149

Query: 378 QEWEQVVIHRDVKASNVLLDGELNGR-----LGDFGLARLYDHGTDPQT-THVVGTLGYL 431
                  +HRD+K  N+LL            +GDFGLAR +  G   +  TH + TL Y 
Sbjct: 150 SRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF--GIPIRQFTHEIITLWYR 204

Query: 432 APE---HTRTGKATTSADVFSFGAFLLEVACGR 461
            PE    +R    +TS D++S      E+    
Sbjct: 205 PPEILLGSRH--YSTSVDIWSIACIWAEMLMKT 235

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 96.8 bits (241), Expect = 5e-22
 Identities = 49/278 (17%), Positives = 91/278 (32%), Gaps = 61/278 (21%)

Query: 244 LDHGPHRFRYKDLYIATKGFREK--------ELLGTGGFGRVYRGTLPKSQIEIAVK--- 292
           + H  H    ++      G   +          +G G +G V      +++   A+K   
Sbjct: 1   MHHHHHHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMN 60

Query: 293 --KISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSL----- 345
             KI   + + ++    E+  + +L H N+ +L      +  + LV +    G L     
Sbjct: 61  KNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLN 120

Query: 346 ---------------------------DKYLYDQPKVTLNWIQRF------RVIKGVALG 372
                                      +           +            +++ +   
Sbjct: 121 VFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSA 180

Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRL--GDFGLARLY---DHGTDPQTTHVVGT 427
           L YLH    Q + HRD+K  N L     +  +   DFGL++ +   ++G     T   GT
Sbjct: 181 LHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGT 237

Query: 428 LGYLAPE--HTRTGKATTSADVFSFGAFLLEVACGRRP 463
             ++APE  +T         D +S G  L  +  G  P
Sbjct: 238 PYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVP 275

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 96.2 bits (240), Expect = 5e-22
 Identities = 66/294 (22%), Positives = 105/294 (35%), Gaps = 67/294 (22%)

Query: 266 KELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLR-HRNLVQLL 324
            + LG G F    +    KS    AVK IS       ++   EI ++     H N+V+L 
Sbjct: 16  DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK---EITALKLCEGHPNIVKLH 72

Query: 325 GYCRRKGELLLVYDYMPNGSL-DKYLYDQPKVTLNWIQR---F------RVIKGVALGLF 374
                +    LV + +  G L ++            I++   F       +++ +   + 
Sbjct: 73  EVFHDQLHTFLVMELLNGGELFER------------IKKKKHFSETEASYIMRKLVSAVS 120

Query: 375 YLHQEWEQVVIHRDVKASNVLL---DGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYL 431
           ++H   +  V+HRD+K  N+L    +  L  ++ DFG ARL      P  T    TL Y 
Sbjct: 121 HMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT-PCFTLHYA 176

Query: 432 APEHTRTGKATTSADVFSFGA---FLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGEL 488
           APE         S D++S G     +L    G+ P Q    S        +     +G+ 
Sbjct: 177 APELLNQNGYDESCDLWSLGVILYTML---SGQVPFQSHDRSLTCTSAVEIMKKIKKGDF 233

Query: 489 -----------LEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ 531
                       EA+D             L+  L L     DP  R  M  +  
Sbjct: 234 SFEGEAWKNVSQEAKD-------------LIQGL-L---TVDPNKRLKMSGLRY 270

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 96.1 bits (240), Expect = 5e-22
 Identities = 60/234 (25%), Positives = 103/234 (44%), Gaps = 47/234 (20%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEI-AVKKISHES-RQG-----------MKEFVAEI 309
           +     +G G +G+V++    K+     A+K++  ++  +G           ++      
Sbjct: 13  YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH----- 67

Query: 310 VSIGRLRHRNLVQLL-----GYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFR 364
             +    H N+V+L          R+ +L LV++++    L  YL   P+  +       
Sbjct: 68  --LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTET--- 121

Query: 365 VIKGVAL----GLFYLHQEWEQVVIHRDVKASNVLLD--GELNGRLGDFGLARLYDHGTD 418
            IK +      GL +LH      V+HRD+K  N+L+   G++  +L DFGLAR+Y     
Sbjct: 122 -IKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQI--KLADFGLARIYS---F 172

Query: 419 PQT-THVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSE 471
               T VV TL Y APE        T  D++S G    E+   R+P+  +G S+
Sbjct: 173 QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL-FRGSSD 224

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 97.5 bits (243), Expect = 6e-22
 Identities = 55/251 (21%), Positives = 96/251 (38%), Gaps = 49/251 (19%)

Query: 245 DHGPHRFRYKDLY-----IATKGFREK----ELLGTGGFGRVYRGTLPKSQIEIAVKKIS 295
                 F + DL      +  K  R++    + LG+G  G V      K+  ++A++ IS
Sbjct: 110 LSRNKVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIIS 169

Query: 296 --------HESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDK 347
                               EI  + +L H  ++++  +   + +  +V + M  G L  
Sbjct: 170 KRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGEL-- 226

Query: 348 YLYDQPKVTLNWI---QRF------RVIKGVALGLFYLHQEWEQVVIHRDVKASNVLL-- 396
                     + +   +R            + L + YLH   E  +IHRD+K  NVLL  
Sbjct: 227 ---------FDKVVGNKRLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSS 274

Query: 397 -DGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE---HTRTGKATTSADVFSFGA 452
            + +   ++ DFG +++    +  +T  + GT  YLAPE      T     + D +S G 
Sbjct: 275 QEEDCLIKITDFGHSKILGETSLMRT--LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGV 332

Query: 453 FLLEVACGRRP 463
            L     G  P
Sbjct: 333 ILFICLSGYPP 343

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 95.8 bits (239), Expect = 7e-22
 Identities = 58/202 (28%), Positives = 89/202 (44%), Gaps = 12/202 (5%)

Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVA-EIVSIGRLRHRNLVQLLG 325
           + LG G +G V       ++  +AVK +  +      E +  EI     L H N+V+  G
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72

Query: 326 YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRF--RVIKGVALGLFYLHQEWEQV 383
           + R      L  +Y   G L   +     +     QRF  +++ GV     YLH      
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV----YLHG---IG 125

Query: 384 VIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTH-VVGTLGYLAPE-HTRTGKA 441
           + HRD+K  N+LLD   N ++ DFGLA ++ +    +  + + GTL Y+APE   R    
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185

Query: 442 TTSADVFSFGAFLLEVACGRRP 463
               DV+S G  L  +  G  P
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELP 207

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 95.4 bits (238), Expect = 7e-22
 Identities = 51/211 (24%), Positives = 87/211 (41%), Gaps = 21/211 (9%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEF---VAEIVSIGRLRHRN 319
           F+  ++LG G F  V       +  E A+K +         +      E   + RL H  
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91

Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKG------VALGL 373
            V+L    +   +L     Y  NG L KY+             F           +   L
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI--------GSFDETCTRFYTAEIVSAL 143

Query: 374 FYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTH-VVGTLGYLA 432
            YLH    + +IHRD+K  N+LL+ +++ ++ DFG A++    +     +  VGT  Y++
Sbjct: 144 EYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVS 200

Query: 433 PEHTRTGKATTSADVFSFGAFLLEVACGRRP 463
           PE      A  S+D+++ G  + ++  G  P
Sbjct: 201 PELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 94.6 bits (236), Expect = 1e-21
 Identities = 71/318 (22%), Positives = 125/318 (39%), Gaps = 72/318 (22%)

Query: 244 LDHGPHRFRYKDLYIATKGFREK----ELLGTGGFGRVYRGTLPKSQIEIAVKKI--SHE 297
           + H  H    ++       F E+     +LG G FG V +     +Q E AVK I  +  
Sbjct: 1   MHHHHHHSSGRENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA 60

Query: 298 SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTL 357
             +     + E+  + +L H N+++L           +V +    G L            
Sbjct: 61  KNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL-----------F 109

Query: 358 NWI---QRF------RVIKGVALGLFYLHQEWEQVVIHRDVKASNVLL---DGELNGRLG 405
           + I   +RF      R+IK V  G+ Y+H+     ++HRD+K  N+LL   + + + ++ 
Sbjct: 110 DEIIKRKRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKII 166

Query: 406 DFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGA---FLLEVACGRR 462
           DFGL+  +   T  +    +GT  Y+APE  R G      DV+S G     LL    G  
Sbjct: 167 DFGLSTCFQQNTKMKD--RIGTAYYIAPEVLR-GTYDEKCDVWSAGVILYILL---SGTP 220

Query: 463 PIQRQGPSENLILVDWVFDFW--NRGELLEA---RDPNLGTEY---VAEE-LELVLKLGL 513
           P                  F+  N  ++L+                ++++  +L+ K  +
Sbjct: 221 P------------------FYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRK--M 260

Query: 514 LCSHSDPTARPSMRQVVQ 531
           L     P+ R +  Q ++
Sbjct: 261 LT--FHPSLRITATQCLE 276

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 94.5 bits (236), Expect = 1e-21
 Identities = 61/213 (28%), Positives = 100/213 (46%), Gaps = 32/213 (15%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVA-----EIVSIGRLRH 317
           +   E +G G +G VY+      +   A+KKI  E      E +      EI  +  L+H
Sbjct: 4   YHGLEKIGEGTYGVVYKAQNNYGET-FALKKIRLEKE---DEGIPSTTIREISILKELKH 59

Query: 318 RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKV-TLNWIQRF--RVIKGVALGLF 374
            N+V+L      K  L+LV++++    L K L            + F  +++ G+A    
Sbjct: 60  SNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIA---- 114

Query: 375 YLHQEWEQVVIHRDVKASNVLLD--GELNGRLGDFGLARLYDHGTDPQT-THVVGTLGYL 431
           Y H      V+HRD+K  N+L++  GEL  ++ DFGLAR +  G   +  TH + TL Y 
Sbjct: 115 YCHDRR---VLHRDLKPQNLLINREGEL--KIADFGLARAF--GIPVRKYTHEIVTLWYR 167

Query: 432 APE---HTRTGKATTSADVFSFGAFLLEVACGR 461
           AP+    ++    +T+ D++S G    E+  G 
Sbjct: 168 APDVLMGSKK--YSTTIDIWSVGCIFAEMVNGT 198

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 97.9 bits (244), Expect = 1e-21
 Identities = 63/207 (30%), Positives = 96/207 (46%), Gaps = 14/207 (6%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRN 319
           FR+  +LG GGFG V    +  +    A KK+  +    R+G    + E   + ++  R 
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 245

Query: 320 LVQLLGYC-RRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRV-IKGVALGLFYLH 377
           +V L  Y    K  L LV   M  G L  ++Y   +       R       +  GL  LH
Sbjct: 246 VVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFP-EARAVFYAAEICCGLEDLH 303

Query: 378 QEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTH-VVGTLGYLAPEHT 436
               + +++RD+K  N+LLD   + R+ D GLA    H  + QT    VGT+GY+APE  
Sbjct: 304 ---RERIVYRDLKPENILLDDHGHIRISDLGLAV---HVPEGQTIKGRVGTVGYMAPEVV 357

Query: 437 RTGKATTSADVFSFGAFLLEVACGRRP 463
           +  + T S D ++ G  L E+  G+ P
Sbjct: 358 KNERYTFSPDWWALGCLLYEMIAGQSP 384

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 94.2 bits (235), Expect = 1e-21
 Identities = 56/231 (24%), Positives = 88/231 (38%), Gaps = 52/231 (22%)

Query: 260 TKGFREK----ELLGTGGFGRVYRGTLPKSQIEIAVK-----KISHESRQGMKEFVAEIV 310
           +  F +     E LG G F  V R     + +E A K     K+S    Q ++    E  
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLER---EAR 57

Query: 311 SIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWI---QRF---- 363
              +L+H N+V+L    + +    LV+D +  G L              I   + +    
Sbjct: 58  ICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL-----------FEDIVAREFYSEAD 106

Query: 364 --RVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNG---RLGDFGLARLYDHGTD 418
               I+ +   + Y H      ++HR++K  N+LL  +  G   +L DFGLA   +    
Sbjct: 107 ASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE- 162

Query: 419 PQTTHVVGTLGYLAPE---HTRTGKATTSADVFSFGA---FLLEVACGRRP 463
                  GT GYL+PE        K     D+++ G     LL    G  P
Sbjct: 163 -AWHGFAGTPGYLSPEVLKKDPYSKP---VDIWACGVILYILL---VGYPP 206

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 93.8 bits (234), Expect = 1e-21
 Identities = 55/213 (25%), Positives = 84/213 (39%), Gaps = 35/213 (16%)

Query: 266 KELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLG 325
           +  +G G +G V       ++I  A KKI     + +  F  EI  +  L H N+++L  
Sbjct: 14  ENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYE 73

Query: 326 YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWI---QRF------RVIKGVALGLFYL 376
                 ++ LV +    G L              +   + F      R++K V   + Y 
Sbjct: 74  TFEDNTDIYLVMELCTGGEL-----------FERVVHKRVFRESDAARIMKDVLSAVAYC 122

Query: 377 HQEWEQVVIHRDVKASNVLL---DGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAP 433
           H+     V HRD+K  N L      +   +L DFGLA  +  G   +T   VGT  Y++P
Sbjct: 123 HK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT--KVGTPYYVSP 177

Query: 434 EHTRTGKATTSADVFSFGA---FLLEVACGRRP 463
           +    G      D +S G     LL   CG  P
Sbjct: 178 QVLE-GLYGPECDEWSAGVMMYVLL---CGYPP 206

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 95.5 bits (238), Expect = 2e-21
 Identities = 57/218 (26%), Positives = 107/218 (49%), Gaps = 34/218 (15%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGR-LRHRNLV 321
           +   +++G G FG V++  L +S  E+A+KK+  + R   +E     + I R ++H N+V
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESD-EVAIKKVLQDKRFKNRE-----LQIMRIVKHPNVV 95

Query: 322 QLLGYCRRKGE------LLLVYDYMPNGSLDKYLYDQPK----VTLNWIQRFR--VIKGV 369
            L  +    G+      L LV +Y+P  ++ +      K    + +  I+ +   +++ +
Sbjct: 96  DLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSL 154

Query: 370 ALGLFYLHQEWEQVVIHRDVKASNVLLDGELNG-RLGDFGLARLYDHGTDPQTTHVVGTL 428
           A    Y+H      + HRD+K  N+LLD      +L DFG A++   G +P  +++  + 
Sbjct: 155 A----YIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG-EPNVSYIC-SR 205

Query: 429 GYLAPE--HTRTGKATTSADVFSFGAFLLEVACGRRPI 464
            Y APE     T   TT+ D++S G  + E+    +P+
Sbjct: 206 YYRAPELIFGAT-NYTTNIDIWSTGCVMAEL-MQGQPL 241

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 95.1 bits (237), Expect = 2e-21
 Identities = 47/201 (23%), Positives = 84/201 (41%), Gaps = 27/201 (13%)

Query: 266 KELLGTGGFGRVYRGTLPKSQIEIAVKKIS------HESRQGMKEFVAEIVSIGRLRHRN 319
            E LG+G F  V +     + +E A K I              +E   E+  + ++ H N
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPN 76

Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSL-----DKYLYDQPKVTLNWIQRFRVIKGVALGLF 374
           ++ L      + +++L+ + +  G L      K    + + T         IK +  G+ 
Sbjct: 77  IITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT-------SFIKQILDGVN 129

Query: 375 YLHQEWEQVVIHRDVKASNVLL----DGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGY 430
           YLH    + + H D+K  N++L        + +L DFGLA   + G + +   + GT  +
Sbjct: 130 YLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN--IFGTPEF 184

Query: 431 LAPEHTRTGKATTSADVFSFG 451
           +APE          AD++S G
Sbjct: 185 VAPEIVNYEPLGLEADMWSIG 205

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 94.7 bits (236), Expect = 3e-21
 Identities = 54/218 (24%), Positives = 84/218 (38%), Gaps = 34/218 (15%)

Query: 266 KELLGTGGFGRVYRGTLPKSQIEIAVK-----KISHESRQGMKEFVAEIVSIGRLRHRNL 320
            E++G G F  V R    ++  + AVK     K +       ++   E      L+H ++
Sbjct: 29  CEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHI 88

Query: 321 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRF------RVIKGVALGLF 374
           V+LL      G L +V+++M        L  +     +    +        ++ +   L 
Sbjct: 89  VELLETYSSDGMLYMVFEFMDGAD----LCFEIVKRADAGFVYSEAVASHYMRQILEALR 144

Query: 375 YLHQEWEQVVIHRDVKASNVLLDGELNG---RLGDFGLARLYDHGTDPQTTHVVGTLGYL 431
           Y H   +  +IHRDVK   VLL  + N    +LG FG+A              VGT  ++
Sbjct: 145 YCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG-RVGTPHFM 200

Query: 432 APE---HTRTGKATTSADVFSFGA---FLLEVACGRRP 463
           APE       GK     DV+  G     LL    G  P
Sbjct: 201 APEVVKREPYGKP---VDVWGCGVILFILL---SGCLP 232

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 96.3 bits (240), Expect = 3e-21
 Identities = 64/297 (21%), Positives = 110/297 (37%), Gaps = 71/297 (23%)

Query: 266 KELLGTGGFGRVYRGTLPKSQIEIAVKKIS-------------HESRQGMKEFVAEIVSI 312
              LG+G +G V          E A+K I                  +  +E   EI  +
Sbjct: 41  VRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLL 100

Query: 313 GRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSL-----DKYLYDQPKVTLNWIQRFRVIK 367
             L H N+++L      K    LV ++   G L     +++ +D+            ++K
Sbjct: 101 KSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAA-------NIMK 153

Query: 368 GVALGLFYLHQEWEQVVIHRDVKASNVLL---DGELNGRLGDFGLARLYDHGTDPQTTHV 424
            +  G+ YLH+     ++HRD+K  N+LL   +  LN ++ DFGL+  +      +    
Sbjct: 154 QILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRD--R 208

Query: 425 VGTLGYLAPEHTRTGKATTSADVFSFGA---FLLEVACGRRPIQRQGPSENLILVDWVFD 481
           +GT  Y+APE  +  K     DV+S G     LL   CG  P                  
Sbjct: 209 LGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILL---CGYPP------------------ 246

Query: 482 FW--NRGELLEA---RDPNLGTEY---VAEE-LELVLKLGLLCSHSDPTARPSMRQV 529
           F   N  ++++                +++E  EL+    +L    D   R +  + 
Sbjct: 247 FGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKL--MLT--YDYNKRCTAEEA 299

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 94.8 bits (236), Expect = 3e-21
 Identities = 59/241 (24%), Positives = 95/241 (39%), Gaps = 60/241 (24%)

Query: 259 ATKGFREK----ELLGTGGFGRVYRGTLPKSQIEIAVKKI-------SHESRQGMKEFVA 307
           A K F +K    +++G G    V R     +  E AVK +       S E  + ++E   
Sbjct: 88  AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATR 147

Query: 308 EIVSIGRLR----HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWI--- 360
               I  LR    H +++ L+        + LV+D M  G L            +++   
Sbjct: 148 RETHI--LRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGEL-----------FDYLTEK 194

Query: 361 QRF------RVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYD 414
                     +++ +   + +LH      ++HRD+K  N+LLD  +  RL DFG +   +
Sbjct: 195 VALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLE 251

Query: 415 HGTDPQTTHVVGTLGYLAPE---------HTRTGKATTSADVFSFGA---FLLEVACGRR 462
            G   +   + GT GYLAPE         H   GK     D+++ G     LL    G  
Sbjct: 252 PGEKLRE--LCGTPGYLAPEILKCSMDETHPGYGKE---VDLWACGVILFTLL---AGSP 303

Query: 463 P 463
           P
Sbjct: 304 P 304

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 93.9 bits (234), Expect = 3e-21
 Identities = 47/201 (23%), Positives = 84/201 (41%), Gaps = 27/201 (13%)

Query: 266 KELLGTGGFGRVYRGTLPKSQIEIAVKKIS------HESRQGMKEFVAEIVSIGRLRHRN 319
            E LG+G F  V +     + +E A K I              +E   E+  + ++ H N
Sbjct: 17  GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHN 76

Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSL-----DKYLYDQPKVTLNWIQRFRVIKGVALGLF 374
           ++ L      + +++L+ + +  G L      K    + + T         IK +  G+ 
Sbjct: 77  VITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT-------SFIKQILDGVN 129

Query: 375 YLHQEWEQVVIHRDVKASNVLL----DGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGY 430
           YLH    + + H D+K  N++L        + +L DFGLA   + G + +   + GT  +
Sbjct: 130 YLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN--IFGTPEF 184

Query: 431 LAPEHTRTGKATTSADVFSFG 451
           +APE          AD++S G
Sbjct: 185 VAPEIVNYEPLGLEADMWSIG 205

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 93.8 bits (234), Expect = 3e-21
 Identities = 55/216 (25%), Positives = 83/216 (38%), Gaps = 41/216 (18%)

Query: 266 KELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLG 325
            E+LG+G F  V+      +    A+K I             EI  + +++H N+V L  
Sbjct: 14  MEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLED 73

Query: 326 YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWI---QRF------RVIKGVALGLFYL 376
                    LV   +  G L            + I     +       VI+ V   + YL
Sbjct: 74  IYESTTHYYLVMQLVSGGEL-----------FDRILERGVYTEKDASLVIQQVLSAVKYL 122

Query: 377 HQEWEQVVIHRDVKASNVLL---DGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAP 433
           H   E  ++HRD+K  N+L    +      + DFGL+++  +G     +   GT GY+AP
Sbjct: 123 H---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG---IMSTACGTPGYVAP 176

Query: 434 E---HTRTGKATTSADVFSFGA---FLLEVACGRRP 463
           E        KA    D +S G     LL   CG  P
Sbjct: 177 EVLAQKPYSKA---VDCWSIGVITYILL---CGYPP 206

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 93.8 bits (234), Expect = 3e-21
 Identities = 44/211 (20%), Positives = 84/211 (39%), Gaps = 31/211 (14%)

Query: 266 KELLGTGGFGRVYRGTLPKSQIEIAVKKIS--HESRQGMKEFVAEIVSIGRLRHRNLVQL 323
            E LG G FG V+R     S+     K +      +  +K+   EI  +   RHRN++ L
Sbjct: 10  AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKK---EISILNIARHRNILHL 66

Query: 324 LGYCRRKGELLLVYDYMPNGSL------DKYLYDQPKVTLNWIQRFRVIKGVALGLFYLH 377
                   EL+++++++    +        +  ++ ++          +  V   L +LH
Sbjct: 67  HESFESMEELVMIFEFISGLDIFERINTSAFELNEREIV-------SYVHQVCEALQFLH 119

Query: 378 QEWEQVVIHRDVKASNVLLDGELNGRL--GDFGLARLYDHGTDPQTTHVVGTLGYLAPEH 435
                 + H D++  N++     +  +   +FG AR    G + +   +     Y APE 
Sbjct: 120 S---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL--LFTAPEYYAPEV 174

Query: 436 TRTGKATTSADVFSFGA---FLLEVACGRRP 463
            +    +T+ D++S G     LL    G  P
Sbjct: 175 HQHDVVSTATDMWSLGTLVYVLL---SGINP 202

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 94.7 bits (236), Expect = 6e-21
 Identities = 58/230 (25%), Positives = 88/230 (38%), Gaps = 45/230 (19%)

Query: 258 IATKGFREK----ELLGTGGFGRVYRGTLPKSQIEIAVKKI--SHESRQGMKEFVAEIVS 311
           I    F E+    E LG G F  V R     +  E A   I     S +  ++   E   
Sbjct: 4   ITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARI 63

Query: 312 IGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWI---QRF----- 363
              L+H N+V+L      +G   L++D +  G L              I   + +     
Sbjct: 64  CRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGEL-----------FEDIVAREYYSEADA 112

Query: 364 -RVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNG---RLGDFGLARLYDHGTDP 419
              I+ +   + + H   +  V+HR++K  N+LL  +L G   +L DFGLA   +     
Sbjct: 113 SHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQA 169

Query: 420 QTTHVVGTLGYLAPE---HTRTGKATTSADVFSFGA---FLLEVACGRRP 463
                 GT GYL+PE       GK     D+++ G     LL    G  P
Sbjct: 170 WFG-FAGTPGYLSPEVLRKDPYGKP---VDLWACGVILYILL---VGYPP 212

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 92.2 bits (230), Expect = 6e-21
 Identities = 52/216 (24%), Positives = 90/216 (41%), Gaps = 33/216 (15%)

Query: 266 KELLGTGGFGRVYRGTLPKSQIEIAVKKI------SHESRQGMKEFVAEIVSIGRLRHRN 319
            E LG+G F  V +     +  E A K I      S       +E   E+  +  +RH N
Sbjct: 10  GEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPN 69

Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSL-----DKYLYDQPKVTLNWIQRFRVIKGVALGLF 374
           ++ L      K +++L+ + +  G L     +K    + + T       + +K +  G+ 
Sbjct: 70  IITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEAT-------QFLKQILDGVH 122

Query: 375 YLHQEWEQVVIHRDVKASNVLL---DGELNG-RLGDFGLARLYDHGTDPQTTHVVGTLGY 430
           YLH    + + H D+K  N++L   +      +L DFG+A   + G + +   + GT  +
Sbjct: 123 YLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN--IFGTPEF 177

Query: 431 LAPEHTRTGKATTSADVFSFGA---FLLEVACGRRP 463
           +APE          AD++S G     LL    G  P
Sbjct: 178 VAPEIVNYEPLGLEADMWSIGVITYILL---SGASP 210

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 95.2 bits (237), Expect = 8e-21
 Identities = 60/212 (28%), Positives = 98/212 (46%), Gaps = 21/212 (9%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRN 319
           F +  +LG GGFG V+   +  +    A KK++ +    R+G +  + E   + ++  R 
Sbjct: 187 FLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRF 246

Query: 320 LVQLLGYC-RRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKG------VALG 372
           +V L  Y    K +L LV   M  G +  ++Y+  +        F+  +       +  G
Sbjct: 247 IVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDN----PGFQEPRAIFYTAQIVSG 301

Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTH-VVGTLGYL 431
           L +LH   ++ +I+RD+K  NVLLD + N R+ D GLA   +       T    GT G++
Sbjct: 302 LEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAV--ELKAGQTKTKGYAGTPGFM 356

Query: 432 APEHTRTGKATTSADVFSFGAFLLEVACGRRP 463
           APE     +   S D F+ G  L E+   R P
Sbjct: 357 APELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 91.1 bits (227), Expect = 1e-20
 Identities = 56/204 (27%), Positives = 98/204 (48%), Gaps = 17/204 (8%)

Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHES--RQGMKEFVA-EIVSIGRLRHRNLVQL 323
           + LG G FG+V  G    +  ++AVK ++ +      +   +  EI ++   RH ++++L
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76

Query: 324 LGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRF--RVIKGVALGLFYLHQEWE 381
                   +  +V +Y+  G L  Y+    +V     +R   +++  V     Y H+   
Sbjct: 77  YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVD----YCHR--- 129

Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGK- 440
            +V+HRD+K  NVLLD  +N ++ DFGL+ +   G   +T+   G+  Y APE    G+ 
Sbjct: 130 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAAPEVIS-GRL 186

Query: 441 -ATTSADVFSFGAFLLEVACGRRP 463
            A    D++S G  L  + CG  P
Sbjct: 187 YAGPEVDIWSCGVILYALLCGTLP 210

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 94.0 bits (234), Expect = 1e-20
 Identities = 64/282 (22%), Positives = 110/282 (39%), Gaps = 52/282 (18%)

Query: 266 KELLGTGGFGRVYRGTLPKSQIEIAVKKI--SHESRQGMKEFVAEIVSIGRLRHRNLVQL 323
             +LG G FG V +     +Q E AVK I  +    +     + E+  + +L H N+++L
Sbjct: 27  VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKL 86

Query: 324 LGYCRRKGELLLVYDYMPNGSL-----DKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQ 378
                      +V +    G L      +  + +           R+IK V  G+ Y+H+
Sbjct: 87  FEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA-------RIIKQVFSGITYMHK 139

Query: 379 EWEQVVIHRDVKASNVLL---DGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEH 435
                ++HRD+K  N+LL   + + + ++ DFGL+  +   T  +    +GT  Y+APE 
Sbjct: 140 ---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD--RIGTAYYIAPEV 194

Query: 436 TRTGKATTSADVFSFGA---FLLEVACGRRPIQRQGPSE--NLIL---VDWVFDFWNRGE 487
            R G      DV+S G     LL    G  P   +   +    +      +    W    
Sbjct: 195 LR-GTYDEKCDVWSAGVILYILL---SGTPPFYGKNEYDILKRVETGKYAFDLPQWRTIS 250

Query: 488 LLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQV 529
             +A+D             L+ K  +L     P+ R +  Q 
Sbjct: 251 -DDAKD-------------LIRK--MLT--FHPSLRITATQC 274

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 92.4 bits (230), Expect = 1e-20
 Identities = 60/235 (25%), Positives = 92/235 (39%), Gaps = 48/235 (20%)

Query: 247 GPHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFV 306
           G +R    D +        +  LG G    VYR     +Q   A+K +        K   
Sbjct: 45  GSNRDALSDFFEV------ESELGRGATSIVYRCKQKGTQKPYALKVLK--KTVDKKIVR 96

Query: 307 AEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWI---QRF 363
            EI  + RL H N+++L        E+ LV + +  G L            + I     +
Sbjct: 97  TEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGEL-----------FDRIVEKGYY 145

Query: 364 ------RVIKGVALGLFYLHQEWEQVVIHRDVKASNVLL---DGELNGRLGDFGLARLYD 414
                   +K +   + YLH   E  ++HRD+K  N+L      +   ++ DFGL+++ +
Sbjct: 146 SERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202

Query: 415 HGTDPQTTHVVGTLGYLAPE---HTRTGKATTSADVFSFGA---FLLEVACGRRP 463
           H    +T  V GT GY APE       G      D++S G     LL   CG  P
Sbjct: 203 HQVLMKT--VCGTPGYCAPEILRGCAYGPE---VDMWSVGIITYILL---CGFEP 249

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 92.4 bits (230), Expect = 2e-20
 Identities = 56/221 (25%), Positives = 86/221 (38%), Gaps = 48/221 (21%)

Query: 266 KELLGTGGFGRVYRGTLPKSQIEIAVK-----KISHESRQGMKEFVAEIVSIGRLRHRNL 320
           KE LG G F  V R     + +E A K     K+S    Q ++    E     +L+H N+
Sbjct: 34  KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLER---EARICRKLQHPNI 90

Query: 321 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWI---QRF------RVIKGVAL 371
           V+L    + +    LV+D +  G L              I   + +        I+ +  
Sbjct: 91  VRLHDSIQEESFHYLVFDLVTGGEL-----------FEDIVAREFYSEADASHCIQQILE 139

Query: 372 GLFYLHQEWEQVVIHRDVKASNVLLDGELNG---RLGDFGLARLYDHGTDPQTTHVVGTL 428
            + Y H      ++HR++K  N+LL  +  G   +L DFGLA   +           GT 
Sbjct: 140 SIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE--AWHGFAGTP 194

Query: 429 GYLAPE---HTRTGKATTSADVFSFGA---FLLEVACGRRP 463
           GYL+PE        K     D+++ G     LL    G  P
Sbjct: 195 GYLSPEVLKKDPYSKP---VDIWACGVILYILL---VGYPP 229

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 91.6 bits (228), Expect = 2e-20
 Identities = 55/204 (26%), Positives = 91/204 (44%), Gaps = 22/204 (10%)

Query: 269 LGTGGFGRVYRGTLPKSQIEIAVK-----KISHESRQGMKEFVAEIVSIGRLRHRNLVQL 323
           +G G F +V       +  E+A+K     +++  S Q +     E+  +  L H N+V+L
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLF---REVRIMKILNHPNIVKL 79

Query: 324 LGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQR-FR-VIKGVALGLFYLHQEWE 381
                 +  L L+ +Y   G +  YL    ++     +  FR ++  V     Y HQ   
Sbjct: 80  FEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQ----YCHQ--- 132

Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGK- 440
           + ++HRD+KA N+LLD ++N ++ DFG +  +  G         G   Y APE  + GK 
Sbjct: 133 KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAF--CGAPPYAAPELFQ-GKK 189

Query: 441 -ATTSADVFSFGAFLLEVACGRRP 463
                 DV+S G  L  +  G  P
Sbjct: 190 YDGPEVDVWSLGVILYTLVSGSLP 213

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 91.2 bits (227), Expect = 3e-20
 Identities = 50/216 (23%), Positives = 90/216 (41%), Gaps = 33/216 (15%)

Query: 266 KELLGTGGFGRVYRGTLPKSQIEIAVKKI------SHESRQGMKEFVAEIVSIGRLRHRN 319
            E LG+G F  V +     + ++ A K I      S       ++   E+  +  ++H N
Sbjct: 16  GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPN 75

Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSL-----DKYLYDQPKVTLNWIQRFRVIKGVALGLF 374
           ++ L      K +++L+ + +  G L     +K    + + T         +K +  G++
Sbjct: 76  VITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT-------EFLKQILNGVY 128

Query: 375 YLHQEWEQVVIHRDVKASNVLL---DGELNG-RLGDFGLARLYDHGTDPQTTHVVGTLGY 430
           YLH      + H D+K  N++L   +      ++ DFGLA   D G + +   + GT  +
Sbjct: 129 YLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEF 183

Query: 431 LAPEHTRTGKATTSADVFSFGA---FLLEVACGRRP 463
           +APE          AD++S G     LL    G  P
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILL---SGASP 216

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 91.2 bits (227), Expect = 3e-20
 Identities = 64/323 (19%), Positives = 114/323 (35%), Gaps = 59/323 (18%)

Query: 230 RMKRKFAEELEDWELDHGPHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEI 289
                 +  LE       P ++   D Y  +K     ++LG G  G+V      ++  + 
Sbjct: 3   HHHHHHSSGLEVLFQGPEPKKYAVTDDYQLSK-----QVLGLGVNGKVLECFHRRTGQKC 57

Query: 290 AVKKISHESRQGMKEFVAEIVSIGRL-RHRNLVQLLGYC----RRKGELLLVYDYMPNGS 344
           A+K +    +        E+    +     ++V +L         K  LL++ + M  G 
Sbjct: 58  ALKLLYDSPKARQ-----EVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGE 112

Query: 345 LDKYLYDQPKVTLNWIQRF------RVIKGVALGLFYLHQEWEQVVIHRDVKASNVLL-- 396
               L+   ++     Q F       +++ +   + +LH      + HRDVK  N+L   
Sbjct: 113 ----LFS--RIQERGDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTS 163

Query: 397 -DGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGA--- 452
            + +   +L DFG A+               T  Y+APE     K   S D++S G    
Sbjct: 164 KEKDAVLKLTDFGFAKETTQN---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMY 220

Query: 453 FLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEY---VAEE-LELV 508
            LL   CG  P           +   +      G+                V+E+  +L+
Sbjct: 221 ILL---CGFPPFYSNTGQA---ISPGMKRRIRLGQY------GFPNPEWSEVSEDAKQLI 268

Query: 509 LKLGLLCSHSDPTARPSMRQVVQ 531
               LL   +DPT R ++ Q + 
Sbjct: 269 RL--LLK--TDPTERLTITQFMN 287

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 90.9 bits (226), Expect = 4e-20
 Identities = 67/280 (23%), Positives = 109/280 (38%), Gaps = 50/280 (17%)

Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHE--SRQGMKEFVA------EIVSIGRLRHR 318
             LG+G FG V+     +   E+ VK I  E        E         EI  + R+ H 
Sbjct: 30  SPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHA 89

Query: 319 NLVQLLGYCRRKGELLLVYDYMPNGS-LDKYLYDQPKVTLNWIQR-FR-VIKGVALGLFY 375
           N++++L     +G   LV +   +G  L  ++   P++        FR ++  V     Y
Sbjct: 90  NIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVG----Y 145

Query: 376 LHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEH 435
           L     + +IHRD+K  N+++  +   +L DFG A   + G    T    GT+ Y APE 
Sbjct: 146 LRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTF--CGTIEYCAPE- 199

Query: 436 TRTGK--ATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEA-- 491
              G        +++S G  L  +     P                  F    E +EA  
Sbjct: 200 VLMGNPYRGPELEMWSLGVTLYTLVFEENP------------------FCELEETVEAAI 241

Query: 492 RDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ 531
             P      V++EL  ++  GLL     P  R ++ ++V 
Sbjct: 242 HPPY----LVSKELMSLVS-GLL--QPVPERRTTLEKLVT 274

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 90.4 bits (225), Expect = 4e-20
 Identities = 52/225 (23%), Positives = 87/225 (38%), Gaps = 44/225 (19%)

Query: 266 KELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLR-HRNLVQLL 324
           +++LG G   RV       +  E AVK I  +          E+  + + + HRN+++L+
Sbjct: 18  EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77

Query: 325 GYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQR---F------RVIKGVALGLFY 375
            +   +    LV++ M  GS+           L+ I +   F       V++ VA  L +
Sbjct: 78  EFFEEEDRFYLVFEKMRGGSI-----------LSHIHKRRHFNELEASVVVQDVASALDF 126

Query: 376 LHQEWEQVVIHRDVKASNVLLDGELNG---RLGDFGLARLYDHGTD------PQTTHVVG 426
           LH    + + HRD+K  N+L +        ++ DF L        D      P+     G
Sbjct: 127 LH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCG 183

Query: 427 TLGYLAPE-----HTRTGKATTSADVFSFGA---FLLEVACGRRP 463
           +  Y+APE                D++S G     LL    G  P
Sbjct: 184 SAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILL---SGYPP 225

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 90.5 bits (225), Expect = 7e-20
 Identities = 59/203 (29%), Positives = 94/203 (46%), Gaps = 17/203 (8%)

Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVA-EIVSIGRLRHRNLVQLLG 325
           + +G+G FG         ++  +AVK I  E    + E V  EI++   LRH N+V+   
Sbjct: 26  KDIGSGNFGVARLMRDKLTKELVAVKYI--ERGAAIDENVQREIINHRSLRHPNIVRFKE 83

Query: 326 YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRF--RVIKGVALGLFYLHQEWEQV 383
                  L ++ +Y   G L + + +  + + +  + F  +++ GV+    Y H      
Sbjct: 84  VILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVS----YCHS---MQ 136

Query: 384 VIHRDVKASNVLLDGELNGRL--GDFGLARLYDHGTDPQTTHVVGTLGYLAPEH-TRTGK 440
           + HRD+K  N LLDG    RL   DFG ++     + P++T  VGT  Y+APE   R   
Sbjct: 137 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLRQEY 194

Query: 441 ATTSADVFSFGAFLLEVACGRRP 463
               ADV+S G  L  +  G  P
Sbjct: 195 DGKIADVWSCGVTLYVMLVGAYP 217

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 90.4 bits (225), Expect = 8e-20
 Identities = 61/224 (27%), Positives = 98/224 (43%), Gaps = 33/224 (14%)

Query: 260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRN 319
              F+ + + G G FG V  G    + + +A+KK+  + R   +E +  +  +  L H N
Sbjct: 22  MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRE-LQIMQDLAVLHHPN 80

Query: 320 LVQLLGYCRRKGE-------LLLVYDYMPNGSLDKYL--YDQPKVTLNWI-------QRF 363
           +VQL  Y    GE       L +V +Y+P+ +L +    Y + +V    I       Q  
Sbjct: 81  IVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLI 139

Query: 364 RVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRL--GDFGLARLYDHGTDPQT 421
           R        +  LH      V HRD+K  NVL++ E +G L   DFG A+      +P  
Sbjct: 140 R-------SIGCLHLPSVN-VCHRDIKPHNVLVN-EADGTLKLCDFGSAKKLSPS-EPNV 189

Query: 422 THVVGTLGYLAPEHTRTGKA-TTSADVFSFGAFLLEVACGRRPI 464
            ++  +  Y APE     +  TT+ D++S G    E+     PI
Sbjct: 190 AYIC-SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEM-MLGEPI 231

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 88.6 bits (220), Expect = 2e-19
 Identities = 57/210 (27%), Positives = 91/210 (43%), Gaps = 23/210 (10%)

Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVK-----KISHESRQGMKEFVA-EIVSIGRLRHR-- 318
            LLG+GGFG VY G      + +A+K     +IS          V  E+V + ++     
Sbjct: 49  PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 108

Query: 319 NLVQLLGYCRRKGELLLVYDY-MPNGSLDKYLYDQPKVTLNWIQR-FR-VIKGVALGLFY 375
            +++LL +  R    +L+ +   P   L  ++ ++  +     +  F  V++ V     +
Sbjct: 109 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR----H 164

Query: 376 LHQEWEQVVIHRDVKASNVLLDGE-LNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE 434
            H      V+HRD+K  N+L+D      +L DFG   L     D   T   GT  Y  PE
Sbjct: 165 CHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPE 218

Query: 435 HTRTGK-ATTSADVFSFGAFLLEVACGRRP 463
             R  +    SA V+S G  L ++ CG  P
Sbjct: 219 WIRYHRYHGRSAAVWSLGILLYDMVCGDIP 248

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 87.7 bits (218), Expect = 3e-19
 Identities = 51/214 (23%), Positives = 85/214 (39%), Gaps = 29/214 (13%)

Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHE---SRQGMKEFVA-EIVSIGRLRHRNLVQ 322
           +LLG G +G+V      ++    AVK +  +        +  V  EI  + RLRH+N++Q
Sbjct: 11  DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70

Query: 323 LLG--YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLF------ 374
           L+   Y   K ++ +V +Y   G  +  + D        +   R     A G F      
Sbjct: 71  LVDVLYNEEKQKMYMVMEYCVCGMQE--MLD-------SVPEKRFPVCQAHGYFCQLIDG 121

Query: 375 --YLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVV-GTLGYL 431
             YLH    Q ++H+D+K  N+LL      ++   G+A          T     G+  + 
Sbjct: 122 LEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQ 178

Query: 432 APEHTRTGK--ATTSADVFSFGAFLLEVACGRRP 463
            PE        +    D++S G  L  +  G  P
Sbjct: 179 PPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 89.5 bits (222), Expect = 5e-19
 Identities = 56/204 (27%), Positives = 100/204 (49%), Gaps = 17/204 (8%)

Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHES--RQGMKEFVA-EIVSIGRLRHRNLVQL 323
           + LG G FG+V  G    +  ++AVK ++ +      +   +  EI ++   RH ++++L
Sbjct: 22  DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81

Query: 324 LGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRF--RVIKGVALGLFYLHQEWE 381
                   ++ +V +Y+  G L  Y+    ++     +R   +++ GV     Y H+   
Sbjct: 82  YQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVD----YCHR--- 134

Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGK- 440
            +V+HRD+K  NVLLD  +N ++ DFGL+ +   G   +T+   G+  Y APE    G+ 
Sbjct: 135 HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAAPEVIS-GRL 191

Query: 441 -ATTSADVFSFGAFLLEVACGRRP 463
            A    D++S G  L  + CG  P
Sbjct: 192 YAGPEVDIWSSGVILYALLCGTLP 215

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 87.3 bits (217), Expect = 6e-19
 Identities = 47/201 (23%), Positives = 82/201 (40%), Gaps = 18/201 (8%)

Query: 269 LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLR-HRNLVQLLGYC 327
           LG G +  V+      +  ++ VK +    +   K+   EI  +  LR   N++ L    
Sbjct: 44  LGRGKYSEVFEAINITNNEKVVVKILKPVKK---KKIKREIKILENLRGGPNIITLADIV 100

Query: 328 R--RKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVI 385
           +        LV++++ N    +       +T   I+ +  +  +   L Y H      ++
Sbjct: 101 KDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFY--MYEILKALDYCHSMG---IM 152

Query: 386 HRDVKASNVLLDGELNG-RLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKA-TT 443
           HRDVK  NV++D E    RL D+GLA  Y  G +      V +  +  PE     +    
Sbjct: 153 HRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE--YNVRVASRYFKGPELLVDYQMYDY 210

Query: 444 SADVFSFGAFLLEVACGRRPI 464
           S D++S G  L  +   + P 
Sbjct: 211 SLDMWSLGCMLASMIFRKEPF 231

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 87.4 bits (217), Expect = 9e-19
 Identities = 54/208 (25%), Positives = 91/208 (43%), Gaps = 15/208 (7%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVS----IGRLRHR 318
           F     +G G FG+V       ++   A+K ++ +      E V  +      +  L H 
Sbjct: 17  FEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNE-VRNVFKELQIMQGLEHP 75

Query: 319 NLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQ 378
            LV L    + + ++ +V D +  G L  +L          + +  + + + + L YL  
Sbjct: 76  FLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETV-KLFICE-LVMALDYLQ- 132

Query: 379 EWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE--HT 436
              Q +IHRD+K  N+LLD   +  + DF +A +    T   T  + GT  Y+APE   +
Sbjct: 133 --NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MAGTKPYMAPEMFSS 188

Query: 437 RTGKA-TTSADVFSFGAFLLEVACGRRP 463
           R G   + + D +S G    E+  GRRP
Sbjct: 189 RKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 87.8 bits (218), Expect = 9e-19
 Identities = 60/259 (23%), Positives = 95/259 (36%), Gaps = 51/259 (19%)

Query: 229 IRMKRKFAEELEDWELDHGPHRFRYKDLYIATKGFREKELLGTGGFGRVY----RGT--- 281
           +R  +     L  ++        + +DL +  + +   +++G G FG V     + T   
Sbjct: 41  LRKNKNIDNFLSRYK----DTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKV 96

Query: 282 -----LPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLV 336
                L K ++ I     +         F  E   +       +VQL    +    L +V
Sbjct: 97  YAMKLLSKFEM-IKRSDSAF--------FWEERDIMAFANSPWVVQLFYAFQDDRYLYMV 147

Query: 337 YDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVA--------LGLFYLHQEWEQVVIHRD 388
            +YMP G L           +N +  + V +  A        L L  +H       IHRD
Sbjct: 148 MEYMPGGDL-----------VNLMSNYDVPEKWARFYTAEVVLALDAIHS---MGFIHRD 193

Query: 389 VKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE----HTRTGKATTS 444
           VK  N+LLD   + +L DFG     +     +    VGT  Y++PE        G     
Sbjct: 194 VKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRE 253

Query: 445 ADVFSFGAFLLEVACGRRP 463
            D +S G FL E+  G  P
Sbjct: 254 CDWWSVGVFLYEMLVGDTP 272

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 86.6 bits (215), Expect = 1e-18
 Identities = 52/233 (22%), Positives = 89/233 (38%), Gaps = 50/233 (21%)

Query: 261 KGFREK----ELLGTGGFGRVYRGTLPKSQIEIAVKKIS--------HESRQGMKEFVAE 308
           K  R++    + LG+G  G V      K+  ++A+K IS                    E
Sbjct: 6   KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65

Query: 309 IVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWI---QRF-- 363
           I  + +L H  ++++  +   + +  +V + M  G L            + +   +R   
Sbjct: 66  IEILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGEL-----------FDKVVGNKRLKE 113

Query: 364 ----RVIKGVALGLFYLHQEWEQVVIHRDVKASNVLL---DGELNGRLGDFGLARLYDHG 416
                    + L + YLH   E  +IHRD+K  NVLL   + +   ++ DFG +++    
Sbjct: 114 ATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 170

Query: 417 TDPQTTHVVGTLGYLAPE---HTRTGKATTSADVFSFGA---FLLEVACGRRP 463
           +      + GT  YLAPE      T     + D +S G      L    G  P
Sbjct: 171 S--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICL---SGYPP 218

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 86.5 bits (215), Expect = 1e-18
 Identities = 45/193 (23%), Positives = 84/193 (43%), Gaps = 11/193 (5%)

Query: 265 EKELLGTGGFGRVYRGTLPKSQIEIAVKKI--SHESRQGMKEFVAEIVSIGRLRHR-NLV 321
             + LG G F  V +     +  E A K +      +    E + EI  +   +    ++
Sbjct: 33  TSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVI 92

Query: 322 QLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
            L        E++L+ +Y   G +      +    ++     R+IK +  G++YLH   +
Sbjct: 93  NLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLH---Q 149

Query: 382 QVVIHRDVKASNVLLDGELNG---RLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRT 438
             ++H D+K  N+LL         ++ DFG++R   H  + +   ++GT  YLAPE    
Sbjct: 150 NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELRE--IMGTPEYLAPEILNY 207

Query: 439 GKATTSADVFSFG 451
              TT+ D+++ G
Sbjct: 208 DPITTATDMWNIG 220

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 87.1 bits (216), Expect = 1e-18
 Identities = 50/216 (23%), Positives = 87/216 (40%), Gaps = 38/216 (17%)

Query: 266 KELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGR--LRHRNLVQL 323
            ++LG G  G+V +    ++Q + A+K +    +   +E     V +     +  ++V++
Sbjct: 67  SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKAR-RE-----VELHWRASQCPHIVRI 120

Query: 324 LGYC----RRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRF------RVIKGVALGL 373
           +         +  LL+V + +  G     L+   ++     Q F       ++K +   +
Sbjct: 121 VDVYENLYAGRKCLLIVMECLDGGE----LFS--RIQDRGDQAFTEREASEIMKSIGEAI 174

Query: 374 FYLHQEWEQVVIHRDVKASNVLLDGELNG---RLGDFGLARLYDHGTDPQTTHVVGTLGY 430
            YLH      + HRDVK  N+L   +      +L DFG A+         T     T  Y
Sbjct: 175 QYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT--PCYTPYY 229

Query: 431 LAPEHTRTGKATTSADVFSFGA---FLLEVACGRRP 463
           +APE     K   S D++S G     LL   CG  P
Sbjct: 230 VAPEVLGPEKYDKSCDMWSLGVIMYILL---CGYPP 262

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 85.4 bits (212), Expect = 3e-18
 Identities = 65/204 (31%), Positives = 106/204 (51%), Gaps = 18/204 (8%)

Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHE--SRQGMKEFVA-EIVSIGRLRHRNLVQL 323
           E LG G FG+V   T  K+Q ++A+K IS +   +  M   V  EI  +  LRH ++++L
Sbjct: 15  ETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL 74

Query: 324 LGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRF--RVIKGVALGLFYLHQEWE 381
                   ++++V +Y   G L  Y+ ++ ++T +  +RF  ++I  +     Y H+   
Sbjct: 75  YDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIE----YCHR--- 126

Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGK- 440
             ++HRD+K  N+LLD  LN ++ DFGL+ +   G   +T+   G+  Y APE    GK 
Sbjct: 127 HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPEVIN-GKL 183

Query: 441 -ATTSADVFSFGAFLLEVACGRRP 463
            A    DV+S G  L  +  GR P
Sbjct: 184 YAGPEVDVWSCGIVLYVMLVGRLP 207

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 84.7 bits (210), Expect = 3e-18
 Identities = 51/212 (24%), Positives = 89/212 (41%), Gaps = 25/212 (11%)

Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVK-----KISHESRQGMKEFVA-EIVSIGRLR---- 316
            LLG GGFG V+ G     ++++A+K     ++   S          E+  + ++     
Sbjct: 37  PLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGG 96

Query: 317 HRNLVQLLGYCRRKGELLLVYDY-MPNGSLDKYLYDQPKVTLNWIQR-FR-VIKGVALGL 373
           H  +++LL +   +   +LV +  +P   L  Y+ ++  +     +  F  V+  +    
Sbjct: 97  HPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQ--- 153

Query: 374 FYLHQEWEQVVIHRDVKASNVLLDGELNG-RLGDFGLARLYDHGTDPQTTHVVGTLGYLA 432
            + H    + V+HRD+K  N+L+D      +L DFG   L  H          GT  Y  
Sbjct: 154 -HCHS---RGVVHRDIKDENILIDLRRGCAKLIDFGSGALL-HDEPYTDF--DGTRVYSP 206

Query: 433 PEHTRTGK-ATTSADVFSFGAFLLEVACGRRP 463
           PE     +     A V+S G  L ++ CG  P
Sbjct: 207 PEWISRHQYHALPATVWSLGILLYDMVCGDIP 238

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 86.0 bits (213), Expect = 4e-18
 Identities = 48/228 (21%), Positives = 81/228 (35%), Gaps = 50/228 (21%)

Query: 263 FREKELLGTGGFGRVY----RGT--------LPKSQIEIAVKKISHESRQGMKEFVAEIV 310
           F   +++G G FG V     +          L K ++ +   + +         F  E  
Sbjct: 76  FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEM-LKRAETAC--------FREERD 126

Query: 311 SIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRV----- 365
            +     + +  L    +    L LV DY   G L           L  + +F       
Sbjct: 127 VLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDL-----------LTLLSKFEDRLPEE 175

Query: 366 -----IKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ 420
                +  + + +  +HQ      +HRD+K  N+L+D   + RL DFG           Q
Sbjct: 176 MARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ 232

Query: 421 TTHVVGTLGYLAPE-----HTRTGKATTSADVFSFGAFLLEVACGRRP 463
           ++  VGT  Y++PE         G+     D +S G  + E+  G  P
Sbjct: 233 SSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 84.2 bits (209), Expect = 4e-18
 Identities = 54/235 (22%), Positives = 96/235 (40%), Gaps = 50/235 (21%)

Query: 266 KELLGTGGFGRVYRGTLPKSQIEIAVKKIS-------------------------HESRQ 300
           K+ +G G +G V            A+K +S                             +
Sbjct: 18  KDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPR 77

Query: 301 GMKEFVA-EIVSIGRLRHRNLVQLLGY----CRRKGELLLVYDYMPNGSLDKYLYDQP-- 353
           G  E V  EI  + +L H N+V+L          +  L +V++ +  G + +    +P  
Sbjct: 78  GPIEQVYQEIAILKKLDHPNVVKL--VEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLS 135

Query: 354 -KVTLNWIQRFR-VIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR 411
                 +   F+ +IKG+     YLH    Q +IHRD+K SN+L+  + + ++ DFG++ 
Sbjct: 136 EDQARFY---FQDLIKGIE----YLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVSN 185

Query: 412 LYDHGTDPQTTHVVGTLGYLAPEHTRTGKAT---TSADVFSFGAFLLEVACGRRP 463
            +    D   ++ VGT  ++APE     +      + DV++ G  L     G+ P
Sbjct: 186 EFKGS-DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 82.1 bits (203), Expect = 2e-17
 Identities = 36/286 (12%), Positives = 92/286 (32%), Gaps = 49/286 (17%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRN 319
           +R     G     + ++        ++A+  +  +       ++E ++  + + R+    
Sbjct: 33  YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPG 92

Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQE 379
           + ++L     +   L+V +++  GSL +     P      +   R ++ +A      H+ 
Sbjct: 93  VARVLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSP----VGAIRAMQSLAAAADAAHRA 148

Query: 380 WEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTG 439
               V       S V +  +  G +                   V+     +        
Sbjct: 149 G---VALSIDHPSRVRVSID--GDV-------------------VLAYPATMPD------ 178

Query: 440 KATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTE 499
            A    D+   GA L  +   R P+   G    L   +        G+ +E  D +    
Sbjct: 179 -ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTA----GQPIEPADIDRD-- 231

Query: 500 YVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERDVALPAISAL 545
            +  ++  V     +    D   R +   ++ ++++  A+   + +
Sbjct: 232 -IPFQISAVA-ARSV--QGDGGIRSAS-TLLNLMQQATAVADRTEV 272

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 82.5 bits (204), Expect = 5e-17
 Identities = 64/282 (22%), Positives = 109/282 (38%), Gaps = 27/282 (9%)

Query: 229 IRMKRKFAEELEDWELDHGPHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIE 288
           +   +  A+ L+  E    P   R K++ +    F   +++G G F  V    + ++   
Sbjct: 33  LAQDKYVADFLQWAE----PIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQV 88

Query: 289 IAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLGYC-RRKGELLLVYDYMPNGS 344
            A+K ++      R  +  F  E   +     R + QL  +  + +  L LV +Y   G 
Sbjct: 89  YAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH-FAFQDENYLYLVMEYYVGGD 147

Query: 345 LDKYLYDQ-PKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGR 403
           L   L     ++      RF  +  + + +  +H+      +HRD+K  N+LLD   + R
Sbjct: 148 LLTLLSKFGERIPAEMA-RF-YLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIR 202

Query: 404 LGDFGLARLYDHGTDPQTTHVVGTLGYLAPE-------HTRTGKATTSADVFSFGAFLLE 456
           L DFG           ++   VGT  YL+PE          TG      D ++ G F  E
Sbjct: 203 LADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYE 262

Query: 457 VACGRRPIQRQGPSE--NLILVDWV-FDFWNRGELL--EARD 493
           +  G+ P      +E    I+            E +  EARD
Sbjct: 263 MFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARD 304

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 81.2 bits (201), Expect = 7e-17
 Identities = 53/204 (25%), Positives = 89/204 (43%), Gaps = 12/204 (5%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEF---VAEIVSIGRLRHRN 319
           F   + LGTG FGRV      +S    A+K +  +    +K+    + E   +  +    
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102

Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQE 379
           LV+L    +    L +V +Y+  G +  +L    + +     RF     + L   YLH  
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPH-ARF-YAAQIVLTFEYLH-- 158

Query: 380 WEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTG 439
               +I+RD+K  N+L+D +   ++ DFG A+     T    T + GT   LAPE   + 
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT---WT-LCGTPEALAPEIILSK 213

Query: 440 KATTSADVFSFGAFLLEVACGRRP 463
               + D ++ G  + E+A G  P
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPP 237

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 82.2 bits (203), Expect = 9e-17
 Identities = 53/233 (22%), Positives = 96/233 (41%), Gaps = 26/233 (11%)

Query: 244 LDHGPHRFRYKD-LYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQ 300
           +D+  +     D  +   K ++  + +G+G  G V           +A+KK+S   +++ 
Sbjct: 44  VDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQT 103

Query: 301 GMKEFVAEIVSIGRLRHRNLVQLL------GYCRRKGELLLVYDYMP---NGSLDKYLYD 351
             K    E+V +  + H+N++ LL             ++ LV + M       +   L  
Sbjct: 104 HAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDH 163

Query: 352 QPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR 411
           +    L + Q    IK       +LH      +IHRD+K SN+++  +   ++ DFGLAR
Sbjct: 164 ERMSYLLY-QMLCGIK-------HLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 212

Query: 412 LYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPI 464
                T    T  V T  Y APE         + D++S G  + E+    + +
Sbjct: 213 TAG--TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV-RHKIL 262

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 80.1 bits (198), Expect = 2e-16
 Identities = 51/234 (21%), Positives = 96/234 (41%), Gaps = 26/234 (11%)

Query: 243 ELDHGPHRFRYKD-LYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISH--ESR 299
           + D+  +     D  +   K ++  + +G+G  G V        +  +A+KK+S   +++
Sbjct: 6   KRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQ 65

Query: 300 QGMKEFVAEIVSIGRLRHRNLVQLL------GYCRRKGELLLVYDYMP---NGSLDKYLY 350
              K    E+V +  + H+N++ LL             ++ +V + M       +   L 
Sbjct: 66  THAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELD 125

Query: 351 DQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLA 410
            +    L + Q          G+ +LH      +IHRD+K SN+++  +   ++ DFGLA
Sbjct: 126 HERMSYLLY-QMLC-------GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA 174

Query: 411 RLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPI 464
           R     T    T  V T  Y APE         + D++S G  + E+      +
Sbjct: 175 RTAG--TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI-KGGVL 225

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 80.1 bits (198), Expect = 2e-16
 Identities = 56/231 (24%), Positives = 103/231 (44%), Gaps = 26/231 (11%)

Query: 246 HGPHRFR-YKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGM 302
            G +R    K  +     +R+ + +G+G +G V      ++  ++A+KK+    +S    
Sbjct: 9   SGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFA 68

Query: 303 KEFVAEIVSIGRLRHRNLVQLL------GYCRRKGELLLVYDYMPNGSLDKYLYDQPKVT 356
           K    E+  +  +RH N++ LL             +  LV  +M    L K +  +  + 
Sbjct: 69  KRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT-DLGKLMKHEK-LG 126

Query: 357 LNWIQRF--RVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYD 414
            + IQ    +++KG    L Y+H      +IHRD+K  N+ ++ +   ++ DFGLAR   
Sbjct: 127 EDRIQFLVYQMLKG----LRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR--- 176

Query: 415 HGTDPQTTHVVGTLGYLAPE-HTRTGKATTSADVFSFGAFLLEVACGRRPI 464
              D + T  V T  Y APE      + T + D++S G  + E+    + +
Sbjct: 177 -QADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMI-TGKTL 225

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 79.7 bits (197), Expect = 3e-16
 Identities = 56/231 (24%), Positives = 103/231 (44%), Gaps = 26/231 (11%)

Query: 246 HGPHRFR-YKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGM 302
              +R    K ++   + ++    +G+G +G V      K+ + +AVKK+S   +S    
Sbjct: 13  PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 72

Query: 303 KEFVAEIVSIGRLRHRNLVQLL------GYCRRKGELLLVYDYMPNGSLDKYLYDQPKVT 356
           K    E+  +  ++H N++ LL             ++ LV   M    L+  +  Q  +T
Sbjct: 73  KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQK-LT 130

Query: 357 LNWIQRF--RVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYD 414
            + +Q    ++++G    L Y+H      +IHRD+K SN+ ++ +   ++ DFGLAR   
Sbjct: 131 DDHVQFLIYQILRG----LKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR--- 180

Query: 415 HGTDPQTTHVVGTLGYLAPE-HTRTGKATTSADVFSFGAFLLEVACGRRPI 464
             T  + T  V T  Y APE          + D++S G  + E+    R +
Sbjct: 181 -HTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL-TGRTL 229

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 78.9 bits (195), Expect = 5e-16
 Identities = 65/226 (28%), Positives = 101/226 (44%), Gaps = 27/226 (11%)

Query: 253 YKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKIS-HESRQGMKEFVAEIVS 311
              ++     +     +G G +G V       +++ +A+KKIS  E +   +  + EI  
Sbjct: 19  RGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKI 78

Query: 312 IGRLRHRNLVQLL-----GYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRF--- 363
           + R RH N++ +          +  ++ +V D M    L K L  Q  ++ + I  F   
Sbjct: 79  LLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET-DLYKLLKTQH-LSNDHICYFLYQ 136

Query: 364 --RVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYD--HGTDP 419
             R       GL Y+H      V+HRD+K SN+LL+   + ++ DFGLAR+ D  H    
Sbjct: 137 ILR-------GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTG 186

Query: 420 QTTHVVGTLGYLAPEHTRTGKA-TTSADVFSFGAFLLEVACGRRPI 464
             T  V T  Y APE     K  T S D++S G  L E+    RPI
Sbjct: 187 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML-SNRPI 231

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 78.9 bits (195), Expect = 5e-16
 Identities = 56/228 (24%), Positives = 99/228 (43%), Gaps = 23/228 (10%)

Query: 247 GPHRFR-YKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISH--ESRQGMK 303
           G ++    K  +   K +     +G+G +G V      +S  ++A+KK+S   +S    K
Sbjct: 9   GFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAK 68

Query: 304 EFVAEIVSIGRLRHRNLVQLL------GYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTL 357
               E++ +  ++H N++ LL         R   +  LV  +M    L K +    K + 
Sbjct: 69  RAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQKIM--GLKFSE 125

Query: 358 NWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT 417
             IQ    +  +  GL Y+H      V+HRD+K  N+ ++ +   ++ DFGLAR      
Sbjct: 126 EKIQYL--VYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLAR----HA 176

Query: 418 DPQTTHVVGTLGYLAPE-HTRTGKATTSADVFSFGAFLLEVACGRRPI 464
           D + T  V T  Y APE          + D++S G  + E+    + +
Sbjct: 177 DAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEML-TGKTL 223

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 78.1 bits (193), Expect = 5e-16
 Identities = 54/221 (24%), Positives = 91/221 (41%), Gaps = 28/221 (12%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQ 322
           + + + LG GG G V+          +A+KKI     Q +K  + EI  I RL H N+V+
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 72

Query: 323 LLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVT-LNWIQRFRVIKGVAL---------- 371
           +       G  L             Y+  +   T L       V++   L          
Sbjct: 73  VFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLA-----NVLEQGPLLEEHARLFMY 127

Query: 372 ----GLFYLHQEWEQVVIHRDVKASNVLLDGE-LNGRLGDFGLARLYDHGTDPQT--THV 424
               GL Y+H      V+HRD+K +N+ ++ E L  ++GDFGLAR+ D     +   +  
Sbjct: 128 QLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEG 184

Query: 425 VGTLGYLAPEHTRTGKA-TTSADVFSFGAFLLEVACGRRPI 464
           + T  Y +P    +    T + D+++ G    E+    + +
Sbjct: 185 LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEML-TGKTL 224

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 78.2 bits (193), Expect = 1e-15
 Identities = 54/253 (21%), Positives = 99/253 (39%), Gaps = 65/253 (25%)

Query: 260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRN 319
           +K +   + LGTG FG V      +S    A+KK+  + R   +E    +  +  L H N
Sbjct: 6   SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRE----LDIMKVLDHVN 61

Query: 320 LVQLLGYCRRKGE--------------------------------------LLLVYDYMP 341
           +++L+ Y    G+                                      L ++ +Y+P
Sbjct: 62  IIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP 121

Query: 342 NGSLDKYLYDQPK----VTLNWIQRFR--VIKGVALGLFYLHQEWEQVVIHRDVKASNVL 395
           + +L K L    +    + +N I  +   + + V     ++H      + HRD+K  N+L
Sbjct: 122 D-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG----FIHS---LGICHRDIKPQNLL 173

Query: 396 LD---GELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKA-TTSADVFSFG 451
           ++     L  +L DFG A+      +P   ++  +  Y APE        T S D++S G
Sbjct: 174 VNSKDNTL--KLCDFGSAKKLIPS-EPSVAYIC-SRFYRAPELMLGATEYTPSIDLWSIG 229

Query: 452 AFLLEVACGRRPI 464
               E+    +P+
Sbjct: 230 CVFGEL-ILGKPL 241

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 77.2 bits (191), Expect = 1e-15
 Identities = 60/220 (27%), Positives = 95/220 (43%), Gaps = 44/220 (20%)

Query: 263 FREKELLGTGGFGRVY----RGT--------LPKSQIEIAVKKISHESRQGMKEFVAEIV 310
           F+    LGTG FGRV+    R          L K  + + +K++ H           E +
Sbjct: 8   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIV-VRLKQVEHT--------NDERL 58

Query: 311 SIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKG-- 368
            +  + H  ++++ G  +   ++ ++ DY+  G L   L           QRF       
Sbjct: 59  MLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKS--------QRFPNPVAKF 110

Query: 369 ----VALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTH- 423
               V L L YLH    + +I+RD+K  N+LLD   + ++ DFG A+       P  T+ 
Sbjct: 111 YAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKY-----VPDVTYT 162

Query: 424 VVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRP 463
           + GT  Y+APE   T     S D +SFG  + E+  G  P
Sbjct: 163 LCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 76.6 bits (189), Expect = 3e-15
 Identities = 53/230 (23%), Positives = 92/230 (40%), Gaps = 28/230 (12%)

Query: 253 YKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVA----- 307
             +L+     +  +  + +G +G V  G   +    +A+K++ +    G    +      
Sbjct: 14  IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGI-PVAIKRVFNTVSDGRTVNILSDSFL 72

Query: 308 ------EIVSIGRLRHRNLVQLL-----GYCRRKGELLLVYDYMPNGSLDKYLY-DQPKV 355
                 EI  +    H N++ L             +L LV + M    L + ++  +  +
Sbjct: 73  CKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVI 131

Query: 356 TLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH 415
           +   IQ F  +  + LGL  LH   E  V+HRD+   N+LL    +  + DF LAR    
Sbjct: 132 SPQHIQYF--MYHILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAREDT- 185

Query: 416 GTDPQTTHVVGTLGYLAPE-HTRTGKATTSADVFSFGAFLLEVACGRRPI 464
             D   TH V    Y APE   +    T   D++S G  + E+   R+ +
Sbjct: 186 -ADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMF-NRKAL 233

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 75.2 bits (185), Expect = 1e-14
 Identities = 58/206 (28%), Positives = 89/206 (43%), Gaps = 12/206 (5%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEF---VAEIVSIGRLRHRN 319
           F   +LLG G FG+V       +    A+K +  E      E    + E   +   RH  
Sbjct: 150 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPF 209

Query: 320 LVQLLGYC-RRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQ 378
           L  L  Y  +    L  V +Y   G L  +L  +   + +   RF   + +   L YLH 
Sbjct: 210 LTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRA-RFYGAE-IVSALDYLHS 266

Query: 379 EWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVV-GTLGYLAPEHTR 437
           E  + V++RD+K  N++LD + + ++ DFGL +  +   D  T     GT  YLAPE   
Sbjct: 267 E--KNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVLE 322

Query: 438 TGKATTSADVFSFGAFLLEVACGRRP 463
                 + D +  G  + E+ CGR P
Sbjct: 323 DNDYGRAVDWWGLGVVMYEMMCGRLP 348

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 73.8 bits (182), Expect = 2e-14
 Identities = 61/241 (25%), Positives = 94/241 (39%), Gaps = 52/241 (21%)

Query: 254 KDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKIS-HESRQGMKEFVAEIVSI 312
           + +Y  +  F+ K LLG G +G V   T   +   +A+KKI   +        + EI  +
Sbjct: 4   RIVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKIL 63

Query: 313 GRLRHRNLVQLL-----GYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIK 367
              +H N++ +             E+ ++ + M        L+             RVI 
Sbjct: 64  KHFKHENIITIFNIQRPDSFENFNEVYIIQELM-----QTDLH-------------RVIS 105

Query: 368 GVAL--------------GLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLY 413
              L               +  LH      VIHRD+K SN+L++   + ++ DFGLAR+ 
Sbjct: 106 TQMLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARII 162

Query: 414 D---------HGTDPQTTHVVGTLGYLAPEHTRTGKA-TTSADVFSFGAFLLEVACGRRP 463
           D          G        V T  Y APE   T    + + DV+S G  L E+   RRP
Sbjct: 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELF-LRRP 221

Query: 464 I 464
           I
Sbjct: 222 I 222

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 75.1 bits (184), Expect = 2e-14
 Identities = 54/211 (25%), Positives = 86/211 (40%), Gaps = 22/211 (10%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKIS-------HESRQGMKE-FVAEIVSIGR 314
           F    +LG G FG+V       +    AVK +         +    M E  V  +     
Sbjct: 343 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG--- 399

Query: 315 LRHRNLVQLLGYC-RRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKG-VALG 372
            +   L QL   C +    L  V +Y+  G L  ++    +               +A+G
Sbjct: 400 -KPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEP---HAVFYAAEIAIG 454

Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLA 432
           LF+L     + +I+RD+K  NV+LD E + ++ DFG+ +  +      T    GT  Y+A
Sbjct: 455 LFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE-NIWDGVTTKTFCGTPDYIA 510

Query: 433 PEHTRTGKATTSADVFSFGAFLLEVACGRRP 463
           PE         S D ++FG  L E+  G+ P
Sbjct: 511 PEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 73.5 bits (181), Expect = 3e-14
 Identities = 51/208 (24%), Positives = 96/208 (46%), Gaps = 19/208 (9%)

Query: 268 LLGTGGFGRVY--RGTLPKSQIEI-AVKKISHESRQGMKEFVAEIVS----IGRLRHRN- 319
           +LGTG +G+V+  R        ++ A+K +   +     +      +    +  +R    
Sbjct: 61  VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 120

Query: 320 LVQLLGYC-RRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQ 378
           LV L  Y  + + +L L+ DY+  G L  +L  + + T + + +   +  + L L +LH 
Sbjct: 121 LVTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFTEHEV-QI-YVGEIVLALEHLH- 176

Query: 379 EWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE---H 435
             +  +I+RD+K  N+LLD   +  L DFGL++ +      +     GT+ Y+AP+    
Sbjct: 177 --KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRG 234

Query: 436 TRTGKATTSADVFSFGAFLLEVACGRRP 463
             +G    + D +S G  + E+  G  P
Sbjct: 235 GDSGH-DKAVDWWSLGVLMYELLTGASP 261

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 73.0 bits (180), Expect = 3e-14
 Identities = 57/202 (28%), Positives = 97/202 (48%), Gaps = 13/202 (6%)

Query: 268 LLGTGGFGRVY--RGTLPKSQIEI-AVKKISHES--RQGMKEFVAEIVSIGRLRHRNLVQ 322
           +LG G FG+V+  +        ++ A+K +   +   +       E   +  + H  +V+
Sbjct: 31  VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVK 90

Query: 323 LLGYC-RRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
           L  Y  + +G+L L+ D++  G L   L  +   T   + +F  +  +AL L +LH    
Sbjct: 91  LH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDV-KF-YLAELALALDHLH---S 144

Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKA 441
             +I+RD+K  N+LLD E + +L DFGL++          +   GT+ Y+APE       
Sbjct: 145 LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS-FCGTVEYMAPEVVNRRGH 203

Query: 442 TTSADVFSFGAFLLEVACGRRP 463
           T SAD +SFG  + E+  G  P
Sbjct: 204 TQSADWWSFGVLMFEMLTGTLP 225

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 72.6 bits (179), Expect = 4e-14
 Identities = 52/212 (24%), Positives = 97/212 (45%), Gaps = 31/212 (14%)

Query: 268 LLGTGGFGRVY--RGTLPKSQIEI-AVKKISHESRQGMKEFVA----EIVSI-------G 313
           +LG GG+G+V+  R     +  +I A+K +        K  +     +            
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLK-------KAMIVRNAKDTAHTKAERNILE 76

Query: 314 RLRHRNLVQLLGYC-RRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALG 372
            ++H  +V L+ Y  +  G+L L+ +Y+  G L   L  +     +    F  +  +++ 
Sbjct: 77  EVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTA-CF-YLAEISMA 133

Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTH-VVGTLGYL 431
           L +LH   ++ +I+RD+K  N++L+ + + +L DFGL +      D   TH   GT+ Y+
Sbjct: 134 LGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKE--SIHDGTVTHTFCGTIEYM 188

Query: 432 APEHTRTGKATTSADVFSFGAFLLEVACGRRP 463
           APE         + D +S GA + ++  G  P
Sbjct: 189 APEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>1qmo_A Mannose binding lectin, FRIL; crosslink, hematopoietic progenitor, sugar complex; HET: MAN; 3.5A {Dolichos lab lab} SCOP: b.29.1.1 Length = 113

 Score = 67.2 bits (164), Expect = 8e-14
 Identities = 17/54 (31%), Positives = 25/54 (46%), Gaps = 1/54 (1%)

Query: 13  ANGTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGLFNDTN 66
            +  + SF T   F I + Y S+   G+AF IA    +       +LGLF + N
Sbjct: 61  DSAVLTSFDTIINFEISTPYTSRIADGLAFFIAPPDSVISY-HGGFLGLFPNAN 113

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 71.5 bits (175), Expect = 1e-13
 Identities = 68/356 (19%), Positives = 112/356 (31%), Gaps = 106/356 (29%)

Query: 263 FREK----ELLGTGGFGRVYRGTL-----PKSQIEIAVKKISHESRQG-----------M 302
            R++    + LG G FG+V            +   +AVK +   +              +
Sbjct: 20  PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL 79

Query: 303 KEF----------------------VAEIVSIGRLRH---RNLVQLLGYCRRKGELLLVY 337
                                    + E    G L         + + Y  +        
Sbjct: 80  IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGK 139

Query: 338 DYMPNGSLDKYLY--------------DQPKVTLNWIQRFRVIKG--------------- 368
           DY+    +D                     + +L+ ++     +                
Sbjct: 140 DYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYS 199

Query: 369 --VALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVG 426
             VA G+ +L     +  IHRD+ A N+LL  +   ++ DFGLAR  D   DP   +V  
Sbjct: 200 FQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLAR--DIYKDP--DYVRK 252

Query: 427 TLGYL-----APEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVF 480
               L     APE       T  +DV+SFG  L E+   G  P       E         
Sbjct: 253 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE------FC 306

Query: 481 DFWNRGELLEARDPNLGTEYVAEEL-ELVLKLGLLCSHSDPTARPSMRQVVQILER 535
                G  + A  P    +Y   E+ + +L     C H +P+ RP+  ++V+ L  
Sbjct: 307 RRLKEGTRMRA--P----DYTTPEMYQTMLD----CWHGEPSQRPTFSELVEHLGN 352

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 72.2 bits (177), Expect = 1e-13
 Identities = 47/210 (22%), Positives = 80/210 (38%), Gaps = 49/210 (23%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVA-----EIVSIGRLRH 317
           +  + L+GTG +G V        +  +A+KKI                  EI  + RL H
Sbjct: 55  YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFE---DLIDCKRILREIAILNRLNH 111

Query: 318 RNLVQLL-----GYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRF--RVIKGVA 370
            ++V++L         +  EL +V +   +    K       +T   I+     ++ G  
Sbjct: 112 DHVVKVLDIVIPKDVEKFDELYVVLEIADS-DFKKLFRTPVYLTELHIKTLLYNLLVG-- 168

Query: 371 LGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH--------------- 415
             + Y+H      ++HRD+K +N L++ + + ++ DFGLAR  D+               
Sbjct: 169 --VKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRED 223

Query: 416 -----------GTDPQTTHVVGTLGYLAPE 434
                          Q T  V T  Y APE
Sbjct: 224 DMNLVTFPHTKNLKRQLTGHVVTRWYRAPE 253

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 70.7 bits (174), Expect = 2e-13
 Identities = 57/208 (27%), Positives = 86/208 (41%), Gaps = 27/208 (12%)

Query: 268 LLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVA---EIVSI-------GRLRH 317
           LLG G FG+V       +    A+K +        KE +    E+             RH
Sbjct: 12  LLGKGTFGKVILVREKATGRYYAMKILR-------KEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 318 RNLVQLLGYC-RRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYL 376
             L  L  Y  +    L  V +Y   G L  +L  +   T     RF   + +   L YL
Sbjct: 65  PFLTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERA-RFYGAE-IVSALEYL 121

Query: 377 HQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVV-GTLGYLAPEH 435
           H    + V++RD+K  N++LD + + ++ DFGL +  +  +D  T     GT  YLAPE 
Sbjct: 122 H---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEV 176

Query: 436 TRTGKATTSADVFSFGAFLLEVACGRRP 463
                   + D +  G  + E+ CGR P
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 70.8 bits (174), Expect = 2e-13
 Identities = 58/213 (27%), Positives = 87/213 (40%), Gaps = 36/213 (16%)

Query: 268 LLGTGGFGRVY----RGT--------LPKSQIEIAVKKISH---ESRQGMKEFVAEIVSI 312
           ++G G FG+V     +          L K  I +  K+  H   E            V +
Sbjct: 45  VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAI-LKKKEEKHIMSERN----------VLL 93

Query: 313 GRLRHRNLVQLLGYC-RRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVAL 371
             ++H  LV L  +  +   +L  V DY+  G L  +L  +         RF     +A 
Sbjct: 94  KNVKHPFLVGLH-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRA-RF-YAAEIAS 150

Query: 372 GLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTH-VVGTLGY 430
            L YLH      +++RD+K  N+LLD + +  L DFGL +  ++     TT    GT  Y
Sbjct: 151 ALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNSTTSTFCGTPEY 205

Query: 431 LAPEHTRTGKATTSADVFSFGAFLLEVACGRRP 463
           LAPE         + D +  GA L E+  G  P
Sbjct: 206 LAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 69.9 bits (172), Expect = 3e-13
 Identities = 57/218 (26%), Positives = 93/218 (42%), Gaps = 36/218 (16%)

Query: 263 FREKELLGTGGFGRV----YRGT--------LPKSQIEIAVKKISH---ESRQGMKEFVA 307
           F   ++LG G FG+V    ++ T        L K  + +    +     E R      V 
Sbjct: 19  FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVV-LMDDDVECTMVEKR------VL 71

Query: 308 EIVSIGRLRHRNLVQLLGYC-RRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVI 366
            +       H  L  +     + K  L  V +Y+  G L  ++    K  L+   R    
Sbjct: 72  SLAW----EHPFLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLS---RATFY 123

Query: 367 KG-VALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVV 425
              + LGL +LH    + +++RD+K  N+LLD + + ++ DFG+ +  +   D +T    
Sbjct: 124 AAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKE-NMLGDAKTNTFC 179

Query: 426 GTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRP 463
           GT  Y+APE     K   S D +SFG  L E+  G+ P
Sbjct: 180 GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 70.0 bits (172), Expect = 4e-13
 Identities = 56/212 (26%), Positives = 87/212 (41%), Gaps = 34/212 (16%)

Query: 268 LLGTGGFGRV----YRGT--------LPKSQIEIAVKKISH---ESRQGMKEFVAEIVSI 312
           +LG G FG+V     +GT        L K  + I    +     E R      V  +   
Sbjct: 27  VLGKGSFGKVMLSERKGTDELYAVKILKKDVV-IQDDDVECTMVEKR------VLALPG- 78

Query: 313 GRLRHRNLVQLLGYC-RRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVAL 371
              +   L QL   C +    L  V +Y+  G L  ++    +        F     +A+
Sbjct: 79  ---KPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHA-VF-YAAEIAI 132

Query: 372 GLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYL 431
           GLF+L     + +I+RD+K  NV+LD E + ++ DFG+ +         T    GT  Y+
Sbjct: 133 GLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV-TTKTFCGTPDYI 188

Query: 432 APEHTRTGKATTSADVFSFGAFLLEVACGRRP 463
           APE         S D ++FG  L E+  G+ P
Sbjct: 189 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 69.2 bits (170), Expect = 6e-13
 Identities = 55/214 (25%), Positives = 88/214 (41%), Gaps = 38/214 (17%)

Query: 268 LLGTGGFGRVY----RGT--------LPKSQIEIAVKKISH---ESRQGMKEFVAEIVSI 312
           +LG G FG+V     + T        L K  I +    +     E R      +  +   
Sbjct: 30  VLGKGSFGKVMLARVKETGDLYAVKVLKKDVI-LQDDDVECTMTEKR------ILSLAR- 81

Query: 313 GRLRHRNLVQLLGYC-RRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKG-VA 370
               H  L QL   C +    L  V +++  G L  ++    +       R R     + 
Sbjct: 82  ---NHPFLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEA---RARFYAAEII 134

Query: 371 LGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTH-VVGTLG 429
             L +LH   ++ +I+RD+K  NVLLD E + +L DFG+ +  +   +  TT    GT  
Sbjct: 135 SALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGICNGVTTATFCGTPD 189

Query: 430 YLAPEHTRTGKATTSADVFSFGAFLLEVACGRRP 463
           Y+APE  +      + D ++ G  L E+ CG  P
Sbjct: 190 YIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 69.2 bits (170), Expect = 7e-13
 Identities = 62/222 (27%), Positives = 96/222 (43%), Gaps = 36/222 (16%)

Query: 268 LLGTGGFGRVY----RGT--------LPKSQIEIAVKKISH---ESRQGMKEFVAEIVSI 312
           ++G G + +V     + T        + K  +    + I     E        V E  S 
Sbjct: 16  VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELV-NDDEDIDWVQTEKH------VFEQAS- 67

Query: 313 GRLRHRNLVQLLGYC-RRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVAL 371
               H  LV L   C + +  L  V +Y+  G L  ++  Q K+      RF   + ++L
Sbjct: 68  ---NHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHA-RFYSAE-ISL 121

Query: 372 GLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTH-VVGTLGY 430
            L YLH   E+ +I+RD+K  NVLLD E + +L D+G+ +  +      TT    GT  Y
Sbjct: 122 ALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNY 176

Query: 431 LAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSEN 472
           +APE  R      S D ++ G  + E+  GR P    G S+N
Sbjct: 177 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN 218

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 68.9 bits (169), Expect = 1e-12
 Identities = 61/223 (27%), Positives = 94/223 (42%), Gaps = 38/223 (17%)

Query: 268 LLGTGGFGRVY----RGT--------LPKSQIEIAVKKISH---ESRQGMKEFVAEIVSI 312
           ++G G + +V     + T        + K  +    + I     E        V E  S 
Sbjct: 59  VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELV-NDDEDIDWVQTEKH------VFEQAS- 110

Query: 313 GRLRHRNLVQLLGYC-RRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKG-VA 370
               H  LV L   C + +  L  V +Y+  G L  ++  Q K+        R     ++
Sbjct: 111 ---NHPFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEE---HARFYSAEIS 163

Query: 371 LGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVV-GTLG 429
           L L YLH   E+ +I+RD+K  NVLLD E + +L D+G+ +  +      TT    GT  
Sbjct: 164 LALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPN 218

Query: 430 YLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSEN 472
           Y+APE  R      S D ++ G  + E+  GR P    G S+N
Sbjct: 219 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN 261

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 68.6 bits (168), Expect = 2e-12
 Identities = 45/221 (20%), Positives = 85/221 (38%), Gaps = 38/221 (17%)

Query: 235 FAEELEDWELDHGPHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKI 294
           + + +++  +        Y              L+G G +G VY      ++  +A+KK+
Sbjct: 15  YFQGIKNVHVPD-----NYIIK----------HLIGRGSYGYVYLAYDKNTEKNVAIKKV 59

Query: 295 SH--ESRQGMKEFVAEIVSIGRLRHRNLVQLL-----GYCRRKGELLLVYDYMPNGSLDK 347
           +   E     K  + EI  + RL+   +++L          +  EL +V +   +  L K
Sbjct: 60  NRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIADS-DLKK 118

Query: 348 YLYDQPKVTLNWIQRF-----RVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNG 402
                  +T   I+               G  ++H   E  +IHRD+K +N LL+ + + 
Sbjct: 119 LFKTPIFLTEEHIKTILYNLLL-------GENFIH---ESGIIHRDLKPANCLLNQDCSV 168

Query: 403 RLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATT 443
           ++ DFGLAR  +   D    + +       P +    K  T
Sbjct: 169 KVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLT 209

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 66.4 bits (161), Expect = 5e-12
 Identities = 36/216 (16%), Positives = 65/216 (30%), Gaps = 51/216 (23%)

Query: 246 HGPHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES------- 298
            GP  F +    + T+  +  E +G G FG V++     +   +A+K I+ E        
Sbjct: 8   KGPVPFSH---CLPTEKLQRCEKIGEGVFGEVFQTIADHTP--VAIKIIAIEGPDLVNGS 62

Query: 299 -RQGMKEFVAEIV---------SIGRLRHRNLVQLLGYCRRKG----ELLLVYDYM---- 340
            ++  +E + EI+              R    + L      +G     LL  +D+     
Sbjct: 63  HQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTK 122

Query: 341 --PNGSLDKYLYDQ-----------------PKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
              N   D +  DQ                      +      ++  +   L        
Sbjct: 123 GSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLR 182

Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT 417
               HRD+   NVLL      +L      +     +
Sbjct: 183 --FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPS 216

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 66.0 bits (160), Expect = 2e-11
 Identities = 80/599 (13%), Positives = 167/599 (27%), Gaps = 197/599 (32%)

Query: 68  GNETNHVFAVELDTIKSHGFLDINDNHVGIDINSLKSESSAPAGYYVEYDGLEKR---TN 124
             E    F  E+    ++ FL          ++ +K+E   P+     Y     R    N
Sbjct: 75  QEEMVQKFVEEVLR-INYKFL----------MSPIKTEQRQPSMMTRMYIEQRDRLYNDN 123

Query: 125 VTLAPINIPRPRSLNTMSLSRDLSSVLNDAMYV------GF--SSSTGSVLASHYIL-GW 175
              A  N+ R +      L + L   L  A  V      G   +     V  S+ +    
Sbjct: 124 QVFAKYNVSRLQPYLK--LRQALLE-LRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKM 180

Query: 176 SFKI------NGQAEELNLSQLPKL-PRVGPKKRSK-FLTIGLPVICVSVIFAAVSGVVY 227
            FKI      N  + E  L  L KL  ++ P   S+   +  + +   S+          
Sbjct: 181 DFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQ--------- 231

Query: 228 VIRMKRKFAEE--------LED-WELDH-----------------------GPHRFRYKD 255
              ++R    +        L +                                   +  
Sbjct: 232 -AELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHIS 290

Query: 256 LYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQG-----------MKE 304
           L   +      E+       +          ++   + +  E               +++
Sbjct: 291 LDHHSMTLTPDEVKSL--LLKY---------LDCRPQDLPREVLTTNPRRLSIIAESIRD 339

Query: 305 FVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQ----------PK 354
            +A   +    +H N  +L         +L   +Y       + ++D+          P 
Sbjct: 340 GLA---TWDNWKHVNCDKLTTIIESSLNVLEPAEY-------RKMFDRLSVFPPSAHIPT 389

Query: 355 VTLN--W-----------IQRFR----VIKGVALGLFYLHQEWEQVVIHRDVKASNVLLD 397
           + L+  W           + +      V K        +        I+ ++K   +  +
Sbjct: 390 ILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPS------IYLELKV-KLENE 442

Query: 398 GELNGRLGD-FGLARLYD--HGTDPQT-----THVVGTLGYLAPEHTRTGKATTSADVFS 449
             L+  + D + + + +D      P       +H    +G+    H +  +      +F 
Sbjct: 443 YALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSH----IGH----HLKNIEHPERMTLFR 494

Query: 450 -----FGAFLLEVACGRRPIQRQGPSENLI--LVDWVFDFWNRGELLEARDPNLGTEYVA 502
                F  FL       + I+    + N    +++ +         +   DP      V 
Sbjct: 495 MVFLDFR-FL------EQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKY-ERLVN 546

Query: 503 EELELVLKLG--LLCS-HSDPTARPSMRQVVQILERDVALPAISALRLSTSGITYLEGF 558
             L+ + K+   L+CS ++D         +++I           AL      I + E  
Sbjct: 547 AILDFLPKIEENLICSKYTD---------LLRI-----------ALMAEDEAI-FEEAH 584

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 57.6 bits (138), Expect = 8e-09
 Identities = 82/521 (15%), Positives = 147/521 (28%), Gaps = 173/521 (33%)

Query: 47  TRGLPGARPSQYLGLFNDTNLGNETNHVFAVELDTIKSHGFLDINDNHV-----G----- 96
            + L   RP++ + +      G       A  LD   S+      D  +           
Sbjct: 141 RQALLELRPAKNVLIDGVLGSGK---TWVA--LDVCLSYKVQCKMDFKIFWLNLKNCNSP 195

Query: 97  -------------IDINSLKSESSAPAGYYVEYDGLEKRTNVTLAPINIPRPRSL----- 138
                        ID N   S S   +   +    ++      L   + P    L     
Sbjct: 196 ETVLEMLQKLLYQIDPN-WTSRSDHSSNIKLRIHSIQAELRRLLK--SKPYENCLLVLLN 252

Query: 139 --------------NTMSLSRDLSSVLNDAMYVGFSSSTGSVLASHYILGWSFKINGQAE 184
                           +  +R    V +       +++T  +   H+ +  +     + +
Sbjct: 253 VQNAKAWNAFNLSCKILLTTRF-KQVTDFLS----AATTTHISLDHHSMTLT---PDEVK 304

Query: 185 ELNLSQ-----LPKLPRVGPKKRSKFLTIGLPVICVSVIFAAVSGVVYVIRMKRKFAEEL 239
            L L +        LPR              P   +S+I A            R      
Sbjct: 305 SL-LLKYLDCRPQDLPREVLT--------TNPRR-LSII-AE---------SIRDGLATW 344

Query: 240 EDWE-----------------LDHGPHRFRYKDLYIATKGFRE-----KELLGTGGFGRV 277
           ++W+                 L+   +R  +  L +    F         LL       +
Sbjct: 345 DNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSV----FPPSAHIPTILLS------L 394

Query: 278 YRGTLPKSQIEIAVKKISHES---RQGMKEFVAEIVSIG-RLR---------HRNLVQLL 324
               + KS + + V K+   S   +Q  KE    I SI   L+         HR++V   
Sbjct: 395 IWFDVIKSDVMVVVNKLHKYSLVEKQP-KESTISIPSIYLELKVKLENEYALHRSIVD-- 451

Query: 325 GYCRRKGELLLVYDYMPNGSLDKYLY----------DQP-KVTLNWIQRFRVIKGVALGL 373
            Y   K       D +    LD+Y Y          + P ++TL     FR++       
Sbjct: 452 HYNIPKT---FDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTL-----FRMV------- 496

Query: 374 FYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLY-DHGTD--PQTTHVVGTLGY 430
            +L   + +  I  D  A N    G +   L      + Y  +  D  P+   +V  +  
Sbjct: 497 -FLDFRFLEQKIRHDSTAWNA--SGSILNTLQQL---KFYKPYICDNDPKYERLVNAILD 550

Query: 431 LAPEHTRTGKATTSADVFSFG-----AFLLEVACGRRPIQR 466
             P+       +   D+           + E A   + +QR
Sbjct: 551 FLPKIEENLICSKYTDLLRIALMAEDEAIFEEA--HKQVQR 589

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 47.2 bits (111), Expect = 2e-05
 Identities = 71/438 (16%), Positives = 135/438 (30%), Gaps = 147/438 (33%)

Query: 241 DWELDHGPHRFRYKD-LYIATKGFRE----KELLGTGGFGRVYRGTLPKSQIEIAVKKIS 295
           D+E   G H+++YKD L +    F +    K++        + +  L K +I+  +    
Sbjct: 8   DFET--GEHQYQYKDILSVFEDAFVDNFDCKDVQ------DMPKSILSKEEIDHIIMSKD 59

Query: 296 HESR-------------QGMKEFVAEIVSIGRLRHRNLVQLLGY-CRRKGELLLVYDYMP 341
             S              + +++FV E++   R+ ++ L+  +    R+   +  +Y    
Sbjct: 60  AVSGTLRLFWTLLSKQEEMVQKFVEEVL---RINYKFLMSPIKTEQRQPSMMTRMYIE-- 114

Query: 342 NGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIH------RDVKASNVL 395
               D+   D        + R +    +   L  L    + V+I       +   A +V 
Sbjct: 115 --QRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPA-KNVLIDGVLGSGKTWVALDVC 171

Query: 396 LDGELNGRLGD------FG-----------LARLYDHGTDPQTTHVVGTLGYLAPEHTRT 438
           L  ++  ++                     L +L  +  DP  T           +H+  
Sbjct: 172 LSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLL-YQIDPNWTS--------RSDHSSN 222

Query: 439 GKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEA------- 491
            K        S  A L      RR ++ +     L+++    +  N  +   A       
Sbjct: 223 IKLRIH----SIQAEL------RRLLKSKPYENCLLVLL---NVQNA-KAWNAFNLSCKI 268

Query: 492 ----RDPNL--------GTEYVAEELELVL----KLGLL--CSHSDPTARPSMRQVVQIL 533
               R   +         T    +   + L       LL       P   P  R+V+   
Sbjct: 269 LLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLP--REVLTTN 326

Query: 534 ERDVALPAISAL-----------------RLST---SGITYLEG------FDDFAVSNPP 567
            R +++  I+                   +L+T   S +  LE       FD  +V    
Sbjct: 327 PRRLSI--IAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSV---- 380

Query: 568 SMGFTRPSSV--AESLLS 583
              F  P S      LLS
Sbjct: 381 ---F--PPSAHIPTILLS 393

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 63.9 bits (156), Expect = 2e-11
 Identities = 39/182 (21%), Positives = 73/182 (40%), Gaps = 33/182 (18%)

Query: 247 GPH---RFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMK 303
           GPH     + K   I        ++LG G  G+V +    ++Q + A+K +  +  +  +
Sbjct: 1   GPHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARR 59

Query: 304 EFVAEIVSIGR--LRHRNLVQLLGYC----RRKGELLLVYDYMPNGSLDKYLYDQPKVTL 357
           E     V +     +  ++V+++         +  LL+V + +  G     L+   ++  
Sbjct: 60  E-----VELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGE----LFS--RIQD 108

Query: 358 NWIQRF------RVIKGVALGLFYLHQEWEQVVIHRDVKASNVLL---DGELNGRLGDFG 408
              Q F       ++K +   + YLH      + HRDVK  N+L          +L DFG
Sbjct: 109 RGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFG 165

Query: 409 LA 410
            A
Sbjct: 166 FA 167

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 63.9 bits (156), Expect = 4e-11
 Identities = 64/264 (24%), Positives = 101/264 (38%), Gaps = 77/264 (29%)

Query: 241 DWELDHGPHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISH--ES 298
           D  +       +Y+ +          + LG G +G V++    ++   +AVKKI    ++
Sbjct: 4   DRHVLR-----KYELV----------KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQN 48

Query: 299 RQGMKEFVAEIVSIGRLR-HRNLVQLLGYCRRKG--ELLLVYDYMPNGSLDKYLYDQPKV 355
               +    EI+ +  L  H N+V LL   R     ++ LV+DYM          D    
Sbjct: 49  STDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYME--------TD---- 96

Query: 356 TLNWIQRFRVIKGVAL--------------GLFYLHQEWEQVVIHRDVKASNVLLDGELN 401
            L+      VI+   L               + YLH      ++HRD+K SN+LL+ E +
Sbjct: 97  -LH-----AVIRANILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECH 147

Query: 402 GRLGDFGLARLY--------------------DHGTDPQTTHVVGTLGYLAPEHTRTGKA 441
            ++ DFGL+R +                         P  T  V T  Y APE       
Sbjct: 148 VKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTK 207

Query: 442 -TTSADVFSFGAFLLEVACGRRPI 464
            T   D++S G  L E+    +PI
Sbjct: 208 YTKGIDMWSLGCILGEIL-CGKPI 230

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 59.3 bits (144), Expect = 1e-09
 Identities = 49/241 (20%), Positives = 93/241 (38%), Gaps = 40/241 (16%)

Query: 247 GPHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKI---SHESRQGMK 303
           G H     + Y   + +     LG G F  V+      +   +A+K +      +     
Sbjct: 6   GYHPAFKGEPYKDAR-YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAED 64

Query: 304 EF-------VAEIVSIGRLRHRNLVQLLGYCRRKGE----LLLVYDYMPNGSLDKYLYDQ 352
           E         A+      +   ++++LL +   KG     +++V++      L + L   
Sbjct: 65  EIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFE-----VLGENLLAL 119

Query: 353 PK------VTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLD------GEL 400
            K      + L ++++    K + LGL Y+H+     +IH D+K  NVL++        +
Sbjct: 120 IKKYEHRGIPLIYVKQI--SKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLI 175

Query: 401 NGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACG 460
             ++ D G A  YD       T+ + T  Y +PE          AD++S    + E+  G
Sbjct: 176 QIKIADLGNACWYDE----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITG 231

Query: 461 R 461
            
Sbjct: 232 D 232

>2ltn_B PEA lectin, beta chain; 1.70A {Pisum sativum} SCOP: b.29.1.1 PDB: 1hkd_B 1rin_B* 1ofs_B* 1bqp_B* 1loe_B 1loa_B* 1loc_B* 1lod_B* 1lob_B 1lof_B* 1log_B* 1lof_D* 1les_B* 2b7y_B* 1lgc_B* 1lgb_B* 1len_B 1lem_B 2lal_B Length = 52

 Score = 50.2 bits (120), Expect = 2e-08
 Identities = 15/38 (39%), Positives = 25/38 (65%)

Query: 140 TMSLSRDLSSVLNDAMYVGFSSSTGSVLASHYILGWSF 177
           T+S    L  V+ + + +GFS++TG+  A+H +L WSF
Sbjct: 5   TLSDVVSLKDVVPEWVRIGFSATTGAEYAAHEVLSWSF 42

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 51.7 bits (124), Expect = 4e-07
 Identities = 43/208 (20%), Positives = 87/208 (41%), Gaps = 27/208 (12%)

Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVKKI-SHES--RQGMKE--FVAEIVSIGRLRHRNLV 321
           +++G G FG+V +    K    +A+K + + +   RQ  +E   +  +    +    N++
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVI 162

Query: 322 QLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPK------VTLNWIQRFRVIKGVALGLFY 375
            +L     +  + + ++      L   LY+  K       +L  +++F     +   L  
Sbjct: 163 HMLENFTFRNHICMTFE-----LLSMNLYELIKKNKFQGFSLPLVRKF--AHSILQCLDA 215

Query: 376 LHQEWEQVVIHRDVKASNVLLDGELNG--RLGDFGLARLYDHGTDPQTTHVVGTLGYLAP 433
           LH+     +IH D+K  N+LL  +     ++ DFG +    +      T++  +  Y AP
Sbjct: 216 LHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSC---YEHQRVYTYIQ-SRFYRAP 268

Query: 434 EHTRTGKATTSADVFSFGAFLLEVACGR 461
           E     +     D++S G  L E+  G 
Sbjct: 269 EVILGARYGMPIDMWSLGCILAELLTGY 296

>1gv9_A P58/ergic-53; lectin, carbohydrate binding; 1.46A {Rattus norvegicus} SCOP: b.29.1.13 PDB: 1r1z_A 3a4u_A 3lcp_A Length = 260

 Score = 50.6 bits (120), Expect = 5e-07
 Identities = 22/174 (12%), Positives = 52/174 (29%), Gaps = 27/174 (15%)

Query: 19  SFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGLFNDTNLGNETNHVFAVE 78
           ++     F + +        G+A      +GL G        +F   ++ N       + 
Sbjct: 87  NWEVEVTFRV-TGRGRIGADGLAIWYTENQGLDG-------PVFGSADMWN----GVGIF 134

Query: 79  LDTIKSHGFLDINDNHVGIDINSLKSE------SSAPAGYYVEYDGLEKRTNVTLA---- 128
            D+  + G  +     V  +   +  +      + A A    ++          +     
Sbjct: 135 FDSFDNDGKKNNPAIVVVGNNGQINYDHQNDGATQALASCQRDFRNKPYPVRAKITYYQK 194

Query: 129 ----PINIPRPRSLNTMSLSRDLSSV-LNDAMYVGFSSSTGSVLASHYILGWSF 177
                IN       N       + ++ +    + G S++TG +   H +L +  
Sbjct: 195 TLTVMINNGFTPDKNDYEFCAKVENMVIPTQGHFGISAATGGLADDHDVLSFLT 248

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 50.9 bits (122), Expect = 5e-07
 Identities = 49/206 (23%), Positives = 71/206 (34%), Gaps = 53/206 (25%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQ-----IEIAVKKISHESRQGMKEF-----VAEIVSI 312
           ++    +G GGFG +Y   +  S+         VK    ++     E       A+   I
Sbjct: 37  WKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQI 96

Query: 313 GRLRHRNLVQLLG-----YCRRKGELLLVYDYM------PNGSLDKYLYDQPKVTLNWIQ 361
            +      ++ LG           +    Y +M          L K      K       
Sbjct: 97  QKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS--DLQKIYEANAK------- 147

Query: 362 RFRVIKGVA-LG------LFYLHQEWEQVVIHRDVKASNVLLDGELNGR---LGDFGLAR 411
           RF   K V  L       L Y+H   E   +H D+KASN+LL    N     L D+GLA 
Sbjct: 148 RFS-RKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLL-NYKNPDQVYLVDYGLAY 202

Query: 412 LY-DHGT------DPQTTHVVGTLGY 430
            Y   G       DP+  H  GT+ +
Sbjct: 203 RYCPEGVHKAYAADPKRCH-DGTIEF 227

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 49.9 bits (119), Expect = 1e-06
 Identities = 45/278 (16%), Positives = 77/278 (27%), Gaps = 89/278 (32%)

Query: 335 LVYDYMPNG-SLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASN 393
           +V++ +  G  L K++       L      ++I+ V  GL YLH +    +IH D+K  N
Sbjct: 122 MVFEVL--GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPEN 177

Query: 394 VLL-------------------------------------------------DGELNGRL 404
           +LL                                                   +L  ++
Sbjct: 178 ILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKI 237

Query: 405 GDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPI 464
            D G A           T  + T  Y + E        T AD++S      E+A G    
Sbjct: 238 ADLGNACWVHK----HFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLF 293

Query: 465 QRQGPSENLILVD---------------------WVFDFWNR-GELLEARDPNLGT---- 498
           +     E     D                     +  +F+ + G+L              
Sbjct: 294 EPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEV 353

Query: 499 -----EYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ 531
                E+  EE        L      P  R +  + ++
Sbjct: 354 LVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 49.7 bits (119), Expect = 1e-06
 Identities = 36/204 (17%), Positives = 66/204 (32%), Gaps = 49/204 (24%)

Query: 263 FREKELLGTGGFGRVYRGT--------LPKSQIEIAVK------KISHES----RQGMKE 304
           ++ K        G +Y               + + ++K      ++ +E     R     
Sbjct: 44  WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPL 103

Query: 305 FVAEIVSIGRLRHRNLVQLLGYCRRKGEL-LLVYDYMPNG-SLDKYLYDQPKVTLNWIQR 362
            V +   +       +   +G+   + +   LV   +  G SL   L   PK  L+    
Sbjct: 104 QVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPKHVLS---- 157

Query: 363 FRVIKGVAL-------GLFYLHQEWEQVVIHRDVKASNVLLDGELNGR--LGDFGLARLY 413
               + V          L +LH   E   +H +V A N+ +D E   +  L  +G A  Y
Sbjct: 158 ---ERSVLQVACRLLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRY 211

Query: 414 -DHGT------DPQTTHVVGTLGY 430
              G         ++ H  G L +
Sbjct: 212 CPSGKHVAYVEGSRSPH-EGDLEF 234

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 49.7 bits (119), Expect = 1e-06
 Identities = 50/224 (22%), Positives = 88/224 (39%), Gaps = 31/224 (13%)

Query: 257 YIATKG------FREKELLGTGGFGRVYRGTLPKSQIEIAVKKI-SHES--RQGMKE--F 305
           YI   G      +    L+G G FG+V +      Q  +A+K I + ++   Q   E   
Sbjct: 44  YIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRL 103

Query: 306 VAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPK------VTLNW 359
           +  +          +V L  +   +  L LV++      L   LYD  +      V+LN 
Sbjct: 104 LELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFE-----MLSYNLYDLLRNTNFRGVSLNL 158

Query: 360 IQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNG--RLGDFGLARLYDHGT 417
            ++F   + +   L +L    E  +IH D+K  N+LL        ++ DFG +       
Sbjct: 159 TRKF--AQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC---QLG 212

Query: 418 DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGR 461
                ++  +  Y +PE         + D++S G  L+E+  G 
Sbjct: 213 QRIYQYIQ-SRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 47.0 bits (112), Expect = 9e-06
 Identities = 41/201 (20%), Positives = 74/201 (36%), Gaps = 46/201 (22%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFV--------AEIVSIGR 314
           +   + +G+GGFG +Y         + A   +  E ++    F         A+   I +
Sbjct: 39  WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKK 98

Query: 315 LRHRNLVQLLG--YCRRKGELL--------LVYDYMPNG-SLDKYLYDQPKVTLNW---- 359
              R  +  LG       G           +V + +  G  L K          +     
Sbjct: 99  WIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQKISGQNGTFKKSTVLQL 156

Query: 360 -IQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGR--LGDFGLARLY-DH 415
            I+   V++       Y+H   E   +H D+KA+N+LL  +   +  L D+GL+  Y  +
Sbjct: 157 GIRMLDVLE-------YIH---ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPN 206

Query: 416 GT------DPQTTHVVGTLGY 430
           G       +P+  H  GT+ +
Sbjct: 207 GNHKQYQENPRKGH-NGTIEF 226

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 45.8 bits (109), Expect = 2e-05
 Identities = 39/199 (19%), Positives = 64/199 (32%), Gaps = 67/199 (33%)

Query: 254 KDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVK--KISHESRQGMKE-----FV 306
             L +    FR  + +G G FG +  G    +   +A+K   +   + Q   E      +
Sbjct: 3   GVLMVGPN-FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQL 61

Query: 307 AEIVSIGRLRH----------------RNLVQLLGYCRRKGEL---LLVYDYMPNGSLDK 347
                I ++ +                 +L  L   C R   L   L++   +       
Sbjct: 62  GSGDGIPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQL------- 114

Query: 348 YLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGR---- 403
                       I R            Y+H    + +I+RDVK  N L+    N      
Sbjct: 115 ------------ISRME----------YVH---SKNLIYRDVKPENFLIGRPGNKTQQVI 149

Query: 404 -LGDFGLARLYDHGTDPQT 421
            + DF LA+ Y    DP+T
Sbjct: 150 HIIDFALAKEY---IDPET 165

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 44.3 bits (105), Expect = 6e-05
 Identities = 39/182 (21%), Positives = 73/182 (40%), Gaps = 30/182 (16%)

Query: 255 DLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGR 314
           +L +  + +R    +G+G FG +Y GT   +  E+A+K    +++        E      
Sbjct: 4   ELRVGNR-YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHI--ESKIYKM 60

Query: 315 LRH-RNLVQLLGYCRRKGELLLVYDYMPNG-SLDKYLYDQPKVTLNWIQRFRVIKGVALG 372
           ++    +  +          ++V + +  G SL+       +       +F +   + L 
Sbjct: 61  MQGGVGIPTIRWCGAEGDYNVMVMELL--GPSLEDLFNFCSR-------KFSLKTVLLLA 111

Query: 373 ------LFYLHQEWEQVVIHRDVKASNVLLDGELNG---RLGDFGLARLYDHGTDPQT-T 422
                 + Y+H    +  IHRDVK  N L+     G    + DFGLA+ Y    D +T  
Sbjct: 112 DQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY---RDARTHQ 165

Query: 423 HV 424
           H+
Sbjct: 166 HI 167

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 43.9 bits (104), Expect = 8e-05
 Identities = 37/195 (18%), Positives = 68/195 (34%), Gaps = 69/195 (35%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVK--KISHESRQGMKE-----FVAEIVSIGRL 315
           ++    +G G FG ++ GT   +  ++A+K      ++ Q   E      +A    I  +
Sbjct: 12  YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNV 71

Query: 316 RH----------------RNLVQLLGYCRRKGEL---LLVYDYMPNGSLDKYLYDQPKVT 356
            +                 +L  LL  C RK  +    +    M                
Sbjct: 72  YYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQM---------------- 115

Query: 357 LNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGR------LGDFGLA 410
              + R +           +H   E+ +++RD+K  N L+ G  N +      + DFG+ 
Sbjct: 116 ---LARVQ----------SIH---EKSLVYRDIKPDNFLI-GRPNSKNANMIYVVDFGMV 158

Query: 411 RLYDHGTDPQT-THV 424
           + Y    DP T  H+
Sbjct: 159 KFY---RDPVTKQHI 170

>2dur_A VIP36;, vesicular integral-membrane protein VIP36; beta sandwich, carbohydrate binding protein, cargo receptor, transport; HET: MAN; 1.65A {Canis lupus familiaris} PDB: 2dup_A 2duq_A* 2duo_A* 2e6v_A* Length = 253

 Score = 42.6 bits (99), Expect = 2e-04
 Identities = 25/174 (14%), Positives = 52/174 (29%), Gaps = 26/174 (14%)

Query: 19  SFSTTFVFSI-LSEYQSQSGHGIAFVIASTRGLPGARPSQYLGLFNDTNLGNETNHVFAV 77
            +     F +  +  ++  G GIA      R +PG         F+            A+
Sbjct: 63  DWEMHVHFKVHGTGKKNLHGDGIALWYTRDRLVPGPVFGS-KDNFHG----------LAI 111

Query: 78  ELDTIKSHGFLDINDNHVGIDINSLKSE--------SSAPAGYYVEYDGLEKRTNVTLA- 128
            LDT  +    +    ++ + +N+             +  AG   ++   +  T + +  
Sbjct: 112 FLDTYPNDETTERVFPYISVMVNNGSLSYDHSKDGRWTELAGCTADFRNRDHDTFLAVRY 171

Query: 129 -----PINIPRPRSLNTMSLSRDLSSVLNDAMYVGFSSSTGSVLASHYILGWSF 177
                 +           +        L    Y G S+ TG +  +H I+    
Sbjct: 172 SRGRLTVMTDLEDKNEWKNCIDITGVRLPTGYYFGASAGTGDLSDNHDIISMKL 225

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 42.7 bits (100), Expect = 3e-04
 Identities = 37/170 (21%), Positives = 68/170 (40%), Gaps = 28/170 (16%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLV- 321
           FR    +G+G FG +Y GT  ++  E+A+K  + +++     +  E      L+    + 
Sbjct: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLY--ESKIYRILQGGTGIP 66

Query: 322 QLLGYCRRKGELLLVYDYMPNG-SLDKYLYDQPK------VTLNWIQRFRVIKGVALGLF 374
            +  +       +LV D +  G SL+       +      V +   Q    ++       
Sbjct: 67  NVRWFGVEGDYNVLVMDLL--GPSLEDLFNFCSRKLSLKTVLMLADQMINRVE------- 117

Query: 375 YLHQEWEQVVIHRDVKASNVLLDGELNGR---LGDFGLARLYDHGTDPQT 421
           ++H    +  +HRD+K  N L+          + DFGLA+ Y    D  T
Sbjct: 118 FVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY---RDTST 161

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	586
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3ipv_A	251	Lectin alpha chain; galactose binding, SEED lectin	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3zyr_A	261	Lectin; sugar binding protein, N-glycan; HET: NAG	100.0
3ujo_A	281	Legume lectin; carbohydrate-binding, galactose, ad	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
1hql_A	257	Lectin; xenograft antigen, sugar BI protein; HET:	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
1dbn_A	239	MAL, protein (leukoagglutinin); plant lectin, carb	100.0
1fny_A	237	BARK lectin, BARK agglutinin I,polypeptide A; legu	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
1fx5_A	242	UEA-I, UE-I, anti-H(O) lectin I; legume lectin, HO	100.0
1v6i_A	232	Agglutinin, PNA, galactose-binding lectin; open qu	100.0
1gzc_A	239	Erythrina crista-galli lectin; carbohydrate, sugar	100.0
2eig_A	234	Lectin; L-fucosyl, N-acetyl-D-glucosamine, SUG bin	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
1qnw_A	242	Chitin binding lectin, UEA-II; carbohydrate bindin	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2bqp_A	234	Protein (PEA lectin); D-glucopyranose complex, sug	100.0
1gsl_A	243	Griffonia simplicifolia lectin 4; glycoprotein, ma	100.0
2fmd_A	240	Lectin, agglutinin, BMA; legume lectin, beta sandw	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
1sbf_A	253	Soybean agglutinin; lectin; HET: NAG GAL; 2.43A {G	100.0
1g7y_A	253	Stem/LEAF lectin DB58; jelly roll fold, sugar bind	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
1fat_A	252	Phytohemagglutinin-L; glycoprotein, plant defense	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
1wbf_A	242	Protein (agglutinin); lectin (agglutinin), legume	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
1f9k_A	238	Acidic lectin; legume lectin, glycosylated protein	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
1n47_A	233	Isolectin B4; cancer antigen, vicia villosa lectin	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
1avb_A	226	Arcelin-1; lectin-like glycoprotein, plant defense	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
1ioa_A	240	Arcelin-5A, ARC5A; lectin-like proteins, plant def	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
1dhk_B	223	Bean lectin-like inhibitor, porcine pancreatic alp	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
2ltn_A	181	PEA lectin, alpha chain; 1.70A {Pisum sativum} SCO	100.0
1qmo_E	133	Mannose binding lectin, FRIL; crosslink, hematopoi	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.96
1nls_A	237	Concanavalin A; lectin, agglutinin; 0.94A {Canaval	99.96
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.93
2dur_A	253	VIP36;, vesicular integral-membrane protein VIP36;	99.92
1gv9_A	260	P58/ergic-53; lectin, carbohydrate binding; 1.46A	99.91
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.89
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.81
2a6y_A	256	EMP47P (FORM1); beta sandwich, carbohydrate bindin	99.7
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.66
1qmo_A	113	Mannose binding lectin, FRIL; crosslink, hematopoi	99.64
2ltn_B	52	PEA lectin, beta chain; 1.70A {Pisum sativum} SCOP	99.49
1nls_A	237	Concanavalin A; lectin, agglutinin; 0.94A {Canaval	99.43
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.32
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.2
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.04
2a6z_A	222	EMP47P (FORM2); beta sandwich, carbohydrate bindin	98.97
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.9
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.63
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.59
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.55
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.49
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.32
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.26
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.12
2a6v_A	226	EMP46P; beta sandwich, carbohydrate binding protei	98.05
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.91
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.78
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.75
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.63
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.44
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.36
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.31
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.24
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.21
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.1
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.97
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	96.83
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.72
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.38
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.3
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.73
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	94.12
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	88.49
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	86.71
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	84.69
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	82.97
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	81.0

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=4.5e-56  Score=458.82  Aligned_cols=262  Identities=27%  Similarity=0.427  Sum_probs=210.1

Q ss_pred             cCCcccceeEeecCceEEEEEEeC-----CCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEE
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLP-----KSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELL  334 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~  334 (586)
                      .++|...++||+|+||+||+|++.     .++..||||+++..+.+..++|.+|+++|++++|||||+++|+|.+.+.++
T Consensus        40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~  119 (329)
T 4aoj_A           40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL  119 (329)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            356777899999999999999875     357889999998777777789999999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhhcCC-------------CccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCC
Q 007869          335 LVYDYMPNGSLDKYLYDQP-------------KVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELN  401 (586)
Q Consensus       335 lV~E~~~~gsL~~~l~~~~-------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~  401 (586)
                      ||||||++|+|.++|+...             ..+++|.+++.|+.|||+||.|||+   ++||||||||+||||+++++
T Consensus       120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLKp~NILl~~~~~  196 (329)
T 4aoj_A          120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGLV  196 (329)
T ss_dssp             EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTE
T ss_pred             EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHhhEEECCCCc
Confidence            9999999999999997642             2469999999999999999999998   89999999999999999999


Q ss_pred             eEEccccceeeccCCCC-CceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHH
Q 007869          402 GRLGDFGLARLYDHGTD-PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWV  479 (586)
Q Consensus       402 ~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v  479 (586)
                      +||+|||+|+....... ...+...||+.|||||++.+..++.++|||||||+||||+| |+.||......+   +.+.+
T Consensus       197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~---~~~~i  273 (329)
T 4aoj_A          197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE---AIDCI  273 (329)
T ss_dssp             EEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH---HHHHH
T ss_pred             EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH---HHHHH
Confidence            99999999997654322 23345679999999999999999999999999999999999 899998654322   22222


Q ss_pred             HhhhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhccCCC
Q 007869          480 FDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERDVALP  540 (586)
Q Consensus       480 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~p  540 (586)
                          .++..     +..    +......+.+|+.+||+.||++||||.||++.|+.....|
T Consensus       274 ----~~g~~-----~~~----p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~p  321 (329)
T 4aoj_A          274 ----TQGRE-----LER----PRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQAP  321 (329)
T ss_dssp             ----HHTCC-----CCC----CTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHSC
T ss_pred             ----HcCCC-----CCC----cccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhCC
Confidence                22221     111    1122356788999999999999999999999998765433

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=2.9e-56  Score=454.14  Aligned_cols=258  Identities=27%  Similarity=0.468  Sum_probs=213.6

Q ss_pred             cCCcccceeEeecCceEEEEEEeC-----CCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEE
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLP-----KSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELL  334 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~  334 (586)
                      .++|...+.||+|+||+||+|++.     .++..||||+++..+.+..++|.+|+++|++++|||||+++|+|.+.+.++
T Consensus        12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~   91 (299)
T 4asz_A           12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   91 (299)
T ss_dssp             GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence            356788899999999999999875     357789999998777777789999999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhhcCC-----------CccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeE
Q 007869          335 LVYDYMPNGSLDKYLYDQP-----------KVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGR  403 (586)
Q Consensus       335 lV~E~~~~gsL~~~l~~~~-----------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~k  403 (586)
                      ||||||++|+|.++|+...           ...++|.+++.|+.|||+||.|||+   ++||||||||+||||++++++|
T Consensus        92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDlKp~NILl~~~~~~K  168 (299)
T 4asz_A           92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVK  168 (299)
T ss_dssp             EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEE
T ss_pred             EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccCHhhEEECCCCcEE
Confidence            9999999999999997642           3579999999999999999999998   8999999999999999999999


Q ss_pred             EccccceeeccCCCCC-ceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHh
Q 007869          404 LGDFGLARLYDHGTDP-QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFD  481 (586)
Q Consensus       404 L~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~  481 (586)
                      |+|||+|+........ ......||+.|||||++.++.++.++|||||||+||||+| |+.||......+   +...   
T Consensus       169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~---~~~~---  242 (299)
T 4asz_A          169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---VIEC---  242 (299)
T ss_dssp             ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH---HHHH---
T ss_pred             ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH---
Confidence            9999999876443222 2233579999999999999999999999999999999998 899998654322   2222   


Q ss_pred             hhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 007869          482 FWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERD  536 (586)
Q Consensus       482 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  536 (586)
                       ..++....     .    +......+.+|+.+||+.||++||||+||++.|+..
T Consensus       243 -i~~~~~~~-----~----p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~  287 (299)
T 4asz_A          243 -ITQGRVLQ-----R----PRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNL  287 (299)
T ss_dssp             -HHHTCCCC-----C----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -HHcCCCCC-----C----CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence             22222211     1    112335678899999999999999999999999864

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=2.8e-55  Score=447.44  Aligned_cols=266  Identities=27%  Similarity=0.455  Sum_probs=208.1

Q ss_pred             hhhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc--cchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEE
Q 007869          257 YIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELL  334 (586)
Q Consensus       257 ~~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~  334 (586)
                      ++..+++...+.||+|+||+||+|++.+   .||||+++..  +.+..++|.+|++++++++|||||+++|+|.+ +.++
T Consensus        32 ei~~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~  107 (307)
T 3omv_A           32 EIEASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLA  107 (307)
T ss_dssp             BCCTTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCE
T ss_pred             EEcHHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEE
Confidence            4455678889999999999999999854   4999998643  34556789999999999999999999999865 5689


Q ss_pred             EEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeecc
Q 007869          335 LVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYD  414 (586)
Q Consensus       335 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~  414 (586)
                      ||||||++|+|.++|+... ..++|.+++.|+.|||+||.|||+   ++||||||||+||||++++++||+|||+|+...
T Consensus       108 iVmEy~~gGsL~~~l~~~~-~~l~~~~~~~i~~qia~gL~yLH~---~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~  183 (307)
T 3omv_A          108 IVTQWCEGSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKS  183 (307)
T ss_dssp             EEEECCSSCBHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCSSSEEEETTEEEEECCCSSCBC--
T ss_pred             EEEEcCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCccCCccCHHHEEECCCCcEEEeeccCceecc
Confidence            9999999999999997653 469999999999999999999998   899999999999999999999999999998765


Q ss_pred             CCC-CCceeeeccCCCccCcccccC---CCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCcccc
Q 007869          415 HGT-DPQTTHVVGTLGYLAPEHTRT---GKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLE  490 (586)
Q Consensus       415 ~~~-~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~  490 (586)
                      ... .......+||+.|||||++.+   +.++.++|||||||+||||+||+.||........  +.    ....++.   
T Consensus       184 ~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~--~~----~~~~~~~---  254 (307)
T 3omv_A          184 RWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQ--II----FMVGRGY---  254 (307)
T ss_dssp             ----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH--HH----HHHHTTC---
T ss_pred             cCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHH--HH----HHHhcCC---
Confidence            432 223445689999999999864   4689999999999999999999999986543221  11    1111111   


Q ss_pred             ccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc-cCCCc
Q 007869          491 ARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERD-VALPA  541 (586)
Q Consensus       491 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~-~~~p~  541 (586)
                       ..|.+. .........+.+|+.+||+.||++||||.||++.|+.. .++|.
T Consensus       255 -~~p~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~lpk  304 (307)
T 3omv_A          255 -ASPDLS-KLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSLPK  304 (307)
T ss_dssp             -CCCCST-TSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTCCC
T ss_pred             -CCCCcc-cccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccCCC
Confidence             112111 11223345678899999999999999999999888643 24444

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.5e-55  Score=450.74  Aligned_cols=257  Identities=26%  Similarity=0.426  Sum_probs=211.2

Q ss_pred             CCcccceeEeecCceEEEEEEeC-----CCCeEEEEEEecccc-chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEE
Q 007869          261 KGFREKELLGTGGFGRVYRGTLP-----KSQIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELL  334 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~  334 (586)
                      .+++..+.||+|+||+||+|++.     .+++.||||+++... ....++|.+|+.++++++|||||+++|+|.+.+.++
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~  105 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS  105 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence            34566788999999999999974     356789999997543 344578999999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhhcCC--------------CccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCC
Q 007869          335 LVYDYMPNGSLDKYLYDQP--------------KVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGEL  400 (586)
Q Consensus       335 lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~  400 (586)
                      ||||||++|+|.++|....              ...++|.++++|+.|||+||.|||+   ++||||||||+||||++++
T Consensus       106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLK~~NILl~~~~  182 (308)
T 4gt4_A          106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATRNVLVYDKL  182 (308)
T ss_dssp             EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGG
T ss_pred             EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCccccceEECCCC
Confidence            9999999999999996532              2468999999999999999999998   8999999999999999999


Q ss_pred             CeEEccccceeeccCCCC-CceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHH
Q 007869          401 NGRLGDFGLARLYDHGTD-PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDW  478 (586)
Q Consensus       401 ~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~  478 (586)
                      ++||+|||+|+....... ...+...||+.|||||++.++.++.++|||||||+||||+| |+.||.+....+   +.+.
T Consensus       183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~---~~~~  259 (308)
T 4gt4_A          183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD---VVEM  259 (308)
T ss_dssp             CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH---HHHH
T ss_pred             CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH---HHHH
Confidence            999999999997644322 23345689999999999999999999999999999999998 899998654321   2222


Q ss_pred             HHhhhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 007869          479 VFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERD  536 (586)
Q Consensus       479 v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  536 (586)
                      +    .++....         .+......+.+|+.+||+.||++||||.||++.|+.-
T Consensus       260 i----~~~~~~~---------~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          260 I----RNRQVLP---------CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             H----HTTCCCC---------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             H----HcCCCCC---------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            2    2222211         1122345678899999999999999999999999753

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.4e-53  Score=440.54  Aligned_cols=250  Identities=24%  Similarity=0.310  Sum_probs=212.3

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEecC
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYM  340 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  340 (586)
                      +.|+..+.||+|+||+||+|+++.+++.||||++........+.+.+|+++|++++|||||++++++.+++.+|||||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            46888999999999999999999999999999998766666677899999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCCc
Q 007869          341 PNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ  420 (586)
Q Consensus       341 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~  420 (586)
                      ++|+|.+++.+.   .+++.++..++.||+.||.|||+   ++||||||||+||||+.++++||+|||+|+.+..... .
T Consensus       154 ~gg~L~~~l~~~---~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~-~  226 (346)
T 4fih_A          154 EGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-R  226 (346)
T ss_dssp             TTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-C
T ss_pred             CCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEECCCCCEEEecCcCceecCCCCC-c
Confidence            999999999764   58999999999999999999998   9999999999999999999999999999998754332 3


Q ss_pred             eeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCccc
Q 007869          421 TTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEY  500 (586)
Q Consensus       421 ~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~  500 (586)
                      .+..+||+.|||||++.+..|+.++|||||||++|||++|+.||......+   +...+.    +     ...+.+.  .
T Consensus       227 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~---~~~~i~----~-----~~~~~~~--~  292 (346)
T 4fih_A          227 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK---AMKMIR----D-----NLPPRLK--N  292 (346)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHHHH----H-----SSCCCCS--C
T ss_pred             ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH---HHHHHH----c-----CCCCCCC--c
Confidence            455789999999999999999999999999999999999999998654322   111111    1     1112221  1


Q ss_pred             cHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          501 VAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       501 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      .......+.+++.+||+.||++|||+.|+++
T Consensus       293 ~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          293 LHKVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            1122355778889999999999999999986

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=7.1e-54  Score=443.40  Aligned_cols=251  Identities=24%  Similarity=0.393  Sum_probs=206.6

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc--cchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEe
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYD  338 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E  338 (586)
                      ++|+..+.||+|+||+||+|+++.+++.||||++...  .....+.|.+|+++|++++|||||++++++.+++.+|||||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            6899999999999999999999999999999999754  33446789999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCC
Q 007869          339 YMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD  418 (586)
Q Consensus       339 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~  418 (586)
                      ||++|+|.++|.......+++.+.+.|+.||+.||.|||+   ++||||||||+||||+.++++||+|||+|+.+.... 
T Consensus       104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-  179 (350)
T 4b9d_A          104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV-  179 (350)
T ss_dssp             CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH-
T ss_pred             CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCCEEEcccccceeecCCc-
Confidence            9999999999987766678899999999999999999998   999999999999999999999999999998764321 


Q ss_pred             CceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCc
Q 007869          419 PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGT  498 (586)
Q Consensus       419 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~  498 (586)
                      ...+..+||+.|||||++.+..|+.++|||||||+||||+||+.||...+..+   +   .... .++..     +.+..
T Consensus       180 ~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~---~---~~~i-~~~~~-----~~~~~  247 (350)
T 4b9d_A          180 ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN---L---VLKI-ISGSF-----PPVSL  247 (350)
T ss_dssp             HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---H---HHHH-HHTCC-----CCCCT
T ss_pred             ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH---H---HHHH-HcCCC-----CCCCc
Confidence            12345689999999999999999999999999999999999999998654321   1   1111 11111     12222


Q ss_pred             cccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          499 EYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       499 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      .+    ...+.+|+.+||+.||++|||+.|+++
T Consensus       248 ~~----s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          248 HY----SYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             TS----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             cC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            22    245778889999999999999999986

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=5.1e-53  Score=435.00  Aligned_cols=253  Identities=23%  Similarity=0.246  Sum_probs=207.6

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEec
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY  339 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  339 (586)
                      .+.|...++||+|+||+||+|+++.+++.||||+++.+..     ..+|+.++++++|||||++++++.+++.++|||||
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  131 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL  131 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            4568888999999999999999999999999999976432     24799999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCC-CeEEccccceeeccCCCC
Q 007869          340 MPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGEL-NGRLGDFGLARLYDHGTD  418 (586)
Q Consensus       340 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~-~~kL~DFGla~~~~~~~~  418 (586)
                      |++|+|.++|...  ..+++.++..++.||+.||.|||+   ++||||||||+||||+.++ ++||+|||+|+.+.....
T Consensus       132 ~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~  206 (336)
T 4g3f_A          132 LEGGSLGQLIKQM--GCLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL  206 (336)
T ss_dssp             CTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred             cCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence            9999999999765  368999999999999999999998   9999999999999999987 699999999998754322


Q ss_pred             C----ceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCC
Q 007869          419 P----QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDP  494 (586)
Q Consensus       419 ~----~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~  494 (586)
                      .    .....+||+.|||||++.+..|+.++|||||||++|||+||+.||......+....   +.   ....-.     
T Consensus       207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~---i~---~~~~~~-----  275 (336)
T 4g3f_A          207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLK---IA---SEPPPI-----  275 (336)
T ss_dssp             -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHH---HH---HSCCGG-----
T ss_pred             ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHH---HH---cCCCCc-----
Confidence            1    12335799999999999999999999999999999999999999987654432211   11   111000     


Q ss_pred             CCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 007869          495 NLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERD  536 (586)
Q Consensus       495 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  536 (586)
                         .+........+.+++.+||+.||.+|||+.|+++.|...
T Consensus       276 ---~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~  314 (336)
T 4g3f_A          276 ---REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKA  314 (336)
T ss_dssp             ---GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence               011222335677888999999999999999999988654

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=6.7e-53  Score=431.31  Aligned_cols=266  Identities=27%  Similarity=0.349  Sum_probs=205.0

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccC----eEEEE
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKG----ELLLV  336 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~----~~~lV  336 (586)
                      ++|...+.||+|+||+||+|++  +++.||||+++..... ...+..|+..+.+++|||||+++++|.+.+    .++||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV   79 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence            4577889999999999999998  4678999999654322 233456777788899999999999998764    68999


Q ss_pred             EecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhccc-----CCcEEeCCCCCCCeeecCCCCeEEcccccee
Q 007869          337 YDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEW-----EQVVIHRDVKASNVLLDGELNGRLGDFGLAR  411 (586)
Q Consensus       337 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-----~~~ivHrDIkp~NIll~~~~~~kL~DFGla~  411 (586)
                      ||||++|+|.++|+..   .++|..+++++.|+++||.|||+.+     .++||||||||+||||++++++||+|||+|+
T Consensus        80 ~Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~  156 (303)
T 3hmm_A           80 SDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             EECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             ecCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence            9999999999999765   5899999999999999999999731     3489999999999999999999999999999


Q ss_pred             eccCCCCC---ceeeeccCCCccCcccccCC------CCCCcceEEehhHHHHHHHhCCCCCCCCCCCccc----h----
Q 007869          412 LYDHGTDP---QTTHVVGTLGYLAPEHTRTG------KATTSADVFSFGAFLLEVACGRRPIQRQGPSENL----I----  474 (586)
Q Consensus       412 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~----~----  474 (586)
                      ........   .....+||+.|||||++.+.      .++.++|||||||+||||+||+.|+......+..    .    
T Consensus       157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~  236 (303)
T 3hmm_A          157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP  236 (303)
T ss_dssp             EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence            87654322   22346899999999998754      4678999999999999999998887543321110    0    


Q ss_pred             hhHHHHhhhccCccccccCCCCCccc-cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 007869          475 LVDWVFDFWNRGELLEARDPNLGTEY-VAEELELVLKLGLLCSHSDPTARPSMRQVVQILERD  536 (586)
Q Consensus       475 l~~~v~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  536 (586)
                      ..+.+....    .....+|.+.... ..+..+.+.+|+.+||+.||++||||.||++.|++.
T Consensus       237 ~~~~~~~~~----~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l  295 (303)
T 3hmm_A          237 SVEEMRKVV----CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL  295 (303)
T ss_dssp             CHHHHHHHH----TTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred             hHHHHHHHH----hcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence            011111111    1122344443322 345677889999999999999999999999999753

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.8e-52  Score=423.56  Aligned_cols=246  Identities=25%  Similarity=0.419  Sum_probs=199.8

Q ss_pred             cccceeEeecCceEEEEEEeCCCCeEEEEEEeccc--cchhHHHHHHHHHHhcccCCCceeeeeeeeec----cCeEEEE
Q 007869          263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRR----KGELLLV  336 (586)
Q Consensus       263 f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~----~~~~~lV  336 (586)
                      |+..+.||+|+||+||+|++..++..||||++...  .....+.|.+|+++|++++|||||+++++|..    ++.++||
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv  107 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV  107 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence            36677899999999999999999999999999654  33445779999999999999999999999864    3568999


Q ss_pred             EecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCc--EEeCCCCCCCeeecC-CCCeEEccccceeec
Q 007869          337 YDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQV--VIHRDVKASNVLLDG-ELNGRLGDFGLARLY  413 (586)
Q Consensus       337 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--ivHrDIkp~NIll~~-~~~~kL~DFGla~~~  413 (586)
                      ||||++|+|.++|.+.  ..+++..+..++.||++||.|||+   ++  ||||||||+||||++ ++.+||+|||+|+..
T Consensus       108 mEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~ylH~---~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~  182 (290)
T 3fpq_A          108 TELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  182 (290)
T ss_dssp             EECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             EeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCCCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence            9999999999999765  368899999999999999999998   55  999999999999985 789999999999864


Q ss_pred             cCCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccC
Q 007869          414 DHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARD  493 (586)
Q Consensus       414 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d  493 (586)
                      ..   ......+||+.|||||++.+ +++.++|||||||+||||+||+.||........  +    ......+..     
T Consensus       183 ~~---~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~--~----~~~i~~~~~-----  247 (290)
T 3fpq_A          183 RA---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--I----YRRVTSGVK-----  247 (290)
T ss_dssp             CT---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--H----HHHHTTTCC-----
T ss_pred             CC---CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHH--H----HHHHHcCCC-----
Confidence            32   23456789999999999864 699999999999999999999999975433211  1    111112111     


Q ss_pred             CCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          494 PNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       494 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      |.   .++......+.+++.+||+.||++|||+.|+++
T Consensus       248 ~~---~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          248 PA---SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             CG---GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CC---CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            10   111112235778889999999999999999985

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=4.8e-53  Score=439.85  Aligned_cols=265  Identities=26%  Similarity=0.370  Sum_probs=216.6

Q ss_pred             hhhhhhcCCcccceeEeecCceEEEEEEeCCC-----CeEEEEEEecccc-chhHHHHHHHHHHhcccCC-Cceeeeeee
Q 007869          254 KDLYIATKGFREKELLGTGGFGRVYRGTLPKS-----QIEIAVKKISHES-RQGMKEFVAEIVSIGRLRH-RNLVQLLGY  326 (586)
Q Consensus       254 ~el~~a~~~f~~~~~LG~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H-~niv~l~~~  326 (586)
                      +++++..++|+..+.||+|+||+||+|++...     ++.||||++.... ....++|.+|+++|.+++| ||||+++|+
T Consensus        57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~  136 (353)
T 4ase_A           57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA  136 (353)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEE
Confidence            45667778999999999999999999997543     3679999997653 3445779999999999965 899999999


Q ss_pred             eecc-CeEEEEEecCCCCChhhhhhcCC--------------CccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCC
Q 007869          327 CRRK-GELLLVYDYMPNGSLDKYLYDQP--------------KVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKA  391 (586)
Q Consensus       327 ~~~~-~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp  391 (586)
                      |.+. +.++||||||++|+|.++|+...              +..++|.+++.++.|||+||.|||+   ++||||||||
T Consensus       137 ~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~---~~iiHRDLK~  213 (353)
T 4ase_A          137 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAA  213 (353)
T ss_dssp             ECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSG
T ss_pred             EEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh---CCeecCccCc
Confidence            9764 57899999999999999997642              2458999999999999999999998   8999999999


Q ss_pred             CCeeecCCCCeEEccccceeeccCCCCC-ceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCC
Q 007869          392 SNVLLDGELNGRLGDFGLARLYDHGTDP-QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGP  469 (586)
Q Consensus       392 ~NIll~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~  469 (586)
                      +|||+++++++||+|||+|+.+...... ..+...||+.|||||++.++.++.++|||||||+||||+| |+.||.....
T Consensus       214 ~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~  293 (353)
T 4ase_A          214 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI  293 (353)
T ss_dssp             GGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             cceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCH
Confidence            9999999999999999999976544332 3345689999999999999999999999999999999998 9999987544


Q ss_pred             CccchhhHHHHhhhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 007869          470 SENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERD  536 (586)
Q Consensus       470 ~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  536 (586)
                      .+.      +.....++...     ....    .....+.+++.+||+.||++|||+.|+++.|+..
T Consensus       294 ~~~------~~~~i~~g~~~-----~~p~----~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~l  345 (353)
T 4ase_A          294 DEE------FCRRLKEGTRM-----RAPD----YTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  345 (353)
T ss_dssp             SHH------HHHHHHHTCCC-----CCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHH------HHHHHHcCCCC-----CCCc----cCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence            321      12222222211     1111    1234577888999999999999999999998753

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=2.4e-52  Score=441.74  Aligned_cols=250  Identities=24%  Similarity=0.313  Sum_probs=212.3

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEecC
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYM  340 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  340 (586)
                      +.|+..+.||+|+||.||+|+++.+++.||||++........+.+.+|+.+|++++|||||++++++...+.+|||||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~  230 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  230 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence            56899999999999999999999999999999998766666677999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCCc
Q 007869          341 PNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ  420 (586)
Q Consensus       341 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~  420 (586)
                      ++|+|.+++...   .+++.++..++.||+.||.|||+   ++||||||||+||||+.++.+||+|||+|+.+..... .
T Consensus       231 ~gG~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH~---~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~-~  303 (423)
T 4fie_A          231 EGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-R  303 (423)
T ss_dssp             TTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC-C
T ss_pred             CCCcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEecCccceECCCCCc-c
Confidence            999999999754   58999999999999999999998   9999999999999999999999999999998754332 3


Q ss_pred             eeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCccc
Q 007869          421 TTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEY  500 (586)
Q Consensus       421 ~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~  500 (586)
                      ....+||+.|||||++.+..|+.++|||||||++|||++|+.||......+   +...+.    ++     ..+.+..  
T Consensus       304 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~---~~~~i~----~~-----~~~~~~~--  369 (423)
T 4fie_A          304 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK---AMKMIR----DN-----LPPRLKN--  369 (423)
T ss_dssp             BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHHHH----HS-----CCCCCSC--
T ss_pred             ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH---HHHHHH----cC-----CCCCCcc--
Confidence            456789999999999999999999999999999999999999997654322   111111    11     1111111  


Q ss_pred             cHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          501 VAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       501 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      .......+.+|+.+||+.||++|||+.|+++
T Consensus       370 ~~~~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          370 LHKVSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             TTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            1112345678889999999999999999986

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=9.1e-53  Score=428.21  Aligned_cols=248  Identities=22%  Similarity=0.316  Sum_probs=210.0

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc---cchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEE
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY  337 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  337 (586)
                      ++|+..+.||+|+||+||+|+++.+++.||||++.+.   .....+.+.+|+++|++++|||||++++++.+++.+||||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            4699999999999999999999999999999999754   2344678999999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCC
Q 007869          338 DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT  417 (586)
Q Consensus       338 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~  417 (586)
                      |||++|+|.++|.+.  ..+++.+...++.||+.||.|||+   ++|+||||||+||||+.++.+||+|||+|+.+....
T Consensus       112 Ey~~gG~L~~~i~~~--~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~  186 (311)
T 4aw0_A          112 SYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES  186 (311)
T ss_dssp             CCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred             ecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence            999999999999765  368899999999999999999998   999999999999999999999999999999875433


Q ss_pred             -CCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCC
Q 007869          418 -DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNL  496 (586)
Q Consensus       418 -~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l  496 (586)
                       .......+||+.|||||++.+..|+.++||||+||++|||+||+.||...+..+   +...    ..++.      +.+
T Consensus       187 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~---~~~~----i~~~~------~~~  253 (311)
T 4aw0_A          187 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL---IFAK----IIKLE------YDF  253 (311)
T ss_dssp             TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHH----HHHTC------CCC
T ss_pred             CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHH----HHcCC------CCC
Confidence             233456789999999999999999999999999999999999999997643221   1111    11111      111


Q ss_pred             CccccHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 007869          497 GTEYVAEELELVLKLGLLCSHSDPTARPSMRQVV  530 (586)
Q Consensus       497 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl  530 (586)
                      ...++    ..+.+|+.+||+.||++|||++|++
T Consensus       254 p~~~s----~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          254 PEKFF----PKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             CTTCC----HHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             CcccC----HHHHHHHHHHccCCHhHCcChHHHc
Confidence            12222    4567888999999999999999874

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.3e-51  Score=413.81  Aligned_cols=246  Identities=24%  Similarity=0.370  Sum_probs=193.0

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc---chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEE
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY  337 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  337 (586)
                      ++|+..+.||+|+||+||+|++..+++.||||++....   ....+.+.+|++++++++||||+++++++.+++.+++||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            57999999999999999999999999999999997542   334567999999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCC
Q 007869          338 DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT  417 (586)
Q Consensus       338 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~  417 (586)
                      ||+ +|+|.+++...  ..+++.+...++.||+.||+|||+   ++|+||||||+|||+++++++||+|||+|+......
T Consensus        93 Ey~-~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~  166 (275)
T 3hyh_A           93 EYA-GNELFDYIVQR--DKMSEQEARRFFQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN  166 (275)
T ss_dssp             ECC-CEEHHHHHHHS--CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred             eCC-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCChHHeEECCCCCEEEeecCCCeecCCCC
Confidence            999 68999999775  368999999999999999999998   999999999999999999999999999998765432


Q ss_pred             CCceeeeccCCCccCcccccCCCC-CCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCC
Q 007869          418 DPQTTHVVGTLGYLAPEHTRTGKA-TTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNL  496 (586)
Q Consensus       418 ~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l  496 (586)
                        .....+||+.|||||++.+..+ +.++||||+||++|||+||+.||...+..+   +.    +...++.      +.+
T Consensus       167 --~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~---~~----~~i~~~~------~~~  231 (275)
T 3hyh_A          167 --FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPV---LF----KNISNGV------YTL  231 (275)
T ss_dssp             ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH----HHHHHTC------CCC
T ss_pred             --ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHH---HH----HHHHcCC------CCC
Confidence              3345789999999999988876 579999999999999999999997643211   11    1111221      111


Q ss_pred             CccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          497 GTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       497 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      ....    ...+.+++.+||+.||++|||++|+++
T Consensus       232 p~~~----s~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          232 PKFL----SPGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             CTTS----CHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CCCC----CHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            1122    245678889999999999999999987

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.5e-51  Score=419.02  Aligned_cols=249  Identities=24%  Similarity=0.316  Sum_probs=197.5

Q ss_pred             cCCcccceeEeecCceEEEEEEeC---CCCeEEEEEEecccc--chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEE
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLP---KSQIEIAVKKISHES--RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELL  334 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~  334 (586)
                      .++|+..+.||+|+||+||+|+..   .+++.||||++....  ......+.+|+++|++++|||||++++++.+.+.++
T Consensus        23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~  102 (304)
T 3ubd_A           23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLY  102 (304)
T ss_dssp             GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEE
T ss_pred             ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence            357999999999999999999873   467889999997542  223346889999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeecc
Q 007869          335 LVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYD  414 (586)
Q Consensus       335 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~  414 (586)
                      ||||||++|+|.++|.+.  ..+++.++..++.||+.||.|||+   ++|+||||||+|||++.++++||+|||+|+...
T Consensus       103 ivmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~  177 (304)
T 3ubd_A          103 LILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESI  177 (304)
T ss_dssp             EEECCCTTCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred             EEEEcCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence            999999999999999765  368999999999999999999998   999999999999999999999999999998654


Q ss_pred             CCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCC
Q 007869          415 HGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDP  494 (586)
Q Consensus       415 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~  494 (586)
                      ... ......+||+.|||||++.+..++.++|||||||++|||+||+.||...+..+   +...+    .++.      +
T Consensus       178 ~~~-~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~---~~~~i----~~~~------~  243 (304)
T 3ubd_A          178 DHE-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE---TMTMI----LKAK------L  243 (304)
T ss_dssp             ----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH----HHCC------C
T ss_pred             CCC-ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH---HHHHH----HcCC------C
Confidence            332 23345789999999999999999999999999999999999999998654322   11111    1111      1


Q ss_pred             CCCccccHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 007869          495 NLGTEYVAEELELVLKLGLLCSHSDPTARPSM-----RQVVQ  531 (586)
Q Consensus       495 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~-----~evl~  531 (586)
                      ......    ...+.+++.+||+.||++|||+     +|+++
T Consensus       244 ~~p~~~----s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~  281 (304)
T 3ubd_A          244 GMPQFL----SPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR  281 (304)
T ss_dssp             CCCTTS----CHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred             CCCCcC----CHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence            111112    2456788899999999999984     56653

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=3.1e-50  Score=410.14  Aligned_cols=250  Identities=22%  Similarity=0.353  Sum_probs=190.5

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccc-hhHHHHHHHHHHhcccCCCceeeeeeeeeccC--------
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR-QGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKG--------  331 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~--------  331 (586)
                      ++|+..+.||+|+||+||+|+++.+++.||||++..... ...+.+.+|+++|++++|||||++++++.+.+        
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            358889999999999999999999999999999976543 34567999999999999999999999987544        


Q ss_pred             ----eEEEEEecCCCCChhhhhhcCCC-ccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEcc
Q 007869          332 ----ELLLVYDYMPNGSLDKYLYDQPK-VTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGD  406 (586)
Q Consensus       332 ----~~~lV~E~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~D  406 (586)
                          .+++|||||++|+|.+++..... ...++..++.|+.||++||.|||+   ++|+||||||+|||++.++.+||+|
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~---~~IiHRDlKp~NILl~~~~~vKl~D  161 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGD  161 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHH---CcCccccCcHHHeEECCCCcEEEcc
Confidence                37999999999999999986643 234566788999999999999998   8999999999999999999999999


Q ss_pred             ccceeeccCCCCC-----------ceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchh
Q 007869          407 FGLARLYDHGTDP-----------QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLIL  475 (586)
Q Consensus       407 FGla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l  475 (586)
                      ||+|+.+......           ..+..+||+.|||||++.+..|+.++|||||||++|||++   ||....  +..  
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~--~~~--  234 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM--ERV--  234 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH--HHH--
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc--HHH--
Confidence            9999976543221           1234679999999999999999999999999999999996   775321  111  


Q ss_pred             hHHHHhhhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          476 VDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       476 ~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                       .... ...+..     .|    .........+.+++.+||+.||++|||+.|+++
T Consensus       235 -~~~~-~~~~~~-----~p----~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          235 -RTLT-DVRNLK-----FP----PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             -HHHH-HHHTTC-----CC----HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -HHHH-HHhcCC-----CC----CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence             1111 011111     11    111223345567899999999999999999986

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.1e-47  Score=395.54  Aligned_cols=285  Identities=38%  Similarity=0.659  Sum_probs=250.3

Q ss_pred             cccchhhhhhhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeee
Q 007869          249 HRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCR  328 (586)
Q Consensus       249 ~~~~~~el~~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~  328 (586)
                      .++.+.++..++++|+..+.||+|+||.||+|++. ++..||||++........+.+.+|++++++++||||+++++++.
T Consensus        27 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  105 (321)
T 2qkw_B           27 YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCD  105 (321)
T ss_dssp             ---CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECC
T ss_pred             eeecHHHHHHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence            45667788889999999999999999999999975 57789999998777677788999999999999999999999999


Q ss_pred             ccCeEEEEEecCCCCChhhhhhcCC--CccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEcc
Q 007869          329 RKGELLLVYDYMPNGSLDKYLYDQP--KVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGD  406 (586)
Q Consensus       329 ~~~~~~lV~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~D  406 (586)
                      ..+..++||||+++|+|.+++....  ...++|.+++.++.|+++||.|||+   ++|+||||||+|||++.++.+||+|
T Consensus       106 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~D  182 (321)
T 2qkw_B          106 ERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITD  182 (321)
T ss_dssp             CTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCSTTEEECTTCCEEECC
T ss_pred             CCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcC---CCeecCCCCHHHEEECCCCCEEEee
Confidence            9999999999999999999997653  2468999999999999999999998   8999999999999999999999999


Q ss_pred             ccceeeccCCCC-CceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhcc
Q 007869          407 FGLARLYDHGTD-PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNR  485 (586)
Q Consensus       407 FGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~  485 (586)
                      ||+++....... .......||+.|+|||++.+..++.++|||||||++|||++|+.||....+.+......|.......
T Consensus       183 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~  262 (321)
T 2qkw_B          183 FGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNN  262 (321)
T ss_dssp             CTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTT
T ss_pred             cccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccc
Confidence            999987543222 2234456899999999999999999999999999999999999999887766666677787777777


Q ss_pred             CccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 007869          486 GELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERDV  537 (586)
Q Consensus       486 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  537 (586)
                      +.+....++.+......+....+.+++.+||+.||++|||+.|+++.|+...
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l  314 (321)
T 2qkw_B          263 GQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYAL  314 (321)
T ss_dssp             TCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence            7777778888777778888999999999999999999999999999998754

>3ipv_A Lectin alpha chain; galactose binding, SEED lectin, hemagglutinin, legume lectin fungal, sugar binding protein; 2.04A {Spatholobus parviflorus} PDB: 3ipv_B 3usu_B* 3usu_A*

Probab=100.00  E-value=2.4e-48  Score=379.03  Aligned_cols=171  Identities=31%  Similarity=0.451  Sum_probs=155.0

Q ss_pred             CcccCCCCCCCCCCeeeeeEEEEEEEEEeCCCCCCCCcEEEEEecCCCCCCCCCCCcccccccCCCCCCCccEEEEEeec
Q 007869            2 PFKNKNSNSSTANGTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGLFNDTNLGNETNHVFAVELDT   81 (586)
Q Consensus         2 p~~~~~~~~~~~~~~~asF~t~F~f~i~~~~~~~~g~GlaF~l~p~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEfDt   81 (586)
                      ||+||++.+    |++|||+|+|+|.|.+.+...+||||||||+|....|. +.||||||||.+++ +.+||+|||||||
T Consensus        56 Pi~l~d~~t----g~vaSFsT~F~F~I~~~~~~~~gdGlAF~lap~~~~~~-~~gg~LGL~n~~~~-~~~n~~vAVEFDT  129 (251)
T 3ipv_A           56 PINIWDSAT----GLVASFATSFRFTIYAPNIATIADGLAFFLAPVASAPD-SGGGFLGLFDSAVS-GSTYQTVAVEFDT  129 (251)
T ss_dssp             CEECBCTTT----CCBCEEEEEEEEECCCSSTTSCCEEEEEEEEETTCCCC-CCGGGTTTCSSSSC-CTTSCCEEEEEEC
T ss_pred             CEEeecCCC----CceeeEEEEEEEEEeCCCCCCCCCceEEEEecCCCCCC-CCCceeeeccccCC-CccCcEEEEEEec
Confidence            899999988    99999999999999988778899999999999876665 57999999998876 7789999999999


Q ss_pred             cccCCCCCCCCCeeEEeCCCCcccccccC--------ceEEEEcCeeeEEEEEEeecCCCCCCccceeeeeecchhcccc
Q 007869           82 IKSHGFLDINDNHVGIDINSLKSESSAPA--------GYYVEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSVLND  153 (586)
Q Consensus        82 ~~~~~~~d~~~~hvgidvns~~s~~~~~~--------~~~i~y~~~~~~l~v~~~~~~~~~~~~~~~ls~~~dL~~~l~~  153 (586)
                      ++|.+|+||++|||||||||+.|.++.++        ..||+||+.+++|+|++++.+.  |.. |+|++.|||+++|||
T Consensus       130 ~~n~~~~Dp~~nHVGIdvNsi~S~~t~~~~l~~G~~~~v~I~Yd~~tk~L~V~l~~~~~--~~~-~~ls~~vdL~~~l~e  206 (251)
T 3ipv_A          130 YENTVFTDPPYTHIGFDVNSISSIKTVKWSLANGEAAKVLITYNSAVKLLVASLVYPSS--KTS-FILADIVDLSSVLPE  206 (251)
T ss_dssp             SCCGGGTCCSSCEEEEEESSSSCSEEEECCCCTTCEEEEEEEEETTTTEEEEEEECTTT--CCE-EEEEEECCHHHHSCS
T ss_pred             ccccccCCCCCCeEEEEcCCCcccccceeEecCCCEEEEEEEEeCCCCEEEEEEecCCC--Ccc-ceEEEEechHHhCCC
Confidence            99998999999999999999999887654        3699999999999999997543  444 899999999999999


Q ss_pred             ceeeeeecCCCcc---ceeeeeeeccccccC
Q 007869          154 AMYVGFSSSTGSV---LASHYILGWSFKING  181 (586)
Q Consensus       154 ~~~vGFsastg~~---~~~~~i~~Wsf~~~~  181 (586)
                      +||||||||||..   .|.|+|++|+|++..
T Consensus       207 ~v~VGFSAsTG~~~~~~e~h~IlsWsF~s~l  237 (251)
T 3ipv_A          207 WVRVGFSAATGASGGKIETHDVFSWSFASKL  237 (251)
T ss_dssp             EEEEEEEEEECSSTTCCCCCEEEEEEEEEEE
T ss_pred             cEEEEEEEecCCCccccceeEEEEEEEEEEC
Confidence            9999999999998   899999999999753

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=2.1e-47  Score=394.16  Aligned_cols=291  Identities=41%  Similarity=0.721  Sum_probs=251.7

Q ss_pred             CCcccchhhhhhhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccc-hhHHHHHHHHHHhcccCCCceeeeee
Q 007869          247 GPHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR-QGMKEFVAEIVSIGRLRHRNLVQLLG  325 (586)
Q Consensus       247 ~~~~~~~~el~~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~~  325 (586)
                      ....|+++++...+++|+..+.||+|+||.||+|.+. ++..||||++..... .....+.+|++++++++||||+++++
T Consensus        16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~   94 (326)
T 3uim_A           16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG   94 (326)
T ss_dssp             CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred             ccceecHHHHHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence            3578999999999999999999999999999999865 577899999976532 22346899999999999999999999


Q ss_pred             eeeccCeEEEEEecCCCCChhhhhhcCCC--ccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeE
Q 007869          326 YCRRKGELLLVYDYMPNGSLDKYLYDQPK--VTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGR  403 (586)
Q Consensus       326 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~k  403 (586)
                      +|...+..++||||+++|+|.+++.....  ..++|..++.++.|++.||.|||+.+..+|+||||||+|||++.++.+|
T Consensus        95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~k  174 (326)
T 3uim_A           95 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAV  174 (326)
T ss_dssp             EECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEE
T ss_pred             EEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEE
Confidence            99999999999999999999999987543  4599999999999999999999993333999999999999999999999


Q ss_pred             EccccceeeccCCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCC--CCCccchhhHHHHh
Q 007869          404 LGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQ--GPSENLILVDWVFD  481 (586)
Q Consensus       404 L~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~--~~~~~~~l~~~v~~  481 (586)
                      |+|||+++..............||+.|+|||++.+..++.++|||||||++|||++|+.||...  .......+.+|+..
T Consensus       175 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  254 (326)
T 3uim_A          175 VGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG  254 (326)
T ss_dssp             ECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT
T ss_pred             eccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH
Confidence            9999999987655444455567999999999999889999999999999999999999999632  12233456778887


Q ss_pred             hhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhccC
Q 007869          482 FWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERDVA  538 (586)
Q Consensus       482 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~  538 (586)
                      ......+....++.+...+.......+.+++.+||+.||.+|||+.|+++.|++...
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  311 (326)
T 3uim_A          255 LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL  311 (326)
T ss_dssp             TTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSC
T ss_pred             HhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcch
Confidence            777777778888888888888999999999999999999999999999999987543

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.6e-48  Score=407.78  Aligned_cols=263  Identities=23%  Similarity=0.292  Sum_probs=204.5

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc--cchhHHHHHHHHHHhcccCCCceeeeeeeeec------cC
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRR------KG  331 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~------~~  331 (586)
                      .++|+..+.||+|+||+||+|++..+++.||||++...  .....+.+.+|+++|++++|||||++++++..      .+
T Consensus        53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~  132 (398)
T 4b99_A           53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK  132 (398)
T ss_dssp             CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred             CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence            35799999999999999999999999999999999754  23345678999999999999999999998763      36


Q ss_pred             eEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEcccccee
Q 007869          332 ELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR  411 (586)
Q Consensus       332 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~  411 (586)
                      .+|||||||+ |+|.+++...  ..+++.++..++.||+.||.|||+   ++||||||||+|||++.++.+||+|||+|+
T Consensus       133 ~~~ivmE~~~-g~L~~~i~~~--~~l~~~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~  206 (398)
T 4b99_A          133 SVYVVLDLME-SDLHQIIHSS--QPLTLEHVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMAR  206 (398)
T ss_dssp             CEEEEEECCS-EEHHHHHTSS--SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             EEEEEEeCCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CcCcCCCcCccccccCCCCCEEEeecceee
Confidence            7899999995 7899999765  468999999999999999999998   999999999999999999999999999998


Q ss_pred             eccCCC---CCceeeeccCCCccCcccccCC-CCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCc
Q 007869          412 LYDHGT---DPQTTHVVGTLGYLAPEHTRTG-KATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGE  487 (586)
Q Consensus       412 ~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~  487 (586)
                      .+....   .......+||+.|||||++.+. .++.++||||+||++|||++|+.||.+.+..+....+   ........
T Consensus       207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I---~~~~g~p~  283 (398)
T 4b99_A          207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLI---MMVLGTPS  283 (398)
T ss_dssp             CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHH---HHHHCCCC
T ss_pred             ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHH---HHhcCCCC
Confidence            764322   2234457899999999998775 4689999999999999999999999876543322211   11100000


Q ss_pred             --------------cccccCCCCCcc---ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          488 --------------LLEARDPNLGTE---YVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       488 --------------~~~~~d~~l~~~---~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                                    ......+.....   ........+.+|+.+||+.||++|||+.|+++
T Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  344 (398)
T 4b99_A          284 PAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR  344 (398)
T ss_dssp             GGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             hHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence                          000000110000   00111345778999999999999999999986

>3zyr_A Lectin; sugar binding protein, N-glycan; HET: NAG BMA MAN GOL; 1.65A {Platypodium elegans} SCOP: b.29.1.1 PDB: 3zvx_A* 1ukg_A* 1q8o_A* 1q8q_A* 1q8s_A* 1q8v_A* 1q8p_A* 2auy_A* 2gme_A 2gmm_A* 2gmp_A* 2gn3_A* 2gn7_A* 2gnb_A* 2gnd_A* 2gnm_A* 2gnt_A 2phf_A* 2phr_A* 2pht_A* ...

Probab=100.00  E-value=1.6e-47  Score=374.39  Aligned_cols=170  Identities=31%  Similarity=0.466  Sum_probs=153.7

Q ss_pred             CcccCCCCCCCCCCeeeeeEEEEEEEEEeCCCCCCCCcEEEEEecCCC-CCCCCCCCcccccccCCCCC-CCccEEEEEe
Q 007869            2 PFKNKNSNSSTANGTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTRG-LPGARPSQYLGLFNDTNLGN-ETNHVFAVEL   79 (586)
Q Consensus         2 p~~~~~~~~~~~~~~~asF~t~F~f~i~~~~~~~~g~GlaF~l~p~~~-~~~~~~g~~lGl~~~~~~~~-~~~~~vaVEf   79 (586)
                      ||+|||+.+    |++|||+|+|+|.|.+. ...+||||||||+|... +|.+++||||||||.+++++ ..||+|||||
T Consensus        64 Pv~l~d~~t----g~vaSFsT~F~F~I~~~-~~~~gdGlAF~lap~~~~~p~~~~g~~LGL~n~~~~g~~~~n~~vAVEF  138 (261)
T 3zyr_A           64 QVRLWEKST----NRVANLQTQFSFFLSSP-LSNPADGIAFFIAPPDTTIPSGSAGGLLGLFNPRTALNESANQVLAVEF  138 (261)
T ss_dssp             CEECBCTTT----CCBEEEEEEEEEEEECS-SSSCCCEEEEEEECTTCCCCTTCCGGGTTTCCTTTTTCGGGCCCEEEEE
T ss_pred             CEEeecCCC----CCceeEEEEEEEEEecC-CCCCCccEEEEEccCCCCCCCCCCCceeeeecccccCCCccCcEEEEEE
Confidence            899999988    99999999999999986 67799999999999865 48888999999999987754 5789999999


Q ss_pred             ecc---ccCCCCCCCCCeeEEeCCCCcccccccC--------ceEEEEcCeeeEEEEEEeecCCCCCCccceeeeeecch
Q 007869           80 DTI---KSHGFLDINDNHVGIDINSLKSESSAPA--------GYYVEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLS  148 (586)
Q Consensus        80 Dt~---~~~~~~d~~~~hvgidvns~~s~~~~~~--------~~~i~y~~~~~~l~v~~~~~~~~~~~~~~~ls~~~dL~  148 (586)
                      ||+   +|.+| ||++|||||||||+.|.+++++        ..||+||+.+++|+|++++.+.   .. |+|++.+||+
T Consensus       139 DT~~~~~n~~~-Dp~~nHVGIdvNsi~S~~s~~~~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~---~~-~~ls~~vdL~  213 (261)
T 3zyr_A          139 DTFFAQNSNTW-DPNYQHIGIDVNSIRSSKVVRWERREGKTLNVLVTYNPSTRTIDVVATYPDG---QR-YQLSHVVDLT  213 (261)
T ss_dssp             ECCCCTTTCTT-SCSSCEEEEEESSSSCSEEEECCCCTTCCEEEEEEEETTTTEEEEEEECTTC---CE-EEEEEECCGG
T ss_pred             eccccccCcCC-CCCCCeEEEEcCCCCccccccccccCCceEEEEEEEcCCCCEEEEEEEcCCC---CC-eEEEEEechH
Confidence            999   99888 9999999999999999887664        3699999999999999997542   24 8999999999


Q ss_pred             hccccceeeeeecCCCccceeeeeeeccccccC
Q 007869          149 SVLNDAMYVGFSSSTGSVLASHYILGWSFKING  181 (586)
Q Consensus       149 ~~l~~~~~vGFsastg~~~~~~~i~~Wsf~~~~  181 (586)
                      ++|||+||||||||||...|.|+|++|+|++..
T Consensus       214 ~~l~e~v~VGFSAsTG~~~e~h~IlsWsF~s~l  246 (261)
T 3zyr_A          214 TILPEWVRVGFSAASGEQFQTHNLESWSFTSTL  246 (261)
T ss_dssp             GTSCSEEEEEEEEEESSSCCEEEEEEEEEEEEE
T ss_pred             HhCcCcEEEEEEecCCCccceEEEEEEEEEEEc
Confidence            999999999999999999999999999999863

>3ujo_A Legume lectin; carbohydrate-binding, galactose, adenine binding protein; HET: ADE GAL; 2.00A {Dolichos lablab} PDB: 3ujq_A* 3uk9_A* 3ul2_A* 1fat_A* 1g8w_A*

Probab=100.00  E-value=1.2e-47  Score=378.16  Aligned_cols=170  Identities=31%  Similarity=0.511  Sum_probs=153.8

Q ss_pred             CcccCCCCCCCCCCeeeeeEEEEEEEEEeCCCCCCCCcEEEEEecCCCCCCCCCCCcccccccCCCCCCCccEEEEEeec
Q 007869            2 PFKNKNSNSSTANGTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGLFNDTNLGNETNHVFAVELDT   81 (586)
Q Consensus         2 p~~~~~~~~~~~~~~~asF~t~F~f~i~~~~~~~~g~GlaF~l~p~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEfDt   81 (586)
                      ||++||+.+    |++|||+|+|+|.|.+.+...+||||||+|+|....|. ++||||||||.+++ +.+||+|||||||
T Consensus        76 Pi~l~d~~t----g~vaSFsTsFsF~I~~~~~~~~gdGlAF~laP~~~~p~-~~gg~LGL~n~~~~-~~~n~~vAVEFDT  149 (281)
T 3ujo_A           76 PIQIWDNTT----GTVASWATSFTFNLQAPNAASPADGLAFALVPVGSQPK-DKGGFLGLFDSKNY-ASSNQTVAVEFDT  149 (281)
T ss_dssp             CEECBCSSS----CCBEEEEEEEEEECCCSSTTSCCEEEEEEEEETTCCCC-CCGGGTTTCSCSSC-CTTSCCEEEEECC
T ss_pred             CEEcccCCC----CCceeEEEEEEEEEecCCCCCCCCceEEEEecCCCCCC-CCcceeeeccccCC-CccCcEEEEEEec
Confidence            899999988    99999999999999988778899999999999876664 68999999998876 7889999999999


Q ss_pred             cccCCCCCCCCCeeEEeCCCCcccccccC--------ceEEEEcCeeeEEEEEEeecCCCCCCccceeeeeecchhcccc
Q 007869           82 IKSHGFLDINDNHVGIDINSLKSESSAPA--------GYYVEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSVLND  153 (586)
Q Consensus        82 ~~~~~~~d~~~~hvgidvns~~s~~~~~~--------~~~i~y~~~~~~l~v~~~~~~~~~~~~~~~ls~~~dL~~~l~~  153 (586)
                      ++|.+| ||++|||||||||+.|.+++++        ..||+||+.+++|+|++++.+.  |.. |+|++.+||+++|||
T Consensus       150 ~~N~e~-Dp~~nHVGIDvNSi~S~~t~~~~l~~G~~~~vwI~Yd~~tk~L~V~l~~~~~--~~~-~~lS~~vDL~~~L~e  225 (281)
T 3ujo_A          150 FYNGGW-DPTERHIGIDVNSIKSIKTTSWDFANGENAEVLITYDSSTNLLVASLVHPSQ--KTS-FIVSERVDLTSVLPE  225 (281)
T ss_dssp             SCCCSS-CCSSSEEEEEESSSCCSCEEECCCCSSCCEEEEEEECTTTCEEEEEEECTTT--CCC-EEEEEECCSTTTSCS
T ss_pred             cccccC-CCCCCeEEEEcCCCCccccccccccCCCEEEEEEEEeCCCCEEEEEEecCCC--CCC-ceEEEEechHHhccC
Confidence            999888 9999999999999999887664        3699999999999999997654  334 899999999999999


Q ss_pred             ceeeeeecCCCc---cceeeeeeeccccccC
Q 007869          154 AMYVGFSSSTGS---VLASHYILGWSFKING  181 (586)
Q Consensus       154 ~~~vGFsastg~---~~~~~~i~~Wsf~~~~  181 (586)
                      +||||||||||.   ..|.|+|++|+|+++.
T Consensus       226 ~v~VGFSAsTG~~~~~~e~H~IlsWSFss~l  256 (281)
T 3ujo_A          226 WVSVGFSATTGLSKGYVETNEVLSWSFASKL  256 (281)
T ss_dssp             EEEEEEEEEECSSTTSCCCCEEEEEEEEEEE
T ss_pred             cEEEEEEeecCCCCcccceeEEEEEEEEEEc
Confidence            999999999996   5899999999999863

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=7.9e-47  Score=418.15  Aligned_cols=252  Identities=23%  Similarity=0.310  Sum_probs=212.1

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEecC
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYM  340 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  340 (586)
                      ++|++.+.||+|+||.||+|+++.+++.||||++........+.+.+|+++|++++|||||++++++.+.+.++||||||
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~  236 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  236 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence            57999999999999999999999999999999998766666678999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCC--CCeEEccccceeeccCCCC
Q 007869          341 PNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGE--LNGRLGDFGLARLYDHGTD  418 (586)
Q Consensus       341 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~--~~~kL~DFGla~~~~~~~~  418 (586)
                      ++|+|.++|... ...+++.++..++.||++||.|||+   ++|+||||||+|||++.+  +.+||+|||+|+.+.... 
T Consensus       237 ~gg~L~~~i~~~-~~~l~e~~~~~~~~qi~~al~ylH~---~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~-  311 (573)
T 3uto_A          237 SGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ-  311 (573)
T ss_dssp             CCCBHHHHHTCT-TSCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS-
T ss_pred             CCCcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC-
Confidence            999999999654 3469999999999999999999998   999999999999999854  789999999999875432 


Q ss_pred             CceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCc
Q 007869          419 PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGT  498 (586)
Q Consensus       419 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~  498 (586)
                       .....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+....+.   ...+    ..+.      ..+..
T Consensus       312 -~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~---~~~i----~~~~------~~~~~  377 (573)
T 3uto_A          312 -SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET---LRNV----KSCD------WNMDD  377 (573)
T ss_dssp             -EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH---HHHH----HTTC------CCCCS
T ss_pred             -ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH---HHHH----HhCC------CCCCc
Confidence             34557899999999999999999999999999999999999999986543221   1111    1111      11111


Q ss_pred             cccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          499 EYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       499 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      .........+.+|+.+||+.||.+|||+.|+++
T Consensus       378 ~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          378 SAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            111122345678889999999999999999987

>1hql_A Lectin; xenograft antigen, sugar BI protein; HET: GLA MBG NAG; 2.20A {Griffonia simplicifolia} SCOP: b.29.1.1 PDB: 1gnz_A*

Probab=100.00  E-value=8.8e-47  Score=371.18  Aligned_cols=185  Identities=30%  Similarity=0.449  Sum_probs=153.4

Q ss_pred             CcccCCCCCCCCCCeeeeeEEEEEEEEEeCCCCCCCCcEEEEEecCCCCCCCCCCCcccccccCC-CCCCCccEEEEEee
Q 007869            2 PFKNKNSNSSTANGTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGLFNDTN-LGNETNHVFAVELD   80 (586)
Q Consensus         2 p~~~~~~~~~~~~~~~asF~t~F~f~i~~~~~~~~g~GlaF~l~p~~~~~~~~~g~~lGl~~~~~-~~~~~~~~vaVEfD   80 (586)
                      ||+||++.+    |+++||+|+|+|+|.+. ...+||||||+|+|....| +++|+||||||.++ +++..||+||||||
T Consensus        57 Pv~l~d~~t----g~vasFsT~F~F~I~~~-~~~~gdGlAF~l~p~~~~~-~~~g~~LGl~n~~~~~~~~~n~~vAVEFD  130 (257)
T 1hql_A           57 PVQLWDNKT----ESVASFYTEFTFFLKIT-GNGPADGLAFFLAPPDSDV-KDAGEYLGLFNKSTATQPSKNQVVAVEFD  130 (257)
T ss_dssp             CEECCCSTT----CCCCEEEEEEEEEEEEC-SSCCCCEEEEEEECTTCCC-CCCGGGTTTSCTTTTTCGGGCCCEEEEEE
T ss_pred             CEecccCCC----CCeeceEEEEEEEEecC-CCCCCCcEEEEEecCCCCC-CCCCccccccccccccCCccCceEEEEec
Confidence            899999887    99999999999999987 6779999999999976544 48899999999875 36788999999999


Q ss_pred             ccccCCCCCCCCCeeEEeCCCCcccccccC-----------ceEEEEcCeeeEEEEEEeecCCCCCCccceeeeeecchh
Q 007869           81 TIKSHGFLDINDNHVGIDINSLKSESSAPA-----------GYYVEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSS  149 (586)
Q Consensus        81 t~~~~~~~d~~~~hvgidvns~~s~~~~~~-----------~~~i~y~~~~~~l~v~~~~~~~~~~~~~~~ls~~~dL~~  149 (586)
                      |++|.+|+||++|||||||||+.|.++.++           ..||+||+.+++|+|++.+...   .. |+|++.+||+.
T Consensus       131 T~~N~~~~Dp~~nHVGIdvNs~~S~~s~~~~~~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~---~~-~~ls~~vdL~~  206 (257)
T 1hql_A          131 TWTNPNFPEPSYRHIGINVNSIVSVATKRWEDSDIFSGKIATARISYDGSAEILTVVLSYPDG---SD-YILSHSVDMRQ  206 (257)
T ss_dssp             CSCCSSSCCCSSCEEEEEESSSSCSEEEECCHHHHTSCSCEEEEEEEETTTTEEEEEEEETTT---EE-EEEEEECCGGG
T ss_pred             ccccccccCCCCCceeeeeCCccccceeccCcccccCCceEEEEEEEeCCCCEEEEEEecCCC---Cc-eeeEEeechHH
Confidence            999999999999999999999998766543           3699999999999999987543   24 89999999999


Q ss_pred             ccccceeeeeecCCC-ccceeeeeeeccccccCccccccccCCCCCCC
Q 007869          150 VLNDAMYVGFSSSTG-SVLASHYILGWSFKINGQAEELNLSQLPKLPR  196 (586)
Q Consensus       150 ~l~~~~~vGFsastg-~~~~~~~i~~Wsf~~~~~~~~~~~~~~~~~~~  196 (586)
                      +||++|||||||||| ...|.|+|++|+|+++++.+..+.+.+|++|+
T Consensus       207 ~l~e~~~vGFSAsTG~~~~~~H~IlsWsF~s~~~~~~~~~~~~p~~~~  254 (257)
T 1hql_A          207 NLPESVRVGISASTGNNQFLTVYILSWRFSSNLQSTSVKAAMEPEITR  254 (257)
T ss_dssp             TSCSEEEEEEEEECCSCCCEEEEEEEEEEEEEC---------------
T ss_pred             hcCCceEEEEEeccCCCccceeEEEEEEeEecCCCCCcccccCCCCCc
Confidence            999999999999999 89999999999999999888898999998875

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=5.5e-46  Score=388.75  Aligned_cols=201  Identities=26%  Similarity=0.357  Sum_probs=172.5

Q ss_pred             hhcCCcccceeEeecCceEEEEEEeC---CCCeEEEEEEeccccchhHHHHHHHHHHhccc-CCCceeeeeeeeeccCeE
Q 007869          258 IATKGFREKELLGTGGFGRVYRGTLP---KSQIEIAVKKISHESRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKGEL  333 (586)
Q Consensus       258 ~a~~~f~~~~~LG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~~~~  333 (586)
                      ...+.|++.+.||+|+||+||+|+++   .+++.||||++.....  ...+.+|+++|.++ +||||+++++++.+.+.+
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~--~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~   95 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH--PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV   95 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC--HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC--HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence            34578999999999999999999864   4578899999865433  35688999999998 699999999999999999


Q ss_pred             EEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCC-CCeEEccccceee
Q 007869          334 LLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGE-LNGRLGDFGLARL  412 (586)
Q Consensus       334 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~-~~~kL~DFGla~~  412 (586)
                      ++||||+++|+|.+++.     .+++.+...++.||+.||.|||+   ++|+||||||+|||++.+ +.+||+|||+|+.
T Consensus        96 ~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~---~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~  167 (361)
T 4f9c_A           96 VIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQ---FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQG  167 (361)
T ss_dssp             EEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence            99999999999999983     47888999999999999999998   999999999999999877 7999999999986


Q ss_pred             ccCCCC---------------------------CceeeeccCCCccCcccccCC-CCCCcceEEehhHHHHHHHhCCCCC
Q 007869          413 YDHGTD---------------------------PQTTHVVGTLGYLAPEHTRTG-KATTSADVFSFGAFLLEVACGRRPI  464 (586)
Q Consensus       413 ~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVyS~Gvvl~ElltG~~p~  464 (586)
                      ......                           ...+..+||+.|||||++.+. .++.++||||+||++|||++|+.||
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf  247 (361)
T 4f9c_A          168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF  247 (361)
T ss_dssp             CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred             cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence            543211                           112345799999999999775 4899999999999999999999999


Q ss_pred             CCCC
Q 007869          465 QRQG  468 (586)
Q Consensus       465 ~~~~  468 (586)
                      ....
T Consensus       248 ~~~~  251 (361)
T 4f9c_A          248 YKAS  251 (361)
T ss_dssp             SCCS
T ss_pred             CCCC
Confidence            7543

>1dbn_A MAL, protein (leukoagglutinin); plant lectin, carbohydrate binding, sialyllactose, sugar BIN protein; HET: NAG SIA GAL BGC; 2.75A {Maackia amurensis} SCOP: b.29.1.1

Probab=100.00  E-value=2.4e-46  Score=364.52  Aligned_cols=170  Identities=32%  Similarity=0.506  Sum_probs=153.3

Q ss_pred             CcccCCCCCCCCCCeeeeeEEEEEEEEEeCCCCCCCCcEEEEEecCCC-CCCCCCCCcccccccCCCCCCCccEEEEEee
Q 007869            2 PFKNKNSNSSTANGTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTRG-LPGARPSQYLGLFNDTNLGNETNHVFAVELD   80 (586)
Q Consensus         2 p~~~~~~~~~~~~~~~asF~t~F~f~i~~~~~~~~g~GlaF~l~p~~~-~~~~~~g~~lGl~~~~~~~~~~~~~vaVEfD   80 (586)
                      ||++|++.+    |+++||+|+|+|.|.+.+...+||||||+|+|... +|.+++|+||||||.++ ++..||+||||||
T Consensus        55 Pi~l~~~~t----g~vaSFsT~F~F~I~~~~~~~~gdGlAF~l~p~~~~~p~~~~g~~LGl~n~~~-~~~~~~~vAVEFD  129 (239)
T 1dbn_A           55 PVRIWGNTT----GSVASFSTSFTFVVKAPNPDITSDGLAFYLAPPDSQIPSGSVSKYLGLFNNSN-SDSSNQIVAVEFD  129 (239)
T ss_dssp             CEECBCTTT----CCBCEEEEEEEEECCCSSTTSCCEEEEEEEECTTCCCCSSSCGGGTTSCSSSC-CCTTSCCEEEEEE
T ss_pred             CEecccCCC----CCccceEEEEEEEEeCCCCCCCCCCEEEEEecCCCCCCcCCCCCcccccccCC-CCccccEEEEEEe
Confidence            899999988    99999999999999987777899999999999765 68889999999999764 4779999999999


Q ss_pred             cccc---CCCCCCCCCeeEEeCCCCcccccccC--------ceEEEEcCeeeEEEEEEeecCCCCCCccceeeeeecchh
Q 007869           81 TIKS---HGFLDINDNHVGIDINSLKSESSAPA--------GYYVEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSS  149 (586)
Q Consensus        81 t~~~---~~~~d~~~~hvgidvns~~s~~~~~~--------~~~i~y~~~~~~l~v~~~~~~~~~~~~~~~ls~~~dL~~  149 (586)
                      |++|   .+ +||++|||||||||+.|.+++++        .+||+||+.+++|+|++++.+.  |.. |+|++.+||++
T Consensus       130 T~~n~~~~~-~Dp~~nHVGIdvNs~~S~~~~~~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~-~~ls~~vdL~~  205 (239)
T 1dbn_A          130 TYFAHSYDP-WDPNYRHIGIDVNGIESIKTVQWDWINGGVAFATITYLAPNKTLIASLVYPSN--QTT-FSVAASVDLKE  205 (239)
T ss_dssp             CCCCTTTCT-TSCSSCEEEEEESSSSCSEEEECCCCTTCCEEEEEEEEGGGTEEEEEEEETTT--TEE-EEEEEECCHHH
T ss_pred             ccccCcccc-cCCCCCcEEEecCCccccceEcccccCCCEEEEEEEEeCCCcEEEEEEccCCC--CCc-ceEEEEechHH
Confidence            9999   77 59999999999999999887753        3699999999999999987643  444 89999999999


Q ss_pred             ccccceeeeeecCCCcc--ceeeeeeecccccc
Q 007869          150 VLNDAMYVGFSSSTGSV--LASHYILGWSFKIN  180 (586)
Q Consensus       150 ~l~~~~~vGFsastg~~--~~~~~i~~Wsf~~~  180 (586)
                      +|||+||||||||||..  .|.|+|++|+|+++
T Consensus       206 ~l~e~v~VGFSAsTG~~~~~~~h~IlsWsF~s~  238 (239)
T 1dbn_A          206 ILPEWVRVGFSAATGYPTEVETHDVLSWSFTST  238 (239)
T ss_dssp             HSCSEEEEEEEEEECSGGGCCCCEEEEEEEEEE
T ss_pred             hCCccEEEEEEeccCCCccceeeEEEEEEeEec
Confidence            99999999999999998  99999999999863

>1fny_A BARK lectin, BARK agglutinin I,polypeptide A; legume lectin, jelly roll, sugar binding protein; 1.81A {Robinia pseudoacacia} SCOP: b.29.1.1 PDB: 1fnz_A*

Probab=100.00  E-value=3.3e-46  Score=362.70  Aligned_cols=169  Identities=31%  Similarity=0.511  Sum_probs=150.1

Q ss_pred             CcccCCCCCCCCCCeeeeeEEEEEEEEEeCCCCCCCCcEEEEEecCCCCCCCCCCCcccccccCCCCCCCccEEEEEeec
Q 007869            2 PFKNKNSNSSTANGTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGLFNDTNLGNETNHVFAVELDT   81 (586)
Q Consensus         2 p~~~~~~~~~~~~~~~asF~t~F~f~i~~~~~~~~g~GlaF~l~p~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEfDt   81 (586)
                      ||++|++.+    |+++||+|+|+|.|.+.+...+||||||+|+|....| +++|+||||||.++ ++..||+|||||||
T Consensus        55 Pi~l~d~~t----g~vaSFsT~F~F~I~~~~~~~~gdGlAF~l~p~~~~~-~~~g~~LGl~n~~~-~~~~~~~vAVEFDT  128 (237)
T 1fny_A           55 PFQIWDSTT----GNVASFVTSFTFIIQAPNPATTADGLAFFLAPVDTQP-LDLGGMLGIFKDGY-FNKSNQIVAVEFDT  128 (237)
T ss_dssp             CEECBCTTT----CCBCEEEEEEEEECCCSSTTSCCEEEEEEEEETTCCC-CCCGGGTTTCC----CCTTSCCEEEEEEC
T ss_pred             CEecccCCC----CCccceEEEEEEEEeCCCCCCCCCCEEEEeccCCCCC-CCCCCcccccccCC-CCccccEEEEEeec
Confidence            899999988    9999999999999998777789999999999986555 48899999999764 47799999999999


Q ss_pred             cccCCCCCCCCCeeEEeCCCCcccccccC--------ceEEEEcCeeeEEEEEEeecCCCCCCccceeeeeecchhcccc
Q 007869           82 IKSHGFLDINDNHVGIDINSLKSESSAPA--------GYYVEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSVLND  153 (586)
Q Consensus        82 ~~~~~~~d~~~~hvgidvns~~s~~~~~~--------~~~i~y~~~~~~l~v~~~~~~~~~~~~~~~ls~~~dL~~~l~~  153 (586)
                      ++|.+ +||++|||||||||+.|.++.++        .+||+||+.+++|+|++++.+.  |.. |+|++.+||+++|||
T Consensus       129 ~~n~~-~Dp~~nHVGIdvNsi~S~~~~~~~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~-~~ls~~vdL~~~l~e  204 (237)
T 1fny_A          129 FSNGD-WDPKGRHLGINVNSIESIKTVPWNWTNGEVANVFISYEASTKSLTASLVYPSL--ETS-FIIDAIVDVKIVLPE  204 (237)
T ss_dssp             SCCTT-TCCSSSEEEEEESSSSCSEEEECCCCTTCCEEEEEEEEGGGTEEEEEEEETTT--TEE-EEEEEECCHHHHSCS
T ss_pred             ccCcc-cCCCCCceEEecCCccccccccccccCCCEEEEEEEEeCCCcEEEEEEecCCC--CCc-ceEEEEechHHhCCC
Confidence            99988 49999999999999999887753        3699999999999999987543  444 899999999999999


Q ss_pred             ceeeeeecCCCcc---ceeeeeeecccccc
Q 007869          154 AMYVGFSSSTGSV---LASHYILGWSFKIN  180 (586)
Q Consensus       154 ~~~vGFsastg~~---~~~~~i~~Wsf~~~  180 (586)
                      +||||||||||..   .|.|+|++|+|+++
T Consensus       205 ~v~VGFSAsTG~~~~~~~~h~IlsWsF~s~  234 (237)
T 1fny_A          205 WVRFGFSATTGIDKGYVQTNDVLSWSFESN  234 (237)
T ss_dssp             EEEEEEEEEECSSTTCCCCCEEEEEEEEEE
T ss_pred             cEEEEEEEeeCCCCcccceeEEEEEEEEEe
Confidence            9999999999998   99999999999875

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=9.2e-46  Score=408.58  Aligned_cols=250  Identities=23%  Similarity=0.304  Sum_probs=203.0

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc---chhHH---HHHHHHHHhcccCCCceeeeeeeeeccCeE
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES---RQGMK---EFVAEIVSIGRLRHRNLVQLLGYCRRKGEL  333 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~---~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~  333 (586)
                      -++|+..++||+|+||+||+|+++.++..||||++.+..   .+...   ....++.+++.++|||||++++++.+.+.+
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l  267 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL  267 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence            467999999999999999999999999999999996531   12222   334457778888999999999999999999


Q ss_pred             EEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeec
Q 007869          334 LLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLY  413 (586)
Q Consensus       334 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~  413 (586)
                      |||||||+||+|.++|.+.  ..+++..+..++.||+.||.|||+   ++||||||||+||||+.++.+||+|||+|+.+
T Consensus       268 ylVmEy~~GGdL~~~l~~~--~~l~E~~a~~y~~qIl~aL~yLH~---~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~  342 (689)
T 3v5w_A          268 SFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDF  342 (689)
T ss_dssp             EEEECCCCSCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHeEEeCCCCEEecccceeeec
Confidence            9999999999999999765  368899999999999999999998   99999999999999999999999999999976


Q ss_pred             cCCCCCceeeeccCCCccCcccccC-CCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCcccccc
Q 007869          414 DHGTDPQTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEAR  492 (586)
Q Consensus       414 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~  492 (586)
                      ...   .....+||+.|||||++.. ..|+.++|+|||||+||||++|+.||......+...+.....    ..      
T Consensus       343 ~~~---~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~----~~------  409 (689)
T 3v5w_A          343 SKK---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL----TM------  409 (689)
T ss_dssp             SSC---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHH----HC------
T ss_pred             CCC---CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhc----CC------
Confidence            543   2345689999999999964 579999999999999999999999997654433221111111    11      


Q ss_pred             CCCCCccccHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 007869          493 DPNLGTEYVAEELELVLKLGLLCSHSDPTARPS-----MRQVVQ  531 (586)
Q Consensus       493 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~  531 (586)
                      .+.....+    ...+.+|+.+||+.||.+|++     +.|+++
T Consensus       410 ~~~~p~~~----S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          410 AVELPDSF----SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             CCCCCTTS----CHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred             CCCCCccC----CHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence            11111222    245678888999999999998     688764

>1fx5_A UEA-I, UE-I, anti-H(O) lectin I; legume lectin, HOMO-dimer, fucose specific lectin, SUG binding protein; HET: NAG FUC BMA MAN; 2.20A {Ulex europaeus} SCOP: b.29.1.1 PDB: 1jxn_A*

Probab=100.00  E-value=7.2e-46  Score=361.49  Aligned_cols=170  Identities=32%  Similarity=0.451  Sum_probs=151.7

Q ss_pred             CcccCCCCCCCCCCeeeeeEEEEEEEEEeC-CCCCCCCcEEEEEecCCCCCCCCCCCcccccccCCCCCCCccEEEEEee
Q 007869            2 PFKNKNSNSSTANGTVFSFSTTFVFSILSE-YQSQSGHGIAFVIASTRGLPGARPSQYLGLFNDTNLGNETNHVFAVELD   80 (586)
Q Consensus         2 p~~~~~~~~~~~~~~~asF~t~F~f~i~~~-~~~~~g~GlaF~l~p~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEfD   80 (586)
                      ||+||++.+    |+++||+|+|+|.|.+. +...+||||||+|+|....| +++|+||||||.++ ++..||+||||||
T Consensus        54 Pv~l~~~~t----g~vaSFsT~F~F~I~~~~~~~~~gdGlAF~l~p~~~~~-~~~g~~LGl~n~~~-~~~~n~~vAVEFD  127 (242)
T 1fx5_A           54 PIHIWNCNT----GELASFITSFSFFMETSANPKAATDGLTFFLAPPDSPL-RRAGGYFGLFNDTK-CDSSYQTVAVEFD  127 (242)
T ss_dssp             CEECEETTT----TEECEEEEEEEEEEEESSCGGGCCCEEEEEEECTTCCC-CBCGGGTTTBSSSC-CCGGGCCEEEEEE
T ss_pred             CEEeecCCC----CCccceEEEEEEEEecCCCCCCCCCcEEEEEecCCCCC-CCCCCcccccccCC-CCccCcEEEEEec
Confidence            899999887    99999999999999987 56778999999999986554 48899999999765 4789999999999


Q ss_pred             ccccCCC-CCCCCCeeEEeCCCCccccccc----------CceEEEEcCeeeEEEEEEeecCCCCCCccceeeeeecchh
Q 007869           81 TIKSHGF-LDINDNHVGIDINSLKSESSAP----------AGYYVEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSS  149 (586)
Q Consensus        81 t~~~~~~-~d~~~~hvgidvns~~s~~~~~----------~~~~i~y~~~~~~l~v~~~~~~~~~~~~~~~ls~~~dL~~  149 (586)
                      |++|.+| +||++|||||||||+.|.++++          ...||+||+.+++|+|++++.+.  |.. |+|++.+||++
T Consensus       128 T~~N~~~~~Dp~~nHVGIdvNs~~S~~~~~~~l~~G~~~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~-~~ls~~vdL~~  204 (242)
T 1fx5_A          128 TIGSPVNFWDPGFPHIGIDVNCVKSINAERWNKRYGLNNVANVEIIYEASSKTLTASLTYPSD--QTS-ISVTSIVDLKE  204 (242)
T ss_dssp             CCCTTTSTTSCSSCEEEEEESSSSCSEEEECCCCCSGGGCEEEEEEEETTTTEEEEEEEETTT--TEE-EEEEEECCGGG
T ss_pred             cccCcccccCCCCCeEEEecCCccccceecccccCCCceeEEEEEEEeCCCCEEEEEEecCCC--Ccc-ceeeEEechHH
Confidence            9999987 7999999999999999876653          34699999999999999987643  444 89999999999


Q ss_pred             ccccceeeeeecCC--CccceeeeeeeccccccC
Q 007869          150 VLNDAMYVGFSSST--GSVLASHYILGWSFKING  181 (586)
Q Consensus       150 ~l~~~~~vGFsast--g~~~~~~~i~~Wsf~~~~  181 (586)
                      +|||+|||||||||  |.. |.|+|++|+|+++.
T Consensus       205 ~l~e~v~VGFSAsT~~G~~-~~h~IlsWsF~s~l  237 (242)
T 1fx5_A          205 ILPEWVSVGFSGSTYIGRQ-ATHEVLNWYFTSTF  237 (242)
T ss_dssp             TSCSEEEEEEEEEEETTSC-EEEEEEEEEEEEES
T ss_pred             hCCccEEEEEEecccCCCc-ceeEEEEEEeEeec
Confidence            99999999999999  988 99999999999864

>1v6i_A Agglutinin, PNA, galactose-binding lectin; open quaternary association, orthorhombic, carbohydrate specificity, protein crystallography; HET: GAL GLC; 2.15A {Arachis hypogaea} SCOP: b.29.1.1 PDB: 1bzw_A* 1v6j_A* 1v6k_A* 1v6l_A* 1v6m_A 1v6n_A 1v6o_A 2dva_A* 1cq9_A 1ciw_A* 1qf3_A* 1rir_A* 1rit_A* 2dh1_A 1cr7_A* 2dv9_A* 2dvb_A* 2dvd_A* 2dvf_A 2dvg_A* ...

Probab=100.00  E-value=9e-46  Score=358.52  Aligned_cols=167  Identities=31%  Similarity=0.450  Sum_probs=151.4

Q ss_pred             CcccCCCCCCCCCCeeeeeEEEEEEEEEeCCCCCCCCcEEEEEecCC-CCCCCC-CCCcccccccCCCCCCCccEEEEEe
Q 007869            2 PFKNKNSNSSTANGTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTR-GLPGAR-PSQYLGLFNDTNLGNETNHVFAVEL   79 (586)
Q Consensus         2 p~~~~~~~~~~~~~~~asF~t~F~f~i~~~~~~~~g~GlaF~l~p~~-~~~~~~-~g~~lGl~~~~~~~~~~~~~vaVEf   79 (586)
                      ||++|++.+    |+++||+|+|+|.|.+.+...+||||||+|+|.. .+|.++ +|+||||+|.    ++.||+|||||
T Consensus        51 Pi~l~~~~t----g~vaSFsT~F~F~I~~~~~~~~gdGlAF~l~p~~~~~p~~~~~g~~LGl~n~----~~~~~~vAVEF  122 (232)
T 1v6i_A           51 PVRIWSSAT----GNVASFLTSFSFEMKDIKDYDPADGIIFFIAPEDTQIPAGSIGGGTLGVSDT----KGAGHFVGVEF  122 (232)
T ss_dssp             CEECBCTTT----CCBCEEEEEEEEEEECCSSSBCCCEEEEEEEETTCCCCTTCCCGGGTTTSCT----TSEEEEEEEEE
T ss_pred             CEEeecCCC----CCccceEEEEEEEEecCCCCCCCCCEEEEEecCCCCCCCCcCCCcccccccC----CCcccEEEEEe
Confidence            899999988    9999999999999998777789999999999976 468888 9999999986    56899999999


Q ss_pred             eccccCCCCCCCCCeeEEeCCCCcccccccC--------ceEEEEcCeeeEEEEEEeecCCCCCCccceeeeeecchhcc
Q 007869           80 DTIKSHGFLDINDNHVGIDINSLKSESSAPA--------GYYVEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSVL  151 (586)
Q Consensus        80 Dt~~~~~~~d~~~~hvgidvns~~s~~~~~~--------~~~i~y~~~~~~l~v~~~~~~~~~~~~~~~ls~~~dL~~~l  151 (586)
                      ||++|.+++||++|||||||||+.|.+++++        .+||+||+.+++|+|++++ +  +|.. |+|++.+||+++|
T Consensus       123 DT~~n~~~~Dp~~nHVGIdvns~~S~~~~~~~l~~G~~~~v~I~Yd~~~~~L~V~l~~-~--~~~~-~~ls~~vdL~~~l  198 (232)
T 1v6i_A          123 DTYSNSEYNDPPTDHVGIDVNSVDSVKTVPWNSVSGAVVKVTVIYDSSTKTLSVAVTN-D--NGDI-TTIAQVVDLKAKL  198 (232)
T ss_dssp             ECSCCGGGTCCSSCEEEEEEEESSCSEEEECCCCTTCEEEEEEEEETTTTEEEEEEEC-T--TSCE-EEEEEECCHHHHS
T ss_pred             ecccccccCCCCCCeEEEEcCCccccccccccccCCCEEEEEEEEeCCCcEEEEEEec-C--CCCc-ceEEEEechHHhC
Confidence            9999999899999999999999999887653        3699999999999999997 3  4555 9999999999999


Q ss_pred             ccceeeeeecCCCc--cceeeeeeeccccccC
Q 007869          152 NDAMYVGFSSSTGS--VLASHYILGWSFKING  181 (586)
Q Consensus       152 ~~~~~vGFsastg~--~~~~~~i~~Wsf~~~~  181 (586)
                      ||+|||||| |||.  ..|.|+|++|+|+++.
T Consensus       199 ~e~v~VGFS-sTG~~~~~~~h~IlsWsF~s~l  229 (232)
T 1v6i_A          199 PERVKFGFS-ASGSLGGRQIHLIRSWSFTSTL  229 (232)
T ss_dssp             CSEEEEEEE-EECCSSBCCEEEEEEEEEEEEE
T ss_pred             CccEEEEEE-ecCCCccccEEEEEEEEEEeec
Confidence            999999999 9998  5899999999998753

>1gzc_A Erythrina crista-galli lectin; carbohydrate, sugar binding protein, saccharide, protein-carbohydrate interactions, lactose, glycoprotein; HET: LAT; 1.58A {Erythrina crista-galli} SCOP: b.29.1.1 PDB: 1gz9_A* 1fyu_A* 1ax0_A* 1ax1_A* 1ax2_A* 1axy_A* 1axz_A* 1lte_A* 1sfy_A* 1v00_A* 1uzz_A 1uzy_A* 3n35_A* 3n36_A* 3n3h_A*

Probab=100.00  E-value=1.1e-45  Score=359.87  Aligned_cols=169  Identities=33%  Similarity=0.525  Sum_probs=150.8

Q ss_pred             CcccCCCCCCCCCCeeeeeEEEEEEEEEeCC-CCCCCCcEEEEEecCCCCCCCCCCCcccccccCCCCCCCccEEEEEee
Q 007869            2 PFKNKNSNSSTANGTVFSFSTTFVFSILSEY-QSQSGHGIAFVIASTRGLPGARPSQYLGLFNDTNLGNETNHVFAVELD   80 (586)
Q Consensus         2 p~~~~~~~~~~~~~~~asF~t~F~f~i~~~~-~~~~g~GlaF~l~p~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEfD   80 (586)
                      ||++|++.+    |+++||+|+|+|.|.+.+ ...+||||||+|+|....| +++|+||||||.++ ++..||+||||||
T Consensus        56 Pi~l~~~~t----g~vaSFsT~F~F~I~~~~~~~~~gdGlAF~l~p~~~~~-~~~g~~LGl~n~~~-~~~~~~~vAVEFD  129 (239)
T 1gzc_A           56 PVHMWDSTT----GTVASFETRFSFSIEQPYTRPLPADGLVFFMGPTKSKP-AQGYGYLGVFNNSK-QDNSYQTLAVEFD  129 (239)
T ss_dssp             CEECBCTTT----CCBCEEEEEEEEECCCCCSSSCCCEEEEEEEECSSCCC-CCCGGGTTTCSSSS-CCGGGCCEEEEEE
T ss_pred             CEecccCCC----CCccceEEEEEEEEeCCCCCCCCCCcEEEEEecCCCCC-CCCCCcccccccCC-CCccccEEEEEEe
Confidence            899999887    999999999999999876 6778999999999976555 48899999999764 5779999999999


Q ss_pred             ccccCCCCCCCCCeeEEeCCCCcccccccC--------ceEEEEcCeeeEEEEEEeecCCCCCCccceeeeeecchhccc
Q 007869           81 TIKSHGFLDINDNHVGIDINSLKSESSAPA--------GYYVEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSVLN  152 (586)
Q Consensus        81 t~~~~~~~d~~~~hvgidvns~~s~~~~~~--------~~~i~y~~~~~~l~v~~~~~~~~~~~~~~~ls~~~dL~~~l~  152 (586)
                      |++|. |+||++|||||||||+.|.++.++        ..||+||+.+++|+|++++.+.  |.. |+|++.+||+++||
T Consensus       130 T~~n~-~dDp~~nHVGIdvns~~S~~~~~~~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~-~~ls~~vdL~~~l~  205 (239)
T 1gzc_A          130 TFSNP-WDPPQVPHIGIDVNSIRSIKTQPFQLDNGQVANVVIKYDAPSKILHVVLVYPSS--GAI-YTIAEIVDVKQVLP  205 (239)
T ss_dssp             CSCCT-TSCSSSSEEEEEESSSSCSEEEECCCCTTCEEEEEEEEETTTTEEEEEEECTTT--CCE-EEEEEECCHHHHSC
T ss_pred             ccccc-CCCCCCCeEEEecCCccccccccccccCCCEEEEEEEEeCCCcEEEEEEecCCC--Ccc-ceEEEEechHHhCC
Confidence            99998 878999999999999999887754        3699999999999999987543  445 89999999999999


Q ss_pred             cceeeeeecCCCc---cceeeeeeecccccc
Q 007869          153 DAMYVGFSSSTGS---VLASHYILGWSFKIN  180 (586)
Q Consensus       153 ~~~~vGFsastg~---~~~~~~i~~Wsf~~~  180 (586)
                      |+||||||||||.   ..|.|+|++|+|+++
T Consensus       206 e~v~VGFSAsTG~~~~~~~~h~IlsWsF~s~  236 (239)
T 1gzc_A          206 DWVDVGLSGATGAQRDAAETHDVYSWSFQAS  236 (239)
T ss_dssp             SEEEEEEEEEECSSTTCCCCCEEEEEEEEEE
T ss_pred             CceEEEEEeccCCCccccceEEEEEEEeEEe
Confidence            9999999999997   489999999999875

>2eig_A Lectin; L-fucosyl, N-acetyl-D-glucosamine, SUG binding protein; HET: NAG; 2.00A {Lotus tetragonolobus}

Probab=100.00  E-value=6.2e-45  Score=352.68  Aligned_cols=166  Identities=30%  Similarity=0.438  Sum_probs=150.6

Q ss_pred             CcccCCCCCCCCCCeeeeeEEEEEEEEEeCCCCCCCCcEEEEEecCC-CCCCCCCCCcccccccCCCCCCCccEEEEEee
Q 007869            2 PFKNKNSNSSTANGTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTR-GLPGARPSQYLGLFNDTNLGNETNHVFAVELD   80 (586)
Q Consensus         2 p~~~~~~~~~~~~~~~asF~t~F~f~i~~~~~~~~g~GlaF~l~p~~-~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEfD   80 (586)
                      ||++|++.+    |+++||+|+|+|.|.+.....+||||||+|+|.. .+|.+++|+||||||.+   ++.||+||||||
T Consensus        48 Pv~l~~~~t----g~vaSFsT~F~F~I~~~~~~~~gdGlAF~l~p~~~~~p~~~~g~~LGl~n~~---~~~~~~vAVEFD  120 (234)
T 2eig_A           48 PVPIWDSAT----GNVASFITSFSFIVSNVQRYPPTDGVVFFLAPWGTEIPPNSQGGYLGITDSS---NSQNQFVAVEFD  120 (234)
T ss_dssp             CEECBCTTT----CCBCEEEEEEEEEEEECTTSCCCCEEEEEEEETTCCCCTTCCGGGTTTCCTT---CSCCCCEEEEEE
T ss_pred             CEEeecCCC----CCccceEEEEEEEEeCCCCCCCCCcEEEEEecCCCCCCcCCCCCccccccCC---CccccEEEEEec
Confidence            899999987    9999999999999998877789999999999976 47888899999999976   668999999999


Q ss_pred             ccccCCCCCCCC---CeeEEeCCCCcccccccC--------ceEEEEcCeeeEEEEEEeecCCCCCCccceeeeeecchh
Q 007869           81 TIKSHGFLDIND---NHVGIDINSLKSESSAPA--------GYYVEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSS  149 (586)
Q Consensus        81 t~~~~~~~d~~~---~hvgidvns~~s~~~~~~--------~~~i~y~~~~~~l~v~~~~~~~~~~~~~~~ls~~~dL~~  149 (586)
                      |++|.  +||++   |||||||||+.|.+++++        .+||+||+.+++|+|++++ +  .|.. |+|++.+||++
T Consensus       121 T~~N~--~Dp~~~~~nHVGIdvNsi~S~~~~~~~l~~g~~~~v~I~Yd~~~~~L~V~l~~-~--~~~~-~~ls~~vdL~~  194 (234)
T 2eig_A          121 SHPNV--WDPKSLRSSHIGIDVNSIMSLKAVNWNRVSGSLEKATIIYDSDTKILTVVMTH-Q--NGQI-TTISQEIDLKT  194 (234)
T ss_dssp             CSCCT--TSCTTTCSSEEEEEESSSSCSEEEECCCCTTCCEEEEEEEETTTTEEEEEEEE-T--TSCE-EEEEEECCHHH
T ss_pred             cccCc--cCCCCCCCCceEEecCCccccceecccccCCCEEEEEEEEeCCCcEEEEEEec-C--CCCc-ceEeEeechHH
Confidence            99997  59999   999999999999887653        3699999999999999998 4  3555 89999999999


Q ss_pred             ccccceeeeeecCC--CccceeeeeeeccccccC
Q 007869          150 VLNDAMYVGFSSST--GSVLASHYILGWSFKING  181 (586)
Q Consensus       150 ~l~~~~~vGFsast--g~~~~~~~i~~Wsf~~~~  181 (586)
                      +|||+|||||||||  |.. |.|+|++|+|+++.
T Consensus       195 ~l~e~v~VGFSAsT~~G~~-~~h~IlsWsF~s~l  227 (234)
T 2eig_A          195 VLPEKVSVGFSATTWNPER-ERHDIYSWSFTSTL  227 (234)
T ss_dssp             HSCSEEEEEEEEEECSSCC-EEEEEEEEEEEEEC
T ss_pred             hcCCceEEEEEeeecCCCc-ceeEEEEEEEEecC
Confidence            99999999999999  988 99999999999864

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=4.6e-45  Score=374.02  Aligned_cols=260  Identities=26%  Similarity=0.388  Sum_probs=213.7

Q ss_pred             hcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEe
Q 007869          259 ATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYD  338 (586)
Q Consensus       259 a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E  338 (586)
                      ..++|...+.||+|+||.||+|.+..++..||+|++........+.|.+|++++++++||||+++++++.+.+..++|||
T Consensus         8 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   87 (310)
T 3s95_A            8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITE   87 (310)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEE
Confidence            34678889999999999999999999999999999977777777889999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCC
Q 007869          339 YMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD  418 (586)
Q Consensus       339 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~  418 (586)
                      |+++|+|.+++.... ..+++.+++.++.|+++||.|||+   .+|+||||||+|||++.++.+||+|||+++.......
T Consensus        88 ~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  163 (310)
T 3s95_A           88 YIKGGTLRGIIKSMD-SQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT  163 (310)
T ss_dssp             CCTTCBHHHHHHHCC-TTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred             ecCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence            999999999998753 468999999999999999999998   8999999999999999999999999999987644322


Q ss_pred             Cc-------------eeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhcc
Q 007869          419 PQ-------------TTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNR  485 (586)
Q Consensus       419 ~~-------------~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~  485 (586)
                      ..             .....||+.|+|||++.+..++.++|||||||++|||++|..|+............. .....  
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~-~~~~~--  240 (310)
T 3s95_A          164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN-VRGFL--  240 (310)
T ss_dssp             ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBC-HHHHH--
T ss_pred             cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhh-hhccc--
Confidence            11             114579999999999999999999999999999999999999987643322110000 00000  


Q ss_pred             CccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 007869          486 GELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERD  536 (586)
Q Consensus       486 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  536 (586)
                         .....+        .....+.+++.+||+.||++|||+.++++.|+..
T Consensus       241 ---~~~~~~--------~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l  280 (310)
T 3s95_A          241 ---DRYCPP--------NCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETL  280 (310)
T ss_dssp             ---HHTCCT--------TCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---cccCCC--------CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence               000011        1123477889999999999999999999998753

>1qnw_A Chitin binding lectin, UEA-II; carbohydrate binding; HET: NAG; 2.35A {Ulex europaeus} SCOP: b.29.1.1 PDB: 1dzq_A* 1qoo_A* 1qos_A* 1qot_A*

Probab=100.00  E-value=6e-45  Score=354.96  Aligned_cols=169  Identities=31%  Similarity=0.515  Sum_probs=152.1

Q ss_pred             CcccCCCCCCCCCCeeeeeEEEEEEEEEeCCCCCCCCcEEEEEecCC-CCCCCCCCCcccccccCCCCCCCccEEEEEee
Q 007869            2 PFKNKNSNSSTANGTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTR-GLPGARPSQYLGLFNDTNLGNETNHVFAVELD   80 (586)
Q Consensus         2 p~~~~~~~~~~~~~~~asF~t~F~f~i~~~~~~~~g~GlaF~l~p~~-~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEfD   80 (586)
                      ||++|++.+    |+++||+|+|+|.|.+. ...+||||||+|+|.. .+|.+++|+||||||.++ ++..||+||||||
T Consensus        55 Pv~l~~~~t----g~vasFsT~F~F~I~~~-~~~~gdGlAF~l~p~~~~~p~~~~g~~LGl~n~~~-~~~~~~~vAVEFD  128 (242)
T 1qnw_A           55 PIQIWDSIT----GKVASFATSFSFVVKAD-KSDGVDGLAFFLAPANSQIPSGSSAGMFGLFSSSD-SKSSNQIIAVEFD  128 (242)
T ss_dssp             CEECBCTTT----CCBCEEEEEEEEECCBS-SSCCCCEEEEEEEETTCCCCTTCCGGGTTTCSSSS-CCTTSCCEEEEEE
T ss_pred             CEeeecCCC----CCcccEEEEEEEEEecC-CCCCCCCEEEEEecCCCCCCcCCCCCcccccccCC-CCccccEEEEEee
Confidence            899999887    99999999999999987 6778999999999976 468889999999999765 4778999999999


Q ss_pred             cc----ccCCCCCCCCCeeEEeCCCCcccccccC--------ceEEEEcCeeeEEEEEEeecCCCCCCccceeeeeecch
Q 007869           81 TI----KSHGFLDINDNHVGIDINSLKSESSAPA--------GYYVEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLS  148 (586)
Q Consensus        81 t~----~~~~~~d~~~~hvgidvns~~s~~~~~~--------~~~i~y~~~~~~l~v~~~~~~~~~~~~~~~ls~~~dL~  148 (586)
                      |+    +|.  +||++|||||||||+.|.++.++        ..||+||+.+++|+|++.+.+.  |.. |+|++.+||+
T Consensus       129 T~~~~~~N~--~Dp~~nHVGIdvNs~~S~~~~~~~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~-~~ls~~vdL~  203 (242)
T 1qnw_A          129 TYFGKAYNP--WDPDFKHIGIDVNSIKSIKTVKWDWRNGEVADVVITYRAPTKSLTVCLSYPSD--GTS-NIITASVDLK  203 (242)
T ss_dssp             CCCCTTTCT--TSCSSCEEEEEESSSSCSEEEECCCCTTCCEEEEEEEEGGGTEEEEEEECTTT--CCE-EEEEEECCHH
T ss_pred             cccccccCC--CCCCCCcEEEecCCccccceecccccCCCEEEEEEEEeCCCcEEEEEEecCCC--Ccc-eeEEEeechH
Confidence            99    887  59999999999999999887653        3699999999999999987543  445 8999999999


Q ss_pred             hccccceeeeeecCCCcc--ceeeeeeeccccccC
Q 007869          149 SVLNDAMYVGFSSSTGSV--LASHYILGWSFKING  181 (586)
Q Consensus       149 ~~l~~~~~vGFsastg~~--~~~~~i~~Wsf~~~~  181 (586)
                      .+|||+|||||||+||..  .|.|+|++|+|+++.
T Consensus       204 ~~l~e~v~VGFSAsTG~~~~~~~h~IlsWsF~s~l  238 (242)
T 1qnw_A          204 AILPEWVSVGFSGGVGNAAEFETHDVLSWYFTSNL  238 (242)
T ss_dssp             HHSCSEEEEEEEEEESCGGGCBCCEEEEEEEEEEC
T ss_pred             HhcCCceEEEEEeccCCCccceEEEEEEEEeEeec
Confidence            999999999999999999  999999999999864

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.3e-44  Score=369.07  Aligned_cols=251  Identities=24%  Similarity=0.379  Sum_probs=211.9

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEec
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY  339 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  339 (586)
                      .++|+..+.||+|+||.||+|.+..++..||||++........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   98 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence            46799999999999999999999889999999999876666677899999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCC
Q 007869          340 MPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP  419 (586)
Q Consensus       340 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~  419 (586)
                      +++|+|.+++...   .+++.++..++.|++.||.|||+   ++|+||||||+|||++.++++||+|||+++....... 
T Consensus        99 ~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  171 (297)
T 3fxz_A           99 LAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-  171 (297)
T ss_dssp             CTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred             CCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc-
Confidence            9999999999765   58889999999999999999998   8999999999999999999999999999987654332 


Q ss_pred             ceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCcc
Q 007869          420 QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTE  499 (586)
Q Consensus       420 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~  499 (586)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+..      ......+      .+.+  .
T Consensus       172 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~------~~~~~~~------~~~~--~  237 (297)
T 3fxz_A          172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL------YLIATNG------TPEL--Q  237 (297)
T ss_dssp             CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------HHHHHHC------SCCC--S
T ss_pred             ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHHhCC------CCCC--C
Confidence            334567999999999999999999999999999999999999999764332111      1111111      1111  1


Q ss_pred             ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          500 YVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       500 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      ........+.+++.+||+.||++|||+.|+++
T Consensus       238 ~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          238 NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            11223355778899999999999999999986

>2bqp_A Protein (PEA lectin); D-glucopyranose complex, sugar binding protein; HET: GLC; 1.90A {Pisum sativum} SCOP: b.29.1.1

Probab=100.00  E-value=1.6e-44  Score=351.75  Aligned_cols=171  Identities=31%  Similarity=0.485  Sum_probs=152.7

Q ss_pred             CcccCCCCCCCCCCeeeeeEEEEEEEEEeCCCCCCCCcEEEEEecCCCCCCCCCCCcccccccCCCCCCCccEEEEEeec
Q 007869            2 PFKNKNSNSSTANGTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGLFNDTNLGNETNHVFAVELDT   81 (586)
Q Consensus         2 p~~~~~~~~~~~~~~~asF~t~F~f~i~~~~~~~~g~GlaF~l~p~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEfDt   81 (586)
                      ||+||++.+    |+++||+|+|+|.|.+.....+||||||+|+|....|. ++|+||||||.++ ++..||+|||||||
T Consensus        49 Pv~l~~~~~----~~~~sFst~F~F~I~~~~~~~~gdGlAF~l~p~~~~p~-~~g~~LGl~n~~~-~~~~~~~vAVEFDT  122 (234)
T 2bqp_A           49 PIHIWDRET----GNVANFVTSFTFVINAPNSYNVADGFTFFIAPVDTKPQ-TGGGYLGVFNSAE-YDKTTQTVAVEFDT  122 (234)
T ss_dssp             CEECBCTTT----CCBCEEEEEEEEEEECSSTTSCCCEEEEEEEETTCCCC-CCGGGTTTCSCSS-CCGGGCCEEEEEEC
T ss_pred             CEEcccCCC----CceeeEEEEEEEEEeCCCCCCCCCcEEEEEecCCCCCC-CCCCccccccccC-CCCCCcEEEEEEec
Confidence            899999988    99999999999999987777899999999999876666 8899999999874 57889999999999


Q ss_pred             cccCCCCCCC--CCeeEEeCCCCcccccccC--------ceEEEEcCeeeEEEEEEeecCCC---CCCccceeeeeecch
Q 007869           82 IKSHGFLDIN--DNHVGIDINSLKSESSAPA--------GYYVEYDGLEKRTNVTLAPINIP---RPRSLNTMSLSRDLS  148 (586)
Q Consensus        82 ~~~~~~~d~~--~~hvgidvns~~s~~~~~~--------~~~i~y~~~~~~l~v~~~~~~~~---~~~~~~~ls~~~dL~  148 (586)
                      ++|.+ +||+  +||||||||++.|.++.++        ..||+||+.+++|+|++.+...+   +|.. |+|++.+||+
T Consensus       123 ~~N~~-~Dp~~~~nHVgIdvns~~S~~s~~~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~~~~~~p~~-~~ls~~vdL~  200 (234)
T 2bqp_A          123 FYNAA-WDPSNRDRHIGIDVNSIKSVNTKSWKLQNGEEANVVIAFNAATNVLTVSLTYPNNSLEEEVTS-YTLSDVVSLK  200 (234)
T ss_dssp             SCCTT-TSCTTCCCEEEEEESSSSCSEEEECCCCTTCEEEEEEEEETTTTEEEEEEEECC------CEE-EEEEEECCGG
T ss_pred             ccCcc-cCCCCCCCceeEeeCCccccceEeeEEcCCCEEEEEEEEeCCCCEEEEEEecCCCCcccCCCc-ceEEEEechH
Confidence            99988 5999  9999999999998877653        36999999999999999987655   5666 9999999999


Q ss_pred             hccccceeeeeecCCCccceeeeeeecccccc
Q 007869          149 SVLNDAMYVGFSSSTGSVLASHYILGWSFKIN  180 (586)
Q Consensus       149 ~~l~~~~~vGFsastg~~~~~~~i~~Wsf~~~  180 (586)
                      .+||++||||||||||...|.|+|++|+|+++
T Consensus       201 ~~l~~~~yvGFSAsTG~~~~~H~IlsWsF~s~  232 (234)
T 2bqp_A          201 DVVPEWVRIGFSATTGAEYAAHEVLSWSFHSE  232 (234)
T ss_dssp             GTSCSEEEEEEEEECSSSCCEEEEEEEEEEEE
T ss_pred             HhCCCceEEEEEeccCCCcccEEEEEEEEEee
Confidence            99999999999999999999999999999874

>1gsl_A Griffonia simplicifolia lectin 4; glycoprotein, manganese; HET: FUC GAL MAG NAG BMA; 2.00A {Griffonia simplicifolia} SCOP: b.29.1.1 PDB: 1lec_A* 1led_A*

Probab=100.00  E-value=1.1e-44  Score=353.67  Aligned_cols=168  Identities=30%  Similarity=0.409  Sum_probs=150.4

Q ss_pred             CcccCCCCCCCCCCeeeeeEEEEEEEEEeCCCCCCCCcEEEEEecCCCCCCCCCCCcccccccCCC-CCCCccEEEEEee
Q 007869            2 PFKNKNSNSSTANGTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGLFNDTNL-GNETNHVFAVELD   80 (586)
Q Consensus         2 p~~~~~~~~~~~~~~~asF~t~F~f~i~~~~~~~~g~GlaF~l~p~~~~~~~~~g~~lGl~~~~~~-~~~~~~~vaVEfD   80 (586)
                      ||+||+ .+    |+++||+|+|+|+|.+. ...+||||||+|+|....| +++|+||||||.+++ ++..||+||||||
T Consensus        59 Pv~l~~-~t----g~vasFsT~F~F~I~~~-~~~~gdGlAF~l~p~~~~~-~~~g~~LGl~n~~~~~~~~~n~~vAVEFD  131 (243)
T 1gsl_A           59 PVFLWD-ST----GKAASFYTSFTFLLKNY-GAPTADGLAFFLAPVDSSV-KDYGGFLGLFRHETAADPSKNQVVAVEFD  131 (243)
T ss_dssp             CEECBC-TT----SCBCEEEEEEEEEEEES-SSSCBCEEEEEEEETTCCC-CCCGGGTTTSCTTTTTCGGGCCCEEEEEE
T ss_pred             CEEccC-CC----CCcCceEEEEEEEEecC-CCCCCCCEEEEEecCCCCC-CCCCCcccccccccccCCccCcEEEEEec
Confidence            899999 77    99999999999999987 6778999999999986554 488999999998764 6788999999999


Q ss_pred             ccccCCCCCCCCCeeEEeCCCCcccccccC-----------ceEEEEcCeeeEEEEEEeecCCCCCCccceeeeeecchh
Q 007869           81 TIKSHGFLDINDNHVGIDINSLKSESSAPA-----------GYYVEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSS  149 (586)
Q Consensus        81 t~~~~~~~d~~~~hvgidvns~~s~~~~~~-----------~~~i~y~~~~~~l~v~~~~~~~~~~~~~~~ls~~~dL~~  149 (586)
                      |++|.+|+||++||||||+||+.|.++.++           .+||+||+.+++|+|++.+...   .. |+|++.+||+.
T Consensus       132 T~~N~~~~Dp~~nHvGIdvns~~S~~~~~~~l~~~~~g~~~~v~I~Yd~~~~~L~V~l~~~~~---~~-~~ls~~vdL~~  207 (243)
T 1gsl_A          132 TWINKDWNDPPYPHIGIDVNSIVSVATTRWENDDAYGSSIATAHITYDARSKILTVLLSYEHG---RD-YILSHVVDLAK  207 (243)
T ss_dssp             CSCCGGGTCCSSCEEEEEESSSSCSEEEECCHHHHTSCCEEEEEEEEETTTTEEEEEEEETTS---CE-EEEEEECCHHH
T ss_pred             cccccccCCCCCCceeeccCCccccceeeeEEeccCCCcEEEEEEEEeCCCCEEEEEEecCCC---Cc-eeEEEEechHH
Confidence            999999999999999999999998766542           3699999999999999987543   24 89999999999


Q ss_pred             ccccceeeeeecCCCccceeeeeeeccccccC
Q 007869          150 VLNDAMYVGFSSSTGSVLASHYILGWSFKING  181 (586)
Q Consensus       150 ~l~~~~~vGFsastg~~~~~~~i~~Wsf~~~~  181 (586)
                      +||++|||||||||| ..|.|+|++|+|+++.
T Consensus       208 ~l~~~~~vGFSAsTG-~~~~h~IlsWsF~s~l  238 (243)
T 1gsl_A          208 VLPQKVRIGFSAGVG-YDEVTYILSWHFFSTL  238 (243)
T ss_dssp             HSCSEEEEEEEEEEC-BSEEEEEEEEEEEEEC
T ss_pred             hCCCceEEEEEeccC-CcceeEEEEEEEEeec
Confidence            999999999999999 9999999999999864

>2fmd_A Lectin, agglutinin, BMA; legume lectin, beta sandwich, protein-carbohydrate complex, sugar binding protein; HET: MAN; 1.90A {Bowringia mildbraedii}

Probab=100.00  E-value=1.2e-44  Score=353.53  Aligned_cols=170  Identities=33%  Similarity=0.455  Sum_probs=150.7

Q ss_pred             CcccCCCCCCCCCCeeeeeEEEEEEEEEeCCCCCCCCcEEEEEecCCCCCCC-CCCCcccccccCCCCCCCccEEEEEee
Q 007869            2 PFKNKNSNSSTANGTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGA-RPSQYLGLFNDTNLGNETNHVFAVELD   80 (586)
Q Consensus         2 p~~~~~~~~~~~~~~~asF~t~F~f~i~~~~~~~~g~GlaF~l~p~~~~~~~-~~g~~lGl~~~~~~~~~~~~~vaVEfD   80 (586)
                      ||+||++ +    |+++||+|+|+|.|.+. ...+||||||+|+|....|.+ ++|+||||||.+++++..||+||||||
T Consensus        56 Pv~l~~~-~----g~~~sFst~F~F~I~~~-~~~~gdGlAF~l~p~~~~p~~g~~g~~LGl~n~~~~~~~~n~~vAVEfD  129 (240)
T 2fmd_A           56 PIRLWQS-S----SLVASFETTFTFSISQG-SSTPADALTFFIASPDTKIPSGSGGRLLGLFGSSNNAGSDNGVVSVEFD  129 (240)
T ss_dssp             CEECCCT-T----CSEEEEEEEEEEECCBS-SSSCCCEEEEEEECTTCCCCTTCCGGGTTTCSCCC----CCCEEEEEEE
T ss_pred             CEEeeCC-C----CCcCcEEEEEEEEEecC-CCCCCCcEEEEEecCCCCCCccCCCCcccccccCcCCCCcCcEEEEEec
Confidence            8999998 7    99999999999999987 677999999999998766765 889999999988777789999999999


Q ss_pred             ccccCCCCCCCCCeeEEeCCCCcccccccC--------ceEEEEcCeeeEEEEEEeecCCCCCCccceeeeeecchhccc
Q 007869           81 TIKSHGFLDINDNHVGIDINSLKSESSAPA--------GYYVEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSVLN  152 (586)
Q Consensus        81 t~~~~~~~d~~~~hvgidvns~~s~~~~~~--------~~~i~y~~~~~~l~v~~~~~~~~~~~~~~~ls~~~dL~~~l~  152 (586)
                      |++|.+++||++||||||+|++.|.++.++        ..||+||+.+++|+|++.+...   .. |+|++.+||+.+||
T Consensus       130 T~~N~~~~Dp~~nHvgIdvns~~S~~s~~~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~---~~-~~ls~~vdL~~~l~  205 (240)
T 2fmd_A          130 TYPNTDIGDPNYRHIGIDVNSIRSKAASKWDWQNGKTATAHISYNSASKRLSVVSSYPNS---SP-VVVSFDVELNNVBP  205 (240)
T ss_dssp             CSCCGGGTCCSSCEEEEEESSSSCSEEEECCCCSSCEEEEEEEEETTTTEEEEEEECTTS---CC-EEEEEECCGGGTSC
T ss_pred             cccccccCCCCCCceeeccccccccceeEEEeeCCCEEEEEEEEeCCCCEEEEEEecCCC---Cc-eEEEEEechHHhCC
Confidence            999998889999999999999999877653        3699999999999999987543   34 89999999999999


Q ss_pred             cceeeeeecCCCccceeeeeeeccccccC
Q 007869          153 DAMYVGFSSSTGSVLASHYILGWSFKING  181 (586)
Q Consensus       153 ~~~~vGFsastg~~~~~~~i~~Wsf~~~~  181 (586)
                      ++||||||||||...|.|+|++|+|+++.
T Consensus       206 ~~~yvGFSAsTG~~~~~H~IlsWsF~s~~  234 (240)
T 2fmd_A          206 BWVRVGFSATTGQYTQTNNILAWSFRSSL  234 (240)
T ss_dssp             SEEEEEEEEECCSSCBCCEEEEEEEEEEE
T ss_pred             CceEEEEEeccCCccccEEEEEEEeEecC
Confidence            99999999999999999999999998763

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.5e-44  Score=372.80  Aligned_cols=274  Identities=25%  Similarity=0.377  Sum_probs=214.0

Q ss_pred             hhhhhhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccC--
Q 007869          254 KDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKG--  331 (586)
Q Consensus       254 ~el~~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~--  331 (586)
                      .++....++|+..+.||+|+||.||+|++.  +..||||++..... ....+..|+.++++++||||+++++++....  
T Consensus        17 ~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   93 (322)
T 3soc_A           17 ENLYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSV   93 (322)
T ss_dssp             CCEEETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSS
T ss_pred             cccccchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCC
Confidence            355566788999999999999999999985  67899999965533 3345677999999999999999999998754  


Q ss_pred             --eEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCC----------cEEeCCCCCCCeeecCC
Q 007869          332 --ELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQ----------VVIHRDVKASNVLLDGE  399 (586)
Q Consensus       332 --~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~----------~ivHrDIkp~NIll~~~  399 (586)
                        .+++||||+++|+|.+++...   .++|..++.++.|+++||.|||+   .          +|+||||||+|||++.+
T Consensus        94 ~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~---~~~~l~~~~~~~ivH~Dlkp~Nill~~~  167 (322)
T 3soc_A           94 DVDLWLITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHE---DIPGLKDGHKPAISHRDIKSKNVLLKNN  167 (322)
T ss_dssp             SEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTC---CEEEETTEEECEEECSCCSGGGEEECTT
T ss_pred             CceEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHh---hccccccccCCCEEeCCCChHhEEECCC
Confidence              479999999999999999765   48999999999999999999998   6          99999999999999999


Q ss_pred             CCeEEccccceeeccCCCCC-ceeeeccCCCccCcccccCC-----CCCCcceEEehhHHHHHHHhCCCCCCCCCCCccc
Q 007869          400 LNGRLGDFGLARLYDHGTDP-QTTHVVGTLGYLAPEHTRTG-----KATTSADVFSFGAFLLEVACGRRPIQRQGPSENL  473 (586)
Q Consensus       400 ~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-----~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~  473 (586)
                      +.+||+|||+++........ ......||+.|+|||++.+.     .++.++|||||||++|||++|+.||.........
T Consensus       168 ~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~  247 (322)
T 3soc_A          168 LTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML  247 (322)
T ss_dssp             CCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCC
T ss_pred             CeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhcc
Confidence            99999999999876544322 23346799999999999763     4567899999999999999999999875443322


Q ss_pred             hhhHHHHh-----hhccCccccccCCCCCccc-cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 007869          474 ILVDWVFD-----FWNRGELLEARDPNLGTEY-VAEELELVLKLGLLCSHSDPTARPSMRQVVQILERD  536 (586)
Q Consensus       474 ~l~~~v~~-----~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  536 (586)
                      ........     .+.+........|.+...+ .......+.+++.+||+.||++|||+.|+++.|++.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l  316 (322)
T 3soc_A          248 PFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM  316 (322)
T ss_dssp             TTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             chhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            11111000     0000001111223322221 224567789999999999999999999999999763

>1sbf_A Soybean agglutinin; lectin; HET: NAG GAL; 2.43A {Glycine max} SCOP: b.29.1.1 PDB: 1sbd_A* 1sbe_A* 1g9f_A* 2sba_A*

Probab=100.00  E-value=1.3e-44  Score=354.47  Aligned_cols=167  Identities=31%  Similarity=0.489  Sum_probs=150.2

Q ss_pred             CcccCCCCCCCCCCeeeeeEEEEEEEEEeCCCCCCCCcEEEEEecCCCCCCCCCCCcccccccCCCCCCCccEEEEEeec
Q 007869            2 PFKNKNSNSSTANGTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGLFNDTNLGNETNHVFAVELDT   81 (586)
Q Consensus         2 p~~~~~~~~~~~~~~~asF~t~F~f~i~~~~~~~~g~GlaF~l~p~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEfDt   81 (586)
                      ||++|++.+    |+++||+|+|+|.|.+.+...+||||||+|+|....| +++|+||||||.+   +..||+|||||||
T Consensus        56 Pv~l~d~~t----g~vaSFsT~F~F~I~~~~~~~~gdGlAF~l~p~~~~~-~~~g~~LGL~n~~---~~~n~~vAVEFDT  127 (253)
T 1sbf_A           56 PIHIWDKET----GSVASFAASFNFTFYAPDTKRLADGLAFFLAPIDTKP-QTHAGYLGLFNEN---ESGDQVVAVEFDT  127 (253)
T ss_dssp             CEECBCTTT----CCBCEEEEEEEEEEECSSTTSCCEEEEEEEEETTCCC-CCCGGGTTTCCTT---SCCCSCEEEEEEC
T ss_pred             CEecccCCC----CcccceEEEEEEEEeCCCCCCCCCcEEEEEecCCCCC-CCCCCccccccCC---CcccceEEEEecc
Confidence            899999988    9999999999999998777789999999999986555 4889999999976   6689999999999


Q ss_pred             cccCCCCCCCCCeeEEeCCCCcccccccC--------ceEEEEcCeeeEEEEEEeecCCCCCCccceeeeeecchhcccc
Q 007869           82 IKSHGFLDINDNHVGIDINSLKSESSAPA--------GYYVEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSVLND  153 (586)
Q Consensus        82 ~~~~~~~d~~~~hvgidvns~~s~~~~~~--------~~~i~y~~~~~~l~v~~~~~~~~~~~~~~~ls~~~dL~~~l~~  153 (586)
                      ++|.  +||++|||||||||+.|.++.++        ..||+||+.+++|+|++++...  |.. |+|++.+||+.+|||
T Consensus       128 ~~N~--~Dp~~nHVGIdvNs~~S~~t~~~~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~-~~ls~~vdL~~~l~e  202 (253)
T 1sbf_A          128 FRNS--WDPPNPHIGINVNSIRSIKTTSWDLANNKVAKVLITYDASTSLLVASLVYPSQ--RTS-NILSDVVDLKTSLPE  202 (253)
T ss_dssp             SCCT--TCCSSSEEEEEESSSSCSEEEECCCCTTCCEEEEEEEETTTTEEEEEEEETTT--TEE-EEEEEECCHHHHSCS
T ss_pred             ccCC--CCCCCCcEEEEcCCccccceecccccCCCeeEEEEEEeCCCcEEEEEEecCCC--CCc-ceEEEEechHHhCCC
Confidence            9997  59999999999999999887653        3699999999999999987543  444 899999999999999


Q ss_pred             ceeeeeecCCCcc--ceeeeeeeccccccC
Q 007869          154 AMYVGFSSSTGSV--LASHYILGWSFKING  181 (586)
Q Consensus       154 ~~~vGFsastg~~--~~~~~i~~Wsf~~~~  181 (586)
                      +||||||||||..  .|.|+|++|+|+++.
T Consensus       203 ~~~VGFSAsTG~~~~~~~H~IlsWsF~s~l  232 (253)
T 1sbf_A          203 WVRIGFSAATGLDIPGESHDVLSWSFASNL  232 (253)
T ss_dssp             EEEEEEEEEECSSSCCCEEEEEEEEEEEEE
T ss_pred             ceEEEEEeccCCCccceeeEEEEEEeEeec
Confidence            9999999999998  999999999999863

>1g7y_A Stem/LEAF lectin DB58; jelly roll fold, sugar binding protein; HET: NAG FUC FUL; 2.50A {Vigna unguiculata subsp} SCOP: b.29.1.1 PDB: 1lul_A 1lu1_A* 1bjq_A* 1lu2_A*

Probab=100.00  E-value=9.9e-45  Score=355.76  Aligned_cols=170  Identities=29%  Similarity=0.460  Sum_probs=152.1

Q ss_pred             CcccCCCCCCCCCCeeeeeEEEEEEEEEeCCCCCCCCcEEEEEecCCCCCCCCCCCcccccccCCCCCCCccEEEEEeec
Q 007869            2 PFKNKNSNSSTANGTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGLFNDTNLGNETNHVFAVELDT   81 (586)
Q Consensus         2 p~~~~~~~~~~~~~~~asF~t~F~f~i~~~~~~~~g~GlaF~l~p~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEfDt   81 (586)
                      ||++|++.+    |+++||+|+|+|.|.+.....+||||||+|+|....| +++|+||||||.++ ++..||+|||||||
T Consensus        53 Pv~l~d~~t----g~vaSFsT~F~F~I~~~~~~~~gdGlAF~l~p~~~~~-~~~g~~LGl~n~~~-~~~~n~~vAVEFDT  126 (253)
T 1g7y_A           53 PIQIYDKST----GAVASWATSFTANIFAPNKSSSADGIAFALVPVGSEP-KSNSGFLGVFDSDV-YDNSAQTVAVEFDT  126 (253)
T ss_dssp             CEECBCTTT----CCBCEEEEEEEEECCCSSGGGCCCEEEEEEEETTCCC-CCCGGGTTTCSCSS-CCGGGCCEEEEEEC
T ss_pred             CEEeecCCC----CCccceEEEEEEEEecCCCCCCCCcEEEEEecCCCCC-CCCCCcccccccCC-CCccCceEEEEecc
Confidence            899999988    9999999999999998766778999999999986555 48899999999774 47799999999999


Q ss_pred             cccCCCCCCCCCeeEEeCCCCcccccccC--------ceEEEEcCeeeEEEEEEeecCCCCCCccceeeeeecchhcccc
Q 007869           82 IKSHGFLDINDNHVGIDINSLKSESSAPA--------GYYVEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSVLND  153 (586)
Q Consensus        82 ~~~~~~~d~~~~hvgidvns~~s~~~~~~--------~~~i~y~~~~~~l~v~~~~~~~~~~~~~~~ls~~~dL~~~l~~  153 (586)
                      ++|.+ +||++||||||+||+.|.++.++        ..||+||+.+++|+|++.+...  |.. |+|++.+||+.+||+
T Consensus       127 ~~N~~-~Dp~~nHVGIdvns~~S~~t~~~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~-~~ls~~vdL~~~l~e  202 (253)
T 1g7y_A          127 FSNTD-WDPTSRHIGIDVNSIKSIRTASWGLANGQNAEILITYNAATSLLVASLVHPSR--RTS-YIVSERVDITNELPE  202 (253)
T ss_dssp             SCCTT-TCCSSCEEEEEESSSSCSEEEECCCCTTSEEEEEEEEETTTTEEEEEEEETTT--TEE-EEEEEECCHHHHSCS
T ss_pred             eeccC-cCCCCCcEeeccCCccccceeccccCCCCeEEEEEEEeCCCCEEEEEEecCCC--CCc-ceEEEEechHHhCCC
Confidence            99988 59999999999999999887653        3699999999999999987543  444 899999999999999


Q ss_pred             ceeeeeecCCCcc---ceeeeeeeccccccC
Q 007869          154 AMYVGFSSSTGSV---LASHYILGWSFKING  181 (586)
Q Consensus       154 ~~~vGFsastg~~---~~~~~i~~Wsf~~~~  181 (586)
                      +||||||||||..   .|.|+|++|+|+++.
T Consensus       203 ~~~VGFSAsTG~~~~~~~~H~IlsWsF~s~l  233 (253)
T 1g7y_A          203 YVSIGFSATTGLSEGYTETHDVLSWSFASKL  233 (253)
T ss_dssp             EEEEEEEEECCSSSSCCCCCEEEEEEEEEEE
T ss_pred             ceEEEEEeCcCCCCcccceeEEEEEEEEeeC
Confidence            9999999999998   999999999999863

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=4.6e-44  Score=369.06  Aligned_cols=264  Identities=23%  Similarity=0.316  Sum_probs=217.9

Q ss_pred             CcccchhhhhhhcCC----------cccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCC
Q 007869          248 PHRFRYKDLYIATKG----------FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRH  317 (586)
Q Consensus       248 ~~~~~~~el~~a~~~----------f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H  317 (586)
                      +..++++++..+++.          |...+.||+|+||.||+|++..++..||||++........+.+.+|+.++++++|
T Consensus        22 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h  101 (321)
T 2c30_A           22 SGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH  101 (321)
T ss_dssp             ---CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCC
T ss_pred             CCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCC
Confidence            345777887777764          6777899999999999999988899999999987766677889999999999999


Q ss_pred             CceeeeeeeeeccCeEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeec
Q 007869          318 RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLD  397 (586)
Q Consensus       318 ~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~  397 (586)
                      |||+++++++...+..++||||+++++|.+++...   .+++..+..++.|+++||.|||+   .+|+||||||+|||++
T Consensus       102 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~  175 (321)
T 2c30_A          102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV---RLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSILLT  175 (321)
T ss_dssp             TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEC
T ss_pred             CCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEC
Confidence            99999999999999999999999999999998643   58999999999999999999998   8999999999999999


Q ss_pred             CCCCeEEccccceeeccCCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhH
Q 007869          398 GELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVD  477 (586)
Q Consensus       398 ~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~  477 (586)
                      .++++||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+   ...
T Consensus       176 ~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~---~~~  251 (321)
T 2c30_A          176 LDGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ---AMK  251 (321)
T ss_dssp             TTCCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHH
T ss_pred             CCCcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHH
Confidence            999999999999987654322 2345679999999999999999999999999999999999999997643211   111


Q ss_pred             HHHhhhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          478 WVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       478 ~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                      .+.         ....+.+..  .......+.+++.+||+.||++|||+.|+++.
T Consensus       252 ~~~---------~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  295 (321)
T 2c30_A          252 RLR---------DSPPPKLKN--SHKVSPVLRDFLERMLVRDPQERATAQELLDH  295 (321)
T ss_dssp             HHH---------HSSCCCCTT--GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHh---------cCCCCCcCc--cccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            111         111122111  11223457788889999999999999999863

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=2e-43  Score=361.03  Aligned_cols=281  Identities=33%  Similarity=0.578  Sum_probs=230.0

Q ss_pred             CCcccchhhhhhhcCCcccc------eeEeecCceEEEEEEeCCCCeEEEEEEeccc----cchhHHHHHHHHHHhcccC
Q 007869          247 GPHRFRYKDLYIATKGFREK------ELLGTGGFGRVYRGTLPKSQIEIAVKKISHE----SRQGMKEFVAEIVSIGRLR  316 (586)
Q Consensus       247 ~~~~~~~~el~~a~~~f~~~------~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~----~~~~~~~~~~Ei~~l~~l~  316 (586)
                      ....|++.++..++++|...      +.||+|+||.||+|..  ++..||||++...    .....+.+.+|+.++++++
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~   88 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ   88 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC
Confidence            35789999999999999988      9999999999999997  4668999998653    2344578999999999999


Q ss_pred             CCceeeeeeeeeccCeEEEEEecCCCCChhhhhhcCC-CccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCee
Q 007869          317 HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQP-KVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVL  395 (586)
Q Consensus       317 H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIl  395 (586)
                      ||||+++++++...+..++||||+++++|.+++.... ...+++..++.++.|+++||.|||+   .+|+||||||+|||
T Consensus        89 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil  165 (307)
T 2nru_A           89 HENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANIL  165 (307)
T ss_dssp             CTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEE
T ss_pred             CCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecCCCCHHHEE
Confidence            9999999999999999999999999999999997532 3468999999999999999999998   89999999999999


Q ss_pred             ecCCCCeEEccccceeeccCCCCC-ceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccch
Q 007869          396 LDGELNGRLGDFGLARLYDHGTDP-QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLI  474 (586)
Q Consensus       396 l~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~  474 (586)
                      ++.++.+||+|||+++........ ......||+.|+|||.+.+ .++.++||||||+++|||++|+.||........  
T Consensus       166 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--  242 (307)
T 2nru_A          166 LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL--  242 (307)
T ss_dssp             ECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB--
T ss_pred             EcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH--
Confidence            999999999999999876543222 2234579999999998864 589999999999999999999999986544332  


Q ss_pred             hhHHHHhhhcc-CccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 007869          475 LVDWVFDFWNR-GELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERD  536 (586)
Q Consensus       475 l~~~v~~~~~~-~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  536 (586)
                      +..+....... ..+....++.+ ..........+.+++..||+.||.+|||+.++++.|++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l  304 (307)
T 2nru_A          243 LLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM  304 (307)
T ss_dssp             TTHHHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             HHHHHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            22222222111 12223333333 334567778899999999999999999999999999864

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.7e-44  Score=370.27  Aligned_cols=267  Identities=28%  Similarity=0.440  Sum_probs=206.0

Q ss_pred             cchhhhhhhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc--chhHHHHHHHHHHhcccCCCceeeeeeeee
Q 007869          251 FRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES--RQGMKEFVAEIVSIGRLRHRNLVQLLGYCR  328 (586)
Q Consensus       251 ~~~~el~~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~  328 (586)
                      +...++....++|+..+.||+|+||.||+|++  .+..||||++....  ....+++.+|++++++++||||+++++++.
T Consensus        27 ~~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~  104 (309)
T 3p86_A           27 MDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVT  104 (309)
T ss_dssp             -----CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             CCcccccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence            44556667778999999999999999999987  46789999987653  344567999999999999999999999999


Q ss_pred             ccCeEEEEEecCCCCChhhhhhcCCC-ccchhHHHHHHHHHHHHHHHHhhcccCCc--EEeCCCCCCCeeecCCCCeEEc
Q 007869          329 RKGELLLVYDYMPNGSLDKYLYDQPK-VTLNWIQRFRVIKGVALGLFYLHQEWEQV--VIHRDVKASNVLLDGELNGRLG  405 (586)
Q Consensus       329 ~~~~~~lV~E~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--ivHrDIkp~NIll~~~~~~kL~  405 (586)
                      ..+..++||||+++|+|.+++..... ..+++..++.++.|+++||.|||+   .+  |+||||||+|||++.++.+||+
T Consensus       105 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~~~ivH~Dikp~NIll~~~~~~kL~  181 (309)
T 3p86_A          105 QPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN---RNPPIVHRNLKSPNLLVDKKYTVKVC  181 (309)
T ss_dssp             STTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHT---SSSCCCCTTCCGGGEEECTTCCEEEC
T ss_pred             ECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHc---CCCCEECCCCChhhEEEeCCCcEEEC
Confidence            99999999999999999999976532 348899999999999999999998   77  9999999999999999999999


Q ss_pred             cccceeeccCCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhcc
Q 007869          406 DFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNR  485 (586)
Q Consensus       406 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~  485 (586)
                      |||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+   ....+..   .
T Consensus       182 Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~---~~~~~~~---~  254 (309)
T 3p86_A          182 DFGLSRLKASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ---VVAAVGF---K  254 (309)
T ss_dssp             CCC------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH---HHHHHHH---S
T ss_pred             CCCCCccccccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHh---c
Confidence            999998654322 22344679999999999999999999999999999999999999997654322   1111100   0


Q ss_pred             CccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhccC
Q 007869          486 GELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERDVA  538 (586)
Q Consensus       486 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~  538 (586)
                      .     ....+..    .....+.+++.+||+.||.+|||+.++++.|+....
T Consensus       255 ~-----~~~~~~~----~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~  298 (309)
T 3p86_A          255 C-----KRLEIPR----NLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK  298 (309)
T ss_dssp             C-----CCCCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred             C-----CCCCCCc----cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            0     0111111    222457788999999999999999999999986543

>1fat_A Phytohemagglutinin-L; glycoprotein, plant defense protein, lectin; HET: NAG; 2.80A {Phaseolus vulgaris} SCOP: b.29.1.1 PDB: 1g8w_A*

Probab=100.00  E-value=1.7e-44  Score=353.97  Aligned_cols=168  Identities=32%  Similarity=0.494  Sum_probs=150.7

Q ss_pred             CcccCCCCCCCCCCeeeeeEEEEEEEEEeCCCCCCCCcEEEEEecCCCCCCCCCCCcccccccCCCCCCCccEEEEEeec
Q 007869            2 PFKNKNSNSSTANGTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGLFNDTNLGNETNHVFAVELDT   81 (586)
Q Consensus         2 p~~~~~~~~~~~~~~~asF~t~F~f~i~~~~~~~~g~GlaF~l~p~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEfDt   81 (586)
                      ||+||++.+    |+++||+|+|+|.|.+.+...+||||||+|+|....| +++|+||||||.+   ++.||+|||||||
T Consensus        54 Pv~l~d~~t----g~vaSFsT~F~F~I~~~~~~~~gdGlAF~l~p~~~~~-~~~g~~LGl~n~~---~~~~~~vAVEFDT  125 (252)
T 1fat_A           54 PIQIWDNTT----GTVASFATSFTFNIQVPNNAGPADGLAFALVPVGSQP-KDKGGFLGLFDGS---NSNFHTVAVEFDT  125 (252)
T ss_dssp             EEECEETTT----TEEEEEEEEEEEECCCCSSCBCCEEEEEEEEETTCCC-CCSGGGTTTCCSS---CCCCCCEEEEEEC
T ss_pred             CEecccCCC----CcccceEEEEEEEEeCCCCCCCCCcEEEEEccCCCCC-CCCCccccccccC---CccCcEEEEEeec
Confidence            899999887    9999999999999998766778999999999986555 4889999999976   6689999999999


Q ss_pred             cccCCCCCCCCCeeEEeCCCCcccccccC--------ceEEEEcCeeeEEEEEEeecCCCCCCccceeeeeecchhcccc
Q 007869           82 IKSHGFLDINDNHVGIDINSLKSESSAPA--------GYYVEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSVLND  153 (586)
Q Consensus        82 ~~~~~~~d~~~~hvgidvns~~s~~~~~~--------~~~i~y~~~~~~l~v~~~~~~~~~~~~~~~ls~~~dL~~~l~~  153 (586)
                      ++|.+ +||++||||||+|++.|.++.++        ..||+||+.+++|+|++.+...  |.. |+|++.+||+.+||+
T Consensus       126 ~~N~~-~Dp~~nHVGIdvNs~~S~~~~~~~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~-~~ls~~vdL~~~l~e  201 (252)
T 1fat_A          126 LYNKD-WDPTERHIGIDVNSIRSIKTTRWDFVNGENAEVLITYDSSTNLLVASLVYPSQ--KTS-FIVSDTVDLKSVLPE  201 (252)
T ss_dssp             SCCTT-TCCSSCEEEEEESSSSCSEEEECCCCTTCEEEEEEEEETTTTEEEEEEEETTT--TEE-EEEEEECCHHHHSCS
T ss_pred             ccCCC-CCCCCCeEEEecCCccccceecccccCCCEEEEEEEEeCCCCEEEEEEecCCC--CCc-ceEEEEechHHhCCC
Confidence            99988 59999999999999999887653        3699999999999999987543  444 899999999999999


Q ss_pred             ceeeeeecCCCcc---ceeeeeeeccccccC
Q 007869          154 AMYVGFSSSTGSV---LASHYILGWSFKING  181 (586)
Q Consensus       154 ~~~vGFsastg~~---~~~~~i~~Wsf~~~~  181 (586)
                      +||||||||||..   .|.|+|++|+|+++.
T Consensus       202 ~~~VGFSAsTG~~~~~~~~H~IlsWsF~s~l  232 (252)
T 1fat_A          202 WVSVGFSATTGINKGNVETNDVLSWSFASKL  232 (252)
T ss_dssp             EEEEEEEEEECSSTTBCCCCEEEEEEEEEEE
T ss_pred             ceEEEEEeccCCCCcccceEEEEEEEEEeeC
Confidence            9999999999998   999999999999863

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=2.5e-44  Score=385.83  Aligned_cols=267  Identities=22%  Similarity=0.252  Sum_probs=216.3

Q ss_pred             cccchhhhhhhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc---chhHHHHHHHHHHhcccCCCceeeeee
Q 007869          249 HRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLG  325 (586)
Q Consensus       249 ~~~~~~el~~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~~  325 (586)
                      ..+.++++....++|+..++||+|+||+||+|+++.+++.||||++....   ....+.+.+|+.++.+++||||+++++
T Consensus        62 ~~~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~  141 (437)
T 4aw2_A           62 FTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHY  141 (437)
T ss_dssp             HHHHHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEE
T ss_pred             ccchhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence            44567888899999999999999999999999999999999999997532   222334889999999999999999999


Q ss_pred             eeeccCeEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEc
Q 007869          326 YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLG  405 (586)
Q Consensus       326 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~  405 (586)
                      +|.+.+.++||||||++|+|.+++... ...+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+
T Consensus       142 ~~~~~~~~~lV~Ey~~gg~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILl~~~g~vkL~  217 (437)
T 4aw2_A          142 AFQDDNNLYLVMDYYVGGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLA  217 (437)
T ss_dssp             EEECSSEEEEEECCCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEEC
T ss_pred             EEeeCCEEEEEEecCCCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeeEcCCCCEEEc
Confidence            999999999999999999999999764 2468999999999999999999998   899999999999999999999999


Q ss_pred             cccceeeccCCCCCceeeeccCCCccCccccc-----CCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHH
Q 007869          406 DFGLARLYDHGTDPQTTHVVGTLGYLAPEHTR-----TGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVF  480 (586)
Q Consensus       406 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~  480 (586)
                      |||+|+.............+||+.|+|||++.     .+.++.++|||||||++|||++|+.||...+..+..   ..+.
T Consensus       218 DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~---~~i~  294 (437)
T 4aw2_A          218 DFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETY---GKIM  294 (437)
T ss_dssp             CCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH---HHHH
T ss_pred             chhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHH---Hhhh
Confidence            99999876554433344568999999999987     567899999999999999999999999865432211   1111


Q ss_pred             hhhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCC--CCCHHHHHH
Q 007869          481 DFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTA--RPSMRQVVQ  531 (586)
Q Consensus       481 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~  531 (586)
                         ....  ....|......    ...+.+++.+||+.+|++  ||+++|+++
T Consensus       295 ---~~~~--~~~~p~~~~~~----s~~~~dLi~~lL~~~~~r~~r~~~~eil~  338 (437)
T 4aw2_A          295 ---NHKE--RFQFPTQVTDV----SENAKDLIRRLICSREHRLGQNGIEDFKK  338 (437)
T ss_dssp             ---THHH--HCCCCSSCCCS----CHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred             ---hccc--cccCCcccccC----CHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence               0000  01112111112    244667778888888888  999999986

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=4e-44  Score=364.74  Aligned_cols=261  Identities=23%  Similarity=0.390  Sum_probs=209.1

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc---cchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEE
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLV  336 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV  336 (586)
                      .++|+..+.||+|+||.||+|++..++..||+|++...   .....+.+.+|+.++++++||||+++++++...+..++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            46799999999999999999999989999999998543   234457799999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCC
Q 007869          337 YDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHG  416 (586)
Q Consensus       337 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~  416 (586)
                      |||+++++|.+++...  ..+++..++.++.|+++||.|||+   .+|+||||||+|||++.++++||+|||+++.....
T Consensus        90 ~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  164 (294)
T 4eqm_A           90 MEYIEGPTLSEYIESH--GPLSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET  164 (294)
T ss_dssp             EECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred             EeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence            9999999999999765  368899999999999999999998   89999999999999999999999999999876544


Q ss_pred             CCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCC
Q 007869          417 TDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNL  496 (586)
Q Consensus       417 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l  496 (586)
                      .........||+.|+|||++.+..++.++|||||||++|||++|+.||......+      .........      .+..
T Consensus       165 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~------~~~~~~~~~------~~~~  232 (294)
T 4eqm_A          165 SLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVS------IAIKHIQDS------VPNV  232 (294)
T ss_dssp             ----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHH------HHHHHHSSC------CCCH
T ss_pred             cccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHhhcc------CCCc
Confidence            3334445679999999999999999999999999999999999999997643211      111111111      1111


Q ss_pred             CccccHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHhhcc
Q 007869          497 GTEYVAEELELVLKLGLLCSHSDPTARP-SMRQVVQILERDV  537 (586)
Q Consensus       497 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~evl~~L~~~~  537 (586)
                      ...........+.+++.+|++.||.+|| +++++.+.|+...
T Consensus       233 ~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~  274 (294)
T 4eqm_A          233 TTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL  274 (294)
T ss_dssp             HHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred             chhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence            1111222345678899999999999998 8999999998654

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=2.5e-44  Score=371.74  Aligned_cols=259  Identities=28%  Similarity=0.479  Sum_probs=209.8

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCC---eEEEEEEeccc-cchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEE
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQ---IEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLL  335 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~---~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~l  335 (586)
                      .++|+..+.||+|+||.||+|.+..++   ..||||++... .....+.|.+|+.++++++||||+++++++...+..++
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  127 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI  127 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence            456888999999999999999987444   45999999765 34455789999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccC
Q 007869          336 VYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH  415 (586)
Q Consensus       336 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~  415 (586)
                      ||||+++|+|.+++.... ..+++.+++.++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++....
T Consensus       128 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  203 (325)
T 3kul_A          128 VTEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED  203 (325)
T ss_dssp             EEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred             EeeCCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence            999999999999996553 468999999999999999999998   8999999999999999999999999999997654


Q ss_pred             CCCCc--eeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccCcccccc
Q 007869          416 GTDPQ--TTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEAR  492 (586)
Q Consensus       416 ~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~  492 (586)
                      .....  .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+   +...+    ..+.     
T Consensus       204 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~~~~----~~~~-----  271 (325)
T 3kul_A          204 DPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD---VISSV----EEGY-----  271 (325)
T ss_dssp             ---CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH---HHHHH----HTTC-----
T ss_pred             CccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH---HHHHH----HcCC-----
Confidence            43222  223456788999999998999999999999999999999 999997643321   11111    1111     


Q ss_pred             CCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhccC
Q 007869          493 DPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERDVA  538 (586)
Q Consensus       493 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~  538 (586)
                      .+..    .......+.+++..||+.||.+|||+.++++.|+....
T Consensus       272 ~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~  313 (325)
T 3kul_A          272 RLPA----PMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIR  313 (325)
T ss_dssp             CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCC----CCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            1111    11223567889999999999999999999999987654

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=5.6e-44  Score=375.82  Aligned_cols=259  Identities=27%  Similarity=0.441  Sum_probs=212.3

Q ss_pred             hcCCcccceeEeecCceEEEEEEeC-------CCCeEEEEEEecccc-chhHHHHHHHHHHhccc-CCCceeeeeeeeec
Q 007869          259 ATKGFREKELLGTGGFGRVYRGTLP-------KSQIEIAVKKISHES-RQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRR  329 (586)
Q Consensus       259 a~~~f~~~~~LG~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~  329 (586)
                      ..++|...+.||+|+||.||+|++.       .++..||||++.... ....+.+.+|+.+++++ +||||++++++|..
T Consensus        79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  158 (370)
T 2psq_A           79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  158 (370)
T ss_dssp             CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred             cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence            4467889999999999999999864       345679999997653 34567899999999999 89999999999999


Q ss_pred             cCeEEEEEecCCCCChhhhhhcCC--------------CccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCee
Q 007869          330 KGELLLVYDYMPNGSLDKYLYDQP--------------KVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVL  395 (586)
Q Consensus       330 ~~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIl  395 (586)
                      .+.+++||||+++|+|.+++....              ...+++.+++.++.||++||.|||+   ++|+||||||+|||
T Consensus       159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIl  235 (370)
T 2psq_A          159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVL  235 (370)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEE
T ss_pred             CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchhhEE
Confidence            999999999999999999997653              1358899999999999999999998   89999999999999


Q ss_pred             ecCCCCeEEccccceeeccCCCC-CceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccc
Q 007869          396 LDGELNGRLGDFGLARLYDHGTD-PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENL  473 (586)
Q Consensus       396 l~~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~  473 (586)
                      ++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+  
T Consensus       236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~--  313 (370)
T 2psq_A          236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--  313 (370)
T ss_dssp             ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--
T ss_pred             ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH--
Confidence            99999999999999997654322 12333567889999999999999999999999999999999 999997654322  


Q ss_pred             hhhHHHHhhhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 007869          474 ILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERD  536 (586)
Q Consensus       474 ~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  536 (586)
                       +...    ...+..     +..    .......+.+++.+||+.||.+||++.|+++.|+..
T Consensus       314 -~~~~----~~~~~~-----~~~----~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~i  362 (370)
T 2psq_A          314 -LFKL----LKEGHR-----MDK----PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  362 (370)
T ss_dssp             -HHHH----HHTTCC-----CCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -HHHH----HhcCCC-----CCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence             1111    111111     111    112235678889999999999999999999999864

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.4e-44  Score=394.95  Aligned_cols=264  Identities=27%  Similarity=0.439  Sum_probs=219.7

Q ss_pred             hhhhhhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeE
Q 007869          254 KDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGEL  333 (586)
Q Consensus       254 ~el~~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~  333 (586)
                      .++....++|...+.||+|+||.||+|++..++..||||++..... ..++|.+|+.+|++++||||++++++|...+..
T Consensus       213 ~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  291 (495)
T 1opk_A          213 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF  291 (495)
T ss_dssp             SCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             cccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcE
Confidence            4455566789999999999999999999988889999999976543 467899999999999999999999999999999


Q ss_pred             EEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeec
Q 007869          334 LLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLY  413 (586)
Q Consensus       334 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~  413 (586)
                      ++||||+++|+|.+++.......+++..++.++.||++||.|||+   ++|+||||||+|||++.++.+||+|||+++..
T Consensus       292 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  368 (495)
T 1opk_A          292 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLM  368 (495)
T ss_dssp             EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCTTCEECC
T ss_pred             EEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhEEECCCCcEEEeecccceec
Confidence            999999999999999987666679999999999999999999998   89999999999999999999999999999976


Q ss_pred             cCCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccCcccccc
Q 007869          414 DHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEAR  492 (586)
Q Consensus       414 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~  492 (586)
                      ............++..|+|||++....++.++|||||||++|||++ |+.||......+   +.+.+    ..+...   
T Consensus       369 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~---~~~~~----~~~~~~---  438 (495)
T 1opk_A          369 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYELL----EKDYRM---  438 (495)
T ss_dssp             TTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHHHH----HTTCCC---
T ss_pred             cCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH---HHHHH----HcCCCC---
Confidence            5432222233456789999999999999999999999999999999 999997654322   11111    111111   


Q ss_pred             CCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 007869          493 DPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERDV  537 (586)
Q Consensus       493 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  537 (586)
                            .........+.+++.+||+.||++|||+.++++.|+...
T Consensus       439 ------~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~  477 (495)
T 1opk_A          439 ------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  477 (495)
T ss_dssp             ------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             ------CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence                  111122356778899999999999999999999998754

>1wbf_A Protein (agglutinin); lectin (agglutinin), legume lectin, protein crystallography, group specificity, saccharide free form; HET: NAG; 2.30A {Psophocarpus tetragonolobus} SCOP: b.29.1.1 PDB: 2d3s_A* 2dtw_A* 1wbl_A* 2dty_A* 2du0_A* 2du1_A* 2e51_A* 2e53_A* 2zmk_A* 2zml_A* 2zmn_A* 2e7t_A* 2e7q_A*

Probab=100.00  E-value=5.5e-44  Score=348.17  Aligned_cols=166  Identities=33%  Similarity=0.495  Sum_probs=148.1

Q ss_pred             CcccCCCCCCCCCCeeeeeEEEEEEEEEeC-CCCCCCCcEEEEEecCCCCCCCCCCCcccccccCCCCCCCccEEEEEee
Q 007869            2 PFKNKNSNSSTANGTVFSFSTTFVFSILSE-YQSQSGHGIAFVIASTRGLPGARPSQYLGLFNDTNLGNETNHVFAVELD   80 (586)
Q Consensus         2 p~~~~~~~~~~~~~~~asF~t~F~f~i~~~-~~~~~g~GlaF~l~p~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEfD   80 (586)
                      ||+||++.+    |+++||+|+|+|+|.+. +...+||||||+|+|....| +++|+||||||.+    +.||+||||||
T Consensus        55 Pv~l~d~~t----g~vaSFsT~F~F~I~~~~~~~~~gdGlAF~l~p~~~~~-~~~g~~LGl~n~~----~~~~~vAVEFD  125 (242)
T 1wbf_A           55 PVQVWDSTT----GNVASFETRFSFSIRQPFPRPHPADGLVFFIAPPNTQT-GEGGGYFGIYNPL----SPYPFVAVEFD  125 (242)
T ss_dssp             CEECBCTTT----CCBCEEEEEEEEECCCSCCSSCCCEEEEEEEECSSCCC-CCCGGGTTTCCTT----SCCCCEEEEEE
T ss_pred             CEecccCCC----CCeeeEEEEEEEEEeCCCCCCCCCCcEEEEEecCCCCC-CCCCCccccccCC----CcCcEEEEEec
Confidence            899999887    99999999999999986 56778999999999986554 4889999999875    67999999999


Q ss_pred             ccccCCCCCCCCCeeEEeCCCCcccccccC--------ceEEEEcCeeeEEEEEEeecCCCCCCccceeeeeecchhccc
Q 007869           81 TIKSHGFLDINDNHVGIDINSLKSESSAPA--------GYYVEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSVLN  152 (586)
Q Consensus        81 t~~~~~~~d~~~~hvgidvns~~s~~~~~~--------~~~i~y~~~~~~l~v~~~~~~~~~~~~~~~ls~~~dL~~~l~  152 (586)
                      |++|.  +||++||||||||++.|.++.++        ..||+||+.+++|+|++.+...  |.. |+|++.+||+.+||
T Consensus       126 T~~N~--~Dp~~nHVGIdvNs~~S~~~~~~~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~-~~ls~~vdL~~~l~  200 (242)
T 1wbf_A          126 TFRNT--WDPQIPHIGIDVNSVISTKTVPFTLDNGGIANVVIKYDASTKILHVVLVFPSL--GTI-YTIADIVDLKQVLP  200 (242)
T ss_dssp             CSCCT--TCCSSSEEEEEESSSSCSEEEECCCCTTSCEEEEEEEETTTTEEEEEEEETTT--TEE-EEEEEECCHHHHSC
T ss_pred             cccCC--CCCCCCeEEEECCCccccceeeeEecCCCEEEEEEEEeCCCCEEEEEEccCCC--CCc-ceEEEEechHHhcC
Confidence            99997  59999999999999999877653        3699999999999999987643  444 89999999999999


Q ss_pred             cceeeeeecCC----Ccc---ceeeeeeeccccccC
Q 007869          153 DAMYVGFSSST----GSV---LASHYILGWSFKING  181 (586)
Q Consensus       153 ~~~~vGFsast----g~~---~~~~~i~~Wsf~~~~  181 (586)
                      ++|||||||||    |..   .|.|+|++|+|+++.
T Consensus       201 e~v~VGFSAsTg~~~G~~~~~~~~h~IlsWsF~s~l  236 (242)
T 1wbf_A          201 ESVNVGFSAATGDPSGKQRNATETHDILSWSFSASL  236 (242)
T ss_dssp             SEEEEEEEEEECCGGGCCTTCCCCCEEEEEEEEEEC
T ss_pred             CceEEEEEEeecCcCCccccccceEEEEEEEeEecC
Confidence            99999999999    888   899999999999864

>1f9k_A Acidic lectin; legume lectin, glycosylated protein, H-antigenic specificity agglutinin, sugar binding protein; HET: NAG MAN AMG; 3.00A {Psophocarpus tetragonolobus} SCOP: b.29.1.1 PDB: 1fay_A*

Probab=100.00  E-value=1e-43  Score=346.20  Aligned_cols=166  Identities=31%  Similarity=0.464  Sum_probs=148.5

Q ss_pred             CcccCCCCCCCCCCeeeeeEEEEEEEEEeC-CCCCCCCcEEEEEecCCCCCCCCCCCcccccccCCCCCCCccEEEEEee
Q 007869            2 PFKNKNSNSSTANGTVFSFSTTFVFSILSE-YQSQSGHGIAFVIASTRGLPGARPSQYLGLFNDTNLGNETNHVFAVELD   80 (586)
Q Consensus         2 p~~~~~~~~~~~~~~~asF~t~F~f~i~~~-~~~~~g~GlaF~l~p~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEfD   80 (586)
                      ||+||++.+    |+++||+|+|+|+|.+. ....+||||||+|+|....| +++|+||||||.+   +. ||+||||||
T Consensus        55 Pv~l~d~~~----g~vasFsT~F~F~I~~~~~~~~~gdGlAF~l~p~~~~~-~~~g~~LGl~n~~---~~-~~~vAVEFD  125 (238)
T 1f9k_A           55 PIKIWDSTT----GNVASFETRFSFNITQPYAYPEPADGLTFFMVPPNSPQ-GEDGGNLGVFKPP---EG-DNAFAVEFD  125 (238)
T ss_dssp             CEECBCTTT----CCBCEEEEEEEEEEECCCSSSCCCEEEEEEEECTTCCC-CCSGGGTTTCCSS---CC-SCCEEEEEE
T ss_pred             CEEeecCCC----CCeeeEEEEEEEEEecCCCCCCCCCcEEEEEccCCCCC-CCCCCcccccccC---CC-CcEEEEEEe
Confidence            899999887    99999999999999987 66779999999999986555 4889999999976   45 999999999


Q ss_pred             ccccCCCCCCCCCeeEEeCCCCcccccccC--------ceEEEEcCeeeEEEEEEeecCCCCCCccceeeeeecchhccc
Q 007869           81 TIKSHGFLDINDNHVGIDINSLKSESSAPA--------GYYVEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSVLN  152 (586)
Q Consensus        81 t~~~~~~~d~~~~hvgidvns~~s~~~~~~--------~~~i~y~~~~~~l~v~~~~~~~~~~~~~~~ls~~~dL~~~l~  152 (586)
                      |++|.  +||++||||||||++.|.++.++        ..||+||+.+++|+|++.+...  |.. |+|++.+||+.+||
T Consensus       126 T~~N~--~Dp~~nHVgIdvns~~S~~s~~~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~-~~ls~~vdL~~~l~  200 (238)
T 1f9k_A          126 TFQNT--WDPQVPHIGIDVNSIVSSKTLHFQLENGGVANVVIKYDSPTKILNVVLAFHSV--GTV-YTLSNIVDLKQEFP  200 (238)
T ss_dssp             CSCCT--TCCSSSEEEEEESSSSCSEEEECCCCTTCCEEEEEEEETTTTEEEEEEEETTT--TEE-EEEEEECCHHHHST
T ss_pred             cccCC--CCCCCCeEEEecCCccccceEeecccCCCEEEEEEEEeCCCCEEEEEEecCCC--CCc-eeEEEEechHHhCC
Confidence            99997  59999999999999999877653        3699999999999999987643  444 89999999999999


Q ss_pred             c--ceeeeeecCCCcc---ceeeeeeeccccccC
Q 007869          153 D--AMYVGFSSSTGSV---LASHYILGWSFKING  181 (586)
Q Consensus       153 ~--~~~vGFsastg~~---~~~~~i~~Wsf~~~~  181 (586)
                      +  +||||||||||..   .|.|+|++|+|+++.
T Consensus       201 ~~~~~~vGFSAsTG~~~~~~~~h~IlsWsF~s~~  234 (238)
T 1f9k_A          201 NSEWVNVGLSATTGYQKNAVETHEIISWSFTSSL  234 (238)
T ss_dssp             TCSEEEEEEEEEECSSTTCCCEEEEEEEEEEEEC
T ss_pred             CCceEEEEEEeCcCCCCcccceEEEEEeEeEeec
Confidence            9  9999999999998   999999999999864

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=9.9e-45  Score=368.74  Aligned_cols=265  Identities=23%  Similarity=0.396  Sum_probs=208.2

Q ss_pred             hcCCcccceeEeecCceEEEEEE----eCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeecc--Ce
Q 007869          259 ATKGFREKELLGTGGFGRVYRGT----LPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRK--GE  332 (586)
Q Consensus       259 a~~~f~~~~~LG~G~~g~Vy~~~----~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~--~~  332 (586)
                      ..++|+..+.||+|+||.||+|+    ...++..||||++........+.+.+|++++++++||||+++++++...  ..
T Consensus         8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   87 (295)
T 3ugc_A            8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN   87 (295)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTS
T ss_pred             CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCc
Confidence            34678899999999999999998    4567889999999877777778899999999999999999999998654  56


Q ss_pred             EEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceee
Q 007869          333 LLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARL  412 (586)
Q Consensus       333 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~  412 (586)
                      .++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+   .+|+||||||+|||++.++++||+|||+++.
T Consensus        88 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~  163 (295)
T 3ugc_A           88 LKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKV  163 (295)
T ss_dssp             CEEEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred             eEEEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHhhEEEcCCCeEEEccCccccc
Confidence            899999999999999997763 368999999999999999999998   8999999999999999999999999999987


Q ss_pred             ccCCCCC--ceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCC---------ccchhhHHHHh
Q 007869          413 YDHGTDP--QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPS---------ENLILVDWVFD  481 (586)
Q Consensus       413 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~---------~~~~l~~~v~~  481 (586)
                      .......  ......+|..|+|||++.+..++.++|||||||++|||++|..|+......         ........+..
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (295)
T 3ugc_A          164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE  243 (295)
T ss_dssp             ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred             ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHH
Confidence            6543221  223345778899999999999999999999999999999999998642110         00011111111


Q ss_pred             hhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 007869          482 FWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERD  536 (586)
Q Consensus       482 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  536 (586)
                      ....+..     +    .........+.+++.+||+.||++|||+.|+++.|+..
T Consensus       244 ~~~~~~~-----~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l  289 (295)
T 3ugc_A          244 LLKNNGR-----L----PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI  289 (295)
T ss_dssp             HHHTTCC-----C----CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHhccCc-----C----CCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence            1111111     1    11122335678899999999999999999999999763

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=6.2e-44  Score=369.31  Aligned_cols=251  Identities=24%  Similarity=0.365  Sum_probs=209.0

Q ss_pred             hhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc--cchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEE
Q 007869          258 IATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLL  335 (586)
Q Consensus       258 ~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~l  335 (586)
                      ...++|+..+.||+|+||.||+|++..++..||||++...  .....+.+.+|++++++++||||+++++++...+..++
T Consensus        12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l   91 (328)
T 3fe3_A           12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYL   91 (328)
T ss_dssp             CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence            3456899999999999999999999989999999999754  33455678999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccC
Q 007869          336 VYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH  415 (586)
Q Consensus       336 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~  415 (586)
                      ||||+++|+|.+++....  .+++..+..++.|+++||.|||+   .+|+||||||+|||++.++++||+|||+++....
T Consensus        92 v~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  166 (328)
T 3fe3_A           92 IMEYASGGEVFDYLVAHG--RMKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTV  166 (328)
T ss_dssp             EECCCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSS
T ss_pred             EEECCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCCHHHEEEcCCCCEEEeeccCceecCC
Confidence            999999999999997653  58889999999999999999998   8999999999999999999999999999987654


Q ss_pred             CCCCceeeeccCCCccCcccccCCCCC-CcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCC
Q 007869          416 GTDPQTTHVVGTLGYLAPEHTRTGKAT-TSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDP  494 (586)
Q Consensus       416 ~~~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~  494 (586)
                      ..  ......||+.|+|||++.+..++ .++|||||||++|||++|+.||......+   +.+    ....+..      
T Consensus       167 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~----~i~~~~~------  231 (328)
T 3fe3_A          167 GG--KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE---LRE----RVLRGKY------  231 (328)
T ss_dssp             SC--GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH----HHHHCCC------
T ss_pred             CC--ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH---HHH----HHHhCCC------
Confidence            32  33456799999999999888775 79999999999999999999997653221   111    1111111      


Q ss_pred             CCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          495 NLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       495 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                      .....    ....+.+++.+||+.||.+|||++|+++.
T Consensus       232 ~~p~~----~s~~~~~li~~~L~~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          232 RIPFY----MSTDCENLLKRFLVLNPIKRGTLEQIMKD  265 (328)
T ss_dssp             CCCTT----SCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred             CCCCC----CCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            11111    22456788889999999999999999863

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1e-43  Score=364.71  Aligned_cols=245  Identities=26%  Similarity=0.314  Sum_probs=197.3

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc--chhHHHHHHHHHHhccc-CCCceeeeeeeeeccCeEEEEE
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES--RQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKGELLLVY  337 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~lV~  337 (586)
                      ++|+..++||+|+||+||+|++..++..||||++....  ......+..|+..+.++ +||||++++++|.+.+..++||
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~  136 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT  136 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence            67999999999999999999999889999999986542  23344566677666666 9999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCC
Q 007869          338 DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT  417 (586)
Q Consensus       338 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~  417 (586)
                      ||+ +++|.+++.... ..++|..++.++.|++.||.|||+   .+|+||||||+|||++.++++||+|||+++......
T Consensus       137 e~~-~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~  211 (311)
T 3p1a_A          137 ELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG  211 (311)
T ss_dssp             ECC-CCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred             ecc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEccceeeeecccCC
Confidence            999 779999887653 469999999999999999999998   899999999999999999999999999998765432


Q ss_pred             CCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCC
Q 007869          418 DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLG  497 (586)
Q Consensus       418 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~  497 (586)
                        ......||+.|+|||++.+ .++.++|||||||++|||++|..|+.....          +....++..        .
T Consensus       212 --~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~----------~~~~~~~~~--------~  270 (311)
T 3p1a_A          212 --AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG----------WQQLRQGYL--------P  270 (311)
T ss_dssp             -----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH----------HHHHTTTCC--------C
T ss_pred             --CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH----------HHHHhccCC--------C
Confidence              3344579999999999875 799999999999999999999877653211          111111111        1


Q ss_pred             ccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          498 TEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       498 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      ..+.......+.+++.+||+.||++|||+.|+++
T Consensus       271 ~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          271 PEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence            1111223466888999999999999999999985

>1n47_A Isolectin B4; cancer antigen, vicia villosa lectin, glycoprotein TN-bindin protein, carbohydrate recognition, sugar binding protein; HET: NAG FUC TNR; 2.70A {Vicia villosa} SCOP: b.29.1.1

Probab=100.00  E-value=1.1e-43  Score=344.77  Aligned_cols=166  Identities=30%  Similarity=0.502  Sum_probs=147.6

Q ss_pred             CcccCCCCCCCCCCeeeeeEEEEEEEEEeCCCCCCCCcEEEEEecCCCCCCCCCCCcccccccCCCCCCCccEEEEEeec
Q 007869            2 PFKNKNSNSSTANGTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGLFNDTNLGNETNHVFAVELDT   81 (586)
Q Consensus         2 p~~~~~~~~~~~~~~~asF~t~F~f~i~~~~~~~~g~GlaF~l~p~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEfDt   81 (586)
                      ||++|++.+      ++||+|+|+|+|.+.+...+||||||+|+|....|. ++|+||||||.++ ++..||+|||||||
T Consensus        55 Pi~l~d~~~------~~sFsT~F~F~I~~~~~~~~gdGlAF~l~p~~~~p~-~~g~~LGl~n~~~-~~~~n~~vAVEFDT  126 (233)
T 1n47_A           55 PIHIHDNTT------LASFTTSFSFVMAAPAAAAVADGLAFFLAPPDTQPQ-ARGGFLGLFADRA-HDASYQTVAVEFDT  126 (233)
T ss_dssp             CEECBCSSC------BCEEEEEEEEECCCSSTTSCCEEEEEEEECTTCCCC-CCGGGTTTCSSSS-CCGGGCCEEEEEEC
T ss_pred             CEeccCCCC------cCCEEEEEEEEEeCCCCCCCCCcEEEEEecCCCCCC-CCCCcccccccCC-CCccCceEEEEecc
Confidence            899998743      999999999999987777899999999999876665 8899999999774 57889999999999


Q ss_pred             cccCCCCCCCCCeeEEeCCCCcccccccC--------ceEEEEcCeeeEEEEEEeecCCCCCCccceeeeeecchhcccc
Q 007869           82 IKSHGFLDINDNHVGIDINSLKSESSAPA--------GYYVEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSVLND  153 (586)
Q Consensus        82 ~~~~~~~d~~~~hvgidvns~~s~~~~~~--------~~~i~y~~~~~~l~v~~~~~~~~~~~~~~~ls~~~dL~~~l~~  153 (586)
                      ++|.  +||++||||||+||+.|.++.++        ..||+||+.+++|+|++.+...  +.. |+|++.+||+.+||+
T Consensus       127 ~~N~--~Dp~~nHvGIdvns~~S~~~~~~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~-~~ls~~vdL~~~l~~  201 (233)
T 1n47_A          127 YSNA--WDPNYTHIGIDTNGIESKKTTPFDMVYGEKANIVITYQASTKALAASLVFPVS--QTS-YAVSARVDLRDILPE  201 (233)
T ss_dssp             SCCT--TSCSSCEEEEEESSSSCSEEEECCCCTTSCEEEEEEEETTTTEEEEEEEETTT--TEE-EEEEEECCGGGTSCS
T ss_pred             ccCC--CCCCCCcEEEccCCccccccccccccCCCEEEEEEEEeCCCCEEEEEEecCCC--CCc-ceEEEEechHHhCCC
Confidence            9997  59999999999999999877653        3699999999999999987543  234 899999999999999


Q ss_pred             ceeeeeecCCCcc---ceeeeeeecccccc
Q 007869          154 AMYVGFSSSTGSV---LASHYILGWSFKIN  180 (586)
Q Consensus       154 ~~~vGFsastg~~---~~~~~i~~Wsf~~~  180 (586)
                      +||||||||||..   .|.|+|++|+|+++
T Consensus       202 ~~~vGFSAsTG~~~~~~~~h~IlsWsF~s~  231 (233)
T 1n47_A          202 YVRVGFSATTGLNAGVVETHDIVSWSFAVS  231 (233)
T ss_dssp             EEEEEEEEEECSSTTCCCCCEEEEEEEEEE
T ss_pred             ceEEEEEeccCCCccccceeEEEEEEEEee
Confidence            9999999999998   99999999999874

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=4.8e-44  Score=373.78  Aligned_cols=268  Identities=25%  Similarity=0.374  Sum_probs=216.8

Q ss_pred             cchhhhhhhcCCcccceeEeecCceEEEEEE-----eCCCCeEEEEEEecccc-chhHHHHHHHHHHhccc-CCCceeee
Q 007869          251 FRYKDLYIATKGFREKELLGTGGFGRVYRGT-----LPKSQIEIAVKKISHES-RQGMKEFVAEIVSIGRL-RHRNLVQL  323 (586)
Q Consensus       251 ~~~~el~~a~~~f~~~~~LG~G~~g~Vy~~~-----~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l  323 (586)
                      +...++....++|+..+.||+|+||.||+|+     ...++..||||++.... ....+.+.+|++++.++ +||||+++
T Consensus        12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~   91 (359)
T 3vhe_A           12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   91 (359)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence            4456677788999999999999999999998     45667899999997643 34456799999999999 89999999


Q ss_pred             eeeeeccC-eEEEEEecCCCCChhhhhhcCCC------------------------------------------------
Q 007869          324 LGYCRRKG-ELLLVYDYMPNGSLDKYLYDQPK------------------------------------------------  354 (586)
Q Consensus       324 ~~~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~------------------------------------------------  354 (586)
                      +++|...+ ..++||||+++|+|.+++.....                                                
T Consensus        92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (359)
T 3vhe_A           92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK  171 (359)
T ss_dssp             EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred             eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence            99988765 48999999999999999976532                                                


Q ss_pred             ----------------ccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCC
Q 007869          355 ----------------VTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD  418 (586)
Q Consensus       355 ----------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~  418 (586)
                                      ..+++..++.++.|+++||.|||+   ++|+||||||+|||++.++.+||+|||+++.......
T Consensus       172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~  248 (359)
T 3vhe_A          172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD  248 (359)
T ss_dssp             ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT
T ss_pred             ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCcEEEEeccceeeeccccc
Confidence                            128899999999999999999998   8999999999999999999999999999987644332


Q ss_pred             -CceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccCccccccCCCC
Q 007869          419 -PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNL  496 (586)
Q Consensus       419 -~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l  496 (586)
                       .......||+.|+|||++.+..++.++|||||||++|||++ |+.||......+..      ......+..     +..
T Consensus       249 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~------~~~~~~~~~-----~~~  317 (359)
T 3vhe_A          249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF------CRRLKEGTR-----MRA  317 (359)
T ss_dssp             CEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH------HHHHHHTCC-----CCC
T ss_pred             chhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHH------HHHHHcCCC-----CCC
Confidence             22344678999999999999999999999999999999998 99999875543211      111111111     111


Q ss_pred             CccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 007869          497 GTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERD  536 (586)
Q Consensus       497 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  536 (586)
                      ...    ....+.+++..||+.||.+|||+.|+++.|+..
T Consensus       318 ~~~----~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~  353 (359)
T 3vhe_A          318 PDY----TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  353 (359)
T ss_dssp             CTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCC----CCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence            111    224577888999999999999999999999763

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=4.1e-44  Score=377.23  Aligned_cols=260  Identities=29%  Similarity=0.529  Sum_probs=200.7

Q ss_pred             hcCCcccceeEeecCceEEEEEEeC---CCCeEEEEEEeccc-cchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEE
Q 007869          259 ATKGFREKELLGTGGFGRVYRGTLP---KSQIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELL  334 (586)
Q Consensus       259 a~~~f~~~~~LG~G~~g~Vy~~~~~---~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~  334 (586)
                      ..++|+..+.||+|+||.||+|++.   .++..||||++... .....++|.+|+.++++++||||++++++|...+..+
T Consensus        43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  122 (373)
T 2qol_A           43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM  122 (373)
T ss_dssp             CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred             CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceE
Confidence            3467899999999999999999986   45678999999765 3345578999999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeecc
Q 007869          335 LVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYD  414 (586)
Q Consensus       335 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~  414 (586)
                      +||||+++|+|.+++... ...+++.+++.++.||++||.|||+   .+|+||||||+|||++.++.+||+|||+++...
T Consensus       123 lv~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  198 (373)
T 2qol_A          123 IVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRVLE  198 (373)
T ss_dssp             EEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence            999999999999999765 3468999999999999999999998   899999999999999999999999999998765


Q ss_pred             CCCCCc--eeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccCccccc
Q 007869          415 HGTDPQ--TTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEA  491 (586)
Q Consensus       415 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~  491 (586)
                      ......  .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+   +...+    ..+...  
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~---~~~~i----~~~~~~--  269 (373)
T 2qol_A          199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD---VIKAV----DEGYRL--  269 (373)
T ss_dssp             ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH---HHHHH----HTTEEC--
T ss_pred             cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH----HcCCCC--
Confidence            432221  122345788999999999999999999999999999998 999997643221   11111    111110  


Q ss_pred             cCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhccC
Q 007869          492 RDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERDVA  538 (586)
Q Consensus       492 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~  538 (586)
                        + .    .......+.+++.+||+.||++||++.++++.|+....
T Consensus       270 --~-~----~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~  309 (373)
T 2qol_A          270 --P-P----PMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR  309 (373)
T ss_dssp             --C-C----CTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --C-C----CccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHh
Confidence              0 0    11223567889999999999999999999999987543

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=2.2e-44  Score=379.88  Aligned_cols=261  Identities=25%  Similarity=0.416  Sum_probs=212.4

Q ss_pred             hhhhhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc-chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeE
Q 007869          255 DLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGEL  333 (586)
Q Consensus       255 el~~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~  333 (586)
                      ++....++|...+.||+|+||.||+|++..++..||||.+.... ....++|.+|++++++++||||++++++|...+..
T Consensus       108 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  187 (377)
T 3cbl_A          108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPI  187 (377)
T ss_dssp             TTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             ccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCc
Confidence            34455678899999999999999999998888999999987543 33345789999999999999999999999999999


Q ss_pred             EEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeec
Q 007869          334 LLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLY  413 (586)
Q Consensus       334 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~  413 (586)
                      ++||||+++|+|.+++... ...+++..++.++.|+++||.|||+   ++|+||||||+|||++.++.+||+|||+++..
T Consensus       188 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~  263 (377)
T 3cbl_A          188 YIVMELVQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREE  263 (377)
T ss_dssp             EEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             EEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCcCCcccCHHHEEEcCCCcEEECcCCCceec
Confidence            9999999999999999764 2358899999999999999999998   89999999999999999999999999999864


Q ss_pred             cCCCCCc-eeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccCccccc
Q 007869          414 DHGTDPQ-TTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEA  491 (586)
Q Consensus       414 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~  491 (586)
                      ....... .....+++.|+|||.+..+.++.++|||||||++|||++ |+.||......+   ..    .....+.... 
T Consensus       264 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~---~~----~~~~~~~~~~-  335 (377)
T 3cbl_A          264 ADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ---TR----EFVEKGGRLP-  335 (377)
T ss_dssp             TTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH---HH----HHHHTTCCCC-
T ss_pred             CCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HH----HHHHcCCCCC-
Confidence            4321111 112235778999999998999999999999999999998 999997643321   11    1122221111 


Q ss_pred             cCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 007869          492 RDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER  535 (586)
Q Consensus       492 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  535 (586)
                       .|       ......+.+++.+||+.||++|||+.++++.|+.
T Consensus       336 -~~-------~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~  371 (377)
T 3cbl_A          336 -CP-------ELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQS  371 (377)
T ss_dssp             -CC-------TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -CC-------CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence             11       1123567788999999999999999999999975

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=3.2e-44  Score=363.28  Aligned_cols=264  Identities=27%  Similarity=0.439  Sum_probs=221.7

Q ss_pred             hhhhhhhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCe
Q 007869          253 YKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGE  332 (586)
Q Consensus       253 ~~el~~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~  332 (586)
                      ++++....++|+..+.||+|+||.||+|.+..++..||+|++.... ...+.+.+|++++++++||||+++++++...+.
T Consensus         5 ~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   83 (288)
T 3kfa_A            5 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP   83 (288)
T ss_dssp             CCTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             hhcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            4556667888999999999999999999999889999999997543 345789999999999999999999999999999


Q ss_pred             EEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceee
Q 007869          333 LLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARL  412 (586)
Q Consensus       333 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~  412 (586)
                      .++||||+++++|.+++.......+++..++.++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||+++.
T Consensus        84 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~  160 (288)
T 3kfa_A           84 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRL  160 (288)
T ss_dssp             EEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHH---HTCCCSCCSGGGEEECGGGCEEECCCCGGGT
T ss_pred             EEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHH---CCccCCCCCcceEEEcCCCCEEEccCcccee
Confidence            9999999999999999988766779999999999999999999998   8999999999999999999999999999987


Q ss_pred             ccCCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccCccccc
Q 007869          413 YDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEA  491 (586)
Q Consensus       413 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~  491 (586)
                      .............+|+.|+|||++.+..++.++||||||+++|||++ |+.||.......   ..+.+.    ..     
T Consensus       161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~---~~~~~~----~~-----  228 (288)
T 3kfa_A          161 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYELLE----KD-----  228 (288)
T ss_dssp             SCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---HHHHHH----TT-----
T ss_pred             ccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHh----cc-----
Confidence            66544333444567889999999999999999999999999999999 999997654322   111111    11     


Q ss_pred             cCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 007869          492 RDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERD  536 (586)
Q Consensus       492 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  536 (586)
                      ..+..    .......+.+++.+|++.||.+|||+.++++.|+..
T Consensus       229 ~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~  269 (288)
T 3kfa_A          229 YRMER----PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM  269 (288)
T ss_dssp             CCCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCC----CCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence            01111    112235678889999999999999999999998764

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=4.6e-43  Score=367.43  Aligned_cols=252  Identities=21%  Similarity=0.315  Sum_probs=208.4

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccch------hHHHHHHHHHHhcccCCCceeeeeeeeeccCeE
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQ------GMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGEL  333 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~  333 (586)
                      .+.|...+.||+|+||.||+|++..++..||+|.+......      ..+.+.+|+.++++++||||+++++++...+..
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            46799999999999999999999999999999999764321      347799999999999999999999999999999


Q ss_pred             EEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCC----CeEEccccc
Q 007869          334 LLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGEL----NGRLGDFGL  409 (586)
Q Consensus       334 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~----~~kL~DFGl  409 (586)
                      ++||||+++|+|.+++...  ..+++..+..++.||+.||.|||+   .+|+||||||+|||++.++    .+||+|||+
T Consensus        91 ~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~~~vkl~DFG~  165 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL  165 (361)
T ss_dssp             EEEEECCCSCBHHHHHTTC--SCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCSS
T ss_pred             EEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeCCCCCccCEEEEecCC
Confidence            9999999999999999654  468999999999999999999998   8999999999999998776    799999999


Q ss_pred             eeeccCCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccc
Q 007869          410 ARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELL  489 (586)
Q Consensus       410 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~  489 (586)
                      ++......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+   +...    ...+.  
T Consensus       166 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~---~~~~----i~~~~--  234 (361)
T 2yab_A          166 AHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---TLAN----ITAVS--  234 (361)
T ss_dssp             CEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HHHH----HHTTC--
T ss_pred             ceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH---HHHH----HHhcC--
Confidence            99765432  2344679999999999999899999999999999999999999997653321   1111    11111  


Q ss_pred             cccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          490 EARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       490 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                          ......+.......+.+++.+||+.||.+|||+.|+++
T Consensus       235 ----~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          235 ----YDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             ----CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ----CCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                01111111122356778899999999999999999985

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.6e-42  Score=356.71  Aligned_cols=272  Identities=21%  Similarity=0.259  Sum_probs=216.2

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc-chhHHHHHHHHHHhcccCCCceeeeeeeeeccC--eEEEE
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKG--ELLLV  336 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~--~~~lV  336 (586)
                      .++|...+.||+|+||.||+|++..++..||||++.... ....+.+.+|++++++++||||+++++++...+  ..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence            457899999999999999999999889999999997543 344677889999999999999999999988655  78999


Q ss_pred             EecCCCCChhhhhhcCCC-ccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeee----cCCCCeEEcccccee
Q 007869          337 YDYMPNGSLDKYLYDQPK-VTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLL----DGELNGRLGDFGLAR  411 (586)
Q Consensus       337 ~E~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll----~~~~~~kL~DFGla~  411 (586)
                      |||+++++|.+++..... ..+++.+++.++.|+++||.|||+   .+|+||||||+|||+    +.++.+||+|||+++
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~  164 (319)
T 4euu_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (319)
T ss_dssp             EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred             EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence            999999999999976532 348999999999999999999998   899999999999999    788889999999999


Q ss_pred             eccCCCCCceeeeccCCCccCccccc--------CCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccc-hhhHHHHhh
Q 007869          412 LYDHGTDPQTTHVVGTLGYLAPEHTR--------TGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENL-ILVDWVFDF  482 (586)
Q Consensus       412 ~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~-~l~~~v~~~  482 (586)
                      ......  ......||+.|+|||++.        +..++.++|||||||++|||++|+.||......... .....+...
T Consensus       165 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  242 (319)
T 4euu_A          165 ELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG  242 (319)
T ss_dssp             ECCTTC--CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred             ecCCCC--ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence            765433  233457999999999986        577899999999999999999999999764432211 111111111


Q ss_pred             hccCcc-----------ccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 007869          483 WNRGEL-----------LEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERD  536 (586)
Q Consensus       483 ~~~~~~-----------~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  536 (586)
                      ......           .-..+..............+.+++.+||+.||++|||+.|+++....+
T Consensus       243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~  307 (319)
T 4euu_A          243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI  307 (319)
T ss_dssp             CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred             CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence            000000           000011112234567778889999999999999999999999988654

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.6e-43  Score=362.45  Aligned_cols=252  Identities=19%  Similarity=0.275  Sum_probs=209.2

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEec
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY  339 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  339 (586)
                      .++|+..+.||+|+||.||+|++..++..||+|.+.... .....+.+|+.++++++||||+++++++.+.+..++||||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   82 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence            468999999999999999999999999999999997543 3446789999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecC--CCCeEEccccceeeccCCC
Q 007869          340 MPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDG--ELNGRLGDFGLARLYDHGT  417 (586)
Q Consensus       340 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~--~~~~kL~DFGla~~~~~~~  417 (586)
                      +++|+|.+++... ...+++.+++.++.|+++||.|||+   .+|+||||||+|||++.  ++.+||+|||+++......
T Consensus        83 ~~g~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~---~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~  158 (321)
T 1tki_A           83 ISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD  158 (321)
T ss_dssp             CCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred             CCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC
Confidence            9999999999654 2468999999999999999999998   89999999999999987  7899999999999765432


Q ss_pred             CCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCC
Q 007869          418 DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLG  497 (586)
Q Consensus       418 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~  497 (586)
                        ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+   +.+.+.    ++..      ...
T Consensus       159 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~i~----~~~~------~~~  223 (321)
T 1tki_A          159 --NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ---IIENIM----NAEY------TFD  223 (321)
T ss_dssp             --EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHHHH----HTCC------CCC
T ss_pred             --ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH---HHHHHH----cCCC------CCC
Confidence              3455689999999999998889999999999999999999999997643321   111111    1110      010


Q ss_pred             ccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          498 TEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       498 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      ..........+.+++.+||+.||.+|||+.|+++
T Consensus       224 ~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~  257 (321)
T 1tki_A          224 EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             hhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            0001122356788999999999999999999997

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=2.6e-43  Score=363.84  Aligned_cols=254  Identities=24%  Similarity=0.341  Sum_probs=205.4

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccc-hhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEe
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR-QGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYD  338 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E  338 (586)
                      .++|+..+.||+|+||.||+|++..+++.||||++..... ...+.+.+|+.++++++||||+++++++...+..++|||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            3689999999999999999999998999999999865432 334668899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCC
Q 007869          339 YMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD  418 (586)
Q Consensus       339 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~  418 (586)
                      |+++|+|.+++...  ..+++.+++.++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++.+.....
T Consensus        86 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  160 (323)
T 3tki_A           86 YCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  160 (323)
T ss_dssp             CCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             cCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccccchHHEEEeCCCCEEEEEeeccceeccCCc
Confidence            99999999999654  358899999999999999999998   8999999999999999999999999999987643321


Q ss_pred             -CceeeeccCCCccCcccccCCCC-CCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCC
Q 007869          419 -PQTTHVVGTLGYLAPEHTRTGKA-TTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNL  496 (586)
Q Consensus       419 -~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l  496 (586)
                       .......||+.|+|||++.+..+ +.++|||||||++|||++|+.||........ ....|..     ....  ..+  
T Consensus       161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~~-----~~~~--~~~--  230 (323)
T 3tki_A          161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWKE-----KKTY--LNP--  230 (323)
T ss_dssp             ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH-HHHHHHT-----TCTT--STT--
T ss_pred             ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHHhc-----cccc--CCc--
Confidence             22335679999999999987775 7789999999999999999999986544321 1111111     1000  000  


Q ss_pred             CccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          497 GTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       497 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                          .......+.+++.+||+.||++|||+.|+++.
T Consensus       231 ----~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          231 ----WKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             ----GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ----cccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence                11223456788999999999999999999864

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.6e-43  Score=362.42  Aligned_cols=252  Identities=22%  Similarity=0.347  Sum_probs=207.9

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccch------hHHHHHHHHHHhcccCCCceeeeeeeeeccCeE
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQ------GMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGEL  333 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~  333 (586)
                      .+.|...+.||+|+||.||+|.+..++..||+|++......      ..+.+.+|+.++++++||||+++++++...+..
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   89 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   89 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            35688899999999999999999989999999999764321      357799999999999999999999999999999


Q ss_pred             EEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCC----CeEEccccc
Q 007869          334 LLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGEL----NGRLGDFGL  409 (586)
Q Consensus       334 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~----~~kL~DFGl  409 (586)
                      ++||||+++++|.+++...  ..+++..++.++.|++.||.|||+   .+|+||||||+|||++.++    .+||+|||+
T Consensus        90 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~  164 (326)
T 2y0a_A           90 ILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL  164 (326)
T ss_dssp             EEEEECCCSCBHHHHHTTS--SCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEEEcCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHH---CCeEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence            9999999999999999654  468999999999999999999998   8999999999999998877    799999999


Q ss_pred             eeeccCCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccc
Q 007869          410 ARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELL  489 (586)
Q Consensus       410 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~  489 (586)
                      ++......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.   ...+.    ..   
T Consensus       165 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---~~~~~----~~---  232 (326)
T 2y0a_A          165 AHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET---LANVS----AV---  232 (326)
T ss_dssp             CEECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHH---HHHHH----HT---
T ss_pred             CeECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH---HHHHH----hc---
Confidence            99765432  23346799999999999989999999999999999999999999976432211   11110    00   


Q ss_pred             cccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          490 EARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       490 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                         ...............+.+++.+||+.||++|||+.|+++
T Consensus       233 ---~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          233 ---NYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             ---CCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ---CCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence               111111111122356778899999999999999999986

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=8.1e-43  Score=355.06  Aligned_cols=263  Identities=27%  Similarity=0.416  Sum_probs=203.7

Q ss_pred             hcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcc--cCCCceeeeeeeeec----cCe
Q 007869          259 ATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGR--LRHRNLVQLLGYCRR----KGE  332 (586)
Q Consensus       259 a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~--l~H~niv~l~~~~~~----~~~  332 (586)
                      ..++|+..+.||+|+||.||+|++  ++..||||++....   .+.+..|.+++..  ++||||+++++++..    .+.
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~   80 (301)
T 3q4u_A            6 VARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQ   80 (301)
T ss_dssp             CGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG---HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             ccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc---chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCce
Confidence            356899999999999999999998  57789999986542   3455566666555  799999999998654    356


Q ss_pred             EEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhccc-----CCcEEeCCCCCCCeeecCCCCeEEccc
Q 007869          333 LLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEW-----EQVVIHRDVKASNVLLDGELNGRLGDF  407 (586)
Q Consensus       333 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-----~~~ivHrDIkp~NIll~~~~~~kL~DF  407 (586)
                      .++||||+++|+|.+++...   .+++..++.++.|+++||.|||+..     +++|+||||||+|||++.++.+||+||
T Consensus        81 ~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  157 (301)
T 3q4u_A           81 LWLITHYHEMGSLYDYLQLT---TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADL  157 (301)
T ss_dssp             EEEEECCCTTCBHHHHHTTC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred             eEEehhhccCCCHHHHHhhc---ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeC
Confidence            89999999999999999543   6899999999999999999999211     289999999999999999999999999


Q ss_pred             cceeeccCCCCCc---eeeeccCCCccCcccccCC------CCCCcceEEehhHHHHHHHhC----------CCCCCCCC
Q 007869          408 GLARLYDHGTDPQ---TTHVVGTLGYLAPEHTRTG------KATTSADVFSFGAFLLEVACG----------RRPIQRQG  468 (586)
Q Consensus       408 Gla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~s~ksDVyS~Gvvl~ElltG----------~~p~~~~~  468 (586)
                      |+++.........   .....||+.|+|||++.+.      .++.++|||||||++|||++|          +.||....
T Consensus       158 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~  237 (301)
T 3q4u_A          158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV  237 (301)
T ss_dssp             TTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred             CCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccC
Confidence            9998765443221   2234799999999999876      455799999999999999999          78886543


Q ss_pred             CCccchhhHHHHhhhccCccccccCCCCCc-cccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 007869          469 PSENLILVDWVFDFWNRGELLEARDPNLGT-EYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER  535 (586)
Q Consensus       469 ~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~-~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  535 (586)
                      ...... .. ......    .....+.+.. .+.......+.+++.+||+.||++|||+.|+++.|++
T Consensus       238 ~~~~~~-~~-~~~~~~----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~  299 (301)
T 3q4u_A          238 PNDPSF-ED-MRKVVC----VDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK  299 (301)
T ss_dssp             CSSCCH-HH-HHHHHT----TSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCcch-hh-hhHHHh----ccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence            332211 11 111111    1111222222 2344567889999999999999999999999999975

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=2.6e-43  Score=353.07  Aligned_cols=258  Identities=28%  Similarity=0.429  Sum_probs=211.4

Q ss_pred             hhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEE
Q 007869          258 IATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY  337 (586)
Q Consensus       258 ~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  337 (586)
                      ...++|+..+.||+|+||.||+|.+.. +..||||++..... ..+++.+|++++.+++||||+++++++...+..++||
T Consensus         5 l~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (268)
T 3sxs_A            5 LKREEITLLKELGSGQFGVVKLGKWKG-QYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVT   82 (268)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             echhheeeeeeeccCCCceEEEEEecC-ceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEE
Confidence            445789999999999999999998864 66799999976543 3467999999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCC
Q 007869          338 DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT  417 (586)
Q Consensus       338 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~  417 (586)
                      ||+++++|.+++... ...+++..++.++.|+++||.|||+   .+|+||||||+|||++.++.+||+|||+++......
T Consensus        83 e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  158 (268)
T 3sxs_A           83 EYISNGCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFLES---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ  158 (268)
T ss_dssp             ECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred             EccCCCcHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence            999999999999765 2368999999999999999999998   899999999999999999999999999998765443


Q ss_pred             CCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccCccccccCCCC
Q 007869          418 DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNL  496 (586)
Q Consensus       418 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l  496 (586)
                      ........+|+.|+|||.+.+..++.++||||||+++|||++ |+.||......+.      ... ...+.  ....+..
T Consensus       159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~------~~~-~~~~~--~~~~~~~  229 (268)
T 3sxs_A          159 YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEV------VLK-VSQGH--RLYRPHL  229 (268)
T ss_dssp             EEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHH------HHH-HHTTC--CCCCCTT
T ss_pred             hhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHH------HHH-HHcCC--CCCCCCc
Confidence            323334456778999999998899999999999999999999 9999976443211      111 11111  0111111


Q ss_pred             CccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 007869          497 GTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERDV  537 (586)
Q Consensus       497 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  537 (586)
                             ....+.+++..||+.||.+|||+.|+++.|+...
T Consensus       230 -------~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~  263 (268)
T 3sxs_A          230 -------ASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR  263 (268)
T ss_dssp             -------SCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred             -------ChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence                   1245778899999999999999999999998643

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.1e-43  Score=366.95  Aligned_cols=258  Identities=24%  Similarity=0.388  Sum_probs=203.1

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeE----EEEEEeccc-cchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEE
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIE----IAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELL  334 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~----vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~  334 (586)
                      .++|+..+.||+|+||.||+|++..++..    ||+|.+... .....++|.+|+.++++++||||++++++|...+ .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~   92 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence            45789999999999999999998766554    588887543 3345678999999999999999999999998765 78


Q ss_pred             EEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeecc
Q 007869          335 LVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYD  414 (586)
Q Consensus       335 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~  414 (586)
                      +|+||+++|+|.+++.... ..+++..++.++.|+++||.|||+   ++|+||||||+|||++.++++||+|||+++...
T Consensus        93 ~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~  168 (327)
T 3poz_A           93 LITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             EEEECCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred             EEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence            9999999999999998753 468999999999999999999998   899999999999999999999999999999765


Q ss_pred             CCCCC-ceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccCcccccc
Q 007869          415 HGTDP-QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEAR  492 (586)
Q Consensus       415 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~  492 (586)
                      ..... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+   +...+    ..+..    
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~~~----~~~~~----  237 (327)
T 3poz_A          169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSIL----EKGER----  237 (327)
T ss_dssp             TTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHHH----HTTCC----
T ss_pred             CCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH---HHHHH----HcCCC----
Confidence            43322 2234467889999999999999999999999999999999 999998654332   11111    11111    


Q ss_pred             CCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhccC
Q 007869          493 DPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERDVA  538 (586)
Q Consensus       493 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~  538 (586)
                       ...    .......+.+++.+||+.||.+||++.|+++.|+....
T Consensus       238 -~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~  278 (327)
T 3poz_A          238 -LPQ----PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             -CCC----CTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred             -CCC----CccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence             011    11223467788999999999999999999999987543

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=8.9e-44  Score=356.77  Aligned_cols=257  Identities=26%  Similarity=0.413  Sum_probs=209.9

Q ss_pred             hhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEE
Q 007869          258 IATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY  337 (586)
Q Consensus       258 ~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  337 (586)
                      ...++|+..+.||+|+||.||+|++.. +..||+|++..... ..+++.+|++++++++||||+++++++.+.+..++||
T Consensus         7 i~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (269)
T 4hcu_A            7 IDPSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF   84 (269)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             eChhhceeeheecCCCccEEEEEEecC-CCeEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEE
Confidence            345678899999999999999999864 66799999976543 3467999999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCC
Q 007869          338 DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT  417 (586)
Q Consensus       338 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~  417 (586)
                      ||+++++|.+++.... ..+++..++.++.|+++||.|||+   .+|+||||||+|||++.++.+||+|||+++......
T Consensus        85 e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  160 (269)
T 4hcu_A           85 EFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ  160 (269)
T ss_dssp             ECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred             EeCCCCcHHHHHHhcC-cccCHHHHHHHHHHHHHHHHHHHh---CCeecCCcchheEEEcCCCCEEeccccccccccccc
Confidence            9999999999997653 468999999999999999999998   899999999999999999999999999998654322


Q ss_pred             CCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccCccccccCCCC
Q 007869          418 DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNL  496 (586)
Q Consensus       418 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l  496 (586)
                      ........+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+   ....    ...+.  ....+. 
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~---~~~~----~~~~~--~~~~~~-  230 (269)
T 4hcu_A          161 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---VVED----ISTGF--RLYKPR-  230 (269)
T ss_dssp             HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHH----HHTTC--CCCCCT-
T ss_pred             cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH---HHHH----HhcCc--cCCCCC-
Confidence            222233456788999999998999999999999999999999 999997643321   1111    11110  111111 


Q ss_pred             CccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 007869          497 GTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERD  536 (586)
Q Consensus       497 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  536 (586)
                        .    ....+.+++.+||+.||++||++.|+++.|+..
T Consensus       231 --~----~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l  264 (269)
T 4hcu_A          231 --L----ASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI  264 (269)
T ss_dssp             --T----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --c----CCHHHHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence              1    134577888999999999999999999999763

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=3.4e-43  Score=367.80  Aligned_cols=275  Identities=22%  Similarity=0.268  Sum_probs=217.5

Q ss_pred             CcccchhhhhhhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccC-----CCceee
Q 007869          248 PHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLR-----HRNLVQ  322 (586)
Q Consensus       248 ~~~~~~~el~~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-----H~niv~  322 (586)
                      ...+++++.....++|+..+.||+|+||.||+|++..++..||||++... ....+.+..|+.++++++     ||||++
T Consensus        22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~  100 (360)
T 3llt_A           22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVK  100 (360)
T ss_dssp             GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred             ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence            45677888888899999999999999999999999989999999999643 334466788999999886     999999


Q ss_pred             eeeeeeccCeEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecC----
Q 007869          323 LLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDG----  398 (586)
Q Consensus       323 l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~----  398 (586)
                      +++++...+..++||||+ +++|.+++.......+++..+..++.||+.||.|||+   ++|+||||||+|||++.    
T Consensus       101 ~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~  176 (360)
T 3llt_A          101 YHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYFE  176 (360)
T ss_dssp             EEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCTTCC
T ss_pred             ccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCcccEEEcccccc
Confidence            999999999999999999 9999999988766679999999999999999999998   99999999999999975    


Q ss_pred             ---------------------CCCeEEccccceeeccCCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHH
Q 007869          399 ---------------------ELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEV  457 (586)
Q Consensus       399 ---------------------~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~El  457 (586)
                                           ++.+||+|||+++.....    .....||+.|+|||++.+..++.++|||||||++|||
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el  252 (360)
T 3llt_A          177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAEL  252 (360)
T ss_dssp             EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHH
T ss_pred             ccccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHH
Confidence                                 789999999999875432    2345789999999999999999999999999999999


Q ss_pred             HhCCCCCCCCCCCccchhhHHH---------HhhhccCc-------cccccCCCCCcc-------------ccHHHHHHH
Q 007869          458 ACGRRPIQRQGPSENLILVDWV---------FDFWNRGE-------LLEARDPNLGTE-------------YVAEELELV  508 (586)
Q Consensus       458 ltG~~p~~~~~~~~~~~l~~~v---------~~~~~~~~-------~~~~~d~~l~~~-------------~~~~~~~~l  508 (586)
                      ++|+.||......+........         ........       .....-|.....             +.......+
T Consensus       253 l~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l  332 (360)
T 3llt_A          253 YTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELF  332 (360)
T ss_dssp             HHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHH
T ss_pred             HHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHH
Confidence            9999999765432221111110         00000000       000000110000             000111567


Q ss_pred             HHHHHHhcccCCCCCCCHHHHHH
Q 007869          509 LKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       509 ~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      .+++.+||+.||++|||+.|+++
T Consensus       333 ~~li~~~L~~dP~~Rpta~elL~  355 (360)
T 3llt_A          333 CDFLYSILQIDPTLRPSPAELLK  355 (360)
T ss_dssp             HHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHHHHHHhcCChhhCCCHHHHhc
Confidence            79999999999999999999975

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=3.9e-44  Score=387.32  Aligned_cols=264  Identities=26%  Similarity=0.444  Sum_probs=214.9

Q ss_pred             chhhhhhhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccC
Q 007869          252 RYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKG  331 (586)
Q Consensus       252 ~~~el~~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~  331 (586)
                      ...++.+..++|...+.||+|+||.||+|.+.. +..||||++.... ...+.|.+|++++++++||||+++++++. .+
T Consensus       179 ~~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~  255 (454)
T 1qcf_A          179 EKDAWEIPRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KE  255 (454)
T ss_dssp             CTTCSBCCGGGEEEEEEEECCSSEEEEEEEETT-TEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SS
T ss_pred             cccceeechHHeEEEEEcccCCceEEEEEEECC-ccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CC
Confidence            345567778899999999999999999999964 5679999997654 34678999999999999999999999987 56


Q ss_pred             eEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEcccccee
Q 007869          332 ELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR  411 (586)
Q Consensus       332 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~  411 (586)
                      ..++||||+++|+|.+++.......+++..++.++.||++||.|||+   ++|+||||||+|||++.++.+||+|||+++
T Consensus       256 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~  332 (454)
T 1qcf_A          256 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLAR  332 (454)
T ss_dssp             SCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTCCEEECSTTGGG
T ss_pred             ccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEECCCCcEEEeeCCCce
Confidence            78999999999999999976544468888999999999999999998   899999999999999999999999999998


Q ss_pred             eccCCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccCcccc
Q 007869          412 LYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLE  490 (586)
Q Consensus       412 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~  490 (586)
                      ..............+|..|+|||++..+.++.++|||||||++|||++ |+.||......+   +...+    .++... 
T Consensus       333 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~---~~~~i----~~~~~~-  404 (454)
T 1qcf_A          333 VIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---VIRAL----ERGYRM-  404 (454)
T ss_dssp             GBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---HHHHH----HHTCCC-
T ss_pred             EcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH---HHHHH----HcCCCC-
Confidence            754321111223456789999999998999999999999999999999 999997654322   11111    111111 


Q ss_pred             ccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 007869          491 ARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERDV  537 (586)
Q Consensus       491 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  537 (586)
                       ..|       ......+.+++.+||+.||++|||+.++++.|+...
T Consensus       405 -~~~-------~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~  443 (454)
T 1qcf_A          405 -PRP-------ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFY  443 (454)
T ss_dssp             -CCC-------TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred             -CCC-------CCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence             111       122356788999999999999999999999998643

>1avb_A Arcelin-1; lectin-like glycoprotein, plant defense, insecticidal activi lectin; HET: NAG; 1.90A {Phaseolus vulgaris} SCOP: b.29.1.1

Probab=100.00  E-value=3e-43  Score=339.88  Aligned_cols=161  Identities=30%  Similarity=0.485  Sum_probs=144.0

Q ss_pred             CcccCCCCCCCCCCeeeeeEEEEEEEEEeCCCCCCCCcEEEEEecCCCCCCCCCCCcccccccCCCCCCCccEEEEEeec
Q 007869            2 PFKNKNSNSSTANGTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGLFNDTNLGNETNHVFAVELDT   81 (586)
Q Consensus         2 p~~~~~~~~~~~~~~~asF~t~F~f~i~~~~~~~~g~GlaF~l~p~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEfDt   81 (586)
                      ||++|++.+    |+++||+|+|+|.|.+.+...+||||||+|+|....|. ++|+||||||.+ +++..||+|||||||
T Consensus        51 Pv~l~~~~~----g~vaSFsT~F~F~I~~~~~~~~gdGlAF~l~p~~~~p~-~~g~~LGl~n~~-~~~~~~~~vAVEFDT  124 (226)
T 1avb_A           51 PIQINDRTI----DNLASFSTNFTFRINAKNIENSAYGLAFALVPVGSRPK-LKGRYLGLFNTT-NYDRDAHTVAVVFDT  124 (226)
T ss_dssp             CEECEEGGG----TEEEEEEEEEEEEEEESSTTSCCEEEEEEEEETTCCCC-CCGGGTTTCSCS-SCCGGGCCEEEEEET
T ss_pred             CEEeecCCC----CCcccEEEEEEEEEeCCCCCCCCCcEEEEEecCCCCCC-CCCCcccccccC-CCCCcccEEEEEecC
Confidence            899999887    99999999999999988777899999999999876666 889999999976 457789999999999


Q ss_pred             cccCCCCCCCCCeeEEeCCCCcccccccC----------ceEEEEcCeeeEEEEEEeecCCCCCCccceeeeeecchhcc
Q 007869           82 IKSHGFLDINDNHVGIDINSLKSESSAPA----------GYYVEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSVL  151 (586)
Q Consensus        82 ~~~~~~~d~~~~hvgidvns~~s~~~~~~----------~~~i~y~~~~~~l~v~~~~~~~~~~~~~~~ls~~~dL~~~l  151 (586)
                      +         +|||||||||+.|.+++++          ..||+||+.+++|+|++++.+.+  .. |+|++.+||+++|
T Consensus       125 ~---------~nHVGIdvNs~~S~~t~~~~~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~~--~~-~~ls~~vdL~~~l  192 (226)
T 1avb_A          125 V---------SNRIEIDVNSIRPIATESCNFGHNNGEKAEVRITYDSPKNDLRVSLLYPSSE--EK-CHVSATVPLEKEV  192 (226)
T ss_dssp             T---------TTEEEEEESSSSCSEEEECCSGGGTTCEEEEEEEEEGGGTEEEEEEEETTTT--EE-EEEEEECCHHHHS
T ss_pred             c---------CCccceeecCcccCccccCCccccCCCeEEEEEEEeCCCcEEEEEEeecCCC--cc-ceEEEEechHHhC
Confidence            8         6999999999999876643          36999999999999999875432  24 8999999999999


Q ss_pred             ccceeeeeecCCCcc---ceeeeeeecccccc
Q 007869          152 NDAMYVGFSSSTGSV---LASHYILGWSFKIN  180 (586)
Q Consensus       152 ~~~~~vGFsastg~~---~~~~~i~~Wsf~~~  180 (586)
                      ||+||||||||||..   .|.|+|++|+|+++
T Consensus       193 ~e~~~VGFSAsTG~~~~~~~~h~IlsWsF~s~  224 (226)
T 1avb_A          193 EDWVSVGFSATSGSKKETTETHNVLSWSFSSN  224 (226)
T ss_dssp             CSEEEEEEEEEECSSGGGCEEEEEEEEEEEEE
T ss_pred             CCceEEEEEeccCCCCcccceeEEEEEEEEee
Confidence            999999999999998   99999999999864

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=4.6e-43  Score=378.43  Aligned_cols=254  Identities=30%  Similarity=0.416  Sum_probs=209.4

Q ss_pred             hhhhhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccC-eE
Q 007869          255 DLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKG-EL  333 (586)
Q Consensus       255 el~~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~-~~  333 (586)
                      ++....++|+..+.||+|+||.||+|.+.  +..||||+++...  ..+.|.+|+.++++++||||+++++++...+ ..
T Consensus       187 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  262 (450)
T 1k9a_A          187 GWALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL  262 (450)
T ss_dssp             TCBCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCE
T ss_pred             ccccChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCce
Confidence            34456678899999999999999999985  5689999997654  4578999999999999999999999987664 79


Q ss_pred             EEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeec
Q 007869          334 LLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLY  413 (586)
Q Consensus       334 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~  413 (586)
                      ++||||+++|+|.+++.......+++..++.++.||++||.|||+   ++|+||||||+|||++.++.+||+|||+++..
T Consensus       263 ~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~  339 (450)
T 1k9a_A          263 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA  339 (450)
T ss_dssp             EEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEECCCCCEEEeeCCCcccc
Confidence            999999999999999987655567899999999999999999998   89999999999999999999999999999864


Q ss_pred             cCCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccCcccccc
Q 007869          414 DHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEAR  492 (586)
Q Consensus       414 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~  492 (586)
                      ...    .....++..|+|||++.+..++.++|||||||++|||++ |+.||......+.   ..    ...++...   
T Consensus       340 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~---~~----~i~~~~~~---  405 (450)
T 1k9a_A          340 SST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---VP----RVEKGYKM---  405 (450)
T ss_dssp             C----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTH---HH----HHHTTCCC---
T ss_pred             ccc----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HH----HHHcCCCC---
Confidence            322    122357899999999999999999999999999999998 9999987554331   11    11122111   


Q ss_pred             CCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 007869          493 DPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER  535 (586)
Q Consensus       493 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  535 (586)
                        ..    .......+.+++.+||+.||.+|||+.++++.|+.
T Consensus       406 --~~----p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~  442 (450)
T 1k9a_A          406 --DA----PDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEH  442 (450)
T ss_dssp             --CC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             --CC----CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence              11    11223567788999999999999999999999975

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=3.6e-43  Score=359.87  Aligned_cols=263  Identities=25%  Similarity=0.416  Sum_probs=214.9

Q ss_pred             hhhhhcCCcccceeEeecCceEEEEEEe-----CCCCeEEEEEEeccc-cchhHHHHHHHHHHhcccCCCceeeeeeeee
Q 007869          255 DLYIATKGFREKELLGTGGFGRVYRGTL-----PKSQIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCR  328 (586)
Q Consensus       255 el~~a~~~f~~~~~LG~G~~g~Vy~~~~-----~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~  328 (586)
                      ++....++|...+.||+|+||.||+|.+     ..++..||||++... .....+.+.+|++++++++||||+++++++.
T Consensus        17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~   96 (314)
T 2ivs_A           17 KWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACS   96 (314)
T ss_dssp             TTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             ccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEe
Confidence            3445667899999999999999999987     345588999999764 3445678999999999999999999999999


Q ss_pred             ccCeEEEEEecCCCCChhhhhhcCCC----------------------ccchhHHHHHHHHHHHHHHHHhhcccCCcEEe
Q 007869          329 RKGELLLVYDYMPNGSLDKYLYDQPK----------------------VTLNWIQRFRVIKGVALGLFYLHQEWEQVVIH  386 (586)
Q Consensus       329 ~~~~~~lV~E~~~~gsL~~~l~~~~~----------------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH  386 (586)
                      ..+..++||||+++++|.+++.....                      ..+++.+++.++.||++||.|||+   ++|+|
T Consensus        97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH  173 (314)
T 2ivs_A           97 QDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVH  173 (314)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH---TTEEC
T ss_pred             cCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH---CCCcc
Confidence            99999999999999999999986532                      348899999999999999999998   89999


Q ss_pred             CCCCCCCeeecCCCCeEEccccceeeccCCCCC-ceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCC
Q 007869          387 RDVKASNVLLDGELNGRLGDFGLARLYDHGTDP-QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPI  464 (586)
Q Consensus       387 rDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~  464 (586)
                      |||||+|||++.++.+||+|||+++........ ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||
T Consensus       174 ~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~  253 (314)
T 2ivs_A          174 RDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY  253 (314)
T ss_dssp             CCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             cccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCC
Confidence            999999999999999999999999876543221 2233467889999999999899999999999999999999 99999


Q ss_pred             CCCCCCccchhhHHHHhhhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 007869          465 QRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERD  536 (586)
Q Consensus       465 ~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  536 (586)
                      ......+   +..    ....+..     +....    .....+.+++.+||+.||++||++.|+++.|++.
T Consensus       254 ~~~~~~~---~~~----~~~~~~~-----~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~  309 (314)
T 2ivs_A          254 PGIPPER---LFN----LLKTGHR-----MERPD----NCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM  309 (314)
T ss_dssp             TTCCGGG---HHH----HHHTTCC-----CCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCHHH---HHH----HhhcCCc-----CCCCc----cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            7654322   111    1111111     11111    2235678889999999999999999999999764

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=6.4e-43  Score=362.97  Aligned_cols=249  Identities=24%  Similarity=0.288  Sum_probs=207.4

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc---cchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEE
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLV  336 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV  336 (586)
                      .++|+..+.||+|+||+||+|+...+++.||||++...   .....+.+.+|+.++++++||||+++++++...+.+++|
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            36789999999999999999999999999999999764   234456789999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCC
Q 007869          337 YDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHG  416 (586)
Q Consensus       337 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~  416 (586)
                      |||+++|+|.+++...  ..+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++.....
T Consensus        84 ~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  158 (337)
T 1o6l_A           84 MEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD  158 (337)
T ss_dssp             EECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred             EeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence            9999999999999764  358888999999999999999998   89999999999999999999999999999864322


Q ss_pred             CCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCC
Q 007869          417 TDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNL  496 (586)
Q Consensus       417 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l  496 (586)
                      . .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+   +.+.+    ..+.      ..+
T Consensus       159 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~~~~i----~~~~------~~~  224 (337)
T 1o6l_A          159 G-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---LFELI----LMEE------IRF  224 (337)
T ss_dssp             T-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH----HHCC------CCC
T ss_pred             C-CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHH---HHHHH----HcCC------CCC
Confidence            2 23345689999999999999999999999999999999999999997643211   11111    1111      111


Q ss_pred             CccccHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 007869          497 GTEYVAEELELVLKLGLLCSHSDPTARP-----SMRQVVQ  531 (586)
Q Consensus       497 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~  531 (586)
                      ...    ....+.+++.+||+.||++||     ++.|+++
T Consensus       225 p~~----~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~  260 (337)
T 1o6l_A          225 PRT----LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             CTT----SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             CCC----CCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence            111    234567888899999999999     8999975

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-43  Score=367.49  Aligned_cols=265  Identities=25%  Similarity=0.429  Sum_probs=215.2

Q ss_pred             hhhhhhcCCcccceeEeecCceEEEEEEeCC-----CCeEEEEEEecccc-chhHHHHHHHHHHhcccCCCceeeeeeee
Q 007869          254 KDLYIATKGFREKELLGTGGFGRVYRGTLPK-----SQIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYC  327 (586)
Q Consensus       254 ~el~~a~~~f~~~~~LG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~~~~  327 (586)
                      .++....++|+..+.||+|+||.||+|++..     ++..||||++.... ....+.+.+|+.++++++||||++++++|
T Consensus        40 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~  119 (343)
T 1luf_A           40 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC  119 (343)
T ss_dssp             HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             ceeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            3445567889999999999999999999863     45889999997653 34457799999999999999999999999


Q ss_pred             eccCeEEEEEecCCCCChhhhhhcCC----------------------CccchhHHHHHHHHHHHHHHHHhhcccCCcEE
Q 007869          328 RRKGELLLVYDYMPNGSLDKYLYDQP----------------------KVTLNWIQRFRVIKGVALGLFYLHQEWEQVVI  385 (586)
Q Consensus       328 ~~~~~~~lV~E~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iv  385 (586)
                      ...+..++||||+++|+|.+++....                      ...+++.+++.++.||++||.|||+   ++|+
T Consensus       120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~---~~iv  196 (343)
T 1luf_A          120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFV  196 (343)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCC
T ss_pred             ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCee
Confidence            99999999999999999999997642                      1468999999999999999999998   8999


Q ss_pred             eCCCCCCCeeecCCCCeEEccccceeeccCCCC-CceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCC
Q 007869          386 HRDVKASNVLLDGELNGRLGDFGLARLYDHGTD-PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRP  463 (586)
Q Consensus       386 HrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p  463 (586)
                      ||||||+|||++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.|
T Consensus       197 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p  276 (343)
T 1luf_A          197 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP  276 (343)
T ss_dssp             CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             cCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCc
Confidence            999999999999999999999999986543221 22334568999999999998999999999999999999999 9999


Q ss_pred             CCCCCCCccchhhHHHHhhhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 007869          464 IQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERDV  537 (586)
Q Consensus       464 ~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  537 (586)
                      |......+   +.    ....++...     ....    .....+.+++.+||+.||.+||++.++++.|++..
T Consensus       277 ~~~~~~~~---~~----~~~~~~~~~-----~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~  334 (343)
T 1luf_A          277 YYGMAHEE---VI----YYVRDGNIL-----ACPE----NCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  334 (343)
T ss_dssp             TTTSCHHH---HH----HHHHTTCCC-----CCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCCCChHH---HH----HHHhCCCcC-----CCCC----CCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHH
Confidence            97643221   11    111222211     1111    22346778899999999999999999999998754

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=5.1e-44  Score=375.73  Aligned_cols=262  Identities=26%  Similarity=0.438  Sum_probs=210.4

Q ss_pred             cCCcccceeEeecCceEEEEEEe-----CCCCeEEEEEEeccc-cchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeE
Q 007869          260 TKGFREKELLGTGGFGRVYRGTL-----PKSQIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGEL  333 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~-----~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~  333 (586)
                      .++|+..+.||+|+||.||+|++     ..++..||||++... ..+....+.+|+.++++++||||+++++++...+..
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  149 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  149 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            46788999999999999999994     346678999999654 344556799999999999999999999999999999


Q ss_pred             EEEEecCCCCChhhhhhcCC-----CccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCC---CeEEc
Q 007869          334 LLVYDYMPNGSLDKYLYDQP-----KVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGEL---NGRLG  405 (586)
Q Consensus       334 ~lV~E~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~---~~kL~  405 (586)
                      ++||||+++|+|.+++....     ...+++.+++.++.||++||.|||+   ++|+||||||+|||++.++   .+||+
T Consensus       150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEEecCCCCceEEEC
Confidence            99999999999999997642     2458999999999999999999998   8999999999999999554   59999


Q ss_pred             cccceeeccCCC-CCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhh
Q 007869          406 DFGLARLYDHGT-DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFW  483 (586)
Q Consensus       406 DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~  483 (586)
                      |||+++...... ........||+.|+|||++.+..++.++|||||||++|||++ |+.||......+   +.+.+    
T Consensus       227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~---~~~~i----  299 (367)
T 3l9p_A          227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE---VLEFV----  299 (367)
T ss_dssp             CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---HHHHH----
T ss_pred             CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHH----
Confidence            999998653322 223344678999999999999999999999999999999998 999997653321   11111    


Q ss_pred             ccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhccCCC
Q 007869          484 NRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERDVALP  540 (586)
Q Consensus       484 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~p  540 (586)
                      ..+..     +....    .....+.+++.+||+.||++||++.++++.|+....-|
T Consensus       300 ~~~~~-----~~~~~----~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~  347 (367)
T 3l9p_A          300 TSGGR-----MDPPK----NCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP  347 (367)
T ss_dssp             HTTCC-----CCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred             HcCCC-----CCCCc----cCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence            11111     11111    12345778899999999999999999999998654433

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-42  Score=367.84  Aligned_cols=254  Identities=19%  Similarity=0.239  Sum_probs=210.6

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEec
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY  339 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  339 (586)
                      .++|+..+.||+|+||.||+|++..++..||+|++..........+.+|++++++++||||+++++++...+..++||||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            36799999999999999999999999999999999876555567899999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecC--CCCeEEccccceeeccCCC
Q 007869          340 MPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDG--ELNGRLGDFGLARLYDHGT  417 (586)
Q Consensus       340 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~--~~~~kL~DFGla~~~~~~~  417 (586)
                      +++|+|.+++... ...+++..++.++.||+.||.|||+   .+|+||||||+|||++.  ++.+||+|||+++......
T Consensus       130 ~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~  205 (387)
T 1kob_A          130 LSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE  205 (387)
T ss_dssp             CCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred             CCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccchHHeEEecCCCCceEEEecccceecCCCc
Confidence            9999999999754 3468999999999999999999998   89999999999999974  5779999999999765432


Q ss_pred             CCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCC
Q 007869          418 DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLG  497 (586)
Q Consensus       418 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~  497 (586)
                        ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+   ....+.    ....  ..++...
T Consensus       206 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~---~~~~i~----~~~~--~~~~~~~  274 (387)
T 1kob_A          206 --IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE---TLQNVK----RCDW--EFDEDAF  274 (387)
T ss_dssp             --CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HHHHHH----HCCC--CCCSSTT
T ss_pred             --ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHH---HHHHHH----hCCC--CCCcccc
Confidence              3345579999999999999999999999999999999999999997643211   111111    1110  0111111


Q ss_pred             ccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          498 TEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       498 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                      .    .....+.+++.+||+.||.+|||+.|+++.
T Consensus       275 ~----~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          275 S----SVSPEAKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             T----TSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             c----cCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence            1    223457788999999999999999999874

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=3.8e-42  Score=349.58  Aligned_cols=262  Identities=17%  Similarity=0.188  Sum_probs=212.9

Q ss_pred             hcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhccc-CCCceeeeeeeeeccCeEEEEE
Q 007869          259 ATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKGELLLVY  337 (586)
Q Consensus       259 a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~lV~  337 (586)
                      ..++|+..+.||+|+||.||+|++..++..||||++....  ..+.+.+|+..+.++ +|+|++++++++......++||
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~   85 (298)
T 1csn_A            8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI   85 (298)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence            3567999999999999999999998899999999986543  234678899999999 8999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCC-----eEEccccceee
Q 007869          338 DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELN-----GRLGDFGLARL  412 (586)
Q Consensus       338 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~-----~kL~DFGla~~  412 (586)
                      ||+ +++|.+++.... ..+++..++.++.|+++||.|||+   ++|+||||||+|||++.++.     +||+|||+++.
T Consensus        86 e~~-~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~  160 (298)
T 1csn_A           86 DLL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  160 (298)
T ss_dssp             ECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             Eec-CCCHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence            999 999999998653 358999999999999999999998   89999999999999987766     99999999997


Q ss_pred             ccCCCCC------ceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccC
Q 007869          413 YDHGTDP------QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRG  486 (586)
Q Consensus       413 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~  486 (586)
                      .......      ......||+.|+|||++.+..++.++|||||||++|||++|+.||..............+.......
T Consensus       161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  240 (298)
T 1csn_A          161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST  240 (298)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred             cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc
Confidence            7654321      2345679999999999999999999999999999999999999998755433222221111111000


Q ss_pred             ccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 007869          487 ELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERD  536 (586)
Q Consensus       487 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  536 (586)
                      ...         .........+.+++..||+.||++||++.++++.|+..
T Consensus       241 ~~~---------~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~  281 (298)
T 1csn_A          241 PLR---------ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV  281 (298)
T ss_dssp             CHH---------HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             cHH---------HHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHH
Confidence            000         00111235678899999999999999999999999764

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=2.1e-43  Score=356.55  Aligned_cols=261  Identities=23%  Similarity=0.396  Sum_probs=199.9

Q ss_pred             hhhhhcCCcccceeEeecCceEEEEEEeCCC---CeEEEEEEeccc-cchhHHHHHHHHHHhcccCCCceeeeeeeeecc
Q 007869          255 DLYIATKGFREKELLGTGGFGRVYRGTLPKS---QIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRK  330 (586)
Q Consensus       255 el~~a~~~f~~~~~LG~G~~g~Vy~~~~~~~---~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~  330 (586)
                      +.....++|+..+.||+|+||.||+|.+..+   +..||+|++... .....+.+.+|+.++++++||||+++++++. .
T Consensus         9 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~   87 (281)
T 1mp8_A            9 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E   87 (281)
T ss_dssp             CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-S
T ss_pred             ceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-c
Confidence            3445567899999999999999999998643   456999998764 3344567999999999999999999999985 4


Q ss_pred             CeEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccce
Q 007869          331 GELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLA  410 (586)
Q Consensus       331 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla  410 (586)
                      +..++||||+++++|.+++... ...+++..++.++.|+++||.|||+   .+|+||||||+|||++.++.+||+|||++
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  163 (281)
T 1mp8_A           88 NPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLS  163 (281)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC----
T ss_pred             CccEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHEEECCCCCEEECccccc
Confidence            6789999999999999999765 3468999999999999999999998   89999999999999999999999999999


Q ss_pred             eeccCCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccCccc
Q 007869          411 RLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELL  489 (586)
Q Consensus       411 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~  489 (586)
                      +..............+|+.|+|||++....++.++|||||||++|||++ |+.||......+   ....+    .++.. 
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~---~~~~i----~~~~~-  235 (281)
T 1mp8_A          164 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGRI----ENGER-  235 (281)
T ss_dssp             ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHHH----HTTCC-
T ss_pred             cccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH---HHHHH----HcCCC-
Confidence            8765543333344567889999999998899999999999999999996 999998654332   11111    11111 


Q ss_pred             cccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 007869          490 EARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERD  536 (586)
Q Consensus       490 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  536 (586)
                          +..    .......+.+++.+||+.||++|||+.|+++.|+..
T Consensus       236 ----~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  274 (281)
T 1mp8_A          236 ----LPM----PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  274 (281)
T ss_dssp             ----CCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----CCC----CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                111    112235677889999999999999999999999753

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.9e-43  Score=364.00  Aligned_cols=271  Identities=25%  Similarity=0.413  Sum_probs=200.1

Q ss_pred             chhhhhhhcCCcccceeEeecCceEEEEEEeCCCCe---EEEEEEeccc--cchhHHHHHHHHHHhcccCCCceeeeeee
Q 007869          252 RYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQI---EIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGY  326 (586)
Q Consensus       252 ~~~el~~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~---~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~~~  326 (586)
                      ..+++....++|+..+.||+|+||.||+|++..++.   .||||++...  .....+.+.+|++++++++||||++++++
T Consensus        14 ~~~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   93 (323)
T 3qup_A           14 KLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGV   93 (323)
T ss_dssp             --CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEE
T ss_pred             HhhhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhce
Confidence            345667778899999999999999999999876654   7999999765  34556789999999999999999999999


Q ss_pred             eeccCeE------EEEEecCCCCChhhhhhcCC----CccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeee
Q 007869          327 CRRKGEL------LLVYDYMPNGSLDKYLYDQP----KVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLL  396 (586)
Q Consensus       327 ~~~~~~~------~lV~E~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll  396 (586)
                      +...+..      ++||||+++|+|.+++....    ...+++..++.++.|+++||.|||+   ++|+||||||+|||+
T Consensus        94 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~Dikp~NIli  170 (323)
T 3qup_A           94 SLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCML  170 (323)
T ss_dssp             EECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEE
T ss_pred             eeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc---CCcccCCCCcceEEE
Confidence            9877654      99999999999999996532    2358999999999999999999998   899999999999999


Q ss_pred             cCCCCeEEccccceeeccCCCC-CceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccch
Q 007869          397 DGELNGRLGDFGLARLYDHGTD-PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLI  474 (586)
Q Consensus       397 ~~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~  474 (586)
                      ++++.+||+|||+++....... .......+|+.|+|||.+.+..++.++|||||||++|||++ |+.||......+   
T Consensus       171 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---  247 (323)
T 3qup_A          171 AEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE---  247 (323)
T ss_dssp             CTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---
T ss_pred             cCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH---
Confidence            9999999999999987644322 12234457889999999999999999999999999999999 999998654332   


Q ss_pred             hhHHHHhhhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhccCCCc
Q 007869          475 LVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERDVALPA  541 (586)
Q Consensus       475 l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~p~  541 (586)
                      +...+    ..+..     +..    .......+.+++.+||+.||++|||+.++++.|+....-|.
T Consensus       248 ~~~~~----~~~~~-----~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~  301 (323)
T 3qup_A          248 IYNYL----IGGNR-----LKQ----PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLS  301 (323)
T ss_dssp             HHHHH----HTTCC-----CCC----CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred             HHHHH----hcCCC-----CCC----CCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhh
Confidence            11111    11111     111    11223567889999999999999999999999987654443

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.3e-42  Score=350.80  Aligned_cols=250  Identities=22%  Similarity=0.313  Sum_probs=198.7

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccc--------------------------hhHHHHHHHHHHhc
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR--------------------------QGMKEFVAEIVSIG  313 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------------------------~~~~~~~~Ei~~l~  313 (586)
                      .++|+..+.||+|+||.||+|++..++..||||++.....                          ...+.+.+|+++++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            4689999999999999999999999999999999865421                          12356899999999


Q ss_pred             ccCCCceeeeeeeeec--cCeEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCC
Q 007869          314 RLRHRNLVQLLGYCRR--KGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKA  391 (586)
Q Consensus       314 ~l~H~niv~l~~~~~~--~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp  391 (586)
                      +++||||+++++++..  .+..++||||+++++|.+++..   ..+++.+++.++.|+++||.|||+   .+|+||||||
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp  165 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHY---QKIIHRDIKP  165 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCG
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCH
Confidence            9999999999999986  5689999999999999987643   368999999999999999999998   8999999999


Q ss_pred             CCeeecCCCCeEEccccceeeccCCCCCceeeeccCCCccCcccccCCC---CCCcceEEehhHHHHHHHhCCCCCCCCC
Q 007869          392 SNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGK---ATTSADVFSFGAFLLEVACGRRPIQRQG  468 (586)
Q Consensus       392 ~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~s~ksDVyS~Gvvl~ElltG~~p~~~~~  468 (586)
                      +|||++.++++||+|||+++...... .......||+.|+|||++.+..   ++.++|||||||++|||++|+.||....
T Consensus       166 ~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~  244 (298)
T 2zv2_A          166 SNLLVGEDGHIKIADFGVSNEFKGSD-ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER  244 (298)
T ss_dssp             GGEEECTTSCEEECCCTTCEECSSSS-CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             HHEEECCCCCEEEecCCCcccccccc-ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence            99999999999999999998765432 2234467999999999997665   3778999999999999999999997542


Q ss_pred             CCccchhhHHHHhhhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          469 PSENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       469 ~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      ..   .+.    ..........   +. ...    ....+.+++.+||+.||++|||+.|+++
T Consensus       245 ~~---~~~----~~~~~~~~~~---~~-~~~----~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          245 IM---CLH----SKIKSQALEF---PD-QPD----IAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             HH---HHH----HHHHHCCCCC---CS-SSC----CCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             HH---HHH----HHHhcccCCC---CC-ccc----cCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            21   111    1111111110   10 111    2245778899999999999999999875

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.1e-43  Score=363.45  Aligned_cols=265  Identities=25%  Similarity=0.388  Sum_probs=213.9

Q ss_pred             hhhhhcCCcccceeEeecCceEEEEEEe-----CCCCeEEEEEEeccc-cchhHHHHHHHHHHhccc-CCCceeeeeeee
Q 007869          255 DLYIATKGFREKELLGTGGFGRVYRGTL-----PKSQIEIAVKKISHE-SRQGMKEFVAEIVSIGRL-RHRNLVQLLGYC  327 (586)
Q Consensus       255 el~~a~~~f~~~~~LG~G~~g~Vy~~~~-----~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~  327 (586)
                      +.....++|...+.||+|+||.||+|++     ..++..||||++... .....+.+.+|+.++.++ +||||+++++++
T Consensus        39 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  118 (344)
T 1rjb_A           39 KWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC  118 (344)
T ss_dssp             GGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            3456678899999999999999999997     345678999999754 233457899999999999 999999999999


Q ss_pred             eccCeEEEEEecCCCCChhhhhhcCCC---------------------ccchhHHHHHHHHHHHHHHHHhhcccCCcEEe
Q 007869          328 RRKGELLLVYDYMPNGSLDKYLYDQPK---------------------VTLNWIQRFRVIKGVALGLFYLHQEWEQVVIH  386 (586)
Q Consensus       328 ~~~~~~~lV~E~~~~gsL~~~l~~~~~---------------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivH  386 (586)
                      ...+..++||||+++|+|.+++.....                     ..+++..++.++.||++||.|||+   ++|+|
T Consensus       119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH  195 (344)
T 1rjb_A          119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVH  195 (344)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEE
T ss_pred             eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCccc
Confidence            999999999999999999999976532                     247899999999999999999998   89999


Q ss_pred             CCCCCCCeeecCCCCeEEccccceeeccCCCCC-ceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCC
Q 007869          387 RDVKASNVLLDGELNGRLGDFGLARLYDHGTDP-QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPI  464 (586)
Q Consensus       387 rDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~  464 (586)
                      |||||+|||++.++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||++ |+.||
T Consensus       196 ~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~  275 (344)
T 1rjb_A          196 RDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY  275 (344)
T ss_dssp             TTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred             CCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCc
Confidence            999999999999999999999999876544322 2334567899999999999999999999999999999998 99999


Q ss_pred             CCCCCCccchhhHHHHhhhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 007869          465 QRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERDV  537 (586)
Q Consensus       465 ~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  537 (586)
                      ........  ...    ....+.     .+..    .......+.+++.+||+.||.+|||+.++++.|+...
T Consensus       276 ~~~~~~~~--~~~----~~~~~~-----~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~  333 (344)
T 1rjb_A          276 PGIPVDAN--FYK----LIQNGF-----KMDQ----PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQL  333 (344)
T ss_dssp             TTCCCSHH--HHH----HHHTTC-----CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             ccCCcHHH--HHH----HHhcCC-----CCCC----CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence            87544321  111    111111     1111    1112356778899999999999999999999998754

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=9.3e-43  Score=366.87  Aligned_cols=249  Identities=25%  Similarity=0.362  Sum_probs=201.1

Q ss_pred             ccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEecCCCC
Q 007869          264 REKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNG  343 (586)
Q Consensus       264 ~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~g  343 (586)
                      ...+.||+|+||.||+|....++..||+|++........+.+.+|++++++++||||+++++++...+..+|||||++++
T Consensus        92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~  171 (373)
T 2x4f_A           92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG  171 (373)
T ss_dssp             EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred             ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence            33678999999999999999899999999998776666788999999999999999999999999999999999999999


Q ss_pred             ChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeee--cCCCCeEEccccceeeccCCCCCce
Q 007869          344 SLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLL--DGELNGRLGDFGLARLYDHGTDPQT  421 (586)
Q Consensus       344 sL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll--~~~~~~kL~DFGla~~~~~~~~~~~  421 (586)
                      +|.+++... ...+++..++.++.||++||.|||+   .+|+||||||+|||+  +.++++||+|||+++......  ..
T Consensus       172 ~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~--~~  245 (373)
T 2x4f_A          172 ELFDRIIDE-SYNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--KL  245 (373)
T ss_dssp             EEHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC--BC
T ss_pred             cHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc--cc
Confidence            999998765 3468899999999999999999998   899999999999999  567889999999999765432  23


Q ss_pred             eeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCcccc
Q 007869          422 THVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYV  501 (586)
Q Consensus       422 ~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~  501 (586)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||......+  .+.......+           .+.....
T Consensus       246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~--~~~~i~~~~~-----------~~~~~~~  312 (373)
T 2x4f_A          246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE--TLNNILACRW-----------DLEDEEF  312 (373)
T ss_dssp             CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHH--HHHHHHHTCC-----------CSCSGGG
T ss_pred             ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccC-----------CCChhhh
Confidence            34579999999999998999999999999999999999999997654321  1111111000           0000111


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          502 AEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       502 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      ......+.+++.+||+.||.+|||+.|+++
T Consensus       313 ~~~~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          313 QDISEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             TTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            122356788899999999999999999997

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=2.2e-43  Score=365.13  Aligned_cols=264  Identities=26%  Similarity=0.406  Sum_probs=214.7

Q ss_pred             hhhhhcCCcccceeEeecCceEEEEEEeCCCCe-----EEEEEEecccc-chhHHHHHHHHHHhccc-CCCceeeeeeee
Q 007869          255 DLYIATKGFREKELLGTGGFGRVYRGTLPKSQI-----EIAVKKISHES-RQGMKEFVAEIVSIGRL-RHRNLVQLLGYC  327 (586)
Q Consensus       255 el~~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~-----~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~  327 (586)
                      ++....++|+..+.||+|+||.||+|.+..++.     .||+|.+.... ....+.+.+|+.+++++ +||||+++++++
T Consensus        40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~  119 (333)
T 2i1m_A           40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC  119 (333)
T ss_dssp             GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            566778899999999999999999999866543     79999997653 34456799999999999 899999999999


Q ss_pred             eccCeEEEEEecCCCCChhhhhhcCC------------CccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCee
Q 007869          328 RRKGELLLVYDYMPNGSLDKYLYDQP------------KVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVL  395 (586)
Q Consensus       328 ~~~~~~~lV~E~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIl  395 (586)
                      ...+..++||||+++|+|.+++....            ...+++..++.++.|++.||.|||+   ++|+||||||+|||
T Consensus       120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl  196 (333)
T 2i1m_A          120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVL  196 (333)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGCE
T ss_pred             ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCcccceEE
Confidence            99999999999999999999997532            2357899999999999999999998   89999999999999


Q ss_pred             ecCCCCeEEccccceeeccCCCCC-ceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccc
Q 007869          396 LDGELNGRLGDFGLARLYDHGTDP-QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENL  473 (586)
Q Consensus       396 l~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~  473 (586)
                      ++.++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||++ |+.||........ 
T Consensus       197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~-  275 (333)
T 2i1m_A          197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK-  275 (333)
T ss_dssp             EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH-
T ss_pred             ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH-
Confidence            999999999999999876543322 2234567889999999998999999999999999999998 9999976543321 


Q ss_pred             hhhHHHHhhhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 007869          474 ILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERD  536 (586)
Q Consensus       474 ~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  536 (586)
                       ....+    ..+..  ...+.       .....+.+++..||+.||.+|||+.|+++.|+..
T Consensus       276 -~~~~~----~~~~~--~~~~~-------~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~  324 (333)
T 2i1m_A          276 -FYKLV----KDGYQ--MAQPA-------FAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ  324 (333)
T ss_dssp             -HHHHH----HHTCC--CCCCT-------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -HHHHH----hcCCC--CCCCC-------CCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence             11111    11110  01111       1135677889999999999999999999999753

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.5e-43  Score=369.82  Aligned_cols=262  Identities=27%  Similarity=0.432  Sum_probs=214.1

Q ss_pred             hhhcCCcccceeEeecCceEEEEEEeCC-------CCeEEEEEEeccc-cchhHHHHHHHHHHhccc-CCCceeeeeeee
Q 007869          257 YIATKGFREKELLGTGGFGRVYRGTLPK-------SQIEIAVKKISHE-SRQGMKEFVAEIVSIGRL-RHRNLVQLLGYC  327 (586)
Q Consensus       257 ~~a~~~f~~~~~LG~G~~g~Vy~~~~~~-------~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~  327 (586)
                      ....++|...+.||+|+||.||+|++..       .+..||||++... .....+.+.+|+++++++ +||||++++++|
T Consensus        65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~  144 (382)
T 3tt0_A           65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC  144 (382)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence            3455789999999999999999999643       3467999999765 334457899999999999 999999999999


Q ss_pred             eccCeEEEEEecCCCCChhhhhhcCC--------------CccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCC
Q 007869          328 RRKGELLLVYDYMPNGSLDKYLYDQP--------------KVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASN  393 (586)
Q Consensus       328 ~~~~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~N  393 (586)
                      ...+..++||||+++|+|.+++....              ...+++.+++.++.||++||.|||+   .+|+||||||+|
T Consensus       145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~N  221 (382)
T 3tt0_A          145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARN  221 (382)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGG
T ss_pred             ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCcce
Confidence            99999999999999999999998653              2358999999999999999999998   899999999999


Q ss_pred             eeecCCCCeEEccccceeeccCCCC-CceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCc
Q 007869          394 VLLDGELNGRLGDFGLARLYDHGTD-PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSE  471 (586)
Q Consensus       394 Ill~~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~  471 (586)
                      ||++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+
T Consensus       222 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~  301 (382)
T 3tt0_A          222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE  301 (382)
T ss_dssp             EEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred             EEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999999987654322 22334567889999999999999999999999999999999 999997643221


Q ss_pred             cchhhHHHHhhhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 007869          472 NLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERDV  537 (586)
Q Consensus       472 ~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  537 (586)
                         +.    ....++..     +.....    ....+.+++.+||+.||++|||+.|+++.|++..
T Consensus       302 ---~~----~~~~~~~~-----~~~~~~----~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~  351 (382)
T 3tt0_A          302 ---LF----KLLKEGHR-----MDKPSN----CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV  351 (382)
T ss_dssp             ---HH----HHHHTTCC-----CCCCSS----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---HH----HHHHcCCC-----CCCCcc----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence               11    11112211     111111    2346778899999999999999999999998754

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=3.5e-42  Score=364.34  Aligned_cols=270  Identities=19%  Similarity=0.231  Sum_probs=210.3

Q ss_pred             hhcCCcccceeEeec--CceEEEEEEeCCCCeEEEEEEecccc--chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeE
Q 007869          258 IATKGFREKELLGTG--GFGRVYRGTLPKSQIEIAVKKISHES--RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGEL  333 (586)
Q Consensus       258 ~a~~~f~~~~~LG~G--~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~  333 (586)
                      ...++|+..+.||+|  +||.||+|++..++..||||++....  ....+.+.+|+.++++++||||+++++++...+..
T Consensus        22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  101 (389)
T 3gni_B           22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL  101 (389)
T ss_dssp             CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEE
Confidence            455789999999999  99999999999899999999997653  34456788999999999999999999999999999


Q ss_pred             EEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeec
Q 007869          334 LLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLY  413 (586)
Q Consensus       334 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~  413 (586)
                      ++||||+++|+|.+++.......+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||++...
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~  178 (389)
T 3gni_B          102 WVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSM  178 (389)
T ss_dssp             EEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             EEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccccceee
Confidence            999999999999999987755679999999999999999999998   89999999999999999999999999998754


Q ss_pred             cCCCC------CceeeeccCCCccCcccccC--CCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhc-
Q 007869          414 DHGTD------PQTTHVVGTLGYLAPEHTRT--GKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWN-  484 (586)
Q Consensus       414 ~~~~~------~~~~~~~gt~~y~aPE~~~~--~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~-  484 (586)
                      .....      .......||+.|+|||++.+  ..++.++|||||||++|||++|+.||......+...  ........ 
T Consensus       179 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~--~~~~~~~~~  256 (389)
T 3gni_B          179 ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLL--EKLNGTVPC  256 (389)
T ss_dssp             EETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHH--HC-------
T ss_pred             ccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHH--HHhcCCCCc
Confidence            32211      11223478999999999987  578999999999999999999999998654433211  00000000 


Q ss_pred             ---------------------cCcccc---ccCCC------CCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          485 ---------------------RGELLE---ARDPN------LGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       485 ---------------------~~~~~~---~~d~~------l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                                           ......   ...+.      ....+.......+.+++.+||+.||++|||+.|+++.
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h  334 (389)
T 3gni_B          257 LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  334 (389)
T ss_dssp             -------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             cccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence                                 000000   00000      0001112233568889999999999999999999853

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.4e-42  Score=351.27  Aligned_cols=255  Identities=25%  Similarity=0.505  Sum_probs=206.6

Q ss_pred             hhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccch-------hHHHHHHHHHHhcccCCCceeeeeeeeecc
Q 007869          258 IATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQ-------GMKEFVAEIVSIGRLRHRNLVQLLGYCRRK  330 (586)
Q Consensus       258 ~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~  330 (586)
                      ...++|+..+.||+|+||.||+|++..++..||||++......       ..+.+.+|++++++++||||+++++++...
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   95 (287)
T 4f0f_A           16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP   95 (287)
T ss_dssp             CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred             hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence            3457899999999999999999999989999999998654321       126789999999999999999999999766


Q ss_pred             CeEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCc--EEeCCCCCCCeeecCCCC-----eE
Q 007869          331 GELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQV--VIHRDVKASNVLLDGELN-----GR  403 (586)
Q Consensus       331 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--ivHrDIkp~NIll~~~~~-----~k  403 (586)
                      .  ++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+   .+  |+||||||+|||++.++.     +|
T Consensus        96 ~--~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~---~~~~ivH~dikp~Nil~~~~~~~~~~~~k  169 (287)
T 4f0f_A           96 P--RMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQN---QNPPIVHRDLRSPNIFLQSLDENAPVCAK  169 (287)
T ss_dssp             T--EEEEECCTTCBHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCSCCSGGGEEESCCCTTCSCCEE
T ss_pred             C--eEEEEecCCCCHHHHHhccc-CCccHHHHHHHHHHHHHHHHHHHh---CCCCeecCCCCcceEEEeccCCCCceeEE
Confidence            5  69999999999999887653 478999999999999999999998   77  999999999999988776     99


Q ss_pred             EccccceeeccCCCCCceeeeccCCCccCcccc--cCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHh
Q 007869          404 LGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHT--RTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFD  481 (586)
Q Consensus       404 L~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~  481 (586)
                      |+|||+++....    ......||+.|+|||++  ....++.++|||||||++|||++|+.||......+. ....... 
T Consensus       170 l~Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~-  243 (287)
T 4f0f_A          170 VADFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI-KFINMIR-  243 (287)
T ss_dssp             ECCCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH-HHHHHHH-
T ss_pred             eCCCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH-HHHHHHh-
Confidence            999999985332    34456799999999998  445678999999999999999999999986544321 1111111 


Q ss_pred             hhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 007869          482 FWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER  535 (586)
Q Consensus       482 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  535 (586)
                        ..     ...+....    .....+.+++.+||+.||.+|||+.|+++.|++
T Consensus       244 --~~-----~~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~  286 (287)
T 4f0f_A          244 --EE-----GLRPTIPE----DCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE  286 (287)
T ss_dssp             --HS-----CCCCCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             --cc-----CCCCCCCc----ccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence              11     11111212    223567888999999999999999999999975

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=3.1e-42  Score=353.75  Aligned_cols=263  Identities=25%  Similarity=0.327  Sum_probs=203.7

Q ss_pred             hcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc--chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEE
Q 007869          259 ATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES--RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLV  336 (586)
Q Consensus       259 a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV  336 (586)
                      ..++|+..+.||+|+||.||+|++.. +..||+|++....  ....+.+.+|++++++++||||+++++++...+..++|
T Consensus        19 l~~~y~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   97 (311)
T 3niz_A           19 LMEKYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLV   97 (311)
T ss_dssp             SSCEEEEEEEEEECSSCEEEEEEETT-SCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEE
T ss_pred             hHhhhHhhhhccCCCCeEEEEEEECC-CCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEE
Confidence            45789999999999999999999954 7889999997542  23346789999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCC
Q 007869          337 YDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHG  416 (586)
Q Consensus       337 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~  416 (586)
                      |||++ ++|.+++.... ..+++..+..++.|+++||.|||+   .+|+||||||+|||++.++.+||+|||+++.....
T Consensus        98 ~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~  172 (311)
T 3niz_A           98 FEFME-KDLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIP  172 (311)
T ss_dssp             EECCS-EEHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred             EcCCC-CCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence            99997 58888886653 468899999999999999999998   89999999999999999999999999999976543


Q ss_pred             CCCceeeeccCCCccCcccccC-CCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCc--------
Q 007869          417 TDPQTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGE--------  487 (586)
Q Consensus       417 ~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~--------  487 (586)
                      .. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....   +........        
T Consensus       173 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~---i~~~~~~~~~~~~~~~~  248 (311)
T 3niz_A          173 VR-SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPK---IFSILGTPNPREWPQVQ  248 (311)
T ss_dssp             CC----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHH---HHHHHCCCCTTTSGGGT
T ss_pred             cc-cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHH---HHHHHCCCChHHhhhhh
Confidence            22 2344578999999999876 5689999999999999999999999987655432211   111110000        


Q ss_pred             --------cccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          488 --------LLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       488 --------~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                              .....+..............+.+++.+||+.||++|||++|+++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             TSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             ccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence                    00000000000011112356788999999999999999999986

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=2.8e-42  Score=356.75  Aligned_cols=260  Identities=17%  Similarity=0.159  Sum_probs=210.9

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhccc-CCCceeeeeeeeeccCeEEEEEe
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKGELLLVYD  338 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~lV~E  338 (586)
                      .++|+..+.||+|+||.||+|+...++..||||++.....  .+.+..|+++++++ +||||+++++++...+..++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e   85 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE   85 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence            4689999999999999999999988999999999875432  24688999999999 99999999999999999999999


Q ss_pred             cCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCC-----eEEccccceeec
Q 007869          339 YMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELN-----GRLGDFGLARLY  413 (586)
Q Consensus       339 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~-----~kL~DFGla~~~  413 (586)
                      |+ +++|.+++... ...+++..++.++.|+++||.|||+   .+|+||||||+|||++.++.     +||+|||+++.+
T Consensus        86 ~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~---~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~  160 (330)
T 2izr_A           86 LL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY  160 (330)
T ss_dssp             CC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred             eC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence            99 99999999865 3478999999999999999999998   89999999999999998887     999999999976


Q ss_pred             cCCCCC------ceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCc
Q 007869          414 DHGTDP------QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGE  487 (586)
Q Consensus       414 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~  487 (586)
                      ......      ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.......+...    .
T Consensus       161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~----~  236 (330)
T 2izr_A          161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDT----K  236 (330)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHH----H
T ss_pred             ecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhh----h
Confidence            543221      124568999999999999999999999999999999999999999876543322211111110    0


Q ss_pred             cccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 007869          488 LLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERD  536 (586)
Q Consensus       488 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  536 (586)
                      ..   .+.  ........ .+.+++..||+.||.+||++.++++.|+..
T Consensus       237 ~~---~~~--~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~  279 (330)
T 2izr_A          237 RA---TPI--EVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDL  279 (330)
T ss_dssp             HH---SCH--HHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             cc---CCH--HHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence            00   000  00000112 678889999999999999999999988743

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.3e-42  Score=364.34  Aligned_cols=253  Identities=23%  Similarity=0.315  Sum_probs=207.3

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc--cchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEE
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY  337 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  337 (586)
                      .++|+..+.||+|+||.||+|++..++..||+|++...  .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~  107 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF  107 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            46789999999999999999999999999999999754  2344567899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCC---CeEEccccceeecc
Q 007869          338 DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGEL---NGRLGDFGLARLYD  414 (586)
Q Consensus       338 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~---~~kL~DFGla~~~~  414 (586)
                      ||+++|+|.+++...  ..+++..+..++.||++||.|||+   ++|+||||||+|||++.++   .+||+|||+++...
T Consensus       108 e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~  182 (362)
T 2bdw_A          108 DLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN  182 (362)
T ss_dssp             CCCCSCBHHHHHTTC--SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred             ecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence            999999999998765  368899999999999999999998   8999999999999998654   59999999998765


Q ss_pred             CCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCC
Q 007869          415 HGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDP  494 (586)
Q Consensus       415 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~  494 (586)
                      ...  ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+   +..    ....+...   .+
T Consensus       183 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~---~~~----~i~~~~~~---~~  250 (362)
T 2bdw_A          183 DSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR---LYA----QIKAGAYD---YP  250 (362)
T ss_dssp             TCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH----HHHHTCCC---CC
T ss_pred             CCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH---HHH----HHHhCCCC---CC
Confidence            332  2344679999999999999899999999999999999999999997643211   111    11111110   01


Q ss_pred             CCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          495 NLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       495 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                      .   .........+.+++.+||+.||++||++.|+++.
T Consensus       251 ~---~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          251 S---PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             T---TGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             c---ccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            0   0011223557788899999999999999999853

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1e-42  Score=358.85  Aligned_cols=250  Identities=19%  Similarity=0.325  Sum_probs=199.6

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc-chhHHHHHHHHHHhcccCCCceeeeeeeeeccC--------
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKG--------  331 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~--------  331 (586)
                      ++|+..+.||+|+||.||+|++..++..||||++.... ....+.+.+|++++++++||||++++++|.+.+        
T Consensus         6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   85 (332)
T 3qd2_B            6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM   85 (332)
T ss_dssp             HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred             hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence            56888999999999999999999889999999997543 335578999999999999999999999886543        


Q ss_pred             -------------------------------------------------eEEEEEecCCCCChhhhhhcCCC-ccchhHH
Q 007869          332 -------------------------------------------------ELLLVYDYMPNGSLDKYLYDQPK-VTLNWIQ  361 (586)
Q Consensus       332 -------------------------------------------------~~~lV~E~~~~gsL~~~l~~~~~-~~l~~~~  361 (586)
                                                                       ..++||||+++++|.+++..... ....+..
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~  165 (332)
T 3qd2_B           86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV  165 (332)
T ss_dssp             HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred             hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence                                                             38999999999999999987643 3456667


Q ss_pred             HHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCC-----------CceeeeccCCCc
Q 007869          362 RFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD-----------PQTTHVVGTLGY  430 (586)
Q Consensus       362 ~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~-----------~~~~~~~gt~~y  430 (586)
                      ++.++.||++||.|||+   ++|+||||||+|||++.++.+||+|||+++.......           .......||+.|
T Consensus       166 ~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y  242 (332)
T 3qd2_B          166 CLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY  242 (332)
T ss_dssp             HHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred             HHHHHHHHHHHHHHHHh---CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence            89999999999999998   8999999999999999999999999999998765421           122345799999


Q ss_pred             cCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCccccHHHHHHHHH
Q 007869          431 LAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLK  510 (586)
Q Consensus       431 ~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~  510 (586)
                      +|||++.+..++.++|||||||++|||++|..|+...     ....    ......        .. ..........+.+
T Consensus       243 ~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~-----~~~~----~~~~~~--------~~-~~~~~~~~~~~~~  304 (332)
T 3qd2_B          243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER-----VRII----TDVRNL--------KF-PLLFTQKYPQEHM  304 (332)
T ss_dssp             SCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH-----HHHH----HHHHTT--------CC-CHHHHHHCHHHHH
T ss_pred             cChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH-----HHHH----HHhhcc--------CC-CcccccCChhHHH
Confidence            9999999999999999999999999999987664210     0010    011111        11 1112233456688


Q ss_pred             HHHHhcccCCCCCCCHHHHHH
Q 007869          511 LGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       511 l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      ++.+||+.||++|||+.|+++
T Consensus       305 li~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          305 MVQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             HHHHHHCSSGGGSCCHHHHHH
T ss_pred             HHHHHccCCCCcCCCHHHHhh
Confidence            999999999999999999986

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=6.7e-43  Score=357.71  Aligned_cols=264  Identities=25%  Similarity=0.410  Sum_probs=215.5

Q ss_pred             hhhhcCCcccceeEeecCceEEEEEEe-----CCCCeEEEEEEeccccc-hhHHHHHHHHHHhccc-CCCceeeeeeeee
Q 007869          256 LYIATKGFREKELLGTGGFGRVYRGTL-----PKSQIEIAVKKISHESR-QGMKEFVAEIVSIGRL-RHRNLVQLLGYCR  328 (586)
Q Consensus       256 l~~a~~~f~~~~~LG~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~  328 (586)
                      +....++|+..+.||+|+||.||+|++     ..++..||||++..... ...+.+.+|+.+++++ +||||+++++++.
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   97 (313)
T 1t46_A           18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT   97 (313)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe
Confidence            445567899999999999999999985     45678899999976533 3457799999999999 9999999999999


Q ss_pred             ccCeEEEEEecCCCCChhhhhhcCCC----------------ccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCC
Q 007869          329 RKGELLLVYDYMPNGSLDKYLYDQPK----------------VTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKAS  392 (586)
Q Consensus       329 ~~~~~~lV~E~~~~gsL~~~l~~~~~----------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~  392 (586)
                      ..+..++||||+++|+|.+++.....                ..+++.+++.++.|+++||.|||+   ++|+||||||+
T Consensus        98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~  174 (313)
T 1t46_A           98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAAR  174 (313)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGG
T ss_pred             cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccc
Confidence            99999999999999999999976532                248999999999999999999998   89999999999


Q ss_pred             CeeecCCCCeEEccccceeeccCCCCCc-eeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCC
Q 007869          393 NVLLDGELNGRLGDFGLARLYDHGTDPQ-TTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPS  470 (586)
Q Consensus       393 NIll~~~~~~kL~DFGla~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~  470 (586)
                      |||++.++.+||+|||+++......... .....||+.|+|||++.+..++.++|||||||++|||++ |+.||......
T Consensus       175 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~  254 (313)
T 1t46_A          175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD  254 (313)
T ss_dssp             GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred             eEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch
Confidence            9999999999999999998765543221 233567889999999999999999999999999999999 99999765433


Q ss_pred             ccchhhHHHHhhhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 007869          471 ENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERDV  537 (586)
Q Consensus       471 ~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  537 (586)
                      ..  ....+    ..+     ..+....    .....+.+++.+||+.||.+|||+.|+++.|++..
T Consensus       255 ~~--~~~~~----~~~-----~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  306 (313)
T 1t46_A          255 SK--FYKMI----KEG-----FRMLSPE----HAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI  306 (313)
T ss_dssp             HH--HHHHH----HHT-----CCCCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             hH--HHHHh----ccC-----CCCCCcc----cCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence            21  11111    111     1111111    12356778899999999999999999999998643

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=2.5e-43  Score=356.06  Aligned_cols=262  Identities=27%  Similarity=0.422  Sum_probs=210.1

Q ss_pred             hhhhhhhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCe
Q 007869          253 YKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGE  332 (586)
Q Consensus       253 ~~el~~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~  332 (586)
                      +..+....++|+..+.||+|+||.||+|.+. ++..||||++..... ..+++.+|++++.+++||||+++++++...+.
T Consensus        16 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   93 (283)
T 3gen_A           16 YGSWEIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRP   93 (283)
T ss_dssp             CCTTBCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             CCCccCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCC
Confidence            3455566788999999999999999999986 466799999976543 34679999999999999999999999999999


Q ss_pred             EEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceee
Q 007869          333 LLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARL  412 (586)
Q Consensus       333 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~  412 (586)
                      .++||||+++++|.+++... ...+++.+++.++.|+++||.|||+   ++|+||||||+|||++.++.+||+|||+++.
T Consensus        94 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~  169 (283)
T 3gen_A           94 IFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRY  169 (283)
T ss_dssp             EEEEECCCTTCBHHHHHHCG-GGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTSCEEECSTTGGGG
T ss_pred             eEEEEeccCCCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCccceEEEcCCCCEEEcccccccc
Confidence            99999999999999999764 2468999999999999999999998   8999999999999999999999999999986


Q ss_pred             ccCCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccCccccc
Q 007869          413 YDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEA  491 (586)
Q Consensus       413 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~  491 (586)
                      .............+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+   ...    ...++.  ..
T Consensus       170 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~---~~~----~~~~~~--~~  240 (283)
T 3gen_A          170 VLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE---TAE----HIAQGL--RL  240 (283)
T ss_dssp             BCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH---HHH----HHHTTC--CC
T ss_pred             ccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH---HHH----HHhccc--CC
Confidence            54322112233456788999999998899999999999999999998 999997654321   111    111111  01


Q ss_pred             cCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 007869          492 RDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERD  536 (586)
Q Consensus       492 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  536 (586)
                      ..+.   .    ....+.+++.+||+.||.+|||+.++++.|+..
T Consensus       241 ~~~~---~----~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~  278 (283)
T 3gen_A          241 YRPH---L----ASEKVYTIMYSCWHEKADERPTFKILLSNILDV  278 (283)
T ss_dssp             CCCT---T----CCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCC---c----CCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence            1111   1    124677889999999999999999999998753

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=6.6e-43  Score=371.95  Aligned_cols=262  Identities=22%  Similarity=0.258  Sum_probs=212.6

Q ss_pred             chhhhhhhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc---chhHHHHHHHHHHhcccCCCceeeeeeeee
Q 007869          252 RYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLGYCR  328 (586)
Q Consensus       252 ~~~el~~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~  328 (586)
                      .++++....++|+..+.||+|+||+||+|+++.++..||+|++....   ....+.+.+|+.+++.++||||++++++|.
T Consensus        60 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~  139 (410)
T 3v8s_A           60 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQ  139 (410)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             HHHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence            45677788899999999999999999999999999999999996532   223345889999999999999999999999


Q ss_pred             ccCeEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEcccc
Q 007869          329 RKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFG  408 (586)
Q Consensus       329 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFG  408 (586)
                      +.+.+++||||+++|+|.+++...   .+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||
T Consensus       140 ~~~~~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFG  213 (410)
T 3v8s_A          140 DDRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFG  213 (410)
T ss_dssp             CSSEEEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             ECCEEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeeECCCCCEEEeccc
Confidence            999999999999999999999764   57888899999999999999998   899999999999999999999999999


Q ss_pred             ceeeccCCCCCceeeeccCCCccCcccccCCC----CCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhc
Q 007869          409 LARLYDHGTDPQTTHVVGTLGYLAPEHTRTGK----ATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWN  484 (586)
Q Consensus       409 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~  484 (586)
                      +|+.............+||+.|+|||++.+..    ++.++|||||||++|||++|+.||...+..+.   ...+   . 
T Consensus       214 ~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~---~~~i---~-  286 (410)
T 3v8s_A          214 TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT---YSKI---M-  286 (410)
T ss_dssp             TCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HHHH---H-
T ss_pred             eeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhH---HHHH---H-
Confidence            99876544322334568999999999997665    78999999999999999999999986543221   1111   1 


Q ss_pred             cCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCC--CCCHHHHHHH
Q 007869          485 RGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTA--RPSMRQVVQI  532 (586)
Q Consensus       485 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~--RPs~~evl~~  532 (586)
                      ++.. ....|.. ..+    ...+.+++.+||+.+|.+  ||++.|+++.
T Consensus       287 ~~~~-~~~~p~~-~~~----s~~~~~li~~lL~~~~~rlgR~~~~ei~~H  330 (410)
T 3v8s_A          287 NHKN-SLTFPDD-NDI----SKEAKNLICAFLTDREVRLGRNGVEEIKRH  330 (410)
T ss_dssp             THHH-HCCCCTT-CCC----CHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred             hccc-cccCCCc-ccc----cHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence            1000 0011110 111    245677888899999988  9999999963

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.2e-42  Score=355.87  Aligned_cols=264  Identities=28%  Similarity=0.366  Sum_probs=203.9

Q ss_pred             hcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccc-----hhHHHHHHHHHHhccc---CCCceeeeeeeeecc
Q 007869          259 ATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR-----QGMKEFVAEIVSIGRL---RHRNLVQLLGYCRRK  330 (586)
Q Consensus       259 a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~Ei~~l~~l---~H~niv~l~~~~~~~  330 (586)
                      .+++|+..+.||+|+||.||+|++..+++.||||++.....     .....+.+|+.+++++   +||||++++++|...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            46789999999999999999999988999999999864321     1234566777777766   499999999999875


Q ss_pred             C-----eEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEc
Q 007869          331 G-----ELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLG  405 (586)
Q Consensus       331 ~-----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~  405 (586)
                      .     ..++||||+. ++|.+++.......+++..++.++.|+++||.|||+   ++|+||||||+|||++.++.+||+
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~  162 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLA  162 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCTTTEEECTTSCEEEC
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEEe
Confidence            4     5899999996 699999988766669999999999999999999998   899999999999999999999999


Q ss_pred             cccceeeccCCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhcc
Q 007869          406 DFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNR  485 (586)
Q Consensus       406 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~  485 (586)
                      |||+++......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+..   ..+......
T Consensus       163 Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~---~~i~~~~~~  237 (308)
T 3g33_A          163 DFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQL---GKIFDLIGL  237 (308)
T ss_dssp             SCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHH---HHHHHHHCC
T ss_pred             eCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHhCC
Confidence            999998664332  334568999999999999999999999999999999999999999765432211   111111100


Q ss_pred             ---Cccc------c-cc---CCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          486 ---GELL------E-AR---DPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       486 ---~~~~------~-~~---d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                         ....      . ..   .+........+....+.+++.+||+.||++|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          238 PPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             CCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence               0000      0 00   000000111123356788999999999999999999985

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=2e-43  Score=381.57  Aligned_cols=263  Identities=29%  Similarity=0.433  Sum_probs=208.5

Q ss_pred             hhhhhhhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCe
Q 007869          253 YKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGE  332 (586)
Q Consensus       253 ~~el~~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~  332 (586)
                      ...+.+..++|+..+.||+|+||.||+|.+.. +..||||++..... ..++|.+|++++++++||||+++++++.+ +.
T Consensus       176 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~  252 (452)
T 1fmk_A          176 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EP  252 (452)
T ss_dssp             TTCSBCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred             ccccccChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-Cc
Confidence            34455667789999999999999999999975 45699999976542 35789999999999999999999999876 67


Q ss_pred             EEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceee
Q 007869          333 LLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARL  412 (586)
Q Consensus       333 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~  412 (586)
                      .++||||+++|+|.+++.......+++.+++.++.|+++||.|||+   ++|+||||||+|||+++++.+||+|||+++.
T Consensus       253 ~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~  329 (452)
T 1fmk_A          253 IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARL  329 (452)
T ss_dssp             CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC-
T ss_pred             eEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEECCCCCEEECCCcccee
Confidence            8999999999999999975433468899999999999999999998   8999999999999999999999999999987


Q ss_pred             ccCCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccCccccc
Q 007869          413 YDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEA  491 (586)
Q Consensus       413 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~  491 (586)
                      .............+|..|+|||++..+.++.++|||||||++|||++ |+.||......+   ..+    ...++...  
T Consensus       330 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~---~~~----~i~~~~~~--  400 (452)
T 1fmk_A          330 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---VLD----QVERGYRM--  400 (452)
T ss_dssp             -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHH----HHHTTCCC--
T ss_pred             cCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH---HHH----HHHcCCCC--
Confidence            65433223334457889999999999999999999999999999999 999997654321   111    11122111  


Q ss_pred             cCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 007869          492 RDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERDV  537 (586)
Q Consensus       492 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  537 (586)
                         .    ........+.+++.+||+.||++|||+.++++.|+...
T Consensus       401 ---~----~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~  439 (452)
T 1fmk_A          401 ---P----CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  439 (452)
T ss_dssp             ---C----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred             ---C----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence               1    11123356788999999999999999999999998643

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.1e-42  Score=359.41  Aligned_cols=262  Identities=20%  Similarity=0.238  Sum_probs=206.9

Q ss_pred             hhhhhhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc-----cchhHHHHHHHHHHhcccCCCceeeeeeeee
Q 007869          254 KDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE-----SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCR  328 (586)
Q Consensus       254 ~el~~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~  328 (586)
                      .++....++|+..+.||+|+||.||+|+...++..||+|++...     .....+.+.+|++++++++||||+++++++.
T Consensus        19 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~   98 (345)
T 3hko_A           19 GSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYE   98 (345)
T ss_dssp             BCHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             chhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhc
Confidence            34566678899999999999999999999999999999998654     2345678999999999999999999999999


Q ss_pred             ccCeEEEEEecCCCCChhhhhhcC--------------------------------------CCccchhHHHHHHHHHHH
Q 007869          329 RKGELLLVYDYMPNGSLDKYLYDQ--------------------------------------PKVTLNWIQRFRVIKGVA  370 (586)
Q Consensus       329 ~~~~~~lV~E~~~~gsL~~~l~~~--------------------------------------~~~~l~~~~~~~i~~~ia  370 (586)
                      +.+..++||||+++|+|.+++...                                      ....+++..++.++.|++
T Consensus        99 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~  178 (345)
T 3hko_A           99 DEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIF  178 (345)
T ss_dssp             CSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHH
T ss_pred             cCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHH
Confidence            999999999999999999998521                                      022356778889999999


Q ss_pred             HHHHHhhcccCCcEEeCCCCCCCeeecCCC--CeEEccccceeeccCCCCC---ceeeeccCCCccCcccccC--CCCCC
Q 007869          371 LGLFYLHQEWEQVVIHRDVKASNVLLDGEL--NGRLGDFGLARLYDHGTDP---QTTHVVGTLGYLAPEHTRT--GKATT  443 (586)
Q Consensus       371 ~~L~yLH~~~~~~ivHrDIkp~NIll~~~~--~~kL~DFGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~--~~~s~  443 (586)
                      +||.|||+   .+|+||||||+|||++.++  .+||+|||+++.+......   ......||+.|+|||++.+  ..++.
T Consensus       179 ~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~  255 (345)
T 3hko_A          179 SALHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGP  255 (345)
T ss_dssp             HHHHHHHH---TTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCT
T ss_pred             HHHHHHHH---CCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCc
Confidence            99999998   8999999999999998766  8999999999976542221   2345679999999999865  67899


Q ss_pred             cceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCC
Q 007869          444 SADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTAR  523 (586)
Q Consensus       444 ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R  523 (586)
                      ++|||||||++|||++|+.||......+.      .........       .............+.+++.+||+.||.+|
T Consensus       256 ~~DiwslG~il~el~~g~~pf~~~~~~~~------~~~~~~~~~-------~~~~~~~~~~~~~~~~li~~~l~~~p~~R  322 (345)
T 3hko_A          256 KCDAWSAGVLLHLLLMGAVPFPGVNDADT------ISQVLNKKL-------CFENPNYNVLSPLARDLLSNLLNRNVDER  322 (345)
T ss_dssp             HHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHHCCC-------CTTSGGGGGSCHHHHHHHHHHSCSCTTTS
T ss_pred             HHHHHHHHHHHHHHHHCCCCCCCCChHHH------HHHHHhccc-------ccCCcccccCCHHHHHHHHHHcCCChhHC
Confidence            99999999999999999999976543221      111111110       00011111123567788999999999999


Q ss_pred             CCHHHHHH
Q 007869          524 PSMRQVVQ  531 (586)
Q Consensus       524 Ps~~evl~  531 (586)
                      |++.|+++
T Consensus       323 ps~~~~l~  330 (345)
T 3hko_A          323 FDAMRALQ  330 (345)
T ss_dssp             CCHHHHHH
T ss_pred             CCHHHHhc
Confidence            99999986

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=3.4e-42  Score=363.32  Aligned_cols=251  Identities=24%  Similarity=0.313  Sum_probs=207.5

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc---cchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEE
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLV  336 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV  336 (586)
                      .++|+..+.||+|+||.||++....++..||+|++...   .....+.+.+|++++++++||||+++++++...+..++|
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   93 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV   93 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            46789999999999999999999999999999998654   234457889999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCC
Q 007869          337 YDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHG  416 (586)
Q Consensus       337 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~  416 (586)
                      |||+++|+|.+++...  ..+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.+...
T Consensus        94 ~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~  168 (384)
T 4fr4_A           94 VDLLLGGDLRYHLQQN--VHFKEETVKLFICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE  168 (384)
T ss_dssp             ECCCTTEEHHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence            9999999999999765  358899999999999999999998   89999999999999999999999999999976543


Q ss_pred             CCCceeeeccCCCccCcccccC---CCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccC
Q 007869          417 TDPQTTHVVGTLGYLAPEHTRT---GKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARD  493 (586)
Q Consensus       417 ~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d  493 (586)
                      .  ......||+.|+|||++..   ..++.++|||||||++|||++|+.||..........+.....    ..      .
T Consensus       169 ~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~----~~------~  236 (384)
T 4fr4_A          169 T--QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFE----TT------V  236 (384)
T ss_dssp             C--CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHH----HC------C
T ss_pred             C--ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHh----hc------c
Confidence            2  3455689999999999864   458999999999999999999999998654433221111111    11      0


Q ss_pred             CCCCccccHHHHHHHHHHHHHhcccCCCCCCC-HHHHHH
Q 007869          494 PNLGTEYVAEELELVLKLGLLCSHSDPTARPS-MRQVVQ  531 (586)
Q Consensus       494 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-~~evl~  531 (586)
                      .....    .....+.+++.+||+.||.+||+ +.++++
T Consensus       237 ~~~p~----~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          237 VTYPS----AWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             CCCCT----TSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             cCCCC----cCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence            11111    12356778889999999999999 777764

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=2.3e-42  Score=371.68  Aligned_cols=253  Identities=23%  Similarity=0.276  Sum_probs=206.5

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc--chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEE
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES--RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY  337 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  337 (586)
                      .++|+..+.||+|+||.||+|....++..+|+|++....  ....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus        10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~   89 (444)
T 3soa_A           10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF   89 (444)
T ss_dssp             HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence            467889999999999999999999999999999997643  334567899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeec---CCCCeEEccccceeecc
Q 007869          338 DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLD---GELNGRLGDFGLARLYD  414 (586)
Q Consensus       338 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~---~~~~~kL~DFGla~~~~  414 (586)
                      ||+++|+|.+.+....  .+++..+..++.||++||.|||+   ++|+||||||+|||++   .++.+||+|||+++...
T Consensus        90 E~~~gg~L~~~i~~~~--~~~e~~~~~i~~qil~aL~~lH~---~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~  164 (444)
T 3soa_A           90 DLVTGGELFEDIVARE--YYSEADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVE  164 (444)
T ss_dssp             CCCBCCBHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCC
T ss_pred             EeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEeccCCCCcEEEccCceeEEec
Confidence            9999999999998763  58899999999999999999998   8999999999999998   46789999999998765


Q ss_pred             CCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCC
Q 007869          415 HGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDP  494 (586)
Q Consensus       415 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~  494 (586)
                      ... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+   +.    .....+... ...+
T Consensus       165 ~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~---~~----~~i~~~~~~-~~~~  235 (444)
T 3soa_A          165 GEQ-QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR---LY----QQIKAGAYD-FPSP  235 (444)
T ss_dssp             TTC-CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HH----HHHHHTCCC-CCTT
T ss_pred             CCC-ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHH---HH----HHHHhCCCC-CCcc
Confidence            432 22345689999999999999999999999999999999999999997643221   11    111111111 0111


Q ss_pred             CCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          495 NLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       495 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      .. .    .....+.+++.+||+.||.+|||+.|+++
T Consensus       236 ~~-~----~~s~~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          236 EW-D----TVTPEAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             TT-T----TSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             cc-c----cCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            11 1    12345778889999999999999999986

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=4e-42  Score=354.18  Aligned_cols=246  Identities=25%  Similarity=0.311  Sum_probs=206.3

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc---chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEE
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLV  336 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV  336 (586)
                      .++|+..+.||+|+||.||+++...+++.||+|++....   ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence            357889999999999999999999899999999997542   23456788999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCC
Q 007869          337 YDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHG  416 (586)
Q Consensus       337 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~  416 (586)
                      |||+++|+|.+++....  .+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++.... 
T Consensus        85 ~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~-  158 (318)
T 1fot_A           85 MDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-  158 (318)
T ss_dssp             ECCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSS-
T ss_pred             EeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChheEEEcCCCCEEEeecCcceecCC-
Confidence            99999999999998753  58888999999999999999998   8999999999999999999999999999987543 


Q ss_pred             CCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCC
Q 007869          417 TDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNL  496 (586)
Q Consensus       417 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l  496 (586)
                         ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+   ..   .... ++.      ...
T Consensus       159 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~---~~i~-~~~------~~~  222 (318)
T 1fot_A          159 ---VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK---TY---EKIL-NAE------LRF  222 (318)
T ss_dssp             ---CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH---HH---HHHH-HCC------CCC
T ss_pred             ---ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---HH---HHHH-hCC------CCC
Confidence               2334679999999999999999999999999999999999999997643211   11   1111 111      111


Q ss_pred             CccccHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 007869          497 GTEYVAEELELVLKLGLLCSHSDPTARP-----SMRQVVQ  531 (586)
Q Consensus       497 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~  531 (586)
                      ...+    ...+.+++.+|++.||.+||     +++|+++
T Consensus       223 p~~~----~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          223 PPFF----NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             CTTS----CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             CCCC----CHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence            1112    24577888899999999999     8899884

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.4e-42  Score=360.27  Aligned_cols=248  Identities=25%  Similarity=0.332  Sum_probs=204.9

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc---chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEE
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLV  336 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV  336 (586)
                      -++|...+.||+|+||.||+|.+..++..||||++....   ......+.+|+.++++++||||+++++++...+..++|
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            367999999999999999999999999999999986532   23346789999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCC
Q 007869          337 YDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHG  416 (586)
Q Consensus       337 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~  416 (586)
                      |||+ +|+|.+++...  ..+++..+..++.|++.||.|||+   .+|+||||||+|||+++++++||+|||+++.....
T Consensus        88 ~E~~-~g~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~  161 (336)
T 3h4j_B           88 IEYA-GGELFDYIVEK--KRMTEDEGRRFFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG  161 (336)
T ss_dssp             ECCC-CEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH---HTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred             EECC-CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence            9999 78999988765  358899999999999999999998   89999999999999999999999999999876543


Q ss_pred             CCCceeeeccCCCccCcccccCCCC-CCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCC
Q 007869          417 TDPQTTHVVGTLGYLAPEHTRTGKA-TTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPN  495 (586)
Q Consensus       417 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~  495 (586)
                      .  ......||+.|+|||++.+..+ ++++|||||||++|||++|+.||......+....       ...+      ...
T Consensus       162 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~-------i~~~------~~~  226 (336)
T 3h4j_B          162 N--FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK-------VNSC------VYV  226 (336)
T ss_dssp             B--TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCC-------CCSS------CCC
T ss_pred             c--ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHH-------HHcC------CCC
Confidence            2  2344579999999999988776 7899999999999999999999986543221100       0000      011


Q ss_pred             CCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          496 LGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       496 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                      .    +......+.+++.+||+.||.+|||+.|+++.
T Consensus       227 ~----p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  259 (336)
T 3h4j_B          227 M----PDFLSPGAQSLIRRMIVADPMQRITIQEIRRD  259 (336)
T ss_dssp             C----CTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred             C----cccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence            1    11123456788899999999999999999863

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-42  Score=369.88  Aligned_cols=267  Identities=22%  Similarity=0.244  Sum_probs=214.9

Q ss_pred             CcccchhhhhhhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc---chhHHHHHHHHHHhcccCCCceeeee
Q 007869          248 PHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLL  324 (586)
Q Consensus       248 ~~~~~~~el~~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~  324 (586)
                      +..++++++....++|+..+.||+|+||+||+++.+.+++.||||++....   ....+.+.+|..++.+++||||++++
T Consensus        48 ~~~~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~  127 (412)
T 2vd5_A           48 PIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH  127 (412)
T ss_dssp             HHHHHHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEE
T ss_pred             hhhhhhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEE
Confidence            345677888888999999999999999999999999999999999997532   22334588999999999999999999


Q ss_pred             eeeeccCeEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEE
Q 007869          325 GYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRL  404 (586)
Q Consensus       325 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL  404 (586)
                      +++.+.+.+++||||+++|+|.+++.+.. ..+++..+..++.||+.||.|||+   ++|+||||||+|||++.++++||
T Consensus       128 ~~~~~~~~~~lVmE~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILld~~g~vkL  203 (412)
T 2vd5_A          128 FAFQDENYLYLVMEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRL  203 (412)
T ss_dssp             EEEECSSEEEEEECCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEE
T ss_pred             EEEeeCCEEEEEEcCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccCHHHeeecCCCCEEE
Confidence            99999999999999999999999997642 368899999999999999999998   89999999999999999999999


Q ss_pred             ccccceeeccCCCCCceeeeccCCCccCccccc-------CCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhH
Q 007869          405 GDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTR-------TGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVD  477 (586)
Q Consensus       405 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~  477 (586)
                      +|||+++.............+||+.|+|||++.       ...++.++|||||||++|||++|+.||......+..   .
T Consensus       204 ~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~---~  280 (412)
T 2vd5_A          204 ADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETY---G  280 (412)
T ss_dssp             CCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH---H
T ss_pred             eechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHH---H
Confidence            999999876554333334568999999999987       457899999999999999999999999765432211   1


Q ss_pred             HHHhhhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCC---CCHHHHHH
Q 007869          478 WVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTAR---PSMRQVVQ  531 (586)
Q Consensus       478 ~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R---Ps~~evl~  531 (586)
                      .+..   ...  ....|.....    ....+.+++.+||+ +|.+|   |+++|+++
T Consensus       281 ~i~~---~~~--~~~~p~~~~~----~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~  327 (412)
T 2vd5_A          281 KIVH---YKE--HLSLPLVDEG----VPEEARDFIQRLLC-PPETRLGRGGAGDFRT  327 (412)
T ss_dssp             HHHT---HHH--HCCCC----C----CCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred             HHHh---ccc--CcCCCccccC----CCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence            1110   000  0011111111    23457788889999 99998   68999875

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.5e-42  Score=362.22  Aligned_cols=254  Identities=22%  Similarity=0.285  Sum_probs=205.6

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc-----chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEE
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES-----RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELL  334 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~  334 (586)
                      .+.|+..+.||+|+||.||+|++..+++.||||++....     ....+.+.+|+.++++++||||+++++++...+..+
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            356888999999999999999999999999999986432     123578999999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhhcC--CCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCC---eEEccccc
Q 007869          335 LVYDYMPNGSLDKYLYDQ--PKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELN---GRLGDFGL  409 (586)
Q Consensus       335 lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~---~kL~DFGl  409 (586)
                      +||||+++++|.+++...  ....+++..+..++.||++||.|||+   ++|+||||||+|||++.++.   +||+|||+
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            999999999999888653  22358899999999999999999998   89999999999999986654   99999999


Q ss_pred             eeeccCCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccc
Q 007869          410 ARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELL  489 (586)
Q Consensus       410 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~  489 (586)
                      ++...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.....    .+..    ....+...
T Consensus       180 a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~----~i~~~~~~  250 (351)
T 3c0i_A          180 AIQLGESG-LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE----RLFE----GIIKGKYK  250 (351)
T ss_dssp             CEECCTTS-CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH----HHHH----HHHHTCCC
T ss_pred             eeEecCCC-eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH----HHHH----HHHcCCCC
Confidence            98765432 223446799999999999999999999999999999999999999976321    1111    11111110


Q ss_pred             cccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          490 EARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       490 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                            ............+.+++.+||+.||++|||+.|+++
T Consensus       251 ------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          251 ------MNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             ------CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ------CCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence                  000000112356778899999999999999999985

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=3.9e-43  Score=362.56  Aligned_cols=259  Identities=27%  Similarity=0.434  Sum_probs=206.6

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeE----EEEEEecccc-chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEE
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIE----IAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELL  334 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~----vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~  334 (586)
                      .++|+..+.||+|+||.||+|++..++..    ||+|.+.... ....+.+.+|+.++++++||||++++++|. .+..+
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~   90 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ   90 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence            35788999999999999999998777655    7888775432 334456788999999999999999999986 45689


Q ss_pred             EEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeecc
Q 007869          335 LVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYD  414 (586)
Q Consensus       335 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~  414 (586)
                      +||||+++|+|.+++... ...+++..++.++.|+++||.|||+   .+|+||||||+|||++.++++||+|||+++...
T Consensus        91 ~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  166 (325)
T 3kex_A           91 LVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLP  166 (325)
T ss_dssp             EEEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHHH---TTCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred             EEEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHHh---CCCCCCccchheEEECCCCeEEECCCCcccccC
Confidence            999999999999999765 3478999999999999999999998   899999999999999999999999999999765


Q ss_pred             CCCCC-ceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccCcccccc
Q 007869          415 HGTDP-QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEAR  492 (586)
Q Consensus       415 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~  492 (586)
                      ..... ......||..|+|||++.+..++.++|||||||++|||++ |+.||......+.   .+.    ...+...  .
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~~~----~~~~~~~--~  237 (325)
T 3kex_A          167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEV---PDL----LEKGERL--A  237 (325)
T ss_dssp             CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHH---HHH----HHTTCBC--C
T ss_pred             cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHH---HHH----HHcCCCC--C
Confidence            44322 2344578889999999999999999999999999999999 9999987554321   111    1111111  1


Q ss_pred             CCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhccCC
Q 007869          493 DPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERDVAL  539 (586)
Q Consensus       493 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~  539 (586)
                      .+..       ....+.+++.+||+.||.+||++.++++.|+....-
T Consensus       238 ~~~~-------~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~  277 (325)
T 3kex_A          238 QPQI-------CTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD  277 (325)
T ss_dssp             CCTT-------BCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred             CCCc-------CcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            1111       122466788899999999999999999999876543

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=8.5e-43  Score=349.64  Aligned_cols=251  Identities=29%  Similarity=0.465  Sum_probs=194.7

Q ss_pred             hcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc----chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEE
Q 007869          259 ATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES----RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELL  334 (586)
Q Consensus       259 a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~  334 (586)
                      ..++|+..+.||+|+||.||+|.+.  +..||||++....    ....+.+.+|++++++++||||+++++++...+..+
T Consensus         5 ~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (271)
T 3dtc_A            5 DFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLC   82 (271)
T ss_dssp             CTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CE
T ss_pred             chhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceE
Confidence            3468999999999999999999984  6789999987543    233567899999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCc---EEeCCCCCCCeeecC--------CCCeE
Q 007869          335 LVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQV---VIHRDVKASNVLLDG--------ELNGR  403 (586)
Q Consensus       335 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~---ivHrDIkp~NIll~~--------~~~~k  403 (586)
                      +||||+++++|.+++...   .+++..++.++.|+++||.|||+   ++   |+||||||+|||++.        ++.+|
T Consensus        83 lv~e~~~~~~L~~~~~~~---~~~~~~~~~i~~~l~~~l~~lH~---~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~k  156 (271)
T 3dtc_A           83 LVMEFARGGPLNRVLSGK---RIPPDILVNWAVQIARGMNYLHD---EAIVPIIHRDLKSSNILILQKVENGDLSNKILK  156 (271)
T ss_dssp             EEEECCTTEEHHHHHTSS---CCCHHHHHHHHHHHHHHHHHHHH---SSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEE
T ss_pred             EEEEcCCCCCHHHHhhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCCCceeecCCchHHEEEecccccccccCcceE
Confidence            999999999999998543   68899999999999999999998   66   999999999999986        67899


Q ss_pred             EccccceeeccCCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhh
Q 007869          404 LGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFW  483 (586)
Q Consensus       404 L~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~  483 (586)
                      |+|||+++......   .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.......   .   .....
T Consensus       157 l~Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~---~~~~~  227 (271)
T 3dtc_A          157 ITDFGLAREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA---V---AYGVA  227 (271)
T ss_dssp             ECCCCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHH---H---HHHHH
T ss_pred             EccCCccccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---H---HHhhh
Confidence            99999998654332   234578999999999999999999999999999999999999997643211   1   11111


Q ss_pred             ccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 007869          484 NRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER  535 (586)
Q Consensus       484 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  535 (586)
                       ....    .+..    .......+.+++.+||+.||.+|||+.|+++.|+.
T Consensus       228 -~~~~----~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~  270 (271)
T 3dtc_A          228 -MNKL----ALPI----PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT  270 (271)
T ss_dssp             -TSCC----CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred             -cCCC----CCCC----CcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence             1111    1111    11223567889999999999999999999999974

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.6e-42  Score=361.75  Aligned_cols=253  Identities=25%  Similarity=0.313  Sum_probs=192.5

Q ss_pred             hhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEE
Q 007869          258 IATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY  337 (586)
Q Consensus       258 ~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  337 (586)
                      ...+.|+..+.||+|+||.||+|++..++..||||++....  ..+.+.+|++++++++||||+++++++...+..++||
T Consensus        50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  127 (349)
T 2w4o_A           50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVL  127 (349)
T ss_dssp             CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEE
Confidence            34578999999999999999999999889999999997543  3366889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecC---CCCeEEccccceeecc
Q 007869          338 DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDG---ELNGRLGDFGLARLYD  414 (586)
Q Consensus       338 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~---~~~~kL~DFGla~~~~  414 (586)
                      ||+++++|.+++...  ..+++.+++.++.|+++||.|||+   .+|+||||||+|||++.   ++.+||+|||+++...
T Consensus       128 e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~  202 (349)
T 2w4o_A          128 ELVTGGELFDRIVEK--GYYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE  202 (349)
T ss_dssp             CCCCSCBHHHHHTTC--SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred             EeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence            999999999999765  358899999999999999999998   89999999999999975   8899999999998764


Q ss_pred             CCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCC
Q 007869          415 HGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDP  494 (586)
Q Consensus       415 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~  494 (586)
                      ...  ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.  +    .....+.... ...+
T Consensus       203 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~----~~~i~~~~~~-~~~~  273 (349)
T 2w4o_A          203 HQV--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF--M----FRRILNCEYY-FISP  273 (349)
T ss_dssp             ------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH--H----HHHHHTTCCC-CCTT
T ss_pred             ccc--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH--H----HHHHHhCCCc-cCCc
Confidence            322  23346799999999999999999999999999999999999999976443211  1    1111111110 0111


Q ss_pred             CCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          495 NLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       495 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                           ........+.+++.+||+.||++|||+.|+++
T Consensus       274 -----~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          274 -----WWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             -----TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -----hhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                 11122356778899999999999999999986

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=7.3e-43  Score=351.86  Aligned_cols=261  Identities=28%  Similarity=0.455  Sum_probs=211.2

Q ss_pred             hhhhhhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeE
Q 007869          254 KDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGEL  333 (586)
Q Consensus       254 ~el~~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~  333 (586)
                      ++.....++|+..+.||+|+||.||+|.+. ++..||||++.... ...+.+.+|++++++++||||+++++++.. +..
T Consensus         6 ~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~   82 (279)
T 1qpc_A            6 DEWEVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPI   82 (279)
T ss_dssp             CTTBCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred             hhcccCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCc
Confidence            345556678999999999999999999986 46679999997543 345789999999999999999999999874 568


Q ss_pred             EEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeec
Q 007869          334 LLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLY  413 (586)
Q Consensus       334 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~  413 (586)
                      ++||||+++++|.+++.......+++..++.++.|+++||.|||+   .+|+||||||+|||+++++.+||+|||+++..
T Consensus        83 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  159 (279)
T 1qpc_A           83 YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLI  159 (279)
T ss_dssp             EEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHhhEEEcCCCCEEECCCcccccc
Confidence            999999999999999975433468999999999999999999998   89999999999999999999999999999976


Q ss_pred             cCCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccCcccccc
Q 007869          414 DHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEAR  492 (586)
Q Consensus       414 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~  492 (586)
                      ............++..|+|||++.+..++.++||||||+++|||++ |+.||......+   +...+    .++.     
T Consensus       160 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~~~----~~~~-----  227 (279)
T 1qpc_A          160 EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---VIQNL----ERGY-----  227 (279)
T ss_dssp             SSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHHHH----HTTC-----
T ss_pred             cCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH---HHHHH----hccc-----
Confidence            5433222233457889999999998899999999999999999999 999997643321   11111    1111     


Q ss_pred             CCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 007869          493 DPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERD  536 (586)
Q Consensus       493 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  536 (586)
                      .+....    .....+.+++..|++.||++|||+.++++.|+..
T Consensus       228 ~~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  267 (279)
T 1qpc_A          228 RMVRPD----NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF  267 (279)
T ss_dssp             CCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCcc----cccHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence            111111    1235677888999999999999999999999764

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=4.3e-42  Score=348.90  Aligned_cols=263  Identities=23%  Similarity=0.320  Sum_probs=203.8

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc--chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEe
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES--RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYD  338 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E  338 (586)
                      ++|+..+.||+|+||+||+|++..++..||||++....  ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            57899999999999999999999999999999997543  3345778999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCC
Q 007869          339 YMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD  418 (586)
Q Consensus       339 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~  418 (586)
                      |+++ +|.+.+... ...+++..+..++.|+++||.|||+   ++|+||||||+|||++.++.+||+|||+++...... 
T Consensus        82 ~~~~-~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~---~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  155 (292)
T 3o0g_A           82 FCDQ-DLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-  155 (292)
T ss_dssp             CCSE-EHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC-
T ss_pred             cCCC-CHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecCCcc-
Confidence            9975 666666543 2468999999999999999999998   899999999999999999999999999998765432 


Q ss_pred             CceeeeccCCCccCcccccCCC-CCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCc------cccc
Q 007869          419 PQTTHVVGTLGYLAPEHTRTGK-ATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGE------LLEA  491 (586)
Q Consensus       419 ~~~~~~~gt~~y~aPE~~~~~~-~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~------~~~~  491 (586)
                      .......||+.|+|||++.+.. ++.++|||||||++|||++|..|+........  ....+.+......      ....
T Consensus       156 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~--~~~~i~~~~~~~~~~~~~~~~~~  233 (292)
T 3o0g_A          156 RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPTEEQWPSMTKL  233 (292)
T ss_dssp             SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH--HHHHHHHHHCCCCTTTCTTGGGS
T ss_pred             ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHH--HHHHHHHHhCCCChhhhhhhccc
Confidence            2334467899999999998766 79999999999999999999888654332211  1111111110000      0000


Q ss_pred             cC---------CCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          492 RD---------PNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       492 ~d---------~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      .+         ..............+.+++.+||+.||++|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence            00         00001111223456778899999999999999999986

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=4.1e-42  Score=363.98  Aligned_cols=257  Identities=24%  Similarity=0.308  Sum_probs=205.4

Q ss_pred             hcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc---chhHHHHHHHHHHhccc-CCCceeeeeeeeeccCeEE
Q 007869          259 ATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES---RQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKGELL  334 (586)
Q Consensus       259 a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~  334 (586)
                      ..++|+..++||+|+||+||+|+++.++..||||++....   ....+.+..|..++.++ +||||+++++++...+.++
T Consensus        50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  129 (396)
T 4dc2_A           50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF  129 (396)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred             ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence            3467999999999999999999999999999999997642   23345688899999887 8999999999999999999


Q ss_pred             EEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeecc
Q 007869          335 LVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYD  414 (586)
Q Consensus       335 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~  414 (586)
                      +||||+++|+|..++...  ..+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++...
T Consensus       130 lV~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFGla~~~~  204 (396)
T 4dc2_A          130 FVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL  204 (396)
T ss_dssp             EEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEEEcCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence            999999999999999765  358899999999999999999998   899999999999999999999999999998533


Q ss_pred             CCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccc--hhhHHHHhhhccCcccccc
Q 007869          415 HGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENL--ILVDWVFDFWNRGELLEAR  492 (586)
Q Consensus       415 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~--~l~~~v~~~~~~~~~~~~~  492 (586)
                      .. .......+||+.|+|||++.+..++.++|||||||++|||++|+.||......+..  ...+.+.+....+.     
T Consensus       205 ~~-~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~-----  278 (396)
T 4dc2_A          205 RP-GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ-----  278 (396)
T ss_dssp             CT-TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCC-----
T ss_pred             cC-CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccc-----
Confidence            22 22345578999999999999999999999999999999999999999754322211  11122222221111     


Q ss_pred             CCCCCccccHHHHHHHHHHHHHhcccCCCCCCCH------HHHHH
Q 007869          493 DPNLGTEYVAEELELVLKLGLLCSHSDPTARPSM------RQVVQ  531 (586)
Q Consensus       493 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~------~evl~  531 (586)
                       ..+...    ....+.+++.+||+.||.+||++      .|+++
T Consensus       279 -~~~p~~----~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~  318 (396)
T 4dc2_A          279 -IRIPRS----LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG  318 (396)
T ss_dssp             -CCCCTT----SCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHH
T ss_pred             -cCCCCc----CCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhc
Confidence             111111    23456788889999999999995      56654

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.4e-42  Score=347.38  Aligned_cols=252  Identities=23%  Similarity=0.350  Sum_probs=206.3

Q ss_pred             hcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc--cchhHHHHHHHHHHhcccCCCceeeeeeeeecc--CeEE
Q 007869          259 ATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRK--GELL  334 (586)
Q Consensus       259 a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~--~~~~  334 (586)
                      ..++|+..+.||+|+||.||+|++.  +..||||++...  .....+.+.+|+.++++++||||+++++++...  +..+
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   85 (271)
T 3kmu_A            8 DFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPT   85 (271)
T ss_dssp             CGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCE
T ss_pred             CHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeE
Confidence            3457889999999999999999985  678999999764  334456799999999999999999999999877  7889


Q ss_pred             EEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCc--EEeCCCCCCCeeecCCCCeEEccccceee
Q 007869          335 LVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQV--VIHRDVKASNVLLDGELNGRLGDFGLARL  412 (586)
Q Consensus       335 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--ivHrDIkp~NIll~~~~~~kL~DFGla~~  412 (586)
                      +||||+++|+|.+++.......+++.+++.++.|+++||.|||+   .+  |+||||||+|||++.++.+||+|||++..
T Consensus        86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~  162 (271)
T 3kmu_A           86 LITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT---LEPLIPRHALNSRSVMIDEDMTARISMADVKFS  162 (271)
T ss_dssp             EEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTT---SSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred             eeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhc---CCCceecCCCccceEEEcCCcceeEEeccceee
Confidence            99999999999999988766679999999999999999999998   77  99999999999999999999999998764


Q ss_pred             ccCCCCCceeeeccCCCccCcccccCCCCCC---cceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccc
Q 007869          413 YDHGTDPQTTHVVGTLGYLAPEHTRTGKATT---SADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELL  489 (586)
Q Consensus       413 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~---ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~  489 (586)
                      ...      ....||+.|+|||++.+..++.   ++|||||||++|||++|+.||......+      ........+   
T Consensus       163 ~~~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~~~~~~---  227 (271)
T 3kmu_A          163 FQS------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME------IGMKVALEG---  227 (271)
T ss_dssp             TSC------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHH------HHHHHHHSC---
T ss_pred             ecc------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHH------HHHHHHhcC---
Confidence            322      2346899999999998766554   7999999999999999999997643321      111111111   


Q ss_pred             cccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 007869          490 EARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERD  536 (586)
Q Consensus       490 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  536 (586)
                        ..+.....    ....+.+++..||+.||++|||+.|+++.|+..
T Consensus       228 --~~~~~~~~----~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l  268 (271)
T 3kmu_A          228 --LRPTIPPG----ISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM  268 (271)
T ss_dssp             --CCCCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --CCCCCCCC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence              11222122    234577888999999999999999999999764

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=6.6e-43  Score=365.19  Aligned_cols=250  Identities=23%  Similarity=0.311  Sum_probs=202.1

Q ss_pred             hcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc---cchhHHHHHHHHHHhccc-CCCceeeeeeeeeccCeEE
Q 007869          259 ATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE---SRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKGELL  334 (586)
Q Consensus       259 a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~  334 (586)
                      ..++|+..+.||+|+||+||+|++..++..||||++...   .....+.+..|..++.++ +||||+++++++...+.++
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  100 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF  100 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence            456899999999999999999999999999999999754   233456788999999988 7999999999999999999


Q ss_pred             EEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeecc
Q 007869          335 LVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYD  414 (586)
Q Consensus       335 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~  414 (586)
                      +||||+++|+|.+++...  ..+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++...
T Consensus       101 lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~  175 (353)
T 3txo_A          101 FVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI  175 (353)
T ss_dssp             EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             EEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCCHHHEEECCCCCEEEccccceeecc
Confidence            999999999999999765  358899999999999999999998   899999999999999999999999999998543


Q ss_pred             CCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCC
Q 007869          415 HGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDP  494 (586)
Q Consensus       415 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~  494 (586)
                      ... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+   +.+    ...++..      
T Consensus       176 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~---~~~----~i~~~~~------  241 (353)
T 3txo_A          176 CNG-VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD---LFE----AILNDEV------  241 (353)
T ss_dssp             C----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH----HHHHCCC------
T ss_pred             cCC-ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH---HHH----HHHcCCC------
Confidence            221 23445689999999999998899999999999999999999999997654321   111    1111111      


Q ss_pred             CCCccccHHHHHHHHHHHHHhcccCCCCCCCH------HHHHH
Q 007869          495 NLGTEYVAEELELVLKLGLLCSHSDPTARPSM------RQVVQ  531 (586)
Q Consensus       495 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~------~evl~  531 (586)
                      .....    ....+.+++.+||+.||.+||++      .|+++
T Consensus       242 ~~p~~----~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          242 VYPTW----LHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             CCCTT----SCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             CCCCC----CCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence            11111    22456788889999999999998      77764

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=4e-42  Score=346.08  Aligned_cols=251  Identities=23%  Similarity=0.302  Sum_probs=207.9

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEec
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY  339 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  339 (586)
                      .++|+..+.||+|+||.||+|.+..++..||+|++........+.+.+|++++++++||||+++++++...+..++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL   87 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence            35688999999999999999999999999999999877666678899999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeee---cCCCCeEEccccceeeccCC
Q 007869          340 MPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLL---DGELNGRLGDFGLARLYDHG  416 (586)
Q Consensus       340 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll---~~~~~~kL~DFGla~~~~~~  416 (586)
                      +++++|.+++...  ..+++..++.++.|++.||.|||+   ++|+||||||+|||+   +.++.+||+|||++......
T Consensus        88 ~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~  162 (277)
T 3f3z_A           88 CTGGELFERVVHK--RVFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG  162 (277)
T ss_dssp             CCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT
T ss_pred             cCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc
Confidence            9999999998765  358899999999999999999998   899999999999999   78899999999999876543


Q ss_pred             CCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCC
Q 007869          417 TDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNL  496 (586)
Q Consensus       417 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l  496 (586)
                      .  ......||+.|+|||++.+ .++.++||||||+++|||++|+.||......+   ..    ....++..      ..
T Consensus       163 ~--~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~----~~~~~~~~------~~  226 (277)
T 3f3z_A          163 K--MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSE---VM----LKIREGTF------TF  226 (277)
T ss_dssp             S--CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH----HHHHHCCC------CC
T ss_pred             c--chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHH---HH----HHHHhCCC------CC
Confidence            2  2344579999999999865 49999999999999999999999997643321   11    11111111      00


Q ss_pred             CccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          497 GTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       497 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      ...........+.+++.+|++.||++|||+.++++
T Consensus       227 ~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          227 PEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             CchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            00000012356778899999999999999999985

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=3.3e-42  Score=349.19  Aligned_cols=261  Identities=26%  Similarity=0.370  Sum_probs=200.2

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc--chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEe
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES--RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYD  338 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E  338 (586)
                      ++|+..+.||+|+||.||+|+. .++..||+|++....  ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE   80 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEE
Confidence            4788999999999999999998 567889999986543  2334678999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCC
Q 007869          339 YMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD  418 (586)
Q Consensus       339 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~  418 (586)
                      |+++ +|.+++.... ..+++..+..++.|+++||.|||+   ++|+||||||+|||++.++.+||+|||+++...... 
T Consensus        81 ~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  154 (288)
T 1ob3_A           81 HLDQ-DLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-  154 (288)
T ss_dssp             CCSE-EHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             ecCC-CHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEeECccccccCccc-
Confidence            9975 9999887643 468889999999999999999998   899999999999999999999999999998764322 


Q ss_pred             CceeeeccCCCccCcccccCC-CCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccC--------ccc
Q 007869          419 PQTTHVVGTLGYLAPEHTRTG-KATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRG--------ELL  489 (586)
Q Consensus       419 ~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~--------~~~  489 (586)
                      .......||+.|+|||++.+. .++.++|||||||++|||++|+.||......+..   ..+.......        ...
T Consensus       155 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  231 (288)
T 1ob3_A          155 RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQL---MRIFRILGTPNSKNWPNVTEL  231 (288)
T ss_dssp             -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCCCCTTTSTTGGGS
T ss_pred             cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHHCCCChhhchhhhcc
Confidence            123345789999999998764 5899999999999999999999999765432211   1111111000        000


Q ss_pred             cccCCCCC-------ccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          490 EARDPNLG-------TEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       490 ~~~d~~l~-------~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      ...++...       ..+.......+.+++.+||+.||++|||+.|+++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            00111110       1111123456778999999999999999999985

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=5.5e-43  Score=361.50  Aligned_cols=266  Identities=23%  Similarity=0.333  Sum_probs=213.1

Q ss_pred             hcCCcccceeEeecCceEEEEEE----eCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeee--ccCe
Q 007869          259 ATKGFREKELLGTGGFGRVYRGT----LPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCR--RKGE  332 (586)
Q Consensus       259 a~~~f~~~~~LG~G~~g~Vy~~~----~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~--~~~~  332 (586)
                      ..++|+..+.||+|+||.||+|+    ...++..||||++........+.+.+|++++++++||||+++++++.  ..+.
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~  100 (327)
T 3lxl_A           21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQS  100 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCE
T ss_pred             chhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCce
Confidence            34678899999999999999999    45678899999998777677788999999999999999999999886  4567


Q ss_pred             EEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceee
Q 007869          333 LLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARL  412 (586)
Q Consensus       333 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~  412 (586)
                      .++||||+++++|.+++.... ..+++..++.++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++.
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~  176 (327)
T 3lxl_A          101 LRLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKL  176 (327)
T ss_dssp             EEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred             EEEEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChhhEEECCCCCEEEccccccee
Confidence            899999999999999997642 368999999999999999999998   8999999999999999999999999999997


Q ss_pred             ccCCCCC--ceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCc--------cchhhHHHHhh
Q 007869          413 YDHGTDP--QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSE--------NLILVDWVFDF  482 (586)
Q Consensus       413 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~--------~~~l~~~v~~~  482 (586)
                      .......  ......||..|+|||++.+..++.++|||||||++|||++|+.||.......        .......+...
T Consensus       177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (327)
T 3lxl_A          177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL  256 (327)
T ss_dssp             CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHH
T ss_pred             cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHH
Confidence            6543321  1233467888999999999899999999999999999999999986432110        00000111111


Q ss_pred             hccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 007869          483 WNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERDV  537 (586)
Q Consensus       483 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  537 (586)
                      ...+.         ...........+.+++.+||+.||.+|||+.|+++.|+...
T Consensus       257 ~~~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~  302 (327)
T 3lxl_A          257 LEEGQ---------RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLW  302 (327)
T ss_dssp             HHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-
T ss_pred             hhccc---------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            11111         11112223456788999999999999999999999998754

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=6.2e-42  Score=352.81  Aligned_cols=252  Identities=21%  Similarity=0.325  Sum_probs=208.2

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccch------hHHHHHHHHHHhcccCCCceeeeeeeeeccCeE
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQ------GMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGEL  333 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~  333 (586)
                      .++|+..+.||+|+||.||+|++..++..||||++......      ..+++.+|+.++++++||||+++++++...+..
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            45688999999999999999999989999999999764321      357799999999999999999999999999999


Q ss_pred             EEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCC----CeEEccccc
Q 007869          334 LLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGEL----NGRLGDFGL  409 (586)
Q Consensus       334 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~----~~kL~DFGl  409 (586)
                      ++||||+++++|.+++...  ..+++..++.++.|++.||.|||+   .+|+||||||+|||++.++    .+||+|||+
T Consensus        91 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~---~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~  165 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL  165 (321)
T ss_dssp             EEEECCCCSCBHHHHHHTC--SCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred             EEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence            9999999999999999764  468999999999999999999998   8999999999999999887    799999999


Q ss_pred             eeeccCCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccc
Q 007869          410 ARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELL  489 (586)
Q Consensus       410 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~  489 (586)
                      ++......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+   ...   . .....  
T Consensus       166 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~---~-i~~~~--  234 (321)
T 2a2a_A          166 AHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE---TLA---N-ITSVS--  234 (321)
T ss_dssp             CEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HHH---H-HHTTC--
T ss_pred             ceecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH---HHH---H-HHhcc--
Confidence            98765432  2344579999999999999999999999999999999999999997643221   111   1 11110  


Q ss_pred             cccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          490 EARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       490 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                          ..............+.+++.+||+.||++|||+.|+++
T Consensus       235 ----~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          235 ----YDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             ----CCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             ----cccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                11111111122356788999999999999999999986

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=3.5e-42  Score=354.19  Aligned_cols=264  Identities=26%  Similarity=0.394  Sum_probs=192.8

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccc-hhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEe
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR-QGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYD  338 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E  338 (586)
                      .++|+..+.||+|+||.||+|.+..++..||||++..... ...+.+.+|++++++++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            4678999999999999999999998999999999976532 334678899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhcCC----CccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeecc
Q 007869          339 YMPNGSLDKYLYDQP----KVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYD  414 (586)
Q Consensus       339 ~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~  414 (586)
                      |++ |+|.+++....    ...+++..+..++.||++||.|||+   .+|+||||||+|||++.++.+||+|||+++...
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            997 69999886532    2358899999999999999999998   899999999999999999999999999998765


Q ss_pred             CCCCCceeeeccCCCccCcccccCC-CCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccC-------
Q 007869          415 HGTDPQTTHVVGTLGYLAPEHTRTG-KATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRG-------  486 (586)
Q Consensus       415 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~-------  486 (586)
                      .... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||......+..   ..+.......       
T Consensus       160 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~~~~  235 (317)
T 2pmi_A          160 IPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQL---KLIFDIMGTPNESLWPS  235 (317)
T ss_dssp             SCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCSCCTTTCGG
T ss_pred             CCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHhCCCChhHhhh
Confidence            4322 23345789999999998764 6899999999999999999999999865432211   1111111000       


Q ss_pred             -ccccccCCCCC----ccc--------cHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          487 -ELLEARDPNLG----TEY--------VAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       487 -~~~~~~d~~l~----~~~--------~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                       .......+...    ...        .......+.+++.+||+.||++|||+.|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          236 VTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             GGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence             00000000000    000        0012246788999999999999999999975

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=5.7e-42  Score=346.94  Aligned_cols=253  Identities=24%  Similarity=0.375  Sum_probs=205.9

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCC-------eEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCe
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQ-------IEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGE  332 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~-------~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~  332 (586)
                      .++|...+.||+|+||.||+|++..++       ..||+|++........+.+.+|++++++++||||+++++++...+.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE   86 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence            467889999999999999999987655       5799999987776777889999999999999999999999999999


Q ss_pred             EEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCC--------eEE
Q 007869          333 LLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELN--------GRL  404 (586)
Q Consensus       333 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~--------~kL  404 (586)
                      .++||||+++|+|.+++.... ..+++..++.++.|+++||.|||+   ++|+||||||+|||++.++.        +||
T Consensus        87 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl  162 (289)
T 4fvq_A           87 NILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGNPPFIKL  162 (289)
T ss_dssp             CEEEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred             CEEEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHhh---CCeECCCcCcceEEEecCCcccccccceeee
Confidence            999999999999999998753 358899999999999999999998   89999999999999998887        999


Q ss_pred             ccccceeeccCCCCCceeeeccCCCccCcccccC-CCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhh
Q 007869          405 GDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFW  483 (586)
Q Consensus       405 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~  483 (586)
                      +|||+++....     .....||+.|+|||++.+ ..++.++|||||||++|||++|..|+.......  ....    ..
T Consensus       163 ~Dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~--~~~~----~~  231 (289)
T 4fvq_A          163 SDPGISITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQ--RKLQ----FY  231 (289)
T ss_dssp             CCCCSCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--HHHH----HH
T ss_pred             ccCcccccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchH--HHHH----Hh
Confidence            99999875422     233568999999999987 678999999999999999999655544322211  1111    11


Q ss_pred             ccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhccC
Q 007869          484 NRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERDVA  538 (586)
Q Consensus       484 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~  538 (586)
                      ...       +.+....    ...+.+++.+||+.||++|||+.|+++.|+....
T Consensus       232 ~~~-------~~~~~~~----~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~  275 (289)
T 4fvq_A          232 EDR-------HQLPAPK----AAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT  275 (289)
T ss_dssp             HTT-------CCCCCCS----SCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred             hcc-------CCCCCCC----CHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            110       0010111    2346788899999999999999999999987654

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=8.1e-42  Score=355.90  Aligned_cols=256  Identities=24%  Similarity=0.308  Sum_probs=205.7

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc---chhHHHHHHHHHHhccc-CCCceeeeeeeeeccCeEEE
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES---RQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKGELLL  335 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~l  335 (586)
                      .++|+..+.||+|+||.||+|+++.+++.||||++....   ....+.+..|..++.++ +||||+++++++...+.+++
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   87 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF   87 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence            357889999999999999999999999999999997642   33456688999999988 89999999999999999999


Q ss_pred             EEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccC
Q 007869          336 VYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH  415 (586)
Q Consensus       336 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~  415 (586)
                      ||||+++|+|.+++...  ..+++..+..++.||+.||.|||+   ++|+||||||+|||++.++++||+|||+++....
T Consensus        88 v~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~  162 (345)
T 3a8x_A           88 VIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  162 (345)
T ss_dssp             EECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred             EEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence            99999999999999764  358899999999999999999998   8999999999999999999999999999986432


Q ss_pred             CCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccc--hhhHHHHhhhccCccccccC
Q 007869          416 GTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENL--ILVDWVFDFWNRGELLEARD  493 (586)
Q Consensus       416 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~--~l~~~v~~~~~~~~~~~~~d  493 (586)
                      .. .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+..  ...+.+.+....+.      
T Consensus       163 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~------  235 (345)
T 3a8x_A          163 PG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ------  235 (345)
T ss_dssp             TT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCC------
T ss_pred             CC-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCC------
Confidence            22 2344568999999999999999999999999999999999999999753322110  11111222211111      


Q ss_pred             CCCCccccHHHHHHHHHHHHHhcccCCCCCCCH------HHHHH
Q 007869          494 PNLGTEYVAEELELVLKLGLLCSHSDPTARPSM------RQVVQ  531 (586)
Q Consensus       494 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~------~evl~  531 (586)
                      ..+...    ....+.+++.+||+.||.+||++      .|+++
T Consensus       236 ~~~p~~----~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~  275 (345)
T 3a8x_A          236 IRIPRS----LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG  275 (345)
T ss_dssp             CCCCTT----SCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHT
T ss_pred             CCCCCC----CCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhc
Confidence            111111    23457788889999999999995      56653

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1e-41  Score=344.15  Aligned_cols=252  Identities=23%  Similarity=0.321  Sum_probs=207.0

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc--cchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEE
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY  337 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  337 (586)
                      .++|+..+.||+|+||.||+|.+..++..||+|++...  .....+.+.+|+.++++++||||+++++++...+..++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            47899999999999999999999999999999999654  3344577899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCC---eEEccccceeecc
Q 007869          338 DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELN---GRLGDFGLARLYD  414 (586)
Q Consensus       338 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~---~kL~DFGla~~~~  414 (586)
                      ||+++++|.+.+...  ..+++..+..++.|++.||.|||+   .+|+||||||+||+++.++.   +||+|||++....
T Consensus        85 e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~  159 (284)
T 3kk8_A           85 DLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN  159 (284)
T ss_dssp             CCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             ecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence            999999999988765  358899999999999999999998   89999999999999986655   9999999998765


Q ss_pred             CCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCC
Q 007869          415 HGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDP  494 (586)
Q Consensus       415 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~  494 (586)
                      ...  ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+   ....    ...+... ...+
T Consensus       160 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~---~~~~----~~~~~~~-~~~~  229 (284)
T 3kk8_A          160 DSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR---LYAQ----IKAGAYD-YPSP  229 (284)
T ss_dssp             SSC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHH----HHHTCCC-CCTT
T ss_pred             cCc--cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH---HHHH----HHhcccc-CCch
Confidence            432  2334679999999999999999999999999999999999999997643221   1111    1111111 0111


Q ss_pred             CCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          495 NLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       495 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      .. .    .....+.+++.+||+.||++|||+.|+++
T Consensus       230 ~~-~----~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          230 EW-D----TVTPEAKSLIDSMLTVNPKKRITADQALK  261 (284)
T ss_dssp             TT-T----TSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             hh-c----ccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            10 1    12245778889999999999999999986

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=8.6e-43  Score=357.60  Aligned_cols=255  Identities=22%  Similarity=0.331  Sum_probs=197.6

Q ss_pred             hcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc---cchhHHHHHHHHHHhcccCCCceeeeeeeeeccC----
Q 007869          259 ATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKG----  331 (586)
Q Consensus       259 a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~----  331 (586)
                      ..++|+..+.||+|+||.||+|++..+++.||||++...   .......+.+|++++++++||||+++++++....    
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~   89 (311)
T 3ork_A           10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP   89 (311)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred             ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence            346899999999999999999999889999999999764   2334567899999999999999999999987654    


Q ss_pred             eEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEcccccee
Q 007869          332 ELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR  411 (586)
Q Consensus       332 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~  411 (586)
                      ..++||||+++++|.+++....  .+++.+++.++.|+++||.|||+   ++|+||||||+|||++.++.+||+|||+++
T Consensus        90 ~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  164 (311)
T 3ork_A           90 LPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIAR  164 (311)
T ss_dssp             EEEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred             ccEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence            3499999999999999997653  58899999999999999999998   899999999999999999999999999998


Q ss_pred             eccCCCC--CceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccc
Q 007869          412 LYDHGTD--PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELL  489 (586)
Q Consensus       412 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~  489 (586)
                      .......  .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+      ............
T Consensus       165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~------~~~~~~~~~~~~  238 (311)
T 3ork_A          165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS------VAYQHVREDPIP  238 (311)
T ss_dssp             -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHCCCCC
T ss_pred             cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHhcCCCCC
Confidence            7654322  12334579999999999999999999999999999999999999997643321      111111111100


Q ss_pred             cccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          490 EARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       490 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      .       ..........+.+++.+||+.||++||+..++++
T Consensus       239 ~-------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~  273 (311)
T 3ork_A          239 P-------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMR  273 (311)
T ss_dssp             H-------HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred             c-------ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHH
Confidence            0       0001112356778899999999999998766654

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=3.1e-42  Score=356.03  Aligned_cols=251  Identities=23%  Similarity=0.264  Sum_probs=183.4

Q ss_pred             ceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccC-CCceeeeeeeeeccCeEEEEEecCCCCC
Q 007869          266 KELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLR-HRNLVQLLGYCRRKGELLLVYDYMPNGS  344 (586)
Q Consensus       266 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~~~~~~~~~~~lV~E~~~~gs  344 (586)
                      .+.||+|+||.||+|++..++..||||++...   ....+.+|+.++.+++ ||||+++++++.+.+..++||||+++|+
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~   92 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE   92 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence            47899999999999999999999999999653   3466788999999997 9999999999999999999999999999


Q ss_pred             hhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCC---CeEEccccceeeccCCCCCce
Q 007869          345 LDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGEL---NGRLGDFGLARLYDHGTDPQT  421 (586)
Q Consensus       345 L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~---~~kL~DFGla~~~~~~~~~~~  421 (586)
                      |.+++...  ..+++.++..++.|++.||.|||+   ++|+||||||+|||++.++   .+||+|||+++....... ..
T Consensus        93 L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~-~~  166 (325)
T 3kn6_A           93 LFERIKKK--KHFSETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-PL  166 (325)
T ss_dssp             HHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred             HHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC-cc
Confidence            99999875  368999999999999999999998   8999999999999997665   899999999987654322 23


Q ss_pred             eeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCcccc
Q 007869          422 THVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYV  501 (586)
Q Consensus       422 ~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~  501 (586)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.||..............+......+..      ....+..
T Consensus       167 ~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~------~~~~~~~  240 (325)
T 3kn6_A          167 KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDF------SFEGEAW  240 (325)
T ss_dssp             -----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCC------CCCSHHH
T ss_pred             cccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCC------CCCcccc
Confidence            4457899999999999999999999999999999999999999865432211111112222222211      1111111


Q ss_pred             HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          502 AEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       502 ~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      ......+.+++.+||+.||.+|||+.|+++
T Consensus       241 ~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          241 KNVSQEAKDLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             HTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred             cCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence            223456788999999999999999999874

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=6.5e-42  Score=350.45  Aligned_cols=265  Identities=25%  Similarity=0.306  Sum_probs=202.9

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc--chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEe
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES--RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYD  338 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E  338 (586)
                      ++|+..+.||+|+||.||+|++..++..||||++....  ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            57899999999999999999999889999999986543  2335678899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCC
Q 007869          339 YMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD  418 (586)
Q Consensus       339 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~  418 (586)
                      |+++++|.+++...  ..+++..+..++.|+++||.|||+   .+|+||||||+|||++.++.+||+|||+++.......
T Consensus        83 ~~~~~~l~~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  157 (311)
T 4agu_A           83 YCDHTVLHELDRYQ--RGVPEHLVKSITWQTLQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD  157 (311)
T ss_dssp             CCSEEHHHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             eCCCchHHHHHhhh--cCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCccc
Confidence            99999999988654  358899999999999999999998   8999999999999999999999999999987653322


Q ss_pred             CceeeeccCCCccCcccccC-CCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHH--------HhhhccCccc
Q 007869          419 PQTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWV--------FDFWNRGELL  489 (586)
Q Consensus       419 ~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v--------~~~~~~~~~~  489 (586)
                       ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+........        ...+......
T Consensus       158 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (311)
T 4agu_A          158 -YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYF  236 (311)
T ss_dssp             ---------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGG
T ss_pred             -ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccc
Confidence             2334578999999999876 56899999999999999999999999875443322111110        0011111110


Q ss_pred             ---cccCCCCCccc---cHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          490 ---EARDPNLGTEY---VAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       490 ---~~~d~~l~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                         ...++......   .......+.+++.+||+.||.+|||++|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          237 SGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             TTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             ccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence               01111110000   0122345788999999999999999999986

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=3.9e-42  Score=348.82  Aligned_cols=264  Identities=25%  Similarity=0.455  Sum_probs=199.8

Q ss_pred             hhhhhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc--cchhHHHHHHHHHHhcccCCCceeeeeeeeeccCe
Q 007869          255 DLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGE  332 (586)
Q Consensus       255 el~~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~  332 (586)
                      ...+..++|+..+.||+|+||.||+|++.+   .||||++...  .....+.|.+|++++++++||||+++++++. .+.
T Consensus        18 ~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-~~~   93 (289)
T 3og7_A           18 DWEIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQ   93 (289)
T ss_dssp             CCBCCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSS
T ss_pred             CCccCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc-CCc
Confidence            344567789999999999999999998753   4999998754  3445678999999999999999999999764 456


Q ss_pred             EEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceee
Q 007869          333 LLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARL  412 (586)
Q Consensus       333 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~  412 (586)
                      .++||||+++++|.+++.... ..+++..++.++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++.
T Consensus        94 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~  169 (289)
T 3og7_A           94 LAIVTQWCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATE  169 (289)
T ss_dssp             CEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECCCC----
T ss_pred             cEEEEEecCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCCCEEEccceeccc
Confidence            899999999999999996553 468999999999999999999998   8999999999999999999999999999986


Q ss_pred             ccCCC-CCceeeeccCCCccCccccc---CCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCcc
Q 007869          413 YDHGT-DPQTTHVVGTLGYLAPEHTR---TGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGEL  488 (586)
Q Consensus       413 ~~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~  488 (586)
                      ..... ........||+.|+|||++.   ...++.++|||||||++|||++|+.||......+.  +.+    ....+..
T Consensus       170 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~----~~~~~~~  243 (289)
T 3og7_A          170 KSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--IIE----MVGRGSL  243 (289)
T ss_dssp             --------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH--HHH----HHHHTSC
T ss_pred             cccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH--HHH----Hhccccc
Confidence            54322 12234467999999999986   56788899999999999999999999976543221  111    1112211


Q ss_pred             ccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 007869          489 LEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERDV  537 (586)
Q Consensus       489 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  537 (586)
                      ..    .+ ..........+.+++.+||+.||.+|||+.++++.|+...
T Consensus       244 ~~----~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~  287 (289)
T 3og7_A          244 SP----DL-SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA  287 (289)
T ss_dssp             CC----CT-TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             Cc----ch-hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence            11    11 1111223356888999999999999999999999998643

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=4.3e-42  Score=358.67  Aligned_cols=246  Identities=22%  Similarity=0.273  Sum_probs=207.1

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc---chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEE
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLV  336 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV  336 (586)
                      .++|+..+.||+|+||.||++++..++..||||++....   ....+.+.+|+.++++++||||+++++++.+.+.+++|
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  119 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence            357899999999999999999999899999999996542   23457789999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCC
Q 007869          337 YDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHG  416 (586)
Q Consensus       337 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~  416 (586)
                      |||+++|+|.+++....  .+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++.....
T Consensus       120 ~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~  194 (350)
T 1rdq_E          120 MEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             EECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             EcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCcccccCccceEEECCCCCEEEcccccceeccCC
Confidence            99999999999997653  58889999999999999999998   99999999999999999999999999999976432


Q ss_pred             CCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCC
Q 007869          417 TDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNL  496 (586)
Q Consensus       417 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l  496 (586)
                          .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+   +.    .....+..      .+
T Consensus       195 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~~----~~i~~~~~------~~  257 (350)
T 1rdq_E          195 ----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ---IY----EKIVSGKV------RF  257 (350)
T ss_dssp             ----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH----HHHHHCCC------CC
T ss_pred             ----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH---HH----HHHHcCCC------CC
Confidence                334679999999999999999999999999999999999999997643211   11    11111111      11


Q ss_pred             CccccHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 007869          497 GTEYVAEELELVLKLGLLCSHSDPTARPS-----MRQVVQ  531 (586)
Q Consensus       497 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~  531 (586)
                      ...+    ...+.+++.+||+.||.+||+     ++|+++
T Consensus       258 p~~~----~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          258 PSHF----SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             CTTC----CHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             CCCC----CHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence            1122    345778889999999999998     888875

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.8e-42  Score=354.95  Aligned_cols=268  Identities=25%  Similarity=0.373  Sum_probs=216.2

Q ss_pred             cchhhhhhhcCCcccceeEeecCceEEEEEEe-----CCCCeEEEEEEecccc-chhHHHHHHHHHHhccc-CCCceeee
Q 007869          251 FRYKDLYIATKGFREKELLGTGGFGRVYRGTL-----PKSQIEIAVKKISHES-RQGMKEFVAEIVSIGRL-RHRNLVQL  323 (586)
Q Consensus       251 ~~~~el~~a~~~f~~~~~LG~G~~g~Vy~~~~-----~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l  323 (586)
                      +...++....++|+..+.||+|+||.||+|++     ..++..||||++.... ....+.+.+|+.++.++ +||||+++
T Consensus        17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~   96 (316)
T 2xir_A           17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   96 (316)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence            44556667788999999999999999999984     3567889999997653 33456799999999999 79999999


Q ss_pred             eeeeeccC-eEEEEEecCCCCChhhhhhcCCC--------------ccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCC
Q 007869          324 LGYCRRKG-ELLLVYDYMPNGSLDKYLYDQPK--------------VTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRD  388 (586)
Q Consensus       324 ~~~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrD  388 (586)
                      ++++...+ ..++||||+++++|.+++.....              ..+++..++.++.|+++||.|||+   .+|+|||
T Consensus        97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~d  173 (316)
T 2xir_A           97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRD  173 (316)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH---TTCCCSC
T ss_pred             EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh---CCccccc
Confidence            99987654 58999999999999999987542              128899999999999999999998   8999999


Q ss_pred             CCCCCeeecCCCCeEEccccceeeccCCCCC-ceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCC
Q 007869          389 VKASNVLLDGELNGRLGDFGLARLYDHGTDP-QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQR  466 (586)
Q Consensus       389 Ikp~NIll~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~  466 (586)
                      |||+|||++.++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||++ |+.||..
T Consensus       174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~  253 (316)
T 2xir_A          174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  253 (316)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence            9999999999999999999999876543322 2334568999999999999999999999999999999998 9999976


Q ss_pred             CCCCccchhhHHHHhhhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 007869          467 QGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERD  536 (586)
Q Consensus       467 ~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  536 (586)
                      ....+..      ......+..     +.....    ....+.+++.+||+.||.+|||+.|+++.|+..
T Consensus       254 ~~~~~~~------~~~~~~~~~-----~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  308 (316)
T 2xir_A          254 VKIDEEF------CRRLKEGTR-----MRAPDY----TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  308 (316)
T ss_dssp             CCCSHHH------HHHHHHTCC-----CCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cchhHHH------HHHhccCcc-----CCCCCC----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            5433211      111111111     111111    224577888999999999999999999999764

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1e-42  Score=348.13  Aligned_cols=257  Identities=26%  Similarity=0.401  Sum_probs=209.3

Q ss_pred             hhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEE
Q 007869          258 IATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY  337 (586)
Q Consensus       258 ~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  337 (586)
                      ...++|+..+.||+|+||.||+|.+. ++..||+|++..... ..+.+.+|++++++++||||+++++++...+..++||
T Consensus         5 i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (267)
T 3t9t_A            5 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVT   82 (267)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             EchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEE
Confidence            34567889999999999999999986 466899999976543 3467999999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCC
Q 007869          338 DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT  417 (586)
Q Consensus       338 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~  417 (586)
                      ||+++++|.+++.... ..+++..++.++.|+++||.|||+   .+|+||||||+||+++.++.+||+|||+++......
T Consensus        83 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~  158 (267)
T 3t9t_A           83 EFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ  158 (267)
T ss_dssp             CCCTTCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred             eCCCCCcHHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEECCCCCEEEccccccccccccc
Confidence            9999999999997653 468899999999999999999998   899999999999999999999999999998654321


Q ss_pred             CCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccCccccccCCCC
Q 007869          418 DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNL  496 (586)
Q Consensus       418 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l  496 (586)
                      ........+|..|+|||++.+..++.++||||||+++|||++ |+.||......+   ....    ...+..  ...+. 
T Consensus       159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~----i~~~~~--~~~~~-  228 (267)
T 3t9t_A          159 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---VVED----ISTGFR--LYKPR-  228 (267)
T ss_dssp             HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHH----HHTTCC--CCCCT-
T ss_pred             ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH---HHHH----HhcCCc--CCCCc-
Confidence            112223457789999999998899999999999999999999 899997643221   1111    111110  11111 


Q ss_pred             CccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 007869          497 GTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERD  536 (586)
Q Consensus       497 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  536 (586)
                            .....+.+++.+||+.||++||++.++++.|+..
T Consensus       229 ------~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l  262 (267)
T 3t9t_A          229 ------LASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI  262 (267)
T ss_dssp             ------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ------cCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                  1234577889999999999999999999999763

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=2.5e-41  Score=342.93  Aligned_cols=262  Identities=18%  Similarity=0.221  Sum_probs=205.3

Q ss_pred             hcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeee-eccCeEEEEE
Q 007869          259 ATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYC-RRKGELLLVY  337 (586)
Q Consensus       259 a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~-~~~~~~~lV~  337 (586)
                      ..++|+..+.||+|+||.||+|++..++..||||++......  +.+..|++++.+++|++++..+.++ ...+..++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C--CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc--hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence            457899999999999999999999889999999987554322  4578899999999988877777765 5667889999


Q ss_pred             ecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeee---cCCCCeEEccccceeecc
Q 007869          338 DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLL---DGELNGRLGDFGLARLYD  414 (586)
Q Consensus       338 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll---~~~~~~kL~DFGla~~~~  414 (586)
                      ||+ +++|.+++.... ..+++..++.++.|++.||.|||+   ++|+||||||+|||+   +.++.+||+|||+++...
T Consensus        85 e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~  159 (296)
T 4hgt_A           85 ELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             ECC-CCBHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             Ecc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence            999 999999997543 368999999999999999999998   899999999999999   788999999999999765


Q ss_pred             CCCC------CceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCcc
Q 007869          415 HGTD------PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGEL  488 (586)
Q Consensus       415 ~~~~------~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~  488 (586)
                      ....      .......||+.|+|||++.+..++.++|||||||++|||++|+.||..............+.........
T Consensus       160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  239 (296)
T 4hgt_A          160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI  239 (296)
T ss_dssp             CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred             CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh
Confidence            5432      1223567999999999999999999999999999999999999999875544322222111111000000


Q ss_pred             ccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 007869          489 LEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERD  536 (586)
Q Consensus       489 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  536 (586)
                       ..        ........+.+++..||+.||++|||+.++++.|+..
T Consensus       240 -~~--------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~  278 (296)
T 4hgt_A          240 -EV--------LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  278 (296)
T ss_dssp             -HH--------HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred             -hh--------hhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHH
Confidence             00        0011135678899999999999999999999999764

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1e-42  Score=358.23  Aligned_cols=270  Identities=23%  Similarity=0.433  Sum_probs=218.3

Q ss_pred             ccchhhhhhhcCCcccceeEeecCceEEEEEEeC-----CCCeEEEEEEecccc-chhHHHHHHHHHHhcccCCCceeee
Q 007869          250 RFRYKDLYIATKGFREKELLGTGGFGRVYRGTLP-----KSQIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQL  323 (586)
Q Consensus       250 ~~~~~el~~a~~~f~~~~~LG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l  323 (586)
                      .+..+++....++|+..+.||+|+||.||+|++.     .++..||||++.... ......+.+|++++++++||||+++
T Consensus        14 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~   93 (322)
T 1p4o_A           14 VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRL   93 (322)
T ss_dssp             CCCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCE
T ss_pred             ccChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeee
Confidence            3455677788899999999999999999999875     356789999997543 3345679999999999999999999


Q ss_pred             eeeeeccCeEEEEEecCCCCChhhhhhcCC--------CccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCee
Q 007869          324 LGYCRRKGELLLVYDYMPNGSLDKYLYDQP--------KVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVL  395 (586)
Q Consensus       324 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIl  395 (586)
                      ++++...+..++||||+++|+|.+++....        ...+++..++.++.|++.||.|||+   ++|+||||||+|||
T Consensus        94 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~NIl  170 (322)
T 1p4o_A           94 LGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCM  170 (322)
T ss_dssp             EEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEE
T ss_pred             EEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCCccCCCccceEE
Confidence            999999999999999999999999997532        1356889999999999999999998   89999999999999


Q ss_pred             ecCCCCeEEccccceeeccCCCC-CceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccc
Q 007869          396 LDGELNGRLGDFGLARLYDHGTD-PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENL  473 (586)
Q Consensus       396 l~~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~  473 (586)
                      ++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+  
T Consensus       171 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--  248 (322)
T 1p4o_A          171 VAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ--  248 (322)
T ss_dssp             ECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH--
T ss_pred             EcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHH--
Confidence            99999999999999986543321 12233467889999999999999999999999999999999 889987643211  


Q ss_pred             hhhHHHHhhhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhccC
Q 007869          474 ILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERDVA  538 (586)
Q Consensus       474 ~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~  538 (586)
                       +..    ...++....     ...    .....+.+++.+||+.||.+|||+.|+++.|+....
T Consensus       249 -~~~----~~~~~~~~~-----~~~----~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          249 -VLR----FVMEGGLLD-----KPD----NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             -HHH----HHHTTCCCC-----CCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             -HHH----HHHcCCcCC-----CCC----CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence             111    111221111     111    223557788999999999999999999999987654

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=4.8e-42  Score=351.57  Aligned_cols=253  Identities=29%  Similarity=0.444  Sum_probs=198.7

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEec
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY  339 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  339 (586)
                      .++|+..+.||+|+||.||+|++.  +..||||++...  ...+.|.+|++++++++||||+++++++.+  ..++||||
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~   80 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEY   80 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEEC
T ss_pred             HhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEc
Confidence            457888999999999999999984  578999998644  345789999999999999999999999874  47999999


Q ss_pred             CCCCChhhhhhcCCC-ccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCC-eEEccccceeeccCCC
Q 007869          340 MPNGSLDKYLYDQPK-VTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELN-GRLGDFGLARLYDHGT  417 (586)
Q Consensus       340 ~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~-~kL~DFGla~~~~~~~  417 (586)
                      +++|+|.+++..... ..+++..++.++.|+++||.|||+...++|+||||||+|||++.++. +||+|||+++..... 
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-  159 (307)
T 2eva_A           81 AEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-  159 (307)
T ss_dssp             CTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--------
T ss_pred             CCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc-
Confidence            999999999986643 24778899999999999999999855478999999999999998886 799999999865432 


Q ss_pred             CCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCC
Q 007869          418 DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLG  497 (586)
Q Consensus       418 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~  497 (586)
                         .....||+.|+|||++.+..++.++|||||||++|||++|+.||........    ...+... .+.     .+...
T Consensus       160 ---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~----~~~~~~~-~~~-----~~~~~  226 (307)
T 2eva_A          160 ---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF----RIMWAVH-NGT-----RPPLI  226 (307)
T ss_dssp             --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH----HHHHHHH-TTC-----CCCCB
T ss_pred             ---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH----HHHHHHh-cCC-----CCCcc
Confidence               2334689999999999999999999999999999999999999976433211    1111111 111     11111


Q ss_pred             ccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 007869          498 TEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERD  536 (586)
Q Consensus       498 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  536 (586)
                      ..    ....+.+++.+||+.||++|||+.++++.|+..
T Consensus       227 ~~----~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  261 (307)
T 2eva_A          227 KN----LPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHL  261 (307)
T ss_dssp             TT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cc----cCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            11    234577889999999999999999999999764

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=4.2e-41  Score=341.58  Aligned_cols=262  Identities=18%  Similarity=0.218  Sum_probs=208.8

Q ss_pred             hcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeee-eccCeEEEEE
Q 007869          259 ATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYC-RRKGELLLVY  337 (586)
Q Consensus       259 a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~-~~~~~~~lV~  337 (586)
                      ..++|+..+.||+|+||.||+|++..+++.||||++......  +.+.+|+.++++++|++++..+.++ ...+..++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 3uzp_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC--CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch--hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence            357899999999999999999999889999999998655432  4688999999999998877766665 5667889999


Q ss_pred             ecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeee---cCCCCeEEccccceeecc
Q 007869          338 DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLL---DGELNGRLGDFGLARLYD  414 (586)
Q Consensus       338 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll---~~~~~~kL~DFGla~~~~  414 (586)
                      ||+ +++|.+++.... ..+++..++.++.|++.||.|||+   ++|+||||||+|||+   +.++.+||+|||+++...
T Consensus        85 e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~  159 (296)
T 3uzp_A           85 ELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             ECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             Eec-CCCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence            999 999999997543 468999999999999999999998   899999999999999   488899999999999766


Q ss_pred             CCCCC------ceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCcc
Q 007869          415 HGTDP------QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGEL  488 (586)
Q Consensus       415 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~  488 (586)
                      .....      ......||+.|+|||++.+..++.++|||||||++|||++|+.||..............+.........
T Consensus       160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  239 (296)
T 3uzp_A          160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI  239 (296)
T ss_dssp             CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred             ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch
Confidence            54321      224567999999999999999999999999999999999999999875443322222111111000000


Q ss_pred             ccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 007869          489 LEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERD  536 (586)
Q Consensus       489 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  536 (586)
                       ...        .......+.+++.+||+.||.+||++.++++.|+..
T Consensus       240 -~~~--------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~  278 (296)
T 3uzp_A          240 -EVL--------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  278 (296)
T ss_dssp             -HHH--------TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred             -HHH--------HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHH
Confidence             000        011225678899999999999999999999999764

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=4e-42  Score=360.50  Aligned_cols=256  Identities=22%  Similarity=0.260  Sum_probs=196.8

Q ss_pred             hhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEE
Q 007869          258 IATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY  337 (586)
Q Consensus       258 ~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  337 (586)
                      ...++|+..+.||+|+||.||+++...++..||||++..... ..+.+.+|+.++++++||||+++++++...+..++||
T Consensus        17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~   95 (361)
T 3uc3_A           17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIM   95 (361)
T ss_dssp             CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEE
Confidence            345789999999999999999999998999999999975432 3367889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCC--eEEccccceeeccC
Q 007869          338 DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELN--GRLGDFGLARLYDH  415 (586)
Q Consensus       338 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~--~kL~DFGla~~~~~  415 (586)
                      ||+++|+|.+++....  .+++..++.++.|++.||.|||+   ++|+||||||+|||++.++.  +||+|||+++....
T Consensus        96 e~~~~~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~---~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~  170 (361)
T 3uc3_A           96 EYASGGELYERICNAG--RFSEDEARFFFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL  170 (361)
T ss_dssp             ECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTCCSCCCCGGGEEECSSSSCCEEECCCCCC-----
T ss_pred             EeCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCceEEEeecCccccccc
Confidence            9999999999997643  58899999999999999999998   99999999999999987765  99999999985332


Q ss_pred             CCCCceeeeccCCCccCcccccCCCCCCc-ceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCC
Q 007869          416 GTDPQTTHVVGTLGYLAPEHTRTGKATTS-ADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDP  494 (586)
Q Consensus       416 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~k-sDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~  494 (586)
                      ..  ......||+.|+|||++.+..++.+ +|||||||++|||++|+.||.........  ...+..... .....   |
T Consensus       171 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~--~~~~~~~~~-~~~~~---~  242 (361)
T 3uc3_A          171 HS--QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDY--RKTIQRILS-VKYSI---P  242 (361)
T ss_dssp             ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCH--HHHHHHHHT-TCCCC---C
T ss_pred             cC--CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHH--HHHHHHHhc-CCCCC---C
Confidence            22  2344579999999999988887665 89999999999999999999865443322  111111111 11000   0


Q ss_pred             CCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          495 NLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       495 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                      . ...    ....+.+++.+||+.||++|||+.|+++.
T Consensus       243 ~-~~~----~s~~~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          243 D-DIR----ISPECCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             T-TSC----CCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             C-cCC----CCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence            0 001    12456788999999999999999999863

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.3e-41  Score=347.94  Aligned_cols=270  Identities=26%  Similarity=0.356  Sum_probs=203.7

Q ss_pred             hhhhhhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcc--cCCCceeeeeeeeecc-
Q 007869          254 KDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGR--LRHRNLVQLLGYCRRK-  330 (586)
Q Consensus       254 ~el~~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~--l~H~niv~l~~~~~~~-  330 (586)
                      ..-....++|+..+.||+|+||.||+|++.  +..||||++.....   ..+..|.+++..  ++||||+++++++... 
T Consensus        30 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~  104 (337)
T 3mdy_A           30 LVQRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEE---ASWFRETEIYQTVLMRHENILGFIAADIKGT  104 (337)
T ss_dssp             HHHTTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEESC
T ss_pred             ccccccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecccc---chhhhHHHHHHHHhhcCCCeeeEEEEEccCC
Confidence            333445578999999999999999999985  77899999864432   334445555444  5999999999999877 


Q ss_pred             ---CeEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhccc-----CCcEEeCCCCCCCeeecCCCCe
Q 007869          331 ---GELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEW-----EQVVIHRDVKASNVLLDGELNG  402 (586)
Q Consensus       331 ---~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-----~~~ivHrDIkp~NIll~~~~~~  402 (586)
                         ...++||||+++|+|.+++...   .+++..++.++.|++.||.|||+..     ..+|+||||||+|||++.++.+
T Consensus       105 ~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~  181 (337)
T 3mdy_A          105 GSWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTC  181 (337)
T ss_dssp             GGGCEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCE
T ss_pred             CCCCceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCE
Confidence               7899999999999999999765   5899999999999999999999820     1299999999999999999999


Q ss_pred             EEccccceeeccCCCCC---ceeeeccCCCccCcccccCCCCCCc------ceEEehhHHHHHHHhC----------CCC
Q 007869          403 RLGDFGLARLYDHGTDP---QTTHVVGTLGYLAPEHTRTGKATTS------ADVFSFGAFLLEVACG----------RRP  463 (586)
Q Consensus       403 kL~DFGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~s~k------sDVyS~Gvvl~ElltG----------~~p  463 (586)
                      ||+|||+++.+......   ......||+.|+|||++.+...+.+      +|||||||++|||++|          +.|
T Consensus       182 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p  261 (337)
T 3mdy_A          182 CIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP  261 (337)
T ss_dssp             EECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred             EEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccccc
Confidence            99999999876543221   1224579999999999988776665      9999999999999999          556


Q ss_pred             CCCCCCCccchhhHHHHhhhccCccccccCCCCCccc-cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 007869          464 IQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEY-VAEELELVLKLGLLCSHSDPTARPSMRQVVQILERDV  537 (586)
Q Consensus       464 ~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  537 (586)
                      |..........  .......    ......+.....+ .......+.+++.+||+.||.+|||+.|+++.|+...
T Consensus       262 ~~~~~~~~~~~--~~~~~~~----~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~  330 (337)
T 3mdy_A          262 YHDLVPSDPSY--EDMREIV----CIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMS  330 (337)
T ss_dssp             TTTTSCSSCCH--HHHHHHH----TTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HhhhcCCCCch--hhhHHHH----hhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHH
Confidence            55433222110  0111111    1111223222222 2356778999999999999999999999999998643

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.1e-41  Score=362.15  Aligned_cols=252  Identities=22%  Similarity=0.277  Sum_probs=194.2

Q ss_pred             CCcccc-eeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcc-cCCCceeeeeeeeec----cCeEE
Q 007869          261 KGFREK-ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGR-LRHRNLVQLLGYCRR----KGELL  334 (586)
Q Consensus       261 ~~f~~~-~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~-l~H~niv~l~~~~~~----~~~~~  334 (586)
                      ++|... ++||+|+||+||+|.+..++..||||++...     ..+.+|++++.+ .+||||+++++++..    .+.++
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~  135 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL  135 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence            456555 7899999999999999999999999999632     456788888755 489999999998875    56799


Q ss_pred             EEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecC---CCCeEEcccccee
Q 007869          335 LVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDG---ELNGRLGDFGLAR  411 (586)
Q Consensus       335 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~---~~~~kL~DFGla~  411 (586)
                      |||||+++|+|.+++.......+++..+..|+.||+.||.|||+   .+|+||||||+|||++.   ++.+||+|||+++
T Consensus       136 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~  212 (400)
T 1nxk_A          136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK  212 (400)
T ss_dssp             EEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             EEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCcceEEEecCCCCccEEEEeccccc
Confidence            99999999999999987655679999999999999999999998   89999999999999987   7899999999998


Q ss_pred             eccCCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccc-hhhHHHHhhhccCcccc
Q 007869          412 LYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENL-ILVDWVFDFWNRGELLE  490 (586)
Q Consensus       412 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~-~l~~~v~~~~~~~~~~~  490 (586)
                      ......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||......... .....    ...+... 
T Consensus       213 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~----i~~~~~~-  285 (400)
T 1nxk_A          213 ETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR----IRMGQYE-  285 (400)
T ss_dssp             ECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHH----HHHTCCC-
T ss_pred             ccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHH----HHcCccc-
Confidence            754322  234567899999999999999999999999999999999999999865433211 01111    1111111 


Q ss_pred             ccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          491 ARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       491 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                      ...+..     ......+.+++.+||+.||++|||+.|+++.
T Consensus       286 ~~~~~~-----~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  322 (400)
T 1nxk_A          286 FPNPEW-----SEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  322 (400)
T ss_dssp             CCTTTT-----TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             CCCccc-----ccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            001110     1123457788999999999999999999974

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=7.2e-42  Score=350.53  Aligned_cols=260  Identities=23%  Similarity=0.261  Sum_probs=201.9

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc---chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEE
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLV  336 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV  336 (586)
                      -++|+..+.||+|+||.||+|++..++..||||++....   ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence            367999999999999999999999889999999997642   23347789999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCC
Q 007869          337 YDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHG  416 (586)
Q Consensus       337 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~  416 (586)
                      |||+++++|.+++...  ..+++.+++.++.|+++||.|||+   .+|+||||||+|||++.++.+||+|||++......
T Consensus       113 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  187 (309)
T 2h34_A          113 MRLINGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAHA---AGATHRDVKPENILVSADDFAYLVDFGIASATTDE  187 (309)
T ss_dssp             EECCCCEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred             EEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CcCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence            9999999999999765  358899999999999999999998   89999999999999999999999999999876544


Q ss_pred             CCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCC
Q 007869          417 TDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNL  496 (586)
Q Consensus       417 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l  496 (586)
                      .........||+.|+|||++.+..++.++||||||+++|||++|+.||......       ...........    .+  
T Consensus       188 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~~~----~~--  254 (309)
T 2h34_A          188 KLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-------VMGAHINQAIP----RP--  254 (309)
T ss_dssp             ---------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-------HHHHHHHSCCC----CG--
T ss_pred             ccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-------HHHHHhccCCC----Cc--
Confidence            333334567999999999999999999999999999999999999999754221       11111111100    00  


Q ss_pred             CccccHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHhhccC
Q 007869          497 GTEYVAEELELVLKLGLLCSHSDPTARP-SMRQVVQILERDVA  538 (586)
Q Consensus       497 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~evl~~L~~~~~  538 (586)
                       ..........+.+++.+||+.||++|| +++++++.|+....
T Consensus       255 -~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~  296 (309)
T 2h34_A          255 -STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALA  296 (309)
T ss_dssp             -GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC
T ss_pred             -cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHH
Confidence             011112234577889999999999999 99999999987654

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.7e-42  Score=360.94  Aligned_cols=251  Identities=24%  Similarity=0.358  Sum_probs=206.1

Q ss_pred             hhhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc---chhHHHHHHHHHHhccc-CCCceeeeeeeeeccCe
Q 007869          257 YIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES---RQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKGE  332 (586)
Q Consensus       257 ~~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~~~  332 (586)
                      ....++|...+.||+|+||+||+|+++.+++.||||++....   ....+.+..|..++.++ +||||+++++++...+.
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~   92 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN   92 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence            345678999999999999999999999999999999997642   33456788899999887 99999999999999999


Q ss_pred             EEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceee
Q 007869          333 LLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARL  412 (586)
Q Consensus       333 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~  412 (586)
                      +++||||+++|+|.+++...  ..+++.++..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++.
T Consensus        93 ~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~  167 (345)
T 1xjd_A           93 LFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKE  167 (345)
T ss_dssp             EEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence            99999999999999999764  358889999999999999999998   8999999999999999999999999999986


Q ss_pred             ccCCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCcccccc
Q 007869          413 YDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEAR  492 (586)
Q Consensus       413 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~  492 (586)
                      ..... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......+   +...    ...+      
T Consensus       168 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~~~~----i~~~------  233 (345)
T 1xjd_A          168 NMLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE---LFHS----IRMD------  233 (345)
T ss_dssp             CCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHH----HHHC------
T ss_pred             cccCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH---HHHH----HHhC------
Confidence            43222 23445689999999999999999999999999999999999999997643321   1111    1111      


Q ss_pred             CCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 007869          493 DPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMR-QVV  530 (586)
Q Consensus       493 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~-evl  530 (586)
                      .+.....    ....+.+++.+||+.||++||++. +++
T Consensus       234 ~~~~p~~----~s~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          234 NPFYPRW----LEKEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             CCCCCTT----SCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             CCCCCcc----cCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence            1111111    224577888999999999999997 665

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.6e-42  Score=356.94  Aligned_cols=260  Identities=24%  Similarity=0.384  Sum_probs=203.6

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeE----EEEEEeccc-cchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEE
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIE----IAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELL  334 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~----vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~  334 (586)
                      .++|+..+.||+|+||.||+|++..++..    ||+|.+... .....+.+.+|+.++++++||||++++++|...+ .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~   92 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence            46799999999999999999998776654    477777543 3445678999999999999999999999998765 78


Q ss_pred             EEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeecc
Q 007869          335 LVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYD  414 (586)
Q Consensus       335 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~  414 (586)
                      +|+||+++|+|.+++.... ..+++..++.++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++...
T Consensus        93 ~v~~~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~  168 (327)
T 3lzb_A           93 LITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             EEECCCSSCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred             EEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhh---CCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence            9999999999999998753 468899999999999999999998   899999999999999999999999999998765


Q ss_pred             CCCCC-ceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccCcccccc
Q 007869          415 HGTDP-QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEAR  492 (586)
Q Consensus       415 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~  492 (586)
                      ..... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+   +...+    ..+..    
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~~~~----~~~~~----  237 (327)
T 3lzb_A          169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSIL----EKGER----  237 (327)
T ss_dssp             -----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHHH----HTTCC----
T ss_pred             CccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HHHHH----HcCCC----
Confidence            43221 2233457889999999999999999999999999999999 999998654432   11111    11111    


Q ss_pred             CCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhccCCC
Q 007869          493 DPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERDVALP  540 (586)
Q Consensus       493 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~p  540 (586)
                       +..    .......+.+++.+||+.||.+||++.|+++.|+....-|
T Consensus       238 -~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  280 (327)
T 3lzb_A          238 -LPQ----PPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARDP  280 (327)
T ss_dssp             -CCC----CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTSH
T ss_pred             -CCC----CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhCc
Confidence             111    1112345778889999999999999999999998766543

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=3.7e-42  Score=353.26  Aligned_cols=274  Identities=23%  Similarity=0.231  Sum_probs=214.4

Q ss_pred             CCcccchhhhhhhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeee
Q 007869          247 GPHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGY  326 (586)
Q Consensus       247 ~~~~~~~~el~~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~  326 (586)
                      +...++-+.+....++|+..+.||+|+||.||+++...++..||||++........+.+.+|++++++++||||++++++
T Consensus        15 ~~~~~~g~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   94 (317)
T 2buj_A           15 ENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAY   94 (317)
T ss_dssp             -CCSEEEEEEEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEE
T ss_pred             cceeecccEEEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence            33444555566677889999999999999999999988899999999977666677889999999999999999999999


Q ss_pred             ee----ccCeEEEEEecCCCCChhhhhhcC--CCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCC
Q 007869          327 CR----RKGELLLVYDYMPNGSLDKYLYDQ--PKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGEL  400 (586)
Q Consensus       327 ~~----~~~~~~lV~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~  400 (586)
                      +.    .....++||||+++|+|.+++...  ....+++.+++.++.|+++||.|||+   .+|+||||||+|||++.++
T Consensus        95 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dlkp~NIl~~~~~  171 (317)
T 2buj_A           95 CLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEG  171 (317)
T ss_dssp             EEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTS
T ss_pred             EEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCC
Confidence            87    345789999999999999998752  23568999999999999999999998   8999999999999999999


Q ss_pred             CeEEccccceeeccCCCCC--------ceeeeccCCCccCcccccCCC---CCCcceEEehhHHHHHHHhCCCCCCCCCC
Q 007869          401 NGRLGDFGLARLYDHGTDP--------QTTHVVGTLGYLAPEHTRTGK---ATTSADVFSFGAFLLEVACGRRPIQRQGP  469 (586)
Q Consensus       401 ~~kL~DFGla~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~s~ksDVyS~Gvvl~ElltG~~p~~~~~~  469 (586)
                      .+||+|||+++........        ......||+.|+|||++....   ++.++|||||||++|||++|+.||.....
T Consensus       172 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~  251 (317)
T 2buj_A          172 QPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQ  251 (317)
T ss_dssp             CEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHH
T ss_pred             CEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhc
Confidence            9999999998864321110        012345799999999987554   68999999999999999999999964211


Q ss_pred             CccchhhHHHHhhhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 007869          470 SENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERDV  537 (586)
Q Consensus       470 ~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  537 (586)
                      .... .....    .. ...   .+ .    .......+.+++.+||+.||.+||++.++++.|+...
T Consensus       252 ~~~~-~~~~~----~~-~~~---~~-~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~  305 (317)
T 2buj_A          252 KGDS-VALAV----QN-QLS---IP-Q----SPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ  305 (317)
T ss_dssp             TTSC-HHHHH----HC-C-----CC-C----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred             ccch-hhHHh----hc-cCC---CC-c----cccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence            1100 11000    01 000   01 0    1112356788899999999999999999999998754

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=9.3e-42  Score=357.92  Aligned_cols=268  Identities=18%  Similarity=0.197  Sum_probs=206.0

Q ss_pred             hhcCCcccceeEeecCceEEEEEEeCCC-----CeEEEEEEeccccchh-----------HHHHHHHHHHhcccCCCcee
Q 007869          258 IATKGFREKELLGTGGFGRVYRGTLPKS-----QIEIAVKKISHESRQG-----------MKEFVAEIVSIGRLRHRNLV  321 (586)
Q Consensus       258 ~a~~~f~~~~~LG~G~~g~Vy~~~~~~~-----~~~vavK~~~~~~~~~-----------~~~~~~Ei~~l~~l~H~niv  321 (586)
                      ...++|+..+.||+|+||.||+|.+..+     +..||||++.......           ...+..|+..+.+++||||+
T Consensus        32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv  111 (364)
T 3op5_A           32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP  111 (364)
T ss_dssp             TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred             cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence            3566899999999999999999998764     4789999987654221           12345567778888999999


Q ss_pred             eeeeeeecc----CeEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeec
Q 007869          322 QLLGYCRRK----GELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLD  397 (586)
Q Consensus       322 ~l~~~~~~~----~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~  397 (586)
                      ++++++...    ...+|||||+ +++|.+++... ...+++..++.|+.||+.||.|||+   ++|+||||||+|||++
T Consensus       112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~---~~iiHrDlkp~Nill~  186 (364)
T 3op5_A          112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIHE---HEYVHGDIKASNLLLN  186 (364)
T ss_dssp             CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEE
T ss_pred             eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeEEecCCHHHEEEe
Confidence            999998764    4589999999 99999999775 3469999999999999999999998   8999999999999999


Q ss_pred             --CCCCeEEccccceeeccCCCCC------ceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCC
Q 007869          398 --GELNGRLGDFGLARLYDHGTDP------QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGP  469 (586)
Q Consensus       398 --~~~~~kL~DFGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~  469 (586)
                        .++.+||+|||+++.+......      ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus       187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~  266 (364)
T 3op5_A          187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK  266 (364)
T ss_dssp             SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred             cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence              8899999999999876533211      12345699999999999999999999999999999999999999986433


Q ss_pred             CccchhhHHHHhhhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 007869          470 SENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERD  536 (586)
Q Consensus       470 ~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  536 (586)
                      ...  ...+....+. ..+....++.+..   ......+.+++..||+.||.+||++.++++.|+..
T Consensus       267 ~~~--~~~~~~~~~~-~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~  327 (364)
T 3op5_A          267 DPK--YVRDSKIRYR-ENIASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQG  327 (364)
T ss_dssp             CHH--HHHHHHHHHH-HCHHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             CHH--HHHHHHHHhh-hhHHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Confidence            221  1111111111 1111111111110   11135677888899999999999999999998764

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.4e-41  Score=346.20  Aligned_cols=264  Identities=25%  Similarity=0.377  Sum_probs=207.2

Q ss_pred             cCCcccceeEeecCceEEEEEE----eCCCCeEEEEEEecccc-chhHHHHHHHHHHhcccCCCceeeeeeeeecc--Ce
Q 007869          260 TKGFREKELLGTGGFGRVYRGT----LPKSQIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRK--GE  332 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~----~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~--~~  332 (586)
                      .+.|+..+.||+|+||.||+|+    ...++..||||++.... ....+.+.+|++++++++||||+++++++...  +.
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   99 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG   99 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred             hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence            3458889999999999999999    46678999999997543 34457899999999999999999999999876  66


Q ss_pred             EEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceee
Q 007869          333 LLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARL  412 (586)
Q Consensus       333 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~  412 (586)
                      .++||||+++++|.+++.... ..+++..++.++.|++.||.|||+   ++|+||||||+|||++.++.+||+|||+++.
T Consensus       100 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  175 (302)
T 4e5w_A          100 IKLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKA  175 (302)
T ss_dssp             EEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhc---CCcccCCCchheEEEcCCCCEEECccccccc
Confidence            899999999999999996543 358999999999999999999998   8999999999999999999999999999997


Q ss_pred             ccCCCCC--ceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCC--------CCccchhhHHHHhh
Q 007869          413 YDHGTDP--QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQG--------PSENLILVDWVFDF  482 (586)
Q Consensus       413 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~--------~~~~~~l~~~v~~~  482 (586)
                      .......  ......||..|+|||++.+..++.++|||||||++|||++|+.|+....        +.........+...
T Consensus       176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (302)
T 4e5w_A          176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT  255 (302)
T ss_dssp             CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHH
T ss_pred             ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHH
Confidence            7654321  2234568889999999999999999999999999999999999864321        00000001111111


Q ss_pred             hccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 007869          483 WNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERD  536 (586)
Q Consensus       483 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  536 (586)
                      ...+.     ...    ........+.+++.+||+.||.+|||+.++++.|+..
T Consensus       256 ~~~~~-----~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  300 (302)
T 4e5w_A          256 LKEGK-----RLP----CPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL  300 (302)
T ss_dssp             HHTTC-----CCC----CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HhccC-----CCC----CCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence            11111     111    1122335678899999999999999999999999763

>1ioa_A Arcelin-5A, ARC5A; lectin-like proteins, plant defense proteins, lectin; HET: NAG FUC; 2.70A {Phaseolus vulgaris} SCOP: b.29.1.1

Probab=100.00  E-value=5.8e-42  Score=333.49  Aligned_cols=160  Identities=28%  Similarity=0.428  Sum_probs=142.1

Q ss_pred             CcccCCCCCCCCCCeeeeeEEEEEEEEEeCCCCCCCCcEEEEEecCCCCCCCCCCCcccccccCCCCCCCccEEEEEeec
Q 007869            2 PFKNKNSNSSTANGTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGLFNDTNLGNETNHVFAVELDT   81 (586)
Q Consensus         2 p~~~~~~~~~~~~~~~asF~t~F~f~i~~~~~~~~g~GlaF~l~p~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEfDt   81 (586)
                      ||++|++.      +++||+|+|+|.|.+.+...+||||||+|+|....|. ++|+||||||.+ ++++.||+|||||||
T Consensus        55 Pi~l~d~~------~vaSFsT~F~F~I~~~~~~~~gdGlAF~l~p~~~~p~-~~g~~LGL~n~~-~~~~~~~~vAVEFDT  126 (240)
T 1ioa_A           55 PIQIKDSN------NVASFNTNFTFIIRAKNQSISAYGLAFALVPVNSPPQ-KKQEFLGIFNTN-NPEPNARTVAVVFNT  126 (240)
T ss_dssp             CEECBCSS------CBEEEEEEEEEECCBSCTTSCCEEEEEEEEETTCCCC-CCGGGTTTCCCS-SCCGGGCCEEEEEET
T ss_pred             CEEccCCC------ccccEEEEEEEEEeCCCCCCCCCcEEEEEecCCCCCC-CCCCcccccccC-CCCCcCcEEEEEecC
Confidence            89999873      5999999999999987777899999999999876666 889999999976 457789999999999


Q ss_pred             cccCCCCCCCCCeeEEeCCCCcccccccC----------ceEEEEcCeeeEEEEEEeecCCCCCCccceeeeeecchhcc
Q 007869           82 IKSHGFLDINDNHVGIDINSLKSESSAPA----------GYYVEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSVL  151 (586)
Q Consensus        82 ~~~~~~~d~~~~hvgidvns~~s~~~~~~----------~~~i~y~~~~~~l~v~~~~~~~~~~~~~~~ls~~~dL~~~l  151 (586)
                      +         +|||||||||+.|.+++++          ..||+||+.+++|+|++++.+.  +.. |+|++.+||+++|
T Consensus       127 ~---------~nHVGIdvNs~~S~~t~~~~~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~--~~~-~~ls~~vdL~~~l  194 (240)
T 1ioa_A          127 F---------KNRIDFDKNFIKPYVNENCDFHKYNGEKTDVQITYDSSNNDLRVFLHFTVS--QVK-CSVSATVHLEKEV  194 (240)
T ss_dssp             T---------TTEEEEEESSSSCSEEEECCHHHHCSSCEEEEEEEETTTTEEEEEEEETTT--CCE-EEEEEECCGGGTS
T ss_pred             c---------CCceeeeeCCccccccccCCccccCCCEEEEEEEEeCCCcEEEEEEecCCC--Ccc-ceeEEEechHHhC
Confidence            8         6999999999999877653          3699999999999999987643  334 8999999999999


Q ss_pred             ccceeeeeecCCCcc---ceeeeeeeccccccC
Q 007869          152 NDAMYVGFSSSTGSV---LASHYILGWSFKING  181 (586)
Q Consensus       152 ~~~~~vGFsastg~~---~~~~~i~~Wsf~~~~  181 (586)
                      ||+||||||||||..   .|.|+|++|+|++++
T Consensus       195 ~e~v~VGFSAsTG~~~~~~~~H~IlsWsF~s~~  227 (240)
T 1ioa_A          195 DEWVSVGFSPTSGLTEDTTETHDVLSWSFSSKF  227 (240)
T ss_dssp             CSEEEEEEEEEECSSTTTCBCCEEEEEEEEEEE
T ss_pred             CCceEEEEEeccCCCCcccceeEEEEEEEEeeC
Confidence            999999999999998   999999999999864

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.4e-41  Score=342.39  Aligned_cols=249  Identities=24%  Similarity=0.411  Sum_probs=185.7

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc---chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEE
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY  337 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  337 (586)
                      ++|+..+.||+|+||.||+|+...++..||||++....   ....+.+.+|+.++++++||||+++++++...+..++||
T Consensus        11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (278)
T 3cok_A           11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL   90 (278)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence            57889999999999999999998889999999996542   233467899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCC
Q 007869          338 DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT  417 (586)
Q Consensus       338 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~  417 (586)
                      ||+++++|.+++... ...+++.+++.++.|+++||.|||+   .+|+||||||+||+++.++.+||+|||++.......
T Consensus        91 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~  166 (278)
T 3cok_A           91 EMCHNGEMNRYLKNR-VKPFSENEARHFMHQIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH  166 (278)
T ss_dssp             ECCTTEEHHHHHHTC-SSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSSCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred             ecCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC
Confidence            999999999999765 3468999999999999999999998   899999999999999999999999999998765332


Q ss_pred             CCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCC
Q 007869          418 DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLG  497 (586)
Q Consensus       418 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~  497 (586)
                      . ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+...          ...   ..+....
T Consensus       167 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~----------~~~---~~~~~~~  232 (278)
T 3cok_A          167 E-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN----------KVV---LADYEMP  232 (278)
T ss_dssp             --------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---------------CC---SSCCCCC
T ss_pred             C-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH----------HHh---hcccCCc
Confidence            2 2234578999999999998889999999999999999999999997654322110          000   0011111


Q ss_pred             ccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          498 TEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       498 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      ..    ....+.+++.+||+.||++|||+.++++
T Consensus       233 ~~----~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          233 SF----LSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             TT----SCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             cc----cCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence            11    2345778899999999999999999985

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=3.1e-42  Score=357.07  Aligned_cols=262  Identities=27%  Similarity=0.431  Sum_probs=211.4

Q ss_pred             hhhcCCcccceeEeecCceEEEEEEeC-------CCCeEEEEEEecccc-chhHHHHHHHHHHhccc-CCCceeeeeeee
Q 007869          257 YIATKGFREKELLGTGGFGRVYRGTLP-------KSQIEIAVKKISHES-RQGMKEFVAEIVSIGRL-RHRNLVQLLGYC  327 (586)
Q Consensus       257 ~~a~~~f~~~~~LG~G~~g~Vy~~~~~-------~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~  327 (586)
                      ....++|+..+.||+|+||.||+|.+.       .++..||||++.... ....+.+.+|+++++++ +||||+++++++
T Consensus        31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  110 (334)
T 2pvf_A           31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC  110 (334)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence            445678999999999999999999975       356789999997653 34567799999999999 999999999999


Q ss_pred             eccCeEEEEEecCCCCChhhhhhcCCC--------------ccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCC
Q 007869          328 RRKGELLLVYDYMPNGSLDKYLYDQPK--------------VTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASN  393 (586)
Q Consensus       328 ~~~~~~~lV~E~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~N  393 (586)
                      ...+..++||||+++|+|.+++.....              ..+++..++.++.||++||.|||+   .+|+||||||+|
T Consensus       111 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~N  187 (334)
T 2pvf_A          111 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARN  187 (334)
T ss_dssp             CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGG
T ss_pred             ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCccce
Confidence            999999999999999999999976532              248899999999999999999998   899999999999


Q ss_pred             eeecCCCCeEEccccceeeccCCCCC-ceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCc
Q 007869          394 VLLDGELNGRLGDFGLARLYDHGTDP-QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSE  471 (586)
Q Consensus       394 Ill~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~  471 (586)
                      ||++.++.+||+|||+++........ ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+
T Consensus       188 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~  267 (334)
T 2pvf_A          188 VLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE  267 (334)
T ss_dssp             EEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred             EEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH
Confidence            99999999999999999876543221 2233467889999999998899999999999999999999 999997643221


Q ss_pred             cchhhHHHHhhhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 007869          472 NLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERDV  537 (586)
Q Consensus       472 ~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  537 (586)
                         +...    ...+..     +....    .....+.+++.+||+.||.+||++.|+++.|++..
T Consensus       268 ---~~~~----~~~~~~-----~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~  317 (334)
T 2pvf_A          268 ---LFKL----LKEGHR-----MDKPA----NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL  317 (334)
T ss_dssp             ---HHHH----HHHTCC-----CCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---HHHH----HhcCCC-----CCCCc----cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence               1111    111111     11111    12345778889999999999999999999998653

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=2e-42  Score=349.23  Aligned_cols=259  Identities=24%  Similarity=0.406  Sum_probs=206.0

Q ss_pred             hhhcCCcccceeEeecCceEEEEEEeCC---CCeEEEEEEeccc-cchhHHHHHHHHHHhcccCCCceeeeeeeeeccCe
Q 007869          257 YIATKGFREKELLGTGGFGRVYRGTLPK---SQIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGE  332 (586)
Q Consensus       257 ~~a~~~f~~~~~LG~G~~g~Vy~~~~~~---~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~  332 (586)
                      ....++|...+.||+|+||.||+|++..   ++..||||.+... .....+.+.+|+.++++++||||+++++++.+. .
T Consensus         8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~   86 (281)
T 3cc6_A            8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-P   86 (281)
T ss_dssp             SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-S
T ss_pred             eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-C
Confidence            3456789999999999999999998643   3456999999765 334567899999999999999999999998754 5


Q ss_pred             EEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceee
Q 007869          333 LLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARL  412 (586)
Q Consensus       333 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~  412 (586)
                      .++||||+++++|.+++.... ..+++..++.++.|+++||.|||+   ++|+||||||+|||++.++.+||+|||+++.
T Consensus        87 ~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  162 (281)
T 3cc6_A           87 TWIIMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRY  162 (281)
T ss_dssp             CEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred             CEEEEecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEECCCCcEEeCccCCCcc
Confidence            689999999999999997643 358899999999999999999998   8999999999999999999999999999987


Q ss_pred             ccCCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccCccccc
Q 007869          413 YDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEA  491 (586)
Q Consensus       413 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~  491 (586)
                      .............+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+   ....+    ..+..   
T Consensus       163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~---~~~~~----~~~~~---  232 (281)
T 3cc6_A          163 IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD---VIGVL----EKGDR---  232 (281)
T ss_dssp             C---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG---HHHHH----HHTCC---
T ss_pred             cccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH---HHHHH----hcCCC---
Confidence            65443333344567889999999998899999999999999999998 999997644322   11111    11111   


Q ss_pred             cCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 007869          492 RDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERD  536 (586)
Q Consensus       492 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  536 (586)
                        +.....    ....+.+++.+||+.||++||++.|+++.|+..
T Consensus       233 --~~~~~~----~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~  271 (281)
T 3cc6_A          233 --LPKPDL----CPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV  271 (281)
T ss_dssp             --CCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --CCCCCC----CCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence              111111    224577888999999999999999999999753

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=7.7e-42  Score=353.22  Aligned_cols=264  Identities=20%  Similarity=0.300  Sum_probs=209.5

Q ss_pred             cchhhhhhhcCCcccc-eeEeecCceEEEEEEeCCCCeEEEEEEecccc--chhHHHHHHHHHHhccc-CCCceeeeeee
Q 007869          251 FRYKDLYIATKGFREK-ELLGTGGFGRVYRGTLPKSQIEIAVKKISHES--RQGMKEFVAEIVSIGRL-RHRNLVQLLGY  326 (586)
Q Consensus       251 ~~~~el~~a~~~f~~~-~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l-~H~niv~l~~~  326 (586)
                      ..++......+.|... +.||+|+||.||+|+...++..||||++....  ......+.+|+.++.++ +||||++++++
T Consensus        18 ~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~   97 (327)
T 3lm5_A           18 LYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEV   97 (327)
T ss_dssp             CCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred             hHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence            3445555556677776 89999999999999999899999999987542  33467899999999999 56999999999


Q ss_pred             eeccCeEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecC---CCCeE
Q 007869          327 CRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDG---ELNGR  403 (586)
Q Consensus       327 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~---~~~~k  403 (586)
                      +...+..++||||+++|+|.+++.......+++.+++.++.|++.||.|||+   .+|+||||||+|||++.   ++.+|
T Consensus        98 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~---~givH~Dikp~NIl~~~~~~~~~~k  174 (327)
T 3lm5_A           98 YENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIK  174 (327)
T ss_dssp             EECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESCBTTBCCEE
T ss_pred             EEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCChHHEEEecCCCCCcEE
Confidence            9999999999999999999999977655679999999999999999999998   89999999999999987   78999


Q ss_pred             EccccceeeccCCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhh
Q 007869          404 LGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFW  483 (586)
Q Consensus       404 L~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~  483 (586)
                      |+|||+++......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+...   .+.   
T Consensus       175 L~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~---~i~---  246 (327)
T 3lm5_A          175 IVDFGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYL---NIS---  246 (327)
T ss_dssp             ECCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---HHH---
T ss_pred             EeeCccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHH---HHH---
Confidence            99999999765432  2334679999999999999999999999999999999999999997644322111   000   


Q ss_pred             ccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          484 NRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       484 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                       +..      ..............+.+++.+||+.||.+|||++|+++.
T Consensus       247 -~~~------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h  288 (327)
T 3lm5_A          247 -QVN------VDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH  288 (327)
T ss_dssp             -HTC------CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred             -hcc------cccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence             000      000011111223557788999999999999999999853

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.3e-41  Score=374.17  Aligned_cols=256  Identities=27%  Similarity=0.354  Sum_probs=212.4

Q ss_pred             hhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc---cchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEE
Q 007869          258 IATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELL  334 (586)
Q Consensus       258 ~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~  334 (586)
                      ...++|+..+.||+|+||.||+|++..++..||||++...   .......+.+|+++|++++||||+++++++...+.++
T Consensus       181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~  260 (576)
T 2acx_A          181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC  260 (576)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence            4567799999999999999999999999999999999654   2334567899999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeecc
Q 007869          335 LVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYD  414 (586)
Q Consensus       335 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~  414 (586)
                      +||||+++|+|.+++.......+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++...
T Consensus       261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~---~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~  337 (576)
T 2acx_A          261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVP  337 (576)
T ss_dssp             EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCchheEEEeCCCCeEEEecccceecc
Confidence            99999999999999987665669999999999999999999998   899999999999999999999999999998765


Q ss_pred             CCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCC
Q 007869          415 HGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDP  494 (586)
Q Consensus       415 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~  494 (586)
                      ...  ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........   +.......      ..
T Consensus       338 ~~~--~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~---i~~~i~~~------~~  406 (576)
T 2acx_A          338 EGQ--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE---VERLVKEV------PE  406 (576)
T ss_dssp             TTC--CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHH---HHHHHHHC------CC
T ss_pred             cCc--cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHH---HHHHhhcc------cc
Confidence            432  23446899999999999998999999999999999999999999987543221111   11111111      11


Q ss_pred             CCCccccHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 007869          495 NLGTEYVAEELELVLKLGLLCSHSDPTARP-----SMRQVVQ  531 (586)
Q Consensus       495 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~  531 (586)
                      ....    .....+.+++.+||+.||.+||     ++.|+++
T Consensus       407 ~~p~----~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          407 EYSE----RFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             CCCT----TSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             cCCc----cCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence            1111    1234577888899999999999     7888875

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=6.1e-42  Score=345.30  Aligned_cols=249  Identities=26%  Similarity=0.381  Sum_probs=204.0

Q ss_pred             hcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc---chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEE
Q 007869          259 ATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLL  335 (586)
Q Consensus       259 a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~l  335 (586)
                      +.++|+..+.||+|+||.||+|.+..++..||||++....   ....+.+.+|+.++++++||||+++++++...+..++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   86 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL   86 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence            4568999999999999999999999999999999986532   2335678999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccC
Q 007869          336 VYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH  415 (586)
Q Consensus       336 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~  415 (586)
                      ||||+++++|.+++...  ..+++..++.++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||++.....
T Consensus        87 v~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~  161 (279)
T 3fdn_A           87 ILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS  161 (279)
T ss_dssp             EECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHT---TTCEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred             EEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence            99999999999999765  358889999999999999999998   8999999999999999999999999999865433


Q ss_pred             CCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCC
Q 007869          416 GTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPN  495 (586)
Q Consensus       416 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~  495 (586)
                      .   ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+.   .    ......      ...
T Consensus       162 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~----~~~~~~------~~~  225 (279)
T 3fdn_A          162 S---RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET---Y----KRISRV------EFT  225 (279)
T ss_dssp             ---------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH---H----HHHHHT------CCC
T ss_pred             c---cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHH---H----HHHHhC------CCC
Confidence            2   23445789999999999999999999999999999999999999975432211   1    111111      111


Q ss_pred             CCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          496 LGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       496 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                      ...    .....+.+++.+||+.||.+|||+.|+++.
T Consensus       226 ~~~----~~~~~~~~li~~~l~~~p~~Rps~~e~l~h  258 (279)
T 3fdn_A          226 FPD----FVTEGARDLISRLLKHNPSQRPMLREVLEH  258 (279)
T ss_dssp             CCT----TSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred             CCC----cCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            111    122456788899999999999999999963

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=4e-42  Score=370.70  Aligned_cols=251  Identities=24%  Similarity=0.291  Sum_probs=197.6

Q ss_pred             hcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc---cchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEE
Q 007869          259 ATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLL  335 (586)
Q Consensus       259 a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~l  335 (586)
                      ..++|+..+.||+|+||.||+|....++..||||++...   .......+.+|+.++++++||||++++++|...+.+++
T Consensus       146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l  225 (446)
T 4ejn_A          146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF  225 (446)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred             ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence            346789999999999999999999999999999999754   33445678899999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccC
Q 007869          336 VYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH  415 (586)
Q Consensus       336 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~  415 (586)
                      ||||+++|+|.+++...  ..+++..+..++.||+.||.|||+  +++|+||||||+|||++.++.+||+|||+++....
T Consensus       226 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~--~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  301 (446)
T 4ejn_A          226 VMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK  301 (446)
T ss_dssp             EECCCSSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHH--HTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred             EEeeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhh--cCCEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence            99999999999999765  368899999999999999999996  27899999999999999999999999999986433


Q ss_pred             CCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCC
Q 007869          416 GTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPN  495 (586)
Q Consensus       416 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~  495 (586)
                      .. .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+   +.+.+.    ...      ..
T Consensus       302 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~~~~i~----~~~------~~  367 (446)
T 4ejn_A          302 DG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---LFELIL----MEE------IR  367 (446)
T ss_dssp             ------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHH----HCC------CC
T ss_pred             CC-cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH---HHHHHH----hCC------CC
Confidence            22 22345689999999999999999999999999999999999999997643321   111111    111      11


Q ss_pred             CCccccHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 007869          496 LGTEYVAEELELVLKLGLLCSHSDPTARP-----SMRQVVQ  531 (586)
Q Consensus       496 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~  531 (586)
                      ....    ....+.+++.+||+.||.+||     +++|+++
T Consensus       368 ~p~~----~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          368 FPRT----LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             CCTT----SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             CCcc----CCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence            1111    224577888999999999999     9999985

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.6e-42  Score=347.17  Aligned_cols=258  Identities=24%  Similarity=0.408  Sum_probs=208.1

Q ss_pred             hhcCCcccce-eEeecCceEEEEEEeC--CCCeEEEEEEeccc-cchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeE
Q 007869          258 IATKGFREKE-LLGTGGFGRVYRGTLP--KSQIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGEL  333 (586)
Q Consensus       258 ~a~~~f~~~~-~LG~G~~g~Vy~~~~~--~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~  333 (586)
                      ...++|...+ .||+|+||.||+|++.  .++..||||++... .....+.+.+|++++++++||||+++++++ ..+..
T Consensus         6 ~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~   84 (287)
T 1u59_A            6 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEAL   84 (287)
T ss_dssp             CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSE
T ss_pred             ccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCc
Confidence            3445666666 9999999999999864  46778999999765 334567899999999999999999999999 45668


Q ss_pred             EEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeec
Q 007869          334 LLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLY  413 (586)
Q Consensus       334 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~  413 (586)
                      ++||||+++++|.+++... ...+++..++.++.|+++||.|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus        85 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~  160 (287)
T 1u59_A           85 MLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKAL  160 (287)
T ss_dssp             EEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEEeCCCCCHHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCchheEEEcCCCCEEECcccceeee
Confidence            9999999999999999754 3468999999999999999999998   89999999999999999999999999999976


Q ss_pred             cCCCCC--ceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccCcccc
Q 007869          414 DHGTDP--QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLE  490 (586)
Q Consensus       414 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~  490 (586)
                      ......  ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+   +...+    ..+..  
T Consensus       161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~~i----~~~~~--  231 (287)
T 1u59_A          161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VMAFI----EQGKR--  231 (287)
T ss_dssp             TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH---HHHHH----HTTCC--
T ss_pred             ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH---HHHHH----hcCCc--
Confidence            543221  1223456899999999988889999999999999999998 999997654322   11111    11111  


Q ss_pred             ccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 007869          491 ARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERD  536 (586)
Q Consensus       491 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  536 (586)
                         +..    .......+.+++..||+.||++||++.++++.|+..
T Consensus       232 ---~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  270 (287)
T 1u59_A          232 ---MEC----PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  270 (287)
T ss_dssp             ---CCC----CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---CCC----CCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence               111    112235678889999999999999999999999764

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.8e-42  Score=355.13  Aligned_cols=260  Identities=27%  Similarity=0.505  Sum_probs=203.7

Q ss_pred             hcCCcccceeEeecCceEEEEEEeCCC----CeEEEEEEecccc-chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeE
Q 007869          259 ATKGFREKELLGTGGFGRVYRGTLPKS----QIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGEL  333 (586)
Q Consensus       259 a~~~f~~~~~LG~G~~g~Vy~~~~~~~----~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~  333 (586)
                      ..++|...+.||+|+||.||+|.+..+    +..||||++.... ......+.+|+.++++++||||+++++++...+..
T Consensus        42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  121 (333)
T 1mqb_A           42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM  121 (333)
T ss_dssp             CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred             ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCc
Confidence            346778889999999999999987644    3469999997643 33456799999999999999999999999999999


Q ss_pred             EEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeec
Q 007869          334 LLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLY  413 (586)
Q Consensus       334 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~  413 (586)
                      ++||||+++++|.+++.... ..+++.+++.++.|+++||.|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus       122 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  197 (333)
T 1mqb_A          122 MIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVL  197 (333)
T ss_dssp             EEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             EEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence            99999999999999997652 468999999999999999999998   89999999999999999999999999999876


Q ss_pred             cCCCCC--ceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccCcccc
Q 007869          414 DHGTDP--QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLE  490 (586)
Q Consensus       414 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~  490 (586)
                      ......  ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+   +..    ...++..  
T Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~---~~~----~~~~~~~--  268 (333)
T 1mqb_A          198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE---VMK----AINDGFR--  268 (333)
T ss_dssp             -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHH----HHHTTCC--
T ss_pred             ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH---HHH----HHHCCCc--
Confidence            543221  1223356889999999999999999999999999999999 999997643221   111    1111111  


Q ss_pred             ccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhccC
Q 007869          491 ARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERDVA  538 (586)
Q Consensus       491 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~  538 (586)
                         +..    .......+.+++.+||+.||.+||++.++++.|+....
T Consensus       269 ---~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~  309 (333)
T 1mqb_A          269 ---LPT----PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR  309 (333)
T ss_dssp             ---CCC----CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             ---CCC----cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence               111    11223567888999999999999999999999987553

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=7.5e-42  Score=357.11  Aligned_cols=250  Identities=22%  Similarity=0.303  Sum_probs=205.8

Q ss_pred             hcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc---cchhHHHHHHHHHHhccc-CCCceeeeeeeeeccCeEE
Q 007869          259 ATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE---SRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKGELL  334 (586)
Q Consensus       259 a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~  334 (586)
                      ..++|+..+.||+|+||+||+|+...+++.||||++...   .....+.+..|..++..+ +||||+++++++...+.++
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~   97 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY   97 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence            446899999999999999999999988999999999764   234456788999999988 8999999999999999999


Q ss_pred             EEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeecc
Q 007869          335 LVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYD  414 (586)
Q Consensus       335 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~  414 (586)
                      +||||+++|+|.+++....  .+++..++.++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++...
T Consensus        98 lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~  172 (353)
T 2i0e_A           98 FVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI  172 (353)
T ss_dssp             EEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEEcCCCcEEEEeCCcccccc
Confidence            9999999999999997643  58899999999999999999998   899999999999999999999999999998643


Q ss_pred             CCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCC
Q 007869          415 HGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDP  494 (586)
Q Consensus       415 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~  494 (586)
                      ... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+   +.+.+   . .+.      +
T Consensus       173 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~---~~~~i---~-~~~------~  238 (353)
T 2i0e_A          173 WDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---LFQSI---M-EHN------V  238 (353)
T ss_dssp             CTT-CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH---H-HCC------C
T ss_pred             cCC-cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHH---HHHHH---H-hCC------C
Confidence            222 23445689999999999999999999999999999999999999997643221   11111   1 111      1


Q ss_pred             CCCccccHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 007869          495 NLGTEYVAEELELVLKLGLLCSHSDPTARPS-----MRQVVQ  531 (586)
Q Consensus       495 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~  531 (586)
                      ....    .....+.+++.+||+.||.+||+     ++++++
T Consensus       239 ~~p~----~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          239 AYPK----SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             CCCT----TSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred             CCCC----CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence            1111    22345778889999999999995     577764

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=2.2e-42  Score=357.13  Aligned_cols=263  Identities=22%  Similarity=0.314  Sum_probs=194.9

Q ss_pred             cchhhhhhhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccC-CCceeeeeeeee-
Q 007869          251 FRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLR-HRNLVQLLGYCR-  328 (586)
Q Consensus       251 ~~~~el~~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~~~~~-  328 (586)
                      +....+.....+|+..+.||+|+||.||+|++..++..||||++........+.+.+|+.++.++. ||||+++++++. 
T Consensus        18 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~   97 (337)
T 3ll6_A           18 FVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASI   97 (337)
T ss_dssp             STTCEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred             hhcceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccc
Confidence            334455566778999999999999999999998889999999997776666788999999999996 999999999983 


Q ss_pred             -------ccCeEEEEEecCCCCChhhhhhcC-CCccchhHHHHHHHHHHHHHHHHhhcccCCc--EEeCCCCCCCeeecC
Q 007869          329 -------RKGELLLVYDYMPNGSLDKYLYDQ-PKVTLNWIQRFRVIKGVALGLFYLHQEWEQV--VIHRDVKASNVLLDG  398 (586)
Q Consensus       329 -------~~~~~~lV~E~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--ivHrDIkp~NIll~~  398 (586)
                             .....++||||+. |+|.+++... ....+++..++.++.||+.||.|||+   .+  |+||||||+|||++.
T Consensus        98 ~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~~~ivH~Dikp~NIl~~~  173 (337)
T 3ll6_A           98 GKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR---QKPPIIHRDLKVENLLLSN  173 (337)
T ss_dssp             CTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCCCCCGGGCEECT
T ss_pred             cccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCEEEccCCcccEEECC
Confidence                   3456899999995 7999988652 23469999999999999999999998   77  999999999999999


Q ss_pred             CCCeEEccccceeeccCCCCC-----------ceeeeccCCCccCcccc---cCCCCCCcceEEehhHHHHHHHhCCCCC
Q 007869          399 ELNGRLGDFGLARLYDHGTDP-----------QTTHVVGTLGYLAPEHT---RTGKATTSADVFSFGAFLLEVACGRRPI  464 (586)
Q Consensus       399 ~~~~kL~DFGla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~---~~~~~s~ksDVyS~Gvvl~ElltG~~p~  464 (586)
                      ++.+||+|||+++........           ......||+.|+|||++   .+..++.++|||||||++|||++|+.||
T Consensus       174 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~  253 (337)
T 3ll6_A          174 QGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF  253 (337)
T ss_dssp             TSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC
T ss_pred             CCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCC
Confidence            999999999999876543221           11235689999999998   5667899999999999999999999999


Q ss_pred             CCCCCCccchhhHHHHhhhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 007869          465 QRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERD  536 (586)
Q Consensus       465 ~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  536 (586)
                      ........      .     .+.......    ..    ....+.+++.+||+.||.+||++.|+++.|+..
T Consensus       254 ~~~~~~~~------~-----~~~~~~~~~----~~----~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~  306 (337)
T 3ll6_A          254 EDGAKLRI------V-----NGKYSIPPH----DT----QYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEI  306 (337)
T ss_dssp             -----------------------CCCCTT----CC----SSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             cchhHHHh------h-----cCcccCCcc----cc----cchHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            75432210      0     001100000    11    113367788999999999999999999999754

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.8e-42  Score=365.17  Aligned_cols=244  Identities=14%  Similarity=0.126  Sum_probs=193.6

Q ss_pred             hhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc---cchhHHHHHHHH---HHhcccCCCceeeee-------
Q 007869          258 IATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE---SRQGMKEFVAEI---VSIGRLRHRNLVQLL-------  324 (586)
Q Consensus       258 ~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei---~~l~~l~H~niv~l~-------  324 (586)
                      ...++|...+.||+|+||.||+|++..++..||||++...   .....+.+.+|+   +.+++++||||++++       
T Consensus        70 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~  149 (377)
T 3byv_A           70 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF  149 (377)
T ss_dssp             CCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCS
T ss_pred             CCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhh
Confidence            4457899999999999999999999888999999999743   334567899999   566666899999998       


Q ss_pred             eeeeccC-----------------eEEEEEecCCCCChhhhhhcCC-----CccchhHHHHHHHHHHHHHHHHhhcccCC
Q 007869          325 GYCRRKG-----------------ELLLVYDYMPNGSLDKYLYDQP-----KVTLNWIQRFRVIKGVALGLFYLHQEWEQ  382 (586)
Q Consensus       325 ~~~~~~~-----------------~~~lV~E~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~~L~yLH~~~~~  382 (586)
                      +++...+                 ..++||||+ +|+|.+++....     ...+++..++.|+.||++||.|||+   +
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~  225 (377)
T 3byv_A          150 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---Y  225 (377)
T ss_dssp             EEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH---T
T ss_pred             hhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh---C
Confidence            5555443                 278999999 689999997532     2356678999999999999999998   8


Q ss_pred             cEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCCceeeeccCCCccCcccccCC-----------CCCCcceEEehh
Q 007869          383 VVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTG-----------KATTSADVFSFG  451 (586)
Q Consensus       383 ~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~s~ksDVyS~G  451 (586)
                      +|+||||||+|||++.++++||+|||+++....    ......| +.|+|||++.+.           .++.++||||||
T Consensus       226 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG  300 (377)
T 3byv_A          226 GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALG  300 (377)
T ss_dssp             TEECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHH
T ss_pred             CeecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHH
Confidence            999999999999999999999999999986332    3445577 999999999887           899999999999


Q ss_pred             HHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          452 AFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       452 vvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      |++|||++|+.||......+....   +         ... .    ...    ...+.+++.+||+.||++|||+.|+++
T Consensus       301 ~il~elltg~~Pf~~~~~~~~~~~---~---------~~~-~----~~~----~~~~~~li~~~L~~dp~~Rpt~~e~l~  359 (377)
T 3byv_A          301 LVIYWIWCADLPITKDAALGGSEW---I---------FRS-C----KNI----PQPVRALLEGFLRYPKEDRLLPLQAME  359 (377)
T ss_dssp             HHHHHHHHSSCCC------CCSGG---G---------GSS-C----CCC----CHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred             HHHHHHHHCCCCCcccccccchhh---h---------hhh-c----cCC----CHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence            999999999999976543321110   0         000 0    111    245778889999999999999999985

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.8e-41  Score=360.05  Aligned_cols=273  Identities=21%  Similarity=0.260  Sum_probs=214.8

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc-chhHHHHHHHHHHhcccCCCceeeeeeeeeccC--eEEEE
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKG--ELLLV  336 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~--~~~lV  336 (586)
                      .++|...+.||+|+||.||+|++..++..||||++.... ....+.+.+|++++++++||||+++++++...+  ..++|
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv   87 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence            457899999999999999999999989999999997643 344577889999999999999999999988654  78999


Q ss_pred             EecCCCCChhhhhhcCCC-ccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeee----cCCCCeEEcccccee
Q 007869          337 YDYMPNGSLDKYLYDQPK-VTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLL----DGELNGRLGDFGLAR  411 (586)
Q Consensus       337 ~E~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll----~~~~~~kL~DFGla~  411 (586)
                      |||+++|+|.+++..... ..+++..++.++.||+.||.|||+   .+|+||||||+|||+    +.++.+||+|||+++
T Consensus        88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~  164 (396)
T 4eut_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (396)
T ss_dssp             ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred             EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence            999999999999976432 348999999999999999999998   899999999999999    778889999999998


Q ss_pred             eccCCCCCceeeeccCCCccCcccccC--------CCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccc-hhhHHHHhh
Q 007869          412 LYDHGTDPQTTHVVGTLGYLAPEHTRT--------GKATTSADVFSFGAFLLEVACGRRPIQRQGPSENL-ILVDWVFDF  482 (586)
Q Consensus       412 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~-~l~~~v~~~  482 (586)
                      ......  ......||+.|+|||++..        ..++.++|||||||++|||++|+.||......... .....+...
T Consensus       165 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~  242 (396)
T 4eut_A          165 ELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG  242 (396)
T ss_dssp             ECCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS
T ss_pred             EccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC
Confidence            765432  2334579999999999865        56788999999999999999999999754432211 111111110


Q ss_pred             hcc-----------CccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 007869          483 WNR-----------GELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERDV  537 (586)
Q Consensus       483 ~~~-----------~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  537 (586)
                      ...           +.+.-..+..............+.+++.+||+.||++||++.|+++.++..+
T Consensus       243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il  308 (396)
T 4eut_A          243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL  308 (396)
T ss_dssp             CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHH
T ss_pred             CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHh
Confidence            000           0000000111122345677788899999999999999999999998887643

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=2.1e-41  Score=350.55  Aligned_cols=270  Identities=25%  Similarity=0.379  Sum_probs=198.5

Q ss_pred             hhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeee-----ccCe
Q 007869          258 IATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCR-----RKGE  332 (586)
Q Consensus       258 ~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~-----~~~~  332 (586)
                      ...++|+..+.||+|+||.||+|+.  ++..||||++....... .....|+..+..++||||+++++++.     ....
T Consensus        10 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~-~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   86 (336)
T 3g2f_A           10 LDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQN-FINEKNIYRVPLMEHDNIARFIVGDERVTADGRME   86 (336)
T ss_dssp             CCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHH-HHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             cChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhh-HHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence            3457899999999999999999987  56889999997543321 12234455566689999999998553     2346


Q ss_pred             EEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhccc------CCcEEeCCCCCCCeeecCCCCeEEcc
Q 007869          333 LLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEW------EQVVIHRDVKASNVLLDGELNGRLGD  406 (586)
Q Consensus       333 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~------~~~ivHrDIkp~NIll~~~~~~kL~D  406 (586)
                      .++||||+++|+|.+++...   ..++..++.++.||++||.|||+.+      ..+|+||||||+|||++.++.+||+|
T Consensus        87 ~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~D  163 (336)
T 3g2f_A           87 YLLVMEYYPNGSLXKYLSLH---TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD  163 (336)
T ss_dssp             EEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECC
T ss_pred             EEEEEecCCCCcHHHHHhhc---ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEee
Confidence            79999999999999999765   3588899999999999999999821      11999999999999999999999999


Q ss_pred             ccceeeccCCCC-------CceeeeccCCCccCcccccC-------CCCCCcceEEehhHHHHHHHhCCCCCCCCCCCcc
Q 007869          407 FGLARLYDHGTD-------PQTTHVVGTLGYLAPEHTRT-------GKATTSADVFSFGAFLLEVACGRRPIQRQGPSEN  472 (586)
Q Consensus       407 FGla~~~~~~~~-------~~~~~~~gt~~y~aPE~~~~-------~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~  472 (586)
                      ||+++.+.....       .......||+.|+|||++.+       ..++.++|||||||++|||++|+.|+........
T Consensus       164 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~  243 (336)
T 3g2f_A          164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE  243 (336)
T ss_dssp             CTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCC
T ss_pred             ccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhH
Confidence            999987654321       12234579999999999976       3567799999999999999999877754332211


Q ss_pred             ch-hh----------HHHHhhhccCccccccCCCCCc--cccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 007869          473 LI-LV----------DWVFDFWNRGELLEARDPNLGT--EYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERDV  537 (586)
Q Consensus       473 ~~-l~----------~~v~~~~~~~~~~~~~d~~l~~--~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  537 (586)
                      .. ..          +..........    ..+.+..  .........+.+++.+||+.||++|||+.|+++.|+...
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll  317 (336)
T 3g2f_A          244 YQMAFQTEVGNHPTFEDMQVLVSREK----QRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELM  317 (336)
T ss_dssp             CCCTTHHHHCSSCCHHHHHHHHTTSC----CCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHhhhcccCCCchHHHHHhhhcccc----cCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHH
Confidence            10 00          00011111111    1111111  112345667899999999999999999999999998643

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=5.8e-43  Score=385.55  Aligned_cols=264  Identities=28%  Similarity=0.431  Sum_probs=213.7

Q ss_pred             chhhhhhhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccC
Q 007869          252 RYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKG  331 (586)
Q Consensus       252 ~~~el~~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~  331 (586)
                      ...++.+..++|+..+.||+|+||.||+|.+.. +..||||++..... ..++|.+|+++|++++||||+++++++.+ +
T Consensus       258 ~~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~  334 (535)
T 2h8h_A          258 AKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-E  334 (535)
T ss_dssp             STTCSBCCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred             CccceecchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee-c
Confidence            345566777889999999999999999999975 45699999976542 35789999999999999999999999876 6


Q ss_pred             eEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEcccccee
Q 007869          332 ELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR  411 (586)
Q Consensus       332 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~  411 (586)
                      ..+|||||+++|+|.++|.......+++.+++.|+.||++||.|||+   ++|+||||||+|||+++++.+||+|||+++
T Consensus       335 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~  411 (535)
T 2h8h_A          335 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLAR  411 (535)
T ss_dssp             SCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCTTSTT
T ss_pred             cceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEEcCCCcEEEcccccce
Confidence            78999999999999999975433468899999999999999999998   899999999999999999999999999998


Q ss_pred             eccCCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccCcccc
Q 007869          412 LYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLE  490 (586)
Q Consensus       412 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~  490 (586)
                      ..............++..|+|||++....++.++|||||||+||||++ |+.||......+   +.+    ...++... 
T Consensus       412 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~---~~~----~i~~~~~~-  483 (535)
T 2h8h_A          412 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---VLD----QVERGYRM-  483 (535)
T ss_dssp             TCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH---HHH----HHHTTCCC-
T ss_pred             ecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH----HHHcCCCC-
Confidence            654321111223456789999999999999999999999999999999 999997643321   111    11122111 


Q ss_pred             ccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 007869          491 ARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERDV  537 (586)
Q Consensus       491 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  537 (586)
                          .    ........+.+++.+||+.||++|||+.++++.|+...
T Consensus       484 ----~----~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~  522 (535)
T 2h8h_A          484 ----P----CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  522 (535)
T ss_dssp             ----C----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred             ----C----CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence                0    11122356788999999999999999999999998643

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.3e-41  Score=343.29  Aligned_cols=251  Identities=23%  Similarity=0.341  Sum_probs=203.9

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccc------hhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEE
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR------QGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELL  334 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~  334 (586)
                      ++|+..+.||+|+||.||+|++..++..||+|.+.....      ...+.+.+|+.++++++||||+++++++...+..+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV   84 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence            568889999999999999999998899999999875421      13578999999999999999999999999999999


Q ss_pred             EEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCC----CeEEccccce
Q 007869          335 LVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGEL----NGRLGDFGLA  410 (586)
Q Consensus       335 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~----~~kL~DFGla  410 (586)
                      +||||+++++|.+++...  ..+++.+++.++.|+++||.|||+   .+|+||||||+||+++.++    .+||+|||++
T Consensus        85 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~  159 (283)
T 3bhy_A           85 LILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA  159 (283)
T ss_dssp             EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             EEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChHHEEEecCCCCCCceEEEecccc
Confidence            999999999999999764  368899999999999999999998   8999999999999998877    8999999999


Q ss_pred             eeccCCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCcccc
Q 007869          411 RLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLE  490 (586)
Q Consensus       411 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~  490 (586)
                      +......  ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+   ...    .....    
T Consensus       160 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~----~~~~~----  226 (283)
T 3bhy_A          160 HKIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE---TLT----NISAV----  226 (283)
T ss_dssp             EECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHH----HHHTT----
T ss_pred             eeccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH---HHH----HhHhc----
Confidence            8765432  2234578999999999999999999999999999999999999997643221   111    01111    


Q ss_pred             ccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          491 ARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       491 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                        ...............+.+++.+||+.||++||++.|+++
T Consensus       227 --~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  265 (283)
T 3bhy_A          227 --NYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE  265 (283)
T ss_dssp             --CCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             --ccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence              111111111122356788999999999999999999986

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=2.9e-41  Score=354.16  Aligned_cols=258  Identities=17%  Similarity=0.139  Sum_probs=205.3

Q ss_pred             chhhhhhhcCCcccceeEeecCceEEEEEE-----eCCCCeEEEEEEeccccchhHHHHHHHHHHhcccC---CCceeee
Q 007869          252 RYKDLYIATKGFREKELLGTGGFGRVYRGT-----LPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLR---HRNLVQL  323 (586)
Q Consensus       252 ~~~el~~a~~~f~~~~~LG~G~~g~Vy~~~-----~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~---H~niv~l  323 (586)
                      ...++....++|...+.||+|+||.||+|.     ...++..||||++.....   .++..|++++.+++   |+||+++
T Consensus        56 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~e~~~~~~l~~~~~~~iv~~  132 (365)
T 3e7e_A           56 PKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP---WEFYIGTQLMERLKPSMQHMFMKF  132 (365)
T ss_dssp             SSCEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCH---HHHHHHHHHHHHSCGGGGGGBCCE
T ss_pred             cceeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCCh---hHHHHHHHHHHHhhhhhhhhhhhh
Confidence            345666778899999999999999999994     556788899999976543   45666666666665   9999999


Q ss_pred             eeeeeccCeEEEEEecCCCCChhhhhhcC---CCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecC--
Q 007869          324 LGYCRRKGELLLVYDYMPNGSLDKYLYDQ---PKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDG--  398 (586)
Q Consensus       324 ~~~~~~~~~~~lV~E~~~~gsL~~~l~~~---~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~--  398 (586)
                      ++++...+..++||||+++|+|.+++...   ....+++..++.|+.||++||.|||+   ++|+||||||+|||++.  
T Consensus       133 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~---~~ivHrDiKp~NIll~~~~  209 (365)
T 3e7e_A          133 YSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGF  209 (365)
T ss_dssp             EEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECGGG
T ss_pred             heeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEecccc
Confidence            99999999999999999999999999742   23569999999999999999999998   89999999999999988  


Q ss_pred             ---------CCCeEEccccceeeccCCC-CCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCC
Q 007869          399 ---------ELNGRLGDFGLARLYDHGT-DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQG  468 (586)
Q Consensus       399 ---------~~~~kL~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~  468 (586)
                               ++.+||+|||+|+.+.... ........||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       210 ~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~  289 (365)
T 3e7e_A          210 LEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNE  289 (365)
T ss_dssp             TCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEE
T ss_pred             cCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCC
Confidence                     8999999999998765322 223445689999999999999999999999999999999999999996432


Q ss_pred             CCccchhhHHHHhhhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCC-CCHHHHHHHHhhc
Q 007869          469 PSENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTAR-PSMRQVVQILERD  536 (586)
Q Consensus       469 ~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~R-Ps~~evl~~L~~~  536 (586)
                      ....              .    ....+.....   .+.+.+++..|++.+|.+| |+++++.+.|+..
T Consensus       290 ~~~~--------------~----~~~~~~~~~~---~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~  337 (365)
T 3e7e_A          290 GGEC--------------K----PEGLFRRLPH---LDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKV  337 (365)
T ss_dssp             TTEE--------------E----ECSCCTTCSS---HHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred             CCce--------------e----echhccccCc---HHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHH
Confidence            2110              0    0111111112   2345566777999999998 6788887777653

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=5.9e-42  Score=347.71  Aligned_cols=261  Identities=28%  Similarity=0.424  Sum_probs=207.4

Q ss_pred             hhhhhhcCCcccce-eEeecCceEEEEEE--eCCCCeEEEEEEecccc--chhHHHHHHHHHHhcccCCCceeeeeeeee
Q 007869          254 KDLYIATKGFREKE-LLGTGGFGRVYRGT--LPKSQIEIAVKKISHES--RQGMKEFVAEIVSIGRLRHRNLVQLLGYCR  328 (586)
Q Consensus       254 ~el~~a~~~f~~~~-~LG~G~~g~Vy~~~--~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~  328 (586)
                      .++....++|...+ .||+|+||.||+|.  ...++..||||++....  ....+++.+|++++++++||||+++++++ 
T Consensus         9 ~~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-   87 (291)
T 1xbb_A            9 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-   87 (291)
T ss_dssp             --CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-
T ss_pred             ceeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-
Confidence            34455567788887 99999999999995  45667889999997643  33457899999999999999999999999 


Q ss_pred             ccCeEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEcccc
Q 007869          329 RKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFG  408 (586)
Q Consensus       329 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFG  408 (586)
                      ..+..++||||+++++|.+++....  .+++..++.++.|+++||.|||+   .+|+||||||+|||++.++.+||+|||
T Consensus        88 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg  162 (291)
T 1xbb_A           88 EAESWMLVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFG  162 (291)
T ss_dssp             ESSSEEEEEECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCT
T ss_pred             CCCCcEEEEEeCCCCCHHHHHHhCc--CCCHHHHHHHHHHHHHHHHHHHh---CCeEcCCCCcceEEEeCCCcEEEccCC
Confidence            5667899999999999999998753  58889999999999999999998   899999999999999999999999999


Q ss_pred             ceeeccCCCCCc--eeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhcc
Q 007869          409 LARLYDHGTDPQ--TTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNR  485 (586)
Q Consensus       409 la~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~  485 (586)
                      +++.........  .....+|+.|+|||++.+..++.++||||||+++|||++ |+.||......+   +..    ....
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~----~~~~  235 (291)
T 1xbb_A          163 LSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---VTA----MLEK  235 (291)
T ss_dssp             TCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHH----HHHT
T ss_pred             cceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHH----HHHc
Confidence            998765433221  222356789999999998889999999999999999999 999997643321   111    1112


Q ss_pred             CccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 007869          486 GELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERD  536 (586)
Q Consensus       486 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  536 (586)
                      +..     +..    .......+.+++..||+.||.+||++.++++.|+..
T Consensus       236 ~~~-----~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  277 (291)
T 1xbb_A          236 GER-----MGC----PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  277 (291)
T ss_dssp             TCC-----CCC----CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             CCC-----CCC----CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            111     111    112235678899999999999999999999999763

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=7.4e-42  Score=350.51  Aligned_cols=266  Identities=25%  Similarity=0.451  Sum_probs=204.5

Q ss_pred             chhhhhhhcCCcccceeEeecCceEEEEEEeCC---CCeEEEEEEeccc--cchhHHHHHHHHHHhcccCCCceeeeeee
Q 007869          252 RYKDLYIATKGFREKELLGTGGFGRVYRGTLPK---SQIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGY  326 (586)
Q Consensus       252 ~~~el~~a~~~f~~~~~LG~G~~g~Vy~~~~~~---~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~~~  326 (586)
                      .++++....++|...+.||+|+||.||+|.+..   ++..||||++...  .....+.+.+|+.++++++||||++++++
T Consensus        25 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~  104 (313)
T 3brb_A           25 KLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGV  104 (313)
T ss_dssp             CTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEE
T ss_pred             hHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEE
Confidence            456677788899999999999999999998754   4568999998754  33445779999999999999999999999


Q ss_pred             eeccC-----eEEEEEecCCCCChhhhhhcC----CCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeec
Q 007869          327 CRRKG-----ELLLVYDYMPNGSLDKYLYDQ----PKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLD  397 (586)
Q Consensus       327 ~~~~~-----~~~lV~E~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~  397 (586)
                      +...+     ..++||||+++++|.+++...    ....+++..++.++.|+++||.|||+   ++|+||||||+|||++
T Consensus       105 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~  181 (313)
T 3brb_A          105 CIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN---RNFLHRDLAARNCMLR  181 (313)
T ss_dssp             EEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCSGGGEEEC
T ss_pred             EeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEc
Confidence            98754     359999999999999998542    23568999999999999999999998   8999999999999999


Q ss_pred             CCCCeEEccccceeeccCCCC-CceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchh
Q 007869          398 GELNGRLGDFGLARLYDHGTD-PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLIL  475 (586)
Q Consensus       398 ~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l  475 (586)
                      .++.+||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |+.||......+   +
T Consensus       182 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~  258 (313)
T 3brb_A          182 DDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE---M  258 (313)
T ss_dssp             TTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG---H
T ss_pred             CCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH---H
Confidence            999999999999987644322 12334567889999999999999999999999999999999 889987654322   1


Q ss_pred             hHHHHhhhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 007869          476 VDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERD  536 (586)
Q Consensus       476 ~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  536 (586)
                      .+.+    ..+.     .+..    .......+.+++.+||+.||.+||++.++++.|+..
T Consensus       259 ~~~~----~~~~-----~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l  306 (313)
T 3brb_A          259 YDYL----LHGH-----RLKQ----PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKL  306 (313)
T ss_dssp             HHHH----HTTC-----CCCC----BTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHH----HcCC-----CCCC----CccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            1111    1111     1111    112235678889999999999999999999999864

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=5.1e-41  Score=343.79  Aligned_cols=261  Identities=24%  Similarity=0.383  Sum_probs=199.8

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc---cchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEE
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLV  336 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV  336 (586)
                      .++|+..+.||+|+||.||+|....++..||||++...   .....+.+.+|+.++++++||||+++++++...+..++|
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv  110 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV  110 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence            35799999999999999999999888999999999753   334557789999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhcC--CCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeecc
Q 007869          337 YDYMPNGSLDKYLYDQ--PKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYD  414 (586)
Q Consensus       337 ~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~  414 (586)
                      |||+++++|.+++...  ....+++..++.++.|+++||.|||+   .+|+||||||+|||++.++.+||+|||+++...
T Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~  187 (310)
T 2wqm_A          111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFS  187 (310)
T ss_dssp             EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred             EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence            9999999999998642  23468899999999999999999998   899999999999999999999999999998765


Q ss_pred             CCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCC
Q 007869          415 HGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDP  494 (586)
Q Consensus       415 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~  494 (586)
                      .... ......||+.|+|||++.+..++.++||||||+++|||++|+.||....... ..+..    ....+..     +
T Consensus       188 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~----~~~~~~~-----~  256 (310)
T 2wqm_A          188 SKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-YSLCK----KIEQCDY-----P  256 (310)
T ss_dssp             ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCH-HHHHH----HHHTTCS-----C
T ss_pred             CCCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhH-HHHHH----HhhcccC-----C
Confidence            4321 2234578999999999999999999999999999999999999997643221 11111    1111111     1


Q ss_pred             CCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 007869          495 NLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERDV  537 (586)
Q Consensus       495 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  537 (586)
                      ....   ......+.+++.+||+.||.+|||+.++++.|++..
T Consensus       257 ~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~  296 (310)
T 2wqm_A          257 PLPS---DHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMH  296 (310)
T ss_dssp             CCCT---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCcc---cccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence            1110   112345778889999999999999999999998654

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.4e-42  Score=357.44  Aligned_cols=254  Identities=22%  Similarity=0.357  Sum_probs=198.0

Q ss_pred             hhhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc--cchhHHHHHHHHHHhcccCC--CceeeeeeeeeccCe
Q 007869          257 YIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRH--RNLVQLLGYCRRKGE  332 (586)
Q Consensus       257 ~~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H--~niv~l~~~~~~~~~  332 (586)
                      ....+.|+..+.||+|+||.||++... ++..||||++...  ..+..+.+.+|+.++.+++|  |||+++++++...+.
T Consensus         5 ~~~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~   83 (343)
T 3dbq_A            5 SVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY   83 (343)
T ss_dssp             ESSSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             eeecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCE
Confidence            345677999999999999999999985 5778999998754  34455789999999999976  999999999999999


Q ss_pred             EEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceee
Q 007869          333 LLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARL  412 (586)
Q Consensus       333 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~  412 (586)
                      .++||| +.+++|.+++...  ..+++.++..++.||++||.|||+   .+|+||||||+|||++ ++.+||+|||+++.
T Consensus        84 ~~lv~e-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~---~~iiHrDikp~NIll~-~~~~kl~DFG~a~~  156 (343)
T 3dbq_A           84 IYMVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQ  156 (343)
T ss_dssp             EEEEEC-CCSEEHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEE-TTEEEECCCSSSCC
T ss_pred             EEEEEe-CCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEE-CCcEEEeecccccc
Confidence            999999 5588999999875  368889999999999999999998   8999999999999997 57899999999987


Q ss_pred             ccCCCCC-ceeeeccCCCccCcccccC-----------CCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHH
Q 007869          413 YDHGTDP-QTTHVVGTLGYLAPEHTRT-----------GKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVF  480 (586)
Q Consensus       413 ~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~  480 (586)
                      ....... ......||+.|+|||++.+           ..++.++|||||||++|||++|+.||......  .   ....
T Consensus       157 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~---~~~~  231 (343)
T 3dbq_A          157 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ--I---SKLH  231 (343)
T ss_dssp             C------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH--H---HHHH
T ss_pred             cCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH--H---HHHH
Confidence            6543322 2345679999999999864           67889999999999999999999999753221  1   1111


Q ss_pred             hhhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          481 DFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       481 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                      ...         ++.....+.......+.+++.+||+.||.+|||+.|+++.
T Consensus       232 ~~~---------~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          232 AII---------DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             HHH---------CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHh---------cCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence            111         1111111111122457788899999999999999999864

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=7.1e-42  Score=382.49  Aligned_cols=259  Identities=25%  Similarity=0.419  Sum_probs=205.4

Q ss_pred             hhhcCCcccce-eEeecCceEEEEEEeC--CCCeEEEEEEecccc-chhHHHHHHHHHHhcccCCCceeeeeeeeeccCe
Q 007869          257 YIATKGFREKE-LLGTGGFGRVYRGTLP--KSQIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGE  332 (586)
Q Consensus       257 ~~a~~~f~~~~-~LG~G~~g~Vy~~~~~--~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~  332 (586)
                      ....+++...+ .||+|+||.||+|.+.  +++..||||+++... ....++|.+|+++|++++||||++++++|.. +.
T Consensus       331 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~  409 (613)
T 2ozo_A          331 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EA  409 (613)
T ss_dssp             BCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SS
T ss_pred             eccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CC
Confidence            34445555555 7999999999999875  456779999997653 3456889999999999999999999999976 56


Q ss_pred             EEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceee
Q 007869          333 LLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARL  412 (586)
Q Consensus       333 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~  412 (586)
                      .++||||+++|+|.+++... ...+++..++.++.||++||.|||+   ++|+||||||+|||+++++.+||+|||+++.
T Consensus       410 ~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiHrDlkp~NILl~~~~~vkL~DFGla~~  485 (613)
T 2ozo_A          410 LMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKISDFGLSKA  485 (613)
T ss_dssp             EEEEEECCTTCBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCSTTTT
T ss_pred             eEEEEEeCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCcCCHHHEEEcCCCcEEEeeccCccc
Confidence            89999999999999999765 3468999999999999999999998   8999999999999999999999999999987


Q ss_pred             ccCCCCCc--eeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccCccc
Q 007869          413 YDHGTDPQ--TTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELL  489 (586)
Q Consensus       413 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~  489 (586)
                      ........  .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+   +.+    ...++...
T Consensus       486 ~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~---~~~----~i~~~~~~  558 (613)
T 2ozo_A          486 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VMA----FIEQGKRM  558 (613)
T ss_dssp             CC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH---HHH----HHHTTCCC
T ss_pred             ccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH---HHH----HHHcCCCC
Confidence            64332211  222346789999999999999999999999999999998 999998754432   111    22222211


Q ss_pred             cccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 007869          490 EARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERD  536 (586)
Q Consensus       490 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  536 (586)
                      .         ........+.+++..||+.||++||++.++++.|+..
T Consensus       559 ~---------~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~  596 (613)
T 2ozo_A          559 E---------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  596 (613)
T ss_dssp             C---------CCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred             C---------CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            1         1122335678899999999999999999999999753

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.2e-41  Score=354.51  Aligned_cols=266  Identities=17%  Similarity=0.183  Sum_probs=201.4

Q ss_pred             cCCcccceeEeecCceEEEEEEeCC---CCeEEEEEEeccccch-----------hHHHHHHHHHHhcccCCCceeeeee
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPK---SQIEIAVKKISHESRQ-----------GMKEFVAEIVSIGRLRHRNLVQLLG  325 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~---~~~~vavK~~~~~~~~-----------~~~~~~~Ei~~l~~l~H~niv~l~~  325 (586)
                      .++|...+.||+|+||.||+|.+..   ++..+|||+.......           ....+.+|+..+..++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            4679999999999999999999976   7788999998765322           1234678889999999999999999


Q ss_pred             eeec----cCeEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCC-
Q 007869          326 YCRR----KGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGEL-  400 (586)
Q Consensus       326 ~~~~----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~-  400 (586)
                      ++..    .+..++||||+ +++|.+++....  .+++.+++.++.||+.||.|||+   .+|+||||||+|||++.++ 
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~  189 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGYKNP  189 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEESSST
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCcCHHHEEEccCCC
Confidence            9987    67899999999 999999997653  78999999999999999999998   8999999999999998877 


Q ss_pred             -CeEEccccceeeccCCCC------CceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccc
Q 007869          401 -NGRLGDFGLARLYDHGTD------PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENL  473 (586)
Q Consensus       401 -~~kL~DFGla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~  473 (586)
                       .+||+|||+++.+.....      .......||+.|+|||++.+..++.++|||||||++|||++|+.||.........
T Consensus       190 ~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~  269 (345)
T 2v62_A          190 DQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA  269 (345)
T ss_dssp             TSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH
T ss_pred             CcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHH
Confidence             999999999987643221      1124457999999999999999999999999999999999999999653222111


Q ss_pred             hhhHHHHhhhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 007869          474 ILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERDV  537 (586)
Q Consensus       474 ~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  537 (586)
                       . ......... .+.........   .......+.+++..||+.||++||++.++++.|+...
T Consensus       270 -~-~~~~~~~~~-~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~  327 (345)
T 2v62_A          270 -V-QTAKTNLLD-ELPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG  327 (345)
T ss_dssp             -H-HHHHHHHHH-TTTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred             -H-HHHHHhhcc-cccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence             1 111111000 00000000000   0012346788889999999999999999999998643

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=6.5e-42  Score=357.06  Aligned_cols=247  Identities=29%  Similarity=0.417  Sum_probs=202.1

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc---chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEE
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY  337 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  337 (586)
                      +.|+..+.||+|+||.||+|+...++..||||++....   ....+.+.+|++++++++||||+++++++...+..++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            45888899999999999999998899999999997542   334567899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCC
Q 007869          338 DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT  417 (586)
Q Consensus       338 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~  417 (586)
                      ||++ |+|.+++... ...+++..+..++.|+++||.|||+   .+|+||||||+|||++.++.+||+|||+++....  
T Consensus       134 e~~~-g~l~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~--  206 (348)
T 1u5q_A          134 EYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--  206 (348)
T ss_dssp             ECCS-EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--
T ss_pred             ecCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEeeccCceecCC--
Confidence            9997 6888887643 2468999999999999999999998   8999999999999999999999999999986543  


Q ss_pred             CCceeeeccCCCccCccccc---CCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCC
Q 007869          418 DPQTTHVVGTLGYLAPEHTR---TGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDP  494 (586)
Q Consensus       418 ~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~  494 (586)
                         .....||+.|+|||++.   .+.++.++|||||||++|||++|+.||......+      ........      ..+
T Consensus       207 ---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~------~~~~~~~~------~~~  271 (348)
T 1u5q_A          207 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYHIAQN------ESP  271 (348)
T ss_dssp             ---BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHHS------CCC
T ss_pred             ---CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHHhc------CCC
Confidence               23457999999999984   5678999999999999999999999997643211      11111111      111


Q ss_pred             CCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          495 NLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       495 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                      .....   .....+.+++.+||+.||++|||+.++++.
T Consensus       272 ~~~~~---~~~~~l~~li~~~l~~dP~~Rps~~~ll~h  306 (348)
T 1u5q_A          272 ALQSG---HWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  306 (348)
T ss_dssp             CCCCT---TSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             CCCCC---CCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence            11111   112456788889999999999999999864

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=6.4e-42  Score=351.30  Aligned_cols=260  Identities=23%  Similarity=0.296  Sum_probs=200.9

Q ss_pred             CCccc-ceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhccc-CCCceeeeeeeeeccCeEEEEEe
Q 007869          261 KGFRE-KELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKGELLLVYD  338 (586)
Q Consensus       261 ~~f~~-~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~lV~E  338 (586)
                      +.|++ .+.||+|+||.||+|++..++..||||++........+.+.+|++++.++ +||||+++++++...+..++|||
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   91 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE   91 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence            45666 47899999999999999888999999999876666677899999999985 79999999999999999999999


Q ss_pred             cCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCC---eEEccccceeeccC
Q 007869          339 YMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELN---GRLGDFGLARLYDH  415 (586)
Q Consensus       339 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~---~kL~DFGla~~~~~  415 (586)
                      |+++++|.+++...  ..+++..+..++.||++||.|||+   ++|+||||||+|||++.++.   +||+|||+++....
T Consensus        92 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~  166 (316)
T 2ac3_A           92 KMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL  166 (316)
T ss_dssp             CCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred             cCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence            99999999999765  358889999999999999999998   89999999999999988766   99999999986543


Q ss_pred             CCC------CceeeeccCCCccCcccccC-----CCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchh--------h
Q 007869          416 GTD------PQTTHVVGTLGYLAPEHTRT-----GKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLIL--------V  476 (586)
Q Consensus       416 ~~~------~~~~~~~gt~~y~aPE~~~~-----~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l--------~  476 (586)
                      ...      .......||+.|+|||++..     ..++.++|||||||++|||++|+.||......+....        .
T Consensus       167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  246 (316)
T 2ac3_A          167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQ  246 (316)
T ss_dssp             ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHH
T ss_pred             CCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHH
Confidence            211      12233569999999999875     5588999999999999999999999987543321000        0


Q ss_pred             HHHHhhhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          477 DWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       477 ~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      ..+.....++..      .............+.+++.+||+.||.+|||+.|+++
T Consensus       247 ~~~~~~i~~~~~------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          247 NMLFESIQEGKY------EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             HHHHHHHHHCCC------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHhccCc------ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence            001111111111      1100000112356788999999999999999999987

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-41  Score=344.80  Aligned_cols=256  Identities=27%  Similarity=0.362  Sum_probs=202.9

Q ss_pred             CcccceeEeecCceEEEEEEeCCCC---eEEEEEEecccc-chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeE-EEE
Q 007869          262 GFREKELLGTGGFGRVYRGTLPKSQ---IEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGEL-LLV  336 (586)
Q Consensus       262 ~f~~~~~LG~G~~g~Vy~~~~~~~~---~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~-~lV  336 (586)
                      .|...++||+|+||.||+|.+..++   ..||+|.+.... ....+.+.+|+.++++++||||+++++++...+.. ++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            3556789999999999999965443   379999997643 34567899999999999999999999999876654 999


Q ss_pred             EecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCC
Q 007869          337 YDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHG  416 (586)
Q Consensus       337 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~  416 (586)
                      |||+.+|+|.+++... ...+++..++.++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++.....
T Consensus       102 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~  177 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLAE---QKFVHRDLAARNCMLDESFTVKVADFGLARDILDR  177 (298)
T ss_dssp             ECCCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTG
T ss_pred             EecccCCCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEeCcCCCcccccCC
Confidence            9999999999999764 3468899999999999999999998   89999999999999999999999999999865432


Q ss_pred             C---CCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccC
Q 007869          417 T---DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARD  493 (586)
Q Consensus       417 ~---~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d  493 (586)
                      .   ........+|+.|+|||.+.+..++.++|||||||++|||++|..|+.......  .+...+.    .+..     
T Consensus       178 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~--~~~~~~~----~~~~-----  246 (298)
T 3pls_A          178 EYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF--DLTHFLA----QGRR-----  246 (298)
T ss_dssp             GGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGG--GHHHHHH----TTCC-----
T ss_pred             cccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHH--HHHHHhh----cCCC-----
Confidence            1   112334567899999999999999999999999999999999666554332221  1111111    1110     


Q ss_pred             CCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 007869          494 PNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERD  536 (586)
Q Consensus       494 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  536 (586)
                      +....    .....+.+++.+||+.||.+|||+.++++.|++.
T Consensus       247 ~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~  285 (298)
T 3pls_A          247 LPQPE----YCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI  285 (298)
T ss_dssp             CCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCc----cchHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            11111    1224677889999999999999999999999764

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=7.2e-42  Score=353.14  Aligned_cols=257  Identities=28%  Similarity=0.467  Sum_probs=205.9

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEE--EEEEeccc-cchhHHHHHHHHHHhccc-CCCceeeeeeeeeccCeEEE
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEI--AVKKISHE-SRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKGELLL  335 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~v--avK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~l  335 (586)
                      .++|+..+.||+|+||.||+|++..++..+  |+|++... .....+.+.+|++++.++ +||||+++++++...+..++
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l  103 (327)
T 1fvr_A           24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL  103 (327)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred             HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence            367899999999999999999998777655  99998753 334456789999999999 99999999999999999999


Q ss_pred             EEecCCCCChhhhhhcCC--------------CccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCC
Q 007869          336 VYDYMPNGSLDKYLYDQP--------------KVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELN  401 (586)
Q Consensus       336 V~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~  401 (586)
                      ||||+++++|.+++....              ...+++.+++.++.||++||.|||+   ++|+||||||+|||++.++.
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~  180 (327)
T 1fvr_A          104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYV  180 (327)
T ss_dssp             EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGC
T ss_pred             EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCccceEEEcCCCe
Confidence            999999999999997653              2468999999999999999999998   89999999999999999999


Q ss_pred             eEEccccceeeccCCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHH
Q 007869          402 GRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVF  480 (586)
Q Consensus       402 ~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~  480 (586)
                      +||+|||+++......  ......+++.|+|||++.+..++.++|||||||++|||++ |+.||......+   +    .
T Consensus       181 ~kL~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~---~----~  251 (327)
T 1fvr_A          181 AKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---L----Y  251 (327)
T ss_dssp             EEECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---H----H
T ss_pred             EEEcccCcCccccccc--cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH---H----H
Confidence            9999999998533211  2233467889999999988889999999999999999998 999997653221   1    1


Q ss_pred             hhhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 007869          481 DFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERDV  537 (586)
Q Consensus       481 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  537 (586)
                      .....+.     .+.....    ....+.+++.+||+.||.+|||+.|+++.|+...
T Consensus       252 ~~~~~~~-----~~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  299 (327)
T 1fvr_A          252 EKLPQGY-----RLEKPLN----CDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  299 (327)
T ss_dssp             HHGGGTC-----CCCCCTT----BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHhhcCC-----CCCCCCC----CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            1111111     1111112    2355778899999999999999999999997643

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=9e-42  Score=361.13  Aligned_cols=264  Identities=27%  Similarity=0.383  Sum_probs=194.7

Q ss_pred             hcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc--cchhHHHHHHHHHHhcccC-CCceeeeeeeeeccC--eE
Q 007869          259 ATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE--SRQGMKEFVAEIVSIGRLR-HRNLVQLLGYCRRKG--EL  333 (586)
Q Consensus       259 a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~-H~niv~l~~~~~~~~--~~  333 (586)
                      ..++|+..+.||+|+||.||+|.+..++..||||++...  .....+.+.+|+.++.+++ ||||+++++++...+  .+
T Consensus         7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~   86 (388)
T 3oz6_A            7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV   86 (388)
T ss_dssp             HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred             ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence            346899999999999999999999999999999998643  3344567889999999997 999999999997543  78


Q ss_pred             EEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeec
Q 007869          334 LLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLY  413 (586)
Q Consensus       334 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~  413 (586)
                      ++|||||+ ++|.+++...   .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.+
T Consensus        87 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  159 (388)
T 3oz6_A           87 YLVFDYME-TDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSF  159 (388)
T ss_dssp             EEEEECCS-EEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred             EEEecccC-cCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence            99999997 6999999764   58888999999999999999998   89999999999999999999999999999875


Q ss_pred             cCCC--------------------CCceeeeccCCCccCcccccC-CCCCCcceEEehhHHHHHHHhCCCCCCCCCCCcc
Q 007869          414 DHGT--------------------DPQTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIQRQGPSEN  472 (586)
Q Consensus       414 ~~~~--------------------~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~  472 (586)
                      ....                    ....+..+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~  239 (388)
T 3oz6_A          160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ  239 (388)
T ss_dssp             SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             cccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            4311                    112344689999999999976 6789999999999999999999999987543322


Q ss_pred             chhhHHHHhhhccCcc--ccc-------------------cCCCCCcccc------------HHHHHHHHHHHHHhcccC
Q 007869          473 LILVDWVFDFWNRGEL--LEA-------------------RDPNLGTEYV------------AEELELVLKLGLLCSHSD  519 (586)
Q Consensus       473 ~~l~~~v~~~~~~~~~--~~~-------------------~d~~l~~~~~------------~~~~~~l~~l~~~Cl~~d  519 (586)
                      ...+   .........  ...                   ........+.            ......+.+++.+||+.|
T Consensus       240 ~~~i---~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~d  316 (388)
T 3oz6_A          240 LERI---IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFN  316 (388)
T ss_dssp             HHHH---HHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSS
T ss_pred             HHHH---HHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccC
Confidence            1111   110000000  000                   0000000000            011346788999999999


Q ss_pred             CCCCCCHHHHHHH
Q 007869          520 PTARPSMRQVVQI  532 (586)
Q Consensus       520 P~~RPs~~evl~~  532 (586)
                      |++|||+.|+++.
T Consensus       317 P~~R~t~~e~l~H  329 (388)
T 3oz6_A          317 PNKRISANDALKH  329 (388)
T ss_dssp             GGGSCCHHHHTTS
T ss_pred             cccCCCHHHHhCC
Confidence            9999999999864

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=2.5e-41  Score=366.02  Aligned_cols=264  Identities=22%  Similarity=0.232  Sum_probs=199.8

Q ss_pred             hcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc--cchhHHHHHHHHHHhcccCCCceeeeeeeeecc------
Q 007869          259 ATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRK------  330 (586)
Q Consensus       259 a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~------  330 (586)
                      ..++|+..+.||+|+||.||+|++..++..||||++...  .....+.+.+|+.++++++||||+++++++...      
T Consensus        60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  139 (464)
T 3ttj_A           60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF  139 (464)
T ss_dssp             EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred             ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccC
Confidence            457899999999999999999999999999999999754  334567789999999999999999999998654      


Q ss_pred             CeEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccce
Q 007869          331 GELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLA  410 (586)
Q Consensus       331 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla  410 (586)
                      ...++||||+++ +|.+.+..    .+++..+..++.||+.||.|||+   .+|+||||||+|||++.++++||+|||++
T Consensus       140 ~~~~lv~E~~~~-~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDlkp~NIll~~~~~~kl~DFG~a  211 (464)
T 3ttj_A          140 QDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLA  211 (464)
T ss_dssp             CEEEEEEECCSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred             CeEEEEEeCCCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChHhEEEeCCCCEEEEEEEee
Confidence            467999999975 56666643    48889999999999999999998   89999999999999999999999999999


Q ss_pred             eeccCCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhH---------H---
Q 007869          411 RLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVD---------W---  478 (586)
Q Consensus       411 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~---------~---  478 (586)
                      +......  ..+..+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+.         +   
T Consensus       212 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~  289 (464)
T 3ttj_A          212 RTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK  289 (464)
T ss_dssp             -----CC--CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTT
T ss_pred             eecCCCc--ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHH
Confidence            8765432  3445689999999999999999999999999999999999999998754322211100         0   


Q ss_pred             ----HHhhhccCccc------cccCC---CCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          479 ----VFDFWNRGELL------EARDP---NLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       479 ----v~~~~~~~~~~------~~~d~---~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                          ...........      .....   ....+........+.+|+.+||+.||++|||+.|+++.
T Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  356 (464)
T 3ttj_A          290 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  356 (464)
T ss_dssp             SCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             cchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                00000000000      00000   00011112235678899999999999999999999863

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=3.3e-41  Score=341.45  Aligned_cols=251  Identities=25%  Similarity=0.332  Sum_probs=199.4

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc-chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEec
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY  339 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  339 (586)
                      ++|...+.||+|+||.||++....++..||+|++.... ....+.+.+|++++++++||||+++++++...+..++||||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  101 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET  101 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence            56889999999999999999999899999999997653 33467899999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcC--CCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeee---cCCCCeEEccccceeecc
Q 007869          340 MPNGSLDKYLYDQ--PKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLL---DGELNGRLGDFGLARLYD  414 (586)
Q Consensus       340 ~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll---~~~~~~kL~DFGla~~~~  414 (586)
                      +++|+|.+++...  ....+++..++.++.|+++||.|||+   .+|+||||||+|||+   +.++.+||+|||+++...
T Consensus       102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~  178 (285)
T 3is5_A          102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK  178 (285)
T ss_dssp             CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred             CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence            9999999998653  12468999999999999999999998   899999999999999   456789999999998765


Q ss_pred             CCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCC
Q 007869          415 HGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDP  494 (586)
Q Consensus       415 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~  494 (586)
                      ...  ......||+.|+|||++. +.++.++|||||||++|||++|+.||......+   ......  ......     +
T Consensus       179 ~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~---~~~~~~--~~~~~~-----~  245 (285)
T 3is5_A          179 SDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE---VQQKAT--YKEPNY-----A  245 (285)
T ss_dssp             ----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHH--HCCCCC-----C
T ss_pred             Ccc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHH---HHhhhc--cCCccc-----c
Confidence            432  234567999999999985 568999999999999999999999997643221   111100  000000     0


Q ss_pred             CCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          495 NLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       495 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      ......    ...+.+++.+||+.||++|||+.|+++
T Consensus       246 ~~~~~~----~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          246 VECRPL----TPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             C--CCC----CHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             cccCcC----CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            000111    245678889999999999999999985

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.6e-42  Score=356.46  Aligned_cols=264  Identities=24%  Similarity=0.406  Sum_probs=209.9

Q ss_pred             cCCcccceeEeecCceEEEEEE----eCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccC--eE
Q 007869          260 TKGFREKELLGTGGFGRVYRGT----LPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKG--EL  333 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~----~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~--~~  333 (586)
                      .++|+..+.||+|+||.||+|+    ...++..||||++........+.+.+|++++++++||||+++++++...+  ..
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  119 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL  119 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence            4568889999999999999998    45678899999998777677788999999999999999999999987654  78


Q ss_pred             EEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeec
Q 007869          334 LLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLY  413 (586)
Q Consensus       334 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~  413 (586)
                      ++||||+++++|.+++.... ..+++.+++.++.|+++||.|||+   .+|+||||||+|||++.++.+||+|||+++..
T Consensus       120 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~  195 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVL  195 (326)
T ss_dssp             EEEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence            99999999999999998753 368999999999999999999998   89999999999999999999999999999976


Q ss_pred             cCCCCC--ceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCC---------CccchhhHHHHhh
Q 007869          414 DHGTDP--QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGP---------SENLILVDWVFDF  482 (586)
Q Consensus       414 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~---------~~~~~l~~~v~~~  482 (586)
                      ......  ......++..|+|||.+.+..++.++|||||||++|||++|+.|+.....         .........+.+.
T Consensus       196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (326)
T 2w1i_A          196 PQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIEL  275 (326)
T ss_dssp             CSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHH
T ss_pred             cccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHH
Confidence            543321  12234577889999999988899999999999999999999998863210         0000011111111


Q ss_pred             hccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 007869          483 WNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERD  536 (586)
Q Consensus       483 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  536 (586)
                      ...+..     +..    .......+.+++.+||+.||++|||+.|+++.|+..
T Consensus       276 ~~~~~~-----~~~----~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l  320 (326)
T 2w1i_A          276 LKNNGR-----LPR----PDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI  320 (326)
T ss_dssp             HHTTCC-----CCC----CTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             hhcCCC-----CCC----CCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            111111     111    112235678899999999999999999999999763

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=3.1e-42  Score=354.64  Aligned_cols=260  Identities=28%  Similarity=0.386  Sum_probs=205.1

Q ss_pred             CcccceeEeecCceEEEEEEe----CCCCeEEEEEEecccc-chhHHHHHHHHHHhcccCCCceeeeeeeeecc--CeEE
Q 007869          262 GFREKELLGTGGFGRVYRGTL----PKSQIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRK--GELL  334 (586)
Q Consensus       262 ~f~~~~~LG~G~~g~Vy~~~~----~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~--~~~~  334 (586)
                      .|+..+.||+|+||.||++.+    ..++..||||++.... ....+.+.+|++++++++||||+++++++...  ...+
T Consensus        32 ~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  111 (318)
T 3lxp_A           32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQ  111 (318)
T ss_dssp             GEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEE
T ss_pred             HHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEE
Confidence            348899999999999988764    3467889999997653 34467799999999999999999999999874  6789


Q ss_pred             EEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeecc
Q 007869          335 LVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYD  414 (586)
Q Consensus       335 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~  414 (586)
                      +||||+++|+|.+++...   .+++..++.++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++...
T Consensus       112 lv~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  185 (318)
T 3lxp_A          112 LVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  185 (318)
T ss_dssp             EEECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred             EEEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEEcCCCCEEECCcccccccc
Confidence            999999999999999765   48899999999999999999998   899999999999999999999999999999875


Q ss_pred             CCCCC--ceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCc--------cchhhHHHHhhhc
Q 007869          415 HGTDP--QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSE--------NLILVDWVFDFWN  484 (586)
Q Consensus       415 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~--------~~~l~~~v~~~~~  484 (586)
                      .....  ......+|..|+|||++.+..++.++|||||||++|||++|+.||.......        .......+.+...
T Consensus       186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (318)
T 3lxp_A          186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE  265 (318)
T ss_dssp             TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHH
T ss_pred             ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHh
Confidence            54321  1234567889999999999899999999999999999999999986532110        0000001111111


Q ss_pred             cCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 007869          485 RGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERD  536 (586)
Q Consensus       485 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  536 (586)
                      .+.     .    ..........+.+++.+||+.||.+|||+.|+++.|+..
T Consensus       266 ~~~-----~----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l  308 (318)
T 3lxp_A          266 RGE-----R----LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTV  308 (318)
T ss_dssp             TTC-----C----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccc-----C----CCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            111     1    111122335688899999999999999999999999753

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=2.7e-41  Score=365.99  Aligned_cols=252  Identities=24%  Similarity=0.424  Sum_probs=209.0

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc---chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEE
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLV  336 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV  336 (586)
                      .++|...+.||+|+||.||+|++..++..||||++....   ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv   94 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV   94 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            467899999999999999999999899999999997542   23456789999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCC
Q 007869          337 YDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHG  416 (586)
Q Consensus       337 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~  416 (586)
                      |||+++|+|.+++...  ..+++..++.++.||+.||.|||+   .+|+||||||+|||++.++++||+|||+++.....
T Consensus        95 ~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~  169 (476)
T 2y94_A           95 MEYVSGGELFDYICKN--GRLDEKESRRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG  169 (476)
T ss_dssp             EECCSSEEHHHHTTSS--SSCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred             EeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCCCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence            9999999999999754  468999999999999999999998   89999999999999999999999999999976543


Q ss_pred             CCCceeeeccCCCccCcccccCCCC-CCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCC
Q 007869          417 TDPQTTHVVGTLGYLAPEHTRTGKA-TTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPN  495 (586)
Q Consensus       417 ~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~  495 (586)
                      .  ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||......+   +..    ...++...   .| 
T Consensus       170 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~---~~~----~i~~~~~~---~p-  236 (476)
T 2y94_A          170 E--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT---LFK----KICDGIFY---TP-  236 (476)
T ss_dssp             C--CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH---HHH----HHHTTCCC---CC-
T ss_pred             c--cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH---HHH----HHhcCCcC---CC-
Confidence            2  2344679999999999988765 689999999999999999999997643321   111    11111110   11 


Q ss_pred             CCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHhh
Q 007869          496 LGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ--ILER  535 (586)
Q Consensus       496 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~  535 (586)
                        ...    ...+.+++.+||+.||.+|||+.|+++  .+.+
T Consensus       237 --~~~----s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~  272 (476)
T 2y94_A          237 --QYL----NPSVISLLKHMLQVDPMKRATIKDIREHEWFKQ  272 (476)
T ss_dssp             --TTC----CHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHT
T ss_pred             --ccC----CHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhh
Confidence              111    245678889999999999999999996  4444

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=5.8e-42  Score=345.29  Aligned_cols=252  Identities=31%  Similarity=0.432  Sum_probs=199.6

Q ss_pred             hhhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeecc-CeEEE
Q 007869          257 YIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRK-GELLL  335 (586)
Q Consensus       257 ~~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~-~~~~l  335 (586)
                      ....++|+..+.||+|+||.||++.+.  +..||||++....  ..+.+.+|++++++++||||+++++++... +..++
T Consensus        17 ~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~l   92 (278)
T 1byg_A           17 ALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI   92 (278)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEE
T ss_pred             cCChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEE
Confidence            345578999999999999999999884  6789999997543  457799999999999999999999987654 57899


Q ss_pred             EEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccC
Q 007869          336 VYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH  415 (586)
Q Consensus       336 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~  415 (586)
                      ||||+++++|.+++.......+++..++.++.|+++||.|||+   ++|+||||||+||+++.++.+||+|||+++....
T Consensus        93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~  169 (278)
T 1byg_A           93 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  169 (278)
T ss_dssp             EECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred             EEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence            9999999999999976544457889999999999999999998   8999999999999999999999999999986543


Q ss_pred             CCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccCccccccCC
Q 007869          416 GTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEARDP  494 (586)
Q Consensus       416 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~  494 (586)
                      .    .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||......+   +.    ....++.     .+
T Consensus       170 ~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~----~~~~~~~-----~~  233 (278)
T 1byg_A          170 T----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VV----PRVEKGY-----KM  233 (278)
T ss_dssp             ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HH----HHHTTTC-----CC
T ss_pred             c----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH---HH----HHHhcCC-----CC
Confidence            2    223467899999999998999999999999999999998 999997653322   11    1111111     11


Q ss_pred             CCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 007869          495 NLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER  535 (586)
Q Consensus       495 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  535 (586)
                      ....    .....+.+++.+||+.||.+||++.|+++.|+.
T Consensus       234 ~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~  270 (278)
T 1byg_A          234 DAPD----GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEH  270 (278)
T ss_dssp             CCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCcc----cCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHH
Confidence            1111    223567788899999999999999999999875

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.2e-40  Score=345.54  Aligned_cols=267  Identities=27%  Similarity=0.385  Sum_probs=209.7

Q ss_pred             hhhhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcc--cCCCceeeeeeeeeccC--
Q 007869          256 LYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGR--LRHRNLVQLLGYCRRKG--  331 (586)
Q Consensus       256 l~~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~--l~H~niv~l~~~~~~~~--  331 (586)
                      -....++|...+.||+|+||.||+|++  ++..||||++...   ..+.+..|++++..  ++||||+++++++...+  
T Consensus        37 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~  111 (342)
T 1b6c_B           37 QRTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGT  111 (342)
T ss_dssp             HHHHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSS
T ss_pred             cccccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCc
Confidence            344567899999999999999999998  4788999999644   33567788888877  79999999999998775  


Q ss_pred             --eEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhccc-----CCcEEeCCCCCCCeeecCCCCeEE
Q 007869          332 --ELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEW-----EQVVIHRDVKASNVLLDGELNGRL  404 (586)
Q Consensus       332 --~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-----~~~ivHrDIkp~NIll~~~~~~kL  404 (586)
                        ..++||||+++|+|.+++...   .+++.+++.++.|++.||.|||...     +.+|+||||||+|||++.++++||
T Consensus       112 ~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL  188 (342)
T 1b6c_B          112 WTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI  188 (342)
T ss_dssp             CCCEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEE
T ss_pred             cceeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEE
Confidence              799999999999999999764   5899999999999999999999210     289999999999999999999999


Q ss_pred             ccccceeeccCCCCC---ceeeeccCCCccCcccccCCC------CCCcceEEehhHHHHHHHhC----------CCCCC
Q 007869          405 GDFGLARLYDHGTDP---QTTHVVGTLGYLAPEHTRTGK------ATTSADVFSFGAFLLEVACG----------RRPIQ  465 (586)
Q Consensus       405 ~DFGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~s~ksDVyS~Gvvl~ElltG----------~~p~~  465 (586)
                      +|||+++........   ......||+.|+|||++.+..      ++.++|||||||++|||++|          +.||.
T Consensus       189 ~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~  268 (342)
T 1b6c_B          189 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY  268 (342)
T ss_dssp             CCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred             EECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcc
Confidence            999999876654322   123457999999999997652      34689999999999999999          67876


Q ss_pred             CCCCCccchhhHHHHhhhccCccccccCCCCCccc-cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 007869          466 RQGPSENLILVDWVFDFWNRGELLEARDPNLGTEY-VAEELELVLKLGLLCSHSDPTARPSMRQVVQILERD  536 (586)
Q Consensus       466 ~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  536 (586)
                      .....+.. ...+. .....    ....+.+...+ ..+....+.+++.+||+.||++|||+.|+++.|+..
T Consensus       269 ~~~~~~~~-~~~~~-~~~~~----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i  334 (342)
T 1b6c_B          269 DLVPSDPS-VEEMR-KVVCE----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL  334 (342)
T ss_dssp             TTSCSSCC-HHHHH-HHHTT----SCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccCcCccc-HHHHH-HHHHH----HHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence            54332211 11111 11111    11223332222 346677899999999999999999999999999763

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.5e-41  Score=354.51  Aligned_cols=262  Identities=18%  Similarity=0.169  Sum_probs=206.1

Q ss_pred             cCCcccceeEeecCceEEEEEEeCC--------CCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceee---------
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPK--------SQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQ---------  322 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~---------  322 (586)
                      .++|+..+.||+|+||.||+|++..        .+..||||++...     +.+.+|++++++++||||++         
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            4689999999999999999999976        3788999998654     45789999999999999998         


Q ss_pred             ------eeeeeec-cCeEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCee
Q 007869          323 ------LLGYCRR-KGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVL  395 (586)
Q Consensus       323 ------l~~~~~~-~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIl  395 (586)
                            +++++.. .+..++||||+ +++|.+++.......+++..++.++.||++||.|||+   ++|+||||||+|||
T Consensus       116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIl  191 (352)
T 2jii_A          116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHE---NEYVHGNVTAENIF  191 (352)
T ss_dssp             TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCGGGEE
T ss_pred             ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEE
Confidence                  5667665 67899999999 9999999987655679999999999999999999998   89999999999999


Q ss_pred             ecCCC--CeEEccccceeeccCCCCC------ceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCC
Q 007869          396 LDGEL--NGRLGDFGLARLYDHGTDP------QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQ  467 (586)
Q Consensus       396 l~~~~--~~kL~DFGla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~  467 (586)
                      ++.++  .+||+|||+++.+......      ......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  271 (352)
T 2jii_A          192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNC  271 (352)
T ss_dssp             EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred             EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence            99998  8999999999876532211      123357999999999999999999999999999999999999999865


Q ss_pred             CCCccchhhHHHHhhhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 007869          468 GPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERD  536 (586)
Q Consensus       468 ~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  536 (586)
                      ..... .+..........  .....++.....   .....+.+++.+||+.||++||++.++++.|+..
T Consensus       272 ~~~~~-~~~~~~~~~~~~--~~~~~~~~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  334 (352)
T 2jii_A          272 LPNTE-DIMKQKQKFVDK--PGPFVGPCGHWI---RPSETLQKYLKVVMALTYEEKPPYAMLRNNLEAL  334 (352)
T ss_dssp             TTCHH-HHHHHHHHHHHS--CCCEECTTSCEE---CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             CcCHH-HHHHHHHhccCC--hhhhhhhccccC---CCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHH
Confidence            43221 111111111111  111111111100   1125677888899999999999999999999764

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-41  Score=358.56  Aligned_cols=256  Identities=29%  Similarity=0.434  Sum_probs=195.5

Q ss_pred             CcccceeEeecCceEEEEEEeCCC---CeEEEEEEeccc-cchhHHHHHHHHHHhcccCCCceeeeeeeeec-cCeEEEE
Q 007869          262 GFREKELLGTGGFGRVYRGTLPKS---QIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRR-KGELLLV  336 (586)
Q Consensus       262 ~f~~~~~LG~G~~g~Vy~~~~~~~---~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~-~~~~~lV  336 (586)
                      .|...+.||+|+||.||+|++..+   ...||||.+... .....++|.+|+.++++++||||++++++|.. .+..++|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            466778999999999999987432   346899998654 34556789999999999999999999998754 5678999


Q ss_pred             EecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCC
Q 007869          337 YDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHG  416 (586)
Q Consensus       337 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~  416 (586)
                      |||+++|+|.+++... ...+++..++.++.||++||.|||+   ++|+||||||+|||+++++.+||+|||+++.....
T Consensus       170 ~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~  245 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK  245 (373)
T ss_dssp             EECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             EECCCCCCHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCccchheEEECCCCCEEEeecccccccccc
Confidence            9999999999999765 3468889999999999999999998   89999999999999999999999999999865432


Q ss_pred             CC---CceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccCcccccc
Q 007869          417 TD---PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEAR  492 (586)
Q Consensus       417 ~~---~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~  492 (586)
                      ..   .......+|+.|+|||++.+..++.++|||||||++|||++ |..||......+.   ...+    .++...  .
T Consensus       246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~---~~~~----~~~~~~--~  316 (373)
T 3c1x_A          246 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI---TVYL----LQGRRL--L  316 (373)
T ss_dssp             ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCH---HHHH----HTTCCC--C
T ss_pred             ccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHH---HHHH----HcCCCC--C
Confidence            21   12234567889999999999999999999999999999999 6777766544321   1111    111111  1


Q ss_pred             CCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 007869          493 DPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERDV  537 (586)
Q Consensus       493 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  537 (586)
                      .|.       .....+.+++.+||+.||++||++.|+++.|+...
T Consensus       317 ~p~-------~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~  354 (373)
T 3c1x_A          317 QPE-------YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF  354 (373)
T ss_dssp             CCT-------TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCC-------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            111       12345778899999999999999999999998643

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=7.3e-42  Score=354.81  Aligned_cols=243  Identities=22%  Similarity=0.338  Sum_probs=203.8

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccc--------hhHHHHHHHHHHhcccCCCceeeeeeeeeccC
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR--------QGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKG  331 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~  331 (586)
                      .++|+..+.||+|+||.||+|++..++..||||++.....        ...+.+.+|+.++++++||||+++++++...+
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~  102 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG  102 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence            4578999999999999999999999999999999976421        13345788999999999999999999999999


Q ss_pred             eEEEEEecCCCC-ChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccce
Q 007869          332 ELLLVYDYMPNG-SLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLA  410 (586)
Q Consensus       332 ~~~lV~E~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla  410 (586)
                      ..++||||+.+| +|.+++....  .+++..++.++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||++
T Consensus       103 ~~~lv~e~~~~g~~l~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a  177 (335)
T 3dls_A          103 FFQLVMEKHGSGLDLFAFIDRHP--RLDEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSA  177 (335)
T ss_dssp             EEEEEEECCTTSCBHHHHHHTCC--CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEEEEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeEEeccCHHHEEEcCCCcEEEeecccc
Confidence            999999999777 9999997653  58899999999999999999998   89999999999999999999999999999


Q ss_pred             eeccCCCCCceeeeccCCCccCcccccCCCC-CCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccc
Q 007869          411 RLYDHGTDPQTTHVVGTLGYLAPEHTRTGKA-TTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELL  489 (586)
Q Consensus       411 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~  489 (586)
                      +......  ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||......                 ..
T Consensus       178 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----------------~~  238 (335)
T 3dls_A          178 AYLERGK--LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET-----------------VE  238 (335)
T ss_dssp             EECCTTC--CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-----------------TT
T ss_pred             eECCCCC--ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-----------------Hh
Confidence            9765433  2345679999999999988876 78999999999999999999999652110                 00


Q ss_pred             cccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          490 EARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       490 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                      ....+.  ..    ....+.+++.+||+.||++|||+.++++.
T Consensus       239 ~~~~~~--~~----~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          239 AAIHPP--YL----VSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             TCCCCS--SC----CCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             hccCCC--cc----cCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            001110  11    12457788899999999999999999874

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.8e-41  Score=362.62  Aligned_cols=253  Identities=24%  Similarity=0.321  Sum_probs=194.5

Q ss_pred             hcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc--------chhHHHHHHHHHHhcccCCCceeeeeeeeecc
Q 007869          259 ATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES--------RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRK  330 (586)
Q Consensus       259 a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~  330 (586)
                      ..++|...+.||+|+||.||+|.+..++..||||++....        ......+.+|+.+|++++||||+++++++.. 
T Consensus       133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-  211 (419)
T 3i6u_A          133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-  211 (419)
T ss_dssp             HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-
T ss_pred             hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-
Confidence            3568999999999999999999999999999999987542        1122358899999999999999999999854 


Q ss_pred             CeEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCC---CCeEEccc
Q 007869          331 GELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGE---LNGRLGDF  407 (586)
Q Consensus       331 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~---~~~kL~DF  407 (586)
                      +..++||||+++|+|.+++...  ..+++..+..++.|+++||.|||+   ++|+||||||+|||++.+   ..+||+||
T Consensus       212 ~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kl~DF  286 (419)
T 3i6u_A          212 EDYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDF  286 (419)
T ss_dssp             SEEEEEEECCTTCBGGGGTSSS--CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSSSCCEEECCS
T ss_pred             CceEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCCCcceEEEeec
Confidence            5589999999999999998765  368999999999999999999998   899999999999999754   45999999


Q ss_pred             cceeeccCCCCCceeeeccCCCccCcccccC---CCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhc
Q 007869          408 GLARLYDHGTDPQTTHVVGTLGYLAPEHTRT---GKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWN  484 (586)
Q Consensus       408 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~  484 (586)
                      |+++.....  .......||+.|+|||++.+   ..++.++|||||||++|||++|+.||........  +.+.+    .
T Consensus       287 G~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~--~~~~i----~  358 (419)
T 3i6u_A          287 GHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQI----T  358 (419)
T ss_dssp             STTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC--HHHHH----H
T ss_pred             ccceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH--HHHHH----h
Confidence            999876532  23345679999999999853   5678899999999999999999999976443221  11111    1


Q ss_pred             cCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          485 RGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       485 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      .+...      ...+........+.+++.+||+.||++|||+.|+++
T Consensus       359 ~~~~~------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          359 SGKYN------FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             TTCCC------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             cCCCC------CCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            11110      000111122356788999999999999999999986

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=3.4e-41  Score=338.66  Aligned_cols=252  Identities=25%  Similarity=0.336  Sum_probs=206.3

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc-chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEec
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY  339 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  339 (586)
                      ++|+..+.||+|+||.||+|++..++..||||++.... ....+.+.+|+.++++++||||+++++++...+..++||||
T Consensus         7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (276)
T 2yex_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   86 (276)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEe
Confidence            56888999999999999999999889999999997543 34457789999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCC-
Q 007869          340 MPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD-  418 (586)
Q Consensus       340 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~-  418 (586)
                      +++++|.+++...  ..+++..++.++.|+++||.|||+   .+|+||||||+||+++.++.+||+|||++........ 
T Consensus        87 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~  161 (276)
T 2yex_A           87 CSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  161 (276)
T ss_dssp             CTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             cCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcch
Confidence            9999999999654  368899999999999999999998   8999999999999999999999999999987643321 


Q ss_pred             CceeeeccCCCccCcccccCCCC-CCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCC
Q 007869          419 PQTTHVVGTLGYLAPEHTRTGKA-TTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLG  497 (586)
Q Consensus       419 ~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~  497 (586)
                      .......||+.|+|||++.+..+ +.++||||||+++|||++|+.||........ ....|..     ....    ... 
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~-----~~~~----~~~-  230 (276)
T 2yex_A          162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWKE-----KKTY----LNP-  230 (276)
T ss_dssp             CCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HHHHHHT-----TCTT----STT-
T ss_pred             hcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHhhh-----cccc----cCc-
Confidence            12334678999999999987765 7799999999999999999999986543221 1122211     1000    000 


Q ss_pred             ccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          498 TEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       498 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                         .......+.+++.+||+.||.+|||+.|+++
T Consensus       231 ---~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          231 ---WKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             ---GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ---hhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence               1112345678899999999999999999975

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.4e-41  Score=351.41  Aligned_cols=250  Identities=22%  Similarity=0.313  Sum_probs=195.0

Q ss_pred             hcCCcccceeEeecCceEEEEEEeC---CCCeEEEEEEecccc----chhHHHHHHHHHHhcccCCCceeeeeeeeeccC
Q 007869          259 ATKGFREKELLGTGGFGRVYRGTLP---KSQIEIAVKKISHES----RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKG  331 (586)
Q Consensus       259 a~~~f~~~~~LG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~  331 (586)
                      ..++|+..+.||+|+||.||+++..   .++..||+|++....    ......+.+|+.++++++||||+++++++...+
T Consensus        15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   94 (327)
T 3a62_A           15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGG   94 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCC
Confidence            3467999999999999999999984   578899999997642    233456889999999999999999999999999


Q ss_pred             eEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEcccccee
Q 007869          332 ELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR  411 (586)
Q Consensus       332 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~  411 (586)
                      ..++||||+++++|.+++...  ..+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++
T Consensus        95 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~  169 (327)
T 3a62_A           95 KLYLILEYLSGGELFMQLERE--GIFMEDTACFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCK  169 (327)
T ss_dssp             CEEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred             EEEEEEeCCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHh---CCEEcccCCHHHeEECCCCcEEEEeCCccc
Confidence            999999999999999999764  357888999999999999999998   899999999999999999999999999998


Q ss_pred             eccCCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccc
Q 007869          412 LYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEA  491 (586)
Q Consensus       412 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~  491 (586)
                      ...... .......||+.|+|||++.+..++.++|||||||++|||++|+.||......+   ..+.+.    +..    
T Consensus       170 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~----~~~----  237 (327)
T 3a62_A          170 ESIHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK---TIDKIL----KCK----  237 (327)
T ss_dssp             ----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHHH----HTC----
T ss_pred             ccccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH---HHHHHH----hCC----
Confidence            643322 12334579999999999999999999999999999999999999997643221   111111    111    


Q ss_pred             cCCCCCccccHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 007869          492 RDPNLGTEYVAEELELVLKLGLLCSHSDPTARP-----SMRQVVQ  531 (586)
Q Consensus       492 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~  531 (586)
                        ..+..    .....+.+++.+||+.||.+||     ++.|+++
T Consensus       238 --~~~p~----~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          238 --LNLPP----YLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             --CCCCT----TSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             --CCCCC----CCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence              11111    1234577888999999999999     7778875

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=3.7e-41  Score=339.68  Aligned_cols=249  Identities=22%  Similarity=0.399  Sum_probs=206.4

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeec----------
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRR----------  329 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~----------  329 (586)
                      .++|+..+.||+|+||.||+|++..++..||+|++....    +.+.+|++++++++||||+++++++..          
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   85 (284)
T 2a19_B           10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSK   85 (284)
T ss_dssp             HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC------
T ss_pred             ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccc
Confidence            356889999999999999999998889999999997653    346789999999999999999998854          


Q ss_pred             ------cCeEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeE
Q 007869          330 ------KGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGR  403 (586)
Q Consensus       330 ------~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~k  403 (586)
                            ....++||||+++++|.+++.......+++..++.++.|++.||.|||+   .+|+||||||+|||++.++.+|
T Consensus        86 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~k  162 (284)
T 2a19_B           86 NSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVK  162 (284)
T ss_dssp             ---CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEE
T ss_pred             cccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHEEEcCCCCEE
Confidence                  4568999999999999999976655678999999999999999999998   8999999999999999999999


Q ss_pred             EccccceeeccCCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhh
Q 007869          404 LGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFW  483 (586)
Q Consensus       404 L~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~  483 (586)
                      |+|||+++......  ......||+.|+|||++.+..++.++||||||+++|||++|..|+...        ..+ ....
T Consensus       163 l~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--------~~~-~~~~  231 (284)
T 2a19_B          163 IGDFGLVTSLKNDG--KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--------SKF-FTDL  231 (284)
T ss_dssp             ECCCTTCEESSCCS--CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--------HHH-HHHH
T ss_pred             ECcchhheeccccc--cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--------HHH-HHHh
Confidence            99999998765432  233457999999999999999999999999999999999999887421        011 1111


Q ss_pred             ccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhccC
Q 007869          484 NRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERDVA  538 (586)
Q Consensus       484 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~  538 (586)
                      ..+.        +...++    ..+.+++.+||+.||.+||++.|+++.|+....
T Consensus       232 ~~~~--------~~~~~~----~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~  274 (284)
T 2a19_B          232 RDGI--------ISDIFD----KKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK  274 (284)
T ss_dssp             HTTC--------CCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred             hccc--------ccccCC----HHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence            1111        111122    346788889999999999999999999976543

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1.6e-40  Score=351.35  Aligned_cols=263  Identities=21%  Similarity=0.250  Sum_probs=208.2

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccC--------CCceeeeeeeee---
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLR--------HRNLVQLLGYCR---  328 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~--------H~niv~l~~~~~---  328 (586)
                      .++|+..+.||+|+||.||+|++..++..||||++... ....+.+.+|+.++++++        |+||+++++++.   
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            47899999999999999999999999999999999654 334567889999999985        888999999987   


Q ss_pred             -ccCeEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCC-cEEeCCCCCCCeeecCCC------
Q 007869          329 -RKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQ-VVIHRDVKASNVLLDGEL------  400 (586)
Q Consensus       329 -~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~-~ivHrDIkp~NIll~~~~------  400 (586)
                       .....++||||+ +++|.+.+.......+++..++.++.||++||.|||+   + +|+||||||+|||++.++      
T Consensus       115 ~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~givHrDikp~NIll~~~~~~~~~~  190 (397)
T 1wak_A          115 VNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHT---KCRIIHTDIKPENILLSVNEQYIRRL  190 (397)
T ss_dssp             TTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECCCCSGGGEEECCCHHHHHHH
T ss_pred             CCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHeeEeccchhhhhh
Confidence             566899999999 6777777766655679999999999999999999998   7 999999999999998775      


Q ss_pred             -------------------------------------------CeEEccccceeeccCCCCCceeeeccCCCccCccccc
Q 007869          401 -------------------------------------------NGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTR  437 (586)
Q Consensus       401 -------------------------------------------~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~  437 (586)
                                                                 .+||+|||+++.....    .....||+.|+|||++.
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~  266 (397)
T 1wak_A          191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLI  266 (397)
T ss_dssp             HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHH
T ss_pred             hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhhc
Confidence                                                       7999999999876542    23457899999999999


Q ss_pred             CCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccch---hhHHHHhhhc-------------------cCccccccCCC
Q 007869          438 TGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLI---LVDWVFDFWN-------------------RGELLEARDPN  495 (586)
Q Consensus       438 ~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~---l~~~v~~~~~-------------------~~~~~~~~d~~  495 (586)
                      +..++.++|||||||++|||++|+.||......+...   ....+.+...                   .+......+..
T Consensus       267 ~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (397)
T 1wak_A          267 GSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLK  346 (397)
T ss_dssp             TSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCC
T ss_pred             CCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccC
Confidence            9999999999999999999999999998655433211   1111111000                   00000000000


Q ss_pred             C---------CccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          496 L---------GTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       496 l---------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      .         ...........+.+|+.+||+.||++|||+.|+++
T Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          347 PWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             CCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             CcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence            0         01234566778999999999999999999999985

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.5e-41  Score=359.87  Aligned_cols=253  Identities=22%  Similarity=0.359  Sum_probs=198.1

Q ss_pred             hhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc--cchhHHHHHHHHHHhcccC--CCceeeeeeeeeccCeE
Q 007869          258 IATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE--SRQGMKEFVAEIVSIGRLR--HRNLVQLLGYCRRKGEL  333 (586)
Q Consensus       258 ~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~--H~niv~l~~~~~~~~~~  333 (586)
                      ...+.|+..+.||+|+||.||+|.+.. +..||||++...  ..+..+.+.+|+.++.+++  ||||+++++++...+.+
T Consensus        53 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~  131 (390)
T 2zmd_A           53 VKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI  131 (390)
T ss_dssp             ETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             ccCCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEE
Confidence            344569999999999999999999865 778999998654  3445678999999999996  59999999999999999


Q ss_pred             EEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeec
Q 007869          334 LLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLY  413 (586)
Q Consensus       334 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~  413 (586)
                      ++||| +.+++|.+++....  .+++.++..++.||+.||.|||+   .+|+||||||+|||++ ++.+||+|||+++.+
T Consensus       132 ~lv~E-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~  204 (390)
T 2zmd_A          132 YMVME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQM  204 (390)
T ss_dssp             EEEEE-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCCGGGEEES-SSCEEECCCSSSCCC
T ss_pred             EEEEe-cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEEE-CCeEEEEecCccccc
Confidence            99999 56889999998763  67888999999999999999998   8999999999999996 578999999999876


Q ss_pred             cCCCCC-ceeeeccCCCccCcccccC-----------CCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHh
Q 007869          414 DHGTDP-QTTHVVGTLGYLAPEHTRT-----------GKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFD  481 (586)
Q Consensus       414 ~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~  481 (586)
                      ...... ......||+.|+|||++.+           ..++.++|||||||++|||++|+.||......     ......
T Consensus       205 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-----~~~~~~  279 (390)
T 2zmd_A          205 QPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----ISKLHA  279 (390)
T ss_dssp             ---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-----HHHHHH
T ss_pred             cCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH-----HHHHHH
Confidence            543221 2345679999999999865           46889999999999999999999999754321     111111


Q ss_pred             hhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          482 FWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       482 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                      ...         +.....+.......+.+++.+||+.||.+||++.|+++.
T Consensus       280 ~~~---------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          280 IID---------PNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             HHC---------TTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HhC---------ccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence            111         111111111113457788899999999999999999864

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=2.2e-41  Score=352.23  Aligned_cols=252  Identities=25%  Similarity=0.312  Sum_probs=202.3

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhccc-CCCceeeeeeeeeccCeEEEEEe
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKGELLLVYD  338 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~lV~E  338 (586)
                      .++|+..+.||+|+||.||+|.++.++..||||++......    ..+|++++.++ +||||+++++++.+.+..++|||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E   96 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE   96 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred             cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence            45788999999999999999999999999999999765432    35688888888 79999999999999999999999


Q ss_pred             cCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCC----CCeEEccccceeecc
Q 007869          339 YMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGE----LNGRLGDFGLARLYD  414 (586)
Q Consensus       339 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~----~~~kL~DFGla~~~~  414 (586)
                      |+++|+|.+++...  ..+++..+..++.||+.||.|||+   .+|+||||||+|||+.++    +.+||+|||+++...
T Consensus        97 ~~~gg~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~---~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~  171 (342)
T 2qr7_A           97 LMKGGELLDKILRQ--KFFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR  171 (342)
T ss_dssp             CCCSCBHHHHHHTC--TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred             CCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence            99999999999765  358899999999999999999998   899999999999998433    349999999999765


Q ss_pred             CCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCC
Q 007869          415 HGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDP  494 (586)
Q Consensus       415 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~  494 (586)
                      .... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..........+.    .....+...     
T Consensus       172 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~----~~i~~~~~~-----  241 (342)
T 2qr7_A          172 AENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEIL----ARIGSGKFS-----  241 (342)
T ss_dssp             CTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHH----HHHHHCCCC-----
T ss_pred             CCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHH----HHHccCCcc-----
Confidence            4322 234467899999999998888999999999999999999999999764322211111    111122211     


Q ss_pred             CCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          495 NLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       495 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                       +...+.......+.+++.+||+.||++||++.|+++
T Consensus       242 -~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          242 -LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             -CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             -cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence             111111122355778889999999999999999986

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=4.8e-41  Score=340.97  Aligned_cols=253  Identities=27%  Similarity=0.426  Sum_probs=202.7

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEecC
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYM  340 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  340 (586)
                      ++|....+||+|+||.||+|.+..++..||||.+........+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus        22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  101 (295)
T 2clq_A           22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV  101 (295)
T ss_dssp             CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence            45566679999999999999999899999999998776666788999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCC-CccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecC-CCCeEEccccceeeccCCCC
Q 007869          341 PNGSLDKYLYDQP-KVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDG-ELNGRLGDFGLARLYDHGTD  418 (586)
Q Consensus       341 ~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~-~~~~kL~DFGla~~~~~~~~  418 (586)
                      ++++|.+++.... ...+++..+..++.|++.||.|||+   .+|+||||||+|||++. ++.+||+|||+++...... 
T Consensus       102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~-  177 (295)
T 2clq_A          102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN-  177 (295)
T ss_dssp             SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---
T ss_pred             CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHh---CCEEccCCChhhEEEECCCCCEEEeecccccccCCCC-
Confidence            9999999997653 2456788899999999999999998   89999999999999987 8999999999998764322 


Q ss_pred             CceeeeccCCCccCcccccCCC--CCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCC
Q 007869          419 PQTTHVVGTLGYLAPEHTRTGK--ATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNL  496 (586)
Q Consensus       419 ~~~~~~~gt~~y~aPE~~~~~~--~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l  496 (586)
                      .......||+.|+|||++.+..  ++.++||||||+++|||++|+.||..........   +....       ....+.+
T Consensus       178 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~~~~~-------~~~~~~~  247 (295)
T 2clq_A          178 PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAM---FKVGM-------FKVHPEI  247 (295)
T ss_dssp             ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHH---HHHHH-------HCCCCCC
T ss_pred             CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHH---Hhhcc-------ccccccc
Confidence            2233457899999999987653  7899999999999999999999997543221100   00000       0112222


Q ss_pred             CccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          497 GTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       497 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      ...+    ...+.+++.+||+.||++||++.++++
T Consensus       248 ~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          248 PESM----SAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             CTTS----CHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             cccC----CHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            2222    345778889999999999999999985

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.5e-41  Score=351.41  Aligned_cols=265  Identities=23%  Similarity=0.320  Sum_probs=197.1

Q ss_pred             hhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccc--hhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEE
Q 007869          258 IATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR--QGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLL  335 (586)
Q Consensus       258 ~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~l  335 (586)
                      ...++|+..+.||+|+||.||+|++..++..||||++.....  ...+.+.+|++++++++||||+++++++...+..++
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  110 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHL  110 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEE
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEE
Confidence            445679999999999999999999999999999999975432  234568899999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeec-----CCCCeEEccccce
Q 007869          336 VYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLD-----GELNGRLGDFGLA  410 (586)
Q Consensus       336 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~-----~~~~~kL~DFGla  410 (586)
                      ||||++ |+|.+++....  .+++..+..++.||++||.|||+   ++|+||||||+|||++     .++.+||+|||++
T Consensus       111 v~e~~~-~~L~~~~~~~~--~~~~~~~~~i~~ql~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a  184 (329)
T 3gbz_A          111 IFEYAE-NDLKKYMDKNP--DVSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA  184 (329)
T ss_dssp             EEECCS-EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred             EEecCC-CCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCEECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence            999997 59999997764  58889999999999999999998   8999999999999994     4556999999999


Q ss_pred             eeccCCCCCceeeeccCCCccCcccccCC-CCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhh--ccCc
Q 007869          411 RLYDHGTDPQTTHVVGTLGYLAPEHTRTG-KATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFW--NRGE  487 (586)
Q Consensus       411 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~--~~~~  487 (586)
                      +...... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||......+..  ........  ....
T Consensus       185 ~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~  261 (329)
T 3gbz_A          185 RAFGIPI-RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQL--FKIFEVLGLPDDTT  261 (329)
T ss_dssp             HHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHHHHHCCCCTTT
T ss_pred             cccCCcc-cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHH--HHHHHHhCCCchhh
Confidence            8765332 223445789999999999875 4899999999999999999999999765432211  11110000  0000


Q ss_pred             --------cccccCCCCCcccc-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          488 --------LLEARDPNLGTEYV-----AEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       488 --------~~~~~d~~l~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                              ......+.......     ......+.+++.+||+.||++|||+.|+++
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          262 WPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             STTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence                    00000111111111     112356788999999999999999999986

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=2.2e-42  Score=348.12  Aligned_cols=258  Identities=24%  Similarity=0.346  Sum_probs=207.0

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc--cchhHHHHHHHHHHhcccCCCceeeeeeeee--ccCeEEE
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCR--RKGELLL  335 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~--~~~~~~l  335 (586)
                      .++|+..+.||+|+||.||++....+++.||+|++...  .....+.+.+|++++++++||||+++++++.  ..+..++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            46789999999999999999999989999999999754  3344567999999999999999999999874  4678999


Q ss_pred             EEecCCCCChhhhhhcCC--CccchhHHHHHHHHHHHHHHHHhhcccCCc-----EEeCCCCCCCeeecCCCCeEEcccc
Q 007869          336 VYDYMPNGSLDKYLYDQP--KVTLNWIQRFRVIKGVALGLFYLHQEWEQV-----VIHRDVKASNVLLDGELNGRLGDFG  408 (586)
Q Consensus       336 V~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~-----ivHrDIkp~NIll~~~~~~kL~DFG  408 (586)
                      ||||+++++|.+++....  ...+++..++.++.|++.||.|||+   .+     |+||||||+|||++.++.+||+|||
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg  161 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHR---RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG  161 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HC------CCCCCSGGGEEECSSSCEEECCCC
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhc---ccCCCCeeEEeccchhhEEEcCCCCEEEecCc
Confidence            999999999999997532  3458999999999999999999998   66     9999999999999999999999999


Q ss_pred             ceeeccCCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCcc
Q 007869          409 LARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGEL  488 (586)
Q Consensus       409 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~  488 (586)
                      +++...... .......||+.|+|||++.+..++.++||||||+++|||++|+.||......   .+..    ...++..
T Consensus       162 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~----~i~~~~~  233 (279)
T 2w5a_A          162 LARILNHDT-SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK---ELAG----KIREGKF  233 (279)
T ss_dssp             HHHHC---C-HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH----HHHHTCC
T ss_pred             hheeecccc-ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH---HHHH----HHhhccc
Confidence            998754322 1123457899999999999989999999999999999999999999764321   1111    1112211


Q ss_pred             ccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 007869          489 LEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERDV  537 (586)
Q Consensus       489 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  537 (586)
                           +.+...    ....+.+++.+||+.||++||++.|+++.+....
T Consensus       234 -----~~~~~~----~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~  273 (279)
T 2w5a_A          234 -----RRIPYR----YSDELNEIITRMLNLKDYHRPSVEEILENPLILE  273 (279)
T ss_dssp             -----CCCCTT----SCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCG
T ss_pred             -----ccCCcc----cCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhh
Confidence                 111112    2356778889999999999999999998775543

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=2.6e-41  Score=345.18  Aligned_cols=251  Identities=23%  Similarity=0.330  Sum_probs=204.1

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEec
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY  339 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  339 (586)
                      .++|...+.||+|+||.||+++...++..||+|++........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL   87 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence            35788899999999999999999988999999999866554556789999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeee---cCCCCeEEccccceeeccCC
Q 007869          340 MPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLL---DGELNGRLGDFGLARLYDHG  416 (586)
Q Consensus       340 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll---~~~~~~kL~DFGla~~~~~~  416 (586)
                      +++++|.+++...  ..+++..++.++.|++.||.|||+   .+|+||||||+||++   ++++.+||+|||+++.....
T Consensus        88 ~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~  162 (304)
T 2jam_A           88 VSGGELFDRILER--GVYTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG  162 (304)
T ss_dssp             CCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB
T ss_pred             CCCccHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC
Confidence            9999999998764  358889999999999999999998   899999999999999   78899999999999764322


Q ss_pred             CCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCC
Q 007869          417 TDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNL  496 (586)
Q Consensus       417 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l  496 (586)
                         ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+   +.+    ...++...  .....
T Consensus       163 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~----~i~~~~~~--~~~~~  230 (304)
T 2jam_A          163 ---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK---LFE----KIKEGYYE--FESPF  230 (304)
T ss_dssp             ---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHH----HHHHCCCC--CCTTT
T ss_pred             ---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH---HHH----HHHcCCCC--CCccc
Confidence               2234578999999999999999999999999999999999999997643211   111    11111110  01111


Q ss_pred             CccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          497 GTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       497 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                          .......+.+++.+||+.||++||++.|+++
T Consensus       231 ----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          231 ----WDDISESAKDFICHLLEKDPNERYTCEKALS  261 (304)
T ss_dssp             ----TTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             ----cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                1122356778899999999999999999996

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.2e-40  Score=340.00  Aligned_cols=250  Identities=26%  Similarity=0.443  Sum_probs=209.0

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc-chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEe
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYD  338 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E  338 (586)
                      .+.|+..+.||+|+||.||+|+...++..||||++.... ....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  100 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME  100 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence            356889999999999999999998889999999997553 3456789999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCC
Q 007869          339 YMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD  418 (586)
Q Consensus       339 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~  418 (586)
                      |+++++|.+++...   .+++..++.++.|++.||.|||+   .+|+||||||+||+++.++++||+|||++....... 
T Consensus       101 ~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~-  173 (303)
T 3a7i_A          101 YLGGGSALDLLEPG---PLDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-  173 (303)
T ss_dssp             CCTTEEHHHHHTTS---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB-
T ss_pred             eCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChheEEECCCCCEEEeecccceecCccc-
Confidence            99999999998643   68899999999999999999998   899999999999999999999999999998765432 


Q ss_pred             CceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCc
Q 007869          419 PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGT  498 (586)
Q Consensus       419 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~  498 (586)
                      .......||+.|+|||++.+..++.++||||||+++|||++|+.||......+   ....+    ..+     ..+.+..
T Consensus       174 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~----~~~-----~~~~~~~  241 (303)
T 3a7i_A          174 IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK---VLFLI----PKN-----NPPTLEG  241 (303)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHHH----HHS-----CCCCCCS
T ss_pred             cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH---HHHHh----hcC-----CCCCCcc
Confidence            12344578999999999999999999999999999999999999997543211   11111    111     1122222


Q ss_pred             cccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          499 EYVAEELELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       499 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                      .++    ..+.+++..||+.||.+|||+.|+++.
T Consensus       242 ~~~----~~l~~li~~~l~~dp~~Rps~~~ll~~  271 (303)
T 3a7i_A          242 NYS----KPLKEFVEACLNKEPSFRPTAKELLKH  271 (303)
T ss_dssp             SCC----HHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred             ccC----HHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            222    457788899999999999999999863

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=8.1e-41  Score=339.01  Aligned_cols=249  Identities=24%  Similarity=0.377  Sum_probs=201.6

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc--cchhHHHHHHHHHHhcccCCCceeeeeeeeec----cCeE
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRR----KGEL  333 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~----~~~~  333 (586)
                      .+.|...+.||+|+||.||+|.+..++..||+|++...  .....+.+.+|+.++++++||||+++++++..    ....
T Consensus        25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  104 (290)
T 1t4h_A           25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI  104 (290)
T ss_dssp             SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred             ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence            34578888999999999999999999999999998754  34456779999999999999999999998865    3568


Q ss_pred             EEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCc--EEeCCCCCCCeeec-CCCCeEEccccce
Q 007869          334 LLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQV--VIHRDVKASNVLLD-GELNGRLGDFGLA  410 (586)
Q Consensus       334 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--ivHrDIkp~NIll~-~~~~~kL~DFGla  410 (586)
                      ++||||+++++|.+++...  ..+++..++.++.|++.||.|||+   .+  |+||||||+|||++ .++.+||+|||++
T Consensus       105 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~  179 (290)
T 1t4h_A          105 VLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA  179 (290)
T ss_dssp             EEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred             EEEEEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHc---CCCCEEECCCCHHHEEEECCCCCEEEeeCCCc
Confidence            9999999999999999764  358889999999999999999998   67  99999999999997 7889999999999


Q ss_pred             eeccCCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCcccc
Q 007869          411 RLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLE  490 (586)
Q Consensus       411 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~  490 (586)
                      ......   ......||+.|+|||++. +.++.++|||||||++|||++|+.||........  ..    .....+... 
T Consensus       180 ~~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~----~~~~~~~~~-  248 (290)
T 1t4h_A          180 TLKRAS---FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--IY----RRVTSGVKP-  248 (290)
T ss_dssp             GGCCTT---SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--HH----HHHTTTCCC-
T ss_pred             cccccc---ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHH--HH----HHHhccCCc-
Confidence            754332   334567999999999886 4699999999999999999999999976433221  11    111111111 


Q ss_pred             ccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          491 ARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       491 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                             ..+.......+.+++.+||+.||.+|||+.|+++
T Consensus       249 -------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          249 -------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             -------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -------cccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence                   1111112245788899999999999999999986

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=3.5e-41  Score=342.39  Aligned_cols=250  Identities=23%  Similarity=0.382  Sum_probs=208.0

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc---chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEE
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLV  336 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV  336 (586)
                      .++|...+.||+|+||.||++.+..++..||+|++....   ....+.+.+|+.++++++||||+++++++...+..++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            457889999999999999999999999999999986542   34456789999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCC
Q 007869          337 YDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHG  416 (586)
Q Consensus       337 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~  416 (586)
                      |||+++++|.+++...  ..+++.+++.++.|+++||.|||+   .+|+||||||+|||++.++++||+|||+++.....
T Consensus        94 ~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  168 (294)
T 2rku_A           94 LELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD  168 (294)
T ss_dssp             EECCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             EecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence            9999999999988764  368899999999999999999998   89999999999999999999999999999876533


Q ss_pred             CCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCC
Q 007869          417 TDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNL  496 (586)
Q Consensus       417 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l  496 (586)
                      .. ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+.      ... ...+.      ..+
T Consensus       169 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~------~~~-~~~~~------~~~  234 (294)
T 2rku_A          169 GE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET------YLR-IKKNE------YSI  234 (294)
T ss_dssp             TC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHH-HHTTC------CCC
T ss_pred             cc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------HHH-Hhhcc------CCC
Confidence            22 23446789999999999988899999999999999999999999976432211      111 11111      111


Q ss_pred             CccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          497 GTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       497 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                      ....    ...+.+++.+||+.||++|||+.|+++.
T Consensus       235 ~~~~----~~~~~~li~~~l~~~p~~Rps~~~ll~~  266 (294)
T 2rku_A          235 PKHI----NPVAASLIQKMLQTDPTARPTINELLND  266 (294)
T ss_dssp             CTTS----CHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             cccc----CHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence            1112    2457788899999999999999999863

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=3.1e-41  Score=343.31  Aligned_cols=257  Identities=28%  Similarity=0.436  Sum_probs=201.7

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCC---CeEEEEEEeccc-cchhHHHHHHHHHHhcccCCCceeeeeeeee-ccCeEE
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKS---QIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCR-RKGELL  334 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~---~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~-~~~~~~  334 (586)
                      ...|+..+.||+|+||.||+|++..+   ...+|+|.+... .....+.+.+|+.++++++||||++++++|. .++..+
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  103 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  103 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence            34578889999999999999997543   346899998764 3345578999999999999999999999865 456789


Q ss_pred             EEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeecc
Q 007869          335 LVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYD  414 (586)
Q Consensus       335 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~  414 (586)
                      +||||+++|+|.+++... ...+++..++.++.|+++||.|||+   ++|+||||||+|||+++++.+||+|||+++...
T Consensus       104 ~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~  179 (298)
T 3f66_A          104 VVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMY  179 (298)
T ss_dssp             EEEECCTTCBHHHHHHCT-TCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred             EEEeCCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEECCCCCEEECccccccccc
Confidence            999999999999999764 3467889999999999999999998   899999999999999999999999999998654


Q ss_pred             CCCC---CceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccCcccc
Q 007869          415 HGTD---PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLE  490 (586)
Q Consensus       415 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~  490 (586)
                      ....   .......||+.|+|||.+.+..++.++||||||+++|||++ |.+||......+   ......    ++..  
T Consensus       180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~---~~~~~~----~~~~--  250 (298)
T 3f66_A          180 DKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD---ITVYLL----QGRR--  250 (298)
T ss_dssp             CGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT---HHHHHH----TTCC--
T ss_pred             ccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH---HHHHHh----cCCC--
Confidence            3221   12334567889999999999999999999999999999999 555665443322   111111    1110  


Q ss_pred             ccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 007869          491 ARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERD  536 (586)
Q Consensus       491 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  536 (586)
                      ...+   ..    ....+.+++.+||+.||.+|||+.|+++.|+..
T Consensus       251 ~~~~---~~----~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~  289 (298)
T 3f66_A          251 LLQP---EY----CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI  289 (298)
T ss_dssp             CCCC---TT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCC---cc----CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            0111   11    124577889999999999999999999999864

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=2.2e-41  Score=356.03  Aligned_cols=257  Identities=13%  Similarity=0.081  Sum_probs=186.2

Q ss_pred             hhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccc---hhHHHHHHHHHHhccc--CCCceeeee-------e
Q 007869          258 IATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR---QGMKEFVAEIVSIGRL--RHRNLVQLL-------G  325 (586)
Q Consensus       258 ~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~Ei~~l~~l--~H~niv~l~-------~  325 (586)
                      ....+|...+.||+|+||.||+|++..++..||||++.....   ...+.+.+|+.++..+  +||||++++       +
T Consensus        59 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d  138 (371)
T 3q60_A           59 QGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSD  138 (371)
T ss_dssp             CCEEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCE
T ss_pred             CCceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeeh
Confidence            345569999999999999999999998999999999987532   3445677885444444  699988755       3


Q ss_pred             eeecc-----------------CeEEEEEecCCCCChhhhhhcCCCccchhHHH------HHHHHHHHHHHHHhhcccCC
Q 007869          326 YCRRK-----------------GELLLVYDYMPNGSLDKYLYDQPKVTLNWIQR------FRVIKGVALGLFYLHQEWEQ  382 (586)
Q Consensus       326 ~~~~~-----------------~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~------~~i~~~ia~~L~yLH~~~~~  382 (586)
                      ++...                 ...++||||++ |+|.+++.... ..+.+..+      +.++.||++||.|||+   +
T Consensus       139 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~---~  213 (371)
T 3q60_A          139 AVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD-FVYVFRGDEGILALHILTAQLIRLAANLQS---K  213 (371)
T ss_dssp             EEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH-HSCCCCHHHHHHHHHHHHHHHHHHHHHHHH---T
T ss_pred             heecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc-cccchhhhhhhhhHHHHHHHHHHHHHHHHH---C
Confidence            33322                 34899999998 89999997642 23455566      7888999999999998   8


Q ss_pred             cEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCCceeeeccCCCccCcccccC--CCCCCcceEEehhHHHHHHHhC
Q 007869          383 VVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRT--GKATTSADVFSFGAFLLEVACG  460 (586)
Q Consensus       383 ~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~s~ksDVyS~Gvvl~ElltG  460 (586)
                      +|+||||||+|||++.++.+||+|||+++....    ......+|+.|+|||++.+  ..++.++|||||||++|||++|
T Consensus       214 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg  289 (371)
T 3q60_A          214 GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL  289 (371)
T ss_dssp             TEEETTCSGGGEEECTTSCEEECCGGGEEETTC----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred             CCccCcCCHHHEEECCCCCEEEEecceeeecCC----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence            999999999999999999999999999997542    2224567899999999987  6799999999999999999999


Q ss_pred             CCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          461 RRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       461 ~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      +.||..........        +........................+.+++.+||+.||++|||+.|+++
T Consensus       290 ~~Pf~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          290 FLPFGLVTPGIKGS--------WKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             SCSTTBCCTTCTTC--------CCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             CCCCCCcCcccccc--------hhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            99998764322110        0000000001111111111123456778899999999999999999974

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.1e-41  Score=351.60  Aligned_cols=262  Identities=25%  Similarity=0.327  Sum_probs=197.5

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccch-hHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEec
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQ-GMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY  339 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  339 (586)
                      ++|...+.||+|+||.||+|++..++..||||++...... ....+.+|++++++++||||+++++++...+..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            5788999999999999999999988999999999754322 122456799999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCC
Q 007869          340 MPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP  419 (586)
Q Consensus       340 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~  419 (586)
                      ++ |+|.+++.... ..+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++...... .
T Consensus        82 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-~  155 (324)
T 3mtl_A           82 LD-KDLKQYLDDCG-NIINMHNVKLFLFQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-K  155 (324)
T ss_dssp             CS-EEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred             cc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCcCHHHEEECCCCCEEEccCcccccccCCc-c
Confidence            97 69999887653 368899999999999999999998   899999999999999999999999999998654322 2


Q ss_pred             ceeeeccCCCccCcccccC-CCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCc-----------
Q 007869          420 QTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGE-----------  487 (586)
Q Consensus       420 ~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~-----------  487 (586)
                      ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+..   ..+........           
T Consensus       156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~~~~~~~~~  232 (324)
T 3mtl_A          156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQL---HFIFRILGTPTEETWPGILSNE  232 (324)
T ss_dssp             -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCCCCTTTSTTGGGCH
T ss_pred             ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHhCCCChHhchhhhcch
Confidence            2334578999999999876 56899999999999999999999999875433221   11111111000           


Q ss_pred             -cccccCCCCCcc----ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          488 -LLEARDPNLGTE----YVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       488 -~~~~~d~~l~~~----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                       ......+.....    ........+.+++.+||+.||.+|||++|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  281 (324)
T 3mtl_A          233 EFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK  281 (324)
T ss_dssp             HHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence             000000110000    01112356778999999999999999999986

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1.1e-41  Score=358.29  Aligned_cols=247  Identities=25%  Similarity=0.297  Sum_probs=194.3

Q ss_pred             hcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc---chhHHHHHHHHHH-hcccCCCceeeeeeeeeccCeEE
Q 007869          259 ATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES---RQGMKEFVAEIVS-IGRLRHRNLVQLLGYCRRKGELL  334 (586)
Q Consensus       259 a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~-l~~l~H~niv~l~~~~~~~~~~~  334 (586)
                      ..++|+..+.||+|+||+||+|+++.++..||||++....   ....+.+..|..+ ++.++||||+++++++...+.++
T Consensus        36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~  115 (373)
T 2r5t_A           36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY  115 (373)
T ss_dssp             CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEE
T ss_pred             ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEE
Confidence            3467899999999999999999999999999999997653   2334556777776 57789999999999999999999


Q ss_pred             EEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeecc
Q 007869          335 LVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYD  414 (586)
Q Consensus       335 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~  414 (586)
                      +||||+++|+|.+++...  ..+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++...
T Consensus       116 lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~  190 (373)
T 2r5t_A          116 FVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENI  190 (373)
T ss_dssp             EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred             EEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence            999999999999999764  357888899999999999999998   899999999999999999999999999998643


Q ss_pred             CCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCC
Q 007869          415 HGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDP  494 (586)
Q Consensus       415 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~  494 (586)
                      ... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||......+   +.+.+    ..+.      .
T Consensus       191 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~---~~~~i----~~~~------~  256 (373)
T 2r5t_A          191 EHN-STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE---MYDNI----LNKP------L  256 (373)
T ss_dssp             CCC-CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHH---HHHHH----HHSC------C
T ss_pred             cCC-CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH---HHHHH----Hhcc------c
Confidence            322 23445689999999999999999999999999999999999999997643221   11111    1111      1


Q ss_pred             CCCccccHHHHHHHHHHHHHhcccCCCCCCCHHH
Q 007869          495 NLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQ  528 (586)
Q Consensus       495 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~e  528 (586)
                      .+....    ...+.+++.+||+.||.+||++.+
T Consensus       257 ~~~~~~----~~~~~~li~~lL~~dp~~R~~~~~  286 (373)
T 2r5t_A          257 QLKPNI----TNSARHLLEGLLQKDRTKRLGAKD  286 (373)
T ss_dssp             CCCSSS----CHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred             CCCCCC----CHHHHHHHHHHcccCHHhCCCCCC
Confidence            111112    245678888999999999999853

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=2.4e-41  Score=341.16  Aligned_cols=245  Identities=21%  Similarity=0.326  Sum_probs=200.5

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc--cchhHHHHHHHHHHhccc-CCCceeeeeeeeeccCeEEEE
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE--SRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKGELLLV  336 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~lV  336 (586)
                      .++|+..+.||+|+||.||+|++..++..||||++...  ......++.+|+..+.++ +||||+++++++...+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv   89 (289)
T 1x8b_A           10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ   89 (289)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred             cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            45788999999999999999999988999999998754  334456789999999999 999999999999999999999


Q ss_pred             EecCCCCChhhhhhcCCC--ccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecC----------------
Q 007869          337 YDYMPNGSLDKYLYDQPK--VTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDG----------------  398 (586)
Q Consensus       337 ~E~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~----------------  398 (586)
                      |||+++++|.+++.....  ..+++..++.++.||++||.|||+   ++|+||||||+|||++.                
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~  166 (289)
T 1x8b_A           90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW  166 (289)
T ss_dssp             EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC-----------------
T ss_pred             EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence            999999999999976422  468999999999999999999998   89999999999999984                


Q ss_pred             ---CCCeEEccccceeeccCCCCCceeeeccCCCccCcccccCC-CCCCcceEEehhHHHHHHHhCCCCCCCCCCCccch
Q 007869          399 ---ELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTG-KATTSADVFSFGAFLLEVACGRRPIQRQGPSENLI  474 (586)
Q Consensus       399 ---~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~  474 (586)
                         ...+||+|||++.......     ...||+.|+|||++.+. .++.++|||||||++|||++|++++.....     
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~-----  236 (289)
T 1x8b_A          167 ASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ-----  236 (289)
T ss_dssp             ---CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH-----
T ss_pred             cCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH-----
Confidence               4479999999998765422     23589999999999766 566899999999999999999887643211     


Q ss_pred             hhHHHHhhhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          475 LVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       475 l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                           +....++..     +.+...+    ...+.+++.+||+.||++|||+.|+++
T Consensus       237 -----~~~~~~~~~-----~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          237 -----WHEIRQGRL-----PRIPQVL----SQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             -----HHHHHTTCC-----CCCSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -----HHHHHcCCC-----CCCCccc----CHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence                 111112211     2222222    245778889999999999999999985

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=5.5e-41  Score=339.21  Aligned_cols=247  Identities=23%  Similarity=0.324  Sum_probs=206.2

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc---chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEE
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLV  336 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV  336 (586)
                      .++|+..+.||+|+||.||+|+...++..||||++....   ....+.+.+|++++++++||||+++++++...+..++|
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   92 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM   92 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence            357889999999999999999999899999999986542   23356789999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCC
Q 007869          337 YDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHG  416 (586)
Q Consensus       337 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~  416 (586)
                      |||+++++|.+++....  .+++..++.++.|+++||.|||+   .+|+||||||+||+++.++.+||+|||++......
T Consensus        93 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~  167 (284)
T 2vgo_A           93 LEFAPRGELYKELQKHG--RFDEQRSATFMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL  167 (284)
T ss_dssp             ECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred             EEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence            99999999999997653  58889999999999999999998   89999999999999999999999999999765432


Q ss_pred             CCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCC
Q 007869          417 TDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNL  496 (586)
Q Consensus       417 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l  496 (586)
                         ......||+.|+|||++.+..++.++||||||+++|||++|+.||......+   ..   .. ....      +...
T Consensus       168 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~---~~-~~~~------~~~~  231 (284)
T 2vgo_A          168 ---RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE---TH---RR-IVNV------DLKF  231 (284)
T ss_dssp             ---CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH---HH---HH-HHTT------CCCC
T ss_pred             ---ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH---HH---HH-Hhcc------ccCC
Confidence               2234578999999999999999999999999999999999999997643211   11   11 1111      1111


Q ss_pred             CccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          497 GTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       497 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      ...    ....+.+++.+|++.||.+||++.++++
T Consensus       232 ~~~----~~~~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          232 PPF----LSDGSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             CTT----SCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCc----CCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence            111    2245678889999999999999999986

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=6.3e-42  Score=353.57  Aligned_cols=264  Identities=26%  Similarity=0.444  Sum_probs=207.6

Q ss_pred             hhcCCcccceeEeecCceEEEEEEe-----CCCCeEEEEEEeccc-cchhHHHHHHHHHHhcccCCCceeeeeeeeeccC
Q 007869          258 IATKGFREKELLGTGGFGRVYRGTL-----PKSQIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKG  331 (586)
Q Consensus       258 ~a~~~f~~~~~LG~G~~g~Vy~~~~-----~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~  331 (586)
                      ...++|+..+.||+|+||.||+|++     ..++..||||++... ......++.+|+.++++++||||+++++++...+
T Consensus        27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  106 (327)
T 2yfx_A           27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL  106 (327)
T ss_dssp             CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence            3557899999999999999999994     456778999999654 3445567999999999999999999999999999


Q ss_pred             eEEEEEecCCCCChhhhhhcCCC-----ccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecC---CCCeE
Q 007869          332 ELLLVYDYMPNGSLDKYLYDQPK-----VTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDG---ELNGR  403 (586)
Q Consensus       332 ~~~lV~E~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~---~~~~k  403 (586)
                      ..++||||+++++|.+++.....     ..+++..++.++.|+++||.|||+   .+|+||||||+|||++.   +..+|
T Consensus       107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~i~H~dlkp~NIli~~~~~~~~~k  183 (327)
T 2yfx_A          107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAK  183 (327)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred             CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeecCcCCHhHEEEecCCCcceEE
Confidence            99999999999999999987532     358899999999999999999998   89999999999999984   45699


Q ss_pred             EccccceeeccCCCC-CceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHh
Q 007869          404 LGDFGLARLYDHGTD-PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFD  481 (586)
Q Consensus       404 L~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~  481 (586)
                      |+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++ |+.||......+   +.+.+  
T Consensus       184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~~~~~--  258 (327)
T 2yfx_A          184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE---VLEFV--  258 (327)
T ss_dssp             ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---HHHHH--
T ss_pred             ECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH---HHHHH--
Confidence            999999986543322 22334568999999999998999999999999999999998 999997643211   11111  


Q ss_pred             hhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhccCCC
Q 007869          482 FWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERDVALP  540 (586)
Q Consensus       482 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~p  540 (586)
                        ..+..     +....    .....+.+++.+||+.||.+||++.++++.|+....-+
T Consensus       259 --~~~~~-----~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~  306 (327)
T 2yfx_A          259 --TSGGR-----MDPPK----NCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP  306 (327)
T ss_dssp             --HTTCC-----CCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred             --hcCCC-----CCCCC----CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence              11111     11111    12346778899999999999999999999998654433

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.2e-41  Score=348.80  Aligned_cols=263  Identities=26%  Similarity=0.374  Sum_probs=204.7

Q ss_pred             cccchhhhhhhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhccc-CCCceeeeeeee
Q 007869          249 HRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRL-RHRNLVQLLGYC  327 (586)
Q Consensus       249 ~~~~~~el~~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~  327 (586)
                      ..+...++....++|+..+.||+|+||.||+|++..++..||||++.... ...+.+.+|+.++.++ +||||+++++++
T Consensus        12 ~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   90 (326)
T 2x7f_A           12 DEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAF   90 (326)
T ss_dssp             ----CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEE
T ss_pred             hhccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEE
Confidence            34566677788899999999999999999999998889999999986543 3347789999999999 899999999998


Q ss_pred             ec------cCeEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCC
Q 007869          328 RR------KGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELN  401 (586)
Q Consensus       328 ~~------~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~  401 (586)
                      ..      .+..++||||+++++|.+++.......+++..++.++.||+.||.|||+   .+|+||||||+|||++.++.
T Consensus        91 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~  167 (326)
T 2x7f_A           91 IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAE  167 (326)
T ss_dssp             EECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCC
T ss_pred             eeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCcHHHEEEcCCCC
Confidence            76      4679999999999999999987655678899999999999999999998   89999999999999999999


Q ss_pred             eEEccccceeeccCCCCCceeeeccCCCccCccccc-----CCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhh
Q 007869          402 GRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTR-----TGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILV  476 (586)
Q Consensus       402 ~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~  476 (586)
                      +||+|||++........ ......||+.|+|||++.     ...++.++|||||||++|||++|+.||........   .
T Consensus       168 ~kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~  243 (326)
T 2x7f_A          168 VKLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA---L  243 (326)
T ss_dssp             EEECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH---H
T ss_pred             EEEeeCcCceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH---H
Confidence            99999999987643221 233457899999999987     56789999999999999999999999975432211   1


Q ss_pred             HHHHhhhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          477 DWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       477 ~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                         .... ..     ..+.....   .....+.+++.+||+.||.+||++.++++
T Consensus       244 ---~~~~-~~-----~~~~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          244 ---FLIP-RN-----PAPRLKSK---KWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             ---HHHH-HS-----CCCCCSCS---CSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             ---HHhh-cC-----ccccCCcc---ccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence               1111 11     11111111   11245778888999999999999999986

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.5e-41  Score=381.01  Aligned_cols=247  Identities=28%  Similarity=0.434  Sum_probs=198.7

Q ss_pred             eeEeecCceEEEEEEe--CCCCeEEEEEEecccc--chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEecCCC
Q 007869          267 ELLGTGGFGRVYRGTL--PKSQIEIAVKKISHES--RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPN  342 (586)
Q Consensus       267 ~~LG~G~~g~Vy~~~~--~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~  342 (586)
                      +.||+|+||.||+|.+  ..++..||||+++...  ....+++.+|++++++++||||++++++|.. +..++|||||++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            4799999999999955  4567889999997643  3346789999999999999999999999965 458999999999


Q ss_pred             CChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCC--Cc
Q 007869          343 GSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD--PQ  420 (586)
Q Consensus       343 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~--~~  420 (586)
                      |+|.+++...  ..+++..++.|+.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++.+.....  ..
T Consensus       454 g~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~---~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  528 (635)
T 4fl3_A          454 GPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA  528 (635)
T ss_dssp             EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------
T ss_pred             CCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHH---CCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccc
Confidence            9999999765  368899999999999999999998   8999999999999999999999999999987654322  12


Q ss_pred             eeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCcc
Q 007869          421 TTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTE  499 (586)
Q Consensus       421 ~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~  499 (586)
                      .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+       +......+...     ..   
T Consensus       529 ~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~-------~~~~i~~~~~~-----~~---  593 (635)
T 4fl3_A          529 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-------VTAMLEKGERM-----GC---  593 (635)
T ss_dssp             ------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHHHHHTTCCC-----CC---
T ss_pred             ccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHHcCCCC-----CC---
Confidence            233457889999999999999999999999999999998 999997654322       11122222211     11   


Q ss_pred             ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 007869          500 YVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER  535 (586)
Q Consensus       500 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  535 (586)
                       .......+.+++..||+.||++||++.++++.|+.
T Consensus       594 -p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~  628 (635)
T 4fl3_A          594 -PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN  628 (635)
T ss_dssp             -CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             -CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence             11233567888999999999999999999999975

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=5.6e-41  Score=367.98  Aligned_cols=256  Identities=25%  Similarity=0.330  Sum_probs=209.2

Q ss_pred             hcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc---chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEE
Q 007869          259 ATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLL  335 (586)
Q Consensus       259 a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~l  335 (586)
                      ..++|...++||+|+||+||+|+++.+++.||||++....   ....+.+..|++++++++||||+++++++...+.+++
T Consensus       183 ~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~l  262 (543)
T 3c4z_A          183 GEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCL  262 (543)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             ChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEE
Confidence            4467899999999999999999999899999999997542   2345678999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhhcCC--CccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeec
Q 007869          336 VYDYMPNGSLDKYLYDQP--KVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLY  413 (586)
Q Consensus       336 V~E~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~  413 (586)
                      ||||+++|+|.+++....  ...+++..++.++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++.+
T Consensus       263 VmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~---~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~  339 (543)
T 3c4z_A          263 VMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVEL  339 (543)
T ss_dssp             EECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH---cCCcccCCChHHEEEeCCCCEEEeecceeeec
Confidence            999999999999997653  3468999999999999999999998   89999999999999999999999999999976


Q ss_pred             cCCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccC
Q 007869          414 DHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARD  493 (586)
Q Consensus       414 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d  493 (586)
                      ..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.........  .+...... .+.      
T Consensus       340 ~~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~--~~~~~~i~-~~~------  409 (543)
T 3c4z_A          340 KAGQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN--KELKQRVL-EQA------  409 (543)
T ss_dssp             CTTCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCH--HHHHHHHH-HCC------
T ss_pred             cCCCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhH--HHHHHHHh-hcc------
Confidence            54322 234458999999999999999999999999999999999999999875432211  11111111 111      


Q ss_pred             CCCCccccHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 007869          494 PNLGTEYVAEELELVLKLGLLCSHSDPTARPSM-----RQVVQ  531 (586)
Q Consensus       494 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~-----~evl~  531 (586)
                      .....    .....+.+++.+||+.||.+||++     .++++
T Consensus       410 ~~~p~----~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~  448 (543)
T 3c4z_A          410 VTYPD----KFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT  448 (543)
T ss_dssp             CCCCT----TSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred             cCCCc----ccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence            11111    223456788889999999999975     56653

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.2e-41  Score=346.53  Aligned_cols=265  Identities=27%  Similarity=0.402  Sum_probs=187.5

Q ss_pred             hhhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc-chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEE
Q 007869          257 YIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLL  335 (586)
Q Consensus       257 ~~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~l  335 (586)
                      ....++|+..+.||+|+||.||+|.+..++..||||++.... ....+++.+|+.++++++||||+++++++...+..++
T Consensus        11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   90 (303)
T 2vwi_A           11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL   90 (303)
T ss_dssp             --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred             ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence            345678999999999999999999998888999999986543 3445678999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhhc------CCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccc
Q 007869          336 VYDYMPNGSLDKYLYD------QPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGL  409 (586)
Q Consensus       336 V~E~~~~gsL~~~l~~------~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGl  409 (586)
                      ||||+++++|.+++..      .....+++..++.++.|+++||.|||+   .+|+||||||+||+++.++.+||+|||+
T Consensus        91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~  167 (303)
T 2vwi_A           91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGV  167 (303)
T ss_dssp             EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred             EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCCChhhEEEcCCCCEEEEeccc
Confidence            9999999999999864      123468999999999999999999998   8999999999999999999999999999


Q ss_pred             eeeccCCCC----CceeeeccCCCccCcccccC-CCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhc
Q 007869          410 ARLYDHGTD----PQTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWN  484 (586)
Q Consensus       410 a~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~  484 (586)
                      ++.......    .......||+.|+|||++.. ..++.++|||||||++|||++|+.||......+...   .......
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~~~~~~~  244 (303)
T 2vwi_A          168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLM---LTLQNDP  244 (303)
T ss_dssp             HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHH---HHHTSSC
T ss_pred             hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHH---HHhccCC
Confidence            986543221    12234579999999999875 568999999999999999999999998654322110   0100000


Q ss_pred             cCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          485 RGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       485 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      ........++.....+    ...+.+++.+||+.||.+||++.|+++
T Consensus       245 ~~~~~~~~~~~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          245 PSLETGVQDKEMLKKY----GKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             CCTTC-----CCCCCC----CHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             Cccccccccchhhhhh----hHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            0000001111111222    245778889999999999999999986

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=5.1e-41  Score=363.25  Aligned_cols=195  Identities=28%  Similarity=0.394  Sum_probs=157.3

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc--cchhHHHHHHHHHHhcccCCCceeeeeeeeec-----cCe
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRR-----KGE  332 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~-----~~~  332 (586)
                      .++|+..+.||+|+||.||+|++..++..||||++...  .....+.+.+|+++|++++||||+++++++..     .+.
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            46899999999999999999999989999999999653  33445779999999999999999999999843     357


Q ss_pred             EEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceee
Q 007869          333 LLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARL  412 (586)
Q Consensus       333 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~  412 (586)
                      +++||||+ +++|.+++...  ..+++..+..++.||+.||.|||+   .+|+||||||+||||+.++.+||+|||+++.
T Consensus       132 ~~lv~e~~-~~~L~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~---~~iiHrDlKp~NILl~~~~~~kl~DFGla~~  205 (458)
T 3rp9_A          132 LYVVLEIA-DSDFKKLFRTP--VYLTELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLART  205 (458)
T ss_dssp             EEEEECCC-SEEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred             EEEEEecc-ccchhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHh---CCcCCCCCChhhEEECCCCCEeecccccchh
Confidence            99999998 57999998764  368999999999999999999998   8999999999999999999999999999997


Q ss_pred             ccCCCC--------------------------CceeeeccCCCccCcccc-cCCCCCCcceEEehhHHHHHHHhC
Q 007869          413 YDHGTD--------------------------PQTTHVVGTLGYLAPEHT-RTGKATTSADVFSFGAFLLEVACG  460 (586)
Q Consensus       413 ~~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~s~ksDVyS~Gvvl~ElltG  460 (586)
                      ......                          ...+..+||+.|+|||++ ....++.++|||||||++|||++|
T Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg  280 (458)
T 3rp9_A          206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM  280 (458)
T ss_dssp             TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred             ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence            643221                          123446789999999976 566799999999999999999993

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=5.8e-41  Score=351.01  Aligned_cols=201  Identities=28%  Similarity=0.401  Sum_probs=178.7

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc-cchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEe
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYD  338 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E  338 (586)
                      .++|+..+.||+|+||.||+|.+..++..||+|++... .....+.+.+|+.++++++||||+++++++...+..++|||
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  111 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME  111 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence            46799999999999999999999989999999999765 33445779999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCC-cEEeCCCCCCCeeecCCCCeEEccccceeeccCCC
Q 007869          339 YMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQ-VVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT  417 (586)
Q Consensus       339 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~-~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~  417 (586)
                      |+++++|.+++....  .+++..+..++.|++.||.|||+   . +|+||||||+|||++.++++||+|||+++..... 
T Consensus       112 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-  185 (360)
T 3eqc_A          112 HMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLRE---KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  185 (360)
T ss_dssp             CCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred             CCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---hCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc-
Confidence            999999999997653  58889999999999999999997   5 7999999999999999999999999999765332 


Q ss_pred             CCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCC
Q 007869          418 DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQG  468 (586)
Q Consensus       418 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~  468 (586)
                        ......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       186 --~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  234 (360)
T 3eqc_A          186 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD  234 (360)
T ss_dssp             --C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCC
T ss_pred             --cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence              2234578999999999999999999999999999999999999997643

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=3.5e-41  Score=349.44  Aligned_cols=249  Identities=23%  Similarity=0.391  Sum_probs=207.6

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc---cchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEE
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLV  336 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV  336 (586)
                      .++|...+.||+|+||.||++.+..++..||+|++...   .....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            35788899999999999999999999999999998754   234456789999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCC
Q 007869          337 YDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHG  416 (586)
Q Consensus       337 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~  416 (586)
                      |||+++++|.+++...  ..+++.+++.++.|+++||.|||+   ++|+||||||+|||++.++.+||+|||+++.....
T Consensus       120 ~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  194 (335)
T 2owb_A          120 LELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD  194 (335)
T ss_dssp             ECCCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             EecCCCCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCCEecCCCchhEEEcCCCCEEEeeccCceecccC
Confidence            9999999999998764  368899999999999999999998   89999999999999999999999999999876533


Q ss_pred             CCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCC
Q 007869          417 TDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNL  496 (586)
Q Consensus       417 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l  496 (586)
                      .. ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.      ... ...+.      ..+
T Consensus       195 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~~~-~~~~~------~~~  260 (335)
T 2owb_A          195 GE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKET------YLR-IKKNE------YSI  260 (335)
T ss_dssp             TC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH------HHH-HHHTC------CCC
T ss_pred             cc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHH------HHH-HhcCC------CCC
Confidence            22 23446799999999999998999999999999999999999999976432211      111 11111      111


Q ss_pred             CccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          497 GTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       497 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      ...+    ...+.+++.+||+.||++||++.|+++
T Consensus       261 ~~~~----~~~~~~li~~~l~~dp~~Rps~~ell~  291 (335)
T 2owb_A          261 PKHI----NPVAASLIQKMLQTDPTARPTINELLN  291 (335)
T ss_dssp             CTTS----CHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             CccC----CHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            1112    245678889999999999999999986

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.7e-41  Score=350.99  Aligned_cols=266  Identities=25%  Similarity=0.376  Sum_probs=203.4

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc--chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEE
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES--RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY  337 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  337 (586)
                      .++|+..+.||+|+||.||+|++..++..||||++....  ....+.+.+|+.++++++||||+++++++...+..++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence            357889999999999999999999989999999986543  233466889999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCC
Q 007869          338 DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT  417 (586)
Q Consensus       338 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~  417 (586)
                      ||+++++|.+++...  ..+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++......
T Consensus       104 e~~~~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  178 (331)
T 4aaa_A          104 EFVDHTILDDLELFP--NGLDYQVVQKYLFQIINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG  178 (331)
T ss_dssp             ECCSEEHHHHHHHST--TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred             ecCCcchHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHH---CCEEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence            999999998887654  358899999999999999999998   899999999999999999999999999998755432


Q ss_pred             CCceeeeccCCCccCcccccCC-CCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhH--------HHHhhhccCcc
Q 007869          418 DPQTTHVVGTLGYLAPEHTRTG-KATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVD--------WVFDFWNRGEL  488 (586)
Q Consensus       418 ~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~--------~v~~~~~~~~~  488 (586)
                      . ......||+.|+|||++.+. .++.++|||||||++|||++|+.||......+......        .....+.....
T Consensus       179 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (331)
T 4aaa_A          179 E-VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPV  257 (331)
T ss_dssp             ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGG
T ss_pred             c-ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccc
Confidence            2 23345789999999999775 78999999999999999999999997654322111100        00111111111


Q ss_pred             -ccccCCCCCccc-----cHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          489 -LEARDPNLGTEY-----VAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       489 -~~~~d~~l~~~~-----~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                       .....+......     .......+.+++.+||+.||.+|||+.|+++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          258 FAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             GTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             cccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence             111111111111     1123467889999999999999999999985

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.7e-41  Score=349.47  Aligned_cols=266  Identities=26%  Similarity=0.310  Sum_probs=200.6

Q ss_pred             hhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccch-----hHHHHHHHHHHhcccCCCceeeeeeeeeccCe
Q 007869          258 IATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQ-----GMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGE  332 (586)
Q Consensus       258 ~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~  332 (586)
                      ...++|+..+.||+|+||.||+|++..++..||||++......     ..+.+.+|++++++++||||+++++++...+.
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN   86 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence            3457899999999999999999999988999999999753221     12468899999999999999999999999999


Q ss_pred             EEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceee
Q 007869          333 LLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARL  412 (586)
Q Consensus       333 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~  412 (586)
                      .++||||+++ +|.+++... ...+++..+..++.|+++||.|||+   .+|+||||||+|||++.++.+||+|||+++.
T Consensus        87 ~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  161 (346)
T 1ua2_A           87 ISLVFDFMET-DLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKS  161 (346)
T ss_dssp             CEEEEECCSE-EHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred             eEEEEEcCCC-CHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHEEEcCCCCEEEEeccccee
Confidence            9999999975 898888665 3468889999999999999999998   8999999999999999999999999999987


Q ss_pred             ccCCCCCceeeeccCCCccCcccccCC-CCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCcc---
Q 007869          413 YDHGTDPQTTHVVGTLGYLAPEHTRTG-KATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGEL---  488 (586)
Q Consensus       413 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~---  488 (586)
                      ..... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||......+.  + ..+.........   
T Consensus       162 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~--~-~~i~~~~~~~~~~~~  237 (346)
T 1ua2_A          162 FGSPN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQ--L-TRIFETLGTPTEEQW  237 (346)
T ss_dssp             TTSCC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--H-HHHHHHHCCCCTTTS
T ss_pred             ccCCc-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHH--H-HHHHHHcCCCChhhh
Confidence            65432 233446789999999999764 488999999999999999999999976543221  1 111111100000   


Q ss_pred             ---ccccC---CCCCcccc-----HHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          489 ---LEARD---PNLGTEYV-----AEELELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       489 ---~~~~d---~~l~~~~~-----~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                         ....+   ........     ......+.+++.+||+.||++|||+.|+++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          238 PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             SSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             hhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence               00000   00000001     1223668889999999999999999999874

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=9.8e-41  Score=350.47  Aligned_cols=255  Identities=24%  Similarity=0.364  Sum_probs=206.1

Q ss_pred             hhhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccc--------hhHHHHHHHHHHhccc-CCCceeeeeeee
Q 007869          257 YIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR--------QGMKEFVAEIVSIGRL-RHRNLVQLLGYC  327 (586)
Q Consensus       257 ~~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~Ei~~l~~l-~H~niv~l~~~~  327 (586)
                      ....++|+..+.||+|+||.||+|++..++..||||++.....        ...+.+.+|+.++.++ +||||+++++++
T Consensus        90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  169 (365)
T 2y7j_A           90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY  169 (365)
T ss_dssp             HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence            3445679999999999999999999988899999999865431        2245688999999999 899999999999


Q ss_pred             eccCeEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccc
Q 007869          328 RRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDF  407 (586)
Q Consensus       328 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DF  407 (586)
                      ...+..++||||+++++|.+++...  ..+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+||
T Consensus       170 ~~~~~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~---~gi~H~Dlkp~NIl~~~~~~ikl~Df  244 (365)
T 2y7j_A          170 ESSSFMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDF  244 (365)
T ss_dssp             EBSSEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCC
T ss_pred             eeCCEEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEEec
Confidence            9999999999999999999999764  368899999999999999999998   89999999999999999999999999


Q ss_pred             cceeeccCCCCCceeeeccCCCccCcccccC------CCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHh
Q 007869          408 GLARLYDHGTDPQTTHVVGTLGYLAPEHTRT------GKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFD  481 (586)
Q Consensus       408 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~  481 (586)
                      |++..+....  ......||+.|+|||++.+      ..++.++|||||||++|||++|+.||.......   ....+  
T Consensus       245 G~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~---~~~~i--  317 (365)
T 2y7j_A          245 GFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL---MLRMI--  317 (365)
T ss_dssp             TTCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH--
T ss_pred             CcccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHH---HHHHH--
Confidence            9998765432  2345679999999999863      358899999999999999999999997643211   11111  


Q ss_pred             hhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          482 FWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       482 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                        ..+...      ............+.+++.+||+.||++|||+.|+++
T Consensus       318 --~~~~~~------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          318 --MEGQYQ------FSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             --HHTCCC------CCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             --HhCCCC------CCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence              111100      000000011345778999999999999999999986

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=8.1e-41  Score=365.19  Aligned_cols=251  Identities=25%  Similarity=0.389  Sum_probs=200.9

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc--chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEE
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES--RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY  337 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  337 (586)
                      .+.|+..+.||+|+||.||+|++..++..||||++....  ......+.+|+.++++++||||++++++|...+..++||
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  115 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM  115 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            456899999999999999999999899999999997642  334577899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCC---CCeEEccccceeecc
Q 007869          338 DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGE---LNGRLGDFGLARLYD  414 (586)
Q Consensus       338 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~---~~~kL~DFGla~~~~  414 (586)
                      ||+++|+|.+++...  ..+++..+..++.||++||.|||+   .+|+||||||+|||++..   +.+||+|||+++...
T Consensus       116 e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~  190 (494)
T 3lij_A          116 ECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE  190 (494)
T ss_dssp             ECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred             ecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence            999999999988765  358889999999999999999998   899999999999999764   459999999998765


Q ss_pred             CCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCC
Q 007869          415 HGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDP  494 (586)
Q Consensus       415 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~  494 (586)
                      ...  ......||+.|+|||++. +.++.++|||||||++|||++|+.||......+   +..    ....+...     
T Consensus       191 ~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~----~i~~~~~~-----  255 (494)
T 3lij_A          191 NQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE---ILR----KVEKGKYT-----  255 (494)
T ss_dssp             TTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH----HHHHTCCC-----
T ss_pred             CCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH---HHH----HHHhCCCC-----
Confidence            432  334467999999999986 569999999999999999999999998654321   111    11111111     


Q ss_pred             CCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          495 NLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       495 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                       ............+.+++.+||+.||.+|||+.|+++
T Consensus       256 -~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          256 -FDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             -CCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             -CCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence             000001112345778889999999999999999985

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.1e-41  Score=352.30  Aligned_cols=261  Identities=23%  Similarity=0.316  Sum_probs=198.6

Q ss_pred             hcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc--cchhHHHHHHHHHHhcccCCCceeeeeeeeecc------
Q 007869          259 ATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRK------  330 (586)
Q Consensus       259 a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~------  330 (586)
                      ..++|+..+.||+|+||.||+|++..++..||||++...  .....+.+.+|++++++++||||+++++++...      
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  102 (367)
T 1cm8_A           23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF  102 (367)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence            356899999999999999999999999999999999653  333456789999999999999999999998765      


Q ss_pred             CeEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccce
Q 007869          331 GELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLA  410 (586)
Q Consensus       331 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla  410 (586)
                      ...++||||+ +++|.+++...   .+++..+..++.||++||.|||+   .+|+||||||+|||++.++.+||+|||++
T Consensus       103 ~~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a  175 (367)
T 1cm8_A          103 TDFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLA  175 (367)
T ss_dssp             CCCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             ceEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCHHHEEEcCCCCEEEEeeecc
Confidence            3469999999 88999999764   58889999999999999999998   89999999999999999999999999999


Q ss_pred             eeccCCCCCceeeeccCCCccCcccccC-CCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHH--------Hh
Q 007869          411 RLYDHGTDPQTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWV--------FD  481 (586)
Q Consensus       411 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v--------~~  481 (586)
                      +....    ..+...||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....+...        +.
T Consensus       176 ~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~  251 (367)
T 1cm8_A          176 RQADS----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQ  251 (367)
T ss_dssp             EECCS----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             ccccc----ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHH
Confidence            97543    2344678999999999877 67999999999999999999999999865432211111000        00


Q ss_pred             hhccCc-------cccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          482 FWNRGE-------LLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       482 ~~~~~~-------~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      .+....       +.......+ ..........+.+++.+||+.||.+|||+.|+++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~  307 (367)
T 1cm8_A          252 RLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  307 (367)
T ss_dssp             TCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HhhhHHHHHHHHhCCCCCCCCH-HHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence            000000       000000000 0111122356788899999999999999999987

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=5e-40  Score=347.11  Aligned_cols=212  Identities=20%  Similarity=0.248  Sum_probs=181.9

Q ss_pred             cchhhhhhhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccC-CC-----ceeeee
Q 007869          251 FRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLR-HR-----NLVQLL  324 (586)
Q Consensus       251 ~~~~el~~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H~-----niv~l~  324 (586)
                      +..++.....++|+..+.||+|+||.||+|++..++..||||++... ....+++..|+.++..++ |+     ++++++
T Consensus        44 ~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~  122 (382)
T 2vx3_A           44 YIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLK  122 (382)
T ss_dssp             BCCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEE
T ss_pred             EEeecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEee
Confidence            44455556678999999999999999999999989999999999753 234566788888888874 44     499999


Q ss_pred             eeeeccCeEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeec--CCCCe
Q 007869          325 GYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLD--GELNG  402 (586)
Q Consensus       325 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~--~~~~~  402 (586)
                      +++...+..++||||++ ++|.+++.......+++..+..++.|++.||.|||+. +.+|+||||||+|||++  .++.+
T Consensus       123 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~  200 (382)
T 2vx3_A          123 RHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAI  200 (382)
T ss_dssp             EEEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCE
T ss_pred             eeeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcE
Confidence            99999999999999995 5999999887656799999999999999999999941 37899999999999994  57889


Q ss_pred             EEccccceeeccCCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCC
Q 007869          403 RLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGP  469 (586)
Q Consensus       403 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~  469 (586)
                      ||+|||+++.....    .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus       201 kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~  263 (382)
T 2vx3_A          201 KIVDFGSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE  263 (382)
T ss_dssp             EECCCTTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             EEEeccCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            99999999876432    2346789999999999999999999999999999999999999986543

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.5e-40  Score=338.00  Aligned_cols=253  Identities=25%  Similarity=0.357  Sum_probs=206.3

Q ss_pred             hcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc---------chhHHHHHHHHHHhcccC-CCceeeeeeeee
Q 007869          259 ATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES---------RQGMKEFVAEIVSIGRLR-HRNLVQLLGYCR  328 (586)
Q Consensus       259 a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---------~~~~~~~~~Ei~~l~~l~-H~niv~l~~~~~  328 (586)
                      ..++|+..+.||+|+||.||+|++..++..||||++....         ....+.+.+|++++++++ ||||+++++++.
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   94 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            3468999999999999999999999999999999996542         123456889999999995 999999999999


Q ss_pred             ccCeEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEcccc
Q 007869          329 RKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFG  408 (586)
Q Consensus       329 ~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFG  408 (586)
                      ..+..++||||+++++|.+++...  ..+++..++.++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg  169 (298)
T 1phk_A           95 TNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFG  169 (298)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCT
T ss_pred             cCCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEcCCCcEEEeccc
Confidence            999999999999999999999764  368899999999999999999998   899999999999999999999999999


Q ss_pred             ceeeccCCCCCceeeeccCCCccCccccc------CCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhh
Q 007869          409 LARLYDHGTDPQTTHVVGTLGYLAPEHTR------TGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDF  482 (586)
Q Consensus       409 la~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~  482 (586)
                      ++.......  ......||+.|+|||++.      ...++.++||||||+++|||++|+.||......+   ....    
T Consensus       170 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~~----  240 (298)
T 1phk_A          170 FSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML---MLRM----  240 (298)
T ss_dssp             TCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHH----
T ss_pred             chhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH---HHHH----
Confidence            998765432  234457899999999985      4568899999999999999999999997543211   1111    


Q ss_pred             hccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          483 WNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       483 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      ...+...      ............+.+++.+||+.||.+|||+.|+++
T Consensus       241 ~~~~~~~------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          241 IMSGNYQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             HHHTCCC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HhcCCcc------cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence            1111110      000111123356788899999999999999999985

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.1e-41  Score=352.00  Aligned_cols=257  Identities=23%  Similarity=0.324  Sum_probs=205.8

Q ss_pred             hcCCcccceeEeecCceEEEEEEeC---CCCeEEEEEEecccc----chhHHHHHHHHHHhccc-CCCceeeeeeeeecc
Q 007869          259 ATKGFREKELLGTGGFGRVYRGTLP---KSQIEIAVKKISHES----RQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRK  330 (586)
Q Consensus       259 a~~~f~~~~~LG~G~~g~Vy~~~~~---~~~~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~  330 (586)
                      ..++|+..+.||+|+||.||+++..   .++..||||++....    ....+.+.+|++++.++ +||||+++++++...
T Consensus        52 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~  131 (355)
T 1vzo_A           52 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE  131 (355)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred             cccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC
Confidence            3467999999999999999999984   478899999986532    23345678899999999 699999999999999


Q ss_pred             CeEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccce
Q 007869          331 GELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLA  410 (586)
Q Consensus       331 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla  410 (586)
                      +..++||||+++++|.+++....  .+++..+..++.||++||.|||+   ++|+||||||+|||++.++++||+|||++
T Consensus       132 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~DfG~a  206 (355)
T 1vzo_A          132 TKLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLS  206 (355)
T ss_dssp             TEEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred             ceEEEEeecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCcEEEeeCCCC
Confidence            99999999999999999997653  58899999999999999999998   89999999999999999999999999999


Q ss_pred             eeccCCCCCceeeeccCCCccCcccccCC--CCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCcc
Q 007869          411 RLYDHGTDPQTTHVVGTLGYLAPEHTRTG--KATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGEL  488 (586)
Q Consensus       411 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~  488 (586)
                      +.+............||+.|+|||++.+.  .++.++|||||||++|||++|+.||.........  .........    
T Consensus       207 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~--~~~~~~~~~----  280 (355)
T 1vzo_A          207 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ--AEISRRILK----  280 (355)
T ss_dssp             EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH--HHHHHHHHH----
T ss_pred             eecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchH--HHHHHHHhc----
Confidence            87654333334456899999999999853  4789999999999999999999999865433221  111111110    


Q ss_pred             ccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHHHH
Q 007869          489 LEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARP-----SMRQVVQIL  533 (586)
Q Consensus       489 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~~L  533 (586)
                         ..+....    .....+.+++.+||+.||.+||     ++.|+++..
T Consensus       281 ---~~~~~~~----~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~  323 (355)
T 1vzo_A          281 ---SEPPYPQ----EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL  323 (355)
T ss_dssp             ---CCCCCCT----TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred             ---cCCCCCc----ccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence               1111111    2234577888999999999999     999998653

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=5.3e-41  Score=354.65  Aligned_cols=263  Identities=22%  Similarity=0.259  Sum_probs=199.1

Q ss_pred             hhhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeecc------
Q 007869          257 YIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRK------  330 (586)
Q Consensus       257 ~~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~------  330 (586)
                      ....++|+..+.||+|+||.||+|++..++..||||++......    ..+|++++++++||||+++++++...      
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~   78 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK   78 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence            45678899999999999999999999999999999998654322    24799999999999999999998443      


Q ss_pred             --------------------------------CeEEEEEecCCCCChhhhhhc--CCCccchhHHHHHHHHHHHHHHHHh
Q 007869          331 --------------------------------GELLLVYDYMPNGSLDKYLYD--QPKVTLNWIQRFRVIKGVALGLFYL  376 (586)
Q Consensus       331 --------------------------------~~~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~~L~yL  376 (586)
                                                      ..+++||||++ |+|.+.+..  .....+++..+..++.||++||.||
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L  157 (383)
T 3eb0_A           79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI  157 (383)
T ss_dssp             -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence                                            34889999997 588877754  2235789999999999999999999


Q ss_pred             hcccCCcEEeCCCCCCCeeec-CCCCeEEccccceeeccCCCCCceeeeccCCCccCcccccCC-CCCCcceEEehhHHH
Q 007869          377 HQEWEQVVIHRDVKASNVLLD-GELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTG-KATTSADVFSFGAFL  454 (586)
Q Consensus       377 H~~~~~~ivHrDIkp~NIll~-~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVyS~Gvvl  454 (586)
                      |+   .+|+||||||+|||++ .++.+||+|||+++.+....  ......||+.|+|||++.+. .++.++|||||||++
T Consensus       158 H~---~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il  232 (383)
T 3eb0_A          158 HS---LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF  232 (383)
T ss_dssp             HT---TTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS--CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred             HH---CcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC--CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence            98   8999999999999998 68899999999999765432  23445789999999998765 489999999999999


Q ss_pred             HHHHhCCCCCCCCCCCccchhhHHHHhhhc---------cCccccccCCCCCc-----cccHHHHHHHHHHHHHhcccCC
Q 007869          455 LEVACGRRPIQRQGPSENLILVDWVFDFWN---------RGELLEARDPNLGT-----EYVAEELELVLKLGLLCSHSDP  520 (586)
Q Consensus       455 ~ElltG~~p~~~~~~~~~~~l~~~v~~~~~---------~~~~~~~~d~~l~~-----~~~~~~~~~l~~l~~~Cl~~dP  520 (586)
                      |||++|+.||......+...  ..+.....         +....+..-|....     .+.......+.+++.+||+.||
T Consensus       233 ~ell~g~~pf~~~~~~~~~~--~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP  310 (383)
T 3eb0_A          233 GELILGKPLFSGETSIDQLV--RIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEP  310 (383)
T ss_dssp             HHHHHSSCSSCCSSHHHHHH--HHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSG
T ss_pred             HHHHhCCCCCCCCChHHHHH--HHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCCh
Confidence            99999999998754332211  11100000         00001111111111     1112234567899999999999


Q ss_pred             CCCCCHHHHHH
Q 007869          521 TARPSMRQVVQ  531 (586)
Q Consensus       521 ~~RPs~~evl~  531 (586)
                      .+|||+.|+++
T Consensus       311 ~~R~t~~e~l~  321 (383)
T 3eb0_A          311 DLRINPYEAMA  321 (383)
T ss_dssp             GGSCCHHHHHT
T ss_pred             hhCCCHHHHhc
Confidence            99999999985

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=5.5e-41  Score=349.99  Aligned_cols=267  Identities=26%  Similarity=0.359  Sum_probs=203.2

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc--chhHHHHHHHHHHhcccCCCceeeeeeeeec--------c
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES--RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRR--------K  330 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~--------~  330 (586)
                      ++|+..+.||+|+||.||+|++..++..||||++....  ......+.+|++++++++||||+++++++..        .
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   96 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred             cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence            57999999999999999999999899999999986543  2334678899999999999999999999876        4


Q ss_pred             CeEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccce
Q 007869          331 GELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLA  410 (586)
Q Consensus       331 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla  410 (586)
                      +..++||||++ ++|.+.+.... ..+++.++..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||++
T Consensus        97 ~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  171 (351)
T 3mi9_A           97 GSIYLVFDFCE-HDLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLA  171 (351)
T ss_dssp             CEEEEEEECCS-EEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             ceEEEEEeccC-CCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence            56899999997 47877776543 468999999999999999999998   89999999999999999999999999999


Q ss_pred             eeccCCCC---CceeeeccCCCccCcccccC-CCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhh----
Q 007869          411 RLYDHGTD---PQTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDF----  482 (586)
Q Consensus       411 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~----  482 (586)
                      +.+.....   .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....+......    
T Consensus       172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  251 (351)
T 3mi9_A          172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE  251 (351)
T ss_dssp             EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence            87653221   22344678999999999876 45899999999999999999999999875433222111111000    


Q ss_pred             ----hccCccccccCCCC-CccccHHH------HHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          483 ----WNRGELLEARDPNL-GTEYVAEE------LELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       483 ----~~~~~~~~~~d~~l-~~~~~~~~------~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                          .............. ......+.      ...+.+++.+||+.||++|||+.|+++.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  312 (351)
T 3mi9_A          252 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  312 (351)
T ss_dssp             TSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence                00000000000000 00001111      2347789999999999999999999863

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=2.7e-41  Score=341.96  Aligned_cols=254  Identities=23%  Similarity=0.302  Sum_probs=189.7

Q ss_pred             hhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc--chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEE
Q 007869          258 IATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES--RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLL  335 (586)
Q Consensus       258 ~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~l  335 (586)
                      ...++|+..+.||+|+||.||+|.+..+++.||||++....  ....+.+..+...++.++||||+++++++...+..++
T Consensus         4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~l   83 (290)
T 3fme_A            4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWI   83 (290)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEE
T ss_pred             ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEE
Confidence            34578999999999999999999999899999999997642  2223344555566888899999999999999999999


Q ss_pred             EEecCCCCChhhhhhcC--CCccchhHHHHHHHHHHHHHHHHhhcccCC-cEEeCCCCCCCeeecCCCCeEEccccceee
Q 007869          336 VYDYMPNGSLDKYLYDQ--PKVTLNWIQRFRVIKGVALGLFYLHQEWEQ-VVIHRDVKASNVLLDGELNGRLGDFGLARL  412 (586)
Q Consensus       336 V~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~-~ivHrDIkp~NIll~~~~~~kL~DFGla~~  412 (586)
                      ||||++ |+|.+++...  ....+++..++.++.|++.||.|||+   + +|+||||||+|||++.++.+||+|||+++.
T Consensus        84 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  159 (290)
T 3fme_A           84 CMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHS---KLSVIHRDVKPSNVLINALGQVKMCDFGISGY  159 (290)
T ss_dssp             EEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HSCCCCCCCSGGGCEECTTCCEEBCCC-----
T ss_pred             EEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecCCccc
Confidence            999997 5888877541  23578999999999999999999998   6 999999999999999999999999999987


Q ss_pred             ccCCCCCceeeeccCCCccCcccc----cCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCcc
Q 007869          413 YDHGTDPQTTHVVGTLGYLAPEHT----RTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGEL  488 (586)
Q Consensus       413 ~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~  488 (586)
                      .....  ......||+.|+|||++    .+..++.++|||||||++|||++|+.||........ .+    .......  
T Consensus       160 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~----~~~~~~~--  230 (290)
T 3fme_A          160 LVDDV--AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ-QL----KQVVEEP--  230 (290)
T ss_dssp             ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHH-HH----HHHHHSC--
T ss_pred             ccccc--cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHH-HH----HHHhccC--
Confidence            65432  22334799999999996    556789999999999999999999999975432211 11    1111111  


Q ss_pred             ccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          489 LEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       489 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                          .+....   ......+.+++.+||+.||++|||+.|+++
T Consensus       231 ----~~~~~~---~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          231 ----SPQLPA---DKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             ----CCCCCT---TTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             ----CCCccc---ccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence                111111   112345778889999999999999999986

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.8e-40  Score=355.91  Aligned_cols=202  Identities=19%  Similarity=0.274  Sum_probs=177.9

Q ss_pred             hcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhccc------CCCceeeeeeeeeccCe
Q 007869          259 ATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRL------RHRNLVQLLGYCRRKGE  332 (586)
Q Consensus       259 a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l------~H~niv~l~~~~~~~~~  332 (586)
                      ...+|+..+.||+|+||.||+|.+..++..||||++.... ...+++.+|+.++..+      +|+||+++++++...+.
T Consensus        95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~  173 (429)
T 3kvw_A           95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH  173 (429)
T ss_dssp             ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred             ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence            3457999999999999999999999999999999997542 3345677788887777      57799999999999999


Q ss_pred             EEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCC--eEEccccce
Q 007869          333 LLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELN--GRLGDFGLA  410 (586)
Q Consensus       333 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~--~kL~DFGla  410 (586)
                      .++||||+. ++|.+++.......+++..+..++.||++||.|||+   .+|+||||||+|||++.++.  +||+|||++
T Consensus       174 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a  249 (429)
T 3kvw_A          174 ICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSS  249 (429)
T ss_dssp             EEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---HTEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             EEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEccCCCcceEEeecccc
Confidence            999999995 699999988766679999999999999999999998   89999999999999999887  999999999


Q ss_pred             eeccCCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCC
Q 007869          411 RLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGP  469 (586)
Q Consensus       411 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~  469 (586)
                      +....    ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus       250 ~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~  304 (429)
T 3kvw_A          250 CYEHQ----RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDE  304 (429)
T ss_dssp             EETTC----CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             eecCC----cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCH
Confidence            86543    23345789999999999999999999999999999999999999987543

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=2.1e-40  Score=338.09  Aligned_cols=252  Identities=23%  Similarity=0.321  Sum_probs=202.5

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc----chhHHHHHHHHHHhcccCCCceeeeeeeee--ccCeE
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES----RQGMKEFVAEIVSIGRLRHRNLVQLLGYCR--RKGEL  333 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~--~~~~~  333 (586)
                      .++|+..+.||+|+||.||++.+..++..||+|++....    ....+.+.+|++++++++||||+++++++.  +.+..
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            367999999999999999999999899999999997542    234578999999999999999999999984  45689


Q ss_pred             EEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeec
Q 007869          334 LLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLY  413 (586)
Q Consensus       334 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~  413 (586)
                      ++||||++++ |.+++.......+++..++.++.|+++||.|||+   ++|+||||||+|||++.++.+||+|||++...
T Consensus        84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~  159 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEAL  159 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEcCCCcEEeecccccccc
Confidence            9999999876 8888876656679999999999999999999998   89999999999999999999999999999876


Q ss_pred             cCCCC-CceeeeccCCCccCcccccCCC--CCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCcccc
Q 007869          414 DHGTD-PQTTHVVGTLGYLAPEHTRTGK--ATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLE  490 (586)
Q Consensus       414 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~--~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~  490 (586)
                      ..... .......||+.|+|||++.+..  ++.++|||||||++|||++|+.||......+   +    ......+.   
T Consensus       160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~----~~~i~~~~---  229 (305)
T 2wtk_C          160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYK---L----FENIGKGS---  229 (305)
T ss_dssp             CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---H----HHHHHHCC---
T ss_pred             CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH---H----HHHHhcCC---
Confidence            54322 2234457999999999997654  3779999999999999999999997643211   1    11111111   


Q ss_pred             ccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          491 ARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       491 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                         ..+...    ....+.+++.+||+.||.+|||+.|+++.
T Consensus       230 ---~~~~~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          230 ---YAIPGD----CGPPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             ---CCCCSS----SCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             ---CCCCCc----cCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence               111112    23456788899999999999999999964

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=4.3e-41  Score=366.36  Aligned_cols=252  Identities=25%  Similarity=0.379  Sum_probs=207.5

Q ss_pred             hcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc---chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEE
Q 007869          259 ATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLL  335 (586)
Q Consensus       259 a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~l  335 (586)
                      ..++|+..+.||+|+||.||+|++..++..||||++....   ....+.+.+|+.++++++||||+++++++...+..++
T Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  103 (484)
T 3nyv_A           24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL  103 (484)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            3467899999999999999999999899999999986542   3456789999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeee---cCCCCeEEccccceee
Q 007869          336 VYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLL---DGELNGRLGDFGLARL  412 (586)
Q Consensus       336 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll---~~~~~~kL~DFGla~~  412 (586)
                      ||||+++|+|.+++...  ..+++..+..++.||+.||.|||+   ++|+||||||+|||+   +.++.+||+|||+++.
T Consensus       104 v~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  178 (484)
T 3nyv_A          104 VGEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTH  178 (484)
T ss_dssp             EECCCCSCBHHHHHHTC--SCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred             EEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence            99999999999999765  358899999999999999999998   899999999999999   5678999999999987


Q ss_pred             ccCCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCcccccc
Q 007869          413 YDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEAR  492 (586)
Q Consensus       413 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~  492 (586)
                      +....  ......||+.|+|||++.+ .++.++|||||||++|||++|+.||......+   +...    ..++...   
T Consensus       179 ~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~----i~~~~~~---  245 (484)
T 3nyv_A          179 FEASK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD---ILKK----VEKGKYT---  245 (484)
T ss_dssp             BCCCC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHH----HHHCCCC---
T ss_pred             ccccc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH---HHHH----HHcCCCC---
Confidence            65432  3344679999999999865 69999999999999999999999998654321   1111    1111111   


Q ss_pred             CCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          493 DPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       493 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                         ............+.+++.+||+.||.+|||+.|+++
T Consensus       246 ---~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          246 ---FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             ---CCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence               000111122356778899999999999999999985

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.8e-40  Score=342.79  Aligned_cols=264  Identities=20%  Similarity=0.288  Sum_probs=207.8

Q ss_pred             hcCCcccceeEeecCceEEEEEEe-CCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCc------eeeeeeeeeccC
Q 007869          259 ATKGFREKELLGTGGFGRVYRGTL-PKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRN------LVQLLGYCRRKG  331 (586)
Q Consensus       259 a~~~f~~~~~LG~G~~g~Vy~~~~-~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~n------iv~l~~~~~~~~  331 (586)
                      ..++|+..+.||+|+||.||+|.+ ..++..||||++.... ...+.+.+|++++++++|+|      ++++++++...+
T Consensus        12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~   90 (339)
T 1z57_A           12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG   90 (339)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred             ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence            346899999999999999999998 5678899999996543 34567889999999997765      999999999999


Q ss_pred             eEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecC-------------
Q 007869          332 ELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDG-------------  398 (586)
Q Consensus       332 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~-------------  398 (586)
                      ..++||||+ +++|.+++.......+++..+..++.|+++||.|||+   ++|+||||||+|||++.             
T Consensus        91 ~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~  166 (339)
T 1z57_A           91 HICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKR  166 (339)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred             cEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeccccccccCCcccc
Confidence            999999999 8999999988766678999999999999999999998   89999999999999987             


Q ss_pred             ------CCCeEEccccceeeccCCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCcc
Q 007869          399 ------ELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSEN  472 (586)
Q Consensus       399 ------~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~  472 (586)
                            ++.+||+|||+++.....    .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+.
T Consensus       167 ~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~  242 (339)
T 1z57_A          167 DERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH  242 (339)
T ss_dssp             EEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH
T ss_pred             ccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH
Confidence                  668999999999875432    2345789999999999999999999999999999999999999986543322


Q ss_pred             chhhHHH--------HhhhccCccccc--cC---------------CCCC--ccccHHHHHHHHHHHHHhcccCCCCCCC
Q 007869          473 LILVDWV--------FDFWNRGELLEA--RD---------------PNLG--TEYVAEELELVLKLGLLCSHSDPTARPS  525 (586)
Q Consensus       473 ~~l~~~v--------~~~~~~~~~~~~--~d---------------~~l~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPs  525 (586)
                      .......        +...........  .+               ..+.  ..........+.+++.+||+.||.+|||
T Consensus       243 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt  322 (339)
T 1z57_A          243 LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRIT  322 (339)
T ss_dssp             HHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred             HHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccC
Confidence            1111110        000000000000  00               0000  0112344677889999999999999999


Q ss_pred             HHHHHH
Q 007869          526 MRQVVQ  531 (586)
Q Consensus       526 ~~evl~  531 (586)
                      +.|+++
T Consensus       323 ~~ell~  328 (339)
T 1z57_A          323 LREALK  328 (339)
T ss_dssp             HHHHTT
T ss_pred             HHHHhc
Confidence            999975

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.4e-40  Score=364.12  Aligned_cols=253  Identities=23%  Similarity=0.372  Sum_probs=204.5

Q ss_pred             hhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccc-------------hhHHHHHHHHHHhcccCCCceeeee
Q 007869          258 IATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR-------------QGMKEFVAEIVSIGRLRHRNLVQLL  324 (586)
Q Consensus       258 ~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~Ei~~l~~l~H~niv~l~  324 (586)
                      ...++|...+.||+|+||.||+|++..++..||||++.....             ...+.+.+|+.++++++||||++++
T Consensus        33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~  112 (504)
T 3q5i_A           33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF  112 (504)
T ss_dssp             CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence            345789999999999999999999999999999999865421             3356789999999999999999999


Q ss_pred             eeeeccCeEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCC---C
Q 007869          325 GYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGEL---N  401 (586)
Q Consensus       325 ~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~---~  401 (586)
                      +++...+..++||||+++|+|.+++...  ..+++..+..++.||+.||.|||+   .+|+||||||+|||++.++   .
T Consensus       113 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~  187 (504)
T 3q5i_A          113 DVFEDKKYFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLN  187 (504)
T ss_dssp             EEEECSSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESSTTCCSS
T ss_pred             EEEEcCCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCcHHHEEEecCCCCcc
Confidence            9999999999999999999999998765  358999999999999999999998   8999999999999998765   6


Q ss_pred             eEEccccceeeccCCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHh
Q 007869          402 GRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFD  481 (586)
Q Consensus       402 ~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~  481 (586)
                      +||+|||+++......  ......||+.|+|||++. +.++.++|||||||++|||++|+.||......+   +..    
T Consensus       188 ~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~----  257 (504)
T 3q5i_A          188 IKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD---IIK----  257 (504)
T ss_dssp             EEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH----
T ss_pred             EEEEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHH----
Confidence            9999999999765432  334567999999999986 569999999999999999999999998654322   111    


Q ss_pred             hhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          482 FWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       482 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      ....+...      ............+.+++.+||+.||.+|||+.|+++
T Consensus       258 ~i~~~~~~------~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          258 KVEKGKYY------FDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN  301 (504)
T ss_dssp             HHHHCCCC------CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHcCCCC------CCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            11111110      000000112356788899999999999999999985

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=9.6e-41  Score=343.92  Aligned_cols=252  Identities=25%  Similarity=0.325  Sum_probs=199.1

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc--------chhHHHHHHHHHHhcccCCCceeeeeeeeeccC
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES--------RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKG  331 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~  331 (586)
                      .++|...+.||+|+||.||+|++..++..||||++....        ......+.+|++++++++||||+++++++...+
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   88 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED   88 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence            357889999999999999999999999999999986532        122345889999999999999999999987665


Q ss_pred             eEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCC---eEEcccc
Q 007869          332 ELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELN---GRLGDFG  408 (586)
Q Consensus       332 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~---~kL~DFG  408 (586)
                       .++||||+++++|.+++...  ..+++..++.++.||++||.|||+   ++|+||||||+|||++.++.   +||+|||
T Consensus        89 -~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg  162 (322)
T 2ycf_A           89 -YYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFG  162 (322)
T ss_dssp             -EEEEEECCTTEETHHHHSTT--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSSSCCEEECCCT
T ss_pred             -eEEEEecCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEecCCCCCeEEEccCc
Confidence             89999999999999998754  368899999999999999999998   89999999999999987654   9999999


Q ss_pred             ceeeccCCCCCceeeeccCCCccCccccc---CCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhcc
Q 007869          409 LARLYDHGTDPQTTHVVGTLGYLAPEHTR---TGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNR  485 (586)
Q Consensus       409 la~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~  485 (586)
                      +++.....  .......||+.|+|||++.   ...++.++|||||||++|||++|+.||........  +.+.+.    .
T Consensus       163 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~----~  234 (322)
T 2ycf_A          163 HSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKDQIT----S  234 (322)
T ss_dssp             TCEECCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--HHHHHH----H
T ss_pred             cceecccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--HHHHHH----h
Confidence            99876432  1223457899999999973   56789999999999999999999999976543321  111111    1


Q ss_pred             CccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          486 GELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       486 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      +...      ............+.+++.+||+.||++||++.++++
T Consensus       235 ~~~~------~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          235 GKYN------FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             TCCC------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             Cccc------cCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence            1110      000111122356788999999999999999999985

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=2e-40  Score=339.93  Aligned_cols=252  Identities=26%  Similarity=0.387  Sum_probs=202.5

Q ss_pred             hcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEe
Q 007869          259 ATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYD  338 (586)
Q Consensus       259 a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E  338 (586)
                      ..+.|+..+.||+|+||.||+|.+..++..||||++....  ..+.+.+|+.++.+++||||+++++++...+..++|||
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  104 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME  104 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence            4567999999999999999999999889999999997643  34678999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCC
Q 007869          339 YMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD  418 (586)
Q Consensus       339 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~  418 (586)
                      |+++++|.+++... ...+++..++.++.|++.||.|||+   .+|+||||||+||+++.++.+||+|||++........
T Consensus       105 ~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~  180 (314)
T 3com_A          105 YCGAGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA  180 (314)
T ss_dssp             CCTTEEHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS
T ss_pred             cCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc
Confidence            99999999998643 2468899999999999999999998   8999999999999999999999999999987654322


Q ss_pred             CceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCc
Q 007869          419 PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGT  498 (586)
Q Consensus       419 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~  498 (586)
                       ......||+.|+|||++.+..++.++||||||+++|||++|+.||........      ..... ..     ..+... 
T Consensus       181 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~~~~-~~-----~~~~~~-  246 (314)
T 3com_A          181 -KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRA------IFMIP-TN-----PPPTFR-  246 (314)
T ss_dssp             -CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHH-HS-----CCCCCS-
T ss_pred             -ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH------HHHHh-cC-----CCcccC-
Confidence             23345789999999999999999999999999999999999999975432111      11000 00     111111 


Q ss_pred             cccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          499 EYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       499 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                       ........+.+++.+||+.||.+|||+.++++
T Consensus       247 -~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          247 -KPELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             -SGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             -CcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence             11112356778899999999999999999986

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=7.8e-41  Score=344.54  Aligned_cols=267  Identities=25%  Similarity=0.368  Sum_probs=205.7

Q ss_pred             hhhhcCCcccceeEeecCceEEEEEEeC-CCCeEEEEEEeccccc--hhHHHHHHHHHHhccc---CCCceeeeeeeee-
Q 007869          256 LYIATKGFREKELLGTGGFGRVYRGTLP-KSQIEIAVKKISHESR--QGMKEFVAEIVSIGRL---RHRNLVQLLGYCR-  328 (586)
Q Consensus       256 l~~a~~~f~~~~~LG~G~~g~Vy~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l---~H~niv~l~~~~~-  328 (586)
                      +..+.++|+..+.||+|+||.||+|++. .++..||||++.....  .....+.+|+.+++++   +||||++++++|. 
T Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~   85 (326)
T 1blx_A            6 LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTV   85 (326)
T ss_dssp             CCCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEE
T ss_pred             ccCchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeee
Confidence            3456688999999999999999999985 6788999999865422  2223566777777666   8999999999987 


Q ss_pred             ----ccCeEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEE
Q 007869          329 ----RKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRL  404 (586)
Q Consensus       329 ----~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL  404 (586)
                          .....++||||++ |+|.+++.......+++..++.++.|+++||.|||+   .+|+||||||+|||++.++.+||
T Consensus        86 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~gi~H~dlkp~Nili~~~~~~kl  161 (326)
T 1blx_A           86 SRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKL  161 (326)
T ss_dssp             EECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEE
T ss_pred             cccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHHHeEEcCCCCEEE
Confidence                5677999999997 699999987765668999999999999999999998   89999999999999999999999


Q ss_pred             ccccceeeccCCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhc
Q 007869          405 GDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWN  484 (586)
Q Consensus       405 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~  484 (586)
                      +|||+++......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+.   ...+.....
T Consensus       162 ~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~i~~~~~  236 (326)
T 1blx_A          162 ADFGLARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ---LGKILDVIG  236 (326)
T ss_dssp             CSCCSCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HHHHHHHHC
T ss_pred             ecCcccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHH---HHHHHHHcC
Confidence            9999998654321  23446789999999999999999999999999999999999999986543221   111111100


Q ss_pred             cC---cc----------ccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          485 RG---EL----------LEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       485 ~~---~~----------~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      ..   ..          ...........+.......+.+++.+||+.||.+|||+.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          237 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             CCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            00   00          0000000001111223456778999999999999999999985

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.3e-40  Score=349.09  Aligned_cols=267  Identities=26%  Similarity=0.314  Sum_probs=207.0

Q ss_pred             hhhhhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc-chhHHHHHHHHHHhcccCCCceeeeeeeeecc---
Q 007869          255 DLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRK---  330 (586)
Q Consensus       255 el~~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~---  330 (586)
                      +.....++|+..+.||+|+||.||+|.+..++..||||++.... ....+.+.+|++++.+++||||+++++++...   
T Consensus        21 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  100 (364)
T 3qyz_A           21 QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIE  100 (364)
T ss_dssp             CBCCCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTT
T ss_pred             EeccccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCcc
Confidence            34445678999999999999999999999899999999997543 33457789999999999999999999998754   


Q ss_pred             --CeEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEcccc
Q 007869          331 --GELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFG  408 (586)
Q Consensus       331 --~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFG  408 (586)
                        ...++||||++ |+|.+++...   .+++.++..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||
T Consensus       101 ~~~~~~iv~e~~~-~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg  173 (364)
T 3qyz_A          101 QMKDVYIVQDLME-TDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFG  173 (364)
T ss_dssp             TCCCEEEEEECCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred             ccceEEEEEcccC-cCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChHhEEECCCCCEEEEeCc
Confidence              46899999996 6999998764   58899999999999999999998   899999999999999999999999999


Q ss_pred             ceeeccCCCCC--ceeeeccCCCccCcccccC-CCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhcc
Q 007869          409 LARLYDHGTDP--QTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNR  485 (586)
Q Consensus       409 la~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~  485 (586)
                      +++........  ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+....+   ......
T Consensus       174 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i---~~~~~~  250 (364)
T 3qyz_A          174 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHI---LGILGS  250 (364)
T ss_dssp             TCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHH---HHHHCS
T ss_pred             ceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHH---HHHhCC
Confidence            99976543221  1244689999999998754 45899999999999999999999999876543322111   100000


Q ss_pred             Cc---------------cccccCCCCC--ccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          486 GE---------------LLEARDPNLG--TEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       486 ~~---------------~~~~~d~~l~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      ..               ......+...  ..........+.+++.+||+.||++|||+.|+++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          251 PSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             CCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            00               0000000000  0011112356788999999999999999999986

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=4.9e-40  Score=356.75  Aligned_cols=260  Identities=17%  Similarity=0.214  Sum_probs=207.8

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCC-CceeeeeeeeeccCeEEEEEe
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRH-RNLVQLLGYCRRKGELLLVYD  338 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H-~niv~l~~~~~~~~~~~lV~E  338 (586)
                      .++|++.++||+|+||.||+|++..++..||||++......  .++..|++++..++| +++..+..++...+..+||||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            46899999999999999999999888999999988654332  457899999999987 556666667777888999999


Q ss_pred             cCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeee---cCCCCeEEccccceeeccC
Q 007869          339 YMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLL---DGELNGRLGDFGLARLYDH  415 (586)
Q Consensus       339 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll---~~~~~~kL~DFGla~~~~~  415 (586)
                      |+ +++|.+++.... ..+++..++.|+.||+.||.|||+   ++|+||||||+||||   +.++.+||+|||+++.+..
T Consensus        84 ~~-g~sL~~ll~~~~-~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~  158 (483)
T 3sv0_A           84 LL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD  158 (483)
T ss_dssp             CC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             CC-CCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence            99 999999997543 368999999999999999999998   899999999999999   6889999999999997665


Q ss_pred             CCCC------ceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccc
Q 007869          416 GTDP------QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELL  489 (586)
Q Consensus       416 ~~~~------~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~  489 (586)
                      ....      ......||+.|+|||++.+..++.++|||||||+||||++|+.||..............+........+.
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~  238 (483)
T 3sv0_A          159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIE  238 (483)
T ss_dssp             TTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHH
T ss_pred             CccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHH
Confidence            4321      1235679999999999999999999999999999999999999998765543222222211111000000


Q ss_pred             cccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 007869          490 EARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER  535 (586)
Q Consensus       490 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  535 (586)
                      .         ........+.+++..||+.||++||++.++++.|+.
T Consensus       239 ~---------l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~  275 (483)
T 3sv0_A          239 A---------LCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRD  275 (483)
T ss_dssp             H---------HHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred             H---------HhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence            0         001123567889999999999999999999998865

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.1e-40  Score=363.28  Aligned_cols=252  Identities=23%  Similarity=0.353  Sum_probs=204.3

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc--cchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEE
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY  337 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  337 (586)
                      .++|+..+.||+|+||.||+|++..++..||||++...  .......+.+|++++++++||||+++++++...+..++||
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  100 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence            35789999999999999999999989999999998653  2334578999999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeec---CCCCeEEccccceeecc
Q 007869          338 DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLD---GELNGRLGDFGLARLYD  414 (586)
Q Consensus       338 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~---~~~~~kL~DFGla~~~~  414 (586)
                      ||+++|+|.+++...  ..+++..+..++.||+.||.|||+   ++|+||||||+|||++   .++.+||+|||+++...
T Consensus       101 e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~  175 (486)
T 3mwu_A          101 ELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ  175 (486)
T ss_dssp             CCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBC
T ss_pred             EcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEEECCcCeECC
Confidence            999999999988765  358899999999999999999998   8999999999999995   45679999999998665


Q ss_pred             CCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCC
Q 007869          415 HGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDP  494 (586)
Q Consensus       415 ~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~  494 (586)
                      ...  ......||+.|+|||++.+ .++.++|||||||++|||++|+.||......+   +...    ...+...     
T Consensus       176 ~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~----i~~~~~~-----  240 (486)
T 3mwu_A          176 QNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD---ILKR----VETGKYA-----  240 (486)
T ss_dssp             CC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHH----HHHTCCC-----
T ss_pred             CCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHH----HHhCCCC-----
Confidence            432  2344679999999999875 59999999999999999999999997653321   1111    1111111     


Q ss_pred             CCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          495 NLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       495 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                       ............+.+++.+||+.||.+|||+.|+++.
T Consensus       241 -~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          241 -FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             -SCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             -CCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence             0001111223557788999999999999999999973

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=3.8e-41  Score=343.11  Aligned_cols=254  Identities=26%  Similarity=0.384  Sum_probs=201.6

Q ss_pred             hcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEe
Q 007869          259 ATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYD  338 (586)
Q Consensus       259 a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E  338 (586)
                      ..+.|+..+.||+|+||.||+|.+..++..||+|++........+.+.+|++++++++||||+++++++...+..++|||
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   96 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE   96 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence            44679999999999999999999998899999999987766677889999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCC
Q 007869          339 YMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD  418 (586)
Q Consensus       339 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~  418 (586)
                      |+++++|.+++.... ..+++..++.++.|+++||.|||+   .+|+||||||+|||++.++.+||+|||++....... 
T Consensus        97 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  171 (302)
T 2j7t_A           97 FCPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL-  171 (302)
T ss_dssp             CCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-
T ss_pred             eCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEECCCCCEEEEECCCCccccccc-
Confidence            999999999987642 368899999999999999999998   899999999999999999999999999986432211 


Q ss_pred             CceeeeccCCCccCcccc-----cCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccC
Q 007869          419 PQTTHVVGTLGYLAPEHT-----RTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARD  493 (586)
Q Consensus       419 ~~~~~~~gt~~y~aPE~~-----~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d  493 (586)
                      .......||+.|+|||++     ....++.++|||||||++|||++|+.||......+      ....... +.     .
T Consensus       172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~-~~-----~  239 (302)
T 2j7t_A          172 QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR------VLLKIAK-SD-----P  239 (302)
T ss_dssp             HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHHHHHH-SC-----C
T ss_pred             cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH------HHHHHhc-cC-----C
Confidence            112335789999999998     46678999999999999999999999997643221      1111111 11     1


Q ss_pred             CCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          494 PNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       494 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      +...  ........+.+++.+||+.||.+|||+.++++
T Consensus       240 ~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          240 PTLL--TPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             CCCS--SGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             cccC--CccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            1110  11122345778889999999999999999975

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=7.6e-41  Score=350.26  Aligned_cols=270  Identities=22%  Similarity=0.257  Sum_probs=201.1

Q ss_pred             cchhhhhhhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccc-----------hhHHHHHHHHHHhcccCCCc
Q 007869          251 FRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR-----------QGMKEFVAEIVSIGRLRHRN  319 (586)
Q Consensus       251 ~~~~el~~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~Ei~~l~~l~H~n  319 (586)
                      ...+++....++|+..+.||+|+||.||+|.+.. +..||||++.....           ...+.+.+|++++++++|||
T Consensus        12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~   90 (362)
T 3pg1_A           12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPN   90 (362)
T ss_dssp             HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTT
T ss_pred             HHHHHHHHhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcC
Confidence            3467788889999999999999999999999865 78899999865321           12377999999999999999


Q ss_pred             eeeeeeeeec-----cCeEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCe
Q 007869          320 LVQLLGYCRR-----KGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNV  394 (586)
Q Consensus       320 iv~l~~~~~~-----~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NI  394 (586)
                      |+++++++..     ....++||||++ |+|.+++... ...+++..+..++.||+.||.|||+   .+|+||||||+||
T Consensus        91 iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NI  165 (362)
T 3pg1_A           91 ILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHPGNI  165 (362)
T ss_dssp             BCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGE
T ss_pred             ccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHH---CcCEecCCChHHE
Confidence            9999999843     346899999997 6888888754 3468999999999999999999998   8999999999999


Q ss_pred             eecCCCCeEEccccceeeccCCCCCceeeeccCCCccCcccccC-CCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccc
Q 007869          395 LLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIQRQGPSENL  473 (586)
Q Consensus       395 ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~  473 (586)
                      |++.++.+||+|||+++......  ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+..
T Consensus       166 l~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~  243 (362)
T 3pg1_A          166 LLADNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQL  243 (362)
T ss_dssp             EECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred             EEcCCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            99999999999999998544322  3345678999999999876 67899999999999999999999999865432211


Q ss_pred             hhhHHHHhhhccCc------------------cccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          474 ILVDWVFDFWNRGE------------------LLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       474 ~l~~~v~~~~~~~~------------------~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      .   .+........                  ....................+.+++.+||+.||.+|||+.|+++
T Consensus       244 ~---~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  316 (362)
T 3pg1_A          244 N---KIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALR  316 (362)
T ss_dssp             H---HHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             H---HHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHc
Confidence            1   1111000000                  00000000000111122356788999999999999999999986

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=2.3e-40  Score=341.89  Aligned_cols=258  Identities=21%  Similarity=0.269  Sum_probs=201.2

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccC-CCceeeeeeeeec--cCeEEEE
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLR-HRNLVQLLGYCRR--KGELLLV  336 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~~~~~~--~~~~~lV  336 (586)
                      .++|+..+.||+|+||.||+|++..++..||||++....   .+.+.+|++++++++ ||||+++++++..  ....++|
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv  111 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  111 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence            367999999999999999999998899999999996443   467899999999997 9999999999987  6678999


Q ss_pred             EecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCC-CeEEccccceeeccC
Q 007869          337 YDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGEL-NGRLGDFGLARLYDH  415 (586)
Q Consensus       337 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~-~~kL~DFGla~~~~~  415 (586)
                      |||+++++|.+++.     .+++..+..++.|+++||.|||+   ++|+||||||+|||++.++ .+||+|||+++....
T Consensus       112 ~e~~~~~~l~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~  183 (330)
T 3nsz_A          112 FEHVNNTDFKQLYQ-----TLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  183 (330)
T ss_dssp             EECCCCCCHHHHGG-----GCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred             EeccCchhHHHHHH-----hCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence            99999999999884     37888999999999999999998   8999999999999999776 899999999987654


Q ss_pred             CCCCceeeeccCCCccCcccccC-CCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHH--------HhhhccC
Q 007869          416 GTDPQTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWV--------FDFWNRG  486 (586)
Q Consensus       416 ~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v--------~~~~~~~  486 (586)
                      ..  ......||..|+|||++.+ ..++.++|||||||++|||++|+.||........ .+....        .....+.
T Consensus       184 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~-~l~~~~~~~~~~~~~~~~~~~  260 (330)
T 3nsz_A          184 GQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD-QLVRIAKVLGTEDLYDYIDKY  260 (330)
T ss_dssp             TC--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH-HHHHHHHHHCHHHHHHHHHHT
T ss_pred             CC--ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHH-HHHHHHHhcCCchhhhHHHHh
Confidence            33  2334578999999999877 6789999999999999999999999965432211 111000        0000000


Q ss_pred             ccc------cccC--------CCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          487 ELL------EARD--------PNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       487 ~~~------~~~d--------~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      ...      ....        ..............+.+++.+||+.||++|||++|+++
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          261 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             TCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             ccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            000      0000        00000111112456788999999999999999999986

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=4.8e-40  Score=345.87  Aligned_cols=262  Identities=22%  Similarity=0.242  Sum_probs=195.7

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc--cchhHHHHHHHHHHhcccCCCceeeeeeeeeccC------
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKG------  331 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~------  331 (586)
                      .++|+..+.||+|+||.||+|++..++..||||++...  .....+.+.+|+.++++++||||+++++++...+      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            47899999999999999999999989999999999753  3344567899999999999999999999987654      


Q ss_pred             eEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEcccccee
Q 007869          332 ELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR  411 (586)
Q Consensus       332 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~  411 (586)
                      ..++||||++ ++|.+.+..    .+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++
T Consensus       104 ~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~  175 (371)
T 2xrw_A          104 DVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR  175 (371)
T ss_dssp             EEEEEEECCS-EEHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCCCC--
T ss_pred             ceEEEEEcCC-CCHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEEEeeccc
Confidence            7899999996 578888853    47888999999999999999998   899999999999999999999999999998


Q ss_pred             eccCCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhh---------------
Q 007869          412 LYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILV---------------  476 (586)
Q Consensus       412 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~---------------  476 (586)
                      ......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||......+....+               
T Consensus       176 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  253 (371)
T 2xrw_A          176 TAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL  253 (371)
T ss_dssp             ----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTS
T ss_pred             cccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHh
Confidence            754322  234467999999999999999999999999999999999999999765432111000               


Q ss_pred             -HHHHhhhccCcc-----ccccCCC----CCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          477 -DWVFDFWNRGEL-----LEARDPN----LGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       477 -~~v~~~~~~~~~-----~~~~d~~----l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                       ..+.....+...     .....+.    ...+........+.+++.+||+.||++|||++|+++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  318 (371)
T 2xrw_A          254 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  318 (371)
T ss_dssp             CHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             hhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence             000000000000     0000000    001112233567889999999999999999999986

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=2e-40  Score=355.90  Aligned_cols=200  Identities=27%  Similarity=0.383  Sum_probs=170.6

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc--cchhHHHHHHHHHHhcccCCCceeeeeeeeecc-----Ce
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRK-----GE  332 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~-----~~  332 (586)
                      .++|+..+.||+|+||.||+|++..++..||||++...  .....+.+.+|+++|++++||||+++++++...     +.
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            57899999999999999999999999999999999753  334457899999999999999999999999766     57


Q ss_pred             EEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceee
Q 007869          333 LLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARL  412 (586)
Q Consensus       333 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~  412 (586)
                      .++||||+. ++|.+++...  ..+++..+..++.||+.||.|||+   .+|+||||||+|||++.++.+||+|||+++.
T Consensus       105 ~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qil~aL~~LH~---~givHrDlkp~NILl~~~~~~kL~DFGla~~  178 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKTP--IFLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLART  178 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEEecCC-cCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence            999999996 6999999764  468999999999999999999998   8999999999999999999999999999997


Q ss_pred             ccCCCC---------------------CceeeeccCCCccCcccc-cCCCCCCcceEEehhHHHHHHHhCCCCCC
Q 007869          413 YDHGTD---------------------PQTTHVVGTLGYLAPEHT-RTGKATTSADVFSFGAFLLEVACGRRPIQ  465 (586)
Q Consensus       413 ~~~~~~---------------------~~~~~~~gt~~y~aPE~~-~~~~~s~ksDVyS~Gvvl~ElltG~~p~~  465 (586)
                      ......                     ...+..+||+.|+|||++ ....++.++|||||||++|||++|..|+.
T Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~  253 (432)
T 3n9x_A          179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI  253 (432)
T ss_dssp             C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred             ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence            654321                     123557899999999986 55679999999999999999998655543

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=9.6e-41  Score=335.60  Aligned_cols=250  Identities=23%  Similarity=0.404  Sum_probs=198.3

Q ss_pred             hcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc---chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEE
Q 007869          259 ATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLL  335 (586)
Q Consensus       259 a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~l  335 (586)
                      ..++|...+.||+|+||.||+|++..++..||||++....   ....+.+.+|+.++++++||||+++++++...+..++
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   88 (276)
T 2h6d_A            9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM   88 (276)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence            3468999999999999999999998889999999996542   2345678999999999999999999999999999999


Q ss_pred             EEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccC
Q 007869          336 VYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH  415 (586)
Q Consensus       336 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~  415 (586)
                      ||||+++++|.+++....  .+++..++.++.|+++||.|||+   .+|+||||||+|||++.++.+||+|||++.....
T Consensus        89 v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  163 (276)
T 2h6d_A           89 VMEYVSGGELFDYICKHG--RVEEMEARRLFQQILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD  163 (276)
T ss_dssp             EEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHH---HCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred             EEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChhhEEECCCCCEEEeecccccccCC
Confidence            999999999999997653  58889999999999999999998   8999999999999999999999999999987644


Q ss_pred             CCCCceeeeccCCCccCcccccCCCC-CCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCC
Q 007869          416 GTDPQTTHVVGTLGYLAPEHTRTGKA-TTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDP  494 (586)
Q Consensus       416 ~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~  494 (586)
                      ..  ......||+.|+|||.+.+..+ +.++||||||+++|||++|+.||......+   +.    +....+.      .
T Consensus       164 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~----~~~~~~~------~  228 (276)
T 2h6d_A          164 GE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT---LF----KKIRGGV------F  228 (276)
T ss_dssp             ---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH----HHHHHCC------C
T ss_pred             Cc--ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH---HH----HHhhcCc------c
Confidence            32  2234578999999999987765 689999999999999999999997543211   11    1111111      1


Q ss_pred             CCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          495 NLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       495 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                      .+....    ...+.+++.+||+.||.+|||+.|+++.
T Consensus       229 ~~~~~~----~~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          229 YIPEYL----NRSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             CCCTTS----CHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             cCchhc----CHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            111111    2457788899999999999999999973

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=3.2e-41  Score=341.53  Aligned_cols=259  Identities=28%  Similarity=0.398  Sum_probs=199.1

Q ss_pred             hcCCcccceeEeecCceEEEEEEeCC-C--CeEEEEEEeccc---cchhHHHHHHHHHHhcccCCCceeeeeeeeeccCe
Q 007869          259 ATKGFREKELLGTGGFGRVYRGTLPK-S--QIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGE  332 (586)
Q Consensus       259 a~~~f~~~~~LG~G~~g~Vy~~~~~~-~--~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~  332 (586)
                      ..++|+..+.||+|+||.||+|++.. +  +..||||++...   .....+.+.+|++++++++||||+++++++...+ 
T Consensus        16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-   94 (291)
T 1u46_A           16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-   94 (291)
T ss_dssp             CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred             chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-
Confidence            45679999999999999999998632 2  346899998754   3345678999999999999999999999998765 


Q ss_pred             EEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceee
Q 007869          333 LLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARL  412 (586)
Q Consensus       333 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~  412 (586)
                      .++||||+++++|.+++... ...+++..++.++.|+++||.|||+   ++|+||||||+|||++.++.+||+|||+++.
T Consensus        95 ~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~  170 (291)
T 1u46_A           95 MKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRA  170 (291)
T ss_dssp             CEEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             ceeeEecccCCCHHHHHHhc-cCCcCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEEcCCCCEEEcccccccc
Confidence            89999999999999999764 2468899999999999999999998   8999999999999999999999999999987


Q ss_pred             ccCCCCC--ceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccCccc
Q 007869          413 YDHGTDP--QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELL  489 (586)
Q Consensus       413 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~  489 (586)
                      .......  ......+|..|+|||++.+..++.++||||||+++|||++ |+.||......+   +.   ......+.  
T Consensus       171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~---~~~~~~~~--  242 (291)
T 1u46_A          171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ---IL---HKIDKEGE--  242 (291)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HH---HHHHTSCC--
T ss_pred             ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHH---HH---HHHHccCC--
Confidence            6543321  1223467889999999998889999999999999999999 999997653321   11   11111111  


Q ss_pred             cccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 007869          490 EARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERDV  537 (586)
Q Consensus       490 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  537 (586)
                         .+..    .......+.+++.+||+.||.+||++.++++.|++..
T Consensus       243 ---~~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  283 (291)
T 1u46_A          243 ---RLPR----PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ  283 (291)
T ss_dssp             ---CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             ---CCCC----CcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence               0111    1122356788899999999999999999999998754

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.1e-40  Score=356.79  Aligned_cols=259  Identities=26%  Similarity=0.326  Sum_probs=196.5

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeecc------CeEE
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRK------GELL  334 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~------~~~~  334 (586)
                      .+|+..+.||+|+||.||+|++..++..||||++.....    .+.+|++++++++||||++++++|...      ..++
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            468889999999999999999998899999999865432    234799999999999999999988542      2477


Q ss_pred             EEEecCCCCChhhhhhc--CCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCC-CCeEEcccccee
Q 007869          335 LVYDYMPNGSLDKYLYD--QPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGE-LNGRLGDFGLAR  411 (586)
Q Consensus       335 lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~-~~~kL~DFGla~  411 (586)
                      +||||+++ +|.+.+..  .....+++..+..++.||++||.|||+   ++|+||||||+|||++.+ +.+||+|||+++
T Consensus       130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~  205 (420)
T 1j1b_A          130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAK  205 (420)
T ss_dssp             EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChhhEEEeCCCCeEEeccchhhh
Confidence            99999975 66666543  223578999999999999999999998   899999999999999965 568999999999


Q ss_pred             eccCCCCCceeeeccCCCccCcccccCC-CCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhh-------h
Q 007869          412 LYDHGTDPQTTHVVGTLGYLAPEHTRTG-KATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDF-------W  483 (586)
Q Consensus       412 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~-------~  483 (586)
                      .+....  ......||+.|+|||++.+. .++.++|||||||++|||++|+.||......+.+  .+.+...       +
T Consensus       206 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l--~~i~~~lg~p~~~~~  281 (420)
T 1j1b_A          206 QLVRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL--VEIIKVLGTPTREQI  281 (420)
T ss_dssp             ECCTTC--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHHHHHCSCCHHHH
T ss_pred             hcccCC--CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHHhCCCCHHHH
Confidence            765432  23346789999999998765 7899999999999999999999999875432221  1111100       0


Q ss_pred             c--cCccccccCCCCCcc-----ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          484 N--RGELLEARDPNLGTE-----YVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       484 ~--~~~~~~~~d~~l~~~-----~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      .  .....+...|.+...     +.......+.+|+.+||+.||.+||++.|+++
T Consensus       282 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          282 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             HHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence            0  001111111211110     11122356889999999999999999999985

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=2.2e-40  Score=336.67  Aligned_cols=252  Identities=25%  Similarity=0.421  Sum_probs=195.0

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeec----------
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRR----------  329 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~----------  329 (586)
                      .++|+..+.||+|+||.||+|++..++..||||++... ....+.+.+|+.++++++||||+++++++.+          
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA   83 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence            35788999999999999999999888999999999653 3445789999999999999999999998754          


Q ss_pred             ---cCeEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEcc
Q 007869          330 ---KGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGD  406 (586)
Q Consensus       330 ---~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~D  406 (586)
                         .+..++||||+++++|.+++.... ..+++..++.++.|+++||.|||+   .+|+||||||+|||++.++.+||+|
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dlkp~Nil~~~~~~~kl~d  159 (303)
T 1zy4_A           84 VKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGD  159 (303)
T ss_dssp             --CEEEEEEEEECCCSCBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECC
T ss_pred             cccCCceEEEEecCCCCCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHHh---CCeecccCCHHhEEEcCCCCEEEee
Confidence               457899999999999999998653 467888999999999999999998   8999999999999999999999999


Q ss_pred             ccceeeccCCC-------------CCceeeeccCCCccCcccccCC-CCCCcceEEehhHHHHHHHhCCCCCCCCCCCcc
Q 007869          407 FGLARLYDHGT-------------DPQTTHVVGTLGYLAPEHTRTG-KATTSADVFSFGAFLLEVACGRRPIQRQGPSEN  472 (586)
Q Consensus       407 FGla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~  472 (586)
                      ||+++......             ........||+.|+|||++.+. .++.++|||||||++|||++   ||....  + 
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~--~-  233 (303)
T 1zy4_A          160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM--E-  233 (303)
T ss_dssp             CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH--H-
T ss_pred             CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch--h-
Confidence            99998754321             1122345789999999999764 68999999999999999998   443211  1 


Q ss_pred             chhhHHHHhhhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          473 LILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       473 ~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                        ..+... .....      .......+.......+.+++.+||+.||.+|||+.++++
T Consensus       234 --~~~~~~-~~~~~------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          234 --RVNILK-KLRSV------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             --HHHHHH-HHHST------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --HHHHHH-hcccc------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence              111111 11111      111112223334456788999999999999999999986

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=3.5e-40  Score=343.73  Aligned_cols=263  Identities=25%  Similarity=0.308  Sum_probs=202.3

Q ss_pred             hcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc-chhHHHHHHHHHHhcccCCCceeeeeeeeecc-----Ce
Q 007869          259 ATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRK-----GE  332 (586)
Q Consensus       259 a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~-----~~  332 (586)
                      ..++|+..+.||+|+||.||+|++..++..||||++.... ......+.+|++++++++||||+++++++...     ..
T Consensus         9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   88 (353)
T 2b9h_A            9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE   88 (353)
T ss_dssp             SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred             cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence            4578999999999999999999999899999999996543 33456788999999999999999999988754     67


Q ss_pred             EEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceee
Q 007869          333 LLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARL  412 (586)
Q Consensus       333 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~  412 (586)
                      .++||||+. ++|.+++...   .+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||+++.
T Consensus        89 ~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  161 (353)
T 2b9h_A           89 VYIIQELMQ-TDLHRVISTQ---MLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARI  161 (353)
T ss_dssp             EEEEECCCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEEeccC-ccHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEcCCCcEEEEecccccc
Confidence            899999996 6999998764   58899999999999999999998   8999999999999999999999999999987


Q ss_pred             ccCCCCC---------ceeeeccCCCccCcccccC-CCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhh
Q 007869          413 YDHGTDP---------QTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDF  482 (586)
Q Consensus       413 ~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~  482 (586)
                      .......         ......||+.|+|||++.. ..++.++|||||||++|||++|+.||......+...   .+...
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~~~~~  238 (353)
T 2b9h_A          162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLL---LIFGI  238 (353)
T ss_dssp             CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHH
T ss_pred             cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHH---HHHHH
Confidence            6532211         1223578999999998754 678999999999999999999999998654222111   11111


Q ss_pred             hccCc---cc------------ccc--CCCCC-ccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          483 WNRGE---LL------------EAR--DPNLG-TEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       483 ~~~~~---~~------------~~~--d~~l~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      .....   ..            ...  .+... ..........+.+++.+||+.||++|||+.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          239 IGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             HCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            00000   00            000  00000 0001122356778999999999999999999986

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=3.4e-40  Score=343.09  Aligned_cols=260  Identities=20%  Similarity=0.251  Sum_probs=207.0

Q ss_pred             hcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchh-----------------HHHHHHHHHHhcccCCCcee
Q 007869          259 ATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQG-----------------MKEFVAEIVSIGRLRHRNLV  321 (586)
Q Consensus       259 a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~Ei~~l~~l~H~niv  321 (586)
                      ..++|+..+.||+|+||.||+|..  ++..||||++.......                 .+.+.+|+.++++++||||+
T Consensus        29 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~  106 (348)
T 2pml_X           29 YINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCL  106 (348)
T ss_dssp             EETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBC
T ss_pred             ccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcc
Confidence            357899999999999999999999  78899999987542211                 17899999999999999999


Q ss_pred             eeeeeeeccCeEEEEEecCCCCChhhh------hhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCee
Q 007869          322 QLLGYCRRKGELLLVYDYMPNGSLDKY------LYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVL  395 (586)
Q Consensus       322 ~l~~~~~~~~~~~lV~E~~~~gsL~~~------l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIl  395 (586)
                      ++++++...+..++||||+++++|.++      +.......+++..++.++.|++.||.|||+  +++|+||||||+|||
T Consensus       107 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dl~p~Nil  184 (348)
T 2pml_X          107 TCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNIL  184 (348)
T ss_dssp             CCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHH--TSCEECCCCCGGGEE
T ss_pred             eEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhc--cCCEeecCCChHhEE
Confidence            999999999999999999999999999      665445679999999999999999999996  379999999999999


Q ss_pred             ecCCCCeEEccccceeeccCCCCCceeeeccCCCccCcccccCC-CCCC-cceEEehhHHHHHHHhCCCCCCCCCCCccc
Q 007869          396 LDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTG-KATT-SADVFSFGAFLLEVACGRRPIQRQGPSENL  473 (586)
Q Consensus       396 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~-ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~  473 (586)
                      ++.++.+||+|||+++.....   ......||..|+|||++.+. .++. ++|||||||++|||++|+.||........ 
T Consensus       185 ~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-  260 (348)
T 2pml_X          185 MDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE-  260 (348)
T ss_dssp             ECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHH-
T ss_pred             EcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHH-
Confidence            999999999999999876443   33456799999999999877 5666 99999999999999999999986544211 


Q ss_pred             hhhHHHHhhhccCccccccC---------CCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          474 ILVDWVFDFWNRGELLEARD---------PNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       474 ~l~~~v~~~~~~~~~~~~~d---------~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                       +...    ...+......+         +.............+.+++.+||+.||.+|||+.|+++
T Consensus       261 -~~~~----i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          261 -LFNN----IRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             -HHHH----HTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             -HHHH----HhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence             1111    11111110000         00000001223356788999999999999999999986

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=9.6e-41  Score=350.76  Aligned_cols=260  Identities=23%  Similarity=0.293  Sum_probs=187.0

Q ss_pred             hcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc--cchhHHHHHHHHHHhcccCCCceeeeeeeeecc------
Q 007869          259 ATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRK------  330 (586)
Q Consensus       259 a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~------  330 (586)
                      ..++|+..+.||+|+||.||+|.+..++..||||++...  .....+.+.+|++++++++||||+++++++...      
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  106 (367)
T 2fst_X           27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF  106 (367)
T ss_dssp             EETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred             CCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence            457899999999999999999999999999999999653  334456788999999999999999999998654      


Q ss_pred             CeEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccce
Q 007869          331 GELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLA  410 (586)
Q Consensus       331 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla  410 (586)
                      ...++|+||+ +++|.+++..   ..+++..+..++.||++||.|||+   .+|+||||||+|||++.++.+||+|||++
T Consensus       107 ~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kL~DFG~a  179 (367)
T 2fst_X          107 NDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLA  179 (367)
T ss_dssp             CCCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC----
T ss_pred             CeEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHhhEEECCCCCEEEeecccc
Confidence            5689999999 7899998865   368999999999999999999998   89999999999999999999999999999


Q ss_pred             eeccCCCCCceeeeccCCCccCcccccC-CCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccC---
Q 007869          411 RLYDHGTDPQTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRG---  486 (586)
Q Consensus       411 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~---  486 (586)
                      +....    ..+...||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+...   .+.+.....   
T Consensus       180 ~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~---~i~~~~g~p~~~  252 (367)
T 2fst_X          180 RHTAD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK---LILRLVGTPGAE  252 (367)
T ss_dssp             ---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHHHCSCCHH
T ss_pred             ccccc----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHHhCCCCHH
Confidence            86543    2344679999999999877 678999999999999999999999998654322211   111110000   


Q ss_pred             --------c---cccccCCCCCccc---cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          487 --------E---LLEARDPNLGTEY---VAEELELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       487 --------~---~~~~~d~~l~~~~---~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                              .   ............+   .......+.+|+.+||+.||.+|||+.|+++.
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h  312 (367)
T 2fst_X          253 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  312 (367)
T ss_dssp             HHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence                    0   0000000000000   01123557889999999999999999999863

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=2.9e-40  Score=373.05  Aligned_cols=251  Identities=22%  Similarity=0.303  Sum_probs=207.4

Q ss_pred             hhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc---cchhHHHHHHHHHHhccc-CCCceeeeeeeeeccCeE
Q 007869          258 IATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE---SRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKGEL  333 (586)
Q Consensus       258 ~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~~~~  333 (586)
                      ...++|+..++||+|+||+||+|++..+++.||||++...   .....+.+..|..++..+ +||||+++++++...+.+
T Consensus       338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~  417 (674)
T 3pfq_A          338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL  417 (674)
T ss_dssp             --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred             ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence            3456899999999999999999999999999999999754   234456788999999988 799999999999999999


Q ss_pred             EEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeec
Q 007869          334 LLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLY  413 (586)
Q Consensus       334 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~  413 (586)
                      +|||||+++|+|.+++....  .+++..+..++.||+.||.|||+   ++|+||||||+||||+.++.+||+|||+++..
T Consensus       418 ~lV~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~---~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~  492 (674)
T 3pfq_A          418 YFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN  492 (674)
T ss_dssp             EEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TSEECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred             EEEEeCcCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCeEeccCChhhEEEcCCCcEEEeecceeecc
Confidence            99999999999999998653  58899999999999999999998   89999999999999999999999999999864


Q ss_pred             cCCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccC
Q 007869          414 DHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARD  493 (586)
Q Consensus       414 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d  493 (586)
                      .... .......||+.|+|||++.+..++.++|||||||+||||++|+.||...+..+   +.+   . ..++.      
T Consensus       493 ~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~---~~~---~-i~~~~------  558 (674)
T 3pfq_A          493 IWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---LFQ---S-IMEHN------  558 (674)
T ss_dssp             CCTT-CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH---H-HHSSC------
T ss_pred             ccCC-cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHH---HHH---H-HHhCC------
Confidence            3322 23455789999999999999999999999999999999999999998654321   111   1 11111      


Q ss_pred             CCCCccccHHHHHHHHHHHHHhcccCCCCCCCH-----HHHHH
Q 007869          494 PNLGTEYVAEELELVLKLGLLCSHSDPTARPSM-----RQVVQ  531 (586)
Q Consensus       494 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~-----~evl~  531 (586)
                      ..+    .......+.+|+..||+.||++||++     +|+++
T Consensus       559 ~~~----p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          559 VAY----PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             CCC----CTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             CCC----CccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence            111    11223557788889999999999997     77764

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=4.9e-40  Score=339.24  Aligned_cols=257  Identities=23%  Similarity=0.339  Sum_probs=182.5

Q ss_pred             hhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc-chhHHHHHHHHH-HhcccCCCceeeeeeeeeccCeEEE
Q 007869          258 IATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES-RQGMKEFVAEIV-SIGRLRHRNLVQLLGYCRRKGELLL  335 (586)
Q Consensus       258 ~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~-~l~~l~H~niv~l~~~~~~~~~~~l  335 (586)
                      ...++|+..+.||+|+||.||+|.+..++..||||++.... .....++..|+. +++.++||||+++++++...+..++
T Consensus        19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~l   98 (327)
T 3aln_A           19 FTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWI   98 (327)
T ss_dssp             CCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEE
T ss_pred             cCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEE
Confidence            44578999999999999999999999899999999997653 233455666666 7778899999999999999999999


Q ss_pred             EEecCCCCChhhhhhc---CCCccchhHHHHHHHHHHHHHHHHhhcccCC-cEEeCCCCCCCeeecCCCCeEEcccccee
Q 007869          336 VYDYMPNGSLDKYLYD---QPKVTLNWIQRFRVIKGVALGLFYLHQEWEQ-VVIHRDVKASNVLLDGELNGRLGDFGLAR  411 (586)
Q Consensus       336 V~E~~~~gsL~~~l~~---~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~-~ivHrDIkp~NIll~~~~~~kL~DFGla~  411 (586)
                      ||||+++ +|.+++..   .....+++..+..++.|++.||.|||+   . +|+||||||+|||++.++.+||+|||+++
T Consensus        99 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~  174 (327)
T 3aln_A           99 CMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE---NLKIIHRDIKPSNILLDRSGNIKLCDFGISG  174 (327)
T ss_dssp             EECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH---HHSCCCSCCCGGGEEEETTTEEEECCCSSSC
T ss_pred             EEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhc---cCCEeECCCCHHHEEEcCCCCEEEccCCCce
Confidence            9999975 88777753   223578899999999999999999998   6 99999999999999999999999999998


Q ss_pred             eccCCCCCceeeeccCCCccCcccc----cCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCc
Q 007869          412 LYDHGTDPQTTHVVGTLGYLAPEHT----RTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGE  487 (586)
Q Consensus       412 ~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~  487 (586)
                      ......  ......||+.|+|||++    .+..++.++|||||||++|||++|+.||........     ...      .
T Consensus       175 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~~~------~  241 (327)
T 3aln_A          175 QLVDSI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-----QLT------Q  241 (327)
T ss_dssp             C--------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------C------C
T ss_pred             eccccc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH-----HHH------H
Confidence            764332  22334799999999998    456789999999999999999999999976432110     000      0


Q ss_pred             cccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          488 LLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       488 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      ......+.+...........+.+++.+||+.||.+||++.++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          242 VVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             CCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence            11111111111111122356788899999999999999999975

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.1e-39  Score=342.24  Aligned_cols=263  Identities=21%  Similarity=0.300  Sum_probs=204.2

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccC-----------CCceeeeeeeee
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLR-----------HRNLVQLLGYCR  328 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-----------H~niv~l~~~~~  328 (586)
                      .++|...+.||+|+||.||+|++..++..||||++... ....+.+.+|+.++.+++           ||||+++++++.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            46899999999999999999999889999999999753 234467889999999886           899999999988


Q ss_pred             ccC----eEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCC-cEEeCCCCCCCeeec------
Q 007869          329 RKG----ELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQ-VVIHRDVKASNVLLD------  397 (586)
Q Consensus       329 ~~~----~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~-~ivHrDIkp~NIll~------  397 (586)
                      ..+    ..++||||+ +++|.+++.......+++..+..++.||+.||.|||+   + +|+||||||+|||++      
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~~ivH~Dikp~NIll~~~~~~~  172 (373)
T 1q8y_A           97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDIKPENVLMEIVDSPE  172 (373)
T ss_dssp             EEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCCSGGGEEEEEEETTT
T ss_pred             ccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHh---cCCEEecCCChHHeEEeccCCCc
Confidence            654    789999999 8999999987666679999999999999999999998   7 999999999999994      


Q ss_pred             CCCCeEEccccceeeccCCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccc----
Q 007869          398 GELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENL----  473 (586)
Q Consensus       398 ~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~----  473 (586)
                      ..+.+||+|||+++.....    .....||+.|+|||++.+..++.++|||||||++|||++|+.||.........    
T Consensus       173 ~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~  248 (373)
T 1q8y_A          173 NLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD  248 (373)
T ss_dssp             TEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred             CcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHH
Confidence            4457999999999876542    23457899999999999999999999999999999999999999865432110    


Q ss_pred             hhhHHHH-----------------hhhccCccccccCC-CC---------CccccHHHHHHHHHHHHHhcccCCCCCCCH
Q 007869          474 ILVDWVF-----------------DFWNRGELLEARDP-NL---------GTEYVAEELELVLKLGLLCSHSDPTARPSM  526 (586)
Q Consensus       474 ~l~~~v~-----------------~~~~~~~~~~~~d~-~l---------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~  526 (586)
                      .+.....                 ..+........... ..         ...+.......+.+++.+||+.||++|||+
T Consensus       249 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~  328 (373)
T 1q8y_A          249 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA  328 (373)
T ss_dssp             HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred             HHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCH
Confidence            0110000                 00000000000000 00         012345667889999999999999999999


Q ss_pred             HHHHH
Q 007869          527 RQVVQ  531 (586)
Q Consensus       527 ~evl~  531 (586)
                      .|+++
T Consensus       329 ~ell~  333 (373)
T 1q8y_A          329 GGLVN  333 (373)
T ss_dssp             HHHHT
T ss_pred             HHHhh
Confidence            99986

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=9.7e-41  Score=342.28  Aligned_cols=262  Identities=23%  Similarity=0.324  Sum_probs=197.4

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeee-----------
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCR-----------  328 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~-----------  328 (586)
                      .++|+..+.||+|+||.||+|.+..+++.||||++........+.+.+|++++++++||||+++++++.           
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            467999999999999999999999889999999998777677788999999999999999999999873           


Q ss_pred             ---ccCeEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeec-CCCCeEE
Q 007869          329 ---RKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLD-GELNGRL  404 (586)
Q Consensus       329 ---~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~-~~~~~kL  404 (586)
                         ..+..++||||++ |+|.+++...   .+++..++.++.|+++||.|||+   ++|+||||||+|||++ +++.+||
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~kl  162 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLEQG---PLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKI  162 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTTEEEE
T ss_pred             cccccCceeEEeeccC-CCHHHHhhcC---CccHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCeEEE
Confidence               4467899999997 6999998643   58889999999999999999998   8999999999999997 5679999


Q ss_pred             ccccceeeccCCCC--CceeeeccCCCccCcccccC-CCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHh
Q 007869          405 GDFGLARLYDHGTD--PQTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFD  481 (586)
Q Consensus       405 ~DFGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~  481 (586)
                      +|||+++.......  .......+|..|+|||.+.. ..++.++|||||||++|||++|+.||......+..   ..+..
T Consensus       163 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~---~~~~~  239 (320)
T 2i6l_A          163 GDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQM---QLILE  239 (320)
T ss_dssp             CCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHH
T ss_pred             ccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHH---HHHHH
Confidence            99999987643221  12234567999999998865 67899999999999999999999999865432211   11100


Q ss_pred             hhcc---C---cc--------c-cccCCCCC-ccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          482 FWNR---G---EL--------L-EARDPNLG-TEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       482 ~~~~---~---~~--------~-~~~d~~l~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      ....   .   .+        . ....+... ..........+.+++.+||+.||++|||+.|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          240 SIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             HSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             hcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence            0000   0   00        0 00001000 0011122456788999999999999999999986

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1.2e-39  Score=339.08  Aligned_cols=264  Identities=19%  Similarity=0.232  Sum_probs=205.4

Q ss_pred             hcCCcccceeEeecCceEEEEEEeCCCC-eEEEEEEeccccchhHHHHHHHHHHhcccCCCc------eeeeeeeeeccC
Q 007869          259 ATKGFREKELLGTGGFGRVYRGTLPKSQ-IEIAVKKISHESRQGMKEFVAEIVSIGRLRHRN------LVQLLGYCRRKG  331 (586)
Q Consensus       259 a~~~f~~~~~LG~G~~g~Vy~~~~~~~~-~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~n------iv~l~~~~~~~~  331 (586)
                      ..++|+..+.||+|+||.||+|....++ ..||||++.... ...+.+..|+.++++++|++      ++.+++++...+
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~   95 (355)
T 2eu9_A           17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG   95 (355)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT
T ss_pred             ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC
Confidence            3578999999999999999999987665 789999996542 34567889999999998766      899999999999


Q ss_pred             eEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeee---------------
Q 007869          332 ELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLL---------------  396 (586)
Q Consensus       332 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll---------------  396 (586)
                      ..++||||+ +++|.+++.......+++.+++.++.||+.||.|||+   ++|+||||||+|||+               
T Consensus        96 ~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~  171 (355)
T 2eu9_A           96 HMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSC  171 (355)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred             eEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecccccccccccccc
Confidence            999999999 6788888877655679999999999999999999998   899999999999999               


Q ss_pred             ----cCCCCeEEccccceeeccCCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCcc
Q 007869          397 ----DGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSEN  472 (586)
Q Consensus       397 ----~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~  472 (586)
                          +.++.+||+|||+++.....    .....||+.|+|||++.+..++.++|||||||++|||++|+.||......+.
T Consensus       172 ~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~  247 (355)
T 2eu9_A          172 EEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREH  247 (355)
T ss_dssp             CEEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             cccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence                66889999999999874432    2345799999999999999999999999999999999999999986543222


Q ss_pred             chhhHHHH--------hhhccCccccc----c-------------CCCCC--ccccHHHHHHHHHHHHHhcccCCCCCCC
Q 007869          473 LILVDWVF--------DFWNRGELLEA----R-------------DPNLG--TEYVAEELELVLKLGLLCSHSDPTARPS  525 (586)
Q Consensus       473 ~~l~~~v~--------~~~~~~~~~~~----~-------------d~~l~--~~~~~~~~~~l~~l~~~Cl~~dP~~RPs  525 (586)
                      ........        ...........    .             .+.+.  ..........+.+++.+||+.||++|||
T Consensus       248 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt  327 (355)
T 2eu9_A          248 LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRIT  327 (355)
T ss_dssp             HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred             HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcC
Confidence            11111110        00000000000    0             00000  0012234557889999999999999999


Q ss_pred             HHHHHH
Q 007869          526 MRQVVQ  531 (586)
Q Consensus       526 ~~evl~  531 (586)
                      +.|+++
T Consensus       328 ~~e~l~  333 (355)
T 2eu9_A          328 LAEALL  333 (355)
T ss_dssp             HHHHTT
T ss_pred             HHHHhc
Confidence            999974

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=8.6e-40  Score=339.32  Aligned_cols=262  Identities=22%  Similarity=0.289  Sum_probs=178.9

Q ss_pred             hcCCcccc-eeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHH-HHhcccCCCceeeeeeeeec----cCe
Q 007869          259 ATKGFREK-ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEI-VSIGRLRHRNLVQLLGYCRR----KGE  332 (586)
Q Consensus       259 a~~~f~~~-~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei-~~l~~l~H~niv~l~~~~~~----~~~  332 (586)
                      ..++|... ++||+|+||.||+|++..+++.||||++.....     ..+|+ ..+..++||||+++++++..    ...
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~  100 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK-----ARQEVDHHWQASGGPHIVCILDVYENMHHGKRC  100 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH-----HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH-----HHHHHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence            44678884 579999999999999998999999999965321     22223 33556799999999999876    456


Q ss_pred             EEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecC---CCCeEEccccc
Q 007869          333 LLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDG---ELNGRLGDFGL  409 (586)
Q Consensus       333 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~---~~~~kL~DFGl  409 (586)
                      .++||||+++|+|.+++.......+++.+++.++.|++.||.|||+   ++|+||||||+|||++.   ++.+||+|||+
T Consensus       101 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~---~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~  177 (336)
T 3fhr_A          101 LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGF  177 (336)
T ss_dssp             EEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEEecCCCceEEEecccc
Confidence            8999999999999999987766679999999999999999999998   89999999999999976   45599999999


Q ss_pred             eeeccCCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccc
Q 007869          410 ARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELL  489 (586)
Q Consensus       410 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~  489 (586)
                      ++.....   ......||+.|+|||++.+..++.++|||||||++|||++|+.||..........   ........+.. 
T Consensus       178 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~~~~~~~~~~~-  250 (336)
T 3fhr_A          178 AKETTQN---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISP---GMKRRIRLGQY-  250 (336)
T ss_dssp             CEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------
T ss_pred             ceecccc---ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhh---hHHHhhhcccc-
Confidence            9865432   2334578999999999988889999999999999999999999997654322100   00000000000 


Q ss_pred             cccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHhhccCCC
Q 007869          490 EARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ--ILERDVALP  540 (586)
Q Consensus       490 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~~~~~p  540 (586)
                        ..+.   .........+.+++.+||+.||.+|||+.|+++  .+......|
T Consensus       251 --~~~~---~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~  298 (336)
T 3fhr_A          251 --GFPN---PEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVP  298 (336)
T ss_dssp             --CCCT---TTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGGGSC
T ss_pred             --ccCc---hhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccccCC
Confidence              0010   001122355778889999999999999999997  455443333

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=2.1e-40  Score=372.95  Aligned_cols=262  Identities=23%  Similarity=0.398  Sum_probs=207.9

Q ss_pred             hhhhhhcCCcccceeEeecCceEEEEEEeCC---CCeEEEEEEeccc-cchhHHHHHHHHHHhcccCCCceeeeeeeeec
Q 007869          254 KDLYIATKGFREKELLGTGGFGRVYRGTLPK---SQIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRR  329 (586)
Q Consensus       254 ~el~~a~~~f~~~~~LG~G~~g~Vy~~~~~~---~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~  329 (586)
                      .+.....++|+..+.||+|+||.||+|.+..   .+..||||++... .....+.|.+|+.++++++||||+++++++.+
T Consensus       383 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~  462 (656)
T 2j0j_A          383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE  462 (656)
T ss_dssp             GGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence            3455566788999999999999999999854   3467999998754 33445779999999999999999999999854


Q ss_pred             cCeEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccc
Q 007869          330 KGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGL  409 (586)
Q Consensus       330 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGl  409 (586)
                       +..++||||+++|+|.+++... ...+++..++.++.|+++||.|||+   ++|+||||||+|||++.++.+||+|||+
T Consensus       463 -~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDikp~NILl~~~~~vkL~DFG~  537 (656)
T 2j0j_A          463 -NPVWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGL  537 (656)
T ss_dssp             -SSCEEEEECCTTCBHHHHHHHT-TTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCC
T ss_pred             -CceEEEEEcCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchHhEEEeCCCCEEEEecCC
Confidence             5689999999999999999765 3468999999999999999999998   8999999999999999999999999999


Q ss_pred             eeeccCCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccCcc
Q 007869          410 ARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGEL  488 (586)
Q Consensus       410 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~  488 (586)
                      ++..............+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+   ....+    ..+..
T Consensus       538 a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~---~~~~i----~~~~~  610 (656)
T 2j0j_A          538 SRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGRI----ENGER  610 (656)
T ss_dssp             CCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHH----HHTCC
T ss_pred             CeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH---HHHHH----HcCCC
Confidence            98765443333344567889999999998899999999999999999997 999997654321   11111    11111


Q ss_pred             ccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 007869          489 LEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERD  536 (586)
Q Consensus       489 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  536 (586)
                           +...    ......+.+++.+||+.||.+||++.++++.|+..
T Consensus       611 -----~~~~----~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i  649 (656)
T 2j0j_A          611 -----LPMP----PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  649 (656)
T ss_dssp             -----CCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -----CCCC----ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence                 1111    12235677889999999999999999999998753

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=4e-40  Score=344.21  Aligned_cols=269  Identities=22%  Similarity=0.271  Sum_probs=192.7

Q ss_pred             hhhhhhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCe-
Q 007869          254 KDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGE-  332 (586)
Q Consensus       254 ~el~~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~-  332 (586)
                      .+.....++|+..+.||+|+||.||+|++..++..||||++..... ....+.+|++.+..++||||+++++++...+. 
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~   94 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER   94 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT-CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc-ccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence            3455667899999999999999999999998899999999865432 23456788888999999999999999875443 


Q ss_pred             ------EEEEEecCCCCChhhhhhc--CCCccchhHHHHHHHHHHHHHHHHhh--cccCCcEEeCCCCCCCeeecC-CCC
Q 007869          333 ------LLLVYDYMPNGSLDKYLYD--QPKVTLNWIQRFRVIKGVALGLFYLH--QEWEQVVIHRDVKASNVLLDG-ELN  401 (586)
Q Consensus       333 ------~~lV~E~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~~L~yLH--~~~~~~ivHrDIkp~NIll~~-~~~  401 (586)
                            .++||||+++ +|.+.+..  .....+++..+..++.|++.||.|||  +   ++|+||||||+|||++. ++.
T Consensus        95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~ivH~Dlkp~NIll~~~~~~  170 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS---VNVCHRDIKPHNVLVNEADGT  170 (360)
T ss_dssp             CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTT---TCCBCSCCCGGGEEEETTTTE
T ss_pred             cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCC---CCeecCcCCHHHEEEeCCCCc
Confidence                  8899999976 55544432  23356888899999999999999999  6   89999999999999996 899


Q ss_pred             eEEccccceeeccCCCCCceeeeccCCCccCcccccCCC-CCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHH
Q 007869          402 GRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGK-ATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVF  480 (586)
Q Consensus       402 ~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~  480 (586)
                      +||+|||+++......  ......||+.|+|||++.+.. ++.++|||||||++|||++|+.||......+..  ...+.
T Consensus       171 ~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~--~~~~~  246 (360)
T 3e3p_A          171 LKLCDFGSAKKLSPSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQL--HEIVR  246 (360)
T ss_dssp             EEECCCTTCBCCCTTS--CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHHH
T ss_pred             EEEeeCCCceecCCCC--CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHH--HHHHH
Confidence            9999999998765432  233457899999999986654 899999999999999999999999875432211  11111


Q ss_pred             ----------hhhcc-CccccccCC-CC-----CccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          481 ----------DFWNR-GELLEARDP-NL-----GTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       481 ----------~~~~~-~~~~~~~d~-~l-----~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                                ..... .......+. ..     ...........+.+++.+||+.||.+|||+.|+++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  314 (360)
T 3e3p_A          247 VLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC  314 (360)
T ss_dssp             HHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence                      00000 000000000 00     00011123467889999999999999999999986

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=3.4e-40  Score=338.32  Aligned_cols=265  Identities=21%  Similarity=0.341  Sum_probs=201.6

Q ss_pred             CCCcccchhhhhhhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc--cchhHHHHHHHHHHhcccC--CCcee
Q 007869          246 HGPHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE--SRQGMKEFVAEIVSIGRLR--HRNLV  321 (586)
Q Consensus       246 ~~~~~~~~~el~~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~--H~niv  321 (586)
                      .+...+.+..+....++|+..+.||+|+||.||++.+.. +..||||++...  .....+.+.+|++++.+++  ||||+
T Consensus        13 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv   91 (313)
T 3cek_A           13 LGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKII   91 (313)
T ss_dssp             -------CCEEEETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBC
T ss_pred             CCCCCCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCC-CcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceE
Confidence            345667777888888999999999999999999999864 778999999654  3445678999999999997  59999


Q ss_pred             eeeeeeeccCeEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCC
Q 007869          322 QLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELN  401 (586)
Q Consensus       322 ~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~  401 (586)
                      ++++++...+..++||| +.+++|.+++....  .+++..++.++.|+++||.|||+   .+|+||||||+|||+++ +.
T Consensus        92 ~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~-~~  164 (313)
T 3cek_A           92 RLYDYEITDQYIYMVME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVD-GM  164 (313)
T ss_dssp             CEEEEEECSSEEEEEEC-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEET-TE
T ss_pred             EEEEEeecCCEEEEEEe-cCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEEEC-Ce
Confidence            99999999999999999 56889999998753  68888999999999999999998   89999999999999975 78


Q ss_pred             eEEccccceeeccCCCCC-ceeeeccCCCccCcccccC-----------CCCCCcceEEehhHHHHHHHhCCCCCCCCCC
Q 007869          402 GRLGDFGLARLYDHGTDP-QTTHVVGTLGYLAPEHTRT-----------GKATTSADVFSFGAFLLEVACGRRPIQRQGP  469 (586)
Q Consensus       402 ~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~  469 (586)
                      +||+|||+++........ ......||+.|+|||++.+           ..++.++|||||||++|||++|+.||.....
T Consensus       165 ~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~  244 (313)
T 3cek_A          165 LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN  244 (313)
T ss_dssp             EEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCS
T ss_pred             EEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHH
Confidence            999999999876543221 2234578999999999875           4688899999999999999999999975432


Q ss_pred             CccchhhHHHHhhhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          470 SENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       470 ~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                      ..     .........         .....+.......+.+++.+||+.||.+||++.|+++.
T Consensus       245 ~~-----~~~~~~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  293 (313)
T 3cek_A          245 QI-----SKLHAIIDP---------NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  293 (313)
T ss_dssp             HH-----HHHHHHHCT---------TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HH-----HHHHHHHhc---------ccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence            11     111111111         11111111113457788889999999999999999863

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=7e-40  Score=344.63  Aligned_cols=259  Identities=22%  Similarity=0.279  Sum_probs=199.5

Q ss_pred             hcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc--cchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeE---
Q 007869          259 ATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGEL---  333 (586)
Q Consensus       259 a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~---  333 (586)
                      ..++|...+.||+|+||.||+|++..++..||||++...  .....+.+.+|+.++++++||||+++++++...+..   
T Consensus        40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  119 (371)
T 4exu_A           40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF  119 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred             ccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence            357899999999999999999999999999999999764  333457789999999999999999999999877654   


Q ss_pred             ---EEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccce
Q 007869          334 ---LLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLA  410 (586)
Q Consensus       334 ---~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla  410 (586)
                         ++||||+. ++|.+++..    .+++..+..++.|++.||.|||+   .+|+||||||+|||++.++.+||+|||++
T Consensus       120 ~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kL~Dfg~a  191 (371)
T 4exu_A          120 YDFYLVMPFMQ-TDLQKIMGM----EFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLA  191 (371)
T ss_dssp             CCCEEEEECCC-EEHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred             eeEEEEEcccc-ccHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCcCHHHeEECCCCCEEEEecCcc
Confidence               99999996 688888732    48899999999999999999998   89999999999999999999999999999


Q ss_pred             eeccCCCCCceeeeccCCCccCcccccC-CCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhcc----
Q 007869          411 RLYDHGTDPQTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNR----  485 (586)
Q Consensus       411 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~----  485 (586)
                      +....    ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+...   .+......    
T Consensus       192 ~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~---~i~~~~~~~~~~  264 (371)
T 4exu_A          192 RHADA----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLT---QILKVTGVPGTE  264 (371)
T ss_dssp             ------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHHHCCCCHH
T ss_pred             ccccc----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHH---HHHHHhCCCcHH
Confidence            86543    2334578999999999877 678999999999999999999999998654322111   00000000    


Q ss_pred             -------C---ccccccCCCCCcc---ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          486 -------G---ELLEARDPNLGTE---YVAEELELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       486 -------~---~~~~~~d~~l~~~---~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                             .   .............   ........+.+++.+||+.||++|||+.|+++.
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          265 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             HHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence                   0   0000000000000   011224567889999999999999999999863

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=7.4e-40  Score=347.31  Aligned_cols=262  Identities=23%  Similarity=0.306  Sum_probs=194.7

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCe------E
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGE------L  333 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~------~  333 (586)
                      ..+|+..+.||+|+||.||+|++..++. ||+|++......    ..+|++++++++||||+++++++...+.      +
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~  113 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL  113 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence            3468899999999999999999977665 899988654322    2369999999999999999999865443      8


Q ss_pred             EEEEecCCCCChhhhhhc-CCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeec-CCCCeEEcccccee
Q 007869          334 LLVYDYMPNGSLDKYLYD-QPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLD-GELNGRLGDFGLAR  411 (586)
Q Consensus       334 ~lV~E~~~~gsL~~~l~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~-~~~~~kL~DFGla~  411 (586)
                      ++||||++++.+...... .....+++..+..++.||++||.|||+   .+|+||||||+|||++ .++.+||+|||+++
T Consensus       114 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~  190 (394)
T 4e7w_A          114 NLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAK  190 (394)
T ss_dssp             EEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             EEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence            899999976544333321 123468899999999999999999998   8999999999999999 79999999999999


Q ss_pred             eccCCCCCceeeeccCCCccCcccccCC-CCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHH--------Hhh
Q 007869          412 LYDHGTDPQTTHVVGTLGYLAPEHTRTG-KATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWV--------FDF  482 (586)
Q Consensus       412 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v--------~~~  482 (586)
                      ......  ......||+.|+|||++.+. .++.++|||||||++|||++|+.||......+....+...        +..
T Consensus       191 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~  268 (394)
T 4e7w_A          191 ILIAGE--PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKT  268 (394)
T ss_dssp             ECCTTC--CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred             cccCCC--CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            765433  23345789999999998765 5899999999999999999999999875433221111000        000


Q ss_pred             hccCccccccCCCCCc-----cccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          483 WNRGELLEARDPNLGT-----EYVAEELELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       483 ~~~~~~~~~~d~~l~~-----~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                      . ........-+....     .+.......+.+++.+||+.||.+|||+.|+++.
T Consensus       269 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  322 (394)
T 4e7w_A          269 M-NPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH  322 (394)
T ss_dssp             H-CGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             h-ChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence            0 00011111111111     1111233578899999999999999999999863

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=4.8e-40  Score=337.62  Aligned_cols=263  Identities=25%  Similarity=0.406  Sum_probs=205.0

Q ss_pred             chhhhhhhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc--chhHHHHHHHHHHhcccCCCceeeeeeeeec
Q 007869          252 RYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES--RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRR  329 (586)
Q Consensus       252 ~~~el~~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~  329 (586)
                      ..++.....++|+..+.||+|+||.||+|.+.+   .+|+|++....  ....+.+.+|+.++++++||||+++++++..
T Consensus        24 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~  100 (319)
T 2y4i_B           24 FLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS  100 (319)
T ss_dssp             CGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEEC
T ss_pred             ccccccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEec
Confidence            445666777899999999999999999999854   49999986542  2334567889999999999999999999999


Q ss_pred             cCeEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccc
Q 007869          330 KGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGL  409 (586)
Q Consensus       330 ~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGl  409 (586)
                      .+..++||||+++++|.+++.... ..+++..++.++.|+++||.|||+   .+|+||||||+|||++ ++.+||+|||+
T Consensus       101 ~~~~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~NIl~~-~~~~~l~Dfg~  175 (319)
T 2y4i_B          101 PPHLAIITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGL  175 (319)
T ss_dssp             SSCEEEECBCCCSEEHHHHTTSSC-CCCCSHHHHHHHHHHHHHHHHHHH---TTCCCCCCCSTTEEEC---CCEECCCSC
T ss_pred             CCceEEEeecccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChhhEEEe-CCCEEEeecCC
Confidence            999999999999999999997653 468899999999999999999998   8999999999999998 67999999999


Q ss_pred             eeeccCCC----CCceeeeccCCCccCcccccC---------CCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhh
Q 007869          410 ARLYDHGT----DPQTTHVVGTLGYLAPEHTRT---------GKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILV  476 (586)
Q Consensus       410 a~~~~~~~----~~~~~~~~gt~~y~aPE~~~~---------~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~  476 (586)
                      ++......    ........||+.|+|||++..         ..++.++|||||||++|||++|+.||......+     
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-----  250 (319)
T 2y4i_B          176 FSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA-----  250 (319)
T ss_dssp             CC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH-----
T ss_pred             ccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----
Confidence            87653221    112234568999999999864         357889999999999999999999997643221     


Q ss_pred             HHHHhhhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 007869          477 DWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERDV  537 (586)
Q Consensus       477 ~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  537 (586)
                       ..+. ...+.     .+.....   .....+.+++.+||+.||++|||+.++++.|+...
T Consensus       251 -~~~~-~~~~~-----~~~~~~~---~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~  301 (319)
T 2y4i_B          251 -IIWQ-MGTGM-----KPNLSQI---GMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLP  301 (319)
T ss_dssp             -HHHH-HHTTC-----CCCCCCS---SCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-
T ss_pred             -HHHH-hccCC-----CCCCCcC---CCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence             1111 11111     1111110   11234778889999999999999999999998754

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=9.9e-40  Score=330.66  Aligned_cols=252  Identities=24%  Similarity=0.361  Sum_probs=204.2

Q ss_pred             hcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc--chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEE
Q 007869          259 ATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES--RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLV  336 (586)
Q Consensus       259 a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV  336 (586)
                      ..++|+..+.||+|+||.||+|+...++..||||++....  ....+.+.+|++++++++||||+++++++...+..++|
T Consensus        20 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   99 (287)
T 2wei_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (287)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEE
Confidence            3467999999999999999999998889999999986542  34567899999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCC---CCeEEccccceeec
Q 007869          337 YDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGE---LNGRLGDFGLARLY  413 (586)
Q Consensus       337 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~---~~~kL~DFGla~~~  413 (586)
                      |||+++++|.+++....  .+++.+++.++.|++.||.|||+   .+|+||||||+||+++.+   +.+||+|||+++..
T Consensus       100 ~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~  174 (287)
T 2wei_A          100 GELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF  174 (287)
T ss_dssp             ECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTB
T ss_pred             EEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChhhEEEecCCCcccEEEeccCcceee
Confidence            99999999999887643  58899999999999999999998   899999999999999754   46999999999866


Q ss_pred             cCCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccC
Q 007869          414 DHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARD  493 (586)
Q Consensus       414 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d  493 (586)
                      ....  ......||+.|+|||.+.+ .++.++||||||+++|||++|+.||......+   +..    ....+....  +
T Consensus       175 ~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~----~~~~~~~~~--~  242 (287)
T 2wei_A          175 QQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD---ILK----RVETGKYAF--D  242 (287)
T ss_dssp             CCCS--SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH----HHHHCCCCC--C
T ss_pred             cCCC--ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHH---HHH----HHHcCCCCC--C
Confidence            5432  2234568999999999865 58999999999999999999999997643221   111    111111110  0


Q ss_pred             CCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          494 PNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       494 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                        .  .........+.+++.+||+.||++|||+.|+++
T Consensus       243 --~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          243 --L--PQWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             --S--GGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --c--hhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence              0  000112355778899999999999999999987

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.6e-39  Score=339.29  Aligned_cols=256  Identities=23%  Similarity=0.300  Sum_probs=198.3

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc--cchhHHHHHHHHHHhcccCCCceeeeeeeeeccCe-----
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGE-----  332 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~-----  332 (586)
                      .++|...+.||+|+||.||+|++..++..||||++...  .....+.+.+|+.++++++||||+++++++...+.     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            46799999999999999999999999999999999654  23345678999999999999999999999987654     


Q ss_pred             -EEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEcccccee
Q 007869          333 -LLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR  411 (586)
Q Consensus       333 -~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~  411 (586)
                       .++||||+. ++|.+++..    .+++..+..++.||++||.|||+   ++|+||||||+|||++.++.+||+|||+++
T Consensus       103 ~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~  174 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMGL----KFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLAR  174 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTTS----CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred             eEEEEecccc-CCHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEeECCCCcEEEeeccccc
Confidence             499999997 688888743    48899999999999999999998   899999999999999999999999999998


Q ss_pred             eccCCCCCceeeeccCCCccCcccccC-CCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhh-------
Q 007869          412 LYDHGTDPQTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFW-------  483 (586)
Q Consensus       412 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~-------  483 (586)
                      ....    ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||......+...   .+....       
T Consensus       175 ~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~---~i~~~~~~~~~~~  247 (353)
T 3coi_A          175 HADA----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLT---QILKVTGVPGTEF  247 (353)
T ss_dssp             C------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHH---HHHHHHCBCCHHH
T ss_pred             CCCC----CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHHhCCCCHHH
Confidence            6543    2334578999999999876 678999999999999999999999998654322111   110000       


Q ss_pred             ----ccC-------ccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          484 ----NRG-------ELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       484 ----~~~-------~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                          .+.       .+.....+.+ ..........+.+++.+||+.||++|||+.|+++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          248 VQKLNDKAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             HTTCSCHHHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HHHHhhHHHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                000       0000001111 0111223456788899999999999999999986

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.3e-39  Score=346.54  Aligned_cols=200  Identities=25%  Similarity=0.362  Sum_probs=155.3

Q ss_pred             ccc-ceeEeecCceEEEEEEeC--CCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeee--ccCeEEEEE
Q 007869          263 FRE-KELLGTGGFGRVYRGTLP--KSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCR--RKGELLLVY  337 (586)
Q Consensus       263 f~~-~~~LG~G~~g~Vy~~~~~--~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~--~~~~~~lV~  337 (586)
                      |.. .++||+|+||.||+|++.  .++..||||++.....  ...+.+|+.+|++++||||+++++++.  .....++||
T Consensus        22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~   99 (405)
T 3rgf_A           22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF   99 (405)
T ss_dssp             EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEE
T ss_pred             hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEE
Confidence            444 457999999999999975  4578899999975432  356889999999999999999999995  467899999


Q ss_pred             ecCCCCChhhhhhcC-------CCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeee----cCCCCeEEcc
Q 007869          338 DYMPNGSLDKYLYDQ-------PKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLL----DGELNGRLGD  406 (586)
Q Consensus       338 E~~~~gsL~~~l~~~-------~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll----~~~~~~kL~D  406 (586)
                      ||++ ++|.+++...       ....+++..++.|+.||+.||.|||+   .+|+||||||+|||+    +.++.+||+|
T Consensus       100 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~D  175 (405)
T 3rgf_A          100 DYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIAD  175 (405)
T ss_dssp             ECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred             eCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence            9996 5888877532       12358999999999999999999998   899999999999999    6788999999


Q ss_pred             ccceeeccCCCC--CceeeeccCCCccCcccccCC-CCCCcceEEehhHHHHHHHhCCCCCCCCC
Q 007869          407 FGLARLYDHGTD--PQTTHVVGTLGYLAPEHTRTG-KATTSADVFSFGAFLLEVACGRRPIQRQG  468 (586)
Q Consensus       407 FGla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVyS~Gvvl~ElltG~~p~~~~~  468 (586)
                      ||+++.......  .......||+.|+|||++.+. .++.++|||||||++|||++|+.||....
T Consensus       176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~  240 (405)
T 3rgf_A          176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  240 (405)
T ss_dssp             TTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred             CCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence            999987654322  223456899999999999874 58999999999999999999999997644

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.2e-38  Score=326.71  Aligned_cols=255  Identities=22%  Similarity=0.292  Sum_probs=182.0

Q ss_pred             hhhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccc--hhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEE
Q 007869          257 YIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR--QGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELL  334 (586)
Q Consensus       257 ~~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~  334 (586)
                      ....++|+..+.||+|+||.||+|.+..++..||||++.....  ...+.+..+..+++.++||||+++++++...+..+
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~  100 (318)
T 2dyl_A           21 QAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVF  100 (318)
T ss_dssp             ECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             hhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEE
Confidence            3445678899999999999999999998899999999976532  22233445556778889999999999999999999


Q ss_pred             EEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCC-cEEeCCCCCCCeeecCCCCeEEccccceeec
Q 007869          335 LVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQ-VVIHRDVKASNVLLDGELNGRLGDFGLARLY  413 (586)
Q Consensus       335 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~-~ivHrDIkp~NIll~~~~~~kL~DFGla~~~  413 (586)
                      +||||+ ++.+..+.... ...+++..++.++.|+++||.|||+   + +|+||||||+|||++.++.+||+|||+++..
T Consensus       101 lv~e~~-~~~~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  175 (318)
T 2dyl_A          101 IAMELM-GTCAEKLKKRM-QGPIPERILGKMTVAIVKALYYLKE---KHGVIHRDVKPSNILLDERGQIKLCDFGISGRL  175 (318)
T ss_dssp             EEECCC-SEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHH---HHCCCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred             EEEecc-CCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHh---hCCEEeCCCCHHHEEECCCCCEEEEECCCchhc
Confidence            999999 45555554432 3468899999999999999999997   5 8999999999999999999999999999865


Q ss_pred             cCCCCCceeeeccCCCccCccccc-----CCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCcc
Q 007869          414 DHGTDPQTTHVVGTLGYLAPEHTR-----TGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGEL  488 (586)
Q Consensus       414 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~  488 (586)
                      ....  ......||+.|+|||++.     ...++.++|||||||++|||++|+.||.......  ..   ....... . 
T Consensus       176 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~---~~~~~~~-~-  246 (318)
T 2dyl_A          176 VDDK--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF--EV---LTKVLQE-E-  246 (318)
T ss_dssp             -------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHH--HH---HHHHHHS-C-
T ss_pred             cCCc--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccH--HH---HHHHhcc-C-
Confidence            4432  233457999999999984     4568899999999999999999999997643211  11   1111111 1 


Q ss_pred             ccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          489 LEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       489 ~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                          .+.+..  .......+.+++.+||+.||.+||++.++++
T Consensus       247 ----~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          247 ----PPLLPG--HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             ----CCCCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ----CCCCCc--cCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence                111110  0012245778889999999999999999985

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.2e-39  Score=334.02  Aligned_cols=246  Identities=24%  Similarity=0.376  Sum_probs=193.1

Q ss_pred             hhhhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccch------hHHHHHHHHHHhccc----CCCceeeeee
Q 007869          256 LYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQ------GMKEFVAEIVSIGRL----RHRNLVQLLG  325 (586)
Q Consensus       256 l~~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~Ei~~l~~l----~H~niv~l~~  325 (586)
                      .....++|+..+.||+|+||.||+|++..++..||||++......      ....+.+|+.++.++    +||||+++++
T Consensus        26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~  105 (312)
T 2iwi_A           26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD  105 (312)
T ss_dssp             -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred             hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence            334567899999999999999999999888999999999654321      223456789999888    8999999999


Q ss_pred             eeeccCeEEEEEec-CCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeec-CCCCeE
Q 007869          326 YCRRKGELLLVYDY-MPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLD-GELNGR  403 (586)
Q Consensus       326 ~~~~~~~~~lV~E~-~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~-~~~~~k  403 (586)
                      ++...+..++|+|| +.+++|.+++...  ..+++..++.++.|+++||.|||+   .+|+||||||+|||++ .++.+|
T Consensus       106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~k  180 (312)
T 2iwi_A          106 WFETQEGFMLVLERPLPAQDLFDYITEK--GPLGEGPSRCFFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRRGCAK  180 (312)
T ss_dssp             EC-----CEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH---HTEECCCCSGGGEEEETTTTEEE
T ss_pred             EEecCCeEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChhhEEEeCCCCeEE
Confidence            99999999999999 7899999999764  358899999999999999999998   8999999999999999 889999


Q ss_pred             EccccceeeccCCCCCceeeeccCCCccCcccccCCCCC-CcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhh
Q 007869          404 LGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKAT-TSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDF  482 (586)
Q Consensus       404 L~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s-~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~  482 (586)
                      |+|||+++.....   ......||..|+|||++.+..+. .++|||||||++|||++|+.||....        +...  
T Consensus       181 l~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--------~~~~--  247 (312)
T 2iwi_A          181 LIDFGSGALLHDE---PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ--------EILE--  247 (312)
T ss_dssp             ECCCSSCEECCSS---CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--------HHHH--
T ss_pred             EEEcchhhhcccC---cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH--------HHhh--
Confidence            9999999876543   23345789999999998877664 58999999999999999999996421        0000  


Q ss_pred             hccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          483 WNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       483 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                         .      ...+...    ....+.+++.+||+.||++|||+.|+++.
T Consensus       248 ---~------~~~~~~~----~~~~~~~li~~~l~~~p~~Rps~~e~l~~  284 (312)
T 2iwi_A          248 ---A------ELHFPAH----VSPDCCALIRRCLAPKPSSRPSLEEILLD  284 (312)
T ss_dssp             ---T------CCCCCTT----SCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             ---h------ccCCccc----CCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               0      0111111    23457788899999999999999999973

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1.5e-38  Score=341.47  Aligned_cols=250  Identities=22%  Similarity=0.278  Sum_probs=186.8

Q ss_pred             CcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhccc-CCCceeeeeeeeeccCeEEEEEecC
Q 007869          262 GFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKGELLLVYDYM  340 (586)
Q Consensus       262 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~lV~E~~  340 (586)
                      .|...+.||+|+||+||.+.. .++..||||++....   .+.+.+|++++.++ +||||+++++++...+..++||||+
T Consensus        16 ~~~~~~~LG~G~~g~V~~~~~-~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~   91 (434)
T 2rio_A           16 LVVSEKILGYGSSGTVVFQGS-FQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC   91 (434)
T ss_dssp             CEEEEEEEEECSTTCEEEEEE-SSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred             eeeccCeEeeCCCeEEEEEEE-ECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence            345578899999999976544 457899999986542   35678999999887 8999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCcc-----chhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCC-------------CCe
Q 007869          341 PNGSLDKYLYDQPKVT-----LNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGE-------------LNG  402 (586)
Q Consensus       341 ~~gsL~~~l~~~~~~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~-------------~~~  402 (586)
                      . |+|.+++.......     ..+..++.++.||+.||.|||+   ++|+||||||+|||++.+             +.+
T Consensus        92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~  167 (434)
T 2rio_A           92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRI  167 (434)
T ss_dssp             S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred             C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCcccccccccCCCceEE
Confidence            5 69999997653211     2344567899999999999998   899999999999999754             489


Q ss_pred             EEccccceeeccCCCCC---ceeeeccCCCccCcccccC-------CCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCc
Q 007869          403 RLGDFGLARLYDHGTDP---QTTHVVGTLGYLAPEHTRT-------GKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSE  471 (586)
Q Consensus       403 kL~DFGla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~  471 (586)
                      ||+|||+++........   ......||+.|+|||++.+       ..++.++|||||||++|||++ |+.||......+
T Consensus       168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~  247 (434)
T 2rio_A          168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE  247 (434)
T ss_dssp             EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred             EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence            99999999987543321   1234579999999999965       568999999999999999999 999997543221


Q ss_pred             cchhhHHHHhhhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          472 NLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       472 ~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                          .....     +...   .+.............+.+++.+||+.||.+|||+.|+++
T Consensus       248 ----~~i~~-----~~~~---~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          248 ----SNIIR-----GIFS---LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             ----HHHHH-----TCCC---CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ----HHHhc-----CCCC---cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence                11111     1100   011111123455677889999999999999999999985

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=8.5e-40  Score=336.89  Aligned_cols=245  Identities=24%  Similarity=0.376  Sum_probs=201.1

Q ss_pred             hhhhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccch------hHHHHHHHHHHhcccC--CCceeeeeeee
Q 007869          256 LYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQ------GMKEFVAEIVSIGRLR--HRNLVQLLGYC  327 (586)
Q Consensus       256 l~~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~Ei~~l~~l~--H~niv~l~~~~  327 (586)
                      .....++|+..+.||+|+||.||+|++..++..||||++......      ..+.+.+|+.++++++  |+||+++++++
T Consensus        38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~  117 (320)
T 3a99_A           38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF  117 (320)
T ss_dssp             --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred             cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence            334567899999999999999999999989999999999764321      2245778999999996  59999999999


Q ss_pred             eccCeEEEEEecCCC-CChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeec-CCCCeEEc
Q 007869          328 RRKGELLLVYDYMPN-GSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLD-GELNGRLG  405 (586)
Q Consensus       328 ~~~~~~~lV~E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~-~~~~~kL~  405 (586)
                      ...+..++|+||+.+ ++|.+++...  ..+++..++.++.|+++||.|||+   .+|+||||||+|||++ +++.+||+
T Consensus       118 ~~~~~~~lv~e~~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~kL~  192 (320)
T 3a99_A          118 ERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLI  192 (320)
T ss_dssp             ECSSEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEEC
T ss_pred             ecCCcEEEEEEcCCCCccHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCcEeCCCCHHHEEEeCCCCCEEEe
Confidence            999999999999976 8999999764  368889999999999999999998   8999999999999999 78899999


Q ss_pred             cccceeeccCCCCCceeeeccCCCccCcccccCCCC-CCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhc
Q 007869          406 DFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKA-TTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWN  484 (586)
Q Consensus       406 DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~  484 (586)
                      |||+++.....   ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||.....        ..     
T Consensus       193 Dfg~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~--------~~-----  256 (320)
T 3a99_A          193 DFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--------II-----  256 (320)
T ss_dssp             CCTTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--------HH-----
T ss_pred             eCccccccccc---cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh--------hh-----
Confidence            99999876542   2334579999999999987765 6889999999999999999999964210        00     


Q ss_pred             cCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          485 RGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       485 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      .+..      .....+    ...+.+++.+||+.||++|||+.|+++
T Consensus       257 ~~~~------~~~~~~----~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          257 RGQV------FFRQRV----SSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             HCCC------CCSSCC----CHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             cccc------cccccC----CHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0100      011112    245778889999999999999999986

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.4e-38  Score=338.35  Aligned_cols=253  Identities=22%  Similarity=0.353  Sum_probs=188.2

Q ss_pred             hhhhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhccc-CCCceeeeeeeeeccCeEE
Q 007869          256 LYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKGELL  334 (586)
Q Consensus       256 l~~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~  334 (586)
                      +.....+|+..++||+|+||+||.... .+++.||||++......   .+.+|+++++++ +||||+++++++.+.+..+
T Consensus        19 ~~i~~~~y~~~~~LG~G~~G~V~~~~~-~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~   94 (432)
T 3p23_A           19 VIVGKISFCPKDVLGHGAEGTIVYRGM-FDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQY   94 (432)
T ss_dssp             EEETTEEEEEEEEEEECGGGCEEEEEE-SSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEE
T ss_pred             EEEccEEEecCCeeecCcCEEEEEEEE-eCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEE
Confidence            445566799999999999998553332 35678999999654332   356799999999 8999999999999999999


Q ss_pred             EEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecC-----CCCeEEccccc
Q 007869          335 LVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDG-----ELNGRLGDFGL  409 (586)
Q Consensus       335 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~-----~~~~kL~DFGl  409 (586)
                      +||||+. |+|.+++.... ..+.+...+.++.||++||.|||+   .+|+||||||+|||++.     ...+||+|||+
T Consensus        95 lv~E~~~-g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~  169 (432)
T 3p23_A           95 IAIELCA-ATLQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGL  169 (432)
T ss_dssp             EEEECCS-EEHHHHHHSSS-CCCCSSCHHHHHHHHHHHHHHHHH---TTCCCCCCSTTSEEECCCBTTTBCCEEECCTTE
T ss_pred             EEEECCC-CCHHHHHHhcC-CCccchhHHHHHHHHHHHHHHHHH---CcCEeCCCCHHHEEEecCCCCCceeEEEecccc
Confidence            9999996 69999997653 345555677899999999999998   89999999999999943     34688999999


Q ss_pred             eeeccCCCC--CceeeeccCCCccCccccc---CCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhh
Q 007869          410 ARLYDHGTD--PQTTHVVGTLGYLAPEHTR---TGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFW  483 (586)
Q Consensus       410 a~~~~~~~~--~~~~~~~gt~~y~aPE~~~---~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~  483 (586)
                      ++.......  .......||+.|+|||++.   ...++.++|||||||++|||++ |+.||.......    ...   ..
T Consensus       170 a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~----~~~---~~  242 (432)
T 3p23_A          170 CKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ----ANI---LL  242 (432)
T ss_dssp             EECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH----HHH---HT
T ss_pred             eeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH----HHH---Hh
Confidence            987654321  2234567999999999997   4567889999999999999999 999986532211    000   01


Q ss_pred             ccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          484 NRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       484 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      .. .......+      .......+.+++.+||+.||.+|||+.|+++
T Consensus       243 ~~-~~~~~~~~------~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          243 GA-CSLDCLHP------EKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             TC-CCCTTSCT------TCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cc-CCccccCc------cccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence            00 00111111      1233445778999999999999999999984

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=2.1e-38  Score=338.28  Aligned_cols=246  Identities=16%  Similarity=0.140  Sum_probs=187.4

Q ss_pred             hhhhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc---chhHHHHHHHHHHhcccCC-Cceeeee-------
Q 007869          256 LYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES---RQGMKEFVAEIVSIGRLRH-RNLVQLL-------  324 (586)
Q Consensus       256 l~~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H-~niv~l~-------  324 (586)
                      +...+++|...++||+|+||.||+|++..+++.||||++....   ....+.+.+|+.+++.++| +|...+.       
T Consensus        73 ~~~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~  152 (413)
T 3dzo_A           73 LGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIF  152 (413)
T ss_dssp             SSSCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCC
T ss_pred             CCCCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhccccc
Confidence            4445567888899999999999999999889999999987432   2336789999999999987 3221111       


Q ss_pred             --------------eeeec-----cCeEEEEEecCCCCChhhhhh-----cCCCccchhHHHHHHHHHHHHHHHHhhccc
Q 007869          325 --------------GYCRR-----KGELLLVYDYMPNGSLDKYLY-----DQPKVTLNWIQRFRVIKGVALGLFYLHQEW  380 (586)
Q Consensus       325 --------------~~~~~-----~~~~~lV~E~~~~gsL~~~l~-----~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~  380 (586)
                                    .++..     ....+++|+++ +++|.+++.     ......+++..++.++.||++||.|||+  
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~--  229 (413)
T 3dzo_A          153 PFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH--  229 (413)
T ss_dssp             CCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH--
T ss_pred             chhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh--
Confidence                          11111     12457777766 689999885     2334578999999999999999999998  


Q ss_pred             CCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCCceeeeccCCCccCcccc----------cCCCCCCcceEEeh
Q 007869          381 EQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHT----------RTGKATTSADVFSF  450 (586)
Q Consensus       381 ~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~s~ksDVyS~  450 (586)
                       ++|+||||||+|||++.++.+||+|||+++.....    .....| +.|+|||++          ....++.++|||||
T Consensus       230 -~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSl  303 (413)
T 3dzo_A          230 -YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTL  303 (413)
T ss_dssp             -TTEECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHH
T ss_pred             -CCcccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHH
Confidence             99999999999999999999999999999875432    344577 999999999          55568899999999


Q ss_pred             hHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 007869          451 GAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVV  530 (586)
Q Consensus       451 Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl  530 (586)
                      ||++|||++|+.||......+...   .+         .. ..+    .+    ...+.+++.+||+.||++||++.+++
T Consensus       304 Gvil~elltg~~Pf~~~~~~~~~~---~~---------~~-~~~----~~----~~~~~~li~~~l~~dP~~Rpt~~~~l  362 (413)
T 3dzo_A          304 GLAIYWIWCADLPNTDDAALGGSE---WI---------FR-SCK----NI----PQPVRALLEGFLRYPKEDRLLPLQAM  362 (413)
T ss_dssp             HHHHHHHHHSSCCCCTTGGGSCSG---GG---------GS-SCC----CC----CHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred             HHHHHHHHHCCCCCCCcchhhhHH---HH---------Hh-hcc----cC----CHHHHHHHHHHccCChhhCcCHHHHH
Confidence            999999999999997654322111   00         00 001    11    25578888999999999999988875


Q ss_pred             H
Q 007869          531 Q  531 (586)
Q Consensus       531 ~  531 (586)
                      +
T Consensus       363 ~  363 (413)
T 3dzo_A          363 E  363 (413)
T ss_dssp             T
T ss_pred             h
Confidence            3

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=2.8e-37  Score=314.72  Aligned_cols=231  Identities=20%  Similarity=0.263  Sum_probs=181.4

Q ss_pred             CCcccc-eeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHh-cccCCCceeeeeeeeec----cCeEE
Q 007869          261 KGFREK-ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSI-GRLRHRNLVQLLGYCRR----KGELL  334 (586)
Q Consensus       261 ~~f~~~-~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l-~~l~H~niv~l~~~~~~----~~~~~  334 (586)
                      ++|... +.||+|+||.||++.+..++..||||++...     ..+.+|+.++ +.++||||+++++++..    .+..+
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   91 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   91 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence            456665 7899999999999999989999999999642     4567888888 55599999999999876    67899


Q ss_pred             EEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecC---CCCeEEcccccee
Q 007869          335 LVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDG---ELNGRLGDFGLAR  411 (586)
Q Consensus       335 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~---~~~~kL~DFGla~  411 (586)
                      +||||+++|+|.+++.......+++..++.++.|++.||.|||+   .+|+||||||+|||++.   ++.+||+|||++.
T Consensus        92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~  168 (299)
T 3m2w_A           92 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK  168 (299)
T ss_dssp             EEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEecCCCCCcEEEecccccc
Confidence            99999999999999988766679999999999999999999998   89999999999999998   7889999999987


Q ss_pred             eccCCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccc
Q 007869          412 LYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEA  491 (586)
Q Consensus       412 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~  491 (586)
                      ...                       +..++.++|||||||++|||++|+.||..........       .... .+ ..
T Consensus       169 ~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~-------~~~~-~~-~~  216 (299)
T 3m2w_A          169 ETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP-------GMKT-RI-RM  216 (299)
T ss_dssp             ECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------C-------CSCC-SS-CT
T ss_pred             ccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhH-------HHHH-HH-hh
Confidence            532                       2346789999999999999999999997643321100       0000 00 00


Q ss_pred             cCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          492 RDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       492 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      ................+.+++.+||+.||.+|||+.|+++
T Consensus       217 ~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~  256 (299)
T 3m2w_A          217 GQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  256 (299)
T ss_dssp             TCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            0001100000122456788999999999999999999996

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=9.1e-38  Score=316.75  Aligned_cols=232  Identities=14%  Similarity=0.140  Sum_probs=185.7

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc---chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEE
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLV  336 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV  336 (586)
                      .++|+..+.||+|+||.||+|++..+++.||||++....   .+..+.+.+|+..+.+++||||+++++++...+..++|
T Consensus        30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  109 (286)
T 3uqc_A           30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVV  109 (286)
T ss_dssp             TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEE
Confidence            367999999999999999999999889999999997653   33457899999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCC
Q 007869          337 YDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHG  416 (586)
Q Consensus       337 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~  416 (586)
                      |||+++++|.+++...   . ...+..+|+.|+++||.|||+   ++|+||||||+|||++.++.+||++++        
T Consensus       110 ~e~~~g~~L~~~l~~~---~-~~~~~~~i~~ql~~aL~~lH~---~givH~Dikp~NIll~~~g~~kl~~~~--------  174 (286)
T 3uqc_A          110 AEWIRGGSLQEVADTS---P-SPVGAIRAMQSLAAAADAAHR---AGVALSIDHPSRVRVSIDGDVVLAYPA--------  174 (286)
T ss_dssp             EECCCEEEHHHHHTTC---C-CHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEETTSCEEECSCC--------
T ss_pred             EEecCCCCHHHHHhcC---C-ChHHHHHHHHHHHHHHHHHHH---CCCccCCCCcccEEEcCCCCEEEEecc--------
Confidence            9999999999999543   2 334678899999999999998   899999999999999999999998443        


Q ss_pred             CCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCC
Q 007869          417 TDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNL  496 (586)
Q Consensus       417 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l  496 (586)
                                   |++|       ++.++|||||||++|||++|+.||......+.....   .... .+.      +..
T Consensus       175 -------------~~~~-------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~---~~~~-~~~------~~~  224 (286)
T 3uqc_A          175 -------------TMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA---ERDT-AGQ------PIE  224 (286)
T ss_dssp             -------------CCTT-------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC---CBCT-TSC------BCC
T ss_pred             -------------ccCC-------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH---HHHh-ccC------CCC
Confidence                         3333       688999999999999999999999875543211000   0000 000      000


Q ss_pred             CccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 007869          497 GTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERDV  537 (586)
Q Consensus       497 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  537 (586)
                      ...........+.+++.+||+.||++| |+.|+++.|+...
T Consensus       225 ~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~  264 (286)
T 3uqc_A          225 PADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQAT  264 (286)
T ss_dssp             HHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHH
T ss_pred             hhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHh
Confidence            011112233567889999999999999 9999999998743

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=2e-38  Score=352.53  Aligned_cols=259  Identities=27%  Similarity=0.338  Sum_probs=201.4

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc-cchhHHHHHHHHHHhcccCCCceeeeeeeeec------cCeE
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRR------KGEL  333 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~------~~~~  333 (586)
                      ++|+..+.||+|+||.||+|.+..++..||||++... .....+.+.+|++++++++||||+++++++..      .+..
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~   93 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP   93 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence            6799999999999999999999888999999998764 34456779999999999999999999998765      6778


Q ss_pred             EEEEecCCCCChhhhhhcCC-CccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCC---eEEccccc
Q 007869          334 LLVYDYMPNGSLDKYLYDQP-KVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELN---GRLGDFGL  409 (586)
Q Consensus       334 ~lV~E~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~---~kL~DFGl  409 (586)
                      ++||||+++|+|.+++.... ...+++..++.++.|++.||.|||+   .+|+||||||+|||++.++.   +||+|||+
T Consensus        94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs---~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~  170 (676)
T 3qa8_A           94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGY  170 (676)
T ss_dssp             CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHH---TTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred             EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence            99999999999999998643 2368899999999999999999998   89999999999999997665   99999999


Q ss_pred             eeeccCCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhc-----
Q 007869          410 ARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWN-----  484 (586)
Q Consensus       410 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~-----  484 (586)
                      ++......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||......     ..|......     
T Consensus       171 a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~-----~~~~~~i~~~~~~~  243 (676)
T 3qa8_A          171 AKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP-----VQWHGKVREKSNEH  243 (676)
T ss_dssp             CCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH-----HHSSTTCC------
T ss_pred             cccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch-----hhhhhhhhcccchh
Confidence            98765432  234467999999999999999999999999999999999999999753211     111110000     


Q ss_pred             -------cCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHH
Q 007869          485 -------RGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQV  529 (586)
Q Consensus       485 -------~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~ev  529 (586)
                             .+.....................+.+++..||+.||++|||+.|+
T Consensus       244 ~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~el  295 (676)
T 3qa8_A          244 IVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN  295 (676)
T ss_dssp             CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTC
T ss_pred             hhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHH
Confidence                   011100001011122334456778899999999999999998763

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.1e-37  Score=353.30  Aligned_cols=238  Identities=21%  Similarity=0.297  Sum_probs=193.4

Q ss_pred             cCCcccceeEeecCceEEEEEEeCC-CCeEEEEEEeccc-cchhHHHHHHHHHHhcccCCCceeeeeeeeeccCe-----
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPK-SQIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGE-----  332 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~-----  332 (586)
                      .++|++.+.||+|+||.||+|.+.. ++..||||++... .....+.+.+|++++.+++||||+++++++...+.     
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            4789999999999999999999875 6889999998654 33455678999999999999999999999987665     


Q ss_pred             EEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceee
Q 007869          333 LLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARL  412 (586)
Q Consensus       333 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~  412 (586)
                      .+|||||+++++|.+++..    .+++.+++.++.||++||.|||+   ++|+||||||+|||++.+ .+||+|||+++.
T Consensus       159 ~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~---~giiHrDlkp~NIll~~~-~~kl~DFG~a~~  230 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVSR  230 (681)
T ss_dssp             EEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred             eEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHH---CCCeecccChHHeEEeCC-cEEEEecccchh
Confidence            7999999999999987743    68999999999999999999998   899999999999999986 899999999987


Q ss_pred             ccCCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCcccccc
Q 007869          413 YDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEAR  492 (586)
Q Consensus       413 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~  492 (586)
                      ....     ....||+.|+|||++.++. +.++|||||||++|||++|..|+.......                +    
T Consensus       231 ~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~----------------~----  284 (681)
T 2pzi_A          231 INSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG----------------L----  284 (681)
T ss_dssp             TTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS----------------C----
T ss_pred             cccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc----------------c----
Confidence            6532     3457999999999987654 889999999999999999998876421110                0    


Q ss_pred             CCCCCccccHHHHHHHHHHHHHhcccCCCCCCC-HHHHHHHHh
Q 007869          493 DPNLGTEYVAEELELVLKLGLLCSHSDPTARPS-MRQVVQILE  534 (586)
Q Consensus       493 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-~~evl~~L~  534 (586)
                       +  ...........+.+++.+||+.||.+||+ ++++.+.|.
T Consensus       285 -~--~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~  324 (681)
T 2pzi_A          285 -P--EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLT  324 (681)
T ss_dssp             -C--TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred             -c--ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHH
Confidence             0  00111223356788999999999999996 555555554

>1dhk_B Bean lectin-like inhibitor, porcine pancreatic alpha-amylase; CO (hydrolase-inhibitor), complex (hydrolase-inhibitor) comple; HET: NAG; 1.85A {Phaseolus vulgaris} SCOP: b.29.1.1 PDB: 1viw_B*

Probab=100.00  E-value=1.4e-37  Score=298.61  Aligned_cols=144  Identities=29%  Similarity=0.464  Sum_probs=122.2

Q ss_pred             CcccCCCCCCCCCCeeeeeEEEEEEEEEeCCCCCCCCcEEEEEecCCCCCCCCCCCcccccccCCCCCCCccEEEEEeec
Q 007869            2 PFKNKNSNSSTANGTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGLFNDTNLGNETNHVFAVELDT   81 (586)
Q Consensus         2 p~~~~~~~~~~~~~~~asF~t~F~f~i~~~~~~~~g~GlaF~l~p~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEfDt   81 (586)
                      ||++|++.+    |+++||+|+|+|.|.+.+...+||||||+|+|....|.                   +++|||||||
T Consensus        48 Pi~l~~~~~----g~vaSFsT~F~F~I~~~~~~~~gdGlAF~l~p~~~~p~-------------------~~~vAVEFDT  104 (223)
T 1dhk_B           48 PIQIRDSTT----GNVASFDTNFTMNIRTHRQANSAVGLDFVLVPVQPESK-------------------GDTVTVEFDT  104 (223)
T ss_dssp             CEESEETTT----TEECEEEEEEEEEEECCC---CCSEEEEEEEEC-------------------------CCEEEEEET
T ss_pred             CEEeecCCC----CCccceEEEEEEEEeCCCCCCCCCceEEEEecCCCCCC-------------------ccEEEEEecC
Confidence            899999887    99999999999999987777899999999999754331                   3489999999


Q ss_pred             cccCCCCCCCCCeeEEeCCCCcccccccC----------ceEEEEcCeeeEEEEEEeecCCCCCCccceeeeeecchhcc
Q 007869           82 IKSHGFLDINDNHVGIDINSLKSESSAPA----------GYYVEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSVL  151 (586)
Q Consensus        82 ~~~~~~~d~~~~hvgidvns~~s~~~~~~----------~~~i~y~~~~~~l~v~~~~~~~~~~~~~~~ls~~~dL~~~l  151 (586)
                      +         +||||||+||+ |.+++++          ..||+||+.+++|+|++++.+.+  .. |+|++.+||+++|
T Consensus       105 ~---------~nHVGIdvNsi-S~~~~~~~~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~~--~~-~~ls~~vdLs~~l  171 (223)
T 1dhk_B          105 F---------LSRISIDVNNN-DIKSVPWDVHDYDGQNAEVRITYNSSTKVFSVSLSNPSTG--KS-NNVSTTVELEKEV  171 (223)
T ss_dssp             T---------TTEEEEEETTE-EEEEEECCGGGTTTSCEEEEEEEETTTTEEEEEEECTTTC--CE-EEEEEECCCCSGG
T ss_pred             C---------CCcccccCCcc-ccccccCCccccCCCEEEEEEEEeCCCCEEEEEEecCCCC--cc-ceEEEEechHHhC
Confidence            8         69999999999 8877553          36999999999999999875432  34 8999999999999


Q ss_pred             ccceeeeeecCCCcc---ceeeeeeeccccccC
Q 007869          152 NDAMYVGFSSSTGSV---LASHYILGWSFKING  181 (586)
Q Consensus       152 ~~~~~vGFsastg~~---~~~~~i~~Wsf~~~~  181 (586)
                      |++|||||||+||..   .|.|+|++|+|++++
T Consensus       172 ~e~~~VGFSAsTG~~~~~~~~H~IlsWsF~s~~  204 (223)
T 1dhk_B          172 YDWVSVGFSATSGAYQWSYETHDVLSWSFSSKF  204 (223)
T ss_dssp             GSEEEEEEEEEECSGGGSCCEEEEEEEEEEEEC
T ss_pred             CCceEEEEEeccCCCccccceEEEEEEEEEecc
Confidence            999999999999998   999999999999865

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=8.2e-37  Score=316.55  Aligned_cols=241  Identities=17%  Similarity=0.186  Sum_probs=183.7

Q ss_pred             hcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc--------chhHHHHHHHHHHhcccC---------CCcee
Q 007869          259 ATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES--------RQGMKEFVAEIVSIGRLR---------HRNLV  321 (586)
Q Consensus       259 a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--------~~~~~~~~~Ei~~l~~l~---------H~niv  321 (586)
                      ..++|+..+.||+|+||+||+|++  ++..||||++....        ....+.+.+|+.++++++         ||||+
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv   95 (336)
T 2vuw_A           18 PTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFI   95 (336)
T ss_dssp             CHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBC
T ss_pred             ccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchh
Confidence            346788999999999999999998  56899999997652        223477889999988886         55555


Q ss_pred             eeee-----------------eeec-------------cCeEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHH
Q 007869          322 QLLG-----------------YCRR-------------KGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVAL  371 (586)
Q Consensus       322 ~l~~-----------------~~~~-------------~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~  371 (586)
                      ++.+                 ++..             .+..++||||+++|++.+.+.+   ..+++..+..++.||+.
T Consensus        96 ~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~  172 (336)
T 2vuw_A           96 GLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTA  172 (336)
T ss_dssp             CEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHH
T ss_pred             hhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHH
Confidence            5544                 4443             6789999999999987777644   35789999999999999


Q ss_pred             HHHHhh-cccCCcEEeCCCCCCCeeecCCC--------------------CeEEccccceeeccCCCCCceeeeccCCCc
Q 007869          372 GLFYLH-QEWEQVVIHRDVKASNVLLDGEL--------------------NGRLGDFGLARLYDHGTDPQTTHVVGTLGY  430 (586)
Q Consensus       372 ~L~yLH-~~~~~~ivHrDIkp~NIll~~~~--------------------~~kL~DFGla~~~~~~~~~~~~~~~gt~~y  430 (586)
                      ||.||| +   ++|+||||||+|||++.++                    .+||+|||+|+.....      ...||+.|
T Consensus       173 aL~~lH~~---~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y  243 (336)
T 2vuw_A          173 SLAVAEAS---LRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVS  243 (336)
T ss_dssp             HHHHHHHH---HCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCT
T ss_pred             HHHHHHHh---CCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecc
Confidence            999999 7   8999999999999999887                    8999999999976532      35799999


Q ss_pred             cCcccccCCCCCCcceEEehhHH-HHHHHhCCCCCCCCCCCccchhhHHHHhhhccCcccc--ccCCCCCccccHHHHHH
Q 007869          431 LAPEHTRTGKATTSADVFSFGAF-LLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLE--ARDPNLGTEYVAEELEL  507 (586)
Q Consensus       431 ~aPE~~~~~~~s~ksDVyS~Gvv-l~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~--~~d~~l~~~~~~~~~~~  507 (586)
                      +|||++.+.. +.++|||||+++ .+++++|..||...         .|......  .+..  .................
T Consensus       244 ~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~---------~~~~~~~~--~~~~~~~~~~~~~~~~~~~~s~~  311 (336)
T 2vuw_A          244 MDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV---------LWLHYLTD--KMLKQMTFKTKCNTPAMKQIKRK  311 (336)
T ss_dssp             TCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH---------HHHHHHHH--HHHHTCCCSSCCCSHHHHHHHHH
T ss_pred             cChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch---------hhhhHHHH--hhhhhhccCcccchhhhhhcCHH
Confidence            9999998666 889999998777 77788899887421         11110000  0000  01111112234456778


Q ss_pred             HHHHHHHhcccCCCCCCCHHHHH
Q 007869          508 VLKLGLLCSHSDPTARPSMRQVV  530 (586)
Q Consensus       508 l~~l~~~Cl~~dP~~RPs~~evl  530 (586)
                      +.+++.+||+.|     |++|++
T Consensus       312 ~~dli~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          312 IQEFHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             HHHHHHHGGGSS-----SHHHHH
T ss_pred             HHHHHHHHhccC-----CHHHHH
Confidence            999999999976     898887

>2ltn_A PEA lectin, alpha chain; 1.70A {Pisum sativum} SCOP: b.29.1.1 PDB: 1bqp_A* 1hkd_A 1ofs_A* 1rin_A* 1lof_C* 1len_A 1lem_A 1les_A* 2lal_A 1loe_A 1loa_A* 1loc_A* 1lod_A* 1lob_A 1lof_A* 1log_A* 1lgc_A* 1lgb_A* 2b7y_A*

Probab=100.00  E-value=4.3e-34  Score=265.21  Aligned_cols=121  Identities=30%  Similarity=0.471  Sum_probs=109.5

Q ss_pred             CcccCCCCCCCCCCeeeeeEEEEEEEEEeCCCCCCCCcEEEEEecCCCCCCCCCCCcccccccCCCCCCCccEEEEEeec
Q 007869            2 PFKNKNSNSSTANGTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGLFNDTNLGNETNHVFAVELDT   81 (586)
Q Consensus         2 p~~~~~~~~~~~~~~~asF~t~F~f~i~~~~~~~~g~GlaF~l~p~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEfDt   81 (586)
                      ||+||++.+    |+++||+|+|+|.|.+.+...+||||||||+|....|. ++||||||||.+ +++..||+|||||||
T Consensus        49 Pv~l~d~~t----g~vaSFsT~F~F~I~~~~~~~~gdGlAF~l~p~~~~p~-~~g~~LGL~n~~-~~~~~n~~vAVEFDT  122 (181)
T 2ltn_A           49 PIHIWDRET----GNVANFVTSFTFVINAPNSYNVADGFTFFIAPVDTKPQ-TGGGYLGVFNSA-EYDKTTQTVAVEFDT  122 (181)
T ss_dssp             CEECBCTTT----CCBCEEEEEEEEEEECSSTTSCCCEEEEEEEETTCCCC-CCGGGTTTCSCS-SCCTTSCCEEEEEEC
T ss_pred             CEEeecCCC----CCccceEEEEEEEEecCCCCCCCCceEEEEecCCCCCC-CCCccccccccC-CCCccccEEEEEecc
Confidence            899999888    99999999999999987777899999999999876666 889999999987 457889999999999


Q ss_pred             cccCCCCCCC--CCeeEEeCCCCcccccccC--------ceEEEEcCeeeEEEEEEee
Q 007869           82 IKSHGFLDIN--DNHVGIDINSLKSESSAPA--------GYYVEYDGLEKRTNVTLAP  129 (586)
Q Consensus        82 ~~~~~~~d~~--~~hvgidvns~~s~~~~~~--------~~~i~y~~~~~~l~v~~~~  129 (586)
                      ++|.+ +||+  +|||||||||+.|.+++++        .+||+||+.+++|+|+|++
T Consensus       123 ~~n~~-~Dp~~~~nHVGIdvNs~~S~~t~~~~l~~G~~~~v~I~Yd~~~~~L~V~l~~  179 (181)
T 2ltn_A          123 FYNAA-WDPSNRDRHIGIDVNSIKSVNTKSWKLQNGEEANVVIAFNAATNVLTVSLTY  179 (181)
T ss_dssp             SCCTT-TSCTTCCCEEEEEESSSSCSEEEECCCCTTCCEEEEEEEETTTTEEEEEEEE
T ss_pred             ccccc-cCCCCCCCEEEEEcCCccccceeccccCCCCEEEEEEEEECCCCEEEEEEec
Confidence            99988 5999  9999999999999888754        3699999999999999985

>1qmo_E Mannose binding lectin, FRIL; crosslink, hematopoietic progenitor, sugar complex; HET: MAN; 3.5A {Dolichos lab lab} SCOP: b.29.1.1

Probab=100.00  E-value=2.1e-33  Score=245.49  Aligned_cols=106  Identities=33%  Similarity=0.441  Sum_probs=96.8

Q ss_pred             ccEEEEEeeccccCCCCCCCCCeeEEeCCCCcccccccC--------ceEEEEcCeeeEEEEEEeecCCCCCCccceeee
Q 007869           72 NHVFAVELDTIKSHGFLDINDNHVGIDINSLKSESSAPA--------GYYVEYDGLEKRTNVTLAPINIPRPRSLNTMSL  143 (586)
Q Consensus        72 ~~~vaVEfDt~~~~~~~d~~~~hvgidvns~~s~~~~~~--------~~~i~y~~~~~~l~v~~~~~~~~~~~~~~~ls~  143 (586)
                      ||+|||||||++|.+|+||++|||||||||+.|.+++++        ..||+||+.+++|+|++++.+. +  . |+|++
T Consensus         1 n~~vAVEFDT~~N~e~~Dp~~nHVGIdvNsi~S~~s~~~~l~sG~~~~v~I~Yd~~~~~L~V~l~~~~~-~--~-p~ls~   76 (133)
T 1qmo_E            1 SNVVAVEFDTYLNPDYGDPNYIHIGIDVNSIRSKVTAKWDWQNGKIATAHISYNSVSKRLSVTSYYAGS-K--P-ATLSY   76 (133)
T ss_dssp             CCCEEEEEECSCCGGGTCCSSCEEEEEESSSSCSEEEECCCCTTSCEEEEEEEETTTTEEEEEEECSSS-C--C-EEEEE
T ss_pred             CCEEEEEEeCCcCccccCCCCCeeEEecccccccceeeeEEcCCCEEEEEEEEeCCCcEEEEEEccCCC-c--c-ceEEE
Confidence            689999999999999889999999999999999887764        3699999999999999987543 2  4 89999


Q ss_pred             eecchhccccceeeeeecCCCccceeeeeeeccccccC
Q 007869          144 SRDLSSVLNDAMYVGFSSSTGSVLASHYILGWSFKING  181 (586)
Q Consensus       144 ~~dL~~~l~~~~~vGFsastg~~~~~~~i~~Wsf~~~~  181 (586)
                      .+||+++||++||||||||||...|.|+|++|+|+++.
T Consensus        77 ~vdLs~~l~e~v~VGFSAsTG~~~~~h~IlsWsF~s~l  114 (133)
T 1qmo_E           77 DIELHTVLPEWVRVGLSASTGQDKERNTVHSWSFTSSL  114 (133)
T ss_dssp             ECCGGGTSCSEEEEEEEEECSSSCCEEEEEEEEEEEEE
T ss_pred             eechHHhccccEEEEEEeccCCCcceeEEEEEEEEeeC
Confidence            99999999999999999999999999999999999863

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.96  E-value=6.8e-31  Score=290.53  Aligned_cols=186  Identities=17%  Similarity=0.073  Sum_probs=132.3

Q ss_pred             EeecCceEEEEEEeCCCCeEEEEEEeccc----------cchhHHHHHHHHHHhccc-CCCceeeeeeeeeccCeEEEEE
Q 007869          269 LGTGGFGRVYRGTLPKSQIEIAVKKISHE----------SRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKGELLLVY  337 (586)
Q Consensus       269 LG~G~~g~Vy~~~~~~~~~~vavK~~~~~----------~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~lV~  337 (586)
                      ++.|+.|.+.+++....+..+|+|++...          .....++|.+|+++|+++ .|+||+++++++++++..||||
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM  321 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM  321 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence            55666666666555555778999998653          123456799999999999 7999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCC
Q 007869          338 DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT  417 (586)
Q Consensus       338 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~  417 (586)
                      ||++|++|.++|....  +++..   +|+.||++||.|||+   ++||||||||+||||++++++||+|||+|+......
T Consensus       322 Eyv~G~~L~d~i~~~~--~l~~~---~I~~QIl~AL~ylH~---~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~  393 (569)
T 4azs_A          322 EKLPGRLLSDMLAAGE--EIDRE---KILGSLLRSLAALEK---QGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC  393 (569)
T ss_dssp             ECCCSEEHHHHHHTTC--CCCHH---HHHHHHHHHHHHHHH---TTCEESCCCGGGEEECTTSCEEECCCTTEESCC---
T ss_pred             ecCCCCcHHHHHHhCC--CCCHH---HHHHHHHHHHHHHHH---CCceeccCchHhEEECCCCCEEEeecccCeeCCCCC
Confidence            9999999999998764  34433   589999999999998   999999999999999999999999999999765433


Q ss_pred             CCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCC
Q 007869          418 DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPI  464 (586)
Q Consensus       418 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~  464 (586)
                      . .....+||++|||||++.+ .+..++|+||+|++++++.++..++
T Consensus       394 ~-~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~  438 (569)
T 4azs_A          394 S-WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW  438 (569)
T ss_dssp             C-CSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred             c-cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence            2 3345789999999999864 5677899999999988876665443

>1nls_A Concanavalin A; lectin, agglutinin; 0.94A {Canavalia ensiformis} SCOP: b.29.1.1 PDB: 1bxh_A* 1apn_A 1ces_A 1cjp_A* 1c57_A 1cvn_A* 1con_A 1dq1_A 1dq2_A 1dq4_A 1dq5_A 1dq6_A 1enq_A 1enr_A 1ens_A 1gic_A* 1dq0_A 1hqw_A 1gkb_A* 1i3h_A ...

Probab=99.96  E-value=8.1e-30  Score=246.67  Aligned_cols=107  Identities=35%  Similarity=0.464  Sum_probs=97.6

Q ss_pred             CccEEEEEeeccccCCCCCCCCCeeEEeCCCCcccccccC--------ceEEEEcCeeeEEEEEEeecCCCCCCccceee
Q 007869           71 TNHVFAVELDTIKSHGFLDINDNHVGIDINSLKSESSAPA--------GYYVEYDGLEKRTNVTLAPINIPRPRSLNTMS  142 (586)
Q Consensus        71 ~~~~vaVEfDt~~~~~~~d~~~~hvgidvns~~s~~~~~~--------~~~i~y~~~~~~l~v~~~~~~~~~~~~~~~ls  142 (586)
                      +||+|||||||++|.+|+||++|||||||||+.|.+++++        ..||+||+.+++|+|++++...   .. |+|+
T Consensus         1 ~n~~vAVEFDT~~n~~~~Dp~~nHVGIdvNs~~S~~~~~~~l~~g~~~~v~I~Yd~~~~~L~V~l~~~~~---~~-~~ls   76 (237)
T 1nls_A            1 ADTIVAVELDTYPNTDIGDPSYPHIGIDIKSVRSKKTAKWNMQNGKVGTAHIIYNSVDKRLSAVVSYPNA---DS-ATVS   76 (237)
T ss_dssp             CCCEEEEEEECSCCGGGTCCSSCEEEEEESSSSCSEEEECCCCTTCEEEEEEEEETTTTEEEEEEECTTS---CC-EEEE
T ss_pred             CCCEEEEEEeCCCCcccCCCCCCeeeEecCCccccccccccccCCCEEEEEEEEeCCCCEEEEEEecCCC---Cc-ceEE
Confidence            4899999999999999999999999999999999887764        3699999999999999986533   34 8999


Q ss_pred             eeecchhccccceeeeeecCCCccceeeeeeeccccccC
Q 007869          143 LSRDLSSVLNDAMYVGFSSSTGSVLASHYILGWSFKING  181 (586)
Q Consensus       143 ~~~dL~~~l~~~~~vGFsastg~~~~~~~i~~Wsf~~~~  181 (586)
                      +.+||+++|+|+||||||||||...|.|+|++|+|++.+
T Consensus        77 ~~vdLs~~l~e~~~VGFSAsTG~~~~~h~IlsWsF~s~~  115 (237)
T 1nls_A           77 YDVDLDNVLPEWVRVGLSASTGLYKETNTILSWSFTSKL  115 (237)
T ss_dssp             EECCGGGTSCSEEEEEEEEECSSSCCCCEEEEEEEEEEE
T ss_pred             EeeChHHhCccccEEEEEeccCCcceeeeeEEEEEEecc
Confidence            999999999999999999999999999999999999864

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.93  E-value=1.8e-27  Score=261.61  Aligned_cols=185  Identities=15%  Similarity=0.148  Sum_probs=145.6

Q ss_pred             ccceeEeecCceEEEEEEeCCCCeEEEEEEeccccc--------hhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEE
Q 007869          264 REKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR--------QGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLL  335 (586)
Q Consensus       264 ~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~l  335 (586)
                      ...++||+|+||.||+|..  .+..+++|+......        ...+.+.+|++++++++||||+++..++...+..+|
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l  416 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI  416 (540)
T ss_dssp             ---------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred             CCCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence            4467899999999999965  356789998644211        123458999999999999999977777777778899


Q ss_pred             EEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccC
Q 007869          336 VYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH  415 (586)
Q Consensus       336 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~  415 (586)
                      ||||+++++|.+++..          +..++.|+++||.|||+   ++|+||||||+|||++.  ++||+|||+++....
T Consensus       417 VmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~---~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~  481 (540)
T 3en9_A          417 MMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHK---NDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNL  481 (540)
T ss_dssp             EEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHH---TTEECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred             EEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHH---CcCccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence            9999999999999865          45789999999999998   89999999999999998  999999999998654


Q ss_pred             CCCCc------eeeeccCCCccCcccccC--CCCCCcceEEehhHHHHHHHhCCCCCC
Q 007869          416 GTDPQ------TTHVVGTLGYLAPEHTRT--GKATTSADVFSFGAFLLEVACGRRPIQ  465 (586)
Q Consensus       416 ~~~~~------~~~~~gt~~y~aPE~~~~--~~~s~ksDVyS~Gvvl~ElltG~~p~~  465 (586)
                      .....      .....||+.|||||++..  ..|+..+|+|+..+-.++-+.++.+|.
T Consensus       482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            32111      135689999999999976  567888999999999888887777653

>2dur_A VIP36;, vesicular integral-membrane protein VIP36; beta sandwich, carbohydrate binding protein, cargo receptor, transport; HET: MAN; 1.65A {Canis lupus familiaris} PDB: 2dup_A 2duq_A* 2duo_A* 2e6v_A*

Probab=99.92  E-value=4.3e-25  Score=217.98  Aligned_cols=148  Identities=19%  Similarity=0.157  Sum_probs=108.1

Q ss_pred             CeeeeeEEEEEEEEEeCCC-CCCCCcEEEEEecCCCCCCCCCCCcccccccCCCCCCCccEEEEEeeccccCCCCCCCCC
Q 007869           15 GTVFSFSTTFVFSILSEYQ-SQSGHGIAFVIASTRGLPGARPSQYLGLFNDTNLGNETNHVFAVELDTIKSHGFLDINDN   93 (586)
Q Consensus        15 ~~~asF~t~F~f~i~~~~~-~~~g~GlaF~l~p~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEfDt~~~~~~~d~~~~   93 (586)
                      -.++||+|+|+|+|.+... ..+||||||+|+|...    ..|++||+.+       .++.|||||||+.|.++.|++..
T Consensus        59 i~~~sF~t~F~F~I~~~~~~~~~gdGlAF~l~~~~~----~~G~~lG~~~-------~~~gvAVefDT~~n~~~~~~~~~  127 (253)
T 2dur_A           59 CFLKDWEMHVHFKVHGTGKKNLHGDGIALWYTRDRL----VPGPVFGSKD-------NFHGLAIFLDTYPNDETTERVFP  127 (253)
T ss_dssp             BCCSSEEEEEEEEEECCCCTTCCCCEEEEEEESCCS----CEETBTEECS-------SCEEEEEEEECSCCCTTCCSCSS
T ss_pred             CccCcEEEEEEEEEecCCCCCcCCCcEEEEEECCCC----CCCcccCcCC-------CCCEEEEEEECCCCCCCCCCCCc
Confidence            5678999999999997755 5789999999998653    3578999732       36789999999999765444455


Q ss_pred             eeEEeCCCCc-cc----------------c----cccCceEEEEcCeeeEEEEEEeecCCCCCCccceeeeeecchhccc
Q 007869           94 HVGIDINSLK-SE----------------S----SAPAGYYVEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSVLN  152 (586)
Q Consensus        94 hvgidvns~~-s~----------------~----~~~~~~~i~y~~~~~~l~v~~~~~~~~~~~~~~~ls~~~dL~~~l~  152 (586)
                      ||++++|.-. +-                .    ..+...||+|++.  .|+|++.+.+.. +.. ++++  ++ ..+||
T Consensus       128 ~I~~~~n~gs~~~d~~~dg~~~~~~~c~~~~~n~g~~~~v~I~Y~~~--~L~V~l~~~~~~-~~~-~~~~--~~-~v~Lp  200 (253)
T 2dur_A          128 YISVMVNNGSLSYDHSKDGRWTELAGCTADFRNRDHDTFLAVRYSRG--RLTVMTDLEDKN-EWK-NCID--IT-GVRLP  200 (253)
T ss_dssp             EEEEEEEESCCCCCGGGTTGGGCCEEEECCCBTCSSCEEEEEEEETT--EEEEEEECSSSS-CCE-EEEE--EC-CEECC
T ss_pred             EEEEEecCCceeeeccCCCcccccccccHhhccCCCCeEEEEEEECC--EEEEEEeCCCCC-Cce-EEEE--eC-CcccC
Confidence            6666555311 00                0    0112368999965  899999875432 333 3433  34 33589


Q ss_pred             cceeeeeecCCCccceeeeeeecccccc
Q 007869          153 DAMYVGFSSSTGSVLASHYILGWSFKIN  180 (586)
Q Consensus       153 ~~~~vGFsastg~~~~~~~i~~Wsf~~~  180 (586)
                      ++|||||||+||...+.|+|++|+|.+-
T Consensus       201 ~~~yvGfSAaTG~~~~~h~Ilswsf~sl  228 (253)
T 2dur_A          201 TGYYFGASAGTGDLSDNHDIISMKLFQL  228 (253)
T ss_dssp             SSBEEEEEEEESSSCCEEEEEEEEEEEC
T ss_pred             CCcEEEEEeccCCCcceEEEEEEEEEec
Confidence            9999999999999999999999999863

>1gv9_A P58/ergic-53; lectin, carbohydrate binding; 1.46A {Rattus norvegicus} SCOP: b.29.1.13 PDB: 1r1z_A 3a4u_A 3lcp_A

Probab=99.91  E-value=2.2e-25  Score=220.58  Aligned_cols=149  Identities=13%  Similarity=0.180  Sum_probs=110.8

Q ss_pred             CeeeeeEEEEEEEEEeCCCCCCCCcEEEEEecCCCCCCCCCCCcccccccCCCCCCCccEEEEEeeccccCCCC-CC---
Q 007869           15 GTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGLFNDTNLGNETNHVFAVELDTIKSHGFL-DI---   90 (586)
Q Consensus        15 ~~~asF~t~F~f~i~~~~~~~~g~GlaF~l~p~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEfDt~~~~~~~-d~---   90 (586)
                      ..++||+|+|+|+|.... ..+||||||+|+|...    .+|++||+.       ..++.|||||||+.|.++. +|   
T Consensus        83 ~~~~sF~t~F~F~I~~~~-~~~gdGlAF~l~~~~~----~~g~~~G~~-------~~~~gvaVefDT~~N~~~~~~p~I~  150 (260)
T 1gv9_A           83 AAFENWEVEVTFRVTGRG-RIGADGLAIWYTENQG----LDGPVFGSA-------DMWNGVGIFFDSFDNDGKKNNPAIV  150 (260)
T ss_dssp             BCCSSEEEEEEEEEECSS-SCCCCEEEEEEESSCC----CEEEETTEC-------SCCEEEEEEEECCCC-----CCEEE
T ss_pred             ccccCEEEEEEEEEecCC-CCCCCeEEEEEecCCC----CCCCccCCC-------CCCCEEEEEEECCCCCCCCCCCceE
Confidence            678999999999998754 4689999999998643    357888883       3467799999999986531 22   


Q ss_pred             ---CCCeeEEeCCC-Cccccc-----------ccCceEEEEcCeeeEEEEEEeecCCCCCCccceeeeeecchhccccce
Q 007869           91 ---NDNHVGIDINS-LKSESS-----------APAGYYVEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSVLNDAM  155 (586)
Q Consensus        91 ---~~~hvgidvns-~~s~~~-----------~~~~~~i~y~~~~~~l~v~~~~~~~~~~~~~~~ls~~~dL~~~l~~~~  155 (586)
                         +++|+|||+|+ +.|...           .+...||+|++.  .|+|++.+...+.... ..++..+| ..+||+++
T Consensus       151 ~~indg~~~~d~~~d~~s~~~~~c~~~~~n~g~~~~~~I~Y~~~--~L~V~l~~~~~~~~~~-~~~~~~vd-~~~LP~~~  226 (260)
T 1gv9_A          151 VVGNNGQINYDHQNDGATQALASCQRDFRNKPYPVRAKITYYQK--TLTVMINNGFTPDKND-YEFCAKVE-NMVIPTQG  226 (260)
T ss_dssp             EEEEESCCCCCHHHHHHHHCSEEECCCCBSCSSCEEEEEEEETT--EEEEEEECSSCCCTTC-CEEEEEET-TCCCCSSB
T ss_pred             EEeCCCceEeecCCCcccceeeccChhhccCCCcEEEEEEEECC--EEEEEEeeccCCCCCc-ceEEEEEc-ccccCCCc
Confidence               46788888875 433221           123368999975  8999998632111112 36778888 67799999


Q ss_pred             eeeeecCCCccceeeeeeeccccc
Q 007869          156 YVGFSSSTGSVLASHYILGWSFKI  179 (586)
Q Consensus       156 ~vGFsastg~~~~~~~i~~Wsf~~  179 (586)
                      ||||||+||...+.|+|++|+|..
T Consensus       227 ~vGfSAaTG~~~e~hdIlsw~~~~  250 (260)
T 1gv9_A          227 HFGISAATGGLADDHDVLSFLTFQ  250 (260)
T ss_dssp             EEEEEEECCSSCCEEEEEEEEEEE
T ss_pred             EEEEEEeCCCCcceEEEEEEEEEE
Confidence            999999999999999999999875

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.89  E-value=7.2e-24  Score=213.94  Aligned_cols=151  Identities=15%  Similarity=0.044  Sum_probs=122.2

Q ss_pred             hhhhhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccc------------------hhHHHHHHHHHHhcccC
Q 007869          255 DLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR------------------QGMKEFVAEIVSIGRLR  316 (586)
Q Consensus       255 el~~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~Ei~~l~~l~  316 (586)
                      .+......|+..+.||+|+||.||+|.+ .++..||||.++....                  .....+.+|+.++++++
T Consensus        84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~  162 (282)
T 1zar_A           84 RLVRSGKVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ  162 (282)
T ss_dssp             HHHHTTSCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHhCCeEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence            3444555677779999999999999999 7788999999964321                  13456899999999999


Q ss_pred             CCceeeeeeeeeccCeEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeee
Q 007869          317 HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLL  396 (586)
Q Consensus       317 H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll  396 (586)
                        | +++.+++.. +..++||||+++++|.+ +..        .....++.|+++||.|||+   .+|+||||||+|||+
T Consensus       163 --~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~---~giiHrDlkp~NILl  226 (282)
T 1zar_A          163 --G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLV  226 (282)
T ss_dssp             --T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEE
T ss_pred             --C-CCcCeEEec-cceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHH---CCCEeCCCCHHHEEE
Confidence              5 677775543 56799999999999998 422        1234689999999999998   999999999999999


Q ss_pred             cCCCCeEEccccceeeccCCCCCceeeeccCCCccCccccc
Q 007869          397 DGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTR  437 (586)
Q Consensus       397 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~  437 (586)
                      + ++.+||+|||+|+.              +..|+|||++.
T Consensus       227 ~-~~~vkl~DFG~a~~--------------~~~~~a~e~l~  252 (282)
T 1zar_A          227 S-EEGIWIIDFPQSVE--------------VGEEGWREILE  252 (282)
T ss_dssp             E-TTEEEECCCTTCEE--------------TTSTTHHHHHH
T ss_pred             E-CCcEEEEECCCCeE--------------CCCCCHHHHHH
Confidence            9 99999999999974              34578999874

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.81  E-value=7.9e-20  Score=181.87  Aligned_cols=140  Identities=16%  Similarity=0.115  Sum_probs=108.6

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeE--EEEEEeccccch------------------------hHHHHHHHHHHhcc
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIE--IAVKKISHESRQ------------------------GMKEFVAEIVSIGR  314 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~--vavK~~~~~~~~------------------------~~~~~~~Ei~~l~~  314 (586)
                      .-|...+.||+|+||.||+|.+..++..  ||||+++.....                        ....+.+|+..|.+
T Consensus        47 ~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~  126 (258)
T 1zth_A           47 YITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER  126 (258)
T ss_dssp             SEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred             CchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence            3367789999999999999998666788  999987543111                        11367899999999


Q ss_pred             cCCCce--eeeeeeeeccCeEEEEEecCCC-C----ChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhh-cccCCcEEe
Q 007869          315 LRHRNL--VQLLGYCRRKGELLLVYDYMPN-G----SLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLH-QEWEQVVIH  386 (586)
Q Consensus       315 l~H~ni--v~l~~~~~~~~~~~lV~E~~~~-g----sL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH-~~~~~~ivH  386 (586)
                      ++|+++  +.++.+    +..+|||||+.+ |    +|.++...     .++.....++.|++.+|.||| +   .+|+|
T Consensus       127 l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~---~givH  194 (258)
T 1zth_A          127 AKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQE---AELVH  194 (258)
T ss_dssp             HHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHT---SCEEC
T ss_pred             HHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHH---CCEEe
Confidence            988864  334432    356899999942 4    56655422     335577889999999999999 7   89999


Q ss_pred             CCCCCCCeeecCCCCeEEccccceeecc
Q 007869          387 RDVKASNVLLDGELNGRLGDFGLARLYD  414 (586)
Q Consensus       387 rDIkp~NIll~~~~~~kL~DFGla~~~~  414 (586)
                      |||||+|||+++  .++|+|||+|....
T Consensus       195 rDlkp~NILl~~--~~~liDFG~a~~~~  220 (258)
T 1zth_A          195 ADLSEYNIMYID--KVYFIDMGQAVTLR  220 (258)
T ss_dssp             SSCSTTSEEESS--SEEECCCTTCEETT
T ss_pred             CCCCHHHEEEcC--cEEEEECcccccCC
Confidence            999999999998  99999999998653

>2a6y_A EMP47P (FORM1); beta sandwich, carbohydrate binding protein, cargo receptor, structural genomics, NPPSFA; 1.42A {Saccharomyces cerevisiae} SCOP: b.29.1.13

Probab=99.70  E-value=1.7e-17  Score=163.24  Aligned_cols=148  Identities=17%  Similarity=0.158  Sum_probs=106.5

Q ss_pred             cCCCCCCCCCCe-eeeeEEEEEEEEEeCCCCCCCCcEEEEEecCCCCCCCCCCCcccccccCCCCCCCccEEEEEeeccc
Q 007869            5 NKNSNSSTANGT-VFSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGLFNDTNLGNETNHVFAVELDTIK   83 (586)
Q Consensus         5 ~~~~~~~~~~~~-~asF~t~F~f~i~~~~~~~~g~GlaF~l~p~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEfDt~~   83 (586)
                      +|+..+    .. +++|+|+|+|+|.... ..+||||||.+++....|  ..|+.+|.++       ...-+||||||+.
T Consensus        58 iW~~~p----~~~~~~f~~~f~FrI~g~~-~~~gdGlAfwlt~~~~~~--~~g~~~G~~~-------~f~GlaV~fDT~~  123 (256)
T 2a6y_A           58 LWLKQG----FDLKDSFTMEWTFRSVGYS-GQTDGGISFWFVQDSNIP--RDKQLYNGPV-------NYDGLQLLVDNNG  123 (256)
T ss_dssp             EEESSC----EEESSCEEEEEEEEEESCC-SCCSCEEEEEEEECSSSC--CCCTBTTBCT-------TCEEEEEEEESCS
T ss_pred             EeeCCC----CcccCCEEEEEEEEEecCC-CCCCCeEEEEEeCCCCcc--cCCcccCcCC-------CCCEEEEEEECCC
Confidence            455555    76 8899999999998653 348999999999865333  5677888853       2234899999997


Q ss_pred             cCCCCCCC------CCeeEEeCCCCcccccc-----------cCceEEEEc-CeeeEEEEEEeecCCCCCCccceeeeee
Q 007869           84 SHGFLDIN------DNHVGIDINSLKSESSA-----------PAGYYVEYD-GLEKRTNVTLAPINIPRPRSLNTMSLSR  145 (586)
Q Consensus        84 ~~~~~d~~------~~hvgidvns~~s~~~~-----------~~~~~i~y~-~~~~~l~v~~~~~~~~~~~~~~~ls~~~  145 (586)
                      |.   .|.      +.|+++|.+++.+....           +...+|.|+ +..+.|+|.+..       +.|.....|
T Consensus       124 n~---~p~i~~~~Ndg~~~~d~~~~~~~~~~~c~~~~rn~~~~~~v~I~Y~~~~~~~L~V~i~~-------~~c~~~~~v  193 (256)
T 2a6y_A          124 PL---GPTLRGQLNDGQKPVDKTKIYDQSFASCLMGYQDSSVPSTIRVTYDLEDDNLLKVQVDN-------KVCFQTRKV  193 (256)
T ss_dssp             TT---CSEEEEEEEESSSCCCGGGHHHHCSEEEECCCTTCSSCEEEEEEEEGGGTSEEEEEETT-------EEEEEESCE
T ss_pred             CC---CceEEEEECCCceecccCCCcccceecceeecccCCCcEEEEEEEecCCCcEEEEEEcC-------EEEEEECcE
Confidence            73   232      56888887763322211           223579999 778889999863       113333333


Q ss_pred             cchhccccce-eeeeecCCC---ccceeeeeeecccccc
Q 007869          146 DLSSVLNDAM-YVGFSSSTG---SVLASHYILGWSFKIN  180 (586)
Q Consensus       146 dL~~~l~~~~-~vGFsastg---~~~~~~~i~~Wsf~~~  180 (586)
                          .||+++ |+||||+||   ...+.|.|++|+|...
T Consensus       194 ----~LP~~~~~~GfSAaTG~~~~~~d~hdIls~~~~~~  228 (256)
T 2a6y_A          194 ----RFPSGSYRIGVTAQNGAVNNNAESFEIFKMQFFNG  228 (256)
T ss_dssp             ----ECCSEEEEEEEEEECCSGGGCCCEEEEEEEEEEES
T ss_pred             ----EeCCCCeEEEEEEeCCCCCCCcceEEEEEEEEEec
Confidence                378887 699999999   7789999999999873

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.66  E-value=9.8e-17  Score=166.83  Aligned_cols=142  Identities=10%  Similarity=-0.005  Sum_probs=97.3

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccc--------------hhHHHHHHHHHHhcccCCCceeeeeee
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR--------------QGMKEFVAEIVSIGRLRHRNLVQLLGY  326 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~--------------~~~~~~~~Ei~~l~~l~H~niv~l~~~  326 (586)
                      .-|++.+.||+|++|.||+|... +|..||||+++....              ........++++.....|+|+.+++..
T Consensus        95 ~iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~  173 (397)
T 4gyi_A           95 DVYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEE  173 (397)
T ss_dssp             SCSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred             CEEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhc
Confidence            34889999999999999999985 578899998753210              001122222222222334444433321


Q ss_pred             eec------cCeEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCC
Q 007869          327 CRR------KGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGEL  400 (586)
Q Consensus       327 ~~~------~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~  400 (586)
                      ...      ....+|||||+++++|.++...        .....++.|++.+|.|||+   .+||||||||.|||+++++
T Consensus       174 gv~vp~p~~~~~~~LVME~i~G~~L~~l~~~--------~~~~~l~~qll~~l~~lH~---~gIVHrDLKp~NILl~~dg  242 (397)
T 4gyi_A          174 GFPVPEPIAQSRHTIVMSLVDALPMRQVSSV--------PDPASLYADLIALILRLAK---HGLIHGDFNEFNILIREEK  242 (397)
T ss_dssp             TCSCCCEEEEETTEEEEECCSCEEGGGCCCC--------SCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEEEEE
T ss_pred             CCCCCeeeeccCceEEEEecCCccHhhhccc--------HHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeCCC
Confidence            111      1123799999999888765421        1234678999999999998   8999999999999998776


Q ss_pred             ----------CeEEccccceeecc
Q 007869          401 ----------NGRLGDFGLARLYD  414 (586)
Q Consensus       401 ----------~~kL~DFGla~~~~  414 (586)
                                .+.|+||+-+....
T Consensus       243 d~~d~~~~~~~~~iID~~Q~V~~~  266 (397)
T 4gyi_A          243 DAEDPSSITLTPIIIXFPQMVSMD  266 (397)
T ss_dssp             CSSCTTSEEEEEEECCCTTCEETT
T ss_pred             CcccccccccceEEEEeCCcccCC
Confidence                      38999999877544

>1qmo_A Mannose binding lectin, FRIL; crosslink, hematopoietic progenitor, sugar complex; HET: MAN; 3.5A {Dolichos lab lab} SCOP: b.29.1.1

Probab=99.64  E-value=2.4e-16  Score=134.37  Aligned_cols=58  Identities=31%  Similarity=0.525  Sum_probs=53.1

Q ss_pred             CcccCCCCCCCCCCeeeeeEEEEEEEEEeCCCCCCCCcEEEEEecCCCCCCCCCCCcccccccC
Q 007869            2 PFKNKNSNSSTANGTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGLFNDT   65 (586)
Q Consensus         2 p~~~~~~~~~~~~~~~asF~t~F~f~i~~~~~~~~g~GlaF~l~p~~~~~~~~~g~~lGl~~~~   65 (586)
                      ||++||+ +    |+||||+|+|+|.|.+.+...+||||||+|+|....|. ++|+||||||.+
T Consensus        55 Pv~l~d~-t----g~vaSFsT~F~F~I~~~~~~~~gdGlAF~lap~~~~p~-s~g~~LGL~n~~  112 (113)
T 1qmo_A           55 PLRLWED-S----AVLTSFDTIINFEISTPYTSRIADGLAFFIAPPDSVIS-YHGGFLGLFPNA  112 (113)
T ss_dssp             CEECCCT-T----EEEEEEEEEEEEEEECSSSSCCCCEEEEEEECTTCCCC-CCGGGTTTCSSC
T ss_pred             CEEeeCC-C----CCEEeeEEEEEEEEecCCCCCCCCeEEEEecCCCCCCC-CCccccccccCC
Confidence            8999998 8    99999999999999988777899999999999877777 899999999864

>2ltn_B PEA lectin, beta chain; 1.70A {Pisum sativum} SCOP: b.29.1.1 PDB: 1hkd_B 1rin_B* 1ofs_B* 1bqp_B* 1loe_B 1loa_B* 1loc_B* 1lod_B* 1lob_B 1lof_B* 1log_B* 1lof_D* 1les_B* 2b7y_B* 1lgc_B* 1lgb_B* 1len_B 1lem_B 2lal_B

Probab=99.49  E-value=6.8e-15  Score=105.99  Aligned_cols=43  Identities=35%  Similarity=0.545  Sum_probs=41.2

Q ss_pred             ceeeeeecchhccccceeeeeecCCCccceeeeeeeccccccC
Q 007869          139 NTMSLSRDLSSVLNDAMYVGFSSSTGSVLASHYILGWSFKING  181 (586)
Q Consensus       139 ~~ls~~~dL~~~l~~~~~vGFsastg~~~~~~~i~~Wsf~~~~  181 (586)
                      |+|++.+||+++|+|+|||||||+||...|.|+|++|+|++++
T Consensus         4 p~ls~~vdLs~~l~e~v~VGFSAsTG~~~~~h~IlsWsF~s~~   46 (52)
T 2ltn_B            4 YTLSDVVSLKDVVPEWVRIGFSATTGAEYAAHEVLSWSFHSEL   46 (52)
T ss_dssp             EEEEEECCHHHHSCSEEEEEEEEECCSSCCEEEEEEEEEEEEE
T ss_pred             eeEEEEEcHHHhcCceEEEEEEeccCCcceeEEEEEeEEEeec
Confidence            8999999999999999999999999999999999999998764

>1nls_A Concanavalin A; lectin, agglutinin; 0.94A {Canavalia ensiformis} SCOP: b.29.1.1 PDB: 1bxh_A* 1apn_A 1ces_A 1cjp_A* 1c57_A 1cvn_A* 1con_A 1dq1_A 1dq2_A 1dq4_A 1dq5_A 1dq6_A 1enq_A 1enr_A 1ens_A 1gic_A* 1dq0_A 1hqw_A 1gkb_A* 1i3h_A ...

Probab=99.43  E-value=8.7e-14  Score=134.43  Aligned_cols=58  Identities=40%  Similarity=0.617  Sum_probs=52.1

Q ss_pred             CcccCCCCCCCCCCeeeeeEEEEEEEEEeCCCCCCCCcEEEEEecCC-CCCCCCCCCcccccccC
Q 007869            2 PFKNKNSNSSTANGTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTR-GLPGARPSQYLGLFNDT   65 (586)
Q Consensus         2 p~~~~~~~~~~~~~~~asF~t~F~f~i~~~~~~~~g~GlaF~l~p~~-~~~~~~~g~~lGl~~~~   65 (586)
                      ||+||+. +    +++|||+|+|+|.|.+. ...+||||||||+|.. .+|.+++||||||||.+
T Consensus       178 Pv~lwd~-~----~~vaSFsT~F~F~I~~~-~~~~g~GlAF~lap~~~~~p~~~~g~~LGL~n~~  236 (237)
T 1nls_A          178 PVHIWES-S----AVVASFEATFTFLIKSP-DSHPADGIAFFISNIDSSIPSGSTGRLLGLFPDA  236 (237)
T ss_dssp             CEECCCT-T----EEEEEEEEEEEEECCCS-SSSCCCEEEEEEECTTCCCCTTCCGGGTTTCSSC
T ss_pred             CEEeecC-C----CCEeeeEEEEEEEEecC-CCCCCccEEEEECCCCCCCCCCCCcCeeccccCC
Confidence            8999986 6    89999999999999876 4568999999999977 58989999999999975

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.32  E-value=6.2e-12  Score=124.57  Aligned_cols=144  Identities=15%  Similarity=0.056  Sum_probs=112.8

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccC-CCceeeeeeeeeccCeEEEEEe
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLR-HRNLVQLLGYCRRKGELLLVYD  338 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~~~~~~~~~~~lV~E  338 (586)
                      -.+|+....++.|+.+.||++...  +..+++|+...........+.+|+.+++.+. +..+.++++++...+..++|||
T Consensus        13 l~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e   90 (263)
T 3tm0_A           13 IEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS   90 (263)
T ss_dssp             HTTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred             hccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEE
Confidence            346778888898999999999864  4679999987532222346888999999884 6778899999998889999999


Q ss_pred             cCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcc---------------------------------------
Q 007869          339 YMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQE---------------------------------------  379 (586)
Q Consensus       339 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~---------------------------------------  379 (586)
                      |++|.+|.+.+..       ......++.+++++|..||+.                                       
T Consensus        91 ~i~G~~l~~~~~~-------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (263)
T 3tm0_A           91 EADGVLCSEEYED-------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTP  163 (263)
T ss_dssp             CCSSEEHHHHCCT-------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCS
T ss_pred             ecCCeehhhccCC-------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccccc
Confidence            9999999876421       123346789999999999971                                       


Q ss_pred             -----------------cCCcEEeCCCCCCCeeecCCCCeEEccccceee
Q 007869          380 -----------------WEQVVIHRDVKASNVLLDGELNGRLGDFGLARL  412 (586)
Q Consensus       380 -----------------~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~  412 (586)
                                       ....++|+|+++.|||++++..+.|+||+.+..
T Consensus       164 ~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          164 FKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             SSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             CCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                             015599999999999998765567999987754

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.20  E-value=3.8e-11  Score=118.17  Aligned_cols=139  Identities=17%  Similarity=0.123  Sum_probs=100.6

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCc--eeeeeeeeeccCeEEEEE
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRN--LVQLLGYCRRKGELLLVY  337 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~n--iv~l~~~~~~~~~~~lV~  337 (586)
                      ..++....+.+.|..+.||++... ++..+++|.....   ....+..|+.+++.+.+.+  +.+++++....+..++||
T Consensus        19 ~~~~~~~~~~~gg~~~~v~~~~~~-~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~   94 (264)
T 1nd4_A           19 LFGYDWAQQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLL   94 (264)
T ss_dssp             TTTCEEEECSCTTSSCEEEEEECT-TSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEE
T ss_pred             cCCCceEecccCCCCceEEEEecC-CCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEE
Confidence            344554443345566999999763 4567999997654   2245778999998886544  556888888888899999


Q ss_pred             ecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhccc-------------------------------------
Q 007869          338 DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEW-------------------------------------  380 (586)
Q Consensus       338 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~-------------------------------------  380 (586)
                      ||++|.+|.  ...     .   ....++.++++.|..||+..                                     
T Consensus        95 e~i~G~~l~--~~~-----~---~~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (264)
T 1nd4_A           95 GEVPGQDLL--SSH-----L---APAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG  164 (264)
T ss_dssp             ECCSSEETT--TSC-----C---CHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred             EecCCcccC--cCc-----C---CHhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccC
Confidence            999998884  211     1   12356778888888888631                                     


Q ss_pred             ------------------CCcEEeCCCCCCCeeecCCCCeEEccccceee
Q 007869          381 ------------------EQVVIHRDVKASNVLLDGELNGRLGDFGLARL  412 (586)
Q Consensus       381 ------------------~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~  412 (586)
                                        ...++|+|++|.|||++++..+.|+||+.+..
T Consensus       165 ~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          165 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             ccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                              12399999999999998776677999998764

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.04  E-value=7.2e-10  Score=115.02  Aligned_cols=142  Identities=11%  Similarity=0.163  Sum_probs=106.7

Q ss_pred             cceeEeecCceEEEEEEeCCCCeEEEEEEec--ccc-chhHHHHHHHHHHhcccC--CCceeeeeeeeecc---CeEEEE
Q 007869          265 EKELLGTGGFGRVYRGTLPKSQIEIAVKKIS--HES-RQGMKEFVAEIVSIGRLR--HRNLVQLLGYCRRK---GELLLV  336 (586)
Q Consensus       265 ~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~--~~~-~~~~~~~~~Ei~~l~~l~--H~niv~l~~~~~~~---~~~~lV  336 (586)
                      ..+.|+.|.++.||+....+  ..+++|+..  ... ......+.+|+.+++.+.  +..+++++.++.+.   +..++|
T Consensus        42 ~~~~l~~G~sn~~y~v~~~~--~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v  119 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTPG--QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI  119 (359)
T ss_dssp             EEEECCC-CCSCEEEEECSS--CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred             eEEEcCCcccceEEEEEECC--ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence            35678999999999998753  468888876  322 122356788999999886  45688899988776   458999


Q ss_pred             EecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhccc------------------------------------
Q 007869          337 YDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEW------------------------------------  380 (586)
Q Consensus       337 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~------------------------------------  380 (586)
                      |||+++..+.+...    ..++..++..++.++++.|..||+..                                    
T Consensus       120 me~v~G~~l~~~~~----~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (359)
T 3dxp_A          120 MEFVSGRVLWDQSL----PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP  195 (359)
T ss_dssp             EECCCCBCCCCTTC----TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred             EEecCCeecCCCcc----ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence            99999988854221    23567788889999999999999720                                    


Q ss_pred             -------------------CCcEEeCCCCCCCeeecCCCC--eEEccccceee
Q 007869          381 -------------------EQVVIHRDVKASNVLLDGELN--GRLGDFGLARL  412 (586)
Q Consensus       381 -------------------~~~ivHrDIkp~NIll~~~~~--~kL~DFGla~~  412 (586)
                                         ...++|+|+++.|||++.++.  +.|+||+.+..
T Consensus       196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                               257999999999999987653  68999999875

>2a6z_A EMP47P (FORM2); beta sandwich, carbohydrate binding protein, cargo receptor, structural genomics, NPPSFA; 1.00A {Saccharomyces cerevisiae} SCOP: b.29.1.13 PDB: 2a70_A 2a71_A

Probab=98.97  E-value=6.3e-10  Score=106.86  Aligned_cols=135  Identities=17%  Similarity=0.196  Sum_probs=84.4

Q ss_pred             eeeEEEEEEEEEeCCCCCCCCcEEEEEecCCCCCCCCCCCcccccccCCCCCCCccEEEEEeeccccCCCCCCCCCeeEE
Q 007869           18 FSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGLFNDTNLGNETNHVFAVELDTIKSHGFLDINDNHVGI   97 (586)
Q Consensus        18 asF~t~F~f~i~~~~~~~~g~GlaF~l~p~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEfDt~~~~~~~d~~~~hvgi   97 (586)
                      .+|+++|+|+|.... ..+||||||.+++....+  ..|..+|.-+      .-+. +||+|||+.|.      .++|.+
T Consensus        61 ~~weie~~Fri~g~~-~~~gdGlA~W~t~~~~~~--~~g~~~G~~~------~f~G-L~I~~Dt~~n~------~p~i~~  124 (222)
T 2a6z_A           61 DSFTMEWTFRSVGYS-GQTDGGISFWFVQDSNIP--RDKQLYNGPV------NYDG-LQLLVDNNGPL------GPTLRG  124 (222)
T ss_dssp             SCEEEEEEEEEESCC-SCCSCEEEEEEEECSSSC--CCCTBTTBCT------TCEE-EEEEEESCSTT------SSEEEE
T ss_pred             CCEEEEEEEEEeCCC-CCCCCEEEEEEECCCccc--CCCcccCCCC------CCCE-EEEEEECCCCC------CceEEE
Confidence            479999999998653 348999999999764311  2344444421      1122 69999998762      234443


Q ss_pred             eCCCCc-c----------ccc---------ccCceEEEEc-CeeeEEEEEEeecCCCCCCccceeeeeecchhccccc-e
Q 007869           98 DINSLK-S----------ESS---------APAGYYVEYD-GLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSVLNDA-M  155 (586)
Q Consensus        98 dvns~~-s----------~~~---------~~~~~~i~y~-~~~~~l~v~~~~~~~~~~~~~~~ls~~~dL~~~l~~~-~  155 (586)
                      .+|.-. +          ...         .+...+|.|+ .....|.|.+..       ..|.-...|+    ||+. .
T Consensus       125 ~~ndG~~~yd~~~~~~~~~~~C~~~~rn~~~~~~~rI~Y~~~~~~~l~v~id~-------~~C~~~~~v~----LP~~~~  193 (222)
T 2a6z_A          125 QLNDGQKPVDKTKIYDQSFASCLMGYQDSSVPSTIRVTYDLEDDNLLKVQVDN-------KVCFQTRKVR----FPSGSY  193 (222)
T ss_dssp             EEEESSSCCCGGGHHHHCSEEEECCCTTEEEEEEEEEEEEGGGTSEEEEEETT-------EEEEEESCCC----CCSSEE
T ss_pred             EECCCCeeeccCCCccccccccceeccCCCCcEEEEEEEEcCCCcEEEEEEcC-------eEEEEeCCee----cCCCCc
Confidence            332211 0          000         0112458997 556678887752       2254444555    4555 4


Q ss_pred             eeeeecCCC---ccceeeeeeeccccc
Q 007869          156 YVGFSSSTG---SVLASHYILGWSFKI  179 (586)
Q Consensus       156 ~vGFsastg---~~~~~~~i~~Wsf~~  179 (586)
                      |+||||+||   ...+.|.|++|++..
T Consensus       194 y~G~SA~TG~l~~~~d~hdil~~~~~~  220 (222)
T 2a6z_A          194 RIGVTAQNGAVNNNAESFEIFKMQFFN  220 (222)
T ss_dssp             EEEEEEECCSGGGCCCEEEEEEEEEEE
T ss_pred             EEEEEEcCCCCCCCCccEEEEEEEEEc
Confidence            799999999   778999999998763

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.90  E-value=4e-10  Score=114.24  Aligned_cols=184  Identities=17%  Similarity=0.183  Sum_probs=121.4

Q ss_pred             ceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccC-CCc--eeeeeeeeeccC---eEEEEEec
Q 007869          266 KELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLR-HRN--LVQLLGYCRRKG---ELLLVYDY  339 (586)
Q Consensus       266 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H~n--iv~l~~~~~~~~---~~~lV~E~  339 (586)
                      .+.++.|....||+..     ..+++|+....  .....+.+|...|+.+. +..  +.+++......+   ..++|||+
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~   97 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTK   97 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEEC
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcc
Confidence            4569999999999863     35889986533  34567889999998883 322  445555544333   35889999


Q ss_pred             CCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcc----------------------------------------
Q 007869          340 MPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQE----------------------------------------  379 (586)
Q Consensus       340 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~----------------------------------------  379 (586)
                      ++|.+|.+....    .++..++..++.++++.|..||+.                                        
T Consensus        98 i~G~~l~~~~~~----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  173 (304)
T 3sg8_A           98 IKGVPLTPLLLN----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV  173 (304)
T ss_dssp             CCCEECCHHHHH----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred             cCCeECCccccc----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence            999888754322    355566777788888888888851                                        


Q ss_pred             ---------------cCCcEEeCCCCCCCeeecC--CCCeEEccccceeeccCCCCCceeeeccCCCc---cCcccccC-
Q 007869          380 ---------------WEQVVIHRDVKASNVLLDG--ELNGRLGDFGLARLYDHGTDPQTTHVVGTLGY---LAPEHTRT-  438 (586)
Q Consensus       380 ---------------~~~~ivHrDIkp~NIll~~--~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y---~aPE~~~~-  438 (586)
                                     ....++|+|+++.||++++  ...+.|+||+.+..-....+     ......+   ..|+.... 
T Consensus       174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D-----l~~~~~~~~~~~~~~~~~~  248 (304)
T 3sg8_A          174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND-----FISLMEDDEEYGMEFVSKI  248 (304)
T ss_dssp             HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH-----HHTTCCTTTSCCHHHHHHH
T ss_pred             HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH-----HHHHHhhccccCHHHHHHH
Confidence                           1246899999999999998  45678999999876432110     0011111   22221110 


Q ss_pred             ----CC---------CCCcceEEehhHHHHHHHhCCCCCC
Q 007869          439 ----GK---------ATTSADVFSFGAFLLEVACGRRPIQ  465 (586)
Q Consensus       439 ----~~---------~s~ksDVyS~Gvvl~ElltG~~p~~  465 (586)
                          +.         .....+.|+++.++|++.+|+.++.
T Consensus       249 l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~  288 (304)
T 3sg8_A          249 LNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY  288 (304)
T ss_dssp             HHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred             HHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence                00         1122588999999999999987753

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.59  E-value=4.2e-07  Score=89.92  Aligned_cols=136  Identities=19%  Similarity=0.157  Sum_probs=99.6

Q ss_pred             eEeecCce-EEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccC-CCceeeeeeeeeccCeEEEEEecCCCCCh
Q 007869          268 LLGTGGFG-RVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLR-HRNLVQLLGYCRRKGELLLVYDYMPNGSL  345 (586)
Q Consensus       268 ~LG~G~~g-~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~~~~~~~~~~~lV~E~~~~gsL  345 (586)
                      .+..|..| .||+.....++..+.+|+-...   ...++..|...|+.+. +--+.++++++...+..++|||++++.++
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~  107 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTA  107 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEH
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccc
Confidence            45556655 6999888777777999987543   3456788999888874 33367889999988999999999999888


Q ss_pred             hhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcc----------------------------------------------
Q 007869          346 DKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQE----------------------------------------------  379 (586)
Q Consensus       346 ~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~----------------------------------------------  379 (586)
                      .+.....      ......+..++++.|..||+.                                              
T Consensus       108 ~~~~~~~------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  181 (272)
T 4gkh_A          108 FQVLEEY------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK  181 (272)
T ss_dssp             HHHHHHC------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred             cccccCC------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence            7765332      122334566677777777731                                              


Q ss_pred             ---------cCCcEEeCCCCCCCeeecCCCCeEEccccceee
Q 007869          380 ---------WEQVVIHRDVKASNVLLDGELNGRLGDFGLARL  412 (586)
Q Consensus       380 ---------~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~  412 (586)
                               ....++|+|+++.|||++++..+-|+||+.+..
T Consensus       182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                     012489999999999999877677999998764

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.49  E-value=1.1e-06  Score=88.90  Aligned_cols=136  Identities=20%  Similarity=0.118  Sum_probs=92.9

Q ss_pred             ceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCC---ceeeeeeeee-ccCeEEEEEecCC
Q 007869          266 KELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHR---NLVQLLGYCR-RKGELLLVYDYMP  341 (586)
Q Consensus       266 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~---niv~l~~~~~-~~~~~~lV~E~~~  341 (586)
                      .+.++.|....||+.     +..+++|+...  ......+..|..+|..+.+.   .+.+.+.++. ..+..++||||++
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~   96 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ   96 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence            456889999999988     34588888532  23456789999999999653   3566677764 4556789999999


Q ss_pred             CCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcc------------------------------------------
Q 007869          342 NGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQE------------------------------------------  379 (586)
Q Consensus       342 ~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~------------------------------------------  379 (586)
                      |..|.+....    .++..++..++.++++.|..||+.                                          
T Consensus        97 G~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l  172 (306)
T 3tdw_A           97 GQILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL  172 (306)
T ss_dssp             SEECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred             CeECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence            9888763211    122333444444444444444431                                          


Q ss_pred             ---------------cCCcEEeCCCCCCCeeecC---CCC-eEEccccceee
Q 007869          380 ---------------WEQVVIHRDVKASNVLLDG---ELN-GRLGDFGLARL  412 (586)
Q Consensus       380 ---------------~~~~ivHrDIkp~NIll~~---~~~-~kL~DFGla~~  412 (586)
                                     ....++|+|+++.|||++.   ++. +.|+||+.+..
T Consensus       173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                           2346899999999999987   455 48999998765

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.26  E-value=2.1e-06  Score=88.47  Aligned_cols=82  Identities=10%  Similarity=-0.010  Sum_probs=56.4

Q ss_pred             ceeE-eecCceEEEEEEeC---C---CCeEEEEEEecccc---chhHHHHHHHHHHhcccCC---Cceeeeeeeeecc--
Q 007869          266 KELL-GTGGFGRVYRGTLP---K---SQIEIAVKKISHES---RQGMKEFVAEIVSIGRLRH---RNLVQLLGYCRRK--  330 (586)
Q Consensus       266 ~~~L-G~G~~g~Vy~~~~~---~---~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H---~niv~l~~~~~~~--  330 (586)
                      .+.| +.|....+|+....   +   ++..+++|+.....   ......+..|+.+++.+..   -.+.+++.++...  
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            4667 88889999998763   1   14578888865432   1012456788888888743   3467788887665  


Q ss_pred             -CeEEEEEecCCCCChhh
Q 007869          331 -GELLLVYDYMPNGSLDK  347 (586)
Q Consensus       331 -~~~~lV~E~~~~gsL~~  347 (586)
                       +..++||||++|..+.+
T Consensus       105 ~g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             TSSCEEEEECCCCBCCCB
T ss_pred             cCCceEEEEecCCCChhh
Confidence             45789999999877654

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.12  E-value=8.9e-06  Score=85.20  Aligned_cols=76  Identities=9%  Similarity=0.062  Sum_probs=49.2

Q ss_pred             ceeEeecCceEEEEEEeCCCCeEEEEEEeccccc-------hhHHHHHHHHHHhcccCC--Cc-eeeeeeeeeccCeEEE
Q 007869          266 KELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR-------QGMKEFVAEIVSIGRLRH--RN-LVQLLGYCRRKGELLL  335 (586)
Q Consensus       266 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~Ei~~l~~l~H--~n-iv~l~~~~~~~~~~~l  335 (586)
                      .+.||.|..+.||++....++..++||......+       ...+.+..|.+++..+..  +. +.+++.+.  .+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CCccEE
Confidence            4679999999999998765567899998653221       123456778888887732  33 44555443  344689


Q ss_pred             EEecCCCC
Q 007869          336 VYDYMPNG  343 (586)
Q Consensus       336 V~E~~~~g  343 (586)
                      ||||+++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999764

>2a6v_A EMP46P; beta sandwich, carbohydrate binding protein, cargo receptor, structural genomics, NPPSFA; 1.52A {Saccharomyces cerevisiae} SCOP: b.29.1.13 PDB: 2a6w_A 2a6x_A

Probab=98.05  E-value=4.8e-05  Score=72.63  Aligned_cols=136  Identities=13%  Similarity=0.125  Sum_probs=77.2

Q ss_pred             eeeEEEEEEEEEeCCCCCCCCcEEEEEecCCCCCCCCCCCcccccccCCCCCCCccEEEEEeeccccCCCCCCCCCeeEE
Q 007869           18 FSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGLFNDTNLGNETNHVFAVELDTIKSHGFLDINDNHVGI   97 (586)
Q Consensus        18 asF~t~F~f~i~~~~~~~~g~GlaF~l~p~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEfDt~~~~~~~d~~~~hvgi   97 (586)
                      .+|+.+|+|+|..... .+||||||-++.....   ..|...|-..     +.-+. +||.|||+.|.      ...|-+
T Consensus        64 ~~weiev~Fri~G~~~-~~gdGlA~Wyt~~~~~---~~g~vfGg~~-----d~f~G-lgI~~Dt~~n~------~p~i~~  127 (226)
T 2a6v_A           64 DAMTIEWTFRSFGFRG-STKGGLAFWLKQGNEG---DSTELFGGSS-----KKFNG-LMILLRLDDKL------GESVTA  127 (226)
T ss_dssp             SCEEEEEEEEEESCCS-CCSCEEEEEEECSCCC---CCCTBTTTBC-----SSCEE-EEEEEEEETTT------EEEEEE
T ss_pred             CCeEEEEEEEEecCCC-CCCCEEEEEEECCCCC---CCcccccccC-----CCccE-EEEEEECCCCC------CceEEE
Confidence            4699999999986533 3799999999954321   1232222100     01112 68999998652      111211


Q ss_pred             eCC-CCcccc---c--------------ccCceEEEEc-CeeeEEEEEEeecCCCCCCccceeeeeecchhccccceeee
Q 007869           98 DIN-SLKSES---S--------------APAGYYVEYD-GLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSVLNDAMYVG  158 (586)
Q Consensus        98 dvn-s~~s~~---~--------------~~~~~~i~y~-~~~~~l~v~~~~~~~~~~~~~~~ls~~~dL~~~l~~~~~vG  158 (586)
                      -+| +-.+-.   .              .+....|.|. ...+.|.|.+..       +.|.-...|+|...  ...|+|
T Consensus       128 ~~NDGt~~yd~~~~~~~g~C~~~~rn~~~~t~~ri~Y~~~~~~~l~v~id~-------~~Cf~~~~v~LP~g--~~~yfG  198 (226)
T 2a6v_A          128 YLNDGTKDLDIESSPYFASCLFQYQDSMVPSTLRLTYNPLDNHLLKLQMDN-------RVCFQTRKVKFMGS--SPFRIG  198 (226)
T ss_dssp             EEEESSSCCCTTTSCCSEEEECCCSSCSSCEEEEEEEEGGGTSEEEEEETT-------EEEEEESCCCGGGT--SCBEEE
T ss_pred             EECCCCcccCCCCCcccceEeEeccCCCCCEEEEEEEEccCCCEEEEEEcC-------CeeEEECCeecCCC--CccEEE
Confidence            111 111100   0              1112348885 335678887752       22443344554421  224999


Q ss_pred             eecCCCccceeeeeeecccc
Q 007869          159 FSSSTGSVLASHYILGWSFK  178 (586)
Q Consensus       159 Fsastg~~~~~~~i~~Wsf~  178 (586)
                      |||+||...+.|.|++-.+.
T Consensus       199 iSAaTg~~~D~hdils~~~~  218 (226)
T 2a6v_A          199 TSAINDASKESFEILKMKLY  218 (226)
T ss_dssp             EEEECCTTCCEEEEEEEEEE
T ss_pred             EEEcCCCCcccEEEEEEEEE
Confidence            99999998899999997654

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.91  E-value=6.9e-05  Score=76.22  Aligned_cols=141  Identities=17%  Similarity=0.231  Sum_probs=80.1

Q ss_pred             ceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCC--Cceeeeee------eeeccCeEEEEE
Q 007869          266 KELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRH--RNLVQLLG------YCRRKGELLLVY  337 (586)
Q Consensus       266 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H--~niv~l~~------~~~~~~~~~lV~  337 (586)
                      .+.|+.|..+.||+....+ + .+++|+.....    ..+..|+.++..|..  -.+.+++.      +....+..+++|
T Consensus        37 ~~~l~gG~~n~~~~v~~~~-~-~~vlk~~~~~~----~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~  110 (346)
T 2q83_A           37 IDVIQGNQMALVWKVHTDS-G-AVCLKRIHRPE----KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVY  110 (346)
T ss_dssp             EEECC----CEEEEEEETT-E-EEEEEEECSCH----HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEE
T ss_pred             eeeccccccCcEEEEEeCC-C-CEEEEecCCCH----HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEE
Confidence            3456667789999998743 3 48899986521    233345555554421  12333333      123456789999


Q ss_pred             ecCCCCChh--------------hhhhcC------CC------ccchhHHHH----------------------------
Q 007869          338 DYMPNGSLD--------------KYLYDQ------PK------VTLNWIQRF----------------------------  363 (586)
Q Consensus       338 E~~~~gsL~--------------~~l~~~------~~------~~l~~~~~~----------------------------  363 (586)
                      ||++|..+.              ..++..      +.      ..-.|...+                            
T Consensus       111 ~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~  190 (346)
T 2q83_A          111 DWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQ  190 (346)
T ss_dssp             ECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHH
T ss_pred             EeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHH
Confidence            999987553              011110      00      001222110                            


Q ss_pred             ---HHHHHHHHHHHHhhc----------ccCCcEEeCCCCCCCeeecCCCCeEEccccceee
Q 007869          364 ---RVIKGVALGLFYLHQ----------EWEQVVIHRDVKASNVLLDGELNGRLGDFGLARL  412 (586)
Q Consensus       364 ---~i~~~ia~~L~yLH~----------~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~  412 (586)
                         .+..++..++.+|+.          .....++|+|+++.|||++.++.+.|+||+.+..
T Consensus       191 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          191 EIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence               111223445666653          1357899999999999998788899999997753

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.78  E-value=0.00014  Score=72.55  Aligned_cols=80  Identities=16%  Similarity=0.187  Sum_probs=57.3

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCC---ceeeeeeeeeccCeEEEEE
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHR---NLVQLLGYCRRKGELLLVY  337 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~---niv~l~~~~~~~~~~~lV~  337 (586)
                      ......+.+|.|..+.||+.+.. +|+.+.+|+...........|..|...|+.|.-.   -+.+++++.    .-++||
T Consensus        15 ~~v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~   89 (288)
T 3f7w_A           15 REVAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAM   89 (288)
T ss_dssp             CCEEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEE
T ss_pred             CCeEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEE
Confidence            34556788999999999999985 4678999987655444445688899988887421   244555543    237899


Q ss_pred             ecCCCCCh
Q 007869          338 DYMPNGSL  345 (586)
Q Consensus       338 E~~~~gsL  345 (586)
                      ||++.+..
T Consensus        90 e~l~~~~~   97 (288)
T 3f7w_A           90 EWVDERPP   97 (288)
T ss_dssp             ECCCCCCC
T ss_pred             EeecccCC
Confidence            99987654

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.75  E-value=0.00022  Score=72.05  Aligned_cols=139  Identities=15%  Similarity=0.121  Sum_probs=92.6

Q ss_pred             ccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccC---CCceeeeeeeeeccCeEEEEEecC
Q 007869          264 REKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLR---HRNLVQLLGYCRRKGELLLVYDYM  340 (586)
Q Consensus       264 ~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~---H~niv~l~~~~~~~~~~~lV~E~~  340 (586)
                      ...+.|+.|....+|+....  +..+++|+....   ....+..|...|+.|.   ...++++++++...+..++||||+
T Consensus        39 ~~~~~l~gG~~n~~y~v~~~--~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l  113 (312)
T 3jr1_A           39 KHKEKLYSGEMNEIWLINDE--VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEAL  113 (312)
T ss_dssp             CEEEEECCSSSSEEEEEESS--SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECC
T ss_pred             eeeEEeCCccceeeeEEEEC--CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEec
Confidence            34567999999999999863  456889987543   2467888998888883   356888999888888899999999


Q ss_pred             CCCChhh-----------hhhcCCC---c-----------------cchhHHHH---HHHH----------------HHH
Q 007869          341 PNGSLDK-----------YLYDQPK---V-----------------TLNWIQRF---RVIK----------------GVA  370 (586)
Q Consensus       341 ~~gsL~~-----------~l~~~~~---~-----------------~l~~~~~~---~i~~----------------~ia  370 (586)
                      ++..+..           .|+....   .                 .-+|...+   ++..                .+.
T Consensus       114 ~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~  193 (312)
T 3jr1_A          114 NKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIV  193 (312)
T ss_dssp             CCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHH
T ss_pred             cCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHH
Confidence            9886531           1222111   0                 11344322   1111                111


Q ss_pred             HHH-HHhhc-ccCCcEEeCCCCCCCeeecCCCCeEEcccc
Q 007869          371 LGL-FYLHQ-EWEQVVIHRDVKASNVLLDGELNGRLGDFG  408 (586)
Q Consensus       371 ~~L-~yLH~-~~~~~ivHrDIkp~NIll~~~~~~kL~DFG  408 (586)
                      +.+ ..|.. .....++|+|+.+.|++++.++ +.|.|+.
T Consensus       194 ~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          194 QIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            111 23321 2247899999999999999887 8899973

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.63  E-value=0.00021  Score=75.28  Aligned_cols=79  Identities=14%  Similarity=0.068  Sum_probs=46.9

Q ss_pred             CCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCCceeeeccCCCccCcccccCC---CCCCcceEEehhHHHHHH
Q 007869          381 EQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTG---KATTSADVFSFGAFLLEV  457 (586)
Q Consensus       381 ~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~s~ksDVyS~Gvvl~El  457 (586)
                      ...++|+|+++.|||++.++ ++|+||+.+..-....+.......-...|.+|+.....   ......++......+|+.
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL  309 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence            47899999999999998776 99999998875321111000000001345666554311   111234555777777777


Q ss_pred             HhC
Q 007869          458 ACG  460 (586)
Q Consensus       458 ltG  460 (586)
                      +++
T Consensus       310 y~~  312 (420)
T 2pyw_A          310 FNK  312 (420)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            655

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.44  E-value=0.00041  Score=73.42  Aligned_cols=74  Identities=19%  Similarity=0.225  Sum_probs=50.1

Q ss_pred             ceeEeecCceEEEEEEeCC-------CCeEEEEEEeccccchhHHHHHHHHHHhcccCCCce-eeeeeeeeccCeEEEEE
Q 007869          266 KELLGTGGFGRVYRGTLPK-------SQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNL-VQLLGYCRRKGELLLVY  337 (586)
Q Consensus       266 ~~~LG~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~~~~~~~~~~~lV~  337 (586)
                      .+.|+.|-...+|++...+       .+..+.+|+.....  ....+..|..++..+...++ .++++.+..    .+|+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~  151 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  151 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence            4568888899999998753       24578899884321  11455678888888843333 567766543    3899


Q ss_pred             ecCCCCCh
Q 007869          338 DYMPNGSL  345 (586)
Q Consensus       338 E~~~~gsL  345 (586)
                      ||+++.+|
T Consensus       152 e~l~G~~l  159 (429)
T 1nw1_A          152 EYIPSRPL  159 (429)
T ss_dssp             CCCCEEEC
T ss_pred             EEeCCccc
Confidence            99986554

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.36  E-value=0.0011  Score=66.85  Aligned_cols=143  Identities=15%  Similarity=0.086  Sum_probs=80.0

Q ss_pred             ceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCc--eeeeeee------eeccCeEEEEE
Q 007869          266 KELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRN--LVQLLGY------CRRKGELLLVY  337 (586)
Q Consensus       266 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~n--iv~l~~~------~~~~~~~~lV~  337 (586)
                      .+.|+.|....+|+....+ + .+++|......  ..+.+..|+.++..+...+  +.+++..      ....+..++++
T Consensus        27 ~~~i~~G~~n~~~~v~~~~-g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~  102 (322)
T 2ppq_A           27 YKGIAEGVENSNFLLHTTK-D-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALI  102 (322)
T ss_dssp             EEEECC---EEEEEEEESS-C-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEE
T ss_pred             eeccCCCcccceEEEEeCC-c-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEE
Confidence            4557778889999998743 3 58899886521  1234456777766663222  2333321      12235678999


Q ss_pred             ecCCCCChhh--------------hhhcC------CC----ccchhHHHHHH------------HHHHHHHHHHhhcc--
Q 007869          338 DYMPNGSLDK--------------YLYDQ------PK----VTLNWIQRFRV------------IKGVALGLFYLHQE--  379 (586)
Q Consensus       338 E~~~~gsL~~--------------~l~~~------~~----~~l~~~~~~~i------------~~~ia~~L~yLH~~--  379 (586)
                      ||++|..+..              .++..      +.    ....|...+.-            ...+.+.+.++++.  
T Consensus       103 ~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~  182 (322)
T 2ppq_A          103 SFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWP  182 (322)
T ss_dssp             ECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCC
T ss_pred             EeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCc
Confidence            9998865421              01110      00    01223321110            01134445555432  


Q ss_pred             --cCCcEEeCCCCCCCeeecCCCCeEEccccceee
Q 007869          380 --WEQVVIHRDVKASNVLLDGELNGRLGDFGLARL  412 (586)
Q Consensus       380 --~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~  412 (586)
                        ....++|+|+++.|||++++..+.|+||+.+..
T Consensus       183 ~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          183 KDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             CSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             ccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence              236799999999999999875568999987753

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.31  E-value=0.0012  Score=70.19  Aligned_cols=75  Identities=9%  Similarity=0.053  Sum_probs=48.5

Q ss_pred             ceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCce-eeeeeeeeccCeEEEEEecCCCCC
Q 007869          266 KELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNL-VQLLGYCRRKGELLLVYDYMPNGS  344 (586)
Q Consensus       266 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~~~~~~~~~~~lV~E~~~~gs  344 (586)
                      .+.|+.|-...+|++...+.+..+++|+......... +-..|..++..|...++ .++++.+.  +  .+||||+++.+
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~  187 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII-NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA  187 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS-CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc-CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence            4678889999999998865446788998754322111 12578888888854444 56777663  2  25999998765


Q ss_pred             h
Q 007869          345 L  345 (586)
Q Consensus       345 L  345 (586)
                      |
T Consensus       188 l  188 (458)
T 2qg7_A          188 L  188 (458)
T ss_dssp             C
T ss_pred             C
Confidence            5

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.24  E-value=0.0013  Score=68.20  Aligned_cols=142  Identities=22%  Similarity=0.194  Sum_probs=84.7

Q ss_pred             ceeEeecCceEEEEEEeCC-------CCeEEEEEEeccccchhHHHHHHHHHHhcccC-CCceeeeeeeeeccCeEEEEE
Q 007869          266 KELLGTGGFGRVYRGTLPK-------SQIEIAVKKISHESRQGMKEFVAEIVSIGRLR-HRNLVQLLGYCRRKGELLLVY  337 (586)
Q Consensus       266 ~~~LG~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~~~~~~~~~~~lV~  337 (586)
                      .+.|..|-...+|++....       .+..+.+|+..... .......+|..+++.+. +.-..++++.+..    .+||
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~-~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~  129 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL-QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE  129 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc-chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence            3557778888999998743       34578898864322 23456678998888874 3223567766654    2899


Q ss_pred             ecCCCCChhhh-----------------hhcCC----Cccc-hhHHHHHHHHHHHH-------------------HHHHh
Q 007869          338 DYMPNGSLDKY-----------------LYDQP----KVTL-NWIQRFRVIKGVAL-------------------GLFYL  376 (586)
Q Consensus       338 E~~~~gsL~~~-----------------l~~~~----~~~l-~~~~~~~i~~~ia~-------------------~L~yL  376 (586)
                      ||++|..|...                 |+...    +... -|.++.++..++..                   .+..|
T Consensus       130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L  209 (379)
T 3feg_A          130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL  209 (379)
T ss_dssp             ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred             EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence            99998665421                 11110    1111 34455555544322                   12333


Q ss_pred             hc-----ccCCcEEeCCCCCCCeeecCC----CCeEEccccceee
Q 007869          377 HQ-----EWEQVVIHRDVKASNVLLDGE----LNGRLGDFGLARL  412 (586)
Q Consensus       377 H~-----~~~~~ivHrDIkp~NIll~~~----~~~kL~DFGla~~  412 (586)
                      .+     .....++|+|+.+.|||++.+    +.+.|+||..+..
T Consensus       210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            21     123579999999999999876    6899999998864

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.21  E-value=0.00095  Score=66.79  Aligned_cols=137  Identities=13%  Similarity=0.043  Sum_probs=75.3

Q ss_pred             ceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCce-eeeeeeeeccCeEEEEEecC-CCC
Q 007869          266 KELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNL-VQLLGYCRRKGELLLVYDYM-PNG  343 (586)
Q Consensus       266 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~~~~~~~~~~~lV~E~~-~~g  343 (586)
                      .+.|+.|....+|+.      ..+++|+........ ....+|+..++.+...++ .++++++.+  .-++++||+ ++.
T Consensus        23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~~~~--~~~~v~e~i~~g~   93 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHVDPA--TGVMVTRYIAGAQ   93 (301)
T ss_dssp             CEEEESCSSEEEEEE------TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEECTT--TCCEEEECCTTCE
T ss_pred             eeEcCCcccccccee------eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEEECC--CCEEEEeecCCCc
Confidence            678999999999998      348888876532211 123457777766643222 456655433  346899999 665


Q ss_pred             Chhhh------------------hhcCCC-c--cc-hhHHHHHHHH--------------HHHHHHHH----hh-cccCC
Q 007869          344 SLDKY------------------LYDQPK-V--TL-NWIQRFRVIK--------------GVALGLFY----LH-QEWEQ  382 (586)
Q Consensus       344 sL~~~------------------l~~~~~-~--~l-~~~~~~~i~~--------------~ia~~L~y----LH-~~~~~  382 (586)
                      +|...                  ++..+. .  .. .+.....+..              .+.+.+..    |. .....
T Consensus        94 ~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~  173 (301)
T 3dxq_A           94 TMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPL  173 (301)
T ss_dssp             ECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCC
T ss_pred             cCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCc
Confidence            55321                  111110 0  00 0111111100              01111111    11 11235


Q ss_pred             cEEeCCCCCCCeeecCCCCeEEccccceee
Q 007869          383 VVIHRDVKASNVLLDGELNGRLGDFGLARL  412 (586)
Q Consensus       383 ~ivHrDIkp~NIll~~~~~~kL~DFGla~~  412 (586)
                      .++|+|+.+.||+ ..++.+.|+||..+..
T Consensus       174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          174 AACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            6999999999999 5667889999998865

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.10  E-value=0.0025  Score=64.58  Aligned_cols=32  Identities=38%  Similarity=0.436  Sum_probs=28.1

Q ss_pred             CCcEEeCCCCCCCeeecCC----CCeEEccccceee
Q 007869          381 EQVVIHRDVKASNVLLDGE----LNGRLGDFGLARL  412 (586)
Q Consensus       381 ~~~ivHrDIkp~NIll~~~----~~~kL~DFGla~~  412 (586)
                      ...++|+|+.+.|||++.+    ..+.|+||+.+..
T Consensus       182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            4689999999999999874    6789999998875

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.97  E-value=0.0023  Score=65.88  Aligned_cols=75  Identities=9%  Similarity=0.113  Sum_probs=44.0

Q ss_pred             ceeEeecCceEEEEEEeCCC--------CeEEEEEEeccccchhHHHHHHHHHHhcccCCCc-eeeeeeeeeccCeEEEE
Q 007869          266 KELLGTGGFGRVYRGTLPKS--------QIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRN-LVQLLGYCRRKGELLLV  336 (586)
Q Consensus       266 ~~~LG~G~~g~Vy~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~n-iv~l~~~~~~~~~~~lV  336 (586)
                      .+.|+.|....+|+....++        +..+++|+....... ..+...|..+++.+...+ ..++++..  .  -++|
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v  112 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE-LYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI  112 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG-TSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc-eecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence            35577888889999987531        256888887543222 112356777777774333 34566544  2  2689


Q ss_pred             EecCCCCCh
Q 007869          337 YDYMPNGSL  345 (586)
Q Consensus       337 ~E~~~~gsL  345 (586)
                      |||+++..+
T Consensus       113 ~e~i~G~~l  121 (369)
T 3c5i_A          113 EEWLYGDPL  121 (369)
T ss_dssp             EECCCSEEC
T ss_pred             EEEecCCcC
Confidence            999987654

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=96.83  E-value=0.011  Score=59.46  Aligned_cols=141  Identities=15%  Similarity=0.159  Sum_probs=79.5

Q ss_pred             eeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCc--eeeeeee-----eeccCeEEEEEec
Q 007869          267 ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRN--LVQLLGY-----CRRKGELLLVYDY  339 (586)
Q Consensus       267 ~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~n--iv~l~~~-----~~~~~~~~lV~E~  339 (586)
                      ..|+ |....||+.... ++..+++|...... .....+..|...+..+....  +++++..     ....+..+++|||
T Consensus        32 ~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~  108 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDE-DRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPS  108 (328)
T ss_dssp             EEEC-CSSSEEEEECCT-TCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEEC
T ss_pred             Eeec-CcccceEEEEcC-CCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEe
Confidence            4566 888899988764 34568999986431 12345666777777764222  3444432     1224566889999


Q ss_pred             CCCCChhh----h----------hhc----CC---CccchhHHH----------------------HHHHHHHHHHHHHh
Q 007869          340 MPNGSLDK----Y----------LYD----QP---KVTLNWIQR----------------------FRVIKGVALGLFYL  376 (586)
Q Consensus       340 ~~~gsL~~----~----------l~~----~~---~~~l~~~~~----------------------~~i~~~ia~~L~yL  376 (586)
                      ++|..+..    .          ++.    ..   ....++...                      ...+..++..+.-+
T Consensus       109 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~  188 (328)
T 1zyl_A          109 VGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAH  188 (328)
T ss_dssp             CCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHH
T ss_pred             cCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHH
Confidence            98755421    0          111    00   011111110                      01111112222211


Q ss_pred             hc-ccCCcEEeCCCCCCCeeecCCCCeEEccccceee
Q 007869          377 HQ-EWEQVVIHRDVKASNVLLDGELNGRLGDFGLARL  412 (586)
Q Consensus       377 H~-~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~  412 (586)
                      -. .....++|+|+++.|||++ + .+.|+||+.+..
T Consensus       189 ~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          189 WREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             hhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            11 1246799999999999999 4 899999988764

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.38  E-value=0.02  Score=58.27  Aligned_cols=32  Identities=31%  Similarity=0.376  Sum_probs=28.3

Q ss_pred             CCcEEeCCCCCCCeeecCCCCeEEccccceee
Q 007869          381 EQVVIHRDVKASNVLLDGELNGRLGDFGLARL  412 (586)
Q Consensus       381 ~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~  412 (586)
                      ...++|+|+.+.||++++++.+.|+||+.+..
T Consensus       205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            36799999999999999878899999987764

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.30  E-value=0.005  Score=58.00  Aligned_cols=99  Identities=15%  Similarity=0.029  Sum_probs=64.0

Q ss_pred             CChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCCcee
Q 007869          343 GSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTT  422 (586)
Q Consensus       343 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~~~  422 (586)
                      -+|.+.|... ..++++.++|.++.|.+.+|.-+-..  ..-..+=+.|..|++..+|++.+.+ ..+.           
T Consensus        33 vSL~eIL~~~-~~PlsEEqaWALc~Qc~~~L~~~~~~--~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------   97 (229)
T 2yle_A           33 LSLEEILRLY-NQPINEEQAWAVCYQCCGSLRAAARR--RQPRHRVRSAAQIRVWRDGAVTLAP-AADD-----------   97 (229)
T ss_dssp             EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHT--TCCCCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred             ccHHHHHHHc-CCCcCHHHHHHHHHHHHHHHHhhhhc--ccCCceecCCcceEEecCCceeccc-cccc-----------
Confidence            4788888765 35899999999999999998776210  1111233446889999998888764 1110           


Q ss_pred             eeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh
Q 007869          423 HVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC  459 (586)
Q Consensus       423 ~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt  459 (586)
                        .....+.+||... ...+.+.=|||+|++||.-+-
T Consensus        98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD  131 (229)
T 2yle_A           98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD  131 (229)
T ss_dssp             -----------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred             --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence              1123466888763 345678899999999999874

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.73  E-value=0.051  Score=56.99  Aligned_cols=141  Identities=12%  Similarity=0.133  Sum_probs=83.7

Q ss_pred             ceeEeecCceEEEEEEeCCC-------CeEEEEEEeccccchhHHHHHHHHHHhcccCCCc-eeeeeeeeeccCeEEEEE
Q 007869          266 KELLGTGGFGRVYRGTLPKS-------QIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRN-LVQLLGYCRRKGELLLVY  337 (586)
Q Consensus       266 ~~~LG~G~~g~Vy~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~n-iv~l~~~~~~~~~~~lV~  337 (586)
                      .+.|..|-...+|+......       +..+++|+....... .-+-.+|..+++.+.-.+ ..++++.+.  +  ++||
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~-~idR~~E~~~l~~L~~~gi~P~l~~~~~--~--~~I~  149 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGK-FYDSKVELDVFRYLSNINIAPNIIADFP--E--GRIE  149 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-C-CCCHHHHHHHHHHHHHTTSSCCEEEEET--T--EEEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcch-hcCHHHHHHHHHHHHhcCCCCCEEEEcC--C--CEEE
Confidence            45677788889999987531       456888887543322 112356777777774222 345555332  2  7899


Q ss_pred             ecCCCCChhhh-h----------------hc----C-------CCccchhHHHHHHHHHH-------------------H
Q 007869          338 DYMPNGSLDKY-L----------------YD----Q-------PKVTLNWIQRFRVIKGV-------------------A  370 (586)
Q Consensus       338 E~~~~gsL~~~-l----------------~~----~-------~~~~l~~~~~~~i~~~i-------------------a  370 (586)
                      ||++|..|..- +                +.    .       .+.+..|.++.++..++                   .
T Consensus       150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~  229 (424)
T 3mes_A          150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL  229 (424)
T ss_dssp             ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred             EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence            99998764310 0                00    0       11112344444333322                   1


Q ss_pred             HHHHHhhc---------------------ccCCcEEeCCCCCCCeeecCCCCeEEccccceee
Q 007869          371 LGLFYLHQ---------------------EWEQVVIHRDVKASNVLLDGELNGRLGDFGLARL  412 (586)
Q Consensus       371 ~~L~yLH~---------------------~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~  412 (586)
                      ..+..|.+                     .....++|+|+.+.||+ +.++.+.|+||..|..
T Consensus       230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence            22333321                     12356999999999999 7888999999998875

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=94.12  E-value=0.21  Score=51.86  Aligned_cols=30  Identities=30%  Similarity=0.396  Sum_probs=25.5

Q ss_pred             cEEeCCCCCCCeee------cCCCCeEEccccceee
Q 007869          383 VVIHRDVKASNVLL------DGELNGRLGDFGLARL  412 (586)
Q Consensus       383 ~ivHrDIkp~NIll------~~~~~~kL~DFGla~~  412 (586)
                      .++|+|+.+.|||+      +++..++++||..|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            46899999999999      4466799999998865

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=88.49  E-value=0.17  Score=34.47  Aligned_cols=27  Identities=11%  Similarity=0.273  Sum_probs=11.7

Q ss_pred             EehhhHH-HHHHHHHHHHHhhhhhhcch
Q 007869          208 IGLPVIC-VSVIFAAVSGVVYVIRMKRK  234 (586)
Q Consensus       208 i~~~~~~-~~~~~~~~~~~~~~~r~~~~  234 (586)
                      |+..+.+ +++++++++.+++++|+|++
T Consensus        13 IA~gVVgGv~~~~ii~~~~~~~~RRr~~   40 (44)
T 2ks1_B           13 IATGMVGALLLLLVVALGIGLFMRRRHI   40 (44)
T ss_dssp             STHHHHHHHHHHHHHHHHHHHHHHTTTC
T ss_pred             EEeehhHHHHHHHHHHHHHHHHhhhhHh
Confidence            4444433 33333344444555555443

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=86.71  E-value=0.19  Score=34.11  Aligned_cols=20  Identities=10%  Similarity=0.049  Sum_probs=9.1

Q ss_pred             HHHHHHHHHHHhhhhhhcch
Q 007869          215 VSVIFAAVSGVVYVIRMKRK  234 (586)
Q Consensus       215 ~~~~~~~~~~~~~~~r~~~~  234 (586)
                      +++++++++.+++++|+|++
T Consensus        20 v~~v~ii~~~~~~~~RRRr~   39 (44)
T 2l2t_A           20 LFILVIVGLTFAVYVRRKSI   39 (44)
T ss_dssp             HHHHHHHHHHHHHHHHTTCS
T ss_pred             HHHHHHHHHHHHHHhhhhhh
Confidence            33333444444555555543

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=84.69  E-value=0.087  Score=55.95  Aligned_cols=60  Identities=10%  Similarity=0.149  Sum_probs=16.9

Q ss_pred             ceeEeecCceEEEEEEeCCCCeEEEE------EEeccc--cchhHHHHHHHHHHhcccCCCceeeeeeeee
Q 007869          266 KELLGTGGFGRVYRGTLPKSQIEIAV------KKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCR  328 (586)
Q Consensus       266 ~~~LG~G~~g~Vy~~~~~~~~~~vav------K~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~  328 (586)
                      .+.||   ||.||+|.+.....+|||      |.....  ..+....|.+|..++..++|||+++.+++..
T Consensus       147 ~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          147 YEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             TTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred             cccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence            44566   999999999765567888      766542  2334457888999999999999999988754

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=82.97  E-value=2.6  Score=39.39  Aligned_cols=116  Identities=8%  Similarity=0.053  Sum_probs=78.3

Q ss_pred             CCCceeeeeeeeeccCeEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCee
Q 007869          316 RHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVL  395 (586)
Q Consensus       316 ~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIl  395 (586)
                      .||+.++. .+-...+.+.+.|+.-+.+.=...+     ..++...+++++.+|+....+++.     -+|--|+|+||+
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~i-----k~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL~  111 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNI-----KSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDELF  111 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGG-----GGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGEE
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHHH-----HhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceEE
Confidence            68888866 4666677788878765433222223     246677889999999998876664     367789999999


Q ss_pred             ecCCCCeEEccccceeeccCCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCC
Q 007869          396 LDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQ  465 (586)
Q Consensus       396 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~  465 (586)
                      ++.++.+++.-.|+-..+.                  |.-     .++..=.-.+=|++..+++++..|+
T Consensus       112 f~~~~~p~i~~RGik~~l~------------------P~~-----~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          112 FTRDGLPIAKTRGLQNVVD------------------PLP-----VSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             ECTTSCEEESCCEETTTBS------------------CCC-----CCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             EcCCCCEEEEEccCccCCC------------------CCC-----CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            9999999998877643221                  110     1111112245678888999988875

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=81.00  E-value=3.1  Score=39.01  Aligned_cols=83  Identities=10%  Similarity=-0.019  Sum_probs=60.0

Q ss_pred             CCCceeeeeeeeeccCeEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHH-HhhcccCCcEEeCCCCCCCe
Q 007869          316 RHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLF-YLHQEWEQVVIHRDVKASNV  394 (586)
Q Consensus       316 ~H~niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~-yLH~~~~~~ivHrDIkp~NI  394 (586)
                      .||++  -...-...+.+.+.|+.-+++.=...++     .++...+++++.+|+.... +++.     -+|--|+|+||
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~-----~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~NL  115 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR-----KTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPENL  115 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH-----TSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGGE
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH-----hcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCceE
Confidence            67777  3334467788888888664443333342     4566788888998888776 5554     46778999999


Q ss_pred             eecCCCCeEEccccce
Q 007869          395 LLDGELNGRLGDFGLA  410 (586)
Q Consensus       395 ll~~~~~~kL~DFGla  410 (586)
                      ++|.++.++|.-.|+-
T Consensus       116 ~f~~~~~p~i~hRGi~  131 (219)
T 4ano_A          116 MFNRALEPFFLHVGVK  131 (219)
T ss_dssp             EECTTCCEEESCCEET
T ss_pred             EEeCCCcEEEEEcCCc
Confidence            9999999999887764

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	586
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-70
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	7e-69
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-67
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	3e-66
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	3e-65
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	8e-65
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	3e-63
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	7e-63
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-61
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	1e-60
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-60
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-60
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	1e-59
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	6e-59
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	6e-59
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	7e-59
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	9e-59
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	3e-58
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	3e-58
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	3e-57
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-56
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-56
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	3e-56
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-55
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-55
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-55
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-54
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	1e-54
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-54
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	4e-54
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-53
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-51
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	4e-51
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	5e-50
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-49
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	5e-47
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	8e-47
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	8e-47
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-45
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	5e-45
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	4e-44
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	7e-43
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	1e-42
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	3e-42
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	3e-42
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	3e-42
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	3e-42
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	4e-42
d1hqla_	236	b.29.1.1 (A:) Legume lectin {Griffonia simplicifol	5e-42
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	5e-42
d1leda_	243	b.29.1.1 (A:) Legume lectin {West-central african	1e-41
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-41
d1g9fa_	251	b.29.1.1 (A:) Legume lectin {Soybean (Glycine max)	3e-41
d1g7ya_	253	b.29.1.1 (A:) Legume lectin {Horse gram (Dolichos	4e-41
d1gzca_	239	b.29.1.1 (A:) Legume lectin {Cockspur coral tree (	6e-41
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	1e-40
d1fx5a_	240	b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus	2e-40
d1qnwa_	237	b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus	2e-40
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-40
d1g8wa_	233	b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also ar	3e-40
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-39
g1qmo.1	230	b.29.1.1 (A:,E:) Legume lectin {Field bean (Dolich	2e-39
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	5e-39
d1f9ka_	234	b.29.1.1 (A:) Legume lectin {Winged bean (Psophoca	1e-38
d1ukga_	241	b.29.1.1 (A:) Legume lectin {Bloodwood tree (Ptero	4e-38
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	6e-38
d1v6ia_	232	b.29.1.1 (A:) Legume lectin {Peanut (Arachis hypog	9e-38
d1avba_	226	b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also ar	3e-37
d1fnya_	237	b.29.1.1 (A:) Legume lectin {Black locust (Robinia	4e-37
d2d3sa1	237	b.29.1.1 (A:1-237) Legume lectin {Winged bean (Pso	4e-37
d1n47a_	233	b.29.1.1 (A:) Legume lectin {Hairy vetch (Vicia vi	5e-37
g2ltn.1	229	b.29.1.1 (A:,B:) Legume lectin {Garden pea (Pisum	1e-36
d1dbna_	239	b.29.1.1 (A:) Legume lectin {Maackia amurensis, le	5e-36
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-35
d1ioaa_	228	b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also ar	4e-35
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	5e-35
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	6e-34
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	5e-33
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-32
d1nlsa_	237	b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia	9e-32
d1nlsa_	237	b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia	1e-14
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	3e-31
d1dhkb_	204	b.29.1.1 (B:) Phytohemagglutinin-L, PHA-L, also ar	2e-28
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	6e-25
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	3e-20
d1gv9a_	228	b.29.1.13 (A:) Carbohydrate-recognition domain of	5e-14
d2a6va1	218	b.29.1.13 (A:9-226) Emp46p N-terminal domain {Bake	7e-05

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  226 bits (576), Expect = 2e-70
 Identities = 69/300 (23%), Positives = 131/300 (43%), Gaps = 35/300 (11%)

Query: 240 EDWELDHGPHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR 299
           +DWE+  G                   + +G+G FG VY+G      + + +  ++  + 
Sbjct: 1   DDWEIPDG--------------QITVGQRIGSGSFGTVYKGKW-HGDVAVKMLNVTAPTP 45

Query: 300 QGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNW 359
           Q ++ F  E+  + + RH N++  +GY     +L +V  +    SL  +L+         
Sbjct: 46  QQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHIIET-KFEM 103

Query: 360 IQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP 419
           I+   + +  A G+ YLH +    +IHRD+K++N+ L  +L  ++GDFGLA +    +  
Sbjct: 104 IKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS 160

Query: 420 -QTTHVVGTLGYLAPEHTRT---GKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLIL 475
            Q   + G++ ++APE  R       +  +DV++FG  L E+  G+ P            
Sbjct: 161 HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN------ 214

Query: 476 VDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER 535
            D +     RG       P+L ++  +   + + +L   C       RP   Q++  +E 
Sbjct: 215 RDQIIFMVGRGY----LSPDL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIEL 269

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  221 bits (565), Expect = 7e-69
 Identities = 70/295 (23%), Positives = 124/295 (42%), Gaps = 35/295 (11%)

Query: 240 EDWELDHGPHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR 299
           ++WE+                +  +  E LG G FG V+ G       ++AVK +  +  
Sbjct: 6   DEWEVPR--------------ETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSL-KQGS 49

Query: 300 QGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNW 359
                F+AE   + +L+H+ LV+L      +  + ++ +YM NGSL  +L     + L  
Sbjct: 50  MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTI 108

Query: 360 IQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP 419
            +   +   +A G+ ++    E+  IHRD++A+N+L+   L+ ++ DFGLARL +     
Sbjct: 109 NKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165

Query: 420 QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWV 479
                   + + APE    G  T  +DV+SFG  L E+    R                 
Sbjct: 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP--------------- 210

Query: 480 FDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILE 534
           +      E+++  +            E + +L  LC    P  RP+   +  +LE
Sbjct: 211 YPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLE 265

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  219 bits (559), Expect = 1e-67
 Identities = 71/288 (24%), Positives = 125/288 (43%), Gaps = 19/288 (6%)

Query: 248 PHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVA 307
           P    Y    +       K  LG G +G VY G   K  + +AVK +  ++ + ++EF+ 
Sbjct: 4   PSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLK 62

Query: 308 EIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIK 367
           E   +  ++H NLVQLLG C R+    ++ ++M  G+L  YL +  +  ++ +    +  
Sbjct: 63  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 122

Query: 368 GVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGT 427
            ++  + YL +   +  IHRD+ A N L+      ++ DFGL+RL    T          
Sbjct: 123 QISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFP 179

Query: 428 LGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGE 487
           + + APE     K +  +DV++FG  L E+A                     +   +  +
Sbjct: 180 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP---------------YPGIDLSQ 224

Query: 488 LLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER 535
           + E  + +   E      E V +L   C   +P+ RPS  ++ Q  E 
Sbjct: 225 VYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET 272

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  216 bits (550), Expect = 3e-66
 Identities = 75/293 (25%), Positives = 125/293 (42%), Gaps = 29/293 (9%)

Query: 266 KELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLG 325
           +E +G G FG V+RG       E+AVK  S    +      AEI     LRH N++  + 
Sbjct: 8   QESIGKGRFGEVWRGKWRGE--EVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIA 64

Query: 326 YCRRKG----ELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQE-- 379
              +      +L LV DY  +GSL  YL       +      ++    A GL +LH E  
Sbjct: 65  ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHMEIV 121

Query: 380 ---WEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP---QTTHVVGTLGYLAP 433
               +  + HRD+K+ N+L+       + D GLA  +D  TD       H VGT  Y+AP
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181

Query: 434 E------HTRTGKATTSADVFSFGAFLLEVACGRRPIQR----QGPSENLILVDWVFDFW 483
           E      + +  ++   AD+++ G    E+A            Q P  +L+  D   +  
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241

Query: 484 NRGELLEARDPNLGTEYV-AEELELVLKLGLLCSHSDPTARPSMRQVVQILER 535
            +    +   PN+   +   E L ++ K+   C +++  AR +  ++ + L +
Sbjct: 242 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ 294

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (542), Expect = 3e-65
 Identities = 72/295 (24%), Positives = 118/295 (40%), Gaps = 35/295 (11%)

Query: 240 EDWELDHGPHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR 299
           + WE+                +  R +  LG G FG V+ GT   +   +A+K +     
Sbjct: 10  DAWEIPR--------------ESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTL-KPGT 53

Query: 300 QGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNW 359
              + F+ E   + +LRH  LVQL         + +V +YM  GSL  +L  +    L  
Sbjct: 54  MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRL 112

Query: 360 IQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP 419
            Q   +   +A G+ Y+ +      +HRD++A+N+L+   L  ++ DFGLARL +     
Sbjct: 113 PQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 169

Query: 420 QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWV 479
                   + + APE    G+ T  +DV+SFG  L E+    R                 
Sbjct: 170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP--------------- 214

Query: 480 FDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILE 534
           +      E+L+  +         E  E +  L   C   +P  RP+   +   LE
Sbjct: 215 YPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLE 269

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  212 bits (540), Expect = 8e-65
 Identities = 75/308 (24%), Positives = 143/308 (46%), Gaps = 38/308 (12%)

Query: 251 FRYKDLYIATKGFREK---------ELLGTGGFGRVYRGTLP---KSQIEIAVKKI-SHE 297
           F ++D   A + F ++         +++G G FG V  G L    K +I +A+K + S  
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 298 SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTL 357
           + +  ++F++E   +G+  H N++ L G   +   ++++ ++M NGSLD +L        
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF- 125

Query: 358 NWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT 417
             IQ   +++G+A G+ YL        +HRD+ A N+L++  L  ++ DFGL+R  +  T
Sbjct: 126 TVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182

Query: 418 DPQTTH----VVGTLGYLAPEHTRTGKATTSADVFSFGAFLLE-VACGRRPIQRQGPSEN 472
              T          + + APE  +  K T+++DV+S+G  + E ++ G RP         
Sbjct: 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP--------- 233

Query: 473 LILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQI 532
                  +      +++ A + +       +    + +L L C   D   RP   Q+V  
Sbjct: 234 -------YWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286

Query: 533 LERDVALP 540
           L++ +  P
Sbjct: 287 LDKMIRNP 294

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (526), Expect = 3e-63
 Identities = 65/273 (23%), Positives = 112/273 (41%), Gaps = 23/273 (8%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQ 322
               + LGTG FG V  G   + Q ++A+K I  E      EF+ E   +  L H  LVQ
Sbjct: 6   LTFLKELGTGQFGVVKYGKW-RGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQ 63

Query: 323 LLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQ 382
           L G C ++  + ++ +YM NG L  YL +         Q   + K V   + YL  +   
Sbjct: 64  LYGVCTKQRPIFIITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLESKQ-- 120

Query: 383 VVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKAT 442
             +HRD+ A N L++ +   ++ DFGL+R         +      + +  PE     K +
Sbjct: 121 -FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS 179

Query: 443 TSADVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYV 501
           + +D+++FG  + E+ + G+ P                ++ +   E  E     L     
Sbjct: 180 SKSDIWAFGVLMWEIYSLGKMP----------------YERFTNSETAEHIAQGLRLYRP 223

Query: 502 AEELELVLKLGLLCSHSDPTARPSMRQVVQILE 534
               E V  +   C H     RP+ + ++  + 
Sbjct: 224 HLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (524), Expect = 7e-63
 Identities = 61/273 (22%), Positives = 110/273 (40%), Gaps = 21/273 (7%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQ 322
               + +G+G FG V+ G       ++A+K I  E     ++F+ E   + +L H  LVQ
Sbjct: 7   LTFVQEIGSGQFGLVHLGYWLNKD-KVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQ 64

Query: 323 LLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQ 382
           L G C  +  + LV+++M +G L  YL  Q  +         +   V  G+       E 
Sbjct: 65  LYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLF-AAETLLGMCLDVCEGM---AYLEEA 120

Query: 383 VVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKAT 442
            VIHRD+ A N L+      ++ DFG+ R         +T     + + +PE     + +
Sbjct: 121 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS 180

Query: 443 TSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVA 502
           + +DV+SFG  + EV    +       +  +          +         P L + +V 
Sbjct: 181 SKSDVWSFGVLMWEVFSEGKIPYENRSNSEV--------VEDISTGFRLYKPRLASTHVY 232

Query: 503 EELELVLKLGLLCSHSDPTARPSMRQVVQILER 535
           +       +   C    P  RP+  ++++ L  
Sbjct: 233 Q-------IMNHCWKERPEDRPAFSRLLRQLAE 258

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (515), Expect = 2e-61
 Identities = 66/288 (22%), Positives = 123/288 (42%), Gaps = 28/288 (9%)

Query: 254 KDLYIATKGFREKEL-LGTGGFGRVYRGTLP--KSQIEIAVKKISHESRQG-MKEFVAEI 309
           K L++        ++ LG G FG V +G     K QI++A+K +   + +   +E + E 
Sbjct: 1   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60

Query: 310 VSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGV 369
             + +L +  +V+L+G C+ +  L+LV +    G L K+L  + +  +       ++  V
Sbjct: 61  QIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKRE-EIPVSNVAELLHQV 118

Query: 370 ALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLY--DHGTDPQTTHVVGT 427
           ++G+ YL ++     +HRD+ A NVLL      ++ DFGL++    D       +     
Sbjct: 119 SMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWP 175

Query: 428 LGYLAPEHTRTGKATTSADVFSFGAFLLEV-ACGRRPIQRQGPSENLILVDWVFDFWNRG 486
           L + APE     K ++ +DV+S+G  + E  + G++P                +      
Sbjct: 176 LKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP----------------YKKMKGP 219

Query: 487 ELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILE 534
           E++   +     E   E    +  L   C       RP    V Q + 
Sbjct: 220 EVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 267

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (509), Expect = 1e-60
 Identities = 68/290 (23%), Positives = 138/290 (47%), Gaps = 26/290 (8%)

Query: 258 IATKGFREKELLGTGGFGRVYRGTLP----KSQIEIAVKKISHESRQGMK-EFVAEIVSI 312
           I       ++++G G FG VY+G L     K ++ +A+K +     +  + +F+ E   +
Sbjct: 4   IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIM 63

Query: 313 GRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALG 372
           G+  H N+++L G   +   ++++ +YM NG+LDK+L ++     + +Q   +++G+A G
Sbjct: 64  GQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG-EFSVLQLVGMLRGIAAG 122

Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP--QTTHVVGTLGY 430
           + YL        +HRD+ A N+L++  L  ++ DFGL+R+ +   +    T+     + +
Sbjct: 123 MKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRW 179

Query: 431 LAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLE 490
            APE     K T+++DV+SFG  + EV                      +   +  E+++
Sbjct: 180 TAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP---------------YWELSNHEVMK 224

Query: 491 ARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERDVALP 540
           A +         +    + +L + C   +   RP    +V IL++ +  P
Sbjct: 225 AINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 274

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (508), Expect = 1e-60
 Identities = 80/295 (27%), Positives = 123/295 (41%), Gaps = 41/295 (13%)

Query: 242 WELDHGPHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQG 301
           W L+               K  +  + +G G FG V  G    +  ++AVK I +++   
Sbjct: 2   WALNM--------------KELKLLQTIGKGEFGDVMLGDYRGN--KVAVKCIKNDATA- 44

Query: 302 MKEFVAEIVSIGRLRHRNLVQLLGYC-RRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWI 360
            + F+AE   + +LRH NLVQLLG     KG L +V +YM  GSL  YL  + +  L   
Sbjct: 45  -QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGD 103

Query: 361 QRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ 420
              +    V   + YL        +HRD+ A NVL+  +   ++ DFGL +         
Sbjct: 104 CLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS----T 156

Query: 421 TTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVF 480
                  + + APE  R  K +T +DV+SFG  L E+    R    + P +       V 
Sbjct: 157 QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK------DVV 210

Query: 481 DFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER 535
               +G  ++A D           +    ++   C H D   RPS  Q+ + LE 
Sbjct: 211 PRVEKGYKMDAPD------GCPPAV---YEVMKNCWHLDAAMRPSFLQLREQLEH 256

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (512), Expect = 2e-60
 Identities = 65/302 (21%), Positives = 117/302 (38%), Gaps = 35/302 (11%)

Query: 258 IATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGM-KEFVAEIVSIGRLR 316
           +    F +   LG G  G V++ +   S + +A K I  E +  +  + + E+  +    
Sbjct: 3   LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN 62

Query: 317 HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYL 376
              +V   G     GE+ +  ++M  GSLD+ L    +  +      +V   V  GL YL
Sbjct: 63  SPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR--IPEQILGKVSIAVIKGLTYL 120

Query: 377 HQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHT 436
            +  +  ++HRDVK SN+L++     +L DFG++       D      VGT  Y++PE  
Sbjct: 121 RE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRSYMSPERL 175

Query: 437 RTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNL 496
           +    +  +D++S G  L+E+A GR PI      E  ++     +          R P  
Sbjct: 176 QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235

Query: 497 GTEYVAEELELVLKLGLL---------------------------CSHSDPTARPSMRQV 529
                  +    + +  L                           C   +P  R  ++Q+
Sbjct: 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 295

Query: 530 VQ 531
           + 
Sbjct: 296 MV 297

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (506), Expect = 1e-59
 Identities = 78/278 (28%), Positives = 124/278 (44%), Gaps = 27/278 (9%)

Query: 266 KELLGTGGFGRVYRGTLPKS---QIEIAVKKISHESRQG-MKEFVAEIVSIGRLRHRNLV 321
            E++G G FG VY GTL  +   +I  AVK ++  +  G + +F+ E + +    H N++
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91

Query: 322 QLLGYC-RRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEW 380
            LLG C R +G  L+V  YM +G L  ++ ++                VA G+ +L  + 
Sbjct: 92  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH-NPTVKDLIGFGLQVAKGMKFLASKK 150

Query: 381 EQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHG---TDPQTTHVVGTLGYLAPEHTR 437
               +HRD+ A N +LD +   ++ DFGLAR        +    T     + ++A E  +
Sbjct: 151 ---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 207

Query: 438 TGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLG 497
           T K TT +DV+SFG  L E+     P     P  ++   D          LL    P   
Sbjct: 208 TQKFTTKSDVWSFGVLLWELMTRGAP-----PYPDVNTFDITVYLLQGRRLL---QP--- 256

Query: 498 TEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER 535
            EY  + L    ++ L C H     RPS  ++V  +  
Sbjct: 257 -EYCPDPL---YEVMLKCWHPKAEMRPSFSELVSRISA 290

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  197 bits (501), Expect = 6e-59
 Identities = 71/278 (25%), Positives = 115/278 (41%), Gaps = 31/278 (11%)

Query: 260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQG---MKEFVAEIVSIGRLR 316
            K F +   +G G FG VY     ++   +A+KK+S+  +Q     ++ + E+  + +LR
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73

Query: 317 HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYL 376
           H N +Q  G   R+    LV +Y    + D     +    L  ++   V  G   GL YL
Sbjct: 74  HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP--LQEVEIAAVTHGALQGLAYL 131

Query: 377 HQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEH- 435
           H      +IHRDVKA N+LL      +LGDFG A +            VGT  ++APE  
Sbjct: 132 HSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA-----PANSFVGTPYWMAPEVI 183

Query: 436 --TRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARD 493
                G+     DV+S G   +E+A  + P+        L  +             +   
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI------------AQNES 231

Query: 494 PNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ 531
           P L + + +E     +     C    P  RP+   +++
Sbjct: 232 PALQSGHWSEYFRNFVD---SCLQKIPQDRPTSEVLLK 266

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (500), Expect = 6e-59
 Identities = 71/291 (24%), Positives = 124/291 (42%), Gaps = 38/291 (13%)

Query: 263 FREKELLGTGGFGRVYRGTLPKS--QIEIAVKKIS-HESRQGMKEFVAEIVSIGRL-RHR 318
            + ++++G G FG+V +  + K   +++ A+K++  + S+   ++F  E+  + +L  H 
Sbjct: 12  IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 71

Query: 319 NLVQLLGYCRRKGELLLVYDYMPNGSLDKYLY--------------DQPKVTLNWIQRFR 364
           N++ LLG C  +G L L  +Y P+G+L  +L               +    TL+  Q   
Sbjct: 72  NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 131

Query: 365 VIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHV 424
               VA G+ YL    ++  IHRD+ A N+L+      ++ DFGL+R  +     + T  
Sbjct: 132 FAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV--KKTMG 186

Query: 425 VGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWN 484
              + ++A E       TT++DV+S+G  L E+                      +    
Sbjct: 187 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP---------------YCGMT 231

Query: 485 RGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER 535
             EL E        E      + V  L   C    P  RPS  Q++  L R
Sbjct: 232 CAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 282

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (497), Expect = 7e-59
 Identities = 68/277 (24%), Positives = 117/277 (42%), Gaps = 25/277 (9%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES--RQGMKEFVAEIVSIGRLRHRNL 320
           +     +GTG +GR  +         +  K++ + S      +  V+E+  +  L+H N+
Sbjct: 6   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65

Query: 321 VQLLGYC--RRKGELLLVYDYMPNGSLDKYLYDQPK--VTLNWIQRFRVIKGVALGLFYL 376
           V+       R    L +V +Y   G L   +    K    L+     RV+  + L L   
Sbjct: 66  VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 125

Query: 377 HQ--EWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE 434
           H+  +    V+HRD+K +NV LDG+ N +LGDFGLAR+ +H T       VGT  Y++PE
Sbjct: 126 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS-FAKAFVGTPYYMSPE 184

Query: 435 HTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDP 494
                     +D++S G  L E+     P       E              G++ E +  
Sbjct: 185 QMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELA------------GKIREGKFR 232

Query: 495 NLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ 531
            +   Y  E  E++ +      +     RPS+ ++++
Sbjct: 233 RIPYRYSDELNEIITR----MLNLKDYHRPSVEEILE 265

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (499), Expect = 9e-59
 Identities = 71/316 (22%), Positives = 129/316 (40%), Gaps = 42/316 (13%)

Query: 248 PHRFRYKDLY-IATKGFREKELLGTGGFGRVYRGTLPK-----SQIEIAVKKISHESRQG 301
           P +  Y   +          + LG G FG+V   T        + + +AVK +   +   
Sbjct: 9   PTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLT 68

Query: 302 MKE-FVAEIVSIGRL-RHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQ------- 352
            +E  ++E+  +  L  H N+V LLG C   G  L++ +Y   G L  +L  +       
Sbjct: 69  EREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICS 128

Query: 353 ---------PKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGR 403
                     ++ L+          VA G+ +L  +     IHRD+ A N+LL      +
Sbjct: 129 KTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITK 185

Query: 404 LGDFGLAR-LYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRR 462
           + DFGLAR + +        +    + ++APE       T  +DV+S+G FL E+     
Sbjct: 186 ICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGS 245

Query: 463 PIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTA 522
                 P ++              ++++     L  E+   E+     +   C  +DP  
Sbjct: 246 SPYPGMPVDSKFY-----------KMIKEGFRMLSPEHAPAEM---YDIMKTCWDADPLK 291

Query: 523 RPSMRQVVQILERDVA 538
           RP+ +Q+VQ++E+ ++
Sbjct: 292 RPTFKQIVQLIEKQIS 307

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (494), Expect = 3e-58
 Identities = 67/274 (24%), Positives = 117/274 (42%), Gaps = 24/274 (8%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQ 322
           +     LG G FG+VY+    ++ +  A K I  +S + +++++ EI  +    H N+V+
Sbjct: 14  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 73

Query: 323 LLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQ 382
           LL     +  L ++ ++   G++D  + +  +  L   Q   V K     L YLH     
Sbjct: 74  LLDAFYYENNLWILIEFCAGGAVDAVMLELER-PLTESQIQVVCKQTLDALNYLHDNK-- 130

Query: 383 VVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE-----HTR 437
            +IHRD+KA N+L   + + +L DFG++      T  +    +GT  ++APE      ++
Sbjct: 131 -IIHRDLKAGNILFTLDGDIKLADFGVSAKNTR-TIQRRDSFIGTPYWMAPEVVMCETSK 188

Query: 438 TGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLG 497
                  ADV+S G  L+E+A    P     P         V     + E      P   
Sbjct: 189 DRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR-------VLLKIAKSEPPTLAQP--- 238

Query: 498 TEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ 531
               +   +  LK    C   +  AR +  Q++Q
Sbjct: 239 -SRWSSNFKDFLK---KCLEKNVDARWTTSQLLQ 268

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  195 bits (495), Expect = 3e-58
 Identities = 68/313 (21%), Positives = 122/313 (38%), Gaps = 47/313 (15%)

Query: 252 RYKDLYIATKGFREKELLGTGGFGRVYRGTLP-----KSQIEIAVKKISHESRQGM-KEF 305
           +   L            +G G FGRV++   P     +    +AVK +  E+   M  +F
Sbjct: 4   KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63

Query: 306 VAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVT--------- 356
             E   +    + N+V+LLG C     + L+++YM  G L+++L      T         
Sbjct: 64  QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123

Query: 357 -------------LNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGR 403
                        L+  ++  + + VA G+ YL +      +HRD+   N L+   +  +
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVK 180

Query: 404 LGDFGLAR-LYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRR 462
           + DFGL+R +Y         +    + ++ PE     + TT +DV+++G  L E+     
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240

Query: 463 PIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTA 522
                 P   +   + V  +   G +L   +              +  L  LC    P  
Sbjct: 241 Q-----PYYGM-AHEEVIYYVRDGNILACPE---------NCPLELYNLMRLCWSKLPAD 285

Query: 523 RPSMRQVVQILER 535
           RPS   + +IL+R
Sbjct: 286 RPSFCSIHRILQR 298

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (486), Expect = 3e-57
 Identities = 68/277 (24%), Positives = 115/277 (41%), Gaps = 29/277 (10%)

Query: 265 EKELLGTGGFGRVYRGTLP--KSQIEIAVKKISHESRQG--MKEFVAEIVSIGRLRHRNL 320
           E + LG+G FG V +G     K    +AVK + +E+       E +AE   + +L +  +
Sbjct: 11  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70

Query: 321 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEW 380
           V+++G C  +   +LV +    G L+KYL       +       ++  V++G+ YL +  
Sbjct: 71  VRMIGICEAE-SWMLVMEMAELGPLNKYLQQNRH--VKDKNIIELVHQVSMGMKYLEESN 127

Query: 381 EQVVIHRDVKASNVLLDGELNGRLGDFGLARLY--DHGTDPQTTHVVGTLGYLAPEHTRT 438
               +HRD+ A NVLL  +   ++ DFGL++    D       TH    + + APE    
Sbjct: 128 ---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184

Query: 439 GKATTSADVFSFGAFLLE-VACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLG 497
            K ++ +DV+SFG  + E  + G++P                +      E+    +    
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQKP----------------YRGMKGSEVTAMLEKGER 228

Query: 498 TEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILE 534
               A     +  L  LC   D   RP    V   L 
Sbjct: 229 MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR 265

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (481), Expect = 1e-56
 Identities = 60/276 (21%), Positives = 113/276 (40%), Gaps = 28/276 (10%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNL 320
            +    +G G F  VY+G   ++ +E+A  ++     ++   + F  E   +  L+H N+
Sbjct: 11  LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70

Query: 321 VQLLGYC----RRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYL 376
           V+         + K  ++LV + M +G+L  YL       +         + +  GL +L
Sbjct: 71  VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV--MKIKVLRSWCRQILKGLQFL 128

Query: 377 HQEWEQVVIHRDVKASNVLLDGELNG-RLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEH 435
           H      +IHRD+K  N+ + G     ++GD GLA L           V+GT  ++APE 
Sbjct: 129 HTRTPP-IIHRDLKCDNIFITGPTGSVKIGDLGLATLKR---ASFAKAVIGTPEFMAPEM 184

Query: 436 TRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPN 495
               K   S DV++FG  +LE+A    P      +  +              +     P 
Sbjct: 185 YE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR-----------VTSGVKPA 232

Query: 496 LGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ 531
              +    E++ +++    C   +   R S++ ++ 
Sbjct: 233 SFDKVAIPEVKEIIE---GCIRQNKDERYSIKDLLN 265

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (482), Expect = 2e-56
 Identities = 63/272 (23%), Positives = 114/272 (41%), Gaps = 21/272 (7%)

Query: 260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRN 319
            K +   E +G G  G VY      +  E+A+++++ + +   +  + EI+ +   ++ N
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQE 379
           +V  L       EL +V +Y+  GSL   + +      +  Q   V +     L +LH  
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM---DEGQIAAVCRECLQALEFLHSN 135

Query: 380 WEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTG 439
               VIHRD+K+ N+LL  + + +L DFG           + + +VGT  ++APE     
Sbjct: 136 Q---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP-EQSKRSTMVGTPYWMAPEVVTRK 191

Query: 440 KATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTE 499
                 D++S G   +E+  G  P   + P   L L+             E ++P    E
Sbjct: 192 AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI-------ATNGTPELQNP----E 240

Query: 500 YVAEELELVLKLGLLCSHSDPTARPSMRQVVQ 531
            ++      L     C   D   R S ++++Q
Sbjct: 241 KLSAIFRDFLN---RCLDMDVEKRGSAKELLQ 269

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (479), Expect = 3e-56
 Identities = 65/272 (23%), Positives = 108/272 (39%), Gaps = 28/272 (10%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKIS---HESRQGMKEFVAEIVSIGRLRHRN 319
           F     LG G FG VY     +S+  +A+K +     E      +   E+     LRH N
Sbjct: 8   FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67

Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQE 379
           +++L GY      + L+ +Y P G++ + L    K   +  +    I  +A  L Y H  
Sbjct: 68  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK--FDEQRTATYITELANALSYCH-- 123

Query: 380 WEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTG 439
             + VIHRD+K  N+LL      ++ DFG +    H    + T + GTL YL PE     
Sbjct: 124 -SKRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTTLCGTLDYLPPEMIEGR 179

Query: 440 KATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTE 499
                 D++S G    E   G+ P +     E               + +   +      
Sbjct: 180 MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY-------------KRISRVEFTFPDF 226

Query: 500 YVAEELELVLKLGLLCSHSDPTARPSMRQVVQ 531
                 +L+ +        +P+ RP +R+V++
Sbjct: 227 VTEGARDLISR----LLKHNPSQRPMLREVLE 254

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (479), Expect = 1e-55
 Identities = 71/318 (22%), Positives = 120/318 (37%), Gaps = 49/318 (15%)

Query: 248 PHRFRYKDLY-IATKGFREKELLGTGGFGRVYRGTLPKSQ-----IEIAVKKISHESRQG 301
              + Y   +    +     ++LG+G FG+V   T          I++AVK +  ++   
Sbjct: 23  FREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSS 82

Query: 302 MKE-FVAEIVSIGRL-RHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKV---- 355
            +E  ++E+  + +L  H N+V LLG C   G + L+++Y   G L  YL  + +     
Sbjct: 83  EREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSED 142

Query: 356 -----------------TLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDG 398
                             L +         VA G+ +L     +  +HRD+ A NVL+  
Sbjct: 143 EIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTH 199

Query: 399 ELNGRLGDFGLAR-LYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLE- 456
               ++ DFGLAR +          +    + ++APE    G  T  +DV+S+G  L E 
Sbjct: 200 GKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEI 259

Query: 457 VACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCS 516
            + G  P        N              +L++         Y  EE+     +   C 
Sbjct: 260 FSLGVNPYPGIPVDANFY------------KLIQNGFKMDQPFYATEEIY---IIMQSCW 304

Query: 517 HSDPTARPSMRQVVQILE 534
             D   RPS   +   L 
Sbjct: 305 AFDSRKRPSFPNLTSFLG 322

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (473), Expect = 2e-55
 Identities = 63/272 (23%), Positives = 108/272 (39%), Gaps = 22/272 (8%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKE-FVAEIVSIGRLRHRNLV 321
           +   + LG G +G V       ++  +AVK +  +      E    EI     L H N+V
Sbjct: 7   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66

Query: 322 QLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
           +  G+ R      L  +Y   G L   +  +P + +      R    +  G+ YLH    
Sbjct: 67  KFYGHRREGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVVYLHGIG- 123

Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTH-VVGTLGYLAPEHTRTGK 440
             + HRD+K  N+LLD   N ++ DFGLA ++ +    +  + + GTL Y+APE  +  +
Sbjct: 124 --ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181

Query: 441 -ATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTE 499
                 DV+S G  L  +  G  P  +   S            W   +        +   
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD------WKEKKTYLNPWKKID-- 233

Query: 500 YVAEELELVLKLGLLCSHSDPTARPSMRQVVQ 531
             +  L L+ K        +P+AR ++  + +
Sbjct: 234 --SAPLALLHK----ILVENPSARITIPDIKK 259

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (473), Expect = 2e-55
 Identities = 73/287 (25%), Positives = 110/287 (38%), Gaps = 27/287 (9%)

Query: 257 YIATKGFREKELLGTGGFGRVYRGTLPKS---QIEIAVKKISHE---SRQGMKEFVAEIV 310
            I  K  R  E LG G FG V RG         + +AVK +  +     + M +F+ E+ 
Sbjct: 4   LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVN 63

Query: 311 SIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVA 370
           ++  L HRNL++L G       + +V +  P GSL   L              R    VA
Sbjct: 64  AMHSLDHRNLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQG-HFLLGTLSRYAVQVA 121

Query: 371 LGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP--QTTHVVGTL 428
            G+ YL  +     IHRD+ A N+LL      ++GDFGL R      D      H     
Sbjct: 122 EGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF 178

Query: 429 GYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGEL 488
            + APE  +T   + ++D + FG  L E+    +      P   L     +      GE 
Sbjct: 179 AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE-----PWIGLNGSQILHKIDKEGER 233

Query: 489 LEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER 535
           L         E   +++     + + C    P  RP+   +   L  
Sbjct: 234 LPR------PEDCPQDI---YNVMVQCWAHKPEDRPTFVALRDFLLE 271

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (471), Expect = 1e-54
 Identities = 71/311 (22%), Positives = 132/311 (42%), Gaps = 39/311 (12%)

Query: 248 PHRFRYKDLY------IATKGFREKELLGTGGFGRVYRGTLP-----KSQIEIAVKKISH 296
           P  F   D+Y      +A +       LG G FG VY G        + +  +A+K ++ 
Sbjct: 1   PEYFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNE 60

Query: 297 E-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPK- 354
             S +   EF+ E   +      ++V+LLG   +    L++ + M  G L  YL      
Sbjct: 61  AASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPA 120

Query: 355 -------VTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDF 407
                     +  +  ++   +A G+ YL        +HRD+ A N ++  +   ++GDF
Sbjct: 121 MANNPVLAPPSLSKMIQMAGEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDF 177

Query: 408 GLAR-LYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQR 466
           G+ R +Y+     +    +  + +++PE  + G  TT +DV+SFG  L E+A        
Sbjct: 178 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ--- 234

Query: 467 QGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSM 526
             P + L   + V  F   G LL+  D            +++ +L  +C   +P  RPS 
Sbjct: 235 --PYQGLS-NEQVLRFVMEGGLLDKPD---------NCPDMLFELMRMCWQYNPKMRPSF 282

Query: 527 RQVVQILERDV 537
            +++  ++ ++
Sbjct: 283 LEIISSIKEEM 293

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (468), Expect = 1e-54
 Identities = 59/299 (19%), Positives = 121/299 (40%), Gaps = 38/299 (12%)

Query: 241 DWELDHGPHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQ---IEIAVKKISHE 297
           D+E+     R                  +G G FG V++G     +   + +A+K   + 
Sbjct: 1   DYEIQR--ERIELG------------RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC 46

Query: 298 SRQGMKE-FVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVT 356
           +   ++E F+ E +++ +  H ++V+L+G    +  + ++ +    G L  +L  +   +
Sbjct: 47  TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKY-S 104

Query: 357 LNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHG 416
           L+          ++  L YL     +  +HRD+ A NVL+      +LGDFGL+R  +  
Sbjct: 105 LDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 161

Query: 417 TDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILV 476
           T  + +     + ++APE     + T+++DV+ FG  + E+        +   + ++I  
Sbjct: 162 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI-- 219

Query: 477 DWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER 535
                    G +       +          L+ K    C   DP+ RP   ++   L  
Sbjct: 220 ---------GRIENGERLPMPPNCPPTLYSLMTK----CWAYDPSRRPRFTELKAQLST 265

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  186 bits (473), Expect = 2e-54
 Identities = 60/271 (22%), Positives = 107/271 (39%), Gaps = 21/271 (7%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQ 322
           +   E LGTG FG V+R T   +    A K +        +    EI ++  LRH  LV 
Sbjct: 28  YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 87

Query: 323 LLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQ 382
           L        E++++Y++M  G L + + D+    ++  +    ++ V  GL ++H   E 
Sbjct: 88  LHDAFEDDNEMVMIYEFMSGGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMH---EN 143

Query: 383 VVIHRDVKASNVLLDGELNGR--LGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGK 440
             +H D+K  N++   + +    L DFGL    D     + T   GT  + APE      
Sbjct: 144 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFAAPEVAEGKP 201

Query: 441 ATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEY 500
                D++S G     +  G  P   +   E L  V           + ++    +  + 
Sbjct: 202 VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV-----KSCDWNMDDSAFSGISEDG 256

Query: 501 VAEELELVLKLGLLCSHSDPTARPSMRQVVQ 531
                + + K       +DP  R ++ Q ++
Sbjct: 257 K----DFIRK----LLLADPNTRMTIHQALE 279

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (467), Expect = 4e-54
 Identities = 59/279 (21%), Positives = 111/279 (39%), Gaps = 26/279 (9%)

Query: 263 FREKELLGTGGFGRVYRGTLPKS----QIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRH 317
           F++ ++LG+G FG VY+G         +I +A+K++    S +  KE + E   +  + +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70

Query: 318 RNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLH 377
            ++ +LLG C     + L+   MP G L  Y+ +                 +A G+ YL 
Sbjct: 71  PHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNI-GSQYLLNWCVQIAKGMNYLE 128

Query: 378 QEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR-LYDHGTDPQTTHVVGTLGYLAPEHT 436
                 ++HRD+ A NVL+    + ++ DFGLA+ L     +         + ++A E  
Sbjct: 129 DRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185

Query: 437 RTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNL 496
                T  +DV+S+G  + E+                      +D     E+    +   
Sbjct: 186 LHRIYTHQSDVWSYGVTVWELMTFGSKP---------------YDGIPASEISSILEKGE 230

Query: 497 GTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER 535
                      V  + + C   D  +RP  R+++    +
Sbjct: 231 RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 269

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (463), Expect = 1e-53
 Identities = 72/301 (23%), Positives = 127/301 (42%), Gaps = 42/301 (13%)

Query: 263 FREKELLGTGGFGRVYRGTL-------PKSQIEIAVKKISHE-SRQGMKEFVAEIVSIGR 314
               + LG G FG+V            P    ++AVK +  + + + + + ++E+  +  
Sbjct: 15  LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKM 74

Query: 315 L-RHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQ--------------PKVTLNW 359
           + +H+N++ LLG C + G L ++ +Y   G+L +YL  +              P+  L+ 
Sbjct: 75  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS 134

Query: 360 IQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP 419
                    VA G+ YL     +  IHRD+ A NVL+  +   ++ DFGLAR   H    
Sbjct: 135 KDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 191

Query: 420 QTTHVV-GTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDW 478
           + T      + ++APE       T  +DV+SFG  L E+                     
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP-------------- 237

Query: 479 VFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERDVA 538
            +      EL +        +  +     +  +   C H+ P+ RP+ +Q+V+ L+R VA
Sbjct: 238 -YPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296

Query: 539 L 539
           L
Sbjct: 297 L 297

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  178 bits (452), Expect = 2e-51
 Identities = 51/271 (18%), Positives = 98/271 (36%), Gaps = 21/271 (7%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQ 322
           +   E LG+G FG V+R     +      K I+            EI  + +L H  L+ 
Sbjct: 31  YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN 90

Query: 323 LLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQ 382
           L      K E++L+ +++  G L   +  +    ++  +    ++    GL ++H   E 
Sbjct: 91  LHDAFEDKYEMVLILEFLSGGELFDRIAAEDY-KMSEAEVINYMRQACEGLKHMH---EH 146

Query: 383 VVIHRDVKASNVLLDGELNGR--LGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGK 440
            ++H D+K  N++ + +      + DFGLA   +   D        T  + APE      
Sbjct: 147 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP--DEIVKVTTATAEFAAPEIVDREP 204

Query: 441 ATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEY 500
                D+++ G     +  G  P   +   E L  V          E  E    ++  E 
Sbjct: 205 VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNV-----KRCDWEFDEDAFSSVSPEA 259

Query: 501 VAEELELVLKLGLLCSHSDPTARPSMRQVVQ 531
                + +          +P  R ++   ++
Sbjct: 260 K----DFIKN----LLQKEPRKRLTVHDALE 282

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (445), Expect = 4e-51
 Identities = 58/279 (20%), Positives = 105/279 (37%), Gaps = 32/279 (11%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRN 319
           F+  ++LG G F  V       +  E A+K +          +     E   + RL H  
Sbjct: 10  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69

Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQE 379
            V+L    +   +L     Y  NG L KY+           + +     +   L YLH +
Sbjct: 70  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY--TAEIVSALEYLHGK 127

Query: 380 WEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH-GTDPQTTHVVGTLGYLAPEHTRT 438
               +IHRD+K  N+LL+ +++ ++ DFG A++        +    VGT  Y++PE    
Sbjct: 128 G---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 184

Query: 439 GKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEA---RDPN 495
             A  S+D+++ G  + ++  G  P                F   N   + +     + +
Sbjct: 185 KSACKSSDLWALGCIIYQLVAGLPP----------------FRAGNEYLIFQKIIKLEYD 228

Query: 496 LGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILE 534
              ++  +  +LV K        D T R    ++     
Sbjct: 229 FPEKFFPKARDLVEK----LLVLDATKRLGCEEMEGYGP 263

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (438), Expect = 5e-50
 Identities = 74/321 (23%), Positives = 120/321 (37%), Gaps = 54/321 (16%)

Query: 238 ELEDWELDHGPHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQ-----IEIAVK 292
           +   WE      R +              + LG G FG+V                +AVK
Sbjct: 4   DASKWEFPR--DRLKLG------------KPLGRGAFGQVIEADAFGIDKTATCRTVAVK 49

Query: 293 KISHESRQG-MKEFVAEIVSIGR-LRHRNLVQLLGYCRRKGE-LLLVYDYMPNGSLDKYL 349
            +   +     +  ++E+  +     H N+V LLG C + G  L+++ ++   G+L  YL
Sbjct: 50  MLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 109

Query: 350 Y--------------DQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVL 395
                          D  K  L           VA G+ +L        IHRD+ A N+L
Sbjct: 110 RSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNIL 166

Query: 396 LDGELNGRLGDFGLAR-LYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFL 454
           L  +   ++ DFGLAR +Y      +       L ++APE       T  +DV+SFG  L
Sbjct: 167 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 226

Query: 455 LEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLL 514
            E+           P   + + +        G  + A D      Y   E+    +  L 
Sbjct: 227 WEIFSLGAS-----PYPGVKIDEEFCRRLKEGTRMRAPD------YTTPEM---YQTMLD 272

Query: 515 CSHSDPTARPSMRQVVQILER 535
           C H +P+ RP+  ++V+ L  
Sbjct: 273 CWHGEPSQRPTFSELVEHLGN 293

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  172 bits (436), Expect = 1e-49
 Identities = 56/270 (20%), Positives = 103/270 (38%), Gaps = 18/270 (6%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKE-FVAEIVSIGRLRHRNLV 321
           +  +++LGTG F  V      ++Q  +A+K I+ ++ +G +     EI  + +++H N+V
Sbjct: 11  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 70

Query: 322 QLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
            L       G L L+   +  G L   + ++   T     R   I  V   + YLH    
Sbjct: 71  ALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRL--IFQVLDAVKYLHDLGI 128

Query: 382 QVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKA 441
                +        LD +    + DFGL+++ D G+    +   GT GY+APE       
Sbjct: 129 VHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS--VLSTACGTPGYVAPEVLAQKPY 186

Query: 442 TTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYV 501
           + + D +S G     + CG  P   +  ++    +          E       ++     
Sbjct: 187 SKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQI-----LKAEYEFDSPYWDDISDSAK 241

Query: 502 AEELELVLKLGLLCSHSDPTARPSMRQVVQ 531
               + +          DP  R +  Q +Q
Sbjct: 242 ----DFIRH----LMEKDPEKRFTCEQALQ 263

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  164 bits (415), Expect = 5e-47
 Identities = 62/283 (21%), Positives = 104/283 (36%), Gaps = 28/283 (9%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRN 319
           +   E+LG GG   V+     +   ++AVK +  +          F  E  +   L H  
Sbjct: 9   YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 68

Query: 320 LVQLLGYCRRKGE----LLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFY 375
           +V +      +        +V +Y+   +L   ++ +    +   +   VI      L +
Sbjct: 69  IVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQALNF 126

Query: 376 LHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP--QTTHVVGTLGYLAP 433
                +  +IHRDVK +N+++      ++ DFG+AR      +   QT  V+GT  YL+P
Sbjct: 127 S---HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 183

Query: 434 EHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARD 493
           E  R       +DV+S G  L EV  G  P     P                     AR 
Sbjct: 184 EQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQH-----VREDPIPPSARH 238

Query: 494 PNLGTEYVAEELELVLKLGLLCSHSDPTARP-SMRQVVQILER 535
             L  +       +VLK        +P  R  +  ++   L R
Sbjct: 239 EGLSADLD----AVVLK----ALAKNPENRYQTAAEMRADLVR 273

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (417), Expect = 8e-47
 Identities = 53/280 (18%), Positives = 106/280 (37%), Gaps = 25/280 (8%)

Query: 254 KDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIG 313
           K+LY   + +   E LG G FG V+R     S+     K +  +          EI  + 
Sbjct: 1   KELY---EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILN 56

Query: 314 RLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGL 373
             RHRN++ L        EL+++++++    + + + +     LN  +    +  V   L
Sbjct: 57  IARHRNILHLHESFESMEELVMIFEFISGLDIFERI-NTSAFELNEREIVSYVHQVCEAL 115

Query: 374 FYLHQEWEQVVIHRDVKASNVLLDGELNGR--LGDFGLARLYDHGTDPQTTHVVGTLGYL 431
            +LH      + H D++  N++     +    + +FG AR    G + +         Y 
Sbjct: 116 QFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF--TAPEYY 170

Query: 432 APEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEA 491
           APE  +    +T+ D++S G  +  +  G  P   +   +       + +     E    
Sbjct: 171 APEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ-------IIENIMNAEYT-- 221

Query: 492 RDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ 531
            D     E   E ++ V +        +  +R +  + +Q
Sbjct: 222 FDEEAFKEISIEAMDFVDR----LLVKERKSRMTASEALQ 257

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (417), Expect = 8e-47
 Identities = 70/331 (21%), Positives = 127/331 (38%), Gaps = 43/331 (12%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE---SRQGMKEFVAEIVSIGR-LRHR 318
           F   ++LG G FG+V+     K+    A+K +  +       ++  + E   +     H 
Sbjct: 4   FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63

Query: 319 NLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQ 378
            L  +    + K  L  V +Y+  G L  ++    K  L+    +     + LGL +L  
Sbjct: 64  FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFY--AAEIILGLQFL-- 119

Query: 379 EWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRT 438
              + +++RD+K  N+LLD + + ++ DFG+ +    G     T   GT  Y+APE    
Sbjct: 120 -HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT-FCGTPDYIAPEILLG 177

Query: 439 GKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGT 498
            K   S D +SFG  L E+  G+ P   Q   E    +     F+ R    EA+D     
Sbjct: 178 QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKD----- 232

Query: 499 EYVAEELELVLKLGLLCSHSDPTARPSMRQVV------------QILERDVALPAISALR 546
                   L++K        +P  R  +R  +            ++  +++  P    + 
Sbjct: 233 --------LLVK----LFVREPEKRLGVRGDIRQHPLFREINWEELERKEIDPPFRPKV- 279

Query: 547 LSTSGITYLEGFDDFAVSNPPSMGFTRPSSV 577
                      FD   ++  P + F   + +
Sbjct: 280 ---KSPFDCSNFDKEFLNEKPRLSFADRALI 307

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  159 bits (404), Expect = 2e-45
 Identities = 68/285 (23%), Positives = 114/285 (40%), Gaps = 36/285 (12%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKI--------SHESRQGMKE-FVAEIVSIG 313
           +  KE+LG G    V R     +  E AVK I        S E  Q ++E  + E+  + 
Sbjct: 5   YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64

Query: 314 RLR-HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALG 372
           ++  H N++QL           LV+D M  G L  YL +  KVTL+  +  ++++ +   
Sbjct: 65  KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIMRALLEV 122

Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLA 432
           +  LH   +  ++HRD+K  N+LLD ++N +L DFG +   D G   +   V GT  YLA
Sbjct: 123 ICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE--KLREVCGTPSYLA 177

Query: 433 PEHTRTGKA------TTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRG 486
           PE                 D++S G  +  +  G  P   +     L ++          
Sbjct: 178 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI-----MSGNY 232

Query: 487 ELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ 531
           +       +          +LV +         P  R +  + + 
Sbjct: 233 QFGSPEWDDYSDTVK----DLVSR----FLVVQPQKRYTAEEALA 269

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  161 bits (407), Expect = 5e-45
 Identities = 61/273 (22%), Positives = 105/273 (38%), Gaps = 29/273 (10%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE---SRQGMKEFVAEIVSIGRLR--- 316
           F    ++G GGFG VY      +    A+K +  +    +QG    + E + +  +    
Sbjct: 6   FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65

Query: 317 HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYL 376
              +V +        +L  + D M  G L  +L      +   ++ +     + LGL ++
Sbjct: 66  CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFY--AAEIILGLEHM 123

Query: 377 HQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHT 436
           H  +   V++RD+K +N+LLD   + R+ D GLA  +      +    VGT GY+APE  
Sbjct: 124 HNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KPHASVGTHGYMAPEVL 177

Query: 437 RTGKA-TTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPN 495
           + G A  +SAD FS G  L ++  G  P ++    +   +                    
Sbjct: 178 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM----------AVE 227

Query: 496 LGTEYVAEELELVLKLGLLCSHSDPTARPSMRQ 528
           L   +  E   L+          D   R     
Sbjct: 228 LPDSFSPELRSLLEG----LLQRDVNRRLGCLG 256

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (399), Expect = 4e-44
 Identities = 56/274 (20%), Positives = 110/274 (40%), Gaps = 27/274 (9%)

Query: 266 KELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRL-RHRNLVQLL 324
            ++LG G  G+V +    ++Q + A+K +    +        E+    R  +  ++V+++
Sbjct: 17  SQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-----ARREVELHWRASQCPHIVRIV 71

Query: 325 GYCR----RKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEW 380
                    +  LL+V + +  G L   + D+        +   ++K +   + YLH   
Sbjct: 72  DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH--- 128

Query: 381 EQVVIHRDVKASNVLLDGELNG---RLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTR 437
              + HRDVK  N+L   +      +L DFG A+         T     T  Y+APE   
Sbjct: 129 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPEVLG 186

Query: 438 TGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLG 497
             K   S D++S G  +  + CG  P            +        R  + +   PN  
Sbjct: 187 PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG------LAISPGMKTRIRMGQYEFPNPE 240

Query: 498 TEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ 531
              V+EE++++++       ++PT R ++ + + 
Sbjct: 241 WSEVSEEVKMLIR---NLLKTEPTQRMTITEFMN 271

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (387), Expect = 7e-43
 Identities = 57/291 (19%), Positives = 109/291 (37%), Gaps = 33/291 (11%)

Query: 251 FRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKI------SHESRQGMKE 304
           FR +++      +   E LG+G F  V +     + ++ A K I      S       ++
Sbjct: 3   FRQENV---DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED 59

Query: 305 FVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFR 364
              E+  +  ++H N++ L      K +++L+ + +  G L  +L ++  +T      F 
Sbjct: 60  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEF- 118

Query: 365 VIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGR----LGDFGLARLYDHGTDPQ 420
               +   L  ++      + H D+K  N++L      +    + DFGLA   D G   +
Sbjct: 119 ----LKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN--E 172

Query: 421 TTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVF 480
             ++ GT  ++APE          AD++S G     +  G  P       E L  V  V 
Sbjct: 173 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV- 231

Query: 481 DFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ 531
                 E  +    N          + + +        DP  R +++  +Q
Sbjct: 232 ----NYEFEDEYFSNTSALAK----DFIRR----LLVKDPKKRMTIQDSLQ 270

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (386), Expect = 1e-42
 Identities = 67/290 (23%), Positives = 117/290 (40%), Gaps = 27/290 (9%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEI-AVKKISHESRQGMKE-----FVAEIVSIGRLR 316
           +     +G G +G+V++    K+     A+K++  ++ +          VA +  +    
Sbjct: 9   YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 68

Query: 317 HRNLVQLLGYC-----RRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVAL 371
           H N+V+L   C      R+ +L LV++++       YL   P+  +       ++  +  
Sbjct: 69  HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTT-YLDKVPEPGVPTETIKDMMFQLLR 127

Query: 372 GLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYL 431
           GL +LH      V+HRD+K  N+L+      +L DFGLAR+Y        T VV TL Y 
Sbjct: 128 GLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM--ALTSVVVTLWYR 182

Query: 432 APEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILV----------DWVFD 481
           APE        T  D++S G    E+   +   +     + L  +          DW  D
Sbjct: 183 APEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 242

Query: 482 FWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ 531
                +   ++      ++V +  EL   L L C   +P  R S    + 
Sbjct: 243 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  152 bits (385), Expect = 3e-42
 Identities = 64/322 (19%), Positives = 119/322 (36%), Gaps = 42/322 (13%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRN 319
           F+    LGTG FGRV+      +    A+K +  E     + ++    E + +  + H  
Sbjct: 6   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65

Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQE 379
           ++++ G  +   ++ ++ DY+  G L   L    +      + +     V L L YLH  
Sbjct: 66  IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFY--AAEVCLALEYLH-- 121

Query: 380 WEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTG 439
             + +I+RD+K  N+LLD   + ++ DFG A+         T  + GT  Y+APE   T 
Sbjct: 122 -SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD----VTYTLCGTPDYIAPEVVSTK 176

Query: 440 KATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTE 499
               S D +SFG  + E+  G  P       +               E +   +      
Sbjct: 177 PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTY-------------EKILNAELRFPPF 223

Query: 500 YVAEELELVLKLGLLCSHSDPTARPSMRQ--VVQILE----RDVALPAISALRLST---- 549
           +  +  +L+ +        D + R    Q     +      ++V    + +  + T    
Sbjct: 224 FNEDVKDLLSR----LITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEP 279

Query: 550 ---SGITYLEGFDDFAVSNPPS 568
               G      FD +   +   
Sbjct: 280 PIQQGQGDTSQFDKYPEEDINY 301

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (383), Expect = 3e-42
 Identities = 62/283 (21%), Positives = 109/283 (38%), Gaps = 18/283 (6%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKI--SHESRQGMKEFVAEIVSIGRLRHRNL 320
           F++ E +G G +G VY+     +   +A+KKI    E+       + EI  +  L H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63

Query: 321 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEW 380
           V+LL     + +L LV++++ +  L K++       +        +  +  GL +     
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFC---H 119

Query: 381 EQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGK 440
              V+HRD+K  N+L++ E   +L DFGLAR +       T  VV               
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179

Query: 441 ATTSADVFSFGAFLLEVACGRRP------------IQRQGPSENLILVDWVFDFWNRGEL 488
            +T+ D++S G    E+   R              I R   + + ++   V    +    
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239

Query: 489 LEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ 531
                    ++ V    E    L     H DP  R S +  + 
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (386), Expect = 3e-42
 Identities = 70/298 (23%), Positives = 116/298 (38%), Gaps = 28/298 (9%)

Query: 256 LYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGM-KEFVAEIVSIGR 314
           ++     +     +G G +G V       +++ +A+KKIS    Q   +  + EI  + R
Sbjct: 3   VFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLR 62

Query: 315 LRHRNLVQLLGYCR----RKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVA 370
            RH N++ +    R     + + + +  ++    L K L  Q    L+       +  + 
Sbjct: 63  FRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH---LSNDHICYFLYQIL 119

Query: 371 LGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQT--THVVGTL 428
            GL Y+H      V+HRD+K SN+LL+   + ++ DFGLAR+ D   D     T  V T 
Sbjct: 120 RGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 176

Query: 429 GYLAPEHTRTGKATT-SADVFSFGAFLLEVACGRRPIQRQGPSENL-----ILVDWVFDF 482
            Y APE     K  T S D++S G  L E+   R     +   + L     IL     + 
Sbjct: 177 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 236

Query: 483 WNRGELLEA---------RDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ 531
            N    L+A         ++               L L       +P  R  + Q + 
Sbjct: 237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (382), Expect = 3e-42
 Identities = 69/285 (24%), Positives = 110/285 (38%), Gaps = 24/285 (8%)

Query: 265 EK-ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKE-----FVAEIVSIGRLRHR 318
           EK + LG G F  VY+     +   +A+KKI    R   K+      + EI  +  L H 
Sbjct: 1   EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60

Query: 319 NLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQ 378
           N++ LL     K  + LV+D+M        +     + L        +     GL YLHQ
Sbjct: 61  NIIGLLDAFGHKSNISLVFDFMETDLE--VIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ 118

Query: 379 EWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE-HTR 437
            W   ++HRD+K +N+LLD     +L DFGLA+ +        TH V T  Y APE    
Sbjct: 119 HW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAY-THQVVTRWYRAPELLFG 174

Query: 438 TGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILV----------DWVFDFWNRGE 487
                   D+++ G  L E+      +      + L  +           W         
Sbjct: 175 ARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY 234

Query: 488 LLEARDPNLGTEYVAEEL-ELVLKLGLLCSHSDPTARPSMRQVVQ 531
           +     P +   ++     + +L L       +P AR +  Q ++
Sbjct: 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  151 bits (382), Expect = 4e-42
 Identities = 52/281 (18%), Positives = 101/281 (35%), Gaps = 24/281 (8%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQ 322
           +R    +G+G FG +Y GT   +  E+A+K    +++    +   E      ++    + 
Sbjct: 9   YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIP 66

Query: 323 LLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQ 382
            + +C  +G+  ++   +   SL+  L++      +      +   +   + Y+H    +
Sbjct: 67  TIRWCGAEGDYNVMVMELLGPSLE-DLFNFCSRKFSLKTVLLLADQMISRIEYIH---SK 122

Query: 383 VVIHRDVKASNVLLDGELNGRL---GDFGLARLYDHGTDPQ------TTHVVGTLGYLAP 433
             IHRDVK  N L+     G L    DFGLA+ Y      Q        ++ GT  Y + 
Sbjct: 123 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 182

Query: 434 EHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARD 493
                 + +   D+ S G  L+    G  P Q    +      + + +       +    
Sbjct: 183 NTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK-----MSTPI 237

Query: 494 PNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILE 534
             L   Y +E    +      C       +P    + Q+  
Sbjct: 238 EVLCKGYPSEFATYLNF----CRSLRFDDKPDYSYLRQLFR 274

>d1hqla_ b.29.1.1 (A:) Legume lectin {Griffonia simplicifolia, lectin I-b4 [TaxId: 3850]} Length = 236

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Griffonia simplicifolia, lectin I-b4 [TaxId: 3850]

 Score =  149 bits (377), Expect = 5e-42
 Identities = 53/192 (27%), Positives = 85/192 (44%), Gaps = 23/192 (11%)

Query: 2   PFKNKNSNSSTANGTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGL 61
           P +  ++ +     +V SF T F F +     +    G+AF +A           +YLGL
Sbjct: 54  PVQLWDNKT----ESVASFYTEFTFFL-KITGNGPADGLAFFLAPP-DSDVKDAGEYLGL 107

Query: 62  FNDTNLGN-ETNHVFAVELDTIKSHGFLDINDNHVGIDINSLKSESSAP----------- 109
           FN +       N V AVE DT  +  F + +  H+GI++NS+ S ++             
Sbjct: 108 FNKSTATQPSKNQVVAVEFDTWTNPNFPEPSYRHIGINVNSIVSVATKRWEDSDIFSGKI 167

Query: 110 AGYYVEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSVLNDAMYVGFSSSTGSVLA- 168
           A   + YDG  +   V L+  +         +S S D+   L +++ VG S+STG+    
Sbjct: 168 ATARISYDGSAEILTVVLSYPDGSDY----ILSHSVDMRQNLPESVRVGISASTGNNQFL 223

Query: 169 SHYILGWSFKIN 180
           + YIL W F  N
Sbjct: 224 TVYILSWRFSSN 235

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  150 bits (380), Expect = 5e-42
 Identities = 66/283 (23%), Positives = 109/283 (38%), Gaps = 20/283 (7%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKI--SHESRQGMKEFVAEIVSIGRLRHRNL 320
           +   E +G G +G VY+      +   A+KKI    E        + EI  +  L+H N+
Sbjct: 4   YHGLEKIGEGTYGVVYKAQNNYGE-TFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62

Query: 321 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEW 380
           V+L      K  L+LV++++        L D  +  L  +     +  +  G+ Y H   
Sbjct: 63  VKLYDVIHTKKRLVLVFEHLDQDLK--KLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120

Query: 381 EQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGK 440
              V+HRD+K  N+L++ E   ++ DFGLAR +       T  +V            + K
Sbjct: 121 ---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKK 177

Query: 441 ATTSADVFSFGAFLLEVACGRRPIQRQGPSENL-----ILVDWVFDFWNRGELLEARDPN 495
            +T+ D++S G    E+  G         ++ L     IL       W     L   DPN
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237

Query: 496 LGTEYVAEELELVLKLG-----LL--CSHSDPTARPSMRQVVQ 531
                       +  L      LL      DP  R + +Q ++
Sbjct: 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280

>d1leda_ b.29.1.1 (A:) Legume lectin {West-central african legume (Griffonia simplicifolia) [TaxId: 3850]} Length = 243

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: West-central african legume (Griffonia simplicifolia) [TaxId: 3850]

 Score =  148 bits (374), Expect = 1e-41
 Identities = 50/176 (28%), Positives = 74/176 (42%), Gaps = 19/176 (10%)

Query: 14  NGTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGLFNDTNLGNET-N 72
            G   SF T+F F +L  Y + +  G+AF +A            +LGLF      + + N
Sbjct: 66  TGKAASFYTSFTF-LLKNYGAPTADGLAFFLAPV-DSSVKDYGGFLGLFRHETAADPSKN 123

Query: 73  HVFAVELDTIKSHGFLDINDNHVGIDINSLKSESSAPAGYY-----------VEYDGLEK 121
            V AVE DT  +  + D    H+GID+NS+ S ++                 + YD   K
Sbjct: 124 QVVAVEFDTWINKDWNDPPYPHIGIDVNSIVSVATTRWENDDAYGSSIATAHITYDARSK 183

Query: 122 RTNVTLAPINIPRPRSLNTMSLSRDLSSVLNDAMYVGFSSSTGSVLASHYILGWSF 177
              V L+  +         +S   DL+ VL   + +GFS+  G      YIL W F
Sbjct: 184 ILTVLLSYEHGRDY----ILSHVVDLAKVLPQKVRIGFSAGVGYD-EVTYILSWHF 234

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (382), Expect = 2e-41
 Identities = 65/289 (22%), Positives = 111/289 (38%), Gaps = 28/289 (9%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQ 322
           + + +++G G FG VY+  L  S   +A+KK+  + R        E+  + +L H N+V+
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVR 77

Query: 323 LLGYCRRKGE------LLLVYDYMPNGSLDKYL-YDQPKVTLNWIQRFRVIKGVALGLFY 375
           L  +    GE      L LV DY+P         Y + K TL  I     +  +   L Y
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137

Query: 376 LHQEWEQVVIHRDVKASNVLLDGE-LNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE 434
           +H      + HRD+K  N+LLD +    +L DFG A+    G +P  +++          
Sbjct: 138 IHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSYICSRYYRAPEL 193

Query: 435 HTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVF------------DF 482
                  T+S DV+S G  L E+  G+         + L+ +  V               
Sbjct: 194 IFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 253

Query: 483 WNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ 531
           +   +  + +       +        + L        PTAR +  +   
Sbjct: 254 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302

>d1g9fa_ b.29.1.1 (A:) Legume lectin {Soybean (Glycine max) [TaxId: 3847]} Length = 251

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Soybean (Glycine max) [TaxId: 3847]

 Score =  147 bits (373), Expect = 3e-41
 Identities = 51/210 (24%), Positives = 86/210 (40%), Gaps = 24/210 (11%)

Query: 2   PFKNKNSNSSTANGTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGL 61
           P    +  + +    V SF+ +F F+  +    +   G+AF +A     P      + G 
Sbjct: 56  PIHIWDKETGS----VASFAASFNFTFYAPDTKRLADGLAFFLAPIDTKPQ----THAGY 107

Query: 62  FNDTNLGNETNHVFAVELDTIKSHGFLDINDNHVGIDINSLKSESSAPAGYY-------- 113
               N     + V AVE DT ++    D  + H+GI++NS++S  +              
Sbjct: 108 LGLFNENESGDQVVAVEFDTFRNSW--DPPNPHIGINVNSIRSIKTTSWDLANNKVAKVL 165

Query: 114 VEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSVLNDAMYVGFSSSTGSVLA--SHY 171
           + YD        +L     P  R+ N +S   DL + L + + +GFS++TG  +   SH 
Sbjct: 166 ITYDASTSLLVASLV---YPSQRTSNILSDVVDLKTSLPEWVRIGFSAATGLDIPGESHD 222

Query: 172 ILGWSFKINGQAEELNLSQLPKLPRVGPKK 201
           +L WSF  N      N+  L  L      +
Sbjct: 223 VLSWSFASNLPHASSNIDPL-DLTSFVLHE 251

>d1g7ya_ b.29.1.1 (A:) Legume lectin {Horse gram (Dolichos biflorus), different isoforms [TaxId: 3840]} Length = 253

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Horse gram (Dolichos biflorus), different isoforms [TaxId: 3840]

 Score =  147 bits (372), Expect = 4e-41
 Identities = 54/205 (26%), Positives = 94/205 (45%), Gaps = 25/205 (12%)

Query: 2   PFKNKNSNSSTANGTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGL 61
           P +  + ++    G V S++T+F  +I +  +S S  GIAF +      P +  S +LG+
Sbjct: 53  PIQIYDKST----GAVASWATSFTANIFAPNKSSSADGIAFALVPVGSEPKS-NSGFLGV 107

Query: 62  FNDTNLGNETNHVFAVELDTIKSHGFLDINDNHVGIDINSLKSESSAPAGYY-------- 113
           F+     N +    AVE DT  +  + D    H+GID+NS+KS  +A  G          
Sbjct: 108 FDSDVYDN-SAQTVAVEFDTFSNTDW-DPTSRHIGIDVNSIKSIRTASWGLANGQNAEIL 165

Query: 114 VEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSVLNDAMYVGFSSSTGSVLA---SH 170
           + Y+        +L     P  R+   +S   D+++ L + + +GFS++TG       +H
Sbjct: 166 ITYNAATSLLVASLVH---PSRRTSYIVSERVDITNELPEYVSIGFSATTGLSEGYTETH 222

Query: 171 YILGWSFKIN----GQAEELNLSQL 191
            +L WSF          E L+++  
Sbjct: 223 DVLSWSFASKLPDDSTTEPLDIASY 247

>d1gzca_ b.29.1.1 (A:) Legume lectin {Cockspur coral tree (Erythrina crista-galli) [TaxId: 49817]} Length = 239

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Cockspur coral tree (Erythrina crista-galli) [TaxId: 49817]

 Score =  146 bits (369), Expect = 6e-41
 Identities = 54/192 (28%), Positives = 87/192 (45%), Gaps = 22/192 (11%)

Query: 2   PFKNKNSNSSTANGTVFSFSTTFVFSILSEY-QSQSGHGIAFVIASTRGLPGARPSQYLG 60
           P    +S + T    V SF T F FSI   Y +     G+ F +  T+  P      YLG
Sbjct: 56  PVHMWDSTTGT----VASFETRFSFSIEQPYTRPLPADGLVFFMGPTKSKPAQ-GYGYLG 110

Query: 61  LFNDTNLGNETNHVFAVELDTIKSHGFLDINDNHVGIDINSLKSESSAPAGY-------- 112
           +FN++   N +    AVE DT  +  +      H+GID+NS++S  + P           
Sbjct: 111 VFNNSKQDN-SYQTLAVEFDTFSNP-WDPPQVPHIGIDVNSIRSIKTQPFQLDNGQVANV 168

Query: 113 YVEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSVLNDAMYVGFSSSTGS---VLAS 169
            ++YD   K  +V L   +     ++ T++   D+  VL D + VG S +TG+      +
Sbjct: 169 VIKYDAPSKILHVVLVYPSSG---AIYTIAEIVDVKQVLPDWVDVGLSGATGAQRDAAET 225

Query: 170 HYILGWSFKING 181
           H +  WSF+ + 
Sbjct: 226 HDVYSWSFQASL 237

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  146 bits (370), Expect = 1e-40
 Identities = 44/285 (15%), Positives = 97/285 (34%), Gaps = 28/285 (9%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRN-LV 321
           ++    +G G FG ++ GT   +  ++A+K     S     +   E  +   L     + 
Sbjct: 7   YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIP 64

Query: 322 QLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWE 381
            +  + +     +LV D +  G   + L D      +        K +   +  +H+   
Sbjct: 65  NVYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE--- 119

Query: 382 QVVIHRDVKASNVLLDGELNG-----RLGDFGLARLYD------HGTDPQTTHVVGTLGY 430
           + +++RD+K  N L+    +       + DFG+ + Y       H    +  ++ GT  Y
Sbjct: 120 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 179

Query: 431 LAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLE 490
           ++       + +   D+ + G   +    G  P Q    + N    + +      GE  +
Sbjct: 180 MSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI------GEKKQ 233

Query: 491 ARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER 535
           +           EE    +       +    A P    +  +  +
Sbjct: 234 STPLRELCAGFPEEFYKYMH---YARNLAFDATPDYDYLQGLFSK 275

>d1fx5a_ b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus), UEA-I [TaxId: 3902]} Length = 240

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Furze (Ulex europaeus), UEA-I [TaxId: 3902]

 Score =  145 bits (366), Expect = 2e-40
 Identities = 56/189 (29%), Positives = 82/189 (43%), Gaps = 22/189 (11%)

Query: 2   PFKNKNSNSSTANGTVFSFSTTFVF-SILSEYQSQSGHGIAFVIASTRGLPGARPSQYLG 60
           P    N N+    G + SF T+F F    S     +  G+ F +A     P  R   Y G
Sbjct: 54  PIHIWNCNT----GELASFITSFSFFMETSANPKAATDGLTFFLAPP-DSPLRRAGGYFG 108

Query: 61  LFNDTNLGNETNHVFAVELDTIKSHG-FLDINDNHVGIDINSLKSESSAPAGYY------ 113
           LFNDT   + +    AVE DTI S   F D    H+GID+N +KS ++            
Sbjct: 109 LFNDTK-CDSSYQTVAVEFDTIGSPVNFWDPGFPHIGIDVNCVKSINAERWNKRYGLNNV 167

Query: 114 ----VEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSVLNDAMYVGFSSSTG-SVLA 168
               + Y+   K    +L     P  ++  +++   DL  +L + + VGFS ST     A
Sbjct: 168 ANVEIIYEASSKTLTASLTY---PSDQTSISVTSIVDLKEILPEWVSVGFSGSTYIGRQA 224

Query: 169 SHYILGWSF 177
           +H +L W F
Sbjct: 225 THEVLNWYF 233

>d1qnwa_ b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus), UEA-II [TaxId: 3902]} Length = 237

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Furze (Ulex europaeus), UEA-II [TaxId: 3902]

 Score =  145 bits (366), Expect = 2e-40
 Identities = 48/191 (25%), Positives = 83/191 (43%), Gaps = 20/191 (10%)

Query: 2   PFKNKNSNSSTANGTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGL 61
           P +  +S +      V SF+T+F F + ++  S    G+AF +A       +  S  +  
Sbjct: 53  PIQIWDSITGK----VASFATSFSFVVKADK-SDGVDGLAFFLAPANSQIPSGSSAGMFG 107

Query: 62  FNDTNLGNETNHVFAVELDTIKSHGF--LDINDNHVGIDINSLKSESSAPAGYY------ 113
              ++    +N + AVE DT     +   D +  H+GID+NS+KS  +    +       
Sbjct: 108 LFSSSDSKSSNQIIAVEFDTYFGKAYNPWDPDFKHIGIDVNSIKSIKTVKWDWRNGEVAD 167

Query: 114 --VEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSVLNDAMYVGFSSSTGSV--LAS 169
             + Y    K   V L+  +       N ++ S DL ++L + + VGFS   G+     +
Sbjct: 168 VVITYRAPTKSLTVCLSYPSDGTS---NIITASVDLKAILPEWVSVGFSGGVGNAAEFET 224

Query: 170 HYILGWSFKIN 180
           H +L W F  N
Sbjct: 225 HDVLSWYFTSN 235

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (371), Expect = 2e-40
 Identities = 65/298 (21%), Positives = 116/298 (38%), Gaps = 34/298 (11%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQG--MKEFVAEIVSIGRLRHRNL 320
           + +   +G G FG V++    K+  ++A+KK+  E+ +       + EI  +  L+H N+
Sbjct: 12  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 71

Query: 321 VQLLGYC--------RRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALG 372
           V L+  C        R KG + LV+D+  +           K TL+ I+R      + + 
Sbjct: 72  VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRV-----MQML 126

Query: 373 LFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTH---VVGTLG 429
           L  L+      ++HRD+KA+NVL+  +   +L DFGLAR +    + Q       V TL 
Sbjct: 127 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186

Query: 430 YLAPEHTRTGKA-TTSADVFSFGAFLLEVACGRRPIQRQGPSENL-----ILVDWVFDFW 483
           Y  PE     +      D++  G  + E+      +Q       L     +      + W
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246

Query: 484 NRGELLEARDPNLGTEYVAEELELVLKLGLL----------CSHSDPTARPSMRQVVQ 531
              +  E  +     +    +++  LK  +               DP  R      + 
Sbjct: 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304

>d1g8wa_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 233

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Phytohemagglutinin-L, PHA-L, also arcelin
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score =  144 bits (364), Expect = 3e-40
 Identities = 53/187 (28%), Positives = 90/187 (48%), Gaps = 23/187 (12%)

Query: 2   PFKNKNSNSSTANGTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGL 61
           P +  ++ +    GTV SF+T+F F+I     +    G+AF +      P      +LGL
Sbjct: 54  PIQIWDNTT----GTVASFATSFTFNIQVPNNAGPADGLAFALVPVGSQPKD-KGGFLGL 108

Query: 62  FNDTNLGNETNHVFAVELDTIKSHGFLDINDNHVGIDINSLKSESSAPAGYY-------- 113
           F+ +N      H  AVE DT+ +  + D  + H+GID+NS++S  +    +         
Sbjct: 109 FDGSN---SNFHTVAVEFDTLYNKDW-DPTERHIGIDVNSIRSIKTTRWDFVNGENAEVL 164

Query: 114 VEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSVLNDAMYVGFSSSTGSV---LASH 170
           + YD        +L     P  ++   +S + DL SVL + + VGFS++TG     + ++
Sbjct: 165 ITYDSSTNLLVASLVY---PSQKTSFIVSDTVDLKSVLPEWVSVGFSATTGINKGNVETN 221

Query: 171 YILGWSF 177
            +L WSF
Sbjct: 222 DVLSWSF 228

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (362), Expect = 2e-39
 Identities = 59/279 (21%), Positives = 100/279 (35%), Gaps = 40/279 (14%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKE------FVAEIVSIGRLR 316
           ++   LLG+GGFG VY G      + +A+K +  +      E         E+V + ++ 
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65

Query: 317 --HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLF 374
                +++LL +  R    +L+ +             +    L           V   + 
Sbjct: 66  SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVR 124

Query: 375 YLHQEWEQVVIHRDVKASNVLLDGELNG-RLGDFGLARLYDHGTDPQTTHVVGTLGYLAP 433
           +        V+HRD+K  N+L+D      +L DFG   L     D   T   GT  Y  P
Sbjct: 125 HC---HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK---DTVYTDFDGTRVYSPP 178

Query: 434 EHTRTGKA-TTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEAR 492
           E  R  +    SA V+S G  L ++ CG  P                  F +  E++  +
Sbjct: 179 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIP------------------FEHDEEIIRGQ 220

Query: 493 DPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ 531
                    +E   L+      C    P+ RP+  ++  
Sbjct: 221 -VFFRQRVSSECQHLIRW----CLALRPSDRPTFEEIQN 254

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (362), Expect = 5e-39
 Identities = 60/277 (21%), Positives = 97/277 (35%), Gaps = 28/277 (10%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRN 319
           F   +LLG G FG+V       +    A+K +  E   ++  +   V E   +   RH  
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66

Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQE 379
           L  L    +    L  V +Y   G L  +L  +   T    + +      A  +  L   
Sbjct: 67  LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFY-----GAEIVSALEYL 121

Query: 380 WEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTG 439
             + V++RD+K  N++LD + + ++ DFGL +              GT  YLAPE     
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG-ISDGATMKTFCGTPEYLAPEVLEDN 180

Query: 440 KATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTE 499
               + D +  G  + E+ CGR P   Q                   EL+   +      
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF-------------ELILMEEIRFPRT 227

Query: 500 YVAEELELVLKLGLLCSHSDPTARPSMRQ--VVQILE 534
              E   L+          DP  R         +++E
Sbjct: 228 LSPEAKSLLAG----LLKKDPKQRLGGGPSDAKEVME 260

>d1f9ka_ b.29.1.1 (A:) Legume lectin {Winged bean (Psophocarpus tetragonolobus), acidic lectin [TaxId: 3891]} Length = 234

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Winged bean (Psophocarpus tetragonolobus), acidic lectin [TaxId: 3891]

 Score =  139 bits (352), Expect = 1e-38
 Identities = 53/190 (27%), Positives = 81/190 (42%), Gaps = 28/190 (14%)

Query: 2   PFKNKNSNSSTANGTVFSFSTTFVFSILSEY-QSQSGHGIAFVIASTRGLPGARPSQYLG 60
           P K  +S +      V SF T F F+I   Y   +   G+ F +          P    G
Sbjct: 55  PIKIWDSTTGN----VASFETRFSFNITQPYAYPEPADGLTFFMVPPNS-----PQGEDG 105

Query: 61  LFNDTNLGNETNHVFAVELDTIKSHGFLDINDNHVGIDINSLKS--------ESSAPAGY 112
                    E ++ FAVE DT ++    D    H+GID+NS+ S        E+   A  
Sbjct: 106 GNLGVFKPPEGDNAFAVEFDTFQNTW--DPQVPHIGIDVNSIVSSKTLHFQLENGGVANV 163

Query: 113 YVEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSVL--NDAMYVGFSSSTG---SVL 167
            ++YD   K  NV LA  ++    +L   S   DL      ++ + VG S++TG   + +
Sbjct: 164 VIKYDSPTKILNVVLAFHSVGTVYTL---SNIVDLKQEFPNSEWVNVGLSATTGYQKNAV 220

Query: 168 ASHYILGWSF 177
            +H I+ WSF
Sbjct: 221 ETHEIISWSF 230

>d1ukga_ b.29.1.1 (A:) Legume lectin {Bloodwood tree (Pterocarpus angolensis) [TaxId: 182271]} Length = 241

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Bloodwood tree (Pterocarpus angolensis) [TaxId: 182271]

 Score =  138 bits (349), Expect = 4e-38
 Identities = 46/188 (24%), Positives = 76/188 (40%), Gaps = 19/188 (10%)

Query: 2   PFKNKNSNSSTANGTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGL 61
                  +    +  V +F + F FS+ S   + +     F+      +P       LGL
Sbjct: 55  QVHLWEKS----SSRVANFQSQFSFSLKSPLSNGADGIAFFIAPPDTTIPSGSGGGLLGL 110

Query: 62  FNDTNLGNET-NHVFAVELDTIKS--HGFLDINDNHVGIDINSLKSESSAPAGYY----- 113
           F      N + N V AVE DT  +      D N  H+GID+NS++S  +           
Sbjct: 111 FAPGTAQNTSANQVIAVEFDTFYAQDSNTWDPNYPHIGIDVNSIRSVKTVKWDRRDGQSL 170

Query: 114 ---VEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSVLNDAMYVGFSSSTGSVLASH 170
              V ++   +  +V     +  R      +S   D+ SVL + + VGFS+++G    +H
Sbjct: 171 NVLVTFNPSTRNLDVVATYSDGTRY----EVSYEVDVRSVLPEWVRVGFSAASGEQYQTH 226

Query: 171 YILGWSFK 178
            +  WSF 
Sbjct: 227 TLESWSFT 234

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (351), Expect = 6e-38
 Identities = 53/284 (18%), Positives = 103/284 (36%), Gaps = 20/284 (7%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKI--SHESRQGMKEFVAEIVSIGRLRHRNL 320
           + + E +G G +G V++    ++   +A+K++    +        + EI  +  L+H+N+
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63

Query: 321 VQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEW 380
           V+L        +L LV+++        +      +    ++ F  +  +  GL + H   
Sbjct: 64  VRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSF--LFQLLKGLGFCHSRN 121

Query: 381 EQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGK 440
              V+HRD+K  N+L++     +L +FGLAR +       +  VV               
Sbjct: 122 ---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL 178

Query: 441 ATTSADVFSFGAFLLEVACGRRP-------------IQRQGPSENLILVDWVFDFWNRGE 487
            +TS D++S G    E+A   RP             I R   +        +    +   
Sbjct: 179 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238

Query: 488 LLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ 531
                        V +       L       +P  R S  + +Q
Sbjct: 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282

>d1v6ia_ b.29.1.1 (A:) Legume lectin {Peanut (Arachis hypogaea) [TaxId: 3818]} Length = 232

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Peanut (Arachis hypogaea) [TaxId: 3818]

 Score =  137 bits (346), Expect = 9e-38
 Identities = 49/185 (26%), Positives = 69/185 (37%), Gaps = 19/185 (10%)

Query: 2   PFKNKNSNSSTANGTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGL 61
           P +  +S +    G V SF T+F F +          GI F IA              G 
Sbjct: 51  PVRIWSSAT----GNVASFLTSFSFEMKDIKDYDPADGIIFFIAPEDTQIP--AGSIGGG 104

Query: 62  FNDTNLGNETNHVFAVELDTIKSHGFLDINDNHVGIDINSLKSESSAPAGYY-------- 113
               +      H   VE DT  +  + D   +HVGID+NS+ S  + P            
Sbjct: 105 TLGVSDTKGAGHFVGVEFDTYSNSEYNDPPTDHVGIDVNSVDSVKTVPWNSVSGAVVKVT 164

Query: 114 VEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSVLNDAMYVGFSSSTGSV-LASHYI 172
           V YD   K  +V +   N        T++   DL + L + +  GFS+S        H I
Sbjct: 165 VIYDSSTKTLSVAVTNDNGDIT----TIAQVVDLKAKLPERVKFGFSASGSLGGRQIHLI 220

Query: 173 LGWSF 177
             WSF
Sbjct: 221 RSWSF 225

>d1avba_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 226

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Phytohemagglutinin-L, PHA-L, also arcelin
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score =  135 bits (341), Expect = 3e-37
 Identities = 47/192 (24%), Positives = 77/192 (40%), Gaps = 31/192 (16%)

Query: 2   PFKNKNSNSSTANGTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGL 61
           P +  +         + SFST F F I ++    S +G+AF +      P     +YLGL
Sbjct: 51  PIQINDRTI----DNLASFSTNFTFRINAKNIENSAYGLAFALVPVGSRPKL-KGRYLGL 105

Query: 62  FNDTNLGNETNHVFAVELDTIKSHGFLDINDNHVGIDINSLKSESSAPAGYY-------- 113
           FN TN           + D        D   N + ID+NS++  ++    +         
Sbjct: 106 FNTTN----------YDRDAHTVAVVFDTVSNRIEIDVNSIRPIATESCNFGHNNGEKAE 155

Query: 114 --VEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSVLNDAMYVGFSSSTGS---VLA 168
             + YD  +    V+L   +      +   S +  L   + D + VGFS+++GS      
Sbjct: 156 VRITYDSPKNDLRVSLLYPSSEEKCHV---SATVPLEKEVEDWVSVGFSATSGSKKETTE 212

Query: 169 SHYILGWSFKIN 180
           +H +L WSF  N
Sbjct: 213 THNVLSWSFSSN 224

>d1fnya_ b.29.1.1 (A:) Legume lectin {Black locust (Robinia pseudoacacia) [TaxId: 35938]} Length = 237

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Black locust (Robinia pseudoacacia) [TaxId: 35938]

 Score =  135 bits (341), Expect = 4e-37
 Identities = 50/191 (26%), Positives = 86/191 (45%), Gaps = 21/191 (10%)

Query: 2   PFKNKNSNSSTANGTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGL 61
           PF+  +S +      V SF T+F F I +   + +  G+AF +A     P       LG+
Sbjct: 55  PFQIWDSTTGN----VASFVTSFTFIIQAPNPATTADGLAFFLAPVDTQPLD-LGGMLGI 109

Query: 62  FNDTNLGNETNHVFAVELDTIKSHGFLDINDNHVGIDINSLKSESSAPAGYY-------- 113
           F D    N++N + AVE DT  +  + D    H+GI++NS++S  + P  +         
Sbjct: 110 FKDGY-FNKSNQIVAVEFDTFSNGDW-DPKGRHLGINVNSIESIKTVPWNWTNGEVANVF 167

Query: 114 VEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSVLNDAMYVGFSSSTGSVLAS---H 170
           + Y+   K    +L   ++        +    D+  VL + +  GFS++TG        +
Sbjct: 168 ISYEASTKSLTASLVYPSLETS---FIIDAIVDVKIVLPEWVRFGFSATTGIDKGYVQTN 224

Query: 171 YILGWSFKING 181
            +L WSF+ N 
Sbjct: 225 DVLSWSFESNL 235

>d2d3sa1 b.29.1.1 (A:1-237) Legume lectin {Winged bean (Psophocarpus tetragonolobus), basic agglutinin [TaxId: 3891]} Length = 237

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Winged bean (Psophocarpus tetragonolobus), basic agglutinin [TaxId: 3891]

 Score =  135 bits (341), Expect = 4e-37
 Identities = 49/195 (25%), Positives = 79/195 (40%), Gaps = 28/195 (14%)

Query: 2   PFKNKNSNSSTANGTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGL 61
           P +  +S +    G V SF T F FSI   +             +           Y G+
Sbjct: 54  PVQVWDSTT----GNVASFETRFSFSIRQPFPRPHPADGLVFFIAPPNTQTGEGGGYFGI 109

Query: 62  FNDTNLGNETNHVFAVELDTIKSHGFLDINDNHVGIDINSLKS--------ESSAPAGYY 113
           +N  +         AVE DT ++    D    H+GID+NS+ S        ++   A   
Sbjct: 110 YNPLS----PYPFVAVEFDTFRNTW--DPQIPHIGIDVNSVISTKTVPFTLDNGGIANVV 163

Query: 114 VEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSVLNDAMYVGFSSSTGSV------- 166
           ++YD   K  +V L   ++    ++   +   DL  VL +++ VGFS++TG         
Sbjct: 164 IKYDASTKILHVVLVFPSLGTIYTI---ADIVDLKQVLPESVNVGFSAATGDPSGKQRNA 220

Query: 167 LASHYILGWSFKING 181
             +H IL WSF  + 
Sbjct: 221 TETHDILSWSFSASL 235

>d1n47a_ b.29.1.1 (A:) Legume lectin {Hairy vetch (Vicia villosa), isolectin b4 [TaxId: 3911]} Length = 233

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Hairy vetch (Vicia villosa), isolectin b4 [TaxId: 3911]

 Score =  135 bits (341), Expect = 5e-37
 Identities = 51/178 (28%), Positives = 82/178 (46%), Gaps = 18/178 (10%)

Query: 14  NGTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGLFNDTNLGNETNH 73
           N T+ SF+T+F F + +   +    G+AF +A     P A    +LGLF D    + +  
Sbjct: 61  NTTLASFTTSFSFVMAAPAAAAVADGLAFFLAPPDTQPQA-RGGFLGLFADRA-HDASYQ 118

Query: 74  VFAVELDTIKSHGFLDINDNHVGIDINSLKSESSAPAGYY--------VEYDGLEKRTNV 125
             AVE DT  +    D N  H+GID N ++S+ + P            + Y    K    
Sbjct: 119 TVAVEFDTYSNAW--DPNYTHIGIDTNGIESKKTTPFDMVYGEKANIVITYQASTKALAA 176

Query: 126 TLAPINIPRPRSLNTMSLSRDLSSVLNDAMYVGFSSSTGS---VLASHYILGWSFKIN 180
           +L         ++   S   DL  +L + + VGFS++TG    V+ +H I+ WSF ++
Sbjct: 177 SLVFPVSQTSYAV---SARVDLRDILPEYVRVGFSATTGLNAGVVETHDIVSWSFAVS 231

>d1dbna_ b.29.1.1 (A:) Legume lectin {Maackia amurensis, leukoagglutinin [TaxId: 37501]} Length = 239

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Maackia amurensis, leukoagglutinin [TaxId: 37501]

 Score =  132 bits (334), Expect = 5e-36
 Identities = 55/190 (28%), Positives = 94/190 (49%), Gaps = 21/190 (11%)

Query: 2   PFKNKNSNSSTANGTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTR-GLPGARPSQYLG 60
           P +   + + +    V SFST+F F + +     +  G+AF +A     +P    S+YLG
Sbjct: 55  PVRIWGNTTGS----VASFSTSFTFVVKAPNPDITSDGLAFYLAPPDSQIPSGSVSKYLG 110

Query: 61  LFNDTNLGNETNHVFAVELDTIKSHGF--LDINDNHVGIDINSLKSESSAPAGYY----- 113
           LFN++N  + +N + AVE DT  +H +   D N  H+GID+N ++S  +    +      
Sbjct: 111 LFNNSN-SDSSNQIVAVEFDTYFAHSYDPWDPNYRHIGIDVNGIESIKTVQWDWINGGVA 169

Query: 114 ---VEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSVLNDAMYVGFSSSTG--SVLA 168
              + Y    K    +L   +     S+   + S DL  +L + + VGFS++TG  + + 
Sbjct: 170 FATITYLAPNKTLIASLVYPSNQTTFSV---AASVDLKEILPEWVRVGFSAATGYPTEVE 226

Query: 169 SHYILGWSFK 178
           +H +L WSF 
Sbjct: 227 THDVLSWSFT 236

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (338), Expect = 1e-35
 Identities = 60/291 (20%), Positives = 115/291 (39%), Gaps = 32/291 (10%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKI--SHESRQGMKEFVAEIVSIGRLRHRNL 320
           +R+ + +G+G +G V      ++  ++A+KK+    +S    K    E+  +  +RH N+
Sbjct: 20  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 79

Query: 321 VQLLGYCRRKG------ELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLF 374
           + LL             +  LV  +M  G+    L    K  L   +   ++  +  GL 
Sbjct: 80  IGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEK--LGEDRIQFLVYQMLKGLR 135

Query: 375 YLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE 434
           Y+H        HRD+K  N+ ++ +   ++ DFGLAR  D      T +VV         
Sbjct: 136 YIHAAGII---HRDLKPGNLAVNEDCELKILDFGLARQAD---SEMTGYVVTRWYRAPEV 189

Query: 435 HTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENL-----ILVDWVFDFWNRGELL 489
                + T + D++S G  + E+  G+   +     + L     +      +F  R +  
Sbjct: 190 ILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD 249

Query: 490 EARDPNLGT-EYVAEELELVLK------LGLL--CSHSDPTARPSMRQVVQ 531
           EA++   G  E   ++   +L       + LL      D   R +  + + 
Sbjct: 250 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300

>d1ioaa_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris), G02771, arcelin-5a [TaxId: 3885]} Length = 228

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Phytohemagglutinin-L, PHA-L, also arcelin
species: Kidney bean (Phaseolus vulgaris), G02771, arcelin-5a [TaxId: 3885]

 Score =  129 bits (326), Expect = 4e-35
 Identities = 46/182 (25%), Positives = 74/182 (40%), Gaps = 19/182 (10%)

Query: 2   PFKNKNSNSSTANGTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGL 61
           P + K+S        V SF+T F F I ++ QS S +G+AF +      P  +  ++LG+
Sbjct: 55  PIQIKDS------NNVASFNTNFTFIIRAKNQSISAYGLAFALVPV-NSPPQKKQEFLGI 107

Query: 62  FNDTNLGNETNHVFAVELDTIKSHGFLDINDNHVGIDINSLKSESSAPAGYY---VEYDG 118
           FN  N         AV  +T K+    D + N +   +N                + YD 
Sbjct: 108 FNTNN-PEPNARTVAVVFNTFKNRI--DFDKNFIKPYVNENCDFHKYNGEKTDVQITYDS 164

Query: 119 LEKRTNVTLAPINIPRPRSLNTMSLSRDLSSVLNDAMYVGFSSSTGSV---LASHYILGW 175
                 V L         S+   S +  L   +++ + VGFS ++G       +H +L W
Sbjct: 165 SNNDLRVFLHFTVSQVKCSV---SATVHLEKEVDEWVSVGFSPTSGLTEDTTETHDVLSW 221

Query: 176 SF 177
           SF
Sbjct: 222 SF 223

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  133 bits (335), Expect = 5e-35
 Identities = 50/212 (23%), Positives = 89/212 (41%), Gaps = 12/212 (5%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRN 319
           F   + LGTG FGRV      +S    A+K +  +     + ++  + E   +  +    
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102

Query: 320 LVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQE 379
           LV+L    +    L +V +Y+  G +  +L    +   +          + L   YLH  
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR--FSEPHARFYAAQIVLTFEYLHSL 160

Query: 380 WEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTG 439
               +I+RD+K  N+L+D +   ++ DFG A+        +T  + GT   LAPE   + 
Sbjct: 161 D---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWTLCGTPEALAPEIILSK 213

Query: 440 KATTSADVFSFGAFLLEVACGRRPIQRQGPSE 471
               + D ++ G  + E+A G  P     P +
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  129 bits (325), Expect = 6e-34
 Identities = 56/315 (17%), Positives = 113/315 (35%), Gaps = 42/315 (13%)

Query: 246 HGPHRFRYKDLYIATKG---FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGM 302
                + Y+   +       ++    LG G +  V+      +  ++ VK +    +   
Sbjct: 17  RPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK--- 73

Query: 303 KEFVAEIVSIGRLR-HRNLVQLLGYCRRKGE--LLLVYDYMPNGSLDKYLYDQPKVTLNW 359
           K+   EI  +  LR   N++ L    +        LV++++ N    +        TL  
Sbjct: 74  KKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ-----TLTD 128

Query: 360 IQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGE-LNGRLGDFGLARLYDHGTD 418
                 +  +   L Y H      ++HRDVK  NV++D E    RL D+GLA  Y  G +
Sbjct: 129 YDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 185

Query: 419 PQTTHVVGTLGYLAPE-HTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSE------ 471
                 V +  +  PE          S D++S G  L  +   + P      +       
Sbjct: 186 Y--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI 243

Query: 472 -NLILVDWVFDFWNRGEL-LEARDPNLGTEYVAEELELVLKLGLLCSHS----------- 518
             ++  + ++D+ ++  + L+ R  ++   +  +  E  +        S           
Sbjct: 244 AKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLL 303

Query: 519 --DPTARPSMRQVVQ 531
             D  +R + R+ ++
Sbjct: 304 RYDHQSRLTAREAME 318

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (320), Expect = 5e-33
 Identities = 47/219 (21%), Positives = 91/219 (41%), Gaps = 18/219 (8%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKIS--HESRQGMKEFVAEIVSIGRLRHRNL 320
           ++  + +G+G  G V           +A+KK+S   +++   K    E+V +  + H+N+
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78

Query: 321 VQLLGYCRRKG------ELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLF 374
           + LL     +       ++ LV + M          +         +   ++  +  G+ 
Sbjct: 79  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-----HERMSYLLYQMLCGIK 133

Query: 375 YLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPE 434
           +LH      +IHRD+K SN+++  +   ++ DFGLAR    GT    T  V T  Y APE
Sbjct: 134 HLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAPE 188

Query: 435 HTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENL 473
                    + D++S G  + E+   +     +   +  
Sbjct: 189 VILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQW 227

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (315), Expect = 1e-32
 Identities = 63/289 (21%), Positives = 119/289 (41%), Gaps = 30/289 (10%)

Query: 258 IATKGFREKELLGTGGFGRVYRG---TLPKSQIEIAVKKISH----ESRQGMKEFVAEIV 310
           +  + F   ++LGTG +G+V+     +   +    A+K +      +  +  +    E  
Sbjct: 21  VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQ 80

Query: 311 SIGRLRHR-NLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGV 369
            +  +R    LV L    + + +L L+ DY+  G L  +L  + + T + +Q +  +  +
Sbjct: 81  VLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIY--VGEI 138

Query: 370 ALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLG 429
            L L +LH   +  +I+RD+K  N+LLD   +  L DFGL++ +      +     GT+ 
Sbjct: 139 VLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIE 195

Query: 430 YLAPEHTRTGKA--TTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGE 487
           Y+AP+  R G +    + D +S G  + E+  G  P    G   +   +           
Sbjct: 196 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI---------SR 246

Query: 488 LLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQ--VVQILE 534
            +   +P    E  A   +L+ +        DP  R         +I E
Sbjct: 247 RILKSEPPYPQEMSALAKDLIQR----LLMKDPKKRLGCGPRDADEIKE 291

>d1nlsa_ b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia ensiformis) [TaxId: 3823]} Length = 237

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Concanavalin A
species: Jack bean (Canavalia ensiformis) [TaxId: 3823]

 Score =  120 bits (303), Expect = 9e-32
 Identities = 36/114 (31%), Positives = 59/114 (51%), Gaps = 12/114 (10%)

Query: 72  NHVFAVELDTIKSHGFLDINDNHVGIDINSLKSESSAPAGYY--------VEYDGLEKRT 123
           + + AVELDT  +    D +  H+GIDI S++S+ +A             + Y+ ++KR 
Sbjct: 2   DTIVAVELDTYPNTDIGDPSYPHIGIDIKSVRSKKTAKWNMQNGKVGTAHIIYNSVDKRL 61

Query: 124 NVTLAPINIPRPRSLNTMSLSRDLSSVLNDAMYVGFSSSTGSVLASHYILGWSF 177
           +  ++  N        T+S   DL +VL + + VG S+STG    ++ IL WSF
Sbjct: 62  SAVVSYPNADSA----TVSYDVDLDNVLPEWVRVGLSASTGLYKETNTILSWSF 111

>d1nlsa_ b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia ensiformis) [TaxId: 3823]} Length = 237

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Concanavalin A
species: Jack bean (Canavalia ensiformis) [TaxId: 3823]

 Score = 71.1 bits (174), Expect = 1e-14
 Identities = 23/66 (34%), Positives = 28/66 (42%), Gaps = 7/66 (10%)

Query: 2   PFKNKNSNSSTANGTVFSFSTTFVFSILSEYQSQSGHGIAFVIAST-RGLPGARPSQYLG 60
           P     S+       V SF  TF F I S   S    GIAF I++    +P     + LG
Sbjct: 178 PVHIWESS-----AVVASFEATFTFLIKSPD-SHPADGIAFFISNIDSSIPSGSTGRLLG 231

Query: 61  LFNDTN 66
           LF D N
Sbjct: 232 LFPDAN 237

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (306), Expect = 3e-31
 Identities = 57/294 (19%), Positives = 108/294 (36%), Gaps = 38/294 (12%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKIS--HESRQGMKEFVAEIVSIGRLRHRNL 320
           ++    +G+G +G V      K+ + +AVKK+S   +S    K    E+  +  ++H N+
Sbjct: 20  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 79

Query: 321 VQLLGYCRRKGEL-----LLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFY 375
           + LL        L     + +  ++    L+  +  Q    L       +I  +  GL Y
Sbjct: 80  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHVQFLIYQILRGLKY 136

Query: 376 LHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEH 435
           +H      +IHRD+K SN+ ++ +   ++ DFGLAR  D      T +V           
Sbjct: 137 IHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYVATRWYRAPEIM 190

Query: 436 TRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENL-----ILVDWVFDFWNRGELLE 490
                   + D++S G  + E+  GR         + L     ++     +   +     
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 250

Query: 491 ARD-------------PNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ 531
           AR+              N+        ++L+ K        D   R +  Q + 
Sbjct: 251 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEK----MLVLDSDKRITAAQALA 300

>d1dhkb_ b.29.1.1 (B:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 204

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Phytohemagglutinin-L, PHA-L, also arcelin
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score =  110 bits (275), Expect = 2e-28
 Identities = 40/179 (22%), Positives = 74/179 (41%), Gaps = 29/179 (16%)

Query: 2   PFKNKNSNSSTANGTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGL 61
           P + ++S +      V SF T F  +I +  Q+ S  G+ FV+   +             
Sbjct: 48  PIQIRDSTTGN----VASFDTNFTMNIRTHRQANSAVGLDFVLVPVQPESK--------- 94

Query: 62  FNDTNLGNETNHVFAVELDTIKSHGFLDINDNHVGIDINSLKSESSAPAGYYVEYDGLEK 121
                          VE DT  S   +D+N+N +      +       A   + Y+   K
Sbjct: 95  ----------GDTVTVEFDTFLSRISIDVNNNDIKSVPWDVHDYDGQNAEVRITYNSSTK 144

Query: 122 RTNVTLAPINIPRPRSLNTMSLSRDLSSVLNDAMYVGFSSSTGSVLAS---HYILGWSF 177
             +V+L+  +  +  +++T   + +L   + D + VGFS+++G+   S   H +L WSF
Sbjct: 145 VFSVSLSNPSTGKSNNVST---TVELEKEVYDWVSVGFSATSGAYQWSYETHDVLSWSF 200

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  104 bits (259), Expect = 6e-25
 Identities = 44/238 (18%), Positives = 78/238 (32%), Gaps = 19/238 (7%)

Query: 263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQ 322
           +     LG G F  V+      +   +A+K +    +   +    EI  + R+   +  +
Sbjct: 15  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTK 73

Query: 323 LLGYCRRKGELLLVY--DYMPNGSL------------DKYLYDQPKVTLNWIQRFRVIKG 368
                      LL +     PNG                 +       +  I   ++ K 
Sbjct: 74  EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133

Query: 369 VALGLFYLHQEWEQVVIHRDVKASNVLLDGE-LNGRLGDFGLARLYDHG-TDPQTTHVVG 426
           + LGL Y+H      +IH D+K  NVL++       L    +A L +    D   T+ + 
Sbjct: 134 LLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 191

Query: 427 TLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWN 484
           T  Y +PE          AD++S    + E+  G    +           D +     
Sbjct: 192 TREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 249

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 86.8 bits (214), Expect = 3e-20
 Identities = 30/159 (18%), Positives = 52/159 (32%), Gaps = 20/159 (12%)

Query: 267 ELLGTGGFGRVYRGTLPKSQIEIAVK----------KISHESRQGMKEFVAEIVSIGRLR 316
           +L+G G    V+     K   E  VK          K+  +   G   F    +   R  
Sbjct: 6   KLMGEGKESAVFNCYSEKFG-ECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64

Query: 317 HRNLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYL 376
            R L +L G    K     VY +  N  L + +  +    +       V+  +   +   
Sbjct: 65  FRALQKLQGLAVPK-----VYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKF 119

Query: 377 HQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH 415
           +      ++H D+   NVL+  E    + DF  +     
Sbjct: 120 YHRG---IVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGE 154

>d1gv9a_ b.29.1.13 (A:) Carbohydrate-recognition domain of P58/ERGIC-53 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 228

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Lectin leg-like
domain: Carbohydrate-recognition domain of P58/ERGIC-53
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 69.4 bits (169), Expect = 5e-14
 Identities = 20/178 (11%), Positives = 49/178 (27%), Gaps = 35/178 (19%)

Query: 19  SFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGLFNDTNLGNETNHVFAVE 78
           ++        ++        G+A      +GL G       G         +  +   + 
Sbjct: 62  NWEVEV-TFRVTGRGRIGADGLAIWYTENQGLDG----PVFG-------SADMWNGVGIF 109

Query: 79  LDTIKSHGFLDINDNHVGIDINSLKSESSAPAGYY-------------------VEYDGL 119
            D+  + G    N+  + +  N+ +                              +    
Sbjct: 110 FDSFDNDG--KKNNPAIVVVGNNGQINYDHQNDGATQALASCQRDFRNKPYPVRAKITYY 167

Query: 120 EKRTNVTLAPINIPRPRSLNTMSLSRDLSSVLNDAMYVGFSSSTGSVLASHYILGWSF 177
           +K   V +     P          ++  + V+    + G S++TG +   H +L +  
Sbjct: 168 QKTLTVMINNGFTPDKNDYE--FCAKVENMVIPTQGHFGISAATGGLADDHDVLSFLT 223

>d2a6va1 b.29.1.13 (A:9-226) Emp46p N-terminal domain {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 218

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Lectin leg-like
domain: Emp46p N-terminal domain
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 41.9 bits (98), Expect = 7e-05
 Identities = 26/190 (13%), Positives = 51/190 (26%), Gaps = 32/190 (16%)

Query: 2   PFKNKNSNSSTANGTVFSFSTTFVFSI-LSEYQSQSGHGIAFVIASTRGLPGARPS-QYL 59
           P KN   +           + T  ++     ++  +  G+AF +                
Sbjct: 41  PGKNTKGSLWLKPEYSIKDAMTIEWTFRSFGFRGSTKGGLAFWLKQGNEGDSTELFGGSS 100

Query: 60  GLFNDTNLGNETNHVFAVELDTIKSHGF---LDINDNHVGIDINSLKSESSAPAGYYVEY 116
             FN             + L      G      +ND    +DI S        A    +Y
Sbjct: 101 KKFNG----------LMILLRLDDKLGESVTAYLNDGTKDLDIESSPYF----ASCLFQY 146

Query: 117 DGLEKRTNVTLAPINIPRPRSLNTMSL---------SRDLSSVLNDAMYVGFSSSTGSVL 167
                 + + L    +      + + L         +R +  + +    +G S+   +  
Sbjct: 147 QDSMVPSTLRLTYNPL----DNHLLKLQMDNRVCFQTRKVKFMGSSPFRIGTSAINDASK 202

Query: 168 ASHYILGWSF 177
            S  IL    
Sbjct: 203 ESFEILKMKL 212

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	586
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1hqla_	236	Legume lectin {Griffonia simplicifolia, lectin I-b	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1leda_	243	Legume lectin {West-central african legume (Griffo	100.0
d1fx5a_	240	Legume lectin {Furze (Ulex europaeus), UEA-I [TaxI	100.0
d1qnwa_	237	Legume lectin {Furze (Ulex europaeus), UEA-II [Tax	100.0
d1gzca_	239	Legume lectin {Cockspur coral tree (Erythrina cris	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d2d3sa1	237	Legume lectin {Winged bean (Psophocarpus tetragono	100.0
d1g9fa_	251	Legume lectin {Soybean (Glycine max) [TaxId: 3847]	100.0
d1f9ka_	234	Legume lectin {Winged bean (Psophocarpus tetragono	100.0
d1g7ya_	253	Legume lectin {Horse gram (Dolichos biflorus), dif	100.0
d1dbna_	239	Legume lectin {Maackia amurensis, leukoagglutinin	100.0
d1g8wa_	233	Phytohemagglutinin-L, PHA-L, also arcelin {Kidney	100.0
g1qmo.1	230	Legume lectin {Field bean (Dolichos lablab), Fril	100.0
d1v6ia_	232	Legume lectin {Peanut (Arachis hypogaea) [TaxId: 3	100.0
d1fnya_	237	Legume lectin {Black locust (Robinia pseudoacacia)	100.0
d1n47a_	233	Legume lectin {Hairy vetch (Vicia villosa), isolec	100.0
d1ukga_	241	Legume lectin {Bloodwood tree (Pterocarpus angolen	100.0
g2ltn.1	229	Legume lectin {Garden pea (Pisum sativum) [TaxId:	100.0
d1ioaa_	228	Phytohemagglutinin-L, PHA-L, also arcelin {Kidney	99.98
d1avba_	226	Phytohemagglutinin-L, PHA-L, also arcelin {Kidney	99.97
d1dhkb_	204	Phytohemagglutinin-L, PHA-L, also arcelin {Kidney	99.96
d1nlsa_	237	Concanavalin A {Jack bean (Canavalia ensiformis) [	99.94
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.88
d1gv9a_	228	Carbohydrate-recognition domain of P58/ERGIC-53 {R	99.73
d1nlsa_	237	Concanavalin A {Jack bean (Canavalia ensiformis) [	99.34
d2a6va1	218	Emp46p N-terminal domain {Baker's yeast (Saccharom	99.26
d2a6za1	221	Emp47p N-terminal domain {Baker's yeast (Saccharom	99.18
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.54
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.95
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.61
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.9
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.9
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	95.78

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.1e-54  Score=436.63  Aligned_cols=271  Identities=25%  Similarity=0.410  Sum_probs=225.9

Q ss_pred             CcccchhhhhhhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeee
Q 007869          248 PHRFRYKDLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYC  327 (586)
Q Consensus       248 ~~~~~~~el~~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~  327 (586)
                      |..-.|+++++..++|+..+.||+|+||+||+|++..++..||||+++.+. ...++|.+|+++|++++|||||+++++|
T Consensus         4 p~~p~~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~   82 (287)
T d1opja_           4 PSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVC   82 (287)
T ss_dssp             TTSTTCCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CCCCCCcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccE
Confidence            344456667777789999999999999999999999889999999997543 3457899999999999999999999999


Q ss_pred             eccCeEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccc
Q 007869          328 RRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDF  407 (586)
Q Consensus       328 ~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DF  407 (586)
                      .+.+..++||||+++|+|.+++.......+++..++.|+.|||+||.|||+   ++|+||||||+||||++++++||+||
T Consensus        83 ~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DF  159 (287)
T d1opja_          83 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADF  159 (287)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCC
T ss_pred             eeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHH---CCcccCccccCeEEECCCCcEEEccc
Confidence            999999999999999999999988767789999999999999999999998   89999999999999999999999999


Q ss_pred             cceeeccCCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCc
Q 007869          408 GLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGE  487 (586)
Q Consensus       408 Gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~  487 (586)
                      |+|+..............||+.|+|||++.++.++.++|||||||++|||++|..|+........  +    .+....+.
T Consensus       160 G~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~--~----~~~i~~~~  233 (287)
T d1opja_         160 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ--V----YELLEKDY  233 (287)
T ss_dssp             CCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--H----HHHHHTTC
T ss_pred             cceeecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH--H----HHHHhcCC
Confidence            99997665444344456789999999999999999999999999999999998777654332211  1    11122221


Q ss_pred             cccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 007869          488 LLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERDV  537 (586)
Q Consensus       488 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  537 (586)
                           .+..    .......+.+|+.+||+.||++|||+.|+++.|+...
T Consensus       234 -----~~~~----~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~  274 (287)
T d1opja_         234 -----RMER----PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  274 (287)
T ss_dssp             -----CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             -----CCCC----CccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence                 1111    1122356788999999999999999999999997643

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.7e-53  Score=432.51  Aligned_cols=258  Identities=26%  Similarity=0.460  Sum_probs=199.6

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCe---EEEEEEeccc-cchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEE
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQI---EIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLV  336 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~---~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV  336 (586)
                      ++|+..++||+|+||+||+|+++.++.   .||||++... .....++|.+|+++|++++|||||+++|+|...+.+++|
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            345667899999999999999875543   5899998654 444567899999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCC
Q 007869          337 YDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHG  416 (586)
Q Consensus       337 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~  416 (586)
                      ||||++|+|.+++.... ..++|.+++.++.|||+||.|||+   ++|+||||||+||||+.++++||+|||+++.+...
T Consensus       106 ~Ey~~~g~L~~~~~~~~-~~l~~~~~~~i~~qia~gl~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~  181 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD  181 (299)
T ss_dssp             EECCTTEEHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             EEecCCCcceeeecccc-CCCCHHHHHHHHHHHHHHHHHHhh---CCCccCccccceEEECCCCcEEECCcccceEccCC
Confidence            99999999999887653 468999999999999999999998   89999999999999999999999999999976543


Q ss_pred             CCC----ceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccCccccc
Q 007869          417 TDP----QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEA  491 (586)
Q Consensus       417 ~~~----~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~  491 (586)
                      ...    ......||+.|||||++.++.++.++|||||||++|||+| |+.||......+   +...+.    ++..   
T Consensus       182 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~---~~~~i~----~~~~---  251 (299)
T d1jpaa_         182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD---VINAIE----QDYR---  251 (299)
T ss_dssp             --------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHHH----TTCC---
T ss_pred             CCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH---HHHHHH----cCCC---
Confidence            322    1223468999999999999999999999999999999998 899997654321   222221    1111   


Q ss_pred             cCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhccC
Q 007869          492 RDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERDVA  538 (586)
Q Consensus       492 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~  538 (586)
                        +..    .......+.+++.+||+.||++||||.||++.|++...
T Consensus       252 --~~~----~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~  292 (299)
T d1jpaa_         252 --LPP----PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR  292 (299)
T ss_dssp             --CCC----CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             --CCC----CccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence              111    12234567889999999999999999999999986543

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-53  Score=423.82  Aligned_cols=260  Identities=27%  Similarity=0.458  Sum_probs=205.3

Q ss_pred             hhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc--cchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEE
Q 007869          258 IATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLL  335 (586)
Q Consensus       258 ~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~l  335 (586)
                      +..++|+..+.||+|+||+||+|++.+   .||||+++..  +.+..+.|.+|++++++++||||+++++++.+ +.+++
T Consensus         5 i~~~~~~~~~~lG~G~fg~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~l   80 (276)
T d1uwha_           5 IPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAI   80 (276)
T ss_dssp             CCTTCCCCCSEEEECSSCEEEEEESSS---EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred             cccccEEEEEEEeeCCCcEEEEEEECC---EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEE
Confidence            445788999999999999999998743   5999998654  45567889999999999999999999999865 56899


Q ss_pred             EEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccC
Q 007869          336 VYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH  415 (586)
Q Consensus       336 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~  415 (586)
                      ||||+++|+|.+++.... ..+++.+++.|+.|||+||+|||+   ++||||||||+||||+.++++||+|||+|+....
T Consensus        81 v~Ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~  156 (276)
T d1uwha_          81 VTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR  156 (276)
T ss_dssp             EEECCCEEEHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC---
T ss_pred             EEecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHhc---CCEeccccCHHHEEEcCCCCEEEccccceeeccc
Confidence            999999999999997653 469999999999999999999998   8999999999999999999999999999987654


Q ss_pred             CCC-CceeeeccCCCccCcccccC---CCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccc
Q 007869          416 GTD-PQTTHVVGTLGYLAPEHTRT---GKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEA  491 (586)
Q Consensus       416 ~~~-~~~~~~~gt~~y~aPE~~~~---~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~  491 (586)
                      ... .......||+.|||||++.+   ..++.++|||||||++|||+||+.||.........  ...+.    ++.    
T Consensus       157 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~--~~~~~----~~~----  226 (276)
T d1uwha_         157 WSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI--IFMVG----RGY----  226 (276)
T ss_dssp             ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH--HHHHH----HTS----
T ss_pred             cCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHH--HHHHh----cCC----
Confidence            322 23345689999999999864   35789999999999999999999999865443211  11111    111    


Q ss_pred             cCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 007869          492 RDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERD  536 (586)
Q Consensus       492 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  536 (586)
                      ..|.+ ........+.+.+++.+||+.||++|||++|+++.|+..
T Consensus       227 ~~p~~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l  270 (276)
T d1uwha_         227 LSPDL-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELL  270 (276)
T ss_dssp             CCCCG-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCcc-hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            11111 111222345678899999999999999999999999764

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-53  Score=425.19  Aligned_cols=258  Identities=27%  Similarity=0.424  Sum_probs=210.1

Q ss_pred             hhhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEE
Q 007869          257 YIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLV  336 (586)
Q Consensus       257 ~~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV  336 (586)
                      ++..++|+..+.||+|+||.||+|+++ ++..||||++.... ...++|.+|++++++++|||||+++|+|.+ +..++|
T Consensus         9 ei~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv   85 (272)
T d1qpca_           9 EVPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYII   85 (272)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred             ecCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEE
Confidence            344568889999999999999999986 46789999997543 345789999999999999999999998865 567999


Q ss_pred             EecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCC
Q 007869          337 YDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHG  416 (586)
Q Consensus       337 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~  416 (586)
                      |||+++|+|.+++.......++|.++++|+.||++||.|||+   ++|+||||||+||||++++.+||+|||+|+.+...
T Consensus        86 ~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~  162 (272)
T d1qpca_          86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN  162 (272)
T ss_dssp             EECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred             EEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccchhheeeecccceeeccccceEEccCC
Confidence            999999999998876555569999999999999999999998   89999999999999999999999999999987654


Q ss_pred             CCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCC
Q 007869          417 TDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNL  496 (586)
Q Consensus       417 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l  496 (586)
                      .........||+.|||||++.++.++.++|||||||++|||+||..|+.......  .+...    ..++.     .+..
T Consensus       163 ~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~--~~~~~----i~~~~-----~~~~  231 (272)
T d1qpca_         163 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP--EVIQN----LERGY-----RMVR  231 (272)
T ss_dssp             CEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHH----HHTTC-----CCCC
T ss_pred             ccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH--HHHHH----HHhcC-----CCCC
Confidence            4334445678999999999999999999999999999999999766654332211  11111    11221     1111


Q ss_pred             CccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 007869          497 GTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER  535 (586)
Q Consensus       497 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  535 (586)
                      ..    ...+.+.+++.+||+.||++||||.||++.|+.
T Consensus       232 p~----~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~  266 (272)
T d1qpca_         232 PD----NCPEELYQLMRLCWKERPEDRPTFDYLRSVLED  266 (272)
T ss_dssp             CT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             cc----cChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence            11    123457788999999999999999999999874

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-53  Score=420.21  Aligned_cols=256  Identities=25%  Similarity=0.392  Sum_probs=199.1

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEec
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY  339 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  339 (586)
                      .++|+..+.||+|+||.||+|++.+ +..||||++.... ...++|.+|++++++++||||++++|+|...+..++||||
T Consensus         4 p~~~~~~~~iG~G~fg~Vy~~~~~~-~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~   81 (263)
T d1sm2a_           4 PSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF   81 (263)
T ss_dssp             CSCEEEEEEEECCSSCCEEEEEETT-TEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             hHHcEEEEEEeeCCCeEEEEEEECC-CCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEe
Confidence            4678899999999999999999864 5679999997643 3457899999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCC
Q 007869          340 MPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP  419 (586)
Q Consensus       340 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~  419 (586)
                      +++|+|.+++... ...++|..++.++.|||+||.|||+   ++|+||||||+|||+++++++||+|||+++........
T Consensus        82 ~~~g~L~~~l~~~-~~~~~~~~~~~i~~qia~gl~~lH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~  157 (263)
T d1sm2a_          82 MEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT  157 (263)
T ss_dssp             CTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred             cCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHhhhc---cceeecccchhheeecCCCCeEecccchheeccCCCce
Confidence            9999999998765 3468899999999999999999998   89999999999999999999999999999977654444


Q ss_pred             ceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCcc
Q 007869          420 QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTE  499 (586)
Q Consensus       420 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~  499 (586)
                      ......||+.|+|||++.+..++.++|||||||++|||+|+..|+.......  .+.+.+    ..+.  ....|..   
T Consensus       158 ~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~--~~~~~i----~~~~--~~~~p~~---  226 (263)
T d1sm2a_         158 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS--EVVEDI----STGF--RLYKPRL---  226 (263)
T ss_dssp             -------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHH--HHHHHH----HHTC--CCCCCTT---
T ss_pred             eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHH--HHHHHH----HhcC--CCCCccc---
Confidence            4445679999999999999999999999999999999999654443322211  112211    1111  1112221   


Q ss_pred             ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 007869          500 YVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERD  536 (586)
Q Consensus       500 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  536 (586)
                          ....+.+++.+||+.||++||||+|+++.|++.
T Consensus       227 ----~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i  259 (263)
T d1sm2a_         227 ----ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI  259 (263)
T ss_dssp             ----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----cCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence                234678899999999999999999999999863

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-52  Score=421.10  Aligned_cols=250  Identities=24%  Similarity=0.377  Sum_probs=211.7

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEecC
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYM  340 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  340 (586)
                      ++|+..+.||+|+||+||+|++..+++.||||++........+.+.+|++++++++||||+++++++...+.+++||||+
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            57999999999999999999999999999999998766666678999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCCc
Q 007869          341 PNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ  420 (586)
Q Consensus       341 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~  420 (586)
                      ++|+|.+++.++   .+++.++..++.||+.||.|||+   ++|+||||||+|||++.++++||+|||+|+.+..... .
T Consensus       100 ~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~-~  172 (293)
T d1yhwa1         100 AGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K  172 (293)
T ss_dssp             TTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-C
T ss_pred             CCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCcHHHeEECCCCcEeeccchhheeeccccc-c
Confidence            999999988764   58899999999999999999998   8999999999999999999999999999998754332 3


Q ss_pred             eeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCccc
Q 007869          421 TTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEY  500 (586)
Q Consensus       421 ~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~  500 (586)
                      ....+||+.|+|||++.+..++.++|||||||++|||++|+.||......+.      .......+      .+.+  ..
T Consensus       173 ~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~------~~~~~~~~------~~~~--~~  238 (293)
T d1yhwa1         173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA------LYLIATNG------TPEL--QN  238 (293)
T ss_dssp             BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHHHHC------SCCC--SS
T ss_pred             ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHH------HHHHHhCC------CCCC--CC
Confidence            4456899999999999999999999999999999999999999976443221      11111111      1111  11


Q ss_pred             cHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          501 VAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       501 ~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      .......+.+++.+||+.||++|||+.|+++
T Consensus       239 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         239 PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             GGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             cccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            1222356778899999999999999999985

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-52  Score=416.43  Aligned_cols=252  Identities=25%  Similarity=0.345  Sum_probs=205.1

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc-chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEec
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY  339 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  339 (586)
                      ++|+..+.||+|+||+||+|+++.+++.||||++.... .+..+.+.+|++++++++||||+++++++.+.+..+|||||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy   84 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   84 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence            57899999999999999999999999999999997643 33446789999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCC-
Q 007869          340 MPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD-  418 (586)
Q Consensus       340 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~-  418 (586)
                      +++|+|.++|...  ..+++.++..++.||++||.|||+   ++|+||||||+|||+++++++||+|||+|+....... 
T Consensus        85 ~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~al~ylH~---~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~  159 (271)
T d1nvra_          85 CSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  159 (271)
T ss_dssp             CTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             cCCCcHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHH---cCCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence            9999999999654  468999999999999999999998   8999999999999999999999999999997654332 


Q ss_pred             CceeeeccCCCccCcccccCCCC-CCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCC
Q 007869          419 PQTTHVVGTLGYLAPEHTRTGKA-TTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLG  497 (586)
Q Consensus       419 ~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~  497 (586)
                      ...+..+||+.|||||++.+..+ +.++|||||||++|||++|+.||......... ...+     ......    ... 
T Consensus       160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~-~~~~-----~~~~~~----~~~-  228 (271)
T d1nvra_         160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDW-----KEKKTY----LNP-  228 (271)
T ss_dssp             CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH-HHHH-----HTTCTT----STT-
T ss_pred             ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH-HHHH-----hcCCCC----CCc-
Confidence            23445789999999999988776 57899999999999999999999765433211 1111     111000    000 


Q ss_pred             ccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          498 TEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       498 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                         .......+.+++.+||+.||++|||++|+++
T Consensus       229 ---~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         229 ---WKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             ---GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ---cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence               1112245667888999999999999999975

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-52  Score=419.01  Aligned_cols=263  Identities=25%  Similarity=0.471  Sum_probs=205.3

Q ss_pred             hcCCcccceeEeecCceEEEEEEeCCCC----eEEEEEEeccc-cchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeE
Q 007869          259 ATKGFREKELLGTGGFGRVYRGTLPKSQ----IEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGEL  333 (586)
Q Consensus       259 a~~~f~~~~~LG~G~~g~Vy~~~~~~~~----~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~  333 (586)
                      .++.|+..++||+|+||.||+|.+..++    ..||||++... ......+|.+|++++++++|||||+++|+|.+.+..
T Consensus         5 ~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~   84 (283)
T d1mqba_           5 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM   84 (283)
T ss_dssp             CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred             CHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCce
Confidence            4467888999999999999999986544    47999999754 334456799999999999999999999999999999


Q ss_pred             EEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeec
Q 007869          334 LLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLY  413 (586)
Q Consensus       334 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~  413 (586)
                      ++||||+.+++|.+++.... ..++|.+++.++.||+.||.|||+   ++|+||||||+||||+.++.+||+|||+++.+
T Consensus        85 ~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~gl~~lH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~  160 (283)
T d1mqba_          85 MIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVL  160 (283)
T ss_dssp             EEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             EEEEEecccCcchhhhhccc-ccccHHHHHHHHHHHHHhhhhccc---cccccCccccceEEECCCCeEEEcccchhhcc
Confidence            99999999999999887653 469999999999999999999998   89999999999999999999999999999976


Q ss_pred             cCCCCC--ceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccc
Q 007869          414 DHGTDP--QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEA  491 (586)
Q Consensus       414 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~  491 (586)
                      ......  ......||+.|||||++.++.++.++|||||||++|||++|..|+.......  .+.+    ...++.    
T Consensus       161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~--~~~~----~i~~~~----  230 (283)
T d1mqba_         161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH--EVMK----AINDGF----  230 (283)
T ss_dssp             -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHH----HHHTTC----
T ss_pred             cCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHH--HHHH----HHhccC----
Confidence            543322  2234568999999999999999999999999999999999766665433221  1111    122221    


Q ss_pred             cCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhccCCC
Q 007869          492 RDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERDVALP  540 (586)
Q Consensus       492 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~~p  540 (586)
                       .+..    +......+.+|+.+||+.||++||||.||++.|++....|
T Consensus       231 -~~~~----~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p  274 (283)
T d1mqba_         231 -RLPT----PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP  274 (283)
T ss_dssp             -CCCC----CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred             -CCCC----chhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhCc
Confidence             1111    1223356788999999999999999999999998765443

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-52  Score=412.49  Aligned_cols=246  Identities=26%  Similarity=0.384  Sum_probs=207.9

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc---cchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEE
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY  337 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  337 (586)
                      ++|+..+.||+|+||+||+|+++.+++.||||++...   .....+.+.+|++++++++||||+++++++.+++..++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            4688899999999999999999999999999998643   2344577899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCC
Q 007869          338 DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT  417 (586)
Q Consensus       338 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~  417 (586)
                      ||+++|+|.+++...  ..+++..+..++.||++||+|||+   ++|+||||||+|||++.++++||+|||+|+..... 
T Consensus        86 Ey~~~g~L~~~l~~~--~~l~e~~~~~i~~qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~-  159 (263)
T d2j4za1          86 EYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-  159 (263)
T ss_dssp             ECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC-
T ss_pred             eecCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeeeeccccceecCCCCEeecccceeeecCCC-
Confidence            999999999999765  368999999999999999999998   89999999999999999999999999999865432 


Q ss_pred             CCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCC
Q 007869          418 DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLG  497 (586)
Q Consensus       418 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~  497 (586)
                        ......||+.|||||++.+..++.++|||||||++|||++|+.||...+..+   +.    ....++.      +.+.
T Consensus       160 --~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~---~~----~~i~~~~------~~~p  224 (263)
T d2j4za1         160 --RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE---TY----KRISRVE------FTFP  224 (263)
T ss_dssp             --CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH---HH----HHHHTTC------CCCC
T ss_pred             --cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH---HH----HHHHcCC------CCCC
Confidence              2345689999999999999999999999999999999999999997643321   11    1111111      1111


Q ss_pred             ccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          498 TEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       498 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      ..    ..+.+.+++.+||+.||++|||++|+++
T Consensus       225 ~~----~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         225 DF----VTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             TT----SCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             cc----CCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence            11    2345678888999999999999999986

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-52  Score=416.88  Aligned_cols=257  Identities=25%  Similarity=0.427  Sum_probs=209.1

Q ss_pred             hhcCCccccee-EeecCceEEEEEEeC--CCCeEEEEEEecccc-chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeE
Q 007869          258 IATKGFREKEL-LGTGGFGRVYRGTLP--KSQIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGEL  333 (586)
Q Consensus       258 ~a~~~f~~~~~-LG~G~~g~Vy~~~~~--~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~  333 (586)
                      ...++|...+. ||+|+||+||+|+++  +++..||||+++... ....++|.+|+++|++++|||||+++|+|.. +.+
T Consensus         5 l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~   83 (285)
T d1u59a_           5 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EAL   83 (285)
T ss_dssp             CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSE
T ss_pred             ecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeE
Confidence            44456777774 999999999999875  345679999997653 4456789999999999999999999999865 468


Q ss_pred             EEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeec
Q 007869          334 LLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLY  413 (586)
Q Consensus       334 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~  413 (586)
                      +|||||+++|+|.+++... +..+++.+++.++.|||+||.|||+   ++|+||||||+|||++.++.+||+|||+++.+
T Consensus        84 ~lvmE~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~  159 (285)
T d1u59a_          84 MLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKAL  159 (285)
T ss_dssp             EEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEEeCCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCcCchhheeeccCCceeeccchhhhcc
Confidence            9999999999999998654 3468999999999999999999998   89999999999999999999999999999987


Q ss_pred             cCCCCC--ceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccCcccc
Q 007869          414 DHGTDP--QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLE  490 (586)
Q Consensus       414 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~  490 (586)
                      ......  ......||+.|+|||++.++.++.++|||||||++|||+| |+.||......+   +.    ....++... 
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~---~~----~~i~~~~~~-  231 (285)
T d1u59a_         160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VM----AFIEQGKRM-  231 (285)
T ss_dssp             TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH---HH----HHHHTTCCC-
T ss_pred             cccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH---HH----HHHHcCCCC-
Confidence            544321  2234568999999999999999999999999999999998 999998654322   11    122223221 


Q ss_pred             ccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 007869          491 ARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER  535 (586)
Q Consensus       491 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  535 (586)
                          ..    +......+.+|+.+||+.||++|||+.+|++.|+.
T Consensus       232 ----~~----p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~  268 (285)
T d1u59a_         232 ----EC----PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA  268 (285)
T ss_dssp             ----CC----CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             ----CC----CCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence                11    11223567789999999999999999999999875

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-51  Score=415.89  Aligned_cols=252  Identities=26%  Similarity=0.362  Sum_probs=209.3

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEecC
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYM  340 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  340 (586)
                      +.|+..+.||+|+||+||+|++..++..||||++........+.|.+|+++|++++||||+++++++.+.+.+++||||+
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            46888999999999999999999999999999998777677788999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCCc
Q 007869          341 PNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ  420 (586)
Q Consensus       341 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~  420 (586)
                      ++|+|.+++.+.. ..+++.++..++.||++||.|||+   ++|+||||||+|||++.++++||+|||+|+...... ..
T Consensus        92 ~~g~L~~~~~~~~-~~l~e~~~~~i~~qi~~gL~ylH~---~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~~  166 (288)
T d2jfla1          92 AGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QR  166 (288)
T ss_dssp             TTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-HH
T ss_pred             CCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---CCEEEeecChhheeECCCCCEEEEechhhhccCCCc-cc
Confidence            9999999986542 468999999999999999999998   899999999999999999999999999998654321 12


Q ss_pred             eeeeccCCCccCccccc-----CCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCC
Q 007869          421 TTHVVGTLGYLAPEHTR-----TGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPN  495 (586)
Q Consensus       421 ~~~~~gt~~y~aPE~~~-----~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~  495 (586)
                      .....||+.|+|||++.     ...++.++|||||||++|||++|+.||......+..  .. +   . .+.     .+.
T Consensus       167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~--~~-i---~-~~~-----~~~  234 (288)
T d2jfla1         167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVL--LK-I---A-KSE-----PPT  234 (288)
T ss_dssp             HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH--HH-H---H-HSC-----CCC
T ss_pred             ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHH--HH-H---H-cCC-----CCC
Confidence            23467999999999984     456889999999999999999999999875443211  11 1   1 111     111


Q ss_pred             CCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          496 LGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       496 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      +.  ........+.+++.+||+.||++|||+.|+++
T Consensus       235 ~~--~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         235 LA--QPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             CS--SGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CC--ccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            11  11223356778889999999999999999975

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-52  Score=415.51  Aligned_cols=254  Identities=25%  Similarity=0.390  Sum_probs=195.9

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc--cchhHHHHHHHHHHhcccCCCceeeeeeeeec--cCeEEEE
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRR--KGELLLV  336 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~--~~~~~lV  336 (586)
                      ++|+..+.||+|+||+||+|+++.+++.||||++...  .....+.+.+|++++++++||||+++++++.+  .+.+++|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            5789999999999999999999999999999998764  33445679999999999999999999998864  4568999


Q ss_pred             EecCCCCChhhhhhcC--CCccchhHHHHHHHHHHHHHHHHhhccc--CCcEEeCCCCCCCeeecCCCCeEEccccceee
Q 007869          337 YDYMPNGSLDKYLYDQ--PKVTLNWIQRFRVIKGVALGLFYLHQEW--EQVVIHRDVKASNVLLDGELNGRLGDFGLARL  412 (586)
Q Consensus       337 ~E~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~yLH~~~--~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~  412 (586)
                      |||+++|+|.+++...  ....+++..++.++.||++||.|||+..  ..+|+||||||+|||++.++++||+|||+|+.
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            9999999999998653  2356999999999999999999999832  23599999999999999999999999999997


Q ss_pred             ccCCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCcccccc
Q 007869          413 YDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEAR  492 (586)
Q Consensus       413 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~  492 (586)
                      +..... ......||+.|||||++.+..++.++|||||||++|||+||+.||...+..+   +.    ....++..    
T Consensus       164 ~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~---~~----~~i~~~~~----  231 (269)
T d2java1         164 LNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE---LA----GKIREGKF----  231 (269)
T ss_dssp             C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HH----HHHHHTCC----
T ss_pred             cccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH---HH----HHHHcCCC----
Confidence            654332 2345789999999999999999999999999999999999999997643221   11    11122221    


Q ss_pred             CCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          493 DPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       493 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                       +.+...++    +.+.+++.+||+.||++|||+.|+++
T Consensus       232 -~~~~~~~s----~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         232 -RRIPYRYS----DELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             -CCCCTTSC----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -CCCCcccC----HHHHHHHHHHcCCChhHCcCHHHHHh
Confidence             11212222    45778889999999999999999975

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-51  Score=407.06  Aligned_cols=253  Identities=27%  Similarity=0.424  Sum_probs=213.3

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEec
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY  339 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  339 (586)
                      .++|+..++||+|+||+||+|+++ ++..||||+++.... ..++|++|++++++++||||++++|+|.+++.+++||||
T Consensus         3 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey   80 (258)
T d1k2pa_           3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY   80 (258)
T ss_dssp             CCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEEC
T ss_pred             hHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEc
Confidence            468899999999999999999985 677899999976543 457899999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCC
Q 007869          340 MPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP  419 (586)
Q Consensus       340 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~  419 (586)
                      +++|+|.+++.... ..+++..+++++.|+++||.|||+   ++|+||||||+|||+++++.+||+|||+++........
T Consensus        81 ~~~g~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~  156 (258)
T d1k2pa_          81 MANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT  156 (258)
T ss_dssp             CTTEEHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred             cCCCcHHHhhhccc-cCCcHHHHHHHHHHHHHHHHHHhh---cCcccccccceeEEEcCCCcEEECcchhheeccCCCce
Confidence            99999999986653 468899999999999999999998   89999999999999999999999999999876655444


Q ss_pred             ceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCc
Q 007869          420 QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGT  498 (586)
Q Consensus       420 ~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~  498 (586)
                      ......||+.|+|||++.+..++.++|||||||++|||+| |+.||......+   +.    ....++..  ...|.   
T Consensus       157 ~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~---~~----~~i~~~~~--~~~p~---  224 (258)
T d1k2pa_         157 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE---TA----EHIAQGLR--LYRPH---  224 (258)
T ss_dssp             CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH---HH----HHHHTTCC--CCCCT---
T ss_pred             eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH---HH----HHHHhCCC--CCCcc---
Confidence            4455679999999999999999999999999999999998 899998654322   11    11222211  11222   


Q ss_pred             cccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHh
Q 007869          499 EYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILE  534 (586)
Q Consensus       499 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~  534 (586)
                          .....+.+++.+||+.||++|||++|+++.|.
T Consensus       225 ----~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~  256 (258)
T d1k2pa_         225 ----LASEKVYTIMYSCWHEKADERPTFKILLSNIL  256 (258)
T ss_dssp             ----TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             ----cccHHHHHHHHHHccCCHhHCcCHHHHHHHhh
Confidence                12256788999999999999999999999884

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-51  Score=420.79  Aligned_cols=205  Identities=27%  Similarity=0.396  Sum_probs=182.4

Q ss_pred             hhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc-chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEE
Q 007869          258 IATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLV  336 (586)
Q Consensus       258 ~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV  336 (586)
                      ...++|+..+.||+|+||+||+|++..++..||+|++.... ....+.+.+|+.+|++++|||||+++++|.+.+.+++|
T Consensus         3 l~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV   82 (322)
T d1s9ja_           3 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC   82 (322)
T ss_dssp             CCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            34678999999999999999999999999999999997653 34456799999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCC
Q 007869          337 YDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHG  416 (586)
Q Consensus       337 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~  416 (586)
                      ||||++|+|.+++.+..  .+++..+..++.|+++||.|||+  .++|+||||||+|||+++++++||+|||+|+.....
T Consensus        83 mEy~~gg~L~~~l~~~~--~l~~~~~~~~~~qil~aL~yLH~--~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~  158 (322)
T d1s9ja_          83 MEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  158 (322)
T ss_dssp             EECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred             EEcCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHH--hCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC
Confidence            99999999999997653  58899999999999999999997  137999999999999999999999999999976432


Q ss_pred             CCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCC
Q 007869          417 TDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGP  469 (586)
Q Consensus       417 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~  469 (586)
                         .....+||+.|||||++.+..++.++||||+||++|||++|+.||...+.
T Consensus       159 ---~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~  208 (322)
T d1s9ja_         159 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA  208 (322)
T ss_dssp             ---TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCT
T ss_pred             ---ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH
Confidence               23456899999999999999999999999999999999999999986543

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-51  Score=420.71  Aligned_cols=260  Identities=26%  Similarity=0.387  Sum_probs=210.7

Q ss_pred             hhcCCcccceeEeecCceEEEEEEeCCCC-----eEEEEEEeccc-cchhHHHHHHHHHHhccc-CCCceeeeeeeeecc
Q 007869          258 IATKGFREKELLGTGGFGRVYRGTLPKSQ-----IEIAVKKISHE-SRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRK  330 (586)
Q Consensus       258 ~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~-----~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~  330 (586)
                      +..++|+..++||+|+||+||+|++...+     ..||||++... .......+.+|+.+|.++ +|||||+++++|.+.
T Consensus        34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~  113 (325)
T d1rjba_          34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS  113 (325)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             CCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence            45578999999999999999999986543     36999998654 334456799999999998 899999999999999


Q ss_pred             CeEEEEEecCCCCChhhhhhcCCC---------------------ccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCC
Q 007869          331 GELLLVYDYMPNGSLDKYLYDQPK---------------------VTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDV  389 (586)
Q Consensus       331 ~~~~lV~E~~~~gsL~~~l~~~~~---------------------~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDI  389 (586)
                      +.+++|||||++|+|.++|+....                     ..++|..++.++.||++||.|||+   ++||||||
T Consensus       114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~---~~IiHRDl  190 (325)
T d1rjba_         114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDL  190 (325)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTC
T ss_pred             CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccC
Confidence            999999999999999999976432                     358999999999999999999998   89999999


Q ss_pred             CCCCeeecCCCCeEEccccceeeccCCCCC-ceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCC
Q 007869          390 KASNVLLDGELNGRLGDFGLARLYDHGTDP-QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQ  467 (586)
Q Consensus       390 kp~NIll~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~  467 (586)
                      ||+|||++.++++||+|||+|+........ ......||+.|||||++.++.++.++|||||||++|||+| |+.||.+.
T Consensus       191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~  270 (325)
T d1rjba_         191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI  270 (325)
T ss_dssp             SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             chhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCC
Confidence            999999999999999999999976654332 2335678999999999999999999999999999999997 89999875


Q ss_pred             CCCccchhhHHHHhhhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 007869          468 GPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER  535 (586)
Q Consensus       468 ~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  535 (586)
                      ...+.  +...    ...+.     .+..    +......+.+|+.+||+.||++|||++||++.|..
T Consensus       271 ~~~~~--~~~~----~~~~~-----~~~~----p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~  323 (325)
T d1rjba_         271 PVDAN--FYKL----IQNGF-----KMDQ----PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC  323 (325)
T ss_dssp             CCSHH--HHHH----HHTTC-----CCCC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CHHHH--HHHH----HhcCC-----CCCC----CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHhC
Confidence            54322  1111    11211     1111    11223567889999999999999999999999964

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-50  Score=404.12  Aligned_cols=246  Identities=24%  Similarity=0.409  Sum_probs=199.2

Q ss_pred             cccceeEeecCceEEEEEEeCCCCeEEEEEEeccc--cchhHHHHHHHHHHhcccCCCceeeeeeeeec----cCeEEEE
Q 007869          263 FREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRR----KGELLLV  336 (586)
Q Consensus       263 f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~----~~~~~lV  336 (586)
                      |+..+.||+|+||+||+|++..++..||+|++...  .....+.|.+|+++|++++||||+++++++..    .+.+++|
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv   90 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV   90 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence            35667899999999999999999999999998754  33445679999999999999999999999864    3568999


Q ss_pred             EecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCc--EEeCCCCCCCeeec-CCCCeEEccccceeec
Q 007869          337 YDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQV--VIHRDVKASNVLLD-GELNGRLGDFGLARLY  413 (586)
Q Consensus       337 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~--ivHrDIkp~NIll~-~~~~~kL~DFGla~~~  413 (586)
                      |||+++|+|.+++.+.  ..+++..+..++.||++||+|||+   ++  |+||||||+|||++ +++.+||+|||+|+..
T Consensus        91 mE~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~gl~yLH~---~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~  165 (270)
T d1t4ha_          91 TELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  165 (270)
T ss_dssp             EECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             EeCCCCCcHHHHHhcc--ccccHHHHHHHHHHHHHHHHHHHH---CCCCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence            9999999999999765  368889999999999999999998   66  99999999999996 5789999999999864


Q ss_pred             cCCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccC
Q 007869          414 DHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARD  493 (586)
Q Consensus       414 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d  493 (586)
                      ..   ......+||+.|||||++.+ +++.++|||||||++|||++|+.||........  +    .+....+..     
T Consensus       166 ~~---~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~--~----~~~i~~~~~-----  230 (270)
T d1t4ha_         166 RA---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ--I----YRRVTSGVK-----  230 (270)
T ss_dssp             CT---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH--H----HHHHTTTCC-----
T ss_pred             cC---CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH--H----HHHHHcCCC-----
Confidence            32   23345789999999999865 699999999999999999999999975433221  1    111112111     


Q ss_pred             CCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          494 PNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       494 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      |   ..+.......+.+++.+||+.||++|||+.|+++
T Consensus       231 ~---~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         231 P---ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             C---GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             C---cccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence            1   1111122345778899999999999999999975

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-51  Score=409.60  Aligned_cols=247  Identities=28%  Similarity=0.429  Sum_probs=199.6

Q ss_pred             eeEeecCceEEEEEEeC--CCCeEEEEEEeccc--cchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEecCCC
Q 007869          267 ELLGTGGFGRVYRGTLP--KSQIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYMPN  342 (586)
Q Consensus       267 ~~LG~G~~g~Vy~~~~~--~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~~~  342 (586)
                      ++||+|+||+||+|.+.  ++++.||||+++..  +....++|.+|+++|++++||||++++++|.. +..+|||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            57999999999999864  34578999999654  33345789999999999999999999999965 457899999999


Q ss_pred             CChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCCc--
Q 007869          343 GSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDPQ--  420 (586)
Q Consensus       343 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~~--  420 (586)
                      |+|.+++...  ..++|.+++.|+.||++||.|||+   ++|+||||||+|||++.++.+||+|||+++.+.......  
T Consensus        92 g~L~~~l~~~--~~l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~  166 (277)
T d1xbba_          92 GPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA  166 (277)
T ss_dssp             EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred             CcHHHHHhhc--cCCCHHHHHHHHHHHHHHHhhHHh---CCcccCCCcchhhcccccCcccccchhhhhhcccccccccc
Confidence            9999999865  368999999999999999999998   899999999999999999999999999999765443322  


Q ss_pred             eeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCcc
Q 007869          421 TTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTE  499 (586)
Q Consensus       421 ~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~  499 (586)
                      .....||+.|||||++.+..++.++|||||||++|||+| |+.||......+   +.    ....++...     ..   
T Consensus       167 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~---~~----~~i~~~~~~-----~~---  231 (277)
T d1xbba_         167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---VT----AMLEKGERM-----GC---  231 (277)
T ss_dssp             ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HH----HHHHTTCCC-----CC---
T ss_pred             ccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH---HH----HHHHcCCCC-----CC---
Confidence            234578999999999999999999999999999999998 899998654321   11    122222211     11   


Q ss_pred             ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 007869          500 YVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER  535 (586)
Q Consensus       500 ~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  535 (586)
                       +......+.+|+.+||+.||++|||+++|++.|+.
T Consensus       232 -p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~  266 (277)
T d1xbba_         232 -PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN  266 (277)
T ss_dssp             -CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             -CcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence             11223567789999999999999999999988864

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-51  Score=413.29  Aligned_cols=259  Identities=28%  Similarity=0.413  Sum_probs=204.5

Q ss_pred             hhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEE
Q 007869          258 IATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY  337 (586)
Q Consensus       258 ~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  337 (586)
                      +..++|++.+.||+|+||+||+|+++++ ..||||++.... ...+.|.+|+.++++++|||||+++++|.+ +..++||
T Consensus        14 i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~   90 (285)
T d1fmka3          14 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT   90 (285)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             cCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEE
Confidence            3346799999999999999999999765 569999996543 345789999999999999999999999855 5689999


Q ss_pred             ecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCC
Q 007869          338 DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT  417 (586)
Q Consensus       338 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~  417 (586)
                      ||+++|+|..++.......++|.+++.++.||++||.|||+   ++|+||||||+||||+.++++||+|||+++......
T Consensus        91 Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~---~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~  167 (285)
T d1fmka3          91 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE  167 (285)
T ss_dssp             CCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred             EecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhh---hheecccccceEEEECCCCcEEEcccchhhhccCCC
Confidence            99999999999876544579999999999999999999998   899999999999999999999999999999776544


Q ss_pred             CCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCC
Q 007869          418 DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLG  497 (586)
Q Consensus       418 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~  497 (586)
                      ........||+.|+|||++..+.++.++|||||||++|||+||..|+.......  .+..++.    ++.     .+...
T Consensus       168 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~--~~~~~i~----~~~-----~~~~~  236 (285)
T d1fmka3         168 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR--EVLDQVE----RGY-----RMPCP  236 (285)
T ss_dssp             --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHH----TTC-----CCCCC
T ss_pred             ceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHH--HHHHHHH----hcC-----CCCCC
Confidence            444455679999999999999999999999999999999999776665433221  1222221    111     11111


Q ss_pred             ccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 007869          498 TEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERDV  537 (586)
Q Consensus       498 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  537 (586)
                      .    ...+.+.+++.+||+.||++||+|.+|++.|+.-.
T Consensus       237 ~----~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~  272 (285)
T d1fmka3         237 P----ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  272 (285)
T ss_dssp             T----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred             c----ccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence            1    22356778999999999999999999999998643

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=3.9e-50  Score=415.99  Aligned_cols=253  Identities=23%  Similarity=0.303  Sum_probs=211.9

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEecC
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYM  340 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  340 (586)
                      ++|++.+.||+|+||.||+|++..++..||||++........+.+.+|+++|++++||||+++++++.+.+.++||||||
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  105 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  105 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            57999999999999999999999999999999998766666678999999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeec--CCCCeEEccccceeeccCCCC
Q 007869          341 PNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLD--GELNGRLGDFGLARLYDHGTD  418 (586)
Q Consensus       341 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~--~~~~~kL~DFGla~~~~~~~~  418 (586)
                      ++|+|.+++.... ..+++..+..|+.||+.||.|||+   ++||||||||+|||++  .++.+||+|||+|+.+.... 
T Consensus       106 ~gg~L~~~l~~~~-~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~-  180 (350)
T d1koaa2         106 SGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ-  180 (350)
T ss_dssp             CSCBHHHHHTCTT-SCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS-
T ss_pred             CCCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHh---cCCeeeeechhHeeeccCCCCeEEEeecchheeccccc-
Confidence            9999999996543 469999999999999999999998   9999999999999995  46789999999999765432 


Q ss_pred             CceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCc
Q 007869          419 PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGT  498 (586)
Q Consensus       419 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~  498 (586)
                       ......||+.|||||++.+..++.++|||||||++|||++|+.||.+.+..+.   ...+    ..+.      .....
T Consensus       181 -~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~---~~~i----~~~~------~~~~~  246 (350)
T d1koaa2         181 -SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET---LRNV----KSCD------WNMDD  246 (350)
T ss_dssp             -CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHHH----HHTC------CCSCC
T ss_pred             -ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHH---HHHH----HhCC------CCCCc
Confidence             34557899999999999999999999999999999999999999976533221   1111    1111      11111


Q ss_pred             cccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          499 EYVAEELELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       499 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                      .......+.+.+++.+||+.||++|||++|+++.
T Consensus       247 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         247 SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            1111223557788999999999999999999873

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.3e-50  Score=412.27  Aligned_cols=252  Identities=24%  Similarity=0.359  Sum_probs=192.4

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc-chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEe
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYD  338 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E  338 (586)
                      .+.|+..+.||+|+||+||+|+++.+++.||||++.... ....+.+.+|+.+|++++||||+++++++.+.+.++||||
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE   87 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ   87 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            356899999999999999999999999999999997653 2334568899999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeec---CCCCeEEccccceeeccC
Q 007869          339 YMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLD---GELNGRLGDFGLARLYDH  415 (586)
Q Consensus       339 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~---~~~~~kL~DFGla~~~~~  415 (586)
                      ||++|+|.++|...  ..+++.++..++.||+.||.|||+   ++|+||||||+|||+.   +++.+||+|||+|+....
T Consensus        88 ~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~  162 (307)
T d1a06a_          88 LVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP  162 (307)
T ss_dssp             CCCSCBHHHHHHTC--SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred             ccCCCcHHHhhhcc--cCCCHHHHHHHHHHHHHHHHhhhh---ceeeeEEecccceeecccCCCceEEEeccceeEEccC
Confidence            99999999999765  468999999999999999999998   9999999999999994   578999999999987654


Q ss_pred             CCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCC
Q 007869          416 GTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPN  495 (586)
Q Consensus       416 ~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~  495 (586)
                      ..  .....+||+.|||||++.+..++.++|||||||++|||++|+.||......+   +...+    .++...  ..+.
T Consensus       163 ~~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~---~~~~i----~~~~~~--~~~~  231 (307)
T d1a06a_         163 GS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK---LFEQI----LKAEYE--FDSP  231 (307)
T ss_dssp             ------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHH----HTTCCC--CCTT
T ss_pred             CC--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH---HHHHH----hccCCC--CCCc
Confidence            32  2344689999999999999999999999999999999999999997643321   11111    111110  1111


Q ss_pred             CCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          496 LGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       496 l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                          ........+.+++.+||+.||++|||+.|+++
T Consensus       232 ----~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         232 ----YWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             ----TTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ----cccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence                11122355778899999999999999999987

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-51  Score=409.71  Aligned_cols=249  Identities=22%  Similarity=0.314  Sum_probs=205.9

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc---cchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEE
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY  337 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  337 (586)
                      ++|+..+.||+|+||+||+|+++.+++.||||++...   .....+.+.+|++++++++||||+++++++.+++.+++||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            5689999999999999999999999999999999653   2344577999999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCC
Q 007869          338 DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT  417 (586)
Q Consensus       338 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~  417 (586)
                      ||+++|+|.+++...  ..+++..+..++.|++.||+|||+   ++|+||||||+|||+++++.+||+|||+|+.+....
T Consensus        88 Ey~~gg~L~~~~~~~--~~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~  162 (288)
T d1uu3a_          88 SYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES  162 (288)
T ss_dssp             CCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             EccCCCCHHHhhhcc--CCCCHHHHHHHHHHHHHHHHhhcc---ccEEcCcCCccccccCCCceEEecccccceecccCC
Confidence            999999999998765  368899999999999999999998   999999999999999999999999999999875433


Q ss_pred             C-CceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCC
Q 007869          418 D-PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNL  496 (586)
Q Consensus       418 ~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l  496 (586)
                      . ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+   +.    ....++.      +.+
T Consensus       163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~---~~----~~i~~~~------~~~  229 (288)
T d1uu3a_         163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL---IF----QKIIKLE------YDF  229 (288)
T ss_dssp             -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH----HHHHTTC------CCC
T ss_pred             cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH---HH----HHHHcCC------CCC
Confidence            2 23445689999999999999999999999999999999999999998643221   11    1111111      111


Q ss_pred             CccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          497 GTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       497 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      ...+    ...+.+|+.+||+.||++|||++|+++
T Consensus       230 p~~~----s~~~~~li~~~L~~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         230 PEKF----FPKARDLVEKLLVLDATKRLGCEEMEG  260 (288)
T ss_dssp             CTTC----CHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred             CccC----CHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence            1222    245678899999999999999999754

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1e-49  Score=413.04  Aligned_cols=252  Identities=18%  Similarity=0.260  Sum_probs=211.4

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEecC
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYM  340 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  340 (586)
                      +.|++.+.||+|+||.||+|++..++..||||++........+.+.+|+++|++++||||+++++++.+++.++||||||
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  108 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL  108 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            57999999999999999999999999999999998766555678899999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeec--CCCCeEEccccceeeccCCCC
Q 007869          341 PNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLD--GELNGRLGDFGLARLYDHGTD  418 (586)
Q Consensus       341 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~--~~~~~kL~DFGla~~~~~~~~  418 (586)
                      ++|+|.+++... ...+++.++..|+.||+.||.|||+   ++|+||||||+||||+  .++.+||+|||+|+.+.... 
T Consensus       109 ~gg~L~~~~~~~-~~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~-  183 (352)
T d1koba_         109 SGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE-  183 (352)
T ss_dssp             CCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-
T ss_pred             CCChHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccccccccccccCCCeEEEeecccceecCCCC-
Confidence            999999887654 3469999999999999999999998   9999999999999997  57899999999999876432 


Q ss_pred             CceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCc
Q 007869          419 PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGT  498 (586)
Q Consensus       419 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~  498 (586)
                       ......||+.|+|||++.+..++.++|||||||++|||+||+.||.+....+   +...+    .++..      ....
T Consensus       184 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~---~~~~i----~~~~~------~~~~  249 (352)
T d1koba_         184 -IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE---TLQNV----KRCDW------EFDE  249 (352)
T ss_dssp             -CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HHHHH----HHCCC------CCCS
T ss_pred             -ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH---HHHHH----HhCCC------CCCc
Confidence             3455789999999999999999999999999999999999999997654322   11111    11111      1111


Q ss_pred             cccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          499 EYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       499 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      .........+.+|+.+||+.||.+|||+.|+++
T Consensus       250 ~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  282 (352)
T d1koba_         250 DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  282 (352)
T ss_dssp             STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             ccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            111122345678899999999999999999987

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.1e-50  Score=409.79  Aligned_cols=251  Identities=28%  Similarity=0.415  Sum_probs=206.1

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc---chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEE
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES---RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY  337 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  337 (586)
                      +.|+..+.||+|+||+||+|++..++..||||++....   ....+.+.+|+++|++++|||||++++++.+.+..++||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            35888999999999999999999999999999997543   334567999999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCC
Q 007869          338 DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT  417 (586)
Q Consensus       338 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~  417 (586)
                      |||++|+|..++...  ..+++.++..++.||++||.|||+   ++|+||||||+|||++.++++||+|||+|+....  
T Consensus        95 E~~~~g~l~~~~~~~--~~l~e~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~--  167 (309)
T d1u5ra_          95 EYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--  167 (309)
T ss_dssp             ECCSEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--
T ss_pred             EecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEECCCCCEEEeecccccccCC--
Confidence            999999998776554  468999999999999999999998   8999999999999999999999999999986543  


Q ss_pred             CCceeeeccCCCccCcccccC---CCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCC
Q 007869          418 DPQTTHVVGTLGYLAPEHTRT---GKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDP  494 (586)
Q Consensus       418 ~~~~~~~~gt~~y~aPE~~~~---~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~  494 (586)
                         .....||+.|||||++.+   +.++.++|||||||++|||++|+.||......+.      ..... .+     ..+
T Consensus       168 ---~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~------~~~i~-~~-----~~~  232 (309)
T d1u5ra_         168 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------LYHIA-QN-----ESP  232 (309)
T ss_dssp             ---BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HHHHH-HS-----CCC
T ss_pred             ---CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHH------HHHHH-hC-----CCC
Confidence               234579999999999864   4689999999999999999999999976433211      11111 11     111


Q ss_pred             CCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHhhc
Q 007869          495 NLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ--ILERD  536 (586)
Q Consensus       495 ~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~~  536 (586)
                      .+...   ...+.+.+++.+||+.||.+|||+.|+++  .+.+.
T Consensus       233 ~~~~~---~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~  273 (309)
T d1u5ra_         233 ALQSG---HWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  273 (309)
T ss_dssp             CCSCT---TSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred             CCCCC---CCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCC
Confidence            11111   11245778889999999999999999986  45443

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-49  Score=402.59  Aligned_cols=252  Identities=22%  Similarity=0.338  Sum_probs=209.0

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc------chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeE
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES------RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGEL  333 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~------~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~  333 (586)
                      .+.|+..+.||+|+||+||+|+++.+++.||||++....      ....+.+.+|+++|++++|||||++++++.+.+.+
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            357999999999999999999999999999999986532      12357899999999999999999999999999999


Q ss_pred             EEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCC----CeEEccccc
Q 007869          334 LLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGEL----NGRLGDFGL  409 (586)
Q Consensus       334 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~----~~kL~DFGl  409 (586)
                      +||||||++|+|.++|...  ..+++..+..++.|+++||.|||+   ++|+||||||+|||++.++    .+||+|||+
T Consensus        89 ~iv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~qi~~al~yLH~---~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~  163 (293)
T d1jksa_          89 ILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL  163 (293)
T ss_dssp             EEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEEEcCCCccccchhccc--cccchhHHHHHHHHHHHHHHhhhh---cceeecccccceEEEecCCCcccceEecchhh
Confidence            9999999999999999765  368999999999999999999998   9999999999999998776    499999999


Q ss_pred             eeeccCCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccc
Q 007869          410 ARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELL  489 (586)
Q Consensus       410 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~  489 (586)
                      |+......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+.   ..    ...++.  
T Consensus       164 a~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~---~~----~i~~~~--  232 (293)
T d1jksa_         164 AHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET---LA----NVSAVN--  232 (293)
T ss_dssp             CEECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HH----HHHTTC--
T ss_pred             hhhcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHH---HH----HHHhcC--
Confidence            99765432  33456799999999999999999999999999999999999999986543221   11    111111  


Q ss_pred             cccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          490 EARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       490 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                          ..............+.+++.+||+.||++|||++|+++
T Consensus       233 ----~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         233 ----YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             ----CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ----CCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                11111111122356778999999999999999999986

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-50  Score=403.25  Aligned_cols=257  Identities=24%  Similarity=0.412  Sum_probs=199.1

Q ss_pred             hhcCCcccceeEeecCceEEEEEEeCCC---CeEEEEEEeccc-cchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeE
Q 007869          258 IATKGFREKELLGTGGFGRVYRGTLPKS---QIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGEL  333 (586)
Q Consensus       258 ~a~~~f~~~~~LG~G~~g~Vy~~~~~~~---~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~  333 (586)
                      +..++|+..+.||+|+||.||+|++..+   +..||||.+... .....+.|.+|++++++++||||++++++|. .+.+
T Consensus         4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~   82 (273)
T d1mp8a_           4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV   82 (273)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred             cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeE
Confidence            3446789999999999999999998643   356999998654 3344567999999999999999999999996 4678


Q ss_pred             EEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeec
Q 007869          334 LLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLY  413 (586)
Q Consensus       334 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~  413 (586)
                      ++||||+++|+|.+++... ...+++..++.++.||++||.|||+   ++|+||||||+|||+++++++||+|||+|+..
T Consensus        83 ~iv~E~~~~g~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~  158 (273)
T d1mp8a_          83 WIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM  158 (273)
T ss_dssp             EEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred             EEEEEeccCCcHHhhhhcc-CCCCCHHHHHHHHHHHHHHhhhhcc---cCeeccccchhheeecCCCcEEEccchhheec
Confidence            9999999999999988665 3478999999999999999999998   99999999999999999999999999999987


Q ss_pred             cCCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccCcccccc
Q 007869          414 DHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEAR  492 (586)
Q Consensus       414 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~  492 (586)
                      ........+...||+.|+|||++.+..++.++|||||||++|||+| |+.||......+   +...+    .++...   
T Consensus       159 ~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~---~~~~i----~~~~~~---  228 (273)
T d1mp8a_         159 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGRI----ENGERL---  228 (273)
T ss_dssp             ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHHH----HTTCCC---
T ss_pred             cCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH---HHHHH----HcCCCC---
Confidence            6554445556778999999999999999999999999999999998 899997754432   11111    222211   


Q ss_pred             CCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 007869          493 DPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER  535 (586)
Q Consensus       493 d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  535 (586)
                        ..    .......+.+++.+||+.||++|||+.||++.|+.
T Consensus       229 --~~----~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~  265 (273)
T d1mp8a_         229 --PM----PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST  265 (273)
T ss_dssp             --CC----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             --CC----CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence              11    11223567888999999999999999999998875

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.4e-50  Score=408.79  Aligned_cols=265  Identities=25%  Similarity=0.416  Sum_probs=215.3

Q ss_pred             hhhhhhhcCCcccceeEeecCceEEEEEEeCC-----CCeEEEEEEeccccc-hhHHHHHHHHHHhcccCCCceeeeeee
Q 007869          253 YKDLYIATKGFREKELLGTGGFGRVYRGTLPK-----SQIEIAVKKISHESR-QGMKEFVAEIVSIGRLRHRNLVQLLGY  326 (586)
Q Consensus       253 ~~el~~a~~~f~~~~~LG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~~~-~~~~~~~~Ei~~l~~l~H~niv~l~~~  326 (586)
                      +.+++...++|+..+.||+|+||+||+|++++     ++..||||++..... +..++|.+|+++|++++||||++++++
T Consensus         5 ~~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~   84 (301)
T d1lufa_           5 LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV   84 (301)
T ss_dssp             HHHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             hhhccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence            44566677899999999999999999999753     457899999976533 345679999999999999999999999


Q ss_pred             eeccCeEEEEEecCCCCChhhhhhcCC----------------------CccchhHHHHHHHHHHHHHHHHhhcccCCcE
Q 007869          327 CRRKGELLLVYDYMPNGSLDKYLYDQP----------------------KVTLNWIQRFRVIKGVALGLFYLHQEWEQVV  384 (586)
Q Consensus       327 ~~~~~~~~lV~E~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~i  384 (586)
                      |...+..++||||+++|+|.++++...                      ...+++..++.|+.|++.||+|||+   ++|
T Consensus        85 ~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~i  161 (301)
T d1lufa_          85 CAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKF  161 (301)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTC
T ss_pred             eccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc---CCe
Confidence            999999999999999999999997532                      1348899999999999999999998   999


Q ss_pred             EeCCCCCCCeeecCCCCeEEccccceeeccCCCC-CceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCC-C
Q 007869          385 IHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD-PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGR-R  462 (586)
Q Consensus       385 vHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~-~  462 (586)
                      |||||||+|||+|.++++||+|||+|+.+..... ...+...||+.|+|||++.+..++.++|||||||++|||++|. +
T Consensus       162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~  241 (301)
T d1lufa_         162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ  241 (301)
T ss_dssp             CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             EeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCC
Confidence            9999999999999999999999999986644322 2334567899999999999999999999999999999999986 5


Q ss_pred             CCCCCCCCccchhhHHHHhhhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 007869          463 PIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERD  536 (586)
Q Consensus       463 p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  536 (586)
                      ||......+   +...    ..++...     ....    .....+.+|+.+||+.||++||||.||+++|++.
T Consensus       242 p~~~~~~~e---~~~~----v~~~~~~-----~~p~----~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i  299 (301)
T d1lufa_         242 PYYGMAHEE---VIYY----VRDGNIL-----ACPE----NCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM  299 (301)
T ss_dssp             TTTTSCHHH---HHHH----HHTTCCC-----CCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             CCCCCCHHH---HHHH----HHcCCCC-----CCCc----cchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence            676543322   1221    2223221     1111    2234678899999999999999999999999874

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-50  Score=399.19  Aligned_cols=249  Identities=32%  Similarity=0.450  Sum_probs=198.4

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeec-cCeEEEEEe
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRR-KGELLLVYD  338 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~-~~~~~lV~E  338 (586)
                      -++|+..+.||+|+||.||+|+++  +..||||+++.+.  ..++|.+|++++++++||||++++|+|.+ .+.+++|||
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~e   81 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE   81 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred             HHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEe
Confidence            356788899999999999999994  5689999996543  34789999999999999999999999865 466899999


Q ss_pred             cCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCC
Q 007869          339 YMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD  418 (586)
Q Consensus       339 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~  418 (586)
                      |+++|+|.++|.......++|..+++|+.||++||.|||+   .+|+||||||+|||++.++.+||+|||+++.....  
T Consensus        82 y~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~--  156 (262)
T d1byga_          82 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--  156 (262)
T ss_dssp             CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred             ccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhcccccc---CceeccccchHhheecCCCCEeecccccceecCCC--
Confidence            9999999999977655568999999999999999999998   89999999999999999999999999999865432  


Q ss_pred             CceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCC
Q 007869          419 PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLG  497 (586)
Q Consensus       419 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~  497 (586)
                        .....+|..|+|||++.++.+++++|||||||++|||+| |+.|+......+   +..++    .++.     .+...
T Consensus       157 --~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~---~~~~i----~~~~-----~~~~~  222 (262)
T d1byga_         157 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPRV----EKGY-----KMDAP  222 (262)
T ss_dssp             -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HHHHH----TTTC-----CCCCC
T ss_pred             --CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH---HHHHH----HcCC-----CCCCC
Confidence              233568999999999999999999999999999999998 677776543322   22222    1221     12221


Q ss_pred             ccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 007869          498 TEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER  535 (586)
Q Consensus       498 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  535 (586)
                      .    .....+.+++.+||+.||++||||.++++.|++
T Consensus       223 ~----~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~  256 (262)
T d1byga_         223 D----GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEH  256 (262)
T ss_dssp             T----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             c----cCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence            1    223567788999999999999999999999975

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-49  Score=406.05  Aligned_cols=255  Identities=25%  Similarity=0.398  Sum_probs=203.7

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCe----EEEEEEeccc-cchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEE
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQI----EIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLL  335 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~----~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~l  335 (586)
                      .+|+..++||+|+||+||+|++..+++    +||||++... +.+..++|.+|++++++++|||||+++|+|.++ ..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence            469999999999999999999876664    5899988653 445568899999999999999999999999875 5678


Q ss_pred             EEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccC
Q 007869          336 VYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDH  415 (586)
Q Consensus       336 V~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~  415 (586)
                      ++||+.+|+|.+++... ...+++..+++++.|||+||.|||+   ++|+||||||+|||++.++.+||+|||+|+....
T Consensus        88 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~  163 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  163 (317)
T ss_dssp             EEECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred             EEEeccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHHH---cCcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence            89999999999988775 3578999999999999999999998   8999999999999999999999999999997654


Q ss_pred             CCCC-ceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccCccccccC
Q 007869          416 GTDP-QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLEARD  493 (586)
Q Consensus       416 ~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d  493 (586)
                      .... ......||+.|+|||++.++.++.++|||||||++|||+| |+.||......+   +..    ...++..     
T Consensus       164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~---~~~----~i~~~~~-----  231 (317)
T d1xkka_         164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISS----ILEKGER-----  231 (317)
T ss_dssp             TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG---HHH----HHHHTCC-----
T ss_pred             ccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH---HHH----HHHcCCC-----
Confidence            4332 2334578999999999999999999999999999999998 788887654332   111    1122211     


Q ss_pred             CCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 007869          494 PNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERD  536 (586)
Q Consensus       494 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  536 (586)
                      +..    +......+.+++.+||+.||++|||+.|+++.|++.
T Consensus       232 ~~~----p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~  270 (317)
T d1xkka_         232 LPQ----PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM  270 (317)
T ss_dssp             CCC----CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCC----CcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence            111    112235677899999999999999999999988764

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.6e-48  Score=396.99  Aligned_cols=245  Identities=25%  Similarity=0.311  Sum_probs=206.1

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc---cchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEE
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY  337 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  337 (586)
                      ++|++.+.||+|+||+||+|+++.+++.||||++...   .....+.+.+|+.++++++||||+++++++.+.+.+++||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            4688999999999999999999999999999999753   2344678999999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCC
Q 007869          338 DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT  417 (586)
Q Consensus       338 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~  417 (586)
                      ||+++|+|..++....  .+++.....++.||+.||.|||+   ++|+||||||+|||++.++++||+|||+|+..... 
T Consensus        84 E~~~gg~l~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~-  157 (316)
T d1fota_          84 DYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-  157 (316)
T ss_dssp             CCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred             eecCCccccccccccc--cccccHHHHHHHHHHHhhhhhcc---CcEEccccCchheeEcCCCCEEEecCccceEeccc-
Confidence            9999999999987764  56777888899999999999998   89999999999999999999999999999976532 


Q ss_pred             CCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCC
Q 007869          418 DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLG  497 (586)
Q Consensus       418 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~  497 (586)
                         .....||+.|||||++.+..++.++|||||||++|||++|+.||...+..+   +.    ....++.      ....
T Consensus       158 ---~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~~----~~i~~~~------~~~p  221 (316)
T d1fota_         158 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK---TY----EKILNAE------LRFP  221 (316)
T ss_dssp             ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH---HH----HHHHHCC------CCCC
T ss_pred             ---cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHH---HH----HHHHcCC------CCCC
Confidence               345689999999999999999999999999999999999999998654321   11    1111111      1111


Q ss_pred             ccccHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 007869          498 TEYVAEELELVLKLGLLCSHSDPTARP-----SMRQVVQ  531 (586)
Q Consensus       498 ~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~  531 (586)
                      ...    ...+.+++.+||+.||.+||     |++++++
T Consensus       222 ~~~----s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         222 PFF----NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             TTS----CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             CCC----CHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence            112    24567888899999999996     8999875

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-48  Score=396.41  Aligned_cols=265  Identities=28%  Similarity=0.341  Sum_probs=204.4

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccC----eEEEE
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKG----ELLLV  336 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~----~~~lV  336 (586)
                      +.|...+.||+|+||.||+|++  ++..||||+++..... ...+..|+..+.+++||||++++++|.+.+    .+++|
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv   79 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence            4577788999999999999997  4678999999654322 223445666777899999999999998654    68999


Q ss_pred             EecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcc-----cCCcEEeCCCCCCCeeecCCCCeEEcccccee
Q 007869          337 YDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQE-----WEQVVIHRDVKASNVLLDGELNGRLGDFGLAR  411 (586)
Q Consensus       337 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~-----~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~  411 (586)
                      ||||++|+|.++|++.   .++|.++++++.|+|.||.|||+.     .+++|+||||||+||||++++++||+|||+++
T Consensus        80 ~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~  156 (303)
T d1vjya_          80 SDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             EECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             EecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence            9999999999999865   589999999999999999999973     24799999999999999999999999999999


Q ss_pred             eccCCCCC---ceeeeccCCCccCcccccCCC------CCCcceEEehhHHHHHHHhCCCCCCCCCCCccc--------h
Q 007869          412 LYDHGTDP---QTTHVVGTLGYLAPEHTRTGK------ATTSADVFSFGAFLLEVACGRRPIQRQGPSENL--------I  474 (586)
Q Consensus       412 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~--------~  474 (586)
                      ........   ......||+.|+|||++....      ++.++|||||||+||||+||..|+.........        .
T Consensus       157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~  236 (303)
T d1vjya_         157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP  236 (303)
T ss_dssp             EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence            87554322   234568999999999987543      577899999999999999999887543322110        0


Q ss_pred             hhHHHHhhhccCccccccCCCCCccc-cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 007869          475 LVDWVFDFWNRGELLEARDPNLGTEY-VAEELELVLKLGLLCSHSDPTARPSMRQVVQILER  535 (586)
Q Consensus       475 l~~~v~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  535 (586)
                      ..+......    .....+|.+.... ..+....+.+|+.+||+.||++|||+.||++.|++
T Consensus       237 ~~~~~~~~~----~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~  294 (303)
T d1vjya_         237 SVEEMRKVV----CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ  294 (303)
T ss_dssp             CHHHHHHHH----TTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred             hHHHHHHHH----hccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence            111111111    1122334443332 34566778999999999999999999999999875

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-48  Score=399.28  Aligned_cols=249  Identities=24%  Similarity=0.291  Sum_probs=209.0

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc---cchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEE
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLV  336 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV  336 (586)
                      -++|+..+.||+|+||+||+|+++.+++.||||++.+.   .....+.+.+|+.+|++++||||+++++++.+.+.+++|
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv   83 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence            45799999999999999999999999999999999754   234567789999999999999999999999999999999


Q ss_pred             EecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCC
Q 007869          337 YDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHG  416 (586)
Q Consensus       337 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~  416 (586)
                      ||||++|+|.+++....  .+++.....++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+|+.....
T Consensus        84 ~ey~~gg~L~~~~~~~~--~~~e~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~  158 (337)
T d1o6la_          84 MEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD  158 (337)
T ss_dssp             EECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred             eeccCCCchhhhhhccc--CCcHHHHHHHHHHHhhhhhhhhh---cCccccccCHHHeEecCCCCEEEeecccccccccC
Confidence            99999999999997753  57888899999999999999998   99999999999999999999999999999865433


Q ss_pred             CCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCC
Q 007869          417 TDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNL  496 (586)
Q Consensus       417 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l  496 (586)
                      . ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+   +.    +....+.      +.+
T Consensus       159 ~-~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~---~~----~~i~~~~------~~~  224 (337)
T d1o6la_         159 G-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---LF----ELILMEE------IRF  224 (337)
T ss_dssp             T-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HH----HHHHHCC------CCC
T ss_pred             C-cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH---HH----HHHhcCC------CCC
Confidence            2 23445789999999999999999999999999999999999999998754321   11    1111111      111


Q ss_pred             CccccHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 007869          497 GTEYVAEELELVLKLGLLCSHSDPTARPS-----MRQVVQ  531 (586)
Q Consensus       497 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~  531 (586)
                      ...++    ..+.+|+.+||+.||.+||+     ++|+++
T Consensus       225 p~~~s----~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         225 PRTLS----PEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             CTTSC----HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             CccCC----HHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence            12222    34678889999999999995     788875

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-49  Score=400.54  Aligned_cols=256  Identities=28%  Similarity=0.452  Sum_probs=205.1

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCe--EEEEEEeccc-cchhHHHHHHHHHHhccc-CCCceeeeeeeeeccCeEEEE
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQI--EIAVKKISHE-SRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRRKGELLLV  336 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~--~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~~~~~~lV  336 (586)
                      ++|+..++||+|+||.||+|++++++.  .||||++... ..+..++|.+|+++|+++ +||||++++++|.+++.+++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            678889999999999999999987765  4788887543 344566899999999999 799999999999999999999


Q ss_pred             EecCCCCChhhhhhcCC--------------CccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCe
Q 007869          337 YDYMPNGSLDKYLYDQP--------------KVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNG  402 (586)
Q Consensus       337 ~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~  402 (586)
                      |||+++|+|.++|+...              ...++|.++++++.|||+||.|||+   ++|+||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~---~~iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc---CCccccccccceEEEcCCCce
Confidence            99999999999997542              3578999999999999999999998   899999999999999999999


Q ss_pred             EEccccceeeccCCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCC-CCCCCCCCccchhhHHHHh
Q 007869          403 RLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRR-PIQRQGPSENLILVDWVFD  481 (586)
Q Consensus       403 kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~-p~~~~~~~~~~~l~~~v~~  481 (586)
                      ||+|||+++......  ......||..|+|||.+.++.++.++|||||||++|||++|.. ||...+..+   +.+.+  
T Consensus       167 kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~---~~~~i--  239 (309)
T d1fvra_         167 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---LYEKL--  239 (309)
T ss_dssp             EECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHG--
T ss_pred             EEccccccccccccc--cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH---HHHHH--
Confidence            999999998654322  2234568999999999999999999999999999999999765 565433211   22222  


Q ss_pred             hhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 007869          482 FWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERDV  537 (586)
Q Consensus       482 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  537 (586)
                        .++.     .+....    .....+.+|+.+||+.||++||||+||++.|++..
T Consensus       240 --~~~~-----~~~~~~----~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~  284 (309)
T d1fvra_         240 --PQGY-----RLEKPL----NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  284 (309)
T ss_dssp             --GGTC-----CCCCCT----TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --HhcC-----CCCCCc----cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence              1221     121111    22356778899999999999999999999987643

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.6e-48  Score=391.68  Aligned_cols=258  Identities=23%  Similarity=0.328  Sum_probs=203.4

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc---cchhHHHHHHHHHHhcccCCCceeeeeeeeeccC----e
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKG----E  332 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~----~  332 (586)
                      .++|++.+.||+|+||.||+|++..+++.||||+++..   +....+.|.+|++++++++||||+++++++...+    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            36799999999999999999999999999999999754   2344567999999999999999999999987654    4


Q ss_pred             EEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceee
Q 007869          333 LLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARL  412 (586)
Q Consensus       333 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~  412 (586)
                      .+|||||+++++|.+++...  ..+++.+++.++.||++||.|||+   ++|+||||||+|||++.++..+|+|||.++.
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~--~~l~~~~~~~i~~qi~~al~~lH~---~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~  160 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARA  160 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred             EEEEEECCCCCEehhhhccc--CCCCHHHHHHHHHHHHHHHHHHHh---CCccCccccCcccccCccccceeehhhhhhh
Confidence            89999999999999988765  368999999999999999999998   9999999999999999999999999999986


Q ss_pred             ccCCCC--CceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCcccc
Q 007869          413 YDHGTD--PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLE  490 (586)
Q Consensus       413 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~  490 (586)
                      ......  .......||+.|+|||++.+..+++++|||||||++|||+||+.||......+      ........+... 
T Consensus       161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~------~~~~~~~~~~~~-  233 (277)
T d1o6ya_         161 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS------VAYQHVREDPIP-  233 (277)
T ss_dssp             CC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHCCCCC-
T ss_pred             hccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHH------HHHHHHhcCCCC-
Confidence            543322  23445689999999999999999999999999999999999999997643321      111112221111 


Q ss_pred             ccCCCCCccccHHHHHHHHHHHHHhcccCCCCCC-CHHHHHHHHhh
Q 007869          491 ARDPNLGTEYVAEELELVLKLGLLCSHSDPTARP-SMRQVVQILER  535 (586)
Q Consensus       491 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RP-s~~evl~~L~~  535 (586)
                            ...........+.+++.+||+.||.+|| |++++++.|.+
T Consensus       234 ------~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r  273 (277)
T d1o6ya_         234 ------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR  273 (277)
T ss_dssp             ------GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             ------CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence                  0111112235677888999999999999 89999888765

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-48  Score=397.02  Aligned_cols=262  Identities=21%  Similarity=0.260  Sum_probs=207.1

Q ss_pred             CCcccc-eeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhccc-CCCceeeeeeeeec----cCeEE
Q 007869          261 KGFREK-ELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRL-RHRNLVQLLGYCRR----KGELL  334 (586)
Q Consensus       261 ~~f~~~-~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~~----~~~~~  334 (586)
                      ++|.+. ++||+|+||+||+|++..+++.||||+++..     ..+.+|++++.++ +||||+++++++.+    ++.++
T Consensus        11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~   85 (335)
T d2ozaa1          11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   85 (335)
T ss_dssp             GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence            578776 4699999999999999999999999998643     4577899987665 89999999999865    46789


Q ss_pred             EEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecC---CCCeEEcccccee
Q 007869          335 LVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDG---ELNGRLGDFGLAR  411 (586)
Q Consensus       335 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~---~~~~kL~DFGla~  411 (586)
                      +|||||++|+|.++|.......+++.++..|+.||+.||.|||+   ++|+||||||+|||+++   ++.+||+|||+|+
T Consensus        86 ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~---~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~  162 (335)
T d2ozaa1          86 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK  162 (335)
T ss_dssp             EEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred             EEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHH---cCCccccccccccccccccccccccccccceee
Confidence            99999999999999987655679999999999999999999998   99999999999999985   4579999999999


Q ss_pred             eccCCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccc
Q 007869          412 LYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEA  491 (586)
Q Consensus       412 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~  491 (586)
                      ......  ......||+.|||||++.+..++.++|||||||++|||+||+.||......+...   .+......+     
T Consensus       163 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~---~~~~~i~~~-----  232 (335)
T d2ozaa1         163 ETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP---GMKTRIRMG-----  232 (335)
T ss_dssp             ECCCCC--CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCSC-----
T ss_pred             eccCCC--ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHH---HHHHHHhcC-----
Confidence            765433  3345689999999999999999999999999999999999999997654432111   111111111     


Q ss_pred             cCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH--HHhhccCCCc
Q 007869          492 RDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ--ILERDVALPA  541 (586)
Q Consensus       492 ~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~--~L~~~~~~p~  541 (586)
                       ...+...........+.+|+.+||+.||++|||+.|+++  .+.+....|.
T Consensus       233 -~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~~  283 (335)
T d2ozaa1         233 -QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQ  283 (335)
T ss_dssp             -SSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTTSSCC
T ss_pred             -CCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCCCCCC
Confidence             111111112233466888999999999999999999997  3544444444

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-49  Score=398.44  Aligned_cols=264  Identities=25%  Similarity=0.357  Sum_probs=202.1

Q ss_pred             hhhhhcCCcccceeEeecCceEEEEEEeCC-----CCeEEEEEEeccc-cchhHHHHHHHHHHhccc-CCCceeeeeeee
Q 007869          255 DLYIATKGFREKELLGTGGFGRVYRGTLPK-----SQIEIAVKKISHE-SRQGMKEFVAEIVSIGRL-RHRNLVQLLGYC  327 (586)
Q Consensus       255 el~~a~~~f~~~~~LG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~  327 (586)
                      ++++..++|+..+.||+|+||.||+|++..     +++.||||++... .....+.+..|...+.++ +|+||+++++++
T Consensus         7 ~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~   86 (299)
T d1ywna1           7 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC   86 (299)
T ss_dssp             HHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeee
Confidence            333445689999999999999999999743     4468999999754 334456788899888887 689999999988


Q ss_pred             ecc-CeEEEEEecCCCCChhhhhhcCC--------------CccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCC
Q 007869          328 RRK-GELLLVYDYMPNGSLDKYLYDQP--------------KVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKAS  392 (586)
Q Consensus       328 ~~~-~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~  392 (586)
                      ... +.+++|||||++|+|.++|+...              ...+++.+++.++.||++||.|||+   ++|+||||||+
T Consensus        87 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~ivHrDlKp~  163 (299)
T d1ywna1          87 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAAR  163 (299)
T ss_dssp             CSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGG
T ss_pred             ccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh---CCCcCCcCCcc
Confidence            764 56899999999999999997542              2358899999999999999999998   89999999999


Q ss_pred             CeeecCCCCeEEccccceeeccCCCCC-ceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCC-CCCCCCCCC
Q 007869          393 NVLLDGELNGRLGDFGLARLYDHGTDP-QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGR-RPIQRQGPS  470 (586)
Q Consensus       393 NIll~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~-~p~~~~~~~  470 (586)
                      ||||++++++||+|||+|+........ ......||+.|+|||++.++.++.++|||||||++|||+||. .||......
T Consensus       164 NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~  243 (299)
T d1ywna1         164 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID  243 (299)
T ss_dssp             GEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred             ceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH
Confidence            999999999999999999876544332 334567999999999999999999999999999999999975 577654433


Q ss_pred             ccchhhHHHHhhhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 007869          471 ENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERD  536 (586)
Q Consensus       471 ~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  536 (586)
                      +.      +.....++..     +.....    ....+.+++.+||+.||++|||+.|+++.|+..
T Consensus       244 ~~------~~~~~~~~~~-----~~~~~~----~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i  294 (299)
T d1ywna1         244 EE------FCRRLKEGTR-----MRAPDY----TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  294 (299)
T ss_dssp             HH------HHHHHHHTCC-----CCCCTT----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HH------HHHHHhcCCC-----CCCCcc----CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            21      1122222221     111111    234577899999999999999999999999753

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-48  Score=396.04  Aligned_cols=252  Identities=28%  Similarity=0.431  Sum_probs=202.8

Q ss_pred             ceeEeecCceEEEEEEeCCCC---eEEEEEEeccc-cchhHHHHHHHHHHhcccCCCceeeeeeeeec-cCeEEEEEecC
Q 007869          266 KELLGTGGFGRVYRGTLPKSQ---IEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRR-KGELLLVYDYM  340 (586)
Q Consensus       266 ~~~LG~G~~g~Vy~~~~~~~~---~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~-~~~~~lV~E~~  340 (586)
                      .++||+|+||+||+|++..++   ..||||+++.. +....++|.+|++++++++||||++++|+|.+ ++..++|||||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            578999999999999986543   46899999753 44556789999999999999999999999875 56899999999


Q ss_pred             CCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCC-
Q 007869          341 PNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP-  419 (586)
Q Consensus       341 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~-  419 (586)
                      ++|+|.+++... ...+++..+++++.|+|+||.|||+   .+|+||||||+|||+++++.+||+|||+++........ 
T Consensus       112 ~~g~l~~~~~~~-~~~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~  187 (311)
T d1r0pa_         112 KHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS  187 (311)
T ss_dssp             TTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred             ecCchhhhhccc-cccchHHHHHHHHHHHHHhhhhhcc---cCcccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence            999999998765 3467888999999999999999998   89999999999999999999999999999976543222 


Q ss_pred             --ceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCC
Q 007869          420 --QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLG  497 (586)
Q Consensus       420 --~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~  497 (586)
                        ......||+.|+|||.+.++.++.++||||||+++|||+||+.||.......  .+..++.    ++..  ...|.  
T Consensus       188 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~--~~~~~i~----~g~~--~~~p~--  257 (311)
T d1r0pa_         188 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF--DITVYLL----QGRR--LLQPE--  257 (311)
T ss_dssp             TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHHH----TTCC--CCCCT--
T ss_pred             ceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH--HHHHHHH----cCCC--CCCcc--
Confidence              2234578999999999999999999999999999999999888876543221  1222221    2221  11121  


Q ss_pred             ccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 007869          498 TEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERD  536 (586)
Q Consensus       498 ~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  536 (586)
                           .....+.+++.+||+.||++||+|.||++.|++.
T Consensus       258 -----~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i  291 (311)
T d1r0pa_         258 -----YCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI  291 (311)
T ss_dssp             -----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -----cCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence                 1234577899999999999999999999999764

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=4.2e-48  Score=388.00  Aligned_cols=251  Identities=25%  Similarity=0.364  Sum_probs=206.7

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccc---------hhHHHHHHHHHHhcccC-CCceeeeeeeeecc
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR---------QGMKEFVAEIVSIGRLR-HRNLVQLLGYCRRK  330 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~Ei~~l~~l~-H~niv~l~~~~~~~  330 (586)
                      ++|+..+.||+|+||+||+|++..+++.||||++.....         ...+.+.+|+.++++++ ||||+++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            678999999999999999999999999999999865421         12346889999999997 99999999999999


Q ss_pred             CeEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccce
Q 007869          331 GELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLA  410 (586)
Q Consensus       331 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla  410 (586)
                      +..+||||||++|+|.++|..+  ..+++.++..++.||++||+|||+   ++|+||||||+|||++.++.+||+|||++
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a  157 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFS  157 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             cceEEEEEcCCCchHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH---cCCcccccccceEEEcCCCCeEEccchhe
Confidence            9999999999999999999765  368999999999999999999998   89999999999999999999999999999


Q ss_pred             eeccCCCCCceeeeccCCCccCcccccC------CCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhc
Q 007869          411 RLYDHGTDPQTTHVVGTLGYLAPEHTRT------GKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWN  484 (586)
Q Consensus       411 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~  484 (586)
                      +......  ..+...||+.|+|||++.+      ..++.++||||+||++|||++|+.||......+       ......
T Consensus       158 ~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~-------~~~~i~  228 (277)
T d1phka_         158 CQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-------MLRMIM  228 (277)
T ss_dssp             EECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHH
T ss_pred             eEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH-------HHHHHH
Confidence            9876533  3345689999999999853      346889999999999999999999998654321       111111


Q ss_pred             cCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          485 RGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       485 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      ++...      ............+.+++.+||++||++|||+.|+++
T Consensus       229 ~~~~~------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         229 SGNYQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             HTCCC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             hCCCC------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            11111      111111123356778899999999999999999875

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-49  Score=393.86  Aligned_cols=256  Identities=28%  Similarity=0.397  Sum_probs=198.6

Q ss_pred             cCCcccceeEeecCceEEEEEEeCC---CCeEEEEEEeccc---cchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeE
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPK---SQIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGEL  333 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~---~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~  333 (586)
                      .++|+..+.||+|+||.||+|++..   ....||||++...   ..+..++|.+|+++|++++||||++++|+|.+ +..
T Consensus         7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~   85 (273)
T d1u46a_           7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM   85 (273)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred             hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence            4578899999999999999998643   2347999998754   34456789999999999999999999999976 467


Q ss_pred             EEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeec
Q 007869          334 LLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLY  413 (586)
Q Consensus       334 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~  413 (586)
                      ++||||+++|+|.+++... ...+++..++.++.|||+||.|||+   ++|+||||||+|||++.++++||+|||+++..
T Consensus        86 ~lv~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~  161 (273)
T d1u46a_          86 KMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRAL  161 (273)
T ss_dssp             EEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             heeeeeecCcchhhhhhcc-cCCCCHHHHHHHHHHHHHHHHHhhh---CCEeeeeecHHHhccccccceeeccchhhhhc
Confidence            8999999999999988765 3469999999999999999999998   89999999999999999999999999999987


Q ss_pred             cCCCCC--ceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCccchhhHHHHhhhccCcccc
Q 007869          414 DHGTDP--QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSENLILVDWVFDFWNRGELLE  490 (586)
Q Consensus       414 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~  490 (586)
                      ......  ......||..|+|||++.+..++.++|||||||++|||+| |+.||...+..+   ...++   ...+..  
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~---~~~~i---~~~~~~--  233 (273)
T d1u46a_         162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ---ILHKI---DKEGER--  233 (273)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHH---HTSCCC--
T ss_pred             ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH---HHHHH---HhCCCC--
Confidence            554332  2234567889999999999999999999999999999998 899997653322   22222   122211  


Q ss_pred             ccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 007869          491 ARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER  535 (586)
Q Consensus       491 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  535 (586)
                         +....    .....+.+|+.+||+.||++|||+.||++.|++
T Consensus       234 ---~~~~~----~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~  271 (273)
T d1u46a_         234 ---LPRPE----DCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE  271 (273)
T ss_dssp             ---CCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ---CCCcc----cccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence               11111    222457789999999999999999999999975

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-48  Score=398.43  Aligned_cols=272  Identities=25%  Similarity=0.390  Sum_probs=218.4

Q ss_pred             CCcccchhh-hhhhcCCcccceeEeecCceEEEEEEeC-----CCCeEEEEEEecccc-chhHHHHHHHHHHhccc-CCC
Q 007869          247 GPHRFRYKD-LYIATKGFREKELLGTGGFGRVYRGTLP-----KSQIEIAVKKISHES-RQGMKEFVAEIVSIGRL-RHR  318 (586)
Q Consensus       247 ~~~~~~~~e-l~~a~~~f~~~~~LG~G~~g~Vy~~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~  318 (586)
                      .|.+++++. +....++|+..++||+|+||.||+|++.     .++..||||+++... .....+|.+|+.+++++ +||
T Consensus         8 ~~~~~~~~~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~Hp   87 (311)
T d1t46a_           8 DPTQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM   87 (311)
T ss_dssp             CTTTSCCCGGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCT
T ss_pred             CcccCCCcccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCC
Confidence            455666544 4456688999999999999999999863     456789999997653 33456799999999999 799


Q ss_pred             ceeeeeeeeeccCeEEEEEecCCCCChhhhhhcCC----------------CccchhHHHHHHHHHHHHHHHHhhcccCC
Q 007869          319 NLVQLLGYCRRKGELLLVYDYMPNGSLDKYLYDQP----------------KVTLNWIQRFRVIKGVALGLFYLHQEWEQ  382 (586)
Q Consensus       319 niv~l~~~~~~~~~~~lV~E~~~~gsL~~~l~~~~----------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~  382 (586)
                      |||+++++|.+.+..++|||||++|+|.++++...                ...+++..+..++.||++||+|||+   +
T Consensus        88 nIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~---~  164 (311)
T d1t46a_          88 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---K  164 (311)
T ss_dssp             TBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---T
T ss_pred             CEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---C
Confidence            99999999999999999999999999999997642                2368899999999999999999998   8


Q ss_pred             cEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCC-ceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhC-
Q 007869          383 VVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP-QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACG-  460 (586)
Q Consensus       383 ~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG-  460 (586)
                      +|+||||||+|||++.++.+||+|||+++........ ..+...||+.|+|||++.++.++.++|||||||++|||+|+ 
T Consensus       165 ~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g  244 (311)
T d1t46a_         165 NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLG  244 (311)
T ss_dssp             TCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTT
T ss_pred             CeeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCC
Confidence            9999999999999999999999999999977654332 23446889999999999999999999999999999999995 


Q ss_pred             CCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhc
Q 007869          461 RRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERD  536 (586)
Q Consensus       461 ~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~  536 (586)
                      ++|+......+.  +...    ..++.     .+..    .......+.+|+.+||+.||++||||.|++++|++.
T Consensus       245 ~p~~~~~~~~~~--~~~~----i~~~~-----~~~~----~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~  305 (311)
T d1t46a_         245 SSPYPGMPVDSK--FYKM----IKEGF-----RMLS----PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ  305 (311)
T ss_dssp             CCSSTTCCSSHH--HHHH----HHHTC-----CCCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCCCCHHHH--HHHH----HhcCC-----CCCC----cccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence            555544433221  1111    11211     1111    111235678899999999999999999999999864

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-48  Score=396.75  Aligned_cols=264  Identities=24%  Similarity=0.424  Sum_probs=213.8

Q ss_pred             hhhhcCCcccceeEeecCceEEEEEEeCC-----CCeEEEEEEeccc-cchhHHHHHHHHHHhcccCCCceeeeeeeeec
Q 007869          256 LYIATKGFREKELLGTGGFGRVYRGTLPK-----SQIEIAVKKISHE-SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRR  329 (586)
Q Consensus       256 l~~a~~~f~~~~~LG~G~~g~Vy~~~~~~-----~~~~vavK~~~~~-~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~  329 (586)
                      +++..++|...+.||+|+||.||+|.+..     .+..||||+++.. ..+....|.+|++++++++||||++++++|..
T Consensus        15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~   94 (308)
T d1p4oa_          15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ   94 (308)
T ss_dssp             TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred             eeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence            44555788899999999999999998742     3568999999754 33445679999999999999999999999999


Q ss_pred             cCeEEEEEecCCCCChhhhhhcCC--------CccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCC
Q 007869          330 KGELLLVYDYMPNGSLDKYLYDQP--------KVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELN  401 (586)
Q Consensus       330 ~~~~~lV~E~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~  401 (586)
                      .+..++||||+++|+|.+++....        ...+++..+.+++.|+|+||.|||+   ++|+||||||+|||++++++
T Consensus        95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~---~~ivHrDlk~~NiLld~~~~  171 (308)
T d1p4oa_          95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFT  171 (308)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCC
T ss_pred             CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeeceEcCCceeecCCce
Confidence            999999999999999999986531        2357899999999999999999998   89999999999999999999


Q ss_pred             eEEccccceeeccCCCCC-ceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCC-CCCCCCCCCccchhhHHH
Q 007869          402 GRLGDFGLARLYDHGTDP-QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGR-RPIQRQGPSENLILVDWV  479 (586)
Q Consensus       402 ~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~-~p~~~~~~~~~~~l~~~v  479 (586)
                      +||+|||+++.+...... ......||+.|+|||.+.++.++.++|||||||++|||+||+ .||......+      +.
T Consensus       172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~------~~  245 (308)
T d1p4oa_         172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ------VL  245 (308)
T ss_dssp             EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH------HH
T ss_pred             EEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHH------HH
Confidence            999999999976543322 233457899999999999999999999999999999999985 6665433221      11


Q ss_pred             HhhhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhccC
Q 007869          480 FDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERDVA  538 (586)
Q Consensus       480 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~~  538 (586)
                       ....++....     ...    .....+.+++.+||+.||++||||++|++.|++...
T Consensus       246 -~~i~~~~~~~-----~p~----~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         246 -RFVMEGGLLD-----KPD----NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             -HHHHTTCCCC-----CCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             -HHHHhCCCCC-----Ccc----cchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence             1112222211     111    123568889999999999999999999999988654

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=3.5e-47  Score=395.99  Aligned_cols=249  Identities=23%  Similarity=0.298  Sum_probs=202.0

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc---chhHHHH---HHHHHHhcccCCCceeeeeeeeeccCeEE
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES---RQGMKEF---VAEIVSIGRLRHRNLVQLLGYCRRKGELL  334 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~---~~~~~~~---~~Ei~~l~~l~H~niv~l~~~~~~~~~~~  334 (586)
                      ++|++.++||+|+||.||+|++..++..||||++....   ......+   ..|+++++.++||||+++++++...+.++
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            57999999999999999999999999999999986431   1222333   44577888889999999999999999999


Q ss_pred             EEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeecc
Q 007869          335 LVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYD  414 (586)
Q Consensus       335 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~  414 (586)
                      +||||+++|+|.++|...  ..+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+|+.+.
T Consensus        84 ivmE~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~ylH~---~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~  158 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFS  158 (364)
T ss_dssp             EEECCCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred             EEEEecCCCcHHHHHHhc--ccccHHHHHHHHHHHHHHHHHHHH---CCccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence            999999999999999765  357888999999999999999998   999999999999999999999999999999765


Q ss_pred             CCCCCceeeeccCCCccCcccccC-CCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccC
Q 007869          415 HGTDPQTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARD  493 (586)
Q Consensus       415 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d  493 (586)
                      ..   ......||+.|+|||++.. ..++.++|||||||++|||+||+.||......+...+.    .....      ..
T Consensus       159 ~~---~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~----~~~~~------~~  225 (364)
T d1omwa3         159 KK---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID----RMTLT------MA  225 (364)
T ss_dssp             SS---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHH----HHSSS------CC
T ss_pred             CC---cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHH----Hhccc------CC
Confidence            43   2344679999999999875 46899999999999999999999999875543321111    11101      11


Q ss_pred             CCCCccccHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 007869          494 PNLGTEYVAEELELVLKLGLLCSHSDPTARPS-----MRQVVQ  531 (586)
Q Consensus       494 ~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~  531 (586)
                      +.....+    ...+.+++.+||+.||++|||     ++|+++
T Consensus       226 ~~~~~~~----s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         226 VELPDSF----SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             CCCCSSS----CHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             CCCCCCC----CHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence            1111222    245778889999999999999     688874

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-47  Score=393.46  Aligned_cols=251  Identities=19%  Similarity=0.271  Sum_probs=207.8

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEecC
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDYM  340 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~~  340 (586)
                      ++|++.+.||+|+||+||+|+++.+++.||||++.....+ ...+.+|+++|++++||||+++++++.+.+.++||||||
T Consensus         5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~-~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~   83 (321)
T d1tkia_           5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI   83 (321)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH-HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc-HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence            5789999999999999999999999999999999765433 356889999999999999999999999999999999999


Q ss_pred             CCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecC--CCCeEEccccceeeccCCCC
Q 007869          341 PNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDG--ELNGRLGDFGLARLYDHGTD  418 (586)
Q Consensus       341 ~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~--~~~~kL~DFGla~~~~~~~~  418 (586)
                      ++|+|.++|.... ..+++.++..++.||++||.|||+   ++|+||||||+|||++.  ..++||+|||+++.....  
T Consensus        84 ~gg~L~~~i~~~~-~~l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~--  157 (321)
T d1tkia_          84 SGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG--  157 (321)
T ss_dssp             CCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT--
T ss_pred             CCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHH---cCCCcccccccceeecCCCceEEEEcccchhhccccC--
Confidence            9999999997653 468999999999999999999998   99999999999999984  458999999999976543  


Q ss_pred             CceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCCc
Q 007869          419 PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLGT  498 (586)
Q Consensus       419 ~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~~  498 (586)
                      .......||+.|+|||.+.+..++.++|||||||++|||++|+.||......+   +..   . ..++.      ..+..
T Consensus       158 ~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~---~~~---~-i~~~~------~~~~~  224 (321)
T d1tkia_         158 DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ---IIE---N-IMNAE------YTFDE  224 (321)
T ss_dssp             CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHH---H-HHHTC------CCCCH
T ss_pred             CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH---HHH---H-HHhCC------CCCCh
Confidence            23455689999999999999999999999999999999999999998654321   111   1 11111      11111


Q ss_pred             cccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          499 EYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       499 ~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      .........+.+++.+||+.||++|||+.|+++
T Consensus       225 ~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         225 EAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             hhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            111112345778899999999999999999987

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-48  Score=395.10  Aligned_cols=261  Identities=27%  Similarity=0.430  Sum_probs=209.2

Q ss_pred             hhcCCcccceeEeecCceEEEEEEeCCCC-------eEEEEEEecccc-chhHHHHHHHHHHhccc-CCCceeeeeeeee
Q 007869          258 IATKGFREKELLGTGGFGRVYRGTLPKSQ-------IEIAVKKISHES-RQGMKEFVAEIVSIGRL-RHRNLVQLLGYCR  328 (586)
Q Consensus       258 ~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~-------~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l-~H~niv~l~~~~~  328 (586)
                      +..++|...+.||+|+||.||+|+...++       ..||||+++.+. .....++.+|+..+.++ +||||++++++|.
T Consensus        10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~   89 (299)
T d1fgka_          10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT   89 (299)
T ss_dssp             CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence            34567888999999999999999875433       479999997654 34457899999999998 8999999999999


Q ss_pred             ccCeEEEEEecCCCCChhhhhhcCC--------------CccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCe
Q 007869          329 RKGELLLVYDYMPNGSLDKYLYDQP--------------KVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNV  394 (586)
Q Consensus       329 ~~~~~~lV~E~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NI  394 (586)
                      +++..++||||+++|+|.++|....              ...+++.+++.++.||+.||+|||+   ++||||||||+||
T Consensus        90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~---~~ivHrDiKp~Ni  166 (299)
T d1fgka_          90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNV  166 (299)
T ss_dssp             SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGE
T ss_pred             cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh---CCEEeeeecccce
Confidence            9999999999999999999997553              2458999999999999999999998   9999999999999


Q ss_pred             eecCCCCeEEccccceeeccCCCCC-ceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHh-CCCCCCCCCCCcc
Q 007869          395 LLDGELNGRLGDFGLARLYDHGTDP-QTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVAC-GRRPIQRQGPSEN  472 (586)
Q Consensus       395 ll~~~~~~kL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~Ellt-G~~p~~~~~~~~~  472 (586)
                      |++.++.+||+|||+++........ ......||+.|+|||++.++.+++++|||||||++|||++ |+.||......  
T Consensus       167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~--  244 (299)
T d1fgka_         167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--  244 (299)
T ss_dssp             EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--
T ss_pred             eecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH--
Confidence            9999999999999999977654332 3345678999999999999999999999999999999998 68888654321  


Q ss_pred             chhhHHHHhhhccCccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhhcc
Q 007869          473 LILVDWVFDFWNRGELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILERDV  537 (586)
Q Consensus       473 ~~l~~~v~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~~~  537 (586)
                           .+.+.+.++..     +.....    ....+.+|+.+||+.||++|||+.||++.|++..
T Consensus       245 -----~~~~~i~~~~~-----~~~p~~----~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~  295 (299)
T d1fgka_         245 -----ELFKLLKEGHR-----MDKPSN----CTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV  295 (299)
T ss_dssp             -----HHHHHHHTTCC-----CCCCSS----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -----HHHHHHHcCCC-----CCCCcc----chHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHh
Confidence                 12222223221     111112    2345788999999999999999999999998753

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.5e-47  Score=396.70  Aligned_cols=245  Identities=22%  Similarity=0.277  Sum_probs=206.9

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc---cchhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEE
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE---SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVY  337 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~  337 (586)
                      ++|++.+.||+|+||.||+|+++.+++.||||++...   .....+.+.+|+++|++++||||+++++++...+..++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            5799999999999999999999999999999998653   2344567899999999999999999999999999999999


Q ss_pred             ecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCC
Q 007869          338 DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGT  417 (586)
Q Consensus       338 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~  417 (586)
                      ||+.+|+|.+++....  .+++..+..++.||+.||.|||+   ++||||||||+|||++.++++||+|||+|+.+... 
T Consensus       121 e~~~~g~l~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~---~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~-  194 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-  194 (350)
T ss_dssp             ECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred             ccccccchhhhHhhcC--CCCHHHHHHHHHHHHHHHHHHHh---CCEecCcCCHHHcccCCCCCEEeeeceeeeecccc-
Confidence            9999999999997653  58899999999999999999998   89999999999999999999999999999976532 


Q ss_pred             CCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCCC
Q 007869          418 DPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNLG  497 (586)
Q Consensus       418 ~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l~  497 (586)
                         .....||+.|||||++.+..++.++|||||||++|||++|+.||...+...   +...+    ..+.      +...
T Consensus       195 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~~~~i----~~~~------~~~p  258 (350)
T d1rdqe_         195 ---TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ---IYEKI----VSGK------VRFP  258 (350)
T ss_dssp             ---BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH----HHCC------CCCC
T ss_pred             ---cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHH---HHHHH----hcCC------CCCC
Confidence               334689999999999999999999999999999999999999997643211   11111    1111      1111


Q ss_pred             ccccHHHHHHHHHHHHHhcccCCCCCC-----CHHHHHH
Q 007869          498 TEYVAEELELVLKLGLLCSHSDPTARP-----SMRQVVQ  531 (586)
Q Consensus       498 ~~~~~~~~~~l~~l~~~Cl~~dP~~RP-----s~~evl~  531 (586)
                      ...    ...+.+++.+||+.||.+|+     |++++++
T Consensus       259 ~~~----s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         259 SHF----SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             TTC----CHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             ccC----CHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence            122    24567888899999999994     8999985

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-47  Score=383.65  Aligned_cols=267  Identities=25%  Similarity=0.332  Sum_probs=203.5

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc--chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEe
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES--RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYD  338 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E  338 (586)
                      ++|++.+.||+|+||+||+|++..+++.||||++....  ....+.+.+|+++|++++||||+++++++.+.+..++|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            58999999999999999999999999999999996543  2345789999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCC
Q 007869          339 YMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD  418 (586)
Q Consensus       339 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~  418 (586)
                      |+.+ ++.+++.......+++..+..++.||+.||.|||+   ++||||||||+|||++.++++||+|||+|+...... 
T Consensus        82 ~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~---~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~-  156 (298)
T d1gz8a_          82 FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-  156 (298)
T ss_dssp             CCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS-
T ss_pred             ecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhc---CCEEccccCchheeecccCcceeccCCcceeccCCc-
Confidence            9965 55556655555679999999999999999999998   999999999999999999999999999998765432 


Q ss_pred             CceeeeccCCCccCcccccCCC-CCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHH--------HhhhccCccc
Q 007869          419 PQTTHVVGTLGYLAPEHTRTGK-ATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWV--------FDFWNRGELL  489 (586)
Q Consensus       419 ~~~~~~~gt~~y~aPE~~~~~~-~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v--------~~~~~~~~~~  489 (586)
                      .......||+.|+|||.+.... ++.++|||||||++|||++|+.||...+..+....+--.        +.........
T Consensus       157 ~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  236 (298)
T d1gz8a_         157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY  236 (298)
T ss_dssp             BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred             ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccc
Confidence            2334457999999999877665 578999999999999999999999765432211100000        0000000000


Q ss_pred             cccCCCCC-ccc---cHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          490 EARDPNLG-TEY---VAEELELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       490 ~~~d~~l~-~~~---~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                      ....+... ..+   .......+.+++.+||+.||++|||+.|+++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             CTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            00000000 000   11122567788999999999999999999974

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-47  Score=388.17  Aligned_cols=258  Identities=26%  Similarity=0.305  Sum_probs=197.7

Q ss_pred             cceeEeecCceEEEEEEeCCCCeEEEEEEeccccch-----hHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEec
Q 007869          265 EKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQ-----GMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYDY  339 (586)
Q Consensus       265 ~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E~  339 (586)
                      ..++||+|+||+||+|+++.+++.||||++......     ..+.+.+|++++++++||||+++++++..++..++||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            357899999999999999999999999998654322     134688999999999999999999999999999999999


Q ss_pred             CCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCCC
Q 007869          340 MPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTDP  419 (586)
Q Consensus       340 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~~  419 (586)
                      +.++++..++...  ..+++..+..++.||++||+|||+   ++|+||||||+|||++.++.+||+|||+|+....... 
T Consensus        82 ~~~~~~~~~~~~~--~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~-  155 (299)
T d1ua2a_          82 METDLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR-  155 (299)
T ss_dssp             CSEEHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-
T ss_pred             hcchHHhhhhhcc--cCCCHHHHHHHHHHHHHHHHHhhc---cceecccCCcceEEecCCCccccccCccccccCCCcc-
Confidence            9888777665433  468888999999999999999998   9999999999999999999999999999987654332 


Q ss_pred             ceeeeccCCCccCcccccCC-CCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCc---------cc
Q 007869          420 QTTHVVGTLGYLAPEHTRTG-KATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGE---------LL  489 (586)
Q Consensus       420 ~~~~~~gt~~y~aPE~~~~~-~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~---------~~  489 (586)
                      .....+||+.|+|||++... .++.++|||||||++|||++|+.||......+...   .+.+......         ..
T Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~---~i~~~~~~~~~~~~~~~~~~~  232 (299)
T d1ua2a_         156 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLT---RIFETLGTPTEEQWPDMCSLP  232 (299)
T ss_dssp             CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---HHHHHHCCCCTTTSSSTTSST
T ss_pred             cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHH---HHHHhcCCCChhhccchhccc
Confidence            23346799999999998755 57999999999999999999999997654332211   1111110000         00


Q ss_pred             cc----cCCCCC-ccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          490 EA----RDPNLG-TEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       490 ~~----~d~~l~-~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      ..    ..+... ........+.+.+|+.+||+.||++|||++|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             hhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence            00    000000 0001112356788999999999999999999986

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-47  Score=389.60  Aligned_cols=247  Identities=24%  Similarity=0.378  Sum_probs=205.1

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc---cchhHHHHHHHHHHhc-ccCCCceeeeeeeeeccCeEEEE
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE---SRQGMKEFVAEIVSIG-RLRHRNLVQLLGYCRRKGELLLV  336 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~---~~~~~~~~~~Ei~~l~-~l~H~niv~l~~~~~~~~~~~lV  336 (586)
                      ++|...+.||+|+||+||+|+++.+++.||||+++..   .....+.+..|..++. .++||||+++++++.+++.+++|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            5789999999999999999999999999999999753   2344566777877766 58999999999999999999999


Q ss_pred             EecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCC
Q 007869          337 YDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHG  416 (586)
Q Consensus       337 ~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~  416 (586)
                      |||+++|+|.+++....  .+++.++..++.||+.||.|||+   ++|+||||||+|||+++++++||+|||+++.....
T Consensus        82 mEy~~~g~L~~~i~~~~--~~~e~~~~~~~~qi~~al~ylH~---~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~  156 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG  156 (320)
T ss_dssp             EECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EeecCCCcHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCcccceeecCCCceeccccchhhhcccc
Confidence            99999999999997653  57888999999999999999998   89999999999999999999999999999865443


Q ss_pred             CCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccccccCCCC
Q 007869          417 TDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLEARDPNL  496 (586)
Q Consensus       417 ~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~~~d~~l  496 (586)
                      . ...+...||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+       +......+      .+..
T Consensus       157 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~-------~~~~i~~~------~~~~  222 (320)
T d1xjda_         157 D-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE-------LFHSIRMD------NPFY  222 (320)
T ss_dssp             T-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHHHC------CCCC
T ss_pred             c-ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH-------HHHHHHcC------CCCC
Confidence            2 23445689999999999999999999999999999999999999998654321       11111111      1222


Q ss_pred             CccccHHHHHHHHHHHHHhcccCCCCCCCHH-HHH
Q 007869          497 GTEYVAEELELVLKLGLLCSHSDPTARPSMR-QVV  530 (586)
Q Consensus       497 ~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~-evl  530 (586)
                      ....    ...+.+|+.+||+.||.+||++. |++
T Consensus       223 p~~~----s~~~~dli~~~L~~dP~~R~s~~~~l~  253 (320)
T d1xjda_         223 PRWL----EKEAKDLLVKLFVREPEKRLGVRGDIR  253 (320)
T ss_dssp             CTTS----CHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             CccC----CHHHHHHHHHhcccCCCCCcCHHHHHH
Confidence            1122    24577888999999999999996 675

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-46  Score=380.33  Aligned_cols=266  Identities=24%  Similarity=0.332  Sum_probs=198.2

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCC-CeEEEEEEeccccc--hhHHHHHHHHHHhccc---CCCceeeeeeeeec----
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKS-QIEIAVKKISHESR--QGMKEFVAEIVSIGRL---RHRNLVQLLGYCRR----  329 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~-~~~vavK~~~~~~~--~~~~~~~~Ei~~l~~l---~H~niv~l~~~~~~----  329 (586)
                      .++|++.+.||+|+||+||+|++..+ ++.||||++.....  .....+.+|+.+|+.+   +||||++++++|..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            46899999999999999999998654 67799999865422  2233456777776665   89999999998853    


Q ss_pred             -cCeEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEcccc
Q 007869          330 -KGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFG  408 (586)
Q Consensus       330 -~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFG  408 (586)
                       ....+++|||++++++...... ....+++..+..++.|++.||+|||+   ++|+||||||+|||+++++.+||+|||
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~yLH~---~~ivHrDiKp~NILi~~~~~~kl~dfg  161 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFG  161 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHS-CTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred             cCceEEEEEEeccCCchhhhhhc-cCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecCCCccEEEEcCCCCeeecchh
Confidence             3578999999988776544433 34578899999999999999999998   999999999999999999999999999


Q ss_pred             ceeeccCCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHh-----hh
Q 007869          409 LARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFD-----FW  483 (586)
Q Consensus       409 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~-----~~  483 (586)
                      +++.....  .......||+.|+|||++.+..++.++||||+||++|||++|+.||...+..+....+.....     .+
T Consensus       162 ~~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  239 (305)
T d1blxa_         162 LARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW  239 (305)
T ss_dssp             SCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGS
T ss_pred             hhhhhccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcc
Confidence            99865432  234456899999999999999999999999999999999999999986543322111100000     00


Q ss_pred             ccC-----ccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          484 NRG-----ELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       484 ~~~-----~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      ...     .......+.....+.....+.+.+|+.+||+.||++|||+.|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             CTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            000     000000000011112222355678899999999999999999975

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=9.9e-46  Score=372.93  Aligned_cols=264  Identities=24%  Similarity=0.335  Sum_probs=199.9

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc--chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEe
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES--RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYD  338 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E  338 (586)
                      ++|+..+.||+|+||+||+|+++ +++.||||++....  ....+.+.+|+.+|++++||||+++++++...+..++++|
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e   80 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE   80 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEE
Confidence            57899999999999999999986 57889999996642  3335789999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCC
Q 007869          339 YMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD  418 (586)
Q Consensus       339 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~  418 (586)
                      |+.++.+..+....  ..+++..+..++.||+.||+|||+   .+|+||||||+|||++.++.+||+|||++........
T Consensus        81 ~~~~~~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~---~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~  155 (286)
T d1ob3a_          81 HLDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR  155 (286)
T ss_dssp             CCSEEHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             eehhhhHHHHHhhc--CCcchhhhHHHHHHHHHHHHHhcc---CcEEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence            99877766665443  468999999999999999999998   8999999999999999999999999999987654322


Q ss_pred             CceeeeccCCCccCcccccCC-CCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHH-----hhhc----cCcc
Q 007869          419 PQTTHVVGTLGYLAPEHTRTG-KATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVF-----DFWN----RGEL  488 (586)
Q Consensus       419 ~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~-----~~~~----~~~~  488 (586)
                       ......|++.|+|||.+... .++.++|||||||++|||++|+.||......+....+....     ..+.    ....
T Consensus       156 -~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  234 (286)
T d1ob3a_         156 -KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKY  234 (286)
T ss_dssp             -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred             -ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhc
Confidence             23445789999999998754 56899999999999999999999997654322111110000     0000    0000


Q ss_pred             ---ccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          489 ---LEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       489 ---~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                         .....+.....+.......+.+++.+||+.||++|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         235 DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence               0000111111111222356778899999999999999999974

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8e-47  Score=378.35  Aligned_cols=240  Identities=24%  Similarity=0.389  Sum_probs=197.4

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccc------hhHHHHHHHHHHhcccC--CCceeeeeeeeeccCe
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR------QGMKEFVAEIVSIGRLR--HRNLVQLLGYCRRKGE  332 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~Ei~~l~~l~--H~niv~l~~~~~~~~~  332 (586)
                      ++|++.++||+|+||+||+|++..++..||||++.....      .....+.+|+.++++++  ||||+++++++.+.+.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            579999999999999999999999999999999865321      12234678999999996  8999999999999999


Q ss_pred             EEEEEecCCC-CChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecC-CCCeEEccccce
Q 007869          333 LLLVYDYMPN-GSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDG-ELNGRLGDFGLA  410 (586)
Q Consensus       333 ~~lV~E~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~-~~~~kL~DFGla  410 (586)
                      .++||||+.+ +++.+++...  ..+++..+..++.||++||.|||+   ++|+||||||+|||++. ++.+||+|||+|
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~~--~~l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NIll~~~~~~vkl~DFG~a  158 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSG  158 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             EEEEEEeccCcchHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHH---CCCccccCcccceEEecCCCeEEECccccc
Confidence            9999999976 5788887654  368899999999999999999998   99999999999999985 478999999999


Q ss_pred             eeccCCCCCceeeeccCCCccCcccccCCCC-CCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCccc
Q 007869          411 RLYDHGTDPQTTHVVGTLGYLAPEHTRTGKA-TTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELL  489 (586)
Q Consensus       411 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~  489 (586)
                      +.....   ..+...||+.|+|||++.+..+ +.++|||||||++|||++|+.||.....         +.    ++.  
T Consensus       159 ~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~---------i~----~~~--  220 (273)
T d1xwsa_         159 ALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE---------II----RGQ--  220 (273)
T ss_dssp             EECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH---------HH----HCC--
T ss_pred             eecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH---------Hh----hcc--
Confidence            875432   3345689999999999987765 5678999999999999999999965210         00    111  


Q ss_pred             cccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          490 EARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       490 ~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                          ......++    ..+.+++.+||+.||++|||++|+++
T Consensus       221 ----~~~~~~~s----~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         221 ----VFFRQRVS----SECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             ----CCCSSCCC----HHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ----cCCCCCCC----HHHHHHHHHHccCCHhHCcCHHHHhc
Confidence                11111222    45678889999999999999999986

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-44  Score=369.10  Aligned_cols=267  Identities=26%  Similarity=0.351  Sum_probs=197.4

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc--cchhHHHHHHHHHHhcccCCCceeeeeeeeec--------c
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRR--------K  330 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~--------~  330 (586)
                      ++|++.+.||+|+||+||+|++..+++.||||++...  .....+.+.+|+++|++++|||++++++++..        .
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~   89 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   89 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred             CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence            6899999999999999999999989999999998654  33445778999999999999999999998754        3


Q ss_pred             CeEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccce
Q 007869          331 GELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLA  410 (586)
Q Consensus       331 ~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla  410 (586)
                      +..++||||+.++.+.......  ..++......++.|+++||.|||+   ++|+||||||+|||++.++.+||+|||++
T Consensus        90 ~~~~iv~e~~~~~~~~~~~~~~--~~~~~~~~~~i~~qil~~l~~lH~---~~ivHrDlKp~NILl~~~~~~kl~dfg~~  164 (318)
T d3blha1          90 GSIYLVFDFCEHDLAGLLSNVL--VKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLA  164 (318)
T ss_dssp             -CEEEEEECCCEEHHHHHTCTT--CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             ceEEEEEeccCCCccchhhhcc--cccccHHHHHHHHHHHHHHHHhcc---CCEEecCcCchheeecCCCcEEeeeccee
Confidence            4689999999877766554333  457778888999999999999998   99999999999999999999999999999


Q ss_pred             eeccCCCC---CceeeeccCCCccCcccccCC-CCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccC
Q 007869          411 RLYDHGTD---PQTTHVVGTLGYLAPEHTRTG-KATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRG  486 (586)
Q Consensus       411 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~  486 (586)
                      +.......   .......||+.|+|||++.+. .+++++|||||||++|||++|+.||......+...............
T Consensus       165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  244 (318)
T d3blha1         165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE  244 (318)
T ss_dssp             EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChh
Confidence            87653321   122335799999999998765 68999999999999999999999997654322221111111000000


Q ss_pred             --------ccccccCCCCC-ccccHH------HHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          487 --------ELLEARDPNLG-TEYVAE------ELELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       487 --------~~~~~~d~~l~-~~~~~~------~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                              ........... .....+      ....+++|+.+||+.||++|||++|+++.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H  305 (318)
T d3blha1         245 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  305 (318)
T ss_dssp             TSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             hccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence                    00000000000 000111      12355688999999999999999999864

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-44  Score=375.82  Aligned_cols=260  Identities=26%  Similarity=0.297  Sum_probs=195.0

Q ss_pred             CcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeeeeeeeecc------CeEEE
Q 007869          262 GFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRK------GELLL  335 (586)
Q Consensus       262 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~------~~~~l  335 (586)
                      +|+..++||+|+||+||+|++..+++.||||++......    +.+|+++|++++||||++++++|...      ..++|
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            577889999999999999999999999999999765322    34799999999999999999998543      35799


Q ss_pred             EEecCCCCChhhhhhc-CCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCC-CeEEccccceeec
Q 007869          336 VYDYMPNGSLDKYLYD-QPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGEL-NGRLGDFGLARLY  413 (586)
Q Consensus       336 V~E~~~~gsL~~~l~~-~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~-~~kL~DFGla~~~  413 (586)
                      |||||+++.+..+... .....+++.++..++.||++||+|||+   ++|+||||||+|||++.++ .+||+|||+++..
T Consensus        97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~---~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHh---cCCcccCCCcceEEEecCCCceeEecccchhhc
Confidence            9999986644443321 234579999999999999999999998   9999999999999999775 8999999999976


Q ss_pred             cCCCCCceeeeccCCCccCcccccC-CCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHH--------HHhhhc
Q 007869          414 DHGTDPQTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDW--------VFDFWN  484 (586)
Q Consensus       414 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~--------v~~~~~  484 (586)
                      ....  ......||..|+|||.+.+ ..++.++||||+||++|||++|+.||......+....+-.        .+....
T Consensus       174 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~  251 (350)
T d1q5ka_         174 VRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN  251 (350)
T ss_dssp             CTTS--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred             cCCc--ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhc
Confidence            5433  2334679999999998765 4689999999999999999999999976543322111100        000000


Q ss_pred             cCccccccCCCCC-----ccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          485 RGELLEARDPNLG-----TEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       485 ~~~~~~~~d~~l~-----~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      .. .....-+...     ..........+.+|+.+||+.||++|||+.|+++
T Consensus       252 ~~-~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  302 (350)
T d1q5ka_         252 PN-YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  302 (350)
T ss_dssp             C----CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cc-hhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00 0000001110     0111122345778889999999999999999986

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9.7e-44  Score=360.59  Aligned_cols=259  Identities=17%  Similarity=0.188  Sum_probs=198.6

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCceeee-eeeeeccCeEEEEEec
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNLVQL-LGYCRRKGELLLVYDY  339 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~niv~l-~~~~~~~~~~~lV~E~  339 (586)
                      ++|+..+.||+|+||.||+|++..+++.||||++......  +++..|++++++++|+|++.. .++....+..++||||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~   84 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   84 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS--CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC--HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence            5699999999999999999999999999999998765332  457889999999987775555 4555677889999999


Q ss_pred             CCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeec---CCCCeEEccccceeeccCC
Q 007869          340 MPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLD---GELNGRLGDFGLARLYDHG  416 (586)
Q Consensus       340 ~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~---~~~~~kL~DFGla~~~~~~  416 (586)
                      + +++|.+.+.... ..+++..+..++.|++.||+|||+   ++|+||||||+|||++   .+..+||+|||+|+.+...
T Consensus        85 ~-~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~---~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~  159 (299)
T d1ckia_          85 L-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  159 (299)
T ss_dssp             C-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred             c-CCchhhhhhhcc-CCCcHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence            9 567776665543 468999999999999999999998   9999999999999875   4567999999999987543


Q ss_pred             CC------CceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCcccc
Q 007869          417 TD------PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLE  490 (586)
Q Consensus       417 ~~------~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~  490 (586)
                      ..      .......||+.|||||++.+..++.++|||||||++|||++|+.||........................  
T Consensus       160 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~--  237 (299)
T d1ckia_         160 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI--  237 (299)
T ss_dssp             TTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH--
T ss_pred             ccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCCh--
Confidence            22      1234568999999999999999999999999999999999999999875543322211111100000000  


Q ss_pred             ccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 007869          491 ARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER  535 (586)
Q Consensus       491 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  535 (586)
                         +    .........+.+++..||+.+|++||++.++.+.|+.
T Consensus       238 ---~----~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  275 (299)
T d1ckia_         238 ---E----VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN  275 (299)
T ss_dssp             ---H----HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHH
T ss_pred             ---h----HhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence               0    0011123557788889999999999999999888865

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-44  Score=373.79  Aligned_cols=267  Identities=24%  Similarity=0.260  Sum_probs=199.0

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc-chhHHHHHHHHHHhcccCCCceeeeeeeeeccC----eEE
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES-RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKG----ELL  334 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~----~~~  334 (586)
                      +.+|+..+.||+|+||+||+|++..+++.||||++.... ....+.+++|+++|++++||||+++++++....    ..+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            457999999999999999999999899999999997543 344567899999999999999999999987543    234


Q ss_pred             EEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeecc
Q 007869          335 LVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYD  414 (586)
Q Consensus       335 lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~  414 (586)
                      ++++|+.+|+|.+++...   .+++..+..++.|++.||+|||+   ++||||||||+|||+++++.+||+|||+++...
T Consensus        87 ~l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~---~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~  160 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD  160 (345)
T ss_dssp             EEEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence            455667799999999764   58999999999999999999998   899999999999999999999999999998764


Q ss_pred             CCCC--CceeeeccCCCccCcccccC-CCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccC-----
Q 007869          415 HGTD--PQTTHVVGTLGYLAPEHTRT-GKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRG-----  486 (586)
Q Consensus       415 ~~~~--~~~~~~~gt~~y~aPE~~~~-~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~-----  486 (586)
                      ....  ......+||+.|+|||++.. ..++.++||||+||++|||++|+.||......+.......+.......     
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (345)
T d1pmea_         161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI  240 (345)
T ss_dssp             GGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTC
T ss_pred             CCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhh
Confidence            4322  22345679999999999854 467899999999999999999999997654322111111000000000     


Q ss_pred             -----ccccccCCCCCc-c---ccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          487 -----ELLEARDPNLGT-E---YVAEELELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       487 -----~~~~~~d~~l~~-~---~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                           .......+.... .   ........+.+++.+||+.||.+|||+.|+++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                 000000011000 0   001112457789999999999999999999863

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-44  Score=371.94  Aligned_cols=261  Identities=23%  Similarity=0.307  Sum_probs=196.4

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc--cchhHHHHHHHHHHhcccCCCceeeeeeeeeccC------
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKG------  331 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~------  331 (586)
                      .++|+..+.||+|+||+||+|++..+++.||||+++..  .....+.+.+|+++|++++|||||+++++|...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            46899999999999999999999999999999999754  3344567899999999999999999999997654      


Q ss_pred             eEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEcccccee
Q 007869          332 ELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLAR  411 (586)
Q Consensus       332 ~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~  411 (586)
                      .+++||||+ +.+|..++...   .+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+|+
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~---~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~  169 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR  169 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             eEEEEEecc-cccHHHHHHhc---cccHHHHHHHHHHHHHHHHHHHh---CCCcccccCcchhhccccccccccccccee
Confidence            579999999 66788777544   58999999999999999999998   999999999999999999999999999998


Q ss_pred             eccCCCCCceeeeccCCCccCcccccCC-CCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHH--------Hhh
Q 007869          412 LYDHGTDPQTTHVVGTLGYLAPEHTRTG-KATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWV--------FDF  482 (586)
Q Consensus       412 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v--------~~~  482 (586)
                      ....    ..+...||+.|+|||++.+. .++.++||||+||++|||++|+.||...+..+........        +..
T Consensus       170 ~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (346)
T d1cm8a_         170 QADS----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQR  245 (346)
T ss_dssp             ECCS----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHT
T ss_pred             ccCC----ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhh
Confidence            7643    23456799999999998764 5689999999999999999999999765432211111000        000


Q ss_pred             hccC-------ccccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHH
Q 007869          483 WNRG-------ELLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQI  532 (586)
Q Consensus       483 ~~~~-------~~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~  532 (586)
                      ....       ...+.....+ ..........+.+|+.+||+.||.+|||+.|+++.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H  301 (346)
T d1cm8a_         246 LQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  301 (346)
T ss_dssp             CSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             hcchhhhhhhccCCcccccch-HHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            0000       0000000000 01111122456788899999999999999999973

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-43  Score=358.65  Aligned_cols=263  Identities=22%  Similarity=0.286  Sum_probs=205.6

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc--chhHHHHHHHHHHhcccCCCceeeeeeeeeccCeEEEEEe
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES--RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRKGELLLVYD  338 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~~~~~lV~E  338 (586)
                      ++|++.+.||+|+||+||+|++..+++.||||+++...  ....+.+.+|+.++++++||||+++++++...+..++|+|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            57999999999999999999999999999999986543  3446789999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceeeccCCCC
Q 007869          339 YMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARLYDHGTD  418 (586)
Q Consensus       339 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~~~~~~~  418 (586)
                      ++.+++|..++...  ..+++..+..++.|+++||+|||+   ++|+||||||+|||++.++.+||+|||.++.......
T Consensus        82 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~q~~~aL~~lH~---~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~  156 (292)
T d1unla_          82 FCDQDLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR  156 (292)
T ss_dssp             CCSEEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS
T ss_pred             eccccccccccccc--cccchhHHHHHHHHHHHHHHHhhc---CCEeeecccCcccccccCCceeeeecchhhcccCCCc
Confidence            99999998887655  467888999999999999999998   8999999999999999999999999999998654332


Q ss_pred             CceeeeccCCCccCcccccCCC-CCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccC---------cc
Q 007869          419 PQTTHVVGTLGYLAPEHTRTGK-ATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRG---------EL  488 (586)
Q Consensus       419 ~~~~~~~gt~~y~aPE~~~~~~-~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~---------~~  488 (586)
                       ......++..|+|||++.... ++.++|||||||++|||++|+.||.........  ...+.......         ..
T Consensus       157 -~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  233 (292)
T d1unla_         157 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ--LKRIFRLLGTPTEEQWPSMTKL  233 (292)
T ss_dssp             -CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHH--HHHHHHHHCCCCTTTCTTGGGS
T ss_pred             -cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHH--HHHHHhhcCCCChhhhhhhhhc
Confidence             233456788999999987665 689999999999999999999997653332211  11111111000         00


Q ss_pred             ccc-----cC-CCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          489 LEA-----RD-PNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       489 ~~~-----~d-~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      ...     .. ..............+.+|+.+||+.||++|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            000     00 00001111222345778889999999999999999975

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=3.2e-43  Score=355.64  Aligned_cols=260  Identities=17%  Similarity=0.185  Sum_probs=206.8

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCC-CceeeeeeeeeccCeEEEEEe
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRH-RNLVQLLGYCRRKGELLLVYD  338 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H-~niv~l~~~~~~~~~~~lV~E  338 (586)
                      .++|++.+.||+|+||+||+|++..+++.||||++.....  ...+.+|++.+..++| +|++.+++++......++|||
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme   81 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   81 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence            4689999999999999999999999999999999865432  2456788888888865 899999999999999999999


Q ss_pred             cCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecC-----CCCeEEccccceeec
Q 007869          339 YMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDG-----ELNGRLGDFGLARLY  413 (586)
Q Consensus       339 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~-----~~~~kL~DFGla~~~  413 (586)
                      |+ +++|.+++.... ..+++..+..++.|++.||.|||+   ++|+||||||+|||++.     ++.+||+|||+|+.+
T Consensus        82 ~~-~~~l~~~~~~~~-~~~~~~~~~~i~~q~~~~l~~lH~---~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~  156 (293)
T d1csna_          82 LL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  156 (293)
T ss_dssp             CC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             ec-CCCHHHHHHhhc-cchhhHHHHHHHHHHHHHHHHHHH---CCceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence            99 789999887653 468899999999999999999998   99999999999999964     567999999999986


Q ss_pred             cCCCC------CceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCc
Q 007869          414 DHGTD------PQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGE  487 (586)
Q Consensus       414 ~~~~~------~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~  487 (586)
                      .....      .......||+.|||||++.+..++.++|||||||++|||++|+.||..............+........
T Consensus       157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~  236 (293)
T d1csna_         157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP  236 (293)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred             ccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCC
Confidence            54321      123346799999999999999999999999999999999999999987655433222111111110000


Q ss_pred             cccccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHHHHhh
Q 007869          488 LLEARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQILER  535 (586)
Q Consensus       488 ~~~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~~L~~  535 (586)
                      . ...        ....++.+.+++..|++.+|++||+.+.+.+.|+.
T Consensus       237 ~-~~l--------~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~  275 (293)
T d1csna_         237 L-REL--------CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSK  275 (293)
T ss_dssp             H-HHH--------TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred             h-HHh--------cCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence            0 000        11122457778888999999999999988887765

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-44  Score=368.99  Aligned_cols=253  Identities=23%  Similarity=0.325  Sum_probs=203.2

Q ss_pred             CCcccceeEeecCceEEEEEEe---CCCCeEEEEEEeccc----cchhHHHHHHHHHHhcccCC-CceeeeeeeeeccCe
Q 007869          261 KGFREKELLGTGGFGRVYRGTL---PKSQIEIAVKKISHE----SRQGMKEFVAEIVSIGRLRH-RNLVQLLGYCRRKGE  332 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~---~~~~~~vavK~~~~~----~~~~~~~~~~Ei~~l~~l~H-~niv~l~~~~~~~~~  332 (586)
                      ++|+..+.||+|+||+||+|+.   +.+++.||||++...    .....+.+.+|++++++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            5699999999999999999987   446889999998653    22334678899999999977 899999999999999


Q ss_pred             EEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceee
Q 007869          333 LLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARL  412 (586)
Q Consensus       333 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~  412 (586)
                      .++||||+.+|+|.+++....  .++......++.||+.||.|||+   ++|+||||||+|||++.++.+||+|||+++.
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~--~~~e~~~~~~~~Qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~  178 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKE  178 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred             eeeeeecccccHHHHHHHhcc--cccHHHHHHHHHHHHHHHHHhhc---CCEEeccCCccceeecCCCCEEEeeccchhh
Confidence            999999999999999997764  45677888899999999999998   8999999999999999999999999999987


Q ss_pred             ccCCCCCceeeeccCCCccCcccccCC--CCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCcccc
Q 007869          413 YDHGTDPQTTHVVGTLGYLAPEHTRTG--KATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGELLE  490 (586)
Q Consensus       413 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~~~~  490 (586)
                      +............|++.|+|||.+...  .++.++|||||||+||||++|+.||......+....+   ......     
T Consensus       179 ~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i---~~~~~~-----  250 (322)
T d1vzoa_         179 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI---SRRILK-----  250 (322)
T ss_dssp             CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHH---HHHHHH-----
T ss_pred             hcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---HHhccc-----
Confidence            654443344557899999999999754  4688999999999999999999999876554422111   111101     


Q ss_pred             ccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCC-----HHHHHH
Q 007869          491 ARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPS-----MRQVVQ  531 (586)
Q Consensus       491 ~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs-----~~evl~  531 (586)
                       ..+....    .....+.+++.+||++||.+|||     ++|+++
T Consensus       251 -~~~~~~~----~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         251 -SEPPYPQ----EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             -CCCCCCT----TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             -CCCCCcc----cCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence             0111111    22356778888999999999994     788875

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=5.5e-43  Score=359.73  Aligned_cols=258  Identities=21%  Similarity=0.246  Sum_probs=198.2

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccC-CCceeeeeeeeec--cCeEEEEE
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLR-HRNLVQLLGYCRR--KGELLLVY  337 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~~~~~~--~~~~~lV~  337 (586)
                      ++|++.++||+|+||+||+|++..+++.||||+++...   .+++.+|+++|++++ ||||+++++++..  ...+++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence            57999999999999999999999999999999996543   467889999999995 9999999999874  35699999


Q ss_pred             ecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCC-CeEEccccceeeccCC
Q 007869          338 DYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGEL-NGRLGDFGLARLYDHG  416 (586)
Q Consensus       338 E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~-~~kL~DFGla~~~~~~  416 (586)
                      ||+++++|..+.     ..+++..+..++.||+.||.|||+   ++|+||||||+|||++.++ .+||+|||+|+.....
T Consensus       112 e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~---~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~  183 (328)
T d3bqca1         112 EHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  183 (328)
T ss_dssp             ECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred             eecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhh---cccccccccccceEEcCCCCeeeecccccceeccCC
Confidence            999999998764     258888999999999999999998   9999999999999998655 5999999999976543


Q ss_pred             CCCceeeeccCCCccCcccccCCC-CCCcceEEehhHHHHHHHhCCCCCCCCCCCccch-h----------hHHHHhhhc
Q 007869          417 TDPQTTHVVGTLGYLAPEHTRTGK-ATTSADVFSFGAFLLEVACGRRPIQRQGPSENLI-L----------VDWVFDFWN  484 (586)
Q Consensus       417 ~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~-l----------~~~v~~~~~  484 (586)
                      .  ......||+.|+|||.+.+.. ++.++||||+||+++||++|+.||.......... .          .+|....-.
T Consensus       184 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~  261 (328)
T d3bqca1         184 Q--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI  261 (328)
T ss_dssp             C--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred             C--cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccc
Confidence            3  334567899999999987654 7999999999999999999999997654321110 0          011100000


Q ss_pred             cC--cccccc--CCCC------CccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          485 RG--ELLEAR--DPNL------GTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       485 ~~--~~~~~~--d~~l------~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                      ..  ......  .+..      ...........+.+|+.+||+.||++|||++|+++
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             CCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00  000000  0000      00011112345778899999999999999999985

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.6e-43  Score=361.79  Aligned_cols=260  Identities=21%  Similarity=0.241  Sum_probs=192.6

Q ss_pred             CCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccc--cchhHHHHHHHHHHhcccCCCceeeeeeeeec------cCe
Q 007869          261 KGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHE--SRQGMKEFVAEIVSIGRLRHRNLVQLLGYCRR------KGE  332 (586)
Q Consensus       261 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~------~~~  332 (586)
                      ++|++.++||+|+||+||+|++..++..||||++...  +....+.+.+|+.++++++||||+++++++..      .+.
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            6799999999999999999999999999999999754  33445678999999999999999999999863      368


Q ss_pred             EEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceee
Q 007869          333 LLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARL  412 (586)
Q Consensus       333 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~  412 (586)
                      +++||||+.++.+ +.+.    ..+++..+..++.||+.||.|||+   ++|+||||||+|||++.++.+|++|||+++.
T Consensus        97 ~~iv~Ey~~~~l~-~~~~----~~~~~~~i~~~~~qil~gl~~LH~---~giiHrDlKP~Nil~~~~~~~kl~df~~~~~  168 (355)
T d2b1pa1          97 VYLVMELMDANLC-QVIQ----MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART  168 (355)
T ss_dssp             EEEEEECCSEEHH-HHHT----SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             eEEEEeccchHHH-Hhhh----cCCCHHHHHHHHHHHHHHHHHhhh---cccccccCCccccccccccceeeechhhhhc
Confidence            8999999966544 4443    247889999999999999999998   8999999999999999999999999999987


Q ss_pred             ccCCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhh---------HHH----
Q 007869          413 YDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILV---------DWV----  479 (586)
Q Consensus       413 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~---------~~v----  479 (586)
                      .....  ..+...||+.|+|||++.+..+++++||||+||+++||++|+.||...+.......+         ++.    
T Consensus       169 ~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~  246 (355)
T d2b1pa1         169 AGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ  246 (355)
T ss_dssp             --------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSC
T ss_pred             ccccc--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhh
Confidence            55432  334567999999999999999999999999999999999999999765322111000         000    


Q ss_pred             ---HhhhccCc-c-----c----cccCCCCCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          480 ---FDFWNRGE-L-----L----EARDPNLGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       480 ---~~~~~~~~-~-----~----~~~d~~l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                         ........ .     .    .... .............+.+|+.+||+.||++|||++|+++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~  310 (355)
T d2b1pa1         247 PTVRNYVENRPKYAGLTFPKLFPDSLF-PADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  310 (355)
T ss_dssp             HHHHHHHHTSCCCCCCCHHHHSCGGGS-CCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hhHHHHhhcCccccccccccccccccc-cccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence               00000000 0     0    0000 1111223345567889999999999999999999985

>d1hqla_ b.29.1.1 (A:) Legume lectin {Griffonia simplicifolia, lectin I-b4 [TaxId: 3850]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Griffonia simplicifolia, lectin I-b4 [TaxId: 3850]

Probab=100.00  E-value=4.7e-42  Score=332.74  Aligned_cols=169  Identities=31%  Similarity=0.465  Sum_probs=148.4

Q ss_pred             CcccCCCCCCCCCCeeeeeEEEEEEEEEeCCCCCCCCcEEEEEecCCCCCCCCCCCcccccccCCCC-CCCccEEEEEee
Q 007869            2 PFKNKNSNSSTANGTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGLFNDTNLG-NETNHVFAVELD   80 (586)
Q Consensus         2 p~~~~~~~~~~~~~~~asF~t~F~f~i~~~~~~~~g~GlaF~l~p~~~~~~~~~g~~lGl~~~~~~~-~~~~~~vaVEfD   80 (586)
                      ||+||+..+    +++|||+|+|+|.|... ...+||||||+|+|... +.+..|+|||+++..+.+ ...+++||||||
T Consensus        54 Pv~l~~~~t----~~~asFsT~F~F~i~~~-~~~~gDGlAFvl~p~~~-~~~~~G~~lGl~~~~~~~~~~~~~~vAVEFD  127 (236)
T d1hqla_          54 PVQLWDNKT----ESVASFYTEFTFFLKIT-GNGPADGLAFFLAPPDS-DVKDAGEYLGLFNKSTATQPSKNQVVAVEFD  127 (236)
T ss_dssp             CEECCCSTT----CCCCEEEEEEEEEEEEC-SSCCCCEEEEEEECTTC-CCCCCGGGTTTSCTTTTTCGGGCCCEEEEEE
T ss_pred             CEEeecCCC----CceeEEEEEEEEEEeCC-CCCCCceEEEEEeCCCC-CCCCCccccccccccccCCcccCceEEEEee
Confidence            899999888    99999999999999874 56689999999998654 345789999999987654 357999999999


Q ss_pred             ccccCCCCCCCCCeeEEeCCCCcccccccC-----------ceEEEEcCeeeEEEEEEeecCCCCCCccceeeeeecchh
Q 007869           81 TIKSHGFLDINDNHVGIDINSLKSESSAPA-----------GYYVEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSS  149 (586)
Q Consensus        81 t~~~~~~~d~~~~hvgidvns~~s~~~~~~-----------~~~i~y~~~~~~l~v~~~~~~~~~~~~~~~ls~~~dL~~  149 (586)
                      |++|.+++||++||||||+|++.|.++.++           .+||+||+.+++|+|+|+..   +|.. |+|++.|||++
T Consensus       128 T~~n~~~~D~~~nHIgIdvns~~s~~~~~~~~~~l~~G~~~~v~I~Yd~~~~~L~V~l~~~---~~~~-~~ls~~vdL~~  203 (236)
T d1hqla_         128 TWTNPNFPEPSYRHIGINVNSIVSVATKRWEDSDIFSGKIATARISYDGSAEILTVVLSYP---DGSD-YILSHSVDMRQ  203 (236)
T ss_dssp             CSCCSSSCCCSSCEEEEEESSSSCSEEEECCHHHHTSCSCEEEEEEEETTTTEEEEEEEET---TTEE-EEEEEECCGGG
T ss_pred             CccCCCCCCCCCCEEEEEcCCcccccccccccccccCCCEEEEEEEEeCCCcEEEEEEecC---CCCC-eeEEEEeCHHH
Confidence            999999999999999999999998876542           36899999999999999863   4555 89999999999


Q ss_pred             ccccceeeeeecCCCcc-ceeeeeeecccccc
Q 007869          150 VLNDAMYVGFSSSTGSV-LASHYILGWSFKIN  180 (586)
Q Consensus       150 ~l~~~~~vGFsastg~~-~~~~~i~~Wsf~~~  180 (586)
                      +|+++||||||||||.. .+.|+|++|+|+++
T Consensus       204 ~l~~~v~vGFSasTG~~~~~~h~I~sWsF~s~  235 (236)
T d1hqla_         204 NLPESVRVGISASTGNNQFLTVYILSWRFSSN  235 (236)
T ss_dssp             TSCSEEEEEEEEECCSCCCEEEEEEEEEEEEE
T ss_pred             hCCCcEEEEEEeECCCCCceEEEEEEeEeEec
Confidence            99999999999999975 67899999999874

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-42  Score=358.25  Aligned_cols=259  Identities=23%  Similarity=0.288  Sum_probs=196.5

Q ss_pred             cCCcccceeEeecCceEEEEEEeCCCCeEEEEEEecccc--chhHHHHHHHHHHhcccCCCceeeeeeeeecc-----Ce
Q 007869          260 TKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHES--RQGMKEFVAEIVSIGRLRHRNLVQLLGYCRRK-----GE  332 (586)
Q Consensus       260 ~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~~~Ei~~l~~l~H~niv~l~~~~~~~-----~~  332 (586)
                      +++|+..+.||+|+||+||+|++..+++.||||++....  ....+.+.+|+++|++++|||++++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            578999999999999999999999999999999997543  34456789999999999999999999998633     34


Q ss_pred             EEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEccccceee
Q 007869          333 LLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLGDFGLARL  412 (586)
Q Consensus       333 ~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~  412 (586)
                      .++++||+.+|+|.+++..+   .+++..+..++.||+.||+|||+   ++|+||||||+|||++.++.+|++|||++..
T Consensus        97 ~~~i~~~~~gg~L~~~~~~~---~l~e~~~~~i~~qil~aL~~LH~---~giiHrDiKp~NILi~~~~~~kl~dfg~a~~  170 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARH  170 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred             eEEEEEeecCCchhhhcccc---cccHHHHHHHHHHHHHHHHHHHh---CCCcccccCCccccccccccccccccchhcc
Confidence            46667778899999999654   58999999999999999999998   8999999999999999999999999999976


Q ss_pred             ccCCCCCceeeeccCCCccCcccccCCC-CCCcceEEehhHHHHHHHhCCCCCCCCCCCccchhhHHHHhhhccCc----
Q 007869          413 YDHGTDPQTTHVVGTLGYLAPEHTRTGK-ATTSADVFSFGAFLLEVACGRRPIQRQGPSENLILVDWVFDFWNRGE----  487 (586)
Q Consensus       413 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~~l~~~v~~~~~~~~----  487 (586)
                      ...    ......||+.|+|||...+.. ++.++|||||||++|||++|+.||...+.......   +........    
T Consensus       171 ~~~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~---i~~~~~~~~~~~~  243 (348)
T d2gfsa1         171 TDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL---ILRLVGTPGAELL  243 (348)
T ss_dssp             CTG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---HHHHHCCCCHHHH
T ss_pred             cCc----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHH---HHHhcCCCChHHh
Confidence            432    334467899999999876654 68999999999999999999999976543221111   100000000    


Q ss_pred             ----------cccc--cCCCCCc-cccHHHHHHHHHHHHHhcccCCCCCCCHHHHHH
Q 007869          488 ----------LLEA--RDPNLGT-EYVAEELELVLKLGLLCSHSDPTARPSMRQVVQ  531 (586)
Q Consensus       488 ----------~~~~--~d~~l~~-~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl~  531 (586)
                                ....  ..+.... .........+.+|+.+||+.||++|||+.|+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~  300 (348)
T d2gfsa1         244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  300 (348)
T ss_dssp             TTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence                      0000  0000000 000112245678899999999999999999986

>d1leda_ b.29.1.1 (A:) Legume lectin {West-central african legume (Griffonia simplicifolia) [TaxId: 3850]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: West-central african legume (Griffonia simplicifolia) [TaxId: 3850]

Probab=100.00  E-value=2.4e-41  Score=328.88  Aligned_cols=168  Identities=30%  Similarity=0.424  Sum_probs=147.1

Q ss_pred             CcccCCCCCCCCCCeeeeeEEEEEEEEEeCCCCCCCCcEEEEEecCCCCCCCCCCCcccccccCCCCC-CCccEEEEEee
Q 007869            2 PFKNKNSNSSTANGTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGLFNDTNLGN-ETNHVFAVELD   80 (586)
Q Consensus         2 p~~~~~~~~~~~~~~~asF~t~F~f~i~~~~~~~~g~GlaF~l~p~~~~~~~~~g~~lGl~~~~~~~~-~~~~~vaVEfD   80 (586)
                      ||+||++ +    +++|||+|+|+|.|... ...+||||||+|+|... +.+..|++||+++..+.++ ..|++||||||
T Consensus        59 Pv~l~~~-t----~~~asFsT~F~f~i~~~-~~~~gdGlAF~l~p~~~-~~~~~g~~lGl~~~~~~~~~~~~~~vAVEFD  131 (243)
T d1leda_          59 PVFLWDS-T----GKAASFYTSFTFLLKNY-GAPTADGLAFFLAPVDS-SVKDYGGFLGLFRHETAADPSKNQVVAVEFD  131 (243)
T ss_dssp             CEECBCT-T----SCBCEEEEEEEEEEEES-SSSCBCEEEEEEEETTC-CCCCCGGGTTTCCTTTTTCGGGCCCEEEEEE
T ss_pred             CeEecCC-C----CcEeeEEEEEEEEcCCC-CCCCCCceEEEEcCCCC-CCCCCccccccccccccCCCccCcEEEEEEe
Confidence            8999985 5    89999999999988765 55689999999999764 4457899999999877654 47899999999


Q ss_pred             ccccCCCCCCCCCeeEEeCCCCcccccccC-----------ceEEEEcCeeeEEEEEEeecCCCCCCccceeeeeecchh
Q 007869           81 TIKSHGFLDINDNHVGIDINSLKSESSAPA-----------GYYVEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSS  149 (586)
Q Consensus        81 t~~~~~~~d~~~~hvgidvns~~s~~~~~~-----------~~~i~y~~~~~~l~v~~~~~~~~~~~~~~~ls~~~dL~~  149 (586)
                      |++|.+++||++||||||+|++.|..+.++           ..||+||+.+++|+|+++..   +|.. |+|++.|||++
T Consensus       132 T~~n~~~~d~~~nHVgIdvns~~s~~~~~~~~~~~~~g~~~~v~I~Yd~~~~~L~V~l~~~---~~~~-p~ls~~idL~~  207 (243)
T d1leda_         132 TWINKDWNDPPYPHIGIDVNSIVSVATTRWENDDAYGSSIATAHITYDARSKILTVLLSYE---HGRD-YILSHVVDLAK  207 (243)
T ss_dssp             CSCCGGGTCCSSCEEEEEESSSSCSEEEECCHHHHTSCCEEEEEEEEETTTTEEEEEEEET---TSCE-EEEEEECCHHH
T ss_pred             CccccccCCCCCCceEEEecCcccccccccccCCcccCceeEEEEEEECCCCEEEEEEeeC---CCCC-ceEEEecCHHH
Confidence            999999999999999999999999877653           35899999999999999863   5555 89999999999


Q ss_pred             ccccceeeeeecCCCccceeeeeeeccccccC
Q 007869          150 VLNDAMYVGFSSSTGSVLASHYILGWSFKING  181 (586)
Q Consensus       150 ~l~~~~~vGFsastg~~~~~~~i~~Wsf~~~~  181 (586)
                      +|+++||||||||||. .|.|+|++|+|+++.
T Consensus       208 ~l~~~vyvGFSAsTG~-~~~h~I~sWsF~s~l  238 (243)
T d1leda_         208 VLPQKVRIGFSAGVGY-DEVTYILSWHFFSTL  238 (243)
T ss_dssp             HSCSEEEEEEEEEECB-SEEEEEEEEEEEEEC
T ss_pred             hcCCcEEEEEEcccCC-cceeeEEEEEEEeeC
Confidence            9999999999999995 699999999999753

>d1fx5a_ b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus), UEA-I [TaxId: 3902]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Furze (Ulex europaeus), UEA-I [TaxId: 3902]

Probab=100.00  E-value=3.3e-40  Score=321.55  Aligned_cols=170  Identities=32%  Similarity=0.465  Sum_probs=147.9

Q ss_pred             CcccCCCCCCCCCCeeeeeEEEEEEEEEeC-CCCCCCCcEEEEEecCCCCCCCCCCCcccccccCCCCCCCccEEEEEee
Q 007869            2 PFKNKNSNSSTANGTVFSFSTTFVFSILSE-YQSQSGHGIAFVIASTRGLPGARPSQYLGLFNDTNLGNETNHVFAVELD   80 (586)
Q Consensus         2 p~~~~~~~~~~~~~~~asF~t~F~f~i~~~-~~~~~g~GlaF~l~p~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEfD   80 (586)
                      ||++|+..+    ++++||+|+|+|.|... ....+||||||+|+|.. .|.+++|++|||++.++ ++..+++||||||
T Consensus        54 Pv~l~~~~t----~~~~sF~t~F~f~i~~~~~~~~ggdG~AFvl~p~~-~~~~~~g~~lGl~~~~~-~~~~~~~vAVEFD  127 (240)
T d1fx5a_          54 PIHIWNCNT----GELASFITSFSFFMETSANPKAATDGLTFFLAPPD-SPLRRAGGYFGLFNDTK-CDSSYQTVAVEFD  127 (240)
T ss_dssp             CEECEETTT----TEECEEEEEEEEEEEESSCGGGCCCEEEEEEECTT-CCCCBCGGGTTTBSSSC-CCGGGCCEEEEEE
T ss_pred             CceeecCCC----CceeeeEEEEEEEEeCCCCCCCCCCcEEEEECCCC-CCCCCCCccccccccCC-CCccCceEEEEee
Confidence            899999988    99999999999999765 34568999999999864 46678999999999764 4567899999999


Q ss_pred             ccccC-CCCCCCCCeeEEeCCCCcccccccC----------ceEEEEcCeeeEEEEEEeecCCCCCCccceeeeeecchh
Q 007869           81 TIKSH-GFLDINDNHVGIDINSLKSESSAPA----------GYYVEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSS  149 (586)
Q Consensus        81 t~~~~-~~~d~~~~hvgidvns~~s~~~~~~----------~~~i~y~~~~~~l~v~~~~~~~~~~~~~~~ls~~~dL~~  149 (586)
                      |++|. +++||+.||||||+||+.+..+..+          ..||+||+.+++|.|++.+..  +|.. |+|++.|||+.
T Consensus       128 T~~n~~~~~D~~~nHIgid~ns~~s~~~~~~~~~~~~g~~~~v~I~Yd~~~~~L~V~l~~~~--~~~~-~~ls~~vdLs~  204 (240)
T d1fx5a_         128 TIGSPVNFWDPGFPHIGIDVNCVKSINAERWNKRYGLNNVANVEIIYEASSKTLTASLTYPS--DQTS-ISVTSIVDLKE  204 (240)
T ss_dssp             CCCTTTSTTSCSSCEEEEEESSSSCSEEEECCCCCSGGGCEEEEEEEETTTTEEEEEEEETT--TTEE-EEEEEECCGGG
T ss_pred             ccccccccCCCCCCceEEccCCcccccccccccccCCCCeEEEEEEEcCCCCEEEEEEecCC--Ccee-eEEeEEEchHH
Confidence            99985 6789999999999999998765542          358999999999999998643  5555 89999999999


Q ss_pred             ccccceeeeeecCCCc-cceeeeeeecccccc
Q 007869          150 VLNDAMYVGFSSSTGS-VLASHYILGWSFKIN  180 (586)
Q Consensus       150 ~l~~~~~vGFsastg~-~~~~~~i~~Wsf~~~  180 (586)
                      +|+++||||||||||. ..|.|+|++|+|+++
T Consensus       205 ~l~~~v~vGFSasTG~~~~~~H~I~sWsFsst  236 (240)
T d1fx5a_         205 ILPEWVSVGFSGSTYIGRQATHEVLNWYFTST  236 (240)
T ss_dssp             TSCSEEEEEEEEEEETTSCEEEEEEEEEEEEE
T ss_pred             hCCCcEEEEEEeECCCCCCceEEEEEEEeEEe
Confidence            9999999999999996 569999999999975

>d1qnwa_ b.29.1.1 (A:) Legume lectin {Furze (Ulex europaeus), UEA-II [TaxId: 3902]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Furze (Ulex europaeus), UEA-II [TaxId: 3902]

Probab=100.00  E-value=5.8e-39  Score=312.35  Aligned_cols=170  Identities=31%  Similarity=0.536  Sum_probs=147.5

Q ss_pred             CcccCCCCCCCCCCeeeeeEEEEEEEEEeCCCCCCCCcEEEEEecCCC-CCCCCCCCcccccccCCCCCCCccEEEEEee
Q 007869            2 PFKNKNSNSSTANGTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTRG-LPGARPSQYLGLFNDTNLGNETNHVFAVELD   80 (586)
Q Consensus         2 p~~~~~~~~~~~~~~~asF~t~F~f~i~~~~~~~~g~GlaF~l~p~~~-~~~~~~g~~lGl~~~~~~~~~~~~~vaVEfD   80 (586)
                      ||+||++.+    ++++||+|+|+|.|.+. ...+||||||+|+|... .|.++.|+++|+++..+ +...+++||||||
T Consensus        53 Pi~l~~~~~----~~~~sF~t~F~f~i~~~-~~~ggdG~aF~l~p~~~~~~~~~~~~~~g~~~~~~-~~~~~~~vAVEFD  126 (237)
T d1qnwa_          53 PIQIWDSIT----GKVASFATSFSFVVKAD-KSDGVDGLAFFLAPANSQIPSGSSAGMFGLFSSSD-SKSSNQIIAVEFD  126 (237)
T ss_dssp             CEECBCTTT----CCBCEEEEEEEEECCBS-SSCCCCEEEEEEEETTCCCCTTCCGGGTTTCSSSS-CCTTSCCEEEEEE
T ss_pred             CEEecCCCC----cceeeEEEEEEEEEecC-CCCCcceeEEEEeCCCCCCCCCCccccccccCCCC-CCCcccEEEEEee
Confidence            899999888    99999999999999765 55689999999999764 46677788889988653 4678999999999


Q ss_pred             ccccCCCC--CCCCCeeEEeCCCCcccccccC--------ceEEEEcCeeeEEEEEEeecCCCCCCccceeeeeecchhc
Q 007869           81 TIKSHGFL--DINDNHVGIDINSLKSESSAPA--------GYYVEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSV  150 (586)
Q Consensus        81 t~~~~~~~--d~~~~hvgidvns~~s~~~~~~--------~~~i~y~~~~~~l~v~~~~~~~~~~~~~~~ls~~~dL~~~  150 (586)
                      |++|.+++  ||++||||||+|++.|..+..+        ..||+||+.+++|+|++...  .+|.. |+|++.|||+++
T Consensus       127 T~~n~~~~~~d~~~nHvgid~ns~~s~~~~~~~~~~G~~~~v~I~Yd~~~~~L~V~l~~~--~~~~~-p~ls~~vDLs~~  203 (237)
T d1qnwa_         127 TYFGKAYNPWDPDFKHIGIDVNSIKSIKTVKWDWRNGEVADVVITYRAPTKSLTVCLSYP--SDGTS-NIITASVDLKAI  203 (237)
T ss_dssp             CCCCTTTCTTSCSSCEEEEEESSSSCSEEEECCCCTTCCEEEEEEEEGGGTEEEEEEECT--TTCCE-EEEEEECCHHHH
T ss_pred             ceecCCcCCCCCCCCeEEEECCCCCcccccccccCCCcEEEEEEEEcCCCcEEEEEEecC--CCCcc-ceEEEEEChHHh
Confidence            99998765  5899999999999998766543        36899999999999999854  36766 999999999999


Q ss_pred             cccceeeeeecCCCcc--ceeeeeeecccccc
Q 007869          151 LNDAMYVGFSSSTGSV--LASHYILGWSFKIN  180 (586)
Q Consensus       151 l~~~~~vGFsastg~~--~~~~~i~~Wsf~~~  180 (586)
                      |+++||||||||||..  .|.|+|++|+|+++
T Consensus       204 l~~~vyvGFSasTG~~~~~q~h~I~sWsF~s~  235 (237)
T d1qnwa_         204 LPEWVSVGFSGGVGNAAEFETHDVLSWYFTSN  235 (237)
T ss_dssp             SCSEEEEEEEEEESCGGGCBCCEEEEEEEEEE
T ss_pred             CCCcEEEEEEeECCCCCCccEeEEEEeEeEEe
Confidence            9999999999999975  48999999999975

>d1gzca_ b.29.1.1 (A:) Legume lectin {Cockspur coral tree (Erythrina crista-galli) [TaxId: 49817]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Cockspur coral tree (Erythrina crista-galli) [TaxId: 49817]

Probab=100.00  E-value=1.4e-38  Score=309.87  Aligned_cols=170  Identities=32%  Similarity=0.496  Sum_probs=146.3

Q ss_pred             CcccCCCCCCCCCCeeeeeEEEEEEEEEeCC-CCCCCCcEEEEEecCCCCCCCCCCCcccccccCCCCCCCccEEEEEee
Q 007869            2 PFKNKNSNSSTANGTVFSFSTTFVFSILSEY-QSQSGHGIAFVIASTRGLPGARPSQYLGLFNDTNLGNETNHVFAVELD   80 (586)
Q Consensus         2 p~~~~~~~~~~~~~~~asF~t~F~f~i~~~~-~~~~g~GlaF~l~p~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEfD   80 (586)
                      ||+||++.+    ++++||+|+|+|.|.... ...+||||||+|+|.... .+..|++||+++.... ...++.||||||
T Consensus        56 Pv~l~~~~~----~~~~sFst~F~f~i~~~~~~~~g~dG~aF~l~p~~~~-~~~~~g~lg~~~~~~~-~~~~~~vaVEFD  129 (239)
T d1gzca_          56 PVHMWDSTT----GTVASFETRFSFSIEQPYTRPLPADGLVFFMGPTKSK-PAQGYGYLGVFNNSKQ-DNSYQTLAVEFD  129 (239)
T ss_dssp             CEECBCTTT----CCBCEEEEEEEEECCCCCSSSCCCEEEEEEEECSSCC-CCCCGGGTTTCSSSSC-CGGGCCEEEEEE
T ss_pred             CeEecCCCC----CceeeEEEEEEEEEecCCCCCCCCCeEEEEECCCCCC-CCCCcccccccccCCC-CCccceEEEEEE
Confidence            899999888    999999999999997553 456899999999997643 3567889999877654 356788999999


Q ss_pred             ccccCCCCCCCCCeeEEeCCCCcccccccC--------ceEEEEcCeeeEEEEEEeecCCCCCCccceeeeeecchhccc
Q 007869           81 TIKSHGFLDINDNHVGIDINSLKSESSAPA--------GYYVEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSVLN  152 (586)
Q Consensus        81 t~~~~~~~d~~~~hvgidvns~~s~~~~~~--------~~~i~y~~~~~~l~v~~~~~~~~~~~~~~~ls~~~dL~~~l~  152 (586)
                      |++| +++||++||||||+|++.|..+.+.        ..||+||+.+++|.|++...  .+|.. |+|++.+||+++|+
T Consensus       130 T~~n-~~~d~~~~HvgI~vn~~~s~~t~~~~l~~G~~~~v~I~Yd~~~~~L~V~l~~~--~~~~~-~~ls~~vdL~~~l~  205 (239)
T d1gzca_         130 TFSN-PWDPPQVPHIGIDVNSIRSIKTQPFQLDNGQVANVVIKYDAPSKILHVVLVYP--SSGAI-YTIAEIVDVKQVLP  205 (239)
T ss_dssp             CSCC-TTSCSSSSEEEEEESSSSCSEEEECCCCTTCEEEEEEEEETTTTEEEEEEECT--TTCCE-EEEEEECCHHHHSC
T ss_pred             cccc-CCCCCCCCEEEEEECCccccccCCccccCCCEEEEEEEEeCCCcEEEEEEecC--CCCcc-eeeeeEechHHhcC
Confidence            9999 5789999999999999999877653        35899999999999999864  36666 89999999999999


Q ss_pred             cceeeeeecCCCc---cceeeeeeeccccccC
Q 007869          153 DAMYVGFSSSTGS---VLASHYILGWSFKING  181 (586)
Q Consensus       153 ~~~~vGFsastg~---~~~~~~i~~Wsf~~~~  181 (586)
                      ++|||||||+||.   ..|.|+|++|+|+++.
T Consensus       206 ~~vyvGFSAsTG~~~~~~~~H~V~sWsF~s~l  237 (239)
T d1gzca_         206 DWVDVGLSGATGAQRDAAETHDVYSWSFQASL  237 (239)
T ss_dssp             SEEEEEEEEEECSSTTCCCCCEEEEEEEEEEE
T ss_pred             CcEEEEEEEEcCCCCCCceeeEEEEEEeEeeC
Confidence            9999999999995   4689999999999863

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.4e-37  Score=323.23  Aligned_cols=263  Identities=21%  Similarity=0.237  Sum_probs=192.9

Q ss_pred             CcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccC-----------CCceeeeeeeeecc
Q 007869          262 GFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLR-----------HRNLVQLLGYCRRK  330 (586)
Q Consensus       262 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-----------H~niv~l~~~~~~~  330 (586)
                      +|++.++||+|+||+||+|++..+++.||||+++.... ..+.+.+|++++++++           |+||+++++++...
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~   92 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK   92 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred             cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence            49999999999999999999999999999999976532 3467788998888875           57899999988654


Q ss_pred             --CeEEEEEecCCCCC-hhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCC------
Q 007869          331 --GELLLVYDYMPNGS-LDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELN------  401 (586)
Q Consensus       331 --~~~~lV~E~~~~gs-L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~------  401 (586)
                        ...+++++++..+. ............+++..+..++.||++||.|||+  ..+|+||||||+|||++.++.      
T Consensus        93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~~~  170 (362)
T d1q8ya_          93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQ  170 (362)
T ss_dssp             ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred             cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCcccccce
Confidence              45667777665543 3333444445678888999999999999999997  478999999999999986543      


Q ss_pred             eEEccccceeeccCCCCCceeeeccCCCccCcccccCCCCCCcceEEehhHHHHHHHhCCCCCCCCCCCccc----hhhH
Q 007869          402 GRLGDFGLARLYDHGTDPQTTHVVGTLGYLAPEHTRTGKATTSADVFSFGAFLLEVACGRRPIQRQGPSENL----ILVD  477 (586)
Q Consensus       402 ~kL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~s~ksDVyS~Gvvl~ElltG~~p~~~~~~~~~~----~l~~  477 (586)
                      +|++|||.+......    .....||+.|+|||++....++.++||||+||+++||++|+.||.........    .+..
T Consensus       171 ~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~  246 (362)
T d1q8ya_         171 IKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ  246 (362)
T ss_dssp             EEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred             eeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHH
Confidence            999999999865432    23467999999999999999999999999999999999999999754332111    1111


Q ss_pred             HHHh-----------------hhccCccccccCCC----------CCccccHHHHHHHHHHHHHhcccCCCCCCCHHHHH
Q 007869          478 WVFD-----------------FWNRGELLEARDPN----------LGTEYVAEELELVLKLGLLCSHSDPTARPSMRQVV  530 (586)
Q Consensus       478 ~v~~-----------------~~~~~~~~~~~d~~----------l~~~~~~~~~~~l~~l~~~Cl~~dP~~RPs~~evl  530 (586)
                      .+..                 ..............          ............+.+|+.+|++.||.+|||++|++
T Consensus       247 ~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L  326 (362)
T d1q8ya_         247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV  326 (362)
T ss_dssp             HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHH
T ss_pred             HHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence            1110                 00000000000000          01123456677889999999999999999999998


Q ss_pred             H
Q 007869          531 Q  531 (586)
Q Consensus       531 ~  531 (586)
                      +
T Consensus       327 ~  327 (362)
T d1q8ya_         327 N  327 (362)
T ss_dssp             T
T ss_pred             c
Confidence            6

>d2d3sa1 b.29.1.1 (A:1-237) Legume lectin {Winged bean (Psophocarpus tetragonolobus), basic agglutinin [TaxId: 3891]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Winged bean (Psophocarpus tetragonolobus), basic agglutinin [TaxId: 3891]

Probab=100.00  E-value=4.8e-38  Score=305.39  Aligned_cols=165  Identities=33%  Similarity=0.501  Sum_probs=142.4

Q ss_pred             CcccCCCCCCCCCCeeeeeEEEEEEEEEeC-CCCCCCCcEEEEEecCCCCCCCCCCCcccccccCCCCCCCccEEEEEee
Q 007869            2 PFKNKNSNSSTANGTVFSFSTTFVFSILSE-YQSQSGHGIAFVIASTRGLPGARPSQYLGLFNDTNLGNETNHVFAVELD   80 (586)
Q Consensus         2 p~~~~~~~~~~~~~~~asF~t~F~f~i~~~-~~~~~g~GlaF~l~p~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEfD   80 (586)
                      ||+||++.+    ++++||+|+|+|.|... ....+||||||+|+|... +.+..|++||+++..    ..+++||||||
T Consensus        54 pi~l~~~~~----~~~~sF~t~F~f~i~~~~~~~~g~dGlaFvl~p~~~-~~~~~gg~lG~~~~~----~~~~~vaVEFD  124 (237)
T d2d3sa1          54 PVQVWDSTT----GNVASFETRFSFSIRQPFPRPHPADGLVFFIAPPNT-QTGEGGGYFGIYNPL----SPYPFVAVEFD  124 (237)
T ss_dssp             CEECBCTTT----CCBCEEEEEEEEECCCSCCSSCCCEEEEEEEECSSC-CCCBCGGGTTTBCTT----SCCCCEEEEEE
T ss_pred             CEEeecCCC----CceeeEEEEEEEEeecCCCCCCCCCeEEEEeCCCCc-cCCccccccccccCC----CcCceEEEEEE
Confidence            899999988    99999999999999764 345678999999998653 456788999998764    45788999999


Q ss_pred             ccccCCCCCCCCCeeEEeCCCCcccccccC--------ceEEEEcCeeeEEEEEEeecCCCCCCccceeeeeecchhccc
Q 007869           81 TIKSHGFLDINDNHVGIDINSLKSESSAPA--------GYYVEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSVLN  152 (586)
Q Consensus        81 t~~~~~~~d~~~~hvgidvns~~s~~~~~~--------~~~i~y~~~~~~l~v~~~~~~~~~~~~~~~ls~~~dL~~~l~  152 (586)
                      |++|.  +||++||||||+|++.|.++..+        ..||+||+.+++|.|++....  +|.. |+++..+||+.+|+
T Consensus       125 T~~n~--~d~~~nHvgI~vns~~s~~~~~~~l~~G~~~~v~I~Yd~~~~~L~V~l~~~~--~~~~-~~ls~~vdL~~~l~  199 (237)
T d2d3sa1         125 TFRNT--WDPQIPHIGIDVNSVISTKTVPFTLDNGGIANVVIKYDASTKILHVVLVFPS--LGTI-YTIADIVDLKQVLP  199 (237)
T ss_dssp             CSCCT--TCCSSSEEEEEESSSSCSEEEECCCCTTCEEEEEEEEETTTTEEEEEEEETT--TTEE-EEEEEECCHHHHSC
T ss_pred             eecCC--CCCCCCcEEEEcCCCccccccceeecCCCEEEEEEEEECCCCEEEEEEEcCC--CCcc-cceeeEechHHhCC
Confidence            99996  59999999999999998766543        368999999999999998754  4555 89999999999999


Q ss_pred             cceeeeeecCCCc-------cceeeeeeecccccc
Q 007869          153 DAMYVGFSSSTGS-------VLASHYILGWSFKIN  180 (586)
Q Consensus       153 ~~~~vGFsastg~-------~~~~~~i~~Wsf~~~  180 (586)
                      ++||||||||||.       ..|.|+|++|+|+++
T Consensus       200 ~~vyvGFSasTG~~~~~~~~~~e~h~I~sWsFss~  234 (237)
T d2d3sa1         200 ESVNVGFSAATGDPSGKQRNATETHDILSWSFSAS  234 (237)
T ss_dssp             SEEEEEEEEEECCGGGCCTTCCCCCEEEEEEEEEE
T ss_pred             CcEEEEEEeECCCCccCccccceeeEEEEeEeEee
Confidence            9999999999995       468999999999975

>d1g9fa_ b.29.1.1 (A:) Legume lectin {Soybean (Glycine max) [TaxId: 3847]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Soybean (Glycine max) [TaxId: 3847]

Probab=100.00  E-value=1.9e-37  Score=303.97  Aligned_cols=170  Identities=30%  Similarity=0.480  Sum_probs=142.5

Q ss_pred             CcccCCCCCCCCCCeeeeeEEEEEEEEEeCCCCCCCCcEEEEEecCCCCCCCCCCCcccccccCCCCCCCccEEEEEeec
Q 007869            2 PFKNKNSNSSTANGTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGLFNDTNLGNETNHVFAVELDT   81 (586)
Q Consensus         2 p~~~~~~~~~~~~~~~asF~t~F~f~i~~~~~~~~g~GlaF~l~p~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEfDt   81 (586)
                      ||+||++.+    ++++||+|+|+|.|.......+||||||+|+|.... .+..||+||+++..   ...++.|||||||
T Consensus        56 Pv~l~~~~~----~~~~sf~t~f~F~i~~~~~~~~gDGlAFvl~p~~~~-~~~~~g~lG~~~~~---~~~~~~vaVEFDT  127 (251)
T d1g9fa_          56 PIHIWDKET----GSVASFAASFNFTFYAPDTKRLADGLAFFLAPIDTK-PQTHAGYLGLFNEN---ESGDQVVAVEFDT  127 (251)
T ss_dssp             CEECBCC-C----CCBCEEEEEEEEEEECSCC--CCEEEEEEEEETTCC-CCCCGGGTTTCCTT---SCCCSCEEEEEEC
T ss_pred             CEEccCCCC----ccceeeEEEEEEEEecCCCCCCCCceEEEEecCCCC-CCCccCccCccccc---CCCcceEEEEEec
Confidence            899999988    999999999999999888888999999999997643 45678899998764   3457889999999


Q ss_pred             cccCCCCCCCCCeeEEeCCCCcccccccC--------ceEEEEcCeeeEEEEEEeecCCCCCCccceeeeeecchhcccc
Q 007869           82 IKSHGFLDINDNHVGIDINSLKSESSAPA--------GYYVEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSVLND  153 (586)
Q Consensus        82 ~~~~~~~d~~~~hvgidvns~~s~~~~~~--------~~~i~y~~~~~~l~v~~~~~~~~~~~~~~~ls~~~dL~~~l~~  153 (586)
                      ++|.  +||++||||||+|++.|..+..+        ..||+||+.+++|.|++...  .+|.. |++++.+||+.+|++
T Consensus       128 ~~n~--~D~~~~Hvgi~~n~~~s~~~~~~~l~~g~~~~v~I~Yd~~~~~L~v~l~~~--~~~~~-~~l~~~vdL~~~l~~  202 (251)
T d1g9fa_         128 FRNS--WDPPNPHIGINVNSIRSIKTTSWDLANNKVAKVLITYDASTSLLVASLVYP--SQRTS-NILSDVVDLKTSLPE  202 (251)
T ss_dssp             C-CT--TSCSSSEEEEEESSSSCSEEEECCCCTTCCEEEEEEEETTTTEEEEEEEEG--GGTEE-EEEEEECCC-CCSCS
T ss_pred             ccCC--CCCCCCcEeEEecCcccccccceEecCCCEEEEEEEEECCccEEEEEEecC--CCCcc-eeEEEEecchhhCCC
Confidence            9996  59999999999999998766543        36899999999999999753  36666 899999999999999


Q ss_pred             ceeeeeecCCCccc--eeeeeeeccccccCccc
Q 007869          154 AMYVGFSSSTGSVL--ASHYILGWSFKINGQAE  184 (586)
Q Consensus       154 ~~~vGFsastg~~~--~~~~i~~Wsf~~~~~~~  184 (586)
                      +||||||||||...  |.|+|++|+|+++.+++
T Consensus       203 ~~yvGFSAsTG~~~~~~~h~I~sWsF~s~~~~~  235 (251)
T d1g9fa_         203 WVRIGFSAATGLDIPGESHDVLSWSFASNLPHA  235 (251)
T ss_dssp             EEEEEEEEEECSSSCCCEEEEEEEEEEEEECC-
T ss_pred             cEEEEEEeecCCCCCCceeEEEEeEeECCCCCC
Confidence            99999999999754  88999999999875443

>d1f9ka_ b.29.1.1 (A:) Legume lectin {Winged bean (Psophocarpus tetragonolobus), acidic lectin [TaxId: 3891]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Winged bean (Psophocarpus tetragonolobus), acidic lectin [TaxId: 3891]

Probab=100.00  E-value=5e-37  Score=297.81  Aligned_cols=165  Identities=33%  Similarity=0.508  Sum_probs=140.9

Q ss_pred             CcccCCCCCCCCCCeeeeeEEEEEEEEEeCC-CCCCCCcEEEEEecCCCCCCCCCCCcccccccCCCCCCCccEEEEEee
Q 007869            2 PFKNKNSNSSTANGTVFSFSTTFVFSILSEY-QSQSGHGIAFVIASTRGLPGARPSQYLGLFNDTNLGNETNHVFAVELD   80 (586)
Q Consensus         2 p~~~~~~~~~~~~~~~asF~t~F~f~i~~~~-~~~~g~GlaF~l~p~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEfD   80 (586)
                      ||+||++.+    ++++||+|+|+|.|.+.. ...+||||||+|+|.. .|.+..|+++|+++..    ..++.||||||
T Consensus        55 Pv~l~~~~~----~~~~sFsT~F~f~i~~~~~~~~g~dG~aF~i~p~~-~~~~~~g~~~g~~~~~----~~~~~vaVEFD  125 (234)
T d1f9ka_          55 PIKIWDSTT----GNVASFETRFSFNITQPYAYPEPADGLTFFMVPPN-SPQGEDGGNLGVFKPP----EGDNAFAVEFD  125 (234)
T ss_dssp             CEECBCTTT----CCBCEEEEEEEEEEECCCSSSCCCEEEEEEEECTT-CCCCCSGGGTTTCCSS----CCSCCEEEEEE
T ss_pred             CEEeeCCCC----CcCcceEEEEEEEEECCCCCCCccceEEEEECCCC-CCcccccccccccCCC----CccceEEEEEe
Confidence            899999888    999999999999998653 3457899999999865 3666788999987763    35678999999


Q ss_pred             ccccCCCCCCCCCeeEEeCCCCcccccccC--------ceEEEEcCeeeEEEEEEeecCCCCCCccceeeeeecchhccc
Q 007869           81 TIKSHGFLDINDNHVGIDINSLKSESSAPA--------GYYVEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSVLN  152 (586)
Q Consensus        81 t~~~~~~~d~~~~hvgidvns~~s~~~~~~--------~~~i~y~~~~~~l~v~~~~~~~~~~~~~~~ls~~~dL~~~l~  152 (586)
                      |++|.  +||++||||||+|++.|.++.++        ..||+||+.+++|.|++....  +|.. |+|++.|||+.+|+
T Consensus       126 T~~n~--~Dp~~nHvgi~~ns~~s~~~~~~~l~~G~~~~v~I~Yd~~~~~l~V~l~~~~--~~~~-~~ls~~idL~~~l~  200 (234)
T d1f9ka_         126 TFQNT--WDPQVPHIGIDVNSIVSSKTLHFQLENGGVANVVIKYDSPTKILNVVLAFHS--VGTV-YTLSNIVDLKQEFP  200 (234)
T ss_dssp             CSCCT--TCCSSSEEEEEESSSSCSEEEECCCCTTCCEEEEEEEETTTTEEEEEEEETT--TTEE-EEEEEECCHHHHST
T ss_pred             ccccC--CCCCCCcEeEecCCccccccccccccCCCEEEEEEEEcCCCcEEEEEEEeCC--CCcc-ceEEEEEcHHHhcC
Confidence            99996  69999999999999998765543        368999999999999998754  4444 89999999999997


Q ss_pred             --cceeeeeecCCCc---cceeeeeeecccccc
Q 007869          153 --DAMYVGFSSSTGS---VLASHYILGWSFKIN  180 (586)
Q Consensus       153 --~~~~vGFsastg~---~~~~~~i~~Wsf~~~  180 (586)
                        ++||||||||||.   ..|.|+|++|+|+++
T Consensus       201 ~~~~v~vGFSasTG~~~~~~~~h~I~sWsF~s~  233 (234)
T d1f9ka_         201 NSEWVNVGLSATTGYQKNAVETHEIISWSFTSS  233 (234)
T ss_dssp             TCSEEEEEEEEEECSSTTCCCEEEEEEEEEEEE
T ss_pred             CCCEEEEEEEeecCCCCCceeeeEEEEEEeEEe
Confidence              6799999999994   468999999999874

>d1g7ya_ b.29.1.1 (A:) Legume lectin {Horse gram (Dolichos biflorus), different isoforms [TaxId: 3840]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Horse gram (Dolichos biflorus), different isoforms [TaxId: 3840]

Probab=100.00  E-value=5.6e-37  Score=301.57  Aligned_cols=169  Identities=30%  Similarity=0.501  Sum_probs=146.9

Q ss_pred             CcccCCCCCCCCCCeeeeeEEEEEEEEEeCCCCCCCCcEEEEEecCCCCCCCCCCCcccccccCCCCCCCccEEEEEeec
Q 007869            2 PFKNKNSNSSTANGTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGLFNDTNLGNETNHVFAVELDT   81 (586)
Q Consensus         2 p~~~~~~~~~~~~~~~asF~t~F~f~i~~~~~~~~g~GlaF~l~p~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEfDt   81 (586)
                      ||+||++.+    ++++||+|+|+|.|.+.....+||||||+|+|....+ +..||+||+++.... ...++.+||||||
T Consensus        53 pv~l~~~~~----~~~~sF~t~F~F~i~~~~~~~ggDGlAF~l~~~~~~~-~~~~g~lgl~~~~~~-~~~~~~vaVEFDT  126 (253)
T d1g7ya_          53 PIQIYDKST----GAVASWATSFTANIFAPNKSSSADGIAFALVPVGSEP-KSNSGFLGVFDSDVY-DNSAQTVAVEFDT  126 (253)
T ss_dssp             CEECBCTTT----CCBCEEEEEEEEECCCSSGGGCCCEEEEEEEETTCCC-CCCGGGTTTCSCSSC-CGGGCCEEEEEEC
T ss_pred             CeEeecCCC----CceeeEEEEEEEEEecCCCCCCCCceEEEEeCCCCCC-CCCcccccccccCCC-CCcCceEEEEEec
Confidence            899999988    9999999999999987766779999999999976544 457889999987654 4567889999999


Q ss_pred             cccCCCCCCCCCeeEEeCCCCcccccccC--------ceEEEEcCeeeEEEEEEeecCCCCCCccceeeeeecchhcccc
Q 007869           82 IKSHGFLDINDNHVGIDINSLKSESSAPA--------GYYVEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSVLND  153 (586)
Q Consensus        82 ~~~~~~~d~~~~hvgidvns~~s~~~~~~--------~~~i~y~~~~~~l~v~~~~~~~~~~~~~~~ls~~~dL~~~l~~  153 (586)
                      ++|.++ ||+++|||||+|++.|..+++.        ..||+||+.+++|.|++...  .+|.. |++++.+||+.+||+
T Consensus       127 ~~n~~~-d~~~~Hvgi~~ns~~s~~~~~~~~~~g~~~~v~I~Yd~~~~~L~v~l~~~--~~~~~-~~ls~~vdL~~~l~~  202 (253)
T d1g7ya_         127 FSNTDW-DPTSRHIGIDVNSIKSIRTASWGLANGQNAEILITYNAATSLLVASLVHP--SRRTS-YIVSERVDITNELPE  202 (253)
T ss_dssp             SCCTTT-CCSSCEEEEEESSSSCSEEEECCCCTTSEEEEEEEEETTTTEEEEEEEET--TTTEE-EEEEEECCHHHHSCS
T ss_pred             eecCCC-CCCCCcEEEeeCCcccccccCCCccCCCEEEEEEEEeCCcEEEEEEEecC--CCCCc-eEEEEEechhhcCCC
Confidence            999875 9999999999999998776553        35899999999999999753  36666 899999999999999


Q ss_pred             ceeeeeecCCCc---cceeeeeeecccccc
Q 007869          154 AMYVGFSSSTGS---VLASHYILGWSFKIN  180 (586)
Q Consensus       154 ~~~vGFsastg~---~~~~~~i~~Wsf~~~  180 (586)
                      +|||||||+||.   ..|.|+|++|+|+++
T Consensus       203 ~~yvGFSAsTG~~~~~~~~H~IlsWsF~s~  232 (253)
T d1g7ya_         203 YVSIGFSATTGLSEGYTETHDVLSWSFASK  232 (253)
T ss_dssp             EEEEEEEEECCSSSSCCCCCEEEEEEEEEE
T ss_pred             cEEEEEEeEcCCCCCcccccEEEEEEeEEe
Confidence            999999999994   468999999999874

>d1dbna_ b.29.1.1 (A:) Legume lectin {Maackia amurensis, leukoagglutinin [TaxId: 37501]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Maackia amurensis, leukoagglutinin [TaxId: 37501]

Probab=100.00  E-value=6.8e-37  Score=299.03  Aligned_cols=171  Identities=32%  Similarity=0.525  Sum_probs=148.2

Q ss_pred             CcccCCCCCCCCCCeeeeeEEEEEEEEEeCCCCCCCCcEEEEEecCC-CCCCCCCCCcccccccCCCCCCCccEEEEEee
Q 007869            2 PFKNKNSNSSTANGTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTR-GLPGARPSQYLGLFNDTNLGNETNHVFAVELD   80 (586)
Q Consensus         2 p~~~~~~~~~~~~~~~asF~t~F~f~i~~~~~~~~g~GlaF~l~p~~-~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEfD   80 (586)
                      ||++|++.+    ++++||+|+|+|.|.+.....+||||||+|+|.. ..+.++.|++||+++..+ ++..++.+|||||
T Consensus        55 pi~l~~~~~----~~~~sFst~F~F~i~~~~~~~~gdG~AF~l~~~~~~~~~~~~g~~lGl~~~~~-~~~~~~~~aVEfD  129 (239)
T d1dbna_          55 PVRIWGNTT----GSVASFSTSFTFVVKAPNPDITSDGLAFYLAPPDSQIPSGSVSKYLGLFNNSN-SDSSNQIVAVEFD  129 (239)
T ss_dssp             CEECBCTTT----CCBCEEEEEEEEECCCSSTTSCCEEEEEEEECTTCCCCSSSCGGGTTSCSSSC-CCTTSCCEEEEEE
T ss_pred             CEEccCCCC----ccceEEEEEEEEEEECCCCCCCCCCEEEEEeCCCccCCcccCccccccccccC-CCcccCeeeeEEe
Confidence            899999988    9999999999999988777789999999999866 456678889999998664 4567899999999


Q ss_pred             ccccCCCC--CCCCCeeEEeCCCCcccccccC--------ceEEEEcCeeeEEEEEEeecCCCCCCccceeeeeecchhc
Q 007869           81 TIKSHGFL--DINDNHVGIDINSLKSESSAPA--------GYYVEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSV  150 (586)
Q Consensus        81 t~~~~~~~--d~~~~hvgidvns~~s~~~~~~--------~~~i~y~~~~~~l~v~~~~~~~~~~~~~~~ls~~~dL~~~  150 (586)
                      |++|.+++  ||+.+|||||+|++.|..+...        ..||+|++.++.|.|++....  +|.. |.+++.+||+++
T Consensus       130 T~~n~~~~~~d~~~~hvgid~n~~~s~~~~~~~~~~g~~~~~~i~y~~~~~~l~v~l~~~~--~~~~-~~ls~~vdL~~~  206 (239)
T d1dbna_         130 TYFAHSYDPWDPNYRHIGIDVNGIESIKTVQWDWINGGVAFATITYLAPNKTLIASLVYPS--NQTT-FSVAASVDLKEI  206 (239)
T ss_dssp             CCCCTTTCTTSCSSCEEEEEESSSSCSEEEECCCCTTCCEEEEEEEEGGGTEEEEEEEETT--TTEE-EEEEEECCHHHH
T ss_pred             eeecCCCCCCCCCCceeeEEcCCccccccccceEeCCceeEEEEEEcCCCCEEEEEEEecC--CCcc-EEEEEecchHHh
Confidence            99998764  7899999999999988765543        258999999999999998643  5555 889999999999


Q ss_pred             cccceeeeeecCCCcc--ceeeeeeecccccc
Q 007869          151 LNDAMYVGFSSSTGSV--LASHYILGWSFKIN  180 (586)
Q Consensus       151 l~~~~~vGFsastg~~--~~~~~i~~Wsf~~~  180 (586)
                      |+++||||||||||..  .|.|+|++|+|+++
T Consensus       207 l~~~vyvGFSAsTG~~~~~~~H~I~sWsFss~  238 (239)
T d1dbna_         207 LPEWVRVGFSAATGYPTEVETHDVLSWSFTST  238 (239)
T ss_dssp             SCSEEEEEEEEEECSGGGCCCCEEEEEEEEEE
T ss_pred             cCCcEEEEEEEeCCCCCCcceeEEEEEEeEEe
Confidence            9999999999999964  57899999999874

>d1g8wa_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Phytohemagglutinin-L, PHA-L, also arcelin
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=100.00  E-value=1.3e-36  Score=294.92  Aligned_cols=167  Identities=31%  Similarity=0.503  Sum_probs=145.3

Q ss_pred             CcccCCCCCCCCCCeeeeeEEEEEEEEEeCCCCCCCCcEEEEEecCCCCCCCCCCCcccccccCCCCCCCccEEEEEeec
Q 007869            2 PFKNKNSNSSTANGTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGLFNDTNLGNETNHVFAVELDT   81 (586)
Q Consensus         2 p~~~~~~~~~~~~~~~asF~t~F~f~i~~~~~~~~g~GlaF~l~p~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEfDt   81 (586)
                      ||+||++.+    +.++||+|+|+|.|.......+||||||+|+|.... .++.|++||+++..   +..++.|||||||
T Consensus        54 Pi~l~~~~~----~~~~sF~t~f~f~i~~~~~~~~gDGlAF~l~~~~~~-~g~~g~~lG~~~g~---~~~~~~vaVEFDT  125 (233)
T d1g8wa_          54 PIQIWDNTT----GTVASFATSFTFNIQVPNNAGPADGLAFALVPVGSQ-PKDKGGFLGLFDGS---NSNFHTVAVEFDT  125 (233)
T ss_dssp             CEECBCTTT----CCBEEEEEEEEEECCCCSSCBCCEEEEEEEEETTCC-CCCCGGGTTTCCSS---CCCCCCEEEEEEC
T ss_pred             CeEeecCCC----CceeeEEEEEEEEEecCCCCCCCCeEEEEEecCCCC-CCcccccCCccccC---CCcccEEEEEeec
Confidence            899999988    999999999999999877777999999999997654 45788999998764   3467889999999


Q ss_pred             cccCCCCCCCCCeeEEeCCCCcccccccC--------ceEEEEcCeeeEEEEEEeecCCCCCCccceeeeeecchhcccc
Q 007869           82 IKSHGFLDINDNHVGIDINSLKSESSAPA--------GYYVEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSVLND  153 (586)
Q Consensus        82 ~~~~~~~d~~~~hvgidvns~~s~~~~~~--------~~~i~y~~~~~~l~v~~~~~~~~~~~~~~~ls~~~dL~~~l~~  153 (586)
                      +.|.++ ||+.|||||++|++.+..+...        ..||+||+.+++|.|++....  +|.. |+++..+||+.+||+
T Consensus       126 ~~N~~~-d~~~~Hvgi~~n~~~s~~~~~~~~~~g~~~~~~I~yd~~~~~l~v~l~~~~--~~~~-~~l~~~vdL~~~l~~  201 (233)
T d1g8wa_         126 LYNKDW-DPTERHIGIDVNSIRSIKTTRWDFVNGENAEVLITYDSSTNLLVASLVYPS--QKTS-FIVSDTVDLKSVLPE  201 (233)
T ss_dssp             SCCTTT-CCSSCEEEEEESSSSCSEEEECCCCTTCCEEEEEEEETTTTEEEEEEEETT--TTEE-EEEEEECCHHHHSCS
T ss_pred             ccCCCC-CCCCCeEEEECCCcceeeeccccccCCcEEEEEEEEeCCCcEEEEEEEeCC--CCCc-EEEEEEechhHcCCC
Confidence            999875 9999999999999998766543        358999999999999998643  5555 899999999999999


Q ss_pred             ceeeeeecCCCc---cceeeeeeecccccc
Q 007869          154 AMYVGFSSSTGS---VLASHYILGWSFKIN  180 (586)
Q Consensus       154 ~~~vGFsastg~---~~~~~~i~~Wsf~~~  180 (586)
                      +|||||||+||.   ..|.|+|++|+|+++
T Consensus       202 ~~yvGFSAsTG~~~~~~~~h~I~sWsFss~  231 (233)
T d1g8wa_         202 WVSVGFSATTGINKGNVETNDVLSWSFASK  231 (233)
T ss_dssp             EEEEEEEEEECSSTTBCCCCEEEEEEEEEE
T ss_pred             cEEEEEEEEcCCCCCCceeeEEEEEEEEEE
Confidence            999999999994   468899999999974

>d1v6ia_ b.29.1.1 (A:) Legume lectin {Peanut (Arachis hypogaea) [TaxId: 3818]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Peanut (Arachis hypogaea) [TaxId: 3818]

Probab=100.00  E-value=1.3e-35  Score=288.16  Aligned_cols=169  Identities=29%  Similarity=0.354  Sum_probs=140.7

Q ss_pred             CcccCCCCCCCCCCeeeeeEEEEEEEEEeCCCCCCCCcEEEEEecCCCCCCCCCCCcccccccCCCCCCCccEEEEEeec
Q 007869            2 PFKNKNSNSSTANGTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGLFNDTNLGNETNHVFAVELDT   81 (586)
Q Consensus         2 p~~~~~~~~~~~~~~~asF~t~F~f~i~~~~~~~~g~GlaF~l~p~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEfDt   81 (586)
                      ||+||++.+    ++++||+|+|+|.|.......+||||||+|+|.......  +++.|++....+.+..++.|||||||
T Consensus        51 Pi~l~~~~~----~~~~sf~t~f~f~i~~~~~~~~gDG~AF~l~~~~~~~~~--~~~~g~~~~~~~~~~~~~~~aVEfDT  124 (232)
T d1v6ia_          51 PVRIWSSAT----GNVASFLTSFSFEMKDIKDYDPADGIIFFIAPEDTQIPA--GSIGGGTLGVSDTKGAGHFVGVEFDT  124 (232)
T ss_dssp             CEECBCTTT----CCBCEEEEEEEEEEECCSSSBCCCEEEEEEEETTCCCCT--TCCCGGGTTTSCTTSEEEEEEEEEEC
T ss_pred             CEEccCCCC----CccceeEEEEEEEeccCCCCCCCCeEEEEEECCCCCCCC--CccCCcccccccCCCCCceEEEEEEe
Confidence            899999988    999999999999999888888999999999997643322  22223332223345678999999999


Q ss_pred             cccCCCCCCCCCeeEEeCCCCcccccccC--------ceEEEEcCeeeEEEEEEeecCCCCCCccceeeeeecchhcccc
Q 007869           82 IKSHGFLDINDNHVGIDINSLKSESSAPA--------GYYVEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSVLND  153 (586)
Q Consensus        82 ~~~~~~~d~~~~hvgidvns~~s~~~~~~--------~~~i~y~~~~~~l~v~~~~~~~~~~~~~~~ls~~~dL~~~l~~  153 (586)
                      ++|.+++||+++|||||+|++.+......        ..||+||+.+++|.|++...   ++.. |.++..+||+.+||+
T Consensus       125 ~~n~~~~d~~~~Higid~n~~~s~~~~~~~~~~g~~~~v~I~Yd~~~~~L~V~~~~~---~~~~-~~l~~~vdL~~~l~~  200 (232)
T d1v6ia_         125 YSNSEYNDPPTDHVGIDVNSVDSVKTVPWNSVSGAVVKVTVIYDSSTKTLSVAVTND---NGDI-TTIAQVVDLKAKLPE  200 (232)
T ss_dssp             SCCGGGTCCSSCEEEEEEEESSCSEEEECCCCTTCEEEEEEEEETTTTEEEEEEECT---TSCE-EEEEEECCHHHHSCS
T ss_pred             EecCCCCCCCCccEeEeeCCcccccccccccCCCCEEEEEEEEeCCceEEEEEEecC---CCCc-ceEEEEEchhhccCC
Confidence            99998899999999999999987655432        36899999999999999853   4445 889999999999999


Q ss_pred             ceeeeeecCCCcc-ceeeeeeecccccc
Q 007869          154 AMYVGFSSSTGSV-LASHYILGWSFKIN  180 (586)
Q Consensus       154 ~~~vGFsastg~~-~~~~~i~~Wsf~~~  180 (586)
                      +||||||||||.. .|.|+|++|+|+++
T Consensus       201 ~vyvGFSAsTG~~~~~~H~I~sWsFss~  228 (232)
T d1v6ia_         201 RVKFGFSASGSLGGRQIHLIRSWSFTST  228 (232)
T ss_dssp             EEEEEEEEECCSSBCCEEEEEEEEEEEE
T ss_pred             cEEEEEEEECCCCCCcccEEEEeEeEEe
Confidence            9999999999975 59999999999975

>d1fnya_ b.29.1.1 (A:) Legume lectin {Black locust (Robinia pseudoacacia) [TaxId: 35938]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Black locust (Robinia pseudoacacia) [TaxId: 35938]

Probab=100.00  E-value=8.9e-36  Score=290.83  Aligned_cols=170  Identities=31%  Similarity=0.502  Sum_probs=145.8

Q ss_pred             CcccCCCCCCCCCCeeeeeEEEEEEEEEeCCCCCCCCcEEEEEecCCCCCCCCCCCcccccccCCCCCCCccEEEEEeec
Q 007869            2 PFKNKNSNSSTANGTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGLFNDTNLGNETNHVFAVELDT   81 (586)
Q Consensus         2 p~~~~~~~~~~~~~~~asF~t~F~f~i~~~~~~~~g~GlaF~l~p~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEfDt   81 (586)
                      ||+||++.+    ++++||+|+|+|.|.......+||||||+|+|.+..+ +..||+||+++... .+..++.+||||||
T Consensus        55 Pi~l~~~~~----~~~~sF~t~F~F~i~~~~~~~~gDG~AF~l~~~~~~~-~~~gg~lg~~~~~~-~~~~~~~~aVefDT  128 (237)
T d1fnya_          55 PFQIWDSTT----GNVASFVTSFTFIIQAPNPATTADGLAFFLAPVDTQP-LDLGGMLGIFKDGY-FNKSNQIVAVEFDT  128 (237)
T ss_dssp             CEECBCTTT----CCBCEEEEEEEEECCCSSTTSCCEEEEEEEEETTCCC-CCCGGGTTTCC----CCTTSCCEEEEEEC
T ss_pred             CeEcccCCC----CcceeeEEEEEEEEecCCCCCCCCeeEEEEcCCCCCc-ccccCcccccCCCC-ccCccceEEEEecc
Confidence            899999988    9999999999999988877889999999999976433 56788999987643 35678899999999


Q ss_pred             cccCCCCCCCCCeeEEeCCCCcccccccC--------ceEEEEcCeeeEEEEEEeecCCCCCCccceeeeeecchhcccc
Q 007869           82 IKSHGFLDINDNHVGIDINSLKSESSAPA--------GYYVEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSVLND  153 (586)
Q Consensus        82 ~~~~~~~d~~~~hvgidvns~~s~~~~~~--------~~~i~y~~~~~~l~v~~~~~~~~~~~~~~~ls~~~dL~~~l~~  153 (586)
                      +.|.++ ||+++||||++|++.|..+.+.        ..||+||+.+++|.|++....  ++.. |+++..+||+.+||+
T Consensus       129 ~~n~~~-d~~~~Higi~~n~~~s~~~~~~~~~~g~~~~v~I~Y~~~~~~l~v~l~~~~--~~~~-~~l~~~vdL~~~l~~  204 (237)
T d1fnya_         129 FSNGDW-DPKGRHLGINVNSIESIKTVPWNWTNGEVANVFISYEASTKSLTASLVYPS--LETS-FIIDAIVDVKIVLPE  204 (237)
T ss_dssp             SCCTTT-CCSSSEEEEEESSSSCSEEEECCCCTTCCEEEEEEEEGGGTEEEEEEEETT--TTEE-EEEEEECCHHHHSCS
T ss_pred             ccccCC-CCCCceEEEecCCCcccccccccccCCcEEEEEEEEeCCccEEEEEEEeCC--CCcc-eeEEEEechhhcCCC
Confidence            999876 9999999999999998765442        368999999999999998654  4555 899999999999999


Q ss_pred             ceeeeeecCCCc---cceeeeeeeccccccC
Q 007869          154 AMYVGFSSSTGS---VLASHYILGWSFKING  181 (586)
Q Consensus       154 ~~~vGFsastg~---~~~~~~i~~Wsf~~~~  181 (586)
                      +|||||||+||.   ..|.|+|++|+|+++.
T Consensus       205 ~~yvGFSAsTG~~s~~~e~H~I~sWsF~s~l  235 (237)
T d1fnya_         205 WVRFGFSATTGIDKGYVQTNDVLSWSFESNL  235 (237)
T ss_dssp             EEEEEEEEEECSSTTCCCCCEEEEEEEEEEE
T ss_pred             cEEEEEEEECCCCCCcccccEEEEeEeEEeC
Confidence            999999999994   4689999999999863

>d1n47a_ b.29.1.1 (A:) Legume lectin {Hairy vetch (Vicia villosa), isolectin b4 [TaxId: 3911]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Hairy vetch (Vicia villosa), isolectin b4 [TaxId: 3911]

Probab=100.00  E-value=2.5e-35  Score=286.35  Aligned_cols=166  Identities=30%  Similarity=0.498  Sum_probs=142.4

Q ss_pred             CcccCCCCCCCCCCeeeeeEEEEEEEEEeCCCCCCCCcEEEEEecCCCCCCCCCCCcccccccCCCCCCCccEEEEEeec
Q 007869            2 PFKNKNSNSSTANGTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGLFNDTNLGNETNHVFAVELDT   81 (586)
Q Consensus         2 p~~~~~~~~~~~~~~~asF~t~F~f~i~~~~~~~~g~GlaF~l~p~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEfDt   81 (586)
                      ||++|+.      +.++||+|+|+|.|.......+||||||+|+|.... .+..|++||+++.+.. +..++.|||||||
T Consensus        55 Pv~l~~~------~~~~sF~t~f~f~i~~~~~~~~gDGlAF~l~~~~~~-~~~~gg~lGl~~~~~~-~~~~~~~aVefDT  126 (233)
T d1n47a_          55 PIHIHDN------TTLASFTTSFSFVMAAPAAAAVADGLAFFLAPPDTQ-PQARGGFLGLFADRAH-DASYQTVAVEFDT  126 (233)
T ss_dssp             CEECBCS------SCBCEEEEEEEEECCCSSTTSCCEEEEEEEECTTCC-CCCCGGGTTTCSSSSC-CGGGCCEEEEEEC
T ss_pred             CEEccCC------CeeeeEEEEEEEEEeCCCCCCCCCceEEEECCCCCC-CCCCCCccccccccCC-CCcCceEEEEEEe
Confidence            8899986      348999999999998887788999999999987643 4567899999977654 4567889999999


Q ss_pred             cccCCCCCCCCCeeEEeCCCCcccccccC--------ceEEEEcCeeeEEEEEEeecCCCCCCccceeeeeecchhcccc
Q 007869           82 IKSHGFLDINDNHVGIDINSLKSESSAPA--------GYYVEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSVLND  153 (586)
Q Consensus        82 ~~~~~~~d~~~~hvgidvns~~s~~~~~~--------~~~i~y~~~~~~l~v~~~~~~~~~~~~~~~ls~~~dL~~~l~~  153 (586)
                      +.|.  +||++||||||+|++.|..+.++        ..||+||+.+++|.|++...  .+|.. |.+++.+||+.+|++
T Consensus       127 ~~n~--~d~~~~higi~~n~~~s~~~~~~~l~~g~~~~v~I~Y~~~~~~l~v~l~~~--~~~~~-~~ls~~vdL~~~l~~  201 (233)
T d1n47a_         127 YSNA--WDPNYTHIGIDTNGIESKKTTPFDMVYGEKANIVITYQASTKALAASLVFP--VSQTS-YAVSARVDLRDILPE  201 (233)
T ss_dssp             SCCT--TSCSSCEEEEEESSSSCSEEEECCCCTTSCEEEEEEEETTTTEEEEEEEET--TTTEE-EEEEEECCGGGTSCS
T ss_pred             eecC--CCCCCCceeEccCCccccccccceecCCCEEEEEEEEcCCCeEEEEEEEeC--CCCcc-EEEEEEechHHhcCC
Confidence            9986  59999999999999998765543        35899999999999999864  35655 899999999999999


Q ss_pred             ceeeeeecCCCc---cceeeeeeecccccc
Q 007869          154 AMYVGFSSSTGS---VLASHYILGWSFKIN  180 (586)
Q Consensus       154 ~~~vGFsastg~---~~~~~~i~~Wsf~~~  180 (586)
                      +|||||||+||.   ..|.|+|++|+|+++
T Consensus       202 ~vyvGFSAsTG~~~~~~~~H~I~sWsFss~  231 (233)
T d1n47a_         202 YVRVGFSATTGLNAGVVETHDIVSWSFAVS  231 (233)
T ss_dssp             EEEEEEEEEECSSTTCCCCCEEEEEEEEEE
T ss_pred             cEEEEEEEecCCCCCcccccEEEEEEeEEE
Confidence            999999999994   468999999999974

>d1ukga_ b.29.1.1 (A:) Legume lectin {Bloodwood tree (Pterocarpus angolensis) [TaxId: 182271]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Legume lectin
species: Bloodwood tree (Pterocarpus angolensis) [TaxId: 182271]

Probab=100.00  E-value=2e-34  Score=281.85  Aligned_cols=170  Identities=30%  Similarity=0.437  Sum_probs=146.2

Q ss_pred             CcccCCCCCCCCCCeeeeeEEEEEEEEEeCCCCCCCCcEEEEEecCC-CCCCCCCCCcccccccCC-CCCCCccEEEEEe
Q 007869            2 PFKNKNSNSSTANGTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTR-GLPGARPSQYLGLFNDTN-LGNETNHVFAVEL   79 (586)
Q Consensus         2 p~~~~~~~~~~~~~~~asF~t~F~f~i~~~~~~~~g~GlaF~l~p~~-~~~~~~~g~~lGl~~~~~-~~~~~~~~vaVEf   79 (586)
                      ||+||+..+    ++++||+|+|+|.|... ...+||||||+++|.. ..|....|+++|+++... .+...|+.+||||
T Consensus        55 Pi~l~~~~~----~~~~sF~t~F~f~i~~~-~~~~~~g~~f~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~n~~vaVEf  129 (241)
T d1ukga_          55 QVHLWEKSS----SRVANFQSQFSFSLKSP-LSNGADGIAFFIAPPDTTIPSGSGGGLLGLFAPGTAQNTSANQVIAVEF  129 (241)
T ss_dssp             CEECEETTT----TEEEEEEEEEEEEEECS-SSSCCCEEEEEEECTTCCCCTTCCGGGTTTSCGGGTTCGGGCCCEEEEE
T ss_pred             CeecccCCC----CceeeeEEEEEEEEecC-CCCCCCceEEEEeCCCCCcccccCcccccccccccccCCccCcccceec
Confidence            899999888    99999999999999765 4458999999999854 557777888888887654 3456889999999


Q ss_pred             eccccCCCC--CCCCCeeEEeCCCCcccccccC--------ceEEEEcCeeeEEEEEEeecCCCCCCccceeeeeecchh
Q 007869           80 DTIKSHGFL--DINDNHVGIDINSLKSESSAPA--------GYYVEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSS  149 (586)
Q Consensus        80 Dt~~~~~~~--d~~~~hvgidvns~~s~~~~~~--------~~~i~y~~~~~~l~v~~~~~~~~~~~~~~~ls~~~dL~~  149 (586)
                      ||+.|.+.+  ||++||||||+|++.|.++...        .+||+||+.+++|.|++...   +|.. |.+++.+||+.
T Consensus       130 Dt~~n~~~~~~~~~~~Higid~n~~~s~~~~~~~~~~g~~~~v~I~Yd~~~~~L~v~~~~~---~~~~-~~l~~~vdL~~  205 (241)
T d1ukga_         130 DTFYAQDSNTWDPNYPHIGIDVNSIRSVKTVKWDRRDGQSLNVLVTFNPSTRNLDVVATYS---DGTR-YEVSYEVDVRS  205 (241)
T ss_dssp             ECCCCTTTCTTSCSSCEEEEEESSSSCSEEEECCCCTTCCEEEEEEEETTTTEEEEEEEET---TCCE-EEEEEECCGGG
T ss_pred             cCEecCccCCCCCCCccEeeecCCcccccccccccCCCcEEEEEEEEeCCCcEEEEEEccC---CCCc-eEEEEEEehHH
Confidence            999986544  5889999999999998766542        36899999999999999863   5555 88999999999


Q ss_pred             ccccceeeeeecCCCccceeeeeeecccccc
Q 007869          150 VLNDAMYVGFSSSTGSVLASHYILGWSFKIN  180 (586)
Q Consensus       150 ~l~~~~~vGFsastg~~~~~~~i~~Wsf~~~  180 (586)
                      +|+++||||||||||...|.|+|++|+|+++
T Consensus       206 ~l~~~~yvGFSAsTG~~~~~H~IlsWsFss~  236 (241)
T d1ukga_         206 VLPEWVRVGFSAASGEQYQTHTLESWSFTST  236 (241)
T ss_dssp             TSCSEEEEEEEEEESSSCCEEEEEEEEEEEE
T ss_pred             hCCCcEEEEEEEecCCCCceeEEEEeEEEEE
Confidence            9999999999999999999999999999975

>d1ioaa_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris), G02771, arcelin-5a [TaxId: 3885]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Phytohemagglutinin-L, PHA-L, also arcelin
species: Kidney bean (Phaseolus vulgaris), G02771, arcelin-5a [TaxId: 3885]

Probab=99.98  E-value=1.5e-33  Score=273.22  Aligned_cols=166  Identities=27%  Similarity=0.439  Sum_probs=140.1

Q ss_pred             CcccCCCCCCCCCCeeeeeEEEEEEEEEeCCCCCCCCcEEEEEecCCCCCCCCCCCcccccccCCCCCCCccEEEEEeec
Q 007869            2 PFKNKNSNSSTANGTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGLFNDTNLGNETNHVFAVELDT   81 (586)
Q Consensus         2 p~~~~~~~~~~~~~~~asF~t~F~f~i~~~~~~~~g~GlaF~l~p~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEfDt   81 (586)
                      ||++|+.      ++++||+|+|+|.|.+.+...+||||||+|+|... +.+..|++||+++.+. ++..++.|||||||
T Consensus        55 Pv~l~~~------~~~~sFst~F~f~i~~~~~~~~gDGlAF~l~~~~~-~~~~~g~~lgl~~~~~-~~~~~~~vave~dt  126 (228)
T d1ioaa_          55 PIQIKDS------NNVASFNTNFTFIIRAKNQSISAYGLAFALVPVNS-PPQKKQEFLGIFNTNN-PEPNARTVAVVFNT  126 (228)
T ss_dssp             CEECBCS------SCBEEEEEEEEEECCBSCTTSCCEEEEEEEEETTC-CCCCCGGGTTTCCCSS-CCGGGCCEEEEEET
T ss_pred             ceEecCC------CceeeEEEEEEEEEecCCCCCCCCEEEEEEeCCCC-CCCCCccccccccccC-CCCcceeEEEEecC
Confidence            8899974      66999999999999988777899999999999764 4456788999998654 45678899999999


Q ss_pred             cccCCCCCCCCCeeEEeCCCCccccc---ccCceEEEEcCeeeEEEEEEeecCCCCCCccceeeeeecchhccccceeee
Q 007869           82 IKSHGFLDINDNHVGIDINSLKSESS---APAGYYVEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSVLNDAMYVG  158 (586)
Q Consensus        82 ~~~~~~~d~~~~hvgidvns~~s~~~---~~~~~~i~y~~~~~~l~v~~~~~~~~~~~~~~~ls~~~dL~~~l~~~~~vG  158 (586)
                      +.|.  .|++.+|+++++++..+...   .....||+||+.+++|.|++...  .+|.. |++++.+||+++|+++||||
T Consensus       127 ~~n~--~~~~~~~~~~~~~~~~~~~~~~g~~~~v~I~Yd~~~~~l~V~l~~~--~~~~~-~~ls~~vdL~~~l~~~vyvG  201 (228)
T d1ioaa_         127 FKNR--IDFDKNFIKPYVNENCDFHKYNGEKTDVQITYDSSNNDLRVFLHFT--VSQVK-CSVSATVHLEKEVDEWVSVG  201 (228)
T ss_dssp             TTTE--EEEEESSSSCSEEEECCHHHHCSSCEEEEEEEETTTTEEEEEEEET--TTCCE-EEEEEECCGGGTSCSEEEEE
T ss_pred             cccc--ccCCCCccceecccccccccccCcEEEEEEEEcCCCCEEEEEEEeC--CCCce-eeEEEEEchHHcCCCcEEEE
Confidence            9885  58889999999887654322   23457999999999999999874  35666 89999999999999999999


Q ss_pred             eecCCC---ccceeeeeeecccccc
Q 007869          159 FSSSTG---SVLASHYILGWSFKIN  180 (586)
Q Consensus       159 Fsastg---~~~~~~~i~~Wsf~~~  180 (586)
                      ||||||   ...|.|+|++|+|+++
T Consensus       202 FSAsTG~~~~~~~~h~I~sWsFss~  226 (228)
T d1ioaa_         202 FSPTSGLTEDTTETHDVLSWSFSSK  226 (228)
T ss_dssp             EEEEECSSTTTCBCCEEEEEEEEEE
T ss_pred             EEeecCCCCCCceEEEEEEEEeEEe
Confidence            999999   4568999999999974

>d1avba_ b.29.1.1 (A:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Phytohemagglutinin-L, PHA-L, also arcelin
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.97  E-value=6.1e-32  Score=261.53  Aligned_cols=162  Identities=28%  Similarity=0.445  Sum_probs=139.3

Q ss_pred             CCcccCCCCCCCCCCeeeeeEEEEEEEEEeCCCCCCCCcEEEEEecCCCCCCCCCCCcccccccCCCCCCCccEEEEEee
Q 007869            1 MPFKNKNSNSSTANGTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGLFNDTNLGNETNHVFAVELD   80 (586)
Q Consensus         1 ~p~~~~~~~~~~~~~~~asF~t~F~f~i~~~~~~~~g~GlaF~l~p~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEfD   80 (586)
                      .||++|++.+    +.++||+|+|+|.|.+.....+||||||+++|....+ +..|+++|+++.          ++||||
T Consensus        50 ~Pv~l~~~~~----~~~~sF~t~f~f~i~~~~~~~~gDG~aF~i~~~~~~~-g~~gg~~gl~~~----------~~v~fd  114 (226)
T d1avba_          50 APIQINDRTI----DNLASFSTNFTFRINAKNIENSAYGLAFALVPVGSRP-KLKGRYLGLFNT----------TNYDRD  114 (226)
T ss_dssp             SCEECEEGGG----TEEEEEEEEEEEEEEESSTTSCCEEEEEEEEETTCCC-CCCGGGTTTCSC----------SSCCGG
T ss_pred             CCeEcccCCC----CcccceEEEEEEEEecCCCCCCCceEEEEEccCCCCC-CCccccCCcccc----------cccccc
Confidence            3899999988    9999999999999998878889999999999976443 467889999764          368999


Q ss_pred             ccccCCCCCCCCCeeEEeCCCCcccccccC----------ceEEEEcCeeeEEEEEEeecCCCCCCccceeeeeecchhc
Q 007869           81 TIKSHGFLDINDNHVGIDINSLKSESSAPA----------GYYVEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSV  150 (586)
Q Consensus        81 t~~~~~~~d~~~~hvgidvns~~s~~~~~~----------~~~i~y~~~~~~l~v~~~~~~~~~~~~~~~ls~~~dL~~~  150 (586)
                      |+.|...+|+..||||||+|+..+..+...          ..||+||+.+++|.|++....  +|.. |.++..+||+.+
T Consensus       115 t~~~~~~~d~~~nhi~i~~n~~~s~~~~~~~~~~~~g~~~~v~I~Yd~~~~~L~V~l~~~~--~~~~-~~~~~~vdL~~~  191 (226)
T d1avba_         115 AHTVAVVFDTVSNRIEIDVNSIRPIATESCNFGHNNGEKAEVRITYDSPKNDLRVSLLYPS--SEEK-CHVSATVPLEKE  191 (226)
T ss_dssp             GCCEEEEEETTTTEEEEEESSSSCSEEEECCSGGGTTCEEEEEEEEEGGGTEEEEEEEETT--TTEE-EEEEEECCHHHH
T ss_pred             ceeccccccCCCCEEEEeCCCCccccccccccccCCCeEEEEEEEEcCCCcEEEEEEEeCC--CCcc-EEEEEEecHHHc
Confidence            999876569999999999999988765442          358999999999999998753  5555 889999999999


Q ss_pred             cccceeeeeecCCCc---cceeeeeeecccccc
Q 007869          151 LNDAMYVGFSSSTGS---VLASHYILGWSFKIN  180 (586)
Q Consensus       151 l~~~~~vGFsastg~---~~~~~~i~~Wsf~~~  180 (586)
                      ||++|||||||+||.   ..|.|+|++|+|+++
T Consensus       192 l~~~~y~GFSAaTG~~s~~~~~H~IlsWsF~s~  224 (226)
T d1avba_         192 VEDWVSVGFSATSGSKKETTETHNVLSWSFSSN  224 (226)
T ss_dssp             SCSEEEEEEEEEECSSGGGCEEEEEEEEEEEEE
T ss_pred             cCCcEEEEEEEEcCCCCCCeeeeEEEEEEeEEe
Confidence            999999999999995   468999999999974

>d1dhkb_ b.29.1.1 (B:) Phytohemagglutinin-L, PHA-L, also arcelin {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Phytohemagglutinin-L, PHA-L, also arcelin
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.96  E-value=4.7e-30  Score=243.97  Aligned_cols=153  Identities=27%  Similarity=0.436  Sum_probs=125.3

Q ss_pred             CcccCCCCCCCCCCeeeeeEEEEEEEEEeCCCCCCCCcEEEEEecCCCCCCCCCCCcccccccCCCCCCCccEEEEEeec
Q 007869            2 PFKNKNSNSSTANGTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGLFNDTNLGNETNHVFAVELDT   81 (586)
Q Consensus         2 p~~~~~~~~~~~~~~~asF~t~F~f~i~~~~~~~~g~GlaF~l~p~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEfDt   81 (586)
                      ||+||++.+    ++++||+|+|+|.|.+.....+||||||+++|...                   ...++.+||||||
T Consensus        48 Pi~l~~~~~----~~~~sF~t~F~f~i~~~~~~~~gdGlaf~~~~~~~-------------------~~~~~~~~vefDt  104 (204)
T d1dhkb_          48 PIQIRDSTT----GNVASFDTNFTMNIRTHRQANSAVGLDFVLVPVQP-------------------ESKGDTVTVEFDT  104 (204)
T ss_dssp             CEESEETTT----TEECEEEEEEEEEEECCC---CCSEEEEEEEEC-------------------------CCEEEEEET
T ss_pred             CEeccCCCC----cccccEEEEEEEEEecCCCCCCCceEEEEecCCCC-------------------CCCCcEeeEeeEc
Confidence            899999988    99999999999999988777799999999998532                   2345679999999


Q ss_pred             cccCCCCCCCCCeeEEeCCCCcccccccCceEEEEcCeeeEEEEEEeecCCCCCCccceeeeeecchhccccceeeeeec
Q 007869           82 IKSHGFLDINDNHVGIDINSLKSESSAPAGYYVEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSVLNDAMYVGFSS  161 (586)
Q Consensus        82 ~~~~~~~d~~~~hvgidvns~~s~~~~~~~~~i~y~~~~~~l~v~~~~~~~~~~~~~~~ls~~~dL~~~l~~~~~vGFsa  161 (586)
                      +.|....|++.+|++...............+||+||+.+++|+|++....  +|.. +.|++.+||+.+||++|||||||
T Consensus       105 ~~n~~~~d~~~~~~~~~~~~~~~~~g~~~~v~I~Yd~~~~~L~V~l~~~~--~~~~-~~l~~~vdL~~~l~~~~yvGFSA  181 (204)
T d1dhkb_         105 FLSRISIDVNNNDIKSVPWDVHDYDGQNAEVRITYNSSTKVFSVSLSNPS--TGKS-NNVSTTVELEKEVYDWVSVGFSA  181 (204)
T ss_dssp             TTTEEEEEETTEEEEEEECCGGGTTTSCEEEEEEEETTTTEEEEEEECTT--TCCE-EEEEEECCCCSGGGSEEEEEEEE
T ss_pred             ccccccCccccccccccccccEecCCCEEEEEEEEcCCCEEEEEEEecCC--CCCc-eeEEEEecchhccCCcEEEEEEe
Confidence            98876667888888877766655555566789999999999999998654  4545 88999999999999999999999


Q ss_pred             CCCcc---ceeeeeeecccccc
Q 007869          162 STGSV---LASHYILGWSFKIN  180 (586)
Q Consensus       162 stg~~---~~~~~i~~Wsf~~~  180 (586)
                      |||..   .|.|+|++|+|+++
T Consensus       182 aTG~~~~~~e~H~IlsWsFss~  203 (204)
T d1dhkb_         182 TSGAYQWSYETHDVLSWSFSSK  203 (204)
T ss_dssp             EECSGGGSCCEEEEEEEEEEEE
T ss_pred             ecCCCCCCceeeEEEEEEEEec
Confidence            99964   58899999999864

>d1nlsa_ b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia ensiformis) [TaxId: 3823]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Concanavalin A
species: Jack bean (Canavalia ensiformis) [TaxId: 3823]

Probab=99.94  E-value=1e-27  Score=229.43  Aligned_cols=106  Identities=35%  Similarity=0.507  Sum_probs=96.6

Q ss_pred             CccEEEEEeeccccCCCCCCCCCeeEEeCCCCcccccccC--------ceEEEEcCeeeEEEEEEeecCCCCCCccceee
Q 007869           71 TNHVFAVELDTIKSHGFLDINDNHVGIDINSLKSESSAPA--------GYYVEYDGLEKRTNVTLAPINIPRPRSLNTMS  142 (586)
Q Consensus        71 ~~~~vaVEfDt~~~~~~~d~~~~hvgidvns~~s~~~~~~--------~~~i~y~~~~~~l~v~~~~~~~~~~~~~~~ls  142 (586)
                      +|++|||||||++|.+++||++||||||+|++.|.++.++        ..||+||+.+++|.|++..   .+|.. |+++
T Consensus         1 an~ivAVEFDT~~N~~~~Dp~~nHIgIdvns~~S~~~~~~~l~~G~~~~v~I~Yd~~~~~L~V~~~~---~~~~~-~~ls   76 (237)
T d1nlsa_           1 ADTIVAVELDTYPNTDIGDPSYPHIGIDIKSVRSKKTAKWNMQNGKVGTAHIIYNSVDKRLSAVVSY---PNADS-ATVS   76 (237)
T ss_dssp             CCCEEEEEEECSCCGGGTCCSSCEEEEEESSSSCSEEEECCCCTTCEEEEEEEEETTTTEEEEEEEC---TTSCC-EEEE
T ss_pred             CCCEEEEEEECCcCCCCCCCCCCEEEEEeCCCCccceecccccCCCEEEEEEEEecCCcEEEEEEec---CCCCC-eEEE
Confidence            4899999999999998899999999999999999877654        3589999999999999984   35555 8999


Q ss_pred             eeecchhccccceeeeeecCCCccceeeeeeecccccc
Q 007869          143 LSRDLSSVLNDAMYVGFSSSTGSVLASHYILGWSFKIN  180 (586)
Q Consensus       143 ~~~dL~~~l~~~~~vGFsastg~~~~~~~i~~Wsf~~~  180 (586)
                      +.+||+++|+++||||||||||...|.|+|++|+|++.
T Consensus        77 ~~vdL~~~l~~~vyvGFSAsTG~~~~~h~I~sWsFsS~  114 (237)
T d1nlsa_          77 YDVDLDNVLPEWVRVGLSASTGLYKETNTILSWSFTSK  114 (237)
T ss_dssp             EECCGGGTSCSEEEEEEEEECSSSCCCCEEEEEEEEEE
T ss_pred             EEEChHHhCCCcEEEEEEeecCCCccceEEEEEEEEee
Confidence            99999999999999999999999999999999999875

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.88  E-value=3.7e-23  Score=194.20  Aligned_cols=163  Identities=14%  Similarity=0.073  Sum_probs=119.8

Q ss_pred             ccceeEeecCceEEEEEEeCCCCeEEEEEEeccccc------------------hhHHHHHHHHHHhcccCCCceeeeee
Q 007869          264 REKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESR------------------QGMKEFVAEIVSIGRLRHRNLVQLLG  325 (586)
Q Consensus       264 ~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~Ei~~l~~l~H~niv~l~~  325 (586)
                      ...++||+|+||.||+|++. ++..||||+++....                  ........|...+.++.|.+++..++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~   81 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA   81 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred             hhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence            45789999999999999985 578899998753210                  11233567888999999999988876


Q ss_pred             eeeccCeEEEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhcccCCcEEeCCCCCCCeeecCCCCeEEc
Q 007869          326 YCRRKGELLLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEWEQVVIHRDVKASNVLLDGELNGRLG  405 (586)
Q Consensus       326 ~~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~~~~ivHrDIkp~NIll~~~~~~kL~  405 (586)
                      +..    .+++|||+++..+.+         ++......++.|++++|.|||+   ++|+||||||+|||++++ .++|+
T Consensus        82 ~~~----~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~---~giiHrDiKP~NILv~~~-~~~li  144 (191)
T d1zara2          82 WEG----NAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVSEE-GIWII  144 (191)
T ss_dssp             EET----TEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEETT-EEEEC
T ss_pred             ecC----CEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhh---CCEEEccCChhheeeeCC-CEEEE
Confidence            532    379999998765543         3334556789999999999998   899999999999999965 59999


Q ss_pred             cccceeeccCCCCCceeeeccCCCccCc------ccccCCCCCCcceEEehhHHH
Q 007869          406 DFGLARLYDHGTDPQTTHVVGTLGYLAP------EHTRTGKATTSADVFSFGAFL  454 (586)
Q Consensus       406 DFGla~~~~~~~~~~~~~~~gt~~y~aP------E~~~~~~~s~ksDVyS~Gvvl  454 (586)
                      |||+|+...+....         .|...      |. ..++|+.++|+||..--+
T Consensus       145 DFG~a~~~~~~~~~---------~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         145 DFPQSVEVGEEGWR---------EILERDVRNIITY-FSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             CCTTCEETTSTTHH---------HHHHHHHHHHHHH-HHHHHCCCCCHHHHHHHH
T ss_pred             ECCCcccCCCCCcH---------HHHHHHHHHHHHH-HcCCCCCcccHHHHHHHH
Confidence            99999876533211         01111      11 235678899999976444

>d1gv9a_ b.29.1.13 (A:) Carbohydrate-recognition domain of P58/ERGIC-53 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Lectin leg-like
domain: Carbohydrate-recognition domain of P58/ERGIC-53
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.73  E-value=7e-18  Score=162.26  Aligned_cols=148  Identities=12%  Similarity=0.132  Sum_probs=99.5

Q ss_pred             CeeeeeEEEEEEEEEeCCCCCCCCcEEEEEecCCCCCCCCCCCcccccccCCCCCCCccEEEEEeeccccCCCCCCCCCe
Q 007869           15 GTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGLFNDTNLGNETNHVFAVELDTIKSHGFLDINDNH   94 (586)
Q Consensus        15 ~~~asF~t~F~f~i~~~~~~~~g~GlaF~l~p~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEfDt~~~~~~~d~~~~h   94 (586)
                      -.+.+|+|+|+|.+... ...+||||||+++|..    +..|+.+|.       ...++-+||||||+.|.  ++++.+|
T Consensus        58 ~~~~~F~~~f~f~~~~~-~~~ggdG~aF~i~~~~----~~~g~~~G~-------~~~~~glaVefDt~~n~--~~~~~~~  123 (228)
T d1gv9a_          58 AAFENWEVEVTFRVTGR-GRIGADGLAIWYTENQ----GLDGPVFGS-------ADMWNGVGIFFDSFDND--GKKNNPA  123 (228)
T ss_dssp             BCCSSEEEEEEEEEECS-SSCCCCEEEEEEESSC----CCEEEETTE-------CSCCEEEEEEEECCCC-------CCE
T ss_pred             ccccCcEEEEEEeccCC-CCCCCCEEEEEEecCC----CCCCCccCc-------CCCCceEEEEEEccccc--CCCCCCc
Confidence            34678999999999763 4568999999999754    234556665       22334589999999986  4777888


Q ss_pred             eEEeCCCCccccc-------------------ccCceEEEEcCeeeEEEEEEeecCCCCCCccceeeeeecchhccccce
Q 007869           95 VGIDINSLKSESS-------------------APAGYYVEYDGLEKRTNVTLAPINIPRPRSLNTMSLSRDLSSVLNDAM  155 (586)
Q Consensus        95 vgidvns~~s~~~-------------------~~~~~~i~y~~~~~~l~v~~~~~~~~~~~~~~~ls~~~dL~~~l~~~~  155 (586)
                      +.+++|.......                   .....+|.|+...+.++|++.......... ......++ ...++++|
T Consensus       124 ~~~~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~l~v~i~~~~~~~~~~-~~~~~~~~-~~~l~~~~  201 (228)
T d1gv9a_         124 IVVVGNNGQINYDHQNDGATQALASCQRDFRNKPYPVRAKITYYQKTLTVMINNGFTPDKND-YEFCAKVE-NMVIPTQG  201 (228)
T ss_dssp             EEEEEEESCCCCCHHHHHHHHCSEEECCCCBSCSSCEEEEEEEETTEEEEEEECSSCCCTTC-CEEEEEET-TCCCCSSB
T ss_pred             EEEEecCCcceeeecCCCccccccceeeeecCCceEEEEEEEecCCEEEEEEeccccCCCcc-eeEEEEec-ccccCCCE
Confidence            8877664331100                   001234666666788999987544333322 33333333 55689999


Q ss_pred             eeeeecCCCccceeeeeeecccc
Q 007869          156 YVGFSSSTGSVLASHYILGWSFK  178 (586)
Q Consensus       156 ~vGFsastg~~~~~~~i~~Wsf~  178 (586)
                      |+|||||||...+.|.|++|.+.
T Consensus       202 y~GFTAsTG~~~~~H~I~s~~~~  224 (228)
T d1gv9a_         202 HFGISAATGGLADDHDVLSFLTF  224 (228)
T ss_dssp             EEEEEEECCSSCCEEEEEEEEEE
T ss_pred             EEEEEEeCCCCcCeEEEEEEEEE
Confidence            99999999999999999999875

>d1nlsa_ b.29.1.1 (A:) Concanavalin A {Jack bean (Canavalia ensiformis) [TaxId: 3823]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Legume lectins
domain: Concanavalin A
species: Jack bean (Canavalia ensiformis) [TaxId: 3823]

Probab=99.34  E-value=3.7e-13  Score=127.57  Aligned_cols=60  Identities=40%  Similarity=0.593  Sum_probs=51.9

Q ss_pred             CCcccCCCCCCCCCCeeeeeEEEEEEEEEeCCCCCCCCcEEEEEecCC-CCCCCCCCCcccccccCC
Q 007869            1 MPFKNKNSNSSTANGTVFSFSTTFVFSILSEYQSQSGHGIAFVIASTR-GLPGARPSQYLGLFNDTN   66 (586)
Q Consensus         1 ~p~~~~~~~~~~~~~~~asF~t~F~f~i~~~~~~~~g~GlaF~l~p~~-~~~~~~~g~~lGl~~~~~   66 (586)
                      -||+|||. +    ++++||+|+|+|.|.+.. ..+||||||||+|.. .+|.++.|+||||||.++
T Consensus       177 ~Pv~l~d~-t----~~~~SFsT~F~F~I~~~~-~~~gdG~aF~iap~~~~~p~~~~g~~LGL~n~~n  237 (237)
T d1nlsa_         177 APVHIWES-S----AVVASFEATFTFLIKSPD-SHPADGIAFFISNIDSSIPSGSTGRLLGLFPDAN  237 (237)
T ss_dssp             SCEECCCT-T----EEEEEEEEEEEEECCCSS-SSCCCEEEEEEECTTCCCCTTCCGGGTTTCSSCC
T ss_pred             CCEEEECC-C----CcEeeEEEEEEEEEecCC-CCCCCCEEEEEeCCCCCCCCCCCCCeeeeccCCC
Confidence            39999985 5    899999999999998754 568999999999964 678889999999999763

>d2a6va1 b.29.1.13 (A:9-226) Emp46p N-terminal domain {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Lectin leg-like
domain: Emp46p N-terminal domain
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.26  E-value=1.5e-11  Score=116.03  Aligned_cols=135  Identities=13%  Similarity=0.105  Sum_probs=80.8

Q ss_pred             eeEEEEEEEEEeCCCCCCCCcEEEEEecCCCCCC-CCCCCcccccccCCCCCCCccEEEEEeeccccCCCCCCCCCeeEE
Q 007869           19 SFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPG-ARPSQYLGLFNDTNLGNETNHVFAVELDTIKSHGFLDINDNHVGI   97 (586)
Q Consensus        19 sF~t~F~f~i~~~~~~~~g~GlaF~l~p~~~~~~-~~~g~~lGl~~~~~~~~~~~~~vaVEfDt~~~~~~~d~~~~hvgi   97 (586)
                      +|+++|+|.|... ...+||||||.+.+...... +..+|..+.|+         . +||||||+.|.      .+||.+
T Consensus        60 ~f~i~~~F~i~g~-~~~~~dG~afw~~~~~~~~~~~~~~G~~~~f~---------G-laV~fDt~~n~------~~~i~~  122 (218)
T d2a6va1          60 AMTIEWTFRSFGF-RGSTKGGLAFWLKQGNEGDSTELFGGSSKKFN---------G-LMILLRLDDKL------GESVTA  122 (218)
T ss_dssp             CEEEEEEEEEESC-CSCCSCEEEEEEECSCCCCCCTBTTTBCSSCE---------E-EEEEEEEETTT------EEEEEE
T ss_pred             cceEEEEEEEeCC-CCCCCCcEEEEEEcCCcccCCCcccccCCCcc---------e-EEEEEECCCCC------CCeEEE
Confidence            5999999999864 45689999999996432111 11122233322         2 79999998763      367777


Q ss_pred             eCCCCccc---cc-ccC-ce-------------EEEEcCeee-EEEEEEeecCCCCCCccceeeeeecchhccccceeee
Q 007869           98 DINSLKSE---SS-APA-GY-------------YVEYDGLEK-RTNVTLAPINIPRPRSLNTMSLSRDLSSVLNDAMYVG  158 (586)
Q Consensus        98 dvns~~s~---~~-~~~-~~-------------~i~y~~~~~-~l~v~~~~~~~~~~~~~~~ls~~~dL~~~l~~~~~vG  158 (586)
                      .+|.-...   .+ ... ..             .|.|+..+. .+.|.+..       +.|+-...|+|  ..++++|+|
T Consensus       123 ~~ndGs~~~~~~~d~~~g~c~~~~~~~~~~~~~~i~Y~~~~~~~l~v~id~-------~~c~~t~~i~l--p~~~~~yfG  193 (218)
T d2a6va1         123 YLNDGTKDLDIESSPYFASCLFQYQDSMVPSTLRLTYNPLDNHLLKLQMDN-------RVCFQTRKVKF--MGSSPFRIG  193 (218)
T ss_dssp             EEEESSSCCCTTTSCCSEEEECCCSSCSSCEEEEEEEEGGGTSEEEEEETT-------EEEEEESCCCG--GGTSCBEEE
T ss_pred             EeCCCCccccccCCcccceEEecccCCCCcEEEEEEEECcccceEEEEeCC-------cEEEEECCeec--CCCCcEEEE
Confidence            65532110   00 011 11             255554332 23443320       11333333444  245679999


Q ss_pred             eecCCCccceeeeeeeccccc
Q 007869          159 FSSSTGSVLASHYILGWSFKI  179 (586)
Q Consensus       159 Fsastg~~~~~~~i~~Wsf~~  179 (586)
                      |||+||...+.|.|++|++..
T Consensus       194 ~SA~Tg~~~d~~dIls~~~~~  214 (218)
T d2a6va1         194 TSAINDASKESFEILKMKLYD  214 (218)
T ss_dssp             EEEECCTTCCEEEEEEEEEES
T ss_pred             EEECCCCCcCcEEEEEEEEEe
Confidence            999999999999999999864

>d2a6za1 b.29.1.13 (A:7-227) Emp47p N-terminal domain {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: All beta proteins
fold: Concanavalin A-like lectins/glucanases
superfamily: Concanavalin A-like lectins/glucanases
family: Lectin leg-like
domain: Emp47p N-terminal domain
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.18  E-value=1.1e-10  Score=110.47  Aligned_cols=133  Identities=13%  Similarity=0.120  Sum_probs=74.6

Q ss_pred             eeEEEEEEEEEeCCCCCCCCcEEEEEecCCCCCCCCCCCcccccccCCCCCCCccEEEEEeeccccCCCCCCCCCeeEEe
Q 007869           19 SFSTTFVFSILSEYQSQSGHGIAFVIASTRGLPGARPSQYLGLFNDTNLGNETNHVFAVELDTIKSHGFLDINDNHVGID   98 (586)
Q Consensus        19 sF~t~F~f~i~~~~~~~~g~GlaF~l~p~~~~~~~~~g~~lGl~~~~~~~~~~~~~vaVEfDt~~~~~~~d~~~~hvgid   98 (586)
                      +|+++|.|+|... ...+||||||++++....  ...|+++|.-+       ...-+||||||+.|.    ....|+.++
T Consensus        61 ~f~~~~~F~i~g~-~~~ggdG~af~~~~~~~~--~~~g~~~G~~~-------~~~GlaV~fDt~~n~----~~~~~~~~n  126 (221)
T d2a6za1          61 SFTMEWTFRSVGY-SGQTDGGISFWFVQDSNI--PRDKQLYNGPV-------NYDGLQLLVDNNGPL----GPTLRGQLN  126 (221)
T ss_dssp             CEEEEEEEEEESC-CSCCSCEEEEEEEECSSS--CCCCTBTTBCT-------TCEEEEEEEESCSTT----SSEEEEEEE
T ss_pred             CeEEEEEEEEeCC-CCCCCCcEEEEEEcCCCc--cccccccccCC-------CCceEEEEEECCCCC----CCceEEEec
Confidence            5999999999864 456899999999975422  23445555411       123389999998773    222233444


Q ss_pred             CCCCcccccc----cC-c-------------eEEEEcCeeeE-EEEEEeecCCCCCCccceeeeeecchhccccceeeee
Q 007869           99 INSLKSESSA----PA-G-------------YYVEYDGLEKR-TNVTLAPINIPRPRSLNTMSLSRDLSSVLNDAMYVGF  159 (586)
Q Consensus        99 vns~~s~~~~----~~-~-------------~~i~y~~~~~~-l~v~~~~~~~~~~~~~~~ls~~~dL~~~l~~~~~vGF  159 (586)
                      .++..-....    .. .             ..|.|+..++. +.|.+..       ..|.-...+.   +.++.+|+||
T Consensus       127 dgt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~I~y~~~~~~~l~v~id~-------~~c~~~~~v~---lp~~~~~fG~  196 (221)
T d2a6za1         127 DGQKPVDKTKIYDQSFASCLMGYQDSSVPSTIRVTYDLEDDNLLKVQVDN-------KVCFQTRKVR---FPSGSYRIGV  196 (221)
T ss_dssp             ESSSCCCGGGHHHHCSEEEECCCTTEEEEEEEEEEEEGGGTSEEEEEETT-------EEEEEESCCC---CCSSEEEEEE
T ss_pred             CCCccccccCCcccccceeeecccCCCCCEEEEEEEecCccceEEEEecC-------cEeEEECCee---cCCCCEEEEE
Confidence            3333211110    01 1             23555543332 4444421       1121111122   2256789999


Q ss_pred             ecCCCccceeeeeeec
Q 007869          160 SSSTGSVLASHYILGW  175 (586)
Q Consensus       160 sastg~~~~~~~i~~W  175 (586)
                      ||+||...+.|.+..+
T Consensus       197 SA~TG~~~~~hd~~~i  212 (221)
T d2a6za1         197 TAQNGAVNNNAESFEI  212 (221)
T ss_dssp             EEECCSGGGCCCEEEE
T ss_pred             EEccCCccCCCceEEE
Confidence            9999998888886655

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.54  E-value=1.7e-07  Score=89.80  Aligned_cols=149  Identities=15%  Similarity=0.070  Sum_probs=101.1

Q ss_pred             hhhhhcCCcccceeEeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccC-CCceeeeeeeeeccCeE
Q 007869          255 DLYIATKGFREKELLGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLR-HRNLVQLLGYCRRKGEL  333 (586)
Q Consensus       255 el~~a~~~f~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~-H~niv~l~~~~~~~~~~  333 (586)
                      |+..--.+|+..+..+.+....||+...  ++..+.||+...........+.+|...+..+. +--+.+++.++...+..
T Consensus         8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~   85 (263)
T d1j7la_           8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS   85 (263)
T ss_dssp             HHHHHHTTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred             HHHHhhhceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence            3444445666555544445578998864  34457889887665544456778888877663 33367788888888899


Q ss_pred             EEEEecCCCCChhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhccc---------------------------------
Q 007869          334 LLVYDYMPNGSLDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQEW---------------------------------  380 (586)
Q Consensus       334 ~lV~E~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~~~---------------------------------  380 (586)
                      ++|||++++.++.+.....       .....++.++++.|..||+..                                 
T Consensus        86 ~lv~~~l~G~~~~~~~~~~-------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (263)
T d1j7la_          86 NLLMSEADGVLCSEEYEDE-------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW  158 (263)
T ss_dssp             EEEEECCSSEEHHHHTTTC-------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred             EEEEEeccccccccccccc-------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence            9999999998886654221       112234555666666666310                                 


Q ss_pred             -----------------------CCcEEeCCCCCCCeeecCCCCeEEccccceee
Q 007869          381 -----------------------EQVVIHRDVKASNVLLDGELNGRLGDFGLARL  412 (586)
Q Consensus       381 -----------------------~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~  412 (586)
                                             ...++|+|+.|.|||++++...-|+||+.+..
T Consensus       159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                   12489999999999999876667999998764

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.95  E-value=2.3e-05  Score=74.01  Aligned_cols=131  Identities=18%  Similarity=0.124  Sum_probs=83.9

Q ss_pred             eEeecCc-eEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCC--CceeeeeeeeeccCeEEEEEecCCCCC
Q 007869          268 LLGTGGF-GRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRH--RNLVQLLGYCRRKGELLLVYDYMPNGS  344 (586)
Q Consensus       268 ~LG~G~~-g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H--~niv~l~~~~~~~~~~~lV~E~~~~gs  344 (586)
                      .+..|.. +.||+....+ +..+.+|.......   ..+..|...++.+..  -.+.++++++.+.+..++|||++++.+
T Consensus        17 ~~~~G~s~~~v~r~~~~~-~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~   92 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQG-RPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQD   92 (255)
T ss_dssp             ECSCTTSSCEEEEEECTT-SCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEE
T ss_pred             EcCCcccCCeEEEEEeCC-CCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccc
Confidence            3445553 5789998744 55688888755432   245667777776632  336678888888888999999998876


Q ss_pred             hhhhhhcCCCccchhHHHHHHHHHHHHHHHHhhc----------------------------------------------
Q 007869          345 LDKYLYDQPKVTLNWIQRFRVIKGVALGLFYLHQ----------------------------------------------  378 (586)
Q Consensus       345 L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~yLH~----------------------------------------------  378 (586)
                      +.+....          ...++.++++.|.-||+                                              
T Consensus        93 ~~~~~~~----------~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (255)
T d1nd4a_          93 LLSSHLA----------PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF  162 (255)
T ss_dssp             TTTSCCC----------HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred             ccccccc----------HHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence            6442100          01112223333333331                                              


Q ss_pred             ---------ccCCcEEeCCCCCCCeeecCCCCeEEccccceee
Q 007869          379 ---------EWEQVVIHRDVKASNVLLDGELNGRLGDFGLARL  412 (586)
Q Consensus       379 ---------~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~  412 (586)
                               .....++|+|+.|.|||++++..+-|+||+.+..
T Consensus       163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence                     1123489999999999999876678999987754

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.61  E-value=0.00011  Score=74.21  Aligned_cols=78  Identities=10%  Similarity=0.076  Sum_probs=48.2

Q ss_pred             ceeEeecCceEEEEEEeCCCCeEEEEEEecccc-------chhHHHHHHHHHHhccc-CC--CceeeeeeeeeccCeEEE
Q 007869          266 KELLGTGGFGRVYRGTLPKSQIEIAVKKISHES-------RQGMKEFVAEIVSIGRL-RH--RNLVQLLGYCRRKGELLL  335 (586)
Q Consensus       266 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-------~~~~~~~~~Ei~~l~~l-~H--~niv~l~~~~~~~~~~~l  335 (586)
                      .+.||.|....||+.....++..++||.-....       .........|.+.|+.+ .+  ..+++++.+.  ....++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEE
Confidence            345899999999999987777789999754321       11223345677777655 22  3455666554  344578


Q ss_pred             EEecCCCCCh
Q 007869          336 VYDYMPNGSL  345 (586)
Q Consensus       336 V~E~~~~gsL  345 (586)
                      |||++++..+
T Consensus       109 vmE~L~~~~~  118 (392)
T d2pula1         109 VMEDLSHLKI  118 (392)
T ss_dssp             EECCCTTSEE
T ss_pred             EEeccCCccc
Confidence            9999976543

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.90  E-value=0.00083  Score=65.73  Aligned_cols=135  Identities=17%  Similarity=0.181  Sum_probs=76.5

Q ss_pred             ceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCCCce-----eeeee--eeeccCeEEEEEecCCCCChh
Q 007869          274 FGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNL-----VQLLG--YCRRKGELLLVYDYMPNGSLD  346 (586)
Q Consensus       274 ~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~ni-----v~l~~--~~~~~~~~~lV~E~~~~gsL~  346 (586)
                      --.||++... +|..+++|..+.. ....+++..|...+..|....+     +..-+  .....+..+.++++++|..+.
T Consensus        35 EN~vy~v~~~-dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~  112 (325)
T d1zyla1          35 ENRVYQFQDE-DRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFE  112 (325)
T ss_dssp             SSEEEEECCT-TCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECC
T ss_pred             cceeEEEEcC-CCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCC
Confidence            3589999885 4667999998654 2334667778887777743222     12111  234456788999998765432


Q ss_pred             h----hh----------hc----C---CCccchhH----------------------HHHHHHHHHHHHHHHh-hcccCC
Q 007869          347 K----YL----------YD----Q---PKVTLNWI----------------------QRFRVIKGVALGLFYL-HQEWEQ  382 (586)
Q Consensus       347 ~----~l----------~~----~---~~~~l~~~----------------------~~~~i~~~ia~~L~yL-H~~~~~  382 (586)
                      .    .+          +.    .   .+..+++.                      .....+.++...+.-+ .+....
T Consensus       113 ~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~  192 (325)
T d1zyla1         113 ADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTV  192 (325)
T ss_dssp             SSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCC
T ss_pred             CCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCc
Confidence            1    11          00    0   00111111                      1111222222222221 222346


Q ss_pred             cEEeCCCCCCCeeecCCCCeEEccccceee
Q 007869          383 VVIHRDVKASNVLLDGELNGRLGDFGLARL  412 (586)
Q Consensus       383 ~ivHrDIkp~NIll~~~~~~kL~DFGla~~  412 (586)
                      ++||+|+.+.|||++++  ..++||+-|..
T Consensus       193 ~liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         193 LRLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             EECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             eeecCCCCcccEEEeCC--ceEEechhccc
Confidence            79999999999999754  56899998764

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.90  E-value=0.0018  Score=65.11  Aligned_cols=75  Identities=19%  Similarity=0.233  Sum_probs=49.7

Q ss_pred             ceeEeecCceEEEEEEeCC-------CCeEEEEEEeccccchhHHHHHHHHHHhcccCCCce-eeeeeeeeccCeEEEEE
Q 007869          266 KELLGTGGFGRVYRGTLPK-------SQIEIAVKKISHESRQGMKEFVAEIVSIGRLRHRNL-VQLLGYCRRKGELLLVY  337 (586)
Q Consensus       266 ~~~LG~G~~g~Vy~~~~~~-------~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H~ni-v~l~~~~~~~~~~~lV~  337 (586)
                      .+.|+.|-.-.+|++....       ....|.+++.. .. .......+|..+++.+.-.++ .++++++..    .+|+
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~-~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~  120 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NP-ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  120 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Cc-chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence            3568888889999998753       23456666654 22 223445678888888743344 467777753    6899


Q ss_pred             ecCCCCChh
Q 007869          338 DYMPNGSLD  346 (586)
Q Consensus       338 E~~~~gsL~  346 (586)
                      ||+++..|.
T Consensus       121 efi~g~~l~  129 (395)
T d1nw1a_         121 EYIPSRPLS  129 (395)
T ss_dssp             CCCCEEECC
T ss_pred             EEeccccCC
Confidence            999876553

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=95.78  E-value=0.045  Score=52.29  Aligned_cols=157  Identities=13%  Similarity=0.009  Sum_probs=80.7

Q ss_pred             chhhhhhhcCCccccee-----EeecCceEEEEEEeCCCCeEEEEEEeccccchhHHHHHHHHHHhcccCC-----Ccee
Q 007869          252 RYKDLYIATKGFREKEL-----LGTGGFGRVYRGTLPKSQIEIAVKKISHESRQGMKEFVAEIVSIGRLRH-----RNLV  321 (586)
Q Consensus       252 ~~~el~~a~~~f~~~~~-----LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~Ei~~l~~l~H-----~niv  321 (586)
                      +-+|+...-++|...++     |..|---+.|+....+ + .+++|+.....  ..++...|++.+..|..     |..+
T Consensus         4 s~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~-g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi   79 (316)
T d2ppqa1           4 TEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTK-D-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL   79 (316)
T ss_dssp             CHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESS-C-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECC-C-cEEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccc
Confidence            44555555666655433     4456667889988754 3 48899886432  12344556666666633     2222


Q ss_pred             eeee---eeeccCeEEEEEecCCCCChhhhh--------------hc---C---C--C-ccchhH---------------
Q 007869          322 QLLG---YCRRKGELLLVYDYMPNGSLDKYL--------------YD---Q---P--K-VTLNWI---------------  360 (586)
Q Consensus       322 ~l~~---~~~~~~~~~lV~E~~~~gsL~~~l--------------~~---~---~--~-~~l~~~---------------  360 (586)
                      ...+   +....+....++.+..+......-              +.   .   .  . ....|.               
T Consensus        80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (316)
T d2ppqa1          80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  159 (316)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence            2111   122344566677776654332110              00   0   0  0 000000               


Q ss_pred             -HHHHHHHHHHHHHHHhhc-ccCCcEEeCCCCCCCeeecCCCCeEEccccceee
Q 007869          361 -QRFRVIKGVALGLFYLHQ-EWEQVVIHRDVKASNVLLDGELNGRLGDFGLARL  412 (586)
Q Consensus       361 -~~~~i~~~ia~~L~yLH~-~~~~~ivHrDIkp~NIll~~~~~~kL~DFGla~~  412 (586)
                       .....+..+...+.-.+. ....++||+|+.+.||+++++...-|.||+.+..
T Consensus       160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence             111122222222222221 2357899999999999999887778999998763